The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether

Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether

Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether is an organic compoumd with a complex molecular structure.
It has applications in various chemical processes and research areas.
PubCompare.ai's AI-powered platform can help researchers optimize their work with this compound by identifying the most effective protocols from published literature, preprints, and patents.
Our platform uses advanced comparisons to streamlie your research and achive better results.

Most cited protocols related to «Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether»

EXAMPLE 1

Synthesis of [4-(Biphenyl-4 ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid (compound 1)
[Figure (not displayed)]
Step 1. Preparation of 5-Methoxy-2-methyl-phenol (compound 1A)
[Figure (not displayed)]
2-Hydroxy-4-methoxy-benzaldehyde (3 g, 19.7 mmol), ammonium formate (6.2 g, 99 mmol) and palladium/carbon (900 mg @10%) were added to 26 ml glacial acetic acid and heated at 110° C. for 1 h. The reaction was cooled, filtered, and diluted with water (100 ml). The crude product was extracted with chloroform (3×50 ml), washed with water, brine, and dried over anhydrous sodium sulfate. The resulting solution was concentrated and used for the next step without further purification. MS m/z 139 (M+1).
Step 2. Preparation of 5-Methoxy-2-methyl-4-thiocyanato-phenol (compound 1B)
[Figure (not displayed)]
The product from Example 1A (3.5 g, 25 mmol), sodium thiocyanate (6.48 g, 80 mmol), and sodium bromide (2.6 g, 25 mmol) were dissolved in 30 ml anhydrous methanol. Bromine (4.4 g, 28 mmol) was added drop wise over 15 minutes and allowed to stir at ambient temperature for 1 h. Brine was added (50 ml) and the crude product was extracted into ethyl acetate (3×100 ml). The combined organic extracts were washed with brine, dried over anhydrous sodium sulfate, decanted, and concentrated to afford the title product in good purity. 400 MHz 1H NMR (DMSO-d6) δ 10.13 (s, 1H), 7.25 (s, 1H), 6.54 (s, 1H), 3.77 (s, 3H), 2.0 (s, 3H); MS m/z 196 (M+1).
Step 3. Preparation of (5-Methoxy-2-methyl-4-thiocyanato-phenoxy)-acetic acid methyl ester (compound 1C)
[Figure (not displayed)]
The product from Example 1B (620 mg, 3.2 mmol), methyl bromoacetate (854 mg, 3.5 mmol), and cesium carbonate (3.1 g, 9.6 mmol) were stirred in 10 ml anhydrous acetonitrile at ambient temperature for 1 h. The reaction was filtered through Celite®, concentrated, and purified using normal phase chromatography. 400 MHz 1H NMR (DMSO-d6) δ 7.33 (s, 1H), 6.72 (s, 1H), 4.93 (s, 2H), 3.84 (s, 3H), 3.66 (s, 3H), 2.09 (s, 3H); MS m/z 268 (M+1).
Step 4. Preparation of (4Mercapto-5-methoxy-2-methyl-phenoxy)-acetic acid methyl ester (compound 1D)
[Figure (not displayed)]
The product from Example 1C (1.1 g, 4.1 mmol) and dithiothreitol (824 mg, 5.4 mmol) were dissolved in 20 ml methanol with 2.5 ml water. The solution was refluxed for 4 h, cooled, concentrated, and purified by normal phase chromatography. 400 MHz 1H NMR (DMSO-d6) δ 7.02 (s, 1H), 6.54 (s, 1H), 4.79 (s, 2H), 4.41 (s, 1H), 3.72 (s, 3H), 3.64 (s, 3H), 2.02 (s, 3H); MS m/z 243 (M+1).
Step 5. Preparation of 4-Bromomethyl-biphenyl (compound 1E)
[Figure (not displayed)]
Biphenyl-4-yl-methanol (500 mg, 2.72 mmol) phosphorus tribromide (809 mg, 2.99 mmol), and lithium bromide (260 mg, 2.99 mmol) were dissolved in 10 ml DMF and stirred at ambient temperature for 1 h. Water (10 ml) was added and the crude product was extracted into dichloromethane, dried over anhydrous sodium sulfate, filtered through silica gel, and concentrated. MS m/z 167 (M+1-Br).
Step 6. Preparation of [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid methyl ester (compound 1F)
[Figure (not displayed)]
The product from Example 1D (100 mg, 0.38 mmol), the product from Example 1E (92 mg, 0.38 mmol) and cesium carbonate (250 mg, 0.76 mmol) were added to 5 ml acetonitrile and stirred at ambient temperature for 4 hr. The reaction was filtered through Celite®, concentrated and purified through normal phase chromatography. MS m/z 409 (M+1).
Step 7. Preparation of [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid (compound 1)
The product from Example 1F (101 mg) was dissolved in 10 ml THF/water solution (10:1). Lithium hydroxide monohydrate (300 mg) was added and stirred for 30 minutes. 2 Normal aqueous HCl was added to pH<5 and then washed with ethyl acetate. The organic extract was dried over anhydrous sodium sulfate, decanted, and concentrated. The title product was recrystallized from chloroform/hexanes. mp 60-62° C.; 400 MHz 1H NMR (DMSO-d6) δ 12.94 (br(s), 1H), 7.58 (d, 2H, J=8 Hz), 7.52 (d, 2H, J=8 Hz), 7.39 (t, 2H, J=7.2 Hz), 7.30 (m, 3H), 7.02 (s, 1H), 6.52 (s, 1H), 4.69 (s, 2H), 4.01 (s, 2H), 3.73 (s, 3H), 2.01 (s, 3H). MS m/z 393 (M−1). Anal. Calc'd for C32H22O4S.3H2O C, 69.05; H, 5.07; found: C, 69.04; H, 5.35.

EXAMPLE 2

Synthesis of [4-Biphenyl-4-ylmethylsulfanyl)-2-methyl-phenoxy]-acetic acid (compound 2)
[Figure (not displayed)]
Step 1. Preparation of 2-Methyl-4-thiocyanato-phenol (compound 2A)
[Figure (not displayed)]
The title compound was prepared in a manner analogous to Example 1B from 2-methylphenol. 400 MHz 1H NMR (DMSO-d6) δ 10.09 (s, 1H), 7.36 (s, 1H), 7.30 (d, 1H, J=8.1 Hz), 6.83 (d, 1H, J=8.1 Hz), 2.08 (s, 3H); MS m/z 166 (M+1).
Step 2. Preparation of (2-Methyl-4-thiocyanato-phenoxy)-acetic acid methyl ester (compound 2B)
[Figure (not displayed)]
The title compound was prepared from 2 Example 2A in a manner analogous to Example 1C. 400 MHz 1H NMR (DMSO-d6) δ 7.46 (s, 1H), 6.95 (d, 1H, J=8.5 Hz), 6.80 (d, 1H, J=8.5 Hz), 4.86 (s, 2H), 3.65 (s, 3H), 2.17 (s, 3H); MS m/z 238 (M+1).
Step 3. Preparation of (4-Mercapto-2-methyl-phenoxy)-acetic acid methyl ester (compound 2C)
[Figure (not displayed)]
The title compound was prepared from (2-methyl-4-thiocyanato-phenoxy)-acetic acid methyl ester in a manner analogous to Example 1D. 400 MHz 1H NMR (DMSO-d6) δ 7.05 (s, 1H), 7.00 (d, 1H, J=10.3 Hz), 6.70 (d, 1H, J=10.3 Hz), 5.00 (s, 1H), 4.73 (s, 1H), 3.63 (s, 3H), 2.09 (s, 3H); MS m/z 213 (M+1).
Step 4. Preparation of [4-(Biphenyl-4-ylmethylsulfanyl)-2-methyl-phenoxy]-acetic acid methyl ester (compound 2D)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 2C and 1E. MS m/z 379 (M+1).
Step 5. Preparation of [4-(Biphenyl-4ylmethylsulfanyl)-2-methyl-phenoxy]-acetic acid (compound 2)
The title compound was prepared in the manner analogous to Example 1. mp 138° C.; 400 MHz 1H NMR (DMSO-d6) δ 7.59 (d, 2H, J=9.5 Hz); 7.53 (d, 2H, J=9.5 Hz), 7.40 (m, 2H), 7.31(m, 3H), 7.14 (d, 1H, J=1.7 Hz), 7.09 (d, 1H, J=10.7 Hz), 6.70 (d, 1H, J=10.7 Hz), 4.62 (s, 2H), 4.11 (s, 2H), 2.09 (s, 3H); MS m/z 363 (M−1).

EXAMPLE 3

Synthesis of [2-Methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 3)
[Figure (not displayed)]
Step 1. Preparation of (4′-Trifluoromethyl-biphenyl-4-yl)-methanol (compound 3A)
[Figure (not displayed)]
1-Bromo-4-trifluoromethyl-benzene (814 mg, 3.62 mmol), 4-hydroxymethylphenylboronic acid (600 mg, 3.98 mmol), cesium carbonate (2.36 g, 7.24 mmol), and PdCl2(dppf) (132 mg, 0.181 mmol) were added to 10 ml of a 1:1 solution of DMF/THF. The reaction was flushed with nitrogen and heated to 90° C. for 1 h. The reaction was cooled, poured into diethyl ether and washed with water (2×50 ml), brine (1×50 ml) and dried over anhydrous sodium sulfate. The crude product was filtered through silica gel, eluted: with diethyl ether, and concentrated to provide the title compound. MS m/z 251 (M−1).
Step 2. Preparation of 4-Chloromethyl-4′-trifluoromethyl-biphenyl (compound 3B)
[Figure (not displayed)]
The product from Example 3A was dissolved in 10 ml methylene chloride. Triethylarnine (468 mg, 4.62 mol) and methanesulfonyl chloride (422 mg, 3.68 mmol) were then added and stirred for 18 h. The reaction was poured into water and extracted with methylene chloride. The organic solution was dried over anhydrous sodium sulfate, decanted and concentrated to provide the title compound that was used without further purification. MS m/z 235 (M-Cl+1).
Step 3. Preparation of [2-Methyl-4(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 3C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 3B and 2C. MS m/z 447 (M+1).
Step 4. Preparation of [2-Methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 3)
The title compound was prepared in the manner analogous to Example 1 using 3C. mp 140-141° C.; 400 MHz 1H NMR (DMSO-d6) δ 12.95 (br(s), 1H), 7.82 (d, 2H, J=8.4 Hz), 7.74 (d, 2H, J=8.4 Hz), 7.61 (d, 2H, J=8.4 Hz), 7.35 (d, 2H, J=8.4 Hz), 7.10 (m, 2H), 6.70 (d, 1H, J=8.4 Hz), 4.62 (s, 2H), 4.13 (s, 2H), 2.08 (s, 3H); MS m/z 431 (M−1). Anal. Calc'd for C23H19F3O3S.0.7 H2O C, 62.07; H, 4.62; found: C, 61.98; H, 4.22.

EXAMPLE 4

Synthesis of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 4)
[Figure (not displayed)]
Step 1. Preparation of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 4A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 1D and 3B. MS m/z 477 (M+1).
Step 2. Preparation of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 4)
The title compound was prepared in the manner analogous to Example 1 using 4A. mp 170-171° C.; 400 MHz 1H NMR (DMSO-d6) δ 7.81 (d, 2H, J=8 Hz), 7.60 (d, 2H, J 8.4 Hz), 7.32 (d, 2H, J=8.4 Hz), 7.02 (s, 1H), 6.52 (s, 1H), 4.70 (s, 2H), 4.03 (s, 2H), 3.73 (s, 3H), 2.00 (s, 3H). MS m/z 463 (M+1). Anal. Calc'd for C24H21F3NO4S.0.1 H2O C, 62.09; H, 4.60; found: C, 62.00; H, 4.36.

EXAMPLE 5

Synthesis of [5-Methoxy-2-methyl-4-(2′,4′,6′-trimethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 5)
[Figure (not displayed)]
Step 1. Preparation of [5-Methoxy-2-methyl-4-(2′,4′,6′-trimethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 5A)
[Figure (not displayed)]
2-Bromo-1,3,5-trimethyl-benzene (396 mg, 2mmol), 4-hydroxymethylphenylboronic acid (334 mg, 2.2 mmol), cesium carbonate (1.3 g, 4 mmol), and PdCl2(dppf) (82 mg, 0.1 mmol) were added to 5 ml of a 1:1 solution of DMF/THF. The reaction was flushed with nitrogen and heated to 90° C. for 1 h. The reaction was cooled, poured into diethyl ether and washed with water (2×10 ml), brine (1×10 ml) and dried over anhydrous sodium sulfate. The organic solution was filtered through silica gel, eluted with diethyl ether, and concentrated. The crude product was dissolved in 10 ml dichloromethane. Added to this solution were triethylamine (202 mg, 2 mmol) then methanesulfonyl chloride (184 mg, 1.6 mmol) and allowed to stir at ambient temperature for 18 h. The reaction was poured into water and extracted with methylene chloride. The organic solution was dried over anhydrous sodium sulfate, decanted and concentrated to provide the crude alkyl chloride. The product from Example 1D (387 mg, 1.6 mmol), the crude 4′-chloromethyl-2,4,6-trimethyl-biphenyl, and cesium carbonate (1 g, 3.06 mmol) were stirred in 10 ml acetonitrile for 3 h, filtered, concentrated, and purified by normal phase chromatography to afford the title product. MS m/z 451 (M+1).
Step 2. Preparation of [5-Methoxy-2-methyl-4-(2′,4′,6′-trimethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid
The title compound was prepared in the manner analogous to Example 1 using 5A. mp 141° C.; 400 MHz 1H NMR (DMSO-d6) δ 12.81 (br(s), 1H), 7.04 (d, 2H, J=8.4 Hz), 6.77 (m, 3H), 6.69 (s, 2H), 6.36 (s, 1H), 4.43 (s, 2H), 3.82 (s, 2H), 3.58 (s, 3H), 2.03 (s, 3H), 1.82 (s, 3H), 1.67 (s, 6H). MS m/z 437 (M+1).

EXAMPLE 6

Synthesis of [4-(4′-Chloro-3′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-2-methyl-phenoxy]-acetic acid (compound 6)
[Figure (not displayed)]
Step 1. Preparation of (4′-Chloro-3′-trifluoromethyl-biphenyl-4-yl)-methanol (compound 6A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3A using 4-bromo-1-chloro-2-trifluoromethyl-benzene. MS m/z 288 (M+1).

    • Step 2. Preparation of 4-Chloro-4′-chloromethyl-3′-trifluoromethyl-biphenyl (compound 6B)
      [Figure (not displayed)]
      The title compound was prepared in the manner analogous to Example 3B using 6A. MS m/z 305 (M).
      Step 3. Preparation of [4-(4′-Chloro-3′-trifluoromethyl-biphenyl-4ylmethylsulfanyl)-2-methyl-phenoxy]-acetic acid methyl ester (compound 6C)
      [Figure (not displayed)]
      The title compound was prepared in the manner analogous to Example 1F using 2C and 6B. MS m/z 481 (M+1).
      Step 4. Preparation of [4-(4′-Chloro-3′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-2-methyl-phenoxy]-acetic acid (compound 6)
      The title compound was prepared in the manner analogous to Example 1 using 6C. 400 MHz 1H NMR (DMSO-d6) δ 7.97 (s, 1H), 7.92 (d, 1H, J=10.5 Hz), 7.74 (d, 1H, J=10.5 Hz), 7.64 (d, 2H, J=8.9 Hz), 7.34 (d, 2H, J=8.9 Hz), 7.14 (s, 1H), 7.08 (d, 1H, J=11.0 Hz), 6.70 (d, 1H, J=11.0 Hz), 4.62 (s, 2H), 4.12 (s, 2H), 2.08 (s, 3H); MS m/z 465 (M−1).

EXAMPLE 7

Synthesis of [4-(2′,4′-Dichloro-biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxyl-acetic acid (compound 7)
[Figure (not displayed)]
Step 1. Preparation of [4(2′,4′-Dichloro-biphenyl-4ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid methyl ester (compound 7A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 5A using 1D and 1-bromo-2,4-dichloro-benzene. MS m/z 479 (M+2).
Step 2. Preparation of [4-(2′,4′-Dichloro-biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid (compound 7)
The title compound was prepared in the manner analogous to Example 1 using 7A. 400 MHz 1H NMR (DMSO-d6) δ 12.95 (br(s, 1H), 7.67 (dd, 1H, J′=2 Hz, J=8.4 Hz), 7.43 (d, 1H, J=2.4 Hz), 7.37 (s, 1H), 7.28 (s, 4H), 7.02 (s, 1H), 6.52 (s, 1H), 4.70 (s, 2H), 4.02 (s, 2H), 3.72 (s, 3H), 2.01 (s, 3H); MS m/z 465 (M+2).

EXAMPLE 8

Synthesis of [4-(3′,4′-Dichloro-biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid (compound 8)
[Figure (not displayed)]
Step 1. Preparation of [4-(3′,4′-Dichloro-biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid methyl ester (compound 8A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 5A using 1D and 4-bromo-1,2-dichloro-benzene. MS m/z 479 (M+2).
Step 2. Preparation of [4-(3′,4′-Dichloro-biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid (compound 8)
The title compound was prepared in the manner analogous to Example 1 using 8A. mp 161-162° C.; 400 MHz 1H NMR (DMSO-d6) δ 7.87 (d, 1H, J=2 Hz), 7.57-7.66 (m, 4H), 7.29 (d, 2H, J=8.4 Hz), 7.01 (s, 1H),6.52. (s, 1H), 4.69 (s, 2H), 4.02 (s, 2H), 3.72 (s, 3H), 2.03 (s, 3H); MS m/z 494 (M+1).

EXAMPLE 9

Synthesis of [5-Methoxy-2-methyl-4-(3′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 9)
[Figure (not displayed)]
Step 1. Preparation of [5-Methoxy-2-methyl-4-(3′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 9A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 5A using 1D and 1-bromo-3-trifluoromethyl-benzene. MS m/z 477 (M+1).
Step 2. Preparation of [5-Methoxy-2-methyl-4-(3′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 9)
The title compound was prepared in the manner analogous to Example 1 using 9A. mp 138-139° C.; 400 MHz 1H NMR (DMSO-d6) δ 12.95 (br(s), 1H), 7.91 (m, 2), 7.63 (m, 4H), 7.32 (d, 2H, J=8.4 Hz), 7.02 (s, 1H), 6.52 (s, 1H), 4.69 (s, 2H), 4.03 (s, 2H), 3.73 (s, 3H), 2.06 (s, 3H); MS m/z 463 (M+1).

EXAMPLE 10

Synthesis of [4-(4′-Fluoro-biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid (compound 10)
[Figure (not displayed)]
Step 1. Preparation of (4′-Fluoro-biphenyl-4-yl)-methanol (compound 10A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3A using 1-bromo-4-fluorobenzene. MS m/z 185 (M-H2O).
Step 2. Preparation of 4-Chloromethyl-4′-fluoro-biphenyl (compound 10B).
[Figure (not displayed)]

The title compound was prepared in the manner analogous to Example 3B using 10A. MS m/z 222 (M+2).

Step 3. Preparation of [4(4′-Fluoro-biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid methyl ester (compound 10C)
[Figure (not displayed)]

The title compound was prepared in the manner analogous to Example 1F using 10B and 1D. MS m/z 427 (M+1).

Step 4. Preparation of [4-(4′-Fluoro-biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid

The title compound was prepared in the manner analogous to Example 1 using 10C. 400 MHz 1H NMR (DMSO-d6) δ 12.93 (br(s), 1H), 7.62 (m, 2H), 7.49 (d, 2H, J=8.4 Hz), 7.27 (d, 2H, J=8.4 Hz), 7.22 (m, 2H), 7.02 (s, 1H), 6.52 (s, 1H), 4.69 (s, 2H), 4.01 (s, 2H), 3.73 (s, 3H), 2.01 (s, 3H). MS m/z 411 (M−1).

EXAMPLE 11

Synthesis of [5-Methoxy-2-methyl-4-(3′-trifluoromethoxy-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 11)
[Figure (not displayed)]
Step 1. Preparation of [5-Methoxy-2-methyl-4(3′-trifluoromethoxy-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 11A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 5A using 1D and 1-bromo-3-trifluoromethoxy-benzene. MS m/z 493 (M+1).
Step 2. Preparation of [5-Methoxy-2-methyl-4-(3′-trifluoromethoxy-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 11)
The title compound was prepared in the manner analogous to Example 1 using 11A. mp 137° C.; 400 m/z 1H NMR (DMSO-d6) δ 12.95 (br(s), 1H), 7.66 (d, 1H, J=8.8 Hz), 7.56 (m, 4H), 7.30 (m, 3H), 7.02 (s, 1H), 6.52 (s, 1H), 4.69 (s, 2H), 4.02 (s, 2H), 3.73 (s, 3H), 2.01 (s, 3H). MS m/z 493 (M+1).

EXAMPLE 12

Synthesis of [7-(4′-Trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid (compound 12)
[Figure (not displayed)]
Step 1. Preparation of Indan-4-ol (compound 12A)
[Figure (not displayed)]
A mixture of 4-hydroxy-indan-1-one (5.0 g, 33.7 mmol), sodium cyanoborohydride (6.4 g, 101.1 mmol), and zinc iodide (32.3 g, 101.1 mmol) in dichloroethane, was heated at reflux for two hours. The reaction mixture was then filtered through 50 g SiO2 while still warm, eluting further with dichloroethane. The filtrate was collected and concentrated under vacuum. The residue was added to diethyl ether and the resulting white precipitate was filtered off. The filtrate was collected and concentrated in vacuo to give 4.2 g of the title, compound with purity high enough for subsequent use. 400 MHz 1H NMR (DMSO-d6) δ 9.06 (s, 1H), 6.86 (t, 1H, J=7.8 Hz), 6.59 (d, 1H, J=7.8 Hz), 6.48 (d, 1H, J=7.8 Hz), 2.75 (t, 2H, J=7.3 Hz), 2.67 (t, 2H, J=7.3 Hz), 1.92 (m, 2H).
Step 2. Preparation of 7-Thiocyanato-indan-4-ol (compound 12B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1B using 12A. MS m/z 192 (M+1).
Step 3. Preparation of (7-Mercapto-indan-4-yloxy)-acetic acid methyl ester (compound 12C)
[Figure (not displayed)]
7-Thiocyanato-indan-4ol (Example 12B) ( 1.47 g, 7.7 mmol), cesium carbonate (3.77 g, 11.6 mmol) and methyl bromoacetate (1.24 g, 8.08 mmol) were stirred in 20 ml acetonitrile at ambient temperature for 4 h. The reaction was filtered and concentrated. The crude product was treated under the conditions of Example 1D to afford the title product. MS m/z 239 (M+1).
Step 4. Preparation of [7-(4′-Trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid methyl ester (compound 12D)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 3B. MS m/z 473 (M+1).
Step 5. Preparation of 17-(4′-Trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid (compound 12)
The title compound was prepared in the manner analogous to Example 1 using 12D. mp 158-159° C.; 400 MHz 1H NMR (DMSO-d6) δ 12.94 (br(s), 1H), 7.82 (d, 2H, J=8 Hz), 7.74 (d, 2H, J=8.8 Hz), 7.60 (d, 2H, J=6.4 Hz), 7.31 (d, 2H, J=8 Hz), 7.08 (d, 1H, J=8.8 Hz), 6.58 (d, 1H, J=8.4 Hz), 4.61 (s, 2H), 4.06 (s, 2H), 2.72 (m, 4H), 1.90 (q, 2H); MS m/z 457 (M−1).

EXAMPLE 13

Synthesis of [4-(4-Benzyloxy-benzylsulfanyl)-2-methyl-phenoxy]-acetic acid (compound 13)
[Figure (not displayed)]
Step 1. Preparation of [4-(4Benzyloxy-benzylsulfanyl)-2-methyl-phenoxy]-acetic acid methyl ester (compound 13A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 1-chloromethyl-4-benzyloxy-benzene and 2C. MS m/z 409 (M+1).
Step 2. Preparation of [4-(4-Benzyloxy-benzylsulfanyl)-2-methyl-phenoxy]-acetic acid (compound 13)
The title compound was prepared in the manner analogous to Example 1 and 13A. mp 120-121° C.; 400 MHz 1H NMR (DMSO-d6) δ 7.39-7.25 (m, 5H), 7.15-7.03 (m, 4), 6.85 (d, 2H, J=8.5 Hz), 6.68 (d, 1H, J 8.4 Hz), 5.00 (s, 2H), 4.62 (s, 2H), 4.00 (s, 2H), 2.08 (s, 3H); MS m/z 395 (M+1).

EXAMPLE 14

Synthesis of {5-Methoxy-2-methyl-4-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid (compound 14)
[Figure (not displayed)]
Step 1. Preparation of [4-(4-Trifluoromethyl-benzyloxy)-phenyl]-methanol (compound 14A)
[Figure (not displayed)]
4-Hydroxymethyl-phenol (1 g, 8.06 mmol), 1-Chloromethyl-4-trifluoromethyl-benzene (1.57 g, 8.06 mmol), and cesium carbonate (5.26 g, 16.12 mmol) were refluxed in acetonitrile for 20 h, cooled, filtered, and concentrated to give the title compound. MS m/z 265 (M-H2O+1).
Step 2. Preparation of 4-Chloromethyl-(4-trifluoromethyl-benzyloxy-benzene) (compound 14B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 14A. MS m/z 265 (M-Cl+1).
Step 3. Preparation of {5-Methoxy-2-methyl-4-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 14C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 14B and 1D. MS m/z 507 (M+1).
Step 4. Preparation of {5-Methoxy-2-methyl-4-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid (compound 14)
The title compound was prepared in the manner analogous to Example 1 using 14C. mp 145° C.; 400 MHz 1H NMR (DMSO-d6) δ 12.94 (br(s), 1H), 7.70 (d, 2H, J=8 Hz), 7.76 (d, 2H, J=8 Hz), 7.14 (d, 2H, J=8.8 Hz), 6.97 (s, 1H), 6.87 (m, 2H), 6.50 (s, 1H), 5.14 (s, 2H), 4.68 (s, 2H), 3.91 (s, 2H), 3.71 (s, 3H), 2.00 (s, 3H); MS m/z 491 (M−1).

EXAMPLE 15

Synthesis of {2-Methyl-4-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid (compound 15)
[Figure (not displayed)]
Step 1. Preparation of {2-Methyl-4-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 15A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 2C and 14B. MS m/z 477 (M+1).
Step 2. Preparation of {2-Methyl-4-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid (compound 15)
The title compound was prepared in the manner analogous to Example 1 using 15A. mp 133° C.; 400 MHz 1H NMR (DMSO-d6) δ 7.70 (d, 2H, J=8 Hz), 7.76 (d, 2H, J=8 Hz), 7.14 (d, 2H, J=8.8 Hz), 7.09 (m, 1H), 7.04 (dd, 1H, J=2.4 Hz, J′=8.4 Hz), 6.87 (m, 2H), 6.68 (d, 1H, J=8.4 Hz), 5.14 (s, 2H), 4.61 (s, 2H), 3.99 (s, 2H), 2.08 (s, 3H); MS m/z 461 (M−1).

EXAMPLE 16

Synthesis of [5-Methoxy-2-methyl-4-(3′-trifluoromethoxy-biphenyl-3-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 16)
[Figure (not displayed)]
Step 1. Preparation of (3′-Trifluoromethoxy-biphenyl-3-yl)-methanol (compound 16A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3A using 3-hydroxymethylphenylboronic acid and 1-bromo-3-trifluoromethoxy-benzene. MS m/z 251 (M−1).
Step 2. Preparation of 3-Chloromethyl-3′-trifluoromethoxy-biphenyl (compound 16B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 16A. MS m/z 251 (M−1).
Step 2. Preparation of [5-Methoxy-2-methyl-4-(3′-trifluoromethoxy-biphenyl-3-ylmethylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 16C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 16B and 1D. MS m/z 491 (M−1).
Step 4. Preparation of [5-Methoxy-2-methyl-4-(3′-trifluoromethoxy-biphenyl-3-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 16)
The title compound was prepared in the manner analogous to Example 1 using 16C. mp 92-94° C.; 400 MHz 1H NMR (DMSO-d6) δ 12.96 (br(s), 1H), 7.55-7.24 (m, 8H), 7.01 (s, 1H), 6.52 (s, 1H), 4.68 (s, 2H), 4.03 (s, 2H), 3.72 (s, 3H), 1.99 (s, 3H); MS m/z 479 (M+1).

EXAMPLE 17

Synthesis of [4-(9H-Fluoren-2-ylmethylsulfanyl-2-methyl-phenoxy]-acetic acid (compound 17)
[Figure (not displayed)]
Step 1. Preparation of (9H-Fluoren-2-yl)-methanol (compound 17A)
[Figure (not displayed)]
9H-Fluorene-2-carbaldehyde (500 mg, 2.6 mmol) was dissolved in 10 ml methanol. Sodium borohydride (200 mg, 5.2 mmol) was added and allowed to stir at ambient temperature for 1 h. Water (10 ml) was added and the crude product was extracted into ethyl acetate (50 ml), washed with brine (50 ml), dried over anhydrous sodium sulfate, decanted and concentrated to afford the title product in good purity. MS m/z 195 (M+1).
Step 2. Preparation of 2-Chloromethyl-9H-fluorene (compound 17B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 17A. MS m/z 179 (M-Cl+1).
Step 3. Preparation of [4-(9H-Fluoren-2-ylmethylsulfanyl-2-methyl-phenoxy]-acetic acid methyl ester (compound 17C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 17B and 2C. MS m/z 422 (M+1).
Step 4. Preparation of [4-(9H-Fluoren-2-ylmethylsulfanyl-2-methyl-phenoxy]-acetic acid (compound 17)
The title compound was prepared in the manner analogous to Example 1 using 17C. 400 MHz 1H NMR (DMSO-d6) δ 12.93 (br(s), 1H), 7.80 (d, 1H, J=7.6 Hz), 7.23 (d, 1H, J=8 Hz), 7.5 (d, 1H, J=7.6 Hz), 7.43 (s, 1H), 7.31 (t, 1H, J′=6.4 Hz), 7.24 (m, 2H), 7.15 (m, 1H), 7.08 (dd, 1H, J=2.4 Hz, J=8.4 Hz), 6.7 (d, 1H, J=8.8 Hz), 4.62 (s, 2H), 4.13 (s, 2H), 3.82 (s, 2H), 2.09 (s, 3H). MS m/z 375 (M−1). Anal. Calc'd for C23H20O3S.0.3 H2O C, 72.34; H, 5.44; found: C, 72.46; H, 5.20.

EXAMPLE 18

Synthesis of {{5-Methoxy-2-methyl-4-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-phenoxy}-acetic acid (compound 18)
[Figure (not displayed)]
Preparation of [4-(5-Trifluoromethyl-pyridin-2-yl)-phenyl]-methanol (compound 18A)
[Figure (not displayed)]
The title compound was prepared from 2-Chloro-5-trifluoromethyl-pyridine and 4-(hydroxymethyl)boronic acid PdCl2(dppb) catalyst in the manner analogous to Example 3A. 400 MHz 1H NMR (DMSO-d6) δ 8.98 (s, 1H), 8.2 (dd, 1H, J=2.4 Hz, J′=8.4 Hz), 8.09 (m, 3H), 7.42 (d, 2H, J=8.54 Hz), 5.23 (t, 1H), 4.54 (d, 2H, J=6 Hz); MS m/z 254 (M+1).
Preparation of 2-(4-Chloromethyl-phenyl) 5-trifluoromethyl-pyridine (compound 18B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 18A. MS m/z 272 (M+1).
Preparation of {5-Methoxy-2-methyl-4-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 18C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 1D and 18B. MS m/z 478 (M+1).
Preparation of {5-Methoxy-2-methyl-4-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-phenoxy}-acetic acid (compound 18)
The title compound was prepared from the product of Example 18C in the manner analogous to Example 1. mp 225° C. (dec.); 400 MHz 1H NMR (DMSO-d6) δ 8.97 (s, 1H), 8.2 (dd, 1H, J=2.4 Hz, J′=8.4 Hz), 8.13 (m, 1H), 8.01 (d, 2H, J=8.4 Hz), 7.34 (s, 2H, J=8.4 Hz), 6.95 (s, 1H), 6.42 (s, 1H), 4.23 (s, 2H), 4.01 (s, 2H), 3.69 (s, 3H), 1.96 (s, 3H) MS m/z 464 (M+1).

EXAMPLE 19

Synthesis of 45-Methoxy-2-methyl-4-[6-(4-trifluoromethyl-phenyl)-pyridin-3-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 19)
[Figure (not displayed)]
Step 1. Preparation of [4-(6-Chloro-pyridin-3-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid methyl ester (compound 19A)
[Figure (not displayed)]
The title compound was prepared from 2-Chloro-5-chloromethyl-pyridine and 1D in a manner analogous to Example 1F. MS m/z 370 (M+2).
Step 2. Preparation of {5-Methoxy-2-methyl-4-[6-(4-trifluoromethyl-phenyl)-pyridin-3-ylmethylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 19B)
[Figure (not displayed)]
The title compound was prepared from the product of Example 19A and 1-bromo-4-trifluoromethyl-benzene in a manner analogous to Example 3A. MS m/z 478 (M+1).
Step 3. Preparation of {5-Methoxy-2-methyl-4-[6-(4-trifluoromethyl-phenyl)-pyridin-3-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 19)
The title compound was prepared from the product of Example 19B in the manner analogous to Example 1. mp 203° C. (dec.); 400 MHz 1H NMR (DMSO-d6) δ 8.34 (d, 1H, J=1.6 Hz), 8.21 (d, 2H, J=8 Hz), 7.92 (d, 1H, J=8.4 Hz), 7.77 (d, 2H, J=8.4 Hz), 7.65 (dd 1H, J′=2.4 Hz, J=8.4 Hz), 6.93 (s, 1H), 6.39 (s, 1H), 4.15 (s, 2H), 4.00 (s, 2H), 3.66 (s, 3H), 1.95 (s, 3H). MS m/z 464 (M+1).

EXAMPLE 20

Synthesis of [5-Chloro-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 20)
[Figure (not displayed)]
Step 1. Preparation of 5-Chloro-2-methyl-4-thiocyanato-phenol (compound 20A)
[Figure (not displayed)]
The title compound was prepared in a manner analogous to Example 1B from 5-chloro-2-methyl-phenol. 400 MHz 1H NMR (DMSO-d6) δ 10.60 (s, 1H), 7.54 (s, 1H), 6.98 (s, 1H), 2.07 (s, 3H).
Step 2. Preparation of (5-Chloro-2-methyl-4-thiocyanato-phenoxy)-acetic acid methyl ester(compound 20B)
[Figure (not displayed)]
The title compound was prepared from the product of Example 20A in a manner analogous to Example 1C. 400 MHz 1H NMR (DMSO-d6) δ 7.62 (s, 1H), 7.40 (s, 1H), 4.94 (s, 2H), 3.65 (s, 3H), 2.15 (s, 3H).
Step 3. Preparation of (5-Chloro-4-mercapto-2-methyl-phenoxy)-acetic acid methyl ester (compound 20C)
[Figure (not displayed)]
The title compound was prepared from (5-chloro-2-methyl-4-thiocyanato-phenoxy)-acetic acid methyl ester in a manner analogous to Example 1D. 400 MHz 1H NMR (DMSO-d6) δ 7.27 (s, 1H), 6.97 (s, 1H), 5.31 (s, 1H), 4.79 (s, 2H), 3.64 (s, 3H), 2.07 (s, 3H).
Step 4. Preparation of [5-Chloro-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)phenoxy]-acetic acid methyl ester (compound 20D)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 3B and 20C. 400 MHz 1H NMR (DMSO-d6) δ 7.82 (d, 2H, J=8.3 Hz), 7.74 (d, 2H, J=8.3 Hz), 7.62 (d, 2H, J=8.3 Hz), 7.39 (d, 2H, J=8.3 Hz), 7.27 (s, 1H), 7.00 (s, 1H), 4.82 (s, 2H), 4.20 (s, 2H), 3.64 (s, 3H), 2.09 (s, 3H); MS m/z 480 (M+).
Step 5. Preparation of [5-Chloro-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 20)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1 using 20D. mp 161-162° C.; 400 MHz 1H NMR (DMSO-d6) δ 7.83 (d, 2H, J=8.3 Hz), 7.74 (d, 2H, J=8.3 Hz), 7.62 (d, 2H, J=8.3 Hz), 7.51 (d, 2H, J=8.3 Hz), .7.26 (s, 1H), 6.95 (s, 1H), 4.69 (s, 2H), 4.20 (s, 2H), 2.08 (s, 3H); MS m/z 467 (M+1).

EXAMPLE 21

Synthesis of [3-Methoxy-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 21)
[Figure (not displayed)]
Step 1. Preparation of 3-Methoxy-4-thiocyanato-phenol (compound 21A)
[Figure (not displayed)]
The title compound was prepared in a manner analogous to Example 1B from 3-methoxy-phenol. 400 MHz 1H NMR (DMSO-d6) δ 10.21 (s, 1H), 7.34 (d, 1H, J=8.3 Hz), 6.53 (s, 1H), 6.43 (d, 1H, J=8.3 Hz), 3.81 (s, 3H).
Step 2. Preparation of (3-Methoxy-4-thiocyanato-phenoxy)-acetic acid methyl ester (compound 21B)
[Figure (not displayed)]
The title compound was prepared from the product of Example 21A in a manner analogous to Example 1C. MS m/z 227 (M-CN).
Step 4. Preparation of (4-Mercapto-3-methoxy-phenoxy)-acetic acid methyl ester (compound 21C)
[Figure (not displayed)]
The title compound was prepared from (3-Methoxy-4-thiocyanato-phenoxy)-acetic acid methyl ester in a manner analogous to Example 1D. 400 MHz 1H NMR (DMSO-d6) δ 7.13 (d, 1H, J=8.5 Hz), 6.56 (s, 1H), 6.39 (d, 1H, J=8.5 Hz), 4.72 (s, 2H), 4.51 (s, 1H), 3.75 (s, 3H), 3.64 (s, 3H).
Step 5. Preparation of [3-Methoxy-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 21D)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 3B and 21C. 400 MHz 1H NMR (DMSO-d6) δ 7.81 (d, 2H, J=8.3 Hz), 7.53 (d, 2H, J=8.3 Hz), 7.59 (d, 2H, J=8.3 Hz), 7.32 (d, 2H, J=8.3 Hz), 7.11 (d, 1H, J=8.5 Hz), 6.56 (s, 1H), 6.37 (d, 1H, J=8.5 Hz), 4.73 (s, 2H), 4.04 (s, 2H), 3.76 (s, 3H), 3.63 (s, 3H); MS m/z 463 (M+1).
Step 6. Preparation of [3-Methoxy-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 21)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1 using 21D. 400 MHz 1H NMR (DMSO-d6) δ 7.83 (d, 2H, J=8.3 Hz), 7.76 (d, 2H, J=8.3 Hz), 7.61 (d, 2H, J=8.3 Hz), 7.34.(d, 2H, J=8.3 Hz), 7.13 (d, 1H, J=8.5 Hz), 6.56 (s, 1H), 6.39 (d, 1H, J=8.5 Hz), 4.63 (s, 2H), 4.06 (s, 2H), 3.77 (s, 3H); MS m/z 449 (M+1). Anal. Calc'd for C23H19F3O4S, C, 61.60; H, 4.27; found: C, 61.35; H, 4.25.

EXAMPLE 22

Synthesis of {2-Methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-ethylsulfanyl]-phenoxy}-acetic acid (compound 22)
[Figure (not displayed)]
Step 1. Preparation of 2-(4′-Trifluoromethyl-biphenyl-4-yl)-ethanol (compound 22A)
[Figure (not displayed)]
A mixture of 2-(4-bromo-phenyl)-ethanol (2.3 ml, 3.3 g, 16.4 mmol), 4-trifluoromethylphenylboronic acid (5.0 g, 26.3 mmol), 1.0 M aqueous sodium carbonate solution (44.0 ml), and tetrakis(triphenylphosphine)palladium (0.98 g, 0.85 mmol) in 180 ml of ethanol and 180 ml of toluene was heated at reflux for 4 h. The cooled reaction mixture was diluted with 500 ml of ethyl acetate and filtered through a bed of Celite filter-aid. The filtrate was washed with 5% aqueous sodium carbonate solution (2×750 ml) and brine (3×750 ml), then dried over anhydrous sodium sulfate and concentrated. The crude product was purified by normal phase chromatography. MS m/z 266 (M).
Step 2. Preparation of 4-(2-Bromo-ethyl)-4′-trifluoromethyl-biphenyl (compound 22B)
[Figure (not displayed)]
A solution of 2-(4′-trifluoromethyl-biphenyl-4-yl)-ethanol (2.8 g, 10.3 mmol) and carbon tetrabromide (3.8 g, 11.5 mmol) in 50 ml of dichloromethane was cooled in ice, and triphenylphosphine (2.9 g, 11.1 mmol) was added in portions over 10 minutes. The mixture was stirred at room temperature for 18 h, and the solvent was evaporated. The residue was stirred in 75 ml of ether, and the mixture was filtered. The insoluble material was washed on the funnel with fresh ether (3×75 ml). The combined ether filtrates were concentrated, and the crude product was purified by normal phase chromatography. MS m/z 328 (M−1).
Step 3. Preparation of {2-Methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-ethylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 22C)
[Figure (not displayed)]
A solution 4-(2-bromo-ethyl)-4′-trifluoromethyl-biphenyl (0.66 g, 2.0 mmol) and (4-mercapto-2-methyl-phenoxy)-acetic acid methyl ester (0.42 g, 2.0 mmol) in 10 ml of acetonitrile was treated with cesium carbonate (1.3 g, 4.0 mmol), and the mixture was stirred at room temperature for 18 h. The reaction mixture was added to 200 ml of brine and extracted with ethyl acetate (4×75 ml). The combined extracts were washed with brine (2×200 ml), then dried over anhydrous sodium sulfate and concentrated. The crude product was purified by normal phase chromatography. MS m/z 461 (M+1).
Step 4. Preparation of {2-Methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-ethylsulfanyl]-phenoxy}acetic acid (compound 22)
A solution of {2-methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-ethylsulfanyl]-phenoxy}-acetic acid methyl ester (0.78 g, 1.7 mmol) in 10 ml of tetrahydrofuran and 2.0 ml of water was treated with lithium hydroxide monohydrate (0.21 g, 5.0 mmol), and the mixture was stirred at room temperature for 2 h. The reaction mixture was diluted with 5.0 ml of water and made strongly acidic by the addition of 4.0 N hydrochloric acid. The mixture was extracted with ethyl acetate (4×30 ml), and the combined extracts were washed with brine (2×50 ml), then dried over anhydrous sodium sulfate and concentrated. The crude product was recrystallized from ethyl acetate/hexane. mp 132-134° C.; IR (thin film) cm−1: 1741, 1709, 1490, 1326, 1239, 1110; 400 MHz 1H NMR (DMSO-6) δ 7.82 (d, 2H, J=8.0 Hz), 7.74 (d, 2H, J=8.0 Hz), 7.61 (d, 2H, J=8.3 Hz), 7.31 (d, 2H, J=8.3 Hz), 7.15 (m, 2H), 6.75 (d, 1H, J=8.3 Hz), 4.64 (s, 2H), 3.11 (t, 2H, J=7.6 Hz), 2.82 (t, 2H, J=7.6 Hz), 2.12 (s, 3H); MS m/z 447 (M+1). Anal. Calc'd for C24H21F3O3S: C, 64.56; H, 4.74; found: C, 64.45; H, 4.58.

EXAMPLE 23

Synthesis of {5-Methoxy-2-methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-ethylsulfanyl]-phenoxy}-acetic acid (compound 23)
[Figure (not displayed)]
Step 1. Preparation of {5-Methoxy-2-methyl-4-[2-(4-trifluoromethyl-biphenyl-4-yl)-ethylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 23A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 22C using 4-(2-bromo-ethyl)-4′-trifluoromethyl-biphenyl and 1D. MS m/z 491 (M+1).
Step 2. Preparation of {5-Methoxy-2-methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-ethylsulfanyl]-phenoxy}-acetic acid (compound 23)
The title compound was prepared in the manner analogous to Example 1 using {5-methoxy-2-methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-ethylsulfanyl]-phenoxy}-acetic acid methyl ester. mp 169-171° C.; IR (thin film) cm−1: 1718, 1500, 1330, 1162, 1109, 1052; 400 MHz 1H NMR (DMSO-d6) δ 7.82 (d, 2H, J=8.3 Hz), 7.74 (d, 2H, J=8.6 Hz), 7.61 (d, 2H, J=8.3 Hz), 7.31 (d, 2H, J=8.3 Hz), 7.06 (s, 1H), 6.53 (s, 1H), 4.69 (s, 2H), 3.73 (s, 3H), 3.02 (t, 2H, J=7.5 Hz), 2.78 (t, 2H, J=7.5 Hz), 2.06 (s, 3H); MS m/z 477 (M+1). Anal. Calc'd for C25H23F3O4S: C, 63.02; H, 4.87; found: C, 62.77; H, 4.62.

EXAMPLE 24

Synthesis of {2-Methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-vinyl]-phenoxy}-acetic acid (compound 24)
[Figure (not displayed)]
Step 1. Preparation of (4-Bromo-2-methyl-phenoxy)-acelic acid methyl ester (compound 24A)
[Figure (not displayed)]
A solution of o-tolyloxy-acetic acid methyl ester (Belleney J., et al., J. Heterocyclic Chem., 1984; 21:1431; 3.7 g, 20.5 mmol) in 70 ml of acetonitrile was treated in portions over 10 minutes with N-bromosuccinimide (3.8 g, 21.3 mmol). The mixture was stirred at room temperature for 18 h, and the solvent was evaporated. The residue was stirred in 75 ml of carbon tetrachloride, and the mixture was filtered. The insoluble material was washed on the funnel with fresh carbon tetrachloride (2×50 ml). The combined filtrates were concentrated, and the crude product was purified by normal phase chromatography. MS m/z 258 (M−1).
Step 2. Preparation of 4-Trifluoromethyl-4′-vinyl-biphenyl (compound 24B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3A using 1-bromo-4-vinyl-benzene and 4-trifluoromethylphenylboronic acid. MS m/z 248 (M).
Step 3. Preparation of {2-Methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-vinyl]-phenoxy}-acetic acid methyl ester and {2-methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-vinyl]-phenoxy}-acetic acid (compound 24)
A mixture of 4-trifluoromethyl-4′-vinyl-biphenyl (1.9 g, 7.7 mmol), (4-Bromo-2-methyl-phenoxy)-acetic acid methyl ester (2.0 g, 7.7 mmol), anhydrous sodium acetate (1.2 g, 14.6 mmol), N,N-dimethylglycine (0.23 g, 2.2 mmol), and palladium acetate (0.025 g, 0.11 mmol) in 10 ml of 1-methyl-pyrrolidin-2-one was heated at 130° C. for 10 h. The reaction mixture was partitioned between 250 ml of brine and 300 ml of ethyl acetate. The total mixture was filtered through a bed of Celite filter-aid. The organic layer was washed with 5% aqueous sodium carbonate solution (3×250 ml) and brine (2×250 ml), then dried over anhydrous sodium sulfate and concentrated. The residue was purified by normal phase chromatography to give {2-methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-vinyl]-phenoxy}-acetic acid methyl ester; MS m/z 427 (M+1).

During the above sodium carbonate washings, a precipitate formed and was removed by filtration. The solid was stirred for 18 h in a solution of 150 ml of water, 50 ml of methanol, and 50 ml of 4.0 N hydrochloric acid. The acidified product was filtered and recrystallized from aqueous acetonitrile to give {2-methyl-4-[2-(4′-trifluoromethyl-biphenyl-4-yl)-vinyl]-phenoxy}-acetic acid. mp 243-245° C.; IR (thin film) cm−1: 1746, 1717, 1502, 1323, 1125, 1069; 400 MHz 1H NMR (DMSO-d6) δ 7.88 (d, 2H, J=8.0 Hz), 7.76 (d, 2H, J=8.3 Hz), 7.71 (d, 2H, J=8.5 Hz), 7.64 (d, 2H, J=8.5 Hz), 7.43 (d, 1H, J=1.7 Hz), 7.32 (dd, 1H, J=2.1, 8.5 Hz), 7.21 (d, 1H, J=16.5 Hz), 7.10 (d, 1H, J=16.4 Hz), 6.79 (d, 1H, J=8.5 Hz), 4.68 (s, 2H), 2.18 (s, 3H); MS m/z 413 (M+1). Anal. Calc'd for C24H19F3O3: C, 69.90; H, 4.64; found: C, 69.77; H, 4.57.

EXAMPLE 26

Synthesis of {7-[4-(5-Trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 26)
[Figure (not displayed)]
Step 1. Preparation of {7-[4-(5-Trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 26A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 18B and 12C. MS m/z 474 (M+1).
Step 2. Preparation of {7-[4-(5-Trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 26)
[Figure (not displayed)]
The title compound was prepared from the product of Example 26A in the manner analogous to Example 1. mp 220° C. (dec.); 400 MHz 1H NMR (DMSO-d6) δ 12.94 (s, 1H), 8.97 (s, 1H), 8.2 (dd, 1H, J=2 Hz, J′=8.8 Hz), 8.13 (d, 1H, J=8.4 Hz), 8.01 (d, 2H, J=8.4 Hz), 7.34 (d, 2H, J=8.8 Hz), 7.07 (d, 1H, J=8.4 Hz), 6.57 (d, 1H, J=8 Hz), 4.61 (s, 2), 4.07 (s, 2H), 2.72 (m, 4H), 1.89 (m, 2H). MS m/z 460 (M+1).

EXAMPLE 27

Synthesis of {5-Methyl-7-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 27)
[Figure (not displayed)]
Step 1. Preparation of {5-Methyl-7-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 27A)
[Figure (not displayed)]
The title compound was prepared from the products of Example 18B and (7-mercapto-5-methyl-indan-4-yloxy)-acetic acid methyl ester (prepared in a similar manner as described for Example 12C) in a manner analogous to Example 1F. MS m/z 488 (M+1).
Step 2. Preparation of {5-Methyl-7-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-indan-4yloxy}-acetic acid (compound 27)
[Figure (not displayed)]
The title compound was prepared from the product of Example 27A in the manner analogous to Example 1. mp 186° C. ; 400 MHz 1H NMR (DMSO-d6) δ 12.94 (s, 1H), 8.97 (s, 1H), 8.24 (dd, 1H, J=2 Hz, J′=8.8 Hz), 8.14 (d, 1H, J=8.4 Hz), 8.01 (d, 2H, J=8.4 Hz), 7.34 (d, 2H, J=8.8 Hz), 6.99 (s, 1H), 4.41 (s, 2H), 4.13 (s, 2H), 2.83 (t, 2H, J=7.2 Hz), 2.62 (t, 2H, J=7.2 Hz), 2.13 (s, 3H), 1.87 (m, 2H). MS m/z 474 (M+1).

EXAMPLE 28

Synthesis of [5-Methyl-7-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid (compound 28)
[Figure (not displayed)]
Step 1. Preparation of [5-Methyl-7-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid methyl ester (compound 28A)
[Figure (not displayed)]
The title compound was prepared from the product of Example 3B and (7-Mercapto-5-methyl-indan-4-yloxy)-acetic acid methyl ester in a manner analogous to Example 1F. MS m/z 487 (M+1).
Step 2. Preparation of [5-Methyl-7-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid (compound 28)
[Figure (not displayed)]
The title compound was prepared from the product of Example 28A in the manner analogous to Example 1. mp 177° C.; 400 MHz 1H NMR (DMSO-d6) δ 12.82 (s, 1H), 7.82(d, 2H, J=8 Hz),7.75 (d, J=8 Hz), 7.61 (d, 2H, J=8 Hz), 7.35 (d, 2H, J=8 Hz), 6.99 (s, 1H), 4.41 (s, 2H), 4.12 (s, 2H), 2.83 (t, 2H, J=7.2 Hz), 2.62 (t, 2H, J=7.2 Hz), 2.13 (s, 3H), 1.89 (m, 2H). MS m/z 473 (M+1).

EXAMPLE 29

Synthesis of (4-{4-[2-(3-Fluoro-phenyl)-vinyl]-benzylsulfanyl}-5-methoxy-2-methyl-phenoxy)-acetic acid (compound 29)
[Figure (not displayed)]
Step 1. Preparation of {4-[2-(3-Fluoro-phenyl)-vinyl]-phenyl}-methanol (compound 29A)
[Figure (not displayed)]
(4-Bromo-phenyl)-methanol (1 g, 5.35 mmol), 3-fluorostyrene (718 mg, 5.89 mmol), palladium acetate (60 mg, 0.3 mmol), and triphenylphosphine (140 mg, 0.6 mmol) were heated in triethylamine at 90° C. in a sealed tube for 18 h. The reaction was concentrated and purified by normal phase chromatography to afford the title compound. MS m/z 227 (M−1).
Step 2. Preparation of {4-[2-(3-Fluoro-phenyl)-vinyl]-phenyl}-chloromethane (compound 29B)
[Figure (not displayed)]
The title compound was prepared from the product of Example 29A in a manner analogous to Example 3B. MS m/z 245 (M−1).
Step 3. Preparation of (4-{4-[2-(3-Fluoro-phenyl)-vinyl]-benzylsulfanyl}-5-methoxy-2-methyl-phenoxy)-acetic acid methyl ester (compound 29C)
[Figure (not displayed)]
The title compound was prepared from the product of Example 29B and the product of Example 1D in a manner analogous to Example 1F. MS m/z 453 (M+1).
Step 4. Preparation of (4-{4-[2-(3-Fluoro-phenyl)-vinyl]-benzylsulfanyl}-5-methoxy-2-methyl-phenoxy)-acetic acid (compound 29)
[Figure (not displayed)]
The title compound was prepared from the product of Example 29C in the manner analogous to Example 1. mp 154° C. (dec.); 400 MHz 1H NMR (DMSO-d6) δ 12.94 (s, 1H), 7.46-7.34 (m, 5H), 7.27-7.15 (m, 4H), 7.06-6.99 (m, 2H), 6.52 (s, 1H), 4.69 (s, 2H), 3.98 (s, 2H), 3.73 (s, 3H), 2.00 (s, 3H), MS m/z 439 (M+1).

EXAMPLE 30

Synthesis of {2-Methyl-4-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-phenoxy}-acetic acid (compound 30)
[Figure (not displayed)]
Step 1. Preparation of {2-Methyl-4-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 30A)
[Figure (not displayed)]
The title compound was prepared from the product of Example 2C and the product of Example 18B in a manner analogous to Example 1F. MS m/z 448 (M+1).
Preparation of {2-Methyl-4-[4-(5-trifluoromethyl-pyridin-2-y)-benzylsulfanyl]-phenoxy}-acetic acid
[Figure (not displayed)]
The title compound was prepared from the product of Example 30A in the manner analogous to Example 1. 400 MHz 1H NMR (DMSO-d6) δ 8.97 (s, 1H), 8.2 (dd, 1H, J=2 Hz, J′=8.8 Hz), 8.13 (d, 1H, J=8.4 Hz), 8.01 (d, 2H, J=8.4 Hz), 7.36 (d, 2H, J=8.4 Hz), 7.07 (s, 1H), 7.01 (dd, 1H, J=8.4 Hz, J′=2.4 Hz), 6.57 (d, 1H, J=8.8 Hz), 4.09 (s, 2H), 4.06 (s, 2H), 2.04 (s, 3H). MS m/z 434 (M+1).

EXAMPLE 31

Synthesis of {4-[4-(2,4-Difluoro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 31)
[Figure (not displayed)]
Step 1. Preparation of [4-(2,4-Difluoro-benzyloxy)phenyl]-methanol (compound 31A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 14A using 1-bromomethyl-2,4-difluoro-benzene and 4-hydroxymethyl-phenol. MS m/z 233 (M-OH).
Step 2. Preparation of 1-(4-Chloromethyl-phenoxymethyl)-2,4-difluoro-benzene (compound 31B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 31A. MS m/z 233 (M-Cl).
Step 3. Preparation of {4-[4-(2,4-Difluoro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid methyl ester (compound 31C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 31B and 2C. MS m/z 445 (M+1).
Step 4. Preparation of {4-[4-(2,4-Difluoro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid
[Figure (not displayed)]
To a solution of the product from Example 31C (1.5 g, 3.3 mmol) in a mixture of 20 mL of tetrahydrofuran and 4 mL of water was added lithium hydroxide monohydrate (0.42 g, 9.9 mmol). The reaction mixture was stirred at room temperature for 18 hrs and then evaporated to afford a residue, which was suspended in 50 mL of water. The mixture was acidified with 1N hydrochloric acid to pH 2. The precipitated solid was collected be filtration, washed with water, and then dried to provide the title compound without any further purification. mp 139-141° C.; IR (KBr) cm−1: 3081, 2917, 1735, 1604, 1508, 1233; 400 MHz 1H NMR (DMSO-d6): δ 7.51-7.59 (m, 1H), 7.02-7.31 (m, 6H), 6.85-6.92 (m, 2H), 6.68 (d, 1H, J=8.6 Hz), 5.01 (s, 2H), 4.60 (s, 2H), 4.00 (s, 2H), 2.08 (s, 3H); MS m/z 429 (M−1). Anal. Calc'd for C23H20F2O4S: C, 64.17; H, 4.68; found: C, 64.11; H, 4.59.

EXAMPLE 32

Synthesis of {4-[4-(2,4-Dichloro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 32)
[Figure (not displayed)]
Step 1. Preparation of [4-(2,4-Dichloro-benzyloxy)-phenyl]-methanol (compound 32A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 14A using 2,4-dichloro-1-chloromethyl-benzene and 4-hydroxymethyl-phenol. MS m/z 265 (M-OH).
Step 2. Preparation of 2,4-Dichloro-1-(4-chloromethyl-phenoxymethyl)-benzene (compound 32B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 32A. MS m/z 265 (M-Cl).
Step 3. Preparation of {4-[4-(2,4-Dichloro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid methyl ester (compound 32C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 32B and 2C. MS m/z 477 (M+1).
Step 4. Preparation of {4-[4-(2,4-Dichloro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 32)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1 using 32C. mp 143-145° C.; IR (KBr) cm−1: 3062, 2936, 1724, 1492, 1227, 1192; 400 MHz 1H NMR (DMSO-d6): δ 12.97 (br(s), 1H), 7.64 (d, 1H, J=2.0 Hz), 7.54 (d, 1H, J=8.3 Hz), 7.42 (dd, 1H, J=8.3, 2.0 Hz), 7.01-7.20 (m, 4H), 6.84-6.92 (m, 2H), 6.69 (d, 1H, J=8.5 Hz), 5.05 (s, 2H), 4.62 (s, 2H), 4.01 (s, 2H), 2.08 (s, 3H); MS m/z 461 (M−1). Anal. Calc'd for C23H20Cl2O4S: C, 59.62; H, 4.35; found: C, 59.33; H, 4.28.

EXAMPLE 33

Synthesis of {4-[4-(4-Methoxy-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 33)
[Figure (not displayed)]
Step 1. Preparation of [4-(4-Methoxy-benzyloxy)-phenyl]-methanol (compound 33A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 14A using 1-chloromethyl-4-methoxy-benzene and 4-hydroxymethyl-phenol. MS m/z 227 (M-OH).
Step 2. Preparation of 4-Methoxy-1-(4-chloromethyl-phenoxymethyl)-benzene (compound 33B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 33A. MS m/z 227 (M-Cl).
Step 3. Preparation of {4-[4-(4Methoxy-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid methyl ester (compound 33C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 33B and 2C. MS m/z 439 (M+1).
Step 4. Preparation of {4-[4(4-Methoxy-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 33)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1 using 33C. mp 150-152° C.; HPLC: area %=96.69, r.t.=2.93 min., γ=214 nm, mobile phase=acetonitrile/water with 0.10% TFA; IR (KBr) cm−1: 2929, 1728, 1707, 1513, 1491, 1225; 400 MHz 1H NMR (DMSO-d6): δ 12.98 (br(s), 1H), 7.27-7.34 (m, 2H), 7.02-7.16 (m, 4H), 6.81-6.91 (m, 4H), 6.69 (d, 1H, J=8.6 Hz), 4.91 (s, 2H), 4.61 (s, 2H), 3.99 (s, 2H), 3.69 (s, 3H), 2.08 (s, 3H); MS m/z 423 (M−1). Anal. Calc'd for C24H24O5S: C, 67.90; H, 5.70; found: C, 67.48; H, 5.59.

EXAMPLE 34

Synthesis of {4-[4-(4-tert-Butyl-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 34)
[Figure (not displayed)]
Step 1. Preparation of [4-(4-tert-Butyl-benzyloxy)-phenyl]-methanol (compound 34A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 14A using 1-bromomethyl-4-tert-butyl-benzene and 4-hydroxymethyl-phenol. MS m/z 253 (M-OH).
Step 2. Preparation of 4-tert-Butyl-1-(4-chloromethyl-phenoxymethyl)-benzene (compound 34B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 34A. MS m/z 253 (M-Cl).
Step 3. Preparation of {4-[4-(4-tert-Butyl-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid methyl ester (compound 34C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 34B and 2C. MS m/z 465 (M+1).
Step 4. Preparation of {4-[4-(4-tert-Butyl-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 34)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1 using 34C. mp 135-137° C.; IR (KBr) cm−1: 2961, 2908, 1751, 1495, 1233, 1194; 400 MHz 1H NMR (DMSO-d6): δ 13.00 (br(s), 1H), 7.27-7.38 (m, 4H), 7.02-7.17 (m, 4H), 6.82-6.88 (m, 2H), 6.69 (d, 1H, J=8.5 Hz), 4.96 (s, 2H), 4.61 (s, 2H), 3.99 (s, 2H), 2.08 (s, 3H), 1.22 (s, 9H); MS m/z 451 (M+1). Anal. Calc'd for C27H30O4S: C, 71.97; H, 6.71; found: C, 71.66; H, 6.52.

EXAMPLE 35

Synthesis of {2-Methyl-4-[4-(4-trifluoromethoxy-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid (compound 35)
[Figure (not displayed)]
Step 1. Preparation of [4-(4-Acetoxy-benzylsulfanyl)-2-methyl-phenoxy]-acetic acid methyl ester (compound 35A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using acetic acid 4-chloromethyl-phenyl ester and 2C. MS m/z 361 (M+1).
Step 2. Preparation of [4-(4Hydroxy-benzylsulfanyl)-2-methyl-phenoxy]-acetic acid (compound 35B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1 using 35A. MS m/z 303 (M−1).
Step 3. Preparation of [4-(4-Hydroxy-benzylsulfanyl)-2-methyl-phenoxy]-acetic acid methyl ester (compound 35C)
[Figure (not displayed)]
To a solution of the product from Example 35B (0.43 g, 1.4 mmol) in 14 mL of 2,2-dimethoxy propane was added 1.4 mL of concentrated hydrochloric acid. The reaction mixture was stirred at room temperature for 18 hours. The mixture was concentrated and purified by flash chromatography to provide the title compound. MS m/z 317 (M−1).
Step 4. Preparation of {2-Methyl-4-[4(4-trifluoromethoxy-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 35D)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 1-bromomethyl-4-trifluoromethoxy-benzene and 35C. MS m/z 493 (M+1).
Step 5. Preparation of {2-Methyl-4-[4-(4-trifluoromethoxy-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid (compound 35)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1 using 35D. mp 141-142° C.; 400 MHz 1H NMR (DMSO-d4): δ 12.96 (br(s), 1H), 7.46-7.57 (m, 2H), 7.28-7.38 (m, 2H), 7.00-7.20 (m, 4H), 6.82-6.91 (m, 2H), 6.69 (d, 1H, J=8.6 Hz), 5.05 (s, 2H), 4.62 (s, 2H), 4.00 (s, 2H), 2.08 (s, 3H); MS m/z 477 (M−1). Anal. Calc'd for C24H21F3O5S: C, 60.25; H, 4.42; found: C, 59.92; H, 4.07.

EXAMPLE 36

Synthesis of {6-Methyl-8-[4-(5-trifluoromethyl-pyridine-2-yl)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 36)
[Figure (not displayed)]
Step 1. {6-Methyl-8-[4-(5-trifluoromethyl-pyridine-2-yl)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid methyl ester (compound 36A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using (8-mercapto-6-methyl-chroman-5-yloxy)-acetic acid methyl ester and 18B. MS m/z 504 (M+1).
Step 2. {6-Methyl-8-[4-(5-trifluoromethyl-pyridine-2-yl)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid methyl ester (compound 36)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1 using 36A. mp 156-157° C.; IR (KBr) cm−1: 2928, 1731, 1710, 1603, 1329, 1113, 1082; 400 MHz 1H NMR (DMSO-d6): δ 12.84 (br(s), 1H), 8.97 (s, 1H), 8.22 (dd, 1H, J=8.4, 2.0 Hz), 8.12 (d, 1H, J=8.4 Hz), 8.04 (d, 2H, J=8.2 Hz), 7.42 (d, 2H, J=8.2 Hz), 6.88 (s, 1H), 4.29 (s, 2H), 4.05-4.14 (m, 4H), 2.64 (t, 2H, J=6.3 Hz), 2.04 (s, 3H), 1.81 (pentet, 2H) ; MS m/z 490 (M+1). Anal. Calc'd for C25H22F3NO4S: C, 61.34; H, 4.53; N, 2.86; found: C, 60.96; H, 4.48; N, 2.79.

EXAMPLE 37

Synthesis of {5-Chloro-2-methyl-4-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-phenoxy}-acetic acid (compound 37)
[Figure (not displayed)]
Step 1. Preparation of {5-Chloro-2-methyl-4-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 37A)
[Figure (not displayed)]
Compound 37A was prepared in the manner analogous to Example 1F using the products from Example 18B and Example 20C. MS m/z 482 (M+).
Step 2. Preparation of {5-chloro-2-methyl-4-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-phenoxy}-acetic acid (compound 37)
The title compound was prepared in the manner analogous to Example 1 using 37A. IR cm−1:1708, 1122; 400 MHz 1H NMR (DMSO-d6) δ 8.97 (s, 1H), 8.22 (d, 1H, J=8.3 Hz), 8.12 (d, 1H, J=8.3 Hz), 8.04 (d, 2H, J=8.3 Hz), 7.43 (d, 2H, J=8.3 Hz), 7.25 (s, 1H), 6.94 (s, 1H), 4.70 (s, 2H), 4.21 (s, 2H), 2.06 (s, 3H). Anal. Calc'd for C22H17ClF3NO3S: C, 56.47, H, 3.66, N 2.99; found: C, 56.48, H, 3.28, N 3.04.

EXAMPLE 38

Synthesis of [5-hydroxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxyl-acetic acid (compound 38)
[Figure (not displayed)]

A solution of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid, prepared according to Example 4,(1.0 g, 2.2 mmol) in 75 mL DCM at 0° C., was treated with dropwise addition of BBr3 (5.5 mL of a 1.0 M solution in DCM). After 30 minutes, the reaction was carefully quenched with 50% NH4OH. The reaction was then acidified to pH 1 with conc. HCl, and extracted with EtOAC. The organic layer was dried (Na2SO4) and concentrated in vacuo. The crude reaction mixture was then taken up in MeOH, followed by addition of 50 μL H2SO4, and then refluxing for 3 hours. The reaction was then diluted with EtOAc, washed 1×50 mL water, dried (Na2SO4), and the reaction concentrated in vacuo. The resulting ester was purified by recrystallization from EtOAC/Hexanes. The ester was then saponified in the same manner as described for Example 1, to give the title compound in 37% overall yield. IR cm−1:3408, 1752, 1323; 400 MHz 1H NMR (DMSO-d6) δ 9.56 (s, 1H), 7.82 (d, 2H, J=8.4 Hz), 7.74 (d, 2H, J=8.4 Hz), 7.31 (d, 2H, J=8.4 Hz), 6.92 (s, 1H), 6.30 (s, 1H), 4.55 (s, 2H), 4.00 (s, 2H), 1.95 (s, 3H). Anal. Calc'd for C23H19F3NO4S.0.1 H2O C, 61.35; H, 4.30; found: C, 61.08; H, 3.92.

EXAMPLE 39

Synthesis of [5-Methoxy-2-methyl-4(3-methyl-4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 39)
[Figure (not displayed)]
Step 1. Preparation of (3-Methyl-4′-trifluoromethyl-biphenyl-4-yl)-methanol (compound 39A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3A using (4-bromo-2-methyl-phenyl)-methanol and 4-(trifluoromethyl)benzeneboronic acid. MS m/z 249 (M-OH).
Step 2. Preparation of 4chloromethyl-3-methyl-4′-trifluoromethyl-biphenyl (compound 39B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 39A. 400 MHz 1H NMR (DMSO-d6) δ 7.84 (d, 2H, J=8.3 Hz), 7.76 (d, 2H, J=8.3 Hz), 7.57 (s, 1H), 7.48 (m, 2H), 4.80 (s, 2H), 2.41 (s, 3H).
Step 3. Preparation of [5-Methoxy-2-methyl-4-(3-methyl-4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 39C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 1D and39B. MS m/z491 (M+1).
Step 4. Preparation of [5-Methoxy-2-methyl-4-(methyl-4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 39)
The title compound was prepared in the manner analogous to Example 1 using 39C. IR cm−1:1740, 1322; 400 MHz 1H NMR (DMSO-d6) δ 7.81 (d, 2H, J=8.1 Hz), 7.73 (d, 2H, J=8.1 Hz), 7.51 (s, 1H), 7.39 (d, 1H, J=7.8 Hz), 7.16 (d, 1H, J=7.8 Hz), 7.04 (s, 1H), 6.53 (s, 1H), 4.71 (s, 2H), 4.00 (s, 2H), 3.73 (s, 3H), 2.39 (s, 3H), 2.02 (s, 3H); MS m/z 477 (M+1). Anal. Calc'd for C25H23F3O4S.0.1 H2O; C, 62.78; H, 4.89; found: C, 62.57; H, 4.82.

EXAMPLE 40

Synthesis of {7-[4-(4-trifluoromethyl-benzyl)-benzylsulfanyl]-indan-4yloxy}-acetic acid (compound 40)
[Figure (not displayed)]
Step 1. Preparation of 4-(4-trifluoromethyl-benzyl)-benzoic acid methyl ester (compound 40A)
[Figure (not displayed)]
A solution of 1-bromo-4-trifluoromethyl-benzene (10.0 g, 44.4 mmol) in THF at −78° C. was treated with dropwise addition of n-butyl lithium (33.3 mL of a 1.6 M solution in hexanes). After 20 minutes, 4-formyl-benzoic acid methyl ester in 50 mL THF was added. The reaction was allowed to come to room temperature and after 1 H, quenched with sat. NH4Cl. The reaction was then concentrated in vacuo, taken up in EtOAc, and washed with 2 M HCl (1×100 mL), brine (1×100 mL), dried (Na2SO4) and the solvent removed in vacuo to give the alcohol intermediate. Purification by flash column chromatography (gradient elution: 5% EtOAc/hexane to 40% EtOAc/hexane) gave 6.2 g of the alcohol intermediate. 4.0 g (12.9 mmol) of the intermediate was then hydrogenated in EtOAc using 0.5 g of 10% Pd(OH)2/C as catalyst. Filtration through Celite® , and concentration in vacuo gave the title compound (3.60 g, 95%). MS m/z 295 (M+1).
Step 2. Preparation of [4-(4-trifluoromethyl-benzyl)-phenyl]-methanol (compound 40B)
[Figure (not displayed)]
A solution of 40A (3.6 g, 12.2 mmol) in 75 mL THF at room temperature was treated portionwise with lithium aluminum hydride (0.97 g, 25.6 mmol). After 1 hour, the reaction mixture was carefully quenched with sat. NH4Cl. The reaction mixture was then extracted with EtOAc, and the organic layer washed with 2 M HCl (1×50 mL), brine (1×50 mL), dried (Na2SO4) and the solvent removed in vacuo. Purification by flash column chromatography (gradient elution: 5% EtOAc/hexane to 40% EtOAc/hexane) gave the title compound (2.8 g, 86%). MS m/z 265 (M−1).
Step 3. Preparation of Chloro-[4-(4-trifluoromethyl-benzyl)-phenyl]-methane (compound 40C)
[Figure (not displayed)]
The title compound was prepared in a similar manner as described for 3B using 40B and thionyl chloride. 400 MHz 1H NMR (DMSO-d6) 7.59 (d, 2H, J=8.4 Hz), 7.40 (d, 2H, J=8.4 Hz), 7.31 (d, 2H, J=8.4 Hz), 7.20 (d, 2H, J=8.4 Hz), 4.67 (s, 2H), 3.99 (s, 2H).
Step 4. Preparation of {7-[4-(4-Trifluoromethyl-benzyl)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 40D)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using the products from Example 12C and Example 40C. MS m/z 487 (M+1).
Step 5. Preparation of {7-[4-(4-trifluoromethyl-benzyl)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 40)
The title compound was prepared in the manner analogous to Example 1 using 40D. IR cm−1: 1745, 1704,1325; 400 MHz 1H NMR (DMSO-d6) δ 7.58 (d, 2H, J=8.1 Hz), 7.37 (d, 2H, J=8.1 Hz), 7.09 (s, 2H), 7.05 (d, 2H, J=8.3 Hz), 6.55 (d, 1H, J=8.3 Hz), 4.60 (s, 2H), 3.94 (s, 4H), 2.71 (t, 2H, J=8.3 Hz), 2.58 (t, 2H, J=8.3 Hz), 1.81 (m, 2H); MS m/z 473 (M+1). Anal. Calc'd for C26H23F3O3S.0.1 H2O, C, 65.84; H, 4.93; found: C, 65.58; H, 4.96.

EXAMPLE 41

Synthesis of {4-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-5-methoxy-2-methyl-phenoxy}-acetic acid (compound 41)
[Figure (not displayed)]
Step 1. Preparation of {4-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-5-methoxy-2-methyl-phenoxy}-acetic acid methyl ester (compound 41A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 1D and 3-chloromethyl-5-(4-chloro-phenyl)-isoxazole. MS m/z 434 (M+1).
Step 2. Preparation of {4-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-5-methoxy-2-methyl-phenoxy}-acetic acid (compound 41)
The title compound was prepared in the manner analogous to Example 1 using 41A. IR cm−1:1747, 1432; 400 MHz 1H NMR (DMSO-d6) δ 7.81 (d, 2H, J=8.8 Hz), 7.53 (d, 2H, J=8.8 Hz), 7.05 (s, 1H), 6.92 (s, 1H), 6.52 (s, 1H), 4.69 (s, 2H), 4.01 (s, 2H), 3.71 (s, 3H), 2.00 (s, 3H); MS m/z 420 (M+1). Anal. Calc'd for C20H18ClNO5S, C 57.21; H, 4.32 N, 3.34; found: C, 56.84; H, 4.62, N, 2.96.

EXAMPLE 42

Synthesis of {2-Methyl-4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 42)
[Figure (not displayed)]
Step 1. Preparation of 5-(4-Trifluoromethyl-phenyl)-isoxazole-3-carboxylic acid ethyl ester (compound 42A)
[Figure (not displayed)]
Sodium hydride (1.6 g, 63.7 mmol, 95%) was added to a solution of 1(4-trifluoromethyl-phenyl)-ethanone (10.0 g, 53.1 mmol) and oxalic acid diethyl ester (8.7 mL, 63.7 mmol) in 75 mL dry DMF at 0° C. The reaction was allowed to come to room temperature and then heated to 45° C. for 45 minutes. The reaction was then cooled, concentrated in vacuo, and the residue taken up in EtOAc. The organic layer was then washed with 2 M HCl (1×100 mL), dried (Na2SO4) and the solvent removed in vacuo. Purification by flash column chromatography (gradient elution: 5% EtOAc/hexane to 55% EtOAc/hexane) gave the intermediate 2,4-dioxo-4-(4-trifluoromethyl-phenyl)-butyric acid ethyl ester (12.2 g, 80%) which was then taken up in EtOH and refluxed in the presence of hydroxyl amine hydrochloride (10.2 g, 132.3 mmol) for 3H. The reaction was then cooled, diluted with EtOAc, washed with dilute NaHCO3, brine, dried (Na2SO4), and concentrated in vacuo. Recrystallization from EtOAc/hexane gave 5.2 g of the title compound. MS m/z 286 (M+1).
Step 2. Preparation of [5-(4-Trifluoromethyl-phenyl)-isoxazol-3-yl]-methanol (compound 42B)
[Figure (not displayed)]
The title compound was prepared in a manner analogous to Example 40B using 42A. MS m/z 244 (M+1).
Step 3. Preparation of 3-chloromethyl-5-(4-trifluoromethyl-phenyl)-isoxazole (compound 42C)
[Figure (not displayed)]
The title compound was prepared in a manner analogous to Example 3B using 42B. MS m/z 262 (M+1).
Step 4. Preparation of {2-methyl-4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 42
[Figure (not displayed)]
The title compound was prepared in a manner analogous to Example 1F using 42C and 2C. MS m/z 438 (M+1).
Step 5. Preparation of {2Methyl-4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 42)
The title compound was prepared in a manner analogous to Example 1 using 42D. IR cm−1:1746, 1326; 400 MHz 1H NMR (DMSO-d6) δ 12.97 (br(s), 1H), 8.02 (d, 2H, J=8.0 Hz), 7.83 (d, 2H, J=8.0 Hz), 7.20 (s, 1H), 7.15 (s, 2H), 6.71 (d, 1H, J=8.5 Hz), 4.63 (s, 2H), 4.14 (s, 2H), 2.08 (s, 3H); MS m/z 424 (M+1). Anal. Calc'd for C20H16F3NO4S C, 56.73; H, 3.81; N, 3.31 found: C, 56.59; H, 3.58; N, 3.22.

EXAMPLE 43

Synthesis of {5-Methoxy-2methyl-4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 43)
[Figure (not displayed)]
Step 1. Preparation of {5-Methoxy-2-methyl-4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 43A)
[Figure (not displayed)]
The title compound was prepared in a manner analogous to Example 1F using 42C and 1D. MS n/z 468 (M+1).
Step 2. Preparation of {5-Methoxy-2-methyl-4-15-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 43)
The title compound was prepared in a manner analogous to Example 1 using 43A. IR cm−1: 1745, 1322; 400 MHz 1H NMR (DMSO-d6) δ 12.96 (br(s), 1H), 8.01 (d, 2H, J=8.3 Hz), 7.83 (d, 2H, J=8.3 Hz), 7.07 (s, 2H), 6.52 (s, 1H), 4.70 (s, 2H), 4.03 (s, 2H), 3.71 (s, 3H), 1.99 (s, 3H); MS m/z 454 (M+1). Anal. Calc'd for C21H18F3NO5S. 0.1H2O C, 54.46; H, 3.92; N, 3.01 found: C, 54.54; H, 3.74; N, 2.93.

EXAMPLE 44

Synthesis of {7-[5-(4-Trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 44)
[Figure (not displayed)]
Step 1. Preparation of {7-[5-(4-Trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 44A)
[Figure (not displayed)]
The title compound was prepared in a manner analogous to Example 1F using 42C and 12C. MS m/z 464 (M+1).
Step 2. Preparation of {7-[5-(4-Trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 44)
The title compound was prepared in a manner analogous to Example 1 using 44A. 400 MHz 1H NMR (DMSO-d6) δ 12.94 (br(s), 1H), 8.01 (d, 2H, J=8.4 Hz), 7.83 (d, 2H, J=8.4 Hz), 7.09 (s, 2H), 6.58 (d, 1H, J=8.6 Hz), 4.62 (s, 2H), 4.08 (s, 2H), 2.77 (m, 4H), 1.89 (m, 2H); MS m/z 450 (M+1). Anal. Calc'd for C22H18F3NO4S C, 58.79; H, 4.04; N, 3.12 found: C, 58.59; H, 3.80; N, 3.01.

EXAMPLE 45

Synthesis of {2-Methyl-4-[3-(4-trifluoromethyl-phenyl)-isoxazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 45)
[Figure (not displayed)]
Step 1. Preparation of 5-chloromethyl-3-(4-trifluoromethyl-phenyl)-isoxazole (compound 45A)
[Figure (not displayed)]
A solution of 4-trifluoromethyl-benzaldehyde oxime (8.9 g, 47.1 mmol) in 100 mL DCM was added to a rapidly stirred solution of propargyl chloride (47.1 mmol), triethyl amine (4.71 mmol) and 91 mL of commercial bleach (6.5% by weight) all in 50 mL DCM at 0° C. After 1 hour the layers were separated and the organic layer dried (Na2SO4), and concentrated in vacuo. Purification by flash column chromatography (gradient elution: 5% EtOAc/hexane to 25% EtOAc/hexane) gave the title compound (2.9 g, 23%) MS m/z 262 (M+1).
Step 2. Preparation of {2-Methyl-4-[3-(4-trifluoromethyl-phenyl)-isoxazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 45B)
[Figure (not displayed)]
The title compound was prepared in a manner analogous to Example 1F using 45A and 2C. MS m/z 438 (M+1).
Step 3. Preparation of {2-Methyl-4-[3-(4-trifluoromethyl-phenyl)-isoxazol-5-ylmethylsulfanyl]-3-phenoxy}-acetic acid (compound 45)
The title compound was prepared in a manner analogous to Example 1 using 45B. IR cm−1: 1747; 400 MHz 1H NMR (DMSO-d6) δ 12.97 (br(s), 1H), 7.99 (d, 2H, J=8.0 Hz), 7.81 (d, 2H, J=8.0 Hz), 7.21 (s, 1H), 7.16 (d, 1H, J=8.5 Hz), 6.86 (s, 1H), 6.74 (d, 1H, J=8.5 Hz), 4.63 (s, 2H), 4.30 (s, 2H), 2.09 (s, 3H); MS m/z 424 (M+1).

EXAMPLE 46

Synthesis of {5-Methoxy-2-methyl-4-[3(4-trifluoromethyl-phenyl)-isoxazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 46)
[Figure (not displayed)]
Step 1. Preparation of {5-Methoxy-2-methyl-4-[3-(4-trifluoromethyl-phenyl)-isoxazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 46A)
[Figure (not displayed)]
The title compound was prepared in a manner analogous to Example 1F using 45A and 1D. MS m/z 468 (M+1).
Step 2. Preparation of {5-Methoxy-2-methyl-4-[3-(4-trifluoromethyl-phenyl)-isoxazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 46)
The title compound was prepared in a manner analogous to Example 1 using 46A. IR cm−1:1752,1711; 400 MHz 1H NMR (DMSO-d6) δ 12.96 (br(s), 1H), 7.98 (d, 2H, J=8.1 Hz), 7.81 (d,2H, J=8.1 Hz), 7.09 (s, 1H),6.80 (s, 1H),6.54 (s, 1H),4.71 (s, 2H), 4.18 (s, 2H), 3.79 (s, 3H), 2.00 (s, 3H); MS m/z 454 (M+1)

EXAMPLE 47

Synthesis of [2-Methyl-4-(4-phenoxy-benzylsulfanyl)-phenoxy]-acetic acid (compound 47)
[Figure (not displayed)]
Step 1. Preparation of [2-Methyl-4-(4-phenoxy-benzylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 47A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F with 1-chloromethyl-4-phenoxy-benzene and 2C. MS m/z 321 (M-methylacetate).
Step 2. Preparation of [2-Methyl-4-(4-phenoxy-benzylsulfanyl)-phenoxy]-acetic acid (compound 47)
The title compound was prepared in the manner analogous to Example 1 using 47A. 400 MHz 1H NMR (DMSO-d6) δ 12.95 (br(s), 1H), 7.33 (m, 2H), 7.22 (m, 2H), 7.07 (m, 3H), 6.93 (m, 2H), 6.87 (m, 2H), 6.71 (d, 1H, J=8.3 Hz), 4.62 (s, 2H), 4.04 (s, 2H), 2.09 (s, 3H). MS m/z 379 (M−1).

EXAMPLE 48

Synthesis of [7-(4′-Trifluoromethyl-biphenyl-3-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid (compound 48)
[Figure (not displayed)]
Step 1. Preparation of (4′-Trifluoromethyl-biphenyl-3-yl)-methanol (compound 48A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3A with 1-bromo-4-trifluoromethyl-benzene and 3-(hydroxymethyl)phenyl boronic acid. MS m/z 251 (M−1).
Step 2. Preparation of 3-Chloromethyl-4′-trifluoromethyl-biphenyl (compound 48B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 48A. MS m/z 236 (M+1-Cl).
Step 3. Preparation of [7-(4′-Trifluoromethyl-biphenyl-3-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid methyl ester (compound 48C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 48B. MS m/z 473 (M+1).
Step 4. Preparation of [7-(4′-Trifluoromethyl-biphenyl-3-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid (compound 48)
The title compound was prepared in the manner analogous to Example 1 using 48C. 400 MHz 1H NMR (DMSO-d6) δ 12.96 (br(s), 1H), 7.75 (d, 2H, J=8.3 Hz), 7.67 (d, 2H, J=8.1 Hz), 7.52 (m, 1H), 7.37 (t, 1H, J=7.6 Hz), 7.29 (m, 2H), 7.13 (d, 1H, J=8.5 Hz), 6.61 (d, 1H, J=8.5 Hz), 4.63 (s, 2H), 4.05 (s, 2H), 2.71 (t, 2H), 2.58 (t, 2H), 1.81 (m, 2H). MS m/z 459 (M+1).

EXAMPLE 49

Synthesis or [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-3-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 49)
[Figure (not displayed)]
Step 1. Preparation of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-3-ylmethylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 49A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 48B and 1D. MS m/z 477 (M+1).
Step 2. Preparation of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-3-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 49)
The title compound was prepared in the manner analogous to Example 1 using 49A. 400 MHz 1H NMR (DMSO-d6) δ 12.96 (br(s), 1H), 7.73 (d, 2H, J=9 Hz), 7.71 (d, 2H, J=9 Hz), 7.50 (m, 1H), 7.42 (m, 1H), 7.36 (t, 1H, J=7.8 Hz), 7.28 (m, 1H), 6.99 (s, 1H), 6.53 (s, 1H), 4.70 (s, 2H), 4.03 (s, 2H), 3.73 (s, 3H), 1.99 (s, 3H). MS m/z 463 (M+1).

EXAMPLE 50

Synthesis of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethanesulfonyl)-phenoxy]-acetic acid (compound 50)
[Figure (not displayed)]
Step 1. Preparation of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethanesulfonyl)-phenoxy]-acetic acid methyl ester (compound 50A)
[Figure (not displayed)]
Example 4 (200 mg) was dissolved in 5 ml dichloromethane. Excess m-chloroperbenzoic acid (300 mg) was added and the reaction was allowed to stir 3 h. The solvent was removed under vacuum and the crude product was purified by MPLC. MS m/z 509 (M+1).
Step 2. Preparation of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethanesulfonyl)-phenoxy]-acetic acid (compound 50)
The title compound was prepared in the manner analogous to Example 1 using 50A. 400 MHz 1H NMR (DMSO-d6) δ 13.13 (br(s), 1H), 7.85 (d, 2H, J=8.1 Hz), 7.77 (d, 2H, J=8.3 Hz), 7.66 (d, 2H, J=8.6 Hz), 7.3 (m, 3H), 6.76 (s, 1H), 4.89 (s, 2H), 4.67 (s, 2H), 3.96 (s, 3H), 2.04 (s, 3H). MS m/z 495 (M+1).

EXAMPLE 51

Synthesis of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethanesulfinyl)-phenoxy]-acetic acid (compound 51)
[Figure (not displayed)]
Step 1. Preparation of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethanesulfinyl)-phenoxy]-acetic acid methyl ester (compound 51A)
[Figure (not displayed)]
Example 4 (0.5 g, 1.0 mmol) was dissolved in 25 ml dichloromethane followed by the addition of 2-benzenesulfonyl-3-phenyl-oxaziridine (0.274, 1.04 mmol). The reaction was stirred 1 h. 10 ml water was added, the layers were separated, and dichloromethane solution was dried over anhydrous sodium sulfate, decanted, and concentrated. The product was recrystallized from ethyl acetate to give the title product. MS m/z 493 (M+1).
Step 2. Preparation of [5-Methoxy-2-methyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethanesulfinyl)-phenoxy]-acetic acid (compound 51)
The title compound was prepared in the manner analogous to Example 1 using 51A. 400 MHz 1H NMR (DMSO-d6) δ 7.83 (d, 2H, J=8.78 Hz), 7.76 (d, 2H, J=8.30 Hz), 7.59 (d, 2H, J=8.30 Hz), 7.11 (d, 2H, J=8.30 Hz), 7.02 (s, 1H), 6.64 (s, 1H), 4.79 (s, 2H), 4.20 (d, 1H, J=12.7 Hz), 3.91 (d, 1H, J=12.4 Hz), 3.76 (s, 3H), 2.03 (s, 3H). MS m/z 479 (M+1).

EXAMPLE 52

Synthesis of [2-Propyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 52)
[Figure (not displayed)]
Step 1. Preparation of [2-Propyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid methyl ester (compound 52A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 48B and (4-Mercapto-2-propyl-phenoxy)-acetic acid methyl ester, prepared from 2-propylphenol in a manner analagous to Example 2. MS m/z 475 (M+1).
Step 2. Preparation of [2-Propyl-4-(4′-trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-phenoxy]-acetic acid (compound 52)
The title compound was prepared in the manner analogous to Example 1 using 52A. 400 MHz 1H NMR (DMSO-d6) δ 7.81 (d, 2H, J=8.5 Hz), 7.74 (d, 2H, J=8.5 Hz), 7.60 (d, 2H, J=8.1 Hz), 7.33 (d, 2H, J=8.3 Hz), 7.10 (m, 1H), 7.02 (m, 1H), 6.71 (d, 1H, J=8.5 Hz), 4.60 (s, 2H), 4.11 (s, 2H), 1.43 (m, 2H), 0.77 (m, 3H). MS m/z 459 (M−1).

EXAMPLE 53

Synthesis of {7-[3-(5-Trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 53)
[Figure (not displayed)]
Step 1. Preparation of [3-(5-Trifluoromethyl-pyridin-2-yl)-phenyl]-methanol (compound 53A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3A using 3-(hydroxymethyl)phenyl boronic acid and 2-chloro-5-trifluoromethyl-pyridine. MS m/z 253 (M+1).
Step 2. Preparation of 2-(3-Chloromethyl-phenyl)-5-trifluoromethyl-pyridine (compound 53B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 53A. MS m/z 237 (M+1-Cl).
Step 3. Preparation of {7-[3-(5-Trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 53C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 53B. MS m/z 474 (M+1).
Step 4. Preparation of {7-[3-(5-Trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 53)
The title compound was prepared in the manner analogous to Example 1 using 53C. 400 MHz 1H NMR (DMSO-d6) δ 8.98 (m, 1H), 8.23 (dd, 1H, J=1.7 Hz, J′=8.5 Hz), 7.99 (m, 2H), 7.87 (s, 1H), 7.39 (t, 1H, J=7.6 Hz), 7.33 (m, 1H), 7.11 (d, 1H, J=8.5 Hz), 6.58 (d, 1H, J=8.5 Hz), 4.61 (s, 2H), 4.08 (s, 2H), 2.70 (t, 2H, J=7.3 Hz), 2.63 (t, 2H, J=7.6 Hz), 1.84 (m, 2H). MS m/z 460 (M+1).

EXAMPLE 54

Synthesis of (5-Methoxy-2-methyl-4-{2-[1-(4-trifluoromethyl-benzyl)-1H-indol-3-yl]-ethylsulfanyl}-phenoxy)-acetic acid (compound 54)
[Figure (not displayed)]
Step 1. Preparation of {4-[2-(1H-Indol-3-yl)-ethylsulfanyl]-5-methoxy-2-methyl-phenoxy}-acetic acid methyl ester (compound 54A)
[Figure (not displayed)]
The compound 1D (1.622 g, 6.7 mmol) and 3-(2-bromo-ethyl)-1H-indole (1.50 g, 6.69 mmol) was dissolved in 5 ml DMF. Potassium carbonate (1.11 g, 8.03 mmol) was added followed by stirring at room temperature for 3 h. The reaction was filtered, concentrated and purified by MPLC to give the title compound. MS m/z 225 (M+1).
Step 2. Preparation of (5-Methoxy-2-methyl-4-{2-[1-(4-trifluoromethyl-benzyl)-1H-indol-3-yl]-ethylsulfanyl}-phenoxy)-acetic acid methyl ester (compound 54B)
[Figure (not displayed)]
The compound 54A (0.300 g, 0.778 mmol) was dissolved in 5 ml DMF. NaH was added and stirred for ½ h. 4-trifluoromethylbenzyl bromide (0.223 g, 0.934 mmol) was added and the reaction was stirred for 1.5 h. 10 ml 2N HCl was added to pH<4. The DMF solution was partitioned between 30 ml water and 30 ml ethyl. acetate. The organic solution was washed 2×30 ml water 1×30 ml brine, dried over sodium sulfate, decanted, concentrated and purified by MPLC to give the title product. MS m/z 544 (m+1).
Step 3. Preparation of (5-Methoxy-2-methyl-4-{2-[l-(4-trifluoromethyl-benzyl)-1H-indol-3-yl]-ethylsulfanyl}-phenoxy)-acetic acid (compound 54)
The title compound was prepared in the manner analogous to Example 1 using 54B. 400 MHz 1H NMR (DMSO-d6) δ 13.0 (br(s), 1H) 7.60 (d, 1H, J=8.1 Hz), 7.42 (d, 1H, J=7.96 Hz), 7.31 (m, 4H), 7.04 (m, 2H), 6.96 (m, 1H), 6.53 (s, 1H), 5.43 (s, 2H), 4.70 (s, 2H), 3.72 (s, 3H), 3.03 (t, 2H, J=8.8 Hz), 2.86 (t, 2H, J=7.6 Hz), 2.04 (s, 3H). MS m/z 530 (M+1).

EXAMPLE 55

Synthesis of [7-(4′-Trifluoromethyl-biphenyl-2-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid (compound 55)
[Figure (not displayed)]
Step 1. Preparation of [7-(4′-Trifluoromethyl-biphenyl-2-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid methyl ester (compound 55A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C. and 2-chloromethyl-4′-trifluoromethyl-biphenyl, which was prepared in a manner analogous to Examples 3A and 3B. MS m/z 473 (M+1).
Step 2. Preparation of [7-(4′-Trifluoromethyl-biphenyl-2-ylmethylsulfanyl)-indan-4-yloxy]-acetic acid (compound 55)
The title compound was prepared in the manner analogous to Example 1 using 55A. 400 MHz 1H NMR (DMSO-d6) δ 12.97 (br(s), 1H), 7.68 (d, 2H, J=8.5 Hz), 7.32 (m, 5H), 7.11 (m, 1H), 6.77 (d, 1H, J=8.5 Hz), 6.47 (d, 1H, J=8.3 Hz), 4.62 (s, 2H), 3.87 (s, 2H), 2.70 (m, 2H), 1.76 (m, 2H). MS m/z 459 (M+1).

EXAMPLE 56

Synthesis of {5-Methoxy-2-methyl-4-[2-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid (compound 56)
[Figure (not displayed)]
Step 1. Preparation of {5-Methoxy-2-methyl-4-[2-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 56A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 81A and 1D. MS m/z 507 (M+1).
Step 2. Preparation of 5-Methoxy-2-methyl-4-[2-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid (compound 56)
The title compound was prepared in the manner analogous to Example 1 using 56A. 400 MHz 1H NMR (DMSO-d6) δ 12.95 (br(s), 1H), 7.67 (m, 4H), 7.12 (m, 2H), 6.96 (m, 2H), 6.80 (m, 1H), 6.49 (s, 1H), 5.19 (s, 2H), 4.68 (s, 2H), 3.99 (s, 2H), 3.67 (s, 3H), 1.96 (s, 3H). MS m/z 493 (M+1).

EXAMPLE 57

Synthesis of {4-[4-(4-Fluoro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 57)
[Figure (not displayed)]
Step 1. Preparation of [4-(4-Fluoro-benzyloxy)-phenyl]-methanol (compound 57A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 14A using 1-bromomethyl-4-fluoro-benzene and 4-hydroxymethyl-phenol. MS m/z 215 (M-OH).
Step 2. Preparation of 1-(4-Chloromethyl-phenoxymethyl)-4difluoro-benzene (compound 57B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 57A. MS m/z 215 (M-Cl).
Step 3. Preparation of {4-[4-(4-Fluoro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid methyl ester (compound 57C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 57B and 2C. MS m/z 427 (M+1).
Step 4. Preparation of {4-[4-(4-Fluoro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 57)
The title compound was prepared in the manner analogous to Example 1 using the product from Example 57C. mp 154-155° C.; IR (KBr) cm−1: 3050, 2925, 1727, 1495, 1228, 1156; 400 MHz 1H NMR (MSO-d6): δ 13.00 (br(s), 1H), 7.37-7.48 (m, 2H) 6.99-7.22 (m, 6H), 6.80-6.90 (m, 2H), 6.69 (d, 1H, J=8.5 Hz), 4.98 (s, 2H), 4.61 (s, 2H), 4.00 (s, 2H), 2.08 (s, 3H); MS m/z 411 (M−1). Anal. Calc'd for C23H21FO4S: C, 66.97; H, 5.13; found: C, 66.64; H, 4.88.

EXAMPLE 58

Synthesis of {4-[4-(4-Chloro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 58)
[Figure (not displayed)]
Step 1. Preparation of {4-[4(4Chloro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid methyl ester (compound 58A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using I-bromomethyl-4-chloro-benzene and the product from Example 35C. MS m/z 443 (M+1).
Step. 2. Preparation of {4-[4-(4-Chloro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy)-acetic acid (compound 58)
The title compound was prepared in the manner analogous to Example 1 using 58A. mp 164° C.; IR (KBr) cm−1: 3062, 1727, 1612, 1493, 1226, 1193; 400 MHz 1H NMR (DMSO-d6): δ 12.99 (br(s), 1H), 7.36-7.44 (m, 4H), 7.01-7.17 (m, 4H), 6.81-6.89 (m, 2H), 6.69 (d, 1H, J=8.5 Hz), 5.01 (s, 2H), 4.61 (s, 2H), 4.00 (s, 2H), 2.08 (s, 3H); MS m/z 427 (M−1). Anal. Calc'd for C23H21ClO4S: C, 64.40; H, 4.93; found: C, 64.43; H, 4.81.

EXAMPLE 59

Synthesis of 4-[4-(2,5-Dichloro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 59)
[Figure (not displayed)]
Step 1. Preparation of {4-[4-(2,5-Dichloro-benzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid methyl ester (compound 59A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 2-bromomethyl-1,4-dichloro-benzene and the product prepared from Example 35C. m/z 265 (M-211).
Step 2. Preparation of {4-[4-(2,4-Dichlorobenzyloxy)-benzylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 59)
The title compound was prepared in the manner analogous to Example 1 using 59A. mp 101-103° C.; IR (KBr) cm−1: 3077, 1715, 1608, 1496, 1437, 1234; 400 MHz 1H NMR (DMSO-d6): δ 7.37-7.63 (m, 3H), 6.99-7.20 (m, 4H), 6.85-6.94 (m, 2H), 6.63 (d, 1H, J=8.5 Hz), 5.05 (s, 2H), 4.45 (s, 2H), 3.99 (s, 2H), 2.07 (s, 3H); HPLC: area %=97.61, r.t.=5.56 min., λ=214 nm, mobile phase=acetonitrile/water with 0.10% TFA; MS m/z 461 (M−1). Anal. Calc'd for C23H20Cl2O4S: C, 59.62; H, 4.35; found: C, 58.04; H, 4.26.

EXAMPLE 60

Synthesis of {2-Methyl-4-[4-(pyridine-2-ylmethoxy)-benzylsulfanyl]-phenoxy}-acetic acid (compound 60)
[Figure (not displayed)]
Step 1. Preparation of {2-Methyl-4-[4-(pyridine-2-ylmethoxy)-benzylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 60A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 2-bromomethyl-pyridine hydrochloride and the product prepared from Example 35C. MS m/z 410 (M+1).
Step 2. Preparation of {2-Methyl-4-[4-(pyridine-2-ylmethoxy)-benzylsulfanyl]-phenoxy)-acetic acid (compound 60)
The title compound was prepared in the manner analogous to Example 1 using 60A. mp 150° C.; IR (KBr) cm−1: 2917, 1723, 1605, 1511, 1490,1217; 400 MHz 1H NMR (DMSO-d6): δ 12.95 (brs, 1H), 8.49-8.55 (s, 1H), 7.73-7.81 (m, 1H), 7.40-7.48 (m, 1H), 7.24-7.33 (m, 1H), 7.00-7.19 (m, 4H), 6.83-6.93 (m, 2H), 6.69 (d, 1H, J=8.5 Hz), 5.08 (s, 2H), 4.62 (s, 2H), 4.00 (s, 2H), 2.08 (s, 3H); HPLC: area %=96.24, r.t.=1.95 min., γ=214 nm, mobile phase=acetonitrile/water with 0.10% TFA; MS m/z 396 (M+1). Anal. Calc'd for C22H21NO4S: C, 66.82; H, 5.35; N, 3.54; found: C, 66.12; H, 5.09; N, 3.44.

EXAMPLE 61

Synthesis of {5-Chloro-2-methyl-4-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic acid (compound 61)
[Figure (not displayed)]
Step 1. Preparation of (5-Chloro-2-methyl-4-[4-(4trifluoromethyl-benzyloxy)-benzyl-sulfanyl]-phenoxy}-acetic acid methyl ester (compound 61A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 14B and 20C. MS m/z 265 (M−245).
Step 2. Preparation of {5-Chloro-2-methyl-4-[4-(4-trifluoromethyl-benzyloxy)-benzyl-sulfanyl]-phenoxy}-acetic acid (compound 61)
The title compound was prepared in the manner analogous to Example 1 using 61A. mp 142-143° C.; IR (KBr) cm−1: 3074, 1747, 1321, 1234, 1175, 1124; 400 MHz 1H NMR (DMSO-d6): δ 13.01 (br(s), 1H), 7.67-7.73 (m, 2H), 7.57-7.64 (m, 2H), 7.16-7.25 (m, 4H), 6.87-6.95 (m, 4H), 5.15 (s, 2H), 4.69 (s, 2H), 4.07 (s, 2H), 2.07 (s, 3H); MS m/z 495 (M−1). Anal. Calc'd for C24H20ClF3O4S: C, 58.01; H, 4.06; found: C, 57.73; H, 4.06.

EXAMPLE 62

Synthesis of {7-[4-(2,4Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 62)
[Figure (not displayed)]
Step 1. Preparation of {7-[4(2,4-Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 62A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 4chloromethyl-(2,4-dichloro-benzyloxy-benzene) prepared from 4-hydroxymethyl-phenol and 1-chloromethyl-2,4-dichloro-benzene in the manner analagous to Examples 14A and 14B. MS m/z 503 (M+1).
Step 2. Preparation of {7-[4-(2,4-Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 62)
The title compound was prepared in the manner analogous to Example 1 using 62A. mp 149-150° C.; IR (KBr) cm−1: 3089, 1734, 1512, 1473, 1295, 1234; 400 MHz 1H NMR (DMSO-d6): δ 13.11 (br(s), 1H), 7.40-7.71 (m, 3H), 6.88-7.19 (m, 5H), 6.58 (d, 1H, J=8.5 Hz), 5.07 (s, 2H), 4.61 (s, 2H), 3.96 (s, 2H), 2.77 (t, 2H, t, J=7.4 Hz), 2.69 (t, 2H, J=7.4 Hz), 1.91 (pentet, 2H); MS m/z 487 (M−1). Anal. Calc'd for C25H22Cl2O4S: C, 61.35; H, 4.53; found: C, 60.95; H, 4.41.

EXAMPLE 63

Synthesis of {7-[4-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 63)
[Figure (not displayed)]
Step 1. Preparation of {7-[4-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 63A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 14B and 12C. MS m/z 265 (M−237).
Step 2. Preparation of {7-[4-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 63)
The title compound was prepared in the manner analogous to Example 1 using 63A. mp 145° C.; IR (KBr) cm−1: 2968, 1740, 1510, 1325, 1248, 1110; 400 MHz 1H NMR (DMSO-d6): δ 12.99 (br(s), 1H), 7.66-7.75 (m, 2H), 7.55-7.65 (m, 2H); 7.01-7.15 (m, 3H) 6.83-6.90 (m, 2H), 6.56 (d, 1H, J=8.5 Hz), 5.14 (s, 2H), 4.60 (s, 2H), 3.93 (s, 2H), 2.74 (t, 2H, t, J=7.6 Hz), 2.65 (t, 2H, J=7.4 Hz), 1.87 (pentet, 2H); MS m/z 487 (M−1). Anal. Calc'd for C26H23F3O4S: C, 63.92; H, 4.75; found: C, 63.95; H, 4.65.

EXAMPLE 64

Synthesis of {5-Methyl-7-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 64)
[Figure (not displayed)]
Step 1. Preparation of {5-Methyl-7-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4yloxy}-acetic acid methyl ester (compound 64A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 14B and (7-mercapto-5-methyl-indan-4-yloxy)-acetic acid methyl ester, which was prepared in a similar manner as described for Example 12C. MS m/z 265 (M−251).
Step 2. Preparation of {5-Methyl-7-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 64)
The title compound was prepared in the manner analogous to Example 1 using 64A. mp 165-167° C.; IR (KBr) cm−1: 3039, 1707, 1516, 1329, 1163, 1112; 400 MHz 1H NMR (DMSO-d6) δ 12.81 (br(s), 1H), 7.66-7.74 (m, 2H), 7.56-7.64 (m, 2H); 7.11-7.19 (m, 2H), 6.94 (s, 1H), 6.85-6.91 (m, 2H), 5.15 (s, 2H), 4.40 (s, 2H), 3.99 (s, 2H), 2.81 (t, 2H, J=7.4 Hz), 2.59 (t, 2H, J=7.4 Hz), 2.13 (s, 3H), 1.86 (pentet, 2H); MS m/z 501 (M−1). Anal. Calc'd for C27H25F3O4S: C, 64.53; H, 5.01; found: C, 64.33; H, 4.82.

EXAMPLE 65

Synthesis of {7-[4-(4-Fluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 65)
[Figure (not displayed)]
Step 1. Preparation of {7-[4-(4-Fluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 65A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 4-chloromethyl-(4-fluoro-benzyloxy-benzene), prepared from 4-hydroxymethyl-phenol and 1-bromomethyl-4-fluoro-benzene in a manner analagous to Examples 14A and 14B. MS m/z 453 (M+1).
Step 2. Preparation of {7-[4-(4-Fluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 65)
The title compound was prepared in the manner analogous to Example 1 using 65A. mp 153-155° C.; IR (KBr) cm−1: 3117, 3028, 1731, 1512, 1471, 1231; 400 MHz 1H NMR (DMSO-d6): δ 12.94 (br(s), 1H), 7.39-7.47 (m, 2H), 7.01-7.20 (m, 5H); 6.82-6.89 (m, 2H) 6.56 (d, 1H, J=8.4 Hz), 4.99 (s, 2H), 4.61 (s, 2H), 3.94 (s, 2H), 2.75 (t, 2H, J=7.5 Hz), 2.67 (t, 2H, J=7.5 Hz), 1.89 (pentet, 2H); MS m/z 437 (M−1). Anal. Calc'd for C25H23FO4S: C, 68.48; H, 5.29; found: C, 68.24; H, 5.15.

EXAMPLE 66

Synthesis of {7-[4-(2,4-Difluoro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 66)
[Figure (not displayed)]
Step 1. Preparation of {17-[4(2,4-Difluoro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 66A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 4chloromethyl-(2,4-difluoro-benzyloxy-benzene) prepared from 4-hydroxymethyl-phenol and 1-bromomethyl-2,4-difluoro-benzene in the manner analagous to Examples 14A and 14B. MS m/z 471 (M+1).
Step 2. Preparation of {7-[4-(2,4-Difluoro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 66)
The title compound was prepared in the manner analogous to Example 1 using 66A. mp 158-160° C.; IR (KBr) cm−1: 3065, 3043, 1751, 1510, 1433, 1239; 400 MHz 1H NMR (DMSO-d6): δ 12.94 (br(s), 1H), 7.51-7.61 (m, 1H), 7.21-7.30 (m, 1H); 7.01-7.16 (m, 4H) 6.83-6.92 (m, 2H), 6.57 (d, 1H, J=8.5 Hz), 5.01 (s, 2H), 4.61 (s, 2H), 3.94 (s, 2H), 2.76 (t, 2H, J=7.4 Hz), 2.68 (t, 2H, J=7.4 Hz), 1.90 (pentet, 2H); MS m/z 455 (M−1). Anal. Calc'd for C25H22F2O4S: C, 65.78; H, 4.86; found: C, 65.58; H, 4.83.

EXAMPLE 67

Synthesis of {7-[4-(4-tert-Butyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 67)
[Figure (not displayed)]
Step 1. Preparation of {7-[4(4-tert-Butyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 67A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 4-chloromethyl-(4-tert-butyl-benzyloxy-benzene) prepared from 4-hydroxymethyl-phenol and 1-bromomethyl-4-tert-butyl-benzene in the manner analagous to Examples 14A and 14B. m/z 491 (M+1).
Step 2. Preparation of {7-[4(4-tert-Butyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 67)
The title compound was prepared in the manner analogous to Example 1 using 67A. mp 152-153° C.; IR (KBr) cm−1: 3134, 3032, 1745, 1708, 1473, 1228; 400 MHz 1H NMR (DMSO-d6): δ 12.94 (br(s), 1H), 7.25-7.39 (m, 4H), 7.01-7.14 (m, 3H) 6.80-6.89 (m, 2H), 6.57 (d, 1H, J=8.5 Hz), 4.97 (s, 2H), 4.61 (s, 2H), 3.93 (s, 2H), 2.75 (t, 2H, J=7.5 Hz), 2.67 (t, 2H, J=7.5 Hz), 1.89 (pentet, 2H), 1.22 (s, 9H); MS m/z 475 (M−1). Anal. Calc'd for C29H32O4S: C, 73.08; H, 6.77; found: C, 72.97; H, 6.84.

EXAMPLE 68

Synthesis of {7-[4-(4-Methoxy-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 68)
[Figure (not displayed)]
Step 1. Preparation of {7-[4-(4-Methoxy-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 68A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 4-chloromethyl-(4-methoxy-benzyloxy-benzene) prepared from 4-hydroxymethyl-phenol and 1-bromomethyl-4-methoxy-benzene in the manner analagous to Examples 14A and 14B. MS m/z 465 (M+1).
Step 2. Preparation of {7-[4-(4-Methoxy-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 68)
The title compound was prepared in the manner analogous to Example 1 using 68A. mp 183-185° C.; IR (KBr) cm−1: 3015, 2588, 1742, 1716, 1514, 1243; 400 MHz 1H NMR (DMSO-d6): δ 12.97 (br(s), 1H), 7.26-7.34 (m, 2H), 7.06-7.13 (m, 2H) 7.04 (d, 1H, J=8.5 Hz), 6.80-6.92 (m, 4H), 6.56 (d, 1H, J=8.5 Hz), 4.92 (s, 2H), 4.60 (s, 2H), 3.93 (s, 2H), 3.69 (s, 3H), 2.75 (t, 2H, J=7.3 Hz), 2.67 (t, 2H, J=7.3 Hz), 1.89 (pentet, 2H); MS m/z 449 (M−1). Anal. Calc'd for C26H26O5S: C, 69.31; H, 5.82; found: C, 69.00; H, 5.74.

EXAMPLE 69

Synthesis of [7-(4Benzyloxy-benzylsulfanyl)-indan-4-yloxy]-acetic acid (compound 69)
[Figure (not displayed)]
Step 1. Preparation of [7-(4-Benzyloxy-benzylsulfanyl)-indan-4-yloxy]-acetic acid methyl ester (compound 69A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 1-benzyloxy-4-chloromethyl-benzene prepared from 4-hydroxymethyl-phenol and 4-bromomethyl-benzene in the manner analagous to Examples 14A and 14B. MS m/z 435 (M+1).
Step 2. Preparation of [7-(4-Benzyloxy-benzylsulfanyl)-indan-4-yloxy]-acetic acid (compound 69)
The title compound was prepared in the manner analogous to Example 1 using 69A. mp 145-147° C.; IR (KBr) cm−1: 3066, 2584, 1742, 1511, 1234; 400 MHz 1H NMR (DMSO-d6): δ 12.94 (br(s), 1H), 7.21-7.44 (m, 5H), 6.99-7.15 (m, 3H) 6.80-6.90 (m, 2H), 6.56 (d, 1H, J=8.3 Hz), 5.01 (s, 2H), 4.61 (s, 2H), 3.93 (s, 2H), 2.75 (t, 2H, J=7.3 Hz), 2.67 (t, 2H, J=7.3 Hz), 1.89 (pentet, 2H); MS m/z 419 (M−1). Anal. Calc'd for C25H24O4S: C, 71.40; H, 5.75; found: C, 71.46; H, 5.75.

EXAMPLE 70

Synthesis of {7-[4-(4-Chloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 70)
[Figure (not displayed)]
Step 1. Preparation of {7-[4(4Chloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 70A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 1-(4-chloro-benzyloxy)4chloromethyl benzene prepared from 1-bromomethyl-4-chloro-benzene and 4-hydroxymethyl-phenol in the manner analagous to Examples 14A and 14B. MS m/z 469 (M+1).
Step 4. Preparation of {7-[4-(4-Chloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 70)
The title compound was prepared in the manner analogous to Example 1 using 70A. mp 170-172° C.; IR (KBr) cm−1: 3054, 25.77, 1731, 1710, 1471, 1234; 400 MHz 1H NMR (DMSO-d6): δ 12.95 (br(s), 1H), 7.39 (s, 4H), 6.99-7.25 (m, 3H), 6.79-6.97 (m, 2H), 6.56 (d, 1H, J=8.4 Hz), 5.01 (s, 2H), 4.60 (s, 2H), 3.93 (s, 2H), 2.74 (t, 2H, J=7.4 Hz), 2.66 (t, 2H, J=7.4 Hz), 1.88 (pentet, 2H); MS m/z 453 (M−1). Anal. Calc'd for C25H23ClO4S: C, 66.00; H, 5.10; found: C, 65.95; H, 4.97.

EXAMPLE 71

Synthesis of {7-[4-(2,5-Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 71)
[Figure (not displayed)]
Step 1. Preparation of {7-[4(2,5-Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 71A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 1,4-Dichloro-2-(4-chloromethyl-phenoxymethyl)-benzene prepared from 1,4-dichloro-2-chloromethyl-benzene and 4-hydroxymethyl-phenol in the manner analagous to Examples 14A and 14B. MS m/z 265 (M−237).
Step 2. Preparation of {7-[4-(2,5-Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}acetic acid (compound 71)
The title compound was prepared in the manner analogous to Example 1 using 71A. mp 158-160° C.; IR (KBr) cm−1: 3070, 2573, 1747, 1716, 1236, 1106; 400 MHz 1H NMR (DMSO-d6): δ 12.95 (br(s), 1H), 7.57-7.62 (m, 1H) 7.47-7.53 (m, 1H), 7.38-7.45 (m, 1H), 7.08-7.16 (m, 2H), 7.04 (d, 1H, J=8.5 Hz), 6.85-6.92 (m, 2H), 6.56 (d, 1H, J=8.5 Hz), 5.06 (s, 2H), 4.61 (s, 2H), 3.94 (s, 2H), 2.75 (t, 2H, J=7.3 Hz), 2.67 (t, 2H, J=7.3 Hz), 1.89 (pentet, 2H); MS m/z 487 (M−1). Anal. Calc'd for C25H22Cl2O4S: C, 61.35; H, 4.53; found: C, 61.24; H, 4.43.

EXAMPLE 72

Synthesis of {7-[4-(3,4-Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 72)
[Figure (not displayed)]
Step 1. Preparation of {7-[4(3,4Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 72A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 1,2-Dichloro-4-(4-chloromethyl-phenoxymethyl)-benzene prepared from 1-bromomethyl-3,4-dichloro-benzene and 4-hydroxymethyl-phenol in the manner analagous to Examples 14A and 14B. MS m/z 503 (M+1).
Step 2. Preparation of {7-[4-(3,4Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 72)
The title compound was prepared in the manner analogous to Example 1 using 72A. mp 168° C.; IR (KBr) cm−1: 3084, 3039, 1744, 1708, 1244, 1226; 400 Mz 1H NMR (DMSO-d6): δ 12.95 (br(s), 1H), 7.57-7.67 (m, 2H) 7.37 (dd, 1H, J=8.3, 2.0 Hz), 7.01-7.14 (m, 3H), 6.82-6.89 (m, 2H), 6.56 (d, 1H, J=8.4 Hz), 5.04 (s, 2H), 4.61 (s, 2H), 3.93 (s, 2H), 2.75 (t, 2H, J=7.4 Hz), 2.66 (t, 2H, J=7.4 Hz), 1.88 (pentet, 2H); MS m/z 487 (M−1). Anal. Calc'd for C25H22Cl2O4S: C, 61.35; H, 4.53; found: C, 61.13; H, 4.38.

EXAMPLE 73

Synthesis of {7-[4-(4Chloro-3-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 73)
[Figure (not displayed)]
Step 1. Preparation of {7-[4-(4-Chloro-3-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 73A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 1-Chloro-4-(4-chloromethyl-phenoxymethyl)-2-trifluoromethyl-benzene prepared from 1-bromomethyl-4-chloro-3-trifluoromethyl-benzene and 4-hydroxymethyl-phenol in the manner analagous to Examples 14A and 14B. MS m/z 299 (M−237).
Step 2. Preparation of {7-[4-(4-Chloro-3-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 73)
The title compound was prepared in the manner analogous to Example 1 using 73A. mp 151-152° C.; IR (KBr) cm−1: 3076, 3050, 1748, 1426, 1244, 1109; 400 MHz 1H NMR (DMSO-d6): δ 12.94 (br(s), 1H), 7.87 (s, 1H), 7.68-7.72 (m, 2H) 7.00-7.15 (m, 3H), 6.82-6.92 (m, 2H), 6.56 (d, 1H, J=8.5 Hz), 5.12 (s, 2H), 4.61 (s, 2H), 3.94 (s, 2H), 2.74 (t, 2H, J=7.5 Hz), 2.66 (t, 2H, J=7.5 Hz), 1.87 (pentet, 2H); MS m/z 521 (M−1). Anal. Calc'd for C26H22ClF3O4S: C, 59.71; H, 4.24; found: C, 59.54; H, 4.11.

EXAMPLE 74

Synthesis of {7-[4-(4-Fluoro-3-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 74)
[Figure (not displayed)]
Step 1. Preparation of {7-[4-(4-Fluoro-3-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 74A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 4-(4-Chloromethyl-phenoxymethyl)-1-fluoro-2-trifluoromethyl-benzene prepared from 1-bromomethyl-4-fluoro-3-trifluoromethyl-benzene and 4-hydroxymethyl-phenol in the manner analagous to Examples 14A and 14B. MS m/z 283 (M−237).
Step 2. Preparation of {7-[4-(4-Fluoro-3-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 74)
The title compound was prepared in the manner analogous to Example 1 using 74A. mp 116-117° C.; IR (KBr) cm−1: 3028, 1741, 1704, 1511, 1235, 1110; 400 MHz 1H NMR (DMSO-d6): δ 12.96 (br(s), 1H), 7.74-7.85 (m, 2H) 7.45-7.54 (m, 1H), 7.08-7.15 (m, 2H), 7.04 (d, 1H, J=8.5 Hz), 6.84-6.91 (m, 2H), 6.56 (d, 1H, J=8.5 Hz), 5.09 (s, 2H), 4.61 (s, 2H), 3.94 (s, 2H), 2.75 (t, 2H, J=7.5 Hz), 2.66 (t, 2H, J=7.5 Hz), 1.88 (pentet, 2H); MS m/z 505 (M−1). Anal. Calc'd for C26H22F4O4S: C, 61.65; H, 4.38; found: C, 61.50; H, 4.07.

EXAMPLE 75

Synthesis of {7-[4-(4-Trifluoromethoxy-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 75)
[Figure (not displayed)]
Step 1. Preparation of [7-(4-Acetoxy-benzylsulfanyl)-indan-4-yloxy]-acetic acid methyl ester (compound 75A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 35A using acetic acid 4-chloromethyl-phenyl ester and 12C. MS m/z 387 (M+1).
Step 2. Preparation of [7-(4-Hydroxy-benzysulfanyl)-indan-4-yloxy]-acetic acid (compound 75B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 35B using 75A. MS m/z 391 (M−1).
Step 3. Preparation of [7-(4-Hydroxy-benzylsulfanyl)-indan-4-yloxy]-acetic acid methyl ester (compound 75C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 35C using the product from Example 75B. MS m/z 237 (M−107).
Step 4. Preparation of {7-[4-(4-Trifluoromethoxy-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 75D)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 1-bromomethyl-4-trifluoromethoxy-benzene and 75C. MS m/z 519 (M+1).
Step 5. Preparation of {7-[4-(4-Trifluoromethoxy-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 75)
The title compound was prepared in the manner analogous to Example 1 using 75D. mp 140-142° C.; IR (KBr) cm−1: 3072, 3043, 1724, 1511, 1226, 1156; 400 MHz 1H NMR (DMSO-6): δ 12.95 (br(s), 1H), 7.47-7.57 (m, 2H), 7.29-7.39 (m, 2H), 7.00-7.16 (m, 3H), 6.81-6.91 (m, 2H), 6.56 (d, 1H, J=8.5 Hz), 5.05 (s, 2H), 4.61 (s, 2H), 3.94 (s, 2H), 2.75 (t, 2H, J=7.4 Hz), 2.67 (t, 2H, J=7.4 Hz), 1.88 (pentet, 2H) MS m/z 503 (M−1). Anal. Calc'd for C26H23F3O5S: C, 61.90; H, 4.60; found: C, 61.53; H, 4.36.

EXAMPLE 76

Synthesis of {7-[4-(4-Fluoro-2-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 76)
[Figure (not displayed)]
Step 1. Preparation of {7-[4-(4-Fuoro-2-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 76A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 1-bromomethyl-fluoro-2-trifluoromethyl-benzene and the product prepared from Example 75C. MS m/z 283
Step 2. Preparation of {7-[4-(4-Fluoro-2-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 76)
The title compound was prepared in the manner analogous to Example 1 using 76A. mp 125-127° C.; IR (KBr) cm−1: 3132, 3032, 1742, 1708, 1244, 1110; 400 MHz 1H NR (DMSO-d6): δ 12.95 (br(s), 1H), 7.71-7.81 (m, 1H), 7.65 (dd, 1H, J=9.3, 2.6 Hz), 7.51-7.61 (m, 1H), 7.01-7.19 (m, 3H), 6.81-6.91 (m, 2H), 6.57 (d, 1H, J=8.5 Hz), 5.11 (s, 2H), 4.61 (s, 2H), 3.95 (s, 2H), 2.75 (t, 2H, J=7.4 Hz), 2.66 (t, 2H, J=7.4 Hz), 1.89 (pentet, 2H); MS m/z 502 (M−1). Anal. Calc'd for C26H22F4O4S: C, 61.65; H, 4.38; found: C, 61.28; H, 4.12.

EXAMPLE 77

Synthesis of {7-[4-(3,5-Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 77)
[Figure (not displayed)]
Step 1. Preparation of {7-[4(3,5-Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 77A)
[Figure (not displayed)]
The product from Example 75C (0.42 g, 1 mmoles), (3,5-dichlorophenyl)-methanol (0.24 g, 1.3 mmoles), triphenyl phosphine (0.38 g, 1.5 mmoles), and 0.23 mL of diethyl azodicarboxylate (0.25 g, 1.5 mmoles) were dissolved in 9 mL of tetrahydrofuran. The reaction mixture was stirred at room temperature under nitrogen for 18 hrs. The reaction mixture was evaporated to give a residue, which was flash chromatographed (silica gel, 20% ethyl acetate in hexane) to afford the title compound in good purity. MS m/z 265
Step 2. Preparation of {7-[4-(3,5-Dichloro-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 77)
The title compound was prepared in the manner analogous to Example 1 using 77A. mp 134-135° C.; IR (KBr) cm−1: 3070, 1747, 1708, 1572, 1432, 1244; 400 MHz 1H NMR (DMSO-d6): δ 12.95 (br(s), 1H), 7.51-7.53 (m, 1H), 7.42-7.45 (m, 2H), 7.07-7.13 (m, 2H), 7.04 (d, 1H, J=8.6 Hz), 6.83-6.90 (m, 2H), 6.56 (d, 1H, J=8.6 Hz), 5.05 (s, 2H), 4.61 (s, 2H), 3.93 (s, 2H), 2.75 (t, 2H, J=7.5 Hz), 2.66 (t, 2H, 7.5 Hz), 1.88 (pentet, 2H); MS m/z 487 (M−1). Anal. Calc'd for C25H22Cl2O4S: C, 61.35; H, 4.53; found: C, 61.01; H, 436.

EXAMPLE 78

Synthesis of {7-[4-Methoxy-3-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 78)
[Figure (not displayed)]
Step 1. Preparation of [4-Methoxy-3-(4-trifluoromethyl-benzyloxy)-phenyl]-methanol (compound 78A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 14A using 1-bromomethyl-4-trifluoromethyl-benzene and 5-hydroxymethyl-2-methoxy-phenol. MS m/z 295 (M-OH).
Step 2. Preparation of 4-Chloromethyl-1-methoxy-2-(4-trifluoromethyl-benzyloxy)-benzene (compound 78B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 78A. MS m/z 295 (M-Cl).
Step 3. Preparation of {7-[4-Methoxy-3-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 78C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 78B and 12C. MS m/z 373 (M−159).
Step 4. Preparation of {7-[4-Methoxy-3-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 78)
The title compound was prepared in the manner analogous to Example 1 using 78C. mp 150-151° C.; IR (KBr) cm−1: 3046, 1722, 1515, 1328, 1232, 1106; 400 MHz 1H NMR (DMSO-d6): δ 12.95 (br(s), 1H), 7.71 (d, 2H, J=8.1 Hz), 7.58 (d, 2H, J=8.1 Hz), 7.03 (d, 1H, J=8.5 Hz), 6.70-6.86 (m, 3H), 6.57 (d, 1H, J=8.5 Hz), 5.01 (s, 2H), 4.61 (s, 2H), 3.89 (s, 2H), 3.69 (s, 3H), 2.75 (t, 2H, J=7.3 Hz), 2.62 (t, 2H, J=7.3 Hz), 1.87 (pentet, 2H); MS m/z 517 (M−1). Anal. Calc'd for C27H25F3O5S: C, 62.54; H, 4.86; found: C, 62.54; H, 4.71.

EXAMPLE 79

Synthesis of {7-[3-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 79)
[Figure (not displayed)]
Step 1. Preparation of [3-(4-trifluoromethyl-benzyloxy)-phenyl]-methanol (compound 79A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 14A using 1-bromomethyl-4-trifluoromethyl-benzene and 3-hydroxymethyl-phenol. MS m/z 265 (M-OH).
Step 2. Preparation of 1-(4-trifluoromethyl-benzyloxy)-3-chloromethyl-benzene (Compound 79B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 79A. MS m/z 265 (M-Cl).
Step 3. Preparation of {7-[3-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 79C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 79B and 12C. MS m/z 503 (M+1).
Step 4. Preparation of {7-[3-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 79)
The title compound was prepared in the manner analogous to Example 1 using 79C. mp 145-146° C.; IR (KBr) cm−1: 3076, 3028, 1705, 1318, 1232, 1109; 400 MHz 1H NMR (DMSO-d6): δ 12.94 (br(s), 1H), 7.71 (d, 2H, J=8.2 Hz), 7.59 (d, 2H, J=8.0 Hz), 7.10-7.19 (m, 1H), 7.05 (d, 1H, J=8.5 Hz), 6.75-6.86 (m, 4H), 6.58 (d, 1H, J=8.5 Hz), 5.08 (s, 2H), 4.61 (s, 2H), 3.95 (s, 2H), 2.75 (t, 2H, J=7.5 Hz), 2.64 (t, 2H, J=7.5 Hz), 1.88 (pentet, 2H); MS m/z 487 (M−1). Anal. Calc'd for C26H23F3O4S: C, 63.92; H, 4.75; found: C, 63.78; H, 4.53.

EXAMPLE 80

Synthesis of {7-[3-(4-Chloro-3-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 80)
[Figure (not displayed)]
Step 1. Preparation of [3-(4Chloro-3-trifluoromethyl-benzyloxy)-phenyl]-methanol (compound 80A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 14A using 4-bromomethyl-1-chloro-2-trifluoromethyl-benzene and 3-hydroxymethyl-phenol. MS m/z 299 (M-OH).
Step 2. Preparation of 1-Chloro-4-(3-chloromethyl-phenoxymethyl)-2-trifluoromethyl-benzene (compound 80B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 80A. MS n/z 299 (M-Cl).
Step 3. Preparation of {7-[3-(4-Chloro-3-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 80C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 80B and 12C. MS m/z 537 (M+1).
Step 4. Preparation of {7-[3-(4-Chloro-3-trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 80)
The title compound was prepared in the manner analogous to Example 1 using 80C. mp 121-122° C.; IR (KBr) cm−1: 3027, 2584, 1742, 1255, 1129, 1109; 400 MHz 1H NMR (DMSO-d6): δ 12.95 (br(s), 1H), 7.87 (s, 1H), 7.64-7.75 (m, 2H), 7.09-7.19 (m, 1H), 7.01-7.09 (m, 1H), 6.73-6.88 (m, 3H), 6.56 (d, 1H, J=8.5 Hz), 5.06 (s, 2H), 4.60 (s, 2H), 3.95 (s, 2H), 2.74 (t, 2H, J=7.4 Hz), 2.63 (t, 2H, J=7.4 Hz), 1.87 (pentet, 2H); MS m/z 523 (M+1). Anal. Calc'd for C26H22ClF3O4S: C, 59.71; H, 4.24; found: C, 59.45; H, 4.08.

EXAMPLE 81

Synthesis of {7-[2-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 81)
[Figure (not displayed)]
Step 1. Preparation of [2-(4-Trifluoromethyl-benzyloxy)-phenyl]-methanol (compound 81A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 14A using 1-bromomethyl-4-trifluoromethyl-benzene and 2-hydroxymethyl-phenol. MS m/z 265 (M-OH).
Step 2. Preparation of 1-(4-trifluoromethyl-benzyloxy)-2-chloromethyl-benzene (compound 81B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 81A. MS m/z 265 (M-Cl).
Step 3. Preparation of {7-[2-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 81C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 81B and 12C. MS m/z 503 (M+1).
Step 4. Preparation of {7-[2-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-indan-4-yloxy}-acetic acid (compound 81)
The title compound was prepared in the manner analogous to Example 1 using 81C. mp 150-152° C.; IR (KBr) cm−1: 3074, 3042, 1701, 1324, 1124, 1099; 400 MHz 1H NMR (DMSO-d6): δ 7.58-7.75 (m, 2H), 6.92-7.20 (m, 4H), 6.80 (t, 1H, J=7.5 Hz), 6.51 (d, 1H, J=8.5 Hz), 5.16 (s, 2H), 4.57 (s, 2H), 3.99 (s, 2H), 2.70 (t, 2H, J=7.5 Hz), 2.62 (t, 2H, J=7.5 Hz), 1.80 (pentet, 2H); MS m/z 487 (M−1). Anal. Calc'd for C26H23F3O4S: C, 63.92; H, 4.75; found: C, 63.54; H, 4.52.

EXAMPLE 82

Synthesis of {7-[3-Dichloro-4-(4-trifluoromethyl-benzyloxy)-benzylsulfonyl]-indan-4-yloxy}-acetic acid lithium salt (compound 82)
[Figure (not displayed)]
Step 1. Preparation of [3,5-Dichloro-(4-trifluoromethyl-benzyloxy)-phenyl]-methanol (compound 82A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 14A using 1-bromomethyl-4-trifluoromethyl-benzene and 2,6-dichloro-4-hydroxymethyl-phenol. MS m/z 191 (M−159).
Step 2. Preparation of 1,3-Dichloro-5-chloromethyl-2-(4-trifluoromethyl-benzyloxy)-benzene (compound 82B)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 3B using 82A. MS m/z 333 (M-Cl).
Step 3. Preparation of {7-[3,5-Dichloro-4-(4-trifluoromethyl-benzyloxy)-benzylsulfonyl]-indan-4-yloxy}-acetic acid methyl ester (compound 82C)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 82B and 12C. MS m/z 571 (M+1).
Step 4. Preparation of The Lithium Salt of {7-[3,5-Dichloro-4(4-trifluoromethyl-benzyloxy)-benzylsulfonyl]-indan-4-yloxy}-acetic acid (compound 82)
The title compound, in unprotonated form, was prepared in the manner analogous to Example 1 using 82C. mp 235° C. dec; IR (KBr) cm−1: 3414, 1622, 1591, 1472, 1326, 1265; 400 MHz 1H NMR (DMSO-d6): δ 7.66-7.77 (m, 4H), 7.26 (s, 2H), 6.99 (d, 1H, J=8.5 Hz), 6.45 (d, 1H, J=8.5 Hz), 5.03 (s, 2H), 4.02 (s, 2H), 3.92 (s, 2H), 2.73 (t, 2H, J=7.3 Hz), 2.65 (t, 2H, J=7.3 Hz), 1.88 (pentet, 2H); MS m/z 555 (M−1). Anal. Calc'd for C26H20Cl2F3O4S: Li: 0.50 H2O: C, 54.56; H, 3.70; Li, 1.21; H2O, 1.57; found: C, 54.63; H, 3.68; Li, 1.46; H2O, 1.61.

EXAMPLE 83

Synthesis of {8-[4-(4Trifluoromethyl-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 83)
[Figure (not displayed)]
Step 1. Preparation of {8-[4-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid methyl ester (compound 83A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using (8-mercapto-chroman-5-yloxy)-acetic acid methyl ester and 14B. MS m/z 519 (M+1).
Step 2. Preparation of {8-[4(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 83)
The title compound was prepared in the manner analogous to Example 1 using 83A. mp 143-144° C.; HPLC: area %=96.02, r.t.=3.770 min, γ=214 nm, mobile phase=acetonitrile/water w/0.10% TFA; IR (KBr) cm−1: 3042, 2581, 1739, 1714, 1325, 1116; 400 MHz 1H NMR (DMSO-d6): δ 12.95 (br(s), 1H), 7.66-7.74 (m, 2H), 7.56-7.63 (m, 2H); 7.10-7.17 (m, 2H), 6.92 (d, 1H, J=8.7 Hz), 6.83-6.89 (m, 2H), 6.26 (d, 1H, J=8.5 Hz), 5.13 (s, 2H), 4.58 (s, 2H), 4.08 (t, 2H, J=4.8 Hz), 3.90 (s, 2H), 2.55 (t, 2H, J=6.5 Hz), 1.83 (pentet, 2H); MS m/z 503 (M−1). Anal. Calc'd for C26H23F3O5S: C, 61.90; H, 4.60; found: C, 61.41; H, 4.50.

EXAMPLE 84

Synthesis of {8-[3-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 84)
[Figure (not displayed)]
Step 1. Preparation of {8-[3-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid methyl ester (compound 84A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using (8-mercapto-chroman-5-yloxy)-acetic acid methyl ester and 79B. MS m/z 519 (M+1).
Step 2. Preparation of {8-[3-(4-Trifluoromethyl-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 84)
The title compound was prepared in the manner analogous to Example 1 using 84A. mp 113-115° C.; HPLC: area %=97.30, r.t.=3.140 min, γ=214 nm, mobile phase=acetonitrile/water w/0.10% TFA; IR (KBr) cm: 2952, 2577, 1742, 1582, 1323, 1120; 400 MHz 1H NMR (DMSO-d6): δ 7.67-7.74 (m, 2H), 7.56-7.63 (m, 2H); 7.13 (t, 1H, J=7.8 Hz), 6.76-6.93 (m, 4H), 6.22 (d, 1H, J=8.7 Hz), 5.08 (s, 2H), 4.45 (s, 2H), 4.08 (t, 2H, J=4.8 Hz), 3.91 (s, 2H), 2.54 (t, 2H, J=6.6 Hz), 1.82 (pentet, 2H); MS m/z 505 (M+1). Anal. Calc'd for C26H23F3O5S: C, 61.90; H, 4.60; found: C, 61.49; H, 4.44.

EXAMPLE 85

Synthesis of {8-[4-(2,5-Dichloro-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 85)
[Figure (not displayed)]
Step 1. Preparation of {8-[4-(2,5-Dichloro-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid methyl ester (compound 85A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using (8-mercapt-ochroman-5-yloxy)-acetic acid methyl ester and 1,4-Dichloro-2-(4-chloromethyl-phenoxymethyl)-benzene prepared in the manner analagous to Example 71A. m/z 519 (M+1).
Step 2. Preparation of {8-[4-(2,5-Dichloro-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 85)
The title compound was prepared in the manner analogous to Example 1 using 85A. mp 98-100° C.; IR (KBr) cm−1: 3038, 2854, 1729, 1508, 1240, 1124; 400 MHz 1H NMR (MSOd-6): δ 12.95 (br(s), 1H), 7.57-7.62 (m, 1H), 7.39-7.53 (m, 2H); 7.12-7.20 (m, 2H), 6.84-6.96 (m, 3H), 6.26 (d, 1H, J=8.6 Hz), 5.05 (s, 2H), 4.58 (s, 2H), 4.09 (t, 2H, J=4.9 Hz), 3.92 (s, 2H), 2.55 (t, 2H, J=6.5 Hz), 1.83 (pentet, 2H); MS m/z 503 (M−1). Anal. Calc'd for C25H22Cl2O5S: C, 59.41; H, 4.39; found: C, 59.20; H, 4.20.

EXAMPLE 86

Synthesis of {8-[4-(5-Trifluoromethyl-pyridine-2-yl)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 86)
[Figure (not displayed)]
Step 1. {8-[4-(5-Trifluoromethyl-pyridine-2-yl)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid methyl ester (compound 86A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using (8-mercapto-chroman-5-yloxy)-acetic acid methyl ester and 18B. MS m/z 490 (M+1).
Step 2. {8-[4-(5-Trifluoromethyl-pyridine-2-yl)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 86)
The title compound was prepared in the manner analogous to Example 1 using 86A. mp 178-179° C.; IR (KBr) cm−1: 3034, 2577, 1707, 1604, 1332, 1111; 400 MHz 1H NMR (DMSO-d6): δ 12.95 (br(s), 1H), 8.97 (s, 1H), 7.99-8.24 (m, 4H), 7.33-7.40 (m, 2H), 6.95 (d, 2H, J=8.5 Hz), 6.26 (d, 2H, J=8.6 Hz), 4.57 (s, 2H), 4.11 (t, 2H, J=4.9 Hz), 4.04 (s, 2H), 2.56 (t, 2H, J=6.5 Hz), 1.84 (pentet, 2H); MS m/z 476 (M+1). Anal. Calc'd for C24H20F3NO4S: C, 60.63; H, 4.24; N, 2.95; found: C, 60.31; H, 4.24; N, 3.02.

EXAMPLE 87

Synthesis of {7-[5-(2-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 87)
[Figure (not displayed)]
Step 1. Preparation of {7-[5-(2-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 87A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using commercially available 3-chloromethyl-5-(2-chloro-phenyl)isoxazole and 12C. MS m/z 430 (M+1).
Step 2. Preparation of {7-[5-(2-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 87)
The title compound was prepared in the manner analogous to Example 1 using 87A. mp 161-162° C.; IR (KBr) cm−1: 3177, 3065, 1706, 1475, 1432, 1233; 400 MHz 1H NMR (DMSO-d6): δ 13.00 (bs, 1H), 7.78-7.85 (m, 1H), 7.58-7.64 (m, 1H), 7.42-7.53 (m, 2H), 7.15 (d, 1H, J=8.6 Hz), 6.84 (s, 1H), 6.60 ( d, 1H, J=8.6 Hz), 4.62 (s, 2H), 4.09 (s, 2H), 2.72-2.82 (m, 4H), 1.91 (pentet, 2H); MS m/z 416 (M+1). Anal. Calc'd for C21H18ClNO4S: C, 60.65; H, 4.36; N, 3.37; found: C, 60.56; H, 4.28; N, 3.16.

EXAMPLE 88

Synthesis of {7-[3-(2,6-Dichloro-phenyl)-5-methyl-isoxazol-4-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 88)
[Figure (not displayed)]
Step 1. Preparation of {7-[3-(2,6-Dichloro-phenyl)-5-methyl-isoxazol-4-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 88A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using commercially available 4-bromomethyl-3-(2,6-dichloro-phenyl)-5-methyl-isoxazole and 12C. MS m/z 478 (M+1).
Step 2. Preparation of {7-[3-(2,6-Dichloro-phenyl)-5-methyl-isoxazol-4-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 88)
The title compound was prepared in the manner analogous to Example 1 using 88A. mp 151-152° C.; IR (KBr) cm−1: 3084, 1743, 1430, 1277, 1245, 1106; 400 MHz 1H NMR (DMSO-d6): δ 12.97 (br(s), 1H), 7.47-7.70 (m, 3H), 6.90 (d, 1H, J=8.5 Hz), 6.52 (d, 1H, J=8.5 Hz), 4.63 (s, 2H), 3.58 (s, 2H), 2.75 (t, 2H, J=7.6 Hz), 2.65 (t, 2H, J=7.6 Hz), 2.07 (s, 3H), 1.89 (pentet, 2H) MS m/z 464 (M+1). Anal. Calc'd for C22H19Cl2NO4S: C, 56.90; H, 4.12; N, 3.02; found: C, 56.51; H, 3.96; N, 2.95.

EXAMPLE 89

Synthesis of {7-[3-(4-Trifluoromethyl-phenyl)-isoxazol-5-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 89)
[Figure (not displayed)]
Step 1. Preparation of {7-[3-(4-Trifluoromethyl-phenyl)-isoxazol-5-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 89A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 42C and 12C. MS m/z 464 (M+1).
Step 2. Preparation of {7-[3-(4-Trifluoromethyl-phenyl)-isoxazol-5-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 89)
The title compound was prepared in the manner analogous to Example 1 using 89A. mp 166-168° C.; HPLC: area %=96.95, r.t.=3.140 min, γ=214 nm, mobile phase=acetonitrile/water w/0.10% TFA. IR (KBr) cm−1: 3140, 3085, 1742, 1322, 1255, 1109; 400 MHz 1H NMR (DMSO-d6): δ 12.96 (br(s), 1H), 7.99 (d, 2H, J=8.3 Hz), 7.81 (d, 2H, J=8.3 Hz), 7.14 (d, 1H, J=8.4 Hz), 6.81 (s, 1H), 6.61 (d, 1H, J=8.4 Hz), 4.63 (s, 2H), 4.23 (s, 2H), 2.76 (t, 4H, J=7.5 Hz), 1.91 (pentet, 2H); MS m/z 450 (M+1). Anal. Calc'd for C22H18F3NO4S: C, 58.79; H, 4.04; N, 3.12; found: C, 58.38; H, 3.92; N, 2.95.

EXAMPLE 90

Synthesis of {7-[2-(4′-Trifluoromethyl-biphenyl-4yl)-ethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 90)
[Figure (not displayed)]
Step 1. Preparation of {7-[2-(4′-Trifluoromethyl-biphenyl-4-yl)-ethylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 90A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 12C and 4-(2-bromo-ethyl)-4′-trifluoromethyl-biphenyl (compound 22B). MS m/z 487 (M+1).
Step 2. Preparation of {7-[2-(4′-Trifluoromethyl-biphenyl-4-yl)-ethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 90)
The title compound was prepared in the manner analogous to Example 1 using 90A. mp 170-172° C.; IR (thin film)cm−1: 1724, 1471, 1327, 1239, 1175, 1110; 400 MHz 1H NMR (DMSO-d6) δ 12.96 (br s, 1H), 7.82 (d, 2H, J=8.3 Hz), 7.74 (d, 2H, J=8.3 Hz),7.61 (d, 2H, J=8.3 Hz), 7.31 (d, 2H, J=8.3 Hz), 7.12 (d, 2H, J=8.5 Hz), 6.62 (d, 1H, J=8.5 Hz), 4.63 (s, 2H), 3.08 (t, 2H, J=7.6 Hz), 2.80 (m, 6H), 1.96 (m, 2H); MS m/z 471 (M−1). Anal. Calc'd for C26H23F3O3S: C, 66.09; H, 4.91; found: C, 65.95; H, 4.63.

EXAMPLE 91

Synthesis of {7-[2-(4′-Trifluoromethyl-biphenyl-4-yl)-ethyl]-indan-4-yloxy}-acetic acid (compound 91)
[Figure (not displayed)]
Step 1. Preparation of (Indan-4-yloxy)-acetic acid methyl ester (compound 91A)
[Figure (not displayed)]
Compound 91A was prepared from indan-4-ol and bromo-acetic acid methyl ester in the manner analogous to Example 1C. 400 MHz 1H NMR (DMSO-d6) δ 7.00 (t, 1H, J=7.8 Hz), 6.79 (d, 1H, J=7.3 Hz), 6.56 (d, 1H, J=8.1 Hz), 4.74 (s, 2H), 3.63 (s, 3H), 2.77 (m, 4H), 1.95 (m, 2H).
Step 2. Preparation of (4′-Trifluoromethyl-biphenyl-4-yl)-acetic acid (compound 91B)
[Figure (not displayed)]
A mixture of (4-bromo-phenyl)-acetic acid (10.2 g, 47.4 mmol), 4-trifluoromethylphenylboronic acid (10.0 g, 52.7 mmol), and 50% water-wet 5% palladium on charcoal catalyst (4.6 g) in 50 ml of water and 8.0 ml of 2-propanol was treated dropwise over 30 minutes with a solution of sodium carbonate (6.8 g, 64.2 mmol) in 18 ml of water. The mixture was heated at 65-70° C. for 3 h, then cooled to 40° C. and treated with 13.0 ml of a solution of 2-propanol/water/2.0 N aqueous sodium hydroxide solution (70/15/1). The reaction mixture was filtered through a bed of Celite filter-aid, and the filter cake was washed 5× with the above 2-propanol/water/2.0 N aqueous sodium hydroxide solution. The combined filtrates were diluted with 125 ml of water, and the solution was digested on the steam bath with charcoal and filtered. The filtrate was diluted with an additional 150 ml of water and made strongly acidic by the addition of 4.0 N hydrochloric acid. The precipitated product was filtered and suspended in 350 ml of water plus 50 ml of methanol. The new mixture was stirred for several hours and filtered again. The crude product was recrystallized from aqueous acetonitrile. A sample recrystallized a second time from aqueous acetonitrile had mp 158-160° C.; MS m/z 280 (M).
Step 3. Preparation of (4′-Trifluoromethyl-biphenyl-4-yl)-acetyl chloride (compound 91C)
[Figure (not displayed)]
A suspension 91B (2.0 g, 7.1 mmol) and 5 drops of N,N-dimethylformamide in 30 ml of dichloromethane was cooled in ice and treated dropwise with a solution of oxalyl chloride (0.70 ml, 1.0 g, 8.0 mmol) in 10 ml of dichloromethane. The ice bath was removed, and the mixture was stirred at room temperature for 3 h. The solution was filtered, and the filtrate was evaporated. The residue quickly crystallized to yield the acid chloride intermediate, which was used immediately in the next step.
Step 4. Preparation of {7-[2-(4′-Trifluoromethyl-biphenyl-4-yl-acetyl]-indan-4-yloxy)-acetic acid methyl ester (compound 91D)
[Figure (not displayed)]
A solution of 91C (2.1 g, 7.0 mmol) in 25 ml of 1,2-dichloro-ethane was cooled in ice and treated with anhydrous ferric chloride (1.2 g, 7.4 mmol). The mixture was stirred, and a solution of 91A (1.5 g, 7.3 mmol) in 10 ml of 1,2-dichloro-ethane was added dropwise. The mixture was stirred at room temperature for 18 h. The reaction mixture was added to 300 g of ice and of brine and extracted with ethyl acetate (4×10 ml). The combined extracts were washed with 5% aqueous sodium bicarbonate solution (4×250 ml) and brine (1×250 ml), then dried over anhydrous sodium sulfate and concentrated. The crude product was purified by normal phase chromatography. A sample recrystallized from ethyl acetate/hexane had mp 141-143° C.; MS m/z 467 (M−1).
Step 5. Preparation of {7-[2-(4′-Trifluoromethyl-biphenyl-4-yl)-ethyl]-indan-4-yloxy}-acetic acid methyl ester (compound 91E)
[Figure (not displayed)]
A solution of 91D (1.0 g, 2.1 mmol) in 10.0 ml of trifluoroacetic acid was treated dropwise with triethylsilane (1.5 ml, 1.1 g, 9.4 mmol). The mixture was stirred at room temperature for 3 h and then added to 200 g of ice and water. The precipitated solid was extracted out with ethyl acetate (4×100 ml). The combined extracts were washed with brine (1×250 ml), 5% aqueous sodium bicarbonate solution (4×250 ml), and brine again, then dried over anhydrous sodium sulfate and concentrated. The crude product was purified by normal phase chromatography. 400 MHz 1H NMR (DMSO-d6) δ 7.82 (d, 2H, J=8.3 Hz), 7.75 (d, 2H, J=8.3 Hz), 7.61 (d, 2H, J=8.3 Hz), 7.30 (d, 2H, J=8.3 Hz), 6.90 (d, 1H, J=8.3 Hz), 6.53 (d, 1H, J=8.3 Hz), 4.71 (s, 2H), 3.63 (s, 2H), 2.77 (m, 8H), 1.94 (m, 2H).
Step 6. Preparation of {7-[2-(4′-Trifluoromethyl-biphenyl-4-yl)-ethyl]-indan-4-yloxy}-acetic acid (compound 91)
The title compound was prepared in the manner analogous to Example 1 using 91E. mp 188-190° C.; IR (thin film) cm−1: 1745, 1322, 1252, 1170, 1112, 1071; 400 MHz 1H NMR (DMSO-d6) δ 12.89 (br s, 1H), 7.83 (d, 2H, J=8.1 Hz), 7.74 (d, 2H, J=8.5 Hz), 7.61 (d, 2H, J=8.1 Hz), 7.30 (d, 2H, J=8.3 Hz), 6.90 (d, 1H, J=8.3 Hz), 6.51 (d, 1H, J=8.3 Hz), 4.58 (s, 2H), 2.75(m, 8H), 2.45 (m, 2H); MS m/z 439 (M−1). Anal. Calc'd for C26H23F3O3: C, 70.90; H, 5.26; found: C, 70.92; H, 5.01.

EXAMPLE 92

Synthesis of {5-Methyl-7-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-2,3-dihydro-benzofuran-4-yloxy}-acetic acid (compound 92)
[Figure (not displayed)]
Step 1. Preparation of {5-Methyl-7-[4-(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-2,3-dihydro-benzofuran-4-yloxy}-acetic acid methyl ester (compound 92A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 18B and 7-mercapto-5-methy-2,3-dihydro-benzofuran-4-yloxy)-acetic acid methyl ester (prepared in a similar manner as described for Example 12C). mp 94-95° C.; MS m/z 490 (M+1).
Step 2. Preparation of (5-Methyl-7-[4(5-trifluoromethyl-pyridin-2-yl)-benzylsulfanyl]-2,3-dihydro-benzofuran-4-yloxy)-acetic acid (compound 92)
The title compound was prepared in the manner analogous to Example 1 using 92A. mp 155-157° C.; IR (thin film) cm−1: 1732, 1587, 1416, 1331, 1211, 1129; 400 MHz 1H NMR (DMSO-d6) δ 12.89 (br s, 1H), 8.97 (m, 1H), 8.21 (dd, 1H, J=2.0, 8.5 Hz), 8.12 (d, 1H, J=8.3 Hz), 8.02 (d, 2H, J=8.3 Hz), 7.34 (d, 2H, J=8.5 Hz), 6.83 (s, 1H), 4.56 (s, 2H), 4.48 (t, 2H, J=8.7 Hz), 4.08 (s, 2H), 3.24 (t, 2H, J=8.7 Hz), 2.02 (s, 3H); MS m/z 474 (M−1). Anal. Calc'd for C24H20F3NO4S: C, 60.63; H, 4.24; N, 2.95; found: C, 60.54; H, 4.19; N, 2.94.

EXAMPLE 93

Synthesis of [8-(4′-Trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-chroman-5-yloxy]-acetic acid (compound 93)
[Figure (not displayed)]
Step 1. Preparation of [8-(4′-Trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-chroman-5-yloxy]-acetic acid methyl ester (compound 93A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 18B and (8-mercapto-chroman-5-yloxy)-acetic acid methyl ester. mp 122-124° C.; MS m/z 489 (M+1).
Step 2. Preparation of [8-(4′-Trifluoromethyl-biphenyl-4-ylmethylsulfanyl)-chroman-5-yloxy]-acetic acid (compound 93)
The title compound was prepared in the manner analogous to Example 1 using 93A. mp 170-172° C.; IR (thin film) cm−1: 1717, 1584, 1473, 1330, 1231, 1118; 400 MHz 1H NMR (DMSO-d6) δ 12.94 (br s, 1H), 7.82 (d, 2H, J=8.1 Hz), 7.74 (d, 2H, J=8.5 Hz), 7.60 (d, 2H, J=8.3 Hz), 7.34 (d, 2H, J=8.3 Hz), 6.96 (d, 2H, J=8.8 Hz), 6.28 (d, 2H, J=8.8 Hz), 4.58 (s, 2H), 4.11 (t, 2H, J=5.0 Hz), 4.03 (s, 2H), 2.56 (t, 2H, J=6.5 Hz), 1.84 (m, 2H); MS m/z 473 (M−1). Anal. Calc'd for C25H21F3O4S: C, 63.28; H, 4.46; found: C, 63.28; H, 4.26.

EXAMPLE 94

Synthesis of {8-[5-(4-Trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-chroman-5-yloxy-}-acetic acid (compound 94)
[Figure (not displayed)]
Step 1. Preparation of {8-[5-(4-Trifluoromethyl-phenyl)-isoxazol-3-ymethylsulfanyl]-chroman-5-yloxy}acetic acid methyl ester (compound 94A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 42C and (8-mercapto-chroman-5-yloxy)-acetic acid methyl ester. mp 112-113° C.; MS m/z 480 (M+1).
Step 2. Preparation of {8-[5-(4-Trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 94)
The title compound was prepared in the manner analogous to Example 1 using 94A. The crude product was recrystallized from ethyl acetate/hexane to yield the final product. mp 171-173° C.; IR (thin film) cm−1: 1722, 1432, 1322, 1232, 1103, 1065; 400 MHz 1H NMR (DMSO-d6) δ 12.94 (br s, 1H), 8.01 (d, 2H, J=8.1 Hz), 7.84 (d, 2H, J=8.3 Hz), 7.09 (s, 1H), 7.03 (d, 1H, J=8.5 Hz), 6.29 (d, 1H, J=8.5 Hz), 4.59 (s, 2H), 4.08 (t, 2H, J=5.0 Hz), 4.04 (s, 2H), 2.55 (t, 2H, J=6.5 Hz), 1.83 (m, 2H); MS m/z 464 (M−1). Anal. Calc'd for C22H18F3NO5S: C, 56.77; H, 3.90; N, 3.01; found: C, 56.80; H, 3.58; N, 3.07.

EXAMPLE 95

Synthesis of {8-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 95)
[Figure (not displayed)]
Step 1. Preparation of {8-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-chroman-5-yloxy}-acetic acid methyl ester (compound 95A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 3-chloromethyl-5-(4-chloro-phenyl)-isoxazole and (8-mercapto-chroman-5-yloxy)-acetic acid methyl ester. mp 131-133° C.; MS m/z 446 (M+1).
Step 2. Preparation of {8-[5-(4Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 95)
The title compound was prepared in the manner analogous to Example 1 using 95A. mp 181-183° C.; IR (thin film) cm−1: 1723, 1612, 1479, 1428, 1231, 1134; 400 MHz 1H NMR (DMSO-d6) δ 12.95 (br s, 1H), 7.82 (m, 2H), 7.54 (m, 2H), 7.02 (d, 1H, J=8.8 Hz), 6.94 (s, 1H), 6.29 (d, 1H, J=8.5 Hz), 4.59 (s, 2H), 4.08 (t, 2H, J=5.0 Hz), 4.01 (s, 2H), 2.55 (t, 2H, J=6.6 Hz), 1.83 (m, 2H); MS m/z 430 (M−1). Anal. Calc'd for C21H18ClNO5S: C, 58.40; H, 4.20; N, 3.24; found: C, 58.30; H, 3.91; N, 3.28.

EXAMPLE 96

Synthesis of {4-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 96)
[Figure (not displayed)]
Step 1. Preparation of {4-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-2-methyl-phenoxy}-acetic acid methyl ester (compound 96A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 3-chloromethyl-5-(4-chloro-phenyl)-isoxazole and 2C. mp 79-80° C.; MS m/z 404 (M+1).
Step 2. Preparation of {4-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-2-methyl-phenoxy}-acetic acid (compound 96)
The title compound was prepared in the manner analogous to Example 1 using 96A. mp 152-153° C.; IR (thin film) cm−1: 1724, 1495, 1433, 1309, 1225, 1196; 400 MHz 1H NMR (DMSO-d6) δ 12.96 (br s, 1H), 7.82 (m, 2H), 7.54 (m, 2H), 7.19 (d, 1H, J=1.5 Hz), 7.12 (dd, 1H, J=2.1, 8.4 Hz), 6.97 (s, 1H), 6.72 (d, 1H, J=8.5 Hz), 4.63 (s, 2H), 4.11 (s, 2H), 2.09 (s, 3H); MS m/z 388 (M−1). Anal. Calc'd for C19H16ClNO4S: C, 58.54; H, 4.14; N, 3.59; found: C, 58.53; H, 4.08; N, 3.50.

EXAMPLE 97

Synthesis of {7-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 97)
[Figure (not displayed)]
Step 1. Preparation of {7-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 97A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 3-chloromethyl-5-(4-chloro-phenyl)-isoxazole and 12C. mp 112-114° C.; MS m/z 430 (M+1).
Step 2. Preparation of {7-[5-(4-Chloro-phenyl)-isoxazol-3-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 97)
The title compound was prepared in the manner analogous to Example 1 using 97A. mp 157-159° C.; IR (thin film) cm−1: 1731, 1612, 1465, 1433, 1231, 1110; 400 MHz 1H NMR (DMSO-d6) δ 7.81 (m, 2H), 7.54 (m, 2H), 7.10 (d, 1H, J=8.3 Hz), 6.95 (s, 1H), 6.59 (d, 1H, J=8.5 Hz), 4.62 (s, 2H), 4.06 (s, 2H), 2.77 (m, 4H), 1.92 (m, 2H); MS m/z 414 (M−1). Anal. Calc'd for C21H18ClNO4S: C, 60.65; H, 4.36; N, 3.37; found: C, 60.62; H, 4.10; N, 3.31.

EXAMPLE 98

Synthesis of {7-[3-(4-Chloro-phenyl)-isoxazol-5-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid (compound 98)
[Figure (not displayed)]
Step 1. Preparation of {7-[3-(4-Chloro-phenyl)-isoxazol-5-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid methyl ester (compound 98A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 5-chloromethyl-3-(4-chloro-phenyl)-isoxazole and 12C. mp 92-94° C.; MS m/z 430 (M+1).
Step 2. Preparation of {7-[3-(4-Chloro-phenyl)-isoxazol-5-ylmethylsulfanyl]-indan-4-yloxy}-acetic acid
The title compound was prepared in the manner analogous to Example 1 using 98A. mp 158-160° C.; IR (thin film) cm−1: 1741, 1574, 1476, 1429, 1252, 1110; 400 MHz 1H NMR (DMSO-d6) δ 7.78 (m, 2H), 7.51 (m, 2H), 7.13 (d, 1H, J=8.6 Hz), 6.72 (s, 1H), 6.60 (d, 1H, J=8.5 Hz), 4.62 (s, 2H), 4.20 (s, 2H), 2.76 (m, 4H), 1.91 (m, 2H); MS m/z 414 (M−1). Anal. Calc'd for C21H18ClNO4S: C, 60.65; H, 4.36; N, 3.37; found: C, 60.55; H, 4.17; N, 3.34.

EXAMPLE 99

Synthesis of {5-Chloro-2-methyl-4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 99)
[Figure (not displayed)]
Step 1. Preparation of {5-Chloro-2-methyl-4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-phenoxy}-acetic acid methyl ester (compound 99A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 3-chloromethyl-5-(4-chloro-phenyl)-isoxazole and 20C. mp 120-121° C.; MS m/z 472 (M+1).
Step 2. Preparation of {5-Chloro-2-methyl-4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-phenoxy}-acetic acid (compound 99)
The title compound was prepared in the manner analogous to Example 1 using 99A. mp 180-182° C.; IR (thin film) cm−1: 1743, 1484, 1325, 1236, 1165, 1111; 400MHz 1H NMR (DMSO-d6) δ 13.03 (br s, 1H), 8.03 (d, 2H, J=8.1 Hz), 7.84 (d, 2H, J=8.3 Hz), 7.33 (s, 1H), 7.14 (s, 1H), 6.96 (s, 1H), 4.71 (s, 2H), 4.23 (s, 2H), 2.07 (s, 3H); MS m/z 456 (M−1). Anal. Calc'd for C20H15ClF3NO4S: C, 52.47; H, 3.30; N, 3.06; found: C, 52.39; H, 3.02; N, 2.86.

EXAMPLE 100

Synthesis of 2-[2-butyl-4-({4-[4-(trifluoromethyl)phenyl]phenyl}methylthio)phenoxy]acetic acid (compound 100)
[Figure (not displayed)]
Step 1. Preparation of 2-((1E)buta-1,3-dienyl)-1-methoxybenzene (compound 100A)
[Figure (not displayed)]
Methyltriphenylphosphonium bromide (42.9 g, 0.12 mol) was suspended in 400 ml of anhydrous THF under nitrogen and cooled to −78° C. Sodium hydride (60% in mineral oil, 6.0 g, 0.15 mol) was added portionwise. The reaction mixture was allowed to warm up slowly to room temperature and stirred at the same temperature for 1 h, then 2-methoxycinnamaldehyde (16.2 g, 0.10 mol) in 200 ml of THF was added dropwise at room temperature, and stirred at the same temperature for 3 h. Water (200 ml) and diethyl ether (800 ml) were added. The organic layer was separated, dried over sodium sulfate, concentrated, and purified using normal phase chromatography to afford the title product. 400 MHz 1H NMR (CDCl3) δ 7.48-6.56 (m, 7H), 5.32 (d, 1H), 5.16 (d, l1H), 3.84 (s, 3H).
Step 2. Preparation of 2-butyl-1-methoxybenzene (compound 100B)
[Figure (not displayed)]
A mixture of the product from example 100A (12.8 g, 0.08 mol) and palladium/carbon (10%, 50% water, 12 g) in 400 ml of ethyl acetate was hydrogenated at 50 psi, at room temperature overnight, then filtered through Celite®, and concentrated to give 100B. 400 MHz1H NMR (CDCl3) δ 7.16 (m, 2H), 6.85 (m, 2H), 3.81 (s, 3H), 2.61 (m, 2H), 1.57 (m, 2H), 1.38 (m, 2H), 0.92 (t, 3H).
Step 3. Preparation of 2-butylphenol (compound 100C)
[Figure (not displayed)]
To a stirred solution of the product from example 100B (13.1 g, 0.08 mol) in 400 ml of dichloromethane at −78° C. was added dropwise a solution of boron tribromide (100.2 g, 0.4 mol) in 200 ml of dichloromethane. After the completion of addition of boron tribromide, the reaction mixture was maintained at −78° C. for 1 h, then allowed to reach room temperature and stirred at the same temperature overnight. The mixture was cooled to 0° C., and carefully quenched with 100 ml of water. The mixture was extracted with ethyl acetate, washed with brine, dried over sodium sulfate, and concentrated to give 100C. 400 MHz 1H NMR (CDCl3) δ 7.10 (m, 2H), 6.86 (m, 1H), 6.78 (d, 1H), 4.61 (brs, 1H), 2.61 (m, 2H), 1.60 (m, 2H), 1.40 (m, 2H), 0.96 (t, 3H).
Step 4. Preparation of (3-butyl-4-hydroxyphenyl)thiocarbonitrile (compound 100D)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1B with the product from example 100C (2.38 g, 0.016 mol), sodium thiocyanate (5.14 g, 0.063 mol), sodium bromide (1.63 g, 0.016 mol), and bromine (2.8 g, 0.017 mol) in methanol. 400 MHz 1H NMR (CDCl3) δ 7.30 (m, 2H), 6.81 (d, 1H), 5.49 (brs, 1H), 2.60 (m, 2H), 1.59 (m, 2H), 1.38 (m, 2H), 0.95 (t, 3H).
Step 5. Preparation of methyl 2-(2-butyl-4-cyanothiophenoxy)acetate (compound 100E)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1C with the product from example 100D (2.80 g, 0.014 mol), methyl bromoacetate (2.28 g, 0.015 mol), and cesium carbonate (6.60 g, 0.020 mol) in 100 ml of acetonitrile. 400 MHz 1H NMR (CDCl3) δ 7.38 (m, 2H), 6.72 (d, 1H), 4.66 (s, 2H), 3.80 (s, 3H), 2.67 (m, 2H), 1.57 (m, 2H), 1.38 (m, 2H), 0.98 (t, 3H).
Step 6. Preparation of methyl 2-(2-butyl-4-sulfanylphenoxy)acetate (compound 100F)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1D with the product from example 100E (2.79 g, 10.0 mmol), dithiothreitol (3.08 g, 20.0 mmol), and 0.2 M potassium dihydrogenphosphate (15 ml) in 60 ml of methanol. 400 MHz 1H NMR (CDCl3) δ 7.11 (m, 2H), 6.60 (d, 1H), 4.61 (s, 2H), 3.81 (s, 3H), 3.36 (s, 1H), 2.63 (m, 2H), 1.57 (m, 2H), 1.38 (m, 2H), 0.98 (t, 3H).
Step 7. Preparation of methyl 2-[2-butyl-4-({4-[4-(trifluoromethyl)phenyl]phenyl}methylthio)phenoxy]acetate (compound 100G)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using 100F and 1-(bromomethyl)-4-[4-(trifluoromethyl)phenyl]benzene prepared from and phosphorous tribromide and (4′-trifluoromethyl-biphenyl-4-yl)-methanol in a manner analagous to Example 3B. 400 MHz 1H NMR (CDCl3) δ 7.68 (m, 4H), 7.51 (d, 2H), 7.29 (d, 2H), 7.15 (m, 2H), 6.60 (d, 1H), 4.62 (s, 2H), 4.04 (s, 2H), 3.79 (s, 3H), 2.60 (m, 2H), 1.55 (m, 2H), 1.35 (m, 2H), 0.88 (t, 3H).
Step 8. Preparation of 2-[2-butyl-4-({4-[4-(trifluoromethyl)phenyl]phenyl}methylthio)phenoxy]acetic acid (compound 100)
The title compound was prepared in the manner analogous to Example 1 with the product from example 100G. mp 155-157° C.; 400 MHz 1H NMR (DMSOd-6) δ 7.88 (d, 2H), 7.80 (d, 2H), 7.65 (d, 2H), 7.38 (d, 2H), 7.17 (dd, 1H), 7.09 (d, 1H), 6.79 (d, 1H), 4.65 (s, 2H), 4.17 (s, 2H), 2.50 (m, 2H), 1.43 (m, 2H), 1.22 (m, 2H), 0.81 (t, 3H). MS m/z 473 (M−1). Anal. Calc'd for C26H25O3SF3: C, 65.81; H, 5.31; Found: C, 65.95; H, 5.36.

EXAMPLE 101

Preparation of {6-methyl-8-[4-(4-trifluoromethyl-benzyloxy)-benzyl-sulfanyl]-chroman-5-yloxy}-acetic acid (compound 101)
[Figure (not displayed)]
Step 1. {6-methyl-8-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid methyl ester (compound 101A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using (8-mercapto-6-methyl-chroman-5-yloxy)-acetic acid methyl ester and the product from Example 14B. MS m/z 533 (M+1).
Step 2. {6-methyl-8-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-chroman-5-yloxy}-acetic acid (compound 101)
2N KOH solution (5 ml) was added to a stirred slurry of the product from Example 101A (0.4g, 0.75 mmol) in 2-3 ml of methanol, and the mixture was heated briefly on a steambath until nearly clear, then stirred at room temp. After 3 hours the mixture was diluted with 15-20 ml of ice-water and acidified with H3PO4. After 15 minutes the precipitate was filtered off, rinsed 3× with water, and dried to afford the title product, 0.2g, 51%.400 MHz 1H NMR (DMSO-d6) δ 7.70 (d, 2H, J=8 Hz), 7.59 (d, 2H, J=8 Hz), 7.18 (d, 2H, J=8.5 Hz), 6.88 (d, 2H, J=8.5 Hz), 6.83 (s, 1H), 5.14 (s, 2H), 4.21 (s, 2H), 4.06 (t, 2H, J=4.9Hz), 3.95 (s, 2H), 2.63 (t, 2H, J=6.3Hz), 2.03 (s, 3H), 1.79 (quint, 2H); MS m/z 517 (M−1).

EXAMPLE 102

Preparation of {4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-5,6,7,8-tetrahydro-naphthalen-1-yloxy}-acetic acid (compound 102)
[Figure (not displayed)]
Step 1. {4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-5,6,7,8-tetrahydro-naphthalen-1-yloxy}-acetic acid methyl ester (compound 102A)
[Figure (not displayed)]
The title compound was prepared in the manner analogous to Example 1F using (4-mercapto-5,6,7,8-tetrahydro-naphthalen-1-yloxy)-acetic acid methyl ester and the product from Example 42C; recrystallization from methanol afforded the title compound. MS m/z 478 (M+1).
Step 2. {4-[5-(4-trifluoromethyl-phenyl)-isoxazol-3-ylmethylsulfanyl]-5,6,7,8-tetrahydro-naphthalen-1-yloxy}-acetic acid (compound 102)
The title compound was prepared in the manner analogous to Example 1 using the product from Example 102A. mp 167-170° C; 400 MHz 1H NMR (DMSO-d6) δ 8.01 (d, 2H, J=8 Hz), 7.83 (d, 2H, J=8.3 Hz), 7.14 (d, 2H, J=8.5 Hz), 7.07 (s, 1H), 6.58 (d, 2H, J=8.8 Hz), 4.56 (s, 2H), 4.07 (s, 2H), 2.64 (m, 2H), 2.53 (m, 2H), 1.60 (m, 4H,); MS m/z 464 (M+1).
The compounds of the present invention can also be prepared using combinatorial chemistry methods. In particular, compounds of Examples 103-134 were prepared using combinatorial chemistry analagous to that previously described in Examples 1-102. The combinatorial chemistry methods useful in the present invention include those where an activated alcohol is contacted with a thiol followed by saponification of the resulting ester to afford the desired products. Such methods can be illustrated by previously described Scheme 1 where compound D is an exemplary thiol, compound Y is an exemplary activated alcohol, and compound F is an exemplary desired product.

Full text: Click here
Patent 2005

Example 2

Due to air-sensitive nature of ligand the organic phase is prepared under a nitrogen atmosphere. The organic phase is formed from Pd(OAc)2 (0.94 g, 98%) dissolved in chloroform (27 g) and then stirred for 10 minutes followed by addition of 2-dicyclohexylphosphino-2′, 4′,6′-triisopropyl-1,1′-biphenyl (2.0 g, 98%, 1:1 Pd:P). To this mixture is added polymethylene polyphenylene di-isocyanate (PMPPI) (10.0 g) and the contents stirred for a further 120 minutes. This organic phase mixture is then added to an aqueous phase, cooled to 1° C., containing 40% REAX 100 M solution (7.99 g), 20% TERGITOL XD solution (3.99 g) and 25% Poly Vinyl Alcohol (PVOH) solution (6.39 g) in deionised water (67.10 ml) while shearing (using a FISHER 4-blade retreat-curve stirrer) at 500 rpm for 8 minutes. The reaction was maintained under inert atmosphere (N2) throughout. After 8 minutes the shear rate was reduced to 160 rpm and few drops of de-foamer (DrewPLus S-4382) were added during the onset of polymerisation (detected by carbon dioxide evolution). The suspension thus obtained was stirred at 1° C. for a further 30 minutes, then maintained at 5° C. for 18 hours, warmed to 45° C. and maintained at this temperature for a further 2 hours. The microcapsules were then filtered though a polyethylene frit (20 micron porosity) and the capsules washed on a filter bed according to the following sequence: deionised water (5×100 ml), DMF (2×50 ml), ethanol (2×50 ml), toluene (2×50 ml), hexane (2×50 ml), and finally dried in a vacuum oven at 50° C.

Example of Library Synthesis Utilizing Multicomponent Reactions

96 different oligonucleotide tags, A1-A96 were synthesized using the protocol above, maintained on solid-support and deprotected on the terminal amine using the following protocol (in this example 96 different oligonucleotides are used).

However, the protocol is not fixed and can easily be scaled to any number between 1 and 10.000 or beyond 10.000 in a high-throughput format at any desired scale suitable for the experimenter.

Deprotection

Protected oligonucleotides A1-A96 maintained on solid-support

To each column add 0.3 ml Dichloromethane (DCM).

Incubate at RT for 15 min

Add 0.3 ml 2% DCA in DCM Incubate 1 min and drain

Add 0.3 ml 2% DCA in DMF. Incubate 5 min and drain (turn yellow)

Repeat until no color development

Wash ×3 with 0.3 ml DCM and inc. 5 min.

Each of the tags A1-A96 on solid support was reacted with a unique building block (BBa1-a96) using an acylation reaction as shown elsewhere in the examples. Building blocks were selected as suitably protected NH—R—COOH, NR′—R—COOH, NH—CH(R)—COOH, NR′—CH(R)—COOH, NR′—R—COOH or NH—R′—NR—CH2—COOH reactants where R or R′ can be any chemical entity f.ex a chemical entity listed elsewhere in this application.

The protection group used in this example is preferable Fmoc, which was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Orthogonal protection groups on R-groups are present whenever relevant for the feasibility of the overall library chemistry.

Multicomponent Reactions for Generation of Position 2 Building Blocks (BBb1-b96)

Multicomponent Reactions (MCRs) are convergent reactions, in which three or more starting materials react to form a product, where basically all or most of the atoms contribute to the newly formed product (A. Dömling, I. Ugi, Angew. Chem. Intl. Ed. 2000, 39, 3168).

In an MCR, a product is assembled according to a cascade of elementary chemical reactions. Thus, there is a network of reaction equilibria, which all finally flow into an irreversible step yielding the product. The challenge is to conduct an MCR in such a way that the network of pre-equilibrated reactions channel into the main product and do not yield side products.

The result is clearly dependent on the reaction conditions: solvent, temperature, catalyst, concentration, the kind of starting materials and functional groups. (A. Dömling in: Multicomponent Reactions (J. Zhu, H. Bienayme) Wiley-VCH, Weinheim 2005, p. 76).

More than 500 different scaffolds have been described in the literature so far, where 18 of these scaffolds are shown herein below. Many of these reactions are base catalyzed which works well in combination with DNA.

Other MCR's requires acidic catalysis which is known to be troublesome in combination with DNA. In these cases a mild lewis catalysis like NH4Cl, LiBr in aprotic solvents, should be used.

Some of the procedures described below require an alternative protection strategy for the phosphate backbone or the nucleobases. The phosphate groups in the DNA backbone are usually protected with cyanoethyl group, but alternative protection groups for the phosphates like the methyl and other more stable groups are known from the literature.

Multicomponent reaction can be combined with a reaction where suitable R groups react and thus forms a ring structure. One example of this is ring closure metathesis (Chem. Commun. 2003 596) where 2 of the R groups contain an alkene functionality.

[Figure (not displayed)]
[Figure (not displayed)]

The above formulas are illustrative of 18 examples of scaffolds generated by multicomponent reactions.

Uqi 4 component reaction used for generation of position 2 building blocks (BBb1-b96): After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, an array of 3 isonitrils and 4 aldehydes were mixed with 8 acids, each mixture transferred to one individual oligonucleotide and allowed to react at ambient temperature ranging from 20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position 2.

Add the acid 25 μl 0.5 M in DCM, add isonitrile 25 μl 0.5M in DCM, add aldehyde 25 μl 0.5 M in DCM and add 25 μl alcohol (methanol, ethanol, isopropanol, trifluoroethanol, hexaisofluoroisopropanol or the likes). Heated in a sealed multiposition plate in the microwave oven for 15 min or allowed to react at ambient temperature for 24-48 hours.

Aldehydes selected from the list of: aldehydes list No. 2

Acids selected from the list of: Acids list No. 4

Isonitriles selected from the list of: isonitrile (methyl ester) list No. 1

Protection groups was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

TOSMIC van Leusen 3 Component Reaction Used for Generation of Position 2 Building Blocks (BBb1-b96):

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, an array of 8 isonitriles and 12 aldehydes were created, each mixture transferred to one individual oligonucleotide and allowed to react at ambient temperature ranging from 20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position 2. (M. van Leusen, J. Wildeman, O. H. Oldenziel, J. Org. Chem. 1977, 42, 1153. A. M. van Leusen, Heterocycl. Chem. 1980, 5, S-111)

Add the aldehyde 25 μl 0.5 M in DMF incubate for 30 minutes, add isonitrile (TOSMIC reagent) 25 μl 0.5M in DCM and add triethylamine, diisopropylethylamine or morpholine 25 μl 2 M in DCM. Heated in a sealed multiposition plate in the microwave oven for 15 min or allowed to react at ambient temperature for 24-48 hours.

Aldehydes selected from the list of: aldehydes list No. 2

Isonitrile selected from the list of: isonitrile(tosmic) list No. 1

Protection groups was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Petasis 3 Component Reaction Used for Generation of Position 2 Building Blocks (BBb1-b96):

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, an array of 8 aldehydes and 12 boronic acids were created and allowed to react at ambient temperature ranging from 20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position 2.

Add the aldehyde 25 μl 0.5 M in DCM incubate for 10 minutes mix with boronic acid 25 μl 1 M in DCM. Heated in a sealed multiposition plate in the microwave oven for 15 min or allowed to react at ambient temperature for 24-48 hours.

Aldehydes selected from the list of: aldehydes list No. 2

Boronic acids selected from the list of: Boronic acids list No. 3

Protection groups was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Example of Library Synthesis Utilizing Organocatalytic Reactions

96 different oligonucleotide tags, A1-A96 were synthesized using the protocol above, maintained on solid-support and deprotected on the terminal amine using the following protocol (in this example 96 different oligonucleotides are used). However, the protocol is not fixed and can easily be scaled to any number between 1 and 10.000 or beyond 10.000 in a high-throughput format at any desired scale suitable for the experimenter.

Deprotection

Protected oligonucleotides A1-A96 maintained on solid-support To each column add 0.3 ml Dichloromethane (DCM). Incubate at RT for 15 min Add 0.3 ml 2% DCA in DCM Incubate 1 min and drain Add 0.3 ml 2% DCA in DMF. Incubate 5 min and drain (turn yellow) Repeat until no color development Wash ×3 with 0.3 ml DCM and inc. 5 min. Each of the tags A1-A96 on solid support was reacted with a unique building block (BBa1-a96) using an acylation reaction as shown elsewhere in the examples. Building blocks were selected as suitably protected NH—R—COOH, NR′—R—COOK NH—CH(R)—COOH, NR′—CH(R)—COOH, NR′—R—COOH or NH—R′—NR—CH2—COOH reactants where R or R′ can be any chemical entity f.ex a chemical entity listed elsewhere in this application. The protection group used in this example is Fmoc, was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Orthogonal protection groups on R-groups are present whenever relevant for the feasibility of the overall library chemistry.

Organocatalytic Reactions for Generation of Position 2 Building Blocks (BBb1-b96)

Organocatalytic reaction have in the past ten years received an increasingly interest. Iminium-, enamine- and recently SOMO catalysis open a wide range of chemical reactions performed in the presence of DNA since all three types of activation lowers the activation energy of the chemical reactions and conditions are mild compared to traditional activation like Lewis acid catalysis. If the catalyst responsible for the organocatalytic reactions are carefully selected these types of reaction all runs with high enantioselectivity or diastereoselectivity, if stereoselectivity in the reaction, is undesired an achiral catalyst is chosen.

1,4-Addition of Electron-Rich Benzenes to α,β-Unsaturated Aldehydes.

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, 12 different anilines were attached to the oligonucleotide complexes using an acylation reaction as shown elsewhere in the examples, each aniline added to 8 positions. An array of reactions are created by addition of 8 different croton aldehydes, preactivated with the catalyst, to each of the 12 anilines, attached to different oligonucleotides and allowed to react at ambient temperature ranging from +20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position2. J. Am. Chem. Soc. 2002, 7894.

Add the aniline 25 μl 0.1 M in DMF, add HATU (2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and 24 μl 0.1 M, 25 μl 0.2 M Dipea (diisopropylamine) in DMF.

Incubate for 1 hour at 25° C.

Washed with 3×DMF, 3×DCM.

A mixture of the crotonaldehyde 25 μl 0.5 M in DCM, catalyst ((2S,5S)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one) 25 μl 0.05M in DCM and 24 μl 0.05 M HCl (made from 4N HCl in dioxane, pH are carefully checked in a test mixture of catalyst and HCl). Incubate 30 min and transfer to oligonucleotide, allow to react at ambient temperature for 24 48 hours

Anilines selected from the list of: anilines List No. 6

Crotonaldehydes selected from the list of: crotonaldehydes List No. 7

Protection groups was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Orpanocatalytical Cyclopropanations of α,β-Unsaturated Aldehydes.

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, 12 different methylketones were attached to the oligonucleotide complexes using an acylation reaction as shown elsewhere in the examples, transformed into the corresponding dimethylsulfonylide as described below, each ylide is present in 8 positions. An array of reactions are created by addition of 8 different crotonaldehydes, preactivated with the catalyst, to each of the 12 ylides formed from the methylketones, attached to different oligonucleotides and allowed to react at ambient temperature ranging from +20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position 2. J. Am. Chem. Soc. 2005, 3240.

Add the methylketone 25 μl 0.1 M in DMF, add HATU (2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and 24 μl 0.1 M, 25 μl 0.2 M Dipea (diisopropylamine) in DMF.

Incubate for 1 hour at 25° C.

Washed with 3×DMF, 3×DCM.

Methylketones are transformed into α-keto bromides or iodides by reaction with NBS (N-bromo-succinimide) or NIS (N-iodo-succinimide), respectively. Other reagents with similar reactivity is also possible.

Add 100 μl 0.1 M NBS in CHCl3.

Incubate for 60 min at ambient temperature.

Washed with 3×DCM.

Add 100 μl 0.5 M dimethylsulfide in DCM.

Incubate for 60 min at ambient temperature.

Washed with 3×DCM.

A mixture of the crotonaldehyde 25 μl 0.5 M in CHCl3 and catalyst ((S)-(−)-indoline-2-carboxylic acid) 25 μl 0.05M in DCM

Incubate 30 min and transfer to oligonucleotide, allow to react at ambient temperature for 24 48 hours.

Crotonaldehydes selected from the list of: crotonaldehydes List No. 7

Methylketones selected from the list of: Methylketones List No. 8

Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Cross-Aldol Reaction of Aldehydes.

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, 12 different carboxylic acid-aldehydes were attached to the oligonucleotide complexes using an acylation reaction as shown elsewhere in the examples, An array of reactions are created by addition of 8 different aldehydes, premixed with the catalyst, to each of the 12 aldehydes attached to different oligonucleotides and allowed to react at ambient temperature ranging from +20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position 2. J. Am. Chem. Soc. 2002, 6798.

Add the carboxylic acid—aldehyde 25 μl 0.1 M in DMF, add HATU (2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and 24 μl 0.1 M, 25 μl 0.2 M Dipea (diisopropylamine) in DMF.

Incubate for 1 hour at 25° C.

Washed with 3×DMF, 3×DCM.

A mixture of the aldehyde 25 μl 0.5 M in DMF and catalyst ((S)-proline) 25 μl 0.05M in DMF.

Transfer to oligonucleotide, allow to react at ambient temperature for 24-48 hours

Aldehydes selected from the list of: aldehydes list No. 2

Carboxylic acid-aldehydes selected from the list of: Carboxylic acids—aldehydes List No. 5

Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Examples of Library Synthesis Utilizing Heterocycle Generating Reactions.

96 different oligonucleotide tags, A1-A96 were synthesized using the protocol above, maintained on solid-support and deprotected on the terminal amine using the following protocol (in this example 96 different oligonucleotides are used). However, the protocol is not fixed and can easily be scaled to any number between 1 and 10.000 or beyond 10.000 in a high-throughput format at any desired scale suitable for the experimenter.

Deprotection

Protected oligonucleotides A1-A96 maintained on solid-support To each column add 0.3 ml Dichloromethane (DCM). Incubate at RT for 15 min Add 0.3 ml 2% DCA in DCM Incubate 1 min and drain Add 0.3 ml 2% DCA in DMF. Incubate 5 min and drain (turn yellow) Repeat until no color development Wash ×3 with 0.3 ml DCM and inc. 5 min. Each of the tags A1-A96 on solid support was reacted with a unique building block (BBa1-a96) using an acylation reaction as shown elsewhere in the examples. Building blocks were selected as suitably protected NH—R—COOH, NR′—R—COOH, NH—CH(R)—COOH, NR′—CH(R)—COOH, NR′—R—COOH or NH—R′—NR—CH2—COOH reactants where R or R′ can be any chemical entity f.ex a chemical entity listed elsewhere in this application. The protection group used in this example is Fmoc, was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Orthogonal protection groups on R-groups are present whenever relevant for the feasibility of the overall library chemistry.

Reactions Between Di-Nucleophiles and Di-Electrophiles for Generation of Position 2 Building Blocks (BBb1-b96)

Several reactions which generates heterocycles are known, most of these reactions can be used in connection with protected DNA when conditions are carefully selected. Obvious strong protic acid must be avoided, but mild Lewis acids like NH4Cl, LiBr or similar can be used as alternatives when the right solvent and temperature is applied (Name Reactions in Heterocyclic Chemistry, Lie Jack Li, 2005

Knorr Pyrazole Synthesis.

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, 12 different carboxylic acid-aldehydes were attached to the oligonucleotide complexes using an acylation reaction as shown elsewhere in the examples, each aldehyde added to 8 positions. These aldehydes were transformed into the corresponding hydrazines by reductive amination using either trifluoroacetic acid hydrazide, Fmoc hydrazide (9-fluorenylmethyl carbazate) or hydrazine hydrochloride followed by subsequent deprotection. An array of reactions are created by addition of 8 different dicarbonyls or β-ketoesters, to each of the 12 hydrazines aldehydes attached to different oligonucleotides and allowed to react at ambient temperature ranging from 20-150° C., using standard heating or microwave heating, giving rise to 9216 formed compounds as a combination of position 1 and position2. Add the carboxylic acid-aldehydes 25 μl 0.1 M in DMF, add HATU (2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and 24 μl 0.1 M, 25 μl 0.2 M Dipea (diisopropylamine) in DMF.

Incubate for 1 hour at 25° C.

Washed with 3×DMF, 3×DCM.

Add Fmoc hydrazide 25 μl 0.1 M in THF, and 25 μl trimethyl orthoformate, incubate for 1 h at rt., add sodiumcyanoborohydride 25 μl 0.1 M in DMF/MeOH 3:1 incubate for 16 h at rt.

Wash with 3×DMF

Add piperidine/DMF 1:4 wait 5 minutes drain and repeat treatment.

Washed with 3×Methanol, 3×DMF, 3×DCM.

Add a mixture of the dicarbonyl 25 μl 0.5 M in THF, catalyst Lithium bromide 25 μl 0.05M in THF to oligonucleotide, allow to react at ambient temperature for 24 48 hours

Carboxylic acid-aldehydes selected from the list: Carboxylic acid-aldehydes List No. 5

Dicarbonyls selected from the list: dicarbonyls List No. 9

Washed with 3×THF, 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Bioinelli Reaction.

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, 12 different carboxylic acid-aldehydes were attached to the oligonucleotide complexes using an acylation reaction as shown elsewhere in the examples, each aldehyde added to 8 positions. An array of reactions are created by addition, of 8 different β-ketoesters or β-ketoamides mixed with either urea or thiourea, to each of the 12 aldehydes attached to different oligonucleotides and allowed to react at ambient temperature ranging from 20-150° C., using standard heating or microwave heating, giving rise to 9216 formed compounds as a combination of position 1 and position2.

Add the carboxylic acid-aldehydes 25 μl 0.1 M in DMF, add HATU (2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and 24 μl 0.1 M, 25 μl 0.2 M Dipea (diisopropylamine) in DMF.

Incubate for 1 hour at 25° C.

Washed with 3×DMF, 3×DCM.

Add a mixture of urea 25 μl 0.5 M in THF, β-ketoester 25 μl 0.5 M in THF and catalyst Lithium bromide 25 μl 0.05M in THF to oligonucleotide, allow to react at ambient temperature for 24 48 hours.

Carboxylic acid-aldehydes selected from the list: Carboxylic acid-aldehydes List No. 5

Dicarbonyls selected from the list: dicarbonyls List No. 9 Washed with 3×THF, 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Reverse Phase Chromatography Purification of Oligonucleotides:

Deprotected Oligoes:

Each oligonucleotide are dissolved in 20 μl solvent A and placed in a sealed 96 well plate and placed in the Waters ACQUITY autosampler. All samples are run through the Waters ACQUITY UPLC System with SQD-MS, controlled by MassLynx 4.1 and collected according to their target mass. MaxEnt is used to deconvolute massspec and compare with target mass (oligo-small molecule complex).

Column: Acquity UPLC BEH C18 1.7 μm 2.1×50 mm (Waters part 186002350)

Method used:

Solvent A: 200 mM HFIP 8.4 mM TEA 5% MeOH in water

Solvent B: 200 mM HFIP 8.4 mM TEA 60% MeOH in water

TimeFlow
(min)(ml/min)% A% B
Gradient:Initial0.99010
0.700.99010
4.500.90100
5.000.90100
5.100.99010
6.000.99010

Column Oven Temperature: 65° C.

UV Detection: 254 nm

MS Detection: ESi(−), 6 min, 550-1300 Da; Cone 35 V; Source Temp 130° C.

Use spilt flow between MS and Fraction Collector (1:9)

Fractions containing the target mass were evaporated furnishing pure oligonucleotide.

Protected Oligoes:

The method outlined above for the Waters ACQUITY equipment can also be used applying protected oligonucleotide. Preferable the buffer content are lowered in both solvent A and B with a factor 10 or simply changed to solvent A: water and solvent B: acetonitrile.

Alternatively:

Full or partial protected oligonucleotides can also be purified using reverse phase cartridges in a single column or a parallel format using one of the different commercial available products such as the Glen-Pack from Glen research or “Discovery DSC-18Lt SPE 96-well Plate” from supelco.

The protected oligonucleotide must be applied on the column dissolved in a solvent composition with a moderate organic solvent strength. Therefore the oligonucleotides needs to be concentrated in a vacuum evaporator if dissolved in pure organics.

Dissolve the protected oligonucleotide in a mixture of water and acetonitrile (preferable with a content of acetonitril below 20%) apply the solution to a preconditioned cartridge water/acetonitrile 9:1 and wash with more water/acetonitrile 9:1. The protected oligonucleotide is eluated with a higher content of acetonitrile in the solvent used. Preferable a stepwise gradient is used starting with water/acetonitril 90:10 up to 90:10, raising 10% per 100 μl, 100 μl solvent per 100 μl adsorbent used.

Examples above from the multicomponent, organocatalytic or heterocyclic generating reactions could be carried out using oligoes detached from the solid support if a photolabile linker is used as the support. Only difference is that the wash procedures must be substituted with the purification protocol above.

Through all following lists, protection groups are applied when necessary, selected from “Protection Groups” 3rd edition 2004 Philip J. Kocienski).

List No. 1—Isonitriles:

Tosmic-isonitriles: (1-PHENYL-1-TOSYL)METHYL ISOCYANIDE; (2,4-DIMETHYLPHENYL)(ISOCYANO)METHYL 4-METHYLPHENYL SULFONE; (3-METHOXYPHENYL)[(4-METHYLPHENYL)SULFONYL]ACETONITRILE; (4-METHOXYPHENYL)[(4-METHYLPHENYL)SULFONYL]ACETONITRILE; [1-(2-FLUOROPHENYL)-1-TOSYL]METHYL ISOCYANIDE; [1-(2-TRIFLUOROMETHYLPHENYL)-1-TOSYL]METHYL ISOCYANIDE; [1-(3-CHLOROPHENYL)-1-TOSYL]METHYL ISOCYANIDE; [1-(3-FLUOROPHENYL)-1-TOSYL]METHYL ISOCYANIDE; [1-(3-TRIFLUOROMETHYLPHENYL)-1-TOSYL]METHYL ISOCYANIDE; [1-(4-TRIFLUOROMETHYLPHENYL)-1-TOSYL]METHYL ISOCYANIDE; 1-(2,3-DICHLOROPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,3-DIMETHOXYPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,4-DIMETHOXYPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,5-DIBROMOPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,5-DICHLOROPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,5-DIMETHOXYPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,6-DICHLOROPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,6-DIMETHOXYPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2-CYCLOPROPYL-1-ISOCYANOETHYLSULFONYL)-4-METHYLBENZENE; 1-(3,4-DIBROMOPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(3,4-DICHLOROPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(3,5-DIBROMOPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(4-DIMETHYLAMINOPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1,3-DICHLORO-5-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 1-[(1-ISOCYANO-3-METHYLBUTYL)SULFONYL]-4-METHYL-BENZENE; 1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-NAPHTHALENE; 1-ALLYL-1-TOSYLMETHYL ISOCYANIDE; 1-BENZYL-1-TOSYLMETHYL ISOCYANIDE; 1-CYCLOBUTYL-1-TOSYLMETHYL ISOCYANIDE; 1-CYCLOHEXYL-1-TOSYLMETHYL ISOCYANIDE; 1-CYCLOPENTYL-1-TOSYLMETHYL ISOCYANIDE; 1-CYCLOPROPYL-1-TOSYLMETHYL ISOCYANIDE; 1-ETHOXYCARBONYL-1-TOSYLMETHYL ISOCYANIDE; 1-ETHYL-1-TOSYLMETHYL ISOCYANIDE; 1-FURAN-2-YL-1-TOSYLMETHYL ISOCYANIDE; 1-ISOCYANO-2-PHENYL-1-TOSYLETHENE; 1-ISOPROPYL-1-TOSYLMETHYL ISOCYANIDE; 1-METHYL-1-TOSYLMETHYL ISOCYANIDE; 1-M-TOLYL-1-TOSYLMETHYL ISOCYANIDE; 1-N-BUTYL-1-TOSYLMETHYL ISOCYANIDE; 1-N-PENTYL-1-TOSYLMETHYL ISOCYANIDE; 1-N-PROPYL-1-TOSYLMETHYL ISOCYANIDE; 1-O-TOLYL-1-TOSYLMETHYL ISOCYANIDE; 1-P-TOLYL-1-TOSYLMETHYL ISOCYANIDE; 1-PYRIDIN-2-YL-1-TOSYLMETHYL ISOCYANIDE; 1-PYRIDIN-3-YL-1-TOSYLMETHYL ISOCYANIDE; 1-PYRIDIN-4-YL-1-TOSYLMETHYL ISOCYANIDE; 1-PYRROL-2-YL-1-TOSYLMETHYL ISOCYANIDE; 1-THIOPHEN-2-YL-1-TOSYLMETHYL ISOCYANIDE; 2,4-DICHLORO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 2-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-NAPHTHALENE; 2-CHLORO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 2-CHLORO-4-FLUORO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 3-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZOIC ACID METHYL ESTER; 3-BROMO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 4-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-1,2-DIMETHOXY-BENZENE; 4-[ISOCYANO(TOLUENE-4-SULPHONYL)METHYL]BIPHENYL; 4-BROMO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 5-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-1,2,3-TRIMETHOXY-BENZENE; 5-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZO[1,3]DIOXOLE; 6-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-2,3-DIHYDRO-BENZO[1,4]DIOXINE; A-(P-TOLYLSULFONYL)-A-((THIEN-3-YL)METHYL)ISOCYANIDE; ALPHA-(P-TOLUENESULFONYL)-4-FLUOROBENZYLISONITRILE; A-TOSYL-(2,3-DIFLUOROBENZYL)ISOCYANIDE; A-TOSYL-(2,4-DIFLUOROBENZYL)ISOCYANIDE; A-TOSYL-(2,5-DIFLUOROBENZYL) ISOCYANIDE; A-TOSYL-(2,6-DIFLUOROBENZYL)ISOCYANIDE; A-TOSYL-(2-BROMOBENZYL) ISOCYANIDE; A-TOSYL-(2-NITROBENZYL) ISOCYANIDE; A-TOSYL-(3,4-DIFLUOROBENZYL) ISOCYANIDE; A-TOSYL-(3,5-DIFLUOROBENZYL) ISOCYANIDE; A-TOSYL-(3-IODOMETHYLBENZYL)ISOCYANIDE; A-TOSYL-(3-NITROBENZYL) ISOCYANIDE; A-TOSYL-(4-CHLOROBENZYL) ISOCYANIDE; A-TOSYL-(4-IODOMETHYLBENZYL)ISOCYANIDE; A-TOSYL-(4-NITROBENZYL) ISOCYANIDE; ISOCYANO(2-METHOXYPHENYL)METHYL-4-METHYLPHENYL SULFONE; ISOCYANO(2-TERT-BUTYLSULFANYLPHENYL)METHYL-4-METHYLPHENYL SULFONE; PHENYLSULFONYLMETHYL ISOCYANIDE; TERT-BUTYL-3-ISOCYANO-3-TOSYLPROPANOATE; TOSYL-(2-FLUORBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-BROMBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-CHLORBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-CYANOBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-FLUORBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-METHYLBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-TRIFLUORMETHYLBENZYL)-METHYLISOCYANIDE; TOSYL-(4-BROMBENZYL)-METHYL-ISOCYANIDE; TOSYL-(4-CHLORBENZYL)-METHYL-ISOCYANIDE; TOSYL-(4-CYANOBENZYL)-METHYL-ISOCYANIDE; TOSYL-(4-FLUORBENZYL)-METHYL-ISOCYANIDE; TOSYL-(4-METHYLBENZYL)-METHYL-ISOCYANIDE; TOSYL-(4-TRIFLUORMETHYLBENZYL)-METHYLISOCYANIDE; TOSYLMETHYL ISOCYANIDE
Methyl esters; METHYL ISOCYANOACETATE; 6-ISOCYANOHEXANOICACIDMETHYL-ESTER; 5-ISOCYANOVALERIC ACID METHYL ESTER; TRANS-4-(ISOCYANOMETHYL)CYCLOHEXANE CARBOXYLIC ACID METHYL ESTER; 11-ISOCYANOUNDECANOIC ACID METHYL ESTER; D,L-3-ISOCYANO-N-BUTYRIC ACID METHYL ESTER; 4-ISOCYANOBUTYRIC ACID METHYL ESTER; 2-ISOCYANO-2-(4-FLUOROPHENYL) ACETIC ACID METHYL ESTER; 2-ISOCYANO-2-(4-CHLOROPHENYL)PROPIONIC ACID METHYL ESTER; 2-ISOCYANO-4-BENZYLOXYCARBONYLBUTYRIC ACID METHYL ESTER; 2,6-DIISOCYANOHEPTANEDIOIC ACID DIMETHYL ESTER; 2-ISOCYANO-2-(4-FLUOROPHENYL)-PROPIONIC ACID METHYL ESTER; 2-ISOCYANO-(INDOL-3-YL)-ACETIC ACID METHYL ESTER; 2-ISOCYANO-4-METHYLPENTANOIC ACID METHYL ESTER; 2-ISOCYANOHEXANOIC ACID METHYL ESTER; 2-ISOCYANOADIPIC ACID DIMETHYL ESTER; 2,5-DIISOCYANOVALERIC ACID METHYL ESTER; 2-(1′-ISOCYANOCYCLOHEXYL) ACETIC ACID METHYL ESTER; METHYL 3-ISOCYANO-3-(3-NITROPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(4-METHYLPHENYL)PROPIONATE; METHYL-3-ISOCYANO-3-(4-BENZYLOXYPHENYL)PROPIONATE; 2-ISOCYANOOCTANOIC ACID METHYL ESTER; 2-ISOCYANOSUCCINIC ACID DIMETHYL ESTER; 2-ISOCYANOVALERIC ACID METHYL ESTER; METHYL 3-ISOCYANO-3-(3-FLUOROPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(4-FLUOROPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(4-ISOPROPYLPHENYL)PROPIONATE; 2-ISOCYANO-3-(BENZYLTHIO)PROPIONIC ACID METHYL ESTER; 2-ISOCYANO-2,4-DIMETHYLPENTANOIC ACID METHYL ESTER; 2-ISOCYANO-4-(METHYLTHIO)BUTYRIC ACID METHYL ESTER; METHYL-2-ISOCYANO-3-(METHYLTHIO)-PROPIONATE; 2-ISOCYANO-3,3-DIMETHYLBUTYRIC ACID METHYL ESTER; METHYL 3-ISOCYANO-3-(2-FLUOROPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(3,4-METHYLENEDIOXYPHENYL)PROPIONATE; 3-DIMETHYLAMINO-2-ISOCYANOACRYLIC ACID METHYL ESTER; 2-ISOCYANO-3-PHENYLPROPIONIC ACID METHYL ESTER; METHYL 3-ISOCYANO-3-(4-HEXYLOXYPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(2,3-DICHLOROPHENYL)PROPIONATE; METHYL-3-ISOCYANO-3-(4-CYANOPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(4-METHYLTHIOPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-PHENYLPROPIONATE; METHYL-3-ISOCYANO-3-(4-BENZALDEHYDEDIETHYLACETAL)PROPIONATE; METHYL-3-ISOCYANO-3-(4-BROMOPHENYL)PROPIONATE; 2-ISOCYANOGLUTARIC ACID METHYL ESTER; METHYL 2-ISOCYANO-3-METHYLPENTANOATE; METHYL 3-ISOCYANO-3-(4-TRIFLUOROMETHYLPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(4-METHOXYPHENYL)PROPIONATE; METHYL-3-ISOCYANO-4-CHLOROBENZOATE; METHYL-3-ISOCYANO-2-METHYLBENZOATE; METHYL 3-ISOCYANO-4-METHYLBENZOATE; METHYL-4-ISOCYANOBENZOATE; METHYL-1-ISOCYANOCYCLOHEXYL-CARBOXYLATE; METHYL 3-ISOCYANOPROPANOATE; METHYL-3-ISOCYANOBENZOATE; METHYL 2-ISOCYANOISOVALERATE; 2-ISOCYANOPROPIONIC ACID METHYL ESTER; METHYL-2-ISOCYANO-ISOBUTYRATE; (S,R)-METHYL-2-ISOCYANO-3-METHYL-3-PHENYLPROPIONATE; METHYL-3-ISOCYANO-(3-METHOXYPHENYL)PROPIONATE; 8-ISOCYANO-OCTANOIC ACID METHYL ESTER; METHYL-4-ISOCYANO-5-CHLORO-2-METHOXYBENZOATE; METHYL-3,5-DIISOCYANOBENZOATE; METHYL-3-METHYLCARBOXYMETHYL-THIO-2-ISOCYANOPROPIONATE; METHYL-2-ISOCYANO-5-CHLORO-BENZOATE; METHYL-2-ISOCYANO-3-METHYL-BENZOATE; METHYL-2-ISOCYANO-6-CHLORO-BENZOATE; METHYL-2-ISOCYANO-6-FLUOR-BENZOATE; METHYL-2-ISOCYANO-5-BROMO-BENZOATE; METHYL-2-ISOCYANO-4,5-DIMETHOXY-BENZOATE; METHYL-3-ISOCYANO-2-NAPHTHALINOATE; METHYL-4-(ISOCYANOMETHYL)-BENZOATE; METHYL-2-ISOCYANO-3,5-DICHLORO-BENZOATE; METHYL-2-ISOCYANO-5-METHYL-BENZOATE; METHYL-2-ISOCYANO-6-METHYL-BENZOATE; METHYL-2-ISOCYANO-5-NITRO-BENZOATE; METHYL-2-ISOCYANO-4-FLUOR-BENZOATE; METHYL-3-ISOCYANOHEXANOATE; METHYL-2-ISOCYANO-3-(4-IMIDAZOLYL)PROPIONATE; METHYL-1-ISOCYANO-1-CYCLOPENTAN-CARBOXYLATE; 2-ISOCYANO-4-(METHYLSELENO) BUTYRIC ACID METHYL ESTER; METHYL-2-ISOCYANOBENZOATE; DIMETHYL 2-ISOCYANOTEREPHTHALATE; METHYL-2-ISOCYANO-4-CHLORO-BENZOATE; SCHOLLKOPF ISOCYANIDE; METHYL-3-[3,5-BIS(TRIFLUOROMETHYL)-PHENYL]-2-ISOCYANO-PROPIONATE; METHYL-2-ISOCYANO-3-(4-CHLORO-PHENYL)-PROPIONATE; METHYL 3-(1H-INDOL-3-YL)-2-ISOCYANOPROPANOATE; METHYL 2-ISOCYANO-3-(4-BENZYLOXY-PHENYL)-PROPIONATE; METHYL-2-ISOCYANO-3-(4-FLUORO-PHENYL)-PROPIONATE; METHYL-4-ISOCYANO-3-METHYL-BENZOATE; METHYL-(−1-ISOCYANOCYCLOPROPYL)-CARBOXYLATE; METHYL-3-ISOCYANO-4-METHOXY-BENZOATE; METHYL 4-ISOCYANOPHENYLACETATE; 2-ISOCYANO-3-ACETYL PROPIONIC ACID METHYL ESTER; METHYL-2-ISOCYANONAPHTHALENE CARBOXYLATE; 2-ISOCYANOPHENYL ACETIC ACID METHYL ESTER; METHYL (2R)-2-AMINO-3-(4,6-DIAMINO-3-ISOCYANO(2-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(4,6-DIAMINO-3-ISOCYANO(2-PYRIDYL))PROPANOATE; METHYL-4-ISOCYANO-3-(TRIFLUOROMETHOXY)-BENZOATE; METHYL-2-ISOCYANO-3-(TRIFLUOROMETHYL)-BENZOATE; METHYL-3-ISOCYANO-5-(TRIFLUOROMETHYL)-BENZOATE; METHYL-2-ISOCYANO-6-(TRIFLUOROMETHYL)-BENZOATE; METHYL-2-HYDROXYMETHYL-ISOCYANO-ACETATE; METHYL-3-(4-T-BUTOXYPHENYL)-2-ISOCYANO-PROPIONATE; METHYL-3-(N—BOC-AMINO)-5-ISOCYANO-BENZOATE; CN-GLY-PRO-OME; METHYL-2-FLUORO-4-ISOCYANOBUTYRATE; METHYL-3-ISOCYANO-4-FLUOROBENZOATE; METHYL-2-ISOCYANO-5-FLUOROBENZOATE; METHYL-2-FLUORO-4-ISOCYANOBENZOATE; METHYL-3-FLUORO-4-ISOCYANOBENZOATE; METHYL-2-FLUORO-5-ISOCYANOBENZOATE; 2-ISOCYANO-BUTANOIC ACID METHYL ESTER
Without methyl ester functionality; TERT-BUTYL ISOCYANIDE; 1,1,3,3-TETRAMETHYLBUTYL ISOCYANIDE; BENZYL ISOCYANIDE; N-BUTYLISOCYANIDE; CYCLOHEXYL ISOCYANIDE; 1,6-DIISOCYANOHEXANE; 1,4-DIISOCYANOBENZENE; 2,6-DIMETHYLPHENYL ISOCYANIDE; I-PROPYLISOCYANIDE; 2-MORPHOLINOETHYL ISOCYANIDE; 3-ISCYANOPROPYLTOSYLATE; (ISOCYANOMETHYL)TRIMETHYLSILANE; DIETHYL ISOCYANOMETHYLPHOSPHONATE; 3-ISOCYANATOPROPYLTRIMETHOXYSILANE; HEXYL ISOCYANIDE; 1-(ISOCYANOMETHYL)-1H-BENZOTRIAZOLE; 4-ETHYLPHENYL ISOCYANIDE; TRIPHENYLMETHYLISOCYANIDE; XANTHOASCIN; XANTOCILLIN; XANTHOCILLIN X MONOMETHYL ETHER; ETHYL ISOCYANIDE; 6-OXABICYCLO(3.1.0)HEX-3-ENE-2-METHANOL, 2-HYDROXY-4-ISOCYANO-ALPHA-METHYL-, (1-ALPHA,2-BETA,2(R*),5-ALPHA)-(−)-; BIS-(4-ISOCYANOPHENYL)METHANE; 3,5-BIS(TRIFLUOROMETHYL)PHENYLISOCYANIDE; 4-CHLORO-2-ISOCYANO-1-METHOXY-BENZENE; 2-ISOCYANO-5-CHLORBENZOTRIFLUORIDE; 2,3-DICHLOROPHENYLISOCYANIDE; 1,3-DICHLORO-5-ISOCYANOBENZENE; 1-ISOCYANO-2,5-DIMETHOXY-4-NITRO-BENZENE; 2-METHOXY-5-NITRO-PHENYL-ISOCYANIDE; 4-NITROPHENYLISOCYANIDE; 2-METHOXY-4-NITROPHENYL ISOCYANIDE; 2-METHYL-5-NITROPHENYL ISOCYANIDE; 4-METHYL-3-NITRO-PHENYLISOCYANIDE; 3-NITROPHENYLISOCYANIDE; CARDIO-SPECT; 1-ADAMANTANEISOCYANIDE; 4-METHOXYBENZYL ISOCYANIDE; 1-ETHOXY-4-(ISOCYANOMETHYL)BENZENE; 3-FLUOROBENZYLISOCYANIDE; 3-CHLOROBENZYLISOCYANIDE; 3-METHOXYBENZYLISOCYANIDE; 2-CHLOROBENZYLISOCYANIDE; 2-METHOXYBENZYLISOCYANIDE; 2-TRIFLUOROMETHYLBENZYLISOCYANIDE; 1-(2-ISOCYANOETHYL)-4-METHOXYBENZENE; 2-METHYLBENZYLISOCYANIDE; 3-METHYLBENZYLISOCYANIDE; 1-(ISOCYANOMETHYL)-4-METHYLBENZENE; 3,4-DIMETHOXYBENZYL ISOCYANIDE; 1,3-BENZODIOXOL-5-YLMETHYL ISOCYANIDE; (1-ISOCYANOETHYL)BENZENE; 2-PHENOXYPHENYLISOCYANIDE; 3-PHENYLPROPYL ISOCYANIDE; (2-ISOCYANOETHYL)BENZENE; 1,3-DICHLORO-2-(2-ISOCYANOETHYL)BENZENE; 4-FLUOROPHENETHYLISOCYANIDE; BETA-METHYLPHENYLETHYLISOCYANIDE; 2-(4-CHLOROPHENYL)ETHYLISOCYANIDE; 1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL ISOCYANIDE; ISOAMYLISOCYANIDE; 2-ISOCYANOMETHYLTETRAHYDRO-FURANE; OCTYL ISOCYANIDE; 3-TRIFLUOROMETHYLBENZYLISOCYANIDE; 2-FLUOROBENZYLISOCYANIDE; 2-METHOXYPHENYL ISOCYANIDE; 3-METHOXYPHENYL ISOCYANIDE; 1-BENZYL-4-ISOCYANOPIPERIDINE; 1-BENZYL-4-(ISOCYANOMETHYL)-4-PHENYLPIPERIDINE; 9-ETHYL-3-ISOCYANO-9H-CARBAZOLE; 2,2-DIPHENYLETHYLISOCYANIDE; 1-ISOCYANO-3,3-DIPHENYLPROPANE; 4-PHENYLBUT-1-YLISOCYANIDE; 2-PENTYL ISOCYANIDE; 2-ISOCYANOBUTANE; 1-PENTYL ISOCYANIDE; DIPHENYLMETHYL ISOCYANIDE; 3,4-DICHLOROPHENYLISOCYANIDE; 3-ISOCYANOBENZONITRILE; 2,2-DIMETHOXYETHYL ISOCYANIDE; CYCLOPENTYL ISOCYANIDE; 2-CYANOPHENYLISONITRILE; 4-ISOCYANOBENZONITRILE; 1-ISOCYANO-2-(TRIFLUOROMETHYL)BENZENE; 3-ISOCYANO-4-CHLOROBENZOTRIFLUORIDE; 3-ISOCYANOBENZOTRIFLUORIDE; 5-ISOCYANO-2-CHLOROBENZOTRIFLUORIDE; 3-(ISOCYANOMETHYL)PYRIDINE; 4-(ISOCYANOMETHYL)PYRIDINE; 5-METHYLHEX-2-YLISOCYANIDE; 2-(ISOCYANOMETHYL)PYRIDINE; 1-BENZOYL-4-(2-ISOCYANOETHYL)PIPERAZINE; 1-(2-ISOCYANOETHYL)-PIPERIDINE; 1-METHYL-3-PHENYLPROPYLISOCYANIDE; 2-BROMOBENZYLISOCYANIDE; 3-BROMOBENZYLISOCYANIDE; 4-METHOXYPHENYL ISOCYANIDE; 4-BENZYLOXYPHENYLISOCYANIDE; 2,4-DICHLOROPHENYL ISOCYANIDE; 1-CHLORO-2-ISOCYANOBENZENE; 2,5-DICHLOROPHENYL ISOCYANIDE; 2,6-DICHLOROPHENYL ISOCYANIDE; 3-CHLORO-4-FLUOROPHENYLISOCYANIDE; 4-CHLORO-2-FLUORO-1-ISOCYANOBENZENE; 5-CHLORO-2-METHYLPHENYL ISOCYANIDE; 3-CHLORO-4-METHYLPHENYLISOCYANIDE; 3-CHLORO-2-METHYL-PHENYL-ISOCYANIDE; 4-SEC-BUTYLPHENYL ISOCYANIDE; 4-TERT-BUTYLPHENYLISOCYANIDE; 2-SEC-BUTYLPHENYL ISOCYANIDE; 2-ISOPROPYL-PHENYLISOCYANIDE; 2-ETHYLPHENYL ISOCYANIDE; 4-ISOPROPYL-PHENYLISOCYANIDE; 4-(TRIFLUORMETHOXY)-PHENYL-ISOCYANIDE; 2,3-DIMETHYLPHENYLISOCYANIDE; 2,4-DIMETHYLPHENYL ISOCYANIDE; 2,5-DIMETHYLPHENYL ISOCYANIDE; 3,5-DIMETHYLPHENYL ISOCYANIDE; 3,4-DIMETHYLPHENYL ISOCYANIDE; N-(4-ISOCYANOPHENYL)-N,N-DIMETHYLAMINE; 1-ISOCYANONAPHTHALENE; CYCLOHEPTYL ISOCYANIDE; CYCLOCTYLISOCYANIDE; 2-CYCLOHEXEN-1-YLETHYLISOCYANIDE; 2-(3,4-DIMETHOXYPHENYL)ETHYLISOCYANIDE; 3,4-DIFLUORPHENYLISOCYANIDE; 2,4-DIFLUOROPHENYL ISOCYANIDE; 1,4-DIISOCYANOBUTANE; 1,3-DIISOCYANOPROPANE; N-(3-ISOCYANOPROPYL)-N,N-DIMETHYLAMINE; N,N-DIETHYL-N-(3-ISOCYANOPROPYL)AMINE; 2-ISOCYANO-N,N-DIMETHYLETHANAMINE; 4-(3-ISOCYANOPROPYL)MORPHOLINE; 3-METHOXYPROPYL ISOCYANIDE; 3-BUTOXYPROP-1-YLISOCYANIDE; 1-ISOCYANO-3-ISOPROPOXYPROPANE; 3-ISOCYANOOCTANE; TERT-AMYLISOCYANIDE; 2-ISOCYANOOCTANE; 5-ISOCYANOMETHYL-2-DIMETHYL-DIOXOLANE; 4-BROMOBENZYLISOCYANIDE; 4-FLUOROBENZYLISOCYANIDE; 4-CHLOROBENZYLISOCYANIDE; (S)-(−)-ALPHA-METHYLBENZYL ISOCYANIDE; ISONITRILOMETHYL PS RESIN; TUNGSTEN(0) PENTACARBONYL-N-PENTYLISONITRILE; 5-CHLORO-2-ISOCYANOPYRIDINE; 5-BROMO-2-ISOCYANOPYRIDINE; 1-ISOCYANO-4-PHENOXYBENZENE; 1-(3-ISOCYANOPHENYL)ETHANONE; 1-FLUORO-3-ISOCYANOBENZENE; 2,6-DIBROMO-4-FLUOROPHENYLISOCYANIDE; 3-BROMO-4-FLUOROBENZYLISOCYANIDE; 5-BROMO-2-FLUOROBENZYLISOCYANIDE; 1-(4-CHLOROPHENYL)ETHYL ISOCYANIDE; 2-CHLORO-6-FLUOROBENZYLISOCYANIDE; 3,4,5-TRIMETHOXYBENZYLISOCYANIDE; 3,5-BIS(TRIFLUOROMETHYL)BENZYLISOCYANIDE; 2,4-DIFLUOROBENZYLISOCYANIDE; 2,5-DIFLUOROBENZYLISOCYANIDE; 2,5-DIMETHYLBENZYLISOCYANIDE; D-(+)-ALPHA-METHYLBENZYLISOCYANIDE; 1-(4-BROMOPHENYL)ETHYLISOCYANIDE; 2-PHENYLPROP-2-YLISOCYANIDE; 4-(TRIFLUOROMETHOXY)BENZYLISOCYANIDE; 2,6-DIFLUORBENZYLISOCYANIDE; 3-(METHYLTHIO)PHENYLISOCYANIDE; 1-BROMO-4-ISOCYANOBENZENE; 3-NITROBENZYLISOCYANIDE; 4-ISOCYANOBENZOPHENONE; 4-ETHOXYPHENYLISOCYANIDE; 2-CHLORO-4-NITROPHENYLISOCYANIDE; 2-ETHOXYPHENYLISOCYANIDE; CYCLOPROPYL ISOCYANIDE; (S)-(+)-1-ISOCYANOINDANE; (R)-(−)-1-ISOCYANOINDANE; 4-BROMO-2-FLUOROBENZYLISOCYANIDE; 4-CHLORO-2-FLUOROBENZYLISOCYANIDE; 1-FLUORO-2-ISOCYANOBENZENE; 4-METHYLPHENYLISOCYANIDE; 4-ISOCYANO-3-NITROBENZOTRIFLUORIDE; 2-METHYLPHENYLISOCYANIDE; 2-METHYL-6-ISOPROPYLPHENYLISOCYANIDE; (S)-3,3-DIMETHYLBUTY-2-YLISOCYANIDE; 4-TERT-BUTYLBENZYLISOCYANIDE; 2,2-DIPHENYLPROPYLISOCYANIDE; 2,4-DIMETHOXYPHENYLISOCYANIDE; 2,5-DIMETHOXYPHENYLISOCYANIDE; 4-BROMO-2-FLUOROPHENYLISOCYANIDE; 3,3-DIMETHYLBUT-1-YLISOCYANIDE; (R)-3,3-DIMETHYLBUT-2-YLISOCYANIDE; 2,2-DIMETHYLPROPYLISOCYANIDE; CYCLODODECYLISOCYANIDE; 1-ISOCYANOINDANE; 2-(3-METHOXYPHENYL)ETHYL-ISOCYANIDE; 3,5-DIMETHYLBENZYLISOCYANIDE; 3-ISOCYANO-4-METHOXY-1,1′-BIPHENYL; 2-ISOCYANO-5-CHLORO-2′-FLUOROBENZOPHENONE; 2-ISOCYANO-2′-FLUORO-5-BROMO-BENZOPHENONE; 2-BROMOPHENYLISOCYANIDE; 3,4-DIMETHOXYPHENYLISOCYANIDE; 3-ISOCYANO-PHENYLFORMAMIDE; 4-FLUOROPHENYL ISOCYANIDE; 4-ISOCYANOACETOPHENONE; 1-ISOCYANO-2-PHENYLBENZENE; 1-CYANO-4-ISOCYANONAPHTHALENE; 2-FLUOROPHENETHYLISOCYANIDE; 2-(3-BROMOPHENYL)ETHYLISOCYANIDE; 2-(4-BROMOPHENYL)ETHYLISOCYANIDE; 2-(2-CHLOROPHENYL)ETHYLISOCYANIDE; 3,4-DICHLOROBENZYLISOCYANIDE; 2,4-DICHLORBENZYLISOCYANIDE; 2-(4-ISOCYANOPHENYL)ETHYL-ISOCYANIDE; 3-METHYLPHENETHYLISOCYANIDE; 4-CHLORO-2-METHOXY-5-METHYLPHENYL ISOCYANIDE; 2,4-DIBROMO-6-METHYLPHENYL-ISOCYANIDE; 2-BROMO-4-METHYLPHENYLISOCYANIDE; 2,5-DIBROMOPHENYLISOCYANIDE; 2-FLUOR-5-NITROPHENYLISOCYANIDE; 2,4,6-TRICHLOROPHENYLISOCYANIDE; 4-BROMO-2-CHLOROPHENYLISOCYANIDE; 2-METHYLPHENETHYLISOCYANIDE; 3-FLUOROPHENETHYLISOCYANIDE; 2,4-DICHLOROPHENETHYLISOCYANIDE; 2-(3-CHLORO-PHENYL)ETHYLISOCYANIDE; 3-CHLORO-2-METHOXYPHENYL-ISOCYANIDE; 1-ISOCYANO-4-(TRIFLUOROMETHYL)BENZENE; 3-BROMOPHENYLISOCYANIDE; 2,6-DIBROMO-4-NITROPHENYLISOCYANIDE; 2,6-DIBROMO-4-METHYLISOCYANIDE; 4-FLUORO-2-METHYLPHENYLISOCYANIDE; 2-METHOXY-5-METHYLPHENYL-ISOCYANIDE; 1-ISOCYANOBENZENE; 1-(2-ISOCYANOETHYL)-PYRROLIDINE; 1-(2-ISOCYANO-ETHYL)-4-METHYL-PIPERAZINE; (5-CHLORO-2-THIENYL)METHYLISOCYANIDE; 2-(THIEN-2-YL)ETHYLISOCYANIDE; 1-(2-ISOCYANOETHYL)-2,2-DIMETHYLPYRROLIDINE; 1-(3-CHLOROPHENYL)ETHYL ISOCYANIDE; 3-(1-ISOCYANO-ETHYL)-PYRIDINE; 4-(1-ISOCYANOETHYL)PYRIDINE; 4-BENZYL-1-(2-ISOCYANO-ETHYL)PIPERIDINE; 1-(2-ISOCYANO-ETHYL)-4-PYRIDIN-2-YL-PIPERAZINE; 1-CYCLOHEXYL-4-(2-ISOCYANO-ETHYL)-PIPERAZINE; 4-(TRIFLUOROMETHYL)BENZYL-ISOCYANIDE; 1-(2-CHLOROPHENYL)ETHYL ISOCYANIDE; 1-(1-ISOCYANO-ETHYL)-2-METHOXY-BENZENE; 1-(5-METHYL-2-THIENYL)ETHYL ISOCYANIDE; 1-(4-FLUOROPHENYL)ETHYLISOCYANIDE; 1-(2-ISOCYANO-ETHYL)-4-PHENYL-PIPERAZINE; 1-(2-ISOCYANOETHYL)-4-(2-PYRROLIDINOETHYL)-PIPERIDINE; N-2-ISOCYANOETHYL-2,3-DIHYDROINDOLE; 1-(2-ISOCYANOETHYL)-1,2,3,4-TETRAHYDROQUINOLINE; 1-(2-ISOCYANOETHYL)-6,7-DIEMTHOXY-1,2,3,4-TETRAHYDROQUINOLINE; 1-(2-ISOCYANO-ETHYL)-4-PHENYL-PIPERIDINE; 1-(3-CHLORO-PROPYL)-4-(2-ISOCYANO-ETHYL)-PIPERAZINE; 1-ALLYL-4-(2-ISOCYANO-ETHYL)-PIPERAZINE; 1-BUTYL-4-(2-ISOCYANOETHYL)PIPERAZINE; 1-(2-ISOCYANO-ETHYL)-4-ISOPROPYL-PIPERAZINE; 4-[4-(2-ISOCYANO-ETHYL)-PIPERAZIN-1-YL]-MORPHOLINE; 1-(2-ISOCYANO-ETHYL)-4-PYRROLIDIN-1-YL-PIPERAZINE; 1-(2-ISOCYANO-ETHYL)-4-(2-METHOXY-ETHYL)-PIPERAZINE; 1-(2-ISOCYANO-ETHYL)-4-(2-DIMETHYLAMINOETHYL)-PIPERAZINE; 1-(2-ISOCYANO-ETHYL)-4-(2-PYRIMIDINO)-PIPERAZINE; 1-(2-ISOCYANO-ETHYL)-4-(2-PYRAZINYL)-PIPERAZINE; 1-CHLORO-4-ISOCYANOBENZENE; 4-(DIETHYLAMINO)PHENYL ISOCYANIDE; 2-ISOCYANO-1-PHENYLETHANOLE; 1-(2-ISOCYANO-ETHYL)-4-PYRIDIN-4-YL-PIPERAZINE; 2-CHLORO-6-METHYLPHENYL ISOCYANIDE; METHYL ISOCYANIDE; 4-(2-DIMETHYLAMINO)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4,4′-DIISOCYANO-BIPHENYL; 4-(ISOCYANOMETHYL)BENZYL-ISOCYANIDE; 1,4-BIS(3-ISOCYANOPROPYL)PIPERAZINE; 3-ISOCYANOPHENYLISOCYANIDE; 1,2-DIISOCYANOCYCLOHEXANE; 1,4-DIISOCYANOCYCLOHEXANE; 1,3-DIISOCYANO-2,2-DIMETHYL-PROPANE; 3-(2-ISOCYANOETHYL)-1H-INDOLE; 4-(3-CHLOROPROPYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-N-BUTYL-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-(2-PYRIMIDINO)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-(2-PYRAZINYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-(2-PYRIDYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-(4-PYRIDYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; N-METHYLPIPERAZINO-ISOCYANO-ACETAMIDE; 6-ISOCYANOQUINOLINE; 3-(ISOCYANOMETHYL)BENZYL-ISOCYANIDE; 1,2-DIISOCYANO-2-METHYLPROPANE; 1,5-DIISOCYANOPENTANE; 1,7-DIISOCYANOHEPTANE; 4,4′-DIISOCYANO-3,3′-DIMETHOXY-BIPHENYL; 1,2-BIS-(2-ISOCYANOETHOXY)-ETHANE; 1,3-BIS(ISOCYANOMETHYL)CYCLO-HEXANE; 4-ALLYL-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-ISOPROPYL-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-CYCLOHEXYL-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-[((2-MORPHOLINO-4-YL)ETHYL)]-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-(2-PYRROLIDINOETHYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; 1,2-DIISOCYANOETHANE; 4-(2-METHOXYETHYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-CHLORO-2-METHYLPHENYL ISOCYANIDE; (S,S)-1,2-DIISOCYANOCYCLO-HEXANE; 4-(2-PYRROLIDINOETHYL)-1-PIPERIDINO-2-ISOCYANOACETAMIDE; 1-PYRROLIDINO-2-ISOCYANOACETAMIDE; 4-(1-PYRROLIDINO)-PIPERIDINO-ISOCYANO-ACETAMIDE; 4-METHYL-PIPERIDINO-ISOCYANO-ACETAMIDE; 1-CYCLOHEXENYLISOCYANIDE; 1,10-DIISOCYANODECANE; 2-(2-ISOCYANOETHYL)PYRIDINE; N-MORPHOLINO-2-ISOCYANOACET-AMIDE; N-PIPERIDINO-2-ISOCYANOACETAMIDE; 4-BENZYL-PIPERIDINO-ISOCYANO-ACETAMIDE; 2,6-DIMETHYL-PIPERIDINO-ISOCYANO-ACETAMIDE; 4-PHENYL-PIPERIDINO-ISOCYANO-ACETAMIDE; (5-METHYL-2-FURYL)METHYL ISOCYANIDE; 1,3-DIMETHYLBUT-1-YLISOCYANIDE; 6-METHYLHEPT-2-YLISOCYANIDE; 2-NAPHTHYL ISOCYANIDE; 2-ISOCYANO-3-PHENYL-PROPIONIC-ACIDMORPHOLINAMIDE; 3,5-DIFLUORBENZYLISOCYANIDE; 4-FORMYLAMINOPHENYLISOCYANIDE; 2-(ISOCYANOMETHYL)FURAN; 2-ISOCYANOPYRIDINE; 2,3-DIHYDRO-6-ISOCYANO-1,4-BENZODIOXINE; 1-CHLORO-3-ISOCYANOBENZENE; 2-CHLORO-5-NITROPHENYLISOCYANIDE; 2,4-DIBROMPHENYLISOCYANIDE; 1-CHLORO-5-ISOCYANO-2,4-DIMETHOXYBENZENE; 3-PHENOXY-PHENYLISOCYANIDE; 3-CHLORO-2-FLUOROPHENYLISOCYANIDE; 1-ISOCYANO-2-METHOXYETHANE; 1-(3-ISOCYANOPROPYL)-1H-IMIDAZOLE; 3,4,5-TRIMETHOXYPHENYLISOCYANIDE; 1-ISOCYANO-3,3-DIETHOXYPROPANE; 1,8-DIISOCYANOOCTANE; 2,2-DIETHOXY-1-ISOCYANOETHANE; 1-(2-ISOCYANOPHENYL)PYRROLE; (R)-(+)-ALPHA-(1-NAPHTHYL)-ETHYL-ISOCYANIDE; (S)-(−)-ALPHA-(1-NAPHTHYL)-ETHYL-ISOCYANIDE; 4-(4-ISOCYANOPHENYL)MORPHOLINE; 4-NITROPHENYLETHYLISOCYANIDE; 5-ISOCYANOMETHYLINDOLE; 3-ISOCYANOPROPYLTRIETHOXYSILANE; 1-(3-ISOCYANOPROPYL)-2-PYRROLIDINONE; 2-(2-ISOCYANOETHOXY)PROPANE; 1-(2-ISOCYANOETHOXY)PROPANE; 1-ETHOXY-2-ISOCYANOETHANE; 2-TERT-BUTOXYETHYL ISOCYANIDE; 1,3-BENZODIOXOL-5-YLISOCYANIDE; 2-ISOCYANO-1,3,5-TRIMETHYLBENZENE; 4-ISOCYANO-1,3,5-TRIMETHYL-1H-PYRAZOLE; 8-ISOCYANOQUINOLINE; (1-ISOCYANO-2-PHENYLETHYL)BENZENE; 1-(ISOCYANOMETHYL)NAPHTHALENE; 4-PHENYLCYCLOHEXENYLISOCYANIDE; 3-CHLORO-5-METHOXYPHENYLISOCYANIDE; 2-IODOPHENYL ISOCYANIDE; 3-CHLORO-4-METHOXYPHENYLISOCYANIDE; 2-(3,4-DIETHOXYPHENYL)ETHYL ISOCYANIDE; 2,4-DIMETHOXYBENZYL ISOCYANIDE; 3-METHYLPHENYL ISOCYANIDE; 2-CHLORO-5-(TRIFLUOROMETHYL)BENZYL-ISOCYANIDE; 1,3-DIETHYL-2-ISOCYANO-BENZENE; 2,3-DICHLOROBENZYLISOCYANIDE; 4-CHLORO-3-(TRIFLUOROMETHYL)BENZYL-ISOCYANIDE; 2,3-DIMETHYLBENZYLISOCYANIDE; 4-METHYL-3-CHLOROBENZYL-ISOCYANIDE; 2,4,6-TRIMETHYLBENZYLISOCYANIDE; 3-CHLORO-4-FLUOROBENZYLISOCYANIDE; 2,6-DICHLOROBENZYLISOCYANIDE; 4-PHENOXY-BENZYLISOCYANIDE; 3-PHENOXYBENZYL ISOCYANIDE; 2-METHYL-3-NITROPHENYL ISOCYANIDE; 2-METHYL-4-NITROPHENYL ISOCYANIDE; ALLYLISOCYANIDE; CYCLOBUTYL ISOCYANIDE; 4-BROMO-2-METHYLPHENYL ISOCYANIDE; 1-ISOPROPYL-2-METHYLPROPYL ISOCYANIDE; 1,7,7-TRIMETHYLBICYCLO[2.2.1]HEPT-2-YL ISOCYANIDE; 4-(2-ISOCYANOETHYL)PYRIDINE; 2-NITROPHENYL ISOCYANIDE; 2-ISOCYANO-N,N-DIMETHYL-2-PYRIDIN-4-YLETHYLENAMINE; 1,2,3,4-TETRAHYDRO-CHINOLINO-1-ISOCYANOACETAMIDE; 4-(METHYLTHIO)PHENYLISOCYANIDE; 2-ISOCYANO-2-METHYLPROPANE HYDROCHLORIDE; 5-ISOCYANO-PYRIDINE-2,4-DIAMINE; 5-BROMO-2-ISOCYANO-1,3-DIMETHYLBENZENE; 2,5-DIFLUORO-PHENYLISOCYANIDE; 2,6-DIFLUORO-PHENYLISOCYANIDE; 2,4,6-TRIFLUORO-PHENYLISOCYANIDE; 2-ETHYL-6-METHYL-PHENYLISOCYANIDE; 2-ISOCYANO-9-FLUORENONE; 2-(TRIFLUORMETHOXY)-PHENYLISOCYANIDE; 2-ISOCYANOBENZOPHENONE; 2-ISOCYANO-5-CHLORBENZO-PHENONE; 2-ISOCYANO-2′,5-DICHLORBENZO-PHENONE; 2-NITRO-4-METHOXYPHENYL-ISOCYANIDE; 2-ISOPROPENYL-PHENYLISOCYANIDE; 2,3,4-TRIFLUORO-PHENYLISOCYANIDE; 2-CHLORO-4-FLUORO-5-METHYL-PHENYLISOCYANIDE; 4-BUTOXY-PHENYLISOCYANIDE; 4-METHOXY-2-METHYL-PHENYL-ISOCYANIDE; 2-METHOXYISOBUTYL ISOCYANIDE; PROPANE, 2-ISOCYANO-2-METHYL-, ZINC COMPLEX; 2-(4-ISOCYANOPHENYL)ACETONITRILE; 5-FLUORO-2-METHYL-PHENYL-ISOCYANIDE; 3,5-DIMETHOXY-PHENYLISOCYANIDE; 4-ISOCYANO-3-CHLOROBENZOTRI-FLUORIDE; 4-OCTYLOXY-PHENYLISOCYANIDE; 5-BROMO-2-METHYL-PHENYL-ISOCYANIDE; 2,4,5-TRIFLUORO-PHENYLISOCYANIDE; 4-VINYL-PHENYLISOCYANIDE; 3,3-DIFLUORO-PHENYLISOCYANIDE; 3-ETHYL-PHENYLISOCYANIDE; 3-FLUORO-2-METHYL-PHENYL-ISOCYANIDE; 4-PROPYL-PHENYLISOCYANIDE; 2-BROMO-4-TRIFLUOROMETHOXY-PHENYLISOCYANIDE; 3-BROMO-4-METHYL-PHENYL-ISOCYANIDE; 1-ISOCYANO-3-(TRIFLUOROMETHOXY)BENZENE; 1,2-DIFLUORO-3-ISOCYANO-BENZENE; 4-HEXYL-PHENYLISOCYANIDE; 2-FLUORO-5-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 2-METHOXY-5-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 4-BROMO-5-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; (3-ISOCYANOPHENYL)(PHENYL)METHANONE; 2-TERT-BUTYL-PHENYLISOCYANIDE; 5-ISOCYANO-1H-INDOLE; 2-FLUORO-5-METHYL-PHENYLISOCYANIDE; 3-FLUORO-4-METHYL-PHENYLISOCYANIDE; 3-TRIFLUOROMETHYL-4-FLUORO-PHENYLISOCYANIDE; 2-METHOXYDIBENZO[B,D]FURAN-3-YL ISOCYANIDE; 1-(ISOCYANOMETHYL)-2,3-DIMETHOXYBENZENE; 6-ISOCYANO-1-METHYL-1H-INDOLE; 5-ISOCYANO-1-METHYL-1H-INDOLE; 6-BROMO-5-ISOCYANO-PYRIDINE-2,4-DIAMINE; 5-ISOCYANO-1H-INDAZOLE; 1-BENZYL-5-ISOCYANO-1H-INDAZOLE; 1-(ISOCYANOMETHYL)-3-(TRIFLUOROMETHOXY)BENZENE; 5-FLUORO-2-ISOCYANO-1,3-DIMETHYL-BENZENE; 1-(2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYL)-3-ISOCYANO-1H-PYRAZOL-5-AMINE; 1-ISOCYANO-3,5-DIMETHYLADAMANTANE; 2,3-DIHYDRO-6-ISOCYANOBENZO[E][1,3]OXAZIN-4-ONE; N-(4-ISOCYANOPHENYL)ACETAMIDE; 3-((1S,3S)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 3-((1R,3R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 4-((1S,3S)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 4-((1R,3R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; (R)-1-(4-ISOCYANOPHENYL)ETHANOL; (S)-1-(4-ISOCYANOPHENYL)ETHANOL; 3-((1R)-1-AMINO-2-HYDROXY-ISOPROPYL)BENZENISOCYANIDE; 3-((1S)-1-AMINO-2-HYDROXY-ISOPROPYL)BENZENISOCYANIDE; 4-((1R)-1-AMINO-2-HYDROXY-ISOPROPYL)BENZENISOCYANIDE; 4-((1S)-1-AMINO-2-HYDROXY-ISOPROPYL)BENZENISOCYANIDE; 4-((1S,3R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 3-((3S,1R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 3-((1S,3R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 4-((3S,1R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 2-ISOCYANO-1-METHOXY-3-METHYL-BENZENE; 1-(2-ISOCYANOETHYL)-3-TRIFLUOROMETHOXYBENZENE; 4-PHENYL-PIPERAZINO-ISOCYANO-ACETAMIDE; 2-CHLORO-4-ISOCYANOMETHYL-PYRIDINE; 2,4′-DIISOCYANO-BIPHENYL; 2,4-DIBROMO-6-FLUORPHENYLISOCYANIDE; 2,6-DIBROMO-4-(TRIFLUOROMETHOXY)PHENYL-ISOCYANIDE; 2,4-DIBROMO-6-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 2,6-DICHLORO-4-(TRIFLUOROMETHOXY)PHENYL-ISOCYANIDE; 2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYL-ISOCYANIDE; 3-(DIFLUOROMETHOXY)PHENYLISOCYANIDE; 1,5-BIS-ISOCYANOMETHYL-2,4-DIMETHYL-BENZENE; R-1-ISOCYANO-1,2,3,4-TETRA-HYDRONAPHTHALENE; 4-BROMO-3,5-DIFLUORO-PHENYLISOCYANIDE; 5-BROMO-2,4-DIFLUORO-PHENYLISOCYANIDE; 2-BROMO-4-FLUOROPHENYLISOCYANIDE; 2-BROMO-5-FLUOROPHENYLISOCYANIDE; 3-BROMO-4-FLUOROPHENYLISOCYANIDE; 4-BROMO-3-FLUOROPHENYLISOCYANIDE; 2-CHLORO-4,6-DIFLUORO-PHENYLISOCYANIDE; 2-CHLORO-4-FLUOROPHENYLISOCYANIDE; 2-CHLORO-5-FLUOROPHENYLISOCYANIDE; 2-CHLORO-6-FLUOROPHENYLISOCYANIDE; 4-CHLORO-3-FLUOROPHENYLISOCYANIDE; 5-CHLORO-2-FLUOROPHENYLISOCYANIDE; 2-CHLORO-5-FLUORO-4-NITROPHENYL-ISOCYANIDE; 4-(DIFLUOROMETHOXY)PHENYLISOCYANIDE; (1S,2R,5R)6,6-DIMETHYLBICYCLO-[3.1.1]HEPT-2-YLMETHYL-ISOCYANIDE; 3-FLUORO-4-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 2-(2-METHOXYPHENOXY)-5-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 3-TRIFLUOROMETHOXY-4-ISOCYANOBENZONITRIL; 2,4-BIS(TRIFLUOROMETHYL)PHENYLISOCYANIDE; 2,5-BIS(TRIFLUOROMETHYL)PHENYLISOCYANIDE; 3,5-BIS(TRIFLUOROMETHYL)-2-METHYL-PHENYLISOCYANIDE; 4-[3,5-DI(TRIFLUOROMETHYL)PHENOXY]-PHENYLISOCYANIDE; 2-BROMO-4-CHLORO-6-FLUOROPHENYLISOCYANIDE; 2-BROMO-5-CHLORO-4-FLUOROPHENYLISOCYANIDE; 2-BROMO-6-CHLORO-4-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 2-BROMO-4,6-DIFLUORO-PHENYLISOCYANIDE; 4-BROMO-2,6-DIFLUORO-PHENYLISOCYANIDE; 5-BROMO-2-FLUOROPHENYLISOCYANIDE; 3-BROMO-4-(TRIFLUOROMETHOXY)-PHENYLISOCYANIDE; 4-BROMO-2-(TRIFLUOROMETHOXY)-PHENYLISOCYANIDE; 4-BROMO-3-(TRIFLUOROMETHOXY)-PHENYLISOCYANIDE; 5-CHLORO-4-FLUORO-2-NITROPHENYL-ISOCYANIDE; 2-CHLORO-4-TRIFLUOROMETHOXY-PHENYLISOCYANIDE; 3-CHLORO-4-TRIFLUOROMETHOXY-PHENYLISOCYANIDE; 3-ISOCYANO-4-(METHYLTHIO)BENZOTRIFLUORIDE; 2-ISOCYANO-5-NITRO-BENZOTRIFLUORIDE; 3-ISOCYANO-4-NITRO-BENZOTRIFLUORIDE; 5-ISOCYANO-2-NITRO-BENZOTRIFLUORIDE; 4-ISOCYANO-NONAFLUOROBIPHENYL; 3-(TRIFLUOROMETHYLTHIO)-PHENYLISOCYANIDE; 4-(TRIFLUOROMETHYLTHIO)PHENYLISOCYANIDE; 4-[(3-(TRIFLUOROMETHYL)PHENYL)SULFANYL]-PHENYLISOCYANIDE; 3-ISOCYANO-4-(4-MORPHOLINO)BENZOTRIFLUORIDE; 3-ISOCYANO-4-(1-PIPERIDINO)-BENZOTRIFLUORIDE; 1,5-DIISOCYANO-NAPHTHALENE; 2-ISOCYANO-9H-FLUORENE; 2-BROMO-4-(TRIFLUOROMETHYL)-6-NITROPHENYL-ISOCYANIDE; 3-CHLORO-4-(TRIFLUOROMETHYL)PHENYL-ISOCYANIDE; 2-ISOCYANO-4-(4-CHLORO-3,5-DIMETHYLPHENOXY)-BENZOTRIFLUORIDE; 2-ISOCYANO-4-CHLORO-2′-FLUOROBENZOPHENONE; 3-CHLORO-5-NITRO-4-(TRIFLUOROMETHYL)-PHENYL-ISOCYANIDE; 2-CHLORO-5-NITRO-4-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 4-ISOCYANO-2-CYANO-3′-(TRIFLUOROMETHYL)DIPHENYL THIOETHER; 4-ISOCYANO-2,5-DIFLUOROBENZONITRILE; 2-ISOCYANO-5-(TRIFLUOROMETHYL)PYRIDINE; 2-ISOCYANO-6-(TRIFLUOROMETHYL)PYRIDINE; 3-ISOCYANO-4-(TRIFLUOROMETHYL)PYRIDINE; 3-ISOCYANO-6-(TRIFLUOROMETHYL)PYRIDINE; 4-BROMO-2-(TRIFLUORMETHYL)PHENYL-ISOCYANIDE; 2-BROMO-5-(TRIFLUORMETHYL)PHENYLISOCYANIDE; 3-BROM-5-(TRIFLUORMETHYL)PHENYL-ISOCYANIDE; 2,2′-DIISOCYANO-BIPHENYL; 2-BROMO-4-(TRIFLUOROMETHYL)PHENYL-ISOCYANIDE; 3-(4-ISOCYANOBENZYLTHIO)-BENZOTRIFLUORIDE; 3-CHLORO-2-FLUOROBENZYLISOCYANIDE; 5-CHLORO-2-FLUOROBENZYLISOCYANIDE; 6-CHLORO-2-FLUORO-3-METHYLBENZYLISOCYANIDE; 2,3-DIFLUORBENZYLISOCYANIDE; 3,4-DIFLUOROBENZYLISOCYANIDE; 2-(DIFLUOROMETHOXY)BENZYLISOCYANIDE; 1,4-DIISOCYANO-2-METHOXY-BENZENE; N-ALLYL-2-ISOCYANO-ACETAMIDE; N-ALLYL-2-ISOCYANO-N-METHYL-ACETAMIDE; N-ALLYL-2-BENZYL-2-ISOCYANO-ACETAMIDE; 2-ISOCYANO-4-METHYL-PENTANOIC ACID ALLYLAMIDE; 2-ISOCYANO-3-(5-IMIDAZO)-PROPIONIC ACID MORPHOLINAMIDE; N-PROPYLISOCYANIDE; 2-HYDROXY-CYCLOHEXYLISOCYANIDE; 3-(DIFLUOROMETHOXY)BENZYLISOCYANIDE; 3-ISOCYANO-2-(2-FLUOROPHENOXY)PYRIDINE; 5-FLUORO-2-ISOCYANOPYRIDINE; 2-ISOCYANO-4-(TRIFLUOROMETHYL)PYRIDINE; N-ALLYL-2-ISOCYANO-N-ETHYL-ACETAMIDE; 2-ISOCYANO-PROPIONIC ACID MORPHOLINAMIDE; PRIAXON 01648; 2-ISOCYANO-CYCLOHEXYLOXY-TRIMETHYLSILANE; 2-(TRIFLUOROMETHOXY)BENZYL-ISOCYANIDE; 5-ISOCYANO-2-CYANOBENZO-TRIFLUORIDE; 1-ETHYL-2-ISOCYANO-3-METHOXY-BENZENE; 4-ISOCYANO-3-P-TOLYL-1H-PYRAZOLE; 1,6-DICHLORO-4-FLUOROPHENYL-ISOCYANIDE; 2-(METHYLTHIO)ETHYLISOCYANIDE; 4-ISOCYANOBIPHENYL; 2-(2-CHLORO-6-FLUOROBENZYLTHIO)ETHYL-ISOCYANIDE; 2-CHLORO-3,6-DIFLUOROBENZYLISOCYANIDE; 3-CHLORO-2,6-DIFLUOROBENZYLISOCYANIDE; 2-CHLORO-4-FLUOROBENZYLISOCYANIDE; DIETHYL-(4-ISOCYANO-PENTYL)-AMINE; 2,6-DINITRO-4-(TRIFLUOROMETHYL)PHENYL-ISOCYANIDE; 2-FLUORO-5-ISOCYANOBENZONITRILE; 2-FLUORO-3-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 3-FLUORO-5-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; BUTYL-(3-ISOCYANO-PROPYL)-(1-ISOCYANO-PROPYL)-AMINE; 4-ISOCYANO-1-METHOXY-2-NITRO-BENZENE; 2-ISOCYANO-5-NITRO-1H-PYRROLE; 2-ISOCYANO-5-NITRO-PYRIDINE; 2-ISOCYANO-3-PHENYL-1-(PYRROLIDIN-1-YL)PROPAN-1-ONE; 2-ISOCYANO-3-PHENYL-1-(PIPERIDIN-1-YL)PROPAN-1-ONE; 1-AMINO-5-ISOCYANOINDOLE; 2-ISOCYANOETHYLTOSYLATE; (E)-3-CHLORO-4,4,4-TRIFLUORO-2-ISOCYANOBUT-2-ENENITRILE; 2-ISOCYANO-3-METHYL-PYRIDINE; 5-ISOCYANO-PYRIDIN-3-OL; 4-ISOCYANOBENZOIC ACID MORPHOLIDE; P-TOLYLTHIOMETHYL ISOCYANIDE; 1-(2-ISOCYANO-ETHYL)-1,2,3,4-TETRAHYDRO-NAPHTHALENE; 2-ISOCYANOETHYL O-TOLYLSULFAMATE; (E)-4,4,4-TRIFLUORO-2-ISOCYANO-3-METHOXYBUT-2-ENENITRILE; 3-BROMO-5-ISOCYANOPYRIDIN-2-AMINE

List No. 2—aldehydes: including aldehydes from list no. 5; (−)-CITRONELLAL; (+)-CITRONELLAL; (1-FORMYL-2-OXO-2-PHENYLETHYL)SODIUM; (1-METHYL-1H-IMIDAZOL-4-YL)-ACETALDEHYDE; (1-METHYLPIPERIDIN-4-YL)ACETALDEHYDE; (1R,3S,5S)-8-METHYL-8-AZABICYCLO[3.2.1]OCTANE-3-CARBALDEHYDE; (1R,4R)-METHYL 4-FORMYLCYCLOHEXANECARBOXYLATE; (1S)-1,3,4-TRIMETHYL-3-CYCLOHEXENE-1-CARBALDEHYDE; (1S,2S)-2-(TRIFLUOROMETHYL)CYCLOPROPANE-1-CARBALDEHYDE; (1S,4R)-BICYCLO[2.2.1]HEPTANE-2-CARBALDEHYDE; (2,2,3-TRIMETHYL-CYCLOPENT-3-ENYL)-ACETALDEHYDE; (2,3,6-TRIFLUOROPHENYL)ACETALDEHYDE; (2,3-DIFLUORO-4-METHYLPHENYL)ACETALDEHYDE; (2,3-DIFLUOROPHENYL)ACETALDEHYDE; (2,4-DIFLUOROPHENYL)ACETALDEHYDE; (2,5-DIFLUORO-PHENYL)-ACETALDEHYDE; (2,6-DIFLUORO-3-METHYLPHENYL)ACETALDEHYDE; (2-CHLORO-5-FLUOROPHENYL)ACETALDEHYDE; (2-CYANO-5-FORMYLPHENYL)BORONIC ACID; (2-FLUORO-3-METHYLPHENYL)ACETALDEHYDE; (2-FORMYL-IMIDAZOL-1-YL)-ACETIC ACID METHYL ESTER; (2-FORMYLPHENOXY)ACETONITRILE; (2-FORMYL-PHENYL)-ACETONITRILE; (2-HYDROXY-PHENYL)-ACETALDEHYDE; (2-METHOXYPHENYL)ACETALDEHYDE; (2-METHYLPHENYL)ACETALDEHYDE; (2-NITROPHENYL)ACETALDEHYDE; (3,4,5-TRIMETHYL-1H-PYRAZOL-1-YL)ACETALDEHYDE; (3,4-DIFLUOROPHENYL)ACETALDEHYDE; (3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETALDEHYDE; (3,5-DIMETHYL-1H-PYRAZOL-4-YL)ACETALDEHYDE COMPOUND WITH METHANOL (1:1); (3AR,3BS,4S,4AS,5AS)-2-OXOOCTAHYDROCYCLOPROPA[3,4]CYCLOPENTA[1,2-B]FURAN-4-CARBALDEHYDE; (3-CHLORO-4-METHYLPHENYL)ACETALDEHYDE; (3-CHLORO-5-FLUOROPHENYL)ACETALDEHYDE; (3-CHLORO-PHENYL)-ACETALDEHYDE; (3-FLUORO-4-METHOXYPHENYL)ACETALDEHYDE; (3-FLUORO-PHENYL)-ACETALDEHYDE; (3-HYDROXY-4-METHOXY-PHENYL)-ACETALDEHYDE; (3-HYDROXY-PHENYL)-ACETALDEHYDE; (3-METHYLPHENYL)ACETALDEHYDE; (3-NITRO-1H-PYRAZOL-1-YL)ACETALDEHYDE; (3-NITRO-PHENYL)-ACETALDEHYDE; (3S)-3-ISOPROPYL-6-OXOHEPTANAL; (4-CHLORO-2-FLUOROPHENYL)ACETALDEHYDE; (4-CHLORO-PHENYL)-ACETALDEHYDE; (4-CHLORO-PHENYL)-OXO-ACETALDEHYDE; (4-ETHYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-FLUORO-2-FORMYLPHENYL)BORONIC ACID; (4-FLUORO-3-METHYL-PHENYL)-OXO-ACETALDEHYDE; (4-FLUORO-PHENYL)-ACETALDEHYDE; (4-FLUORO-PHENYL)-OXO-ACETALDEHYDE; (4-FORMYL-3-METHOXYPHENOXYMETHYL)POLYSTYRENE; (4-ISOPROPYLPHENYL)ACETALDEHYDE; (4-METHOXY-PHENYL)-OXO-ACETALDEHYDE; (4-METHYLPHENYL)(OXO)ACETALDEHYDE; (4-METHYL-PIPERAZIN-1-YL)-ACETALDEHYDE; (4-METHYL-PYRAZOL-1-YL)-ACETALDEHYDE; (4-METHYLSULFANYLPHENYL)ACETALDEHYDE; (4-NITRO-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-NITRO-PHENYL)-ACETALDEHYDE; (4R,5S)-5-(HYDROXYMETHYL)-2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBALDEHYDE; (4S)-2,2-DIMETHYL-1,3-DIOXOLANE-4-ACETALDEHYDE; (5-CHLORO-2-FLUOROPHENYL)ACETALDEHYDE; (5-CHLOROPYRIMIDIN-2-YL)ACETALDEHYDE; (5-FORMYLPYRIDIN-3-YL)BORONIC ACID; (5-METHYL-3-NITRO-PYRAZOL-1-YL)-ACETALDEHYDE; (5-PYRIMIDINYLOXY)-ACETALDEHYDE; (5S)-5,6-DIHYDRO-5-INDOLIZINECARBOXALDEHYDE; (8R)-5,6,7,8-TETRAHYDRO-8-INDOLIZINEACETALDEHYDE; (AR)-A-METHYL-2-FURANACETALDEHYDE; (AR)-A-METHYL-3-FURANACETALDEHYDE; (AS,BS)-A,B-DIMETHYL-1H-PYRROLE-1-PROPANAL; (BR)-A,B-DIMETHYL-1H-PYRROLE-1-PROPANAL; (BR)-B, 1-DIMETHYL-1H-PYRROLE-2-PROPANAL; (BR)-B-METHYL-2,5-DIOXO-1-PYRROLIDINEPROPANAL; (BS)-B,1-DIMETHYL-1H-PYRROLE-2-PROPANAL; (DIMETHYLHYDRAZONO)ACETALDEHYDE; (E)-2-ALLYL-2-ETHYLHEX-3-ENAL; (M-TOLYL)GLYOXAL HYDRATE; (PHENYLSULFANYL)ACETALDEHYDE; (R)-(−)-3-HYDROXYNONANAL; (R)-(+)-2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBOXALDEHYDE; (R)-1,4-DIOXASPIRO[4,5]DECANE-2-CARBOXALDEHYDE; (R)-CYCLOHEX-3-ENECARBALDEHYDE; (S)-2-(1H-PYRROL-1-YL)PROPANAL; (S)-2-(2,5-DIMETHYL-1H-PYRROL-1-YL)PROPANAL; (S)-2-(BENZYLOXY)PROPIONAL; (S)-GLYCERALDEHYDE ACETONIDE; (S,E)-1-(BUT-1-ENYL)-5-OXOPYRROLIDINE-2-CARBALDEHYDE; (TERT-BUTYLDIMETHYLSILYLOXY)ACETALDEHYDE; (TETRAHYDRO-THIOPYRAN-4-YL)-ACETALDEHYDE; [1,2,4]TRIAZINE-3-CARBALDEHYDE; [1,2,4]TRIAZOLO[4,3-A]PYRAZINE-3-CARBALDEHYDE; [1,3]DIOXOLO[4,5-B]PYRIDINE-6-CARBALDEHYDE; [1,3]DIOXOLO[4,5-B]PYRIDINE-7-CARBALDEHYDE; [1,6]NAPHTHYRIDINE-8-CARBALDEHYDE; [1,8]NAPHTHYRIDIN-2-YL-ACETALDEHYDE; [1,8]NAPHTHYRIDINE-2-CARBALDEHYDE; [1,8]NAPHTHYRIDINE-3-CARBALDEHYDE; [4-(2-OXO-ETHYL)-PHENYL]-ACETALDEHYDE; 1-([ETHYL(METHYL)AMINO]METHYL)CYCLOPENTANE-1-CARBALDEHYDE; 1-(1,1-DIMETHYLPROPYL)-2-FORMYLIMIDAZOLE; 1-(1,2-DIMETHYLPROPYL)-2-FORMYLIMIDAZOLE; 1-(1-ETHYLPROPYL)-2-FORMYLIMIDAZOLE; 1-(2,3-DIHYDROXY-PROPYL)-2-FORMYLIMIDAZOLE; 1-(2-CHLOROETHYL)-2-FORMYLIMIDAZOLE; 1-(2-FORMYLIMIDAZOL-1-YL)-PROPAN-2-OL; 1-(2-HYDROXY-1,1-DIMETHYLETHYL)-2-FORMYLIMIDAZOLE; 1-(2-HYDROXY-1-METHYL-ETHYL)-2-FORMYLIMIDAZOLE; 1-(2-HYDROXYETHYL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-HYDROXYETHYL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-HYDROXYETHYL)PIPERIDINE-4-CARBALDEHYDE; 1-(2-HYDROXYPROPYL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-HYDROXYPROPYL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-HYDROXYPROPYL)PIPERIDINE-4-CARBALDEHYDE; 1-(2-METHOXYETHYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-(2-METHOXYETHYL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-METHOXYETHYL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-METHOXYETHYL)PIPERIDINE-4-CARBALDEHYDE; 1-(2-METHYLPROP-2-EN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-METHYLPROP-2-EN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-METHYLPROP-2-EN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(2-METHYLPROPYL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-METHYLPROPYL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-METHYLPROPYL)PIPERIDINE-4-CARBALDEHYDE; 1-(3-CHLORO-PROPYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-(3-HYDROXYPROPYL)PIPERIDINE-2-CARBALDEHYDE; 1-(3-HYDROXYPROPYL)PIPERIDINE-3-CARBALDEHYDE; 1-(3-HYDROXYPROPYL)PIPERIDINE-4-CARBALDEHYDE; 1-(3-METHOXY-PROPYL)-2-FORMYL-1H-IMIDAZOLE; 1-(3-METHYLBUTYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-(BUT-2-YN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(BUT-2-YN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(BUT-2-YN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(BUT-3-EN-2-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(BUT-3-EN-2-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(BUT-3-EN-2-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(BUT-3-YN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(BUT-3-YN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(BUT-3-YN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(BUTAN-2-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(BUTAN-2-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(CYCLOPROPYLMETHYL)PIPERIDINE-2-CARBALDEHYDE; 1-(CYCLOPROPYLMETHYL)PIPERIDINE-3-CARBALDEHYDE; 1-(CYCLOPROPYLMETHYL)PIPERIDINE-4-CARBALDEHYDE; 1-(DIFLUOROMETHYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-(DIFLUOROMETHYL)PIPERIDINE-2-CARBALDEHYDE; 1-(DIFLUOROMETHYL)PIPERIDINE-3-CARBALDEHYDE; 1-(DIFLUOROMETHYL)PIPERIDINE-4-CARBALDEHYDE; 1-(DIMETHYLAMINOMETHYL)CYCLOPENTANECARBOXALDEHYDE; 1-(METHOXYMETHYL)-1H-PYRAZOLE-3-CARBALDEHYDE; 1-(PROP-2-EN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(PROP-2-EN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(PROP-2-EN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(PROP-2-YN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(PROP-2-YN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(PROP-2-YN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(PROPAN-2-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(PROPAN-2-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(PYRIDIN-2-YL)CYCLOBUTANECARBALDEHYDE; 1-(TETRAHYDROPYRANYLOXY)CYCLOPROPANECARBALDEHYDE; 1-(TRIFLUOROMETHYL)CYCLOPROPANECARBALDEHYDE; 1,1-DIOXO-HEXAHYDRO-1LAMBDA6-THIOPYRAN-4-CARBALDEHYDE; 1,2,3,4-TETRAHYDRONAPHTHALENE-1-CARBALDEHYDE; 1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1,2,3-BENZOTHIADIAZOLE-5-CARBOXALDEHYDE; 1,2,4-OXADIAZOLE-3-CARBOXALDEHYDE; 1,2,4-OXADIAZOLE-5-CARBOXALDEHYDE; 1,2,4-THIADIAZOLE-3-CARBOXALDEHYDE; 1,2,4-THIADIAZOLE-3-CARBOXALDEHYDE, 5-METHYL-; 1,2,4-THIADIAZOLE-5-CARBOXALDEHYDE; 1,2,4-THIADIAZOLE-5-CARBOXALDEHYDE, 3-METHYL-; 1,2,4-TRIAZOLO[4,3-A]PYRIDINE-3-CARBOXALDEHYDE; 1,2-BENZENEDICARBOXALDEHYDE, 3-FLUORO; 1,2-BENZISOXAZOLE-3-CARBOXALDEHYDE; 1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 1,3,4-OXADIAZOLE-2-CARBOXALDEHYDE, 5-METHYL-; 1,3,4-THIADIAZOLE-2,5-DICARBOXALDEHYDE; 1,3,4-THIADIAZOLE-2-CARBOXALDEHYDE; 1,3,4-TRIMETHYL-3-CYCLOHEXEN-1-CARBOXALDEHYDE; 1,3,5-TRIAZINE-2-CARBALDEHYDE; 1,3-BENZENEDICARBOXALDEHYDE, 2-CHLORO-; 1,3-BENZENEDICARBOXALDEHYDE, 5-HYDROXY-; 1,3-BENZODIOXOLE-5-CARBOXALDEHYDE, 6-HYDROXY-; 1,3-BENZOTHIAZOLE-2-CARBALDEHYDE; 1,3-DIHYDRO-1-OXO-5-ISOBENZOFURANCARBOXALDEHYDE; 1,3-DIHYDRO-2,1,3-BENZOXADIAZOLE-5-CARBOXALDEHYDE; 1,3-DIHYDRO-FURO[3,4-C]PYRIDINE-6-CARBOXALDEHYDE; 1,3-DIMETHYLPIPERIDINE-4-CARBALDEHYDE; 1,3-DIOXOLANE-2,2-DIACETALDEHYDE; 1,3-DIOXOLANE-2-ACETALDEHYDE, 2-METHYL-; 1,3-DIOXOLANE-4-CARBOXALDEHYDE, 5-(HYDROXYMETHYL)-2,2-DIMETHYL-, (4R,5R)-; 1,3-OXAZOL-2-YLACETALDEHYDE; 1,3-THIAZOL-2-YLACETALDEHYDE; 1,4,5,6-TETRAHYDRO-CYCLOPENTAPYRAZOLE-3-CARBALDEHYDE; 1,4,5-TRIMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1,4,6,7-TETRAHYDROPYRANO[4,3-C]PYRAZOLE-3-CARBALDEHYDE; 1,4,7-TRIOXASPIRO[4.4]NONANE-9-CARBALDEHYDE; 1,4-BENZODIOXAN-6-CARBOXALDEHYDE; 1,4-BENZODIOXIN-5-CARBOXALDEHYDE; 1,4-DIMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1,4-DIMETHYL-5-NITRO-1H-IMIDAZOLE-2-CARBALDEHYDE; 1,4-DIMETHYLPIPERAZINE-2-CARBALDEHYDE; 1,4-DIMETHYLPIPERIDINE-4-CARBALDEHYDE; 1,4-DIOXANE-2-CARBOXALDEHYDE; 1,4-DIOXASPIRO[4.5]DECANE-8-CARBALDEHYDE; 1,5-DIMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 1,5-DIMETHYL-2-BENZIMIDAZOLECARBOXALDEHYDE; 1,5-NAPHTHYRIDINE-2-CARBOXALDEHYDE; 1,5-NAPHTHYRIDINE-3-CARBALDEHYDE; 1,5-NAPHTHYRIDINE-4-CARBOXALDEHYDE; 1,6-DIHYDRO-6-OXO-3-PYRIDAZINECARBOXALDEHYDE; 1,6-NAPHTHYRIDINE-2-CARBOXALDEHYDE; 1,6-NAPHTHYRIDINE-4-CARBOXALDEHYDE; 1,7-NAPHTHYRIDINE-3-CARBALDEHYDE; 1,8-NAPHTHYRIDINE-4-CARBALDEHYDE; 1,8-NAPHTHYRIDINE-4-CARBOXALDEHYDE, 3-HYDROXY-; 1-[(DIMETHYLAMINO)METHYL]CLOHEXANE-1-CARBALDEHYDE; 10-UNDECENAL; 1-ACETYL-2-PIPERIDINECARBOXALDEHYDE; 1-ACETYLAZETIDINE-3-CARBALDEHYDE; 1-ACETYLPIPERIDINE-3-CARBALDEHYDE; 1-ACETYLPIPERIDINE-4-CARBALDEHYDE; 1-ADAMANTANE CARBOXALDEHYDE; 1-ALLYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ALLYLCYCLOHEXANECARBALDEHYDE; 1-AZABICYCLO[2.2.2]OCTANE-2-CARBOXALDEHYDE; 1-AZA-BICYCLO[2.2.2]OCTANE-3-CARBALDEHYDE; 1-AZABICYCLO[2.2.2]OCTANE-4-CARBOXALDEHYDE; 1-BENZOFURAN-3-YLACETALDEHYDE; 1-BENZOFURAN-5-CARBALDEHYDE; 1-BENZOFURAN-6-CARBALDEHYDE; 1-BENZOTHIOPHENE-5-CARBALDEHYDE; 1-BUTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-BUTYLPIPERIDINE-2-CARBALDEHYDE; 1-BUTYLPIPERIDINE-3-CARBALDEHYDE; 1-BUTYLPIPERIDINE-4-CARBALDEHYDE; 1-CYCLOBUTYLMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-CYCLOPENTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-CYCLOPROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ETHYL-1H-1,2,4-TRIAZOLE-5-CARBALDEHYDE; 7; 1-ETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ETHYL-1H-INDOLE-4-CARBALDEHYDE; 1-ETHYL-1H-INDOLE-5-CARBALDEHYDE; 1-ETHYL-1H-INDOLE-6-CARBALDEHYDE; 1-ETHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 1-ETHYL-4-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ETHYL-4-OXOCYCLOHEXANECARBALDEHYDE; 1-ETHYL-AZEPANE-4-CARBALDEHYDE; 1-ETHYLPIPERIDINE-2-CARBALDEHYDE; 1-ETHYLPIPERIDINE-3-CARBALDEHYDE; 1-ETHYLPIPERIDINE-4-CARBALDEHYDE; 1-FLUORONAPHTHALENE-2-CARBALDEHYDE; 1-FLUORONAPHTHALENE-3-CARBOXALDEHYDE; 1-FLUORONAPHTHALENE-7-CARBOXALDEHYDE; 1-FLUORONAPHTHALENE-8-CARBOXALDEHYDE; 1-FORMYL-2-(4-METHOXYPHENYL)-ETHYL; 1-FORMYL-CYCLOBUTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPENTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPROPANECARBOXYLIC ACID METHYL ESTER; 1H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 1H-BENZIMIDAZOLE-1-ACETALDEHYDE; 1H-BENZO[D][1,2,3]TRIAZOLE-5-CARBALDEHYDE; 1H-INDAZOL-3-YLACETALDEHYDE; 1H-INDAZOLE-1-PROPANAL; 1H-INDAZOLE-3,4-DICARBOXALDEHYDE; 1H-INDAZOLE-3,5-DICARBOXALDEHYDE; 1H-INDAZOLE-3-CARBALDEHYDE; 1H-INDAZOLE-4-CARBALDEHYDE; 1H-INDAZOLE-5-CARBALDEHYDE; 1H-INDAZOLE-6-CARBALDEHYDE; 1H-INDAZOLE-7-CARBALDEHYDE; 1H-INDENE-1-CARBOXALDEHYDE, 2,3-DIHYDRO-; 1H-INDENE-2-CARBOXALDEHYDE,2,3-DIHYDRO-; 1H-INDOLE-1-PROPANAL; 1H-PYRAZOL-1-YLACETALDEHYDE; 1H-PYRAZOLE-3-CARBALDEHYDE; 1H-PYRAZOLE-3-CARBALDEHYDE, HYDROCHLORIDE; 1H-PYRAZOLE-3-CARBOXALDEHYDE, 1,4-DIMETHYL-; 1H-PYRAZOLO[3,4-B]PYRIDINE-3-CARBALDEHYDE; 1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBALDEHYDE; 1H-PYRAZOLO[3,4-C]PYRIDINE-4-CARBALDEHYDE; 1H-PYRAZOLO[3,4-C]PYRIDINE-5-CARBALDEHYDE; 1H-PYRAZOLO[3,4-C]PYRIDINE-7-CARBALDEHYDE; 1H-PYRAZOLO[4,3-B]PYRIDINE-5-CARBALDEHYDE; 1H-PYRAZOLO[4,3-B]PYRIDINE-6-CARBALDEHYDE; 1H-PYRAZOLO[4,3-B]PYRIDINE-7-CARBALDEHYDE; 1H-PYRAZOLO[4,3-C]PYRIDINE-4-CARBALDEHYDE; 1H-PYRROLE-1-BUTANAL; 1H-PYRROLE-1-PROPANAL; 1H-PYRROLO[2,3-B]PYRIDINE-1-PROPANAL; 1-HYDROXY-2-NAPHTHALDEHYDE; 1-ISOBUTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ISOPROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ISOPROPYL-AZEPANE-4-CARBALDEHYDE; 1-ISOPROPYLPIPERIDINE-4-CARBALDEHYDE; 1-METHYL-1H-1,2,3-BENZOTRIAZOLE-5-CARBALDEHYDE; 1-METHYL-1H-BENZIMIDAZOLE-5-CARBOXALDEHYDE; 1-METHYL-1H-BENZO[D]IMIDAZOLE-6-CARBALDEHYDE; 1-METHYL-1H-IMIDAZO[4,5-B]PYRIDINE-2-CARBALDEHYDE; 1-METHYL-1H-IMIDAZO[4,5-C]PYRIDINE-2-CARBALDEHYDE; 1-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-METHYL-1H-INDAZOLE-3-CARBALDEHYDE; 1-METHYL-1H-INDAZOLE-4-CARBALDEHYDE; 1-METHYL-1H-INDAZOLE-5-CARBALDEHYDE; 1-METHYL-1H-INDAZOLE-6-CARBALDEHYDE; 1-METHYL-1H-INDAZOLE-7-CARBALDEHYDE; 1-METHYL-1H-INDOLE-3-ACETALDEHYDE; 1-METHYL-1H-INDOLE-4-CARBALDEHYDE; 1-METHYL-1H-INDOLE-5-ACETALDEHYDE; 1-METHYL-1H-INDOLE-5-CARBALDEHYDE; 1-METHYL-1H-INDOLE-6-CARBALDEHYDE; 1-METHYL-1H-INDOLE-7-CARBALDEHYDE; 1-METHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 1-METHYL-1H-PYRAZOLO[3,4-C]PYRIDINE-4-CARBALDEHYDE; 1-METHYL-1H-PYRROLE-2-ACETALDEHYDE; 1-METHYL-1H-PYRROLE-2-PROPANAL; 1-METHYL-2,3-DIHYDRO-1H-PYRROLIZINE-2-CARBALDEHYDE; 1-METHYL-2-FORMYLBENZIMIDAZOLE; 1-METHYL-2-OXO-3-PIPERIDINEACETALDEHYDE; 1-METHYL-3,4-DIHYDROISOQUINOLINE-7-CARBALDEHYDE; 1-METHYL-3-CYCLOHEXENE-1-CARBOXALDEHYDE; 1-METHYL-3-PIPERIDINEACETALDEHYDE; 1-METHYL-4-OXOCYCLOHEXANECARBALDEHYDE; 1-METHYL-4-PIPERIDINECARBALDEHYDE HYDROCHLORIDE; 1-METHYL-5-NITRO-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-METHYL-8-NAPHTHALDEHYDE; 1-METHYL-AZEPANE-4-CARBALDEHYDE; 1-METHYLBENZIMIDAZOLE-4-CARBOXALDEHYDE; 1-METHYLCYCLOHEXANE-1-CARBOXALDEHYDE; 1-METHYL-CYCLOPENTANECARBOXALDEHYDE; 1-METHYLINDOLINE-5-CARBALDEHYDE; 1-METHYLNAPHTHALENE-2-CARBOXALDEHYDE; 1-METHYLNAPHTHALENE-3-CARBOXALDEHYDE; 1-METHYLNAPHTHALENE-5-CARBOXALDEHYDE; 1-METHYLNAPHTHALENE-6-CARBOXALDEHYDE; 1-METHYLNAPHTHALENE-7-CARBOXALDEHYDE; 1-METHYLPIPERIDINE-2-CARBALDEHYDE; 1-METHYLPIPERIDINE-3-CARBALDEHYDE; 1-METHYLPIPERIDINE-4-CARBALDEHYDE; 1-NAPHTHALDEHYDE; 1-NAPHTHALENECARBOXALDEHYDE, 5,6,7,8-TETRAHYDRO; 1-OXO-1,2,3,4-TETRAHYDRONAPHTHALENE-2-CARBALDEHYDE; 1-PENTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-PHENYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-PHENYLCYCLOPENTANECARBALDEHYDE; 1-PHENYLCYCLOPROPANECARBALDEHYDE; 1-PIPERIDINEPROPANAL; 1-PROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-PROPYL-1H-PYRAZOLE-3-CARBALDEHYDE; 1-PROPYLPIPERIDINE-2-CARBALDEHYDE; 1-PROPYLPIPERIDINE-3-CARBALDEHYDE; 1-PROPYLPIPERIDINE-4-CARBALDEHYDE; 1-PYRIDIN-3-YL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-SEC-BUTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-TERT-BUTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-VINYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 2-([(2-HYDROXYETHYL)(METHYL)AMINO]METHYL)-2-METHYLBUTANAL; 2-([2-(DIMETHYLAMINO)ETHYL](PROPYL)AMINO)ACETALDEHYDE; 2-([CYCLOPROPYL(METHYL)AMINO]METHYL)-2-METHYLBUTANAL; 2-([ETHYL(METHYL)AMINO]METHYL)-2-METHYLBUTANAL; 2-([ETHYL(METHYL)AMINO]METHYL)-2-METHYLPENTANAL; 2-(1-(2-OXOETHYL)-1H-PYRAZOL-4-YL)ACETONITRILE; 2-(1,2,4-OXADIAZOL-3-YL)BENZALDEHYDE; 2-(1,3,4-THIADIAZOL-2-YLSULFANYL)ACETALDEHYDE; 2-(1,3-DIOXOLAN-2-YL)ACETALDEHYDE; 2-(1,3-THIAZOL-2-YLSULFANYL)ACETALDEHYDE; OXAZEPAN-4-YL)ACETALDEHYDE; 2-(1-ACETYLAZETIDIN-2-YL)ACETALDEHYDE; 2-(1H-1,2,3-BENZOTRIAZOL-1-YL)ACETALDEHYDE; 2-(1H-1,2,4-TRIAZOL-1-YL)ACETALDEHYDE; 2-(1H-1,2,4-TRIAZOL-5-YLSULFANYL)ACETALDEHYDE; 2-(1H-IMIDAZOL-1-YL)PYRIMIDINE-5-CARBALDEHYDE; 2-(1H-INDOL-1-YL)ACETALDEHYDE; 2-(1H-PYRAZOL-1-YL)BENZALDEHYDE; 2-(1H-PYRAZOL-1-YL)PYRIMIDINE-5-CARBALDEHYDE; 2-(1H-PYRAZOL-3-YL)BENZALDEHYDE; 2-(1H-PYRROL-1-YL)BENZALDEHYDE; 2-(1H-PYRROL-1-YL)PROPANAL; 2-(1-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)ACETALDEHYDE; 2-(1-METHYL-2-OXOPYRROLIDIN-3-YL)ACETALDEHYDE; 2-(1-METHYLETHYL)-3-PYRIDINECARBOXALDEHYDE; 2-(1-METHYLETHYL)-4-PYRIDINECARBOXALDEHYDE; 2-(2-(3-OXOPROPYL)PHENYL)ACETONITRILE; 2-(2,2,2-TRIFLUOROETHOXY)ACETALDEHYDE; 2-(2,2,3,3-TETRAFLUOROPROPOXY)ACETALDEHYDE; 2-(2,2-DIMETHYLMORPHOLIN-4-YL)ACETALDEHYDE; 2-(2,2-DIMETHYLPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(2,3,5-TRIFLUOROPHENYL)ACETALDEHYDE; 2-(2,3-DIFLUOROPHENOXY)ACETALDEHYDE; 2-(2,3-DIHYDRO-1H-INDOL-1-YL)ACETALDEHYDE; 2-(2,3-DIHYDRO-1H-ISOINDOL-2-YL)ACETALDEHYDE; 2-(2,3-DIHYDROBENZOFURAN-5-YL)ACETALDEHYDE; 2-(2,3-DIHYDROBENZOFURAN-6-YL)ACETALDEHYDE; 2-(2,3-DIMETHYLPHENOXY)ACETALDEHYDE; DIMETHYLPHENYL)ACETALDEHYDE; 2-(2,3-DIMETHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(2,4,5-TRIFLUOROPHENYL)ACETALDEHYDE; 2-(2,4,6-TRIFLUOROPHENYL)ACETALDEHYDE; DIFLUOROPHENOXY)ACETALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-2-OXOACETALDEHYDE; 2-(2,4-DIMETHYLPHENOXY)ACETALDEHYDE; 2-(2,4-DIMETHYLPHENYL)ACETALDEHYDE; 2-(2,4-DIMETHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(2,4-DIOXO-1,3-THIAZOLIDIN-3-YL)ACETALDEHYDE; 2-(2,5-DIFLUOROPHENOXY)ACETALDEHYDE; 2-(2,5-DIMETHYLPHENOXY)ACETALDEHYDE; 2-(2,5-DIMETHYLPHENYL)ACETALDEHYDE; 2-(2,5-DIOXOPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(2,6-DIFLUOROPHENYL)ACETALDEHYDE; 2-(2,6-DIMETHYLPHENOXY)ACETALDEHYDE; 2-(2,6-DIMETHYLPHENYL)ACETALDEHYDE; 2-(2,6-DIOXOPIPERIDIN-1-YL)ACETALDEHYDE; 2-(2,7-DIOXOAZEPAN-1-YL)ACETALDEHYDE; 2-(2-[(DIMETHYLAMINO)METHYL]PYRROLIDIN-1-YL)ACETALDEHYDE; 2-(2-AZABICYCLO[2.2.1]HEPTAN-2-YL)ACETALDEHYDE; 2-(2-BUTOXYETHOXY)ACETALDEHYDE; 2-(2-CHLORO-4-FLUOROPHENYL)ACETALDEHYDE; 2-(2-CHLORO-6-FLUOROPHENYL)ACETALDEHYDE; 2-(2-CHLOROPHENOXY)ACETALDEHYDE; 2-(2-CHLOROPHENYL)ACETALDEHYDE; 2-(2-ETHOXYETHOXY)ACETALDEHYDE; 2-(2-ETHOXYPHENYL)ACETALDEHYDE; 2-(2-ETHYL-1H-IMIDAZOL-1-YL)ACETALDEHYDE; 2-(2-ETHYLPHENOXY)ACETALDEHYDE; 2-(2-FLUORO-3-FORMYLPHENYL)ACETONITRILE; 2-(2-FLUORO-5-FORMYLPHENYL)ACETONITRILE; 2-(2-FLUORO-5-METHYLPHENYL)ACETALDEHYDE; 2-(2-FLUOROETHOXY)-BENZALDEHYDE; 2-(2-FLUOROPHENOXY)ACETALDEHYDE; 2-(2-FLUOROPHENYL)-3-OXOPROPANENITRILE; 2-(2-FLUOROPHENYL)ACETALDEHYDE; 2-(2-FORMYL-IMIDAZOL-1-YL)-BUTAN-1-OL; 2-(2-FORMYLIMIDAZOL-1-YL)-PROPANE-1,3-DIOL; 2-(2-FORMYLPIPERIDIN-1-YL)ACETONITRILE; 2-(2-FORMYLPIPERIDIN-1-YL)PROPANENITRILE; 2-(2-FURYL)-2-OXO-ACETALDEHYDE; 2-(2-FURYL)-5-PYRIMIDINECARBALDEHYDE; 2-(2-HYDROXYETHOXY)ACETALDEHYDE; 2-(2-HYDROXYETHOXY)BENZALDEHYDE; 2-(2-METHOXY-5-METHYLPHENYL)ACETALDEHYDE; 2-(2-METHOXYETHOXY)ACETALDEHYDE; 2-(2-METHOXYETHYL)PYRIMIDINE-4-CARBALDEHYDE; 2-(2-METHOXYETHYL)PYRIMIDINE-5-CARBALDEHYDE; 2-(2-METHOXYPHENOXY)ACETALDEHYDE; 2-(2-METHYL-1,4-OXAZEPAN-4-YL)ACETALDEHYDE; 2-(2-METHYL-1H-IMIDAZOL-1-YL)ACETALDEHYDE; 2-(2-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(2-METHYLFURAN-3-YL)ACETALDEHYDE; 2-(2-METHYLPHENOXY)ACETALDEHYDE; 2-(2-METHYLPHENYL)-3-OXOPROPANENITRILE; 2-(2-METHYLPROPOXY)ACETALDEHYDE; 2-(2-METHYLPROPYL)PYRIMIDINE-4-CARBALDEHYDE; 2-(2-METHYLPROPYL)PYRIMIDINE-5-CARBALDEHYDE; 2-(2-METHYLTHIAZOL-5-YL)ACETALDEHYDE; 2-(2-OXO-1,2-DIHYDROPYRIDIN-1-YL)ACETALDEHYDE; 2-(2-OXO-1,2-DIHYDROPYRIMIDIN-1-YL)ACETALDEHYDE; 2-(2-OXO-1,3-THIAZOLIDIN-3-YL)ACETALDEHYDE; 2-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-3-YL)ACETALDEHYDE; 2-(2-OXOAZEPAN-1-YL)ACETALDEHYDE; 2-(2-OXOAZOCAN-1-YL)ACETALDEHYDE; 2-(2-OXOETHOXY)BENZONITRILE; 2-(2-OXOPIPERIDIN-1-YL)ACETALDEHYDE; 2-(2-OXOPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(2-PHENYLHYDRAZONO)ACETALDEHYDE; 2-(2-PROPYNYLOXY)BENZENECARBALDEHYDE; 2-(2-PYRAZINYL)MALONDIALDEHYDE; 2-(2-PYRIDINYLOXY)-ACETALDEHYDE; 2-(2-PYRIDYL)MALONDIALDEHYDE; 2-(3-(DIMETHYLAMINO)PHENYL)ACETALDEHYDE; 2-(3-(NITROMETHYL)OXETAN-3-YL)ACETALDEHYDE; 2-(3,3-DIMETHYLMORPHOLIN-4-YL)ACETALDEHYDE; 2-(3,4,5-TRIFLUOROPHENYL)ACETALDEHYDE; 2-(3,4-DIFLUOROPHENOXY)ACETALDEHYDE; 2-(3,4-DIMETHYLPHENOXY)ACETALDEHYDE; 2-(3,4-DIMETHYLPHENYL)-3-OXOPROPANENITRILE; 2-(3,4-DIMETHYLPHENYL)ACETALDEHYDE; 2-(3,5-DIFLUOROPHENOXY)ACETALDEHYDE; 2-(3,5-DIFLUOROPHENYL)ACETALDEHYDE; 2-(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)ACETALDEHYDE; 2-(3,5-DIMETHYLPHENOXY)ACETALDEHYDE; DIMETHYLPHENYL)ACETALDEHYDE; 2-(3,5-DIOXOMORPHOLIN-4-YL)ACETALDEHYDE; 2-(3,6-DIOXO-1,2,3,6-TETRAHYDROPYRIDAZIN-1-YL)ACETALDEHYDE; 2-(3-CHLORO-2-FLUOROPHENYL)ACETALDEHYDE; 2-(3-CHLORO-4-FLUOROPHENYL)ACETALDEHYDE; 2-(3-CHLOROPHENOXY)ACETALDEHYDE; 2-(3-ETHYLPHENOXY)ACETALDEHYDE; 2-(3-FLUORO-4-FORMYLPHENYL)ACETONITRILE; 2-(3-FLUORO-4-HYDROXYPHENYL)ACETALDEHYDE; 2-(3-FLUORO-4-METHYLPHENYL)ACETALDEHYDE; 2-(3-FLUORO-5-FORMYLPHENYL)ACETONITRILE; 2-(3-FLUORO-5-METHYLPHENYL)ACETALDEHYDE; 2-(3-FLUOROPHENOXY)ACETALDEHYDE; 2-(3-FLUOROPHENYL)-3-OXOPROPANENITRILE; 2-(3-FLUORO-PHENYL)-CYCLOPROPANECARBALDEHYDE; 2-(3-FLUORO-PHENYL)-MALONALDEHYDE; 2-(3-FORMYLPHENOXY)ACETONITRILE; 2-(3-FORMYLPHENYL)ACETONITRILE; 2-(3-FORMYLPIPERIDIN-1-YL)ACETONITRILE; 2-(3-FORMYLPIPERIDIN-1-YL)PROPANENITRILE; 2-(3-HYDROXYPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(3-METHOXYPHENOXY)ACETALDEHYDE; 2-(3-METHOXYPHENYL)ACETALDEHYDE; 2-(3-METHOXYPROPOXY)ACETALDEHYDE; 2-(3-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(3-METHYL-2,4,5-TRIOXIOIMIDAZOLIDIN-1-YL)ACETALDEHYDE; 2-(3-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ACETALDEHYDE; 2-(3-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)ACETALDEHYDE; 2-(3-METHYL-2-OXOIMIDAZOLIDIN-1-YL)ACETALDEHYDE; 2-(3-METHYLBUTOXY)ACETALDEHYDE; 2-(3-METHYLPHENYL)-3-OXOPROPANENITRILE; 2-(3-METHYLPHENYL)MALONDIALDEHYDE; 2-(3-NITRO-1H-1,2,4-TRIAZOL-1-YL)ACETALDEHYDE; 2-(3-OXOPROPANOYL)BENZONITRILE; 2-(4-(DIMETHYLAMINO)PHENYL)ACETALDEHYDE; 2-(4,4-DIMETHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4,5-DIMETHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-3-YL)ACETALDEHYDE; 2-(4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIMIDIN-1-YL)ACETALDEHYDE; 2-(4-ACETYLPIPERAZIN-1-YL)ACETALDEHYDE; 2-(4-CHLORO-3-FLUOROPHENYL)ACETALDEHYDE; 2-(4-CHLOROPHENOXY)ACETALDEHYDE; 2-(4-CHLORO-PHENYL)-PROPIONALDEHYDE; 2-(4-CYCLOPROPYLPIPERAZIN-1-YL)ACETALDEHYDE; 2-(4-ETHOXYPHENYL)ACETALDEHYDE; 2-(4-ETHOXYPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-ETHYL-4-METHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-ETHYLPHENOXY)ACETALDEHYDE; 2-(4-ETHYL-PHENYL)-3-OXO-PROPIONITRILE; 2-(4-ETHYLPHENYL)ACETALDEHYDE; 2-(4-ETHYLPIPERAZIN-1-YL)ACETALDEHYDE; 2-(4-ETHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-FLUORO-2-METHYLPHENYL)ACETALDEHYDE; 2-(4-FLUORO-3-METHOXYPHENYL)ACETALDEHYDE; 2-(4-FLUORO-3-METHYLPHENYL)ACETALDEHYDE; 2-(4-FLUOROPHENOXY)ACETALDEHYDE; 2-(4-FLUOROPHENYL)-3-OXOPROPANENITRILE; 2-(4-FLUOROPHENYL)CYCLOPROPANECARBALDEHYDE; 2-(4-FLUOROPHENYL)MALONDIALDEHYDE; 2-(4-FORMYLPHENOXY)ACETONITRILE; 2-(4-FORMYLPHENYL)ACETONITRILE; 2-(4-FORMYLPIPERIDIN-1-YL)ACETONITRILE; 2-(4-FORMYLPIPERIDIN-1-YL)PROPANENITRILE; 2-(4-HYDROXY-3-METHOXYPHENYL)ACETALDEHYDE; 2-(4-HYDROXYPHENYL)ACETALDEHYDE; 2-(4-HYDROXYPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-METHOXY-2-METHYLPHENYL)ACETALDEHYDE; 2-(4-METHOXY-3-METHYLPHENYL)ACETALDEHYDE; 2-(4-METHOXYPHENOXY)ACETALDEHYDE; 2-(4-METHOXYPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(4-METHYL-2,3-DIOXOPIPERAZIN-1-YL)ACETALDEHYDE; 2-(4-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-3-YL)ACETALDEHYDE; 2-(4-METHYL-2-OXOPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(4-METHYL-6-OXO-1,6-DIHYDROPYRIMIDIN-1-YL)ACETALDEHYDE; 2-(4-METHYLPHENYL)-3-OXOPROPANENITRILE; 2-(4-METHYLPHENYL)MALONDIALDEHYDE; 2-(4-METHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-NITRO-1H-IMIDAZOL-1-YL)ACETALDEHYDE; 2-(4-OXOCYCLOHEXYL)ACETALDEHYDE; 2-(4-OXOPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-PROPYLPHENYL)ACETALDEHYDE; 2-(4-PROPYLPIPERAZIN-1-YL)ACETALDEHYDE; 2-(4-PROPYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-PYRIDYL)MALONDIALDEHYDE; 2-(4-PYRIMIDYL)MALONDIALDEHYDE; DIMETHYL-1,3-DIOXAN-2-YL)ACETALDEHYDE; 2-(5-ETHYLPYRIDIN-2-YL)ACETALDEHYDE; 2-(5-FLUORO-2-METHYLPHENYL)ACETALDEHYDE; 2-(5-FLUOROPYRIDIN-3-YL)ACETALDEHYDE; 2-(5-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(5-METHYL-2-OXO-1,2-DIHYDROPYRIMIDIN-1-YL)ACETALDEHYDE; 2-(5-METHYLFURAN-2-YL)-2-OXOACETALDEHYDE; 2-(5-NITROFURAN-2-YL)-2-OXOACETALDEHYDE; 2-(6-CHLOROPYRIDIN-3-YL)ACETALDEHYDE; 2-(6-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)ACETALDEHYDE; 2-(6-METHYLPYRIDIN-3-YL)ACETALDEHYDE; 2-(7-METHYL-1H-INDAZOL-5-YL)ACETALDEHYDE; 2-(AZEPAN-1-YL)ACETALDEHYDE; 2-(AZOCAN-1-YL)ACETALDEHYDE; 2-(BENZO[D]OXAZOL-2-YL)ACETALDEHYDE; 2-(BENZOFURAN-5-YL)ACETALDEHYDE; 2-(BENZOFURAN-6-YL)ACETALDEHYDE; 2-(BENZYLSULFANYL)ACETALDEHYDE; 2-(BUT-2-YN-1-YLOXY)BENZALDEHYDE; 2-(BUT-3-EN-1-YLOXY)ACETALDEHYDE; 2-(BUT-3-YN-1-YLOXY)BENZALDEHYDE; 2-(BUTYLSULFANYL)ACETALDEHYDE; 2-(CHLOROMETHYL)NICOTINALDEHYDE; 2-(CHLOROMETHYL)PYRIMIDINE-4-CARBALDEHYDE; 2-(CHLOROMETHYL)PYRIMIDINE-5-CARBALDEHYDE; 2-(CYCLOHEPTYLOXY)ACETALDEHYDE; 2-(CYCLOHEXYLMETHOXY)ACETALDEHYDE; 2-(CYCLOHEXYLOXY)ACETALDEHYDE; 2-(CYCLOHEXYLSULFANYL)ACETALDEHYDE; 2-(CYCLOPENTYLOXY)ACETALDEHYDE; 2-(CYCLOPENTYLSULFANYL)ACETALDEHYDE; 2-(CYCLOPROPYLMETHOXY)ACETALDEHYDE; 2-(CYCLOPROPYLMETHYL)PYRIMIDINE-5-CARBALDEHYDE; 2-(DIBUTYLAMINO)ACETALDEHYDE; 2-(DIETHYLAMINO)ACETALDEHYDE; 2-(DIFLUOROMETHOXY)BENZALDEHYDE; 2-(DIFLUOROMETHOXY)PYRAZINE-6-CARBOXALDEHYDE; 2-(DIFLUOROMETHYL)-4-FLUOROBENZALDEHYDE; 2-(DIFLUOROMETHYL)BENZALDEHYDE; 2-(DIMETHYLAMINO)-3-HYDROXYBENZALDEHYDE; 2-(DIMETHYLAMINO)-4-HYDROXYBENZALDEHYDE; 2-(DIMETHYLAMINO)-5-FLUOROBENZALDEHYDE; 2-(DIMETHYLAMINO)-5-HYDROXYBENZALDEHYDE; 2-(DIMETHYLAMINO)-6-HYDROXYBENZALDEHYDE; 2-(DIMETHYLAMINO)-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-(DIMETHYLAMINO)ACETALDEHYDE; 2-(DIMETHYLAMINO)ISONICOTINALDEHYDE; 2-(DIMETHYLAMINO)NICOTINALDEHYDE; 2-(DIMETHYLAMINO)PYRIMIDINE-4-CARBOXALDEHYDE; 2-(DIPROPYLAMINO)ACETALDEHYDE; 2-(ETHYLSULFANYL)ACETALDEHYDE; 2-(FURAN-2-YL)-2-METHYLPROPANAL; 2-(FURAN-2-YL)-2-OXOACETALDEHYDE HYDRATE; 2-(FURAN-2-YL)ACETALDEHYDE; 2-(FURAN-2-YL)BUTANAL; 2-(FURAN-2-YL)PROPANAL; 2-(FURAN-2-YL)PYRIMIDINE-4-CARBALDEHYDE; 2-(FURAN-2-YLMETHOXY)ACETALDEHYDE; 2-(HEPTYLOXY)ACETALDEHYDE; 2-(HEXYLOXY)ACETALDEHYDE; 2-(HYDROXYMETHYL)-4-PYRIDINECARBOXALDEHYDE; 2-(HYDROXYMETHYL)-5-PYRIMIDINECARBOXALDEHYDE; 2-(HYDROXYMETHYL)-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-(HYDROXYMETHYL)PYRIMIDINE-4-CARBALDEHYDE; 2-(ISOQUINOLIN-5-YL)ACETALDEHYDE; 2-(ISOQUINOLIN-6-YL)ACETALDEHYDE; 2-(ISOQUINOLIN-7-YL)ACETALDEHYDE; 2-(METHOXYMETHOXY)BENZALDEHYDE; 2-(METHOXYMETHYL)-5-PYRIMIDINECARBALDEHYDE; 2-(METHOXYMETHYL)-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-(METHOXYMETHYL)PYRIMIDINE-4-CARBALDEHYDE; 2-(METHYL[(1-METHYL-1H-PYRAZOL-4-YL)METHYL]AMINO)ACETALDEHYDE; 2-(METHYL[(1-METHYLPYRROLIDIN-3-YL)METHYL]AMINO)ACETALDEHYDE; 2-(METHYL[(2-METHYLFURAN-3-YL)METHYL]AMINO)ACETALDEHYDE; 2-(METHYL[(5-METHYLFURAN-2-YL)METHYL]AMINO)ACETALDEHYDE; 2-(METHYL[2-(PYRROLIDIN-1-YL)ETHYL]AMINO)ACETALDEHYDE; 2-(METHYLDITHIO)-ISOBUTYRALDEHYDE; 2-(METHYLTHIO)BENZALDEHYDE; 2-(METHYLTHIO)NICOTINALDEHYDE; 2-(METHYLTHIO)PYRIMIDINE-4-CARBALDEHYDE; 2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE; 2-(N,N-DIMETHYLAMINO)BENZALDEHYDE; 2-(NAPHTHALEN-1-YL)ACETALDEHYDE; 2-(OXAN-4-YLMETHOXY)ACETALDEHYDE; 2-(OXAN-4-YLSULFANYL)ACETALDEHYDE; 2-(OXOLAN-3-YL)ACETALDEHYDE; 2-(OXOLAN-3-YLOXY)ACETALDEHYDE; 2-(PENTYLOXY)ACETALDEHYDE; 2-(PIPERIDIN-1-YL)ACETALDEHYDE; 2-(PIPERIDIN-1-YL)BUTANAL; 2-(PROP-2-EN-1-YLOXY)ACETALDEHYDE; 2-(PROPAN-2-YLOXY)ACETALDEHYDE; 2-(PROPAN-2-YLSULFANYL)ACETALDEHYDE; 2-(PROPYLSULFANYL)ACETALDEHYDE; 2-(PYRAZIN-2-YL)ACETALDEHYDE; 2-(PYRIDIN-2-YL)ACETALDEHYDE; 2-(PYRIDIN-2-YL)ACETALDEHYDE N-OXIDE; 2-(PYRIDIN-2-YLSULFANYL)ACETALDEHYDE; 2-(PYRIDIN-3-YL)ACETALDEHYDE; 2-(PYRIDIN-4-YL)ACETALDEHYDE; 2-(PYRIMIDIN-2-YL)ACETALDEHYDE; 2-(PYRIMIDIN-2-YLSULFANYL)ACETALDEHYDE; 2-(PYRIMIDIN-4-YL)ACETALDEHYDE; 2-(PYRIMIDIN-5-YL)ACETALDEHYDE; 2-(PYRROLIDIN-1-YL)ACETALDEHYDE; 2-(QUINOLIN-2-YL)ACETALDEHYDE; 2-(QUINOLIN-3-YL)ACETALDEHYDE; 2-(QUINOLIN-4-YL)ACETALDEHYDE; 2-(QUINOLIN-5-YL)ACETALDEHYDE; 2-(QUINOLIN-6-YL)ACETALDEHYDE; 2-(QUINOLIN-7-YL)ACETALDEHYDE; 2-(QUINOLIN-8-YL)ACETALDEHYDE; 2-(TERT-BUTOXY)ACETALDEHYDE; 2-(TERT-BUTYLSULFANYL)ACETALDEHYDE; 2-(TETRAHYDRO-2H-PYRAN-4-YL)-2-METHYLPROPANAL; 2-(TETRAHYDRO-2H-THIOPYRAN-4-YL)-2-METHYLPROPANAL; 2-(THIOMORPHOLIN-4-YL)ACETALDEHYDE; 2-(THIOPHEN-2-YL)ACETALDEHYDE; 2-(THIOPHEN-2-YLMETHOXY)ACETALDEHYDE; 2-(THIOPHEN-2-YLSULFANYL)ACETALDEHYDE; 2-(THIOPHEN-3-YL)ACETALDEHYDE; 2-(TRIFLUOROMETHYL)BENZALDEHYDE; 2-(TRIFLUOROMETHYL)PROPIONALDEHYDE; 2,2 DIMETHYL-4-CYANOBUTYRALDEHYDE; 2,2,3,3,3-PENTAFLUOROPROPANAL; 2,2,3-TRIMETHYLCYCLOPENT-3-ENE-1-CARBOXALDEHYDE; 2,2,4-TRIMETHYL-3-HYDROXYPENTANAL; 2,2,5-TRIMETHYLHEX-4-ENAL; 2,2,5-TRIMETHYLHEXANAL; 2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-CARBALDEHYDE; 2,2-BIS(ETHYLTHIO)ACETALDEHYDE; 2,2-DICHLOROHEXANAL; 2,2-DICHLOROPENTANAL; 2,2-DIFLUOROACETALDEHYDE; 2,2-DIFLUORO-CYCLOPROPANECARBALDEHYDE; 2,2-DIMETHYL-1,3-DIOXANE-5-CARBALDEHYDE; 2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBOXALDEHYDE; 2,2-DIMETHYL-3-(2-METHYLPYRROLIDIN-1-YL)PROPANAL; 2,2-DIMETHYL-3-(3-METHYLPYRROLIDIN-1-YL)PROPANAL; 2,2-DIMETHYL-3,4-OCTADIENAL; 2,2-DIMETHYL-3-[METHYL(2-METHYLPROPYL)AMINO]PROPANAL; 2,2-DIMETHYL-3-[METHYL(PROPAN-2-YL)AMINO]PROPANAL; 2,2-DIMETHYL-3-[METHYL(PROPYL)AMINO]PROPANAL; 2,2-DIMETHYL-3-MORPHOLIN-4-YLPROPANAL; 2,2-DIMETHYL-3-OXOHEPT-6-ENAL; 2,2-DIMETHYL-3-OXOHEPTANAL; 2,2-DIMETHYL-3-OXOHEXANAL; 2,2-DIMETHYL-3-OXOCTANAL; 2,2-DIMETHYL-3-OXOPENTANAL; 2,2-DIMETHYL-3-PHENYLPROPIONALDEHYDE; 2,2-DIMETHYL-3-PIPERIDIN-1-YLPROPANAL; 2,2-DIMETHYL-3-PYRROLIDIN-1-YLPROPANAL; 2,2-DIMETHYL-4-HEXEN-1-ALDEHYDE; 2,2-DIMETHYL-4-PENTENAL; 2,2-DIMETHYL-5-VINYL-[1,3]DIOXOLANE-4-CARBALDEHYDE; 2,2-DIMETHYLBUTANAL; 2,2-DIMETHYLNONANAL; 2,2-DIMETHYL-SUCCINALDEHYDONITRILE; 2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-CARBALDEHYDE; 2,2-DIMETHYL-TETRAHYDROTHIOPHENE-3-CARBOXALDEHYDE; 2,2′-OXYBISACETALDEHYDE; 2,3-(METHYLENEDIOXY)BENZALDEHYDE; 2,3,4,5-TETRAHYDROXY-PENTANAL; 2,3,4-TRIFLUOROBENZALDEHYDE; 2,3,4-TRIFLUOROBENZENEYL ACETALDEHYDE; 2,3,4-TRIHYDROXY-6-METHYL-BENZALDEHYDE; 2,3,4-TRIHYDROXYBENZALDEHYDE; 2,3,5,6-TETRAMETHYLBENZALDEHYDE; 2,3,5-TRIFLUORO-4-PYRIDINECARBOXALDEHYDE; 2,3,5-TRIFLUOROBENZALDEHYDE; 2,3,6-TRIFLUOROBENZALDEHYDE; 2,3,6-TRIFLUOROPYRIDINE-4-CARBOXALDEHYDE; 2,3,6-TRIMETHYLCYCLOHEXYLMETHANAL; 2,3-DICHLORO-2-METHYLPROPANAL; 2,3-DICHLOROPROPIONALDEHYDE; 2,3-DIFLUORO-4-HYDROXYBENZALDEHYDE; 2,3-DIFLUORO-4-METHOXYBENZALDEHYDE; 2,3-DIFLUORO-4-METHYLBENZALDEHYDE; 2,3-DIFLUORO-5-METHYLBENZALDEHYDE; 2,3-DIFLUORO-6-HYDROXYBENZALDEHYDE; 2,3-DIFLUORO-6-METHOXYBENZALDEHYDE; 2,3-DIFLUORO-6-METHYLBENZALDEHYDE; 2,3-DIFLUOROBENZALDEHYDE; 2,3-DIFLUORO-BENZENEPROPANAL; 2,3-DIFLUOROISONICOTINALDEHYDE; 2,3-DIHYDRO-[1,4]DIOXINO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 2,3-DIHYDRO-[1,4]DIOXINO[2,3-B]PYRIDINE-7-CARBALDEHYDE; 2,3-DIHYDRO-[1,4]DIOXINO[2,3-C]PYRIDINE-7-CARBALDEHYDE; 2,3-DIHYDRO-1,4-BENZODIOXINE-5-CARBALDEHYDE; 2,3-DIHYDRO-1-BENZOFURAN-2-CARBALDEHYDE; 2,3-DIHYDRO-1-BENZOFURAN-7-CARBALDEHYDE; 2,3-DIHYDRO-2,5-DIMETHYL-2-FORMYL-1,4-PYRAN; 2,3-DIHYDRO-2-OXO-3-FURANCARBOXALDEHYDE; 2,3-DIHYDRO-4-BENZOFURANCARBOXALDEHYDE; 2,3-DIHYDRO-BENZO[1,4]DIOXINE-2-CARBALDEHYDE; 2,3-DIHYDROBENZO[B]FURAN-5-CARBOXALDEHYDE; 2,3-DIHYDRO-BENZOFURAN-6-CARBALDEHYDE; 2,3-DIHYDROXY-4-METHOXYBENZALDEHYDE; 2,3-DIHYDROXYBENZALDEHYDE; 2,3-DIMETHOXYBENZALDEHYDE; 2,3-DIMETHOXYISONICOTINALDEHYDE; 2,3-DIMETHYLANISALDEHYDE; 2,3-DIMETHYLBENZALDEHYDE; 2,3-DIMETHYL-BENZENEPROPANAL; 2,3-DIMETHYLISONICOTINALDEHYDE; 2,3-DIMETHYLPENTANAL; 2,3-EPOXYDECANAL; 2,3-EPOXYHEPTANAL; 2,3-EPOXYOCTANAL; 2,3-O-(3-PENTYLIDENE)-D-GLYCERALDEHYDE; 2,3-O-(3-PENTYLIDENE)-L-GLYCERALDEHYDE; 2,3-PYRIDINEDICARBOXALDEHYDE; 2,4,5-TRIFLUORO-3-METHYLBENZALDEHYDE; 2,4,5-TRIFLUOROBENZALDEHYDE; 2,4,5-TRIHYDROXYBENZALDEHYDE; 2,4,5-TRIMETHYLBENZALDEHYDE; 2,4,6-PYRIDINETRICARBOXALDEHYDE; 2,4,6-TRIFLUOROBENZALDEHYDE; 2,4,6-TRIHYDROXYBENZALDEHYDE; 2,4,6-TRIHYDROXYPYRIMIDINE-5-CARBOXALDEHYDE; 2,4,6-TRIIFLUOROPYRIDINE-3-CARBOXALDEHYDE; 2,4,6-TRIMETHYL-3-CYCLOHEXENE-1-CARBOXALDEHYDE; 2,4,6-TRIMETHYLBENZALDEHYDE; 2,4,6-TRIMETHYL-PYRIDINE-3-CARBALDEHYDE; 2,4-DIFLUORO-3-FORMYLBENZONITRILE; 2,4-DIFLUORO-3-HYDROXYBENZALDEHYDE; 2,4-DIFLUORO-3-METHOXYBENZALDEHYDE; 2,4-DIFLUORO-3-METHYLBENZALDEHYDE; 2,4-DIFLUORO-5-METHYLBENZALDEHYDE; 2,4-DIFLUORO-6-HYDROXYBENZALDEHYDE; 2,4-DIFLUORO-6-METHYLBENZALDEHYDE; 2,4-DIFLUOROBENZALDEHYDE; 2,4-DIFLUORONICOTINALDEHYDE; 2,4-DIHYDROXY-3-METHYLBENZALDEHYDE; 2,4-DIHYDROXY-5-METHOXYBENZALDEHYDE; 2,4-DIHYDROXY-6-METHYLBENZALDEHYDE; 2,4-DIHYDROXYBENZALDEHYDE; 2,4-DIHYDROXY-BENZENE-1,3-DICARB-ALDEHYDE; 2,4-DIMETHOXY-5-FORMYLPYRIMIDINE; 2,4-DIMETHOXYBENZALDEHYDE; 2,4-DIMETHOXYNICOTINALDEHYDE; 2,4-DIMETHYL-3-CYCLOHEXENECARBOXALDEHYDE; 2,4-DIMETHYL-3-FLUOROBENZALDEHYDE; 2,4-DIMETHYLBENZALDEHYDE; 2,4-DIMETHYLNICOTINALDEHYDE; 2,4-DIMETHYLPYRIMIDINE-5-CARBALDEHYDE; 2,4-DIOXOTETRAHYDROFURAN-3-CARBALDEHYDE; 2,4-O-ETHYLIDENE-D-ERYTHROSE; 2,4-PYRIDINEDICARBOXALDEHYDE; 2,4-PYRIDINEDICARBOXALDEHYDE, 6-METHYL-; 2,5-ANHYDRO-D-MANNOSE; 2,5-DIFLUORO-3-METHYLBENZALDEHYDE; 2,5-DIFLUORO-4-HYDROXYBENZALDEHYDE; 2,5-DIFLUORO-4-METHOXYBENZALDEHYDE; 2,5-DIFLUORO-4-METHYLBENZALDEHYDE; 2,5-DIFLUORO-6-METHYLBENZALDEHYDE; 2,5-DIFLUOROBENZALDEHYDE; 2,5-DIFLUOROPYRIDINE-3-CARBOXALDEHYDE; 2,5-DIFLUOROPYRIDINE-4-CARBOXALDEHYDE; 2,5-DIHYDRO-1-METHYL-5-OXO-1H-PYRROLE-2-PROPANAL; 2,5-DIHYDRO-5-OXO-2-FURANCARBOXALDEHYDE; 2,5-DIHYDROXY-3-METHOXYBENZENECARBALDEHYDE; 2,5-DIHYDROXYBENZALDEHYDE; 2,5-DIMETHOXY-3-TETRAHYDROFURANCARBOXALDEHYDE; 2,5-DIMETHOXYBENZALDEHYDE; 2,5-DIMETHOXYISONICOTINALDEHYDE; 2,5-DIMETHOXYNICOTINALDEHYDE; 2,5-DIMETHYL-1H-PYRROLE-1-ACETALDEHYDE; 2,5-DIMETHYL-4-METHOXYBENZALDEHYDE; 2,5-DIMETHYLBENZALDEHYDE; 2,5-DIMETHYL-BENZENEPROPANAL; 2,5-DIMETHYLISONICOTINALDEHYDE; 2,5-DIMETHYLPYRIDINE-3-CARBOXALDEHYDE; 2,5-DIMETHYLTEREPHTHALALDEHYDE; 2,5-DIOXO-1-PYRROLIDINEBUTANAL; 2,5-PYRAZINEDICARBOXALDEHYDE; 2,5-PYRIDINEDICARBOXALDEHYDE; 2,6,6-TRIMETHYL-1-CYCLOHEXENE-1-ACETALDEHYDE; 2,6-DIETHYLBENZALDEHYDE; 2,6-DIFLUORO-3-HYDROXYBENZALDEHYDE; 2,6-DIFLUORO-3-METHOXYBENZALDEHYDE; 2,6-DIFLUORO-3-METHYLBENZALDEHYDE; 2,6-DIFLUORO-4-FORMYLBENZONITRILE; 2,6-DIFLUORO-4-HYDROXYBENZALDEHYDE; 2,6-DIFLUORO-4-METHOXYBENZALDEHYDE; 2,6-DIFLUORO-4-METHYLBENZALDEHYDE; 2,6-DIFLUOROBENZALDEHYDE; 2,6-DIFLUOROPYRIDINE-3-CARBOXALDEHYDE; 2,6-DIFLUOROPYRIDINE-4-CARBOXALDEHYDE; 2,6-DIFORMYLPHENOL; 2,6-DIHYDROXY-4-METHYLBENZALDEHYDE; 2,6-DIHYDROXYBENZALDEHYDE; 2,6-DIMETHOXY-3-FORMYLPYRIDINE; 2,6-DIMETHOXYBENZALDEHYDE; 2,6-DIMETHOXYISONICOTINALDEHYDE; 2,6-DIMETHYL-3-HYDROXYBENZALDEHYDE; 2,6-DIMETHYL-3-METHOXYBENZALDEHYDE; 2,6-DIMETHYL-4-FLUOROBENZALDEHYDE; 2,6-DIMETHYL-4-HYDROXYBENZALDEHYDE; 2,6-DIMETHYL-5-HEPTENAL; 2,6-DIMETHYLBENZALDEHYDE; 2,6-DIMETHYL-BENZENEPROPANAL; 2,6-DIMETHYLPHENYLGLYOXAL; 2,6-DIMETHYL-PYRIDINE-3-CARBALDEHYDE; 2,6-DIMETHYLPYRIDINE-4-CARBOXALDEHYDE; 2,6-DIMETHYLPYRIMIDINE-4-CARBALDEHYDE; 2,6-PYRIDINEDICARBOXALDEHYDE; 2,7-NAPHTHYRIDINE-4-CARBALDEHYDE; 2-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]ACETALDEHYDE; 2-[(1-METHYL-1H-PYRAZOL-4-YL)SULFANYL]ACETALDEHYDE; 2-[(2,2-DIMETHYLPROPYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(2-FLUOROPHENYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(2-FLUOROPHENYL)SULFANYL]ACETALDEHYDE; 2-[(2-HYDROXYETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(2-HYDROXYETHYL)(PENTAN-3-YL)AMINO]ACETALDEHYDE; 2-[(2-HYDROXYETHYL)(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[(2-HYDROXYETHYL)(PROPYL)AMINO]ACETALDEHYDE; 2-[(2-HYDROXYETHYL)SULFANYL]ACETALDEHYDE; 2-[(2-HYDROXYPROPYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(2-METHOXYETHYL)(2-METHYLPROPYL)AMINO]ACETALDEHYDE; 2-[(2-METHOXYETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(2-METHOXYETHYL)SULFANYL]ACETALDEHYDE; 2-[(2-METHYLBUTAN-2-YL)OXY]ACETALDEHYDE; 2-[(2-METHYLPHENYL)SULFANYL]ACETALDEHYDE; 2-[(2-METHYLPROPYL)(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[(2-METHYLPROPYL)SULFANYL]ACETALDEHYDE; 2-[(3-FLUOROPHENYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(3-HYDROXYPROPYL)(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[(3-METHOXYPROPYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(3-METHYLCYCLOHEXYL)SULFANYL]ACETALDEHYDE; 2-[(3-METHYLPHENYL)SULFANYL]ACETALDEHYDE; 2-[(4,5-DIMETHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]ACETALDEHYDE; 2-[(4-FLUOROPHENYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(4-FLUOROPHENYL)SULFANYL]ACETALDEHYDE; 2-[(4-HYDROXYPYRIMIDIN-2-YL)SULFANYL]ACETALDEHYDE; 2-[(4-METHYL-1,3-THIAZOL-2-YL)SULFANYL]ACETALDEHYDE; 2-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]ACETALDEHYDE; 2-[(4-METHYLCYCLOHEXYL)OXY]ACETALDEHYDE; 2-[(4-METHYLPENTYL)OXY]ACETALDEHYDE; 2-[(4-METHYLPHENYL)SULFANYL]ACETALDEHYDE; 2-[(4-METHYLPYRIMIDIN-2-YL)SULFANYL]ACETALDEHYDE; 2-[(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]ACETALDEHYDE; 2-[(5-METHYL-1,3,4-THIADIAZOL-2-YL)SULFANYL]ACETALDEHYDE; 2-[(5-METHYLPYRIMIDIN-2-YL)SULFANYL]ACETALDEHYDE; 2-[(CYANOMETHYL)(2-OXOETHYL)AMINO]ACETONITRILE; 2-[(CYANOMETHYL)(3-OXOPROPYL)AMINO]ACETONITRILE; 2-[(CYCLOBUTYLMETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(CYCLOHEXYLMETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(CYCLOPENTYLMETHYL)SULFANYL]ACETALDEHYDE; 2-[(CYCLOPROPYLMETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(CYCLOPROPYLMETHYL)(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[(CYCLOPROPYLMETHYL)(PROPYL)AMINO]ACETALDEHYDE; 2-[(DIETHYLAMINO)METHYL]-2-METHYLBUTANAL; 2-[(DIMETHYLAMINO)METHYL]-2-ETHYLBUTANAL; 2-[(DIMETHYLAMINO)METHYL]-2-METHYLBUTANAL; 2-[(DIMETHYLAMINO)METHYL]-2-METHYLPENTANAL; 2-[(FURAN-2-YLMETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(FURAN-2-YLMETHYL)SULFANYL]ACETALDEHYDE; 2-[(FURAN-3-YLMETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(METHYLSULFANYL)METHYL]PYRIMIDINE-4-CARBALDEHYDE; 2-[(METHYLSULFANYL)METHYL]PYRIMIDINE-5-CARBALDEHYDE; 2-[1,2,4]TRIAZOL-1-YL-BENZALDEHYDE; 2-[2-(3-HYDROXYPROPYL)PYRROLIDIN-1-YL]ACETALDEHYDE; 2-[2-(HYDROXYMETHYL)PYRROLIDIN-1-YL]ACETALDEHYDE; 2-[2-(PROPAN-2-YL)-1H-IMIDAZOL-1-YL]ACETALDEHYDE; 2-[2-(PROPAN-2-YLOXY)ETHOXY]ACETALDEHYDE; 2-[2-(PYRIDIN-2-YL)ETHOXY]ACETALDEHYDE; 2-[2-(THIOPHEN-2-YL)ETHOXY]ACETALDEHYDE; 2-[3-(DIMETHYLAMINO)PYRROLIDIN-1-YL]ACETALDEHYDE; 2-[3-(HYDROXYMETHYL)PHENOXY]ACETALDEHYDE; 2-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]ACETALDEHYDE; 2-[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]ACETALDEHYDE; 2-[4-(HYDROXYMETHYL)PHENOXY]ACETALDEHYDE; 2-[4-(HYDROXYMETHYL)PIPERIDIN-1-YL]ACETALDEHYDE; 2-[4-(PROPAN-2-YL)PIPERAZIN-1-YL]ACETALDEHYDE; 2-[BENZYL(METHYL)AMINO]ACETALDEHYDE; 2-[BIS(2-HYDROXYETHYL)AMINO]ACETALDEHYDE; 2-[BIS(2-METHYLPROPYL)AMINO]ACETALDEHYDE; 2-[BUTYL(2-HYDROXYETHYL)AMINO]ACETALDEHYDE; 2-[BUTYL(CYCLOPROPYL)AMINO]ACETALDEHYDE; 2-[BUTYL(ETHYL)AMINO]ACETALDEHYDE; 2-[BUTYL(METHYL)AMINO]ACETALDEHYDE; 2-[CYCLOHEPTYL(METHYL)AMINO]ACETALDEHYDE; 2-[CYCLOHEXYL(ETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOHEXYL(METHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPENTYL(2-HYDROXYETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPENTYL(ETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPENTYL(METHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(2-HYDROXYETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(2-METHOXYETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(2-METHYLPROPYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(ETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(METHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(PROPYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2,2,2-TRIFLUOROETHYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2-ETHYLBUTYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2-HYDROXYETHYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2-METHOXYETHYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2-METHYLPROPYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2-OXOETHYL)AMINO]-N,N-DIMETHYLACETAMIDE; 2-[ETHYL(FURAN-2-YLMETHYL)AMINO]ACETALDEHYDE; 2-[ETHYL(METHYL)AMINO]ACETALDEHYDE; 2-[ETHYL(METHYL)AMINO]BENZALDEHYDE; 2-[ETHYL(PHENYL)AMINO]ACETALDEHYDE; 2-[ETHYL(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[ETHYL(PROPYL)AMINO]ACETALDEHYDE; 2-[METHYL(1,3-THIAZOL-4-YLMETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(1-METHYLPIPERIDIN-3-YL)AMINO]ACETALDEHYDE; 2-[METHYL(1-METHYLPIPERIDIN-4-YL)AMINO]ACETALDEHYDE; 2-[METHYL(2,2,2-TRIFLUOROETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(2-METHYLPHENYL)AMINO]ACETALDEHYDE; 2-[METHYL(2-METHYLPROPYL)AMINO]ACETALDEHYDE; 2-[METHYL(3-METHYLBUTYL)AMINO]ACETALDEHYDE; 2-[METHYL(3-METHYLPHENYL)AMINO]ACETALDEHYDE; 2-[METHYL(4-METHYLCYCLOHEXYL)AMINO]ACETALDEHYDE; 2-[METHYL(4-METHYLPHENYL)AMINO]ACETALDEHYDE; 2-[METHYL(PENTAN-3-YL)AMINO]ACETALDEHYDE; 2-[METHYL(PENTYL)AMINO]ACETALDEHYDE; 2-[METHYL(PHENYL)AMINO]ACETALDEHYDE; 2-[METHYL(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[METHYL(PROPYL)AMINO]ACETALDEHYDE; 2-[METHYL(PYRIDIN-2-YLMETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(PYRIDIN-3-YLMETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(PYRIDIN-4-YLMETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(THIOPHEN-2-YLMETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(THIOPHEN-3-YLMETHYL)AMINO]ACETALDEHYDE; 2-[PENTYL(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[PROPAN-2-YL(PROPYL)AMINO]ACETALDEHYDE; 2-ACETYL-3-PYRIDINECARBOXALDEHYDE; 2-ACETYL-5-OXO-PENTANOIC ACID METHYL ESTER; 2-ACETYLBENZALDEHYDE; 2-ACETYLPYRIDINE-4-CARBALDEHYDE; 2-ALLYL-3-HYDROXYBENZALDEHYDE; 2-ALLYLOXYBENZALDEHYDE; 2-BENZOFURANGLYOXYLALDEHYDE; 2-BENZOFURANPROPANAL; 2-BROMO-2-METHYL-PROPIONALDEHYDE; 2-BROMO-3-METHYLBUTYRALDEHYDE; 2-BROMOBUTANAL; 2-BROMOMALONALDEHYDE; 2-BROMO-PROPIONALDEHYDE; 2-BUTOXYACETALDEHYDE; 2-BUTYLPYRIMIDINE-4-CARBALDEHYDE; 2-BUTYL-PYRIMIDINE-5-CARBALDEHYDE; 2-BUTYNAL; 2-CHLORO-2-METHYLPROPANAL; 2-CHLORO-3,4-DIHYDROXYBENZALDEHYDE; 2-CHLORO-3,5-DIMETHYLBENZALDEHYDE; 2-CHLORO-3-CYANOBENZALDEHYDE; 2-CHLORO-3-FLUORO-4-FORMYLPYRIDINE; 2-CHLORO-3-FLUORO-4-HYDROXYBENZALDEHYDE; 2-CHLORO-3-FLUORO-6-HYDROXY-BENZALDEHYDE; 2-CHLORO-3-FLUOROBENZALDEHYDE; 2-CHLORO-3-FLUOROMETHYLBENZALDEHYDE; 2-CHLORO-3-FORMYL-4-PICOLINE; 2-CHLORO-3-FORMYL-6-PICOLINE; 2-CHLORO-3-HYDROXYBENZALDEHYDE; 2-CHLORO-3-HYDROXYISONICOTINALDEHYDE; 2-CHLORO-3-METHOXYBENZALDEHYDE; 2-CHLORO-3-METHOXYPYRIDINE-4-CARBOXALDEHYDE; 2-CHLORO-3-METHYLBENZALDEHYDE; 2-CHLORO-3-METHYLPYRIDINE-4-CARBOXALDEHYDE; 2-CHLORO-3-PHENYLPROPANAL; 2-CHLORO-3-PYRIDINECARBOXALDEHYDE; 2-CHLORO-4,6-DIMETHYLPYRIDINE-3-CARBOXALDEHYDE; 2-CHLORO-4-FLUORO-3-METHYLBENZALDEHYDE; 2-CHLORO-4-FLUOROBENZALDEHYDE; 2-CHLORO-4-FLUORO-PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-4-HYDROXYBENZALDEHYDE; 2-CHLORO-4-HYDROXYNICOTINALDEHYDE; 2-CHLORO-4-METHOXYBENZALDEHYDE; 2-CHLORO-4-METHOXYNICOTINALDEHYDE; 2-CHLORO-4-METHOXYPYRIDINE-5-CARBOXALDEHYDE; 2-CHLORO-4-METHYLBENZALDEHYDE; 2-CHLORO-5-FLUORO-3-FORMYLPYRIDINE; 2-CHLORO-5-FLUORO-4-FORMYLPYRIDINE; 2-CHLORO-5-FLUORO-6-FORMYLPYRIDINE; 2-CHLORO-5-FLUOROBENZALDEHYDE; 2-CHLORO-5-FORMYL-4-PICOLINE; 2-CHLORO-5-FORMYL-NICOTINONITRILE; 2-CHLORO-5-HYDROXY-3-PYRIDINECARBOXALDEHYDE; 2-CHLORO-5-HYDROXYBENZALDEHYDE; 2-CHLORO-5-HYDROXYISONICOTINALDEHYDE; 2-CHLORO-5-METHOXYBENZALDEHYDE; 2-CHLORO-5-METHOXYISONICOTINALDEHYDE; 2-CHLORO-5-METHOXYPYRIDINE-3-CARBOXALDEHYDE; 2-CHLORO-5-METHYLBENZALDEHYDE; 2-CHLORO-5-METHYLPYRIDINE-3-CARBALDEHYDE; 2-CHLORO-5-METHYLPYRIDINE-4-CARBOXALDEHYDE; 2-CHLORO-6-CYANOBENZALDEHYDE; 2-CHLORO-6-CYANOISONICOTINALDEHYDE; 2-CHLORO-6-FLUORO-3-METHYLBENZALDEHYDE; 2-CHLORO-6-FLUOROBENZALDEHYDE; 2-CHLORO-6-FLUOROISONICOTINALDEHYDE; 2-CHLORO-6-FLUORONICOTINALDEHYDE; 2-CHLORO-6-FORMYLBENZONITRILE; 2-CHLORO-6-HYDROXYBENZALDEHYDE; 2-CHLORO-6-HYDROXYISONICOTINALDEHYDE; 2-CHLORO-6-HYDROXYNICOTINALDEHYDE; 2-CHLORO-6-METHOXY-4-PYRIDINECARBOXALDEHYDE; 2-CHLORO-6-METHOXYBENZALDEHYDE; 2-CHLORO-6-METHOXYNICOTINALDEHYDE; 2-CHLORO-6-METHYLBENZALDEHYDE; 2-CHLORO-6-METHYLPYRIDINE-4-CARBOXALDEHYDE; 2-CHLOROBENZALDEHYDE; 2-CHLORO-HEXANAL; 2-CHLOROISONICOTINALDEHYDE; 2-CHLOROISONICOTINALDEHYDE HYDRATE; 2-CHLOROMALONALDEHYDE; 2-CHLOROPHENYLGLYOXAL; 2-CHLOROPROPIONALDEHYDE; 2-CHLORO-PYRIDINE-3,5-DICARBALDEHYDE; 2-CHLOROPYRIMIDINE-4,6-DICARBALDEHYDE; 2-CHLOROPYRIMIDINE-4-CARBALDEHYDE; 2-CHLOROPYRIMIDINE-5-CARBALDEHYDE; 2-CYANO-3-FLUOROBENZALDEHYDE; 2-CYANO-3-HYDROXYBENZALDEHYDE; 2-CYANO-4-FLUOROBENZALDEHYDE; 2-CYANO-4-METHOXYBENZALDEHYDE; 2-CYANO-4-METHYLBENZALDEHYDE; 2-CYANO-5-FLUOROBENZALDEHYDE; 2-CYANO-5-HYDROXYBENZALDEHYDE; 2-CYANO-5-METHOXYBENZALDEHYDE; 2-CYANO-5-METHYLBENZALDEHYDE; 2-CYANO-6-FLUOROBENZALDEHYDE; 2-CYANO-6-HYDROXYBENZALDEHYDE; 2-CYANO-6-METHOXYBENZALDEHYDE; 2-CYANO-6-METHYLBENZALDEHYDE; 2-CYANOBENZALDEHYDE; 2-CYANOPYRIDINE-4-CARBOXALDEHYDE; 2-CYCLOBUTOXYACETALDEHYDE; 2-CYCLOHEXYL PROPANAL; 2-CYCLOHEXYLACETALDEHYDE; 2-CYCLOPROPOXYBENZALDEHYDE; 2-CYCLOPROPYL-2-OXOACETALDEHYDE; 2-CYCLOPROPYL-3-PYRIDINECARBOXALDEHYDE; 2-CYCLOPROPYL-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-CYCLOPROPYLACETALDEHYDE; 2-CYCLOPROPYLBENZALDEHYDE; 2-CYCLOPROPYLETHYNYL-BENZALDEHYDE; 2-CYCLOPROPYLPYRIMIDINE-4-CARBALDEHYDE; 2-CYCLOPROPYLPYRIMIDINE-5-CARBALDEHYDE; 2-DECYNAL; 2-DEOXY-D-GLUCOSE; 2-DEOXY-D-RIBOSE; 2-DEOXY-L-GLUCOSE; 2-DEOXY-L-RIBOSE; 2-DIMETHYLAMINO-1,3-DIOXOHEXANE; 2-DIMETHYLAMINO-5-FORMYLBENZONITRILE; 2-DIMETHYLAMINOMETHYL-BENZALDEHYDE; 2-DIMETHYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-ETHENYLBENZALDEHYDE; 2-ETHOXY-3-METHYLPYRIDINE-5-CARBOXALDEHYDE; 2-ETHOXY-4-FLUOROBENZALDEHYDE; 2-ETHOXY-5-FLUOROBENZALDEHYDE; 2-ETHOXY-5-METHYLBENZALDEHYDE; 2-ETHOXYBENZALDEHYDE; 2-ETHOXYNICOTINALDEHYDE; 2-ETHYL-1,3-DITHIOLANE-2-CARBALDEHYDE; 2-ETHYL-2-([ETHYL(METHYL)AMINO]METHYL)BUTANAL; 2-ETHYL-2,3-DIHYDRO-1H-INDENE-2-CARBALDEHYDE; 2-ETHYL-3-HYDROXYBENZALDEHYDE; 2-ETHYL-3-HYDROXYHEXANAL; 2-ETHYL-3-METHYLBUTANAL; 2-ETHYL-3-PYRIDINECARBOXALDEHYDE; 2-ETHYL-4-HYDROXYBENZALDEHYDE; 2-ETHYL-4-PYRIDINECARBOXALDEHYDE; 2-ETHYL-5-HYDROXYBENZALDEHYDE; 2-ETHYL-5-METHYLCYCLOPENTANAL; 2-ETHYL-6-HYDROXYBENZALDEHYDE; 2-ETHYL-6-METHYL-4-PYRIDINECARBOXALDEHYDE; 2-ETHYL-6-METHYLBENZALDEHYDE; 2-ETHYL-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-ETHYLBENZALDEHYDE; 2-ETHYLBUTYRALDEHYDE; 2-ETHYLHEPTANAL; 2-ETHYLHEXANAL; 2-ETHYLHEXENAL; 2-ETHYLPYRIMIDINE-4-CARBALDEHYDE; 2-ETHYLPYRIMIDINE-5-CARBALDEHYDE; 2-ETHYLSULFANYL-PYRIMIDINE-5-CARBALDEHYDE; 2-ETHYNYL-5-PYRIMIDINECARBOXALDEHYDE; 2-ETHYNYLBENZALDEHYDE; 2-FLUORO-3-(CHLOROMETHYL)BENZALDEHYDE; 2-FLUORO-3-(DIFLUOROMETHYL)BENZALDEHYDE; 2-FLUORO-3,4-DIHYDROXY-BENZALDEHYDE; 2-FLUORO-3-FORMYL-4-PICOLINE; 2-FLUORO-3-FORMYLPHENYLBORONIC ACID; 2-FLUORO-3-FORMYLPYRIDINE; 2-FLUORO-3-HYDROXY-4-METHOXYBENZALDEHYDE; 2-FLUORO-3-HYDROXY-6-METHOXYBENZALDEHYDE; 2-FLUORO-3-HYDROXYBENZALDEHYDE; 2-FLUORO-3-HYDROXYISONICOTINALDEHYDE; 2-FLUORO-3-METHOXY-5-METHYLBENZALDEHYDE; 2-FLUORO-3-METHOXYBENZALDEHYDE; 2-FLUORO-3-METHOXYISONICOTINALDEHYDE; 2-FLUORO-3-METHYL-5-METHOXYBENZALDEHYDE; 2-FLUORO-3-METHYLBENZALDEHYDE; 2-FLUORO-3-METHYL-BENZENEPROPANAL; 2-FLUORO-3-METHYLISONICOTINALDEHYDE; 2-FLUORO-3-NITROBENZALDEHYDE; 2-FLUORO-4-(CHLOROMETHYL)BENZALDEHYDE; 2-FLUORO-4,5-DIHYDROXYBENZALDEHYDE; 2-FLUORO-4-FORMYLBENZONITRILE; 2-FLUORO-4-FORMYLPHENYLBORONIC ACID; 2-FLUORO-4-FORMYLPYRIDINE; 2-FLUORO-4-HYDROXYBENZALDEHYDE; 2-FLUORO-4-MERCAPTOBENZALDEHYDE; 2-FLUORO-4-METHOXYBENZALDEHYDE; 2-FLUORO-4-METHYLBENZALDEHYDE; 2-FLUORO-4-NITROBENZALDEHYDE; 2-FLUORO-5-FORMYL-3-PICOLINE; 2-FLUORO-5-FORMYLBENZONITRILE; 2-FLUORO-5-FORMYLPHENYLBORONIC ACID; 2-FLUORO-5-FORMYLPYRIDINE; 2-FLUORO-5-HYDROXYBENZALDEHYDE; 2-FLUORO-5-HYDROXYISONICOTINALDEHYDE; 2-FLUORO-5-HYDROXYNICOTINALDEHYDE; 2-FLUORO-5-MERCAPTOBENZALDEHYDE; 2-FLUORO-5-METHOXYBENZALDEHYDE; 2-FLUORO-5-METHOXYISONICOTINALDEHYDE; 2-FLUORO-5-METHOXYNICOTINALDEHYDE; 2-FLUORO-5-METHYLBENZALDEHYDE; 2-FLUORO-5-METHYLISONICOTINALDEHYDE; 2-FLUORO-5-METHYLPYRIDINE-3-CARBOXALDEHYDE; 2-FLUORO-5-NITROBENZALDEHYDE; 2-FLUORO-6-FORMYLPYRIDINE; 2-FLUORO-6-HYDROXY-3-METHOXYBENZALDEHYDE; 2-FLUORO-6-HYDROXYBENZALDEHYDE; 2-FLUORO-6-HYDROXYISONICOTINALDEHYDE; 2-FLUORO-6-HYDROXYNICOTINALDEHYDE; 2-FLUORO-6-METHOXYBENZALDEHYDE; 2-FLUORO-6-METHOXYISONICOTINALDEHYDE; 2-FLUORO-6-METHOXYNICOTINALDEHYDE; 2-FLUORO-6-METHYLBENZALDEHYDE; 2-FLUORO-6-METHYLISONICOTINALDEHYDE; 2-FLUORO-6-METHYLNICOTINALDEHYDE; 2-FLUORO-6-NITROBENZALDEHYDE; 2-FLUOROBENZALDEHYDE; 2-FLUORONAPHTHALENE-1-CARBOXALDEHYDE; 2-FLUORONAPHTHALENE-3-CARBOXALDEHYDE; 2-FLUORONAPHTHALENE-4-CARBOXALDEHYDE; 2-FLUORONAPHTHALENE-5-CARBOXALDEHYDE; 2-FLUORONAPHTHALENE-6-CARBOXALDEHYDE; 2-FLUORONAPHTHALENE-7-CARBOXALDEHYDE; 2-FLUOROPHENYLGLYOXAL HYDRATE; 2-FORMYL-1,3-BENZOXAZOLE-6-CARBONITRILE; 2-FORMYL-1,3-BENZOXAZOLE-7-CARBONITRILE; 2-FORMYL-1-PIPERIDINECARBOXYLIC ACID METHYL ESTER; 2-FORMYL-3,4-DIHYDRO-2H-PYRAN; 2-FORMYL-3-METHYL-3H-IMIDAZOLE-4-CARBOXYLIC ACID METHYL ESTER; 2-FORMYL-3-METHYLBUTANENITRILE; 2-FORMYL-3-OXO-BUTYRIC ACID ETHYL ESTER; 2-FORMYL-3-PHENYL-PROPIONITRILE; 2-FORMYL-4-METHYLPENTANENITRILE; 2-FORMYL-4-METHYLPHENYLBORONIC ACID; 2-FORMYL-4-PICOLINE; 2-FORMYL-5,6,7,8-TETRAHYDROQUINAZOLINE; 2-FORMYL-5-HYDROXYBENZONITRILE; 2-FORMYL-5-METHYLPHENYLBORONIC ACID; 2-FORMYL-6-METHOXYBENZONITRILE; 2-FORMYL-6-METHYLBENZONITRILE; 2-FORMYL-6-METHYL-CYCLOPENTAIMIDAZOLE; 2-FORMYL-6-METHYLISONICOTINONITRILE; 2-FORMYL-6-METHYLPYRIDINE-4-BORONIC ACID; 2-FORMYLAZULENE; 2-FORMYL-BENZOYL CHLORIDE; 2-FORMYLBUTANENITRILE; 2-FORMYLNICOTINONITRILE; 2-FORMYLPHENYLBORONIC ACID; 2-FORMYLPROPIONIC ACID ETHYL ESTER; 2-FORMYLPYRIDINE-4-BORONIC ACID; 2-FORMYLPYRIMIDINE-4-CARBONITRILE; 2-FURAN-2-YL-BENZALDEHYDE; 2-FURANBUTANAL; 2-FURANPENTANAL; 2H-1,2,3-TRIAZOLE-4-CARBOXALDEHYDE, 5-[(DIMETHYLAMINO)METHYL]-; 2-HEPTYNAL; 2-HEXYNAL; 2H-PYRAN-4-CARBOXALDEHYDE, 4-FLUOROTETRAHYDRO-; 2H-TETRAZOLE-5-CARBALDEHYDE; 2-HYDROXY-1-NAPHTHALDEHYDE; 2-HYDROXY-3-(METHYLTHIO)BENZALDEHYDE; 2-HYDROXY-3,4-DIMETHYL-BENZALDEHYDE; 2-HYDROXY-3,5-DIMETHYL-BENZALDEHYDE; 2-HYDROXY-3,6-DIMETHYLBENZALDEHYDE; 2-HYDROXY-3-ISOPROPYLBENZALDEHYDE; 2-HYDROXY-3-METHOXY-5-METHYL-BENZALDEHYDE; 2-HYDROXY-3-METHOXYBENZALDEHYDE; 2-HYDROXY-3-METHYLBENZALDEHYDE; 2-HYDROXY-3-METHYLISONICOTINALDEHYDE; 2-HYDROXY-4-(METHYLTHIO)BENZALDEHYDE; 2-HYDROXY-4,5-DIMETHYL-BENZALDEHYDE; 2-HYDROXY-4,6-DIMETHYL-BENZALDEHYDE; 2-HYDROXY-4-ISOPROPYLBENZALDEHYDE; 2-HYDROXY-4-METHOXY-6-METHYLBENZALDEHYDE; 2-HYDROXY-4-METHOXYBENZALDEHYDE; 2-HYDROXY-4-METHYLBENZALDEHYDE; 2-HYDROXY-4-METHYLNICOTINALDEHYDE; 2-HYDROXY-4-NITROBENZALDEHYDE; 2-HYDROXY-4-PYRIDINECARBOXALDEHYDE; 2-HYDROXY-5-(HYDROXYMETHYL)BENZALDEHYDE; 2-HYDROXY-5-(METHYLSULFANYL)BENZALDEHYDE; 2-HYDROXY-5-CHLOROMETHYLBENZALDEHYDE; 2-HYDROXY-5-ISOPROPYL-BENZALDEHYDE; 2-HYDROXY-5-METHOXY-3-METHYL-BENZALDEHYDE; 2-HYDROXY-5-METHOXY-4-METHYL-BENZALDEHYDE; 2-HYDROXY-5-METHOXYBENZALDEHYDE; 2-HYDROXY-5-METHYLBENZALDEHYDE; 2-HYDROXY-5-METHYLISONICOTINALDEHYDE; 2-HYDROXY-5-METHYLISOPHTHALALDEHYDE; 2-HYDROXY-5-METHYLNICOTINALDEHYDE; 2-HYDROXY-5-NITROBENZALDEHYDE; 2-HYDROXY-5-NITRONICOTINALDEHYDE; 2-HYDROXY-5-PROPYL-BENZALDEHYDE; 2-HYDROXY-6-(METHYLTHIO)BENZALDEHYDE; 2-HYDROXY-6-ISOPROPYLBENZALDEHYDE; 2-HYDROXY-6-METHOXYBENZALDEHYDE; 2-HYDROXY-6-METHYLBENZALDEHYDE; 2-HYDROXY-6-METHYLISONICOTINALDEHYDE; 2-HYDROXY-6-METHYL-PYRIDINE-3-CARBALDEHYDE; 2-HYDROXY-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-HYDROXY-6-NITROBENZALDEHYDE; 2-HYDROXYHEXANEDIAL; 2-HYDROXYNICOTINALDEHYDE; 2-HYDROXYPYRAZINE-6-CARBOXALDEHYDE; 2-HYDROXYPYRIMIDINE-5-CARBALDEHYDE; 2-HYDROXYQUINOLINE-3-CARBALDEHYDE; 2-HYDROXYQUINOLINE-4-CARBOXALDEHYDE; 2-HYDROXYQUINOLINE-5-CARBOXALDEHYDE; 2-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 2-HYDROXYQUINOLINE-7-CARBOXALDEHYDE; 2-HYDROXYQUINOLINE-8-CARBOXALDEHYDE; 2-HYDROXYTEREPHTHALALDEHYDE; 2-IMIDAZOL-1-YL-BENZALDEHYDE; 2-IMIDAZOL-1-YL-PYRIDINE-3-CARBALDEHYDE; 2-IMIDAZOL-1-YL-PYRIDINE-4-CARBALDEHYDE; 2-ISOPROPOXYBENZALDEHYDE; 2-ISOPROPOXY-PYRIDINE-3-CARBALDEHYDE; 2-ISOPROPYL-6-METHYLBENZALDEHYDE; 2-ISOPROPYLBENZALDEHYDE; 2-ISOPROPYLPYRIMIDINE-4-CARBALDEHYDE; 2-ISOPROPYL-PYRIMIDINE-5-CARBALDEHYDE; 2-MERCAPTO-4-METHOXYBENZALDEHYDE; 2-MERCAPTOBENZALDEHYDE; 2-MESITYLACETALDEHYDE; 2-METHOXY-3,5-DIMETHYLBENZALDEHYDE; 2-METHOXY-3-METHYLBENZALDEHYDE; 2-METHOXY-3-METHYLISONICOTINALDEHYDE; 2-METHOXY-3-PYRIDINECARBOXALDEHYDE; 2-METHOXY-4-MERCAPTOBENZALDEHYDE; 2-METHOXY-4-METHYLBENZALDEHYDE; 2-METHOXY-4-METHYLNICOTINALDEHYDE; 2-METHOXY-5-METHYLBENZALDEHYDE; 2-METHOXY-5-METHYLISONICOTINALDEHYDE; 2-METHOXY-5-METHYLNICOTINALDEHYDE; 2-METHOXY-6-METHYL-3-PYRIDINECARBOXALDEHYDE; 2-METHOXY-6-METHYLBENZALDEHYDE; 2-METHOXY-6-METHYLISONICOTINALDEHYDE; 2-METHOXY-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-METHOXY-PENT-4-YNAL; 2-METHOXYPHENYLGLYOXAL; 2-METHOXYPYRAZINE-6-CARBOXALDEHYDE; 2-METHOXYPYRIDINE-4-CARBOXALDEHYDE; 2-METHOXYPYRIMIDINE-4,6-DICARBALDEHYDE; 2-METHOXYPYRIMIDINE-4-CARBALDEHYDE; 2-METHOXYPYRIMIDINE-5-CARBALDEHYDE; 2-METHYL DECANAL; 2-METHYL OCTANAL; 2-METHYL-1-NAPHTHALDEHYDE; 2-METHYL-1-OXOPENTAN-3-YL ETHANETHIOATE; 2-METHYL-1-OXOPENTAN-3-YL-ETHANETHIOATE; 2-METHYL-2-([METHYL(PROPAN-2-YL)AMINO]METHYL)BUTANAL; 2-METHYL-2-([METHYL(PROPYL)AMINO]METHYL)BUTANAL; 2-METHYL-2-(PYRROLIDIN-1-YLMETHYL)BUTANAL; 2-METHYL-2,3-DIHYDRO-1-BENZOFURAN-5-CARBALDEHYDE; 2-METHYL-2H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 2-METHYL-2-METHYLSULFANYL-PROPIONALDEHYDE; 2-METHYL-2-MORPHOLINOPROPANAL; 2-METHYL-2-PHENYLPROPANAL; 2-METHYL-2-PIPERIDINOPROPANAL; 2-METHYL-3-(1H-PYRROL-1-YL)PROPANAL; 2-METHYL-3-[METHYL(3-OXOPROPYL)AMINO]PROPANENITRILE; 2-METHYL-3-NITROBENZALDEHYDE; 2-METHYL-3-OXO-3-(THIOPHEN-2-YL)PROPANAL; 2-METHYL-3-OXO-BUTANAL; 2-METHYL-3-OXOPROPANENITRILE; 2-METHYL-3-PHENYLPROPANAL; 2-METHYL-3-TOLYLPROPIONALDEHYDE; 2-METHYL-4,5,6,7-TETRAHYDROBENZOFURAN-4-CARBALDEHYDE; 2-METHYL-4,5-DIFLUOROBENZALDEHYDE; 2-METHYL-4-NITROBENZALDEHYDE; 2-METHYL-5-NITROBENZALDEHYDE; 2-METHYL-6-NITROBENZALDEHYDE; 2-METHYL-6-QUINOLINECARBALDEHYDE; 2-METHYLBENZALDEHYDE; 2-METHYLBUTYRALDEHYDE; 2-METHYLCYCLOPROPANE-1-CARBALDEHYDE; 2-METHYLHEPTANAL; 2-METHYLHEXANAL; 2-METHYLISONICOTINALDEHYDE; 2-METHYLISONICOTINALDEHYDE HYDROCHLORIDE; 2-METHYLNAPHTHALENE-3-CARBOXALDEHYDE; 2-METHYLNAPHTHALENE-4-CARBOXALDEHYDE; 2-METHYLNAPHTHALENE-5-CARBOXALDEHYDE; 2-METHYLNAPHTHALENE-6-CARBOXALDEHYDE; 2-METHYLNAPHTHALENE-8-CARBOXALDEHYDE; 2-METHYLNICOTINALDEHYDE; 2-METHYLNONANAL; 2-METHYL-PENT-4-ENAL; 2-METHYLPYRIMIDINE-4,6-DICARBALDEHYDE; 2-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-METHYLPYRIMIDINE-5-CARBALDEHYDE; 2-METHYLQUINOLINE-4-CARBOXALDEHYDE; 2-METHYLTHIOACETALDEHYDE; 2-METHYLVALERALDEHYDE; 2-NAPHTHALDEHYDE; 2-NAPHTHALENECARBOXALDEHYDE, 3-HYDROXY-; 2-NAPHTHYLACETALDEHYDE; 2-NITROBENZALDEHYDE; 2-NITRONICOTINALDEHYDE; 2-NONYNAL; 2-OCTYNAL; 2-OXAZOLECARBOXALDEHYDE, 4-METHYL-; 2-OXAZOLECARBOXALDEHYDE, 5-(1,1-DIMETHYLETHYL)-; 2-OXAZOLECARBOXALDEHYDE, 5-ETHYL-; 2-OXO-2-(PIPERIDIN-1-YL)ACETALDEHYDE; 2-OXO-2-(PYRIDIN-2-YL)ACETALDEHYDE; 2-OXO-2-(PYRIDIN-3-YL)ACETALDEHYDE; 2-OXO-2-(PYRIDIN-4-YL)ACETALDEHYDE; 2-OXO-2H-CHROMENE-7-CARBALDEHYDE; 2-OXO-2-O-TOLYLACETALDEHYDE HYDRATE; 2-OXO-3-OXAZOLIDINEPROPANAL; 2-OXO-3-PHENYL-PROPANAL; 2-OXO-5-(PROPAN-2-YL)CYCLOHEXANE-1-CARBALDEHYDE; 2-OXOBUTANALDEHYDE; 2-OXOHEXAHYDRO-2H-CYCLOPENTA[B]FURAN-4-CARBALDEHYDE; 2-PENTYNAL; 2-PHENYL-2H-1,2,3-TRIAZOLE-4-CARBALDEHYDE; 2-PHENYLBUTANAL; 2-PHENYLCYCLOPROPANECARBALDEHYDE; 2-PHENYLMALONDIALDEHYDE; 2-PHENYLPROPIONALDEHYDE; 2-PROPOXYACETALDEHYDE; 2-PROPOXYBENZALDEHYDE; 2-PROPOXY-PYRIDINE-3-CARBALDEHYDE; 2-PROPYL VALERALDEHYDE; 2-PROPYL-4-PYRIDINECARBOXALDEHYDE; 2-PROPYLHEXANAL; 2-PROPYL-PYRIMIDINE-4-CARBALDEHYDE; 2-PROPYL-PYRIMIDINE-5-CARBALDEHYDE; 2-P-TOLYL-CYCLOPROPANECARBALDEHYDE; 2-PYRAZINEBUTANAL; 2-PYRAZINECARBOXALDEHYDE, 3-METHYL-; 2-PYRAZINECARBOXALDEHYDE, 5-METHYL-; 2-PYRIDAZIN-4-YLMALONALDEHYDE; 2-PYRIDIN-4-YLCYCLOPROPANECARBOXALDEHYDE; 2-PYRIDINECARBOXALDEHYDE; 2-PYRIDINECARBOXALDEHYDE, 1-OXIDE; 2-PYRIDINECARBOXALDEHYDE, 3,4-DIMETHYL-; 2-PYRIDINECARBOXALDEHYDE, 3-ETHENYL-; 2-PYRIDINECARBOXALDEHYDE, 4-ETHYL-; 2-PYRIDINECARBOXALDEHYDE, 6-(METHOXYMETHYL)-; 2-PYRIDINECARBOXALDEHYDE,6-(1-METHYLETHOXY)-; 2-PYRIMIDINECARBONITRILE, 5-FORMYL-; 2-PYRIMIDINECARBOXALDEHYDE; 2-PYRIMIDINECARBOXALDEHYDE, 5-METHYL-; 2-QUINOLINECARBOXALDEHYDE; 2-QUINOLINECARBOXALDEHYDE, 1-OXIDE; 2-QUINOXALINECARBALDEHYDE; 2-QUINOXALINECARBALDEHYDE 4-OXIDE; 2-QUINOXALINECARBOXALDEHYDE, 6-METHYL-; 2-TERT-BUTYLBENZALDEHYDE; 2-TERT-BUTYLISONICOTINALDEHYDE; 2-TERT-BUTYLPYRIMIDINE-4-CARBALDEHYDE; 2-TERT-BUTYLPYRIMIDINE-5-CARBALDEHYDE; 2-THIAZOLECARBOXALDEHYDE; 2-THIENYLGLYOXAL; 2-THIOGLYCERALDEHYDE; 2-THIOPHENEBUTANAL; 2-THIOPHENEGLYOXAL HYDRATE; 3-([ETHYL(METHYL)AMINO]METHYL)OXOLANE-3-CARBALDEHYDE; 3-(1,2,4-OXADIAZOL-3-YL)BENZALDEHYDE; 3-(1,3,4-THIADIAZOL-2-YLSULFANYL)PROPANAL; 3-(1,3-THIAZOL-2-YLSULFANYL)PROPANAL; 3-(1,4-OXAZEPAN-4-YL)PROPANAL; 3-(1,4-THIAZEPAN-4-YL)PROPANAL; 3-(1-ETHYL-1H-PYRAZOL-4-YL)-3-OXOPROPANAL; 3-(1H-1,2,4-TRIAZOL-1-YL)BENZALDEHYDE; 3-(1H-1,2,4-TRIAZOL-5-YLSULFANYL)PROPANAL; 3-(1H-IMIDAZOL-1-YL)BENZALDEHYDE; 3-(1H-PYRAZOL-1-YL)BENZALDEHYDE; 3-(1H-PYRAZOL-1-YL)PROPANAL; 3-(1H-PYRAZOL-3-YL)BENZALDEHYDE; 3-(1H-PYRAZOL-4-YL)BENZALDEHYDE; 3-(1H-PYRROL-1-YL)BENZALDEHYDE; 3-(1H-TETRAZOL-5-YL)BENZALDEHYDE; 3-(1-METHYL-1H-IMIDAZOL-4-YL)-PROPIONALDEHYDE; 3-(1-METHYL-1H-PYRAZOL-4-YL)-3-OXOPROPANAL; 3-(1-METHYL-2-OXO-ETHYL)-BENZONITRILE; 3-(2,2,2-TRIFLUOROETHOXY)PROPANAL; 3-(2,2-DIMETHYLMORPHOLIN-4-YL)PROPANAL; 3-(2,2-DIMETHYLPYRROLIDIN-1-YL)PROPANAL; 3-(2,3-DIMETHYLPIPERIDIN-1-YL)PROPANAL; 3-(2,4-DIFLUORO-PHENYL)-PROPIONALDEHYDE; 3-(2,4-DIMETHYL-PHENYL)-PROPIONALDEHYDE; 3-(2,4-DIMETHYLPIPERIDIN-1-YL)PROPANAL; 3-(2,4-DIOXO-1,3-THIAZOLIDIN-3-YL)PROPANAL; 3-(2,5-DIFLUORO-PHENYL)-PROPIONALDEHYDE; 3-(2,5-DIMETHYLFURAN-3-YL)-3-OXOPROPANAL; 3-(2,5-DIMETHYLMORPHOLIN-4-YL)PROPANAL; 3-(2,5-DIOXOPYRROLIDIN-1-YL)-2-METHYLPROPANAL; 3-(2,5-DIOXOPYRROLIDIN-1-YL)PROPANAL; 3-(2,6-DIFLUORO-PHENYL)-PROPIONALDEHYDE; 3-(2,6-DIMETHYLMORPHOLIN-4-YL)PROPANAL; 3-(2,6-DIMETHYLPIPERIDIN-1-YL)PROPANAL; 3-(2,6-DIOXOPIPERIDIN-1-YL)PROPANAL; 3-(2-BUTOXYETHOXY)PROPANAL; 3-(2-CHLORO-PHENYL)-PROPIONALDEHYDE; 3-(2-CHLORO-PYRIMIDIN-5-YL)-PROPIONALDEHYDE; 3-(2-ETHOXYETHOXY)PROPANAL; 3-(2-ETHYLMORPHOLIN-4-YL)PROPANAL; 3-(2-ETHYLPIPERIDIN-1-YL)PROPANAL; 3-(2-ETHYLPYRROLIDIN-1-YL)PROPANAL; 3-(2-FLUOROPHENOXY)PROPANAL; 3-(2-FLUOROPHENYL)-3-OXOPROPANAL; 3-(2-FLUORO-PHENYL)-PROPIONALDEHYDE; 3-(2-FORMYLIMIDAZOL-1-YL)-PROPAN-1-OL; 3-(2-FORMYL-IMIDAZOL-1-YL)-PROPIONITRILE; 3-(2-FURYL)-3-OXOPROPANAL; 3-(2-FURYL)BENZALDEHYDE; 3-(2H-TETRAZOL-5-YL)BENZALDEHYDE; 3-(2-HYDROXYETHOXY)BENZALDEHYDE; 3-(2-HYDROXYETHYL)BENZALDEHYDE; 3-(2-HYDROXYMETHYL-PHENYL)-PROPIONALDEHYDE; 3-(2-HYDROXYPHENYL)-3-OXOPROPANAL; 3-(2-HYDROXY-PHENYL)-PROPIONALDEHYDE; 3-(2-METHOXY-PHENYL)-PROPIONALDEHYDE; 3-(2-METHOXYPYRIDIN-4-YL)PROPANAL; 3-(2-METHYL-1,4-OXAZEPAN-4-YL)PROPANAL; 3-(2-METHYLMORPHOLIN-4-YL)PROPANAL; 3-(2-METHYLPHENOXY)PROPANAL; 3-(2-METHYLPHENYL)-3-OXOPROPANAL; 3-(2-METHYLPHENYL)PROPANAL; 3-(2-METHYLPIPERIDIN-1-YL)PROPANAL; 3-(2-METHYLPROPOXY)PROPANAL; 3-(2-METHYLPYRROLIDIN-1-YL)PROPANAL; 3-(2-OXO-1,3-THIAZOLIDIN-3-YL)PROPANAL; 3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-3-YL)PROPANAL; 3-(2-OXO-ACETYL)-BENZONITRILE; 3-(2-OXOAZEPAN-1-YL)PROPANAL; 3-(2-OXOETHOXY)BENZALDEHYDE; 3-(2-OXOETHOXY)BENZONITRILE; 3-(2-OXOPIPERIDIN-1-YL)PROPANAL; 3-(2-OXOPYRROLIDIN-1-YL)PROPANAL; 3-(2-PROPEN-1-YL)-BENZALDEHYDE; 3-(3,3-DIMETHYLMORPHOLIN-4-YL)PROPANAL; 3-(3,4-DIFLUORO-PHENYL)-PROPIONALDEHYDE; 3-(3,4-DIHYDROXY-PHENYL)-PROPIONALDEHYDE; 3-(3,5-DIFLUORO-PHENYL)-PROPIONALDEHYDE; 3-(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)PROPANAL; 3-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PROPANAL; 3-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PROPANALHYDRATE; 3-(3,5-DIMETHYLPIPERIDIN-1-YL)PROPANAL; 3-(3,5-DIOXOMORPHOLIN-4-YL)PROPANAL; 3-(3-ALLYL)-5-HEXEN-1-AL; 3-(3-CHLORO-PHENYL)-PROPIONALDEHYDE; 3-(3-CHLOROPYRIDIN-2-YL)PROPANAL; 3-(3-ETHYLMORPHOLIN-4-YL)PROPANAL; 3-(3-ETHYLPIPERIDIN-1-YL)PROPANAL; 3-(3-FLUORO-4-METHYL-PHENYL)-PROPIONALDEHYDE; 3-(3-FLUOROPHENOXY)PROPANAL; 3-(3-FLUOROPHENYL)-3-OXOPROPANAL; 3-(3-FLUOROPHENYL)PROPANAL; 3-(3-HYDROXY-PHENYL)-PROPIONALDEHYDE; 3-(3-HYDROXYPIPERIDIN-1-YL)PROPANAL; 3-(3-HYDROXY-PROP-1-YNYL)-BENZALDEHYDE; 3-(3-HYDROXYPYRROLIDIN-1-YL)-2,2-DIMETHYLPROPANAL; 3-(3-HYDROXYPYRROLIDIN-1-YL)PROPANAL; 3-(3-METHOXYPHENYL)PROPANAL; 3-(3-METHOXYPROPOXY)PROPANAL; 3-(3-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(3-METHYL-2,5-DIOXOPYRROLIDIN-1-YL)PROPANAL; 3-(3-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)PROPANAL; 3-(3-METHYL-2-OXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(3-METHYL-3H-IMIDAZOL-4-YL)-PROPIONALDEHYDE; 3-(3-METHYLBUTOXY)PROPANAL; 3-(3-METHYLMORPHOLIN-4-YL)PROPANAL; 3-(3-METHYLPHENOXY)PROPANAL; 3-(3-METHYLPHENYL)PROPANAL; 3-(3-METHYLPIPERIDIN-1-YL)PROPANAL; 3-(3-METHYLPYRROLIDIN-1-YL)PROPANAL; 3-(3-OXOPROPANOYL)BENZONITRILE; 3-(3-OXO-PROPYL)-BENZONITRILE; 3-(4,4-DIMETHYLPIPERIDIN-1-YL)PROPANAL; 3-(4-CHLORO-PHENYL)-PROPIONALDEHYDE; 3-(4-ETHYL-PHENYL)-PROPIONALDEHYDE; 3-(4-ETHYLPIPERAZIN-1-YL)PROPANAL; 3-(4-ETHYLPIPERIDIN-1-YL)PROPANAL; 3-(4-FLUOROPHENOXY)PROPANAL; 3-(4-FLUOROPHENYL)-3-OXOPROPANAL; 3-(4-FLUOROPHENYL)PROPIONALDEHYDE; 3-(4-HYDROXYMETHYL-PHENYL)-PROPIONALDEHYDE; 3-(4-HYDROXY-PHENYL)-PROPIONALDEHYDE; 3-(4-HYDROXYPIPERIDIN-1-YL)PROPANAL; 3-(4-METHOXYPHENYL)PROPANAL; 3-(4-METHOXYPIPERIDIN-1-YL)PROPANAL; 3-(4-METHYL-1,4-DIAZEPAN-1-YL)PROPANAL; 3-(4-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-3-YL)PROPANAL; 3-(4-METHYL-2-OXOPYRROLIDIN-1-YL)PROPANAL; 3-(4-METHYLPHENOXY)PROPANAL; 3-(4-METHYLPHENYL)-3-OXOPROPANAL; 3-(4-METHYLPHENYL)PROPIONALDEHYDE; 3-(4-METHYLPIPERAZIN-1-YL)PROPANAL; 3-(4-METHYLPIPERIDIN-1-YL)PROPANAL; 3-(4-OXOPIPERIDIN-1-YL)PROPANAL; 3-(5-CHLOROTHIOPHEN-2-YL)PROPANAL; 3-(5-ETHYLTHIOPHEN-2-YL)PROPANAL; 3-(5-METHYL-2-FURYL)BUTYRALDEHYDE; 3-(5-METHYL-2-OXO-1,2-DIHYDROPYRIMIDIN-1-YL)PROPANAL; 3-(5-METHYLFURAN-2-YL)-3-OXOPROPANAL; 3-(5-METHYLTHIEN-2-YL)-3-OXOPROPANAL; 3-(6-CHLORO-PYRIDAZIN-3-YL)-PROPIONALDEHYDE; 3-(ALLYLOXY)BENZALDEHYDE; 3-(AZEPAN-1-YL)PROPANAL; 3-(AZOCAN-1-YL)PROPANAL; 3-(BENZOFURAN-5-YL)PROPANAL; 3-(BENZOFURAN-6-YL)PROPANAL; 3-(BUT-2-YN-1-YLOXY)BENZALDEHYDE; 3-(BUT-3-EN-1-YLOXY)PROPANAL; 3-(BUT-3-YN-1-YLOXY)BENZALDEHYDE; 3-(BUTAN-2-YLOXY)PROPANAL; 3-(BUTAN-2-YLSULFANYL)PROPANAL; 3-(BUTYLSULFANYL)PROPANAL; 3-(CYCLOHEPTYLOXY)PROPANAL; 3-(CYCLOHEXYLMETHOXY)PROPANAL; 3-(CYCLOHEXYLOXY)PROPANAL; 3-(CYCLOHEXYLSULFANYL)PROPANAL; 3-(CYCLOPENTYLOXY)PROPANAL; 3-(CYCLOPENTYLSULFANYL)PROPANAL; 3-(CYCLOPROPYLMETHOXY)PROPANAL; 3-(DIETHYLAMINO)PROPANAL; 3-(DIFLUOROMETHOXY)BENZALDEHYDE; 3-(DIFLUOROMETHOXY)PYRAZINE-2-CARBOXALDEHYDE; 3-(DIMETHYLAMINO)-2-HYDROXYBENZALDEHYDE; 3-(DIMETHYLAMINO)-4-HYDROXYBENZALDEHYDE; 3-(DIMETHYLAMINO)-5-HYDROXYBENZALDEHYDE; 3-(DIMETHYLAMINO)BENZALDEHYDE; 3-(DIMETHYLAMINO)PROPANAL; 3-(DIPROPYLAMINO)PROPANAL; 3-(ETHYLSULFANYL)PROPANAL; 3-(ETHYLTHIO)BUTANAL; 3-(FURAN-2-YL)-2-METHYL-3-OXOPROPANAL; 3-(FURAN-2-YL)PROPANAL; 3-(FURAN-2-YLMETHOXY)PROPANAL; 3-(HEPTYLOXY)PROPANAL; 3-(HEXYLOXY)PROPANAL; 3-(HYDROXYMETHYL)BENZALDEHYDE; 3-(METHOXYMETHOXY)BENZALDEHYDE; 3-(METHYLTHIO)BENZALDEHYDE; 3-(METHYLTHIO)BUTANAL; 3-(METHYLTHIO)HEXANAL; 3-(METHYLTHIO)PROPIONALDEHYDE; 3-(OXAN-2-YLMETHOXY)PROPANAL; 3-(OXAN-4-YL)PROPANAL; 3-(OXAN-4-YLMETHOXY)PROPANAL; 3-(OXAN-4-YLOXY)PROPANAL; 3-(OXAN-4-YLSULFANYL)PROPANAL; 3-(OXOLAN-2-YL)PROPANAL; 3-(OXOLAN-2-YLMETHOXY)PROPANAL; 3-(OXOLAN-3-YLMETHOXY)PROPANAL; 3-(OXOLAN-3-YLOXY)PROPANAL; 3-(PENTYLOXY)PROPANAL; 3-(PHENYLSULFANYL)PROPANAL; 3-(PROP-2-EN-1-YLOXY)PROPANAL; 3-(PROP-2-YNYL)BENZALDEHYDE; 3-(PROPAN-2-YLOXY)PROPANAL; 3-(PROPAN-2-YLSULFANYL)PROPANAL; 3-(PROPYLSULFANYL)PROPANAL; 3-(PYRAZIN-2-YL)BUTANAL; 3-(PYRAZIN-2-YL)PROPANAL; 3-(PYRIDIN-2-YL)PROPANAL; 3-(PYRIDIN-2-YLSULFANYL)PROPANAL; 3-(PYRIDIN-3-YL)PROPANAL; 3-(PYRIMIDIN-2-YL)PROPANAL; 3-(PYRIMIDIN-2-YLSULFANYL)PROPANAL; 3-(PYRIMIDIN-4-YL)PROPANAL; 3-(PYRIMIDIN-5-YL)PROPANAL; 3-(PYRROLIDIN-1-YL)PROPANAL; 3-(TERT-BUTOXY)PROPANAL; 3-(TERT-BUTYLSULFANYL)PROPANAL; 3-(TETRAHYDRO-2H-PYRAN-4-YL)-2,2-DIMETHYLPROPANAL; 3-(TETRAHYDRO-FURAN-3-YL)-PROPIONALDEHYDE; 3-(THIOMORPHOLIN-4-YL)PROPANAL; 3-(THIOPHEN-2-YL)PROPANAL; 3-(THIOPHEN-2-YLMETHOXY)PROPANAL; 3-(THIOPHEN-2-YLSULFANYL)PROPANAL; 3-(THIOPHEN-3-YL)PROPANAL; 3-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-(TRIFLUOROMETHYL)BENZALDEHYDE; 3-(TRIFLUOROMETHYL)BUTYRALDEHYDE; 3(Z)-NONENAL; 3,3,3-TRIFLUOROPROPANAL; 3,3,3-TRIFLUOROPROPIONALDEHYDE HYDRATE; 3,3,4,4,4-PENTAFLUOROBUTANAL; 3,3-DIMETHOXY-2-(HYDROXYMETHYLENE)PROPIONITRILE SODIUM SALT; 3,3-DIMETHYLBUTYRALDEHYDE; 3,4,5-TRIFLUOROBENZALDEHYDE; 3,4,5-TRIHYDROXYBENZALDEHYDE; 3,4,5-TRIHYDROXYBENZALDEHYDE MONOHYDRATE; 3,4,5-TRIMETHYLBENZALDEHYDE; 3,4-DIFLUORO-2-HYDROXYBENZALDEHYDE; 3,4-DIFLUORO-2-METHYLBENZALDEHYDE; 3,4-DIFLUORO-5-METHOXYBENZALDEHYDE; 3,4-DIFLUORO-5-METHYLBENZALDEHYDE; 3,4-DIFLUOROBENZALDEHYDE; 3,4-DIFLUOROPHENYLGLYOXAL; 3,4-DIHYDRO-1H-2-BENZOPYRAN-1-CARBOXALDEHYDE; 3,4-DIHYDRO-1H-2-BENZOPYRAN-3-CARBOXALDEHYDE; 3,4-DIHYDRO-1H-2-BENZOPYRAN-4-CARBOXALDEHYDE; 3,4-DIHYDRO-1H-2-BENZOPYRAN-5-CARBOXALDEHYDE; 3,4-DIHYDRO-1H-2-BENZOPYRAN-6-CARBOXALDEHYDE; 3,4-DIHYDRO-2H-CHROMENE-4-CARBALDEHYDE; 3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 3,4-DIHYDROPHENYLGLYOXAL; 3,4-DIHYDROXY PHENYL GLYOXAL; 3,4-DIHYDROXY-5-METHOXYBENZALDEHYDE; 3,4-DIHYDROXYBENZALDEHYDE; 3,4-DIMETHOXYBENZALDEHYDE; 3,4-DIMETHYL-3-CYCLOHEXENYLMETHANAL; 3,4-DIMETHYLBENZALDEHYDE; 3,4-DIMETHYL-BENZENEPROPANAL; 3,4-PYRIDINEDICARBOXALDEHYDE; 3,5,5-TRIMETHYLHEXANAL; 3,5,6-TRIMETHYL-2-PYRAZINECARBALDEHYDE; 3,5,6-TRIMETHYL-3-CYCLOHEXENE-1-CARBOXALDEHYDE; 3,5-DIETHYLBENZALDEHYDE; 3,5-DIFLUORO-2-HYDROXYBENZALDEHYDE; 3,5-DIFLUORO-2-METHOXYBENZALDEHYDE; 3,5-DIFLUORO-2-METHYLBENZALDEHYDE; 3,5-DIFLUORO-4-HYDROXYBENZALDEHYDE; 3,5-DIFLUORO-4-METHOXYBENZALDEHYDE; 3,5-DIFLUORO-4-PYRIDINECARBOXALDEHYDE; 3,5-DIFLUOROBENZALDEHYDE; 3,5-DIFLUOROPYRIDINE-2-CARBALDEHYDE; 3,5-DIHYDROXYBENZALDEHYDE; 3,5-DIMETHOXYBENZALDEHYDE; 3,5-DIMETHOXY-HEXANAL; 3,5-DIMETHOXYPYRAZINE-2-CARBALDEHYDE; 3,5-DIMETHOXYPYRIDINE-4-CARBOXALDEHYDE; 3,5-DIMETHYL-4-HYDROXYBENZALDEHYDE; 3,5-DIMETHYL-4-METHOXYBENZALDEHYDE; 3,5-DIMETHYLBENZALDEHYDE; 3,5-DIMETHYL-BENZENEPROPANAL; 3,5-DIMETHYLPYRAZINE-2-CARBALDEHYDE; 3,5-DIMETHYLPYRIDINE-2-CARBOXALDEHYDE; 3,5-DIMETHYLPYRIDINE-4-CARBOXALDEHYDE; 3,6-DIFLUORO-2-HYDROXYBENZALDEHYDE; 3,6-DIFLUORO-2-METHOXYBENZALDEHYDE; 3,6-DIFLUOROPICOLINALDEHYDE; 3,7-DIMETHYL-7-HYDROXYOCTANAL; 3,7-DIMETHYLOCTANAL; 3-[(1-CYCLOPROPYLETHYL)(METHYL)AMINO]PROPANAL; 3-[(1-METHOXYPROPAN-2-YL)(METHYL)AMINO]PROPANAL; 3-[(2,2-DIMETHYLPROPYL)(METHYL)AMINO]PROPANAL; 3-[(2-HYDROXYETHYL)(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[(2-HYDROXYETHYL)(METHYL)AMINO]PROPANAL; 3-[(2-HYDROXYETHYL)(PROPAN-2-YL)AMINO]PROPANAL; 3-[(2-HYDROXYETHYL)(PROPYL)AMINO]PROPANAL; 3-[(2-HYDROXYETHYL)SULFANYL]PROPANAL; 3-[(2-HYDROXYPROPYL)(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[(2-HYDROXYPROPYL)(METHYL)AMINO]PROPANAL; 3-[(2-METHOXYETHYL)(2-OXOETHYL)AMINO]PROPANENITRILE; 3-[(2-METHOXYETHYL)(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[(2-METHOXYETHYL)(METHYL)AMINO]PROPANAL; 3-[(2-METHOXYETHYL)SULFANYL]PROPANAL; 3-[(2-METHYLBUTAN-2-YL)OXY]PROPANAL; 3-[(2-METHYLCYCLOHEXYL)OXY]PROPANAL; 3-[(2-METHYLPROPYL)(2-OXOETHYL)AMINO]PROPANENITRILE; 3-[(2-METHYLPROPYL)(PROPAN-2-YL)AMINO]PROPANAL; 3-[(2-METHYLPROPYL)SULFANYL]PROPANAL; 3-[(2-OXOETHYL)(PROPAN-2-YL)AMINO]PROPANENITRILE; 3-[(3,3-DIMETHYLBUTAN-2-YL)(METHYL)AMINO]PROPANAL; 3-[(3-HYDROXYPROPYL)(PROPAN-2-YL)AMINO]PROPANAL; 3-[(3-METHOXYPROPYL)(METHYL)AMINO]PROPANAL; 3-[(3-METHYLCYCLOHEXYL)OXY]PROPANAL; 3-[(3-OXOPROPYL)(PROPAN-2-YL)AMINO]PROPANENITRILE; 3-[(4-METHYLCYCLOHEXYL)OXY]PROPANAL; 3-[(4-METHYLPENTAN-2-YL)OXY]PROPANAL; 3-[(4-METHYLPENTYL)OXY]PROPANAL; 3-[(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]PROPANAL; 3-[(CYCLOBUTYLMETHYL)(METHYL)AMINO]PROPANAL; 3-[(CYCLOPENTYLMETHYL)SULFANYL]PROPANAL; 3-[(CYCLOPROPYLMETHYL)(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[(CYCLOPROPYLMETHYL)(METHYL)AMINO]PROPANAL; 3-[(CYCLOPROPYLMETHYL)(PROPAN-2-YL)AMINO]PROPANAL; 3-[(CYCLOPROPYLMETHYL)(PROPYL)AMINO]PROPANAL; 3-[(DIMETHYLAMINO)METHYL]BENZALDEHYDE; 3-[(DIMETHYLAMINO)METHYL]OXOLANE-3-CARBALDEHYDE; 3-[(FURAN-2-YLMETHYL)(METHYL)AMINO]PROPANAL; 3-[(FURAN-2-YLMETHYL)SULFANYL]PROPANAL; 3-[(FURAN-3-YLMETHYL)(METHYL)AMINO]PROPANAL; 3-[2-(HYDROXYMETHYL)PIPERIDIN-1-YL]PROPANAL; 3-[2-(HYDROXYMETHYL)PYRROLIDIN-1-YL]PROPANAL; 3-[2-(PROPAN-2-YLOXY)ETHOXY]PROPANAL; 3-[3-(DIMETHYLAMINO)PYRROLIDIN-1-YL]PROPANAL; 3-[3-(HYDROXYMETHYL)PIPERIDIN-1-YL]PROPANAL; 3-[4-(HYDROXYMETHYL)PIPERIDIN-1-YL]PROPANAL; 3-[BIS(2-HYDROXYETHYL)AMINO]PROPANAL; 3-[BUTAN-2-YL(ETHYL)AMINO]PROPANAL; 3-[BUTAN-2-YL(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[BUTAN-2-YL(METHYL)AMINO]PROPANAL; 3-[BUTYL(2-HYDROXYETHYL)AMINO]PROPANAL; 3-[BUTYL(CYCLOPROPYL)AMINO]PROPANAL; 3-[BUTYL(ETHYL)AMINO]PROPANAL; 3-[BUTYL(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[BUTYL(METHYL)AMINO]PROPANAL; 3-[CYCLOHEXYL(METHYL)AMINO]PROPANAL; 3-[CYCLOPENTYL(ETHYL)AMINO]PROPANAL; 3-[CYCLOPENTYL(METHYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(2-HYDROXYETHYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(2-METHOXYETHYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(2-METHYLPROPYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(2-OXOETHYL)AMINO]PROPANENITRILE; 3-[CYCLOPROPYL(3-OXOPROPYL)AMINO]PROPANENITRILE; 3-[CYCLOPROPYL(ETHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[CYCLOPROPYL(ETHYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[CYCLOPROPYL(METHYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(PROPYL)AMINO]PROPANAL; 3-[ETHYL(1-METHOXYPROPAN-2-YL)AMINO]PROPANAL; 3-[ETHYL(2-HYDROXYETHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[ETHYL(2-HYDROXYETHYL)AMINO]PROPANAL; 3-[ETHYL(2-METHOXYETHYL)AMINO]PROPANAL; 3-[ETHYL(2-METHYLPROPYL)AMINO]PROPANAL; 3-[ETHYL(2-OXOETHYL)AMINO]PROPANENITRILE; 3-[ETHYL(3-OXOPROPYL)AMINO]-2-METHYLPROPANENITRILE; 3-[ETHYL(3-OXOPROPYL)AMINO]PROPANENITRILE; 3-[ETHYL(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[ETHYL(METHYL)AMINO]PROPANAL; 3-[ETHYL(PROPAN-2-YL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[ETHYL(PROPAN-2-YL)AMINO]PROPANAL; 3-[ETHYL(PROPYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[ETHYL(PROPYL)AMINO]PROPANAL; 3-[METHYL(2,2,2-TRIFLUOROETHYL)AMINO]PROPANAL; 3-[METHYL(2-METHYLBUTYL)AMINO]PROPANAL; 3-[METHYL(2-METHYLPROPYL)AMINO]PROPANAL; 3-[METHYL(2-OXOETHYL)AMINO]BENZONITRILE; 3-[METHYL(2-OXOETHYL)AMINO]BUTANENITRILE; 3-[METHYL(2-OXOETHYL)AMINO]PROPANENITRILE; 3-[METHYL(3-METHYLBUTAN-2-YL)AMINO]PROPANAL; 3-[METHYL(3-METHYLBUTYL)AMINO]PROPANAL; 3-[METHYL(3-OXOPROPYL)AMINO]BUTANENITRILE; 3-[METHYL(3-OXOPROPYL)AMINO]PROPANENITRILE; 3-[METHYL(4-METHYLPENTAN-2-YL)AMINO]PROPANAL; 3-[METHYL(OXAN-4-YL)AMINO]PROPANAL; 3-[METHYL(OXOLAN-2-YLMETHYL)AMINO]PROPANAL; 3-[METHYL(PENTAN-2-YL)AMINO]PROPANAL; 3-[METHYL(PENTAN-3-YL)AMINO]PROPANAL; 3-[METHYL(PENTYL)AMINO]PROPANAL; 3-[METHYL(PHENYL)AMINO]PROPANAL; 3-[METHYL(PROPAN-2-YL)AMINO]PROPANAL; 3-[METHYL(PROPYL)AMINO]PROPANAL; 3-[METHYL(THIOLAN-3-YL)AMINO]PROPANAL; 3-[PROPAN-2-YL(PROPYL)AMINO]PROPANAL; 3-ACETOXYBENZALDEHYDE; 3-ACETYL-4-FLUORO-BENZALDEHYDE; 3-ACETYLBENZALDEHYDE; 3-ALLYL-4-HYDROXYBENZALDEHYDE; 3-ALLYLSALICYLALDEHYDE; 3-BENZYLOXY-PROPIONALDEHYDE; 3-BUTOXYPROPANAL; 3-BUTYNAL; 3-CHLORO-2-FLUORO-4-HYDROXYBENZALDEHYDE; 3-CHLORO-2-FLUOROBENZALDEHYDE; 3-CHLORO-2-FLUOROPYRIDINE-4-CARBOXALDEHYDE; 3-CHLORO-2-FORMYL-4-PICOLINE; 3-CHLORO-2-HYDROXY-5-FORMYLPYRIDINE; 3-CHLORO-2-HYDROXY-5-METHYL-BENZALDEHYDE; 3-CHLORO-2-HYDROXY-6-METHYL-BENZALDEHYDE; 3-CHLORO-2-HYDROXYBENZALDEHYDE; 3-CHLORO-2-HYDROXYISONICOTINALDEHYDE; 3-CHLORO-2-METHOXYBENZALDEHYDE; 3-CHLORO-2-METHOXYPYRIDINE-6-CARBOXALDEHYDE; 3-CHLORO-2-METHYLBENZALDEHYDE; 3-CHLORO-2-METHYLPYRIDINE-4-CARBOXALDEHYDE; 3-CHLORO-2-METHYLPYRIDINE-5-CARBOXALDEHYDE; 3-CHLORO-2-METHYLPYRIDINE-6-CARBOXALDEHYDE; 3-CHLORO-4,5-DIHYDROXYBENZALDEHYDE; 3-CHLORO-4-CYANOBENZALDEHYDE; 3-CHLORO-4-FLUORO-2-HYDROXYBENZALDEHYDE; 3-CHLORO-4-FLUOROBENZALDEHYDE; 3-CHLORO-4-FORMYL-2-METHOXYPYRIDINE; 3-CHLORO-4-FORMYLBENZONITRILE; 3-CHLORO-4-HYDROXYBENZALDEHYDE; 3-CHLORO-4-METHOXYBENZALDEHYDE; 3-CHLORO-4-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 3-CHLORO-4-METHYLBENZALDEHYDE; 3-CHLORO-5-CYANOBENZALDEHYDE; 3-CHLORO-5-FLUORO-2-HYDROXYBENZALDEHYDE; 3-CHLORO-5-FLUORO-4-HYDROXYBENZALDEHYDE; 3-CHLORO-5-FLUOROBENZALDEHYDE; 3-CHLORO-5-FLUOROISONICOTINALDEHYDE; 3-CHLORO-5-FLUOROPICOLINALDEHYDE; 3-CHLORO-5-FORMYL-2-METHOXYPYRIDINE; 3-CHLORO-5-HYDROXYBENZALDEHYDE; 3-CHLORO-5-HYDROXYPICOLINALDEHYDE; 3-CHLORO-5-METHOXYBENZALDEHYDE; 3-CHLORO-5-METHOXYPYRAZINE-2-CARBALDEHYDE; 3-CHLORO-5-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 3-CHLORO-5-METHOXYPYRIDINE-4-CARBOXALDEHYDE; 3-CHLORO-5-METHYLBENZALDEHYDE; 3-CHLORO-5-METHYLPYRIDINE-2-CARBOXALDEHYDE; 3-CHLORO-5-METHYLPYRIDINE-4-CARBOXALDEHYDE; 3-CHLORO-6-FLUOROPICOLINALDEHYDE; 3-CHLORO-6-HYDROXYPICOLINALDEHYDE; 3-CHLORO-6-METHOXYPICOLINALDEHYDE; 3-CHLORO-6-METHYL-PYRIDINE-2-CARBALDEHYDE; 3-CHLOROBENZALDEHYDE; 3-CHLOROISONICOTINALDEHYDE; 3-CHLOROMETHYL-4-HYDROXY-BENZALDEHYDE; 3-CHLOROPROPANAL; 3-CHLORO-PYRAZINE-2-CARBALDEHYDE; 3-CHLOROPYRIDINE-2-CARBOXALDEHYDE; 3-CINNOLINECARBOXALDEHYDE; 3-CYANO-2-FLUOROBENZALDEHYDE; 3-CYANO-2-HYDROXYBENZALDEHYDE; 3-CYANO-2-METHOXYBENZALDEHYDE; 3-CYANO-2-METHYLBENZALDEHYDE; 3-CYANO-4-HYDROXYBENZALDEHYDE; 3-CYANO-4-METHOXYBENZALDEHYDE; 3-CYANO-5-FLUOROBENZALDEHYDE; 3-CYANO-5-HYDROXYBENZALDEHYDE; 3-CYANO-5-METHOXYBENZALDEHYDE; 3-CYANO-5-METHYLBENZALDEHYDE; 3-CYANOBENZALDEHYDE; 3-CYCLOBUTOXYPROPANAL; 3-CYCLOHEPTYLPROPIONALDEHYDE; 3-CYCLOHEXENE-1-CARBOXALDEHYDE; 3-CYCLOHEXYL-3-OXOPROPANAL; 3-CYCLOHEXYLPROPIONALDEHYDE; 3-CYCLOPENTYL-3-OXOPROPANAL; 3-CYCLOPENTYLPROPANAL; 3-CYCLOPROPOXYBENZALDEHYDE; 3-CYCLOPROPOXYISONICOTINALDEHYDE; 3-CYCLOPROPOXYPICOLINALDEHYDE; 3-CYCLOPROPYL-3-OXOPROPANAL; 3-CYCLOPROPYL-4-FLUOROBENZALDEHYDE; 3-CYCLOPROPYLBENZALDEHYDE; 3-DECYNAL; 3-DEOXYGLUCOSONE; 3-DIETHYLAMINO-2,2-DIMETHYL-PROPIONALDEHYDE; 3-DIMETHYLAMINO-2,2-DIMETHYLPROPIONALDEHYDE; 3-ETHOXY-4-FLUOROBENZALDEHYDE; 3-ETHOXY-4-HYDROXYBENZALDEHYDE; 3-ETHOXY-4-METHYLBENZALDEHYDE; 3-ETHOXY-5-FLUOROBENZALDEHYDE; 3-ETHOXYBENZALDEHYDE; 3-ETHOXYPICOLINALDEHYDE; 3-ETHOXYPROPIONALDEHYDE; 3-ETHOXYSALICYLALDEHYDE; 3-ETHYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-ETHYL-1H-INDAZOLE-6-CARBALDEHYDE; 3-ETHYL-2-HYDROXYBENZALDEHYDE; 3-ETHYL-2-PYRAZINECARBOXALDEHYDE; 3-ETHYL-4-FLUOROBENZALDEHYDE; 3-ETHYL-4-FORMYL-BENZONITRILE; 3-ETHYL-4-HYDROXYBENZALDEHYDE; 3-ETHYL-4-METHOXYBENZALDEHYDE; 3-ETHYL-4-PYRIDINECARBOXALDEHYDE; 3-ETHYL-5-HYDROXYBENZALDEHYDE; 3-ETHYLBENZALDEHYDE; 3-ETHYLHEPTANAL; 3-ETHYL-OXETANE-3-CARBALDEHYDE; 3-ETHYNYL-4-METHOXY-BENZALDEHYDE; 3-ETHYNYLBENZALDEHYDE; 3-ETHYNYL-PYRIDINE-4-CARBALDEHYDE; 3-FLUORO-2-FORMYL-4-PICOLINE; 3-FLUORO-2-FORMYL-6-PICOLINE; 3-FLUORO-2-FORMYLPHENYLBORONIC ACID; 3-FLUORO-2-FORMYLPYRIDINE; 3-FLUORO-2-HYDROXY-4-METHYL-BENZALDEHYDE; 3-FLUORO-2-HYDROXY-5-METHYL-BENZALDEHYDE; 3-FLUORO-2-HYDROXY-6-METHOXYBENZALDEHYDE; 3-FLUORO-2-HYDROXY-6-METHYL-BENZALDEHYDE; 3-FLUORO-2-HYDROXYISONICOTINALDEHYDE; 3-FLUORO-2-METHOXYBENZALDEHYDE; 3-FLUORO-2-METHOXYISONICOTINALDEHYDE; 3-FLUORO-2-METHYLBENZALDEHYDE; 3-FLUORO-2-METHYLISONICOTINALDEHYDE; 3-FLUORO-2-NITROBENZALDEHYDE; 3-FLUORO-3-FORMYLOXOLANE; 3-FLUORO-4-FORMYLPHENYLBORONIC ACID; 3-FLUORO-4-HYDROXY-5-METHOXYBENZALDEHYDE; 3-FLUORO-4-HYDROXYBENZALDEHYDE; 3-FLUORO-4-METHOXYBENZALDEHYDE; 3-FLUORO-4-METHYLBENZALDEHYDE; 3-FLUORO-4-NITRO-BENZALDEHYDE; 3-FLUORO-5-(CHLOROMETHYL)BENZALDEHYDE; 3-FLUORO-5-FORMYL-2-METHOXYPYRIDINE; 3-FLUORO-5-FORMYLPHENYLBORONIC ACID; 3-FLUORO-5-FORMYLPYRIDINE; 3-FLUORO-5-HYDROXY-2-PYRIDINECARBOXYLIC ACID; 3-FLUORO-5-HYDROXYBENZALDEHYDE; 3-FLUORO-5-METHOXYBENZALDEHYDE; 3-FLUORO-5-METHOXYPICOLINALDEHYDE; 3-FLUORO-5-METHYLBENZALDEHYDE; 3-FLUORO-5-NITROBENZALDEHYDE; 3-FLUORO-6-FORMYL-2-PICOLINE; 3-FLUORO-6-HYDROXYPYRIDINE-2-CARBOXALDEHYDE; 3-FLUORO-6-METHOXYPICOLINALDEHYDE; 3-FLUOROBENZALDEHYDE; 3-FLUOROISONICOTINALDEHYDE; 3-FLUOROPHENYLGLYOXAL; 3-FLUOROPHENYLGLYOXAL HYDRATE; 3-FLUOROSALICYLALDEHYDE; 3-FORMYL-1H-INDAZOLE-4-CARBONITRILE; 3-FORMYL-1H-INDAZOLE-6-CARBONITRILE; 3-FORMYL-1H-PYRAZOLE-4-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-1-PHENYL-1H-PYRAZOLE; 3-FORMYL-2,2-DIMETHYL-CYCLOPROPANECARBOXYLIC ACID ETHYL ESTER; 3-FORMYL-2-PYRIDINECARBONITRILE; 3-FORMYL-4-HYDROXYBENZONITRILE; 3-FORMYL-4-HYDROXYPHENYLBORONIC ACID; 3-FORMYL-4-METHOXYPYRIDINE; 3-FORMYL-4-METHYLPHENYLBORONIC ACID; 3-FORMYL-4-NITROPYRIDINE 1-OXIDE; 3-FORMYL-5-METHYLPHENYLBORONIC ACID; 3-FORMYL-BENZOYL CHLORIDE; 3-FORMYL-CYCLOPENTANECARBONITRILE; 3-FORMYLISONICOTINONITRILE; 3-FORMYLPHENYLBORONIC ACID; 3-FORMYLPYRIDINE-4-BORONIC ACID; 3-FURAN-3-YL-PROPIONALDEHYDE; 3-FURANBUTANAL; 3-FURANPENTANAL; 3-HEPTYNAL; 3-HEXENAL; 3-HEXYNAL; 3-HYDROXY-2-(METHYLTHIO)BENZALDEHYDE; 3-HYDROXY-2,5-DIMETHYLPYRIDINE-4-CARBOXALDEHYDE; 3-HYDROXY-2-ISOPROPYLBENZALDEHYDE; 3-HYDROXY-2-METHOXYBENZALDEHYDE; 3-HYDROXY-2-METHYL-4-PYRIDINECARBOXALDEHYDE; 3-HYDROXY-2-METHYLBENZALDEHYDE; 3-HYDROXY-2-NITROBENZALDEHYDE; 3-HYDROXY-4(HYDROXYMETHYL)-2-METHYL-5-PYRIDINE-CARBOXALDEHYDE; 3-HYDROXY-4-(METHYLTHIO)BENZALDEHYDE; 3-HYDROXY-4-ISOPROPYLBENZALDEHYDE; 3-HYDROXY-4-METHOXYBENZALDEHYDE; 3-HYDROXY-4-METHYL-BENZALDEHYDE; 3-HYDROXY-4-NITROBENZALDEHYDE; 3-HYDROXY-5-(METHYLTHIO)BENZALDEHYDE; 3-HYDROXY-5-ISOPROPYLBENZALDEHYDE; 3-HYDROXY-5-METHOXYBENZALDEHYDE; 3-HYDROXY-5-METHYLBENZALDEHYDE; 3-HYDROXY-5-NITROBENZALDEHYDE; 3-HYDROXY-6-METHOXY-PYRIDINE-2-CARBALDEHYDE; 3-HYDROXY-6-METHYLPYRIDINE-2-CARBOXALDEHYDE; 3-HYDROXYAMINO-BENZALDEHYDE; 3-HYDROXYBENZALDEHYDE; 3-HYDROXY-BENZO[D]ISOXAZOLE-5-CARBALDEHYDE; 3-HYDROXYMETHYL-4-METHOXY-BENZALDEHYDE; 3-HYDROXYNAPHTHALENE-1-CARBOXALDEHYDE; 3-HYDROXYPHENYLGLYOXAL; 3-HYDROXYPHTHALALDEHYDE; 3-HYDROXYPROPANAL; 3-HYDROXYPYRAZINE-2-CARBOXALDEHYDE; 3-HYDROXYPYRIDINE-2-CARBOXALDEHYDE; 3-HYDROXYPYRIDINE-4-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-2-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-4-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-5-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-7-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-8-CARBOXALDEHYDE; 3-IMIDAZOL-1-YL-PROPIONALDEHYDE; 3-ISOCYANATOBENZALDEHYDE; 3-ISOPROPOXYBENZALDEHYDE; 3-ISOPROPYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-ISOPROPYLBENZALDEHYDE; 3-ISOPROPYLPYRIDINE-2-CARBALDEHYDE; 3-ISOTHIAZOLECARBOXALDEHYDE; 3-ISOTHIAZOLECARBOXALDEHYDE, 4-METHYL-; 3-ISOTHIAZOLECARBOXALDEHYDE, 5-METHYL-; 3-ISOXAZOLECARBOXALDEHYDE, 4-METHYL-; 3-ISOXAZOLECARBOXALDEHYDE, 5-(1-HYDROXY-1-METHYLETHYL)-; 3-MERCAPTO-2-METHYLPENTANAL; 3-MERCAPTOBENZALDEHYDE; 3-METHOXY BUTYRALDEHYDE; 3-METHOXY-2-METHYLBENZALDEHYDE; 3-METHOXY-2-METHYLISONICOTINALDEHYDE; 3-METHOXY-4-METHYLBENZALDEHYDE; 3-METHOXY-4-SULFANYLBENZALDEHYDE; 3-METHOXY-5-METHYLBENZALDEHYDE; 3-METHOXY-5-METHYLPYRAZINE-2-CARBALDEHYDE; 3-METHOXY-6-METHYL-PYRAZINECARBOXALDEHYDE; 3-METHOXYBENZALDEHYDE; 3-METHOXYPHENYLGLYOXAL; 3-METHOXY-PROPIONALDEHYDE; 3-METHOXYPYRAZINE-2-CARBALDEHYDE; 3-METHOXY-PYRIDINE-2-CARBALDEHYDE; 3-METHOXYPYRIDINE-4-CARBOXALDEHYDE; 3-METHYL-[1,2,4]TRIAZINE-5-CARBALDEHYDE; 3-METHYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-METHYL-1H-INDAZOLE-5-CARBALDEHYDE; 3-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBALDEHYDE; 3-METHYL-1-PENTANAL; 3-METHYL-2,3-DIHYDRO-BENZOFURAN-4-CARBALDEHYDE; 3-METHYL-2-NITROBENZALDEHYDE; 3-METHYL-2-PYRIDINECARBOXALDEHYDE; 3-METHYL-2-QUINOXALINECARBALDEHYDE; 3-METHYL-3H-IMIDAZO[4,5-B]PYRIDINE-2-CARBALDEHYDE; 3-METHYL-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBALDEHYDE; 3-METHYL-3-PHENYLBUTYRALDEHYDE; 3-METHYL-4-NITROBENZALDEHYDE; 3-METHYL-4-NITRO-BUTYRALDEHYDE; 3-METHYL-4-PYRIDINECARBOXALDEHYDE; 3-METHYL-5-NITROBENZALDEHYDE; 3-METHYLBENZENE-1,2-DICARBOXALDEHYDE; 3-METHYLHEPTAN-1-AL; 3-METHYLNITROSAMINOPROPIONALDEHYDE; 3-METHYLOCTANAL; 3-METHYLOXETANE-3-CARBALDEHYDE; 3-METHYLPENTANEDIAL; 3-METHYLPYRIDINE-2,5-DICARBALDEHYDE; 3-METHYLQUINOLINE-2-CARBOXALDEHYDE; 3-MORPHOLIN-4-YL-PROPIONALDEHYDE; 3-NITRO-6-PYRIDINECARBOXALDEHYDE; 3-NITROBENZALDEHYDE; 3-NITROISONICOTINALDEHYDE; 3-NITROPROPANAL; 3-NITROPYRIDINE-2-CARBOXALDEHYDE; 3-NITROSALICYLALDEHYDE; 3-NONYNAL; 3-OCTYNAL; 3-OXO-2-(2-THIENYL)PROPANENITRILE; 3-OXO-2-PHENYLPROPANENITRILE; 3-OXO-3-(PYRIDIN-2-YL)PROPANAL; 3-OXO-3-(PYRIDIN-3-YL)PROPANAL; 3-OXO-3-(PYRIDIN-4-YL)PROPANAL; 3-OXO-3-(THIOPHEN-2-YL)PROPANAL; 3-OXO-3-(THIOPHEN-3-YL)PROPANAL; 3-OXO-3-PHENYL-PROPIONALDEHYDE; 3-OXO-BUTANAL; 3-OXOPROPANENITRILE; 3-OXO-PROPIONIC ACID ETHYL ESTER; 3-PENTYNAL; 3-PHENOXYPROPANAL; 3-PHENYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-PHENYL-2H-AZIRENE-2-CARBALDEHYDE; 3-PHENYL-4-PENTENAL; 3-PHENYLBUTYRALDEHYDE; 3-PHENYLPROPIONALDEHYDE; 3-PROP-2-YNYLOXY-BENZALDEHYDE; 3-PROPOXYBENZALDEHYDE; 3-PROPOXYPROPANAL; 3-PROPYLBICYCLO(2.2.1)HEPT-5-ENE-2-CARBALDEHYDE; 3-PROPYLENECARBOXYALDEHYDE; 3-PROPYLSALICYLALDEHYDE; 3-PYRIDAZINECARBOXALDEHYDE, 4-METHYL-; 3-PYRIDAZINECARBOXALDEHYDE, 5-METHYL-; 3-PYRIDIN-4-YL-PROPIONALDEHYDE; 3-PYRIDINECARBOXALDEHYDE; 3-PYRIDINECARBOXALDEHYDE, 1-OXIDE; 3-PYRIDINECARBOXALDEHYDE, 6-(2-HYDROXYETHOXY)-; 3-PYRIDINECARBOXALDEHYDE, 6-ETHYNYL-; 3-PYRIDINECARBOXALDEHYDE, 6-PROPOXY-; 3-QUINOLINECARBOXALDEHYDE; 3-TERT-BUTYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-TERT-BUTYLBENZALDEHYDE; 3-TERT-BUTYLDIMETHYLSILYLPROPYNAL; 3-TRIETHYLSILYLPROPYNAL; 3-TRIMETHYLSILYLPROPYNAL; 3-VINYLBENZALDEHYDE; 4-(1,1-DIFLUORO-ETHYL)-BENZALDEHYDE; 4-(1,2,4-OXADIAZOL-3-YL)BENZALDEHYDE; 4-(1,3-DIOXOLAN-2-YL)BUTANAL; 4-(1,3-OXAZOL-4-YL)BENZALDEHYDE; 4-(1-AZIRIDINYL)-BENZALDEHYDE; 4-(1H-1,2,4-TRIAZOL-1-YL)BENZALDEHYDE; 4-(1H-IMIDAZOL-1-YL)BENZALDEHYDE; 4-(1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-(1H-PYRAZOL-3-YL)BENZALDEHYDE; 4-(1H-PYRAZOL-4-YL)BENZALDEHYDE; 4-(1H-PYRROL-1-YL)BENZALDEHYDE; 4-(1H-TETRAZOL-1-YL)-BENZALDEHYDE; 4-(1H-TETRAZOL-5-YL)BENZALDEHYDE; 4-(1-METHYL-2-OXO-PYRROLIDIN-3-YL)-BUTYRALDEHYDE; 4-(1-METHYLETHYL)-3-PYRIDINECARBOXALDEHYDE; 4-(1-METHYLVINYL)BENZALDEHYDE; 4-(2,2,2-TRIFLUOROETHOXY)BUTANAL; 4-(2-FLUOROETHOXY)-BENZALDEHYDE; 4-(2-FURYL)BENZALDEHYDE; 4-(2H-1,2,3-TRIAZOL-2-YL)BENZALDEHYDE; 4-(2H-TETRAZOL-5-YL)BENZALDEHYDE; 4-(2-HYDROXYETHOXY)BENZALDEHYDE; 4-(2-HYDROXYETHYL)BENZALDEHYDE; 4-(2-OXOACETYL)BENZONITRILE; 4-(2-OXOETHOXY)BENZALDEHYDE; 4-(2-OXOETHOXY)BENZONITRILE; 4-(2-PROPEN-1-YL)-3-PYRIDINECARBOXALDEHYDE; 4-(3-BUTEN-1-YL)-5-METHYL-1H-PYRAZOLE-3-CARBOXALDEHYDE; 4-(3-HYDROXYPROP-1-YNYL)BENZALDEHYDE; 4-(3-METHYLBUTOXY)BUTANAL; 4-(3-OXOPROPANOYL)BENZONITRILE; 4-(3-OXO-PROPYL)-BENZONITRILE; 4-(4-HYDROXYBUT-1-YN-1-YL)BENZALDEHYDE; 4-(BUT-2-YN-1-YLOXY)BENZALDEHYDE; 4-(BUT-3-YN-1-YLOXY)BENZALDEHYDE; 4-(BUTAN-2-YL)-1,3-THIAZOLE-2-CARBALDEHYDE; 4-(CHLOROMETHYL)BENZALDEHYDE; 4-(CHLOROMETHYL)NICOTINALDEHYDE; 4-(DIFLUOROMETHOXY)BENZALDEHYDE; 4-(DIMETHYLAMINO)-2-PYRIDINECARBOXALDEHYDE; 4-(DIMETHYLAMINO)-3-FLUOROBENZALDEHYDE; 4-(DIMETHYLAMINO)-3-HYDROXYBENZALDEHYDE; 4-(DIMETHYLAMINO)-3-METHYLBENZALDEHYDE; 4-(DIMETHYLAMINO)-3-PYRIDINECARBOXALDEHYDE; 4-(DIMETHYLAMINO)BUTANAL; 4-(DIMETHYLAMINO)SALICYLALDEHYDE; 4-(ETHYLTHIO)BENZALDEHYDE; 4-(FLUOROMETHYL)BENZALDEHYDE; 4-(FURAN-2-YL)-4-HYDROXYBUTANAL; 4-(FURAN-2-YL)-4-OXOBUTANAL; 4-(HYDROXY(METHYL)AMINO)BENZALDEHYDE; 4-(HYDROXYMETHYL)-2-PYRIDINECARBOXALDEHYDE; 4-(HYDROXYMETHYL)BENZALDEHYDE; 4-(METHYLSULFINYL)BENZALDEHYDE; 4-(METHYLTHIO)BENZALDEHYDE; 4-(METHYLTHIO)BUTYRALDEHYDE; 4-(OXAZOL-5-YL)BENZALDEHYDE; 4-(PROP-2-YN-1-YLOXY)BENZALDEHYDE; 4-(PROP-2-YNYL)BENZALDEHYDE; 4-(PROPAN-2-YLOXY)BUTANAL; 4-(TRIFLUOROMETHYL)BENZALDEHYDE; 4,4,4-TRIFLUOROBUT-2-YNAL; 4,4,4-TRIFLUOROBUTYRALDEHYDE; 4,4-DIETHOXY-2-BUTYN-1-AL; 4,4-DIFLUORO-CYCLOHEXANECARBALDEHYDE; 4,4-DIMETHOXYBUTANAL; 4,4-DIMETHYL-2,6-DIOXOCYCLOHEXANECARBALDEHYDE; 4,4-DIMETHYL-3-OXO-PENTANAL; 4,5,6,7-TETRAHYDRO-1,3-BENZOTHIAZOLE-2-CARBALDEHYDE; 4,5,6,7-TETRAHYDRO-4-BENZOFURANCARBOXALDEHYDE; 4,5,6,7-TETRAHYDRO-4-OXO-5-BENZOFURANCARBOXALDEHYDE; 4,5,6,7-TETRAHYDROBENZO[D]ISOXAZOLE-3-CARBALDEHYDE; 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIDINE-2-CARBALDEHYDE; 4,5-DIFLUORO-2-HYDROXYBENZALDEHYDE; 4,5-DIFLUORO-2-METHOXYBENZALDEHYDE; 4,5-DIFLUORO-3-HYDROXYBENZALDEHYDE; 4,5-DIFLUOROPYRIDINE-2-CARBALDEHYDE; 4,5-DIMETHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4,5-DIMETHYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 4,5-DIMETHYLPYRIDINE-2-CARBALDEHYDE; 4,6,6-TRIMETHYLHEPTANAL; 4,6-DIFLUORO-5-PYRIMIDINE FORMALDEHYDE; 4,6-DIHYDROXY-2-METHYL-PYRIMIDINE-5-CARBALDEHYDE; 4,6-DIHYDROXY-5-FORMYLPYRIMIDINE; 4,6-DIHYDROXY-PYRIDINE-3-CARBALDEHYDE; 4,6-DIMETHOXYPYRIMIDINE-2YL-CARBALDEHYDE; 4,6-DIMETHOXYPYRIMIDINE-5-CARBALDEHYDE; 4,6-DIMETHYL-2-PYRIMIDINECARBOXALDEHYDE; 4,6-DIMETHYL-3-(1H)INDAZOLE CARBOXALDEHYDE; 4,6-DIMETHYL-3-PYRIDINECARBOXALDEHYDE; 4,6-DIMETHYLCYCLOHEX-3-ENECARBALDEHYDE; 4,6-DIMETHYLPYRIDINE-2-CARBALDEHYDE; 4,7-DIMETHYL-1H-INDAZOLE-3-CARBALDEHYDE; 4,8-DIMETHYLNONANAL; 4-[(DIMETHYLAMINO)METHYL]OXANE-4-CARBALDEHYDE; 4-[1,2,3]TRIAZOL-1-YL-BENZALDEHYDE; 4-[ETHYL(METHYL)AMINO]BENZALDEHYDE; 4-[METHYL(2-OXOETHYL)AMINO]BENZONITRILE; 4-ACETOXY-4-METHYL-1-PENTANAL; 4-ACETOXYBENZALDEHYDE; 4-ACETYL-2-PYRIDINECARBOXALDEHYDE; 4-ACETYLBENZALDEHYDE; 4-ALLYLOXYBENZALDEHYDE; 4-BENZOFURANCARBOXALDEHYDE; 4-BROMOBUTYRALDEHYDE; 4-BUTOXYBUTANAL; 4-BUTYLBENZALDEHYDE; 4-BUTYLCYCLOHEXANE-1-CARBALDEHYDE; 4-CARBOXALDEHYDEBENZOCYCLOBUTENE; 4-CHLORO-2,5-DIMETHYLBENZALDEHYDE; 4-CHLORO-2,6-DIMETHYLBENZALDEHYDE; 4-CHLORO-2,6-DIMETHYLPYRIDINE-3-CARBOXALDEHYDE; 4-CHLORO-2-ETHYL-BENZALDEHYDE; 4-CHLORO-2-FLUOROBENZALDEHYDE; 4-CHLORO-2-FLUOROPYRIDINE-3-CARBOXALDEHYDE; 4-CHLORO-2-FORMYLBENZONITRILE; 4-CHLORO-2-HYDROXYBENZALDEHYDE; 4-CHLORO-2-MERCAPTOBENZALDEHYDE; 4-CHLORO-2-METHOXYBENZALDEHYDE; 4-CHLORO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-2-METHOXYPYRIDINE-5-CARBOXALDEHYDE; 4-CHLORO-2-METHYL-5-PYRIMIDINECARBOXALDEHYDE; 4-CHLORO-2-METHYLBENZALDEHYDE; 4-CHLORO-2-METHYL-PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-2-METHYLPYRIDINE-5-CARBOXALDEHYDE; 4-CHLORO-3,5-DIMETHYLBENZALDEHYDE; 4-CHLORO-3-CYANOBENZALDEHYDE; 4-CHLORO-3-ETHYLBENZALDEHYDE; 4-CHLORO-3-FLUOROBENZALDEHYDE; 4-CHLORO-3-FLUOROPICOLINALDEHYDE; 4-CHLORO-3-FORMYLBENZONITRILE; 4-CHLORO-3-HYDROXYBENZALDEHYDE; 4-CHLORO-3-HYDROXYMETHYL-BENZALDEHYDE; 4-CHLORO-3-METHOXYBENZALDEHYDE; 4-CHLORO-3-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 4-CHLORO-3-METHYLBENZALDEHYDE; 4-CHLORO-3-METHYL-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-5-FLUORO-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-5-FLUORO-PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-5-HYDROXY-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-5-HYDROXY-PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-5-METHOXY-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-5-METHOXYPYRIDINE-3-CARBOXALDEHYDE; 4-CHLORO-5-METHYL-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-5-METHYL-PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-6-FORMYL-NICOTINONITRILE; 4-CHLORO-6-METHOXY-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-6-METHOXYPYRIMIDINE-2-CARBALDEHYDE; 4-CHLORO-6-METHYL-PYRIDINE-2-CARBALDEHYDE; 4-CHLOROBENZALDEHYDE; 4-CHLORO-BUTYRALDEHYDE; 4-CHLOROPICOLINALDEHYDE; 4-CHLOROPYRIDINE-2,6-DICARBOXALDEHYDE; 4-CHLOROPYRIDINE-3-CARBOXALDEHYDE; 4-CHLOROPYRIMIDINE-2-CARBALDEHYDE; 4-CHLOROPYRIMIDINE-5-CARBALDEHYDE; 4-CINNOLINECARBOXALDEHYDE; 4-CYANO-2,5-DIFLUOROBENZALDEHYDE; 4-CYANO-2,6-DIFLUOROBENZALDEHYDE; 4-CYANO-2-FLUOROBENZALDEHYDE; 4-CYANO-2-METHOXYBENZALDEHYDE; 4-CYANO-2-METHYLBENZALDEHYDE; 4-CYANO-3-HYDROXYBENZALDEHYDE; 4-CYANO-3-METHOXY-BENZALDEHYDE; 4-CYANO-3-METHYLBENZALDEHYDE; 4-CYANOBENZALDEHYDE; 4-CYANOPYRIDINE-2-CARBOXALDEHYDE; 4-CYCLOHEXYLBUTYRALDEHYDE; 4-CYCLOPENTYL-BENZALDEHYDE; 4-CYCLOPROPOXYBENZALDEHYDE; 4-CYCLOPROPOXYNICOTINALDEHYDE; 4-CYCLOPROPOXYPICOLINALDEHYDE; 4-CYCLOPROPYL-2-FLUOROBENZALDEHYDE; 4-CYCLOPROPYLBENZALDEHYDE; 4-DIMETHYLAMINO-2-METHYLBENZALDEHYDE; 4-DIMETHYLAMINOBENZALDEHYDE; 4-DIMETHYLAMINOMETHYL-BENZALDEHYDE; 4-ETHOXY-2-HYDROXY-BENZALDEHYDE; 4-ETHOXY-2-METHYLBENZALDEHYDE; 4-ETHOXY-3-FLUOROBENZALDEHYDE; 4-ETHOXY-3-HYDROXYBENZALDEHYDE; 4-ETHOXY-3-METHYLBENZALDEHYDE; 4-ETHOXY-3-METHYL-PYRIDINE-2-CARBALDEHYDE; 4-ETHOXYBENZALDEHYDE; 4-ETHOXYBUTANAL; 4-ETHOXYNICOTINALDEHYDE; 4-ETHOXYPYRIDINE-2-CARBALDEHYDE; 4-ETHYL-2-HYDROXYBENZALDEHYDE; 4-ETHYL-2-THIAZOLECARBOXALDEHYDE; 4-ETHYL-3-HYDROXYBENZALDEHYDE; 4-ETHYL-4-FORMYLHEXANENITRILE; 4-ETHYL-4-FORMYL-TETRAHYDROPYRAN; 4-ETHYL-5-METHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4-ETHYLBENZALDEHYDE; 4-ETHYLOCTANAL; 4-ETHYL-TETRAHYDRO-2H-THIOPYRAN-4-CARBALDEHYDE; 4-ETHYNYLBENZALDEHYDE; 4-ETHYNYL-PYRIDINE-2-CARBALDEHYDE; 4-ETHYNYL-PYRIDINE-3-CARBALDEHYDE; 4-FLUORO-1H-INDAZOLE-3-CARBALDEHYDE; 4-FLUORO-1-NAPHTHALDEHYDE; 4-FLUORO-2-(METHYLTHIO)BENZALDEHYDE; 4-FLUORO-2,3-DIMETHYLBENZALDEHYDE; 4-FLUORO-2-FORMYLPYRIDINE; 4-FLUORO-2-HYDROXYBENZALDEHYDE; 4-FLUORO-2-MERCAPTOBENZALDEHYDE; 4-FLUORO-2-METHOXYBENZALDEHYDE; 4-FLUORO-2-METHYLBENZALDEHYDE; 4-FLUORO-2-METHYL-PYRIDINE-3-CARBALDEHYDE; 4-FLUORO-2-NITROBENZALDEHYDE; 4-FLUORO-3-(CHLOROMETHYL)BENZALDEHYDE; 4-FLUORO-3,5-DIMETHYLBENZALDEHYDE; 4-FLUORO-3-FORMYLPHENYLBORONIC ACID; 4-FLUORO-3-FORMYLPYRIDINE; 4-FLUORO-3-HYDROXYBENZALDEHYDE; 4-FLUORO-3-ISOPROPYLBENZALDEHYDE; 4-FLUORO-3-METHOXYBENZALDEHYDE; 4-FLUORO-3-METHYLBENZALDEHYDE; 4-FLUORO-3-NITROBENZALDEHYDE; 4-FLUORO-4-FORMYLTHIANE; 4-FLUOROBENZALDEHYDE; 4-FLUOROBENZENE-1,2-DICARBOXALDEHYDE; 4-FLUOROBENZO[D]OXAZOLE-2-CARBALDEHYDE; 4-FLUOROBENZOFURAN-7-CARBALDEHYDE; 4-FLUOROBUTYRALDEHYDE; 4-FLUOROPHENYLGLYOXAL HYDRATE; 4-FORMYL-1-PIPERIDINECARBOXYLIC ACID METHYL ESTER; 4-FORMYL-2-METHYLPHENYLBORONIC ACID; 4-FORMYL-3-HYDROXYPHENYLBORONIC ACID; 4-FORMYL-3-METHYLPHENYLBORONIC ACID; 4-FORMYL-4-METHYL-TETRAHYDROPYRAN; 4-FORMYL-4-METHYLTHIANE; 4-FORMYLBENZALDEHYDE-O-METHYL ALDOXIME; 4-FORMYL-BENZENEPROPANAL; 4-FORMYL-BENZOYL CHLORIDE; 4-FORMYL-HEXANOIC ACID METHYL ESTER; 4-FORMYLNICOTINONITRILE; 4-FORMYLPHENYLBORONIC ACID; 4-FORMYLPYRIMIDINE-2-CARBONITRILE; 4-FORMYLTETRAHYDROPYRAN; 4-FORMYL-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID METHYL ESTER; 4H-CYCLOPENTA[D]THIAZOLE-2-CARBOXALDEHYDE, 5,6-DIHYDRO-; 4-HYDROXY-1H-INDAZOLE-3-CARBOXALDEHYDE; 4-HYDROXY-1-METHYL-2,5-CYCLOHEXADIENE-1-CARBALDEHYDE; 4-HYDROXY-1-NAPHTHALDEHYDE; 4-HYDROXY-2-(METHYLTHIO)BENZALDEHYDE; 4-HYDROXY-2,5-DIMETHYLBENZALDEHYDE; 4-HYDROXY-2-ISOPROPYLBENZALDEHYDE; 4-HYDROXY-2-METHOXYBENZALDEHYDE; 4-HYDROXY-2-METHYLBENZALDEHYDE; 4-HYDROXY-2-NITROBENZALDEHYDE; 4-HYDROXY-2-QUINOLINECARBALDEHYDE; 4-HYDROXY-3-(METHYLTHIO)BENZALDEHYDE; 4-HYDROXY-3-ISOPROPYLBENZALDEHYDE; 4-HYDROXY-3-METHOXY-5-METHYLBENZENECARBALDEHYDE; 4-HYDROXY-3-METHYLBENZALDEHYDE; 4-HYDROXY-3-NITROBENZALDEHYDE; 4-HYDROXY-4-METHYL-HEX-2-YNAL; 4-HYDROXY-5-BENZOFURANCARBOXALDEHYDE; 4-HYDROXY-5-METHOXY-2-PYRIDINECARBALDEHYDE; 4-HYDROXY-5-METHYL-1,3-DIALDEHYDE; 4-HYDROXY-5-NITRONICOTINALDEHYDE; 4-HYDROXYBENZALDEHYDE; 4-HYDROXYBENZALDEHYDE POTASSIUM SALT; 4-HYDROXY-BICYCLO[2.2.2]OCTANE-1-CARBOXALDEHYDE; 4-HYDROXYINDANE-5-CARBALDEHYDE; 4-HYDROXYISOPHTHALALDEHYDE; 4-HYDROXYNAPHTHALENE-2-CARBOXALDEHYDE; 4-HYDROXYPHENYL GLYOXAL; 4-HYDROXYPHENYLGLYOXAL HYDRATE; 4-HYDROXYPHTHALALDEHYDE; 4-HYDROXY-PYRIDINE-2-CARBALDEHYDE; 4-HYDROXYPYRIDINE-3-CARBOXALDEHYDE; 4-HYDROXY-QUINOLINE-3-CARBALDEHYDE; 4-HYDROXYQUINOLINE-5-CARBOXALDEHYDE; 4-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 4-HYDROXYQUINOLINE-7-CARBOXALDEHYDE; 4-HYDROXYQUINOLINE-8-CARBOXALDEHYDE; 4-IMIDAZOL-1-YL-BUTYRALDEHYDE; 4-ISOBUTYLBENZALDEHYDE; 4-ISOCYANATOBENZALDEHYDE; 4-ISOPROPOXYBENZALDEHYDE; 4-ISOPROPYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4-ISOPROPYLBENZALDEHYDE; 4-MERCAPTOBENZALDEHYDE; 4-METHOXY-2,6-DIMETHYLBENZALDEHYDE; 4-METHOXY-2-METHYLBENZALDEHYDE; 4-METHOXY-2-PYRIMIDINECARBOXALDEHYDE; 4-METHOXY-3,5-DIMETHYLPICOLINALDEHYDE; 4-METHOXY-3-METHYLBENZALDEHYDE; 4-METHOXY-3-METHYL-PYRIDINE-2-CARBALDEHYDE; 4-METHOXYBUTANAL; 4-METHOXYISOPHTHALALDEHYDE; 4-METHOXYMETHYLBENZALDEHYDE; 4-METHOXYPHENYLACETALDEHYDE; 4-METHOXYPHTHALALDEHYDE; 4-METHOXYPICOLINALDEHYDE; 4-METHOXYPYRIDINE-2,6-DICARBALDEHYDE; 4-METHYL-1,2,5-OXADIAZOLE-3-CARBOXALDEHYDE; 4-METHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4-METHYL-1-NAPHTHALDEHYDE; 4-METHYL-2-(PROP-2-YN-1-YLOXY)BENZALDEHYDE; 4-METHYL-2,6-PYRIDINEDICARBOXALDEHYDE; 4-METHYL-2-NITROBENZALDEHYDE; 4-METHYL-2-PYRIMIDINECARBOXALDEHYDE; 4-METHYL-2-THIAZOLECARBOXALDEHYDE 3-OXIDE; 4-METHYL-3-(1H)INDAZOLE CARBOXALDEHYDE; 4-METHYL-3-NITROBENZALDEHYDE; 4-METHYL-3-NITROPICOLINALDEHYDE; 4-METHYL-3-OXOPENTANAL; 4-METHYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 4-METHYL-4-NITROVALERALDEHYDE; 4-METHYL-5-OXO-PENTANOIC ACID METHYL ESTER; 4-METHYL-5-THIAZOLEACETALDEHYDE; 4-METHYLHEPTANAL; 4-METHYLHEXANAL; 4-METHYLNICOTINALDEHYDE; 4-METHYLPENTALDEHYDE; 4-METHYLPHENYLGLYOXAL HYDRATE; 4-METHYLPYRIDINE-2,5-DICARBALDEHYDE; 4-METHYLPYRIMIDINE-5-CARBALDEHYDE; 4-METHYQUINOLINE-2-CARBOXALDEHYDE; 4-NITRO-2-FORMYLPYRIDINE N-OXIDE; 4-NITROBENZALDEHYDE; 4-NITRONICOTINALDEHYDE; 4-NITRO-PYRIDINE-2-CARBALDEHYDE; 4-N-PROPOXYBENZALDEHYDE; 4-N-PROPYLBENZALDEHYDE; 4-OXO-4-(3-PYRIDYL)-BUTANAL; 4-OXO-4-(PIPERIDIN-1-YL)BUTANAL; 4-OXO-6,7-DIHYDRO-4H-PYRAZOLO[5,1-C][1,4]OXAZINE-2-CARBALDEHYDE; 4-OXOBUTANOIC ACID METHYL ESTER; 4-OXO-TETRAHYDROFURAN-3-CARBOXALDEHYDE; 4-PENTENAL; 4-PHENOXYBUTANAL; 4-PHENYLBUTYRALDEHYDE; 4-PROPYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4-PROPYL-3-PYRIDINECARBOXALDEHYDE; 4-PYRIDAZINECARBOXALDEHYDE, 3-METHYL-; 4-PYRIDAZINECARBOXALDEHYDE, 5-METHYL-; 4-PYRIDAZINECARBOXALDEHYDE, 6-METHYL-; 4-PYRIDIN-2-YLBUTANAL; 4-PYRIDIN-3-YLBUTANAL; 4-PYRIDIN-4-YLBUTANAL; 4-PYRIDINECARBOXALDEHYDE; 4-PYRIDINECARBOXALDEHYDE N-OXIDE; 4-PYRIMIDINECARBOXALDEHYDE, 5-METHYL-; 4-QUINOLINECARBOXALDEHYDE; 4-QUINOLINECARBOXALDEHYDE, 8-HYDROXY-; 4-TERT-BUTYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4-TERT-BUTYLBENZALDEHYDE; 4-TERT-BUTYLCYCLOHEXANE-1-CARBALDEHYDE; 4-TETRAHYDROPYRANYLOXY-BUTANAL; 4-THIAZOLEPROPANAL; 4-VINYL-BENZALDEHYDE; 5-(1,1-DIMETHYLETHYL)-3-ISOXAZOLECARBOXALDEHYDE; 5-(1-METHYLETHYL)-2-PYRIDINECARBOXALDEHYDE; 5-(2-FURYL)ISOXAZOLE-3-CARBALDEHYDE; 5-(2-FURYL)PYRIDINE-2-CARBALDEHYDE; 5-(2-METHYL-PROPENYL)-PYRIDINE-2-CARBALDEHYDE; 5-(CHLOROMETHYL)NICOTINALDEHYDE; 5-(CHLOROMETHYL)PICOLINALDEHYDE; 5-(DIFLUOROMETHOXY)PYRAZINE-2-CARBOXALDEHYDE; 5-(DIMETHYLAMINO)-2-PYRIDINECARBOXALDEHYDE; 5-(DIMETHYLAMINO)PYRAZINE-2-CARBALDEHYDE; 5-(DIMETHYLAMINO)SALICYLALDEHYDE; 5-(FURAN-2-YL)PYRIDINE-3-CARBALDEHYDE; 5-(HYDROXYMETHYL)-2-PYRIDINECARBOXALDEHYDE; 5-(METHOXYMETHYL)-4-METHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 5-(METHYLTHIO)-1H-PYRAZOLE-3-CARBALDEHYDE; 5-(PYRIDIN-2-YL)OXAZOLE-2-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-3-CARBALDEHYDE; 5,5-DIETHOXYPENTANAL; 5,5-DIMETHOXYPENTANAL; 5,5-DIMETHYL-1,3-DIOXANE-2-PROPIONALDEHYDE; 5,5-DIMETHYLHEXANAL; 5,6,7,8-TETRAHYDRO-7-INDOLIZINECARBOXALDEHYDE; 5,6,7,8-TETRAHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 5,6-DIFLUORONICOTINALDEHYDE; 5,6-DIFLUOROPICOLINALDEHYDE; 5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOLE-2-CARBALDEHYDE; 5,6-DIHYDRO-5-INDOLIZINECARBOXALDEHYDE; 5,6-DIMETHOXYNICOTINALDEHYDE; 5,6-DIMETHOXYPICOLINALDEHYDE; 5,6-DIMETHYLPYRIDINE-2-CARBALDEHYDE; 5,7-DIHYDRO-5-OXO-FURO[3,4-B]PYRIDINE-2-CARBOXALDEHYDE; 5-[(DIMETHYLAMINO)METHYL]ISOXAZOLE-3-CARBALDEHYDE; 5-ACETYL-2-PYRIDINECARBOXALDEHYDE; 5-ACETYL-PYRAZINECARBOXALDEHYDE; 5-BENZOTHIAZOLECARBOXALDEHYDE; 5-CHLORO-2,2-DIMETHYLPENTANAL; 5-CHLORO-2,4-DIHYDROXY-BENZALDEHYDE; 5-CHLORO-2-FLUORO-3-FORMYL-4-PICOLINE; 5-CHLORO-2-FLUOROBENZALDEHYDE; 5-CHLORO-2-FLUOROISONICOTINALDEHYDE; 5-CHLORO-2-FLUOROMETHYLBENZALDEHYDE; 5-CHLORO-2-FLUORONICOTINALDEHYDE; 5-CHLORO-2-FORMYLBENZONITRILE; 5-CHLORO-2-FORMYLPYRIDINE; 5-CHLORO-2-HYDROXY-3-METHYLBENZALDEHYDE; 5-CHLORO-2-HYDROXY-4-METHYL-BENZALDEHYDE; 5-CHLORO-2-HYDROXYISONICOTINALDEHYDE; 5-CHLORO-2-HYDROXYNICOTINALDEHYDE; 5-CHLORO-2-MERCAPTOBENZALDEHYDE; 5-CHLORO-2-METHOXYBENZALDEHYDE; 5-CHLORO-2-METHOXYNICOTINALDEHYDE; 5-CHLORO-2-METHOXY-PYRIDINE-4-CARBALDEHYDE; 5-CHLORO-2-METHYLBENZALDEHYDE; 5-CHLORO-2-METHYL-PYRIDINE-3-CARBALDEHYDE; 5-CHLORO-2-METHYL-PYRIDINE-4-CARBALDEHYDE; 5-CHLORO-3-FLUORO-2-HYDROXY-BENZALDEHYDE; 5-CHLORO-3-FLUOROPICOLINALDEHYDE; 5-CHLORO-3-METHOXYPYRAZINE-2-CARBALDEHYDE; 5-CHLORO-3-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 5-CHLORO-3-METHYLPYRIDINE-2-CARBOXALDEHYDE; 5-CHLORO-4-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 5-CHLORO-4-METHOXYPYRIDINE-3-CARBOXALDEHYDE; 5-CHLORO-4-METHYL-PYRIDINE-2-CARBALDEHYDE; 5-CHLORO-4-METHYLPYRIDINE-3-CARBOXALDEHYDE; 5-CHLORO-6-FLUORONICOTINALDEHYDE; 5-CHLORO-6-FLUOROPICOLINALDEHYDE; 5-CHLORO-6-HYDROXYPICOLINALDEHYDE; 5-CHLOROISOPHTHALALDEHYDE; 5-CHLORO-PENTANAL; 5-CHLOROPYRAZINE-2-CARBALDEHYDE; 5-CHLOROPYRIDINE-3-CARBALDEHYDE; 5-CHLOROPYRIMIDINE-2-CARBALDEHYDE; 5-CHLOROPYRIMIDINE-4-CARBOXALDEHYDE; 5-CHLOROSALICYLALDEHYDE; 5-CHLOROTHIAZOLE-2-CARBALDEHYDE; 5-CYANOINDAZOLE-3-CARBOXALDEHYDE; 5-CYANO-2-FLUOROBENZALDEHYDE; 5-CYANO-2-METHOXY BENZALDEHYDE; 5-CYANO-2-METHYLBENZALDEHYDE; 5-CYANOISOPHTHALALDEHYDE; 5-CYCLOPROPOXYNICOTINALDEHYDE; 5-CYCLOPROPOXYPICOLINALDEHYDE; 5-CYCLOPROPYL-1H-PYRAZOLE-3-CARBALDEHYDE; 5-CYCLOPROPYL-2-FLUOROBENZALDEHYDE; 5-CYCLOPROPYL-2-HYDROXYBENZALDEHYDE; 5-CYCLOPROPYLPYRAZINE-2-CARBALDEHYDE; 5-DEOXY-3,4-D1-O-METHYL-D-RIBOSE; 5-DEOXY-3,4-DI-O-METHYL-L-ARABINOSE; 5-DEOXY-D-RIBOSE; 5-DEOXY-L-ARABINOSE; 5-ETHOXY-2-HYDROXY-BENZALDEHYDE; 5-ETHOXYPYRIDINE-2-CARBALDEHYDE; 5-ETHYL-1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 5-ETHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 5-ETHYL-2-HYDROXYBENZENECARBALDEHYDE; 5-ETHYL-2-METHOXYBENZALDEHYDE; 5-ETHYL-2-PYRIDINECARBOXALDEHYDE; 5-ETHYL-3-METHYLBENZALDEHYDE; 5-ETHYL-3-PYRIDINECARBOXALDEHYDE; 5-ETHYLISOXAZOLE-3-CARBALDEHYDE; 5-ETHYNYL-2-METHOXYBENZALDEHYDE; 5-ETHYNYL-2-PYRIDINECARBOXALDEHYDE; 5-ETHYNYLNICOTINALDEHYDE; 5-FLUORO-1H-INDAZOLE-3-CARBALDEHYDE; 5-FLUORO-1-NAPHTHALDEHYDE; 5-FLUORO-2,3-DIHYDROBENZOFURAN-7-CARBOXALDEHYDE; 5-FLUORO-2-FORMYLPHENYLBORONIC ACID; 5-FLUORO-2-FORMYLPYRIDINE; 5-FLUORO-2-HYDROXY-3-METHYLBENZALDEHYDE; 5-FLUORO-2-HYDROXY-4-PYRIDINECARBOXALDEHYDE; 5-FLUORO-2-HYDROXYBENZALDEHYDE; 5-FLUORO-2-HYDROXYNICOTINALDEHYDE; 5-FLUORO-2-MERCAPTOBENZALDEHYDE; 5-FLUORO-2-METHOXYBENZALDEHYDE; 5-FLUORO-2-METHOXYNICOTINALDEHYDE; 5-FLUORO-2-METHYL-3-PYRIDINECARBOXALDEHYDE; 5-FLUORO-2-METHYLBENZALDEHYDE; 5-FLUORO-2-NITROBENZALDEHYDE; 5-FLUORO-4-FORMYL-2-METHOXYPYRIDINE; 5-FLUORO-4-HYDROXYISOPHTHALALDEHYDE; 5-FLUORO-6-HYDROXYNICOTINALDEHYDE; 5-FLUORO-6-HYDROXYPICOLINALDEHYDE; 5-FLUORO-6-METHOXYPICOLINALDEHYDE; 5-FLUORO-6-METHYLNICOTINALDEHYDE; 5-FLUOROBENZO[D]OXAZOLE-2-CARBALDEHYDE; 5-FLUOROISOPHTHALALDEHYDE; 5-FLUORONAPHTHALENE-2-CARBOXALDEHYDE; 5-FLUORO-PYRIMIDINE-2-CARBALDEHYDE; 5-FORMYL-1-INDANONE; 5-FORMYL-2H-PYRAZOLE-3-CARBOXYLIC ACID METHYL ESTER; 5-FORMYL-2-ISOPROXYPYRIDINE; 5-FORMYL-2-METHOXY-4-PICOLINE; 5-FORMYL-2-METHYL-BENZONITRILE; 5-FORMYL-2-METHYLPHENYLBORONIC ACID; 5-FORMYLFURO[2,3-B]PYRIDINE; 5-FORMYL-PYRAZINE-2-CARBOXYLIC ACID METHYL ESTER; 5-FORMYLPYRIDINE-2-BORONIC ACID; 5-FORMYLPYRIDINE-2-BORONIC ACIDHYDRATE; 5-FORMYLPYRIDINE-2-CARBONITRILE; 5-FORNYL-3-PYRIDINECARBONITRILE; 5-FURAN-2-YL-[1,2,4]OXADIAZOLE-3-CARBALDEHYDE; 5-FURAN-2-YL-OXAZOLE-2-CARBALDEHYDE; 5-HEXYNAL; 5-HYDROXY-1H-INDAZOLE-3-CARBOXALDEHYDE; 5-HYDROXY-1H-INDAZOLE-4-CARBALDEHYDE; 5-HYDROXY-2-(METHYLTHIO)BENZALDEHYDE; 5-HYDROXY-2-ISOPROPYLBENZALDEHYDE; 5-HYDROXY-2-METHOXYBENZALDEHYDE; 5-HYDROXY-2-METHOXY-PYRIDINE-4-CARBALDEHYDE; 5-HYDROXY-2-METHYLBENZALDEHYDE; 5-HYDROXY-2-METHYL-BENZENEPROPANAL; 5-HYDROXY-2-NITROBENZALDEHYDE; 5-HYDROXY-4,6-DIMETHYL-3-PYRIDINECARBOXALDEHYDE; 5-HYDROXY-4-BENZOFURANCARBOXALDEHYDE; 5-HYDROXY-6-BENZOFURANCARBOXALDEHYDE; 5-HYDROXY-6-METHYL-2-PYRIDINECARBOXALDEHYDE; 5-HYDROXY-6-NITRONICOTINALDEHYDE; 5-HYDROXYNAPHTHALENE-1-CARBOXALDEHYDE; 5-HYDROXYNAPHTHALENE-2-CARBOXALDEHYDE; 5-HYDROXYNICOTINALDEHYDE; 5-HYDROXYPENTANAL; 5-HYDROXYPYRAZINE-2-CARBOXALDEHYDE; 5-HYDROXYPYRIDINE-2-CARBALDEHYDE; 5-HYDROXYPYRIMIDINE-2-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-2-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-3-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-4-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-7-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-8-CARBOXALDEHYDE; 5-IMIDAZOL-1-YL-PENTANAL; 5-ISOBENZOFURANCARBOXALDEHYDE, 1,3-DIHYDRO-; 5-ISOBUTYL-1H-PYRAZOLE-3-CARBALDEHYDE; 5-ISOBUTYLPYRAZINE-2-CARBALDEHYDE; 5-ISOPROPYL-1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 5-ISOPROPYL-1,3,4-THIADIAZOLE-2-CARBALDEHYDE; 5-ISOPROPYL-3-METHYLBENZALDEHYDE; 5-ISOPROPYLISOXAZOLE-3-CARBALDEHYDE; 5-ISOPROPYLPYRAZINE-2-CARBALDEHYDE; 5-METHANESULFONYLPENTANAL; 5-METHOXY-2-METHYLBENZALDEHYDE; 5-METHOXY-2-PYRIMIDINECARBOXALDEHYDE; 5-METHOXY-3-PYRIDINECARBOXALDEHYDE; 5-METHOXY-6-METHYL-PYRIDINE-2-CARBALDEHYDE; 5-METHOXYISOPHTHALALDEHYDE; 5-METHOXYPENTANAL; 5-METHOXYPYRAZINE-2-CARBALDEHYDE; 5-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 5-METHYL-1,3,4-THIADIAZOLE-2-CARBALDEHYDE; 5-METHYL-1,3-BENZOXAZOLE-2-CARBALDEHYDE; 5-METHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 5-METHYL-1H-INDAZOLE-3-CARBALDEHYDE; 5-METHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 5-METHYL-2-(PROP-2-YN-1-YLOXY)BENZALDEHYDE; 5-METHYL-2-NITROBENZALDEHYDE; 5-METHYL-3-NITROPICOLINALDEHYDE; 5-METHYL-4-(PROPAN-2-YL)-1,3-THIAZOLE-2-CARBALDEHYDE; 5-METHYLFURAN-2-PROPIONALDEHYDE; 5-METHYLHEXANAL; 5-METHYLISOPHTHALALDEHYDE; 5-METHYLISOXAZOLE-3-CARBOXALDEHYDE; 5-METHYLNICOTINALDEHYDE; 5-METHYL-OXAZOLE-2-CARBALDEHYDE; 5-METHYLPYRIDINE-2-CARBOXALDEHYDE; 5-METHYLQUINOLINE-2-CARBALDEHYDE; 5-NITRO-6-METHYL-2-PYRIDINECARBALDEHYDE; 5-NITRONICOTINALDEHYDE; 5-NORBORNENE-2-CARBOXALDEHYDE; 5-OXO-PENTANOIC ACID METHYL ESTER; 5-OXOPENTYL ACETATE; 5-PHENYL-[1,2,4]OXADIAZOLE-3-CARBALDEHYDE; 5-PHENYL-1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 5-PHENYL-1H-PYRAZOLE-3-CARBALDEHYDE; 5-PHENYLISOXAZOLE-3-CARBALDEHYDE; 5-PHENYL-OXAZOLE-2-CARBALDEHYDE; 5-PHENYLPENTANAL; 5-PYRIDIN-3-YL-OXAZOLE-2-CARBALDEHYDE; 5-QUINAZOLINECARBOXALDEHYDE; 5-TERT-BUTYL-1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 5-TERT-BUTYL-1H-PYRAZOLE-3-CARBALDEHYDE; 6-(1-HYDROXY-1-METHYL-ETHYL)-PYRIDINE-3-CARBALDEHYDE; 6-(1-METHYLETHYL)-2-PYRIDINECARBOXALDEHYDE; 6-(1-METHYLETHYL)-3-PYRIDINECARBOXALDEHYDE; 6-(2-FURYL)NICOTINALDEHYDE; 6-(2-HYDROXYPROPAN-2-YL)PICOLINALDEHYDE; 6-(4H-1,2,4-TRIAZOL-4-YL)PYRIDINE-2-CARBOXALDEHYDE; 6-(CHLOROMETHYL)NICOTINALDEHYDE; 6-(CHLOROMETHYL)PYRIDINE-2-CARBALDEHYDE; 6-(DIMETHYLAMINO)-4-METHYLNICOTINALDEHYDE; 6-(DIMETHYLAMINO)NICOTINALDEHYDE; 6-(FLUOROMETHYL)PYRIDINE-2-CARBALDEHYDE; 6-(FURAN-2-YL)PYRIDINE-2-CARBALDEHYDE; 6-(HYDROXYMETHYL)-3-PYRIDINECARBOXALDEHYDE; 6,6-DIMETHOXYHEXANAL; 6,7-DIHYDRO-4H-PYRAZOLO[5,1-C][1,4]OXAZINE-2-CARBALDEHYDE; 6,7-DIHYDRO-4H-PYRAZOLO[5,1-C][1,4]THIAZINE-2-CARBALDEHYDE; 6,7-DIHYDRO-5H-CYCLOPENTA[C]PYRIDINE-3-CARBOXALDEHYDE; 6,7-DIHYDRO-5H-PYRANO[2,3-D]PYRIMIDINE-2-CARBALDEHYDE; 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBALDEHYDE; 6,7-DIMETHYL-1H-INDAZOLE-3-CARBALDEHYDE; 6-[ETHYL(METHYL)AMINO]NICOTINALDEHYDE; 6-ACETYL-NICOTINALDEHYDE; 6-ACETYLPYRIDINE-2-CARBALDEHYDE; 6-BENZOTHIAZOLECARBOXALDEHYDE; 6-CHLORO-1,2,4-TRIAZINE-5-CARBALDEHYDE; 6-CHLORO-2-FLUORO-3-METHYLBENZALDEHYDE; 6-CHLORO-2-FLUOROPYRIDINE-3-CARBOXALDEHYDE; 6-CHLORO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-METHYLPYRIMIDINE-4-CARBALDEHYDE; 6-CHLORO-3-FORMYL-2-PICOLINE; 6-CHLORO-3-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 6-CHLORO-3-METHYLPYRIDINE-2-CARBOXALDEHYDE; 6-CHLORO-4-FLUORO-PYRIDINE-2-CARBALDEHYDE; 6-CHLORO-4-FLUORO-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-4-HYDROXY-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-4-METHOXY-PYRIDINE-2-CARBALDEHYDE; 6-CHLORO-4-METHYLPICOLINALDEHYDE; 6-CHLORO-5-FLUORONICOTINALDEHYDE; 6-CHLORO-5-FLUOROPICOLINALDEHYDE; 6-CHLORO-5-HYDROXY-3-PYRIDINECARBOXALDEHYDE; 6-CHLORO-5-METHOXYPICOLINALDEHYDE; 6-CHLORO-5-METHOXY-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-5-METHYLNICOTINALDEHYDE; 6-CHLOROHEXANAL; 6-CHLORONICOTINALDEHYDE; 6-CHLOROPYRAZINE-2-CARBALDEHYDE; 6-CHLOROPYRIDAZINE-3-CARBALDEHYDE; 6-CHLOROPYRIDINE-2-CARBALDEHYDE; 6-CHLOROPYRIMIDINE-4-CARBALDEHYDE; 6-CYANOPYRIDINE-2-CARBOXALDEHYDE; 6-CYCLOPROPYL-2-FORMYLPYRIMIDINE; 6-CYCLOPROPYL-PYRIDINE-3-CARBALDEHYDE; 6-DEOXY-D-GALACTOSE; 6-DEOXY-L-TALOSE; 6-DIMETHYLAMINO-PYRIDINE-2-CARBALDEHYDE; 6-ETHOXY-5-FLUORO-PYRIDINE-3-CARBALDEHYDE; 6-ETHOXYNICOTINALDEHYDE; 6-ETHOXYPYRIDINE-2-CARBOXALDEHYDE; 6-ETHYL-3-PYRIDINECARBOXALDEHYDE; 6-ETHYNYLPICOLINALDEHYDE; 6-FLUORO-1H-INDAZOLE-5-CARBALDEHYDE; 6-FLUORO-3-(1H)INDAZOLE CARBOXALDEHYDE; 6-FLUORO-3-FORMYL-2-PICOLINE; 6-FLUORO-5-METHOXYNICOTINALDEHYDE; 6-FLUORO-5-METHYLPYRIDINE-2-CARBALDEHYDE; 6-FLUOROBENZO[D]OXAZOLE-2-CARBALDEHYDE; 6-FORMYL NICOTINONITRILE; 6-FORMYL-2-METHYLPYRIDINE-3-BORONIC ACID; 6-FORMYL-2-PYRIDINE CARBOXYLIC ACID METHYL ESTER; 6-FORMYL-4-METHYLPYRIDINE-3-BORONIC ACID; 6-FORMYLFURO[3,2-C]PYRIDINE; 6-FORMYLPYRIDINE-2-BORONIC ACID; 6-FORMYLPYRIDINE-3-BORONIC ACID; 6-HYDROXY-1H-INDAZOLE-3-CARBOXALDEHYDE; 6-HYDROXY-2-METHYLNICOTINALDEHYDE; 6-HYDROXY-2-METHYLPYRIMIDINE-4-CARBALDEHYDE; 6-HYDROXY-2-NAPHTHALDEHYDE; 6-HYDROXY-5-NITRONICOTINALDEHYDE; 6-HYDROXY-5-QUINOLINECARBOXALDEHYDE; 6-HYDROXYISOQUINOLINE-5-CARBALDEHYDE; 6-HYDROXYMETHYL-2-PYRIDINECARBOXALDEHYDE; 6-HYDROXYNAPHTHALENE-1-CARBOXALDEHYDE; 6-HYDROXYNICOTINALDEHYDE; 6-HYDROXYPYRIDAZINE-3-CARBOXALDEHYDE; 6-HYDROXYPYRIDINE-2-CARBOXALDEHYDE; 6-HYDROXYPYRIMIDINE-4-CARBALDEHYDE; 6-HYDROXYQUINOLINE-2-CARBOXALDEHYDE; 6-HYDROXYQUINOLINE-3-CARBOXALDEHYDE; 6-HYDROXYQUINOLINE-4-CARBOXALDEHYDE; 6-HYDROXYQUINOLINE-7-CARBOXALDEHYDE; 6-HYDROXYQUINOLINE-8-CARBOXALDEHYDE; 6-IMIDAZOL-1-YL-HEXANAL; 6-IMIDAZOL-1-YL-PYRIDINE-2-CARBALDEHYDE; 6-METHOXY-2,6-DIMETHYL HEPTANAL; 6-METHOXY-2-METHYLPYRIDINE-3-CARBOXALDEHYDE; 6-METHOXY-2-PYRIDINECARBOXALDEHYDE; 6-METHOXY-3-METHYLPYRIDINE-2-CARBALDEHYDE; 6-METHOXY-3-PYRIDINECARBOXALDEHYDE; 6-METHOXY-5-METHYLNICOTINALDEHYDE; 6-METHOXY-5-METHYLPYRIDINE-2-CARBALDEHYDE; 6-METHOXYPYRIDAZINE-3-CARBALDEHYDE; 6-METHYL-1,3-BENZOXAZOLE-2-CARBALDEHYDE; 6-METHYL-2-(PROPAN-2-YL)PYRIMIDINE-4-CARBALDEHYDE; 6-METHYL-2-PROPYLPYRIMIDINE-4-CARBALDEHYDE; 6-METHYL-2-PYRIDINECARBOXALDEHYDE; 6-METHYL-2-QUINOLINECARBOXALDEHYDE; 6-METHYL-3-(1H)INDAZOLE CARBOXALDEHYDE; 6-METHYL-3-CYCLOHEXENE-1-CARBOXALDEHYDE; 6-METHYL-3-NITROPICOLINALDEHYDE; 6-METHYL-5-QUINOLINECARBALDEHYDE; 6-METHYL-BENZO[1,3]DIOXOLE-5-CARBALDEHYDE; 6-METHYLISOVANILLIN; 6-METHYLNICOTINALDEHYDE; 6-METHYLPYRAZINE-2-CARBOXALDEHYDE; 6-METHYLPYRIDAZINE-3-CARBALDEHYDE; 6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 6-METHYLQUINOLINE-8-CARBOXALDEHYDE; 6-NITROPICOLINALDEHYDE; 6-OXO-HEXANOIC ACID ETHYL ESTER; 6-QUINOLINECARBALDEHYDE; 6-TERT-BUTYL-PYRIDINE-3-CARBALDEHYDE; 7,7-DIMETHOXYHEPTANAL; 7,7-DIMETHYL-2-OXOBICYCLO[2.2.1]HEPTANE-1-CARBALDEHYDE; 7,8-DIHYDRO-5H-PYRANO[4,3-B]PYRIDINE-3-CARBALDEHYDE; 7,8-DIHYDRO-5H-PYRANO[4,3-D]PYRIDINE-4-CARBALDEHYDE; 7,8-DIHYDRO-5H-PYRANO[4,3-D]PYRIMIDINE-2-CARBALDEHYDE; 7,8-DIHYDRO-5H-PYRANO[4,3-D]PYRIMIDINE-4-CARBALDEHYDE; 7-ETHYL-1H-INDAZOLE-5-CARBALDEHYDE; 7-FLUORO-1H-INDAZOLE-3-CARBOXALDEHYDE; 7-FLUORO-1H-INDAZOLE-4-CARBALDEHYDE; 7-FLUOROBENZO[D]OXAZOLE-2-CARBALDEHYDE; 7-FLUORONAPHTHALENE-1-CARBOXALDEHYDE; 7-FORMYL-8-QUINOLINOL; 7-HYDROXY-1,3-BENZODIOXOLE-5-CARBOXALDEHYDE; 7-HYDROXY-3-QUINOLINECARBOXALDEHYDE; 7-HYDROXYISOQUINOLINE-8-CARBALDEHYDE; 7-HYDROXYNAPHTHALENE-1-CARBOXALDEHYDE; 7-HYDROXYNAPHTHALENE-2-CARBOXALDEHYDE; 7-HYDROXYQUINOLINE-2-CARBOXALDEHYDE; 7-HYDROXYQUINOLINE-4-CARBOXALDEHYDE; 7-HYDROXYQUINOLINE-5-CARBOXALDEHYDE; 7-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 7-HYDROXYQUINOLINE-8-CARBALDEHYDE; 7-METHYL-1H-INDAZOLE-3-CARBALDEHYDE; 7-METHYL-1H-INDAZOLE-5-CARBALDEHYDE; 7-METHYL-2-NAPHTHALDEHYDE; 7-METHYLQUINOLINE-3-CARBALDEHYDE; 7-OXO-HEPTANOIC ACID ETHYL ESTER; 7-OXOHEPTYL ACETATE; 8-HYDROXYNAPHTHALENE-1-CARBOXALDEHYDE; 8-HYDROXYNAPHTHALENE-2-CARBOXALDEHYDE; 8-HYDROXYQUINOLINE-2-CARBOXALDEHYDE; 8-HYDROXYQUINOLINE-3-CARBOXALDEHYDE; 8-HYDROXY-QUINOLINE-5-CARBALDEHYDE; 8-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 8-METHYLQUINOLINE-5-CARBALDEHYDE; 8-OXOOCTANENITRILE; 8-QUINOLINECARBALDEHYDE; 9-DECENAL; A,A-DIMETHYL-2-PYRIDINEACETALDEHYDE; ACETALDEHYDE; ACETALDEHYDE, (3-METHYLPHENOXY)-; ACETALDEHYDE, 2-NITRO-; ACETALDEHYDE, IODO-; ACETALDEHYDE, PARA-METHYL PHENOXY; ACETIC ACID 2-FORMYL-PHENYL ESTER; ACETIC ACID 3-METHYL-6-OXO-HEX-2-ENYL ESTER; ACETYLOXYACETALDEHYDE; ADIPALDEHYDE; A-FORMYL-2-PYRIDINEACETONITRILE; A-FORMYL-3-PYRIDINEACETONITRILE; A-FORMYL-4-PYRIDINEACETONITRILE; ALDENAL C-11; ALDOL; ALPHA-CYCLOCIRAL; A-METHYL-3-PYRIDINEPROPANAL; A-METHYL-4-PYRIDINEACETALDEHYDE; BENZALDEHYDE; BENZALDEHYDE ON POLYSTYRENE; BENZALDEHYDE-180; BENZENE-1,2,4-TRICARBALDEHYDE; BENZENE-1,3,5-TRICARBALDEHYDE; BENZENEACETALDEHYDE, 2-FLUORO-4-METHOXY-; BENZENEACETALDEHYDE, A,A-DIFLUORO-; BENZENEACETALDEHYDE, A-FLUORO-; BENZENEBUTANAL, 2-METHYL-; BENZENEBUTANAL, 4-FLUORO-; BENZENEBUTANAL, 4-METHYL-; BENZO[B]FURAN-7-CARBALDEHYDE; BENZO[B]THIOPHENE-4-CARBALDEHYDE; BENZO[B]THIOPHENE-7-CARBALDEHYDE; BENZO[D]ISOXAZOLE-5-CARBALDEHYDE; BENZO[D]OXAZOLE-6-CARBALDEHYDE; BENZONITRILE, 4-(2-OXOETHYL)-; BENZONITRILE, 4-FORMYL-3-HYDROXY-; BENZOOXAZOLE-2-CARBALDEHYDE; BENZYLGLYOXYLATE; BENZYLOXYACETALDEHYDE; BETA-CYANOPROPIONALDEHYDE; BETAINE ALDEHYDE; BETAINE ALDEHYDE CHLORIDE; BICYCLO[2,2,1]HEPTANE-2-CARBOXALDEHYDE; BICYCLO[4.2.0]OCTA-1,3,5-TRIENE-7-CARBALDEHYDE; BROMOACETALDEHYDE; BUTANAL, 2,2-DIETHYL-; BUTANAL, 3-METHOXY-3-METHYL-; BUTYL GLYOXYLATE; BUTYLMALONDIALDEHYDE; BUTYRALDEHYDE; BUTYRALDEHYDE,-BTA-BROMO-ALPHA-OXO-; CAMPHOLENIC ALDEHYDE; CHLORAL; CHLOROACETALDEHYDE; CHROMAN-3-CARBALDEHYDE; CHROMAN-6-CARBALDEHYDE; CHROMAN-8-CARBALDEHYDE; CIS-3-HEXENYL OXY-ACETALDEHYDE; CIS-4-DECENAL; CIS-4-HEPTENAL; CIS-6-NONENAL; CIS-7-DECEN-1-AL; CIS-8-UNDECEN-1-AL; CITRONELLAL; COUMARIN-6-CARBOXALDEHYDE; CYCLOBUTANECARBOXALDEHYDE; CYCLOBUTYL(PHENYL)ACETALDEHYDE; CYCLOBUTYLACETALDEHYDE; CYCLOHEPTANECARBALDEHYDE; CYCLOHEXANECARBOXALDEHYDE; CYCLOHEXANONE-4-CARBOXALDEHYDE; CYCLOOCTANECARBALDEHYDE; CYCLOPENTANECARBALDEHYDE; CYCLOPENTYL ACETALDEHYDE; CYCLOPENTYLMALONDIALDEHYDE; CYCLOPROPANECARBOXALDEHYDE; CYCLOPROPANECARBOXALDEHYDE, 2-PHENYL-, (1R,2R)-; CYCLOPROPYLMALONDIALDEHYDE; DECANAL; DIAZOACETALDEHYDE; DICHLOROACETALDEHYDE; DICHLOROACETALDEHYDE HYDRATE; DIMETHYLMALONDIALDEHYDE; DI-N-BUTYLACETALDEHYDE; ETHOXYACETALDEHYDE; ETHYL 1-FORMYLCYCLOBUTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPENTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPROPANECARBOXYLATE; ETHYL 2-[(2-OXOETHYL)SULFANYL]ACETATE; ETHYL 2-CHLORO-3-OXOPROPANOATE; ETHYL 2-FORMYL-1-CYCLOPROPANECARBOXYLATE; ETHYL 2-FORMYLBUTANOATE; ETHYL 3-FORMYL-1H-PYRAZOLE-5-CARBOXYLATE; ETHYL 4-OXOBUTANOATE; ETHYL ALLYL FORMYLMETHYLCARBAMATE; ETHYL GLYOXALATE; ETHYL-2-FORMYL-3-OXOPROPIONATE; ETHYLMALONDIALDEHYDE; FLUOROACETALDEHYDE; FLUOROMALONALDEHYDE; FORMALDEHYDE/GLUTARALDEHYDE; FURO[2,3-C]PYRIDINE-5-CARBALDEHYDE; FURO[3,2-B]PYRIDINE-6-CARBALDEHYDE; GLUTARALDEHYDE; GLUTARALDEHYDEMONOACETAL; GLYCIDALDEHYDE; GLYCOLALDEHYDE; GLYOXAL; GLYOXAL DIETHYL ACETAL; GLYOXAL DIMETHYL ACETAL; HEPT-6-ENAL; HEPTALDEHYDE; HEX-4-YNAL; HEX-5-ENAL; HEXAHYDRO-4,7-METHANOINDAN-1-CARBOXALDEHYDE; HEXANAL; HEXYL GLYOXYLATE; HYDROXYPIVALDEHYDE; HYDROXYPROPANEDIAL; IMIDAZO[1,2-A]PYRIMIDINE-7-CARBALDEHYDE; IMIDAZO[1,2-B]PYRIDAZINE-6-CARBOXALDEHYDE; IMIDAZO[1,5-A]PYRIDINE-3-CARBALDEHYDE; IMIDAZO[2,1,5-CD]INDOLIZINE-2-CARBOXALDEHYDE; IMIDAZOL-1-YL-ACETALDEHYDE; INDAN-5-CARBALDEHYDE; ISOBUTYRALDEHYDE; ISOPHTHALALDEHYDE; ISOPROPYL GLYOXYLATE; ISOPROPYLMALONDIALDEHYDE; ISOQUINOLINE-1-CARBALDEHYDE; ISOQUINOLINE-3-CARBALDEHYDE; ISOQUINOLINE-4-CARBALDEHYDE; ISOQUINOLINE-5-CARBALDEHYDE; ISOQUINOLINE-6-CARBALDEHYDE; ISOQUINOLINE-7-CARBALDEHYDE; ISOQUINOLINE-8-CARBALDEHYDE; ISOVALERALDEHYDE; ISOXAZOLE-3-CARBALDEHYDE; ISOXAZOLO[4,5-C]PYRIDINE-4-CARBALDEHYDE; MALONDIALDEHYDE; METHOXYACETALDEHYDE; METHYL 2-[(2-OXOETHYL)SULFANYL]ACETATE; METHYL 2-[(3-OXOPROPYL)SULFANYL]ACETATE; METHYL 2-CHLORO-2-FORMYLACETATE; METHYL 2-FORMYLBENZOATE; METHYL 2-FORMYLNICOTINATE; METHYL 2-FORMYLPYRIDINE-4-CARBOXYLATE; METHYL 2-METHYL-3-OXOPROPIONATE; METHYL 3-[(2-OXOETHYL)SULFANYL]PROPANOATE; METHYL 3-FORMYL-2-PYRIDINECARBOXYLATE; METHYL 3-FORMYLBENZOATE; METHYL 3-OXOPROPANOATE; METHYL 4-FORMYLBENZOATE; METHYL 4-FORMYLPYRIDINE-2-CARBOXYLATE; METHYL 4-FORMYLPYRIMIDINE-2-CARBOXYLATE; METHYL 5-FORMYLNICOTINATE; METHYL 5-FORMYLPICOLINATE; METHYL 5-FORMYLPYRIMIDINE-2-CARBOXYLATE; METHYL 6-FORMYLNICOTINATE; METHYL 6-OXOHEXANOATE; METHYL 7-OXOHEPTANOATE; METHYL DIFORMYLACETATE; METHYL GLYOXYLATE; METHYLMALONDIALDEHYDE; MONO METHOXY PEG ALDEHYDE; MORPHOLIN-4-YL-ACETALDEHYDE; MORPHOLIN-4-YL-ACETALDEHYDE HCL; M-TOLUALDEHYDE; N,N-DIMETHYL-2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; N,N-DIMETHYL-2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-BOC-(METHYLAMINO)ACETALDEHYDE; NITROACETALDEHYDE POTASSIUM SALT; NITROMALONALDEHYDE; NITROMALONALDEHYDE SODIUM SALT; NITROMALONALDEHYDE SODIUM SALT HYDRATE; NON-8-ENAL; NONANAL; O-ANISALDEHYDE; OCT-7-ENAL; OCTANAL; OCTANAL, 8-CHLORO-; OCTANEDIAL; OCTYL OXY-ACETALDEHYDE; O-PHTHALALDEHYDE; OXAZOLE-2-CARBALDEHYDE; OXOPENTANAL(4-); P-ANISALDEHYDE; P-AZIDOBENZALDEHYDE; PENT-4-YNAL; PENTAFLUOROPROPIONALDEHYDE HYDRATE; PENTANAL, 5-BROMO-; PENTANOIC ACID, 5-OXO-, ETHYL ESTER; PHENOXY ACETALDEHYDE; PHENYLACETALDEHYDE; PHENYLETHYL OXYACETALDEHYDE; PHENYLGLYOXAL; PHENYLGLYOXAL MONOHYDRATE; PHENYLPROPARGYL ALDEHYDE; P-HYDROXY PHENYL BUTANONE; PINONALDEHYDE; PIPERONAL; PIPERONYL FORMALDEHYDE; P-METHYLPHENYLACETALDEHYDE; PROPANAL, 3-BROMO-; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (R)—; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (S)—; PROPIONALDEHYDE; PROPYLMALONDIALDEHYDE; PROPYNAL; P-TOLUALDEHYDE; PYRAZINE-2,6-DICARBALDEHYDE; PYRAZINE-2-CARBALDEHYDE; PYRAZOLO[1,5-A]PYRIDINE-2-CARBALDEHYDE; PYRIDAZINE-3,6-DICARBALDEHYDE; PYRIDAZINE-3-CARBALDEHYDE; PYRIDAZINE-4-CARBALDEHYDE; PYRIDINE-3,5-DICARBOXALDEHYDE; PYRIDINE-4-ALDEHYDE HYDRATE; PYRIDINIUM, 2-FORMYL-5-HYDROXY-1-PROPYL-, INNER SALT; PYRIDO[2,3-B]PYRAZINE-3-CARBALDEHYDE; PYRIDO[2,3-B]PYRAZINE-6-CARBALDEHYDE; PYRIDO[2,3-B]PYRAZINE-7-CARBOXALDEHYDE; PYRIDO[2,3-E]PYRAZINE-8-CARBALDEHYDE; PYRIDOXAL; PYRIMIDINE-2,4,6-TRICARBALDEHYDE; PYRIMIDINE-2,4-DICARBALDEHYDE; PYRIMIDINE-4,6-DICARBALDEHYDE; PYRIMIDINE-4-CARBOXALDEHYDE; PYRIMIDINE-5-CARBOXALDEHYDE; PYRROLO[1,2-C]PYRIMIDINE-1-CARBOXALDEHYDE; PYRUVIC ALDEHYDE; QUINAZOLINE-2-CARBALDEHYDE; QUINAZOLINE-4-CARBALDEHYDE; QUINAZOLINE-6-CARBALDEHYDE; QUINOLINE-5-CARBALDEHYDE; QUINOLINE-7-CARBALDEHYDE; QUINOXALINE-5-CARBALDEHYDE; QUINOXALINE-6-CARBALDEHYDE; QUINUCLIDINE-2-CARBALDEHYDE; QUINUCLIDINE-3-CARBALDEHYDE; QUINUCLIDINE-4-CARBALDEHYDE; S-2-METHYLBUTANAL; SALICYLALDEHYDE; SALICYLALDEHYDE, SODIUM SALT; SODIUM GLYOXYLATE; SODIUM GLYOXYLATE MONOHYDRATE; SPIROCYCLOHEXYLBUTANE-1,3-DIONE; SUCCINALDEHYDE; TEREPHTHALALDEHYDE; TERT-BUTYL 4-OXOBUTANOATE; TERT-BUTYL 5-OXOPENTANOATE; TERT-BUTYLGLYOXAL; TERT-BUTYLMALONDIALDEHYDE; TETRAHYDRO-2,5-DIMETHOXY-5-METHYLFURAN-3-CARBALDEHYDE; TETRAHYDRO-2-FURANCARBOXALDEHYDE; TETRAHYDRO-2H-PYRAN-2-CARBALDEHYDE; TETRAHYDROFURAN-3-CARBOXALDEHYDE; TETRAHYDRO-PYRAN-3-CARBALDEHYDE; TETRAHYDROPYRAN-4-YLACETALDEHYDE; TETRAHYDRO-THIOPYRAN-3-CARBALDEHYDE; TETRAHYDROTHIOPYRAN-4-CARBALDEHYDE; TRANS-1,4-CYCLOHEXANE DICARBOXALDEHYDE; TRANS-2,2-DIMETHYL-4-HEPTENAL; TRANS-4-DECEN-1-AL; TRANS-4-ETHYL-CYCLOHEXANECARBALDEHYDE; TRANS-4-HEPTENAL; TRIFLUOROACETALDEHYDE; TRIFLUOROACETALDEHYDE HYDRATE; TRIFLUOROPYRUVIC ALDEHYDE; TRIFORMYLMETHANE; TRIMETHYLACETALDEHYDE; TRIPLAL; TRIVERTAL; UNDECANAL; VALERALDEHYDE; VANILLIN; Halogens: (2-BROMO-5-FORMYL-IMIDAZOL-1-YL)-ACETIC ACID METHYL ESTER; (2-CHLORO-3-FORMYL-INDOL-1-YL)-ACETIC ACID METHYL ESTER; (2-CHLORO-5-FORMYL-IMIDAZOL-1-YL)-ACETIC ACID METHYL ESTER; (2E)-2-BROMO-3-(DIMETHYLAMINO)-2-PROPENAL; (2E)-3-(4-BROMOPHENYL)-3-CHLOROACRYLALDEHYDE; (2E)-3-CHLORO-3-(2,4-DIMETHYLPHENYL)-2-METHYLACRYLALDEHYDE; (2Z)-2-CHLORO-2-BUTENAL; (2Z)-3-(4-BROMOPHENYL)-3-CHLOROACRYLALDEHYDE; (4-BROMO-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-CHLORO-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-ACETALDEHYDE; (4-CHLORO-5-FORMYL-2-OXO-THIAZOL-3-YL)-ACETIC ACID ETHYL ESTER; (4-IODO-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-IODO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETALDEHYDE; (8-BROMO-3-METHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL)ACETALDEHYDE; (E)-3-CHLORO-2-METHYL-3-(2-THENYL) ACROLEIN; (Z)-2-(2-(4-BROMOPHENYL)HYDRAZONO)-2-CHLOROACETALDEHYDE; (Z)-2-BROMO-4-OXO-BUT-2-ENOIC ACID ETHYL ESTER; (Z)-3-CHLORO-2-METHYL-3-(2-THENYL) ACROLEIN; (Z)-3-CHLORO-2-METHYL-3-PHENYL-ACRYLALDEHYDE; (Z)-3-CHLORO-3-(3-CHLOROPHENYL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-(4-FLUOROPHENYL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-(4-METHOXYPHENYL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-(4-NITROPHENYL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-(THIOPHEN-3-YL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-PHENYLACRYLALDEHYDE; (Z)-3-CHLORO-3-P-TOLYLACRYLALDEHYDE; (Z)-3-HYDROXY-2-IODOACROLEIN; (Z)-N-(4-CHLORO-3-ETHYL-5-FORMYLTHIAZOL-2(3H)-YLIDENE)BENZENESULFONAMIDE; 1-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)CYCLOHEXANE-1-CARBALDEHYDE; 1-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)CYCLOPENTANE-1-CARBALDEHYDE; 1-((6-CHLOROIMIDAZO[1,2-A]PYRIDIN-2-YL)METHYL)PIPERIDINE-2-CARBALDEHYDE; 1-((6-CHLOROIMIDAZO[1,2-A]PYRIDIN-2-YL)METHYL)PIPERIDINE-3-CARBALDEHYDE; 1-((6-CHLOROIMIDAZO[1,2-A]PYRIDIN-2-YL)METHYL)PIPERIDINE-4-CARBALDEHYDE; 1-((BENZYLOXY)METHYL)-4-IODO-1H-IMIDAZOLE-5-CARBALDEHYDE; 1-(2-BROMO-ALLYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-BROMOPHENYL)-3-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPROP-2-EN-1-YL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPROP-2-EN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-BROMOPROP-2-EN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-BROMOPROP-2-EN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(2-CHLORO-4-FLUOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLORO-4-FLUOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLORO-5-FLUOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLORO-5-FLUOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLORO-ALLYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-CHLOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLOROPROP-2-EN-1-YL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-CHLOROPROP-2-EN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-CHLOROPROP-2-EN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-CHLOROPROP-2-EN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(3-BROMOPHENYL)-3-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-CHLORO-4-FLUOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(3-CHLORO-4-FLUOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(3-CHLOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(3-CHLOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(4-BROMOPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-2-(DIMETHYLAMINO)-1H-IMIDAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-CHLOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(4-CHLOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(BUTAN-2-YL)-3-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-CYCLOPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(PHENYLSULFONYL)-2-IODO-4-AZAINDOLE-6-CARBOXALDEHYDE; 1-(PHENYLSULFONYL)-2-IODO-7-AZAINDOLE-5-CARBALDEHYDE; 1-(PHENYLSULPHONYL)-2-IODO-7-AZAINDOLE-6-CARBALDEHYDE; 1,3-BIS(2,4-DIFLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(2,5-DIFLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(2-CHLOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(2-FLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(2-FLUOROPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(3,4-DIFLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(3,5-DIFLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(3-CHLOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(3-FLUOROPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(4-FLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(4-FLUOROPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-DI-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-[(3-BROMOTHIOPHEN-2-YL)METHYL]-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-[(3-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[(3-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[(3-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[(3-CHLORO-1-BENZOTHIOPHEN-2-YL)METHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[(3-CHLORO-1-BENZOTHIOPHEN-2-YL)METHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[(3-CHLORO-1-BENZOTHIOPHEN-2-YL)METHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[(4-BROMOTHIOPHEN-2-YL)METHYL]-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-[(4-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[(4-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[(4-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[(5-CHLORO-1,3-DIMETHYL-1H-PYRAZOL-4-YL)METHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[(5-CHLORO-1,3-DIMETHYL-1H-PYRAZOL-4-YL)METHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[(5-CHLORO-1,3-DIMETHYL-1H-PYRAZOL-4-YL)METHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHYL]-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-[4-(3-CHLORO-2-THIENYL)-6-METHYL-2-PYRIMIDINYL]-1H-PYRROLE-2-CARBALDEHYDE; 11-CHLORO-13-OXO-8-OXA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 11-CHLORO-13-OXO-8-THIA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 1-ACETYL-3-CHLORO-1H-INDOLE-2-CARBOXALDEHYDE; 1-ALLYL-2-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 1-BENZYL-2-BROMO-1H-IMIDAZOLE-5-CARBALDEHYDE; 1-BENZYL-2-CHLORO-1H-IMIDAZOLE-5-CARBALDEHYDE; 1-BENZYL-3-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-4-IODO-1H-PYRROLE-2-CARBALDEHYDE; 1-BENZYL-5-CHLORO-2,3,6,7-TETRAHYDRO-1H-AZEPINE-4-CARBALDEHYDE HYDROCHLORIDE; 1-BENZYL-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 1-BOC-2-CHLORO-3-FORMYL-INDOLE; 1-BOC-4-CHLORO-5-FORMYL-3,6-DIHYDRO-2H-PYRIDINE; 1-BUTYL-3-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-4-CHLORO-3-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-CYCLOPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-6-CHLORO-5-FORMYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 1-CHLORO-2-FORMYL-3-METHYL-BENZO[4,5]IMIDAZO[1,2-A]PYRIDINE-4-CARBONITRILE; 1-CHLORO-3,4-DIHYDRO-2-NAPHTHALENECARBALDEHYDE; 1-CHLORO-5,7-DIMETHYL-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1-CHLORO-5-METHOXY-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1-CHLORO-6,7-DIMETHOXY-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1-CHLORO-6-METHOXY-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1-CHLORO-7-METHOXY-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1-CHLORO-FORMYL-3H-BENZO[F]CHROMENE; 1H-IMIDAZOLE-4-BROMO-2-CARBOXYALDEHYDE; 1H-INDOLE-1-CARBOXYLIC ACID, 3-BROMO-4-FORMYL-, 1,1-DIMETHYLETHYL ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 4-FORMYL-3-IODO-, 1,1-DIMETHYLETHYL ESTER; 1H-INDOLE-3-ACETALDEHYDE, 2-IODO-1-(PHENYLSULFONYL)-; 1H-INDOLE-3-ACETALDEHYDE, 2-IODO-1-METHYL-; 1H-INDOLE-3-CARBOXALDEHYDE, 2-CHLORO-5-METHOXY-1,6-DIMETHYL-; 1H-INDOLE-3-CARBOXALDEHYDE, 2-CHLORO-5-METHOXY-6-METHYL-; 1H-INDOLE-3-CARBOXALDEHYDE, 2-IODO-; 1H-INDOLE-3-CARBOXALDEHYDE, 2-IODO-1-(METHOXYMETHYL)-; 1H-INDOLE-3-CARBOXALDEHYDE, 2-IODO-1-METHOXY-; 1H-PYRAZOLE-1-PROPANAL, 4-BROMO-BETA-CYCLOPENTYL-, (BETAR)-; 1H-PYRAZOLO[3,4-C]PYRIDINE-7-CARBOXALDEHYDE, 3-CHLORO-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 2-CHLORO-; 1-SEC-BUTYL-4-CHLORO-3-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 1-SEC-BUTYL-6-CHLORO-5-FORMYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 1-TERT-BUTYL-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-CYCLOPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 2-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)-2-ETHYLBUTANAL; 2-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)-2-METHYLBUTANAL; 2-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)-2-METHYLPENTANAL; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-4-ETHYL-1,3-THIAZOLE-5-CARBALDEHYDE; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-4-METHYL-1,3-THIAZOLE-5-CARBALDEHYDE; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-5-FLUOROBENZALDEHYDE; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)ACETALDEHYDE; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)BENZALDEHYDE; 2-([5-CHLORO-1-(4-METHYLPHENYL)-6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL]OXY)BENZALDEHYDE; 2-(1-((BENZYLOXY)METHYL)-4-IODO-1H-IMIDAZOL-5-YL)ACETALDEHYDE; 2-(2H-1,3-BENZODIOXOL-5-YL)-6-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(3-BENZYL-5-BROMO-2,6-DIOXO-2,3-DIHYDROPYRIMIDIN-1(6H)-YL)ACETALDEHYDE; 2-(3-BROMO-1H-INDOL-1-YL)ACETALDEHYDE; 2-(3-BROMO-2-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(3-BROMO-FURAN-2-YL)-4-FORMYL-IMIDAZOLE; 2-(3-BROMO-PHENYL)-6-CHLORO-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(3-BROMO-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(3-CHLORO-1H-INDOL-1-YL)ACETALDEHYDE; 2-(4,5-DIBROMOFURAN-2-YL)-1,3-THIAZOLE-4-CARBALDEHYDE; 2-(4,5-DIBROMOFURAN-2-YL)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)-5-FLUOROBENZALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)-5-NITROBENZALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)-6-CHLOROBENZALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)QUINOLINE-3-CARBALDEHYDE; 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-5-FLUOROBENZALDEHYDE; 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-5-NITROBENZALDEHYDE; 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-6-CHLOROBENZALDEHYDE; 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(4-BROMO-3-NITRO-1H-PYRAZOL-1-YL)ACETALDEHYDE; 2-(4-BROMO-FURAN-2-YL)-4-FORMYL-IMIDAZOLE; 2-(4-BROMOPHENYL)-6-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(4-BROMOPHENYL)-7-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(4-BROMOTHIOPHEN-2-YL)-1,3-THIAZOLE-4-CARBALDEHYDE; 2-(4-BROMOTHIOPHEN-2-YL)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-(4-BROMO-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-CHLORO-1H-PYRAZOL-1-YL)-5-FLUOROBENZALDEHYDE; 2-(4-CHLORO-1H-PYRAZOL-1-YL)-5-NITROBENZALDEHYDE; 2-(4-CHLORO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 2-(4-CHLORO-1H-PYRAZOL-1-YL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(4-CHLORO-1H-PYRAZOL-1-YL)QUINOLINE-3-CARBALDEHYDE; 2-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-5-FLUOROBENZALDEHYDE; 2-(5-BROMO-1H-PYRAZOL-1-YL)ACETALDEHYDE; 2-(5-BROMO-2,6-DIOXO-3-PHENETHYL-2,3-DIHYDROPYRIMIDIN-1(6H)-YL)ACETALDEHYDE; 2-(5-BROMO-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)ACETALDEHYDE; 2-(5-BROMO-3-ETHYL-2,6-DIOXO-2,3-DIHYDROPYRIMIDIN-1(6H)-YL)ACETALDEHYDE; 2-(5-BROMO-3-METHYL-2,6-DIOXO-2,3-DIHYDROPYRIMIDIN-1(6H)-YL)ACETALDEHYDE; 2-(5-BROMO-3-NITRO-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)ACETALDEHYDE; 2-(5-CHLORO-1H-PYRAZOL-1-YL)ACETALDEHYDE; 2,2′-DIFORMYL-4,4′-DIBROMO-3,3′-BITHIOPHENE; 2,3,3-TRICHLOROPROPENAL; 2,3-DICHLORO-4,4,4-TRIFLUOROBUT-2-ENAL; 2,4-DIBROMOTHIAZOLE-5-CARBOXALDEHYDE; 2,4-DICHLORO-1H-INDOLE-3-CARBALDEHYDE; 2,4-DICHLORO-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2,4-DICHLORO-1-PHENYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2,4-DICHLORO-5-THIAZOLECARBOXALDEHYDE; 2,5,6-TRICHLORO-1H-INDOLE-3-CARBALDEHYDE; 2,5-DICHLORO-1H-INDOLE-3-CARBALDEHYDE; 2,5-DICHLORO-1-PHENYL-1H-PYRROLE-3,4-DICARBALDEHYDE; 2,6-DICHLORO-1,4-DIDIHYDROPYRIDINE-3,5-DICARBOXYALDEHYDE; 2,6-DICHLORO-1H-INDOLE-3-CARBALDEHYDE; 2,6-DICHLORO-3-FORMYLPYRIDAZINE; 2,6-DICHLORO-IMIDAZO[1,2-A]PYRIDINE-3-CARBOXALDEHYDE; 2,6-DICHLORO-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXALDEHYDE; 2,7-DICHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-3,5-DICHLOROBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-ETHOXYBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-METHOXYBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-4-METHOXYBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-4-PROPOXYBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-CHLOROBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-METHOXYBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-METHYLBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-NITROBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-6-CHLOROBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]NAPHTHALENE-1-CARBALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3-ETHOXYBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3-METHOXYBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-4-METHOXYBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-4-PROPOXYBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-METHOXYBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-METHYLBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-NITROBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]NAPHTHALENE-1-CARBALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-ETHOXYBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-5-CHLOROBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-5-METHOXYBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-5-NITROBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-6-CHLOROBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-ETHOXYBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-5-CHLOROBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-5-METHOXYBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-5-NITROBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-6-CHLOROBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-5-METHOXYBENZALDEHYDE; 2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 2-[(5-CHLORO-6-OXO-1-PHENYL-1,6-DIHYDROPYRIDAZIN-4-YL)OXY]BENZALDEHYDE; 2-AMINO-4-CHLORO-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-AMINO-4-CHLORO-1-PHENYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-AMINO-4-CHLORO-3-CYANO-5-FORMYLTHIOPHENE; 2-AMINO-4-CHLORO-6-OXO-1H-PYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-CHLOROTHIAZOLE-5-CARBALDEHYDE; 2-AMINO-6-CHLORO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2-AMINO-7-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-5-CARBOXALDEHYDE; 2-AZEPAN-1-YL-4-CHLORO-THIAZOLE-5-CARBALDEHYDE; 2-BIPHENYL-4-YL-6-BROMOIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-BIPHENYL-4-YL-6-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-BROMO-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-BROMO-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-BROMO-2-BUTENAL; 2-BROMO-3-DIMETHYLAMINOACROLEIN; 2-BROMO-3-HYDROXY-2-BUTENE-1,4-DIONE; 2-BROMO-3-HYDROXY-PROPENAL; 2-BROMO-3-ISOPROPOXYACRYLALDEHYDE; 2-BROMO-3-METHYLBUT-2-ENAL; 2-BROMO-4-(4-FLUORO-PHENYL)-5-NITRO-CYCLOHEX-1-ENECARBALDEHYDE; 2-BROMO-5,5-DIMETHYL-CYCLOHEX-1-ENECARBALDEHYDE; 2-BROMO-CYCLOHEX-1-ENECARBALDEHYDE; 2-BROMO-CYCLOPENT-1-ENECARBALDEHYDE; 2-BROMO-PROPENAL; 2-BUTENAL, 3-CHLORO-4-OXO-4-PHENYL-, (E)-; 2-BUTYL-4-CHLORO-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-BUTYL-5-CHLORO-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-BUTYL-5-IODO-3H-IMIDAZOLE-4-CARBALDEHYDE; 2-CHLORO-1-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-1-ETHYL-5-FORMYL-4-METHYL-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBONITRILE; 2-CHLORO-1H-BENZIMIDAZOLE-5-CARBOXALDEHYDE; 2-CHLORO-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-INDOLE-3,5-DICARBALDEHYDE; 2-CHLORO-1-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-5-PHENYL-1H-PYRROLE-3,4-DICARBALDEHYDE; 2-CHLORO-1-PHENYL-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-1-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-3-FORMYL-N,N-DIMETHYL-1H-INDOLE-5-SULFONAMIDE; 2-CHLORO-3-HYDROXY-2-PROPENAL; 2-CHLORO-3-PHENYLPROP-2-ENAL; 2-CHLORO-4-IODO-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-5-(MORPHOLIN-4-YLSULFONYL)-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-(PYRROLIDIN-1-YLSULFONYL)-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-ETHYLCYCLOHEX-1-ENE-1-CARBALDEHYDE; 2-CHLORO-5-HYDROXY-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-HYDROXY-6-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-METHOXY-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-METHOXY-1-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-METHYLCYCLOHEX-1-ENE-1-CARBALDEHYDE; 2-CHLORO-5-PHENYLCYCLOHEX-1-ENE-1-CARBALDEHYDE; 2-CHLORO-6-(4-CHLORO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 2-CHLORO-6-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 2-CHLORO-6-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 2-CHLORO-6-METHYL-4A,8A-DIHYDRO-3-QUINOLINECARBALDEHYDE; 2-CHLORO-6-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-8-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLOROACROLEIN; 2-CHLOROCYCLOHEX-1-ENECARBALDEHYDE; 2-CHLOROCYCLOPENT-1-ENECARBALDEHYDE; 2-CHLORO-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-ETHOXY-4-FORMYLPHENYL 4-CHLORO-1-ETHYLPYRAZOLE-3-CARBOXYLATE; 2-ETHYL-5-CHLORO-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-IODO-4-AZAINDOLE-6-CARBOXALDEHYDE; 3-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)OXOLANE-3-CARBALDEHYDE; 3-([(4-BROMOTHIOPHEN-2-YL)METHYL]METHYL)AMINO)-2,2-DIMETHYLPROPANAL; 3-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)PROPANAL; 3-([4-BROMO-3,5-BIS(DIFLUOROMETHYL)-1H-PYRAZOL-1-YL]METHYL)-4-METHOXYBENZALDEHYDE; 3-(2-BROMO-4-CHLOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(2-BROMO-4-FLUOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(2-BROMO-5-CHLOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(2-BROMO-5-FLUOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(2-BROMOPHENYL)-5-CHLORO-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(2-BROMOPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(3-BROMO-1H-INDOL-1-YL)PROPANAL; 3-(3-BROMOPHENYL)-5-CHLORO-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(3-BROMOPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(1-CYCLOPROPYLETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(BUTAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-BUTYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-CYCLOHEXYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-CYCLOPENTYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-TERT-BUTYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)PROPANAL; 3-(3-CHLORO-1H-INDOL-1-YL)PROPANAL; 3-(3-TERT-BUTYL-5-CHLORO-4-FORMYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(4-[(2-CHLOROPROP-2-EN-1-YL)OXY]PHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(4-[(2-CHLOROPROP-2-EN-1-YL)OXY]PHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(4-BROMO-2-CHLOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(4-BROMO-2-FLUOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(4-BROMO-3-NITRO-1H-PYRAZOL-1-YL)PROPANAL; 3-(4-BROMOPHENYL)-5-CHLORO-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(4-BROMOPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(4-BROMOTHIOPHEN-2-YL)PROPANAL; 3-(4-CHLORO-3-NITRO-PYRAZOL-1-YLMETHYL)-4-METHOXY-BENZALDEHYDE; 3-(4-CHLORO-PYRAZOL-1-YLMETHOXY)-BENZALDEHYDE; 3-(5-BROMO-1H-PYRAZOL-1-YL)PROPANAL; 3-(5-BROMO-2-CHLOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(5-BROMO-2-FLUOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(5-BROMO-3-NITRO-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)PROPANAL; 3-(5-CHLORO-1H-PYRAZOL-1-YL)PROPANAL; 3-(5-CHLORO-3-CYCLOPROPYL-4-FORMYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(5-CHLORO-3-ETHYL-4-FORMYL-1H-PYRAZOL-1-YL)BENZONITRILE; 3-(5-CHLORO-3-ETHYL-4-FORMYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(5-CHLORO-4-FORMYL-3-METHYL-1H-PYRAZOL-1-YL)BENZONITRILE; 3-(5-CHLORO-4-FORMYL-3-METHYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(5-CHLORO-4-FORMYL-3-PHENYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(5-CHLORO-4-FORMYL-3-PROPYL-1H-PYRAZOL-1-Yl)BENZONITRILE; 3-(5-CHLORO-4-FORMYL-3-PROPYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(DIMETHYLAMINO)-2-IODOACROLEIN; 3,4-DIBROMO-5-METHYL-2-PYRROLECARBOXALDEHYDE; 3,4-DIBROMOTHIOPHENE-2,5-DICARBOXALDEHYDE; 3,4-DIBROMOTHIOPHENE-2-CARBOXALDEHYDE; 3,4-DICHLORO-2,5-PYRROLEDICARBOXALDEHYDE; 3,5-DIBROMO-1-(2,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(2,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1H-PYRAZOLE-4-CARBALDEHYDE; 3,5-DIBROMO-2-THIOPHENECARBOXALDEHYDE; 3,5-DICHLORO-1-(2-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(4-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1H-PYRROLE-2,4-DICARBALDEHYDE; 3,5-DICHLORO-1-PHENYL-1H-PYRROLE-2,4-DICARBALDEHYDE; 3,5-DICHLORO-2-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3,5-DICHLORO-2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 3,5-DICHLORO-2-FURANCARBOXALDEHYDE; 3,5-DIIODO-4-METHYL-2-PYRROLECARBOXALDEHYDE; 3-[(2-BROMOPROP-2-EN-1-YL)OXY]-4-METHOXYBENZALDEHYDE; 3-[(2-BROMOPROP-2-EN-1-YL)OXY]-4-NITROBENZALDEHYDE; 3-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-[(2-CHLOROPROP-2-EN-1-YL)OXY]-4-METHOXYBENZALDEHYDE; 3-[(2-CHLOROPROP-2-EN-1-YL)OXY]-4-NITROBENZALDEHYDE; 3-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 3-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-4-NITROBENZALDEHYDE; 3-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-[(4-BROMO-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-BROMO-5-METHYL-3-NITRO-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 3-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-4-NITROBENZALDEHYDE; 3-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-[(4-CHLORO-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-CHLORO-3-NITRO-1H-PYRAZOL-1-YL)METHOXY]BENZALDEHYDE; 3-[(4-CHLORO-5-METHYL-3-NITRO-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-IODO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(5-BROMO-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 3-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 3-[2-(3-BROMOTHIOPHEN-2-YL)-2-OXOETHOXY]BENZALDEHYDE; 3-[5-CHLORO-3-(DIFLUOROMETHYL)-4-FORMYL-1H-PYRAZOL-1-YL]BENZONITRILE; 3-[5-CHLORO-4-FORMYL-3-(PROPAN-2-YL)-1H-PYRAZOL-1-YL]BENZONITRILE; 3-[5-CHLORO-4-FORMYL-3-(PROPAN-2-YL)-1H-PYRAZOL-1-YL]PROPANENITRILE; 3-[5-CHLORO-4-FORMYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]PROPANENITRILE; 3-ALLYL-4-CHLORO-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 3-BENZYL-4-CHLORO-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 3-BENZYLOXYMETHYL-2-BUTYL-5-IODO-3H-IMIDAZOLE-4-CARBALDEHYDE; 3-BROMO INDAZOLE-6-CARBOXALDEHYDE; 3-BROMO-1-(TERT-BUTYLDIMETHYLSILYL)-1H-INDOLE-4-CARBALDEHYDE; 3-BROMO-1H-INDAZOLE-5-CARBALDEHYDE; 3-BROMO-1H-INDOLE-2-CARBALDEHYDE; 3-BROMO-1H-INDOLE-4-CARBALDEHYDE; 3-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 3-BROMO-1-METHYL-1H-INDOLE-2-CARBALDEHYDE; 3-BROMO-2-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-BROMO-2-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-BROMO-2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-2-FORMYLFURAN; 3-BROMO-2-FORMYLPYRROLE; 3-BROMO-4-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-ETHOXYBENZALDEHYDE; 3-BROMO-4-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-METHOXYBENZALDEHYDE; 3-BROMO-4-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-BROMO-4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-ETHOXYBENZALDEHYDE; 3-BROMO-4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-METHOXYBENZALDEHYDE; 3-BROMO-4-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-BROMO-4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-4-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-4-CHLORO-2-METHYL-1-(4-METHYLPHENYL)-6,7-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 3-BROMO-4-FLUORO-6-AZAINDOLE-7-CARBOXALDEHYDE; 3-BROMO-4-FORMYLTHIOPHENE; 3-BROMO-5-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 3-BROMO-5-FLUORO-1-METHYL-1H-INDOLE-2-CARBALDEHYDE; 3-BROMO-5-FORMYLFURAN-2-YLBORONIC ACID; 3-BROMO-5-ISOXAZOLECARBOXALDEHYDE; 3-BROMO-5-METHYL-2-THIOPHENECARBOXALDEHYDE; 3-BROMO-6-AZAINDOLE-7-CARBOXALDEHYDE; 3-BROMO-BENZO[B]THIOPHENE-2-CARBOXALDEHYDE; 3-BROMO-BENZOFURAN-2-CARBALDEHYDE; 3-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 3-BROMOIMIDAZO[1,2-A]PYRIDINE-6-CARBALDEHYDE; 3-BROMO-IMIDAZO[1,2-A]PYRIDINE-8-CARBOXALDEHYDE; 3-BROMO-PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXALDEHYDE; 3-BROMOTHIOPHENE-2-CARBOXALDEHYDE; 3-CHLORO INDAZOLE-6-CARBOXALDEHYDE; 3-CHLORO-1-BENZOFURAN-2-CARBALDEHYDE; 3-CHLORO-1-BENZOTHIOPHENE-2-CARBALDEHYDE; 3-CHLORO-1-ETHYL-1H-PYRROLE-2-CARBALDEHYDE; 3-CHLORO-1H-INDAZOLE-5-CARBALDEHYDE; 3-CHLORO-1H-INDOLE-2-CARBALDEHYDE; 3-CHLORO-1H-INDOLE-4-CARBALDEHYDE; 3-CHLORO-1H-PYRAZOLO[4,3-C]PYRIDINE-7-CARBALDEHYDE; 3-CHLORO-1H-PYRROLE-2,4-DICARBALDEHYDE; 3-CHLORO-1H-PYRROLE-2-CARBALDEHYDE; 3-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 3-CHLORO-1-METHYL-1H-INDOLE-2-CARBALDEHYDE; 3-CHLORO-1-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 3-CHLORO-1-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 3-CHLORO-2-(4-CHLOROPHENYL)-4,4,4-TRIFLUORBUT-2-ENAL; 3-CHLORO-2-(4-CHLORO-PHENYL)-4,4,4-TRIFLUORO-BUT-2-ENAL; 3-CHLORO-2,3-BIS(4-METHOXYPHENYL)ACRYLALDEHYDE; 3-CHLORO-3-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)ACRYLALDEHYDE; 3-CHLORO-3-(2′-FLUORO[1,1-BIPHENYL]-4-YL)-2-METHYLACRYLALDEHYDE; 3-CHLORO-3-(4-CHLOROPHENYL)ACROLEIN; 3-CHLORO-3-(4-NITROPHENYL)ACRYLALDEHYDE; 3-CHLORO-3-(P-CHLOROPHENYL)ACROLEIN; 3-CHLORO-3-PHENYL-PROPENAL; 3-CHLORO-3-TRIFLUOROMETHYL-2-PHENYL-2-PROPENAL; 3-CHLORO-4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-METHOXYBENZALDEHYDE; 3-CHLORO-4-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-CHLORO-4-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 3-CHLORO-5-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 3-CHLORO-5-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-CHLORO-5-PHENYL-5H-PYRAZOLO[4,3-C]PYRIDINE-7-CARBALDEHYDE; 3-CHLORO-6-AZAINDOLE-7-CARBOXALDEHYDE; 3-CHLORO-6-METHOXY-1-BENZOFURAN-2-CARBALDEHYDE; 3-CHLORO-6-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-CHLOROIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 3-CHLOROTHIOPHENE-2-CARBALDEHYDE; 3-CHLOROTHIOPHENE-4-CARBOXALDEHYDE; 3-FORMYL-4-IODOTHIOPHENE; 3-FORMYLPHENYL 3-CHLORO-1-BENZOTHIOPHENE-2-CARBOXYLATE; 3-FORMYLPHENYL 4-CHLORO-1-ETHYLPYRAZOLE-3-CARBOXYLATE; 3-FORMYLPHENYL 4-IODO-1-METHYL-1H-PYRAZOLE-5-CARBOXYLATE; 3-IODO-1H-INDAZOLE-4-CARBALDEHYDE; 3-IODO-1H-INDAZOLE-5-CARBALDEHYDE; 3-IODO-1H-INDAZOLE-6-CARBALDEHYDE; 3-IODO-1H-INDAZOLE-7-CARBALDEHYDE; 3-IODO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-IODO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 3-IODO-4,5-DIMETHYLTHIOPHENE-2-CARBALDEHYDE; 3-IODO-6-AZAINDOLE-7-CARBOXALDEHYDE; 3-IODO-6-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-IODO-IMIDAZO[1,2-A]PYRIDINE-7-CARBALDEHYDE; 3-IODO-IMIDAZO[1,2-A]PYRIDINE-8-CARBALDEHYDE; 3-IODOTHIOPHENE-2-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(1,1-DIOXO-LAMBDA(6)-THIOLAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(1-CYCLOPROPYLETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(2-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(4-METHYLPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(6-METHYLPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(6-METHYLPYRIMIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-CYCLOHEPTYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-CYCLOHEXYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-CYCLOPENTYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 4-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)OXANE-4-CARBALDEHYDE; 4-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-2-METHYLBENZALDEHYDE; 4-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-3,5-DIFLUOROBENZALDEHYDE; 4-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-3-FLUOROBENZALDEHYDE; 4-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-3-METHYLBENZALDEHYDE; 4-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)BENZALDEHYDE; 4-(2-BUTYL-5-FORMYL-4-IODO-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID METHYL ESTER; 4-(3-BROMOTHIEN-2-YL)BENZALDEHYDE; 4-(4-BROMO-1H-PYRAZOL-1-YL)-3-FLUOROBENZALDEHYDE; 4-(4-BROMO-1H-PYRAZOL-1-YL)-3-NITROBENZALDEHYDE; 4-(4-BROMO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-2-METHYLBENZALDEHYDE; 4-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3,5-DIFLUOROBENZALDEHYDE; 4-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3-FLUOROBENZALDEHYDE; 4-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3-METHYLBENZALDEHYDE; 4-(4-CHLORO-1H-PYRAZOL-1-YL)-3-FLUOROBENZALDEHYDE; 4-(4-CHLORO-1H-PYRAZOL-1-YL)-3-NITROBENZALDEHYDE; 4-(4-CHLORO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-2-METHYLBENZALDEHYDE; 4-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3-FLUOROBENZALDEHYDE; 4-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3-METHYLBENZALDEHYDE; 4-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3-NITROBENZALDEHYDE; 4-(4-CHLORO-PYRAZOL-1-YLMETHYL)-5-METHYL-THIOPHENE-2-CARBALDEHYDE; 4-(4-CHLORO-PYRAZOL-1-YLMETHYL)-THIOPHENE-2-CARBALDEHYDE; 4-(5-CHLORO-3-ETHYL-4-FORMYL-1H-PYRAZOL-1-YL)BENZONITRILE; 4-(5-CHLORO-4-FORMYL-3-METHYL-1H-PYRAZOL-1-YL)BENZONITRILE; 4-(5-CHLORO-4-FORMYL-3-PROPYL-1H-PYRAZOL-1-YL)BENZONITRILE; 4,5-DIBROMO-1H-PYRROLE-2-CARBOXALDEHYDE; 4,5-DIBROMO-1-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4,5-DIBROMO-2-FURALDEHYDE; 4,5-DIBROMO-3-METHYLTHIOPHENE-2-CARBALDEHYDE; 4,5-DIBROMOTHIOPHENE-2-CARBOXALDEHYDE; 4,5-DICHLORO-3-THIOPHENECARBOXALDEHYDE; 4,6,8-TRICHLORO-3-FORMYLCOUMARIN; 4,6-DICHLORO-2H-1-BENZOTHIINE-3-CARBALDEHYDE; 4,6-DICHLORO-2H-BENZOPYRAN-3-CARBOXALDEHYDE; 4,6-DICHLORO-2-METHYL-2H-1-BENZOTHIINE-3-CARBALDEHYDE; 4,6-DICHLORO-3-FORMYL-7-METHYLCOUMARIN; 4,6-DICHLORO-3-FORMYLCOUMARIN; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3,5-DIMETHOXYBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3,5-DIMETHYLBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-CHLORO-5-METHOXYBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-CHLOROBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-ETHOXYBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-METHOXYBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-NITROBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-METHOXY-2-NITROBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3,5-DIMETHOXYBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3,5-DIMETHYLBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3-ETHOXYBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3-METHOXYBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3-NITROBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-METHOXY-2-NITROBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-CHLORO-5-METHOXYBENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-CHLOROBENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-ETHOXYBENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-NITROBENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-CHLORO-5-METHOXYBENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-CHLOROBENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-ETHOXYBENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-NITROBENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 4-[(4-CHLORO-1H-PYRAZOL-1-YL)METHOXY]BENZALDEHYDE; 4-[(4-CHLORO-3-NITRO-1H-PYRAZOL-1-YL)METHOXY]BENZALDEHYDE; 4-[(4-CHLORO-3-NITRO-1H-PYRAZOL-1-YL)METHYL]-3-METHOXYBENZALDEHYDE; 4-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-3,5-DIMETHYLBENZALDEHYDE; 4-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 4-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 4-[2-(3-BROMOTHIOPHEN-2-YL)-2-OXOETHOXY]-3-CHLOROBENZALDEHYDE; 4-[2-(3-BROMOTHIOPHEN-2-YL)-2-OXOETHOXY]BENZALDEHYDE; 4-[5-CHLORO-3-(DIFLUOROMETHYL)-4-FORMYL-1H-PYRAZOL-1-YL]BENZONITRILE; 4-[5-CHLORO-4-FORMYL-3-(PROPAN-2-YL)-1H-PYRAZOL-1-YL]BENZONITRILE; 4-AMINO-5-CHLORO-1H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-1-(4-CHLOROBENZYL)-1H-PYRAZOLE-5-CARBALDEHYDE; 4-BROMO-1-(4-CHLOROPHENYL)-1H-PYRAZOLE-5-CARBOXALDEHYDE; 4-BROMO-1-(4-METHYLBENZYL)-1H-PYRAZOLE-5-CARBOXALDEHYDE; 4-BROMO-1-ETHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-1H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-1H-PYRAZOLE-5-CARBALDEHYDE; 4-BROMO-1H-PYRROLE-2-CARBALDEHYDE; 4-BROMO-1-METHYL-1H-IMIDAZOLE-5-CARBOXALDEHYDE; 4-BROMO-1-METHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-1-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-BROMO-1-PROPYL-1H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-2-(4-BROMO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-BROMO-2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-BROMO-2-(4-CHLORO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-BROMO-2-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-BROMO-2,3-THIOPHENEDICARBOXALDEHYDE; 4-BROMO-2,5-BIS(ETHYLSULFANYL)-3-THIOPHENECARBALDEHYDE; 4-BROMO-2-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 4-BROMO-2-ETHYL-2H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-2-FORMYLTHIAZOLE; 4-BROMO-2-FORMYLTHIOPHEN-3-YLBORONIC ACID; 4-BROMO-2-FURALDEHYDE; 4-BROMO-3,5-DIMETHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-BROMO-3-FORMYL-PYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER; 4-BROMO-3-FORMYLTHIOPHEN-2-YLBORONIC ACID; 4-BROMO-3-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-BROMO-3-METHYLTHIOPHENE-2-CARBALDEHYDE; 4-BROMO-5-(4-METHYL-PYRIMIDIN-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE; 4-BROMO-5,6-DIHYDRO-2H-PYRAN-3-CARBALDEHYDE; 4-BROMO-5-[(4-CHLOROPHENYL)THIO]-2-FURALDEHYDE; 4-BROMO-5-[(4-METHYLPHENYL)THIO]-2-FURALDEHYDE; 4-BROMO-5-ETHYL-THIOPHENE-2-CARBALDEHYDE; 4-BROMO-5-FORMYL-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXYLIC ACID BENZYL ESTER; 4-BROMO-5-METHYLTHIOPHENE-2-CARBALDEHYDE; 4-BROMO-5-MORPHOLIN-4-YL-2-FURALDEHYDE; 4-BROMO-5-NITRO-2-THIOPHENECARBOXALDEHYDE; 4-BROMO-5-PROPYLTHIOPHENE-2-CARBALDEHYDE; 4-BROMO-PENT-4-ENAL; 4-BROMOTHIAZOLE-5-CARBALDEHYDE; 4-BROMOTHIOPHENE-2-CARBOXALDEHYDE; 4-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 4-CHLORO-1,3-DIMETHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-1-ETHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 4-CHLORO-1-ETHYL-1H-PYRAZOLE-5-CARBOXALDEHYDE; 4-CHLORO-1-ETHYL-3-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-1-ETHYLPYRAZOLE-3-CARBALDEHYDE; 4-CHLORO-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-1-METHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 4-CHLORO-1-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-1-PROPYL-1H-PYRAZOLE-3-CARBALDEHYDE; 4-CHLORO-2-(1-ACETYL-4-PIPERAZINYL)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(1-METHYL-4-PIPERAZINYL)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(1-METHYLIMIDAZOLYL-2-THIO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(1-PHENYL-ETHYLAMINO)-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(1-PIPERIDIN-4-OL)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(1-PIPERIDINO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(1-PYRROLIDINO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(2,4-DICHLOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(2,4-DIFLUOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(2,6-DIMETHYLPHENYL)-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(2-BENZOXAZOLYLTHIO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(2-CHLOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(2-FLUOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3,4-DICHLOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3,4-DIFLUOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL)-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(3,4-DIMETHOXYPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3,4-DIMETHYLPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3-CHLOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3-FLUOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3-NITROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(4-BROMOHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-CARBOMETHOXYL-1-PIPERIDINYL)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-CHLOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-FLUOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-FLUOROPHENYL)THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(4-METHOXYPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-METHYLPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-METHYLPYRIMIDINYL-2-THIO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-MORPHOLINO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-NITROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-OXO-PIPERIDINYL)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-PHENYL-PIPERAZIN-1-YL)-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(DIETHYLAMINO)-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(DIMETHYLAMINO)-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(PHENYLTHIO)-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(TERT-BUTYLAMINO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-[(2,6-DIETHYLPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(2-CHLOROPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(2-METHOXYPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(2-METHYLPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(3-CHLORO-4-METHYLPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(4-CHLOROPHENYL)SULFANYL]-1-PHENYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(4-METHOXYPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(4-METHYLPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(N-METHYL-N′-3-PHENYLPROPYL)AMINO]-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-[2-(TRIFLUOROMETHYL)PHENOXY]-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-[3-(TRIFLUOROMETHYL)PHENOXY]-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-[4-(TRIFLUOROMETHYL)PHENOXY]-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-ETHOXY-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-FORMYLPHENYL 4-BROMO-1-METHYL-1H-PYRAZOLE-3-CARBOXYLATE; 4-CHLORO-2-FURANCARBOXALDEHYDE; 4-CHLORO-2H-THIOCHROMENE-3-CARBALDEHYDE; 4-CHLORO-2-METHOXY-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-METHOXY-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-METHYL-1-(3-TRIFLUOROMETHYL-PHENYL)-6,7-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 4-CHLORO-2-METHYL-1-(4-METHYLPHENYL)-6,7-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 4-CHLORO-2-MORPHOLIN-1YL-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-OXO-2,3-DIHYDROTHIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-2-OXO-3-PHENYL-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-OXO-3-PROPYL-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-PHENOXY-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-PHENYLAMINO-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-PHENYLTHIAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-(2-CHLOROETHYL)-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-(3-METHYLPHENYL)-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-(4-METHYLPHENYL)-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-ETHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-FORMYL-2H-BENZO[H]CHROMENE; 4-CHLORO-3-FORMYL-2-THIOPHENEBORONIC ACID; 4-CHLORO-3-FORMYL-6-METHYLCOUMARIN; 4-CHLORO-3-FORMYLPYRAZOLE; 4-CHLORO-3-METHYL-1,6-DIPHENYL-6,7-DIHYDRO-1H-INDAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-CHLORO-3-METHYL-1-PROPYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-5-FORMYL-3,6,6-TRIMETHYL-6,7-DIHYDRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER; 4-CHLORO-5-FORMYL-3-METHYL-6,7-DIHYDRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER; 4-CHLORO-5-NITRO-2-FURANCARBOXALDEHYDE; 4-CHLORO-6-FLUORO-2H-1-BENZOTHIINE-3-CARBALDEHYDE; 4-CHLORO-6-FLUORO-2H-BENZOPYRAN-3-CARBOXALDEHYDE; 4-CHLORO-6-FLUORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-6-METHYL-2H-THIOCHROMENE-3-CARBALDEHYDE; 4-CHLORO-9-METHYL-2,9-DIHYDRO-1H-CARBAZOLE-3-CARBOXALDEHYDE; 4-CHLOROTHIAZOLE-5-CARBOXALDEHYDE; 4-CHLOROTHIOPHENE-2-CARBALDEHYDE; 4-FORMYL-2-METHOXYPHENYL 3-CHLORO-1-BENZOTHIOPHENE-2-CARBOXYLATE; 4-FORMYL-2-METHOXYPHENYL 4-CHLORO-1-ETHYLPYRAZOLE-3-CARBOXYLATE; 4-FORMYLPHENYL 4-BROMO-1-METHYL-1H-PYRAZOLE-3-CARBOXYLATE; 4-FORMYLPHENYL 4-CHLORO-1-ETHYLPYRAZOLE-3-CARBOXYLATE; 4-FORMYLPHENYL 4-IODO-1-METHYL-1H-PYRAZOLE-3-CARBOXYLATE; 4-IODO-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-IODO-1H-PYRROLE-2-CARBALDEHYDE; 4-IODO-1-METHYL-1H-IMIDAZOLE-5-CARBOXALDEHYDE; 4-IODO-2,5-DIMETHYLTHIOPHENE-3-CARBALDEHYDE; 4-IODO-2-THIOPHENECARBALDEHYDE; 5-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)FURAN-2-CARBALDEHYDE; 5-(1-CHLOROETHENYL)-1H-PYRROLE-2-CARBOXALDEHYDE; 5-(4-BROMO-1H-PYRAZOL-1-YL)-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-(4-BROMO-3,5-BIS-DIFLUOROMETHYL-PYRAZOL-1-YLMETHYL)-FURAN-2-CARBALDEHYDE; 5-(4-BROMO-3-NITRO-PYRAZOL-1-YLMETHYL)-FURAN-2-CARBALDEHYDE; 5-(4-CHLORO-1H-PYRAZOL-1-YL)-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-(4-CHLORO-PYRAZOL-1-YLMETHYL)-FURAN-2-CARBALDEHYDE; 5-[(4-CHLORO-3-NITRO-1H-PYRAZOL-1-YL)METHYL]-2-FURALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2,6-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUORO-4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUORO-5-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(3,5-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(3-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-ETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-FLUORO-3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-[4-(1-METHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DICHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(2,6-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DICHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(2,6-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLORO-4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLORO-5-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLORO-6-FLUOROBENZYL)-1,6-DIHYDRO-6-OXOPYRIDINE-3-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(2,3-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(2,6-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DICHLOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-BROMO-1-(3,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DICHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DICHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLORO-4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(2,3-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(2,6-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-FLUOROPHENYL)-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(2,3-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(2,6-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-METHOXYBENZYL)PYRROLE-2-CARBALDEHYDE; 5-BROMO-1-(4-METHYLBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-BROMO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1H-PYRAZOLE-3-CARBALDEHYDE; 5-BROMO-1H-PYRROLE-2-CARBALDEHYDE; 5-BROMO-1H-PYRROLE-3-CARBALDEHYDE; 5-BROMO-1-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-BROMO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-BROMO-1-METHYL-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-[4-(1-METHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-PROPYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-PHENYL-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-PHENYL-3-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-PHENYL-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-PHENYL-3-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-PHENYL-3-PROPYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-2-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 5-BROMO-2-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 5-BROMO-2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 5-BROMO-2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 5-BROMO-2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 5-BROMO-2-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 5-BROMO-2-METHYL-2H-INDAZOLE-3-CARBALDEHYDE; 5-BROMO-2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 5-BROMO-3-(2,3,4-TRIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIMETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMO-4-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMO-4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMO-5-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMO-5-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMOPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMOPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-ETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-ETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUORO-4-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUORO-4-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUORO-5-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUORO-5-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-METHYLPROPYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIMETHYLPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIMETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-BROMOPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-BROMOPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUORO-4-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUORO-4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-BROMO-2-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-BROMO-2-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-BROMOPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-BROMOPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLORO-3-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLORO-3-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-ETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-ETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-ETHYLPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-ETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUORO-3-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUORO-3-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(5-BROMO-2-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(5-BROMO-2-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-[4-(1-METHYLETHYL)PHENYL]-1H-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-CHLORO-1-BENZOFURAN-2-CARBALDEHYDE; 5-BROMO-3-ETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-ETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-ETHYL-4-METHYL-PYRROLE-2-CARBOXALDEHYDE; 5-BROMO-3-ETHYL-IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 5-BROMO-3-FORMYL-PYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER; 5-BROMO-3H-IMIDAZOLE-4-CARBALDEHYDE; 5-BROMO-3-METHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-PHENYL-1-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-PHENYL-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-PHENYL-1-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2,6-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUORO-4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUORO-5-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(3,5-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(3-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-ETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-FLUORO-3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-[4-(1-METHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIOXIDOTETRAHYDROTHIEN-3-YL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1,1-DIOXO-1LAMBDA(6)-THIOLAN-3-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1,1-DIOXO-1LAMBDA(6)-THIOLAN-3-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1,1-DIOXO-LAMBDA(6)-THIOLAN-3-YL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHOXY-BENZYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHYLPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHYLPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHYLPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIMETHYLPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,5-DIMETHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,5-DIMETHYLPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,5-DIMETHYLPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,5-DIMETHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLORO-4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLORO-5-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLORO-6-FLUOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; CHLORO-1-(2-FLUOROPHENYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; CHLORO-1-(2-FLUOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHOXYPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHOXYPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; CHLORO-1-(2-METHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; CHLORO-1-(2-METHYLPROPYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHYLPROPYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHYLPROPYL)-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHYLPROPYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; CHLORO-1-(3,4-DICHLOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIMETHYLPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,5-DIMETHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,5-DIMETHYLPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,5-DIMETHYLPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,5-DIMETHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHOXYBENZYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYL-1,1-DIOXO-1LAMBDA6-THIOLAN-3-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYL-1,1-DIOXO-1LAMBDA6-THIOLAN-3-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLBUTYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLBUTYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLBUTYL)-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLBUTYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4,6-DIMETHOXYPYRIMIDIN-2-YL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-FLUOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-1-(4-METHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLPYRIDIN-2-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLPYRIDIN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLPYRIDIN-2-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIDAZIN-3-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIDAZIN-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIDAZIN-3-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIMIDIN-4-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIMIDIN-4-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIMIDIN-4-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PENTAN-3-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PENTAN-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PENTAN-3-YL)-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PENTAN-3-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PROPAN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PROPAN-2-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PYRIDIN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PYRIDIN-4-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PYRIMIDIN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1,3-BIS(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1,3-DIETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1,3-DIMETHYL-2,4,7-TRIOXO-8-PHENYL-1,2,3,4,7,8-HEXAHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXALDEHYDE; 5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1,3-DIPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[(4-METHYLPHENYL)METHYL]-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[(4-METHYLPHENYL)METHYL]-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-CYCLOPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1H-PYRROLE-2,4-DICARBALDEHYDE; 5-CHLORO-1H-PYRROLE-2-CARBALDEHYDE; 5-CHLORO-1-ISOBUTYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-1H-PYRROLE-2,4-DICARBALDEHYDE; 5-CHLORO-1-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-([(4-METHYLPHENYL)SULFANYL]METHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-[(PHENYLSULFANYL)METHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-[4-(1-METHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-PHENYL-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-PHENYL-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-PHENYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-PHENYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-PHENYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-PROPYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-(DIMETHYLAMINO)-1-(4-FLUOROPHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-(DIMETHYLAMINO)-1-(4-METHYLPHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-(DIMETHYLAMINO)-1-PHENYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 5-CHLORO-2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 5-CHLORO-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-2-OXO-3-PHENYL-2,3-DIHYDRO-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-PHENYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-PHENYL-3H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 5-CHLORO-3-([(4-CHLOROPHENYL)SULFANYL]METHYL)-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(2,3-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIMETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-4-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-4-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-4-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-4-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-5-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-5-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-5-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-5-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-5-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-6-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-6-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-6-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-ETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-ETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUORO-4-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUORO-4-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUORO-5-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUORO-5-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-METHYLPROPYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIMETHYLPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIMETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUORO-4-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUORO-4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLORO-3-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLORO-3-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-ETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-ETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-ETHYLPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-ETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUORO-3-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUORO-3-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2,4-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2,5-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(3,5-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(4-METHYLPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(6-METHYLPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(6-METHYLPYRIMIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-[(4-METHYLPHENYL)METHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-[2-(DIMETHYLAMINO)ETHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(2-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(4-METHYLPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(6-METHYLPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(6-METHYLPYRIMIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-[(4-METHYLPHENYL)METHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(PROPAN-2-YL)-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(PROPAN-2-YL)-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(PROPAN-2-YL)-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(PROPAN-2-YL)-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-[2-(DIMETHYLAMINO)-1-FORMYLVINYL]-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-[4-(1-METHYLETHYL)PHENYL]-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-(1-CYCLOPROPYLETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-[2-(DIMETHYLAMINO)ETHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2,4,6-TRIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(3-METHYL-1,1-DIOXO-1LAMBDA6-THIOLAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(4-METHYLPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(6-METHYLPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(6-METHYLPYRIMIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(7H-PURIN-6-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-[(4-METHYLPHENYL)METHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(2,4,6-TRIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(3-METHYL-1,1-DIOXO-1LAMBDA6-THIOLAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(4-METHYLBENZYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(4-METHYLPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(6-METHYLPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(6-METHYLPYRIMIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(7H-PURIN-6-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-[5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PHENYL-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PHENYL-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PROPYL-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PROPYL-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PROPYL-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PROPYLIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 5-CHLORO-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 5-IODO-1H-PYRROLE-2-CARBALDEHYDE; 5-IODO-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-TERT-BUTYL-2-CHLORO-3-HYDROXYMETHYLENE-CYCLOHEX-1-ENE CARBOXALDEHYDE; 5-TERT-BUTYL-2-CHLOROCYCLOHEX-1-ENE-1-CARBALDEHYDE; 6-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE; 6-(4-BROMO-1H-PYRAZOL-1-YL)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE; 6-(4-CHLORO-1H-PYRAZOL-1-YL)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE; 6,8-DIBROMOIMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE; 6,8-DICHLORO-IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 6-[(2-BROMOPROP-2-EN-1-YL)OXY]-2H-1,3-BENZODIOXOLE-5-CARBALDEHYDE; 6-[(2-CHLOROPROP-2-EN-1-YL)OXY]-2H-1,3-BENZODIOXOLE-5-CARBALDEHYDE; 6-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-2H-1,3-BENZODIOXOLE-5-CARBALDEHYDE; 6-BROMO-2-(3,4-DIMETHOXYPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(3-METHOXY-PHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(3-NITROPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(4-BROMOPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(4-CHLOROPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(4-FLUOROPHENYL)-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(4-METHOXYPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(4-NITROPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 6-BROMO-2-METHYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-METHYLPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBALDEHYDE; 6-BROMO-2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-P-TOLYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBOXALDEHYDE; 6-BROMO-3-FORMYL-PYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER; 6-BROMO-4-CHLORO-3-FORMYLCOUMARIN; 6-BROMO-7-METHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-8-(DIMETHYLAMINO)IMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE; 6-BROMO-8-FLUOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMOIMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE; 6-BROMO-IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 6-BROMOIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMOIMIDAZO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 6-BROMO-IMIDAZO[1,2-B]PYRIDAZINE-2-CARBOXYALDEHYDE; 6-CHLORO-1,3-BIS(2-METHOXYETHYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-1,3-DIISOBUTYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-2-(2,4-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(2,5-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3,4-DIMETHOXY-PHENYL)-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3,4-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3-CHLORO-PHENYL)-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3-FLUORO-PHENYL)-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3-METHOXY-PHENYL)-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3-NITRO-PHENYL)-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(4-CHLOROPHENYL)IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(4-FLUORO-PHENYL)-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(4-METHOXY-PHENYL)-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(4-NITRO-PHENYL)-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2,3-DIMETHYL-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXALDEHYDE; 6-CHLORO-2-CYCLOBUTYL-IMIDAZO[1,2-B]PYRIDAZINE-3-CARBALDEHYDE; 6-CHLORO-2-CYCLOPROPYL-IMIDAZO[1,2-B]PYRIDAZINE-3-CARBALDEHYDE; 6-CHLORO-2-METHYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-METHYL-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXALDEHYDE; 6-CHLORO-2-M-TOLYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-PHENYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-P-TOLYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-3-METHYL-5-PHENYL-5H-ISOXAZOLO[5,4-B]PYRROLO[2,3-E]PYRIDINE-7-CARBALDEHYDE; 6-CHLORO-3-METHYL-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXALDEHYDE; 6-CHLORO-5-FORMYL-1-(2-METHOXY-ETHYL)-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-1-(3-METHOXY-PROPYL)-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-1,3-DIMETHYLURACIL; 6-CHLORO-5-FORMYL-1,4-DIMETHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-1-ISOBUTYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-1-ISOPROPYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-4-METHYL-1-(3-METHYL-BUTYL)-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-4-METHYL-2-OXO-1-(TETRAHYDRO-FURAN-2-YLMETHYL)-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-4-METHYL-2-OXO-1-PROPYL-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 6-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLOROIMIDAZO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 6-CHLORO-IMIDAZO[1,2-B]PYRIDAZINE-2-CARBOXALDEHYDE; 6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE-3-CARBALDEHYDE; 6-CHLOROIMIDAZO[2,1-B]THIAZOLE-5-CARBOXALDEHYDE; 7-BROMO-1-CHLORO-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 7-BROMO-2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-BROMO-2-CHLORO-8-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-BROMO-2-METHYL-2H-INDAZOLE-3-CARBALDEHYDE; 7-BROMO-2-METHYL-H-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 7-BROMO-2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 7-BROMO-3-FORMYL-PYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER; 7-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 7-BROMO-IMIDAZO[1,5-A]PYRIDINE-1-CARBALDEHYDE; 7-CHLORO-2-(4-CHLOROPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 7-CHLORO-2-METHYL-H-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 7-CHLORO-5-OXO-5H-THIAZOLO[3,2-A]PYRIMIDINE-6-CARBALDEHYDE; 8-BROMO-6-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 8-BROMO-6-METHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 8-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 8-CHLORO-6-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 8-CHLORO-IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; ALPHA-BROMO-5-NITRO-2-THIOPHENEACROLEIN; ALPHA-BROMOCINNAMALDEHYDE; ALPHA-BROMOCINNAMALDEHYDE; ALPHA-CHLOROCINNAMALDEHYDE; ETHYL (4-CHLORO-5-FORMYL-2-PHENYL-1H-IMIDAZOL-1-YL)ACETATE; ETHYL 2-(5-CHLORO-4-FORMYL-3-METHYL-1H-PYRAZOL-1-YL)-3,3-BIS(METHYLSULFANYL)ACRYLATE; ETHYL 2-(5-CHLORO-4-FORMYL-3-METHYL-1H-PYRAZOL-1-YL)ACETATE; ETHYL 2-ANILINO-4-CHLORO-5-FORMYL-3-THIOPHENECARBOXYLATE; ETHYL 4-CHLORO-5-FORMYL-2-(METHYLAMINO)-3-THIOPHENECARBOXYLATE; ETHYL 4-CHLORO-5-FORMYL-2-METHYL-3-THIOPHENECARBOXYLATE; ETHYL 4-CHLORO-5-FORMYL-3-(METHYLTHIO)-6,7-DIHYDRO-2-BENZOTHIOPHENE-1-CARBOXYLATE; ETHYL 4-CHLORO-5-FORMYL-3-METHYL-6,7-DIHYDRO-1-BENZOFURAN-2-CARBOXYLATE; ETHYL 4-CHLORO-7-FORMYL-5-METHYLPYRROLO[2,1-F][1,2,4]TRIAZINE-6-CARBOXYLATE; ETHYL 5-CHLORO-4-FORMYL-1-METHYL-1H-PYRAZOLE-3-CARBOXYLATE; ETHYL 5-CHLORO-4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLATE; ETHYL 6-CHLORO-4-(4-CHLOROPHENYL)-5-FORMYL-2-METHYL-1,4-DIHYDRO-3-PYRIDINECARBOXYLATE; METHYL 4-BROMO-5-FORMYL-2-THIOPHENECARBOXYLATE; METHYL 5-CHLORO-4-FORMYL-1-METHYL-1H-PYRAZOLE-3-CARBOXYLATE; METHYL 5-CHLORO-4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLATE; N-[(2E)-3-ALLYL-4-CHLORO-5-FORMYL-1,3-THIAZOL-2(3H)-YLIDENE]BENZENESULFONAMIDE; N-[(2E)-3-ALLYL-4-CHLORO-5-FORMYL-1,3-THIAZOL-2(3H)-YLIDENE]THIOPHENE-2-SULFONAMIDE; N-PHENYL-3-FORMYL-4-CHLORO-5-(2-CHLOROETHYL)-6-OXO-1,6-DIHYDROPYRIDINE; TERT-BUTYL 4-FORMYL-3-IODO-1H-INDAZOLE-1-CARBOXYLATE; TERT-BUTYL 5-FORMYL-3-IODO-1H-INDAZOLE-1-CARBOXYLATE; TERT-BUTYL 6-FORMYL-3-IODO-1H-INDAZOLE-1-CARBOXYLATE; TERT-BUTYL 7-FORMYL-3-IODO-1H-INDAZOLE-1-CARBOXYLATE; Primary amine: (2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETYL)UREA; (2-AMINO-1H-IMIDAZOL-4-YL)-ACETALDEHYDE HCL; (2-AMINO-6-METHOXY-PHENYL)-ACETALDEHYDE; (2-AMINOPHENYL)CYCLOHEXYL-METHANONE; (2R)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)ACETIC ACID; (2R)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)ACETIC ACID; (2R)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOIC ACID; (2R)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANOIC ACID; (2S)-1-(3-FORMYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)PYRROLIDINE-2-CARBOXAMIDE; (2S)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)ACETIC ACID; (2S)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)ACETIC ACID; (2S)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOIC ACID; (2S)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANOIC ACID; (3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)UREA; (3R)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANENITRILE; (3R)-3-AMINO-3-(4-FORMYL(2-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(5-FORMYL(2-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(5-FORMYL(3-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(6-FORMYL(2-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANENITRILE; (3S)-3-AMINO-3-(4-FORMYL(2-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(5-FORMYL(2-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(5-FORMYL(3-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(6-FORMYL(2-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANENITRILE; (4-AMINO-PHENYL)-ACETALDEHYDE; (4R)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOIC ACID; (4S)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOIC ACID; (5-FORMYLPYRIMIDIN-2-YL)METHANAMINIUM CHLORIDE; (5R)-5-AMINO-5-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PENTANOIC ACID; (5S)-5-AMINO-5-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PENTANOIC ACID; (E)-3-(5-AMINOFURAN-2-YL)ACRYLALDEHYDE; (S)-4-N-CBZ-AMINO-4-FORMYL BUTYLAMIDE; (Z)-B-AMINOACROLEIN; [2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETYL]UREA; [2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)ACETYL]UREA; [2-(2-CHLORO-4-FORMYLPHENOXY)ACETYL]UREA; [2-(2-ETHOXY-4-FORMYLPHENOXY)ACETYL]UREA; [2-(2-ETHOXY-6-FORMYLPHENOXY)ACETYL]UREA; [2-(2-FORMYL-4-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-4-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYL-4-NITROPHENOXY)ACETYL]UREA; [2-(2-FORMYL-5-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-5-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYL-6-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-6-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYLPHENOXY)ACETYL]UREA; [2-(2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(3-CHLORO-2-FORMYLPHENOXY)ACETYL]UREA; [2-(3-CHLORO-2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(3-FORMYLPHENOXY)ACETYL]UREA; [2-(3-FORMYLPHENOXY)PROPANOYL]UREA; [2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(3-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(4-CHLORO-2-FORMYLPHENOXY)ACETYL]UREA; [2-(4-CHLORO-2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETYL]UREA; [2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2-METHOXYPHENOXY)ACETYL]UREA; [2-(4-FORMYL-2-METHOXYPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2-NITROPHENOXY)ACETYL]UREA; [2-(4-FORMYLPHENOXY)ACETYL]UREA; [2-(4-FORMYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(4-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(5-FORMYL-2-METHOXYPHENOXY)ACETYL]UREA; [2-(5-FORMYL-2-METHOXYPHENOXY)PROPANOYL]UREA; [2-(5-FORMYL-2-NITROPHENOXY)ACETYL]UREA; [3-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [3-(3-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [3-(4-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; 1-(2,6-DIFLUORO-4-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(2,6-DIFLUORO-4-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(2,6-DIFLUORO-4-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(2,6-DIFLUORO-4-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(2-AMINOETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(2-FLUORO-4-FORMYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(2-FLUORO-4-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(2-FLUORO-4-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(2-FLUORO-4-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(2-FLUORO-4-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(2-FORMYL-4-NITROPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(2-FORMYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(2-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(2-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(2-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(2-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(2-OXOETHYL)PIPERIDINE-3-CARBOXAMIDE; 1-(2-OXOETHYL)PIPERIDINE-4-CARBOXAMIDE; 1-(2-OXOETHYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(3-AMINO-PROPYL)-1H-IMIDAZOLE-2-CARBALDEHYDE HCL; 1-(3-CHLORO-2-FORMYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(3-CHLORO-2-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(3-CHLORO-2-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(3-CHLORO-2-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(3-CHLORO-2-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL)PYRROLIDINE-2-CARBOXAMIDE; 1-(3-OXOPROPYL)PIPERIDINE-2-CARBOXAMIDE; 1-(3-OXOPROPYL)PIPERIDINE-3-CARBOXAMIDE; 1-(3-OXOPROPYL)PIPERIDINE-4-CARBOXAMIDE; 1-(3-OXOPROPYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FLUORO-2-FORMYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(4-FLUORO-2-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(4-FLUORO-2-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(4-FLUORO-2-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(4-FLUORO-2-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)PIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)PIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-2-NITROPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(5-BROMO-2-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(5-FORMYL-2-METHOXYBENZYL)PIPERIDINE-4-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)PIPERIDINE-2-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)PIPERIDINE-3-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)PIPERIDINE-4-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)PYRROLIDINE-2-CARBOXAMIDE; 1-(5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)PIPERIDINE-2-CARBOXAMIDE; 1-(5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)PIPERIDINE-3-CARBOXAMIDE; 1-(5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)PIPERIDINE-4-CARBOXAMIDE; 1-(5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)PYRROLIDINE-2-CARBOXAMIDE; 1-(5-FORMYLPYRIMIDIN-2-YL)ETHANAMINIUM CHLORIDE; 1-[(5-FORMYL-2-METHOXYPHENYL)METHYL]PYRROLIDINE-2-CARBOXAMIDE; 1-AMINO-9,10-DIOXO-9,10-DIHYDRO-2-ANTHRACENECARBALDEHYDE; 1-AMINONAPHTHALENE-2-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-3-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-4-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-5-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-6-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-7-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-8-CARBOXALDEHYDE; 1H-INDOLE-3-CARBOXALDEHYDE, 1-[2-(DIMETHYLAMINO)PROPANAMINE]-2-METHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-AMINO-6,7-DIHYDRO-2,3-DIMETHYL-6-OXO-; 2-((1R)-1,2-DIAMINOETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINO-2-METHYLPROPYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINOBUTYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINOETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINOPENTYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINOPROP-2-ENYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINOPROPYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1,2-DIAMINOETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINO-2-METHYLPROPYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINOBUTYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINOETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINOPENTYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINOPROP-2-ENYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINOPROPYL)PYRIDINE-4-CARBALDEHYDE; 2-((3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL)(METHYL)AMINO)ACETAMIDE; 2-((3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL)(PROPAN-2-YL)AMINO)ACETAMIDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(2-METHYLPROPYL)AMINO)ACETAMIDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(METHYL)AMINO)ACETAMIDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(PROPAN-2-YL)AMINO)ACETAMIDE; 2-([(5-FORMYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)ACETAMIDE; 2-([(5-FORMYL-2-METHOXYPHENYL)METHYL](PROPAN-2-YL)AMINO)ACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)BUTANAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)PROPANAMIDE; 2-(2-AMINO-ETHYL)-1H-IMIDAZOLE-4-CARBALDEHYDE 2HCL; 2-(2-AMINOETHYL)PYRIMIDINE-5-CARBALDEHYDE HYDROCHLORIDE; 2-(2-AMINO-PHENYL)-OXAZOLE-4-CARBALDEHYDE; 2-(2-AMINO-PHENYL)-THIAZOLE-4-CARBALDEHYDE; 2-(2-AMINOPYRIMIDIN-5-YL)BENZALDEHYDE; 2-(2-BROMO-4-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)ACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)BUTANAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)PROPANAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)ACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)BUTANAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)PROPANAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)BUTANAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)BUTANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)PROPANAMIDE; 2-(2-CHLORO-6-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)BUTANAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)PROPANAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)ACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)BUTANAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)PROPANAMIDE; 2-(2-FLUORO-4-FORMYLPHENOXY)BENZAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)BUTANAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; 2-(2-FORMYL-4-METHYLPHENOXY)ACETAMIDE; 2-(2-FORMYL-4-METHYLPHENOXY)BUTANAMIDE; 2-(2-FORMYL-4-METHYLPHENOXY)PROPANAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)ACETAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)BUTANAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)PROPANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)BUTANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)ACETAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)BUTANAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)PROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)BUTANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; 2-(2-FORMYLPHENOXY)ACETAMIDE; 2-(2-FORMYLPHENOXY)BENZAMIDE; 2-(2-FORMYLPHENOXY)BUTANAMIDE; 2-(2-FORMYLPHENOXY)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-4,6-DIMETHYLPYRIDINE-3-CARBOXAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)BUTANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)PYRIDINE-3-CARBOXAMIDE; 2-(2-OXOETHOXY)BENZAMIDE; 2-(3-AMINO-PHENYL)-OXAZOLE-4-CARBALDEHYDE; 2-(3-AMINO-PHENYL)-THIAZOLE-4-CARBALDEHYDE; 2-(3-AMINOPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(3-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)BENZAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)BUTANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; 2-(3-FORMYL-1H-INDOL-1-YL)ACETAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-2-METHYLPROPANAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)ACETAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PROPANAMIDE; 2-(3-FORMYL-2-METHYL-INDOL-1-YL)-ACETAMIDE; 2-(3-FORMYL-5-METHOXY-INDOL-1-YL)-ACETAMIDE; 2-(3-FORMYLPHENOXY)ACETAMIDE; 2-(3-FORMYLPHENOXY)BUTANAMIDE; 2-(3-FORMYLPHENOXY)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-4,6-DIMETHYLPYRIDINE-3-CARBOXAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)BUTANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)PYRIDINE-3-CARBOXAMIDE; 2-(3-OXOPROPOXY)BENZAMIDE; 2-(4-(AMINOMETHYL)PHENYL)-2-OXOACETALDEHYDE; 2-(4-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 2-(4-AMINO-PHENYL)-THIAZOLE-4-CARBALDEHYDE; 2-(4-AMINOPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-BROMO-2-FORMYLPHENOXY)ACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)BUTANAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)BUTANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; 2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)BUTANAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; 2-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)ACETAMIDE; 2-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)PROPANAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)BUTANAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; 2-(4-FORMYL-2-METHYLPHENOXY)BENZAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)ACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)BUTANAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)PROPANAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; 2-(4-FORMYL-3-METHOXY-PHENOXY)-ACETAMIDE; 2-(4-FORMYL-3-METHYLPHENOXY)BENZAMIDE; 2-(4-FORMYL-3-PHENYL-1H-PYRAZOL-1-YL)ACETAMIDE; 2-(4-FORMYL-6-METHYLPYRIMIDIN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)ACETAMIDE; 2-(4-FORMYLPHENOXY)BENZAMIDE; 2-(4-FORMYLPHENOXY)BUTANAMIDE; 2-(4-FORMYLPHENOXY)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-4,6-DIMETHYLPYRIDINE-3-CARBOXAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)BUTANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)PYRIDINE-3-CARBOXAMIDE; 2-(4-FORMYLPYRIMIDIN-2-YL)ACETAMIDE; 2-(5-AMINO-6-CHLOROPYRIMIDIN-4-YLOXY)-4-METHYLBENZALDEHYDE; 2-(5-AMINO-6-CHLOROPYRIMIDIN-4-YLOXY)-5-METHYLBENZALDEHYDE; 2-(5-AMINO-6-CHLOROPYRIMIDIN-4-YLOXY)BENZALDEHYDE; 2-(5-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 2-(5-BROMO-3-FORMYL-1H-INDOL-1-YL)ACETAMIDE; 2-(5-BROMO-4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; 2-(5-CHLORO-2-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; 2-(5-CHLORO-4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)BUTANAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)ACETAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)BUTANAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)PROPANAMIDE; 2-(5-FORMYLPYRIMIDIN-2-YL)ACETAMIDE; 2-(6-AMINO-9H-PURIN-9-YL)ACETALDEHYDE; 2-(6-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 2-(AMINOMETHYL)-3-CYCLOPROPOXYBENZALDEHYDE; 2-(AMINOMETHYL)-3-CYCLOPROPOXYISONICOTINALDEHYDE; 2-(AMINOMETHYL)-3-HYDROXYBENZALDEHYDE; 2-(AMINOMETHYL)-3-PYRIDINECARBOXALDEHYDE; 2-(AMINOMETHYL)-4-CYCLOPROPOXYBENZALDEHYDE; 2-(AMINOMETHYL)-4-CYCLOPROPOXYNICOTINALDEHYDE; 2-(AMINOMETHYL)-4-HYDROXYBENZALDEHYDE; 2-(AMINOMETHYL)-4-PYRIDINECARBOXALDEHYDE; 2-(AMINOMETHYL)-5-CYCLOPROPOXYBENZALDEHYDE; 2-(AMINOMETHYL)-5-CYCLOPROPOXYISONICOTINALDEHYDE; 2-(AMINOMETHYL)-5-CYCLOPROPOXYNICOTINALDEHYDE; 2-(AMINOMETHYL)-5-HYDROXYBENZALDEHYDE; 2-(AMINOMETHYL)-5-PYRIMIDINECARBOXALDEHYDE; 2-(AMINOMETHYL)-6-CYCLOPROPOXYBENZALDEHYDE; 2-(AMINOMETHYL)-6-HYDROXYBENZALDEHYDE; 2,3-DIAMINOBENZALDEHYDE; 2,3-DIFLUORO-4-AMINO-PHENYLACETALDEHYDE; 2,3-DIFLUORO-6-AMINO-PHENYLACETALDEHYDE; 2,4,6-TRIAMINO-5-PYRIMIDINECARBOXALDEHYDE; 2,4-DIAMINO-5-METHOXYBENZALDEHYDE; 2,4-DIAMINO-6-HYDROXY-5-PYRIMIDINECARBALDEHYDEHYDRATE; 2,4-DIAMINO-6-HYDROXY-PYRIMIDINE-5-CARBALDEHYDE; 2,4-DIAMINO-6-OXO-1,6-DIHYDRO-5-PYRIMIDINECARBALDEHYDE; 2,4-DIAMINO-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBALDEHYDE; 2,4-DIAMINOBENZALDEHYDE; 2,4-DIAMINOPTERIDINE-6-CARBALDEHYDE; 2,4-DIAMINOPYRIDO[2,3-D]PYRIMIDINE-6-CARBALDEHYDE; 2,4-DIAMINOPYRIMIDINE-5-CARBOXALDEHYDE; 2,4-DIAMINOQUINAZOLINE-6-CARBALDEHYDE; 2,4-HEXADIENOIC ACID, 2-AMINO-5-METHYL-6-OXO-, (E,Z)-; 2,6-DIAMINO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2,6-DIAMINO-4-PHENYLPYRIDINE-3,5-DICARBALDEHYDE; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]ACETAMIDE; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]BUTANAMIDE; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]PROPANAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(2-FORMYL-4-NITROPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(2-FORMYL-4-NITROPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(2-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(2-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(2-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 2-[(2-METHYLPROPYL)(2-OXOETHYL)AMINO]ACETAMIDE; 2-[(2-METHYLPROPYL)(3-OXOPROPYL)AMINO]ACETAMIDE; 2-[(2-OXOETHYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(CYCLOPENTYL)AMINO]ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(3-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 2-[(3-FORMYLQUINOLIN-2-YL)(METHYL)AMINO]ACETAMIDE; 2-[(3-OXOPROPYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)OXY]BENZAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYL-2-NITROPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-2-NITROPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 2-[(5-BROMO-2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(5-BROMO-2-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(5-FORMYL-2-FURYL)METHOXY]BENZAMIDE; 2-[(5-FORMYL-2-METHOXYBENZYL)OXY]BENZAMIDE; 2-[(5-FORMYLFURAN-2-YL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]ACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETAMIDE; 2-[(CARBAMOYLMETHYL)((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL))AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(2,6-DIFLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(2-FLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(2-OXOETHYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(3-CHLORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(3-OXOPROPYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(4-FLUORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(4-FORMYL-2-METHYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(4-FORMYL-3-METHYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[1-(2-FLUORO-4-FORMYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(2-FORMYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(2-OXOETHYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(3-CHLORO-2-FORMYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(3-OXOPROPYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(4-FLUORO-2-FORMYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(4-FORMYL-2-METHYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(4-FORMYL-3-METHYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(4-FORMYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(5-FORMYLFURAN-2-YL)PIPERIDIN-4-YL]ACETAMIDE; 2-[15N]AMINO-2-DEOXY-D-GLUCOSE HYDROCHLORIDE; 2-[3-(AMINOMETHYL)PYRROLIDIN-1-YL]ACETALDEHYDE; 2-[BUTYL((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL))AMINO]ACETAMIDE; 2-[BUTYL(2,6-DIFLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(2-FLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(2-OXOETHYL)AMINO]ACETAMIDE; 2-[BUTYL(3-CHLORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(3-OXOPROPYL)AMINO]ACETAMIDE; 2-[BUTYL(4-FLUORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]ACETAMIDE; 2-[BUTYL(4-FORMYL-2-METHYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(4-FORMYL-3-METHYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(5-FORMYLFURAN-2-YL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(2-FLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(2-OXOETHYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(3-OXOPROPYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(4-FLUORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(4-FORMYL-2-METHYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(4-FORMYL-3-METHYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(5-FORMYLFURAN-2-YL)AMINO]ACETAMIDE; 2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; 2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; 2-AMINO-1H-IMIDAZOLE-4-CARBALDEHYDE HCL; 2-AMINO-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-AMINO-1-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-AMINO-1-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-AMINO-1-PROPANAL; 2-AMINO-3-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-5-CARBOXALDEHYDE; 2-AMINO-3-(2,3-DIFLUOROPHENYL)PYRIDINE-5-CARBOXALDEHYDE; 2-AMINO-3-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-5-CARBOXALDEHYDE; 2-AMINO-3-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-5-CARBOXALDEHYDE; 2-AMINO-3-(PERFLUOROPHENYL)PYRIDINE-5-CARBOXALDEHYDE; 2-AMINO-3-(TRIFLUOROMETHOXY)BENZALDEHYDE; 2-AMINO-3-(TRIFLUOROMETHYL)ISONICOTINALDEHYDE; 2-AMINO-3,4,5,6-TETRAHYDROXYHEXANAL HYDROCHLORIDE; 2-AMINO-3,4,5-TRIFLUOROBENZALDEHYDE; 2-AMINO-3,4,6-TRIFLUORO-5-METHYLBENZALDEHYDE; 2-AMINO-3,5-DIBROMOBENZALDEHYDE; 2-AMINO-3,5-DICHLOROBENZALDEHYDE; 2-AMINO-3,5-DIFLUOROBENZALDEHYDE; 2-AMINO-3,6-DIMETHOXYBENZENECARBALDEHYDE; 2-AMINO-3-BROMOBENZALDEHYDE; 2-AMINO-3-CHLOROBENZALDEHYDE; 2-AMINO-3-CYCLOPROPOXYBENZALDEHYDE; 2-AMINO-3-CYCLOPROPOXYISONICOTINALDEHYDE; 2-AMINO-3-FLUOROBENZALDEHYDE; 2-AMINO-3-FORMYL-6,7-DIMETHYLCHROMONE; 2-AMINO-3-FORMYL-6-METHYLCHROMONE; 2-AMINO-3-FORMYLBENZOIC ACID; 2-AMINO-3-FORMYLCHROMONE; 2-AMINO-3-FORMYLPYRIDINE; 2-AMINO-3-HYDROXY-4-METHOXYBENZALDEHYDE; 2-AMINO-3-HYDROXYBENZALDEHYDE; 2-AMINO-3-IODOBENZALDEHYDE; 2-AMINO-3-METHOXYBENZALDEHYDE; 2-AMINO-3-METHYLBENZALDEHYDE; 2-AMINO-3-METHYLISONICOTINALDEHYDE; 2-AMINO-3-NITROBENZALDEHYDE; 2-AMINO-3-PYRIDINECARBOXALDEHYDE HCL; 2-AMINO-4-(TRIFLUOROMETHOXY)BENZALDEHYDE; 2-AMINO-4-(TRIFLUOROMETHYL)BENZALDEHYDE; 2-AMINO-4-(TRIFLUOROMETHYL)NICOTINALDEHYDE; 2-AMINO-4-(TRIFLUOROMETHYL)PYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4,5-DIMETHOXYBENZALDEHYDE; 2-AMINO-4,6-DICHLOROPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4,6-DIFLUOROBENZALDEHYDE; 2-AMINO-4,6-DIPIPERIDINO-5-PYRIMIDINECARBALDEHYDE; 2-AMINO-4-[BENZYL(METHYL)AMINO]-6-CHLORO-5-PYRIMIDINECARBALDEHYDE; 2-AMINO-4-BENZYLOXYBENZALDEHYDE; 2-AMINO-4-BRBOMOPYRIDINE-6-CARBOXALDEHYDE; 2-AMINO-4-BROMOBENZALDEHYDE; 2-AMINO-4-CHLORO-6-METHYL-PYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-CHLORO-6-MORPHOLIN-4-YLPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-CHLORO-6-PIPERIDINO-5-PYRIMIDINECARBALDEHYDE; 2-AMINO-4-CHLORO-6-PYRROLIDIN-1-YLPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-CHLOROBENZALDEHYDE; 2-AMINO-4-CHLORO-PYRIDINE-3-CARBALDEHYDE; 2-AMINO-4-CHLOROPYRIMIDINE-5-CARBOXALDEHYDE; 2-AMINO-4-CYCLOPROPOXYBENZALDEHYDE; 2-AMINO-4-CYCLOPROPOXYNICOTINALDEHYDE; 2-AMINO-4-ETHOXYBENZALDEHYDE; 2-AMINO-4-FLUOROBENZALDEHYDE; 2-AMINO-4-HYDROXY-3-METHOXY-BENZALDEHYDE; 2-AMINO-4-HYDROXYBENZALDEHYDE; 2-AMINO-4-HYDROXY-PTERIDINE-6-CARBALDEHYDE; 2-AMINO-4-IODOBENZALDEHYDE; 2-AMINO-4-METHOXY-3-PENTYLOXY-BENZALDEHYDE; 2-AMINO-4-METHOXY-6-MORPHOLIN-4-YLPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-METHOXY-6-PYRROLIDIN-1-YLPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-METHOXYBENZALDEHYDE; 2-AMINO-4-METHYL-5-THIAZOLECARBOXALDEHYDE; 2-AMINO-4-METHYLBENZALDEHYDE; 2-AMINO-4-METHYLNICOTINALDEHYDE; 2-AMINO-4-NITRO-5-METHOXYBENZALDEHYDE; 2-AMINO-4-NITROBENZALDEHYDE; 2-AMINO-4-OXOBUTANOIC ACID; 2-AMINO-5-(2-(TRIFLUOROMETHOXY)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(2-(TRIFLUOROMETHOXY)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(2-(TRIFLUOROMETHYL)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(2-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(2,3-DIFLUOROPHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(2,3-DIFLUOROPHENYL)NICOTINALDEHYDE; 2-AMINO-5-(2-FLUOROPHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(2-FLUOROPHENYL)NICOTINALDEHYDE; 2-AMINO-5-(2-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(2-FORMYLPHENYL)NICOTINIC ACID; 2-AMINO-5-(2-OXOPIPERIDIN-1-YL)-BENZALDEHYDE; 2-AMINO-5-(2-OXOPYRROLIDIN-1-YL)BENZALDEHYDE; 2-AMINO-5-(3-(TRIFLUOROMETHOXY)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(3-(TRIFLUOROMETHOXY)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(3-(TRIFLUOROMETHYL)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(3-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(3-FLUOROPHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(3-FLUOROPHENYL)NICOTINALDEHYDE; 2-AMINO-5-(3-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(3-FORMYLPHENYL)NICOTINIC ACID; 2-AMINO-5-(3-OXO-MORPHOLIN-4-YL)-BENZALDEHYDE; 2-AMINO-5-(4-(TRIFLUOROMETHOXY)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(4-(TRIFLUOROMETHOXY)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(4-(TRIFLUOROMETHYL)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(4-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(4-FLUOROPHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(4-FLUOROPHENYL)NICOTINALDEHYDE; 2-AMINO-5-(4-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(4-FORMYLPHENYL)NICOTINIC ACID; 2-AMINO-5-(PERFLUOROPHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(PERFLUOROPHENYL)NICOTINALDEHYDE; 2-AMINO-5-(PHENYLETHYNYL)NICOTINALDEHYDE; 2-AMINO-5-(PYRIDIN-3-YL)ISONICOTINALDEHYDE; 2-AMINO-5-(PYRIDIN-3-YL)NICOTINALDEHYDE; 2-AMINO-5-(PYRIDIN-4-YL)ISONICOTINALDEHYDE; 2-AMINO-5-(PYRIDIN-4-YL)NICOTINALDEHYDE; 2-AMINO-5-(TRIFLUOROMETHOXY)BENZALDEHYDE; 2-AMINO-5-(TRIFLUOROMETHYL)ISONICOTINALDEHYDE; 2-AMINO-5-(TRIFLUOROMETHYL)NICOTINALDEHYDE; 2-AMINO-5-BENZYLOXY-4-METHOXYBENZALDEHYDE; 2-AMINO-5-BENZYLOXYBENZALDEHYDE; 2-AMINO-5-BROMOBENZALDEHYDE; 2-AMINO-5-BROMOISONICOTINALDEHYDE; 2-AMINO-5-BROMONICOTINALDEHYDE; 2-AMINO-5-BROMOPYRIMIDINE-4-CARBALDEHYDE; 2-AMINO-5-CHLOROBENZALDEHYDE; 2-AMINO-5-CHLOROBENZALDEHYDE HYDROBROMIDE; 2-AMINO-5-CHLOROBENZALDEHYDE HYDROCHLORIDE; 2-AMINO-5-CHLOROISONICOTINALDEHYDE; 2-AMINO-5-CHLORONICOTINALDEHYDE; 2-AMINO-5-CYCLOPROPOXY-2,3-DIHYDROPYRIDINE-3-CARBALDEHYDE; 2-AMINO-5-CYCLOPROPOXYISONICOTINALDEHYDE; 2-AMINO-5-ETHOXY-4-METHOXYBENZALDEHYDE; 2-AMINO-5-ETHOXYBENZALDEHYDE; 2-AMINO-5-FLUOROBENZALDEHYDE; 2-AMINO-5-FLUOROISONICOTINALDEHYDE; 2-AMINO-5-FLUORO-PYRIDINE-3-CARBALDEHYDE; 2-AMINO-5-FORMYL-4-(TRIFLUOROMETHYL)THIAZOLE; 2-AMINO-5-FORMYLBENZONITRILE; 2-AMINO-5-FORMYLTHIAZOLE; 2-AMINO-5-FORMYLTHIAZOLE HCL; 2-AMINO-5-HYDROXY-4-METHOXYBENZALDEHYDE; 2-AMINO-5-HYDROXYBENZALDEHYDE; 2-AMINO-5-IODOBENZALDEHYDE; 2-AMINO-5-IODOPYRIDINE-3-CARBOXALDEHYDE; 2-AMINO-5-METHOXY-4-(PHENYLMETHOXY)BENZALDEHYDE; 2-AMINO-5-METHOXYBENZALDEHYDE; 2-AMINO-5-METHYLBENZALDEHYDE; 2-AMINO-5-METHYLISONICOTINALDEHYDE; 2-AMINO-5-METHYLNICOTINALDEHYDE; 2-AMINO-5-NITROBENZALDEHYDE; 2-AMINO-5-PHENYLISONICOTINALDEHYDE; 2-AMINO-5-PHENYLNICOTINALDEHYDE; 2-AMINO-5-PYRIMIDINECARBOXYALDEHYDE; 2-AMINO-6-(1-PIPERIDINYL)-3,5-PYRIDINEDICARBALDEHYDE; 2-AMINO-6-(DIMETHYLAMINO)-4-HYDROXYPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-6-(TRIFLUOROMETHOXY)BENZALDEHYDE; 2-AMINO-6-(TRIFLUOROMETHYL)ISONICOTINALDEHYDE; 2-AMINO-6-(TRIFLUOROMETHYL)NICOTINALDEHYDE; 2-AMINO-6,7-DICHLORO-3-FORMYLCHROMONE; 2-AMINO-6,8-DICHLORO-3-FORMYLCHROMONE; 2-AMINO-6,8-DIMETHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2-AMINO-6-BROMO-3-FORMYLCHROMONE; 2-AMINO-6-BROMO-PYRIDINE-3-CARBALDEHYDE; 2-AMINO-6-CHLORO-3-FORMYLCHROMONE; 2-AMINO-6-CHLORO-7-METHYL-3-FORMYL CHROMONE; 2-AMINO-6-CHLOROBENZALDEHYDE; 2-AMINO-6-CHLOROISONICOTINALDEHYDE; 2-AMINO-6-CHLORO-PYRIDINE-3-CARBALDEHYDE; 2-AMINO-6-CYCLOPROPOXYBENZALDEHYDE; 2-AMINO-6-ETHYL-3-FORMYLCHROMONE; 2-AMINO-6-FLUORO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2-AMINO-6-FLUOROBENZALDEHYDE; 2-AMINO-6-HYDROXYBENZALDEHYDE; 2-AMINO-6-IODOBENZALDEHYDE; 2-AMINO-6-ISOPROPYL-4-OXO-4H-BENZOPYRAN-3-CARBOXALDEHYDE; 2-AMINO-6-METHOXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2-AMINO-6-METHOXYBENZALDEHYDE; 2-AMINO-6-METHYLBENZALDEHYDE; 2-AMINO-6-METHYLISONICOTINALDEHYDE; 2-AMINO-6-METHYL-PYRIDINE-3-CARBALDEHYDE; 2-AMINO-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-AMINO-6-NITROBENZALDEHYDE; 2-AMINO-6-PYRIDINE CARBOXALDEHYDE; 2-AMINO-6-TERT-BUTYL-3-FORMYLCHROMONE; 2-AMINOBENZALDEHYDE; 2-AMINOBENZALDEHYDE HCL; 2-AMINOBENZO[D]THIAZOLE-6-CARBALDEHYDE; 2′-AMINO-BIPHENYL-4-CARBALDEHYDE; 2-AMINONAPHTHALENE-1-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-3-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-4-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-5-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-6-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-7-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-8-CARBOXALDEHYDE; 2-AMINOOXAZOLE-5-CARBALDEHYDE; 2-AMINOPYRIDINE-4-CARBALDEHYDE; 2-AMINOPYRIMIDINE-4-CARBOXALDEHYDE; 2-AMINO-THIAZOLE-4-CARBOXALDEHYDE; 2-AMINOTHIOPHENE-3-CARBOXALDEHYDE; 2-AMINOTHIOPHENE-4-CARBOXALDEHYDE; 2-AMINOTHIOPHENE-5-CARBOXALDEHYDE; 2-CHLORO-3-FORMYL-QUINOLINE-8-CARBOXYLIC ACID AMIDE; 2-CYCLOPROPOXY-3-FORMYLBENZAMIDE; 2-CYCLOPROPOXY-4-FORMYLBENZAMIDE; 2-CYCLOPROPOXY-5-FORMYLBENZAMIDE; 2-CYCLOPROPOXY-6-FORMYLBENZAMIDE; 2-FLUORO-3-AMINOBENZALDEHYDE; 2-FLUORO-6-(2-OXOETHOXY)BENZAMIDE; 2-FLUORO-6-(3-OXOPROPOXY)BENZAMIDE; 2-FORMYL-3-HYDROXYBENZAMIDE; 2-FORMYL-4-HYDROXYBENZAMIDE; 2-FORMYL-5-HYDROXYBENZAMIDE; 2-FORMYL-6-HYDROXYBENZAMIDE; 2-FORMYLBENZYLAMINE; 2-FORMYLBENZYLAMINE HYDROCHLORIDE; 2-NAPHTHALENECARBOXALDEHYDE, 5-AMINO-5,6,7,8-TETRAHYDRO-,(5R)-; 2-THIOPHENECARBOXALDEHYDE, 3-AMINO-5-METHYL-; 3-((1R)-1,2-DIAMINOETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-2-(4-PYRIDYL)ETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-2-HYDROXYETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-2-METHYLPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-3-HYDROXYPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-4-HYDROXYBUTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-5-HYDROXYPENTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINOBUTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINOETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINOPROP-2-ENYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINOPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)AMINOCYCLOPROPYLMETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R,2R)-1-AMINO-2-HYDROXYPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1,2-DIAMINOETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-2-(4-PYRIDYL)ETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-2-HYDROXYETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-2-METHYLPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-3-HYDROXYPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-4-HYDROXYBUTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-5-HYDROXYPENTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINOBUTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINOETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINOPROP-2-ENYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)AMINOCYCLOPROPYLMETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S,2R)-1-AMINO-2-HYDROXYPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-([3-(AMINOMETHYL)PYRROLIDIN-1-YL]METHYL)-4-METHOXYBENZALDEHYDE; 3-(2,4-DICHLORO-6-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2,4-DICHLORO-6-FORMYLPHENOXY)PROPANAMIDE; 3-(2-AMINOETHYLAMINO)-5-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(2-BROMO-4-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-BROMO-4-FORMYLPHENOXY)PROPANAMIDE; 3-(2-BROMO-6-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-BROMO-6-FORMYLPHENOXY)PROPANAMIDE; 3-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)PROPANAMIDE; 3-(2-ETHOXY-4-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-ETHOXY-4-FORMYLPHENOXY)PROPANAMIDE; 3-(2-ETHOXY-6-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-ETHOXY-6-FORMYLPHENOXY)PROPANAMIDE; 3-(2-FORMYL-4-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; 3-(2-FORMYL-4-METHYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-4-METHYLPHENOXY)PROPANAMIDE; 3-(2-FORMYL-4-NITROPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-4-NITROPHENOXY)PROPANAMIDE; 3-(2-FORMYL-5-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; 3-(2-FORMYL-5-PROPOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-5-PROPOXYPHENOXY)PROPANAMIDE; 3-(2-FORMYL-6-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; 3-(2-FORMYL-IMIDAZOL-1-YL)-PROPIONAMIDE; 3-(2-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYLPHENOXY)PROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)-2-METHYLPROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 3-(2-FORMYLTHIOPHEN-4-YL)-6-AMINOPICOLINIC ACID; 3-(2-OXOETHOXY)BENZAMIDE; 3-(3-AMINO-4-ETHYLPHENYL)PROPANAL; 3-(3-AMINOPIPERIDIN-1-YL)PROPANAL; 3-(3-AMINOPYRROLIDIN-1-YL)PROPANAL; 3-(3-CHLORO-2-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(3-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; 3-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PROPANAMIDE; 3-(3-FORMYL-2-HYDROXYPHENYL)BENZAMIDE; 3-(3-FORMYL-4-HYDROXYPHENYL)BENZAMIDE; 3-(3-FORMYL-INDOL-1-YL)-PROPIONAMIDE; 3-(3-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(3-FORMYLPHENOXY)PROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)-2-METHYLPROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 3-(3-OXOPROPOXY)BENZAMIDE; 3-(4-AMINO-IMIDAZOL-1-YL)-PROPIONALDEHYDE 2HCL; 3-(4-AMINOPHENYL)-2-HYDROXYBENZALDEHYDE; 3-(4-AMINOPHENYL)-4-HYDROXYBENZALDEHYDE; 3-(4-AMINOPHENYL)PYRIDINE-4-CARBALDEHYDE; 3-(4-AMINOPIPERIDIN-1-YL)PROPANAL; 3-(4-BROMO-2-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-BROMO-2-FORMYLPHENOXY)PROPANAMIDE; 3-(4-CHLORO-2-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHOXYPHENOXY)PROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; 3-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)PROPANAMIDE; 3-(4-FORMYL-2-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; 3-(4-FORMYL-2-NITROPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-FORMYL-2-NITROPHENOXY)PROPANAMIDE; 3-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE; 3-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)PROPANAMIDE; 3-(4-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-FORMYLPHENOXY)PROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)-2-METHYLPROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 3-(4-FORMYLPYRIDIN-3-YL)BENZAMIDE; 3-(5-AMINO-PYRIDIN-2-YLOXY)BENZALDEHYDE; 3-(5-FORMYL-2-HYDROXYPHENYL)BENZAMIDE; 3-(5-FORMYL-2-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; 3-(5-FORMYL-2-NITROPHENOXY)-2-METHYLPROPANAMIDE; 3-(5-FORMYL-2-NITROPHENOXY)PROPANAMIDE; 3-(5-FORMYL-FURAN-2-YL)-BENZOIC ACID CARBAMOYLMETHYL ESTER; 3-(5-FORMYLPYRIDIN-3-YL)BENZAMIDE; 3-(5-FORMYLTHIOPHEN-2-YL)-6-AMINOPICOLINIC ACID; 3-(AMINOMETHYL)-2-CYCLOPROPOXYBENZALDEHYDE; 3-(AMINOMETHYL)-2-HYDROXYBENZALDEHYDE; 3-(AMINOMETHYL)-4-CYCLOPROPOXYBENZALDEHYDE; 3-(AMINOMETHYL)-4-CYCLOPROPOXYPICOLINALDEHYDE; 3-(AMINOMETHYL)-4-HYDROXYBENZALDEHYDE; 3-(AMINOMETHYL)-5-CYCLOPROPOXYISONICOTINALDEHYDE; 3-(AMINOMETHYL)-5-CYCLOPROPOXYPICOLINALDEHYDE; 3-(AMINOMETHYL)-5-HYDROXYBENZALDEHYDE; 3-[(1-FORMYLNAPHTHALEN-2-YL)OXY]-2-METHYLPROPANAMIDE; 3-[(1-FORMYLNAPHTHALEN-2-YL)OXY]PROPANAMIDE; 3-[(2-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-[(3-AMINOPIPERIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(3-AMINOPYRROLIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(3-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-[(4-AMINOPIPERIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]PROPANAMIDE; 3-[3-(AMINOMETHYL)PYRROLIDIN-1-YL]PROPANAL; 3-ALLYL-4-AMINO-2-THIOXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 3-AMINO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-AMINO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-AMINO-2-(TRIFLUOROMETHOXY)BENZALDEHYDE; 3-AMINO-2-(TRIFLUOROMETHYL)ISONICOTINALDEHYDE; 3-AMINO-2,6-DIMETHYLBENZALDEHYDE; 3-AMINO-2-BROMOBENZALDEHYDE; 3-AMINO-2-BROMOPYRIDINE-4-CARBOXALDEHYDE; 3-AMINO-2-BUTENAL; 3-AMINO-2-CHLOROBENZALDEHYDE; 3-AMINO-2-CHLOROPYRIDINE-4-CARBOXALDEHYDE; 3-AMINO-2-CYCLOPROPOXYBENZALDEHYDE; 3-AMINO-2-ETHYLACROLEIN; 3-AMINO-2-HYDROXYBENZALDEHYDE; 3-AMINO-2-IODOBENZALDEHYDE; 3-AMINO-2-IODOPYRIDINE-4-CARBOXALDEHYDE; 3-AMINO-2-ISOPROPYLACROLEIN; 3-AMINO-2-METHOXYBENZALDEHYDE; 3-AMINO-2-METHYLACRYLALDEHYDE; 3-AMINO-2-METHYLBENZALDEHYDE; 3-AMINO-2-METHYLISONICOTINALDEHYDE; 3-AMINO-2-NITROBENZALDEHYDE; 3-AMINO-2-QUINOLINECARBOXALDEHYDE; 3-AMINO-2-QUINOXALINECARBOXALDEHYDE; 3-AMINO-3-DEOXY-D-MANNOSE, HYDROCHLORIDE; 3-AMINO-4-(4-OXOQUINAZOLIN-3(4H)-YL)BENZALDEHYDE; 3-AMINO-4-(TRIFLUOROMETHOXY)BENZALDEHYDE; 3-AMINO-4-BROMOBENZALDEHYDE; 3-AMINO-4-BROMO-BENZALDEHYDE HYDROCHLORIDE; 3-AMINO-4-CHLOROBENZALDEHYDE; 3′-AMINO-4′-CHLORO-BIPHENYL-4-CARBALDEHYDE; 3-AMINO-4-CYCLOPROPOXYBENZALDEHYDE; 3-AMINO-4-CYCLOPROPOXYPICOLINALDEHYDE; 3-AMINO-4-FLUOROBENZALDEHYDE; 3-AMINO-4-HYDROXYBENZALDEHYDE; 3-AMINO-4-IODOBENZALDEHYDE; 3-AMINO-4-METHOXYBENZALDEHYDE; 3-AMINO-4-METHYL-BENZALDEHYDE; 3-AMINO-4-NITROBENZALDEHYDE; 3-AMINO-4-PYRIDINECARBOXYALDEHYDE HYDROCHLORIDE; 3-AMINO-5-(2-FORMYLPHENYL)BENZOIC ACID; 3-AMINO-5-(3-FORMYLPHENYL)BENZOIC ACID; 3-AMINO-5-(4-FORMYLPHENYL)BENZOIC ACID; 3-AMINO-5-(TRIFLUOROMETHOXY)BENZALDEHYDE; 3-AMINO-5-(TRIFLUOROMETHYL)ISONICOTINALDEHYDE; 3-AMINO-5-(TRIFLUOROMETHYL)PICOLINALDEHYDE; 3-AMINO-5,6,7,8-TETRAHYDROTHIENO[2,3-B]QUINOLINE-2-CARBALDEHYDE; 3-AMINO-5-BROMOBENZALDEHYDE; 3-AMINO-5-BROMOBENZOTHIOPHENE-2-CARBOXALDEHYDE; 3-AMINO-5-BROMOPYRAZINE-2-CARBALDEHYDE; 3-AMINO-5-CHLOROBENZALDEHYDE; 3-AMINO-5-CHLOROBENZOTHIOPHENE-2-CARBOXALDEHYDE; 3-AMINO-5-CHLOROPYRAZINE-2-CARBALDEHYDE; 3-AMINO-5-CYCLOPROPOXYBENZALDEHYDE; 3-AMINO-5-CYCLOPROPOXYISONICOTINALDEHYDE; 3-AMINO-5-CYCLOPROPOXYPICOLINALDEHYDE; 3-AMINO-5-FLUOROBENZOTHIOPHENE-2-CARBOXALDEHYDE; 3-AMINO-5-HYDROXYBENZALDEHYDE; 3-AMINO-5-IODOBENZALDEHYDE; 3-AMINO-5-METHOXYBENZALDEHYDE; 3-AMINO-5-METHYL-2-FURANCARBOXALDEHYDE; 3-AMINO-5-METHYLBENZALDEHYDE; 3-AMINO-5-NITROBENZALDEHYDE; 3-AMINO-6,7,8,9-TETRAHYDROBENZALDEHYDE; 3-AMINO-6-BROMOPYRAZINE-2-CARBALDEHYDE; 3-AMINO-6-CHLOROPYRAZINE-2-CARBALDEHYDE; 3-AMINO-6-FORMYL-2-PYRAZINECARBONITRILE; 3-AMINO-6-TRIFLUOROMETHYL-PYRIDINE-2-CARBALDEHYDE; 3-AMINOBENZALDEHYDE; 3-AMINOBENZALDEHYDE HYDROCHLORIDE; 3′-AMINO-BIPHENYL-4-CARBALDEHYDE; 3-AMINOFURAN-2-CARBALDEHYDE; 3-AMINO-IMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE; 3-AMINOISONICOTINALDEHYDE; 3-AMINOPYRAZINE-2-CARBALDEHYDE; 3-AMINO-PYRIDINE-2-CARBALDEHYDE; 3-AMINO-PYRIDINE-4-CARBALDEHYDE DIHYDROCHLORIDE; 3-AMINOTHIOPHENE-2-CARBALDEHYDE; 3-AMINOTHIOPHENE-4-CARBOXALDEHYDE; 3-AMINOTHIOPHENE-5-CARBOXALDEHYDE; 3-BROMO-2-FORMYLANILINE; 3-CYCLOHEXYL-4-METHOXY-1-OXO-2-PROPANAMINIUM CHLORIDE; 3-CYCLOPROPOXY-2-FORMYLBENZAMIDE; 3-CYCLOPROPOXY-2-FORMYLISONICOTINAMIDE; 3-CYCLOPROPOXY-4-FORMYLBENZAMIDE; 3-CYCLOPROPOXY-4-FORMYLPICOLINAMIDE; 3-CYCLOPROPOXY-5-FORMYLBENZAMIDE; 3-CYCLOPROPOXY-5-FORMYLISONICOTINAMIDE; 3-CYCLOPROPOXY-5-FORMYLPICOLINAMIDE; 3-CYCLOPROPOXY-6-FORMYLPICOLINAMIDE; 3-FLUORO-4-(4-FORMYLPHENOXY)BENZAMIDE; 3-FLUORO-4-[(2-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-FLUORO-4-[(3-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-FLUORO-4-[(4-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-FORMYL BENZAMIDINE HYDROCHLORIDE; 3-FORMYL-2-HYDROXYBENZAMIDE; 3-FORMYL-4-HYDROXYBENZAMIDE; 3-FORMYL-5-HYDROXYBENZAMIDE; 3-FORMYLBENZAMIDE; 3-FORMYLBENZYLAMINE; 3-FORMYLBENZYLAMINE HYDROCHLORIDE; 3-METHOXY-4-(2-OXOETHOXY)BENZAMIDE; 3-METHOXY-4-(3-OXOPROPOXY)BENZAMIDE; 3-NITRO-4-(2-OXOETHOXY)BENZAMIDE; 3-NITRO-4-(3-OXOPROPOXY)BENZAMIDE; 4-((6-AMINOPYRIDIN-2-YL)OXY)BUTANAL; 4-([4-((1R)-1-AMINO-2-CYCLOPROPYLETHYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1R)-1-AMINO-2-METHYLPROPYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1R)-1-AMINOBUTYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1R)-1-AMINOETHYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1R)-1-AMINOPENTYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1R)-1-AMINOPROPYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1S)-1-AMINO-2-CYCLOPROPYLETHYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1S)-1-AMINO-2-METHYLPROPYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1S)-1-AMINOBUTYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1S)-1-AMINOETHYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1S)-1-AMINOPENTYL)PHENYL]METHYL)BENZALDEHYDE; 4-(2-AMINO-1H-IMIDAZOL-4-YL)-BUTYRALDEHYDE HCL; 4-(2-AMINOETHYL)BENZALDEHYDE, [ETHYL-2-14C]-; 4-(2-AMINO-IMIDAZOL-1-YL)-BUTYRALDEHYDE HCL; 4-(2-FLUORO-4-FORMYLPHENOXY)BENZAMIDE; 4-(2-FORMYLPHENOXY)BENZAMIDE; 4-(2-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; 4-(2-METHOXYETHYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE; 4-(2-OXOETHOXY)BENZAMIDE; 4-(3-AMINOPHENYL)-2-FORMYLPHENOL; 4-(3-CARBAMOYL-4-CHLOROPHENYL)-2-FORMYLPHENOL; 4-(3-CHLORO-2-FORMYLPHENOXY)BENZAMIDE; 4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)BENZAMIDE; 4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)BUTANAMIDE; 4-(3-FORMYL-2-HYDROXYPHENYL)BENZAMIDE; 4-(3-FORMYL-4-HYDROXYPHENYL)BENZAMIDE; 4-(3-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; 4-(3-OXOPROPOXY)BENZAMIDE; 4-(4-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 4-(4-FLUORO-2-FORMYLPHENOXY)BENZAMIDE; 4-(4-FORMYL-2-METHYLPHENOXY)BENZAMIDE; 4-(4-FORMYL-3-METHYLPHENOXY)BENZAMIDE; 4-(4-FORMYLPHENOXY)BENZAMIDE; 4-(4-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; 4-(4-FORMYL-PYRIDIN-2-YL)-BENZAMIDE; 4-(4-FORMYLPYRIDIN-3-YL)BENZAMIDE; 4-(5-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 4-(5-FORMYL-2-HYDROXYPHENYL)BENZAMIDE; 4-(5-FORMYLFURAN-2-YL)BENZAMIDE; 4-(5-FORMYL-PYRIDIN-3-YL)-BENZAMIDE; 4-(5-FORMYLTHIOPHEN-2-YL)BENZAMIDE; 4-(6-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 4-(AMINOMETHYL)-2-CYCLOPROPOXYBENZALDEHYDE; 4-(AMINOMETHYL)-2-HYDROXYBENZALDEHYDE; 4-(AMINOMETHYL)-3-CYCLOPROPOXYBENZALDEHYDE; 4-(AMINOMETHYL)-3-CYCLOPROPOXYPICOLINALDEHYDE; 4-(AMINOMETHYL)-3-HYDROXYBENZALDEHYDE; 4-(AMINOMETHYL)-5-CYCLOPROPOXYNICOTINALDEHYDE; 4-(AMINOMETHYL)-5-CYCLOPROPOXYPICOLINALDEHYDE; 4,5-DIAMINO-2,3-DIFLUOROBENZALDEHYDE; 4,5-DIAMINO-2-BROMOBENZALDEHYDE; 4,5-DIAMINO-2-CHLOROBENZALDEHYDE; 4,5-DIAMINO-2-FLUOROBENZALDEHYDE; 4,6-DIAMINONICOTINALDEHYDE; 4,6-DIAMINOPYRIMIDINE-5-CARBALDEHYDE; 4-[(2-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4-[(3-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)OXY]BENZAMIDE; 4-[(4-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4′-AMINO-[1,1′-BIPHENYL]-3-CARBALDEHYDE; 4-AMINO-1,2-DIHYDRO-2-OXO-5-PYRIMIDINECARBOXALDEHYDE; 4-AMINO-1-BENZYLIMIDAZOLE-5-CARBALDEHYDE; 4-AMINO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-AMINO-1H-PYRROLO[3,2-C]PYRIDINE-2-CARBALDEHYDE; 4-AMINO-1-METHYL-1H-PYRROLE-2-CARBOXALDEHYDE; 4-AMINO-2-(TRIFLUOROMETHOXY)BENZALDEHYDE; 4-AMINO-2-(TRIFLUOROMETHYL)BENZALDEHYDE; 4-AMINO-2,3-DIFLUORO-5-NITROBENZALDEHYDE; 4-AMINO-2,6-DICHLOROPYRIDINE-3-CARBALDEHYDE; 4-AMINO-2,6-DICHLOROPYRIMIDINE-5-CARBOXALDEHYDE; 4-AMINO-2,6-DIFLUOROBENZALDEHYDE; 4-AMINO-2,6-DIHYDROXYPYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-2,6-DIMETHYL-3-PYRIDINECARBOXALDEHYDE; 4-AMINO-2,6-DIMETHYL-5-PYRIMIDINECARBOXALDEHYDE; 4-AMINO-2-BENZYLSULFANYL-PYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-2-BROMO-5-NITROBENZALDEHYDE; 4-AMINO-2-BROMOBENZALDEHYDE; 4-AMINO-2-CHLORO-5-NITROBENZALDEHYDE; 4-AMINO-2-CHLORO-BENZALDEHYDE; 4-AMINO-2-CHLORONICOTINALDEHYDE; 4-AMINO-2-CYCLOPROPOXYBENZALDEHYDE; 4-AMINO-2-FLUORO-5-NITROBENZALDEHYDE; 4-AMINO-2-FLUOROBENZALDEHYDE; 4-AMINO-2′-FORMYL[1,1′-BIPHENYL]-3-CARBOXYLIC ACID; 4′-AMINO-2′-HYDROXY-[1,1′-BIPHENYL]-3-CARBALDEHYDE; 4-AMINO-2-HYDROXYBENZALDEHYDE; 4-AMINO-2-IODOBENZALDEHYDE; 4-AMINO-2-MERCAPTOPYRIMIDINE-5-CARBALDEHYDE; 4′-AMINO-2′-METHOXY-[1,1′-BIPHENYL]-3-CARBALDEHYDE; 4-AMINO-2-METHOXY-5-PYRIMIDINECARBOXALDEHYDE; 4-AMINO-2-METHOXYBENZALDEHYDE; 4-AMINO-2-METHOXYNICOTINALDEHYDE; 4-AMINO-2-METHYL-6-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-2-METHYLBENZALDEHYDE; 4-AMINO-2-METHYL-PYRIDINE-3-CARBALDEHYDE; 4-AMINO-2-METHYLPYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-2-METHYLTHIO-PYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-2-NITROBENZALDEHYDE; 4-AMINO-2-PYRROLIDINECARBALDEHYDE; 4-AMINO-3-(TRIFLUOROMETHOXY)BENZALDEHYDE; 4-AMINO-3,5-DIBROMOBENZALDEHYDE; 4-AMINO-3,5-DICHLOROBENZALDEHYDE; 4-AMINO-3,5-DIMETHYLBENZALDEHYDE; 4-AMINO-3-BROMOBENZALDEHYDE; 4-AMINO-3-CHLORO-5-(TRIFLUOROMETHYL)BENZALDEHYDE; 4-AMINO-3-CHLOROBENZALDEHYDE; 4-AMINO-3-CYCLOPROPOXYBENZALDEHYDE; 4-AMINO-3-CYCLOPROPOXYPICOLINALDEHYDE; 4′-AMINO-3′-FLUORO[1,1-BIPHENYL]-2-CARBALDEHYDE; 4′-AMINO-3′-FLUORO[1,1-BIPHENYL]-3-CARBALDEHYDE; 4′-AMINO-3′-FLUORO[1,1-BIPHENYL]-4-CARBALDEHYDE; 4-AMINO-3-FORMYL-BENZOIC ACID METHYL ESTER; 4-AMINO-3-FORMYLPYRIDINE; 4-AMINO-3-HYDROXYBENZALDEHYDE; 4-AMINO-3-IODOBENZALDEHYDE; 4-AMINO-3-METHOXYBENZALDEHYDE; 4-AMINO-3-METHYLBENZALDEHYDE; 4-AMINO-3-NITROBENZALDEHYDE; 4-AMINO-3-PYRIDINECARBOXYALDEHYDE HYDROCHLORIDE; 4-AMINO-4,6-DIDEOXY-D-MANNOSE; 4-AMINO-4′-FORMYL[1,1′-BIPHENYL]-3-CARBOXYLIC ACID; 4-AMINO-5-BROMO-2-CHLOROPYRIDINE-3-CARBALDEHYDE; 4-AMINO-5-CYCLOPROPOXYNICOTINALDEHYDE; 4-AMINO-5-CYCLOPROPOXYPICOLINALDEHYDE; 4-AMINO-5-FORMYL-2-METHOXYPHENYL ACETATE; 4-AMINO-5-IODOPYRIDINE-3-CARBOXALDEHYDE; 4-AMINO-6-(2-OXO-ETHYL)-2-TRIFLUOROMETHYL-QUINOLINE-3-CARBONITRILE; 4-AMINO-6-BROMO-PYRIDINE-2-CARBALDEHYDE; 4-AMINO-6-BROMO-PYRIDINE-3-CARBALDEHYDE; 4-AMINO-6-CHLORO-2-METHYLSULFANYL-PYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-6-CHLORO-5-PYRIMIDINECARBALDEHYDE; 4-AMINO-6-CHLOROPICOLINALDEHYDE; 4-AMINO-6-CHLORO-PYRIDINE-3-CARBALDEHYDE; 4-AMINO-6-FLUORO-3-INDAZOLECARBOXALDEHYDE; 4-AMINO-6-FORMYL-2-TRIFLUOROMETHYL-QUINOLINE-3-CARBONITRILE; 4-AMINOBENZALDEHYDE; 4′-AMINO-BIPHENYL-4-CARBALDEHYDE; 4-AMINOINDOLE-3-CARBOXALDEHYDE; 4-AMINO-N-(4-FORMYL-3-METHYL-PHENYL)-BUTYRAMIDE HYDROCHLORIC ACID; 4-AMINO-PYRIDINE-2-CARBALDEHYDE; 4-AMINO-PYRIDINE-3-CARBALDEHYDE DIHYDROCHLORIDE; 4-AMINO-PYRIDINE-3-CARBALDEHYDE TRIFLUOROACETATE; 4-AMINO-PYRIMIDINE-5-CARBALDEHYDE; 4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZINE-6-CARBALDEHYDE; 4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZINE-7-CARBALDEHYDE; 4-CHLORO-6-AMINO-3-(1H)INDAZOLE CARBOXALDEHYDE; 4-CYCLOPROPOXY-2-FORMYLBENZAMIDE; 4-CYCLOPROPOXY-2-FORMYLNICOTINAMIDE; 4-CYCLOPROPOXY-3-FORMYLBENZAMIDE; 4-CYCLOPROPOXY-3-FORMYLPICOLINAMIDE; 4-CYCLOPROPOXY-5-FORMYLNICOTINAMIDE; 4-CYCLOPROPOXY-5-FORMYLPICOLINAMIDE; 4-CYCLOPROPOXY-6-FORMYLNICOTINAMIDE; 4-CYCLOPROPOXY-6-FORMYLPICOLINAMIDE; 4-FLUORO-3-[(2-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4-FLUORO-3-[(3-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4-FLUORO-3-[(4-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4-FLUORO-3-FORMYLBENZAMIDE; 4-FORMYL BENZAMIDINE HYDROCHLORIDE; 4-FORMYL-1H-PYRAZOLE-1-CARBOTHIOAMIDE; 4-FORMYL-1H-PYRAZOLE-3-CARBOXAMIDE; 4-FORMYL-2H-PYRAZOLE-3-CARBOXYLIC ACID AMIDE; 4-FORMYL-2-HYDROXYBENZAMIDE; 4-FORMYL-3-HYDROXYBENZAMIDE; 4-FORMYLBENZAMIDE; 4-FORMYL-BENZAMIDINE; 4-FORMYLBENZYLAMINE; 4-FORMYLBENZYLAMINE HYDROCHLORIDE; 4-PYRIMIDINECARBOXALDEHYDE, 6-AMINO-2-CYCLOPROPYL-5-FLUORO-; 4-PYRIMIDINECARBOXALDEHYDE, 6-AMINO-5-CHLORO-2-CYCLOPROPYL-; 5-((1R)-1,2-DIAMINOETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1,2-DIAMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1,2-DIAMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2-HYDROXYETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2-HYDROXY-ISOPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINO-2-METHYLPROPYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2-METHYLPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINO-2-METHYLPROPYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOBUTYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOBUTYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINOBUTYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOETHYL)THIOPHENE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPENTYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPENTYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINOPENTYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPROP-2-ENYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPROP-2-ENYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINOPROP-2-ENYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPROPYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINOPROPYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)AMINOCYCLOPROPYLMETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1,2-DIAMINOETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1,2-DIAMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1,2-DIAMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2-HYDROXYETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2-HYDROXY-ISOPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINO-2-METHYLPROPYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2-METHYLPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINO-2-METHYLPROPYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOBUTYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOBUTYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINOBUTYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOETHYL)THIOPHENE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPENTYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPENTYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINOPENTYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPROP-2-ENYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPROP-2-ENYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINOPROP-2-ENYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPROPYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINOPROPYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)AMINOCYCLOPROPYLMETHYL)PYRIDINE-2-CARBALDEHYDE; 5-(2-FORMYLTHIOPHEN-4-YL)-2-AMINOISONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-AMINONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-3-AMINOBENZOIC ACID; 5-(3-AMINOCARBONYLPHENYL)-2-FORMYLPHENOL; 5-(3-AMINOPHENYL)-2-FORMYLPHENOL; 5-(3-AMINOPHENYL)PENTANAL; 5-(3-CARBAMOYL-4-CHLOROPHENYL)-2-FORMYLPHENOL; 5-(3-FORMYL-PHENYL)-NICOTINAMIDE; 5-(4-AMINOPHENYL)-2-HYDROXYBENZALDEHYDE; 5-(4-AMINOPHENYL)PYRIDINE-3-CARBALDEHYDE; 5-(5-AMINO-4-FORMYL-PYRAZOL-1-YL)-2-METHOXY-BENZONITRILE; 5-(5-FORMYLTHIOPHEN-2-YL)-2-AMINOISONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-AMINONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-3-AMINOBENZOIC ACID; 5-(AMINOMETHYL)-2-CYCLOPROPOXYBENZALDEHYDE; 5-(AMINOMETHYL)-2-HYDROXYBENZALDEHYDE; 5-(AMINOMETHYL)-3-CYCLOPROPOXYCYCLOHEXA-1,3-DIENECARBALDEHYDE; 5-(AMINOMETHYL)-3-CYCLOPROPOXYPICOLINALDEHYDE; 5-(AMINOMETHYL)-3-PYRIDINECARBOXALDEHYDE; 5-(AMINOMETHYL)-4-CYCLOPROPOXYNICOTINALDEHYDE; 5-(AMINOMETHYL)-4-CYCLOPROPOXYPICOLINALDEHYDE; 5-AMINO-[1,3,4]THIADIAZOLE-2-CARBALDEHYDE; 5-AMINO-1-BENZYL-1,2,3,6-TETRAHYDROPYRIDINE-4-CARBALDEHYDE; 5-AMINO-1-CYCLOPROPYL-6,7-DIFLUORO-8-METHYL-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 5-AMINO-1H-INDAZOLE-3-CARBOXALDEHYDE; 5-AMINO-1H-PYRAZOLE-3-CARBALDEHYDE; 5-AMINO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-AMINO-1-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-AMINO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-AMINO-2-(4-ETHYLPIPERAZIN-1-YL)BENZALDEHYDE; 5-AMINO-2-(4-METHYLPIPERAZIN-1-YL)BENZALDEHYDE; 5-AMINO-2-(TRIFLUOROMETHOXY)BENZALDEHYDE; 5-AMINO-2,4-DIFLUOROBENZALDEHYDE; 5-AMINO-2-BROMOBENZALDEHYDE; 5-AMINO-2-CHLORO-4-FLUOROBENZALDEHYDE; 5-AMINO-2-CHLOROBENZALDEHYDE; 5-AMINO-2-CHLORO-PYRIDINE-3-CARBALDEHYDE; 5-AMINO-2-CHLORO-PYRIDINE-4-CARBALDEHYDE; 5-AMINO-2-CYCLOPROPOXYBENZALDEHYDE; 5-AMINO-2-FLUOROBENZALDEHYDE; 5-AMINO-2-FLUOROISONICOTINALDEHYDE; 5-AMINO-2-FORMYL-BENZENESULFONIC ACID; 5-AMINO-2-HYDROXYBENZALDEHYDE; 5-AMINO-2-IODOBENZALDEHYDE; 5-AMINO-2-METHOXYBENZALDEHYDE; 5-AMINO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-AMINO-2-METHYLBENZALDEHYDE; 5-AMINO-2-NITROBENZALDEHYDE; 5-AMINO-2-TRIFLUOROMETHYL-PYRIDINE-3-CARBALDEHYDE; 5-AMINO-2-TRIFLUOROMETHYL-PYRIDINE-4-CARBALDEHYDE; 5-AMINO-3-CYCLOPROPOXYPICOLINALDEHYDE; 5-AMINO-4-BROMO-2-CHLOROBENZALDEHYDE; 5-AMINO-4-BROMO-2-FLUOROBENZALDEHYDE; 5-AMINO-4-BROMO-3-FLUOROBENZALDEHYDE; 5-AMINO-4-CHLORO-PYRIDINE-2-CARBALDEHYDE; 5-AMINO-4-CHLORO-PYRIDINE-3-CARBALDEHYDE; 5-AMINO-4-CYCLOPROPOXYNICOTINALDEHYDE; 5-AMINO-4-CYCLOPROPOXYPICOLINALDEHYDE; 5-AMINO-4-NITROTHIOPHENE-2-CARBALDEHYDE; 5-AMINO-6-CHLORO-PYRIDINE-3-CARBALDEHYDE; 5-AMINOBENZO[B]THIOPHENE-2-CARBALDEHYDE; 5-AMINOINDOLE-3-CARBOXALDEHYDE; 5-AMINOISOPHTHALALDEHYDE; 5-AMINONICOTINALDEHYDE; 5-AMINOPICOLINALDEHYDE; 5-AMINO-PYRAZINE-2-CARBALDEHYDE; 5-AMINOPYRIMIDINE-2-CARBALDEHYDE; 5-CYCLOPROPOXY-2-FORMYLBENZAMIDE; 5-CYCLOPROPOXY-2-FORMYLISONICOTINAMIDE; 5-CYCLOPROPOXY-2-FORMYLNICOTINAMIDE; 5-CYCLOPROPOXY-3-FORMYLPICOLINAMIDE; 5-CYCLOPROPOXY-4-FORMYLNICOTINAMIDE; 5-CYCLOPROPOXY-4-FORMYLPICOLINAMIDE; 5-CYCLOPROPOXY-6-FORMYLNICOTINAMIDE; 5-CYCLOPROPOXY-6-FORMYLPICOLINAMIDE; 5-FORMYL-1,4-DIMETHYL-1H-PYRROLE-2-CARBOXAMIDE; 5-FORMYL-2-FURANCARBOXAMIDE; 5-FORMYL-2-HYDROXY-BENZAMIDE; 5-FORMYL-2-METHOXY-BENZAMIDE; 5-FORMYL-2-PYRIDINECARBOXAMIDE; 5-FORMYLTHIOPHENE-2-CARBOXAMIDE; 6-((1R)-1,2-DIAMINOETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1,2-DIAMINOETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1,2-DIAMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1,2-DIAMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINO-2-HYDROXYETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-HYDROXYETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINO-2-METHYLPROPYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-METHYLPROPYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-METHYLPROPYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-METHYLPROPYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINOBUTYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOBUTYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOBUTYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOBUTYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINOETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 64(1R)-1-AMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINOPENTYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPENTYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPENTYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPENTYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINOPROP-2-ENYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROP-2-ENYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROP-2-ENYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROP-2-ENYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINOPROPYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROPYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROPYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROPYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1,2-DIAMINOETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1,2-DIAMINOETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 64(1S)-1,2-DIAMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1,2-DIAMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((18)-1-AMINO-2,2,2-TRIFLUOROETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINO-2-HYDROXYETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-HYDROXYETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINO-2-METHYLPROPYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-METHYLPROPYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-METHYLPROPYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-METHYLPROPYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINOBUTYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOBUTYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOBUTYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOBUTYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINOETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINOPENTYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPENTYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPENTYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPENTYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINOPROP-2-ENYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROP-2-ENYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROP-2-ENYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROP-2-ENYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINOPROPYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROPYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROPYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROPYL)PYRIDINE-3-CARBALDEHYDE; 6-(3-AMINOPHENYL)-2-FORMYLPHENOL; 6-(3-AMINOPHENYL)HEXANAL; 6-(3-CARBAMOYL-4-CHLOROPHENYL)-2-FORMYLPHENOL; 6-(4-AMINOPHENOXY)PYRIDINE-3-CARBOXALDEHYDE; 6-(AMINOMETHYL)-3-CYCLOPROPOXYPICOLINALDEHYDE; 6-(AMINOMETHYL)-4-CYCLOPROPOXY-1,6-DIHYDROPYRIDINE-2-CARBALDEHYDE; 6-(AMINOMETHYL)-4-CYCLOPROPOXYNICOTINALDEHYDE; 6-(AMINOMETHYL)-5-CYCLOPROPOXYNICOTINALDEHYDE; 6-(AMINOMETHYL)-5-CYCLOPROPOXYPICOLINALDEHYDE; 6-AMINO-(1H)INDAZOLE-3-CARBOXALDEHYDE; 6-AMINO-1-(2-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-FURYLMETHYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(2-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(3-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1,3-DIETHYL-5-FORMYLURACIL; 6-AMINO-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-BENZYL-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-BUTYL-5-FORMYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-AMINO-1-ISOBUTYL-3-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-SEC-BUTYL-5-FORMYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-2-(TRIFLUOROMETHYL)NICOTINALDEHYDE; 6-AMINO-2,3,4-TRIFLUOROBENZALDEHYDE; 6-AMINO-2,3-DIFLUOROBENZALDEHYDE; 6-AMINO-2,4-DIOXO-1-(2-PHENYLETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1-(PYRIDIN-3-YLMETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2-BROMO-PYRIDINE-3-CARBALDEHYDE; 6-AMINO-2-METHYLNICOTINALDEHYDE; 6-AMINO-3-(2-(TRIFLUOROMETHOXY)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(2-(TRIFLUOROMETHYL)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(2,3-DIFLUOROPHENYL)PICOLINALDEHYDE; 6-AMINO-3-(2-FLUOROPHENYL)PICOLINALDEHYDE; 6-AMINO-3-(2-FORMYLPHENYL)PICOLINIC ACID; 6-AMINO-3-(3-(TRIFLUOROMETHOXY)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(3-(TRIFLUOROMETHYL)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(3-FLUOROPHENYL)PICOLINALDEHYDE; 6-AMINO-3-(3-FORMYLPHENYL)PICOLINIC ACID; 6-AMINO-3-(4-(TRIFLUOROMETHOXY)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(4-(TRIFLUOROMETHYL)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(4-FLUOROPHENYL)PICOLINALDEHYDE; 6-AMINO-3-(4-FORMYLPHENYL)PICOLINIC ACID; 6-AMINO-3-(PERFLUOROPHENYL)PICOLINALDEHYDE; 6-AMINO-3-(PYRIDIN-3-YL)PICOLINALDEHYDE; 6-AMINO-3-(PYRIDIN-4-YL)PICOLINALDEHYDE; 6-AMINO-3,5-DIBROMOPICOLINALDEHYDE; 6-AMINO-3-BROMO-2,4-DIFLUOROBENZALDEHYDE; 6-AMINO-3-BROMOPICOLINALDEHYDE; 6-AMINO-3-CYCLOPROPOXYCYCLOHEXA-2,4-DIENECARBALDEHYDE; 6-AMINO-3-CYCLOPROPOXYPICOLINALDEHYDE; 6-AMINO-3-PHENYLPICOLINALDEHYDE; 6-AMINO-4-CHLORONICOTINALDEHYDE; 6-AMINO-4-CYCLOPROPOXYNICOTINALDEHYDE; 6-AMINO-4-CYCLOPROPOXYPICOLINALDEHYDE; 6-AMINO-4-FLUORO-3-(1H)INDAZOLE CARBOXALDEHYDE; 6-AMINO-4-METHYL-3-PYRIDINECARBOXALDEHYD; 6-AMINO-4-OXO-1-PHENYL-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-5-(2-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 6-AMINO-5-(2-FLUOROPHENYL)NICOTINALDEHYDE; 6-AMINO-5-(3-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 6-AMINO-5-(3-FLUOROPHENYL)NICOTINALDEHYDE; 6-AMINO-5-(4-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 6-AMINO-5-(4-FLUOROPHENYL)NICOTINALDEHYDE; 6-AMINO-5-(PYRIDIN-3-YL)NICOTINALDEHYDE; 6-AMINO-5-(PYRIDIN-4-YL)NICOTINALDEHYDE; 6-AMINO-5-BROMONICOTINALDEHYDE; 6-AMINO-5-CYCLOPROPOXYNICOTINALDEHYDE; 6-AMINO-5-CYCLOPROPOXYPICOLINALDEHYDE; 6-AMINO-5-FORMYL-1-(2-METHOXY-ETHYL)-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-1-(3-METHOXY-PROPYL)-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-1,4-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-1-ISOBUTYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-1-ISOPROPYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-4-METHYL-1-(3-METHYL-BUTYL)-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-4-METHYL-2-OXO-1-(TETRAHYDRO-FURAN-2-YLMETHYL)-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-4-METHYL-2-OXO-1-PROPYL-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-NITRONICOTINALDEHYDE; 6-AMINO-5-NITROPICOLINALDEHYDE; 6-AMINO-5-PHENYLNICOTINALDEHYDE; 6-AMINO-BENZO[1,3]DIOXOLE-5-CARBALDEHYDE; 6-AMINOINDOLE-3-CARBOXALDEHYDE; 6-AMINONICOTINALDEHYDE; 6-AMINOPYRIMIDINE-4-CARBOXALDEHYDE; 6-FORMYLPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE; 6-METHYL-1-(2-OXOETHYL)PIPERIDINE-3-CARBOXAMIDE; 6-METHYL-1-(3-OXOPROPYL)PIPERIDINE-3-CARBOXAMIDE; 7-AMINO[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-6-CARBALDEHYDE; 7-AMINO[1,8]NAPHTHYRIDINE-2-CARBALDEHYDE; 7-AMINO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-AMINO-2-CYCLOPROPYL-5-METHYL-PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBALDEHYDE; 7-AMINO-2-CYCLOPROPYL-PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBALDEHYDE; 7-AMINO-8-METHYLQUINOLINE-3-CARBALDEHYDE; 7-AMINOBENZO[C][1,2,5]THIADIAZOLE-4-CARBALDEHYDE; 7-AMINOINDOLE-3-CARBOXALDEHYDE; 8-AMINOQUINOLINE-7-CARBALDEHYDE; 9-(3-OXOPROP-1-ENYL)ADENINE; ACETALDEHYDE, AMINOBENZOYL-; ADENOSINE, PERIODATE OXIDIZED; ALAHOPCIN; ALPHA-AMINO-BENZENEACETALDEHYDE; BENZALDEHYDE, 3-AMINO-4-HYDROXY-5-METHOXY-; BENZOOXAZOLE-2-CARBALDEHYDE-4-YLAMINE; BENZOOXAZOLE-2-CARBALDEHYDE-5-YLAMINE; BENZOOXAZOLE-2-CARBALDEHYDE-6-YLAMINE; BENZYL (2R)-5-AMINO-4-METHYL-1-OXOPENTAN-2-YLCARBAMATE; CYTOSINE PROPENAL; DAUNOSAMINE; D-GALACTOSAMINE; D-GALACTOSAMINE HYDROCHLORIDE; D-GLUCOSAMINE 6-SULFATE; D-GLUCOSAMINE HYDROCHLORIDE; D-GLUCOSAMINE HYDROCHLORIDE, [1-14C]-; D-GLUCOSAMINE HYDROCHLORIDE, [6-3H]-; D-GLUCOSAMINE SULFATE; DL-CYSTINE-3,3,3′,3′-D4; D-LYXOSYLAMINE; D-MANNOSAMINE HYDROCHLORIDE; D-MANNOSAMINE HYDROCHLORIDE, [1-14C]-; EPSILON-PYRROLE-LYSINE; ETHYL 2-AMINO-5-(3-OXOPROP-1-ENYL)-3-FUROATE; ETHYL 2-AMINO-6-FORMYLPYRIMIDINE-4-CARBOXYLATE; FORPHENICINE; GALACTOSAMINE HYDROCHLOR-IDE-D-[1-14C]; GLUCOSAMINE; GLUCOSAMINE HYDROCHLORIDE D-[1-14C]; GLUCOSAMINE HYDROCHLORIDE, D-[14C(U)]; GLUCOSAMINE HYDROCHLORIDE, D-[6-3H]; GLUCURONAMIDE; GUANOSINE PERIODATE OXIDIZED; H-LEU-NHOH ACOH; L-2-AMINOADIPATE 6-SEMIALDEHYDE; L-GLUCOSAMINE; MANNOSAMINE HYDROCHLORIDE D [6-3H]; METHYL (2R)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(2-CHLORO-3-FORMYL(4-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(2-FORMYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(3-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(3-FORMYL-2-METHYL(4-HYDROIMIDAZO[1,2-A]PYRIDIN-6-YL))PROPANOATE; METHYL (2R)-2-AMINO-3-(3-FORMYL-4-HYDROXYPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(3-FORMYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(4-FLUORO-3,5-DIFORMYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(4-FLUORO-3-FORMYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(4-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(4-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(4-FORMYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(5-BROMO-4-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(5-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(5-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(5-FORMYL-6-METHOXY(3-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(6-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(2-CHLORO-3-FORMYL(4-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(2-FORMYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(3-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(3-FORMYL-2-METHYL(4-HYDROIMIDAZO[1,2-A]PYRIDIN-6-YL))PROPANOATE; METHYL (2S)-2-AMINO-3-(3-FORMYL-4-HYDROXYPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(3-FORMYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(4-FLUORO-3,5-DIFORMYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(4-FLUORO-3-FORMYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(4-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(4-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(4-FORMYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(5-BROMO-4-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(5-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(5-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(5-FORMYL-6-METHOXY(3-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(6-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (3R)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOATE; METHYL (3R)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (3R)-3-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (3S)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOATE; METHYL (3S)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (3S)-3-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (4R)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOATE; METHYL (4S)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOATE; METHYL 3-((1R)-1-AMINO-2-HYDROXYETHYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1R)-1-AMINO-3-HYDROXYPROPYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1R)-1-AMINO-4-HYDROXYBUTYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1R)-1-AMINO-5-HYDROXYPENTYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1R)-1-AMINOETHYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1S)-1-AMINO-2-HYDROXYETHYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1S)-1-AMINO-3-HYDROXYPROPYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1S)-1-AMINO-4-HYDROXYBUTYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1S)-1-AMINO-5-HYDROXYPENTYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1S)-1-AMINOETHYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-AMINO-5-FORMYLBENZOATE; METHYL 4-AMINO-5-FORMYLPYRIDINE-2-CARBOXYLATE; METHYL 5-((1R)-1-AMINO-2-CYANOETHYL)-3-FORMYL-4-HYDROXYBENZOATE; METHYL 5-((1S)-1-AMINO-2-CYANOETHYL)-3-FORMYL-4-HYDROXYBENZOATE; METHYL 6-AMINO-5-FORMYLPYRIDINE-2-CARBOXYLATE; MURAMIC ACID; MURAMIC ACID HYDRATE; P-AMINOETHYLBENZALDEHYDE HCL; SODIUM, 2-AMINO-4-FORMYL-BENZENESULFONATE; SODIUM, 2-AMINO-5-FORMYL-BENZENESULFONATE; TERT-BUTYL 3-AMINO-4-(4-FORMYLPYRIDIN-3-YL)BENZOATE; TERT-BUTYL 3-AMINO-4-(5-FORMYLPYRIDIN-3-YL)BENZOATE; TERT-BUTYL 5-(AMINOMETHYL)-3-FORMYL-1H-INDOLE-1-CARBOXYLATE; Secondary amine: ((1,3-DIMETHYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)THIO)ACETALDEHYDE; (11-OXO-UNDECYL)-CARBAMIC ACID TERT-BUTYL ESTER; (1-FORMYL-CYCLOPROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (1-FORMYL-VINYL)-CARBAMIC ACID TERT-BUTYL ESTER; (1H-IMIDAZOL-2-YL)-ACETALDEHYDE; (1H-IMIDAZOL-4-YL)-ACETALDEHYDE; (2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ACETALDEHYDE; (2,6-DIOXO-PIPERIDIN-4-YL)-ACETALDEHYDE; (2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETYL)UREA; (2-AMINO-1H-IMIDAZOL-4-YL)-ACETALDEHYDE HCL; (2-CHLORO-4-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-CHLORO-4-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-CHLORO-5-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-CHLORO-5-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-CHLORO-6-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2E)-2-METHYL-3-(1H-PYRROL-2-YL)-2-PROPENAL; (2E)-3-(1H-INDOL-3-YL)-2-PROPENAL; (2E)-3-(1H-PYRROL-2-YL)-2-PROPENAL; (2E)-3-(1H-PYRROLO[2,3-B]PYRIDIN-3-YL)-2-PROPENAL; (2-FLUORO-4-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FLUORO-5-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FLUORO-5-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-1,4-DIMETHYL-1H-INDOL-5-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-1H-PYRROL-3-YL)METHYL ACETATE; (2-FORMYL-3-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-3-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-4,5-DIMETHOXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-4-HYDROXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-4-METHOXY-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-4-METHOXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-4-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-4-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-4-NITRO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-5-METHOXY-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-5-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-5-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-6-METHOXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-6-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-CYCLOHEXYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-PYRIDIN-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-METHYL-3-OXO-PROPYL)-CARBAMIC ACID BENZYL ESTER; (2-METHYL-3-OXO-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-OXO-1-THIOPHEN-3-YL-ETHYL)-CARBAMIC ACID BENZYL ESTER; (2-OXO-1-THIOPHEN-3-YL-ETHYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-PHENYL-1H-INDOL-3-YL)-ACETALDEHYDE; (2R)-3-HYDROXY-2-([(1R)-2-OXO-1-(6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)ETHYL]OXY)PROPANAL; (2R,12BS)-2-ETHYL-1,2,6,7,12,12B-HEXAHYDRO-INDOLO[2,3-A]QUINOLIZINE-3-CARBALDEHYDE; (2S)-2-PYRROLIDINECARBOXALDEHYDE; (2Z)-3-(1H-PYRROL-2-YL)-2-PROPENAL; (3-CHLORO-4-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-CHLORO-4-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-CHLORO-5-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-CHLORO-5-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FLUORO-2-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FLUORO-4-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-FLUORO-4-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FLUORO-5-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-FLUORO-5-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-1H-INDAZOL-6-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-2-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-2-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-4-METHYL-1H-INDOL-7-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-4-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-4-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-BENZYL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-PYRAZIN-2-YL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-PYRAZIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-PYRIDIN-4-YL)-CARBAMIC ACID BENZYL ESTER; (3-OXO-1-PHENYL-PROPYL)-CARBAMIC ACID BENZYL ESTER; (3-OXO-1-PHENYL-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-OXO-3,4-DIHYDRO-2-QUINOXALINYL)(PHENYLHYDRAZONO)ACETALDEHYDE; (3-OXO-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4,4,8-TRIMETHYL-2-OXO-1,2,3,4-TETRAHYDRO-QUINOLIN-6-YL)-ACETALDEHYDE; (4,5-DIFLUORO-2-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-CHLORO-2-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-CHLORO-3-FORMYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-CHLORO-6-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FLUORO-2-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FLUORO-3-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FLUORO-3-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-1H-PYRAZOL-3-YL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-1H-PYRAZOL-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-2-HYDROXY-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-2-HYDROXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-2-METHOXY-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-2-METHOXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-2-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-2-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-2-NITRO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-3-NITRO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-BICYCLO[2.2.2]OCT-1-YL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-OXAZOL-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-PYRIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYLTHIAZOL-2-YL)CARBAMIC ACID TERT-BUTYL ESTER; (5-CHLORO-2-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (5-CHLORO-2-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FLUORO-2-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (5-FLUORO-2-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-2,4-DIMETHYL-1H-PYRROL-3-YL)-ACETIC ACID; (5-FORMYL-2H-[1,2,4]TRIAZOL-3-YL)-CARBAMIC ACID BENZYL ESTER; (5-FORMYL-2H-[1,2,4]TRIAZOL-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-2-HYDROXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-2-METHOXY-PHENYL)-CARBAMIC ACID BENZYL ESTER; (5-FORMYL-2-METHOXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-2-METHYL-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-PYRAZIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID BENZYL ESTER; (5-FORMYL-PYRIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER; (5-FORMYL-PYRIDIN-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-THIAZOL-2-YL)-CARBAMIC ACID BENZYL ESTER; (5-FORMYL-THIAZOL-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-OXO-PENTYL)-CARBAMIC ACID TERT-BUTYL ESTER; (6-CHLORO-4-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (6-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID BENZYL ESTER; (6-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (6-TRIFLUOROMETHYL)-7-AZAINDOLE-3-CARBOXALDEHYDE; (7-OXO-HEPTYL)-CARBAMIC ACID BENZYL ESTER; (7-OXO-HEPTYL)-CARBAMIC ACID TERT-BUTYL ESTER; (9H-FLUOREN-9-YL)METHYL 2-OXOETHYLCARBAMATE; (E)-3-(1H-INDOL-2-YL)-2-PROPENAL; (R)-(+)-2-(BENZYLCARBONYLAMINO)-3-PHENYLPROPANAL; (R)-(1-ETHYL-3-OXO-PROPYL)-CARBAMIC ACID BENZYL ESTER; (R)-(1-ETHYL-3-OXO-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (R)-(3-OXO-1-PHENYL-PROPYL)-CARBAMIC ACID BENZYL ESTER; (R)-(3-OXO-1-PHENYL-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (R)-[1-(4-CHLORO-PHENYL)-3-OXO-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; (R)-[1-(4-METHOXY-PHENYL)-3-OXO-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; (R)-2-OXO-IMIDAZOLIDINE-4-CARBALDEHYDE; (R)-5,6-DIOXO-PIPERAZINE-2-CARBALDEHYDE; (R)-BENZYL 1-OXOPROPAN-2-YLCARBAMATE; (R)-N-(1-ETHYL-3-OXO-PROPYL)-ACETAMIDE; (R)—N-(3-OXO-1-PHENYL-PROPYL)-ACETAMIDE; (R)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)-2-METHYLPROPYLCARBAMATE; (R)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)BUTYLCARBAMATE; (R)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)ETHYLCARBAMATE; (R)-TERT-BUTYL 1-OXOPROPAN-2-YLCARBAMATE; (R)-TERT-BUTYL 3-METHYL-1-OXOBUTAN-2-YLCARBAMATE; (S)-(1-ETHYL-3-OXO-PROPYL)-CARBAMIC ACID BENZYL ESTER; (S)-(1-ETHYL-3-OXO-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (S)-[1-(4-CHLORO-PHENYL)-3-OXO-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; (S)-[1-(4-METHOXY-PHENYL)-3-OXO-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; (S)-2-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-4-YL)ACETALDEHYDE; (S)-2-PIPERIDINECARBOXALDEHYDE HYDROCHLORIDE; (S)-4-(1-BENZYL-2-HYDROXYETHYLAMINO)BENZALDEHYDE; (S)-4-(1-HYDROXYMETHYL-PROPYLAMINO)BENZALDEHYDE; (S)-4-(2-HYDROXY-1-PHENYL-ETHYLAMINO)BENZALDEHYDE; (S)-4-N-CBZ-AMINO-4-FORMYL BUTYLAMIDE; (S)-BENZYL 1-OXOPROPAN-2-YLCARBAMATE; (S)—N-(1-ETHYL-3-OXO-PROPYL)-ACETAMIDE; (S)—N-(2-(2-FORMYL-1-PYRROLIDINYL)-2-OXOETHYL)ACETAMIDE; (S)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)-2-METHYLPROPYLCARBAMATE; (S)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)BUTYLCARBAMATE; (S)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)ETHYLCARBAMATE; (S)-TERT-BUTYL 2-OXO-1-PHENYLETHYLCARBAMATE; (S)-TERT-BUTYL 3-OXO-1-PHENYLPROPYLCARBAMATE; (Z)-2-(3,4-DIHYDROPYRROLO[1,2-A]PYRAZIN-1(2H)-YLIDENE)ACETALDEHYDE; (Z)-2-(PYRROLO[1,2-A]PYRAZIN-1(2H)-YLIDENE)PROPANAL; (Z)-2-METHYL-3-(1H-PYRROL-2-YL)-2-PROPENAL; [1-(2-FORMYL-PHENYL)-AZETIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL ESTER; [1-(3-FORMYL-PHENYL)-AZETIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL ESTER; [1-(3-FORMYL-PHENYL)-PYRROLIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL-ESTER; [1-(4-FORMYL-PHENYL)-AZETIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL ESTER; [1-(4-FORMYL-PHENYL)-PYRROLIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL-ESTER; [2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETYL]UREA; [2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)ACETYL]UREA; [2-(2-CHLORO-4-FORMYLPHENOXY)ACETYL]UREA; [2-(2-ETHOXY-4-FORMYLPHENOXY)ACETYL]UREA; [2-(2-ETHOXY-6-FORMYLPHENOXY)ACETYL]UREA; [2-(2-FORMYL-4-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-4-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYL-4-NITROPHENOXY)ACETYL]UREA; [2-(2-FORMYL-5-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-5-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYL-6-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-6-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYLPHENOXY)ACETYL]UREA; [2-(2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(2-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(2-OXO-ETHYL)-BENZYL]-CARBAMIC ACID BENZYL ESTER; [2-(3-CHLORO-2-FORMYLPHENOXY)ACETYL]UREA; [2-(3-CHLORO-2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(3-FORMYLPHENOXY)ACETYL]UREA; [2-(3-FORMYLPHENOXY)PROPANOYL]UREA; [2-(3-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(3-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(4-CHLORO-2-FORMYLPHENOXY)ACETYL]UREA; [2-(4-CHLORO-2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETYL]UREA; [2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2-METHOXYPHENOXY)ACETYL]UREA; [2-(4-FORMYL-2-METHOXYPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2-NITROPHENOXY)ACETYL]UREA; [2-(4-FORMYLPHENOXY)ACETYL]UREA; [2-(4-FORMYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(4-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(5-FORMYL-2-METHOXYPHENOXY)ACETYL]UREA; [2-(5-FORMYL-2-METHOXYPHENOXY)PROPANOYL]UREA; [2-(5-FORMYL-2-NITROPHENOXY)ACETYL]UREA; [2-(5-FORMYL-FURAN-2-YL)-PHENYL]-CARBAMIC ACID TERT-BUTYL ESTER; [2,2-DIMETHYL-1-(2-OXO-ETHYL)-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; [2,4′-BI-1H-IMIDAZOLE]-4-CARBOXALDEHYDE; [2,4′-BI-1H-IMIDAZOLE]-5-CARBOXALDEHYDE, 1-METHYL; [2-METHYL-1-(2-OXO-ETHYL)-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; [3-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [3-(3-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [3-(4-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [3-(5-FORMYL-FURAN-2-YL)-PHENYL]-CARBAMIC ACID TERT-BUTYL ESTER; [4-(2-OXO-ETHYL)-PHENYL]-CARBAMIC ACID BENZYL ESTER; [4-(2-OXO-ETHYL)-THIAZOL-2-YL]-CARBAMIC ACID BENZYL ESTER; [4-(2-OXO-ETHYL)-THIAZOL-2-YL]-CARBAMIC ACID TERT-BUTYL ESTER; [4-(5-FORMYL-FURAN-2-YL)-PHENYL]-CARBAMIC ACID TERT-BUTYL ESTER; [4-(6-FORMYLPYRIDIN-2-YL)PHENYL]CARBAMIC ACID TERT-BUTYL ESTER; 1-((2R,4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 14(4-OXO-3H,4H-THIENO[3,2-D]PYRIMIDIN-2-YL)METHYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-((4-OXO-3H,4H-THIENO[3,2-D]PYRIMIDIN-2-YL)METHYL)PIPERIDINE-4-CARBALDEHYDE; 1-(1H-IMIDAZOL-2-YL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 1-(1H-IMIDAZOL-2-YL)-PIPERIDINE-3-CARBALDEHYDE; 1-(1H-IMIDAZOL-2-YL)-PIPERIDINE-4-CARBALDEHYDE HCL; 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-3-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(2,6-DIFLUORO-4-FORMYLPHENYL)-N-METHYLPYRROLIDINE-2-CARBOXAMIDE; 1-(2-BENZYLAMINOETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(2-FLUORO-4-FORMYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(2-FORMYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(2-PIPERAZIN-1-YLETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(3,5-ANHYDRO-2-DEOXY-BETA-D-THREO-PENTAFURANOSYL)THIMINE; 1-(3-CHLORO-2-FORMYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(3-FORMYLPHENYL)PIPERAZINE; 1-(4-ANILINOPHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 1-(4-FLUORO-2-FORMYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)-N-METHYLPIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-1H-IMIDAZOL-2-YL)-NAPHTHALEN-2-OL; 1-(4-FORMYL-2-METHYLPHENYL)-N-METHYLPIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)-N-METHYLPYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)-N-METHYLPIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)-N-METHYLPYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(4-PIPERIDINYL)-1H-1,2,3-TRIAZOLE-4-CARBOXALDEHYDE; 1-(5-FORMYLFURAN-2-YL)-N-METHYLPIPERIDINE-2-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)-N-METHYLPYRROLIDINE-2-CARBOXAMIDE; 1-(5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)-N-METHYLPYRROLIDINE-2-CARBOXAMIDE; 1-(7H-PURIN-6-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(7H-PURIN-6-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(7H-PURIN-6-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(7H-PURIN-6-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(FURAN-2-CARBONYL)-3-(2-OXO-1-PHENYL-ETHYL)-UREA; 1-(N-BOC-2-AMINOETHYL)-2-FORMYLIMIDAZOLE; 1-(N-BOC-3-AMINOPROPYL)-2-FORMYLIMIDAZOLE; 1-(PIPERIDIN-2-YLMETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(PIPERIDIN-3-YLMETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(PIPERIDIN-4-YL)-2-FORMYLIMIDAZOLE HCL; 1-(PIPERIDIN-4-YLMETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(PYRROLIDIN-3-YLMETHYL)-2-FORMYLIMIDAZOLE HCL; 1′,2′,3′,4′,5′,6′-HEXAHYDRO-[2,4′]BIPYRIDINYL-5-CARBALDEHYDE; 1,2,3,4-TETRAHYDRO-1-OXOISOQUINOLINE-6-CARBALDEHYDE; 1,2,3,4-TETRAHYDRO-2-OXO-5-QUINOLINECARBOXALDEHYDE; 1,2,3,4-TETRAHYDRO-2-OXO-6-QUINOLINECARBOXALDEHYDE; 1,2,3,4-TETRAHYDRO-8-QUINOLINECARBOXALDEHYDE; 1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOLE-5-CARBALDEHYDE; 1,2,3,4-TETRAHYDROISOQUINOLINE-6-CARBALDEHYDE HYDROCHLORIDE; 1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBALDEHYDE HYDROCHLORIDE; 1,2-DIHYDRO-2-OXO-4-PYRIDINECARBOXALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6,8-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6-METHYL-2-OXO-3-PYRIDINECARBOXALDEHYDE; 1,2-DIHYDRO-7,8-DIMETHYL-2-OXO-QUINOLINE-3-CARBOXALDEHYDE; 1,2-DIHYDRO-7-METHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-8-METHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDROISOQUINOLINE-4-CARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-(PROPYLAMINO)-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-5-(3-OXOPIPERAZIN-1-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1,3-DIMETHYL-5-(5-OXO-1,4-DIAZEPAN-1-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1,3-DIMETHYL-6-(METHYLAMINO)-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,4,5,6-TETRAHYDRO-4-IMINO-6-OXO-S-TRIAZINE-2-CARBOXALDEHYDE; 1,4-DIHYDRO-3-HYDROXY-2-QUINOXALINECARBOXALDEHYDE; 1,4-DIHYDRO-4-OXO-2-PYRIDINECARBOXALDEHYDE; 1,4-DIHYDRO-5-METHYL-4-OXO-3-PYRIDINECARBOXALDEHYDE; 1,4-DIHYDRO-6-METHYL-4-OXO-3-PYRIDINECARBOXALDEHYDE; 1,4-DIMETHYL-3-FORMYLCARBAZOLE; 1,6-DIHYDRO-4-METHYL-6-OXO-PYRANO[4,3-B]PYRROLE-2-CARBOXALDEHYDE; 1-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[(4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL)METHYL]-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-[2-(1H-INDOL-3-YL)-ETHYL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 1-[2-(1H-INDOL-3-YL)-ETHYL]-2-FORMYLIMIDAZOLE; 1-[2-(2-FORMYLPHENOXY)PROPANOYL]-3-METHYLUREA; 1-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHOXYETHYL)UREA; 1-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHYLPROPYL)UREA; 1-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(PROP-2-EN-1-YL)UREA; 1-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(PROPAN-2-YL)UREA; 1-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]-3-METHYLUREA; 1-[2-(3-CHLORO-2-FORMYLPHENOXY)PROPANOYL]-3-METHYLUREA; 1-[2-(3-FORMYLPHENOXY)PROPANOYL]-3-METHYLUREA; 1-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHOXYETHYL)UREA; 1-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHYLPROPYL)UREA; 1-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]-3-METHYLUREA; 1-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]-3-PROPYLUREA; 1-[2-(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ETHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[2-(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ETHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[2-(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ETHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[2-(4-CHLORO-2-FORMYLPHENOXY)PROPANOYL]-3-METHYLUREA; 1-[2-(4-FORMYLPHENOXY)PROPANOYL]-3-METHYLUREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHOXYETHYL)UREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHYLPROPYL)UREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(PROP-2-EN-1-YL)UREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(PROPAN-2-YL)UREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-METHYLUREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-PROPYLUREA; 1-[2-(IMIDAZOL-4-YL)ETHYL]-2-FORMYLIMIDAZOLE; 1-[3-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]-3-METHYLUREA; 1-[3-(4-FORMYLPIPERIDIN-1-YL)PROPANOYL]-3-METHYLUREA; 1-CYCLOOCTYL-6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 1H-BENZIMIDAZOL-2-YL(METHYLSULFONYL)ACETALDEHYDE; 1H-BENZIMIDAZOL-2-YLMALONALDEHYDE; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-CHLORO-; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-IODO-; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-METHYL-; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-NITRO-; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-TRIFLUOROMETHOXY-; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-TRIFLUOROMETHYL-; 1H-BENZIMIDAZOLE-5-CARBALDEHYDE; 1H-BENZO[D]IMIDAZOLE-4-CARBALDEHYDE; 1H-BENZO[D]IMIDAZOLE-6-CARBALDEHYDE; 1H-BENZO[G]INDOLE-3-CARBOXALDEHYDE; 1H-BENZOIMIDAZOLE-2-CARBOXALDEHYDE; 1H-IMIDAZOLE-4-CARBALDEHYDE; 1H-IMIDAZOLE-5-ACETALDEHYDE; 1H-IMIDAZOLE-5-CARBALDEHYDE; 1H-IMIDAZOLE-5-CARBOXALDEHYDE, 4-(1-METHYLETHYL)-; 1H-IMIDAZOLE-5-CARBOXALDEHYDE, 4-ETHYL-; 1H-IMIDAZOLE-5-CARBOXALDEHYDE, 4-PROPYL-; 1H-IMIDAZOLE-5-CARBOXYLIC ACID, 4-FORMYL-, METHYL ESTER; 1H-INDAZOLE-3-CARBOXALDEHYDE, 5-[(CYCLOHEXYLMETHYL)AMINO]-; 1H-INDAZOLE-6-CARBOXAMIDE, 3-FORMYL-N-(4-HYDROXYPHENYL)-; 1H-INDOLE-1-ACETAMIDE, 3-FORMYL-N-2-PROPEN-1-YL-; 1H-INDOLE-1-ACETAMIDE, 3-FORMYL-N-PROPYL-; 1H-INDOLE-1-ACETAMIDE, N-(1,1-DIMETHYLETHYL)-3-FORMYL-; 1H-INDOLE-2,3-DICARBALDEHYDE; 1H-INDOLE-2-CARBALDEHYDE; 1H-INDOLE-2-CARBOXALDEHYDE, 4-METHOXY-; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-5-METHOXY-6-METHYL-, ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 5-ETHOXY-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-4-METHYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-5,6-DIMETHOXY-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-5-METHYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-6-METHOXY-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-6-METHYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-7-METHYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 4-BROMO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 4-FLUORO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 5-ETHOXY-3-FORMYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 5-FORMYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 6-BROMO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 6-BROMO-3-FORMYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 6-CHLORO-3-FORMYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 6-CHLORO-4-FLUORO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 6-FLUORO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 7-BROMO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-3-CARBOXALDEHYDE,2-CYCLOPENTYL-5-(TRIFLUOROMETHYL)-; 1H-INDOLE-3-PROPANAL; 1H-INDOLE-3-PROPANOIC ACID, 2-FORMYL-4,5,6,7-TETRAHYDRO-; 1H-INDOLE-4-CARBOXYLIC ACID, 3-FORMYL-, ETHYL ESTER; 1H-INDOLE-5-ACETALDEHYDE; 1H-INDOLE-5-CARBOXALDEHYDE, 2-METHYL-; 1H-INDOLE-5-CARBOXALDEHYDE, RADICAL ION(1+); 1H-PURINE-8-CARBOXALDEHYDE, 2,3,6,9-TETRAHYDRO-2,6-DIOXO-; 1H-PYRROLE-2,3,5-TRICARBOXALDEHYDE; 1H-PYRROLE-2,3-DICARBALDEHYDE; 1H-PYRROLE-2,4-DICARBALDEHYDE; 1H-PYRROLE-2,5-DICARBALDEHYDE; 1H-PYRROLE-2-CARBOXALDEHYDE, 4-(CHLOROACETYL)-3,5-DIMETHYL-; 1H-PYRROLE-2-CARBOXALDEHYDE, 4-FLUORO-3,5-DIMETHYL-; 1H-PYRROLE-2-CARBOXALDEHYDE, 5-(METHYLTHIO)-; 1H-PYRROLE-2-CARBOXYLIC ACID, 4-FORMYL-2,3-DIHYDRO-, METHYL ESTER; 1H-PYRROLE-2-PROPANAL; 1H-PYRROLE-3-CARBALDEHYDE; 1H-PYRROLE-3-CARBOXALDEHYDE, 4-PHENYL-; 1H-PYRROLE-3-PROPANAL; 1H-PYRROLO[2,3-B]PYRIDINE-2-CARBALDEHYDE; 1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID, 3-FORMYL-, METHYL ESTER; 1H-PYRROLO[2,3-B]PYRIDINE-3,4-DICARBALDEHYDE; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 2-METHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 4-METHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 5-CHLORO-2-ETHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 5-CHLORO-2-METHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 5-METHOXY-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 6-BROMO-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 6-CHLORO-4-METHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-(4-FLUOROPHENYL)-6-(1-METHYLETHYL)-; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-AMINO-6,7-DIHYDRO-2,3-DIMETHYL-6-OXO-; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-CHLORO-3-METHYL; 1H-PYRROLO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 1H-PYRROLO[2,3-C]PYRIDINE-2-CARBALDEHYDE; 1H-PYRROLO[2,3-C]PYRIDINE-5-CARBALDEHYDE; 1H-PYRROLO[3,2-B]PYRIDINE-2-CARBALDEHYDE; 1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 1H-PYRROLO[3,2-B]PYRIDINE-5-CARBOXALDEHYDE; 1H-PYRROLO[3,2-B]PYRIDINE-6-CARBALDEHYDE; 1H-PYRROLO[3,2-B]PYRIDINE-7-CARBOXALDEHYDE; 1H-PYRROLO[3,2-C]PYRIDINE-2-CARBALDEHYDE; 1H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXALDEHYDE; 1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBALDEHYDE; 1-METHYL-4-OXO-4,5-DIHYDRO-1H-PYRAZOLO[3,4-D]PYRIMIDINE-3-CARBALDEHYDE; 1-METHYL-4-OXO-4,5-DIHYDRO-1H-PYRROLO[3,2-C]PYRIDINE-2-CARBALDEHYDE; 1-OXO-1,2,3,4-TETRAHYDROISOQUINOLINE-5-CARBALDEHYDE; 1-OXO-1,2-DIHYDROISOQUINOLINE-4-CARBALDEHYDE; 1-OXO-1,2-DIHYDROISOQUINOLINE-5-CARBALDEHYDE; 1-OXO-1,2-DIHYDROISOQUINOLINE-6-CARBALDEHYDE; 1-OXO-1,2-DIHYDROISOQUINOLINE-7-CARBALDEHYDE; 1-OXOISOINDOLINE-4-CARBALDEHYDE; 1-OXOISOINDOLINE-5-CARBALDEHYDE; 2-((2-HYDROXYETHYL)AMINO)-9-ME-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-((2-METHOXYETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-((2R)-2-PIPERIDYL)PYRIDINE-4-CARBALDEHYDE; 2-((2R)AZETIDIN-2-YL)PYRIDINE-4-CARBALDEHYDE; 2-((2R)PYRROLIDIN-2-YL)PYRIDINE-4-CARBALDEHYDE; 2-((2S)-2-PIPERIDYL)PYRIDINE-4-CARBALDEHYDE; 2-((2S)AZETIDIN-2-YL)PYRIDINE-4-CARBALDEHYDE; 2-((2S)PYRROLIDIN-2-YL)PYRIDINE-4-CARBALDEHYDE; 2-((3,4-DIHYDRO-1(2H)-ISOQUINOLINYLIDENE)-ACETALDEHYDE); 2-((3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL)(METHYL)AMINO)-N-METHYLACETAMIDE; 2-((3R)MORPHOLIN-3-YL)PYRIDINE-4-CARBALDEHYDE; 2-((3S)MORPHOLIN-3-YL)PYRIDINE-4-CARBALDEHYDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(METHYL)AMINO)-N-(PROPAN-2-YL)ACETAMIDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(METHYL)AMINO)-N-METHYLACETAMIDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(PROPYL)AMINO)-N-METHYLACETAMIDE; 2-((FURAN-2-YLMETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-((TETRAHYDROFURAN-2-YLMETHYL)AMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-([(5-FORMYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)-N-METHYLACETAMIDE; 2-(1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL)ACETALDEHYDE HYDROCHLORIDE; 2-(1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)ACETALDEHYDE HYDROCHLORIDE; 2-(1-ADAMANTYL)-5-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 2-(1-ADAMANTYL)-5-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-(1-ETHYL-PENTYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(1H-BENZOIMIDAZOL-2-YLSULFANYL)-3-PHENYL-PROPENAL; 2-(1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 2-(1H-IMIDAZOL-2-YL)-MALONALDEHYDE; 2-(1H-IMIDAZOL-4-YLMETHYL)-BENZALDEHYDE; 2-(1H-INDOL-3-YL)-2-OXOACETALDEHYDE; 2-(1H-INDOL-3-YL)ACETALDEHYDE; 2-(1H-INDOL-3-YL)PROPANAL; 2-(1H-INDOL-4-YLOXY)-ACETALDEHYDE; 2-(1H-INDOL-5-YL)-BENZALDEHYDE; 2-(1H-PYRROL-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(1H-PYRROL-2-YL)OXAZOLE-5-CARBALDEHYDE; 2-(1H-PYRROL-2-YL)PROPANAL; 2-(1H-PYRROL-3-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(1H-PYRROL-3-YL)PROPANAL; 2-(1-METHYL-1H-PYRROL-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(1-METHYL-BUTYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(1-PIPERAZINYL)-3-PYRIDINECARBOXALDEHYDE; 2-(2,3-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(2,3-DIFLUORO-4-METHYL-PHENYL)-4-FORMYLIMIDAZOLE; 2-(2,3-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 2-(2,3-DIHYDRO-BENZOFURAN-5-YL)-4-FORMYL-IMIDAZOLE; 2-(2,3-DIMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2,3-DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,3-DIOXO-2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 2-(2,4,6-TRIMETHYL-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(2,4-DICHLORO-5-FLUORO-PHENYL)-4-FORMYLIMIDAZOLE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; DICHLORO-6-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(2,4-DICHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2,4-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,4-DIMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2,4-DIMETHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,4-DIOXO-1,3-DIAZASPIRO[4.4]NONAN-3-YL)ACETALDEHYDE; 2-(2,4-DIOXO-1,3-DIAZASPIRO[4.5]DECAN-3-YL)ACETALDEHYDE; 2-(2,4-DIOXO-1,3-DIAZASPIRO[4.7]DODECAN-3-YL)ACETALDEHYDE; 2-(2,5-DICHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2,5-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,5-DIMETHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2,5-DIMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2,5-DIMETHYL-1H-PYRROL-3-YL)-4-FORMYLIMIDAZOLE; 2-(2,5-DIMETHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2,5-DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,5-DIMETHYLTHIEN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; DIOXOIMIDAZOLIDIN-1-YL)ACETALDEHYDE; 2-(2,6-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(2,6-DIFLUORO-4-METHOXYPHENYL)-4-FORMYLIMIDAZOLE; 2-(2,6-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,6-DIMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2,6-DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2-AMINO-ETHYL)-1H-IMIDAZOLE-4-CARBALDEHYDE 2HCL; 2-(2-BROMO-4-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-BROMO-4-METHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-BROMO-5-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-BROMO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-CHLORO-4,5-DIFLUOROPHENYL)-4-FORMYLIMIDAZOLE; 2-(2-CHLORO-4-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-CHLORO-4-FLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-4-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-4-FLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-4-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-ETHYLACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-ETHYLPROPANAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-PROP-2-YNYLACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2-CYANOETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(CYCLOPROPYLMETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-CYCLOPENTYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-PHENYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(2-CHLORO-5-FLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-5-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-5-FLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-5-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-5-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-CHLORO-6-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-CHLORO-6-FLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-6-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-6-FLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-6-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROANILINO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(2-CHLORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-CHLOROPHENYL)-4,6-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-4,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5-ETHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-6,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-PHENYLACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(2-ETHOXY-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(2-FLUORO-3-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUORO-4-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUORO-4-NITROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUORO-4-NITROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUORO-5-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUORO-5-METHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUORO-5-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUORO-5-NITROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUORO-5-NITROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUORO-6-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUOROANILINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(2-FLUORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-FLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-7-METHYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FORMYL-1H-IMIDAZOL-1-YL)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYL-1H-IMIDAZOL-1-YL)-N-(3-METHOXYPHENYL)ACETAMIDE; 2-(2-FORMYL-1H-IMIDAZOL-1-YL)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(2-FURYLMETHYL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(TETRAHYDROFURAN-2-YLMETHYL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-PROPYLPROPANAMIDE; 2-(2-FORMYL-4-METHYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-4-METHYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-PROPYLACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-PROPYLPROPANAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(TETRAHYDROFURAN-2-YLMETHYL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-PROPYLPROPANAMIDE; 2-(2-FORMYL-6-METHOXY-PHENOXY)-N-P-TOLYL-ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-FURYLMETHYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHOXYPHENYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-PHENYLETHYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHOXYPHENYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(OXAN-4-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PENTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(TETRAHYDRO-2-FURANYLMETHYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-PENTYLPROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-PHENYLACETAMIDE; 2-(2-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(2-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(1,3-THIAZOL-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYL-4-OXOPENTAN-3-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLCYCLOHEXYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHYL-1,2-OXAZOL-5-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(4-METHYL-1,3-THIAZOL-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLCYCLOHEXYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,3,4-OXADIAZOL-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(5-METHYLHEXAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(HEPTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(OXAN-4-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(OXOLAN-2-YLMETHYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PYRIMIDIN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(THIOPHEN-2-YLMETHYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-[1-(FURAN-2-YL)ETHYL]ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-[1-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-[2-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-[3-(PROPAN-2-YLOXY)PROPYL]ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-METHYLACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-PENTYLPROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-PHENYLACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-PROPYLACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-PROPYLPROPANAMIDE; 2-(2-IODO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-METHOXY-5-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2-METHOXY-NAPHTHALEN-1-YL)-4-FORMYLIMIDAZOLE; 2-(2-METHOXY-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-METHOXY-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(2-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-METHYLSULFANYL-ETHYL)-4-FORMYLIMIDAZOLE; 2-(2-NAPHTHYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-OXOPROPYL)-1H-PYRROLE-3-CARBALDEHYDE; 2-(2-PYRIDINYL)-1H-INDOLE-3-CARBALDEHYDE HYDROCHLORIDE; 2-(2-TRIFLUOROMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-TRIFLUOROMETHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-(TRIFLUOROMETHYL)PHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(3,4-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(3,4-DIMETHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(3,4-DIMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3,4-DIMETHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(3,5-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(3,5-DIMETHOXY-PHENYL)-4-FORMYL-1H-IMIDAZOLE; DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(3-AZETIDINYLOXY)-BENZALDEHYDE; 2-(3-BROMO-4-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-BROMO-4-METHOXYPHENYL)-4-FORMYLIMIDAZOLE; 2-(3-BROMO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-BROMOPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(3-CHLORO-2-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-CYANOETHYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(CYCLOPROPYLMETHYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPENTYLACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(3-CHLORO-4-FLUORO-PHENYL)-4-FORMYLIMIDAZOLE; 2-(3-CHLORO-4-FLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLORO-4-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLORO-4-FLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLORO-4-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-4,6-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-4,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5-ETHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-6,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLORO-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(3-FLUORO-2-METHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-FLUORO-4-METHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(3-FLUORO-4-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-FLUORO-4-METHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-FLUORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-FLUOROPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(3-FLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-7-METHYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FORMYL-1H-INDOL-1-YL)-N-(2-THIENYLMETHYL)ACETAMIDE; 2-(3-FORMYL-1H-PYRROL-2-YL)ACETONITRILE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-N-(PROPAN-2-YL)ACETAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-N-METHYLACETAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-N-METHYLPROPANAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-N-PROPYLPROPANAMIDE; 2-(3-FORMYL-2-METHYL-1H-INDOL-1-YL)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-(2-METHOXY-ETHYL)-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-(TETRAHYDRO-FURAN-2-YLMETHYL)-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-FURAN-2-YLMETHYL-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-ISOPROPYL-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-M-TOLYLACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-O-TOLYL-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-PHENYL-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-P-TOLYLACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHOXYPHENYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(4-METHOXYPHENYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(OXAN-4-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PENTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-MESITYLACETAMIDE; 2-(3-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(3-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-PENTYLPROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-PHENYLACETAMIDE; 2-(3-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(3-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(1,3-THIAZOL-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYL-4-OXOPENTAN-3-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLCYCLOHEXYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHYL-1,2-OXAZOL-5-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(4-METHYL-1,3-THIAZOL-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLCYCLOHEXYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,3,4-OXADIAZOL-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(5-METHYLHEXAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(HEPTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(OXAN-4-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(OXOLAN-2-YLMETHYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PYRIMIDIN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(THIOPHEN-2-YLMETHYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-[1-(FURAN-2-YL)ETHYL]ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-[1-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-[2-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-[3-(PROPAN-2-YLOXY)PROPYL]ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-METHYLACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-PENTYLPROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-PHENYLACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-PROPYLACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-PROPYLPROPANAMIDE; 2-(3-IODO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-METHOXY-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-METHOXYPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(3-METHOXY-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(3-METHYLBENZO[B]THIOPHEN-2-YL)4-FORMYLIMIDAZOLE; 2-(3-METHYLPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(3-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-METHYL-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(3-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-1-YL)ACETALDEHYDE; 2-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-1-YL)BENZALDEHYDE; 2-(3-OXOPIPERAZIN-1-YL)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-(3-OXOPIPERAZIN-1-YL)ACETALDEHYDE; 2-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 2-(3-OXOPIPERAZIN-1-YL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(3-OXOPIPERAZIN-1-YL)QUINOLINE-3-CARBALDEHYDE; 2-(3-PYRIDINYL)-5-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-TRIFLUOROMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-TRIFLUOROMETHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-(TRIFLUOROMETHYL)PHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ACETALDEHYDE; 2-(4,5-DIMETHOXY-2-NITRO-PHENYL)-4-FORMYLIMIDAZOLE; 2-(4,5-DIMETHYL-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-BROMO-2-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-PROP-2-YNYLACETAMIDE; 2-(4-BROMO-3-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-BROMO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-BROMOPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(4-BROMO-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-CYANOETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(CYCLOPROPYLMETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PENTAN-2-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(TETRAHYDROFURAN-2-YLMETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPENTYLACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(4-CHLORO-3-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-CHLORO-3-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-CHLORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-CHLOROPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(4-CHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-CHLOROPHENYL)-4,6-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-4,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5-ETHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-6,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLORO-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-ETHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-ETHOXY-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-ETHOXY-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-ETHYL-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-ETHYLPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYL-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-FLUORO-3-METHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-FLUORO-3-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-FLUORO-3-NITROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUORO-3-NITROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-1,2-DIHYDROQUINOLINE-4-CARBALDEHYDE; 2-(4-FLUORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-FLUOROPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-FLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-7-METHYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-3-METHOXY-PHENOL; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-4-METHOXY-PHENOL; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-4-NITRO-PHENOL; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-5-METHOXY-PHENOL; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-6-METHOXY-PHENOL; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZONITRILE; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-PHENOL; 2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(TETRAHYDROFURAN-2-YLMETHYL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-ISOBUTYLACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-PROPYLACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYL-2-METHOXY-6-NITROPHENOXY)-N-PROP-2-YNYLACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(5-METHYLISOXAZOL-3-YL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(TETRAHYDROFURAN-2-YLMETHYL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-ISOBUTYLACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-FORMYL-2-METHOXY-PHENOXY)-N-O-TOLYL-ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-PHENYLACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-PROPYLPROPANAMIDE; 2-(4-FORMYL-2-METHOXY-PHENOXY)-N-P-TOLYL-ACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-PROPYLACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(OXAN-4-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(PENTAN-3-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-METHYLACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-PHENYLACETAMIDE; 2-(4-FORMYLIMIDAZOL-2-YL)-4-TRIFLUOROMETHOXYPHENOL; 2-(4-FORMYL-IMIDAZOL-2-YL)-5-METHOXY-4-NITROPHENOL; 2-(4-FORMYLPHENOXY)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-FURYLMETHYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHYLCYCLOHEXYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHOXYPHENYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(4-METHOXYPHENYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(4-METHYLBENZYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(OXAN-4-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PENTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(4-FORMYL-PHENOXY)-N-(TETRAHYDRO-FURAN-2-YLMETHYL)-ACETAMIDE; 2-(4-FORMYL-PHENOXY)-N-[2-(1H-IMIDAZOL-4-YL)-ETHYL]-ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-1,3-THIAZOL-2-YLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-2-PYRIDINYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-ISOBUTYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-MESITYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-PENTYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-PENTYLPROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-PHENYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(1,3-THIAZOL-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYL-4-OXOPENTAN-3-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLCYCLOHEXYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHYL-1,2-OXAZOL-5-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(4-METHYL-1,3-THIAZOL-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLCYCLOHEXYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,3,4-OXADIAZOL-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(5-METHYLHEXAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(HEPTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(OXAN-4-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(OXOLAN-2-YLMETHYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PYRIMIDIN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(THIOPHEN-2-YLMETHYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-[1-(FURAN-2-YL)ETHYL]ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-[1-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-[2-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-[3-(PROPAN-2-YLOXY)PROPYL]ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-METHYLACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-PENTYLPROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-PHENYLACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-PROPYLACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-PROPYLPROPANAMIDE; 2-(4H-1,2,4-TRIAZOL-3-YL)-1,3-THIAZOLE-4-CARBALDEHYDE; 2-(4H-1,2,4-TRIAZOL-3-YL)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBALDEHYDE; 2-(4-IODO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-ISOPROPOXY-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-ISOPROPYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-ISOPROPYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-METHOXY-2-NITRO-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-METHOXY-3-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-METHOXY-NAPHTHALEN-1-YL)-4-FORMYL-IMIDAZOLE; 2-(4-METHOXY-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-METHOXYPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(4-METHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-METHOXY-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-METHYL-3-NITRO-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-METHYLPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-TERT-BUTYL-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-TRIFLUOROMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-TRIFLUOROMETHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-3-YL)-BENZALDEHYDE; 2-(5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)-1H-INDOLE-3-CARBALDEHYDE; 2-(5-BROMO-2-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(5-BROMO-2-METHOXY-PHENYL)-4-FORMYLIMIDAZOLE; 2-(5-BROMO-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-BROMO-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-CHLORO-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-CHLORO-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-ETHYL-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-ETHYL-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-FLUORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-1-YL)ACETALDEHYDE; 2-(5-FLUORO-2-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(5-FLUORO-2-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-PROPYLPROPANAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-METHYLACETAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-METHYLPROPANAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-PROPYLACETAMIDE; 2-(5-HYDROXY-1H-INDOL-3-YL)ACETALDEHYDE; 2-(5-IODO-FURAN-2-YL)-4-FORMYL-IMIDAZOLE; 2-(5-ISOPROPYL-2-METHOXY-PHENYL)-4-FORMYLIMIDAZOLE; 2-(5-METHYL-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-METHYL-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-NITRO-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-NITRO-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-NITRO-THIOPHEN-3-YL)-4-FORMYL-IMIDAZOLE; 2-(5-OXO-1,4-DIAZEPAN-1-YL)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-(5-OXO-1,4-DIAZEPAN-1-YL)ACETALDEHYDE; 2-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 2-(5-OXO-1,4-DIAZEPAN-1-YL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(6,10-DIMETHYL-2,4-DIOXO-1,3-DIAZASPIRO[4.5]DECAN-3-YL)ACETALDEHYDE; 2-(6-METHOXY-NAPHTHALEN-2-YL)-4-FORMYL-IMIDAZOLE; 2-(8-METHYL-2,4-DIOXO-1,3-DIAZASPIRO[4.5]DECAN-3-YL)ACETALDEHYDE; 2-(9H-PURIN-6-YLSULFANYL)ACETALDEHYDE; 2-(ALLYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)NICOTINALDEHYDE; 2-(BENZYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(BENZYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(BUTYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(CYCLOHEXYLAMINO)-BENZALDEHYDE; 2-(DIMETHYLAMINO)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 2-(ETHYL[(5-FORMYL-2-METHOXYPHENYL)METHYL]AMINO)-N-METHYLACETAMIDE; 2-(ETHYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(ETHYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(ETHYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(HEXYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(HYDROXYMETHYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(HYDROXYMETHYL)-1H-PYRROLE-3-CARBALDEHYDE; 2-(ISOBUTYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(ISOPROPYLAMINO)-4-METHYLBENZALDEHYDE; 2-(ISOPROPYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(ISOPROPYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(METHYLAMINO)NICOTINALDEHYDE; 2-(METHYLAMINO)PYRIMIDINE-4-CARBOXALDEHYDE; 2-(METHYLTHIO)-4-[(2-METHOXYPHENYL)AMINO]-5-PYRIMIDINECARBOXALDEHYDE; 2-(METHYLTHIO)-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE-4-CARBALDEHYDE; 2-(NAPHTHALEN-1-YLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(PHENYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(PIPERAZIN-1-YL)ACETALDEHYDE; 2-(PIPERAZIN-1-YL)PYRIMIDINE-5-CARBALDEHYDE; 2-(PROPYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(PROPYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(PYRROLIDIN-2-YL)PYRIMIDINE-4-CARBALDEHYDE; 2-(SEC-BUTYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(TERT-BUTYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(TRIFLUOROMETHYL)-1H-BENZO[D]IMIDAZOLE-4-CARBALDEHYDE; 2-(TRIFLUOROMETHYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2,2,2-TRIFLUORO-N-(3-FORMYLPHENYL)ACETAMIDE; 2,3,4,5-TETRAHYDRO-1,4-BENZOXAZEPINE-7-CARBALDEHYDE; 2,3,4,9-TETRAHYDRO-1-H-CARBAZOL-3-CARBALDEHYDE; 2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-8-CARBALDEHYDE; 2,3-DIHYDRO-1H-INDOLE-4-CARBALDEHYDE; 2,3-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 2,3-DIHYDRO-1H-INDOLE-6-CARBALDEHYDE; 2,3-DIHYDRO-1H-PYRIDO[3,4-B][1,4]OXAZINE-8-CARBALDEHYDE; 2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 2,3-DIHYDRO-2-OXOBENZO[D]OXAZOLE-5-CARBALDEHYDE; 2,3-DIHYDRO-3,3-DIMETHYL-2-OXO-1H-PYRROLO[3,2-C]PYRIDINE-4-CARBALDEHYDE; 2,3-DIHYDRO-4-METHYL-2-OXO-5-THIAZOLECARBOXALDEHYDE; 2,3-DIHYDRO-5-METHOXY-3-PHENYL-2-INDOLECARBOXALDEHYDE; 2,3-DIMETHYL-1H-INDOLE-5-CARBALDEHYDE; 2,3-DIMETHYL-1H-INDOLE-7-CARBALDEHYDE; 2,3-DIMETHYL-1H-PYRROLO[2,3-C]PYRIDINE-7-CARBALDEHYDE; 2,3-DIOXO-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE-7-CARBALDEHYDE; 2,3-FORMYL PIPERIDINE; 2,4,5-TRIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 2,4,6-TRIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2,4,6-TRIOXO-HEXAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 2,4,7-TRIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2,4-DIAMINO-6-OXO-1,6-DIHYDRO-5-PYRIMIDINECARBALDEHYDE; 2,4-DIAMINO-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBALDEHYDE; 2,4-DICHLORO-N-(3-FORMYL-PHENYL)-BENZAMIDE; 2,4-DIFLUORO-6-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 2,4-DIHYDROXYMETHYL-3-METHYL PYRROL-5-CARBALDEHYDE; 2,4-DIMETHYL PYRROL-3-CARBALDEHYDE; 2,4-DIMETHYL-3-HYDROXYMETHYL PYRROL-5-CARBALDEHYDE; 2,4-DIMETHYL-5-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,4-DIMETHYL-5-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,4-DIMETHYL-5-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,4-DIMETHYL-5-[5-(4-METHYLPHENYL)-1,3,4-OXADIAZOL-2-YL]-1H-PYRROLE-3-CARBALDEHYDE; 2,5,7-TRIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2,5-DIFORMYL-1H-PYRROLE-3-CARBONITRILE; 2,5-DIMETHYL-1-(2-OXOPIPERIDIN-3-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-1H-IMIDAZOLE-4-CARBOXALDEHYDE; 2,5-DIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2,5-DIMETHYL-1H-PYRROLE-3,4-DICARBALDEHYDE; 2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-(3-PHENYL-1,2,4-OXADIAZOL-5-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-[3-(4-METHYLPHENYL)-1,2,4-OXADIAZOL-5-YL]-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-[5-(4-METHYLPHENYL)-1,3,4-OXADIAZOL-2-YL]-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIOXO-3-PYRROLIDINEACETALDEHYDE; 2,5-DIPHENYL-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DITERT-BUTYL-1H-INDOLE-3-CARBALDEHYDE; 2,6-DIAMINO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2,6-DIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2,7-DIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]-N-METHYLACETAMIDE; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]-N-METHYLPROPANAMIDE; 2-[(2,3-DIMETHYLPHENYL)AMINO]-1,3-THIAZOLE-4-CARBALDEHYDE; 2-[(2,6-DICHLOROPHENYL)AMINO]BENZALDEHYDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(ETHYL)AMINO]-N-ETHYLACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(ETHYL)AMINO]-N-METHYLACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-ETHYLACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-CHLOROPHENYL)AMINO]-BENZALDEHYDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-FORMYL-4-NITROPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-FORMYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(2-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(2-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(2-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-FURYLMETHYL)AMINO]-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[(2-FURYLMETHYL)AMINO]PYRIMIDINE-5-CARBALDEHYDE; 2-[(2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-6-YL)OXY]ACETALDEHYDE; 2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 2-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(ETHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(ETHYL)AMINO]-N-ETHYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(ETHYL)AMINO]-N-METHYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-CYCLOPROPYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-ETHYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(3-FORMYLQUINOLIN-2-YL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-2-NITROPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(4-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(4-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(4-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-OXO-6-PROPYL-1,4-DIHYDROPYRIMIDIN-2-YL)SULFANYL]ACETALDEHYDE; 2-[(5-BROMO-2-FORMYLPHENYL)(ETHYL)AMINO]-N-METHYLACETAMIDE; 2-[(5-BROMO-2-FORMYLPHENYL)(METHYL)AMINO]-N-ETHYLACETAMIDE; 2-[(5-BROMO-2-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(5-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]ACETALDEHYDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-METHYLACETAMIDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-PROPYLACETAMIDE; 2-[(6-METHYL-4-OXO-1,4-DIHYDROPYRIMIDIN-2-YL)SULFANYL]ACETALDEHYDE; 2-[(BENZOYLAMINO)METHYL]-4-FORMYLPHENYL ACETATE; 2-[(CYCLOHEXYLAMINO)(PHENYL)METHYLENE]MALONALDEHYDE; 2-[1-(1H-IMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 2-[2-(1H-IMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 2-[2-(1H-IMIDAZOL-4-YL)-VINYL]-BENZALDEHYDE; 2-[2-(2-METHYLIMIDAZOL-4-YL)-ETHYL]BENZALDEHYDE; 2-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 2-[3-(2-OXO-PYRROLIDIN-1-YL)-PROPYLAMINO]-PYRIMIDINE-4-CARBALDEHYDE; 2-[4-(1,1-DIMETHYLETHYL)PHENYL]-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-[4-(1,1-DIMETHYLETHYL)PHENYL]-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-[4-(1,1-DIMETHYLETHYL)PHENYL]-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-[4-(1,1-DIMETHYLETHYL)PHENYL]-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-[4-(PHENYLAMINO)PHENOXY]ACETALDEHYDE; 2-[ETHYL((3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL))AMINO]-N-METHYLACETAMIDE; 2-[ETHYL((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL))AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(2-FLUORO-4-FORMYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(2-FLUORO-4-FORMYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(2-FORMYL-4-NITROPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(2-FORMYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(2-FORMYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(2-OXOETHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(2-OXOETHYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(3-OXOPROPYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(3-OXOPROPYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FLUORO-2-FORMYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(4-FLUORO-2-FORMYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FORMYL-2-METHYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(4-FORMYL-2-METHYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FORMYL-2-NITROPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FORMYL-3-METHYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(4-FORMYL-3-METHYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FORMYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(4-FORMYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(5-FORMYLFURAN-2-YL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(5-FORMYLFURAN-2-YL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(PIPERIDIN-4-YL)AMINO]ACETALDEHYDE; 2-[METHYL(2-OXOETHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[METHYL(3-OXOPROPYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[METHYL(3-OXOPROPYL)AMINO]-N-PROPYLACETAMIDE; 2-[METHYL(PIPERIDIN-4-YL)AMINO]ACETALDEHYDE; 2-[PIPERIDIN-4-YL(PROPYL)AMINO]ACETALDEHYDE; 2-ACETAMIDO-2-DEOXY-DEXTRO-GALACTOPYRANOSE HYDRATE; 2-ACETAMIDO-4-HYDROXY-6-PTERIDINECARBOXALDEHYDE; 2-AMINO-1H-IMIDAZOLE-4-CARBALDEHYDE HCL; 2-AMINO-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-ANILINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-ANILINOPYRIMIDINE-5-CARBALDEHYDE; 2-BENZAMIDOCINNAMALDEHYDE; 2-BENZO[B]THIOPHEN-2-YL-4-FORMYL-IMIDAZOLE; 2-BENZYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-BROMO-4-FORMYLPIPERIDINE; 2-BROMO-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXALDEHYDE; 2-BUTYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-BUTYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-CHLORO-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE-4-CARBALDEHYDE; 2-CHLORO-6-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 2-CHLORO-6-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 2-CHLORO-6-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 2-CHLORO-6-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 2-CHLORO-6-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 2-CHLORO-N-(3-FORMYL-PHENYL)-BENZAMIDE; 2-CYCLOHEX-3-ENYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-CYCLOHEXYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-CYCLOHEXYL-4,6-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-4,6-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-4,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-4,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-(1,1-DIMETHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-ETHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-6,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-6,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-METHYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-CYCLOPENTYL-1H-INDOLE-3-CARBALDEHYDE; 2-CYCLOPROPOXY-3-(METHYLAMINO)BENZALDEHYDE; 2-CYCLOPROPOXY-3-FORMYL-N-METHYLBENZAMIDE; 2-CYCLOPROPOXY-4-(METHYLAMINO)BENZALDEHYDE; 2-CYCLOPROPOXY-4-FORMYL-N-METHYLBENZAMIDE; 2-CYCLOPROPOXY-5-(METHYLAMINO)BENZALDEHYDE; 2-CYCLOPROPOXY-5-FORMYL-N-METHYLBENZAMIDE; 2-CYCLOPROPOXY-6-(METHYLAMINO)BENZALDEHYDE; 2-CYCLOPROPOXY-6-FORMYL-N-METHYLBENZAMIDE; 2-CYCLOPROPYL-4,6-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-4,6-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-4,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-4,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-(1,1-DIMETHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-ETHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-6,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-6,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-METHOXY-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYLAMINO-PYRIMIDINE-4-CARBALDEHYDE; 2-ETHENYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-ETHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 2-ETHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 2-ETHYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 2-ETHYL-4-FORMYLIMIDAZOLE; 2-ETHYL-4-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-ETHYL-5-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-ETHYL-5-OXO-5,6-DIHYDRO-IMIDAZO[1,2-C]PYRIMIDINE-3-CARBALDEHYDE; 2-FLUORO-4-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 2-FLUORO-4-(PIPERIDIN-3-YL)BENZALDEHYDE HCL; 2-FLUORO-4-(PIPERIDIN-4-YL)BENZALDEHYDE HYDROCHLORIDE; 2-FLUORO-4-(PYRROLIDIN-3-YL)BENZALDEHYDE HCL; 2-FLUORO-5-(1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 2-FLUORO-5-(4-FORMYL-IMIDAZOL-2-YL)-BENZONITRILE; 2-FLUORO-6-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 2-FORMYL-1,4,6,7-TETRAHYDRO-PYRROLO[3,2-C]PYRIDINE-5-CARBOXYLIC ACID TERT-BUTYL ESTER; 2-FORMYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID METHYL ESTER; 2-FORMYL-1H-IMIDAZOLE-4-CARBONITRILE; 2-FORMYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-FORMYL-1H-INDOLE-6-CARBONITRILE; 2-FORMYL-1H-PYRROLE-3-CARBONITRILE; 2-FORMYL-3-HYDROXY-N-METHYLBENZAMIDE; 2-FORMYL-3-METHYL-1-OXO-1,5-DIHYDRO-BENZO[4,5]IMIDAZO[1,2-A]PYRIDINE-4-CARBONITRILE; 2-FORMYL-4-(5-BROMOTHIOPHEN-2-YL)IMIDAZOLE; 2-FORMYL-4-(5-CHLOROTHIOPHEN-2-YL)IMIDAZOLE; 2-FORMYL-4-(5-METHYLTHIOPHEN-2-YL)IMIDAZOLE; 2-FORMYL-4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDINE HYDROCHLORIDE; 2-FORMYL-4-[3-(N-METHYLAMINOCARBONYL)PHENYL]PHENOL; 2-FORMYL-4-HYDROXY-N-METHYLBENZAMIDE; 2-FORMYL-4-METHOXY-N-METHYL-BENZAMIDE; 2-FORMYL-5-[3-(N-METHYLAMINOCARBONYL)PHENYL]PHENOL; 2-FORMYL-5-HYDROXY-N-METHYLBENZAMIDE; 2-FORMYL-5-METHOXY-N-METHYL-BENZAMIDE; 2-FORMYL-5-METHYL-1H-IMIDAZO[4,5-C]PIPERIDINE; 2-FORMYL-5-METHYL-1H-PYRROLE-3,4-DICARBONITRILE; 2-FORMYL-6-[3-(N-METHYLAMINOCARBONYL)PHENYL]PHENOL; 2-FORMYL-6H-FURO[2,3-B]PYRROLE-5-CARBOXYLIC ACID; 2-FORMYL-6-HYDROXY-N-METHYLBENZAMIDE; 2-FORMYL-6-METHOXY-1H-INDOLE; 2-FORMYL-7-METHYL-4,5,6,7-TETRAHYDROBENZOIMIDAZOLE; 2-FORMYL-N-ISOPROPYLTHIAZOLE-4-CARBOXAMIDE; 2-FORMYLPIPERIDINE; 2-FORMYLPIPERIDINE HCL; 2-FURAN-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-FURAN-3-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-FURANCARBOXALDEHYDE, 5-(1H-INDOL-5-YL)-; 2-HEPTYL-1,4-DIHYDRO-4-OXO-3-QUINOLINECARBOXALDEHYDE; 2-HYDROXY-3-(METHYLAMINO)BENZALDEHYDE; 2-HYDROXY-4-(METHYLAMINO)BENZALDEHYDE; 2-HYDROXY-5-(METHYLAMINO)BENZALDEHYDE; 2-HYDROXY-5-METHYL-3-(PIPERIDIN-3-YL)BENZALDEHYDE; 2-HYDROXY-5-METHYL-3-(PIPERIDIN-4-YL)BENZALDEHYDE; 2-HYDROXY-5-METHYL-3-(PYRROLIDIN-3-YL)BENZALDEHYDE; 2-HYDROXY-6-(METHYLAMINO)BENZALDEHYDE; 2-ISOBUTYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-ISOPROPYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-MERCAPTO-1H-INDOLE-3-CARBALDEHYDE; 2-METHOXY-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-METHYL-1H-BENZO[D]IMIDAZOLE-4-CARBALDEHYDE; 2-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-METHYL-1H-INDOLE-3-ACETALDEHYDE; 2-METHYL-1H-INDOLE-4-CARBALDEHYDE; 2-METHYL-1H-INDOLE-7-CARBALDEHYDE; 2-METHYL-1H-PYRROLE-3-CARBALDEHYDE; 2-METHYL-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 2-METHYL-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 2-METHYL-4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 2-METHYL-4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 2-METHYL-4-(METHYLAMINO)BENZALDEHYDE; 2-METHYL-4H-FURO[3,2-B]PYRROLE-5-CARBALDEHYDE; 2-METHYL-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 2-METHYL-5-NITRO-1H-INDOLE-3-CARBALDEHYDE; 2-METHYL-5-OXO-5,6-DIHYDRO-IMIDAZO[1,2-C]PYRIMIDINE-3-CARBALDEHYDE; 2-METHYL-9-OXO-4H,9H-PYRAZOLO[3,2-B]QUINAZOLINE-3-CARBALDEHYDE; 2-METHYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-METHYLAMINO-THIAZOLE-5-CARBALDEHYDE; 2-METHYLIMIDAZOLE-5-CARBOXALDEHYDE; 2-METHYLINDOLE-3-CARBOXALDEHYDE; 2-METHYLSULFANYL-3H-IMIDAZOLE-4-CARBALDEHYDE; 2-METHYLSULFANYL-4-PHENYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-METHYLSULFANYL-5-TRIMETHYLSILANYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-METHYLTHIO-4-ISOAMYLAMINO-5-PYRIMIDINECARBOXALDEHYDE; 2-MORPHOLINECARBOXALDEHYDE; 2-M-TOLYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-M-TOLYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-NAPHTHALEN-1-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-NAPHTHALEN-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-N-BOC-AMINO-3-FORMYLPYRIDINE; 2-O-TOLYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-O-TOLYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-OXO-1,2,6,7,8,9-HEXAHYDROBENZO[G]QUINOLINE-3-CARBALDEHYDE; 2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 2-OXO-1,2-DIHYDROQUINOLINE-7-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-1H-PYRIDO[2,3-B][1,4]OXAZINE-7-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-BENZOOXAZOLE-6-CARBALDEHYDE; 2-OXO-2-PHENYLETHYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; 2-OXO-4-(PROPYLAMINO)-2H-CHROMENE-3-CARBALDEHYDE; 2-OXO-5-PROPYLINDOLINE-3-CARBALDEHYDE; 2-OXO-IMIDAZOLIDINE-4-CARBALDEHYDE; 2-OXOINDOLINE-3-CARBALDEHYDE; 2-PHENETHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-PHENYL-1H-BENZO[D]IMIDAZOLE-4-CARBALDEHYDE; 2-PHENYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-PHENYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXALDEHYDE; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBOXALDEHYDE; 2-PHENYLINDOLE-3-CARBOXALDEHYDE; 2-PIPERAZIN-1-YL-5-TRIFLUOROMETHYLBENZALDEHYDE; 2-PIPERAZIN-1-YL-BENZALDEHYDE; 2-PIPERAZINECARBOXALDEHYDE; 2-PROPENAL, 3-[(4-METHYLPHENYL)AMINO]-2-NITRO-; 2-PROPYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-P-TOLYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-P-TOLYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-PYRIDIN-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-PYRIDIN-2-YL-1H-INDOLE-3-CARBALDEHYDE; 2-PYRIDIN-3-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-PYRIDIN-3-YL-1H-INDOLE-3-CARBALDEHYDE; 2-PYRIDIN-4-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-PYRIDIN-4-YL-1H-INDOLE-3-CARBALDEHYDE; 2-PYRIDINECARBOXALDEHYDE, 4-[4-(METHYLAMINO)-3-NITROPHENOXY]-; 2-PYRIDONE-6-CARBOXALDEHYDE; 2-PYRROLECARBAMIC ACID, 4-FORMYL-3,5-DIMETHYL-; 2-QUINOLIN-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-SEC-BUTYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-STYRYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-TERT-BUTYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-TERT-BUTYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 2-TERT-BUTYL-3-FORMYL-1H-INDOLE-5-CARBONITRILE; 2-TERT-BUTYL-4-CHLORO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-4-FLUORO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5,7-DIFLUORO-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5-CHLORO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5-ISOPROPYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5-PHENYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-7-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-7-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-THIAZOL-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-THIEN-2-YL-1H-INDOLE-3-CARBALDEHYDE; 2-THIOPHEN-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-THIOPHEN-3-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-THIOPHENECARBOXALDEHYDE, 5-(1H-INDOL-5-YL)-; 2-THIOXO-1,2-DIHYDROPYRIDINE-3-CARBALDEHYDE; 2-VINYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 3-((2R)(2-PIPERIDYL))-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2R)AZETIDIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2R)PIPERAZIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2R)PYRROLIDIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2S)(2-PIPERIDYL))-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2S)AZETIDIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2S)PIPERAZIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2S)PYRROLIDIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((3R)MORPHOLIN-3-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((3S)MORPHOLIN-3-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-(1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL)PROPANAL HYDROCHLORIDE; 3-(1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)PROPANAL HYDROCHLORIDE; 3-(1,4-DIAZEPAN-1-YL)PROPANAL; 3-(1H-BENZOIMIDAZOL-2-YLSULFANYL)-3-PHENYL-PROPENAL; 3-(1H-BENZOIMIDAZOL-2-YLSULFANYLMETHYL)-4-METHOXY-BENZALDEHYDE; 3-(1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 3-(1H-IMIDAZOL-2-YL)-PROPIONALDEHYDE; 3-(1H-IMIDAZOL-4-YL)BENZALDEHYDE; 3-(1H-IMIDAZOL-4-YL)-PROPIONALDEHYDE; 3-(1H-IMIDAZOL-4-YLMETHYL)-BENZALDEHYDE; 3-(1H-INDOL-5-YL)BENZALDEHYDE; 3-(1-METHYL-1,2,3,6-TETRAHYDRO-PYRIDIN-4-YL)-1H-INDOLE-5-CARBALDEHYDE; 3-(2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 3-(2,3-DIOXO-2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 3-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2,4-DIMETHYL-5-FORMYL-1H-PYRROLE-3-YL)PROPANOIC ACID; 3-(2,4-DIOXO-1,3-DIAZASPIRO[4.4]NONAN-3-YL)PROPANAL; 3-(2,4-DIOXO-1,3-DIAZASPIRO[4.5]DECAN-3-YL)PROPANAL; 3-(2,4-DIOXO-1,3-DIAZASPIRO[4.7]DODECAN-3-YL)PROPANAL; 3-(2,5-DIOXO-4-PROPYLIMIDAZOLIDIN-1-YL)PROPANAL; 3-(2,5-DIOXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(2-AMINOETHYLAMINO)-5-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(2-BROMO-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-BROMO-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-ETHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-ETHOXY-4-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(2-ETHOXY-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-ETHOXY-6-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(2-ETHOXY-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-ETHOXYCARBONYLETHYL)-2,4-DIMETHYL-5-FORMYLPYRROLE; 3-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-FORMYL-4-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYL-4-METHYL-1H-PYRROL-3-YL)-PROPIONIC ACID; 3-(2-FORMYL-4-METHYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYL-4-NITROPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-FORMYL-5-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYL-5-PROPOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-FORMYL-6-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)PROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)-N-PHENYLPROPANAMIDE; 3-(3-[(METHYLAMINO)METHYL]PIPERIDIN-1-YL)PROPANAL; 3-(3-AZETIDINYLOXY)-BENZALDEHYDE; 3-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(3-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 3-(3-CHLORO-2-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(3-CHLORO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(3-FORMYL-1H-INDOL-5-YL)BENZOIC ACID; 3-(3-FORMYL-1H-INDOL-5-YL)BENZONITRILE; 3-(3-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(3-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)PROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)-N-PHENYLPROPANAMIDE; 3-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-1-YL)PROPANAL; 3-(3-OXOPIPERAZIN-1-YL)PROPANAL; 3-(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(4-BROMO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-BUTYL-4-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 3-(4-CHLORO-2-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(4-CHLORO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-ETHYL-4-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(4-FORMYL-1H-IMIDAZOL-2-YL)-4-NITRO-PHENOL; 3-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 3-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZONITRILE; 3-(4-FORMYL-1H-IMIDAZOL-2-YL)-PHENOL; 3-(4-FORMYL-2,6-DIMETHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-FORMYL-2-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-FORMYL-2-NITROPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)PROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)-N-PHENYLPROPANAMIDE; 3-(4-PHENYL-1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 3-(5-CHLORO-1H-INDOL-3-YL)PROPANAL; 3-(5-FLUORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-1-YL)PROPANAL; 3-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(5-FORMYL-2-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(5-FORMYL-2-NITROPHENOXY)-N-METHYLPROPANAMIDE; 3-(5-FORMYL-4H-1,2,4-TRIAZOL-3-YL)BENZONITRILE; 3-(5-FORMYL-4-METHYL-1H-PYRROL-3-YL)PROPANENITRILE; 3-(5-OXO-1,4-DIAZEPAN-1-YL)PROPANAL; 3-(5-OXO-PYRROLIDIN-3-YL)-BENZALDEHYDE; 3-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)BENZALDEHYDE; 3-(8-METHYL-2,4-DIOXO-1,3-DIAZASPIRO[4.5]DECAN-3-YL)PROPANAL; 3-(9H-PURIN-6-YLSULFANYL)PROPANAL; 3-(AZETIDIN-3-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-(BOC-AMIDINO)-BENZALDEHYDE; 3-(CHLOROMETHYL)-2-FORMYL-1-OXO-1,5-DIHYDROPYRIDO[1,2-A]BENZIMIDAZOLE-4-CARBONITRILE; 3-(CYCLOHEXYLAMINO)-2-ISOPROPYL-3-PHENYLACRYLALDEHYDE; 3-(PIPERAZIN-1-YL)PROPANAL; 3,3-DIMETHYL-2-OXO-2,3-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 3,4,5,6-TETRAHYDROXY-2-(METHYLAMINO)HEXANAL; 3,4,5-TRIMETHYL-1H-PYRROLE-2-CARBOXALDEHYDE; 3,4-BIS(4-FLUOROPHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 3,4-BIS(TRIFLUOROMETHYL)-1H-PYRROLE-2,5-DICARBALDEHYDE; 3,4-BIS(TRIFLUOROMETHYL)-1H-PYRROLE-2-CARBALDEHYDE; 3,4-DIHYDRO-2,3-DIOXO-2H-BENZO[B][1,4]OXAZINE-6-CARBALDEHYDE; 3,4-DIHYDRO-3-OXO-2H-BENZO[B][1,4]OXAZINE-8-CARBALDEHYDE; 3,4-DIHYDRO-3-OXO-2-QUINOXALINECARBOXALDEHYDE; 3,4-DIMETHYL-1H-PYRROLE-2-CARBOXALDEHYDE; 3,4-DIMETHYL-2,5-PYRROLEDICARBOXALDEHYDE; 3,4-DIMETHYL-5-FORMYLPYRROLE-2-CARBOXYLIC ACID; 3,5-DIBROMO-4-(METHYLAMINO)BENZALDEHYDE; 3,5-DICHLORO-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3,5-DICHLORO-4-(METHYLAMINO)BENZALDEHYDE; 3,5-DIFLUORO-4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 3,5-DIFLUORO-4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 3,5-DIMETHYL-1-(7H-PURIN-6-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3,5-DIMETHYL-1H-INDOLE-2-CARBALDEHYDE; 3,5-DIMETHYL-1H-PYRROLE-2-CARBOXALDEHYDE; 3,5-DIMETHYL-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3,5-DIMETHYL-4-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 3,5-DIMETHYL-4-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 3,5-DIMETHYL-PYRROLE-2,4-DICARBOXALDEHYDE; 3,7-DIMETHYL-1H-INDOLE-2-CARBALDEHYDE; 3,7-DIMETHYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURINE-8-CARBALDEHYDE; 3-[(1-FORMYLNAPHTHALEN-2-YL)OXY]-N-METHYLPROPANAMIDE; 3-[(1R)-1-(METHYLAMINO)ETHYL]-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-[(1S)-1-(METHYLAMINO)ETHYL]-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-[(1S)-2-HYDROXY-1-(METHYLAMINO)ETHYL]-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-[(2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(2,5-DIOXOIMIDAZOLIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-6-YL)OXY]PROPANAL; 3-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 3-[(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-NITROPHENYL)AMINO]-1H-INDOLE-2-CARBALDEHYDE; 3-[(5-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]PROPANAL; 3-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-METHYLPROPANAMIDE; 3-[(BENZYLOXYCARBONYL)AMINO]-1-PROPANAL; 3-[1-(1H-IMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 3-[2-(1H-IMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 3-[2-(1H-IMIDAZOL-4-YL)-VINYL]-BENZALDEHYDE; 3-[2-(2-METHYLIMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 3-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 3-[4-(FURAN-2-YL)-4-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL]PROPANAL; 3-[4-(PHENYLAMINO)PHENOXY]PROPANAL; 3-[ETHYL(PIPERIDIN-4-YL)AMINO]PROPANAL; 3-[METHYL(PIPERIDIN-4-YL)AMINO]PROPANAL; 3-[PIPERIDIN-4-YL(PROPYL)AMINO]PROPANAL; 3-ACETAMIDOPHENYLGLYOXAL HYDRATE; 3-ACETYL-4-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 3-AMINO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-ANILINO-2-NITROACRYLALDEHYDE; 3-BUTYL-1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; 3-CHLORO-4-(METHYLAMINO)BENZALDEHYDE; 3-CHLORO-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-CHLORO-4-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 3-CHLORO-5-METHOXY-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-CYANO-4-METHYL-7-AZAINDOLE-4-CARBALDEHYDE; 3-CYCLOPROPOXY-2-(METHYLAMINO)BENZALDEHYDE; 3-CYCLOPROPOXY-2-(METHYLAMINO)ISONICOTINALDEHYDE; 3-CYCLOPROPOXY-2-FORMYL-N-METHYLBENZAMIDE; 3-CYCLOPROPOXY-2-FORMYL-N-METHYLISONICOTINAMIDE; 3-CYCLOPROPOXY-4-(METHYLAMINO)BENZALDEHYDE; 3-CYCLOPROPOXY-4-(METHYLAMINO)PICOLINALDEHYDE; 3-CYCLOPROPOXY-4-FORMYL-N-METHYLBENZAMIDE; 3-CYCLOPROPOXY-4-FORMYL-N-METHYLPICOLINAMIDE; 3-CYCLOPROPOXY-5-(METHYLAMINO)CYCLOHEXA-1,3-DIENECARBALDEHYDE; 3-CYCLOPROPOXY-5-(METHYLAMINO)ISONICOTINALDEHYDE; 3-CYCLOPROPOXY-5-(METHYLAMINO)PICOLINALDEHYDE; 3-CYCLOPROPOXY-5-FORMYL-N-METHYLBENZAMIDE; 3-CYCLOPROPOXY-5-FORMYL-N-METHYLISONICOTINAMIDE; 3-CYCLOPROPOXY-5-FORMYL-N-METHYLPICOLINAMIDE; 3-CYCLOPROPOXY-6-(METHYLAMINO)PICOLINALDEHYDE; 3-CYCLOPROPOXY-6-FORMYL-N-METHYLPICOLINAMIDE; 3-CYCLOPROPYL-1-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; 3-CYCLOPROPYL-1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; 3-DIMETHYLAMINOMETHYL-1H-INDOLE-2-CARBALDEHYDE; 3-ET-5((4-ET-5-FORMYL-3-ME-2H-PYRROL-2-YLIDENE)ME)-4-ME-1H-PYRROLE-2-CARBALDEHYDE; 3-ETHOXY-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-ETHOXY-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-ETHYL-1-[2-(2-FORMYLPHENOXY)PROPANOYL]UREA; 3-ETHYL-1-[2-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; 3-ETHYL-1-[2-(3-FORMYLPHENOXY)PROPANOYL]UREA; 3-ETHYL-1-[2-(3-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; 3-ETHYL-1-[2-(4-FORMYLPHENOXY)PROPANOYL]UREA; 3-ETHYL-1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; 3-ETHYL-1H-INDOLE-2-CARBALDEHYDE; 3-ETHYL-4,5-DIMETHYLPYRROLE-2-CARBOXALDEHYDE; 3-ETHYL-4-METHYL-1H-PYRROLE-2,5-DICARBOXALDEHYDE; 3-ETHYL-4-METHYL-1H-PYRROLE-2-CARBOXALDEHYDE; 3-ETHYL-5-METHYL-1H-INDOLE-2-CARBALDEHYDE; 3-ETHYL-5-OXO-5,6-DIHYDRO-IMIDAZO[1,2-C]PYRIMIDINE-2-CARBALDEHYDE; 3-FLUORO-2-(1-PIPERAZINO)-BENZALDEHYDE; 3-FLUORO-2-(1-PIPERAZINO)-BENZALDEHYDE HYDROCHLORIDE; 3-FLUORO-4-(1-PIPERAZINO)-BENZALDEHYDE HYDROCHLORIDE; 3-FLUORO-4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 3-FLUORO-4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 3-FLUORO-5-(1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 3-FORMALDEHYDE PIPERIDINE; 3-FORMYL-1,6-DIHYDROXYCARBAZOLE; 3-FORMYL-1H-INDOLE-2-CARBONITRILE; 3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-4-CARBONITRILE; 3-FORMYL-1H-INDOLE-4-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-4-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-1H-INDOLE-5-CARBOXYLIC ACID ETHYL ESTER; 3-FORMYL-1H-INDOLE-6-CARBONITRILE; 3-FORMYL-1H-INDOLE-6-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-6-CARBOXYLIC ACID ETHYL ESTER; 3-FORMYL-1H-INDOLE-7-CARBONITRILE; 3-FORMYL-1H-INDOLE-7-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER; 3-FORMYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBONITRILE; 3-FORMYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBONITRILE; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-4-CARBONITRILE; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-4-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-7-CARBONITRILE; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-7-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[3,2-B]PYRIDINE-5-CARBONITRILE; 3-FORMYL-1H-PYRROLO[3,2-B]PYRIDINE-5-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBONITRILE; 3-FORMYL-1H-PYRROLO[3,2-B]PYRIDINE-7-CARBONITRILE; 3-FORMYL-2-HYDROXY-N-METHYLBENZAMIDE; 3-FORMYL-4(1H)-PYRIDONE; 3-FORMYL-4,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-4,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-4-AZAINDOLE-5-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-4-AZAINDOLE-6-CARBOXYLIC ACID; 3-FORMYL-4-AZAINDOLE-6-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-4-HYDROXY-N-METHYLBENZAMIDE; 3-FORMYL-4-METHYL-1H-INDOLE-7-CARBONITRILE; 3-FORMYL-4-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID; 3-FORMYL-4-METHYLINDOLE; 3-FORMYL-4-NITRO-7-AZAINDOLE; 3-FORMYL-5,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-5,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-5-AZAINDOLE; 3-FORMYL-5-HYDROXY-N-METHYLBENZAMIDE; 3-FORMYL-5-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-5-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-5-NITRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER; 3-FORMYL-6-(TRIFLUOROMETHYL)-1H-INDOLE-5-CARBONITRILE; 3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHYL-5-NITRO-7-AZAINDOLE; 3-FORMYL-6-METHYL-7-AZAINDOLE; 3-FORMYLINDOLE-4-BORONIC ACID PINACOL ESTER; 3-FORMYLINDOLE-5-CARBOXYLIC ACID; 3-FORMYLINDOLE-7-CARBOXYLIC ACID ETHYL ESTER; 3-FORMYLINDOLE-7-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-N,N-DIMETHYL-1H-INDOLE-5-SULFONAMIDE; 3-FORMYL-N-METHYL-BENZAMIDE; 3-FORMYLPHENYL PHENYLCARBAMATE; 3H-BENZO[D]IMIDAZOLE-4-CARBALDEHYDE; 3H-IMIDAZO[4,5-B]PYRIDINE-2-CARBOXALDEHYDE; 3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBALDEHYDE; 3H-IMIDAZO[4,5-B]PYRIDINE-7-CARBALDEHYDE; 3-HYDROXY-2-(METHYLAMINO)BENZALDEHYDE; 3-HYDROXY-4-(METHYLAMINO)BENZALDEHYDE; 3-HYDROXY-5-(METHYLAMINO)BENZALDEHYDE; 3-METHOXY-1H-PYRROLE-2-CARBALDEHYDE; 3-METHOXY-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-METHOXY-2-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 3-METHOXY-2-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 3-METHOXY-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-METHOXY-4-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 3-METHOXY-4-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 3-METHYL-1H-PYRROLE-2,4-DICARBALDEHYDE; 3-METHYL-1H-PYRROLE-2,5-DICARBALDEHYDE; 3-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 3-METHYL-3-PHENYLAMINO-BUTYRALDEHYDE; 3-METHYL-4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 3-METHYL-4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 3-METHYL-5-OXO-5,6-DIHYDRO-IMIDAZO[1,2-C]PYRIMIDINE-2-CARBALDEHYDE; 3-N-BOC-AMINO-4-FORMYL-5-METHOXYPYRIDINE; 3-NITRO-1H-PYRROLE-2-CARBALDEHYDE; 3-NITRO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-NITRO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 3-NITRO-4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 3-NITRO-4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 3-NITRO-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-OXO-1,3-DIHYDRO-ISOINDOLE-4-CARBALDEHYDE; 3-OXO-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE-6-CARBALDEHYDE; 3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE; 3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]OXAZINE-6-CARBALDEHYDE; 3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]THIAZINE-6-CARBALDEHYDE; 3-OXOISOINDOLINE-5-CARBALDEHYDE; 3-PHENYL-1H-INDOLE-2-CARBALDEHYDE; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXALDEHYDE; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXALDEHYDE; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBOXALDEHYDE; 3-TERT-BUTYL-1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; 4-((2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL)BENZALDEHYDE; 4-((4-[(1R)-1-(METHYLAMINO)ETHYL]PHENYL)METHYL)BENZALDEHYDE; 4-((4-[(1S)-1-(METHYLAMINO)ETHYL]PHENYL)METHYL)BENZALDEHYDE; 4-((4-[(1S)-2-HYDROXY-1-(METHYLAMINO)ETHYL]PHENYL)METHYL)BENZALDEHYDE; 4-(1,1-DIMETHYLETHYL)-1H-PYRROLE-2-CARBOXALDEHYDE; 4-(1H-BENZIMIDAZOL-6-YLOXY)-3-CHLORO-BENZALDEHYDE; 4-(1H-BENZIMIDAZOL-6-YLOXY)-BENZALDEHYDE; 4-(1H-BENZOIMIDAZOL-2-YLMETHOXY)-3-METHOXY-BENZALDEHYDE; 4′-(1H-IMIDAZOL-2-YL)-[1,1′-BIPHENYL]-3-CARBOXALDEHYDE; 4-(1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 4-(1H-IMIDAZOL-2-YL)-B-OXO-BENZENEPROPANAL; 4-(1H-IMIDAZOL-2-YL)-BUTYRALDEHYDE; 4-(1H-IMIDAZOL-4-YL)BENZALDEHYDE; 4-(1H-IMIDAZOL-4-YL)-BUTYRALDEHYDE; 4-(1H-IMIDAZOL-4-YLMETHYL)-BENZALDEHYDE; 4-(1H-INDOL-3-YL)BUTANAL; 4-(1H-INDOL-4-YL)BENZALDEHYDE; 4-(1H-INDOL-5-YL)BENZALDEHYDE; 4-(2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 4-(2,3-DIOXO-2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 4-(2,4-DIFLUOROPHENYL)-4-PIPERIDINYLMETHANONE HYDROCHLORIDE; 4-(2-[4-(TRIFLUOROMETHYL)PIPERIDINO]ACETYL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(2-AMINO-1H-IMIDAZOL-4-YL)-BUTYRALDEHYDE HCL; 4-(2-CHLOROACETYL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(2-CHLOROPYRIMIDIN-5-YL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 4-(2-FORMYLPIPERIDIN-1-YL)-N-METHYLPYRIDINE-2-CARBOXAMIDE; 4-(2-FORMYLVINYL)-ACETANILIDE; 4-(2-HYDROXY-ETHYLAMINO)-BENZALDEHYDE; 4-(2-PIPERIDIN-4-YLETHYL)IMIDAZOLE-2-CARBALDEHYDE; 4-(2-PROPEN-1-YL)-1H-PYRROLE-2-CARBOXALDEHYDE; 4-(2-PYRROLIDIN-1-YLETHYL)IMIDAZOLE-2-CARBALDEHYDE; 4-(3,9-DIAZASPIRO[5.5]UNDEC-3-YL)BENZALDEHYDE; 4-(3-ACETYLAMINOPHENYL)-2-FORMYLPHENOL; 4-(3-AZETIDINYLOXY)-BENZALDEHYDE; 4-(3-BROMOPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(3-CHLOROPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(3-FLUOROPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 4-(3-FORMYL-1H-INDOL-5-YL)BENZOIC ACID; 4-(3-FORMYL-1H-INDOL-5-YL)BENZONITRILE; 4-(3-FORMYLPIPERIDIN-1-YL)-N-METHYLPYRIDINE-2-CARBOXAMIDE; 4-(3-METHOXYPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-1-YL)BENZALDEHYDE; 4-(3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]OXAZIN-6-YLOXY)BUTANAL; 4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 4-(4-BROMOPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(4-BROMOPHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(4-CHLOROPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(4-CHLOROPHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(4-DIMETHOXYMETHYLIMIDAZOL-2-YL)-BENZALDEHYDE; 4-(4-FLUORO-PHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 4-(4-FLUOROPHENYL)-2-THIOXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-2-NITRO-PHENOL; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-3-METHOXY-PHENOL; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZONITRILE; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-NAPHTHALEN-1-OL; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-PHENOL; 4-(4-FORMYLIMIDAZOL-2-YL)-2,6-DIMETHOXY-PHENOL; 4-(4-FORMYLIMIDAZOL-2-YL)-2,6-DIMETHYL-PHENOL; 4-(4-FORMYLIMIDAZOL-2-YL)-2-METHOXY-6-NITROPHENOL; 4-(4-FORMYLIMIDAZOL-2-YL)-2-METHOXY-PHENOL; 4-(4-FORMYLPIPERIDIN-1-YL)-N-METHYLPYRIDINE-2-CARBOXAMIDE; 4-(4-METHOXYPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(4-METHYL-7-OXO-7,8-DIHYDRO-PYRIDO[2,3-D]PYRIMIDIN-2-YLOXY)BUTYRALDEHYDE; 4-(4-PHENYL-1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 4-(4-PIPERIDINYLOXY)BENZALDEHYDE; 4-(4-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 4-(4-PYRIDIN-3-YL-1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 4-(4-PYRIDIN-4-YL-1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 4-(5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-3-YL)-BENZALDEHYDE; 4-(5-ETHYL-1,3,4-OXADIAZOL-2-YL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-(5-FLUORO-1H-INDOL-3-YL)BUTANAL; 4-(5-FORMYL-4H-1,2,4-TRIAZOL-3-YL)BENZONITRILE; 4-(5-ISOPROPYL-1,3,4-OXADIAZOL-2-YL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 4-(5-OXO-PYRROLIDIN-3-YL)-BENZALDEHYDE; 4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)BENZALDEHYDE; 4-(7-OXO-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-YLOXY)BUTANAL; 4-(BENZYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE; 4-(BENZYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(BENZYLAMINO)-6-CHLORO-5-PYRIMIDINECARBALDEHYDE; 4-(BENZYLOXY)-6-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 4-(BENZYLOXY)-7-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 4-(BOC-AMIDINO)-BENZALDEHYDE; 4-(BUTYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(CYCLOBUTYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE; 4-(CYCLOHEPTYLAMINO)-2-(METHYLSULFANYL)-5-PYRIMIDINECARBALDEHYDE; 4-(CYCLOHEXYLAMINO)-3-NITROBENZALDEHYDE; 4-(CYCLOPENTYLAMINO)-2-(METHYLSULFANYL)-5-PYRIMIDINECARBALDEHYDE; 4-(CYCLOPENTYLAMINO)-6-METHYL-2-(METHYLSULFANYL)-5-PYRIMIDINECARBALDEHYDE; 4-(ETHYLAMINO)-2-(METHYLSULFANYL)-5-PYRIMIDINECARBALDEHYDE; 4-(ETHYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(ETHYLAMINO)-6-METHYL-2-(METHYLSULFANYL)-5-PYRIMIDINECARBALDEHYDE; 4-(METHYLAMINO)-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 4-(METHYLAMINO)-3-NITROBENZALDEHYDE; 4-(N-BOC-AMINO)CYCLOHEXYLETHANAL; 4-(PIPERIDIN-4-YLOXY)BENZALDEHYDE HYDROCHLORIDE; 4-(PROP-1-YNYL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(PYRIDIN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; 4-(PYRIDIN-4-YL)-1H-INDOLE-3-CARBALDEHYDE; 4-(TRIFLUOROMETHYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(TRIFLUOROMETHYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-(TRIFLUOROMETHYL)-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-(TRIFLUOROMETHYL)INDOLE-3-CARBOXALDEHYDE; 4-(TRIMETHYLSILYL)-1H-PYRROLE-2-CARBOXALDEHYDE; 4,4′-DIFORMYLDIPHENYLAMINE; 4,5,6,7,8,9-HEXAHYDRO-1H-CYCLOOCTA[B]PYRROLE-2-CARBALDEHYDE; 4,5,6,7-TETRAFLUOROINDOLE-3-CARBOXALDEHYDE; 4,5,6,7-TETRAHYDRO-1H-INDOLE-2-CARBALDEHYDE; 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINE-3-CARBALDEHYDE; 4,5,6,7-TETRAHYDRO-2H-ISOINDOLE-1,3-DICARBALDEHYDE; 4,5,6,7-TETRAHYDRO-2H-ISOINDOLE-1-CARBALDEHYDE; 4,5,6,7-TETRAHYDRO-4-OXO-2H-PYRROLO[3,4-C]PYRIDINE-1-CARBOXALDEHYDE; 4,5,6,7-TETRAHYDRO-5-OXO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBOXALDEHYDE; 4,5,6,7-TETRAHYDRO-7,7-DIMETHYL-1H-INDOLE-2-CARBOXALDEHYDE; 4,5,6,7-TETRAHYDROBENZOIMIDAZOLE-2-CARBALDEHYDE; 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBALDEHYDE; 4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBALDEHYDE; 4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDINE-2-CARBALDEHYDE; 4,5-DICHLOROINDOLE-3-CARBOXALDEHYDE; 4,5-DIETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4,5-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 4,5-DIHYDRO-4-OXO-3H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXALDEHYDE; 4,5-DIHYDRO-4-OXO-FURO[3,2-C]PYRIDINE-2-CARBOXALDEHYDE; 4,5-DIMETHOXY-1H-INDOLE-3-CARBALDEHYDE; 4,5-DIMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4,5-DIMETHYLPYRROLE-2-CARBOXALDEHYDE; 4,6-DICHLOROINDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-3-INDOLE CARBOXALDEHYDE; 4,7-DICHLOROINDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHOXY-1H-INDOLE-3-CARBALDEHYDE; 4,7-DIMETHYL-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 4-[(2,4-DINITROPHENYL)AMINO]BENZALDEHYDE; 4-[(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]BENZALDEHYDE; 4-[(2-METHOXY)ETHYLAMINO]-2-METHYLTHIO-5-PYRIMIDINECARBOXALDEHYDE; 4-[(2-METHOXYBENZYL)AMINO]-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXALDEHYDE; 4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 4-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 4-[(3-METHOXYBENZYL)AMINO]-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXALDEHYDE; 4-[2-(1H-BENZIMIDAZOL-2-YLTHIO)ETHOXY]BENZALDEHYDE; 4-[2-(1H-IMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 4-[2-(1H-IMIDAZOL-4-YL)-VINYL]BENZALDEHYDE; 4-[2-(2-METHYLIMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 4-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 4-[2-HYDROXY-3-[(1-METHYLETHYL)AMINO]PROPOXY]BENZALDEHYDE; 4-[3-(4-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-[3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-[3-(CYCLOPROPYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 4-[3-(N-ETHYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 4-[4-(ETHYLCARBAMOYL)-3-FLUOROPHENYL]-2-FORMYLPHENOL; 4-[5-(4-FLUOROPHENYL)-1,3,4-OXADIAZOL-2-YL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-[5-(4-METHOXYPHENYL)-1,3,4-OXADIAZOL-2-YL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-[N-(2-PYRIDYLAMINO)ETHOXY]BENZALDEHYDE; 4-ACETAMIDOBENZALDEHYDE; 4-ACETAMIDOPHENYLGLYOXAL HYDRATE; 4-ACETYL-1H-PYRROLE-2-CARBALDEHYDE; 4-ACETYL-3,5-DIMETHYL-PYRROLE-2-CARBOXALDEHYDE; 4-ACETYL-3-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-ACETYL-5-FORMYL-3-METHYL-PYRROLE-2-CARBOXYLIC ACID; 4-ACETYL-5-METHYL-PYRROLE-3-CARBOXALDEHYDE; 4-AMINO-1,2-DIHYDRO-2-OXO-5-PYRIMIDINECARBOXALDEHYDE; 4-AMINO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-AMINO-1H-PYRROLO[3,2-C]PYRIDINE-2-CARBALDEHYDE; 4-AMINO-2-PYRROLIDINECARBALDEHYDE; 4-AMINOINDOLE-3-CARBOXALDEHYDE; 4-AMINO-N-(4-FORMYL-3-METHYL-PHENYL)-BUTYRAMIDE HYDROCHLORIC ACID; 4-BENZYLOXYINDOLE-3-CARBOXALDEHYDE; 4-BENZYLOXYMETHYL-1H-INDOLE-3-CARBALDEHYDE; 4-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-BROMO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-BROMO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-BROMO-2-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 4-BROMO-2-(4-FORMYL-1H-IMIDAZOL-2-YL)-PHENOL; 4-BROMO-2-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 4-BROMO-2-(DIMETHYLAMINO)-1H-INDOLE-3-CARBALDEHYDE; 4-BROMO-5-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-BROMO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-BROMO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-BROMO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-BROMO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-BROMO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-BROMO-7-CHLORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-BROMO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-BROMO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-BROMO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-BROMOINDOLE-3-CARBOXALDEHYDE; 4-BROMO-N-(1-METHYL-3-OXOPROPYL)BENZAMIDE; 4-BUTYL-5-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-CARBOXALDEHYDE-N-ISOPROPYLBENZAMIDE; 4-CHLORO-1H-INDOLE-2-CARBALDEHYDE; 4-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 4-CHLORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-2-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 4-CHLORO-2-CYCLOPROPYL-6-(CYCLOPROPYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 4-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 4-CHLORO-5-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 4-CHLORO-5-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBALDEHYDE; 4-CHLORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-CHLOROINDOLE-3-CARBALDEHYDE; 4-CHLORO-N-(1-METHYL-3-OXOPROPYL)BENZAMIDE; 4-CHLORO-N-(3-FORMYL-PHENYL)-BENZAMIDE; 4-CYCLOHEXYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-CYCLOHEXYL-5-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-CYCLOPROPOXY-2-(METHYLAMINO)BENZALDEHYDE; 4-CYCLOPROPOXY-2-(METHYLAMINO)NICOTINALDEHYDE; 4-CYCLOPROPOXY-2-FORMYL-N-METHYLBENZAMIDE; 4-CYCLOPROPOXY-2-FORMYL-N-METHYLNICOTINAMIDE; 4-CYCLOPROPOXY-3-(METHYLAMINO)BENZALDEHYDE; 4-CYCLOPROPOXY-3-(METHYLAMINO)PICOLINALDEHYDE; 4-CYCLOPROPOXY-3-FORMYL-N-METHYLBENZAMIDE; 4-CYCLOPROPOXY-3-FORMYL-N-METHYLPICOLINAMIDE; 4-CYCLOPROPOXY-5-(METHYLAMINO)NICOTINALDEHYDE; 4-CYCLOPROPOXY-5-(METHYLAMINO)PICOLINALDEHYDE; 4-CYCLOPROPOXY-5-FORMYL-N-METHYLNICOTINAMIDE; 4-CYCLOPROPOXY-5-FORMYL-N-METHYLPICOLINAMIDE; 4-CYCLOPROPOXY-6-(METHYLAMINO)-1,6-DIHYDROPYRIDINE-2-CARBALDEHYDE; 4-CYCLOPROPOXY-6-(METHYLAMINO)NICOTINALDEHYDE; 4-CYCLOPROPOXY-6-ETHYL-1,6-DIHYDROPYRIDINE-2-CARBALDEHYDE; 4-CYCLOPROPOXY-6-FORMYL-N-METHYLNICOTINAMIDE; 4-CYCLOPROPOXY-6-FORMYL-N-METHYLPICOLINAMIDE; 4-CYCLOPROPOXY-6-METHOXY-1,6-DIHYDROPYRIDINE-2-CARBALDEHYDE; 4-CYCLOPROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-ETHENYL-1H-PYRROLE-2-CARBOXALDEHYDE; 4-ETHOXY-1H-INDOLE-3-CARBALDEHYDE; 4-ETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-ETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-ETHYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-ETHYL-3-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-ETHYL-3-METHYL-5-OXO-3-PYRROLINE-2-CARBOXALDEHYDE; 4-ETHYL-5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-ETHYL-5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER; 4-ETHYLINDOLE-3-CARBOXALDEHYDE; 4-ETHYNYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-ETHYNYL-3-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 4-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 4-FLUORO-1H-INDOLE-7-CARBALDEHYDE; 4-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-FLUORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-FLUORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-FLUORO-2-(4-FORMYL-IMIDAZOL-2-YL)-6-METHYLPHENOL; 4-FLUORO-2-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 4-FLUORO-5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FLUORO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-N-(1-METHYL-3-OXOPROPYL)BENZAMIDE; 4-FORMYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-FORMYL-1H-INDOLE-6-CARBOXYLIC ACID ETHYL ESTER; 4-FORMYL-1H-PYRROLE-2-CARBONITRILE; 4-FORMYL-1H-PYRROLE-2-CARBOTHIOIC ACID O-ETHYL ESTER; 4-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2-HYDROXY-N-METHYLBENZAMIDE; 4-FORMYL-2-METHOXYPHENYL METHYLCARBAMATE; 4-FORMYL-2-METHOXYPHENYL PHENYLCARBAMATE; 4-FORMYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-3-HYDROXY-N-METHYLBENZAMIDE; 4-FORMYL-5-METHOXY-N-PHENYLNICOTINAMIDE; 4-FORMYL-5-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER; 4-FORMYL-5-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID METHYL ESTER; 4-FORMYL-7-AZAINDOLE-3-CARBOXYLIC ACID METHYL ESTER; 4-FORMYL-IMIDAZOLE-2-CARBOXYLIC ACID ETHYL ESTER; 4-FORMYL-IMIDAZOLE-2-CARBOXYLIC ACID METHYL ESTER; 4-FORMYL-N-METHYL-BENZAMIDE; 4-FORMYL-N-PHENYL-BENZAMIDE; 4-FORMYLPHENYL 2-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YL)ACETATE; 4-FORMYLPHENYL N-PHENYLCARBAMATE; 4-FORMYLPIPERIDINE; 4-FORMYLPIPERIDINE HCL; 4H-FURO[3,2-B]PYRROLE-2-CARBALDEHYDE; 4-HYDROXY-1H-INDOLE-3-CARBALDEHYDE; 4-HYDROXY-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-HYDROXY-2-(METHYLAMINO)BENZALDEHYDE; 4-HYDROXY-3-(METHYLAMINO)BENZALDEHYDE; 4-HYDROXY-5-AZAINDOLE-3-CARBALDEHYDE; 4-HYDROXYMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE HCL; 4-IMIDAZOLIDINEACETALDEHYDE, 4-[(2S)-2,3-DIHYDROXYPROPYL]-A-HYDROXY-2,5-DIOXO-, (AR,4R)-; 4-IMIDAZOLIDINEACETALDEHYDE, A-HYDROXY-2,5-DIOXO-4-(1,2,3-TRIHYDROXYPROPYL)-, [4S-[AS*,4R*(1R*,2S*)]]-; 4-IODO-7-AZAINDOLE-3-CARBALDEHYDE; 4-ISOPROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBALDEHYDE; 4-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-METHOXY-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-METHOXY-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 4-METHOXY-2-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 4-METHOXY-2-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 4-METHOXY-3-([(5-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]METHYL)BENZALDEHYDE; 4-METHOXY-3-([METHYL(PIPERIDIN-4-YL)AMINO]METHYL)BENZALDEHYDE; 4-METHOXY-3-(PIPERAZIN-1-YLMETHYL)BENZALDEHYDE; 4-METHOXY-3-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 4-METHOXY-3-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 4-METHOXY-3-[(3-OXOPIPERAZIN-1-YL)METHYL]BENZALDEHYDE; 4-METHOXY-3-[(5-OXO-1,4-DIAZEPAN-1-YL)METHYL]BENZALDEHYDE; 4-METHOXY-3-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 4-METHOXY-5-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-METHOXY-7-METHYLINDOLE-3-CARBOXALDEHYDE; 4-METHOXYCARBONYL-7-AZAINDOLE-3-CARBALDEHYDE; 4-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 4-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-METHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-METHYL-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-METHYL-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-METHYL-5-AZAINDOLE-3-CARBOXALDEHYDE; 4-METHYL-5-METHOXY-7-AZAINDOLE-3-CARBALDEHYDE; 4-METHYL-7-NITRO-1H-INDOLE-3-CARBALDEHYDE; 4-METHYLAMINO-2-METHYLSULFANYL-6-(TRIFLUOROMETHYL)PYRIMIDIN-5-CARBALDEHYDE; 4-METHYLAMINO-2-METHYLSULFANYL-PYRIMIDINE-5-CARBALDEHYDE; 4-METHYLINDOLE-2-CARBALDEHYDE; 4-METHYL-INDOLE-6-CARBOXALDEHYDE; 4-N-BOC-AMINO-3-FLUOROBENZALDEHYDE; 4-NITRO-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-NITRO-1H-PYRROLE-2-CARBALDEHYDE; 4-NITRO-1H-PYRROLE-3-CARBALDEHYDE; 4-NITRO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-NITRO-3-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 4-NITROINDOLE-3-CARBOXALDEHYDE; 4-OXO-1H-QUINOLINE-3-CARBALDEHYDE; 4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBOXALDEHYDE; 4-OXO-2,4,6,7-TETRAHYDROPYRANO[3,4-C]PYRROLE-1-CARBALDEHYDE; 4-OXO-3,4-DIHYDROQUINAZOLINE-2-CARBALDEHYDE; 4-OXO-3,4-DIHYDRO-QUINAZOLINE-8-CARBALDEHYDE; 4-OXO-4-(1H-PYRROL-2-YL)BUTANAL; 4-OXO-4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-A]PYRAZINE-2-CARBALDEHYDE; 4-OXO-5,6,7,8-TETRAHYDRO-4H-1,5,8A-TRIAZA-AZULENE-2-CARBALDEHYDE; 4-PHENETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-PHENYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXALDEHYDE; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBOXALDEHYDE; 4-PHENYL-4-PIPERIDINECARBOXALDEHYDE; 4-PHENYLAMINOBENZALDEHYDE; 4-PIPERAZIN-1-YL-BENZALDEHYDE; 4-PIPERAZIN-1-YLBENZALDEHYDE HCL; 4-PIPERIDIN-4-YLMETHYLIMIDAZOLE-2-CARBALDEHYDE HCL; 4-PIPERIDINECARBOXYLIC ACID, 4-FORMYL-; 4-PYRIDIN-2-YL-1H-PYRROLE-2-CARBALDEHYDE; 4-STYRYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-TERTBUTYLOXYCARBONYL-AMINOPHENYLACETALDEHYDE; 4-THIOPHEN-2-YL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-((1H-PYRROL-2-YL)METHYL)-1H-PYRROLE-2-CARBALDEHYDE; 5-((2R)-2-PIPERIDYL)PYRIDINE-2-CARBALDEHYDE; 5-((2R)-2-PIPERIDYL)PYRIDINE-3-CARBALDEHYDE; 5-((2R)AZETIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2R)AZETIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 5-((2R)PIPERAZIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2R)PYRROLIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2R)PYRROLIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 5-((2S)-2-PIPERIDYL)PYRIDINE-2-CARBALDEHYDE; 5-((2S)-2-PIPERIDYL)PYRIDINE-3-CARBALDEHYDE; 5-((2S)AZETIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2S)AZETIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 5-((2S)PIPERAZIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2S)PYRROLIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2S)PYRROLIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 5-((3R)MORPHOLIN-3-YL)PYRIDINE-2-CARBALDEHYDE; 5-((3R)MORPHOLIN-3-YL)PYRIDINE-3-CARBALDEHYDE; 5-((3S)MORPHOLIN-3-YL)PYRIDINE-2-CARBALDEHYDE; 5-((3S)MORPHOLIN-3-YL)PYRIDINE-3-CARBALDEHYDE; 5-(1,1-DIMETHYLETHYL)-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1,1-DIMETHYLETHYL)-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1,1-DIMETHYLETHYL)-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1,1-DIMETHYLETHYL)-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1,1-DIMETHYLETHYL)-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1,3-DIOXO-2,3-DIHYDRO-1H-ISOINDOL-5-YL)-2-FURALDEHYDE; 5-(1-BENZOTHIEN-2-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(1-BENZOTHIEN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE; 5-(1H-IMIDAZOL-2-YL)-PENTANAL; 5-(1H-IMIDAZOL-4-YL)-PENTANAL; 5-(1H-INDOL-2-YL)-2,4-DIMETHOXYBENZALDEHYDE; 5-(1H-INDOL-2-YL)-3-METHOXY-1H-PYRROLE-2-CARBALDEHYDE; 5-(1-METHYLETHYL)-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1-METHYLETHYL)-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1-METHYLETHYL)-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(2,2,6,6-TETRAMETHYL-1,2,3,6-TETRAHYDRO-PYRIDIN-4-YL)-THIOPHENE-2-CARBALDEHYDE; DIHYDRO-1-BENZOFURAN-5-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2,3-DIHYDRO-1H-INDOL-5-YL)-2-FURALDEHYDE; 5-(2,3-DIHYDRO-1H-INDOL-5-YL)-2-THIOPHENECARBALDEHYDE; 5-(2,3-DIOXO-2,3-DIHYDRO-1H-INDOL-5-YL)-2-FURALDEHYDE; 5-(2,3-DIOXO-2,3-DIHYDRO-1H-INDOL-5-YL)-2-THIOPHENE CARBALDEHYDE; 5-(2-BROMOPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(2-CHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2-FLUOROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(2-FURYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2-METHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2-METHOXYPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(2-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2-PROPEN-1-YL)-1H-PYRROLE-2-CARBOXALDEHYDE; 5-(2-THIENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-ACETYLAMINOPHENYL)-2-FORMYLPHENOL; 5-(3-BROMOPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-CHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-CHLORO-PHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 5-(3-CHLOROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-FLUOROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-METHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-METHOXYPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-1-YL)FURAN-2-CARBALDEHYDE; 5-(3-OXOPIPERAZIN-1-YL)FURAN-2-CARBALDEHYDE; 5-(3-QUINOLINYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-THIENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-BROMOPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-CHLORO-3-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-CHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-CHLOROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-FLUOROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-FORMYLIMIDAZOL-2-YL)-2-METHOXY-PHENOL; 5-(4H-1,2,4-TRIAZOL-3-YLTHIO)-2-FURALDEHYDE; 5-(4-METHOXY-PHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 5-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-NITROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-TERT-BUTYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(5-ETHYL-1,3,4-OXADIAZOL-2-YL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 5-(5-ISOPROPYL-1,3,4-OXADIAZOL-2-YL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 5-(5-OXO-1,4-DIAZEPAN-1-YL)FURAN-2-CARBALDEHYDE; 5-(5-PYRIMIDINYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(6-METHYL-1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE; 5-(AZETIDIN-3-YL)PICOLINALDEHYDE; 5-(BENZYLOXY)-1H-PYRROLO[3,2-B]PYRIDINE-2-CARBALDEHYDE; 5-(METHYLAMINO)-2-PYRIDINECARBOXALDEHYDE; 5-(N1-PIPERAZINYL)THIOPHENE-2-CARBOXALDEHYDE; 5-(PIPERAZIN-1-YL)FURAN-2-CARBALDEHYDE; 5-(PIPERIDIN-3-YL)PICOLINALDEHYDE; 5-(PIPERIDIN-4-YL)PICOLINALDEHYDE; 5-(PYRIDIN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(PYRIDIN-4-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(PYRROLIDIN-3-YL)PICOLINALDEHYDE; 5-(TRIFLUOROMETHOXY)INDOLE-3-CARBOXALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(TRIMETHYLSILYL)-1H-PYRROLE-2-CARBOXALDEHYDE; 5,5′-METHYLENEBIS(1H-PYRROLE-2-CARBALDEHYDE); 5,5′-METHYLENEBIS(3,4-DIMETHYL-1H-PYRROLE-2-CARBALDEHYDE); 5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE-3-CARBALDEHYDE; 5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDINE-2-CARBALDEHYDE; 5,6,7,8-TETRAHYDRO-7-OXO-PYRIDO[2,3-D]PYRIMIDINE-2-CARBOXALDEHYDE; 5,6,7,8-TETRAHYDRO-IMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE; 5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE-2-CARBALDEHYDE; 5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE-4-CARBALDEHYDE; 5,6-DICHLORO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 5,6-DICHLORO-1H-INDOLE-2-CARBALDEHYDE; 5,6-DICHLOROINDOLE-3-CARBOXALDEHYDE; 5,6-DIFLUORO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 5,6-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 5,6-DIMETHOXY-1H-INDOLE-3-CARBALDEHYDE; 5,6-DIMETHYL-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 5,6-DIOXO-PIPERAZINE-2-CARBALDEHYDE; 5,7-DICHLORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 5,7-DICHLORO-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 5,8-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 5-[(2,2,6,6-TETRAMETHYL-4-OXO-3-PIPERIDINYLIDENE)METHYL]-2-THIOPHENECARBALDEHYDE; 5-[(4-METHYLPHENYL)SULFANYL]-2-PHENYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-[(5-METHYL-1H-BENZIMIDAZOL-2-YL)THIO]-2-FURALDEHYDE; 5-[(7-CHLORO-4-QUINOLINYL)AMINO]-2-HYDROXYBENZALDEHYDE; 5-[3-(1,3-DIOXOLAN-2-YL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[3-(CYCLOPROPYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 5-[3-(N-ETHYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 5-[3-(TRIFLUOROMETHYL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[4-(1,3-DIOXOLAN-2-YL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[4-(DIMETHYLAMINO)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[4-(ETHYLCARBAMOYL)-3-FLUOROPHENYL]-2-FORMYLPHENOL; 5-[4-(METHYLSULFANYL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[4-(METHYLSULFONYL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[4-(TRIFLUOROMETHYL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[5-(4-FLUOROPHENYL)-1,3,4-OXADIAZOL-2-YL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 5-[5-(4-METHOXYPHENYL)-1,3,4-OXADIAZOL-2-YL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 5-ACETYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-AMINO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-AMINO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-AMINOINDOLE-3-CARBOXALDEHYDE; 5-ANILINO-3-PHENYL-4-ISOXAZOLECARBALDEHYDE; 5-BENZOYL-1H-INDOLE-3-CARBALDEHYDE; 5-BENZYLOXY-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBOXALDEHYDE; 5-BENZYLOXYINDOLE-3-CARBOXALDEHYDE; 5-BENZYLOXYMETHYL-1H-INDOLE-3-CARBALDEHYDE; 5-BROMO-1H-INDOLE-2-CARBALDEHYDE; 5-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-BROMO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 5-BROMO-2-(2-FLUOROANILINO)BENZALDEHYDE; 5-BROMO-2-(4-FLUOROANILINO)BENZALDEHYDE; 5-BROMO-2-(DIMETHYLAMINO)-1H-INDOLE-3-CARBALDEHYDE; 5-BROMO-2-(METHYLAMINO)NICOTINALDEHYDE; 5-BROMO-2-[(2-FURYLMETHYL)AMINO]BENZALDEHYDE; 5-BROMO-2-CYCLOPROPYL-1H-INDOLE-3-CARBOXALDEHYDE; 5-BROMO-2-CYCLOPROPYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 5-BROMO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-BROMO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-BROMO-2-TERT-BUTYL-1H-INDOLE-3-CARBALDEHYDE; 5-BROMO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5-BROMO-3-FORMYL-6-METHYL-7-AZAINDOLE; 5-BROMO-3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 5-BROMO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-BROMO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-4-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-BROMO-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-BROMO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-BROMO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-BROMO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-BROMOBENZIMIDAZOLE-2-CARBOXALDEHYDE; 5-BROMOINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-1H-INDOLE-2-CARBALDEHYDE; 5-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 5-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 5-CHLORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 5-CHLORO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 5-CHLORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2,5-DIMETHYLANILINO)BENZALDEHYDE; 5-CHLORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2-FLUOROANILINO)BENZALDEHYDE; 5-CHLORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(3-CHLORO-4-METHYLANILINO)BENZALDEHYDE; 5-CHLORO-2-(3-CHLOROANILINO)BENZALDEHYDE; 5-CHLORO-2-(3-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(4-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(4-ETHOXYANILINO)BENZALDEHYDE; 5-CHLORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(5-CHLORO-2-METHYLANILINO)BENZALDEHYDE; 5-CHLORO-2-(METHYLAMINO)NICOTINALDEHYDE; 5-CHLORO-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 5-CHLORO-2-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 5-CHLORO-2-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 5-CHLORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-CYCLOHEXYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-CYCLOPROPYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-CHLORO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-CHLORO-2-PHENYL-1H-INDOLE-3-CARBALDEHYDE; 5-CHLORO-3-ETHYLAMINO-PYRIDINE-2-CARBALDEHYDE; 5-CHLORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5-CHLORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER; 5-CHLORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID METHYL ESTER; 5-CHLORO-3-FORMYL-6-METHYL-7-AZAINDOLE; 5-CHLORO-3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 5-CHLORO-3-METHYLAMINO-PYRIDINE-2-CARBALDEHYDE; 5-CHLORO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-6-FLUORO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 5-CHLORO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-CHLOROINDOLE-3-CARBOXALDEHYDE; 5-CYANO-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXALDEHYDE; 5-CYANOINDOLE-3-CARBOXALDEHYDE; 5-CYCLOPROPOXY-2-(METHYLAMINO)BENZALDEHYDE; 5-CYCLOPROPOXY-2-(METHYLAMINO)ISONICOTINALDEHYDE; 5-CYCLOPROPOXY-2-(METHYLAMINO)NICOTINALDEHYDE; 5-CYCLOPROPOXY-2-FORMYL-N-METHYLBENZAMIDE; 5-CYCLOPROPOXY-2-FORMYL-N-METHYLISONICOTINAMIDE; 5-CYCLOPROPOXY-2-FORMYL-N-METHYLNICOTINAMIDE; 5-CYCLOPROPOXY-3-(METHYLAMINO)PICOLINALDEHYDE; 5-CYCLOPROPOXY-3-FORMYL-N-METHYLPICOLINAMIDE; 5-CYCLOPROPOXY-4-(METHYLAMINO)NICOTINALDEHYDE; 5-CYCLOPROPOXY-4-(METHYLAMINO)PICOLINALDEHYDE; 5-CYCLOPROPOXY-4-FORMYL-N-METHYLNICOTINAMIDE; 5-CYCLOPROPOXY-4-FORMYL-N-METHYLPICOLINAMIDE; 5-CYCLOPROPOXY-6-(METHYLAMINO)NICOTINALDEHYDE; 5-CYCLOPROPOXY-6-(METHYLAMINO)PICOLINALDEHYDE; 5-CYCLOPROPOXY-6-FORMYL-N-METHYLNICOTINAMIDE; 5-CYCLOPROPOXY-6-FORMYL-N-METHYLPICOLINAMIDE; 5-CYCLOPROPYL-1H-INDOLE-3-CARBALDEHYDE; 5′-DEOXYINOSINE DIALDEHYDE; 5-DIETHYLAMINO-2-(4-FORMYLIMIDAZOL-2-YL)-PHENOL; 5-ETHOXY-1H-INDOLE-3-CARBALDEHYDE; 5-ETHOXY-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 5-ETHYL-2-FORMYL-1H-PYRROLE-3-CARBONITRILE; 5-ETHYL-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-ETHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ETHYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-ETHYL-4-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-ETHYNYL-3,4-DIMETHYL-1H-PYRROLE-2-CARBALDEHYDE; 5-FLUORO-1,2-DIHYDRO-2-OXO-4-PYRIDINECARBOXALDEHYDE; 5-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 5-FLUORO-1H-PYRROLE-2-CARBALDEHYDE; 5-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 5-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 5-FLUORO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 5-FLUORO-2-(2,3,4-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(2,4,5-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 5-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 5-FLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 5-FLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-FLUORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5-FLUORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER; 5-FLUORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID METHYL ESTER; 5-FLUORO-3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 5-FLUORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-6-IODO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 5-FLUORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-FLUOROBENZIMIDAZOLE-2-CARBOXALDEHYDE; 5-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-INDOLE-7-CARBOXALDEHYDE; 5-FORMYL-1H-PYRROL-2-YLBORONIC ACID; 5-FORMYL-1H-PYRROLE-2-CARBONITRILE; 5-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-1H-PYRROLE-3-CARBONITRILE; 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-FORMYL-2,4-DIMETHYLPYRROLE-3-PROPIONIC ACID, METHYL ESTER; 5-FORMYL-2-HYDROXY-N-METHYLBENZAMIDE; 5-FORMYL-2-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID METHYL ESTER; 5-FORMYL-3,4-DIMETHYL-1H-PYRROLE-2-CARBONITRILE; 5-FORMYL-3,4-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER; 5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-4-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-4-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER; 5-FORMYL-4-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID METHYL ESTER; 5-FORMYL-4-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-FORMYLIMIDAZOLE-4-CARBOXYLIC ACID METHYL ESTER; 5-FORMYLPYRROLE-2-CARBOXYLIC ACID METHYL ESTER; 5-FORMYLURACIL; 5-FORMYLURIDINE; 5H-PYRIMIDO[5,4-B]INDOLE-8-CARBOXALDEHYDE; 5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXALDEHYDE; 5-HYDROXY-1H-INDOLE-3-CARBALDEHYDE; 5-HYDROXY-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-HYDROXY-2-(METHYLAMINO)BENZALDEHYDE; 5-HYDROXY-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-HYDROXY-4-AZAINDOLE-3-CARBALDEHYDE; 5-HYDROXY-4-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-IODO-7-AZAINDOLE-3-CARBOXALDEHYDE; 5-ISOPROPYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ISOPROPYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-METHOXY INDOLE-3-CARBOXALDEHYDE, [3-14C]; 5-METHOXY-1H-INDOLE-2-CARBALDEHYDE; 5-METHOXY-1H-INDOLE-4-CARBALDEHYDE; 5-METHOXY-1H-PYRROLE-2-CARBOXALDEHYDE; 5-METHOXY-1H-PYRROLO[2,3-C]PYRIDINE-2-CARBALDEHYDE; 5-METHOXY-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 5-METHOXY-1H-PYRROLO[3,2-B]PYRIDINE-2-CARBALDEHYDE; 5-METHOXY-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 5-METHOXY-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 5-METHOXY-2-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 5-METHOXY-2-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 5-METHOXY-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 5-METHOXY-3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 5-METHOXY-4-METHYLINDOLE-3-CARBOXALDEHYDE; 5-METHOXY-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-METHOXYBENZIMIDAZOLE-2-CARBOXALDEHYDE; 5-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-METHOXYINDOLE-7-CARBOXALDEHYDE; 5-METHYL-1-(7H-PURIN-6-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-METHYL-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE HYDROCHLORIDE; 5-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-METHYL-1H-INDOLE-2-CARBALDEHYDE; 5-METHYL-1H-INDOLE-7-CARBOXALDEHYDE; 5-METHYL-1H-PYRROLE-2,4-DICARBALDEHYDE; 5-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 5-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-METHYL-2-(2,3,4-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(2,4,5-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRROLE-2-CARBALDEHYDE; 5-METHYL-4-AZAINDOLE-3-CARBALDEHYDE; 5-METHYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-METHYL-4-NITRO-1H-PYRROLE-2-CARBALDEHYDE; 5-METHYL-4-NITRO-1H-PYRROLE-3-CARBALDEHYDE; 5-METHYL-4-PROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-METHYLINDOLE-3-CARBOXALDEHYDE; 5-NITRO-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-NITRO-1H-INDOLE-2-CARBALDEHYDE; 5-NITRO-1H-INDOLE-3-CARBALDEHYDE; 5-NITRO-1H-PYRROLE-2-CARBALDEHYDE; 5-NITRO-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBALDEHYDE; 5-NITRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-NITRO-2-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 5-NITRO-2-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 5-NITRO-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 5-OXO-4,5-DIHYDROPYRAZINE-2-CARBALDEHYDE; 5-PHENYL-1H-INDOLE-3-CARBALDEHYDE; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXALDEHYDE; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXALDEHYDE; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBOXALDEHYDE; 5-PHENYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-PHENYLPYRROLE-2-CARBOXALDEHYDE; 5-P-TOLYL-1H-PYRROLE-2-CARBALDEHYDE; 5-TERT-BUTYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-TERT-BUTYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-TERT-BUTYL-2-CYCLOPENTYL-1H-INDOLE-3-CARBALDEHYDE; 5-TERT-BUTYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-TERT-BUTYL-PYRROLE-2-CARBALDEHYDE; 5-THIEN-2-YL-1H-PYRROLE-2-CARBALDEHYDE; 6-((2R)-2-PIPERIDYL)PYRIDINE-2-CARBALDEHYDE; 6-((2R)-2-PIPERIDYL)PYRIDINE-3-CARBALDEHYDE; 6-((2R)AZETIDIN-2-YL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((2R)AZETIDIN-2-YL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((2R)AZETIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 6-((2R)AZETIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 6-((2R)PYRROLIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 6-((2R)PYRROLIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 6-((2S)-2-PIPERIDYL)PYRIDINE-2-CARBALDEHYDE; 6-((2S)-2-PIPERIDYL)PYRIDINE-3-CARBALDEHYDE; 6-((2S)AZETIDIN-2-YL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((2S)AZETIDIN-2-YL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((2S)AZETIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 6-((2S)AZETIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 6-((2S)PYRROLIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 6-((2S)PYRROLIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 6-((3R)MORPHOLIN-3-YL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((3R)MORPHOLIN-3-YL)PYRIDINE-2-CARBALDEHYDE; 6-((3R)MORPHOLIN-3-YL)PYRIDINE-3-CARBALDEHYDE; 6-((3S)MORPHOLIN-3-YL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((3S)MORPHOLIN-3-YL)PYRIDINE-2-CARBALDEHYDE; 6-((3S)MORPHOLIN-3-YL)PYRIDINE-3-CARBALDEHYDE; 6-(1H-IMIDAZOL-2-YL)-HEXANAL; 6-(1H-IMIDAZOL-4-YL)-HEXANAL; 6-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 6-(2-METHOXYBENZYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-2-CARBALDEHYDE; 6(3,9-DIAZASPIRO[5.5]UNDEC-3-YL)NICOTINALDEHYDE; 6-(3-ACETYLAMINOPHENYL)-2-FORMYLPHENOL; 6-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 6-(3-OXOPIPERAZIN-1-YL)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE; 6-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 6-(4-FORMYL-1H-IMIDAZOL-2-YL)-NAPHTHALEN-2-OL; 6-(4-FORMYLIMIDAZOL-2-YL)2,3-DIMETHOXYBENZOIC ACID; 6-(5-OXO-1,4-DIAZEPAN-1-YL)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE; 6-(AMINOMETHYL)-4-CYCLOPROPOXY-1,6-DIHYDROPYRIDINE-2-CARBALDEHYDE; 6-(BENZYLAMINO)-5-NITRONICOTINALDEHYDE; 6-(BENZYLAMINO)NICOTINALDEHYDE; 6-(BENZYLOXY)-5-METHYL-1H-INDOLE-3-CARBALDEHYDE; 6-(BUTYLAMINO)NICOTINALDEHYDE; 6-(CYCLOPROPYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-2-CARBALDEHYDE; 6-(CYCLOPROPYLAMINO)NICOTINALDEHYDE; 6-(ETHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-2-CARBALDEHYDE; 6-(ETHYLAMINO)NICOTINALDEHYDE; 6-(ISOPENTYLAMINO)-5-NITRONICOTIN-ALDEHYDE; 6-(ISOPROPYLAMINO)-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-(ISOPROPYLAMINO)NICOTINALDEHYDE; 6-(METHYLAMINO)NICOTINALDEHYDE; 6-(PHENYLAMINO)NICOTINALDEHYDE; 6-(PIPERIDIN-4-YLOXY)NICOTINALDEHYDE; 6-(PROPYLAMINO)NICOTINALDEHYDE; 6-(PYRIDIN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; 6-(PYRIDIN-4-YL)-1H-INDOLE-3-CARBALDEHYDE; 6-(PYRROLIDIN-3-YL)NICOTINALDEHYDE; 6-(TERT-BUTYLAMINO)NICOTINALDEHYDE; 6-(TRIFLUOROMETHOXY)-1H-INDOLE-3-CARBALDEHYDE; 6-(TRIFLUOROMETHYL)-1H-IMIDAZO[4,5-B]PYRIDINE-2-CARBALDEHYDE; 6-(TRIFLUOROMETHYL)-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-(TRIFLUOROMETHYL)-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-(TRIFLUOROMETHYL)INDOLE-3-CARBOXALDEHYDE; 6,7-DICHLOROINDOLE-3-CARBOXALDEHYDE; 6,7-DIETHOXY-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 6,7-DIFLUORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 6-[(1-BENZYL-4-PIPERIDYL)AMINO]NICOTINALDEHYDE; 6-[(2-METHOXYETHYL)AMINO]-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-[3-(CYCLOPROPYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 6-[3-(N-ETHYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 6-[4-(ETHYLCARBAMOYL)-3-FLUOROPHENYL]-2-FORMYLPHENOL; 6-ACETAMIDOHEXANAL; 6-AMINO-1-(2-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-FURYLMETHYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(2-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(3-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-BENZYL-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-AMINO-1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-2,4-DIOXO-1-(2-PHENYLETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1-(PYRIDIN-3-YLMETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-4-OXO-1-PHENYL-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINOINDOLE-3-CARBOXALDEHYDE; 6-AZAINDOLE-3-CARBOXALDEHYDE; 6-BENZOYL-1H-INDOLE-3-CARBALDEHYDE; 6-BENZYLOXYINDOLE-3-CARBOXALDEHYDE; 6-BENZYLOXYMETHYL-1H-INDOLE-3-CARBALDEHYDE; 6-BROMO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-BROMO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-BROMO-1H-INDOLE-2-CARBALDEHYDE; 6-BROMO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(DIMETHYLAMINO)-1H-INDOLE-3-CARBALDEHYDE; 6-BROMO-2-OXO-1,2,3,4-TETRAHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-BROMO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-BROMO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-BROMO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-BROMO-4-OXO-3,4-DIHYDROQUINAZOLINE-2-CARBALDEHYDE; 6-BROMO-5-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-BROMO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-BROMO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-BROMO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-BROMOINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-CHLORO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-CHLORO-1H-INDOLE-2-CARBALDEHYDE; 6-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-CYCLOHEXYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-2-CYCLOPROPYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-2-METHYL-1H-BENZO[D]IMIDAZOLE-5-CARBALDEHYDE; 6-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 6-CHLORO-4-(METHYLAMINO)NICOTINALDEHYDE; 6-CHLORO-4-AZAINDOLE-3-CARBALDEHYDE; 6-CHLORO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-5-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-5-METHOXY-1H-INDOLE-3-CARBALDEHYDE; 6-CHLORO-7-FLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-METHYL-1H-INDOLE-2-CARBALDEHYDE; 6-CHLOROINDOLE-3-CARBOXALDEHYDE; 6-ETHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-ETHOXYINDOLE-3-CARBOXALDEHYDE; 6-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-ETHYLINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 6-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 6-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 6-FLUORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-FLUORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-3-CARBALDEHYDE; 6-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 6-FLUORO-4,5-DIHYDRO-IMIDAZOL[1,5-A]QUINOXALIN-3-CARBALDEHYDE; 6-FLUORO-4-AZAINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-4-HYDROXY-1H-INDOLE-2-CARBALDEHYDE; 6-FLUORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-4-METHOXY-1H-INDOLE-2-CARBALDEHYDE; 6-FLUORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-7-METHYL-1H-INDOLE-2-CARBALDEHYDE; 6-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-FORMYL-2,3-DIHYDRO-1H-INDOLE HYDROCHLORIDE; 6-FORMYL-2-THIOURACIL; 6-FORMYL-2-THIOURACIL HYDRATE; 6-FORMYL-3-IMINO-4-METHYL-N-PHENYL-3,4-DIHYDRO-2-PYRAZINECARBOXAMIDE; 6-FORMYL-8-FLUORO-2H-1,4-BENZOXAZIN-3(4H)-ONE; 6-FORMYL-N-ISOPROPYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2-CARBOXAMIDE; 6-FORMYL-URACIL MONOHYDRATE; 6H-THIENO[2,3-B]PYRROLE-3-CARBOXALDEHYDE; 6-HYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBALDEHYDE; 6-HYDROXY-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-HYDROXY-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-HYDROXY-4-AZAINDOLE-3-CARBALDEHYDE; 6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-HYDROXYNICOTINALDEHYDE; 6-IODO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-METHOXY-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-METHOXY-1H-INDOLE-3-CARBALDEHYDE; 6-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 6-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 6-METHOXY-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-METHOXY-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-METHOXY-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 6-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 6-METHOXY-9H-PURINE-8-CARBALDEHYDE; 6-METHYL-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-METHYL-1H-INDOLE-2-CARBALDEHYDE; 6-METHYL-1H-INDOLE-4-CARBALDEHYDE; 6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-METHYL-2-OXO-1,2-DIHYDROQUINOLIN-3-CARBALDEHYDE; 6-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 6-METHYL-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 6-METHYL-5-AZAINDOLE-3-CARBOXALDEHYDE; 6-METHYLINDOLE-3-CARBOXALDEHYDE; 6-NITRO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-NITRO-1H-INDOLE-3-CARBALDEHYDE; 6-NITRO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-NITRO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 6-OXO-5,6,7,8-TETRAHYDRO-IMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE; 6-OXO-5,6-DIHYDRO-[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBALDEHYDE; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXALDEHYDE; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXALDEHYDE; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE; 6-PIPERAZIN-1-YLNICOTINALDEHYDE; 6-QUINOXALINECARBOXALDEHYDE, 3,4-DIHYDRO-3-OXO-; 6-TRIFLUOROMETHOXY-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-TRIFLUOROMETHYL-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 7-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 7-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 7-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 7-(PYRIDIN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; 7-(PYRIDIN-4-YL)-1H-INDOLE-3-CARBALDEHYDE; 7-(TRIFLUOROMETHYL)-1H-INDOLE-2-CARBALDEHYDE; 7-(TRIFLUOROMETHYL)-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-(TRIFLUOROMETHYL)INDOLE-3-CARBOXALDEHYDE; 7-AMINO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-AMINOINDOLE-3-CARBOXALDEHYDE; 7-AZAINDOLE-4-CARBOXALDEHYDE; 7-BENZYLOXYINDOLE-3-CARBALDEHYDE; 7-BENZYLOXYMETHYL-1H-INDOLE-3-CARBALDEHYDE; 7-BROMO-1H-INDOLE-2-CARBALDEHYDE; 7-BROMO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-BROMO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-BROMO-2-CYCLOPROPYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-BROMO-2-CYCLOPROPYL-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 7-BROMO-3-FORMYL-1H-INDOLE; 7-BROMO-4-CHLORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 7-BROMO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 7-BROMO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-BROMO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-BROMO-4-METHYL-1H-INDOLE-3-CARBALDEHYDE; 7-BROMO-5-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 7-BROMO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-BROMO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-BROMO-5-METHYL-1H-INDOLE-2-CARBOXALDEHYDE; 7-BROMO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 7-BROMO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-BROMO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-CHLORO-1H-INDOLE-2-CARBALDEHYDE; 7-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 7-CHLORO-1H-INDOLE-4-CARBALDEHYDE; 7-CHLORO-1H-INDOLE-5-CARBALDEHYDE; 7-CHLORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-CHLORO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-CHLORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(3-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(4-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-CYCLOHEXYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-CYCLOHEXYL-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-CYCLOPROPYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-CYCLOPROPYL-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-CYCLOPROPYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-3,3-DIMETHYL-2,3-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 7-CHLORO-3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 7-CHLORO-4-(TRIFLUOROMETHYL)-1H-INDOLE-2-CARBALDEHYDE; 7-CHLORO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-4-METHYL-1H-INDOLE-3-CARBALDEHYDE; 7-CHLORO-5-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 7-CHLORO-5-FLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-FLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-FLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-FLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-FLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-METHYL-1H-INDOLE-2-CARBOXALDEHYDE; 7-CHLORO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-ETHOXY-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-ETHOXYINDOLE-3-CARBOXALDEHYDE; 7-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 7-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 7-FLUORO-1H-INDOLE-5-CARBALDEHYDE; 7-FLUORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-FLUORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 7-FLUORO-2-(2,3,4-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(2,4,5-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(2-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(3-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(4-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-3,3-DIMETHYL-2,3-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 7-FLUORO-3,3-DIMETHYL-2-OXO-2,3-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 7-FLUORO-4-HYDROXY-1H-INDOLE-2-CARBALDEHYDE; 7-FLUORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-FLUORO-4-METHOXY-1H-INDOLE-2-CARBALDEHYDE; 7-FLUORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-FLUORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-FORMYLGRAMINE; 7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBALDEHYDE; 7-HYDROXY-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-HYDROXY-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-INDOLINECARBOXALDEHYDE; 7-METHOXY-1H-INDOLE-2-CARBALDEHYDE; 7-METHOXY-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-METHOXY-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-METHOXY-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 7-METHOXY-2-OXO-1,2-D1HYDRO-QUINOLINE-3-CARBALDEHYDE; 7-METHOXY-3-INDOLECARBOXALDEHYDE; 7-METHYL-1H-INDOLE-2-CARBALDEHYDE; 7-METHYL-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-METHYL-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-METHYL-2-(2,3,4-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(2,4,5-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(2-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(3-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(4-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-PHENYL-1H-INDOLE-3-CARBALDEHYDE; 7-METHYL-4-OXO-2-P-TOLYLAMINO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-5-AZAINDOLE-3-CARBOXALDEHYDE; 7-METHYLINDOLE-3-CARBOXALDEHYDE; 7-METHYLSULFANYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 7-NITRO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-NITROINDOLE-3-CARBOXALDEHYDE; 7-OXO-2,3,6,7-TETRAHYDRO-[1,4]DIOXINO[2,3-G]QUINOLINE-8-CARBALDEHYDE; 8-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 8-CHLORO-5-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-4-CARBALDEHYDE; 8-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 8-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 8-METHYL-3-OXO-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE-6-CARBALDEHYDE; 8-OXO-3,4,8,9-TETRAHYDRO-2H,7H-[1,4]DIOXEPINO[2,3-F]INDOLE-9-CARBALDEHYDE; 9H-CARBAZOLE-2-CARBALDEHYDE; 9H-CARBAZOLE-3-CARBALDEHYDE; 9H-PYRIDO[3,4-B]INDOLE-1-CARBOXALDEHYDE; 9-METHYL-4-OXO-2-(2-PYRIMIDINYLAMINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; ACETAMIDE, N-(2-FORMYL-1H-INDOL-5-YL)-; ACETAMIDE, N-[4-(2-FORMYL-1H-PYRROL-1-YL)PHENYL]-; ACETYL D-MANNOSAMINE N-[MANNOSAMINE-1-14C]; ACETYL-D-GALACTOSAMINE, N-[GALACTOSAMINE-1-14C]; ACETYL-D-GLUCOSAMINE N-[GLUCOSAMINE-6-3H]; ACETYL-D-GLUCOSAMINE, N-[GLUCOSAMINE-1-14C]; ACETYL-D-MANNOSAMINE, N-[MANNOSAMINE-6-3H]; ALAHOPCIN; ALLYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; ALORACETAM; AZETIDINE-2-CARBOXALDEHYDE; AZETIDINE-3-CARBOXALDEHYDE; BENZAMIDE, N-(4,6-DIMETHYL-2-PYRIDINYL)-4-FORMYL-; BENZYL (2R)-5-AMINO-4-METHYL-1-OXOPENTAN-2-YLCARBAMATE; BENZYL (4-FORMYL-1H-IMIDAZOL-2-YL)METHYLCARBAMATE; BENZYL (4-FORMYL-6-METHYLPYRIMIDIN-2-YL)METHYLCARBAMATE; BENZYL (4-FORMYLPYRIMIDIN-2-YL)METHYLCARBAMATE; BENZYL (5-FORMYLPYRIMIDIN-2-YL)METHYLCARBAMATE; BENZYL 2-(4-FORMYL-1H-IMIDAZOL-2-YL)ETHYLCARBAMATE; BENZYL 2-(5-FORMYLPYRIMIDIN-2-YL)ETHYLCARBAMATE; BENZYL 2-(FORMYLMETHYL)PHENYLCARBAMATE; BENZYL 2-OXOETHYLCARBAMATE; BENZYL 3-FORMYL-1H-INDOLE-2-CARBOXYLATE; BENZYL 3-FORMYLBICYCLO[2.2.1]HEPT-5-EN-2-YLCARBAMATE; BENZYL 4-ETHYL-5-FORMYL-3-METHYL-2-PYRROLECARBOXYLATE; BENZYL 4-FORMYLBENZYLCARBAMATE; BENZYL 4-FORMYLPYRIDIN-2-YLCARBAMATE; BENZYL 4-OXOBUTYLCARBAMATE; BENZYL 5-FORMYL-2-HYDROXYPHENYLCARBAMATE; BENZYL 6-FORMYLPYRIDIN-3-YLCARBAMATE; BENZYL CIS-4-FORMYLCYCLOHEXYLCARBAMATE; BENZYL FORMYL(4-HYDROXYPHENYL)METHYLCARBAMATE; BENZYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; BENZYL N-[(5-FORMYL-2-THIENYL)METHYL]CARBAMATE; BML-244; BOC-1-AMINO-1-CYCLOPENTANECARBOXALDEHYDE; BOC-ALA-ALDEHYDE; BOC-L-CYSTEINAL; BOC-L-ISOLEUCINAL; BOC-L-METHIONINAL; BOC-L-VALINAL; BUTYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; BUTYRAMIDO-MALONALDEHYDIC ACID; CALPAIN INHIBITOR III; CARBAMIC ACID, (1-FORMYLPROPYL)-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, (2,2-DIMETHYL-3-OXOPROPYL)-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, (3-OXOPROPYL)-, ETHYL ESTER; CARBAMIC ACID, (3-OXOPROPYL)-, METHYL ESTER; CARBAMIC ACID, (5-OXOPENTYL)-, PHENYLMETHYL ESTER; CARBAMIC ACID, [(1S)-1-FORMYL-2-(PHENYLMETHOXY)ETHYL]-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, [(1S)-1-FORMYLPROPYL]-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, N-(1,1-DIMETHYL-2-OXOETHYL)-, PHENYLMETHYL ESTER; CARBAMIC ACID, N-(3-OXOPROPYL)-, 9H-FLUOREN-9-YLMETHYL ESTER; CARBAMIC ACID, N-(4-OXOBUTYL)-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, N-(6-OXOHEXYL)-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, N-(6-OXOHEXYL)-, PHENYLMETHYL ESTER; CARBAMIC ACID, N-(8-OXOOCTYL)-, PHENYLMETHYL ESTER; CHROMOGEN I; CIS-N-(4-FORMYL-CYCLOHEXYL)-ACETAMIDE; DIETHYL-[4-(4-FORMYLIMIDAZOL-2-YL)-PHENYL]-AMINE; ETHOXY-N-(2-FORMYL(3-THIENYL))FORMAMIDE; ETHYL (1S,2S)-2-FORMYL-1-(4-METHOXYPHENYL)-3-METHYLBUTYLCARBAMATE; ETHYL (3-FORMYL-1H-INDOL-2-YL)ACETATE; ETHYL 2-(4-FORMYLPHENYL)IMIDAZOLE-4-CARBOXYLATE; ETHYL 2-(ACETYLAMINO)-2-CYANO-3-METHYL-5-OXOPENTANOATE; ETHYL 2-CYANO-3-(5-FORMYL-1H-PYRROL-2-YL)-2-PROPENOATE; ETHYL 3,5-DIMETHYL-4-(3-OXOPROP-1-ENYL)-1H-PYRROLE-2-CARBOXYLATE; ETHYL 3-FORMYL-1H-INDOLE-2-CARBOXYLATE; ETHYL 3-FORMYL-5-METHOXY-1H-INDOLE-2-CARBOXYLATE; ETHYL 3-FORMYL-5-METHYL-1H-INDOLE-2-CARBOXYLATE; ETHYL 3-FORMYL-7-(METHYLSULFANYL)-1H-INDOLE-2-CARBOXYLATE; ETHYL 3-FORMYL-7-NITRO-1H-INDOLE-2-CARBOXYLATE; ETHYL 4,6-DICHLORO-3-FORMYL-1H-INDOLE-2-CARBOXYLATE; ETHYL 4-FORMYL-1H-PYRROLE-2-CARBOXYLATE; ETHYL 4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE; ETHYL 4-FORMYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLATE; ETHYL 4-FORMYL-5-METHYL-1H-PYRROLE-3-CARBOXYLATE; ETHYL 5-(ACETYLAMINO)-4-FORMYL-3-METHYLTHIOPHENE-2-CARBOXYLATE; ETHYL 5-BROMO-3-FORMYL-1H-INDOLE-2-CARBOXYLATE; ETHYL 5-ETHYL-3-FORMYL-1H-INDOLE-2-CARBOXYLATE; ETHYL 5-FORMYL-1H-PYRROLE-2-CARBOXYLATE; ETHYL 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE; ETHYL 5-FORMYL-2-OXO-2,3-DIHYDRO-1H-IMIDAZOLE-4-CARBOXYLATE; ETHYL 5-FORMYLIMIDAZOLE-4-CARBOXYLATE; ETHYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; ETHYL N-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; ETHYL N-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; ETHYL N-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; FMOC-ALA-ALDEHYDE; FMOC-D-ALA-ALDEHYDE; GLUCOSAMIDE HCL; GUANOSINE PERIODATE OXIDIZED; HEXYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; IMIDAZOLE-2-CARBOXALDEHYDE; INDOLE-3,4-DICARBOXALDEHYDE; INDOLE-3,5-DICARBOXALDEHYDE; INDOLE-3,6-DICARBOXALDEHYDE; INDOLE-3,7-DICARBOXALDEHYDE; INDOLE-3-CARBOXALDEHYDE; INDOLE-4-CARBOXALDEHYDE; INDOLE-5-CARBOXALDEHYDE; INDOLE-6-CARBOXALDEHYDE; INDOLE-7-CARBOXALDEHYDE; ISOBUTYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; ISOINDOLINE-4-CARBALDEHYDE HCL; METHYL 2-FLUORO-4-FORMYLPHENYLCARBAMATE; METHYL 3-((2R)AZETIDIN-2-YL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((2S)AZETIDIN-2-YL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-(3-FORMYL-1H-INDOL-5-YL)BENZOATE; METHYL 3-(AZETIDIN-3-YL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-[(1R)-1-(METHYLAMINO)ETHYL]-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-[(1S)-1-(METHYLAMINO)ETHYL]-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-[(1S)-2-HYDROXY-1-(METHYLAMINO)ETHYL]-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-FLUORO-4-FORMYLPHENYLCARBAMATE; METHYL 3-FORMYL-1H-INDOLE-2-CARBOXYLATE; METHYL 3-FORMYL-1H-INDOLE-5-CARBOXYLATE; METHYL 3-FORMYL-4-HYDROXY-5-(PIPERIDIN-3-YL)BENZOATE; METHYL 3-FORMYL-4-HYDROXY-5-(PIPERIDIN-4-YL)BENZOATE; METHYL 3-FORMYL-4-HYDROXY-5-(PYRROLIDIN-3-YL)BENZOATE; METHYL 3-FORMYL-4-METHOXY-1H-INDOLE-2-CARBOXYLATE; METHYL 3-FORMYL-5-METHANESULFONYL-1H-INDOLE-2-CARBOXYLATE; METHYL 3-FORMYL-5-METHOXY-1H-INDOLE-2-CARBOXYLATE; METHYL 3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLATE; METHYL 3-FORMYLINDOLE-6-CARBOXYLATE; METHYL 3-FORMYLPHENYLCARBAMATE; METHYL 4-(3-FORMYL-1H-INDOL-5-YL)BENZOATE; METHYL 4-FORMYL-1H-PYRROLE-2-CARBOXYLATE; METHYL 4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE; METHYL 4-FORMYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLATE; METHYL 4-FORMYLPHENYLCARBAMATE; METHYL 5-(2-FORMYL-1H-PYRROL-1-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXYLATE; METHYL 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE; METHYL 5-FORMYLPYRROLE-3-CARBOXYLATE; METHYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; METHYL N-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; METHYL N-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; METHYL N-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; METHYL3-FORMYL-4,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLATE; N-((5-FORMYLFURAN-2-YL)METHYL)ACETAMIDE; N-(1,1-DIMETHYLETHYL)-N′-(3-FORMYL-1H-INDAZOL-4-YL)-UREA; N-(1,1-DIMETHYLETHYL)-N′-(3-FORMYL-1H-INDAZOL-5-YL)-UREA; N-(1,1-DIMETHYLETHYL)-N′-(3-FORMYL-1H-INDAZOL-7-YL)-UREA; N-(11-OXO-UNDECYL)-ACETAMIDE; N-(1-CYCLOPROPYLETHYL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(1-METHYL-3-OXOPROPYL)-1-BENZOTHIOPHENE-2-CARBOXAMIDE; N-(1-METHYL-3-OXOPROPYL)BENZAMIDE; N-(2-(DIETHYLAMINO)ETHYL)-5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE; N-(2-(FORMYLMETHYL)BENZYL)ACETAMIDE; N-(2-(FORMYLMETHYL)PHENYOACETAMIDE; N-(2,3-DIMETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2,3-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2,3-DIMETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2,4-DIMETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2,4-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2,4-DIMETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2,5-DIMETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2,5-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2,5-DIMETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2,6-DICHLORO-4-FORMYLPHENYL)ACETAMIDE; N-(2,6-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2-ACETAMIDOETHYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-ACETAMIDOETHYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-ACETAMIDOETHYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-BROMO-5-FORMYLPYRIDIN-3-YL)PIVALAMIDE; N-(2-CHLORO-3-FORMYLPYRIDIN-4-YL)PIVALAMIDE; N-(2-CHLORO-6-FORMYLPYRIDIN-3-YL)PIVALAMIDE; N-(2-CHLOROPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2-CHLOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CHLOROPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2-CHLOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CHLOROPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2-CHLOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CYANO-5-FORMYLPYRIDIN-3-YL)PIVALAMIDE; N-(2-CYANOETHYL)-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CYANOETHYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CYANOETHYL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-(2-CYANOETHYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CYANOETHYL)-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(2-ETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2-ETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2-ETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2-FLUOROPHENYL)-2-(2-FORMYL-1H-IMIDAZOL-1-YL)ACETAMIDE; N-(2-FLUOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-FLUOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-FLUOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N′-(2-FORMYL-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE; N-(2-FORMYL-3-METHOXYPHENYL)-2,2-DIMETHYLPROPANAMIDE; N-(2-FORMYL-3-METHOXYPYRIDIN-4-YL)PIVALAMIDE; N-(2-FORMYL-4,5-DIMETHOXY-PHENYL)-ACETAMIDE; N-(2-FORMYL-4-METHOXY-PHENYL)-ACETAMIDE; N-(2-FORMYL-4-METHYL-PHENYL)-ACETAMIDE; N-(2-FORMYL-4-NITROPHENYL)ACETAMIDE; N-(2-FORMYL-5,8-DIOXO-5,8-DIHYDROQUINOLIN-7-YL)ACETAMIDE; N′-(2-FORMYL-5-METHOXY-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE; N-(2-FORMYL-5-METHOXY-PHENYL)-ACETAMIDE; N′-(2-FORMYL-5-METHYL-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE; N′-(2-FORMYL-5-METHYL-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE HYDROCHLORIDE; N-(2-FORMYL-5-METHYL-PHENYL)-ACETAMIDE; N′-(2-FORMYL-6-METHYL-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE; N-(2-FORMYL-6-METHYL-PHENYL)-ACETAMIDE; N-(2-FORMYLFURO[3,2-B]PYRIDIN-7-YL)PIVALAMIDE; N-(2-FORMYLPHENYL)-3-NITROBENZAMIDE; N-(2-FORMYL-PHENYL)-ACETAMIDE; N-(2-FORMYLPHENYL)CYCLOPROPANECARBOXAMIDE; N-(2-FORMYLPHENYL)FORMAMIDE; N-(2-FORMYLQUINOLIN-6-YL)ACETAMIDE; N-(2-METHOXYETHYL)-2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; N-(2-METHOXYETHYL)-2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-(2-METHYL-3-OXO-PROPYL)-ACETAMIDE; N-(2-OXO-1-THIOPHEN-3-YL-ETHYL)-ACETAMIDE; N-(3,4-DIFLUORO-2-FORMYLPHENYL)PIVALAMIDE; N-(3,4-DIMETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(3,4-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(3,4-DIMETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3,5-DIMETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(3,5-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(2-FORMYL-1H-IMIDAZOL-1-YL)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-CYANOTHIOPHEN-2-YL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-CYANOTHIOPHEN-2-YL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-CYANOTHIOPHEN-2-YL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-DIMETHYLAMINO-PROPYL)-4-FORMYL-BENZAMIDE; N′-(3-ETHYL-5-FORMYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-PYRIMIDIN-4-YL)-N,N-DIMETHYL-FORMAMIDINE; N-(3-FLUOROPHENYL)-2-(2-FORMYL-1H-IMIDAZOL-1-YL)ACETAMIDE; N-(3-FLUOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-FLUOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-FLUOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3′-FORMYL[1,1′-BIPHENYL]-3-YL)ACETAMIDE; N-(3′-FORMYL[1,1′-BIPHENYL]-4-YL)ACETAMIDE; N-(3-FORMYL-2-METHYL-PHENYL)-ACETAMIDE; N-(3-FORMYL-2-PYRIDINYL)-2,2-DIMETHYLPROPANAMIDE; N-(3-FORMYL-4-METHYL-PHENYL)-ACETAMIDE; N-(3-FORMYL-4-PYRIDINYL)-2,2-DIMETHYLPROPANAMIDE; N-(3-FORMYL-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)PIVALAMIDE; N-(3-FORMYL-5-METHYLPYRIDIN-2-YL)PIVALAMIDE; N-(3-FORMYL-BENZYL)-ACETAMIDE; N-(3-FORMYLPHENYL)-4-METHOXYBENZAMIDE; N-(3-FORMYL-PHENYL)-4-METHYL-BENZAMIDE; N-(3-FORMYL-PYRAZIN-2-YL)-ACETAMIDE; N-(3-FORMYL-PYRIDIN-2-YL)-ACETAMIDE; N-(3-FORMYL-PYRIDIN-4-YL)-ACETAMIDE; N-(3-FORMYLQUINOLIN-7-YL)ACETAMIDE; N-(3-OXO-1-PHENYLPROPYL)ACETAMIDE; N-(4-((5-FORMYL-2-METHOXYBENZYL)OXY)PHENYL)ACETAMIDE; N-(4-(2-OXOACETYL)PHENYL)ACETAMIDE; N-(4-[(2-FORMYLPIPERIDIN-1-YL)METHYL]-1,3-THIAZOL-2-YL)ACETAMIDE; N-(4-[(2-OXOETHYL)SULFANYL]PHENYL)ACETAMIDE; N-(4-[(3-FORMYLPIPERIDIN-1-YL)METHYL]-1,3-THIAZOL-2-YL)ACETAMIDE; N-(4-[(3-OXOPROPYL)SULFANYL]PHENYL)ACETAMIDE; N-(4-[(4-FORMYLPIPERIDIN-1-YL)METHYL]-1,3-THIAZOL-2-YL)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(2-FORMYL-1H-IMIDAZOL-1-YL)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4-ETHOXYPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(4-ETHOXYPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(4-ETHOXYPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(4-ETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(4-ETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(4-ETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(4-FLUOROPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(4-FLUOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4-FLUORO-PHENYL)-2-(3-FORMYL-INDOL-1-YL)-ACETAMIDE; N-(4-FLUOROPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(4-FLUOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4-FLUOROPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(4-FLUOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4′-FORMYL[1,1-BIPHENYL]-2-YL)ACETAMIDE; N-(4′-FORMYL[1,1-BIPHENYL]-3-YL)ACETAMIDE; N-(4′-FORMYL[1,1′-BIPHENYL]-4-YL)ACETAMIDE; N-(4-FORMYL-1,3-THIAZOL-2-YL)ACETAMIDE; N-(4-FORMYL-1H-PYRAZOL-3-YL)-ACETAMIDE; N-(4-FORMYL-2-HYDROXY-PHENYL)-ACETAMIDE; N-(4-FORMYL-2-METHOXY-PHENYL)-ACETAMIDE; N-(4-FORMYL-2-METHOXYPYRIDIN-3-YL)PIVALAMIDE; N-(4-FORMYL-2-METHYL-PHENYL)-ACETAMIDE; N-(4-FORMYL-2-TRIFLUOROMETHOXY-PHENYL)-ACETAMIDE; N-(4-FORMYL-3-METHYLPHENYL)ACETAMIDE; N-(4-FORMYL-3-NITRO-PHENYL)-ACETAMIDE; N-(4-FORMYL-PYRIDIN-2-YL)-ACETAMIDE; N-(4-FORMYL-PYRIDIN-3-YL)-2,2-DIMETHYL-PROPIONAMIDE; N-(4-FORMYLPYRIDIN-3-YL)ACETAMIDE; N′-(5-[(5-FORMYL-1H-PYRROL-3-YL)CARBONYL]-1,3-THIAZOL-2-YL)-N,N-DIMETHYLIMINOFORMAMIDE; N-(5-BROMO-2-FORMYL-QUINOLIN-6-YL)-ACETAMIDE; N-(5-BROMO-2-FORMYL-QUINOLIN-8-YL)-ACETAMIDE; N-(5-BROMO-4-FORMYL-1,3-THIAZOL-2-YL)ACETAMIDE; N′-(5-CHLORO-2-FORMYL-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE; N-(5-CHLORO-3-FORMYLPYRIDIN-2-YL)PIVALAMIDE; N-(5-FLUORO-3-FORMYLPYRIDIN-2-YL)PIVALAMIDE; N-(5-FORMYL-1H-IMIDAZOL-2-YL)-ACETAMIDE; N-(5-FORMYL-2H-[1,2,4]TRIAZOL-3-YL)-ACETAMIDE; N-(5-FORMYL-2-HYDROXYPHENYL)ACETAMIDE; N-(5-FORMYL-2-METHOXY-PHENYL)-ACETAMIDE; N-(5-FORMYL-2-METHYLPHENYL)ACETAMIDE; N-(5-FORMYL-2-THIENYL)ACETAMIDE; N-(5-FORMYL-FURAN-2-YLMETHYL)-BENZAMIDE; N-(5-FORMYL-PYRIDIN-2-YL)-ACETAMIDE; N-(5-FORMYL-PYRIDIN-3-YL)-ACETAMIDE; N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINE; N-(5-FORMYL-THIAZOL-2-YL)-ACETAMIDE; N-(5-OXO-PENTYL)-ACETAMIDE; N-(6-CHLORO-3-FORMYL-PYRIDIN-2-YL)-2,2-DIMETHYL-PROPIONAMIDE; N-(6-FLUORO-3-FORMYLPYRIDIN-2-YL)PIVALAMIDE; N-(6-FORMYL-BENZO[1,3]DIOXOL-5-YL)-ACETAMIDE; N-(6-FORMYL-PYRIDIN-2-YL)-ACETAMIDE; N-(6-FORMYLPYRIDIN-2-YL)PIVALAMIDE; N-(7-FORMYL-[1,8]NAPHTHYRIDIN-2-YL)-ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-(BUTAN-2-YL)-2-(3-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(3-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-(BUTAN-2-YL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-(BUTAN-2-YL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(BUTAN-2-YL)-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-(BUTAN-2-YL)-2-(4-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-(BUTAN-2-YL)-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-3-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PROPANAMIDE; N-(CYANOMETHYL)-2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-ETHOXY-6-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYL-4-NITROPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYANOMETHYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYANOMETHYL)-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(5-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(TERT-BUTYL)-2-(2-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; N-(TERT-BUTYL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(TERT-BUTYL)-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(TERT-BUTYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-[2-(2-FORMYLPHENOXY)PHENYL]ACETAMIDE; N-[2-(2-FORMYLPIPERIDIN-1-YL)ETHYL]ACETAMIDE; N-[2-(2-OXOETHOXY)PHENYL]ACETAMIDE; N-[2-(3-FORMYL-2-HYDROXYPHENYL)PHENYL]-2,2-DIMETHYLPROPANAMIDE; N-[2-(3-FORMYL-4-HYDROXYPHENYL)PHENYL]-2,2-DIMETHYLPROPANAMIDE; N-[2-(3-FORMYLPIPERIDIN-1-YL)ETHYL]ACETAMIDE; N-[2-(3-OXOPROPOXY)PHENYL]ACETAMIDE; N-[2-(4-FORMYLPHENOXY)PHENYL]ACETAMIDE; N-[2-(4-FORMYLPIPERIDIN-1-YL)ETHYL]ACETAMIDE; N-[2-(4-FORMYLPYRIDIN-3-YL)PHENYL]-2,2-DIMETHYLPROPANAMIDE; N-[2-(5-FORMYL-2-FURYL)PHENYL]ACETAMIDE; N-[2-(5-FORMYL-2-HYDROXYPHENYL)PHENYL]-2,2-DIMETHYLPROPANAMIDE; N-[2-(5-FORMYLPYRIDIN-3-YL)PHENYL]-2,2-DIMETHYLPROPANAMIDE; N-[2-OXO-1-(2-OXO-1,2-DIHYDRO-QUINOLIN-4-YLMETHYL)-ETHYL]-ACETAMIDE; N-[3-(2-OXOETHOXY)PHENYL]ACETAMIDE; N-[3-(3-OXOPROPOXY)PHENYL]ACETAMIDE; N-[3-(5-FORMYL-2-FURYL)PHENYL]ACETAMIDE; N-[3-(BENZYLOXY)-4-FORMYLPHENYL]ACETAMIDE; N-[4-(2-FORMYLPHENOXY)PHENYL]ACETAMIDE; N-[4-(2-OXOETHOXY)PHENYL]ACETAMIDE; N-[4-(2-OXO-ETHYL)-PHENYL]-ACETAMIDE; N-[4-(2-OXO-ETHYL)-THIAZOL-2-YL]-ACETAMIDE; N-[4-(2-OXO-ETHYL)-THIAZOL-2-YL]-FORMAMIDE; N-[4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PHENYL]ACETAMIDE; N-[4-(3-OXOPROPOXY)PHENYL]ACETAMIDE; N-[4-(3-OXO-PROPYL)-PHENYL]-ACETAMIDE; N-[4-(5-FORMYL-2-FURYL)PHENYL]ACETAMIDE; N-ACETYL-D-GALACTOSAMINE; N-ACETYL-D-GLUCOSAMINE; N-ACETYL-D-GLUCOSAMINE-2-3H; N-ACETYL-D-MANNOSAMINE; N-ACETYL-D-MANNOSAMINE MONOHYDRATE; N-ACETYLMURAMIC ACID; N-BENZYL-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-BENZYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-BENZYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BENZYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-BENZYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BENZYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-BENZYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BENZYLAMINOACETALDEHYDE; N-BOC-D-PHENYLALANINAL; N-BOC-L-PHENYLALANINAL; N-BUTYL-2-(2-CHLORO-4-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(2-CHLORO-4-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-BUTYL-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-BUTYL-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-BUTYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BUTYL-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-BUTYL-2-(3-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(3-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BUTYL-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-BUTYL-2-(4-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(4-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-BUTYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-BUTYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-BUTYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BUTYL-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-BUTYL-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-CYCLOHEPTYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEPTYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEPTYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-CYCLOHEPTYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEXYL-2-(2-FORMYL-1H-IMIDAZOL-1-YL)ACETAMIDE; N-CYCLOHEXYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-CYCLOHEXYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEXYL-2-(3-FORMYL-2-METHYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOHEXYL-2-(3-FORMYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOHEXYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-CYCLOHEXYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEXYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-CYCLOHEXYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-CYCLOHEXYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-CYCLOHEXYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEXYL-3-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOHEXYL-3-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOHEXYL-3-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPENTYL-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPENTYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPENTYL-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPENTYL-2-(3-FORMYL-2-METHYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOPENTYL-2-(3-FORMYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOPENTYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPENTYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPENTYL-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPENTYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-CYCLOPENTYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPENTYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPENTYL-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(METHYL)AMINO)ACETAMIDE; N-CYCLOPROPYL-2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-ETHOXY-6-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-4-NITROPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-5-PROPOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)ACETAMIDE; N-CYCLOPROPYL-2-(3-FORMYL-2-METHYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOPROPYL-2-(3-FORMYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOPROPYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPROPYL-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(5-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETAMIDE; N-CYCLOPROPYL-2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-3-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(2-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-3-(3-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-3-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(4-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-3-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-4-FORMYLBENZAMIDE; N-ETHYL-2-((3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL)(METHYL)AMINO)ACETAMIDE; N-ETHYL-2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(METHYL)AMINO)ACETAMIDE; N-ETHYL-2-([(5-FORMYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)ACETAMIDE; N-ETHYL-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-2-(2-FORMYL-4-METHYLPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-4-NITROPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-4-NITROPHENOXY)PROPANAMIDE; N-ETHYL-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-2-(2-FORMYL-5-PROPOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-ETHYL-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)ACETAMIDE; N-ETHYL-2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PROPANAMIDE; N-ETHYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-ETHYL-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-ETHYL-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; N-ETHYL-2-(4-FORMYL-2-METHOXY-6-NITROPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-2-(4-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYL-2-NITROPHENOXY)PROPANAMIDE; N-ETHYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-ETHYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-ETHYL-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-2-(5-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-ETHYL-2-(5-FORMYL-2-NITROPHENOXY)PROPANAMIDE; N-ETHYL-2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]ACETAMIDE; N-ETHYL-2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(2-FORMYL-4-NITROPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FORMYL-2-NITROPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETAMIDE; N-ETHYL-2-[ETHYL((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL))AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(2-FLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(2-FORMYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(2-OXOETHYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(4-FLUORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(4-FORMYL-2-METHYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(4-FORMYL-3-METHYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(4-FORMYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(5-FORMYLFURAN-2-YL)AMINO]ACETAMIDE; N-ETHYL-2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; N-ETHYL-2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-ETHYL-3-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-3-(2-FORMYL-4-NITROPHENOXY)PROPANAMIDE; N-ETHYL-3-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-3-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-3-(2-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-3-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-3-(3-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-3-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-3-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; N-ETHYL-3-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-3-(4-FORMYL-2-NITROPHENOXY)PROPANAMIDE; N-ETHYL-3-(4-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-3-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-3-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-3-(5-FORMYL-2-NITROPHENOXY)PROPANAMIDE; N-ETHYL-3-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]PROPANAMIDE; N-ETHYL-4-(2-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; N-ETHYL-4-(3-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; N-ETHYL-4-(4-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; N-ETHYLGLUCOSAMINE; N-METHYL-1-(2-OXOETHYL)PIPERIDINE-4-CARBOXAMIDE; N-METHYL-1-(3-OXOPROPYL)PIPERIDINE-2-CARBOXAMIDE; N-METHYL-1-(3-OXOPROPYL)PIPERIDINE-4-CARBOXAMIDE; N-METHYL-1-(3-OXOPROPYL)PYRROLIDINE-2-CARBOXAMIDE; N-METHYL-2-[(2-OXOETHYL)(PROPYL)AMINO]ACETAMIDE; N-METHYL-2-[(3-OXOPROPYL)(PROPYL)AMINO]ACETAMIDE; N-METHYL-2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; N-METHYL-2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-NITROSO-4-METHYLAMINOBENZALDEHYDE; N-OCTYL-D-GLUCOSAMINE; N-PROPANOYL-D-GLUCOSAMINE; N-TERT-BOC-2-(4-FORMYL-2-METHOXYPHENOXY)ETHYLAMINE-D3; N-TERT-BUTYL-2-(2-CHLORO-4-FORMYLPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(2-CHLORO-4-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-TERT-BUTYL-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-TERT-BUTYL-2-(3-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(3-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-TERT-BUTYL-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-TERT-BUTYL-2-(4-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(4-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-TERT-BUTYL-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-TERT-BUTYL-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-TERT-BUTYL-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; OROTALALDEHYDE; PHENACETURIC ACID,-ALPHA-FORMYL-ALPHA-METHYL-; PIPERIDINE-3-CARBALDEHYDE; PRINCETON PBMR041959; PROPANAMIDE, N-(2-FORMYLPHENYL)-2,2-DIMETHYL; PROPYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; PYRROLE-2-CARBOXALDEHYDE; PYRROLIDINE-2-CARBALDEHYDE; RARECHEM AQ NN 0175; RO 08-2750; T-BUTYL N-(2-OXOETHYL)CABAMATE; TERT-BUTYL (1S,2R)-1-(5-FORMYLOXAZOL-2-YL)-2-METHYLBUTYLCARBAMATE; TERT-BUTYL (1S,2S)-1-(5-FORMYLOXAZOL-2-YL)-2-METHYLBUTYLCARBAMATE; TERT-BUTYL (2S)-1-OXO-3-PHENYLBUTAN-2-YLCARBAMATE; TERT-BUTYL (4-FORMYL-2-METHOXYPYRIDIN-3-YL)CARBAMATE; TERT-BUTYL (4-FORMYL-5-METHYLISOXAZOL-3-YL)CARBAMATE; TERT-BUTYL (5-FORMYL-2-NAPHTHYL)CARBAMATE; TERT-BUTYL (5-FORMYLPYRIDIN-2-YL)CARBAMATE; TERT-BUTYL (6-CHLORO-3-FORMYLPYRIDIN-2-YL)CARBAMATE; TERT-BUTYL (R)-1-FORMYL-3-METHYLBUTYL CARBAMATE; TERT-BUTYL (S)-1-FORMYL-2-(4-HYDROXYPHENYL)ETHYLCARBAMATE; TERT-BUTYL (S)1-FORMYL-3-METHYLBUTYLCARBAMATE; TERT-BUTYL [(1S)-2-CYCLOHEXYL-1-FORMYLETHYL]CARBAMATE; TERT-BUTYL [(1S,3S)-1-FORMYL-3-METHYLPENTYL]CARBAMATE; TERT-BUTYL 1-(FORMYLMETHYL)CYCLOHEXYL CARBAMATE; TERT-BUTYL 1-FORMYL-2-(3-HYDROXYPHENYL)ETHYLCARBAMATE; TERT-BUTYL 1-FORMYLPENTYLCARBAMATE; TERT-BUTYL 1-OXOPROPAN-2-YLCARBAMATE; TERT-BUTYL 2-(5-FORMYLPYRIMIDIN-2-YLAMINO)ACETATE; TERT-BUTYL 2-(FORMYLMETHYL)BENZYLCARBAMATE; TERT-BUTYL 2-(FORMYLMETHYL)PHENYLCARBAMATE; TERT-BUTYL 2,6-DICHLORO-4-FORMYLPHENYLCARBAMATE; TERT-BUTYL 2-CHLORO-3-FORMYLPYRIDIN-4-YLCARBAMATE; TERT-BUTYL 2-FLUORO-6-FORMYLPHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-3-METHOXYPHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-4-(TRIFLUOROMETHYL)PHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-4,6-DIMETHYLPHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-5-(TRIFLUOROMETHYL)PHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-5-METHOXYPHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-6-(TRIFLUOROMETHYL)PHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-6,7-DIHYDROTHIAZOLO[5,4-C]PYRIDINE-5(4H)-CARBOXYLATE; TERT-BUTYL 2-FORMYL-6-METHYLPHENYLCARBAMATE; TERT-BUTYL 2-FORMYLFURAN-3-YLCARBAMATE; TERT-BUTYL 2-FORMYLPROPAN-2-YLCARBAMATE; TERT-BUTYL 2-FORMYLQUINOLIN-6-YLCARBAMATE; TERT-BUTYL 2-FORMYLQUINOLIN-8-YLCARBAMATE; TERT-BUTYL 2-METHYL-5-OXOPENT-3-YN-2-YLCARBAMATE; TERT-BUTYL 3-(2-OXOETHYL)PYRIDIN-2-YLCARBAMATE; TERT-BUTYL 3,4,5-TRIFLUORO-2-FORMYLPHENYLCARBAMATE; TERT-BUTYL 3,4-DIFLUORO-2-FORMYLPHENYLCARBAMATE; TERT-BUTYL 3-CHLORO-2-FORMYLPHENYLCARBAMATE; TERT-BUTYL 3-FORMYL-1H-INDOL-4-YLCARBAMATE; TERT-BUTYL 3-FORMYL-5-(TRIFLUOROMETHYL)THIEN-2-YLCARBAMATE; TERT-BUTYL 3-FORMYLBENZYLCARBAMATE; TERT-BUTYL 3-FORMYLPYRIDIN-4-YLCARBAMATE; TERT-BUTYL 3-METHYL-1-OXOBUTAN-2-YLCARBAMATE; TERT-BUTYL 4-(2-OXOETHYL)PYRIDIN-2-YLCARBAMATE; TERT-BUTYL 4-CHLORO-2-FORMYLBENZYLCARBAMATE; TERT-BUTYL 4-CHLORO-2-FORMYLPHENYLCARBAMATE; TERT-BUTYL 4-CHLORO-3-FORMYLPYRIDIN-2-YLCARBAMATE; TERT-BUTYL 4-CHLORO-5-FORMYLPYRIDIN-2-YLCARBAMATE; TERT-BUTYL 4-FLUORO-2-FORMYLPHENYLCARBAMATE; TERT-BUTYL 4-FORMYL-3-(TRIFLUOROMETHYL)PHENYLCARBAMATE; TERT-BUTYL 4-FORMYLBENZO[D]THIAZOL-2-YLCARBAMATE; TERT-BUTYL 4-FORMYLPYRIDIN-2-YLCARBAMATE; TERT-BUTYL 4-FORMYLPYRIDIN-3-YLCARBAMATE; TERT-BUTYL 4-OXOBUT-2-YNYLCARBAMATE; TERT-BUTYL 5-(5-FORMYLOXAZOL-2-YL)-1-METHYL-1H-PYRROL-3-YLCARBAMATE; TERT-BUTYL 5-CHLORO-4-FORMYLPYRIDIN-2-YLCARBAMATE; TERT-BUTYL 5-FLUORO-4-FORMYLPYRIDIN-2-YLCARBAMATE; TERT-BUTYL 5-FORMYL-3,4-DIMETHYL-1H-PYRROLE-2-CARBOXYLATE; TERT-BUTYL 6-(2-OXOETHYL)PYRIDIN-2-YLCARBAMATE; TERT-BUTYL 6-FORMYL-2,3-DIMETHYLPHENYLCARBAMATE; TERT-BUTYL 6-FORMYLPYRIDIN-3-YLCARBAMATE; TERT-BUTYL 6-FORMYLPYRIMIDIN-4-YLCARBAMATE; TERT-BUTYL CIS-4-(2-OXOETHYL)CYCLOHEXYLCARBAMATE; TERT-BUTYL CIS-4-FORMYLCYCLOHEXYLCARBAMATE; TERT-BUTYL FORMYL(4-HYDROXYPHENYL)METHYLCARBAMATE; TERT-BUTYL N-(1-BENZYL-2-OXOETHYL)CARBAMATE; TERT-BUTYL N-(2-FORMYL-1-BENZOFURAN-5-YL)CARBAMATE; TERT-BUTYL N-(4-FORMYLBENZYL)CARBAMATE; TERT-BUTYL TRANS-4-(2-OXOETHYL)CYCLOHEXYLCARBAMATE; TERT-BUTYL TRANS-4-FORMYLCYCLOHEXYLCARBAMATE; TERT-BUTYL(S)-2-(4-FLUOROCYCLOHEXYL)-1-FORMYLETHYLCARBAMATE; THEOPHYLLINEACETIC ALDEHYDE; TRANS-3-(2,4-DIFLUOROPHENYL)PYRROLIDINE-2-CARBALDEHYDE; TRANS-4-(BENZYLOXYCARBONYLAMINO)CYCLOHEXANECARBALDEHYDE; TRANS-BENZYL (-4-FORMYLCYCLOHEXYL)METHYLCARBAMATE; TRANS-TERT-BUTYL (4-FORMYLCYCLOHEXYL)METHYLCARBAMATE; TRIAZOLAL;

List No. 3—Boronic Acids:

(1-([2-(TRIMETHYLSILYL)ETHOXY]METHYL)-1H-IMIDAZOL-4-YL)BORONIC ACID; (1-([2-(TRIMETHYLSILYL)ETHOXY]METHYL)-1H-IMIDAZOL-5-YL)BORONIC ACID; (1-(2-(DIMETHYLAMINO)ETHOXY)-1H-PYRAZOL-4-YL)BORONIC ACID; (1-(3-METHOXYPROPYL)-1H-PYRAZOL-4-YL)BORONIC ACID; (1,2,3,4-TETRAHYDRO-1-OXO-6-ISOQUINOLINYL)-BORONIC ACID; (1,2-DIHYDRO-2-OXO-5-PYRIMIDINYL)-BORONIC ACID; (1,2-DIHYDRO-4,8-DIMETHOXY-2-OXO-3-QUINOLINYL)-BORONIC ACID; (1-[(4-METHYLPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDIN-3-YL)BORONIC ACID; (1-[(BENZYLOXY)CARBONYL]-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)BORONIC ACID; (1-[TERT-BUTYL(DIMETHYL)SILYL]-1H-INDOL-3-YL)BORONIC ACID; (1-[TERT-BUTYL(DIMETHYL)SILYL]-1H-PYRROLO[2,3-B]PYRIDIN-5-YL)BORONIC ACID; (10-PHENYLANTHRACEN-9-YL)BORONIC ACID; (1-ACETYL-2,3-DIHYDRO-1H-INDOL-5-YL)BORONIC ACID; (1-BENZYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)BORONIC ACID; (1-BENZYLINDAZOL-5-YL)BORONIC ACID; (1-CYCLOPROPYL-1H-PYRAZOL-4-YL)BORONIC ACID; (1-METHYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)BORONIC ACID; (1-METHYL-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)BORONIC ACID; (1-METHYLBENZIMIDAZOLE-2-YL)BORONIC ACID; (1-OXO-1,3-DIHYDROISOBENZOFURAN-4-YL)BORONIC ACID; (1-OXO-1,3-DIHYDROISOBENZOFURAN-5-YL)BORONIC ACID; (1-OXO-1,3-DIHYDROISOBENZOFURAN-6-YL)BORONIC ACID; (1-OXO-1,3-DIHYDROISOBENZOFURAN-7-YL)BORONIC ACID; (1-OXO-2-PHENYLISOINDOLIN-4-YL)BORONIC ACID; (1-OXO-2-PHENYLISOINDOLIN-5-YL)BORONIC ACID; (1-OXO-2-PHENYLISOINDOLIN-6-YL)BORONIC ACID; (1-OXO-2-PHENYLISOINDOLIN-7-YL)BORONIC ACID; (1-OXO-2-PROPYLISOINDOLIN-4-YL)BORONIC ACID; (1-OXO-2-PROPYLISOINDOLIN-5-YL)BORONIC ACID; (1-OXO-2-PROPYLISOINDOLIN-6-YL)BORONIC ACID; (1-OXO-2-PROPYLISOINDOLIN-7-YL)BORONIC ACID; (1-OXOISOINDOLIN-7-YL)BORONIC ACID; (1R)-1-(2-THIENYLACETYLAMINO)-1-(3-CARBOXYPHENYL)METHYLBORONIC ACID; (1R,2S)-2-METHYLCYCLOPROPYLBORONIC ACID; (1S)-1,7,7-TRIMETHYLBICYCLO[2.2.1]HEPT-2-EN-2-YLBORONIC ACID; (1S,2S)-2-(CHLOROMETHYL)CYCLOPROPYLBORONIC ACID; (1S,2S)-2-METHYLCYCLOPROPYLBORONIC ACID; (1S,2S)-2-PHENYLCYCLOPROPYLBORONIC ACID; (1S,2S)-2-PROPYLCYCLOPROPYLBORONIC ACID; (1-TRITYL-1H-1,2,3-BENZOTRIAZOL-5-YL)BORONIC ACID; (1-TRITYL-1H-IMIDAZOL-4-YL)BORONIC ACID; (2-([(1,3-DIMETHYL-1H-PYRAZOL-5-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(2,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(2,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(2,5-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(2,5-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(2-CHLOROPHENYL)METHOXY]METHYL)PHENYL)BORANEDIOL; (2-([(2-CHLOROPHENYL)SULFANYL]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([(2E)-3-PHENYLPROP-2-EN-1-YL]OXY)PHENYL)BORANEDIOL; (2-([(2-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(3,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(3,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(3-CHLOROPHENYL)SULFANYL]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([(3-CHLOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(3-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([(4,6-DIMETHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(4-CHLOROPHENYL)SULFANYL]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([(4-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([(CYCLOHEXYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([(CYCLOPROPYLMETHYL)(PROPYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([3-(1H-IMIDAZOL-1-YL)PROPYL]AMINO)PYRIMIDIN-5-YL)BORONIC ACID; (2-([4-(DIMETHYLAMINO)PIPERIDIN-1-YL]METHYL)PHENYL)BORANEDIOL; (2-([4-(PROPAN-2-YL)PIPERAZIN-1-YL]METHYL)PHENYL)BORANEDIOL; (2-([BENZYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([BIS(2-METHOXYETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([BIS(2-METHYLPROPYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([BUTYL(CYCLOPROPYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([CYCLOHEPTYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([CYCLOHEXYL(ETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([CYCLOHEXYL(METHYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([CYCLOPENTYL(ETHYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([CYCLOPROPYL(2-METHOXYETHYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([ETHYL(2-ETHYLBUTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([ETHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([METHYL(1-METHYLPIPERIDIN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([METHYL(4-METHYLCYCLOHEXYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([METHYL(PYRIDIN-2-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([METHYL(PYRIDIN-3-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([METHYL(PYRIDIN-4-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-(2-(DIMETHYLAMINO)ETHOXY)PYRIDIN-4-YL)BORONIC ACID; (2-(2-HYDROXYETHYL)-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-(2-HYDROXYETHYL)-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-(2-HYDROXYETHYL)-1-OXOISOINDOLIN-6-YL)BORONIC ACID; (2-(2-HYDROXYETHYL)-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-(2-METHOXYETHYL)PYRIDIN-4-YL)BORONIC ACID; (2-(3-(DIMETHYLAMINO)PROPYL)PYRIDIN-4-YL)BORONIC ACID; (2-(3-METHOXYPROPYL)PYRIDIN-4-YL)BORONIC ACID; (2-(4-CHLORO-BENZYL)-AMINOPYRIMIDIN-5-YL)BORONIC ACID; (2-(CYANOMETHYL)-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-(CYANOMETHYL)-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-(CYANOMETHYL)-1-OXOISOINDOLIN-6-YL)BORONIC ACID; (2-(CYANOMETHYL)-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-(N-(3,4-DIMETHYLISOXAZOL-5-YL)-N-((2-METHOXYETHOXY)METHYL)SULFAMOYL)PHENYL)BORONIC ACID; (2-(N-(3,4-DIMETHYLISOXAZOL-5-YL)SULFAMOYL)PHENYL)BORONIC ACID; (2-(N-(TERT-BUTYL)SULFAMOYL)-5-ISOBUTYLTHIOPHEN-3-YL)BORONIC ACID; (2,2-DIMETHYL-2,3-DIHYDRO-1-BENZOFURAN-5-YL)BORANEDIOL; (2,3,5,6-TETRACHLOROPHENYL)BORANEDIOL; (2,3-DIFLUORO-4-PROPYLPHENYL)-BORONIC ACID; (2,3-DIMETHOXY-5-METHYLPHENYL)BORONIC ACID; (2,4-DIFLUORO-5-METHYLPHENYL)BORONIC ACID; (2,4-DIMETHYLTHIAZOLE)-5-BORONIC ACID; (2,6-DIETHYLPHENYL)BORONIC ACID; (2,6-DIMETHOXY-4-METHYLPHENYL)BORONIC ACID; (2,6-DIMETHOXY-4-PYRIMIDINYL)-BORONIC ACID; (2,6-DIMETHYL-4-METHOXYPHENYL)BORONIC ACID; (2-[(1-BENZYLPIPERIDIN-4-YL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(1-ETHYL-1H-PYRAZOL-4-YL)METHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[(1-ETHYL-1H-PYRAZOL-4-YL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(1-ETHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (2-[(1-METHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (2-[(1-PHENYLETHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(2,2-DIMETHYLMORPHOLIN-4-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(2,3-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2,3-DIMETHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(2,4-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2,4-DIMETHYLPIPERIDIN-1-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(2,5-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2,6-DICHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2-BUTOXYETHOXY)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(2-CHLORO-6-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2-CHLOROPHENYL)METHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[(2-CHLOROPHENYL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(2E)-BUT-2-EN-1-YLOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[(2E)-BUT-2-EN-1-YLOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(2E)-BUT-2-EN-1-YLOXY]NAPHTHALEN-1-YL)BORANEDIOL; (2-[(2E)-BUT-2-EN-1-YLOXY]PHENYL)BORANEDIOL; (2-[(2-FLUOROPHENYL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(2-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2-FURYLMETHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(2-METHOXYETHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(2-METHYLPENTYL)OXY]PHENYL)BORANEDIOL; (2-[(2-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2-METHYLPROP-2-EN-1-YL)OXY]NAPHTHALEN-1-YL)BORANEDIOL; (2-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (2-[(2-PHENYLETHOXY)METHYL]PHENYL)BORANEDIOL; (2-[(2-PHENYLETHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(3,3-DIMETHYLMORPHOLIN-4-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(3,4-DICHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(3,4-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(3,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(3-CHLOROPHENYL)METHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[(3-CHLOROPHENYL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(3-FLUOROPHENYL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(3-HYDROXYPROPYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(3-METHOXYPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(3-METHYLBUT-2-EN-1-YL)OXY]NAPHTHALEN-1-YL)BORANEDIOL; (2-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (2-[(3-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(3-MORPHOLIN-4-YLPROPYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(3-PHENYLPROP-2-YN-1-YL)OXY]PHENYL)BORANEDIOL; (2-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(4-CHLOROPHENYL)METHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[(4-CHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(4-CYCLOPROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(4-ETHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(4-ETHYLPIPERIDIN-1-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(4-FLUOROPHENYL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(4-METHOXYBENZOYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(4-METHOXYPHENYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(4-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)BORONIC ACID DIHYDROCHLORIDE; (2-[(4-PROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(4-PROPYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(BENZYLOXY)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(BENZYLSULFANYL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(CYCLOHEPTYLOXY)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(CYCLOHEXYLMETHOXY)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(CYCLOHEXYLMETHOXY)METHYL]PHENYL)BORANEDIOL; (2-[(CYCLOPENTYLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-[(DIBUTYLAMINO)METHYL]PHENYL)BORANEDIOL; (2-[(DIISOPROPYLAMINO)CARBONYL]-3-METHOXYPHENYL)BORONIC ACID; (2-[(METHYLAMINO)SULFONYL]PHENYL)BORONIC ACID; (2-[(OCTYLOXY)METHYL]PHENYL)BORANEDIOL; (2-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (2-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-[(OXOLAN-3-YLOXY)METHYL]PHENYL)BORANEDIOL; (2-[(PYRIDIN-4-YLMETHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(TERT-BUTOXYCARBONYL)AMINO]-5-FLUOROPHENYL)BORONIC ACID; (2-[2-(DIETHYLAMINO)ETHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[2-(DIETHYLAMINO)ETHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[2-(DIETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(DIMETHYLAMINO)ETHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[2-(DIMETHYLAMINO)ETHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[2-(DIMETHYLAMINO)ETHOXY]NAPHTHALEN-1-YL)BORANEDIOL; (2-[2-(DIMETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(MORPHOLIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(PYRIDIN-2-YL)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(PYRIDIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(PYRROLIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (2-[3-(2,2,2-TRIFLUOROETHOXY)PROPOXY]PHENYL)BORANEDIOL; (2-[BENZYL(METHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-ACETYL-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-ACETYL-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-ACETYL-1-OXOISOINDOLIN-6-YL)BORONIC ACID; (2-ACETYL-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-AMINO-4-CARBOXYPHENYL)BORONIC ACID; (2-AMINO-4-CYANO)BENZENEBORONIC ACID, HYDROCHLORIDE; (2-AMINO-4-METHOXYCARBONYLPHENYL)BORONIC ACID HYDROCHLORIDE; (2-AMINOPHENYL)BORONIC ACID HYDROCHLORIDE; (2-ANILINOPYRIMIDIN-5-YL)BORONIC ACID; (2-BENZYLPHENYL)BORANEDIOL; (2-BOC-AMINOMETHYL-5-FLUOROPHENYL)BORONIC ACID; (2-BOC-AMINOPHENYL)BORONIC ACID; (2-BUTOXYNAPHTHALEN-1-YL)BORANEDIOL; (2-CHLORO-3-HYDROXYPHENYL)-BORONIC ACID; (2-CHLORO-5-ISOPROPYLPHENYL)BORONIC ACID; (2-CHLORO-8-METHOXY-3-QUINOLINYL)-BORONIC ACID; (2-CYCLOHEXYLAMINOPYRIMIDIN-5-YL)BORONIC ACID; (2-ETHYL-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-ETHYL-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-ETHYL-1-OXOISOINDOLIN-6-YL)BORONIC ACID; (2-ETHYL-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-ETHYNYLPHENYL)BORONIC ACID; (2-FLUORO-5-([(2-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(2-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(3-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(4-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(4-METHYLCYCLOHEXYL)OXY]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(4-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(5-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([METHYL(OXAN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([METHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-[(2,2,3,3-TETRAFLUOROPROPOXY)METHYL]PHENYL)BORANEDIOL; (2-FLUORO-5-[(4-METHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-FLUORO-5-[(4-METHYL-1,4-DIAZEPAN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-FLUORO-5-[(HEPTYLOXY)METHYL]PHENYL)BORANEDIOL; (2-FLUORO-5-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (2-FLUORO-5-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-ISOPROPOXY-5-TRIFLUOROMETHYLPHENYL)BORONIC ACID; (2-ISOPROPYL-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-ISOPROPYL-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-ISOPROPYL-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-ISOPROPYLPYRIMIDIN-5-YL)BORONIC ACID; (2-METHOXY-5-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([(4-METHYLPENTYL)OXY]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([2-(PROPAN-2-YLOXY)ETHOXY]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([METHYL(2,2,2-TRIFLUOROETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([METHYL(3-METHYLBUTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([METHYL(PENTAN-3-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([METHYL(PENTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([PROPAN-2-YL(PROPYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(4-METHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(OXAN-4-YLOXY)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(PHENYLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(PYRIDIN-2-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(PYRIMIDIN-2-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-NITROPHENYL)BORONIC ACID; (2-METHOXY-5-PYRIDINYL)BORONIC ACID HYDROCHLORIDE; (2-METHOXY-6-METHYLPHENYL)BORONIC ACID; (2-METHYL-1,3-BENZOXAZOL-6-YL)BORONIC ACID; (2-METHYL-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-METHYL-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-METHYL-1-OXOISOINDOLIN-6-YL)BORONIC ACID; (2-METHYL-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-METHYL-2,3-DIHYDRO-1-BENZOFURAN-5-YL)BORANEDIOL; (2-METHYL-3-CARBOXYPHENYL)BORONIC ACID; (2-METHYL-4-CARBOXYPHENYL)BORONIC ACID; (2-METHYL-5-NITROPHENYL)BORONIC ACID; (2-METHYL-5-PHENYL-3-THIENYL)-BORONIC ACID; (2-METHYL-5-QUINOLINYL)BORONIC ACID HYDRATE; (2-METHYLPYRIMIDIN-5-YL)BORONIC ACID; (2-METHYLQUINOLIN-5-YL)BORONIC ACID; (2-METHYLQUINOLIN-8-YL)BORANEDIOL; (2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL)BORONIC ACID; (2-OXO-2,3-DIHYDRO-1H-PYRIDO[2,3-B][1,4]OXAZIN-7-YL)BORONIC ACID; (2-PHENOXYPYRIMIDIN-5-YL)BORONIC ACID; (2-PIPERAZIN-1-YLPYRIMIDIN-5-YL)BORONIC ACID; (2-PIPERIDIN-1-YLPYRIMIDIN-5-YL)BORONIC ACID; (2-PROPOXYNAPHTHALEN-1-YL)BORANEDIOL; (2-PROPOXYPYRIMIDIN-5-YL)BORONIC ACID; (2-PYRROLIDIN-1-YLPYRIMIDIN-5-YL)BORONIC ACID; (2-TERT-BUTYLPYRIMIDIN-5-YL)BORONIC ACID; (3-([(2,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(2,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(2,5-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(2,5-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(2-CHLOROPHENYL)METHOXY]METHYL)PHENYL)BORANEDIOL; (3-([(2E)-3-PHENYLPROP-2-EN-1-YL]OXY)PHENYL)BORANEDIOL; (3-([(2-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(3,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(3,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(3-CHLOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(3-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([(4,6-DIMETHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(4-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([CYCLOHEXYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([4-(DIMETHYLAMINO)PIPERIDIN-1-YL]METHYL)PHENYL)BORANEDIOL; (3-([4-(PROPAN-2-YL)PIPERAZIN-1-YL]METHYL)PHENYL)BORANEDIOL; (3-([BENZYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([BIS(2-METHOXYETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([BIS(2-METHYLPROPYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([BUTYL(ETHYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([CYCLOHEPTYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([CYCLOHEXYL(ETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([CYCLOPENTYL(METHYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([CYCLOPROPYL(PROPYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([ETHYL(2-ETHYLBUTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([ETHYL(2-METHOXYETHYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([ETHYL(2-METHYLPROPYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([ETHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([METHYL(1-METHYLPIPERIDIN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([METHYL(4-METHYLCYCLOHEXYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([METHYL(PYRIDIN-2-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([METHYL(PYRIDIN-3-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([METHYL(PYRIDIN-4-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-(2-[(3-METHOXYPROPYL)(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[(4-METHYLPENTYL)OXY]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[(CYCLOBUTYLMETHYL)(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL)PHENYL)BORONIC ACID; (3-(2-[2-(PROPAN-2-YLOXY)ETHOXY]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[BUTYL(ETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[CYCLOPENTYL(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[CYCLOPROPYL(PROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[ETHYL(2-METHOXYETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[ETHYL(2-METHYLPROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[METHYL(2,2,2-TRIFLUOROETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[METHYL(3-METHYLBUTYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[METHYL(PENTAN-3-YL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[METHYL(PENTYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[PROPAN-2-YL(PROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(3-BENZYOXY)PROPOXY)PHENYL BORONIC ACID; (3,4-DIETHOXYPHENYL)BORANEDIOL; (3,4-DIPROPOXYPHENYL)BORANEDIOL; (3,5-DIMETHOXY-D6)-PHENYLBORONIC ACID; (3,5-DIMETHOXYPHENYL)METHANOL-4-BORONIC ACID; (3,5-DIMETHYL-1-PHENYL-1H-PYRAZOL-4-YL)BORANEDIOL; (3,5-DIMETHYL-D6)-PHENYLBORONIC ACID; (3,5-DINITRO-2-METHYLPHENYL)BORONIC ACID; (3,5-DIPHENYLPHENYL)BORONIC ACID; (3,6-DIAMINO-9-ACRIDINYL)-BORONIC ACID; (3-[(1-METHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (3-[(1-METHYLPIPERIDIN-2-YL)METHOXY]PHENYL)BORONIC ACID; (3-[(2,3-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2,4-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2,5-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2-CHLORO-4-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2-CHLORO-6-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2E)-BUT-2-EN-1-YLOXY]PHENYL)BORANEDIOL; (3-[(2-METHYL-1,4-OXAZEPAN-4-YL)METHYL]PHENYL)BORANEDIOL; (3-[(2-METHYLPENTYL)OXY]PHENYL)BORANEDIOL; (3-[(2-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (3-[(2-PHENYLETHOXY)METHYL]PHENYL)BORANEDIOL; (3-[(3,4-DICHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(3,4-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(3,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (3-[(3-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(3-PHENYLPROP-2-YN-1-YL)OXY]PHENYL)BORANEDIOL; (3-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4,5-DIMETHYL-1H-IMIDAZOL-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4-CYCLOPROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4-ETHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)BORONIC ACID DIHYDROCHLORIDE; (3-[(4-PROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4-PROPYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(CYCLOHEXYLMETHOXY)METHYL]PHENYL)BORANEDIOL; (3-[(CYCLOHEXYLOXY)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(CYCLOHEXYLSULFANYL)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(CYCLOPENTYLSULFANYL)METHYL]PHENYL)BORANEDIOL; (3-[(DIBUTYLAMINO)METHYL]PHENYL)BORANEDIOL; (3-[(DIPROPYLAMINO)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(HEXYLOXY)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(OCTYLOXY)METHYL]PHENYL)BORANEDIOL; (3-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (3-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (3-[(OXOLAN-3-YLOXY)METHYL]PHENYL)BORANEDIOL; (3-[(TERT-BUTOXYCARBONYL)AMINO]-5-METHYLISOXAZOL-4-YL)BORONIC ACID; (3-[(TRIMETHYLSILYL)ETHYNYL]PHENYL)BORONIC ACID; (3-[1-(DIMETHYLAMINO)ETHYL]PHENYL)BORONIC ACID; (3-[2-(1,4-OXAZEPAN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(1,4-THIAZEPAN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(4,5-DIMETHYL-1H-IMIDAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(4-METHYLPIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(AZEPAN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(CYCLOHEXYLOXY)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(CYCLOHEXYLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(DIETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(DIMETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(DIPROPYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(HEXYLOXY)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(OXAN-4-YLOXY)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(OXAN-4-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PHENYLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PYRIDIN-2-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PYRIDIN-2-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PYRIDIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PYRIMIDIN-2-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PYRROLIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[3-(2,2,2-TRIFLUOROETHOXY)PROPOXY]PHENYL)BORANEDIOL; (3-[4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL]PHENYL)BORONIC ACID; (3-ACETAMIDO-2-NITRO)BENZENEBORONIC ACID; (3-ACETAMIDOMETHYLPHENYL)BORONIC ACID; (3-ALLYLAMINOCARBONYL)BENZENEBORONIC ACID; (3-AMINO-4-CHLOROPHENYL)BORONIC ACID HYDROCHLORIDE; (3-AMINO-5-METHOXYCARBONYLPHENYL)BORONIC ACID; (3-AMINO-5-NITROPHENYL)BORONIC ACID; (3-AMINO-5-NITROPHENYL)BORONIC ACID HYDROCHLORIDE; (3-AMINOMETHYLPHENYL)BORONIC ACID; (3-AMINOMETHYLPHENYL)BORONIC ACID HYDROCHLORIDE; (3-BENZYLOXYCARBONYL-5-NITROPHENYL)BORONIC ACID; (3-BOC-AMINO-4-METHYLPHENYL)BORONIC ACID; (3-BOC-AMINO-5-NITROPHENYL)BORONIC ACID; (3-BOC-AMINOPHENYL)BORONIC ACID; (3-CARBAMOTHIOYL)BENZENEBORONIC ACID; (3-CHLORO-4-ETHOXYCARBONYL)BENZENEBORONIC ACID; (3-CHLORO-4-METHOXYCARBONYL)BENZENEBORONIC ACID; (3-CHLORO-5-CYANOPHENYL)BORONIC ACID; (3-CYCLOHEXYLPROPYL)BORONIC ACID; (3-ETHOXYCARBONYL-5-NITROPHENYL)BORONIC ACID; (3-ETHYL-1H-INDAZOL-4-YL)BORONIC ACID; (3-FLUORO-4-([(2-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(2-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(3-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(4-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(4-METHYLCYCLOHEXYL)OXY]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(4-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(5-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([METHYL(OXAN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([METHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-[(2,2,3,3-TETRAFLUOROPROPOXY)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-4-[(4-METHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-4-[(4-METHYL-1,4-DIAZEPAN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-4-[(HEPTYLOXY)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-4-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-4-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-5-METHOXYCARBONYLPHENYL)BORONIC ACID; (3-FLUORO-5-TRIFLUOROMETHYLPHENYL)BORONIC ACID; (3-FORMYLOXYPHENYL)BORONIC ACID; (3-METHANESULFONYLAMINOMETHYLPHENYL)BORONIC ACID; (3-METHYL-4-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (3-METHYL-4-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (3-METHYL-4-CARBOXYPHENYL)BORONIC ACID; (3-METHYL-5-METHOXY-D6)-PHENYLBORONIC ACID; (3-NITRO-4-ISOBUTYLPHENYL)BORONIC ACID; (3-PHENYLAMINOCARBONYLPHENYL)BORONIC ACID; (3-T-BUTYL-5-METHYLPHENYL)BORONIC ACID; (3-TERT-BUTOXYPHENYL)BORONIC ACID; (4-((1-METHYL-1H-IMIDAZOL-4-YL)METHOXY)PHENYL)BORONIC ACID; (4-([(1,3-DIMETHYL-1H-PYRAZOL-5-YL)SULFANYL]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(2,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(2,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(2,5-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(2,5-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(2-CHLOROPHENYL)METHOXY]METHYL)PHENYL)BORANEDIOL; (4-([(2-CHLOROPHENYL)SULFANYL]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(2-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(3,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(3,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(3-CHLOROPHENYL)SULFANYL]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(3-CHLOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(3-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([(3-METHYLCYCLOHEXYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(4,6-DIMETHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(4-CHLOROPHENYL)SULFANYL]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(4-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([(CYCLOHEXYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([(CYCLOPROPYLMETHYL)(PROPYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(TERT-BUTOXYCARBONYL)(METHYL)AMINO]METHYL)PHENYL)BORONIC ACID; (4-([4-(DIMETHYLAMINO)PIPERIDIN-1-YL]METHYL)PHENYL)BORANEDIOL; (4-([4-(PROPAN-2-YL)PIPERAZIN-1-YL]METHYL)PHENYL)BORANEDIOL; (4-([BENZYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([BIS(2-METHOXYETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([BIS(2-METHYLPROPYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([BUTYL(CYCLOPROPYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([CYCLOHEPTYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([CYCLOHEXYL(ETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([CYCLOHEXYL(METHYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([CYCLOPENTYL(ETHYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([CYCLOPROPYL(2-METHOXYETHYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([ETHYL(2-ETHYLBUTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([ETHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(1-METHYLPIPERIDIN-3-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(1-METHYLPIPERIDIN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(4-METHYLCYCLOHEXYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(PYRIDIN-2-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(PYRIDIN-3-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(PYRIDIN-4-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-(2-[(3-METHOXYPROPYL)(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[(4-METHYLPENTYL)OXY]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[(CYCLOBUTYLMETHYL)(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL)PHENYL)BORONIC ACID; (4-(2-[2-(PROPAN-2-YLOXY)ETHOXY]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[BUTYL(ETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[CYCLOPENTYL(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[CYCLOPROPYL(PROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[ETHYL(2-METHOXYETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[ETHYL(2-METHYLPROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[METHYL(2,2,2-TRIFLUOROETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[METHYL(3-METHYLBUTYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[METHYL(PENTAN-3-YL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[METHYL(PENTYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[PROPAN-2-YL(PROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-AMINO-2-OXOETHOXY)PHENYL)BORONIC ACID; (4-(2-HYDROXYETHYL)PIPERAZIN-1-YL)(3-BORONOPHENYL)METHANONE, HCL; (4-(2-MORPHOLINO-2-OXOETHOXY)PHENYL)BORONIC ACID; (4-(2-OXO-2-THIOMORPHOLINOETHOXY)PHENYL)BORONIC ACID; (4-(2S)-3-AMINO-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-OXOPROPYLPHENYL)BORONIC ACID; (4-(4-(2-(DIMETHYLAMINO)ACETYL)PIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(4-(2-HYDROXYETHYL)PIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(4-BENZYLPIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(4-ETHYLPIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(4-ISOPROPYLPIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(4-PROPYLPIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(5H,6H,7H,8H-IMIDAZO[1,2-A]PYRAZIN-7-YLMETHYL)PHENYL)BORANEDIOL; (4-[(1-METHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (4-[(1-METHYLPIPERIDIN-2-YL)METHOXY]PHENYL)BORONIC ACID; (4-[(2,2-DIMETHYLMORPHOLIN-4-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(2,3-DIMETHYLPIPERIDIN-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(2,4-DICHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2,4-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2,5-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2-BUTOXYETHOXY)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(2-CHLORO-4-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2-CHLORO-6-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2-CHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2E)-BUT-2-EN-1-YLOXY]PHENYL)BORANEDIOL; (4-[(2-METHYL-1,4-OXAZEPAN-4-YL)METHYL]PHENYL)BORANEDIOL; (4-[(2-METHYLPENTYL)OXY]PHENYL)BORANEDIOL; (4-[(2-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (4-[(2-PHENYLETHOXY)METHYL]PHENYL)BORANEDIOL; (4-[(3,3-DIMETHYLMORPHOLIN-4-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(3,4-DICHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(3,4-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(3,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (4-[(3-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(3-PHENYLPROP-2-YN-1-YL)OXY]PHENYL)BORANEDIOL; (4-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(4,5-DIMETHYL-1H-IMIDAZOL-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(4-CYCLOPROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(4-ETHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(4-ETHYLPIPERIDIN-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)BORONIC ACID; (4-[(4-PROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(4-PROPYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(BENZYLOXY)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(BENZYLSULFANYL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(CYCLOHEPTYLOXY)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(CYCLOHEXYLMETHOXY)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(CYCLOHEXYLMETHOXY)METHYL]PHENYL)BORANEDIOL; (4-[(CYCLOPENTYLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-[(DIBUTYLAMINO)METHYL]PHENYL)BORANEDIOL; (4-[(DIMETHYLAMINO)METHYL]PHENYL)BORONIC ACID HYDROCHLORIDE; (4-[(OCTYLOXY)METHYL]PHENYL)BORANEDIOL; (4-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (4-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-[(OXOLAN-3-YLOXY)METHYL]PHENYL)BORANEDIOL; (4-[(TERT-BUTOXYCARBONYL)AMINO]PYRIDIN-3-YL)BORONIC ACID; (4-[(TRIMETHYLSILYL)ETHYNYL]PHENYL)BORONIC ACID; (4-[[TERT-BUTYL(DIMETHYL)SILYL]OXY]-2-METHOXYPHENYL)BORONIC ACID; (4-[1-(1-PIPERIDINYL)ETHYL]PHENYL)BORONIC ACID; (4-[1-(1-PYRROLIDINYL)ETHYL]PHENYL)BORONIC ACID; (4-[1-(4-MORPHOLINYL)ETHYL]PHENYL)BORONIC ACID; (4-[1-(DIMETHYLAMINO)ETHYL]PHENYL)BORONIC ACID; (4-[2-(1,4-OXAZEPAN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(1,4-THIAZEPAN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(4,5-DIMETHYL-1H-IMIDAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(4-METHYLPIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(AZEPAN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(CYCLOHEXYLOXY)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(CYCLOHEXYLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(DIETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(DIMETHYLAMINO)ETHOXY]-3-METHYLPHENYL)BORANEDIOL; (4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(DIPROPYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(HEXYLOXY)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(MORPHOLIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(OXAN-4-YLOXY)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(OXAN-4-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PHENYLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PYRIDIN-2-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PYRIDIN-2-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PYRIDIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PYRIMIDIN-2-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (4-[2,2′:6′,2″-TERPYRIDIN]-4′-YLPHENYL)-4′-BORONIC ACID; (4-[3-(2,2,2-TRIFLUOROETHOXY)PROPOXY]PHENYL)BORANEDIOL; (4-[3-(PIPERIDIN-1-YL)PROPOXY]PHENYL)BORANEDIOL; (4-[4-(DIMETHYLAMINO)BUTYL]PHENYL)BORONIC ACID; (4-ACETAMIDOMETHYLPHENYL)BORONIC ACID; (4-ALLYLAMINOCARBONYL)BENZENEBORONIC ACID; (4-AMINO-2-FLUOROPHENYL)BORONIC ACID; (4-AMINOSULFONYLPHENYL)BORONIC ACID; (4-BENZYLOXYCARBONYL-2-NITRO)BENZENEBORONIC ACID; (4-BOC-AMINOPHENYL)BORONIC ACID; (4-BUTOXY-3-METHYLPHENYL)BORANEDIOL; (4-CBZ-AMINOPHENYL)BORONIC ACID; (4-CHLORO-2-ETHOXYCARBONYL)BENZENEBORONIC ACID; (4-CHLORO-2-METHYLTHIAZOLO[4,5-C]PYRIDIN-7-YL)BORONIC ACID; (4-CHLORO-3-HYDROXYPHENYL)BORONIC ACID; (4-CYANO-2-NITROPHENYL)BORONIC ACID; (4-ETHOXY-2-ETHYLPHENYL)BORONIC ACID; (4-ETHOXY-3,5-DIMETHOXYPHENYL)BORONIC ACID; (4-ETHOXY-3-TRIFLUOROMETHYLPHENYL)BORONIC ACID; (4-FLUORO-5-ISOPROPYL-2-METHOXYPHENYL)BORONIC ACID; (4-FLUOROPHENYLAMINOMETHYL)-4-BENZENEBORONIC ACID; (4-FLUOROPHENYLAMINOMETHYLENE)-4-BENZENEBORONIC ACID; (4-HEXYL-2-THIENYL)-BORONIC ACID; (4-HYDROXY-2-METHYL)PHENYLBORONIC ACID; (4-HYDROXY-3-NITROPHENYL)BORONIC ACID; (4-ISOPROPYL-2-METHOXYPHENYL)BORONIC ACID; (4-METHANESULFONYLAMINOMETHYLPHENYL)BORONIC ACID; (4-METHOXY-2,6-DIMETHYLPHENYL)BORONIC ACID HYDRATE; (4-METHOXY-3-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([(4-METHYLPENTYL)OXY]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([2-(PROPAN-2-YLOXY)ETHOXY]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([METHYL(2,2,2-TRIFLUOROETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([METHYL(3-METHYLBUTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([METHYL(PENTAN-3-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([METHYL(PENTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([PROPAN-2-YL(PROPYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(4-METHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(OXAN-4-YLOXY)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(PHENYLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(PYRIDIN-2-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(PYRIMIDIN-2-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-TRIFLUOROMETHYLPHENYL)BORONIC ACID; (4-METHOXYCARBONYLMETHYL)PHENYLBORONIC ACID; (4-METHYL-1-NAPHTHALENE)BORONIC ACID; (4-METHYL-2-NITROPHENYL)BORONIC ACID; (4-OXO-1,4-DIHYDROQUINAZOLIN-6-YL)BORONIC ACID; (4-PHENYLAMINOCARBONYLPHENYL)BORONIC ACID; (4-PROPOXY-3-METHYLPHENYL)BORONIC ACID; (4-PYRROLIDIN-1-YLPHENYL)BORONIC ACID; (4-SEC-BUTYLPHENYL)BORONIC ACID; (4-TERT-BUTYL-2-METHOXYPHENYL)BORONIC ACID; (4-THIOMORPHOLINOPHENYL)BORONIC ACID; (5-([(1,3-DIMETHYL-1H-PYRAZOL-5-YL)SULFANYL]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(2-CHLOROPHENYL)SULFANYL]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(3-CHLOROPHENYL)SULFANYL]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(4-CHLOROPHENYL)SULFANYL]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-([(CYCLOPROPYLMETHYL)(PROPYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(TERT-BUTOXYCARBONYL)AMINO]METHYL)PYRIDIN-3-YL)BORONIC ACID; (5-([BUTYL(CYCLOPROPYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([BUTYL(ETHYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-([CYCLOHEXYL(METHYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([CYCLOPENTYL(ETHYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([CYCLOPENTYL(METHYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-([CYCLOPROPYL(2-M ETHOXYETHYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([CYCLOPROPYL(PROPYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-([ETHYL(2-METHOXYETHYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-([ETHYL(2-METHYLPROPYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-(METHYLTHIO)PYRIDIN-3-YLTHIO)METHYLBORONIC ACID; (5′-(PIPERIDIN-2-YL)-[3,3′-BIPYRIDIN]-5-YL)BORONIC ACID; (5′-(PROP-1-YN-1-YL)[3,3′-BIPYRIDIN]-5-YL)BORONIC ACID; (5,7-DICHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINYL)-BORONIC ACID; (5-[(2,2-DIMETHYLMORPHOLIN-4-YL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(2-BUTOXYETHOXY)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(3,3-DIMETHYLMORPHOLIN-4-YL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-[(3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(4-ETHYLPIPERIDIN-1-YL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(ACETYLAMINO)METHYL]PYRIDIN-3-YL)BORONIC ACID; (5-[(BENZYLOXY)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(BENZYLSULFANYL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(CYCLOHEPTYLOXY)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(CYCLOHEXYLMETHOXY)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(CYCLOHEXYLOXY)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-[(CYCLOHEXYLSULFANYL)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-[(DIPROPYLAMINO)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-[(HEXYLOXY)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-ACETAMIDO-2-NITRO)BENZENEBORONIC ACID; (5-AMINO-1-NAPHTHALENYL)-BORONIC ACID; (5-AMINO-2-HYDROXYMETHYLPHENYL)BORONIC ACID, HCL, DIHYDRATE; (5-CHLORO-2-[(2,2-DIMETHYLPROPOXY)CARBONYL]PHENYL)BORONIC ACID; (5-CHLORO-2-METHOXYPYRIDIN-4-YL)BORONIC ACID; (5-CHLOROBENZO[B]THIOPHEN-2-YL)BORONIC ACID; (5-FLUORO-2-([(2-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(2-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(3-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(4-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(4-METHYLCYCLOHEXYL)OXY]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(4-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(5-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([METHYL(OXAN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([METHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-[(1-METHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(2,2,3,3-TETRAFLUOROPROPOXY)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[(2-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(3-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(4-METHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[(4-METHYL-1,4-DIAZEPAN-1-YL)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[(4-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(HEPTYLOXY)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(2,2,2-TRIFLUOROETHOXY)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(3-METHYLBUTOXY)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(MORPHOLIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(PYRIDIN-2-YL)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(PYRIDIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(PYRROLIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[3-(PYRROLIDIN-1-YL)PROPOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-THIENYL)BORONIC ACID; (5-HYDROXYPYRIDIN-2-YL)BORONIC ACID; (5-ISOPROPYL-1H-INDAZOL-4-YL)BORONIC ACID; (5-METHYL-2-[(1-METHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(2-METHYLPENTYL)OXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(2-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(3-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(4-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(2,2,2-TRIFLUOROETHOXY)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(3-METHYLBUTOXY)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(MORPHOLIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(PYRIDIN-2-YL)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(PYRIDIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(PYRROLIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[3-(PYRROLIDIN-1-YL)PROPOXY]PHENYL)BORANEDIOL; (5-PHENOXY-3-PYRIDINYL)BORONIC ACID; (5-TRIFLUOROMETHYLBENZO[B]THIOPHEN-2-YL)BORONIC ACID; (6-(TERT-BUTOXYCARBONYL)-5,6,7,8-TETRAHYDRO-1,6-NAPHTHYRIDIN-3-YL)BORONIC ACID; (6-AMINOPYRIDIN-3-YL)BORONIC ACID; (6-ETHOXY-5-FLUOROPYRIDIN-3-YL)BORONIC ACID; (7-BUTYL-2-NAPHTHALENYL)BORONIC ACID; (7-CHLORO-1-BENZOTHIOPHEN-2-YL)BORANEDIOL; (7-HEPTYL-2-NAPHTHALENYL)BORONIC ACID; (8-METHOXY-2-METHYL-5-QUINOLINYL)BORONIC ACID TRIHYDRATE; (8-METHOXY-2-METHYLQUINOLIN-5-YL)BORONIC ACID; (8-METHOXY-2-METHYLQUINOLIN-5-YL)BORONIC ACID TRIHYDRATE; (8-METHOXYQUINOLIN-5-YL)BORONIC ACID; (8-METHYL-5-QUINOLINYL)BORONIC ACID HYDRATE; (9-ETHYL-9H-CARBAZOL-3-YL)BORONIC ACID; (9-METHYL-9H-CARBAZOL-3-YL)BORONIC ACID; (E)-(2-(FURAN-2-YL)VINYL)BORONIC ACID; (E)-(2-CYCLOPENTYLETHENYL)BORONIC ACID; (E)-3-((1H-PYRROL-2-YL)METHYLENE)-2-OXOINDOLIN-5-YLBORONIC ACID; (E)-3-(3-ETHOXY-3-OXOPROP-1-ENYL)-2-FLUOROPHENYLBORONIC ACID; (E)-3-(TRIFLUOROMETHYL)STYRYLBORONIC ACID; (E)-3-ACETOXYPROP-1-ENYLBORONIC ACID; (E)-3-METHOXYSTYRYLBORONIC ACID; (E)-3-PHENOXYPROP-1-ENYLBORONIC ACID; (E)-4-(N′-HYDROXYCARBAMIMIDOYL)PHENYLBORONIC ACID; (E)-4-AMINOBUT-2-ENYLBORONIC ACID HYDROCHLORIDE; (E)-5-(2-ETHOXYCARBONYLETHEN-1-YL)-2-FLUOROPHENYLBORONIC ACID; (E)-5-CHLORO-1-PENTENEBORONIC ACID; (E)-BUT-2-EN-2-YLBORONIC ACID; (FURAN-2-YLMETHYL)BORONIC ACID; (M-ACRYLAMIDOPHENYL)BORONIC ACID; (PYRIDIN-2-YLTHIO)METHYLBORONIC ACID; (PYRIDINE-D4)-4-BORONIC ACID; (PYRIMIDINE-2-D1)-5-BORONIC ACID; (S)-4-(2-AMINO-3-TERT-BUTOXY-3-OXOPROPYL)PHENYLBORONIC ACID; (Z)-CYCLOOCTENYLBORONIC ACID; [1-(TERT-BUTOXYCARBONYL)-1H-PYRROLO[2,3-B]PYRIDIN-2-YL]BORONIC ACID; [1,2,4]TRIAZOLO[1,5-A]PYRIDINE-6-BORONIC ACID; [1,2,5]OXADIAZOLO[3,4-B]PYRIDIN-6-YLBORONIC ACID; [1,3]DIOXOLO[4,5-B]PYRIDINE-6-BORONIC ACID; [10-(1-NAPHTHALENYL)-9-ANTHRACENYL]BORONIC ACID; [10-[4-(2-NAPHTHALENYL)PHENYL]-9-ANTHRACENYL]-BORONIC ACID; [2-(([(2-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [2-(([(3-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [2-((METHYL[(1-METHYL-1H-IMIDAZOL-2-YL)METHYL]AMINO)METHYL)PHENYL]BORANEDIOL; [2-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [2-(1H-INDAZOL-1-YLMETHYL)PHENYL]BORANEDIOL; [2-(1H-PYRAZOL-1-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(1H-PYRROL-1-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(2,2,2-TRIFLUOROETHOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(2,2,2-TRIFLUOROETHOXY)PYRIMIDIN-5-YL]BORONIC ACID; [2-(2,3-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,3-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,3-DIHYDRO-1H-INDOL-1-YLMETHYL)PHENYL]BORANEDIOL; [2-(2,3-DIHYDRO-1H-ISOINDOL-2-YLMETHYL)PHENYL]BORANEDIOL; [2-(2,3-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [242,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,5-DIMETHYL-1H-PYRROL-1-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(2,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,6-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,6-DIMETHYLMORPHOLIN-4-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(2,6-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-CHLORO-4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-CHLORO-4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-CHLORO-5-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-CHLOROPHENOXYMETHYL)-5-FLUOROPHENYL]BORANEDIOL; [2-(2-ETHOXYETHOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(2-ETHOXYETHOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(2-ETHOXYETHOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(2-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-METHOXYETHOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(2-METHOXYETHOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(2-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [2-(2-METHYLPROPOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(2-PHENOXYETHOXY)PHENYL]BORANEDIOL; [2-(2-PHENYLETHOXY)PHENYL]BORANEDIOL; [2-(3,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [243,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(3,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [243,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)-4-METHOXYPHENYL]BORONIC ACID; [2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)-4-METHOXYPHENYL]BORONIC ACID HYDROCHLORIDE; [2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)-4-METHYLPHENYL]BORONIC ACID; [2-(3,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(3-CHLOROPHENOXYMETHYL)-5-FLUOROPHENYL]BORANEDIOL; [2-(3-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(3-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(3-METHOXYPROPOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(3-METHYLBUTOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(3-METHYLBUTOXY)PHENYL]BORANEDIOL; [2-(3-PHENYLPROPOXY)PHENYL]BORANEDIOL; [2-(4-CHLORO-2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(4-CHLORO-3-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(4-CHLOROPHENOXYMETHYL)-5-FLUOROPHENYL]BORANEDIOL; [2-(4-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(4-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(4-N-BOC-PIPERAZIN-1-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(ALLYLAMINO)PYRIMIDIN-5-YL]BORONIC ACID; [2-(AZEPAN-1-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [2-(AZOCAN-1-YLMETHYL)-5-FLUOROPHENYL]BORANEDIOL; [2-(BENZYLAMINO)PYRIMIDIN-5-YL]BORONIC ACID; [2-(BUT-3-EN-2-YLOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(BUT-3-EN-2-YLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(BUT-3-EN-2-YLOXY)PHENYL]BORANEDIOL; [2-(BUTAN-2-YLOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(BUTAN-2-YLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(BUTAN-2-YLOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(BUTAN-2-YLOXY)PHENYL]BORANEDIOL; [2-(CYCLOBUTOXYMETHYL)-5-FLUOROPHENYL]BORANEDIOL; [2-(CYCLOBUTOXYMETHYL)PHENYL]BORANEDIOL; [2-(CYCLOHEXYLMETHOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(CYCLOHEXYLMETHOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(CYCLOHEXYLMETHOXY)PHENYL]BORANEDIOL; [2-(CYCLOHEXYLOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(CYCLOHEXYLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(CYCLOHEXYLOXY)PHENYL]BORANEDIOL; [2-(CYCLOPENTYLMETHOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(CYCLOPENTYLMETHOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(CYCLOPENTYLOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(CYCLOPENTYLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(CYCLOPENTYLOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(CYCLOPENTYLOXY)PHENYL]BORANEDIOL; [2-(CYCLOPROPYLMETHOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(DIBENZYLAMINO)PYRIMIDIN-5-YL]BORONIC ACID; [2-(DIETHYLAMINO)PYRIMIDIN-5-YL]BORONIC ACID; [2-(DIMETHYLAMINO)PHENYL]BORONIC ACID HYDROCHLORIDE HYDRATE; [2-(E-3-METHOXY-3-OXO-1-PROPEN-1-YL)PHENYL]BORONIC ACID; [2-(HEPTYLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(HEPTYLOXY)PHENYL]BORANEDIOL; [2-(HEXYLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(HEXYLOXY)PHENYL]BORANEDIOL; [2-(MORPHOLIN-4-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [2-(NONYLOXY)PHENYL]BORANEDIOL; [2-(OCTAHYDROQUINOLIN-1(2H)-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(OCTYLOXY)PHENYL]BORANEDIOL; [2-(OXAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [2-(OXAN-4-YLMETHOXY)PHENYL]BORANEDIOL; [2-(OXOLAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [2-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [2-(PENTYLOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(PENTYLOXY)PHENYL]BORANEDIOL; [2-(PIPERIDIN-1-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [2-(PROP-2-EN-1-YLOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(PYRIDIN-3-YLMETHOXY)PHENYL]BORANEDIOL; [2-(PYRIMIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [2-(PYRROLIDIN-1-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [2-(TRIFLUOROMETHOXY)PYRIMIDIN-5-YL]BORONIC ACID; [2-(TRIFLUOROMETHYL)QUINAZOLIN-4-YL]BORONIC ACID; [2-(TRIFLUOROMETHYL)QUINOLIN-5-YL]BORONIC ACID; [2-(TRIFLUOROMETHYL)QUINOLIN-6-YL]BORONIC ACID; [2,4-BIS(PROPAN-2-YL)PHENYL]BORANEDIOL; [2-[(TERT-BUTOXYCARBONYL)AMINO]PYRIMIDIN-5-YL]BORONIC ACID; [2-[2-(TRIPHENYLMETHYL)-2H-TETRAZOL-5-YL]PHENYL]BORONIC ACID; [2-AMINO-5-(TRIFLUOROMETHYL)PHENYL]BORONIC ACID; [2-FLUORO-3-(METHOXYCARBONYL)PHENYL]BORONIC ACID; [2-FLUORO-3-(TRIFLUOROMETHOXY)PHENYL]BORONIC ACID; [2-FLUORO-5-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(2-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(3-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(3-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-METHOXY-5-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [2-METHOXY-5-(1,4-THIAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [2-METHOXY-5-(PHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(([(2-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [3-(([(3-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [3-(1,3-DIOXOLAN-2-YL)-2-FLUOROPHENYL]BORONIC ACID; [3-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [3-(1H-INDAZOL-1-YLMETHYL)PHENYL]BORANEDIOL; [3-(1H-PYRAZOL-3-YL)PHENYL]BORONIC ACID; [3-(1H-PYRAZOL-5-YL)PHENYL]BORONIC ACID HYDRATE; [3-(1-METHOXYETHYL)PHENYL]BORONIC ACID; [3-(2,3-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,3-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,3-DIHYDRO-1H-INDOL-1-YLMETHYL)PHENYL]BORANEDIOL; [3-(2,3-DIHYDRO-1H-ISOINDOL-2-YLMETHYL)PHENYL]BORANEDIOL; [3-(2,3-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,6-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,6-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-CARBOXYETHYL)PHENYL]BORONIC ACID; [3-(2-CHLORO-4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-CHLORO-4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-CHLORO-5-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-CYCLOBUTOXYETHOXY)PHENYL]BORANEDIOL; [3-(2-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [3-(2-PHENYLETHOXY)PHENYL]BORANEDIOL; [3-(3,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3,5-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3-HYDROXYPROPYL)PHENYL]BORONIC ACID; [3-(3-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3-METHYLBUTOXY)PHENYL]BORANEDIOL; [3-(3-PHENYLPROPOXY)PHENYL]BORANEDIOL; [3-(4-CHLORO-1H-BENZOTHIAZOL-2-YL)PHENYL]-BORONIC ACID; [3-(4-CHLORO-2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(4-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(4-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(AZEPAN-1-YLMETHYL)-4-METHOXYPHENYL]BORANEDIOL; [3-(AZEPAN-1-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [3-(BUT-3-EN-2-YLOXY)PHENYL]BORANEDIOL; [3-(BUTAN-2-YLOXY)PHENYL]BORANEDIOL; [3-(CYCLOBUTOXYMETHYL)-4-METHOXYPHENYL]BORANEDIOL; [3-(CYCLOBUTOXYMETHYL)PHENYL]BORANEDIOL; [3-(CYCLOPENTYLOXY)PHENYL]BORANEDIOL; [3-(E-3-METHOXY-3-OXO-1-PROPEN-1-YL)PHENYL]BORONIC ACID; [3-(HEPTYLOXY)PHENYL]BORANEDIOL; [3-(HEXYLOXY)PHENYL]BORANEDIOL; [3-(ISOBUTYLAMINOCARBONYL)PHENYL]BORONIC ACID; [3-(MORPHOLIN-4-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [3-(N-ISOPROPYLAMINOCARBONYL)PHENYL]BORONIC ACID; [3-(NONYLOXY)PHENYL]BORANEDIOL; [3-(OCTYLOXY)PHENYL]BORANEDIOL; [3-(OXAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [3-(OXOLAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [3-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [3-(PENTYLOXY)PHENYL]BORANEDIOL; [3-(PYRIDIN-3-YLMETHOXY)PHENYL]BORANEDIOL; [3-(PYRIDIN-4-YLMETHOXY)PHENYL]BORANEDIOL; [3-(PYRIMIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [3-(PYRROLIDIN-1-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [3,3′-BIPYRIDIN]-5-YLBORONIC ACID; [3-FLUORO-4-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(2-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(3-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(3-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(2-METHYLPROPOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(3-METHYLBUTOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(PENTYLOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(PROP-2-EN-1-YLOXY)PHENYL]BORANEDIOL; [4-(([(2-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [4-(([(3-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [4-(1′(3′-AMINOPROPYLL)IMIDAZOLE-1-CARBONYL)PHENYL] BORONIC ACID; [4-(1,3,4-OXADIAZOL-2-YL)PHENYL]BORONIC ACID; [4-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [4-(1-AMINO-4′-METHYLPIPERAZINE-1-CARBONYL)PHENYL]BORONIC ACID; [4-(1-ETHOXYETHYL)PHENYL]BORONIC ACID; [4-(1-ETHOXYETHYL)PHENYL]BORONIC ACID HYDRATE; [4-(1H-INDAZOL-1-YLMETHYL)PHENYL]BORANEDIOL; [4-(1H-PYRAZOL-1-YL)PHENYL]BORONIC ACID; [4-(1H-PYRAZOL-5-YL)PHENYL]BORONIC ACID; [4-(1-METHOXYETHYL)PHENYL]BORONIC ACID; [4-(2,3-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,3-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,3-DIHYDRO-1H-INDOL-1-YLMETHYL)PHENYL]BORANEDIOL; [4-(2,3-DIHYDRO-1H-ISOINDOL-2-YLMETHYL)PHENYL]BORANEDIOL; [4-(2,3-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,6-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,6-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-CHLORO-4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-CHLORO-4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-CHLORO-5-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-CHLOROPHENOXYMETHYL)-3-FLUOROPHENYL]BORANEDIOL; [4-(2-CYCLOBUTOXYETHOXY)PHENYL]BORANEDIOL; [4-(2-ETHOXYCARBONYLETHYL)PHENYL]BORONIC ACID; [4-(2-ETHOXYETHOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(2-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-METHOXYETHOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(2-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [4-(2-PHENYL-1H-BENZIMIDAZOL-1-YL)PHENYL]BORONIC ACID; [4-(2-PHENYLETHOXY)PHENYL]BORANEDIOL; [4-(2-PIPERIDIN-1-YLETHYL)PHENYL]BORONIC ACID; [4-(3,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3,5-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PHENYL]BORONIC ACID; [4-(3,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3-CHLOROPHENOXYMETHYL)-3-FLUOROPHENYL]BORANEDIOL; [4-(3-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3-METHOXYPROPOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(3-PHENYLPROPOXY)PHENYL]BORANEDIOL; [4-(4′-AMINOMORPHOLINE-1-CARBONYL)PHENYL] BORONIC ACID; [4-(4-CHLORO-2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(4-CHLOROPHENOXYMETHYL)-3-FLUOROPHENYL]BORANEDIOL; [4-(4-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(4-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(4-TERT-BUTYLPHENYL)PHENYL]BORANEDIOL; [4-(AZEPAN-1-YLMETHYL)PHENYL]BORONIC ACID; [4-(AZOCAN-1-YLMETHYL)-3-FLUOROPHENYL]BORANEDIOL; [4-(BUT-2-EN-1-YLOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(BUT-3-EN-2-YLOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(BUT-3-EN-2-YLOXY)PHENYL]BORANEDIOL; [4-(BUTAN-2-YLOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(BUTAN-2-YLOXY)PHENYL]BORANEDIOL; [4-(CYCLOBUTOXYMETHYL)-3-FLUOROPHENYL]BORANEDIOL; [4-(CYCLOBUTOXYMETHYL)PHENYL]BORANEDIOL; [4-(CYCLOHEXYLOXY)PHENYL]BORANEDIOL; [4-(CYCLOPENTYLOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(CYCLOPROPYLMETHOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(DIFLUOROMETHOXY)-2-METHOXYPHENYL]BORONIC ACID; [4-(E-3-METHOXY-3-OXO-1-PROPEN-1-YL)PHENYL]BORONIC ACID; [4-(MORPHOLIN-4-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [4-(OXOLAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [4-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [4-(PIPERAZIN-1-YL)PHENYL]BORONIC ACID; [4-(PIPERAZIN-1-YLMETHYL)PHENYL]BORONIC ACID DIHYDROCHLORIDE; [4-(PYRIMIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [4-(TRANS-4-N-PROPYLCYCLOHEXYL)PHENYL]BORONIC ACID; [4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [4-(TRIPHENYLSILYL)PHENYL]BORONIC ACID; [4-CHLORO-2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PHENYL]BORONIC ACID; [4-FLUORO-3-(HYDROXYMETHYL)PHENYL]BORONIC ACID; [4-METHOXY-2-(1H-PYRAZOL-1-YL)PHENYL]BORONIC ACID; [4-METHOXY-3-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [4-METHOXY-3-(1,4-THIAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [4-METHOXY-3-(PHENOXYMETHYL)PHENYL]BORANEDIOL; [4-METHYL-2-(1H-PYRAZOL-1-YL)PHENYL]BORONIC ACID; [4-TRIFLUOROMETHYL-6-[3-(TRIFLUOROMETHYL)PHENYL]PYRIMIDIN-2-YL]BORONIC ACID; [4-TRIFLUOROMETHYL-6-[4-(TRIFLUOROMETHYL)PHENYL]PYRIMIDIN-2-YL]BORONIC ACID; [5-(1,3-DIOXOLAN-2-YL)-2-FLUOROPHENYL]BORONIC ACID; [5-(2-CHLOROPHENOXYMETHYL)-2-FLUOROPHENYL]BORANEDIOL; [5-(3-CHLOROPHENOXYMETHYL)-2-FLUOROPHENYL]BORANEDIOL; [5-(4-CHLOROPHENOXYMETHYL)-2-FLUOROPHENYL]BORANEDIOL; [5-(AZEPAN-1-YLMETHYL)-2-METHOXYPHENYL]BORANEDIOL; [5-(AZOCAN-1-YLMETHYL)-2-FLUOROPHENYL]BORANEDIOL; [5-(BUTYLCARBAMOYL)-2-FLUOROPHENYL]BORONIC ACID; [5-(CYCLOBUTOXYMETHYL)-2-FLUOROPHENYL]BORANEDIOL; [5-(CYCLOBUTOXYMETHYL)-2-METHOXYPHENYL]BORANEDIOL; [5-(DIMETHYLCARBAMOYL)-2-FLUOROPHENYL]BORONIC ACID; [5,6,7,8-TETRAHYDROQUINAZOLIN-2-YL]BORONIC ACID; [5-BENZYLOXY-1-TOSYLINDOL-3-YL]BORONIC ACID; [5-FLUORO-2-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-METHOXYETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-METHYLPROPOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-PHENYLETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(3-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(3-METHYLBUTOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(3-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(HEPTYLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(HEXYLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(OCTYLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(OXAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(OXAN-4-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(OXOLAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PENTYLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PROP-2-EN-1-YLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PYRIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PYRIDIN-3-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PYRIDIN-4-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PYRIMIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(2,2,2-TRIFLUOROETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(2-PHENYLETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(3-METHYLBUTOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(OCTYLOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(OXAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(OXAN-4-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(OXOLAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PENTYLOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PROP-2-EN-1-YLOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PYRIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PYRIDIN-3-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PYRIDIN-4-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PYRIMIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [6-(1-NAPHTHYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-3-YL]BORONIC ACID; [6-(2-METHOXYETHOXY)NAPHTHALEN-2-YL]BORANEDIOL; [6-(2-METHYLBUTOXY)NAPHTHALEN-2-YL]BORANEDIOL; [6-(2-METHYLPROPOXY)NAPHTHALEN-2-YL]BORANEDIOL; [6-(2-NAPHTHYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(3-METHYLBUTOXY)NAPHTHALEN-2-YL]BORANEDIOL; [6-(4-ETHYLPHENYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL]BORONIC ACID; [6-(M-TOLYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(O-TOLYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(P-TOLYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2YL]BORONIC ACID; [6-(TERT-BUTYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(TRIFLUOROMETHOXY)PYRIDIN-3-YL]BORONIC ACID; [6-CYCLOPROPYLPYRIMIDIN-2-YL]BORONIC ACID; [6-METHOXY-1-TOSYLINDOL-3-YL]BORONIC ACID; 1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)PYRAZOLE-5-BORONIC ACID; 1-([2-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([2-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-4-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE; 1-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-4,6-DIMETHYL-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-4-METHYL-1,2,3,4-TETRAHYDROPYRAZINE-2,3-DIONE; 1-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-4-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)-4-METHOXYPHENYL]METHYL)-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-4,6-DIMETHYL-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-4-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([4-(DIHYDROXYBORANYL)-2-FLUOROPHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE; 1-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-4,6-DIMETHYL-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-4-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([5-(DIHYDROXYBORANYL)-2-METHOXYPHENYL]METHYL)-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-(1-BOC-PIPERIDINO)PYRAZOLE-4-BORONIC ACID; 1-(1-ETHOXYETHYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(2-(DIMETHYLAMINO)ETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-(PYRROLIDIN-1-YL)ETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-(TERT-BUTYLDIMETHYLSILYLOXY)ETHYL)-1H-PYRAZOL-3-YLBORONIC ACID; 1-(2-(TERT-BUTYLDIMETHYLSILYLOXY)ETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2,2,2-TRIFLUOROETHYL)-1H-PYRAZOLE-4-BORONIC ACID; 1-(2,2,2-TRIFLUOROETHYL)-1H-PYRAZOLE-5-BORONIC ACID; 1-(2,2-DIETHOXYETHYL)PYRAZOLE-4-BORONIC ACID; 1-(2,2-DIFLUOROETHYL)-PYRROL-2-YLBORONIC ACID; 1-(2,2-DIFLUOROETHYL)-PYRROL-3-YLBORONIC ACID; 1-(2,2-DIMETHYLPROPANOYL)-1H-PYRROL-2-YLBORONIC ACID; 1-(2-[4-(DIHYDROXYBORANYL)PHENOXY]ETHYL)-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-(2-AMINO-2-OXOETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-AMINOETHY)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-CHLOROPHENYL)PYRAZOLE-4-BORONIC ACID; 1-(2-HYDROXYETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-METHOXYETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-METHOXYETHYL)-PYRROL-2-YLBORONIC ACID; 1-(2-METHOXYETHYL)-PYRROL-3-YLBORONIC ACID; 1-(3-(DIMETHYLAMINO)PROPYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(3,3-DIETHOXYPROPYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(3,3-DIETHOXYPROPYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(3-CHLOROPHENYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(3-CHLOROPHENYL)-1H-PYRAZOLE-3-BORONIC ACID; 1-(3-CHLOROPHENYL)-4-(ETHOXYCARBONYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(3-HYDROXYPROPYL)-1H-PYRROL-3-YLBORONIC ACID; 1-(3-METHYLBUTYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-BORONIC ACID; 1-(3-PYRIDINYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(4-BORONOBENZOYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(4-BORONOPHENYLSULFONYL)AZETIDINE; 1-(4-CARBOXYBUTYL)INDOLE-5-BORONIC ACID; 1-(4-CHLOROBENZOYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YLBORONIC ACID; 1-(4-CHLOROPHENYL)-4-(ETHOXYCARBONYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(4-FLUOROPHENYL)PYRAZOLE-4-BORONIC ACID; 1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(4-PYRIDINOMETHYL)PYRAZOLE-4-BORONIC ACID; 1-(4-PYRIDINYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(5-METHOXY-5-OXOPENTYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(6-CHLOROPYRIMIDIN-4-YL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(BENZYL)-5-INDOLINEBORONIC ACID; 1-(CYCLOPROPYLMETHYL)-1H-PYRAZOLE-5-BORONIC ACID; 1-(CYCLOPROPYLMETHYL)-PYRROL-2-YLBORONIC ACID; 1-(CYCLOPROPYLMETHYL)-PYRROL-3-YLBORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-2-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-3-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-4-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-5-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-6-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-7-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-8-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-2-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-3-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-4-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-5-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-6-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-7-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-8-BORONIC ACID; 1-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 1-(METHOXYMETHYL)-2-(PHENYLTHIO)-1H-IMIDAZOL-5-YLBORONIC ACID; 1-(METHYLSULFONYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(METHYLSULFONYL)-PYRROL-2-YLBORONIC ACID; 1-(METHYLSULFONYL)-PYRROL-3-YLBORONIC ACID; 1-(N,N-DIMETHYLSULFAMOYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(N,N-DIMETHYLSULFAMOYL)-3-(PYRIDIN-2-YL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(N,N-DIMETHYLSULFAMOYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(N,N-DIMETHYLSULFAMOYL)-3-ETHYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-(N,N-DIMETHYLSULFAMOYL)-3-METHYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-(PHENYLSULFONYL)-1H-INDOL-3-YLBORONIC ACID; 1-(PHENYLSULFONYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(PHENYLSULFONYL)-1H-PYRROLO[3,2-C]PYRIDINE-2-YLBORONIC ACID; 1-(PHENYLSULFONYL)-2-INDOLEBORONIC ACID; 1-(PHENYLSULFONYL)PYRROLE-2-BORONIC ACID; 1-(PHENYLSULPHONYL)-1H-INDOLE-5-BORONIC ACID; 1-(P-TOLUENESULFONYL)-INDOLE-2-BORONIC ACID; 1-(PYRIDIN-2-YLMETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(PYRIDIN-3-YLMETHYL)PYRAZOLE-4-BORONIC ACID; 1-(T-BUTOXYCARBONYL)PYRAZOLE-5-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDRO-4,4-DIMETHYLQUINOLIN-7-YL-7-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-1H-INDOL-5-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-1H-PYRROLO[3,2-C]PYRIDIN-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-2-OXOINDOLIN-5-YLBORONIC ACID; 1′-(TERT-BUTOXYCARBONYL)-2-OXOSPIRO[INDOLINE-3,4′-PIPERIDINE]-5-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYLINDOLIN-5-YL-5-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYLINDOLIN-6-YL-6-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-3-METHYL-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-4-CHLORO-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-4-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-4-METHYL-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-(PENT-4-ENYL)-1H-PYRROL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-(TRIFLUOROMETHOXY)INDOLE-2-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-(TRIISOPROPYLSILYLOXY)-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5,7-DIMETHOXY-1H-INDOL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-FLUORO-1H-INDOL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-INDOLINEBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-METHOXY-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-METHOXY-1H-INDOL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-METHOXY-1H-PYRROLO[3,2-B]PYRIDIN-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-METHYL-1H-PYRROL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-6-CHLORO-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-6-ETHYL-5-FLUORO-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-7-CHLORO-5-METHOXY-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-7-METHOXY-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-7-METHYL-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)INDOLE-2-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)INDOLE-3-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)INDOLIN-6-YL-6-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)PYRROLE-2-BORONIC ACID; 1-(TERT-BUTOXYCARBONYLAMINO)NAPHTHALEN-2-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-1H-INDOL-5-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-1H-INDOL-6-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-4-CHLORO-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-4-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-4-METHYL-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-7-CHLORO-1H-INDOL-3-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-7-FLUORO-1H-INDOL-3-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-PYRROL-3-YLBORONIC ACID; 1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-INDAZOLE-5-BORONIC ACID; 1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(TETRAHYDRO-2H-PYRAN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(TETRAHYDRO-2H-PYRAN-2-YL)PYRAZOLE-4-BORONIC ACID; 1-(TETRAHYDRO-2H-PYRAN-4-YL)VINYLBORONIC ACID; 1-(THIAZOL-2-YLMETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-2-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-3-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-4-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-5-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-6-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-7-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-8-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-2-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-3-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-4-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-5-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-6-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-7-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-8-BORONIC ACID; 1-(TRIISOPROPYLSILYL)-1H-INDOLE-3-BORONIC ACID; 1-(TRIISOPROPYLSILYL)-1H-PYRAZOL-3-YLBORONIC ACID; 1-(TRIISOPROPYLSILYL)-PYRROL-2-YLBORONIC ACID; 1-(TRIISOPROPYLSILYL)PYRROLE-3-BORONIC ACID; 1-(TRIMETHYLSILYL)-1H-PYRROL-3-YLBORONIC ACID; 1,1-(ETHYLENEDITHIO)-INDANE-5-BORONIC ACID; 1,10-PHENANTHROLIN-2-YLBORONIC ACID; 1,2,2-TRIMETHYL-CYCLOPROPYL BORONIC ACID; 1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL-6-BORONIC ACID HCL; 1,2,3,4-TETRAHYDROISOQUINOLIN-6-YLBORONIC ACID; 1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL-7-BORONIC ACID HYDROCHLORIDE; 1,2,3,6-TETRAHYDROPYRIDIN-4-YLBORONIC ACID HYDROCHLORIDE; 1,2,3,6-TETRAHYDROPYRIDINE-4-YL-BORONIC ACID; 1,2,3-TRIAZOLE-5-BORONIC ACID; 1,2,5,6-TETRAHYDROPYRIDIN-3-YLBORONIC ACID; 1,2-DIHYDRO-NAPHTHALENE-3-BORONIC ACID; 1,2-DIMETHYL-1H-IMIDAZOL-5-YLBORONIC ACID; 1,2-DIMETHYL-1H-INDOLE-7-BORONIC ACID; 1,3,4-THIADIAZOL-2-YLBORONIC ACID; 1,3,4-TRIMETHYL-1H-PYRAZOLE-5-BORONIC ACID; 1,3,5-TRIMETHYL-1H-PYRAZOL-4-YLBORONIC ACID; 1,3,5-TRIMETHYL-1H-PYRAZOLE-4-BORONIC ACID, HYDROCHLORIDE; 1,3-BENZOTHIAZOL-2-YLBORONIC ACID; 1,3-BENZOTHIAZOL-6-YLBORONIC ACID; 1,3-BENZOXAZOLE-5-BORONIC ACID; 1,3-BENZOXAZOLE-6-BORONIC ACID; 1,3-BIS(METHOXYMETHYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-BORONIC ACID; 1,3-DICHLORO-4-METHOXY-BENZENE-2-YLBORONIC ACID; 1,3-DIHYDRO-2-BENZOFURAN-5-YLBORANEDIOL; 1,3-DIHYDRO-2H-PYRROLO[2,3-B]PYRIDIN-2-ONE-4-BORONIC ACID; 1,3-DIMETHYL-1H-INDAZOLE-4-BORONIC ACID; 1,3-DIMETHYL-1H-INDAZOLE-5-BORONIC ACID; 1,3-DIMETHYL-1H-INDAZOLE-6-BORONIC ACID; 1,3-DIMETHYL-1H-INDAZOLE-7-BORONIC ACID; 1,3-DIMETHYL-1H-PYRAZOL-4-YLBORONIC ACID; 1,3-DIMETHYLPYRAZOLE-5-BORONIC ACID; 1,3-DIMETHYLPYRIMIDINE-2,4-DIONE-5-BORONIC ACID; 1,3-OXAZOL-5-YLBORONIC ACID; 1,4-BENZODIOXANE-5-BORONIC ACID; 1,4-BENZODIOXANE-6-BORONIC ACID; 1,4-BENZODIOXIN-2-YLBORONIC ACID; 1,4-DIHYDROQUINAZOLIN-5-YLBORONIC ACID; 1,4-DIMETHOXYNAPHTHALEN-2-YLBORONIC ACID; 1,4-DIMETHYL-1H-INDAZOLE-5-BORONIC ACID; 1,4-DIMETHYL-1H-INDAZOLE-6-BORONIC ACID; 1,4-DIOXA-SPIRO[4,5]DEC-7-EN-8-BORONIC ACID; 1,5-DIMETHYL-1H-INDAZOLE-4-BORONIC ACID; 1,5-DIMETHYL-1H-INDAZOLE-6-BORONIC ACID; 1,5-DIMETHYL-1H-INDOL-2-YLBORONIC ACID; 1,5-DIMETHYLPYRAZOLE-4-BORONIC ACID; 1,5-DIMETHYL-PYRROL-3-YLBORONIC ACID; 1,6-DIMETHYL-1H-INDAZOLE-4-BORONIC ACID; 1,6-DIMETHYL-1H-INDAZOLE-5-BORONIC ACID; 1,7-DIMETHYL-1H-INDAZOLE-4-BORONIC ACID; 1,7-DIMETHYL-1H-INDAZOLE-5-BORONIC ACID; 1,7-NAPHTHYRIDIN-4-YLBORONIC ACID; 1,7-NAPHTHYRIDINE-3-BORONIC ACID; 1,8-NAPHTHALIC ANHYDRIDE-4-BORONIC ACID; 1,8-NAPHTHYRIDIN-2-YLBORONIC ACID; 1,8-NAPHTHYRIDIN-4-YLBORONIC ACID; 1-[1,3]-DIOXOLAN-2-YLMETHYL-1H-PYRAZOLE-4-BORONIC ACID; 1-[5-(DIHYDROXYBORYL)PYRIMIDIN-2-YLPIPERIDINE-3-CARBOXYLIC ACID; 10-(2-NAPHTHYL)ANTHRACENE-9-BORONIC ACID; 1-ACETYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YLBORONIC ACID; 1-ACETYL-4-CHLORO-PYRROL-3-YLBORONIC ACID; 1-ACETYL-4-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 1-ACETYL-4-METHYL-PYRROL-3-YLBORONIC ACID; 1-ACETYL-PYRROL-3-YLBORONIC ACID; 1-ACETYLPYRROLIDIN-2-YLBORONIC ACID; 1-ALLYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-AMINONAPHTHALENE-2-BORONIC ACID; 1-AMINONAPHTHALENE-3-BORONIC ACID; 1-AMINONAPHTHALENE-4-BORONIC ACID; 1-AMINONAPHTHALENE-6-BORONIC ACID; 1-AMINONAPHTHALENE-7-BORONIC ACID; 1-AMINONAPHTHALENE-8-BORONIC ACID; 1-BENZENESULFONYL-1H-INDOLE-4-BORONIC ACID; 1-BENZENESULFONYL-1H-INDOLE-7-BORONIC ACID; 1-BENZOTHIEN-7-YLBORONIC ACID; 1-BENZYL-1,2,3,4-TETRAHYDRO-6-QUINOLINYLBORONIC ACID; 1-BENZYL-1H-PYRAZOLE-4-BORONIC ACID; 1-BENZYL-4-CHLORO-PYRROL-3-YLBORONIC ACID; 1-BENZYL-4-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 1-BENZYL-4-METHYL-PYRROL-3-YLBORONIC ACID; 1-BENZYL-PIPERIDINE-4-BORONIC ACID; 1-BENZYL-PYRROL-2-YLBORONIC ACID; 1-BENZYL-PYRROL-3-YLBORONIC ACID; 1-BIPHENYLENYLBORONIC ACID; 1-BOC-1,2,3,4-TETRAHYDRO-QUINOLINE-6-BORONIC ACID; 1-BOC-3,5-DIMETHYLPYRAZOLE-4-BORONIC ACID; 1-BOC-3-TRIFLUOROMETHYLPYRAZOLE-5-BORONIC ACID; 1-BOC-5,6-DICHLORO-1H-INDOLE-2-BORONIC ACID; 1-BOC-5-CHLORO-1H-INDOLE-2-BORONIC ACID; 1-BOC-5-CYANO-1H-INDOLE-2-BORONIC ACID; 1-BOC-5-FLUOROINDOLE-2-BORONIC ACID; 1-BOC-5-METHYL-1H-INDOLE-2-BORONIC ACID; 1-BOC-5-TBDMSO-INDOLE-2-BORONIC ACID; 1-BOC-6-CYANOINDOLE-2-BORONIC ACID; 1-BOC-6-METHOXYINDOLE-2-BORONIC ACID; 1-BOC-6-METHYLINDOLE-2-BORONIC ACID; 1-BOC-PIPERIDINE-4-BORONIC ACID; 1-BOC-PYRROLO[2,3-C]PYRIDINE-3-YLBORONIC ACID; 1-BUTENYLBORONIC ACID; 1-CARBOXYLMETHYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-CHLOROISOQUINOLINE-4-BORONIC ACID; 1-CHLORONAPHTHALENE-2-BORONIC ACID; 1-CHLORONAPHTHALENE-3-BORONIC ACID; 1-CHLORONAPHTHALENE-4-BORONIC ACID; 1-CHLORONAPHTHALENE-5-BORONIC ACID; 1-CHLORONAPHTHALENE-6-BORONIC ACID; 1-CHLORONAPHTHALENE-7-BORONIC ACID; 1-CHLORONAPHTHALENE-8-BORONIC ACID; 1-CYCLOHEXEN-1-YL-BORONIC ACID; 1-CYCLOHEXYL-1H-PYRAZOLE-5-BORONIC ACID; 1-CYCLOHEXYLVINYLBORONIC ACID; 1-CYCLOPENTYL-1H-PYRAZOLE-4-BORONIC ACID; 1-CYCLOPENTYL-PYRROL-3-YLBORONIC ACID; 1-ETHYL-1H-PYRAZOL-5-YLBORONIC ACID; 1-ETHYL-1H-PYRAZOLE-4-BORONIC ACID; 1-ETHYL-3-METHYL-1H-PYRAZOLE-5-BORONIC ACID; 1-ETHYL-3-PHENYL-1H-INDOL-2-YLBORONIC ACID; 1-ETHYL-PYRROL-3-YLBORONIC ACID; 1-FLUORONAPHTHALENE-2-BORONIC ACID; 1-FLUORONAPHTHALENE-3-BORONIC ACID; 1-FLUORONAPHTHALENE-5-BORONIC ACID; 1-FLUORONAPHTHALENE-6-BORONIC ACID; 1-FLUORONAPHTHALENE-7-BORONIC ACID; 1-FLUORONAPHTHALENE-8-BORONIC ACID; 1H-1,2,3-BENZOTRIAZOL-5-YLBORONIC ACID; 1H-1,2,3-BENZOTRIAZOL-6-YLBORONIC ACID; 1H-BENZIMIDAZOL-4-YLBORONIC ACID; 1H-BENZIMIDAZOL-5-YLBORONIC ACID; 1H-BENZIMIDAZOLE-5-BORONIC ACID, HYDROCHLORIDE SALT; 1H-BENZO[D]IMIDAZOL-6-YLBORONIC ACID; 1H-IMIDAZOL-2-YLBORONIC ACID HYDROCHLORIDE; 1H-IMIDAZOL-4-YLBORONIC ACID; 1H-IMIDAZOL-5-YLBORONIC ACID; 1H-INDAZOLE-4-BORONIC ACID; 1H-INDAZOLE-5-BORONIC ACID; 1H-INDAZOLE-5-BORONIC ACID HYDROCHLORIDE; 1H-INDAZOLE-7-BORONIC ACID; 1H-INDENE-2-BORONIC ACID; 1H-INDOL-2-YLBORONIC ACID; 1H-INDOL-4-YLBORONIC ACID HYDROCHLORIDE; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-4-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-4-METHOXY-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(1-METHYLETHOXY)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(1-PIPERIDINYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(1-PIPERIDINYLCARBONYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(1-PIPERIDINYLMETHYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(4-METHYL-1-PIPERAZINYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(CYCLOHEXYLAMINO)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(DIETHYLAMINO)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(DIMETHYLAMINO)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(METHYLTHIO)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[(4,4-DIMETHOXY-1-PIPERIDINYL)METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[(4-METHYL-1-PIPERAZINYL)CARBONYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[(4-METHYL-1-PIPERAZINYL)SULFONYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[(DIETHYLAMINO)METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[(DIMETHYLAMINO)METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[[[2-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]ETHYL]AMINO]METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[[[3-(DIMETHYLAMINO)-2,2-DIMETHYLPROPYL]AMINO]METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[[[DIMETHYL(1-METHYLETHYL)SILYL]OXY]METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[2-(1-PIPERIDINYL)ETHOXY]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[2-(4-MORPHOLINYL)ETHOXY]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[3-(1,3-DIOXOLAN-2-YL)PROPYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[3-(DIMETHYLAMINO)PROPYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-HYDROXY-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-NITRO-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-(TRIFLUOROMETHOXY)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-(TRIFLUOROMETHYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-[[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-ETHOXY-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-HYDROXY-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-7-CHLORO-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-7-HYDROXY-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 4-[[BIS(1-METHYLETHYL)AMINO]CARBONYL]-2-BORONO-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 5-BORONO-2,3-DIHYDRO-7-NITRO-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-PYRAZOLE-1-BENZYL-4-BORONIC ACID; 1H-PYRAZOLE-3-BORONIC ACID; 1H-PYRAZOLE-3-BORONIC ACID HYDRATE; 1H-PYRAZOLE-4-BORONIC ACID; 1H-PYRAZOLE-4-BORONIC ACID HCL; 1H-PYRAZOLE-5-BORONIC ACID; 1H-PYRAZOLO[3,4-B]PYRIDINE-5-BORONIC ACID; 1H-PYRAZOLO[3,4-C]PYRIDINE-4-BORONIC ACID; 1H-PYRAZOLO[4,3-B]PYRIDINE-6-BORONIC ACID; 1H-PYRAZOLO[4,3-B]PYRIDINE-7-BORONIC ACID; 1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 1H-PYRROLO[2,3-B]PYRIDIN-5-YLBORONIC ACID; 1H-PYRROLO[2,3-B]PYRIDINE-2-BORONIC ACID; 1H-PYRROLO[2,3-B]PYRIDINE-3-BORONIC ACID; 1H-PYRROLO[2,3-B]PYRIDINE-6-BORONIC ACID; 1H-PYRROLO[2,3-C]PYRIDINE-3-YLBORONIC ACID; 1H-PYRROLO[3,2-B]PYRIDIN-5-YLBORONIC ACID; 1H-PYRROLO[3,2-B]PYRIDIN-6-YLBORONIC ACID; 1H-PYRROLO[3,2-B]PYRIDINE-2-BORONIC ACID; 1H-PYRROLO[3,2-B]PYRIDINE-3-BORONIC ACID; 1H-PYRROLO[3,2-B]PYRIDINE-7-BORONIC ACID; 1-HYDROXYL-2-NAPHTHALENEBORONIC ACID; 1-ISOBUTYL-1H-PYRAZOL-5-YLBORONIC ACID; 1-ISOBUTYL-1H-PYRAZOLE-4-BORONIC ACID; 1-ISOPROPYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-ISOPROPYL-1H-PYRAZOLE-5-BORONIC ACID; 1-ISOPROPYL-1H-PYRROL-3-YLBORONIC ACID; 1-ISOPROPYL-3-METHYL-1H-PYRAZOLE-5-BORONIC ACID; 1-ISOPROPYL-PYRROL-2-YLBORONIC ACID; 1-ISOQUINOLYLBORONIC ACID; 1-METHOXYNAPHTHALENE-2-BORONIC ACID; 1-METHOXYNAPHTHALENE-3-BORONIC ACID; 1-METHOXYNAPHTHALENE-5-BORONIC ACID; 1-METHOXYNAPHTHALENE-6-BORONIC ACID; 1-METHOXYNAPHTHALENE-7-BORONIC ACID; 1-METHOXYNAPHTHALENE-8-BORONIC ACID; 1-METHYL-1,2,3-TRIAZOLE-4-BORONIC ACID; 1-METHYL-1H-BENZOIMIDAZOLE-6-BORONIC ACID; 1-METHYL-1H-IMIDAZOL-5-YLBORONIC ACID; 1-METHYL-1H-INDAZOLE-4-BORONIC ACID HYDROCHLORIDE; 1-METHYL-1H-INDAZOLE-5-BORONIC ACID; 1-METHYL-1H-PYRAZOL-3-YLBORONIC ACID; 1-METHYL-1H-PYRAZOL-5-YLBORONIC ACID; 1-METHYL-1H-PYRAZOLE-4-BORONIC ACID; 1-METHYL-1H-PYRAZOLE-4-BORONIC ACID HYDROCHLORIDE; 1-METHYL-1H-PYRROL-2-YL BORONIC ACID; 1-METHYL-1H-PYRROL-3-YLBORONIC ACID; 1-METHYL-2-(TRIPHENYL-METHYL)ISOINDOLE-5-BORONIC ACID; 1-METHYL-2-OXOINDOLIN-6-YLBORONIC ACID; 1-METHYL-3-CYCLOPROPYL-1H-PYRAZOLE-5-BORONIC ACID; 1-METHYL-3-ETHYL-1H-PYRAZOLE-5-BORONIC ACID; 1-METHYL-3-ISOPROPYL-1H-PYRAZOLE-5-BORONIC ACID; 1-METHYL-3-TERT-BUTYL-1H-PYRAZOLE-5-BORONIC ACID; 1-METHYL-3-TRIFLUOROMETHYLPYRAZOLE-5-BORONIC ACID; 1-METHYL-4-CHLORO-1H-PYRAZOLE-5-BORONIC ACID; 1-METHYL-5-PHENYL-PYRROL-3-YLBORONIC ACID; 1-METHYLINDAZOLE-4-BORONIC ACID; 1-METHYLINDAZOLE-6-BORONIC ACID; 1-METHYLINDAZOLE-7-BORONIC ACID; 1-METHYLINDOLE-5-BORONIC ACID; 1-METHYLNAPHTHALENE-2-BORONIC ACID; 1-METHYLNAPHTHALENE-3-BORONIC ACID; 1-METHYLNAPHTHALENE-5-BORONIC ACID; 1-METHYLNAPHTHALENE-6-BORONIC ACID; 1-METHYLNAPHTHALENE-7-BORONIC ACID; 1-METHYLNAPHTHALENE-8-BORONIC ACID; 1-METHYL-PIPERIDINE-4-BORONIC ACID; 1-NAPHTHALENEBORONIC ACID; 1-NAPHTHALENECARBOXYLIC ACID, 5-BORONIC ACID; 1-N-BOC-PYRROLE-3-BORONIC ACID; 1-N-BOC-PYRROLIDIN-2-YLBORONIC ACID; 1-NEOPENTYL-1H-PYRAZOLE-5-BORONIC ACID; 1-NONANEBORONIC ACID; 1-N-THP-PYRAZOL-3-YLBORONIC ACID; 1-PENTEN-YL BORONIC ACID; 1-PENTENYLBORONIC ACID; 1-PHENYL-1H-INDOL-2-YLBORONIC ACID; 1-PHENYL-1H-PYRAZOLE-4-BORONIC ACID; 1-PHENYL-1H-PYRROL-2-YLBORONIC ACID; 1-PHENYL-3,4-DIHYDROPYRROLO[1,2-A]PYRAZIN-6-YLBORONIC ACID; 1-PHENYL-CYCLOPROPYL-1-BORONIC ACID; 1-PHENYL-PYRROL-3-YLBORONIC ACID; 1-PHENYLSULFONYLINDOLE-6-BORONIC ACID; 1-PHENYLVINYLBORONIC ACID; 1-PIPERIDINECARBOXYLIC ACID, 4-(4-BORONOPHENYL)-4-(4-CHLOROPHENYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1-PROPYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-PROPYL-1H-PYRAZOL-5-YLBORONIC ACID; 1-P-TOLYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-PYRENEBORONIC ACID; 1-TBDMS-INDOLE-4-BORONIC ACID; 1-TERT-BUTOXYCARBONYL-1H-PYRAZOLE-4-BORONIC ACID; 1-TERT-BUTYL-1H-PYRAZOLE-4-BORONIC ACID; 1-TERT-BUTYL-1H-PYRAZOLE-5-BORONIC ACID; 1-TERT-BUTYL-4-(ETHOXYCARBONYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-TERT-BUTYLOXYCARBONYL-PYRRAZOLE-3-BORIC ACID; 1-TERT-BUTYRONYCARBONYL-3-BORIC INDAZOLE; 1-TOSYL-1H-PYRROLO[2,3-B]PYRIDIN-3-YLBORONIC ACID; 2-((1-(TERT-BUTOXYCARBONYL)AZEPAN-3-YL)METHYL)PHENYLBORONIC ACID; 2-((1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 2-((1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 2-((2′-CHLORO-5′-(TRIFLUOROMETHYL)PHENOXY)METHYL)PHENYLBORONIC ACID; 2-((3-(TRIFLUOROMETHYL)PHENOXY)METHYL)PHENYLBORONIC ACID; 2-((3-CYCLOPROPYLUREIDO)METHYL)PHENYLBORONIC ACID; 2-((3-ETHYLUREIDO)METHYL)PHENYLBORONIC ACID; 2-((3-METHYLUREIDO)METHYL)PHENYLBORONIC ACID; 2-((4′-(TRIFLUOROMETHOXY)PHENOXY)METHYL)PHENYLBORONIC ACID; 2-((BENZYLOXY)CARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL-6-BORONIC ACID; 2-((BENZYLOXYCARBONYLAMINO)METHYL)PHENYLBORONIC ACID; 2-((DIETHYLAMINO)METHYL)PHENYLBORONIC ACID; 2-((DIISOPROPYLAMINO)METHYL)PHENYLBORONIC ACID; 2-((DIMETHYLAMINO)METHYL)-5-NITROPHENYLBORONIC ACID; 2-((DIMETHYLAMINO)METHYL)THIAZOL-5-YLBORONIC ACID; 2-((TERT-BUTOXYCARBONYLAMINO)METHYL)-5-NITROPHENYLBORONIC ACID; 2-((TERT-BUTOXYCARBONYLAMINO)METHYL)PYRIMIDIN-5-YLBORONIC ACID; 2-([2-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-2,3-DIHYDROPYRIDAZIN-3-ONE; 2-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-2,3-DIHYDROPYRIDAZIN-3-ONE; 2-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-2,3-METHYLPYRIDINE-4-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(2,4-DICHLOROPHENYLMETHOXY)PHENYLBORONIC ACID; 2-(2,5-DIHYDRO-1H-PYRROL-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(2,5-DIMETHYL-1H-PYRROL-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(2,5-DIMETHYLPYRROL-1-YL)-5-CHLOROPYRIDINE-4-BORONIC ACID; 2-(2-[3-(DIHYDROXYBORANYL)PHENOXY]ETHYL)-2,3-DIHYDROPYRIDAZIN-3-ONE; 2-(2-AMINO-2-OXOETHYL)PHENYLBORONIC ACID; 2-(2-BORONOPHENOXYMETHYL)BENZONITRILE; 2-(2-BORONOPHENYL)ACETIC ACID; 2-(2-CARBOXYVINYL)BENZENEBORONIC ACID; 2-(2′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 2-(2-CHLOROETHYL)-4,5-DIMETHOXYPHENYLBORONIC ACID; 2-(2-CHLOROETHYL)PHENYLBORONIC ACID; 2-(2-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 2-(2-CHLOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(2-FLUOROPHENOXY)PHENYLBORONIC ACID; 2-(2-FLUOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(2-FURYL)PYRIMIDINE-5-BORONIC ACID; 2-(2H-TETRAZOL-5-YL)-PHENYLBORONIC ACID; 2-(2-HYDROXYETHYL)PHENYLBORONIC ACID; 2-(2′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 2-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 2-(2-METHOXYPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(2-METHYL-1,3-DIOXOLAN-2-YL)PHENYLBORONIC ACID; 2-(2-METHYLIMIDAZOL-1-YL)PYRIMIDINE-4-BORONIC ACID; 2-(2-METHYLIMIDAZOL-1-YL)PYRIMIDINE-5-BORONIC ACID; 2-(2-METHYLPIPERIDIN-1-YL)THIAZOLE-4-BORONIC ACID; 2-(2-OXOPYRROLIDIN-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(2-PYRIDYL)PYRIMIDINE-5-BORONIC ACID; 2-(2-TERT-BUTYLPHENOXY)PYRIDIN-3-YLBORONIC ACID; 2-(2-THIENYL)PYRIMIDINE-5-BORONIC ACID; 2-(2-TOLYL)PYRIMIDINE-5-BORONIC ACID; 2-(2-TRIFLUOROMETHYL-PHENYL)-ETHENEBORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(3,3-DIETHOXYPROPOXY)PHENYLBORONIC ACID; 2-(3-BORONOPHENOXYMETHYL)BENZONITRILE; 2-(3-BORONOPHENYL)-2-METHYL-1,3-DIOXOLANE; 2-(3-BORONOPHENYL)-5-METHYL-1,3,4-OXADIAZOLE; 2-(3-BORONOPHENYL)ACETIC ACID; 2-(3′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 2-(3-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 2-(3-CHLOROPHENYL)ETHENEBORONIC ACID; 2-(3-CHLOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(3-CYANOPHENYLMETHOXY)PHENYLBORONIC ACID; 2-(3′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 2-(3-FLUOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(3-FLUORO-PROPOXY)-BENZENEBORONIC ACID; 2-(3-FURYL)PYRIMIDINE-5-BORONIC ACID; 2-(3-HYDROXYPROPOXY)PYRIMIDIN-5-YLBORONIC ACID; 2-(3-HYDROXYPYRROLIDIN-1-YL)PYRIMIDINE-4-BORONIC ACID; 2-(3-METHOXYPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(3-METHOXYPROPOXY)PHENYLBORONIC ACID; 2-(3-METHYL-1H-PYRAZOL-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(3-METHYL-1H-PYRAZOL-1-YL)PYRIMIDINE-4-BORONIC ACID; 2-(3-METHYL-1H-PYRAZOL-1-YL)THIAZOLE-4-BORONIC ACID; 2-(3-METHYLPIPERIDIN-1-YL)THIAZOLE-4-BORONIC ACID; 2-(3-PHENYLBORONIC ACID)-2-METHYL-OXETANE; 2-(3-PYRIDYL)PYRIMIDINE-5-BORONIC ACID; 2-(3-THIENYL)PYRIMIDINE-5-BORONIC ACID; 2-(3-TOLYL)PYRIMIDINE-5-BORONIC ACID; 2-(4-(CYCLOHEXYLOXY)PIPERIDIN-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-(T-BUTOXYCARBONYL)PIPERAZIN-1-YL)PYRIDINE-3-BORONIC ACID; 2-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YLBORONIC ACID; 2-(4-ACETYLPIPERAZIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(4-BENZYLOXYPHENYL)PYRIMIDINE-5-BORONIC ACID; 2-(4-BORONOBENZOYL)HYDRAZINECARBOTHIOAMIDE; 2-(4-BORONOBENZOYL)-N-METHYLHYDRAZINECARBOTHIOAMIDE; 2-(4-BORONOPHENOXYMETHYL)BENZONITRILE; 2-(4-BORONOPHENYL)-2-METHYLPROPANENITRILE; 2-(4-BORONOPHENYL)-2-METHYLPROPANOIC ACID; 2-(4-BORONOPHENYL)-5,6-DIHYDRO-4H-1,3-OXAZINE; 2-(4-BORONOPHENYL)ACETIC ACID; 2-(4-CBZ-PIPERAZIN-1-YL)PYRIDINE-5-BORONIC ACID; 2-(4-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 2-(4-CHLOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-CYANOPHENYLMETHOXY)PHENYLBORONIC ACID; 2-(4-DIHYDROXYBORANE)PHENYL-4-CARBOXY-6-METHYLQUINOLINE; 2-(4-DIHYDROXYBORANE)PHENYL-4-CARBOXYQUINOLINE; 2-(4′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 2-(4-FLUOROPHENYL)CYCLOPROPYLBORONIC ACID; 2-(4-FLUOROPHENYL)PYRIDIN-4-YLBORONIC ACID; 2-(4-FLUOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-HYDROXYPIPERIDIN-1-YL)-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-(4′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 2-(4-METHOXYBENZYLOXY)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-METHOXYPHENYL)PYRIDIN-4-YLBORONIC ACID; 2-(4-METHOXYPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-METHYL-1H-PYRAZOL-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-METHYL-1H-PYRAZOL-1-YL)PYRIMIDINE-4-BORONIC ACID; 2-(4-METHYL-1H-PYRAZOL-1-YL)THIAZOLE-4-BORONIC ACID; 2-(4-METHYLIMIDAZOL-1-YL)PYRIMIDINE-5-BORONIC ACID; 2-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(4-METHYLPIPERAZIN-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-METHYLPIPERIDIN-1-YL)THIAZOLE-4-BORONIC ACID; 2-(4-NITROPHENYL)ETHENYLBORONIC ACID; 2-(4-PENTYLOXYPHENYL)PYRIMIDINE-5-BORONIC ACID; 2-(4-PENTYLPHENYL)PYRIMIDINE-5-BORONIC ACID; 2-(4-PYRIDYL)PYRIMIDINE-5-BORONIC ACID; 2-(4-TERT-BUTYLPHENYL)ACETYLENE-1-BORONIC ACID; 2-(4-TOLYL)PYRIMIDINE-5-BORONIC ACID; 2-(5-(3,3,3-TRIFLUOROPROPYL)-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-(DIMETHYLAMINO)-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-[1,3]DIOXOLAN-2-YL-2,4-DIMETHOXY-PHENYL)-BORONIC ACID; 2-(5-ETHOXY-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-ISOBUTYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-ISOPROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-PROPYL-1,3,4-THIADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(ALLYLOXY)-5-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 2-(AMINOMETHYL)-5-FLUOROBENZENEBORONIC ACID HYDROCHLORIDE; 2-(AMINOMETHYL)-5-FLUOROPHENYLBORONIC ACID; 2-(AMINOMETHYL)-5-NITROPHENYLBORONIC ACID; 2-(AMINOMETHYL)PHENYL BORONIC ACID; 2-(AMINOMETHYL)PHENYLBORONIC ACID, HCL; 2-(AMINOMETHYL)THIAZOL-5-YLBORONIC ACID; 2-(AZETIDIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(AZETIDINE-1-CARBONYL)PHENYLBORONIC ACID; 2-(AZIRIDINE-1-CARBONYL)PHENYLBORONIC ACID; 2-(BENZYL(METHYL)AMINO)QUINOLIN-6-YLBORONIC ACID; 2-(BENZYLAMINO)PYRIDIN-4-YLBORONIC ACID; 2-(BENZYLOXY)-3,5-DIFLUOROPHENYLBORONIC ACID; 2-(BENZYLOXY)-3-CHLOROPHENYLBORONIC ACID; 2-(BENZYLOXY)-3-METHYLPHENYLBORONIC ACID; 2-(BENZYLOXY)-4-(DIMETHYLAMINO)PYRIMIDINE-5-BORONIC ACID; 2-(BENZYLOXY)-4-METHOXYPHENYLBORONIC ACID; 2-(BENZYLOXY)-4-METHYLPHENYLBORONIC ACID; 2-(BENZYLOXY)-5-BORONOBENZOIC ACID; 2-(BENZYLOXY)-5-ETHOXYPHENYLBORONIC ACID; 2-(BENZYLOXY)-5-FLUOROPYRIDIN-3-YLBORONIC ACID; 2-(BENZYLOXY)-5-METHOXYPHENYLBORONIC ACID; 2-(BENZYLOXY)-5-TERT-BUTYLPHENYLBORONIC ACID; 2-(BENZYLOXY)NAPHTHALEN-1-YLBORONIC ACID; 2-(BENZYLOXY)PYRIDINE-4-BORONIC ACID; 2-(BENZYLOXY)PYRIMIDIN-5-YLBORONIC ACID; 2-(BENZYLOXYCARBONYLAMINO)ETHYLBORONIC ACID; 2-(BIPHENYL)PHENYLBORONIC ACID; 2-(BOC-AMINO)THIAZOLE-5-BORONIC ACID; 2-(BOC-AMINOMETHYL)PYRIDINE-4-BORONIC ACID; 2-(BUTOXYCARBONYLAMINO)PYRIDIN-3-YLBORONIC ACID; 2-(CHLOROMETHYL)-5-NITROPHENYLBORONIC ACID; 2-(CYANOMETHYL)PHENYLBORONIC ACID; 2-(CYCLOBUTOXY)PYRIMIDINE-5-BORONIC ACID; 2-(CYCLOBUTYL)PYRIMIDINE-5-BORONIC ACID; 2-(CYCLOBUTYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(CYCLOHEXYL)PYRIMIDINE-5-BORONIC ACID; 2-(CYCLOHEXYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(CYCLOHEXYLETHYL)BORONIC ACID; 2-(CYCLOHEXYLOXY)METHYLPHENYLBORONIC ACID; 2-(CYCLOHEXYLOXY)PYRIMIDIN-5-YLBORONIC ACID; 2-(CYCLOPENTOXY)PYRIMIDINE-5-BORONIC ACID; 2-(CYCLOPENTYL)PYRIDINE-4-BORONIC ACID; 2-(CYCLOPENTYL)PYRIMIDINE-5-BORONIC ACID; 2-(CYCLOPENTYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(CYCLOPROPANECARBOXAMIDO)PHENYLBORONIC ACID; 2-(CYCLOPROPYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(CYCLOPROPYLCARBAMOYL)-5-METHYLPYRIDIN-4-YLBORONIC ACID; 2-(CYCLOPROPYLCARBAMOYL)PYRIDIN-4-YLBORONIC ACID; 2-(CYCLOPROPYLMETHOXY)-4-TRIFLUOROMETHYLPHENYLBORONIC ACID; 2-(CYCLOPROPYLMETHOXY)PHENYLBORONIC ACID; 2-(CYCLOPROPYLMETHOXY)PYRIDINE-5-BORONIC ACID; 2-(DICYCLOHEXYLPHOSPHINO)PHENYLBORONIC ACID; 2-(DIETHYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(DIFLUOROMETHOXY)-5-FLUOROPHENYLBORONIC ACID; 2-(DIFLUOROMETHOXY)-6-FLUOROPHENYLBORONIC ACID; 2-(DIFLUOROMETHOXY)-BENZENEBORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-1-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-3-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-4-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-5-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-6-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-7-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-8-BORONIC ACID; 2-(DIFLUOROMETHOXY)PYRAZINE-6-BORONIC ACID; 2-(DIFLUOROMETHYL)-5-FLUOROPHENYLBORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-1-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-3-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-4-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-5-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-6-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-7-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-8-BORONIC ACID; 2-(DIHYDROXYBORYL)-3-THIOPHENECARBOXYLIC ACID; 2-(DIHYDROXYBORYL)-4-METHOXYBENZOIC ACID; 2-(DIHYDROXYBORYL)-5-METHOXYBENZOIC ACID; 2-(DIISOPROPYLCARBANOYL) PHENYLBORONIC ACID; 2-(DIMETHYLAMINE)PHENYLBORONIC ACID; 2-(DIMETHYLAMINO)-4,6-DIMETHYLPYRIMIDIN-5-YLBORONIC ACID; 2-(DIMETHYLAMINO)-4-METHOXYPYRIMIDIN-5-YLBORONIC ACID; 2-(DIMETHYLAMINO)-5-METHYLPHENYLBORONIC ACID; 2-(DIMETHYLAMINO)-5-PYRIDINYL BORONIC ACID HYDROCHLORIDE; 2-(DIMETHYLAMINO)-6-OXO-1,6-DIHYDROPYRIMIDIN-5-YLBORONIC ACID; 2-(DIMETHYLAMINO)BENZENEBORONIC ACID HYDROCHLORIDE; 2-(DIMETHYLAMINO)PYRIDINE-3-BORONIC ACID; 2-(DIMETHYLAMINO)PYRIDINE-5-BORONIC ACID HYDRATE; 2-(DIMETHYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(DIMETHYLAMINOCARBONYL)BENZENEBORONIC ACID; 2-(E-CYANOVINYL)PHENYLBORONIC ACID; 2-(ETHOXYCARBONYL)-1H-IMIDAZOL-5-YLBORONIC ACID; 2-(ETHOXYCARBONYL)-1-METHYL-1H-IMIDAZOL-5-YLBORONIC ACID; 2-(ETHOXYCARBONYL)-4-FLUOROPHENYLBORONIC ACID; 2-(ETHOXYCARBONYL)FURAN-3-BORONIC ACID; 2-(ETHOXYCARBONYL)PYRIDINE-4-BORONIC ACID; 2-(ETHOXYCARBONYL)THIOPHEN-3-YLBORONIC ACID; 2-(ETHOXY-D5)-PHENYLBORONIC ACID; 2-(ETHOXY-D5)-PYRIMIDINE-5-BORONIC ACID; 2-(ETHYL-D5)-PHENYLBORONIC ACID; 2-(ETHYL-D5)-PYRIMIDINE-5-BORONIC ACID; 2-(FURAN-2-YL)PYRIDINE-4-BORONIC ACID; 2-(HYDROXY)PYRIDINE-4-BORONIC ACID; 2-(HYDROXYMETHYL)-6-METHOXYPHENYLBORONIC ACID; 2-(HYDROXYMETHYL)FURAN-3-YLBORONIC ACID; 2-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 2-(HYDROXYMETHYL)PHENYLBORONIC ACID; 2-(HYDROXYMETHYL)THIOPHEN-3-YLBORONIC ACID; 2-(IMIDAZOL-1-YL)PYRIMIDINE-4-BORONIC ACID; 2-(IMIDAZOL-1-YL)PYRIMIDINE-5-BORONIC ACID; 2-(IMIDAZOL-1-YL)THIAZOLE-4-BORONIC ACID; 2-(ISOBUTOXY)PYRIDINE-3-BORONIC ACID; 2-(ISOBUTYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(ISOPROPOXY)PYRIDINE-4-BORONIC ACID; 2-(ISO-PROPOXY-D7)-PHENYLBORONIC ACID; 2-(ISO-PROPOXY-D7)-PYRIMIDINE-5-BORONIC ACID; 2-(ISOPROPYL)PYRIDINE-4-BORONIC ACID; 2-(ISO-PROPYL-D7)-PHENYLBORONIC ACID; 2-(ISO-PROPYL-D7)-PYRIDINE-4-BORONIC ACID; 2-(ISO-PROPYL-D7)-PYRIMIDINE-5-BORONIC ACID; 2-(METHANESULFONYLAMINO)PHENYLBORONIC ACID; 2-(METHOXYCARBONYL)-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(METHOXYCARBONYL)-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(METHOXYCARBONYL)-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-(METHOXYCARBONYL)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(METHOXYCARBONYL)-5-PHENYLTHIOPHEN-3-YLBORONIC ACID; 2-(METHOXYCARBONYL)PYRIDINE-4-BORONIC ACID; 2-(METHOXYCARBONYL)QUINOLIN-8-YLBORONIC ACID; 2-(METHOXY-D3)-PHENYLBORONIC ACID; 2-(METHOXY-D3)-PYRIDINE-4-BORONIC ACID; 2-(METHOXY-D3)-PYRIMIDINE-5-BORONIC ACID; 2-(METHOXYMETHOXY)-5-METHYLPHENYLBORONIC ACID; 2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 2-(METHYL-13C,D3)PYRIDINE-4-BORONIC ACID; 2-(METHYLAMINO)-6-OXO-1,6-DIHYDROPYRIMIDIN-5-YLBORONIC ACID; 2-(METHYLAMINO)PYRIDIN-4-YLBORONIC ACID; 2-(METHYLAMINO)PYRIMIDIN-5-YLBORONIC ACID; 2-(METHYL-D3)-PHENYLBORONIC ACID; 2-(METHYL-D3)-PYRIDINE-4-BORONIC ACID; 2-(METHYL-D3)-PYRIMIDINE-5-BORONIC ACID; 2-(METHYLSULFINYL)PHENYLBORONIC ACID; 2-(METHYLSULFONAMIDO)PYRIMIDIN-5-YLBORONIC ACID; 2-(METHYLSULFONYL)PHENYLBORONIC ACID; 2-(METHYLSULFONYL)PYRIDINE-5-BORONIC ACID; 2-(METHYLTHIO)PHENYLBORONIC ACID; 2-(METHYLTHIO)PYRIDINE-3-BORONIC ACID; 2-(METHYLTHIO)PYRIMIDINE-5-BORONIC ACID; 2-(METHYLTHIOL-D3)-PHENYLBORONIC ACID; 2-(MORPHOLIN-1-YL)PHENYLBORONIC ACID HCL; 2-(MORPHOLIN-1YL)PYRIMIDIN-5-YLBORONIC ACID HCL; 2-(MORPHOLIN-4-YL)PYRIDINE-4-BORONIC ACID; 2-(MORPHOLIN-4-YLCARBONYL)BENZENEBORONIC ACID; 2-(MORPHOLINO)PHENYLBORONIC ACID; 2-(MORPHOLINOMETHYL)PHENYLBORONIC ACID; 2-(MORPHOLINOMETHYL)PYRIDIN-4-YLBORONIC ACID; 2-(MORPHOLINOSULFONYL)PHENYLBORONIC ACID; 2-(N,N-DIETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 2-(N,N-DIMETHYLAMINO)PYRIDINE-5-BORONIC ACID 2HCL; 2-(N,N-DIMETHYLAMINOMETHYL)PHENYLBORONIC ACID; 2-(N,N-DIMETHYLSULFAMOYL)PYRIDIN-3-YLBORONIC ACID; 2-(N,N-DIMETHYLSULFAMOYLOXY)PHENYLBORONIC ACID; 2-(N,N-DIMETHYLSULPHAMOYL)BENZENEBORONIC ACID; 2-(N,N-METHYLETHYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(NAPHTHALEN-1-YL)PHENYLBORONIC ACID; 2-(NAPHTHALEN-1-YL)PYRIDINE-4-BORONIC ACID; 2-(NAPHTHALEN-2-YL)PHENYLBORONIC ACID; 2-(N-BENZYLSULFAMOYL)-5-METHYLPHENYLBORONIC ACID; 2-(N-BOC-AMINOMETHYL)-4-FLUOROPHENYLBORONIC ACID; 2-(N-ETHYLSULFAMOYL)PHENYLBORONIC ACID; 2-(N-METHYL-N-PHENYL)AMINOMETHYLBENZENEBORONIC ACID; 2-(N-PHENYLAMINOMETHYL)PHENYLBORONIC ACID; 2-(N-PROPOXY-D7)-PYRIMIDINE-5-BORONIC ACID; 2-(N-PROPYL)PYRIMIDINE-5-BORONIC ACID; 2-(N-PROPYL-D7)-PYRIDINE-4-BORONIC ACID; 2-(N-PROPYL-D7)-PYRIDINE-5-BORONIC ACID; 2-(N-PROPYL-D7)-PYRIMIDINE-5-BORONIC ACID; 2-(N-PROPYLSULFAMOYL)PHENYLBORONIC ACID; 2-(N-TERT-BUTYLSULFAMOYL)-5-PROPYLTHIOPHEN-3-YLBORONIC ACID; 2-(PERFLUOROPHENYL)-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(PERFLUOROPHENYL)-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(PERFLUOROPHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(PERFLUOROPHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(PERFLUOROPHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(PERFLUOROPHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(PIPERAZIN-1-YL)PYRIDIN-3-YLBORONIC ACID; 2-(PIPERAZIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(PIPERAZIN-1-YL)THIAZOLE-4-BORONIC ACID-HCL; 2-(PIPERAZIN-1-YLMETHYL)PHENYLBORONIC ACID; 2-(PIPERIDIN-1-YL)-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-(PIPERIDIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(PIPERIDIN-1-YLMETHYL)PHENYLBORONIC ACID; 2-(PIPERIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 2-(PIPERIDINO)PHENYLBORONIC ACID HCL; 2-(PROP-1-YNYL)PYRIDIN-4-YLBORONIC ACID; 2-(PROPAN-2-YLOXY)NAPHTHALENE-1-BORONIC ACID; 2-(PYRIDIN-2-YL)PHENYLBORONIC ACID; 2-(PYRIDIN-2-YLMETHOXY)PHENYLBORONIC ACID; 2-(PYRIDIN-4-YLMETHOXY)PHENYLBORONIC ACID; 2-(PYRIDINE-3-YL)PHENYLBORONIC ACID; 2-(PYRIDINE-4-YL)PHENYLBORONIC ACID; 2-(PYRROLIDIN-1-YL)-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-(PYRROLIDIN-1-YL)PHENYLBORONIC ACID HYDROCHLORIDE; 2-(PYRROLIDIN-1-YL)PYRIDINE-3-BORONIC ACID; 2-(PYRROLIDINO)PHENYLBORONIC ACID; 2-(PYRROLIDINYLSULFONYL)PHENYLBORONIC ACID; 2-(TERT-BUTOXY)PYRIDINE-4-BORONIC ACID; 2-(TERT-BUTOXYCARBONYL(METHYL)AMINO)PYRIMIDIN-5-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-5-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL-6-BORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-2,3,4,5-TETRAHYDRO-1H-BENZO[C]AZEPIN-7-YL-7-BORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-2,3,4,5-TETRAHYDRO-1H-BENZO[C]AZEPIN-8-YL-8-BORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-5-CHLOROPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-5-METHOXYPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)PHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)PYRIDIN-3-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-3-FLUOROPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-4-CYANOPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-5-CHLOROPYRIDIN-4-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-5-METHOXYPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-6-METHOXYPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)BIPHENYL-3-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)PYRIDIN-3-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-THIOPHENE-3-BORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-THIOPHENE-4-BORONIC ACID; 2-(TERT-BUTOXYMETHYL)PHENYLBORONIC ACID; 2-(TERT-BUTYL)PYRIDINE-4-BORONIC ACID; 2-(TERT-BUTYLAMINO)SULFONYLPHENYLBORONIC ACID; 2-(TERT-BUTYLCARBAMOYL)-5-ISOBUTYLTHIOPHEN-3-YLBORONIC ACID; 2-(TERT-BUTYLCARBONYLAMINO)-6-CHLOROPHENYLBORONIC ACID; 2-(TERT-BUTYLCARBONYLAMINO)PHENYLBORONIC ACID; 2-(TETRAHYDRO-2H-PYRAN-4-YLOXY)PYRIDIN-4-YLBORONIC ACID; 2-(TETRAHYDRO-FURAN-3-YLOXY)PYRIMIDINE-5-BORONIC ACID; 2-(TETRAHYDROPYRAN-2-YLOXY)PHENYLBORONIC ACID; 2-(TETRAHYDROPYRAN-4-YLOXYMETHY)PHENYLBORONIC ACID; 2-(TETRAZOL-5-YL)PHENYLBORONIC ACID; 2-(THIOMORPHOLINOMETHYL)PHENYLBORONIC ACID; 2-(THIOPHEN-2-YL)PYRIDINE-4-BORONIC ACID; 2-(THIOPHEN-2-YLMETHOXYMETHYL)PHENYLBORONIC ACID; 2-(THIOPHEN-3-YL)PHENYLBORONIC ACID; 2-(TOLYL-D7)-BORONIC ACID; 2-(TRIETHYLSILYL)BENZOTHIOPHENE-7-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-1-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-3-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-4-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-5-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-6-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-7-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-8-BORONIC ACID; 2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-(TRIFLUOROMETHOXY)PYRAZINE-6-BORONIC ACID; 2-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-6-BORONIC ACID; 2-(TRIFLUOROMETHYL)-1H-BENZIMIDAZOLE-5-BORONIC ACID, HYDROCHLORIDE SALT; 2-(TRIFLUOROMETHYL)-1H-INDOL-5-YLBORONIC ACID; 2-(TRIFLUOROMETHYL)-1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 2-(TRIFLUOROMETHYL)-3-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-3-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-3-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-3-FLUORO-PHENYLBORONIC ACID; 2-(TRIFLUOROMETHYL)-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-NITROPHENYLBORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-1-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-3-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-5-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-6-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-7-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-8-BORONIC ACID; 2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(TRIFLUOROMETHYLTHIO)-BENZENEBORONIC ACID; 2-(TRIMETHYLSILYL)BENZO[B]THIOPHEN-7-YLBORONIC ACID; 2,1,3-BENZOTHIADIAZOL-4-YLBORONIC ACID; 2,2,4,4-TETRAFLUORO-4H-BENZO[1,3]DIOXINE-6-BORONIC ACID; 2,2,4,4-TETRAMETHYL-3,4-DIHYDROBENZOTHIOPYRANYL-6-BORONIC ACID; 2,2′:6′,2″-TERPYRIDINE-4′-BORONIC ACID; 2,2′-BIPYRIDIN-4-YLBORONIC ACID; 2,2′-BITHIOPHENE-5-BORONIC ACID; 2,2-DIFLUOROBENZO[1,3]DIOXOLE-4-BORONIC ACID; 2,2-DIFLUORO-BENZO[1,3]DIOXOLE-5-BORONIC ACID; 2,2-DIMETHYL-2,3-DIHYDRO-1-BENZOFURAN-4-BORONIC ACID; 2,2-DIMETHYL-2,3-DIHYDRO-1-BENZOFURAN-6-BORONIC ACID; 2,2-DIMETHYL-3,4-DIHYDRO-2H-CHROMEN-6-YLBORONIC ACID; 2,2-DIMETHYLETHENYLBORONIC ACID; 2,2-DIMETHYLPROPYL-4′-(TRIFLUOROMETHYL)BENZOATE-2′-BORONIC ACID; 2,2-DIMETHYLPROPYL-4′-METHOXYBENZOATE-2′-BORONIC ACID; 2,2-DIPHENYLVINYLBORONIC ACID; 2,3,4,5,6-PENTAFLUOROBENZENEBORONIC ACID; 2,3,4,5,6-PENTAMETHYLPHENYLBORONIC ACID; 2,3,4,5-TETRAFLUOROPHENYLBORONIC ACID; 2,3,4,6-TETRAFLUOROPHENYLBORONIC ACID; 2,3,4-TRICHLORO-5-NITROPHENYLBORONIC ACID; 2,3,4-TRICHLOROPHENYLBORONIC ACID; 2,3,4-TRIFLUOROPHENYLBORONIC ACID; 2,3,4-TRIMETHOXYPHENYLBORONIC ACID; 2,3,4-TRIS(BENZYLOXY)PHENYLBORONIC ACID; 2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 2,3,5,6-TETRAMETHYLPHENYLBORONIC ACID; 2,3,5-TRICHLOROPHENYLBORONIC ACID; 2,3,5-TRIFLUOROPHENYLBORONIC ACID; 2,3,6-TRICHLOROPHENYLBORONIC ACID; 2,3,6-TRIFLUOROPHENYLBORONIC ACID; 2,3,6-TRIMETHOXYPHENYLBORONIC ACID; 2,3-DICHLORO-4-METHOXYPHENYLBORONIC ACID; 2,3-DICHLORO-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2,3-DICHLORO-6-FLUOROPHENYLBORONIC ACID; 2,3-DICHLOROPHENYLBORONIC ACID; 2,3-DICHLOROPYRIDINE-4-BORONIC ACID; 2,3-DICHLOROPYRIDINE-5-BORONIC ACID; 2,3-DIFLUORO-4-(5-NONYL-1,3-DIOXAN-2-YL)PHENYLBORONIC ACID; 2,3-DIFLUORO-4-(HEPTYLOXY)PHENYLBORONIC ACID; 2,3-DIFLUORO-4-(N-HEXYLOXY)PHENYLBORONIC ACID; 2,3-DIFLUORO-4-BENZYLPHENYLBORONIC ACID; 2,3-DIFLUORO-4-ETHOXYPHENYLBORONIC ACID; 2,3-DIFLUORO-4-ETHYLPHENYLBORONIC ACID; 2,3-DIFLUORO-4′-HEPTYLBIPHENYL-4-BORONIC ACID; 2,3-DIFLUORO-4-HEPTYLPHENYL BORONIC ACID; 2,3-DIFLUORO-4-HEXYLPHENYL BORONIC ACID; 2,3-DIFLUORO-4-HYDROXYPHENYLBORONIC ACID; 2,3-DIFLUORO-4-ISOBUTYLPHENYLBORONIC ACID; 2,3-DIFLUORO-4-METHOXYPHENYLBORONIC ACID; 2,3-DIFLUORO-4-METHYLPHENYLBORONIC ACID; 2,3-DIFLUORO-4-N-BUTYLPHENYLBORONIC ACID; 2,3-DIFLUORO-4′-PENTYLBIPHENYL-4-BORONIC ACID; 2,3-DIFLUORO-4-PENTYLOXYPHENYLBORONIC ACID; 2,3-DIFLUORO-4-PENTYLPHENYLBORONIC ACID; 2,3-DIFLUORO-5-NITROPHENYLBORONIC ACID; 2,3-DIFLUORO-6-BENZYLOXYPHENYLBORONIC ACID; 2,3-DIFLUORO-6-ETHOXYPHENYLBORONIC ACID; 2,3-DIFLUORO-6-METHOXYPHENYLBORONIC ACID; 2,3-DIFLUOROPHENYLBORONIC ACID; 2,3-DIFLUOROPYRIDINE-4-BORONIC ACID; 2,3-DIHYDRO-1,4-BENZODIOXIN-2-YLBORONIC ACID; 2,3-DIHYDRO-1-BENZOFURAN-7-BORONIC ACID; 2,3-DIHYDRO-1H-INDEN-5-YLBORANEDIOL; 2,3-DIHYDRO-5-FURYLBORONIC ACID; 2,3-DIHYDRO-8-METHOXYBENZO[B][1,4]DIOXIN-5-YL-5-BORONIC ACID; 2,3-DIHYDROBENZOFURAN-5-BORONIC ACID; 2,3-DIHYDROTHIENO[3,4-B][1,4]DIOXIN-5-YLBORONIC ACID; 2,3-DIMETHOXY-1-TERT-BUTYL-PHENYL-5-BORONIC ACID; 2,3-DIMETHOXYPHENYLBORONIC ACID; 2,3-DIMETHOXYPYRIDINE-4-BORONIC ACID; 2,3-DIMETHYL-2H-INDAZOL-6-YLBORONIC ACID; 2,3-DIMETHYL-4-HYDROXYMETHYLPHENYLBORONIC ACID; 2,3-DIMETHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-7-YLBORONIC ACID; 2,3-DIMETHYLANTHRACEN-10-YL-10-BORONIC ACID; 2,3-DIMETHYLBENZO[B]THIOPHENE-7-BORONIC ACID; Z,3′-DIMETHYLBIPHENYL-2-YLBORONIC ACID; 2,3-DIMETHYLINDAZOLE-5-BORONIC ACID; 2,3-DIMETHYLPHENYLBORONIC ACID; 2,3-DIMETHYLPYRIDIN-4-YLBORONIC ACID; 2,3-METHYLENEDIOXYPHENYLBORONIC ACID; 2,4-(DIMETHYL)PYRIMIDINE-5-BORONIC ACID; 2,4,5-TRICHLOROPHENYLBORONIC ACID; 2,4,5-TRIFLUOROPHENYLBORONIC ACID; 2,4,5-TRIMETHYLPHENYLBORONIC ACID; 2,4,6-(TRIMETHYL)PYRIMIDINE-5-BORONIC ACID; 2,4,6-TRICHLOROPHENYLBORONIC ACID; 2,4,6-TRIFLUORO-3-HYDROXYPHENYLBORONIC ACID; 2,4,6-TRIFLUORO-3-METHYLPHENYLBORONIC ACID; 2,4,6-TRIFLUOROPHENYLBORONIC ACID; 2,4,6-TRIISOPROPYLBENZENEBORONIC ACID; 2,4,6-TRIMETHOXYPHENYLBORONIC ACID; 2,4,6-TRIMETHYLPHENYLBORONIC ACID; 2,4,6-TRIMETHYLPYRIDIN-3-YLBORONIC ACID; 2,4,6-TRICHLOROPYRIDINE-3-BORONIC ACID; 2,4-BIS(BENZYLOXY)PHENYLBORONIC ACID; 2,4-BIS(BENZYLOXY)PYRIMIDINE-5-BORONIC ACID; 2,4-BIS(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2,4-DI(TERT-BUTOXY)PYRIMIDIN-5-YLBORONIC ACID HYDRATE; 2,4-DIAMINOPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIBUTOXYPHENYLBORONIC ACID; 2,4-DICHLORO-3-CYANOPHENYLBORONIC ACID; 2,4-DICHLORO-3-METHOXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-(2-(DIMETHYLAMINO)ETHOXY)PHENYLBORONIC ACID; 2,4-DICHLORO-5-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 2,4-DICHLORO-5-(CYCLOPENTYLOXY)PHENYLBORONIC ACID; 2,4-DICHLORO-5-(CYCLOPROPYLMETHOXY)PHENYLBORONIC ACID; 2,4-DICHLORO-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2,4-DICHLORO-5-ETHOXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-HYDROXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-ISOBUTOXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-ISOPROPOXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-METHOXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-NITROPHENYLBORONIC ACID; 2,4-DICHLORO-5-PROPOXYPHENYLBORONIC ACID; 2,4-DICHLORO-6-ETHYLPHENYLBORONIC ACID; 2,4-DICHLORO-6-HYDROXYPHENYLBORONIC ACID; 2,4-DICHLORO-6-METHOXYPHENYLBORONIC ACID; 2,4-DICHLOROPHENYLBORONIC ACID; 2,4-DICHLOROPYRIDINE-3-BORONIC ACID; 2,4-DICHLOROPYRIDINE-5-BORONIC ACID HYDRATE; 2,4-DICHLOROPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIETHOXYPHENYLBORONIC ACID; 2,4-DIETHOXYPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIFLUORO-3-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2,4-DIFLUORO-3-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 2,4-DIFLUORO-3-CYANOPHENYLBORONIC ACID; 2,4-DIFLUORO-5-NITROPHENYLBORONIC ACID; 2,4-DIFLUORO-6-HYDROXYPHENYLBORONIC ACID; 2,4-DIFLUOROPHENYLBORONIC ACID; 2,4-DIFLUOROPYRIDINE-3-BORONIC ACID; 2,4-DIFLUOROPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIHYDROXYPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIISOPROPOXYPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIMETHOXY-6-METHYLPHENYLBORONIC ACID; 2,4-DIMETHOXYPHENYLBORONIC ACID; 2,4-DIMETHOXYPYRIDIN-3-YLBORONIC ACID; 2,4-DIMETHOXYPYRIMIDINE-5-BORONIC ACID; 2,4-DIMETHYL-3-METHOXYBENZENEBORONIC ACID; 2,4-DIMETHYL-6-METHOXYPHENYLBORONIC ACID; 2′,4′-DIMETHYLBIPHENYL-2-YLBORONIC ACID; 2,4-DIMETHYLPHENYLBORONIC ACID; 2,4-DIMETHYLPYRIDINE-3-BORONIC ACID; 2,4-DIOXOHEXAHYDROPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIPHENYL-5-PYRIMIDINYLBORONIC ACID; 2,4-DIPROPOXYPHENYLBORONIC ACID; 2,4-DITERT-BUTOXYPYRIMIDIN-5-YLBORONIC ACID; 2,5-BIS(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 2,5-DICHLORO-4-METHOXY-BENZENEBORONIC ACID; 2,5-DICHLORO-4-METHYL-BENZENEBORONIC ACID; 2,5-DICHLOROPHENYLBORONIC ACID; 2,5-DICHLOROPYRIDINE-3-BORONIC ACID; 2,5-DICHLOROPYRIDINE-4-BORONIC ACID; 2,5-DICHLOROTHIOPHENE-3-BORONIC ACID; 2,5-DIFLUORO-4-BENZYLOXYPHENYLBORONIC ACID; 2,5-DIFLUORO-4-ETHOXYPHENYLBORONIC ACID; 2,5-DIFLUORO-4-HYDROXYPHENYLBORONIC ACID; 2,5-DIFLUORO-4-METHOXYPHENYLBORONIC ACID; 2,5-DIFLUORO-6-ETHOXYPHENYLBORONIC ACID; 2,5-DIFLUOROPHENYLBORONIC ACID; 2,5-DIFLUOROPYRIDINE-3-BORONIC ACID; 2,5-DIFLUOROPYRIDINE-4-BORONIC ACID; 2,5-DIMETHOXYPHENYLBORONIC ACID; 2,5-DIMETHOXYPYRIMIDIN-4-YLBORONIC ACID; 2,5-DIMETHYL-4-ETHOXYPHENYLBORONIC ACID; 2,5-DIMETHYL-4-METHOXYPHENYLBORONIC ACID; 2′,5′-DIMETHYLBIPHENYL-2-YLBORONIC ACID; 2,5-DIMETHYLPHENYLBORONIC ACID; 2,5-DIMETHYLPYRIDIN-3-YLBORONIC ACID; 2,5-DIMETHYLTHIOPHENE-3-BORONIC ACID; 2,6-BIS(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2,6-DICHLORO-3-METHYLPHENYLBORONIC ACID; 2,6-DICHLORO-3-NITROPHENYLBORONIC ACID; 2,6-DICHLORO-4-METHYLPHENYLBORONIC ACID; 2,6-DICHLOROBENZYLBORONIC ACID; 2,6-DICHLOROPHENYLBORONIC ACID; 2,6-DICHLOROPYRIDINE-3-BORONIC ACID; 2,6-DICHLOROPYRIDINE-4-BORONIC ACID; 2,6-DICYANOPYRIDINE-4-BORONIC ACID; 2,6-DIETHOXYPYRIDINE-3-BORONIC ACID; 2,6-DIETHYLPYRIDINE-4-BORONIC ACID; 2,6-DIFLUORO-3-(2′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 2,6-DIFLUORO-3-(2′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 2,6-DIFLUORO-3-(3′,5-DIMETHOXYBENZYLOXY)PHENYLBORONIC ACID; 2,6-DIFLUORO-3-ETHOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-3-HYDROXYPHENYLBORONIC ACID; 2,6-DIFLUORO-3-ISOPROPOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-3-METHOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-3-NITROPHENYLBORONIC ACID; 2,6-DIFLUORO-3-PROPOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-4-(3-FLUOROPHENOXY)PHENYLBORONIC ACID; 2,6-DIFLUORO-4-ETHOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-4-HYDROXYPHENYLBORONIC ACID; 2,6-DIFLUORO-4-METHOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-4-METHYLPHENYLBORONIC ACID; 2,6-DIFLUORO-4-MORPHOLIN-4-YL-PHENYL BORONIC ACID; 2,6-DIFLUOROPHENYLBORONIC ACID; 2,6-DIFLUOROPYRIDINE-3-BORONIC ACID; 2,6-DIFLUOROPYRIDINE-3-BORONIC ACID HYDRATE; 2,6-DIFLUOROPYRIDINE-4-BORONIC ACID; 2,6-DIHYDROXYBENZENEBORONIC ACID; 2,6-DIISOPROPYLPHENYLBORONIC ACID; 2,6-DIMETHOXYPHENYLBORONIC ACID; 2,6-DIMETHOXYPYRIDIN-4-YLBORONIC ACID; 2,6-DIMETHOXYPYRIDINE-3-BORONIC ACID; 2,6-DIMETHYL-4-CHLOROPHENYLBORONIC ACID; 2,6-DIMETHYL-4-ETHOXYPHENYLBORONIC ACID; 2,6-DIMETHYLPHENYLBORONIC ACID; 2,6-DIMETHYLPYRIDINE-3-BORONIC ACID; 2,6-DIMETHYL-PYRIDINE-4-BORONIC ACID; 2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YLBORONIC ACID; 2,6-DIPHENYLPYRIDIN-4-YLBORONIC ACID; 2,6-DIPHENYLPYRIMIDIN-4-YLBORONIC ACID; 2,7-NAPHTHYRIDINE-4-BORONIC ACID; 2-[(1,2′,3′,4′-TETRAHYDRO-5-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 2-[(1-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 2-[(2,2-DIMETHYLPROPANOYL)AMINO]PYRIDINE-3-BORONIC ACID; 2-[(2′,6′-DIISOPROPYLPHENOXY)METHYL]PHENYLBORONIC ACID; 2-[(2-ISOPROPYL-5-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 2-[(2-METHYLPHENOXY)METHYL]BENZENEBORONIC ACID; 2-[(3′,5′-DIFLUOROPHENOXY)METHYL]PHENYLBORONIC ACID; 2-[(3-DIMETHYLANILINO)METHYL]BENZENEBORONIC ACID; 2-[(4′-(2-METHOXYETHYL)PHENOXY)METHYL]PHENYLBORONIC ACID; 2-[(4′-CHLORO-1-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 2-[(4′-TERT-BUTYL-2′-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 2-[2-(4-METHYL-PIPERAZIN-1-YL)-ETHOXY]-PHENYLBORONIC ACID; 2-[2-(4-METHYL-PIPERIDIN-1-YL)-ETHOXY]-PHENYLBORONIC ACID; 2-ACETAMIDO-5-AMINOPHENYLBORONIC ACID; 2-ACETAMIDO-5-CHLOROPHENYLBORONIC ACID; 2-ACETAMIDOBENZO[D]OXAZOL-5-YLBORONIC ACID; 2-ACETAMIDOBENZO[D]OXAZOL-6-YLBORONIC ACID; 2-ACETAMIDOPHENYLBORONIC ACID; 2-ACETAMIDOPYRIDINE-5-BORONIC ACID; 2-ACRYLAMIDOPHENYLBORONIC ACID; 2-ALLYLOXYPHENYLBORONIC ACID; 2-AMINO-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-AMINO-3-(TRIFLUOROMETHYL)-PYRIDINE-5-BORONIC ACID; 2-AMINO-3,4,5-TRIFLUOROPHENYLBORONIC ACID; 2-AMINO-3,5-DIFLUOROPHENYLBORONIC ACID; 2-AMINO-3-FLUOROPYRIDINE-4-BORONIC ACID; 2-AMINO-3-METHYLPYRIDINE-4-BORONIC ACID; 2-AMINO-4-(2-METHYLPROPYL)PHENYLBORONIC ACID; 2-AMINO-4-(ETHOXYCARBONYL)BENZENEBORONIC ACID HYDROCHLORIDE; 2-AMINO-4-(IMINO(METHOXY)METHYL)PHENYLBORONIC ACID HCL; 2-AMINO-4-(ISOPROPOXYCARBONYL)PHENYLBORONIC ACID, HCL; 2-AMINO-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-AMINO-4-(TRIFLUOROMETHYL)PYRIMIDIN-5-YLBORONIC ACID; 2-AMINO-4,5-DIFLUOROPHENYLBORONIC ACID; 2-AMINO-4-BORONOBUTANOIC ACID; 2-AMINO-4-CARBOXYBENZENEBORONIC ACID HYDROCHLORIDE; 2-AMINO-4-CHLOROPHENYL BORONIC ACID; 2-AMINO-4-METHOXYCARBONYL PHENYLBORONIC ACID; 2-AMINO-4-METHOXYPYRIMIDIN-5-YLBORONIC ACID; 2-AMINO-4-METHYLPYRIDINE-3-BORONIC ACID; 2-AMINO-4-METHYLPYRIMIDIN-5-YLBORONIC ACID; 2-AMINO-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-AMINO-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-AMINO-5-CHLOROPHENYLBORONIC ACID; 2-AMINO-5-CHLORO-PYRIDINE-4-BORONIC ACID; 2-AMINO-5-FLUOROBENZENEBORONIC ACID HYDROCHLORIDE; 2-AMINO-5-FLUOROPHENYLBORONIC ACID; 2-AMINO-5-METHOXYPHENYLBORONIC ACID; 2-AMINO-5-METHYLPYRIDINE-3-BORONIC ACID; 2-AMINO-5-METHYLPYRIDINE-4-BORONIC ACID; 2-AMINO-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-AMINO-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-AMINO-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-AMINO-6-FLUOROPYRIDIN-3-YLBORONIC ACID; 2-AMINO-6-FLUOROPYRIDIN-4-YLBORONIC ACID; 2-AMINO-6-METHOXYPYRIDINE-3-BORONIC ACID; 2-AMINO-6-METHYL-5-NITROPHENYLBORONIC ACID; 2-AMINO-6-METHYLPYRIDINE-3-BORONIC ACID; 2-AMINO-6-METHYLPYRIDINE-4-BORONIC ACID; 2-AMINO-6-METHYLPYRIMIDINE-4-BORONIC ACID; 2-AMINOBENZO[D]OXAZOL-5-YLBORONIC ACID; 2-AMINOCARBONYLPHENYLBORONIC ACID; 2-AMINOETHYL BORONIC ACID; 2-AMINOMETHYL-4-FLUOROPHENYLBORONIC ACID, HCL; 2-AMINONAPHTHALENE-1-BORONIC ACID; 2-AMINONAPHTHALENE-3-BORONIC ACID; 2-AMINONAPHTHALENE-4-BORONIC ACID; 2-AMINONAPHTHALENE-5-BORONIC ACID; 2-AMINONAPHTHALENE-6-BORONIC ACID; 2-AMINONAPHTHALENE-7-BORONIC ACID; 2-AMINONAPHTHALENE-8-BORONIC ACID; 2-AMINOPHENYLBORONIC ACID; 2-AMINOPYRIDINE-3-BORONIC ACID; 2-AMINOPYRIDINE-4-BORONIC ACID; 2-AMINOPYRIMIDIN-4-YLBORONIC ACID; 2-AMINOPYRIMIDINE-5-BORONIC ACID; 2-AMINOPYRIMIDINE-5-BORONIC ACID HCL; 2-AMINOQUINAZOLIN-6-YLBORONIC ACID; 2-ANTHRACENYLBORONIC ACID; 2-BENZYL-1,3-DIOXOISOINDOLIN-5-YLBORONIC ACID; 2-BENZYL-1-OXO-1,2-DIHYDROISOQUINOLIN-6-YLBORONIC ACID; 2-BENZYL-2H-INDAZOL-6-YLBORONIC ACID; 2-BENZYLCYCLOPROPYLBORONIC ACID; 2-BENZYLOXY-3-FLUOROPHENYLBORONIC ACID; 2-BENZYLOXY-4-FLUOROPHENYLBORONIC ACID; 2-BENZYLOXY-5-CHLOROPHENYLBORONIC ACID; 2-BENZYLOXY-5-CHLOROPYRIDINE-3-BORONIC ACID; 2-BENZYLOXY-5-FLUOROPHENYLBORONIC ACID; 2-BENZYLOXY-5-METHYLPHENYLBORONIC ACID; 2-BENZYLOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 2-BENZYLOXY-6-FLUOROPHENYLBORONIC ACID; 2-BENZYLOXYPHENYLBORONIC ACID; 2-BENZYLOXYPYRIDINE-3-BORONIC ACID; 2-BENZYLTHIOPHENYLBORONIC ACID; 2-BIPHENYLBORONIC ACID; 2-BOC-AMINOMETHYL-PHENYLBORONIC ACID; 2-BORONO-1-METHYL-1H-INDOLE-5-CARBOXYLIC ACID; 2-BORONO-1-METHYL-1H-INDOLE-6-CARBOXYLIC ACID; 2-BORONO-4,5-DIMETHOXYBENZOIC ACID; 2-BORONO-4-CHLOROBENZOIC ACID; 2-BORONO-5-FLUOROBENZOIC ACID; 2-BORONO-5-TERT-BUTOXYBENZOIC ACID; 2-BORONO-6-(TRIFLUOROMETHYL)BENZOIC ACID; 2-BORONO-6-METHOXYBENZOIC ACID; 2-BORONO-6-METHOXYISONICOTINIC ACID; 2-BORONO-7-METHOXYBENZO[B]THIOPHENE-4-CARBOXYLIC ACID; 2-BORONOBENZENESULFONAMIDE; 2-BORONOBENZO[B]THIOPHENE-5-CARBOXYLIC ACID; 2-BORONOBENZO[B]THIOPHENE-6-CARBOXYLIC ACID; 2-BORONOBENZO[B]THIOPHENE-7-CARBOXYLIC ACID; 2-BUTOXY-3,5-DIMETHYLPHENYLBORONIC ACID; 2-BUTOXY-4-CHLOROPHENYLBORONIC ACID; 2-BUTOXY-4-FLUOROPHENYLBORONIC ACID; 2-BUTOXY-5-CHLOROPHENYLBORONIC ACID; 2-BUTOXY-5-CHLOROPYRIDINE-3-BORONIC ACID; 2-BUTOXY-5-FLUOROPHENYLBORONIC ACID; 2-BUTOXY-5-METHYLPHENYLBORONIC ACID; 2-BUTOXY-6-FLUOROPHENYLBORONIC ACID; 2-BUTOXYPHENYLBORONIC ACID; 2-BUTYLBORONIC ACID; 2-BUTYLTHIO-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-CARBAMOYL-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CARBAMOYL-4-FLUOROPHENYLBORONIC ACID; 2-CARBAMOYL-5-CHLOROPHENYLBORONIC ACID; 2-CARBAMOYLTHIAZOL-5-YLBORONIC ACID; 2-CARBOXY-4-CHLOROPHENYLBORONIC ACID; 2-CARBOXY-5-FLUOROPHENYLBORONIC ACID; 2-CARBOXY-6-METHOXYPYRIDINE-3-BORONIC ACID; 2-CARBOXYPHENYLBORONIC ACID; 2-CARBOXYPYRIDINE-4-BORONIC ACID; 2-CARBOXYTHIOPHENE-3-BORONIC ACID; 2-CARBOXYTHIOPHENE-4-BORONIC ACID; 2-CHLORO-1-METHYL-1H-IMIDAZOL-5-YLBORONIC ACID; 2-CHLORO-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-CHLORO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CHLORO-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-CHLORO-3,4-DIFLUOROPHENYLBORONIC ACID; 2-CHLORO-3,5-DIFLUOROPHENYLBORONIC ACID; 2-CHLORO-3,6-DIFLUOROPHENYLBORONIC ACID; 2-CHLORO-3-CYANOPHENYLBORONIC ACID; 2-CHLORO-3-CYANOPYRIDINE-4-BORONIC ACID; 2-CHLORO-3-ETHOXY-6-FLUOROPHENYLBORONIC ACID; 2-CHLORO-3-ETHOXYPHENYLBORONIC ACID; 2-CHLORO-3-FLUORO-5-PICOLINE-4-BORONIC ACID; 2-CHLORO-3-FLUOROPHENYLBORONIC ACID; 2-CHLORO-3-FLUOROPYRIDINE-4-BORONIC ACID; 2-CHLORO-3-FLUOROPYRIDINE-4-BORONIC ACID HYDRATE; 2-CHLORO-3-FLUOROPYRIDINE-5-BORONIC ACID; 2-CHLORO-3-HYDROXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-3-METHOXYPHENYLBORONIC ACID; 2-CHLORO-3-METHOXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-3-METHYLPHENYLBORONIC ACID; 2-CHLORO-3-METHYLPYRIDINE-4-BORONIC ACID; 2-CHLORO-3-METHYLPYRIDINE-5-BORONIC ACID; 2-CHLORO-3-PROPOXYPHENYLBORONIC ACID; 2-CHLORO-4-(2-METHOXY-2-OXOETHYL)PHENYLBORONIC ACID; 2-CHLORO-4-(ETHOXYCARBONYL)BENZENEBORONIC ACID; 2-CHLORO-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CHLORO-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-CHLORO-4,5-DIFLUOROPHENYLBORONIC ACID; 2-CHLORO-4,6-DIFLUOROPHENYLBORONIC ACID; 2-CHLORO-4,6-DIMETHOXYPYRIMIDIN-5-YLBORONIC ACID; 2-CHLORO-4-[((1,1-DIMETHYLETHYL)DIMETHYLSILYL)OXY]PHENYLBORONIC ACID; 2-CHLORO-4-CYANOPHENYLBORONIC ACID; 2-CHLORO-4-CYANOPYRIDIN-3-YLBORONIC ACID; 2-CHLORO-4-ETHOXYPHENYLBORONIC ACID; 2-CHLORO-4-FLUORO-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-CHLORO-4-FLUORO-5-METHOXYPHENYLBORONIC ACID; 2-CHLORO-4-FLUORO-5-METHYLPHENYLBORONIC ACID; 2-CHLORO-4-FLUOROPHENYLBORONIC ACID; 2-CHLORO-4-FLUOROPYRIDINE-3-BORONIC ACID; 2-CHLORO-4-HYDROXYPHENYLBORONIC ACID; 2-CHLORO-4-ISOPROPROXYPHENYLBORONIC ACID; 2-CHLORO-4-METHOXY-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-CHLORO-4-METHOXY-5-METHYL-BENZENEBORONIC ACID; 2-CHLORO-4-METHOXYPHENYLBORONIC ACID; 2-CHLORO-4-METHOXYPYRIDINE-3-BORONIC ACID; 2-CHLORO-4-METHOXYPYRIDINE-5-BORONIC ACID; 2-CHLORO-4-METHYLPHENYLBORONIC ACID; 2-CHLORO-4-METHYLPYRIDINE-3-BORONIC ACID; 2-CHLORO-4-METHYLPYRIDINE-5-BORONIC ACID; 2-CHLORO-4-METHYLPYRIMIDINE-5-BORONIC ACID; 2-CHLORO-4-PHENYLPYRIDINE-3-BORONIC ACID; 2-CHLORO-4-TRIFLUOROMETHOXYPHENYLBORONIC ACID; 2-CHLORO-5-(1,3-DIOXOLAN-2-YL)PYRIDIN-3-YLBORONIC ACID; 2-CHLORO-5-(4-FLUOROPHENYL)THIOPHEN-3-YLBORONIC ACID; 2-CHLORO-5-(ETHOXYCARBONYL)BENZENEBORONIC ACID; 2-CHLORO-5-(ETHYLSULFONYL)PHENYLBORONIC ACID; 2-CHLORO-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-CHLORO-5-(OXAZOL-2-YL)PHENYLBORONIC ACID; 2-CHLORO-5-(THIAZOL-2-YL)PHENYLBORONIC ACID; 2-CHLORO-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-CHLORO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CHLORO-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-CHLORO-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-CHLORO-5-(TRIFLUOROMETHYL)THIOPHENE-3-BORONIC ACID; 2-CHLORO-5-BORONOBENZAMIDE; 2-CHLORO-5-CYANOPHENYLBORONIC ACID; 2-CHLORO-5-CYANOPYRIDINE-3-BORONIC ACID; 2-CHLORO-5-ETHOXYBENZENEBORONIC ACID; 2-CHLORO-5-FLUORO-3-PICOLINE-4-BORONIC ACID; 2-CHLORO-5-FLUORO-6-METHYLPHENYLBORONIC ACID; 2-CHLORO-5-FLUOROPHENYLBORONIC ACID; 2-CHLORO-5-FLUOROPYRIDINE-3-BORONIC ACID; 2-CHLORO-5-FLUOROPYRIDINE-4-BORONIC ACID; 2-CHLORO-5-HYDROXYMETHYLPHENYLBORONIC ACID; 2-CHLORO-5-HYDROXYPHENYLBORONIC ACID; 2-CHLORO-5-HYDROXYPYRIDINE-3-BORONIC ACID; 2-CHLORO-5-HYDROXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-5-ISOBUTOXYPHENYLBORONIC ACID; 2-CHLORO-5-ISOPROPOXYPHENYLBORONIC ACID; 2-CHLORO-5-METHOXY-4-METHYLBENZENEBORONIC ACID; 2-CHLORO-5-METHOXYPHENYLBORONIC ACID; 2-CHLORO-5-METHOXYPYRIDINE-3-BORONIC ACID; 2-CHLORO-5-METHOXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-5-METHOXYPYRIDINE-4-BORONIC ACID, MONOLITHIUM SALT; 2-CHLORO-5-METHYLPHENYLBORONIC ACID; 2-CHLORO-5-METHYLPYRIDINE-3-BORONIC ACID; 2-CHLORO-5-METHYLPYRIDINE-4-BORONIC ACID; 2-CHLORO-5-NITROPHENYLBORONIC ACID; 2-CHLORO-5-PHENYLPYRIDIN-3-YLBORONIC ACID; 2-CHLORO-5-PROPOXYPHENYLBORONIC ACID; 2-CHLORO-6-(1H-PYRAZOL-1-YL)PYRIDINE-3-BORONIC ACID; 2-CHLORO-6-(METHOXYMETHOXY)PHENYLBORONIC ACID; 2-CHLORO-6-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-CHLORO-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CHLORO-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-CHLORO-6-CYANOPHENYLBORONIC ACID; 2-CHLORO-6-FLUORO-3-(METHOXYMETHOXY)PHENYLBORONIC ACID; 2-CHLORO-6-FLUORO-3-HYDROXYPHENYLBORONIC ACID; 2-CHLORO-6-FLUORO-3-METHOXYPHENYLBORONIC ACID; 2-CHLORO-6-FLUORO-3-METHYLPHENYLBORONIC ACID; 2-CHLORO-6-FLUORO-5-METHYLPHENYLBORONIC ACID; 2-CHLORO-6-FLUOROPHENYLBORONIC ACID; 2-CHLORO-6-HYDROXYPHENYLBORONIC ACID; 2-CHLORO-6-HYDROXYPYRIDINE-3-BORONIC ACID; 2-CHLORO-6-HYDROXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-6-ISOPROPYLPYRIDINE-3-BORONIC ACID; 2-CHLORO-6-ISOPROPYLPYRIDINE-4-BORONIC ACID; 2-CHLORO-6-METHOXY-4-(METHOXYMETHYL)PHENYLBORONIC ACID; 2-CHLORO-6-METHOXYPHENYLBORONIC ACID; 2-CHLORO-6-METHOXYPYRIDINE-3-BORONIC ACID; 2-CHLORO-6-METHOXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-6-METHYLPHENYLBORONIC ACID; 2-CHLORO-6-METHYLPYRIDINE-3-BORONIC ACID; 2-CHLORO-6-PHENYLPYRIDIN-3-YLBORONIC ACID; 2-CHLOROFURAN-3-YLBORONIC ACID; 2-CHLORONAPHTHALENE-1-BORONIC ACID; 2-CHLORONAPHTHALENE-3-BORONIC ACID; 2-CHLORONAPHTHALENE-4-BORONIC ACID; 2-CHLORONAPHTHALENE-5-BORONIC ACID; 2-CHLORONAPHTHALENE-6-BORONIC ACID; 2-CHLORONAPHTHALENE-7-BORONIC ACID; 2-CHLORONAPHTHALENE-8-BORONIC ACID; 2-CHLOROPHENYLBORONIC ACID; 2-CHLOROPYRIDINE-3-BORONIC ACID; 2-CHLOROPYRIDINE-4-BORONIC ACID; 2-CHLOROPYRIDINE-5-BORONIC ACID; 2-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-CHLOROPYRIMIDINE-5-BORONIC ACID; 2-CHLOROQUINOLINE-3-BORONIC ACID; 2-CHLOROTHIOPHENE-3-BORONIC ACID; 2′-CYANO-2-FLUOROBIPHENYL-3-YLBORONIC ACID; 2-CYANO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CYANO-3-FLUOROPHENYLBORONIC ACID; 2-CYANO-3-HYDROXYPHENYLBORONIC ACID; 2-CYANO-3-METHOXYPHENYLBORONIC ACID; 2-CYANO-3-METHYLPHENYLBORONIC ACID; 2-CYANO-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CYANO-4-FLUOROPHENYLBORONIC ACID; 2-CYANO-4-HYDROXYPHENYLBORONIC ACID; 2-CYANO-4-METHOXYPHENYLBORONIC ACID; 2-CYANO-4-METHYLPHENYLBORONIC ACID; 2-CYANO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CYANO-5-FLUOROPHENYLBORONIC ACID; 2-CYANO-5-HYDROXYPHENYLBORONIC ACID; 2-CYANO-5-METHOXYPHENYLBORONIC ACID; 2-CYANO-5-METHYLPHENYLBORONIC ACID; 2-CYANO-6-FLUOROPHENYLBORONIC ACID; 2-CYANO-6-HYDROXYPHENYLBORONIC ACID; 2-CYANO-6-METHOXYPHENYLBORONIC ACID; 2-CYANO-6-METHYLPHENYLBORONIC ACID; 2-CYANO-6-METHYLPYRIMIDINE-4-BORONIC ACID; 2-CYANOMETHOXYPHENYLBORONIC ACID; 2-CYANOPHENYLBORONIC ACID; 2-CYANOPYRIDINE-3-BORONIC ACID; 2-CYANOPYRIDINE-4-BORONIC ACID; 2-CYANOPYRIMIDIN-5-YLBORONIC ACID; 2-CYANOPYRIMIDINE-4-BORONIC ACID; 2-CYANOTHIAZOL-5-YLBORONIC ACID; 2-CYANOTHIOPHEN-3-YLBORONIC ACID; 2-CYCLOBUTYLPHENYLBORONIC ACID; 2-CYCLOHEXYL-CYCLOPROPYL-1-BORONIC ACID; 2-CYCLOHEXYLETHENYLBORONIC ACID; 2-CYCLOHEXYLOXY-5-METHYLPYRIDINE-3-BORONIC ACID; 2-CYCLOPROPOXYPHENYLBORONIC ACID; 2-CYCLOPROPYL-1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 2-CYCLOPROPYLPHENYLBORONIC ACID; 2-CYCLOPROPYLPYRIDINE-4-BORONIC ACID; 2-CYCLOPROPYLPYRIMIDIN-5-YLBORONIC ACID; 2-DIFLUOROMETHOXY-3-FLUORO-BENZENEBORONIC ACID; 2-DIFLUOROMETHOXY-3-METHYL-BENZENEBORONIC ACID; 2-DIFLUOROMETHOXY-4-FLUORO-BENZENEBORONIC ACID; 2-DIFLUOROMETHOXY-5-METHYL-BENZENEBORONIC ACID; 2-DIFLUOROMETHOXY-5-TRIFLUOROMETHYL-BENZENEBORONIC ACID; 2-DIFLUOROMETHYL-PHENYLBORONIC ACID; 2-DIMETHYLAMINO-6-METHOXYPHENYLBORONIC ACID; 2-DIMETHYLAMINOPYRIDINE-4-BORONIC ACID; 2-DIMETHYLAMINOPYRIMIDINYL-5-BORONIC ACID; 2-ETHOXY-1-NAPHTHALENEBORONIC ACID; 2-ETHOXY-3-FLUOROPHENYLBORONIC ACID; 2-ETHOXY-4-FLUOROPHENYLBORONIC ACID; 2-ETHOXY-4-METHYL-5-PYRIDINYLBORONIC ACID; 2-ETHOXY-4-METHYLPYRIDINE-3-BORONIC ACID; 2-ETHOXY-4-TRIFLUOROMETHYLPHENYLBORONIC ACID; 2-ETHOXY-5-(TRIFLUOROMETHOXY)BENZENEBORONIC ACID; 2-ETHOXY-5-FLUOROPHENYLBORONIC ACID; 2-ETHOXY-5-FLUOROPYRIDINE-4-BORONIC ACID; 2-ETHOXY-5-HYDROXYPHENYLBORONIC ACID; 2-ETHOXY-5-METHOXYPHENYLBORONIC ACID; 2-ETHOXY-5-METHYLPHENYLBORONIC ACID; 2-ETHOXY-5-METHYLPYRIDIN-3-YLBORONIC ACID; 2-ETHOXY-5-PYRIDINEBORONIC ACID; 2-ETHOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 2-ETHOXY-6-FLUOROPHENYLBORONIC ACID; 2-ETHOXY-6-METHYLPYRIDINE-3-BORONIC ACID; 2-ETHOXYCARBONYL-5-FLUOROPHENYLBORONIC ACID; 2-ETHOXYCARBONYLMETHYLPHENYLBORONIC ACID; 2-ETHOXYCARBONYLPHENYLBORONIC ACID; 2-ETHOXYMETHYLPHENYLBORONIC ACID; 2-ETHOXYPHENYLBORONIC ACID; 2-ETHOXYPYRIDINE-3-BORONIC ACID; 2-ETHOXYPYRIDINE-4-BORONIC ACID; 2-ETHOXYPYRIMIDINE-5-BORONIC ACID; 2-ETHOXYQUINOLIN-3-YLBORONIC ACID; 2-ETHOXYQUINOLIN-6-YLBORONIC ACID; 2-ETHYL-3,5-DIMETHYLPHENYLBORONIC ACID; 2-ETHYLBENZOFURAN-3-YLBORONIC ACID; 2-ETHYLPHENYLBORONIC ACID; 2-ETHYLPYRIDINE-3-BORONIC ACID; 2-ETHYLPYRIDINE-4-BORONIC ACID; 2-ETHYLPYRIMIDIN-5-YLBORONIC ACID; 2-ETHYLSULFINYLPHENYLBORONIC ACID; 2-ETHYLSULFONYLPHENYLBORONIC ACID; 2-ETHYLTHIO-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-ETHYLTHIOPHENYLBORONIC ACID; 2-ETHYLTHIOPYRIDINE-5-BORONIC ACID; 2-FLUORO-3-(ETHOXYCARBONYL)PHENYLBORONIC ACID; 2-FLUORO-3-(HYDROXYMETHYL)PHENYLBORONIC ACID; 2-FLUORO-3-(N,N-DIMETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 2-FLUORO-3-(PIPERIDIN-1-YLMETHYL)PHENYLBORONIC ACID; 2-FLUORO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-FLUORO-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-FLUORO-3,4-METHYLENEDIOXYPHENYLBORONIC ACID; 2-FLUORO-3-HYDROXYPHENYLBORONIC ACID; 2-FLUORO-3-HYDROXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-3-ISOBUTOXYPHENYLBORONIC ACID; 2-FLUORO-3-ISOPROPOXYPHENYLBORONIC ACID; 2-FLUORO-3-METHOXYPHENYLBORONIC ACID; 2-FLUORO-3-METHOXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-3-METHOXYPYRIDINE-5-BORONIC ACID; 2-FLUORO-3-METHYLPHENYLBORONIC ACID; 2-FLUORO-3-METHYLPYRIDINE-4-BORONIC ACID; 2-FLUORO-3-METHYLPYRIDINE-5-BORONIC ACID; 2-FLUORO-3-NITROPHENYLBORONIC ACID; 2-FLUORO-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 2-FLUORO-4-(3-(PYRROLIDIN-1-YL)PHENOXY)PHENYLBORONIC ACID; 2-FLUORO-4-(3-FLUOROPHENOXY)PHENYLBORONIC ACID; 2-FLUORO-4-(5-FLUOROPYRIDIN-3-YLOXY)PHENYLBORONIC ACID; 2-FLUORO-4-(6-FLUOROPYRIDIN-3-YLOXY)PHENYLBORONIC ACID; 2-FLUORO-4-(METHOXY-D3)-PHENYLBORONIC ACID; 2-FLUORO-4-(METHYLSULFONYL)PHENYLBORONIC ACID; 2-FLUORO-4-(N-ETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 2-FLUORO-4-(PHENYLAMINO)PHENYLBORONIC ACID; 2-FLUORO-4-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 2-FLUORO-4-(PYRIDIN-3-YLOXY)PHENYLBORONIC ACID; 2-FLUORO-4-(TERT-BUTOXYCARBONYLAMINO)PHENYLBORONIC ACID; 2-FLUORO-4-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PHENYLBORONIC ACID; 2-FLUORO-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-FLUORO-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-FLUORO-4-BIPHENYLYLBORONIC ACID; 2-FLUORO-4-ETHOXYCARBONYLPHENYLBORONIC ACID; 2-FLUORO-4-HYDROXYPHENYLBORONIC ACID; 2-FLUORO-4-ISOPROPOXYPHENYLBORONIC ACID; 2-FLUORO-4-METHOXYCARBONYLPHENYLBORONIC ACID; 2-FLUORO-4-METHOXYPHENYLBORONIC ACID; 2-FLUORO-4-METHYLPHENYLBORONIC ACID; 2-FLUORO-4-METHYLPYRIDINE-3-BORONIC ACID; 2-FLUORO-4-METHYLPYRIDINE-5-BORONIC ACID; 2-FLUORO-4-PHENYLPYRIDIN-3-YLBORONIC ACID; 2-FLUORO-4-PROPOXYPHENYLBORONIC ACID; 2-FLUORO-4-TRIFLUOROMETHOXYPHENYLBORONIC ACID; 2-FLUORO-5-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 2-FLUORO-5-(1-MORPHOLINOETHYL)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-5-(4-(METHYLTHIO)BENZYL)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-5-(HYDRAZINOCARBONYL)BENZENEBORONIC ACID; 2-FLUORO-5-(ISOPROPYLCARBAMOYL)BENZENEBORONIC ACID; 2-FLUORO-5-(METHOXY(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 2-FLUORO-5-(METHOXYCARBAMOYL)BENZENEBORONIC ACID; 2-FLUORO-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-FLUORO-5-(METHOXY-D3)-PHENYLBORONIC ACID; 2-FLUORO-5-(METHYLCARBAMOYL)BENZENEBORONIC ACID; 2-FLUORO-5-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 2-FLUORO-5-(MORPHOLINOMETHYL)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-5-(PHENYLCARBAMOYL)BENZENEBORONIC ACID; 2-FLUORO-5-(PIPERIDIN-1-YLCARBONYL)BENZENEBORONIC ACID; 2-FLUORO-5-(PROPYLCARBAMOYL)BENZENEBORONIC ACID; 2-FLUORO-5-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 2-FLUORO-5-(THIOMORPHOLINOMETHYL)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-FLUORO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-FLUORO-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-FLUORO-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-FLUORO-5-HYDROXYMETHYLPHENYLBORONIC ACID; 2-FLUORO-5-HYDROXYPHENYLBORONIC ACID; 2-FLUORO-5-HYDROXYPYRIDINE-3-BORONIC ACID; 2-FLUORO-5-HYDROXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-5-ISOBUTOXYPHENYLBORONIC ACID; 2-FLUORO-5-ISOPROPOXYPHENYLBORONIC ACID; 2-FLUORO-5-ISOPROPYLPHENYLBORONIC ACID; 2-FLUORO-5-METHOXYPHENYLBORONIC ACID; 2-FLUORO-5-METHOXYPYRIDINE-3-BORONIC ACID; 2-FLUORO-5-METHOXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-5-METHYLPHENYLBORONIC ACID; 2-FLUORO-5-METHYLPYRIDINE-3-BORONIC ACID; 2-FLUORO-5-METHYLPYRIDINE-4-BORONIC ACID; 2-FLUORO-5-NITROPHENYLBORONIC ACID; 2-FLUORO-5-PHENOXYPHENYLBORONIC ACID; 2-FLUORO-5-PROPOXYPHENYLBORONIC ACID; 2-FLUORO-5-VINYLPYRIDIN-3-YLBORONIC ACID; 2-FLUORO-6-(2-METHOXYETHOXY)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-6-(HYDROXYMETHYL)PHENYLBORONIC ACID; 2-FLUORO-6-(METHYLTHIOMETHOXY)PHENYLBORONIC ACID; 2-FLUORO-6-(PROP-1-YNYL)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-FLUORO-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-FLUORO-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-FLUORO-6-HYDROXYPHENYLBORONIC ACID; 2-FLUORO-6-HYDROXYPYRIDINE-3-BORONIC ACID; 2-FLUORO-6-HYDROXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-6-ISOPROPOXYPHENYLBORONIC ACID; 2-FLUORO-6-METHOXY-3-METHYLPHENYLBORONIC ACID; 2-FLUORO-6-METHOXYPHENYLBORONIC ACID; 2-FLUORO-6-METHOXYPYRIDINE-3-BORONIC ACID; 2-FLUORO-6-METHOXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-6-METHYLPHENYLBORONIC ACID; 2-FLUORO-6-METHYLPYRIDINE-3-BORONIC ACID; 2-FLUORO-6-METHYLPYRIDINE-4-BORONIC ACID; 2-FLUORO-6-MORPHOLINOPYRIDIN-3-YLBORONIC ACID; 2-FLUORO-6-PHENOXYPHENYLBORONIC ACID; 2-FLUORO-6-PHENYLPYRIDINE-3-BORONIC ACID; 2-FLUORO-6-PICOLINE-5-BORONIC ACID; 2-FLUORO-6-PROPOXYPHENYLBORONIC ACID; 2-FLUOROBENZO[B]THIOPHEN-3-YLBORONIC ACID; 2-FLUORONAPHTHALENE-1-BORONIC ACID; 2-FLUORONAPHTHALENE-3-BORONIC ACID; 2-FLUORONAPHTHALENE-4-BORONIC ACID; 2-FLUORONAPHTHALENE-5-BORONIC ACID; 2-FLUORONAPHTHALENE-6-BORONIC ACID; 2-FLUORONAPHTHALENE-7-BORONIC ACID; 2-FLUORONAPHTHALENE-8-BORONIC ACID; 2-FLUOROPHENYLBORONIC ACID; 2-FLUOROPYRIDINE-3-BORONIC ACID; 2-FLUOROPYRIDINE-3-BORONIC ACID HYDRATE; 2-FLUOROPYRIDINE-3-BORONIC ACID TRIHYDRATE; 2-FLUOROPYRIDINE-4-BORONIC ACID; 2-FLUOROPYRIDINE-5-BORONIC ACID; 2-FLUOROPYRIMIDIN-5-YLBORONIC ACID; 2-FLUOROQUINOLINE-3-BORONIC ACID; 2-HEPTYLCYCLOPROPYLBORONIC ACID; 2-HEXYL-CYCLOPROPYL-1-BORONIC ACID; 2-HEXYLTHIOPHENE-3-BORONIC ACID; 2H-ISOQUINOLIN-1-ONE-6-BORONIC ACID; 2H-ISOQUINOLIN-1-ONE-7-BORONIC ACID; 2H-PYRANO[3,2-B]PYRIDIN-7-YLBORONIC ACID; 2-HYDROXY-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-HYDROXY-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-HYDROXY-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-HYDROXY-3-METHYLPHENYLBORONIC ACID; 2-HYDROXY-3-METHYLPYRIDINE-4-BORONIC ACID; 2-HYDROXY-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-HYDROXY-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-HYDROXY-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-HYDROXY-4-METHOXYPHENYLBORONIC ACID; 2-HYDROXY-4-METHYLPHENYLBORONIC ACID; 2-HYDROXY-4-METHYLPYRIDINE-3-BORONIC ACID; 2-HYDROXY-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-HYDROXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-HYDROXY-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-HYDROXY-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-HYDROXY-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-HYDROXY-5-METHOXYPHENYLBORONIC ACID; 2-HYDROXY-5-METHYLPHENYLBORONIC ACID; 2-HYDROXY-5-METHYLPYRIDINE-3-BORONIC ACID; 2-HYDROXY-5-METHYLPYRIDINE-4-BORONIC ACID; 2-HYDROXY-6-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-HYDROXY-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-HYDROXY-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-HYDROXY-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-HYDROXY-6-METHOXYPHENYLBORONIC ACID; 2-HYDROXY-6-METHYLPHENYLBORONIC ACID; 2-HYDROXY-6-METHYLPYRIDINE-3-BORONIC ACID; 2-HYDROXY-6-METHYLPYRIDINE-4-BORONIC ACID; 2-HYDROXYL-1-NAPHTHALENEBORONIC ACID; 2-HYDROXYMETHYL-4-METHOXYPHENYLBORONIC ACID; 2-HYDROXYPHENYLBORONIC ACID; 2-HYDROXYPYRAZINE-6-BORONIC ACID; 2-HYDROXYPYRIDIN-3-YLBORONIC ACID; 2-HYDROXYPYRIMIDINE-5-BORONIC ACID; 2-HYDROXYQUINOLIN-3-YLBORONIC ACID; 2-HYDROXYQUINOLINE-4-BORONIC ACID; 2-HYDROXYQUINOLINE-5-BORONIC ACID; 2-HYDROXYQUINOLINE-6-BORONIC ACID; 2-HYDROXYQUINOLINE-7-BORONIC ACID; 2-HYDROXYQUINOLINE-8-BORONIC ACID; 2-ISOBUTOXY-5-METHYLPHENYLBORONIC ACID; 2-ISOBUTOXY-6-METHOXYPHENYLBORONIC ACID; 2-ISOBUTOXYPHENYLBORONIC ACID; 2-ISOPROPOXY-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-ISOPROPOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-ISOPROPOXY-5-METHYLPHENYLBORONIC ACID; 2-ISOPROPOXY-6-METHOXYPHENYLBORONIC ACID; 2-ISOPROPOXYPHENYLBORONIC ACID; 2-ISOPROPOXYPYRIDINE-3-BORONIC ACID; 2-ISOPROPOXYPYRIMIDIN-5-YLBORONIC ACID; 2-ISOPROPYL-1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 2-ISOPROPYL-6-METHOXYPYRIDIN-3-YLBORONIC ACID; 2-ISOPROPYL-7-METHOXYPYRAZOLO[1,5-A]PYRIDIN-3-YLBORONIC ACID; 2-ISOPROPYLPHENYLBORONIC ACID; 2-ISOPROPYLTHIO-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-ISOPROXYPYRIDINE-5-BORONIC ACID; 2-METHOXY-1-NAPHTHALENEBORONIC ACID; 2-METHOXY-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHOXY-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHOXY-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-METHOXY-3-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 2-METHOXY-3-METHYLPHENYL BORONIC ACID; 2-METHOXY-3-METHYLPYRIDINE-4-BORONIC ACID; 2-METHOXY-4-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-METHOXY-4-(TRIFLUOROMETHOXY)-PHENYLBORONIC ACID; 2-METHOXY-4-(TRIFLUOROMETHYL)-PHENYLBORONIC ACID; 2-METHOXY-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-METHOXY-4-METHYLPHENYLBORONIC ACID; 2-METHOXY-4-METHYLPYRIDINE-3-BORONIC ACID; 2-METHOXY-4-METHYL-PYRIDINE-5-BORONIC ACID; 2-METHOXY-4-PHENYLPYRIDINE-3-BORONIC ACID; 2-METHOXY-5-(PYRIDINE-4-YL)PHENYLBORONIC ACID; 2-METHOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHOXY-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-METHOXY-5-METHYLPHENYLBORONIC ACID; 2-METHOXY-5-METHYLPYRIDINE-3-BORONIC ACID; 2-METHOXY-5-METHYLPYRIDINE-4-BORONIC ACID; 2-METHOXY-5-METHYLTHIOPHEN-3-YLBORONIC ACID; 2-METHOXY-5-PHENYLPYRIDIN-3-YLBORONIC ACID; 2-METHOXY-5-PROPYLPHENYLBORONIC ACID; 2-METHOXY-5-PYRIDINEBORONIC ACID; 2-METHOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 2-METHOXY-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-METHOXY-6-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHOXY-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHOXY-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-METHOXY-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-METHOXY-6-CARBOXYPYRIDINE-4-BORONIC ACID; 2-METHOXY-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-METHOXY-6-ISOPROPYLPYRIDINE-3-BORONIC ACID; 2-METHOXY-6-METHYLPYRIDIN-3-YLBORONIC ACID; 2-METHOXY-6-METHYLPYRIDINE-4-BORONIC ACID; 2-METHOXY-6-METHYLTHIOPHENYLBORONIC ACID; 2-METHOXY-6-PHENYLPYRIDINE-3-BORONIC ACID; 2-METHOXYCARBONYL-1,3-BENZOXAZOLE-5-BORONIC ACID; 2-METHOXYCARBONYL-1,3-BENZOXAZOLE-6-BORONIC ACID; 2-METHOXYCARBONYL-3,5-DIFLUOROPHENYLBORONIC ACID; 2-METHOXYCARBONYL-3-FLUOROPHENYLBORONIC ACID; 2-METHOXYCARBONYL-3-METHOXYPHENYLBORONIC ACID; 2-METHOXYCARBONYL-3-METHYLPHENYLBORONIC ACID; 2-METHOXYCARBONYL-4-METHOXYPHENYLBORONIC ACID; 2-METHOXYCARBONYL-4-METHYLPHENYLBORONIC ACID; 2-METHOXYCARBONYLINDOLE-5-BORONIC ACID; 2-METHOXYCARBONYLPHENYLBORONIC ACID; 2-METHOXYMETHOXY-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHOXYMETHYLPHENYLBORONIC ACID; 2-METHOXYNAPHTHALENE-4-BORONIC ACID; 2-METHOXYNAPHTHALENE-5-BORONIC ACID; 2-METHOXYNAPHTHALENE-7-BORONIC ACID; 2-METHOXYNAPHTHALENE-8-BORONIC ACID; 2-METHOXYPHENYLBORONIC ACID; 2-METHOXYPYRAZINE-6-BORONIC ACID; 2-METHOXYPYRIDINE-3-BORONIC ACID; 2-METHOXYPYRIDINE-3-BORONIC ACID HYDRATE; 2-METHOXYPYRIDINE-3-BORONIC ACID-HCL; 2-METHOXYPYRIDINE-4-BORONIC ACID; 2-METHOXYPYRIDINE-6-BORONIC ACID, HYDROCHLORIDE SALT; 2-METHOXYPYRIMIDINE-4-BORONIC ACID; 2-METHOXYPYRIMIDINE-5-BORONIC ACID; 2-METHOXYQUINOLIN-6-YLBORONIC ACID; 2-METHOXYQUINOLINE-3-BORONIC ACID; 2-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-6-BORONIC ACID; 2-METHYL-1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 2-METHYL-1,3-BENZOXAZOLE-5-BORONIC ACID; 2-METHYL-1-[(4-METHYLPHENYL)SULFONYL]-1H-INDOLE-3-BORONIC ACID; 2-METHYL-1H-BENZIMIDAZOLE-5-BORONIC ACID, HYDROCHLORIDE SALT; 2-METHYL-1-OXO-1,2-DIHYDROISOQUINOLIN-6-YLBORONIC ACID; 2-METHYL-2-(4-BORONOPHENYL)PROPYLAMINE, HCL; 2-METHYL-2H-INDAZOLE-6-BORONIC ACID; 2-METHYL-2H-INDAZOLE-7-BORONIC ACID; 2-METHYL-3-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(2,4,5-TRICHLOROPHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(PERFLUOROPHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHYL-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHYL-3-NITROPHENYLBORONIC ACID; 2-METHYL-4-(METHOXYMETHOXY)PHENYLBORONIC ACID; 2-METHYL-4-(MORPHOLINOSULFONYL)PHENYLBORONIC ACID; 2-METHYL-4-(N-METHYLSULFAMOYL)PHENYLBORONIC ACID; 2-METHYL-4-(N-PROPYLSULFAMOYL)PHENYLBORONIC ACID; 2-METHYL-4-(PIPERIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-4-(PYRROLIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-4-(TRIFLUOROMETHOXY)BENZENEBORONIC ACID; 2-METHYL-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHYL-4-CYANOPHENYLBORONIC ACID; 2-METHYL-4-FLUORO-PYRAZOLE-3-BORONIC ACID; 2-METHYL-4-NITROPHENYLBORONIC ACID; 2-METHYL-5-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 2-METHYL-5-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-METHYL-5-(5-METHYL-4H-1,2,4-TRIAZOL-3-YL)PHENYLBORONIC ACID; 2-METHYL-5-(N-MORPHOLINYLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-5-(OXAZOL-2-YL)PHENYLBORONIC ACID; 2-METHYL-5-(PIPERIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-5-(PYRROLIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-5-(THIAZOL-2-YL)PHENYLBORONIC ACID; 2-METHYL-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHYL-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHYL-5-(TRIFLUOROMETHYLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-5-AMINOPYRIDINE-4-BORONIC ACID; 2-METHYL-5-CHLOROPYRIDINE-4-BORONIC ACID; 2-METHYL-5-HYDROXYCABONYL-3-BORONIC ACID; 2-METHYL-5-METHOXYPYRIDINE-4-BORONIC ACID; 2-METHYL-6-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(2,4,5-TRICHLOROPHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(2,4,5-TRICHLOROPHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(PERFLUOROPHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(PERFLUOROPHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHYL-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHYL-6-METHOXYPYRIDINE-3-BORONIC ACID; 2-METHYLBENZO[B]THIOPHEN-3-YLBORONIC ACID; 2-METHYLBENZOTHIAZOLE-4-BORONIC ACID; 2-METHYLBENZOTHIAZOLE-5-BORONIC ACID; 2-METHYLBENZOTHIAZOLE-6-BORONIC ACID; 2-METHYLBENZOTHIAZOLE-7-BORONIC ACID; 2′-METHYLBIPHENYL-2-YLBORONIC ACID; 2-METHYLFURAN-3-BORONIC ACID; 2-METHYLINDAZOLE-4-BORONIC ACID; 2-METHYLINDAZOLE-5-BORONIC ACID; 2-METHYLNAPHTHALENE-1-BORONIC ACID; 2-METHYLNAPHTHALENE-3-BORONIC ACID; 2-METHYLNAPHTHALENE-4-BORONIC ACID; 2-METHYLNAPHTHALENE-5-BORONIC ACID; 2-METHYLNAPHTHALENE-7-BORONIC ACID; 2-METHYLPHENYLBORONIC ACID; 2-METHYLPYRIDINE-3-BORONIC ACID; 2-METHYLPYRIDINE-4-BORONIC ACID; 2-METHYLPYRIMIDIN-4-YLBORONIC ACID; 2-METHYLQUINOLIN-4-YLBORONIC ACID; 2-METHYLQUINOLINE-6-BORONIC ACID; 2-METHYLQUINOLINE-7-BORONIC ACID; 2-METHYLTHIAZOL-5-YLBORONIC ACID; 2-METHYLTHIAZOLE-4-BORONIC ACID; 2-METHYLTHIO-5-TRIFLUOROMETHOXYPHENYLBORONIC ACID; 2-METHYLTHIO-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-METHYLTHIO-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-METHYLTHIOPHENE-3-BORONIC ACID; 2-METHYLTHIOPYRIDINE-5-BORONIC ACID; 2-MORPHOLINO-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-MORPHOLINOPYRIDINE-3-BORONIC ACID; 2-MORPHOLINOPYRIDINE-3-BORONIC ACID-HCL; 2-MORPHOLINOPYRIMIDIN-5-YLBORONIC ACID; 2-MORPHOLINOPYRIMIDINE-4-BORONIC ACID; 2-N,N-DIETHYLSULFAMOYLPHENYLBORONIC ACID; 2-NAPHTHALENEBORONIC ACID; 2-NITRO-5-AMINOPHENYLBORIC ACID; 2-NITRO-5-CARBOXYPHENYLBORONIC ACID; 2-NITROPHENYLBORONIC ACID; 2-NORBORNEN-2-YLBORONIC ACID; 2-OXO-1,2-DIHYDROPYRIDIN-3-YLBORONIC ACID; 2-OXO-1,2-DIHYDROQUINOLIN-3-YLBORONIC ACID; 2-OXO-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOL-5-YLBORONIC ACID; 2-OXO-2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDIN-5-YLBORONIC ACID; 2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-6-YL-BORONIC ACID; 2-PHENOXYPHENYLBORONIC ACID; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-BORONIC ACID; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-BORONIC ACID; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-BORONIC ACID; 2-PHENYLCYCLOPROPYLBORONIC ACID; 2-PHENYLFURAN-3-YLBORONIC ACID; 2-PHENYLIMIDAZO[1,2-A]PYRIDIN-6-YLBORONIC ACID; 2-PHENYLOXAZOL-5-YLBORONIC ACID; 2-PHENYLPYRIDIN-4-YLBORONIC ACID; 2-PHENYLPYRIDINE-3-BORONIC ACID; 2-PHENYLPYRIMIDINE-4-BORONIC ACID; 2-PHENYLPYRIMIDINE-5-BORONIC ACID; 2-PHENYLTHIAZOL-5-YLBORONIC ACID; 2-PHENYLTHIOPHEN-3-YLBORONIC ACID; 2-PICOLINE-3-BORONIC ACID HCL; 2-PICOLINE-4-BORONIC ACID HCL; 2-PICOLINE-5-BORONIC ACID HYDRATE; 2-PROPEN-1-YL-BORONIC ACID; 2-PROPOXYPHENYLBORONIC ACID; 2-PROPOXYPYRIDINE-3-BORONIC ACID; 2-PROPYLBENZO[D]OXAZOL-6-YLBORONIC ACID; 2-PROPYLTHIO-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-P-TERPHENYLBORONIC ACID; 2-P-TOLYLPYRIDIN-4-YLBORONIC ACID; 2-PYRAZOL-1-YL-PHENYL-BORONIC ACID; 2-PYRIDINEBORONIC ACID; 2-PYRROLIDIN-1-YLPYRIDINE-3-BORONIC ACID HYDROCHLORIDE; 2-PYRROLYLBORONIC ACID; 2-QUINOXALINYLBORONIC ACID; 2-SEC-BUTOXY-5-CHLOROPYRIDIN-3-YLBORONIC ACID; 2-TERT-BUTOXY-PYRIMIDINE-5-BORONIC ACID; 2-TERT-BUTYL-1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 2-TRIFLUOROACETYLAMINOPHENYLBORONIC ACID; 2-TRIFLUOROMETHYL-5-PYRIDINEBORIC ACID; 2-TRIFLUOROMETHYL-6-CHLORO-5-PYRIDINEBORIC ACID; 2-TRIPHENYLENYLBORONIC ACID; 2-VINYLPHENYLBORONIC ACID; 3-((1-(TERT-BUTOXYCARBONYL)AZEPAN-3-YL)METHYL)PHENYLBORONIC ACID; 3-((1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 34(1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 3-((2-(MESITYLSULFONYL)HYDRAZONO)METHYL)PHENYLBORONIC ACID; 3-((2′-CHLORO-5′-(TRIFLUOROMETHYL)PHENOXY)METHYL)PHENYLBORONIC ACID; 3-((4′-(2-METHOXYETHYL)PHENOXY)METHYL)PHENYLBORONIC ACID; 3-((4′-(TRIFLUOROMETHOXY)PHENOXY)METHYL)PHENYLBORONIC ACID; 3-((BUTOXYCARBONYLAMINO)METHYL)PHENYLBORONIC ACID; 3-((DIETHYLCARBAMOYL)OXY)PYRIDINE-4-BORONIC ACID; 3-((DIMETHYLAMINO)METHYL)PHENYLBORONIC ACID; 3-((PHENYLAMINO)METHYL)PHENYLBORONIC ACID; 34(TETRAHYDROFURAN-2-YL)METHYLCARBAMOYL)PHENYLBORONIC ACID; 3-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-3,4-DIHYDROPYRIMIDIN-4-ONE; 3-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-3,4-DIHYDROPYRIMIDIN-4-ONE; 3-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-3,4-DIHYDROPYRIMIDIN-4-ONE; 3-(1-(PYRROLIDIN-1-YL)ETHYL)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)-4-CYANOPIPERIDIN-4-YL)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YL)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YLOXY)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)PHENYLBORONIC ACID; 3-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YLOXY)-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(1,2,4-OXADIAZOL-3-YL)-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-(1,3-DIOXOLAN-2-YL)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(1-ADAMANTYL)-4-METHOXYPHENYLBORONIC ACID; 3-(1H-1,2,3-TRIAZOL-4-YL)PHENYLBORONIC ACID; 3-(1H-1,2,4-TRIAZOL-3-YL-CARBAMOYL)PHENYLBORONIC ACID; 3-(1H-IMIDAZOL-2-YL)PHENYLBORONIC ACID; 3-(1H-PYRAZOL-4-YL)PHENYLBORONIC ACID; 3-(1H-PYRAZOL-5-YL)PHENYLBORONIC ACID; 3-(1H-PYRROL-1-YL)PHENYLBORONIC ACID; 3-(1H-PYRROLE-1-CARBONYL)PHENYLBORONIC ACID; 3-(1H-TETRAZOL-5-YLCARBAMOYL)BENZENEBORONIC ACID HYDROCHLORIDE; 3-(1-HYDROXYETHYL)PHENYLBORONIC ACID; 3-(1-ISOPROPYLPIPERIDIN-4-YLCARBAMOYL)PHENYLBORONIC ACID; 3-(1-METHYLETHYLSULFONAMIDO)PHENYLBORONIC ACID; 3-(1-PROPYLTHIO)-BENZENEBORONIC ACID; 3-(1-PYRROLIDINO)PHENYLBORONIC ACID HCL; 3-(2-(DIMETHYLAMINO)ETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-(2-(PIPERIDIN-1-YL)ETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-(2-(PIPERIDIN-1-YL)ETHYLCARBAMOYL)PHENYLBORONIC ACID HYDROCHLORIDE; 3-(2-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(2,2,2-TRICHLOROACETAMIDO)BENZENEBORONIC ACID; 3-(2,2,2-TRIFLUOROACETAMIDO)BENZENEBORONIC ACID; 3-(2,2,2-TRIFLUORO-ETHOXY)-4,5-DIFLUORO-BENZENEBORONIC ACID; 3-(2,2,2-TRIFLUOROETHOXY)PHENYLBORONIC ACID; 3-(2,2,2-TRIFLUOROETHYLTHIO)-BENZENEBORONIC ACID; 3-(2,2-DICYANOVINYL)PHENYLBORONIC ACID; 3-(2,2-DIFLUORO-ETHOXY)-4,5-DIFLUORO-BENZENEBORONIC ACID; 3-(2,2-DIFLUOROETHOXY)PHENYLBORONIC ACID; 3-(2,2-DIFLUOROETHYLTHIO)-BENZENEBORONIC ACID; 3-(2,2-DIMETHOXYETHOXY)PHENYLBORONIC ACID; 3-(2,3-DIFLUOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(2,3-DIFLUOROPHENYL)-2-METHYLPYRIDINE-4-BORONIC ACID; 3-(2,4,5-TRICHLOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(2,4-DICHLOROPHENYLMETHOXY)PHENYLBORONIC ACID; 3-(2,5-DIOXOIMIDAZOLIDIN-4-YL)PHENYLBORONIC ACID; 3-(2,6-DICHLOROPHENYLMETHOXY)PHENYLBORONIC ACID; 3-(2-AMINOETHYL)PHENYLBORONIC ACID HYDROCHLORIDE; 3-(2-CARBOXYVINYL)BENZENEBORONIC ACID; 3-(2′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 3-(2-CHLOROETHYLCARBAMOYL)BENZENEBORONIC ACID; 3-(2-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 3-(2-CYANOETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(2-ETHOXY-2-OXOETHOXY)PHENYLBORONIC ACID; 3-(2-ETHOXYCARBONYLETHYL)PHENYLBORONIC ACID; 3-(2′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 3-(2H-TETRAZOL-5-YL)-PHENYL-BORONIC ACID; 3-(2-HYDROXYETHYL)PHENYLBORONIC ACID; 3-(2-HYDROXYETHYLAMINO)PYRIDIN-2-YLBORONIC ACID; 3-(2-HYDROXYETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-(2-HYDROXYPROPAN-2-YL)PYRIDINE-2-BORONIC ACID; 3-(2-METHOXY-2-OXOETHOXY)PHENYLBORONIC ACID; 3-(2-METHOXY-2-OXOETHYL)PHENYLBORONIC ACID; 3-(2′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 3-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 3-(2-METHOXYETHOXY)THIOPHEN-2-YLBORONIC ACID; 3-(2-METHOXYETHYLAMINOCARBONYL)BENZENEBORONIC ACID; 3-(2-MORPHOLINOETHOXY)PHENYLBORONIC ACID; 3-(2-N,N-DIETHYLAMINOETHYLAMINOCARBONYL)PHENYLBORONIC ACID, HCL; 3-(2-NITRO-4-TRIFLUOROMETHYLPHENOXY)PHENYLBORONIC ACID; 3-(2-NITROETHYL)PHENYLBORONIC ACID; 3-(2-NITROPHENOXY)PHENYLBORONIC ACID; 3-(2-THIAZOLYL)AMINOCARBONYLPHENYLBORONIC ACID; 3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(3-(METHOXYCARBONYL)PYRROLIDIN-1-YL)PHENYLBORONIC ACID; 3-(3-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(3′-(TRIFLUOROMETHYL)PHENOXYMETHYL)PHENYLBORONIC ACID; 3-(3,3-DIETHOXYPROPOXY)PHENYLBORONIC ACID; 3-(3,5-DICHLOROPHENYLCARBAMOYL)-4-FLUOROPHENYLBORONIC ACID; 3-(3′,5′-DIMETHOXYBENZYLOXY)PHENYLBORONIC ACID; 3-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PHENYLBORONIC ACID; 3-(3,5-DIMETHYLISOXAZOL-4-YL)PHENYLBORONIC ACID; 3-(3,7-DIMETHYLOCTYLOXY)BENZENEBORONIC ACID; 3-(3-BORONOPHENYL)ACRYLONITRILE; 3-(3-CARBOXYPROPIONYLAMINO)PHENYLBORONIC ACID; 3-(3-CHLORO-4-FLUOROPHENYLCARBAMOYL)-4-FLUOROPHENYLBORONIC ACID; 3-(3′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 3-(3-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 3-(3-CHLOROPROPYLCARBAMOYL)BENZENEBORONIC ACID; 3-(3-CHLOROPROPYLSULPHONAMIDO)BENZENEBORONIC ACID; 3-(3-ETHOXY-3-OXOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-(3-ETHYLTHIOUREIDO)PHENYLBORONIC ACID; 3-(3′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 3-(3-FLUOROPHENYLCARBAMOYL)PHENYLBORONIC ACID; 3-(3-FLUOROPROPYLOXY)-BENZENEBORONIC ACID; 3-(3-ISOPROPYLTHIOUREIDO)PHENYLBORONIC ACID; 3-(3′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 3-(3-METHOXYPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-(3-METHYLTHIOUREIDO)PHENYLBORONIC ACID; 3-(4-(TERT-BUTOXYCARBONYL)PIPERAZINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(4-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(4-ACETAMIDOPHENYLAMINO)PHENYLBORONIC ACID; 3-(4-ACETYLPIPERAZIN-1-YL)PHENYLBORONIC ACID; 3-(4-AMINOBENZYL)PHENYLBORONIC ACID; 3-(4-AMINOPHENYLAMINO)PHENYLBORONIC ACID; 3-(4-BORONOPHENOXYMETHYL)BENZONITRILE; 3-(4-BORONOPHENYL)CYCLOBUTANONE ETHYLENE KETAL; 3-(4-CARBOETHOXYBUTYL)PHENYLBORONIC ACID; 3-(4-CARBOXYBUTOXY)-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-(4′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 3-(4-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 3-(4-CYANOPHENYL)AMINOCARBONYLPHENYLBORONIC ACID; 3-(4-CYANOPHENYLMETHOXY)PHENYLBORONIC ACID; 3-(4-CYCLOPROPYLPIPERAZIN-1-YL)PHENYLBORONIC ACID; 3-(4-ETHOXYCARBONYLBUTYLOXY)-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-(4-FLUORO-2-NITROPHENOXY)PHENYLBORONIC ACID; 3-(4′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YLBORONIC ACID; 3-(4-FLUOROPHENYL)AMINOCARBONYLPHENYLBORONIC ACID; 3-(4′-HEPTYLOXYPHENOXYMETHYL)PHENYLBORONIC ACID; 3-(4-METHOXY)BENZYLOXY-5-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 3-(4′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 3-(4-METHYLPIPERAZIN-1-YL)PHENYLBORONIC ACID; 3-(4-METHYLPIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(4-NITROPHENOXY)PHENYLBORONIC ACID; 3-(5-(TRIFLUOROMETHYL)PYRIDIN-2-YLOXY)PHENYLBORONIC ACID; 3-(5-METHYL-1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-(9H-CARBAZOL-9-YL)PHENYLBORONIC ACID; 3-(ACETOXYMETHYL)PHENYLBORONIC ACID; 3-(ALLYLOXY)-4,5-DIFLUOROPHENYLBORONIC ACID; 3-(ALLYLOXYMETHYL)-4-METHOXYPHENYLBORONIC ACID; 3-(ALLYLOXYMETHYL)PHENYLBORONIC ACID; 3-(ALLYLTHIO)-BENZENEBORONIC ACID; 3-(AMINOCARBONYL)-4-FLUOROBENZENEBORONIC ACID; 3-(AMINOCARBONYL)-5-FLUOROBENZENEBORONIC ACID; 3-(AMINOMETHYL)-2-FLUOROPHENYLBORONIC ACID, HCL; 3′-(AMINOMETHYL)BIPHENYL-3-YLBORONIC ACID; 3-(AZETIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(AZIRIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(BENZYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 3-(BENZYLAMINO)-5-CHLOROPHENYLBORONIC ACID; 3-(BENZYLAMINO)-5-NITROBENZENEBORONIC ACID HYDROCHLORIDE; 3-(BENZYLCARBAMOYL)-4-FLUOROPHENYLBORONIC ACID; 3-(BENZYLCARBAMOYL)-5-FLUOROBENZENEBORONIC ACID; 3-(BENZYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(BENZYLOXY)-2,4-DICHLOROPHENYLBORONIC ACID; 3-(BENZYLOXY)-2,6-DIFLUOROPHENYLBORONIC ACID; 3-(BENZYLOXY)-4-FLUOROPHENYLBORONIC ACID; 3-(BENZYLOXY)-4-METHOXYPHENYLBORONIC ACID; 3-(BENZYLOXY)-4-METHYLPHENYLBORONIC ACID; 3-(BENZYLOXY)-5-CHLOROPHENYLBORONIC ACID; 3-(BENZYLOXY)-5-METHYLPHENYLBORONIC ACID; 3-(BENZYLOXYCARBONYLAMINO)-5-NITROPHENYLBORONIC ACID; 3-(BIS(2-HYDROXYETHYL)AMINO)PYRIDIN-2-YLBORONIC ACID; 3-(BOC-AMINOMETHYL)-PYRIDINE-4-BORONIC ACID; 3-(BUT-3-ENYLOXY)-4-METHOXYPHENYLBORONIC ACID; 3-(BUT-3-ENYLOXY)PHENYLBORONIC ACID; 3-(BUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(BUTYLSULFONAMIDO)PHENYLBORONIC ACID; 3-(CARBOXYMETHOXY)-5-FLUOROBENZENEBORONIC ACID; 3-(CBZ-AMINO)-5-FLUOROPHENYLBORONIC ACID; 3-(CHLOROMETHYL)BENZENEBORONIC ACID; 3-(CYCLOBUTYL)FURAN-2-BORONIC ACID; 3-(CYCLOBUTYL)THIOPHENE-2-BORONIC ACID; 3-(CYCLOBUTYLTHIO)PHENYLBORONIC ACID; 3-(CYCLOHEXYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 3-(CYCLOHEXYL)FURAN-2-BORONIC ACID; 3-(CYCLOHEXYL)THIOPHENE-2-BORONIC ACID; 3-(CYCLOHEXYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(CYCLOHEXYLCARBAMOYL)-4-FLUOROBENZENEBORONIC ACID; 3-(CYCLOHEXYLCARBAMOYL)-5-FLUOROBENZENEBORONIC ACID; 3-(CYCLOHEXYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(CYCLOHEXYLMETHOXY)PHENYLBORONIC ACID; 3-(CYCLOHEXYLOXY)METHYLPHENYLBORONIC ACID; 3-(CYCLOHEXYLOXY)PHENYLBORONIC ACID; 3-(CYCLOHEXYLSULFONYL)PHENYLBORONIC ACID; 3-(CYCLOPENTYL)FURAN-2-BORONIC ACID; 3-(CYCLOPENTYL)THIOPHENE-2-BORONIC ACID; 3-(CYCLOPENTYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(CYCLOPENTYLOXY)-4-METHOXYBENZENEBORONIC ACID; 3-(CYCLOPENTYLOXY)-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-(CYCLOPENTYLOXY)-5-METHYLPHENYLBORONIC ACID; 3-(CYCLOPROPANESULFONAMIDO)PHENYLBORONIC ACID; 3-(CYCLOPROPYL)FURAN-2-BORONIC ACID; 3-(CYCLOPROPYL)THIOPHENE-2-BORONIC ACID; 3-(CYCLOPROPYLAMINO)BENZO[D]ISOXAZOL-5-YLBORONIC ACID; 3-(CYCLOPROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(CYCLOPROPYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(CYCLOPROPYLMETHOXY)-5-METHYLPHENYLBORONIC ACID; 3-(CYCLOPROPYLMETHOXY)PHENYLBORONIC ACID; 3-(CYCLOPROPYLMETHYL)THIOPHENYLBORONIC ACID; 3-(CYCLOPROPYLSULFONYL)PHENYLBORONIC ACID; 3-(DANSYLAMINO)PHENYLBORONIC ACID; 3-(DIETHYLCARBAMOYL)-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 3-(DIETHYLCARBAMOYL)-2-FLUOROPHENYLBORONIC ACID; 3-(DIETHYLCARBAMOYL)-4-FLUOROBENZENEBORONIC ACID; 3-(DIETHYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(DIETHYLCARBAMOYL)FURAN-2-YLBORONIC ACID; 3-(DIETHYLCARBAMOYL)THIOPHEN-2-YLBORONIC ACID; 3-(DIFLUOROMETHOXY)-2-FLUOROPHENYLBORONIC ACID; 3-(DIFLUOROMETHOXY)-5-FLUOROPHENYLBORONIC ACID; 3-(DIFLUOROMETHOXY)-BENZENEBORONIC ACID; 3-(DIFLUOROMETHOXY)PYRAZINE-2-BORONIC ACID; 3-(DIFLUOROMETHYL)-4-FLUOROPHENYLBORONIC ACID; 3-(DIHYDROXYBORYL)-4-METHOXYPYRIDINIUM; 3-(DIISOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-(DIMETHOXYMETHYL)-4-NITROPHENYLBORONIC ACID; 3-(DIMETHYLCARBAMOYL)-4-FLUOROBENZENEBORONIC ACID; 3-(DIMETHYLCARBAMOYL)-5-NITROBENZENEBORONIC ACID; 3-(DIMETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-(DIPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-(ETHOXYCARBONYL)-5-METHOXYBENZOFURAN-2-YLBORONIC ACID; 3-(ETHOXYCARBONYL)THIOPHEN-2-YLBORONIC ACID; 3-(ETHOXY-D5)-PHENYLBORONIC ACID; 3-(ETHYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 3-(ETHYLCARBAMOYL)-4-FLUOROBENZENEBORONIC ACID; 3-(ETHYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(ETHYL-D5)-PHENYLBORONIC ACID; 3-(ETHYLSULFONAMIDO)PHENYLBORONIC ACID; 3-(FURFURYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(HYDROXYIMINO)METHYLPHENYLBORONIC ACID; 3-(HYDROXYMETHYL)-5-METHYLPHENYLBORONIC ACID; 3-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 3-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 3-(HYDROXYMETHYL)PHENYLBORONIC ACID; 3-(ISOBUTYRAMIDO)BENZENEBORONIC ACID; 3-(ISOPROPOXYCARBONYL)PHENYLBORONIC ACID; 3-(ISO-PROPOXY-D7)-PHENYLBORONIC ACID; 3-(ISO-PROPYL)FURAN-2-BORONIC ACID; 3-(ISO-PROPYL)THIOPHENE-2-BORONIC ACID; 3-(ISO-PROPYL-D7)-PHENYLBORONIC ACID; 3-(METHOXYCARBAMOYL)PHENYLBORONIC ACID; 3-(METHOXYCARBONYL)FURAN-2-BORONIC ACID; 3-(METHOXYCARBONYL)PYRIDINE-2-BORONIC ACID; 3-(METHOXY-D3)-PHENYLBORONIC ACID; 3-(METHOXYMETHOXY)PHENYLBORONIC ACID; 3-(METHYLAMINO)BENZO[D] ISOXAZOL-5-YLBORONIC ACID; 3-(METHYLAMINO)PYRIDIN-2-YLBORONIC ACID; 3-(METHYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(METHYL-D3)-5-FLUOROPHENYLBORONIC ACID; 3-(METHYL-D3)-PHENYLBORONIC ACID; 3′-(METHYLSULFONYL)BIPHENYL-3-YLBORONIC ACID; 3-(METHYLSULFONYL)PHENYLBORONIC ACID; 3-(METHYLSULFONYLAMINO)PHENYLBORONIC ACID; 3-(METHYLTHIO)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(METHYLTHIO)PHENYLBORONIC ACID; 3-(METHYLTHIO)THIOPHEN-2-YLBORONIC ACID; 3-(METHYLTHIOL-D3)-PHENYLBORONIC ACID; 3-(MORPHOLIN-4-YLSULPHONYL)BENZENEBORONIC ACID; 3-(MORPHOLINE-4-CARBONYL)-5-NITROPHENYLBORONIC ACID; 3-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 3-(MORPHOLINO)PHENYLBORONIC ACID; 3-(MORPHOLINOMETHYL)PHENYLBORONIC ACID; 3-(N,N-DIETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(N,N-DIETHYLSULPHAMOYL)BENZENEBORONIC ACID; 3-(N,N-DIMETHYLAMINO)PHENYLBORONIC ACID; 3-(N,N-DIMETHYLSULFAMOYLAMINO)PHENYLBORONIC ACID; 3-(N,N-DIMETHYLSULPHONAMIDO)BENZENEBORONIC ACID; 3-(N,O-DIMETHYLHYDROXYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(NAPHTHALEN-2-YL)PHENYLBORONIC ACID; 3-(N-BENZYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(N-BENZYLSULFAMOYL)-4-METHOXYPHENYLBORONIC ACID; 3-(N-BOC-AMINOMETHYL)PHENYLBORONIC ACID; 3-(N-BUTYLCARBAMOYL)-4-FLUOROPHENYLBORONIC ACID; 3-(N-BUTYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(N-CYCLOPROPYLSULPHAMOYL)BENZENEBORONIC ACID; 3-(NEOPENTYLOXY)PHENYLBORONIC ACID; 3-(NEOPENTYLOXYSULFONYL)PHENYLBORONIC ACID; 3-(N-ETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(N-ETHYLSULFAMOYL)PHENYLBORONIC ACID; 3-(N-ISOPROPYLAMINOCARBONYL)-5-NITROPHENYLBORONIC ACID; 3-(N-ISOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 3-(N-METHYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(N-PROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(N-T-BUTYL-N-METHYLSULFAMOYL)PHENYLBORONIC ACID; 3-(OXETAN-3-YL)PHENYLBORONIC ACID; 3-(PERFLUOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(PHENYLAMINO)PHENYLBORONIC ACID; 3-(PHENYLAMINOCARBONYL)-5-NITROPHENYLBORONIC ACID; 3-(PIPERIDIN-1-YL)-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(PIPERIDIN-1-YL)PHENYLBORONIC ACID; 3-(PIPERIDIN-1-YLMETHYL)PHENYLBORONIC ACID; 3-(PIPERIDIN-1-YLMETHYL)PHENYLBORONIC ACID, HCL; 3-(PIPERIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 3-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(PIPERIDINO)PHENYLBORONIC ACID HCL; 3-(PROPOXYCARBONYL)PHENYLBORONIC ACID; 3-(PROPYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(PROPYLSULFONAMIDO)PHENYLBORONIC ACID; 3-(P-TOLYLCARBAMOYL)PHENYLBORONIC ACID; 3-(PYRIDIN-2-YL)PHENYL BORONIC ACID; 3-(PYRIDIN-2-YLAMINO)PHENYLBORONIC ACID; 3-(PYRIDIN-2-YLMETHOXY)PHENYLBORONIC ACID; 3-(PYRIDIN-4-YLAMINO)PHENYLBORONIC ACID; 3-(PYRIDINE-3-YL)PHENYLBORONIC ACID; 3-(PYRIDINE-4-YL)PHENYLBORONIC ACID; 3-(PYRROLIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 3-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(PYRROLIDINO)PHENYLBORONIC ACID; 3-(T-BUTOXYCARBONYLAMINO)-4-CHLOROPHENYLBORONIC ACID; 3-(T-BUTYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(T-BUTYLDIMETHYLSILYLOXY)-4-CHLORO-2-FLUOROPHENYLBORONIC ACID; 3-(T-BUTYLDIMETHYLSILYLOXY)-4-METHOXYPHENYLBORONIC ACID; 3-(T-BUTYLDIMETHYLSILYLOXY)PHENYLBORONIC ACID; 3-(T-BUTYLTHIO)PHENYLBORONIC ACID; 3-(TERT-BUTOXYCARBONYL)-2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPIN-7-YL-7-BORONIC ACID; 3-(TERT-BUTOXYCARBONYL)PHENYLBORONIC ACID; 3-(TERT-BUTOXYCARBONYLAMINO)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(TERT-BUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(TERT-BUTYLCARBAMOYL)-4-FLUOROPHENYLBORONIC ACID; 3-(TERT-BUTYLDIMETHYLSILYLOXY)-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-(TETRAHYDRO-2H-PYRAN-2-YLOXY)PHENYLBORONIC ACID; 3-(TETRAHYDRO-2H-PYRAN-4-YL)METHOXYPHENYLBORONIC ACID; 3-(TETRAHYDROPYRAN-4-YLOXYMETHY)PHENYLBORONIC ACID; 3-(TETRAZOL-5-YL)PHENYLBORONIC ACID; 3-(THIOMORPHOLIN-4-YLCARBONYL)BENZENEBORONIC ACID; 3-(THIOPHEN-2-YLMETHOXYMETHYL)PHENYLBORONIC ACID; 3-(TOLYL-D7)-BORONIC ACID; 3-(TRANS-4-HYDROXYCYCLOHEXYLCARBAMOYL)PHENYLBORONIC ACID; 3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-(TRIFLUOROMETHOXY)PYRAZINE-2-BORONIC ACID; 3-(TRIFLUOROMETHYL)-1-TRITYL-1H-PYRAZOL-4-YLBORONIC ACID; 3-(TRIFLUOROMETHYL)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-(TRIFLUOROMETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-(TRIFLUOROMETHYL)-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-(TRIFLUOROMETHYL)-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(ETHOXY-D5)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(ETHYL-D5)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(ISO-PROPOXY-D7)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(ISO-PROPYL-D7)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(METHOXY-D3)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(METHYL-D3)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-METHYL-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-VINYLPHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(TRIFLUOROMETHYLTHIO)-BENZENEBORONIC ACID; 3,3-DIMETHYL-1-BUTENYLBORONIC ACID; 3,3-DIMETHYL-2-OXOINDOLIN-6-YLBORONIC ACID; 3,4-(METHYLENE-D2)-DIOXYPHENYLBORONIC ACID; 3,4,5-TRICHLORO-2-METHYLPHENYLBORONIC ACID; 3,4,5-TRICHLOROPHENYLBORONIC ACID; 3,4,5-TRIFLUOROPHENYLBORONIC ACID; 3,4,5-TRIMETHOXYPHENYLBORONIC ACID; 3,4,5-TRIS(BENZYLOXY)PHENYLBORONIC ACID; 3,4-BIS(2-METHYLBUTYLOXY)BENZENEBORONIC ACID; 3,4-BIS(2-METHYLPROPYLOXY)BENZENEBORONIC ACID; 3,4-BIS(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3,4-DIAMINOPHENYLBORONIC ACID; 3,4-DICHLORO-2-METHYLPHENYLBORONIC ACID; 3′,4′-DICHLORO-4-BIPHENYLBORONIC ACID; 3,4-DICHLORO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3,4-DICHLOROPHENYLBORONIC ACID; 3,4-DIFLUORO-2-ISOPROPOXYPHENYLBORONIC ACID; 3,4-DIFLUORO-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 3,4-DIFLUORO-5-(TRIFLUOROMETHYL)-PHENYLBORONIC ACID; 3,4-DIFLUORO-5-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 3,4-DIFLUORO-5-METHOXYBENZENEBORONIC ACID; 3,4-DIFLUORO-5-NITROPHENYLBORONIC ACID; 3,4-DIFLUOROPHENYLBORONIC ACID; 3,4-DIHYDRO-1H-2-BENZOPYRAN-1-BORONIC ACID; 3,4-DIHYDRO-1H-2-BENZOPYRAN-3-BORONIC ACID; 3,4-DIHYDRO-1H-2-BENZOPYRAN-4-BORONIC ACID; 3,4-DIHYDRO-1H-2-BENZOPYRAN-5-BORONIC ACID; 3,4-DIHYDRO-1H-2-BENZOPYRAN-6-BORONIC ACID; 3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-6-YLBORONIC ACID; 3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YLBORONIC ACID; 3,4-DIHYDRO-2H-1-BENZOPYRAN-6-YLBORANEDIOL; 3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZIN-7-YLBORONIC ACID; 3,4-DIHYDRO-2H-PYRAN-6-YLBORONIC ACID; 3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-6-BORONIC ACID; 3,4-DIMETHOXYPHENYLBORONIC ACID; 3,4-DIMETHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-6-YLBORONIC ACID; 3,4-DIMETHYL-5-FLUORO-PHENYLBORONIC ACID; 3′,4′-DIMETHYLBIPHENYL-2-YLBORONIC ACID; 3,4-DIMETHYLPHENYLBORONIC ACID; 3,4-METHYLENEDIOXYPHENYLBORONIC ACID; 3,5,5,8,8-PENTAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YLBORONIC ACID; 3,5,5,8,8-PENTAMETHYL-5,8-DIHYDRONAPHTHALEN-2-BORONIC ACID; 3,5-BIS((TERT-BUTYLSILYLOXY)METHYL)PHENYLBORONIC ACID; 3,5-BIS(TERT-BUTYLDIMETHYLSILYLOXY)PHENYLBORONIC ACID; 3,5-BIS(TRIFLUOROMETHYL)BENZYLBORONIC ACID; 3,5-BIS(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3,5-DIAMINOPHENYL BORONIC ACID; 3,5-DICHLORO-2-FLUOROPYRIDIN-4-YLBORONIC ACID; 3,5-DICHLORO-2-METHOXYPHENYLBORONIC ACID; 3,5-DICHLORO-2-METHYLPHENYLBORONIC ACID; 3,5-DICHLORO-4-CYANOPHENYLBORONIC ACID; 3,5-DICHLORO-4-ETHOXYPHENYLBORONIC ACID; 3,5-DICHLORO-4-METHOXYPHENYLBORONIC ACID; 3,5-DICHLOROPHENYLBORONIC ACID; 3,5-DICHLOROPYRIDINE-2-BORONIC ACID; 3,5-DICHLOROPYRIDINE-4-BORONIC ACID; 3,5-DICHLOROTHIOPHEN-2-YLBORONIC ACID; 3,5-DICYANOPHENYLBORONIC ACID; 3,5-DIFLUORO-2-HYDROXYPHENYLBORONIC ACID; 3,5-DIFLUORO-2-METHOXYPHENYLBORONIC ACID; 3,5-DIFLUORO-2-NITROPHENYLBORONIC ACID; 3,5-DIFLUORO-4-(HYDROXYMETHYL)PHENYLBORONIC ACID; 3,5-DIFLUORO-4-(METHOXYCARBONYL)PHENYLBORONIC ACID; 3,5-DIFLUORO-4-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 3,5-DIFLUORO-4-CHLOROPHENYLBORONIC ACID; 3,5-DIFLUORO-4-DIFLUOROMETHOXY-BENZENEBORONIC ACID; 3,5-DIFLUORO-4-HYDROXYPHENYLBORONIC ACID; 3,5-DIFLUORO-4-METHOXY-PHENYLBORONIC ACID; 3,5-DIFLUOROPHENYLBORONIC ACID; 3,5-DIFLUOROPYRIDINE-4-BORONIC ACID; 3,5-DIFLUOROPYRIDINE-4-BORONIC ACID HYDRATE; 3,5-DIMETHOXYPHENYLBORONIC ACID; 3,5-DIMETHYL-1-(THP)PYRAZOLE-4-BORONIC ACID; 3,5-DIMETHYL-1H-PYRAZOL-4-YLBORONIC ACID HYDROCHLORIDE; 3,5-DIMETHYL-4-(3′,5′-DIMETHOXYBENZYLOXY)PHENYLBORONIC ACID; 3,5-DIMETHYL-4-CHLOROPHENYLBORONIC ACID; 3,5-DIMETHYL-4-ETHOXYPHENYLBORONIC ACID; 3,5-DIMETHYL-4-FLUORO-PHENYLBORONIC ACID; 3,5-DIMETHYL-4-ISOPROPOXYPHENYLBORONIC ACID; 3,5-DIMETHYL-4-METHOXYPHENYLBORONIC ACID; 3,5-DIMETHYL-4-PROPOXYPHENYLBORONIC ACID; 3,5-DIMETHYLBENZO[B]THIOPHEN-2-YLBORONIC ACID; 3,5-DIMETHYLISOXAZOLE-4-BORONIC ACID; 3,5-DIMETHYLPHENYLBORONIC ACID; 3,5-DIMETHYLTHIOPHEN-2-YLBORONIC ACID; 3,5-DINITRO-4-METHYLPHENYLBORONIC ACID; 3,5-DINITROPHENYL BORONIC ACID; 3,5-DI-T-BUTYLPHENYLBORONIC ACID; 3,6-DIFLUORO-2-HYDROXYPHENYLBORONIC ACID; 3,6-DIFLUORO-2-METHOXYPHENYLBORONIC ACID; 3,6-DIHYDRO-2H-PYRAN-4-BORONIC ACID; 3,6-DIMETHOXYLPYRIDAZINE-4-BORONIC ACID; 3,6-DIMETHYLPYRAZIN-2-YLBORONIC ACID; 3,6-DIMETHYLPYRIDINE-2-BORONIC ACID; 3-[(1-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 3-[(2-FLUOROPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 3-[(2-ISOPROPYL-5-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 3-[(2-MORPHOLIN-4-YLETHYL)CARBAMOYL]BENZENEBORONIC ACID HYDROCHLORIDE; 3-[(2-PYRROLIDIN-1-YLETHYL)CARBAMOYL]BENZENEBORONIC ACID HYDROCHLORIDE; 3-[(3-METHOXY-3-OXOPROPYL)CARBAMOYL]BENZENEBORONIC ACID; 3-[(4′-CHLORO-1-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 3-[(4-CHLORO-3-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 3-[(4-CHLOROPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 3-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]BENZENEBORONIC ACID HYDROCHLORIDE; 3-[(4′-TERT-BUTYL-2′-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 3-[(BENZYLOXY)METHYL]PYRIDINE-2-BORONIC ACID; 3-[(E)-2-NITROVINYL]PHENYLBORONIC ACID; 3-[2-(DIHYDROXYBORANYL)PHENOXYMETHYL]PYRIDINE-2-CARBONITRILE; 3-[3-(DIHYDROXYBORANYL)PHENOXYMETHYL]BENZONITRILE; 3-[3-(DIHYDROXYBORANYL)PHENOXYMETHYL]PYRIDINE-2-CARBONITRILE; 3-[4-(DIHYDROXYBORANYL)PHENOXYMETHYL]PYRIDINE-2-CARBONITRILE; 3-[METHOXY(METHYL)CARBAMOYL]-5-NITROPHENYLBORONIC ACID; 3-[N-(4-METHOXYBENZYL)SULFAMOYL]PHENYLBORONIC ACID; 3-[N-CYCLOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL]PHENYLBORONIC ACID; 3-ACETAMIDO-4-NITROPHENYLBORONIC ACID; 3-ACETAMIDO-5-BORONOBENZOIC ACID; 3-ACETAMIDOBENZO[D]ISOXAZOL-5-YLBORONIC ACID; 3-ACETAMIDOBENZO[D]ISOXAZOL-6-YLBORONIC ACID; 3-ACETAMIDOPHENYLBORONIC ACID; 3-ACETOXY-4-METHOXYPHENYLBORONIC ACID; 3-ALLYLOXYPHENYLBORONIC ACID; 3-AMINO-1H-INDAZOL-6-YLBORONIC ACID; 3-AMINO-2-(METHOXYCARBONYL)PYRIDINE-5-BORONIC ACID; 3-AMINO-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-AMINO-2-CYANOPYRIDINE-5-BORONIC ACID; 3-AMINO-2-FLUOROPYRIDINE-5-BORONIC ACID; 3-AMINO-2-METHYLPYRIDINE-4-BORONIC ACID; 3-AMINO-2-METHYLPYRIDINE-5-BORONIC ACID; 3-AMINO-3-(2-BORONOPHENYL)PROPANOIC ACID; 3-AMINO-3-(3-BORONOPHENYL)PROPANOIC ACID; 3-AMINO-3-(4-BORONOPHENYL)PROPANOIC ACID; 3-AMINO-4,5-DIFLUOROPHENYLBORONIC ACID; 3-AMINO-4-CHLOROPHENYLBORONIC ACID; 3-AMINO-4-FLUOROPHENYLBORONIC ACID; 3-AMINO-4-FLUOROPHENYLBORONIC ACID HYDROCHLORIDE; 3-AMINO-4-METHOXYPHENYLBORONIC ACID; 3-AMINO-4-METHOXYPHENYLBORONIC ACID HCL; 3-AMINO-4-METHYLPHENYLBORONIC ACID; 3-AMINO-4-METHYLPHENYLBORONIC ACID HYDROCHLORIDE; 3-AMINO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-AMINO-5-CARBOXYLPHENYLBORONIC ACID; 3-AMINO-5-CHLOROPYRIDIN-2-YLBORONIC ACID; 3-AMINO-5-CYANOBENZENEBORONIC ACID HYDROCHLORIDE; 3-AMINO-5-CYANOPHENYLBORONIC ACID; 3-AMINO-5-DIETHYLCARBAMOYLPHENYLBORONIC ACID, HCL; 3-AMINO-5-ETHOXYCARBONYLPHENYLBORONIC ACID; 3-AMINO-5-FLUOROPHENYLBORONIC ACID; 3-AMINO-5-METHOXYCARBONYLPHENYLBORONIC ACID, HCL; 3-AMINO-5-METHOXYPYRIDIN-2-YLBORONIC ACID; 3-AMINO-6,7′[7′,8′,8′-TRICYANOQUINODIMETHANEPHENYLBORONIC ACID; 3-AMINO-6-METHOXYPYRAZIN-2-YLBORONIC ACID; 3-AMINO-8-HYDROXY-1,10-PHENANTHROLIN-2-YLBORONIC ACID; 3-AMINOCARBONYL-2-FLUOROPHENYLBORONIC ACID; 3-AMINOCARBONYLPHENYLBORONIC ACID; 3-AMINOPHENYLBORONIC ACID; 3-AMINOPHENYLBORONIC ACID HYDROCHLORIDE; 3-AMINOPHENYLBORONIC ACID MONOHYDRATE; 3-AMINOPYRAZIN-2-YLBORONIC ACID; 3-AMINOPYRIDINE-2-BORONIC ACID; 3-AMINOPYRIDINE-4-BORONIC ACID; 3-AMINOPYRIDINE-5-BORONIC ACID; 3-AMINOQUINOLIN-6-YLBORONIC ACID; 3-BENYLOXY-4-CHLORO-PHENYLBORONIC ACID; 3-BENZYLOXY-2-CHLORO-6-FLUOROPHENYLBORONIC ACID; 3-BENZYLOXY-4-CHLORO-2-FLUOROPHENYLBORONIC ACID; 3-BENZYLOXY-5-FLUOROPHENYLBORONIC ACID; 3-BENZYLOXYCARBONYLPHENYLBORONIC ACID; 3-BENZYLOXYPHENYLBORONIC ACID; 3-BIPHENYLBORONIC ACID; 3-BORONO-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-BORONO-2-METHOXYBENZOIC ACID; 3-BORONO-4-FLUOROBENZOIC ACID ETHYL ESTER; 3-BORONO-4-METHOXYBENZOIC ACID; 3-BORONO-5-CHLOROBENZAMIDE; 3-BORONO-5-METHOXY-BENZOIC ACID, 1-METHYL ESTER; 3-BORONO-A,A-DIMETHYL-BENZENEACETIC ACID; 3-BORONOBENZENESULFONAMIDE; 3-BORONOBENZOHYDRAZIDE; 3-BORONOISONICOTINIC ACID; 3-BORONO-N-(2,3-DIMETHYLPHENYL)BENZAMIDE; 3-BORONO-N-(2,4-DIMETHYLPHENYL)BENZAMIDE; 3-BORONO-N-(2,5-DIMETHYLPHENYL)BENZAMIDE; 3-BORONO-N-(2-CHLORO-4-METHYLPHENYL)BENZAMIDE; 3-BUTOXY-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-BUTOXY-2,6-DIFLUOROPHENYLBORONIC ACID; 3-BUTOXY-2-CHLOROPHENYLBORONIC ACID; 3-BUTOXY-4-CHLORO-2-FLUOROPHENYLBORONIC ACID; 3-BUTOXY-4-CHLOROPHENYLBORONIC ACID; 3-BUTOXY-4-METHOXYPHENYLBORONIC ACID; 3-BUTOXY-5-CHLOROPHENYLBORONIC ACID; 3-BUTOXY-5-METHOXYPHENYLBORONIC ACID; 3-BUTOXY-5-METHYLPHENYLBORONIC ACID; 3-BUTOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 3-BUTOXYCARBONYLAMINOPHENYLBORONIC ACID; 3-BUTOXYCARBONYLPHENYLBORONIC ACID; 3-BUTOXYPHENYLBORONIC ACID; 3-CARBAMOYL-5-NITROPHENYLBORONIC ACID; 3′-CARBAMOYLBIPHENYL-3-YLBORONIC ACID; 3-CARBOXY-2,4-DIFLUOROPHENYLBORONIC ACID; 3-CARBOXY-2-FLUOROPHENYLBORONIC ACID; 3-CARBOXY-4,5-DIFLUOROPHENYLBORONIC ACID; 3-CARBOXY-4-CHLOROPHENYLBORONIC ACID; 3-CARBOXY-4-FLUOROPHENYLBORONIC ACID; 3-CARBOXY-4-METHOXYPHENYLBORONIC ACID; 3-CARBOXY-5-CHLOROBENZENEBORONIC ACID; 3-CARBOXY-5-FLUOROPHENYLBORONIC ACID; 3-CARBOXY-5-FLUOROPYRIDINE-4-BORONIC ACID; 3-CARBOXY-5-METHOXYPHENYLBORONIC ACID; 3-CARBOXY-5-METHYLPHENYLBORONIC ACID; 3-CARBOXY-5-NITROPHENYLBORONIC ACID; 3-CARBOXYFURAN-2-BORONIC ACID; 3-CARBOXYMETHYL-6-FLUOROPHENYLBORONIC ACID; 3-CARBOXYPHENYLBORONIC ACID; 3-CHLORO-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 3-CHLORO-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-CHLORO-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-CHLORO-2-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 3-CHLORO-2,4-DIFLUOROBENZENEBORONIC ACID; 3-CHLORO-2,5-DIFLUOROPHENYLBORONIC ACID; 3-CHLORO-2,6-DIFLUOROPHENYLBORONIC ACID; 3-CHLORO-2-CYANOPHENYLBORONIC ACID; 3-CHLORO-2-FLUOROPHENYLBORONIC ACID; 3-CHLORO-2-FLUOROPYRIDINE-4-BORONIC ACID; 3-CHLORO-2-HYDROXYMETHYLPHENYLBORONIC ACID; 3-CHLORO-2-HYDROXYPHENYLBORONIC ACID; 3-CHLORO-2-HYDROXYPYRIDINE-4-BORONIC ACID; 3-CHLORO-2-ISOBUTOXYPYRIDINE-5-BORONIC ACID; 3-CHLORO-2-METHOXYPHENYLBORONIC ACID; 3-CHLORO-2-METHOXYPYRIDINE-4-BORONIC ACID; 3-CHLORO-2-METHOXYPYRIDINE-5-BORONIC ACID; 3-CHLORO-2-METHOXYPYRIDINE-6-BORONIC ACID; 3-CHLORO-2-METHYLPHENYLBORONIC ACID; 3-CHLORO-2-METHYLPYRIDINE-4-BORONIC ACID; 3-CHLORO-2-METHYLPYRIDINE-5-BORONIC ACID; 3-CHLORO-2-METHYLPYRIDINE-6-BORONIC ACID; 3-CHLORO-2-MORPHOLINOPYRIDINE-4-BORONIC ACID; 3-CHLORO-4-(2,2,2-TRIFLUOROETHOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(2,2-DIFLUOROETHOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(2′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(2′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(3′,5′-DIMETHOXYBENZYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(3′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(4′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(CYCLOHEXYLCARBAMOYL)BENZENEBORONIC ACID; 3-CHLORO-4-(CYCLOPENTYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(CYCLOPENTYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(CYCLOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(CYCLOPROPYLMETHOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(HYDRAZINOCARBONYL)BENZENEBORONIC ACID; 3-CHLORO-4-(HYDROXYMETHYL)PHENYLBORONIC ACID; 3-CHLORO-4-(MORPHOLINE-4-CARBONYL)BENZENEBORONIC ACID; 3-CHLORO-4-(N,N-DIETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(N,N-DIMETHYLCARBAMOYL)BENZENEBORONIC ACID; 3-CHLORO-4-(N-BENZYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(N-ETHYLCARBAMOYL)BENZENEBORONIC ACID; 3-CHLORO-4-(N-ISOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(N-METHYLCARBAMOYL)BENZENEBORONIC ACID; 3-CHLORO-4-(N-TERT-BUTYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-CHLORO-4-(PYRROLIDINYL-1-CARBONYL)PHENYLBORONIC ACID; 3-CHLORO-4-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PHENYLBORONIC ACID; 3-CHLORO-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-CHLORO-4,5-DIFLUOROPHENYLBORONIC ACID; 3-CHLORO-4-CYANOPHENYLBORONIC ACID; 3-CHLORO-4-ETHOXYPHENYLBORONIC ACID; 3-CHLORO-4-FLUORO-5-NITROPHENYLBORONIC ACID; 3-CHLORO-4-FLUOROPHENYLBORONIC ACID; 3-CHLORO-4-HYDROXYPHENYLBORONIC ACID; 3-CHLORO-4-ISOPROPOXYPHENYLBORONIC ACID; 3-CHLORO-4-METHOXY-5-METHYLPHENYLBORONIC ACID; 3-CHLORO-4-METHOXYPHENYLBORONIC ACID; 3-CHLORO-4-METHOXYPYRIDINE-2-BORONIC ACID; 3-CHLORO-4-METHYLPHENYLBORONIC ACID; 3-CHLORO-4-METHYLPYRIDINE-2-BORONIC ACID; 3-CHLORO-4-MORPHOLINOPHENYLBORONIC ACID; 3-CHLORO-4-PROPOXYPHENYLBORONIC ACID; 3-CHLORO-4-PYRIDINEBORONIC ACID; 3-CHLORO-4-PYRIDINEBORONIC ACID HYDRATE; 3-CHLORO-4-PYRIDINEBORONIC ACID PENTAHYDRATE; 3-CHLORO-5-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 3-CHLORO-5-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-CHLORO-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-CHLORO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YLBORONIC ACID; 3-CHLORO-5-ETHOXYPHENYLBORONIC ACID; 3-CHLORO-5-FLUORO-4-METHYLPHENYLBORONIC ACID; 3-CHLORO-5-FLUOROPHENYLBORONIC ACID; 3-CHLORO-5-FLUOROPYRIDINE-4-BORONIC ACID; 3-CHLORO-5-HYDROXYPYRIDINE-2-BORONIC ACID; 3-CHLORO-5-ISOBUTOXYPHENYLBORONIC ACID; 3-CHLORO-5-METHOXYCARBONYL-PHENYL-BORONIC ACID; 3-CHLORO-5-METHOXYPHENYLBORONIC ACID; 3-CHLORO-5-METHOXYPYRIDINE-2-BORONIC ACID; 3-CHLORO-5-METHOXYPYRIDINE-4-BORONIC ACID; 3-CHLORO-5-METHYLPHENYLBORONIC ACID; 3-CHLORO-5-METHYLPYRIDINE-2-BORONIC ACID; 3-CHLORO-5-METHYLPYRIDINE-4-BORONIC ACID; 3-CHLORO-5-PROPOXYPHENYLBORONIC ACID; 3-CHLORO-5-VINYLPHENYLBORONIC ACID; 3-CHLORO-6-METHOXYPYRIDIN-2-YLBORONIC ACID; 3-CHLORO-6-METHYLPYRIDINE-2-BORONIC ACID; 3′-CHLORO-BIPHENYL-4-BORONIC ACID; 3-CHLOROCARBONYLPHENYLBORONIC ACID; 3-CHLOROPHENYLBORONIC ACID; 3-CHLOROPYRIDINE-2-BORONIC ACID; 3-CHLOROTHIOPHENE-2-BORONIC ACID; 3-CHLOROTHIOPHENE-4-BORONIC ACID; 3-CYANO-2-FLUOROPHENYLBORONIC ACID; 3-CYANO-2-HYDROXYPHENYLBORONIC ACID; 3-CYANO-2-METHOXYPHENYLBORONIC ACID; 3-CYANO-2-METHYLPHENYLBORONIC ACID; 3-CYANO-4-FLUOROPHENYLBORONIC ACID; 3-CYANO-4-HYDROXYPHENYLBORONIC ACID; 3-CYANO-4-ISOPROPOXYPHENYLBORONIC ACID; 3-CYANO-4-METHOXYPHENYLBORONIC ACID; 3-CYANO-4-METHYLPHENYLBORONIC ACID; 3-CYANO-4-PROPOXYPHENYLBORONIC ACID; 3-CYANO-5-(PROP-1-YNYL)PHENYLBORONIC ACID; 3-CYANO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-CYANO-5-FLUOROPHENYLBORONIC ACID; 3-CYANO-5-HYDROXYPHENYLBORONIC ACID; 3-CYANO-5-METHOXYPHENYLBORONIC ACID; 3-CYANO-5-METHYLPHENYLBORONIC ACID; 3-CYANO-5-NITROPHENYLBORONIC ACID; 3′-CYANOBIPHENYL-3-YLBORONIC ACID; 3-CYANOMETHOXYPHENYLBORONIC ACID; 3-CYANOMETHYLPHENYLBORONIC ACID; 3-CYANOPHENYLBORONIC ACID; 3-CYANOPYRAZIN-2-YLBORONIC ACID; 3-CYANOPYRIDINE-2-BORONIC ACID; 3-CYANOPYRIDINE-4-BORONIC ACID; 3-CYANOTHIOPHEN-2-YLBORONIC ACID; 3-CYCLOBUTYLPHENYLBORONIC ACID; 3-CYCLOPROPOXYPHENYLBORONIC ACID; 3-CYCLOPROPYLL-1H-PYRAZOLE-5-BORONIC ACID; 3-CYCLOPROPYLPHENYLBORONIC ACID; 3-CYCLOPROPYLPYRIDIN-4-YLBORONIC ACID; 3-DIFLUOROMETHOXY-4-FLUORO-BENZENEBORONIC ACID; 3-DIFLUOROMETHOXY-4-METHYL-BENZENEBORONIC ACID; 3-DIFLUOROMETHYL-PHENYLBORONIC ACID; 3-DIMETHYLAMINOPHENYLBORONIC ACID HCL; 3-ETHOXY-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-ETHOXY-2-FLUOROPHENYLBORONIC ACID; 3-ETHOXY-4-FLUOROPHENYLBORONIC ACID; 3-ETHOXY-4-METHOXYPHENYLBORONIC ACID; 3-ETHOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-ETHOXY-5-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 3-ETHOXY-5-AMINOPYRIDINE-4-BORONIC ACID; 3-ETHOXY-5-FLUOROPHENYLBORONIC ACID; 3-ETHOXY-5-METHYLPHENYLBORONIC ACID; 3-ETHOXY-5-METHYLPYRIDINE-4-BORONIC ACID; 3-ETHOXYCARBONYL-4-FLUOROPHENYLBORONIC ACID; 3-ETHOXYCARBONYLMETHYLPHENYLBORONIC ACID; 3-ETHOXYCARBONYLPHENYLBORONIC ACID; 3-ETHOXYNAPHTHALEN-2-YLBORONIC ACID; 3-ETHOXYPHENYLBORONIC ACID; 3-ETHOXYPYRIDINE-4-BORONIC ACID; 3-ETHYLAMINOPHENYLBORONIC ACID; 3-ETHYLFURAN-2-BORONIC ACID; 3-ETHYLPHENYLBORONIC ACID; 3-ETHYLSULFINYLPHENYLBORONIC ACID; 3-ETHYLSULFONYLPHENYLBORONIC ACID; 3-ETHYLTHIOPHENE-2-BORONIC ACID; 3-ETHYLTHIOPHENYLBORONIC ACID; 3-FLUORO-1H-PYRROLO[2,3-B]PYRIDIN-5-YLBORONIC ACID; 3-FLUORO-1-METHYL-1H-PYRROLE-2-BORONIC ACID; 3-FLUORO-2-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 3-FLUORO-2-(METHYLTHIOMETHOXY)PHENYLBORONIC ACID; 3-FLUORO-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-FLUORO-2-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 3-FLUORO-2-HYDROXYPHENYLBORONIC ACID; 3-FLUORO-2-HYDROXYPYRIDINE-4-BORONIC ACID; 3-FLUORO-2-METHOXY-5-(METHYLTHIO)BENZENEBORONIC ACID; 3-FLUORO-2-METHOXYPHENYLBORONIC ACID; 3-FLUORO-2-METHOXYPYRIDINE-4-BORONIC ACID; 3-FLUORO-2-METHOXYPYRIDINE-5-BORONIC ACID; 3-FLUORO-2-METHYLPHENYLBORONIC ACID; 3-FLUORO-2-METHYLPYRIDINE-4-BORONIC ACID; 3-FLUORO-2-MORPHOLINOPYRIDINE-4-BORONIC ACID; 3-FLUORO-4-((4-METHOXYBENZYLOXY)CARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-FLUORO-4-(2,2,2-TRIFLUOROETHOXY)PHENYLBORONIC ACID; 3-FLUORO-4-(2-HYDROXYETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-4-(4-METHOXYBENZYLTHIO)PHENYLBORONIC ACID; 3-FLUORO-4-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 3-FLUORO-4-(ISOPROPYLCARBAMOYL)BENZENEBORONIC ACID; 3-FLUORO-4-(METHOXY(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-4-(METHOXYCARBAMOYL)BENZENEBORONIC ACID; 3-FLUORO-4-(METHOXYMETHOXY)PHENYLBORONIC ACID; 3-FLUORO-4-(METHYLCARBAMOYL)BENZENEBORONIC ACID; 3-FLUORO-4-(METHYLSULFONYL)PHENYLBORONIC ACID; 3-FLUORO-4-(METHYLTHIO)PHENYLBORONIC ACID; 3-FLUORO-4-(PHENYLCARBAMOYL)BENZENEBORONIC ACID; 3-FLUORO-4-(PIPERIDIN-1-YLCARBONYL)BENZENEBORONIC ACID; 3-FLUORO-4-(PROPYLCARBAMOYL)BENZENEBORONIC ACID; 3-FLUORO-4-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-FLUORO-4-(THIOPHEN-2-YLMETHOXYMETHYL)PHENYLBORONIC ACID; 3-FLUORO-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-FLUORO-4-BIPHENYLBORONIC ACID; 3-FLUORO-4′-HEPTYLBIPHENYL-4-BORONIC ACID; 3-FLUORO-4-HYDRAZINOCARBONYLPHENYLBORONIC ACID; 3-FLUORO-4-HYDROXYPHENYLBORONIC ACID; 3-FLUORO-4-ISOPROPOXYPHENYLBORONIC ACID; 3-FLUORO-4-METHOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 3-FLUORO-4-METHOXYCARBONYLPHENYLBORONIC ACID; 3-FLUORO-4-METHOXYPHENYLBORONIC ACID; 3-FLUORO-4-METHYLPHENYLBORONIC ACID; 3-FLUORO-4-MORPHOLINOPHENYLBORONIC ACID; 3-FLUORO-4-N-METHYL, N-ETHYLAMIDYL PHENYLBORONIC ACID; 3-FLUORO-4′-PENTYLBIPHENYL-4-BORONIC ACID; 3-FLUORO-4-PROPOXYPHENYLBORONIC ACID; 3-FLUORO-4-TRIFLUOROMETHYL-PHENYLBORONIC ACID; 3-FLUORO-5-(2,2,2-TRIFLUOROETHOXY)BENZENEBORONIC ACID; 3-FLUORO-5-(DIETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-5-(ETHOXY-D5)-PHENYLBORONIC ACID; 3-FLUORO-5-(ETHYL-D5)-PHENYLBORONIC ACID; 3-FLUORO-5-(HYDRAZINECARBONYL)PHENYLBORONIC ACID; 3-FLUORO-5-(ISO-PROPOXY-D7)-PHENYLBORONIC ACID; 3-FLUORO-5-(ISO-PROPYL-D7)-PHENYLBORONIC ACID; 3-FLUORO-5-(METHOXY-D3)-PHENYLBORONIC ACID; 3-FLUORO-5-(METHYLCARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-5-(MORPHOLIN-4-YLCARBONYL)BENZENEBORONIC ACID; 3-FLUORO-5-(PIPERIDIN-1-YLCARBONYL)BENZENEBORONIC ACID; 3-FLUORO-5-(PROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-5-ETHOXYCARBONYLPHENYLBORONIC ACID; 3-FLUORO-5-HYDROXYPHENYLBORONIC ACID; 3-FLUORO-5-HYDROXYPYRIDINE-2-BORONIC ACID; 3-FLUORO-5-ISOBUTOXYPHENYLBORONIC ACID; 3-FLUORO-5-ISOPROPOXYPHENYLBORONIC ACID; 3-FLUORO-5-METHOXYPHENYLBORONIC ACID; 3-FLUORO-5-METHOXYPYRIDINE-2-BORONIC ACID; 3-FLUORO-5-METHYLPHENYLBORONIC ACID; 3-FLUORO-5-METHYLPYRIDINE-4-BORONIC ACID; 3-FLUORO-5-MORPHOLINOPHENYLBORONIC ACID; 3-FLUORO-5-PYRROLIDINOPHENYLBORONIC ACID; 3-FLUORO-5-VINYLPHENYLBORONIC ACID; 3-FLUOROBENZYLBORONIC ACID; 3′-FLUORO-BIPHENYL-4-BORONIC ACID; 3-FLUOROISOQUINOLIN-7-YLBORONIC ACID; 3-FLUOROPHENYLBORONIC ACID; 3-FLUOROPYRIDINE-2-BORONIC ACID; 3-FLUOROPYRIDINE-4-BORONIC ACID; 3-FLUOROPYRIDINE-4-BORONIC ACID HYDRATE; 3-HEXYLTHIOPHENE-2-BORONIC ACID; 3-HYDROXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-HYDROXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-HYDROXY-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-HYDROXY-2-METHOXYPHENYLBORONIC ACID; 3-HYDROXY-2-METHYLPHENYLBORONIC ACID; 3-HYDROXY-2-METHYLPYRIDINE-4-BORONIC ACID; 3-HYDROXY-4-(METHOXYCARBONYL)PHENYLBORONIC ACID; 3-HYDROXY-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-HYDROXY-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-HYDROXY-4-METHOXYPHENYLBORONIC ACID; 3-HYDROXY-4-METHYLPHENYLBORONIC ACID; 3-HYDROXY-4-MORPHOLINOPHENYLBORONIC ACID; 3-HYDROXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-HYDROXY-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-HYDROXY-5-METHOXYPHENYLBORONIC ACID; 3-HYDROXY-5-METHYLPHENYLBORONIC ACID; 3-HYDROXY-5-NITROPHENYLBORONIC ACID; 3-HYDROXYMETHYL-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-HYDROXYMETHYL-4-METHYLPHENYLBORONIC ACID; 3-HYDROXYMETHYLTHIOPHENE-2-BORONIC ACID; 3-HYDROXYNAPHTHALENE-1-BORONIC ACID; 3-HYDROXYNAPHTHALENE-2-BORONIC ACID; 3-HYDROXYPHENYLBORONIC ACID; 3-HYDROXYPYRAZINE-2-BORONIC ACID; 3-HYDROXYPYRIDINE-2-BORONIC ACID; 3-HYDROXYPYRIDINE-4-BORONIC ACID; 3-HYDROXYQUINOLINE-2-BORONIC ACID; 3-HYDROXYQUINOLINE-4-BORONIC ACID; 3-HYDROXYQUINOLINE-5-BORONIC ACID; 3-HYDROXYQUINOLINE-6-BORONIC ACID; 3-HYDROXYQUINOLINE-7-BORONIC ACID; 3-HYDROXYQUINOLINE-8-BORONIC ACID; 3-ISOBUTOXY-4-METHOXYPHENYLBORONIC ACID; 3-ISOBUTOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-ISOBUTOXY-5-METHYLPHENYLBORONIC ACID; 3-ISOBUTOXYPHENYLBORONIC ACID; 3-ISOPROPOXY-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-ISOPROPOXY-4-METHOXYPHENYLBORONIC ACID; 3-ISOPROPOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-ISOPROPOXY-5-METHYLPHENYLBORONIC ACID; 3-ISOPROPOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 3-ISOPROPOXYPHENYLBORONIC ACID; 3-ISOPROPROXY-4-METHYLPHENYLBORONIC ACID; 3-ISOPROPYLPHENYLBORONIC ACID; 3-ISOTHIOCYANOPHENYLBORONIC ACID; 3-MALEIMIDOPHENYL BORONIC ACID; 3-MERCAPTOPHENYLBORONIC ACID; 3-METHACRYLAMIDOPHENYLBORONIC ACID; 3-METHOXY-1-PROPENYLBORONIC ACID; 3-METHOXY-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-METHOXY-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-METHOXY-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-METHOXY-2,5-DIMETHYLPHENYLBORONIC ACID; 3-METHOXY-2-HYDROXYPHENYLBORONIC ACID; 3-METHOXY-2-METHYLPHENYLBORONIC ACID; 3-METHOXY-2-METHYLPYRIDINE-4-BORONIC ACID; 3-METHOXY-3-OXOPROP-1-EN-2-YLBORONIC ACID; 3-METHOXY-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-METHOXY-4-(PYRIDIN-3-YLMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-4-(PYRIDIN-4-YLMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-4-CARBOXYPHENYLBORONIC ACID; 3-METHOXY-4-METHOXYCARBONYLPHENYLBORONIC ACID; 3-METHOXY-4-METHYLPHENYLBORONIC ACID; 3-METHOXY-4-MORPHOLINOPHENYLBORONIC ACID; 3-METHOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-5-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 3-METHOXY-5-AMINOPYRIDINE-4-BORONIC ACID; 3-METHOXY-5-METHYLPHENYLBORONIC ACID; 3-METHOXY-5-METHYLPYRIDINE-4-BORONIC ACID; 3-METHOXY-5-PROPOXYPHENYLBORONIC ACID; 3-METHOXY-6-(4-METHOXYPHENYL)PYRIDAZIN-4-YLBORONIC ACID; 3′-METHOXY-BIPHENYL-4-BORONIC ACID; 3-METHOXYCARBONYL-5-METHYLPHENYLBORONIC ACID; 3-METHOXYCARBONYL-5-NITROPHENYLBORONIC ACID; 3-METHOXYCARBONYLPHENYLBORONIC ACID; 3-METHOXYMETHOXY-4-METHYLPHENYLBORONIC ACID; 3-METHOXYMETHYLPHENYLBORONIC ACID; 3-METHOXYNAPHTHALENE-2-BORONIC ACID; 3-METHOXYPHENYLBORONIC ACID; 3-METHOXYPYRAZINE-2-BORONIC ACID; 3-METHOXYPYRIDINE-2-BORONIC ACID; 3-METHOXYPYRIDINE-4-BORONIC ACID; 3-METHOXYPYRIDINE-4-BORONIC ACID HYDRATE; 3-METHOXYTHIOPHENE-2-BORONIC ACID; 3-METHYL-1-(TETRAHYDROPYRAN-2-YL)-1H-INDAZOLE-4-BORONIC ACID; 3-METHYL-1-BUTYLBORONIC ACID; 3-METHYL-1H-INDAZOLE-4-BORONIC ACID; 3-METHYL-1H-INDAZOLE-5-BORONIC ACID; 3-METHYL-1H-INDAZOLE-6-BORONIC ACID; 3-METHYL-1H-INDAZOLE-7-BORONIC ACID; 3-METHYL-1H-PYRAZOL-4-YLBORONIC ACID; 3-METHYL-1-PROPYL-1H-PYRAZOL-5-YLBORONIC ACID; 3-METHYL-2-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(2,4,5-TRICHLOROPHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(PERFLUOROPHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-METHYL-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-METHYL-2-BUTEN-2-YLBORONIC ACID; 3-METHYL-2-PROPOXYPYRIDINE-5-BORONIC ACID; 3-METHYL-3H-QUINAZOLIN-4-ONE-6-BORONIC ACID; 3-METHYL-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-METHYL-4-MORPHOLINOPHENYLBORONIC ACID; 3-METHYL-4-TRIFLUOROMETHOXYPHENYLBORONIC ACID; 3-METHYL-4-TRIFLUOROMETHYL-PHENYLBORONIC ACID; 3-METHYL-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-METHYL-5-NITROPYRIDIN-2-YLBORONIC ACID; 3-METHYL-5-PROPOXYPHENYLBORONIC ACID; 3-METHYLBENZO[B]THIOPHENE-2-BORONIC ACID; 3-METHYLBENZOFURAN-2-YLBORONIC ACID; 3′-METHYLBIPHENYL-2-YLBORONIC ACID; 3-METHYLFURAN-2-YLBORONIC ACID; 3-METHYLPHENYLBORONIC ACID; 3-METHYLPYRAZINE-2-BORONIC ACID; 3-METHYLPYRIDINE-2-BORONIC ACID; 3-METHYLPYRIDINE-4-BORONIC ACID; 3-METHYLSULFAMOYLPHENYLBORONIC ACID; 3-METHYLSULFINYLPHENYLBORONIC ACID; 3-METHYLTHIOPHENE-2-BORONIC ACID; 3-MORPHOLINOPHENYLBORONIC ACID HYDROCHLORIDE; 3-MORPHOLINOPYRIDINE-2-BORONIC ACID; 3-N-CYCLOHEXYLSULFAMOYLPHENYLBORONIC ACID; 3-NITRO-5-(PIPERIDIN-1-YLCARBONYL)BENZENEBORONIC ACID; 3-NITRO-5-(PYRROLIDIN-1-YLCARBONYL)BENZENEBORONIC ACID; 3-NITRO-5-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 3-NITRO-5-VINYLPHENYLBORONIC ACID; 3′-NITRO-BIPHENYL-4-BORONIC ACID; 3-NITROPHENYLBORONIC ACID; 3-NITROPYRIDINE-2-BORONIC ACID; 3-OXO-2,3-DIHYDROPYRIDAZIN-4-YLBORONIC ACID; 3-OXO-6-(TRIFLUOROMETHYL)ISOINDOLIN-5-YLBORONIC ACID; 3-OXO-6-PHENYLISOINDOLIN-5-YLBORONIC ACID; 3-OXOISOINDOLIN-5-YLBORONIC ACID; 3-PHENOXYPHENYLBORONIC ACID; 3-PHENYL-1H-PYRAZOLE-5-BORONIC ACID; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-BORONIC ACID; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-BORONIC ACID; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-BORONIC ACID; 3-PHENYLISOXAZOLE-5-BORONIC ACID; 3-PHENYLPROPYLBORONIC ACID; 3-PHENYLPYRIDINE-2-BORONIC ACID; 3-PHENYLPYRIDINE-4-BORONIC ACID; 3-PHENYLTHIOPHENE-2-BORONIC ACID; 3-PICOLINE-4-BORONIC ACID HCL; 3-PICOLINE-5-BORONIC ACIDHYDRATE; 3-PROPOXY-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-PROPOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-PROPOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 3-PROPOXYPHENYLBORONIC ACID; 3-P-TOLYLISOXAZOL-5-YLBORONIC ACID; 3-PYRAZOL-1-YL-PHENYLBORONIC ACID; 3-PYRIDINECARBOXYLIC ACID-6-BORONIC ACID; 3-PYRROLIDINYLBORONIC ACID; 3-PYRROLIDINYLPYRIDINE-2-BORONIC ACID; 3-PYRROLYLBORONIC ACID; 3-QUINOLINEBORONIC ACID; 3-QUINOLINEBORONIC ACID, HCL; 3-T-BDMSTHIOPHENYLBORONIC ACID; 3-T-BUTOXYCARBOXYPHENYLBORONIC ACID; 3-T-BUTYL-5-CARBOXYPHENYLBORONIC ACID; 3-TERT-BUTOXYMETHYLPHENYLBORONIC ACID; 3-TERT-BUTYL-1H-PYRAZOLE-5-BORONIC ACID; 3-TERT-BUTYLPHENYLBORONIC ACID; 3-TRIFLUOROMETHYLBENZYLBORONIC ACID; 3′-TRIFLUOROMETHYL-BIPHENYL-4-BORONIC ACID; 3-TRIMETHYLSILYLPHENYLBORONIC ACID; 3-VINYLPHENYLBORONIC ACID; 4-((1-(TERT-BUTOXYCARBONYL)AZEPAN-3-YL)METHYL)PHENYLBORONIC ACID; 4-((1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 4-((1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 4-((1-NAPHTHYLOXY)METHYL)PHENYLBORONIC ACID; 4-((3,3-DIFLUOROPYRROLIDIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((3,3-DIMETHYLPYRROLIDIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((3-HYDROXYPYRROLIDIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((4-(TRIFLUOROMETHYL)PIPERIDIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((4H-1,2,4-TRIAZOL-3-YL)METHOXY)PHENYLBORONIC ACID; 4-((4H-1,2,4-TRIAZOL-4-YL)CARBAMOYL)PHENYLBORONIC ACID, HCL; 4-((4-METHOXYPIPERIDIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((BENZYLOXYCARBONYLAMINO)METHYL)PHENYLBORONIC ACID; 4-((DIETHYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 4-((DIMETHOXYPHOSPHORYL)METHYL)PHENYLBORONIC ACID; 4-((DIMETHYLAMINO)METHYL)PHENYLBORONIC ACID; 4-((DI-TERT-BUTOXYPHOSPHORYL)METHYL)PHENYLBORONIC ACID; 4-((N,N-DIMETHYLSULFAMOYL)METHYL)PHENYLBORONIC ACID; 4-((N-BOC-AMINO)METHYL)PHENYLBORONIC ACID; 4-((N-METHYLACETAMIDO)METHYL)PHENYLBORONIC ACID; 4-((PHENYLAMINO)METHYL)PHENYLBORONIC ACID; 4-((PYRIDIN-4-YLOXY)METHYL)PHENYLBORONIC ACID; 4-((TETRAHYDROFURAN-2-YL)METHYLCARBAMOYL)PHENYLBORONIC ACID; 4-([1,3]DIOXOLAN-2-YLMETHOXY)-PHENYLBORONIC ACID; 4-(1-(BENZYLOXYCARBONYLAMINO)CYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-(HYDROXYMETHYL)CYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-(METHOXYCARBONYL)CYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-(MORPHOLINE-4-CARBONYL)CYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YL)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YLOXY)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYLAMINO)CYCLOPROPYL)PHENYLBORONIC ACID; 4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 4-(1,3-DIOXOLAN-2-YL)-2,6-DIFLUOROPHENYLBORONIC ACID; 4-(1,3-DIOXOLAN-2-YL)-2,6-DIMETHOXYPHENYLBORONIC ACID; 4-(1-ALLYL-PIPERIDIN-2-YL)-BENZENEBORONIC ACID; 4-(1-ALLYL-PYRROLIDIN-2YL)BENZENEBORONIC ACID; 4-(1-AMINOCYCLOPROPYL)PHENYLBORONIC ACID HYDROCHLORIDE; 4-(1-AMINOETHYL)PHENYLBORONIC ACID; 4-(1-BENZYL-1H-PYRAZOL-4-YL)-2-FLUOROPHENYLBORONIC ACID; 4-(1-BENZYL-1H-PYRAZOL-4-YL)PHENYLBORONIC ACID; 4-(1-BENZYLPIPERIDIN-4-YL)PHENYLBORONIC ACID; 4-(1-BOC-PIPERIDIN-4-YLOXY)-2-METHOXYPHENYLBORONIC ACID; 4(1-BOC-PIPERIDIN-4-YLOXY)-3-METHOXYPHENYLBORONIC ACID; 4-(1-BOC-PIPERIDIN-4-YLOXY)PHENYLBORONIC ACID; 4-(1-BOC-PYRROLIDIN-2-YL)BENZENEBORONIC ACID; 4-(1-BOC-PYRROLIDIN-3-YLOXY)PHENYLBORONIC ACID; 4-(1-CARBAMOYLCYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-CARBOXYCYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-CYANOCYCLOPROPYL)PHENYLBORONIC ACID; 4-(1H-1,2,3-TRIAZOL-4-YL)PHENYLBORONIC ACID; 4-(1H-IMIDAZOL-1-YL)PHENYLBORONIC ACID; 4-(1H-PYRAZOL-1-YLSULFONYL)PHENYLBORONIC ACID; 4-(1H-PYRROL-1-YL)PHENYLBORONIC ACID; 4-(1H-PYRROL-1-YLSULFONYL)PHENYLBORONIC ACID; 4-(1H-TETRAZOL-5-YL)BUTYLBORONIC ACID; 4-(1H-TETRAZOL-5-YLCARBAMOYL)BENZENEBORONIC ACID HYDROCHLORIDE; 4-(1-HYDROXY-1-PHENYL)METHYLPHENYLBORONIC ACID; 4-(1-HYDROXYETHYL)PHENYLBORONIC ACID; 4-(1-METHYL-1H-IMIDAZOL-2-YL)PHENYLBORONIC ACID; 4-(1-PHENYL-1H-BENZO[D]IMIDAZOL-2-YL)PHENYLBORONIC ACID; 4-(1-PYRROLIDINYLMETHYL)PHENYLBORONIC ACID; 4-(2-(1,3-DIOXOISOINDOLIN-2-YL)ETHOXY)PHENYLBORONIC ACID; 4-(2-(1H-IMIDAZOL-1-YL)ETHOXY)PHENYLBORONIC ACID; 4-(2-(1H-PYRAZOL-1-YL)ETHOXY)PHENYLBORONIC ACID; 4-(2-(BENZYLOXYCARBONYLAMINO)ETHYL)PHENYLBORONIC ACID; 4-(2-(DIETHYLAMINO)ETHYLCARBAMOYL)PHENYLBORONIC ACID, HCL; 4-(2-(DIMETHYLAMINO)-2-OXOETHYL)PHENYLBORONIC ACID; 4-(2-(DIMETHYLAMINO)ETHOXY)-3-METHOXYPHENYLBORONIC ACID; 4-(2-(DIMETHYLAMINO)ETHYLCARBAMOYL)PHENYLBORONIC ACID, HCL; 4-(2-(DIMETHYLAMINO)ETHYLSULFONYL)PHENYLBORONIC ACID; 4-(2-(METHYLAMINO)-2-OXOETHOXY)PHENYLBORONIC ACID; 4-(2-(METHYLAMINO)-2-OXOETHYL)PHENYLBORONIC ACID; 4-(2-(METHYLAMINO)ACETAMIDO)PHENYLBORONIC ACID; 4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYLBORONIC ACID; 4-(2-(T-BUTOXYCARBONYLAMINO)ETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-(2,2,2-TRIFLUOROACETAMIDO)NAPHTHALEN-1-YLBORONIC ACID; 4-(2,2,2-TRIFLUOROETHOXY)PHENYLBORONIC ACID; 4-(2,2,2-TRIFLUOROETHYLAMINOCARBONYL)BENZENEBORONIC ACID; 4-(2,2-DIFLUOROETHOXY)PHENYLBORONIC ACID; 4-(2,2-DIMETHOXYETHOXY)PHENYLBORONIC ACID; 4-(2,2-DIMETHYLPROPANOYL)-4H-1,4-BENZOXAZIN-3-YLBORONIC ACID; 4-(2,2-DIPHENYLVINYL)PHENYLBORONIC ACID; 4-(2,4-DIFLUOROPHENOXY)PHENYLBORONIC ACID; 4-(2,4-DIOXOIMIDAZOLIDIN-5-YL)PHENYBORONIC ACID; 4-(2,5-DIMETHYL-1H-PYRROL-1-YL)PHENYLBORONIC ACID; 4-(2,6-DICHLOROPHENYLMETHOXY)PHENYLBORONIC ACID; 4-(2-ACETAMIDOETHOXY)PHENYLBORONIC ACID; 4-(2-ACETAMIDOETHYL)PHENYLBORONIC ACID; 4-(2-AMINOPHENOXY)PHENYLBORONIC ACID, HCL; 4-(2-CARBOXYETHYL)PHENYLBORONIC ACID; 4-(2-CARBOXYVINYL)BENZENEBORONIC ACID; 4-(2′-CHLOROBENZYLOXY)-3,5-DIMETHYLPHENYLBORONIC ACID; 4-(2-CHLOROETHOXY)PHENYLBORONIC ACID; 4-(2-CHLOROETHYLCARBAMOYL)BENZENEBORONIC ACID; 4-(2-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 4-(2-CYANOETHYL)PHENYLBORONIC ACID; 4-(2-CYANOETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(2-CYANOVINYL)PHENYLBORONIC ACID; 4-(2-ETHOXY-2-OXOETHOXY)BENZENEBORONIC ACID; 4-(2-ETHOXY-2-OXOETHYLTHIO)PHENYLBORONIC ACID; 4-(2′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 4-(2-FLUOROETHOXY)PHENYLBORONIC ACID; 4-(2-FLUOROPHENOXY)PHENYLBORONIC ACID; 4-(2-FLUOROPHENYL)FURAN-2-BORONIC ACID; 4-(2-FLUOROPHENYL)THIOPHENE-2-BORONIC ACID; 4-(2-FURYL)PYRIDINE-2-BORONIC ACID; 4-(2H-TETRAZOL-5-YL)-PHENYLBORONIC ACID; 4-(2-HYDROXYETHOXY)-3-METHOXYPHENYLBORONIC ACID; 4-(2-HYDROXYETHYL)PHENYLBORONIC ACID; 4-(2-HYDROXYETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-(2-HYDROXYPROPAN-2-YL)PYRIDINE-2-BORONIC ACID; 4-(2-HYDROXYPROPAN-2-YL)PYRIDINE-3-BORONIC ACID; 4-(2-METHOXY-2-OXOETHOXY)PHENYLBORONIC ACID; 4-(2-METHOXY-2-OXOETHYL)-2-METHYLPHENYLBORONIC ACID; 4-(2′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 4-(2-METHOXYCARBONYLETHYL)PHENYLBORONIC ACID; 4-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 4-(2-METHOXYETHYL)PHENYLBORONIC ACID; 4-(2-METHOXYETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-(2-METHOXYPHENYL)FURAN-2-BORONIC ACID; 4-(2-METHOXYPHENYL)THIOPHENE-2-BORONIC ACID; 4-(2-METHYL-1,3-DIOXOLAN-2-YL)PHENYLBORONIC ACID; 4-(2-METHYLTHIAZOL-5-YL)PHENYLBORONIC ACID; 4-(2-MORPHOLINOETHOXY)PHENYLBORONIC ACID, HCL; 4-(2-MORPHOLINOETHYL)PHENYLBORONIC ACID; 4-(2-MORPHOLINOETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-(2-NITRO-4-(TRIFLUOROMETHYL)PHENOXY)PHENYLBORONIC ACID; 4-(2-NITROETHYL)PHENYLBORONIC ACID; 4-(2-NITROPHENOXY)BENZENEBORONIC ACID; 4-(2-O-THP-HYDROXY-ETHYL)-PHENYL-BORONIC ACID; 4-(2-OXO-2-(PROPYLAMINO)ETHYL)PHENYLBORONIC ACID; 4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYLBORONIC ACID; 4-(2-OXOPYRROLIDIN-1-YL)PHENYLBORONIC ACID; 4-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)PHENYLBORONIC ACID; 4-(2-PYRIDYL)PHENYLBORONIC ACID; 4-(2-TETRAHYDROPYRANYLOXY)PHENYLBORONIC ACID; 4-(2-THIAZOLYL)AMINOCARBONYLPHENYLBORONIC ACID; 4-(2-THIAZOLYL)THIOPHENE-2-BORONIC ACID; 4-(2-THIENYL)PHENYLBORONIC ACID; 4-(2-THIENYL)PYRIDINE-2-BORONIC ACID; 4-(2-TOLYL)FURAN-2-BORONIC ACID; 4-(2-TOLYL)THIOPHENE-2-BORONIC ACID; 4-(3-(2-ACETYLHYDRAZINYL)-3-OXOPROPYL)PHENYLBORONIC ACID; 4-(3-(DIMETHYLAMINO)PHENOXY)PHENYLBORONIC ACID; 4-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(3′-(TRIFLUOROMETHYL)PHENOXYMETHYL)PHENYLBORONIC ACID; 4-(3,3-DIETHOXYPROPOXY)PHENYLBORONIC ACID; 4-(3,4,4-TRIFLUORO-BUT-3-EN-1-YL-OXY)-PHENYLBORONIC ACID; 4-(3,5-DIMETHOXYBENZYLOXY)PHENYLBORONIC ACID; 4-(3,7-DIMETHYLOCTYLOXY)BENZENEBORONIC ACID; 4-(3-CHLOROBENZYLAMINO)PHENYLBORONIC ACID; 4-(3′-CHLOROBENZYLOXY)-3,5-DIMETHYLPHENYLBORONIC ACID; 4-(3-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 4-(3-CHLOROPHENOXY)-3-METHOXYPHENYLBORONIC ACID; 4-(3-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 4-(3-CHLOROPROPYLCARBAMOYL)BENZENEBORONIC ACID; 4-(3-ETHYLUREIDO)-3-METHOXYPHENYLBORONIC ACID; 4-(3-ETHYLUREIDO)PHENYLBORONIC ACID; 4-(3′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 4-(3-FLUOROPHENOXY)-2-METHYLPHENYLBORONIC ACID; 4-(3-FLUOROPHENOXY)-2-NITROPHENYLBORONIC ACID; 4-(3-FLUOROPHENYL)FURAN-2-BORONIC ACID; 4-(3-FLUOROPHENYL)THIOPHENE-2-BORONIC ACID; 4-(3-FLUOROPHENYLCARBAMOYL)PHENYLBORONIC ACID; 4-(3-FLUORO-PROPOXY)-BENZENEBORONIC ACID; 4-(3-HYDRAZINYL-3-OXOPROPYL)PHENYLBORONIC ACID; 4-(3-HYDROXYPROPYL)PHENYLBORONIC ACID; 4-(3-HYDROXYPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-(3-ISOPROPYL-2-OXOIMIDAZOLIDIN-1-YL)PHENYLBORONIC ACID; 4-(3-METHOXYPHENYL)FURAN-2-BORONIC ACID; 4-(3-METHOXYPHENYL)THIOPHENE-2-BORONIC ACID; 4-(3-METHOXYPROPOXY)PHENYLBORONIC ACID; 4-(3-METHOXYPROPYLCARBAMOYL)BENZENEBORONIC ACID; 4-(3-METHYL-2-OXOIMIDAZOLIDIN-1-YL)PHENYLBORONIC ACID; 4-(3-METHYL-2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)PHENYLBORONIC ACID; 4-(3-METHYLOXETAN-3-YL)METHOXYPHENYLBORONIC ACID; 4-(3-METHYLTHIOUREIDO)PHENYLBORONIC ACID; 4-(3-PROPYL-1,2,4-OXADIAZOL-5-YL)PHENYLBORONIC ACID; 4-(3-TOLYL)FURAN-2-BORONIC ACID; 4-(3-TOLYL)THIOPHENE-2-BORONIC ACID; 4-(4-(2-HYDROXYETHYL)PIPERAZINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(4′-(2-PENTYLOXY)PHENYL)PHENYLBORONIC ACID; 4-(4-(BENZYLOXY)PHENOXY)PHENYLBORONIC ACID; 4-(4-(DIMETHYLAMINO)PIPERAZIN-1-YL)PHENYLBORONIC ACID; 4-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)PHENYLBORONIC ACID; 4-(4,4,6-TRIMETHYL-1,3-DIOXAN-2-YL)PHENYLBORONIC ACID; 4-(4-BENZYLOXYPHENYL)BENZENEBORONIC ACID; 4-(4-BOC-PIPERAZINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(4-BORONOPHENOXYMETHYL)BENZONITRILE; 4-(4-BUTYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(4-CHLORO-2-FLUOROBENZYL)PHENYLBORONIC ACID; 4-(4′-CHLOROBENZYLOXY)-3,5-DIMETHYLPHENYLBORONIC ACID; 4-(4′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 4-(4-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 4-(4-CHLOROPHENYLCARBAMOYL)PHENYLBORONIC ACID; 4-(4-ETHYLCYCLOHEXYL)-2-FLUOROPHENYLBORONIC ACID; 4-(4-ETHYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(4-FLUORO-2-NITROPHENOXY)PHENYLBORONIC ACID; 4-(4′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 4-(4-FLUOROPHENYL)FURAN-2-BORONIC ACID; 4-(4-FLUOROPHENYL)PHENYLBORONIC ACID; 4-(4-FLUOROPHENYL)THIOPHENE-2-BORONIC ACID; 4-(4′-ISOPENTYLOXYPHENYL)PHENYLBORONIC ACID; 4-(4′-ISOPROPOXYPHENYL)PHENYLBORONIC ACID; 4-(4′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 4-(4-METHOXYPHENYL)FURAN-2-BORONIC ACID; 4-(4-METHOXYPHENYL)THIOPHENE-2-BORONIC ACID; 4-(4-METHOXYPIPERIDIN-1-YL)PHENYLBORONIC ACID; 4-(4-METHYLBENZYLOXY)PHENYLBORONIC ACID; 4-(4-METHYLPIPERAZIN-1-YL)PHENYLBORONIC ACID; 4-(4-METHYLPIPERAZINE-1-CARBONYL)PHENYLBORONIC ACID, HCL; 4-(4-METHYL-PIPERAZINESULFONYL)PHENYL BORONIC ACID; 4-(4-METHYLPIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(4-NITROPHENOXY)PHENYLBORONIC ACID; 4-(4-PENTYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(4-PENTYLOXYPHENYL)BENZENEBORONIC ACID; 4-(4-PENTYLPHENYL)BENZENEBORONIC ACID; 4-(4′-PROPOXYPHENYL)PHENYLBORONIC ACID; 4-(4-TOLYL)FURAN-2-BORONIC ACID; 4-(4-TOLYL)THIOPHENE-2-BORONIC ACID; 4-(5-(ETHOXYMETHYL)-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-(METHOXYMETHYL)-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-(METHYLAMINO)-1,3,4-THIADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-AMINO-1,3,4-THIADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-BENZYLOXYPYRIMID-2-YL)PHENYLBORONIC ACID; 4-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-METHYLPYRIDIN-3-YL)PHENYLBORONIC ACID; 4-(5-OXOPYRAZOLIDIN-3-YL)PHENYLBORONIC ACID; 4-(5-PENTYLOXYPYRIMID-2-YL)PHENYLBORONIC ACID; 4-(5-PENTYLOXYTHIEN-2-YL)BENZENEBORONIC ACID; 4-(5-PENTYLPYRIMID-2-YL)PHENYLBORONIC ACID; 4-(5-PENTYLTHIEN-2-YL)BENZENEBORONIC ACID; 4-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(6-METHOXYPYRIDIN-3-YL)PHENYLBORONIC ACID; 4-(9H-CARBOZOL-9-YL)PHENYLBORONIC ACID; 4-(9H-FLUOREN-9-YL)PHENYLBORONIC ACID; 4-(ACETAMIDOMETHYL)-3-METHOXYPHENYLBORONIC ACID; 4-(ACETOXYMETHYL)BENZENEBORONIC ACID; 4-(AMINOMETHYL)-3-FLUOROPHENYLBORONIC ACID, HCL; 4-(AMINOMETHYL)BENZENEBORONIC ACID; 4-(AZIRIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(BENZYL(ETHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-(BENZYL(METHYL)AMINO)PHENYLBORONIC ACID; 4-(BENZYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-(BENZYLAMINO)PHENYLBORONIC ACID; 4-(BENZYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(BENZYLOXY)-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(BENZYLOXY)-2,3-DIFLUOROPHENYLBORONIC ACID; 4-(BENZYLOXY)-2-CHLOROPHENYLBORONIC ACID; 4-(BENZYLOXY)-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(BENZYLOXY)-3,5-DICHLOROPHENYLBORONIC ACID; 4-(BENZYLOXY)-3,5-DIMETHOXYPHENYLBORONIC ACID; 4-(BOC-AMINOMETHYL)PYRIDINE-3-BORONIC ACID; 4-(BUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(BUTYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(BUTYLSULFINYL)PHENYLBORONIC ACID; 4-(BUTYLSULFONAMIDO)PHENYLBORONIC ACID; 4-(BUTYLSULFONYL)PHENYLBORONIC ACID; 4-(CARBOXYMETHOXY)PHENYLBORONIC ACID; 4-(CYANOMETHYL)BENZENEBORONIC ACID; 4-(CYCLOBUTYL)FURAN-2-BORONIC ACID; 4-(CYCLOBUTYL)THIOPHENE-2-BORONIC ACID; 4-(CYCLOHEXYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-(CYCLOHEXYL)FURAN-2-BORONIC ACID; 4-(CYCLOHEXYL)THIOPHENE-2-BORONIC ACID; 4-(CYCLOHEXYLAMINO)PHENYLBORONIC ACID; 4-(CYCLOHEXYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(CYCLOHEXYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(CYCLOHEXYLMETHOXY)PHENYLBORONIC ACID; 4-(CYCLOHEXYLOXY)METHYLPHENYLBORONIC ACID; 4-(CYCLOHEXYLSULFONYL)PHENYLBORONIC ACID; 4-(CYCLOPENTYL)FURAN-2-BORONIC ACID; 4-(CYCLOPENTYL)THIOPHENE-2-BORONIC ACID; 4-(CYCLOPENTYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(CYCLOPENTYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(CYCLOPROPANECARBOXAMIDO)PHENYLBORONIC ACID; 4-(CYCLOPROPANESULFONAMIDO)PHENYLBORONIC ACID; 4-(CYCLOPROPYL)FURAN-2-BORONIC ACID; 4-(CYCLOPROPYL)PYRIDINE-2-BORONIC ACID; 4-(CYCLOPROPYL)THIOPHENE-2-BORONIC ACID; 4-(CYCLOPROPYLAMINO)PHENYLBORONIC ACID; 4-(CYCLOPROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(CYCLOPROPYLMETHOXY)-2-FLUOROPHENYLBORONIC ACID; 4-(CYCLOPROPYLMETHOXY)BENZENEBORONIC ACID; 4-(CYCLOPROPYLMETHYLSULFINYL)PHENYLBORONIC ACID; 4-(CYCLOPROPYLMETHYLSULFONYL)PHENYLBORONIC ACID; 4-(CYCLOPROPYLMETHYLTHIO)PHENYLBORONIC ACID; 4-(CYCLOPROPYLSULFINYL)PHENYLBORONIC ACID; 4-(CYCLOPROPYLSULFONYL)PHENYLBORONIC ACID; 4-(DIBENZYLAMINO)NAPHTHALEN-1-YLBORONIC ACID; 4-(DIBENZYLAMINO)PHENYLBORONIC ACID; 4-(DIETHYLAMINO)PHENYLBORONIC ACID; 4-(DIETHYLCARBAMOYL)-2-METHOXYBENZENEBORONIC ACID; 4-(DIETHYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(DIFLUOROMETHOXY)-2-FLUOROPHENYLBORONIC ACID; 4-(DIFLUOROMETHOXY)BENZOTHIAZOLE-2-BORONIC ACID; 4-(DIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-(DIFLUOROMETHYL)-3-FLUOROPHENYLBORONIC ACID; 4-(DIHYDROXYBORANYL)-2,3-DIFLUOROBENZOIC ACID; 4-(DIHYDROXYBOROPHENYL)ACETYLENE; 4-(DIHYDROXYBORYL)-2-NITROBENZOIC ACID; 4-(DIHYDROXYBORYL)-3-METHOXYBENZOIC ACID; 4-(DIISOPROPYLCARBAMOYL)-2-ETHOXYPYRIDIN-3-YLBORONIC ACID; 4-(DIISOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-(DIISOPROPYLCARBAMOYL)PYRIDIN-3-YLBORONIC ACID; 4-(DIMETHYLAMINO)-2-METHYLPHENYLBORONIC ACID; 4-(DIMETHYLAMINO)PHENYLBORONIC ACID; 4-(DIMETHYLCARBAMOYL)-2-(PROP-1-YNYL)PHENYLBORONIC ACID; 4-(DIMETHYLCARBAMOYL)-2-FLUOROPHENYLBORONIC ACID; 4-(DIMETHYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(DIPHENYLAMINO)PHENYLBORONIC ACID; 4-(DIPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(2-NITROPHENYL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(4-NITROPHENYL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(PYRAZIN-2-YL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(PYRIDIN-2-YL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(PYRIDIN-4-YL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(PYRIMIDIN-2-YL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-2-FURANBORONIC ACID; 4-(ETHOXYCARBONYLDIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(ETHOXY-D5)-PHENYLBORONIC ACID; 4-(ETHOXYMETHOXY)PHENYLBORONIC ACID; 4-(ETHOXYPHENYL-D9)-BORONIC ACID; 4-(ETHYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-(ETHYLAMINO)-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(ETHYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(ETHYL-D5)-PHENYLBORONIC ACID; 4-(ETHYLPHENYL-D9)-BORONIC ACID; 4-(ETHYLSULFONAMIDO)PHENYLBORONIC ACID; 4-(ETHYLSULFONYL)PHENYLBORONIC ACID; 4-(FURAN-2-YL)PHENYLBORONIC ACID; 4-(FURFURYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(HYDROXYIMINO)METHYLPHENYLBORONIC ACID; 4-(HYDROXYMETHYL)-3-(METHYLSULFONYL)PHENYLBORONIC ACID; 4-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 4-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 4-(HYDROXYMETHYL)PHENYLBORONIC ACID; 4-(HYDROXYMETHYL)THIOPHEN-3-YLBORONIC ACID; 4-(ISOBUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(ISOBUTYLSULFINYL)PHENYLBORONIC ACID; 4-(ISOBUTYLSULFONYL)PHENYLBORONIC ACID; 4-(ISOBUTYLTHIO)PHENYLBORONIC ACID; 4-(ISOPENTYLOXY)PHENYLBORONIC ACID; 4-(ISOPENTYLSULFINYL)PHENYLBORONIC ACID; 4-(ISOPENTYLSULFONYL)PHENYLBORONIC ACID; 4-(ISOPENTYLTHIO)PHENYLBORONIC ACID; 4-(ISOPROPOXYCARBONYL)-2-NITROPHENYLBORONIC ACID; 4-(ISOPROPOXYCARBONYLAMINO)PHENYLBORONIC ACID; 4-(ISO-PROPOXY-D7)-PHENYLBORONIC ACID; 4-(ISOPROPYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-(ISO-PROPYL)FURAN-2-BORONIC ACID; 4-(ISO-PROPYL)PYRIDINE-2-BORONIC ACID; 4-(ISO-PROPYL)THIOPHENE-2-BORONIC ACID; 4-(ISOPROPYLAMINO)-3-METHOXYPHENYLBORONIC ACID; 4-(ISOPROPYLAMINO)-5-(METHOXYCARBONYL)THIOPHEN-2-YLBORONIC ACID; 4-(ISOPROPYLAMINO)PHENYLBORONIC ACID; 4-(ISO-PROPYL-D7)-PHENYLBORONIC ACID; 4-(ISO-PROPYLPHENYL-D11)-BORONIC ACID; 4-(ISOPROPYLSULFONYLPHENYL)BORONIC ACID; 4-(METHANESULFINYL)BENZENEBORONIC ACID; 4-(METHANESULFONYLAMINO)PHENYLBORONIC ACID; 4-(METHOXYCARBONYL)-1H-INDOL-2-YLBORONIC ACID; 4-(METHOXYCARBONYL)-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-(METHOXYCARBONYL)-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4′-(METHOXYCARBONYL)BIPHENYL-4-YLBORONIC ACID; 4-(METHOXYCARBONYL)NAPHTHALENE-1-BORONIC ACID; 4-(METHOXYCARBONYL)PYRIDINE-3-BORONIC ACID; 4-(METHOXYCARBONYLAMINO)BENZENEBORONIC ACID; 4-(METHOXY-D3)-PHENYL-BORONIC ACID; 4-(METHOXYMETHOXY)-3,5-DIMETHYLPHENYLBORONIC ACID; 4-(METHOXYMETHOXY)PHENYLBORONIC ACID; 4-(METHOXYMETHYL)-2,6-DIMETHYLPHENYLBORONIC ACID; 4-(METHOXYMETHYL)PHENYLBORONIC ACID; 4-(METHOXYMETHYLTHIO)PHENYLBORONIC ACID; 4-(METHOXYPHENYL-D7)-BORONIC ACID; 4-(METHYL-D3)-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(METHYL-D3)-PHENYLBORONIC ACID; 4-(METHYLSULFONYL)-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(METHYLSULFONYL)PHENYLBORONIC ACID; 4-(METHYLSULFONYLOXY)PHENYLBORONIC ACID; 4-(METHYLTHIO)-1-(PHENYLSULFONYL)-1H-INDOL-2-YLBORONIC ACID; 4-(METHYLTHIO)-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(METHYLTHIO)PHENYLBORONIC ACID; 4-(METHYLTHIOL-D3)-PHENYLBORONIC ACID; 4-(MORPHOLIN-1-YL)PHENYLBORONIC ACID HCL; 4-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 4-(MORPHOLINOMETHYL)PHENYLBORONIC ACID; 4-(MORPHOLINOSULFONYL)PHENYLBORONIC ACID; 4-(N-(1-METHYLPIPERIDIN-4-YL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(2-(TBDMSO)ETHYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(3-CHLORO-2-METHYLPHENYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(3-CHLOROPHENYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(3-CHLOROPROPYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(3-METHYLBUTANOYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(4-FLUORO-3-METHOXYPHENYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(4-HYDROXYCYCLOHEXYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(TERT-BUTOXYCARBONYL)METHYLSULFONAMIDO)PHENYLBORONIC ACID; 4-(N,N-BIS(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N,N-DIETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N,N-DIETHYLAMINOMETHYL)BENZENEBORONIC ACID; 4-(N,N-DIETHYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 4-(N,N-DIMETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N,N-DIMETHYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 4-(N,N-DIMETHYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N,O-DIMETHYLHYDROXYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N-ACETYLSULFAMOYL)PHENYLBORONIC ACID; 4-(NAPHTHALEN-1-YL)PHENYLBORONIC ACID; 4-(NAPHTHALEN-2-YL)PHENYLBORONIC ACID; 4-(NAPHTHALENE-1-YL)-1-NAPHTHALENE BORONIC ACID; 4-(N-BENZYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N-BENZYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-BENZYLSULPHONAMIDO)BENZENEBORONIC ACID; 4-(N-BUTOXYCARBONYL)AMINOPHENYLBORONIC ACID; 4-(N-BUTYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-BUTYLSULPHONAMIDO)BENZENEBORONIC ACID; 4-(N-CYCLOHEXYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-CYCLOHEXYL-N-METHYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-CYCLOHEXYLSULPHONAMIDO)BENZENEBORONIC ACID; 4-(N-CYCLOPENTYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-CYCLOPROPYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 4-(N-CYCLOPROPYLSULFAMOYL)PHENYLBORONIC ACID; 4-(NEOPENTYLOXY)PHENYLBORONIC ACID; 4-(NEOPENTYLOXYSULFONYL)PHENYLBORONIC ACID; 4-(N-ETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N-ETHYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 4-(N-ETHYLSULPHONAMIDO)BENZENEBORONIC ACID; 4-(N′-HYDROXYCARBAMIMIDOYL)BENZENEBORONIC ACID; 4-(N-ISOBUTYRYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-ISOPROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N-ISOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-ISOPROPYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 4-(N-ISOPROPYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-METHYLAMINOCARBONYL)-2-FLUOROPHENYLBORONIC ACID; 4-(N-METHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N-METHYL-N-(1-METHYLPIPERIDIN-4-YL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-METHYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-METHYLSULFAMOYLMETHYL)PHENYLBORONIC ACID; 4-(N-NAPHTHALEN-1-YLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-NONYLOXY)BENZENEBORONIC ACID; 4-(N-OCTYL)BENZENEBORONIC ACID; 4-(N-PIPERIDIN-4-YLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-PROPIONYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-PROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(O-METHYLHYDROXYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(OXAZOL-5-YL)PHENYLBORONIC ACID; 4-(PENTAN-3-YLOXY)PHENYLBORONIC ACID; 4-(PHENETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-(PHENOXYMETHYL)PHENYLBORONIC ACID; 4-(PIPERIDIN-1-YLMETHYL)PHENYLBORONIC ACID; 4-(PIPERIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 4-(PIPERIDIN-4-YLSULFONYL)PHENYLBORONIC ACID; 4-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(PIPERIDINO)PHENYLBORONIC ACID; 4-(PIPERIDINO)PHENYLBORONIC ACID HCL; 4-(PROP-1-YNYL)PYRIDIN-3-YLBORONIC ACID; 4-(PROP-2-YNYL)PHENYLBORONIC ACID; 4-(PROPYLSULFONYL)PHENYLBORONIC ACID; 4-(PYRIDIN-2-YL-AMINOCARBONYL)BENZENEBORONIC ACID; 4-(PYRIDIN-2-YLMETHOXY)PHENYLBORONIC ACID; 4-(PYRIDIN-2-YLOXY)PHENYLBORONIC ACID; 4-(PYRIDIN-3-YLMETHOXY)PHENYLBORONIC ACID; 4-(PYRIDIN-4-YL)PHENYL BORONIC ACID; 4-(PYRIDIN-4-YLAMINO)PHENYLBORONIC ACID; 4-(PYRIDIN-4-YLMETHOXY)PHENYLBORONIC ACID; 4-(PYRIDIN-4-YLOXY)PHENYLBORONIC ACID; 4-(PYRIDINE-3-YL)PHENYLBORONIC ACID; 4-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(PYRROLIDINO)PHENYLBORONIC ACID HCL; 4-(PYRROLIDINYLSULFONYL)PHENYLBORONIC ACID; 4-(T-BOC-(PHENYL)AMINO)PHENYLBORONIC ACID; 4-(TERT-BUTOXY)PYRIDINE-2-BORONIC ACID; 4-(TERT-BUTOXYCARBONYL)-2,3,4,5-TETRAHYDROBENZO[F][1,4]OXAZEPIN-7-YLBORONIC ACID; 4-(TERT-BUTOXYCARBONYL)-3-METHYLPHENYLBORONIC ACID; 4-(TERT-BUTOXYCARBONYL)PHENYLBORONIC ACID; 4-(TERT-BUTOXYCARBONYLAMINO)-2,6-DIMETHYLPHENYLBORONIC ACID; 4-(TERT-BUTOXYCARBONYL-ISOPROPYLAMINO)-BENZENEBORONIC ACID; 4(TERT-BUTOXYCARBONYL-N-METHYLAMINO)-PHENYLBORONIC ACID; 4-(TERT-BUTYL)PYRIDINE-2-BORONIC ACID; 4-(TERT-BUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(TERT-BUTYLAMINOSULPHONYL)BENZENEBORONIC ACID; 4-(TERT-BUTYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(TERT-BUTYLDIMETHYLSILYLOXY)-2-(PROP-1-YNYL)PHENYLBORONIC ACID; 4-(TERT-BUTYLDIMETHYLSILYLOXY)-3,5-DICHLOROPHENYLBORONIC ACID; 4-(TERT-BUTYLDIMETHYLSILYLOXY)-3-METHOXYPHENYLBORONIC ACID; 4-(TERT-BUTYLDIMETHYLSILYLOXY)CYCLOHEX-1-ENYLBORONIC ACID; 4-(TERT-BUTYLDIMETHYLSILYLOXY)PHENYLBORONIC ACID; 4-(TERT-BUTYLTHIO)PHENYLBORONIC ACID; 4-(TETRAHYDRO-2H-PYRAN-2-YL)METHOXYPHENYLBORONIC ACID; 4-(TETRAHYDRO-2H-PYRAN-2-YLSULFANYL)PHENYLBORONIC ACID; 4-(TETRAHYDRO-2H-PYRAN-4-YL)METHOXYPHENYLBORONIC ACID; 4-(TETRAHYDROPYRAN-4-YLOXYMETHY)PHENYLBORONIC ACID; 4-(TETRAZOL-5-YL)PHENYLBORONIC ACID; 4-(THIAZOL-2-YL)FURAN-2-BORONIC ACID; 4-(THIAZOLINE-3-CARBONYL)PHENYLBORONIC ACID; 4-(THIOMORPHOLIN-4-YLCARBONYL)BENZENEBORONIC ACID; 4-(THIOMORPHOLINYLSULFONYL)PHENYLBORONIC ACID; 4-(THIOPHEN-2-YLCARBAMOYL)PHENYLBORONIC ACID; 4-(TOLYL-D7)-BORONIC ACID; 4-(TRANS-4-BUTYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(TRANS-4-ETHYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(TRANS-4-HYDROXYCYCLOHEXYLCARBAMOYL)PHENYLBORONIC ACID; 4-(TRANS-4-PENTYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)-2-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-(TRIFLUOROMETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-(TRIFLUOROMETHYL)-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-(TRIFLUOROMETHYL)-2-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)-2-FURANBORONIC ACID; 4-(TRIFLUOROMETHYL)-2-THIOPHENEBORONIC ACID; 4′-(TRIFLUOROMETHYL)-4-BIPHENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)CYCLOHEX-1-ENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)PYRIDINE-2-BORONIC ACID; 4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID HYDRATE; 4-(TRIFLUOROMETHYL)PYRIMIDINE-5-BORONIC ACID; 4-(TRIFLUOROMETHYLTHIO)-BENZENEBORONIC ACID; 4-(TRIFLUOROVINYLOXYPHENYL)BORONIC ACID; 4-(TRIISOPROPYLSILYLOXY)PHENYL BORONIC ACID; 4-(TRIMETHYLAMMONIUM)METHYLPHENYLBORONIC ACID BROMIDE SALT; 4-(TRIMETHYLAMMONIUM)METHYLPHENYLBORONIC ACID IODIDE SALT; 4-(TRIMETHYLSILYL)THIOPHEN-2-YLBORONIC ACID; 4,4-DIMETHYL-2-OXO-2,4-DIHYDRO-1H-BENZO[D][1,3]OXAZIN-6-YLBORONIC ACID; 4,4-DIMETHYLCYCLOHEXEN-1-YLBORONIC ACID; 4,5,6,7-TETRAHYDRO-3-PYRAZOLO[1,5-A]PYRIDINE BORONIC ACID; 4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDIN-2-YL BORONIC ACID; 4,5-BIS(BENZYLOXY)-2-CHLOROPHENYLBORONIC ACID; 4,5-DICHLORO-2-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 4,5-DICHLORO-2-METHOXYPHENYLBORONIC ACID; 4,5-DICHLOROPYRIDINE-3-BORONIC ACID; 4,5-DICHLOROTHIOPHEN-2-YLBORONIC ACID; 4,5-DIFLUORO-2-ETHOXYPHENYLBORONIC ACID; 4,5-DIFLUORO-2-ISOPROPOXYPHENYLBORONIC ACID; 4,5-DIFLUORO-2-METHOXYPHENYLBORONIC ACID; 4,5-DIFLUORO-2-METHYLPHENYLBORONIC ACID; 4,5-DIFLUORO-2-NITROPHENYLBORONIC ACID; 4,5-DIMETHOXY-2-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4,5-DIMETHYLPYRIDINE-2-BORONIC ACID; 4,5-DIMETHYLPYRIDINE-3-BORONIC ACID; 4,6-DICHLORO-PYRIDINE-2-BORONIC ACID; 4,6-DICHLOROPYRIDINE-3-BORONIC ACID; 4,6-DICHLOROPYRIMIDIN-2-YLBORONIC ACID; 4,6-DIMETHOXYBENZOFURAN-2-YLBORONIC ACID; 4,6-DIMETHOXYPYRIDINE-3-BORONIC ACID; 4,6-DIMETHOXYPYRIMIDIN-5-YLBORONIC ACID; 4,6-DIMETHYLPYRIDINE-2-BORONIC ACID; 4,6-DIMETHYLPYRIDINE-3-BORONIC ACID; 4-[(1,1-DIMETHYLETHOXY)CARBONYL]PHENYLMETHYL)AMINOPHENYLBORONIC ACID; 4-[(2,3-DIFLUOROPHENYL)METHOXY]PHENYLBORONIC ACID; 4-[(2,3-DIMETHYLPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(2,4-DIMETHYLPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(2,5-DIMETHYLPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(2′,6′-DIISOPROPYLPHENOXY)METHYL]PHENYLBORONIC ACID; 4-[(2-CHLORO-4-METHYLPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(2′-CHLORO-5′-(TRIFLUOROMETHYL)PHENOXY)METHYL]PHENYLBORONIC ACID; 4-[(2-FLUOROPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(2-HYDROXYETHYL)THIO]PHENYLBORONIC ACID; 4-[(2-ISOPROPYL-5-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 4-[(2-PIPERIDIN-1-YLETHYL)CARBAMOYL]BENZENEBORONIC ACID HYDROCHLORIDE; 4-[(2-PYRROLIDIN-1-YLETHYL)CARBAMOYL]BENZENEBORONIC ACID HYDROCHLORIDE; 4-[(3-CHLORO-4-METHYLPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(3-ETHOXY-3-OXOPROPYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(4′-(2-METHOXYETHYL)PHENOXY)METHYL]PHENYLBORONIC ACID; 4-[(4′-CHLORO-1-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 4-[(4-FLUOROPHENYL)AMINOCARBONYL]BENZENEBORONIC ACID; 4-[(4-METHOXYBENZYL)SULPHAMOYL]BENZENEBORONIC ACID; 4-[(4-TERT-BUTYL-2-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 4-[(BENZYLOXY)METHYL]PYRIDINE-2-BORONIC ACID; 4-[(FURAN-2-YLMETHOXY)METHYL]PHENYLBORONIC ACID; 4-[(METHYLSULFONYL)METHYL]PHENYLBORONIC ACID; 4-[(THIEN-2-YLMETHOXY)METHYL]BENZENEBORONIC ACID; 4-[4′-(3-PENTYLOXY)PHENYL]PHENYLBORONIC ACID; 4-[4′-(TRIFLUOROMETHOXY)PHENOXYMETHYL]PHENYLBORONIC ACID; 4-[5-(4-DIMETHYLAMINOPHENYL)OXAZOL-2-YL]PHENYLBORONIC ACID; 4-[N-CYCLOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL]PHENYLBORONIC ACID; 4-[N-ETHYL-N-(4-METHOXYBENZYL)SULPHAMOYL]BENZENEBORONIC ACID; 4-[TERT-BUTYL(4-METHOXYBENZYL)SULPHAMOYL]BENZENEBORONIC ACID; 4-ACETAMIDO-2-CYANOPHENYLBORONIC ACID; 4-ACETAMIDO-2-METHYLPHENYLBORONIC ACID; 4-ACETAMIDO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-ACETAMIDO-3-CYANOPHENYLBORONIC ACID; 4-ACETAMIDO-3-METHOXYPHENYLBORONIC ACID; 4-ACETAMIDOPHENYLBORONIC ACID; 4-ACETOXY-3-NITROPHENYLBORONIC ACID; 4-ACETOXYBENZENEBORONIC ACID; 4-ALLYLOXY PHENYL BORONIC ACID; 4-AMINO-3-CYANO-2-(TRIFLUOROMETHYL)QUINOLIN-6-YLBORONIC ACID; 4-AMINO-3-FLUOROBENZENEBORONIC ACID, N-CBZ PROTECTED; 4-AMINO-3-FLUOROPHENYLBORONIC ACID; 4-AMINO-3-FLUOROPHENYLBORONIC ACID HYDROCHLORIDE; 4-AMINO-3-NITROPHENYLBORONIC ACID; 4-AMINO-6-METHOXYPYRIDIN-2-YLBORONIC ACID; 4-AMINO-6-METHYLPYRIDINE-3-BORONIC ACID; 4-AMINOBENZYLBORONIC ACID; 4-AMINOCARBONYLPHENYLBORONIC ACID; 4-AMINOMETHYLPHENYLBORONIC ACID HYDROCHLORIDE; 4-AMINOPHENYLBORONIC ACID; 4-AMINOPHENYLBORONIC ACID HYDROCHLORIDE; 4-AMINOPYRIDIN-3-YLBORONIC ACID; 4-AMINOPYRIDINE-2-BORONIC ACID; 4-BENZAMIDOPHENYLBORONIC ACID; 4-BENZOFURANYL-BORONIC ACID; 4-BENZYLOXY-1H-INDOLE-BORONIC ACID; 4-BENZYLOXY-1-TERT-BUTOXYCARBONYLINDOLE-2-BORONIC ACID; 4-BENZYLOXY-2,5-DIMETHOXYPHENYLBORONIC ACID; 4-BENZYLOXY-2,6-DIFLUOROPHENYLBORONIC ACID; 4-BENZYLOXY-2-DIMETHYLAMINO-PYRIMIDINE-5-BORONIC ACID; 4-BENZYLOXY-2-FLUOROPHENYLBORONIC ACID; 4-BENZYLOXY-2-METHYLPHENYLBORONIC ACID; 4-BENZYLOXY-2-PIPERIDINE-1-YL-PYRIMIDINE-5-BORONIC ACID; 4-BENZYLOXY-3,5-DIFLUOROPHENYLBORONIC ACID; 4-BENZYLOXY-3,5-DIMETHYLPHENYLBORONIC ACID; 4-BENZYLOXY-3-CHLORO-5-METHYLPHENYLBORONIC ACID; 4-BENZYLOXY-3-CHLOROPHENYLBORONIC ACID; 4-BENZYLOXY-3-FLUOROPHENYLBORONIC ACID; 4-BENZYLOXY-3-METHOXYBENZENEBORONIC ACID; 4-BENZYLOXY-3-METHYLPHENYLBORONIC ACID; 4′-BENZYLOXYCARBONYLAMINO-BIPHENYL-4-BORONIC ACID; 4-BENZYLOXYCARBONYLPHENYLBORONIC ACID; 4-BENZYLOXYPHENYLBORONIC ACID; 4-BENZYLTHIOPHENYLBORONIC ACID; 4-BIPHENYLBORONIC ACID; 4′-BORONIC ACID-BIPHENYL-3-CARBOXYLIC ACID METHYL ESTER; 4-BORONO-2-(CYCLOHEXYLOXY)BENZOIC ACID; 4-BORONO-2-(TRIFLUOROMETHYL)BENZOIC ACID; 4-BORONO-2-ISOBUTYLBENZOIC ACID; 4-BORONO-3,5-DIFLUOROBENZOIC ACID; 4-BORONO-3-FLUOROTHIOANISOLE; 4-BORONO-5-FLUORO-2-METHOXYBENZOIC ACID; 4-BORONOBENZENESULFONIC ACID; 4-BORONOBENZOHYDRAZIDE; 4-BORONO-DL-PHENYLALANINE; 4-BORONO-DL-PHENYLALANINE B10 ENRICHED; 4-BORONO-D-PHENYLALANINE; 4-BORONO-D-PHENYLALANINE B10 ENRICHED; 4-BORONO-L-PHENYLALANINE; 4-BORONO-L-PHENYLALANINE B10 ENRICHED; 4-BORONONICOTINIC ACID; 4-BORONOPYRIDINE 1-OXIDE; 4-BUTOXY-2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 4-BUTOXY-2-METHYLPHENYLBORONIC ACID; 4-BUTOXY-3,5-DIMETHYLPHENYLBORONIC ACID; 4-BUTOXY-3-CHLOROPHENYLBORONIC ACID; 4-BUTOXY-3-FLUOROPHENYLBORONIC ACID; 4-BUTOXYPHENYLBORONIC ACID; 4′-BUTYL-3-FLUOROBIPHENYL-4-BORONIC ACID; 4′-BUTYL-4-BIPHENYLBORONIC ACID; 4-BUTYLPHENYLBORONIC ACID; 4-BUTYLPYRIMIDINE-5-BORONIC ACID; 4-BUTYLTHIOPHENYLBORONIC ACID; 4-CARBAMOYL-2-FLUOROBENZENEBORONIC ACID; 4-CARBAMOYL-3-CHLOROPHENYLBORONIC ACID; 4-CARBAMOYL-3-FLUOROPHENYLBORONIC ACID; 4-CARBOXY-2,6-DICHLOROPHENYLBORONIC ACID; 4-CARBOXY-2-CHLOROPHENYLBORONIC ACID; 4-CARBOXY-2-FLUOROPHENYLBORONIC ACID; 4-CARBOXY-2-NITROPHENYLBORONIC ACID; 4-CARBOXY-3-CHLOROPHENYLBORONIC ACID; 4-CARBOXY-3-FLUOROPHENYLBORONIC ACID; 4-CARBOXY-6-CHLOROPYRIDINE-3-BORONIC ACID; 4-CARBOXYNAPHTHALENE-1-BORONIC ACID; 4-CARBOXYPHENYLBORONIC ACID; 4-CHLORO-1-(2,2-DIFLUOROETHYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-(2-METHOXYETHYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-(CYCLOPROPYLMETHYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-(METHYLSULFONYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-(TRIMETHYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-CYCLOPENTYL-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-ETHYL-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1H-INDOLE-2-BORONIC ACID; 4-CHLORO-1-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 4-CHLORO-1-METHYL-1H-PYRROLE-2-BORONIC ACID; 4-CHLORO-1-METHYL-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-PHENYL-PYRROL-3-YLBORONIC ACID; 4-CHLORO-2-((TETRAHYDRO-2H-PYRAN-2-YL)METHOXY)PHENYLBORONIC ACID; 4-CHLORO-2-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 4-CHLORO-2-(CYCLOPENTYLOXY)PHENYLBORONIC ACID; 4-CHLORO-2-(METHOXYMETHYL)PHENYLBORONIC ACID; 4-CHLORO-2-(PIPERIDIN-1-YL)PHENYLBORONIC ACID; 4-CHLORO-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-CHLORO-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-CHLORO-2,3-DIFLUOROPHENYLBORONIC ACID; 4-CHLORO-2,5-DIFLUOROPHENYLBORONIC ACID; 4-CHLORO-2,6-DIFLUOROPHENYLBORONIC ACID; 4-CHLORO-2,6-DIMETHOXYPHENYLBORONIC ACID; 4-CHLORO-2,6-DIMETHYLPYRIDINE-3-BORONIC ACID; 4-CHLORO-2-CYANOPHENYLBORONIC ACID; 4-CHLORO-2-ETHOXYPHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-3-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-3-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-3-ISOPROPOXYPHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-3-METHOXYPHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-3-PROPOXYPHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-5-METHOXYPHENYLBORONIC ACID; 4-CHLORO-2-FLUOROPHENYLBORONIC ACID; 4-CHLORO-2-FURANBORONIC ACID; 4-CHLORO-2-HYDROXY-6-METHYLPHENYLBORONIC ACID; 4-CHLORO-2-HYDROXYPHENYLBORONIC ACID; 4-CHLORO-2-ISOBUTOXYPHENYLBORONIC ACID; 4-CHLORO-2-ISOPROPOXYPHENYLBORONIC ACID; 4-CHLORO-2-METHOXYPHENYLBORONIC ACID; 4-CHLORO-2-METHOXYPYRIDINE-3-BORONIC ACID; 4-CHLORO-2-METHOXYPYRIDINE-5-BORONIC ACID; 4-CHLORO-2-METHYLPHENYLBORONIC ACID; 4-CHLORO-2-METHYLPYRIDINE-3-BORONIC ACID; 4-CHLORO-2-METHYLPYRIDINE-5-BORONIC ACID; 4-CHLORO-2-PROPOXYPHENYLBORONIC ACID; 4-CHLORO-3-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YLOXY)PHENYLBORONIC ACID; 4-CHLORO-3-(2-DIMETHYLAMINOETHOXY)PHENYLBORONIC ACID; 4-CHLORO-3-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 4-CHLORO-3-(CYCLOHEXYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(CYCLOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(DIMETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(ETHOXYCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(ETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(ISOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(N,N-DIETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(N-BUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(N-METHYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(N-MORPHOLINECARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(N-PROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(T-BUTYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-CHLORO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-CHLORO-3-CYANOPHENYLBORONIC ACID; 4-CHLORO-3-ETHOXY-2-FLUOROPHENYLBORONIC ACID; 4-CHLORO-3-ETHOXYPHENYLBORONIC ACID; 4-CHLORO-3-ETHYLPHENYLBORONIC ACID; 4-CHLORO-3-FLUOROPHENYLBORONIC ACID; 4-CHLORO-3-ISOBUTOXYPHENYLBORONIC ACID; 4-CHLORO-3-ISOPROPOXYPHENYLBORONIC ACID; 4-CHLORO-3-METHOXYPHENYLBORONIC ACID; 4-CHLORO-3-METHOXYPYRIDINE-2-BORONIC ACID; 4-CHLORO-3-METHYLPHENYLBORONIC ACID; 4-CHLORO-3-METHYLPYRIDINE-2-BORONIC ACID; 4-CHLORO-3-NITROPHENYLBORONIC ACID; 4-CHLORO-3-PROPOXYPHENYLBORONIC ACID; 4′-CHLORO-4-BIPHENYLBORONIC ACID; 4-CHLORO-5-(METHOXYCARBONYL)THIOPHENE-2-BORONIC ACID; 4-CHLORO-5-METHOXYPYRIDINE-2-BORONIC ACID; 4-CHLORO-5-METHOXYPYRIDINE-3-BORONIC ACID; 4-CHLORO-5-METHYLPYRIDINE-2-BORONIC ACID; 4-CHLORO-5-METHYLPYRIDINE-3-BORONIC ACID; 4-CHLORO-6-(TRIFLUOROMETHYL)PYRIDIN-2-YLBORONIC ACID; 4-CHLORO-6-METHOXYPYRIDIN-2-YLBORONIC ACID; 4-CHLOROCARBONYL-3-FLUOROPHENYLBORONIC ACID; 4-CHLOROCARBONYLPHENYLBORONIC ACID; 4-CHLOROMETHYLPHENYLBORONIC ACID; 4-CHLORO-N-(BOC)-INDOLE-2-BORONIC ACID; 4-CHLOROPHENYLBORONIC ACID; 4-CHLOROPYRIDINE-2-BORONIC ACID; 4-CHLOROPYRIDINE-3-BORONIC ACID; 4-CHLOROPYRIDINE-3-BORONIC ACID, HCL; 4-CHLOROPYRIMIDINE-2-BORONIC ACID; 4-CHLOROPYRIMIDINE-5-BORONIC ACID; 4-CHLORO-PYRROL-3-YLBORONIC ACID; 4-CHLOROQUINOLINE-3-BORONIC ACID; 4-CHLOROTHIOPHEN-2-YLBORONIC ACID; 4-CYANO-1H-INDOL-2-YLBORONIC ACID; 4-CYANO-2,3-DIFLUOROPHENYLBORONIC ACID; 4-CYANO-2,5-DIFLUOROPHENYLBORONIC ACID; 4-CYANO-2,6-DIFLUOROPHENYLBORONIC ACID; 4-CYANO-2-FLUOROPHENYLBORONIC ACID; 4-CYANO-2-HYDROXYPHENYLBORONIC ACID; 4-CYANO-2-METHOXYPHENYLBORONIC ACID; 4-CYANO-2-METHOXYPYRIDIN-3-YLBORONIC ACID; 4-CYANO-2-THIOPHENEBORONIC ACID; 4-CYANO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-CYANO-3,5-DIFLUOROPHENYLBORONIC ACID; 4-CYANO-3-FLUOROPHENYLBORONIC ACID; 4-CYANO-3-HYDROXYPHENYLBORONIC ACID; 4-CYANO-3-METHOXYPHENYLBORONIC ACID; 4-CYANO-3-METHYLBENZO[B]THIOPHEN-2-YLBORONIC ACID; 4-CYANO-3-METHYLPHENYLBORONIC ACID; 4-CYANOBENZO[B]THIOPHEN-2-YLBORONIC ACID; 4-CYANOMETHOXYPHENYLBORONIC ACID; 4-CYANONAPHTHALEN-2-YLBORONIC ACID; 4-CYANOPHENYLBORONIC ACID; 4-CYANOPYRIDINE-2-BORONIC ACID; 4-CYANOPYRIDINE-3-BORONIC ACID; 4-CYANOTHIOPHEN-3-YLBORONIC ACID; 4-CYCLOBUTYL(PHENYL-D4)-BORONIC ACID; 4-CYCLOBUTYLPHENYLBORONIC ACID; 4-CYCLOHEXYLBENZENEBORONIC ACID; 4-CYCLOPENTENYLPHENYLBORONIC ACID; 4-CYCLOPENTOXYPHENYLBORONIC ACID; 4-CYCLOPENTYLPHENYLBORONIC ACID; 4-CYCLOPENTYLPYRIMIDINE-5-BORONIC ACID; 4-CYCLOPROPOXYPHENYLBORONIC ACID; 4-CYCLOPROPYL(PHENYL-D4)-BORONIC ACID; 4-CYCLOPROPYL-BENZENEBORONIC ACID; 4-CYCLOPROPYL-PYRROL-3-YLBORONIC ACID; 4-CYCLOPROPYLTHIOPHENYLBORONIC ACID; 4-DIFLUOROMETHOXY-3-FLUORO-BENZENEBORONIC ACID; 4-DIFLUOROMETHOXY-3-METHYL-BENZENEBORONIC ACID; 4-DIFLUOROMETHOXY-3-TRIFLUOROMETHYL-BENZENEBORONIC ACID; 4-DIFLUOROMETHYL-PHENYLBORONIC ACID; 4-DIMETHYLAMINONAPHTHALENE-1-BORONIC ACID; 4-DIMETHYLAMINOPHENYLBORONIC ACID HYDROCHLORIDE; 4-DIPHENYL-1-NAPHTHALENE BORONIC ACID; 4-ETHOXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-ETHOXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-ETHOXY-2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 4-ETHOXY-2-FLUOROPHENYLBORONIC ACID; 4-ETHOXY-2-METHOXYPHENYLBORONIC ACID; 4-ETHOXY-2-METHYLPHENYLBORONIC ACID; 4-ETHOXY-3-FLUOROPHENYLBORONIC ACID; 4-ETHOXY-3-METHYLPHENYLBORONIC ACID; 4-ETHOXYBIPHENYL-4′-BORONIC ACID; 4-ETHOXYCARBONYL-2-NITROPHENYLBORONIC ACID; 4-ETHOXYCARBONYL-3-FLUOROPHENYLBORONIC ACID; 4-ETHOXYCARBONYL-3-METHOXYPHENYLBORONIC ACID; 4-ETHOXYCARBONYLMETHYLPHENYLBORONIC ACID; 4-ETHOXYCARBONYLPHENYLBORONIC ACID; 4-ETHOXYMETHYLPHENYLBORONIC ACID; 4-ETHOXYPHENYLBORONIC ACID; 4-ETHOXYPYRIDINE-3-BORONIC ACID; 4-ETHYL-3,5-DIMETHYLPHENYLBORONIC ACID; 4′-ETHYL-3-FLUOROBIPHENYL-4-BORONIC ACID; 4′-ETHYL-4-BIPHENYLBORONIC ACID; 4-ETHYL-6-(ETHYL(METHYL)AMINO)PYRIDIN-3-YLBORONIC ACID; 4-ETHYLCYCLOHEXEN-1-YLBORONIC ACID; 4-ETHYLFURAN-2-BORONIC ACID; 4-ETHYLPHENYLBORONIC ACID; 4-ETHYLPYRIDINE-3-BORONIC ACID; 4-ETHYL-PYRROL-3-YLBORONIC ACID; 4-ETHYLSULFINYLPHENYLBORONIC ACID; 4-ETHYLTHIOPHEN-2-YLBORONIC ACID; 4-ETHYLTHIOPHENYLBORONIC ACID; 4-ETHYNYL-2-METHYLPYRIDIN-3-YLBORONIC ACID; 4-FLUORO(PHENYL-D4)-BORONIC ACID; 4-FLUORO-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-FLUORO-1H-INDAZOL-6-YLBORONIC ACID; 4-FLUORO-1H-INDOL-3-YLBORONIC ACID; 4-FLUORO-1H-PYRAZOL-5-YLBORONIC ACID; 4-FLUORO-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 4-FLUORO-1-METHYL-1H-PYRROLE-2-BORONIC ACID; 4-FLUORO-2-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 4-FLUORO-2-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-FLUORO-2-(METHYLSULFONYL)PHENYLBORONIC ACID; 4-FLUORO-2-(METHYLTHIO)PHENYLBORONIC ACID; 4-FLUORO-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-FLUORO-2,3-DIMETHYLPHENYLBORONIC ACID; 4-FLUORO-2,5-DIMETHYLPHENYLBORONIC ACID; 4-FLUORO-2-FURANBORONIC ACID; 4-FLUORO-2-HYDROXYPHENYLBORONIC ACID; 4-FLUORO-2-ISOPROPOXYPHENYLBORONIC ACID; 4-FLUORO-2-METHOXY-5-METHYLPHENYLBORONIC ACID; 4-FLUORO-2-METHOXYCARBONYLPHENYLBORONIC ACID; 4-FLUORO-2-METHOXYPHENYLBORONIC ACID; 4-FLUORO-2-METHYLPHENYLBORONIC ACID; 4-FLUORO-2-PROPOXYPHENYLBORONIC ACID; 4-FLUORO-2-THIOPHENEBORONIC ACID; 4-FLUORO-3-(2,2,2-TRIFLUOROETHOXY)PHENYLBORONIC ACID; 4-FLUORO-3-(2-CHLORO-PHENYLCARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(2-HYDROXYETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(ISOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(METHOXY(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4-FLUORO-3-(METHYLCARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 4-FLUORO-3-(N-PROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(PHENYLCARBAMOYL)BENZENEBORONIC ACID; 4-FLUORO-3-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-FLUORO-3-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-FLUORO-3-(TETRAHYDRO-2H-PYRAN-2-YLOXY)PHENYLBORONIC ACID; 4-FLUORO-3-(TETRAZOL-5-YL)PHENYLBORONIC ACID; 4-FLUORO-3-(THIOMORPHOLINOMETHYL)PHENYLBORONIC ACID; 4-FLUORO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-FLUORO-3-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 4-FLUORO-3,5-BIS(TRIMETHYLSILYL)PHENYLBORONIC ACID; 4-FLUORO-3-[(METHOXYAMINO)CARBONYL]BENZENEBORONIC ACID; 4-FLUORO-3-HYDROXYPHENYLBORONIC ACID; 4-FLUORO-3-METHOXYPHENYLBORONIC ACID; 4-FLUORO-3-METHYLPHENYLBORONIC ACID; 4-FLUORO-3-NITROPHENYLBORONIC ACID; 4-FLUOROBENZOFURAN-7-BORONIC ACID; 4-FLUOROBENZYLBORONIC ACID; 4-FLUORONAPHTHALENE-1-BORONIC ACID; 4-FLUOROPHENYLBORONIC ACID; 4-FLUOROPYRIDINE-2-BORONIC ACID; 4-FLUOROPYRIDINE-3-BORONIC ACID; 4-FLUORO-PYRROL-3-YLBORONIC ACID; 4-FLUOROQUINOLINE-3-BORONIC ACID; 4-HEPTYLOXYPHENYLBORONIC ACID; 4-HEXYLOXYPHENYLBORONIC ACID; 4-HEXYLTHIOPHENE-3-BORONIC ACID; 4-HYDROXY-2-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4-HYDROXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-HYDROXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-HYDROXY-2-METHOXYPHENYLBORONIC ACID; 4-HYDROXY-3-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4-HYDROXY-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-HYDROXY-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-HYDROXY-3,5-DIMETHYLPHENYLBORONIC ACID; 4-HYDROXY-3-METHOXYPHENYLBORONIC ACID; 4-HYDROXY-3-METHYLBENZENEBORONIC ACID; 4-HYDROXYBENZOTHIAZOLE-2-BORONIC ACID; 4-HYDROXYL-1-NAPHTHALENEBORONIC ACID; 4-HYDROXYMETHYL-2-METHOXYPHENYLBORONIC ACID; 4-HYDROXYMETHYL-3-METHYLPHENYLBORONIC ACID; 4-HYDROXYNAPHTHALENE-2-BORONIC ACID; 4-HYDROXYPHENYLBORONIC ACID; 4-HYDROXYPYRIDINE-2-BORONIC ACID; 4-HYDROXYPYRIDINE-3-BORONIC ACID; 4-HYDROXYQUINOLINE-2-BORONIC ACID; 4-HYDROXYQUINOLINE-3-BORONIC ACID; 4-HYDROXYQUINOLINE-5-BORONIC ACID; 4-HYDROXYQUINOLINE-6-BORONIC ACID; 4-HYDROXYQUINOLINE-7-BORONIC ACID; 4-HYDROXYQUINOLINE-8-BORONIC ACID; 4′-ISOBUTOXYBIPHENYL-4-YLBORONIC ACID; 4-ISOBUTOXYPHENYLBORONIC ACID; 4′-ISOBUTYL-3′-NITROBIPHENYL-4-YLBORONIC ACID; 4-ISOBUTYLPHENYLBORONIC ACID; 4-ISOBUTYRAMIDOBENZENEBORONIC ACID; 4-ISOPROPOXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-ISOPROPOXY-2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 4-ISOPROPOXY-2,6-DIMETHYLPHENYLBORONIC ACID; 4-ISOPROPOXY-2-METHYLPHENYLBORONIC ACID; 4-ISOPROPOXY-3-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 4-ISOPROPOXY-3-METHYLPHENYLBORONIC ACID; 4-ISOPROPOXYCARBONYLPHENYLBORONIC ACID; 4-ISOPROPOXYPHENYLBORONIC ACID; 4-ISOPROPOXYPHENYLBORONIC ACID HYDRATE; 4-ISOPROPYL-1-(METHYLSULFONYL)-PYRROL-3-YLBORONIC ACID; 4-ISOPROPYL-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-ISOPROPYL-1-(TRIMETHYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-ISOPROPYLPHENYLBORONIC ACID; 4-ISOPROPYLPYRIMIDINE-5-BORONIC ACID; 4-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 4-ISOPROPYLTHIOPHENYLBORONIC ACID; 4-JULOLIDINE BORONIC ACID; 4-MERCAPTOPHENYLBORONIC ACID; 4-METHOXY-1H-INDOL-2-YLBORONIC ACID; 4-METHOXY-2-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-METHOXY-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 4-METHOXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-METHOXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-METHOXY-2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 4-METHOXY-2,3-DIMETHYLPHENYLBORONIC ACID; 4-METHOXY-2-METHYLPHENYLBORONIC ACID; 4-METHOXY-2-NITROPHENYLBORONIC ACID; 4-METHOXY-3-(METHOXYMETHOXY)PHENYLBORONIC ACID; 4-METHOXY-3-(MORPHOLIN-4-YLSULPHONYL)BENZENEBORONIC ACID; 4-METHOXY-3-(N,N-DIETHYLSULFAMOYL)PHENYLBORONIC ACID; 4-METHOXY-3-(PIPERIDIN-1-YLSULPHONYL)BENZENEBORONIC ACID; 4-METHOXY-3-(PYRROLIDIN-1-YLSULPHONYL)BENZENEBORONIC ACID; 4-METHOXY-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-METHOXY-3-METHYLPHENYLBORONIC ACID; 4-METHOXY-3-NITROPHENYLBORONIC ACID; 4-METHOXY-3-PROPOXYPHENYLBORONIC ACID; 4-METHOXY-3-PYRIDINE BORONIC ACID HYDROCHLORIDE; 4-METHOXY-3-PYRIDINEBORONIC ACID; 4′-METHOXY-4-BIPHENYLBORONIC ACID; 4-METHOXY-6-METHYLPYRIDINE-3-BORONIC ACID; 4-METHOXYBENZO[B]THIOPHEN-2-YLBORONIC ACID; 4-METHOXYBENZOTHIAZOLE-2-BORONIC ACID; 4-METHOXYCARBONYL-2-NITROPHENYLBORONIC ACID; 4-METHOXYCARBONYL-3,5-DIMETHYLPHENYLBORONIC ACID; 4-METHOXYCARBONYL-3-METHYLPHENYLBORONIC ACID; 4-METHOXYCARBONYL-3-NITROPHENYLBORONIC ACID; 4-METHOXYCARBONYLPHENYLBORONIC ACID; 4-METHOXYNAPHTHALENE-1-BORONIC ACID; 4-METHOXYPHENYLBORONIC ACID; 4-METHOXYPYRIDINE-2-BORONIC ACID; 4-METHOXYPYRIDINE-3-BORONIC ACID HYDRATE; 4-METHOXYPYRIMIDIN-5-YLBORONIC ACID; 4-METHOXY-QUINOLINE-2-BORONIC ACID; 4-METHYL(PHENYL-D4)-BORONIC ACID; 4-METHYL-1-(METHYLSULFONYL)-PYRROL-3-YLBORONIC ACID; 4-METHYL-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-METHYL-1-(TRIMETHYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-METHYL-1-CYCLOHEXEN-1-YLBORONIC ACID; 4-METHYL-1H-INDAZOLE-5-BORONIC ACID; 4-METHYL-1H-INDAZOLE-6-BORONIC ACID; 4-METHYL-1H-INDOL-3-YLBORONIC ACID; 4-METHYL-1H-INDOLE-2-BORONIC ACID; 4-METHYL-1-PENTENYLBORONIC ACID; 4-METHYL-1-PHENYL-1H-PYRAZOL-3-YLBORONIC ACID; 4-METHYL-2-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(2,4,5-TRICHLOROPHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YLBORONIC ACID; 4-METHYL-2-(PERFLUOROPHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-METHYL-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4′-METHYL-2,2′-BITHIOPHEN-5-YLBORONIC ACID; 4-METHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-6-YLBORONIC ACID; 4-METHYL-2-PHENYLTHIAZOL-5-YLBORONIC ACID; 4-METHYL-3-(4-(PYRIDIN-2-YLMETHOXY)BENZAMIDO)PHENYLBORONIC ACID; 4-METHYL-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-METHYL-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-7-YLBORONIC ACID; 4-METHYL-3-NITROPHENYLBORONIC ACID; 4-METHYL-3-THIOPHENEBORONIC ACID; 4′-METHYL-4-BIPHENYLBORONIC ACID; 4-METHYL-6-(1H-PYRAZOL-1-YL)PYRIDIN-3-YLBORONIC ACID; 4-METHYL-6-(1H-PYRROL-1-YL)PYRIDIN-3-YLBORONIC ACID; 4-METHYLFURAN-2-BORONIC ACID; 4-METHYLPHENYLBORONIC ACID; 4-METHYLPYRIDINE-2-BORONIC ACID; 4-METHYLPYRIDINE-3-BORONIC ACID; 4-METHYLPYRIDINE-3-BORONIC ACID, HYDROCHLORIDE; 4-METHYLPYRIMIDINE-5-BORONIC ACID; 4-METHYL-PYRROL-3-YLBORONIC ACID; 4-METHYLTHIOPHENE-2-BORONIC ACID; 4-MORPHOLINOPHENYLBORONIC ACID; 4-MORPHOLINOQUINOLIN-6-YLBORONIC ACID; 4-N-BOC-AMINO-3-FLUOROPHENYLBORONIC ACID; 4-N-BOC-AMINO-3-METHOXY-PHENYLBORONIC ACID; 4-N-BUTOXY-2-FLUOROPHENYLBORONIC ACID; 4-N-HEPTYLPHENYLBORONIC ACID; 4-N-HEXYLPHENYLBORONIC ACID; 4-NITRO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4′-NITRO-BIPHENYL-4-BORONIC ACID; 4-NITROPHENYLBORONIC ACID; 4-NITROPYRIDINE-2-BORONIC ACID; 4-N-NONYLBENZENEBORONIC ACID; 4-N-PENTYLPHENYLBORONIC ACID; 4-OCTYLOXYPHENYLBORONIC ACID; 4-OXO-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YLBORONIC ACID; 4-PENT-1-YNYLPHENYLBORONIC ACID; 4-PENTENYLBORONIC ACID; 4-PENTYL-2-FLUOROPHENYLBORONIC ACID; 4-PENTYL-3-FLUOROPHENYLBORONIC ACID; 4-PENTYLCYCLOHEX-1-ENYLBORONIC ACID; 4-PENTYLOXY-2-FLUOROPHENYLBORONIC ACID; 4-PENTYLOXY-3-FLUOROPHENYLBORONIC ACID; 4-PENTYLOXYPHENYLBORONIC ACID; 4-PHENOXYPHENYLBORONIC ACID; 4-PHENOXYPYRIDIN-3-YLBORONIC ACID; 4-PHENYL(NAPHTHALENE-1-YL)BORONIC ACID; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-BORONIC ACID; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-BORONIC ACID; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-BORONIC ACID; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-BORONIC ACID; 4-PHENYLFURAN-2-BORONIC ACID; 4-PHENYLPYRIDINE-3-BORONIC ACID; 4-PHENYLPYRIMIDINE-2-BORONIC ACID; 4-PHENYLPYRIMIDINE-5-BORONIC ACID; 4-PHENYL-PYRROL-3-YLBORONIC ACID; 4-PHENYLTHIOPHENE-2-BORONIC ACID; 4-PIVALAMIDOPHENYLBORONIC ACID; 4-PROPOXY-2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 4-PROPOXY-2-METHYLPHENYLBORONIC ACID; 4-PROPOXYCARBONYLPHENYLBORONIC ACID; 4-PROPOXYPHENYLBORONIC ACID; 4′-PROPYL-3-FLUOROBIPHENYL-4-BORONIC ACID; 4′-PROPYL-4-BIPHENYLBORONIC ACID; 4-PROPYLCYCLOHEX-1-ENYLBORONIC ACID; 4-PROPYLPHENYLBORONIC ACID; 4-PROPYLPYRIDIN-3-YLBORONIC ACID; 4-PROPYLSULFANYLPHENYLBORONIC ACID; 4-PROPYLTHIOPHEN-2-YLBORONIC ACID; 4-TBDMS-HYDROXYMETHYLPHENYLBORONIC ACID; 4-T-BUTOXYPHENYLBORONIC ACID; 4-T-BUTYLCYCLOHEXEN-1-YLBORONIC ACID; 4-TERT-BUTOXY-2-CHLOROPYRIMIDIN-5-YLBORONIC ACID; 4′-TERT-BUTOXYCARBONYLAMINO-BIPHENYL-4-BORONIC ACID; 4-TERT-BUTOXYCARBOXYPHENYLBORONIC ACID; 4-TERT-BUTOXYMETHYLPHENYLBORONIC ACID; 4-TERT-BUTYL-2-FURANBORONIC ACID; 4-TERT-BUTYL-2-METHYLPHENYLBORONIC ACID; 4-TERT-BUTYL-3-NITROBENZENEBORONIC ACID; 4′-TERT-BUTYLBIPHENYL-2-YLBORONIC ACID; 4-TERT-BUTYLPHENYLBORONIC ACID; 4-TRIFLUOROACETYL AMINOPHENYLBORONIC ACID; 4-TRIFLUOROMETHOXYPHENYL 4-BORONOBENZENESULFONAMIDE; 4-TRIMETHYLSILYLPHENYLBORONIC ACID; 4-VINYLPHENYLBORONIC ACID; 5-((1-PHENYLETHYL)CARBAMOYL)THIOPHEN-2-YLBORONIC ACID; 5-((4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)METHYL)-2-FLUOROPHENYLBORONIC ACID; 5-((BENZYLOXYCARBONYLAMINO)METHYL)THIOPHENE-2-BORONIC ACID; 5-((BOC-AMINO)METHYL)FURAN-2-BORONIC ACID; 5-((CYCLOPENTYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 5-((CYCLOPROPYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 5-((DIETHYLAMINO)METHYL)FURAN-2-YLBORONIC ACID; 5-((DIMETHYLAMINO)METHYL)FURAN-2-YLBORONIC ACID; 5-((DIMETHYLAMINO)METHYL)PYRIDIN-3-YLBORONIC ACID; 5-((DIMETHYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 5-((ETHYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 5-((ISOPROPYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 5-((METHYLAMINO)METHYL)FURAN-3-YLBORONIC ACID; 5-((METHYLAMINO)METHYL)THIOPHEN-3-YLBORONIC ACID; 5-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-([TERT-BUTYL(DIMETHYL)SILYL]OXY)PYRIDINE-3-BORONIC ACID; 5-(1-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)ETHYL)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-(1-(TERT-BUTYLDIMETHYLSILYLOXY)-2-METHYLPROPAN-2-YL)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-(1-(TERT-BUTYLDIMETHYLSILYLOXY)PROPAN-2-YL)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-(1,3-DIOXOLAN-2-YL)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-(1,3-DIOXOLAN-2-YL)FURAN-2-YLBORONIC ACID; 5-(1,3-DIOXOLAN-2-YL)PYRIDINE-BORONIC ACID; 5-(1-CYANOCYCLOPROPYL)-2-FLUOROPHENYLBORONIC ACID; 5-(1H-INDOL-4-YL)PYRIDIN-3-YLBORONIC ACID; 5-(1H-PYRAZOL-1-YL)PYRAZINE-2-BORONIC ACID; 5-(1H-PYRIDIN-2-ONE)PYRAZINE-2-BORONIC ACID; 5-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(2-FLUOROPHENYL)FURAN-2-BORONIC ACID; 5-(2-FLUOROPHENYL)THIOPHENE-2-BORONIC ACID; 5-(2-FURYL)THIOPHENE-2-BORONIC ACID; 5-(2-HYDROXYPROPAN-2-YL)PYRIDINE-2-BORONIC ACID; 5-(2-HYDROXYPROPAN-2-YL)PYRIDINE-3-BORONIC ACID; 5-(2-METHOXYETHOXY)PYRIDINE-3-BORONIC ACID; 5-(2-METHOXYPHENYL)FURAN-2-BORONIC ACID; 5-(2-METHOXYPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(2-METHOXYPHENYL)THIOPHENE-2-BORONIC ACID; 5-(2-METHYLIMIDAZOL-1-YL)PYRAZINE-2-BORONIC ACID; 5-(2-METHYLPIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(2-THIAZOLYL)THIOPHENE-2-BORONIC ACID; 5-(2-TOLYL)FURAN-2-BORONIC ACID; 5-(2-TOLYL)THIOPHENE-2-BORONIC ACID; 5-(2-TRIFLUOROMETHYLPHENYL)FURAN-2-BORONIC ACID; 5-(2-TRIFLUOROMETHYLPHENYL)THIOPHENE-2-BORONIC ACID; 5-(3-((TERT-BUTOXYCARBONYL)AMINO)PROPANAMIDO)PYRIDINE-3-BORONIC ACID; 5-(3-(AMINOMETHYL)PHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(3-(METHYLSULFONYL)PHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(3,5-DIMETHYLISOXAZOL-4-YL)BENZO[B]THIOPHEN-2-YLBORONIC ACID; 5-(3,5-DIMETHYLISOXAZOL-4-YL)THIOPHEN-2-YLBORONIC ACID; 5-(3-BORONOPHENYL)PENTANOIC ACID; 5-(3-ETHOXYPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(3-METHOXYPHENYL)PYRIDIN-2-YLBORONIC ACID; 5-(3-METHYL-1H-PYRAZOL-1-YL)PYRAZINE-2-BORONIC ACID; 5-(3-METHYLPIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(3-MORPHOLINOPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(3-SULFAMOYLPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(4-(DIMETHYLAMINO)PHENYL)THIOPHEN-2-YLBORONIC ACID; 5-(4-(METHYLSULFONYL)PHENYL)PYRIMIDIN-2-YLBORONIC ACID; 5-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(4,4-DIMETHYL-4,5-DIHYDROOXAZOL-2-YL)PYRIDIN-3-YLBORONIC ACID; 5-(4-CHLOROPHENYL)THIOPHEN-2-YLBORONIC ACID; 5-(4-FLUOROPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(4-FLUOROPHENYL)THIOPHEN-2-YLBORONIC ACID; 5-(4-METHOXYPHENYL)PYRIDIN-2-YLBORONIC ACID; 5-(4-METHOXYPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(4-METHOXYPHENYL)THIOPHEN-2-YLBORONIC ACID; 5-(4-METHYL-1H-PYRAZOL-1-YL)PYRAZINE-2-BORONIC ACID; 5-(4-METHYLPHENYL)THIOPHENE-2-BORONIC ACID; 5-(4-METHYLPIPERAZIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YLBORONIC ACID; 5-(4-METHYLPIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(4-MORPHOLINOPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(4-PENTYLOXYPHENYL)THIOPHENE-2-BORONIC ACID; 5-(4-PENTYLPHENYL)THIOPHENE-2-BORONIC ACID; 5-(5-CHLOROPYRIDIN-3-YLOXY)PYRIDIN-3-YLBORONIC ACID; 5-(5-CYCLOPROPYL-1,3,4-OXADIAZOL-2-YL)-2-METHYLPHENYLBORONIC ACID; 5-(AMINOMETHYL)-2-FLUOROPHENYLBORONIC ACID, HCL; 5-(AMINOMETHYL)THIOPHEN-2-YLBORONIC ACID; 5-(BENZO[D]THIAZOL-2-YL)THIOPHENE-2-BORONIC ACID; 5-(BENZYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID; 5-(BENZYLOXY)-1H-INDOL-2-YLBORONIC ACID; 5-(BENZYLOXY)-2-(DIETHOXYMETHYL)PHENYLBORONIC ACID; 5-(BENZYLOXY)-2,4-DICHLOROPHENYLBORONIC ACID; 5-(BENZYLOXY)-2-BORONOBENZOIC ACID; 5-(BENZYLOXY)-2-CHLOROPHENYLBORONIC ACID; 5-(BENZYLOXY)-2-FLUOROPHENYLBORONIC ACID; 5-(BENZYLOXY)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-(BENZYLOXY)-2-METHYLPHENYLBORONIC ACID; 5-(BENZYLOXY)PYRIDINE-3-BORONIC ACID-HCL; 5-(BENZYLOXYCARBONYLAMINO)-2-FLUOROPHENYLBORONIC ACID; 5-(BOC-AMINO)PYRIDINE-3-BORONIC ACID; 5-(BOC-AMINOMETHYL)THIOPHENE-2-BORONIC ACID; 5-(CYANOMETHYL)THIOPHEN-3-YLBORONIC ACID; 5-(CYCLOBUTYL)FURAN-2-BORONIC ACID; 5-(CYCLOBUTYL)THIOPHENE-2-BORONIC ACID; 5-(CYCLOHEXYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID; 5-(CYCLOPENTOXY)PYRAZINE-2-BORONIC ACID; 5-(CYCLOPROPYL)FURAN-2-BORONIC ACID; 5-(CYCLOPROPYL)THIOPHENE-2-BORONIC ACID; 5-(CYCLOPROPYLCARBAMOYL)-2-FLUOROPHENYLBORONIC ACID; 5-(DIETHOXYMETHYL)FURAN-2-YLBORONIC ACID; 5-(DIETHYLAMINO)PYRAZINE-2-BORONIC ACID; 5-(DIETHYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID; 5-(DIETHYLCARBAMOYL)THIOPHEN-2-YLBORONIC ACID; 5-(DIFLUOROMETHOXY)-2-FLUOROPHENYLBORONIC ACID; 5-(DIFLUOROMETHOXY)BENZOTHIAZOLE-2-BORONIC ACID; 5-(DIFLUOROMETHOXY)PYRAZINE-2-BORONIC ACID; 5-(DIHYDROXYBORYL)-2-THIOPHENECARBOXYLIC ACID; 5-(DIMETHOXYMETHYL)FURAN-2-BORONIC ACID; 5-(DIMETHOXYMETHYL)PYRIDINE-3-BORONIC ACID; 5-(DIMETHYLAMINO)-2-METHYLPHENYLBORONIC ACID; 5-(DIMETHYLAMINO)-3-METHYLPYRIDIN-2-YLBORONIC ACID HYDROCHLORIDE; 5-(DIMETHYLAMINO)BENZO[B]THIOPHEN-2-YLBORONIC ACID; 5-(DIMETHYLAMINO)PYRAZINE-2-BORONIC ACID; 5-(DIMETHYLAMINO)PYRIDIN-2-YLBORONIC ACID; 5-(DIMETHYLAMINO)PYRIDIN-3-YLBORONIC ACID; 5-(DIMETHYLAMINO-D6)-PYRIDINE-3-BORONIC ACID; 5-(DIMETHYLCARBAMOYL)-3-FLUOROPHENYLBORONIC ACID; 5-(DIMETHYLCARBAMOYL)PYRIDINE-3-BORONIC ACID; 5-(ETHOXYCARBONYL)-1H-INDOL-2-YLBORONIC ACID; 5-(ETHOXYCARBONYL)-1H-PYRROL-2-YLBORONIC ACID; 5-(ETHOXYCARBONYL)-2-HYDROXYPHENYLBORONIC ACID; 5-(ETHOXYCARBONYL)-2-METHOXYPHENYLBORONIC ACID; 5-(ETHOXYCARBONYL)-3-PYRIDINYL BORONIC ACID; 5-(ETHOXYCARBONYL)-6-METHYLPYRIDINE-3-BORONIC ACID; 5-(ETHOXYCARBONYL)FURAN-2-BORONIC ACID; 5-(ETHOXYCARBONYL)THIOPHENE-2-BORONIC ACID; 5-(ETHOXYCARBONYL)THIOPHENE-3-BORONIC ACID; 5-(ETHOXYMETHYL)PYRIDINE-3-BORONIC ACID; 5-(ETHYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID; 5-(ETHYLCARBAMOYL)-3-FLUOROPHENYLBORONIC ACID; 5-(ETHYL-D5)-PYRIDINE-3-BORONIC ACID; 5-(ETHYLTHIO)FURAN-3-YLBORONIC ACID; 5-(FURAN-2-YL)FURAN-2-BORONIC ACID; 5-(HYDROXYMETHYL)-3-PYRIDINYL BORONIC ACID; 5-(HYDROXYMETHYL)FURAN-2-YLBORONIC ACID; 5-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 5-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 5-(HYDROXYMETHYL)PYRIDIN-3-YLBORONIC ACID HYDROCHLORIDE; 5-(HYDROXYMETHYL)PYRIDINE-2-BORONIC ACID; 5-(IMIDAZOL-1-YL)PYRAZINE-2-BORONIC ACID; 5-(ISOPROPOXY)PYRAZINE-2-BORONIC ACID; 5-(ISO-PROPYL)FURAN-2-BORONIC ACID; 5-(ISO-PROPYL)THIOPHENE-2-BORONIC ACID; 5-(ISO-PROPYL-D7)-PYRIDINE-3-BORONIC ACID; 5-(METHOXY(METHYL)CARBAMOYL)FURAN-2-YLBORONIC ACID; 5-(METHOXYCARBONYL)-1H-PYRAZOL-3-YLBORONIC ACID; 5-(METHOXYCARBONYL)-1H-PYRROL-3-YLBORONIC ACID; 5-(METHOXYCARBONYL)-1-TOSYL-1H-PYRROL-3-YLBORONIC ACID; 5-(METHOXYCARBONYL)-4-METHYLTHIOPHEN-2-YLBORONIC ACID; 5-(METHOXYCARBONYL)-6-(METHYLTHIO)PYRIDIN-3-YLBORONIC ACID; 5-(METHOXYCARBONYL)FURAN-2-BORONIC ACID; 5-(METHOXYCARBONYL)PYRIDINE-2-BORONIC ACID; 5-(METHOXYCARBONYL)PYRIDINE-3-BORONIC ACID; 5-(METHOXYCARBONYL)THIOPHENE-3-BORONIC ACID; 5-(METHOXY-D3)-PYRAZINE-2-BORONIC ACID; 5-(METHOXY-D3)-PYRIDINE-3-BORONIC ACID; 5-(METHOXYMETHOXY)-2-METHYLPHENYLBORONIC ACID; 5-(METHOXYMETHOXY)-2-METHYLPYRIDIN-4-YLBORONIC ACID; 5-(METHOXYMETHYL)-3-PYRIDINYL BORONIC ACID; 5-(METHOXYMETHYL)THIOPHEN-3-YLBORONIC ACID; 5-(METHYL-D3)-PYRIDINE-3-BORONIC ACID; 5-(METHYLSULFANYL)-2-THIENYLBORONIC ACID; 5-(METHYLSULPHONYL)PYRIDINE-3-BORONIC ACID; 5-(METHYLTHIO)PYRAZINE-2-BORONIC ACID; 5-(METHYLTHIO)PYRIDINE-3-BORONIC ACID; 5-(MORPHOLINOMETHYL)THIOPHEN-2-YLBORONIC ACID; 5-(N,N-DIETHYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 5-(N,N-DIMETHYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 5-(N,N-METHYLETHYLAMINO)PYRAZINE-2-BORONIC ACID; 5-(N-PROPOXY)PYRAZINE-2-BORONIC ACID; 5-(N-PROPYL-D7)-PYRIDINE-3-BORONIC ACID; 5-(N-TERT-BUTYLSULFAMOYL)-2-METHYLBENZENEBORONIC ACID; 5-(N-TERT-BUTYLSULFAMOYL)THIOPHEN-2-YLBORONIC ACID; 5-(O-TBDMS)OXYMETHYLFURAN-2-BORONIC ACID; 5-(OXAZOL-5-YL)FURAN-2-YLBORONIC ACID; 5-(OXAZOL-5-YL)THIOPHEN-2-YLBORONIC ACID; 5-(PERFLUOROETHYL)PYRIDIN-3-YLBORONIC ACID; 5-(PIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(PIPERIDIN-2-YL)PYRIDIN-3-YLBORONIC ACID; 5-(PROP-1-YNYL)PYRIDIN-3-YLBORONIC ACID; 5-(PYRIDIN-3-YLOXY)PYRIDINE-3-BORONIC ACID; 5-(PYRROLIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(T-BUTYLDIMETHYLSILYLOXY)-2,3-DIFLUOROPHENYLBORONIC ACID; 5-(T-BUTYLDIMETHYLSILYLOXY)-2-FLUOROPHENYLBORONIC ACID; 5-(T-BUTYLDIMETHYLSILYLOXY)-2-METHOXYPHENYLBORONIC ACID; 5-(TERT-BUTOXY)PYRAZINE-2-BORONIC ACID; 5-(TERT-BUTOXY)PYRIDINE-2-BORONIC ACID; 5-(TERT-BUTOXYCARBONYL)-4,5,6,7-TETRAHYDROTHIENO[3,4-C]PYRIDIN-3-YLBORONIC ACID; 5-(TERT-BUTOXYCARBONYL)-5,6-DIHYDRO-4H-THIENO[3,2-C]PYRROL-2-YLBORONIC ACID; 5-(TERT-BUTOXYCARBONYL)-5,6-DIHYDRO-4H-THIENO[3,4-C]PYRROL-1-YL BORONIC ACID; 5-(TERT-BUTOXYCARBONYLAMINO)-2-(DIMETHYLAMINO)PHENYLBORONIC ACID; 5-(TERT-BUTOXYCARBONYLAMINO)-2-CHLOROPYRIDIN-4-YLBORONIC ACID; 5-(TERT-BUTOXYCARBONYLAMINO)NAPHTHALEN-1-YLBORONIC ACID; 5-(TERT-BUTYL)PYRAZINE-2-BORONIC ACID; 5-(TERT-BUTYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID; 5-(TERT-BUTYLCARBAMOYL)-4-METHYLTHIOPHEN-2-YLBORONIC ACID; 5-(TERT-BUTYLCARBAMOYL)PYRIDINE-3-BORONIC ACID; 5-(THIAZOL-2-YL)FURAN-2-BORONIC ACID; 5-(THIOPHEN-2-YL)FURAN-2-BORONIC ACID; 5-(TRIFLUOROMETHOXY)PYRAZINE-2-BORONIC ACID; 5-(TRIFLUOROMETHOXY)PYRIDINE-3-BORONIC ACID; 5-(TRIFLUOROMETHYL)-1H-PYRROL-2-YLBORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 5-(TRIFLUOROMETHYL)FURAN-2-BORONIC ACID; 5-(TRIFLUOROMETHYL)PYRIDINE-2-BORONIC ACID; 5-(TRIFLUOROMETHYL)THIOPHENE-2-BORONIC ACID; 5-(TRIFLUOROMETHYL)THIOPHENE-3-BORONIC ACID; 5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-2-NAPHTHALENYLBORONIC ACID; 5,6,7,8-TETRAHYDRO-2-NAPHTHALENYLBORONIC ACID; 5,6,7,8-TETRAHYDROISOQUINOLINE-3-BORONIC ACID; 5,6,7,8-TETRAHYDRONAPHTHALEN-1-YLBORONIC ACID; 5,6,7,8-TETRAHYDROQUINOLINE-2-BORONIC ACID; 5,6-DIFLUOROBENZO[B]THIOPHEN-3-YLBORONIC ACID; 5,6-DIMETHOXY-1H-INDOL-3-YLBORONIC ACID; 5,6-DIMETHOXYPYRAZIN-2-YLBORONIC ACID; 5,6-DIMETHYLPYRIDINE-2-BORONIC ACID; 5,6-DIMETHYLPYRIDINE-3-BORONIC ACID; 5-[(BENZYLOXY)METHYL]PYRIDINE-2-BORONIC ACID; 5-[(TRIMETHYLSILANYL)ETHYNYL]PYRIDINE-3-BORONIC ACID; 5-ACETAMIDO-2-(AMINOMETHYL)PHENYLBORONIC ACID; 5-ACETAMIDO-2-METHYLPHENYLBORONIC ACID; 5-ACRYLAMIDO-2-((DIMETHYLAMINO)METHYL)PHENYLBORONIC ACID; 5-ACRYLAMIDO-2-(AMINOMETHYL)PHENYLBORONIC ACID; 5-ACRYLAMIDO-2-(HYDROXYMETHYL)PHENYLBORONIC ACID; 5-ALLYL-2-METHOXYPHENYLBORONIC ACID; 5-AMINO-2-((TERT-BUTOXYCARBONYLAMINO)METHYL)PHENYLBORONIC ACID; 5-AMINO-2-(HYDROXYMETHYL)BENZENEBORONIC ACID HYDROCHLORIDE; 5-AMINO-2,3-DIFLUOROPHENYLBORONIC ACID; 5-AMINO-2,4-DIFLUOROPHENYLBORONIC ACID; 5-AMINO-2-CHLOROPHENYLBORONIC ACID HYDROCHLORIDE; 5-AMINO-2-CHLOROPYRIDINE-3-BORONIC ACID; 5-AMINO-2-FLUOROPHENYLBORONIC ACID; 5-AMINO-2-FLUOROPHENYLBORONIC ACID HYDROCHLORIDE; 5-AMINO-3-FLUORO-6-(METHOXYCARBONYL)PYRIDIN-2-YLBORONIC ACID; 5-AMINO-6-(2,2,2-TRIFLUOROETHOXY)PYRAZIN-2-YLBORONIC ACID; 5-AMINO-6-(2-METHOXYETHOXY)PYRAZIN-2-YLBORONIC ACID; 5-AMINO-6-(4-(METHOXYCARBONYL)PIPERIDIN-1-YL)PYRAZIN-2-YLBORONIC ACID; 5-AMINO-6-(METHOXYCARBONYL)-3-METHYLPYRIDIN-2-YLBORONIC ACID; 5-AMINO-6-CHLOROPYRIDINE-3-BORONIC ACID; 5-AMINO-6-ETHOXYPYRIDINE-3-BORONIC ACID; 5-AMINO-6-METHOXYPYRAZIN-2-YLBORONIC ACID; 5-AMINO-6-METHOXYPYRIDINE-3-BORONIC ACID; 5-AMINOBENZO[B]THIOPHEN-2-YLBORONIC ACID; 5-AMINOCARBONYLPYRIDINE-2-BORONIC ACID; 5-AMINOPYRAZINE-2-BORONIC ACID; 5-AMINOPYRIDINE-2-BORONIC ACID; 5-AMINOPYRIDINE-3-BORONIC ACID-HCL; 5-AMINOTHIOPHEN-3-YLBORONIC ACID; 5-BENZOTHIOPHENEBORONIC ACID; 5-BENZYLOXY-1-BOC-INDOLE-2-BORONIC ACID; 5-BENZYLOXY-3-PYRIDINYLBORONIC ACID; 5-BORONO-2-(2-HYDROXYPROPAN-2-YL)PYRIDINE 1-OXIDE; 5-BORONO-2,3-DIHYDRO-3-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-1-CARBOXYLIC ACID 1-(1,1-DIMETHYLETHYL) ESTER; 5-BORONO-3-METHYLTHIOPHENE-2-CARBOXYLIC ACID; 5-BORONO-4-CHLORO-2-FLUOROBENZOIC ACID; 5-BORONO-6-FLUOROPICOLINIC ACID; 5-BORONOFURAN-2-CARBOXYLIC ACID; 5-BORONOFURAN-3-CARBOXYLIC ACID; 5-BUTOXY-2,4-DICHLOROPHENYLBORONIC ACID; 5-BUTOXY-2-CHLOROPHENYLBORONIC ACID; 5-BUTOXY-2-FLUOROPHENYLBORONIC ACID; 5-BUTYL-2-(N-TERT-BUTYLSULFAMOYL)THIOPHEN-3-YLBORONIC ACID; 5-BUTYLFURAN-2-YLBORONIC ACID; 5-BUTYLPYRIDIN-2-YLBORONIC ACID; 5-CARBAMOYL-2-CHLOROPHENYLBORONIC ACID; 5-CARBAMOYL-2-FLUOROBENZENEBORONIC ACID; 5-CARBAMOYL-2-HYDROXYPHENYLBORONIC ACID; 5-CARBAMOYLFURAN-3-YLBORONIC ACID; 5-CARBAMOYLTHIOPHEN-2-YLBORONIC ACID; 5-CARBAMOYLTHIOPHEN-3-YLBORONIC ACID; 5-CARBOXY-2-CHLORO-4-METHOXYPHENYLBORONIC ACID; 5-CARBOXY-2-CHLOROPHENYLBORONIC ACID; 5-CARBOXY-2-ETHOXYPHENYLBORONIC ACID; 5-CARBOXY-2-FLUOROPHENYLBORONIC ACID; 5-CARBOXY-2-FLUOROPYRIDINE-3-BORONIC ACID; 5-CARBOXY-6-CHLOROPYRIDINE-3-BORONIC ACID; 5-CARBOXY-6-FLUOROPYRIDINE-3-BORONIC ACID; 5-CARBOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 5-CHLORO-1H-INDOL-3-YLBORONIC ACID; 5-CHLORO-1H-INDOLE-2-BORONIC ACID; 5-CHLORO-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 5-CHLORO-1-METHYL-PYRROL-3-YLBORONIC ACID; 5-CHLORO-2-(ETHOXYCARBONYL)PHENYLBORONIC ACID; 5-CHLORO-2-(METHOXYCARBONYL)PHENYLBORONIC ACID; 5-CHLORO-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 5-CHLORO-2-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 5-CHLORO-2-(PIVALOYLAMINO)PHENYLBORONIC ACID; 5-CHLORO-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 5-CHLORO-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5′-CHLORO-2,2′-BITHIOPHEN-5-YLBORONIC ACID; 5-CHLORO-2,3-DIFLUOROPYRIDIN-4-YLBORONIC ACID; 5-CHLORO-2,4-DIFLUOROPHENYLBORONIC ACID; 5-CHLORO-2-CYANOPHENYLBORONIC ACID; 5-CHLORO-2-ETHOXYPHENYLBORONIC ACID; 5-CHLORO-2-ETHOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-FLUORO-3-METHYLPHENYLBORONIC ACID; 5-CHLORO-2-FLUORO-4-METHOXYPHENYLBORONIC ACID; 5-CHLORO-2-FLUORO-4-METHYLPHENYLBORONIC ACID; 5-CHLORO-2-FLUORO-4-PICOLINE-3-BORONIC ACID; 5-CHLORO-2-FLUOROPHENYLBORONIC ACID; 5-CHLORO-2-FLUOROPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-FLUOROPYRIDINE-4-BORONIC ACID; 5-CHLORO-2-HYDROXYPHENYLBORONIC ACID; 5-CHLORO-2-HYDROXYPYRIDINE-4-BORONIC ACID; 5-CHLORO-2-ISOBUTOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-ISOPROPOXYPHENYLBORONIC ACID; 5-CHLORO-2-ISOPROPOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-METHOXYPHENYLBORONIC ACID; 5-CHLORO-2-METHOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-METHYL-3-NITROBENZENEBORONIC ACID; 5-CHLORO-2-METHYL-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-CHLORO-2-METHYLPHENYLBORONIC ACID; 5-CHLORO-2-METHYLPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-NITROPHENYLBORONIC ACID; 5-CHLORO-2-PROPOXYPHENYLBORONIC ACID; 5-CHLORO-2-PROPOXYPYRIDIN-4-YLBORONIC ACID; 5-CHLORO-2-PROPOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-3-METHOXYPYRIDINE-2-BORONIC ACID; 5-CHLORO-3-METHYLBENZO[B]THIOPHEN-2-YLBORONIC ACID; 5-CHLORO-3-METHYLPYRIDIN-2-YLBORONIC ACID; 5-CHLORO-4-METHOXY-2-METHYLPHENYLBORONIC ACID; 5-CHLORO-4-METHOXYPYRIDINE-2-BORONIC ACID; 5-CHLORO-4-METHOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-4-METHYLPYRIDINE-2-BORONIC ACID; 5-CHLORO-4-METHYLPYRIDINE-3-BORONIC ACID; 5-CHLORO-6-(4-CHLOROPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-CHLORO-6-(4-CHLOROPHENYLAMINO)PYRIDIN-3-YLBORONIC ACID; 5-CHLORO-6-ETHOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-6-HYDROXYPYRIDIN-3-YLBORONIC ACID; 5-CHLORO-6-ISOPROPOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-6-OXO-1,6-DIHYDROPYRIDIN-3-YLBORONIC ACID; 5-CHLORO-6-PROPOXYPYRIDINE-3-BORONIC ACID; 5-CHLOROBENZOFURAN-2-YLBORONIC ACID; 5-CHLOROBIPHENYL-3-YLBORONIC ACID; 5-CHLOROPYRAZINE-2-BORONIC ACID; 5-CHLOROPYRIDINE-2-BORONIC ACID; 5-CHLOROPYRIDINE-3-BORONIC ACID; 5-CHLOROPYRIMIDINE-2-BORONIC ACID; 5-CHLOROPYRIMIDINE-4-BORONIC ACID; 5-CHLORO-PYRROL-3-YLBORONIC ACID; 5-CHLOROTHIOPHENE-2-BORONIC ACID; 5-CHLOROTHIOPHENE-3-BORONIC ACID; 5-CYANO-1H-INDOLE-2-BORONIC ACID; 5-CYANO-1-METHYL-1H-PYRROL-2-YLBORONIC ACID; 5-CYANO-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 5-CYANO-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 5-CYANO-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-CYANO-2-FLUOROPHENYLBORONIC ACID; 5-CYANO-2-HYDROXYPHENYLBORONIC ACID; 5-CYANO-2-HYDROXYPYRIDIN-3-YLBORONIC ACID; 5-CYANO-2-METHOXYPHENYLBORONIC ACID; 5-CYANO-2-METHOXYPYRIDIN-3-YLBORONIC ACID; 5-CYANO-2-METHYLPHENYLBORONIC ACID; 5-CYANO-2-METHYLTHIOPHEN-3-YL-BORONIC ACID; 5-CYANO-2-OXO-1,2-DIHYDROPYRIDIN-3-YLBORONIC ACID; 5-CYANO-3-METHYLPYRIDIN-2-YLBORONIC ACID; 5-CYANO-3-METHYLTHIOPHENE-2-BORONIC ACID; 5-CYANO-3-PYRIDINYL BORONIC ACID; 5-CYANO-4-METHYLTHIOPHENE-2-BORONIC ACID; 5-CYANO-6-ETHOXYPYRIDINE-3-BORONIC ACID; 5-CYANOBENZOFURAN-2-YLBORONIC ACID; 5-CYANOPYRAZINE-2-BORONIC ACID; 5-CYANOPYRIDIN-2-YL-2-BORONIC ACID; 5-CYANOTHIOPHEN-3-YLBORONIC ACID; 5-CYANOTHIOPHENE-2-BORONIC ACID; 5-CYCLOPROPYLPYRIDIN-3-YLBORONIC ACID; 5-ETHOXY-2-FLUOROPHENYLBORONIC ACID; 5-ETHOXYPYRAZINE-2-BORONIC ACID; 5-ETHOXYPYRIDIN-2-YLBORONIC ACID; 5-ETHOXYPYRIDINE-3-BORONIC ACID; 5-ETHOXYTHIOPHEN-2-YLBORONIC ACID; 5-ETHYL-1,3,4-THIADIAZOL-2-YLBORONIC ACID; 5-ETHYL-1H-INDAZOL-4-YL BORONIC ACID; 5-ETHYLFURAN-2-BORONIC ACID; 5-ETHYLPYRIDIN-3-YLBORONIC ACID; 5-ETHYLTHIOPHENYLBORONIC ACID; 5-FLUORO-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 5-FLUORO-1H-INDAZOL-6-YLBORONIC ACID; 5-FLUORO-1H-INDOL-2-YLBORONIC ACID; 5-FLUORO-1-METHYL-1H-INDAZOLE-6-BORONIC ACID; 5-FLUORO-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 5-FLUORO-1-METHYL-PYRROL-3-YLBORONIC ACID; 5-FLUORO-2-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 5-FLUORO-2-(4-FLUOROPHENYLMETHOXY)PHENYLBORONIC ACID; 5-FLUORO-2-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 5-FLUORO-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 5-FLUORO-2-(MORPHOLINOCARBONYL)PHENYLBORONIC ACID; 5-FLUORO-2-(TRIFLUOROETHOXY)PHENYLBORONIC ACID; 5-FLUORO-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-FLUORO-2,3-DIMETHOXYPHENYLBORONIC ACID; 5-FLUORO-2-HYDROXYMETHYLPHENYLBORONIC ACID; 5-FLUORO-2-HYDROXYPHENYLBORONIC ACID; 5-FLUORO-2-HYDROXYPYRIDINE-4-BORONIC ACID; 5-FLUORO-2-ISOPROPOXYPHENYLBORONIC ACID; 5-FLUORO-2-ISOPROPOXYPYRIDINE-4-BORONIC ACID; 5-FLUORO-2-METHOXYCARBONYLPHENYLBORONIC ACID; 5-FLUORO-2-METHOXYPHENYLBORONIC ACID; 5-FLUORO-2-METHOXYPYRIDINE-3-BORONIC ACID; 5-FLUORO-2-METHOXYPYRIDINE-4-BORONIC ACID; 5-FLUORO-2-METHYLPHENYLBORONIC ACID; 5-FLUORO-2-METHYLPYRIDINE-4-BORONIC ACID; 5-FLUORO-2-NITROBENZENEBORONIC ACID; 5-FLUORO-2-PROPOXYPHENYLBORONIC ACID; 5-FLUORO-3-METHYLBENZO[B]THIOPHEN-2-YLBORONIC ACID; 5-FLUORO-3-NITROPYRIDIN-2-YLBORONIC ACID; 5-FLUORO-4-METHOXYPYRIMIDIN-2-YLBORONIC ACID; 5-FLUORO-6-HYDROXYPYRIDIN-3-YLBORONIC ACID; 5-FLUORO-6-METHYLPYRIDINE-2-BORONIC ACID; 5-FLUOROBENZOFURAN-2-YLBORONIC ACID; 5-FLUOROBENZOTHIOPHENE-2-BORONIC ACID; 5-FLUOROPYRAZINE-2-BORONIC ACID; 5-FLUOROPYRIDINE-2-BORONIC ACID; 5-FLUOROPYRIDINE-3-BORONIC ACID; 5-FLUORO-PYRROL-3-YLBORONIC ACID; 5-FLUOROQUINOLINE-8-BORONIC ACID; 5H-[1,3]DIOXOLO[4,5-F]INDOL-7-YLBORONIC ACID; 5-HEXENYLBORONIC ACID; 5-HEXYLTHIOPHENE-2-BORONIC ACID; 5-HEXYLTHIOPHENE-3-BORONIC ACID; 5-HYDROXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 5-HYDROXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-HYDROXY-2-METHOXYPHENYLBORONIC ACID; 5-HYDROXY-2-METHYLPHENYLBORONIC ACID; 5-HYDROXYBENZOTHIAZOLE-2-BORONIC ACID; 5-HYDROXYMETHYL-2-METHOXYPHENYLBORONIC ACID; 5-HYDROXYMETHYLTHIOPHENE-2-BORONIC ACID; 5-HYDROXYNAPHTHALENE-1-BORONIC ACID; 5-HYDROXYNAPHTHALENE-2-BORONIC ACID; 5-HYDROXYPYRAZINE-2-BORONIC ACID; 5-HYDROXYPYRIDINE-3-BORONIC ACID; 5-HYDROXYQUINOLINE-2-BORONIC ACID; 5-HYDROXYQUINOLINE-3-BORONIC ACID; 5-HYDROXYQUINOLINE-4-BORONIC ACID; 5-HYDROXYQUINOLINE-6-BORONIC ACID; 5-HYDROXYQUINOLINE-7-BORONIC ACID; 5-HYDROXYQUINOLINE-8-BORONIC ACID; 5-INDOLYLBORONIC ACID; 5-ISOPROPYL-2-METHOXYPHENYLBORONIC ACID; 5-ISOPROPYL-2-METHOXYQUINOLIN-3-YLBORONIC ACID; 5-ISOPROPYLTHIOPHENE-3-BORONIC ACID; 5-METHOXY-1-(PHENYLSULFONYL)-1H-PYRROLO[3,2-B]PYRIDIN-2-YLBORONIC ACID; 5-METHOXY-1-[(4-METHYLPHENYL)SULFONYL]-1H-INDOL-3-YLBORONIC ACID; 5-METHOXY-1H-INDOL-3-YLBORONIC ACID; 5-METHOXY-1H-INDOLE-2-BORONIC ACID; 5-METHOXY-1H-PYRROLO[3,2-B]PYRIDIN-6-YLBORONIC ACID; 5-METHOXY-1-METHYL-1H-INDOL-3-YLBORONIC ACID; 5-METHOXY-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 5-METHOXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 5-METHOXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-METHOXY-2-METHYLPHENYLBORONIC ACID; 5-METHOXYBENZO[B]THIOPHENE-2-BORONIC ACID; 5-METHOXYBENZOFURAN-2-BORONIC ACID; 5-METHOXYBENZOTHIAZOLE-2-BORONIC ACID; 5-METHOXYCARBONYL-1H-INDOLE-2-BORONIC ACID; 5-METHOXYCARBONYL-2-METHYLPHENYLBORONIC ACID; 5-METHOXYFURAN-2-YLBORONIC ACID; 5-METHOXYPYRAZINE-2-BORONIC ACID; 5-METHOXYPYRIDINE-2-BORONIC ACID; 5-METHOXYPYRIDINE-3-BORONIC ACID; 5-METHOXYTHIOPHENE-2-BORONIC ACID; 5-METHYL-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 5-METHYL-1-HEXENYLBORONIC ACID; 5-METHYL-1H-INDAZOLE-4-BORONIC ACID; 5-METHYL-1H-INDAZOLE-6-BORONIC ACID; 5-METHYL-1H-INDOL-4-YLBORONIC ACID; 5-METHYL-1H-INDOLE-2-BORONIC ACID; 5-METHYL-1-PHENYL-1H-PYRAZOL-4-YLBORONIC ACID; 5-METHYL-2-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(2,4,5-TRICHLOROPHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(2,4,5-TRICHLOROPHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(METHYLTHIO)PHENYLBORONIC ACID; 5-METHYL-2-(PERFLUOROPHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(PERFLUOROPHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 5-METHYL-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YLBORONIC ACID; 5-METHYL-2-PENTYLOXYPYRIDINE-3-BORONIC ACID; 5-METHYL-2-PROPOXYPHENYLBORONIC ACID; 5-METHYL-3-PHENYL-4-ISOXAZOLYLBORONIC ACID; 5-METHYL-5H-PYRROLO[2,3-B]PYRAZIN-3-YLBORONIC ACID; 5-METHYL-6-(METHYL-D3)-PYRIDINE-3-BORONIC ACID; 5-METHYL-6-(METHYLTHIO)PYRIDIN-3-YLBORONIC ACID; 5-METHYL-6-(MORPHOLIN-4-YL)PYRIDINE-3-BORONIC ACID; 5-METHYL-6-MORPHOLINOPYRIDIN-3-YLBORONIC ACID HYDROCHLORIDE; 5-METHYL-6-THIOMORPHOLINOPYRIDIN-3-YLBORONIC ACID; 5-METHYLBENZO[B]THIOPHEN-3-YLBORONIC ACID; 5-METHYLBENZO[B]THIOPHENE-2-BORONIC ACID; 5-METHYLFURAN-2-BORONIC ACID; 5-METHYLFURAN-3-YLBORONIC ACID; 5-METHYLISOXAZOL-4-YLBORONIC ACID; 5-METHYLPYRAZINE-2-BORONIC ACID; 5-METHYLPYRIDINE-2-BORONIC ACID; 5-METHYLPYRIDINE-3-BORONIC ACID; 5-METHYL-PYRROL-3-YLBORONIC ACID; 5-METHYLTHIOPHENE-2-BORONIC ACID; 5-METHYLTHIOPHENE-3-BORONIC ACID; 5-MORPHOLINOPYRAZINE-2-BORONIC ACID; 5-MORPHOLINOPYRIDIN-2-YLBORONIC ACID; 5-MORPHOLINOPYRIDIN-3-YLBORONIC ACID; 5-NITRO-1H-INDOL-2-YLBORONIC ACID; 5-NITROISOQUINOLINE-8-BORONIC ACID; 5-NITROPYRIDIN-2-YLBORONIC ACID; 5-PENTYLOXYTHIOPHENE-2-BORONIC ACID; 5-PENTYLTHIOPHENE-2-BORONIC ACID; 5-PENTYLTHIOSELENOPHENE-2-BORONIC ACID; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-BORONIC ACID; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-BORONIC ACID; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-BORONIC ACID; 5-PHENYL-2-THIENYLBORONIC ACID; 5-PHENYL-3-PYRIDINYL BORONIC ACID; 5-PHENYLFURAN-2-BORONIC ACID; 5-PHENYLPYRIDINE-2-BORONIC ACID; 5-PHENYLPYRIMIDINE-2-BORONIC ACID; 5-PHENYLPYRIMIDINE-4-BORONIC ACID; 5-PHENYL-PYRROL-3-YLBORONIC ACID; 5-PHENYLTHIOPHEN-3-YLBORONIC ACID; 5-PROPOXYBENZOFURAN-2-YLBORONIC ACID; 5-PROPYLPYRIMIDIN-2-YLBORONIC ACID; 5-PROPYLTHIOPHENE-2-BORONIC ACID; 5-SULFAMOYLPYRIDINE-3-BORONIC ACID; 5-SULFAMOYLTHIOPHEN-2-YLBORONIC ACID; 5-TERT-BUTOXYCARBONYLTHIOPHENE-2-BORONIC ACID; 5-TERT-BUTYL-2-CHLOROPHENYLBORONIC ACID; 5-TERT-BUTYL-2-ETHOXYPHENYLBORONIC ACID; 5-TERT-BUTYL-2-FURANBORONIC ACID; 5-TERT-BUTYL-2-METHOXYBENZENEBORONIC ACID; 5-TERT-BUTYLTHIOPHENE-2-BORONIC ACID; 5-TERT-BUTYLTHIOPHENE-3-BORONIC ACID; 5-TRIFLUOROMETHYL-1H-PYRAZOL-3-YLBORONIC ACID; 5-TRIFLUOROMETHYL-1H-PYRAZOL-4-YLBORONIC ACID; 5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 5-TRIFLUOROMETHYLQUINOLINE-8-BORONIC ACID; 5-TRIMETHYLSILYLTHIOPHENE-2-BORONIC ACID; 6-(1,4-DIOZA-8-AZASPIRO[4.5]DEC-8-YL)PYRIDINE-3-BORONIC ACID; 6-(1-CYANOCYCLOPROPYL)PYRIDINE-3-BORONIC ACID; 6-(1H-1,2,4-TRIAZOL-1-YL)PYRIDIN-3-YLBORONIC ACID; 6-(1H-IMIDAZOL-2-YL)PYRIDIN-3-YLBORONIC ACID; 6-(1H-PYRIDIN-2-ONE)PYRIDINE-2-BORONIC ACID; 6-(1-METHYL-1H-TETRAZOL-5-YL)PYRIDIN-3-YLBORONIC ACID; 6-(2-(METHOXYMETHOXY)PROPAN-2-YL)PYRIDIN-2-YLBORONIC ACID; 6-(2-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(2,3-DIFLUOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(2,3-DIFLUOROPHENYL)-2-METHYLPYRIDINE-3-BORONIC ACID; 6-(2,4,5-TRICHLOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(2,4-DIMETHYLPHENOXY)PYRIDIN-3-YLBORONIC ACID; 6-(2-CYANOPROPAN-2-YL)PYRIDIN-3-YLBORONIC ACID; 6-(2-ETHYLIMIDAZOL-1-YL)PYRIDINE-2-BORONIC ACID; 6-(2-FURYL)PYRIDINE-2-BORONIC ACID; 6-(2-HYDROXYPROPAN-2-YL)PYRIDINE-2-BORONIC ACID; 6-(2-HYDROXYPROPAN-2-YL)PYRIDINE-3-BORONIC ACID; 6-(2-METHOXY-2-OXOETHOXY)PYRIDINE-3-BORONIC ACID; 6-(2-METHYL-2H-TETRAZOL-5-YL)PYRIDIN-3-YLBORONIC ACID; 6-(2-METHYLIMIDAZOL-1-YL)PYRIDINE-2-BORONIC ACID; 6-(2-METHYLPHENYL)PYRIDINE-2-BORONIC ACID; 6-(2-METHYLPIPERIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(2-MORPHOLINOETHOXY)PYRIDINE-3-BORONIC ACID; 6-(2-THIENYL)PYRIDINE-2-BORONIC ACID; 6-(3-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(3-FURAN)PYRIDINE-2-BORONIC ACID; 6-(3-HYDROXYOXETAN-3-YL)PYRIDIN-3-YLBORONIC ACID; 6-(3-HYDROXYPYRROLIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(3-METHYL-1H-PYRAZOL-1-YL)PYRIDINE-2-BORONIC ACID; 6-(3-METHYLPHENYL)PYRIDINE-2-BORONIC ACID; 6-(3-METHYLPIPERIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(3-THIENYL)PYRIDINE-2-BORONIC ACID; 6-(4-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(4-ACETYLPIPERAZIN-1-YL)PYRIDIN-3-YLBORONIC ACID; 6-(4-CHLOROPHENOXY)PYRIDIN-3-YLBORONIC ACID; 6-(4-FLUOROPHENYL)PYRIDINE-3-BORONIC ACID; 6-(4-HYDROXYPIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 6-(4-METHOXYBENZYLCARBAMOYL)PYRIDINE-3-BORONIC ACID; 6-(4-METHOXYBENZYLOXY)PYRIDIN-3-YLBORONIC ACID; 6-(4-METHOXYPHENOXY)PYRIDIN-3-YLBORONIC ACID; 6-(4-METHYL-1H-PYRAZOL-1-YL)PYRIDINE-2-BORONIC ACID; 6-(4-METHYLPHENOXY)PYRIDIN-3-YLBORONIC ACID; 6-(4-METHYLPHENYL)PYRIDINE-2-BORONIC ACID; 6-(4-METHYLPIPERAZIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(4-METHYLPIPERIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(4-MORPHOLINYL)-3-PYRIDINYLBORONIC ACID; 6-(4-MORPHOLINYLMETHYL)-3-PYRIDINYL BORONIC ACID; 6-(4-N-BOC-PIPERAZINE-1-YL)-3-PYRIDINYL BORONIC ACID; 6-(5-CHLOROPYRIDIN-3-YLOXY)PYRIDIN-3-YLBORONIC ACID; 6-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PYRIDIN-3-YLBORONIC ACID; 6-(6-CHLOROPYRIDIN-3-YLOXY)PYRIDIN-3-YLBORONIC ACID; 6-(AMINOCARBONYL)PYRIDINE-3-BORONIC ACID; 6-(AZEPAN-1-YL)PYRIDIN-3-YLBORONIC ACID; 6-(BENZYLOXY)-2-NAPHTHYLBORONIC ACID; 6-(BENZYLOXY)-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YLBORONIC ACID; 6-(BOC-METHYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(CYCLOBUTOXY)PYRIDINE-2-BORONIC ACID; 6-(CYCLOBUTYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(CYCLOHEXYL)PYRIDINE-2-BORONIC ACID; 6-(CYCLOHEXYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(CYCLOHEXYLOXY)PYRIDINE-2-BORONIC ACID; 6-(CYCLOPENTOXY)PYRIDINE-2-BORONIC ACID; 6-(CYCLOPENTYL)PYRIDINE-2-BORONIC ACID; 6-(CYCLOPENTYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(CYCLOPROPYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(CYCLOPROPYLMETHOXY)PYRAZIN-2-YLBORONIC ACID; 6-(DIETHYLAMINO)-4-ETHYLPYRIDIN-3-YLBORONIC ACID; 6-(DIETHYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(DIETHYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(DIFLUOROMETHOXY)BENZOTHIAZOLE-2-BORONIC ACID; 6-(DIMETHOXYMETHYL)PYRIDIN-2-YLBORONIC ACID; 6-(DIMETHYLAMINO)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 6-(DIMETHYLAMINO)-2-METHYLPYRIDINE-3-BORONIC ACID; 6-(DIMETHYLAMINO)-4-ETHYLPYRIDINE-3-BORONIC ACID; 6-(DIMETHYLAMINO)-4-ISOPROPOXYPYRIDIN-3-YLBORONIC ACID; 6-(DIMETHYLAMINO)-4-METHOXYPYRIDIN-3-YLBORONIC ACID; 6-(DIMETHYLAMINO)-4-METHYLPYRIDINE-3-BORONIC ACID; 6-(DIMETHYLAMINO)-5-METHYLPYRIDIN-3-YLBORONIC ACID; 6-(DIMETHYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(DIMETHYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(DIMETHYLCARBAMOYL)PYRIDINE-3-BORONIC ACID; 6-(ETHANESULFONYL)PYRIDINE-3-BORONIC ACID; 6-(ETHYL(METHYL)AMINO)PYRIDINE-3-BORONIC ACID; 6-(ETHYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(ETHYLCARBAMOYL)PYRIDIN-3-YLBORONIC ACID; 6-(ETHYLTHIO)-5-METHYLPYRIDIN-3-YLBORONIC ACID; 6-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 6-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 6-(HYDROXYMETHYL)PYRIDINE-2-BORONIC ACID; 6-(HYDROXYMETHYL)PYRIDINE-3-BORONIC ACID; 6-(IMIDAZOL-1-YL)PYRIDINE-2-BORONIC ACID; 6-(ISO-PROPOXY)PYRIDINE-2-BORONIC ACID; 6-(ISOPROPYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(ISO-PROPYL-D7)-PYRIDINE-3-BORONIC ACID; 6-(ISOPROPYLTHIO)PYRIDINE-3-BORONIC ACID; 6-(METHOXYCARBONYL)INDOLE-2-BORONIC ACID; 6-(METHOXYCARBONYL)PYRIDINE-2-BORONIC ACID; 6-(METHOXYCARBONYL)PYRIDINE-3-BORONIC ACID; 6-(METHOXYMETHOXY)PYRIDIN-3-YLBORONIC ACID; 6-(METHYLAMINO)PYRIDIN-3-YLBORONIC ACID; 6-(METHYLAMINO)PYRIDIN-3-YLBORONIC ACID HYDROCHLORIDE; 6-(METHYLCARBAMOYL)PYRIDIN-3-YLBORONIC ACID; 6-(METHYL-D3)-PYRIDINE-3-BORONIC ACID; 6-(MORPHOLINOMETHYL)PYRIDIN-3-YLBORONIC ACID; 6-(N,N-METHYLETHYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(NEOPENTYLOXY)PYRIDINE-3-BORONIC ACID; 6-(N-PROPOXY)PYRIDINE-2-BORONIC ACID; 6-(PERFLUOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(PHENYLTHIO)PYRIDIN-3-YLBORONIC ACID; 6-(PIPERAZIN-1-YL)PYRIDINE-3-BORONIC ACID; 6-(PIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 6-(PIPERIDIN-1-YL)PYRIDIN-3-YLBORONIC ACID; 6-(PIPERIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(PIVALAMIDO)PYRIDINE-3-BORONIC ACID; 6-(PROP-1-YNYL)PYRAZIN-2-YLBORONIC ACID; 6-(PROP-1-YNYL)PYRIMIDIN-4-YLBORONIC ACID; 6-(PROPYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(PYRIDIN-3-YLOXY)PYRIDINE-3-BORONIC ACID; 6-(PYRROL-1-YL)-3-PYRIDINYL BORONIC ACID; 6-(PYRROLIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 6-(PYRROLIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(PYRROLIDIN-1-YL)PYRIDINE-3-BORONIC ACID; 6-(QUINOLIN-3-YL)PYRIDIN-3-YLBORONIC ACID; 6-(TERT-BUTOXY)PYRIDINE-2-BORONIC ACID; 6-(TERT-BUTOXYCARBONYLAMINO)PYRIDIN-3-YLBORONIC ACID; 6-(TERT-BUTOXYMETHYL)PYRIDIN-3-YLBORONIC ACID; 6-(TERT-BUTYL)PYRIDINE-2-BORONIC ACID; 6-(TERT-BUTYLDIMETHYLSILYLOXY)-1H-INDOL-2-YLBORONIC ACID; 6-(TETRAHYDRO-2H-PYRAN-2-YLOXY)-2-NAPHTHYLBORONIC ACID; 6-(TETRAHYDRO-2H-PYRAN-4-YLOXY)PYRIDIN-3-YLBORONIC ACID; 6-(TETRAHYDRO-FURAN-3-YLOXY)PYRIDINE-2-BORONIC ACID; 6-(TRIFLUOROMETHYL)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-(TRIFLUOROMETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-(TRIFLUOROMETHYL)-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-(TRIFLUOROMETHYL)PYRIDINE-2-BORONIC ACID; 6,6,6-TRIFLUOROHEXANEBORONIC ACID; 6,7-DIHYDRO-5H-CYCLOPENTA[B]PYRIDINE-2-BORONIC ACID; 6,7-DIMETHOXY-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 6-[(4-CHLOROPHENYL)THIO]PYRIDIN-3-YLBORONIC ACID; 6-[(4-METHYLPHENYL)THIO]PYRIDIN-3-YLBORONIC ACID; 6-[(BENZYLOXY)METHYL]PYRIDINE-2-BORONIC ACID; 6-[(DIETHYLAMINO)CARBONYL]PYRIDINE-3-BORONIC ACID; 6-[4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL]PYRIDINE-2-BORONIC ACID; 6-ACETAMIDO-4-METHYLPYRIDINE-3-BORONIC ACID; 6-ACETAMIDO-5-METHYLPYRIDIN-3-YLBORONIC ACID; 6-ACETOXYNAPHTHALEN-2-YLBORONIC ACID; 6-AMINO-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-AMINO-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 6-AMINO-2-METHOXYPYRIDINE-3-BORONIC ACID; 6-AMINO-2-METHOXYPYRIDINE-4-BORONIC ACID; 6-AMINO-2-METHYLPYRIDINE-3-BORONIC ACID; 6-AMINO-2-METHYLPYRIMIDIN-4-YLBORONIC ACID; 6-AMINO-4-(TRIFLUOROMETHYL)PYRIDIN-3-YLBORONIC ACID; 6-AMINO-4-CHLOROPYRIDIN-3-YLBORONIC ACID; 6-AMINO-5-FLUOROPYRIDINE-3-BORONIC ACID; 6-AMINO-5-METHOXYPYRIDIN-3-YLBORONIC ACID; 6-AMINO-5-METHYLPYRIDINE-3-BORONIC ACID; 6-AMINO-5-SULFAMOYLPYRIDINE-3-BORONIC ACID; 6-AMINOPYRAZINE-2-BORONIC ACID; 6-AMINOPYRIDAZIN-3-YL-3-BORONIC ACID; 6-AMINOPYRIDINE-2-BORONIC ACID; 6-AMINOPYRIDINE-3-BORONIC ACID-HCL; 6-BENZOXY-5-FLUOROPYRIDINE-3-BORONIC ACID; 6-BENZYLOXY-1-BOC-INDOLE-2-BORONIC ACID; 6-BENZYLOXY-1H-INDOLE-2-BORONIC ACID; 6-BENZYLOXY-2-FLUORO-3-METHYLPHENYLBORONIC ACID; 6-BENZYLOXYPYRIDINE-3-BORONIC ACID; 6-BORONOBENZO[D][1,3]DIOXOLE-5-CARBOXYLIC ACID; 6-BUTOXY-5-CHLOROPYRIDINE-3-BORONIC ACID; 6-BUTOXY-5-METHYLPYRIDINE-3-BORONIC ACID; 6-BUTOXYPYRIDINE-3-BORONIC ACID; 6-CARBOXY-2-NAPHTHALENEBORONIC ACID; 6-CARBOXYPYRIDINE-3-BORONIC ACID; 6-CHLORO-(4-TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-CHLORO(PYRAZINE-D2)-2-BORONIC ACID; 6-CHLORO-1-METHYL-1H-PYRROLO[2,3-B]PYRIDIN-2-YLBORONIC ACID; 6-CHLORO-1-METHYLINDOLE-2-BORONIC ACID; 6-CHLORO-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6′-CHLORO-2,3′-BIPYRIDIN-5-YLBORONIC ACID; 6-CHLORO-2,3-DIFLUOROPHENYLBORONIC ACID; 6-CHLORO-2-FLUORO-3-METHOXYPHENYLBORONIC ACID; 6-CHLORO-2-FLUOROPYRIDINE-3-BORONIC ACID; 6-CHLORO-2-METHOXYPYRIDINE-3-BORONIC ACID; 6-CHLORO-2-METHYLPYRIDINE-3-BORONIC ACID; 6-CHLORO-2-METHYLPYRIMIDINE-4-BORONIC ACID; 6-CHLORO-3-METHOXYPYRIDINE-2-BORONIC ACID; 6-CHLORO-3-METHYLPYRIDINE-2-BORONIC ACID; 6-CHLORO-3-OXOISOINDOLIN-5-YLBORONIC ACID; 6-CHLORO-4-(TRIFLUOROMETHYL)PYRIDINE-2-BORONIC ACID; 6-CHLORO-4-FLUOROPYRIDINE-3-BORONIC ACID; 6-CHLORO-4-METHOXYPYRIDINE-2-BORONIC ACID; 6-CHLORO-4-METHYLPYRIDINE-2-BORONIC ACID; 6-CHLORO-5-METHOXYPYRIDINE-3-BORONIC ACID; 6-CHLOROBENZO[B]THIOPHEN-3-YLBORONIC ACID; 6-CHLOROPYRAZINE-2-BORONIC ACID; 6-CHLOROPYRIDAZIN-3-YL-3-BORONIC ACID; 6-CHLOROPYRIDINE-2-BORONIC ACID; 6-CHLOROPYRIMIDINE-4-BORONIC ACID; 6-CYANO-3-METHYLBENZO[B]THIOPHEN-2-YLBORONIC ACID; 6-CYANO-3-OXOISOINDOLIN-5-YLBORONIC ACID; 6-CYANOBENZO[B]THIOPHEN-2-YLBORONIC ACID; 6-CYANOPYRAZINE-2-BORONIC ACID; 6-CYANOPYRIDIN-3-YLBORONIC ACID; 6-CYANOPYRIDINE-2-BORONIC ACID; 6-CYCLOPROPYLPYRIDIN-3-YLBORONIC ACID; 6-CYCLOPROPYLPYRIDINE-2-BORONIC ACID; 6-ETHOXY-2-METHYLPYRIDINE-3-BORONIC ACID; 6-ETHOXY-2-NAPHTHALENEBORONIC ACID; 6-ETHOXYPYRIDINE-2-BORONIC ACID; 6-ETHYL-1,6-DIHYDROPYRIMIDIN-5-YLBORONIC ACID; 6-ETHYLPYRIDINE-2-BORONIC ACID; 6-FLUORO-1H-INDOLE-2-BORONIC ACID; 6-FLUORO-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 6-FLUORO-2-(2-METHOXYETHOXY)PYRIDIN-3-YLBORONIC ACID; 6-FLUORO-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-FLUORO-2,3′-BIPYRIDIN-5-YLBORONIC ACID; 6-FLUORO-3-OXOISOINDOLIN-5-YLBORONIC ACID; 6-FLUOROBENZO[B]THIEN-2-YL BORONIC ACID; 6-FLUOROPYRIDAZIN-3-YLBORONIC ACID; 6-FLUOROPYRIDINE-2-BORONIC ACID; 6-FLUOROQUINOLINE-8-BORONIC ACID; 6-HYDROXY-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-HYDROXY-2-METHYLPYRIDINE-3-BORONIC ACID; 6-HYDROXY-2-NAPHTHALENEBORONIC ACID; 6-HYDROXY-5-(TETRAHYDROPYRAN-2-YL)NAPHTHALENE-2-BORONIC ACID; 6-HYDROXYBENZOTHIAZOLE-2-BORONIC ACID; 6-HYDROXYNAPHTHALENE-1-BORONIC ACID; 6-HYDROXYPYRIDIN-3-YLBORONIC ACID; 6-HYDROXYPYRIDINE-2-BORONIC ACID; 6-HYDROXYQUINOLINE-2-BORONIC ACID; 6-HYDROXYQUINOLINE-3-BORONIC ACID; 6-HYDROXYQUINOLINE-4-BORONIC ACID; 6-HYDROXYQUINOLINE-5-BORONIC ACID; 6-HYDROXYQUINOLINE-7-BORONIC ACID; 6-HYDROXYQUINOLINE-8-BORONIC ACID; 6-INDAZOLYBORONIC ACID; 6-INDAZOLYBORONIC ACID HCL; 6-ISOBUTOXY-5-METHYLPYRIDINE-3-BORONIC ACID; 6-ISOPROPOXYBENZO[B]THIOPHEN-2-YLBORONIC ACID; 6-ISOPROPYL-2-METHYLBENZENEBORONIC ACID; 6-ISO-PROPYLPYRIDINE-2-BORONIC ACID; 6-METHOXY-1,5-NAPHTHYRIDINE-4-BORONIC ACID; 6-METHOXY-1,7-NAPHTHYRIDIN-4-YLBORONIC ACID; 6-METHOXY-1H-INDOL-2-YLBORONIC ACID; 6-METHOXY-1H-INDOL-3-YLBORONIC ACID; 6-METHOXY-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-METHOXY-2-ETHYLPYRIDINE-3-BORONIC ACID; 6-METHOXY-2-NAPHTHALENEBORONIC ACID; 6-METHOXY-3-OXOISOINDOLIN-5-YLBORONIC ACID; 6-METHOXY-5-METHYLPYRIDINE-3-BORONIC ACID; 6-METHOXYBENZO[B]THIOPHENE-2-BORONIC ACID; 6-METHOXYBENZOFURAN-2-BORONIC ACID; 6-METHOXYBENZOTHIAZOLE-2-BORONIC ACID; 6-METHOXYPYRIDAZIN-3-YL-3-BORONIC ACID; 6-METHOXYPYRIDINE-2-BORONIC ACID; 6-METHYL-1H-INDAZOLE-4-BORONIC ACID; 6-METHYL-1H-INDAZOLE-5-BORONIC ACID; 6-METHYL-1H-INDOL-3-YLBORONIC ACID; 6-METHYL-1H-INDOLE-2-BORONIC ACID; 6-METHYL-2-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(2,4,5-TRICHLOROPHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(PERFLUOROPHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-NAPHTHALENEBORONIC ACID; 6-METHYLBENZO[B]THIEN-2-YL BORONIC ACID; 6-METHYLBENZOFURAN-2-YLBORONIC ACID; 6-METHYLPYRAZINE-2-BORONIC ACID; 6-METHYLPYRIDINE-2-BORONIC ACID; 6-METHYLPYRIDINE-3-BORONIC ACID; 6-METHYLQUINOLINE-8-BORONIC ACID; 6-MORPHOLINOPYRAZINE-2-BORONIC ACID; 6-MORPHOLINOPYRIDINE-2-BORONIC ACID; 6-NITROPYRIDIN-3-YLBORONIC ACID; 6-OXO-1,6-DIHYDROPYRAZIN-2-YLBORONIC ACID; 6-PENTYLNAPTHALENE-2-BORONIC ACID; 6-PENTYLOXYNAPHTHALENE-2-BORONIC ACID; 6-PHENOXYPYRIDIN-3-YLBORONIC ACID; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-BORONIC ACID; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-BORONIC ACID; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-BORONIC ACID; 6-PHENYLPYRIDINE-2-BORONIC ACID; 6-PHENYLPYRIDINE-3-BORONIC ACID; 6-PHENYLPYRIMIDINE-4-BORONIC ACID; 6-PROPOXYBENZOFURAN-2-YLBORONIC ACID; 6-PROPOXYPYRIDINE-3-BORONIC ACID; 6-PROPYLPYRIDIN-3-YLBORONIC ACID; 6-QUINAZOLINEBORONIC ACID; 6-QUINOLINYLBORONIC ACID HYDRATE; 6-SEC-BUTYLPYRAZIN-2-YLBORONIC ACID; 6-T-BUTYLDIMETHYLSILYLOXY-2-NAPHTHALENEBORONIC ACID; 6-TERT-BUTYLNAPHTHALEN-2-YLBORONIC ACID; 6-TERT-BUTYLPYRIDIN-3-YLBORONIC ACID; 6-THIOMORPHOLINOPYRIDIN-3-YLBORONIC ACID; 7-(DIFLUOROMETHOXY)BENZOTHIAZOLE-2-BORONIC ACID; 7-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 7-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 7-(TERT-BUTYLDIMETHYLSILYLOXY)-1H-INDOL-2-YLBORONIC ACID; 7-(TRIFLUOROMETHYL)PYRIDO[2,3-D]PYRIMIDIN-4-YLBORONIC ACID; 7-CHLORO-1H-PYRAZOLO[3,4-C]PYRIDINE-4-BORONIC ACID; 7-CHLOROBENZO[B]THIOPHEN-3-YLBORONIC ACID; 7-CHLOROQUINOLINE-4-BORONIC ACID; 7-CYANOBENZO[B]THIOPHEN-2-YLBORONIC ACID; 7-FLUORO-2-METHYLQUINOLINE-8-BORONIC ACID; 7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLBORONIC ACID; 7-HYDROXYBENZOTHIAZOLE-2-BORONIC ACID; 7-HYDROXYNAPHTHALENE-1-BORONIC ACID; 7-HYDROXYNAPHTHALENE-2-BORONIC ACID; 7-HYDROXYQUINOLINE-2-BORONIC ACID; 7-HYDROXYQUINOLINE-3-BORONIC ACID; 7-HYDROXYQUINOLINE-4-BORONIC ACID; 7-HYDROXYQUINOLINE-5-BORONIC ACID; 7-HYDROXYQUINOLINE-6-BORONIC ACID; 7-HYDROXYQUINOLINE-8-BORONIC ACID; 7-METHOXY-1H-INDOL-2-YLBORONIC ACID; 7-METHOXY-1H-INDOL-3-YLBORONIC ACID; 7-METHOXY-2-METHYLQUINOLIN-4-YLBORONIC ACID; 7-METHOXYBENZO[B]THIOPHENE-2-BORONIC ACID; 7-METHOXYBENZOFURAN-2-BORONIC ACID; 7-METHOXYBENZOFURAN-3-YLBORONIC ACID; 7-METHOXYBENZOTHIAZOLE-2-BORONIC ACID; 7-METHOXYQUINOLIN-4-YLBORONIC ACID; 7-METHYL-1-(TRIISOPROPYLSILYL)-1H-INDOL-3-YLBORONIC ACID; 7-METHYL-1H-INDAZOLE-4-BORONIC ACID; 7-METHYL-1H-INDAZOLE-5-BORONIC ACID; 7-METHYL-1H-INDOL-2-YLBORONIC ACID; 7-METHYL-1-NAPHTHALENEBORONIC ACID; 7-METHYLIMIDAZO[1,2-A]PYRIDINE-6-BORONIC ACID; 7-PHENYL-1H-INDOL-2-YLBORONIC ACID; 7-PROPOXYBENZOFURAN-2-YLBORONIC ACID; 8-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 8-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 8-CHLORO-1,7-NAPHTHYRIDINE-3-BORONIC ACID; 8-CHLORO-2-METHYL-1,7-NAPHTHYRIDIN-5-YLBORONIC ACID; 8-FLUORO-2-METHYLQUINOLINE-7-BORONIC ACID; 8-FLUORO-7-HYDROXYQUINOXALIN-6-YLBORONIC ACID; 8-FLUOROQUINOLIN-3-YLBORONIC ACID; 8-FLUOROQUINOLIN-6-YLBORONIC ACID; 8-FLUOROQUINOLINE-7-BORONIC ACID; 8-FLUOROQUINOXALIN-6-YLBORONIC ACID; 8-HYDROXYNAPHTHALENE-1-BORONIC ACID; 8-HYDROXYNAPHTHALENE-2-BORONIC ACID; 8-HYDROXYQUINOLINE-2-BORONIC ACID; 8-HYDROXYQUINOLINE-3-BORONIC ACID; 8-HYDROXYQUINOLINE-4-BORONIC ACID; 8-HYDROXYQUINOLINE-5-BORONIC ACID; 8-HYDROXYQUINOLINE-6-BORONIC ACID; 8-HYDROXYQUINOLINE-7-BORONIC ACID; 8-ISOQUINOLINEBORONIC ACID; 8-METHOXYQUINOLINE-7-BORONIC ACID; 8-METHYL-5-QUINOLINYLBORONIC ACID; 8-OXATRICYCLO[7.4.0.0(2,7)]TRIDECA-1(9),2(7),3,5,10,12-HEXAEN-4-YLBORANEDIOL; 8-TRIFLUOROMETHOXYQUINOLINE-5-BORONIC ACID; 8-TRIFLUOROMETHYLQUINOLINE-6-BORONIC ACID; 9,9-DIETHYLFLUORENE-2-BORONIC ACID; 9,9-DIMETHYL-9H-FLUOREN-2-YL-BORONIC ACID; 9-ACRIDINYL-BORONIC ACID; 9-ANTHRACENEBORONIC ACID; 9H-CARBAZOL-3-YLBORONIC ACID; 9H-FLUOREN-9-YLBORONIC ACID; 9-PHENANTHRENEBORONIC ACID; 9-PHENYLCARBAZOLE-3-BORONIC ACID; ABH; ACENAPHTHENE-5-BORONIC ACID; ACETAMIDOMETHYLBORONIC ACID; ACETYL BOROARGININE TRIFLUOROACETATE; ALLENYLBORONIC ACID; ALPHA-(TRIFLUOROMETHYL)ETHENYL BORONIC ACID; AMINO[4-(DIHYDROXYBORYL)PHENYL]ACETIC ACID; B-(1,6-DIHYDRO-6-OXO-3-PYRIDINYL)-BORONIC ACID; B-(1-METHYL-1H-INDOL-4-YL)-BORONIC ACID; B-(2′-CHLORO[2,4′-BIPYRIDIN]-4-YL)-BORONIC ACID; B-(3,6-DIHYDRO-1,1-DIOXIDO-2H-THIOPYRAN-4-YL)-BORONIC ACID; B-(3-ETHYNYLPHENYL)-BORONIC ACID; B-(4-AMINO-3-PYRIDINYL)-BORONIC ACID HYDROCHLORIDE; B-(4′-CYANO[1,1′-BIPHENYL]-4-YL)-BORONIC ACID; B-(5-FLUORO-1,6-DIHYDRO-6-OXO-3-PYRIDINYL)-BORONIC ACID; B-(5-METHOXY-1-METHYL-1H-PYRROLO[3,2-B]PYRIDIN-6-YL)-BORONIC ACID; B-(9,10-DIPHENYL-2-ANTHRACENYL)BORONIC ACID; B-[1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-BORONIC ACID; B-[2-(DIFLUOROMETHYL)-1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-BORONIC ACID; B-[2,6-DIMETHYL-4-(PHENYLMETHOXY)PHENYL]-BORONIC ACID; B-[3-(1-PROPYN-1-YL)PHENYL]-BORONIC ACID; B-[3,4-BIS[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]METHYLPHENYL]-BORONIC ACID; B-[3,5-BIS[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]PHENYL]-BORONIC ACID; B-[4,2′:6′,4″-TERPYRIDIN]-4′-YL-BORONIC ACID; B-[4-[(TETRAHYDRO-1,1-DIOXIDO-2H-THIOPYRAN-4-YL)AMINO]PHENYL]-BORONIC ACID; B-[4-[[(TETRAHYDRO-1,1-DIOXIDO-2H-THIOPYRAN-4-YL)AMINO]SULFONYL]PHENYL]-BORONIC ACID; B-[4-[BIS(4-METHYLPHENYL)AMINO]PHENYL]-BORONIC ACID; B-[5-(3-METHOXYPHENYL)-3-PYRIDINYL]-BORONIC ACID; B-[5-[(PHENYLSULFONYL)AMINO]-3-PYRIDINYL]BORONIC ACID; B-5H-PYRROLO[3,2-B:4,5-B′]DIPYRIDIN-3-YL-BORONIC ACID; B-6-BENZOFURANYL-BORONIC ACID; BEC; BEC AMMONIUM SALT; BEC, HYDROCHLORIDE; BENZAMIDOMETHYLBORONIC ACID; BENZENE-1,4-DIBORONIC ACID MONO-MIDA ESTER; BENZIMIDAZOLE-2-BORONIC ACID; BENZO[B]THIOPHENE-2-BORONIC ACID; BENZO[C][1,2,5]OXADIAZOLE-5-BORONIC ACID; BENZO[D]ISOXAZOL-4-YLBORONIC ACID; BENZO[D]ISOXAZOL-5-YLBORONIC ACID; BENZO[D]ISOXAZOL-6-YLBORONIC ACID; BENZO[D]OXAZOL-7-YLBORONIC ACID; BENZOCYCLOBUTENE-4-BORONIC ACID; BENZOFURAN-2-BORONIC ACID; BENZOFURAN-3-BORONIC ACID; BENZOFURAN-5-BORONIC ACID; BENZOPYRAZINE-6-BORONIC ACID HCL; BENZOTHIOPHENE-3-BORONIC ACID; BENZYLBORONIC ACID; BIPHENYL-2-YLBORONIC ACID HYDRATE; BOC-3-AMINOPYRIDINE-4-BORONIC ACID; BOC-4-AMINO-6-METHYLPYRIDINE-3-BORONIC ACID; BOC-L-PROLINEBORONIC ACID; BORONIC ACID, (2,3,4,5-TETRAHYDRO-3-METHYL-1H-3-BENZAZEPIN-7-YL)-; BORONIC ACID, [2-(1-PIPERIDINYLCARBONYL)PHENYL]-; BORONIC ACID, [2-(1-PYRROLIDINYLCARBONYL)PHENYL]-; BORONIC ACID, [3-(1-METHYLETHYL)-1H-INDAZOL-4-YL]-; BORONIC ACID, [3-(1-NAPHTHALENYL)PHENYL]-; BORONIC ACID, [3-(1-PYRROLIDINYLMETHYL)PHENYL]-, HYDROCHLORIDE, PROPAN-2-OL; BORONIC ACID, [3-(PHENYLMETHYL)PHENYL]-; BORONIC ACID, [4-(1-PIPERIDINYLMETHYL)PHENYL]-, HYDROCHLORIDE; BORONIC ACID, [4-(1-PYRROLIDINYLMETHYL)PHENYL]-, HYDROCHLORIDE; BORONIC ACID, [4-(2-AMINO-3-HYDROXYPROPYL)PHENYL]-; BORONIC ACID, [4-(MERCAPTOMETHYL)PHENYL]-; BORONIC ACID, [4-(PHENYLMETHYL)PHENYL]-; BORONIC ACID, [4-[(2R)-2-AMINO-3-HYDROXYPROPYL]PHENYL]-; BORONIC ACID, [4-[(2S)-2-AMINO-3-HYDROXYPROPYL]PHENYL]-; BORONIC ACID, [4-CHLORO-1-[TRIS(1-METHYLETHYL)SILYL]-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-; BORONIC ACID, B-(1,2,3,4-TETRAHYDRO-7-ISOQUINOLINYL)-; BORONIC ACID, B-(3-METHOXY-6-PHENYL-4-PYRIDAZINYL)-; BORONIC ACID, B-(5-HYDROXYBENZO[B]THIEN-2-YL)-; BORONIC ACID, B-[2-[1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL]PHENYL]-; BORONIC ACID, B-[3,5-DICHLORO-2-(2,2-DIFLUOROETHOXY)PHENYL]-; BORONIC ACID, B-[3-METHOXY-6-(6-METHOXY-3-PYRIDINYL)-4-PYRIDAZINYL]-; BORONIC ACID, B-[5-(2-METHYLPHENYL)-3-PYRIDINYL]-; BORONIC ACID, B-[5-[(E)-[4-OXO-3-(2-PROPEN-1-YL)-2-THIOXO-5-THIAZOLIDINYLIDENE]METHYL]-2-THIENYL]-; BORONIC ACID, B-[6-(6-FLUORO-3-PYRIDINYL)-3-METHOXY-4-PYRIDAZINYL]-; BORTEZOMIB; BORTEZOMIB-D8; B-PYRIDO[2,3-B]PYRAZIN-7-YL-BORONIC ACID; BUT-1-ENE-4-BORONIC ACID; BZ-PHE-BOROLEU; CARBAZOL-4-YLBORONIC ACID; CARBAZOLE-1-BORONIC ACID; CEP-18770; CHROMABORA II; CHROMAN-8-BORONIC ACID; CIS-1-PROPENE-1-BORONIC ACID; CIS-2-METHYL-CYCLOPROPYL BORONIC ACID; COMBI-BLOCKS BB-2570; CYCLOBUTYLBORONIC ACID; CYCLOHEPTANEBORONIC ACID; CYCLOHEPTEN-1-YLBORONIC ACID; CYCLOHEXYLBORONIC ACID; CYCLOHEXYLMETHYLBORONIC ACID; CYCLOPENTEN-1-YLBORONIC ACID; CYCLOPENTYLBORONIC ACID; CYCLOPROPYLBORONIC ACID; CYCLOPROPYLBORONIC ACID MONOHYDRATE; DIBENZOFURAN-1-BORONIC ACID; DIBENZOFURAN-4-BORONIC ACID; DIBENZOTHIOPHENE-2-BORONIC ACID; DIBENZOTHIOPHENE-4-BORONIC ACID; DITHIENO[3,2-B:2′,3′-D]THIOPHENE-2-BORONIC ACID; E-(4-BUTYLPHENYL)ETHENYLBORONIC ACID; E-1-OCTENYLBORONIC ACID; E-HEXEN-1-YLBORONIC ACID; E-PENTADECENE-1-BORONIC ACID; E-PHENYLETHENYLBORONIC ACID; ETHYL (3-BORONOBENZOYLAMINO)ACETATE; ETHYL (4-BORONOBENZOYLAMINO)ACETATE; ETHYL 3-BORONOCINNAMATE; ETHYL 4-BORONOCINNAMATE; ETHYLBORONIC ACID; ETHYL-D5-BORONIC ACID; FERROCENEBORONIC ACID; FLUORANTHENE-3-BORONIC ACID; FLUORENE-2-BORONIC ACID; FURAN-2-BORONIC ACID; FURAN-3-BORONIC ACID; FURO[2,3-C]PYRIDINE-7-BORONIC ACID; FURO[3,2-C]PYRIDINE-4-BORONIC ACID; HEPT-6-ENYLBORONIC ACID; HEPTYLBORONIC ACID; HEX-5-EN-2-YLBORONIC ACID; HEXADECYLBORONIC ACID; H-PYRAZOLO[3,4-B]PYRIDINE-4-BORONIC ACID; IMIDAZO[1,2-A]PYRAZINE-6-BORONIC ACID; IMIDAZO[1,2-A]PYRIDIN-3-YLBORONIC ACID; IMIDAZO[1,2-A]PYRIDIN-8-YLBORONIC ACID; IMIDAZO[1,2-A]PYRIDINE-6-BORONIC ACID; IMIDAZO[1,2-A]PYRIMIDIN-3-YLBORONIC ACID; IMIDAZO[1,2-A]PYRIMIDIN-6-YLBORONIC ACID; IMIDAZO[1,5-A]PYRIDIN-5-YLBORONIC ACID; IMIDAZOLE-2-BORONIC ACID; INDAZOLE-3-BORONIC ACID; INDAZOLE-4-BORONIC ACID HYDROCHLORIDE; INDOLE-3-BORONIC ACID; INDOLE-4-BORONIC ACID; INDOLE-6-BORONIC ACID; INDOLE-7-BORONIC ACID; INDOLIN-6-YLBORONIC ACID; ISOBUTYLBORONIC ACID; ISOINDOLIN-1-ONE-4-BORONIC ACID; ISOINDOLIN-1-ONE-5-BORONIC ACID; ISOPROPYLBORONIC ACID; ISO-PROPYL-D7-BORONIC ACID; ISOQUINOLIN-4-YLBORONIC ACID HYDROCHLORIDE; ISOQUINOLIN-5-YLBORONIC ACID HYDROCHLORIDE; ISOQUINOLIN-6-YLBORONIC ACID HYDROCHLORIDE; ISOQUINOLINE-3-BORONIC ACID; ISOQUINOLINE-4-BORONIC ACID; ISOQUINOLINE-5-BORONIC ACID; ISOQUINOLINE-6-BORONIC ACID; ISOQUINOLINE-7-BORONIC ACID; ISOTHIAZOLE-4-BORONIC ACID; ISOTHIAZOLE-5-BORONIC ACID; ISOXAZOL-3-YLBORONIC ACID; ISOXAZOLE-4-BORONIC ACID; ISOXAZOLE-5-BORONIC ACID; LITHIUM (3-FLUORO-6-METHYLPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (3-METHYLPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (4-(1,3-DIOXOLAN-2-YL)PYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (4-METHYLPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (5-CHLOROPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (5-CYANOPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (5-FLUOROPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (5-METHOXYPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (6-(1,3-DIOXOLAN-2-YL)PYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (6-METHOXYPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (PYRAZIN-2-YL)TRIHYDROXYBORATE; LITHIUM (PYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (QUINOLIN-2-YL)TRIHYDROXYBORATE; LITHIUM TRIHYDROXY(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)BORATE; LITHIUM TRIHYDROXY(5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)BORATE; LITHIUM TRIHYDROXY(6-(TRIFLUOROMETHYL)PYRIDIN-2-YL)BORATE; LITHIUM TRIHYDROXY(6-METHYLPYRIDIN-2-YL)BORATE; LITHIUM TRIHYDROXY(ISOQUINOLIN-1-YL)BORATE; L-PHENYLALANINE, 4-BORONO-, HYDROCHLORIDE; M-AMINOPHENYLBORONIC ACID-AGAROSE; METHYL (4-BORONOBENZOYLAMINO)ACETATE; METHYL 3-(3-BORONOPHENYL)PROPIONATE; METHYL 3-(4-BORONOBENZAMIDO)PROPIONATE; METHYL 3-BORONO-4-METHOXYBENZOATE; METHYL 4-BORONO-3-CHLOROBENZOATE; METHYL 4-BORONOBENZENESULFONAMIDE; METHYL PYRIDINE-2-BORONIC ACID-4-CARBOXYLATE; METHYLBORONIC ACID; METHYL-D3-BORONIC ACID; MLN-2238; N-(2-DIHYDROXYBORYLBENZYL)-N-METHYLM-TOLYLAMINE; N-(2-HYDROXYETHYL) 3-BORONOBENZENESULFONAMIDE; N-(2-HYDROXYETHYL) 4-BORONOBENZENESULFONAMIDE; N-(3,4-DIFLUOROPHENYL) 3-BORONOBENZAMIDE; N-(3-CHLORO-2-METHYLPHENYL) 3-BORONOBENZAMIDE; N-(3-CHLORO-4-FLUOROPHENYL) 3-BORONOBENZAMIDE; N-(4-FLUOROPHENYL) 4-BORONOBENZENESULFONAMIDE; N-(4-METHOXYBENZYL) 4-BORONOBENZAMIDE; N-(4-PHENYLBORONIC)SUCCINAMIC ACID; N-(BOC)-4-FLUOROINDOLE-2-BORONIC ACID; N-(BOC)-6-FLUOROINDOLE-2-BORONIC ACID; N-(BOC)-7-FLUOROINDOLE-2-BORONIC ACID; N-(METHYL-D3)-INDAZOLE-5-BORONIC ACID; N-(METHYL-D3)-INDAZOLE-6-BORONIC ACID; N-(P-TOLUENESULFONYL)INDOLE-3-BORONIC ACID; N-(TERT-BUTOXYCARBONYL)-4-METHYLINDOLE-2-BORONIC ACID; N-(THIAZOLINE-2-YL) 3-BORONOBENZAMIDE; N-(THIAZOLINE-2-YL) 4-BORONOBENZAMIDE; N,N,2-TRIMETHYLANILINE-4-BORONIC ACID; N,N-DIETHYL 4-BORONOBENZENESULFONAMIDE; N-[4-METHOXY-3-(4-METHYLPIPERAZIN-1-YL)-PHENYL]-4-CARBAMIDOBENZENEBORONIC ACID; N-2-TRIFLUOROMETHYLPHENYL 4-BORONOBENZAMIDE; N-BENZYL 3-BORONO-4-METHYLBENZENESULFONAMIDE; N-BENZYL 3-BORONOBENZENESULFONAMIDE; N-BOC-5-(DIETHOXYMETHYL)PYRROLE-2-BORONIC ACID; N-BOC-5-CHLORO-INDOL-3-YL BORONIC ACID; N-BOC-PYRROLIDIN-2-(S)-YLBORONIC ACID; N-BOC-PYRROLIDINYL-3-BORONIC ACID; N-BUTYL 3-BORONOBENZENESULFONAMIDE; N-BUTYLBORONIC ACID; N-CYCLOPROPYL 4-BORONO-2-FLUOROBENZAMIDE; N-DECYLBORONIC ACID; N-DIETHYL 3-BORONO-5-CHLOROBENZAMIDE; N-DIMETHYL 3-BORONO-5-CHLOROBENZAMIDE; N-DODECYLBORONIC ACID; NEOPENTYLBORONIC ACID; N-ETHYL 3-BORONO-5-CHLOROBENZAMIDE; N-ETHYL-5-INDOLE BORONIC ACID; N-HEXYLBORONIC ACID; N-ISOPROPYL 3-BORONOBENZENESULFONAMIDE; N-METHYL 2-BORONO-4-FLUOROBENZAMIDE; N-METHYL 3-BORONO-5-CHLOROBENZAMIDE; N-METHYL-4-PYRIDINEBORONIC ACID IODIDE; N-METHYLINDOLE-2-BORONIC ACID; N-PENTYLBORONIC ACID; N-PROPYLBORONIC ACID; N-PROPYL-D7-BORONIC ACID; N-P-TOLYL 4-BORONOBENZENESULFONAMIDE; N-TETRADECYLBORONIC ACID; N-TRIDECANEBORONIC ACID; N-UNDECANEBORONIC ACID; OCT-7-ENYLBORONIC ACID; OCTADECYLBORONIC ACID; OCTYLBORONIC ACID; OXAZOL-2-YLBORONIC ACID; OXINDOLE-6-BORONIC ACID; P-(4-PROPYLCYCLOHEXYL)PHENYLBORONIC ACID; PERYLENE-3-BORONIC ACID; PHENANTHREN-2-YL-2-BORONIC ACID; PHENANTHREN-3-YL-3-BORONIC ACID; PHENETHYLBORONIC ACID; PHENOXATHIIN-4-BORONIC ACID; PHENYLALANINE, 4-BORONO-, HYDROCHLORIDE; PHENYLBORONIC ACID; PHENYLBORONIC ACID, [RING-14C]-; PHENYL-D5-BORONIC ACID; PIPERIDIN-4-YLBORONIC ACID HYDROCHLORIDE; PIPERIDINE-4-BORONIC ACID; PIVALAMIDOMETHYLBORONIC ACID; PROP-1-EN-2-YLBORONIC ACID; PROPIONAMIDOMETHYLBORONIC ACID; PYRAZIN-2-YLBORONIC ACID; PYRAZOLE-3-BORONIC ACID, HYDROCHLORIDE; PYRAZOLO[1,5-A]PYRIDIN-3-YLBORONIC ACID; PYRAZOLO[1,5-A]PYRIDIN-5-YLBORONIC ACID; PYRAZOLO[1,5-A]PYRIDIN-7-YLBORONIC ACID; PYRIDAZIN-3-YLBORONIC ACID; PYRIDAZIN-4-YLBORONIC ACID; PYRIDINE-3-BORONIC ACID; PYRIDINE-3-BORONIC ACID HCL; PYRIDINE-4-BORONIC ACID; PYRIDINE-4-BORONIC ACID HYDRATE; PYRIDINE-4-BORONIC ACID HYDROCHLORIDE; PYRIDO[3,4-D]PYRIDAZINE-5-BORONIC ACID; PYRIMIDIN-2-YLBORONIC ACID; PYRIMIDIN-5-YL-5-BORONIC ACID MONOHYDRATE; PYRIMIDINE-4-BORONIC ACID; PYRIMIDINE-5-BORONIC ACID; QUINAZOLIN-4-YLBORONIC ACID; QUINAZOLIN-7-YLBORONIC ACID; QUINOLINE-2-BORONIC ACID; QUINOLINE-4-BORONIC ACID; QUINOLINE-5-BORONIC ACID; QUINOLINE-6-BORONIC ACID; QUINOLINE-6-BORONIC ACID HYDROCHLORIDE; QUINOLINE-7-BORONIC ACID; QUINOLINE-8-BORONIC ACID; QUINOXALINE-6-BORONIC ACID; RACEMIC, TRANS-1-CHLOROMETHYL-CYCLOPROPYL-2-BORONIC ACID; RACEMIC, TRANS-1-PROPYL-CYCLOPROPYL-2-BORONIC ACID; S-(2-BORONOETHYL)-L-CYSTEINE HYDROCHLORIDE; SELENOPHENE-2-BORONIC ACID; SODIUM (TRIHYDROXY)PHENYLBORATE; SODIUM PYRIDINE-3-TRIHYDROXYBORATE; SODIUM THIOPHENE-2-TRIHYDROXYBORATE; SODIUM THIOPHENE-3-TRIHYDROXYBORATE; TALABOSTAT; T-BUTYL 3-BORONOBENZENESULFONAMIDE; TERT-BUTYLBORONIC ACID; TETRAHYDROFURAN-3-BORONIC ACID; TETRAHYDROPYRAN-3-BORONIC ACID; TETRAHYDROPYRAN-4-BORONIC ACID; THIANTHRENE-1-BORONIC ACID; THIANTHRENE-2-BORONIC ACID; THIAZOL-5-YLBORONIC ACID; THIAZOLE-2-BORONIC ACID; THIAZOLE-4-BORONIC ACID; THIENO[2,3-B]PYRIDIN-2-YLBORONIC ACID; THIENO[2,3-C]PYRIDINE-7-BORONIC ACID; THIENO[3,2-B]THIOPHENE-2-BORONIC ACID; THIENO[3,2-C]PYRIDIN-2-YL BORONIC ACID; THIENO[3,2-C]PYRIDINE-4-BORONIC ACID; THIOPHENE-2-BORONIC ACID; THIOPHENE-2-CARBOXYLIC ACID METHYL ESTER-5-BORIC ACID; THIOPHENE-3-BORONIC ACID; TRANS-(4-PENTYLCYCLOHEXYL)CYCLOHEX-1-ENYLBORONIC ACID; TRANS-(4-PROPYLCYCLOHEXYL)CYCLOHEX-1-ENYLBORONIC ACID; TRANS-1-PROPEN-1-YLBORONIC ACID; TRANS-2-(3-CHLOROPHENYL)CYCLOPROPANEBORONIC ACID; TRANS-2-(3-FLUOROPHENYL)CYCLOPROPANEBORONIC ACID; TRANS-2-(3-FLUOROPHENYL)VINYLBORONIC ACID; TRANS-2-(3-METHOXYPHENYL)CYCLOPROPANEBORONIC ACID; TRANS-2-(4-BIPHENYL)VINYLBORONIC ACID; TRANS-2-(4-CHLOROPHENYL)VINYLBORONIC ACID; TRANS-2-(4-FLUOROPHENYL)CYCLOPROPANEBORONIC ACID; TRANS-2-(4-FLUOROPHENYL)VINYLBORONIC ACID; TRANS-2-(4-METHOXYPHENYL)VINYLBORONIC ACID; TRANS-2-(4-METHYLPHENYL)CYCLOPROPANEBORONIC ACID; TRANS-2-(4-METHYLPHENYL)VINYLBORONIC ACID; TRANS-2-(6-CHLOROPYRIDIN-3-YL)CYCLOPROPANEBORONIC ACID; TRANS-2-(6-METHOXYPYRIDIN-3-YL)CYCLOPROPANEBORONIC ACID; TRANS-2-(6-METHYLPYRIDIN-3-YL)CYCLOPROPANEBORONIC ACID; TRANS-2-[4-(TRIFLUOROMETHYL)PHENYL]CYCLOPROPANEBORONIC ACID; TRANS-2-[4-(TRIFLUOROMETHYL)PHENYL]VINYLBORONIC ACID; TRANS-2-[6-(TRIFLUOROMETHYL)PYRIDIN-3-YL]CYCLOPROPANEBORONIC ACID; TRANS-2-CHLOROMETHYLVINYLBORONIC ACID; TRANS-2-METHYL-CYCLOPROPYL BORONIC ACID; TRANS-2-PHENYLCYCLOPROPYLBORONIC ACID; TRANS-2-PYRIDIN-3-YLCYCLOPROPANEBORONIC ACID; TRANS-3,3,3-TRIFLUOROPROPENE-1-BORONIC ACID; TRANS-3-PHENYLPROPEN-1-YL-BORONIC ACID; TRANS-4-(BETA-NITROVINYL)BENZENEBORONIC ACID; TRANS-HEPTENYLBORONIC ACID; TRANS-NONENYLBORONIC ACID; TRIMETHYLSILYLETHYNYLBORONIC ACID; URACIL-5-BORONIC ACID; VILDAGLIPTIN-BORONIC ACID; VINYL BORONIC ACID; Z-1-HEXENYLBORONIC ACID

List No. 4—Acids: ((AMINOCARBONYL)AMINO)ACETIC ACID HYDRATE; (−)-(1S,4R)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID; (+)-4-AMINO-2-FLUOROBUTYRIC ACID; (+/−)-2-ACETOXYPROPIONIC ACID; (+/−)-2-AMINO-CYCLOHEXANECARBOXYLIC ACID; (+/−)-CIS-3-METHYL-2-PIPERIDINECARBOXYLIC ACID; (+/−)-THREO-3-METHYLASPARTIC ACID; (+/−)-TRANS-AZETIDINE-2,4-DICARBOXYLIC ACID; (+/−)-TRANS-EPOXYSUCCINIC ACID; (1-AMINO-1H-IMIDAZOL-2-YL)-ACETIC ACID; (1-AMINOCYCLOPENTYL)ACETIC ACID; (1H-[1,2,3]TRIAZOL-4-YL)-ACETIC ACID; (1H-IMIDAZOL-2-YL)-ACETIC ACID; (1H-PYRAZOL-3-YL)-ACETIC ACID; (1H-PYRROL-2-YL)-ACETIC ACID; (1-METHYL-1H-IMIDAZOL-2-YL)-ACETIC ACID; (1-METHYL-1H-IMIDAZOL-4-YL)-ACETIC ACID; (1-METHYL-1H-PYRAZOL-3-YL)ACETIC ACID; (1-METHYL-1H-PYRAZOL-4-YL)-ACETIC ACID; (1-METHYL-1H-PYRAZOL-5-YL)ACETIC ACID; (1-METHYL-1H-PYRROL-3-YL)ACETIC ACID; (1-METHYLHYDRAZINO)ACETIC ACID; (1-METHYLPYRROLIDIN-2-YL)ACETIC ACID; (1R,2R)-(+2-AMINO-1-CYCLOPENTANECARBOXYLIC ACID; (1R,2R)-2-(CHLOROMETHYL)CYCLOPROPANECARBOXYLIC ACID; (1R,2R)-2-AMINOCYCLOHEXANECARBOXYLIC ACID; (1R,2R)-CYCLOBUTANE-1,2-DICARBOXYLIC ACID; (1R,2R,4R)-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID; (1R,2S)-(−)-2-AMINO-CYCLOHEMNECARBOXYLIC ACID; (1R,2S)-2-AMINO-4-METHYLENECYCLOPENTANECARBOXYLIC ACID; (1R,2S)-2-AMINO-CYCLOHEX-3-ENECARBOXYLIC ACID; (1R,2S)-2-AMINO-CYCLOPENTANECARBOXYLIC ACID; (1R,2S)-2-METHYLCYCLOPROPANECARBOXYLIC ACID; (1R,2S)-2-PROPYLCYCLOPROPANECARBOXYLIC ACID; (1R,2S,4R)-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID; (1R,3R)-(3-AMINOCYCLOPENTYL)-ACETIC ACID; (1R,3R)-3-AMINOCYCLOHEXANECARBOXYLIC ACID; (1R,3R)-3-AMINO-CYCLOPENTANE CARBOXYLIC ACID; (1R,3S)-(3-AMINOCYCLOPENTYL)-ACETIC ACID; (1R,3S)-1-AMINO-3-HYDROXYCYCLOPENTANECARBOXYLIC ACID; (1R,3S)-3-AMINO-CYCLOHEXANECARBOXYLIC ACID; (1R,3S)-3-AMINOCYCLOPENTANECARBOXYLIC ACID; (1R,3S,4R)-2-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID; (1R,3S,4S)-2-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID; (1R,3S,4S)-3-AMINO-4-FLUOROCYCLOPENTANECARBOXYLIC ACID; (1R,4R)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID; (1R,4S)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID; (1R,4S,5R)-BICYCLO[2.1.1]HEXANE-5-CARBOXYLIC ACID; (1R,4S,5S)-BICYCLO[2.1.1]HEXANE-5-CARBOXYLIC ACID; (1R,5S,6R)-BICYCLO[3.1.1]HEPTANE-6-CARBOXYLIC ACID; (1R,5S,6S)-BICYCLO[3.1.1]HEPTANE-6-CARBOXYLIC ACID; (1R,6R)-6-AMINOCYCLOHEX-3-ENE-1-CARBOXYLIC ACID; (1S)-1-METHYL-2-CYCLOHEXENE-1-CARBOXYLIC ACID; (1S)-3-OXO-CYCLOPENTANEACETIC ACID; (1S,2R)-(−)-2-AMINOCYCLOHEX-3-ENECARBOXYLIC ACID; (1S,2R)-2-(METHOXYCARBONYL)CYCLOPROPANECARBOXYLIC ACID; (1S,2R)-2-AMINO-2-METHYLCYCLOPENTANECARBOXYLIC ACID; (1S,2R)-2-AMINOCYCLOPENTANECARBOXYLIC ACID; (1S,2R)-2-PROPYLCYCLOPROPANECARBOXYLIC ACID; (1S,2S)-2-(HYDROXYMETHYL)CYCLOPROPANECARBOXYLIC ACID; (1S,2S)-2-AMINOCYCLOHEXANECARBOXYLIC ACID; (1S,2S)-2-AMINO-CYCLOPETANECARBOXYLIC ACID; (1S,2S)-3-METHYLENECYCLOPROPANE-1,2-DICARBOXYLIC ACID; (1S,2S)-CYCLOPROPANE-1,2-DICARBOXYLIC ACID; (1S,2S,5R)-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID; (1S,3R)-(3-AMINOCYCLOPENTYL)-ACETIC ACID; (1S,3R)-1-AMINO-3-HYDROXYCYCLOPENTANECARBOXYLIC ACID; (1S,3R)-3-AMINO-CYCLOHEXANECARBOXYLIC ACID; (1S,3R)-3-AMINOCYCLOPENTANECARBOXYLIC ACID; (1S,3R)-3-AMINOMETHYL-CYCLOPENTANECARBOXYLIC ACID; (1S,3S)-(3-AMINOCYCLOPENTYL)-ACETIC ACID; (1S,3S)-3-AMINOCYCLOHEXANECARBOXYLIC ACID; (1S,3S)-3-AMINOCYCLOPENTANECARBOXYLIC ACID; (1S,3S)-3-AMINOMETHYL-CYCLOPENTANECARBOXYLIC ACID; (1S,3S)-3-HYDROXY-CYCLOPENTANECARBOXYLIC ACID; (1S,5R)-2-AZABICYCLO[3.1.0]HEXANE-1-CARBOXYLIC ACID; (1-VINYL-CYCLOBUTYL)-ACETIC ACID; (2-AMINO-1H-IMIDAZOL-4-YL)-ACETIC ACID; (2-AMINO-2-METHYL-PROPOXY)-ACETIC ACID; (2-AMINO-2-OXOETHOXY)ACETIC ACID; (2-AMINO-ETHOXY)-ACETIC ACID; (2E)-((AMINOCARBONOTHIOYL)HYDRAZONO)ACETIC ACID; (2E)-2-(HYDROXYIMINO)HEXANOIC ACID; (2E)-2-[(AMINOCARBONYL)HYDRAZONO]PROPANOIC ACID; (2E)-3-(1H-PYRROL-3-YL)-2-PROPENOIC ACID; (2E)-3-(DIMETHYLCARBAMOYL)PROP-2-ENOIC ACID; (2E)-3-(ETHYLCARBAMOYL)PROP-2-ENOIC ACID; (2E)-3,4-DIMETHYLHEX-2-ENOIC ACID; (2E)-3,4-DIMETHYLPENT-2-ENOIC ACID; (2E)-3,5-DIMETHYLHEX-2-ENOIC ACID; (2E)-3-CYCLOPROPYLBUT-2-ENOIC ACID; (2E)-3-ETHYL-4-METHYLPENT-2-ENOIC ACID; (2E)-3-METHOXY-2-METHYL-2-PROPENOIC ACID; (2E)-4-(DIMETHYLAMINO)BUT-2-ENOIC ACID; (2E,4E)-2-CYANO-2,4-HEXADIENOIC ACID; (2-FURYL)GLYOXYLIC ACID; (2-METHYL-1H-IMIDAZOL-1-YL)ACETIC ACID; (2-METHYL-1H-IMIDAZOL-4-YL)-ACETIC ACID; (2-METHYL-ALLYLOXY)-ACETIC ACID; (2-METHYLAMINO-ETHOXY)-ACETIC ACID; (2-METHYL-CYCLOPENTYL)-ACETIC ACID; (2-OXO-1,3-OXAZOLIDIN-3-YL)ACETIC ACID; (2-OXO-IMIDAZOLIDIN-1-YL)-ACETIC ACID; (2-OXO-PYRROLIDIN-1-YL)-ACETIC ACID; (2-PYRROLIDINYLIDENEAMINO)ACETIC ACID; (2R)-1-FORMYLPYRROLIDINE-2-CARBOXYLIC ACID; (2R)-1-METHYL-2-PIPERIDINECARBOXYLIC ACID; (2R)-2-(ACETYLOXY)-PROPANOIC ACID; (2R)-2-(ISOPROPYLAMINO)PROPANOIC ACID; (2R)-2,5-DIHYDRO-5-OXO-2-FURANACETIC ACID; (2R)-2-AMINO-2-(3-FURYL)ACETIC ACID; (2R)-2-AMINO-2-CYCLOBUTYLPROPANOIC ACID; (2R)-2-AMINO-2-CYCLOPROPYLPROPANOIC ACID; (2R)-2-AMINO-4-METHYLHEXANOIC ACID; (2R)-2-AZIDO-3-HYDROXY-2-METHYL-PROPANOIC ACID; (2R)-2-METHYL-2-PIPERIDINECARBOXYLIC ACID; (2R)-2-PROPANAMIDOPROPANOIC ACID; (2R)-4-AMINO-2-HYDROXY-4-OXOBUTANOIC ACID; (2R)-HYDROXYBUTANEDIOIC ACID 1-METHYL ESTER; (2R)-OXIRANE-2-CARBOXYLIC ACID; (2R,3R)-3-AMINO-2-OXETANECARBOXYLIC ACID; (2R,3S)-3-AMINO-2-OXETANECARBOXYLIC ACID; (2R,3R)-(−)-EPOXYSUCCINIC ACID; (2R,3R)-2-AMINO-3-HYDROXY-4-METHYL-VALERIC ACID; (2R,3R)-2-AMINO-3-HYDROXY-HEXANOIC ACID; (2R,3R)-2-AMINO-3-HYDROXY-PENTANOIC ACID; (2R,3R)-2-AMINO-3-HYDROXY-SUCCINIC ACID; (2R,3R)-2-AMINO-3-METHYLOXYBUTANOIC ACID; (2R,3R)-3-AMINO-2-HYDROXYHEXANOIC ACID; (2R,3R)-3-AMINO-2-METHYL-BUTANOIC ACID; (2R,3R)-3-HYDROXY-D-ISOVALINE; (2R,3R)-3-METHYL-PYRROLINE-2-CARBOXYLIC ACID; (2R,3S)-(+2-AMINO-3-HYDROXY-4-METHYLPENTANOIC ACID; (2R,3S)-2-AMINO-3-HYDROXY-PENTANOIC ACID; (2R,3S)-2-AMINO-3-HYDROXY-SUCCINIC ACID; (2R,3S)-2-AMINO-3-METHYLSUCCINIC ACID; (2R,3S)-3-AMINO-2-HYDROXYHEXANOIC ACID; (2R,3S)-3-AMINO-2-METHYL-BUTANOIC ACID; (2R,3S)-3-HYDROXY-D-ISOVALINE; (2R,4R)-(+)-AZETIDINE-2,4-DICARBOXYLIC ACID; (2R,4R)-4-(METHYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID; (2R,4R)-4-FLUOROPYRROLIDINE-2-CARBOXYLIC ACID; (2R,4R)-4-METHYL-2-PYROOLIDINE CARBOXYLIC ACID; (2R,4R)-4-METHYLPIPERIDINE-2-CARBOXYLIC ACID; (2R,4S)-4-(METHYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID; (2R,4S)-4-FLUOROPYRROLIDINE-2-CARBOXYLIC ACID; (2R,4S)-4-HYDROXY-1-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; (2R,4S)-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID; (2S)-2-(1H-PYRROL-1-YL)PROPANOIC ACID; (2S)-2-(1H-TETRAZOL-1-YL)PROPANOIC ACID; (2S)-2-(CARBAMOYLAMINO)-3-HYDROXYPROPANOIC ACID; (2S)-2-(CARBAMOYLAMINO)PROPANOIC ACID; (2S)-2,3-DIHYDROXYPROPANOIC ACID; (2S)-2-[(METHOXYCARBONYL)AMINO]PROPANOIC ACID; (2S)-2-[(METHYLCARBAMOYL)AMINO]PROPANOIC ACID; (2S)-2-AMINO-2-(3-FURYL)ACETIC ACID; (2S)-2-AMINO-2,3-DIMETHYLBUTANOIC ACID; (2S)-2-AMINO-2-CYCLOBUTYLPROPANOIC ACID; (2S)-2-AMINO-2-CYCLOPROPYLPROPANOIC ACID; (2S)-2-AMINO-3-(2-METHYLENECYCLOPROPYL)PROPANOIC ACID; (2S)-2-AMINO-4-FLUORO-BUTANOIC ACID; (2S)-2-AMINO-4-METHYLHEXANOIC ACID; (2S)-2-AMINO-5-HEXENOIC ACID; (2S)-2-AMINOPENT-4-ENOIC ACID; (2S)-2-BUTOXYPROPANOIC ACID; (2S)-2-METHYL-3-(METHYLSULFANYL)PROPANOIC ACID; (2S)-2-PROPANAMIDOPROPANOIC ACID; (2S)-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID; (2S)-5-HYDROXY-2-PIPERIDINECARBOXYLIC ACID; (2S)-5-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; (2S)AZETIDINE-2-CARBOXYLIC ACID; (2S)-HYDROXYBUTANEDIOIC ACID 1-METHYL ESTER; (2S)-NORBORNANE-2-CARBOXYLIC ACID; (2S)-OXIRANE-2-CARBOXYLIC ACID; (2S)PIPERIDINE-2-CARBOXYLIC ACID; (2S,3S)-3-AMINO-2-OXETANECARBOXYLIC ACID; (2S,3R)-(+)-2-AMINO-3-HYDROXY-4-METHYLPENTANOIC ACID; (2S,3R)-2-AMINO-3-HYDROXY-PENTANOIC ACID; (2S,3R)-2-AMINO-3-METHYLSUCCINIC ACID; (2S,3R)-3-AMINO-2-HYDROXYHEXANOIC ACID; (2S,3R)-3-HYDROXY-L-ISOVALINE; (2S,3S)-(+)-2-AMINO-3-METHYLPENTANOIC-UL-14C ACID HYDROCHLORIDE; (2S,3S)-2-AMINO-3-ETHOXYBUTANOIC ACID; (2S,3S)-2-AMINO-3-HYDROXY-4-METHYL-VALERIC ACID; (2S,3S)-2-AMINO-3-HYDROXY-HEXANOIC ACID; (2S,3S)-2-AMINO-3-HYDROXY-PENTANOIC ACID; (2S,3S)-2-AMINO-3-METHOXYBUTANOIC ACID; (2S,3S)-2-HYDROXY-3-METHYLPENTANOIC ACID; (2S,3S)-3-AMINO-2-HYDROXYHEXANOIC ACID; (2S,3S)-3-HYDROXY-L-ISOVALINE; (2S,3S)-3-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; (2S,3S)-DIAMINOSUCCINIC ACID; (2S,4R)-4-(AMINOMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-(HYDROXYMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-(METHYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-AMINOPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-CYANOPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-FLUOROPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-HYDROXY-1-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID; (2S,4S)-(−)-AZETIDINE-2,4-DICARBOXYLIC ACID; (2S,4S)-4-(AMINOMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-4-(METHYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-4-AMINOPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-4-CYANOPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-4-FLUOROPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID; (2Z)-3-([AMINO(IMINO)METHYL]SULFANYL)-2-PROPENOIC ACID; (2Z)-3-CYCLOPROPYL-2-PROPENOIC ACID; (2Z)-3-THIOCYANATO-2-PROPENOIC ACID; (2Z,4E)-HEXA-2,4-DIENOIC ACID; (3-AMINO-1H-1,2,4-TRIAZOL-1-YL)ACETIC ACID; (3-AMINO-1H-1,2,4-TRIAZOL-5-YL)ACETIC ACID; (3-AMINO-PROPOXY)-ACETIC ACID; (3-AMINOPYRAZOL-1-YL)ACETIC ACID; (3-AMINO-PYRROLIDIN-1-YL)-ACETIC ACID; (3-AMINO-TETRAHYDRO-FURAN-2-YL)-ACETIC ACID; (3-HYDROXY-1H-PYRAZOL-4-YL)ACETIC ACID; (3-HYDROXY-PYRROLIDIN-1-YL)-ACETIC ACID; (3-METHYL)PYRROLIDIN-2-YL ACETIC ACID; (3-METHYL-[1,2,4]OXADIAZOL-5-YL)-ACETIC ACID; (3-METHYL-1H-PYRAZOL-1-YL)ACETIC ACID; (3-METHYL-1H-PYRROL-2-YL)-ACETIC ACID; (3-METHYL-3H-IMIDAZOL-4-YL)-ACETIC ACID; (3-METHYL-4,5-DIHYDRO-1H-PYRAZOL-1-YL)ACETIC ACID; (3-METHYLBUTOXY)ACETIC ACID; (3-OXO-PYRROLIDIN-1-YL)-ACETIC ACID; (3R)-3-(ACETYLAMINO)BUTANOIC ACID; (3R)-3-AMINO-3-HYDROXYPROPANOIC ACID; (3R)-3-AMINO-4-METHYLHEXANOIC ACID; (3R)-3-AMINOPYRROLIDINE-3-CARBOXYLIC ACID; (3R)-THIOMORPHOLINECARBOXYLIC ACID; (3R,2R)-2,3-DIAMINOBUTYRIC ACID; (3R,4R)-3-AMINO-4-HYDROXYPENTANOIC ACID; (3R,4S)-1-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID; (3S)-1,3-DIOXANE-2-METHYL-4-CARBOXYLIC ACID; (3S)-1-METHYL-3-PIPERIDINECARBOXYLIC ACID; (3S)-3-(ACETYLAMINO)BUTANOIC ACID; (3S)-3-AMINO-4-METHYLHEXANOIC ACID; (3S)-3-AMINOPYRROLIDINE-3-CARBOXYLIC ACID; (3S,2R)-2,3-DIAMINOBUTYRIC ACID; (3S,2S)-2,3-DIAMINOBUTYRIC ACID; (3S,4S)-4-METHYLPYRROLIDINE-3-CARBOXYLIC ACID; (4,5-DIHYDRO-1H-IMIDAZOL-2-YLAMINO)-ACETIC ACID; (4,5-DIHYDRO-3H-PYRROL-2-YLAMINO)-ACETIC ACID; (4-AMINO-1H-PYRAZOL-1-YL)ACETIC ACID; (4E)-2-AMINOHEX-4-ENOIC ACID; (4-METHYL-[1,2,3]TRIAZOL-1-YL)-ACETIC ACID; (4-METHYL-1H-IMIDAZOL-2-YL)-ACETIC ACID; (4-METHYL-1H-PYRAZOL-1-YL)ACETIC ACID; (4-METHYL-FURAZAN-3-YL)-ACETIC ACID; (4R)-1,3-THIAZINANE-4-CARBOXYLIC ACID; (4R)-2-AMINO-4,5-DIHYDRO-1,3-THIAZOLE-4-CARBOXYLIC ACID; (4R)-3-METHYL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID; (4S)-1,3-THIAZINANE-4-CARBOXYLIC ACID; (4S)-4-AMINO-D-PROLINE; (4S)-4-METHYLHEPTANOIC ACID; (4S)-4-METHYL-L-PROLINE; (4S)-4-METHYL-NORLEUCINE; (4S,2RS)-2-METHYLTHIAZOLIDINE-4-CARBOXYLIC ACID; (5-AMINO-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; (5-AMINO-1H-TETRAZOL-1-YL)ACETIC ACID; (5-AMINO-2H-TETRAZOL-2-YL)ACETIC ACID; (5-AMINO-4H-[1,2,4]TRIAZOL-3-YL)-ACETIC ACID; (5-METHYL-1H-PYRAZOL-3-YL)-ACETIC ACID; (5-METHYL-1H-TETRAZOL-1-YL)ACETIC ACID; (5-METHYL-2H-[1,2,4]TRIAZOL-3-YL)-ACETIC ACID; (5-METHYL-4,5-DIHYDRO-1H-PYRAZOL-1-YL)ACETIC ACID; (5-METHYL-4H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; (5-METHYL-FURAN-2-YL)-ACETIC ACID; (5-METHYL-IMIDAZOL-1-YL)-ACETIC ACID; (5-METHYL-PYRAZOL-1-YL)-ACETIC ACID; (5-OXO-2,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; (5-OXO-2,5-DIHYDRO-1H-PYRAZOL-3-YL)ACETIC ACID; (5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; (ALLYLSULFINYL)ACETIC ACID; (ALLYLTHIO)ACETIC ACID; (ALPHAR)-ALPHA-HYDROXY-CYCLOPROPANEPROPANOIC ACID; (ALPHAS)-ALPHA-HYDROXY-CYCLOBUTANEPROPANOIC ACID; (ALPHAS)-ALPHA-HYDROXY-CYCLOPROPANEPROPANOIC ACID; (AMIDINOTHIO)ACETIC ACID; (AMINOSULFONYL)ACETIC ACID; (AR)-A-HYDROXY-2-FURANACETIC ACID; (BUTYLTHIO)ACETIC ACID; (BUTYRYLAMINO)ACETIC ACID; (CYCLOBUTYLCARBAMOYL)FORMIC ACID; (CYCLOPENTYLAMINO)ACETIC ACID; (D,L)-2-AMINO-HEPT-6-ENOIC ACID; (DIETHYLAMINO)(OXO)ACETIC ACID; (E)-2-(METHOXYIMINO)ACETIC ACID; (E)-3-(1H-IMIDAZOL-5-YL)-2-PROPENOIC ACID; (E)-3-(1H-PYRROL-1-YL)-2-PROPENOIC ACID; (E)-3-(1H-PYRROL-2-YL)ACRYLIC ACID; (E)-3,4,4-TRIMETHYLPENT-2-ENOIC ACID; (E)-3-CYANO-3-(METHYLIMINO)-2-OXOPROPANOIC ACID; (E)-3-CYCLOBUTYLACRYLIC ACID; (E)-3-CYCLOPENTYLACRYLIC ACID; (E)-3-CYCLOPROPYLACRYLIC ACID; (E)-3-METHOXY-2-BUTENOIC ACID; (E)-4,4-DIMETHYL-2-PENTENOIC ACID; (E)-5-(METHYLTHIO)PENT-2-ENOIC ACID; (E)-5-METHYL-HEX-2-ENOIC ACID; (ETHYLTHIO)ACETIC ACID; (ISOBUTYLAMINO)(OXO)ACETIC ACID; (ISOBUTYLTHIO)ACETIC ACID; (ISOBUTYRYLAMINO)ACETIC ACID; (ISOPROPENYLAMINO)ACETIC ACID; (ISOPROPYLTHIO)ACETIC ACID; (METHYLTHIO)ACETIC ACID; (N′-ACETYL-N-METHYL-HYDRAZINO)-ACETIC ACID; (N-CARBOXYMETHYL-HYDRAZINO)-ACETIC ACID; (N-HYDROXYCARBAMIMIDOYL)-ACETIC ACID; (PROP-2-YNYLTHIO)ACETIC ACID; (PROPYLAMINO)ACETIC ACID; (PROPYLTHIO)ACETIC ACID; (PYRROL-3-YL)-ACETIC ACID; (R)-(−)-2-AMINO-2-METHYLBUTANEDIOIC ACID; (R)-(+2-METHYLGLUTARIC ACID; (R)-(−)-5-OXOTETRAHYDROFURAN-2-CARBOXYLIC ACID; (R)-(−)-CITRAMALIC ACID; (R)-(−)-NIPECOTIC ACID; (R)-(+)-2,2-DIMETHYL-1,3-DIOXOLAN-4-CARBOXYLATE; (R)-(+)-2-CHLOROPROPIONIC ACID; (R)-(+)-2-METHOXYPROPIONIC ACID; (R)-(+)-2-TETRAHYDROFUROIC ACID; (R)-(+)-3-CYCLOHEXENECARBOXYLIC ACID; (R)-(+)-3-METHYLSUCCINIC ACID 1-MONOMETHYL ESTER; (R)-(+)-4-OXO-2-AZETIDINECARBOXYLIC ACID; (R)-(+)-METHYLSUCCINIC ACID; (R)-(2-HYDROXYPYRROLIDIN-1-YL)-ACETIC ACID; (R)-(3-AMINO-PYRROLIDIN-1-YL)-ACETIC ACID; (R)-(3-HYDROXYPYRROLIDIN-1-YL)-ACETIC ACID; (R)-1,2,3,6-TETRAHYDROPYRIDINE-2-CARBOXYLIC ACID; (R)-1-AMINO-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID; (R)-1-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; (R)-2-(PIPERIDIN-2-YL)ACETIC ACID; (R)-2-(PIPERIDIN-3-YL)ACETIC ACID; (R)-2-(PYRROLIDIN-3-YL)ACETIC ACID; (R)-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID; (R)-2,3-DIMETHYLBUTANOIC ACID; (R)-2,5-DIMETHYLHEX-5-ENOIC ACID; (R)-2-AMINO-2-METHYL-4-PENTENOIC ACID; (R)-2-AMINO-2-METHYL-PENTANOIC ACID; (R)-2-AMINO-3-(CARBAMOYLOXY)PROPANOIC ACID; (R)-2-AMINO-3-CYANOPROPANOIC ACID; (R)-2-AMINO-3-HYDROXY-3-METHYLBUTANOIC ACID; (R)-2-AMINO-3-METHOXYLPROPANOIC ACID; (R)-2-AMINO-4-METHOXYBUTYRIC ACID; (R)-2-AMINO-5-METHYLHEXANOIC ACID; (R)-2-AMINO-BUTYRIC ACID HYDROCHLORIDE; (R)-2-AMINOHEPT-6-YNOIC ACID; (R)-2-AMINOHEX-5-YNOIC ACID; (R)-2-AMINOMETHYL-3-METHYL-BUTYRIC ACID; (R)-2-AMINOMETHYL-4-METHYL-PENTANOIC ACID; (R)-2-AMINO-N-METHYL-SUCCINAMIC ACID; (R)-2-CHLORO-3-METHYLBUTYRIC ACID; (R)-2-CHLOROBUTYRIC ACID; (R)-2-HYDROXY-2-METHYLBUTYRIC ACID; (R)-2-HYDROXY-4-METHYLPENTANOIC ACID; (R)-2-HYDROXYBUTYRIC ACID; (R)-2-HYDROXYMETHYLBUTANOIC ACID; (R)-2-HYDROXYMETHYLHEXANOIC ACID; (R)-2-HYDROXYMETHYL-PENTANOIC ACID; (R)-2-HYDROXYMETHYLPROPANOIC ACID; (R)-2-METHYL-4-NITROBUTANOIC ACID; (R)-2-METHYLHEPT-6-ENOIC ACID; (R)-2-METHYLPENTANOIC ACID; (R)-2-METHYLPROLINE; (R)-2-MORPHOLINEACETIC ACID; (R)-2-OXOHEXAHYDROPYRIMIDINE-4-CARBOXYLIC ACID; (R)-2-OXO-IMIDAZOLIDINE-4-CARBOXYLIC ACID; (R)-2-VINYLHEX-5-ENOIC ACID; (R)-2-VINYLHEXANOIC ACID; (R)-2-VINYLPENT-4-ENOIC ACID; (R)-2-VINYLPENTANOIC ACID; (R)-3-(HYDROXYMETHYL)PENT-4-ENOIC ACID; (R)-3,3,3-TRIFLUORO-2-HYDROXYPROPIONIC ACID; (R)-3,4-DIAMINOBUTYRIC ACID; (R)-3,5-DIAMINOPENTANOIC ACID; (R)-3-AMINO-2-(HYDROXYMETHYL)PROPANOIC ACID; (R)-3-AMINO-2-METHYLPROPANOIC ACID-HCL; (R)-3-AMINO-2-METHYL-PROPIONIC ACID; (R)-3-AMINO-3-CYCLOBUTYL-PROPIONIC ACID; (R)-3-AMINO-3-CYCLOPROPYL-PROPIONIC ACID; (R)-3-AMINO-3-METHYLPENTANOIC ACID; (R)-3-AMINO-4-METHYL-PENTANOIC ACID; (R)-3-AMINO-5-METHYL-HEXANOIC ACID; (R)-3-AMINO-BUTANOIC ACID HYDROCHLORIDE SALT; (R)-3-AMINOBUTYRIC ACID; (R)-3-AMINO-HEPT-6-ENOIC ACID; (R)-3-AMINOHEX-5-ENOIC ACID; (R)-3-AMINO-L-PROLINE; (R)-3-AMINO-PENTANOIC ACID; (R)-3-AMINOTETRAHYDRO-2H-PYRAN-3-CARBOXYLIC ACID; (R)-3-AMINOTETRAHYDROFURAN-3-CARBOXYLIC ACID; (R)-3-AMINOTETRAHYDROTHIOPHENE-3-CARBOXYLIC ACID; (R)-3-CHLOROLACTIC ACID; (R)-3-HYDROXYBUTYRIC ACID; (R)-3-METHYLHEPTANOIC ACID; (R)-3-METHYLHEMNOIC ACID; (R)-3-METHYL-PENTANOIC ACID; (R)-4-AMINO-2-HYDROXYBUTYRIC ACID; (R)-4-AMINO-3-HYDROXYBUTANOIC ACID; (R)-4-AMINOHEX-5-ENOIC ACID; (R)-4-OXO-2-PIPERRIDINE CARBOXYLIC ACID; (R)-4-OXOPYRROLIDINE-2-CARBOXYLIC ACID; (R)-5-AMINO-4-HYDROXYPENTANOIC ACID; (R)-5-OXO-PIPERAZINE-2-CARBOXYLIC ACID; (R)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; (R)-6-OXO-PIPERAZINE-2-CARBOXYLIC ACID; (R)-ALPHA-ALLYLALANINE H2O; (R)-ALPHA-ETHYLALANINE H2O; (R)-ALPHA-PROPARGYLALANINE; (R)-AMINO-FURAN-2-YL-ACETIC ACID; (R)-HEXAHYDRO-1H-AZEPINE-2-CARBOXYLIC ACID; (R)-ISOSERINE; (R)-MORPHOLIN-3-YL-ACETIC ACID; (R)-MORPHOLINE-2-CARBOXYLIC ACID; (R)-MORPHOLINE-3-CARBOXYLIC ACID; (R)-PIPERAZINE-2-CARBOXYLIC ACID; (R)-PIPERIDINE-2-CARBOXYLIC ACID; (R)-PYRROLIDINE-3-CARBOXYLIC ACID; (R)-TETRAHYDRO-3-FURANCARBOXYLIC ACID; (R)-TRIMETHYLLACTIC ACID; (R,S)-2-AMINO-3-HYDROXY-2-METHYLPROPIONIC ACID HYDRATE; (R,S)-2-AMINO-3-HYDROXY-3-METHYLBUTANOIC ACID; (R,S)-2-AMINOPENT-4-YNOIC ACID HYDROCHLORIDE; (RS)-(TETRAZOL-5-YL)GLYCINE; (S)-(+2-ACETOXYPROPIONIC ACID; (S)-(−)-2-AMINO-2-METHYL-4-PENTENOIC ACID HYDRATE; (S)-(−)-2-CHLOROPROPIONIC ACID; (S)-(−)-2-HYDROXY-3,3-DIMETHYLBUTYRIC ACID; (S)-(−)-2-METHOXYPROPIONIC ACID; (S)-(+3,3,3-TRIFLUORO-2-HYDROXYPROPANOIC ACID; (S)-(−)-3-CYCLOHEXENECARBOXYLIC ACID; (S)-(+4-AMINO-2-HYDROXYBUTYRIC ACID; (S)-(−)-4-OXO-2-AZETIDINECARBOXYLIC ACID; (S)-(−)-METHYLSUCCINIC ACID; (S)-(−)-TETRAHYDRO-2-FUROIC ACID; (S)-(−)-THIOLACTIC ACID; (S)-(+)-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID; (S)-(+)-2-AMINO-2-METHYLBUTANOIC ACID MONOHYDRATE; (S)-(+)-2-AMINO-3-HYDROXY-3-METHYLBUTANOIC ACID; (S)-(+)-2-HYDROXY-3-METHYLBUTYRIC ACID; (S)-(+)-2-METHYLBUTYRIC ACID; (S)-(+)-2-METHYLGLUTARIC ACID; (S)-(+)-5-OXOTETRAHYDROFURAN-2-CARBOXYLIC ACID; (S)-(+)-CITRAMALIC ACID; (S)-(+)-NIPECOTIC ACID; (S)-(+)-SERINE-UL-14C HYDROCHLORIDE; (S)-(+)-VALINE-UL-14C HYDROCHLORIDE; (S)-(2-HYDROXYPYRROLIDIN-1-YL)-ACETIC ACID; (S)-(3-AMINO-PYRROLIDIN-1-YL)-ACETIC ACID; (S)-(3-HYDROXYPYRROLIDIN-1-YL)-ACETIC ACID; (S)-1,2,3,4-TETRAHYDRO-PYRIDINE-2-CARBOXYLIC ACID; (S)-1,4-OXAZEPANE-3-CARBOXYLIC ACID; (S)-1-AMINO-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID; (S)-1-ISOPROPYL-AZETIDINE-2-CARBOXYLIC ACID; (S)-2-(2-PYRROLIDINYL)ACETIC ACID; (S)-2-(PIPERIDIN-2-YL)ACETIC ACID; (S)-2-(PIPERIDIN-3-YL)ACETIC ACID; (S)-2-(PYRROLIDIN-3-YL)ACETIC ACID; (S)-2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBOXYLIC ACID; (S)-2,3-DIMETHYLBUTANOIC ACID; (S)-2,4-DIHYDROXYBUTYRIC ACID; (S)-2,5-DIMETHYLHEX-5-ENOIC ACID; (S)-2-AMINO-2-(MERCAPTOMETHOXY)ACETIC ACID; (S)-2-AMINO-2-FURANACETIC ACID; (S)-2-AMINO-2-METHYL-4-PENTENOIC ACID; (S)-2-AMINO-2-METHYL-PENTANOIC ACID; (S)-2-AMINO-3-METHOXYPROPANOIC ACID; (S)-2-AMINO-4-(METHYLAMINO)-4-OXOBUTANOIC ACID; (S)-2-AMINO-4-CYANOBUTYRIC ACID; (S)-2-AMINO-4-METHOXYBUTYRIC ACID; (S)-2-AMINO-5-METHYLHEXANOIC ACID; (S)-2-AMINO-6-HEPTENOIC ACID; (S)-2-AMINOHEPT-6-YNOIC ACID; (S)-2-AMINOHEX-5-YNOIC ACID; (S)-2-AMINOMETHYL-3-METHYL-BUTYRIC ACID; (S)-2-AMINOMETHYL-4-METHYL-PENTANOIC ACID; (S)-2-CHLORO-3-METHYLBUTYRIC ACID; (S)-2-CHLORO-N-BUTYRIC ACID; (S)-2-FLUORO-4-METHYLPENTANOIC ACID; (S)-2-HYDROXY-2,3-DIMETHYLBUTANOIC ACID; (S)-2-HYDROXY-2-METHYLBUTYRIC ACID; (S)-2-HYDROXYBUTYRIC ACID; (S)-2-HYDROXYMETHYL-HEXANOIC ACID; (S)-2-HYDROXYMETHYL-PENTANOIC ACID; (S)-2-HYDROXYPENTANOIC ACID; (S)-2-MERCAPTOBUTANOIC ACID; (S)-2-METHYL-1,4,5,6-TETRAHYDROPYRIMIDINE-4-CARBOXYLIC ACID; (S)-2-METHYLHEPT-6-ENOIC ACID; (S)-2-METHYLPENTENOIC ACID; (S)-2-METHYLPIPERIDINE-2-CARBOXYLIC ACID; (S)-2-METHYLSUCCINIC ACID 1-METHYL ESTER; (S)-2-MORPHOLINEACETIC ACID; (S)-2-OXOHEXAHYDROPYRIMIDINE-4-CARBOXYLIC ACID; (S)-2-PIPERIDINONE-6-CARBOXYLIC ACID; (S)-2-PYRROLIDIN-1-YL-PROPIONIC ACID; (S)-2-VINYLHEX-5-ENOIC ACID; (S)-2-VINYLHEXANOIC ACID; (S)-2-VINYLPENT-4-ENOIC ACID; (S)-2-VINYLPENTANOIC ACID; (S)-3-(HYDROXYMETHYL)PENT-4-ENOIC ACID; (S)-3,4-DIAMINOBUTYRIC ACID; (S)-3,5-DIAMINOPENTANOIC ACID; (S)-3-AMINO-2-(HYDROXYMETHYL)PROPANOIC ACID; (S)-3-AMINO-2-METHYLPROPANOIC ACID-HCL; (S)-3-AMINO-2-METHYL-PROPIONIC ACID; (S)-3-AMINO-3-CYCLOBUTYL-PROPIONIC ACID; (S)-3-AMINO-3-CYCLOPROPYL-PROPIONIC ACID; (S)-3-AMINO-3-METHYLPENTANOIC ACID; (S)-3-AMINO-4,4-DIMETHYL-PENTANOIC ACID; (S)-3-AMINO-4-METHYL-PENTANOIC ACID; (S)-3-AMINO-5-METHYL-HEXANOIC ACID; (S)-3-AMINOBUTANOIC ACID; (S)-3-AMINO-HEPT-6-ENOIC ACID; (S)-3-AMINO-HEX-5-ENOIC ACID; (S)-3-AMINO-PENTANOIC ACID; (S)-3-AMINOTETRAHYDRO-2H-PYRAN-3-CARBOXYLIC ACID; (S)-3-AMINOTETRAHYDROFURAN-3-CARBOXYLIC ACID; (S)-3-AMINOTETRAHYDROTHIOPHENE-3-CARBOXYLIC ACID; (S)-3-HYDROXY-2-METHYL-PROPIONIC ACID; (S)-3-HYDROXY-4-METHOXY-4-OXOBUTANOIC ACID; (S)-3-HYDROXYBUTYRIC ACID; (S)-3-METHYLHEPTANOIC ACID; (S)-3-METHYLHEXANOIC ACID; (S)-3-METHYL-PENTANOIC ACID; (S)-4,4-DIMETHYL-PYRROLIDINE-2-CARBOXYLIC ACID; (S)-4,5-DIDEHYDROPIPECOLIC ACID; (S)-4-AMINO-3-HYDROXYBUTANOIC ACID; (S)-4-AMINOHEX-5-ENOIC ACID; (S)-4-METHYLHEXANOIC ACID; (S)-4-OXO-2-PIPERIDINE CARBOXYLIC ACID; (S)-5-AMINO-4-HYDROXYPENTANOIC ACID; (S)-5-METHYLHEPTANOIC ACID; (S)-5-OXO-PIPERAZINE-2-CARBOXYLIC ACID; (S)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; (S)-6-OXO-PIPERAZINE-2-CARBOXYLIC ACID; (S)-A-AMINO-2-HYDROXYBUTANOIC ACID; (S)-ALPHA-METHYLCYSTEINE; (S)-ALPHA-PROPARGYLALANINE; (S)-AMINO-(1H-IMIDAZOL-2-YL)-ACETIC ACID; (S)-HEXAHYDRO-1H-AZEPINE-2-CARBOXYLIC ACID; (S)-ISOSERINE; (S)-MORPHOLIN-3-YL-ACETIC ACID; (S)-MORPHOLINE-2-CARBOXYLIC ACID; (S)-MORPHOLINE-3-CARBOXYLIC ACID; (S)-OXAZOLIDINE-4-CARBOXYLIC ACID; (S)-PIPERAZINE-2-CARBOXYLIC ACID; (S)-PYRROLIDINE-3-CARBOXYLIC ACID; (S)-TETRAHYDRO-3-FURANCARBOXYLIC ACID; (S)-THIOMORPHOLINE-3-CARBOXYLIC ACID; (SEC-BUTYLAMINO)(OXO)ACETIC ACID; (TERT-BUTYLAMINO)(OXO)ACETIC ACID; (TERT-BUTYLTHIO)ACETIC ACID; (TETRAHYDRO-FURAN-2-YL)-ACETIC ACID; (TETRAHYDRO-FURAN-3-YL)-ACETIC ACID; (TETRAHYDRO-PYRAN-2-YL)-ACETIC ACID; (TETRAHYDRO-PYRAN-4-YLIDENE)-ACETIC ACID; (TRIFLUOROMETHOXY)ACETIC ACID; (TRIMETHYLSILYL)ACETIC ACID; (Z)-3-(1H-PYRROL-2-YL)-2-PROPENOIC ACID; (Z)-3-(2-FURANYL)-2-PROPENOIC ACID; (Z)-3-CYCLOPROPYLBUT-2-ENOIC ACID; (Z)-HEX-2-ENOIC ACID; [(2-AMINO-2-OXOETHYL)THIO]ACETIC ACID; [(2-METHOXYETHYL)(METHYL)AMINO]ACETIC ACID; [(2-METHOXYETHYL)CARBAMOYL]FORMIC ACID; [(2-METHYLBUTYL)AMINO]ACETIC ACID; [(2-METHYLCYCLOPROPYL)CARBAMOYL]FORMIC ACID; [(3-METHYLBUTYL)AMINO]ACETIC ACID; [(CYCLOPROPYLMETHYL)THIO]ACETIC ACID; [(PROP-2-EN-1-YL)CARBAMOYL]FORMIC ACID; [(PROP-2-YN-1-YL)CARBAMOYL]FORMIC ACID; [ETHYL(METHYL)AMINO]ACETIC ACID; 1-(2-AMINOETHYL)CYCLOPROPANECARBOXYLIC ACID; 1-(2-PROPYN-1-YL)-1H-PYRROLE-2-CARBOXYLIC ACID; 1-(AMINOMETHYL)CYCLOBUTANE-1-CARBOXYLIC ACID; 1-(AMINOMETHYL)CYCLOPENTANECARBOXYLIC ACID; 1-(AMINOMETHYL)CYCLOPROPANECARBOXYLIC ACID; 1-(CARBOXYMETHYL)PYRIDINIUM; 1-(CHLOROCARBONYL)-CYCLOPROPANECARBOXYLIC ACID; 1-(CYCLOPROPYLMETHYL)CYCLOPROPANECARBOXYLIC ACID; 1-(DIMETHYLAMINO)CYCLOBUTANE-1-CARBOXYLIC ACID; 1-(DIMETHYLAMINO)CYCLOPROPANECARBOXYLIC ACID; 1-(ETHYLAMINO)CYCLOBUTANE-1-CARBOXYLIC ACID; 1-(HYDROXYMETHYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(HYDROXYMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-(HYDROXYMETHYL)-CYCLOPENTANECARBOXYLIC ACID; 1-(HYDROXYMETHYL)CYCLOPROPANECARBOXYLIC ACID; 1-(METHOXYMETHYL)CYCLOBUTANECARBOXYLIC ACID; 1-(METHOXYMETHYL)CYCLOPROPANECARBOXYLIC ACID; 1-(METHYLAMINO)CYCLOBUTANE-1-CARBOXYLIC ACID; 1-(METHYLAMINO)CYCLOPENTANE-1-CARBOXYLIC ACID; 1-(METHYLCARBAMOYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 1,1-CYCLOBUTANEDICARBOXYLIC ACID; 1,1-CYCLOPROPANEDICARBOXYLIC ACID; 1,1-CYCLOPROPANEDICARBOXYLIC ACID MONOMETHYL ESTER; 1,1-DICYCLOPROPANECARBOXYLIC ACID; 1,2,3,6-TETRAHYDRO-PYRIDINE-2-CARBOXYLIC ACID; 1,2,3,6-TETRAHYDRO-PYRIDINE-4-CARBOXYLIC ACID; 1,2,3-THIADIAZOLE-4-CARBOXYLIC ACID; 1,2,3-THIADIAZOLE-5-CARBOXYLIC ACID; 1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 1,2,4-OXADIAZOLE-3-CARBOXYLIC ACID; 1,2,4-OXADIAZOLE-5-CARBOXYLIC ACID; 1,2,4-TRIAZINE-3-CARBOXYLIC ACID; 1,2,4-TRIAZINE-5-CARBOXYLIC ACID; 1,2,4-TRIAZOLE-1-ACETIC ACID; 1,2,5,6-TETRAHYDROPYRIDINE-3-CARBOXYLIC ACID; 1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID; 1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID, 4-(METHYLAMINO)-; 1,2,5-THIADIAZOLE-3-CARBOXYLIC ACID; 1,2-CYCLOPROPANEDICARBOXYLIC ACID, (1R,2R)-REL-; 1,2-CYCLOPROPANEDICARBOXYLIC ACID, (1R,2S)-REL-; 1,2-DIMETHYL-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 1,3,4-OXADIAZOLE-2-CARBOXYLIC ACID; 1,3,4-THIADIAZOLE-2-CARBOXYLIC ACID; 1,3,5,7-CYCLOOCTATETRAENECARBOXYLIC ACID; 1,3,5-TRIAZINE-2-CARBOXYLIC ACID; 1,3-ACETONEDICARBOXYLIC ACID; 1,3-DIHYDRO-IMIDAZOL-2-ONE-5-METHYL-4-CARBOXYLIC ACID; 1,3-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1,3-DIMETHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 1,3-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 1,3-DIMETHYL-PYRROLIDINE-3-CARBOXYLIC ACID; 1,3-METHYLENECYCLOBUTANE CARBOXYLIC ACID; 1,3-OXATHIOLANE-2-CARBOXYLIC ACID, 5-OXO-; 1,3-THIAZINANE-4-CARBOXYLIC ACID; 1,3-THIAZOL-4-YLACETIC ACID; 1,4,5,6-TETRAHYDRO-PYRIDAZINE-3-CARBOXYLIC ACID; 1,4-DIHYDRO-2-METHYLBENZOIC ACID; 1,4-DIHYDRO-4-OXO-2-PYRIDINECARBOXYLIC ACID; 1,4-DIHYDROBENZOIC ACID; 1,4-DIOXANE-2-CARBOXYLIC ACID; 1,4-OXAZEPANE-3-CARBOXYLIC ACID; 1,5-DIMETHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 1,5-DIMETHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 1,6-DIHYDRO-6-OXOPYRIMIDINE-4-CARBOXYLIC ACID; 1-ACETYL-2-AZETIDINECARBOXYLIC ACID; 1-ACETYL-3-AZETIDINECARBOXYLIC ACID; 1-ACETYLCYCLOPROPANECARBOXYLIC ACID; 1-ALLYL-AZETIDINE-2-CARBOXYLIC ACID; 1-ALLYLCYCLOPROPANECARBOXYLIC ACID; 1-AMINO-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 1-AMINO-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID; 1-AMINO-2-ETHENYLCYCLOPROPANECARBOXYLIC ACID; 1-AMINO-2-METHYLCYCLOPENTANECARBOXYLIC ACID; 1-AMINO-2-METHYLENE-CYCLOPROPANECARBOXYLIC ACID; 1-AMINO-3,3-DIMETHYL-CYCLOBUTANECARBOXYLIC ACID; 1-AMINO-3-HYDROXYCYCLOBUTANECARBOXYLIC ACID; 1-AMINO-3-METHYLCYCLOPENTANECARBOXYLIC ACID; 1-AMINOAZETIDINE-2-CARBOXYLIC ACID; 1-AMINOCYCLOBUTANECARBOXYLIC ACID; 1-AMINOCYCLOHEXANECARBOXYLIC ACID; 1-AMINOCYCLOPENT-3-ENECARBOXYLIC ACID; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; 1-AMINO-CYCLOPROPANE-1-CARBOXYLIC ACID HYDROCHLORIDE; 1-AZABICYCLO[2.2.1]HEPTANE-4-CARBOXYLIC ACID; 1-AZETIDINEACETIC ACID; 1-CARBAMOYL-AZETIDINE-3-CARBOXYLIC ACID; 1-CARBOXYCYCLOPROPANECARBOXAMIDE; 1-CUBANECARBOXYLIC ACID; 1-CYANO-1-CYCLOPROPANECARBOXYLIC ACID; 1-CYANOCYCLOBUTANECARBOXYLIC ACID; 1-CYANOCYCLOPENTANECARBOXYLIC ACID; 1-CYCLOBUTENE-1-CARBOXYLIC ACID; 1-CYCLOHEXENE-1-CARBOXYLIC ACID; 1-CYCLOHEXENYLACETIC ACID; 1-CYCLOPENTENE-1-CARBOXYLIC ACID, 2-AMINO-; 1-CYCLOPENTENECARBOXYLIC ACID; 1-CYCLOPROPYL-2-AZETIDINECARBOXYLIC ACID; 1-ETHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 1-ETHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 1-ETHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-ETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-ETHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 1-ETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 1-ETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 1-ETHYL-4-OXO-2-AZETIDINECARBOXYLIC ACID; 1-ETHYL-AZETIDINE-3-CARBOXYLIC ACID; 1-ETHYLCYCLOBUTANECARBOXYLIC ACID; 1-ETHYLCYCLOPENTANE-1-CARBOXYLIC ACID; 1-ETHYLCYCLOPROPANECARBOXYLIC ACID; 1-ETHYLPYRROLIDINE-2-CARBOXYLIC ACID; 1-ETHYLPYRROLIDINE-3-CARBOXYLIC ACID; 1-FLUOROCYCLOHEXANECARBOXYLIC ACID; 1-FLUORO-CYCLOPROPANECARBOXYLIC ACID; 1-FORMYLPYRROLIDINE-2-CARBOXYLIC ACID; 1-FORMYLPYRROLIDINE-3-CARBOXYLIC ACID; 1H-[1,2,3]TRIAZOLE-4-CARBOXYLIC ACID; 1H-1,2,3-TRIAZOLE-1-ACETIC ACID; 1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID, 5-METHYL-; 1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID, 1-AMINO-; 1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID, 5-AMINO-2,3-DIHYDRO-; 1H-1,2,4-TRIAZOLE-5-CARBOXYLIC ACID; 1H-IMIDAZOL-1-YL(OXO)ACETIC ACID; 1H-IMIDAZOL-4-YL(OXO)ACETIC ACID; 1H-IMIDAZOLE-1-ACETIC ACID, ALPHA-METHYL-, (R)-; 1H-IMIDAZOLE-1-ACETIC ACID,-ALPHA-FLUORO-; 1H-IMIDAZOLE-2-CARBOXYLIC ACID; 1H-IMIDAZOLE-2-CARBOXYLIC ACID HYDROCHLORIDE; 1H-IMIDAZOLE-2-CARBOXYLIC ACID, 4,5-DIHYDRO-5-OXO-; 1H-IMIDAZOLE-4-CARBOXYLIC ACID; 1H-IMIDAZOLE-5-CARBOXYLIC ACID; 1H-PYRAZOL-1-YLACETIC ACID; 1H-PYRAZOLE-3-CARBOXYLIC ACID; 1H-PYRAZOLE-4-CARBOXYLIC ACID; 1H-PYRAZOLE-4-CARBOXYLIC ACID HYDRATE; 1H-PYRROL-1-YLACETIC ACID; 1H-PYRROLE-2-CARBOXYLIC ACID, 3,4-DIFLUORO-; 1H-TETRAZOLE-1-ACETIC ACID; 1H-TETRAZOLE-5-ACETIC ACID; 1H-TETRAZOLE-5-CARBOXYLIC ACID; 1-HYDROXY-1-CYCLOPROPANECARBOXYLIC ACID; 1-HYDROXY-2-PIPERIDINECARBOXYLIC ACID; 1-HYDROXY-3-METHYLCYCLOPENTANE-1-CARBOXYLIC ACID; 1-HYDROXY-CYCLOBUTANECARBOXYLIC ACID; 1-HYDROXY-CYCLOHEXANECARBOXYLIC ACID; 1-HYDROXY-CYCLOPENTANECARBOXYLIC ACID; 1-ISOPROPYL-AZETIDINE-2-CARBOXYLIC ACID; 1-ISOPROPYLAZETIDINE-3-CARBOXYLIC ACID; 1-METHOXYCYCLOPENTANE-1-CARBOXYLIC ACID; 1-METHYL-1-CYCLOHEXANECARBOXYLIC ACID; 1-METHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 1-METHYL-1H-1,2,3-TRIAZOLE-5-CARBOXYLIC ACID; 1-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 1-METHYL-1H-1,2,4-TRIAZOLE-5-CARBOXYLIC ACID; 1-METHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 1-METHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 1-METHYL-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 1-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 1-METHYL-2,5-DIHYDRO-1H-PYRROLE-2-CARBOXYLIC ACID; 1-METHYL-2-CYCLOHEXENE-1-CARBOXYLIC ACID; 1-METHYL-2-IMIDAZOLINE-4-CARBOXYLIC ACID; 1-METHYL-3-AZETIDINECARBOXYLIC ACID; 1-METHYL-3-CYCLOHEXENECARBOXYLIC ACID; 1-METHYL-4-OXO-2-AZETIDINECARBOXYLIC ACID; 1-METHYL-5-OXO-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-METHYL-5-OXOPYRROLIDINE-2-CARBOXYLIC ACID; 1-METHYL-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; 1-METHYLCYCLOBUTANECARBOXYLIC ACID; 1-METHYLCYCLOPENTANECARBOXYLIC ACID; 1-METHYLCYCLOPROPANE-1-CARBOXYLIC ACID; 1-METHYLIMIDAZOLE-2-CARBOXYLIC ACID HYDRATE; 1-METHYLPIPERAZINE-2-CARBOXYLIC ACID; 1-METHYL-PIPERIDINE-2-CARBOXYLIC ACID; 1-METHYLPIPERIDINE-3-CARBOXYLIC ACID; 1-METHYLPIPERIDINE-4-CARBOXYLIC ACID; 1-METHYL-PYRROLE-2-ACETIC ACID; 1-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; 1-METHYLPYRROLIDINE-2-CARBOXYLIC ACID HYDRATE; 1-METHYLPYRROLIDINE-3-CARBOXYLIC ACID; 1-NITRO-3-AZETIDINECARBOXYLIC ACID; 1-PROPYL-AZETIDINE-2-CARBOXYLIC ACID; 1-PROPYLCYCLOBUTANECARBOXYLIC ACID; 1-VINYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-VINYL-1H-PYRROLE-2-CARBOXYLIC ACID; 2-([(2E)-3-CHLOROPROP-2-EN-1-YL]AMINO)ACETIC ACID; 2-([(METHYLCARBAMOYL)METHYL]AMINO)ACETIC ACID; 2-([2-(DIMETHYLAMINO)ETHYL]AMINO)ACETIC ACID; 2-(1-(HYDROXYMETHYL)CYCLOPROPYL)ACETIC ACID; 2-(1,2,4-OXADIAZOL-5-YL)ACETIC ACID; 2-(1,2-OXAZOL-4-YL)ACETIC ACID; 2-(1H-1,2,4-TRIAZOL-1-YL)PROPANOIC ACID; 2-(1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; 2-(1H-IMIDAZOL-1-YL)PROPANOIC ACID; 2-(1H-PYRAZOL-1-YL)PROPANOIC ACID; 2-(1H-PYRROL-1-YL)PROPANOIC ACID; 2-(1H-PYRROL-2-YL)PROPANOIC ACID; 2-(1-HYDROXYCYCLOBUTYL)ACETIC ACID; 2-(1-HYDROXYCYCLOBUTYL)PROPANOIC ACID; 2-(1-HYDROXYCYCLOPENTYL)ACETIC ACID; 2-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; 2-(1-METHYL-3-PYRROLIDINYL)ACETIC ACID; 2-(1-METHYLHYDRAZINO)PROPANOIC ACID; 2-(2-AMINOACETAMIDO)ACETIC ACID-15N2; 2-(2-CH LOROETHOXY)ACETIC ACID; 2-(2-CYANO-ETHYLAMINO)-PROPIONIC ACID; 2-(2-ETHOXYETHOXY)ACETIC ACID; 2-(2H-TETRAZOL-5-YL)ACETIC ACID; 2-(2-HYDROXYETHOXY)ACETIC ACID; 2-(2-HYDROXYETHOXY)BUTANOIC ACID; 2-(2-HYDROXYETHOXY)PROPANOIC ACID; 2-(2-METHOXYETHOXY)ACETIC ACID; 2-(2-METHOXYETHOXY)PROPANOIC ACID; 2-(2-METHYL-1H-IMIDAZOL-5-YL)ACETIC ACID; 2-(2-METHYLENECYCLOPROPYL)ACETIC ACID; 2-(2-METHYLPROPOXY)PROPANOIC ACID; 2-(2-METHYLPROPYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 2-(2-METHYLPYRROLIDIN-1-YL)ACETIC ACID; 2-(3-AMINO-1H-PYRAZOL-5-YL)ACETIC ACID; 2-(3H-IMIDAZOL-4-YL)ACETIC ACID; 2-(3-HYDROXYAZETIDIN-1-YL)ACETIC ACID; 2-(3-HYDROXYAZETIDIN-1-YL)PROPANOIC ACID; 2-(3-HYDROXYOXOLAN-3-YL)ACETIC ACID; 2-(3-HYDROXYPROPOXY)ACETIC ACID; 2-(3-HYDROXYPROPOXY)PROPANOIC ACID; 2-(3-METHOXYPROPOXY)ACETIC ACID; 2-(3-METHYL-1H-PYRROL-1-YL)ACETIC ACID; 2-(3-METHYLPYRROLIDIN-1-YL)ACETIC ACID; 2-(3-OXOCYCLOPENTYL)ACETIC ACID; 2-(3-PYRROLIDINYLIDENE)ACETIC ACID; 2-(4-METHYL)PYRROLIDINYL ACETIC ACID; 2-(5-AMINO-1H-1,2,4-TRIAZOL-1-YL)ACETIC ACID; 2-(5-AMINO-1H-PYRAZOL-1-YL)ACETIC ACID; 2-(5-METHYL-1,3,4-OXADIAZOL-2-YL)ACETIC ACID; 2-(5-METHYL-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; 2-(5-METHYLPYRROLIDIN-2-YL)ACETIC ACID; 2-(5-OXO-4,5-DIHYDRO-1H-PYRAZOL-3-YL)ACETIC ACID; 2-(5-OXOPYRROLIDIN-2-YL)ACETIC ACID; 2-(ALLYLAMINO)ACETIC ACID; 2-(ALLYLTHIO)PROPANOIC ACID; 2-(AMINOAMINOCARBONYLAMINO)ACETIC ACID; 2-(AMINOMETHYL)-2-ETHYLBUTANOIC ACID; 2-(AMINOMETHYL)-3-METHYLBUTANOIC ACID; 2-(AMINOMETHYL)-4-METHYLPENTANOIC ACID; 2-(AMINOMETHYL)BUTANOIC ACID; 2-(AMINOMETHYL)CYCLOPROPANECARBOXYLIC ACID; 2-(AMINOMETHYL)PENTANOIC ACID; 2-(AMINOOXY)ACETIC ACID; 2-(AZETIDIN-1-YL)-2-OXOACETIC ACID; 2-(BUT-2-EN-1-YLOXY)ACETIC ACID; 2-(BUT-3-EN-1-YLOXY)ACETIC ACID; 2-(BUT-3-EN-1-YLOXY)PROPANOIC ACID; 2-(BUT-3-EN-2-YLAMINO)ACETIC ACID; 2-(BUT-3-EN-2-YLAMINO)PROPANOIC ACID; 2-(BUT-3-EN-2-YLSULFANYL)ACETIC ACID; 2-(BUT-3-ENAMIDO)ACETIC ACID; 2-(BUT-3-YN-1-YLAMINO)ACETIC ACID; 2-(BUT-3-YN-1-YLAMINO)PROPANOIC ACID; 2-(BUT-3-YN-1-YLSULFANYL)ACETIC ACID; 2-(BUTAN-2-YLAMINO)ACETIC ACID; 2-(BUTAN-2-YLAMINO)PROPANOIC ACID; 2-(BUTAN-2-YLOXY)ACETIC ACID; 2-(BUTAN-2-YLSULFANYL)ACETIC ACID; 2-(BUTYLAMINO)ACETIC ACID; 2-(BUTYLAMINO)PROPANOIC ACID; 2-(CYANOMETHYLTHIO)ACETIC ACID; 2-(CYCLOBUTYLAMINO)ACETIC ACID; 2-(CYCLOBUTYLAMINO)PROPANOIC ACID; 2-(CYCLOBUTYLMETHOXY)-ACETIC ACID; 2-(CYCLOBUTYLMETHYL)ACRYLIC ACID; 2-(CYCLOPENTYLOXY)ACETIC ACID; 2-(CYCLOPROPYLAMINO)-2-METHYLPROPANOIC ACID; 2-(CYCLOPROPYLAMINO)-2-OXOACETIC ACID; 2-(CYCLOPROPYLAMINO)ACETIC ACID; 2-(CYCLOPROPYLAMINO)BUTANOIC ACID; 2-(CYCLOPROPYLAMINO)PROPANOIC ACID; 2-(CYCLOPROPYLCARBAMOYL)ACETIC ACID; 2-(CYCLOPROPYLMETHOXY)-ACETIC ACID; 2-(CYCLOPROPYLMETHOXY)PROPANOIC ACID; 2-(DIETHYLAMINO)PROPANOIC ACID; 2-(DIMETHYLAMINO)-2-METHYLBUTANOIC ACID; 2-(DIMETHYLAMINO)-2-METHYLPROPANOIC ACID; 2-(DIMETHYLAMINO)BUTANOIC ACID; 2-(DIMETHYLAMINO)PENTANOIC ACID; 2-(DIMETHYLAMINO)PROPANOIC ACID; 2-(DIMETHYLCARBAMOYL)ACETIC ACID; 2-(ETHANESULFINYL)ACETIC ACID; 2-(ETHOXYCARBONYLAMINO)ACETIC ACID; 2-(ETHYLAMINO)-2-METHYLBUTANOIC ACID; 2-(ETHYLAMINO)-2-METHYLPROPANOIC ACID; 2-(ETHYLAMINO)-3-METHOXYPROPANOIC ACID; 2-(ETHYLAMINO)-3-METHYLBUTANOIC ACID; 2-(ETHYLAMINO)ACETIC ACID HYDROCHLORIDE; 2-(ETHYLAMINO)BUTANOIC ACID; 2-(ETHYLAMINO)PENTANOIC ACID; 2-(ETHYLAMINO)PROPANOIC ACID; 2-(ETHYLCARBAMOYL)ACETIC ACID; 2-(ETHYLSULFANYL)-2-METHYLPROPANOIC ACID; 2-(ETHYLSULFANYL)BUTANOIC ACID; 2-(ETHYLTHIO)PROPANOIC ACID; 2-(FORMYLOXY)PROPANOIC ACID; 2-(FURAN-2-YL)PROPANOIC ACID; 2-(FURAN-3-YL)-2-HYDROXYACETIC ACID; 2-(HYDROXYMETHYL)-BUTANOIC ACID; 2-(HYDROXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-(ISOPROPYLIDENEAMINOOXY)PROPIONIC ACID; 2-(ISOPROPYLTHIO)PROPANOIC ACID; 2-(METHOXY(METHYL)AMINO)-2-OXOACETIC ACID; 2-(METHOXYCARBONYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 2-(METHYLAMINO)-3-(METHYLSULFANYL)PROPANOIC ACID; 2-(METHYLAMINO)BUTANOIC ACID; 2-(METHYLAMINO)HEXANOIC ACID; 2-(METHYLAMINO)PENTANOIC ACID; 2-(METHYLCARBAMOYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 2-(METHYLSULFANYL)BUTANOIC ACID; 2-(METHYLTHIO)PROPANOIC ACID; 2-(N-CYCLOBUTYL-N-METHYLAMINO)ACETIC ACID; 2-(N-ETHYLACETAMIDO)ACETIC ACID; 2-(N-METHYLACETAMIDO)ACETIC ACID; 2-(N-METHYLACETAMIDO)PROPANOIC ACID; 2-(N-METHYLFORMAMIDO)PROPANOIC ACID; 2-(N-METHYL-HYDRAZINO)-BUTYRIC ACID; 2-(N-METHYL-N-PROPYLAMINO)ACETIC ACID; 2-(N-METHYLPROP-2-YNAMIDO)ACETIC ACID; 2-(N-PROPYLFORMAMIDO)ACETIC ACID; 2-(OXETAN-3-YLIDENE)ACETIC ACID; 2-(OXOLAN-3-YLAMINO)ACETIC ACID; 2-(OXOLAN-3-YLIDENE)ACETIC ACID; 2-(OXOLAN-3-YLOXY)ACETIC ACID; 2-(PENT-4-ENYLOXY)ACETIC ACID; 2-(PENTAN-2-YLAMINO)ACETIC ACID; 2-(PENTAN-3-YLAMINO)ACETIC ACID; 2-(PENTAN-3-YLOXY)ACETIC ACID; 2-(PENTYLAMINO)ACETIC ACID; 2-(PENTYLOXY)ACETIC ACID; 2-(PROP-2-EN-1-YLAMINO)BUTANOIC ACID; 2-(PROP-2-EN-1-YLAMINO)PROPANOIC ACID; 2-(PROP-2-EN-1-YLOXY)ACETIC ACID; 2-(PROP-2-EN-1-YLOXY)BUTANOIC ACID; 2-(PROP-2-EN-1-YLOXY)PROPANOIC ACID; 2-(PROP-2-YN-1-YLAMINO)ACETIC ACID; 2-(PROP-2-YN-1-YLAMINO)PROPANOIC ACID; 2-(PROP-2-YN-1-YLOXY)ACETIC ACID; 2-(PROP-2-YN-1-YLOXY)BUTANOIC ACID; 2-(PROP-2-YN-1-YLOXY)PROPANOIC ACID; 2-(PROP-2-YN-1-YLSULFANYL)PROPANOIC ACID; 2-(PROP-2-YNAMIDO)ACETIC ACID; 2-(PROP-2-YNAMIDO)PROPANOIC ACID; 2-(PROPAN-2-YL)PENTANOIC ACID; 2-(PROPAN-2-YLAMINO)ACETIC ACID; 2-(PROPAN-2-YLAMINO)BUTANOIC ACID; 2-(PROPAN-2-YLOXY)BUTANOIC ACID; 2-(PROPYLAMINO)BUTANOIC ACID; 2-(PROPYLAMINO)PROPANOIC ACID; 2-(PROPYLCARBAMOYL)ACETIC ACID; 2-(PROPYLSULFANYL)PROPANOIC ACID; 2(S),3(R)-2-AMINO-3-HYDROXYPENT-4-YNOIC ACID; 2(S)-AMINO-4-AZIDO-BUTANOIC ACID; 2-(TERT-BUTOXY)PROPANOIC ACID; 2-(TERT-BUTYLAMINO)ACETIC ACID; 2-(TRIFLUOROMETHYL)ACRYLIC ACID; 2,2,3,3-TETRAMETHYLCYCLOPROPANECARBOXYLIC ACID; 2,2,3-TRIMETHYL-3-BUTENOIC ACID; 2,2,3-TRIMETHYLBUTANOIC ACID; 2,2,3-TRIMETHYLPENTANOIC ACID; 2,2,4-TRIMETHYL-4-PENTENOIC ACID; 2,2,4-TRIMETHYLPENTANOIC ACID; 2,2-BIS(HYDROXYMETHYL)BUTYRIC ACID; 2,2-BIS(HYDROXYMETHYL)PROPIONIC ACID; 2,2-DIAMINO-3-MERCAPTO-PROPIONIC ACID; 2,2-DICHLOROPROPIONIC ACID; 2,2-DICYCLOPROPYLACETIC ACID; 2,2-DIETHYLBUTYRIC ACID; 2,2-DIETHYLCYCLOPROPANECARBOXYLIC ACID; 2,2-DIFLUORO-3-HYDROXYBUTANOIC ACID; 2,2-DIFLUORO-3-METHYLBUTYRIC ACID; 2,2-DIFLUOROBUTYRIC ACID; 2,2-DIFLUOROCYCLOBUTANECARBOXYLIC ACID; 2,2-DIFLUOROCYCLOPROPANECARBOXYLIC ACID; 2,2-DIFLUOROPENT-4-ENOIC ACID; 2,2-DIFLUOROPENTANOIC ACID; 2,2-DIFLUOROPROPIONIC ACID; 2,2-DIMETHYL CYCLOPROPYL CARBOXYLIC ACID; 2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBOXYLIC ACID; 2,2-DIMETHYL-3-(METHYLSULFANYL)PROPANOIC ACID; 2,2-DIMETHYL-3-HYDROXYPROPIONIC ACID; 2,2-DIMETHYL-3-OXOBUTANOIC ACID; 2,2-DIMETHYL-4-OXO-PENTANOIC ACID; 2,2-DIMETHYL-4-PENTENOIC ACID; 2,2-DIMETHYL-5-HEXENOIC ACID; 2,2-DIMETHYL-5-HEXYNOIC ACID; 2,2-DIMETHYLBUT-3-ENOIC ACID; 2,2-DIMETHYL-BUT-3-YNOIC ACID; 2,2-DIMETHYLBUTYRIC ACID; 2,2-DIMETHYL-CYCLOPENTANECARBOXYLIC ACID; 2,2-DIMETHYLHEXANOIC ACID; 2,2-DIMETHYL-MALONAMIC ACID; 2,2-DIMETHYL-MALONIC ACID MONOMETHYL ESTER; 2,2-DIMETHYLSUCCINIC ACID; 2,2-DIMETHYLVALERIC ACID; 2,3,3,3-TETRAFLUOROPROPANOIC ACID; 2,3,3-TRIMETHYLBUTANOIC ACID; 2,3,3-TRIMETHYLPROPIONIC ACID; 2,3,4-TRIHYDROXYBUTANOIC ACID; 2,3:4,5-DIEPOXY-HEXANOIC ACID; 2,3-ANHYDRO-4-DEOXY-PENTARIC ACID; 2,3-DIAMINOBUTYRIC ACID; 2,3-DIAMINOPROPIONIC ACID; 2,3-DICHLOROPROPIONIC ACID; 2,3′-DIENE-VALPROIC ACID; 2,3-DIENEVALPROIC ACID; 2,3-DIETHYLCYCLOPROP-2-ENE-1-CARBOXYLIC ACID; 2,3-DIHYDRO-2-OXO-4-PYRIDINECARBOXYLIC ACID; 2,3-DIHYDRO-3-OXO-5-1SOTHIAZOLECARBOXAMIDE; 2,3-DIHYDRO-4-METHYL-3-OXO-5-1SOXAZOLECARBOXYLIC ACID; 2,3-DIHYDROXYISOVALERIC ACID; 2,3-DIMERCAPTOPROPIONIC ACID; 2,3-DIMETHYL-2-(METHYLAMINO)BUTANOIC ACID; 2,3-DIMETHYLPENTANOIC ACID; 2,3-DIMETHYLSUCCINIC ACID; 2,3-EPOXYPROPANOIC ACID; 2,4,4-TRIMETHYLPENTANOIC ACID; 2,4,6-OCTATRIENOIC ACID; 2,4-DIAMINO-2-METHYL-BUTYRIC ACID; 2,4-DIAMINO-BUTYRIC ACID; 2,4-DIENE VALPROIC ACID; 2,4-DIMETHYL-2-PENTENOIC ACID; 2,4-DIMETHYL-3-FUROIC ACID; 2,4-DIMETHYLHEXANOIC ACID; 2,4-DIMETHYL-OXAZOLE-5-CARBOXYLIC ACID; 2,4-DIMETHYLPENTANOIC ACID; 2,4-DIMETHYLPYRROLE-3-CARBOXYLIC ACID; 2,5-DIHYDRO-4-METHYL-5-OXO-3-FURANCARBOXYLIC ACID; 2,5-DIHYDRO-5-OXO-2-FURANACETIC ACID; 2,5-DIHYDRO-5-OXO-3-FURANCARBOXYLIC ACID; 2,5-DIHYDRO-FURAN-2-CARBOXYLIC ACID; 2,5-DIMETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID; 2,5-DIMETHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2,5-DIMETHYL-3-FUROIC ACID; 2,5-DIMETHYL-HEX-4-ENOIC ACID; 2,5-DIMETHYLHEXANOIC ACID; 2,5-DIMETHYLPYRROLE-3-CARBOXYLIC ACID; 2,5-DIOXO-PYRROLIDINE-3-CARBOXYLIC ACID; 2,6-HEPTADIENOIC ACID; 2-[(1-CARBAMOYLETHYL)AMINO]ACETIC ACID; 2-[(1-CYANOETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(1-CYANOETHYL)SULFANYL]ACETIC ACID; 2-[(1-CYANOPROPYL)AMINO]ACETIC ACID; 2-[(1-CYCLOPROPYLETHYL)AMINO]ACETIC ACID; 2-[(1-HYDROXY-2-METHYLPROPAN-2-YL)AMINO]ACETIC ACID; 2-[(1-HYDROXYBUTAN-2-YL)AMINO]ACETIC ACID; 2-[(1-HYDROXYPROPAN-2-YL)AMINO]ACETIC ACID; 2-[(1-HYDROXYPROPAN-2-YL)AMINO]PROPANOIC ACID; 2-[(1-METHOXYPROPAN-2-YL)AMINO]ACETIC ACID; 2-[(2,2-DIFLUOROETHYL)AMINO]ACETIC ACID; 2-[(2,2-DIMETHYLCYCLOPROPYL)AMINO]ACETIC ACID; 2-[(2,2-DIMETHYLPROPYL)AMINO]ACETIC ACID; 2-[(2-AMINOETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(2-AMINOETHYL)(METHYL)AMINO]PROPANOIC ACID; 2-[(2-AMINOETHYL)AMINO]-2-METHYLPROPANOIC ACID; 2-[(2-AMINOETHYL)CARBAMOYL]ACETIC ACID; 2-[(2-AMINOETHYL)SULFANYL]ACETIC ACID; 2-[(2-AMINOETHYL)SULFANYL]PROPANOIC ACID; 2-[(2-CARBAMOYLETHYL)AMINO]ACETIC ACID; 2-[(2-CHLOROPROP-2-EN-1-YL)AMINO]ACETIC ACID; 2-[(2-CYANOETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(2E)-BUT-2-EN-1-YL(METHYL)AMINO]ACETIC ACID; 2-[(2E)-BUT-2-EN-1-YLAMINO]PROPANOIC ACID; 2-[(2E)-BUT-2-EN-1-YLSULFANYL]ACETIC ACID; 2-[(2E)-BUT-2-ENAMIDO]ACETIC ACID; 2-[(2-ETHOXYETHYL)AMINO]ACETIC ACID; 2-[(2-HYDROXY-2-METHYLPROPYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYBUTYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYETHYL)(METHYL)AMINO]PROPANOIC ACID; 2-[(2-HYDROXYETHYL)AMINO]-2-METHYLPROPANOIC ACID; 2-[(2-HYDROXYETHYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYETHYL)AMINO]PROPANOIC ACID; 2-[(2-HYDROXYETHYL)CARBAMOYL]ACETIC ACID; 2-[(2-HYDROXYETHYL)SULFANYL]ACETIC ACID; 2-[(2-HYDROXYPROPYL)(METHYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYPROPYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYPROPYL)AMINO]PROPANOIC ACID; 2-[(2-METHOXY-2-OXOETHYL)AMINO]ACETIC ACID; 2-[(2-METHOXYACETYL)AMINO]ACETIC ACID; 2-[(2-METHOXYETHYL)AMINO]ACETIC ACID; 2-[(2-METHOXYETHYL)AMINO]PROPANOIC ACID; 2-[(2-METHYLBUTAN-2-YL)AMINO]ACETIC ACID; 2-[(2-METHYLBUTAN-2-YL)OXY]ACETIC ACID; 2-[(2-METHYLCYCLOPROPYL)AMINO]ACETIC ACID; 2-[(2-METHYLCYCLOPROPYL)AMINO]PROPANOIC ACID; 2-[(2-METHYLPROP-2-EN-1-YL)AMINO]ACETIC ACID; 2-[(2-METHYLPROP-2-EN-1-YL)AMINO]PROPANOIC ACID; 2-[(2-METHYLPROP-2-EN-1-YL)SULFANYL]ACETIC ACID; 2-[(2-METHYLPROPYL)AMINO]ACETIC ACID; 2-[(3-AMINOPROPYL)AMINO]ACETIC ACID; 2-[(3-CYANOPROPYL)AMINO]ACETIC ACID; 2-[(3E)-THIOLAN-3-YLIDENE]ACETIC ACID; 2-[(3-HYDROXYPROPYL)(METHYL)AMINO]ACETIC ACID; 2-[(3-HYDROXYPROPYL)AMINO]ACETIC ACID; 2-[(3-HYDROXYPROPYL)AMINO]PROPANOIC ACID; 2-[(3-METHOXYPROPYL)AMINO]ACETIC ACID; 2-[(3-METHYLBUT-2-EN-1-YL)AMINO]ACETIC ACID; 2-[(3-METHYLBUTAN-2-YL)AMINO]ACETIC ACID; 2-[(4-HYDROXYBUTYL)AMINO]ACETIC ACID; 2-[(AMINOCARBONYL)AMINO]-3-HYDROXYPROPANOIC ACID; 2-[(AMINOCARBONYL)AMINO]BUTANOIC ACID; 2-[(AMINOTHIOXOMETHYL)AMINO]ACETIC ACID; 2-[(CARBAMOYLMETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(CARBAMOYLMETHYL)AMINO]ACETIC ACID; 2-[(CARBAMOYLMETHYL)AMINO]PROPANOIC ACID; 2-[(CYANOMETHANE)SULFINYL]ACETIC ACID; 2-[(CYANOMETHYL)(ETHYL)AMINO]ACETIC ACID; 2-[(CYANOMETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(CYANOMETHYL)(METHYL)AMINO]PROPANOIC ACID; 2-[(CYANOMETHYL)AMINO]ACETIC ACID; 2-[(CYANOMETHYL)AMINO]PROPANOIC ACID; 2-[(CYANOMETHYL)CARBAMOYL]ACETIC ACID; 2-[(CYANOMETHYL)SULFANYL]PROPANOIC ACID; 2-[(CYCLOBUTYLMETHYL)AMINO]ACETIC ACID; 2-[(CYCLOPROPYLCARBONYL)AMINO]ACETIC ACID; 2-[(CYCLOPROPYLMETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(CYCLOPROPYLMETHYL)AMINO]ACETIC ACID; 2-[(CYCLOPROPYLMETHYL)AMINO]PROPANOIC ACID; 2-[(ETHYLCARBAMOYL)AMINO]ACETIC ACID; 2-[(METHOXYCARBONYL)(METHYL)AMINO]ACETIC ACID; 2-[(METHOXYCARBONYL)AMINO]ACETIC ACID; 2-[(METHOXYCARBONYL)AMINO]PROPANOIC ACID; 2-[(METHYLCARBAMOYL)AMINO]ACETIC ACID; 2-[(METHYLCARBAMOYL)AMINO]PROPANOIC ACID; 2-[(METHYLCARBAMOYL)METHOXY]ACETIC ACID; 2-[(PROP-2-EN-1-YL)CARBAMOYL]ACETIC ACID; 2-[(PROP-2-YN-1-YL)CARBAMOYL]ACETIC ACID; 2-[(PROPAN-2-YL)AMINO]PROPANOIC ACID; 2-[(PROPAN-2-YL)CARBAMOYL]ACETIC ACID; 2-[1-(MERCAPTOMETHYL)CYCLOPROPYL]ACETIC ACID; 2-[2-(DIAMINOMETHYLIDENE)HYDRAZONO]PROPANOIC ACID; 2-[BUT-2-YN-1-YL(METHYL)AMINO]ACETIC ACID; 2-[BUT-3-YN-1-YL(METHYL)AMINO]ACETIC ACID; 2-[BUTAN-2-YL(METHYL)AMINO]ACETIC ACID; 2-[BUTYL(METHYL)AMINO]ACETIC ACID; 2-[CARBAMOYL(ETHYL)AMINO]ACETIC ACID; 2-[CYCLOPROPYL(ETHYL)AMINO]ACETIC ACID; 2-[CYCLOPROPYL(METHYL)AMINO]ACETIC ACID; 2-[CYCLOPROPYL(METHYL)AMINO]PROPANOIC ACID; 2-[ETHYL(2-HYDROXYETHYL)AMINO]ACETIC ACID; 2-[ETHYL(METHYL)AMINO]-2-METHYLPROPANOIC ACID; 2-[ETHYL(METHYL)AMINO]BUTANOIC ACID; 2-[ETHYL(METHYL)AMINO]PROPANOIC ACID; 2-[ETHYL(METHYL)CARBAMOYL]ACETIC ACID; 2-[ETHYL(PROP-2-EN-1-YL)AMINO]ACETIC ACID; 2-[ETHYL(PROP-2-YN-1-YL)AMINO]ACETIC ACID; 2-[ETHYL(PROPAN-2-YL)AMINO]ACETIC ACID; 2-[ETHYL(PROPYL)AMINO]ACETIC ACID; 2-[METHOXY(METHYL)CARBAMOYL]ACETIC ACID; 2-[METHYL(2-METHYLPROP-2-EN-1-YL)AMINO]ACETIC ACID; 2-[METHYL(2-METHYLPROPYL)AMINO]ACETIC ACID; 2-[METHYL(METHYLCARBAMOYL)AMINO]ACETIC ACID; 2-[METHYL(PROP-2-EN-1-YL)AMINO]ACETIC ACID; 24METHYL(PROP-2-EN-1-YL)AMINOPROPANOIC ACID; 2-[METHYL(PROP-2-YN-1-YL)AMINO]ACETIC ACID; 2-[METHYL(PROP-2-YN-1-YL)AMINO]PROPANOIC ACID; 2-[METHYL(PROPAN-2-YL)AMINO]PROPANOIC ACID; 2-[METHYL(PROPIONYL)AMINO]ACETIC ACID; 2-[METHYL(PROPYL)AMINO]PROPANOIC ACID; 2-ACETAMIDO-2-METHYLPROPANOIC ACID; 2-ACETAMIDOACRYLIC ACID; 2-ACETAMIDOBUTYRIC ACID; 2-ACETYL-3-OXO-BUTANOIC ACID; 2-ACETYLAMINO-2-HYDROXY-ACETIC ACID; 2-ALLYL-4-PENTENOIC ACID; 2-AMINO-1,3-OXAZOLE-4-CARBOXYLIC ACID; 2-AMINO-1-ETHOXY-CYCLOPROPANECARBOXYLIC ACID; 2-AMINO-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-AMINO-2-(1-METHYLCYCLOPROPYL)PROPIONIC ACID; 2-AMINO-2-(OXETAN-3-YL)ACETIC ACID; 2-AMINO-2-CYCLOBUTYLPROPIONIC ACID; 2-AMINO-2-CYCLOPROPYLPROPIONIC ACID; 2-AMINO-2-HYDROXY-ACETIC ACID; 2-AMINO-2-METHYL-3-(METHYLSULFANYL)PROPANOIC ACID; 2-AMINO-2-METHYL-3-METHOXY-PROPANOIC ACID; 2-AMINO-2-METHYL-3-METHYLAMINO-PROPANOIC ACID; 2-AMINO-2-METHYL-4-METHOXY-BUTYRIC ACID; 2-AMINO-2-METHYL-4-PENTENOIC ACID; 2-AMINO-2-METHYL-5-HYDROXY-PENTANOIC ACID; 2-AMINO-2-METHYLBUT-3-YNOIC ACID; 2-AMINO-2-METHYLBUTYRIC ACID; 2-AMINO-2-METHYL-CYCLOPENTANECARBOXYLIC ACID; 2-AMINO-2-METHYLPENTANOIC ACID; 2-AMINO-2-METHYLSUCCINIC ACID; 2-AMINO-3-(DIMETHYLAMINO)-2-METHYLPROPANOIC ACID; 2-AMINO-3-(ETHYLSULFANYL)PROPANOIC ACID; 2-AMINO-3-(METHYLAMINO)PROPANOIC ACID; 2-AMINO-3-[ETHYL(METHYL)AMINO]PROPANOIC ACID; 2-AMINO-3-[METHYLTHIO]BUTYRIC ACID; 2-AMINO-3-BUTENOIC ACID; 2-AMINO-3-CYANOPROPANOIC ACID; 2-AMINO-3-ETHOXY-2-METHYLPROPANOIC ACID; 2-AMINO-3-ETHOXYPROPANOIC ACID; 2-AMINO-3-ETHYL-PENTANOIC ACID; 2-AMINO-3-FLUOROBUTYRIC ACID; 2-AMINO-3-HYDROXY-2-METHYLBUTANOIC ACID; 2-AMINO-3-HYDROXY-4-METHYL-VALERIC ACID; 2-AMINO-3-HYDROXYBUTANOIC ACID; 2-AMINO-3-METHOXY-2-METHYLPROPANOIC ACID; 2-AMINO-3-METHYLENE-CYCLOBUTANECARBOXYLIC ACID; 2-AMINO-3-METHYL-HEXANOIC ACID; 2-AMINO-3-METHYLPENT-4-ENOIC ACID; 2-AMINO-3-METHYLPENTANOIC ACID; 2-AMINO-3-PROPOXYPROPANOIC ACID; 2-AMINO-4(5)-IMIDAZOLEACETIC ACID; 2-AMINO-4-(DIMETHYLAMINO)BUTANOIC ACID; 2-AMINO-4,4-DIFLUOROBUTANOIC ACID; 2-AMINO-4-BORONOBUTANOIC ACID; 2-AMINO-4-ETHOXYBUTANOIC ACID; 2-AMINO-4-FLUORO-BUTANOIC ACID; 2-AMINO-4-HEXYNOIC ACID; 2-AMINO-4-METHOXY-2-METHYLBUTANOIC ACID; 2-AMINO-4-METHOXYBUTANOIC ACID; 2-AMINO-4-METHYL-1,3-OXAZOLE-5-CARBOXYLIC ACID; 2-AMINO-4-METHYL-3-PENTENOIC ACID; 2-AMINO-4-METHYLENE-CYCLOBUTANECARBOXYLIC ACID; 2-AMINO-4-METHYLENE-CYCLOPENTANECARBOXYLIC ACID; 2-AMINO-4-METHYLHEXANOIC ACID; 2-AMINO-4-METHYL-PENT-4-ENOIC ACID; 2-AMINO-4-OXOBUTANOIC ACID; 2-AMINO-4-THIAZOLINIC ACID; 2-AMINO-5-HYDROXYLEVULINIC ACID; 2-AMINO-5-HYDROXYVALERIC ACID; 2-AMINO-5-METHOXYPENTANOIC ACID; 2-AMINO-5-METHYLHEX-4-ENOIC ACID; 2-AMINOBICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID; 2-AMINOCYCLOHEX-1-ENECARBOXYLIC ACID; 2-AMINOCYCLOPENTANEACETIC ACID; 2-AMINO-CYCLOPENTANECARBOXYLIC ACID; 2-AMINO-CYCLOPROPANECARBOXYLIC ACID; 2-AMINOHEPTANOIC ACID; 2-AMINOHEX-5-ENOIC ACID; 2-AMINOHEX-5-YNOIC ACID; 2-AMINOISOBUTYRIC ACID; 2-AMINOISOBUTYRIC-15N ACID; 2-AMINOISONICOTINIC ACID; 2-AMINOMETHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-AMINONICOTINIC ACID; 2-AMINOOXAZOLE-5-CARBOXYLIC ACID; 2-AMINOPYRIMIDINE-4-CARBOXYLIC ACID; 2-AMINOPYRIMIDINE-5-CARBOXYLIC ACID; 2-AMINOTHIAZOLE-4-CARBOXYLIC ACID; 2-AMINOTHIAZOLE-5-CARBOXYLIC ACID; 2-AMINOTHIOPHENE-3-CARBOXYLIC ACID; 2-AZABICYCLO[2.1.1]HEXANE-1-CARBOXYLIC ACID; 2-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID; 2-AZETIDINECARBOXYLIC ACID, 3-AMINO-4-OXO-; 2-AZIDO-2-METHYLPROPIONIC ACID; 2-AZIDOACETIC ACID; 2-AZIDOPROPANOIC ACID; 2-BUTOXYACETIC ACID; 2-BUTOXYPROPANOIC ACID; 2-BUTYLCYCLOPROPANECARBOXYLIC ACID; 2-BUTYNOIC ACID; 2-CARBAMOYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-CARBOXYETHYL ACRYLATE; 2-CARBOXYL MALONIC ACID; 2-CHLORO-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 2-CHLORO-2-FLUORO-CYCLOPROPANECARBONIC ACID; 2-CHLORO-3-FUROIC ACID; 2-CHLORO-3-HYDROXYBUTANOIC ACID; 2-CHLORO-3-METHOXYPROPIONIC ACID; 2-CHLORO-3-METHYLBUTANOIC ACID; 2-CHLOROACRYLIC ACID; 2-CHLOROBUTYRIC ACID; 2-CHLOROCYCLOPENT-1-ENE-1-CARBOXYLIC ACID; 2-CHLOROFURAN-4-CARBOXYLIC ACID; 2-CHLOROOXAZOLE-4-CARBOXYLIC ACID; 2-CHLOROPROPIONIC ACID; 2-CHLOROPROPIONIC ACID, [1-14C]; 2-CYANO-2-ETHYLBUTANOIC ACID; 2-CYANO-2-HEXENOIC ACID; 2-CYANO-2-METHYLACETIC ACID; 2-CYANO-2-METHYLPROPANOIC ACID; 2-CYANO-3-METHYL-BUT-2-ENOIC ACID; 2-CYANO-3-METHYLBUTANOIC ACID; 2-CYANO-4-METHYLPENTANOIC ACID; 2-CYANO-4-PYRIDINE CARBOXYLIC ACID; 2-CYANOBENZOIC ACID; 2-CYANOBUTANOIC ACID; 2-CYANO-OXAZOLE-4-CARBOXYLIC ACID; 2-CYANOPYRIDINE-3-CARBOXYLIC ACID; 2-CYANOPYRIMIDINE-5-CARBOXYLIC ACID; 2-CYCLOHEXYLIDENEACETIC ACID; 2-CYCLOPENTANONE CARBOXYLATE; 2-CYCLOPENTENE-1-ACETIC ACID; 2-CYCLOPENTENE-1-CARBOXYLIC ACID; 2-CYCLOPENTENE-1-CARBOXYLIC ACID, 4-AMINO-; 2-CYCLOPENTYL-2-HYDROXYACETIC ACID; 2-CYCLOPENTYLIDENEACETIC ACID; 2-CYCLOPENTYLIDENEPROPANOIC ACID; 2-CYCLOPENTYLPROPANOIC ACID; 2-CYCLOPROPYL-2-(ETHYLAMINO)ACETIC ACID; 2-CYCLOPROPYL-2-(METHYLAMINO)ACETIC ACID; 2-CYCLOPROPYL-2-(METHYLAMINO)PROPANOIC ACID; 2-CYCLOPROPYL-2-FORMAMIDOACETIC ACID; 2-CYCLOPROPYL-2-HYDROXYACETIC ACID; 2-CYCLOPROPYL-2-HYDROXYPROPANOIC ACID; 2-CYCLOPROPYL-2-METHOXYPROPANOIC ACID; 2-CYCLOPROPYL-2-METHYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-CYCLOPROPYL-2-OXOACETIC ACID; 2-CYCLOPROPYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-CYCLOPROPYLPROPANOIC ACID; 2-ENEVALPROIC ACID; 2-ETHOXY-2,2-DIFLUOROACETIC ACID; 2-ETHOXY-2-METHYLBUTANOIC ACID; 2-ETHOXY-2-METHYLPROPANOIC ACID; 2-ETHOXY-2-OXOACETIC ACID; 2-ETHOXY-3-HYDROXYPROPANOIC ACID; 2-ETHOXY-3-METHOXYPROPANOIC ACID; 2-ETHOXY-3-METHYLBUTANOIC ACID; 2-ETHOXY-3-METHYLCYCLOPROPANECARBOXYLIC ACID; 2-ETHOXY-4-HYDROXYBUTANOIC ACID; 2-ETHOXYBUTANOIC ACID; 2-ETHOXYCYCLOPROPANE-1-CARBOXYLIC ACID; 2-ETHOXYPROPANOIC ACID; 2-ETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID; 2-ETHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-ETHYL-2-(METHYLAMINO)BUTANOIC ACID; 2-ETHYL-2-HEXENOIC ACID; 2-ETHYL-2-HEXENOIC ACID, PREDOMINANTLY TRANS; 2-ETHYL-2-HYDROXYBUTYRIC ACID; 2-ETHYL-2-METHOXYBUTANOIC ACID; 2-ETHYL-2-METHYLPENTANOIC ACID; 2-ETHYL-3,3-DIMETHYL-2-OXIRANECARBOXYLIC ACID; 2-ETHYL-3H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-ETHYL-3-HYDROXY-3-METHYLBUTANOIC ACID; 2-ETHYL-3-HYDROXYBUTANOIC ACID; 2-ETHYL-3-HYDROXYPENTANOIC ACID; 2-ETHYL-3-METHYLBUTANOIC ACID; 2-ETHYL-3-METHYLPENTANOIC ACID; 2-ETHYL-4-METHOXYBUTANOIC ACID; 2-ETHYL-4-METHYLPENTANOIC ACID; 2-ETHYLACRYLIC ACID; 2-ETHYLBUTYRIC ACID; 2-ETHYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-ETHYLHEXANOIC ACID; 2-ETHYLPENTANOIC ACID; 2-ETHYLPROLINE; 2-ETHYLSUCCINIC ACID; 2-ETHYNYL-BENZOIC ACID; 2-FLUORO-1,3-THIAZOLE-4-CARBOXYLIC ACID; 2-FLUORO-3-METHYLBUTYRIC ACID; 2-FLUORO-3-OXOBUTANOIC ACID; 2-FLUOROACRYLIC ACID; 2-FLUOROBENZOIC ACID; 2-FLUORO-BETA-ALANINE HYDROCHLORIDE; 2-FLUOROISOBUTYRIC ACID; 2-FLUORO-L-PROLINE; 2-FLUORONICOTINIC ACID; 2-FLUORO-OXAZOLE-4-CARBOXYLIC ACID; 2-FLUOROPROPIONIC ACID; 2-FLUOROPYRIDINE-4-CARBOXYLIC ACID; 2-FLUORO-THIAZOLE-5-CARBOXYLIC ACID; 2-FORMAMIDO-2-METHYLPROPANOIC ACID; 2-FORMYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-FORMYLCYCLOPENT-2-ENECARBOXYLIC ACID; 2-FURANACETIC ACID, TETRAHYDRO-5-OXO-; 2-FUROIC ACID; 2-FURYLACETIC ACID; 2-GUANIDINOPROPIONIC ACID; 2-GUANIDINO-PROPIONIC ACID; 2H-1,2,3-TRIAZOLE-2-ACETIC ACID; 2-HEPTENOIC ACID; 2-HEPTYNOIC ACID; 2-HEXYNOIC ACID; 2H-PYRAN-2-ONE-6-CARBOXYLIC ACID; 2H-PYRAZOLE-3-CARBOXYLIC ACID; 2H-PYRROLE-2-CARBOXYLIC ACID, 5-AMINO-3,4-DIHYDRO-4-METHYLENE-, (2S)-; 2H-PYRROLE-2-CARBOXYLIC ACID, 5-AMINO-3,4-DIHYDRO-; 2H-PYRROLE-2-CARBOXYLIC ACID, 5-AMINO-3,4-DIHYDRO-,(2R)-; 2H-TETRAZOL-2-YLACETIC ACID; 2H-TETRAZOLE-5-CARBOXYLIC ACID; 2-HYDRAZINO-3-METHYLBUTANOIC ACID; 2-HYDRAZINOBUTANOIC ACID; 2-HYDRAZINYLACETIC ACID; 2-HYDROXY-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-HYDROXY-2,3-DIMETHYLBUTANOIC ACID; 2-HYDROXY-2,4-DIMETHYLPENTANOIC ACID; 2-HYDROXY-2-METHYL-3-OXOBUTANOIC ACID; 2-HYDROXY-2-METHYL-BUT-3-ENOIC ACID; 2-HYDROXY-2-METHYLBUTYRIC ACID; 2-HYDROXY-2-METHYLPENTANOIC ACID; 2-HYDROXY-3,3-DIMETHYLBUTANOIC ACID; 2-HYDROXY-3-BUTENOIC ACID; 2-HYDROXY-3-BUTYNOIC ACID; 2-HYDROXY-3-METHYL-3-BUTEN-1-OIC ACID; 2-HYDROXY-3-METHYLBUTYRIC ACID; 2-HYDROXY-3-METHYLHEXANOIC ACID; 2-HYDROXY-3-METHYLPENTANOIC ACID; 2-HYDROXY-3-NITRO-PROPANOIC ACID; 2-HYDROXY-3-PYRAZINECARBOXYLIC ACID; 2-HYDROXY-4,4-DIMETHYLPENTANOIC ACID; 2-HYDROXY-4-AMINO BUTANOIC ACID; 2-HYDROXY-4-METHOXY-2-METHYLBUTANOIC ACID; 2-HYDROXY-5-THIAZOLECARBOXYLIC ACID; 2-HYDROXYAMINO-BUTYRIC ACID; 2-HYDROXYAMINO-PENTANOIC ACID; 2-HYDROXYCYCLOHEXANECARBOXYLIC ACID; 2-HYDROXYHEPTANOIC ACID; 2-HYDROXYIMINO-BUTYRIC ACID; 2-HYDROXYISOBUTYRIC ACID; 2-HYDROXYISONICOTINIC ACID; 2-HYDROXYNICOTINIC ACID; 2-HYDROXY-PENT-4-ENOIC ACID; 2-HYDROXYPYRIMIDINE-4-CARBOXYLIC ACID; 2-HYDROXYPYRIMIDINE-5-CARBOXYLIC ACID; 2-HYDROXYVALERIC ACID; 2-IMIDAZOLIDONE-4-CARBOXYLIC ACID; 2-ISOBUTOXYACETIC ACID; 2-ISOBUTYLAMINO-PROPIONIC ACID; 2-ISOPROPOXYPROPANOIC ACID; 2-KETOGLUTARIC ACID; 2-MERCAPTO-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 2-MERCAPTOBUTYRIC ACID; 2-MERCAPTOISOBUTYRIC ACID; 2-MERCAPTOPROPIONIC ACID; 2-METHANESULFINYLACETIC ACID; 2-METHANESULFINYLPROPANOIC ACID; 2-METHOXY-2-METHYLBUTANOIC ACID; 2-METHOXY-2-METHYLPENTANOIC ACID; 2-METHOXY-2-METHYLPROPANOIC ACID; 2-METHOXYBUTANOIC ACID; 2-METHOXYCROTONIC ACID; 2-METHOXYPENTANOIC ACID; 2-METHOXYPROPANOIC ACID; 2-METHYL CYCLOBUTANECARBOXYLIC ACID; 2-METHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID; 2-METHYL-1,3-OXAZOLE-5-CARBOXYLIC ACID; 2-METHYL-1,3-THIAZOLE-4-CARBOXYLIC ACID; 2-METHYL-1,3-THIAZOLE-5-CARBOXYLIC ACID; 2-METHYL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID; 2-METHYL-1,4,5,6-TETRAHYDROPYRIMIDINE-4-CARBOXYLIC ACID; 2-METHYL-1-CYCLOHEXANECARBOXYLIC ACID; 2-METHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-METHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID HYDRATE; 2-METHYL-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 2-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 2-METHYL-2-(METHYLAMINO)BUTANOIC ACID; 2-METHYL-2-(METHYLAMINO)PENTANOIC ACID; 2-METHYL-2-(METHYLSULFANYL)BUTANOIC ACID; 2-METHYL-2-(METHYLSULFANYL)PROPANOIC ACID; 2-METHYL-2-(N-METHYLFORMAMIDO)PROPANOIC ACID; 2-METHYL-2-(PROP-2-EN-1-YLAMINO)PROPANOIC ACID; 2-METHYL-2-(PROP-2-EN-1-YLOXY)PROPANOIC ACID; 2-METHYL-2-(PROP-2-YN-1-YLAMINO)PROPANOIC ACID; 2-METHYL-2-(PROPAN-2-YL)CYCLOPROPANE-1-CARBOXYLIC ACID; 2-METHYL-2-(PROPAN-2-YLAMINO)PROPANOIC ACID; 2-METHYL-2-(PROPAN-2-YLOXY)PROPANOIC ACID; 2-METHYL-2-(PROPYLAMINO)PROPANOIC ACID; 2-METHYL-2-ETHYLBUTYRIC ACID; 2-METHYL-2-HEPTENOIC ACID; 2-METHYL-2-HEXENOIC ACID; 2-METHYL-2-PENTENOIC ACID; 2-METHYL-2-PIPERIDINECARBOXYLIC ACID; 2-METHYL-2-PROPOXYPROPANOIC ACID; 2-METHYL-2-PROPYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-METHYL-2-THIAZOLIDINECARBOXYLIC ACID; 2-METHYL-3-(METHYLAMINO)PROPANOIC ACID; 2-METHYL-3-(METHYLSULFANYL)PROPANOIC ACID; 2-METHYL-3-(PROP-2-EN-1-YLAMINO)PROPANOIC ACID; 2-METHYL-3-(PROP-2-YN-1-YLAMINO)PROPANOIC ACID; 2-METHYL-3-(PROPAN-2-YLAMINO)PROPANOIC ACID; 2-METHYL-3-(PROPYLAMINO)PROPANOIC ACID; 2-METHYL-3-BUTENOIC ACID; 2-METHYL-3-CYCLOHEXENE-1-CARBOXYLIC ACID; 2-METHYL-3-FUROIC ACID; 2-METHYL-3-HYDROXYBUTYRIC ACID; 2-METHYL-3-PENTENOIC ACID; 2-METHYL-4,5-DIHYDRO-FURAN-3-CARBOXYLIC ACID; 2-METHYL-4,5-DIHYDROOXAZOLE-4-CARBOXYLIC ACID; 2-METHYL-4,5-DIHYDROTHIOPHENE-3-CARBOXYLIC ACID; 2-METHYL-4-OXOHEXANOIC ACID; 2-METHYL-4-OXOPENTANOIC ACID; 2-METHYL-4-PENTENOIC ACID; 2-METHYLACETOACETIC ACID; 2-METHYLBUTYRIC ACID; 2-METHYLCYCLOPENTANECARBOXYLIC ACID; 2-METHYLCYCLOPROPANECARBOXYLIC ACID; 2-METHYL-CYSTEINE; 2-METHYL-D-SERINE; 2-METHYLENECYCLOPROPANECARBOXYLIC ACID; 2-METHYLENE-PENTANEDIOIC ACID; 2-METHYLENE-SUCCINIC ACID 1-METHYL ESTER; 2-METHYLGLUTARIC ACID; 2-METHYLHEPTANOIC ACID; 2-METHYLHEXANOIC ACID; 2-METHYLISONICOTINIC ACID; 2-METHYLISOXAZOLE-4-CARBOXYLIC ACID; 2-METHYL-L-SERINE; 2-METHYLNICOTINIC ACID; 2-METHYL-PIPERIDINE-3-CARBOXYLIC ACID; 2-METHYLPROLINE; 2-METHYLPYRIMIDINE-4-CARBOXYLIC ACID; 2-METHYLPYRIMIDINE-5-CARBOXYLIC ACID; 2-METHYLTETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID; 2-METHYL-TETRAHYDRO-FURAN-2-CARBOXYLIC ACID; 2-METHYLTHIOPHENE-3-CARBOXYLIC ACID; 2-METHYLVALERIC ACID; 2-MORPHOLINEACETIC ACID; 2-NITROCYCLOPROPANECARBOXYLIC ACID; 2-OCTYNOIC ACID; 2-OXA-BICYCLO[2.1.1]HEXANE-5-CARBOXYLIC ACID; 2-OXA-BICYCLO[3.1.0]HEX-3-ENE-6-CARBOXYLIC ACID; 2-OXABICYCLO[3.1.0]HEXANE-6-CARBOXYLIC ACID; 2-OXABICYCLO[4.1.0]HEPTANE-7-CARBOXYLIC ACID; 2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 2-OXO-1,2-DIHYDROPYRIDINE-4-CARBOXYLIC ACID; 2-OXO-1,3-OXAZOLIDINE-4-CARBOXYLIC ACID; 2′-OXO-1H-PYRROLE-3-ACETIC ACID; 2-OXO-2-(1H-PYRROL-2-YL)ACETIC ACID; 2-OXO-2,3-DIHYDRO-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-OXO-2H-PYRAN-3-CARBOXYLIC ACID; 2-OXO-3H-PYRIMIDINE-4-CARBOXYLIC ACID; 2-OXO-3-OXA-BICYCLO[3.1.0]HEXANE-1-CARBOXYLIC ACID; 2-OXOBUTYRIC ACID; 2-OXOCYCLOHEXANECARBOXYLIC ACID; 2-OXOCYCLOPENTANEACETIC ACID; 2-OXOPENTANOIC ACID; 2-OXO-PIPERIDINE-3-CARBOXYLIC ACID; 2-OXOPIPERIDINE-4-CARBOXYLIC ACID; 2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; 2-PENTYNOIC ACID; 2-PIPERIDINE ACETIC ACID; 2-PROPOXYACETIC ACID; 2-PROPOXYBUTANOIC ACID; 2-PROPOXYPROPANOIC ACID; 2-PROPYL-3-PENTENOIC ACID; 2-PROPYL-3-PENTYNOIC ACID; 2-PROPYL-4-PENTENOIC ACID; 2-PROPYLACRYLIC ACID; 2-PROPYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-PYRAZINE ACETIC ACID; 2-PYRAZINECARBOXYLIC ACID; 2-PYRAZINECARBOXYLIC ACID 4-OXIDE; 2-PYRAZINECARBOXYLIC ACID, 5-FLUORO-; 2-PYRIDINECARBOXYLIC ACID, HYDRATE; 2-PYRIDINECARBOXYLIC ACID, 6-AMINO-2,3-DIHYDRO-; 2-PYRIDYLACETIC ACID; 2-PYRIMIDINEACETIC ACID; 2-PYRROLIDIN-1-YLPROPANOIC ACID; 2-PYRROLIDINYL ACETIC ACID; 2R,3R-2-METHYL-PIPERIDINE-3-CARBOXYLIC ACID; 2S,3R-2-METHYL-PIPERIDINE-3-CARBOXYLIC ACID; 2S,3S-2-METHYL-PIPERIDINE-3-CARBOXYLIC ACID; 2-SULFANYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-SULFANYLCYCLOPENTANE-1-CARBOXYLIC ACID; 2-TETRAHYDROFUROIC ACID; 2-THIABICYCLO[3.1.0]HEX-3-ENE-6-CARBOXYLIC ACID; 2-THIOPHENEACETIC ACID; 2-THIOPHENECARBOXYLIC ACID; 2-THIOPHENECARBOXYLIC ACID, [CARBOXYL-14C]; 2-THIOPHENECARBOXYLIC ACID, 4-FLUORO-; 2-THIOPHENECARBOXYLIC ACID, 5-AMINO-; 3-(1,2,3,4-TETRAAZOL-2-YL)PROPANOIC ACID; 3-(1,2,4-OXADIAZOL-3-YL)PROPANOIC ACID; 3-(1,2,4-OXADIAZOL-5-YL)PROPANOIC ACID; 3-(1,2,5-OXADIAZOL-3-YL)PROPANOIC ACID; 3-(1,3-OXAZOL-2-YL)PROPANOIC ACID; 3-(1H-[1,2,3]TRIAZOL-4-YL)-PROPIONIC ACID; 3-(1H-1,2,3-TRIAZOL-1-YL)PROPANOIC ACID; 3-(1H-1,2,4-TRIAZOL-1-YL)PROPANOIC ACID; 3-(1H-1,2,4-TRIAZOL-3-YL)PROPANOIC ACID; 3-(1H-IMIDAZOL-1-YL)PROPANOIC ACID; 3-(1H-IMIDAZOL-2-YL)-ACRYLIC ACID; 3-(1H-IMIDAZOL-2-YL)-PROPIONIC ACID; 3-(1H-PYRAZOL-1-YL)PROPANOIC ACID; 3-(1H-PYRAZOL-4-YL)-ACRYLIC ACID; 3-(1H-PYRAZOL-4-YL)PROPANOIC ACID; 3-(1H-PYRAZOL-5-YL)PROPANOIC ACID; 3-(1H-PYRROL-1-YL)PROPANOIC ACID; 3-(1H-PYRROL-2-YL)PROPANOIC ACID; 3-(1H-TETRAZOL-1-YL)PROPANOIC ACID; 3-(1H-TETRAZOL-5-YL)PROPANOIC ACID; 3-(1-METHYLCYCLOPROPYL)PROPANOIC ACID; 3-(2-FURYL)ACRYLIC ACID; 3-(2-FURYL)PROP-2-YNOIC ACID; 3-(2-FURYL)PROPANOIC ACID; 3-(2-HYDROXYETHOXY)PROPANOIC ACID; 3-(2-METHOXYETHOXY)PROPANOIC ACID; 3-(2-METHYLPROPOXY)PROPANOIC ACID; 3-(2-PYRIDYL)ACRYLIC ACID; 3-(2-PYRIDYL)PROP-2-YNOIC ACID; 3-(3,3-DIMETHYL-2-OXIRANYLIDENE)-PROPANOIC ACID; 3-(3-FURYL)ACRYLIC ACID; 3-(3-HYDROXYAZETIDIN-1-YL)PROPANOIC ACID; 3-(3-HYDROXYPROPOXY)PROPANOIC ACID; 3-(3-PYRIDYL)ACRYLIC ACID; 3-(4H-1,2,4-TRIAZOL-4-YL)PROPANOIC ACID; 3-(4-PYRIDYL)ACRYLIC ACID; 3-(ACETYLOXY)-2-AMINOPROPANOIC ACID; 3-(ACETYLTHIO)PROPIONIC ACID; 3-(AMINOMETHYL)-OXOLANE-3-CARBOXYLIC ACID; 3-(BUT-2-EN-1-YLOXY)PROPANOIC ACID; 3-(BUT-3-EN-1-YLOXY)PROPANOIC ACID; 3-(BUT-3-EN-2-YLAMINO)PROPANOIC ACID; 3-(BUT-3-YN-1-YLAMINO)PROPANOIC ACID; 3-(BUTAN-2-YLAMINO)PROPANOIC ACID; 3-(BUTAN-2-YLOXY)PROPANOIC ACID; 3-(BUTYLAMINO)PROPANOIC ACID; 3-(CARBAMOYLAMINO)-2-METHYLPROPANOIC ACID; 3-(CARBAMOYLAMINO)BUTANOIC ACID; 3-(CARBOXYMETHYL)-1,2,3-OXADIAZOL-3-IUM-5-OLATE; 3-(CARBOXYMETHYL)-1,3-THIAZOL-3-IUM; 3-(CYCLOBUTYLAMINO)PROPANOIC ACID; 3-(CYCLOPROPYLAMINO)-2-METHYLPROPANOIC ACID; 3-(CYCLOPROPYLAMINO)-2-PROPENOIC ACID; 3-(CYCLOPROPYLAMINO)BUTANOIC ACID; 3-(CYCLOPROPYLMETHOXY)PROPANOIC ACID; 3-(DIETHYLAMINO)PROPANOIC ACID; 3-(DIMETHYLAMINO)-2-(METHYLAMINO)PROPANOIC ACID; 3-(DIMETHYLAMINO)-2-METHYLPROPANOIC ACID; 3-(DIMETHYLAMINO)BUTANOIC ACID; 3-(DIMETHYLAMINO)PENTANOIC ACID; 3-(DIMETHYLAMINO)PROPANOIC ACID; 3-(ETHYLAMINO)-2-METHYLPROPANOIC ACID; 3-(ETHYLAMINO)BUTANOIC ACID; 3-(ETHYLAMINO)PROPANOIC ACID; 3-(ETHYLCARBAMOYL)PROPANOIC ACID; 3-(ETHYLSULFANYL)-2-METHYLPROPANOIC ACID; 3-(ETHYLSULFANYL)BUTANOIC ACID; 3-(ETHYLTHIO)PROPANOIC ACID; 3-(FURAN-3-YL)PROPANOIC ACID; 3-(HYDROXYAMINO)ALANINE-15N; 3-(HYDROXYMETHYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-(HYDROXYMETHYL)CYCLOBUTANECARBOXYLIC ACID; 3-(HYDROXYMETHYL)-CYCLOPENTANECARBOXYLIC ACID; 3-(HYDROXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-(IMIDAZOL-4-YL)PROPIONIC ACID; 3-(ISOBUTYLAMINO)PROPANOIC ACID; 3-(ISOPROPYLAMINO)PROPANOIC ACID; 3-(ISOPROPYL-METHYL-AMINO)-PROPIONIC ACID; 3-(ISOPROPYLTHIO)PROPANOIC ACID; 3-(ISOXAZOL-4-YL)PROPANOIC ACID; 3-(METHYLAMINO)-3-OXOPROPANOIC ACID; 3-(METHYLAMINO)BUTANOIC ACID; 3-(METHYLAMINO)OXOLANE-3-CARBOXYLIC ACID; 3-(METHYLAMINO)PROPANOIC ACID HYDROCHLORIDE; 3-(METHYLAMINO)PROPIONIC ACID; 3-(METHYLCARBAMOYL)PROP-2-ENOIC ACID; 3-(METHYLSULFANYL)BUTANOIC ACID; 3-(METHYLSULFANYL)PENTANOIC ACID; 3-(N-METHYLAMINO)-L-ALANINE; 3-(N-METHYLFORMAMIDO)PROPANOIC ACID; 3-(N-METHYL-HYDRAZINO)-PROPIONIC ACID; 3-(PROP-2-EN-1-YLAMINO)BUTANOIC ACID; 3-(PROP-2-EN-1-YLAMINO)PROPANOIC ACID; 3-(PROP-2-EN-1-YLSULFANYL)PROPANOIC ACID; 3-(PROP-2-YN-1-YLAMINO)BUTANOIC ACID; 3-(PROP-2-YN-1-YLAMINO)PROPANOIC ACID; 3-(PROP-2-YN-1-YLOXY)PROPANOIC ACID; 3-(PROP-2-YN-1-YLSULFANYL)PROPANOIC ACID; 3-(PROP-2-YNAMIDO)PROPANOIC ACID; 3-(PROPAN-2-YLAMINO)BUTANOIC ACID; 3-(PROPIONYLAMINO)PROPANOIC ACID; 3-(PROPYLAMINO)BUTANOIC ACID; 3-(PROPYLAMINO)PROPANOIC ACID; 3-(PROPYLSULFANYL)PROPANOIC ACID; 3-(PYRROL-3-YL)-PROPIONIC ACID; 3-(TETRAHYDRO-FURAN-2-YL)-PROPIONIC ACID; 3-(TRIMETHYLSILYL)PROPIOLIC ACID; 3,3,3-TRIFLUORO-DL-ALANINE; 3,3,3-TRIFLUOROLACTIC ACID; 3,3,3-TRIFLUOROPROPIONIC ACID; 3,3-DICHLOROACRYLIC ACID; 3,3-DIFLUOROCYCLOBUTANECARBOXYLIC ACID; 3,3-DIFLUOROPROPANOIC ACID; 3,3-DIMETHOXYPROPANOIC ACID; 3,3-DIMETHYL-2-(METHYLAMINO)BUTANOIC ACID; 3,3-DIMETHYL-4-OXOVALERIC ACID; 3,3-DIMETHYL-4-PENTENOIC ACID; 3,3-DIMETHYLACRYLIC ACID; 3,3-DIMETHYLBUTYRIC ACID; 3,3-DIMETHYLCYCLOBUTANECARBOXYLIC ACID; 3,3-DIMETHYLHEXANOIC ACID; 3,3-DIMETHYLPENTANOIC ACID; 3,3-DITHIOPROPIONIC ACID; 3,4,4-TRIMETHYLPENTANOIC ACID; 3,4-DEHYDRO-DL-PROLINE; 3,4-DEHYDRO-D-PROLINE; 3,4-DEHYDRO-L-PROLINE; 3,4-DEHYDRO-L-PROLINE HYDROCHLORIDE; 3,4-DIAMINOBUTYRIC ACID; 3,4-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID; 3,4-DIHYDRO-2H-PYRAN-5-CARBOXYLIC ACID; 3,4-DIHYDRO-2H-PYRROLE-2-CARBOXYLIC ACID; 3,4-DIHYDRO-3-OXO-2-PYRAZINECARBOXYLIC ACID; 3,4-DIHYDRO-4-OXO-2-PYRIMIDINECARBOXYLIC ACID; 3,4-DIMETHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3,4-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 3,4-DIMETHYLHEXANOIC ACID; 3,4-DIMETHYLISOXAZOLE-5-CARBOXYLIC ACID; 3,4-DIMETHYLPENTANOIC ACID; 3,4-EPOXY-2-HYDROXY-VALERIC ACID; 3,4-METHYLENEDIOXYBUTANOIC ACID; 3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 3,5-DIMETHYL-3H-IMIDAZOLE-4-CARBOXYLIC ACID; 3,5-DIMETHYL-4,5-DIHYDROISOXAZOLE-5-CARBOXYLIC ACID; 3,5-DIMETHYL-FURAN-2-CARBOXYLIC ACID; 3,5-DIMETHYLHEXANOIC ACID; 3,5-DIMETHYLISOXAZOLE-4-CARBOXYLIC ACID; 3,6-DIHYDRO-6-OXO-3-PYRIDAZINECARBOXYLIC ACID; 3-[(1-HYDROXYPROPAN-2-YL)AMINO]PROPANOIC ACID; 3-[(2-AMINOETHYL)(METHYL)AMINO]PROPANOIC ACID; 3-[(2-AMINOETHYL)AMINO]PROPANOIC ACID; 3-[(2-AMINOETHYL)SULFANYL]PROPANOIC ACID; 3-[(2-CYANOETHYL)AMINO]PROPANOIC ACID; 3-[(2E)-BUT-2-EN-1-YLAMINO]PROPANOIC ACID; 3-[(2-HYDROXYETHYL)(METHYL)AMINO]PROPANOIC ACID; 3-[(2-HYDROXYETHYL)AMINO]-2-METHYLPROPANOIC ACID; 3-[(2-HYDROXYETHYL)AMINO]BUTANOIC ACID; 3-[(2-HYDROXYETHYL)AMINO]PROPANOIC ACID; 3-[(2-HYDROXYPROPYL)AMINO]PROPANOIC ACID; 3-[(2-METHOXYETHYL)AMINO]PROPANOIC ACID; 3-[(2-METHYLCYCLOPROPYL)AMINO]PROPANOIC ACID; 3-[(2-METHYLPROP-2-EN-1-YL)AMINO]PROPANOIC ACID; 3-[(3-AMINOPROPYL)AMINO]PROPANOIC ACID; 3-[(3-HYDROXYPROPYL)AMINO]PROPANOIC ACID; 3-[(CARBAMOYLMETHYL)AMINO]PROPANOIC ACID; 3-[(CYANOMETHYL)(METHYL)AMINO]PROPANOIC ACID; 3-[(CYANOMETHYL)AMINO]PROPANOIC ACID; 3-[(CYANOMETHYL)SULFANYL]PROPANOIC ACID; 3-[(CYCLOPROPYLMETHYL)AMINO]PROPANOIC ACID; 3-[(METHOXYCARBONYL)AMINO]PROPANOIC ACID; 3-[(METHYLCARBAMOYL)AMINO]PROPANOIC ACID; 3-[1,3]DIOXOLAN-2-YL-PROPIONIC ACID; 3-[ACETYL(METHYL)AMINO]PROPANOIC ACID; 3-[CARBAMOYL(METHYL)AMINO]PROPANOIC ACID; 3-[CYCLOPROPYL(METHYL)AMINO]PROPANOIC ACID; 3-[ETHYL(METHYL)AMINO]-2-METHYLPROPANOIC ACID; 3-[ETHYL(METHYL)AMINO]BUTANOIC ACID; 3-[ETHYL(METHYL)AMINO]PROPANOIC ACID; 3-[METHYL(PROP-2-EN-1-YL)AMINO]PROPANOIC ACID; 3-[METHYL(PROP-2-YN-1-YL)AMINO]PROPANOIC ACID; 3-[METHYL(PROPYL)AMINO]PROPANOIC ACID; 3-ACETAMIDO-2-METHYLPROPANOIC ACID; 3-ACETAMIDOBUTANOIC ACID; 3-ACETYLACRYLIC ACID; 3-ALLYLOXYPROPIONIC ACID; 3-AMINO-1,2,4-TRIAZOLE-5-CARBOXYLIC ACID; 3-AMINO-1,2,4-TRIAZOLE-5-CARBOXYLIC ACID HYDRATE; 3-AMINO-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-AMINO-1H-PYRROLE-2-CARBOXYLIC ACID; 3-AMINO-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-AMINO-1-METHYLPYRROLIDINE-3-CARBOXYLIC ACID; 3-AMINO-2-(CYCLOPROPYLMETHYL)PROPANOIC ACID; 3-AMINO-2,2-DIFLUORO-PROPIONIC ACID; 3-AMINO-2,2-DIMETHYL-PROPANOIC ACID; 3-AMINO-2-CYANOBUT-2-ENOIC ACID; 3-AMINO-2-CYANOPROPIONIC ACID; 3-AMINO-2-HYDROXY-HEXANOIC ACID; 3-AMINO-2-METHYLPROPANOIC ACID HYDROCHLORIDE; 3-AMINO-2-METHYL-PROPIONIC ACID HYDRATE; 3-AMINO-3,6-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID; 3-AMINO-3-CYCLOBUTYL-PROPIONIC ACID; 3-AMINO-3-CYCLOPROPYL-PROPIONIC ACID; 3-AMINO-3-METHYL-BUTYRIC ACID; 3-AMINO-3-METHYLPENTANOIC ACID; 3-AMINO-3-OXOPROPANOIC ACID; 3-AMINO-4-(CARBOXYMETHYL)FURAZANE; 3-AMINO-4-(METHYLTHIO)-BUTANOIC ACID; 3-AMINO-4,4-DIMETHYL-PENTANOIC ACID; 3-AMINO-4-HYDROXYBUTYRIC ACID; 3-AMINO-4-METHYLHEXANOIC ACID; 3-AMINO-4-METHYL-PENT-4-ENOIC ACID; 3-AMINO-4-METHYLPENTANOIC ACID; 3-AMINO-4-OXO-PENTANOIC ACID; 3-AMINO-4-PYRIDAZINECARBOXYLIC ACID; 3-AMINO-4-PYRROLECARBOXYLIC ACID; 3-AMINO-5-ISOXAZOLECARBOXYLIC ACID; 3-AMINO-5-METHYLHEXANOIC ACID; 3-AMINOAZETIDINE-3-CARBOXYLIC ACID; 3-AMINOBENZOIC ACID; 3-AMINOCYCLOBUTANECARBOXYLIC ACID; 3-AMINOCYCLOHEXANECARBOXYLIC ACID; 3-AMINOCYCLOPENTANECARBOXYLIC ACID; 3-AMINOFURAN-2-CARBOXYLIC ACID; 3-AMINOHEPTANOIC ACID; 3-AMINO-HEXANOIC ACID; 3-AMINOISONICOTINIC ACID; 3-AMINOISOTHIAZOLE-4-CARBOXYLIC ACID; 3-AMINO-L-ALANINE HYDROCHLORIDE; 3-AMINOMETHYL-FURAN-2-CARBOXYLIC ACID; 3-AMINOOXETANE-3-CARBOXYLIC ACID; 3-AMINOPENTANE-3-CARBOXYLIC ACID; 3-AMINOPENTANEDIOIC ACID; 3-AMINO-PENTANOIC ACID; 3-AMINOPYRAZINE-2-CARBOXYLIC ACID; 3-AMINOPYRAZOLE-4-CARBOXYLIC ACID; 3-AMINOPYRIDINE-2-CARBOXYLIC ACID; 3-AMINOPYRROLIDINE-3-CARBOXYLIC ACID; 3-AMINOTETRAHYDRO-2H-PYRAN-3-CARBOXYLIC ACID; 3-AMINO-TETRAHYDRO-FURAN-2-CARBOXYLIC ACID; 3-AMINOTETRAHYDROFURAN-3-CARBOXYLIC ACID; 3-AMINO-TETRAHYDRO-THIOPHENE-2-CARBOXYLIC ACID; 3-AMINO-TETRAHYDRO-THIOPHENE-3-CARBOXYLIC ACID; 3-AMINOTHIETANE-3-CARBOXYLIC ACID; 3-AMINOTHIOPHENE-2-CARBOXYLIC ACID; 3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID; 3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID; 3-AZIDO-2-METHYLPROPANOIC ACID; 3-AZIDO-3-METHYLBUTYRIC ACID; 3-AZIDOBUTANOIC ACID; 3-AZIDOPROPANOIC ACID; 3-BUTOXYPROPANOIC ACID; 3-BUTYNOIC ACID; 3-CARBAMOYL-2,3-DIMETHYLPROP-2-ENOIC ACID; 3-CARBAMOYLPROP-2-ENOIC ACID; 3-CARBOXY-1,1-DIMETHYL-, (E)-2-PROPENYL; 3-CARBOXY-1-METHYLPYRIDINIUM; 3-CHLORO-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-CHLORO-1H-PYRROLE-2-CARBOXYLIC ACID; 3-CHLORO-2,2-DIMETHYLBUT-3-ENOIC ACID; 3-CHLORO-2,2-DIMETHYLPROPIONIC ACID; 3-CHLORO-2-OXOPROPANOIC ACID; 3-CHLOROBUTYRIC ACID; 3-CHLOROCROTONIC ACID; 3-CHLOROCYCLOBUTANECARBOXYLIC ACID; 3-CHLOROFURAN-2-CARBOXYLIC ACID; 3-CHLOROFURAN-4-CARBOXYLIC ACID; 3-CHLOROISOXAZOLE-5-CARBOXYLIC ACID; 3-CHLORO-L-ALANINE; 3-CHLOROPROPIONIC ACID; 3-CYANOBENZOIC ACID; 3-CYANOISONICOTINIC ACID; 3-CYANOPROPANOIC ACID; 3-CYANOPYRIDINE-2-CARBOXYLIC ACID; 3-CYCLOHEXENE-1-CARBOXYLIC ACID; 3-CYCLOPENT-1-ENYL-ACRYLIC ACID; 3-CYCLOPENTENE-1-CARBOXYLIC ACID; 3-CYCLOPENTYLPROPIONIC ACID; 3-CYCLOPROPYL-2,2-DIMETHYL-PROPIONIC ACID; 3-CYCLOPROPYL-2-METHYL-PROPIONIC ACID; 3-CYCLOPROPYL-3-HYDROXY-2-METHYLPROPANOIC ACID; 3-CYCLOPROPYL-3-HYDROXYBUTANOIC ACID; 3-CYCLOPROPYL-3-HYDROXYPROPANOIC ACID; 3-CYCLOPROPYL-3-OXO-PROPIONIC ACID; 3-CYCLOPROPYLBUTANOIC ACID; 3-CYCLOPROPYLPROP-2-YNOIC ACID; 3-CYCLOPROPYLPROPIONIC ACID; 3-ETHOXY-2-(METHYLAMINO)PROPANOIC ACID; 3-ETHOXY-2-BUTENOIC ACID; 3-ETHOXYACRYLIC ACID; 3-ETHOXYPROPIONIC ACID; 3-ETHYL CYCLOBUTANECARBOXYLIC ACID; 3-ETHYL-1,2,4-OXADIAZOLE-5-CARBOXYLIC ACID; 3-ETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-ETHYL-2-HEXENOIC ACID; 3-ETHYL-2-HYDROXYPENTANOIC ACID; 3-ETHYL-3-HYDROXYPENTANOIC ACID; 3-ETHYL-4,5-DIHYDROISOXAZOLE-5-CARBOXYLIC ACID; 3-ETHYL-4-METHYLPENTANOIC ACID; 3-ETHYLHEXANOIC ACID; 3-ETHYLOXETANE-3-CARBOXYLIC ACID; 3-ETHYLOXOLANE-3-CARBOXYLIC ACID; 3-ETHYLPENT-2-ENOIC ACID; 3-ETHYLPENTANOIC ACID; 3-ETHYLPYRROLIDINE-3-CARBOXYLIC ACID; 3-ETHYNYL-BENZOIC ACID; 3-ETHYNYLPICOLINIC ACID; 3-FLUORO-2,2-DIMETHYLPROPANOIC ACID; 3-FLUORO-2-THIOPHENECARBOXYLIC ACID; 3-FLUOROBENZOIC ACID; 3-FLUOROCYCLOBUTANECARBOXYLIC ACID; 3-FLUORO-DL-ALANINE; 3-FLUORO-DL-NORLEUCINE; 3-FLUORO-DL-VALINE; 3-FLUOROISONICOTINIC ACID; 3-FLUOROPROPANOIC ACID; 3-FLUOROPYRIDINE-2-CARBOXYLIC ACID; 3-FORMAMIDO-2-METHYLPROPANOIC ACID; 3-FORMAMIDOPROPANOIC ACID; 3-FORMYL-2-FUROIC ACID; 3-FUROIC ACID; 3-FURYL(OXO)ACETIC ACID; 3-GUANIDINOPROPIONIC ACID; 3H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID, 5-AMINO-; 3-HEPTENOIC ACID; 3H-TETRAFLUOROPROPIONIC ACID; 3-HYDROXY-1H-PYRROLE-2-CARBOXYLIC ACID; 3-HYDROXY-1-METHYLPYRROLIDINE-3-CARBOXYLIC ACID; 3-HYDROXY-2-(PROPAN-2-YL)BUTANOIC ACID; 3-HYDROXY-2,2,3-TRIMETHYLBUTANOIC ACID; 3-HYDROXY-2,2-DIMETHYLBUTANOIC ACID; 3-HYDROXY-2,2-DIMETHYLPENTANOIC ACID; 3-HYDROXY-2,3-DIMETHYLBUTANOIC ACID; 3-HYDROXY-2,3-DIMETHYLPENTANOIC ACID; 3-HYDROXY-2,4-DIMETHYLPENTANOIC ACID; 3-HYDROXY-2-METHYLHEXANOIC ACID; 3-HYDROXY-2-METHYLPENTANOIC ACID; 3-HYDROXY-2-METHYLPROPANOIC ACID; 3-HYDROXY-2-OXOPROPANOIC ACID; 3-HYDROXY-3,4-DIMETHYLPENTANOIC ACID; 3-HYDROXY-3-METHYLCYCLOBUTANECARBOXYLIC ACID; 3-HYDROXY-3-METHYL-N-VALERIC ACID; 3-HYDROXY-4,4-DIMETHYLPENTANOIC ACID; 3-HYDROXY-4-METHYLHEXANOIC ACID; 3-HYDROXY-4-METHYLPENTANOIC ACID; 3-HYDROXY-4-PYRIDINECARBOXYLIC ACID; 3-HYDROXY-5-METHYLHEXANOIC ACID; 3-HYDROXYASPARTIC ACID; 3-HYDROXYBENZOIC ACID; 3-HYDROXYBUTYRIC ACID; 3-HYDROXYCYCLOBUTANECARBOXYLIC ACID; 3-HYDROXY-CYCLOPENTANECARBOXYLIC ACID; 3-HYDROXYGLUTARIC ACID; 3-HYDROXYHEXANOIC ACID; 3-HYDROXYISOXAZOLE-5-CARBOXYLIC ACID; 3-HYDROXY-N-METHYLVALINE; 3-HYDROXYOXOLANE-3-CARBOXYLIC ACID; 3-HYDROXYPENT-4-ENOIC ACID; 3-HYDROXYPICOLINIC ACID; 3-HYDROXYPROPIONIC ACID; 3-HYDROXYTETRAHYDRO-3-THIOPHENECARBOXYLIC ACID; 3-HYDROXYTHIOPHENE-2-CARBOXYLIC ACID; 3-ISOPROPOXY-3-OXOPROPANOIC ACID; 3-ISOPROPOXYPROPANOIC ACID; 3-ISOPROPYL-CYCLOBUTANECARBOXYLIC ACID; 3-ISOTHIOUREIDOPROPIONIC ACID; 3-ISOXAZOL-3-YLPROPANOIC ACID; 3-ISOXAZOL-5-YLPROPANOIC ACID; 3-ISOXAZOLEACETIC ACID; 3-ISOXAZOLEACETIC ACID, 5-HYDROXY-; 3-ISOXAZOLECARBOXYLIC ACID; 3-ISOXAZOLIDIN-2-YLPROPANOIC ACID; 3-MERCAPTOISOBUTYRIC ACID; 3-MERCAPTOPROPIONIC ACID; 3-METHANESULFINYLPROPANOIC ACID; 3-METHOXY-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-METHOXY-2-(METHYLAMINO)PROPANOIC ACID; 3-METHOXY-2,2-DIMETHYLPROPANOIC ACID; 3-METHOXY-2-FUROIC ACID; 3-METHOXY-2-METHYL-2-(METHYLAMINO)PROPANOIC ACID; 3-METHOXY-2-METHYL-3-OXOPROPANOIC ACID; 3-METHOXY-2-METHYLPROPANOIC ACID; 3-METHOXYBUT-2-ENOIC ACID; 3-METHOXYBUTYRIC ACID; 3-METHOXYCYCLOBUTANECARBOXYLIC ACID; 3-METHOXY-ISOXAZOLE-5-CARBOXYLIC ACID; 3-METHOXYPROPIONIC ACID; 3-METHOXYVALINE; 3-METHYL-1,2,4-OXADIAZOLE-5-CARBOXYLIC ACID; 3-METHYL-1-CYCLOHEXANECARBOXYLIC ACID; 3-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 3-METHYL-2-(METHYLAMINO)PENTANOIC ACID; 3-METHYL-2-(METHYLSULFANYL)BUTANOIC ACID; 3-METHYL-2-FUROIC ACID; 3-METHYL-2-HEXENOIC ACID; 3-METHYL-2-OXO-2,3-DIHYDRO-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 3-METHYL-2-OXOBUTYRIC ACID; 3-METHYL-2-OXOVALERIC ACID; 3-METHYL-2-PENTENOIC ACID; 3-METHYL-2-SULFANYLBUTANOIC ACID; 3-METHYL-2-THIOPHENECARBOXYLIC ACID; 3-METHYL-4,5-DIHYDROISOXAZOLE-5-CARBOXYLIC ACID; 3-METHYL-4-ISOXAZOLECARBOXYLIC ACID; 3-METHYL-4-OXO-2-PENTENOIC ACID; 3-METHYL-4-OXOHEXANOIC ACID; 3-METHYL-4-PENTENOIC ACID; 3-METHYL-4-PIPERIDINECARBOXYLIC ACID; 3-METHYL-4-PYRIDAZINECARBOXYLIC ACID; 3-METHYL-4-PYRIDINECARBOXYLIC ACID; 3-METHYL-5,6-DIHYDRO-1,4-DIOXINE-2-CARBOXYLIC ACID; 3-METHYL-5-ISOXAZOLEACETIC ACID; 3-METHYL-5-OXO-4,5-DIHYDRO-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-METHYL-5-OXO-PYRROLIDINE-2-CARBOXYLIC ACID; 3-METHYLBUT-3-ENOIC ACID; 3-METHYL-CYCLOBUTANEACETIC ACID; 3-METHYLCYCLOBUTYLCARBOXYLIC ACID; 3-METHYLENECYCLOBUTANECARBOXYLIC ACID; 3-METHYLENECYCLOPROPANE-TRANS-1,2-DICARBOXYLIC ACID; 3-METHYLENEPENTANEDIOIC ACID; 3-METHYLGLUTACONIC ACID; 3-METHYLGLUTARIC ACID; 3-METHYLHEPTANOIC ACID; 3-METHYLHEXANOIC ACID; 3-METHYLIDENECYCLOPROPANE-1,2-DICARBOXYLIC ACID; 3-METHYLISOTHIAZOLE-4-CARBOXYLIC ACID; 3-METHYLISOTHIAZOLE-5-CARBOXYLIC ACID; 3-METHYLISOXAZOLE-5-CARBOXYLIC ACID; 3-METHYLOXANE-3-CARBOXYLIC ACID; 3-METHYLOXETANE-3-CARBOXYLIC ACID; 3-METHYL-OXOLANE-3-CARBOXYLIC ACID; 3-METHYL-PENT-2-ENOIC ACID; 3-METHYLPENTANOIC ACID; 3-METHYLPICOLINIC ACID; 3-METHYLPIPERAZINE-2-CARBOXYLIC ACID; 3-METHYL-PIPERIDINE-3-CARBOXYLIC ACID; 3-METHYLPROLINE; 3-METHYLPYRAZINE-2-CARBOXYLIC ACID; 3-METHYL-PYRROLIDINE-3-CARBOXYLIC ACID; 3-METHYLTHIOPROPIONIC ACID; 3-MORPHOLINECARBOXYLIC ACID; 3-NITROPROPIONIC ACID; 3-OCTENOIC ACID; 3-OXABICYCLO[3.1.0]HEXANE-6-CARBOXYLIC ACID; 3-OXALURIC ACID; 3-OXAZOL-5-YL-PROPIONIC ACID; 3-OXO-1-CYCLOHEXANECARBOXYLIC ACID; 3-OXO-2,3-DIHYDROISOXAZOLE-5-CARBOXYLIC ACID; 3-OXO-2,3-DIHYDRO-PYRIDAZINE-4-CARBOXYLIC ACID; 3-OXO-2,3-DIHYDROPYRIDINE-5-CARBOXYLIC ACID; 3-OXOCYCLOBUTANECARBOXYLIC ACID; 3-OXOCYCLOPENT-1-ENECARBOXYLIC ACID; 3-OXOCYCLOPENTANECARBOXYLIC ACID; 3-OXOPENTANOIC ACID; 3-OXO-PIPERAZINE-2-CARBOXYLIC ACID; 3-OXO-PIPERIDINE-2-CARBOXYLIC ACID; 3-OXOPROPANOIC ACID; 3-PENTENOIC ACID; 3-PIPERIDINE ACETIC ACID; 3-PROPOXY-PROPIONIC ACID; 3-PYRIDAZINEACETIC ACID; 3-PYRIDIN-3-YLPROP-2-YNOIC ACID; 3-PYRIDIN-4-YLPROP-2-YNOIC ACID; 3-PYRIDINECARBOXYLIC ACID, 5-ETHYNYL-; 3-PYRIDINECARBOXYLIC ACID, HYDRATE; 3-PYRIDYLACETIC ACID; 3-PYRROLIDIN-1-YL-PROPIONIC ACID; 3-PYRROLIDIN-2-YL-PROPIONIC ACID; 3-PYRROLIDINEACETIC ACID; 3-PYRROLIDINECARBOXYLIC ACID, 4-AMINO-; 3-SULFANYLPENTANOIC ACID; 3-TERT-BUTOXYPROPIONIC ACID; 3-TERT-BUTYL-DL-ALANINE; 3-THIOLNORVALINE; 3-THIOPHENEACETIC ACID; 3-THIOPHENECARBOXYLIC ACID; 3-THIOPHENECARBOXYLIC ACID, 2-FLUORO-; 3-THIOPHENECARBOXYLIC ACID, 5-AMINO-; 3-TRIMETHYLSILYLPROPIONIC ACID; 3-UREIDOPROPIONIC ACID; 3-VINYLBENZOIC ACID; 4-(1-METHYLCYCLOPROPYL)BUTANOIC ACID; 4-(2-HYDROXYETHOXY)BUTANOIC ACID; 4-(ALLYLOXY)BUTANOIC ACID; 4-(AMINOMETHYL)-1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID; 4-(CYCLOPROPYLAMINO)BUTANOIC ACID; 4-(DIMETHYLAMINO)-3-HYDROXYBUTANOIC ACID; 4-(DIMETHYLAMINO)BUTANOIC ACID; 4-(DIMETHYLAMINO)PENTANOIC ACID; 4-(ETHYLAMINO)BUTANOIC ACID; 4-(ETHYLSULFANYL)BUTANOIC ACID; 4-(HYDROXYMETHYL)FURAN-2-CARBOXYLIC ACID; 4-(ISOPROPYLAMINO)BUTANOIC ACID; 4-(METHYLAMINO)BUTYRIC ACID; 4-(METHYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID; 4-(METHYLCARBAMOYL)BUTANOIC ACID; 4-(METHYLSULFANYL)BUTANOIC ACID; 4-(METHYLSULFANYL)PENTANOIC ACID; 4-(PROP-2-EN-1-YLAMINO)BUTANOIC ACID; 4-(PROP-2-YN-1-YLAMINO)BUTANOIC ACID; 4-(PROP-2-YN-1-YLOXY)BUTANOIC ACID; 4-(PROPAN-2-YLOXY)BUTANOIC ACID; 4-(PROPYLAMINO)BUTANOIC ACID; 4,4,4-TRIFLUOROBUT-2-YNOIC ACID; 4,4,4-TRIFLUOROBUTYRIC ACID; 4,4,4-TRIFLUOROCROTONIC ACID; 4,4-DIAMINO-3-OXOPENTANOIC ACID; 4,4-DIFLUORO-2-METHYLBUTANOIC ACID; 4,4-DIFLUORO-BUT-2-ENOIC ACID; 4,4-DIFLUOROBUTANOIC ACID; 4,4-DIFLUOROPENTANOIC ACID; 4,4-DIMETHOXY-BUT-2-ENOIC ACID; 4,4-DIMETHOXYBUTANOIC ACID; 4,4-DIMETHYL-2-OXO-PENTANOIC ACID; 4,4-DIMETHYL-3-OXOPENTANOIC ACID; 4,4-DIMETHYLHEXANOIC ACID; 4,4-DIMETHYLPENTANOIC ACID; 4,4-DIMETHYL-PYRROLIDINE-3-CARBOXYLIC ACID; 4,5-DEHYDRO-LEUCINE; 4,5-DIHYDRO-FURAN-3-CARBOXYLIC ACID; 4,5-DIHYDRO-OXAZOLE-4-CARBOXYLIC ACID; 4,5-DIHYDROTHIAZOLE-5-CARBOXYLIC ACID; 4,5-DIMETHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4,5-DIMETHYL-2-FUROIC ACID; 4,5-DIMETHYL-ISOXAZOLE-3-CARBOXYLIC ACID; 4,5-DIOXOVALERIC ACID; 4,5-EPOXY-2-HEXENOIC ACID; 4-[(2-HYDROXYETHYL)AMINO]BUTANOIC ACID; 4-[(CYANOMETHYL)AMINO]BUTANOIC ACID; 4-[ETHYL(METHYL)AMINO]BUTANOIC ACID; 4-ACETAMIDOBUTYRIC ACID; 4-ACETYLBUTYRIC ACID; 4-AMINO-[1,2,5]THIADIAZOLE-3-CARBOXYLIC ACID; 4-AMINO-1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID; 4-AMINO-1-CYCLOHEXENE-1-CARBOXYLIC ACID; 4-AMINO-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-AMINO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-AMINO-1H-PYRAZOLE-5-CARBOXYLIC ACID; 4-AMINO-1H-PYRROLE-2-CARBOXYLIC ACID; 4-AMINO-1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-AMINO-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 4-AMINO-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-AMINO-2,2-DIFLUOROBUTYRIC ACID; 4-AMINO-2,2-DIMETHYL-BUTYRIC ACID; 4-AMINO-2,4-DIMETHYL-PENTANOIC ACID; 4-AMINO-2-HYDROXY-3,3-DIMETHYLBUTANOIC ACID; 4-AMINO-3,3-DIFLUOROBUTANOIC ACID; 4-AMINO-3,3-DIMETHYLBUTANOIC ACID; 4-AMINO-3,4-DIMETHYL-PENTANOIC ACID; 4-AMINO-3-METHYLISOXAZOLE-5-CARBOXYLIC ACID; 4-AMINO-4-METHYLPENTANOIC ACID; 4-AMINO-5-FLUOROPENTANOIC ACID; 4-AMINO-5-IMIDAZOLECARBOXYLIC ACID; 4-AMINO-5-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-AMINO-5-METHYLFURAN-2-CARBOXYLIC ACID; 4-AMINO-5-METHYLHEXANOIC ACID; 4-AMINOBENZOIC ACID; 4-AMINOBUTANOIC ACID HYDROCHLORIDE; 4-AMINOBUTYRIC ACID; 4-AMINOCYCLOHEMNECARBOXYLIC ACID; 4-AMINO-ISOTHIAZOLE-3-CARBOXYLIC ACID; 4-AMINOMETHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-AMINONICOTINIC ACID; 4-AMINOPIPERIDINE-3-CARBOXYLIC ACID; 4-AMINOPIPERIDINE-4-CARBOXYLIC ACID; 4-AMINO-PYRIDAZINE-3-CARBOXYLIC ACID; 4-AMINOPYRIDINE-2-CARBOXYLIC ACID; 4-AMINOPYRIMIDINE-2-CARBOXYLIC ACID; 4-AMINOPYRIMIDINE-5-CARBOXYLIC ACID; 4-AMINO-TETRAHYDRO-FURAN-3-CARBOXYLIC ACID; 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID; 4-AMINO-TETRAHYDRO-THIOPHENE-3-CARBOXYLIC ACID; 4-AMINOTHIOPHENE-2-CARBOXYLIC ACID; 4-AMINOTHIOPHENE-3-CARBOXYLIC ACID; 4-CARBOXYL BENZOCYCLOBUTENE; 4-CHLORO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-CHLORO-1H-PYRAZOLE-5-CARBOXYLIC ACID; 4-CHLORO-1H-PYRROLE-2-CARBOXYLIC ACID; 4-CHLOROBUTYRIC ACID; 4-CHLOROBUTYRIC ACID, [1-14C]; 4-CHLOROFURAN-2-CARBOXYLIC ACID; 4-CYANO-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-CYANO-1H-PYRROLE-2-CARBOXYLIC ACID; 4-CYANO-2-PYRIDINECARBOXYLIC ACID; 4-CYANO-3-PYRIDINECARBOXYLIC ACID; 4-CYANOBENZOIC ACID; 4-CYANOBENZOIC ACID, [CYANO-14C]; 4-CYANOBUTANOIC ACID; 4-CYCLOHEPTENE-1-CARBOXYLIC ACID; 4-CYCLOPROPYL-4-HYDROXYBUTANOIC ACID; 4-CYCLOPROPYL-4-OXOBUTYRIC ACID; 4-ETHOXY-2-METHYLBUTANOIC ACID; 4-ETHOXY-4-OXOBUTANOIC ACID; 4-ETHOXYBUTANOIC ACID; 4-ETHOXYPENTANOIC ACID; 4-ETHYLHEXANOIC ACID; 4-ETHYNYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-ETHYNYL-BENZOIC ACID; 4-FLUORO-2-AZABICYCLO[2.1.1]HEXANE-1-CARBOXYLIC ACID; 4-FLUORO-2-PYRROLIDINECARBOXYLIC ACID; 4-FLUORO-3-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 4-FLUORO-4-PIPERIDINECARBOXYLIC ACID; 4-FLUOROBENZOIC ACID; 4-FLUOROBUTYRIC ACID; 4-FLUORO-CYCLOHEXANECARBOXYLIC ACID; 4-FLUORO-L-THREONINE; 4-FLUORONICOTINIC ACID; 4-FLUOROPYRIDAZINE-3-CARBOXYLIC ACID; 4-FLUOROPYRIDINE-2-CARBOXYLIC ACID; 4-FLUORO-TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID; 4-FORMAMIDOBUTYRIC ACID; 4-FORMYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-GUANIDINOBUTYRIC ACID; 4H-1,2,4-TRIAZOL-4-YLACETIC ACID; 4H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 4-HEXENOIC ACID; 4-HEXYNOIC ACID, 2-AMINO-, (2R)-; 4-HEXYNOIC ACID, 2-AMINO-, (2S)-; 4H-IMIDAZOLE-5-CARBOXYLIC ACID; 4-HYDROXY-2-METHYLHEXANOIC ACID; 4-HYDROXY-2-METHYLPENTANOIC ACID; 4-HYDROXY-2-PYRROLINE-2-CARBOXYLIC ACID; 4-HYDROXY-2-THIOPHENECARBOXYLIC ACID; 4-HYDROXY-3-METHYLHEXANOIC ACID; 4-HYDROXY-3-METHYLPENTANOIC ACID; 4-HYDROXY-4-METHYLPENT-2-YNOIC ACID; 4-HYDROXY-5-METHYLHEXANOIC ACID; 4-HYDROXYBENZOIC ACID; 4-HYDROXYBENZOIC ACID [CARBOXYL-14C]; 4-HYDROXY-BUT-2-ENOIC ACID; 4-HYDROXY-BUT-2-YNOIC ACID; 4-HYDROXYBUTYRIC ACID; 4-HYDROXYBUTYRIC ACID, [2,3-3H]-; 4-HYDROXYCYCLOHEXANE CARBOXYLIC ACID, [CARBOXYL-14C]; 4-HYDROXYCYCLOHEXANECARBOXYLIC ACID; 4-HYDROXY-DL-PROLINE; 4-HYDROXY-FURAZAN-3-CARBOXYLIC ACID; 4-HYDROXYHEPTANOIC ACID; 4-HYDROXYHEXANOIC ACID; 4-HYDROXYIMINO-PENTANOIC ACID; 4-HYDROXYISOLEUCINE; 4-HYDROXY-L-ISOLEUCINE; 4-HYDROXYMETHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-HYDROXYMETHYL-PYRROLIDINE-3-CARBOXYLIC ACID; 4-HYDROXYNICOTINIC ACID; 4-HYDROXYOXANE-4-CARBOXYLIC ACID; 4-HYDROXYPENTANOIC ACID; 4-HYDROXYPIPECOLIC ACID; 4-HYDROXYPIPERIDINE-4-CARBOXYLIC ACID; 4-HYDROXYPYRIDAZINE-3-CARBOXYLIC ACID; 4-HYDROXYPYRIDINE-2-CARBOXYLIC ACID; 4-HYDROXYPYRIMIDINE-5-CARBOXYLIC ACID; 4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID; 4-HYDROXY-TETRAHYDRO-2-FUROIC ACID; 4-ISOTHIAZOLECARBOXYLIC ACID; 4-MERCAPTO-2-PYRROLIDINECARBOXYLIC ACID; 4-MERCAPTOBUTYRIC ACID; 4-MERCAPTO-PENTANOIC ACID; 4-METHOXY-2-(METHYLAMINO)BUTANOIC ACID; 4-METHOXY-2,2-DIMETHYLBUTANOIC ACID; 4-METHOXY-2-METHYLBUTANOIC ACID; 4-METHOXYBUTANOIC ACID; 4-METHOXYPENTANOIC ACID; 4-METHOXY-PYRROLIDINE-3-CARBOXYLIC ACID; 4-METHYL HYDROGEN L-ASPARTATE; 4-METHYL PYRIDINE-2-CARBOXYLIC ACID, [CARBOXYL-14C]; 4-METHYL-1,2,3-THIADIAZOLE-5-CARBOXYLIC ACID; 4-METHYL-1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID; 4-METHYL-1,3-OXAZOLE-5-CARBOXYLIC ACID; 4-METHYL-1-CYCLOHEXANECARBOXYLIC ACID; 4-METHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-METHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID HYDRATE; 4-METHYL-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 4-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-METHYL-2,5-CYCLOHEXADIENE-1-CARBOXYLIC ACID; 4-METHYL-2-OXOVALERIC ACID; 4-METHYL-2-PENTENOIC ACID; 4-METHYL-2-PENTYNOIC ACID; 4-METHYL-2-PYRIMIDINECARBOXYLIC ACID; 4-METHYL-2-PYRROLIDINE CARBOXYLIC ACID; 4-METHYL-2-THIOPHENECARBOXYLIC ACID; 4-METHYL-3-FURANCARBOXYLIC ACID; 4-METHYL-3-PENTENOIC ACID; 4-METHYL-3-PYRIDAZINECARBOXYLIC ACID; 4-METHYL-3-PYRROLIDINECARBOXYLIC ACID; 4-METHYL-4H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 4-METHYL-5-ISOTHIAZOLECARBOXYLIC ACID; 4-METHYL-5-OXO-2,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-METHYL-5-OXO-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-METHYL-5-OXOTETRAHYDRO-3-FURANCARBOXYLIC ACID; 4-METHYL-5-OXY-FURAZAN-3-CARBOXYLIC ACID; 4-METHYLBICYCLO[3.1.0]HEX-2-ENE-6-CARBOXYLIC ACID; 4-METHYLENE-5-OXO-4,5-DIHYDROFURAN-3-CARBOXYLIC ACID; 4-METHYLENE-L-PROLINE; 4-METHYLHEPTANOIC ACID; 4-METHYLHEXANOIC ACID; 4-METHYLIDENECYCLOHEXANE-1-CARBOXYLIC ACID; 4-METHYLISOXAZOLE-3-CARBOXYLIC ACID; 4-METHYLISOXAZOLE-5-CARBOXYLIC ACID; 4-METHYL-MORPHOLINE-2-CARBOXYLIC ACID; 4-METHYL-MORPHOLINE-3-CARBOXYLIC ACID; 4-METHYLNICOTINIC ACID; 4-METHYLOXAZOLE-2-CARBOXYLIC ACID; 4-METHYLPENT-4-ENOIC ACID; 4-METHYLPENTANOIC ACID; 4-METHYLPIPERAZINE-2-CARBOXYLIC ACID; 4-METHYL-PIPERIDINE-2-CARBOXYLIC ACID; 4-METHYLPIPERIDINE-4-CARBOXYLIC ACID; 4-METHYLPYRAZOLE-3-CARBOXYLIC ACID; 4-METHYLPYRIDINE-2-CARBOXYLIC ACID; 4-METHYLPYRIMIDINE-5-CARBOXYLIC ACID; 4-METHYLPYRROLE-2-CARBOXYLIC ACID; 4-METHYLTETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID; 4-METHYLTHIAZOLE-2-CARBOXYLIC ACID; 4-METHYLTHIAZOLE-5-CARBOXYLIC ACID; 4-METHYLTHIOPHENE-3-CARBOXYLIC ACID; 4-NITROBUTANOIC ACID; 4-OXAZOLEACETIC ACID; 4-OXAZOLEACETIC ACID, 2-METHYL-; 4-OXAZOLECARBOXYLIC ACID; 4-OXAZOLIDINECARBOXYLIC ACID; 4-OXO-1,4-DIHYDRO-PYRIMIDINE-5-CARBOXYLIC ACID; 4-OXOAZETIDINE-2-CARBOXYLIC ACID; 4-OXOCYCLOHEXANECARBOXYLIC ACID; 4-OXOHEPTANOIC ACID; 4-OXOHEXANOIC ACID; 4-OXOPIPERIDINE-2-CARBOXYLIC ACID; 4-OXO-PIPERIDINE-3-CARBOXYLIC ACID; 4-OXO-PROLINE; 4-OXOPYRROLIDINE-3-CARBOXYLIC ACID; 4-OXO-TETRAHYDROFURAN-3-CARBOXYLIC ACID; 4-OXOTETRAHYDROTHIOPHENE-3-CARBOXYLIC ACID; 4-PENTENOIC ACID; 4-PENTYNOIC ACID; 4-PROPOXYBUTANOIC ACID; 4-PYRIDINEACETIC ACID; 4-PYRIDINEACRYLIC ACID; 4-PYRIMIDINEACETIC ACID; 4-PYRIMIDINECARBOXYLIC ACID, 5-HYDROXY-; 4-UREIDO-BUTYRIC ACID; 4-VINYLBENZOIC ACID; 4-YN-VPA; 5-(AMINOMETHYL)-2-FUROIC ACID; 5-(DIMETHYLAMINO)PENTANOIC ACID; 5-(HYDROXYMETHYL)-1H-PYRROLE-2-CARBOXYLIC ACID; 5-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID; 5-(HYDROXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 5-(METHYLAMINO)FURAN-2-CARBOXYLIC ACID; 5-(METHYLSULFANYL)PENTANOIC ACID; 5,5-DIMETHYLHEXANOIC ACID; 5,5-DIMETHYL-PYRROLIDINE-2-CARBOXYLIC ACID; 5,6-DIHYDRO-[1,4]DIOXINE-2-CARBOXYLIC ACID; 5,6-DIHYDRO-1,4-OXATHIINE-2-CARBOXYLIC ACID; 5,6-DIHYDRO-2H-PYRAN-3-CARBOXYLIC ACID; 5,6-DIHYDRO-4H-PYRAN-2-CARBOXYLIC ACID; 5,6-DIHYDRO-5-OXO-2-PYRAZINECARBOXYLIC ACID; 5-ACETYLVALERIC ACID; 5-AMINO CAPROIC ACID; 5-AMINO-1H-[1,2,3]TRIAZOLE-4-CARBOXYLIC ACID; 5-AMINO-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-AMINO-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 5-AMINO-1H-PYRAZOLE-3-ACETIC ACID; 5-AMINO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-AMINO-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-AMINO-1H-PYRROLE-2-CARBOXYLIC ACID; 5-AMINO-1-METHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 5-AMINO-1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-AMINO-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-AMINO-2-PYRAZINECARBOXYLIC ACID; 5-AMINO-2-PYRIDINECARBOXYLIC ACID; 5-AMINO-3-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-AMINO-3-METHYL-ISOXAZOLE-4-CARBOXYLIC ACID; 5-AMINO-3-OXO-2,3-DIHYDRO-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-AMINO-4,5-DIHYDRO-3H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-AMINO-4H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID MONOHYDRATE; 5-AMINO-4H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-AMINO-5-OXOPENTANOIC ACID; 5-AMINO-FURAN-2-CARBOXYLIC ACID; 5-AMINOLEVULINIC ACID; 5-AMINONICOTINIC ACID; 5-AMINOPENTANOIC ACID HYDRATE; 5-AMINO-PYRIDAZINE-4-CARBOXYLIC ACID; 5-AMINOPYRIMIDINE-2-CARBOXYLIC ACID; 5-AMINO-PYRIMIDINE-4-CARBOXYLIC ACID; 5-AMINOVALERIC ACID; 5-AZASPIRO[2.4]HEPTANE-1-CARBOXYLIC ACID; 5-AZIDO-PENTANOIC ACID; 5-CHLORO-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 5-CHLORO-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-CHLORO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-CHLORO-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-CHLORO-2H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID; 5-CHLORO-5-HEXENOIC ACID; 5-CHLOROFURAN-2-CARBOXYLIC ACID; 5-CHLORO-ISOXAZOLE-3-CARBOXYLIC ACID; 5-CHLOROVALERIC ACID; 5-CYANO-1H-PYRROLE-2-CARBOXYLIC ACID; 5-CYANO-2-FURANCARBOXYLIC ACID; 5-CYANO-3-PYRIDINECARBOXYLIC ACID; 5-CYANOPENTANOIC ACID; 5-CYANOPYRIDINE-2-CARBOXYLIC ACID; 5-ETHENYL-2-FURANCARBOXYLIC ACID; 5-ETHENYL-2-PYRIDINECARBOXYLIC ACID; 5-ETHENYL-3-PYRIDINECARBOXYLIC ACID; 5-ETHOXYPENTANOIC ACID; 5-ETHYL-1,2,4-OXADIAZOLE-3-CARBOXYLIC ACID; 5-ETHYL-1,3,4-OXADIAZOLE-2-CARBOXYLIC ACID; 5-ETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID; 5-ETHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 5-ETHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-ETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-ETHYL-4H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-ETHYL-FURAN-2-CARBOXYLIC ACID; 5-ETHYL-ISOXAZOLE-3-CARBOXYLIC ACID; 5-ETHYL-ISOXAZOLE-4-CARBOXYLIC ACID; 5-ETHYNYLPICOLINIC ACID; 5-FLUORO-2-THIOPHENECARBOXYLIC ACID; 5-FLUORO-3-THIOPHENECARBOXYLIC ACID; 5-FLUORO-L-PROLINE; 5-FLUORONICOTINIC ACID; 5-FLUOROPIPERIDINE-3-CARBOXYLIC ACID; 5-FLUOROPYRIDINE-2-CARBOXYLIC ACID; 5-FLUOROPYRIMIDINE-2-CARBOXYLIC ACID; 5-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-2-FURANCARBOXYLIC ACID; 5-HEXENOIC ACID; 5-HEXYNOIC ACID; 5H-TETRAAZOL-5-YLACETIC ACID; 5-HYDROXY-1,2,4-TRIAZINE-6-CARBOXYLIC ACID; 5-HYDROXY-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-HYDROXY-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-HYDROXY-1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-HYDROXY-2-PYRIMIDINECARBOXYLIC ACID; 5-HYDROXY-3-PIPERIDINECARBOXYLIC ACID; 5-HYDROXYFURAN-2-CARBOXYLIC ACID; 5-HYDROXYHEXANOIC ACID; 5-HYDROXY-L-NORVALINE; 5-HYDROXYMETHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 5-HYDROXYMETHYL-2-FURANCARBOXYLIC ACID; 5-HYDROXYNICOTINIC ACID; 5-HYDROXYPENTANOIC ACID; 5-HYDROXYPICOLINIC ACID; 5-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID; 5-HYDROXYPYRAZINE-2-CARBOXYLIC ACID; 5-HYDROXYPYRAZINE-3-CARBOXYLIC ACID; 5-METHOXY-2-FUROIC ACID; 5-METHOXY-2-METHYLPENTANOIC ACID; 5-METHOXY-3-METHYLPENT-2-ENOIC ACID; 5-METHOXY-3-METHYLPENTANOIC ACID; 5-METHOXY-ISOXAZOLE-4-CARBOXYLIC ACID; 5-METHOXYPENTANOIC ACID; 5-METHYL-[1,3,4]OXADIAZOLE-2-CARBOXYLIC ACID; 5-METHYL-1,2,3-OXADIAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1,2,3-THIADIAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1,2,4-OXADIAZOLE-3-CARBOXYLIC ACID; 5-METHYL-1,3,4-THIADIAZOLE-2-CARBOXYLIC ACID; 5-METHYL-1,3-DIOXANE-5-CARBOXYLIC ACID; 5-METHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 5-METHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-METHYL-2-FUROIC ACID; 5-METHYL-2H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID; 5-METHYL-2H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 5-METHYL-2-OXO-2,3-DIHYDRO-OXAZOLE-4-CARBOXYLIC ACID; 5-METHYL-2-PYRAZINECARBOXYLIC ACID; 5-METHYL-2-THIOPHENECARBOXYLIC ACID; 5-METHYL-3,4-DIHYDRO-2H-PYRROLE-2-CARBOXYLIC ACID; 5-METHYL-4H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-METHYL-4-HEXENOIC ACID; 5-METHYL-4-OXOHEXANOIC ACID; 5-METHYL-5-HEXENOIC ACID; 5-METHYLFURAN-3-CARBOXYLIC ACID; 5-METHYLHEPT-4-ENOIC ACID; 5-METHYLHEPTANOIC ACID; 5-METHYLHEXANOIC ACID; 5-METHYLISOTHIAZOLE-4-CARBOXYLIC ACID; 5-METHYLISOXAZOLE-3-CARBOXYLIC ACID; 5-METHYLISOXAZOLE-4-CARBOXYLIC ACID; 5-METHYLNICOTINIC ACID; 5-METHYLOXAZOLE-2-CARBOXYLIC ACID; 5-METHYLPICOLINIC ACID; 5-METHYLPROLINE; 5-METHYL-PYRIDAZINE-4-CARBOXYLIC ACID; 5-METHYLPYRIMIDINE-2-CARBOXYLIC ACID; 5-METHYLPYRIMIDINE-4-CARBOXYLIC ACID; 5-METHYLTHIAZOLE-2-CARBOXYLIC ACID; 5-METHYLTHIAZOLE-4-CARBOXYLIC ACID; 5-METHYLTHIOPHENE-3-CARBOXYLIC ACID; 5-NORBORNENE-2-CARBOXYLIC ACID; 5-NORBORNENE-2-CARBOXYLIC ACID, PREDOMINANTLY ENDO; 5-OXASPIRO[2.4]HEPTANE-1-CARBOXYLIC ACID; 5-OXO-2,5-DIHYDRO-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-OXO-2,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-OXO-2-HEXENOIC ACID; 5-OXO-4,5-DIHYDRO-1H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID; 5-OXO-4,5-DIHYDRO-1H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID HYDRATE; 5-OXO-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-OXO-4,5-DIHYDROPYRAZINE-2-CARBOXYLIC ACID; 5-OXO-CYCLOHEX-1-ENECARBOXYLIC ACID; 5-OXO-HEPTANOIC ACID; 5-OXOPIPERAZINE-2-CARBOXYLIC ACID; 5-OXOPIPERIDINE-2-CARBOXYLIC ACID; 5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; 5-OXOTETRAHYDROTHIOPHENE-3-CARBOXYLIC ACID; 5-PYRIMIDINEACETIC ACID; 5-SULFANYLFURAN-2-CARBOXYLIC ACID; 5-SULFANYLPENTANOIC ACID; 5-THIAZOLEACETIC ACID; 6-AMINO-[1,2,4]TRIAZINE-5-CARBOXYLIC ACID; 6-AMINO-2,3,4,5-TETRAHYDRO-3-PYRIDINECARBOXYLIC ACID; 6-AMINO-6-OXO-HEXANOIC ACID; 6-AMINOCAPROIC ACID; 6-AMINONICOTINIC ACID; 6-AMINOPYRAZINE-2-CARBOXYLIC ACID; 6-AMINOPYRIDAZINE-3-CARBOXYLIC ACID; 6-AMINOPYRIDINE-2-CARBOXYLIC ACID; 6-AMINO-PYRIMIDINE-4-CARBOXYLIC ACID; 6-CYANONICOTINIC ACID; 6-CYANOPYRIDINE-2-CARBOXYLIC ACID; 6-ETHYNYLNICOTINIC ACID; 6-FLUORONICOTINIC ACID; 6-FLUOROPYRIDINE-2-CARBOXYLIC ACID; 6-HEPTENOIC ACID; 6-HEPTYNOIC ACID; 6-HYDROXYCAPROIC ACID; 6-HYDROXYNICOTINIC ACID; 6-HYDROXYPICOLINIC ACID; 6-HYDROXYPYRIDAZINE-3-CARBOXYLIC ACID; 6-HYDROXYPYRIMIDINE-4-CARBOXYLIC ACID; 6-MERCAPTOHEXANOIC ACID; 6-METHOXYHEXANOIC ACID; 6-METHYL-1,2,3,4-TETRAHYDROPYRIDINE-3-CARBOXYLIC ACID; 6-METHYL-2-PIPERIDINE CARBOXYLIC ACID; 6-METHYL-3,4-DIHYDRO-2H-PYRAN-5-CARBOXYLIC ACID; 6-METHYL-3-PIPERIDINECARBOXYLIC ACID; 6-METHYL-6-HEPTENOIC ACID; 6-METHYLHEPTANOIC ACID; 6-METHYLNICOTINIC ACID; 6-METHYLPICOLINIC ACID; 6-METHYLPYRAZINE-2-CARBOXYLIC ACID; 6-METHYLPYRIDAZINE-3-CARBOXYLIC ACID; 6-METHYLPYRIMIDINE-4-CARBOXYLIC ACID; 6-OXABICYCLO[3.1.0]HEXANE-3-CARBOXYLIC ACID; 6-OXO-1,4,5,6-TETRAHYDROPYRIDAZINE-3-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDROPYRAZINE-2-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDRO-PYRIDAZINE-3-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDROPYRIDAZINE-4-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDROPYRIDINE-2-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDRO-PYRIMIDINE-5-CARBOXYLIC ACID; 6-OXO-3H-PYRIMIDINE-4-CARBOXYLIC ACID; 6-OXO-HEXAHYDRO-PYRIDAZINE-3-CARBOXYLIC ACID; 6-OXO-PIPERAZINE-2-CARBOXYLIC ACID; 6-OXO-PIPERIDINE-2-CARBOXYLIC ACID; 6-OXOPIPERIDINE-3-CARBOXYLIC ACID; 7-AMINOHEPTANOIC ACID; 7-HYDROXYHEPTANOIC ACID; 7-OCTENOIC ACID; 7-OXA-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID; 7-OXOHEPTANOIC ACID; AC-ALA-OH; AC-D-ALA-OH; ACETAMIDINE ACETATE; ACETATE BUFFER; ACETIC ACID; ACETIC ACID-ACETONITRILE; ACETIC ACID-AMMONIUM ACETATE; ACETOACETIC ACID; ACETONE CARBOXYMETHOXIME; ACETONITRILE WITH AMMONIUM ACETATE; ACETOXYACETIC ACID; ACETYL-D-2-AMINOBUTYRIC ACID; ACETYLENEDICARBOXYLIC ACID; ACETYLPYRUVIC ACID; ACONIC ACID; ACRYLAMIDO BUFFER; ACRYLATE, AMMONIUM; ACRYLIC ACID; ADIPIC ACID; A-FLUORO-B-ALANINE; ALA-GLY; ALANINE-NH2 ACETATE SALT; ALANOSINE; ALBIZZIIN; ALFA-NITRO ACETIC ACID; ALLO-DL-3-THIOBUTYRINE; ALLO-O-ETHYL-D-THR; ALLYLMALONIC ACID; ALPHA-(METHYLAMINO)ISOBUTYRIC ACID; ALPHA-AMINO-2-CYCLOPENTENYLACETIC ACID; ALPHA-METHYL-D-ALLYLGLYCINE; ALPHA-METHYL-DL-SERINE; ALPHA-METHYL-D-PROPARGYLGLYCINE; ALPHA-METHYL-D-VALINE; ALPHA-METHYL-L-ALLYLGLYCINE; ALPHA-METHYL-L-ASP; ALPHA-METHYL-L-PROLINE; ALPHA-METHYL-L-PROPARGYLGLYCINE; AMINO-(1H-IMIDAZOL-2-YL)-ACETIC ACID; AMINO-(PYRROLIDIN-3-YL)-ACETIC ACID; AMINO-(TETRAHYDRO-FURAN-3-YL)-ACETIC ACID; AMINO-CYCLOPROPYL-ACETIC ACID; AMINO-FURAN-2-YL-ACETIC ACID; AMINO-FURAN-3-YL-ACETIC ACID; AMINOMALONIC ACID; AMINOOXYACETIC ACID, HYDROCHLORIDE SALT; AMINO-PYRROL-2-YL-ACETIC ACID; AMMONIUM ACETATE; AMMONIUM ACETATE BUFFER; AMMONIUM BENZOATE; AMMONIUM BIOXALATE MONOHYDRATE; AMMONIUM HYDROGEN MALEATE; AMMONIUM HYDROGEN SUCCINATE; AMMONIUM HYDROGENOXALATE HEMIHYDRATE; AMMONIUM ISOVALERATE; AMMONIUM LACTATE; AMMONIUM OXALATE; AMMONIUM OXALATE MONOHYDRATE; AMMONIUM PROPIONATE; AMMONIUM TRIFLUOROACETATE; ANGELIC ACID; ANTHRANILIC ACID; ATROPIC ACID; AZALEUCINE; AZEPANE-2-CARBOXYLIC ACID; AZEPANE-3-CARBOXYLIC ACID; AZEPANE-4-CARBOXYLIC ACID; AZETIDIN-3-YLACETIC ACID; AZETIDIN-3-YLIDENEACETIC ACID; AZETIDIN-3-YLIDENEACETIC ACID HYDROCHLORIDE; AZETIDINE-2-CARBOXYLIC ACID; AZETIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE; AZETIDINE-3-CARBOXYLIC ACID; AZETIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE; AZIRIDINE-2-CARBOXYLIC ACID; BENZOCYCLOBUTYL-1-CARBOXYLIC ACID; BENZOIC ACID; BENZOIC ACID, 2-ETHENYL-; BENZOIC ACID-12C7; BETA-ALANINE; BETA-ASPARTYL HYDRAZIDE; BETA-CHLORO-DL-ALANINE; BETA-CHLOROLACTIC ACID; BETA-CYANO-L-ALANINE; BETA-FLUOROLACTIC ACID; BETA-HOMOALANINE HYDROCHLORIDE; BETA-HYDROXYISOVALERIC ACID; BETA-HYDROXYLEUCINE; BETA-HYDROXYNORLEUCINE; BETA-HYDROXYNORVALINE; BETA-METHOXYVALINE; BETA-METHYLGUANADINOPROPIONIC ACID; BETA-METHYLLEVULINIC ACID; BETA-N,N-DIMETHYLAMINO-D-ALA; BETA-N,N-DIMETHYLAMINO-L-ALA; BETA-N-ETHANOLAMINO-D-ALA; BETA-N-ETHANOLAMINO-L-ALA; BETA-N-METHYLAMINO-D-ALA; BETA-T-BUTYL-D-ALANINE; BETA-THIOLNORVALINE; BICYCLO[2.2.1]HEPTANE-1-CARBOXYLIC ACID; BICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID; BICYCLO[3.1.0]HEX-2-ENE-6-CARBOXYLIC ACID; BICYCLO[3.1.0]HEXANE-3-CARBOXYLIC ACID; BICYCLO[3.2.0]HEPTANE-3-CARBOXYLIC ACID; BICYCLO[4.1.0]HEPTANE-7-CARBOXYLIC ACID; BICYCLO[4.2.0]OCTA-1(6),2,4-TRIENE-2-CARBOXYLIC ACID; BROMOACETIC ACID; BROMOPROPIOLIC ACID; BUTANOIC ACID, 2-AMINO-3-OXO-; BUTYRAMIDINE HOAC; BUTYRIC ACID; CARBAMIMIDOYL-ACETIC ACID; CARBAMOYL-DL-ALA-OH; CARBOXYMETHYLNITROSOUREA; CHLOROACETIC ACID; CHLORODIFLUOROACETIC ACID; CHLOROFLUOROACETIC ACID; CIS,CIS-MUCONIC ACID; CIS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID; CIS-2-AMINO-1-CYCLOPENTANECARBOXYLIC ACID; CIS-2-AMINO-2-METHYL-CYCLOPENTANECARBOXYLIC ACID; CIS-2-AMINO-4-CYCLOHEXENE-1-CARBOXYLIC ACID; CIS-2-AMINO-CYCLOHEX-3-ENECARBOXYLIC ACID; CIS-2-FLUORO-CYCLOPROPANECARBOXYLIC ACID; CIS-2-HYDROXY-1-CYCLOPENTANECARBOXYLIC ACID; CIS-2-METHYLCYCLOPROPANECARBOXYLIC ACID; CIS-3-(1H-IMIDAZOL-4-YL)-2-PROPENOIC ACID; CIS-3-AMINOCYCLOBUTANECARBOXYLIC ACID; CIS-3-AMINOCYCLOHEXANECARBOXYLIC ACID; CIS-3-AMINO-TETRAHYDROPYRAN-4-CARBOXYLIC ACID; CIS-3-CHLOROACRYLIC ACID; CIS-3-CHLOROCYCLOBUTANECARBOXYLIC ACID; CIS-3-FLUOROCYCLOBUTANECARBOXYLIC ACID; CIS-3-HEXENOIC ACID; CIS-3-HYDROXYCYCLOBUTANECARBOXYLIC ACID; CIS-3-HYDROXY-DL-PROLINE; CIS-3-METHYL-2-HEXENOIC ACID; CIS-3-METHYL-CYCLOBUTANEACETIC ACID; CIS-3-METHYLCYCLOBUTANECARBOXYLIC ACID; CIS-4-AMINOCROTONIC ACID; CIS-4-AMINOCYCLOHEXANECARBOXYLIC ACID; CIS-4-HYDROXYCYCLOHEXANECARBOXYLIC ACID; CIS-4-HYDROXY-DL-PROLINE; CIS-4-HYDROXY-D-PROLINE; CIS-4-HYDROXY-L-PROLINE; CIS-4-HYDROXY-TETRAHYDRO-2-FUROIC ACID; CIS-4-MERCAPTO-L-PROLINE; CIS-AZETIDINE-2,4-DICARBOXYLIC ACID; CIS-CYCLOBUTANE-1,2-DICARBOXYLIC ACID; CIS-CYCLOBUTANE-1,3-DICARBOXYLIC ACID; CIS-EPOXYSUCCINIC ACID; CIS-L-3-HYDROXYPROLINE; CITRACONIC ACID; COMANIC ACID; COUMALIC ACID; CREATINE; CROTONIC ACID; CROTYL GLYCINE; CYANO(METHOXYIMINO)ACETIC ACID; CYANO(METHOXYIMINO)ACETIC ACID; CYANOACETIC ACID; CYANOACRYLIC ACID; CYCLOBUTANE-1,1-DICARBOXYLIC ACID MONOAMIDE; CYCLOBUTANE-1,3-DICARBOXYLIC ACID; CYCLOBUTANECARBOXYLIC ACID; CYCLOBUTANEPROPANOIC ACID; CYCLOBUTYL-ACETIC ACID; CYCLOBUTYLIDENEACETIC ACID; CYCLOBUTYL-OXO-ACETIC ACID; CYCLOBUTYLPROPIONIC ACID; CYCLOCREATINE; CYCLOHEPTANECARBOXYLIC ACID; CYCLOHEXANECARBOXYLIC ACID; CYCLOHEXYLACETIC ACID; CYCLOLEUCINE; CYCLOPENTANECARBOXYLIC ACID; CYCLOPENTENYL ACETIC ACID; CYCLOPENTYLACETIC ACID; CYCLOPROPANE-1,2-DICARBOXYLIC ACID; CYCLOPROPANECARBOXYLIC ACID; CYCLOPROPANECARBOXYLIC ACID HYDRAZINE; CYCLOPROPANECARBOXYLIC ACID, 1-AMINO-2-ETHENYL-, (1R,2S)-; CYCLOPROPANECARBOXYLIC ACID, 2-(CHLOROCARBONYL)-, TRANS-; CYCLOPROPYLACETIC ACID; CYCLOPROPYL-HYDROXYIMINO-ACETIC ACID; CYCLOPROPYLIDENE-ACETIC ACID; D(−)-ISOVALINE; D-(+)-MALIC ACID; D,L-2-AMINO-3-(HYDROXY-15N2-AMINO)PROPIONIC ACID; D,L-2-AMINO-3-(HYDROXYAMINO)PROPIONIC ACID; D,L-ALANOSINE; D-2,3-DIAMINOPROPIONIC ACID; D-2,4-DIAMINOBUTYRIC ACID; D-2-AMINO-5-METHYLHEX-4-ENOIC ACID; D-2-AMINOBUTYRIC ACID; D-2-AZIRIDINECARBOXYLIC ACID; D-2-HYDROXYPENTANEDIOIC ACID; D-3-METHYLASPARTIC ACID; D-3-THIOBUTYRINE; D-3-THIOLNORVALINE; D-6-HYDROXYNORLEUCINE; D-6-OXO-PIPECOLINIC ACID; D-ALA-3-CL; D-ALANINE; D-ALBIZZIIN; D-ALLOISOLEUCINE; D-ALLYLGLYCINE; D-ALPHA-HYDROXYISOVALERIC ACID; D-ASPARAGINE; D-ASPARTIC ACID; D-ASPARTIC ACID BETA-HYDROXAMATE; D-ASPARTIC ACID-BETA-METHYL ESTER; D-AZETIDINE-2-CARBOXYLIC ACID; D-BETA,BETA-DIETHYLALANINE; D-BETA-HOMOSERINE; D-CANALINE; D-CYCLOBUTYLALANINE; D-CYCLOBUTYLGLYCINE; D-CYCLOPENTYLGLYCINE; D-CYCLOPROPYLALANINE; D-CYCLOPROPYLGLYCINE; D-CYSTEINE; D-D-HYDROXYNORVALINE; D-GLUTAMIC ACID; D-GLUTAMINE; D-GLYCERIC ACID; D-HOMOCYSTEINE; D-HOMOSERINE; DICHLOROACETIC ACID; DICHLOROFLUOROACETIC ACID; DIETHYLAMINE ACETATE; DIETHYLAMINO-ACETIC ACID; DIFLUOROACETIC ACID; DIFLUOROMETHYLTHIOACETIC ACID; DIFLUORO-PROPANEDIOIC ACID; DIGLYCOLIC ACID; DIHYDROXYACETIC ACID; DIHYDROXYFUMARIC ACID; DIMETHYLMALONIC ACID; D-ISOASPARAGINE; D-ISOGLUTAMINE; D-ISOLEUCINE; D-ISOTHREONINE; DL-2,3-DIAMINOPROPIONIC ACID HYDROCHLORIDE; DL-2,3-DIAMINOSUCCINIC ACID; DL-2-AMINO-4-PENTENOIC ACID; DL-2-AMINOBUTYRIC ACID; DL-2-FLUORO-3-ALANINE; DL-2-HYDROXY-N-BUTYRIC ACID; DL-2-ISOPROPYLSERINE; DL-3-AMINOBUTYRIC ACID; DL-3-AMINOISOBUTYRIC ACID; DL-3-METHYLASPARTIC ACID; DL-3-THIOBUTYRINE; DL-4-AMINO-2-FLUOROBUTYRIC ACID; DL-4-AMINO-3-HYDROXYBUTYRIC ACID; DL-6-HYDROXYNORLEUCINE; D-LACTIC ACID; DL-ALANINE; DL-ALANYL-GLYCINE; DL-ALLO-ISOLEUCINE; DL-ALLO-THREONINE; DL-ALPHA-HYDROXYCAPROIC ACID; DL-ALPHA-METHYLLEUCINE; DL-ASPARAGINE; DL-ASPARTIC ACID; DL-BETA-HYDROXYNORVALINE; DL-CIS-4-FLUORO-5-PYRROLIDONE-2-CARBOXYLIC ACID; DL-CITRAMALIC ACID; DL-CYCLOBUTYLALANINE; DL-CYCLOBUTYLGLYCINE; DL-CYCLOPENTYLGLYCINE; DL-CYCLOPROPYLALANINE; DL-CYSTEINE; D-LEUCINE; DL-GLUTAMIC ACID; DL-GLUTAMIC ACID ALPHA-AMIDE; DL-GLUTAMINE; DL-GLYCERIC ACID; DL-HOMOCYSTEINE; DL-HOMOLEUCINE; DL-HOMOSERINE; DL-ISOLEUCINE; DL-ISOSERINE; DL-LEUCIC ACID; DL-LEUCINE; DL-LYSINE; DL-MALIC ACID; DL-METHIONINE; DL-METHYLTARTRONIC ACID; DL-NORLEUCINE; DL-NORVALINE; DL-O-METHYLSERINE; DL-ORNITHINE; DL-PENICILLAMINE; DL-PIPECOLINIC ACID; DL-PROLINE; DL-PROPARGYLGLYCINE; DL-PYROGLUTAMIC ACID; DL-SERINE; DL-S-METHYL-CYS-OH; DL-TERT-LEUCINE; DL-THREO-BETA-HYDROXYASPARTIC ACID; DL-THREONINE; DL-TRANS-2,6-DIAMINO-4-HEXENOIC ACID; DL-TRANS-4-FLUORO-5-PYRROLIDONE-2-CARBOXYLIC ACID; DL-TRANS-HYDROXYPROLINE; DL-VALINE; D-LYSINE; D-METHALLYLGLYCINE; D-METHIONINE; D-NORLEUCINE; D-NORVALINE; D-ORNITHINE; D-PENICILLAMINE; D-PROLINE; D-PROPARGYLGLYCINE; D-PYROGLUTAMIC ACID; D-SERINE; D-S-METHYL-CYS-OH; D-TERT-LEUCINE; D-THIAZOLIDINE-4-CARBOXYLIC ACID; D-THREONINE; D-TRANS-4-FLUORO-5-PYRROLIDONE-2-CARBOXYLIC ACID; D-VALINE; D-VINYLGLYCINE; EPOXY METHACRYLATE; ERYTHRO-BETA-HYDROXY-L-ASPARTIC ACID; ERYTHRO-DL-BETA-HYDROXYNORLEUCINE; ERYTHRO-DL-BETA-HYDROXYNORVALINE; ETHOXYACETIC ACID; ETHOXYMETHYLENECYANOACETIC ACID; ETHYL HYDROGEN MALONATE; ETHYLMALONIC ACID; FLUOROACETIC ACID; FOR-D-ALA-OH; FOR-D-VAL-OH; FORMIMINOGLYCINE; FUMARIC ACID; FUMARIC ACID MONOETHYL ESTER; FURAN-3-YL-ACETIC ACID; GABA; GABACULINE; GAMMA-ACETYLENIC GABA; GAMMA-CHLORO-ALPHA-AMINOBUTYRIC ACID; GAMMA-METHYL-L-LEUCINE; GAMMA-METHYLPROLINE; GLUTACONIC ACID; GLUTARIC ACID; GLYCINE; GLYCINE AMIDE ACETATE; GLYCINE HYDROCHLORIDE; GLYCOLIC ACID; GLYCYLDEHYDROALANINE; GLYCYL-DL-ALANINE; GLYCYLGLYCINE; GLYCYL-L-ALANINE; GLYCYL-SARCOSINE; GLY-D-ALA; GLYOXILIC ACID OXIME; GLYOXYLIC ACID; GLYOXYLIC ACID MONOHYDRATE; GLYOXYLIC ACID SEMICARBAZONE; GUANIDINE ACETATE; GUANIDINE OXALATE; HADACIDIN; H-ALPHA-ME-D-LEU-OH; H-ALPHA-ME-DL-VAL-OH; H-ALPHA-ME-LEU-OH; H-ASP-NH2; H-ASP-OME; H-BETA-ALA-GLY-OH; HCL/ACOH; H-D-ALA-GLY-OH; H-D-ALLO-THR-OH; H-D-ASP-OME; H-D-DAP-OH HCL; H-DL-ASP-OME; H-DL-GLU-OH; H-DL-MELEU-OH; H-D-MEALA-OH HCL; H-D-PRA-OH HCL; H-D-SER(AC)-OH; H-D-THR(ME)-OH; HEPT-4-EN-6-YNOIC ACID; HEPT-5-ENOIC ACID; HEPTA-4,6-DIENOIC ACID; HEPTANOIC ACID; HEXA-4,5-DIENOIC ACID; HEXAHYDROPYRIDAZINE-3-CARBOXYLIC ACID; HEXAHYDROPYRIMIDINE-2-CARBOXYLIC ACID; HEXANOIC ACID; H-GLU-2-CHLOROTRITYL RESIN; H-GLY-BETA-ALA-OH; H-L-DAB-OH; H-MEILE-OH; H-MEVAL-OH; H-PRA-OH HCL; HYDANTOIC ACID; HYDRAZINE ACETATE; HYDRAZINE MONOOXALATE; HYDROCHLORIC ACID-PROPIONIC ACID; HYDROXYIMINO-ACETIC ACID; HYDROXYLAMINE ACETATE; HYPOGLYCIN; IMIDAZOL-1-YL-ACETIC ACID; IMIDAZOLE-4-ACETIC ACID; IMINODIACETIC ACID; IMMOBILIZED IMINODIACETIC ACID; ISOBUTYL ACRYLIC ACID; ISOBUTYRIC ACID; ISOCROTONIC ACID; ISONICOTINIC ACID; ISONICOTINIC ACID N-OXIDE; ISONIPECOTIC ACID; ISOPROPOXYACETIC ACID; ISOPROPYLMALONIC ACID; ISOTHIAZOLE-3-CARBOXYLIC ACID; ISOTHIAZOLE-5-CARBOXYLIC ACID; ISOVALERIC ACID; ISOXAZOLE-4-CARBOXYLIC ACID; ISOXAZOLE-5-CARBOXYLIC ACID; ITACONIC ACID; ITACONIC ACID MONOMETHYL ESTER; KETOMALONIC ACID; KETOMALONIC ACID MONOHYDRATE; L-(−)-MALIC ACID; L-(−)-THREO-3-HYDROXYASPARTIC ACID; L-(+)-LACTIC ACID; L-2,3-DIAMINOPROPIONIC ACID; L-2-ACETAMIDOBUTYRIC ACID; L-2-AMINO-5-METHYLHEX-4-ENOIC ACID; L-2-AMINOADIPATE 6-SEMIALDEHYDE; L-2-AMINOBUTYRIC ACID; L-2-AMINOBUTYRIC ACID HYDROCHLORIDE; L-2-AZIRIDINECARBOXYLIC ACID; L-2-METHYLCYSTEINE; L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID; L-3-METHYLASPARTIC ACID; L-3-THIOBUTYRINE; L-3-THIOLNORVALINE; L-6-HYDROXYNORLEUCINE; LACTIC ACID; L-ALANINE; L-ALANINE HYDROCHLORIDE; L-ALLO-ISOLEUCINE; L-ALLO-THREONINE; L-ALLYLGLYCINE; L-ASPARAGINE; L-ASPARTIC ACID; L-ASPARTIC ACID BETA-HYDROXAMATE; L-ASPARTIC ACID-AGAROSE; L-AZETIDINE-2-CARBOXYLIC ACID; L-AZETIDINE-2-CARBOXYLIC ACID HCL; L-BETA,BETA-DIETHYLALANINE; L-BETA-HOMOALANINE HYDROCHLORIDE; L-BETA-HOMOSERINE; L-BETA-HOMOTHREONINE; L-CANALINE; L-CYCLOBUTYLALANINE; L-CYCLOBUTYLGLYCINE; L-CYCLOPENTYLGLYCINE; L-CYCLOPROPYLALANINE; L-CYCLOPROPYLGLYCINE; L-CYSTEINE; LEVULINIC ACID; L-GLUTAMIC ACID; L-GLUTAMINE; L-HOMOCYSTEINE; L-HOMOSERINE; L-HYDROXYPROLINE; L-ISOGLUTAMINE; L-ISOLEUCINE; L-ISOTHREONINE; L-ISOVALINE; LITHIUM SUCCINATE; L-LEUCIC ACID; L-LEUCINE; L-LYSINE; L-METHIONINE; L-NORLEUCINE; L-NORVALINE; L-ORNITHINE; L-PENICILLAMINE; L-PIPECOLIC ACID; L-PROLINE; L-PROLINE HYDRATE; L-PROPARGYLGLYCINE; L-PYROGLUTAMIC ACID; L-SERINE; L-SERINE [G-3 H]; L-SERINE HYDROCHLORIDE; L-TERT-LEUCINE; L-THIAZOLIDINE-4-CARBOXYLIC ACID; L-THREONIC ACID; L-THREONINE; L-THREONINE-AGAROSE; L-TRANS-4-FLUORO-5-PYRROLIDONE-2-CARBOXYLIC ACID; L-VALINE; L-VINYLGLYCINE; MALEAMIC ACID; MALEIC ACID; MALEIC ACID MONOETHYL ESTER; MALEIC ACID MONOMETHYL ESTER; MALEIC ACID MONOSODIUM SALT; MALONIC ACID; MERCAPTOACETIC ACID; MESACONIC ACID; MESO-2,3-DIAMINOSUCCINIC ACID; MESO-2,3-DIMETHYLSUCCINIC ACID; METHACRYLATE, AMMONIUM; METHACRYLIC ACID; METHANESULFONYLACETIC ACID; METHOXYACETIC ACID; METHOXYCARBONYLOXY-ACETIC ACID; METHYL HYDROGEN GLUTARATE; METHYLMALONIC ACID; METHYLSUCCINIC ACID; MONO-AMMONIUM CITRACONATE; MONOMETHYL AMINOMALONATE; MONOMETHYL FUMARATE; MONOMETHYL MALONATE; MONO-METHYL SUCCINATE; MORPHOLIN-3-YL-ACETIC ACID; MORPHOLIN-4-YL-ACETIC ACID; MORPHOLINE-2-CARBOXYLIC ACID; M-TOLUIC ACID; N-(1-CYANO-1-METHYLETHYL)GLYCINE; N-(2-AMINOETHYL)GLYCINE; N-(2CT RESIN)-L-MET-OH; N-(2-CYANOETHYL)-ALANINE; N-(2-CYANOETHYL)GLYCINE; N-(4-AMINOBUTYL)-GLYCINE; N-(TERT-BUTYL)HYDROXYLAMINE ACETATE; N,N-DIMETHYL(2-HYDROXYETHYL)AMMONIUM ACETATE; N,N-DIMETHYLGLYCINE; N,N-DIMETHYLGLYCINE HYDROCHLORIDE; N,N-DIMETHYL-L-ALA-OH; N,N-DIMETHYL-L-VALINE; N,N-DIMETHYLOXAMIC ACID; N,N-DIMETHYLSUCCINAMIC ACID; N,N-DIMETHYLVALINE; N-[(DIMETHYLAMINO)CARBONYL]GLYCINE; N-ACETYL-BETA-ALANINE; N-ACETYL-DL-ALANINE; N-ACETYL-DL-SERINE; N-ACETYLGLYCINE; N-ACETYL-L-SERINE; N-ALPHA-METHYL-L-2-AMINO PENTANOIC ACID; N-ALPHA-METHYL-L-2-AMINO-CAPROIC ACID; N-ALPHA-METHYL-L-ALANINE HYDROCHLORIDE; N-ALPHA-METHYL-L-THREONINE; N-AMINO-D-PROLINE; N-CARBAMYL-ALPHA-AMINO-ISOBUTYRIC ACID; N-ETHYLGLYCINE; N-ETHYL-L-PROLINE; N-ETHYLMALEAMIC ACID; N-FORMYL CYSTEINE; N-FORMYL-DL-2-AMINO-N-BUTYRIC ACID; N-FORMYL-DL-ALANINE; N-FORMYL-DL-VALINE; N-FORMYLGLYCINE; N-FORMYL-L-ALANINE; N-FORMYL-L-PROLINE; N-FORMYL-L-VALINE; NH2-L-ILE-OH; NH2-L-LEU-OH; NH2-L-PRO-OH; NICOTINIC ACID; NICOTINIC ACID N-OXIDE; NIPECOTIC ACID; N-ISOPROPYL-N-METHYLGLYCINE; NITRAMINOACETIC ACID; N-ME-CIS-HYDROXYPROLINE; N-ME-DL-VAL-OH; N-METHACRYLOYLGLYCINE; N-METHYL-2-METHYLENE-SUCCINAMIC ACID; N-METHYL-D-ALANINE; N-METHYL-D-ASPARTIC ACID; N-METHYL-D-ISOLEUCINE; N-METHYL-DL-ALANINE; N-METHYL-DL-ASPARTIC ACID; N-METHYL-DL-ISOLEUCINE; N-METHYL-D-PROLINE MONOHYDRATE; N-METHYLHYDROXYLAMINE OXALATE; N-METHYLIMINODIACETIC ACID; N-METHYL-L-ALANINE; N-METHYL-L-ASPARTIC ACID; N-METHYL-L-CYSTEINE; N-METHYL-L-LEUCINE; N-METHYL-L-PROLINE; N-METHYL-L-PROLINE MONOHYDRATE; N-METHYL-L-SERINE; N-METHYLMALEAMIC ACID; N-METHYLSUCCINAMIC ACID; N-NITROSARCOSINE; N-NITROSO-D-PROLINE; N-NITROSO-L-AZETIDINE-2-CARBOXYLIC ACID; N-NITROSO-L-PROLINE; N-NITROSO-N-METHYL-3-AMINOPROPIONIC ACID; N-NITROSO-N-METHYL-4-AMINOBUTYRIC ACID; N-NITROSOSARCOSINE; NORVALINE, 4-OXO-; N-OXALYLGLYCINE; N-PROPIONYLALANINE; N-PROPIONYLGLYCINE; O-(AMINOCARBONYL)SERINE; O-ACETYL-L-SERINE; OCTANOIC ACID; O-METHYLISOUREA ACETATE; O-METHYL-L-THREONINE; O-TBU-(S)-LACTIC ACID; O-TOLUIC ACID; OXALACETIC ACID; OXALIC ACID; OXALIC ACID DIHYDRATE; OXALIC ACID MONO-(N-METHYL)-AMIDE; OXALYL MONOGUANYLHYDRAZIDE; OXALYSINE; OXAMIC ACID; OXAMIC ACID AMMONIUM SALT; OXAZOLE-2-CARBOXYLIC ACID; OXAZOLE-5-CARBOXYLIC ACID; OXETANE-2-CARBOXYLIC ACID; OXETANE-2-CARBOXYLIC ACID AMMONIASALT; OXETANE-3-CARBOXYLIC ACID; OXETIN; OXIRANE-(2S,3S)-DICARBOXYLIC ACID MONOMETHYL ESTER; OXIRANE-2,3-DICARBOXYLIC ACID; OXIRANE-2,3-DICARBOXYLIC ACID MONOMETHYL ESTER; OXO(PROPYLAMINO)ACETIC ACID; OXO-PYRROLIDIN-1-YL-ACETIC ACID; PENT-3-YNOIC ACID; PEROXYMALEIC ACID; PHENYLACETIC ACID; PHENYLPROPIOLIC ACID; PHOSPHONOACETIC ACID; PICOLINIC ACID; PICOLINIC ACID N-OXIDE; PICOLINIC ACID, [3H]-; PIPERAZIN-1-YL-ACETIC ACID; PIPERAZIN-2-YLACETIC ACID; PIPERAZINE-2-CARBOXYLIC ACID; PIPERIDAZINE-3-(R)-CARBOXYLIC ACID; PIPERIDIN-1-YL-ACETIC ACID; PIPERIDIN-4-YLACETIC ACID; PIPERIDIN-4-YLIDENE-ACETIC ACID; PIPERIDINIUM ACETATE; PIVALIC ACID; POTASSIUM BINOXALATE; PROPANEDIOIC ACID MONOPOTASSIUM SALT; PROPANOIC ACID, 2-HYDRAZINO-2-METHYL-; PROPIOLIC ACID; PROPIONIC ACID; PROPYLMALONIC ACID; P-TOLUIC ACID; PYRIDAZIN-4-YLACETIC ACID; PYRIDAZINE-3-CARBOXYLIC ACID; PYRIDAZINE-4-CARBOXYLIC ACID; PYRIDINE 2-CARBOXYLIC ACID, [CARBOXY-14C]; PYRIDINIUM ACETATE; PYRIMIDINE-2-CARBOXYLIC ACID; PYRIMIDINE-4-CARBOXYLIC ACID; PYRIMIDINE-5-CARBOXYLIC ACID; PYRROLE-2-CARBOXYLIC ACID; PYRROLE-3-CARBOXYLIC ACID; PYRROLE-3-CARBOXYLIC ACID HYDRATE; PYRROLIDIN-1-YL-ACETIC ACID; PYRROLIDINE-3-CARBOXYLIC ACID; PYRUVIC ACID; R-2-AMINOBUTYRIC ACID [CARBOXYL-14C]; R-2-AMINOHEPTANOIC ACID; S-2-AMINOBUTYRIC ACID [CARBOXYL-14C]; S-2-AMINOHEPTANOIC ACID; S-2-CHLOROVALERIC ACID; S-ACETYLTHIOACETIC ACID; SALICYLIC ACID; SARCOSINE; SAR-GLY-OH; S-CYANOCYSTEINE; S-ETHYL-L-CYSTEINE; S-HYPOGLYCINE A; SIGLURE ACID; S-METHYL-L-CYSTEINE; SODIUM ACID OXALATE; SODIUM HYDROGEN FUMARATE; SODIUM HYDROGEN OXALATE; SORBIC ACID; SPIRO[2.2]PENTANE-1-CARBOXYLIC ACID; SPIRO[2.3]HEXANE-1-CARBOXYLIC ACID; SPIRO[2.4]HEPTANE-1-CARBOXYLIC ACID; SQUARAIN-CARBOXYLATE; SUCCINAMIC ACID; SUCCINIC ACID; SUCCINIC ACID MONOSODIUM SALT; SUCCINIC SEMIALDEHYDE; SULFOACETIC ACID; TARTRONIC ACID; TERT-BUTOXY ACETIC ACID; TETRAHYDRO-2H-PYRAN-3-CARBOXYLIC ACID; TETRAHYDRO-2H-PYRAN-3-YLACETIC ACID; TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID; TETRAHYDRO-2H-THIOPYRAN-3-CARBOXYLIC ACID; TETRAHYDRO-3-FUROIC ACID; TETRAHYDRO-5-OXO-2-FURANCARBOXYLIC ACID; TETRAHYDROPYRANYL-4-ACETIC ACID; TETRAHYDROTHIOPHENE-2-CARBOXYLIC ACID; TETRAHYDROTHIOPHENE-3-CARBOXYLIC ACID; TETRAHYDROTHIOPYRAN-4-CARBOXYLIC ACID; THIAZOL-2-YL-ACETIC ACID; THIAZOLE-2-CARBOXYLIC ACID; THIAZOLE-4-CARBOXYLIC ACID; THIAZOLE-5-CARBOXYLIC ACID; THIAZOLIDINE-2-CARBOXYLIC ACID; THIAZOLIDINE-4-CARBOXYLIC ACID; THIOMORPHOLINE-2-CARBOXYLIC ACID; THIOMORPHOLINE-3-CARBOXYLIC ACID; THREO-D-BETA-HYDROXYNORLEUCINE; THREO-DL-BETA-HYDROXYNORLEUCINE; THREO-DL-BETA-HYDROXYNORVALINE; THREO-L-BETA-HYDROXYNORLEUCINE; THREONINE, L-[14C(U)]; TIGLIC ACID; TRANS,TRANS-MUCONIC ACID; TRANS-2,4-PENTADIENOIC ACID; TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID; TRANS-2-AMINO-4-CYCLOHEXENE-1-CARBOXYLIC ACID; TRANS-2-AMINO-CYCLOPENTANECARBOXYLIC ACID; TRANS-2-BUTENE-1,4-DICARBOXYLIC ACID; TRANS-2-CHLOROMETHYL-1-CYCLOPROPANECARBOXYLIC ACID; TRANS-2-FLUORO-CYCLOPROPANECARBOXYLIC ACID; TRANS-2-HEXENOIC ACID; TRANS-2-HYDROXYMETHYL-1-CYCLOPROPANECARBOXYLIC ACID; TRANS-2-OCTENOIC ACID; TRANS-2-PENTENOIC ACID; TRANS-3-AMINOCYCLOBUTANECARBOXYLIC ACID; TRANS-3-CHLOROACRYLIC ACID; TRANS-3-CHLOROCYCLOBUTANECARBOXYLIC ACID; TRANS-3-FLUOROCYCLOBUTANECARBOXYLIC ACID; TRANS-3-HEXENOIC ACID; TRANS-3-HYDROXYCYCLOBUTANECARBOXYLIC ACID; TRANS-3-HYDROXYHEPT-4-ENOIC ACID; TRANS-3-HYDROXYHEX-4-ENOIC ACID; TRANS-3-HYDROXY-L-PROLINE; TRANS-3-METHYL-CYCLOBUTANEACETIC ACID; TRANS-3-METHYLCYCLOBUTANECARBOXYLIC ACID; TRANS-4-AMINOCROTONIC ACID HYDROCHLORIDE; TRANS-4-AMINOCYCLOHEXANECARBOXYLIC ACID; TRANS-4-HYDROXYCYCLOHEXANECARBOXYLIC ACID; TRANS-4-HYDROXY-D-PROLINE; TRANS-4-HYDROXY-TETRAHYDRO-2-FUROIC ACID; TRANS-4-METHYLCYCLOHEXANECARBOXYLIC ACID; TRANS-CINNAMIC ACID; TRANS-CYCLOBUTANE-1,2-DICARBOXYLIC ACID; TRANS-CYCLOBUTANE-1,3-DICARBOXYLIC ACID; TRIFLUOROACETIC ACID; TRIMETHYLAMMONIUM ACETATE; TRIMETHYLPYRUVIC ACID; UROCANIC ACID; VALERIC ACID; VALPROIC ACID; VIGABATRIN; VINYLACETIC ACID

List No. 5—Carboxylic Acids Aldehydes

((2-FORMYL-3-THIENYL)THIO)ACETIC ACID; ([2-(2-FORMYLPHENOXY)ETHYL]THIO)ACETIC ACID; ([2-(4-FORMYL-2-METHOXYPHENOXY)ETHYL]THIO)ACETIC ACID; ([2-(4-FORMYLPHENOXY)ETHYL]THIO)ACETIC ACID; ([3-(2-FORMYLPHENOXY)PROPYL]THIO)ACETIC ACID; ([3-(4-FORMYLPHENOXY)PROPYL]THIO)ACETIC ACID; ([4-(2-FORMYL-1H-PYRROL-1-YL)PHENYL]THIO)ACETIC ACID; ([4-FORMYL-3-METHYL-1-(4-METHYLBENZYL)-1H-PYRAZOL-5-YL]THIO)ACETIC ACID; (2-BROMO-4-CHLORO-6-FORMYLPHENOXY)ACETIC ACID; (2-BROMO-4-FORMYL-6-METHOXYPHENOXY)ACETIC ACID; (2-BROMO-4-FORMYLPHENOXY)ACETIC ACID; (2-BROMO-6-CHLORO-4-FORMYLPHENOXY)ACETIC ACID; (2-BROMO-6-ETHOXY-4-FORMYLPHENOXY)ACETIC ACID; (2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)ACETIC ACID; (2-CHLORO-4-FORMYLPHENOXY)ACETIC ACID; (2-CHLORO-6-ETHOXY-4-FORMYLPHENOXY)ACETIC ACID; (2E)-2,3-DIBROMO-4-OXOBUT-2-ENOIC ACID; (2-ETHOXY-4-FORMYLPHENOXY)ACETIC ACID; (2-ETHOXY-6-FORMYLPHENOXY)ACETIC ACID; (2-FORMYL-1H-PYRROL-1-YL)(PHENYL)ACETIC ACID; (2-FORMYL-1H-PYRROL-1-YL)ACETIC ACID; (2-FORMYL-6-METHOXY-4-NITROPHENOXY)ACETIC ACID; (2-FORMYL-IMIDAZOL-1-YL)-PHENYL-ACETIC ACID; (2R)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)ACETIC ACID; (2R)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)ACETIC ACID; (2R)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOIC ACID; (2R)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANOIC ACID; (2RS)-2-(4-FORMYLPHENYL)PROPANOIC ACID; (2S)-2-(2-FORMYL-1H-PYRROL-1-YL)-3-PHENYLPROPANOIC ACID; (2S)-2-(2-FORMYL-1H-PYRROL-1-YL)-4-METHYLPENTANOIC ACID; (2S)-2-(2-FORMYL-1H-PYRROL-1-YL)PROPANOIC ACID; (2S)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)ACETIC ACID; (2S)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)ACETIC ACID; (2S)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOIC ACID; (2S)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANOIC ACID; (2S,3R)-2-BENZYL-5-FORMYL-2,3-DIHYDROBENZOFURAN-3-CARBOXYLIC ACID; (2S,3R)-5-FORMYL-2-METHYL-2,3-DIHYDROBENZOFURAN-3-CARBOXYLIC ACID; (2Z)-2,3-DICHLORO-4-OXOBUT-2-ENOIC ACID; (3-FORMYL-2-METHYL-INDOL-1-YL)-ACETIC ACID; (3-FORMYL-4-NITROPHENOXY)ACETIC ACID; (3-FORMYL-5-METHOXY-1H-INDOL-1-YL)ACETIC ACID; (4-BROMO-2-FORMYL-6-METHOXYPHENOXY)ACETIC ACID; (4-BROMO-2-FORMYLPHENOXY)ACETIC ACID; (4-CHLORO-2-FORMYL-6-METHOXYPHENOXY)ACETIC ACID; (4-CHLORO-2-FORMYLPHENOXY)ACETIC ACID; (4-FORMYL-2,6-DIMETHOXYPHENOXY)ACETIC ACID; (4-FORMYL-2-IODO-6-METHOXYPHENOXY)ACETIC ACID; (4-FORMYL-2-IODOPHENOXY)ACETIC ACID; (4-FORMYL-2-M ETHOXYPHENOXY)ACETIC ACID; (4-FORMYL-3,5-DIMETHOXYPHENOXY)ACETIC ACID; (4-FORMYL-3-METHOXYPHENYL)ACETIC ACID; (4-FORMYL-3-PHENYL-1H-PYRAZOL-1-YL)ACETIC ACID; (4-FORMYL-BENZENESULFONYLAMINO)-ACETIC ACID; (4′-FORMYL-BIPHENYL-2-YL)-ACETIC ACID; (4′-FORMYL-BIPHENYL-3-YL)-ACETIC ACID; (4′-FORMYL-BIPHENYL-4-YL)-ACETIC ACID; (4R)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOIC ACID; (4S)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOIC ACID; (5-BROMO-2-ETHOXY-4-FORMYLPHENOXY)ACETIC ACID; (5-BROMO-4-FORMYL-2-METHOXYPHENOXY)ACETIC ACID; (5-CHLORO-2-ETHOXY-4-FORMYLPHENOXY)ACETIC ACID; (5-CHLORO-4-FORMYL-2-METHOXYPHENOXY)ACETIC ACID; (5-FORMYL-2,4-DIMETHYL-1H-PYRROL-3-YL)-ACETIC ACID; (5-FORMYL-2-METHOXYPHENOXY)ACETIC ACID; (5-FORMYL-4-HYDROXY-6-OXO-3-PHENYLPYRIDAZIN-1(6H)-YL)ACETIC ACID; (5-FORMYL-IMIDAZO[2,1-B]THIAZOL-6-YLSULFANYL)-ACETIC ACID; (5R)-5-AMINO-5-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PENTANOIC ACID; (5S)-5-AMINO-5-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PENTANOIC ACID; (R)-3-((R)-2-((R)-2-ACETAMIDO-3-METHYLBUTANAMIDO)PROPANAMIDO)-4-OXOBUTANOIC ACID; [(2-FORMYL-1-METHYL-1H-INDOL-3-YL)THIO]ACETIC ACID; [(3-ETHOXY-5-FORMYL-2-HYDROXY-BENZYL)-METHYL-AMINO]-ACETIC ACID; [(3-FORMYL-1-METHYL-1H-INDOL-2-YL)THIO]ACETIC ACID; [(3-FORMYL-6-METHOXYQUINOLIN-2-YL)THIO]ACETIC ACID; [(4-FORMYL-2-NITROPHENYL)THIO]ACETIC ACID; [(4-FORMYL-3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)THIO]ACETIC ACID; [(5-FORMYL-2-HYDROXY-3-METHOXY-BENZYL)-METHYL-AMINO]-ACETIC ACID; [[1-(2-CHLOROBENZYL)-4-FORMYL-3-METHYL-1H-PYRAZOL-5-YL]THIO]ACETIC ACID; [[1-(4-CHLOROBENZYL)-4-FORMYL-3-METHYL-1H-PYRAZOL-5-YL]THIO]ACETIC ACID; [2-(2-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(3-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(4-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PHENOXY]ACETIC ACID; [4-FORMYL-3-(4-METHOXYPHENYL)-1H-PYRAZOL-1-YL]ACETIC ACID; [5-(4-FORMYLBENZYLIDENE)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-3-YL]ACETIC ACID; 1-(2,4-DICHLOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(2,5-DICHLOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(2,5-DIMETHYLBENZYL)-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-(2-BROMOPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(2-CHLORO-4-FLUOROBENZYL)-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-(2-CHLORO-4-FORMYLPHENOXY)CYCLOHEXANE-1-CARBOXYLIC ACID; 1-(2-CHLORO-4-FORMYLPHENOXY)CYCLOPENTANE-1-CARBOXYLIC ACID; 1-(2-CHLOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(2-FLUOROBENZYL)-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-(2-FLUOROBENZYL)-3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 1-(2-FLUOROBENZYL)-3-FORMYL-6-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-(3,4-DIMETHYLPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(3-BROMOPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(3-CHLOROBENZYL)-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-(3-CHLOROBENZYL)-4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 1-(3-CHLOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(3-FORMYL-4-HYDROXY-BENZYL)-PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)-2-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)-3-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)-4-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)CYCLOHEPTANE-1-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)CYCLOHEXANE-1-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)CYCLOPENTANE-1-CARBOXYLIC ACID; 1-(4-BROMOPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(4-CHLOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(4-ETHOXYPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(4-ETHYLPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(4-FLUOROBENZYL)-3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 1-(4-FLUOROBENZYL)-4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 1-(4-FLUOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(4-FORMYL-2-PHENYL-1,3-THIAZOL-5-YL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(4-FORMYL-BENZENESULFONYL)-PIPERIDINE-4-CARBOXYLIC ACID; 1-(4-FORMYL-BENZENESULFONYL)-PYRROLIDINE-2-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)-2-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)-3-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)-4-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)CYCLOHEPTANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)CYCLOHEXANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)CYCLOPENTANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENYL)-4-PIPERIDINECARBOXYLIC ACID; 1-(5-FORMYL-2-METHOXYBENZYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1,8-NAPHTHALALDEHYDIC ACID; 1-[(5-FORMYL-2-FURYL)METHYL]PYRAZOLE-4-CARBOXYLIC ACID; 1-[2-(3-FORMYLPHENOXY)ETHYL]-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 1-[2-(4-FORMYLPHENOXY)ETHYL]-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 12-OXO-9(Z)-DODECENOIC ACID; 1-BENZYL-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-BENZYL-3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 1-BENZYL-4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 1-ETHYL-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-ETHYL-3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 1H-INDOLE-1-BUTANOIC ACID, 5-BROMO-3-FORMYL-; 1H-INDOLE-1-BUTANOIC ACID, 7-ETHYL-3-FORMYL-; 1H-INDOLE-3-PROPANOIC ACID, 2-FORMYL-4,5,6,7-TETRAHYDRO-; 1H-PYRAZOLE-3-CARBOXYLIC ACID, 5-FORMYL-1-METHYL-; 1H-PYRROLE-1-ACETIC ACID, 3-FORMYL-; 1-PIPERIDINECARBOXYLIC ACID, 2-(2-FORMYLETHYL)-; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETIC ACID; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)PROPANOIC ACID; 2-(2,6-DIBROMO-4-FORMYLPHENOXY)ACETIC ACID; 2-(2,6-DICHLORO-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-BROMO-4-FORMYL-6-METHOXYPHENOXY)PROPANOIC ACID; 2-(2-BROMO-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-BROMO-6-ETHOXY-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-BROMO-6-FORMYLPHENOXY)ACETIC ACID; 2-(2-BROMO-6-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)PROPANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2,2-DIFLUOROACETIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2,4-DIMETHYLPENTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2-CYCLOPROPYLPROPANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2-ETHYLBUTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2-METHYLBUTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2-METHYLPENTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2-METHYLPROPANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-3-METHOXY-2-METHYLPROPANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-3-METHYLBUTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-4-METHOXY-2-METHYLBUTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)BUTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-(2-CHLORO-6-ETHOXY-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-ETHOXY-4-FORMYL-6-NITROPHENOXY)PROPANOIC ACID; 2-(2-ETHOXY-4-FORMYLPHENOXY)PENTANOIC ACID; 2-(2-ETHOXY-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-ETHOXY-6-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-1H-PYRROL-1-YL)BENZOIC ACID; 2-(2-FORMYL-4-M ETHOXYPHENOXY)ACETIC ACID; 2-(2-FORMYL-4-METHOXYPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-4-METHYLPHENOXY)ACETIC ACID; 2-(2-FORMYL-4-METHYLPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-4-NITROPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-5-METHOXYPHENOXY)ACETIC ACID; 2-(2-FORMYL-5-METHOXYPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-5-PROPOXYPHENOXY)ACETIC ACID; 2-(2-FORMYL-5-PROPOXYPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-6-METHOXY-4-NITROPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-6-METHOXYPHENOXY)ACETIC ACID; 2-(2-FORMYL-6-METHOXYPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-IMIDAZOL-1-YL)-3-PHENYL-PROPIONIC ACID; 2-(2-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID; 2-(2-FORMYLPHENOXY)PENTANOIC ACID; 2-(2-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-FORMYLPHENYL)-4-NITROBENZOIC ACID; 2-(2-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 2-(2-FORMYLPHENYL)-5-METHYLBENZOIC ACID; 2-(2-FORMYLPHENYL)-6-METHYLBENZOIC ACID; 2-(2-FORMYLPHENYL)-ISONICOTINIC ACID; 2-(2-FORMYLPHENYL)NICOTINIC ACID; 2-(2-FORMYL-PYRROL-1-YL)-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHENE-3-CARBOXYLIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-4-CHLOROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-4-FLUOROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-4-NITROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-5-FLUOROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-5-METHOXYBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-5-METHYLBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-6-CHLOROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-6-FLUOROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-6-METHYLBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)BENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)ISONICOTINIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)NICOTINIC ACID; 2-(2-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2-(3-CARBOXYPHENOXY)-4-CHLORO-5-THIAZOLECARBOXALDEHYDE; 2-(3-CHLORO-2-FORMYLPHENOXY)ACETIC ACID; 2-(3-CHLORO-2-FORMYLPHENOXY)PROPANOIC ACID; 2-(3-FORMYL-1H-INDOL-1-YL)BUTANOIC ACID; 2-(3-FORMYL-1H-INDOL-1-YL)PROPANOIC ACID; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-4,5-DIMETHYL-3-THIOPHENECARBOXYLIC ACID; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-BENZOIC ACID; 2-(3-FORMYL-2-METHOXYPHENOXY)PROPANOIC ACID; 2-(3-FORMYL-4-HYDROXY-5-METHOXYPHENYL)ACETIC ACID; 2-(3-FORMYLPHENOXY)-2,4-DIMETHYLPENTANOIC ACID; 2-(3-FORMYLPHENOXY)-2,5-DIMETHYLHEXANOIC ACID; 2-(3-FORMYLPHENOXY)-2-METHYLBUTANOIC ACID; 2-(3-FORMYLPHENOXY)-2-METHYLPENTANOIC ACID; 2-(3-FORMYLPHENOXY)-2-METHYLPROPANOIC ACID; 2-(3-FORMYLPHENOXY)-2-PHENYLACETIC ACID; 2-(3-FORMYLPHENOXY)-2-PROPYLPENTANOIC ACID; 2-(3-FORMYLPHENOXY)-3-METHOXY-2-METHYLPROPANOIC ACID; 2-(3-FORMYLPHENOXY)-3-METHYLBUTANOIC ACID; 2-(3-FORMYLPHENOXY)-4-METHOXY-2-METHYLBUTANOIC ACID; 2-(3-FORMYLPHENOXY)BUTANOIC ACID; 2-(3-FORMYLPHENOXY)PROPANOIC ACID; 2-(3-FORMYLPHENOXYMETHYL)BENZOIC ACID; 2-(3-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-(3-FORMYLPHENYL)-4-NITROBENZOIC ACID; 2-(3-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 2-(3-FORMYLPHENYL)-5-METHYLBENZOIC ACID; 2-(3-FORMYLPHENYL)-6-METHYLBENZOIC ACID; 2-(3-FORMYLPHENYL)ISONICOTINIC ACID; 2-(3-FORMYLPHENYL)NICOTINIC ACID; 2-(3-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(3-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2-(4-BROMO-2-FORMYLPHENOXY)PROPANOIC ACID; 2-(4-CHLORO-2-FORMYL-6-METHOXYPHENOXY)PROPANOIC ACID; 2-(4-CHLORO-2-FORMYLPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-1H-IMIDAZOL-1-YL)ACETIC ACID; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETIC ACID; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)ACETIC ACID; 2-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-2-METHOXY-6-NITROPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-2-METHOXYPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-2-NITROPHENOXY)ACETIC ACID; 2-(4-FORMYL-2-NITROPHENOXY)PROPANOIC ACID; 2-(4-FORMYLPHENOXY)-2,4-DIMETHYLPENTANOIC ACID; 2-(4-FORMYLPHENOXY)-2,5-DIMETHYLHEXANOIC ACID; 2-(4-FORMYLPHENOXY)-2-METHYLBUTANOIC ACID; 2-(4-FORMYLPHENOXY)-2-METHYLPENTANOIC ACID; 2-(4-FORMYLPHENOXY)-2-METHYLPROPANOIC ACID; 2-(4-FORMYLPHENOXY)-2-PHENYLACETIC ACID; 2-(4-FORMYLPHENOXY)-2-PROPYLPENTANOIC ACID; 2-(4-FORMYLPHENOXY)-3-METHOXY-2-METHYLPROPANOIC ACID; 2-(4-FORMYLPHENOXY)-3-METHYLBUTANOIC ACID; 2-(4-FORMYLPHENOXY)-4-METHOXY-2-METHYLBUTANOIC ACID; 2-(4-FORMYLPHENOXY)BUTANOIC ACID; 2-(4-FORMYLPHENOXY)PENTANOIC ACID; 2-(4-FORMYLPHENOXY)PROPANOIC ACID; 2-(4-FORMYLPHENOXYMETHYL)BENZOIC ACID; 2-(4-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-(4-FORMYLPHENYL)-4-NITROBENZOIC ACID; 2-(4-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 2-(4-FORMYLPHENYL)-5-METHYLBENZOIC ACID; 2-(4-FORMYLPHENYL)-6-METHYLBENZOIC ACID; 2-(4-FORMYLPHENYL)ISONICOTINIC ACID; 2-(4-FORMYLPHENYL)NICOTINIC ACID; 2-(4-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(5-(BENZYLOXY)-2-FORMYLPHENOXY)PROPANOIC ACID; 2-(5-FORMYL-1H-BENZIMIDAZOL-1-YL)ACETIC ACID; 2-(5-FORMYL-2-METHOXYPHENOXY)-2-PHENYLACETIC ACID; 2-(5-FORMYL-2-METHOXYPHENOXY)PROPANOIC ACID; 2-(5-FORMYL-2-NITROPHENOXY)ACETIC ACID; 2-(5-FORMYL-2-NITROPHENOXY)PROPANOIC ACID; 2-(5-FORMYLFURAN-2-YL)ACETIC ACID; 2-(5-FORMYL-FURAN-2-YL)-BENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-4-CHLOROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-4-FLUOROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-4-NITROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-5-FLUOROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-5-METHOXYBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-5-METHYLBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-6-CHLOROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-6-FLUOROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-6-METHYLBENZOIC ACID; 2-(5-FORMYL-THIOPHEN-2-YL)-BENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)ISONICOTINIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)NICOTINIC ACID; 2-(5-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(5-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE MONOHYDRATE; 2-(5-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2,2-DIFLUORO-2-(3-FORMYLPHENOXY)ACETIC ACID; 2,2-DIFLUORO-2-(4-FORMYLPHENOXY)ACETIC ACID; 2,3-DIBROMO-4-OXO-BUTYRIC ACID; 2,4-DICHLORO-5-FLUORO-3-FORMYL-BENZOIC ACID; 2,4-DIFLUORO-5-FORMYLBENZOIC ACID; 2,4-HEXADIENOIC ACID, 2-AMINO-5-METHYL-6-OXO-, (E,Z)-; 2,6-DIFLUORO-4-FORMYLBENZOIC ACID; 2-[(1-FORMYL-2-NAPHTHYL)OXY]PROPANOIC ACID; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]ACETIC ACID; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)SULFANYL]ACETIC ACID; 2-[(5-FORMYL-2-METHOXYBENZYL)THIO]NICOTINIC ACID; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETIC ACID; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]PROPANOIC ACID; 2-[2-(3-FORMYL-INDOL-1-YL)-ACETYLAMINO]-BENZOIC ACID; 2-[4-(2-FORMYL-1H-PYRROL-1-YL)PHENOXY]PROPANOIC ACID; 2-[4-(3-FORMYL-2,5-DIMETHYL-1H-1-PYRROLYL)PHENOXY]PROPANOIC ACID; 2-AMINO-3-FORMYLBENZOIC ACID; 2-AMINO-4-OXOBUTANOIC ACID; 2-AMINO-5-(2-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(2-FORMYLPHENYL)NICOTINIC ACID; 2-AMINO-5-(3-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(3-FORMYLPHENYL)NICOTINIC ACID; 2-AMINO-5-(4-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(4-FORMYLPHENYL)NICOTINIC ACID; 2-BROMO-3-CHLORO-4-OXO-2-BUTENOIC ACID; 2-CARBOXY-3-CHLORO-BENZENALDEHYDE; 2-CARBOXYBENZALDEHYDE; 2-CHLORO-4-(2-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-4-(3-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-4-(4-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-4-(5-FORMYL-FURAN-2-YL)-BENZOIC ACID; 2-CHLORO-4-FORMYLBENZOIC ACID; 2-CHLORO-5-(2-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-5-(2-FORMYLPHENYL)ISONICOTINIC ACID; 2-CHLORO-5-(2-FORMYLPHENYL)NICOTINIC ACID; 2-CHLORO-5-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)BENZOIC ACID; 2-CHLORO-5-(3-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-5-(3-FORMYLPHENYL)ISONICOTINIC ACID; 2-CHLORO-5-(3-FORMYLPHENYL)NICOTINIC ACID; 2-CHLORO-5-(4-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-5-(4-FORMYLPHENYL)ISONICOTINIC ACID; 2-CHLORO-5-(4-FORMYLPHENYL)NICOTINIC ACID; 2-CHLORO-5-(5-FORMYL-2-FURYL)BENZOIC ACID; 2-CHLORO-5-FORMYL-BENZOIC ACID; 2-CHLORO-6-FLUORO-3-FORMYL-BENZOIC ACID; 2-CYCLOPROPOXY-3-FORMYLBENZOIC ACID; 2-CYCLOPROPOXY-4-FORMYLBENZOIC ACID; 2-CYCLOPROPOXY-5-FORMYLBENZOIC ACID; 2-CYCLOPROPOXY-6-FORMYLBENZOIC ACID; 2-CYCLOPROPYL-2-(3-FORMYLPHENOXY)PROPANOIC ACID; 2-CYCLOPROPYL-2-(4-FORMYLPHENOXY)PROPANOIC ACID; 2-ETHYL-2-(3-FORMYLPHENOXY)BUTANOIC ACID; 2-ETHYL-2-(4-FORMYLPHENOXY)BUTANOIC ACID; 2-FLUORO-4-(2-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-4-(3-FORMYL-2-HYDROXYPHENYL)BENZOIC ACID; 2-FLUORO-4-(3-FORMYL-4-HYDROXYPHENYL)BENZOIC ACID; 2-FLUORO-4-(3-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-4-(4-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-4-(4-FORMYLPYRIDIN-3-YL)BENZOIC ACID; 2-FLUORO-4-(5-FORMYL-2-HYDROXYPHENYL)BENZOIC ACID; 2-FLUORO-4-(5-FORMYLPYRIDIN-3-YL)BENZOIC ACID; 2-FLUORO-4-FORMYLBENZOIC ACID; 2-FLUORO-5-(2-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-5-(3-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-5-(4-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-5-FORMYLBENZOIC ACID; 2′-FORMYL[1,1′-BIPHENYL]-2-CARBOXYLIC ACID; 2-FORMYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-FORMYL-1H-PYRROLE-1-PROPANOIC ACID; 2-FORMYL-3-HYDROXYBENZOIC ACID; 2-FORMYL-3-NITRO-BENZOIC ACID; 2-FORMYL-4,5-DIMETHOXY-BENZOIC ACID; 2-FORMYL-4-HYDROXY-3-METHOXYBENZOIC ACID; 2-FORMYL-4-HYDROXYBENZOIC ACID; 2-FORMYL-4-NITROPHENOXYACETIC ACID; 2-FORMYL-5-HYDROXYBENZOIC ACID; 2-FORMYL-5-IODO-BENZOIC ACID; 2-FORMYL-5-METHOXY-BENZOIC ACID; 2-FORMYL-5-NITROBENZOIC ACID; 2-FORMYL-6H-FURO[2,3-B]PYRROLE-5-CARBOXYLIC ACID; 2-FORMYL-6-HYDROXYBENZOIC ACID; 2-FORMYL-6-METHOXYBENZOIC ACID; 2′-FORMYL-BIPHENYL-3-CARBOXYLIC ACID; 2′-FORMYL-BIPHENYL-4-CARBOXYLIC ACID; 2-FORMYLCINNAMIC ACID; 2-FORMYLCYCLOPENT-2-ENECARBOXYLIC ACID; 2-FORMYLPHENOXYACETIC ACID; 2-FORMYLQUINOLINE-6-CARBOXYLIC ACID; 2-FORMYLQUINOLINE-8-CARBOXYLIC ACID; 2-FORMYLTHIOPHENE-3-CARBOXYLIC ACID; 2-HYDROXYISOPHTHALALDEHYDE ACID HYDRATE; 2-NAPHTHALENECARBOXYLIC ACID, 5-FORMYL-4-HYDROXY-6,7-DIMETHOXY-; 2-PYRROLECARBAMIC ACID, 4-FORMYL-3,5-DIMETHYL-; 3-(2,4-DIMETHYL-5-FORMYL-1H-PYRROLE-3-YL)PROPANOIC ACID; 3-(2-CHLORO-4-FORMYL-6-METHOXY-PHENOXYMETHYL)-BENZOIC ACID; 3-(2-CHLORO-4-FORMYLPHENOXY)PROPANOIC ACID; 3-(2-CHLORO-4-FORMYLPHENOXY)THIANE-3-CARBOXYLIC ACID; 3-(2-CHLORO-4-FORMYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-(2-ETHOXY-4-FORMYLPHENOXY)PROPANOIC ACID; 3-(2-FORMYL-1H-PYRROL-1-YL)-4-METHYL-BENZOIC ACID; 3-(2-FORMYL-1H-PYRROL-1-YL)BENZOIC ACID; 3-(2-FORMYL-4-METHYL-1H-PYRROL-3-YL)-PROPIONIC ACID; 3-(2-FORMYL-IMIDAZOL-1-YL)-PROPIONIC ACID; 3-(2-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID; 3-(2-FORMYLPHENOXY)PROPANOIC ACID; 3-(2-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 3-(2-FORMYLPHENYL)-2-METHYLBENZOIC ACID; 3-(2-FORMYLPHENYL)-5-HYDROXYBENZOIC ACID; 3-(2-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 3-(2-FORMYLPHENYL)-5-NITROBENZOIC ACID; 3-(2-FORMYLPHENYL)-5-TRIFLUOROMETHYLBENZOIC ACID; 3-(2-FORMYLPHENYL)ISONICOTINIC ACID; 3-(2-FORMYLPHENYL)PICOLINIC ACID; 3-(2-FORMYLPHENYL)PROPANOIC ACID; 3-(2-FORMYLTHIOPHEN-3-YL)PROPIOLIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-2-METHOXYBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-2-METHYLBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-4-CHLOROBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-4-FLUOROBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-CHLOROBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-FLUOROBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-HYDROXYBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-METHOXYBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-NITROBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-TRIFLUOROMETHYLBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-6-AMINOPICOLINIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)ISONICOTINIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)PICOLINIC ACID; 3-(3-FORMYL-1H-INDOL-1-YL)PROPANOIC ACID; 3-(3-FORMYL-1H-INDOL-5-YL)BENZOIC ACID; 3-(3-FORMYL-1H-PYRROL-1-YL)PROPANOIC ACID; 3-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-4-METHYLBENZOIC ACID; 3-(3-FORMYL-2,5-DIMETHYL-PYRROL-1-YL)-2-METHYL-BENZOIC ACID; 3-(3-FORMYL-2,5-DIMETHYL-PYRROL-1-YL)-BENZOIC ACID; 3-(3-FORMYLPHENOXY)PROPANOIC ACID; 3-(3-FORMYLPHENOXY)THIANE-3-CARBOXYLIC ACID; 3-(3-FORMYLPHENOXY)THIOLANE-3-CARBOXYLIC ACID; 3-(3-FORMYLPHENOXYMETHYL)BENZOIC ACID; 3-(3-FORMYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-(3-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 3-(3-FORMYLPHENYL)-2-METHYLBENZOIC ACID; 3-(3-FORMYLPHENYL)-5-HYDROXYBENZOIC ACID; 3-(3-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 3-(3-FORMYLPHENYL)-5-NITROBENZOIC ACID; 3-(3-FORMYLPHENYL)-5-TRIFLUOROMETHYLBENZOIC ACID; 3-(3-FORMYLPHENYL)ISONICOTINIC ACID; 3-(3-FORMYLPHENYL)PICOLINIC ACID; 3-(3-FORMYLPHENYL)PROPANOIC ACID; 3-(3-OXOPROPYL)-BENZOIC ACID; 3-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 3-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)PROPANOIC ACID; 3-(4-FORMYL-2-METHOXYPHENOXY)PROPANOIC ACID; 3-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)PROPANOIC ACID; 3-(4-FORMYLPHENOXY)PROPANOIC ACID; 3-(4-FORMYLPHENOXY)THIANE-3-CARBOXYLIC ACID; 3-(4-FORMYLPHENOXY)THIOLANE-3-CARBOXYLIC ACID; 3-(4-FORMYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-(4-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 3-(4-FORMYLPHENYL)-2-METHYLBENZOIC ACID; 3-(4-FORMYLPHENYL)-3-METHYLBUTANOIC ACID; 3-(4-FORMYLPHENYL)-5-HYDROXYBENZOIC ACID; 3-(4-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 3-(4-FORMYLPHENYL)-5-NITROBENZOIC ACID; 3-(4-FORMYLPHENYL)-5-TRIFLUOROMETHYLBENZOIC ACID; 3-(4-FORMYLPHENYL)ISONICOTINIC ACID; 3-(4-FORMYLPHENYL)PICOLINIC ACID; 3-(4-FORMYLPHENYL)PROPANOIC ACID; 3-(5-FORMYL-2-FURYL)BENZOIC ACID; 3-(5-FORMYL-3-THIENYL)BENZOIC ACID; 3-(5-FORMYL-FURAN-2-YL)-2-METHYL-BENZOIC ACID; 3-(5-FORMYL-FURAN-2-YL)-4-METHYL-BENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-2-METHOXYBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-2-METHYLBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-4-CHLOROBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-4-FLUOROBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-CHLOROBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-FLUOROBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-HYDROXYBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-METHOXYBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-NITROBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-TRIFLUOROMETHYLBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-6-AMINOPICOLINIC ACID; 3-(5-FORMYL-THIOPHEN-2-YL)-BENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)ISONICOTINIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)PICOLINIC ACID; 3-(5-FORMYLTHIOPHEN-3-YL)PROPIOLIC ACID; 3-(7-FORMYL-8-HYDROXY-QUINOLIN-5-YL)-PROPIONIC ACID; 3,4-DIFORMYL-5-(4-METHOXY-3-NITROPHENYL)PENTANOIC ACID; 3,4-DIMETHYL-5-FORMYLPYRROLE-2-CARBOXYLIC ACID; 3-[(1-FORMYL-2-NAPHTHYL)OXY]PROPANOIC ACID; 3-[(2-CHLORO-6-ETHOXY-4-FORMYLPHENOXY)METHYL]BENZOIC ACID; 3-[(4-FORMYL-2-METHOXYPHENOXY)METHYL]BENZOIC ACID; 3-[(4-FORMYLPHENOXY)METHYL]BENZOIC ACID; 3-[2-(3-FORMYL-INDOL-1-YL)-ACETYLAMINO]-BENZOIC ACID; 3-[4-FORMYL-3-(4-METHOXYPHENYL)-1H-PYRAZOL-1-YL]PROPANOIC ACID; 3-AMINO-5-(2-FORMYLPHENYL)BENZOIC ACID; 3-AMINO-5-(3-FORMYLPHENYL)BENZOIC ACID; 3-AMINO-5-(4-FORMYLPHENYL)BENZOIC ACID; 3-BROMO-2-FORMYL-5-NITRO-BENZOIC ACID; 3-CARBOXYBENZALDEHYDE; 3-CARBOXYLIC ACID-1H-INDAZOLE-4-CARBOXALDEHYDE; 3-CHLORO-2-FORMYL-5-NITRO-BENZOIC ACID; 3-CHLORO-2-FORMYLBENZOIC ACID; 3-CHLORO-5-FORMYLPYRIDINE-2-CARBOXYLIC ACID; 3-CYCLOPROPOXY-2-FORMYLBENZOIC ACID; 3-CYCLOPROPOXY-2-FORMYLISONICOTINIC ACID; 3-CYCLOPROPOXY-4-FORMYLBENZOIC ACID; 3-CYCLOPROPOXY-4-FORMYLPICOLINIC ACID; 3-CYCLOPROPOXY-5-FORMYLBENZOIC ACID; 3-CYCLOPROPOXY-5-FORMYLISONICOTINIC ACID; 3-CYCLOPROPOXY-5-FORMYLPICOLINIC ACID; 3-CYCLOPROPOXY-6-FORMYLPICOLINIC ACID; 3-FLUORO-4-(2-FORMYLPHENYL)BENZOIC ACID; 3-FLUORO-4-(3-FORMYLPHENYL)BENZOIC ACID; 3-FLUORO-4-(4-FORMYLPHENYL)BENZOIC ACID; 3′-FORMYL(1,1′-BIPHENYL)-3-CARBOXYLIC ACID; 3′-FORMYL(1,1′-BIPHENYL)-4-CARBOXYLIC ACID; 3′-FORMYL[1,1-BIPHENYL]-2-CARBOXYLIC ACID; 3-FORMYL-1-(2-METHYLBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1-(4-METHOXYBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1-(4-VINYLBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1H-INDAZOLE-4-CARBOXYLIC ACID; 3-FORMYL-1H-INDAZOLE-5-CARBOXYLIC ACID; 3-FORMYL-1H-INDAZOLE-6-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-4-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-6-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-7-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-4-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-7-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[3,2-B]PYRIDINE-5-CARBOXYLIC ACID; 3-FORMYL-1-ISOBUTYL-1H-INDOLE-4-CARBOXYLIC ACID; 3-FORMYL-1-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1-METHYL-1H-INDOLE-4-CARBOXYLIC ACID; 3-FORMYL-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-FORMYL-2-FUROIC ACID; 3-FORMYL-2-THIOPHENECARBOXYLIC ACID; 3-FORMYL-4,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-4-AZAINDOLE-6-CARBOXYLIC ACID; 3′-FORMYL-4′-HYDROXY[1,1′-BIPHENYL]-3-CARBOXYLIC ACID; 3′-FORMYL-4-HYDROXY[1,1-BIPHENYL]-3-CARBOXYLIC ACID; 3′-FORMYL-4′-HYDROXY[1,1-BIPHENYL]-4-CARBOXYLIC ACID; 3-FORMYL-4-HYDROXYBENZOIC ACID; 3-FORMYL-4-METHOXY-BENZOIC ACID; 3-FORMYL-4-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID; 3-FORMYL-5,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-5-HYDROXYBENZOIC ACID; 3-FORMYL-5-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-5-METHOXY-BENZOIC ACID; 3-FORMYL-5-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1-(2-METHYLBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1-(4-METHOXYBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1-(4-METHYLBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1-(4-VINYLBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYLINDOL-1-YL-ACETIC ACID; 3-FORMYLINDOLE-5-CARBOXYLIC ACID; 3-FORMYLPHENOXYACETIC ACID; 3-FORMYLPICOLINIC ACID; 3-FORMYLSALICYLIC ACID; 3-OXOPROPANOIC ACID; 4-([(4-FORMYL-2-METHOXYPHENOXY)ACETYL]AMINO)BENZOIC ACID; 4-([2-(1,3-BENZOXAZOL-2-YL)-3-OXO-1-PROPENYL]AMINO)-2-HYDROXYBENZOIC ACID; 4-(2,6-DIHYDROXYBENZOYL)-3-FORMYL-5-HYDROXYBENZOIC ACID; 4-(2-BUTYL-5-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID; 4-(2-CARBOXYTHIOPHEN-3-YL)BENZALDEHYDE; 4-(2-CARBOXYTHIOPHENE-4-YL)-2-FORMYLPHENOL; 4-(2-CHLORO-4-FORMYLPHENOXY)BUTANOIC ACID; 4-(2-CHLORO-4-FORMYLPHENOXY)OXANE-4-CARBOXYLIC ACID; 4-(2-CHLORO-4-FORMYLPHENOXY)PENTANOIC ACID; 4-(2-CHLORO-4-FORMYLPHENOXY)THIANE-4-CARBOXYLIC ACID; 4-(2-CHLORO-4-FORMYLPHENOXYMETHYL)-1,3-THIAZOLE-2-CARBOXYLIC ACID; 4-(2-ETHOXY-4-FORMYLPHENOXYMETHYL)BENZOIC ACID; 4-(2-FORMYL-1H-PYRROL-1-YL)-3-METHYL-BENZOIC ACID; 4-(2-FORMYL-1H-PYRROL-1-YL)BENZOIC ACID; 4-(2-FORMYL-IMIDAZOL-1-YL)-BUTYRIC ACID; 4-(2-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID; 4-(2-FORMYLPHENYL)-2-HYDROXYBENZOIC ACID; 4-(2-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 4-(2-FORMYLPHENYL)-2-NITROBENZOIC ACID; 4-(2-FORMYLPHENYL)-3-HYDROXYBENZOIC ACID; 4-(2-FORMYLPHENYL)-3-METHOXYBENZOIC ACID; 4-(2-FORMYLPHENYL)-3-METHYLBENZOIC ACID; 4-(2-FORMYLPHENYL)NICOTINIC ACID; 4-(2-FORMYLPHENYL)PICOLINIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-2-CHLOROBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-2-FLUOROBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-2-HYDROXYBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-2-METHOXYBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-2-NITROBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-3-FLUOROBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-3-HYDROXYBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-3-METHOXYBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-3-METHYLBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)NICOTINIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)PICOLINIC ACID; 4-(2-OXOACETYL)BENZOIC ACID; 4-(3-CARBOXY-4-CHLOROPHENYL)-2-FORMYLPHENOL; 4-(3-CARBOXY-5-FLUOROPHENYL)-2-FORMYLPHENOL; 4-(3-FORMYL-1H-INDOL-5-YL)BENZOIC ACID; 4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-BENZENEACETIC ACID; 4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)BENZENECARBOXYLIC ACID; 4-(3-FORMYL-2,5-DIMETHYL-PYRROL-1-YL)-3-METHYL-BENZOIC ACID; 4-(3-FORMYL-4-NITRO-PHENOXY)-BUTYRIC ACID; 4-(3-FORMYLPHENOXY)BUTANOIC ACID; 4-(3-FORMYLPHENOXY)OXANE-4-CARBOXYLIC ACID; 4-(3-FORMYLPHENOXY)PENTANOIC ACID; 4-(3-FORMYLPHENOXY)THIANE-4-CARBOXYLIC ACID; 4-(3-FORMYLPHENOXYMETHYL)-1,3-THIAZOLE-2-CARBOXYLIC ACID; 4-(3-FORMYLPHENOXYMETHYL)-5-METHYLFURAN-2-CARBOXYLIC ACID; 4-(3-FORMYLPHENOXYMETHYL)BENZOIC ACID; 4-(3-FORMYLPHENYL)-2-HYDROXYBENZOIC ACID; 4-(3-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 4-(3-FORMYLPHENYL)-2-NITROBENZOIC ACID; 4-(3-FORMYLPHENYL)-3-HYDROXYBENZOIC ACID; 4-(3-FORMYLPHENYL)-3-METHOXYBENZOIC ACID; 4-(3-FORMYLPHENYL)-3-METHYLBENZOIC ACID; 4-(3-FORMYLPHENYL)NICOTINIC ACID; 4-(3-FORMYLPHENYL)PICOLINIC ACID; 4-(3-FORMYL-PYRIDIN-2-YL)-BENZOIC ACID; 4-(3-METHOXY-4-FORMYL)PHENOXYBUTYRIC ACID; 4-(3-OXOPROPYL)-BENZOIC ACID; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 4-(4-FORMYL-2-METHOXYPHENOXY)BUTANOIC ACID; 4-(4-FORMYL-3,5-DIMETHOXYPHENOXY)BUTYRIC ACID; 4-(4-FORMYLPHENOXY)BENZOIC ACID; 4-(4-FORMYLPHENOXY)BUTANOIC ACID; 4-(4-FORMYLPHENOXY)OXANE-4-CARBOXYLIC ACID; 4-(4-FORMYLPHENOXY)PENTANOIC ACID; 4-(4-FORMYLPHENOXY)THIANE-4-CARBOXYLIC ACID; 4-(4-FORMYLPHENOXYMETHYL)-1,3-THIAZOLE-2-CARBOXYLIC ACID; 4-(4-FORMYLPHENOXYMETHYL)-5-METHYLFURAN-2-CARBOXYLIC ACID; 4-(4-FORMYLPHENOXYMETHYL)BENZOIC ACID; 4-(4-FORMYLPHENYL)-2-HYDROXYBENZOIC ACID; 4-(4-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 4-(4-FORMYLPHENYL)-2-NITROBENZOIC ACID; 4-(4-FORMYLPHENYL)-3-HYDROXYBENZOIC ACID; 4-(4-FORMYLPHENYL)-3-METHOXYBENZOIC ACID; 4-(4-FORMYLPHENYL)-3-METHYLBENZOIC ACID; 4-(4-FORMYLPHENYL)NICOTINIC ACID; 4-(4-FORMYLPHENYL)PICOLINIC ACID; 4-(5-CARBOXY-2-FLUOROPHENYL)-2-FORMYLPHENOL; 4-(5-FORMYL-2-FURYL)BENZOIC ACID; 4-(5-FORMYL-2-FURYL)THIOPHENE-2-CARBOXYLIC ACID; 4-(5-FORMYL-3-THIENYL)BENZOIC ACID; 4-(5-FORMYL-FURAN-2-YL)-2-HYDROXY-BENZOIC ACID; 4-(5-FORMYL-FURAN-2-YL)-3-METHYL-BENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-2-CHLOROBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-2-FLUOROBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-2-HYDROXYBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-2-METHOXYBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-2-NITROBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-3-FLUOROBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-3-HYDROXYBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-3-METHOXYBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-3-METHYLBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)BENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)NICOTINIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)PICOLINIC ACID; 4′-(BENZYLOXY)-3′-FORMYL[1,1-BIPHENYL]-3-CARBOXYLIC ACID; 4′-(BENZYLOXY)-3′-FORMYL[1,1-BIPHENYL]-4-CARBOXYLIC ACID; 4,5-DIOXOVALERIC ACID; 4-[(2,6-DICHLORO-4-FORMYLPHENOXY)METHYL]BENZOIC ACID; 4-[(2-BROMO-4-FORMYLPHENOXY)METHYL]BENZOIC ACID; 4-[(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)METHYL]BENZOIC ACID; 4-[(2-CHLORO-6-ETHOXY-4-FORMYLPHENOXY)METHYL]BENZOIC ACID; 4-[(2-FORMYL-6-METHOXYPHENOXY)METHYL]BENZOIC ACID; 4-[(2-FORMYLPHENOXY)METHYL]BENZOIC ACID; 4-[(3-FORMYLPHENOXY)METHYL]-5-METHYLISOXAZOLE-3-CARBOXYLIC ACID; 4-[(4-BROMO-2-FORMYLPHENOXY)METHYL]BENZOIC ACID; 4-[(4-FORMYL-2-METHOXYPHENOXY)METHYL]BENZOIC ACID; 4-[(4-FORMYL-3-HYDROXYPHENOXY)METHYL]BENZENECARBOXYLIC ACID; 4-[(4-FORMYLPHENOXY)METHYL]-5-METHYLISOXAZOLE-3-CARBOXYLIC ACID; 4-[(Z)-2-(3-FORMYL-4-HYDROXYPHENYL)DIAZENYL]BENZENECARBOXYLIC ACID; 4-[1-(HYDROXYMETHYLENE)-2-OXOETHYL]-3-NITROBENZOIC ACID; 4-[2-(3-FORMYL-INDOL-1-YL)-ACETYLAMINO]-BENZOIC ACID; 4-[3-(2-CHLOROPHENYL)-4-FORMYL-1H-PYRAZOL-1-YL]BENZOIC ACID; 4-[4-FORMYL-3-(4-METHOXYPHENYL)-1H-PYRAZOL-1-YL]BENZOIC ACID; 4-ACETYL-5-FORMYL-3-METHYL-PYRROLE-2-CARBOXYLIC ACID; 4-AMINO-2′-FORMYL[1,1-BIPHENYL]-3-CARBOXYLIC ACID; 4-AMINO-4′-FORMYL[1,1-BIPHENYL]-3-CARBOXYLIC ACID; 4-AMINO-PYRIDINE-3-CARBALDEHYDE TRIFLUOROACETATE; 4-BROMO-2-FORMYL-5-NITRO-BENZOIC ACID; 4-BROMO-2-FORMYLBENZOIC ACID; 4-BROMO-3-FORMYL-6-INDAZOLECARBOXYLIC ACID; 4-CARBONYLCYCLOHEXANECARBOXYLIC ACID; 4-CARBONYLPHENYLACETIC ACID; 4-CARBOXY-2,6-DIFLUOROBENZALDEHYDE; 4-CARBOXYBENZALDEHYDE; 4-CHLORO-2-(2-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-2-(3-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-2-(4-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-2-FORMYL-5-NITRO-BENZOIC ACID; 4-CHLORO-3-(2-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-3-(3-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-3-(4-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-3-(5-FORMYL-FURAN-2-YL)-BENZOIC ACID; 4-CHLORO-6-CARBOXYLIC ACID-3-(1H)INDAZOLE CARBOXALDEHYDE; 4-CYANO-2-FORMYLBENZOIC ACID; 4-CYCLOPROPOXY-2-FORMYLBENZOIC ACID; 4-CYCLOPROPOXY-2-FORMYLNICOTINIC ACID; 4-CYCLOPROPOXY-3-FORMYLBENZOIC ACID; 4-CYCLOPROPOXY-3-FORMYLPICOLINIC ACID; 4-CYCLOPROPOXY-5-FORMYLNICOTINIC ACID; 4-CYCLOPROPOXY-5-FORMYLPICOLINIC ACID; 4-CYCLOPROPOXY-6-FORMYLNICOTINIC ACID; 4-CYCLOPROPOXY-6-FORMYLPICOLINIC ACID; 4-ETHYL-5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FLUORO-2-(2-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-2-(3-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-2-(4-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-3-(2-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-3-(3-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-3-(4-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-3-FORMYL-6-INDAZOLECARBOXYLIC ACID; 4-FLUORO-3-FORMYL-BENZOIC ACID; 4-FLUORO-5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-[1,1-BIPHENYL]-2-CARBOXYLIC ACID; 4-FORMYL-1-(2-METHOXYPHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(2-METHYLPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(3-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(3-METHOXYPHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(3-METHYLPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(4-ISOPROPYLPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(4-METHOXYBENZYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(4-METHYLPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(MESITYLMETHYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1,2,5-TRIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-1-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(2-METHYLBENZYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(2-METHYLPHENYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(3-METHYLBENZYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(3-METHYLPHENYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(4-METHYLBENZYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(4-METHYLPHENYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2-HYDROXYBENZOIC ACID; 4′-FORMYL-2′ETHYLBIPHENYL-4-CARBOXYLIC ACID; 4-FORMYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-3-HYDROXYBENZOIC ACID; 4-FORMYL-3-METHOXY-PHENOXYACETIC ACID; 4-FORMYL-3-THIOPHENECARBOXYLIC ACID; 4′-FORMYL-4-HYDROXY[1,1′-BIPHENYL]-3-CARBOXYLIC ACID; 4-FORMYLBICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID; 4′-FORMYL-BIPHENYL-2-CARBOXYLIC ACID; 4′-FORMYLBIPHENYL-3-CARBOXYLIC ACID; 4′-FORMYL-BIPHENYL-4-CARBOXYLIC ACID; 4-FORMYLCINNAMIC ACID; 4-FORMYLNAPHTHALENE-1-CARBOXYLIC ACID; 4-FORMYLNICOTINIC ACID; 4-FORMYLPHENOXYACETIC ACID; 4-FORMYLQUINOLINE-6-CARBOXYLIC ACID; 4-FORMYLQUINOLINE-8-CARBOXYLIC ACID; 4-PIPERIDINECARBOXYLIC ACID, 4-FORMYL-; 4-PYRIMIDINECARBOXYLIC ACID, 5-FORMYL-; 5-((3-FORMYL-1H-INDOL-1-YL)METHYL)FURAN-2-CARBOXYLIC ACID; 5-(2-CARBOXYTHIOPHENE-4-YL)-2-FORMYLPHENOL; 5-(2-CHLORO-4-FORMYLPHENOXY)PENTANOIC ACID; 5-(2-CHLORO-4-FORMYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 5-(2-CHLORO-4-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 5-(2-CHLORO-4-FORMYLPHENOXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 5-(2-FORMYL-1H-PYRROL-1-YL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-(2-FORMYLPHENYL)-2-FUROIC ACID; 5-(2-FORMYLPHENYL)-2-HYDROXYISONICOTINIC ACID; 5-(2-FORMYLPHENYL)-2-HYDROXYNICOTINIC ACID; 5-(2-FORMYLPHENYL)-2-METHOXYNICOTINIC ACID; 5-(2-FORMYLPHENYL)-2-THIOPHENECARBOXYLIC ACID; 5-(2-FORMYLPHENYL)-6-HYDROXYNICOTINIC ACID; 5-(2-FORMYLPHENYL)NICOTINIC ACID; 5-(2-FORMYLPHENYL)-PICOLINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-AMINOISONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-AMINONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-CHLOROBENZOIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-CHLOROISONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-CHLORONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-FLUOROBENZOIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-HYDROXYISONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-HYDROXYNICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-METHOXYNICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-3-AMINOBENZOIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-6-HYDROXYNICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)NICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)PICOLINIC ACID; 5-(3-ALLYLOXY-4-FORMYL-PHENOXY)-PENTANOIC ACID; 5-(3-CARBOXY-4-CHLOROPHENYL)-2-FORMYLPHENOL; 5-(3-CARBOXY-5-FLUOROPHENYL)-2-FORMYLPHENOL; 5-(3-CARBOXYPHENYL)-2-FORMYLPHENOL; 5-(3-FORMYL-1H-INDOL-1-YL)THIOPHENE-2-CARBOXYLIC ACID; 5-(3-FORMYLPHENOXY)PENTANOIC ACID; 5-(3-FORMYLPHENOXYMETHYL)-1,2-OXAZOLE-3-CARBOXYLIC ACID; 5-(3-FORMYLPHENOXYMETHYL)-2-METHYLFURAN-3-CARBOXYLIC ACID; 5-(3-FORMYLPHENOXYMETHYL)-3-METHYLFURAN-2-CARBOXYLIC ACID; 5-(3-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 5-(3-FORMYLPHENOXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 5-(3-FORMYLPHENYL)-2-FUROIC ACID; 5-(3-FORMYLPHENYL)-2-HYDROXYISONICOTINIC ACID; 5-(3-FORMYLPHENYL)-2-HYDROXYNICOTINIC ACID; 5-(3-FORMYLPHENYL)-2-METHOXYNICOTINIC ACID; 5-(3-FORMYLPHENYL)-6-HYDROXYNICOTINIC ACID; 5-(3-FORMYLPHENYL)NICOTINIC ACID; 5-(3-FORMYLPHENYL)PICOLINIC ACID; 5-(4-CARBOXY-3-FLUOROPHENYL)-2-FORMYLPHENOL; 5-(4-CARBOXYPHENYL)-2-FORMYLPHENOL; 5-(4-FORMYL-3,5-DIMETHOXYPHENOXY)PENTANOIC ACID; 5-(4-FORMYL-3-HYDROXY-PHENOXY)-PENTANOIC ACID; 5-(4-FORMYLPHENOXY)PENTANOIC ACID; 5-(4-FORMYLPHENOXYMETHYL)-1,2-OXAZOLE-3-CARBOXYLIC ACID; 5-(4-FORMYLPHENOXYMETHYL)-2-METHYLFURAN-3-CARBOXYLIC ACID; 5-(4-FORMYLPHENOXYMETHYL)-3-METHYLFURAN-2-CARBOXYLIC ACID; 5-(4-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 5-(4-FORMYLPHENOXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 5-(4-FORMYLPHENYL)-2-FUROIC ACID; 5-(4-FORMYLPHENYL)-2-HYDROXYISONICOTINIC ACID; 5-(4-FORMYLPHENYL)-2-HYDROXYNICOTINIC ACID; 5-(4-FORMYLPHENYL)-2-METHOXYNICOTINIC ACID; 5-(4-FORMYLPHENYL)-6-HYDROXYNICOTINIC ACID; 5-(4-FORMYLPHENYL)NICOTINIC ACID; 5-(4-FORMYLPHENYL)-PICOLINIC ACID; 5-(5-CARBOXY-2-FLUOROPHENYL)-2-FORMYLPHENOL; 5-(5-FORMYL-2-FURYL)-2-HYDROXYBENZOIC ACID; 5-(5-FORMYL-2-FURYL)-2-METHYLBENZOIC ACID; 5-(5-FORMYL-2-THIENYL)-2-HYDROXYBENZOIC ACID; 5-(5-FORMYL-FURAN-2-YL)-THIOPHENE-2-CARBOXYLIC ACID; 5-(5-FORMYLPYRIDIN-2-YL)THIOPHENE-2-CARBOXYLIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-AMINOISONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-AMINONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-CHLOROBENZOIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-CHLOROISONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-CHLORONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-FLUOROBENZOIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-HYDROXYISONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-HYDROXYNICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-METHOXYNICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-3-AMINOBENZOIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-6-HYDROXYNICOTINIC ACID; 5-(5-FORMYL-THIOPHEN-2-YL)-FURAN-2-CARBOXYLIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)NICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)PICOLINIC ACID; 5-(5-FORMYL-THIOPHEN-3-YL)-FURAN-2-CARBOXYLIC ACID; 5-(6-FORMYLPYRIDIN-2-YL)THIOPHENE-2-CARBOXYLIC ACID; 5-[(2-FORMYL-6-METHOXYPHENOXY)METHYL]-2-FUROIC ACID; 5-[(2-FORMYLPHENOXY)METHYL]-2-FUROIC ACID; 5-[(3-FORMYLPHENOXY)METHYL]-2-FUROIC ACID; 5-[(4-FORMYLPHENOXY)METHYL]-2-FUROIC ACID; 5-BROMO-2-FORMYL-BENZOIC ACID; 5-BROMO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5-CARBOXYVANILLIN; 5-CHLORO-2-(3-OXOPROPYL)-BENZOIC ACID; 5-CHLORO-2-FORMYL-BENZOIC ACID; 5-CHLORO-3-(2-FORMYLPHENYL)BENZOIC ACID; 5-CHLORO-3-(3-FORMYLPHENYL)BENZOIC ACID; 5-CHLORO-3-(4-FORMYLPHENYL)BENZOIC ACID; 5-CHLORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5-CHLORO-4-FORMYL-1-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-CHLORO-4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-CYCLOPROPOXY-2-FORMYLBENZOIC ACID; 5-CYCLOPROPOXY-2-FORMYLISONICOTINIC ACID; 5-CYCLOPROPOXY-2-FORMYLNICOTINIC ACID; 5-CYCLOPROPOXY-3-FORMYLPICOLINIC ACID; 5-CYCLOPROPOXY-4-FORMYLNICOTINIC ACID; 5-CYCLOPROPOXY-4-FORMYLPICOLINIC ACID; 5-CYCLOPROPOXY-6-FORMYLNICOTINIC ACID; 5-CYCLOPROPOXY-6-FORMYLPICOLINIC ACID; 5-FLUORO-2-(2-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-2-(3-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-2-(4-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-2-FORMYLBENZOIC ACID; 5-FLUORO-3-(2-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-3-(3-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-3-(4-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5′-FORMYL-[2,2′]BIFURANYL-5-CARBOXYLIC ACID; 5′-FORMYL-[2,2]BITHIOPHENYL-5-CARBOXYLIC ACID; 5′-FORMYL-[2,3′]BITHIOPHENYL-5-CARBOXYLIC ACID; 5-FORMYL-1-BENZOFURAN-2-CARBOXYLIC ACID; 5-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-2,4-DIMETHOXY-BENZOIC ACID; 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-FORMYL-2-FURANCARBOXYLIC ACID; 5-FORMYL-2-METHOXYBENZOIC ACID; 5-FORMYL-2-PYRIDINECARBOXYLIC ACID; 5-FORMYL-2-THIOPHENECARBOXYLIC ACID; 5′-FORMYL-3,3′-BITHIOPHENE-5-CARBOXYLIC ACID; 5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-4-HYDROXYPICOLINIC ACID; 5-FORMYL-4-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-4-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-FORMYL-4-METHYLTHIOPHENE-2-CARBOXYLIC ACID; 5-FORMYL-4-PHENANTHRENECARBOXYLIC ACID; 5-FORMYLNICOTINIC ACID; 5-FORMYLSALICYLIC ACID; 5-FORMYL-THIAZOLE-4-CARBOXYLIC ACID; 5-FORMYLTHIOPHENE-3-CARBOXYLIC ACID; 5-THIAZOLECARBOXYLIC ACID, 2-FORMYL; 6-(2-CARBOXYTHIOPHENE-4-YL)-2-FORMYLPHENOL; 6-(2-FORMYLPHENYL)NICOTINIC ACID; 6-(2-FORMYLPHENYL)PICOLINIC ACID; 6-(2-FORMYLTHIOPHEN-4-YL)NICOTINIC ACID; 6-(2-FORMYLTHIOPHEN-4-YL)PICOLINIC ACID; 6-(3-CARBOXY-4-CHLOROPHENYL)-2-FORMYLPHENOL; 6-(3-CARBOXY-5-FLUOROPHENYL)-2-FORMYLPHENOL; 6-(3-CARBOXYPHENYL)-2-FORMYLPHENOL; 6-(3-FORMYLPHENYL)NICOTINIC ACID; 6-(3-FORMYLPHENYL)PICOLINIC ACID; 6-(4-CARBOXYPHENYL)-2-FORMYLPHENOL; 6-(4-FORMYLIMIDAZOL-2-YL)2,3-DIMETHOXYBENZOIC ACID; 6-(4-FORMYLPHENYL)NICOTINIC ACID; 6-(4-FORMYLPHENYL)PICOLINIC ACID; 6-(5-CARBOXY-2-FLUOROPHENYL)-2-FORMYLPHENOL; 6-(5-FORMYLTHIOPHEN-2-YL)NICOTINIC ACID; 6-(5-FORMYLTHIOPHEN-2-YL)PICOLINIC ACID; 6-AMINO-3-(2-FORMYLPHENYL)PICOLINIC ACID; 6-AMINO-3-(3-FORMYLPHENYL)PICOLINIC ACID; 6-AMINO-3-(4-FORMYLPHENYL)PICOLINIC ACID; 6-BROMO-3-FORMYL-4-INDAZOLECARBOXYLIC ACID; 6-CHLORO-2-(2-FORMYLPHENYL)BENZOIC ACID; 6-CHLORO-2-(3-FORMYLPHENYL)BENZOIC ACID; 6-CHLORO-2-(4-FORMYLPHENYL)BENZOIC ACID; 6-CHLORO-3-CARBOXALDEHYDE-(1H)INDAZOLE-4-CARBOXYLIC ACID; 6-FLUORO-2-(2-FORMYLPHENYL)BENZOIC ACID; 6-FLUORO-2-(3-FORMYLPHENYL)BENZOIC ACID; 6-FLUORO-2-(4-FORMYLPHENYL)BENZOIC ACID; 6-FLUORO-3-FORMYL-4-INDAZOLECARBOXYLIC ACID; 6-FORMYL-2,3-DIMETHOXYBENZOIC ACID; 6-FORMYLPYRIDINE-2-CARBOXYLIC ACID; 7-OXOHEPTANOIC ACID; 8-FORMYL-4H-1,3-BENZODIOXINE-6-CARBOXYLIC ACID; 9-OXONONANOIC ACID; AC-VAD-CHO; ALAHOPCIN; BUTYRAMIDO-MALONALDEHYDIC ACID; CHEMDIV-BB BB01-2130; D-(+)GLUCURONIC ACID; D-GLUCURONIC ACID, [6-14C]; EPSILON-PYRROLE-LYSINE; FORPHENICINE; GLYOXYLIC ACID; GLYOXYLIC ACID MONOHYDRATE; L-2-AMINOADIPATE 6-SEMIALDEHYDE; LABOTEST-BB LT00441298; L-IDURONIC ACID, SODIUM SALT; MORPHOLIN-4-YL-ACETALDEHYDE CF3CO2H; MUCOBROMIC ACID; MUCOCHLORIC ACID; MURAMIC ACID; MURAMIC ACID HYDRATE; N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINE; N-(5-FORMYLPYRIMIDIN-2-YL)-N-METHYLGLYCINE; N-ACETYLMURAMIC ACID; PHENACETURIC ACID,-ALPHA-FORMYL-ALPHA-METHYL-; SUCCINIC SEMIALDEHYDE; TRAUMATIN; TUCARESOL; VELARESOL

List No. 6 anilines: Anilines selected from the list of: 2-((5-[3-(DIMETHYLAMINO)PHENYL]-1,3,4-OXADIAZOL-2-YL)SULFANYL)ACETIC ACID; (3-DIMETHYLAMINO-PHENOXY)-ACETIC ACID; 5-OXO-(+/−)-TRANS-4-(2-(N,N-DIMETHYLAMINO)PHENYL)-PYRROLIDINE-2-CARBOXYLIC ACID; 5-OXO-(+/−)-TRANS-4-(3-(N,N-DIMETHYLAMINO)PHENYL)-PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-1-(TERT-BUTOXYCARBONYL)-4-[3-(DIMETHYL-AMINO)PHENOXY]-2-PYRROLIDINECARBOXYLIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]PROPANOIC ACID; 2-[3-(DIMETHYLAMINO)PHENOXY]PROPANOIC ACID; 2-[3-(DIMETHYLAMINO)PHENOXY]-3-METHYLBUTANOIC ACID; 4-[3-(DIMETHYLAMINO)PHENOXY]BUTANOIC ACID; 2-AMINO-3-[2-(DIMETHYLAMINO)PHENYL]PROPANOIC ACID; 3-[2-(DIMETHYLAMINO)PHENYL]-2-[(TERT-BUTOXY)CARBONYLAMINO]PROPANOIC ACID; (2S,4R)-4-[3-(DIMETHYLAMINO)PHENOXY]-1-[(1-TERT-BUTOXY)CARBONYL]PYRROLIDINE-2-CARBOXYLIC ACID; 2-(2-(DIMETHYLAMINO)PHENYL)ACETIC ACID; 2-(3-(DIMETHYLAMINO)PHENYL)ACETIC ACID; 3-(DIMETHYLAMINO)-BENZENEPROPANOIC ACID; (4S)-4-AMINO-4-[2-(DIMETHYLAMINO)PHENYL]BUTANOIC ACID; (5S)-5-AMINO-5-[2-(DIMETHYLAMINO)PHENYL]PENTANOIC ACID; (5R)-5-AMINO-5-[2-(DIMETHYLAMINO)PHENYL]PENTANOIC ACID; (4R)-4-AMINO-4-[2-(DIMETHYLAMINO)PHENYL]BUTANOIC ACID; 3-[2-(DIMETHYLAMINO)PHENYL]PROP-2-ENOIC ACID; 3-[2-CHLORO-6-(DIMETHYLAMINO)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[4-BROMO-2-(DIMETHYLAMINO)PHENYL]PROP-2-ENOIC ACID; 1-(4-AMINO-2-DIMETHYLAMINO-PHENYL)-ACETIC ACID; 2-([2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)ACETIC ACID; 3-([2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)PROPANOIC ACID; 2-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)ACETIC ACID; 4-([2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)BUTANOIC ACID; 2-((5-[3-(DIMETHYLAMINO)PHENYL]-4H-1,2,4-TRIAZOL-3-YL)SULFANYL)ACETIC ACID; 3-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)PROPANOIC ACID; (2E)-3-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)PROP-2-ENOIC ACID; 2-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 2-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 3-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)PROPANOIC ACID; 5-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)PENTANOIC ACID; (2E)-3-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)PROP-2-ENOIC ACID; 4-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)BUTANOIC ACID; 3-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)PROPANOIC ACID; 4-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)BUTANOIC ACID; 5-[3-(DIMETHYLAMINO)PHENOXY]PENTANOIC ACID; 2-(([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)METHOXY)ACETIC ACID; 2-(([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)METHOXY)ACETIC ACID; (2S)-2-AMINO-2-[2-(DIMETHYLAMINO)PHENYL]ACETIC ACID; (2R)-2-AMINO-2-[2-(DIMETHYLAMINO)PHENYL]ACETIC ACID; (2S)-2-AMINO-2-[3-(DIMETHYLAMINO)PHENYL]ACETIC ACID; (2R)-2-AMINO-2-[3-(DIMETHYLAMINO)PHENYL]ACETIC ACID; 2-[3-(DIMETHYLAMINO)PHENOXY]BUTANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-2-(METHYLAMINO)PROPANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-2-(ETHYLAMINO)PROPANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-2-(PROPYLAMINO)PROPANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-2-(PROPAN-2-YLAMINO)PROPANOIC ACID; 2-(CYCLOPROPYLAMINO)-3-[3-(DIMETHYLAMINO)PHENOXY]PROPANOIC ACID; [5-(3-DIMETHYLAMINO-PHENYL)-4-METHYL-4H-[1,2,4]TRIAZOL-3-YLSULFANYL]-ACETIC ACID; 2-AMINO-3-[3-(DIMETHYLAMINO)PHENOXY]PROPANOIC ACID; 2-([2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)PROPANOIC ACID; 2-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)PROPANOIC ACID; 2-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)ACETIC ACID; 4-[3-(DIMETHYLAMINO)PHENOXY]-2-(ETHYLAMINO)BUTANOIC ACID; 2-[3-(DIMETHYLAMINO)PHENOXY]CYCLOPENTANE-1-CARBOXYLIC ACID; 2-AMINO-4-[3-(DIMETHYLAMINO)PHENOXY]BUTANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]PENTANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-2-ETHOXYPROPANOIC ACID; 4-[3-(DIMETHYLAMINO)PHENOXY]-2-(METHYLAMINO)BUTANOIC ACID; 5-[3-(DIMETHYLAMINO)PHENOXYMETHYL]OXOLANE-2-CARBOXYLIC ACID; 4-[3-(DIMETHYLAMINO)PHENOXY]PENTANOIC ACID; 2-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)ACETIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-4,4,4-TRIFLUOROBUTANOIC ACID; 4-[3-(DIMETHYLAMINO)PHENOXY]-2-ETHOXYBUTANOIC ACID; 2-[3-(DIMETHYLAMINO)PHENOXY]CYCLOHEXANE-1-CARBOXYLIC ACID; [3-BENZOYL-2-(DIMETHYLAMINO)PHENYL]ACETIC ACID; 4-(2-PYRROLIDIN-1-YL-PHENYLCARBAMOYL)-BUTYRIC ACID; 2-AMINO-3-(2-PYRROLIDINYLPHENYL)PROPANOIC ACID; 2-[(TERT-BUTOXY)CARBONYLAMINO]-3-(2-PYRROLIDINYLPHENYL)PROPANOIC ACID; 1-PHENYLPYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-FLUOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-METHOXYPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-[3-(TRIFLUOROMETHYL)PHENYL]PYRROLIDINE-3-CARBOXYLIC ACID; 3-(1-PYRROLIDINYL)-BENZENEPROPANOIC ACID; 2-(1-PYRROLIDINYL)-BENZENEPROPANOIC ACID; (5R)-5-AMINO-5-(2-PYRROLIDINYLPHENYL)PENTANOIC ACID; (5S)-5-AMINO-5-(2-PYRROLIDINYLPHENYL)PENTANOIC ACID; (4R)-4-AMINO-4-(2-PYRROLIDINYLPHENYL)BUTANOIC ACID; (4S)-4-AMINO-4-(2-PYRROLIDINYLPHENYL)BUTANOIC ACID; 3-PYRROLIDINECARBOXYLIC ACID, 1-(2-CHLORO-3-HYDROXYPHENYL)-; (2E)-3-[2-CHLORO-6-(PYRROLIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 3-[2-(PYRROLIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[4-BROMO-2-(PYRROLIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 3-(([2-(PYRROLIDIN-1-YL)PHENYL]METHYL)AMINO)PROPANOIC ACID; 2-(([2-(PYRROLIDIN-1-YL)PHENYL]METHYL)AMINO)ACETIC ACID; 2-([2-(PYRROLIDIN-1-YL)PHENYL]SULFAMOYL)ACETIC ACID; (2E)-3-([2-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)PROP-2-ENOIC ACID; (2E)-3-([3-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)PROP-2-ENOIC ACID; 2-([3-(PYRROLIDIN-1-YL)PHENYL]SULFAMOYL)ACETIC ACID; 4-(([2-(PYRROLIDIN-1-YL)PHENYL]METHYL)AMINO)BUTANOIC ACID; 3-([3-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)PROPANOIC ACID; 3-([2-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)PROPANOIC ACID; 3-[2-CHLORO-6-(3-METHYLPYRROLIDIN-1-YL)PHENYL]DROP-2-ENOIC ACID; 3-[4-BROMO-2-(3-METHYLPYRROLIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 3-[2-(3-METHYLPYRROLIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (R)-[1-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-PYRROLIDIN-3-YLOXY]-ACETIC ACID; 4-([3-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)BUTANOIC ACID; 5-OXO-1-(2-PYRROLIDIN-1-YL-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID; 5-OXO-1-(3-PYRROLIDIN-1-YL-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-METHYL-3-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-FLUORO-5-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-[2-(TRIFLUOROMETHYL)PHENYL]PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-SULFAMOYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-[2-(METHYLSULFAMOYL)PHENYL]PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-METHYL-5-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CYANOPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-FLUORO-2-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYL-5-METHYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYL-3-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYL-5-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 2-([2-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)ACETIC ACID; 1-(5-FLUORO-2-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2,3-DIFLUORO-6-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(5-CHLORO-2-CYANOPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 2-([3-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)ACETIC ACID; 1-(2-CYANO-5-METHYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-CHLORO-2-CYANOPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID N-(2-PIPERIDIN-1-YL-PHENYL)-SUCCINAMIC ACID; 4-(2-PIPERIDIN-1-YL-PHENYLCARBAMOYL)-BUTYRIC ACID; 1-(2-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 2-AMINO-2-(1-PHENYLPIPERIDIN-4-YL)ACETIC ACID; TERT-BUTOXYCARBONYLAMINO-(1-PHENYL-PIPERIDIN-4-YL)-ACETIC ACID; [(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)]-(1-PHENYL-PIPERIDIN-4-YL)-ACETIC ACID; 2-(4-AMINO-1-(3-METHOXYPHENYL)PIPERIDIN-4-YL)ACETIC ACID; 2-(4-AMINO-1-PHENYLPIPERIDIN-4-YL)ACETIC ACID; 1-(2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-[2-(METHYLSULFONYL)PHENYL]PIPERIDINE-3-CARBOXYLIC ACID; 1-[2-(METHYLSULFONYL)PHENYL]PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CYANOPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-PHENYL-4-PIPERIDINECARBOXYLIC ACID; 2-AMINO-3-(2-PIPERIDYLPHENYL)PROPANOIC ACID; 2-[(TERT-BUTOXY)CARBONYLAMINO]-3-[2-(4-HYDROXYPIPERIDYL)PHENYL]PROPANOIC ACID; 2-[(TERT-BUTOXY)CARBONYLAMINO]-3-(2-PIPERIDYLPHENYL)PROPANOIC ACID; (S,S)-3-METHYL-1-(2-PIPERIDINOPHENYL)BUTYLAMINE, N-ACETYL-GLUTAMATE SALT; 2-(1-PHENYLPIPERIDIN-4-YLIDENE)ACETIC ACID; (E)-3-(2-(PIPERIDIN-1-YL)PHENYL)ACRYLIC ACID; 2-(1-PHENYLPIPERIDIN-4-YL)ACETIC ACID; 1-[(2-ISOPROPYLSULFONYL-5-TRIFLUOROMETHYL)PHENYL]PIPERIDINE-4-CARBOXYLIC ACID; 1-[(2-ISOPROPYLSULFONYL-5-TRIFLUOROMETHYL)PHENYL]PIPERIDINE-3-CARBOXYLIC ACID; 2-(1-(3-METHOXYPHENYL)PIPERIDIN-4-YLIDENE)ACETIC ACID; 2-(1-(3-METHOXYPHENYL)PIPERIDIN-4-YL)ACETIC ACID; 3-(1-PIPERIDINYL)-BENZENEPROPANOIC ACID; 2-(1-PIPERIDINYL)-BENZENEPROPANOIC ACID; (5R)-5-AMINO-5-(2-PIPERIDYLPHENYL)PENTANOIC ACID; (5S)-5-AMINO-5-(2-PIPERIDYLPHENYL)PENTANOIC ACID; (5R)-5-AMINO-5-[2-(4-HYDROXYPIPERIDYL)PHENYL]PENTANOIC ACID; (5S)-5-AMINO-5-[2-(4-HYDROXYPIPERIDYL)PHENYL]PENTANOIC ACID; 1-(5-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(5-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(5-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(3-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(3-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(3-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(5-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(5-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(5-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-CYANO-3-FLUOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-CHLORO-2-CYANOPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CYANO-3-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(2-CYANO-3-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(2-CYANO-3-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(3-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(3-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(5-CHLORO-2-CYANOPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(5-BROMO-2-CYANOPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-BROMO-2-CYANOPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(5-CYANO-2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(5-CYANO-2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (5)-1-(2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(5-CYANO-2-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; (S)-1-(2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(5-CYANO-2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (4R)-4-AMINO-4-(2-PIPERIDYLPHENYL)BUTANOIC ACID; (4S)-4-AMINO-4-(2-PIPERIDYLPHENYL)BUTANOIC ACID; (4R)-4-AMINO-4-[2-(4-HYDROXYPIPERIDYL)PHENYL]BUTANOIC ACID; (4S)-4-AMINO-4-[2-(4-HYDROXYPIPERIDYL)PHENYL]BUTANOIC ACID; (2E)-3-[4-BROMO-2-(PIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 1-(2-CARBAMOYLPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYLPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(5-CHLORO-2-NITROPHENYL)-4-PIPERIDINECARBOXYLIC ACID; (2E)-3-[2-CHLORO-6-(PIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(3-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(4-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 1-PHENYL-4-PIPERIDINAMINEACETATE; 1-(3-METHYLPHENYL)-4-PIPERIDINAMINEACETATE; 1-(2-FLUOROPHENYL)-4-PIPERIDINAMINEACETATE; 1-(3-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-SULFAMOYLPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; (2E)-3-[4-BROMO-2-(3-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(4-METHOXYPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(3-ETHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(3,5-DIMETHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[4-BROMO-2-(4-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 1-(2-SULFAMOYLPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (2E)-3-[2-CHLORO-6-(4-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-CHLORO-6-(3-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 1-(3-FLUORO-2-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-FLUORO-2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(3-FLUORO-5-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(3-FLUORO-5-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-AMINO-PHENYL)-PIPERIDINE-4-CARBOXYLIC ACID; 3-[2-(4-ETHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 3-[1-(2-CYANOPHENYL)PIPERIDIN-3-YL]PROPANOIC ACID; 1-[2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; 5-OXO-1-(2-PIPERIDIN-1-YL-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYL-5-METHYLPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 2-[1-(3-CHLORO-2-CYANOPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 2-[1-(2-NITROPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 1-(2-CARBAMOYL-5-CHLOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 2-([2-(PIPERIDIN-1-YL)PHENYL]CARBAMOYL)ACETIC ACID; 1-(5-FLUORO-2-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CYANO-5-METHYLPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-[2-(TRIFLUOROMETHYL)PHENYL]PIPERIDINE-4-CARBOXYLIC ACID; 2-[1-(2-CYANOPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 2-[1-(2-CYANO-5-METHYLPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 2-[1-(5-CHLORO-2-CYANOPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 3-[2-(4,4-DIMETHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 1-(2-CARBAMOYL-5-METHYLPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-METHYL-3-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-METHYL-5-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 2-[1-(3-NITROPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 1-(2-CYANO-5-METHYLPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYL-3-CHLOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 2-[1-(2-CARBAMOYLPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 3-[1-(2-CYANOPHENYL)PIPERIDIN-4-YL]PROPANOIC ACID; 1-(5-FLUORO-2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-METHYL-3-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-[2-(TRIFLUOROMETHYL)PHENYL]PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-METHYL-5-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CARBAMOYL-3-CHLOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CARBAMOYL-5-CHLOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-PHENYL-3-PIPERIDINECARBOXYLIC ACID 3-(HEXAHYDRO-1H-AZEPIN-1-YL)-BENZENEPROPANOIC ACID; 2-(HEXAHYDRO-1H-AZEPIN-1-YL)-BENZENEPROPANOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)-4-BROMOPHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)-6-CHLOROPHENYL]PROP-2-ENOIC ACID

List No. 7—crotonaldehydes: ALL-TRANS-RETINAL; 3-(2-FURYL)ACROLEIN; 2-NITROCINNAMALDEHYDE; CITRAL; TRANS-CINNAMALDEHYDE; 2-METHOXYCINNAMALDEHYDE; 4-DIMETHYLAMINOCINNAMALDEHYDE; CROTONALDEHYDE; 2,4-HEXADIENAL; TRANS,TRANS-2,4-HEPTADIENAL; TRANS,TRANS-2,4-NONADIENAL; TRANS,TRANS-2,4-DECADIENAL; TRANS-2-HEXENAL; TRANS-2-HEPTENAL; TRANS-2-OCTENAL; 4-NITROCINNAMALDEHYDE; TRANS-2-NONENAL; 3,3-DIPHENYLACROLEIN; TRANS-2-PENTENAL; 3-(5-NITRO-2-FURYL)ACROLEIN; 3-METHYL-2-BUTENAL; TRANS,TRANS-5-(4-(DIMETHYLAMINO)PHENYL)-2,4-PENTADIENAL; (2E,4E)-5-(4-NITRO-PHENYL)-PENTA-2,4-DIENAL; TRANS-2-DODECENAL; FEMA 3082; 2,4-OCTADIENAL; TRANS,TRANS-2,4-UNDECADIENAL; TRANS,TRANS-2,4-DODECADIENAL; TRANS-2-DECENAL; TRANS-2-UNDECENAL; 2-TRANS-6-CIS-DODECADIENAL; 4-METHOXYCINNAMALDEHYDE; 3-(THIOPHEN-2-YL)ACRYLALDEHYDE; (4-OXO-2-BUTEN-1-YL)TRIPHENYLPHOSPHONIUM BROMIDE; (1,3,3-TRIMETHYL-1,3-DIHYDRO-INDOL-2-YLIDENE)-ACETALDEHYDE; FARNESAL; TETRABUTYLAMMONIUM GLUTACONALDEHYDE ENOLATE; 3-CHLORO-3-PHENYL-PROPENAL; 2-BENZAMIDOCINNAMALDEHYDE; 2-(1,3,3-TRIMETHYLINDOLIN-2-YLIDENE)ACETALDEHYDE; METHYL-(5S,6S)-EPOXY-11-OXO-(7E,9E)-UNDECADIENOATE; 4-HYDROXY-3-METHOXYCINNAMALDEHYDE; TRANS-4-(DIETHYLAMINO)CINNAMALDEHYDE; SINAPINALDEHYDE; 13-CIS-RETINAL; (Z)-3-CHLORO-3-PHENYLACRYLALDEHYDE; (Z)-3-CHLORO-3-(4-FLUOROPHENYL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-(4-METHOXYPHENYL)ACRYLALDEHYDE; 9-CIS-RETINAL; 11-CIS RETINAL; 3-NITROCINNAMALDEHYDE; TRANS-2-TETRADECENAL; 4-CHLOROCINNAMALDEHYDE; BETA-(4-PYRIDYL)ACROLEIN OXALATE; FUMARALDEHYDE MONO(DIMETHYL ACETAL); 3-CHLORO-3-(P-CHLOROPHENYL)ACROLEIN; FUMARALDEHYDIC ACID METHYL ESTER; TRANS,TRANS-2,6-NONADIENAL; (Z)-3,7-DIMETHYLOCTA-2,6-DIENAL; TRANS,TRANSMUCONALDEHYDE; ETHYL TRANS-4-OXO-2-BUTENOATE; DIMETHYL DECADIENAL; 4-ACETOXY-3-METHOXYCINNAMALDEHYDE; DECA-2,4,6,8-TETRAENAL; 3,3-DIMETHYLCYCLOHEXYLIDENEACETALDEHYDE; 11-(2-FURYL)UNDECA-2,4,6,8,10-PENTAENAL; 3-(1-ACETYL-1H-INDOL-3-YL)ACRYLALDEHYDE; ETHYL CITRAL; 4-OXO-3-(3-OXOPROP-1-ENYL)-4H-CHROMEN-6-YL ACETATE; 3-(7-METHYL-4-OXO-4H-CHROMEN-3-YL)ACRYLALDEHYDE; 4-OXO-3-(3-OXOPROP-1-ENYL)-4H-CHROMEN-7-YL ACETATE; 3-(1-OXO-1H-BENZO[F]CHROMEN-2-YL)ACRYLALDEHYDE; 3-(4-TERT-BUTYL-PHENYL)-PROPENAL; LIMONENAL; (2E,4E,6E)-6-(3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE)HEXA-2,4-DIENAL; (E)-3,7-DIMETHYL-4-(3-METHYLBUT-2-EN-1-YL)OCTA-2,6-DIENAL; 3,4,5-TRIMETHOXYCINNAMALDEHYDE; 4-HYDROXYCINNAMALDEHYDE; 4-METHYL-2-PENTENAL; CIS-2-HEXENAL; 3-CHLORO-3-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)ACRYLALDEHYDE; 4-KETORETINAL; (E)-4-HYDROXYHEXENAL; 1-(3-OXO-1-PROPENYL)-2-NAPHTHYL ACETATE; 3-BROMOCINNAMALDEHYDE; 2-CHLOROCINNAMALDEHYDE; ETHYL 3,5-DIMETHYL-4-(3-OXOPROP-1-ENYL)-1H-PYRROLE-2-CARBOXYLATE; 2-[(1E)-3-OXOPROP-1-EN-1-YL]PHENYL ACETATE; 3-CHLORO-3-(4-NITROPHENYL)ACRYLALDEHYDE; (2E)-3-(4-BROMOPHENYL)-3-CHLOROACRYLALDEHYDE; 3-CHLORO-3-(4-CHLOROPHENYL)ACROLEIN; 2-HYDROXYCINNAMALDEHYDE; 4-HYDROPEROXY-2-NONENAL; ETHYL 2-AMINO-5-(3-OXOPROP-1-ENYL)-3-FUROATE; 2-HEXENAL; 3-AMINO-2-BUTENAL; 3-(3-PYRIDYL)ACROLEIN; (Z)-3-CHLORO-3-(4-NITROPHENYL)ACRYLALDEHYDE; (5-METHYL-2,4-DIPHENYL-6H-1,3-OXAZIN-6-YLIDENE)ACETALDEHYDE; (2E,4E)-5-(4-FLUOROPHENYL)-2,4-PENTADIENAL; 4-BROMOCINNAMALDEHYDE; AURORA KA-3085; (1-CHLORO-2-FORMYLVINYL)FERROCENE; 4-DIBUTYLAMINOCINNAMALDEHYDE; 4-FLUOROCINNAMALDEHYDE; (E)-3-[3′-(4″-FLUOROPHENYL)-1′-(1″-METHYLETHYL)-1H-INDOL-2″-YL]-2-PROPNAL; (2E)-3-(1H-PYRROL-2-YL)-2-PROPENAL; 4-HYDROXYRETINAL; GRANDLURE; 3-(5-METHYL-2-PHENYL-3-INDOLIZINYL)-3-PHENYLACRYLALDEHYDE; 3-(5-METHYL-2-PHENYL-3-INDOLIZINYL)ACRYLALDEHYDE; 3-(4-[6-(3-OXO-1-PROPENYL)IMIDAZO[1,2-A]PYRIDIN-2-YL]PHENYL)ACRYLALDEHYDE; (2E,4E)-5-(4-CHLOROPHENYL)-2,4-PENTADIENAL; TRAUMATIN; (Z)-3,5-DIMETHYLHEX-2-ENAL; (E)-3,4,8-TRIMETHYL-NONA-2,7-DIENAL; (Z)-3,7-DIMETHYL-OCTA-2,7-DIENAL; (2E)-3-(1-BENZYL-1H-1,2,3-TRIAZOL-4-YL)ACRYLALDEHYDE; 4-ISOPROPYLCINNAMALDEHYDE; 2,4,6-TRIMETHYLCINNAMALDEHYDE; (2E)-3-[5-(4-METHYL-3-NITROPHENYL)-2-FURYL]ACRYLALDEHYDE; (2Z)-3-(2-MERCAPTO-1H-BENZIMIDAZOL-1-YL)-3-PHENYLACRYLALDEHYDE; (2E)-3-[5-(3-NITROPHENYL)-2-FURYL]ACRYLALDEHYDE; (2E)-3-[5-(2-CHLOROPHENYL)-2-FURYL]ACRYLALDEHYDE; (2E)-3-[5-(3-CHLORO-4-METHYLPHENYL)-2-FURYL]ACRYLALDEHYDE; (2E)-3-[5-(4-CHLOROPHENYL)-2-FURYL]ACRYLALDEHYDE; 2,6-DIFLUOROCINNAMIC ALDEHYDE; 4-(TRIFLUOROMETHOXY)CINNAMIC ALDEHYDE; 2-CHLORO-4-FLUOROCINNAMALDEHYDE; ALL-TRANS-3-HYDROXYRETINAL; CINNAMALDEHYDE-UL (RING-14C); 3-[(2R,3R)-3-PENTYLOXIRANYL]-2E-PROPENAL; 4-OXO 2-NONENAL-D3; 4-(2-FORMYLVINYL)BENZONITRILE; (+/−)-4-HYDROXY-9,9,9-D3-NON-2E-ENAL; 4-OXO-2-NONENAL; 2-CHLORO-6-FLUOROCINNAMALDEHYDE; 3-CHLOROCINNAMALDEHYDE; 2,3-DIMETHOXYCINNAMALDEHYDE; 2,3-DICHLOROCINNAMALDEHYDE; 2,4-DIFLUOROCINNAMALDEHYDE; 4-PHENYLCINNAMALDEHYDE; 2-FLUOROCINNAMALDEHYDE; 2-PROPENAL, 3-(3-METHYLPHENYL)-,(2E); 3-FLUOROCINNAMALDEHYDE; 2-PROPENAL, 3-(4-METHYLPHENYL)-,(2E); 2-METHYLCINNAMALDEHYDE; 2-PROPENAL, 3-(4-(ACETYLOXY)PHENYL)-,(2E); 4-OXO-2-HEXENAL; 3-(2-HYDROXY-NAPHTHALEN-1-YL)-PROPENAL; (2Z)-3-(4-BROMOPHENYL)-3-CHLOROACRYLALDEHYDE; 3-METHYL-HEX-2-ENAL; (E)-3,6-DIMETHYL-HEPTA-2,5-DIENAL; 3-(NAPHTHALEN-2-YL)ACRYLALDEHYDE; 2-BROMOCINNAMALDEHYDE; (2E,13Z)-OCTADECA-2,13-DIENAL; (2E)-OCTADEC-2-ENAL; 3-(TRIFLUOROMETHYL)CINNAMALDEHYDE; (E)-3-[5-TERT-BUTYLDIMETHYLSILYLOXYMETHYL-2,6-DIISOPROPYL-4-(4-FLUOROPHENYL)-PYRID-3-YL]-PROP-2-ENAL; 3-(9-ANTHRYL)ACROLEIN; (E,E,E)-2,4,6-OCTATRIENAL; 4-(TRIFLUOROMETHYL)CINNAMALDEHYDE; 5-PROP-2-ENAL-1,2:3,4-DI-O-ISOPROPYLIDENE-A-D-GALACTOPYRANOSE; (E)-3-((3AR,6S,6AR)-6-(BENZYLOXY)-TETRAHYDRO-2,2-DIMETHYLFURO[3,2-D][1,3]DIOXOL-5-YL)ACRYLALDEHYDE; (2Z)-3-[(4S)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]PROP-2-ENAL; (2Z)-3-[(4R)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]PROP-2-ENAL; (2E)-3-[6-(BENZYLOXY)-2,2-DIMETHYLTETRAHYDROFURO[3,4-D][1,3]DIOXOL-4-YL]PROP-2-ENAL; (E)-4-(METHYL-PHENYL-AMINO)-BUT-2-ENAL; 3-METHYL-5-[(2,6,6-TRIMETHYLCYCLOHEX-3,3,7,7,7-D5)-1-ENYL]PENTA-2,4-DIENAL; 3-HYDROXYRETINAL-D5; 3-(4-AZIDOPHENYL)ACRYLALDEHYDE; (E)-5,9-ANHYDRO-6,7-O-CYCLOHEXYLIDENE-2,3,4,8-TETRADEOXY-8-C-(ETHOXYCARBONYL)METHYL-3-METHYL-D-ALLO-NON-2-ENAL; (E)-3-[2-CYCLOPROPYL-4-(4-FLUOROPHENYL)-3-QUINOLINYL]-2-PROPENAL; 3-(3-METHOXYPHENYL)ACRYLALDEHYDE; 3-(2-(TRIFLUOROMETHYL)PHENYL)ACRYLALDEHYDE; 4,4-DIMETHYLPENT-2-ENAL; (2E,4E)-7-[(4-METHOXYBENZYL)OXY]-2,4-HEPTADIENAL; (E)-2-HEXADECENAL; (2E,4E)-5-(4-METHOXY-2,3,6-TRIMETHYLPHENYL)-3-METHYLPENTA-2,4-DIENAL; (2E)-3-(5-CHLORO-2-FURYL)ACRYLALDEHYDE; (2E)-3-(5-BROMO-2-FURYL)ACRYLALDEHYDE; 2-(THIETAN-3-YLIDENE)ACETALDEHYDE; 2-(OXETAN-3-YLIDENE)ACETALDEHYDE; 2,4-PENTADIENAL; NONA-2,4,6-TRIENAL; (2Z)-3-(1H-PYRROL-2-YL)-2-PROPENAL; (2E)-3-(3-INDOLIZINYL)-2-PROPENAL; (2E)-3-(1-METHYL-1H-PYRROL-2-YL)-2-PROPENAL; (2E)-3-(1-INDOLIZINYL)-2-PROPENAL; (E)-3-(1-METHYL-5-OXO-2,5-DIHYDRO-1H-PYRROL-3-YL)ACRYLALDEHYDE; (2E)-3-(1H-INDOL-3-YL)-2-PROPENAL; (2E)-3-(1H-PYRROLO[2,3-B]PYRIDIN-3-YL)-2-PROPENAL; (Z)-2-(3,4-DIHYDROPYRROLO[1,2-A]PYRAZIN-1(2H)-YLIDENE)ACETALDEHYDE; (E)-3-(1H-INDOL-2-YL)-2-PROPENAL; (2E)-(3,5,5-TRIMETHYLCYCLOHEX-2-EN-1-YLIDENE)ACETALDEHYDE; 2-BUTENAL, 3-CHLORO-4-OXO-4-PHENYL-, (E)-; 3-(2-PYRIDINYL)-2-PROPENAL; (2E)-3-(2-PYRIDINYL)-2-PROPENAL; (Z)-3-CHLORO-3-(THIOPHEN-3-YL)ACRYLALDEHYDE; (Z)-3-(2,5-DIHYDRO-1-METHYL-5-OXO-1H-PYRROL-3-YL)-2-PROPENAL; 2-((3,4-DIHYDRO-1(2H)-ISOQUINOLINYLIDENE)-ACETALDEHYDE); 2-CYCLOHEPTYLIDENEACETALDEHYDE; (E)-(1-METHYL-2-PIPERIDINYLIDENE)-ACETALDEHYDE; 3-(3-TERT-BUTYL-5-ISOPROPYLPHENYL)BUT-2-ENAL; (Z)-2-BROMO-4-OXO-BUT-2-ENOIC ACID ETHYL ESTER; TRANS,TRANS-5-BROMO-2,4-PENTADIENAL; 3-(5-CHLORO-2-HYDROXY-3-METHOXY-PHENYL)-PROPENAL; 3-(2,3-DICHLORO-6-HYDROXY-5-METHOXY-PHENYL)-PROPENAL; DIBROMO-5-ETHOXY-6-HYDROXY-PHENYL)-PROPENAL; 3-(5-CHLORO-2-HYDROXY-3-NITRO-PHENYL)-PROPENAL; 3-(5-BROMO-2-HYDROXY-3-NITRO-PHENYL)-PROPENAL; 3-(5-BENZYL-3-BROMO-2-HYDROXY-PHENYL)-PROPENAL; 3-(3-BROMO-5-CHLORO-2-HYDROXY-PHENYL)-PROPENAL; 3-(5-BENZYL-2-HYDROXY-3-NITRO-PHENYL)-PROPENAL; 3-(2-HYDROXY-5-NITRO-PHENYL)-PROPENAL; 3-(3,5-DICHLORO-2-HYDROXY-PHENYL)-PROPENAL; 3-(3-BROMO-2-HYDROXY-5-NITRO-PHENYL)-PROPENAL; 3-(5-CHLORO-2-HYDROXY-PHENYL)-PROPENAL; 3-(5-BROMO-2-HYDROXY-PHENYL)-PROPENAL; 3-(3,5-DIBROMO-2-HYDROXY-PHENYL)-PROPENAL; 3-(5-BROMO-2-HYDROXY-3-METHOXY-PHENYL)-PROPENAL; 3-(2-HYDROXY-3-NITRO-PHENYL)-PROPENAL; 3-(5-BENZYL-3-CHLORO-2-HYDROXY-PHENYL)-PROPENAL; 3-(5-BROMO-3-CHLORO-2-HYDROXY-PHENYL)-PROPENAL; 3-(2-HYDROXY-3-METHOXY-5-NITRO-PHENYL)-PROPENAL; 3-(5-BENZYL-2-HYDROXY-PHENYL)-PROPENAL; (E)-3-[2-CYCLOPROPYL-4-(4-FLUOROPHENYL)-3-QUINOLYL]-ACROLEIN; (2E)-3-(2-FURANYL)-2-BUTENAL; (2Z)-3-(3-FURANYL)-2-BUTENAL; (E)-5-(3-OXOPROP-1-ENYL)FURAN-2-CARBALDEHYDE; (E)-3-(5-AMINOFURAN-2-YL)ACRYLALDEHYDE; (2Z)-3-(2-FURANYL)-2-BUTENAL; (2E)-3-(2,5-DIHYDRO-5-OXO-2-FURANYL)-2-PROPENAL; (2E)-3-(4-NITRO-2-FURANYL)-2-PROPENAL; (2Z)-3-(2-FURANYL)-2-PROPENAL; (2E)-3-(3-BENZOFURANYL)-2-PROPENAL; (2E)-3-(5-METHYL-2-FURANYL)-2-PROPENAL; (2E)-3-(2-CHLORO-4-METHOXYPHENYL)-2-PROPENAL; (2E)-3-CYCLOPENTYL-2-PROPENAL; (2Z,4E)-4-(3′,4′-DIHYDRO-1′(2′H)-NAPHTHALEN-1′YLIDENE)-3-METHYL-2-BUTENAL; 3-(1H-BENZOIMIDAZOL-2-YLSULFANYL)-3-PHENYL-PROPENAL; (Z)-3-CHLORO-3-P-TOLYLACRYLALDEHYDE; TERT-BUTYL 4-(2-OXOETHYLIDENE)PIPERIDINE-1-CARBOXYLATE; TERT-BUTYL 3-[(1E)-3-OXOPROP-1-ENYL]AZETIDINE-1-CARBOXYLATE; (Z)-3-CHLORO-3-(3-CHLOROPHENYL)ACRYLALDEHYDE; 4-(2-FORMYLVINYL)-ACETANILIDE; N-[4-(4-FLUOROPHENYL)-6-(1-METHYLETHYL)-5-[(1E)-3-OXO-1-PROPEN-1-YL]-2-PYRIMIDINYL]-N-METHYLMETHANESULFONAMIDE; (E)-2-(2-FURANYL)-2-BUTENEDIAL; (E)-2-(5-METHYL-2-FURANYL)-2-BUTENEDIAL; 4-HYDROXY NONENAL ALKYNE; 3-(2-PYRIDINYL)-2-BUTENAL; (2E)-3-(4-PYRIDINYL)-2-PROPENAL; 3-(HEXAHYDRO-1H-AZEPIN-1-YL)-BENZENEPROPANOIC ACID; 2-(HEXAHYDRO-1H-AZEPIN-1-YL)-BENZENEPROPANOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)-4-BROMOPHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)-6-CHLOROPHENYL]PROP-2-ENOIC ACID

List No. 8—Methylketones: CIS-PINONIC ACID; 2-ACETYLBENZOIC ACID; 4-ACETYLBENZOIC ACID; LEVULINIC ACID; 4,6-DIOXOHEPTANOIC ACID; 4-ACETYLBUTYRIC ACID; N-(ACETOACETYL)GLYCINE; DIACETONEAMINE HYDROGEN OXALATE; 5-ACETYLSALICYLIC ACID; 3-ACETYLACRYLIC ACID; 4-ACETYLPHENOXYACETIC ACID; (4-ACETYLPHENYL)ACETIC ACID; 2-PHENYLLEVULINIC ACID; 4-ACETYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-CARBOXYDEHYDROACETIC ACID; 3,3-DIMETHYL-4-OXOVALERIC ACID; 5-[(4-ACETYLPHENYL)AMINO]-5-OXOPENTANOIC ACID; 3-ACETYLBENZOIC ACID; 5-ACETYLVALERIC ACID; A-ACETYLMANDELIC ACID; ACETOACETIC ACID; 5-ACETYLTHIOPHENE-2-CARBOXYLIC ACID; ACETYLPYRUVIC ACID; 2-(3-ACETYL-2,2-DIMETHYLCYCLOBUTYL)ACETIC ACID; 7-OXOOCTANOIC ACID; 5,7-DIOXOOCTANOIC ACID; N-(ACETOACETYL)ANTHRANILIC ACID; 10-OXOUNDECANOIC ACID; 4-[(2-ACETYL-3-THIENYL)AMINO]-4-OXOBUT-2-ENOIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL]SULFANYL)ACETIC ACID; 2-(([(2-ACETYLPHENYL)CARBAMOYL]METHYL)SULFANYL)ACETIC ACID; 2-(1-ACETYL-2-OXOPROPYL)-5-METHOXYBENZOIC ACID; 2-ACETYLPHENOXY ACETIC ACID; 3-METHYL-4-OXO-2-PENTENOIC ACID; BETA-METHYLLEVULINIC ACID; 2-METHYL-4-OXOPENTANOIC ACID; DIACETONAMINE HYDROGEN OXALATE HYDRATE; 5-[(3-ACETYLPHENYL)AMINO]-5-OXOPENTANOIC ACID; 2-ACETYL-3,6-DIMETHYLBENZOIC ACID; 2-((3-OXO-2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]-1-BUTENYL)AMINO)ACETIC ACID; 2-(4-ACETYL-2,3-DIHYDRO-5-METHYL-2-OXO-1H-PYRROL-3-YL)ACETIC ACID; 4-(4-ACETYLANILINO)-4-OXO-2-BUTENOIC ACID; 9-OXODEC-2-ENOIC ACID; 2-ACETYLTHIAZOLE-4-CARBOXYLIC ACID; 5-ACETYL-2-AMINO-4-HYDROXYBENZOIC ACID; 5-ACETYL-4-HYDROXY-3-METHOXY-FURAN-2-CARBOXYLIC ACID; 4′-ACETYL-BIPHENYL-4-CARBOXYLIC ACID; 1-(4-ACETYLPHENYL)-4-PIPERIDINECARBOXYLIC ACID; (2-ACETYL-4,5-DIMETHOXYPHENYL)ACETIC ACID; 3-(2-OXO-PROPYL)-BENZOIC ACID; 4-(2-OXOPROPYL)BENZOIC ACID; 2-(1,1-DIMETHYL-2-OXO-PROPYL)-MALONIC ACID; 4-(4-ACETYLANILINO)-4-OXOBUTANOIC ACID; 5-OXO-3-PHENYL-HEXANOIC ACID; 4-(4-ACETYLPHENOXY)BENZOIC ACID; (E)-3-(5-ACETYL-FURAN-2-YL)ACRYLIC ACID; 3-ACETYL-4-HYDROXYBENZOIC ACID; [2-(2-OXOPROPOXY)PHENOXY]ACETIC ACID; 2-CYANO-3,3-DIMETHYL-4-OXO-PENTANOIC ACID; 4-ACETYL-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 3-ACETYL-2-OXO-1,2-DIHYDRO-QUINOLINE-4-CARBOXYLIC ACID; 3-ACETYL-4,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 2-[(4-ACETYLPHENYL)SULFANYL]ACETIC ACID; 2-ISOPROPYL-5-OXOHEXANOIC ACID; 4-KETOVALPROIC ACID; 5-OXO-2-PROPYL-HEXANOIC ACID; 2-ACETYL-3,6-DIFLUOROBENZOIC ACID; 3-ACETYL-2-METHYL-QUINOLINE-4-CARBOXYLIC ACID; 5-ACETYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-[(3-ACETYLPHENYL)AMINO]-4-OXOBUTANOIC ACID; (2E)-4-[(3-ACETYLPHENYL)AMINO]-4-OXOBUT-2-ENOIC ACID; 4-HYDROXY-2-METHYL-3-(3-OXO-BUTYL)-QUINOLINE-6-CARBOXYLIC ACID; 8-ACETYL-3A,4,5,9B-TETRAHYDRO-3H-CYCLOPENTA[C]QUINOLINE-4-CARBOXYLIC ACID; 3-METHYL-5-(2-OXO-PROPYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-CARBOXY-4-HYDROXYPHENYLACETONE; 4-ACETYL-3,5-DIOXO-1-METHYLCYCLOHEXANECARBOXYLIC ACID; (4-ACETYL-2-METHOXYPHENOXY)ACETIC ACID; 1-(4-ACETYL-PHENYL)-5-METHYL-1H-[1,2,3]TRIAZOLE-4-CARBOXYLIC ACID; 2-ACETYL-1H-INDOLE-3-CARBOXYLIC ACID; 5-ACETYL-2-ACETYLAMINO-4-METHYL-THIOPHENE-3-CARBOXYLIC ACID; 1-(4-ACETYLPHENYL)-5-OXOPYRROLIDINE-3-CARBOXYLIC ACID; 4-(2-ACETYL-3-OXO-1-BUTENYL)BENZENECARBOXYLIC ACID; N-(M-ACETYLPHENYL)ANTHRANILIC ACID; 2-(4-ACETYLPHENOXY)-2-METHYLPROPANOIC ACID; 4-[(2-ACETYLPHENYL)AMINO]-4-OXOBUTANOIC ACID; 3-ACETYLTHIOPHENE-2-CARBOXYLIC ACID; 9-OXODECANOIC ACID; 3-ACETYL-1H-INDOLE-2-CARBOXYLIC ACID; 2-(([(4-ACETYLPHENYL)CARBAMOYL]METHYL)SULFANYL)ACETIC ACID; 2′-ACETYL-2-BIPHENYLCARBOXYLIC ACID; 4-ACETYL-7-METHOXY-1-BENZOFURAN-2-CARBOXYLIC ACID; 2-(3-OXOBUTANAMIDO)PROPANOIC ACID; 4-METHYL-2-(3-OXOBUTANAMIDO)PENTANOIC ACID; 3-(3-OXOBUTANAMIDO)BENZOIC ACID; 4-(3-OXOBUTANAMIDO)BENZOIC ACID; (3-ACETYLPHENOXY)ACETIC ACID; 2-(2-OXOPROPYL)HEXANOIC ACID; 2-(2-OXOPROPYL)BENZOIC ACID; 2-METHYL-3-ACETYLBENZOIC ACID; 4-ACETYL-1H-PYRROLE-2-CARBOXYLIC ACID; 3-(2-HYDROXY-4,4-DIMETHYL-6-OXO-1-CYCLOHEXENYL)-4-OXOPENTANOIC ACID; 3-((4-OXOPENTANOYL)OXY)-2-PHENYLPROPANOIC ACID; MONO-(2-ETHYL-5-OXOHEXYL)-ADIPATE; (S)-2-TERT-BUTOXYCARBONYLAMINO-4-OXO-PENTANOIC ACID; 3-ACETYL-QUINOLINE-4-CARBOXYLIC ACID; 6-ACETYL-7-METHYL-PYRAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLIC ACID; 6-ACETYL-7-METHYL-PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID; (2-ACETYL-4-METHYLPHENOXY)ACETIC ACID; 4-((5-ACETYL-4-METHYL-1,3-THIAZOL-2-YL)AMINO)-4-OXOBUTANOIC ACID; 3-(2-CARBOXYPHENYL)PENTANE-2,4-DIONE; 4-ACETYL-1-CYCLOPROPYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-[(4-ACETYLPHENOXY)METHYL]-2-FUROIC ACID; 3-([(5-ACETYL-2-METHOXYPHENYL)METHYL]SULFANYL)PROPANOIC ACID; 1-(3-ACETYLPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID; 4-(4-ACETYL-PHENOXY)-BUTYRIC ACID; [(5-ACETYL-3-CYANO-6-METHYLPYRIDIN-2-YL)THIO]ACETIC ACID; 3-(4-ACETYLPHENOXY)PROPANOIC ACID; 3-(3-ACETYL-6-METHYL-4-OXO-4H-PYRAN-2-YLAMINO)-PROPIONIC ACID; 3′-ACETYL-BIPHENYL-2-CARBOXYLIC ACID; (3′-ACETYL-BIPHENYL-3-YL)-ACETIC ACID; 3′-ACETYL-BIPHENYL-3-CARBOXYLIC ACID; 3′-ACETYL-BIPHENYL-4-CARBOXYLIC ACID; (3′-ACETYL-BIPHENYL-4-YL)-ACETIC ACID; 3-METHYL-5-(3-OXOBUTYL)-1-BENZOFURAN-2-CARBOXYLIC ACID; O-(3-OXOBUTYL)-N-PROPYLHYDROXYLAMINE OXALATE SALT; (5-ACETYL-3-THIENYL)ACETIC ACID; 3-(3-ACETYL-BENZENESULFONYLAMINO)-PROPIONIC ACID; 4′-ACETYL-BIPHENYL-3-CARBOXYLIC ACID; (4-ACETYL-PIPERIDIN-1-YL)-ACETIC ACID; 2-[(5-ACETYL-4-METHYL-2-PYRIMIDINYL)SULFANYL]ACETIC ACID; 2,6-DIMETHOXY-4-GLYCOLIC ACID PHENYL ACETONE; (2S)-2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; (2S)-2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; (3-ACETYL-INDOL-1-YL)-ACETIC ACID; 1-(1,2-DIOXOPROPYL)-S-PROLINE; 2-ACETYL-3,4,5,6-TETRAFLUOROBENZOIC ACID; LABOTEST-BB LT03330740; 4-ACETYL-1-BENZYL-PYRROLIDINE-3-CARBOXYLIC ACID; 4-ACETYL-PYRROLIDINE-3-CARBOXYLIC ACID; 2-ACETONICOTINIC ACID; (3-ACETYL-2-METHYL-INDOL-1-YL)-ACETIC ACID; (3-ACETYL-7-ETHYL-INDOL-1-YL)-ACETIC ACID; 6-ACETYL-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID; 3-ACETYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 4-[(4-ACETYLPHENYL)CARBAMOYL]-3-METHYLBUTANOIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL]METHOXY)ACETIC ACID; 2-(([(3-ACETYLPHENYL)CARBAMOYL]METHYL)SULFANYL)ACETIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL]METHOXY)ACETIC ACID; 3-(4-ACETYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)BUTANOIC ACID; 3-(3-ACETYL-2,4-DIMETHYL-PYRROL-1-YL)-PROPIONIC ACID; 3-(4-ACETYL-3,5-DIMETHYL-PYRAZOL-1-YL)-PROPIONIC ACID; 3-AMINO-4-OXO-PENTANOIC ACID; 5-ACETYL-6-METHYL-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBOXYLIC ACID; 2-(4-ACETYLPHENOXY)PROPANOIC ACID; 2-([(4-ACETYLPHENYL)SULFONYL]AMINO)PROPANOIC ACID; ([(3-ACETYLPHENYL)SULFONYL]AMINO)ACETIC ACID; (5-ACETYL-2-METHOXYPHENYL)ACETIC ACID; 2-(2-OXOPROPYLTHIO)BENZOIC ACID; 2-[(4-ACETYL-2-FLUOROPHENYL)SULFANYL]ACETIC ACID; ([(4-ACETYLPHENYL)SULFONYL]AMINO)ACETIC ACID; 5-(4-ACETYLPHENYL)-2-FUROIC ACID; 3-([(4-ACETYLPHENYL)SULFONYL]AMINO)PROPANOIC ACID; 2-(4-ACETYLPHENOXY)-2-PHENYLACETIC ACID; L-4-ACETYLPHE; (4-ACETYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETIC ACID; 3-(4-ACETYL-3,5-DIMETHYL-PYRAZOL-1-YL)-2-METHYL-PROPIONIC ACID; (4-ACETYLANILINO)ACETIC ACID; 5-ACETYL-3-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 7-ACETYL-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID; 2-(2-ACETYL-4-ETHYLPHENOXY)ACETIC ACID; 2′-ACETYLBIPHENYL-3-CARBOXYLIC ACID; 2′-ACETYL[1,1′-BIPHENYL]-4-CARBOXYLIC ACID; 4-(5-ACETYL-2-THIENYL)BENZOIC ACID; 3-(5-ACETYL-2-THIENYL)BENZOIC ACID; 3-(3-ACETYL-INDOL-1-YL)-PROPIONIC ACID; 2-(3-ACETYL-1H-INDOL-1-YL)PROPANOIC ACID; [5-ACETYL-3-(METHOXYCARBONYL)-4-METHYL-1H-PYRROL-2-YL]ACETIC ACID; 4-[(5-ACETYL-4-METHYL-1,3-THIAZOL-2-YL)AMINO]BUTANOIC ACID; (S)-2-AMINO-5-OXO-HEXANOIC ACID, HYDROBROMIDE; (2Z)-4-((4-ACETYLPHENYL)AMINO)-3-METHYL-4-OXOBUT-2-ENOIC ACID; 3-(4-ACETYL-5-METHYL-2-FURYL)PROPANOIC ACID; 5-ACETYLTHIOPHENE-3-CARBOXYLIC ACID; 3-(3-ACETYL-2,5-DIMETHYL-PYRROL-1-YLMETHYL)-BENZOIC ACID; 4-(3-ACETYL-2,5-DIMETHYL-PYRROL-1-YLMETHYL)-BENZOIC ACID; (1-(4-ACETYLPHENYL)-2-OXOHYDRAZINO)ACETIC ACID; DL-3-(P-ACETYLPHENYL)-ALANINE; 2-METHYLACETOACETIC ACID; (3AR,4S,9BS)-8-ACETYL-3A,4,5,9B-TETRAHYDRO-3H-CYCLOPENTA[C]QUINOLINE-4-CARBOXYLIC ACID; 2-ACETYL-3-(4-ETHYLPHENYL)BUTANOIC ACID; 3-(4-ACETYL-PHENYL)-2-AMINO-PROPIONIC ACID HYDROCHLORIDE; [(4-ACETYLBENZYL)OXY]ACETIC ACID; 3-ACETYL-5-NITROBENZOIC ACID; 3-ACETYLADAMANTANE-1-CARBOXYLIC ACID; 2-(3-ACETYL-1H-INDOL-1-YL)BUTANOIC ACID; 4-(3-ACETYL-2,5-DIMETHYL-1H-PYRROL-1-YL)BENZOIC ACID; [2-(2-ACETYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(3-ACETYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(4-ACETYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; 2-ACETYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 5-ACETYL-1H-INDOLE-2-CARBOXYLIC ACID; 7-ACETYL-2-INDOLE CARBOXYLIC ACID; (S)-3-(3-ACETYL-4-HYDROXY-PHENYL)-2-HYDROXY-PROPIONIC ACID; (2S)-3-(3-ACETYL-4-HYDROXYPHENYL)-2-AMINOPROPANOIC ACID; 3-ACETYL-1H-INDOLE-5-CARBOXYLIC ACID; 2-METHYL-6-OXO-HEPTANOIC ACID; (3-ACETYL-2-METHYL-5-PHENYL-1H-PYRROL-1-YL)ACETIC ACID; 5-ACETYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-(2-ACETYL-PHENOXY)-BUTYRIC ACID; 1-(3-ACETYL-PHENYL)-5-METHYL-1H-[1, 2, 3]TRIAZOLE-4-CARBOXYLIC ACID; 1-(3-ACETYL-PHENYL)-5-ISOPROPYL-1H-[1, 2, 3]TRIAZOLE-4-CARBOXYLIC ACID; 1-(3-ACETYL-PHENYL)-5-ETHYL-1H-[1, 2, 3]TRIAZOLE-4-CARBOXYLIC ACID; 1-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]PYRROLIDINE-2-CARBOXYLIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]-3-METHYLBUTANOIC ACID; 6-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]HEXANOIC ACID; 2-(4-ACETYL-2-METHOXYPHENOXY)PROPANOIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 2-[4-(3-OXOBUTYL)PHENOXY]PROPANOIC ACID; 3-(3-ACETYLPHENOXY)PROPANOIC ACID; 2-(3-ACETYLPHENOXY)PROPANOIC ACID; 2-[4-(3-OXOBUTYL)PHENOXY]Acetic ACID; 4-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]BUTANOIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-4-METHYLPENTANOIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3-METHYLBUTANOIC ACID; 1-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]PIPERIDINE-3-CARBOXYLIC ACID; 3-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]BUTANOIC ACID; 4-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]BUTANOIC ACID; 3-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID; 3-(4-ACETYL-2-METHOXYPHENOXY)PROPANOIC ACID; 1-(4-ACETYL-1H-PYRROLE-2-CARBONYL)PIPERIDINE-2-CARBOXYLIC ACID; 3-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]BUTANOIC ACID; 2-(2-ACETYLPHENOXY)-PROPANOIC ACID; 2-[(4-ACETYLBENZENE)(METHYL)SULFONAMIDO]ACETIC ACID; 4′-ACETYL-BIPHENYL-4-ACETIC ACID; 3-[4-(3-OXOBUTYL)PHENOXY]PROPANOIC ACID; 5-(3-ACETYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-ACETYL-2,6-DIMETHYLISONICOTINIC ACID; 2-ACETYL-3-(4-HYDROXYLPHENYL)-ACRYLIC ACID; 3-ACETYL-1H-PYRROLE-2-CARBOXYLIC ACID; (5-ACETYLTHIEN-2-YL)ACETIC ACID; 5-([(4-ACETYLPHENYL)AMINO]METHYL)-2-FUROIC ACID; 5-([(3-ACETYLPHENYL)AMINO]METHYL)-2-FUROIC ACID; 6-ACETYLPICOLINIC ACID; 5-ACETYL-1H-PYRROLE-2-CARBOXYLIC ACID; 2-(4-ACETYL-2-METHOXYPHENOXY)-3-METHYLBUTANOIC ACID; 4-[4-(3-OXOBUTYL)PHENOXY]BUTANOIC ACID; 4-(3-ACETYLPHENOXY)BUTANOIC ACID; 2-(4-ACETYLPHENOXY)-3-METHYLBUTANOIC ACID; 3-METHYL-2-[4-(3-OXOBUTYL)PHENOXY]BUTANOIC ACID; 2-(3-ACETYLPHENOXY)-3-METHYLBUTANOIC ACID; 2-([[1-(2-AMINO-1,3-THIAZOL-4-YL)-2-OXOPROPYLIDENE]AMINO]OXY)-2-METHYLPROPANOIC ACID; (1S,6R)-6-ACETYL-1-METHYL-3-CYCLOHEXENE-1-CARBOXYLIC ACID; 4-(4-ACETYL-2-METHOXYPHENOXY)BUTANOIC ACID; (2S)-2-([(4-ACETYLPHENYL)SULFONYL]AMINO)PROPANOIC ACID; 2-((1S,3S)-3-ACETYL-2,2-DIMETHYLCYCLOBUTYL)ACETIC ACID; 7-ACETYL-4-HYDROXY-QUINOLINE-3-CARBOXYLIC ACID; 2-ACETYL-3-OXO-BUTANOIC ACID; [1-(4-ACETYL-PHENYL)-PIPERIDIN-4-YL]-ACETIC ACID; 4-ACETYLBENZOIC ACID HYDRATE; 2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)ACETIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)ACETIC ACID; 5-ACETYL-2-PYRIDINECARBOXYLIC ACID; 5-ACETYL-2-HYDROXY-3-METHOXY-BENZOIC ACID; 3-ACETYL-6-AMINO-4-METHYLPICOLINIC ACID; 3-ACETYL-6-AMINO-5-METHYLPICOLINIC ACID; 3-[(3-ACETYLPHENYL)SULFAMOYL]PROPANOIC ACID; 3-[(4-ACETYLPHENYL)SULFAMOYL]PROPANOIC ACID; ETHYL 2-ACETYL-4′-NITROCINNAMATE; N-ACETOACETYLANTHRANILIC ACID HYDRATE; 3-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; 3-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; 4-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 4-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 5-ACETYL-3-METHYLTHIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID; 2-ACETYLISONICOTINIC ACID; (4R)-4-(2-ACETYLPHENYL)-4-AMINOBUTANOIC ACID; (4S)-4-(2-ACETYLPHENYL)-4-AMINOBUTANOIC ACID; (4R)-4-(3-ACETYLPHENYL)-4-AMINOBUTANOIC ACID; (4S)-4-(3-ACETYLPHENYL)-4-AMINOBUTANOIC ACID; 3-ISOXAZOLECARBOXYLIC ACID, 5-ACETYL-; (5R)-5-(2-ACETYLPHENYL)-5-AMINOPENTANOIC ACID; (5S)-5-(2-ACETYLPHENYL)-5-AMINOPENTANOIC ACID; (5R)-5-(3-ACETYLPHENYL)-5-AMINOPENTANOIC ACID; (5S)-5-(3-ACETYLPHENYL)-5-AMINOPENTANOIC ACID; BENZOIC ACID, 3-ACETYL-2-AMINO-6-METHOXY-; 3-ACETYL-1-BUTYLINDOLE-6-CARBOXYLIC ACID; 2-[(3-ACETYLBENZENE)(METHYL)SULFONAMIDO]ACETIC ACID; 1-ACETYLCYCLOPROPANECARBOXYLIC ACID; 5-(4-ACETYLPHENOXY)PENTANOIC ACID; 5-(3-ACETYLPHENOXY)PENTANOIC ACID; 2-([(5-ACETYL-2-ETHOXYPHENYL)METHYL]SULFANYL)ACETIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3-HYDROXYBUTANOIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]-3-HYDROXYPROPANOIC ACID; 4-[(4-ACETYL-1H-PYRROL-2-YL)-N-METHYLFORMAMIDO]BUTANOIC ACID; 3-([2-(2-ACETYLPHENOXY)ETHYL]SULFANYL)PROPANOIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL]SULFANYL)PROPANOIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL]SULFANYL)PROPANOIC ACID; 2-[(3-ACETYLBENZENE)SULFONAMIDO]PROPANOIC ACID; 3-(2-ACETYLPHENOXY)PROPANOIC ACID; 3-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 3-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)-N-METHYLFORMAMIDO]ACETIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3-HYDROXYPROPANOIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL]SULFANYL)ACETIC ACID; 2-[(3-ACETYLPHENYL)SULFAMOYL]ACETIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)SULFANYL)PROPANOIC ACID; 4-ACETYL-5-OXO-HEX-2-ENOIC ACID; (S)-3-(3-ACETYL-4-HYDROXY-PHENYL)-2-AMINO-PROPIONIC ACID HYDROCHLORIDE; 2-(2-ACETYL-5-METHOXYPHENYL)ACETIC ACID; N-(((2-ACETYLPHENYL)AMINO)CARBONYL)GLYCINE; N-(((2-ACETYLPHENYL)AMINO)CARBONYL)-BETA-ALANINE; N-(((2-ACETYLPHENYL)AMINO)CARBONYL)-L-ALANINE; BUTANOIC ACID, 2-AMINO-3-OXO-; 2-[(4-ACETYLPHENYL)SULFAMOYL]ACETIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)SULFANYL)ACETIC ACID; 3-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)SULFANYL)PROPANOIC ACID; (2R)-3-(3-ACETYL-4-HYDROXYPHENYL)-2-AMINOPROPANOIC ACID; D-4-ACETYLPHE; AC-THZ-OH; AC-D-THZ-OH; 3′-ACETYL-BIPHENYL-2-ACETIC ACID; 3-[4-(3-OXOBUTYL)PHENOXY]BUTANOIC ACID; 3-(4-ACETYL-2-METHOXYPHENOXY)BUTANOIC ACID; 2-METHYL-3-[4-(3-OXOBUTYL)PHENOXY]PROPANOIC ACID; 3-(4-ACETYL-2-METHOXYPHENOXY)-2-METHYLPROPANOIC ACID; 2-(([(2-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)ACETIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL]AMINO)PROPANOIC ACID; 3-([(5-ACETYL-2-METHOXYPHENYL)METHYL]AMINO)PROPANOIC ACID; 2-(([(4-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)ACETIC ACID; 3-([2-(2-ACETYLPHENOXY)ETHYL]AMINO)PROPANOIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL](METHYL)AMINO)ACETIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)ACETIC ACID; 3-[(4-ACETYLPHENYL)SULFANYL]PROPANOIC ACID; 2-[(4-ACETYLPHENYL)SULFANYL]PROPANOIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL]AMINO)PROPANOIC ACID; 2-[4-(3-OXOBUTYL)PHENOXY]BUTANOIC ACID; 2-(3-ACETYLPHENOXY)BUTANOIC ACID; 4-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)BUTANOIC ACID; 2-(([(3-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)ACETIC ACID; 2-([(5-ACETYL-2-ETHOXYPHENYL)METHYL]AMINO)ACETIC ACID; 3-[(4-ACETYL-2-FLUOROPHENYL)SULFANYL]PROPANOIC ACID; 2-[(4-ACETYL-2-FLUOROPHENYL)SULFANYL]PROPANOIC ACID; ABAMACHEM ABA-1038178; 3-(3-ACETYL-2-METHYL-5-PHENYL-1H-PYRROL-1-YL)PROPANOIC ACID; 2-(3-ACETYLPHENOXY)-2,2-DIFLUOROACETIC ACID; 2,2-DIFLUORO-2-[4-(3-OXOBUTYL)PHENOXY]ACETIC ACID; 2-(4-ACETYLPHENOXY)-2,2-DIFLUOROACETIC ACID; 2-(4-ACETYL-2-METHOXYPHENOXY)-2,2-DIFLUOROACETIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)ACETIC ACID; 4-ACETYL-5-METHYL-3-PROPYL-1H-PYRROLE-2-CARBOXYLIC ACID; 2-(4-ACETYLPHENOXY)BUTANOIC ACID; 2-([(5-ACETYL-2-ETHOXYPHENYL)METHYL](METHYL)AMINO)ACETIC ACID; FCHGROUP FCH243829; 3-METHYL-2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)BUTANOIC ACID; 3-(([(4-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 2-(([(4-ACETYLPHENYL)CARBAMOYL]METHYL)(METHYL)AMINO)ACETIC ACID; (2-ACETYL-1H-IMIDAZOL-1-YL)ACETIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL]AMINO)ACETIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL]AMINO)ACETIC ACID; 4′-ACETYL-2′-METHYLBIPHENYL-4-CARBOXYLIC ACID; 2-(4-ACETYL-2-METHOXYPHENOXY)BUTANOIC ACID; 2-[(4-ACETYLPHENYL)CARBAMOYL]CYCLOPROPANE-1-CARBOXYLIC ACID; 2-[(3-ACETYLPHENYL)CARBAMOYL]CYCLOPROPANE-1-CARBOXYLIC ACID; 3-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 2-[METHYL(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]ACETIC ACID; 2-([(5-ACETYL-2-ETHOXYPHENYL)METHYL]AMINO)PROPANOIC ACID; 4-([2-(2-ACETYLPHENOXY)ETHYL]AMINO)BUTANOIC ACID; 3-(([(2-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 1-([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)PYRROLIDINE-2-CARBOXYLIC ACID; 1-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)CARBONYL]PYRROLIDINE-2-CARBOXYLIC ACID; 3-CARBAMOYL-2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 2-CYCLOPROPYL-2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 1-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]PIPERIDINE-4-CARBOXYLIC ACID; 2-[(4-ACETYLPHENYL)SULFANYL]PYRIDINE-3-CARBOXYLIC ACID; 2-[N-(CYCLOPROPYLMETHYL)(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]ACETIC ACID; 2-(([(2-ACETYLPHENYL)CARBAMOYL]METHYL)(METHYL)AMINO)ACETIC ACID; 3-[N-CYCLOPROPYL-1-(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 5-[4-(3-OXOBUTYL)PHENOXY]PENTANOIC ACID; 5-(4-ACETYL-2-METHOXYPHENOXY)PENTANOIC ACID; 2-(3-ACETYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 3-(3-ACETYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-(4-ACETYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3,3-DIMETHYLBUTANOIC ACID; 3-(([(3-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 3-([(5-ACETYL-2-ETHOXYPHENYL)METHYL]AMINO)PROPANOIC ACID; 2-(([(2-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 4-([(5-ACETYL-2-METHOXYPHENYL)METHYL]AMINO)BUTANOIC ACID; 5-[(3-ACETYLPHENYL)CARBAMOYL]PENTANOIC ACID; 5-[(4-ACETYLPHENYL)CARBAMOYL]PENTANOIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3-METHYLPENTANOIC ACID; 1-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID; 1-[(4-ACETYL-1H-PYRROLE-2-)AMIDO]CYCLOPENTANE-1-CARBOXYLIC ACID; 2-(4-ACETYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)PENTANOIC ACID; 4-[(4-ACETYLPHENYL)SULFANYL]BENZOIC ACID; 2-[(4-ACETYLPHENYL)SULFANYL]BENZOIC ACID; 2-(([(3-ACETYLPHENYL)CARBAMOYL]METHYL)(METHYL)AMINO)ACETIC ACID; 2-[CYCLOPROPYL(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]ACETIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)-N-(PROPAN-2-YL)FORMAMIDO]ACETIC ACID; 2-[N-(BUTAN-2-YL)(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]ACETIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)(PROPAN-2-YL)AMINO)ACETIC ACID; 2-ACETYL-3-HYDROXYTHIOPHENE-5-CARBOXYLIC ACID; 2-(([(4-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 2-(([(3-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 5-ACETYL-2-METHOXYBENZOIC ACID; 3-([2-(2-ACETYLPHENOXY)ETHYL](METHYL)AMINO)PROPANOIC ACID; 3-([(5-ACETYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)PROPANOIC ACID; 2-(3-ACETYL-1H-PYRROL-2-YL)ACETIC ACID; 2,2-DIMETHYL-4-OXO-PENTANOIC ACID; 7-METHYL-8-OXONONANOIC ACID; 4-ACETYL-3-ETHYL-5-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-ACETYL PHENYLALANINE HYDROCHLORIDE; 1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID, 2-ACETYL-; GLYCINE, N-(1-METHYL-3-OXOBUTYLIDENE)-; 2-ACETYL-ALPHA-AMINO-CYCLOPROPANEACETIC ACID; 3-[METHYL(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]PROPANOIC ACID; 4-(2-ACETYLPHENYL)-4-OXOBUTANOIC ACID; 3-[(4-ACETYL-1H-PYRROL-2-YL)-N-ETHYLFORMAMIDO]PROPANOIC ACID; 3-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)-N-ETHYLFORMAMIDO]PROPANOIC ACID; 3-ACETYL-7-BENZOFURANACETIC ACID; 5-OXO-2-HEXENOIC ACID; (2S)-2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3-METHYLPENTANOIC ACID; 2-[ETHYL([((2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]ACETIC ACID; 3-[ETHYL(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]PROPANOIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL](ETHYL)AMINO)ACETIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL](ETHYL)AMINO)ACETIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)(PROPYL)AMINO)ACETIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)-N-ETHYLFORMAMIDO]ACETIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-4-HYDROXYBUTANOIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]-4-HYDROXYBUTANOIC ACID; 4-METHYL-3-(3-OXOBUTANAMIDO)BENZOIC ACID; 3-(3-OXOBUTANAMIDO)-3-(THIOPHEN-2-YL)PROPANOIC ACID; 2-FLUORO-5-(3-OXOBUTANAMIDO)BENZOIC ACID; 4-FLUORO-3-(3-OXOBUTANAMIDO)BENZOIC ACID; 2,4-DIFLUORO-5-(3-OXOBUTANAMIDO)BENZOIC ACID; 2-METHYL-3-(3-OXOBUTANAMIDO)BENZOIC ACID; 3-METHYL-4-(3-OXOBUTANAMIDO)BENZOIC ACID; 2-CHLORO-5-(3-OXOBUTANAMIDO)BENZOIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-2-METHYLPROPANOIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]-2-METHYLPROPANOIC ACID; 3-(4-ACETYLPHENYL)-2-BROMOPROPANOIC ACID; 2-PYRIDINECARBOXYLIC ACID, 3-(2-OXOPROPOXY)-; 2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)-2-METHYLPROPANOIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL](METHYL)AMINO)ACETIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)-3-HYDROXYPROPANOIC ACID; 3-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 3-([(3-ACETYLPHENYL)CARBAMOYL](METHYL)AMINO)PROPANOIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL](ETHYL)AMINO)ACETIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)-2-METHYLPROPANOIC ACID; 6-[(4-ACETYLPHENYL)SULFANYL]PYRIDINE-3-CARBOXYLIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL](METHYL)AMINO)ACETIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)-3-HYDROXYPROPANOIC ACID; 3-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 3-([(4-ACETYLPHENYL)CARBAMOYL](METHYL)AMINO)PROPANOIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL](ETHYL)AMINO)ACETIC ACID; 2-[(4-ACETYLPHENYL)SULFANYL]PYRIDINE-4-CARBOXYLIC ACID; 2-(4-ACETYLPHENOXY)-2,4-DIMETHYLPENTANOIC ACID; 2-(4-ACETYLPHENOXY)-2-METHYLPENTANOIC ACID; 2-CYCLOPROPYL-2-(3-ACETYLPHENOXY)PROPANOIC ACID; 2-(3-ACETYLPHENOXY)-2-ETHYLBUTANOIC ACID; 1-(3-ACETYLPHENOXY)CYCLOHEXANE-1-CARBOXYLIC ACID; 1-(4-ACETYLPHENOXY)CYCLOPENTANE-1-CARBOXYLIC ACID; 2-CYCLOPROPYL-2-(4-ACETYLPHENOXY)PROPANOIC ACID; 2-(4-ACETYLPHENOXY)-2-ETHYLBUTANOIC ACID; 1-(4-ACETYLPHENOXY)CYCLOHEXANE-1-CARBOXYLIC ACID; 4-(4-ACETYLPHENOXY)OXANE-4-CARBOXYLIC ACID; 2-(4-ACETYLPHENOXY)-2-METHYLBUTANOIC ACID; 3-(3-ACETYLPHENOXY)THIOLANE-3-CARBOXYLIC ACID; 2-(3-ACETYLPHENOXY)-2,4-DIMETHYLPENTANOIC ACID; 1-(3-ACETYLPHENOXY)CYCLOPENTANE-1-CARBOXYLIC ACID; 4-(3-ACETYLPHENOXY)OXANE-4-CARBOXYLIC ACID; 2-(3-ACETYLPHENOXY)-2-METHYLPENTANOIC ACID; 2-(3-ACETYLPHENOXY)-2-METHYLBUTANOIC ACID; 2-METHYL-2-[4-(3-OXOBUTYL)PHENOXY]PROPANOIC ACID; 2-METHYL-2-[4-(3-OXOBUTYL)PHENOXY]BUTANOIC ACID; 3-(4-ACETYLPHENOXY)THIOLANE-3-CARBOXYLIC ACID; 2-(4-ACETYL-2-METHOXYPHENOXY)-2-METHYLPROPANOIC ACID; 2-(4-ACETYL-2-M ETHOXYPHENOXY)-2-METHYLBUTANOIC ACID; 2-ACETYL-4-BROMOPHENYLHYDROGENCARBONATE; 3-(2-FURYL)-1-(2-OXOPROPYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-(2-OXOPROPYL)-3H-IMIDAZO[4,5-B]PYRIDINE-2-CARBOXYLIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; 4-(METHOXYCARBONYL)-1-(2-OXOPROPYL)-1H-IMIDAZOLE-5-CARBOXYLIC ACID; (2S)-2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)-3-HYDROXYPROPANOIC ACID; (2S)-2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)-3-HYDROXYPROPANOIC ACID; 5-ACETYL-1,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 5-ACETYL-1-ETHYL-6-METHYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 6-ACETYL-5-METHYL-3-OXO-3,4-DIHYDROPYRAZINE-2-CARBOXYLIC ACID; 5-ACETYL-4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 5-ACETYL-6-METHYL-2-OXO-1-PROPYL-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 2-(1-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]PYRROLIDIN-2-YL)ACETIC ACID; 4-(3-OXOBUTANAMIDO)BUTANOIC ACID; 2-[(4-ACETYL-2-METHOXYPHENYL)SULFANYL]ACETIC ACID; 2-(3-ACETYLPHENOXY)-2-METHYLPROPANOIC ACID; 2-(ACETYL-METHOXYCARBONYLAMINO)BENZOIC ACID; 5-(2-ACETYL-PHENOXYMETHYL)-FURAN-2-CARBOXYLIC ACID; 3-(3-OXOBUTANAMIDO)PROPANOIC ACID; 2-(5-ACETYLFURAN-2-YL)ACETIC ACID; 2-(4-ACETYLPHENOXY)-4-METHOXY-2-METHYLBUTANOIC ACID; 2-(3-ACETYLPHENOXY)-4-METHOXY-2-METHYLBUTANOIC ACID; 5-[2-(3-ACETYL-PHENYL)-PROPYL]-FURAN-2-CARBOXYLIC ACID; 2-[(2-ACETYLNAPHTHALEN-1-YL)OXY]PROPANOIC ACID; 2-(4-ACETYL-3-METHOXYPHENYL)ACETIC ACID; BENZENEACETIC ACID, 3-ACETYL; 4-ACETYL-5-BROMONICOTINIC ACID; 4-ACETYLNICOTINIC ACID; 3-ACETYLISONICOTINIC ACID; 4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1-(2-OXOPROPYL)-1H-PYRROLE-2-CARBOXYLIC ACID; 3-METHYL-2-(3-OXOBUTANAMIDO)BUTANOIC ACID; (2S)-2-(2-ACETYLPHENYL)-2-HYDROXYACETIC ACID; 2-[(3-ACETYLPHENYL)SULFAMOYL]PROPANOIC ACID; 3-ACETYL-2-PYRIDINECARBOXYLIC ACID; 3-ACETYL-5-CHLORO-2-PYRIDINECARBOXYLIC ACID; 2-(2-ACETYL-4-METHYLPHENOXY)PROPANOIC ACID; 2-[(4-ACETYLPHENYL)SULFAMOYL]PROPANOIC ACID; (2R)-2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; (2R)-2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; 3-(4-ACETYLPHENOXY)BENZOIC ACID; 2-(4-ACETYLPHENOXY)BENZOIC ACID; 3-(4-ACETYLPHENOXY)PYRIDINE-2-CARBOXYLIC ACID; 1-(4-ACETYLPHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-(4-ACETYL-2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-(4-ACETYLPHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID; 2-(2-ACETYL-4-CHLOROPHENOXY)PROPANOIC ACID; 4-ACETYLPYRIMIDINE-5-CARBOXYLIC ACID; 5-ACETYL-2-MERCAPTOBENZOIC ACID; 3-[(6-ACETYL-2-NAPHTHALENYL)AMINO]ALANINE; 5-ACETYLPYRIMIDINE-4-CARBOXYLIC ACID; 5-ACETYL-1-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-ACETYL-4-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 2,2-DIMETHYL-3-OXOBUTANOIC ACID; 3-ACETYL-1H-INDOLE-6-CARBOXYLIC ACID; 2-[(4-ACETYLPHENYL)CARBAMOYL]ACETIC ACID; 2-[(3-ACETYLPHENYL)CARBAMOYL]ACETIC ACID; 5-(2-ACETYLPHENYL)-PICOLINIC ACID; 5-(4-ACETYLPHENYL)-PICOLINIC ACID; 5-(3-ACETYLPHENYL)-PICOLINIC ACID; 2-FLUORO-3-OXOBUTANOIC ACID; 2-HYDROXY-2-METHYL-3-OXOBUTANOIC ACID; 5-ACETYL-INDOLE-3-CARBOXYLIC ACID; 2,2-DICHLORO-ACETOACETIC ACID; 5-CHLORO-6-OXO-HEPTANOIC ACID; 4-ACETAMIDO-5-OXO-HEXANOIC ACID; 1-PYRROLIDINECARBOXYLIC ACID, 3-ACETYL-2,4-DIMETHYL-; 1,4-BENZODIOXIN-2-CARBOXYLIC ACID, 2,3-DIHYDRO-6-(2-OXOPROPYL)-; 5-(2-ACETYLPHENYL)-NICOTINIC ACID; 5-(4=ACETYLPHENYL)-NICOTINIC ACID; 4-(4-ACETYL-2-METHOXYPHENOXY)PENTANOIC ACID; 4-(4-ACETYLPHENOXY)PENTANOIC ACID; 5-(5-ACETYLTHIOPHEN-2-YL)-NICOTINIC ACID; 2-(2-ACETYLPHENYL)-ISONICOTINIC ACID; 2-(3-ACETYLPHENYL)-ISONICOTINIC ACID; 2-(4-ACETYLPHENYL)-ISONICOTINIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL](METHYL)AMINO)PROPANOIC ACID; 2-METHYL-2-[METHYL(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]PROPANOIC ACID; 2-ACETYL-5-THIAZOLECARBOXYLIC ACID; 2-(4-ACETYLPHENYL)BENZOIC ACID; 5-ACETYL-2-METHYL-NICOTINIC ACID; GLYCINE, N-(4-ACETYL-2-NITROPHENYL)-; BETA-ALANINE, N-(4-ACETYL-2-NITROPHENYL)-; 4-[4-(3-OXOBUTYL)PHENOXY]BUT-2-ENOIC ACID; 2-(2-ACETYL-5-FLUOROPHENOXY)PROPANOIC ACID; 5-(3-ACETYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 3-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)-2-METHYLPROPANOIC ACID; 5-(4-ACETYLPHENOXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 4-(3-ACETYLPHENOXY)PENTANOIC ACID; 3-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)-2-METHYLPROPANOIC ACID; 5-(3-ACETYLPHENOXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 5-(4-ACETYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL](METHYL)AMINO)PROPANOIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)PROPANOIC ACID; 4-[4-(3-OXOBUTYL)PHENOXY]PENTANOIC ACID; 2-(4-ACETYLPHENOXY)-3-METHOXY-2-METHYLPROPANOIC ACID; 2-(3-ACETYLPHENOXY)-3-METHOXY-2-METHYLPROPANOIC ACID; 2-(2-ACETYLPHENYL)-5-FLUOROPYRIDINE-4-CARBOXYLIC ACID; 3-(2-ACETYLPHENYL)PYRIDINE-2-CARBOXYLIC ACID; 4-(2-ACETYLPHENYL)PYRIDINE-2-CARBOXYLIC ACID; 4-(4-ACETYL-2-METHOXYPHENOXY)BUT-2-ENOIC ACID; 2-(2-ACETYLPHENYL)PYRIDINE-3-CARBOXYLIC ACID; 4-ACETYLTHIOPHENE-2-CARBOXYLIC ACID; 5-(2-ACETYLPHENYL)-2-AMINOPYRIDINE-3-CARBOXYLIC ACID; 3-(2-ACETYLPHENYL)-6-AMINOPYRIDINE-2-CARBOXYLIC ACID; 3-(2-ACETYLPHENYL)PYRIDINE-4-CARBOXYLIC ACID; 6-(2-ACETYLPHENYL)PYRIDINE-3-CARBOXYLIC ACID; 5-(2-ACETYLPHENYL)-2-HYDROXYBENZOIC ACID; 3-(2-ACETYLPHENYL)-4-HYDROXYBENZOIC ACID; 3-(2-ACETYLPHENYL)-5-HYDROXYBENZOIC ACID; 3-(2-ACETYLPHENYL)-2-HYDROXYBENZOIC ACID; (2S)-2-(5-ACETYL-2-CHLORO-6-METHYL(3-PYRIDYL))-2-AMINOPROPANOIC ACID; (2R)-2-(5-ACETYL-2-CHLORO-6-METHYL(3-PYRIDYL))-2-AMINOPROPANOIC ACID; (2S)-2-(5-ACETYL-6-CHLORO(3-PYRIDYL))-2-AMINOPROPANOIC ACID; (2R)-2-(5-ACETYL-6-CHLORO(3-PYRIDYL))-2-AMINOPROPANOIC ACID; (2S)-2-(6-ACETYL(2-PYRIDYL))-2-AMINOPROPANOIC ACID; (2R)-2-(6-ACETYL(2-PYRIDYL))-2-AMINOPROPANOIC ACID; (2R)-2-(6-ACETYL(2-PYRIDYL))-2-AMINOACETIC ACID; (2S)-2-(5-ACETYL-2-CHLORO-6-METHYL(3-PYRIDYL))-2-AMINOACETIC ACID; (2R)-2-(5-ACETYL-2-CHLORO-6-METHYL(3-PYRIDYL))-2-AMINOACETIC ACID; (2S)-2-(5-ACETYL-6-CHLORO(3-PYRIDYL))-2-AMINOACETIC ACID; (2R)-2-(5-ACETYL-6-CHLORO(3-PYRIDYL))-2-AMINOACETIC ACID; (2S)-2-(5-ACETYL(2-PYRIDYL))-2-AMINOPROPANOIC ACID; (2R)-2-(5-ACETYL(2-PYRIDYL))-2-AMINOPROPANOIC ACID; (2S)-2-(5-ACETYL(2-PYRIDYL))-2-AMINOACETIC ACID; (2R)-2-(5-ACETYL(2-PYRIDYL))-2-AMINOACETIC ACID; (2S)-2-(6-ACETYL(2-PYRIDYL))-2-AMINOACETIC ACID; 3-(5-ACETYLTHIOPHEN-3-YL)PROPIOLIC ACID; 3-(2-ACETYLTHIOPHEN-3-YL)PROPIOLIC ACID; 2-(4-ACETYL-5-METHYL-1H-PYRAZOL-1-YL)ACETIC ACID; 5-(4-ACETYLPHENYL)-3-AMINOBENZOIC ACID; 4-(4-ACETYLPHENYL)-3-FLUOROBENZOIC ACID; 5-(3-ACETYLPHENYL)-2-CHLOROBENZOIC ACID; 4-(3-ACETYLPHENYL)-2-CHLOROBENZOIC ACID; 3-(3-ACETYLPHENYL)-5-CHLOROBENZOIC ACID; 2-(3-ACETYLPHENYL)-4-CHLOROBENZOIC ACID; 2-(3-ACETYLPHENYL)-6-CHLOROBENZOIC ACID; 3-(3-ACETYLPHENYL)-4-CHLOROBENZOIC ACID; 2-(4-ACETYLPHENYL)-6-METHYLBENZOIC ACID; 4-(4-ACETYLPHENYL)-3-METHYLBENZOIC ACID; 3-(4-ACETYLPHENYL)-2-METHYLBENZOIC ACID; 2-(4-ACETYLPHENYL)-5-METHYLBENZOIC ACID; 4-(4-ACETYLPHENYL)-3-HYDROXYBENZOIC ACID; 3-(4-ACETYLPHENYL)-5-HYDROXYBENZOIC ACID; 4-(4-ACETYLPHENYL)-2-HYDROXYBENZOIC ACID; 2-(4-ACETYLPHENYL)-4-FLUOROBENZOIC ACID; 2-(4-ACETYLPHENYL)-5-FLUOROBENZOIC ACID; 3-(4-ACETYLPHENYL)-4-FLUOROBENZOIC ACID; 4-(4-ACETYLPHENYL)-2-FLUOROBENZOIC ACID; 5-(4-ACETYLPHENYL)-2-FLUOROBENZOIC ACID; 3-(4-ACETYLPHENYL)-5-FLUOROBENZOIC ACID; 2-(4-ACETYLPHENYL)-6-FLUOROBENZOIC ACID; 4-(4-ACETYLPHENYL)-3-METHOXYBENZOIC ACID; 3-(4-ACETYLPHENYL)-2-METHOXYBENZOIC ACID; 2-(3-ACETYLPHENYL)-6-METHYLBENZOIC ACID; 4-(3-ACETYLPHENYL)-3-METHYLBENZOIC ACID; 3-(3-ACETYLPHENYL)-2-METHYLBENZOIC ACID; 4-(3-ACETYLPHENYL)-2-HYDROXYBENZOIC ACID; 2-(3-ACETYLPHENYL)-4-FLUOROBENZOIC ACID; 2-(3-ACETYLPHENYL)-5-FLUOROBENZOIC ACID; 3-(3-ACETYLPHENYL)-5-FLUOROBENZOIC ACID; 2-(3-ACETYLPHENYL)-6-FLUOROBENZOIC ACID; 4-(3-ACETYLPHENYL)-3-METHOXYBENZOIC ACID; 3-(3-ACETYLPHENYL)-2-METHOXYBENZOIC ACID; 2-(3-ACETYLPHENYL)-5-METHOXYBENZOIC ACID; 3-(3-ACETYLPHENYL)-5-METHOXYBENZOIC ACID; 4-(3-ACETYLPHENYL)-2-METHOXYBENZOIC ACID; 4-(3-ACETYLPHENYL)NICOTINIC ACID; 3-(3-ACETYLPHENYL)-6-AMINOPICOLINIC ACID; 2-(3-ACETYLPHENYL)-5-METHYLBENZOIC ACID; 5-(3-ACETYLPHENYL)-3-AMINOBENZOIC ACID; 4-(3-ACETYLPHENYL)-3-HYDROXYBENZOIC ACID; 3-(3-ACETYLPHENYL)-5-HYDROXYBENZOIC ACID; 3-(3-ACETYLPHENYL)-4-FLUOROBENZOIC ACID; 4-(3-ACETYLPHENYL)-3-FLUOROBENZOIC ACID; 4-(3-ACETYLPHENYL)-2-FLUOROBENZOIC ACID; 5-(3-ACETYLPHENYL)-2-FLUOROBENZOIC ACID; 4-(4-ACETYLPHENYL)NICOTINIC ACID; 3-(4-ACETYLPHENYL)-6-AMINOPICOLINIC ACID; 3-(3-ACETYLPHENYL)ISONICOTINIC ACID; 2-(3-ACETYLPHENYL)NICOTINIC ACID; 5-(3-ACETYLPHENYL)NICOTINIC ACID; 2-(4-ACETYLPHENYL)-5-METHOXYBENZOIC ACID; 3-(4-ACETYLPHENYL)-5-METHOXYBENZOIC ACID; 2-(4-ACETYLPHENYL)-6-CHLOROBENZOIC ACID; 3-(4-ACETYLPHENYL)-4-CHLOROBENZOIC ACID; 4-(4-ACETYLPHENYL)-2-METHOXYBENZOIC ACID; 5-(4-ACETYLPHENYL)-2-CHLOROBENZOIC ACID; 4-(4-ACETYLPHENYL)-2-CHLOROBENZOIC ACID; 3-(4-ACETYLPHENYL)-5-CHLOROBENZOIC ACID; 2-(4-ACETYLPHENYL)-4-CHLOROBENZOIC ACID; 6-(3-ACETYLPHENYL)NICOTINIC ACID; 3-(3-ACETYLPHENYL)PICOLINIC ACID; 4-(3-ACETYLPHENYL)PICOLINIC ACID; 6-(3-ACETYLPHENYL)PICOLINIC ACID; 5-(3-ACETYLPHENYL)-6-HYDROXYNICOTINIC ACID; 5-(3-ACETYLPHENYL)-2-METHOXYNICOTINIC ACID; 4-(4-ACETYLPHENYL)PICOLINIC ACID; 6-(4-ACETYLPHENYL)PICOLINIC ACID; 5-(4-ACETYLPHENYL)-2-AMINOISONICOTINIC ACID; 5-(4-ACETYLPHENYL)-2-AMINONICOTINIC ACID; 5-(4-ACETYLPHENYL)-2-HYDROXYNICOTINIC ACID; 5-(4-ACETYLPHENYL)-2-HYDROXYISONICOTINIC ACID; 5-(4-ACETYLPHENYL)-2-METHOXYNICOTINIC ACID; 5-(3-ACETYLPHENYL)-2-AMINOISONICOTINIC ACID; 5-(3-ACETYLPHENYL)-2-AMINONICOTINIC ACID; 5-(3-ACETYLPHENYL)-2-HYDROXYNICOTINIC ACID; 5-(3-ACETYLPHENYL)-2-HYDROXYISONICOTINIC ACID; 3-(4-ACETYLPHENYL)ISONICOTINIC ACID; 2-(4-ACETYLPHENYL)NICOTINIC ACID; 6-(4-ACETYLPHENYL)NICOTINIC ACID; 3-(4-ACETYLPHENYL)PICOLINIC ACID; 5-(4-ACETYLPHENYL)-6-HYDROXYNICOTINIC ACID; 5-(3-ACETYL-PHENOXY)-FURAN-2-CARBOXYLIC ACID; 5-(4-ACETYL-PHENOXY)-FURAN-2-CARBOXYLIC ACID; 3-ACETYL-4-AZAINDOLE-5-CARBOXYLIC ACID; 3-ACETYL-7-AZAINDOLE-6-CARBOXYLIC ACID; 3-ACETYL-4-AZAINDOLE-7-CARBOXYLIC ACID; 3-ACETYL-4-METHYL-2-PYRROLECARBOXYLIC ACID; 4-ACETYL-5-FORMYL-3-METHYL-PYRROLE-2-CARBOXYLIC ACID; 2-ACETYL-6-NITROBENZOIC ACID; (2-ACETYL-3-HYDROXYPHENOXY)ACETIC ACID; 2,2-DIMETHYL-5-OXOHEXANOIC ACID; 2-BUTYL-5-OXOHEXANOIC ACID; 5-ACETYL-2-FUROIC ACID

List No. 9—Dicarbonyls: FORMYL-2-OXO-2-PHENYLETHYL)SODIUM; (2S)-1-(3-FORMYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)PYRROLIDINE-2-CARBOXAMIDE; (5-FORMYL-6-OXO-3-TRIFLUOROMETHYL-6H-PYRIDAZIN-1-YL)-ACETIC ACID ETHYL ESTER; 1-(3,4-DIMETHYLPHENYL)-3-METHYL-5-OXO-3-PYRAZOLIN-4-CARBALDEHYDE; 1,2-DIHYDRO-6-METHYL-2-OXO-3-PYRIDINECARBOXALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-(PROPYLAMINO)-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-6-(METHYLAMINO)-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,4-DIHYDRO-5-METHYL-4-OXO-3-PYRIDINECARBOXALDEHYDE; 1,4-DIHYDRO-6-METHYL-4-OXO-3-PYRIDINECARBOXALDEHYDE; 11-CHLORO-13-OXO-8-OXA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 11-CHLORO-13-OXO-8-THIA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 1-BENZYL-3-OXOPIPERIDINE-4-CARBALDEHYDE; 1-CYCLOPROPYL-7-FLUORO-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-CYCLOPROPYL-7-FLUORO-8-METHYL-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-ETHOXYCARBONYL-3-FORMYL-4-PIPERIDONE; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-AMINO-6,7-DIHYDRO-2,3-DIMETHYL-6-OXO-; 2-((2-METHOXYETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(2-(METHYLTHIO)PYRIMIDIN-4-YL)MALONALDEHYDE; 2-(3-FLUORO-PHENYL)-6-METHOXY-3-OXO-2,3-DIHYDRO-ISOQUINOLINE-4-CARBALDEHYDE; 2-(4-IODOPHENOXY)MALONDIALDEHYDE; 2-(ALLYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2,2-DIMETHYL-3-OXOHEPT-6-ENAL; 2,2-DIMETHYL-3-OXOHEPTANAL; 2,2-DIMETHYL-3-OXOHEXANAL; 2,2-DIMETHYL-3-OXOOCTANAL; 2,2-DIMETHYL-3-OXOPENTANAL; 2,6-DIAMINO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2,7-DICHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-AMINO-6-CHLORO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2-CHLORO-6-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIMETHYLAMINO-1,3-DIOXOHEXANE; 2-HEPTYL-1,4-DIHYDRO-4-OXO-3-QUINOLINECARBOXALDEHYDE; 2-IODOMALONALDEHYDE; 2-METHYL-3-(3-NITROPHENYL)-3-OXOPROPANAL; 2-METHYL-3-OXO-3-(THIOPHEN-2-YL)PROPANAL; 2-METHYL-3-OXO-BUTANAL; 2-METHYL-5-(MORPHOLIN-4-YL)-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBALDEHYDE; 2-OXO-1-[1-(TRIMETHYLSILYL)-2-PROPENYL]CYCLOHEXANECARBALDEHYDE; 2-OXO-5-(PROPAN-2-YL)CYCLOHEXANE-1-CARBALDEHYDE; 2-OXO-5-PROPYLINDOLINE-3-CARBALDEHYDE; 3-(1,1-BIPHENYL-4-YL)-3-OXOPROPANAL; 3-(1,3-BENZODIOXOL-5-YL)-3-OXOPROPANAL; 3-(1,3-BENZOTHIAZOL-2-YL)-3-OXOPROPANAL; 3-(1-BENZOFURAN-2-YL)-3-OXOPROPANAL; 3-(1-ETHYL-1H-PYRAZOL-4-YL)-3-OXOPROPANAL; 3-(1-ETHYL-3,5-DIMETHYL-1H-PYRAZOL-4-YL)-3-OXOPROPANAL; 3-(1-METHYL-1H-1,3-BENZODIAZOL-2-YL)-3-OXOPROPANAL; 3-(1-METHYL-1H-PYRAZOL-4-YL)-3-OXOPROPANAL; 3-(1-NAPHTHYL)-3-OXOPROPANAL; 3-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-OXOPROPANAL; 3-(2,4-DICHLORO-5-FLUOROPHENYL)-3-OXOPROPANAL; DICHLOROPHENYL)-3-OXOPROPANAL; 3-(2,4-DIFLUOROPHENYL)-3-OXOPROPANAL; 3-(2,5-DICHLOROPHENYL)-3-OXOPROPANAL; 3-(2,5-DIFLUOROPHENYL)-3-OXOPROPANAL; 3-(2,5-DIMETHYLFURAN-3-YL)-3-OXOPROPANAL; 3-(2,6-DICHLORO-3-FLUOROPHENYL)-3-OXOPROPANAL; DIFLUOROPHENYL)-3-OXOPROPANAL; 3-(2-BROMOPHENYL)-3-OXOPROPANAL; 3-(2-CHLOROPHENYL)-3-OXOPROPANAL; 3-(2-ETHOXYPHENYL)-3-OXOPROPANAL; 3-(2-FLUOROPHENYL)-3-OXOPROPANAL; 3-(2-FURYL)-3-OXOPROPANAL; 3-(2-METHOXY-5-METHYLPHENYL)-3-OXOPROPANAL; 3-(2-METHYLPHENYL)-3-OXOPROPANAL; 3-(2-NAPHTHYL)-3-OXOPROPANAL; 3-(2-NITROPHENYL)-3-OXOPROPANAL; 3-(3,4-DICHLOROPHENYL)-3-OXOPROPANAL; 3-(3,4-DIFLUOROPHENYL)-3-OXOPROPANAL; 3-(3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YL)-3-OXOPROPANAL; 3-(3,4-DIMETHOXYPHENYL)-3-OXOPROPANAL; 3-(3,4-DIPROPOXYPHENYL)-3-OXOPROPANAL; 3-(3-BROMOPHENYL)-3-OXOPROPANAL; 3-(3-CHLORO-4-FLUOROPHENYL)-3-OXOPROPANAL; 3-(3-CHLOROPHENYL)-3-OXOPROPANAL; 3-(3-ETHYL-1-BENZOFURAN-2-YL)-3-OXOPROPANAL; 3-(3-FLUOROPHENYL)-3-OXOPROPANAL; 3-(3-NITROPHENYL)-3-OXOPROPANAL; 3-(4-BROMOPHENYL)-3-OXOPROPANAL; 3-(4-ETHOXYPHENYL)-3-OXOPROPANAL; 3-(4-FLUOROPHENYL)-3-OXOPROPANAL; 3-(4-ISOPROPYLPHENYL)-3-OXOPROPANAL; 3-(4-METHYL-3-NITROPHENYL)-3-OXOPROPANAL; 3-(4-METHYLPHENYL)-3-OXOPROPANAL; 3-(4-NITROPHENYL)-3-OXOPROPANAL; 3-(5-BROMO-1-BENZOFURAN-2-YL)-3-OXOPROPANAL; 3-(5-BROMOTHIOPHEN-2-YL)-3-OXOPROPANAL; 3-(5-CHLOROTHIOPHEN-2-YL)-3-OXOPROPANAL; 3-(5-ETHYLTHIOPHEN-2-YL)-3-OXOPROPANAL; 3-(5-METHYLFURAN-2-YL)-3-OXOPROPANAL; 3-(5-METHYLTHIEN-2-YL)-3-OXOPROPANAL; 3-(6-METHOXYNAPHTHALEN-2-YL)-3-OXOPROPANAL; 3-(9H-FLUOREN-2-YL)-3-OXOPROPANAL; 3-(ADAMANTAN-1-YL)-3-OXOPROPANAL; 3-(FURAN-2-YL)-2-METHYL-3-OXOPROPANAL; 3,4-DIHYDRO-3-OXO-2-QUINOXALINECARBOXALDEHYDE; 3-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-3-OXOPROPANAL; 3-[4-(BENZYLOXY)PHENYL]-3-OXOPROPANAL; 3-[4-(METHYLSULFANYL)PHENYL]-3-OXOPROPANAL; 3-CYCLOHEXYL-3-OXOPROPANAL; 3-CYCLOPENTYL-3-OXOPROPANAL; 3-CYCLOPROPYL-3-OXOPROPANAL; 3-FORMYL-2-(METHYLPHENYLAMINO)CHROMONE; 3-FORMYL-4(1H)-PYRIDONE; 3-MESITYL-3-OXOPROPANAL; 3-OXO-3-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)PROPANAL; 3-OXO-3-(4-PROPOXYPHENYL)PROPANAL; 3-OXO-3-(4-PROPYLPHENYL)PROPANAL; 3-OXO-3-(PYRIDIN-3-YL)PROPANAL; 3-OXO-3-(PYRIDIN-4-YL)PROPANAL; 3-OXO-3-(THIOPHEN-3-YL)PROPANAL; 3-OXO-BUTANAL; 4,5,6,7-TETRAHYDRO-4-OXO-5-BENZOFURANCARBOXALDEHYDE; 4-METHYL-3-OXOPENTANAL; 4-OXO-1H-QUINOLINE-3-CARBALDEHYDE; 4-OXO-6-PHENYL-4H-1-BENZOPYRAN-3-CARBOXALDEHYDE; 4-OXO-TETRAHYDROFURAN-3-CARBOXALDEHYDE; 5-(TERT-BUTYLDIMETHYLSILYLOXY)-2-OXOCYCLOHEXANECARBALDEHYDE; 5,6,7-TRIFLUORO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 5-AMINO-1-CYCLOPROPYL-6,7-DIFLUORO-8-METHYL-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 5-BROMO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-CHLORO-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-ETHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ETHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-HYDROXY-3-OXO-2,3-DIHYDRO-1-BENZOXEPINE-4-CARBALDEHYDE; 5-ISOPROPYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 6-(3-OXOPROPANOYL)PYRIDINE-3-BORONIC ACID; 6-(BROMOMETHYL)-1,3-DIETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-(ISOPROPYLAMINO)-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6,7-DICHLORO-3-FORMYLCHROMONE; 6-[(2-METHOXYETHYL)AMINO]-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-BROMO-2-OXO-1,2,3,4-TETRAHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-CHLORO-1,3-BIS(2-METHOXYETHYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-1,3-DIISOBUTYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-8-NITRO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 6-DIMETHYLAMINO-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXALDEHYDE; 6-ISOPROPOXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 6-METHYL-8-NITRO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7,8-DIHYDROXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-BROMO-2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-BROMO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-CHLORO-5-OXO-5H-THIAZOLO[3,2-A]PYRIMIDINE-6-CARBALDEHYDE; 7-FLUORO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-HYDROXY-8-METHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-METHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-NITRO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 8-BROMO-6-METHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 8-NITRO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 8-OXO-3,4,8,9-TETRAHYDRO-2H,7H-[1,4]DIOXEPINO[2,3-F]INDOLE-9-CARBALDEHYDE; ACETALDEHYDE, AMINOBENZOYL-; ALPHA,ALPHA-DICHLORO-BETA-OXO-BENZENEPROPANAL; ALPHA-CHLORO-BETA-OXO-BENZENEPROPANAL; ALPHA-FLUORO-4-METHYL-BETA-OXO-BENZENEPROPANAL; BUTYLMALONDIALDEHYDE; CYCLOPENTYLMALONDIALDEHYDE; CYCLOPROPYLMALONDIALDEHYDE; DIMETHYLMALONDIALDEHYDE; ETHYLMALONDIALDEHYDE; ISOPROPYLMALONDIALDEHYDE; METHYLMALONDIALDEHYDE; N,N-DIMETHYL-4-(3-OXOPROPANOYOBENZENE-1-SULFONAMIDE; PROPYLMALONDIALDEHYDE; TERT-BUTYLMALONDIALDEHYDE; 4-ANTIPYRINECARBOXALDEHYDE; CHROMONE-3-CARBOXALDEHYDE; 4,4-DIMETHYL-3-OXO-PENTANAL; 5,7-DIMETHYL-3-FORMYLCHROMONE; 6,8-DICHLORO-3-FORMYLCHROMONE; 2,4-DIPHENYL-3-OXOBUTYRALDEHYDE; 6-AMINO-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1,3-DIETHYL-5-FORMYLURACIL; 1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-FLUORO-3-FORMYLCHROMONE; 2-AMINO-6-FLUORO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 6-CHLORO-3-FORMYLCHROMONE; 2-AMINO-6-CHLORO-3-FORMYLCHROMONE; 3-FORMYL-6-METHYLCHROMONE; 2-AMINO-3-FORMYL-6-METHYLCHROMONE; AURORA KA-3767; 2-AMINO-6-BROMO-3-FORMYLCHROMONE; 2-AMINO-3-FORMYLCHROMONE; 6-CHLORO-3-FORMYL-7-METHYLCHROMONE; 6-BROMO-3-FORMYLCHROMONE; 3-FORMYL-6-NITROCHROMONE; 5-FORMYLURACIL; 6,7-DIMETHYL-3-FORMYLCHROMONE; 6,8-DIMETHYL-3-FORMYLCHROMONE; 3-FORMYL-6-ISOPROPYLCHROMONE; 6-ETHYL-3-FORMYLCHROMONE; 2-AMINO-3-FORMYL-6,7-DIMETHYLCHROMONE; 2-(2-BENZOXAZOLYL)MALONDIALDEHYDE; 2-(4-PYRIMIDYL)MALONDIALDEHYDE; 2-(4-CHLORO-2-NITROPHENYL)MALONDIALDEHYDE; 2-(3-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(2-NITROPHENYL)MALONDIALDEHYDE; 2-(4-METHOXYPHENYL)MALONDIALDEHYDE; 2-(4-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(4-CHLOROPHENYL)MALONDIALDEHYDE; 2-(4-METHYLPHENYL)MALONDIALDEHYDE; 2-(5-METHOXY-2-NITROPHENYL)MALONDIALDEHYDE MONOHYDRATE; 2-(5-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE MONOHYDRATE; 2-(4-METHYLSULFONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(2-PYRAZINYL)MALONDIALDEHYDE; 2-(2-QUINOXALINYL)MALONDIALDEHYDE; 2-(2-PYRIDYL)MALONDIALDEHYDE; 2-(2-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2-(3-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2-(4-PYRIDYL)MALONDIALDEHYDE; 1,3-DIMETHYL-2,4,6-TRIOXO-HEXAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-HYDROXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-HYDROXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2-BROMOMALONALDEHYDE; 1,2-DIHYDRO-7-METHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-ETHOXY-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 4,4-DIMETHYL-2,6-DIOXOCYCLOHEXANECARBALDEHYDE; 2-AMINO-4-CHLORO-6-OXO-1H-PYRIMIDINE-5-CARBALDEHYDE; 2-OXOINDOLINE-3-CARBALDEHYDE; 2-HYDROXY-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 2-(DIMETHYLAMINO)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 2-(4-NITRO-1H-PYRAZOL-1-YL)MALONALDEHYDE; 1-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 2-OXO-1-PHENYLINDOLINE-3-CARBALDEHYDE; 4-OXO-5-PHENYL-4H-PYRAN-3-CARBOXALDEHYDE; 2-CHLORO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BUTYLTHIO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-(4-METHYLPIPERIDIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLTHIO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 3-OXO-2,5-DIPHENYL-PENT-4-ENAL; 7-METHYL-4-OXO-2-P-TOLYLAMINO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-(METHYLOXY)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-8-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[(CYCLOHEXYLAMINO)(PHENYL)METHYLENE]MALONALDEHYDE; 4-OXO-2-(PHENYLTHIO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBOXALDEHYDE; 4-OXO-2-P-TOLYLSULFANYL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; MALONDIALDEHYDE; 6-CHLORO-5-FORMYL-1,3-DIMETHYLURACIL; 2-[2-(4-METHOXYPHENYL)HYDRAZONO]-3-OXO-3-(2-THIENYL)PROPANAL; 2-[2-(4-CHLOROPHENYL)HYDRAZONO]-3-OXO-3-(2-THIENYL)PROPANAL; 2-[2-(3-METHYLPHENYL)HYDRAZONO]-3-OXO-3-(2-THIENYL)PROPANAL; 3-OXO-2-(2-PHENYLHYDRAZONO)-3-(2-THIENYL)PROPANAL; 3-(2-FURYL)-3-OXO-2-(2-PHENYLHYDRAZONO)PROPANAL; 2-[2-(4-CHLOROPHENYL)HYDRAZONO]-3-(2-FURYL)-3-OXOPROPANAL; 3-(2-FURYL)-2-[2-(4-METHOXYPHENYL)HYDRAZONO]-3-OXOPROPANAL; 3-(2-FURYL)-2-[2-(3-METHYLPHENYL)HYDRAZONO]-3-OXOPROPANAL; 2-[2-(2,3-DIMETHYLPHENYL)HYDRAZONO]-3-(4-METHYLPHENYL)-3-OXOPROPANAL; 2-[2-(2-CHLOROPHENYL)HYDRAZONO]-3-OXO-3-PHENYLPROPANAL; 2-[2-(4-METHOXYPHENYL)HYDRAZONO]-3-OXO-3-PHENYLPROPANAL; 3-(4-METHOXYPHENYL)-3-OXO-2-(2-PHENYLHYDRAZONO)PROPANAL; 3-OXO-3-PHENYL-2-(2-PHENYLHYDRAZONO)PROPANAL; 2-[2-(4-METHYLPHENYL)HYDRAZONO]-3-OXO-3-(4-PYRIDINYL)PROPANAL; 2-[2-(4-FLUOROPHENYL)HYDRAZONO]-3-OXO-3-(4-PYRIDINYL)PROPANAL; 3-(4-CHLOROPHENYL)-3-OXO-2-(2-PHENYLHYDRAZONO)PROPANAL; 2-[2-(4-CHLOROPHENYL)HYDRAZONO]-3-OXO-3-(4-PYRIDINYL)PROPANAL; 3-OXO-2-(2-PHENYLHYDRAZONO)-3-(4-PYRIDINYL)PROPANAL; 9-METHYL-4-OXO-2-(PHENYLTHIO)-4H-PYRIDO[1,2-A]PYRIMDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-PYRROLIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(2,6-DIMETHYL-4-MORPHOLINYL)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(2-CHLOROANILINO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-PYRROLIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-METHYL-1-PIPERIDINYL)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[BENZYL(METHYL)AMINO]-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 6-(BROMOMETHYL)-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 2-[(2-FURYLMETHYL)AMINO]-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 6-AMINO-1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 2-(2-FLUOROANILINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-ANILINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 3-METHYL-5-OXO-1-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-4-CARBALDEHYDE; 3-OXO-3-(THIOPHEN-2-YL)PROPANAL; 3-FORMYL-4-OXO-4H-CHROMEN-7-YL ACETATE; 2-AMINO-6,8-DICHLORO-3-FORMYLCHROMONE; 2-CHLOROMALONALDEHYDE; 6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 5-OXO-2,3-DIHYDRO-1H,5H-PYRIDO[3,2,1-IJ]QUINOLINE-6-CARBALDEHYDE; 4-OXO-1,2-DIHYDRO-4H-PYRROLO[3,2,1-IJ]QUINOLINE-5-CARBALDEHYDE; 2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(2-QUINOLYL)MALONDIALDEHYDE; 1-((2R,4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; HYDROXYPROPANEDIAL; 1-CYCLOOCTYL-6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 2-(AZEPAN-1-YL)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-((2-HYDROXYETHYL)AMINO)-9-ME-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-PYRIDAZIN-4-YLMALONALDEHYDE; 1,2-DIHYDRO-6,8-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 2-(4-QUINOLYL)MALONDIALDEHYDE SESQUIHYDRATE; 2-[ISOPROPYL(METHYL)AMINO]-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; METHYL ((3-FORMYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDIN-2-YL)THIO)ACETATE; 6-METHYL-2-OXO-1,2-DIHYDROQUINOLIN-3-CARBALDEHYDE; 6-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 5,7-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 7-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 8-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 5,8-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 1,2-DIHYDRO-7,8-DIMETHYL-2-OXO-QUINOLINE-3-CARBOXALDEHYDE; 6-ETHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 2-(3-FLUORO-PHENYL)-MALONALDEHYDE; 2-(2-METHOXY-PHENYL)-MALONALDEHYDE; 2-(3-METHOXYPHENYL)MALONDIALDEHYDE; 2-(2-CHLOROPHENYL)MALONDIALDEHYDE; 2-(DIMETHYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-FLUOROPHENYL)MALONDIALDEHYDE; 2-(3,4-DICHLOROPHENYL)MALONDIALDEHYDE; 2-(3-CHLOROPHENYL)MALONDIALDEHYDE; 2-(2-BROMO-PHENYL)-MALONALDEHYDE; 2-(4-BROMOPHENYL)MALONDIALDEHYDE; 2-(4-NITROPHENYL)MALONDIALDEHYDE; 2-(2,4-DINITROPHENYL)MALONDIALDEHYDE; 2-(3,4-DIMETHYL-PHENYL)-MALONALDEHYDE; 8-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-OXO-5,6-DIHYDRO-[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBALDEHYDE; 8-BROMO-6-CHLORO-3-FORMYLCHROMONE; SODIUM 5-FORMYL-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-4-PYRIMIDINOLATE; 2-AMINO-6-CHLORO-7-METHYL-3-FORMYL CHROMONE; 6-METHOXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 2-(4-ETHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 1,3,6-TRIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 2-(ETHYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(2-PYRIMIDINYLAMINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 6-FLUORO-8-NITROCHROMONE-3-CARBOXALDEHYDE; 7-METHYL-2-(4-METHYL-PIPERIDIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-2-(4-METHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-THIOMORPHOLIN-4-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-METHYLPIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7,7-DIMETHYL-2-OXOBICYCLO[2.2.1]HEPTANE-1-CARBALDEHYDE; 9-METHYL-4-OXO-2-THIOMORPHOLIN-4-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; NITROMALONALDEHYDE; NITROMALONALDEHYDE SODIUM SALT; FLUOROMALONALDEHYDE; 7-CHLORO-3-FORMYLCHROMONE; 2-(4-TRIFLUOROMETHOXYPHENYL)MALONDIALDEHYDE; 2-(4-TRIFLUOROMETHYLPHENYL)MALONDIALDEHYDE; 2-(3-TRIFLUOROMETHYLPHENYL)MALONDIALDEHYDE; 2-AMINO-6-ETHYL-3-FORMYLCHROMONE; 2-AMINO-6-ISOPROPYL-4-OXO-4H-BENZOPYRAN-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)MALONDIALDEHYDE; 2,3-DIHYDRO-5-METHYL-3-OXO-2-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 2-(3-BROMOPHENYL)MALONDIALDEHYDE; 2-(4-ETHOXYPHENYL)MALONDIALDEHYDE; 2-(4-PHENYLPHENYL)MALONDIALDEHYDE; 2-PHENYLMALONDIALDEHYDE; 2-(3-METHYLPHENYL)MALONDIALDEHYDE; 2-(4-CHLOROPHENOXY)MALONDIALDEHYDE; 2-(3-CHLOROPHENOXY)MALONDIALDEHYDE; 2-(3,5-DIMETHYLPIPERIDIN-1-YL)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-(4-METHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; (5-FORMYL-4-HYDROXY-6-OXO-3-PHENYLPYRIDAZIN-1(6H)-YL)ACETIC ACID; 5-FORMYLURIDINE; 7-OXO-2,3,6,7-TETRAHYDRO-[1,4]DIOXINO[2,3-G]QUINOLINE-8-CARBALDEHYDE; 4-OXO-4H-BENZO[H]CHROMENE-3-CARBALDEHYDE; 2-FORMYL-3-METHYL-1-OXO-1,5-DIHYDRO-BENZO[4,5]IMIDAZO[1,2-A]PYRIDINE-4-CARBONITRILE; 2-NAPHTHALEN-1-YL-MALONALDEHYDE; 3-(CHLOROMETHYL)-2-FORMYL-1-OXO-1,5-DIHYDROPYRIDO[1,2-A]BENZIMIDAZOLE-4-CARBONITRILE; 6-CHLORO-8-CHLOROMETHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; SPIROCYCLOHEXYLBUTANE-1,3-DIONE; 2-(5-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(2-THIENYLMETHYLENE)MALONALDEHYDE; 2-DIMETHYLAMINO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-((FURAN-2-YLMETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-FLUOROPHENOXY)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(M-TOLYLOXY)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(AZEPAN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 6-AMINO-1-ISOBUTYL-3-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; N′-(3-ETHYL-5-FORMYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-PYRIMIDIN-4-YL)-N,N-DIMETHYL-FORMAMIDINE; 2-AZEPAN-1-YL-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIMETHYLAMINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 2,4,6-TRIOXO-HEXAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-METHOXYPHENOXY)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-AMINO-6-METHOXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2,4-DIOXO-3,4-DIHYDRO-2H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 1-ISOBUTYL-6-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-BOC-3-FORMYL-4-OXO-PIPERIDINE; 1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-ISOBUTYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-(4-METHOXY-BENZYL)-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-ISOBUTYL-6-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 3-BENZYLIDENE-2-OXO-CYCLOHEXANECARBALDEHYDE; 4-QUINOLINYLMALONALDEHYDE; 1-(3,5-ANHYDRO-2-DEOXY-BETA-D-THREO-PENTAFURANOSYL)THIMINE; 2-(5-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2-CHLORO-1-ETHYL-5-FORMYL-4-METHYL-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBONITRILE; 2-OXO-1,2,6,7,8,9-HEXAHYDROBENZO[G]QUINOLINE-3-CARBALDEHYDE; 6-METHOXY-1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 6-AMINO-4-OXO-1-PHENYL-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 3-FORMYL-8-METHOXYCHROMONE; 3-FORMYL-7-METHOXYCHROMONE; 6-METHOXY-1-OXO-1,2,3,4-TETRAHYDRO-[2]-NAPHTHALDEHYDE; 3-FORMYL-5-METHOXYCHROMONE; 2-(1H-IMIDAZOL-2-YL)-MALONALDEHYDE; 6-AMINO-1-BENZYL-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 7-CHLORO-3,5-DIOXO-2,3,4,5-TETRAHYDRO-BENZO[B]OXEPINE-4-CARBALDEHYDE; 2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6,7-DIETHOXY-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-ETHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 6-AMINO-1-(2-FURYLMETHYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 2-(5-CHLORO-1,3-BENZOXAZOL-2-YL)MALONALDEHYDE; 6-AMINO-1-(3-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-HYDROXY-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 3-FORMYL-4-OXO-4H-CHROMEN-6-YL ACETATE; 1-OXO-1,2,3,4-TETRAHYDRONAPHTHALENE-2-CARBALDEHYDE; 2,4-DIAMINO-6-OXO-1,6-DIHYDRO-5-PYRIMIDINECARBALDEHYDE; 5-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 6-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 6-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 4-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 1H-BENZIMIDAZOL-2-YLMALONALDEHYDE; 6-AMINO-2,4-DIOXO-1-(PYRIDIN-3-YLMETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 7-METHYLSULFANYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-ETHYL-7-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 7-METHOXY-1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; TRIFORMYLMETHANE; 3-OXO-3-PHENYL-PROPIONALDEHYDE; 2-AMINO-6-TERT-BUTYL-3-FORMYLCHROMONE; 6-AMINO-2,4-DIOXO-1-(2-PHENYLETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-TERT-BUTYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 3-(4-CHLOROPHENYL)-3-OXOPROPANAL; 3-(4-METHOXYPHENYL)-3-OXOPROPANAL; 2-AMINO-6,8-DIMETHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2-AMINO-6,7-DICHLORO-3-FORMYLCHROMONE; 3-(5-FLUORO-2-HYDROXYPHENYL)-3-OXOPROPANAL; 3-(2-HYDROXYPHENYL)-3-OXOPROPANAL; 3-(2-HYDROXY-5-METHYLPHENYL)-3-OXOPROPANAL; 3-(5-CHLORO-2-HYDROXYPHENYL)-3-OXOPROPANAL; 3-(5-BROMO-2-HYDROXYPHENYL)-3-OXOPROPANAL; 3-OXO-2-PHENOXY-BUTYRALDEHYDE; 8-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-8-METHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-BROMO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1-OXO-1,2,3,4-TETRAHYDRO-2-PHENANTHRENECARBALDEHYDE; 2,2-DIMETHYL-3-OXO-3-PHENYLPROPANAL; NITROMALONALDEHYDE SODIUM SALT HYDRATE; 5-CHLORO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 6-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 6-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 4-(1H-IMIDAZOL-2-YL)-B-OXO-BENZENEPROPANAL; 3-(2,5-DIMETHOXYPHENYL)-3-OXOPROPANAL; 3-(2,4-DIMETHOXYPHENYL)-3-OXOPROPANAL; 3-OXO-3-[2-(TRIFLUOROMETHYL)PHENYL]PROPANAL; 3-OXO-3-[3-(TRIFLUOROMETHYL)PHENYL]PROPANAL; 3-OXO-3-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAL; 3-(2-METHOXYPHENYL)-3-OXOPROPANAL; 3-(3-METHOXYPHENYL)-3-OXOPROPANAL; 3-(3,4-DIMETHYLPHENYL)-3-OXOPROPANAL; 3-(4-ETHYLPHENYL)-3-OXOPROPANAL; 3-(4-TERT-BUTYLPHENYL)-3-OXOPROPANAL; 3-[4-(2-METHYLPROPYL)PHENYL]-3-OXOPROPANAL; 3-OXO-3-[4-(PROPAN-2-YLOXY)PHENYL]PROPANAL; 3-OXO-3-(PYRIDIN-2-YL)PROPANAL; 3-(2,4-DIMETHYLPHENYL)-3-OXOPROPANAL; 3-(2,5-DIMETHYLPHENYL)-3-OXOPROPANAL; 3-(3-FLUORO-4-METHOXYPHENYL)-3-OXOPROPANAL; 2-(3-OXOPROPANOYL)BENZONITRILE; 4-(3-OXOPROPANOYL)BENZONITRILE; 3-(3-OXOPROPANOYL)BENZONITRILE; 3-(3-BROMO-4-FLUOROPHENYL)-3-OXOPROPANAL; (2-CHLORO-1-ETHOXY-1,3-DIOXOPROPAN-2-YL)POTASSIUM; 10-OXO-2,3,5,6-TETRAHYDRO-1H,4H,10H-11-OXA-3A-AZA-BENZO[DE]ANTHRACENE-9-CARBALDEHYDE; 1-FORMYL-CYCLOBUTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPENTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPROPANECARBOXYLIC ACID METHYL ESTER; 1-TERT-BUTYL 4-ETHYL 4-FORMYLPIPERIDINE-1,4-DICARBOXYLATE; 2,3-DIHYDRO-2-OXO-3-FURANCARBOXALDEHYDE; 2,4-DIOXOTETRAHYDROFURAN-3-CARBALDEHYDE; 2,5-DIHYDRO-2-OXO-3-FURANCARBOXALDEHYDE; 2-DIMETHYLAMINO-6-OXO-4-PHENYL-6H-[1,3]OXAZINE-5-CARBALDEHYDE; 2-FORMYL-3-OXO-BUTYRIC ACID ETHYL ESTER; 2-FORMYLPROPIONIC ACID ETHYL ESTER; 2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 2-OXO-4-(PROPYLAMINO)-2H-CHROMENE-3-CARBALDEHYDE; 3-ETHYL-4-FLUOROPHENYL-3-OXOPROPANOATE; 3-OXOPROPANOIC ACID; 3-OXO-PROPIONIC ACID ETHYL ESTER; 4-(BENZYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(BUTYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(ETHYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4,6,8-TRICHLORO-3-FORMYLCOUMARIN; 4,6-DICHLORO-3-FORMYL-7-METHYLCOUMARIN; 4,6-DICHLORO-3-FORMYLCOUMARIN; 4-[(4-METHYLPHENYL)SULFANYL]-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-3-FORMYL-6-METHYLCOUMARIN; 4-CHLORO-6-FLUORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-FORMYL-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID METHYL ESTER; 4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-3-FORMYL-6-METHYLCOUMARIN; 4-HYDROXY-5,7-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6,7-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6,8-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6-CHLORO-3-FORMYLCOUMARIN; 4-PIPERIDINECARBOXYLIC ACID, 4-FORMYL-; 5-(ETHOXYCARBONYL)-2-FORMYL-4-METHYL-1H-PYRROLE-3-PROPANOIC ACID METHYL ESTER; 6,8-DICHLORO-3-FORMYLCOUMARIN; 6-BROMO-4-CHLORO-3-FORMYLCOUMARIN; 6-BROMO-4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 6-CHLORO-4-HYDROXY-7-METHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 6-FLUORO-4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 7-(DIETHYLAMINO)-4-HYDROXY-2-OXOCHROMENE-3-CARBALDEHYDE; 7-DIETHYLAMINO-3-FORMYLCOUMARIN; 8-METHYL-10-OXO-2,3,5,6-TETRAHYDRO-1H,4H, 10H-11-OXA-3A-AZA-BENZO[DE]ANTHRACENE-9-CARBALDEHYDE; BENZYL 3-OXOPROPANOATE; BUTYRAMIDO-MALONALDEHYDIC ACID; DIETHYL FORMYLSUCCINATE; DIMETHYL 2-FORMYLSUCCINATE; ETHYL 1-FORMYLCYCLOBUTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOHEXANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPENTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPROPANECARBOXYLATE; ETHYL 2-(4-BROMOPHENYL)-3-OXOPROPANOATE; ETHYL 2-CHLORO-3-OXOPROPANOATE; ETHYL 2-FORMYLBUTANOATE; ETHYL 3-DIMETHYLAMINO-2-FORMYLACRYLATE; ETHYL 3-OXO-2-PHENYLPROPANOATE; MALONALDEHYDIC ACID, N-METHYLACETAMIDO-, ETHYL ESTER; METHYL 2-(2-BROMOPHENYL)-2-FORMYLACETATE; METHYL 2-CHLORO-2-FORMYLACETATE; METHYL 2-METHYL-3-OXOPROPIONATE; METHYL 3-N,N-DIMETHYLAMINO-2-FORMYLACRYLATE; METHYL 3-OXOPROPANOATE; METHYL A-FORMYLPHENYLACETATE; PHENACETURIC ACID,-ALPHA-FORMYL-ALPHA-METHYL-; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (R)—; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (S)—; ZINC(II) 2-(CARBOXYMETHYL)-2-FORMYLSUCCINATE;

β-keto-esters: (2-CHLORO-1-ETHOXY-1,3-DIOXOPROPAN-2-YL)POTASSIUM; 10-OXO-2,3,5,6-TETRAHYDRO-1H,4H,10H-11-OXA-3A-AZA-BENZO[DE]ANTHRACENE-9-CARBALDEHYDE; 1-FORMYL-CYCLOBUTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPENTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPROPANECARBOXYLIC ACID METHYL ESTER; 1-TERT-BUTYL 4-ETHYL 4-FORMYLPIPERIDINE-1,4-DICARBOXYLATE; 2,3-DIHYDRO-2-OXO-3-FURANCARBOXALDEHYDE; 2,4-DIOXOTETRAHYDROFURAN-3-CARBALDEHYDE; 2,5-DIHYDRO-2-OXO-3-FURANCARBOXALDEHYDE; 2-DIMETHYLAMINO-6-OXO-4-PHENYL-6H-[1,3]OXAZINE-5-CARBALDEHYDE; 2-FORMYL-3-OXO-BUTYRIC ACID ETHYL ESTER; 2-FORMYLPROPIONIC ACID ETHYL ESTER; 2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 2-OXO-4-(PROPYLAMINO)-2H-CHROMENE-3-CARBALDEHYDE; 3-ETHYL-4-FLUOROPHENYL-3-OXOPROPANOATE; 3-OXOPROPANOIC ACID; 3-OXO-PROPIONIC ACID ETHYL ESTER; 4-(BENZYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(BUTYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(ETHYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4,6,8-TRICHLORO-3-FORMYLCOUMARIN; 4,6-DICHLORO-3-FORMYL-7-METHYLCOUMARIN; 4,6-DICHLORO-3-FORMYLCOUMARIN; 4-[(4-METHYLPHENYL)SULFANYL]-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-3-FORMYL-6-METHYLCOUMARIN; 4-CHLORO-6-FLUORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-FORMYL-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID METHYL ESTER; 4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-3-FORMYL-6-METHYLCOUMARIN; 4-HYDROXY-5,7-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6,7-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6,8-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6-CHLORO-3-FORMYLCOUMARIN; 4-PIPERIDINECARBOXYLIC ACID, 4-FORMYL-; 5-(ETHOXYCARBONYL)-2-FORMYL-4-METHYL-1H-PYRROLE-3-PROPANOIC ACID METHYL ESTER; 6,8-DICHLORO-3-FORMYLCOUMARIN; 6-BROMO-4-CHLORO-3-FORMYLCOUMARIN; 6-BROMO-4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 6-CHLORO-4-HYDROXY-7-METHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 6-FLUORO-4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 7-(DIETHYLAMINO)-4-HYDROXY-2-OXOCHROMENE-3-CARBALDEHYDE; 7-DIETHYLAMINO-3-FORMYLCOUMARIN; 8-METHYL-10-OXO-2,3,5,6-TETRAHYDRO-1H,4H,10H-11-OXA-3A-AZA-BENZO[DE]ANTHRACENE-9-CARBALDEHYDE; BENZYL 3-OXOPROPANOATE; BUTYRAMIDO-MALONALDEHYDIC ACID; DIETHYL FORMYLSUCCINATE; DIMETHYL 2-FORMYLSUCCINATE; ETHYL 1-FORMYLCYCLOBUTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOHEXANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPENTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPROPANECARBOXYLATE; ETHYL 2-(4-BROMOPHENYL)-3-OXOPROPANOATE; ETHYL 2-CHLORO-3-OXOPROPANOATE; ETHYL 2-FORMYLBUTANOATE; ETHYL 3-DIMETHYLAMINO-2-FORMYLACRYLATE; ETHYL 3-OXO-2-PHENYLPROPANOATE; MALONALDEHYDIC ACID, N-METHYLACETAMIDO-, ETHYL ESTER; METHYL 2-(2-BROMOPHENYL)-2-FORMYLACETATE; METHYL 2-CHLORO-2-FORMYLACETATE; METHYL 2-METHYL-3-OXOPROPIONATE; METHYL 3-N,N-DIMETHYLAMINO-2-FORMYLACRYLATE; METHYL 3-OXOPROPANOATE; METHYL A-FORMYLPHENYLACETATE; PHENACETURIC ACID,-ALPHA-FORMYL-ALPHA-METHYL-; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (R)—; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (S)—; ZINC(II) 2-(CARBOXYMETHYL)-2-FORMYLSUCCINATE;
β-keto-amides: (2S)-1-(3-FORMYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)PYRROLIDINE-2-CARBOXAMIDE; (5-FORMYL-4-HYDROXY-6-OXO-3-PHENYLPYRIDAZIN-1(6H)-YL)ACETIC ACID; (5-FORMYL-6-OXO-3-TRIFLUOROMETHYL-6H-PYRIDAZIN-1-YL)-ACETIC ACID ETHYL ESTER; 1-((2R,4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; DIMETHYLPHENYL)-3-METHYL-5-OXO-3-PYRAZOLIN-4-CARBALDEHYDE; 1-(4-METHOXY-BENZYL)-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6,8-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6-METHYL-2-OXO-3-PYRIDINECARBOXALDEHYDE; 1,2-DIHYDRO-7,8-DIMETHYL-2-OXO-QUINOLINE-3-CARBOXALDEHYDE; 1,2-DIHYDRO-7-METHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-8-METHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,3,6-TRIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 1,3-DIMETHYL-2,4,6-TRIOXO-HEXAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-(PROPYLAMINO)-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-6-(METHYLAMINO)-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 11-CHLORO-13-OXO-8-OXA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 11-CHLORO-13-OXO-8-THIA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 1-CYCLOOCTYL-6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 1-ETHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-ETHYL-7-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-AMINO-6,7-DIHYDRO-2,3-DIMETHYL-6-OXO-; 1-ISOBUTYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-ISOBUTYL-6-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-ISOBUTYL-6-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 2-((2-HYDROXYETHYL)AMINO)-9-ME-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-((2-METHOXYETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-((FURAN-2-YLMETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(2,6-DIMETHYL-4-MORPHOLINYL)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(2-CHLOROANILINO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(2-FLUOROANILINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(3,5-DIMETHYLPIPERIDIN-1-YL)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(3-FLUORO-PHENYL)-6-METHOXY-3-OXO-2,3-DIHYDRO-ISOQUINOLINE-4-CARBALDEHYDE; 2-(4-ETHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-FLUOROPHENOXY)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-METHOXYPHENOXY)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-METHYL-1-PIPERIDINYL)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(4-METHYLPIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(ALLYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(AZEPAN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(AZEPAN-1-YL)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLTHIO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(BUTYLTHIO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(DIMETHYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(ETHYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2,3-DIHYDRO-5-METHYL-3-OXO-2-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 2,4,6-TRIOXO-HEXAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 2,4-DIAMINO-6-OXO-1,6-DIHYDRO-5-PYRIMIDINECARBALDEHYDE; 2,4-DIOXO-3,4-DIHYDRO-2H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2,6-DIAMINO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2,7-DICHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[(2-FURYLMETHYL)AMINO]-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[BENZYL(METHYL)AMINO]-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[ISOPROPYL(METHYL)AMINO]-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-AMINO-4-CHLORO-6-OXO-1H-PYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-6-CHLORO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2-ANILINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-AZEPAN-1-YL-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-1-ETHYL-5-FORMYL-4-METHYL-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBONITRILE; 2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-6-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-8-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIMETHYLAMINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIMETHYLAMINO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-FORMYL-3-METHYL-1-OXO-1,5-DIHYDRO-BENZO[4,5]IMIDAZO[1,2-A]PYRIDINE-4-CARBONITRILE; 2-HYDROXY-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-METHYL-5-(MORPHOLIN-4-YL)-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBALDEHYDE; 2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-OXO-1,2,6,7,8,9-HEXAHYDROBENZO[G]QUINOLINE-3-CARBALDEHYDE; 2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 2-OXO-1-PHENYLINDOLINE-3-CARBALDEHYDE; 2-OXO-5-PROPYLINDOLINE-3-CARBALDEHYDE; 2-OXOINDOLINE-3-CARBALDEHYDE; (CHLOROMETHYL)-2-FORMYL-1-OXO-1,5-DIHYDROPYRIDO[1,2-A]BENZIMIDAZOLE-4-CARBONITRILE; 3,4-DIHYDRO-3-OXO-2-QUINOXALINECARBOXALDEHYDE; 3-METHYL-5-OXO-1-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-4-CARBALDEHYDE; 4-ANTIPYRINECARBOXALDEHYDE; 4-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 4-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 4-OXO-1,2-DIHYDRO-4H-PYRROLO[3,2,1-IJ]QUINOLINE-5-CARBALDEHYDE; 4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBOXALDEHYDE; 4-OXO-2-(PHENYLTHIO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-P-TOLYLSULFANYL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-PYRROLIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-THIOMORPHOLIN-4-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 5,7-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 5,8-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 5-BROMO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-CHLORO-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ETHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ETHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-FORMYLURACIL; 5-FORMYLURIDINE; 5-ISOPROPYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 5-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-OXO-2,3-DIHYDRO-1H,5H-PYRIDO[3,2,1-IJ]QUINOLINE-6-CARBALDEHYDE; 6-(BROMOMETHYL)-1,3-DIETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-(BROMOMETHYL)-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-(ISOPROPYLAMINO)-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6,7-DIETHOXY-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 6-[(2-METHOXYETHYL)AMINO]-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-FURYLMETHYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(2-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(3-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1,3-DIETHYL-5-FORMYLURACIL; 6-AMINO-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-BENZYL-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-ISOBUTYL-3-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-2,4-DIOXO-1-(2-PHENYLETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1-(PYRIDIN-3-YLMETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-4-OXO-1-PHENYL-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-BROMO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-BROMO-2-OXO-1,2,3,4-TETRAHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-CHLORO-1,3-BIS(2-METHOXYETHYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-1,3-DIISOBUTYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 6-CHLORO-5-FORMYL-1,3-DIMETHYLURACIL; 6-DIMETHYLAMINO-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXALDEHYDE; 6-ETHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 6-HYDROXY-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-METHOXY-1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 6-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-METHYL-2-OXO-1,2-DIHYDROQUINOLIN-3-CARBALDEHYDE; 6-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 6-OXO-5,6-DIHYDRO-[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBALDEHYDE; 7-BROMO-2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-CHLORO-5-OXO-5H-THIAZOLO[3,2-A]PYRIMIDINE-6-CARBALDEHYDE; 7-ETHOXY-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-METHOXY-1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 7-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 7-METHYL-2-(4-METHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-2-(4-METHYL-PIPERIDIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-4-OXO-2-P-TOLYLAMINO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 7-METHYLSULFANYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 7-OXO-2,3,6,7-TETRAHYDRO-[1,4]DIOXINO[2,3-G]QUINOLINE-8-CARBALDEHYDE; 8-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 8-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 8-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 8-OXO-3,4,8,9-TETRAHYDRO-2H,7H-[1,4]DIOXEPINO[2,3-F]INDOLE-9-CARBALDEHYDE; 9-METHYL-2-(4-METHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-(4-METHYLPIPERIDIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-(METHYLOXY)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(2-PYRIMIDINYLAMINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(M-TOLYLOXY)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(PHENYLTHIO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-PYRROLIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-THIOMORPHOLIN-4-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; METHYL ((3-FORMYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDIN-2-YL)THIO)ACETATE; N′-(3-ETHYL-5-FORMYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-PYRIMIDIN-4-YL)-N,N-DIMETHYL-FORMAMIDINE; SODIUM 5-FORMYL-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-4-PYRIMIDINOLATE

Full text: Click here
Patent 2022

Example 1

[Figure (not displayed)]

Step 1 [0003]: To a stirred solution of methyl 2,4-dichloropyrimidine-6-carboxylate [0001] (5 g, 24.16 mmol) in acetonitrile (50 mL) was added 4,4-difluorocyclohexylamine hydrochloride [0002] (4.1 g, 24.158 mmol) and N,N-diisopropyl ethylamine (8.8 mL, 50.72 mmol) at rt and the mixture was stirred for 2 h. The reaction mixture was concentrated under reduced pressure. To the residue water (25 mL) was added, the solid thus formed was filtered and dried by suction to afford 4 g of crude which was purified by column chromatography using 15% ethyl acetate in pet ether as eluent to afford 2.8 g of methyl 2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidine-4-carboxylate [0003] as a white solid. MS(M+1)+=306.0.

Step 2[0004]: To a stirred solution of methyl 2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidine-4-carboxylate [0003] (0.5 g, 1.635 mmol) in tetrahydrofuran (10 mL) was added a solution of lithium aluminum hydride in tetrahydrofuran (2 M, 1.63 mL, 3.27 mmol) at 0° C. The reaction mixture was stirred at rt for 2 h. The reaction mixture was cooled to 0° C., quenched with saturated ammonium chloride solution (2 mL) and extracted with ethyl acetate (2×25 mL). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 0.4 g of crude (2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidin-4-yl)methanol [0004] as a brown gum. MS(M+1/M+3)+=278.2/280.2.

Step 3[0006 and 0007]: To a stirred solution of (2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidin-4-yl)methanol [0004] (1.7 g, 6.12 mmol) in acetonitrile (20 mL) were added ethyl-1H-pyrazole-3-carboxylate [0005] (0.87 g, 6.12 mmol) and cesium carbonate (2.99 g, 9.18 mmol). The reaction mixture was irradiated in microwave at 100° C. for 2 h. The reaction mixture was concentrated under reduced pressure. The residue was quenched with water (15 mL), acidified with 4 N HCl solutions (25 mL) and extracted with ethyl acetate (2×25 mL). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 1.5 g as a mixture of 1-(4-((4,4-difluorocyclohexyl)amino)-6-(hydroxymethyl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylic acid [0006] MS(M+1)+=354.1 and its ethyl ester [0007] MS(M+1)+=382.2.

Step 4[0007]: To a stirred solution of a mixture of 1-(4-((4,4-difluorocyclohexyl)amino)-6-(hydroxymethyl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylic acid [0006] and its ester [0007] (3 g, 8.4 mmol) in ethanol (30 mL) was added conc. sulfuric acid (0.923 mL, 16.98 mmol). The reaction mixture was refluxed at 85° C. for 5 h and concentrated under reduced pressure. The residue was quenched with water (15 mL), neutralized with saturated aqueous sodium bicarbonate solution (20 mL), extracted with ethyl acetate (2×100 mL). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 3.3 g of crude which was purified by column chromatography using 65% ethyl acetate in pet ether as eluent to afford 2 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(hydroxymethyl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0007] as an off-white solid. MS(M+1)+=381.8.

Step 5[0008]: To a stirred solution of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(hydroxymethyl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0007] (2 g, 5.24 mmol) in dichloromethane (10 mL) was added phosphorus tribromide (1.41 g, 5.24 mmol) at 0° C. The reaction mixture was stirred at rt for 1 h. The reaction mixture was quenched with ice cold water (50 mL) and extracted with dichloromethane (2×50 mL). The combined organic extracts was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by column chromatography using 35% ethyl acetate in pet ether as eluent to afford 0.7 g of ethyl 1-(4-(bromomethyl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0008] as a white solid. MS(M+1/M+3)+=444.2/446.1.

Example 2

[Figure (not displayed)]

Step 1[0010]: To a stirred solution of ethyl 1-(4-(bromomethyl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0008] (0.45 g, 1.01 mmol) in tetrahydrofuran (10 mL) were added 4-isopropyl-2-azetidinone [0009] (0.126 g) and sodium tert-butoxide (0.146 g, 1.52 mmol) at 0° C. The reaction mixture was stirred at same temperature for 30 min. The reaction mixture was quenched with water (15 mL) and extracted with ethyl acetate (2×50 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by column chromatography using 28% ethyl acetate in pet ether as eluent to afford ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-((2-isopropyl-4-oxoazetidin-1-yl)methyl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0010] as an off-white solid (0.28 g). MS(M+1)+=476.8.

Step 2[0011]: To a stirred solution of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-((2-isopropyl-4-oxoazetidin-1-yl)methyl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0010] (0.28 g, 0.58 mmol) in tetrahydrofuran (5 mL) was added lithium borohydride (0.038 g, 1.76 mmol) at 0° C. The reaction mixture was stirred at rt for 1.5 h, quenched with ice and extracted with ethyl acetate (2×15 mL). The combined organic layer was washed with brine (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 1-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)-4-isopropylazetidin-2-one [0011] as a white solid (0.220 g). MS(M+1)+=434.9.

Step 3[0012]: To a stirred solution of 1-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)-4-isopropylazetidin-2-one [0011] (0.22 g, 0.506 mmol) in dichloromethane (5 mL) was added diethylaminosulfur trifluoride (0.133 mL, 1.01 mmol) at 0° C. The reaction mixture was stirred at rt for 15 min, quenched with 10% sodium bicarbonate solution (10 mL) and extracted with dichloromethane (2×20 mL). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude which was purified by column chromatography using 32% ethyl acetate in pet ether as eluent to obtain 1-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)-4-isopropylazetidin-2-one [0012], Compound 325 as a white solid (0.037 g).

MS(M+1)+=437.2, 1H NMR (400 MHz, DMSO-d6) δ 8.52 (d, J=2.4 Hz, 1H), 7.63 (d, J=6.4 Hz, 1H), 6.60 (s, 1H), 6.40 (s, 1H), 5.45 (d, JF=48 Hz, 2H), 4.35 (d, J=16.8 Hz, 1H), 4.11 (d, J=16.1 Hz, 2H), 3.59 (s, 1H), 3.55 (m, 1H), 2.92 (dd, J=14.8, 5.2 Hz, 1H), 2.65 (m, 1H), 2.18-1.90 (m, 6H), 1.70-1.60 (m, 2H), 0.88 (dd, J=24 Hz, 6.8 Hz, 6H).

Example 3

[Figure (not displayed)]

Step 1[0014]: To a stirred solution of ethyl 1-(4-(bromomethyl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0008] (0.5 g, 1.012 mmol) in tetrahydrofuran (5 mL) was added 2-pyrrolidone [0013] (0.478 g, 5.63 mmol) and potassium tert-butoxide (0.151 g, 1.351 mmol) at 0° C. The reaction mixture was stirred at same temperature for 15 min. The reaction mixture was quenched with water (10 mL) and extracted with ethyl acetate (2×25 mL). The combined organic extract was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue of was purified by column chromatography using 65% ethyl acetate in pet ether as eluent to afford ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-((2-oxopyrrolidin-1-yl)methyl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0014] as a white solid (0.25 g). MS(M+1)+=449.3.

Step 2[0015]: The procedure is similar to step 2[0011] in example 2. 0.25 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-((2-oxopyrrolidin-1-yl)methyl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0014] gave 0.2 g of 1-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl) pyrrolidin-2-one [0015] as a brown solid. MS(M+1)+=407.4.

Step 3[0016]: The procedure is similar to step 3[0012] in example 2. 0.2 g of 1-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl) pyrrolidin-2-one [0015] gave 0.035 g of 1-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)pyrrolidin-2-one [0016], Compound 321 as a white solid. MS(M+1)+=409.2, 1H NMR (400 MHz, DMSO-d6) δ 8.62 (s, 1H), 7.78 (d, J=7.2 Hz, 1H), 6.66 (dd, J=2.6, 1.3 Hz, 1H), 6.20 (s, 1H), 5.45 (d, JF=48.0 Hz, 2H), 4.27 (s, 2H), 4.18 (bs, 1H), 3.42 (t, J=6.84 Hz, 2H), 2.33 (t, J=8.0 Hz, 2H), 2.15-1.90 (m, 8H), 1.65-1.5 (m, 2H).

Example 4

[Figure (not displayed)]

Step 1[0018]: To a stirred solution of ethyl 1-(4-(bromomethyl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0008] (0.5 g, 1.126 mmol) in acetonitrile (10 mL) were added 3,5-dimethyl pyrazole [0017] (0.119 g, 1.23 mmol) and cesium carbonate (0.550 g, 1.69 mmol). The reaction mixture was irradiated in microwave at 100° C. for 1 h, added water (10 mL) and extracted with ethyl acetate (2×15 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by column chromatography using 55% ethyl acetate in pet ether as eluent to afford 0.23 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0018] as an off-white solid. MS(M+1)+=460.2.

Step 2[0019]: To a stirred solution of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0018] (0.220 g, 0.478 mmol) in tetrahydrofuran (5 mL) was added a solution of lithium aluminium hydride in tetrahydrofuran (478 mL, 2 M, 0.957 mmol) at 0° C. The reaction mixture was stirred at rt for 1 h. The reaction mixture was quenched with saturated aqueous ammonium chloride solution (3 mL) and extracted with ethyl acetate (2×25 mL). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated to afford N-(4,4-difluorocyclohexyl)-6-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-amine [0019] as an off-white solid (0.2 g). MS(M+1)+=418.2.

Step 3[0020]: The procedure is similar to step 3[0012] in example 2. 0.2 g of N-(4,4-difluorocyclohexyl)-6-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-amine [0019] gave 0.036 g of N-(4,4-difluorocyclohexyl)-6-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-amine [0020], Compound 300 as an off-white solid. MS(M+1)+=420.2/421.2, 1H NMR (400 MHz, DMSO-d6) δ 8.62 (s, 1H), 7.82 (d, J=7.4 Hz, 1H), 6.67 (d, J=2.6 Hz, 1H), 5.93 (s, 1H), 5.66 (s, 1H), 5.52-5.40 (d, JF=49.96 Hz, 2H), 5.09 (s, 2H), 4.16 (s, 1H), 2.21 (s, 3H), 2.13 (s, 3H), 2.04-1.92 (m, 6H), 1.54-1.51 (m, 2H).

Example 5

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0022]: 0.850 g of ethyl 1-(4-(bromomethyl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0008] gave 0.830 g of ethyl 1-(4-(((1-(tert-butoxycarbonyl)azetidin-3-yl)oxy)methyl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0022] as a white solid. (Potassium tert-butoxide in tetrahydrofuran at rt, 10 min) MS(M+1)+=537.9.

Step 2[0023]: The procedure is similar to step 2 [0019] in example 4. 0.830 g of ethyl 1-(4-(((1-(tert-butoxycarbonyl)azetidin-3-yl)oxy)methyl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0022] gave 0.570 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methoxy)azetidine-1-carboxylate [0023] as an off-white solid. MS (M+1)+=494.8.

Step 3 [0024]: The procedure is similar to step 3[0012] in example 2. 0.560 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methoxy)azetidine-1-carboxylate [0023] gave 0.225 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methoxy)azetidine-1-carboxylate [0024] as a white solid. MS(M+1)+=496.9.

Step 4 [0025]: To a stirred solution of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methoxy)azetidine-1-carboxylate [0024] (0.2 g, 0.402 mmol) in dichloromethane (5 mL) was added trifluoroacetic acid (0.468 mL, 6.042 mmol) at 0° C. and the mixture was stirred at rt for 2 h. The reaction mixture was concentrated under reduced pressure to afford 0.180 g of 6-((azetidin-3-yloxy)methyl)-N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-amine [0025] as an off-white solid. MS(M+1)+=397.3

Step 5 [0027]: To a stirred solution of 6-((azetidin-3-yloxy)methyl)-N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-amine [0025] (0.180 g, 0.454 mmol) in dichloromethane (5 mL) were added triethylamine (0.17 mL, 1.20 mmol) and methyl chloroformate (0.180 g, 0.81 mmol) at 0° C. The reaction mixture was stirred at same temperature for 10 min., partitioned between dichloromethane (10 mL) and water (3 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude was purified by column chromatography using 75% ethyl acetate in pet ether as eluent to afford 0.125 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methoxy)azetidine-1-carboxylate [0027], Compound 335 as a white solid.

MS(M+1)+=455.2, 1H-NMR (400 MHz, DMSO-d6): δ 8.61 (s, 1H), 7.85 (d, J=6.84 Hz, 1H), 6.64 (s, 1H), 6.52 (s, 1H), 5.45 (d, JF=48.0 Hz, 2H), 4.46 (s, 1H), 4.39 (s, 2H), 4.16-4.14 (m, 3H), 3.82 (s, 2H), 3.56 (s, 3H) 2.15-1.88 (m, 6H), 1.65-1.5 (m, 2H).

Example 6

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0028]: To a stirred solution of methyl-2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidine-4-carboxylate [0003] (6.6 g, 21.589 mmol) in methanol was added methanolic ammonia (60 mL) at rt. After 2 h the reaction mixture was purged with nitrogen to remove excess ammonia and then concentrated under reduced pressure. The residue was diluted with water (100 mL) and stirred for 10 min. The solid formed was filtered, washed with water (25 mL) and dried under vacuum to afford 2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidine-4-carboxamide [0028] as a white solid (5.5 g MS(M+1)+=291.1) and was taken as such tonext step.

Step 2[0029]: To a suspension of 2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidine-4-carboxamide [0028] (5.5 g, 18.92 mmol) in dichloromethane was added triethylamine (9.57 g, 94.6 mmol) and phosphorus oxychloride (7.25 g, 47.3 mmol) at 0° C. and the reaction mixture was stirred at rt. After 1 h the reaction mixture was quenched with ice (100 g) and extracted with dichloromethane (2×100 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford brown oil which was purified by column chromatography using 30% ethyl acetate in hexane as eluent to afford 2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidine-4-carbonitrile [0029] as a pale yellow solid (3.6 g, 70% yield). MS(M+1)+=273.1.

Step 3[0030]: To a solution of 2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidine-4-carbonitrile [0029] (3.6 g, 13.302 mmol) in tetrahydrofuran was added a solution of lithium aluminium hydride in tetrahydrofuran (9.9 mL, 2M solution, 19.803 mmol) at −15° C. and the reaction mixture was stirred at same temperature. Reaction turned dark brown after LAH addition. After 10 min, the reaction mixture was quenched with saturated aqueous sodium sulfate solution at 0° C. and stirred at rt. The suspension was passed through celite bed, washed with chloroform (50 mL). The filtrate was concentrated under reduced pressure to afford 6-(aminomethyl)-2-chloro-N-(4,4-difluorocyclohexyl)pyrimidin-4-amine [0030] as red oil (4.2 g, MS(M+1)+=277.2) and it was taken as such tonext step.

Step 4[0031]: To a solution of 6-(aminomethyl)-2-chloro-N-(4,4-difluorocyclohexyl)pyrimidin-4-amine [0030] (4.2 g, 15.178 mmol) in dichloromethane were added triethylamine (2.3 g, 22.76 mmol) and boc-anhydride (3.9 g, 18.213 mmol) at 0° C. and the reaction mixture was stirred at same temperature. After 1 h, the reaction mixture was quenched with ice and extracted with dichloromethane (2×100 mL). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford as brown oil, which was purified by column chromatography using 30% ethyl acetate in hexane as eluent to afford tert-butyl ((2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidin-4-yl)methyl)carbamate [0031] as a pale yellow solid (2.3 g). MS(M+1)+=377.2.

Step 5[0032]: To a solution of tert-butyl ((2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidin-4-yl)methyl)carbamate [0031] (4.2 g, 15.178 mmol) and ethyl-1H-pyrazole-3-carboxylate [0005] (4.2 g, 15.178 mmol) in acetonitrile was added cesium carbonate (4.2 g, 15.178 mmol) and the reaction mixture was heated at 85° C. in sealed tube. After 2 h, the reaction mixture was filtered, washed with chloroform (50 mL). The combined filtrate was concentrated under reduced pressure to afford pale brown oil which was purified by column chromatography using 35% ethyl acetate in hexane as eluent to afford ethyl 1-(4-(((tert-butoxycarbonyl)amino)methyl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0032] as a pale yellow solid (2.2 g). MS(M+1)+=481.3.

Step 6[0033]: To a solution of ethyl 1-(4-(((tert-butoxycarbonyl)amino)methyl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0032] (2.2 g, 4.578 mmol) in tetrahydrofuran was added a solution of lithium aluminum hydride in tetrahydrofuran (3.43 mL, 2 M, 6.867 mmol) at −20° C. and the reaction mixture was stirred at rt. After 30 min, the reaction mixture was quenched with saturated aqueous sodium sulfate solution at 0° C. and stirred at rt for 10 min. The mixture was passed through celite bed, washed with ethyl acetate (50 mL). The combined filtrate was concentrated under reduced pressure to afford tert-butyl ((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)carbamate [0033] as an off-white solid (1.9 g).

MS(M+1)+=439.1.

Step 7[0034]: To a solution of tert-butyl ((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)carbamate [0033] (1.9 g, 4.333 mmol) in dichloromethane was added diethylaminosulfur trifluoride (1.0 g, 6.499 mmol) at −20° C. and the reaction mixture was stirred at same temperature for 15 min, quenched with saturated aqueous sodium bicarbonate solution at 0° C. and extracted with dichloromethane (2×50 mL). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford a red solid which was purified by column chromatography using 35% ethyl acetate in hexane as eluent to afford tert-butyl ((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)carbamate[0034] as off-white solid (0.75 g). MS(M+1)+=441.2.

Step 8[0036]: To a solution of tert-butyl ((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)carbamate [0034] (0.15 g, 0.340 mmol) in dichloromethane was added dry hydrogen chloride in dioxane (4M) at 0° C. and the reaction mixture was stirred at rt for 1 h, concentrated under reduced pressure and the residue was diluted with dichloromethane (20 mL). To the solution was added triethylamine (˜1.5 mL) at 0° C. followed by acetyl chloride (0.054 g, 0.68 mmol). After 10 min, the reaction mixture was quenched with water, extracted with dichloromethane, washed with water and brine solution. The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford N-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)acetamide [0036], Compound 327 as an off-white solid (0.055 g). MS(M+1)+=383.2, 1H NMR (400 MHz, DMSO-d6) δ 8.63 (s, 1H), 8.49 (s, 1H), 7.81 (s, 1H), 6.65 (s, 1H), 6.28 (s, 1H), 5.42 (d, JF=48 Hz, 2H), 4.13 (bs, 3H), 2.15-1.90 (m, 9H), 1.62-1.45 (m, 2H).

Example 7

[Figure (not displayed)]

Step 1[0038]: To a solution of cyclobutanecarboxylic acid (0.3 g, 2.99 mmol) in dichloromethane was added oxalyl chloride (1.14 g, 8.98 mmol) and N,N-dimethylformamide (0.02 g, 0.3 mmol) at 0° C. and the reaction mixture was stirred rt. After 1 h, the reaction mixture was concentrated under reduced pressure to afford cyclobutanecarbonyl chloride [0038] as brown oil (0.4 g). This was taken as such tonext step.

Step 2[0039]: The procedure is similar to Step 8[0036] in example 6. 0.3 g of tert-butyl ((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)carbamate[0034] gave 0.098 g of N-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)cyclobutanecarboxamide [0039], Compound 328 as pale brown solid. MS(M+1)+=423.2; 1H NMR (400 MHz, DMSO-d6) δ 8.61 (s, 1H), 8.26 (s, 1H), 7.80 (s, 1H), 6.64 (s, 1H), 6.21 (s, 1H), 5.45 (d, JF=48 Hz, 2H), 4.12 (bs, 3H), 3.19-3.07 (m, 1H), 2.25-2.13 (m, 2H), 2.12-1.85 (m, 9H), 1.85-1.75 (m, 1H), 1.65-1.50 (m, 2H).

Example 8

[Figure (not displayed)]

Step 1[0040]: To a solution of tert-butyl ((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)carbamate [0034] (0.3 g, 0.68 mmol) in dichloromethane was added 4M HCl in dioxane (5 mL) at 0° C. and the reaction mixture was stirred at rt for 1 h, concentrated under reduced pressure to afford 6-(aminomethyl)-N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-amine [0040] as an off-white solid. This was taken as such tonext step.

Step 2[0042]: To a solution of 3-oxetanecarboxylic acid [0041] (0.140 g, 1.38 mmol) in N,N-dimethylformamide was added 1-propanephosphonic acid cyclic anhydride ((1.317 g, 2.07 mmol), triethylamine (0.209 g, 2.07 mmol) at 0° C. and the reaction mixture was stirred at rt. After 15 min, 6-(aminomethyl)-N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-amine [0040] (0.26 g, 0.69 mmol) was added to the reaction mixture at 0° C. and stirred at rt for 16 h. The reaction mixture was quenched with water, extracted with ethyl acetate, washed with water and brine. The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford brown oil, which was purified in the Reveleris flash system using ethyl acetate in hexane followed by methanol in chloroform as eluents in 12 g column. The product was isolated at 07% methanol in chloroform as eluent to afford N-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)methyl)oxetane-3-carboxamide, Compound 333 [0042] as a white solid (0.05 g). MS(M+1)+=425.2; 1H NMR (400 MHz, DMSO-d6) δ 8.63 (bs, 1H), 8.54 (bs, 1H), 7.82 (s, 1H), 6.66 (s, 1H), 6.24 (s, 1H), 5.45 (d, JF=48 Hz, 1H), 4.69 (d, J=7.9 Hz, 4H), 4.19 (s, 3H), 3.92-3.82 (m, 1H), 2.12-1.92 (m, 7H), 1.57 (bs, 2H).

Example 9

[Figure (not displayed)]

Step 1[0044]: The procedure is similar to step 1[0003] in Example 1. 1 g of methyl-2,4-dichloropyrimidine-6-carboxylate [0001] gave 1.1 g of methyl 2-chloro-6-((3,3-difluorocyclohexyl)amino)pyrimidine-4-carboxylate [0044] as a white solid.

MS(M+1)+=306.7.

Step 2[0045]: The procedure is similar to step 3[0004] in Example 1. 1.1 g of methyl 2-chloro-6-((3,3-difluorocyclohexyl)amino)pyrimidine-4-carboxylate [0044] gave 2 g of 6-((3,3-difluoro cyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylic acid [0045] as yellow solid. MS(M−1)=350.0. This was taken as such tonext step.

Step 3[0046] Compound 350: To a solution of 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylicacid [0045] (1.9 g, 5.407 mmol) in dichloromethane (10 mL) was added oxalyl chloride (2.74 g, 21.63 mmol) and N,N-dimethylformamide (0.04 g, 0.54 mmol) drop wise at 0° C. Then the reaction mixture was stirred at rt for 1 h. The reaction mixture was concentrated under reduced pressure under N2 atm to afford 2.2 g of 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbonyl chloride. 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbonyl chloride was dissolved in tetrahydrofuran (10 mL) and the reaction mixture was purged with ammonia gas at −10° C. for 15 min. The reaction mixture was concentrated under reduced pressure to afford crude was purified by column chromatography using 6% methanol in chloroform as a solvent to afford 0.4 g of 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxamide (Compound 350) [0046] as an off-white solid.

MS(M+1)+=351.2. 1H-NMR (400 MHz, DMSO-d6): δ 8.10 (d, J=7.60 Hz, 1H), 7.80 (s, 1H), 7.73 (s, 1H), 6.97 (s, 1H), 6.09 (s, 1H), 4.09 (bs, 1H), 2.54 (s, 3H), 2.44 (bs, 1H), 2.18 (s, 3H), 2.12-1.70 (m, 5H), 1.55-1.30 (m, 2H).

Step 4[0047] Compound 351: To a solution of 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxamide [0046] (0.35 g, 0.99 mmol) in dichloromethane was added triethylamine (0.50 g, 4.99 mmol) and trifluoromethanesulfonic anhydride (0.71 g, 2.49 mmol) at 0° C. and the reaction mixture was stirred at same temperature. After 1 h, the reaction mixture was quenched with ice and extracted with chloroform, washed with water and brine solution. The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford a pale brown solid, was purified in the Reveleris flash system instrument using ethyl acetate in hexane as solvent in 24 g column to afford 0.24 g of 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbonitrile (Compound 351) [0047] as an off-white solid. MS(M+1)+=333.2. 1H NMR (400 MHz, DMSO-d6) δ 8.42 (d, J=7.5 Hz, 1H), 6.85 (s, 1H), 6.12 (s, 1H), 4.07 (bs, 1H), 2.54 (s, 3H), 2.42-2.32 (m, 1H), 2.17 (s, 3H), 2.03-1.70 (m, 5H), 1.50-1.32 (m, 2H).

Example 10

[Figure (not displayed)]

Step 1[0048]: To a solution of 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylic acid [0045](0.52 g, 1.48 mmol) in N,N-dimethylformamide (5 mL) was added N,N-diisopropyl ethylamine (1.28 mL, 7.4 mmol), followed by N,O-dimethylhydroxylamine (0.22 g, 2.22 mmol) hydrochloride and HBTU (0.67 g, 1.776). The reaction mixture was stirred at rt for 3 h. The reaction mixture was quenched with ice, extracted with ethyl acetate (2×20 mL). The combined organic layer was washed with water (20 mL), followed by brine (20 mL), dried over anhydrous sodium sulfate to afford 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-N-methoxy-N-methylpyrimidine-4-carboxamide [0048] as a yellow solid (0.6 g). MS(M+1)+=395.0

Step 2[0049] Compound 352: To a solution of 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-N-methoxy-N-methylpyrimidine-4-carboxamide [0045] (0.33 g, 0.836 mmol) in tetrahydrofuran (7 mL) at −70° C. was added methyl magnesium bromide ((3 M solution in tetrahydrofuran) 2.23 mL, 6.69 mmol) drop wise. The reaction mixture was stirred at rt for 10 min. The reaction mixture was quenched with saturated solution of ammonium chloride (5 mL), extracted with ethyl acetate (2×20 mL). The combined organic layer was washed with brine (10 mL) and dried over anhydrous sodium sulfate to afford 0.6 g of crude product which was purified by column chromatography using 56% ethyl acetate in pet ether as eluent to afford 1-(6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)ethan-1-one (Compound 352) [0049] of as a white solid (0.150 g). MS(M+1)+=350.2, 1H NMR (400 MHz, DMSO-d6) δ 8.12 (d, J=7.6 Hz, 1H), 6.84 (s, 1H), 6.12 (s, 1H), 4.13 (s, 1H), 2.56 (d, J=9.1 Hz, 6H), 2.20 (s, 3H), 2.05-1.73 (m, 6H), 1.52-1.31 (m, 2H).

Step 3[0050] Compound 353: To a cooled solution of 1-(6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)ethan-1-one [0049] (0.17 g, 0.486 mmol) in methanol (3 mL) was added sodium borohydride (0.018 g, 0.486 mmol). The reaction mixture was stirred at rt for 10 min, concentrated under reduced pressure, dissolved in water (5 mL), neutralized with 1.5 N HCl solutions (10 mL) and extracted with ethyl acetate (2×20 mL). The combined organic layer was washed with brine (10 mL), dried over anhydrous sodium sulfate to afford 1-(6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)ethan-1-ol (Compound 353) [0050] as a white solid (0.160 g). MS(M+1)+=352.2, 1H-NMR (400 MHz, DMSO-d6): δ 7.70 (s, 1H), 6.51 (s, 1H), 6.03 (s, 1H), 5.36 (s, 1H), 4.46 (s, 1H), 4.07 (s, 2H), 3.32 (m, 1H), 2.16 (s, 1H), 1.99 (s, 3H), 1.95-1.91 (m, 3H), 1.80-1.73 (m, 5H), 1.44-1.38 (m, 2H), 1.34-1.28 (m, 5H),

Step 4[0051 and 0052] Compound 354 and 355: The isomers were separated by Supercritical Fluid Chromatography (SFC) to afford 0.040 g of (+)-1-(6-(((S)-3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)ethan-1-ol (Compound 354) [0051] as a yellow solid MS(M+1)+=352.2, 1H-NMR (400 MHz, DMSO-d6): δ 7.70 (d, J=6.76 Hz, 1H), 6.51 (s, 1H), 6.03 (s, 1H), 5.36 (d, J=4.12 Hz, 1H), 4.46 (t, J=5.36 Hz, 1H), 4.07 (bs, 1H), 2.56 (s, 2H), 2.49-2.48 (m, 1H), 2.16 (s, 3H), 2.10-1.56 (m, 6H), 1.50-1.49 (m, 1H), 1.48-1.35 (m, 4H), and (−)-1-(6-(((S)-3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)ethan-1-ol (Compound 355) [0052] as a yellow solid. MS(M+1)+=352.2, 1H-NMR (400 MHz, DMSO-d6): δ 7.70 (bs, 1H), 6.51 (s, 1H), 6.03 (s, 1H), 5.36 (s, 1H), 4.46 (bs, 1H), 4.07 (bs, 2H), 3.32 (m, 1H), 2.48-2.47 (m, 1H), 2.16 (s, 2H), 2.01-1.99 (m, 3H), 1.99-1.56 (m, 4H), 1.56-1.49 (m, 1H), 1.49-1.30 (m, 4H).

Example 11

[Figure (not displayed)]

Step 1[0053]: Concentrated sulfuric acid (5 mL, 93.80 mmol) was added to a solution of 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylicacid [0045] (1.1 g, 3.130 mmol) in ethanol (20 mL), after addition the reaction mixture was heated at 75° C. for 5 h, concentrated under reduced pressure, diluted with water (20 mL), cooled to 5° C., basified with solid sodium carbonate till pH˜10 and extracted with ethyl acetate (2×100 mL). The combined organic layers were washed with brine (3×300 mL), dried over anhydrous sodium sulfate, filtered and concentrated to afford 1.2 g of ethyl 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylate. This was purified by column chromatography using 20% ethyl acetate in pet ether as eluent to afford ethyl 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylate [0053] as a yellow solid (0.660 g). MS(M+1)+=380.0

Step 2[0054] Compound 356: To a solution of ethyl 6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylate [0053] (0.15 g, 0.395 mmol) in tetrahydrofuran (2 mL), was added methyl magnesium bromide (3 M solution in tetrahydrofuran) 0.32 mL, 0.988 mmol)) drop-wise at 0° C. after addition the reaction mixture was stirred at rt for 3 h. The reaction mixture was cooled to 0° C. and quenched with (1.5 N) HCl solutions (5 mL). It was then extracted with ethyl acetate (2×30 mL). The combined organic layer was washed with water (20 mL), followed by brine (20 mL) and dried over anhydrous sodium sulfate to afford crude product which was purified by preparative HPLC to afford 2-(6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)propan-2-ol (Compound 356) [0054] as an off-white solid (0.070 g). MS(M+1)+=366.2, 1H NMR (400 MHz, DMSO-d6) δ 7.68 (bs, 1H), 6.64 (s, 1H), 6.04 (s, 1H), 5.18 (s, 1H), 4.10 (bs, 1H), 2.48 (s, 3H), 2.58-2.45 (m, 1H), 2.17 (s, 3H), 2.08-1.89 (m, 2H), 1.89-1.65 (m, 3H), 1.55-1.43 (m, 1H), 1.37 (s, 6H), 1.33-1.29 (m, 1H).

Example 13

[Figure (not displayed)]

Step 1[0056] Compound 358: To a solution of (6-((3,3-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)methanol [0055] (0.1 g, 0.296 mmol) in dichloromethane (10 mL) was added diethylaminosulfur trifluoride (0.095 g, 0.592 mmol) drop-wise at 0° C., after addition the reaction mixture was stirred at rt for 18 h. The reaction mixture was diluted with dichloromethane (20 mL). The organic layer was washed with 10% sodium bicarbonate solution (15 mL) to afford crude product which was purified by preparative HPLC to afford N-(3,3-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(fluoromethyl)pyrimidin-4-amine (Compound 358) [0056] as a yellow solid (0.050 g). MS(M+1)+=340.2, 1H NMR (400 MHz, DMSO-d6) δ 7.89 (d, J=7.5 Hz, 1H), 6.43 (s, 1H), 6.07 (s, 1H), 5.31 (d, JF=46.3 Hz, 2H), 4.09 (bs, 1H), 2.53 (s, 3H), 2.49-2.40 (m, 1H), 2.16 (s, 3H), 2.08-1.92 (m, 2H), 1.92-1.65 (m, 3H), 1.55-1.25 (m, 2H).

Example 14

[Figure (not displayed)]

Step 1[0057]: The procedure is similar to step 3[0006] in example 1. 2.2 g of methyl 2-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidine-4-carboxylate [0003] gave 2.8 g of 6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylic acid [0057] as a yellowish solid. MS(M+1)+=352.0.

Step 2[0058]: The procedure is similar to step 4[0007] in example 1, 0.9 g of 6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylic acid [0057] gave 0.71 g of methyl 6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylate [0058] as an yellow solid. MS(M+1)+=366.2.

Step 3[0059] The procedure is similar to step 2[0049] in example 10. 0.65 g of methyl 6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylate [0058] gave 0.13 g of 2-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)propan-2-ol [0059], Compound 152. MS(M+1)+=366.2, 1H-NMR (400 MHz, DMSO-d6): δ 7.62 (s, 1H), 6.64 (s, 1H), 6.03 (s, 1H), 5.17 (s, 1H), 4.05 (bs, 1H), 2.56 (s, 3H), 2.15 (s, 3H), 2.07-1.94 (m, 6H), 1.58-1.55 (m, 2H), 1.37 (s, 6H).

Example 15

[Figure (not displayed)]

Step 1[0060 and 0061] Lithium aluminum hydride (2M THF solution, 31.62 mmol) was added drop-wise at −78° C. to a solution of ethyl 6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylate [0058] (6 g, 15.814 mmol) in tetrahydrofuran (85 mL). After addition the reaction mixture was stirred at −78° C. for 3 h, quenched with water (25 mL) and extracted with ethyl acetate (3×500 mL). The combined organic layer was washed with brine (3×300 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford mixture an which was purified by column chromatography using 50% ethyl acetate in pet ether as eluent to afford of 6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbaldehyde [0060] as an yellow solid (1.2 g MS(M+1)+=338.0) and (6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)methanol [0061], Compound 137 as an yellow solid (2.1 g). MS(M+1)+=336.2, 1H NMR (400 MHz, DMSO-d6) δ 7.67 (d, J=7.7 Hz, 1H), 6.52 (s, 1H), 6.04 (s, 1H), 5.44 (t, J=5.9 Hz, 1H), 4.35 (d, J=5.6 Hz, 2H), 4.04 (bs, 1H), 2.56 (s, 3H), 2.16 (s, 3H), 2.10-1.85 (m, 6H), 1.65-1.56 (m, 2H).

Step 2[0062]: The procedure is similar to step 3[0012] in example 2. 0.25 g of (6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)methanol [0061] gave 0.05 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(fluoromethyl)pyrimidin-4-amine [0062], Compound 165 as an off-white solid.

MS(M+1)+=340.2, 1H-NMR (400 MHz, DMSO-d6): δ 7.83 (d, J=6.96 Hz, 1H), 6.41 (s, 1H), 6.05 (s, 1H), 5.30 (d, JF=46.3 Hz, 2H), 4.04 (bs, 1H), 2.52 (s, 3H), 2.14 (s, 3H), 2.07-1.94 (m, 6H), 1.57-1.54 (m, 2H),

Example 16

[Figure (not displayed)]

Step 1[0063]: The procedure is similar to step 2[0049] in example 10. 2.8 g of 6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbaldehyde [0060] gave 0.48 g of racemate 1-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)ethan-1-ol [0063], as an off-white solid. MS(M+1)+=352.2, 1H-NMR (400 MHz, DMSO-d6): δ 7.64 (d, J=7.20 Hz, 1H), 6.53 (s, 1H), 6.03 (s, 1H), 5.37 (s, 1H), 4.34 (bs, 1H), 4.10 (bs, 1H), 2.13 (s, 3H), 2.06-1.85 (m, 6H), 1.65-1.49 (m, 2H), 1.39-1.22 (m, 6H).

Step 2[0064 and 0065]: 0.48 g of 1-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)ethan-1-ol [63] was purified by chiral preparative HPLC to afford 0.12 g of (−)1-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)ethan-1-ol [0064], Compound 198 as an off-white solid. MS(M+1)+=352.2. SOR: −9.5°, solvent-methanol, concentration=0.2, Temp—27.5° C. 1H-NMR (400 MHz, DMSO-d6): δ 7.67 (d, J=7.48 Hz, 1H), 6.54 (s, 1H), 6.04 (s, 1H), 5.39 (s, 1H), 4.47 (s, 1H), 4.05 (bs, 1H), 2.52 (s, 3H), 2.16 (s, 3H), 2.06-1.94 (m, 6H), 1.58-1.55 (m, 2H), 1.31 (d, J=0.60 Hz, 3H), and 0.12 g of (+)1-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)ethan-1-ol [0065], Compound 199 as an off-white solid. MS(M+1)+=352.2. SOR: +2.5, Solvent-methanol, Concentration=0.200, Temp—27.3° C. 1H NMR (400 MHz, DMSO-d6) δ 7.67 (d, J=7.4 Hz, 1H), 6.54 (s, 1H), 6.04 (s, 1H), 5.39 (s, 1H), 4.47 (bs, 1H), 4.05 (bs, 1H), 2.52 (s, 3H), 2.17 (s, 3H), 2.17-1.85 (m, 6H), 1.65-1.57 (m, 2H), 1.33 (d, J=6.6 Hz, 3H).

Example 17

[Figure (not displayed)]

Step 1[0066]: The procedure is similar to step 3 [0012] in example 2. 0.21 g of 6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbaldehyde [11] gave 0.06 g of N-(4,4-difluorocyclohexyl)-6-(difluoromethyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0066], Compound 142 as an off-white solid. MS(M+1)+=358.2, 1H-NMR (400 MHz, DMSO-d6): δ 8.10 (d, J=7.04 Hz, 1H), 6.77 (t, JF=54.7 Hz, 1H), 6.60 (s, 1H), 6.10 (s, 1H), 4.08 (bs, 1H), 2.56 (s, 3H), 2.16 (s, 3H), 2.12-1.88 (m, 6H), 1.62-1.53 (m, 2H).

Example 18

[Figure (not displayed)]

Step 1[0068]: To a solution of 6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbaldehyde [0060] (0.35 g, 1.043 mmol) and morpholine [0067] (0.09 g, 1.047 mmol) in tetrahydrofuran (15 mL), was added titanium(IV)isopropoxide (0.61 g, 2.08 mmol) at 0° C. After addition the reaction mixture was stirred at rt for 4 h, cooled to 0° C., added ethanol (4 mL) and sodium borohydride in portions. After 16 h the reaction mixture was concentrated under reduced pressure and the residue was basified with sodium bicarbonate solution (25 mL) till pH ˜10, extracted with ethyl acetate (3×100 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product which was purified by column chromatography using 2% methanol in chloroform as eluent to afford of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(morpholinomethyl)pyrimidin-4-amine [0068], Compound 176 as an off-white solid (0.042 g). MS(M+1)+=407.2, 1H NMR (400 MHz, DMSO-d6) δ 7.66 (d, J=7.4 Hz, 1H), 6.50 (s, 1H), 6.04 (s, 1H), 4.03 (bs, 1H), 3.62 (t, J=4.7 Hz, 4H), 3.38 (s, 2H), 2.48 (s, 3H), 2.45 (s, 4H), 2.16 (s, 3H), 2.15-1.88 (m, 6H), 1.65-1.56 (m, 2H).

Example 19

[Figure (not displayed)]

Step 1 [0069]: To a solution of (6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)methanol [0061] (1.4 g, 4.14 mmol) in dichloromethane (55 mL) was added carbon tetrabromide (1.5 g, 4.564 mmol). The reaction mixture was stirred at rt for 16 h. The reaction mixture was diluted with water (25 mL) and extracted with dichloromethane (2×300 mL). The combined organic layer was washed with brine (25 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 6-(bromomethyl)-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0069] as a brownish gum (1.25 g). MS(M+1 and M+3)+=400.2/402.2

Step 2 [0071] NSSY5107.0001: 0.4 g of 6-(bromomethyl)-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0069] and N,N-dimethylamine [0070] (0.18 g, 3.99 mmol) in tetrahydrofuran was heated at 80° C. to afford 0.028 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-((dimethylamino)methyl)pyrimidin-4-amine [0071], Compound 177 as an off-white solid. MS(M+1)+=365.2, 1H NMR (400 MHz, Chloroform-d) δ 6.44 (s, 1H), 5.99 (s, 1H), 5.21 (bs, 1H), 3.89 (bs, 1H), 3.54 (s, 2H), 2.63 (s, 3H), 2.36 (s, 6H), 2.31 (s, 3H), 2.15-2.07 (m, 4H), 1.99-1.83 (m, 2H), 1.72-1.55 (m, 2H).

Example 21

[Figure (not displayed)]

Step 1[0074]: Sodium methoxide (0.33 g, 6.24 mmol) was added to a solution of 6-(bromomethyl)-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0069] (1.25 g, 3.122 mmol) in methanol (60 mL). After addition the reaction mixture was stirred at rt for 48 h, concentrated under reduced pressure, added saturated ammonium chloride solution (25 mL) and extracted with ethyl acetate (3×300 mL). The combined organic layer was washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude and which was purified by preparative HPLC to afford N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(methoxymethyl)pyrimidin-4-amine [0074] as an off-white solid (0.71 g). MS(M+1)+=352.0, 1H NMR (400 MHz, DMSO-d6) δ 7.70 (d, J=7.6 Hz, 1H), 6.43 (s, 1H), 6.05 (s, 1H), 4.30 (s, 2H), 4.04 (bs, 1H), 3.40 (s, 3H), 2.52 (s, 3H), 2.16 (s, 3H), 2.12-1.88 (m, 6H), 1.62-1.56 (m, 2H).

Example 22

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0076]: The procedure is similar to step 1[0003] in example 1. 2.0 g of methyl 2,6-dichloropyrimidine-4-carboxylate [0001] gave 2.56 g of methyl 2-chloro-6-((3,3-difluorocyclopentyl)amino)pyrimidine-4-carboxylate [0076] as a pale brown solid.

MS(M+1)+=292.

Step 2[0077]: The procedure is similar to step 3[0006] in example 1. 2.0 g of methyl 2-chloro-6-((3,3-difluorocyclopentyl)amino)pyrimidine-4-carboxylate [0076] gave 2.1 g of 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylic acid [0077] as a yellow solid. MS(M+1)+=338.

Step 3[0078]: To a solution of 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylic acid [0076] (0.5 g, 1.482 mmol) in dichloromethane (10 mL) was added oxalyl chloride (0.313 g, 3.70 mmol) and N,N-dimethylformamide (0.010 g, 0.148 mmol) drop wise at 0° C. Then the reaction mixture was stirred at rt for 1 h and concentrated under reduced pressure under N2 atm to afford 0.56 g of 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbonyl chloride. 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbonyl chloride (0.51 g, 1.40 mmol) was dissolved in tetrahydrofuran (10 mL) and purged with ammonia gas at −10° C. for 15 min. The reaction mixture was then concentrated under reduced pressure to afford crude which was purified by column chromatography using 6% methanol in chloroform as a eluent to afford 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxamide [33], Compound 183 as a pale brown solid (0.21 g). MS(M+1)+=337, 1H NMR (400 MHz, DMSO-d6): δ 8.27 (d, J=−6.80 Hz, 1H), 7.81 (s, 1H), 7.70 (s, 1H), 6.97 (s, 1H), 6.09 (s, 1H), 4.49-4.50 (m, 1H), 2.58-2.67 (m, 4H), 2.21-2.32 (m, 7H), 1.92-1.82 (m, 1H),

Step 4[0079]: The procedure is similar to Step 4[0047] in example 09. 0.18 g of 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxamide [0078] gave 0.1 g of 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbonitrile [0079], Compound 184 as an off-white solid.

MS(M+1)+=319, 1H NMR (400 MHz, DMSO-d6) δ 8.33 (d, J=2.4 Hz, 1H), 6.90 (s, 1H), 6.09 (s, 1H), 4.46 (bs, 1H), 2.80-257 (m, 1H), 2.55 (s, 3H), 2.35-2.28 (m 2H), 2.18 (s, 3H), 2.11-2.20 (m, 2H), 1.87-1.70 (m, 1H).

Example 23

[Figure (not displayed)]

Step 1[0080]: The procedure is similar to step 4[0007] in example 1. 2.1 g of 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylic acid [0077] gave 1.56 g of ethyl 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylate [0080] as a yellow gummy solid. MS(M+1)+=366.

Step 2[0081]: The procedure is similar to step 2[049] in example 10. 0.25 g of ethyl 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylate [0080] gave 0.03 g of 2-(6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)propan-2-ol [0081], Compound 214 as a yellow solid. MS(M+1)+=352, 1H NMR (400 MHz, DMSO-d6) δ 7.87 (bs, 1H), 6.64 (s, 1H), 6.05 (s, 1H), 5.20 (s, 1H), 4.49 (bs, 1H), 2.59 (m, 2H), 2.34-2.30 (m, 1H), 2.29 (s, 3H), 2.28-2.00 (m, 3H) 1.75 (m, 1H), 1.38 (s, 3H), 1.37 (s, 3H), 1.23 (m, 2H).

Example 24

[Figure (not displayed)]

Step 1[0082]: The procedure is similar to step 2 [0019] in Example 4. 0.18 g of ethyl 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carboxylate [0080] gave 0.04 g of (6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)methanol [0082], Compound 192 as a white solid.

MS(M+1)+=324, 1H NMR (400 MHz, DMSO-d6) δ 7.90 (d, J=7.0 Hz, 1H), 6.51 (s, 1H), 6.04 (s, 1H), 5.45 (t, J=5.8 Hz, 1H), 4.46 (bs, 1H), 4.36 (d, J=5.8 Hz, 2H), 2.58 (s, 3H), 2.37-2.19 (m, 2H), 2.16 (s, 3H), 2.35-1.98 (m, 3H), 1.75 (m, 1H).

Step 2 [0083]:0.3 g of (6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)methanol [0082] gave 0.3 g of 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbaldehyde [0083] as a yellow solid (using Dess-Martin periodinane (2 eq) in dichloromethane).

MS(M+1)+=322.

Step 3 [0084] The procedure is similar to step 3[0012] in example 2. 0.2 g of 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbaldehyde [0083] gave 0.02 g of N-(3,3-difluorocyclopentyl)-6-(difluoromethyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0084], Compound 168 as a white solid. MS(M+1)+=344, 1H-NMR (400 MHz, DMSO-d6): δ 8.33 (d, J=6.80 Hz, 1H), 6.78 (t, JF=54.40 Hz, 1H), 6.61 (s, 1H), 6.11 (s, 1H), 4.47-4.53 (m, 1H), 2.67-2.68 (m, 1H), 2.52 (s, 3H), 2.22-2.34 (m, 7H), 1.92-1.85 (m, 1H),

Example 25

[Figure (not displayed)]

Step 1[0085]: The procedure is similar to step 2[049] in example 10. 0.22 g of 6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine-4-carbaldehyde [0083] gave 0.05 g of 1-(6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)ethan-1-ol [0085], Compound 225 as a pale yellow solid. MS(M+1)+=338, 1H NMR (400 MHz, DMSO-d6) δ 7.89 (s, 1H), 6.54 (s, 1H), 6.05 (s, 1H), 5.39 (d, J=4.6 Hz, 1H), 4.49 (d, J=6.9 Hz, 2H), 2.65-2.55 (m, 2H), 2.35-2.22 (m, 2H), 2.16 (s, 3H), 2.17 (s, 3H) 1.75 (s, 1H), 1.33 (d, J=6.7 Hz, 3H), 1.23 (d, J=3.8 Hz, 1H).

Example 26

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0087A and 0087B]: To a solution of 2,4-dichloro-6-methylpyrimidine [0086] (5 g, 30.67 mmol) in tetrahydrofuran (20 mL) was added 4,4-difluorocyclohexylamine hydrochloride [0002] (5.26 g, 30.67 mmol) and cesium carbonate (19.9 g, 61.3 mmol), then the reaction mixture was heated at 60° C. for 16 h. the reaction mixture was filtered to remove cesium carbonate, the filtrate was concentrated under reduced pressure to afford as an yellow gum and which was purified by column chromatography silica gel (60-120 mesh) using 40% ethyl acetate in pet ether as a eluent to afford 3.5 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] as an off-white solid and 2.8 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-2-amine [0087B]. MS(M+1)+=262.

Step 2[0088]: The procedure is similar to Step 3 [0515] in example 188. 2.5 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 1.5 g of 4-((4,4-difluoro cyclohexyl)amino)-6-methylpyrimidine-2-carbonitrile [0088] at 80° C. for 16 h using sodium cyanide (1.1 eq), DABCO (1.1 eq) in dimethylsulfoxide. MS(M+1)+=243.

Step 3[0089]: The procedure is similar to Step 4 [0516] in example 188. 1.5 g of 4-((4,4-difluoro cyclohexyl)amino)-6-methylpyrimidine-2-carbonitrile [0088] gave 1.5 g of 4-((4,4-difluoro cyclohexyl)amino)-6-methylpyrimidine-2-carbothioamide [0089] using ammonium sulfide (3 eq), triethylamine (2 eq) in N,N-dimethylformamide. MS(M+1)+=287.

Step 4[0091]: To a solution of 4-((4,4-difluoro cyclohexyl)amino)-6-methylpyrimidine-2-carbothioamide [0089] (1.5 g, 5.23 mmol) in ethanol (15 mL) was added bromoacetone (0.86 g, 6.28 mmol), then the reaction mixture was stirred at rt in a closed vial for 16 h. the reaction mixture was concentrated to afford as an brownish gum and which was purified by column of silica gel (60-120 mesh) using 3% methanol in chloroform as eluent to afford as an off-white solid 0.700 g, as an HBr salt, which was dissolved in saturated bicarbonate solution and extracted with ethyl acetate (2×70 mL), the combined organic layer was dried over anhydrous sodium sulfate and concentrated under high vacuum to afford 0.41 g of N-(4,4-difluorocyclohexyl)-6-methyl-2-(4-methylthiazol-2-yl)pyrimidin-4-amine [0091], Compound 231 as an off-white solid. MS(M+1)+=325, 1H NMR (400 MHz, DMSO-d6) δ 7.52 (bs, 1H), 7.39 (d, J=1.1 Hz, 1H), 6.35 (bs, 1H), 4.01 (bs, 1H), 2.43 (s, 3H), 2.29 (s, 3H), 2.07-1.95 (m, 6H), 1.59-1.52 (m, 2H).

Example 27

[Figure (not displayed)]

Step 1[0092]: The procedure is similar to step 3[0006] in Example 1. 4 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 2.6 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0092], Compound 247 as white solid. MS(M+1)+=322.2, 1H NMR (400 MHz, DMSO-d6) δ 7.53 (d, J=7.7 Hz, 1H), 6.21 (s, 1H), 6.03 (s, 1H), 4.01 (bs, 1H), 2.48 (s, 3H), 2.23 (s, 3H), 2.15 (s, 3H), 2.13-1.85 (m, 6H), 1.62-1.47 (m, 2H).

Example 28

[Figure (not displayed)]

Step 2[0094]: The procedure is similar to step 3[0006] in Example 1. 0.3 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 0.26 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methyl pyrimidin-2-yl)-1H-pyrazole-3-carbonitrile [0094], Compound 212 as white solid. MS(M+1)+=319.2, 1H NMR (400 MHz, DMSO-d6) δ 8.81 (s, 1H), 7.81 (s, 1H), 7.19 (s, 1H), 6.32 (s, 1H), 4.16 (bs, 1H), 2.28 (s, 3H), 2.19-1.86 (m, 6H), 1.60-1.45 (m, 2H).

Example 29

[Figure (not displayed)]

Step 1[0096]: The procedure is step 3[0006] in Example 1. 0.3 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 0.21 g of 2-(3-cyclopropyl-1H-pyrazol-1-yl)-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0096], Compound 203 as off-white solid. MS(M+1)+=334.4, 1H NMR (400 MHz, DMSO-d6) δ 8.42 (s, 1H), 7.55 (s, 1H), 6.19 (s, 2H), 4.13 (bs, 1H), 2.25 (s, 3H), 2.14-1.92 (m, 7H), 1.65-1.45 (m, 2H), 1.01-0.87 (m, 2H), 0.79-0.63 (m, 2H).

Example 30

[Figure (not displayed)]

Step 1[0098]: The procedure is step 3[0006] in Example 1. 0.3 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-2-amine [0087B] gave 0.14 g of N-(4,4-difluorocyclohexyl)-4-methyl-6-(3-methyl-1H-pyrazol-1-yl)pyrimidin-2-amine [0098], Compound 120 as a white solid. MS(M+1)+=308, 1H NMR (400 MHz, DMSO-d6) δ 8.52 (bs, 1H), 7.35 (bs, 1H), 6.86 (s, 1H), 6.38 (d, J=2.6 Hz, 1H), 3.99 (d, J=9.8 Hz, 1H), 2.29 (s, 3H), 2.26 (s, 3H), 2.10-1.87 (m, 6H), 1.68-1.50 (m, 2H).

Example 31

[Figure (not displayed)]

Step 1[0099]: To a stirred solution of 2,4-Dichloro-6-methylpyrimidine [0086] (5 g, 30.674 mmol) in tetrahydrofuran (50 mL) was added sodium thiomethoxide (2.14 g, 30.67 mmol) in portions at −10° C. under nitrogen. The mixture was stirred at −10° C. for 3 h. The solid precipitate was filtered, washed with methanol (20 mL) and dried under vacuum to afford 2-chloro-4-methyl-6-(methylthio)pyrimidine [0099] as an yellow solid (5 g). MS(M+1)+=175.

Step 2[0100]: The procedure is step 3[0006] in Example 1. 2.5 g of 2-chloro-4-methyl-6-(methylthio)pyrimidine [0099] gave 3.0 g of 4-methyl-2-(3-methyl-1H-pyrazol-1-yl)-6-(methylthio)pyrimidine [0100] as a yellow liquid. MS(M+1)+=221.

Step 3[0101]: The procedure is similar to step 2[0378] in example 145. 3.0 g of 4-methyl-2-(3-methyl-1H-pyrazol-1-yl)-6-(methylthio)pyrimidine [0100] gave 1.3 g of 4-methyl-2-(3-methyl-1H-pyrazol-1-yl)-6-(methylsulfonyl)pyrimidine [0101] as a yellow solid using 3-chloroperbenzoic acid (3 eq) in dichloromethane. MS(M+1)+=253.

Example 32

[Figure (not displayed)]

Step 1[0102]: To a solution of 4-methyl-2-(3-methyl-1H-pyrazol-1-yl)-6-(methylsulfonyl)pyrimidine [0101] (0.1 g, 0.396 mmol) in dry tetrahydrofuran (8 mL) was added 3,3-difluoro-N-methylcyclopentan-1-amine [0075] (0.096 g, 0.792 mmol) under N2 atm. The reaction mixture was heated at 100° C. in sealed tube for 16 h. The reaction mixture was concentrated under reduced pressure to afford crude and which was purified by column chromatography using 30% ethyl acetate in hexane as a eluent to afford N-(3,3-difluorocyclopentyl)-6-methyl-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine, Compound 150 as a white solid (0.04 g). MS(M+1)+=294, 1H-NMR (400 MHz, DMSO-d6): δ 8.41 (s, 1H), 7.79 (bs, 1H), 6.28 (d, J=2.5 Hz, 1H), 6.2 (bs, 1H), 4.51 (bs, 1H), 2.67-2.58 (m, 1H), 2.24 (s, 3H), 2.24 (s, 3H), 2.20 (m, 2H), 2.10-2.06 (m, 2H), 1.77-1.74 (m, 1H).

Example 35

[Figure (not displayed)]

Step 1[0108]: The procedure is similar to step 1[0106] in example 34. 0.15 g of 4-methyl-2-(3-methyl-1H-pyrazol-1-yl)-6-(methylsulfonyl)pyrimidine [0101] gave 0.08 g of N-((1R,5S)-6,6-difluorobicyclo[3.1.0]hexan-3-yl)-6-methyl-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0108], Compound 245 as an off-white solid. MS(M+1)+=306, 1H NMR (400 MHz, DMSO-d6) δ 8.34 (s, 1H), 7.65 (bs, 1H), 6.30 (d, J=2.6 Hz, 1H), 6.16 (bs, 1H), 4.36 (bs, 1H), 2.45-2.30 (m, 2H), 2.28-2.12 (m, 2H), 2.25 (s, 3H), 2.21 (s, 3H) 1.91 (bs, 2H).

Example 38

[Figure (not displayed)]

Step 1[0114]: The procedure is similar to step 1[0102] in example 32. 0.12 g of 4-methyl-2-(3-methyl-1H-pyrazol-1-yl)-6-(methylsulfonyl)pyrimidine [0101] gave 0.06 g of 6-methyl-2-(3-methyl-1H-pyrazol-1-yl)-N-(4-(trifluoromethyl)cyclohexyl)pyrimidin-4-amine [0114], Compound 144 as a yellow solid. MS(M+1)+=340, 1H NMR (400 MHz, DMSO-d6) δ 8.42 (bs, 1H), 7.50 (bs, 1H), 6.27 (d, J=2.5 Hz, 1H), 6.15 (bs, 1H), 3.89 (bs, 1H), 2.58 (bs, 1H), 2.44 (s, 3H), 2.42 (s, 3H), 2.10-1.95 (m, 2H), 1.91 (d, J=12.2 Hz, 2H), 1.50-1.37 (m, 2H), 1.36-1.20 (m, 2H).

Example 39

[Figure (not displayed)]

Step 1[0115]: The procedure is similar to step 3[0006] in example 1. 2.0 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 0.9 g of N-(4,4-difluorocyclohexyl)-6-methyl-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0115], Compound 148 as an off-white solid. MS(M+1)+=308, 1H-NMR (400 MHz, DMSO-d6): δ 8.44 (bs, 1H), 7.79 (bs, 1H), 6.29-6.19 (m, 2H), 4.13-4.08 (m, 1H), 2.25 (s, 3H), 2.24 (s, 3H), 2.05-1.95 (m, 6H), 1.60-1.54 (m, 2H).

Example 40

[Figure (not displayed)]

Step 1[0117]: The procedure is similar to step 3[0006] in example 1. 0.2 g 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 0.18 g of N-(4,4-difluorocyclohexyl)-6-methyl-2-(3-(trifluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-amine [0117], Compound 200 as an off-white solid. MS(M+1)+=362.0, 1H NMR (400 MHz, DMSO-d6) δ 8.70 (d, J=2.5 Hz, 1H), 7.57 (d, J=7.6 Hz, 1H), 6.90 (d, J=2.7 Hz, 1H), 6.40 (s, 1H), 4.04 (bs, 1H), 2.33 (s, 3H), 2.13-1.94 (m, 6H), 1.65 (qd, J=12.2, 11.3, 4.3 Hz, 2H).

Example 41

[Figure (not displayed)]

Step 1[0119]: The procedure is similar to step 3[0006] in example 1. 0.2 g 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 0.12 g of N-(4,4-difluorocyclohexyl)-2-(4-fluoro-3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0119], Compound 201 as a white solid. MS(M+1)+=340.2, 1H NMR (400 MHz, DMSO-d6) δ 7.59 (d, J=7.6 Hz, 1H), 6.22 (s, 1H), 4.00 (s, 1H), 2.48 (s, 3H), 2.34-2.14 (m, 6H), 2.12-1.88 (m, 6H), 1.55 (t, J=11.5 Hz, 2H).

Example 42

[Figure (not displayed)]

Step 1[0121]: The procedure is similar to The procedure is similar to step 3[0006] in example 1. 0.300 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] and 0.220 g of 3-ethyl pyrazole [0120] gave 0.08 g of N-(4,4-difluorocyclohexyl)-2-(3-ethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0121], Compound 197 as an white solid, MS(M+1)+=336. 1H NMR (400 MHz, DMSO-d6) δ 8.46 (bs, 1H), 7.56 (bs, 1H), 6.34 (d, J=2.5 Hz, 1H), 6.20 (bs, 1H), 4.14 (s, 1H), 2.63 (q, J=7.6 Hz, 2H), 2.26 (s, 3H), 2.12-1.91 (m, 6H), 1.60-1.52 (m, 2H), 1.21 (t, J=7.7 Hz, 3H).

Example 43

[Figure (not displayed)]

Step 1[0123]: The procedure is similar to step 3[0006] in example 1. 0.300 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] and 0.148 g of 4-fluoro pyrazole [0122] gave 0.150 g of N-(4,4-difluorocyclohexyl)-2-(4-fluoro-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0123], Compound 196 as an light yellow solid, MS(M+1)+=312. 1H NMR (400 MHz, DMSO-d6) δ 8.64 (bs, 1H), 7.84 (d, J=4.4 Hz, 1H), 7.66 (bs, 1H), 6.23 (bs, 1H), 4.17 (bs, 1H), 2.26 (s, 3H), 2.10-1.95 (m, 6H), 1.60-1.52 (s, 2H).

Example 44

[Figure (not displayed)]

Step 1[0125]: The procedure is similar to step 3[0006] in example 1. 0.15 g 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 0.1 g of 2-(1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazol-3-yl)acetonitrile [0125], Compound 208 as a white solid. MS(M+1)+=333.1, 1H NMR (400 MHz, DMSO-d6) δ 8.59 (s, 1H), 7.68 (s, 1H), 6.50 (d, J=2.6 Hz, 1H), 6.24 (s, 1H), 4.11 (s, 3H), 2.28 (s, 3H), 2.01 (d, J=42.1 Hz, 6H), 1.56 (s, 2H).

Example 45

[Figure (not displayed)]

Step 1[0127]: To a mixture of 4,4-difluorocyclohexanone [0126] (2 g, 14.911 mmol), ethylamine (1.34 g, 29.82 mmol) and acetic acid (2.68 g, 44.73 mmol) in 1,2-dichloroethane under N2 atmosphere was added sodium triacetoxyborohydride (6.32 g, 29.82 mmol) portion wise at 0° C. The resultant reaction mixture was slowly warmed to rt. After 16 h, the reaction mixture was basified with 1 N sodium hydroxide solution and extracted with 10% methanol in chloroform. The combined organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford N-ethyl-4,4-difluorocyclohexan-1-amine [0127], as brown oil. (1.5 g, 63% yield), MS(M+1)+=164.2. This is taken as such tonext step.

Step 2[0128A & 0128B]: The procedure is similar to step 1[0106] in example 34 (75° C., acetonitrile). 1.2 g of 2,4-dichloro-6-methylpyrimidine [0127] gave 0.6 g of 2-chloro-N-(4,4-difluorocyclohexyl)-N-ethyl-6-methylpyrimidin-4-amine [0128A] as white solid and 0.28 g of 4-chloro-N-(4,4-difluorocyclohexyl)-N-ethyl-6-methylpyrimidin-2-amine [0128B] as yellow solid. MS(M+1)+=290.3.

Step 3[0129]: The procedure is similar to step 3[0006] in Example 1. 0.3 g of 2-chloro-N-(4,4-difluorocyclohexyl)-N-ethyl-6-methylpyrimidin-4-amine [0128A] gave 0.17 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-N-ethyl-6-methylpyrimidin-4-amine [0129], Compound 161 as yellow gum. MS(M+1)+=350.4. 1H NMR (400 MHz, DMSO-d6) δ 6.52 (bs, 1H), 6.05 (s, 1H), 4.58 (bs, 1H), 3.43 (bs, 2H), 2.53 (s, 3H), 2.32 (s, 3H), 2.17 (s, 3H), 2.15-1.85 (m, 4H), 1.83-1.73 (m, 4H), 1.14 (t, J=6.9 Hz, 3H).

Step 4[0130]: The procedure is similar to step 3[0006] in Example 1. 0.2 g 4-chloro-N-(4,4-difluorocyclohexyl)-N-ethyl-6-methylpyrimidin-2-amine [0128B] gave 0.08 g of N-(4,4-difluorocyclohexyl)-4-(3,5-dimethyl-1H-pyrazol-1-yl)-N-ethyl-6-methylpyrimidin-2-amine [0130], Compound 160 as yellow gum. MS(M+1)+=350.4. 1H NMR (400 MHz, DMSO-d6) δ 6.95 (s, 1H), 6.14 (s, 1H), 4.64 (bs, 1H), 3.49 (q, J=6.9 Hz, 2H), 2.66 (s, 3H), 2.33 (s, 3H), 2.19 (s, 3H), 2.12 (bs, 2H), 2.05-1.75 (m, 6H), 1.14 (t, J=6.9 Hz, 3H).

Example 50

[Figure (not displayed)]

Step 1[0143]: The procedure is similar to step 3[0006] in example 1. 0.250 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] and 0.210 g of 3-isopropyl-1H-pyrazole [0142] gave 0.200 g of N-(4,4-difluorocyclohexyl)-2-(3-isopropyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0143], Compound 218 as an off-white solid which was purified by prep HPLC. MS(M+1)+=336, 1H NMR (400 MHz, DMSO-d6) δ 8.48 (s, 1H), 7.66 (s, 1H), 6.39 (d, J=2.7 Hz, 1H), 6.21 (bs, 1H), 4.15 (s, 1H), 3.00-2.95 (m, 1H), 2.27 (s, 3H), 2.14-1.88 (m, 6H), 1.60-1.52 (m, 2H), 1.24 (d, J=6.9 Hz, 6H).

Example 51

[Figure (not displayed)]

Step 1[0144]: The procedure is similar to step 1[0003] in example 1. 0.3 g of 2,4-dichloro-6-methylpyrimidine [0086] gave 0.2 g of 2-chloro-N-(3,3-difluorocyclopentyl)-6-methylpyrimidin-4-amine [0144] as an off-white solid. MS(M+1)+=247.9.

Step 2 [0145]: 0.25 g of 2-chloro-N-(3,3-difluorocyclopentyl)-6-methylpyrimidin-4-amine [0144] and 0.145 g of 3,5-dimethyl pyrazole in acetonitrile was irradiated at 150° C. to afford 0.1 g of N-(3,3-difluorocyclopentyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0145] as a white solid. MS(M+1)+=308.2, 1H NMR (400 MHz, Chloroform-d) δ 6.13 (s, 1H), 6.01 (s, 1H), 5.50 (s, 1H), 4.39 (s, 1H), 2.74-2.54 (m, 4H), 2.44 (d, J=0.6 Hz, 3H), 2.33 (s, 4H), 2.25-1.99 (m, 2H), 1.84 (dq, J=12.5, 7.6 Hz, 2H).

Example 52

[Figure (not displayed)]

Step 1[0146]: The procedure is similar to step 3 [0006] in example 1. 1 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 0.7 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0146] as a pale yellow solid. MS(M+1)+=366.1.

Step 2[0147]: The procedure is similar to step 2[049] in example 10. 0.15 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0146] gave 0.015 g of 2-(1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazol-3-yl)propan-2-ol [0147], Compound 215 as a white solid. MS(M+1)+=352.39, 1H-NMR (400 MHz, DMSO-d6): δ 8.44 (s, 1H), 7.55 (s, 1H), 6.45 (t, J=2.60 Hz, 1H), 6.19 (s, 1H), 5.03 (s, 1H), 4.10-4.09 (m, 1H), 2.26 (s, 3H), 2.05-1.95 (m, 6H), 1.57-1.54 (m, 2H), 1.45 (s, 6H).

Example 53

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0149 & 0150]: The procedure is similar to step 3[0006] in Example 1. 2 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 1.7 g of methyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0149] as an off-white solid MS(M+1)+=380.0 and 0.4 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylicacid [0150] as a brown solid. MS(M+1)+=352.3.

Step 2[0151]: To a solution of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylic acid [0149] (0.7 g, 1.99 mmol) in dichloromethane was added oxalyl chloride (1.0 g, 7.96 mmol) at 0° C. and the reaction mixture was stirred at rt. After 1 h, the reaction mixture was concentrated under reduced pressure in nitrogen atmosphere to afford 1 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carbonyl chloride as a brown solid [0151]. MS(M+1)+=366.6 (methyl ester mass). This was taken as such tonext step.

Step 3[0152]: Ammonia gas was purged to a solution of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carbonyl chloride [0151] (0.7 g, 1.99 mmol) in tetrahydrofuran at −10° C. for 15 min. After 0.5 h, the reaction mixture was brought to rt and purged with nitrogen for 10 min. The reaction mixture was concentrated under reduced pressure to afford a pale brown solid, which was purified in the Reveleris flash system instrument using methanol in chloroform as solvent in 24 g column. The product spot was isolated at 4% Methanol in chloroform as solvent to afford 0.650 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxamide [0152], as white solid. MS(M+1)+=351.2.

Step 4[0153]:NSSY5282.0001. To a solution of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxamide [0152] (0.35 g, 0.85 mmol) in dichloromethane was added triethylamine (0.43 g, 4.28 mmol) and trifluoromethanesulfonic anhydride (0.61 g, 2.14 mmol) at 0° C. and the reaction mixture was stirred at same temperature. After 1 h, the reaction mixture was quenched with ice and extracted with chloroform, washed with water and brine solution. The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford a pale brown solid which was purified in the Reveleris flash system instrument using ethyl acetate in hexane as eluent in 24 g column to afford 0.21 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carbonitrile [0153], Compound 253 as white solid. MS(M+1)+=333.2. 1H NMR (400 MHz, DMSO-d6) δ 8.53 (s, 1H), 7.52 (d, J=7.2 Hz, 1H), 6.37 (s, 1H), 4.05 (bs, 1H), 2.30 (s, 3H), 2.22 (s, 3H), 2.11-1.87 (m, 6H), 1.72-1.56 (m, 2H).

Example 55

[Figure (not displayed)]

Step 2[0156]:NSSy5293.0001. The procedure is similar to step 3[0012] in Example 2. 0.5 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol [0154] gave 0.15 g of N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-4-methyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0156], Compound 258 as white solid. MS(M+1)+=340.2, 1H NMR (400 MHz, DMSO-d6) δ 8.33 (s, 1H), 7.34 (d, J=7.6 Hz, 1H), 6.28 (s, 1H), 5.49 (s, 1H), 5.37 (s, 1H), 4.04 (bs, 1H), 2.26 (s, 3H), 2.13 (s, 3H), 2.11-1.84 (m, 6H), 1.72-1.58 (m, 2H).

Example 56

[Figure (not displayed)]

Step 3[0157]: The procedure is similar to step 3 [0012] in Example 2. 0.4 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carbaldehyde [0155], Compound 246 gave 0.175 g of N-(4,4-difluorocyclohexyl)-2-(3-(difluoromethyl)-4-methyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0157] as white solid. MS(M+1)+=358.0. 1H-NMR (400 MHz, DMSO-d6): δ 8.40 (s, 1H), 7.41 (d, J=7.20 Hz, 1H), 7.00 (t, JF=53.60 Hz, 1H), 6.32 (s, 1H), 4.01 (bs, 1H), 2.29 (s, 3H), 2.19 (s, 3H), 2.15-1.90 (m, 6H), 1.72-1.58 (m, 2H).

Example 57

[Figure (not displayed)]

Step 1[87]: The procedure is similar to step 3[0006] in example 1. 0.5 g 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 0.3 g of 1-(1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazol-3-yl)ethan-1-one [0159] as a white solid. MS(M+1)+=336.0.

Step 2[0160]: The procedure is similar to step 3[0050] in example 10. 0.15 g of 1-(1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazol-3-yl)ethan-1-one [0159] gave 0.1 g of 1-(1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazol-3-yl)ethan-1-ol [0160], Compound 202 as an off-white solid. MS(M+1)+=338.0, 1H NMR (400 MHz, DMSO-d6) δ 8.48 (s, 1H), 7.58 (s, 1H), 6.44 (d, J=2.7 Hz, 1H), 6.21 (s, 1H), 5.20 (d, J=4.8 Hz, 1H), 4.88-4.58 (m, 1H), 4.15 (s, 1H), 2.26 (s, 3H), 2.01 (d, J=41.4 Hz, 6H), 1.56 (d, J=9.3 Hz, 2H), 1.39 (d, J=6.5 Hz, 3H).

Example 58

[Figure (not displayed)]

Step 1[0161]. The procedure is similar to step 2 [0019] in Example 4. 1.4 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0146] gave 0.98 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0161] Compound 204 as an off-white solid.

MS(M+1)+=324, 1H NMR (400 MHz, DMSO-d6) δ 8.50 (s, 1H), 7.59 (bs, 1H), 6.45 (s, 1H), 6.21 (bs, 1H), 5.20 (s, 1H), 4.49 (d, J=5.7 Hz, 2H), 4.16 (bs, 1H), 2.26 (s, 3H), 2.15-1.88 (m, 6H), 1.65-1.48 (m, 2H).

Step 2[0162]:0.9 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0161] gave 0.62 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazole-3-carbaldehyde [0162] as a white solid, using manganese dioxide (5 eq) in dichloromethane. MS(M+1)+=322.3.

Step 3[0163]: The procedure is similar to step 3 [0012] in Example 2. 0.7 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-1H-pyrazole-3-carbaldehyde [0162] gave 0.075 g of N-(4,4-difluorocyclohexyl)-2-(3-(difluoromethyl)-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0163] as an off-white solid. MS(M+1)+=344.2, 1H NMR (400 MHz, DMSO-d6) δ 8.69 (bs, 1H), 7.72 (bs, 1H), 7.12 (t, JF=54.16 Hz, 1H), 6.77 (s, 1H), 6.29 (bs, 1H), 4.18 (bs, 1H), 2.28 (s, 3H), 2.17-1.83 (m, 6H), 1.65-1.57 (m, 2H).

Example 60

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0167]: The procedure is similar to step 3[0006] in example 1. 0.5 g 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] and ethyl 5-methyl-1H-pyrazole-3-carboxylate [0166] (0.35 g, 2.29 mmol) gave 0.7 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-5-methyl-1H-pyrazole-3-carboxylate [0167] as a white solid. MS(M+1)+=348.2.

Step 2 [0168 and 0169]: The procedure is similar to step 2[0019] in example 4. 0.7 g ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-5-methyl-1H-pyrazole-3-carboxylate [0167] gave 0.1 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-5-methyl-1H-pyrazole-3-carbaldehyde [0168] as an off-white solid. MS(M+1)+=338.38 and 0.035 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-5-methyl-1H-pyrazol-3-yl)methanol [0169], Compound 241 as a white solid. MS(M+1)+=336.35, 1H NMR (400 MHz, DMSO-d6) δ 7.57 (d, J=7.7 Hz, 1H), 6.24 (s, 1H), 6.20 (s, 1H), 5.09 (t, J=5.9 Hz, 1H), 4.41 (d, J=6.0 Hz, 2H), 4.02 (s, 1H), 2.54 (s, 3H), 2.25 (s, 3H), 2.12-2.02 (m, 2H), 1.95 (d, J=14.0 Hz, 4H), 1.56 (d, J=11.9 Hz, 2H).

Step 3[0170]: The procedure is similar to step 3[0012] in example 2, 0.1 g 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-5-methyl-1H-pyrazole-3-carbaldehyde [0169] gave 0.018 g of N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-5-methyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0170], Compound 256 as a grey solid. MS(M+1)+=340.4, 1H NMR (400 MHz, DMSO-d6) δ 7.37 (d, J=7.8 Hz, 1H), 6.33 (s, 2H), 5.33 (d, JF=48 Hz, 2H), 3.97 (bs, 1H), 2.56 (s, 3H), 2.28 (s, 3H), 2.13-1.88 (m, 6H), 1.62 (q, J=11.6, 9.6 Hz, 2H).

Example 61

[Figure (not displayed)]

Step 1[0171]: The procedure is similar to step 3 [0012] in example 2. 0.15 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)-5-methyl-1H-pyrazole-3-carbaldehyde [0168] gave 0.075 g of N-(4,4-difluorocyclohexyl)-2-(3-(difluoromethyl)-5-methyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine [0171], Compound 237 as a white solid. MS(M+1)+=358.35, 1H NMR (400 MHz, DMSO-d6) δ 7.72 (d, J=7.6 Hz, 1H), 7.02 (t, JF=54 Hz, 1H), 6.52 (s, 1H), 6.31 (s, 1H), 2.58 (s, 3H), 2.28 (s, 3H), 2.09-1.89 (m, 6H), 1.56 (d, J=12.0 Hz, 2H), 1.25 (d, J=6.2 Hz, 1H).

Example 63

[Figure (not displayed)]

Step 1[0175]: The procedure is similar to step 2[0177] in example 62. 0.2 g of 4-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine [0173] gave 0.1 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0175], Compound 163 as an off-white solid. MS(M+1)+=308.2, 1H-NMR (400 MHz, CDCl3): δ 8.20 (d, J=5.60 Hz, 1H), 6.29 (d, J=5.60 Hz, 1H), 6.02 (s, 1H), 5.53 (s, 1H), 3.88 (s, 1H), 3.22 (s, 3H), 2.34 (s, 3H), 1.97-1.90 (m, 4H), 1.86-1.73 (m, 2H), 1.71-1.65 (m, 2H),

Example 64

[Figure (not displayed)]

Step 1[0177]: The procedure is similar to step 3[0006] in Example 1. 0.5 g of 2,4-dichloro-5-ethylpyrimidine [0176] gave 0.25 g of 2-chloro-N-(4,4-difluorocyclohexyl)-5-ethylpyrimidin-4-amine [0177] as a light brown gum. MS(M+1)+=276.

Step 2[0178]: The procedure is similar to step 2[0174] in Example 62 (without base). 0.25 g of 2-chloro-N-(4,4-difluorocyclohexyl)-5-ethylpyrimidin-4-amine [0177] gave 0.03 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5-ethylpyrimidin-4-amine [0178], Compound 111 as an off-white solid. MS(M+1)+=336.1, 1H NMR (400 MHz, Chloroform-d) δ 8.09 (s, 1H), 6.01 (s, 1H), 4.70 (d, J=7.4 Hz, 1H), 4.17 (d, J=9.8 Hz, 1H), 2.66 (s, 3H), 2.42 (q, J=7.5 Hz, 2H), 2.33 (s, 3H), 2.18 (d, J=10.3 Hz, 4H), 2.01-1.80 (m, 2H), 1.75-1.60 (m, 2H), 1.27 (t, J=7.5 Hz, 3H).

Example 65

[Figure (not displayed)]

Step 1[0180A & 0180B]: To a solution of 2,4-Dichloro-6-ethylpyrimidine [0179] (1 g, 5.64 mmol) and 4,4-Difluorocyclohexylamine Hydrochloride (0.96 g, 5.64 mmol) in acetonitrile was added cesium carbonate (3.68 g, 11.29 g) and the reaction mixture was heated at 65° C. in sealed tube. After 16 h, the reaction mixture was filtered and the filtrate was concentrated to afford a crude product, which was purified by column chromatography to afford 0.8 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-ethylpyrimidin-4-amine [0180A] as colorless oil and 0.5 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-ethylpyrimidin-2-amine [0180B] as colorless oil. MS(M+1)+=276.0.

Step 2[0181]: The procedure is similar to step 3[0006] in Example 1. 0.3 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-ethylpyrimidin-4-amine [0180A] gave 0.05 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-ethylpyrimidin-4-amine [0181], Compound 171 as off-white solid. MS(M+1)+=336.4. 1H NMR (400 MHz, DMSO-d6) δ 7.56 (d, J=7.7 Hz, 1H), 6.23 (s, 1H), 6.04 (s, 1H), 4.03 (bs, 1H), 3.28 (m, 2H), 2.48 (s, 3H), 2.16 (s, 3H), 2.15-1.85 (m, 6H), 1.62-1.49 (m, 2H), 1.18 (t, J=7.5 Hz, 3H).

Step 3[0182]: The procedure is similar to step 3[0006] in Example 1. 0.3 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-ethylpyrimidin-2-amine [0180B] gave 0.95 g of N-(4,4-difluorocyclohexyl)-4-(3,5-dimethyl-1H-pyrazol-1-yl)-6-ethylpyrimidin-2-amine [0182], Compound 169 as white solid. MS(M+1)+=336.4. 1H NMR (400 MHz, DMSO-d6) δ 7.35 (bs, 1H), 6.88 (s, 1H), 6.12 (s, 1H), 3.84 (bs, 1H), 2.64 (s, 3H), 2.60-2.53 (m, 2H), 2.18 (s, 3H), 2.10-1.75 (m, 6H), 1.64-1.52 (m, 2H), 1.18 (t, J=7.6 Hz, 3H).

Example 67

[Figure (not displayed)]

Step 1[0187A and 0187B]: The procedure is similar to Step 1[0180A & 0180B] in example 66. 0.5 g of 2,4-dichloro-6-cyclopropyl pyrimidine [0186] gave 0.3 g of 2-chloro-6-cyclopropyl-N-(3,3-difluorocyclopentyl)pyrimidin-4-amine [0187A] and 0.125 g of 4-chloro-6-cyclopropyl-N-(3,3-difluorocyclopentyl)pyrimidin-2-amine [0187B] both as colorless gums. MS(M+1)+=274.0.

Step 2[0188]: The procedure is similar to step 3[0006] in Example 1.0.3 g of 2-chloro-6-cyclopropyl-N-(3,3-difluorocyclopentyl)pyrimidin-4-amine [0187A] gave 0.175 g of 6-cyclopropyl-N-(3,3-difluorocyclopentyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0188], Compound 217 as white solid. MS(M+1)+=334.2, 1H NMR (400 MHz, DMSO-d6) δ 7.71 (s, 1H), 6.31 (s, 1H), 6.03 (s, 1H), 4.45 (s, 1H), 2.58 (dt, J=13.6, 6.5 Hz, 1H), 2.45 (s, 3H), 2.31-2.17 (m, 2H), 2.15 (s, 3H), 2.06 (dq, J=16.2, 9.1, 8.0 Hz, 2H), 1.93 (s, 1H), 1.72 (dq, J=12.2, 8.5 Hz, 1H), 0.98-0.90 (m, 3H).

Step 3[0189]: The procedure is similar to step 3[0006] in Example 1. 0.125 g of 4-chloro-6-cyclopropyl-N-(3,3-difluorocyclopentyl)pyrimidin-2-amine [0187B] gave 0.045 g 4-cyclopropyl-N-(3,3-difluorocyclopentyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-2-amine [0189], Compound 222 as white solid, MS(M+1)+=334.2. 1H-NMR (400 MHz, DMSO-d6): δ 7.39 (bs, 1H), 6.99 (s, 1H), 6.13 (s, 1H), 4.29 (q, J=7.20 Hz, 1H), 2.64 (s, 3H), 2.35-2.25 (m, 2H), 2.20 (s, 3H), 2.15-1.98 (m, 4H), 1.85-1.73 (m, 1H), 1.12-0.90 (m, 4H).

Example 69

[Figure (not displayed)]

Step 1[0195]: To a solution of 4-chloro-2-(methylsulfanyl)-6-(trifluoromethyl)pyrimidine [0194] (1 g, 4.374 mmol) in acetonitrile (10 mL) was added N,N-diisopropyl ethylamine (0.84 g, 6.56 mmol), followed by 4,4-difluorocyclohexylamine hydrochloride [0002] (0.75 g, 4.374 mmol). The reaction mixture was stirred at rt for 36 h. The reaction mixture was concentrated under reduced pressure. The residue was diluted with ethyl acetate (50 mL). The organic layer was washed with water (10 mL), followed by brine (10 mL). The organic layer was dried over anhydrous sodium sulfate to afford 1.4 g of N-(4,4-difluorocyclohexyl)-2-(methylthio)-6-(trifluoromethyl)pyrimidin-4-amine [0195] as a yellow gum. MS(M+1)+=328.3

Step 2[0196]: To a solution of N-(4,4-difluorocyclohexyl)-2-(methylthio)-6-(trifluoromethyl)pyrimidin-4-amine [0195] (0.55 g, 1.68 mmol) in dichloromethane (10 mL), 3-chloroperbenzoic acid (0.86 g, 5.04 mmol) was added portion-wise at 0° C. The reaction mixture was stirred at rt for 3 h. The reaction mixture was diluted with dichloromethane (50 mL). The organic layer was stirred with saturated solution of sodium thiosulfate solution (20 mL), followed by 10% sodium bicarbonate solution (10 mL), water (10 mL) and brine water (10 mL). The organic layer was dried over anhydrous sodium sulfate to afford 0.6 g of N-(4,4-difluorocyclohexyl)-2-(methylsulfonyl)-6-(trifluoromethyl)pyrimidin-4-amine [0196] as a yellow solid. MS(M+1)+=359.9

Step 3[0197]: To a solution of N-(4,4-difluorocyclohexyl)-2-(methylsulfonyl)-6-(trifluoromethyl)pyrimidin-4-amine [0196] (0.55 g, 1.53 mmol) in acetonitrile (6 mL), was added 3,5-dimethyl pyrazole [0017] (0.22 g, 2.296 mmol) and cesium carbonate (0.748 g, 2.296 mmol). The reaction mixture was irradiated in microwave at 130° C. for 2 h and concentrated under reduced pressure to afford 0.55 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4-amine. This was purified by column chromatography using 60% ethyl acetate in pet ether as solvent to afford 0.090 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4-amine [0197], Compound 162 as a white solid. MS(M+1)+=376.6. 1H NMR (400 MHz, DMSO-d6) δ 8.30 (d, J=7.5 Hz, 1H), 6.74 (s, 1H), 6.13 (s, 1H), 4.09 (bs, 1H), 2.57 (s, 3H), 2.19 (s, 3H), 2.15-1.90 (m, 6H), 1.65-1.52 (m, 2H).

Example 71

[Figure (not displayed)]

Step 1[0201]: The procedure is similar to Step 1[0195] in example 69. 0.5 g of 4-chloro-2-(methylthio)-6-(trifluoromethyl)pyrimidine [0194] gave 0.4 g of N-(3,3-difluorocyclopentyl)-2-(methylthio)-6-(trifluoromethyl)pyrimidin-4-amine [0201] as an off-white solid. MS(M+1)+=314.1.

Step 2[0202]: The procedure is similar to Step 2[0196] in example 69. 0.4 g N-(3,3-difluorocyclopentyl)-2-(methylthio)-6-(trifluoromethyl)pyrimidin-4-amine [0201] gave 0.35 g of N-(3,3-difluorocyclopentyl)-2-(methylsulfonyl)-6-(trifluoromethyl)pyrimidin-4-amine [0202] as an off-white solid. MS(M+1)+=346.2.

Step 3[0203]: The procedure is similar to Step 3[0197] in example 69. 0.2 g N-(3,3-difluorocyclopentyl)-2-(methylsulfonyl)-6-(trifluoromethyl)pyrimidin-4-amine [0202] gave 0.07 g of N-(3,3-difluorocyclopentyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(trifluoromethyl)pyrimidin-4-amine [0203], Compound 167 as a white solid.

MS(M+1)+=362.2, 1H NMR (400 MHz, CDCl3): δ 6.52 (s, 1H), 6.06-5.99 (m, 2H), 4.36 (m, 1H), 2.70-2.65 (m, 4H), 2.39-2.29 (m, 5H), 2.23-2.16 (m, 2H), 2.12-2.09 (m, 1H).

Example 72

[Figure (not displayed)]

Step 1[0204]: The procedure is similar to Step 1[0195] in example 69. 1.0 g of 4-chloro-6-(difluoromethyl)-2-(methylthio)pyrimidine [0190] gave 0.8 g 4-(difluoromethyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidine [0204] as an off-white solid. MS (M+1)+=271.2.

Step 2[0205]: The procedure is similar to Step 2[0196] in example 69. 1.0 g 4-(difluoromethyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidine [0204] gave 0.7 g of 4-(difluoromethyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidine [0205] as an off-white solid. MS(M+1)+=303.1.

Step 3[0206]: The procedure is similar to Step 3[0197] in example 69 (DIPEA as base). 0.4 g of 4-(difluoromethyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidine [0205] gave 0.2 g of N-(4,4-difluorocyclohexyl)-4-(difluoromethyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-2-amine [0206] as a white solid. MS(M+1)+=358.2, 1H NMR (400 MHz, DMSO-d6) δ 7.94 (d, J=7.4 Hz, 1H), 7.19 (s, 1H), 6.76 (t, JF=54 Hz, 1H), 6.21 (s, 1H), 2.68 (s, 3H), 2.21 (s, 3H), 2.12-1.89 (m, 6H), 1.60 (d, J=11.8 Hz, 3H).

Example 73

[Figure (not displayed)]

Step 3[0207]: The procedure is similar to Step 3[0197] in example 69 (DIPEA as base). 0.25 g of 4-(difluoromethyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidine [0205] gave 0.2 g N-(3,3-difluorocyclopentyl)-4-(difluoromethyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-2-amine [0207], Compound 181 as a white solid. MS(M+1)+=344.4, 1H NMR (400 MHz, DMSO-d6) δ 8.25-7.72 (m, 1H), 7.22 (s, 1H), 6.77 (t, JF=54.5 Hz, 1H), 6.20 (s, 1H), 4.35 (s, 1H), 2.67 (s, 3H), 2.55 (d, J=8.1 Hz, 1H), 2.42-1.90 (m, 7H), 1.82 (q, J=9.0 Hz, 1H).

Example 74

[Figure (not displayed)]

Step 1[0208]: The procedure is similar to Step 3[0197] in example 69. 0.3 g 2,4-dichloro-6-cyclopropylpyrimidine [0186] gave 0.2 g of 4-chloro-6-cyclopropyl-N-(4,4-difluorocyclohexyl)pyrimidin-2-amine [0208] as an off-white solid. MS(M+1)+=288.2.

Step 2[0209]: The procedure is similar to Step 3[0197] in example 69. 0.2 g 4-chloro-6-cyclopropyl-N-(4,4-difluorocyclohexyl)pyrimidin-2-amine [0208] gave 0.04 g of 4-cyclopropyl-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-2-amine [0209], Compound 226 as a white solid. MS(M+1)+=348.2, 1H NMR (400 MHz, DMSO-d6): δ 7.91 (m, 1H), 7.60 (m, 1H), 5.82 (s, 1H), 5.06 (m, 1H), 3.55 (s, 2H), 2.57 (m, 1H), 2.43 (s, 3H), 1.51-1.46 (m, 6H), 1.31-1.32 (m, 2H), 1.29 (s, 6H).

Example 75

[Figure (not displayed)]

Step 1[0211]: To a solution of 2-Bromo-4-Hydroxymethylthiazole [0210] (2 g, 10.30 mmol) in N,N-dimethylformamide (20 mL) was added tert-butyl dimethylsilyl chloride (3.2 g, 20.6 mmol) and imidazole (2.80 g, 41.2 mmol), then the reaction mixture was stirred at rt for 5 h. After the completion of the reaction, to the reaction mixture was added ice cold water and extracted with ethyl acetate (2×75 mL), the combined organic layer was dried over anhydrous sodium sulfate and concentrated to afford as an colorless liquid and which was purified by column of silica gel (60-120 mesh) using 15% ethyl acetate in hexane as eluent to afford 3 g of 2-bromo-4-(((tert-butyl dimethylsilyl)oxy)methyl)thiazole [0211] as an colorless liquid.

Step 2[0212]: To a solution of 2-bromo-4-(((tert-butyl dimethylsilyl)oxy)methyl)thiazole [0211] (0.3 g, 0.97 mmol) in tetrahydrofuran (10 mL) at −78° C. under N2 was added n-BuLi (2.5 M in hexane) (0.06, 1.07, 1.) and the resulting brown solution was stirred for 30 min before adding tributyltin chloride (0.38 g, 1.16 mmol) and the reaction mixture was allowed to warm to rt and left overnight. After completion, the reaction mixture was quenched with saturated ammonium chloride solution, extracted with ethyl acetate (2×25 mL). The combined organic layer was dried over anhydrous sodium sulfate and concentrated to afford 0.7 g of 4-(((tert-butyldimethylsilyl)oxy)methyl)-2-(tributylstannyl)thiazole [0212] as a light yellow liquid.

Step 3[0213]: To a solution of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] (0.3 g, 1.14 mmol) in toluene (10 mL) was added 4-(((tert-butyldimethylsilyl)oxy)methyl)-2-(tributylstannyl) thiazole [00212] (0.71 g, 1.37 mmol1.) and purged nitrogen for 5 min, then added tetrakis(triphenylphosphine)palladium(0) (0.26 g, 0.22 mmol0.) to the reaction mixture and was irradiated in microwave at 130° C. for 2 h. the reaction mixture was filtered through celite bed and the filtrate was concentrated to afford as an brownish gum and which was purified by column of silica gel (60-120 mesh), using 50% ethyl acetate in hexane as eluent to afford 0.140 g of 2-(4-(((tert-butyldimethylsilyl)oxy)methyl)thiazol-2-yl)-N-(4,4-difluoro cyclohexyl)-6-methylpyrimidin-4-amine[0213] as an colorless gum. MS(M+1)+=455.

Step 4[0214]: To an ice cooled solution of 2-(4-(((tert-butyldimethylsilyl)oxy)methyl)thiazol-2-yl)-N-(4,4-difluoro cyclohexyl)-6-methylpyrimidin-4-amine [0213] (0.12 g, 0.26 mmol1.) in diethyl ether (10 mL) was added hydrogenchloride (gas) in dioxane, After the completion of the reaction, the solid was filtered and washed with hexane to afford as off-white solid and which was dissolved in saturated sodium bicarbonate solution and extracted with ethyl acetate (2×25 mL), the combined organic layer was dried over anhydrous sodium sulfate and concentrated to afford as an colorless gum and which was purified by column of silica gel (60-120 mesh), using ethyl acetate as eluent to afford 0.055 g of (2-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)thiazol-4-yl)methanol [0214], Compound 270 as an white solid. MS(M+1)+=341, 1H NMR (400 MHz, DMSO-d6) δ 7.53 (s, 2H), 6.35 (s, 1H), 5.39 (t, J=5.7 Hz, 1H), 4.62 (d, J=5.7 Hz, 2H), 4.09 (s, 1H), 2.29 (s, 3H), 2.07-1.95 (m, 6H), 1.59-1.52 (m, 2H).

Step 5[0215]: The procedure is similar to step 3 [0012] in example 2. 0.32 g of (2-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)thiazol-4-yl)methanol [0214] gave 0.18 g of N-(4,4-difluorocyclohexyl)-2-(4-(fluoromethyl)thiazol-2-yl)-6-methylpyrimidin-4-amine [0215], Compound 273 as an light yellow solid, MS(M+1)+=343. 1H NMR (400 MHz, DMSO-d6) δ 7.96 (d, J=3.4 Hz, 1H), 7.57 (bs, 1H), 6.38 (bs, 1H), 5.50 (d, JF=48.5 Hz, 2H), 4.10 (bs, 1H), 2.30 (s, 3H), 2.02-1.95 (m, 6H), 1.61-152 (m, 2H).

Example 76

[Figure (not displayed)]

Step 1[0216]:0.080 g of (2-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)thiazol-4-yl)methanol [0214] gave 0.080 g of 2-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)thiazole-4-carbaldehyde [0216] as an light brownish gum, using Dess-Martin periodinane (2 eq) in dichloromethane.

MS(M+1)+=338 and it was taken as such for next step.

Step 2[00217]: The procedure is similar to step 3 [0012] in example 2. 0.080 g of 2-(4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidin-2-yl)thiazole-4-carbaldehyde [0216] gave 0.032 g of N-(4,4-difluorocyclohexyl)-2-(4-(difluoromethyl)thiazol-2-yl)-6-methylpyrimidin-4-amine [0217], Compound 277 as an light yellow gummy solid.

MS(M+1)+=338. 1H-NMR (400 MHz, DMSO-d6): δ 8.22 (t, J=1.40 Hz, 1H), 7.50 (s, 1H), 7.14 (t, JF=54.52 Hz, 1H), 6.41 (bs, 1H), 4.05 (bs, 1H), 2.32 (s, 3H), 2.09-1.99-1.90 (m, 6H), 1.63-1.57 (m, 2H).

Example 78

[Figure (not displayed)]

Step 1[0220]: To a solution of 0.2 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] and 0.7 g of 2-(tributylstannyl)-4-(trifluoromethyl)thiazole in toluene (8 mL), was degassed with nitrogen for 10 min and tetrakis(triphenylphosphine)palladium(0) was added to the reaction mixture and irradiated in microwave at 130° C. After 2 h, the reaction mixture was passed through celite bed and the filtrate was concentrated to afford a crude product, which was purified by column chromatography to afford 0.025 g of N-(4,4-difluoro cyclohexyl)-6-methyl-2-(4-(trifluoromethyl)thiazol-2-yl)pyrimidin-4-amine [0220], Compound 269 as an light yellow solid. MS(M+1)+=379. 1H NMR (400 MHz, DMSO-d6) δ 8.61 (s, 1H), 7.67 (bs, 1H), 6.41 (bs, 1H), 3.88 (bs, 1H), 2.32 (s, 3H), 2.03-1.95 (d, 6H), 1.60-1.52 (m, 2H).

Example 79

[Figure (not displayed)]

Step 1[0221]: The procedure is similar to step 1[0220] in example 78. 0.2 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 0.016 g of 2-(4-cyclopropylthiazol-2-yl)-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0221], Compound 267 as an yellow solid which was purified by Prep HPLC, MS(M+1)+=351. 1H NMR (400 MHz, DMSO-d6) δ 7.52 (bs, 1H), 7.38 (s, 1H), 6.35 (bs, 1H), 4.04 (bs, 1H), 3.01 (bs, 1H), 2.29 (s, 3H), 2.13-1.91 (m, 6H), 1.60-1.52 (m, 2H), 0.93 (dt, J=8.3, 2.9 Hz, 2H), 0.85 (dt, J=5.2, 2.8 Hz, 2H).

Example 80

[Figure (not displayed)]

Step 1[0222]: The procedure is similar to step 1[220] in example 78. 0.3 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] gave 0.065 g of N-(4,4-difluorocyclohexyl)-2-(4-isopropylthiazol-2-yl)-6-methylpyrimidin-4-amine [0222], Compound 278 as an off-white solid which was purified by Prep HPLC, MS(M+1)+=353. 1H NMR (400 MHz, DMSO-d6) δ 7.52 (bs, 1H), 7.39 (s, 1H), 6.36 (bs, 1H), 4.04 (bs, 1H), 3.12-3.05 (m, 1H), 2.30 (s, 3H), 2.14-1.91 (m, 6H), 1.59-1.52 (m, 2H), 1.28 (d, J=6.9 Hz, 6H).

Example 81

[Figure (not displayed)]

Step 1[0223]: To a solution of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] (0.8 g, 3.056 mmol) and 1,4-diazabicyclo[2.2.2]octane (0.342 g, 3.056 mmol) were dissolved in dimethyl sulfoxide (10 mL) and stirred at rt for 1 h. To the resultant reaction mixture was added sodium cyanide (0.151 g, 3.056 mmol) and stirred at 80° C. for 24 h. The reaction mixture was quenched with water (10 mL) and extracted with ethyl acetate (2×400 mL), the combined organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure to afford 0.500 g of 4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidine-2-carbonitrile [0223] as an off-white solid. MS(M+1)+=253.

Step 2[0224]: The procedure is similar to step 4[0516] in Example 188. 0.4 g of 4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidine-2-carbonitrile [0223] gave 0.4 g of 4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidine-2-carbothioamide [0224] as an off-white solid, ammonium sulfide, triethylamine in n,n-dimethylformamide. MS(M+1)+=287.2

Step 3[0225]: 0.3 g of 4-((4,4-difluorocyclohexyl)amino)-6-methylpyrimidine-2-carbothioamide [0224] and 1.89 g 1-bromobutan-2-one in tetrahydrofuran was heated at 70° C. to afford 0.4 g N-(4,4-difluorocyclohexyl)-2-(4-ethylthiazol-2-yl)-6-methylpyrimidin-4-amine [0225], Compound 279 as a yellow solid. MS(M+1)+=339.0. 1H NMR (400 MHz, DMSO-d6) δ 7.51 (s, 1H), 7.40 (s, 1H), 6.35 (s, 1H), 4.07 (bs, 1H), 2.79 (q, J=7.5 Hz, 2H), 2.29 (s, 3H), 2.16-1.86 (m, 6H), 1.65-1.46 (m, 2H), 1.26 (t, J=7.5 Hz, 3H).

Example 82

[Figure (not displayed)]

Step 1[0282]: The procedure is similar to step 1[0220] in example 78. 0.500 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] and 1.1 g of 2-chloro-6-(tributylstannyl)pyridine [0227] gave 0.040 g of 2-(6-chloropyridin-2-yl)-N-(4,4-difluorocyclohexyl)-6-methyl pyrimidin-4-amine [0282], Compound 230 as a light yellow solid, which was purified by column of silica gel (60-120 mesh) using 60% ethyl acetate in hexane as eluent. MS(M+1)+=339, 1H NMR (400 MHz, DMSO-d6) δ 8.29 (d, J=7.7 Hz, 1H), 7.98 (t, J=7.8 Hz, 1H), 7.59 (d, J=7.7 Hz 1H), 7.48 (bs, 1H), 6.40 (bs, 1H), 4.06 (bs, 1H), 2.33 (s, 3H), 2.17-1.90 (m, 6H), 1.60-1.52 (m, 2H).

Example 83

[Figure (not displayed)]

Step 1[0230]: The procedure is similar to step 1[0220] in example 78. 0.400 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-methylpyrimidin-4-amine [0087A] and 1.16 g of 2-chloro-6-(tributylstannyl)pyridine [0229] gave 0.200 g of N-(4,4-difluorocyclohexyl)-6-methyl-2-(6-methylpyridin-2-yl)pyrimidin-4-amine [0230], Compound 224 as an off-white solid, which was purified by column of silica gel (60-120 mesh) using ethyl acetate as eluent, MS(M+1)+=319, 1H NMR (400 MHz, DMSO-d6) δ 8.05 (d, J=7.6 Hz, 1H), 7.77 (t, J=7.7 Hz, 1H), 7.36 (bs, 1H), 7.30 (d, J=7.5 Hz, 1H), 6.36 (bs, 1H), 4.09 (bs, 1H), 2.53 (s, 3H), 2.31 (s, 3H), 2.10-1.95 (m, 6H), 1.60-1.52 (m, 2H).

Example 87

[Figure (not displayed)]

Step 1[0239]: The procedure is similar to step 1[0191] in example 68. 10 g of 4,6-dichloro-2-(methylthio)pyrimidine [0239] gave 8 g of 4,6-dichloro-2-(methylsulfonyl)pyrimidine [0240] as an off-white solid. MS(M+1)+=228.

Step 2[0241]: To a suspension of sodium hydride (35.2 g) in dichloromethane was added 84.6 g of 3,5-dimethyl pyrazole at 0° C. and the reaction mixture was stirred at rt. After 30 min, 200 g of 4,6-dichloro-2-(methylsulfonyl)pyrimidine [0239] (dissolved in dichloromethane) was added drop wise to the reaction mixture at −78° C. and the reaction mixture was stirred at same temperature. After 2 h, the reaction mixture was quenched with water at −78° C. and diluted with dichloromethane. After 5 min, dichloromethane was decanted and washed with brine solution. The organic layer was dried over sodium sulfate, filtered and concentrated under reduced pressure to afford crude product, which was purified by column chromatography to afford 138 g of 4,6-dichloro-2-(3,5-dimethyl-1h-pyrazol-1-yl)pyrimidine [0241] as an off-white solid. MS(M+1)+=244.2.

Step 3[0242]: To a stirred solution of 4,6-dichloro-2-(3,5-dimethyl-1h-pyrazol-1-yl)pyrimidine [0241] (4.9 g, 20.156 mmol) in acetonitrile (50 mL), was added 4,4-difluorocyclohexylamine hydrochloride [0002] (3.45 g, 20.16 mmol) and N,N-diisopropyl ethylamine (7.01 mL, 40.31 mmol). The reaction mixture was heated at 60° C. for 16 h and concentrated under reduced pressure. Water (50 mL) was added to the residue and the solid formed was filtered to afford a crude product which was purified by column chromatography using 25% ethyl acetate in pet ether as solvent to afford 3.8 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1h-pyrazol-1-yl)pyrimidin-4-amine [0242] as a pale brown solid. MS(M+1)+=342.0.

Step 4[0244]: To a stirred solution of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1h-pyrazol-1-yl)pyrimidin-4-amine [0242] (0.400 g, 1.17 mmol) in dioxane (10 mL), were added 3-oxetanamine (0.171 g, 2.34 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (0.135 g, 0.234 mmol) and cesium carbonate (0.764 g, 2.34 mmol). The reaction mixture was degassed with nitrogen for 10 min, before adding tris(dibenzylideneacetone)dipalladium(0) (0.38 g, 0.117 mmol) and heated at 95° C. for 16 h. The reaction mixture was filtered through celite and filtrate was concentrated under reduced pressure to afford crude product which was purified by preparative HPLC to afford 0.065 g of N4-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-N6-(oxetan-3-yl)pyrimidine-4,6-diamine [0244], Compound 243 as an off-white solid. MS(M+1)+=379.0. 1H NMR (400 MHz, DMSO-d6) δ 7.63 (s, 1H), 6.99 (d, J=7.9 Hz, 1H), 5.99 (s, 1H), 5.25 (s, 1H), 4.78 (s, 3H), 4.47 (s, 2H), 3.82 (s, 1H), 2.55 (s, 3H), 2.14 (s, 3H), 2.07-1.89 (m, 6H), 1.54-1.51 (m, 2H).

Example 88

[Figure (not displayed)]

Step 1[0246]: The procedure is similar to step 2[174] in example 62. 0.350 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] gave 0.015 g of N4-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-N6-(1-(thiazol-2-yl)ethyl)pyrimidine-4,6-diamine[0246], Compound 124 as a yellow solid. MS(M+1)+=434.7, 1H NMR (400 MHz, DMSO-d6) δ 7.72 (s, 1H), 7.66 (d, J=7.3 Hz, 1H), 7.56 (s, 1H), 7.02 (d, J=7.6 Hz, 1H), 5.96 (s, 1H), 5.40 (bs, 2H), 3.72 (bs, 1H), 2.37 (s, 3H), 2.12 (s, 3H), 2.07-1.88 (m, 6H), 1.55 (d, J=6.9 Hz, 5H).

Example 89

[Figure (not displayed)]

Step 1[0248]: The procedure is similar to step 2[0174] in example 62. 0.350 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] gave 0.075 g of 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)amino)-1-methylpyrrolidin-2-one [0248], Compound 125 as a yellow solid. MS(M+1)+=420.8 1H NMR (400 MHz, DMSO-d6) δ 7.10 (s, 1H), 6.92 (d, J=7.8 Hz, 1H), 5.99 (s, 1H), 5.42 (s, 1H), 4.50 (s, 1H), 3.83 (s, 1H), 2.76 (s, 3H), 2.48 (s, 3H), 2.14 (s, 3H), 2.06 (s, 2H), 1.91 (d, J=13.4 Hz, 5H), 1.53 (d, J=11.9 Hz, 2H).

Step 2[0249 and 0250]: 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)amino)-1-methylpyrrolidin-2-one [0248] which was purified by chiral preparative to afford 0.012 g of (+)-3-((6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)amino)-1-methylpyrrolidin-2-one [0249], Compound 128 as an off-white solid [MS(M+1)+=420.8, 1H NMR (400 MHz, DMSO-d6) δ 7.09 (d, J=7.48 Hz, 1H), 6.92 (d, J=7.8 Hz, 1H), 5.99 (s, 1H), 5.41 (s, 1H), 4.49 (bs, 1H), 3.83 (bs, 1H), 2.76 (s, 3H), 2.48 (s, 3H), 2.44 (m, 3H), 2.14 (s, 3H), 2.07-1.78 (m, 7H), 1.54-1.50 (m, 2H) and 0.0115 g of (−)-3-((6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)amino)-1-methylpyrrolidin-2-one [0250], Compound 129 as an off-white solid. MS(M+1)+=420.8, 1H NMR (400 MHz, DMSO-d6) δ 7.10 (s, 1H), 6.92 (d, J=7.9 Hz, 1H), 5.99 (s, 1H), 5.41 (s, 1H), 4.50 (s, 1H), 3.81 (s, 1H), 2.75 (s, 3H), 2.52 (s, 3H), 2.44 (m, 3H) 2.14 (s, 3H), 2.06-1.82 (m, 7H), 1.62-1.48 (m, 2H).

Example 90

[Figure (not displayed)]

Step 1[0251]: To a solution of indium(III)chloride (0.51 g, 2.34 mmol) in tetrahydrofuran was added cyclopropyl magnesium bromide (1.02 g, 7.02 mmol) at −78° C. and stirred at same temperature. After 30 min, the reaction mixture was brought to rt and cannulated to a vial containing 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] (0.8 g, 2.34 mmol) in tetrahydrofuran and heated at 90° C. After 16 h, the reaction mixture was quenched with few drops of methanol, stirred for 10 min, filtered through celite bed which was washed with ethyl acetate. The filtrate was concentrated under reduced pressure and the residue was again dissolved in ethyl acetate and washed with water and brine solution. The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford brown oil, which was purified in the Reveleris flash system instrument using ethyl acetate in hexane as solvent in 25 g column, to afford 0.08 g of 6-cyclopropyl-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0251], Compound 186 as a white solid. MS(M+1)+=348.2, 1H-NMR (400 MHz, DMSO-d6): δ 7.49 (s, 1H), 6.31 (s, 1H), 6.02 (s, 1H), 3.99 (bs, 1H), 2.46 (s, 3H), 2.15 (s, 3H), 2.05-1.92 (m, 7H), 1.62-1.50 (m, 2H), 0.99-0.85 (m, 4H).

Example 92

[Figure (not displayed)]

Step 1 [0255]: The procedure is similar to Step 2[0174] in example 62. 0.3 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.348 g of (1S,4S)-(−)-2-Boc-2,5-diazabicyclo[2.2.1]heptane [0254] gave 0.075 g of tert-butyl (1R)-5-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate [0255] as an white solid.

Step 2 [0256]: tert-Butyl (1R)-5-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate [0255] was acidified by using Hydrochloric acid in dioxane to afford 6-((4R)-2,5-diazabicyclo [2.2.1]heptan-2-yl)-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine hydrochloride salt [0256], Compound 103 as an light yellow solid (55 mg). MS(M+1)+=404, MS(M+1)+=404, 1H NMR (400 MHz, Methanol-d4) δ 6.30 (s, 1H), 5.21 (s, 1H) 4.66 (s, 1H), 3.99-3.78 (m, 3H), 3.52 (s, 2H), 2.72 (s, 3H), 2.33 (s, 4H), 2.20-2.01 (m, 6H), 1.82-1.65 (m, 2H).

Example 93

[Figure (not displayed)]

Step 1 [0258]: The procedure is similar to Step 2[0174] in example 62. 0.3 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.22 g of piperazine-2-carboxamide [0258] gave 0.055 g of 4-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)piperazine-2-carboxamide [0258], Compound 100. MS(M+1)+=435, 1H NMR (400 MHz, DMSO-d6) δ 7.34 (s, 1H), 7.18 (s, 1H), 7.03 (d, J=8.1 Hz, 1H), 6.00 (s, 1H), 5.57 (s, 1H), 4.08 (b, 1H), 3.95-3.80 (m, 2H), 3.19 (dd, J=9.3, 3.4 Hz, 1H), 3.05-2.85 (m, 3H), 2.70-2.60 (m, 2H), 2.49 (s, 3H), 2.15 (s, 3H), 2.07-1.89 (m, 6H), 1.45-1.60 (m, 2H).

Example 94

[Figure (not displayed)]

Step 1 [0260] The procedure is similar to Step 3[0006] in example 1 (solvent dimethyl sulfoxide at 100° C.). 0.12 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.069 g of 2-oxa-6-azaspiro(3,3) heptane [0260] gave 0.08 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H pyrazol-1-yl)-6-(2-oxa-6-azaspiro[3.3]heptan-6-yl)pyrimidin-4-amine, Compound 105 MS(M+1)+=405, 1H NMR (400 MHz, DMSO-d6) δ 7.07 (d, J=8.0 Hz, 1H), 6.00 (s, 1H), 5.19 (s, 1H), 4.72 (s, 4H), 4.11 (s, 4H), 3.86 (bs, 1H), 2.50 (s 3H), 2.14 (s, 3H), 2.15-1.80 (m, 6H), 1.40-1.35 (m, 2H).

Example 95

[Figure (not displayed)]

Step 1[0262]: The procedure is similar to Step 3[0006] in example 1 (solvent dimethyl sulfoxide at 100° C.). 0.6 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.309 g of 2-aminopropanamide [0262] gave 0.038 g of 2-((6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)amino)propanamide, Compound 109 using Cesium carbonate and dimethylsulphoxide at 100° C. for 48 h. MS(M+1)+=394, 1H NMR (400 MHz, DMSO-d6) δ 7.38 (s, 1H), 6.85-7.05 (m, 3H), 5.99 (s, 1H), 5.39 (bs, 1H), 4.24 (bs, 1H), 3.78 (bs, 1H), 2.49 (s, 3H), 2.14 (s, 3H), 2.12-2.00 (m, 2H), 2.0-1.85 (m 4H), 1.61-1.49 (m, 2H), 1.28 (d, J=7.0 Hz, 3H).

Example 96

[Figure (not displayed)]

Step 1[0264]: The procedure is similar to Step 3[0006] in example 1 (100° C., dimethylsulfoxide). 0.15 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.102 g of morpholin-2-ylmethanol [0263] gave 0.14 g of racemate (4-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)morpholin-2-yl)methanol [0264], Compound 110. MS(M+1)+=423, 1H NMR (400 MHz, DMSO-d6) δ 7.09 (d, J=8.0 Hz, 1H), 6.01 (s, 1H), 5.57 (s, 1H), 4.85 (t, J=5.5 Hz, 1H), 4.19-3.96 (m, 2H), 4.07-3.87 (m, 2H), 3.55-3.40 (m, 4H), 2.95-2.85 (m, 1H), 2.66-2.59 (m, 1H), 2.49 (s, 3H), 2.15 (s, 3H), 2.15-1.85 (m, 6H), 1.60-145 (m, 2H).

Step 2[0265 & 0266]: 0.14 g of racemate (4-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)morpholin-2-yl)methanol [0264] was separated by chiral Prep HPLC to afford 0.050 mg of (+)-(4-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)morpholin-2-yl)methanol [0265], Compound 112. MS(M+1)+=423. SOR: +20.909°, C=0.110, S=MeOH, T=23.4° C. 1H NMR (400 MHz, DMSO-d6) δ 7.09 (d, J=8.0 Hz, 1H), 6.01 (s, 1H), 5.57 (s, 1H), 4.85 (t, J=5.5 Hz, 1H), 4.19-3.96 (m, 2H), 4.07-3.87 (m, 2H), 3.55-3.40 (m, 4H), 2.95-2.85 (m, 1H), 2.66-2.59 (m, 1H), 2.49 (s, 3H), 2.15 (s, 3H), 2.15-1.85 (m, 6H), 1.60-145 (m, 2H) and 55 mg of (−)-(4-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)morpholin-2-yl)methanol [0266], Compound 113. MS(M+1)+=423. SOR: −13.889°, C=0.108, S=MeOH, T=23.8° C. 1H NMR (400 MHz, DMSO-d6) δ 7.09 (d, J=8.0 Hz, 1H), 6.01 (s, 1H), 5.57 (s, 1H), 4.85 (t, J=5.5 Hz, 1H), 4.19-3.96 (m, 2H), 4.07-3.87 (m, 2H), 3.55-3.40 (m, 4H), 2.95-2.85 (m, 1H), 2.66-2.59 (m, 1H), 2.49 (s, 3H), 2.15 (s, 3H), 2.15-1.85 (m, 6H), 1.60-145 (m, 2H).

Example 98

[Figure (not displayed)]

Step 1[0270]: To a solution of 4,6-dichloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine [0241] (1 g, 4.11 mmol) and morpholine-2-carboxamide [0269] (0.53 g, 4.11 mmol) in dimethylsulfoxide (8 mL) was added cesium carbonate (2.68 g, 8.22 mmol) under N2 atmosphere. The resultant reaction mixture was heated at 80° C. in a closed vial for 8 h, quenched with water and extracted with ethyl acetate (2×200 mL). The combined organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford as a yellow gum and which was purified by column chromatography using 5% methanol in chloroform as eluent to afford 4-(6-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)morpholine-2-carboxamide [0270] as an off-white solid (0.77 g), MS(M+1)+=337.

Step 2[271]: To a solution of 4-(6-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)morpholine-2-carboxamide [0270] (0.28 g, 0.831 mmol) and 4,4-Difluorocyclohexylamine hydrochloride [0002] (0.28 g, 1.66 mmol) in dimethylsulfoxide (6 mL) was added cesium carbonate (0.541 g, 1.66 mmol) under N2 atmosphere. The resultant reaction mixture was heated at 90° C. in a closed vial for 4 days. The reaction mixture was quenched with water, the solid formed was filtered and dried to afford as brown solid and which was purified by prep HPLC to afford 4-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)morpholine-2-carboxamide [271], Compound 115 as an off-white solid (0.05 g). MS(M+1)+=436. 1H NMR (400 MHz, DMSO-d6) δ 7.40 (s, 1H), 7.12 (s, 1H), 7.10 (bs 1H), 6.00 (s, 1H), 5.51 (s, 1H), 4.74 (bs, 1H), 4.30 (d, J=11.8 Hz, 1H), 4.01-3.83 (m, 2H), 3.65 (dd, J=11.8, 3.8 Hz, 2H), 3.55-3.35 (m, 2H), 2.47 (s, 3H), 2.14 (s, 3H), 2.09-1.85 (m, 6H), 1.62-1.49 (m, 2H).

Example 99

[Figure (not displayed)]

Step 1[0273]: A stirred solution of 4,6-dichloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine [0241] (1.3 g, 5.348 mmol), 1-acetylpiperazine [0272] (0.685 g, 5.348 mmol) and triethylamine (0.82 mL, 5.883 mmol) in acetonitrile (50 mL) was heated at 55° C. for 16 h. The reaction mixture was concentrated under reduced pressure to afford crude product and which was purified by column chromatography using 5% ethyl acetate in hexane as eluent to afford 1-(4-(6-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0273] as an white solid (1.1 g, 64%). MS(M+1)+=335.2.

Step 2[0274]: A stirred suspension of 1-(4-(6-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0273] (0.22 g, 0.657 mmol), 4,4-difluorocyclohexylamine hydrochloride [0002] (0.135 g, 0.788 mmol) and cesium carbonate (0.535 g, 1.642 mmol) in acetonitrile was heated at 150° C. in MW for 5 h. The reaction mixture was concentrated under reduced pressure, added water (10 mL), extracted with chloroform (3*100 mL). The combined organic layer was washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude which was purified by column chromatography using 2% methanol in chloroform as eluent to afford 1-(4-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0274], Compound 102 as an off-white solid (0.043 g, 15%). MS(M+1)+=434, 1H NMR (400 MHz, DMSO-d6) δ 7.09 (d, J=8.0 Hz, 1H), 6.01 (s, 1H), 5.57 (s, 1H), 3.88 (bs, 1H), 3.65-3.42 (m, 8H), 2.48 (s, 3H), 2.15 (s, 3H), 2.05 (s, 6H), 1.95-1.85 (m, 3H), 1.65-1.48 (m, 2H).

Example 100

[Figure (not displayed)]

Step 1 [0275]: The procedure is similar to Step 2[0274] in example 99. 0.2 g of 1-(4-(6-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0273] and 0.1 g of 4-(Trifluoromethyl)Cyclohexanamine [0113] gave 0.06 g of 1-(4-(2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-((4-(trifluoromethyl)cyclohexyl)amino)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0275], Compound 149. MS(M+1)+=466, 1H NMR (400 MHz, DMSO-d6) δ 7.02 (d, J=7.0 Hz, 1H), 6.00 (s, 1H), 5.56 (s, 1H), 3.54-3.45 (m, 9H), 2.48 (s, 3H), 2.34-2.27 (m, 1H), 2.16 (s, 3H), 2.05 (s, 3H), 2.02-1.86 (m, 4H), 1.42-1.23 (m, 4H).

Example 101

[Figure (not displayed)]

Step 1 [0276]: The procedure is similar to Step 2[0274] in example 99 (Using DIPEA, MW, 180° C.). 0.2 g of 1-(4-(6-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0273] and 0.108 g of 3,3-difluorocyclopentan-1-amine [0075] gave 0.065 g of 1-(4-(6-((3,3-difluorocyclopentyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0276], Compound 130. MS(M+1)+=420, 1H NMR (400 MHz, DMSO-d6) δ 7.34 (d, J=7.2 Hz, 1H), 6.03 (s, 1H), 5.58 (d, J=2.3 Hz, 1H), 4.32 (s, 1H), 3.58 (bs, 2H), 3.53 (s, 6H), 2.74-2.56 (m, 1H), 2.48 (s, 3H) 2.35-2.22 (m, 1H), 2.10 (dd, J=45.1, 2.5 Hz, 9H), 1.72 (dt, J=11.9, 8.4 Hz, 1H).

Example 103

[Figure (not displayed)]

Step 1[0279]: The procedure is similar to Step 1[127] in example 45. 0.5 g of 4,4-Difluoro cyclohexanone [0126] and 0.173 g of methylamine, 2M solution in tetrahydrofuran gave 0.52 g of 4,4-difluoro-N-methylcyclohexan-1-amine [0279]. MS(M+1)+=150.

Step 2[0280]: 0.4 g of 1-(4-(6-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0273] and 0.44 g of 4,4-difluoro-N-methylcyclohexan-1-amine [0279] gave 0.190 g of 1-(4-(6-((4,4-difluoro cyclohexyl)(methyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0280], Compound 132 using N,N-diisopropyl ethylamine and acetonitrile in MW at 180° C. for 3 h.

MS(M+1)+=150, 1H NMR (400 MHz, Chloroform-d) δ 6.0 (s, 1H), 5.34 (s, 1H) 4.81 (s, 1H), 3.83 (dd, J=6.5, 4.1 Hz, 2H), 3.75 (dd, J=6.6, 4.2 Hz, 2H), 3.58 (td, J=7.4, 5.2 Hz, 4H), 2.89 (s, 3H), 2.62-2.33 (m, 6H), 2.21 (m, 2H), 2.15 (s, 3H), 1.78 (s, 6H).

Example 105

[Figure (not displayed)]

Step 1[0284]: The procedure is similar to step 2[0011] in example 2. 0.8 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(5-methyl-1,2,4-oxadiazol-3-yl)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0283] gave 0.9 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-(5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0284] as an white solid. MS(M+1)+=394.

Step 2 [0285]: The procedure is similar to step 3[0012] in example 2. 0.45 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-(5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0284] gave 0.24 g of N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)-6-(5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrimidin-4-amine [0285], Compound 331 as a white solid. MS(M+1)+=396, 1H-NMR (400 MHz, DMSO-d6): δ 8.79 (s, 1H), 8.05 (bs, 1H), 7.54 (bs, 1H), 6.83 (d, J=11.52 Hz, 1H), 6.70 (s, 1H), 5.76 (s, 1H), 5.46 (d, JF=48.5 Hz, 2H), 4.22 (bs, 1H), 2.07-1.98 (m, 6H), 1.61-1.59 (m, 2H), 1.39 (d, J=4.0 Hz, 3H).

Step 3[0286]:0.15 g of N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)-6-(5-methyl-4,5-dihydro-1,2,4-oxadiazol-3-yl)pyrimidin-4-amine [0285] gave 0.11 g of N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)-6-(5-methyl-1,2,4-oxadiazol-3-yl)pyrimidin-4-amine [0286], Compound 334 as an off-white solid, using manganese dioxide in dichloromethane. MS(M+1)+=394, 1H-NMR (400 MHz, DMSO-d6): δ 8.69 (s, 1H), 8.22 (d, J=7.32 Hz, 1H), 7.14 (s, 1H), 6.70 (s, 1H), 5.48 (d, JF=48.5 Hz, 2H), 4.26 (bs, 1H), 2.70 (s, 3H), 2.09-2.01 (m, 6H), 1.63-1.61 (m, 2H).

Example 107

[Figure (not displayed)]

Step 1[0292]: To a cooled solution of tert-butyl (4,4-difluorocyclohexyl)(6-((+)-4-hydroxytetrahydro-2H-pyran-3-yl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)carbamate [0290] (0.80 g, 0.157 mmol) in dioxane (5 mL) was added hydrogen chloride gas (5 mL) in dioxane. The reaction mixture was stirred at rt for 2 h. The reaction mixture was concentrated under reduced pressure. The residue was dissolved in water (1 mL). It was then neutralized with 10% sodium bicarbonate solution (20 mL). The aqueous layer was extracted with ethyl acetate (2×20 mL). The combined organic layer was washed with water (10 mL), followed by brine (10 mL) and dried over anhydrous sodium sulfate to afford 0.055 g of (+)-3-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)tetrahydro-2H-pyran-4-ol [0292], Compound 254 as a white solid. MS(M+1)+, 408.4, 1H NMR (400 MHz, DMSO-d6) δ 7.60 (bs, 1H), 6.29 (bs, 1H), 6.03 (s, 1H), 4.85 (d, J=5.5 Hz, 1H), 4.04 (bs, 1H), 3.95-3.80 (m, 3H), 3.39 (t, J=11.2, 2H), 2.48 (s, 3H), 2.16 (s, 3H), 2.05-1.80 (m, 7H), 1.63-1.36 (m, 3H).

Example 108

[Figure (not displayed)]

Step 5[23]: The procedure is similar to step 1 [0292] in example 107. 0.060 g of tert-butyl (4,4-difluorocyclohexyl)(6-((−)-4-hydroxytetrahydro-2H-pyran-3-yl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)carbamate [0291] gave 0.042 g of (−)-3-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)tetrahydro-2H-pyran-4-ol [0293], Compound 257 as a white solid. MS(M+1)+=408.4, 409.4. 1H NMR (400 MHz, DMSO-d6) δ 7.67 (d, J=7.7 Hz, 1H), 6.24 (bs, 1H), 6.06 (s, 1H), 5.39 (bs, 1H), 4.24 (s, 1H), 4.02 (bs, 1H), 3.97-3.80 (m, 1H), 3.80-3.54 (m, 3H), 2.82 (bs, 1H), 2.53 (s, 3H), 2.16 (s, 3H), 2.10-1.7 (m, 7H), 1.57-1.50 (m, 3H).

Example 110

[Figure (not displayed)]

Step 1[0298]: The procedure is similar to Step 2 [0271] in example 98 (16 h). 0.4 g of 4,6-dichloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine [0241] gave 0.350 g of 4-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(1H-pyrazol-1-yl)pyrimidine [0298] as an off-white solid. MS(M+1)+=275.

Step 2[0299]: The procedure is similar to Step 2 [0271] in example 98 (16 h). 0.15 g of 4-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(1H-pyrazol-1-yl)pyrimidine [0298] gave 0.04 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(1H-pyrazol-1-yl)pyrimidin-4-amine [0299], Compound 117 as an off-white solid. MS(M+1)+=374. 1H NMR (400 MHz, DMSO-d6) δ 8.50 (s, 1H), 7.98 (s, 1H), 7.87 (s, 1H), 6.85 (s, 1H), 6.59 (s, 1H), 6.13 (d, J=2.8 Hz, 1H), 4.12 (bs, 1H), 2.61 (s, 3H), 2.20 (s, 3H), 2.15-1.85 (m, 6H), 1.68-1.50 (m, 2H).

Example 111

[Figure (not displayed)]

Step 1[0301]: To a stirred solution of 0.500 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] in 50% aqueous sodium hydroxide solution (2 mL), was added 0.331 g of (2-methyl-2H-1,2,3-triazol-4-yl)methanol [0300] and tetra butyl ammonium hydrogen sulfate (0.200 g, 0.586 mmol). The reaction mixture was heated at 110° C. for 16 h. The reaction mixture was extracted with ethyl acetate (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product, which was purified by column chromatography to afford 0.22 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-((2-methyl-2H-1,2,3-triazol-4-yl)methoxy)pyrimidin-4-amine [0301], Compound 191 as an white solid. MS(M+1)+=419. 1H NMR (400 MHz, DMSO-d6) δ 8.05 (bs, 1H), 7.51 (bs, 1H), 6.09 (s, 1H), 5.70 (bs, 1H), 5.36 (s, 2H), 4.14 (s, 3H), 4.01 (bs, 1H), 2.57 (s, 3H), 2.19 (s, 3H), 2.10-1.90 (m, 6H), 1.60-1.53 (m, 2H).

Example 112

[Figure (not displayed)]

Step 1[0303]: The procedure is similar to step 1[0301] in example 111. 0.250 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.165 g of (1-methyl-1H-1,2,3-triazol-5-yl)methanol [0302] gave 0.150 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-((1-methyl-1H-1,2,3-triazol-5-yl)methoxy)pyrimidin-4-amine [0303], Compound 126 as an white solid. MS(M+1)+=419. 1H NMR (400 MHz, DMSO-d6) δ 8.48 (bs, 1H), 7.48 (bs, 1H), 6.09 (s, 1H), 5.70 (s, 1H), 5.36 (bs, 2H), 4.04 (s, 3H), 4.03 (m, 1H), 2.58 (s, 3H), 2.20 (s, 3H), 2.08-1.91 (m, 6H), 1.50-1.45 (m, 2H).

Example 113

[Figure (not displayed)]

Step 1[0305]: The procedure is similar to step 1[0301] in example 111. 0.150 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] gave 0.030 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-((1-methyl-1H-1,2,4-triazol-5-yl)methoxy)pyrimidin-4-amine[0305], Compound 274.

MS(M+1)+=418.2, 1H NMR (400 MHz, DMSO-d6) δ 7.90 (s, 1H), 7.56 (bs, 1H), 6.08 (s, 1H), 5.76 (bs, 1H), 5.47 (s, 2H), 3.99 (s, 4H), 2.55 (s, 3H), 2.17 (s, 3H), 2.12-1.85 (m, 6H), 1.62-1.45 (m, 2H).

Example 114

[Figure (not displayed)]

Step 1[0307]: The procedure is similar to step 2[0274] in Example 99. 0.15 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.09 g of (2-methyl-2H-1,2,3-triazol-4-yl)methanamine [0306] gave 0.03 g of N4-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-N6-((2-methyl-2H-1,2,3-triazol-4-yl)methyl)pyrimidine-4,6-diamine [0307], Compound 235 as a light yellow solid.

MS(M+1)+=418, 1H NMR (400 MHz, DMSO-d6) δ 7.70 (s, 1H), 7.32 (t, J=5.8 Hz, 1H), 6.93 (d, J=7.5 Hz, 1H), 5.98 (s, 1H), 5.35 (s, 1H), 4.43-4.39 (m, 2H), 4.08 (s, 3H), 3.80 (bs, 1H), 2.46 (s, 3H), 2.13 (s, 3H), 2.15-1.80 (m, 6H), 1.60-1.43 (m, 2H).

Example 115

[Figure (not displayed)]

Step 1[0309]: The procedure is similar to step 2[0274] in Example 99. 0.15 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.09 g of (1-methyl-1H-1,2,3-triazol-4-yl)methanamine [0308] gave 0.04 g of N4-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-N6-((1-methyl-1H-1,2,3-triazol-4-yl)methyl)pyrimidine-4,6-diamine [0309], Compound 233 as an off-white solid.

MS(M+1)+=418, 1H NMR (400 MHz, DMSO-d6) δ 8.09 (bs, 1H), 7.33 (t, J=5.9 Hz, 1H), 6.93 (d, J=7.6 Hz, 1H), 6.00 (s, 1H), 5.37 (s, 1H), 4.42 (d, J=5.8 Hz, 2H), 4.00 (s, 3H), 3.81 (bs, 1H), 2.48 (s, 3H), 2.16 (s, 3H), 2.08-1.87 (m, 6H), 1.53-1.48 (m, 2H).

Example 116

[Figure (not displayed)]

Step 1[0310]: To a stirred solution of 4,6-dichloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine [0241] (2 g, 8.227 mmol) in a mixture of solvent (tetrahydrofuran (20 mL) and water (2 mL)) was added sodium hydroxide (0.65 g, 16.454 mmol). The reaction mixture was stirred at rt for 16 h. The reaction mixture was concentrated under reduced pressure. The residue was dissolved in water, neutralized with 1.5 N HCl solution (˜0.5 mL), and extracted with ethyl acetate (3×50 mL). The combined organic extracts were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 0.550 g of 6-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-ol [0310] as a white solid. MS(M+1)+=225.2.

Step 2[0312]: To a stirred solution of 6-chloro-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-ol [0310] (0.50 g, 0.2226 mmol) in acetonitrile (2 mL) was added sodium chlorodifluoroacetate [0311] (0.54 g, 0.356 mmol) and sodium carbonate (0.47 g, 0.445 mmol). The reaction mixture was heated at 90° C. for 5 h. The reaction mixture was partitioned between ethyl acetate (20 mL) and water (5 mL). The organic extracts was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 0.110 g of 4-chloro-6-(difluoromethoxy)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine [0312] as an off-white solid. MS(M+1)+=275.2/276.2.

Step 3[0313]: To a stirred solution of 4-chloro-6-(difluoromethoxy)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidine [0312] (0.1 g, 0.364 mmol) in acetonitrile (3 mL) was added 4,4-difluorocyclohexylamine hydrochloride (0.125 g, 0.728 mmol) and N,N-diisopropyl ethylamine (0.117 g, 0.91 mmol). The reaction mixture was irradiated in microwave at 130° C. for 2 h. The reaction mixture was filtered through celite and the filtrate was concentrated under reduced pressure to afford crude product which was purified by column chromatography using 35% ethyl acetate in pet ether as solvent to afford 0.035 g of N-(4,4-difluorocyclohexyl)-6-(difluoromethoxy)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0313], Compound 209 as a white solid. MS(M+1)+=336.0/337.0. 1H NMR (400 MHz, DMSO-d6) δ 7.76-7.40 (t, JF=72.8 Hz, 1H), 7.65 (d, 8 Hz, 1H), 6.07 (s, 1H), 5.94 (s, 1H), 3.94 (s, 1H), 2.55 (s, 3H), 2.18 (s, 3H), 2.07-1.95 (m, 6H), 1.63-1.61 (m, 2H).

Example 117

[Figure (not displayed)]

Step 1[55]: The procedure is similar to step 3[0313] in example 116. 0.5 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] gave 0.28 g of (R)-2-((6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)amino)-3-methylbutanamide [0315], Compound 164 0.28 g of as a white solid. MS(M+1)+=422.2. 1H-NMR (400 MHz, DMSO-d6): δ 7.33 (s, 1H), 7.01 (bs, 1H), 6.93 (bs, 1H), 6.71 (bs, 1H), 5.97 (s, 1H), 5.48 (bs, 1H), 4.23 (bs, 1H), 3.74 (bs, 1H), 2.47 (s, 3H), 2.12 (s, 3H), 2.10-2.00 (m, 3H), 2.00-1.80 (m, 4H), 1.62-1.48 (m, 2H), 0.95 (d, J=0.68 Hz, 6H).

Example 118

[Figure (not displayed)]

Step 1[0317]: The procedure is similar to step 3[0313] in example 116. 0.3 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] gave 0.020 g of N4-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-N6-(oxazol-2-ylmethyl)pyrimidine-4,6-diamine [0317], Compound 145 as an light brown solid. MS(M+1)+=404, 1H NMR (400 MHz, DMSO-d6) δ 8.04 (s, 1H), 7.48 (t, J=6.0 Hz, 1H), 7.15 (s, 1H), 7.02 (d, J=7.9 Hz, 1H), 5.98 (s, 1H), 5.43 (s, 1H), 4.55 (d, J=5.9 Hz, 2H), 3.81 (bs, 1H), 2.42 (s, 3H), 2.13 (s, 3H), 2.06-1.90 (m, 6H), 1.50-1.60 (m, 2H).

Example 120

[Figure (not displayed)]

Step 1: The procedure is similar to step 3[0313] in example 116. 0.15 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.088 g of 2-methyl morpholine [0319] gave 0.07 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(2-methylmorpholino)pyrimidin-4-amine [0320], Compound 188. MS(M+1)+=407, 1H-NMR (400 MHz, DMSO-d6): δ 7.07 (d, J=8.00 Hz, 1H), 6.01 (bs, 1H), 5.57 (s, 1H), 4.07-3.89 (m, 2H), 3.89-3.88 (m, 2H), 3.54-3.48 (m, 2H), 2.89-2.83 (m, 1H), 2.57-2.54 (m, 1H), 2.50 (s, 3H), 2.14 (s, 3H), 2.49-2.08 (m, 6H), 1.50-1.49 (m, 2H), 1.12 (d, J=Hz, 3H).

Example 121

[Figure (not displayed)]

Step 1 [0322]: The procedure is similar to Step 2[0274] in example 99. 0.15 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.101 g of 2,6-dimethyl morpholine [0321] gave 0.07 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(2,6-dimethylmorpholino)pyrimidin-4-amine [0322], Compound 190. MS(M+1)+=421, 1H NMR (400 MHz, DMSO-d6) δ 7.07 (d, J=8.0 Hz, 1H), 6.01 (s, 1H), 5.57 (s, 1H), 4.08 (bs, 2H), 3.87 (bs, 1H), 3.57-3.58 (m, 2H), 2.48 (s, 3H), 2.12 (s, 3H), 2.12-1.85 (m, 6H), 1.60-1.49 (m, 2H), 1.15 (d, J=6.2 Hz, 6H). (angular Proton (2H) missing)

Example 122

[Figure (not displayed)]

Step 1 [0324]: The procedure is similar to Step 2[0274] in example 99. 0.15 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.127 g of 2-(morpholin-2-yl)propan-2-ol [0323] gave 0.050 g of 2-(4-(6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)morpholin-2-yl)propan-2-ol [0324], Compound 227. MS(M+1)+=451, 1H NMR (400 MHz, DMSO-d6) δ 7.08 (d, J=7.9 Hz, 1H), 6.01 (s, 1H), 5.57 (s, 1H), 4.56 (s, 1H), 4.21 (bs, 1H), 4.11-3.82 (m, 3H), 3.49-340 (m, 1H), 3.16 (dd, J=10.8, 2.4 Hz, 1H), 2.84 (t, J=11.7 Hz, 1H), 2.70-2.60 (m, 1H), 2.58 (s, 3H), 2.15 (s, 3H), 2.07-1.82 (m, 6H), 1.54-1.47 (m 2H), 1.16 (s, 3H), 1.10 (s, 3H).

Example 123

[Figure (not displayed)]

Step 1[0326]: The procedure is similar to Step 2[0274] in example 99. 0.2 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.196 g of 2-(methoxymethyl)morpholine [0325] gave 0.050 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(2-(methoxymethyl)morpholino)pyrimidin-4-amine [0326], Compound 194. MS(M+1)+=437, 1H NMR (400 MHz, DMSO-d6) δ 7.10 (d, J=8.0 Hz, 1H), 6.01 (s, 1H), 5.57 (s, 1H), 3.80-4.12 (m, 4H), 3.65-3.55 (m, 1H), 3.55-3.49 (m, 1H), 3.45-3.35 (m, 2H), 3.29 (s, 3H), 2.95-2.82 (m, 1H), 2.72-2.61 (m, 1H), 2.48 (s, 3H), 2.14 (s, 3H), 2.10-2.0 (m, 3H), 1.95-2.0 (m, 3H), 1.54-1.45 (m, 2H).

Example 124

[Figure (not displayed)]

Step 1[0328]: The procedure is similar to step 1[0301] in example 111. 0.25 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 0.16 g of (1-methyl-1H-1,2,3-triazol-5-yl)methanol [0327] gave 0.15 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-((1-methyl-1H-1,2,3-triazol-5-yl)methoxy)pyrimidin-4-amine [0328], Compound 189 as an white solid, LCMS(MH+)=419, 1H NMR (400 MHz, DMSO-d6) δ 7.88 (s, 1H), 7.53 (bs, 1H), 6.08 (s, 1H), 5.71 (bs, 1H), 5.47 (s, 2H), 4.11 (s, 3H), 3.43 (bs, 1H), 2.56 (s, 3H), 2.18 (s, 3H), 2.11-1.86 (m, 6H), 1.50-1.45 (m, 2H).

Example 127

[Figure (not displayed)]

Step 3[0335]: The procedure is similar to step 4 [0244] in example 87. 0.3 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0333] gave 0.11 g of 1-(6-((4,4-difluorocyclohexyl)amino)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)-3-methylazetidin-3-ol [0335], Compound 140 as white solid. MS(M+1)+=379.2, 1H NMR (400 MHz, DMSO-d6) δ 8.38 (s, 1H), 7.04 (d, J=7.9 Hz, 1H), 6.25 (d, J=2.5 Hz, 1H), 5.63 (s, 1H), 5.17 (s, 1H), 3.99 (bs, 1H), 3.82 (q, J=8.36 Hz, 4H), 2.24 (s, 3H), 2.12-1.85 (m, 6H), 1.62-1.49 (m, 2H), 1.43 (s, 3H).

Example 128

[Figure (not displayed)]

Step 3[0336]: The procedure is similar to step 3[0313] in Example 116 (at 160° C.). 0.2 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0333] gave 0.058 g of N4-(4,4-difluorocyclohexyl)-N6-(3,3-dimethylcyclobutyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidine-4,6-diamine [0336], Compound 156 as off-white sold. MS(M+1)+=391.4. 1H NMR (400 MHz, DMSO-d6) δ 8.36 (d, J=2.7 Hz, 1H), 7.14 (d, J=6.6 Hz, 1H), 6.91 (d, J=7.7 Hz, 1H), 6.24 (d, J=2.4 Hz, 1H), 5.17 (s, 1H), 3.90 (bs, 2H), 2.23 (s, 3H), 2.18-2.12 (m, 2H), 2.12-1.85 (m, 6H), 1.74 (d, J=8.84 Hz, 2H), 1.62-1.48 (m, 2H), 1.24 (s, 3H), 1.08 (s, 3H).

Example 129

[Figure (not displayed)]

Step 3[0337]: The procedure is similar to step 3[0313] in Example 116 (at 160° C.). 0.2 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0333] gave 0.140 g of N4-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-N6-neopentylpyrimidine-4,6-diamine [0337], Compound 146 as off-white solid. MS(M+1)+=379.2. 1H NMR (400 MHz, DMSO-d6) δ 8.37 (d, J=2.6 Hz, 1H), 6.90-6.71 (m, 2H), 6.24 (d, J=2.5 Hz, 1H), 5.37 (s, 1H), 3.80 (bs, 1H), 3.06 (bs, 2H), 2.24 (s, 3H), 2.15-1.85 (m, 6H), 1.62-1.48 (m, 2H), 0.92 (s, 9H).

Example 131

[Figure (not displayed)]

Step 1[0347] The procedure is similar to Step 3[0313] in example 116 (at 180° C.). 0.2 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0333] and 0.1 g of tert-butyl (3-azabicyclo[3.1.0]hexan-6-yl) carbamate [0346] gave 0.2 g of tert-Butyl (3-(6-((4,4-difluorocyclohexyl)amino)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)-3-azabicyclo [3.1.0]hexan-6-yl)carbamate [0347]. MS(M+1)+=490.2.

Step 2[0348]: A stirred solution of tert-Butyl (3-(6-((4,4-difluorocyclohexyl)amino)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-6-yl)carbamate [0347] (0.2 g, 0.409 mmol) in dichloromethane (5 mL) was cooled to 0° C. Trifluoroacetic acid (0.235 g, 2.042 mmol) was added and the mixture was stirred at rt for 18 h. The reaction mixture was concentrated under reduced pressure to afford crude which was purified by column chromatography using 2% methanol in chloroform as eluent to afford 3-(6-((4,4-difluorocyclohexyl)amino)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)-3-azabicyclo[3.1.0] hexan-6-amine [0348], Compound 155 as white solid (60 mg, 37%). MS(M+1)+=390, 1H NMR (400 MHz, Acetone-d6) δ 8.48 (d, J=2.6 Hz, 1H), 6.34 (d, J=2.6 Hz, 1H), 4.03 (bs, 3H), 3.67 (d, J=11.3 Hz, 2H), 3.40 (t, J=2.4 Hz, 1H), 2.66 (s, 2H), 2.31 (s, 3H), 2.12 (s, 3H), 2.12-1.88 (m, 6H), 1.65-1.55 (m, 2H).

Example 133

[Figure (not displayed)]

Step 1[0351]: To a stirred solution of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0333] (4.1 g, 12.509 mmol) and tert-butyl 3-hydroxyazetidine-1-carboxylate [0021] (4.3 g, 25.018 mmol) in dioxane (40 mL) was added cesium carbonate (6.11 g, 18.763 mmol). The reaction mixture was heated at 100° C. in a sealed tube for 18 h. The reaction mixture was concentrated under reduced pressure. The residue was dissolved in ethyl acetate (50 mL). The organic layer was washed with water (20 mL), followed by brine (20 mL) and dried over anhydrous sodium sulfate to afford crude product which was purified by column chromatography using 45% ethyl acetate in pet ether as solvent to afford 2.1 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0351] as a yellow solid.

MS(M+1)+=465.0.

Step 2[0352]: To a cooled solution of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0351] (2.1 g, 4.52 mmol) in dioxane (10 mL) was added hydrogen chloride gas in dioxane (10 mL). The reaction mixture was stirred at rt for 1 h. The reaction mixture was concentrated under reduced pressure to afford 2.1 g of 6-(azetidin-3-yloxy)-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0352] as a yellow color gum.

Step 3[0354]: To a cooled solution of 6-(azetidin-3-yloxy)-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0352] (0.25 g, 0.686 mmol) in dichloromethane (3 mL) was added triethylamine (0.1 mL, 0.754 mmol), followed by iso-butyryl chloride [0353] (73 g, 0.686 mmol). The reaction mixture was stirred at rt for 1 h and diluted with dichloromethane (20 mL). The organic layer was washed with 10% sodium bicarbonate solution (10 mL), followed by water (10 mL) and brine (10 mL). The organic layer was dried over anhydrous sodium sulfate to afford 0.2 g of crude product which was purified by preparative HPLC to afford 0.06 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2-methylpropan-1-one [0354], Compound 210 as a white solid. MS(M+1)+=435.5, 1H NMR (400 MHz, DMSO-d6) δ 8.44 (d, J=2.4 Hz, 1H), 7.34 (d, J=7.6 Hz, 1H), 6.30 (d, J=2.5 Hz, 1H), 5.74 (s, 1H), 5.40-5.35 (m, 1H), 4.58-3.57 (m, 5H), 2.27 (s, 3H), 2.05-1.85 (m, 7H), 1.60-1.50 (m, 2H), 1.01 (d, J=6.9 Hz, 6H).

Example 134

[Figure (not displayed)]

Step 1[77]: The procedure is similar to step 3[0354] in example 133. 0.8 g of 6-(azetidin-3-yloxy)-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0352] and 0.2 g of methyl chloroformate [0026] gave 0.32 g of 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0355], Compound 205 as a white solid. MS(M+1)+=423.4. 1H NMR (400 MHz, DMSO-d6): δ 8.38 (d, J=2.40 Hz, 1H), 7.31 (d, J=7.60 Hz, 1H), 6.29 (d, J=2.80 Hz, 1H), 5.72 (s, 1H), 5.41-5.38 (m, 1H), 4.37-4.33 (m, 2H), 3.94-3.91 (m, 3H), 3.60 (s, 3H), 2.33 (s, 3H), 2.32-2.09 (m, 6H), 2.05-2.04 (m, 2H).

Example 135

[Figure (not displayed)]

Step 1[0357]: The procedure is similar to step 3[0354] in example 133. 0.8 g of 6-(azetidin-3-yloxy)-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0352] and 0.26 g of pivaloyl chloride [0356] gave 0.4 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0357], Compound 211 as a white solid. MS(M+1)+=449.4. 1H NMR (400 MHz, DMSO-d6) δ 8.40 (d, J=2.6 Hz, 1H), 7.31 (d, J=7.7 Hz, 1H), 6.29 (d, J=2.6 Hz, 1H), 5.73 (s, 1H), 5.39 (tt, J=6.6, 4.1 Hz, 1H), 4.52 (s, 2H), 4.07 (d, J=7.9 Hz, 2H), 3.93 (s, 1H), 2.27 (s, 3H), 2.09-1.89 (m, 6H), 1.62 (d, J=11.4 Hz, 2H), 1.14 (s, 9H).

Example 136

[Figure (not displayed)]

Step 1[45]: The procedure is similar to step 4 [0244] in example 87. 0.4 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0333] and 0.178 g of 3-Oxetanamine [0243] gave 0.07 g of N4-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-N6-(oxetan-3-yl)pyrimidine-4,6-diamine [0358], Compound 141 as yellow solid. MS(M+1)+=364.8. 1H NMR (400 MHz, DMSO-d6) δ 8.37 (s, 1H), 7.66 (d, J=5.8 Hz, 1H), 7.01 (d, J=7.8 Hz, 1H), 6.25 (d, J=2.5 Hz, 1H), 5.22 (bs, 1H), 4.79 (t, J=6.5 Hz, 3H), 4.48 (t, J=5.64 Hz, 2H), 3.87 (bs, 1H), 2.24 (s, 3H), 2.15-1.85 (m, 6H), 1.54-1.45 (m, 2H).

Example 137

[Figure (not displayed)]

Step 1[0360]: The procedure is similar to step 4 [0244] in example 87. 0.2 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0333] and 0.22 g of N,N-dimethylazetidin-3-amine dihydrochloride [0359] gave 0.08 g of N-(4,4-difluorocyclohexyl)-6-(3-(dimethylamino)azetidin-1-yl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0360], Compound 143 as a yellow solid. MS(M+1)+=392.1, 1H NMR (400 MHz, DMSO-d6) δ 8.38 (s, 1H), 7.05 (d, J=8.0 Hz, 1H), 6.25 (d, J=2.6 Hz, 1H), 5.17 (s, 1H), 3.99 (t, J=7.8 Hz, 2H), 3.74 (dd, J=8.7, 5.2 Hz, 2H), 3.20-3.12 (m, 1H), 2.24 (s, 3H), 2.12 (s, 6H), 2.05-1.88 (m, 6H), 1.78 (bs, 1H) 1.60-1.48 (m, 2H).

Example 138

[Figure (not displayed)]

Step 1[0361]: To a solution of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0333] (0.3 g, 0.915 mmol) in acetonitrile (6 mL) was added 3,3-difluorocyclobutanamine hydrochloride [0111] (0.26 g, 1.83 mmol) and N,N-diisopropyl ethylamine (0.236 g, 1.83 mmol). The reaction mixture was heated at 180° C. under microwave for 5 h. The reaction mixture was concentrated under reduced pressure to afford crude product which was purified by column chromatography using 40% ethyl acetate in pet ether to afford 0.130 g of N4-(3,3-difluorocyclobutyl)-N6-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidine-4,6-diamine [0361], Compound 147 as a white solid. MS(M+1)+=399.2. 1H NMR (400 MHz, DMSO-d6) δ 8.37 (s, 1H), 7.42 (d, J=6.1 Hz, 1H), 6.99 (d, J=7.9 Hz, 1H), 6.24 (d, J=2.5 Hz, 1H), 5.24 (s, 1H), 4.08 (bs, 1H), 3.89 (bs, 1H), 3.10-2.90 (m, 2H), 2.64-2.53 (m, 2H), 2.23 (s, 3H), 2.15-1.84 (m, 6H), 1.60-1.49 (m, 2H).

Example 140

[Figure (not displayed)]

Step 1[0364]: The procedure is similar to step 1[0361] in example 138. 0.2 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0333] and 0.156 g of 1-(aminomethyl)-N,N-dimethylcyclobutane-1-amine[0363] gave 0.08 g of N4-(4,4-difluorocyclohexyl)-N6-((1-(dimethylamino)cyclobutyl)methyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidine-4,6-diamine [0364], Compound 157 as a white solid.

MS(M+1)+=420.1, 1H-NMR (400 MHz, DMSO-d6): δ 8.39 (s, 1H), 6.93 (bs, 1H), 6.27 (s, 1H), 5.41 (s, 1H), 3.81-3.4 (m, 3H), 2.33-2.16 (m, 8H), 2.15-1.98 (m, 5H), 1.97-1.85 (m, 4H), 1.84-1.60 (m, 5H), 1.60-1.49 (m, 2H).

Example 142

[Figure (not displayed)]

Step 1[0370]: The procedure is similar to step 1[0361] in example 138. 0.2 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0333] and 0.17 g of 1-ethylazepan-3-amine [0369] gave 0.02 g of N4-(4,4-difluorocyclohexyl)-N6-(1-ethylazepan-3-yl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidine-4,6-diamine [0370], Compound 158 as a yellow solid. MS(M+1)+=434.4. 1H NMR (400 MHz, DMSO-d6) δ 8.38 (s, 1H), 6.91 (bs, 1H), 6.54 (bs, 1H), 6.27 (bs, 1H), 5.34 (bs, 1H), 3.87 (bs, 2H), 2.25 (s, 3H), 2.05 (bs, 4H), 1.91 (s, 7H), 1.73-1.49 (m, 9H), 1.10-0.98 (bs, 3H).

Example 145

[Figure (not displayed)]

Step 1[0377]: To a suspension of 4,6-dichloro-2-(methylthio)pyrimidine [0029] (10 g, 51.26 mmol) in N,N-dimethylformamide (50 mL) was added 3,5-dimethyl pyrazole [0017] (4.9 g, 51.26 mmol), followed by cesium carbonate (25.05 g, 76.89 mmol) and the reaction mixture was heated at 80° C. After 16 h, the reaction mixture was filtered and washed with chloroform. The filtrate was concentrated under reduced pressure and the residue was triturated with water. The solid formed was filtered, washed with water and dried under vacuum to afford 10 g of 4-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidine [0377] as an off-white solid. MS(M+1)+=255.2.

Step 2[0378]: To a solution of 4-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidine [0377] (10 g, 39.255 mmol) in dichloromethane (250 mL) was added 3-chloroperbenzoic acid (20.3 g, 117.36 mmol) in portion-wise at 0° C. The reaction mixture was slowly warmed to rt. After 6 h, the reaction mixture was diluted with dichloromethane, washed with saturated sodium thiosulfate solution and followed by 10% sodium bicarbonate solution. The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 9 g of 4-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidine [0378] as an off-white solid.

MS(M+1)+=287.0.

Step 3[0379]: To the solution of 4-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidine [0378] (2 g, 6.97 mmol) and N-Boc-2,5-Diaza-Bicyclo[2.2.1]Heptane [0254] (1.38 g, 6.97 mmol) in N,N-dimethylformamide was added cesium carbonate (3.4 g, 10.46 mmol) in closed vial and the reaction mixture was heated at 60° C. After 1 h, the reaction mixture was added water and stirred for 10 min. The solid formed was filtered off and the filtrate was washed with water followed by brine. The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford a white solid, which was purified in the Reveleris flash system instrument using ethyl acetate in hexane as solvent to afford 1.8 g of t-butyl (1R,4R)-5-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidin-4-yl)-2,5-diazabicyclo[2.2.1] heptane-2-carboxylate [0379] as white solid. MS(M+1)+=449.3.

Example 147

[Figure (not displayed)]

Step 1[0382]: To a solution of 4-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidine [0377] (1 g, 3.92 mmol) and morpholine-2-carboxamide [0269] (0.76 g, 5.88 mmol) in DMSO (8 mL) was added cesium carbonate (2.55 g, 7.85 mmol) then the reaction mixture was heated at 80° C. in a closed vial for 16 h. After the completion of the reaction, the reaction mixture was quenched with ice-cold water and extracted with ethyl acetate (2×70 mL). The combined organic layer was dried over anhydrous sodium sulfate and concentrated to afford as an brownish gum and which was purified by column of silica gel (60-120 mesh) using 85% ethyl acetate in hexane as eluent to afford 0.6 g of 4-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidin-4-yl)morpholine-2-carboxamide [0382] as an off-white solid. MS(M+1)+=349.

Step 2[0383]: The procedure is similar to Step 2[0378] in example 145. 0.6 g of 4-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidin-4-yl)morpholine-2-carboxamide [0382] gave 0.4 g of 4-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidin-4-yl)morpholine-2-carboxamide [0383] as an white solid, MS(M+1)+=381.

Step 3[0384]: To a solution of 4-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidin-4-yl)morpholine-2-carboxamide [0383] (0.2 g, 0.525 mmol) and 4,4-difluoro cyclohexylamine hydrochloride [0002] (0.18 g, 1.05 mmol) in ethanol (8 mL) was added N,N-diisopropyl ethylamine (0.27 g, 2.10 mmol). The reaction mixture was heated at 90° C. in a closed vial (20 mL) for 5 days. The reaction mixture was concentrated to afford as an brownish gum, which was purified by column using 2% methanol in chloroform as eluent to afford 35 g of 4-(2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)morpholine-2-carboxamide [0384], Compound 114 as an off-white solid. MS(M+1)+=436, 1H-NMR (400 MHz, DMSO-d6): δ 7.38 (m, 1H), 7.16 (bs, 1H), 6.78 (d, J=7.56 Hz, 1H), 6.30 (s, 1H), 6.05 (s, 1H), 4.90 (bs, 1H), 4.26 (bs, 1H), 3.85 (dd, J=7.00, 27.24 Hz, 2H), 3.63 (s, 1H), 3.50-3.44 (m, 2H), 2.59 (s, 3H), 2.16 (s, 3H), 2.15-1.80 (m, 6H), 1.61-1.55 (m, 2H).

Example 149

[Figure (not displayed)]

Step 1[0387]: The procedure is similar to Step 1 [0377] in example 145. 0.5 g of 4-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidine [0377] and 0.194 g of 2-oxa-6-azaspiro[3.3]heptane [0259] gave 0.5 g of 6-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidin-4-yl)-2-oxa-6-azaspiro[3.3]heptane [0387] as an white solid. MS(M+1)+=318.

Step 2[0388]: The procedure is similar to Step 2[0378] in example 145. 0.5 g of 6-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidin-4-yl)-2-oxa-6-azaspiro[3.3]heptane [0387] gave 0.52 g of 6-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidin-4-yl)-2-oxa-6-azaspiro[3.3] heptane [0388] as an brownish gum, MS(M+1)+=350.

Step 3[0389]: The procedure is similar to Step 1 [0382] in example 147 (at 100° C.). 0.45 g of 6-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidin-4-yl)-2-oxa-6-azaspiro [3.3] heptane [0388] gave 0.055 g of N-(4,4-difluorocyclohexyl)-4-(3,5-dimethyl-1H-pyrazol-1-yl)-6-(2-oxa-6-azaspiro[3.3]heptan-6-yl)pyrimidin-2-amine [0389], Compound 108 as an white solid. MS(M+1)+=405, 1H-NMR (400 MHz, DMSO-d6): δ 6.94 (bs, 1H), 6.06 (s, 1H), 5.96 (s, 1H), 4.70 (s, 4H), 4.16 (s, 4H), 3.83 (bs, 1H), 2.59 (s, 3H), 2.16 (s, 3H), 2.10-1.82 (m, 6H), 1.56-1.53 (m, 2H).

Example 150

[Figure (not displayed)]

Step 1[0390]: To a solution of 4-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidine [0377] (4 g, 15.702 mmol) in N,N-dimethyl formamide (40 mL) was added 2-amino propanamide (1.38 g, 15.702 mmol), followed by cesium carbonate (7.67 g, 23.553 mmol) and the reaction mixture was heated at 80° C. for 16 h. The reaction mixture was quenched with ice. The solid formed was filtered to afford crude product which was purified by column chromatography using 50% ethyl acetate in hexane as solvent to afford 2.5 g of 2-((6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidin-4-yl)amino)propanamide [0390] as a yellow solid. MS(M+1)+=307.3

Step 2[0391]: The procedure is similar to step 2[0378] in example 145. 2.7 g of 2-((6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidin-4-yl)amino)propanamide [0390] gave 0.62 g of 2-((6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidin-4-yl)amino)propanamide [0391] as a yellow solid. MS(M+1)+=339.2

Step 3[100]: The procedure is similar to Step 1 [0382] in example 147 (at 100° C.). 0.37 g of 2-((6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidin-4-yl)amino)propanamide [0391] gave 0.05 g of 2-((2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)amino)propanamide [0392], Compound 107 as an off-white solid. MS(M+1)+=394.3. 1H NMR (400 MHz, DMSO-d6) δ 7.45-6.81 (m, 3H), 6.63 (d, J=7.5 Hz, 1H), 6.24 (s, 1H), 6.03 (s, 1H), 4.34 (bs, 1H), 3.83 (bs, 1H), 2.59 (s, 3H), 2.16 (s, 3H), 2.12-1.75 (m, 6H), 1.65-1.45 (m, 2H), 1.28 (d, J=7.1 Hz, 3H).

Example 151

[Figure (not displayed)]

Step 1[0393]: To a solution of 4-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidine [0377] (10 g, 39.255 mmol) in N,N-dimethylformamide (80 mL) was added 1-acetylpiperazine (5.03 g, 39.255 mmol) and cesium carbonate (19.18 g, 58.88 mmol). The reaction mixture was heated at 60° C. in a closed vial in a thermal block for 8 h. The reaction mixture was quenched with ice. The solid formed was filtered to afford 10.3 g of 1-(4-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0393] as a yellow solid. MS(M+1)+=347.4.

Step 2[0394]: To a stirred solution of 1-(4-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylthio)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0393] (5 g, 14.431 mmol) in dichloromethane (50 mL), 3-chloroperbenzoic acid (6.22 g, 36.079 mmol) was added portion-wise at 0° C. The reaction mixture was stirred at rt for 3 h, diluted with dichloromethane (50 mL), washed with saturated solution of sodium thiosulfate (25 mL), followed by 10% sodium bicarbonate solution (20 mL), water (20 mL) and brine (20 mL). The organic layer was dried over anhydrous sodium sulfate to afford 4.5 g of 1-(4-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0394] as a yellow solid. MS(M+1)+=379.0.

Step 3[0395]: 1 The procedure is similar to step 1[0382] in example 147 (at 100° C.). 0.5 g of 1-(4-(6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(methylsulfonyl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0394] gave 0.070 g of 1-(4-(2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)piperazin-1-yl)ethan-1-one [0395], Compound 101 as a white solid. MS(M+1)+=434.4. 1H NMR (400 MHz, DMSO-d6) δ 6.84 (d, J=6.84 Hz, 1H), 6.38 (s, 1H), 6.07 (s, 1H), 3.86 (s, 1H), 3.63 (s, 2H), 3.54-3.47 (m, 6H), 2.61 (s, 3H), 2.18 (s, 3H), 2.04 (s, 5H), 1.99-1.85 (m, 4H), 1.58-1.55 (m, 2H).

Example 153

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0401]: To a stirred solution of (1-(4-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0398] (3.4 g, 9.89 mmol) and imidazole (1.753 g, 14.836 mmol) in dichloromethane (50 mL) was added tert-butyl dimethylsilyl chloride (1.8 g, 11.868 mmol) in portions at 0° C. The reaction mixture was slowly brought to rt for 4 h, concentrated under reduced pressure to afford crude product which was purified by column chromatography using 15% ethyl acetate in hexane as eluent to afford 2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-1H-pyrazol-1-yl)-6-chloro-N-(4,4-difluorocyclohexyl)pyrimidin-4-amine [0401] as yellowish solid (3.6 g, 67%).

MS(M+1)+=459.1.

Step 2[0403]: To a degassed solution of 2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-1H-pyrazol-1-yl)-6-chloro-N-(4,4-difluorocyclohexyl)pyrimidin-4-amine [0401] (3.5 g, 7.614 mmol) and tributyl(vinyl)tin [0402] (3.747 g, 11.462 mmol) in 1,2-dichloroethane (50 mL) was added bis(triphenylphosphine)palladium(II) dichloride (0.268 g, 0.682 mmol). The reaction mixture was heated to 80° C. for 16 h, quenched with water (50 mL) and extracted with ethyl acetate (2×100 mL). The combined organic layer was washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product which was purified by column chromatography using 10% ethyl acetate in hexane as eluent to afford 2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-1H-pyrazol-1-yl)-N-(4,4-difluorocyclohexyl)-6-vinylpyrimidin-4-amine [0403] as off-white solid (2.56 g). MS(M+1)+=450.61

Step 3 [0404]: To a stirred solution of 2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-1H-pyrazol-1-yl)-N-(4,4-difluorocyclohexyl)-6-vinylpyrimidin-4-amine [0403] (2.56 g, 5.694 mmol) and ethyl diazoacetate (0.975 g, 8.540 mmol) in toluene (30 mL) was heated at 100° C. for 16 h. The reaction mixture was concentrated under reduced pressure to afford crude product which was purified by column chromatography using 15% ethyl acetate in hexane as eluent to afford ethyl 2-(2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-1H-pyrazol-1-yl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-4-yl)cyclopropane-1-carboxylate [0404] as an off-white solid (0.5 g, 16%). MS(M+1)+=536.7

Step 4 [0405]: To a stirred solution of ethyl 2-(2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-1H-pyrazol-1-yl)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-4-yl)cyclopropane-1-carboxylate [0404] (0.5 g, 0.933 mmol) in a mixture of tetrahydrofuran (10 mL) and water (5 mL) was added lithium hydroxide monohydrate (0.196 g, 4.666 mmol) and the reaction mixture was stirred at rt for 18 h. The reaction mixture was acidified (pH-4-5) with aqueous hydrochloric acid (1N, 5 mL) and concentrated to dryness to afford 2-(6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)cyclopropane-1-carboxylic acid [0405] as a white solid (0.36 g). MS(M+1)+=340.4

Step 5 [0406]: To a stirred solution of 2-(6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)cyclopropane-1-carboxylic acid [0405] (0.366 g, 0.933 mmol) in tetrahydrofuran (4 mL) in a pressure tube was added triethyl amine (0.33 mL, 2.326 mmol) followed by N-(3-dimethylaminopropyl)-N′-ethyl-carbodiimide (0.267 g, 1.396 mmol) and 1-hydroxybenzotriazole hydrate (0.154 g, 1.116 mmol) at 0° C. The reaction mixture was stirred at 0° C. for 15 min. Then a solution of dimethyl amine in tetrahydrofuran (4.65 mL, 2M) was added. The mixture was stirred with slow warming to rt for 24 h. The reaction mixture was quenched with water (20 mL) and the product was extracted with chloroform (3×50 mL). The combined organic layer was washed with brine (25 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product which was purified by column chromatography using 2% methanol in chloroform as eluent to afford 2-(6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)-N,N-dimethylcyclopropane-1-carboxamide [0406] as off-white solid (0.15 g). MS(M+1)+=421.46.

Step 6 [0407]: The procedure is similar to step 3[0012] in example 2. 0.15 g 2-(6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)-N,N-dimethylcyclopropane-1-carboxamide [0406] gave 0.02 g of 2-(6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)-N,N-dimethylcyclopropane-1-carboxamide [0407], Compound 308 as an off-white solid.

MS(M+1)+=423.45, 1H NMR (400 MHz, DMSO-d6) δ 8.61 (s, 1H), 7.71 (s, 1H), 6.63 (d, J=3.1 Hz, 1H), 6.38 (s, 1H), 5.50 (s, 1H), 5.45 (d, JF=48 Hz, 1H), 4.16 (s, 1H), 3.09 (s, 3H), 2.86 (s, 3H), 2.42 (bs, 1H), 2.29 (s, 1H), 2.19-1.82 (m, 6H), 1.71-1.44 (m, 3H), 1.36 (s, 1H).

Example 154

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0408]: The procedure is similar to step 2 [0241] in example 87. 5 g of 4,6-dichloro-2-(methylsulfonyl)pyrimidine [0240] and 3.3 g of ethyl 4-methyl-1H-pyrazole-3-carboxylate [0148] gave 4.1 g of ethyl 1-(4,6-dichloropyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0408] as off-white solid. MS(M+1)+=302.2.

Step 2[0409]: The procedure is similar to Step 1[0106] in example 34 (acetonitrile as solvent). 2.1 g of ethyl 1-(4,6-dichloropyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0408] gave 1.65 g of ethyl 1-(4-chloro-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0409]. MS(M+1)+=352.2.

Step 3 [0410]: The procedure is similar to Step 4[0244] in example 87. 1.5 g of ethyl 1-(4-chloro-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0409] and 4,4-difluorocyclohexan-1-amine [0002] gave 1.6 g (crude) 1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylic acid [0410] as brown solid. MS(M+1)+=422.2. This was taken as such tonext step.

Step 4[0411]: The procedure is similar to Step 4[0007] in example 1. 1.6 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylic acid [0410] gave 1.35 g of Ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0411], MS(M+1)+=451.1.

Step 4[0412]: The procedure is similar to Step 2[0019] in example 4. 1.35 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0411] gave 0.985 g of 4(1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol [0412], MS(M+1)+=409.1.

Step 5[0413]: The procedure is similar to Step 3[0012] in example 2. 0.46 g of 4(1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol [0412] gave 0.985 g of N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-4-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine [0413], Compound 281.

MS(M+1)+=411.2, MR=146.4-154.0° C., 1H NMR (400 MHz, DMSO-d6) δ 8.37 (s, 1H), 7.16 (d, J=8.0 Hz, 1H), 5.56 (s, 1H), 5.44 (d, JF=48 Hz, 2H), 4.01 (bs, 1H), 3.72-3.65 (m, 4H), 3.51 (bs, 4H), 2.11 (s, 3H), 2.12-1.88 (m, 6H), 1.62-1.54 (m, 2H).

Example 155

[Figure (not displayed)]

Step 1[0414]: 0.51 g of 4(1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol [0412] gave 0.38 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carbaldehyde [0414], using manganese dioxide in dichloromethane. MS(M+1)+=407.

Step 2[0415]: The procedure is similar to Step 3[0012] in example 2. 0.37 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carbaldehyde [0414] gave 0.08 g of N-(4,4-difluorocyclohexyl)-2-(3-(difluoromethyl)-4-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine [0415], Compound 282.

MS(M+1)+=429, 1H NMR (400 MHz, DMSO-d6) δ 8.47 (s, 1H), 7.59 (s, 1H), 7.08 (t, JF=53.34 Hz, 1H), 5.96 (d, J=8.12 Hz, 1H), 4.11 (bs, 1H), 3.74 (s, 4H), 3.52 (s, 4H), 2.16 (s, 3H), 2.12-1.88 (m, 6H), 1.36 (bs, 2H).

Example 158

[Figure (not displayed)]

Step 1[0419]: 2 g of ethyl 1-(4-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0397] and 1.80 g of morpholine [0067] gave 1.85 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0419] (Using acetonitrile, MW, 100° C., 1 h) MS(M+1)+=437 and it was taken as such for next step without further purification.

Step 2[0420]: The procedure is similar to Step 2[0019] in example 4. 1.85 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0419] gave 1.56 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0420]. MS(M+1)+=395.

Step 3[0421]: The procedure is similar to Step 3[0012] in example 2. 0.5 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-morpholinopyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0420] gave 0.1 g of N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine [0421], Compound 280. MS(M+1)+=397, 1H NMR (400 MHz, DMSO-d6) δ 8.57 (d, J=2.6 Hz, 1H), 7.19 (d, J=8.1 Hz, 1H), 6.60 (t, J=1.8 Hz, 1H), 5.59 (s, 1H), 5.42 (d, JF=48 Hz, 2H), 3.93 (bs, 1H), 3.69 (t, J=4.7 Hz, 4H), 3.52 (m, 4H), 2.13-1.85 (m, 6H), 1.55 (m, 2H).

Example 159

[Figure (not displayed)]

Step 1[0423]: The procedure is similar to Step 1[270] in example 98. 1 g of ethyl 1-(4-chloro-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0397] and 0.4 g of thiomorpholine [0422] gave 0.98 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-thiomorpholino pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0423] MS(M+1)+=453 and it was taken as such for next step without further purification.

Step 2[0424]: The procedure is similar to Step 2[0019] in example 4. 0.97 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-thiomorpholinopyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0423] gave 0.78 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-thiomorpholinopyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0424]. MS(M+1)+=411.

Step 3[0425]: The procedure is similar to Step 3[0012] in example 2. 0.45 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-thiomorpholinopyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0424] gave 0.112 g of N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)-6-thiomorpholinopyrimidin-4-amine [0425], Compound 284.

MS(M+1)+=413, 1H NMR (400 MHz, DMSO-d6) δ 8.55 (s, 1H), 7.13 (d, J=8.0 Hz, 1H), 6.59 (s, 1H), 5.58 (s, 1H), 5.40 (d, JF=48.4 Hz, 2H), 4.01 (bs, 1H), 3.90 (s, 4H), 2.74-2.56 (m, 4H), 2.15-1.85 (m, 6H), 1.62-1.44 (m, 2H).

Example 160

[Figure (not displayed)]
[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0426]: To a solution of 4,6-dichloro-2-(methylthio)pyrimidine [0239] (150 g, 768.94 mmol) in acetonitrile (1500 mL) was added 4,4-difluorocyclohexylamine hydrochloride [0002] (158.35 g, 922.733 mmol) and cesium carbonate (526 g, 1614 mmol). The reaction mixture was heated at 75° C. for 16 h. The reaction mixture was filtered to remove cesium carbonate. The filtrate was concentrated under reduced pressure to afford 210 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(methylthio)pyrimidin-4-amine [0426] as a pale yellow solid. MS(M+1)+=294.0/295.0.

Step 2[0427]: To a stirred solution of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(methylthio)pyrimidin-4-amine [0426] (100 g, 340.40 mmol) in acetonitrile (1500 mL), was added 1-boc-3-(hydroxy)azetidine (117.9 g, 680.81 mmol) and cesium carbonate (166.37 g, 510.60 mmol). The reaction mixture was heated to 85° C. for 16 h. The reaction mixture was filtered and washed with ethyl acetate (250 mL). The filtrate was concentrated under reduced pressure to afford crude product, which was purified by column chromatography using 7% ethyl acetate in pet ether as solvent to afford 100 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(methylthio)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0427] as an off-white solid. MS(M+1)+=431.6, 432.4.

Step 3[0428]: To a stirred solution of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(methylthio)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0427] (1.2 g, 2.78 mmol) in tetrahydrofuran (20 mL) was added m-chloroperbenzoic acid (1.44 g, 8.316 mmol) at 0° C. The reaction mixture was stirred at rt for 30 min. The reaction mixture was quenched with aqueous sodium thiosulfate (15 mL) and extracted with ethyl acetate (25 mL). The organic layer was washed with saturated sodium bicarbonate (2×25 mL), water (25 mL) and brine solution (25 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 1.2 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(methylsulfonyl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0428] as a white solid. MS(M+1)+=463.9.

Step 4[0429]: To a stirred solution of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(methylsulfonyl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0428] (2 g, 4.32 mmol) in acetonitrile (15 mL) was added ethyl 1 h-pyrazole-3-carboxylate (1.23 g, 8.648 mmol) and followed by cesium carbonate (2.81 g, 8.64 mmol) under N2 atm. The resultant reaction mixture was heated at 85° C. for 16 h. The reaction mixture was filtered to remove cesium carbonate. The obtained filtrate was concentrated under reduced pressure to afford crude product, which was triturated with pet ether to afford 1.8 g of ethyl 1-(4-((1-(tert-butoxycarbonyl)azetidin-3-yl)oxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0429] as an off-white solid. MS(M+1)+=523.

Step 5[0430]: To a stirred solution of ethyl 1-(4-((1-(tert-butoxycarbonyl)azetidin-3-yl)oxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0429] (80 g, 153.095 mmol) in tetrahydrofuran (800 mL), was added lithium aluminium hydride ((2 M solution in tetrahydrofuran) 114 mL, 229.64 mmol) at −20° C. The reaction mixture was stirred at same temperature for 30 min and quenched with saturated sodium sulfate. The solid was filtered off and the filtrate was dried over anhydrous sodium sulfate and concentrated under reduced pressure to afford crude product, which was purified by column chromatography using 65% ethyl acetate in pet ether as solvent to afford 31 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0430] as an off-white solid. MS(M+1)+=481.2.

Step 6[0431]: To a stirred solution of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0430] (10 g, 20.811 mmol) in dichloromethane (100 mL), was added diethylaminosulfurdiethylaminosulfur trifluoride (4.39 mL, 33.297 mmol) at −20° C. The reaction mixture was stirred at same temperature for 15 min. The reaction mixture was quenched with saturated sodium bicarbonate solution (15 mL), and then extracted with dichloromethane (2×100 mL). The organic layer was washed with brine solution (50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 10.5 g crude product, which was purified by column chromatography using 42% ethyl acetate in pet ether as solvent to afford 3.8 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0431] as an off-white solid. MS(M+1)+=483.3.

Step 7 [0432]: To a stirred solution of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0431] (14 g, 29.015 mmol) in dicholoromethane (140 mL), was added trifluoroacetic acid (41 g, 362.69 mmol) at 0° C. The reaction mixture was stirred at rt for 6 h. The reaction mixture was concentrated under reduced pressure, to the residue water (15 mL) was added and neutralized with saturated sodium bicarbonate solution (25 mL), extracted with ethyl acetate (2×250 mL), the combined organic extracts were washed with brine (25 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 14.2 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2-methylpropan-1-one [0432] as an off-white solid. MS(M+1)+=382.8.

Step 8[0433]: To a stirred solution of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2-methylpropan-1-one [0432] (14.2 g, 37.135 mmol) in dicholoromethane (150 mL), was added triethylamine (10.35 mL, 74.27 mmol) and iso-butyryl chloride [0353] (7.9 g, 74.27 mmol) at 0° C. The reaction mixture was stirred at same temperature for 15 min and partitioned between dicholoromethane (500 mL) and water (50 mL). The organic layer was washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product, which was purified by column chromatography using 28% ethyl acetate in pet ether as solvent to afford 11.4 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2-methylpropan-1-one [0433], Compound 290 as a white solid. MS(M+1)+=453.2. 1H NMR (400 MHz, DMSO-d6) δ 8.54 (d, J=2.4 Hz, 1H), 7.42 (d, J=7.6 Hz, 1H), 6.61 (s, 1H), 5.80 (s, 1H), 5.49-5.37 (d, JF=48.0 Hz, 2H), 5.44-5.41 (m, 1H), 4.46 (bs, 3H), 3.95 (bs, 3H), 2.15-1.90 (m, 6H), 1.67-1.55 (m, 2H), 0.98 (d, J=6.8 Hz, 6H).

Example 161

[Figure (not displayed)]

Step 1[0434]: To a solution of tert-butyl3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0431] (0.25 g, 0.51 mmol) in dichloromethane was added trifluoroacetic acid (0.59 g, 1.03 mmol) at 0° C. and the reaction mixture was stirred at rt. After 16 h, triethylamine (˜1.5 mL, until reaction mixture become basic) was added to the reaction mixture at 0° C., followed by acetyl chloride [0035] (0.082 g, 1.036 mmol) and reaction mixture was stirred at rt. After 10 min, the reaction mixture was quenched with water, extracted with chloroform, washed with water and brine solution. The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford colorless oil, which was purified in the Reveleris flash system instrument using ethyl acetate in hexane as solvent in 12 g column, to afford 0.11 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)ethan-1-one [0434], Compound 289 as white solid. MS(M+1)+=425.2. 1H NMR (400 MHz, DMSO-d6) δ 8.59 (bs, 1H), 7.66 (bs, 1H), 6.67 (s, 1H), 5.75 (bs, 1H), 5.45 (d, JF=48 Hz, 3H), 4.56 (bs, 1H), 4.28 (bs, 1H), 4.13 (dd, J=9.9, 4.0 Hz, 2H), 3.83 (dd, J=10.8, 4.0 Hz, 1H), 2.15-1.88 (m, 6H), 1.80 (s, 3H), 1.65-1.52 (m, 2H).

Example 162

[Figure (not displayed)]

Step 1[0436]: The procedure is similar to step 1[0434] in example 161. 0.25 g of tert-butyl3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0431] and 0.096 g of propionyl chloride [0435] gave 0.12 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)propan-1-one [0436], Compound 288 as white solid. MS(M+1)+=439.7. 1H NMR (400 MHz, DMSO-d6) δ 8.53 (d, J=2.4 Hz, 1H), 7.43 (d, J=7.6 Hz, 1H), 6.60 (s, 1H), 5.80 (s, 1H), 5.48 (d, JF=48 Hz, 2H), 5.42-5.38 (m, 1H), 4.55 (bs, 2H), 4.10 (bs, 3H), 2.18-1.82 (m, 8H), 1.72-1.56 (m, 2H), 1.00 (t, J=7.5 Hz, 3H).

Example 163

[Figure (not displayed)]

Step 1[0438]: The procedure is similar to step 1[0434] in example 161. 0.25 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0431] gave 0.13 g of ethyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate[0438], Compound 287 as white solid. MS(M+1)+=455.2, 1H NMR (400 MHz, DMSO-d6) δ 8.52 (d, J=2.4 Hz, 1H), 7.42 (d, J=7.2 Hz, 1H), 6.61 (s, 1H), 5.80 (s, 1H), 5.45 (d, JF=48 Hz, 2H), 5.43-5.38 (m, 1H), 4.42-4.30 (m, 2H), 4.03 (q, J=7.1 Hz, 2H), 3.91 (dd, J=10.3, 4.2 Hz, 3H), 2.15-1.90 (m, 6H), 1.72-1.55 (m, 2H), 1.19 (t, J=7.1 Hz, 3H).

Example 164

[Figure (not displayed)]

Step 1 [0439]: The procedure is similar to step 1[0434] in example 161. 0.25 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0431] and 0.097 g of methyl chloroformate [0026] gave 0.13 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0439], Compound 291. MS(M+1)+=441, 1H NMR (400 MHz, DMSO-d6) δ 8.52 (d, J=2.7 Hz, 1H), 7.42 (d, J=7.7 Hz, 1H), 6.61 (d, J=2.6 Hz, 1H), 5.79 (s, 1H), 5.43 (d, JF=48 Hz, 2H), 5.46-5.38 (m, 1H), 4.36 (dd, J=9.8, 6.6 Hz, 2H), 3.94 (dd, J=10.0, 4.3 Hz, 3H), 3.60 (s, 3H), 2.15-1.90 (m, 6H), 1.70-1.55 (m, 2H).

Example 165

[Figure (not displayed)]

Step 1 [0440]: The procedure is similar to step 1[0434] in example 161. 0.25 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0431] and 0.124 g of Pivaloyl Chloride [0356] gave 0.13 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0440], Compound 293. MS(M+1)+=467, 1H NMR (400 MHz, DMSO-d6) δ 8.54 (d, J=2.6 Hz, 1H), 7.42 (d, J=7.7 Hz, 1H), 6.67-6.54 (m, 1H), 5.80 (s, 1H), 5.43 (d, JF=48 Hz, 2H) 5.46-5.38 (m, 1H), 4.53 (bs, 2H), 4.10 (bs, 2H), 3.90 (bs, 1H), 2.13-1.88 (m, 6H), 1.68-1.55 (m, 2H), 1.15 (s, 9H).

Example 166

[Figure (not displayed)]

Step 1[0441 and 0442]: The procedure is similar to step 4[0025] in example 5. 1 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0430] gave a mixture of (1-(4-(azetidin-3-yloxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0441] and 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2,2-trifluoroethan-1-one [0442] and taken as such for next step without isolation.

Step 2[0443 and 0442] (0442): The procedure is similar to Step 5[0027] in example 5. A mixture of (1-(4-(azetidin-3-yloxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0441], 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2,2-trifluoroethan-1-one [0442] and 1.05 g of methyl chloroformate [0026] gave 0.2 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0443]. MS(M+1)+=439, and 0.175 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2,2-trifluoroethan-1-one [0442], Compound 319. MS(M+1)+=477, 1H NMR (400 MHz, DMSO-d6) δ 8.45 (d, J=2.7 Hz, 1H), 7.37 (d, J=7.7 Hz, 1H), 6.46 (d, J=2.7 Hz, 1H), 5.77 (s, 1H), 5.52 (tt, J=6.7, 4.3 Hz, 1H), 4.86 (m, 2H), 4.59-4.50 (m, 1H), 4.52 (d, J=5.8 Hz, 2H), 4.43 (m, 1H), 4.12 (m, 1H), 2.21-1.83 (m, 6H), 1.63 (d, J=11.4 Hz, 2H).

Step 3[0444]: To a solution of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0443] (0.3 g, 0.684 mmol) in dichloromethane (7 mL) was added manganese dioxide (0.29 g, 3.42 mmol) and the resultant reaction mixture was stirred at rt for 20 h. The reaction mixture was filtered and the filtrate was concentrated to afford methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-formyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0444] as an off-white solid (0.24 g). MS(M+1)+=437.

Step 4[0445]: The procedure is similar to Step 3[0012] in example 2. 0.18 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-formyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0444] gave 0.09 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0445], Compound 295. MS(M+1)+=459, 1H NMR (400 MHz, DMSO-d6) δ 8.59 (d, J=2.8 Hz, 1H), 7.00 (t, JF=54.8 Hz, 1H) 6.72 (d, J=2.7 Hz, 1H), 5.81 (s, 1H), 5.39 (tt, J=6.7, 4.2 Hz, 1H), 4.35 (ddd, J=9.7, 6.6, 1.2 Hz, 2H), 4.13-3.80 (m, 3H), 3.59 (s, 3H), 2.10-1.80 (m, 6H), 1.73-1.50 (m, 2H).

Example 167

[Figure (not displayed)]

Step 1[0466]: The procedure is similar to Step 3[0444] in example 166. 1 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0430] gave 0.78 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-formyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy) azetidine-1-carboxylate [0466]. MS(M+1)+=479.

Step 2[0447]: The procedure is similar to Step 2[049] in example 10. 0.78 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-formyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy) azetidine-1-carboxylate [0466] gave 0.3 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(1-hydroxyethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0447]. MS(M+1)+=495.

Step 3[0448]: To an ice cooled solution of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(1-hydroxyethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0447] (0.3 g, 0.606 mmol) in methanol (7 mL) was purged dry hydrogen chloride gas for 10 min. The reaction mixture was concentrated to afford 1-(1-(4-(azetidin-3-yloxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazol-3-yl)ethan-1-ol hydrochloride salt [0448] as a yellow solid (0.33 g). MS(M+1)+=396.

Example 168

[Figure (not displayed)]

Step 1 [0449]: The procedure is similar to Step 8[0433] in example 160. 0.18 g of 1-(1-(4-(azetidin-3-yloxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazol-3-yl)ethan-1-ol Hydrochloride salt [0448] and 0.047 g of methyl chloroformate [0026] gave 0.075 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(1-hydroxyethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0449], Compound 307. MS (M+1)+=453, 1H NMR (400 MHz, Chloroform-d) δ 8.36 (d, J=2.6 Hz, 1H), 6.48 (d, J=2.7 Hz, 1H), 5.60 (s, 1H), 5.40 (m, 1H), 3.32 (s, 1H), 5.14 (m, 1H), 4.53-4.33 (m, 2H), 4.11 (dd, J=10.1, 4.3 Hz, 2H), 3.72 (s, 3H), 3.58 (s, 1H), 2.28 (s, 1H), 2.24-2.03 (m, 5H), 2.00-1.80 (m, 2H), 1.75-1.50 (m, 3H).

Example 169

[Figure (not displayed)]

Step 4[0450]: The procedure is similar to Step 8[0433] in example 160. 0.33 g of 1-(1-(4-(azetidin-3-yloxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazol-3-yl)ethan-1-ol Hydrochloride salt [0448] and 0.11 g of pivaloyl chloride [0356] gave 0.17 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(1-hydroxyethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0450], Compound 315. MS(M+1)+=479, 1H NMR (400 MHz, DMSO-d6) δ 8.48 (s, 1H), 7.64 (m, 1H), 6.47 (d, J=2.5 Hz, 1H), 5.71-5.68 (m, 1H), 5.36 (s, 1H), 5.27-5.18 (m, 1H), 4.93-4.66 (m, 2H), 4.29 (m, 2H), 3.83 (m, 1H), 2.26-1.80 (m, 6H), 1.55 (m, 2H), 1.39 (d, J=6.5 Hz, 3H), 1.12 (s, 9H).

Example 170

[Figure (not displayed)]

Step 1[0451 and 0442]: The procedure is similar to Step 2[0443 and 0442] in example 166. A mixture of (1-(4-(azetidin-3-yloxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0441], 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2,2-trifluoroethan-1-one [0442] and 1.05 g of Pivaloyl Chloride [0356] gave 0.5 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0451]. MS(M+1)+=465 and 0.177 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2,2-trifluoroethan-1-one [0442]. MS(M+1)+=477.

Step 2[0452] The procedure is similar to Step 3[0444] in example 166. 0.5 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0451] gave 0.3 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-((1-pivaloylazetidin-3-yl)oxy)pyrimidin-2-yl)-1H-pyrazole-3-carbaldehyde [0452]. MS(M+1)+=463.2.

Step 3[0453]: The procedure is similar to Step 3[0012] in example 2. 0.2 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-((1-pivaloylazetidin-3-yl)oxy)pyrimidin-2-yl)-1H-pyrazole-3-carbaldehyde [0452] gave 0.13 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0453], Compound 298. MS(M+1)+=485.2, MR=186.7-189.6° C., 1H NMR (400 MHz, DMSO-d6) δ 8.62 (s, 1H), 7.50 (d, J=74.8 Hz, 1H), 7.03 (t, JF=54 Hz, 1H), 6.74 (s, 1H), 5.83 (s, 1H), 5.42-5.36 (m, 1H), 4.53 (bs, 2H), 4.10 (bs, 2H), 3.94 (bs, 1H), 2.19-1.77 (m, 6H), 1.60-1.52 (m, 2H), 1.11 (s, 9H).

Example 171

[Figure (not displayed)]

Step 1[0454] The procedure is similar to Step 3[0444] in example 166. 0.2 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2,2-trifluoroethan-1-one [0442] gave 0.2 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-((1-(2,2,2-trifluoroacetyl)azetidin-3-yl)oxy)pyrimidin-2-yl)-1H-pyrazole-3-carbaldehyde [0454]. MS(M+1)+=475.2.

Step 2[0455]: The procedure is similar to Step 3[0012] in example 2. 0.2 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-((1-(2,2,2-trifluoroacetyl)azetidin-3-yl)oxy)pyrimidin-2-yl)-1H-pyrazole-3-carbaldehyde [0454] gave 0.1 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2,2-trifluoroethan-1-one [0455], Compound 299. MS (M+1)+=497 0.2, MR=164.7-170.8° C., 1H NMR (400 MHz, DMSO-d6) δ 8.62 (d, J=2.8 Hz, 1H), 7.53 (d, J=7.6 Hz, 1H), 7.03 (t, JF=54 Hz, 1H), 6.74 (d, J=2.8 Hz, 1H), 5.86 (s, 1H), 5.60-5.30 (m, 1H), 4.86 (bs, 1H), 4.56 (bs, 1H), 4.45 (bs, 1H), 4.13 (bs, 1H), 3.95 (bs, 1H), 2.18-1.82 (m, 6H), 1.64 (t, J=10.8 Hz, 2H).

Example 172

[Figure (not displayed)]

Step 1[0456]: The procedure is similar to step 2 [0274] in Example 99 (at 120° C.). 5 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(methylsulfonyl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0428] gave 3 g of Ethyl 1-(4-((1-(tert-butoxycarbonyl)azetidin-3-yl)oxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0456] as off-white solid. MS(M+1)+=537.2.

Step 2[0457]: The procedure is similar to step 2[0019] in Example 4. 6 g of Ethyl 1-(4-((1-(tert-butoxycarbonyl)azetidin-3-yl)oxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0456] gave 5 g of tert-Butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0457] as off-white solid. MS(M+1)+=495.2.

Step 3[0458]: The procedure is similar to step 1[0292] in Example 107. 5 g of tert-Butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0457] gave 3.5 g of (1-(4-(azetidin-3-yloxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol HCl [0458] as an brown solid. MS(M+1)+=395.2.

Example 173

[Figure (not displayed)]

Step 1[0459]: The procedure is similar to step 8[0433] in Example 160. 1 g of (1-(4-(azetidin-3-yloxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol.HCl [0458] gave 0.6 g of Methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0459] as an off-white solid. MS(M+1)+=453.2

Step 2[0460]: The procedure is similar to step 3[0012] in Example 2. 0.6 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0459] gave 0.3 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0460], Compound 310 as white solid. MS(M+1)+=455.2, 1H NMR (400 MHz, DMSO-d6) δ 8.31 (s, 1H), 7.37 (d, J=7.7 Hz, 1H), 5.76 (s, 1H), 5.45 (d, JF=48 Hz, 3H), 4.36 (ddd, J=9.6, 6.6, 1.1 Hz, 2H), 3.93 (ddd, J=9.6, 4.3, 1.1 Hz, 3H), 3.60 (s, 3H), 2.14 (s, 3H), 2.11-1.88 (m, 6H), 1.70-1.54 (m, 2H).

Example 174

[Figure (not displayed)]

Step 1[0461]: The procedure is similar to step 3[0444] in Example 166. 0.3 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0459] gave 0.2 g of Methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-formyl-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0461] as off-white solid. MS(M+1)+=451.2.

Step 2[0462]: The procedure is similar to step 3[0012] in Example 2. 0.2 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-formyl-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0459] gave 0.075 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0462], Compound 318 as an white solid. MS(M+1)+=473.2, 1H NMR (400 MHz, DMSO-d6) δ 8.39 (s, 1H), 7.45 (d, J=7.8 Hz, 1H), 6.70 (t, JF=54 Hz, 1H), 5.79 (s, 1H), 5.40 (dd, J=7.4, 3.7 Hz, 1H), 4.37 (dd, J=9.9, 6.8 Hz, 2H), 3.93 (dd, J=9.7, 4.4 Hz, 3H), 3.60 (s, 3H), 2.19 (s, 3H), 2.14-1.83 (m, 6H), 1.64 (t, J=10.9 Hz, 2H).

Example 175

[Figure (not displayed)]

Step 1[0463]: The procedure is similar to step 8[0433] in Example 160. 1.1 g of (1-(4-(azetidin-3-yloxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol.HCl [0459] gave 0.6 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0463] as off-white solid. MS(M+1)+=479.2.

Step 2[0464]: The procedure is similar to step 3[0012] in Example 2. 0.3 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0463] gave 0.125 g of 1-(3-((6-((4,4-difluoro cyclohexyl)amino)-2-(3-(fluoromethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0464], Compound 309 as white solid. MS(M+1)+=481.2, 1H NMR (400 MHz, DMSO-d6) δ 8.33 (s, 1H), 7.37 (d, J=7.6 Hz, 1H), 5.76 (s, 1H), 5.48 (s, 1H), 5.46 (bs, 3H), 4.53 (s, 2H), 4.08 (d, J=10.0 Hz, 2H), 2.14 (d, J=1.2 Hz, 3H), 1.94 (td, J=12.8, 12.0, 7.1 Hz, 7H), 1.63 (d, J=11.2 Hz, 2H), 1.14 (d, J=1.9 Hz, 9H).

Example 176

[Figure (not displayed)]

Step 1[0465]: The procedure is similar to step 3[0444] in Example 166. 0.25 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0463] gave 0.2 g 1-(4-((4,4-Difluorocyclohexyl)amino)-6-((1-pivaloylazetidin-3-yl)oxy)pyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carbaldehyde [0465] as off-white solid. MS(M+1)+=477.2.

Step 2[0466]: The procedure is similar to step 3[0012] in Example 2. 0.25 g of 1-(4-((4,4-difluorocyclohexyl)amino)-6-((1-pivaloylazetidin-3-yl)oxy)pyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carbaldehyde [0465] gave 0.07 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-4-methyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0466], Compound 317 as white solid. MS(M+1)+=499.2, 1H NMR (400 MHz, DMSO-d6) δ 8.41 (s, 1H), 7.45 (d, J=7.9 Hz, 1H), 6.9 (t, JF=54 Hz, 1H), 5.80 (s, 1H), 5.43-5.36 (m, 1H), 4.54 (bs, 2H), 4.09 (bs, 2H), 3.94 (bs, 1H), 2.27-2.15 (m, 3H), 2.13-1.88 (m, 6H), 1.64 (t, J=11.1 Hz, 2H), 1.15 (d, J=1.5 Hz, 9H).

Example 177

[Figure (not displayed)]

Step 1[0468]: The procedure is similar to Step 1[270] in example 98. 2.5 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(methylthio)pyrimidin-4-amine [0426] and 2.39 g of 1-Boc-3-Hydroxypyrrolidine [0467] gave 1.25 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(methylthio)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0468] MS(M+1)+=445.

Step 2[0469]: The procedure is similar to Step 2[0378] in example 145. 1.25 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(methylthio)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0468] gave 1.3 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(methylsulfonyl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0469] MS(M+1)+=477.

Step 3[0470]: The procedure is similar to Step 2[0274] in example 99 (at 120° C.). 1.3 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(methylsulfonyl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0469] and 0.708 g of Ethyl 1h-Pyrazole-3-Carboxylate [0005] gave 1.3 g of ethyl 1-(4-((1-(tert-butoxycarbonyl)pyrrolidin-3-yl)oxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0470].

MS(M+1)+=537.

Step 4[0471]: The procedure is similar to Step 2[0019] in example 4. 1.3 g of ethyl 1-(4-((1-(tert-butoxycarbonyl)pyrrolidin-3-yl)oxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0470] gave 1 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0471]. MS(M+1)+=495.

Step 5[0472]: The procedure is similar to step 3[0012] in Example 2. 0.7 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy) pyrrolidine-1-carboxylate [0471] gave 0.25 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0472]. MS(M+1)+=497.

Step 6[0474]: The procedure is similar to Step 1[0434] in example 161. 0.25 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0472] and 0.095 g of methyl chloroformate [0026] gave 0.12 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0474], Compound 297.

MS(M+1)+=455, 1H NMR (400 MHz, DMSO-d6) δ 8.55 (d, J=2.7 Hz, 1H), 7.34 (d, J=7.7 Hz, 1H), 6.61 (dd, J=2.8, 1.2 Hz, 1H), 5.76 (s, 1H), 5.56 (m, 1H), 5.43 (d, JF=48 Hz, 2H), 3.93 (bs, 1H), 3.69 (dd, J=12.2, 4.8 Hz, 1H), 3.62 (s, 3H), 3.53-3.38 (m, 3H), 2.23 (m, 1H), 2.11-1.93 (m, 7H), 1.62 (m, 2H).

Example 178

[Figure (not displayed)]

Step 1[0475]: The procedure is similar to Step 3[0444] in example 166. 0.6 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy) pyrrolidine-1-carboxylate [0471] gave 0.25 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-formyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0475]. MS(M+1)+=493.

Step 2[0476]: The procedure is similar to step 3[0012] in Example 2. 0.4 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-formyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0475] gave 0.24 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0476]. MS(M+1)+=515.

Step 3 and 4[0477 and 0478]: The procedure is similar to Step 1[0434] in example 161. 0.4 g of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0476] and 0.068 g of methyl chloroformate [0026] gave 0.1 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)pyrrolidine-1-carboxylate [0478], Compound 305. MS(M+1)+=473, 1H NMR (400 MHz, DMSO-d6-80° C.) δ 8.63 (d, J=2.4 Hz, 1H), 7.41 (d, J=7.6 Hz, 1H), 7.03 (t, JF=54.4 Hz, 1H), 6.73 (d, J=2.4 Hz, 1H), 5.80 (s, 1H), 5.57 (m, 1H), 3.94 (bs, 1H), 3.69 (dd, J=12.2, 4.8 Hz, 1H), 3.6 (s, 3H), 3.55-3.39 (m, 3H), 2.30-2.15 (m, 1H), 2.11-1.93 (m, 7H), 1.62 (m, 2H).

Example 179

[Figure (not displayed)]

Step 1[0480]: The procedure is similar to Step 1[270] in example 98. 3 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(methylthio)pyrimidin-4-amine [0426] and 2.8 g of 12-Hydroxymethyl-azetidine-1-Carboxylic acid tert-butyl ester [0479] gave 1.4 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(methylthio)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0480]. MS(M+1)+=445.

Step 2[0481]: The procedure is similar to Step 2[0378] in example 145. 1.4 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(methylthio)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0480] gave 1.3 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(methylsulfonyl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0481]. MS(M+1)+=477.

Step 3[0482]: The procedure is similar to Step 2[0274] in example 99 (at 120° C.). 1.3 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(methylsulfonyl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0481] and 0.585 g of Ethyl 1h-Pyrazole-3-Carboxylate gave 1.4 g of ethyl 1-(4-((1-(tert-butoxycarbonyl)azetidin-2-yl)methoxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0482]. MS(M+1)+=537.

Step 4[0483]: The procedure is similar to Step 2[0019] in example 4. 1.4 g of ethyl 1-(4-((1-(tert-butoxycarbonyl)azetidin-2-yl)methoxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0482] gave 1.25 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0483], MS(M+1)+=495.

Step 5[0484]: The procedure is similar to step 3[0012] in Example 2. 0.65 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0483] gave 0.24 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0484]. MS(M+1)+=497.

Step 6 and 7[0485 and 0486]: The procedure is similar to Step 1[0434] in example 161. 0.24 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0484] and 0.054 g of methyl chloroformate [0026] gave 0.1 g of methyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0486], Compound 306. MS(M+1)+=455, 1H NMR (400 MHz, DMSO-d6-80° C.) δ 8.55 (d, J=2.4 Hz, 1H), 7.31 (d, J=8.4 Hz, 1H), 6.60 (m, 1H), 5.80 (s, 1H), 5.38 (d, JF=48 Hz, 2H), 4.45-4.26 (m, 3H), 3.90 (bs, 1H), 3.87-3.80 (m, 2H), 3.55 (s, 3H), 2.40-2.30 (m, 1H), 2.20-2.10 (m, 1H), 2.11-1.93 (m, 6H), 1.62 (m, 2H).

Example 180

[Figure (not displayed)]

Step 1[0487]: The procedure is similar to Step 3[0444] in example 166. 0.5 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0483] gave 0.4 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-formyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0487]. MS(M+1)+=493.

Step 2[0488]: The procedure is similar to step 3[0012] in Example 2. 0.4 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-formyl-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0487] gave 0.21 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0488]. MS(M+1)+=515.

Step 3 and 4[0489 and 0490]: The procedure is similar to Step 1[0434] in example 161. 0.2 g of tert-butyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0488] and 0.073 g of methyl chloroformate [0026] gave 0.09 g of methyl 2-(((6-((4,4-difluorocyclohexyl)amino)-2-(3-(difluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)methyl)azetidine-1-carboxylate [0490], Compound 314. MS(M+1)+=473, 1H NMR (400 MHz, DMSO-d6) δ 8.70 (s, 1H), 7.66 (bs, 1H), 7.13 (t, JF=54.4 Hz, 1H), 6.79 (d, J=2.9 Hz, 1H), 5.81 (bs, 1H), 4.50 (m, 3H), 4.01 (bs, 1H), 3.83 (bs, 2H), 3.54 (s, 3H), 2.29 (m, 1H), 2.20-1.80 (m, 7H), 1.65-1.45 (m, 2H),

Example 181

[Figure (not displayed)]

Step 1[0492]: The procedure is similar to Step 1[270] in example 98. 13 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(methylthio)pyrimidin-4-amine [0426] and 4 g of 3-(benzyloxy)cyclobutan-1-ol [0491] gave 4 g of 6-(3-(benzyloxy)cyclobutoxy)-N-(4,4-difluorocyclohexyl)-2-(methylthio)pyrimidin-4-amine [0492] MS(M+1)+=436.

Step 2[0493]: The procedure is similar to Step 2[0378] in example 145. 3 g of 6-(3-(benzyloxy)cyclobutoxy)-N-(4,4-difluorocyclohexyl)-2-(methylthio)pyrimidin-4-amine [0492] gave 3 g of 6-(3-(benzyloxy)cyclobutoxy)-N-(4,4-difluorocyclohexyl)-2-(methylsulfonyl)pyrimidin-4-amine [0493] MS(M+1)+=468.

Step 3[0494]: The procedure is similar to Step 2[0274] in example 99 (at 120° C.). 3 g of 6-(3-(benzyloxy)cyclobutoxy)-N-(4,4-difluorocyclohexyl)-2-(methylsulfonyl)pyrimidin-4-amine [0493] and 1.37 g of ethyl 1h-Pyrazole-3-carboxylate gave 3 g of ethyl 1-(4-(3-(benzyloxy)cyclobutoxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0494], MS(M+1)+=528.

Step 4[0495]: To a solution of ethyl 1-(4-(3-(benzyloxy)cyclobutoxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0494] (3 g, 5.686 mmol) in methanol was added palladium on carbon (10%) (0.6 g) under N2 atm. The resultant reaction mixture was hydrogenated at 3 kg/Cm3 hydrogen pressure for 24 h. The reaction mixture was filtered through celite bed and washed with methanol. The filtrate was concentrated under reduced pressure to afford as a colorless gum and which was purified by column chromatography using 50% ethyl acetate in hexane as a eluent to afford ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(3-hydroxycyclobutoxy)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0495] as an white solid (2.0 g). MS(M+1)+=438.

Step 5[0496]: The procedure is similar to Step 3[0444] in example 166] (Using Dess-Martin periodinane). 1.5 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(3-hydroxycyclobutoxy)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0495] gave 1.56 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(3-oxo cyclobutoxy)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0496] MS(M+1)+=436.

Example 182

[Figure (not displayed)]

Step 1[0497]: The procedure is similar to step 3[0012] in Example 2. 0.6 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(3-oxocyclobutoxy)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0496] gave 0.33 g of ethyl 1-(4-(3,3-difluorocyclobutoxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0497].

MS(M+1)+=458.

Step 2[0498]: The procedure is similar to Step 2[0019] in example 4. 0.33 g of ethyl 1-(4-(3,3-difluorocyclobutoxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0497] gave 0.26 g of (1-(4-(3,3-difluorocyclobutoxy)-6-((4,4-difluoro cyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0498].

MS(M+1)+=416.

Step 3 [0499]: The procedure is similar to step 3[0012] in Example 2. 0.26 g of (1-(4-(3,3-difluorocyclobutoxy)-6-((4,4-difluorocyclohexyl)amino)pyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0498] gave 0.11 g of 6-(3,3-difluorocyclobutoxy)-N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-amine [0499], Compound 347. MS(M+1)+=418, 1H NMR (400 MHz, DMSO-d6) δ 8.54 (d, J=2.7 Hz, 1H), 7.39 (d, J=7.7 Hz, 1H), 6.61 (s, 1H), 5.78 (s, 1H), 5.43 (d, JF=48.5 Hz, 2H), 5.18 (dd, J=7.9, 4.9 Hz, 1H), 3.95 (bs, 1H), 3.18 (ddt, J=15.4, 11.8, 7.8 Hz, 2H), 2.75 (qd, J=14.2, 4.9 Hz, 2H), 2.10-1.89 (m, 6H), 1.71-1.55 (m, 2H).

Example 183

[Figure (not displayed)]

Step 1[0500]: The procedure is similar to Step 2[0019] in example 4. 0.3 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(3-hydroxycyclobutoxy)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0495] gave 0.25 g of 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)cyclobutan-1-ol [0500].

MS(M+1)+=396.

Step 2[0501]: The procedure is similar to step 3[0012] in Example 2. 0.25 g of 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)cyclobutan-1-ol [0500] gave 0.1 g of N-(4,4-difluorocyclohexyl)-6-(3-fluorocyclobutoxy)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-amine [0501], Compound 346. MS(M+1)+=400, 1H-NMR (400 MHz, DMSO-d6): δ 8.56 (s, 1H), 7.60 (bs, 1H), 6.65 (d, J=1.44 Hz, 1H), 5.69 (bs, 1H), 5.47 (d, JF=48.5 Hz, 2H), 5.45-5.37 (m, 1H), 5.30-5.25 (m, 1H), 4.15 (bs, 1H), 2.68-2.67 (m, 2H), 2.56-2.55 (m, 2H), 2.12-1.89 (m, 6H), 1.65-1.50 (m, 2H).

Example 184

[Figure (not displayed)]

Step 1[0503]: The procedure is similar to step 1[0434] in Example 161. 0.25 g of tert-butyl3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0431] and 0.127 g of isopropyl chloroformate [0502] gave 0.11 g of isopropyl3-((6-((4,4-difluorocyclohexyl)amino)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate[0503], Compound 296 as white solid. (46% yield). MS(M+1)+=469.2. 1H NMR (400 MHz, DMSO-d6) δ 8.57 (bs, 1H), 7.63 (bs, 1H), 6.64 (s, 1H), 5.72 (bs, 1H), 5.45 (d, JF=48 Hz, 3H), 4.85-4.75 (m, 1H), 4.33 (bs, 2H), 3.88 (bs, 3H), 2.15-1.85 (m, 6H), 1.70-1.44 (m, 2H), 1.20 (d, J=6.3 Hz, 6H).

Example 186

[Figure (not displayed)]

Step 1[0507]: The procedure is similar to Step 1 [270] in example 98 (at 80° C. in MW for 1 h) 0.4 g of N-(4,4-difluoro cyclohexyl)-2-(methylsulfonyl)-6-(oxetan-3-yloxy)pyrimidin-4-amine[0506] and 0.23 g of ethyl 1h-Pyrazole-3-carboxylate [005] gave 0.35 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(oxetan-3-yloxy)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0507], MS(M+1)+=332.

Step 2[0508]: To an ice cooled solution of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(oxetan-3-yloxy)pyrimidin-2-yl)-1H-pyrazole-3-carboxylate [0507] (0.35 g, 0.826 mmol) in tetrahydrofuran (10 mL) was added 2M solution of lithium aluminium hydride in tetrahydrofuran (0.062 g, 1.65 mmol), after completion of addition the reaction mixture was slowly warmed to rt and stirred for 10 min. The reaction mixture was quenched with saturated ammonium chloride solution and extracted with ethyl acetate (2×30 mL), the combined organic layer was dried over anhydrous sodium sulfate and concentrated to afford (1-(4-((4,4-difluorocyclohexyl)amino)-6-(oxetan-3-yloxy)pyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0508] as an off-white gum 0.350 g, MS(M+1)+=325.

Step 3[0509]: The procedure is similar to step 3[0012] in Example 2. 0.35 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-(oxetan-3-yloxy)pyrimidin-2-yl)-1H-pyrazol-3-yl)methanol [0508] gave 0.1 g of N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-1H-pyrazol-1-yl)-6-(oxetan-3-yloxy)pyrimidin-4-amine [0509], Compound 285 MS(M+1)+=384, 1H-NMR (400 MHz, DMSO-d6): δ 8.50 (d, J=2.40 Hz, 1H), 7.41 (d, J=7.60 Hz, 1H), 6.60 (t, J=1.20 Hz, 1H), 5.78 (s, 1H), 5.64 (t, J=6.00 Hz, 1H), 5.41 (d, JF=48.5 Hz, 2H), 4.90 (m, 2H), 4.60 (m, 2H), 4.01 (m, 1H), 2.10-1.98 (m, 6H), 1.95-1.61 (m, 2H).

Example 187

[Figure (not displayed)]

Step 1[0510]: The procedure is similar to Step 2 [0274] in example 99 (at 100° C.). 0.5 g of N-(4,4-difluoro cyclohexyl)-2-(methylsulfonyl)-6-(oxetan-3-yloxy)pyrimidin-4-amine [0506] and 0.318 g of ethyl 4-methylpyrazole-3-carboxylate [0148] gave 0.5 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(oxetan-3-yloxy)pyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0510] as an off-white solid. MS(M+1)+=438.

Step 2[0511]: The procedure is similar to Step 2 [0019] in example 4. 0.5 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-6-(oxetan-3-yloxy)pyrimidin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0510] gave 0.4 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-(oxetan-3-yloxy)pyrimidin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol [0511] as a brown solid. MS(M+1)+=396.

Step 3[0512]: The procedure is similar to Step 3 [0012] in example 2. 0.4 g of (1-(4-((4,4-difluorocyclohexyl)amino)-6-(oxetan-3-yloxy)pyrimidin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol [0511] gave 0.12 g of N-(4,4-difluorocyclohexyl)-2-(3-(fluoromethyl)-4-methyl-1H-pyrazol-1-yl)-6-(oxetan-3-yloxy)pyrimidin-4-amine [0512], Compound 304 as a white solid. MS(M+1)+=398, 1H NMR (400 MHz, DMSO-d6) δ 8.35 (bs, 1H), 7.61 (bs, 1H), 5.61 (bs, 2H), 5.42 (d, JF=48.5 Hz, 2H), 4.95-4.88 (m, 2H), 4.58 (dd, J=7.5, 5.3 Hz, 2H), 4.14 (bs, 1H), 2.13 (bs, 3H), 2.09-1.85 (m, 6H), 1.59-1.52 (m, 2H).

Example 188

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0513]: To a solution of tert-butyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(methylthio)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0427] (5 g, 11.613 mmol) in tetrahydrofuran was added 4-N,N-dimethylamino pyridine (0.42 g, 3.484 mmol) and boc-anhydride (12.6 g, 58.069 mmol) at 0° C. and the reaction mixture was stirred at rt. After 16 h, the reaction mixture was concentrated under reduced pressure to afford a brown oil, which was purified in the Reveleris flash system instrument using ethyl acetate in hexane as solvent in 0.120 g column to afford tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(methylthio)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0513] as pale yellow oil. (5.8 g, 95% yield). MS(M+1)+=531.1.

Step 2[0514]: The procedure is similar to step 2 [0378] in example 145. 5.8 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(methylthio)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0513] gave 6 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(methylsulfonyl)pyrimidin-4-yl)oxy)azetidine-1carboxylate [0514] as off-white solid. (98% yield). MS(M+1)+=563.9.

Step 3[0515]: To a solution of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(methylthio)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0514], (6 g, 10.66 mmol) in dimethyl sulfoxide was added 1,4-diazabicyclo[2.2.2]octane (1.31 g, 11.730 mmol) followed by sodium cyanide (0.58 g, 11.730 mmol) at 10° C. Then reaction mixture was stirred at rt. After 10 min, the reaction mixture was quenched with ice and stirred for 15 min. The solid formed was filtered, washed with water and dried under vacuum to afford tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-cyanopyrimidin-4-yl)oxy)azetidine-1-carboxylate [0515] as off-white solid. (5 g, 92% yield). MS(M+1)+=509.6.

Step 4[0516]: To a solution of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-cyanopyrimidin-4-yl)oxy)azetidine-1-carboxylate [0515] (5 g, 9.81 mmol) in N,N-dimethylformamide was added triethylamine (1.98 g, 19.62 mmol) and ammonium sulfide in water (20%) (1.33 g, 19.625 mmol) and the reaction mixture was stirred at rt. After 5 min, the reaction mixture was quenched with ice and then extracted with ethyl acetate, washed with water and brine solution. The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-carbamothioylpyrimidin-4-yl)oxy) azetidine-1-carboxylate [0516], as orange solid. (4.5 g, 85% yield). MS(M+1)+=544.6.

Step 5[0518]: To a solution of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-carbamothioylpyrimidin-4-yl)oxy)azetidine-1-carboxylate [0516] (5 g, 9.197 mmol) and ethyl bromopyruvate [0517] (3.58 g, 18.394 mmol) in tetrahydrofuran was stirred at rt. After 4 h, the reaction mixture was quenched with water and extracted with ethyl acetate. The combined organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated to afford a brown gum, which was purified in the Reveleris flash system instrument using ethyl acetate in hexane as solvent in 24 g column, to afford ethyl 2-(4-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-6-((1-(tert-butoxycarbonyl)azetidin-3-yl)oxy)pyrimidin-2-yl)thiazole-4-carboxylate [0518] as a yellow solid. (2.2 g, 40% yield). MS(M+1)+=640.2.

Step 6[0519]: To a stirred solution of ethyl 2-(4-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-6-((1-(tert-butoxycarbonyl)azetidin-3-yl)oxy)pyrimidin-2-yl)thiazole-4-carboxylate [0518] (2.2 g, 3.439 mmol) in tetrahydrofuran was added Lithium aluminum hydride (0.300 g, 7.909 mmol) at −78° C. and stirred at same temperature. After 3 h, the reaction mixture was slowly warmed to −10° C. After 1 h, the reaction mixture was quenched with saturated ammonium chloride solution drop wise at −10° C. and stirred at rt for 10 min. The reaction mixture was filtered through celite bed, washed with tetrahydrofuran and the filtrate was concentrated to afford tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(hydroxymethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0519] a yellow solid. (1.5 g, crude). MS(M+1)+=598.0.

Step 7[0520]: The procedure is similar to step 3 [0012] in example 2. 1.5 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(hydroxymethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0519], 1.2 g gave tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(fluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0520] as orange solid (0.6 g, 50% yield). MS(M+1)+=600.1.

Example 189

[Figure (not displayed)]

Step 1[0521]: The procedure is similar to step 8 [0036] in Example 6 (using TFA). 0.27 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(fluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate[0520] and 0.08 g of methyl chloroformate [0026] gave 0.130 g of methyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(fluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0521], Compound 313 as a yellow solid (65% yield). MS(M+1)+=458.2. 1H NMR (400 MHz, DMSO-d6) δ 8.01 (d, J=3.3 Hz, 1H), 7.62 (bs, 1H), 5.90 (bs, 1H), 5.50 (d, JF=48 Hz, 2H), 5.38 (bs, 1H), 4.35 (bs, 3H), 3.94 (bs, 2H), 3.58 (s, 3H), 2.15-1.88 (m, 6H), 1.65-1.50 (m, 2H).

Example 190

[Figure (not displayed)]

Step 1[0522]: The procedure is similar to step 8 [0036] in Example 6 (using TFA). 0.25 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(fluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0520] and 0.1 g of pivaloyl chloride [0356] gave 0.15 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(4-(fluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0522], Compound 316 as an off-white solid. MS(M+1)+=484.2. 1H NMR (400 MHz, DMSO-d6) δ 7.92 (s, 1H), 7.35 (d, J=7.2 Hz, 1H), 5.90 (s, 1H), 5.55 (d, JF=48 Hz, 2H), 5.43-5.35 (m, 1H), 4.53 (bs, 2H), 4.08 (bs, 2H), 3.93 (bs, 1H), 2.15-1.90 (m, 6H), 1.70-1.58 (m, 2H), 1.14 (s, 9H).

Example 191

[Figure (not displayed)]

Step 1[0523]: To a solution of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(hydroxymethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0519] (2.5 g, 4.182 mmol) in dichloromethane (30 mL) was added manganese dioxide (3.63 g, 41.828 mmol) under N2 atm. The resultant reaction mixture was stirred at rt for 16 h. The reaction mixture was filtered through celite bed, and washed with tetrahydrofuran, filtrate was concentrated under reduced pressure to afford crude product, which was triturated with ethyl acetate to afford 1.5 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-formylthiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0523] as a yellow solid. MS(M+1)+=596.2.

Step 2[0524]: To a solution of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-formylthiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0523] (0.7 g, 1.175 mmol) in dichloromethane (50 mL) was added diethylaminosulfurdiethylaminosulfur trifluoride (0.37 g, 2.35 mmol) at −20° C. The reaction mixture was allowed to rt for 16 h. The reaction mixture was quenched with saturated sodium bicarbonate solution (20 mL) at 0° C. and extracted with dichloromethane (50 mL), washed with water (20 mL) and brine solution (20 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product, which was purified by column chromatography using 40% ethyl acetate in pet ether as solvent to afford 0.35 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(difluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0524] as a white solid. MS(M+1)+=618.1.

Step 4[0525]: The procedure is similar to step 8 [0036] in Example 6 (using HCl gas). 0.17 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(difluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0524] and 0.06 g of pivaloyl chloride gave 0.075 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(4-(difluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0525], Compound 329 as a white solid. MS(M+1)+=502.2. 1H NMR (400 MHz, DMSO-d6) δ 8.20 (s, 1H), 7.41 (d, J=7.2 Hz, 1H), 7.09 (t, JF=54.8 Hz, 1H), 5.92 (s, 1H), 5.42-5.35 (m, 1H), 4.52 (bs, 2H), 4.09 (bs, 2H), 3.91 (bs, 1H), 2.22-1.88 (m, 6H), 1.72-1.56 (m, 2H), 1.15 (s, 9H).

Example 192

[Figure (not displayed)]

Step 1[0526]: The procedure is similar to step 8 [0036] in Example 6 (using HCl gas). 0.17 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(difluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0524] and 0.13 g of methyl chloroformate [0026] gave 0.060 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(4-(difluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0526], Compound 330 as an off-white solid. MS(M+1)+=476.0. 1H NMR (400 MHz, DMSO-d6) δ 8.28 (s, 1H), 7.75 (bs, 1H), 7.17 (t, JF=55 Hz, 1H), 5.93 (bs, 1H), 5.37 (s, 1H), 4.10 (bs, 1H), 4.36 (s, 2H), 3.94 (s, 2H), 3.58 (s, 3H), 2.15-1.85 (m, 6H), 1.62-1.48 (m, 2H).

Example 193

[Figure (not displayed)]

Step 1[0527]: The procedure is similar to step 8 [0036] in Example 6 (using TFA). 0.2 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(fluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0520] and 0.07 g of iso-butyryl chloride [0353] gave 0.11 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(4-(fluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2-methylpropan-1-one [0527], Compound 342 as a yellow solid. MS(M+1)+=470.2. 1H NMR (400 MHz, DMSO-d6) δ 8.02 (d, J=3.2 Hz, 1H), 7.64 (bs, 1H), 5.91 (bs, 1H), 5.55 (d, JF=48 Hz, 2H), 5.40 (bs, 1H), 4.58 (t, J=9.36 Hz, 1H), 4.01 (bs, 2H), 4.28 (dd, J=10.8, 6.8 Hz, 1H), 4.18 (dd, J=9.8, 4.1 Hz, 1H), 3.84 (dd, J=10.7, 4.2 Hz, 1H), 2.15-1.90 (m, 6H), 1.65-1.53 (m, 2H), 0.99 (t, J=6.9 Hz, 6H).

Example 194

[Figure (not displayed)]

Step 1[0528]: The procedure is similar to step 8 [0036] in Example 6 (using TFA). 0.25 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(fluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0520] and 0.07 g of propionyl chloride [0435] gave 0.15 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(4-(fluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)propan-1-one [0528], Compound 341 as a yellow solid. MS(M+1)+=456.2. 1H NMR (400 MHz, DMSO-d6) δ 7.92 (s, 1H), 7.35 (d, JF=7.6 Hz, 1H), 5.91 (s, 1H), 5.55 (d, JF=48 Hz, 2H), 5.45-5.35 (m, 1H), 4.44 (bs, 2H), 3.92 (bs, 3H), 2.11-1.90 (m, 8H), 1.72-1.55 (m, 2H), 1.00 (t, J=7.3 Hz, 3H).

Example 195

[Figure (not displayed)]

Step 1[0529]: To a solution of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-formylthiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0523] (0.9 g, 1.510 mmol) in tetrahydrofuran (5 mL) was added methyl magnesium bromide (0.9 g, 7.55 mmol) drop-wise at −15° C. (ice+acetone) under inert atm. Resultant reaction mixture was allowed to stir at same −15° C. to rt for 4 h. The reaction mixture was quenched with saturated ammonium chloride solution (10 mL) and product was extracted with dichloromethane (3×30 ml). The combined organic layer were washed with brine (10 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure to afford crude product, which was purified by column chromatography using 70% ethyl acetate in pet ether as solvent to afford 0.320 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(1-hydroxyethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0529] as an off-white solid. MS(M+1)+=612.4.

Step 2[0530]: The procedure is similar to step 8 [0036] in Example 6 (using HCl gas). 0.17 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(1-hydroxyethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0529] and 0.05 g of Methyl chloroformate gave 0.055 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(4-(1-hydroxyethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0530], Compound 344 as a yellow solid. MS(M+1)+=470.2. 1H NMR (400 MHz, DMSO-d6) δ 7.68 (bs, 1H), 7.56 (s, 1H), 5.88 (bs, 1H), 5.39 (d, J=4.44 Hz, 1H), 5.35 (s, 1H), 4.87 (t, J=6.1 Hz, 1H), 4.34 (bs, 2H), 4.01 (bs, 1H), 3.94 (s, 2H), 3.58 (s, 3H), 2.12-1.88 (m, 6H), 1.62-1.50 (m, 2H), 1.42 (d, J=6.5 Hz, 3H).

Example 196

[Figure (not displayed)]

Step 1[0531]: The procedure is similar to step 8 [0036] in Example 6 (using TFA). 0.17 g of tert-butyl 3-((6-((tert-butoxycarbonyl)(4,4-difluorocyclohexyl)amino)-2-(4-(1-hydroxyethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0529] and 0.07 g of pivaloyl chloride gave 0.025 g of [0531], Compound 337 as an off-white solid.

MS(M+1)+=496.2. 1H NMR (400 MHz, DMSO-d6) δ 7.58 (bs, 1H), 7.56 (s, 1H), 5.89 (s, 1H), 5.38 (d, J=4.76 Hz, 1H), 5.35 (b, 1H), 4.87 (t, J=5.36 Hz, 1H), 4.82 (bs, 1H), 4.42-4.25 (m, 2H), 3.83 (bs, 2H), 2.12-1.87 (m, 6H), 1.65-1.50 (m, 2H), 1.48-1.32 (m, 4H), 1.12 (s, 8H).

Example 206

[Figure (not displayed)]

Step 1 [0557]: The procedure is similar to step 5 [0027] in example 5. 0.300 g of 6-(azetidin-3-yloxy)-N-(4,4-difluorocyclohexyl)-2-(4-(trifluoromethyl)thiazol-2-yl)pyrimidin-4-amine [0554] gave 0.042 g of methyl 3-((6-((4,4-difluorocyclohexyl)amino)-2-(4-(trifluoromethyl)thiazol-2-yl)pyrimidin-4-yl)oxy)azetidine-1-carboxylate [0557], Compound 324 as an off-white solid. MS(M+1)+=494, 1H-NMR (400 MHz, DMSO-d6): δ 8.65 (s, 1H), 7.87 (bs, 1H), 5.97 (bs, 1H), 5.38 (s, 1H), 4.01 (bs, 1H), 4.36 (bs, 2H), 3.96 (bs, 2H), 3.58 (s, 3H), 2.06-1.59 (m, 6H), 1.56-1.24 (m, 2H).

Example 209

[Figure (not displayed)]

Step 1[0561]: The procedure is similar to step 5 [0027] in example 5. 0.350 g of 6-(azetidin-3-yloxy)-N-(4,4-difluorocyclohexyl)-2-(4-methylthiazol-2-yl)pyrimidin-4-amine[0559] gave 0.260 g of 1-(3-((6-((4,4-difluorocyclohexyl)amino)-2-(4-methylthiazol-2-yl)pyrimidin-4-yl)oxy)azetidin-1-yl)-2,2-dimethylpropan-1-one [0561], Compound 303 as an off-white solid. MS(M+1)+=440. 1H NMR (400 MHz, DMSO-d6) δ 7.57 (bs, 1H), 7.44 (d, J=1.1 Hz, 1H), 5.86 (bs, 1H), 5.35 (bs, 1H), 4.38-4.32 (m, 2H), 3.99-3.95 (m, 2H), 3.58 (s, 3H), 3.33 (bs, 1H), 2.44 (s, 3H), 2.22-1.85 (m, 6H), 1.59-1.52 (m, 2H).

Example 210

[Figure (not displayed)]

Step 1 [0563]: The procedure is similar to step 1 [0361] in example 138. 0.4 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0242] and 3-amino-2-piperidone [0562] (0.26 g, 2.34 mmol) gave 0.16 g of 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)amino)piperidin-2-one [0563] as a white solid. MS(M+1)+=419.

Step 3 [0564]: To a solution of 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)amino)piperidin-2-one [0563] (0.1 g, 0.23 mmol) in N,N-dimethylformamide (5 mL) was added sodium hydride (0.01 g, 0.26 mmol). The resultant reaction mixture was stirred at rt for 30 min, added iodomethane (0.037 g, 0.26 mmol) and stirred at rt for 1 h. The reaction mixture was quenched in ice and extracted with ethyl acetate (2×20 mL). The combined organic layer was washed with water (10 mL), followed by brine (10 mL) and dried over anhydrous sodium sulfate to afford crude product which was purified by preparative HPLC to afford 0.035 g of 3-((6-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-yl)amino)-1-methylpiperidin-2-one [0564], Compound 133 as a white solid. MS(M+1)+=434.2, 1H NMR (400 MHz, DMSO-d6): δ 6.97 (d, J=8.00 Hz, 1H), 6.87 (d, J=7.80 Hz, 1H), 5.97 (s, 1H), 5.39 (s, 1H), 4.32 (s, 1H), 3.78 (s, 1H), 3.25-3.32 (m, 2H), 2.81 (s, 1H), 2.46 (s, 3H), 2.13 (s, 3H), 2.04-2.06 (m, 3H), 1.82-1.87 (m, 7H), 1.52 (m, 2H).

Example 211

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0566A]: To a stirred solution of 2,4,6-trichloropyridine [0565] (20 g, 109.627 mmol) in acetonitrile (250 mL) was added ethyl 1h-pyrazole-3-carboxylate [0005] (15.6 g, 109.627 mmol) and cesium carbonate (71.43 g, 219 mmol). The reaction mixture was heated at 75° C. for 16 h. The reaction mixture water (75 mL) was added, extracted with ethyl acetate (2×250 mL). The combined organic extracts were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product which was purified by column chromatography using 4% ethyl acetate in pet ether as solvent to afford 9 g of ethyl 1-(4,6-dichloropyridin-2-yl)-1H-pyrazole-3-carboxylate [0566A] as a white solid. MS(M+1)+=286.0.

Step 2[0567A]: To a stirred solution of ethyl 1-(4,6-dichloropyridin-2-yl)-1H-pyrazole-3-carboxylate [0566A] (2 g, 6.99 mmol) in dioxane (20 mL) were added 4,4-difluorocyclohexylamine hydrochloride (1.19 g, 6.990 mmol) cesium carbonate (3.41 g, 10.48 mmol) and 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (0.606 g, 1.04 mmol). Then the reaction mixture was purged with N2 for 5 min before adding palladium (II) acetate (0.158 g, 0.699 mmol). The reaction mixture was irradiated in microwave at 100° C. for 2 h. The reaction mixture was filtered through celite, filtrate was concentrated under reduced pressure to afford 3.3 g of ethyl 1-(6-chloro-4-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-1H-pyrazole-3-carboxylate. This was purified by column chromatography using 11% ethyl acetate in pet ether as solvent to afford 0.450 g of ethyl 1-(4-chloro-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-1H-pyrazole-3-carboxylate [0567A] as an off-white solid. MS(M+1)+=385.2.

Step 3[0568]: The procedure is similar to step 2[0011] in example 2. 0.450 g of ethyl 1-(4-chloro-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-1H-pyrazole-3-carboxylate [0567A] gave 0.350 g of (1-(4-chloro-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-1H-pyrazol-3-yl)methanol [0568] as an off-white solid. MS(M+1)+=343.1.

Step 4[0569]: The procedure is similar to step 3[0012] in example 2. 0.350 g of (1-(4-chloro-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-1H-pyrazol-3-yl)methanol [0568] gave 0.19 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyridin-2-amine[0569] as an off-white solid. MS(M+1)+=345.1.

Example 212

[Figure (not displayed)]

Step 1[0570]: To a stirred solution of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyridin-2-amine [0569] (0.120 g, 0.348 mmol) in toluene (3 mL), was added morpholine [0067] (36 g, 0.417 mmol), sodium-tert-butoxide (0.066 g, 0.692 mmol) and BINAP [rac-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl] (0.033 g, 0.055 mmol). The reaction mixture was purged with N2 for 10 min before adding bis(dibenzylideneacetone)palladium (0.016 g, 0.0278 mmol). The reaction mixture was irradiated in microwave at 100° C. for 2 h. The reaction mixture was filtered through celite, and then the filtrate was concentrated under reduced pressure to afford 0.067 g N-(4,4-difluorocyclohexyl)-6-(3-(fluoromethyl)-1H-pyrazol-1-yl)-4-morpholinopyridin-2-amine [0570], Compound 292 as a pale brown solid. MS(M+1)+=395.5. 1H NMR (400 MHz, DMSO-d6) δ 8.51 (d, J=2.5 Hz, 1H), 6.65 (d, J=1.8 Hz, 1H), 6.64 (s, 1H), 6.46 (d, J=7.6 Hz, 1H), 5.80 (d, J=1.9 Hz, 1H), 5.47-5.35 (d, JF=48.4 Hz, 2H), 3.96 (bs, 1H), 3.71 (t, J=4.8 Hz, 4H), 3.20 (t, J=4.9 Hz, 4H), 2.03-1.93 (m, 6H), 1.54-1.51 (m, 2H).

Example 214

[Figure (not displayed)]

Step 1[0572]: The procedure is similar to step 2[0274] in example 99 (at 100° C.). 0.2 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyridin-2-amine [0569] gave 0.053 g of N-(4,4-difluorocyclohexyl)-6-(3-(fluoromethyl)-1H-pyrazol-1-yl)-4-(oxetan-3-yloxy)pyridin-2-amine [00572], Compound 302 as an off-white solid. MS(M+1)+=383.2. 1H NMR (400 MHz, DMSO-d6) δ 8.54 (d, J=2.5 Hz, 1H), 6.83 (d, J=7.5 Hz, 1H), 6.63 (s, 1H), 6.47 (d, J=1.9 Hz, 1H), 5.70 (d, J=1.9 Hz, 1H), 5.48-5.36 (d, JF=48.4 Hz, 2H), 5.31 (t, J=5.2 Hz, 1H), 4.89 (t, J=6.7 Hz, 2H), 4.56 (dd, J=7.5, 4.8 Hz, 2H), 3.98 (bs, 1H), 2.07-1.94 (m, 6H), 1.52-1.53 (m, 2H).

Example 216

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0578A and 0578B]: To a stirred solution of 2,4,6-trichloropyridine [0565] (25 g, 137.033 mmol) in acetonitrile (400 mL) was added 3,5-dimethylpyrazole [0017] (15.8 g, 164.44 mmol) and cesium carbonate (89 g, 274 mmol). The reaction mixture was heated at 75° C. for 16 h. The reaction mixture was concentrated under reduced pressure. The residue was diluted with water (200 mL) and stirred for 10 min. The solid formed was filtered, washed with water and dried under vacuum to afford crude product, which was purified by column chromatography using 1.5% ethyl acetate in pet ether as solvent to afford 11 g of 2,4-dichloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine 2,4-dichloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine [0578A] as a white solid and 8 g of 2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine [0578B] as a white solid. MS(M+1)+=242.1.

Step 2[0579A and 0579B]: To a stirred solution of 2,4-dichloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine 2,4-dichloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine [0578A] (1 g, 4.13 mmol) in dioxane (10 mL), were added 4,4-difluorocyclohexylamine hydrochloride [0002] (0.850 g, 4.956 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (0.286 g, 0.495 mmol) and cesium carbonate (2.69 g, 8.26 mmol). The reaction mixture was degassed for 10 min, and then added palladium (II) acetate (0.074 g, 0.33 mmol). The reaction mixture was irradiated in microwave at 100° C. for 3 h. The reaction mixture was passed through celite, washed with chloroform (20 mL) and then the filtrate was concentrated under reduced pressure to afford crude product, which was purified by column chromatography using 5% ethyl acetate in pet ether as solvent to afford 0.950 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] and 0.6 g of 2-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-amine [0579B] as a yellow solid. MS(M+1)+=341.2

Step 3 [0580]: To a stirred solution of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] (0.3 g, 0.88 mmol) in dioxane (10 mL), were added 3-oxetanamine [0243] (0.128 g, 1.76 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (0.061 g, 0.105 mmol) and cesium carbonate (0.537 g, 1.76 mmol). The reaction mixture was degassed for 10 min, then added tris(dibenzylideneacetone)dipalladium(0) (0.080 g, 0.088 mmol). The reaction mixture was heated at 95° C. for 16 h. The reaction mixture was filtered through celite, filtrate was concentrated under reduced pressure to afford crude product, which was purified by preparative HPLC to afford 0.060 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4-(oxetan-3-yl)pyridine-2,4-diamine [0580], Compound 228 as an off-white solid. MS(M+1)+=378.2. 1H-NMR (400 MHz, DMSO-d6): δ 6.96 (d, J=4 Hz, 1H), 6.28 (d, J=1.6 Hz, 1H), 6.26 (s, 1H), 5.97 (s, 1H) 5.32 (d, J=1.52 Hz, 1H), 4.83-4.79 (t, J=6.4 Hz, 2H), 4.54-4.46 (m, 1H), 4.43-4.40 (t, J=5.92 Hz, 2H), 3.82 (s, 1H), 2.53 (s, 3H), 2.15 (s, 3H), 2.10-1.81 (m, 6H), 1.53-1.47 (m, 2H).

Example 220

[Figure (not displayed)]

Step 1[0588]: The procedure is similar to step 3[0580] in example 216. 0.25 g of chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] and 0.25 g of (1-methyl-1H-1,2,3-triazol-5-yl)methanamine [0587] gave 0.03 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4-((1-methyl-1H-1,2,3-triazol-5-yl)methyl)pyridine-2,4-diamine [0588], Compound 250 as yellow solid.

MS(M+1)+=417.0, 1H NMR (400 MHz, DMSO-d6) δ 7.62 (s, 1H), 6.80 (t, J=5.7 Hz, 1H), 6.39 (d, J=1.7 Hz, 1H), 6.26 (d, J=7.5 Hz, 1H), 5.97 (s, 1H), 5.52 (d, J=1.7 Hz, 1H), 4.39 (d, J=5.7 Hz, 2H), 4.01 (s, 3H), 3.81 (bs, 1H), 2.54 (s, 3H), 2.15 (s, 3H), 2.10-1.98 (m, 2H), 2.00-1.78 (m, 4H), 1.52-1.40 (m, 2H).

Example 221

[Figure (not displayed)]

Step 1[0589]: The procedure is similar to step 3[0580] in example 216. 0.3 g of chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [579A] and 0.197 g of (2-methyl-2H-1,2,3-triazol-4-yl)methanamine [0306] gave 0.042 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4-((2-methyl-2H-1,2,3-triazol-4-yl)methyl)pyridine-2,4-diamine [0589], Compound 248 as yellow solid. MS(M+1)+=417.0, 1H NMR (400 MHz, DMSO-d6) δ 7.61 (s, 1H), 6.76 (t, J=5.9 Hz, 1H), 6.36 (d, J=1.8 Hz, 1H), 6.25 (d, J=7.6 Hz, 1H), 5.97 (s, 1H), 5.53 (d, J=1.8 Hz, 1H), 4.28 (d, J=5.9 Hz, 2H), 4.11 (s, 3H), 3.80 (bs, 1H), 2.14 (s, 3H), 2.09-1.78 (m, 6H), 1.56-1.40 (m, 2H).

Example 222

[Figure (not displayed)]

Step 1[0590]: The procedure is similar to step 1[0270] in example 98. 5 g of 2,4,6-trichloropyridine [0565] and 2.2 g of 3-methylpyrazole [0091] gave 2.2 g of 2,4-dichloro-6-(3-methyl-1H-pyrazol-1-yl)pyridine [0590] as white solid. MS(M+1)+=229.2.

Step 2[0591]: The procedure is similar to step 3[0580] in example 216. 1 g of 2,4-dichloro-6-(3-methyl-1H-pyrazol-1-yl)pyridine [0590] and 0.82 g of 4,4-difluorocyclohexylamine hydrochloride [0002] gave 0.6 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-methyl-1H-pyrazol-1-yl)pyridin-2-amine [0591] as off-white solid. MS(M+1)+=327.2.

Step 3[0592]: The procedure is similar to step 1[0251] in example 90. 0.28 g of 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0591] gave 0.115 g of 6-cyclopropyl-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine [0592], Compound 182 as white solid MS(M+1)+=333.2. 1H NMR (400 MHz, DMSO-d6) δ 8.39 (d, J=2.4 Hz, 1H), 6.62 (d, J=1.12 Hz, 1H), 6.60 (s, 1H), 6.27 (d, J=2.4 Hz, 1H), 6.09 (d, J=1.3 Hz, 1H), 3.95 (bs, 1H), 2.26 (s, 3H), 2.12-1.90 (m, 6H), 1.92-1.85 (m, 1H), 1.62-1.55 (m, 2H), 1.03-0.92 (m, 2H), 0.76-0.67 (m, 2H).

Example 223

[Figure (not displayed)]

Step 1[0593]: To a cooled (−10° C.) solution of 2,4,6-trichloropyridine [0565] (2 g, 10.96 mmol) in tetrahydrofuran (10 mL) was added sodium thiomethoxide (0.762 g, 10.96 mmol) portion wise under N2 atm. The resultant reaction mixture was stirred at −10° C. After 3 h, the reaction mixture was quenched with water (10 mL) and extracted with ethyl acetate (2×100 mL). The combined organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford as a colorless liquid, which was purified in the Reveleris flash system instrument using ethyl acetate in hexane as solvent in 12 g column to afford 0.9 g of 2,6-dichloro-4-(methylthio)pyridine [0593] as a white solid. MS(M+1)+=195.0.

Step 2[0594]: This procedure is similar to step 1[0270] in example 98. 0.25 g of 2,6-dichloro-4-(methylthio)pyridine [0594] and 0.1 g of 3-methylpyrazole [0091] gave 0.1 g of 2-chloro-6-(3-methyl-1H-pyrazol-1-yl)-4-(methylthio)pyridine [0594] as white solid. MS(M+1)+=240.0.

Step 3[0595]: This procedure is similar to step 2[0378] in example 145. 0.5 g of 2-chloro-6-(3-methyl-1H-pyrazol-1-yl)-4-(methylthio)pyridine [0594] gave 0.52 g of 2-chloro-6-(3-methyl-1H-pyrazol-1-yl)-4-(methylsulfonyl)pyridine [0595] as a white solid. MS(M+1)+=272.0.

Step 4[0596]: The procedure is similar to step 3[0580] in example 216. 0.2 g of 2-chloro-6-(3-methyl-1H-pyrazol-1-yl)-4-(methylsulfonyl)pyridine [0595] gave 0.063 g of N-(4,4-difluorocyclohexyl)-6-(3-methyl-1H-pyrazol-1-yl)-4-(methylsulfonyl)pyridin-2-amine [0596], Compound 153 as a white solid. MS(M+1)+=371.2, 1H NMR (400 MHz, DMSO-d6) δ 8.50 (d, J=2.6 Hz, 1H), 7.52 (d, J=7.4 Hz, 1H), 7.23 (s, 1H), 6.82 (s, 1H), 6.38 (d, J=2.6 Hz, 1H), 4.09 (m, 1H), 3.27 (s, 3H), 2.29 (s, 3H), 2.13-1.96 (m, 6H), 1.61-1.52 (m, 2H).

Example 224

[Figure (not displayed)]

Step 1[0597]: This procedure is similar to Step 3[0580] in example 216. 1 g of 2,4-dichloro-6-(3-methyl-1H-pyrazol-1-yl)pyridine [0590] and 0.822 g of 4,4-difluorocyclohexylamine hydrochloride [0002] gave 0.6 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3-methyl-1H-pyrazol-1-yl)pyridin-2-amine [0597], Compound 179 as an off-white solid. MS(M+1)+=327.0, 1H NMR (400 MHz, DMSO-d6) δ 8.43 (d, J=2.5 Hz, 1H), 7.11 (d, J=7.5 Hz, 1H), 6.88 (d, J=1.5 Hz, 1H), 6.39 (d, J=1.6 Hz, 1H), 6.33 (d, J=1.6 Hz, 1H) 3.99 (s, 1H), 2.26 (s, 3H), 2.13-1.90 (m, 6H), 1.57-1.45 (m, 2H).

Example 225

[Figure (not displayed)]

Step 1[0598]: To a solution of 2,4,6-trichloropyridine [0565] and neopentylamine [0109] in a mixture of tetrahydrofuran and water (20 mL, 1:1) was heated at 70° C. After 18 h, the reaction mixture was concentrated under reduced pressure to afford as brown gum, which was purified in the Reveleris flash system instrument using ethyl acetate in hexane as solvent in 12 g column to afford 2,6-dichloro-N-neopentylpyridin-4-amine [0598] as an off-white solid (1.5 g). MS(M+1)+=334.1.

Step 2[0599]: This procedure is similar to Step 3[0580] in example 216. 0.5 g of 2,6-dichloro-N-neopentylpyridin-4-amine [0598] gave 0.1 g of 2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-neopentylpyridin-4-amine [0599] as an off-white solid. MS(M+1)+=332.1.

Step 3[0600]: This procedure is similar to Step 3[0006] in example 1. 0.1 g of 2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-neopentylpyridin-4-amine [0599], Compound 234 gave 0.015 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4-neopentylpyridine-2,4-diamine [0600] as brown solid. MS(M+1)+=392.2, 1H NMR (400 MHz, Chloroform-d) δ 6.29 (s, 1H), 5.98 (d, J=7.3 Hz, 1H), 5.44 (s, 1H), 3.67 (s, 1H), 2.99 (s, 2H), 2.60 (s, 3H), 2.30-2.20 (m, 6H), 2.08 (bs, 4H), 1.91 (bs, 2H), 1.03 (s, 9H).

Example 226

[Figure (not displayed)]

Step 1[0601]: To a solution of 2,4,6-trichloropyridine [0565] (0.35 g, 1.918 mmol) in tetrahydrofuran (12 mL) was added L-valinamide hydrochloride [0314] (0.3 g, 1.918 mmol) and cesium carbonate (1.37 g, 4.2 mmol), after addition the reaction mixture was stirred at 60° C. for 28 h. The reaction mixture was diluted with water, product was extracted with ethyl acetate (2×100 mL), combined organic layer was washed with brine (100 mL), dried over anhydrous sodium sulfate filtered and concentrated under reduced pressure to afford crude product, which was purified by column chromatography using 25% ethyl acetate in pet ether as solvent to afford 0.11 g of 2-((2,6-dichloropyridin-4-yl)amino)-3-methylbutanamide [0601] as a brown solid. MS(M+1)+=262.4

Step 2[602]: The procedure is similar to step 4[0244] in example 87 (10 h, 100° C.). 0.19 g of [0601] and 0.15 g of 4,4-difluorocyclohexylamine hydrochloride [0002] gave 0.09 g of 2-((2-chloro-6-((4,4-difluorocyclohexyl)amino)pyridin-4-yl)amino)-3-methylbutanamide [0602] as a brown solid. MS(M+1)+=362.7.

Step 3[0603]: The procedure is similar to step 3[0580] in example 216 (10 h, 110° C.). 0.15 g of [0602] and 0.08 g of 3,5-dimethyl pyrazole [0017] gave 0.018 g of 2-((2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)amino)-3-methylbutanamide [0603], Compound 239 as an off-white solid. MS(M+1)+=421.2, 1H NMR (400 MHz, DMSO-d6) δ 8.10 (s, 2H), 7.86 (s, 1H), 7.59 (s, 1H), 7.14 (d, J=7.5 Hz, 1H), 6.91 (s, 1H), 6.41 (s, 1H), 6.08 (s, 1H), 3.88 (bs, 1H), 3.53 (d, J=5.2 Hz, 1H), 2.60 (s, 3H), 2.17 (s, 3H), 2.10-1.88 (m, 6H), 1.62-1.53 (m, 2H), 0.95 (dd, J=10.4, 6.9 Hz, 6H).

Example 227

[Figure (not displayed)]

Step 1[0605]: The procedure is similar to step 4[0244] in example 87 (10 h, 110° C.). 0.31 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] and 0.16 g of c-(5-Methyl-[1,3,4]oxadiazol-2-Y1)-methylamine [0604] gave 0.068 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4-((5-methyl-1,3,4-oxadiazol-2-yl)methyl)pyridine-2,4-diamine [0605], Compound 252 as an off-white solid. MS(M+1)+=417.9, 1H NMR (400 MHz, DMSO-d6) δ 6.97 (s, 1H), 6.36-6.32 (m, 2H), 5.97 (s, 1H), 5.55 (s, 1H), 4.48 (d, J=6.2 Hz, 2H), 3.80 (bs, 1H), 2.53 (s, 3H), 2.47 (s, 3H), 2.14 (s, 3H), 2.10-1.88 (m, 6H), 1.62-1.48 (m, 2H).

Example 228

[Figure (not displayed)]

Step 1 [0606]: The procedure is similar to step 4[0244] in example 87 (20 h, 110° C.). 0.32 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] and 0.12 g of 1-thiazol-2-yl-ethylamine [0245] gave 0.058 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4-(1-(thiazol-2-yl)ethyl)pyridine-2,4-diamine [0606], Compound 255 as an off-white solid. MS(M+1)+=433.2, 1H NMR (400 MHz, DMSO-d6) δ 7.74 (d, J=3.3 Hz, 1H), 7.58 (d, J=3.2 Hz, 1H), 7.04 (d, J=6.6 Hz, 1H), 6.42 (d, J=1.7 Hz, 1H), 6.30 (d, J=7.6 Hz, 1H), 5.97 (s, 1H), 5.44 (d, J=1.8 Hz, 1H), 4.80 (p, J=6.7 Hz, 1H), 3.77 (bs, 1H), 2.52 (s, 3H), 2.15 (s, 3H), 2.10-1.88 (m, 6H), 1.53 (d, J=6.8 Hz, 3H), 1.45 (bs, 2H).

Example 229

[Figure (not displayed)]

Step 1[0607]: The procedure is similar to step 4[0244] in example 87 (at 100° C. for 20 h). 0.25 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] and 0.08 g of oxazol-2-yl-methylamine [0316] gave 0.042 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4-(oxazol-2-ylmethyl)pyridine-2,4-diamine [0607], Compound 259 as an off-white solid.

MS(M+1)+=403.2, 1H NMR (400 MHz, DMSO-d6) δ 8.07 (s, 1H), 7.17 (s, 1H), 6.94 (t, J=6.3 Hz, 1H), 6.37 (d, J=1.8 Hz, 1H), 6.30 (d, J=7.7 Hz, 1H), 5.97 (s, 1H), 5.54 (d, J=1.8 Hz, 1H), 4.39 (d, J=6.3 Hz, 2H), 3.80 (bs, 1H), 2.53 (s, 3H), 2.15 (s, 3H), 2.10-1.88 (m, 6H), 1.65-1.48 (m, 2H).

Example 231

[Figure (not displayed)]

Step 1[0609]: The procedure is similar to step 4[0244] in example 87. 0.3 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] gave 0.03 g of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-(1H-pyrazol-1-yl)pyridin-2-amine [0609], Compound 127 as a white solid. MS(M+1)+=373.7, 1H-NMR (400 MHz, DMSO-d6): δ 8.52 (d, J=2.60 Hz, 1H), 7.79 (d, J=1.60 Hz, 1H), 7.35 (d, J=1.64 Hz, 1H), 7.03 (d, J=7.52 Hz, 1H), 6.80 (d, J=1.68 Hz, 1H), 6.57-6.56 (m, 1H), 6.08 (s, 1H), 3.93-3.91 (m, 1H), 2.61 (s, 3H), 2.19 (s, 3H), 2.09-2.07 (m, 2H), 2.00-1.90 (m, 4H), 1.54-1.60 (m, 2H).

Example 232

[Figure (not displayed)]

Step 1[0610]: The procedure is similar to step 4[0244] in example 87. 0.3 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] gave 0.04 g of racemate 3-((2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)amino)-1-methylpyrrolidin-2-one [0610], Compound 135 as a brown solid. MS(M+1)+=419.2. 1H NMR (400 MHz, DMSO-d6) δ 6.43 (d, J=7.1 Hz, 1H), 6.37 (s, 1H), 6.20 (d, J=7.6 Hz, 1H), 5.97 (s, 1H), 5.58 (s, 1H), 4.10-4.05 (m, 1H), 3.82 (bs, 1H), 3.31 (m, 2H) 2.77 (s, 3H), 2.53 (s, 3H), 2.42 (m, 1H), 2.15 (s, 3H), 2.06 (m, 2H), 1.92 (m, 4H), 1.76 (m, 1H), 1.51-1.41 (m, 2H).

Step 2[0611 and 0612]: Enantiomers were separated by chiral prep HPLC to afford 0.029 g of (+)-3-((2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)amino)-1-methylpyrrolidin-2-one [0611], Compound 138 as a yellow solid. 1H NMR (400 MHz, DMSO-d6) δ 6.42 (d, J=7.4 Hz, 1H), 6.36 (d, J=1.7 Hz, 1H), 6.19 (d, J=7.7 Hz, 1H), 5.96 (s, 1H), 5.58 (d, J=1.8 Hz, 1H), 4.07 (q, J=8.5 Hz, 1H), 3.81 (bs, 1H), 3.33 (s, 1H), 3.30 (d, J=1.4 Hz, 1H), 2.76 (s, 3H), 2.53 (s, 3H), 2.43 (m, 1H), 2.14 (s, 3H), 2.05-1.91 (m, 2H), 1.88-1.80 (m, 4H), 1.78-1.71 (m, 1H), 1.50 (m, 2H), and 0.023 g of (−)-3-((2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)amino)-1-methylpyrrolidin-2-one [0612], Compound 139 as a yellow solid. 1H NMR (400 MHz, DMSO-d6) δ 6.42 (d, J=7.3 Hz, 1H), 6.36 (d, J=1.6 Hz, 1H), 6.19 (d, J=7.8 Hz, 1H), 5.96 (s, 1H), 5.58 (d, J=1.8 Hz, 1H), 4.07 (q, J=8.5 Hz, 1H), 3.79 (bs, 1H), 2.76 (s, 3H), 2.53 (s, 3H), 2.48-2.38 (m, 2H), 2.14 (s, 3H), 2.12-1.88 (m, 6H), 1.85-1.73 (m, 1H), 1.58-1.48 (m, 2H), 0.88-0.75 (m, 1H).

Example 233

[Figure (not displayed)]

Step 1[0613]: The procedure is similar to step 1[0301] in example 111. 0.3 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] gave 0.050 g of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-((1-methyl-1H-1,2,3-triazol-5-yl)methoxy)pyridin-2-amine [0613], Compound 268 as a white solid. MS(M+1)+=418.2. 1H NMR (400 MHz, DMSO-d6) δ 7.82 (s, 1H), 6.74 (d, J=7.6 Hz, 1H), 6.63 (d, J=2.0 Hz, 1H), 6.03 (s, 1H), 5.96 (d, J=1.6 Hz, 1H), 5.31 (s, 2H), 4.04 (s, 3H), 3.87 (bs, 1H), 2.57 (s, 3H), 2.16 (s, 3H), 2.09-1.85 (m, 6H), 1.62-1.45 (m, 2H).

Example 234

[Figure (not displayed)]

Step 1[0614]: To a suspension of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] (0.15 g, 0.44 mmol) and (1-methyl-1H-1,2,4-triazol-5-yl)methanol [0304] (0.14 g, 1.17 mmol) in 50% aq. sodium hydroxide solution (2 mL) was added tetrabutyl ammonium hydrogen Sulfate (0.14 g, 0.44 mmol), then the reaction mixture was heated at 100° C. in a closed vial for 16 h. After the completion of the reaction, the reaction mixture was extracted with ethyl acetate (2×40 mL), the combined organic layer was dried over anhydrous sodium sulfate and concentrated to afford crude and which was purified by column of silica gel (60-120 mesh), using 25% ethyl acetate in hexane as eluent gave 0.03 g of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-((1-methyl-1H-1,2,4-triazol-5-yl)methoxy)pyridin-2-amine [0614], Compound 271 as a white solid. MS(M+1)+=419.6, 1H-NMR (400 MHz, DMSO-d6): δ 7.95 (s, 1H), 6.77 (d, J=7.60 Hz, 1H), 6.62 (d, J=1.96 Hz, 1H), 6.03 (s, 1H), 5.97 (d, J=1.96 Hz, 1H), 5.31 (s, 1H), 3.89 (s, 1H), 3.85-3.84 (m, 1H), 2.57 (s, 3H), 2.15 (s, 3H), 2.07-1.92 (m, 6H), 1.52-1.47 (m, 2H).

Example 235

[Figure (not displayed)]

Step 1[0615]: The procedure is similar to step 1[0614] in example 234. 0.3 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0242] gave 0.065 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-((1-methyl-1H-1,2,4-triazol-3-yl)methoxy)pyrimidin-4-amine [0615] as a white solid (0.065 g). MS(M+1)+=419.6, 1H NMR (400 MHz, DMSO-d6) δ 8.46 (s, 1H), 7.53 (bs, 1H), 6.06 (s, 1H), 5.75 (bs, 1H), 5.31 (s, 2H), 4.01 (bs, 1H), 3.86 (s, 3H), 2.54 (s, 3H), 2.17 (s, 3H), 2.12-1.85 (m, 6H), 1.62-1.50 (m, 2H).

Example 237

[Figure (not displayed)]

Step 1[0618]: The procedure is similar to step 1[0614] in example 234. 0.2 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] and 0.133 g of (2-methyl-2H-1,2,3-triazol-4-yl)methanol [0300] gave 0.07 g of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-((2-methyl-2H-1,2,3-triazol-4-yl)methoxy)pyridin-2-amine [0618], Compound 251 as an off-white solid. MS(M+1)+=418, 1H-NMR (400 MHz, DMSO-d6): δ 7.84 (s, 1H), 6.70 (d, J=7.60 Hz, 1H), 6.59 (d, J=2.00 Hz, 1H), 6.02 (s, 1H), 5.96 (s, 1H), 5.16 (s, 2H), 4.16 (s, 3H), 3.85 (bs, 1H), 2.57 (s, 3H), 2.15 (s, 3H), 2.07-1.87 (m, 6H), 1.52-1.50 (m, 2H).

Example 238

[Figure (not displayed)]

Step 1[0619]: The procedure is similar to step 1[0614] in example 234. 0.2 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] and 0.265 g of (1-methyl-1H-1,2,3-triazol-4-yl)methanol [0302] gave 0.1 g of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-((l-methyl-1H-1,2,3-triazol-4-yl)methoxy)pyridin-2-amine [0619], Compound 244 as an off-white solid. MS(M+1)+=418, 1H NMR (400 MHz, DMSO-d6) δ 8.17 (s, 1H), 6.71 (d, J=7.5 Hz, 1H), 6.59 (d, J=2.0 Hz, 1H), 6.06-5.98 (m, 2H), 5.16 (s, 2H), 4.06 (s, 3H), 3.87 (bs, 1H), 2.58 (s, 3H), 2.16 (s, 3H), 2.11-1.89 (m, 6H), 1.59-1.52 (m, 2H).

Example 239

[Figure (not displayed)]

Step 1[0621]: The procedure is similar to step 4[0244] in example 87. 0.2 g of 4-chloro-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0579A] gave 0.035 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4-(4-methoxybenzyl)pyridine-2,4-diamine [0621], Compound 264 as off-white solid.

MS(M+1)+=442.2. 1H NMR (400 MHz, DMSO-d6) δ 7.34-7.13 (m, 2H), 7.02-6.85 (m, 2H), 6.80 (t, J=6.1 Hz, 1H), 6.35 (d, J=1.8 Hz, 1H), 6.16 (d, J=7.7 Hz, 1H), 5.95 (s, 1H), 5.45 (d, J=1.9 Hz, 1H), 4.18 (d, J=5.9 Hz, 2H), 3.76 (bs, 1H), 3.72 (s, 3H), 2.51 (s, 3H), 2.13 (s, 3H), 2.09-1.75 (m, 6H), 1.46 (q, J=12.0, 10.4 Hz, 2H).

Example 241

[Figure (not displayed)]

Step 1[0626]: To a stirred solution of ethyl 1h-pyrazole-3-carboxylate [0005] (1 g, 6.99 mmol) in tetrahydrofuran (15 mL), methyl magnesium bromide (2.5 g, 2097 mmol) was added at 0° C. The reaction mixture was stirred at rt for 16 h. The reaction mixture was quenched with saturated solution of sodium bisulfate (15 mL), then the reaction mixture was filtered and separated the organic layer, then the aqueous was basified with saturated solution of sodium bicarbonate (20 mL), and then extracted with ethyl acetate (2×200 mL). The combined organic layer was washed with brine solution (25 mL), dried over sodium sulfate, filtered and concentrated under reduced pressure to afford 0.650 g of 2-(1h-pyrazol-3-yl)propan-2-ol [0626] as colorless gum. MS(M+1)+=127.2.

Step 2[0627]: This procedure is similar to Step 1[0270] in example 98. 0.5 g of 2,6-dichloro-4-methyl pyridine [0625] and 0.77 g of 2-(1H-pyrazol-3-yl)propan-2-ol [0626] gave 0.6 g of 2-(1-(6-chloro-4-methylpyridin-2-yl)-1H-pyrazol-3-yl)propan-2-ol [0627] as a yellow liquid. MS(M+1)+=252.0.

Step 3[0628]: This procedure is similar to Step 1[0570] in example 212. 0.35 g of 2-(1-(6-chloro-4-methylpyridin-2-yl)-1H-pyrazol-3-yl)propan-2-ol [0627] and 0.47 g of 4,4-difluorocyclohexylamine hydrochloride [0628] gave 0.06 g of 2-(1-(6-((4,4-difluorocyclohexyl)amino)-4-methylpyridin-2-yl)-1H-pyrazol-3-yl)propan-2-ol [0628], Compound 265 as white solid. MS(M+1)+=351.0, 1H NMR (400 MHz, DMSO-d6) δ 8.39 (d, J=2.5 Hz, 1H), 6.80 (s, 1H), 6.66 (d, J=7.4 Hz, 1H), 6.45 (d, J=2.6 Hz, 1H), 6.18 (s, 1H), 5.02 (s, 1H), 3.97 (bs, 1H), 2.22 (s, 3H), 2.13-1.87 (m, 6H), 1.68-1.50 (m 2H), 1.47 (s, 6H).

Example 242

[Figure (not displayed)]

Step 1[0630]: This procedure is similar to Step 1[0270] in example 98. 0.5 g of 2,6-dichloro-4-(trifluoromethyl)pyridine [0629] and 0.24 g of 3,5-dimethyl pyrazole [0630] gave 0.48 g (crude) of 4-(tert-butyl)-2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine [0603] as a yellow liquid. MS(M+1)+=276.2. This was taken as such tonext step.

Step 2[0631] NSSy5088: This procedure is similar to Step 3[0580] in example 216. 0.48 g (crude) of 4-(tert-butyl)-2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine [0630] and 0.35 g of 4,4-difluorocyclohexylamine hydrochloride [0002] gave 0.28 g of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-(trifluoromethyl)pyridin-2-amine [0631], Compound 170 as a white solid. MS(M+1)+=375.2, 1H NMR (400 MHz, DMSO-d6) δ 7.39 (d, J=7.5 Hz, 1H), 7.07 (s, 1H), 6.62 (s, 1H), 6.11 (s, 1H), 3.93 (bs, 1H), 2.63 (s, 3H), 2.19 (s, 3H), 2.11-1.86 (m, 6H), 1.50-1.58 (m, 2H).

Example 243

[Figure (not displayed)]

Step 1[0633]: This procedure is similar to Step 1[0270] in example 98. 1 g of 2,6-dichloro-4-methyl pyridine [0625] and 0.65 g of 3,5-dimethyl pyrazole [0017] gave 0.6 g of 2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-methylpyridine [0633] as white solid. MS(M+1)+=222.0.

Step 2[0634]. This procedure is similar to Step 3[0580] in example 216. 0.2 g of 2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-methylpyridine [0633] and 0.46 g of 4,4-difluorocyclohexylamine hydrochloride [0002] gave 0.05 g of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-methylpyridin-2-amine [0634], Compound 159 as a white solid. MS(M+1)+=321.2, 1H NMR (400 MHz, DMSO-d6) δ 6.74 (s, 1H), 6.63 (d, J=7.5 Hz, 1H), 6.16 (s, 1H), 6.01 (s, 1H), 3.86 (bs, 1H), 2.56 (s, 3H), 2.17 (s, 3H), 2.15 (s, 3H), 2.15-2.00 (m, 2H), 1.99-1.86 (m, 4H), 1.58-1.45 (m, 2H).

Example 245

[Figure (not displayed)]

Step 1[0637]: The procedure is similar to Step 1[0570] in example 212. 0.2 g of 2-chloro-4-methyl-6-(3-methyl-1H-pyrazol-1-yl)pyridine [0635] and 0.3 g of 4-(trifluoromethyl)cyclohexanamine [0113] gave 0.04 g of 4-methyl-6-(3-methyl-1H-pyrazol-1-yl)-N-(4-(trifluoromethyl)cyclohexyl)pyridin-2-amine [0637], Compound 180 as an off-white solid. MS(M+1)+=339.2, 1H NMR (400 MHz, DMSO-d6) δ 8.36 (d, J=2.5 Hz, 1H), 6.76 (s, 1H), 6.56 (d, J=7.6 Hz, 1H), 6.26 (d, J=2.5 Hz, 1H), 6.14 (s, 1H), 3.76-3.64 (m, 1H), 2.28 (s, 3H), 2.24 (s, 3H), 2.10 (d, J=10.8 Hz, 2H), 1.94 (d, J=12 Hz, 2H), 1.45 (qd, J=12.9, 3.3 Hz, 2H), 1.23 (qd, J=12.9, 3.4 Hz, 2H).

Example 246

[Figure (not displayed)]

Step 1[0639]: This procedure is similar to Step 1[0270] in example 98. 1 g of 2,6-dichloropyridine [0638] and 0.77 g of 3,5-dimethyl pyrazole [0017] gave 0.5 g of 2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine [0639] as a white solid. MS(M+1)+=208.2.

Step 2[0640]: This procedure is similar to Step 3[0580] in example 216. 0.2 g of 2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine [0639] and 0.19 g of 4,4-difluorocyclohexylamine hydrochloride [0002] gave 0.06 g of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0640], Compound 154 as a white solid. MS(M+1)+=307.2, 1H-NMR (400 MHz, DMSO-d6): δ 7.46 (t, J=7.96 Hz, 1H), 7.27 (bs, 1H), 6.77 (d, J=7.52 Hz, 1H), 6.35 (d, J=8.16 Hz, 1H), 6.04 (s, 1H), 3.89-3.88 (m, 1H), 2.59 (s, 3H), 2.17 (s, 3H), 2.04-1.99 (m, 2H), 1.91-1.90 (m, 4H), 1.58-1.52 (m, 2H).

Step 3[0641]: To a solution of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0640] (0.15 g, 0.48 mmol) in tetrahydrofuran (10 mL) was added Lithium bis(trimethylsilyl)amide (0.16 g, 0.97 mmol) drop wise at 0° C. Then the reaction mixture was stirred at rt for 30 min, then iodomethane (0.13 g, 0.97 mmol) was added to the reaction mixture at 0° C. and stirred at rt. After 16 h, the reaction mixture was quenched with ice and extracted with ethyl acetate (2×25 mL). The combined organic layer was washed with brine (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford a yellow liquid which was purified in the Reveleris flash system instrument using ethyl acetate in hexane as solvent in 12 g column, to afford of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N-methylpyridin-2-amine [0641], Compound 166 as a white solid (0.14 g). MS(M+1)+=321.2, 1H NMR (400 MHz, DMSO-d6) δ 7.62 (t, J=8.1 Hz, 1H), 6.99 (d, J=7.7 Hz, 1H), 6.55 (d, J=8.5 Hz, 1H), 6.06 (s, 1H), 4.52 (bs, 1H), 2.86 (s, 3H), 2.62 (s, 3H), 2.18 (s, 3H), 2.13-1.88 (m, 4H), 1.86-1.63 (m, 4H).

Example 247

[Figure (not displayed)]

Step 1[0643]: To a stirred suspension of 2,6-dichloroisonicotinonitrile [0642] (2 g, 11.560 mmol), 3,5-dimethyl pyrazole [0017] (1.222 g, 12.717 mmol) and cesium carbonate (5.650 g, 17.341 mmol) in acetonitrile was heated at 75° C. for 20 h. The reaction mixture was filtered, washed with ethyl acetate. The combined filtrate was concentrated under reduced pressure to afford crude which was purified by column chromatography using 5% ethyl acetate in hexane as eluent to afford 1 g of 2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinonitrile [0643] as a white solid. MS(M+1)+=233.1

Step 2[0644]: This procedure is similar to Step 3[0580] in example 216. 0.3 g of 2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinonitrile [0643] and 0.26 g of 4,4-difluorocyclohexylamine hydrochloride [0002] gave 0.12 g of 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinonitrile [0644], Compound 174 as off-white solid. MS(M+1)+=322.3, 1H-NMR (400 MHz, CDCl3): δ 7.39 (d, J=1.20 Hz, 1H), 6.39 (d, J=0.80 Hz, 1H), 6.01 (d, J=Hz, 1H), 4.62 (d, J=7.60 Hz, 1H), 3.86 (d, J=7.20 Hz, 2H), 2.64 (s, 3H), 2.29 (s, 3H), 1.97-1.90 (m, 4H), 1.89-1.84 (m, 2H), 1.83-1.65 (m, 1H).

Step 3[0645] NSSy5101. To a solution of 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinonitrile [0644] (0.1 g, 0.30 mmol) in tetrahydofuran:water (1:1) was added potassium hydroxide (0.084 g, 1.50 mmol) and the reaction mixture was heated at 60° C. After 8 h, the reaction mixture was concentrated under reduced pressure and the residue was diluted with water and extracted with chloroform. The combined organic layer was washed with brine and dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford brown oil. The crude was purified in the Reveleris flash system instrument using methanol in chloroform as solvent in 12 g column to afford 0.021 g 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinamide [0645], Compound 175 as orange solid. MS(M+1)+=350.2, 1H NMR (400 MHz, DMSO-d6) δ 8.06 (s, 1H), 7.48 (s, 1H), 7.24 (d, J=1.2 Hz, 1H), 6.99 (d, J=7.7 Hz, 1H), 6.73 (d, J=1.2 Hz, 1H), 6.06 (s, 1H), 3.90 (d, J=9.2 Hz, 1H), 2.59 (s, 3H), 2.18 (s, 3H), 2.12-1.74 (m, 6H), 1.74-1.30 (m, 2H).

Example 248

[Figure (not displayed)]

Step 1[0646]: This procedure is similar to Step 2[0019] in example 4. 0.1 g of 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinonitrile [0644] gave 0.026 g of 4-(aminomethyl)-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0646], Compound 195 as brown solid. MS(M+1)+=336.2, 1H NMR (400 MHz, DMSO-d6) δ 8.34 (s, 3H), 7.05 (s, 1H), 6.36 (s, 1H), 6.08 (s, 1H), 3.94 (q, J=5.9 Hz, 3H), 2.60 (s, 3H), 2.18 (s, 3H), 2.10-1.86 (m, 6H), 1.63-1.47 (m, 2H).

Example 249

[Figure (not displayed)]

Step 1[0647]: To a suspension of 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinonitrile [0647] (0.5 g, 1.51 mmol) in conc. hydrochloric acid (10 mL) was heated at 100° C. for 24 h. The reaction mixture was diluted with water and extracted with chloroform (3×50 mL). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product which was purified by column chromatography using 2% methanol in chloroform as eluent to obtain 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinic acid [0647] (0.25 g, 47%) as off-white solid. MS(M+1)+=351.2.

Step 2[0648]: To a stirred solution of 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinic acid [0647] (0.25 g, 0.714 mmol) in ethanol (10 mL) was added conc. sulfuric acid and the mixture was heated at 80° C. for 18 h. The reaction mixture was concentrated under reduced pressure to remove ethanol. The residue was basified with aq. sodium bicarbonate solution. The product was extracted with chloroform (3×25 mL). The combined organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford ethyl 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinate [0648] (0.15 g, 55%) as an off-white solid. MS(M+1)+=378.4.

Step 3[0649]: This procedure is similar to Step 1[0529] in example 195. 0.2 g of ethyl 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinate [0648] gave 0.06 g of 2-(2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)propan-2-ol [0649], Compound 206 as an off-white solid. MS(M+1)+=365.2, 1H NMR (400 MHz, Chloroform-d) δ 7.12 (d, J=1.3 Hz, 1H), 6.44 (d, J=1.3 Hz, 1H), 5.98 (s, 1H), 3.89 (s, 1H), 2.61 (s, 3H), 2.31 (s, 3H), 2.24-2.05 (m, 4H), 2.03-1.75 (m, 4H), 1.64-1.45 (m, 8H).

Example 250

[Figure (not displayed)]

Step 1 [0650]: The procedure is similar to step 2[0019] in example 4 [at −78° C.]. 0.1 g of ethyl 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinate [0648] gave 0.055 g of (2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)methanol [0650], Compound 185 as an off-white solid. MS(M+1)+=337.4, 1H NMR (400 MHz, DMSO-d6) δ 6.85 (s, 1H), 6.73 (d, J=7.6 Hz, 1H), 6.36 (s, 1H), 6.03 (s, 1H), 5.29 (s, 1H), 4.42 (s, 2H), 3.89 (d, J=9.1 Hz, 1H), 2.58 (s, 3H), 2.17 (s, 3H), 2.13-1.86 (m, 6H), 1.54 (q, J=11.6, 10.9 Hz, 2H).

Step 2[0651]: This procedure is similar to Step 3[0444] in example 166. 0.25 g of (2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)methanol [0650] gave 0.1 g of 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinaldehyde [0651] as an off-white solid. MS(M+1)+=335.2.

Step 3[0652]: This procedure is similar to Step 3[0012] in example 2. 0.1 g of 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinaldehyde [0651] gave 0.04 g of N-(4,4-difluorocyclohexyl)-4-(difluoromethyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0652], Compound 213 as an off-white solid. MS(M+1)+=357.1, 1H NMR (400 MHz, Chloroform-d) δ 7.25 (s, 1H), 6.41 (s, 1H), 6.36 (s, 1H), 6.01 (s, 1H), 4.53 (s, 1H), 3.90 (s, 1H), 2.65 (s, 3H), 2.31 (s, 3H), 2.23-2.11 (m, 4H), 2.00-1.81 (m, 2H), 1.75-1.55 (m, 2H).

Example 251

[Figure (not displayed)]

Step 1[0653]: This procedure is similar to Step 3[0012] in example 2. 0.25 g of (2-((4,4-difluoro cyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)methanol [0650] gave 0.01 g of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-4-(fluoromethyl)pyridin-2-amine [0653], Compound 229 as brown solid. MS(M+1)+=339.1, 1H NMR (400 MHz, Chloroform-d) δ 6.87 (s, 1H), 6.45 (s, 1H), 6.09 (s, 1H), 5.48 (s, 1H), 5.36 (s, 1H), 3.81 (s, 2H), 2.62 (s, 3H), 2.38 (s, 3H), 2.23 (bs, 2H), 2.11 (bs, 2H), 1.94 (s, 2H), 1.79 (bs, 2H).

Example 252

[Figure (not displayed)]

Step 1[0654]: This procedure is similar to Step 2[0049] in example 10. 0.1 g of 2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)isonicotinaldehyde [0651] gave 0.05 g of 1-(2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)ethan-1-ol [0654], Compound 207 as off-white solid. MS(M+1)+=351.1, 1H NMR (400 MHz, Chloroform-d) δ 7.04 (s, 1H), 6.32 (s, 1H), 5.98 (s, 1H), 4.83 (q, J=6.5 Hz, 1H), 4.45 (s, 1H), 3.87 (s, 1H), 2.61 (s, 3H), 2.30 (s, 3H), 2.24-2.04 (m, 4H), 2.03-1.79 (m, 2H), 1.8-1.55 (m, 2H), 1.50 (d, J=6.5 Hz, 3H).

Example 253

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0655]: The procedure is similar to step 1[0270] in example 98 [at 50° C. for 6 h]. 6 g of 2,6-dichloroisonicotinonitrile [0642] and 4.9 g of ethyl 1H-pyrazole-3-carboxylate [0005] gave 7.2 g of ethyl 1-(6-chloro-4-cyanopyridin-2-yl)-1H-pyrazole-3-carboxylate [0655] as an off-white solid. MS(M+1)+=277.0.

Step 2[0656]: The procedure is similar to step 3[0580] in example 216 (at 90° C. for 16 h). 2.5 g of ethyl 1-(6-chloro-4-cyanopyridin-2-yl)-1H-pyrazole-3-carboxylate [0655] and 1.5 g of 4,4-difluorocyclohexan-1-amine [0002] gave 1.74 g of ethyl 1-(4-cyano-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-1H-pyrazole-3-carboxylate [0656] as a yellow solid. MS(M+1)+=376.4/377.3

Step 3[0657]: The procedure is similar to step 2[0019] in example 4. 1 g of ethyl 1-(4-cyano-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-1H-pyrazole-3-carboxylate [0656] gave 0.55 g of (1-(4-(aminomethyl)-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-1H-pyrazol-3-yl)methanol [0657] as a brownish solid. MS(M+1)+=338.2

Step 4[0658]: To a solution of (1-(4-(aminomethyl)-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-1H-pyrazol-3-yl)methanol [0657] (0.55 g, 1.63 mmol), in dichloromethane (15 mL) was added acetyl chloride (0.29 g, 4.07 mmol) in drop wise and followed by triethylamine (0.65 g, 6.52 mmol) at 0° C. After addition the reaction mixture was stirred at rt for 1 h. The reaction mixture was diluted with water (10 mL) and extracted with ethyl acetate (2×50 mL). The combined organic layer was washed with brine (10 mL), dried over sodium sulfate, filtered and concentrated under reduced pressure to afford crude product and which was dissolved in methanol:water(1:1) followed by addition of potassium carbonate (0.5 g, 1.18 mmol) and stirred at rt for 15 min. The reaction mixture was concentrated under reduced pressure to afford crude product and which was purified by column chromatography using 5% methanol in chloroform as solvent to afford of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide [0658] as a brown solid (0.38 g). MS(M+1)+=380.2

Step 5[0659]: The procedure is similar to step 3[0012] in example 2. 0.38 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide [0658] gave 0.038 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide [0659], Compound 312 as a white solid. MS(M+1)+=382.3, 1H NMR (400 MHz, DMSO-d6) δ 8.55 (d, J=2.5 Hz, 1H), 8.42 (t, J=6.1 Hz, 1H), 6.91 (s, 1H), 6.89 (s, 1H), 6.63 (s, 1H), 6.28 (s, 1H), 5.45 (d, JF=48 Hz, 2H), 4.16 (d, J=6.1 Hz, 2H), 4.01 (bs, 1H), 2.26-1.92 (m, 6H), 1.89 (s, 3H), 1.62-1.54 (m, 2H).

Example 254

[Figure (not displayed)]

Step 1[0660]: The procedure is similar to step 3[0444] in example 166. 0.35 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide [0658] gave 0.29 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-formyl-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide [0660] as a brown solid.

MS(M+1)+=378.39

Step 2 [0661]: The procedure is similar to step 3[0012] in example 2. 0.29 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-formyl-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide [0660] gave 0.058 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(difluoromethyl)-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide [0661], Compound 301 as an yellowish solid. MS(M+1)+=400.2, 1H-NMR (400 MHz, DMSO-d6): δ 8.64 (d, J=2.44 Hz, 1H), 8.42 (t, J=6.00 Hz, 1H), 7.11 (t, JF=54 Hz, 1H), 6.97 (s, 1H), 6.95 (s, 1H), 6.77 (d, J=2.48 Hz, 1H), 6.33 (s, 1H), 4.18 (d, J=6.00 Hz, 2H), 4.03 (bs, 1H), 2.06-1.98 (m, 6H), 1.90 (s, 3H), 1.59-1.56 (m, 2H).

Example 255

[Figure (not displayed)]

Step 1[0662]: The procedure is similar to step 4[0658] in example 253. 0.5 g of (1-(4-(aminomethyl)-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-1H-pyrazol-3-yl)methanol [0657] gave 0.3 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyridin-4-yl)methyl)isobutyramide [0662] as a brown solid. MS(M+1)+=408.2.

Step 2[0663]: The procedure is similar to step 3[0012] in example 2. 0.3 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(hydroxymethyl)-1H-pyrazol-1-yl)pyridin-4-yl)methyl)isobutyramide [0662] gave 0.1 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(fluoromethyl)-1H-pyrazol-1-yl)pyridin-4-yl)methyl)isobutyramide [0663], Compound 348 as an off-white solid. MS(M+1)+=410.2, 1H NMR (400 MHz, DMSO-d6): δ 8.56 (d, J=2.20 Hz, 1H), 8.32 (t, J=5.84 Hz, 1H), 6.91 (d, J=8.04 Hz, 2H), 6.64 (s, 1H), 6.26 (s, 1H), 5.49 (s, 1H), 5.37 (s, 1H), 4.18 (d, J=5.84 Hz, 2H), 4.02-4.01 (m, 1H), 2.45-2.43 (m, 2H), 2.07-1.97 (m, 6H), 1.56-1.54 (m, 2H), 1.06 (d, J=6.84 Hz, 6H).

Example 256

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0664]: The procedure is similar to step 1[0270] in example 98 [at rt for 16 h]. 10 g of 2,6-dichloroisonicotinonitrile [0642] gave 5 g of ethyl 1-(6-chloro-4-cyanopyridin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0664] as a brownish solid. MS(M+1)+=291.0

Step 2[0665]: The procedure is similar to step 3[0580] in example 216 [at 80° C. for 12 h]. 5 g of ethyl 1-(6-chloro-4-cyanopyridin-2-yl)-4-methyl-1H-pyrazole-3-[0664] gave 1.3 g of ethyl 1-(4-cyano-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0665] as an off-white solid. MS(M+1)+=389.4

Step 3[0666]: The procedure is similar to step 2[0019] in example 4. 1 g of ethyl 1-(4-cyano-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-4-methyl-1H-pyrazole-3-carboxylate [0665] gave 0.61 g of (1-(4-(aminomethyl)-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol [0666] as a brownish solid. MS(M+1)+=351.3.

Step 4[0667]: The procedure is similar to step 4[0658] in example 253. 0.7 g of (1-(4-(aminomethyl)-6-((4,4-difluorocyclohexyl)amino)pyridin-2-yl)-4-methyl-1H-pyrazol-3-yl)methanol [0666] gave 0.4 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(hydroxymethyl)-4-methyl-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide [0667] as an off-white solid. MS(M+1)+=393.4.

Step 5[0668]. The procedure is similar to step 3[0012] in example 2. 0.15 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(hydroxymethyl)-4-methyl-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide [0667] gave 0.12 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(fluoromethyl)-4-methyl-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide. This was purified by column chromatography using 1% methanol in chloroform as solvent to afford 0.028 g of N-((2-((4,4-difluorocyclohexyl)amino)-6-(3-(fluoromethyl)-4-methyl-1H-pyrazol-1-yl)pyridin-4-yl)methyl)acetamide [0668], Compound 349 as an off-white solid. MS(M+1)+=396.2, 1H-NMR (400 MHz, DMSO-d6): δ 8.42 (t, J=5.88 Hz, 1H), 8.36 (s, 1H), 6.88 (s, 1H), 6.86 (s, 1H), 6.26 (s, 1H), 5.45 (d, JF=48 Hz, 2H), 4.16 (d, J=5.96 Hz, 2H), 4.02 (bs, 1H), 2.18 (s, 3H), 2.09-2.06 (m, 6H), 1.90 (s, 3H), 1.50-1.28 (m, 2H).

Example 257

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0669]: To a stirred solution of 2,6-dichloroisonicotinonitrile [0642] (15.0 g, 86.70 mmol) was taken in concentrated hydro chloric acid (120 mL) and heated to 110° C. for 3 h. The reaction mixture was cooled to rt and diluted slowly with ice cold water (300 mL). White solid thus precipitated was filtered, washed with ice cold water (100 mL) and dried under reduced pressure to afford 2,6-dichloroisonicotinic acid [0669] as a white solid (14.18 g, 90%). MS(M+1)+=190.1.

Step 2 [0670]: To a stirred solution of 2,6-dichloroisonicotinic acid [0669] (14.18 g, 73.85 mmol) in ethanol (125 mL) was added concentrated sulfuric acid (0.2 mL, 3.7 mmol). The resultant reaction mixture was heated at 90° C. for 6 h. The reaction mixture was concentrated under reduced pressure. The residue was diluted with ice-water (50 mL) and neutralized with solid sodium bicarbonate. White solid was slowly precipitated out which was filtered, washed with water (200 mL) and dried under reduced pressure to afford ethyl 2,6-dichloroisonicotinate [0670] as a white solid (11.2 g, 68%). MS(M+1)+=221.0.

Step 3 [0671]: The procedure is similar to step 2[0011] in example 2. 14.1 g of ethyl 2,6-dichloroisonicotinate [0670] gave 11.1 g of (2,6-dichloropyridin-4-yl)methanol [0671] MS(M+1)+=179.0.

Step 4 [0672]: To a stirred solution of 2,6-dichloropyridin-4-yl)methanol [0671] (8.6 g, 48.31 mmol) in a mixture of dichloromethane (150 mL) and tetrahydrofuran (20 mL) was added manganese dioxide (21.01 g, 241.55 mmol) under inert atmosphere. The reaction mixture was stirred at rt for 20 h. The reaction mixture was filtered over celite and filtrate was concentrated under reduced pressure to afford crude product which was purified by column chromatography using 15% ethyl acetate in pet ether as eluent to afford 2,6-dichloroisonicotinaldehyde [0672] as a white solid (4.9 g). MS(M+1)+=177.0.

Step 5 [0674]: To a stirred solution of oxazole [0673] (2.69 mL, 42.0 mmol) in tetrahydrofuran (30 mL), was added n-butyl lithium (2.5M in hexane, 16.79 mL, 42.0 mmol) slowly under inert atmosphere at −78° C. and stirred at −78° C. for 30 mins. After 30 min to the reaction mixture was added a solution of 2,6-dichloroisonicotinaldehyde [0672] (4.1 g, 24.158 mmol) in tetrahydrofuran (20 mL) at −78° C. and stirring was continued for 40 min. The reaction mixture was quenched with saturated ammonium chloride solution (10 mL) at −78° C. The reaction mixture was extracted with ethyl acetate (2×50 mL). The combined organic layers were washed with brine solution (25 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product which was purified by column chromatography using 60% ethyl acetate in pet ether as eluent to afford (2,6-dichloropyridin-4-yl)(oxazol-2-yl)methanol [0674] as a white solid (5.7 g). MS(M+1)+=245.

Step 6 [0675]: To a stirred solution of (2,6-dichloropyridin-4-yl)(oxazol-2-yl)methanol [0674] (5.7 g, 23.25 mmol) in dichloromethane (60 mL) was added imidazole (2.37 g, 34.87 mmol) under inert atmosphere at 0° C. and stirred for 1 h. Then tert-butyldimethylsilyl chloride (4.18 g, 27.91 mmol) was added to the reaction mixture at 0° C. and reaction mixture was slowly warmed to rt for 16 h. The reaction mixture was quenched with water (10 mL) and product was extracted with ethyl acetate (2×75 mL). The combined organic layer was washed with brine solution (25 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product which was purified by column chromatography using 20% ethyl acetate in pet ether as eluent to afford 2-(((tert-butyldimethylsilyl)oxy)(2,6-dichloropyridin-4-yl)methyl)oxazole[0675] as colorless liquid (6 g). MS(M+1)+=360.2.

Step 7 [0676]: To a stirred solution of 3,5-dimethyl-1H-pyrazole [0017] (0.64 g, 6.67 mmol) in tetrahydrofuran (20 mL) was added sodium hydride (0.26 g, 6.67 mmol) under inert atmosphere at 0° C. and stirred at same 0° C. for 30 mins. Then to the resultant reaction mixture was added a solution of (2-(((tert-butyldimethylsilyl)oxy)(2,6-dichloropyridin-4-yl)methyl)oxazole) [0675] (2.0 g, 5.56 mmol) in tetrahydrofuran (10 mL) at 0° C. The reaction mixture was heated at 60° C. for 16 h. The reaction mixture was quenched with ice cold water (20 mL). The product was extracted with ethyl acetate (2×50 mL). The combined organic layer was washed with brine solution (20 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product which was purified by column chromatography using 35% ethyl acetate in pet ether as eluent to afford 2-(((tert-butyldimethylsilyl)oxy)(2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)methyl)oxazole [0676] as an off-white solid (0.57 g). MS(M+1)+=420.2.

Step 8 [0677]: The procedure is similar to step 3[0580] in example 216. 0.5 g of 2-(((tert-butyldimethylsilyl)oxy)(2-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)methyl)oxazole [0676] and 4,4-difluorocyclohexylamine hydrochloride [0002] (0.245 g, 1.432 mmol) gave 0.28 g of 4-(((tert-butyldimethylsilyl)oxy)(oxazol-2-yl)methyl)-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0677] as an yellow solid. MS(M+1)+=518.6.

Step 9 [0678]: To a stirred solution of (((tert-butyldimethylsilyl)oxy)(oxazol-2-yl)methyl)-N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-2-amine [0677] (0.3 g, 0.58 mmol) in tetrahydrofuran (10 mL) was added tetrabutylammonium fluoride (1M solution in THF, 1.16 mL, 1.15 mmol) drop wise at 0° C. under inert atmosphere and the resultant reaction mixture was allowed to stir at rt for 1 h. The reaction mixture was quenched with ice cold water (5 mL) and product was extracted with ethyl acetate (2×20 mL). The combined organic layer was washed with brine solution (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford crude product which was purified by column chromatography using ethyl acetate in pet ether as eluent to afford (2-((4,4-difluorocyclohexyl)amino)-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridin-4-yl)(oxazol-2-yl)methanol [0678], Compound 343 as an yellow solid (0.19 g).

MS(M+1)+=404.2, 1H-NMR (400 MHz, DMSO-d6): δ 8.29 (d, J=0.96 Hz, 1H), 7.99 (t, J=0.92 Hz, 1H), 6.92 (d, J=0.48 Hz, 1H), 6.81 (d, J=7.52 Hz, 1H), 6.44 (s, 1H), 6.03 (m, 2H), 5.52 (d, J=4.76 Hz, 1H), 3.89-3.88 (m, 1H), 2.57 (s, 3H), 2.16 (s, 3H), 2.08-1.99 (m, 2H), 1.96-1.93 (m, 4H), 1.57-1.49 (m, 2H),

Example 258

[Figure (not displayed)]
[Figure (not displayed)]

Step 1[0679]: To a solution of 2,4,6-trichloropyridine [0565] (15 g, 82.22 mmol) in ethanol was added methylamine 30% solution in ethanol (15.32 g, 493.32 mmol) at 0° C. and the reaction mixture was stirred at rt in sealed tube. After 2 days, the reaction mixture was concentrated under reduced pressure and triturated with water, the solid formed was filtered and dried under vacuum to afford an off-white solid, which was triturated with dichloromethane and stirred for 10 min. The solid was filtered, washed with dichloromethane and dried under vacuum to afford 2,6-dichloro-N-methylpyridin-4-amine [0679] as a white solid. (7 g, 48% yield). MS(M+1)+=178.1.

Step 2[0680]: To a solution of 2,6-dichloro-N-methylpyridin-4-amine [0679] (8 g, 45.189 mmol) in concentrated sulfuric acid (184 g, 1876.06 mmol) was added nitric acid (2.84 g, 45.189 mmol) slowly drop wise at 0° C. and the reaction mixture was stirred at same temperature. After 1 h, the reaction mixture was cooled to 0° C. and quenched with ice and stirred for 10 min. The solid formed was filtered, washed with water and dried under vacuum to afford 2,6-dichloro-N-methyl-3-nitropyridin-4-amine[0680] as a pale yellow solid. (9.5 g, 95% yield). MS(M+1)+=223.1.

Step 3[0681]: To a suspension of sodium hydride (1.80 g, 45.0388 mmol) in tetrahydrofuran was added 4,4-difluorocyclohexylamine hydrochloride [0002] (3.86 g, 22.519 mmol) at 0° C. and the reaction mixture was stirred at rt for 30 min. Then 2,6-dichloro-N-methyl-3-nitropyridin-4-amine [0680] (5 g, 22.519 mmol) was added to the reaction mixture at 0° C. and the reaction mixture was stirred at rt. After 72 h, the reaction mixture was quenched with ice and stirred for 10 min. The solid formed was filtered and dried under vacuum to afford a yellow solid, which was purified in the Reveleris flash system instrument using ethyl acetate in hexane followed by methanol in chloroform as solvent in 24 g column to afford 6-chloro-N2-(4,4-difluorocyclohexyl)-N4-methyl-3-nitropyridine-2,4-diamine [0681] as an yellow solid, 2.5 g. MS(M+1)+=321.2.

Step 4[0682]: To a suspension of sodium hydride (0.467 g, 11.69 mmol) in tetrahydrofuran was added ethyl 1h-pyrazole-3-carboxylate [0005] (1.33 g, 9.35 mmol) at 0° C. and the reaction mixture was stirred at rt for 30 min. Then 6-chloro-N2-(4,4-difluorocyclohexyl)-N4-methyl-3-nitropyridine-2,4-diamine [0681] (2.5 g, 7.79 mmol) was added to the reaction mixture at 0° C. and the reaction mixture was heated at 65° C. After 120 h, the reaction mixture was quenched with ice and stirred at rt. The solid formed was filtered washed with water and dried under vacuum to afford a yellow solid, which was purified in the Reveleris flash system instrument using methanol in chloroform as solvent in 80 g column to afford ethyl1-(6-((4,4-difluorocyclohexyl)amino)-4-(methylamino)-5-nitropyridin-2-yl)-1H-pyrazole-3-carboxylate [0682] as an yellow solid. (1.3 g, 40% yield). MS(M+1)+=425.2.

Step 5[0683]: To a suspension of ethyl1-(6-((4,4-difluorocyclohexyl)amino)-4-(methylamino)-5-nitropyridin-2-yl)-1H-pyrazole-3-carboxylate [0682] (1.3 g, 3.06 mmol) in dichloromethane and methanol was added Raney nickel (0.7 g, 5.35 mmol) and the reaction mixture was stirred at rt under hydrogen atmosphere. After 72 h, the reaction mixture was filtered through celite bed, washed with dichloromethane. The filtrate was concentrated under reduced pressure to afford ethyl 1-(5-amino-6-((4,4-difluorocyclohexyl)amino)-4-(methylamino)pyridin-2-yl)-1H-pyrazole-3-carboxylate [0683] as a purple solid (1.1 g). MS(M+1)+=395.6.

Step 6 [0684]: To a solution of ethyl 1-(5-amino-6-((4,4-difluorocyclohexyl)amino)-4-(methylamino)pyridin-2-yl)-1H-pyrazole-3-carboxylate [0683] (1.0 g) in formic acid (20 vol) was stirred at rt. After 120 h, the reaction mixture was concentrated under reduced pressure and the residue was neutralized with sodium bicarbonate solution, extracted with ethyl acetate, washed with water and brine solution. The combined organic layer was concentrated under reduced pressure to afford a purple solid, which was purified in the Reveleris flash system instrument using ethyl acetate in hexane as solvent in 12 g column to afford ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-1-methyl-1H-imidazo[4,5-c]pyridin-6-yl)-1H-pyrazole-3-carboxylate [0684] as a purple solid (0.75 g). MS(M+1)+=405.2.

Step 7[0685]: The procedure is similar to step 2[0019] in example 4. 0.75 g of ethyl 1-(4-((4,4-difluorocyclohexyl)amino)-1-methyl-1H-imidazo [4,5-c]pyridin-6-yl)-1H-pyrazole-3-carboxylate [0684] gave 0.65 g of (1-(4-((4,4-difluorocyclohexyl)amino)-1-methyl-1H-imidazo[4,5-c]pyridin-6-yl)-1H-pyrazol-3-yl)methanol [0685] as a purple solid. MS(M+1)+=363.1.

Step 8[0686]: The procedure is similar to step 3[0012] in example 2. 0.65 g of (1-(4-((4,4-difluorocyclohexyl)amino)-1-methyl-1H-imidazo [4,5-c]pyridin-6-yl)-1H-pyrazol-3-yl)methanol [0685] gave 0.165 g of N-(4,4-difluorocyclohexyl)-6-(3-(fluoromethyl)-1H-pyrazol-1-yl)-1-methyl-1H-imidazo[4,5-c]pyridin-4-amine [0686], Compound 286 as a white solid. (30% yield). MS(M+1)+=365.2, 1H NMR (400 MHz, DMSO-d6) δ 8.63 (d, J=2.5 Hz, 1H), 8.05 (s, 1H), 7.22 (s, 1H), 7.01 (d, J=7.9 Hz, 1H), 6.63 (t, J=2 Hz, 1H), 5.40 (d, JF=48.4 Hz, 2H), 4.32 (bs, 1H), 3.80 (s, 3H), 2.17-1.93 (m, 6H), 1.84-1.62 (m, 2H).

Example 259

[Figure (not displayed)]

Step 1[0687]: The procedure is similar to step 4[0682] in example 258. 4 g of 6-chloro-N2-(4,4-difluorocyclohexyl)-N4-methyl-3-nitropyridine-2,4-diamine [0681] gave 1 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-di methyl-1H-pyrazol-1-yl)-N4-methyl-3-nitropyridine-2,4-diamine [0687] as an yellow solid(crude). MS(M+1)+=381.3.

Step 2[0688]: The procedure is similar to step 5[0683] in example 258. 0.5 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4-methyl-3-nitropyridine-2,4-diamine [0687] gave 0.4 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4methylpyridine-2,3,4-triamine [0688] as an yellow solid. MS(M+1)+=351.3.

Step 3[0689]: The procedure is similar to step 6[0684] in example 258. 0.22 g of N2-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-N4-methylpyridine-2,3,4-triamine [0688] gave 0.052 g of N-(4,4-difluorocyclohexyl)-6-(3,5-dimethyl-1H-pyrazol-1-yl)-1-methyl-1H-imidazo[4,5-c]pyridin-4-amine [0689], Compound 266 as an off-white. MS(M+1)+=361.6. 1H NMR (400 MHz, DMSO-d6) δ 8.16 (s, 1H), 7.11 (s, 1H), 6.94 (bs, 1H), 6.04 (s, 1H), 4.17 (bs, 1H), 2.60 (s, 3H), 2.48 (s, 3H), 2.20 (s, 3H), 2.15-1.90 (m, 6H), 1.75-1.63 (m, 2H).

Example 260

[Figure (not displayed)]

Step 1[0692]: To a suspension of ethyl 1-benzyl-3-oxo-4-piperidinecarboxylate hydrochloride [0690] (15 g, 50.37 mmol) in ethanol was added urea [0691] (15.12 g, 251.8 mmol) and sodium methoxide (35.3 g, 654.8 mmol) and the reaction mixture was refluxed at 90° C. under nitrogen atmosphere for 16 h. After the completion of the reaction, the reaction mixture was cooled to 0° C. and the pH of the suspension was adjusted to 6.0 by addition of aqueous hydrochloric acid (1 N solution). The mixture was stirred at rt for 15 min and the solid formed was filtered, washed with hexanes and dried under vacuum to afford 7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione [0692] as an off-white solid (8 g). MS(M+1)+=258.

Step 2[0693]: A suspension of 7-benzyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine-2,4(1H,3H)-dione [0692] (8 g, 31.09 mmol) in phosphorus oxychloride (253 g, 1650 mmol) was heated at 110° C. under nitrogen atmosphere for 48 h. After the completion of the reaction, the reaction mixture was concentrated to remove phosphorus oxychloride and the resultant residue was purified by column of silica gel (60-120 mesh), using 20% ethyl acetate in hexane as eluent to afford 7-benzyl-2,4-dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine [0693] as an light brown liquid (4.5 g). MS(M+1)+=294.

Step 3[0694]: To a solution of 7-benzyl-2,4-dichloro-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine [0693] (0.58 g, 1.97 mmol) and 4,4-difluorocyclohexylamine hydrochloride [0002] (0.33 g, 1.97 mmol) in ethanol (10 mL) was added N,N-diisopropyl ethylamine (0.38 g, 2.95 mmol) and the reaction mixture was heated at 90° C. in a closed vial (20 mL) for 16 h. After the completion of the reaction, the reaction mixture was concentrated to dryness and the residue was purified by column of silica gel (60-120 mesh), using 40% ethyl acetate in hexane as eluent to afford 7-benzyl-2-chloro-N-(4,4-difluorocyclohexyl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine [0694] as an yellow gummy solid (0.421 g). MS(M+1)+=393.

Step 4[0695]: The procedure is similar to step 3 [0580] in example 216 [at 90° C. for 16 h]. 0.42 g of 7-benzyl-2-chloro-N-(4,4-difluorocyclohexyl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine [0694] gave 0.31 g of 7-benzyl-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine [0695], Compound 119 as an off-white solid. MS(M+1)+=453, 1H-NMR (400 MHz, DMSO-d6): δ 7.35-7.28 (m, 4H), 7.30-7.24 (m, 1H), 6.73 (d, J=7.84 Hz, 1H), 6.00 (s, 1H), 4.12 (m, 1H), 3.66 (s, 2H), 2.66-2.51 (m, 2H), (2.49 (s, 3H), 2.47-2.44 (m, 2H), 2.12 (s, 3H), 2.12-1.70 (m, 6H), 1.67-1.64 (m, 2H), 2H are merging with solvent.

Step 5[0696]: To a solution of 7-benzyl-N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine [0695] (0.12 g, 0.265 mmol) in dichloromethane (10 mL) at 0° C. was added 1-chloroethyl chloroformate (0.075 g, 0.53 mmol), then the reaction mixture was heated at 45° C. for 8 h. After the completion of the reaction, the reaction mixture was concentrated to dryness and the resulting residue was dissolved in methanol (10 mL) and refluxed for 1 h and concentrated to dryness to afford an off-white gum and which was triturated with dichloromethane, the obtained solid was filtered and washed with hexane, dried under high vacuum to afford N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5,6,7,8-tetrahydropyrido [3,4-d]pyrimidin-4-amine hydrochloride salt [0696] as an off-white solid (0.061 g).

MS(M+1)+=363, 1H NMR (400 MHz, DMSO-d6) δ 9.72 (s, 2H), 7.46 (d, J=7.3 Hz, 1H), 6.15 (s, 1H), 4.13 (d, J=4.5 Hz, 3H), 3.42 (d, J=6.0 Hz, 2H), 2.70 (d, J=5.9 Hz, 2H), 2.57 (s, 3H), 2.20 (s, 3H), 2.10 (d, J=8.6 Hz, 2H), 1.95 (d, J=14.2 Hz, 3H), 1.73 (m, 2H).

Example 261

[Figure (not displayed)]

Step 1[0697]: To a solution of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5,6,7,8-tetrahydropyrido [3,4-d]pyrimidin-4-amine hydrochloride salt [0696] in acetonitrile (5 mL) was added bromoacetonitrile and followed by cesium carbonate, then the reaction mixture was stirred at 80° C. for 16 h. the reaction mixture was filtered and the filtrate was concentrated to afford as a brownish gum, which was purified by column of silica gel (60-120 mesh), using ethyl acetate as eluent to afford 2-(4-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5,8-dihydropyrido [3,4-d]pyrimidin-7(6H)-yl)acetonitrile [0697], Compound 122 as an Light brown solid (0.016 g). MS(M+1)+=402, 1H-NMR (400 MHz, DMSO-d6): δ 6.81 (d, J=7.92 Hz, 1H), 6.03 (s, 1H), 4.13 (s, 1H), 4.13 (s, 2H), 3.49 (s, 2H), 2.80 (t, J=5.48 Hz, 2H), 2.54 (S, 3H), 2.49-2.49 (m, 2H), 2.15 (s, 3H), 2.08-1.91 (m, 6H), 1.68-1.65 (m, 2H),

Example 262

[Figure (not displayed)]

Step 1[0698]: The procedure is similar to step 1[0697] in example 261. 0.07 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5,6,7,8-tetrahydropyrido [3,4-d]pyrimidin-4-amine hydrochloride salt [0696] gave 0.035 g of 2-(4-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl)acetamide [0698], Compound 121 as an white solid. MS(M+1)+=420, 1H NMR (400 MHz, DMSO-d6) δ 7.30 (s, 1H) 7.14 (s, 1H), 6.78 (d, J=8.0 Hz, 1H), 6.03 (s, 1H), 4.14 (bs, 1H), 3.48 (s, 2H), 3.08 (s, 2H), 2.77 (t, J=5.7 Hz, 2H), 2.54 (s, 3H), 2.16 (s, 3H), 2.15-1.85 (m, 8H), 1.69-1.75 (m, 2H).

Example 263

[Figure (not displayed)]

Step 1[0699]: The procedure is similar to step 1[0697] in example 261 [at 80° C. for 16 h]. 0.07 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5,6,7,8-tetrahydropyrido [3,4-d]pyrimidin-4-amine hydrochloride salt [0696] gave 0.022 g of N-(4,4-difluoro cyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-7-isopropyl-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-amine [0699], Compound 123 as an brownish gum. MS(M+1)+=405, 1H NMR (400 MHz, DMSO-d6) δ 6.72 (d, J=7.9 Hz, 1H), 6.03 (s, 1H), 4.12 (d, J=6.8 Hz, 1H), 3.45 (s, 2H), 2.87 (p, J=6.5 Hz, 1H), 2.73 (t, J=5.7 Hz, 2H), 2.54 (s, 3H), 2.41 (t, J=5.7 Hz, 2H), 2.16 (s, 3H), 2.00 (m, 6H), 1.68 (m, 2H), 1.06 (d, J=6.5 Hz, 6H).

Example 264

[Figure (not displayed)]

Step 1[0700]: The procedure is similar to step 1[0697] in example 261 [at 70° C. for 16 h]. 0.06 g of N-(4,4-difluorocyclohexyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5,6,7,8-tetrahydropyrido [3,4-d]pyrimidin-4-amine hydrochloride salt [0696] gave 0.026 g of 2-(4-((4,4-difluorocyclohexyl)amino)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl)ethan-1-ol [0700], Compound 118 as an light yellow solid. MS(M+1)+=407, 1H NMR (400 MHz, DMSO-d6) δ 6.74 (d, J=7.9 Hz, 1H), 6.03 (s, 1H), 4.51 (t, J=5.4 Hz, 1H), 4.13 (s, 1H), 3.59 (q, J=5.8 Hz, 2H), 3.44 (s, 2H), 2.75 (t, J=5.8 Hz, 2H), 2.58 (t, J=6.0 Hz, 2H), 2.50 (s, 3H), 2.43 (s, 2H), 2.15 (s, 3H), 2.15-1.85 (m, 6H), 1.74-1.60 (m, 2H).

[Figure (not displayed)]

Step 1:

[Figure (not displayed)]

A round-bottomed flask equipped with a teflon-coated stir bar was charged with 4,6-dichloro-2-(methylsulfonyl)pyrimidine (20.0 g, 88.080 mmol, 1.0 eq) in tetrahydrofuran at −10° C. and 3-methyl-1H-pyrazole (7.23 g, 88.080 mmol, 1.0 equiv.) was added dropwise over a period of five minutes via syringe. The reaction mixture was stirred for 16 hours at 25° C. and completion of reaction was determined by TLC. The reaction mixture was portioned between water (500 mL) and ethyl acetate (500 mL). The organic layer was separated and the aqueous layer was extracted with ethyl acetate (2*100 mL). The combined organic layer was dried over sodium sulfate, filtered, and concentrated under reduced pressure to afford crude product which was purified by column chromatography (ethyl acetate/hexane as solvent system) to afford 4,6-dichloro-2-(3-methyl-1H-pyrazol-1-yl)pyrimidine (10.0 g, 43.859 mmol, 50% yield) as a white solid pure form. MS (MH+): m/z=229.1.

Step 2:

[Figure (not displayed)]

A round-bottomed flask equipped with a teflon-coated stir bar was charged with 2,4-dichloro-6-methylpyrimidine (11.0 g, 48.24 mmol, 1.0 equiv.), 4,4-difluorocyclohexan-1-amine hydrochloride (9.89 g, 57.89 mmol, 1.2 equiv.), and CS2CO3 (39.19 g, 120.61 mmol, 2.5 equiv.) in acetonitrile (200 mL). The reaction mixture was stirred for five hours at 80° C. and the completion of reaction was determined by TLC. The reaction mixture was cooled to room temperature and partitioned between water (100 mL) and ethyl acetate (200 mL). The organic layer was separated and the aqueous layer was extracted ethyl acetate (2×100 mL). The combined organic layer was dried over sodium sulfate, filtered, and concentrated under reduced pressure to afford crude product which was purified by column chromatography (ethyl acetate/hexane as solvent system) to afford 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine (11.0 g, 33.62 mmol, 71%) as an off-white solid. MS (MH+): m/z=328.1.

Step 3:

[Figure (not displayed)]

A round-bottomed flask equipped with a teflon-coated stir bar was charged with 6-chloro-N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)pyrimidin-4-amine 5 (14.0 g, 42.79 mmol, 1.0 eq), morpholine (14.91 mL, 171.19 mmol, 4.0 eq), and triethylamine (23.89 mL, 171.19 mmol, 4.0 eq) in acetonitrile (200 mL). The reaction mixture was stirred for 16 hours at 80° C. and completion of reaction was determined by TLC. The reaction mixture was cooled to room temperature and partitioned between water (100 mL) and ethyl acetate (300 mL).

The organic layer was separated and the aqueous layer was extracted ethyl acetate (2×100 mL). The combined organic layer was dried over sodium sulfate, filtered, and concentrated under reduced pressure to afford crude product which was purified by column chromatography (ethyl acetate/hexane as solvent system) to afford N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine (Compound 359) (12.8 g, 33.84 mmol, 79% yield) as an off-white solid. MS (MH+): m/z=379.2. Analytical Data: 1H NMR (400 MHz, DMSO-D6): δ 8.41 (d, J=2 Hz, 1H), 7.07 (d, J=8.3 Hz, 1H), 6.25 (d, J=2.4 Hz, 1H), 5.53 (s, 1H), 3.9 (bs, 1H), 3.67 (t, J=4.4 Hz, 4H), 3.49 (S, 4H), 2.23 (s, 3H), 2.23-1.97 (m, 3H), 1.92-1.90 (m, 3H), 1.55-1.53 (m, 2H).

Full text: Click here
Patent 2020
Not available on PMC !

Example 1

1:1 carbamazepine:saccharin co-crystals (Form I) were prepared. A 12-block experiment was designed with 12 solvents. 1152 crystallization experiments were carried out using the CMAX platform. The co-crystal was obtained from a mixture of isopropyl acetate and heptane. Detailed characterization of the co-crystal is listed in Table V. (See FIGS. 1 and 2)

Example 8

Co-crystals of itraconazole and succinic acid were prepared. Approximately 51.1 mg of cis-itraconazole free base, 0.75 mL of THF, and a magnetic stir bar were charged into a screw cap vial, heated to reflux to dissolve, and then the vial was closed with the screw cap and placed on top of a hot plate maintained at a temperature between 60 and 75 degrees C. A solution of 77.7 mg of succinic acid in 1.58 mL of THF was prepared. 0.20 mL of the succinic acid solution was added to the cis-itraconazole solution and the solution remained clear. 0.75 mL of iso-propylacetate was added and the solution was seeded with <1 mg of the L-tartaric acid co-crystal salt from Example 10 below. The heat was turned off and the sample crystallized as it cooled to room temperature. The cooled sample was suction filtered. It was rinsed with 0.2-0.3 mL of THF. The filter cake was broken-up and allowed to air-dry for 1 hour prior to analysis. (See FIGS. 12 and 13)

Example 9

Co-crystals of itraconazole and fumaric acid were prepared. Approximately 500 mg of cis-itraconazole free base was placed in a 50 mL screw top bottle along with 33.33 mL of tetrahydrofuran (THF). 3.0887 mL of fumaric acid stock solution (prepared in Example 1) was then added to the beaker (resulting in a 1.05:1 ratio of salt former to free base). The cap was screwed on to seal the bottle and the bottle was placed in a 70 degrees C. oven (Model # 1400E, VWR Scientific) and heated for approximately 1 hour. Thereafter, the bottle was removed from the oven, the cap from the bottle was removed, and the sample was allowed to evaporate under flowing air under ambient conditions. When all but about 5 mL of the solvent had evaporated, the remaining solvent was removed by decantation and the solid was isolated by filtering over a Whatman filter using suction. This solid was returned back into the 50 mL bottle with the remaining solid and the bottle was placed into the vacuum oven at approximately 25 mm Hg and the solid was allowed to dry for 4 days prior to analysis. (See FIGS. 14 and 15)

Example 10

Co-crystals of itraconazole and tartaric acid were prepared. Approximately 100.4 mg of cis-itraconazole free base, 0.90 mL of THF, and a magnetic stir bar were charged into a screw cap vial, heated to reflux to dissolve, and then the vial was closed with the screw cap and placed in an oil bath maintained at 70 degrees C. A solution of 138.5 mg of L(+) tartaric acid in 1.15 mL of THF was prepared. 0.21 mL of the L(+)tartaric acid solution was added to the cis-itraconazole solution and the solution remained clear. 0.90 mL of iso-propylacetate was added and the solution was seeded with <1 mg of the salt from a preparation of DL-tartaric acid co-crystal. The sample was allowed to crystallize over about 5 minutes in the 70 degrees C. oil bath before it was removed and allowed to cool to room temperature. The cooled sample was suction filtered. It was rinsed with 0.2-0.3 mL of THF. The filter cake was broken-up and allowed to air-dry for 4 hours prior to analysis. (See FIGS. 16 and 17)

Example 42

A co-crystal with reduced form diversity as compared to the API has been prepared. Co-crystals of carbamazepine and saccharin have been prepared via method shown in example 1.

Co-MWMP##pKa
Crystal Former(g/mol)(° C.)ClassFunctionaliltyacceptorsdonorsMolecular StructureValues
1-Hydroxy-2- naphthoic acid188.18191-1922Carboxylic acid, alcohol12[Figure (not displayed)]
2.7, 13.5
4-aminobenzoic acid137.14187-1882Amine, carboxylic acid13[Figure (not displayed)]
4.7, 4.8
4-aminopyridine94.11158-1593Amine, pyridine12[Figure (not displayed)]
10
4-Chlorobenzene- sulfonic acid192.63671SO3H31[Figure (not displayed)]
0-1
4-ethoxyphenyl urea180.2173-1743Amide, NH23[Figure (not displayed)]
~7-9
7-oxo-DHEA303190-1921Alcohol, Ketone31[Figure (not displayed)]
Acesulfame163.15123-1243SO2, Amide41[Figure (not displayed)]
~5-7
Acetohydroxamic acid75.0789-923Amide, NH, OH22[Figure (not displayed)]
8.7
Adenine135.13200 (sub.)1Amide, NH33[Figure (not displayed)]
3.8
Adipic Acid146.141521Carboxylic acid22HOOC(CH2)4COOH4.44, 5.44
Alanine89.09289-2911Amine, carboxillic acid13[Figure (not displayed)]
2.35, 9.87
Allopurinaol136.11>3503OH, NH42[Figure (not displayed)]
10.2
Arginine174.2244 (dec.)1Amine, COOH27[Figure (not displayed)]
2.18, 9.09, 13.2
Ascorbic acid176.12190-1921C═O, OH64[Figure (not displayed)]
4.17, 11.57
Asparagine132.12234-2351Amine, amide, COOH35[Figure (not displayed)]
2.02, 8.5
Aspartic acid133.1270-2711Amine, COOH24[Figure (not displayed)]
1.88, 3.65, 9.60
Benzenesulfonic Acid158.1843-441SO3H21[Figure (not displayed)]
0.70, 1.58
Benzoic acid*122.12122-1232COOH11[Figure (not displayed)]
4.19
Caffeine194.192383C═O30[Figure (not displayed)]
Camphoric acid200.23186-1892Carboxylic acid22[Figure (not displayed)]
4.72, 5.83
Capric acid172.2731.41Carboxylic acid11CH3(CH2)8COOH4.9
Chrysin254.242851Phenol, ether, ketone22[Figure (not displayed)]
Cinnamic acid144.21333Carboxylic acid11[Figure (not displayed)]
4.4
Citric Acid192.121531OH, COOH44[Figure (not displayed)]
3.13, 4.76, 6.40
Clemizole325.841671Pyrrolidine30[Figure (not displayed)]
Cyclamic acid179.24169-1703NH, SO3H22[Figure (not displayed)]
−2
Cysteine121.151Amine, COOH, SH24[Figure (not displayed)]
1.71, 8.33, 10.78
Dimethylglycine103.1178-1921Amine, Carboxylic acid21[Figure (not displayed)]
2.5
D-Ribose150.13871Alcohol, ether14[Figure (not displayed)]
Fumaric acid116.072871COOH22[Figure (not displayed)]
3.03, 4.38
Galactaric acid210.14255 (dec)1Carboxylic acid, alcohol26[Figure (not displayed)]
3.08, 3.63
Genistein270.24297-2981Alcohol, Phenol, ether, ketone23[Figure (not displayed)]
Gentisic acid154.12199-200 form I, 205 form II2Carboxylic acid, alcohol, phenol13[Figure (not displayed)]
2.93
Glucamine, N-Methyl195.22128-1291Alcohol, Amine56[Figure (not displayed)]
8.03(B)
Gluconic acid196.151311OH, COOH66[Figure (not displayed)]
3.76
Glucosamine179.17881OH56[Figure (not displayed)]
6.91
Glucuronic acid194.141651Carboxylic acid, alcohol, aldehyde25[Figure (not displayed)]
3.18
Glutamic acid147.131601Amine, COOH24[Figure (not displayed)]
2.19, 4.25, 9.67
Glutamine146.15185-1861Amine, Amide, COOH25[Figure (not displayed)]
2.17, 9.13
Glutaric acid132.1198-981COOH22[Figure (not displayed)]
2.7, 4.5
Glycine75.071821Amine, COOH23[Figure (not displayed)]
2.34, 9.6
Glycolic acid76.05801OH, COOH22[Figure (not displayed)]
3.82
Hippuric acid179.17187-1881Amide, NH, COOH22[Figure (not displayed)]
3.55
Histidine155.16287 (dec.)1Amine, COOH, Imidazole24[Figure (not displayed)]
1.78, 5.97, 8.97
Hydroquinone*110.11170-1712OH, Phenol22[Figure (not displayed)]
~10
Imidazole68.0890-911NH11[Figure (not displayed)]
6.92
Ipriflavone280.32115-1171Ketone, ether30[Figure (not displayed)]
Isoleucine131.17168-170 (sub.)1Amine, COOH13[Figure (not displayed)]
2.32, 9.76
Lactobionic acid358.3128-1302Alcohol, carboxylic acid, ether19[Figure (not displayed)]
3.2
Lauric acid200.3244-481Carboxylic acid11CH3(CH2)10COOH~4.5
Leucine131.17145-148 (sub.)1Carboxylic acid, amine13[Figure (not displayed)]
2.36, 9.6
Lysine146.19225 (dec.)1Amine, COOH15[Figure (not displayed)]
2.2, 8.9, 10.28
Maleic116.07138-1391COOH22[Figure (not displayed)]
1.92, 6.23
Malic acid134.09131-1321OH, COOH33[Figure (not displayed)]
3.46, 5.1
Malonic104.061351COOH22[Figure (not displayed)]
2.83, 5.70
Mandelic acid152.151191OH, COOH22[Figure (not displayed)]
3.37
Methionine149.21280-282 (dec.)1Amine, COOH, S-Me23[Figure (not displayed)]
2-3, 9
Nicotinamide122.12128-1311Pyridine, amide22[Figure (not displayed)]
3.3
Nicotinic acid123.11236-2372Carboxylic acid, pyridine21[Figure (not displayed)]
2.07(B), 4.85
Orotic acid156.1345-3462Carboxilic acid, lactam33[Figure (not displayed)]
5.85, 8.95
Oxalic acid90.04189 (dec)2Carboxilic acid22[Figure (not displayed)]
1.27, 4.27
Palmitic acid256.4363-641Carboxylic acid11CH3(CH2)14COOH4.9
Pamoic388.38280 (dec)2Carboxylic acid, phenol24[Figure (not displayed)]
2.51, 3.1
Phenylalanine165.19283 (dec.)1Amine, COOH13[Figure (not displayed)]
~2, ~9
Piperazine86.141061NH02[Figure (not displayed)]
9.82(B)
Procaine236.31611Amine, C═O22[Figure (not displayed)]
8.9(B)
Proline115.13220-222 (dec.)1COOH, NH12[Figure (not displayed)]
1.99, 10.6
p-Toluenesulfonic acid172.2106-1072Sulfonic acid21[Figure (not displayed)]
−1.34
Pyridoxamine168193-1942OH, Amine, Pyridine34[Figure (not displayed)]
~9
Pyridoxine1701602Alcohol, Pyridine33[Figure (not displayed)]
~9
Pyroglutamic acid129.121622Carboxylic acid, Lactam22[Figure (not displayed)]
3.32
Quercetin302.24314 dec.1Phenol, ether, ketone25[Figure (not displayed)]
Resveratrol228.24253-2551Phenol03[Figure (not displayed)]
Saccharin183.19228-2301Amide, C═O, S═O, N—H31[Figure (not displayed)]
2
Salicylic acid, 4-amino153.14150-1513COOH, OH, Analine14[Figure (not displayed)]
3.25, 10, 3.5(B)
Salicylic acid138.121593COOH, OH22[Figure (not displayed)]
2.98, 13.82
Sebacic acid202.25134.51Carboxylic acid22HOOC(CH2)8COOH4.59, 5.59
Serine105.09228 (dec.)1Carboxylic acid, amine, OH23[Figure (not displayed)]
2.21, 9.15
Stearic acid284.4770-711Carboxylic acid11CH3(CH2)16COOH4.9
Succinic acid118.09185-1871Carboxylic acid22[Figure (not displayed)]
4.21, 5.64
Tartaric acid150.09205-2061Carboxylic acid44[Figure (not displayed)]
3.02, 4.36
Threonine119.12255-257 (dec.)1Amine, COOH, OH24[Figure (not displayed)]
2.15, 9.12
TRIS121.13171-1722Amine, OH35[Figure (not displayed)]
5.91, 8.3
Tryptophan204.23289 (dec.)1Amine, COOH, Indole14[Figure (not displayed)]
2.38, 9.39
Tyrosine181.19342-3441Amine, COOH, OH23[Figure (not displayed)]
2.2, 9.11, 10.07
Urea60.06Dec.1C═O, NH214[Figure (not displayed)]
~8
Valine117.153151Amine, COOH13[Figure (not displayed)]
~4.5, ~9
Vitamin K5209.68280-282 (dec.)3Amine, OH13[Figure (not displayed)]
~9
Xylitol152.1593-95 (1)2OH55[Figure (not displayed)]
~9

TABLE II
Co-crystal Former
Co-crystal FormerFunctional GroupInteracting Group
1,5-Napthalene-disulfonic AcidSulfonic AcidpyridineketonealdehydeetheresteramideCarboxylic Acid
1-Hydroxy-2-naphthoic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
1-Hydroxy-2-naphthoic acidalcoholalcoholketonethiolamideamineanalinephenol
4-Aminobenzoic AcidAminealcoholketonethiolamideamineanalinephenol
4-Aminobenzoic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
4-aminopyridineAminealcoholketonethiolamideamineanalinephenol
4-aminopyridinePyridine*alcoholpyridinium**amidenitro*amine*Carboxylic Acid
4-Chlorobenzene-Sulfonic Sulfonic AcidpyridineketonealdehydeetheresteramideCarboxylic Acid
Acid
4-ethoxyphenyl UreaAmidealcoholketonethiolamideamineanalinephenol
4-ethoxyphenyl UreaAminealcoholketonethiolamideamineanalinephenol
7-oxo-DHEAalcoholalcoholketonethiolamideamineanalinephenol
7-oxo-DHEAKetonealcoholthiolamideamineanalinephenol
AcesulfameSulfonepyridineketonealdehydeetheresteramidecarboxilic acid
AcesulfameAmidealcoholketonethiolamideamineanalinephenol
Acetohydroxamic AcidAmidealcoholketonethiolamideamineanalinephenol
Acetohydroxamic AcidAminealcoholketonethiolamideamineanalinephenol
Acetohydroxamic AcidAlcoholalcoholketonethiolamideamineanalinephenol
AdenineAminealcoholketonethiolamideamineanalinephenol
AdenineN*alcoholpyridinium**amidenitro*amine*carboxilic acid
Adipic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
AlanineAminealcoholketonethiolamideamineanalinephenol
AlanineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
AllopurinaolAlcoholalcoholketonethiolamideamineanalinephenol
AllopurinaolAminealcoholketonethiolamideamineanalinephenol
ArginineAminealcoholketonethiolamideamineanalinephenol
ArginineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Ascorbic AcidKetonealcoholthiolamideamineanalinephenol
Ascorbic AcidAlcoholalcoholketonethiolamideamineanalinephenol
Ascorbic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
AsparagineAminealcoholketonethiolamideamineanalinephenol
AsparagineAmidealcoholketonethiolamideamineanalinephenol
AsparagineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Aspartic AcidAminealcoholketonethiolamideamineanalinephenol
Aspartic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Benzenesulfonic AcidSulfonic AcidpyridineketonealdehydeetheresteramideCarboxylic Acid
Benzoic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
CaffeineKetonealcoholthiolamideamineanalinephenol
Camphoric acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Capric acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
GenisteinKetonealcoholthiolamideamineanalinephenol
GenisteinPhenolamineamidesulfoxidenpyridinecyanoaldehyde
GenisteinEtheraromatic-Namideaminearomatic_sSp2 aminesulfoxidechlorate
Cinnamic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Citric AcidAlcoholalcoholketonethiolamideamineanalinephenol
Citric AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
ClemizolePyrrolidine*alcoholpyridinium**amidenitro*amine*carboxilic acid
Cyclamic AcidAminealcoholketonethiolamideamineanalinephenol
Cyclamic AcidSulfonic AcidpyridineketonealdehydeetheresteramideCarboxylic Acid
CysteineAminealcoholketonethiolamideamineanalinephenol
CysteineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
CysteineThiolcarboxylic acidsodiumaldehydeketone-Ncadmium
DimethylglycineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
DimethylglycineAminealcoholketonethiolamideamineanalinephenol
D-riboseEtheraromatic-Namideaminearomatic_sSp2 aminesulfoxidechlorate
D-riboseAlcoholalcoholketonethiolamideamineanalinephenol
Fumaric AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Galactaric acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Galactaric acidalcoholalcoholketonethiolamideamineanalinephenol
ChrysinKetonealcoholthiolamideamineanalinephenol
ChrysinPhenolamineamidesulfoxidenpyridinecyanoaldehyde
ChrysinEtheraromatic-Namideaminearomatic_sSp2 aminesulfoxidechlorate
Gentisic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Gentisic acidPhenolamineamidesulfoxidenpyridinecyanoaldehyde
Glucamine, N-methylalcoholalcoholketonethiolamideamineanalinephenol
Glucamine, N-methylAminealcoholketonethiolamideamineanalinephenol
Gluconic AcidAlcoholalcoholketonethiolamideamineanalinephenol
Gluconic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Glucosaminealcoholalcoholketonethiolamideamineanalinephenol
Glucuronic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Glucuronic acidalcoholalcoholketonethiolamideamineanalinephenol
Glucuronic acidAldehydealcoholketonethiolamideamineanalinephenol
Glutamic AcidAminealcoholketonethiolamideamineanalinephenol
Glutamic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
GlutamineAminealcoholketonethiolamideamineanalinephenol
GlutamineAmidealcoholketonethiolamideamineanalinephenol
GlutamineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Glutaric AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
GlycineAminealcoholketonethiolamideamineanalinephenol
GlycineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Glycolic AcidAlcoholalcoholketonethiolamideamineanalinephenol
Glycolic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Hippuric AcidAmidealcoholketonethiolamideamineanalinephenol
Hippuric AcidAminealcoholketonethiolamideamineanalinephenol
Hippuric AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
HistidineAminealcoholketonethiolamideamineanalinephenol
HistidineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
HistidineImidazoleimidazolechlorineacetamidecarboxylatethionenitro
HydroquinoneAlcoholalcoholketonethiolamideamineanalinephenol
HydroquinonePhenolamineamidesulfoxidenpyridinecyanoaldehyde
ImidazoleAminealcoholketonethiolamideamineanalinephenol
IpriflavoneEtheraromatic-Namideaminearomatic_sSp2 aminesulfoxidechlorate
IpriflavoneKetonealcoholthiolamideamineanalinephenol
IsoleucineAminealcoholketonethiolamideamineanalinephenol
IsoleucineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
lactobionic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Lactobionic acidalcoholalcoholketonethiolamideamineanalinephenol
Lactobionic acidEtheraromatic-Namideaminearomatic_sSp2 aminesulfoxidechlorate
Lauric acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
LeucineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
LeucineAminealcoholketonethiolamideamineanalinephenol
LysineAminealcoholketonethiolamideamineanalinephenol
LysineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
MaleicCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Malic AcidAlcoholalcoholketonethiolamideamineanalinephenol
Malic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
MalonicCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Mandelic AcidAlcoholalcoholketonethiolamideamineanalinephenol
Mandelic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
MethionineAminealcoholketonethiolamideamineanalinephenol
MethionineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
MethionineThioether-Namideamine_sSp2 aminesulfoxidechlorate
NicotinamidePyridine*alcohol**amidenitro*amine*Carboxylic Acid
NicotinamideAmidealcoholketonethiolamideamineanalinephenol
Nicotinic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Nicotinic AcidPyridine*alcohol**amidenitro*amine*Carboxylic Acid
Orotic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Orotic acidLactamalcoholketonethiolamideamineanalinephenol
Oxalic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Palmitic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Pamoic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Pamoic acidalcoholalcoholketonethiolamideamineanalinephenol
Pamoic acidPhenolamineamidesulfoxidenpyridinecyanoaldehyde
PhenylalanineAminealcoholketonethiolamideamineanalinephenol
PhenylalanineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
PiperazineAminealcoholketonethiolamideamineanalinephenol
ProcaineAminealcoholketonethiolamideamineanalinephenol
ProcaineKetonealcoholthiolamideamineanalinephenol
ProlineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
ProlineAminealcoholketonethiolamideamineanalinephenol
p-Toluenesulfonic acidSulfonic AcidpyridineketonealdehydeetheresteramideCarboxylic Acid
PyridoxamineAlcoholalcoholketonethiolamideamineanalinephenol
PyridoxamineAminealcoholketonethiolamideamineanalinephenol
PyridoxaminePyridine*alcohol**amidenitro*amine*Carboxylic Acid
Pyridoxine (4-Pyridoxic Acid)Pyridine*alcoholpyridinium**amidenitro*amine*Carboxylic Acid
Pyridoxine (4-Pyridoxic Acid)Alcoholalcoholketonethiolamideamineanalinephenol
Pyroglutamic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Pyroglutamic acidLactamalcoholketonethiolamideamineanalinephenol
QuercetinKetonealcoholthiolamideamineanalinephenol
QuercetinPhenolamineamidesulfoxidenpyridinecyanoaldehyde
QuercetinEtheraromatic-Namideaminearomatic_sSp2 aminesulfoxidechlorate
ResveratrolKetonealcoholthiolamideamineanalinephenol
ResveratrolPhenolamineamidesulfoxidenpyridinecyanoaldehyde
SaccharinAmidealcoholketonethiolamideamineanalinephenol
SaccharinKetonealcoholthiolamideamineanalinephenol
SaccharinSulfoxidepyridineketonealdehydeetheresteramideCarboxylic Acid
SaccharinAminealcoholketonethiolamideanalinephenol
Salicylic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Salicylic AcidAlcoholalcoholketonethiolamideamineanalinephenol
Salicylic Acid, 4-aminoCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Salicylic Acid, 4-aminoalcoholalcoholketonethiolamideamineanalinephenol
Salicylic Acid, 4-aminoAminealcoholketonethiolamideamineanalinephenol
Sebacic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
SerineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
SerineAminealcoholketonethiolamideamineanalinephenol
SerineAlcoholalcoholketonethiolamideamineanalinephenol
Stearic acidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Succinic AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Tartaric AcidCarboxylic Acidalcoholketonethiolamideamineanalinephenol
ThreonineAminealcoholketonethiolamideamineanalinephenol
ThreonineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Threoninealcoholalcoholketonethiolamideamineanalinephenol
TrisAminealcoholketonethiolamideamineanalinephenol
TrisAlcoholalcoholketonethiolamideamineanalinephenol
TryptophanAminealcoholketonethiolamideamineanalinephenol
TryptophanCarboxylic Acidalcoholketonethiolamideamineanalinephenol
TryptophanIndole*alcoholpyridinium**amidenitro*amine*carboxilic acid
TyrosineAminealcoholketonethiolamideamineanalinephenol
TyrosineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
TyrosineAlcoholalcoholketonethiolamideamineanalinephenol
UreaKetonealcoholthiolamideamineanalinephenol
UreaAminealcoholketonethiolamideamineanalinephenol
UreaAmidealcoholketonethiolamideamineanalinephenol
ValineAminealcoholketonethiolamideamineanalinephenol
ValineCarboxylic Acidalcoholketonethiolamideamineanalinephenol
Vitamin K5Aminealcoholketonethiolamideamineanalinephenol
Vitamin K5Alcoholalcoholketonethiolamideamineanalinephenol
XylitolAlcoholalcoholketonethiolamideamineanalinephenol
Co-crystal FormerInteracting Group
1,5-Napthalene-disulfonic Acidaminemetalsthioethersulfatealcohol
1-Hydroxy-2-naphthoic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetalsaldehyde
1-Hydroxy-2-naphthoic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetalsaldehyde
4-Aminobenzoic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
4-Aminobenzoic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
4-aminopyridinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
4-aminopyridine*sulfonamide*ketoneethertriazoleammoniumoxime*chlorine
4-Chlorobenzene-Sulfonic aminemetalsthioethersulfatealcohol
Acid
4-ethoxyphenyl UreaphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
4-ethoxyphenyl Ureaphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
7-oxo-DHEAphosphatesulfatesulfonenitratepyridinecarboxilic acidmetalsaldehyde
7-oxo-DHEAphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Acesulfameaminemetalsthioethersulfatealcohol
AcesulfamephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Acetohydroxamic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Acetohydroxamic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Acetohydroxamic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Adeninephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Adenine*sulfonamide*ketoneethertriazoleammoniumoxime*chlorine
Adipic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Alaninephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Alaninephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
AllopurinaolphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Allopurinaolphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Argininephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Argininephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Ascorbic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Ascorbic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Ascorbic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Asparaginephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
AsparaginephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Asparaginephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Aspartic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Aspartic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Benzenesulfonic Acidaminemetalsthioethersulfatealcohol
Benzoic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
CaffeinephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Camphoric acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Capric acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
GenisteinphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Genisteinalchoholesterethern-oxidechlorinefluorine
Genisteinchlorinecyanoesteraminenitronitratebromine
Cinnamic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Citric AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Citric Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Clemizole*sulfonamide*ketoneethertriazoleammoniumoxime*chlorine
Cyclamic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Cyclamic Acidaminemetalsthioethersulfatealcohol
Cysteinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Cysteinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
CysteinearsenicchlorinealcoholpotassiumRuRbSb
Dimethylglycinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Dimethylglycinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
D-ribosechlorinecyanoesteraminenitronitratebromine
D-ribosephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Fumaric Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Galactaric acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Galactaric acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetalsaldehyde
ChrysinphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Chrysinalchoholesterethern-oxidechlorinefluorine
Chrysinchlorinecyanoesteraminenitronitratebromine
Gentisic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Gentisic acidalchoholesterethern-oxidechlorinefluorine
Glucamine, N-methylphosphatesulfatesulfonenitratepyridinecarboxilic acidmetalsaldehyde
Glucamine, N-methylphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Gluconic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Gluconic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
GlucosaminephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Glucuronic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Glucuronic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetalsaldehyde
Glucuronic acidphosphatesulfatesulfonenitratepyridinearomaticcarboxilic acidmetals
Glutamic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Glutamic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Glutaminephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
GlutaminephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Glutaminephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Glutaric Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Glycinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Glycinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Glycolic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Glycolic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Hippuric Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Hippuric Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Hippuric Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Histidinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Histidinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
HistidinecyanamideketonecyanoCarboxylic alcoholthiolamine
Acid
HydroquinonephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Hydroquinonealchoholesterethern-oxidechlorinefluorine
Imidazolephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Ipriflavonechlorinecyanoesteraminenitronitratebromine
IpriflavonephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Isoleucinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Isoleucinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
lactobionic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Lactobionic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetalsaldehyde
Lactobionic acidchlorinecyanoesteraminenitronitratebromine
Lauric acidphosphatesulfatesulfonenitratepyridinecarboxilic acid
LeucinephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Leucinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Lysinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Lysinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Maleicphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Malic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Malic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Malonicphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Mandelic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Mandelic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Methioninephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Methioninephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Methioninechlorinecyanoesteraminenitronitratebromine
Nicotinamide*sulfonamide*ketoneethertriazoleammoniumoxime*chlorine
NicotinamidephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Nicotinic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Nicotinic Acid*sulfonamide*ketoneethertriazoleammoniumoxime*chlorine
Orotic acidphosphatesulfatesulfonenitratepyridinecarboxilic acid
Orotic acidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Oxalic acidphosphatesulfatesulfonenitratepyridinecarboxilic acid
Palmitic acidphosphatesulfatesulfonenitratepyridinecarboxilic acid
Pamoic acidphosphatesulfatesulfonenitratepyridinecarboxilic acid
Pamoic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetalsaldehyde
Pamoic acidalchoholesterethern-oxidechlorinefluorine
Phenylalaninephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Phenylalaninephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Piperazinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Procainephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
ProcainephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Prolinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Prolinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
p-Toluenesulfonic acidaminemetalsthioethersulfatealcohol
PyridoxaminephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Pyridoxaminephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Pyridoxamine*sulfonamide*ketoneethertriazoleammoniumoxime*chlorine
Pyridoxine*sulfonamide*ketoneethertriazoleammoniumoxime*chlorine
(4-Pyridoxic Acid)
PyridoxinephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
(4-Pyridoxic Acid)
Pyroglutamic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Pyroglutamic acidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
QuercetinphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Quercetinalchoholesterethern-oxidechlorinefluorine
Quercetinchlorinecyanoesteraminenitronitratebromine
ResveratrolphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Resveratrolalchoholesterethern-oxidechlorinefluorine
SaccharinphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
SaccharinphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Saccharinaminemetalsthioethersulfatealcohol
SaccharinphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Salicylic Acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Salicylic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Salicylic Acid, 4-aminophosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Salicylic Acid, 4-aminophosphatesulfatesulfonenitratepyridinecarboxilic acidmetalsaldehyde
Salicylic Acid, 4-aminophosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Sebacic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
SerinephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Serinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
SerinephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Stearic acidphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Succinic AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Tartaric AcidphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Threoninephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Threoninephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
ThreoninephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Trisphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
TrisphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Tryptophanphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Tryptophanphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Tryptophan*sulfonamide*ketoneethertriazoleammoniumoxime*chlorine
Tyrosinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Tyrosinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
TyrosinephosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
UreaphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Ureaphosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
UreaphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Valinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Valinephosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Vitamin K5phosphatesulfatesulfonenitratepyridinecarboxilic acidmetals
Vitamin K5phosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
XylitolphosphatesulfatesulfonenitratepyridineCarboxylic Acidmetals
Co-crystal FormerInteracting Group
1,5-Napthalene-disulfonic Acid
1-Hydroxy-2-naphthoic acidesterethercyanofuranbrominechlorines-heterocyclic
1-Hydroxy-2-naphthoic acidesterethercyanofuranbrominechlorines-heterocyclic
4-Aminobenzoic Acidaldehydeesterethercyanofuranbrominechlorine
4-Aminobenzoic Acidaldehydeesterethercyanofuranbrominechlorine
4-aminopyridinealdehydeesterethercyanofuranbrominechlorine
4-aminopyridinethioln-heterocyclic ringthionedisulfidepyrrolidindioneiodinehydrazonethiocyanate
4-Chlorobenzene-Sulfonic
Acid
4-ethoxyphenyl Ureaaldehydeesterethercyanofuranbrominechlorine
4-ethoxyphenyl Ureaaldehydeesterethercyanofuranbrominechlorine
7-oxo-DHEAesterethercyanofuranbrominechlorines-heterocyclic
7-oxo-DHEAaldehydeesterethercyanofuranbrominechlorine
Acesulfame
Acesulfamealdehydeesterethercyanofuranbrominechlorine
Acetohydroxamic Acidaldehydeesterethercyanofuranbrominechlorine
Acetohydroxamic Acidaldehydeesterethercyanofuranbrominechlorine
Acetohydroxamic Acidaldehydeesterethercyanofuranbrominechlorine
Adeninealdehydeesterethercyanofuranbrominechlorine
Adeninethioln-heterocyclic ringthionedisulfidepyrrolidindioneiodinehydrazonethiocyanate
Adipic acidaldehydeesterethercyanofuranbrominechlorine
Alaninealdehydeesterethercyanofuranbrominechlorine
Alaninealdehydeesterethercyanofuranbrominechlorine
Allopurinaolaldehydeesterethercyanofuranbrominechlorine
Allopurinaolaldehydeesterethercyanofuranbrominechlorine
Argininealdehydeesterethercyanofuranbrominechlorine
Argininealdehydeesterethercyanofuranbrominechlorine
Ascorbic Acidaldehydeesterethercyanofuranbrominechlorine
Ascorbic Acidaldehydeesterethercyanofuranbrominechlorine
Ascorbic Acidaldehydeesterethercyanofuranbrominechlorine
Asparaginealdehydeesterethercyanofuranbrominechlorine
Asparaginealdehydeesterethercyanofuranbrominechlorine
Asparaginealdehydeesterethercyanofuranbrominechlorine
Aspartic Acidaldehydeesterethercyanofuranbrominechlorine
Aspartic Acidaldehydeesterethercyanofuranbrominechlorine
Benzenesulfonic Acid
Benzoic Acidaldehydeesterethercyanofuranbrominechlorine
Caffeinealdehydeesterethercyanofuranbrominechlorine
Camphoric acidaldehydeesterethercyanofuranbrominechlorine
Capric acidaldehydeesterethercyanofuranbrominechlorine
Genisteinaldehydeesterethercyanofuranbrominechlorine
Genisteinbromineiodineketonesulfonic acidsulfatephosphatephosphonic acidcarboxylic acid
Genisteinaldehydeketoneperoxideepoxideheterocyclic-Siodine
Cinnamic acidaldehydeesterethercyanofuranbrominechlorine
Citric Acidaldehydeesterethercyanofuranbrominechlorine
Citric Acidaldehydeesterethercyanofuranbrominechlorine
Clemizolethioln-heterocyclic ringthionedisulfidepyrrolidindioneiodinehydrazonethiocyanate
Cyclamic Acidaldehydeesterethercyanofuranbrominechlorine
Cyclamic Acid
Cysteinealdehydeesterethercyanofuranbrominechlorine
Cysteinealdehydeesterethercyanofuranbrominechlorine
Cysteine
Dimethylglycinealdehydeesterethercyanofuranbrominechlorine
Dimethylglycinealdehydeesterethercyanofuranbrominechlorine
D-ribosealdehydeketoneperoxideepoxideheterocyclic-Siodine
D-ribosealdehydeesterethercyanofuranbrominechlorine
Fumaric Acidaldehydeesterethercyanofuranbrominechlorine
Galactaric acidaldehydeesterethercyanofuranbrominechlorine
Galactaric acidesterethercyanofuranbrominechlorines-heterocyclic
Chrysinaldehydeesterethercyanofuranbrominechlorine
Chrysinbromineiodineketonesulfonic acidsulfatephosphatephosphonic acidcarboxylic acid
Chrysinaldehydeketoneperoxideepoxideheterocyclic-Siodine
Gentisic acidaldehydeesterethercyanofuranbrominechlorine
Gentisic acidbromineiodineketonesulfonic acidsulfatephosphatephosphonic acidcarboxylic acid
Glucamine, N-methylesterethercyanofuranbrominechlorines-heterocyclic
Glucamine, N-methylaldehydeesterethercyanofuranbrominechlorine
Gluconic Acidaldehydeesterethercyanofuranbrominechlorine
Gluconic Acidaldehydeesterethercyanofuranbrominechlorine
Glucosaminealdehydeesterethercyanofuranbrominechlorine
Glucuronic acidaldehydeesterethercyanofuranbrominechlorine
Glucuronic acidesterethercyanofuranbrominechlorines-heterocyclic
Glucuronic acidaldehydeesterethercyanofuranbrominechlorine
Glutamic Acidaldehydeesterethercyanofuranbrominechlorine
Glutamic Acidaldehydeesterethercyanofuranbrominechlorine
Glutaminealdehydeesterethercyanofuranbrominechlorine
Glutaminealdehydeesterethercyanofuranbrominechlorine
Glutaminealdehydeesterethercyanofuranbrominechlorine
Glutaric Acidaldehydeesterethercyanofuranbrominechlorine
Glycinealdehydeesterethercyanofuranbrominechlorine
Glycinealdehydeesterethercyanofuranbrominechlorine
Glycolic Acidaldehydeesterethercyanofuranbrominechlorine
Glycolic Acidaldehydeesterethercyanofuranbrominechlorine
Hippuric Acidaldehydeesterethercyanofuranbrominechlorine
Hippuric Acidaldehydeesterethercyanofuranbrominechlorine
Hippuric Acidaldehydeesterethercyanofuranbrominechlorine
Histidinealdehydeesterethercyanofuranbrominechlorine
Histidinealdehydeesterethercyanofuranbrominechlorine
Histidine phosphinic acid hemihydratechlorinesulfonylsulfoxideamidefluorinesulfonate ester
Hydroquinonealdehydeesterethercyanofuranbrominechlorine
Hydroquinonebromineiodineketonesulfonic acidsulfatephosphatephosphonic acidcarboxylic acid
Imidazolealdehydeesterethercyanofuranbrominechlorine
Ipriflavonealdehydeketoneperoxideepoxideheterocyclic-Siodine
Ipriflavonealdehydeesterethercyanofuranbrominechlorine
Isoleucinealdehydeesterethercyanofuranbrominechlorine
Isoleucinealdehydeesterethercyanofuranbrominechlorine
lactobionic acidaldehydeesterethercyanofuranbrominechlorine
Lactobionic acidesterethercyanofuranbrominechlorines-heterocyclic
Lactobionic acidaldehydeketoneperoxideepoxideheterocyclic-Siodine
Lauric acidaldehydeesterethercyanofuranbrominechlorine
Leucinealdehydeesterethercyanofuranbrominechlorine
Leucinealdehydeesterethercyanofuranbrominechlorine
Lysinealdehydeesterethercyanofuranbrominechlorine
Lysinealdehydeesterethercyanofuranbrominechlorine
Maleicaldehydeesterethercyanofuranbrominechlorine
Malic Acidaldehydeesterethercyanofuranbrominechlorine
Malic Acidaldehydeesterethercyanofuranbrominechlorine
Malonicaldehydeesterethercyanofuranbrominechlorine
Mandelic Acidaldehydeesterethercyanofuranbrominechlorine
Mandelic Acidaldehydeesterethercyanofuranbrominechlorine
Methioninealdehydeesterethercyanofuranbrominechlorine
Methioninealdehydeesterethercyanofuranbrominechlorine
MethioninealdehydeketoneperoxideepoxideAgSeheterocyclic-Siodine
Nicotinamidethioln-heterocyclic ringthionedisulfidepyrrolidindioneiodinehydrazonethiocyanate
Nicotinamidealdehydeesterethercyanofuranbrominechlorine
Nicotinic Acidaldehydeesterethercyanofuranbrominechlorine
Nicotinic Acidthioln-heterocyclic ringthionedisulfidepyrrolidindioneiodinehydrazonethiocyanate
Orotic acidaldehydeesterethercyanofuranbrominechlorine
Orotic acidaldehydeesterethercyanofuranbrominechlorine
Oxalic acidaldehydeesterethercyanofuranbrominechlorine
Palmitic acidaldehydeesterethercyanofuranbrominechlorine
Pamoic acidaldehydeesterethercyanofuranbrominechlorine
Pamoic acidesterethercyanofuranbrominechlorines-heterocyclic
Pamoic acidbromineiodineketonesulfonic acidsulfatephosphatephosphonic acidcarboxylic acid
Phenylalaninealdehydeesterethercyanofuranbrominechlorine
Phenylalaninealdehydeesterethercyanofuranbrominechlorine
Piperazinealdehydeesterethercyanofuranbrominechlorine
Procainealdehydeesterethercyanofuranbrominechlorine
Procainealdehydeesterethercyanofuranbrominechlorine
Prolinealdehydeesterethercyanofuranbrominechlorine
Prolinealdehydeesterethercyanofuranbrominechlorine
p-Toluenesulfonic acid
Pyridoxaminealdehydeesterethercyanofuranbrominechlorine
Pyridoxaminealdehydeesterethercyanofuranbrominechlorine
Pyridoxaminethioln-heterocyclic ringthionedisulfideiodinehydrazonethiocyanate
Pyridoxinethioln-heterocyclic ringthionedisulfidepyrrolidindioneiodinehydrazonethiocyanate
(4-Pyridoxic Acid)
Pyridoxinealdehydeesterethercyanofuranbrominechlorine
(4-Pyridoxic Acid)
Pyroglutamic acidaldehydeesterethercyanofuranbrominechlorine
Pyroglutamic acidaldehydeesterethercyanofuranbrominechlorine
Quercetinaldehydeesterethercyanofuranbrominechlorine
Quercetinbromineiodineketonesulfonic acidsulfatephosphatephosphonic acidcarboxylic acid
Quercetinaldehydeketoneperoxideepoxideheterocyclic-Siodine
Resveratrolaldehydeesterethercyanofuranbrominechlorine
Resveratrolbromineiodineketonesulfonic acidsulfatephosphatephosphonic acidcarboxylic acid
Saccharinaldehydeesterethercyanofuranbrominechlorine
Saccharinaldehydeesterethercyanofuranbrominechlorine
Saccharin
Saccharinaldehydeesterethercyanofuranbrominechlorine
Salicylic Acidaldehydeesterethercyanofuranbrominechlorine
Salicylic Acidaldehydeesterethercyanofuranbrominechlorine
Salicylic Acid, 4-aminoaldehydeesterethercyanofuranbrominechlorine
Salicylic Acid, 4-aminoesterethercyanofuranbrominechlorines-heterocyclic
Salicylic Acid, 4-aminoaldehydeesterethercyanofuranbrominechlorine
Sebacic acidaldehydeesterethercyanofuranbrominechlorine
Serinealdehydeesterethercyanofuranbrominechlorine
Serinealdehydeesterethercyanofuranbrominechlorine
Serinealdehydeesterethercyanofuranbrominechlorine
Stearic acidaldehydeesterethercyanofuranbrominechlorine
Succinic Acidaldehydeesterethercyanofuranbrominechlorine
Tartaric Acidaldehydeesterethercyanofuranbrominechlorine
Threoninealdehydeesterethercyanofuranbrominechlorine
Threoninealdehydeesterethercyanofuranbrominechlorine
Threoninealdehydeesterethercyanofuranbrominechlorine
Trisaldehydeesterethercyanofuranbrominechlorine
Trisaldehydeesterethercyanofuranbrominechlorine
Tryptophanaldehydeesterethercyanofuranbrominechlorine
Tryptophanaldehydeesterethercyanofuranbrominechlorine
Tryptophanthioln-heterocyclic ringthionedisulfidepyrrolidindioneiodinehydrazonethiocyanate
Tyrosinealdehydeesterethercyanofuranbrominechlorine
Tyrosinealdehydeesterethercyanofuranbrominechlorine
Tyrosinealdehydeesterethercyanofuranbrominechlorine
Ureaaldehydeesterethercyanofuranbrominechlorine
Ureaaldehydeesterethercyanofuranbrominechlorine
Ureaaldehydeesterethercyanofuranbrominechlorine
Valinealdehydeesterethercyanofuranbrominechlorine
Valinealdehydeesterethercyanofuranbrominechlorine
Vitamin K5aldehydeesterethercyanofuranbrominechlorine
Vitamin K5aldehydeesterethercyanofuranbrominechlorine
Xylitolaldehydeesterethercyanofuranbrominechlorine
Co-crystal FormerInteracting Group
1,5-Napthalene-disulfonic Acid
1-Hydroxy-2-naphthoic acidpyridinecyanon-heterocyclicketonephosphate esterfluorinecarbamate
1-Hydroxy-2-naphthoic acidpyridinecyanon-heterocyclicketonephosphate esterfluorinecarbamate
4-Aminobenzoic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
4-Aminobenzoic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
4-aminopyridines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
4-aminopyridine*brominehydroxamic acidcyanocarboxamide*sulfonic acid*phosphoric acidN-oxide
4-Chlorobenzene-Sulfonic
Acid
4-ethoxyphenyl Ureas-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
4-ethoxyphenyl Ureas-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
7-oxo-DHEApyridinecyanon-heterocyclicketonephosphate esterfluorinecarbamate
7-oxo-DHEAs-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Acesulfame
Acesulfames-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Acetohydroxamic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Acetohydroxamic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Acetohydroxamic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Adenines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Adenine*brominehydroxamic acidcyanocarboxamide*sulfonic acid*phosphoric acidN-oxide
Adipic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Alanines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Alanines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Allopurinaols-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Allopurinaols-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Arginines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Arginines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Ascorbic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Ascorbic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Ascorbic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Asparagines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Asparagines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Asparagines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Aspartic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Aspartic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Benzenesulfonic Acid
Benzoic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Caffeines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Camphoric acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Capric acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Genisteins-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Genisteinnitrosulfoneanaline
Genisteinesterethercarboxylic acidsulfatesulfonealcohol
Cinnamic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Citric Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Citric Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Clemizole*brominehydroxamic acidcyanocarboxamide*sulfonic acid*phosphoric acidN-oxide
Cyclamic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Cyclamic Acid
Cysteines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Cysteines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Cysteine
Dimethylglycines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Dimethylglycines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
D-riboseesterethercarboxylic acidsulfatesulfonealcohol
D-riboses-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Fumaric Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Galactaric acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Galactaric acidpyridinecyanon-heterocyclicketonephosphate esterfluorinecarbamate
Chrysins-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Chrysinnitrosulfoneanaline
Chrysinesterethercarboxylic acidsulfatesulfonealcohol
Gentisic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Gentisic acidnitrosulfoneanaline
Glucamine, N-methylpyridinecyanon-heterocyclicketonephosphate esterfluorinecarbamate
Glucamine, N-methyls-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Gluconic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Gluconic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glucosamines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glucuronic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glucuronic acidpyridinecyanon-heterocyclicketonephosphate esterfluorinecarbamate
Glucuronic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glutamic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glutamic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glutamines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glutamines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glutamines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glutaric Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glycines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glycines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glycolic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Glycolic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Hippuric Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Hippuric Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Hippuric Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Histidines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Histidines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Histidine
Hydroquinones-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Hydroquinonenitrosulfoneanaline
Imidazoles-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Ipriflavoneesterethercarboxylic acidsulfatesulfonealcohol
Ipriflavones-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Isoleucines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Isoleucines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
lactobionic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Lactobionic acidpyridinecyanon-heterocyclicketonephosphate esterfluorinecarbamate
Lactobionic acidesterethercarboxylic acidsulfatesulfonealcohol
Lauric acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Leucines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Leucines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Lysines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Lysines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Maleics-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Malic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Malic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Malonics-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Mandelic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Mandelic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Methionines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Methionines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Methionineesterethercarboxylic acidsulfatesulfonealcohol
Nicotinamide*brominehydroxamic acidcyanocarboxamide*sulfonic acid*phosphoric acidN-oxide
Nicotinamides-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Nicotinic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Nicotinic Acid*brominehydroxamic acidcyanocarboxamide*sulfonic acid*phosphoric acidN-oxide
Orotic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Orotic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Oxalic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Palmitic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Pamoic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Pamoic acidpyridinecyanon-heterocyclicketonephosphate esterfluorinecarbamate
Pamoic acidnitrosulfoneanaline
Phenylalanines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Phenylalanines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Piperazines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Procaines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Procaines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Prolines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Prolines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
p-Toluenesulfonic acid
Pyridoxamines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Pyridoxamines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Pyridoxamine*brominehydroxamic acidcyanocarboxamide*sulfonic acid*phosphoric acid N-oxide
Pyridoxine*brominehydroxamic acidcyanocarboxamide*sulfonic acid*phosphoric acidN-oxide
(4-Pyridoxic Acid)
Pyridoxines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
(4-Pyridoxic Acid)
Pyroglutamic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Pyroglutamic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Quercetins-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Quercetinnitrosulfoneanaline
Quercetinesterethercarboxylic acidsulfatesulfonealcohol
Resveratrols-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Resveratrolnitrosulfoneanaline
Saccharins-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Saccharins-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Saccharin
Saccharins-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Salicylic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Salicylic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Salicylic Acid, 4-aminos-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Salicylic Acid, 4-aminopyridinecyanon-heterocyclicketonephosphate esterfluorinecarbamate
Salicylic Acid, 4-aminos-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Sebacic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Serines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Serines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Serines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Stearic acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Succinic Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Tartaric Acids-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Threonines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Threonines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Threonines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Triss-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Triss-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Tryptophans-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Tryptophans-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Tryptophan*brominehydroxamic acidcyanocarboxamide*sulfonic acid*phosphoric acidN-oxide
Tyrosines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Tyrosines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Tyrosines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Ureas-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Ureas-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Ureas-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Valines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Valines-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Vitamin K5s-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Vitamin K5s-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Xylitols-heterocyclicpyridinecyanon-heterocyclicketonephosphate esterfluorine
Co-crystal FormerInteracting Group
1,5-Napthalene-disulfonic Acid
1-Hydroxy-2-naphthoic acidimidazoleBF4
1-Hydroxy-2-naphthoic acidimidazoleBF4
4-Aminobenzoic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
4-Aminobenzoic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
4-aminopyridinecarbamateimidazoleBF4N-SO2thioureaiodine
4-aminopyridineesteretherfluorineacetatethionedithiadiazocyclopentadienyl
4-Chlorobenzene-Sulfonic
Acid
4-ethoxyphenyl UreacarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
4-ethoxyphenyl UreacarbamateimidazoleBF4N-SO2thioureaiodine
7-oxo-DHEAimidazoleBF4
7-oxo-DHEAcarbamateimidazoleBF4N-SO2thioureaiodine
Acesulfame
AcesulfamecarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
Acetohydroxamic AcidcarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
Acetohydroxamic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Acetohydroxamic AcidcarbamateimidazoleBF4N-SO2thioureaiodineepoxide
AdeninecarbamateimidazoleBF4N-SO2thioureaiodine
Adenineesteretherfluorineacetatethionedithiadiazocyclopentadienyl
Adipic acidcarbamateimidazoleBF4N-SO2thioureaiodine
AlaninecarbamateimidazoleBF4N-SO2thioureaiodine
AlaninecarbamateimidazoleBF4N-SO2thioureaiodine
AllopurinaolcarbamateimidazoleBF4N-SO2thioureaiodineepoxide
AllopurinaolcarbamateimidazoleBF4N-SO2thioureaiodine
ArgininecarbamateimidazoleBF4N-SO2thioureaiodine
ArgininecarbamateimidazoleBF4N-SO2thioureaiodine
Ascorbic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Ascorbic AcidcarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Ascorbic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Asparaginecarbamateimidazole BF4N-SO2thioureaiodine
AsparaginecarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
AsparaginecarbamateimidazoleBF4N-SO2thioureaiodine
Aspartic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Aspartic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Benzenesulfonic Acid
Benzoic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
CaffeinecarbamateimidazoleBF4N-SO2thioureaiodine
Camphoric acidcarbamateimidazoleBF4N-SO2thioureaiodine
Capric acidcarbamateimidazoleBF4N-SO2thioureaiodine
GenisteincarbamateimidazoleBF4N-SO2thioureaiodine
Genistein
Genisteinphospphatecyanamide
Cinnamic acidcarbamateimidazoleBF4N-SO2thioureaiodine
Citric AcidcarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Citric AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Clemizoleesteretherfluorineacetatethionedithiadiazocyclopentadienyl
Cyclamic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Cyclamic Acid
CysteinecarbamateimidazoleBF4N-SO2thioureaiodine
CysteinecarbamateimidazoleBF4N-SO2thioureaiodine
Cysteine
Dimethylglycinecarbamateimidazole BF4N-SO2thioureaiodine
DimethylglycinecarbamateimidazoleBF4N-SO2thioureaiodine
D-ribosephospphatecyanamide
D-ribosecarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Fumaric AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Galactaric acidcarbamateimidazoleBF4N-SO2thioureaiodine
Galactaric acidimidazoleBF4
ChrysincarbamateimidazoleBF4N-SO2thioureaiodine
Chrysin
Chrysinphospphatecyanamide
Gentisic acidcarbamateimidazoleBF4N-SO2thioureaiodine
Gentisic acid
Glucamine, N-methylimidazoleBF4
Glucamine, N-methylcarbamateimidazoleBF4N-SO2thioureaiodine
Gluconic AcidcarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Gluconic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
GlucosaminecarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Glucuronic acidcarbamateimidazoleBF4N-SO2thioureaiodine
Glucuronic acidimidazoleBF4
Glucuronic acidcarbamateimidazoleBF4alkanearomaticN-SO2thioureaiodineepoxide
Glutamic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Glutamic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
GlutaminecarbamateimidazoleBF4N-SO2thioureaiodine
GlutaminecarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
GlutaminecarbamateimidazoleBF4N-SO2thioureaiodine
Glutaric AcidcarbamateimidazoleBF4N-SO2thioureaiodine
GlycinecarbamateimidazoleBF4N-SO2thioureaiodine
Glycinecarbamate imidazoleBF4N-SO2thioureaiodine
Glycolic AcidcarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Glycolic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Hippuric AcidcarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
Hippuric AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Hippuric AcidcarbamateimidazoleBF4N-SO2thioureaiodine
HistidinecarbamateimidazoleBF4N-SO2thioureaiodine
HistidinecarbamateimidazoleBF4N-SO2thioureaiodine
Histidine
HydroquinonecarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Hydroquinone
ImidazolecarbamateimidazoleBF4N-SO2thioureaiodine
Ipriflavonephospphatecyanamide
IpriflavonecarbamateimidazoleBF4N-SO2thioureaiodine
IsoleucinecarbamateimidazoleBF4N-SO2thioureaiodine
IsoleucinecarbamateimidazoleBF4N-SO2thioureaiodine
lactobionic acidcarbamateimidazoleBF4N-SO2thioureaiodine
Lactobionic acidimidazoleBF4
Lactobionic acidphospphatecyanamide
Lauric acidcarbamateimidazoleBF4N-SO2thioureaiodine
LeucinecarbamateimidazoleBF4N-SO2thioureaiodine
LeucinecarbamateimidazoleBF4N-SO2thioureaiodine
LysinecarbamateimidazoleBF4N-SO2thioureaiodine
LysinecarbamateimidazoleBF4N-SO2thioureaiodine
MaleiccarbamateimidazoleBF4N-SO2thioureaiodine
Malic AcidcarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Malic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
MaloniccarbamateimidazoleBF4N-SO2thioureaiodine
Mandelic AcidcarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Mandelic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
MethioninecarbamateimidazoleBF4N-SO2thioureaiodine
MethioninecarbamateimidazoleBF4N-SO2thioureaiodine
Methioninephospphate
Nicotinamideesteretherfluorineacetatethionedithiadiazocyclopentadienyl
NicotinamidecarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
Nicotinic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Nicotinic Acidesteretherfluorineacetatethionedithiadiazocyclopentadienyl
Orotic acidcarbamateimidazoleBF4N-SO2thioureaiodine
Orotic acidcarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
Oxalic acidcarbamateimidazoleBF4N-SO2thioureaiodine
Palmitic acidcarbamateimidazoleBF4N-SO2thioureaiodine
Pamoic acidcarbamateimidazoleBF4N-SO2thioureaiodine
Pamoic acidimidazoleBF4
Pamoic acid
PhenylalaninecarbamateimidazoleBF4N-SO2thioureaiodine
PhenylalaninecarbamateimidazoleBF4N-SO2thioureaiodine
PiperazinecarbamateimidazoleBF4N-SO2thioureaiodine
ProcainecarbamateimidazoleBF4N-SO2thioureaiodine
ProcainecarbamateimidazoleBF4N-SO2thioureaiodine
ProlinecarbamateimidazoleBF4N-SO2thioureaiodine
ProlinecarbamateimidazoleBF4N-SO2thioureaiodine
p-Toluenesulfonic acid
PyridoxaminecarbamateimidazoleBF4N-SO2thioureaiodineepoxide
PyridoxaminecarbamateimidazoleBF4N-SO2thioureaiodine
Pyridoxamineesteretherfluorineacetatethionedithiadiazocyclopentadienyl
Pyridoxineesteretherfluorineacetatethionedithiadiazocyclopentadienyl
(4-Pyridoxic Acid)
PyridoxinecarbamateimidazoleBF4N-SO2thioureaiodineepoxide
(4-Pyridoxic Acid)
Pyroglutamic acidcarbamateimidazoleBF4N-SO2thioureaiodine
Pyroglutamic acidcarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
QuercetincarbamateimidazoleBF4N-SO2thioureaiodine
Quercetin
Quercetinphospphatecyanamide
ResveratrolcarbamateimidazoleBF4N-SO2thioureaiodine
Resveratrol
SaccharincarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
SaccharincarbamateimidazoleBF4N-SO2thioureaiodine
Saccharin
SaccharincarbamateimidazoleBF4N-SO2thioureaiodine
Salicylic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Salicylic AcidcarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Salicylic Acid, 4-aminocarbamateimidazoleBF4N-SO2thioureaiodine
Salicylic Acid, 4-aminoimidazoleBF4
Salicylic Acid, 4-aminocarbamateimidazoleBF4N-SO2thioureaiodine
Sebacic acidcarbamateimidazoleBF4N-SO2thioureaiodine
SerinecarbamateimidazoleBF4N-SO2thioureaiodine
SerinecarbamateimidazoleBF4N-SO2thioureaiodine
SerinecarbamateimidazoleBF4N-SO2thioureaiodineepoxide
Stearic acidcarbamateimidazoleBF4N-SO2thioureaiodine
Succinic AcidcarbamateimidazoleBF4N-SO2thioureaiodine
Tartaric AcidcarbamateimidazoleBF4N-SO2thioureaiodine
ThreoninecarbamateimidazoleBF4N-SO2thioureaiodine
ThreoninecarbamateimidazoleBF4N-SO2thioureaiodine
ThreoninecarbamateimidazoleBF4N-SO2thioureaiodineepoxide
TriscarbamateimidazoleBF4N-SO2thioureaiodine
TriscarbamateimidazoleBF4N-SO2thioureaiodineepoxide
TryptophancarbamateimidazoleBF4N-SO2thioureaiodine
TryptophancarbamateimidazoleBF4N-SO2thioureaiodine
Tryptophanesteretherfluorineacetatethionedithiadiazocyclopentadienyl
TyrosinecarbamateimidazoleBF4N-SO2thioureaiodine
TyrosinecarbamateimidazoleBF4N-SO2thioureaiodine
TyrosinecarbamateimidazoleBF4N-SO2thioureaiodineepoxide
UreacarbamateimidazoleBF4N-SO2thioureaiodine
UreacarbamateimidazoleBF4N-SO2thioureaiodine
UreacarbamateimidazoleBF4N-SO2thioureaiodineepoxideperoxide
ValinecarbamateimidazoleBF4N-SO2thioureaiodine
ValinecarbamateimidazoleBF4N-SO2thioureaiodine
Vitamin K5carbamateimidazoleBF4N-SO2thioureaiodine
Vitamin K5carbamateimidazoleBF4N-S02thioureaiodineepoxide
XylitolcarbamateimidazoleBF4N-SO2thioureaiodineepoxide

TABLE III
Functional GroupFunctional Group StructureInteracting Group
pyridine[Figure (not displayed)]
*alcoholpyridinium*amidenitro*amine*carboxilic acid
imidazol[Figure (not displayed)]
imidazolechlorineacetamidecarboxylatethionenitro
Hydroxamic acid[Figure (not displayed)]
hydroxamic acidalcoholphosphinic esteralkanepyridineamide
peroxideR—O—OHesterperoxideamideetheralkaneN-heterocycle
epoxide[Figure (not displayed)]
alkanebrominealcoholesterepoxideamide
thioester[Figure (not displayed)]
aromaticthioesteralkanesulfamidehydroxybromine
thioketone[Figure (not displayed)]
alkanethioketoneketoneSULFAMIDEAMINEthiol
Functional Group
pyridine*sulfonamide*ketoneethertriazolealkaneammoniumoxime*chlorinealkyne
imidazolecyanamideketonecyanocarboxilicalcoholalkanethiolaminephosphinic
acidacid
hemihydrate
Hydroxamic acidsulfonamidecarboxylatephosphineaminearomatic
peroxidearomaticalcoholpyrimidinedioneanalinethiazoleperoxy acidketonecarboxilic acidazide
epoxidealkenehydrazonearomaticthioetherketonealdehydechlorinecarboxilic acidalkyne
thioesteriodineaminecyanothioketoneamidechlorinenitro
thioketonesulfoxideoxochlorinebromineAROMATICalkenesulfoneiodineAZOXY
pyridinthioln-heterocyclic ringthionedisulfidepyrrolidindioneiodinehydrazonethiocyanate*brominearomatic
imidazolechlorinesulfonylsulfoxideamidefluorinesulfonate ester
Hydroxamic acid
peroxidephosphine oxidesulfonamideanaline
epoxideammoniumfluorinenitroaminecyano
thio ster
thioketonepotassiumepoxiden-oxidecyanoironcobaltaminesulfate
pyridinehydroxamic acidcyanocarboxamide*sulfonic acid*phosphoric acidN-oxideesteretherfluorineacetatethione
imidazole
Hydroxamic acid
peroxide
epoxide
thioester
thioketone
pyridinedithiadiazocyclop
entadienyl
imidazole
Hydroxamic acid
peroxide
epoxide
thioester
thioketone
Functional GroupFunctional Group StructureInteracting Group
nitrate ester[Figure (not displayed)]
aromaticamidealkanechlorinenitrate esterbromine
Thiophosphate ester-O[Figure (not displayed)]
amineimidazolecyclic amide
Phosphate ester[Figure (not displayed)]
aromaticalcoholphosphate esteraromatic N- ringpyridineanaline
Ketone[Figure (not displayed)]
alcoholketonethiolamideamineanaline
Aldehyde[Figure (not displayed)]
alcoholketonethiolamideamineanaline
ThiolR—SHcarboxylic acidsodiumaldehydeketonearomatic-Ncadmium
AlcoholR—OHalcoholketonethiolamideamineanaline
Functional Group
nitrate est ralcoholetheracetate
Thiophosphate
ester-O
Phosphate esteraminesodiumpotassiumlithiumcarboxylicamidealkane
acid
Ketonephenolphosphatesulfatesulfonenitratepyridinearomaticcarboxilic acidmetals
Aldehydephenolphosphatesulfatesulfonenitratepyridinearomaticcarboxilic acidmetals
ThiolalkanearsenicchlorinealcoholpotassiumRuaromaticRbSb
Alcoholphenolphosphatesulfatesulfonenitratepyridinearomaticcarboxilic acidmetals
nitrate ester
Thiophosphate
ester-O
Phosphate ester
Ketonealdehydeesterethercyanofuranbrominechlorines-heterocyclic
Aldehydealdehydeesterethercyanofuranbrominechlorines-heterocyclic
Thiol
Alcoholaldehydeesterethercyanofuranbrominechlorines-heterocyclic
nitrate ester
Thiophosphate
ester-O
Phosphate ester
Ketonepyridinecyanon-heterocyclicketonephosphatefluorinecarbamateimidazoleBF4alkane
ester
Aldehydepyridinecyanon-heterocyclicketonephosphatefluorinecarbamateimidazoleBF4alkane
ester
Thiol
Alcoholpyridinecyanon-heterocyclicketonephosphatefluorinecarbamateimidazoleBF4alkane
ester
nitrat ester
Thiophosphate
st r-O
Phosphate ester
KetonearomaticN-SO2thioureaiodine
AldehydearomaticN-SO2thioureaiodineepoxide
Thiol
AlcoholaromaticN-SO2thioureaiodineepoxide
Functional GroupFunctional Group StructureInteracting Group
Thioether[Figure (not displayed)]
aromatic-Namideaminearomatic_sSp2 aminesulfoxide
Ether[Figure (not displayed)]
aromatic-Namideaminearomatic_sSp2 aminesulfoxide
Cyanamide[Figure (not displayed)]
cyanoaminepotassiumaromatic-Nbrominesodium
Thiocyanate[Figure (not displayed)]
aromatic-Sesterether
sP2 amine[Figure (not displayed)]
thioetherethermetalsMoOCl4BF4bromine
Amine primaryR—NH2alcoholketonethiolamideamineanaline
Amine secondaryR2—NHalcoholketonethiolamideamineanaline
Functional Group
Thioetherchloratechlorinealkynecyanoesteraminenitronitratebromine
Etherchloratechlorinealkynecyanoesteraminenitronitratebromine
Cyanamideimidazoleethern-heterocyclicalcoholcesiumAg
Thiocyanate
sP2 aminechlorineSp2 aminesulfateOsmium
Amin primaryphenolphosphatesulfatesulfonenitratepyridinearomaticcarboxilic acidmetals
Amine secondaryphenolphosphatesulfatesulfonenitratepyridinearomaticcarboxilic acidmetals
ThioetheraldehydeketoneperoxideepoxideAgSehetero-iodineester
cyclic-S
EtheraldehydeketoneperoxideepoxideAgSehetero-iodineester
cyclic-S
Cyanamide
Thiocyanate
sP2 amine
Amine primaryaldehydeesterethercyanofuranbrominechlorines-heterocyclic
Amine secondaryaldehydeesterethercyanofuranbrominechlorines-heterocyclic
Thioetherethercarboxylicsulfatesulfonealkanealcoholphospphate
acid
Etherethercarboxylicsulfatesulfonealkanealcoholphospphatecyanamide
acid
Cyanamide
Thiocyanate
sP2 amine
Amine primarypyridinecyanon-heterocyclicketonephosphatefluorinecarbamateimidazoleBF4alkane
ester
Amine secondarypyridinecyanon-heterocyclicketonephosphatefluorinecarbamateimidazoleBF4alkane
ester
Thioether
Ether
Cyanamide
Thiocyanate
sP2 amine
Amine primaryaromaticN-SO2thioureaiodine
Amine secondaryaromaticN-SO2thioureaiodine
Functional GroupFunctional Group StructureInteracting Group
Amin t rtiaryR3—Nalcoholketonethiolamideamineanaline
Amide[Figure (not displayed)]
alcoholketonethiolamideamineanaline
Sulfonic acid[Figure (not displayed)]
pyridineketonealdehydeetheresteramide
Phosphinic acid[Figure (not displayed)]
alkanepotassiumlithiumn-heterocyclicoximeamide
Phosphonic acid[Figure (not displayed)]
alkanepotassiumlithiumn-heterocyclicoximeamide
Carboxylic acid[Figure (not displayed)]
alcoholketonethiolamideamineanaline
Functional Group
Amine tertiaryphenolphosphatesulfatesulfonenitratepyridinearomaticcarboxilic acidmetals
Amidephenolphosphatesulfatesulfonenitratepyridinearomaticcarboxilic acidmetals
Sulfonic acidcarboxilic acidaminemetalsthioethersulfatealcohol
Phosphinic acidphenolaromaticaminealcoholmetals
Phosphonic acidphenolaromaticaminealcoholmetalscarboxylicSp2 amineanaline
acid
Carboxylic acidphenolphosphatesulfatesulfonenitratepyridinearomaticcarboxilic acidmetals
Amine tertiaryaldehydeesterethercyanofuranbrominechlorines-heterocyclic
Amidealdehydeesterethercyanofuranbrominechlorines-heterocyclic
Sulfonic acid
Phosphinic acid
Phosphonic acidetherphosphonicaromatic-Nketonealdehydeimidazole
acid
Carboxylic acidaldehydeesterethercyanofuranbrominechlorines-heterocyclic
Amine tertiarypyridinecyanon-heterocyclicketonephosphatefluorinecarbamateimidazoleBF4alkane
ester
Amidepyridinecyanon-heterocyclicketonephosphatefluorinecarbamateimidazoleBF4alkane
ester
Sulfonic acid
Phosphinic acid
Phosphonic acid
Carboxylic acidpyridinecyanon-heterocyclicketonephosphatefluorinecarbamateimidazoleBF4alkane
ester
Amine tertiaryaromaticN-SO2thioureaiodine
AmidearomaticN-SO2thioureaiodineepoxideperoxide
Sulfonic acid
Phosphinic acid
Phosphonic acid
Carboxylic acidaromaticN-SO2thioureaiodine
Functional GroupFunctional Group StructureInteracting Group
Sulfate ester[Figure (not displayed)]
pyridineketonealdehydeetheresteramide
Oxime[Figure (not displayed)]
alcoholalkaneamineamideetherester
Nitrile[Figure (not displayed)]
metalketonephenolalcoholcyano
Diazo[Figure (not displayed)]
Oxime
NitroNO2pyridineketonealdehydeetheresteramide
S-heterocyclic ring[Figure (not displayed)]
alcoholthioketonethioethers-heterocyclicketonearomatic
Thiophene[Figure (not displayed)]
chlorinefluorineamideketoneNOSO
Functional Group
Sulfate estercarboxilic acidaminemetalsthioethersulfatealcohol
Oximepyridinen-aromaticchloratechlorineSp2-Ndiazothioketonecyanon-oxide
Nitrileamineanalinebromineamidealkanecarboxylicchlorinen-heterocyclicaromatic
acid
Diazo
Nitrocarboxilic acidaminemetalsthioethersulfatealcohol
S-heterocyclic alkeneaminechlorineBF4sulfateesterNOetheramide
ring
ThiopheneCO
Sulfate ester
Oximeketonealdehydecarboxylic acidbrominearomaticpyridineBF4
Nitrilepotassiumaldehydethioetherpyridinen-aromaticbromineethers-aromaticthiophene
Diazo
Nitro
S-heterocyclic iodinecarboxylic sodiumcyanochloridefuran
ringacid
Thiophene
Sulfate ester
Oxime
Nitrile
Diazo
Nitro
S-heterocyclic
ring
Thiophene
Sulfate ester
Oxime
Nitrile
Diazo
Nitro
S-heterocyclic
ring
Thiophene
Functional GroupFunctional Group StructureInteracting Group
N-heterocyclic ring[Figure (not displayed)]
alcoholthioketonethioethers-heterocyclicketonearomatic
O-heterocyclic ring[Figure (not displayed)]
alcoholthioketonethioethers-heterocyclicketonearomatic
Pyrrole[Figure (not displayed)]
chlorinefluorineamideketoneNOSO
Furan[Figure (not displayed)]
s-heterocyclic
Functional Group
N-heterocyclic alkeneaminechlorineBF4sulfateesterNOetheramide
ring
O-heterocyclic alkeneaminechlorineBF4sulfateesterNOetheramide
ring
PyrroleCOimidazolepyridinen-aromaticaldehydecarboxylicsulfatechlorinebromine
acid
Furan
N-heterocyclic iodinecarboxylic sodiumcyanochloridealdehyde
ringacid
O-heterocyclic iodinecarboxylic sodiumcyanochloridealdehyde
ringacid
Pyrroleoximealcoholphenolesterether
Furan
N-heterocyclic
ring
O-heterocyclic
ring
Pyrrole
Furan
N-heterocyclic
ring
O-heterocyclic
ring
Pyrrol
Furan

TABLE IV
APIAPIPatentExample ofExample of
Generic NameChemical NameCAS No.ReferenceTherapeutic UseIndication
(−)-amlodipine 3,5-Pyridinedicarboxylic acid,103129-82-4WO9310779Antihypertensive,Hypertension,
2-((2-aminoethoxy)methyl)-4-(2-othergeneral
chlorophenyl)-1,4-dihydro-6-methyl-,
3-ethyl-5-methyl ester, (S)-[CAS]
(−)-halofenate(−)-Benzeneacetic acid, 4-chloro-Alpha-[3-U.S.6,262,118AntidiabeticDiabetes,
(trifluoromethyl)-phenoxy]-, 2-Type II
(acetylamino)ethyl ester
(R)-salbutamol1,3-Benzenedimethanol, Alpha1-(((1,1-Formulation, Asthma
dimethylethyl)amino)methyl)-4-hydroxy-modified-
[CAS]release, <=24 hr
(R)-salbutamol1,3-Benzenedimethanol, Alpha1-(((1,1-34391-04-3U.S.5,547,994AntiasthmaAsthma
dimethylethyl)amino)methyl)-4-hydroxy-
[CAS]
(R,R)-formoterolFormamide, N-(2-hydroxy-5-(1-hydroxy-2-67346-49-0U.S.5,795,564AntiasthmaAsthma
((2-(4-methoxyphenyl)-1-
methylethyl)amino)ethyl)phenyl)-(R-
(R*,R*))-[CAS]
(S)-doxazosin(S)-1-(4-amino-6,7-dimethoxy-2-70918-18-2WO9409785Prostate disordersBenign
quinazolinyl)-4-(1,4-benzodioxan-2-ylprostatic
carbonyl)piperazinehyperplasia
(S)-fluoxetineBenzenepropanamide, N-methyl-Gamma-AntimigraineMigraine
(4-(trifluoromethyl)phenoxy)-(S)
(S)-oxybutyninBenzeneacetic acid, Alpha-cyclohexyl-119618-22-3UrologicalIncontinence
Alpha-hydroxy-, 4-(diethylamino)-2-
butynyl ester, (S)-[CAS]
1,2-Naphthoquinone524-42-5
17α-Hydroxyprogesterone68-96-2
17-Methyltestosterone58-18-4
195mPt-cisplatinPlatinum-195m, diamminedichloro,U.S.6,074,626Anticancer, Cancer, liver
(SP-4-2)-alkylating
1α-Hydroxycholecalciferol41294-56-8
1-Naphthyl Salicylate550-97-0
1-Naphthylamine-4-84-86-6
sulfonic Acid
1-Theobromineacetic5614-56-2
Acid
2,4,6-Tribromo-m-cresol4619-74-3
2,6-Diamino-2′-butyloxy-617-19-6
3,5′-azopyridine
21-566-78-9
Acetoxypregnenolone
2-Amino-4-picoline695-34-1
2-Aminothiazole96-50-4
2-ethoxybenzoic acid2-Ethoxybenzoic acidDE5134001Analgesic, NSAIDPain, general
2-Naphthol135-19-3
2-Naphthyl Benzoate93-44-7
2-Naphthyl Lactate93-43-6
2-Naphthyl Salicylate613-78-5
2-p-80-02-4
Sulfanilylanilinoethanol
2-Thiouracil141-90-2
3′,3″,5′,5″-76-62-0
Tetra-
bromophenolphthalein
3-Amino-4-589-44-6
hydroxybutyric Acid
3-Bromo-d-camphor76-29-9
3-Hydroxycamphor10373-81-6
3-O-Lauroylpyridoxol1562-13-6
Diacetate
3-Pentadecylcatechol492-89-7
3-Quinuclidinol1619-34-7
4,4′-Oxydi-2-butanol821-33-0
4,4′-Sulfinyldianiline119-59-5
4-Amino-3-352-21-6
hydroxybutyric Acid
4-Amino-3-1078-21-3
phenylbutyric Acid
4-aminosalicylic acidBenzoic acid, 4-amino-2-hydroxy-[CAS]65-49-6GI inflammatory/Inflammatory
bowel disordersbowel
disease
4-Chloro-m-cresol59-50-7
4-Hexylresorcinol136-77-6
4-Salicyloylmorpholine3202-84-4
5′-Nitro-2′-553-20-8
propoxyacetanilide
5-aminolevulinic acid,Pentanoic acid, 5-amino-4-oxo- [CAS]106-60-5DermatologicalKeratosis
5-azacitidine1,3,5-Triaxin-2(1H)-one, 4-amino-1-β-D-320-67-2Anticancer, Myelodysplastic
ribofuransyl- [CAS]antimetabolitesyndrome
5-Bromosalicyl-5798-94-7
hydroxamic Acid
5F-DF-2032-(4-Amino-3-methylphenyl)-6-Anticancer, otherCancer, breast
hydroxybenzothiazole
5-FU2,4(1H,3H)-Pyrimidinedione, 5-fluoro51-21-8Formulation, Cancer, general
[CAS]parenteral,
targeted
5-HT3 antagonistsU.S.6,037,360Male sexual Premature
dysfunctionejaculation
6-Azauridine54-25-1
6-Mercaptopurine50-44-2
8-Hydroxyquinoline148-24-3
9-Aminocamptothecin91421-43-1
A-151892N[2-(2,2,2-Trifluoro-1-hydroxy-1-UrologicalOveractive
trifluoromethyl-ethyl)-naphthalen-1-yl]bladder
amide
α1-Antitrypsin9041-92-3
A-50216H-Purin-6-one, 2-amino-9-(((1S,2R)-1,2-145512-85-2Antiviral, otherInfection,
bis(hydroxymethyl)cyclopropyl)methyl)1,9-varicella
dihydro-[CAS]zoster virus
abacavir2-Cyclopentene-1-methanol, 4-(2-amino-6-136470-78-5EP434450Antiviral, anti-HIVInfection,
(cyclopropylamino)-9H-purin-9-yl)-, (1S-188062-50-2HIV/AIDS
cis)-[CAS]
abaperidone7-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-183849-43-6WO9632389NeurolepticSchizophrenia
yl)piperidin-1-yl]propoxy]-3-
(hydroxymethyl)chromen-4-one
abarelixD-Alaninamide, N-acetyl-3-(2-183552-38-7U.S.5,843,902Anticancer, Cancer,
naphthalenyl)-D-alanyl-4-chloro-D-hormonalprostate
phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-
seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-
leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-
[CAS]
Abciximab143653-53-6
Abecarnil111841-85-1
abetimus169147-32-4U.S.5,552,391ImmunosuppressantLupus
erythematosus,
systemic
abirateroneAndrosta-5,16-dien-3-ol, 17-(3-pyridinyl)-,154229-18-2GB2265624Anticancer, Cancer, prostate
acetate (ester), (3β)-[CAS]hormonal
α-Bisabolol515-69-5
ABLCAmphotericin B [CAS]1397-89-3Formulation, Infection,
30652-87-0conjugate,Candida, general
carbohydrate
ABT-751Benzenesulfonamide, N-[2-[(4-141430-65-1EP472053Anticancer, otherCancer, general
hydroxyphenyl)amino]-3-pyridinyl]-4-
methoxy-[CAS]
AC-5216N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-AnxiolyticAnxiety, general
8-oxo-2-phenyl-9H-purin-9-yl)acetamide
Acadesine2627-69-2
acamprosate1-Propanesulfonic acid, 3-(acetylamino)-77337-76-9GB2051789Dependence Addiction,
[CAS]treatmentalcohol
Acamprosate77337-73-6
Acarbose56180-94-0
acebrophylline7H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-96989-76-3DE3425007AntiasthmaAsthma
1,3-dimethyl-2,6-dioxo-,compd. with trans-
4-[[(2-amino-3,5-
dibromophenyl)methyl]amino]cyclohexanol
(1:1)[CAS]
acebutololButanamide, N-[3-acetyl-4-[2-hydroxy-3-34381-68-5U.S.3,726,919Antihypertensive,
[(1-methylethyl)amino]propoxy]phenyl]-,37517-30-9adrenegic
(+/−)-[CAS]
Acecainide32795-44-1
Acecarbromal77-66-7
aceclofenacBenzeneacetic acid, 2-[(2,6-89796-99-6EP119932Anti-inflammatoryPain,
dichlorophenyl)amino]-, carboxymethylmusculoskeletal
ester[CAS]
Acedapsone77-46-3
Acediasulfone80-03-5
Acefylline652-37-9
Aceglutamide2490-97-3
aceglutamideAluminum, pentakis(N2-acetyl-L-12607-92-0DE2127176AntiulcerUlcer, GI,
glutaminoato)tetrahydroxytri-[CAS]general
acemetacin1H-Indole-3-acetic acid, 1-(4-53164-05-9U.S.3,910,952Anti-inflammatory
chlorobenzoyl)-5-methoxy-2-methyl-,
carboxymethyl ester [CAS]
Acenocoumarol152-72-7
Acetal105-57-7
Acetamidoeugenol305-13-5
Acetaminophen103-90-2
Acetaminosalol118-57-0
Acetanilide103-84-4
Acetarsone97-44-9
Acetazolamide59-66-5
Acetiamine299-89-8
Acetohexamide968-81-0
Acetohydroxamic Acid546-88-3
Acetophenazine2751-68-0
Acetophenone98-86-2
Acetosulfone128-12-1
acetoxoloneOlean-12-en-30-oic acid, 3β-hydroxy-11-29728-34-5U.S.3,764,618Antiulcer
oxo-acetate, aluminium salt [CAS]6277-14-1
Acetrizoat129-63-5
Acetyl3590-05-4
Sulfamethoxypyrazine
Acetylcarnitine14992-62-2
Acetylcholine66-23-9
Acetylcholine60-31-1
Acetylcysteine616-91-1
Acetylleucine149-90-6
Monoethanolamine
Acetylpheneturide13402-08-9
acetylsalicylic acidBenzoic acid, 2-(acetyloxy)-[CAS]50-78-2Formulation, Pain, general
53075-6optimized,
microencapsulate
α-Chloralose15879-93-3
aciclovir6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2-59277-89-3Formulation, Infection, herpes
hydroxyethoxy)methyl]-[CAS]dermal,topicalsimplex virus
Acifran72420-38-3
acipimoxPyrazinecarboxylic acid, 5-methyl-, 4-oxide51037-30-0GB1361967Hypolipaemic/Hyper-
[CAS]Antiatherosclerosislipidaemia,
general
acitazanolastAcetic acid, oxo[[3-(1H-tetrazol-5-114607-46-4EP256507OphthalmologicalConjunctivitis
yl)phenyl]amino]-[CAS]
acitretin2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-55079-83-9SB1468401AntipsoriasisPsoriasis
2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)
[CAS]
aclarubicin57576-44-0U.S.3,988,315Anticancer,
75443-99-1antibiotic
Aclatonium55077-30-0
Napadisilate
Aconitine302-27-2
Acranil ®1684-42-0
Acriflavine8048-52-0
Acrisorcin7527-91-5
acrivastine2-Propenoic acid, 3-[6-[1-(4-methylphenyl)-87848-99-5EP85959Antipruritic/Rhinitis, allergic,
3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-,inflamm, allergicgeneral
(E,E)-[CAS]
acrivastine +Benzenemethanol, Alpha-[1-Antiallergic, Rhinitis, allergic,
pseudoephedrine(methylamino)ethyl]-, hydrochloride, [S-non-asthmaseasonal
(R*,R*)]-, mixtwith 2-Propenoic acid, 3-[6-
[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-
propenyl]-2-pyridinyl]-, (E,E)-
actagardine derivative3,3-dimethyl-1-propylamide HClPeptide antibioticInfection,
monocarboxamide actagardinegeneral
Actarit18699-02-0
ACTH900-60-2
Acyclovir59277-89-3
adapalene2-Naphthalenecarboxylic acid, 6-(4-106685-40-9EP199636AntiacneAcne
methoxy-3-tricyclo[3.3.1.13,7]dec-1-
ylphenyl)-[CAS]
ADCON-LGL 402 [CAS]137802-74-5Formulation, otherFibrosis,
epidural
Adefovir106941-25-7
adefovir dipivoxilPropanoic acid, 2,2-dimethyl-, (((2-(-6-142340-99-6EP205826Antiviral, otherInfection,
amino-9H-purin-9-hepatitis-
yl)ethoxy)methyl)phosphinylidene)bis(oxyB virus
methylene)ester-[CAS]
Adenoscan6-Amino-9-β-D-ribofuranosyl-9H-purine58-61-7Imaging agentDiagnosis,
[CAS]coronary
Adenosine Triphosphate56-65-5
ADEPT156079-88-8Immunoconjugate,Cancer,
othercolorectal
Adinazolam37115-32-5
Adiphenine64-95-9
ADL-10-0101WO9732857Analgesic, otherPain, general
Adrafinil63547-13-7
Adrenalone99-45-6
Adrenochrome54-06-8
adrogolideBenzo(f)thieno(2,3-c)quinoline-9,10-diol,166591-11-3U.S.5,597,832Dependence Addiction,
4,5,5a,6,7,11b-hexahydro-2-propyl-,171752-56-0treatmentcocaine
diacetate (ester), hydrochloride (5aR-
trans)-[CAS]
AEOL-10150U.S.6,103,714NeuroprotectiveUnspecified
AET56-10-0
α-Ethylbenzyl Alcohol93-54-9
AF-2259Benzeneacetic acid, Alpha-methyl-4-(2-66332-77-2DE2726435Anti-inflammatoryInflammation,
methylpropyl)-, 2-methoxyphenyl estergeneral
[CAS]
Afloqualone56287-74-2
AG-041R1H-Indole-3-acetamide, 1-(2,2-199800-49-2WO9419322Alimentary/Unspecified
diethoxyethyl)-2,3-dihydro-N-(4-Metaboloc, other
methylphenyl)-3-((((4-
methylphenyl)amino)carbonyl)amino-2-
oxo-, (3R)-[CAS]
AG-2037N-(5-[2-(2-amino-4(3H)-oxo-5,6,7,8-Anticancer,Cancer, general
tetrahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]-antimetabolite
4-methylthieno-2-yl)glutamic acid
α-Glucose-1-59-56-3
phosphate
AGN-194310Benzoic acid, 4-((4-(4-ethylphenyl)-2,2-229961-45-9WO9709297DermatologicalPsoriasis
dimethyl-2H-1-benzothiopyran-6-
yl)ethynyl)-[CAS]
agomelatineAcetamide, N-(2-(7-methoxy-1-138112-76-2EP447285AntidepressantSleep disorder,
naphthalenyl)ethyl)-[CAS]general
Ahistan518-61-6
AHL-157U.S.5,411,972Hypolipaemic/Atherosclerosis
Antiatherosclerosis
AIT-0349H-Purine-9-propanamide, 1,6-dihydro-6-138117-48-3U.S.5,447,939Cognition enhancerDementia,
oxo-N-(3-(2-oxo-1-pyrrolidinyl)propyl)-senile,
[CAS]general
AIT-202N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]-3-(6-WO9957120AntidepressantUnspecified
oxo-6,9-dihydro-1H-purin-9-yl)propion-
amide
AJ-9677Acetic acid, ((3-((2R)-2-(((2R)-2-(3-244081-42-3AntidiabeticDiabetes,
chlorophenyl)-2-Type II
hydroxyethyl)amino)propyl)-1H-indol-7-
yl)oxy)-[CAS]
AJG-049WO9733885GastroprokineticMotility
dysfunction,
GI, general
Ajmaline12/07/4360
Alacepril74258-86-9
albaconazole4(3H)-Quinazolinone, 7-chloro-3-[(1R,2R)-187949-02-6WO9705131AntifungalInfection,
2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-Candida,
3-(1H01,2,4-triazol-1-yl)propyl]-[CAS]general
albendazoleCarbamic acid, [5-(propylthio)-1H-54029-12-8GB1454326AnthelminticInfection,
benzimidazol-2-yl]-, methyl ester [CAS]54965-21-8helminth,
Albuterol18559-94-9general
Albutoin830-89-7
alclofenacBenzeneacetic acid, 3-chloro-4-(2-22131-79-9GB1174535Anti-inflammatory
propenyloxy)-[CAS]
alclometasonePregna-1,4-diene-3,20-dione, 7-chloro-11-66734-13-2U.S.4,124,707Antipruritic/Inflammation,
hydroxy-16-methyl-17,21-bis(1-67452-97-5inflamm, allergicdermal
oxopropoxy)-, (7Alpha, 11β, 16Alpha)-
[CAS]
Alcuronium23214-96-2
Aldioxa5579-81-7
Aldol107-89-1
Aldosterone52-39-1
alendronatePhosphonic acid, (4-amino-1-121268-17-5GB2118042OsteoporosisOsteoporosis
hydroxybutylidene)bis-[CAS]129318-43-0treatment
Alendronic Acid66376-36-1
Alexidine22573-93-9
alfacalcidol9,10-Secocholesta-5,7,10(19)-triene-1,3-41294-56-8Osteoporosis Osteodystrophy
diol, (1Alpha,3β,5Z,7E)-[CAS]treatment
Alfadolone23930-37-2
Alfaxalone23930-19-0
Alfentanil71195-58-9
alfimeprase259074-76-5FibrinolyticPeripheral
vascular
disease
alfuzosin2-Furancarboxamide, N-[3-[(4-amino-6,7-81403-68-1GB2013679Prostate disordersBenign prostatic
dimethoxy-2-quinazolinyl)methylamino]-81403-80-7hyperplasia
tetrahydro-[CAS]
alfuzosin2-Furancarboxamide, N-[3-[(4-amino-6,7-81403-68-1
dimethoxy-2-quinazolinyl)methylamino]-81403-80-7Formulation, Benign prostatic
propyl]tetrahydro-[CAS]modified-release, hyperplasia
Algestone595-77-7other
Algestone24356-94-3
Acetophenide
Algin9005-38-3
Alglucerase143003-46-7
Alibendol26750-81-2
aliskiren(2S,4S,5S,7S)-5-Amino-N-(2-carbamoyl-2-173334-57-1Antihypertensive,Hypertension,
methylpropyl)-4-hydroxy-2-isopropyl-7-[4-renin systemgeneral
methoxy-3-(3-methoxypropoxy)benzyl]-8-
methylnonanamide
alitertinoin9-cis retinoic acid03/08/5300Antipruritic/Eczema, general
inflamm, allergic
alizapride1H-Benzotriazole-5-carboxamide, 6-59338-93-1GB1475234AntiemeticNausea and
methoxy-N-[[1-(2-propenyl)-2-vomiting,
pyrrolidinyl]methyl]-[CAS]general
Alkannin517-88-4
Alkofanone7527-94-8
Allantoin97-59-6
Allobarbital52-43-7
Allopurinol315-30-0
Allyl Isothiocyanate57-06-7
Allylestrenol432-60-0
almagateMagnesium, [carbonato(2-)]heptahydroxy-66827-12-1U.S.4,447,417Antacid/
(aluminum)tri-, dihydrate72526-11-5Antiflatulent
[CAS]
alminoprofenBenzeneacetic acid, Alpha-methyl-4[(2-39718-89-3U.S.3,957,850Analgesic, NSAID
methyl-2-propenyl)amino]-[CAS]
almitrine1,3,5-Triazine-2,4-diamine, 6-[4-[bis(4-27469-53-0GB1256513RespiratoryBronchitis,
fluorophenyl)methyl]-1-piperazinyl]-N,N′-di-29608-49-9chronic
2-propenyl-, dimethanesulfonate [CAS]
almotriptanPyrrolidine, 1-(((3-(2-(dimethylamino)ethyl)-154323-57-6WO9402460AntimigraineMigraine
1H-indol-5-yl)methyl)sulfonyl)-[CAS]
Aloe-Emodin481-72-1
Aloin5133-19-7
alosetron2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-122852-42-0EP306323GI inflammatory/Irritable bowel
1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-122852-69-1bowel disorderssyndrome
b]indol-1-one [CAS]132414-02-9
alovudineThymidine, 3′-deoxy-3′-fluoro-[CAS]25526-93-6EP470355Antiviral, anti-HIVInfection,
HIV/AIDS
Aloxiprin9014-67-9
Alpha-1 proteaseU.S.5,780,014Formulation,Emphysema,
inhibitorinhalable, topicalalpha-1
antitrypsin
deficiency
Alpha-Ergocryptine, 9,10-dihydro-29261-93-6Formulation, otherParkinson's
dihydroergocryptinemethanesulfonate (salt)-[CAS]disease
Alphaprodine77-20-3
Alpidem82626-01-5
Alpiropride81982-32-3
alprazolam4H-[1,2,4]Triazolo[4,3-a][1,4]-28981-97-7U.S.3,987,052AnxiolyticAnxiety,
benzodiazepine, 8-chloro-1-methyl-general
6-phenyl-[CAS]
Alprenolol13655-52-2
alsactideAlpha-1-17-Carticotropin, 1-β-alanine-17-34765-96-3U.S.3,749,704ACTHArthritis,
[N-(4-aminobutyl)-L-lysinamide]-[CAS]rheumatoid
ALT-711Thiazolium, 4,5-dimethyl-3-(2-oxo-2-181069-80-7WO9622095Symptomatic Hypertension,
phenylethyl)-, bromide [CAS]antidiabeticgeneral
Althiazid5588-16-9
altiniclinePyridine, 3-ethynyl-5-((2S)-1-methyl-2-179120-92-4U.S.5,594,011AntiparkinsonianParkinson's
pyrrolidinyl)-[CAS]disease
altretamine1,3,5-Triazine-2,4,6-triamine,645-05-6U.S.3,424,752Anticancer, Cancer,
N,N,N′,N′,N″,N″-hexamethyl-[CAS]alkylatingovarian
aluminium chlorideAluminium chloride, hexahydrate7446-70-0DermatologicalHyperhidrosis
hexahydrate7784-13-6
Aluminon569-58-4
Aluminum Acetate8006-13-1
Solution
Aluminum Chlorate15477-33-5
Aluminum1327-41-9
Hydroxychloride
Aluminum Potassium10043-67-1
Sulfate
Aluminum Sodium10102-71-3
Sulfate
alusulfAluminum hydroxide sulfate61115-28-4DE2510663UrologicalHyperphos-
(AI7(OH)17(SO4)2), dodecahydrate [CAS]phataemia
Alverine150-59-4
alvimopanGlycine, N-[(2S)-2-[[(3R,4R)-4-(3-156053-89-3EP657428GI inflammatory/Ileus
hydroxyphenyl)-3,4-dimethyl-1-bowel disorders
piperidinyl]methyl]-1-oxo-3-phenylpropyl]-
[CAS]
alvocidib4H-1-Benzopyran-4-one, 2-(2-131740-09-5Anticancer, otherCancer, renal
chlorophenyl)-5,7-dihydroxy-8-(3-hydroxy-146426-40-6
1-methyl-4-piperidinyl)-, cis-(−)-[CAS]
ALX-0646WO9506638AntimigraineMigraine
AM-242,4,6-Triiodophenol609-23-4GI inflammatory/Crohn's disease
bowel disorders
AM-361-Piperazineethanol, 4-[[3,5-bis(1,1-199467-52-2NeuroprotectiveUnspecified
dimethylrthyl)-4-hydroxyphenyl]methyl]-
Alpha-(4-chlorophenyl)-[CAS]
AM-4772-MethoxyoestradiolAntiasthmaAsthma
Amantadine768-94-5
amantanium1-Decanaminium, N,N-dimethyl-N-[2-58158-77-3U.S.4,288,609AntifungalInfection,
[(tricyclo[3.3.1.13,7]dec-1-general
ylcarbonyl)oxy]ethyl]-, bromide [CAS]
Ambazon539-21-9
Ambenonium115-79-7
ambrisentan(+)-(2S)-2-[(4,6-dimethylpyrimidin-2-yl)-177036-94-1Vasodilator,Heart failure
oxy]-3-methoxy-3,3-diphenylpropanoic acidperipheral
ambroxolCyclohexanol, 4-[[(2-amino-3,5-18683-91-5GB1178034COPD treatmentBronchitis,
dibromophenyl)methyl]amino]-, trans-23828-92-4chronic
[CAS]
Ambucaine119-29-9
Ambuphylline5634-34-4
Ambusid3754-19-6
Ambutonium Bromide115-51-5
amcinonidePregna-1,4-diene-3,20-dione, 21-51022-69-6DE2437847Antipsoriasis
(acetyloxy)-16,17-
[cyclopentylidenebis(oxy)]-9-fluoro-11-
hydroxy-, (11β, 16Alpha)-[CAS]
AMD-31001,4,8,11-Tetraazacyclotetradecane, 1,11-155148-31-5U.S.5,612,478HaematologicalChemotherapy-
(1,4-phenylenebis(methylene))bis-,induced injury,
octahydrochloride [CAS]bone marrow,
Amdinocillin32887-01-7leucopenia
Amdinocillin Pivoxil32886-97-8
amdoxovir1,3-Dioxolane-2-methanol, 4-(2,6-diamino-145514-04-1EP656778Antiviral, anti-HIVInfection,
9H-purin-9-yl)-(2R-cis)-[CAS]HIV/AIDS
amelubantCarbamic acid, ((4-((3-((4-(1-(4-346735-24-8DE10000907COPD treatmentChronic
hydroxyphenyl)-1-obstructive
methylethyl)phenoxy)methyl)phenyl)-pulmonary
methoxy)phenyl)iminomethyl)-ethyl esterdisease
[CAS]
AmericaineBenzenemethanaminium, N,N-dimethyl-N-129128-13-8Formulation, Pain, general
[2-[2-[4-(1,1,3,3-inhalable, other
tetramethylbutyl)phenoxy]ethoxy]ethyl]-,
chloride, mixt. with ethyl 4-aminobenzoate
[CAS]
Amezinium30578-37-1
Amfenac51579-82-9
Amidephrine3354-67-4
Amidinomycin3572-60-9
amifostineEthanethiol, 2-[(3-aminopropyl)amino]-,20537-88-6EP131500Radio/Chemotherapy-
dihydrogen phosphate (ester)-[CAS]63717-27-1chemoprotectiveinduced injury,
renal
amiglumidePentanoic acid, 5-(dipentylamino)-4-((2-119363-62-1WO8805774GI inflammatory/Pancreatitis
naphthalenylcarbonyl)amino)-5-oxo-(R)-bowel disorders
[CAS]
amikacin37517-28-5Formulation, Infection,
39831-55-5optimized,general
microencapsulate
Amiloride2609-46-3
Aminacrine90-45-9
amineptineHeptanoic acid, 7-[(10,11-dihydro-5H-30272-08-3U.S.3,758,528Antidepressant
dibenzo[a,d]cyclohepten-5-yl)amino]-57574-09-1
[CAS]
Aminitrozole140-40-9
Amino Acid
Preparations
Aminocaproic Acid
aminoglutethimide2,6-Piperidinedione, 3-(4-aminophenyl)-3-125-84-8U.S.3,944,671Anticancer, Cancer, breast
ethyl-[CAS]hormonal
Aminoguanidine79-17-4
Aminohippurate
Aminometradine642-44-4
Aminopentamide60-46-8
aminophylline1H-Purine-2,6-dione, 3,7-dihydro-1,3-317-34-0Formulation, Asthma
dimethyl-, compd. with 1,2-ethanediaminemodified-
(2:1) [CAS]release, other
Aminopromazine58-37-7
Aminopyrine58-15-1
Aminoquinuride3811-56-1
Aminorex2207-50-3
amiodaroneMethanone, (2-butyl-3-benzofuranyl)[4-[2-1951-25-3U.S.3,248,401AntiarrhythmicArrhythmia,
(diethylamino)ethoxy]-3,5-diiodophenyl]-19774-82-4general
[CAS]
Amiphenazole490-55-1
Amiprilose56824-20-5
amisulprideBenzamide, 4-amino-N-[(1-ethyl-2-71675-85-9U.S.4,401,822NeurolepticSchizophrenia
pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-
methoxy-[CAS]
Amitriptyline50-48-6
amitriptyline +1-Propanamine,3-(10,11-dihydro-5H-Formulation, Pain,
ketaminedibenzo[a,d]cyclohepten-5-ylidene)-N,N-fixed-doseneuropathic
dimethyl + cyclohexanone,2-(2-combinations
chlorophenyl)-2-(methylamino)
Amitriptylinoxide4317-14-0
amlexanox5H-[1]Benzopyrano[2,3-b]pyridine-3-68302-57-8U.S.4,299,963AntiasthmaAsthma
carboxylic acid, 2-amino-7-(1-methylethyl)-
5-oxo-[CAS]
amiodipine3,5-Pyridinedicarboxylic acid, 2-[(2-111470-99-6EP89167AntianginalHypertension,
aminoethoxy)methyl]-4-(2-chlorophenyl)-88150-42-9general
1,4-dihydro-6-methyl-, 3-ethyl 5-methyl88150-47-4
ester [CAS]
Ammoniacum03/07/9000
Ammonium Benzoate1863-63-4
Ammonium Mandelate530-31-4
Ammonium Salicylate528-94-9
Ammonium Valerate42739-38-8
Amobarbital57-43-2
Amocarzine36590-19-9
Amodiaquin86-42-0
amorolfineMorpholine, 4-[3-[4-(1,1-78613-35-1EP24334AntifungalInfection,
dimethylpropyl)phenyl]-2-methylpropyl]-78613-38-4fungal, general
2,6-dimethyl-, cis-[CAS]
Amoscanat26328-53-0
amosulalolBenzenesulfonamide, 5-[1-hydroxy-2-[[2-70958-86-0EP136103Antihypertensive,Hypertension,
(2-methoxyphenoxy)ethyl]amino]ethyl]-2-85320-68-9adrenergicgeneral
methyl-, (+/−)-[CAS]
Amotriphene5585-64-8
amoxapineDibenz[b,f][1,4]oxazepine, 2-chloro-11-(1-14028-44-5GB1192812AntidepressantDepression,
piperazinyl)-[CAS]general
amoxicillin4-Thia-1-azobicyclo[3,2,0]heptane-2-26787-78-0Formulation,Infection,
carboxylic acid, 6-[[amino(4-61336-70-7modified-release,general
hydroxyphenyl)acetyl]amino]-3,3-dimethyl-other
7-oxo-,[2S-[2Alpha,5Alpha,6β(S*)]][CAS]
amoxicillin +74469-00-4GB1508977Formulation, Infection,
potassiumfixed-doserespiratory
clavulancombinationstract, general
AMPAlexPiperidine, 1-(6-quinoxalinylcarbonyl)-154235-83-3U.S.5,650,409PsychostimulantAttention
[CAS]deficit disorder
Amphetamine300-62-9
Amphetaminil17590-01-1
amphotericin BAmphotericin B compd. with (3β)-cholest-5-120895-52-5U.S.4,822,777Formulation, Infection,
en-3-yl hydrogen sulfate (1:1) [CAS]1397-89-3optimized,general
liposomes
ampicillin4-Thia-1-azabicyclo[3.2.0]heptane-2-69-53-4
carboxylic acid, 6-7177-48-2Fomulation,Infection,
[(aminophenylacetyl)amino]-3,3-dimethyl-7-fixed-dosegeneral
oxo-, [2S-[2Alpha,5Alpha,6β(S*)]]combinations
Ampiroxicam99464-64-9
Ampligen38640-92-5
amprenavirCarbamic acid, (3-(((4-161814-49-9U.S.5,783,701Antiviral, anti-HIVInfection,
aminophenyl)sulfonyl)(2-HIV/AIDS
methylpropyl)amino)-2-hydroxy-1-
(phenylmethyl)propyl)-, tetrahydro-3-
furanyl ester, (3S-(3R*(1R*,2S*)))-[CAS]
amrinose[3,4′-Bipyridin]-6(1H)-one, 5-amino-[CAS]60719-84-8U.S.4,004,012Cardiostimulant
75898-90-7
amrubicin5,12-Naphthacenedione, 9-acetyl-9-amino-92395-36-3EP107486Anticancer, antibioticCancer, lung,
7-[(2-deoxy-β-D-erythro-non-small
pentopyranosyl)oxy]-7,8,9,10-tetrahydro-cell
6,11-dihydro-, hydrochloride, (7S,cis)-
[CAS]
amsacrineMethanesulfonamide, N-[4-(9-51264-14-3Anticancer, otherCancer,
acridinylamino)-3-methoxyphenyl]-[CAS]leukaemia,
acute
lymphocytic
amtolmetin guacilGlycine, N-[[1-methyl-5-(4-methylbenzoyl)-87344-06-7GB2115417Analgesic, NSAIDArthritis,
1H-pyrrol-2-yl]acetyl]-, 2-methoxyphenylrheumatiod
ester [CAS]
Amylocaine532-59-2
AN-152WO9719954Anticancer, antibioticCancer, prostate
anabolic steroidsWO9848812CardiovascularHeart failure
Anagestone2740-52-5
anagrelideImidazo[2,1-b]quinazolin-2(3H)-one, 6,7-58579-51-4GB1418822HaematologicalThrombocytosis
dichloro-1,5-dihydro-, monohydrochloride68475-42-3
[CAS]
anastrozole1,3-benzenediacetonitrile,120511-73-1EP296749Anticancer, hormonalCancer, breast
Alpha,Alpha,Alpha,Alpha′-tetramethyl-5-
(1H-1,2,4-triazol-1-ylmethyl)-[CAS]
Anazolene3861-73-2
Ancitabine31698-14-3
Ancrod9046-56-4
andolastN-4′-[5-Tetrazolyl]-phenyl-4-(5-tetrazolyl)-132640-22-3EP460083AntiasthmaAsthma
benzamide
Androisoxazole360-66-7
Androstenediol521-17-5
anecortave21-(Acetyloxy)-17-hydroxypregna-4,9(11)-7753-60-8OphthalmologicalMacular
diene-3,20-dionedegeneration
Anethole4180-23-8;
104-46-1
(unspecified)
Anethole Trithione532-11-6
AngiogenixU.S.6,417,205CardiovascularCardio-
myopathy,
ischaemic
Angiotensin1407-47-2
anhydrovinblastineVincaleukoblastine, 3′,4′-didehydro-4′-38390-45-3U.S.6,011,041Anticancer, otherCancer,
deoxy-[CAS]general
anidulafunginEchinocandin B, 1-((4R,5R)-4,5-dihydroxy-166663-25-8U.S.6,384,013AntifungalInfection,
N2-((4″-(pentyloxy)(1,1′:4′,1″-terphenyl)-4-Candida,
yl)carbonyl)-L-ornithine)-[CAS]general
Anilerdine144-14-9
Aniracetam72432-10-1
Anisindione117-37-3
Anisomycin22862-76-6
Anisotropine80-50-2
Methylbromide
anistreplaseAnistreplase [CAS]81669-57-0EP28489FibrinolyticInfarction,
myocardial
Antazoline91-75-8
Anthiolimine305-97-5
Anthralin1143-38-0
Anthramycin4803-27-4
Anthrarobin577-33-3
Anthrax inhibitorU.S.6,436,933Anti-infective, Infection,
otheranthrax
antiangiogenicU.S.6,426,067Anticancer, otherCancer,
dendrimersgeneral
AnticortL-Ascorbic acid, mixt with 2-186646-39-9WO9640038AnabolicCachexia
(diethylamino)ethyl 4-aminobenzoate
monohydrochloride, disodium hydrogen
phosphate, potassium benzoate and zinc
sulfate (1:1) [CAS]
antidepressantsU.S.5,898,036AntidepressantDepression,
general
anti-invasinsU.S.6,303,302AntifungalInfection,
fungal, general
Antimony Potassium28300-74-5
Tartrate
Antimony Sodium539-54-8
Thioglycollate
Antimony6533-78-4
Thioglycollamide
Antiprogestin19-Norpregna-4,9-dien-3-211254-73-8DE19703061Anticancer, Cancer, breast
one,(acetylphenyl)-20,20,21,21,21-hormonal
pentafluoro-17-hydroxy-(11β, 17Alpha)
[CAS]
Antipyrine60-80-0
Antipyrine Salicylate520-07-0
antithrombin IIIAntithrombin, III [CAS]9000-94-6Blood fractionAntithrombin
III
90170-80-2deficiency
AR-116081U.S.6,107,324NeurolepticUnspecified
AR-A2(R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-AnxiolyticAnxiety, general
1,2,3,4-tetrahydro-2-naphthyl]-4-
morpholinobenzamide
Arachidonic Acid506-32-1
aranidipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-86780-90-7GB2111978Antihypertensive, Hypertension,
2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-othergeneral
oxopropyl ester-[CAS]
arbekacinD-Streptamine, O-3-amino-3-deoxy-Alpha-51025-85-5U.S.4,001,208AminoglycosideInfection,
D-glucopyranosyl-(1-6)-O-[2,6-diamino-75282-65-4antibioticgeneral
2,3,4,6-tetradeoxy-Alpha-D-erythro-
hexopyranosyl-(1-4)]-N1-(4-amino-2-
hydroxy-1-oxobutyl)-2-deoxy-, (S)-[CAS]
Arbidol1H-indole-3-carboxylic acid, 6-bromo-4-131707-23-8WO9008135Immunostimulant,Infection,
((dimethylamino)methyl)-5-hydroxy-1-otherinfluenza
methyl-2-((phenylthio)methyl)-, ethylester,virus
monohydrochloride [CAS]
arbutamine1,2-Benzenediol, 4-[1-hydroxy-2-[[4-(4-128470-16-6WO9220324DiagnosticDiagnosis,
hydroxyphenyl)butyl]amino]ethyl]-, (R)-coronary
[CAS]
Arcitumomab154361-48-5
ardeparinHeparin [CAS]9005-49-6AnticoagulantThrombosis,
venous
arecoline1,2,5,6-Tetrahydro-1-methyl-3-pyridineFormulation,Alzheimer's
carboxylic acid methyl estertransdermal, patchdisease
argatroban2-Piperidinecarboxylic acid, 1-[5-74863-84-6EP8746AnticoagulantThrombosis,
[(aminoiminomethyl)amino]-1-oxo-2-arterial
[[(1,2,3,4-tetrahydro-3-methyl-8-
quinolinyl)sulfonyl]amino]pentyl]-4-methyl-
[CAS]
Arginine74-79-3
Ariflo ®153259-65-5
aripiprazole2(1H)-Quinolinone, 7-[4-[4-(2,3-129722-12-9EP367141NeurolepticSchizophrenia
dichlorophenyl)-1-piperazinyl]butoxy]-3,4-
dihydro-[CAS]
anxiolyticsU.S.5,756,538AnxiolyticAnxiety,
general
AP-521N-Piperonyl-2-amino-1,2,3,4-151227-08-6WO9321189AnxiolyticAnxiety,
tetrahydrobenzo(b)thieno(2,3-c)pyridine-3-general
carbamide
AP-5280U.S.5,965,118Anticancer, Cancer,
alkylatinggeneral
Apalcillin63469-19-2
apaziquone1H-indole-4,7-dione, 5-(1-aziridinyl)-3-114560-48-4WO8706227Anticancer, Cancer,
(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-alkylatingbreast
1-methyl-, (E)-[CAS]
Apazone13539-59-8
α-Phenylbutyramide90-26-6
Apocodeine641-36-1
apominePhosphonic acid, (2-(3,5-bis(1,1-126411-13-0Anticancer, otherCancer,
dimethylethyl)-4-prostate
hydroxyphenyl)ethylidene)bis-tetrakis(1-
methylethyl) ester [CAS]
apomorphine4H-Dibenzo[de,g]quinoline-10,11-diol,314-19-2Formulation,Impotence
5,6,6a,7-tetrahydro-6-methyl-,58-00-4transmucosal,
hydrochloridenasal
apraclonidine1,4-Benzenediamine, 2,6-dichloro-N1-(4,5-66711-21-5U.S.4,517,199AntiglaucomaGlaucoma
dihydro-1H-imidazol-2-yl)-[CAS]73218-79-8
aprepitant3H-1,2,4-Triazol-3-one, 5-[[(2R,3S)-2-170729-80-3U.S.5,719,147AntiemeticChemotherapy-
[(1R)-1-[3,5-induced
bis(trifluoromethyl)phenyl]ethoxy]-3-(4-nausea and
fluorophenyl)-4-morpholinyl]methyl]-1,2-vomiting
dihydro-[CAS]
aprindine1,3-Propanediamine, N-(2,3-dihydro-1H-33237-74-0GB1321424Antiarrhythmic
inden-2-yl)-N′,N′-diethyl-N-phenyl-[CAS]37640-71-4
Aprobarbital77-02-1
Apronalide528-92-7
Aprotinin9087-70-1
Aptiganel137159-92-3
AQ4N9,10-Anthracenedione, 1,4-bis((2-136470-65-0U.S.5,132,327Anticancer, otherCancer,
(dimethyloxidoamino)ethyl)amino)-5,8-general
dihydroxy-[CAS]
AquavanU.S.6,204,257Anaesthetic, Anaesthesia
injectable
arofylline1H-Purine-2,6-dione, 3-(4-chlorophenyl)-136145-07-8EP435811COPD treatmentChronic
3,7-dihydro-1-propyl-[CAS]obstructive
pulmonary
disease
arotinolol2-Thiophenecarboxamide, 5-[2-[[3-[(1,1-104766-23-6U.S.3,932,400Antihypertensive,Hypertension,
dimethylethyl)amino]-2-hydroxypropyl]thio]-68377-92-4adrenergicgeneral
4-thiazolyl]-, (±)-[CAS]
Arsacetin618-22-4
arsenic trioxideArsenic oxide (As2O3) [CAS]1327-53-3Anticancer, otherCancer,
Arsphenamine139-93-5leukemia,
Aesthinol119-96-0acute
Arteether75887-54-6myelogenous
Arteflene123407-36-3
(Z-form)
Artemether71963-77-4
Artemisinin63968-64-9
artemotil3,12-Epoxy-12H-pyrano[4,3-j]-1,2-75887-54-6AntimalarialInfection,
benzodioxepin, 10-ethoxydecahydro-3,6,9-malaria
trimethyl-, [3R-
(3Alpha,5aβ,6β,8aβ,9aAlpha,10Alpha,12β,
12aR*)]-[CAS]
artesunateButanedioic acid mono-88495-63-0Formulation, Infection,
[(3R,5aS,6R,8aS,9R,10R,12R,12aR)-transmu-malaria
decahydro-3,6,9-trimethyl-3,12-epoxy-12H-cosal, systemic
pyrano[4,3-j]-1,2-benzodioxepin-10-
yl]ester
arzoxifeneBenzo(b)thiophene-6-ol, 2-(4-182133-27-3WO9609041Anticancer, Cancer,
methoxyphenyl)-3-(4-(2-(1-hormonalbreast
piperidinyl)ethoxy)phenoxy)-[CAS]
AS-3201Spiro(pyrrolidine-3,4′(1′H)-pyrrolo(1,2-147254-64-6EP520320SymptomaticDiabetic
a)pyrazine)-1′,2,3′,5(2′H)-tetrone, 2′-((4-antidiabeticcomplication,
bromo-2-fluorophenyl)methyl)-, (3′R)-general
[CAS]
ASABenzoic acid, 2-(acetyloxy)-[CAS]50-78-2Formulation, Pain, general
56449-07-1modified-release,
other
α-Santonin481-06-1
Ascaridole512-85-6
Ascorbic Acid50-81-7
asenapine1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, 5-85650-56-2WO9523600NeurolepticPsychosis,
chloro-2,3,3a,12b-tetrahydro-2-methyl-,general
trans-, (Z)-2-butenedioate (1:1) [CAS]
asimadolineBenzeneacetamide, N-[2-(3-hydroxy-1-153205-46-0DE4215213GI inflammatory/Irritable bowel
pyrrolidinyl)-1-phenylethyl]-N-methyl-bowel disorderssyndrome
Alpha-phenyl-, [S-(R*,R*)]-[CAS]
asoprisnil11β-[4-(Hydroxyiminomethyl)phenyl]-17β-199396-76-1EP0648778MensturationEndometriosis
methoxy-17Alpha-(methoxymethyl)estra-disorders
4,9-dien-3-one
Asoxime34433-31-3
Aspartic Acid56-84-8
Aspidin584-28-1
Aspidinol519-40-4
Aspirin50-78-2
Aspirin,
Dipyridamole
aspoxicillinGlycinamide, N-methyl-D-asparaginyl-N-(2-63358-49-6GB1533413Penicillin, injectableInfection,
carboxy-3,3-dimethyl-7-oxo-4-thia-1-respiratory
azabicyclo[3.2.0]hept-6-yl)-D-2-(4-tract, general
hydroxyphenyl)-, [2S-(2Alpha,5Alpha,6β)]-
[CAS]
AST-120AST 120 [CAS]90597-58-3UrologicalRenal failure
Astemizole68844-77-9
asulacrine4-Acridinecarboxamide, 9-[[2-methoxy-4-80841-47-0EP39224Anticancer, otherCancer,
[(methylsulfonyl)amino]phenyl]amino]-N,5-80841-48-1general
dimethyl-[CAS]
AT-1015(N-[2-[4-(5H-Dibenzo[a,d]cyclohepten-5-AntithromboticThrombosis,
ylidene)-piperdino]ethyl]-1-formyl-4-general
piperidinecarboxamide monohydrochloride
monohydrate
atamestaneAndrosta-1,4-diene-3,17-dione, 1-methyl-96301-34-7DE3338212Anticancer, hormonalCancer, breast
[CAS]
atazanavir2,5,6,10,13-Pentaazatetradecanedioic229975-97-7Antiviral, anti-HIVInfection,
acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-HIV/AIDS
4,11-dioxo-9-(phenylmethyl)-6-((4-(2-
pyridinyl)phenyl)methyl)-dimethyl ester,
(3S,8S,9S,12S)-, sulfate (1:1) (salt) [CAS]
atenololBenzeneacetamide, 4-[2-hydroxy-3-[(1-29122-68-7GB1285038Antihypertensive,Hypertension,
methylethyl)amino]propoxy]-[CAS]73677-19-7adrenergicgeneral
atenolol +Benzeneacetamide, 4-[2-hydroxy-3-[(1-73677-19-7U.S.3,836,671Formulation, Hypertension,
chlorthalidonemethylethyl)amino]propoxy]-, mixt. with 2-fixed-dosegeneral
chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-combinations
isoindol-1-yl)benzenesulfonamide [CAS]
atenolol + nifedipineBenzeneacetamide, 4-[2-hydroxy-3-[(1-Formulation, Hypertension,
methylethyl)amino]propoxy]-, + 4-( 2′-fixed-dosegeneral
nitrophenyl)-2,6-dimethyl-3,5-combinations
dicarbomethoxy-1,4-dihydropyridine
α-Terpineol98-55-5
Atevirdine136816-75-6
atipamezole1H-Imidazole, 4-(2-ethyl-2,3-dihydro-1H-104054-27-5EP183492Reproductive/Sexual
inden-2-yl)-[CAS]gonadal,dysfunction,
generalfemale
atiprimod dimaleate2-Azaspivo[4.5]decane-2-propanamine,130065-61-1U.S.5,744,495Antiarthritic,Arthritis,
N,N-diethyl-8,8-dipropyl, dimaleateimmunologicalrheumatoid
ATL-146eU.S.6,232,297Imaging agentUnspecified
α-Tocopherol59-02-9
atomoxetineBenzenepropanamine, N-methyl-Gamma-82248-59-7EP52492NeurologicalAttention
(2-methylphenoxy)-, (R)-[CAS]83015-36-3deficit disorder
atorvastatin1H-Pyrrole-1-heptanoic acid, 2-(4-134523-03-8EP409281Hypolipaemic/Hyper-
fluorophenyl)-β,delta-dihydroxy-5-(1-134523-00-5Antiatherosclerosischolesterolaemia
methylethyl)-3-phenyl-4-
[(phenylamino)carbonyl]-[CAS]
atosibanOxytocin, 1-(3-mercaptopropanoin acid)-2-90779-69-4EP112809Labour inhibitorLabour, preterm
(O-ethyl-D-tyrosine)-4-L-threonine-8-L-
ornithine-[CAS]
atovaquone1,4-Naphthalenedione, 2-[4-(4-95233-18-4EP123238AntifungalInfection,
chlorophenyl)cyclohexyl]-3-hydroxy-, trans-Pneumocystis
[CAS]jiroveci
atovaquone +1,4-Naphthalenedione, 2-[4-(4-AntimalarialInfection,
proguanilchlorophenyl)cyclohexyl]-3-hydroxy-, trans +malaria
N-(4-chloro-phenyl)-N-(1-
methylethyl)imidiodicarbonimidic diamide
atracuriumIsoquinolinium, 2,2′-[1,5-64228-81-5U.S.4,179,557Muscle relaxantSurgery adjunct
pentanediylbis[oxy(3-oxo-3,1-
propanediyl)]]bis[1-[(3,4-
dimethoxyphenyl)methyl]-1,2,3,4-
tetrahydro-6,7-dimethoxy-2-methyl-[CAS]]
atrasentan3-Pyrrolidenecarboxylic acid, 4-(1,3-173937-91-2WO9730045Anticancer, otherCancer, prostate
benzodioxol-5-yl)-1-[2-(dibutylamino)-2-
oxoethyl]-2-(4-methoxyphenyl)-,
(2R,3R,4S)-[CAS]
Atrial Natriuretic85637-73-6
Peptide
Atrolactamide2019-68-3
Atropine51-55-8
Augmentin74469-00-4Formulation, Infection,
modified-respiratory
release, othertract, general
auranofinGold, (1-thio-β-D-glucopyranose 2,3,4,6-34031-32-8U.S.3,708,579Antiarthritic, otherArthritis,
tetraacetato-S)(triethylphosphine)-[CAS]rheumatoid
Aurothioglucose12192-57-3
avasimibeSulfamic acid, [[2,4,6-tris(1-166518-60-1U.S.5,491,172Hypolipaemic/Atherosclerosis
methylethyl)phenyl]acetyl]-, 2,6-bis(1-Antiatherosclerosis
methylethyl)phenyl ester [CAS]
Avobenzone70356-09-1
AWD-12-281AWD 12-281 [CAS]257892-33-4Antiallergic, Rhinitis, allergic,
non-asthmageneral
Azacitidine320-67-2
Azacyclonol115-46-8
azanidazole2-Pyrimidinamine, 4-[2-(1-methyl-5-nitro-62973-76-6U.S.3,882,105Antibacterial, otherInfection,
1H-imidazol-2-yl)ethenyl]-,(E)-[CAS]trichomoniasis
azapropazone1H-Pyrazolo[1,2-a][1,2,4]benzotriazine-13539-59-8FR1440629Anti-inflammatory
1,3(2H)-dione, 5-(dimethylamine)-9-methyl-
2-propyl-[CAS]
Azaserine115-02-6
azasertron2H-1,4-Benzoxazine-8-carboxamide, N-1-123040-16-4EP313393AntiemeticNausea and
azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-123040-94-8vomiting,
dihydro-4-methyl-3-oxo-,123040-96-0general
monohydrochloride-[CAS]123040-69-7
Azatadine3964-81-6
azathipprine6-[(1-Methyl-4-nitro-1H-imidazol-5-yl)thio]-446-86-6Formulation, oral,Transplant
1H-purineotherrejection,
bone marrow
AZD-4282glycineAnalgesic, otherPain,
neuropathic
AZD-61403,4-DifluorophenylcyclopropylamineAntithromboticThrombosis,
arterial
azelaic acidNonanedioic acid [CAS]123-99-9AntiacneAcne
azelastine1(2H)-Phthalazinone, 4-[(4-58581-89-8GB1377231AntiasthmaAsthma
chlorophenyl)methyl]-2-(hexahydro-1-79307-93-0
methyl-1H-azepin-4-yl)-,
monohydrochloride [CAS]
azelnidipine3,5-Pyridinedicarboxylic acid, 2-amino-1,4-123524-52-7EP266922Antihypertensive,Hypertension,
dihydro-6-methyl-4-(3-nitrophenyl)-, 3-[1-othergeneral
(diphenylmethyl)-3-azetidinyl] 5-(1-
methylethyl)ester, (+/−)-[CAS]
Azidamfenicol13838-08-9
Azidocillin17243-38-8
Azimilide149908-53-2
Azintamide1830-32-6
azithromycin9-deoxo-9a-aza-9a-methyl-9a-76801-85-9U.S.4,328,334Macrolide antibioticInfection,
homoerythromycin-A83905-01-5respiratory
92395-24-9tract, lower
azlocillin4-Thia-1-azabicyclo[3.2.0]heptane-2-37091-65-9GB1392849Penicillin, injectableInfection,
carboxylic acid, 3,3-dimethyl-7-oxo-6-[[[[(2-37091-66-0general
oxo-1-imidazolidinyl)carbonyl]amino]-
phenylacetyl]amino]-, [2S-[2 alpha.,5Alpha,
6β(S*)]]-[CAS]
Azosemide27589-33-9
aztreonamPropanoic acid, 2-[[[1-(2-amino-4-thiazolyl)-104184-69-2GB2071650Beta-lactam antibioticInfection,
2-[(2-methyl-4-oxo-1-sulfo-3-78110-38-0general
azetidinyl)amino]-2-
oxoethylidene]amino]oxy]-2-methyl-, [2S-
[2Alpha,3β(Z)]]-[CAS]
azuleneSodium 5-isopropyl-3,8-dimethyl-1-6223-35-4EP88958Formulation, Inflammation,
azulene sulfonatemodified-general
release, other
bacampicillin4-Thia-1-azabicyclo[3.2.0]heptane-2-37661-08-8GB1363506Penicillin, oralInfection,
carboxylic acid, 6-50972-17-3general
[(aminophenylacetyl)amino]-3,3-dimethyl-7-
oxo-, 1-[(ethoxycarbonyl)oxy]ethyl ester,
[2S-[2Alpha,5Alpha,6β(S*))]]-[CAS]
Bacitracin1405-87-4
baclofenβ-(Aminomethyl)-4-1134-47-0Formulation, implantSpastic
chlorobenzenepropanoic acid [CAS]paralysis
Baicalein491-67-8
balofloxacin3-Quinolinecarboxylic acid, 1-cyclopropyl-6-127294-70-6EP342675Quinolone Infection,
fluoro-1,4-dihydro-8-methoxy-7-[3-antibacterialurinary tract
(methylamino)-1-piperidinyl]-4-oxo-[CAS]
balsalazideBenzoic acid, 5-[[4-[[(2-80573-04-2U.S.4,412,992GI inflammatory/Colitis,
carboxyethyl)amino]carbonyl]phenyl]azo]-2bowel disordersulcerative
hydroxy-, (E)-[CAS]
bambuterolCarbamic acid, dimethyl-, 5-[2-[(1,1-81732-46-9EP43807AntiasthmaAsthma
dimethylethyl)amino]-1-hydroxyethyl]-1,3-81732-65-5
phenylene ester, monohydrochloride [CAS]
Bamethan3703-79-5
Bamifylline2016-63-9
Bamipine4945-47-5
Barbital57-44-3
barnidipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-104713-75-9U.S.4,220,649Antihypertensive, Hypertension,
2,6-dimethyl-4-(3-nitrophenyl)-, methyl-1-104757-53-1othergeneral
(phenylmethyl)-3-pyrrolidinyl ester, [S-71863-56-4
(R*,R*)]-
BAS-118N-Methyl-3-[2-(2-Antibacterial, otherInfection,
napthyl)acetylamino]benzamideHelicobacter
pylori
Basic Aluminum1339-92-0
Carbonate Gel
Baslilximab179045-86-4
Batimastat130370-60-4
Batroxobin9039-61-6
Bay-41-22725-cyclopropyl-2-[1(2-fluoro-benzyl)-1H-Male sexualSexual
pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-dysfunctiondysfunction,
4ylaminemale, general
Bay-41-85432-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-CardiovascularUnspecified
b]pyridin-3-yl]-5-(4-morpholinyl)pyrimidine-
4,6-diamine
BAY-43-9006N-(4-chloro-3-(trifluoromethyl)phenyl)-N′-Anticancer, otherCancer, liver
(4-(2-(N-methylcarbamoyl)-4-
pyridyloxy)phenyl)urea
BAY-57-1293N-[5(aminosulfonyl)-4-methyl-1,3-thiazol-2-Antiviral, otherInfection,
yl]-N-methyl-2-[4-(2-herpes
pyridinyl)phenyl]acetamidesimplex virus
bazedoxifenTSE 424 [CAS]198481-33-3EP802183Osteoporosis Osteoporosis
treatment
β-Benzalbutyramide7236-47-7
BBR-3464Platinum(4+), hexaaminedichlorobis(μ-(1,6-172903-00-3U.S.5,744,497Anticancer, Cancer, lung,
hexanediamine-N:N′))tri-stereoisomer,alkylatingnon-small cell
tetranitrate [CAS]
BBR-3576U.S.5,519,029Anticancer, antibioticCancer, prostate
BBR-3610U.S.6,060,616Anticancer, alkylatingCancer, general
β-Carotene7235-40-7
BCH-1868(−)-2-R-dihydroxyphosphinyol-5-(S)-Anticancer,Cancer, general
(guanin-9′-yl-methyl)tetrahydrofuranantimetabolite
Bebeerine477-60-1
Beclamide501-68-8
beclometasonePregna-1,4-diene-3,20-dione, 9-chloro-5534-09-8WO0006132Formulation, Asthma
11β,17,21-trihydroxy-16β-methyl, [CAS]4419-39-0inhalable, solution
Befloxatone134564-82-2
befunololEthanone, 1-[7-[2-hydroxy-3-[(1-39543-79-8Antiglaucoma
methylethyl)amino]propoxy]-2-39552-01-7
benzofuranyl]-[CAS]
Bemegride64-65-3
Benactyzine302-40-9
benazepril1H-1-Benzazepine-1-acetic acid, 3-[[1-86541-74-4EP72352Antihypertensive,Hypertension,
(ethoxycarbonyl)-3-phenylpropyl]amino]-86541-75-5renin systemgeneral
2,3,4,5-tetrahydro-2-oxo-, [S-(R*,R*)]-86541-78-8
[CAS]
bencyclane1-Propanamine, N,N-dimethyl-3-[[1-14286-84-1WO9829409Vasodilator,
(phenylmethyl)cycloheptyl]oxy]-, (E)-2-2179-37-5peripheral
butenedioate (1:1) [CAS]
bendazacL-Lysine, mono[[[1-(phenylmethyl)1H-81919-14-4GB2081708Ophthalmological
indazol-3-yl]oxy]acetate][CAS]20187-55-7
Bendroflumethiazide73-48-3
Benexate78718-25-9
benfluorexEthanol, 2-[[1-methyl-2-[3-23602-78-0GB1175516Hypolipaemic/
(trifluoromethyl)phenyl]ethyl]amino]-,23642-66-2Antiatherosclerosis
benzoate (ester) [CAS]
Benfotiamine22457-89-2
Benfurodil3447-95-8
benidipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-105979-17-7EP63365Antihypertensive, Hypertension,
2,6-dimethyl-4-(3-nitrophenyl)-, methyl 1-91599-74-5othergeneral
(phenylmethyl)-3-piperidinyl ester,
monohydrochloride (R*,R*)-(+/−)-[CAS]
Benorylate5003-48-5
Benoxaprofen67434-14-4
Benoxinate99-43-4
Benperidol2062-84-2
Benproperine2156-27-6
Benserazide322-35-0
bentazepam2H-[1]Benzothieno[2,3-e]-1,4-diazepin-2-29462-18-8DE2005276Anxiolytic
one, 1,3,6,7,8,9-hexahydro-5-phenyl[CAS]
Bentiromide37106-97-1
Bentoquatam1340-69-8
Benzalkonium8001-54-5
Benzarone1477-19-6
benzbromaroneMethanone, (3,5-dibromo-4-3562-84-3U.S.3,012,042Antigout
hydroxyphenyl)(2-ethyl-3-benzofuranyl)-
[CAS]
Benzethonium121-54-0
Benzetimide14051-33-3
Benzilonium1050-48-2
Benziodarone68-90-6
benznidazoleN-benzyl-2-nitroimidazole-1-acetamide22994-85-0GB1138529Protozoacide
benzocaineBenzoic acid, 4-amino-, ethyl ester94-09-7Formulation, Pain,
fixed-dosemusculoskeletal
combinations
Benzoctamine17243-39-9
Benzonatate104-31-4
Benzoxonium Chloride19379-90-9
benzoyl peroxidePeroxide, dibenzoyl [CAS]94-36-0Formulation, otherAcne
Benzoylpas13898-58-3
Benzphetamine156-08-1
Benzpiperylon53-89-4
Benzquinamide63-12-7
Benzthiazide91-33-8
Benztropine132-17-2
benzydamine1-Propanamine, N,N-dimethyl-3-[[1-132-69-4Stomatological,
(phenylmethyl)-1H-indazol-3-yl]oxy]-[CAS]642-72-8reproductive/gonadal,
anti-inflammatory
Benzyl Benzoate120-51-4
Benzylhydrochloro-1824-50-6
thiazide
Benzylmorphine14297-87-1
Bephenium3818-50-6
Hydroxynaphthoate
bepotastine1-Piperidinebutanoic acid, 4-((4-190786-44-8WO9829409Antiallergic, non-Allergy, general
chlorophenyl)-2-pyridinylmethoxy)-, (S)-,190786-43-7asthma
monobenzenesulfonate [CAS]
bepridil1-Pyrrolidineethanamine, β-[(2-64706-54-3EP146155AntianginalAngina, general
methylpropoxy)methyl]-N-phenyl-N-74764-40-2
(phenylmethyl)-[CAS]74764-75-3
beraprost1H-Cyclopenta[b]benzofuran-5-butanoic88475-69-8U.S.4,474,802ProstaglandinPeripheral
acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-88430-50-6vascular disease
hydroxy-4-methyl-1-octen-6-ynyl)-[CAS]
Berberine2086-83-1
Bergapten484-20-8
Bermoprofen78499-27-1
Besipirdine119257-34-0
betahistine2-Pyridineethanamine, N-methyl-,5579-84-0Formulation, Meniere's disease
dihydrochloride5638-76-6modified-
release, <=24 hr
betaineBetaine-[CAS]107-43-7Metabolic and Homocystinuria
enzyme disorders
betamethasonePregna-1,4-diene-3,20-dione, 9-fluoro-378-44-9Formulation, dermal,Psoriasis
11,17,21-trihydroxy-16-methyl-, (11β,16β)-topical
[CAS]
Betamipron3440-28-6
Betasine3734-24-5
betaxolol2-Propanol, 1-[4-[2-63659-18-7U.S.4,252,984Antihypertensive,Hypertension,
(cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-63659-19-8adrenergicgeneral,
methylethyl)amino]-[CAS]glaucoma
Betazole105-20-4
Bethanechol590-63-6
Bethanidine55-73-2
Betoxycaine3818-62-0
β-Eucaine500-34-5
bevantolol2-Propanol, 1-[[2-(3,4-42864-78-8U.S.3,857,891Antihypertensive,Hypertension,
dimethoxyphenyl)ethyl]amino]-3-(3-59170-23-9adrenergicgeneral
methylphenoxy)-[CAS]
Bevonium5205-82-3
bexaroteneBenzoic acid 4-(1-(5,6,7,8-tetrahydro-153559-49-0WO9321146Anticancer, otherCancer,
3,5,5,8,8-pentamethyl-2-lymphoma,
naphthalenyl)-[CAS]T-cell
benzafibratePropanoic acid, 2-[4-[2-[(4-41859-67-0GB1359264Hypolipaemic/
chlorobenzoyl)amino]ethyl]phenoxy]-2-Antitherosclerosis
methyl-[CAS]
Bezitramide15301-48-1
BG-9928166374-48-7CardiostimulantHeart failure
BIA-2-02410,11-dihydro-10-hydroxyimino-5H-199997-15-4WO9745416AntiepilepticEpilepsy,
dibenz/b,f/azepine-5-carboxamidegeneral
BIA-2-093(S)-(−)-10-acetoxy-10,11-dihydro-5H-236395-14-5AntiepilepticEpilepsy,
dibenzo/b,f/azepine-5-carboxamide-[CAS]general
BIA-3-2021-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-274925-86-9EP1010688AntiparkinsonianParkinson's
ethanonedisease
Bialamicol493-75-4
biapenem5H-Pyrazolo[1,2-a][1,2,4]triazol-4-ium, 6-120410-24-4EP289801Beta-Infection,
[[2-carboxy-6-(1-hydroxyethyl)-4-methyl-7-lactam antibioticbeta-
oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]thio]-lactamase
6,7-dihydro-, hydroxide, inner salt, [4R-resistant
[4Alpha,5β,6β(R*)]]-[CAS]
Bibenzonium15585-70-3
Bibrocathol6915-57-7
bicalutamidePropanamide, N-[4-cyano-3-90357-06-5EP100172Anticancer, Cancer,
(trifluoromethyl)phenyl]-3-[(4-hormonalprostate
fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-,
(+/−)-[CAS]
bicifadine3-Azabicyclo[3.1.0]hexane, 1-(4-66504-75-4DE2740562Analgesic, otherPain, general
methylphenyl)-, (+/−)-[CAS]71195-57-8
bicyclicU.S.6,294,585DermatologicalUnspecified
monoterpene diols
Bidisomide116078-65-0
Bietamiverine479-81-2
Bietanautine6888-11-5
Bietaserpine53-18-9
bifermelane1-Butanamine, N-methyl-4-[2-62232-46-6GB1512880Cognition enhancerAttention
(phenylmethyl)phenoxy]-, hydrochloride90293-01-9deficit
[CAS]disorder
Bifluranol34633-34-6
bifonazole1H-Imidazole, 1-([1,1′-biphenyl]-4-60628-96-8U.S.4,118,487AntifungalInfection,
ylphenylmethyl)-[CAS]60629-08-5fungal,
60629-09-6general
bimatoprost5-Heptenamide, 7-(3,5-dihydroxy-2-(3-155206-00-1U.S.5,688,819ProstaglandinGlaucoma
hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-
N-ethyl(1R-
(1Alpha(Z)2β(1E,3S,3Alpha,5Alpha))
[CAS]
bimoclomolN-[2-hydroxy-3-(1-piperidinyl)propoxy]-3-130493-04-8U.S.5,147,874SymptomaticNeuropathy,
pyridinecarboximidoyl chloride, (Z)-2-antidiabeticdiabetic
butanedioate (1:1)
bimosiamose(1,1′-Biphenyl)-3-acetic acid, 3′,3′′′-(1,6-187269-40-5U.S.5,444,050AntiasthmaAsthma
hexanediyl)bis(6′-Alpha-D-
mannopyranosyloxy)-, [CAS]
Binifibrate69047-39-8
binodenosonAdenosine, 2-144348-08-3Vasodilator, Diagnosis,
((cyclohexylmethylene)hydrazino)-[CAS]coronarycoronary
Biomed-101U.S.6,423,744Anticancer, otherCancer, renal
Biotin58-85-5
Biperiden514-65-8
birlcodar2-Piperidinecarboxylic acid, 1-(oxo(3,4,5-174254-13-8Radio/Cancer,
trimethoxyphenyl)acetyl)-,4-(3-pyridinyl)-1-159997-94-1chemosensitizerbreast
(3-(3-pyridinyl)propyl)butyl ester, (S)-, 2-
hydroxy-1,2,3-propanetricarboxylate (1:2)
[CAS]
biriperone1-Butanone, 1-(4-fluorophenyl)-4-42021-34-1DE2333922Neuroleptic
(3,4,6,7,12,12a-
hexahydropyrazino[1′,2′:1,6]pyrido[3,4-
b]indol-2(1H)-yl)-[CAS]
Bisacodyl603-50-9
Bisantrene78186-34-2
Bisbentiamine2667-89-2
Bisdequalinium52951-36-7
Bismuth Aluminate12284-76-3
Bismuth53897-25-9
Butylthiolaurate
Bismuth Ethyl52951-37-8
Camphorate
Bismuth 138-58-9
Iodosubgallate
Bismuth Sodium 53778-50-0
Iodide
Bismuth Sodium5798-43-6
Triglycollamate
Bismuth Subcarbonate5892-10-4
Bismuth Subgallate22650-86-8
Bismuth Subnitrate1304-85-4
Bismuth Subsalicylate14882-18-9
Bismuth5175-83-7
Tribromophenate
bisoprolol2-Propanol, 1-[4-[[2-(1-104344-23-2GB1532380Antihypertensive,Heart failure
methylethoxy)ethoxy]methyl]phenoxy]-3-66722-44-9adrenergic
[(1-methylethyl)amino]-[CAS]
bisoprolol + HCTZ2-Propanol, 1-[4-[[2-(1-Formulation, fixed-Hypertension,
methylethoxy)ethoxy]methyl]phenoxy]-3-dose combinationsgeneral
[(1-methylethyl)amino] mixt. with 6-chloro-
3,4-dihydro-2H-1,2,4-benzothiadiazine-7-
sulfonamide 1,1-dioxide
bisoprolol +2-Propanol, 1-[4-[[2-(1-Formulation, fixed-Hypertension,
trichloromethiazidemethylethoxy)ethoxy]methyl]phenoxy]-3-dose combinationsgeneral
[(1-methylethyl)amino] mixt. with 6-chloro-
3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-
benzothiadiazine-7-sulfonamide 1,1-
dioxide
Bisoxatin14008-48-1
Bithionol97-18-7
Bitolterol30392-40-6
Bitoscanat4044-65-9
BL-3875WO0218378Anti-inflammatoryUnspecified
bleomycinBleomycin [CAS]11056-06-7Formulation, Cancer, head
9041-93-4transdermal,and neck
enhanced
blonanserinCycloocta[b]pyridine, 2-(4-ethyl-1-132810-10-7EP385237NeurolepticSchizophrenia
piperazinyl)-4-(4-fluorophenyl)-
5,6,7,8,9,10-hexahydro-[CAS]
BMS-184476EP639577Anticancer, otherCancer, breast
BMS-387032cis-(+/−)-2-(Ethylthio)-5,7-dihydroxy-8-(3-WO9742949Anticancer, otherCancer,
hydroxy-1-methyl-4-piperidinyl)-4H-1-general
benzopyran-4-one
BN-824514-[2-(aminomethyl)-1,3-thiazol-4-yl]-2,6-di-NeuroprotectiveUnspecified
tert-butylphenol, dihydrochloride
BNP-7787Ethanesulfonic acid, 2,2′-dithiobis-.16208-51-8Radio/Chemotherapy-
disodium salt [CAS]chemoprotectiveinduced
nausea and
vomiting
BO-6535-Benzofuranol, 4,6-bis(1,1-dimethylethyl)-157360-23-1WO9408930Hypolipaemic/Atherosclerosis
2,3-dihydro-2,2-dipentyl-[CAS]Antiatherosclerosis
Bolandiol19793-20-5
Bolasterone1605-89-6
Boldenone846-48-0
bopindolol2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-62658-63-3U.S.4,340,541Antihypertensive,Hypertension,
[(2-methyl-1H-indol-4-yl)oxy]-, benzoate82857-38-3adrenergicgeneral
(ester), (+/−)-[CAS]
Bornyl Chloride464-41-5
Bornyl Salicylate560-88-3
bortezomibBoronic acid, [(1R)-3-methyl-1-[[(2S)-1-oxo179324-69-7U.S.6,271,199Anticancer, otherCancer,
3-phenyl-2-myeloma
[(pyrazinylcarbonyl)amino]propyl]amino]-
butyl]-[CAS]
Bromocriptine25614-03-3
Bromo-118-23-0
diphenhydramine
Bromoform75-25-2
Bromopride4093-35-0
Bromo-3679-64-9
salicychloranilide
bromperidol1-Butanone, 4-[4-(4-bromophenyl)-4-10457-90-6U.S.3,438,991NeurolepticPsychosis,
hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-general
[CAS]
Brompheniramine86-22-6
Broparoestrol479-68-5
Bropirimine56741-95-8
brostallicin4-(2-Bromoacrylamido)-N′′′-(2-Anticancer, otherCancer,
guanidinoethyl)-1-1′,1″,1′′′-tetramethyl-general
N,4′:N′,4″:N′′′,4′′′′-quarter-[pyrrole-2-
carboxamide][CAS]
brotizolam6H-Thieno[3,2-f][1,2,4]triazolo[4,3-57801-81-7U.S.4,094,984Hypnotic/Sedative
a][1,4]diazepine, 2-bromo-4-(2-
chlorophenyl)-9-methyl-[CAS]
Brovincamine57475-17-9
Brozuridine59-14-3
Broxyquinoline521-74-4
Brucine357-57-3
β-Sitosterol83-46-5
Bucetin1083-57-4
Bucillamine65002-17-7
Bucindolol71119-11-4
bucladesineAdenosine, N-(1-oxobutyl)-, cyclic 3′,5′-362-74-3JP51113896CardiostimulantWound
(hydrogen phosphate) 2′-butanoate [CAS]healing
Buclizine82-95-1
Buclosamide575-74-6
Bucolome841-73-6
bucricaine9-Acridinamine, N-butyl-1,2,3,4-tetrahydro-,82636-28-0Anaesthetic, local
monohydrochloride [CAS]
bosentanBenzenesulfonamide, 4-(1,1-147536-97-8EP633259Vasodilator, Hypertension,
dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-peripheralpulmonary
methoxyphenoxy)[2,2′-bipyrimidin]-4-yl]-
[CAS]
BP2,94Phenol, 2-[[[(1R)-2-(1H-imidazol-4-yl)-1-139191-80-3WO9117146RespiratoryRhinitis,
methylethyl]imino]phenylmethyl]-[CAS]general
BP4.897N-[4-[4-(2-methoxyphenyl)-1-EP779284DependenceAddiction,
piperazinyl]butyl]naphthalene-2-treatmentcocaine
carboxamide
β-Propiolactone57-57-8
Bradycor140661-97-8
Brain Natriuretic114471-18-0
Peptide
Brallobarbital561-86-4
brasofensine8-Azabicyclo(3.2.1)octane-2-171655-91-7WO9528401AntiparkinsonianParkinson's
carboxaldehyde, 3-(3,4-dichlorophenyl)-8-disease
methyl-, O-methyloxime, (1R-
(1Alpha,2β(E),3Alpha,5Alpha))-[CAS]
Brequinar96187-53-0
Bretylium61-75-6
Brilliant Green633-03-4
brimonidine6-Quinoxalinamine, 5-bromo-N-(4,5-59803-98-4DE2538620AntiglaucomaGlaucoma
dihydro-1H-imidazol-2-yl)-[CAS]
brinzolamide2H-Thieno(3,2-e)-1,2-thiazine-6-138890-62-7U.S.5,378,703AntiglaucomaGlaucoma
sulfonamide, 4-(ethylamino)-3,4-dihydro-2-
(3-methoxypropyl)-, 1,1-dioxide, (R)-
[CAS]
brivudinUridine, 5-(2-bromoethenyl)-2′-deoxy, (E)-69304-47-8Antiviral, otherInfection,
[CAS]varicella
zoster virus
Brodimoprim56518-41-3
Bromazepam1812-30-2
bromfenacBenzeneacetic acid, 2-amino-3-(4-91714-93-1Formulation, Inflammation,
bromobenzoyl)-[CAS]91714-94-2mucosal, topicalocular
Bromhexine3572-43-8
Bromindione1146-98-1
Bromisovalum496-67-3
Bucumolol58409-59-9
budesonidePregna-1,4-diene-3,20-dione, 16,17-51333-22-3GB1429922AntiasthmaAsthma
[butylidenebis(oxy)]-11,21-dihydroxy-,
(11β,16Alpha)-[CAS]
budesonide +Pregna-1,4-diene-3,20-dione, 16,17-Formulation, fixed-Asthma
formoterol[butylidenebis(oxy)]-11,21-dihydroxy-,dose combinations
(11β,1bAlpha) + formamide, N-[2-hydroxy-
5-[1-hydroxy-2-[[2-(4-methoxyphenol)-1-
methylethyl]amino]ethyl]phenyl]-(R*,R*)-
(±)
budipinePiperidine, 1-(1,1-dimethylethyl)-4,4-57982-78-2DE2825322AntiparkinsonianParkinson's
diphenyl-[CAS]63661-61-0disease
Budralazine36798-79-5
Bufeniode22103-14-6
Bufetolol53684-49-4
bufexamacp-butoxyacetohydroxamic acid2438-72-4U.S.3,479,396Anti-inflammatory
buflomedil1-Butanone, 4-(1-pyrrolidinyl)-1-(2,4,6-35543-24-9GB1325192Vasodilator,
trimethoxyphenyl)-[CAS]55837-25-7peripheral
Buformin692-13-7
Bufuralol54340-62-4
Bumadizon3583-64-0
bumetanideBenzoic acid, 3-(aminosulfonyl)-5-28395-03-1U.S.3,806,534Antihypertensive,Hypertension,
(butylamino)-4-phenoxy-[CAS]diureticgeneral
bunaftine1-Naphthalenecarboxamide, N-butyl-N-[2-32421-46-8DE2009894Antiarrhythmic
(diethylamino)ethyl]-[CAS]
Bunamiodyl Sodium1923-76-8
bunazosin1H-1,4-Diazepine, 1-(4-amino-6,7-52712-76-2GB1398455Antihypertensive,Hypertension,
dimethoxy-2-quinazolinyl)hexahydro-4-(1-80755-51-7adrenergicgeneral
oxobutyl)-[CAS]
bunitrololBenzonitrile, 2-[3-[(1,1-34915-68-9U.S.3,940,489Antihypertensive,
dimethylethyl)amino]-2-hydroxypropoxy]-adrenergic
[CAS]
bupivacaine2-Piperidinecarboxamide, 1-butyl-N-(2,6-38396-39-3Formulation,Anaesthesia
dimethylphenyl)-[CAS]2180-92-9modified-release,
>24 hr
Bupranolol14556-46-8
buprenorphine6,14-Ethenomorphinan-7-methanol, 17-52485-79-7U.S.3,433,791Analgesic, other
(cyclopropylmethyl)-Alpha-(1,1-53152-21-9
dimethylethyl)-4,5-epoxy-18,19-dihydro-3-
hydroxy-6-methoxy-Alpha-methyl-,
[5Alpha,7Alpha(S)]-[CAS]
bupropion1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-31677-93-7U.S.4,425,363AntidepressantDepression,
dimethylethyl)amino]-, (+/−)-[CAS]34911-55-2general
Buramate4663-83-6
buserelinLuteinizing hormone-releasing factor (pig),57982-77-1GB1523623Releasing hormonesCancer,
6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-68630-75-1prostate
ethyl-L-prolinamide)-10-deglycinamide-
[CAS]
buspirone8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-36505-84-7EP276536AnxiolyticAnxiety,
(2-pyrimidinyl)-1-piperazinyl]butyl]-[CAS]general
busulfan1,4-Butanediol, dimethanesulfonate [CAS]55-98-1Formulation, Cancer,
optimized,general
microparticles
busulfan1,4-Butanediol, dimethanesulfonate [CAS]55-98-1Formulation, Cancer,
parenteral, otherleukaemia,
acute
myeolgenous
Butabarbital143-81-7
Butacaine149-16-6
Butacetin2109-73-1
Butalamine22131-35-7
Butalbital77-26-9
Butallylonal1142-70-7
butamben4-Aminobenzoic acid butyl ester [CAS]94-25-7Formulation, Pain, cancer
modified-
release, other
butamirateBenzeneacetic acid, Alpha-ethyl-, 2[2-18109-80-3AntitussiveCough
(diethylamino)ethoxy]ethylester, 2-hydroxy-18109-81-4
1,2,3-propanetricarboxylate (1:1) [CAS]
Butanilicaine3785-21-5
Butaperazine653-03-2
Butaverine55837-14-4
Butazolamide16790-49-1
Butedronic Acid51395-42-7
butenafine1-Naphthalenemethanamine, N-((4-(1,1-101827-46-7EP164697AntifungalInfection,
dimethylethyl)phenyl)methyl)-N-methyl-101828-21-1dermatological
[CAS]
Butethal77-28-1
Butethamate14007-64-8
Butethamine2090-89-3
Buthalital510-90-7
Buthiazide2043-38-1
Butibufen55837-18-8
Butidrine1506-12-3
butobendinebenzoic acid, 3,4,5-trimethoxy-, 1,2-55769-64-7U.S.4,012,473AntiarrhythmicArrhythmia,
ethanediylbis[(methylimino)(2-ethyl-2,1-55769-65-8general
ethanediyl)]ester, [S-(R*,R*)]-[CAS]
butoconazole1H-Imidazole, 1-[4-(4-chlorophenyl)-2-64872-76-0GB1567431AntifungalInfection,
[(2,6-dichlorophenyl)thio]butyl]-, (+/−)-64872-77-1Candida,
[CAS]general
Butoctamide32838-26-9
Butofilolol64552-17-6
butorphanolMorphinan-3,14-diol, 17-(cyclobutylmethyl)-,42408-82-2GB1412129Analgesic, other
[S-(R*,R*)]-2,3-dihydroxybutanedioate58786-99-5
(1:1) (salt) [CAS]
Butoxycaine3772-43-8
Butriptyline35941-65-2
Butropium29025-14-7
Buzepide3691-21-2
BVT-5182WO0208178Anorectic/Obesity
Antiobesity
BXT-510722H-1,2-Benzoselenazine, 3,4-dihydro-4,4-173026-17-0GI inflammatory/Colitis,
dimethyl-[CAS]bowel disordersulcerative
C-13116H-Imidazol[4,5,1-de]acridin-6-one, 5-[[2-Anticancer, otherCancer,
(diethylamino)ethyl]amino]-8-hydroxy-,general
2HCl, 2H2O
cabergolineErgoline-8-carboxamide, N-[3-81409-90-7GB2103603AntiprolactinGala-
(dimethylamino)propyl]-N-85329-89-1ctorrhoea
[(ethylamino)carbonyl]-6-(2-propenyl)-,
(8β)-[CAS]
Cabergoline81409-90-7
Cacodylic Acid75-60-5
Cactinomycin8052-16-2
cadexomer iodineCadexomer iodine [CAS]94820-09-4Anti-infective, otherUlcer,
venostasis
Cadmium Salicylate19010-79-8
Cadralazine64241-34-5
Cafaminol30924-31-3
caffeine1,2,3,-Propanetricarboxylic acid, 2-hydroxy69-22-7RespiratoryApnoea
mixt. with 3,7-dihydro-1,4,7-trimethyl-1H-58-08-2
purine-2,6-dione [CAS]
Calcifediol19356-17-3
Calcipotriene112965-21-6
calcipotriol9,10-Secochola-5,7,10(19),22-tetraene-112965-21-6WO8700834AntipsoriasisPsoriasis
1,3,24-triol, 24-cyclopropyl-,
(1Alpha,3β,5Z,7E,22E)-[CAS]
calcipotriol +9,10-Secochola-5,7,10(19),22-tetraene-Formulation, Psoriasis
beclometasone1,3,24-triol, 24-cyclopropyl-,fixed-dose
(1Alpha,3β,5Z,7E,22E) + Pregna-1,4-combinations
diene-3,20-dione, 9-chloro-11β,17,21-
trihydroxy-16β-methyl, 17,21-dipropionate
calcitriol9,10-Secocholesta-5,7,10(19)-triene-32222-06-3AntipsoriasisPsoriasis
1,3,25-triol, (1Alpha,3β,5Z,7E)-[CAS]
Calcium 3-Aurothio-2-5743-29-3
propanol-1-sulfonate
Calcium69-46-5
Acetylsalicylate
Calcium33659-28-8
Bromolactobionate
Calcium Carbonate471-34-1
Calcium Gluconate299-28-5
Calcium27214-00-2
Glycerophosphate
calciumCalcium D-(+)-4-(2,4-dihydroxy-3,3-17097-76-6EP117260NeurologicalAttention
hopantothenatedimethylbutyramido)butyratedeficit
(hemihydrate) [CAS]disorder
Calcium Iodobehenate1319-91-1
Calcium Iodosterate1301-16-2
Calcium Lactate814-80-2
Calcium Levulinate591-64-0
Calcium Mesoxalate21085-60-9
Calcium N-16649-79-9
Carbamoylaspartate
calcium polycarbophilPolycarbophil, calcium salt-[CAS]126040-58-2GI inflammatory/Irritable
9003-97-9bowel disordersbowel
syndrome
Calcium Propionate4075-81-4
Calcium Succinate140-99-8
caldaret5-methyl-2-(1-piperazinyl)-benzenesulfonic133804-44-1CardiostimulantHeart failure
acid monohydrate
Calusterone17021-26-0
Camazepam36104-80-0
camostatBenzeneacetic acid, 4-[[4-59721-28-7U.S.4,021,472GI inflammatory/Pancreatitis
[(aminoiminomethyl)amino]benzoyl]oxy]-,59721-29-8bowel disorders
2-(dimethylamino)-2-oxoethyl ester,71079-09-9
monomethanesulfonate [CAS]
Camphor76-22-2
Camphotamide4876-45-3
camptothecin4-Ethyl-4-hydroxy-1H-pyrano-Formulation, Cancer,
[I3′4′:6,7]indolizinol[1,2-b;]quinoline-optimized,general
3,14(4H,12H)-dionemicroemulsion
Candesartan139481-59-7
candesartan cilexetil1H-Benzimidazole-7-carboxylic acid, 2-145040-37-5EP520423Antihypertensive,Hypertension,
ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-renin systemgeneral
biphenyl]-4-yl]methyl]-, 1-
[[(cyclohexyloxy)carbonyl]oxy]ethyl ester,
(+/−)-[CAS]
Candoxatril123122-55-4
canertinibN-[4-(3-(Chloro-4-fluoro-phenylamino)-7-(3-289499-45-2Anticancer, otherCancer, lung,
morpholin-4-yl-propoxy)-quinazolin-6-yl]-non-small cell
acrylamide
Canrenone976-71-6
Cantharidin56-25-7
cantuzumab mertansineMaytansine, N2-deacetyl-N2-(3-mercapto-139504-50-0ImmunotoxinCancer,
1-oxopropyl)-, conjugated humanizedcolorectal
C242 monoclonal antibody
capecitabineCytidine, 5-deoxy-5-fluoro-N-154361-50-9EP602454Anticancer,Cancer,
[(pentyloxy)carbonyl]-[CAS]antimetabolitebreast
Capobenic Acid21434-91-3
capravirine1H-imidazole-2-methanol, 5-(3,5-178979-85-6Antiviral, anti-HIVInfection,
dichlorophenyl)thio-4-(1-methylethyl)-1-(4-HIV/AIDS
pyridinyl)methyl carbamate (ester) [CAS]
Capromab151763-64-3
capsaicin creamN-[(4-hydroxy-3-methoxyphenyl)methyl]-8-404-86-4Formulation, dermal,Pain, post-
methyl-, (E)-[CAS]topicalherpetic
Captodiamine486-17-9
captoprilL-Proline, 1-(3-mercapto-2-methyl-1-62571-86-2U.S.4,105,776Antihypertensive, Hypertension,
oxopropyl)-, (S)-[CAS]renin systemgeneral
captopril + HCTZL-Proline, 1-(3-mercapto-2-methyl-1-110075-07-5U.S.4,217,347Antihypertensive,
oxopropyl)-, (S)-, mixt. with 6-chloro-3,4-renin system
dihydro-2H-1,2,4-benzothiadiazine-7-
sulfonamide 1,1-dioxide [CAS]
Capuride5579-13-5
carabersatBenzamide, N-(6-acetyl-3,4-dihydro-3-184653-84-7WO9811890AntiepilepticEpilepsy,
hydroxy-2,2-dimethyl-2H-1-benzopyran-4-general
yl)-4-fluoro, (3R-trans)-[CAS]
Caramiphen77-22-5
carazolol2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[(1-57775-29-8DE2240599Antihypertensive,
methylethyl)amino]-[CAS]adrenergic
Carbachol51-83-2
carbamazepine5H-Dibenz[b,f]azepine-5-carboxamide298-46-4Formulation, Epilepsy,
[CAS]modified-general
release, other
Carbamide Peroxide124-43-6
Carbarsone121-59-5
Carbaryl63-25-2
Carbazochrome13051-01-9
51460-26-5
carbendazimMethyl-2-benzimidazolecarbamateAnticancer, otherCancer,
general
Carbenicillin4697-36-3
Carbenoxolone5697-56-3
Carbetapentane77-23-6
CarbicarbCarbonic acid disodium salt, mixt. with72227-05-5Alimentary/Acidosis
monosodium salt-[CAS]Metabolic, other
Carbidopa28860-95-9
carbidopa +S-Alpha Hydrazino-3,4-dihydroxy-AlphaFormulation, Parkinson's
levodopa-1methyl benzene propanoic acidfixed-dosedisease
monohydrate + 3-hydroxy-L-tyrosinecombinations
Carbimazole22232-54-8
Carbinoxamine486-16-8
Carbocloral541-79-7
carbocysteine151756-26-2EP546272Cystic fibrosisCystic
638-23-3treatmentfibrosis
Carbon Tetrachloride56-23-5
carboplatinPlatinum, diammine[1,1-41575-94-4Anticancer, Cancer,
cyclobutanedicarboxylate(2-)]-, (SP-4-2)-alkylatingovarian
[CAS]
Carboprost35700-23-3
carboprostProsta-5,13-dien-1-oic acid, 9,11,15-58551-69-2U.S.3,728,382ProstaglandinAbortion
trometamoltrihydroxy-15-methyl-,74849-93-7
(5Z,9.alpha.,11Alpha,13E,15S)-, compd.
with 2-amino-2-(hydroxymethyl)-1,3-
propanediol(1:1) [CAS]
Carboquone2,5-Cyclohexadiene-1,4-dione, 2-[2-24279-91-2DE1905224Anticancer,
[(aminocarbonyl)oxy]-1-methoxyethyl]-3,6-antibiotic
bis(1-aziridinyl)-5-methyl-[CAS]
Carbromal77-65-6
Carbubarb960-05-4
Carbutamide339-43-5
Carbuterol34866-47-2
Carfimate3567-38-2
carglumic acidN-Carbamoyl-L-glutamic acid1188-38-1Metabolic and Hyper-
enzyme disordersammonaemia
Cargutocin33605-67-3
Carindacillin35531-88-5
cariporideBenzamide, N-(aminoiminomethyl)-4-(1-159138-80-4EP589336AntianginalAngina,
methylethyl)-3-(methylsulfonyl)-[CAS]159138-81-5general
Cariporide159138-80-4
Carisoprodol78-44-4
carmofur1(2H)-Pyrimidinecarboxamide, 5-fluoro-N-61422-45-5U.S.4,071,519Anticancer,
hexyl-3,4-dihydro-2,4-dioxo-[CAS]antimetabolite
Carmoxirole98323-83-2
carmustineUrea, N,N′-bis(2-chloroethyl)-N-nitroso-154-93-8Formulation, implantCancer, brain
[CAS]
Carnitine461-06-3
Caroverine23465-76-1
Caroxazone18464-39-6
Carphenazine2622-30-2
Carpipramine5942-95-0
carprofen9H-Carbazole-2-acetic acid, 6-chloro-53716-49-7U.S.3,896,145Anti-inflammatory
Alpha-methyl-, (+/−)-[CAS]
Carsalam2037-95-8
carteolol2(1H)-Quinolinone, 5-[3-[(1,1-51781-06-7U.S.3,910,924Antihypertensive,Glaucoma
dimethylethyl)amino]-2-hydroxypropoxy]-51781-21-6adrenergic
3,4-dihydro-, monohydrochloride [CAS]
Carticaine23964-58-1
Carubicin50935-04-1
Carumonam87638-04-8
Carvacrol499-75-2
carvedilol2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[[2-72956-09-3EP4920Antihypertensive,Hypertension,
(2-methoxyphenoxy)ethyl]amino]-[CAS]adrenergicgeneral
Carvone99-49-0
Cascarillin10118-56-6
caspofunginPneumocandin B0, 1-((4R,5S)-5-((2-162808-62-0WO9421677AntifungalInfection,
aminoethyl)amino)-N2-(10,12-dimethyl-1-179463-17-3Aspergillus
oxotetradecyl)-4-hydroxy-L-ornithine)-5-
(threo-3-hydroxy-L-ornithine)-, diacetate
(salt) [CAS]
Catechin154-23-4
cathepsin K inhibitorsN-(1-benzothien-2-ylcarbonyl)-N-[2-(2-WO9613523OsteoporosisOsteoporosis
fluorophenyl)-4-oxo-1,2,3,4-treatment
tetrahydropyrimidin-5-yl]-L-leucinamide
cathepsin S inhibitorsN-(1-benzothien-2-ylcarbonyl)-N-[2-(2-AntiasthmaAsthma
fluorophenyl)-4-oxo-1,2,3,4-
tetrahydropyrimidin-5-yl]-L-leucinamide
CC-401U.S.6,342,595ImmunosuppressantArthritis,
rheumatoid
CCI-779Rapamycin 42-(3-hydroxy-2-162635-04-3Anticancer,Cancer, renal
(hydroxymethyl)-2-methylpropanoate)antibiotic
[CAS]
CCR5 antagonistsWO9732019Antiviral, anti-HIVInfection,
HIV/AIDS
CDC-394U.S.634061Anticancer, otherCancer,
myeloma
CDC-801U.S.5,605,914GI inflammatory/Crohn's
bowel disordersdisease
CEE-03-3101H-3-Benzazepin-7-ol, 5-(2,3-dihydro-7-128022-68-4EP347672DependenceAddiction,
benzofuranyl)-2,3,4,5,-tetrahydro-3-treatmentalcohol
methyl-8-nitro, (5S)-[CAS]
cefactor5-Thia-1-azabicycol[4.2.0]oct-2-ene-2-53994-73-3GB1461323Cephalosporin, oralInfection,
carboxylic acid, 7-70356-03-5Haemophilus
[(aminophenylacetyl)amino]-3-chloro-8-influenzae
oxo-, [6R-[6Alpha,7β(R*)]]-[CAS]prophylaxis
cefadroxil5-Thia-1-azabicycol[4.2.0]oct-2-ene-2-50370-12-2GB1240687Cephalosporin, oralInfection,
carboxylic acid, 7-[[amino(4-66592-87-8general
hydroxyphenyl)acetyl]amino]-3-methyl-8-
oxo-, [6R-[6Alpha,7β(R*)]]-[CAS]
cefalexin5-Thia-1-azabicycol[4.2.0]oct-2-ene-2-105879-42-3U.S.4,775,751Cephalosporin, oralInfection,
carboxylic acid, 7-15686-71-2respiratory
[(aminophenylacetyl)amino]-3-methyl-8-tract, upper
oxo-, [CAS]
cefalexin pivoxil5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-27726-31-4Cephalosporin, oralInfection,
carboxylic acid, 7-general
[(aminophenylacetyl)amino]-3-methyl-8-
oxo-, (2,2-dimethyl-1-oxopropoxy)methyl
ester, monohydrochloride, [6R-
[6Alpha,7β(R*)]]-[CAS]
cefamandole7-D-mandelamido-3[[(1-methyl-1H-tetrazol-34444-01-4U.S.3,641,021Cephalosporin,Infection,
5-yl)thio]methyl]-3-cephem-4-carboxylicinjectablegeneral
acid
cefatrizine5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-51627-14-6GB1460914Cephalosporin, oralInfection,
carboxylic acid, 7-[[amino(4-general
hydroxyphenyl)acetyl]amino]-8-oxo-3-[(1H-
1,2,3-triazol-4-ylthio)methyl]-, [6R-
[6Alpha,7β(R*)]]-[CAS]
Cefazedone56187-47-4
Cefazolin25953-19-9
Cefbuperazone76610-84-9
cefcapene pivoxil7β-[(Z)-2-(2-amino-4-thiazolyl)-2-105889-45-0GB2173194Cephalosporin, oralInfection,
pentenoylamino]-3-carbamoyloxymethyl-3-105889-46-1respiratory
cephem-4-carboxylic acid,tract, general
pivaloyloxymethyl ester HCl-[CAS]
Cefclidin105239-91-6
cefdinir5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-91832-40-5EP105459Cephalosporin, oralInfection,
carboxylic acid, 7-[[(2-amino-4-dermatological
thiazolyl)(hydroxyimino)acetyl]amino]-3-
ethenyl-8-oxo-, [6R-[6Alpha,7β(Z)]]-[CAS]
cefditoren pivoxil5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-104145-95-1JP61178991Cephalosporin, oralInfection,
carboxylic acid, 7-[[(2-amino-4-104146-53-4general
thiazolyl)(methoxyimino)acetyl]amino]-3-[2-117467-28-4
(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (2,2-
dimethyl-1-oxopropoxy)methyl ester, [6R-
[3(Z),6Alpha,7β(Z)]]-[CAS]
cefepimePyrrolidinium, 1-[[7-[[(2-amino-4-107648-80-6EP531981Cephalosporin,Infection,
thiazolyl)(methoxyimino)acetyl]amino]-2-123171-59-5injectablerespiratory
carboxy-8-oxo-5-thia-1-88040-23-7tract, lower
azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-
methyl-, hydroxide, inner salt, [6R-
[6Alpha,7β(Z)]]-[CAS]
Cefetamet65052-63-3
cefetamet pivoxil5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-111696-23-2GB1581854Cephalosporin, oralInfection,
carboxylic acid, 7-[[(2-amino-4-general
thiazolyl)(methoxyimino)acetyl]amino]-3-
methyl-8-oxo-, (2,2-dimethyl-1-
oxopropoxy)methyl ester,
monohydrochloride, [6R-[6Alpha,7β(Z)]]-
[CAS]
cefixime5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-79350-37-1EP30630Cephalosporin, oralInfection,
carboxylic acid, 7-[[(2-amino-4-general
thiazolyl)[(carboxymethoxy)imino]acetyl]-
amino]-3-ethenyl-8-oxo-, [6R-
[6Alpha,7β(Z)]]-[CAS]
cefmenoxime5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-65085-01-0GB1536281Cephalosporin,Infection,
carboxylic acid, 7-[[(2-amino-4-75738-58-8injectableocular
thiazolyl)(methoxyimino)acetyl]amino]-3-
[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-
oxo-, [6R-[6Alpha,7β(Z)]]-[CAS]
cefmetazole5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-56796-20-4GB1449420Cephalosporin,Infection,
carboxylic acid, 7-56796-39-5infectablegeneral
[[[(cyanomethyl)thio]acetyl]amino]-7-
methoxy-3-[[(1-methyl-1H-tetrazol-5-
yl)thio]methyl]-8-oxo-, (6R-cis)-[CAS]
cefminox5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-84305-41-9EP24879Cephalosporin,Infection,
carboxylic acid, 7-[[[(2-amino-2-injectableurinary tract
carboxyethyl)thio]acetyl]amino]-7-
methoxy-3-[[(1-methyl-1H-tetrazol-5-
yl)thio]methyl]-8-oxo-, [6R-
[6Alpha,7Alpha,7(S*)]]-[CAS]
cefodizime5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-69739-16-8U.S.4,590,267Cephalosporin,Infection,
carboxylic acid, 7-[[(2-amino-4-86329-79-5injectablerespiratory
thiazoyl)(methoxyimino)acetyl]amino]-3-tract, lower
[[[5-(carboxymethyl)-4-methyl-2-
thiazolyl]thio]methyl]-8-oxo-, [6R-
[6Alpha,7β(Z)]]-[CAS]
cefonicid5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-61270-78-8GB1547473Cephalosporin,Infection,
carboxylic acid, 7-[(hydroxyphenylacetyl)-61270-58-4injectablegeneral
amino]-8-oxo-3-[[[1-(sulfomethyl)-1H-
tetrazol-5-yl]thio]methyl]-, disodium salt,
[6R-[6Alpha,7β(R*)]]-[CAS]
cefoperazone5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-62893-19-0GB1508071Cephalosporin,Infection,
carboxylic acid, 7-[[[[(4-ethyl-2,3-dioxo-1-injectablegeneral
piperazinyl)carbonyl]amino](4-
hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-
1H-tetrazol-5-yl)thio]methyl]-8-oxo-, [6R-
[6Alpha,7β(R*)]]-[CAS]
cefoperazone +92739-15-6U.S.4,234,579Antibiotic, otherInfection,
sulbactamgeneral
Ceforanide60925-61-3
cefoselis5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-122841-12-7EP307804Cephalosporin,Infection,
carboxylic acid, 7-[[(2-amino-4-122841-10-5injectablegeneral
thiazolyl)(methoxyimino)acetyl]amino]-3-
[[2,3-dihydro-2-(2-hydroxyethyl)-3-amino-
1H-pyrazol-1-yl]methyl]-8-oxo-, [6R-
[6Alpha,7β(Z)]]
cefotazime(6R,7R)-7-[[(2-amino-4-64485-93-4GB1580621Cephalosporin,Infection,
thiazolyl)(methoxyimino)acetyl]amino]-63527-52-6injectablegeneral
cephalsporanic acidsodium salt
Cefotetan69712-56-7
cefotiam5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-61622-34-2U.S.4,080,498Cephalosporin,Infection,
carboxylic acid, 7-[[(2-amino-4-66309-69-1injectablegeneral
thiazolyl)acetyl]amino]-3-[[[1-[2-
(dimethylamino)ethyl]-1H-tetrazol-5-
yl]thio]methyl]-8-oxo-, (6R-trans)-[CAS]
cefotiam hexetil1-(cyclohexloxycarbonyloxy)ethyl 7β-[2-(2-95789-30-3EP128029Cephalosporin, oralInfection,
aminothiazol-4-yl)acetamido]-3-[[[1-(2-respiratory
dimethylaminoethyl)-1H-tetrazol-5-tract, lower
yl]thio]methyl]ceph-3-em-4-carboxylate
2HCl [CAS]
cefoxitin5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-33564-30-5GB1348984Cephalosporin, oralInfection,
carboxylic acid, 3-35607-66-0general
(((aminocarbonyl)oxy)methyl)-7-methoxy-
8-oxo-7-((2-thienylacetyl)amino)-,
monosodium salt, (6R-cis)-[CAS]
cefozopranImidazo[1,2-b]pyridazinium, 1-[[7-[[(5-113359-04-9EP203271Cephalosporin,Infection,
amino-1,2,4-thiadiazol-3-injectablegeneral
yl)(methoxyimino)acetyl]amino]-2-carboxy-
8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-
yl]methyl]-, hydroxide, inner salt, [6R-
[6Alpha,7β(Z)]]-[CAS]
cefpimizolePyridinium, 1-[[2-carboxy-7-[[[[(5-carboxy-84880-03-5EP60028Cephalosporin,Infection,
1H-imidazol-4-yl)carbonyl]amino]-85287-61-2injectablerespiratory
phenylacetyl]amino]-8-oxo-5-thia-1-tract, general
azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-4-
(2-sulfoethyl)-, hydroxide, inner salt,
[6R-[6Alpha,7β(R*)]]-[CAS]
cefpiramide5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-70797-11-4U.S.4,156,724Cephalosporin,Infection,
carboxylic acid, 7-[[[[(4-hydroxy-6-methyl-injectablegeneral
3-pyridinyl)carbonyl]amino](4-
hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-
1H-tetrazol-5-yl)thio]methyl]-8-oxo-, [6R-
[6Alpha,7β(R*)]]-[CAS]
cefpirome5H-1-Pyrindinium, 1-[[7-[[(2-amino-4-84957-29-9EP64740Cephalosporin,Infection,
thiazolyl)(methoxyimino)acetyl]amino]-2-98753-19-6injectablerespiratory
carboxy-8-oxo-5-thia-1-tract, lower
azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-6,7-
dihydro-,hydroxide, inner salt, [6R-
[6Alpha,7β(Z)]]-[CAS]
Cefpodoxime87239-81-4
Proxetil
cefprozil5-Thio-1-azabicyclo[4.2.0]oct-2-ene-2-92665-29-7GB2173798Cephalosporin, oralInfection,
carboxylic acid, 7-[[amino(4-dermatological
hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-
propenyl)-, [6R-[6Alpha,7β(R*)]]-[CAS]
cefroxadine5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-51762-05-1GB1435111Cephalosporin, oralInfection,
carboxylic acid, 7-[(amino-1,4-general
cyclohexadien-1-ylacetyl)amino]-3-
methoxy-8-oxo-, [6R-[6Alpha,7β(R*)]]-
[CAS]
cefsulodinPyridinium, 4-(aminocarbonyl)-1-[[2-52152-93-9GBCephalosporin,Infection,
carboxy-8-oxo-7-62587-73-9injectablepseudomonal
[(phenylsulfoacetyl)amino]-5-thia-1-
azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,
hydroxide, inner salt, [6R-[6Alpha,7β(R*)]]-
[CAS]
ceftazidimePyridinium, 1-[[7-[[(2-amino-4-thiazolyl)[(1-72558-82-8GB2025398Cephalosporin,Infection,
carboxy-1-methylethoxy)imino]acetyl]amino]-injectablerespiratory
2-carboxy-8-oxo-5-thia-1-tract, upper
azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,
hydroxide, inner salt, [6R-[6Alpha,7β(Z)]]-
[CAS]
Cefteram82547-58-8
Ceftezole26973-24-0
ceftibuten5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-97519-39-6EPCephalosporin, oralInfection,
carboxylic acid, 7-[[2-(2-amino-4-thiazolyl)-respiratory
4-carboxy-1-oxo-2-butenyl]amino]-8-oxo-,tract, lower
[6R-[6Alpha,7β(Z)]]-[CAS]
ceftizoxime5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-68401-81-0GB1600735Cephalosporin,Infection,
carboxylic acid, 7-[[2-(2-amino-4-thiazolyl)-68401-82-1injectablegeneral
(methoxyimino)acetyl]amino]-8-oxo-,
[6R-[6Alpha,7β(Z)]]-[CAS]
ceftizoxime5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-113812-94-5JP62209112Cephalosporin, oralInfection,
alapivoxilcarboxylic acid, 7-[[[2-[(2-amino-1-135767-36-1general
oxopropyl)amino]-4-
thiazolyl](methoxyimino)acetyl]amino]-8-
oxo-, (2,2-dimethyl-1-oxopropoxy)methyl
ester, monohydrochloride, [6R-
[6Alpha,7β(Z(S*))]]-[CAS]
ceftriaxone5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-73384-59-5GB2022090Cephalosporin,Infection,
carboxylic acid, 7-[[(2-amino-4-74578-69-1injectablerespiratory
thiazolyl)(methoxyimino)acetyl]amino]-8-tract, lower
oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-
dioxo-1,2,4-triazin-3-yl)thio]methyl]-, [6R-
[6Alpha,7β(Z)]]-[CAS]
cefuroxime axetil5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-15686-71-2GB1571683Cephalosporin, oralInfection,
carboxylic acid, 3-64544-07-6respiratory
[[(aminocarbonyl)oxy]methyl]-7-[[2-tract, upper
furanyl(methoxyimino)acetyl]amino]-8-oxo-,
1-(acetyloxy)ethyl ester, [6R-
[6Alpha,7β(Z)]]-[CAS]
cefuroxime5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-55268-75-2GB1453049Cephalosporin,Infection,
carboxylic acid, 3-56238-63-2injectablegeneral
[[(aminocarbonyl)oxy]methyl]-7-[[2-
furanyl(methoxyimino)acetyl]amino]-8-oxo-,
1-(acetyloxy)ethyl ester, [6R-
[6Alpha,7β(Z)]]-[CAS]
Cefuzonam82219-78-1U.S.5,760,068Antiarthritic, otherArthritis,
celecoxibBenzenesulfonamide, 4-(5-(4-169590-42-5rheumatoid
methylphenyl)-3-(trifluoromethyl)-1H-
pyrazol-1-yl)-[CAS]
celgosivirButanoic acid, octahydro-1,7,8-trihydroxy-121104-96-9U.S.5,017,563Antiviral, otherInfection,
6-indolizinyl ester, [1S-hepatitis virus,
(1Alpha,6β,7Alpha,8β,8aβ)]-[CAS]general
celiprololUrea, N′-[3-acetyl-4-[3-[(1,1-56980-93-9GB1441359Antihypertensive,Angina,
dimethylethyl)amino]-2-57470-78-7adrenergicunstable
hydroxypropoxy]phenyl]-N,N-diethyl-[CAS]
Cellulose Ethyl
Hydroxyethyl Ether
CEP-13479,12-Epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-156177-65-0WO9731002AntiparkinsonianParkinson's
kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-disease
carboxylic acid, 5,16-bis((ethylthio)methyl)-
2,3,9,10,11,12-hexahydro-10-hydroxy-9-
methyl-1-oxo-, methyl ester, (9S,10R,12R)-
[CAS]
CEP-7019,12-Epoxy-1H-diindolo[1,2,3-fg:3′,2′,1′-111358-88-4Anticancer,
kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one-,antimetaboliteCancer,
2,3,9,10,11,12-hexahydro-10-hydroxy-10-prostate
(hydroxymethyl)-9-methyl-, (9S,10S,12R)-
[CAS]
Cephacetrile23239-41-0
Cephaeline493-17-0
Cephalexin15686-71-2
Cephaloglycin3577-1-3
Cephaloridine50-59-9
Cephalosporin C61-24-5
Cephalothin153-61-7
Cephapirin24356-60-3
Cephradine38821-53-3
Cerivastatin145599-86-6
Ceronapril111223-26-8
certoparinHeparin [CAS]9005-49-6AnticoagulantThrombosis,
venous
Ceruletide17650-98-5
CerviprostProsta-5,13-dien-1-oic acid, 11,15-363-24-6Formulation,
dihydroxy-9-oxo-, (5Z,11Alpha,13E,-15S)-dermal, topical
[CAS]
Cetalkonium122-18-9
Cetamolol34919-98-7
Cethexonium1794-74-7
cethromycin2H-Oxacyclotetradecino(4,3-d)oxazole-205110-48-1EP929563Macrolide antibioticInfection,
2,6,8,14(1H,7H,9H)-tetrone 4-respiratory
ethyloctahydro-3a,7,9,11,13,15-tract, general
hexamethyl-11-((3-(3-quinolinyl)-2-
propenyl)oxy)-10-((33.4.6-trideoxy-3-
(dimethylamino)-β-D-xylo-
hexapyranosyl)oxy)-,(3aS,4R,7R,9R,10R,
11R,13R,15R,15aR)-[CAS]
Cetiedil14176-10-4
Cetirizine83881-51-0
cetirizineAcetic acid, [2-[4-[(4-83881-51-0EP58146Antiallergic,Allergy,
chlorophenyl)phenylmethyl]-1-83881-52-1non-asthmageneral
piperazinyl]-, [CAS]
cetirizine +Acetic acid, [2-[4-[(4-83881-52-1Formulation,Allergy,
pseudoephedrinechlorophenyl)phenylmethyl]-1-90-82-4optimized,general
piperazinyl]ethoxy]-, dihyrochloride,microencapsulate
Benzenemethanol, Alpha-[1-
(methylamino)ethyl]-, hydrochloride, [S-
(R*,R*)]-
Cetotiamine137-76-/8
Cetoxime25394-78-9
cetraxateBenzenepropanoic acid, 4-[[[4-27724-96-5JP48075547Antiulcer
(aminomethyl)cyclohexyl]carbonyl]oxy]-,34675-84-8
trans-[CAS]
Cetrimonium57-09-0
Cetrorelix120287-85-6
Cetyldimethylethyl-124-03-8
ammonium
Cetylpyridinium123-03-5
cevimelineSpiro[1-azabicycol[2.2.2]octane-3,5′-107220-27-9EP205247StromatologicalSjogran's
[1,3]oxathiolane], 2′-methyl-, cis-[CAS]107233-08-9syndrome
CG-15217-phenyl-2,4,6-heptatrienoylhydroxamicAnticancer, otherCancer,
acidgeneral
Chaulmoogric Acid29106-32-9
Chenodiol474-25-9
CHF-3381EP951465Analgesic, otherPain,
neuropathic
Chlophedianol791-35-5
Chloracizine800-22-6
chloral1,1-Ethanediol, 2,2,2-trichloro-[CAS]302-17-0Formulation,Insomnia
2218-68-0transmucosal,
515-82-2systemic
Chlorambucil305-03-3
Chloramine-B127-52-6
Chloramine-T127-65-1
Chloramino-121-30-2
phenamide
Chloramphenicol56-75-7
Chlorazanil500-42-5
Chlorbenzoxamine522-18-9
Chlorbetamide97-27-8
Chlorcyclizine82-93-9
Chlordantoin5588-20-5
Chloriazepoxide58-25-3
Chlorguanide500-92-5
Chlorhexadol3563-58-4
chlorhexidine2,4,11,13-55-56-1Formulation, otherXerostomia,
Tetraazatetradecanediimidamide, N,N′′′-Periodontitis
bis(4-chlorophenyl)-3,12-diimino-[CAS]
Chlorisondamine69-27-2
Chlormadinone302-22-7
Chlormerodrin62-37-3
Chlormezanone80-77-3
Chlormidazole3689-76-7
Chlornaphazine494-03-1
Chloroazodin502-98-7
Chlorophyll1406-65-1
Chloroprednisone52080-57-6
Chloroprocaine3858-89-7
Chloropyramine59-32-5
Chloroquine54-05-7
Chlorothen148-65-2
Chlorothiazide58-94-6
Chlorotrianisene569-57-3
Chloroxine773-76-2
Chloroxylenol88-04-0
Chlorozotocin54749-90-5
chlorphenamine2-Pyridinepropanamine, Gamma-(4-132-22-9Formulation,Allergy,
chlorophenyl)-N,N-dimethyl-[CAS]modified-release, general
other
Chlorphenesin104-29-0
886-74-8
Chlorpheniramine132-22-9
Chlorphenoxamide3576-64-5
Chlorphenoxamine77-38-3
Chlorphentermine461-78-9
Chlorproethazine84-01-5
Chlorproguanil537-21-3
chlorproguanil +4,4′-Sulfonyldianiline + 1-(3,4-537-21-3AntimalarialInfection,
dapsoneDichlorophenyl)5-isopropylbiguanide80-08-0malaria
Chlorpromazine50-53-3
Chlorpropamide94-20-2
Chlorprothixene113-59-7
Chlorquinaldol72-80-0
Chlortetracycline57-62-5
Chlorthalidone77-36-1
Chlorthenoxazine(e)132-89-8
Chlorzoxazone95-25-0
Cholic Acid81-25-4
Choline67-48-1
2016-36-6
28319-77-9
choline theophyllinateEthanaminium, 2-hydroxy-N,N,N-4499-40-5Formulation,
trimethyl-, salt with 3,7-dihydro-1,3-modified-
dimethyl-1H-purine-2,6-dione (1:1) [CAS]release, other
choline-L-alfoscerateEthanaminium, 2-[[2,3-28319-77-9JP55028955Cognition enhancerAmnesia
dihydroxypropoxy)hydroxyphosphinyl]oxy]-
N,N,N-trimethyl-, hydroxide, inner salt,
(R)-[CAS]
Chromocarb4940-39-0
Chromonar804-10-4
Chrysoidine532-82-1
CHS-828Guanidine, N-[6-(4-chlorophenoxy)hexyl]-200484-11-3U.S.5,696,140Anticancer, otherCancer,
N′-cyano-N″-4-pyridinyl-[CAS]general
CI-1031Glycine, N-[2-[5-(aminoiminomethyl)-2-183305-24-0WO9638421AntianginalAngina,
hydroxyphenoxy]-6-[3-(4,5-dihydro-1-unstable
methyl-1H-imidazol-2-yl)phenoxy]-3,5-
difluoro-4-pyridinyl]-N-methyl-[CAS]
CI-1040Benzamide, 2-[(2-chloro-4-212631-79-3WO9837881Anticancer, otherCancer,
iodophenyl)amino]-N-(cyclopropylmethoxy)general
3,4-difluoro-[CAS]
cibenzoline1H-Imidazole, 2-(2,2-diphenylcyclopropyl)-53267-01-9GB1417174AntiarrhythmicArrhythmia,
4,5-dihydro-[CAS]general
ciclesonidePregna-1,4-diene-3,20-dione 16,17-126544-47-6DE4129535AntiasthmaAsthma
((cyclohexylmethylene)bis(oxy))-11-
hydroxy-21-(2-methyl-1-oxopropoxy)
(11β,16Alpha) [CAS]
cicletanineFuro[3,4-c]pyridin-7-ol, 3-(4-chlorophenyl)-82747-56-6U.S.4,383,998Antihypertensive,
1,3-dihydro-6-methyl-, (+/−)-[CAS]89943-82-8other
ciclonicate3-Pyridinecarboxylic acid, 3,3,5-53449-58-4DE1910481Vasodilator,Cancer, lung,
trimethylcyclohexyl ester, trans-[CAS]peripheralsmall cell
ciclopirox2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-41621-49-2U.S.3,883,545AntifungalInfection,
4-methyl-, [CAS]29342-05-0fungal, general
Ciclosidomine66564-16-7
ciclosporin ACyclosporin A-[CAS]59865-13-3Formulation, Transplant
optimized,rejection,
microemulsiongeneral
cidofovirPhosphonic acid, [[2-(4-amino-2-oxo-113852-37-2EP253412Antiviral, otherInfection,
1(2H)-pyrimidinyl)-1-cytomegalo-
(hydroxymethyl)ethoxy]methyl]-, (S)-[CAS]virus
Cifenline53267-01-9
cilansetron4H-Pyrido[3,2,1-jk]carbazol-11(8H)-one,120635-74-7EP297651GI inflammatory/Irritable bowel
5,6,9,10-tetrahydro-10-[(2-methyl-1H-bowel disorderssyndrome
imidazol-1-yl)methyl]-, (R)-[CAS]
Cilastatin82009-34-5
cilazapril6H-Pyridazino[1,2-a][1,2]diazepine-1-88768-40-5GB2128984Antihypertensive,Hypertension,
carboxylic acid, 9-[[1-(ethoxycarbonyl)-3-90139-06-3renin systemgeneral
phenylpropyl]amino]octahydro-10-oxo-,
[1S-[1Alpha,9Alpha(R*)]]-[CAS]
cilengitideCyclo(L-arginylglycyl-L-Alpha-aspartyl-D-188968-51-6EP770622Anticancer, otherCancer, lung,
phenylalanyl-N-methyl-L-valyl) [CAS]non-small cell
cilnidipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-102106-21-8EP161877Antihypertensive,Hypertension,
2,6-dimethyl-4-(3-nitrophenyl)-, 2-132203-70-4othergeneral
methoxyethyl 3-phenyl-2-propenyl ester-
[CAS]
cilomilastCis-4-cyano-4-[3-(cyclopentyloxy)-4-153259-65-5U.S.5,602,157COPD treatmentChronic
methoxyphenyl]cyclohexane-1-carboxylicobstructive
acidpulmonary
disease
cilostazol2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-73963-72-1GB2033893AntithromboticPeripheral
tetrazol-5-yl)butoxy]-3,4-dihydro-[CAS]vascular
disease
Cimetidine51481-61-9
cimetropium3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,51598-60-8U.S.3,853,886AntipasmodicMuscle spasm,
9-(cyclopropylmethyl)-7-(3-hydroxy-1-oxo-general
2-phenylpropoxy)-9-methyl-, [7(S)-
(1Alpha,2β,4β,5Alpha,7β)]-[CAS]
cinacalcet1-naphthalenemethanamine,Alpha-methyl-364782-34-3HormoneHyperpara-
N-[3-[3-(trifluoromethyl)phenyl]propyl]-,thyroidsm
(AlphaR)-,
Cinchonidine485-71-2
Cinchonine118-10-5
Cinchophen132-60-5
Cinepazet23887-41-4
Cinepazide23887-46-9
cinepazidePiperazine, 1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-26328-04-1GB1218591Vasodilator,Peripheral
4-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-peripheralvascular
propenyl]-, (Z)-2-butenedioate (1:1) [CAS]disease
Cinitapride66564-14-5
Cinmetacin20168-99-4
Cinnamedrine90-86-8
Cinnarizine298-57-7
cinolazepam1H-1,4-Benzodiazepine-1-propanenitrile, 7-75696-02-5DE2950235Hypnotic/SedativeInsomnia
chloro-5-[2-fluorophenyl)-2,3-dihydro-3-
hydroxy-2-oxo-[CAS]
cinoxacin[1,3]Dioxolo[4,5-g]cinnoline-3-carboxylic28657-80-9GB1296753QuinoloneInfection,
acid, 1-ethyl-1,4-dihydro-4-oxo-[CAS]antibacterialurinary tract
Cinoxate104-28-9
Cinromide58473-74-8
Cioteronel89672-11-7
cipamfylline1H-Purine-2,6-dione, 8-amino-1,3-132210-43-6EP389282Antipruritic/inflamm,Eczema,
bis(cyclopropylmethyl)-3,7-dihydro-[CAS]allergicatopic
cipralisant1H-Imidazole, 4-[(1R,2R)-2-(5,5-dimethyl-213027-19-1U.S.6,008,240PsychostimulantAttention
1-hexynyl)cyclopropyl]-[CAS]deficit
disorder
ciprofibratePropanoic acid, 2-[4-(2,2-52214-84-3GB1385828Hypolipaemic/Hyper-
dichlorocyclopropyl)phenoxy]-2-methyl-Antiatherosclerosislipidaemia,
[CAS]general
ciprofloxacin3-Quinolinecarboxylic acid, 1-cyclopropyl-6-85721-33-1U.S.4,670,444Quinolone Infection,
fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-antibacterialgeneral
[CAS]
ciprofloxacin +3-Quinolinecarboxylic acid, 1-Cyclopropyl-6Formulation, Otitis
fluocinolone, SALfluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)- +fixed-dose
(6Alpha, 11β, 16Alpha)-6,9-Difluoro-combinations
11,21-dihydroxy-16,17-[(1-
methylethylidene)bis-(oxy)]-pregna-1,4-
diene-3,20-dione
Ciramadol63269-31-8
cisaprideBenzamide, 4-amino-5-chloro-N-[1-[3-(4-81098-60-4EP76530Gastroprokinetic
fluorophenoxy)propyl]-3-methoxy-4-
piperidinyl]-2-methoxy-, cis-[CAS]
cisatracuriumIsoquinolinium, 2,2′-[1,5-96946-42-8U.S.5,453,510Muscle relaxantSurgery
pentanediylbis[oxy(3-oxo-3,1-adjunct
propanediyl)]]bis[1-[(3,4-
dimethoxyphenyl)methyl]]-1,2,3,4-
tetrahydro-6,7-dimethoxy-2-methyl-, [1R-
[1Alpha,2Alpha(1′R*,2′R*)]]-, [CAS]
cisplatinPlatinum, diamminedichloro-, (SP-4-2)-15663-27-1U.S.4,177,263Anticancer,
[CAS]alkylating
citalopram5-Isobenzofurancarbonitrile, 1-[3-59729-32-7GB1526331AntidepressantDepression,
(dimethylamino)propyl]-1-(4-fluorophenyl)-59729-33-8general
1,3-dihydro-[CAS]
citicolineCytidine 5′-(trihydrogen diphosphate), P′-987-78-0JP39006541Cognition enhancerInfarction,
[2(trimethylammonio)ethyl]ester, hydroxide,cerebral
inner salt [CAS]
Citiolone1195-16-0
Citric Acid77-92-9
Citrulline372-75-8
cizolirtineEthanamine, N,N-dimethyl-2-[(1-methyl-1H142155-44-0UrologicalIncontinence
pyrazol-5-yl)phenylmethoxy]-, 2-hydroxy-
1,2,3-propanetricarboxylate [CAS]
CJ-136104-(3-[4-(2-Methyl-imidazol-1-yl)-COPD treatmentChronic
phenylsulfanyl]-phenyl)-tetrahydro-pyran-4-obstructive
carboxylic acid amidepulmonary
disease
CKD-6021H-Pyrano[3′,4′:6,7]indolizino[1,2-213819-48-8WO9902530Anticancer, otherCancer,
b)quinoline-3,15(4H,12H)-dione, 4-ethyl-4-ovarian
hydroxy-11-[2-[(1-methylethyl)amino]ethyl]-,
monohydrochloride, (4S)- [CAS]]
cladribineAdenosine, 2-chloro-2′-deoxy-[CAS]4291-63-8EP173059Anticancer,Cancer,
antimetaboliteleukaemia,
hairy cell
Clanobutin30544-61-7
clarithromycinErythromycin, 6-O-methyl-[CAS]81103-11-9EP41355Macrolide antibioticInfection,
respiratory
tract, lower
Clavulanate,
Disodium
Clavulanic Acid58001-44-8
Clebopride55905-53-8
Clemastine15686-51-8
Clemizol442-52-4
Clenbuterol37148-27-9
Clentiazem96125-53-0
clevidipine3,5-Pyridinedicarboxylic acid, 4-(2,3-167221-71-8WO9512578Antihypertensive,Hypertension,
dichlorophenyl)-1,4-dihydro-2,6-dimethyl-,othergeneral
methyl (1-oxobutoxy)methyl ester (±)
[CAS]
clevudine2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-2-163252-36-6Antiviral, otherInfection,
fluoro-β-L-arabinofuranosyl)-5-methyl-hepatitis-B
[CAS]virus
Clidanac28968-07-2
Clidinium3485-62-9
Clinafloxacin105956-97-6
Clindamycin18323-44-9
clindamycin +L-threo-Alpha-D-galacto-Octopyranoside,Formulation, Acne
tretinoinmethyl 7-chloro-6,7,8-trideoxy-6-[[(1-fixed-dose
methyl-4-propyl-2-combinations
pyrrolidinyl)carbonyl]amino]-1-thio, (2S-
trans)- + retinoic acid
clindamycinL-Threo-Alpha-D-galacto-octopyranoside,18323-44-9Formulation,Infection,
methyl 7-chloro-6,7,8-trideoxy-6-[[(1-24729-96-2parenteral, othergynaecolo-
methyl-4-propyl-2-gical
pyrrolidinyl)carbonyl]amino]-1-thio-, 2-
(dihydrogen phosphate), (2S-trans)-
Clinofibrate30299-08-2
Clinprost88931-51-5
clobazam1H-1,5-Benzodiazepine-2,4(3H,5H)-dione,22316-47-8GB1214662Anxiolytic
7-chloro-1-methyl-5-phenyl-[CAS]
Clobenfurol3611-72-1
Clobenoside29899-95-4
Clobenzepam1159-93-9
Clobenzorex13364-32-4
Clobenztropine5627-46-3
clobetasolPregna-1,4-diene-3,20-dione, 21-chloro-9-25122-41-2Formulation, dermal,Psoriasis
fluoro-11,17-dihydroxy-16-methyl-,topical
(11β,16β)-[CAS]
clobetasonePregna-1,4-diene-3,11,20-trione, 21-25122-57-0GB1253831Antipruritic/
chloro-9-fluoro-16-methyl-17-(1-54063-32-0inflamm, allergic
oxobutoxy)-, (16β)-[CAS]
Clobutinol14860-49-2
Clocapramine47739-98-0
Clocinizine298-55-5
Cloconazole77175-51-0
Clocortolone4828-27-7
clodronatePhosphonic acid, (dichloromethylene)bis-22560-50-5Osteoporosis Pain, cancer,
[CAS]treatment,Hyper-
Anticancer, calcaemia of
hormonalmalignancy
Clodronic Acid10596-23-3
clofarabine2-chloro-9-(2-deoxy-2-fluoro-β-D-Anticancer,Cancer,
arabinofurasonyl)adenineantimetaboliteleukaemia,
chronic
lymphocytic
clofazimine3-(p-chloroanilo)-10-(p-chlorophenyl)-2,10-2030-63-9Formulation, Infection,
dihydro-2-(isopropylimino)-phenazineoptimized,tuberculosis
microencapsulate
Clofenamide671-95-4
Clofibrat637-07-0
Clofibric Acid882-09-7
Cloflucarban369-77-7
Clofoctol37693-01-9
Cloforex14261-75-7
Clomacran5310-55-4
Clomestrone4091-75-2
Clometacin25803-14-9
Clomethiazole533-45-9
Clometocillin1926-49-4
Clomiphene911-45-5
Clomipramine303-49-1
Clomocycline1181-54-0
clonazepam2H-1,4-Benzodiazepin-2-one, 5-(2-1622-61-3U.S.4,316,897AntiepilepticEpilepsy,
chlorophenyl)-1,3-dihydro-7-nitro-[CAS]general
clonidine1H-Imidazol-2-amine, N-(2,6-4205-90-7U.S.4,060,084Formulation,Hypertension,
dichlorophenyl)-4,5-dihydro-[CAS]transdermal, patchgeneral
Clonitazene3861-76-5
Clonitrate2612-33-1
Clonixin17737-65-4
Clopamid636-54-4
Clopenthixol982-24-1
Cloperastine3703-76-2
clopidogrelThieno[3,2-c]pyridine-5(4H)-acetic acid,120202-48-4EP99802AntithromboticInfarction,
Alpha-(2-chlorophenyl)-6,7-dihydro-,90055-48-4myocardial
methyl ester, (S)-[CAS]113665-84-2
Clopirac42779-82-8
Cloprednol5251-34-3
cloranolol2-Propanol, 1-(2,5-dichlorophenoxy)-3-39563-28-5U.S.4,310,549Antihypertensive,
[(1,1-dimethylethyl)amino]-[CAS]54247-25-5adrenergic
Clorazepic Acid23887-31-2
Clorexolone2127-1-7
cloricromeneAcetic acid, [[8-chloro-3-[2-68206-94-0U.S.4,349,566Vasodilator,Peripheral
(diethylamino)ethyl]-4-methyl-2-oxo-2H-1-coronaryvascular
benzopyran-7-yl]oxy]-, ethyl ester [CAS]disease
Clorindione1146-99-2
Clorprenaline3811-25-4
Clortermine10389-73-8
Clospirazine24527-27-3
Clostebol1093-58-9
Clothiapine2058-52-8
clotiazepam2H-Thieno[2,3-e]-1,4-diazepin-2-one, 5(2-33671-46-4U.S.3,849,405AnxiolyticAnxiety,
chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-general
[CAS]
clotrimazole1-[(2-chlorophenyl)diphenylmethyl]-1H-23593-75-1U.S.3,705,172Antifungal
imidazole
clotrimazole +Pregna-1,4-diene-3,20-dione, 9-fluoro-11-92522-91-3Formulation, Infection,
betamethasonehydroxy-16-methyl-17,21-bis(1-fixed-dosefungal,
oxopropoxy)-, (11β,16β)-, mixt. with 1-[(2-combinationsgeneral
chlorophenyl)diphenylmethyl]-1H-
imidazole [CAS]
Cloxacillin61-72-3
cloxazolamOxazolo[3,2-d][1,4]benzodiazepin-6(5H)-24166-13-0U.S.3,442,371Anxiolytic
one, 10-chloro-11b-(2-chlorophenyl)-
2,3,7,11b-tetrahydro-[CAS]
Cloxotestosterone53608-96-1
Cloxyquin130-16-5
clozapine5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-5786-21-0U.S.3,539,573NeurolepticSchizophrenia
11-(4-methyl-1-piperazinyl)-[CAS]
CMI-392Trans-2-[3-methoxy-4-(2-p-193739-23-0U.S.5,648,486AntipsoriasisPsoriasis
chlorophenylthio)ethoxy-5-(N′-methyl-N′-
hydroxyureidyl)methylphenyl]-5-(3,4,5-
trimethoxyphenyl)tetrahydrofuran
CMT-32-Naphthacenecarboxamide,15866-90-7U.S.5,837,696Anticancer, otherCancer,
1,4,4a,5,5a,6,11,12a-octahydro-sarcoma,
3,10,12,12a-tetrahydroxy-1,11-dioxo-,Kaposi's
(4aS,5aR,12aS)-[CAS]
CNI-1493Decanediamide, N,N′-bis[3,5-bis[1-164301-51-3U.S.5,750,573Anti-inflammatoryPsoriasis
[(aminoiminomethyl)hydrazono]ethyl]-
phenyl]-, tetrahydrochloride [CAS]
CNS-5161N′-[2-chloro-5-(methylthio)phenyl]-N-160754-76-7WO9427591Analgesic, otherPain,
methyl-N-[3-(methylthio)phenyl]guanideneuropathic
[CAS]
Cobamamide13870-90-1
Cocaethylene529-38-4
Cocaine50-36-2
Codeine76-57-3
52-28-8
CoFactor5,10 methylene-tetrahydrofolateAnticancer,Cancer,
antimetavolitecolorectal
Colchicine64-86-8
colesevelam1-Hexanaminium, N,N,N-trimethyl-6-(2-182815-44-7U.S.5,607,669Hypolipaemic/Hyper-
propenylamino)-, polymer withAntitherosclerosislipidaemia,
(chloromethyl)oxirane, 2-propen-1-aminegeneral
and N-2-propenyl-1-decanamine,
hydrochloride [CAS]
colestilan1H-Imidazole, 2-methyl-, polymer with95522-45-5JP59155421Hypolipaemic/Hyper-
(chloromethyl)oxirane [CAS]Antitherosclerosischolesterol-
aemia
Colestipol26658-42-4
colforsin daropate6-(3-dimethylaminopropionyl)forkolin-138605-00-2EP222413CardiostimulantHeart failure
[CAS]
colfosceril3,5,9-Trioxa-4-phosphapentacosan-1-63-89-8U.S.4,826,821Lung SurfactantRespiratory
aminium, 4-hydroxy-N,N.N-trimethyl-10-99732-49-7distress
oxo-7-[(1-oxohexadecyl)oxy]-, hydroxide,syndrome,
inner salt, 4-oxide, (R)-[CAS]infant
Collagraft138331-02-9Formulation, Regeneration,
implantbone
Colocynthin1398-78-3
Colpormon1247-71-8
coluracetam1-Pyrrolidineacetamide, 2-oxo-N-(5,6,7,8-135463-81-9EP427636Cognition enhancerAlzheimer's
tetrahydro-2,3-dimethylfuro[2,3-b]quinolin-disease
4-yl)-[CAS]
combretastatin A-4disodium combretastatin-A-4-3-O-Anticancer, otherCancer, thyroid
prodrugphosphate
compound B,U.S.6,362,165Antiviral, anti-HIVInfection,
PharmacorHIV/AIDS
conivaptin[1,1′-Biphenyl]-2-carboxamide, N-[4-[(4,5-168626-94-6WO9503305GI inflammatory/Hyponatraemia
dihydro-2-methylimidazo[4,5-d][1-bowel disorders
benzazepin-6(1H)-yl)carbonyl]phenyl]-,
[CAS]
ConnettivinaHyaluronic acid [CAS]9004-61-9Vulnerary
Convallatoxin508-75-8
Coparaffinate8001-60-3
Corticorelin Ovine
Triflutate
Corticosterone50-22-6
Cortisone53-06-5
Cortivazol1110-40-3
Cosyntropin16960-16-0
Cotarnine82-54-2
Cotinine486-56-6
co-trimazineBenzenesulfonamide, 4-amino-N-2-39474-58-3Trimethoprim andInfection,
pyrimidinyl-, mixt. with 5-[(3,4,5-analoguesurinary tract
trimethoxyphenyl)methyl]-2,4-
pyrimidinediamine [CAS]
Coumetarol4366-18-1
CP-2481H-Indene-3-acetamide, 5-fluoro-2-methyl-200803-37-8WO9747303Anticancer, otherBarrett's
N-(phenylmethyl)-1-[(3,4,5-oesophagus
trimethoxyphenyl)methylene]-, (1Z)-
[CAS]
CP-461U.S.5,948,779Anticancer, otherCancer, prostate
CPC-211Acetic acid, dichloro-, sodium salt [CAS]2156-56-1NeuroprotectiveAcidosis, lactic
CPI-1189CPI 1189 [CAS]210475-67-5WO9631462Congnition enhancerDementia, AIDS-
related
CRA-0450WO0202549AnxiolyticUnspecified
creatinol-O-phosphateGuanidine, N-methyl-N-[2-6903-79-3Antianginal
(phosphonooxy)ethyl]-[CAS]
CRL-5861Oxirane, methyl-, polymer with oxirane,106392-12-5U.S.4,837,014AntisicklingAnaemia, sickle
block [CAS]cell
crobenetine(2R,6S)-3-[2(S)-Benzyloxypropyl]-6,11,11-WO9914199NeuroprotectiveIschaemia,
trimethyl-1,2,3,4,5,6,-hexahydro-2,6-cerebral
methano-3-benzazocin-10-ol
croconazole1H-Imidazole, 1-[1-[2-[(3-77175-51-0DE3021467AntifungalInfection,
chlorophenyl)methoxy]phenyl]ethenyl]-fungal,
[CAS]general
cromoglicic acid4H-1-Benzopyran-2-carboxylic acid, 5,5′-53736-52-0Formulation, Conjunctiv-
[(2-hydroxy-1,3-propanediyl)bis(oxy)]bs4-mucosal, topicalitis
oxo-[CAS]
cromolyn4H-1-Benzopyran-2-carboxylic acid, 5,5′-15826-37-6Formulation, Asthma
[(2-hydroxy-1,3-propanediyl)bis(oxy)]bis4-16110-51-3inhalable, solution
oxo-[CAS]
Cropropamide633-47-6
Crotamiton483-63-6
Crotethamide6168-76-9
CrystacideU.S.4,557,935Formulation, dermal,Infection,
topicaldermatological
CS-502EP799823Analgesic, otherPain, general
CS-7584-[(1E,3E)-4-[trans-5-[(1R,2R)-2-(2,4-AntifungalInfection,
difluorophenyl)-2-hydroxy-1-methyl-3-(1H-fungal,
1,2,4-triazol-1-yl)propyl]thio]-1,3-dioxan-2-general
yl]-1,3-butadienyl]-3-fluorobenzonitrile
CS-8341-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic157542-49-9EP599512Beta-lactamInfection,
acid, 6-[(1R)-1-hydroxyethyl]-4-methyl-7-antibioticgeneral
oxo-3-[[(3R)-5-oxo-3-pyrrolidinyl]thio]-,
(2,2-dimethyl-1-oxopropoxy)methyl ester,
(4R,5S,6S)-[CAS]
CT-052923[(2H-benzo[d]1,3-dioxalan-5-CardiovascularRestenosis
methyl)amino][4-(6,7-dimethoxyquinazolin-
4-yl)piperazinyl]methane-1-thione
CT-32228N-(4-bromophenyl)-6-(5-chloro-2-Anticancer, otherCancer,
methylphenyl)-[1,3,5]triazine-2,4-diaminegeneral
Cupric Citrate866-82-0
Cuproxoline13007-93-7
CVT-2584Ethanol, 2,2′-[[6-[[(4-199986-75-9WO9805335CardiovascularRestenosis
methoxyphenyl)methyl]amino]-9-(1-
methylethyl)-9H-purin-2-yl]imino]bis-
[CAS]
CX-659S((S)-6-amino-5-(6-hydroxy-2,5,7,8-DermatologicalEczema,
tetramethylchroman-2-carboxamido)-3-general
methyl-1-phenyl-2,4-(1H,3H)-
pyrmidinedione
Cyacetacide140-87-4
Cyamemazine3546-03-0
Cyanidin528-58-5
CYC400WO00172745Anticancer, otherCancer,
general
Cyclacillin3485-14-1
Cyclandelate456-59-7
Cyclazocine3572-80-3
Cyclexanone15301-52-7
Cyclexedrine532-52-5
cyclidrol3-Cyclohexene-1-methanol, 5-hydroxy-498-71-5COPD treatment,Bronchitis,
Alpha,Alpha,4-trimethyl-[CAS]Respiratorychronic
cyclin D1 inhibitorsU.S.6,033,843Anticancer, Cancer,
hormonalbreast
Cyclizine82-92-8
Cyclobarbital52-31-3
Cyclobendazole31431-43-3
cyclobenzaprine1-Propanamine, 3-(5H-303-53-7Formulation, Muscle
dibenzo[a,d]cyclohepten-5-ylidene)-N,N-modified-spasm,
dimethyl-[CAS]release, othergeneral
Cyclobutyrol512-16-3
Cyclocumarol518-20-7
Cyclodrine52109-93-0
Cyclofenil2624-43-3
Cycloguanil516-21-2
Cyclomethycaine139-62-8
Cycloniumelodide6577-41-9
Cyclopentamine102-45-4
Cyclopenthiazide742-20-1
Cyclopentobarbital76-68-6
Cyclopentolate512-15-2
cyclophosphamideN,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-50-18-0Formulation, Cancer,
oxazaphosphorin-2-amine-2-oxide6055-19-2parenteral, targetedgeneral
monohydrate
cyclopiroxalamine2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-41621-49-2Formulation, Vaginitis
4-methyl-, cmpd with 2-aminoethanol(1:1)transdermal, other
[CAS]
Cycloserine68-41-7
Cyclothiazide2259-96-3
Cyclovalone579-23-7
Cymarin508-77-0
cymserineCarbamic acid, [4-(1-methylethyl)phenyl]-,145209-39-8WO9902154Cognition enhancerAlzheimer's
(3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-disease
trimethylpyrrolo[2,3-b]indol-5-yl ester
[CAS]
Cynarin(e)30964-13-7
CYP26 inhibitorsU.S.6,063,606DermatologicalUnspecified
Cyproheptadine129-03-3
cyproterone(1β,2β)-6-Chloro-1,2-dihydro-17-hydroxy-2098-66-0Radio/Chemotherapy-
3′H-cyclopropa[1,2]pregna-1,4,6-triene-chemoprotectiveinduced injury,
3,20-dione [CAS]general
Cysteamine60-23-1
cystic fibrosis ther[[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methyl-Cystic fibrosisCystic fibrosis
ethyl]phenoxy]methyl]phenyl]methoxy]-treatment
phenyl]iminomethyl]-, ethyl ester
cytarabine2(1H)-Pyrimidinone, 4-amino-1-[5-O-65093-40-5EP239015Anticancer,Myelodysplastic
[hydroxy(octadecyloxy)phosphinyl]-β-D-147-94-4antimetabolitesyndrome
arabinofuranosyl]-, [CAS]
D-24851N-(Pyridin-4-yl)-(1-(4-chlorobenzyl)-indol-3-Anticancer, otherCancer, general
yl)-glyoxyl-amide)
D-44188-Methoxyquinoline-5-[N-(2,5-AntiasthmaAsthma
dichloropyridin-3-yl)]carboxamide
DA-5018Benzeneacetamide, 4-(2-aminoethoxy)-N-174661-97-3U.S.5,242,944Analgesic, otherPain,
(3-(3,4-dimethylphenyl)propyl)-3-methoxy-,musculoskeletal
monohydrochloride [CAS]
DA-6034U.S.6,025,387GI inflammatory/Crohn's disease
bowel disorders
DA-7867KR9957803Antibacterial, otherInfection,
general
DA-7911KR56034Antiarthritic, otherArthritis,
rheumatiod
DA-81593-(1-Methyl-7-oxo-3-propyl-6,7-dihydro-1H-KR353014Male sexualSexual
pyrazolo-[4,3-d]pyrimidin-5-yl)-N-[2-(1-dysfunctiondysfunction,
methylpyrrolidin-2-yl)ethyl]-4-male, general
propoxybenzenesulfonamide
Dacarbazine4342-3-4
Daclizumab152923-56-3
Dactinomycin50-76-0
dalbavancin5,31-Dichloro-38-de(methoxycarbonyl)-7-171500-79-1Peptide antibioticInfection,
demethyl-19-deoxy-56-O-[2-deoxy-2-(10-dermatolo-
methylundecanamido)-β-D-gical
glucopyranurosyl]-38-[N-[3-
(dimethylamino)propyl]carbamoyl]-42-O-
Alpha-D-mannopyranosyl-N15-
methylristomycin A aglycone
Dalfopristin112362-50-2
dalfopristin +Virginiamycin M1, 26-((2-126602-89-9EP248703Antibiotic, otherInfection,
quinupristin(diethylamino)ethyl)sulfonyl)-26,27-dihydro-,respiratry
(26R,27S)-, mixt with 4-(4-tract, general
(dimethylamino)-N-methyl-L-
phenylalanine)-5-(5-((1-
azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-
oxo-L-2-piperidinecarboxylic acid)
virginiamycin S1-[CAS]
dalteparinHeparin-, [CAS]9041-08-1U.S.4,303,651AnticoagulantThrombo-
prophylaxis
Daltroban79094-20-5
δ-Aminolevulinic Acid106-60-5
danaparoidEP66908AnticoagulantThrombosis,
venous
danazolPregna-2,4-dien-20-yno[2,3-d]isoxazol-17-17230-88-5GB905844Menstruation
ol, (17Alpha)-[CAS]disorders
Danthron117-10-2
Dantrolene7261-97-4
dapiprazole1,2,4-Triazolo[4,3-a]pyridine, 5,6,7,8-72822-12-9U.S.4,252,721OphthalmologicalGlaucoma
tetrahydro-3-[2-[4-(2-methylphenyl)-1-72822-13-0
piperazinyl]ethyl]-[CAS]
dapivirine4-[[4-(2,4,6-244767-67-7Antiviral, anti-HIVInfection,
trimethylphenyl)amino]pyrimidin-2-HIV/AIDS
yl]amino]benzonitrile
dapoxetine(+)-(S)-N,N-dimethyl-Alpha-[2-(1-naphthyl-119356-77-3EP288188Male sexualPremature
oxy)ethyl]benzylamine HCldysfunctionejaculation
dapsone4,4′-Sulfonyldianiline80-08-0Formulation, dermal,Acne
topical
daptomycinDaptomycin [CAS]103060-53-3EP178152Peptide antibioticInfection,
dermatological
Darbepoetin Alfa
darifenacin3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-133099-04-4EP388054UrologicalOveractive
5-benzofuranyl)ethyl]-Alpha,Alpha-bladder
diphenyl-. (S)-[CAS]
daunorubicin5,12-Naphthacenedione, 8-acetyl-10-[(3-20830-81-3U.S.5,441,745Formulation,Cancer,
amino-2,3,6-trideoxy-Alpha-L-lyxo-optimized, liposomessarcoma,
hexopyranosyl)oxy]-7,8,9,10-tetrahydro-Kaposi's
6,8,11-trihydroxy-1-methoxy-, (8S-cis)-
[CAS]
DAX< SciClone3-diallyl-8-cyclohexylxanthineCystic fibrosisCystic
treatmentfibrosis
DB-677-tert-Butyldimethylsilyl-10-Anticancer, otherCancer,
hydroxycamptothecingeneral
d-Camphocarboxylic18530-30-8
DCF-987DextranU.S.5,514,665Formulation, otherCystic fibrosis
DDT50-29-3
Deaminooxytocin113-78-0
Deanol108-01-0
Debrisoquin1131-64-2
Decamethonium541-22-0
Decimemide14817-09-5
decitabine1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-23339-46-0Anticancer,Myelo-
deoxy-β-D-erythro-pentofuranosyl)-[CAS]2353-33-5antimetabolitedysplastic
syndrome
declopramideBenzamide, 4-amino-3-chloro-N-(2-891-60-1WO9732582Anticancer, otherCancer,
(diethylamino)ethyl)-[CAS]colorectal
Deferiprone30652-11-0
Deferoxamine70-51-9
deflazacort5′H-Pregna-1,4-dieno[17,16]oxazole-14484-47-0GB1077393HormoneAsthma
3,20-dione, 21-(acetyloxy)-11-hydroxy-2′-74712-90-6
methyl-, (11β,16β)-[CAS]
Defosfamide3733-81-1
degarelixN-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-214766-78-6Anticancer,Cancer,
chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-hormonalprostate
alanyl-L-seryl-4-[[[(4S)-2,6-
dioxohexahydropyrimidin-4-
yl]carbonyl]amino]-L-phenylalanyl-4-
(carbamoylamino)-D-phenylalanyl-L-leucyl-
N6-(1-methylethyl)-L-lysyl-L-prolyl-D-
alaninamide
dehydroascorbic acidL-threo-2,3-Hexodiulosonic acid gamma-490-83-5Cognition enhancerAlzheimer's
lactonedisease
Dehyrdocholic Acid81-23-2
Dehydroemetine4914-30-1
delaprilGlycine, N-(2,3-dihydro-1H-inden-2-yl)-N-83435-66-9EP51391Antihypertensive,Hypertension,
[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-83435-67-0renin systemgeneral
alanyl]-, (S)-[CAS]
delapri + manidipineGlycine, N-(2,3-dihydro-1H-inden-2-yl)-N-FR2733911Formulation, Hypertension,
[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-fixed-dosegeneral
alanyl]-, (S)-3,5-Pyridinedicarboxylic acid,combinations
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,
2-[4-(diphenylmethyl)-1-piperazinyl]ethyl
methyl ester [CAS]
delavirdinePiperazine, 1-[3-[(1-methylethyl)amino]-2-136817-59-9WO9109849Antiviral, anti-HIVInfection,
pyridinyl]-4-[[5-(methylsulfonyl)amino]-1H-HIV/AIDS
indol-2-yl]carbonyl]-[CAS]
Delmadinone13698-49-2
Delmopinol79874-76-3
delorazepam2H-1,4-Benzodiazepin-2-one, 7-chloro-5-2894-67-9CH408029Anxiolytic
(2-chlorophenyl)-1,3-dihydro-[CAS]
delucemine3,3-Bis-(m-fluorophenyl)-N-186495-99-8NeuroprotectiveIschaemia,
methylpropylamine [CAS]cerebral
Demanyl6909-62-2
Demecarium56-94-0
demeclocycline2-Naphthacenecarboxamide, 7-chloro-4-127-33-3Formulation, Infection,
(dimethylamino)-1,4,4a,5,5a,6,11,12a-modified-general
octahydro-3,6,10,12,12a-pentahydroxy-release, <=24 hr
1,11-dioxo-, [4S-
(4Alpha,4aAlpha,5aAlpha,6β,12Alpha)]-
[CAS]
Demecolcine477-30-5
Demegestone10116-22-0
Demexiptilline24701-51-7
denaverineBenzeneacetic acid, Alpha-(2-ethylbutoxy)-3321-06-0DE4133785Analgesic, NSAIDPain,
Alpha-phenyl-, 2-(dimethylamino)ethylmusculo-
ester, [CAS]skeletal
Denileukin Diftitox173146-27-5
Denopamine71771-90-9
Denopterin22006-84-4
Deoxycholic Acid83-44-3
Deoxycorticosterone64-85-7
Deoxydihydro-26086-49-7
streptomycin
Deoxyepinephrine501-15-5
Depreotide161982-62-3
depsipeptideL-Valine, N-[(3S,4E)-3-hydroxy-7-128517-07-7EP352646Anticancer, antibioticCancer,
mercapto-1-oxo-4-heptenyl]-D-valyl-D-general
cysteinyl-(2Z)-2-amino-2-butenoyl-, (4-1)-
lactone, cyclic (1-2)-disulfide [CAS]
Deptropine604-51-3
Dequalinium522-51-0
dersalazineBenzoic acid, 2-hydroxy-5-[[4-[3-[4-(2-188913-57-7U.S.5,747,477Anti-inflammatoryColitis,
methyl-1H-imidazol[4,5-c]pyridin-1-188913-58-8ulcerative
yl]methyl]-1-piperidinyl]-3-oxo-1-phenyl-1-
propenyl]phenyl]azo] (Z) [CAS]
Deserpidine131-01-1
desferrioxamineButanediamide, N′-[5-[[4-[[5-70-51-9AntidotePoisoning,
(acetylhydroxyamino)pentyl]amino]-1,4-metal
dioxobutyl]hydroxyamino]pentyl]-N-(5-
aminopentyl)-N-hydroxy-[CAS]
Desflurane57041-67-5
Desipramine50-47-5
Deslanoside17598-65-1
desloratadine5H-Benzo(5,6)cyclohepta(1,2-b)pyridine, 8-100643-71-8U.S.5,595,997Antiallergic,Rhinitis,
chloro-6,11-dihydro-11-(4-piperidinylidene)-non-asthmaallergic,
[CAS]perennial
deslorelinLuteinizing hormone-releaseing factor (pig),57773-65-6U.S.4,034,082Releasing hormonesCancer,
6-D-tryptophan-9-(N-ethyl-L-prolinamide)-prostate
10-deglycinamide-[CAS]
desmopressinVasopressin, 1-(3-mercaptopropanoic16679-58-6DE2948345HormoneEnuresis
acid)-8-D-arginine-[CAS]
Desogestrel54024-22-5
desogestrel + estradiolEstra-1,3,5(10)-triene-3,17-diol (17β)-,122364-17-4Menopausal disordersHormone
mixt. with (17Alpha)-13-ethyl-11-replacement
methylene-18,19-dinorpregn-4-en-20-yn-therapy
17-ol [CAS]
desogestrel, Akzo18,19-Dinorpregn-4-en-20-yn-17-ol, 13-54024-55-5Formulation, oral,Contraceptive,
Nobelethyl-11-methylene-, (17Alpha)-[CAS]otherfemale
desogestrel +18,19-Dinorpregn-4-en-20-yn-17-ol, 13-54024-22-5U.S.3,927,046Formulation, oral,Contraceptive,
ethinylestrad (1)ethyl-11-methylene-, (17Alpha)-[CAS]71138-35-7otherfemale
Desomorphine427-00-9
Desonide638-94-8
Desoximetasone382-67-2
Detaxtran9015-73-0
DevacadeWO9308176Analgesic, otherPain, general
dexamethasonePregna-1,4-diene-3,20-dione, 9-fluoro-50-02-2Formulation, otherInflammation,
11,17,21-trihydroxy-16-methyl-,2392-39-4ocular
(11β,16Alpha)-[CAS]312-93-6
dexanabinol6H-Dibenzo[b,d]pyran-9-methanol, 3-(1,1-112924-45-5EP427518NeuroprotectiveHead trauma
dimethylheptyl)-6a,7,10,10a-tetrahydro-1-
hydroxy-6,6-dimethyl-, (6aS-trans)-[CAS]
dexecadotrilGlycine, N-[2-[(acetylthio)methyl]-1-oxo-3-112573-72-5EP318377Alimentary/Unspecified
phenylpropyl]-, phenylmethyl ester, (R)-Metabolic, other
[CAS]
dexefaroxan1H-Imidazole, 2-(2-ethyl-2,3-dihydro-2-89197-00-2EP71368Cognition enhancerAlzheimer's
benzofuranyl)-4,5-dihydro-[CAS]89197-32-0disease
Dexetimide21888-98-2
dexibuprofenBenzeneacetic acid, Alpha-methyl-4-(2-51146-56-6Analgesic, NSAIDPain, general
methylpropyl)-, (AlphaS)-[CAS]
dexketoprofenBenzeneacetic acid, 3-benzoyl-Alpha-22161-81-5Anti-inflammatoryInflammation,
methyl-, (S)-[CAS]general
dexloxiglumidePentanoic acid, 4-[(3,4-119817-90-2EP0344184GI inflammatory/Irritable bowel
dichlorobenzoyl)amino]-5-[(3-bowel disorderssyndrome
methoxypropyl)pentylamino]-5-oxo-, (R)-
[CAS]
dexmedetomidine1H-Imidazole, 4-[1-(2,3-113775-47-6EP187471Hypnotic/SedativeAnaesthesia
dimethylphenyl)ethyl]-, (R)-[CAS]86347-15-1
dexmethylphenidate2-Piperidineacetic acid, Alpha-phenyl-,19262-68-1PsychostimulantAttention
methyl ester, (AlphaR,2R)-deficit disorder
Dexpanthenol81-13-0
dexrazoxane2,6-Piperazinedione, 4,4'-(1-methyl-1,2-24584-09-6DE1910283Radio/Chemotherapy-
ethanediyl)bis-, (S)-[CAS]chemoprotectiveinduced injury,
general
Dextran-1Dextran [CAS]9004-54-0Plasma substitute
Dextranomer56087-11-7
Dextroamphetamine51-64-9
dextromethorphanMorphinan, 3-methoxy-17-methyl-,6700-34-1U.S.4,221,788Formulation, oral,Cough,
(9Alpha, 13Alpha, 14Alpha)-,125-71-3otherEmotional
lability
Dextromoramide357-56-2
dextropropoxypheneBenzeneethanol, Alpha-[2-(dimethylamino)469-62-5Formulation, Pain, general
1-methylethyl]-Alpha-phenyl-, propanoatemodified-
(ester), [S-(R*,S*)]-[CAS]release, other
Dezocine53648-55-8
DF-1012N-Tropyl 7-azaindol-3-ylcarboxamide163220-65-3WO9504742RespiratoryRespiratory
disease,
general
DFA-IVdi-D-fructofuranose 2,6':6,2' dianhydrideU.S.5,700,832AntianaemicAnaemia,
aplastic
d-Fenchone4695-62-9
D-Glucuronolactone32449-92-6
Diab IIDiab II309956-85-2U.S.6,153,632AntidiabeticDiabetes,
Type II
diacerein2-Anthracenecarboxylic acid, 4,5-13739-02-1U.S.4,244,968Antiarthritic, otherArthritis,
bis(acetyloxy)-9,10-dihydro-9,10-dioxo-rheumatoid
[CAS]
Diampromide552-25-0
Diamthazole136-96-9
Diathymosulfone5964-62-5
Diatrizoate737-31-5
diazepam2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-439-14-5Formulation,Anxiety,
dihydro-1-methyl-5-phenyl-[CAS]transmucosal, epilepsy,
systemicgeneral
Diaziquone57998-68-2
Diazoxide364-98-7
dibekacinD-Streptamine, O-3-amino-3-deoxy-Alpha-34493-98-6GB1349302AminoglycosideInfection,
D-glucopyranosyl-(1-6)-O-[2,6-diamino-58580-55-5antibioticgeneral
2,3,4,6-tetradeoxy-Alpha-D-erythro-
hexopyranosyl-(1-4)]-2-deoxy-, sulfate
(salt)[CAS]
Dibenzepin4498-32-2
Dibromopropamidine496-00-4
Dibucaine61-12-1
Dichloralphenazone480-30-8
Dichloramine T473-34-7
Dichlorisone7008-26-6
Dichlorobenzyl Alcohol1777-82-8
Dichlorophen97-23-4
Dichlorophenarsine536-29-8
Dichlorphenamide120-97-8
diclofenac + HAHyaluronic acid + benzeneacetic acid, 2-Formulation,Keratosis
[(2,6-dichlorophenyl)amino]-[CAS]transdermal,
systemic
diclofenacBenzeneacetic acid, 2-[(2,6-15307-79-6Formulation,Pain, general
dichlorophenyl)amino]-, [CAS]15307-86-5modified-release,
15307-81-0<=24 hr
Dicloxacillin3116-76-5
Dicumarol66-76-2
Dicyclomine77-19-0
didanosineInosine, 2',3'-dideoxy-[CAS]69655-05-6U.S.4,861,759Antiviral, anti-HIVInfection,
Dideoxyadenosine4097-22-7HIV/AIDS
didoxBenzamide, N,3,4-trihydroxy-[CAS]69839-83-4U.S.4,263,322Anticancer,Cancer,
antimetabolitegeneral
Dienestrol84-17-3
dienogest19-Norpregna-4,9-diene-21-nitrile, 17-65928-58-7GB1524917MenstruationEndometriosis
hydroxy-3-oxo-, (17Alpha)-[CAS]disorders
dienogest + estradiol19-Norpregna-4,9-diene-21-nirtile, 17-Formulation,Contraceptive,
hydroxy-3-oxo-, (17Alpha) + Estra-fixed-dosefemale
1,3,5(10)-triene-3,17-diol(17β)combinations
Diethadione702-54-5
Diethazine60-91-3
Diethylbromo-511-70-6
acetamide
Diethylcarbamazine90-89-1
diethylpropion1-Propanone, 2-(diethylamino)-1-phenyl-90-84-6Formulation, Obesity
[CAS]modified-
Diethylstilbestrol56-53-1release, <=24 hr
Difemerine80387-96-8
Difenamizole20170-20-1
Difenoxin28782-42-5
Difenpiramide51481-40-3
diflomotecan(5R)-5-Ethyl-9,10-difluoro-1,4,5,13-220997-97-7Anticancer, otherCancer,
tetrahydro-5-hydroxy-3H,15H-general
oxepino[3′,4′:6,indolizino[1,2-b]quinoline-
3,15-dione
diflorasonePregna-1,4-diene-3,20-dione, 17,21-33564-31-7U.S.3,980,778Antipsoriasis
bis(acetyloxy)-6,9-difluoro-11-hydroxy-16-2557-49-5
methyl-, (6Alpha,11β,16β)-[CAS]
Difloxacin98106-17-3
Diflucortolone2607-6-9
diflunisal2′,4′-difluoro-4-hydroxy[1,1′-biphenyl]-3-23674-86-4GB1175212Analgesic, NSAIDPain, post-
carboxylic acid22494-42-4operative
Difluprednate23674-86-4
Digitalin752-61-4
Digitoxin71-63-6
digoxinCard-20(22)-enolide, 3-[(O-2,6-dideoxy-β-20830-75-5U.S.4,088,750Formulation, oral,Heart failure
D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-enteric-coated
β-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-
β-D-ribo-hexopyranosyl)oxy]-12,14-
dihydroxy-, (3β,5β,12β)-[CAS]
Dihexyverine561-77-3
Dihydralazine484-23-1
Dihydrocodeine125-28-0
Dihydrocodeinone466-90-0
Enol
dihydroergocryptineErgocryptine, dihydro-[CAS]25447-66-9Formulation, otherDepression,
general
dihydroergotamineErgotaman-3′,6′,18-trione, 9,10-dihydro-511-12-66495535Formulation, Migraine
12′-hydroxy-2′-methyl-5′-(phenylmethyl)-,modified-
(5′Alpha,10Alpha)-[CAS]release, other
Dihydromorphine509-60-4
Dihydrostreptomycin128-46-1
Dihydrotachysterol67-96-9
Dihydroxyaluminum13682-92-3
539-68-4
Diisopromine5966-41-6
Diisopropyl Paraoxon3254-66-8
Diisopropylamine660-27-5
dilazepBenzoic acid, 3,4,5-trimethoxy-,35898-87-4JP51095086Vasodilator,
(tetrahydro-1H-1,4-diazepine-1,4(5H)-coronary
diyl)di-3,1-propanediyl ester [CAS]
Dilevalol75659-07-3
diloxanide2-Furancarboxylic acid, 4-3736-81-0Amoebicide
[(dichloroacetyl)methylamino]phenyl ester579-38-4
[CAS]
diltiazem1,5-Benzothiazepin-4(5H)-one, 3-33286-22-5U.S.4,721,619AntianginalAngina,
(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-42399-41-7U.S.5,529,791hypertension,
dihydro-2-(4-methoxyphenyl)-, (2S-cis)-EP322277general
[CAS]
Dimecrotic Acid7706-67-4
Dimefline1165-48-6
Dimemorfan36309-01-0
Dimenhydrinate523-87-5
Dimenoxadol509-78-4
Dimepheptanol545-90-4
Dimercaprol59-52-9
Dimetacrine4757-55-5
Dimethadione695-53-4
Dimethazan519-30-2
Dimethindene5636-83-9
Dimethisoquin86-80-6
Dimethisterone79-64-1
Dimethocaine94-15-5
Dimethoxanate477-93-0
Dimethyl Sulfoxide67-68-5
Dimethylthiambutene524-84-5
Dimetofrine22950-29-4
Dimorpholamine119-48-2
dinoprostoneProsta-5,13-dien-1-oic acid, 11,15-363-24-6Formulation, Labour,
dihydroxy-9-oxo-, (5Z,11Alpha,13E,15S)-modified-induction
[CAS]release, <=24 hr
diosmectiteSmecta-[CAS]110070-78-5FR2770778AntidiarrhoealDiarrhoea,
general
diosmin4H-1-Benzopyran-4-one, 7-[[6-O-(6-deoxy-520-27-4DE2602314Vasoprotective,
Alpha-L-mannopyranosyl)-,beta,-D-systemic
glucopyranosyl]oxy]-5-hydroxy-2-(3-
hydroxy-4-methoxyphenyl)-[CAS]
Dioxadrol6495-46-1
Dioxaphetyl467-86-7
Dioxethedrine497-75-6
Dioxybenzone131-53-3
Diphemanil62-97-5
Diphenadione82-66-6
Diphencyprone886-38-4
Diphenhydramine58-73-1
Diphenidol972-02-1
Diphenoxylate915-30-0
Diphenylpyraline147-20-6
Diphetarsone515-76-4
Diphtheria &
Tetanus Toxoids And
Acellular Pertussis
Vaccine Adsorbed
Dipipanone467-83-4
dipivefrinPropanoic acid, 2,2-dimethyl-, 4-[1-52365-63-6U.S.3,809,714AntiglaucomaGlaucoma
hydroxy-2-(methylamino)ethyl]-1,2-
phenylene ester, (+/−)-[CAS]
Dipyridamole58-32-2
Dipyrocetyl486-79-3
Dipyrone5907-38-0
diquafosolUridine 5′-(pentahydrogen tetraphosphate)-211427-08-6OphthalmologicalDry eye
5′-ester with uridine, [CAS]syndrome
dirithromycinErythromycin, 9-deoxo-11-deoxy-9,11-62013-04-1DE2515075Macrolide antibioticTonsillitis
[imino[2-(2-methoxyethoxy)ethylidene]oxy]-,
[9S(R)]-[CAS]
disodium pamidronatePhosphonic acid, (3-amino-1-57248-88-1EP177443OsteoporosisHypercal-
hydroxypropylidene)bis-, disodium salttreatmentcaemia of
[CAS]malignancy
Disofenin65717-97-7
disopyramide2-Pyridineacetamide, Alpha-[2-[bis(1-3737-09-5Formulation, Arrhythmia,
methylethyl)amino]ethyl]-Alpha-phenyl-modified-general
[CAS]release, <=24 hr
Distigmine15879-67-2
Disulfamide671-88-5
Disulfiram97-77-8
Ditazol18471-20-0
Dithiazanine514-73-8
dithranol9(10H)-Anthracenone, 1,8-dihydroxy-1143-38-0Formulation,Psoriasis
[CAS]dermal, topical
Ditiocarb148-18-5
Dixanthogen502-55-6
Dixyrazine2470-73-7
DJ-927WO01027115Anticancer, otherCancer,
general
DK-507k(−)-7-[(7S)-7-Amino-5-azaspiro[2,4]heptan-QuinoloneInfection,
5-yl]-6-fluoro-1-[(1R,2S)-2-fluoro-1-antibacterialgeneral
cyclopropyl]-1,4-dihydro-8-methoxy-4-oxo-
3-quinolinecarboxylic acid hydrochloride
monohydrate
DL-Lactic Acid598-82-3
DMDCCytidine, 2′-deoxy-2′-methylene-,113648-25-2WO8807049Anticancer,Cancer,
monohydrochloride [CAS]antimetabolitegeneral
DMXAA5,6-dimethylxanthenone-4-acetic acidAnticancer, otherCancer, lung,
general
DNA StealthU.S.6,132,776Antiviral, anti-HIVInfection,
NucleosidesHIV/AIDS
Dobesilate20123-80-2
dobutamine1,2-Benzenediol, 4-[2-[[3-(4-34368-04-2U.S.3,987,200Cardiostimulant
hydroxyphenyl)-1-49745-95-1
methylpropyl]amino]ethyl]-, (+/−)-[CAS]
Docarpamine74639-40-0
docetaxel(2R,3S)-N-Carboxy-3-phenylisoserine, N-114977-28-5EP253738Anticancer, otherCancer, breast
tert-butyl ester, 13-ester with 5β,20-epoxy-14808-66-6
1,2Alpha,4,7β,10β,13Alpha-
hexahydroxytax-11-en-9-one 4-acetate 2-
benzoate-[CAS]
docosahexaenoic acidEP707487Hypolipaemic/Hyper-
Antiatherosclerosislipidaemia,
general
docosanol1-Docosanol [CAS]661-19-8EP469064Antiviral, otherInfection,
herpes
simplex virus
docusate128-49-4U.S.4,752,617Formulation, dermal,Infection,
577-11-7topicalherpes
simplex virus
prophylaxis
dofetilideMethanesulfonamide, N-[4-[2-[methyl[2-[4-115256-11-6EP245997AntiarrhythmicFibrillation,
[(methylsulfonyl)amino]phenoxy]ethyl]amino]-atrial
ethyl]phenyl]-[CAS]
dolasetron mesilate1H-Indole-3-carboxylic acid, octahydro-3-115956-13-3EP266730AntiemeticChemotherapy-
oxo-2,6-methano-2H-quinolizin-8-yl ester,115956-12-2induced
(2Alpha,6Alpha,8Alpha,9Alphaβ)-,nausea and
monomethanesulfonate-[CAS]vomiting
Domiodol61869-07-6
Domiphen538-71-6
Domitroban112966-96-8
domperidone2H-Benzimidazol-2-one, 5-chloro-1-[1-[3-57808-66-9U.S.4,066,772Antiemetic
(2,3-dihydro-2-oxo-1H-benzimidazol-1-
yl)propyl]-4-piperidinyl]-1,3-dihydro-[CAS]
donepezil1H-Inden-1-one, 2,3-dihydro-5,6-120011-70-3EP296560CognitionAlzheimer's
dimethoxy-2-((1-(phenylmethyl)-4-120014-06-4enhancerdisease
piperidinyl)methyl)-, [CAS]
donitriptanPiperazine, 1-(((3-(2-aminoethyl)-1H-indol-170912-52-4AntimigraineMigraine
5-yl)oxy)acetyl)-4-(4-cyanophenyl)-[CAS]
Dopamine51-61-6
Dopexamine86197-47-9
doramapimodurea, N-[3-(1,1-dimethylethyl)-1-(4-285983-48-4Antiarthritic,Arthritis,
methylphenyl)-1H-pyrazol-5-yl]-N′-[4-[2-(4-immunologicalrheumatoid
morpholinyl)ethoxy)-1-naphthalenyl]-
doranidazole(±)-1,2,4-Butanetriol, 3-((2-nitro-1H-137339-64-1WO9414778Radio/Surgery
imidazol-1-yl)methoxy)-[CAS]chemosensitizeradjunct
doripenem(1R,5S,6S)-2-[(3S,5S)-5-148016-81-3EP528678Beta-lactamInfection,
(sulfamoylaminomethyl)pyrrolidin-3-yl]thio-antibioticurinary
6-[(1R)-1-hydroxyethyl]-1-methylcarbapen-tract
2-em-3-carboxylic acid
dorzolamide4H-Thieno(2,3-b)thiopyran-2-sulfonamide,120279-96-1EP296879AntiglaucomaGlaucoma
4-(ethylamino)-5,6-dihydro-6-methyl-,7,7-
dioxide (4S-trans)-[CAS]
dorzolamide + timolol4H-Thieno(2,3-b)thiopyran-2-sulfonamide,120279-96-1Formulation, Glaucoma
4-(ethylamino)-5,6-dihydro-6-methyl-7,7-26839-75-8fixed-dose
dioxide (4S-trans) + ethyl 2-propanol, 1-26921-17-5combinations
[(1,1-dimethyl)amino]-3-[[4-(4-morpholinyl)-
1,2,5-thiadiazol-3-yl]oxy]-, (S), (Z)-2-
butenedioate (1:1) (salt) [CAS]
dosmalfateAluminium, (μ7-(7-((6-O-(6-deoxy-2,3,4-tri-122312-55-4AntiulcerUlcer, gastric
O-sulfo-Alpha-L-mannosylpyranosyl)-2,3,4-
tri-O-sulfo-β-D-glucopyranosyl)oxy)-5-
hydroxy-2-(4-methoxy-3-(sulfooxy)phenyl-
4H-1-benzopyran-4-onato(7-)))tetradeca-μ-
hydroxyheneicosahydroxytetradeca-μ-
hydroxyheneicosahydroxytetradeca-[CAS]
dosulepine1-Propanamine, 3-dibenzo[b,e]thiepin-113-53-1Antidepressant
11(6H)-ylidene-N,N-dimethyl-[CAS]
Dotarizine84625-59-2
Dothiepin113-53-1
Doxacurium106819-53-8
Doxapram309-29-5
doxazosinPiperazine, 1-(4-amino-6,7-dimethoxy-2-74191-85-8GB2007656Antihypertensive,Hypertension,
quinazolinyl)-4-[(2,3-dihydro-1,4-adrenergicgeneral
benzodioxin-2-yl)carbonyl]-[CAS]
Doxefazepam40762-15-0
Doxenitoin3254-93-1
doxepin1-Propanamine, 3-dibenz[b,e]oxepin-1668-19-5Formulation,Pruritus
11(6H)-ylidene-N,N-dimethyl-dermal, topical
doxercalciferol9,10-secoergosta-5,7,10(19),22-tetraene-54573-75-0U.S.5,104,854HormoneHyperpara-
1,3-diol (1Alpha, 3β, 5Z, 7E, 22E) [CAS]thyroidism
doxifluridineUridine, 5′-deoxy-5-fluoro-[CAS]3094-09-5U.S.4,071,680Anticancer,Cancer,
antimetabolitecolorectal
doxofylline1H-Purine-2,6-dione, 7-(1,3-dioxolan-2-69975-86-6U.S.4,187,308AntiasthmaAsthma
ylmethyl)-3,7-dihydro-1,3-dimethyl-[CAS]
doxorubicin5,12-Naphthacenedione, 10-[(3-amino-23214-92-8EP191824Formulation,Cancer,
2,3,6-trideoxy-Alpha-L-lyxo-optimized, liposomesgeneral
hexopyranosyl)oxy]-7,8,9,10-tetrahydro-
6,8,11-trihydroxy-8-(hydroxyacetyl)-1-
methoxy-, (8S-cis)-[CAS]
doxycycline2-Naphthacenecarboxamine, 4-564-25-0Formulation, Periodontitis
(dimethylamino)-1,4,4a,5,5a,6,11,12a-17086-28-1modified-
octahydro-3,5,10,12,12a-pentahydroxy-6-release, immediate
methyl-1,11-dioxo-[4S-
(4Alpha,4aAlpha,5Alpha,5aAlpha,6Alpha,-
12aAlpha)]-[CAS]
doxylamineN,N-Dimethyl-2-[1-phenyl-1-(2-469-21-4Formulation,Rhinitis,
pyridinyl)ethoxy]ethanaminetransmucosal, allergic,
systemicgeneral
DPC-817β-D-2′,3′-didehydro-2′,3′-dideoxy-5-Antiviral, anti-HIVInfection,
fluorocytidineHIV/AIDS
DPI-3290U.S.5,681,830Analgesic, otherPain, general
DQ-1135-Amino-7-[(3S,4R)-(1-aminocyclopropyl)-QuinoloneInfection,
3-fluoropyrrolidin-1-yl]-1-[(1R,2S)-2-fluoro-]antibacterialgeneral
1-cyclopropyl]-1,4-dihydro-8-methyl-4-oxo-
3-quinolinecarboxylic acid
Drofenine1679-76-1
Droloxifene82413-20-5
Drometrizole2440-22-4
Dromostanolone58-19-5
dronabinol6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-1972-08-3AntiemeticChemotherapy-
tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-induced nausea
trans)-[CAS]and vomiting
dronedarone2-n-Butyl 3-[4-(3-di-n-butylamino-AntiarrhythmicArrhythmia,
propoxy)benzoyl]5-general
methylsulfonamidobenzofuran
Droperidol548-73-2
Droprenilamine57653-27-7
Dropropizine17692-31-8
Drospirenone67392-87-4
Drotaverine14009-24-6
Drotebanol03/02/3176
droxicam2H,5H-1,3-Oxazino[5,6-90101-16-9EP99770Anti-inflammatoryInflammation,
c][1,2]benzothiazine-2,4(3H)-dione, 5-general
methyl-3-(2-pyridinyl)-, 6,6-dioxide [CAS]
droxidopaL-Tyrosine, β,3-dihydroxy-, threo-[CAS]23651-95-8EP128684AntiparkinsonianParkinson's
disease
Droxidopa23651-95-8
DU-1255301,2-Benzisothiazol-3(2H)-one, 2-[4-[4-(7-161611-99-0EP633260AnxiolyticAnxiety,
chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-1-general
piperazinyl]butyl]-, 1,1-dioxide [CAS]
duloxetine2-Thiophenepropanamine, N-methyl-136434-34-9U.S.5,362,886AntidepressantDepression,
Gamma-(1-naphthalenyloxy)-,116539-59-4general
hydrochloride, (S)-[CAS]
duramycinWO9428726Formulation,Cystic fibrosis
inhalable, solution
Durapatite1306-06-5
dutasteride4-Azaandrost-1-ene-17-carboxamide, N-164656-23-9U.S.5,565,467Prostate disordersBenign
(2,5-bis(trifluoromethyl)phenyl)-3-oxo-,prostatic
(5Alpha,17β)-[CAS]hyperplasia
DW-1141N,N-diisopropyl-4-[4-(3-OsteoporosisOsteoporosis
aminobenzo[d]isoxazol-6-yloxy)butoxy]-3-treatment
methoxybenzamide
DW-286a(R)-(−)-7-((4-aminomethyl-4-methyl-3-(Z)-QuinoloneInfection,
methyloxyimino)pyrrolidin-1-yl)-1-antibacterialgeneral
cyclopropyl-6-fluoro-4-oxo-1,4-
dihydro[1,8]naphthyridine-3-carboxylic
acid
DW-471U.S.5,922,871Antiviral, otherInfection,
hepatitis-B
virus
DX-9065a2-Naphthalenepropanoic acid, 7-155204-81-2AntithromboticThrombosis,
(aminoiminomethyl)-Alpha-[4-[[1-(1-general
iminoethyl)-3-pyrrolidinyl]oxy]phenyl]-,
monohydrochloride, pentahydrate, [S-
(R*,R*)]-[CAS]
DY-9760e1H-Indazole, 3-[2-[4-(3-chloro-2-160522-00-9U.S.5,681,954NeuroprotectiveIschaemia,
methylphenyl)-1-piperazinyl)ethyl]-1-(1H-cerebral
imidazol-4-ylmethyl)-5,6-dimethoxy-[CAS]
Dyclonine586-60-7
Dydrogesterone152-62-5
Dymanthine124-28-7
Dyphyllin479-18-5
E-10101-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic186319-97-1Beta-lactamInfection,
acid, 6-[(1R)-1-hydroxyethyl]-3-[[(3S,5S)-5-antibioticgeneral
[(R)-hydroxy(3R)-3-pyrrolidinylmethyl]-3-
pyrrolidinyl]thio]-4-methyl-7-oxo-,
monohydrochloride, (4R,5S,6S)-[CAS]
E-2101N-Ethyl-(1-[1-(2-fluorophenethyl)piperidin-Muscle relaxantMuscle spasm,
4-yl]-1H-indol-6-yl)acetamidegeneral
E2F antagonistsWO9606943Anticancer, otherCancer, general
E-3620Benzamide, 4-amino-5-chloro-N-(8-methyl-151213-86-4EP554794Antacid/Dyspepsia
8-azabicyclo[3.2.1]oct-3-yl)-2-[(1-methyl-2-Antiflatulent
butynyl)oxy]-, monohydrochloride, [3(S)-
endo]-[CAS]
E-5564Alpha-D-Glucopyranose, 3-O-decyl-2-185954-98-7EP536969Septic shockSepsis
deoxy-6-O-(2-deoxy-3-O-((3R)-3-treatment
methoxydecyl)-6-O-methyl-2-(((11Z)-1-oxo-
11-octadecenyl)amino)-4-O-phosphono-β-
D-glucopyranosyl)-2-((1,3-
dioxotetradecyl)amino)-1-(dihydrogen
phosphate), tetrasodium salt [CAS]
E-5842Pyridine, 4-(4-fluorophenyl)-1,2,3,6-220120-14-9NeurolepticSchizophrenia
tetrahydro-1-[4-(1H-1,3,4-triazol-1-yl)butyl]-,
2-hydroxy-1,2,3-propanetricarboxylate
(1:1)[CAS]
E-62591-(4-Aminosulfonylphenyl)-5-(2,4-Antiarthritic, otherUnspecified
difluorophenyl)-4,5-dihydro-3-
trifluoromethyl-1-H-pyrazole
EAA-90[2-(8,9-Dioxo-2,6-diazabicyclo[5.2.0]non-Analgesic, otherPain,
1(7)-en-2-yl)-ethyl]phosphonic acidneuropathic
ε-Acetamidocaproic57-08-9
Acid
ε-Aminocaproic Acid60-32-2
ebastine1-Butanone, 1-[4-(1,1-90729-43-4EP134124Antiallergic, non-Rhinitis,
dimethylethyl)phenyl]-4-[4-asthmaallergic,
(diphenylmethoxy)-1-piperidinyl]-[CAS]seasonal
eberconazole1H-Imidazole, 1-(2,4-dichloro-10,11-128326-82-9ES2012297AntifungalInfection,
dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-130104-32-4derma-
[CAS]tological
ebrotidineBenzenesulfonamide, N-[[[2-[[[2-100981-43-9EP159012AntiulcerUlcer,
[(aminoiminomethyl)amino]-4-duodenal
thiazoly]methyl]thio]ethyl]amino]methylene]-
4-bromo-[CAS]
ebselen1,2-Benzisoselenazol-3(2H)-one, 2-phenyl-60940-34-3EP44971NeuroprotectiveHaemorrhage,
[CAS]subarachnoid
Eburnamonine474-00-0
Ecabapide104775-36-2
ecabet1-Phenanthrenecarboxylic acid,33159-27-2DE3239172AntiulcerUlcer, gastric
1,2,3,4,4a,9,10,10a-octahydro-1,4a-86408-72-2
dimethyl-7-(1-methylehtyl)-6-sulfo-, [1R-
(1Alpha,4aβ,10aAlpha)]-[CAS]
ecadotrilGlycine, N-[2-[(acetylthio)methyl]-1-oxo-3-112573-73-6EP318377Antihypertensive, Hypertension,
phenylpropyl]-,phenylmethyl ester, (S)-othergeneral
[CAS]
Ecgonidine484-93-5
Ecgonine481-37-8
Echothiophate513-10-0
Econazole27220-47-9
ecopipam5H-Benzo[d]naphth[2,1-b]azepin-12-ol, 11-112108-01-7EP230270Anorectic/Obesity
chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-,Antiobesity
(6aS-trans)-[CAS]
ecraprostProsta-8,13-dien-1-oic acid, 11,15-136892-64-3EP423697Vasodilator,Peripheral
dihydroxy-9-(1-oxobutoxy)-, butyl ester,peripheralvascular
(11Alpha,13E,15S)-[CAS]disease
Ectylurea95-04-5
ED-719,10-Secocholesta-5,7,10(19)-triene-104121-92-8EP184206OsteoporosisOsteoporosis
1,3,25-triol, 2-(3-hydroxypropoxy)-,treatment
(1Alpha,2β,3β,5Z,7E)-[CAS]
edaravone3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-89-25-8JP62108814NeuroprotectiveInfarction,
phenyl-[CAS]cerebral
Edatrexate80576-83-6
Edetate Calcium62-33-9
Disodium
Edetate Disodium139-33-3
Edetate Sodium64-02-8
Edetate Trisodium150-38-9
edonentanButanamide,N-[[2′-[[4,5-dimethyl-3-210891-04-6CardiostimulantHeart failure
isoxazoyl)amino]sulfonyl]-4-(2-
oxazolyl)[1,1′-biphenyl]-2-yl]methyl]-N,3,3-
trimethyl-, monohydrate
edotreotide[N-[2-[4,7-Bis[(carboxy-kappaO)methyl]-10-204318-14-9U.S.6,183,721Anticancer, Cancer, lung,
(carboxymethyl)-1,4,7,10-hormonalsmall cell
tetraazacyclododec-1-yl-
kappaN1,kappaN4,kappaN10]acetyl]-D-
phenylalanyl-L-cysteinyl-L-tyrosyl-D-
tryptophyl-L-lysyl-L-threanyl-L-cysteinyl-L-
threoninol cyclic (2-7)-disulfidato(3-)]yttrium
edoxudineUridine, 2′-deoxy-5-ethyl-[CAS]15176-29-1GB1170565Antiviral, otherInfection,
herpes
virus, general
Edrecolomab156586-89-9
Edrophonium116-38-1
EfalithButanedioic acid, lithium salt [CAS]16090-09-8Antipruritic/Eczema,
inflamm, allergicseborrhoeic
efaproxiralPropanoic acid, 2-[4-[2-[(3,5-131179-95-8U.S.5,705,521Radio/Cancer, brain
dimethylphenyl)amino]-2-chemosensitizer
oxoethyl]phenoxy]-2-methyl-[CAS]
efavirenz2H-3,1-Benzoxazin-2-one, 6-chloro-4-154598-52-4WO9403440Antiviral, anti-HIVInfection,
(cyclopropylethynyl)-1,4-dihydro-4-HIV/AIDS
(trifluoromethyl)-, (S)-[CAS]
efletirizine[2-[4-[Bis(p-fluorophenyl)methyl]-1-150756-35-7GB2311940Antiallergic, Allergy, general
piperazinyl]ethoxy]acetic acidnon-asthma
eflornithineDL-Ornithine, 2-(difluoromethyl)-[CAS]70052-12-9U.S.4,413,141Protozoacide, Infection,
67037-37-0dermal, topicaltrypanosomiasis,
African,
Hirsutism
Efloxate119-41-5
eflucimibeBenzeneacetamide, Alpha-(dodecylthio)-N-202340-45-2Hypolipaemic/Hyper-
(4-hydroxy-2,3,5-trimethylphenyl)-(S)-Antiatherosclerosislipidaemia,
[CAS]general
efonidipine3-pyridinecarboxylic acid, 5-(5,5-dimethyl-111011-53-1EP230944Antihypertensive,Hypertension,
1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-111011-63-3othergeneral
2,6-dimethyl-4-(3-nitrophenyl)-, 2-111011-76-8
(phenyl(phenylmethyl)amino)ethyl ester, P-
oxide [CAS]
EGIS-72295-Chloro-4-[3-[N-[2-(3,4-150800-12-7DE4243381AntiarrhythmicArrhythmia,
dimethoxyphenyl)ethyl]-N-190333-92-7general
methylamino]propylamino]-3(2H)-
pyridazinone fumarate [CAS]
eglumegadBicyclo[3.1.0]hexane-2,6-dicarboxylic acid,176199-48-7AnxiolyticAnxiety,
2-amino-, (1S,2S,5R,6S)-[CAS]209216-09-1general
egualen1-Azulenesulfonic acid, 3-ethyl-7-(1-97683-31-3EP147915AntiulcerUlcer, gastric
methylethyl)-,99287-30-6
Elcosapentaenoic10417-94-4
Acid
elarofiban3-Pyridinepropanoic acid, β-[((3R)-1-[1-198958-88-2WO9741102AntithromboticThrombosis,
oxo-3-(4-piperidinyl)propyl]-3-general
piperidinyl]carbonyl]amino]-, (βS)-[CAS]
Elcatonin60731-46-6
Eledoisin69-25-0
eletriptan1H-Indole, 3-((1-methyl-2-143322-58-1U.S.5,607,951AntimigraineMigraine
pyrrolidinyl)methyl)-5-(2-
(phenylsulfonyl)ethyl)-(R)-[CAS]
Elgodipine119413-55-7
Ellagic Acid476-66-4
Elliptinium58337-35-2
Eltoprazine98224-03-4
elvucitabineβ-L-2′,3′-Didehydro-2′,3′-dideoxy-5-181785-84-2Antiviral, otherInfection,
fluorocytidinehepatitis-B
virus
elzasonan(2Z)-4-(3,4-dichlorophenyl)-2-[2-(4-220322-05-4AntidepressantDepression,
methylpiperazin-1-361343-20-6general
yl)benzylidene]thiomorpholin-3-one
monohydrochloride-[CAS]
Embelin550-24-3
Embramine3565-72-8
emedastine1H-Benzimidazole, 1-(2-ethoxyethyl)-2-87233-61-2EP79545Antiallergic, non-Rhinitis,
(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-,87233-62-3asthmaallergic,
(E)-2-butenedioate (1:2) [CAS]general
Emepronium3614-30-0
Emetine483-18-1
Emitefur110690-43-2
EMM-21052517Alpha-Acetoxy-6Alpha-methyl-19-nor-Formulation, Hormone
1β,2β-dihydrocyclopropa[1,2′]pregn-4-ene-fixed-dosereplacement
3,20-dione + Estra-1,3,5(10)-triene-3,17-combinationstherapy
diol(17β)
Emodin518-82-1
emorfazone3(2H)-Pyridazinone, 4-ethoxy-2-methyl-5-38957-41-4JP7224030Anti-inflammatory
(4-morpholinyl)-[CAS]
EMR-62203WO9806722Male sexual Impotence
dysfunction
emtricitabine2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-(2-143491-57-0WO9214743Antiviral, anti-HIVInfection,
(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-HIV/AIDS
cis)-[CAS]
Emylcamate78-28-4
enalaprilL-Proline, 1-[N-[1-(ethoxycarbonyl)-3-76095-16-4U.S.4,374,829Antihypertensive,
phenylpropyl]-L-alanyl]-, (S)-, (Z)-2-renin system
butenedioate [CAS]
Enalaprilat76420-72-9
Enallylpropymal1861-21-8
Encainide66778-36-7
Enciprazine68576-86-3
Endralazine39715-02-1
enfenamic acidBenzoic acid, 2-[(2-phenylethyl)amino]-23049-93-6IN103066Anti-inflammatory
[CAS]
enfluraneEthane, 2-chloro-1-(difluoromethoxy)-1,1,2-13838-16-9U.S.3,469,011Anaesthetic,Anaesthesia
trifluoro-[CAS]inhalation
Enilconazole35554-44-0
Eniluracil59989-18-3
ENMD-0995S-3-amino-phthalidoglutarimideU.S.5,712,291Anticancer, otherCancer,
Enocitabine55726-47-1myeloma
Enol-3-IPA1H-Indole-3-propanoic acid, Alpha-oxo-392-12-1EP106813Hypnotic/SedativeInsomnia
[CAS]
enoxacin1,8-Naphthyridine-3-carboxylic acid, 1-74011-58-8U.S.4,359,578QuinoloneInfection,
ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-antibacterialgeneral
piperazinyl)-[CAS]
enoxaparinHeparin, [CAS]9005-49-6EP40144AntithromboticThrombosis,
9041-08-1venous
enoximone2H-Imidazol-2-one, 1,3-dihydro-4-methyl-5-77671-31-9EP59948CardiostimulantHeart failure
[4-(methylthio)benzoyl]-[CAS]
Enoxolone471-53-4
enprostil4,5-Heptadienoic acid, 7-[3-hydroxy-2-(3-73121-56-9GB2025431ProtaglandinUlcer,
hydroxy-4-phenoxy-1-butenyl)-5-duodenal
oxocyclopentyl]-, methyl ester,
[1Alpha,2β(1E,3R*),3Alpha]-[CAS]
enrasentan1H-Indene-2-carboxylic acid, 1-(1,3-167256-08-8U.S.5,817,693Antihypertensive,Hypertension,
benzodioxol-5-yl)-2,3-dihydro-3-(2-(2-otherpulmonary
hydroxyethoxy)-4-methoxyphenyl)-5-
propoxy-, (1S-(1Alpha,2β,3Alpha))-[CAS]
entacapone2-Propenamide, 2-cyano-3-(4,5-dihydroxy-130929-57-6EP426468AntiparkinsonianParkinson's
3-nitrophenyl)-N,N-diethyl-[CAS]disease
entecavir6H-Purin-6-one, 2-amino-1,9-dihydro-9-142217-69-4EP481754Antiviral, otherInfection,
((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-hepatitis-B
2-methylenecyclopentyl]-[CAS]virus
Enviomycin33103-22-9
epalrestat3-Thiazolidineacetic acid, 5-(2-methyl-3-82159-09-9EP47109SymptomaticNeuropathy,
phenyl-2-propenylidene)-4-oxo-2-thioxo-,antidiabeticdiabetic
(E,E)-[CAS]
EpavirL-lysine-cis-5,8,11,14,17-Antiviral, otherInfection,
eicosapentanoate with L-lysine-cis-herpes
4,7,10,13,16,19-doahexanoatesimplex virus
EPC-K1L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-127061-56-7EP127471NeuroprotectiveInfarction,
tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-cerebral
1-benzopyran-6-yl-hydrogen
phosphate]potassium-[CAS]
eperisone1-Propanone, 1-(4-ethylphenyl)-2-methyl-3-64840-90-0U.S.3,995,047Muscle relaxantSpastic
(1-piperidinyl)-[CAS]paralysis
epervudineUridine, 2′-deoxy-5-(1-methylethyl)-[CAS]60136-25-6DE2918260Antiviral, otherInfection,
herpes
simplex virus
Ephedrine299-42-3
Epicillin26774-90-3
Epimestrol7004-98-0
epinastine1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-80012-43-7DE3008944AntiasthmaAsthma
amine, 9,13b-dihydro-[CAS]
eoinephrine(R)-4-[1-hydroxy-2-(methylamino)-ethyl]-51-43-4Formulation,Anaphylaxis
1,2-benzenediolinhalable, dry
powder
Epirizole18694-40-1
epirubicin5,12-Naphthacenedione, 10-[(3-amino-56390-09-1GB1457632Anticancer,
2,3,6-trideoxy-Alpha-L-arabino-56420-45-2antibiotic
hexopyranosyl)oxy]-7,8,9,10-tetrahydro-
6,8,11-trihydroxy-8-(hydroxyacetyl)-1-
methoxy-, (8S-cis)-[CAS]
Epitiostanol2363-58-8
eplerenonePregn-4-ene-7,21-dicarboxylic acid, 9,11-107724-20-9EP122232Antihypertensive,Hypertension,
epoxy-17-hydroxy-3-oxo-, Gamma-lactone,diureticgeneral
methyl ester (7Alpha, 11Alpha, 17Alpha)-
[CAS]
eplivanserin1-Propanone, 1-(2-fluorophenyl)-3-(4-130580-02-8EP373998AnxiolyticSchizophrenia
hydroxyphenyl)-, O-(2-
(dimethylamino)ethyl)oxime, (Z)-, (E)-2-
butenedioate (2:1) (salt) [CAS]
epoprostenolProsta-5,13-dien-1-oic acid, 6,9-epoxy-35121-78-9DE2720999ProstaglandinHypertension,
11,15-dihydroxy-,61849-14-7pulmonary
(5Z,9Alpha,11Alpha,13E,15S)-[CAS]
Epostane80471-63-2
Eprazinone10402-90-1
Epristeride119169-78-7
eprosartan3-[2-Butyl-1-(4-carboxybenzyl)-1H-133040-01-4EP403159Antihypertensive,Hypertension,
imidazol-5-yl]-2-(2-thienylmethyl)-2-(E)-renin systemgeneral
propenoic acid
Eprozinol32665-36-4
eptapirone4-methyl-2-[4-(4-(pyrimidin-2-yl)-179756-85-5AntidepressantDepression,
piperazino)-butyl]-2H,4H-1,2,4-triazin-3,5-general
dione
eptaplatinPlatinum, [(4R,5R)-2-(1-methylethyl)-1,3-146665-77-2WO9216539Anticancer, Cancer, lung,
dioxolane-4,5-dimethanamine-alkylatingsmall cell
kappaN4,kappaN5][propanedioato(2-)-
kappaO1,kappaO3]-, (SP-4-2)-[CAS]
Eptastigmine101246-68-8
eptazocine1,6-Methano-1H-4-benzazonin-10-ol,72522-13-5U.S.4,082,744Analgesic, other
2,3,4,5,6,7-hexahydro-1,4-dimethyl-, (1S)-
[CAS]
Eptifibatide188627-80-7
Equilenin517-09-9
Equilin474-86-2
ERA-923ERA 923 [CAS]352233-89-7EP802183Female Contraceptive,
contraceptivefemale
erdosteineAcetic acid, [[2-oxo-2-[(tetrahydro-2-oxo-3-84611-23-4EP61386RespiratoryRespiratory
thienyl)amino]ethyl]thio]-[CAS]disease,
general
Ergocornine564-36-3
Ergocorninine564-37-4
Ergoloid Mesylates8067-24-1
Ergonovine60-79-7
Ergosterol57-87-4
ergotamine(5′Alpha)-12′-Hydroxy-2′methyl-113-15-5Formulation,Migraine
(phenylmethyl)ergotaman-3′,6′, 18-trioneinhalable, systemic
Eritadenine23918-98-1
erlotinib4-Quinazolinamine, N-(3-ethynylphenyl)-183319-69-9WO9630347Anticancer, otherCancer, lung,
6,7-bis(2-methoxyethoxy)-,non-small cell
monohydrochloride [CAS]
ertapenem1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic153773-82-1WO9315078Beta-lactam Infection,
acid, 3-[[(3S,5S)-5-[[(3-153832-46-3antibioticGI tract
carboxyphenyl)amino]carbonyl]-3-
pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-
methyl-7-oxo-, [CAS]
Erythrityl Tetranitrate7297-25-8
Erythrocentaurin50276-98-7
erythromycin acistrateErythromycin, 2′-acetate, octadecanoate96128-89-1U.S.4,599,326Macrolide antibioticInfection,
(salt) [CAS]general
Erythromycin Estolate3521-62-8
Erythromycin23067-13-2
Glucoheptonate
Erythromycin3847-29-8
Lactobionate
Erythromycin134-36-1
Propionate
Erythromycin643-22-1
Stearate
erythromycinErythromycin, 2′-propanoate, compd. with84252-03-9EP57489Macrolide antibioticInfection,
stinoprateN-acetyl-L-cysteine (1:1) [CAS]respiratory
tract, lower
erythromycinErythromycin [CAS]114-07-8Formulation, dermal,Acne
topical
Erythrophleine36150-73-9
Esaprazole64204-55-3
escitalopram5-Isobenzofurancarbonitrile, 1-[3-128196-01-0EP347066AntidepressantDepression,
(dimethylamino)propyl]-1-(4-fluorophenyl)-general
1,3-dihydro-, (S)-[CAS]
Esculin531-75-9
Eseridine25573-43-7
esmololBenzenepropanoic acid, 4-[2-hydroxy-3-[(1-81147-92-4U.S.4,387,103Antihypertensive,Tachycardia,
methylethyl)amino]propoxy]-, methyl ester,adrenergicsupra-
(+/−)-[CAS]ventricular
esomeprazolebis (5-methoxy-2-(((4-methoxy-3,5-161973-10-0U.S.5,877,192AntispasmodicGastro-
dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-oesophageal
benzimidazolato)reflux
estazolam4H-[1,2,4]Triazolo[4,3-29975-16-4U.S.3,987,052Hypnotic/Sedative
a][1,4]benzodiazepine, 8-chloro-6-phenyl-
[CAS]
estradiolAndrost-4-en-3-one, 17-hydroxy-, (17β)-58-22-0U.S.5,460,820Formulation,Sexual
[CAS]transdermal, patchdysfunction,
female
estradiolEstra-1,2,5(10)-triene-3,17-diol (17β)-50-28-2EP430491Formulation,Menopausal
[CAS]transdermal, systemicsymptoms,
general
estramustineEstra-1,3,5(10)-triene-3,17-diol (17β)-, 3-2998-57-4Anticancer,Cancer,
[bis(2-chloroethyl)carbamate] 17-[CAS]4891-15-0alkylatingprostate
52205-73-9
Estriol50-27-1
estrogenWO9924041Menopausal disordersMenopausal
symptoms,
general
Estrone53-16-7
eszopiclone1-Piperazinecarboxylic acid, 4-methyl-6-(5-138729-47-2U.S.5,786,357Hypnotic/SedativeInsomnia
chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-
pyrrolo(3,4-b)pyrazin-5-yl ester (S)-[CAS]
Etafedrine7681-79-0
Etafenone90-54-0
Etamiphyllin314-35-2
Etanercept185243-69-0
Etanidazole22668-01-5
Etaqualone7432-25-9
Eterobarb27511-99-5
Ethacridine442-16-0
Ethacrynic Acid58-54-8
Ethadion520-77-4
Ethambutol74-55-5
Ethamivan304-84-7
Ethamsylate2624-44-4
Ethanolamine141-43-5
Ethaverine486-47-5
Ethchlorvynol113-18-8
Ethenzamide938-73-8
Ethiazide1824-58-4
Ethinamate126-52-3
Ethinyl Estradiol57-63-6
ethinyl estradiol19-Norpregna-1,3,5(10)-trien-20-yne-3,17-28913-23-7DE1949095Formulation, Cancer,
diol, 3-(2-propanesulfonate), (17Alpha)-modified-prostate
[CAS]release, >24 hr
Ethionamide536-33-4
Ethisterone434-03-7
Ethoheptazine77-15-6
Ethopropazine522-00-9
Ethosuximide77-67-8
Ethotoin86-35-1
Ethoxzolamide452-35-7
Ethybenztropine524-83-4
Ethyl Alcohol64-17-5
Ethyl Biscoumacetate548-00-5
Ethyl Chloride75-00-3
Ethyl Dibunate5560-69-0
Ethyl Ether60-29-7
ethyl icosapentate5,8,11,14,17-Eicosapentaenoic acid, ethyl86227-47-6JP61043143AntithromboticPeripheral
ester, (all-Z)-[CAS]vascular
disease
ethyl loflazepate1H-1,4-Benzodiazepine-3-carboxylic acid,29177-84-2U.S.3,657,223AnxiolyticAnxiety,
7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-general
oxo-, ethyl ester [CAS]
Ethyl Loflazepate29177-84-2
Ethylamine75-04-7
Ethylene74-85-1
Ethylestrenol965-90-2
Ethylidene 1821-16-5
Dicoumarol
Ethylmethyl-441-61-2
thiambutene
Ethylmorphine76-58-4
Ethylnorepinephrine536-24-3
Ethynodiol1231-93-2
ethynylcytidineUridine, 3′-C-ethynyl-[CAS]180300-49-6WO9618636Anticancer,Cancer,
antimetabolitegeneral
Etidocaine36637-18-0
etidronatePhosphonic acid, (1-hydroxyethylidene)bis-,2809-21-4U.S.4,137,309OsteoporosisOsteoporosis
[CAS]7414-83-7treatment
Etidronic Acid2809-21-4
Etifelmin341-00-4
etifoxine4H-3,1-Benzoxazin-2-amine, 6-chloro-N-21715-46-8U.S.3,725,404Anxiolytic
ethyl-4-methyl-4-phenyl-[CAS]
Etilefrin709-55-7
etilevodopaL-Tyrosine, 3-hydroxy-, ethyl ester [CAS]37178-37-3U.S.5,354,885AntiparkinsonianParkinson's
disease
etiprednolandrosta-1,4-diene-17-carboxylic acid, 17-199331-40-3GI inflammatory/Crohn's
[(dichloroacetyl)oxy]-11-hydroxy-3-oxo-,bowel disordersdisease
ethyl ester, (11β,17Alpha)-
Etiroxate17365-01-4
Etizolam40054-69-1
etodolacPyrano[3,4-b]indole-1-acetic acid, 1,8-41340-25-4U.S.3,939,178Antiarthritic, otherArthritis,
diethyl-1,3,4,9-tetrahydro-[CAS]osteo
Etodroxizine17692-34-1
etofenamateBenzoic acid, 2-[[3-30544-47-9GB1285400Anti-inflammatory,Inflammation,
(trifluoromethyl)phenyl]amino]-, 2-(2-topicalgeneral
hydroxyethoxy)ethyl ester [CAS]
etofibrate3-Pyridinecarboxylic acid, 2-[2-(4-31637-97-5U.S.3,723,446Hypolipaemic/
chlorophenoxy)-2-methyl-1-Antiatherosclerosis
oxopropoxy]ethyl ester [CAS]
Etofylline519-37-9
etofylline clofibratePropanoin acid, 2-(4-chlorophenoxy)-2-54504-70-0DE2308826Hypolipaemic/
methyl-, 2-(1,2,3,6-tetrahydro-1,3-dimethyl-Antiatherosclerosis
2,6-dioxo-7H-purin-7-yl)ethyl ester [CAS]
Etofylline Nicotinate13425-39-3
Etoglucid1954-28-5
Etomidate33125-97-2
Etomidoline21590-92-1
Etonitazene911-65-9
etonogestrel18,19-Dinorpregn-4-en-20-yn-3-one, 13-54048-10-1Formulation,Contraceptive,
ethyl-17-hydroxy-11-methylene, (17Alpha)-implantfemale
[CAS]
Etoperidone52942-31-1
etoposideFuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-33419-42-0GB1205966Anticancer, otherCancer,
6(5aH)-one, 9-[(4,6-O-ethylidene-β-D-testicular
glucopyranosyl)oxy]-5,8,8a,9-tetrahydro-5-
(4-hydroxy-3,5-dimethoxyphenyl)-, [5R-
[5Alpha,5aβ,8aAlpha,9β(R*)]]-[CAS]
etoposide phosphateFuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-117091-64-2EP302473Anticancer, otherCancer,
6(5aH)-one, 9-[(3,5-dimethoxy-4-testicular
(phosphonooxy)phenyl]-9-[(4,6-0-
ethylidene-β-D-glucopyranosyl)oxy]-
5,8,8a,9-tetrahydro-, [5R-
[5Alpha,5aβ,8aAlpha,9β(R*)]]-[CAS]
etoricoxib2,3-Bipyridine, 5-chloro-6′-methyl-3-(4-202409-33-4WO9803484Antiarthritic, otherArthritis,
(methylsulfonyl)phenyl) [CAS]osteo
Etoxadrol28189-85-7
Etozolin73-09-6
etretinate2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-54350-48-0U.S.4,215,215Antipsoriasis
2,3,6-trimethylphenyl)-3,7-dimethyl-, ethyl
ester, (all-E)-[CAS]
Etryptamine2235-90-7
Etymemazine523-54-6
Eucatropine100-91-4
Eugenol97-53-0
EUK-134Manganese, chloro[[2,2- [1,2-81065-76-1U.S.6,046,188CardiovascularUnspecified
ethanediylbis[(nitrilo-
kappaN)methylidyne]]bis(6-
methoxyphenolato-kappaO]]]-, (SP-5-13)-
[CAS]
EUK-189U.S.6,046,188Radio/Chemotherapy-
chemoprotectiveinduced injury,
general
Evans Blue314-13-6
everolimusRapamycin, 42-O-(2-hydroxyethyl)-[CAS]159351-69-6WO9409010ImmunosuppressantTransplant
rejection,
general
exalamideBenzamide, 2-(hexyloxy)-[CAS]53370-90-4GB726786AntifungalInfection,
fungal,
general
Exametazime105613-48-7
exatecan10H,13H-171335-80-1Anticancer, otherCancer,
Benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-pancreatic
b]quinoline-10,13-dione, 1-amino-9-ethyl-5-
fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-
4-methyl-, (1A,9S)-, [CAS]
exemestaneAndrosta-1,4-diene-3,17-dione, 6-107868-30-4DE3622841Anticancer, hormonalCancer,
methylene-[CAS]breast
Exifone52479-85-3
exisulind1H-Indene-3-acetic acid 5-fluoro-2-methyl-59973-80-7Anticancer, otherPolyp
1-((4-(methylsulfonyl)phenyl)methylene)-,
(Z)-[CAS]
Exosurf ®99732-49-7
ezetimibe2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-163222-33-1U.S.5,846,966Hypolipaemic/Hypercholest-
(4-fluorophenyl)-3-hydroxypropyl]-4-(4-Antitherosclerosiserolaemia
hydroxyphenyl)-, (3R,4S)-[CAS]
Factor IX9001-28-9
Factor VIII9001-27-8
Factor XIII9013-56-3
fadolmidine1H-Inden-5-ol, 2,3-dihydro-3-(1H-imidazol-189353-32-0WO9712874Analgesic, otherPain, general
4-ylmethyl), monohydrochloride [CAS]
Fadrozole102676-47-1
falecalcitriol9,10-Secocholesta-5,7,10(19)-triene-83805-11-2JP03099022OsteoporosisHyperpara-
1,3,25-triol, 26,26,26,27,27,27-hexafluoro-,treatmentthyroidism
(1Alpha,3β,5Z,7E)-[CAS]
famciclovir1,3-Propanediol, 2-[2-(2-amino-9H-purin-9-104227-87-4JP61085388Antiviral, otherInfection,
yl)ethyl]-, diacetate (ester)-[CAS]gynaecological
famotidinePropanimidamide, 3-[[[2-76824-35-6U.S.4,283,408AntiilcerUlcer,
[(aminoiminomethyl)amino]-4-duodenal
thiazolyl]methyl]thio]-N-(aminosulfonyl)-
[CAS]
fampridine4-pyridamine504-24-5NeuroprotectiveSpinal cord
injury
fandofloxacin3-Quinolinecarboxylic acid, 6-fluoro-1-(5-164150-85-0U.S.5,496,947Quinolone Infection,
fluoro-2-pyridinyl)-1,4-dihydro-7-(4-methyl-164150-99-6antibacterialurinary tract
1-piperazinyl)-4-oxo, [CAS]
Fantofarone114432-13-2
faropenem daloxate(5R,6S)-6-[1(R)-Hydroxyethyl]-2-[2(R)-Beta-lactamInfection,
tetrahydrofuryl]-2-penem-3-carboxylic acid-antibioticgeneral
5-methyl-2-oxo-1,3-dioxol-4-ylmethyl ester
faropenem4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-122547-49-3EP410727Beta-lactamInfection,
carboxylic acid, 6-(1-hydroxyethyl)-7-oxo-3-antibioticocular
(tetrahydro-2-furanyl)-, [5R-
[3(R*),5Alpha,6Alpha(R*)]]-[CAS]
fasidotrilL-Alanine, N-[(2S)-3-(acetylthio)-2-(1,3-135038-57-2EP419327Antihypertensive,Hypertension,
benzodioxol-5-ylmethyl)-1-oxopropyl]-,renin systemgeneral
phenylmethyl ester [CAS]
fasudil1H-1,4-Diazepine, hexahydro-1-(5-103745-39-7EP187371NeuroprotectiveVasospasm,
isoquinolinylsulfonyl)-[CAS]105628-07-7general
Fazadinium Bromide49564-56-9
febarbamate2,4,6(1H,3H,5H)-Prrimidinetrione, 1-[2-13246-02-1U.S.3,075,983Psychostimulant
[(aminocarbonyl)oxy]-3-butoxypropyl]-5-
ethyl-5-phenyl-[CAS]
Febuprol3102-00-9
febuxostat5-Thiazolecarboxylic acid, 2-[3-cyano-4-(2-144060-53-7WO9209279AntigoutHyper-
methylpropoxy)phenyl]-4-methyl-[CAS]uricaemia
Fedotozine123618-00-8
felbamate1,3-Propanediol, 2-phenyl-, dicarbamate25451-15-4U.S.4,868,327AntiepilepticEpilepsy,
[CAS]general
felbinac[1,1′-Biphenyl]-4-acetic acid [CAS]5728-52-9EP127840Anti-inflammatory,
topical
felodipine3,5-Pyridinedicarboxylic acid, 4-(2,3-72509-76-3U.S.4,264,611Antihypertensive,Hypertension,
dichlorophenyl)-1,4-dihydro-2,6-dimethyl-,othergeneral
ethyl methyl ester [CAS]
Felypressin56-59-7
Femoxetine59859-58-4
Fenbenicillin1926-48-3
fenbufen[1,1′-Biphenyl]-4-butanoic acid, Gamma-36330-85-5U.S.3,784,701Anti-inflammatory
oxo-[CAS]
Fenbutrazate4378-36-3
Fencamfamine1209-98-9
Fencamine28947-50-4
Fenclozic Acid17969-20-9
Fendiline13042-18-7
Fendosal53597-27-6
Fenethylline3736081
Fenfluramine458-24-2
Fenipentol583-03-9
fenofibratePropanoic acid, 2-[4-(4-26129-32-8Formulation, Hyper-
chlorobenzoyl)phenoxy]-2-methyl-, 1-49562-28-9modified-lipidaemia,
methylethyl ester [CAS]release, <=24 hrgeneral
fenoldopam1H-3-Benzazepine-7,8-diol, 6-chloro-67227-56-9EP22330Antihypertensive,Hypertension,
2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-67227-57-0othergeneral
[CAS]
Fenoprofen31879-05-7
Fenoterol13392-18-2
fenoverine10H-Phenothiazine, 10-[[4-(1,3-37561-27-6FR2092639Antispasmodic
benzodioxol-5-ylmethyl)-1-
piperazinyl]acetyl]-[CAS]
Fenoxazoline4846-91-7
Fenoxedil54063-40-0
Fenozolone15302-16-6
Fenpentadiol15687-18-0
Fenpiprane3540-95-2
Fenpiverinium125-60-0
Bromide
Fenproporex15686-61-0
Fenquizone20287-37-0
fenretinideRetinamide, N-(4-hydroxyphenyl)-[CAS]65646-68-6BE847942Anticancer, otherCancer, breast
Fenspiride5053066
fentanylPropanamide, N-phenyl-N-[1-(2-437-38-7Formulation,Anaesthesia,
phenylethyl)-4-piperidinyl]-[CAS]transmucosal, adjunct
systemic
Fentiazac18046-21-4
Fenticlor97-24-5
fenticonazole1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-72479-26-6U.S.4,221,803AntifungalInfection,
[[4-(phenylthio)phenyl]methoxy]ethyl]-73151-29-8gynaecological
[CAS]
Fentonium Bromide5868064
fepradinolBenzenemethanol, Alpha[[(2-hydroxy-1,1-36981-91-6Anti-inflammatory,
dimethylethyl)amino]methyl]-, (+/−)-[CAS]67704-50-1topical
63075-57-8
Feprazone30748-29-9
Ferric Sodium Edetate15708-41-5
ferrioxamine BWO9426263Septic shockRespiratory
treatmentdistress
syndrome,
adult
Ferrocholinate1336-80-7
Ferrous Gluconate299-29-6
ferumoxytolPolyglucose sorbitol carboxymethyl ether-Imaging agentDiagnosis,
coated non-stoichiometric magnetitecancer
fesoterodine2-((1R)-3-(bis(1-methylethyl)amino)-1-286930-03-8UrologicalIncontinence
phenylpropyl)-4-(hydroxymethyl)Phenyl
ester, (2E)-2-butenedioate (1:1) (Salt)-
[CAS]
fexofenadineBenzeneacetic acid, 4-[1-hydroxy-4-153439-40-8U.S.5,345,693Antiallergic, non-Rhinitis,
[4(hydroxydiphenylmethyl(-1-83799-24-0asthmaallergic,
piperidinyl]butyl]-Alpha,Alpha-dimethyl-,138452-21-8seasonal
[CAS]
FibrostatCA2132416VulneraryWound healing
fidarestatSpiro(4H-1-benzopyran-4,4′-imidazolidine)-136087-85-9EP418834SymptomaticNeuropathy,
2-carboxamide, 6-fluoro-2,3-dihydro-2′,5′-antidiabeticdiabetic
dioxo-, (2S-cis)-, [CAS]
fiduxosin8-Phenyl-3-[4-[(3aR,9bR)-1,3a,4,9b-]]208993-54-8Prostate disordersBenign prostatic
tetrahydro-9-methoxy[1]benzopyrano[3,4-c]-hyperplasia
pyrrol-2(3H)-yl]butyl]pyrazino[2′,3′:4,5]-
thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione
finasteride4-Azaandrost-1-ene-17-carboxamide, N-98319-26-7EP155096Prostate disordersBenign
(1,1-dimethylethyl)-3-oxo-, (5Alpha,17β)-prostatic
[CAS]hyperplasia
finrozoleBenzonitrile, 4-(3-(4-fluorophenyl)-2-160146-16-7EP476944UrologicalUrinary
hydroxy-1-(1H-1,2,4-triazol-1-yl)-propyl)-retention
[CAS]
Fipexide34161-24-5
FK-960N-(4-Acetyl-1-piperazinyl)-4-133920-70-4WO9101979CognitionAlzheimer's
fluorobenzamide monohydrate-[CAS]enhancerdisease
Flavopiridol146426-40-6
flavoxate4H-1-Benzopyran-8-carboxylic acid, 3-15301-69-6U.S.2,921,070Urological
methyl-4-oxo-2-phenyl-, 2-(1-3717-88-2
piperidinyl)ethyl ester [CAS]
flecainideBenzamide, N-(2-piperidinylmethyl)-2,5-54143-55-4Formulation, Fibrillation,
bis(2,2,2-trifluoroethoxy)-, [CAS]54143-56-5modified-atrial
release, <=24 hr
fleroxacin3-Quinolinecarboxylic acid, 6,8-difluoro-1-79660-53-0U.S.4,398,029QuinoloneInfection,
(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-79660-72-3antibacterialgeneral
piperazinyl)-4-oxo-[CAS]
Flesinoxan98206-10-1
flibanserin2H-Benzimidazol-2-one, 1,3-dihydro-2-(2-167933-07-5Reproductive/Sexual
(4-(3-(trifluoromethyl)phenyl)-1-gonadal, generaldysfunction,
piperazinyl)ethyl)-[CAS]female
floctafenineBenzoic acid, 2-[[8-(trifluoromethyl)-4-23779-99-9U.S.3,644,368Analgesic, NSAID
quinolinyl]amino]-, 2,3-dihydroxypropyl
ester [CAS]
flomoxef5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-92823-03-5EP128536Cephalosporin,Infection,
carboxylic acid, 7-99665-00-6injectablegeneral
[[[(difluoromethyl)thio]acetyl]amino]-3-
[[[(1-(2-hydroxyethyl)-1H-tetrazol-5-
yl]thio]methyl]-7-methoxy-8-oxo-, (6R-cis)-
[CAS]
Flopropione2295-58-1
Florantyrone519-95-9
Flosequinan76568-02-0
Floxacillin5250-39-5
Floxuridine50-91-9
Fluacizine30223-48-4
Fluanisone1480-19-9
fluasteroneAndrost-5-en-17-one, 16-fluoro-,112859-71-9EP246650CardiovascularKeratosis
(16Alpha)-[CAS]
fluazacort5'H-Pregna-1,4-dieno[17,16-d]oxazole-19888-56-3U.S.3,461,119Antipruritic/
3,20-dione, 21-(acetyloxy)-9-fluoro-11-inflamm, non-
hydroxy-2'-methyl-, (11β,16β)-[CAS]allergic
Flucloronide3693-39-8
flucloxacillin1847-24-1Formulation, otherInfection,
34214-51-2general
Fluconazole1H-1,2,4-Triazole-1-ethanol, Alpha-(2,4-86386-73-4EP96569AntifungalInfection,
difluorophenyl)-Alpha-(1H-1,2,4-triazol-1-dermatological
ylmethyl)-[CAS]
Flucytosine2022-85-7
fludarabine9H-Purin-6-amine, 2-fluoro-9-(5-O-75607-67-9U.S.4,357,324Anticancer,Cancer,
phosphono-β-D-arabinofuranosyl)-[CAS]21679-14-1antimetaboliteleukaemia,
chronic
lymphocytic
Fludeoxyglucose F18105851-17-0
Fludiazepam3900-31-0
Fludrocortisone127-31-1
Flufenamic Acid530-78-9
Fluindione957-56-2
flumazenil4H-Imidazo[1,5-a][1,4]benzodiazepine-3-78755-81-4EP27214Neurological
carboxylic acid, 8-fluoro-5,6-dihydro-5-
methyl-6-oxo-, ethyl ester [CAS]
Flumecinol56430-99-0
Flumequine42835-25-6
Flumethasone2135-17-3
Flumethiazide148-56-1
fluarizinePiperazine, 1-[bis(4-fluorophenyl)methyl]-4-30484-77-6GB1268710Antimigraine
(3-phenyl-2-propenyl)-, (E)-[CAS]52468-60-7
27848-84-6
flunisolidePregna-1,4-diene-3,20-dione, 6-fluoro-3385-03-3U.S.3,124,571AntiasthmaRhinitis,
11,21-dihydroxy-16,17-[(1-allergic,
methylethylidene)bis(oxy)]-,general
(6Alpha,11β,16Alpha)-[CAS]
flunitrazepam2H-1,4-Benzodiazepin-2-one, 5-(2-1622-62-4U.S.3,116,203Hypnotic/
fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-Sedative
[CAS]
Flunoxaprofen66934-18-7
Fluocinolone Acetonide67-73-2
Fluocinonide356-12-7
Fluocortin Butyl41767-29-7
Fluocortolone152-97-6
Fluorescein2321-07-5
Fluoresone2924-67-6
Fluorometholone426-13-1
Fluorosalan4776061
fluorouracil2,4(1H,3H)-Pyrimidinedione, 5-fluoro-51-21-8Formulation,Keratosis
[CAS]transdermal,
enhanced
fluoxetineBenzenepropanamine, N-methyl-Gamma-54910-89-3U.S.4,314,081AntidepressantDepression,
[4-(trifluoromethyl)phenoxy]-, (+/−)-[CAS]56296-78-7general
Fluoxymesterone76-43-7
Flupentixol2709-56-0
Fluperolone2119-75-7
Fluphenazine69-23-8
flupirtineCarbamic acid, [2-amino-6-[[(4-33400-45-2U.S.4,481,205Analgesic, otherPain, post-
fluorophenyl)methyl]amino]-3-pyridinyl]-,56995-20-1operative
ethyl ester [CAS]75507-68-5
Fluprednidene Acetate1255-35-2
Fluprednisolone53-34-9
Fluproquazone40507-23-1
Flurandrenolide1524-88-5
Flurazepam17617-23-1
flurbiprofen[1,1′-Biphenyl]-4-acetic acid, 2-fluoro-5104-49-4U.S.3,793,457Anti-inflammatory
Alpha-methyl-[CAS]
flurithromycinErythromycin, 8-fluoro-mono(ethyl82730-23-2EP56291Macrolide antibioticInfection,
butanedioate) (ester)-[CAS]respiratory
tract,
lower
Flurogestone2529-45-5
Flurothyl333-36-8
Fluroxen406-90-6
Fluspirilene1841-19-6
flutamidePropanamide, 2-methyl-N-[4-nitro-3-13311-84-7U.S.4,329,364Anticancer,
(trifluoromethyl)phenyl]-[CAS]hormonal
flutazolamOxazolo[3,2-d][1,4]benzodiazepin-6(5H)-27060-91-9U.S.3,905,956Anxiolytic
one, 10-chloro-11b-(2-fluorophenyl)-
2,3,7,11b-tetrahydro-7-(2-hydroxyethyl)-
[CAS]
fluticasoneAndrosta-1,4-diene-17-carbothioic acid,80474-14-2Formulation,Asthma
6,9-difluoro-11,17-dihydroxy-16-methyl-3-90566-53-3inhalable, solution
oxo-, S-(fluoromethyl) ester,
(6Alpha,11β,16Alpha,17Alpha)-[CAS]
flutoprazepam2H-1,4-Benzodiazepin-2-one, 7-chloro-1-25967-29-7GB1253368AnxiolyticPsychosis,
(cyclopropylmethyl)-5-(2-fluorophenyl)-1,3-general
dihydro-[CAS]
flutrimazole1H-Imidazole, 1-[(2-fluorophenyl)(4-119006-77-8EP352352AntifungalInfection,
fluorophenyl)phenylmethyl]-[CAS]dermatological
Flutropium Bromide63516-07-4
fluvastatin6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-93957-55-2EP114027Hypolipaemic/Hypercholest-
(1-methylethyl)-1H-indol-2-yl]-3,5-93957-54-1Antiatherosclerosiserolaemia
dihydroxy-, monosodium salt, [R*,S*-(E)]-
(±)-[CAS]
fluvoxamine1-Pentanone, 5-methoxy-1-[4-54739-18-3GB1535226AntidepressantDepression,
(trifluoromethyl)phenyl]-O-(2-61718-82-9general,
aminoethyl)oxime, (E)-[CAS]Obsessive-
compulsive
disorder
Folic Acid59-30-3
Folinic Acid58-05-9
Fomepizole7554-65-6
fominobenBenzamide, N-[3-chloro-2-[[methyl[2-(4-18053-31-1U.S.3,661,903RespiratoryEczema,
morpholinyl)-2-24600-36-0stimulantgeneral
oxoethyl]amino]methyl]phenyl]-[CAS]
Fomivirsen144245-52-3
Fomocaine17692-39-6
Fonazine7456-24-8
fondaparinuxAlpha-D-Glucopyranoside, methyl O-2-104993-28-4AnticoagulantThrombosis,
deoxy-6-O-sulfo-2-(sulfamino)-Alpha-D-114870-03-0venous
glucopyranosyl-(1-4)-O-β-D-
glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di
O-sulfo-2-(sulfoamino)-Alpha-D-
glucopyranosyl-(1-4)-O-2-O-sulfo-Alpha-L-
idopyranuronosyl-(1-4)-2-deoxy-2-
(sulfoamino)-,6-(hydrogen sulfate) [CAS]
Formebolone2454117
formestaneAndrost-4-ene-3,17-dione, 4-hydroxy-566-48-3EP346953Anticancer,Cancer, breast
[CAS]hormonal
Formocortal2825-60-7
formoterolFormamide, N-[2-hydroxy-5-[1-hydroxy-2-43229-80-7GB1415256AntiasthmaAsthma
[[2-(4-methoxyphenyl)-1-73573-87-2
methylethyl]amino]ethyl]phenyl]-, (R*,R*)-
(+/−)-[CAS]
fosamprenavirCarbamic acid, ((1S,2R)-3-(((4-226700-81-8Antiviral, anti-HIVInfection,
aminophenyl)sulfonyl)(2-HIV/AIDS
methylpropyl)amino)-1-(phenylmethyl)-2-
(phosphonooxy)propyl)-C-((3S)-tetrahydro-
3-furanyl ester, [CAS]
foscarnetPhosphinecarboxylic acid, dihydroxy-,34156-56-4U.S.4,839,445Antiviral, otherInfection,
oxide, trisodium salt [CAS]4428-95-9cytomegalo-
virus
63585-09-1
Fosfestrol522-40-7
fosfluconazole2,4-difluoro-Alpha,Alpha-bis(1H-1,2,4-194798-83-9AntifungalInfection,
triazol-1-ylmethyl)benzyl alcohol,fungal,
dihydrogen phosphate (ester)general
fosfomycinPhosphonic acid, (3-methyloxiranyl)-, (2R-23155-02-4GB1223923Antibiotic, otherInfection,
cis)-[CAS]26016-98-8general
fosfomycin Phosphonic acid, (3-methyloxiranyl)-, (2R-78964-85-9EP27597Antibiotic, otherInfection,
trometamolcis)-, compd. with 2-amino-2-urinary tract
(hydroxymethyl)-1,3-propanediol (1:1)-
[CAS]
Fosfosal6064-83-1
fosinoprilL-Proline, 4-cyclohexyl-1-[[[2-methyl-1-(1-88889-14-9EP63896Antihypertensive,Hypertension,
oxopropoxy)propoxy](4-98048-97-6renin systemgeneral
phenylbutyl)phosphinyl]acetyl]-,
(2Alpha,4β)-[CAS]
fosphenytoin2,4-Imidazolidinedione, 5,5-diphenyl-3-92134-98-0U.S.4,260,769AntiepilepticEpilepsy,
[(phosphonooxy)methyl]-[CAS]93390-81-9generalized,
tonic-clonic
fotemustinePhosphonic acid, [1-[[[(2-92118-27-9EP117959Anticancer,Cancer,
chloroethyl)nitrosoamino]carbonyl]amino]-alkylatingmelanoma
ethyl]-, diethyl ester [CAS]
Fropenem106560-14-9
frovatriptan1H-Carbazole-6-carboxamide, 2,3,4,9-158747-02-5WO9922730AntimigraineMigraine
tetrahydro-3-(methylamino)-, (R)-[CAS]
Fructose57-48-7
Fructose-1,6-488-69-7
diphosphate
FTC2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-(2-Antiviral, anti-HIVInfection,
(hydroxymethyl)-1,3-oxathiolan-5-yl)-(4R)HIV/AIDS
FTY-7201,3-Propanediol, 2-amino-2-(2-(4-162359-56-0WO9408943ImmunosuppressantTransplant
octylphenyl)ethyl)-, hydrochloride [CAS]rejection,
general
fudosteineAlanine, 3-((3-hydroxypropyl)thio)-[CAS]13189-98-5U.S.5,047,428AntitussiveCough
fulvestrantEstra-1,3,5(10)-triene-3,17-diol, 7-[9-129453-61-8EP346014Anticancer,Cancer,
[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-,hormonalbreast
(7Alpha,17β)-[CAS]
fumagiline2,4,6,8-Decatetraenedioic acid, mono[5-23110-15-8ProtozoacideInfection,
methoxy-4-[2-methyl-3-(3-methyl-2-GI tract
butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl]
ester, [3R-
[3Alpha,4Alpha(2R*,3R*),5β,6β(all-E)]]-
[CAS]
Fumagillin23110-15-8
Furaltadone139-91-3
Furazabol1239-29-8
Furazolidone67-45-8
Furazolium Chloride5118-17-2
Furonazide3460-67-1
furosemideBenzoic acid, 5-(aminosulfonyl)-4-chloro-2-54-31-9Formulation, Hypertension,
[(2-furanylmethyl)amino]-[CAS]modified-general
release, other
Fursultiamine804-30-8
Furtrethonium7618-86-2
Fusidic Acid06/03/6990
G1, YM BioSciences1-(5-bromofur-2-yl)-2-bromo-2-nitroetheneAntifungalInfection,
gynaecological
G25WO9804252AntimalarialInfection,
malaria
GABA-A Alpha5 WO0206285Cognition enhancerAlzheimer's
inverse agonist,Merdisease
gabapentinCyclohexaneacetic acid, 1-(aminomethyl)-60142-96-3U.S.4,152,326AntiepilepticEpilepsy,
[CAS]general
gabexateBenzoic acid, 4-[[6-39492-01-8U.S.3,751,447GI inflammatory/Pancreatitis
[(aminoiminomethyl)amino]-1-56974-61-9bowel disorders
oxohexyl]oxy]-, ethyl ester,
monomethanesulfonate [CAS]
gaboxadolIsoxazolo[5,4-c]pyridin-3(2H)-one, 4,5,6,7-64603-91-4CA1125288Hypnotic/SedativeSleep disorder,
tetrahydro-[CAS]general
Gadobenat127000-20-8
Dimeglumine
Gadobutrol138071-82-6
Gadodiamide131410-48-5
Gadopentetic Acid80529-93-7
Gadoteridol120066-54-8
Gadoversetamide131069-91-5
Gadoxetic Acid135326-11-3
galantamine(4aS,6R,8aS)-6-Hydroxy-3-methoxy-11-Formulation,Alzheimer's
methyl-5,6,9,10,11,12-hexahydro-4aH-modified-release, disease
benzofuro[3a,3,2-e,f][2]benzazepineother
Galanthamineβ-Alanine, 2-[4-[(2,6-dideoxy-2-fluoro-357-70-0
galarubicinAlpha-L-talopyranosyl)oxy]-1,2,3,4,6,11-140637-82-7EP424899Anticancer,Cancer, breast
hexahydro-2,5,12-trihydroxy-7-methoxy-140637-86-1antibiotic
6,11-dioxo-2-naphthacenyl]-2-oxoethyl
ester, [CAS]
Gallamine Triethiodide65-29-2
Gallic Acid149-91-7
gallium maltolate4H-Pyran-4-one, 3-hydroxy-2-methyl-,Anticancer, otherCancer,
gallium complexmyeloma
gallium nitrateNitric acid, gallium salt [CAS]13494-90-1U.S.4,529,593OsteoporosisHypercalcaemia
treatmentof malignancy
gallopamilBenzeneacetonitrile, Alpha-[3-[[2-(3,4-16662-47-8GB1367677AntianginalAngina, general
dimethoxyphenyl)ethyl]methylamino]propyl]-
3,4,5-trimethoxy-Alpha-(1-methylethyl)-
[CAS]
γ-Aminobutyric Acid56-12-2
Ganaxolone38398-32-2
ganciclovir6H-Purin-6-one, 2-amino-1,9-dihydro-9-[[2-107910-75-8EP49072Antiviral, otherInfection,
hydroxy-1-(hydroxymethyl)ethoxy]methyl]-82410-32-0cytomegalovirus
[CAS]
ganirelix[N-Ac-D-NaI,D-pCl-Phe,D-PaI,D-124904-93-4EP312052Releasing hormonesInfertility,
hArg(Et)2,hArg(Et)2,D-Ala]GnRH-[CAS]female
ganstigmineCarbamic acid, (2-ethylphenyl)-, (3aS,8aS)223585-99-7EP1023297Cognition enhancerAlzheimer's
1,2,3,3a,8,8a-hexahydro-1,3a,8-disease
trimethylpyrrolo[2,3-b]indol-5-yl ester,
gantofiban1-Piperazineacetic acid, 4-[[(5R)-3-[4-183547-57-1EP741133AntithromboticThrombosis,
[imino[(methoxycarbonyl)amino]methyl]-general
phenyl]-2-oxo-5-oxazolidinyl]methyl]-,
ethylester [CAS]
garenoxacin3-Quinolinecarboxylic acid, 1-cyclopropyl-8223652-82-2QuinoloneInfection,
(difluoromethoxy)-7-((1R)-2,3-dihydro-1-antibacterialrespiratory tract,
methyl-1H-isoindol-5-yl)-1,4-dihydro-4-oxo-lower
monomethanesulfonate [CAS]
garnocestim5-73-macrophage inflammatory protein246861-96-1Radio/Chemotherapy-
2Alpha (human gene gro2)-[CAS]chemoprotectiveinduced
injury,
bone marrow,
neutropenia
gatifloxacin3-Quinolinecarboxylic acid, 1-cyclopropyl-6112811-59-3EP230295QuinoloneInfection,
fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-antibacterialrespiratory
1-piperazinyl)-4-oxo-, (+/−)-[CAS]tract, general
Gefarnate51-77-4
gefitinib4-Quinazolinamine, N-(3-chloro-4-184475-35-2WO9633980Anticancer, otherCancer, lung,
fluorophenyl)-7-methoxy-6-(3-(4-non-small cell
morpholinyl)propoxy) [CAS]
gemcabene6,6′-oxybis(2,2-dimethylhexanoate)209789-08-2Hypolipaemic/Hyperlipidaemia,
Antiatherosclerosisgeneral
gemcitabineCytidine, 2′-deoxy-2′, 2′-difluoro-, [CAS]122111-03-9GB2136425Anticancer,Cancer,
95058-81-4antimetabolitepancreatic
gemeprostProsta-2,13-dien-1-oic acid, 11,15-64318-79-2GB1540427Prostaglandin
dihydroxy-16,16-dimethyl-9-oxo-, methyl
ester, (2E,11Alpha,13E,15R)-[CAS]
gemfibrozilPentanoic acid, 5-(2,5-dimethylphenoxy)-25812-30-0U.S.3,674,836Hypolipaemic/Hyper-
2,2-dimethyl-[CAS]Antiatherosclerosislipidaemia,
general
gemifloxacin1,8-Naphthyridine-3-carboxylic acid, 7-(3-175463-14-6U.S.5,869,670QuinoloneInfection,
(aminomethyl)-4-(methoxyimino)-1-antibacterialrespiratory
pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-tract, general
dihydro-4-oxo-[CAS]
gentamicinGentamicin [CAS]1403-66-3Formulation, Infection,
implantgeneral
Gentian Violet548-62-9
Gentiopicrin20831-76-9
Gentisic Acid490-79-9
Gepefrine18840-47-6
gepirone2,6-Piperidinedione, 4,4-dimethyl-1-[4-[4-Formulation,Depression,
(2-pyrimidinyl)-1-piperazinyl]butyl]-[CAS]modified-release,general
other
gestodene18,19-Dinorpregna-4,15-dien-20-yn-3-one,109852-02-0GB1569135Formulation, Contraceptive,
13-ethyl-17-hydroxy-, (17Alpha)-[CAS]60282-87-3fixed-dosefemale
combinations
gestodene + ethinylest18,19-Dinopregna-4,15-dien-20-yn-3-one,Formulation,Contraceptive,
13-ethyl-17-hydroxy-, (17Alpha) mixt withmodified-release,female
19-Norpregna-1,3,5(10)-trien-20-yne->24 hr
13,17-diol (17Alpha)
Gestonorone Caproate1253-28-7
Gestrinone16320-04-0
γ-Hydroxybutyrate591-81-1
gimatecan(4S)-11-[(E)-[(1,1-292618-32-7Anticancer, otherCancer, brain
dimethylethoxy)imino]methyl]-4-ethyl-4-
hydroxy-1-12-dihydro-14H-
pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-
3,14(4H)-dione
Giractide24870-04-0
Gitoxin4562-36-1
GL-406349N,N′-Bis[2-[N-[2-(N2,N5-dimethyl-DL-AntifungalInfection,
lysylamino)-ethyl]carbamoyl]1H-indol-6-yl]-fungal,
1H-indole-2,5-dicarboxamidegeneral
Glafenine3820-67-5
glatiramerL-Glutamic acid, polymer with L-alanine, L-147245-92-9WO5800808Multiple sclerosisMultiple
lysine and L-tyrosine, [CAS]28704-27-0treatmentsclerosis,
relapsing-
remitting
Glibornuride26944-48-9
gliclazideBenzenesulfonamide, N-21187-98-4GB1153982AntidiabeticDiabetes,
[[(hexahydrocyclopenta[c]pyrrol-2(1H)-Type II
yl)amino]carbonyl]-4-methyl-[CAS]
glimepiride1H-Pyrrole-1-carboxamide, 3-ethyl-2,5-93479-97-1WO9303724AntidiabeticDiabetes,
dihydro-4-methyl-N-[2-[4-[[[[(4-Type II
methylcyclohexyl)amino]carbonyl]amino]-
sulfonyl]phenyl]ethyl]-2-oxo-[CAS]
γ-Linolenic Acid506-26-3
glipizidePyrazinecarboxamide, N-[2-[4-29094-61-9U.S.3,669,966Antidiabetic
[[[(cyclohexylamino)carbonyl]amino]sulfonyl]-
phenyl]ethyl]-5-methyl-[CAS]
gliquidoneBenzenesulfonamide, N-33342-05-1GB1277847AntidiabeticDiabetes,
[(cyclohexylamino)carbonyl]-4-[2-(3,4-general
dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-]
2(1H)-isoquinolinyl)ethyl]-[CAS]
glisolamide3-Isoxazolecarboxamide, N-[2-[4-24477-37-0AntidiabeticDiabetes,
[[[(cyclohexylamino)carbonyl]amino]-general
sulfonyl]phenyl]ethyl]-5-methyl-[CAS]
Glisoxepid25046-79-1
Glucametacin52443-21-7
Glucoheptonic Acid87-74-1
Gluconic Acid526-95-4
glucosamineD-Glucose, 2-amino-2-deoxy-, [CAS]29031-19-4DE1953689Antiarthritic, otherArthritis,
3416-24-8osteo
Glucosulfone554-18-7
glufosfamideβ-D-Glucopyranose, 1-(N,N′-bis(2-132682-98-5DE3835772Anticancer,Cancer,
chloroethyl)pheophorodiamidate)-[CAS]alkylatinggeneral
Glutamic Acid56-86-0
Glutaraldehyde111-30-8
Glutethimide77-21-4
Glyburide10238-21-8
Glybuthiazol(e)535-65-9
Glybuzole1492-02-0
Glycerol56-81-5
Glycocyamine352-97-6
Glycol Salicylate87-28-5
Glyconiazide3691-74-5
Glycopyrrolate596-51-0
Glyhexamide451-71-8
Glymidine339-44-6
Glypinamide1228-19-9
GMDPN-acetylglucosaminyl-N-acetylmuramylAnti-infective, otherInfection,
dipeptidegeneral
Gold Sodium12244-57-4
Thiemalat
Gold Sodium10233-88-2
Thiosulfate
goserelinLuteinizing hormone-releasing factor (pig),65807-02-5U.S.4,100,274ReleasingCancer,
6-[O-(1,1-dimethylethyl)-D-serine]-10-hormonesprostate
deglycinamide-, 2-
(aminocarbonyl)hydrazide [CAS]
GPI-1485L-Proline, 1-(3,3-dimethyl-1,2-dioxopentyl)-,186452-09-5AntiparkinsonianParkinson's
3-(3-pyridinyl)propyl ester [CAS]disease
GPI-56932-(Phosphonomethyl)pentanedioic acidU.S.5,672,592Analgesic, otherPain,
neuropathic
Graftskin
granisetron1H-Indazole-3-carboxamide, 1-methyl-N-107007-99-8EP200444AntiemeticChemotherapy-
(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-,109889-09-0induced nausea
endo-[CAS]and vomiting
Grepafloxacin119914-60-2
griseofulvinSpiro[benzofuran-2(3H),1′-[2]cyclohexane]-126-07-8Formulation, dermal,Infection,
3,4′-dione, 7-chloro-2′,4,6-trimeth-oxy-topicaldermatological
6′methyl-, (1′S-trans)-[CAS]
Guaiacol90-05-1
Guaiapate852-42-6
Guaiazulene489-84-9
Guaifenesin93-14-1
guaimesal4H-1,3-Benzodioxin-4-one, 2-(2-81674-79-5GB2098201Anti-inflammatory
methoxyphenoxy)-2-methyl-[CAS]
Guamecycline16545-11-2
Guanabenz5051-62-7
Guanadrel40580-59-4
Guanethidine55-65-2
Guanfacine29110-47-2
Guanoxabenz24047-25-4
Guanoxan2165-19-7
gugulipidPregna-4,17(20)-diene-3,16-dione [CAS]95975-55-6EP447706Hypolipaemic/
Antiatherosclerosis
Gusperimus104317-84-2
GW-280430A(Z)-2-Chlorofumaric acid 1-[3-[-[6,7-Muscle relaxantAnaesthesia,
dimethoxy-2(S)-methyl-1(R)-(3,4,5-adjunct
trimethoxybenzyl)-1,2,3,4-
tetrahydroisoquinolinium-2-yl]propyl]
GW-320659[2S,3S,5R]-2-[3,5-difluorophenyl]-3,5-Anorectic/Obesity
dimethyl-2-morpholinolAntiobesity
GYKI-16084(+)-R-2-[3-[N-(2-U.S.6,194,411Prostate disordersBenign
Benzo[1,4]dioxanylmethyl)amino]-1-prostatic
propyl)-3(2H)-pyridazinone hydrochloridehyperplasia
Hachimycin1394-02-1
Halazepam23092-17-3
Halcinonide3093-35-4
halobetasolPregna-1,4-diene-3,20-dioe, 21-chloro-66852-54-8U.S.4,619,921AntipsoriasisPsoriasis
6,9-difluoro-11-hydroxy-16-methyl-17-(1-
oxopropoxy)-, (6Alpha,11β,16(-[CAS]
halofantrine9-Phenanthrenemethanol, 1,3-dichloro-36167-63-2EP138374AntimalrialInfection,
Alpha-[2-(dibutylamino)ethyl]-6-69756-53-2malaria
(trifluoromethyl)-[CAS]
halometasonePregna-1,4-diene-3,20-dione, 2-chloro-6,9-50629-82-8U.S.4,076,737Antipruritic/
difluoro-11,17,21-trihydroxy-16-methyl-,inflamm, allergic
(6Alpha,11β,16Alpha)-[CAS]
Haloperidol52-86-8
Halopredone57781-14-3
Haloprogin777-11-7
Halopropane679-84-5
Halothane151-67-7
Haloxazolam59128-97-1
harkoseride2(R)-Acetamido-N-benzyl-3-WO9733861AntiepilepticEpilepsy,
methoxypropionamidegeneral
HE-200016Alpha-Bromo-3β-hydroxy-5Alpha-Antiviral, anti-HIVInfection,
androstane-17-oneHIV/AIDS
HealosWO9714376MusculoskeletalRegeneration,
bone
Hematoporphyrin14459-29-1
Hepronicate7237-81-2
Heptabarbital509-86-4
Heptaminol372-66-7
Hetacillin3511-16-8
Hetastarch9004-62-0
Hexachlorophene70-30-4
Hexadimethrine28728-55-4
Bromide
Hexafluorenium317-52-2
Bromide
Hexamethonium60-26-4
Hexamidine3811-75-4
Hexapropymate358-52-1
Hexedine5980-31-4
Hexestrol84-16-2
Hexestrol Bis(β-2691-45-4
diethylaminoethyl
ether)
Hexethal144-00-3
Hexetidine141-94-6
Hexobarbital56-29-1
Hexobendine54-03-5
Hexocyclium Methyl115-63-9
Sulfate
Hexoprenaline3215-70-1
HextendHextend [CAS]235746-51-7U.S.5,407,428Plasma substituteSurgery
adjunct
Hexylcaine532-76-3
HF-029911b-hydroxy androstenedioneOsteoporosisOsteoporosis
treatment
HGP-2Benzeneacetic acid, 4-[2-hydroxy-3-[(1-121009-31-2AntiglaucomaGlaucoma
methylethyl)amino]propoxy]-, 2-
tricyclo[3.3.1.13,7]dec-1-ylethyl ester, (2Z)-
2-butenedioate (1:1) (salt) [CAS]
HGP-6A8-Azoniabicyclo[3.2.1]octabe, 3-(3-ethoxy-113932-41-5AntiepilepticEpilepsy,
1,3-dioxo-2-phenylpropoxy)-8,8-dimethyl-,general
(3-endo)-, methyl sulfate [CAS]
hidrosminHydrosmin-[CAS]120250-44-4Vasoprotective,
systemic
histaminehistamine51-45-6EP0493468Anticancer,Cancer,
immunologicalmelanoma
Histapyrrodine493-80-1
histrelinLuteinizing hormone-releasing factor (pig),76712-82-8EP217659Releasing hormonesPrecocious
6-[1-(phenylmethyl)-D-histidine]-9-(N-ethyl-puberty
L-prolinamide)-10-deglycinamide-[CAS]
HM-101HM 101 [CAS]217311-70-1OsteoporosisOsteoporosis
treatment
HMN-214(E)-4-[2-[2-(p-Anticancer, otherCancer,
methoxybenzenesulfonamide)-general
phenyl]ethenyl]pyridine-1-oxide
Homatropine87-00-3
Homocamfin535-86-4
Homochlorcyclizine848-53-3
Hopantenic Acid18679-90-8
HP-228Glycinamide, N-acetyl-L-norleucyl-L-172617-89-9EP759770Analgesic, otherPain, post-
glutaminyl-L-histidyl-D-phenylalanyl-L-operative
arginyl-D-tryptophyl-[CAS]
Huperzine A102518-79-6
hyaluronanHyaluronic acid [CAS]9004-61-9Formulation, otherRestenosis
Hycanthone3105-97-3
Hydnocarpic Acid459-67-6
Hydralazine86-54-4
Hydrastine118-08-1
Hydrastinine6592-85-4
Hydrochlorothiazide58-93-5
hydrocodoneMorphinan-6-one, 4,5-epoxy-3-hydroxy-17-466-99-9Formulation, Pain, general
methyl-,(5Alpha)-[CAS]125-29-1modified-
release, other
Hydrocortamate76-47-1
hydrocortisonePregn-4-ene-3,20-dione, 21-(acetyloxy)-11-74050-20-7DE2826257DermatologicalUnspecified
hydroxy-17-(1-oxopropoxy)-, (11β)-[CAS]50-23-7
hydrocortisone Pregn-4-ene-3,20-dione, 11-hydroxy-17-(1-72590-77-3DE2910899Antipruritic/inflamm,
butyrate propiooxobutoxy)-21-(1-oxopropoxy)-, (11β)-allergic
[CAS]
Hydroflumethiazide135-09-1
hydromorphoneMorphinan-6-one,4,5-epoxy-3-hydroxy-17-103-90-2Formulation, Pain, general
methyl-,(5Alpha)-, mixt with acetamide, N-16590-41-3fixed-dose
(4-hydroxyphenyl)-, mixt with morphinan-6-466-99-9combinations
one, 17-(cyclopropylmethyl)-4,5-epoxy-
3,14-dihydroxy-, (5Alpha)-
Hydroquinidine1435-55-8
Hydroquinine522-66-7
Hydroquinone123-31-9
Hydroxocobalamin13422-51-0
Hydroxyamphetamine1518-86-1
Hydroxychloroquine118-42-3
Hydroxydione53-10-1
Hydroxypethidine468-56-4
Hydroxyphenamate50-19-1
Hydroxypropyl9004-64-2
Cellulose
Hydroxystilbamidine495-99-8
Hydroxytetracaine490-98-2
Hydroxyzine68-88-2
Hylan G-F 20
Hymecromone90-33-5
hyoscyaminebenzeneacetic acid, Alpha(hydroxymethyl)-,101-31-5Formulation, oral,Ulcer, GI,
8-methyl-8-azabicyclo [3.2.1.]oct-3-ylorally-disintegratinggeneral
ester, [3(S)-endo],
hypericinPhenanthro[1,10,9,8-opqra]perylene-7,14-548-04-9Anticancer, otherCancer, brain
dione, 1,3,4,6,8,13-hexahydroxy-10,11-
dimethyl-[CAS]
IACFT180468-34-2
ibandronic acidPhosphonic acid, [1-hydroxy-3-114084-78-5EP252504OsteoporosisHypercalcaemia
(methylpentylamino)propylidene]bis-treatmentof malignancy
[CAS]
ibopaminePropanoic acid, 2-methyl-, 4-[2-66195-31-1GB1551661CardiostimulantHeart failure
(methylamino)ethyl]-1,2-phenylene ester-
[CAS]
ibopaminePropanoic acid, 2-methyl-, 4-[2-66195-31-1Formulation, Surgery adjunct
(methylamino)ethyl]-1,2-phenylene ester-mucosal, topical
[CAS]
Ibritumomab 206181-63-7
Tiuxetan
ibrolipimPhosphonic acid, [[4-[[(4-bromo-2-133208-93-2EP402033Hypolipaemic/Hypertri-
cyanophenyl)amino]carbonyl]phenyl]-Antiatherosclerosisglyceridaemia
methyl]-, diethyl ester [CAS]
ibudilast1-Propanone, 2-methyl-1-[2-(1-50847-11-5EP215438AntiasthmaAsthma
methylethyl)pyrazolo[1,5-a]pyridin-3-yl]-
[CAS]
Ibufenac1553-60-2
ibuprofen piconolBenzeneacetic acid, Alpha-methyl-4-(2-64622-45-3DE2658610Antipruritic/inflamm,Eczema,
methylpropyl)-, 2-pyridinylmethyl esternon-allergiccontact
[CAS]
ibuprofenBenzeneacetic acid, Alpha-methyl-4-(2-15687-27-1Formulation,Inflammation,
methylpropyl)-[CAS]modified-general
release, other
Ibuproxam53648-05-8
ibutilideMethanesulfonamide, N-[4-[4-122647-31-8JP60239458AntiarrhythmicFibrilation,
(ethylheptylamino)-1-hydroxybutyl]phenyl]-,122647-32-9atrial
(+/−)-, [CAS]
ICA-17043U.S.6,288,122AntisicklingAnaemia,
sickle cell
icodextrinDextrin-[CAS]9004-53-9UrologicalRenal failure
idarubicin5,12-Naphthacenedione, 9-acetyl-7-[(3-58957-92-9U.S.4,471,052Anticancer, Cancer,
amino-2,3,6-trideoxy-Alpha-L-lyxo-86189-66-4antibioticleukaemia,
hexopyranosyl)oxy]-7,8,9,10-tetrahydro-acute
6,9,11-trihydroxy-, (7S-cis)-[CAS]lymphocytic
Idazoxan79944-58-4
IdB-10162-(2,3-dihydro-2-(4-hydroxy-3-134499-06-2EP209038Anticancer, Cancer,
methoxyphenyl)-3-(hydroxymethyl)-1,4-hormonalovarian
benzodioxin-6-yl)-2,3-dihydro-3,5,7-
trihydroxy-4H-1-benzopyran-4-one
phosphatidylcholine complex
idebenone2,5-Cyclohexadiene-1,4-dione, 2-(10-58186-27-9EP58057NeuroprotectiveIschaemia,
hydroxydecyl)-5,6-dimethoxy-3-methyl-cerebral
[CAS]
IDN-51094-Hexenoic acid, 3-[[(1,1-186348-05-0U.S.5,264,591Anticancer, otherCancer,
dimethylethoxy)carbonyl]amino]-2-hydroxy-colorectal
5-methyl-,
(3aS,4R,7R,8aS,9S,10aR,12aS,12bR,13S,
13aS)-7,12a-bis(acetyloxy)-13-
(benzoyloxy)-
3a,4,7,8,8a,9,10,10a,12,12a,12b,13-
dodecahydro-9-hydroxy-5,8a,14,14-
tetramethyl-2,8-dioxo-6,13a-methano-
13aH-oxeto [2″,3″,5′,6′] benzo[1,2:4,5]
cyclodeca [1,2-d] dioxyl-4-yl ester, 2R,3S)
[CAS]
Idoxifen116057-75-1
idraparinuxAlpha-D-Glucopyranoside, methyl O-2,3,4-149920-56-9AU698456AntithromboticThrombosis,
tri-O-methyl-6-O-sulfo-Alpha-D-venous
glucopyranosyl-(1,4)-O-2,3-di-O-methyl-β-
D-glucopyranuronosyl-(1,4)-O-2,3,6-tri-O-
sulfo-Alpha-D-glucopyranosyl-(1-4)-O-2,3-
di-O-methyl-Alpha-L-idopyranuronosyl-
(1-4)-, tris(hydrogen sulfate) nonasodium
salt [CAS]
idrocilamide2-Propenamide, N-(2-hydroxyethyl)-3-6961-46-2U.S.3,659,014Anti-inflammatory,
phenyl-[CAS]topical
ifenprodil(7)-2-(4-benzyl piperidino)-1-p-23210-58-4
hydroxyphenylpropanol tartrate23210-56-2U.S.3,509,164Neuroprotective
ifosfamide2H-1,3,2-Oxazaphosphorin-2-amine, N,3-3778-73-2U.S.3,732,340Anticancer,Cancer, lung,
bis(2-chloroethyl)tetrahydro-,2-oxide [CAS]alkylatinggeneral
iguratimodN-[3-(Formylamino)-4-oxo-6-phenoxy-4H-123663-49-0DE3834204Antiarthritic,Arthritis,
chromen-7-yl] methanesulfonamideotherrheumatoid
ilaprazole1H-Benzimidazole, 2-(((4-methoxy-3-172152-36-2U.S.5,703,097AntiulcerUlcer, GI,
methyl-2-pyridinyl) methyl)sulfinyl)-5-(1H-general
pyrrol-1-yl)-[CAS]
ilomastatButanediamide, N4-hydroxy-N1-(1-(1H-142880-36-2U.S.5,892,112COPD treatmentEmphysema,
indol-3-ylmethyl)-2-(methylamino)-2-smoking-
oxoethyl)-2-(2-methylpropyl)-, (S-(R*,S*))-related
[CAS]
iloperidoneEthanone, 1-[4-[3-[4-(6-fluoro-1,2-133454-47-4U.S.5,776,963NeurolepticSchizophrenia
benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-
methoxyphenyl]-[CAS]
iloprost trometamolPentanoic acid, 5-[hexahydro-5-hydroxy-4-78919-13-8DE3417638ProstaglandinPeripheral
(3-hydroxy-4-methyl-1-octen-6-ynyl)-2(1H)-vascular
pentalenylidene]-[CAS]disease
ILX23-75531Alpha,25-Hydroxy-16-yne vitamin D3Anticancer, otherCancer,
general
imatinib4-((Methyl-1-piperazinyl)methyl)-N-[4-152459-95-5U.S.5,521,184Anticancer, otherCancer,
methyl-3-[[4-(3-pyridinyl)-2-leukaemia,
pyrimidinyl]amino]-phenyl]benzamidechronic
methanesulfonatemyelogenous
imidapril4-Imidazolidinecarboxylic acid, 3-[2-[[(1-89371-37-9EP95163Antihypertensive,Hypertension,
(ethoxycarbonyl)-3-phenylpropyl]amino]-1-89396-94-1renin system,general,
oxopropyl]-1-methyl-2-oxo-, [4S-MusculoskeletalCachexia
[3[R*(R*)],4R*]]-[CAS]
imidazole salicylateBenzoic acid, 2-hydroxy-, compd. with 1H-36364-49-5U.S.4,329,340Anti-inflammatoryPain, general
imidazole (1:1) [CAS]
imipenem1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic64221-86-9GB1570990Beta-lactamInfection,
acid, 6-(1-hydroxyethyl)-3-[[2-74431-23-5antibioticgeneral
[(iminomethyl)amino]ethyl]thio]-7-oxo-, [5R-81129-83-1
[5Alpha,6Alpha(R*)]]-[CAS]
Imipramine50-49-7
Imipramine N-Oxide6929-98-7
imiquimod1H-Imidazol[4,5-c]quinolin-4-amine, 1-(2-99011-02-6EP145340Antiviral, otherInfection,
methylpropyl)-[CAS]human
papilloma
virus
Imolamine318-23-0
implitapideBenzeneacetamide, Alpha-cyclopentyl-4-177469-96-4EP705831Hypolipaemic/Athero-
((2,4-dimethyl-9H-pyrido(2,3-b)indol-9-Antiatherosclerosissclerosis
yl)methyl)-N-((1R)-2-hydroxy-1-
phenylethyl)-(AlphaS)-[CAS]
Improsulfan13425-98-4
Inaperisone99323-21-4
incadronatePhosphonic acid,138330-18-4MusculoskeletalHypercalcaemia
[(cycloheptylamino)methylene]bis-, [CAS]of malignancy
Incadronic Acid124351-85-5
Indalpine63758-79-2
Indanazoline40507-78-6
indapamide4-chloro-N-(2-methylindolin-1-yl)-3-26807-65-8GB1203691Antihypertensive, Hypertension,
sulfamoylbenzamidediureticgeneral
Indecainid74517-78-5
indeloxazineMorpholine, 2-[(1H-inden-7-yloxy)methyl]-60929-23-9JP52083773Cognition enhancerAlzheimer's
[CAS]65043-22-3disease
Indeloxazine65043-22-3
indenolol2-Propanol, 1-[1H-inden-4(or 7)-yloxy]-3-30190-87-5GB1290343Antihypertensive,
[(1-methylethyl)amino]-[CAS]60607-68-3adrenergic
68906-88-7
indinavirD-erthro-Pentonamide, 2,3,5-trideoxy-N-150378-17-9EP0541168Antiviral, anti-HIVInfection,
(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-157810-81-6HIV/AIDS
(((1,1-dimethylethyl)amino)carbonyl)-4-(3-
pyridinylmethyl)-1-piperazinyl)-2-
(phenylmethyl), [1S-[1Alpha(R*),2Alpha]]-,
[CAS]
indiplonAcetamide, N-methyl-N-(3-(3-(2-325715-02-4U.S.6,399,621Hypnotic/SedativeInsomnia
thienylcarbonyl)pyrazolo(1,5-a) pyrimidin-7-
yl)phenyl)-[CAS]
indisetron1H-Indazole-3-carboxamide, N-(3,9-160472-97-9AntiemeticNausea and
dimethyl-3,9-diazabicyclo(3.3.1)non-7-yl)-,vomiting,
diendo-[CAS]general
indisulam1,4-Benzenedisulfonamide, N-(3-chloro-165668-41-7AAnticancer, otherCancer, lung,
1H-indol-7-yl)-[CAS]non-small cell
Indobufen63610-08-2
Indocyanine Green3599-32-4
indometacin1H-Indole-3-acetic acid, 1-(4-53-86-1Formulation, Inflammation,
chlorobenzoyl)-5-methoxy-2-methyl-[CAS]modified-general
release, other
Indoprofen31842-01-0
indoraminBenzamide, N-[1-[2-(1H-indol-3-yl)ethyl]-4-26844-12-2GB1218570Antihypertensive,
piperidinyl]-[CAS]38821-52-2adrenergic
InduclemU.S.5,993,810Labour inducerLabour,
induction
Infliximab170277-31-3
Inosine Pranobex36703-88-5
Inositol87-89-8
Inositol Niacinate6556112
Iobenguane80663-95-2
Iobenzamic Acid3115057
Iobitridol136949-58-1
Iocarmic Acid10397-75-8
Iocetamic Acid16034-77-8
Iodamide440-58-4
iodineIodine [CAS]7553-56-2Formulation, oral,Fibrocystic
otherbreast
disorder
Iodipamide606-17-7
Iodixanol92339-11-2
Iodoalphionic Acid577-91-3
iodochlorhydroxyquin5-Chloro-7-iodo-8-quinolinol130-26-7Cognition enhancerAlzheimer's
disease
Iodoform75-47-8
Iodopyracet300-37-8
Iodopyrrole87-58-1
Iodoquinol83-73-8
Iofetamine 123I75917-92-9
Ioglycamic Acid2618-25-9
Iohexol66108-95-0
Iomeglamic Acid25827-76-3
Iomeprol78649-41-9
Iopamidol60166-93-0
Iopanoic Acid96-83-3
Iopentol89797-00-2
Iophendylate99-79-6
Iophenoxic Acid96-84-4
Iopromide73334-07-3
Iopronic Acid41473-08-9
Iopydol5579-92-0
Iopydone5579-93-1
Iothalamic Acid2276-90-6
Iotrolan79770-24-4
Ioversol87771-40-2
Ioxaglic Acid59017-64-0
Ioxilan107793-72-6
IP-751(3R,4R)-(delta6)-THC-DMH-11-oic acidWO9401429Analgesic, otherPain,
neuropathic
Ipidacrine62732-44-9
IPL-576092Stigmastan-15-one, 22,29-epoxy-137571-30-3U.S.6,046,185AntiasthmaAsthma
3,4,6,7,29-pentahydroxy-,
(3Alpha,4β,5Alpha,6Alpha,7β,14β,22S)-
[CAS]
Ipodate5587-89-3
ipratropium bromide66985-17-9Formulation, Chronic
22254-24-6inhalable, solutionobstructive
pulmonary
disease
ipratpopium(endo,syn)-(±)-3-(3-Hydroxy-1-oxo-2-Formulation, Asthma
phenylpropoxy)-8-methyl-8-(1-methylethyl)-inhalable, topical
8-azoniabicyclo[3.2.1]octane
ipratropium(endo,syn)-(±)-3-(3-Hydroxy-1-oxo-2-Formulation, Asthma
phenylpropoxy)-8-methyl-8-(1-methylethyl)-inhalable, topical
8-azoniabicyclo[3.2.1]octane
iprazochromeHydrazinecarboxamide, 2-[1,2,3,6-7248-21-7Haemostatic
tetrahydro-3-hydroxy-1-(1-methylethyl)-6-
oxo-5H-indol-5-ylidene]-[CAS]
ipriflavone4H-1-Benzopyran-4-one, 7-(1-35212-22-7EP214647OsteoporosisOsteoporosis
methylethoxy)-3-phenyl-[CAS]treatment
Iprindole5560-72-5
Iproclozid3544-35-2
Iponiazid54-92-2
Ipsapiron95847-70-4
irbesartan2-n-butyl-4-spirocyclopentane-1-[((2'-138402-11-6WO9114679Antihypertensive,Hypertension,
tetrazol-5-yl)biphenyl-4-yl)methyl]-2-renin systemgeneral
imidazolin-5-one
IRFI-042Butanedioic acid, mono[2-[2-134867-62-2U.S.5,114,966CardiovascularAtherosclerosis
(acetylthio)ethyl]-2,3-dihydro-4,6,7-
trimethyl-5-benzofuranyl] ester, (+/−)-
[CAS]
IRFI-165N-Cyclopentyl-1-methylimidazo[1,2-191349-26-5EP865442AntidepressantDepression,
a]quinoxalin-4-aminegeneral
Iridomyrmecin485-43-8
irindalone-Imidazolidinone, 1-[2-[4-[3-(4-104113-57-7EP183349AntidepressantDepression,
fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-1-96478-43-2general
piperazinyl]ethyl]-, (1R-trans)-[CAS]
Irinotecan97682-44-5
irofulvenSpiro[cyclopropane-1,5′-[5H]inden]-7′(6′H)-125392-76-9U.S.5,563,176Anticancer, otherCancer,
one, 6′-hydroxy-2′,4′,6′-trimethyl-, (R)-prostate
[CAS]
Iron Sorbitex1338-16-5
irsogladine1,3,5-Triazine-2,4-diamine, 6-(2,5-57381-26-7U.S.4,657,907Antihypertensive,Hypertension,
dichlorophenyl)-[CAS]57381-28-9diureticgeneral
57381-33-6
IS-741Cyclohexanecarboxamide, N-[2-141283-87-6EP465913GI inflammatory/Pancreatitis
[(ethylsulfonyl)amino]-5-(trifluoromethyl)-3-bowel disorders
pyridinyl)-[CAS]
isaglitazone2,4-Thiazolidinedione, 5-[[6-[(2-161600-01-7U.S.5,594,016AntidiabeticDiabetes,
fluorophenyl)methoxy]-2-Type II
naphthalenyl]methyl]-[CAS]
ISAtx-247NZ502362ImmunosuppressantTransplant
rejection,
general
Isbogrel89667-40-3
isepamicinD-Streptamine, O-6-amino-6-deoxy-Alpha-58152-01-5U.S.4,029,882AminoglycosideInfection,
D-glucopyranosyl-(1-4)-O-[3-deoxy-4-C-58152-03-7antibioticdermatological
methyl-3-(methylamino)-β-L-
arabinopyranosyl-(1-6)]-N1-(3-amino-2-
hydroxy-1-oxopropyl)-2-deoxy-, (S)-[CAS]
Isoaminile77-51-0
Isobutyl p-94-14-4
Aminobenzoate
Asocarboxazid59-63-2
isoconazole1-[2-[2-6-dichlorobenzyloxy)-2-(2-,4-24168-96-5GB1244530AntifungalInfection,
dichlorophenyl)ethyl]27523-40-6fungal,
general
Isoetharine530-08-5
isofloxythepin1-Piperazineethanol, 4-[3-fluoro-10,11-106819-39-0GB2010843Neuroleptic
dihydro-8-(1-106819-41-4
methylethyl)dibenzo[b,f]thiepin-10-yl]-70931-18-9
[CAS]
isofluraneEthane, 2-chloro-2-(difluoromethoxy)-1,1,1-26675-46-7U.S.3,535,388Anaesthetic,Anaesthesia
trifluoro-[CAS]inhalation
Isoflurophate55-91-4
Isoladol530-34-7
Isomethadone466-40-0
Isometheptene503-01-5
Isoniazid54-85-3
Isonixin57021-61-1
Isopromethazine303-14-0
Isopropamide Iodide71-81-8
Isopropyl Alcohol67-63-0
isopropyl unoprostone5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-120373-24-2EP289349ProstaglandinGlaucoma
oxodecyl)cyclopentyl)-, 1-methylethylester,
(1R-(1Alpha(Z), 2β,3Alpha,5Alpha))-
[CAS]
Isoproterenol7683-59-2
Isosorbide652-67-5
isosorbide dinitrateD-Glucitol, 1,4:3,6-dianhydro-, dinitrate87-33-2Formulation, Angina,
[CAS]modified-general
release, other
isosorbide mononitrateD-Glucitol, 1,4:3,6-dianhydro-, 5-nitrate16051-77-7Formulation, Angina,
[CAS]modified-general
release, other
Isothipendyl482-15-5
isotretinoinRetinoic acid, 13-cis-[CAS]4759-48-2U.S.4,843,096AntiacneAcne
Isovaleryl 533-32-4
Diethylamide
Isoxepac55453-87-7
Isoxicam34552-84-6
Isoxsuprine395-28-8
isradipine3,5-Pyridinedicarboxylic acid, 4-(4-75695-93-1GB2037766Antihypertensive, Hypertension,
benzofurazanyl)-1,4-dihydro-2,6-dimethyl-,othergeneral
methyl 1-methylethyl ester [CAS]
israpafant6H-Thieno[3,2-f][1,2,4]triazolo[4,3-117279-73-9EP268242AntiasthmaAsthma
a][1,4]diazepine, 4-(2-chlorophenyl)-6,9-
dimethyl-2-[2-[4-(2-
methylpropyl)phenyl]ethyl]-[CAS]
ISV-403U.S.5,447,926Formulation,Conjunctivitis
mucosal, topical
Itasetron123258-84-4
ITF-282ITF 282 [CAS]93615-44-2GB2115821AntianaemicAnaemia,
general
itoprideBenzamide, N-[[4-[2-122892-31-3EP306827GastroprokineticGastritis
(dimethylamino)ethoxy]phenyl]methyl]-3,4-
dimethoxy-, monohydrochloride [CAS]
itraconazole3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-84625-61-8EP6711AntifungalInfection,
dichlorophenyl)-2-(1H-1,2,4-triazol-1-fungal,
ylmethyl)-1,3-dioxolan-4-general
yl]methoxy]phenyl]-1-piperazinyl]phenyl]-
2,4-dihydro-2-(1-methylpropyl)-[CAS]
Itramin13445-63-1
itriglumide1-Naphthalenepropanoic acid, β-[2-[[2-(8-201605-51-8WO9800404AnxiolyticAnxiety,
azaspiro[4.5]dec-8-ylcarbonyl)-4,6-general
dimethylphenyl]amino]-2-oxoethyl]-, (βR)-
[CAS]
iturelixD-Alaninamide N-acetyl-3-(2-naphthalenyl)112568-12-4WO8901944Fertility enhancerInfertility,
D-alanyl-4-chloro-D-phenylalanyl-3-(3-female
pyridinyl)-D-alanyl-L-seryl-N6-(3-
pyridinylcarbonyl)-L-lysyl-N6-(3-
pyridinylcarbonyl)-D-lysyl-L-leucyl-N6-(1-
methylethyl)-L-lysyl-L-prolyl-[CAS]
ivabradine7,8-dimethoxy-3-(3-[[(1S)(4,5-AntianginalAngina,
dimethoxybenzocyclobutan-1-general
yl)methyl]methylamino]propyl)-1,3,4,5-
tetrahydro-2H-benzazepin-2-one
ixabepilone17-Oxa-4-azabicyclo(14.1.0)heptadecane-219989-84-1Anticancer, otherCancer,
5,9-dione, 7,11-dihydroxy-8,8,10,12,16-breast
pentamethyl-3-(1-methyl-2-(2-methyl-4-
thiazolyl)ethenyl,
(1R,3S,7S,10R,11S,12S,16R) [CAS]
J-1041325H-Cyclopenta[b]pyridine-6-carboxylic198279-45-7WO9737665Antihypertensive, Heart failure
acid, 5-(1,3-benzodioxol-5-yl)-2-butyl-7-other
[2[(2S)-2-carboxypropyl]-4-methoxyphenyl]-
6,7-dihydro-, (5S,6R,7R)-[CAS]
J-1070885H-Indole(2,3-a)pyrrolo(3,4-c)carbazole-174402-32-5Anticancer, otherCancer,
5,7(6H)-dione, 12-β-D-glucopyranosyl-bladder
12,13-dihydro-2,10-dihydroxy-6-((2-
hydroxy-1-(hydroxymethyl)ethyl)amino-
[CAS]
J-1133971-[(3R,4R)-1-Cyclooctylmethyl-3-Analgesic, otherPain, general
hydroxymethyl-4-piperidyl]-3-ethyl-1,3-
dihydro-2H-benzimidazole-2-one
Janex-1Phenol, 4-[(6,7-dimethoxy-4-202475-60-3Anticancer, otherCancer,
quinazolinyl)amino]-[CAS]leukaemia,
general
josamycinLeucomycin V, 3-acetate 4B-(3-16846-24-5JP41021759Macrolide antibioticInfection,
methylbutanoate) [CAS]general
JTV-5191,4-Benzothiazepine, 2,3,4,5-tetrahydro-7-145903-06-6WO9212148CardiovascularInfarction,
methoxy-4-[1-oxo-3-[4-(phenylmethyl)-1-myocardial
piperidinyl]propyl]-[CAS]
K-777U.S.6,287,840ProtozoacideInfection,
trypano-
somiasis,
American
Kainic Acid487-79-6
KalimateKalimate-[CAS]92354-70-6Urological
Kallidin342-10-9
KB-130015Acetic acid (2,6-diodo-4-((2-methyl-3-147030-48-6AntiarrhythmicArrhythmia,
benzofuranyl)methyl)phenoxy)-[CAS]general
KCB-328Methanesulfonamide, N-[3-amino-4-[2-[[2-177596-55-3WO9604231AntiarrhythmicArrhythmia,
(3,4-general
dimethoxyphenyl)ethyl]methylamino]ethoxy]-
phenyl]-, monohydrochloride [CAS]
Kebuzone853-34-9
ketamine2-(2-Chlorophenyl)-2-(methylamino)-6740-88-1Formulation,Pain, post-
cyclohexanone hydrochloridetransmucosal, nasaloperative
ketanserin2,4(1H,3H)-Quinazolinedione, 3-[2-[4-(4-74050-98-9EP13612Antihypertensive,Hypertension,
fluorobenzoyl)-1-piperidinyl]ethyl]-[CAS]83846-83-7othergeneral
ketazolam4H-[1,3]Oxazino[3,2-27223-35-4GB1222294Anxiolytic
d][1,4]benzodiazepine-4,7(6H)-dione, 11-
chloro-8,12b-dihydro-2,8-dimethyl-12b-
phenyl-[CAS]
Kethoxal27762-78-3
Ketobemidone469-79-4
ketoconazolePiperazine, 1-acetyl-4-[4-[[2-(2,4-65277-42-1U.S.4,335,125AntifungalInfection,
dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-fungal,
1,3-dioxolan-4-yl]methoxy]phenyl]-, cis-general
[CAS]
ketoprofenmono(3-benzoyl-Alpha-173011-11-5EP502502Formulation,Pain, general
methylbenzeneacetate) [CAS]transdermal,
systemic
ketorolac1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-74103-06-3EP53021Analgesic, NSAID
2,3-dihydro-, (+/−)-[CAS]74103-07-4
Ketorolac
Tromethamine
ketotifen10-H-Benzo[4,5]cyclohepta[1,2-b]thiophen-34580-13-7GB1355539AntiasthmaAsthma
10-one, 4,9-dihydro-4-(1-methyl-4-34580-14-8
piperidinylidene)-, (E)-2-butenedioate (1:1)-
[CAS]
Khellin82-02-0
kinetin9001-29-0DermatologicalPhotodamage
KNI-2724-Thiazolidinecarboxamide, N-(1,1-147318-81-8U.S.5,466,028Antiviral, anti-HIVInfection,
dimethylethyl)-3-[2-hydroxy-3-[[2-[[(5-HIV/AIDS
isoquinolinyloxy)acetyl]amino]-3-
(methylthio)-1-oxopropyl]amino]-1-oxo-4-
phenylbutyl]-, [4R-[3[2S*,3S*(R*)],4R*]]-
[CAS]
KP-103(R,R)-2-(2,4-Difluorophenyl)-3-(4-AntifungalInfection,
methylenepiperidin-1-yl)-1-(1,2,4-triazol-1-general
yl)-2-butanol
KP-157U.S.6,110,961AntidepressantDepression,
general
KP-544WO9919305Cognition enhancerUnspecified
KRN-5500L-glycero-β-L-manno-151276-95-8WO9015811Anticancer, Cancer,
Heptopyranosylamine, 4-deoxy-4-antibioticcolorectal
[[[[(2E,4E)-1-oxo-2,4-
tetradecadienyl]amino]acetyl]amino]-N-1H-
purin-6-yl-[CAS]
KT-136Alpha-D-Glucopyranoside, β-D-121602-88-8Formulation, dermal,Ulcer,
fructofuranosyl, mixt. with 1-ethenyl-2-topicaldecubitus
pyrrolidinone homopolymer compd. with
iodine [CAS]
KUL-7211(−)-2-[(2S)-1,2,3,4-tetrahydro-2-[[(2R)-2-UrologicalUrinary
hydroxy-2-(4-calculus
hydroxphenyl)ethyl]amino]naphthalen-7-
yloxy]-N,N-dimethylacetamide
hydrochloride monohydrate
KW-21706H-Pyrazolo[4,5,1-de]acridin-6-one,5-[(3-207862-44-0Anticancer,Cancer, lung,
aminopropyl)amino]-7,10-dihydroxy-2-[[(2-alkylatingnon-small
hydroxyethyl)amino]methyl-,cell
dihydrochloride [CAS]
KW-60021H-Purine-2,6-dione, 8-(2-(3,4-155270-99-8AntiparkinsonianParkinson's
dimethoxyphenyl)ethenyl)-1,3-diethyl-3,7-disease
dihydro-7-methyl-(E)-[CAS]
KW-71583,3,3-Trifluoro-2-hydroxy-2-methyl-N-(10-UrologicalIncontinence
oxo-4,10-dihydrothieno[3,2-C][1]
benzothiepin-9-yl)propanamide 5,5 dioxide
L-365260Urea, N-(2,3-dihydro-1-methyl-2-oxo-5-118101-09-0EP284256Anticancer, otherCancer,
phenyl-1H-1,4-benzodiazepin-3-yl)-N′-(3-general
methylphenyl)-, (R)-[CAS]
L-5-hydroxy-L-Tryptophan, 5-hydroxy-[CAS]4350-09-8Metabolic andUnspecified
tryptophanenzyme disorders
L-745337Methanesulfonamide, N-[6-[(2,4-158205-05-1WO9413635Analgesic, NSAIDPain, general
difluorophenyl)thio]-2,3-dihydro-1-oxo-1H-
inden-5-yl]-[CAS]
L-758298Phosphonic acid, [3-[[(2R,3S)-2-.(.(1R)-1-172673-20-0WO9523798AntimeticChemotherapy-
[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-induced nausea
fluorophenyl)-4-morpholinyl]methyl]-2,5-and vomiting
dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-[CAS]
L-826141WO9722585AntiasthmaUnspecified
labetalol5-[1-hydroxy-2-[(1-methyl-3-32780-64-6U.S.4,012,444Antihypertensive,
phenylpropyl)amino]ethyl]salicylamide HCl36894-69-6adrenergic
lacidipine3,5-Pyridinedicarboxylic acid, 4-[2-[3-(1,1-103890-78-4GB2164336Antihypertensive,Hypertension,
dimethylethoxy)-3-oxo-1-propenyl]phenyl]-othergeneral
1,4-dihydro-2,6-dimethyl-, diethyl ester, (E)
[CAS]
Lactic Acid
lactitolD-Glucitol, 4-O-β-D-galactopyranosyl-585-86-4HepatoprotectiveInfection,
[CAS]neurological
Lactulose4618-18-2
lafutidineAcetamide, 2-[(2-furanylmethyl)sulfinyl]-N-118288-08-7EP282077AntiulcerUlcer, gastric
[4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-169899-19-8
2-butenyl]-, (Z)-[CAS]
Lamifiban144412-49-7
lamivudine2(1H)-Pyrimidinone, 4-amino-1-[2-134678-17-4EP51397Antiviral, anti-HIVInfection,
(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2R-HIV/AIDS
cis)-[CAS]
lamotrigine1,2,4-Triazine-3,5-diamine, 6-(2,3-84057-84-1EP21121AntiepilepticEpilepsy, partial
dichlorophenyl)-[CAS](focal, local)
landiololBenzenepropanoic acid, 4-[2-hydroxy-3-[[2-133242-30-5EP397031AntiarrhythmicTachycardia,
[(4-general
morpholinylcarbonyl)amino]ethyl]amino]-
propoxy]-, (2,2-dimethyl-1,3-dioxolan-4-
yl)methyl ester, [S-(R*,R*)]-HCL
lanicemine(S)-Alpha-phenyl-2-pyridine ethanamine153322-05-5NeurologicalUnspecified
dihydrochloride
laniquidarMethyl 6,11-dihydro-11-[1-[2-[4-(-2-197509-46-9WO9734897Radio/Cancer, general
quinolylmethoxy)phenyl]ethyl]-4-chemosensitizer
piperidinylidene]-5H-imidazo[2,1-
b][3]benzazepine-3-carboxylate
lanoconazole1H-Imidazole-1-acetonitrile, Alpha-[4-(2-101530-10-3U.S.4,738,976AntifungalInfection,
chlorophenyl)-1,3-dithiolan-2-ylidene]-, (E)-fungal,
(±)-[CAS]general
Lanoteplase171870-23-8
Lanreotide108736-35-2
lansoprazole1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-103577-45-3EP174726AntiulcerUlcer,
trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-duodenal
[CAS]
lanthanum carbonateCarbonic acid, lanthanum(3+) salt587-26-8U.S.5,968,976UrologicalHyperphos-
(3:2)[CAS]phataemia
lapatinib4-Quinazolinamine, N-[3-chloro-4-[(3-388082-78-8Anticancer, otherCancer, breast
fluorobenzyl)methoxy phenyl]-6-[5-[[[2-
[methylsulfonyl]ethyl]amino]methyl]furan-2-
yl]
laquinimod248281-84-7Multiple sclerosisMultiple
treatmentsclerosis,
general
lasofoxifene2-Naphthalenol, 5,6,7,8-tetrahydro-6-190791-29-8WO9716434MenopausalHormone
phenyl-5-(4-(2-(1-disordersreplacement
pyrrolidinyl)ethoxy)phenyl-(5R-cis)-, (S-therapy
(R*,R*))-2,3-dihydroxybutanedioate [CAS]
latamoxef5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-64952-97-2GB1547351Beta-lactamInfection,
carboxylic acid, 7-[[carboxy(4-64953-12-4antibioticgeneral
hydroxyphenyl)acetyl]amino]-7-methoxy-3-
[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-
oxo-[CAS]
latanoprost5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-130209-82-4WO9002553ProstaglandinGlaucoma
hydroxy-5-phenylpentyl)cyclopentyl)-, 1-
methylethyl ester, (1R-
(1Alpha(Z),2β(R*),3Alpha,5Alpha))-[CAS]
Lauroguadine135-43-3
Laurolinium Acetate146-37-2
Lawsone83-72-7
LAX-1111-(Z,Z,Z,Z,Z-eicosa-5,8,11,14,17-NeurolepticSchizophrenia
pentaenoyloxy)-3-(Z,Z,Z,Z,Z-eicosa-
5,8,11,14,17-pentaenoyloxy)-propane
Lazabemide103878-84-8
LB-30057Benzenecarboximidic acid, 4-[(2S)-3-WO9749673AntithromboticThrombosis,
(cyclopentylmethylamino)-2-[(2-venous
naphthalenylsulfonyl)amino]-3-oxopropyl]-,
hydrazide [CAS]
L-Cystine
Lefetamine7262-75-1
leflunomide4-Isoxazolecarboxamide, 5-methyl-N-[4-75706-12-6EP13376Antiarthritic,Arthritis,
(trifluoromethyl)phenyl]-[CAS]immunologicalrheumatoid
leflunomide4-Isoxazolecarboxamide, 5-methyl-N-[4-104981-93-3U.S.5,610,173Anticancer, otherCancer,
(trifluoromethyl)phenyl]-[CAS]75706-12-6ovarian
Leiopyrrole5633-16-9
lenampicillin4-Thia-1-azabicyclo[3.2.0]heptane-2-80734-02-7
carboxylic acid, 6-86273-18-9EP61206Penicillin, oralInfection,
[(aminophenylacetyl)amino]-3,3-dimethyl-7-general
oxo-, (5-methyl-2-oxo-1,3-dioxol-4-
yl)methyl ester, [2S-
[2Alpha,5Alpha,6β(S*)]]-[CAS]
lentinanLentinan [CAS]37339-90-5Anticancer,Cancer,
immunologicalstomach
Lepirudin
lercanidipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-100427-26-7U.S.4,705,797Antihypertenzive,Hypertension,
2,6-dimethyl-4-(3-nitrophenyl)-, 2-[(3,3-132866-11-6othergeneral
diphenylpropyl)methylamino]-1,1-
dimethylethyl methyl ester-, hydrochloride
[CAS]
lerisetron1H-Benzimidazole, 1-(phenylmethyl)-2-(1-143257-98-1U.S.5,256,665AntimeticNausea and
piperazinyl)-[CAS]vomiting,
general
Lesopitron132449-46-8
leteprinimBenzoic acid, 4-((3-(1,6-dihydro-6-oxo-9H-138117-50-7U.S.6,338,963AntiparkinsonianParkinson's
purin-9-yl)-1-oxopropyl)amino)-,disease
monopotassium salt [CAS]
letosteine4-Thiazolidinecarboxylic acid, 2-[2-[(2-53943-88-7U.S.4,032,534COPD treatmentBronchitis,
ethoxy-2-oxoethyl)thio]ethyl]-[CAS]chronic
letrozoleBenzonitrile, 4,4′-(1H-1,2,4-triazol-1-112809-51-5EP236940Anticancer,Cancer, breast
ylmethylene)bis-[CAS]hormonal
Leucocyanidin480-17-1
Leuprolide53714-56-0
leuprolide acetateLuteinizing hormone-releasing factor (pig),53714-56-0Formulation,Cancer,
6-D-leucine-9-(N-ethyl-L-prolinamide)-10-74381-53-6implantprostate
deglycinamide-, monoacetate (salt) [CAS]
leuprorelinLuteinizing hormone-releasing factor (pig),53714-56-0Formulation,Cancer,
6-D-leucine-9-(N-ethyl-L-prolinamide)-10-implantprostate
deglycinamide-, [CAS]
Levallorphan152-02-3
levaminsoleImidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-14769-73-4U.S.4,584,305AnthelminticInfection,
6-phenyl-, (S)-[CAS]16895-80-5helminth,
general
Levcromakalim94535-50-9
levetiracetam1-Pyrrolidineacetamide, Alpha-ethyl-2-oxo-,102767-28-2EP162036AntiepilepticEpilepsy,
(S)-[CAS]general
levobetaxolol2-Propanol, 1-(4-(2-116209-55-3Formulation,Glaucoma
(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-mucosal, topical
methylethyl)amino) hydrochloride [CAS]
levobunolol1(2H)-Naphthalenone, 5-[3-[(1,1-27912-14-7U.S.3,641,152Formulation,Glaucoma
dimethylethyl)amino]-2-hydroxypropoxy]-47141-42-4mucosal, topical
3,4-dihydro-, (S)-[CAS]
levobupivacaine2-Piperidinecarboxamide, 1-butyl-N-(2,6-27262-47-1WO9510276Anaesthetic,Anaesthesia
dimethylphenyl)-, (S)-[CAS]injectable
levocabastine4-Piperidinecarboxylic acid, 1-[4-cyano-4-79449-98-2U.S.4,369,184Antiallergic,Rhinitis, allergic,
(4-fluorophenyl)cyclohexyl]-3-methyl-4-79516-68-0non-asthmageneral
phenyl-, [3S-[1(cis),3Alpha,4β]]-[CAS]79547-78-7
levocetirizineAcetic acid, (2-(4-((4-130018-77-8WO9406429Antiallergic,Allergy, general
chlorophenyl)phenylmethyl)-1-non-asthma
piperazinyl)ethoxy)-, (R)-[CAS]
Levodopa59-92-7
levodropropizine1,2-Propanediol, 3-(4-phenyl-1-99291-25-5EP147847AntitussiveCough
piperazinyl)-, (S)-[CAS]
levofloxacin7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-100986-85-4EP206283QuinoloneInfection,
carboxylic acid, 9-fluoro-2,3-dihydro-3-138199-71-0antibacterialrespiratory
methyl-10-(4-methyl-1-piperazinyl)-7-oxo-,tract, lower
(S)-[CAS]
Levomethadyl Acetate1477-40-3
levomoprolol2-Propanol, 1-(2-methoxyphenoxy)-3-[(1-27058-84-0EP15418Antihypertensive,
methylethyl)amino]-, (S)-[CAS]5741-22-0adrenergic
77164-20-6
levonorgestrel18,19-Dinopregn-4-en-20-yn-3-one, 13-797-63-7Formulation,Contraceptive,
ethyl-17-hydroxy-, (17Alpha)-[CAS]implantfemale
Levophacetoperane24558-01-8
Levopropoxyphene2338-37-6
Levorphanol77-07-6
levosimendanPropanedinitrile, [[4-(1,4,5,6-tetrahydro-4-131741-08-7EP383449CardiostimulantHeart failure
methyl-6-oxo-3-141505-33-1
pyridazinyl)phenyl]hydrazono]-, (R)-[CAS]
levosulprideBenzamide, 5-(aminosulfonyl)-N-[(1-ethyl-23672-07-3GB2014990AntiemeticDyspepsia
2-pyrrolidinyl)methyl]-2-methoxy-, (S)-
[CAS]
Levothyroxine
levovirin1-β-L-ribofuranosyl-1,2,4-triazole-3-Antiviral, otherInfection,
carboxamidehepatitis-
C virus
lexipafantL-Leucine, N-methyl-N-[[4-[(2-methyl-1H-139133-26-9WO9203423NeurologicalDementia,
imidazo[4,5-c]pyridin-1-AIDS-related
yl)methyl]phenyl]sulfonyl]-, ethyl ester-
[CAS]
LF-15-0195WO9624579ImmunosuppressantLupus
erythematosus,
general
LF-16-06872-Pyrrolidinecarboxamide, N-[3-[[4-209733-45-9FR2756562NeuroprotectiveHead trauma
(aminoiminomethyl)benzoyl]amino]propyl]-
1-[[2,4-dichloro-3-[[(2,4-dimethyl-8-
quinolinyl)oxy]methyl]phenyl]sulfonyl]-,
(2S)-[CAS]
LGD-15502,4,6-Octatrienoic acid, 7-(3,5-bis(1,1-178600-20-9Anticancer, otherCancer,
dimethylethyl)phenyl)-3-methyl-cervical
(2E,4E,6E)-[CAS]
LH902-67-9
LH-RH934-40-6
liarozote1H-Benzimidazole, 5-[(3-chlorophenyl)-1H-115575-11-6Formulation, otherPsoriasis
imidazol-1-ylmethyl]-[CAS]
licofelone1H-Pyrrolizine-5-acetic acid, 6-(4-156897-06-2Antiarthritic, otherArthritis,
chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-osteo
phenyl-[CAS]
Licostinel153504-81-5
lidadronatePhosphonic acid, [1-amino-3-63132-38-7WO9702827UrologicalUnspecified
(dimethylamino)propylidene]bis-[CAS]
Lidamidine66871-56-5
lidocaineAcetamide, 2-(diethylamino)-N-(2,6-137-58-6Formulation,Pain, post-
dimethylphenyl)-[CAS]transdermal, patchherpetic
Lidofenin59160-29-1
Lidoflazine3416-26-0
limaprostProsta-2,13-dien-1-oic acid, 11,15-74397-12-9GB2041368ProstaglandinBuerger's
dihydroxy-17,20-dimethyl-9-oxo-,syndrome
(2E,11Alpha,13E,15S,17S)-, [CAS]
Lincomycin154-21-2
Lindan58-89-9
linezolidAcetamide, N-((3-(3-fluoro-4-(4-165800-03-3WO9507271Antibiotic, otherInfection,
morpholinyl)phenyl)-2-oxo-5-dermatological
oxazolidinyl)methyl)-, (S)-[CAS]
Linoleic Acid60-33-3
Linolenic Acid463-40-1
Liothyronine6893023
Lipase9001-62-1
Lipo-dexamethasonePregna-1,4-diene-3,20-dione, 9-fluoro-14899-36-6Formulation, Arthritis,
11,17-dihydroxy-16-methyl-21-[(1-optimized,rheumatoid
oxohexadecyl)oxy]-, (11β,16Alpha)-[CAS]microemulsion
lipo-flurbiprofen[1,1′-Biphenyl]-4-acetic acid, 2-fluoro-91503-79-6JP60208910Formulation, Pain, cancer
Alpha-methyl-, 1-(acetyloxy)ethyl esteroptimized,
[CAS]microemulsion
Lipogel HAEP525655Formulation, Unspecified
optimized,
liposomes
LiquiVentperfluorooctylbromide423-55-2U.S.5,437,272Lung SurfactantRespiratory
distress
syndrome, adult
liranaftateCarbamothioic acid, (6-methoxy-2-88678-31-3GB2124617AntifungalInfection,
pyridinyl)methyl-, O-(5,6,7,8-tetrahydro-2-dermatological
naphthalenyl) ester [CAS]
lisinoprilL-Proline, 1-[N2-(1-carboxy-3-76547-98-3EP12401Antihypertensive,Hypertension,
phenylpropyl)-L-lysyl]-, (S)-[CAS]83915-83-7renin systemgeneral
Lisofyllin100324-81-0
lisurideUrea, N′-[(8Alpha)-9,10-didehydro-6-19875-60-8AntiprolactinAcromegaly
methylergolin-8-yl]-N,N-diethyl-, [CAS]305-13-5
18016-80-3
Lithium Citrate919-16-4
lithiumCarbonic acid, dilithium salt [CAS]554-13-2Formulation, Depression,
modified-bipolar
release, <=24 hr
lixivaptanBenzamide, N-[3-chloro-4-(5H-pyrrolo[2,1-168079-32-1U.S.5,736,540Cardiovascular Heart failure
c][1,4]benzodiazepin-10(11H)-
ylcarbonyl)phenyl]-5-fluoro-2-methyl-
[CAS]
LJP-1082U.S.6,207,160ImmunosuppressantThrombosis,
venous
LLUAlphaS-2,7,8-Trimethyl-6-(β-carboxyethyl)-6-Antihypertensive,Hypertension,
hydroxychromanothergeneral
LMP-160U.S.5,643,893AntiasthmaAsthma
LMP-420U.S.5,643,893Antiarthritic, otherArthritis,
lobaplatinPlatinum, (1,2-cyclobutanedimethanamine-135558-11-1DE4115559Anticancer,Cancer, lung,
N,N′)[2-hydroxypropanoato(2-)-O1,O2]-,alkylatingsmall cell
[SP-4-3-(S),(trans)]-[CAS]
Lobeline90-69-7
Lobenzarit63329-53-3
lodoxamide2,2′-((2-chloro-5-cyano-1,3-63610-09-3U.S.4,439,445AntiasthmaAsthma
phenylene)diimino)bis(2-oxoacetate):2-53882-12-5
amino-2-(hydroxymethyl)-1,3-propanediol
(1:2)
Lofentanil61380-40-3
lofepramineEthanone, 1-(4-chlorophenyl)-2-[[3-(10,11-23047-25-8GB1177525Antidepressant
dihydro-5H-dibenz[b,f]azepin-5-26786-32-3
yl)propyl]methylamino]-[CAS]
lofexidine1H-Imidazole, 2-[1-(2,6-31036-80-3GB1181356Antihypertensive,Hypertension,
dichlorophenoxy)ethyl]-4,5-dihydro-[CAS]adrenergicgeneral
Loflucarban790-69-2
lomefloxacin3-Quinolinecarboxylic acid, 1-ethyl-6,8-98079-51-7EP140116QuinoloneInfection,
difluoro-1,4-dihydro-7-(3-methyl-1-98079-52-8antibacterialrespiratory
piperazinyl)-4-oxo-[CAS]tract, lower
lomerizinePiperazine, 1-[bis(4-fluorophenyl)methyl]-4-101477-54-7EP159566AntimigraineMigraine
[(2,3,4-trimethoxyphenyl)methyl]-, [CAS]101477-55-8
lomifylline7-(5-oxohexyl)theophylline10226-54-7DE2207860Neurological
lomustineUrea, N-(2-chloroethyl)-N′-cyclohexyl-N-13010-47-4JP48075526Anticancer,
nitroso-[CAS]alkylating
lonafarnib1-Piperidinecarboxamide, 4-[2-[4-[(11R)-193275-84-2U.S.5,874,442Anticancer, otherCancer, lung,
3,10-dibromo-8-chloro-6,11-dihydro-5H-non-small cell
benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-
piperidinyl]-2-oxoethyl]-[CAS]
Lonapalene91431-42-4
Lonazolac53808-88-1
lonidamine1H-Indazole-3-carboxylic acid, 1-[(2,4-50264-69-2DE2310031Radio/Cancer, breast
dichlorophenyl)methyl]-[CAS]chemosensitizer
loperamide4-(p-chlorophenyl)-4-hydroxy-N,N-dimethyl-34552-83-5U.S.3,714,159AntidiarrhoealDiarrhoea,
Alpha,Alpha-diphenyl-1-piperidine53179-11-6general
butyramide HCl
loperamide oxide1-Piperidinebutanamide, 4-(4-106900-12-3EP219898AntidiarrhoealDiarrhoea,
chlorophenyl)-4-hydroxy-N,N-dimethyl-general
Alpha,Alpha-diphenyl-, 1-oxide, trans-
[CAS]
loprazolam1H-Imidazo[1,2-a][1,4]benzodiazepin-1-61197-73-7GB1496426Hypnotic/
one, 6-(2-chlorophenyl)-2,4-dihydro-2-[(4-61197-93-1Sedative
methyl-1-piperazinyl)methylene]-8-nitro-70111-54-5
[CAS]
Loprinone106730-54-5
loracarbef1-Azabicyclo[4.2.0]oct-2-ene-2-carboxylic76470-66-1EP14475Cephalosporin, oralInfection,
acid, 7-[(aminophenylacetyl)amino]-3-121961-22-6respiratory
chloro-8-oxo-, [6R-[6Alpha,7β(R*)]]-[CAS]tract, lower
Lorajmine47562-08-3
loratadine1-Piperidinecarboxylic acid, 4-(8-chloro-79794-75-5EP42544Antiallergic,Rhinitis,
5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-non-asthmaallergic,
b]pyridin-11-ylidene)-, ethyl ester-[CAS]general
lorazepam2H,1,4-Benzodiazepin-2-one, 7-chloro-5-846-49-1Formulation, oral,Epilepsy,
(2-chlorophenyl)-1,3-dihydro-3-hydroxy-orally-disintegratinggeneral
lorcainideBenzeneacetamide, N-(4-chlorophenyl)-N-58934-46-6DE2642856Antiarrhythmic
[1-(1-methylethyl)-4-piperidinyl]-[CAS]59729-31-6
lormetazepam2H-1,4-Benzodiazepin-2-one, 7-chloro-5-848-75-9U.S.3,296,249Hypnotic/SedativeInsomnia
(2-chlorophenyl)-1,3-dihydro-3-hydroxy-1-
methyl-[CAS]
lornoxicam2H-Thieno[2,3-e]-1,2-thiazine-3-70374-39-9EP313935Analgesic, NSAIDPain, post-
carboxamide, 6-chloro-4-hydroxy-2-methyl-operative
N-2-pyridinyl-, 1,1-dioxide-[CAS]
losartan1H-Imidazole-5-methanol, 2-butyl-4-chloro-124750-99-8EP253310Antihypertensive,Hypertension,
1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-114798-26-4renin systemgeneral
yl]methyl]-, [CAS]
loteprednolAndrosta-1,4-diene-17-carboxylic acid, 17-82034-46-6GB2079755Anti-inflammatory,Uveitis
[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-,topical
chloromethyl ester, (11β,17Alpha)-[CAS]
Lotrafiban171049-14-2
Lovastatin75330-75-5
Loxapine10/02/1977
loxiglumidePentanoic acid, 4-[(3,4-107097-80-3WO8703869GI inflammatory/Pancreatitis
dichlorobenzoyl)amino]-[(3-bowel disorders
methoxypropyl)pentylamino]-5-oxo-, (±)-
[CAS]
loxoprofenBenzeneacetic acid, Alpha-methyl-4-[(2-68767-14-6EP55588Antiarthritic, otherArthritis,
oxocyclopentyl)methyl]-[CAS]80382-23-6rheumatoid
87828-36-2
Lu-35-1381-[3[[2-[5-chloro-1-(4-fluorophenyl)-3-1H-WO9516684NeurolepticPsychosis,
indolyl]ethyl]methylamino)propyl]-2-general
imidazolidinone hydrochloride]
Lubeluzole144665-07-6
lubiprostone(−)-7-[(2R,4aR,5R,7aR)-2-(1,1-136790-76-6LaxativeConstipation
difluoropentyl)-2-hydroxy-6-
oxooctahydrocyclopenta[b]pyran-5-
yl]heptanoic acid
lucanthoneThioxanthen-9-one, 1-((2-479-50-5Radio/Cancer, brain
(diethylamino)ethyl)amino-4-methyl-[CAS]chemosensitizer
Lucanthone548-57-2
Lumefantrine82186-77-4
lumiracoxibBenzeneacetic acid, 2-((2-chloro-6-220991-20-8Analgesic, NSAIDPain, general
fluorophenyl)amino)-5-methyl-[CAS]
lurtotecan11H-1,4-Dioxino[2,3-155773-58-3Formulation,Cancer,
g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolineoptimized, lipocomesovarian
9,12-[8H,14H]-dione, 8-ethyl-2,3-dihydro-8-
hydroxy-15-[[4-methyl-1-
piperazinyl]methyl]-, [CAS]
lutetium texaphyrinLutetium, bis(acetato-O)[9,10-diethyl-156436-90-7WO9906411Radio/Athero-
20,21-bis-[2-[2-(2-chemosensitizersclerosis
methoxyethoxy)ethoxy]ethoxy]-4,15-
dimethyl-8,11-imino-3,6:16,13-dinitrilo-
1,18-benzodiazacycloeicosine-5,14-
dipropanolatlo-N1,N18,N23,N24,N25]-, (PB
7-11-233′2′4)-[CAS]
LV-216Zinc[2-(2,6-dichloroanilino)phenyl]acetateAnti-inflammatoryArthritis,
rheumatoid
LX-104Hexadecanamide, N-[4-[[2-[2-[[O-(N-158792-45-1Cognition enhancerDementia,
acetyl-Alpha-neuraminosyl)-(2-3)-O-β-D-senile,
galactopyranosyl-(1-4)-O-[6-deoxy-Alpha-general
L-galactopyranosyl]oxy]ethoxy]ethoxy]ethoxy]-
methyl]phenyl]-2-tetradecyl-[CAS]
LY-156735β-methyl-6-chloromelatoninEP655243Hypnotic/SedativeSleep disorder,
general
LY-293111Benzoic acid, 2-[3-[3-[(5-ethyl-4′-fluoro-2-161172-51-6Anticancer, otherCancer,
hydroxy[1,1′-biphenyl]-4-yl)oxy]propoxy]-2-melanoma
propylphenoxy]-[CAS]
LY-2935583-Isoquinolinecarboxylic acid, decahydro-6-154652-83-2Anticancer, otherPain,
[2-(1H-tetrazol-5-yl)ethyl]-, [3S-neuropathic
(3Alpha.,4aAlpha,6β,8aAlpha.)]-[CAS]
LY-3557031,4-Dioxa-8,11-diazacyclohexadec-13-ene-18256-67-7WO9707798Anticancer, otherCancer, lung,
2,5,9,12-tetrone, 10-[(3-chloro-4-non-small cell
methoxyphenyl)methyl]-6,6-dimethyl-3-(2-
methylpropyl)-16-[(1S)-1-[(2S,3R)-3-
phenyloxiranyl]ethyl]-, (3S,10R,13E,16S)-
[CAS]
Lyapolate25053-27-4
Lymecycline992-21-2
Lynestrenol52-76-6
Lypressin50-57-7
Lysine Acetylsalicylate62952-06-1
lysine salicylateL-Lysine, 2-hydroxybenzoate [CAS]59535-08-9WO9624331Analgesic, NSAID
lysophospholipidsWO9843093DiagnosticDiagnostic,
cancer
M-40403Dichloro[(4aR,13aR,17aR,21aR)-U.S.6,180,620Anticancer, otherUnspecified
1,2,3,4,4a,5,6,12,13a,14,15,16,17,17a,18,
19,20,21,21a-eicosahydro-1,7-nitrilo-7H-
dibenzo[b,h][1,4,7,10]tetraazacyclo-
heptadecine-
kappaN5,kappaN13,kappaN18,kappaN21,
kappaN22]manganese
mabuprofenBenzeneacetamide, N-(2-hydroxyethyl)-82821-47-4DE3121595Anti-inflammatory
Alpha-methyl-4-(2-methylpropyl)-, (+/−)-
[CAS]
Mabuterol56341-08-3
Macrophage Colony-81627-83-0
Stimulating Factor
MADU840-50-6
mafenideBenzenesulfonamide, 4-(aminomethyl)-13009-99-9VulneraryBurns
monoacetate [CAS]138-39-6
mafosfamideEthanesulfonic acid, 2-[[2-[bis(2-88859-04-5EP393575Anticancer,Cancer, renal
chloroethyl)amino]tetrahydro-2H-1,3,2-98845-64-8alkylating
oxazaphosphorin-4-yl]thio]-, P-oxide, cis-
(±)-[CAS]
magaldrateAluminum magnesium hydroxide sulfate74978-16-8U.S.2,923,660Antacid/
(Al5Mg10(OH)31(SO4)2), hydrate [CAS]Antiflatulent
Magenta I632-99-5
Magnesium132-49-0
Acetylsalicylate
Magnesium Carbonate39409-82-0
Hydroxid
magnesium chlorideMagnesium chloride (MgCl2) [CAS]7786-30-3Formulation, oral,Nutrition
enteric-coated
Magnesium Citrate3344-18-1
magnesium gluconateD-Gluconic acid, magnesium salt (2:1)3632-91-5Formulation, otherHypertension,
[CAS]general
Magnesium Lactate18917-93-6
Magnesium Salicylate18917-89-0
Malathion121-75-5
Malotilate59937-28-9
Mandelic Acid90-64-2
Mandelic Acid Isoamyl5421045
Ester
Mangafodipir118248-94-5
(free acid);
155319-91-8
(hexa-
hydrogen)
manidipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-89226-50-6EP94159Antihypertensive,Hypertension,
2,6-dimethyl-4-(3-nitrophenyl)-, 2-[4-89226-75-5othergeneral
(diphenylmethyl)-1-piperazinyl]ethyl methyl
ester [CAS]
Mannomustine551-74-6
mannose-6-phosphatemannose-6-phosphateVulneraryWound healing
Maprotilline10262-69-8
maribavir1H-Benzimidazol-2-amine, 5,6-dichloro-N-176161-24-3Antiviral, otherInfection,
(1-methylethyl)-1-β-L-ribofuranosyl-[CAS]cytomegalo-
virus
marimastatN-[2,2-Dimethyl-a(S)-(N-154039-60-8WO9402447Anticancer, otherCancer,
methylcarbamoyl)propyl]-N,3(S)-dihydroxy-pancreatic
2(R)-isobutylsuccinamide
maxacalcitol1,3-Cyclohexanediol, 4-methylene-5-(2-103909-75-7U.S.4,891,364HormoneHyperpara-
(octahydro-1-(1-(3-hydroxy-3-thyroidism
methylbutoxy)ethyl)-7a-methyl-4H-inden-4-
ylidene)ethylidene)-, (1S-
(1Alpha(R*),3aβ,4E(1S*,3R*,5Z),7aAlpha))-
[CAS]
mazindol3H-Imidazo[2,1-a]isoindol-5-ol, 5-(4-22232-71-9U.S.3,763,178Anorectic/Obesity
chlorophenyl)-2,5-dihydro-[CAS]Antiobesity
Mazipredone13085-08-0
MC-5723U.S.6,043,259CardiovascularUnspecified
MCC-478(2-amino-6-(4-methoxyphenylthio)-9-[2-Antiviral, otherInfection,
(phosphonomethoxy)ethyl]purine bis(2,2,2-hepatitis-B
trifluoroethyl)ester)virus
MCI-1543(2H)-Pyridazinone, 4,5-dihydro-6-[4-(4-98326-32-0EP145019CardiostimulantHeart failure
pyridinylamino)phenyl]-,98326-33-1
monohydrochloride [CAS]
m-Cresyl Acetate122-46-3
MDAMGamma-Methylene-10-deazaaminopterinAnticancer,Cancer,
antimetabolitegeneral
MDI-101U.S.4,885,311AntiacneAcne
MDI-403403849-94-5U.S.4,677,120AntiacneAcne
MDL-1009074-Piperidinemethanol, Alpha-(2,3-139290-65-6Hypnotic/SedativeSleep disorder,
dimethoxyphenyl)-1-(2-(4-general
fluorophenyl)ethyl)-, (R)-[CAS]
mebendazolemethyl-5-benzoylbenzimidazole-2-31431-39-7GB1307306Anthelmintic
carbamate
mebeverineBenzoic acid, 3,4-dimethoxy-, 4-[ethyl[2-(4-3625-06-7AntispasmodicIrritable bowel
methoxyphenyl)-1-methylethyl]amino]butylsyndrome
ester [CAS]
Mebhydroline524-81-2
Mebrofenin78266-06-5
Mebutamate64-55-1
mecamylamineBicyclo(2.2.1)heptan-2-amine, N,2,3,3-60-40-2NeurologicalUnspecified
tetramethyl-[CAS]
Mechlorethamine51-75-2
Mechlorethamine302-70-5
Oxide
mecillinam4-Thia-1-azabicyclo[3.2.0]heptane-2-32887-01-7GB1293590Penicillin,Infection,
carboxylic acid, 6-[[(hexahydro-1H-azepin-32887-03-9injectablegeneral
1-yl)methylene]amino]-3,3-dimethyl-7-oxo-,
[2S-(2Alpha,5Alpha,6.beta.)]-[CAS]
Meclizine569-65-3
Meclocycline2013-58-3
meclofenamateBenzoic acid, 2-[(2,6-dichloro-3-6385-02-0Antiarthritic, otherArthritis,
methylphenyl)amino]-, monosodium salt644-62-2osteo
[CAS]
Meclofenamic Acid644-62-2
Meclofenoxate51-68-3
Mecloqualone340-57-8
Mecysteine18598-63-5
Medazepam12/06/2898
medifoxamineEthanamine, N,N-dimethyl-2,2-diphenoxy-32359-34-5FRM5498Antidepressant
[CAS]
Medrogestone977-79-7
Medronic Acid1984-15-2
medroxyprogesteronePregn-4-ene-3,20-dione, 17-(acetyloxy)-6-71-58-9Formulation, fixed-Contraceptive,
methyl-,(6Alpha)520-85-4dose combinationsfemale
Medrysone2668-66-8
Mefenamic Acid61-68-7
Mefenorex17243-57-1
Mefexamide1227-61-8
mefloquine4-Quinolinemethanol, Alpha-2-piperidinyl-51773-92-3GB1594282Antimalarial
2,8-bis(trifluoromethyl)-, (R*,S*)-(±)-[CAS]53230-10-7
69191-18-0
Mefruside7195-27-9
Megestrol595-33-5
Meglumin22154-43-4
131-49-7
meglutol2-hydroxy-2-methyl-1,3-propandicarboxylic503-49-1U.S.3,629,449Hypolipaemic/Hyper-
acidAntiatherosclerosislipidaemia,
general
melagatranGlycine, N-[(1R)-2-[(2S)-2-[[[[4-159776-70-2WO9616671AntithromboticThrombosis,
(aminoiminomethyl)phenyl]methyl]amino]-general
carbonyl]-1-azetidinyl]-1-cyclohexyl-2-
oxoethyl]-[CAS]
melanocortin-4N-[(3R)-1,2,3,4-Tetrahydroisoquinolinium-Anorectic/Obesity
agonist3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)-2-[4-Antiobesity
cyclohexyl-4-(1H-1,2,4-triazol-1-
ylmethyl)piperidin-1-yl]-2-oxoethylamine(1)
Melarsoprol494-79-1
Melengestrol5633-18-1
melevodopaAlanine, 3-(3,4-dihydroxyphenyl)-7101-51-1EP252290AntiparkinsonianParkinson's
methylester [CAS]disease
Melinamide14417-88-0
Melitracen5118-29-6
meloxicam2H-1,2-Benzothiazine-3-carboxamide, 4-71125-38-7U.S.4,233,299Antiarthritic, otherArthritis,
hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-,rheumatoid
1,1-dioxide-[CAS]
melperone1-Butanone, 1-(4-fluorophenyl)-4-(4-1622-79-3BE651144Neuroleptic
methyl-1-piperidinyl)-[CAS]3575-80-2
Melphalan148-82-3
meluadrineBenzenemethanol, 2-chloro-Alpha-(((1,1-134865-37-5EP420120Labour inhibitorLabour,
dimethylethyl)amino)methyl)-4-hydroxy-,preterm
(R)-, (R*,R*))-2,3-dihydroxybutanedioate
(1:1) (salt) [CAS]
memantineTricyclo[3.3.1.13,7]decan-1-amine, 3,5-41100-52-1EP392059Cognition enhancerDementia,
dimethyl [CAS]19982-08-2AIDS-related
MEN-10700Acetamide, 2-[[[(5R,6S)-6-[(1R)-1-195874-55-6WO9406803Beta-lactamInfection,
hydroxyethyl]-2-methyl-7-oxo-4-thia-1-antibioticgeneral
azabicyclo[3.2.0]hept-2-en-3-
yl]methyl]methylamino]-[CAS]
MEN-107555,12-Naphthacenedione, 7-[[4-O-(3-amino-169317-77-5WO9509173Anticancer,Cancer,
2,3,6-trideoxy-Alpha-L-lyxo-antibioticbreast
hexopyranosyl)-2,6-dideoxy-Alpha-L-lyxo-
hexopyranosyl]oxy]-7,8,9,10-tetrahydro-
6,9,11-trihydroxy-9-(hydroxyacetyl)-,
hydrochloride, (7S,9S)-[CAS]
Menadiol481-85-6
Menadione58-27-5
Menadoxime573-01-3
Menbutone3562-99-0
Menogaril71628-96-1
MENT7Alpha-Methyl-19-nortestosteroneFormulation,Contraceptive,
transdermal, systemicmale
mentholCyclohexanol, 5-methyl-2-(1-methlethyl)-1490-04-6Formulation, dermal,Pruritus
[CAS]89-78-1topical
Menthyl Valerate89-47-4
Meobentine46464-11-3
Meparfynol77-75-8
mepartricinPartricin, methyl ester [CAS]11121-32-7U.S.3,780,173AntifungalInfection,
Candida,
general
Mepazine60-89-9
Mepenzolate Bromide76-90-4
Meperidine57-42-1
Mephenesin59-47-2
Mephenoxalone70-07-5
Mephentermine100-92-5
Mephenytoin50-12-4
Mephobarbital115-38-8
Mepindolol23694-81-7
Mepitiostane21362-69-6
mepivacaineN-(2,6-Dimethylphenyl)-1-methyl-2-96-88-8Formulation, Pain, post-
piperidinecarboxamidemodified-operative
release, >24 hr
Mepixanox17854-59-0
Meprednisone1247-42-3
Meprobamate57-53-4
meproscillarinBufa-4,20,22-trienolide, 3-[(6-deoxy-4-O-33396-37-1DE1910207CardiostimulantHeart failure
methyl-Alpha-L-mannopyranosyl)oxy]-14-
hydroxy-, (3β)-[CAS]
meptazinolPhenol, 3-(3-ethylhexahydro-1-methyl-1H-54340-58-8GB1285025Analgesic, otherPain, general
azepin-3-yl)-[CAS]59263-76-2
mequitazine10H-Phenothiazine, 10-(1-29216-28-2GB1250534Antiallergic,
azabicyclo[2.2.2]oct-3-ylmethyl)-[CAS]non-asthma
Meralein4386-35-0
Meralluride8069-64-5
Merbromin129-16-8
Mercaptomerin21259-76-7
Mercumallylic Acid86-36-2
Mercuric Chloride,10124-48-8
Ammoniated
Mercuric Oleate1191-80-6
Mercuric Oxycyanide1335-31-5
merimepodibCarbamic acid, ((3-((((3-methoxy-4-(5-198821-22-6U.S.5,807,878Antiviral, otherInfection,
oxazolyl)phenyl)amino)carbonyl)amino)-hepatitis-
phenyl)methyl)-(3S)-tetrahydro-3-furanylC virus
ester [CAS]
meropenem1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic96036-03-2EP126587Beta-lactamInfection,
acid, 3-[[5-[(dimethylamino)carbonyl]-3-antibioticrespiratory
pyrrolidinyl]thio]-6-(1-hydroxyethyl)-4-tract, lower
methyl-7-oxo-, [4R-
[3(3S*,5S*),4Alpha,5β,6β(R*)]]-[CAS]
Mersalyl492-18-2
Mesalamine89-57-6
mesalazineBenzoic acid, 5-amino-2-hydroxy-[CAS]89-57-6WO5541170Formulation, oral,Colitis,
otherulcerative
Mesna19767-45-4
Mesoridazine5588-33-0
Mestanolone521-11-9
Mesterolone1424-00-6
Mestranol72-33-3
Mesulfen135-58-0
Metaclazepam84031-17-4
Metampicillin6489-97-0
Metapramine21730-16-5
Metaproterenol586-06-1
Metaraminol54-49-9
Metazocine3734-52-9
metergolineCarbamic acid, [[(8β)-1,6-dimethylergolin-17692-51-2GB1401935AntiprolactinAmenorrhoea
8-yl]methyl]-, phenylmethyl ester [CAS]21631-37-8
2706-42-5
metforminImidodicarbonimidic diamide, N,N-dimethyl657-24-9Formulation, Diabetes,
[CAS]modified-Type II
release, <=24 hr
Methacholine62-51-1
Methacycline914-00-1
Methadone76-99-3
Methafurylene531-06-6
Methamphetamine537-46-2
Methandriol521-10-8
Methandrostenolone72-63-9
Methantheline53-46-3
Methapyrilene91-80-5
Methaqualone72-44-6
Metharbital50-11-3
Methazolamide554-57-4
Methdilazine1982-37-2
Methenamine100-97-0
Methenolone153-00-4
Methestrol130-73-4
Methetoin5696-06-0
Methicillin132-92-3
Methimazole60-56-0
Methiodal126-31-8
Methionic Acid503-40-2
Methionine63-68-3
Methisazone1910-68-5
Methitural467-43-6
Methixene02/02/4969
Methocarbamol532-03-6
Methohexital22151-68-4
methotrexateL-Glutamic acid, N-[4-[[(2,4-diamino-6-59-05-2U.S.2,512,572Anticancer,Cancer,
pteridinyl)methyl]methylamino]benzoyl]-antimetabolitegeneral
[CAS]
Methotrimeprazine60-99-1
Methoxamine390-28-3
Methoxsalen298-81-7
Methoxyflurane76-38-0
Methoxyphenamine93-30-1
Methoxypromazine61-01-8
Methscopolamine155-41-9
Methsuximide77-41-8
Methyclothiazide135-07-9
Methyl Blue28983-56-4
Methyl Nicotinate93-60-7
Methyl Propyl Ether557-17-5
Methyl Salicylate119-36-8
Methyl tert-Butyl Ether1634-04-4
Methylbenzethonium25155-18-4
Chloride
Methylcobalamin13422-55-4
methyldopaL-Tyrosine, 3-hydroxy-Alpha-methyl-555-30-6Formulation, Hypertension,
[CAS]modified-general
release, <=24 hr
Methylene Blue61-73-4
Methylergonovine113-42-8
Methylhexaneamide105-41-9
methylphenidate2-Piperidineacetic acid, Alpha-phenyl-,113-45-1Formulation, Attention
methyl ester [CAS]298-59-9modified-deficit
release, multidisorder
Methylprednisolone83-43-2
methylprednisolonePregna-1,4-diene-3,20-dione, 21-86401-95-8EP72547Antipruritic/Pruritus
aceponate(acetyloxy)-11-hydroxy-6-methyl-17-(1-inflamm, allergic
oxopropoxy)-, (6Alpha,11β)-[CAS]
methylprednisolone
suleptanatePregna-1,4-diene-3,20-dione, 11,17-90350-40-6JP59137500AntiasthmaAsthma
dihydroxy-6-methyl-21-[[8-[methyl(2-
sulfoethyl)amino]-1,8-dioxooctyl]oxy]-,
monosodium salt, (6Alpha,11β)-[CAS]
Methylthiouracil56-04-2
Methyltrienolone965-93-5
Methyprylon125-64-4
Methysergide361-37-5
Metiazinic Acid13993-65-2
metipranololPhenol, 4-[2-hydroxy-3-[(1-22664-55-7GB1206148Antihypertensive,
methylethyl)amino]propoxy]-2,3,6-trimethyl-,adrenergic
1-acetate [CAS]
metoclopramideBenzamide, 4-amino-5-chloro-N-[2-364-62-5Formulation, Gastro-
(diethylamino)ethyl]-2-methoxy-[CAS]modified-oesophageal
release, <=24 hrreflux
Metocurine Iodide7601-55-0
Metofenazate388-51-2
metolazone6-Quinazolinesulfonamide, 7-chloro-17560-51-9U.S.4,517,179Antihypertensive,
1,2,3,4-tetrahydro-2-methyl-3-(2-diuretic
methylphenyl)-4-oxo-[CAS]
Metopimazine14008-44-7
Metopon143-52-2
metoprolol2-Propanol, 1-[4-(2-51384-51-1Formulation, Hypertension,
methoxyethyl)phenoxy]-3-[(1-56392-17-7modified-general
methylethyl)amino]-, (+/−)-[CAS]37350-58-6release, other
Metralindole54188-38-4
Metrizamide31112-62-6
Metrizoic Acid1949-45-7
Metron S13946-02-6
Metyrapone54-36-4
Metyrosine672-87-7
Mexazolam31868-18-5
Mexenone1641-17-4
Mexiletine31828-71-4
mezlocillin4-Thia-1-azabicyclo[3.2.0]heptane-2-42057-22-7GB1301961Penicillin,Infection,
carboxylic acid, 3,3-dimethyl-6-[[[[[3-51481-65-3injectablegeneral
(methylsulfonyl)-2-oxo-1-72539-76-5
imidazolidinyl]carbonyl]amino]-
phenylacetyl]amino]-7-oxo-, [2S-
[2Alpha,5Alpha,6β(S*)]]-[CAS]
MFH-244Benzenecarboximidic acid, 3,4,5-95933-76-9U.S.4,623,659CardiovascularReperfusion
trihydroxy-, ethyl ester, hydrochlorideinjury
mianserinDibenzo[c,f]pyrazino[1,2-a]azepine,21535-47-7GB1173783AntidepressantDepression,
1,2,3,4,10,14b-hexahydro-2-methyl-[CAS]24219-97-4general
Mibefradil116644-53-2
Miboplatin103775-75-3
Micafungin235114-32-6
miconazole1H-Imidazole, 1-(2,4-dichlorophenyl)-2[2,4-22916-47-8Formulation, Infection,
dichlorophenyl)methoxy]ethyl]modified-Candida,
release, othergeneral
Micronomicin52093-21-7
midaxifyline1H-Purine-2,6-dione-8-(1-151159-23-8U.S.5,378,844CardiovascularUnspecified
aminocyclopentyl)-3,7-dihydro-1,3-dipropyl-
[CAS]
midazolam4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-59467-70-8U.S.4,280,957Anaesthetic,
chloro-6-(2-fluorophenyl)-1-methyl-[CAS]59467-94-6injectable
midecamycinLeucomycin V, 3,4B-dipropanoate [CAS]35457-80-8U.S.3,761,588MacrolideInfection,
antibioticgeneral
midecamycin acetateLeucomycin V, 3B,9-diacetate 3,4B-55881-07-7JP49124087MacrolideInfection,
dipropanoate [CAS]antibioticgeneral
midesteine2-Thiophenecarbothioic acid, S-[1-methyl-94149-41-4EP120534COPD treatmentEmphysema,
2-oxo-2-[(tetrahydro-2-oxo-3-general
thienyl)amino]ethyl] ester [CAS]
midodrineAcetamide, 2-amino-N-[2-(2,5-42318-56-0EP164571UrologicalIncontinence
dimethoxyphenyl)-2-hydroxyethyl]-[CAS]42794-76-3
midostaurinBenzamide, N-(2,3,10,11,12,13-hexahydro-120685-11-2EP296110Anticancer, otherCancer,
10-methoxy-9-methyl-1-oxo-9,13-epoxy-leukaemia,
1H,9H-diindolo[1,2,3-gh:3′,2′,1′-acute
lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl)-myelogenous
N-methyl-, (9Alpha,10β,11β,13Alpha)-
[CAS]
mifepristoneEstra-4,9-dien-3-one, 11-[4-84371-65-3EP57115AbortifacientAbortion
(dimethylamino)phenyl]-17-hydroxy-17-(1-
propynyl)-, (11β,17β)-[CAS]
miglitol3,4,5-Piperidinetriol, 1-(2-hydroxyethyl)-2-72432-03-2EP55431AntidiabeticDiabetes,
(hydroxymethyl)-, [2R-Type I
(2Alpha,3β,4Alpha,5β)]-[CAS]
miglustat3,4,5-Piperidinetriol, 1-butyl-2-72599-27-0DE2758025Metabolic andGaucher's
(hydroxymethyl)-(2R-(2Alpha, 3β, 4Alpha,enzyme disordersdisease
5β)) [CAS]
mildronateHydrazinium, 2-(2-carboxyethyl)-1,1,1-76144-81-5WO8001068CardiostimulantHeart failure
trimethyl), inner salt-[CAS]
milnacipranCyclopropanecarboxamide, 2-101152-94-7U.S.4,478,836AntidepressantDepression,
(aminomethyl)-N,N-diethyl-1-phenyl-, cis-92623-85-3general
(±)-[CAS]
Miloxacin37065-29-5
milrinone[3,4′-Bipyridine]-5-carbonitrile, 1,6-dihydro-78415-72-2U.S.4,313,951CardiostimulantHeart failure
2-methyl-6-oxo-[CAS]
,iltefosineEthanaminium, 2-53949-20-5EP225608Anticancer, otherCancer, skin,
[[(hexadecyloxy)hydroxyphosphinyl]oxy]-58066-85-6general
N,N,N-trimethyl-, hydroxide, inner salt
[CAS]
minaprine4-Morpholineethanamine, N-(4-methyl-6-25905-77-5GB1345880AntidepressantDepression,
phenyl-3-pyridazinyl)-[CAS]25953-17-7general
minocycline2-Naphthacenecarboxamide, 4,7-10118-90-8Formulation, Infection, oral
bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-optimized,
octahydro-3,10,12,12a-tetrahydroxy-1,11-microparticles
dioxo-, [4S-
(4Alpha,4aAlpha,5a.alpha.,12aAlpha)]-
[CAS]
minodronic acidPhosphonic acid, (1-hydroxy-2-180064-38-4EP354806Anticancer, otherCancer,
imidazo(1,2-a)pyridin-3-ylethylidene)bis-,myeloma
[CAS]
minoxidil2,4-Pyrimidnediamine, 6-(1-piperidinyl)-,38304-91-5U.S.4,139,619Vasodilator,Hypertension,
3-oxide [CAS]peripheralgeneral
Miokamycin55881-07-7
mirtazapinePyrazino[2,1-a]pyrido[2,3-85650-52-8GB1543171AntidepressantDepression,
c][2]benzazepine, 1,2,3,4,10,14b-61337-67-5general
hexahydro-2-methyl-[CAS]
misoprostolProst-13-en-1-oic acid, 11,16-dihydroxy-1659122-46-2U.S.4,301,146ProstaglandinUlcer, gastric
methyl-9-oxo-, methyl ester,59122-48-4
(11Alpha,13E)-(±)-[CAS]
mitemcinalErythromycin, 8,9-didehydro-N-demethyl-9-154802-96-7WO9324509GastroprokineticGastro-
deoxo-6,11-dideoxy-6,9-epoxy-12-O-oesophageal
methyl-N-(1-methylethyl)-11-oxo-, (2E)-2-reflux
butenedioate (2:1) [CAS]
mitiglinideCalcium (2S)-2-benzyl-3-(cis-hexahydro-2-145525-41-3EP507534AntidiabeticDiabetes,
isoindolinylcarbonyl)propionate, dihydrate-Type II
[CAS]
Mitobronitol488-41-5
Mitoguazone459-86-9
mitolactolGalactitol, 1,6-dibromo-1,6-dideoxy-[CAS]10318-26-0U.S.3,993,781Anticancer,Cancer,
alkylatingcervical
mitomycinAzino[2′,3′:3,4]pyrrolo[1,2-a]indole-4,7-50-07-7Formulation,Cancer,
dione, 5-amino-8-parenteral, otherstomach
[[(aminocarbonyl)oxy]methyl]-
1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-
methyl-, [1aS-
(1aAlpha,8β,8aAlpha,8bAlpha)]-[CAS]
Mitotane53-19-0
mitoxantrone9,10-Anthracenedione, 1,4-dihydroxy-5,8-65271-80-9U.S.4,197,249Anticancer, otherCancer,
bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-70476-82-3breast
[CAS]
mitoxantrone9,10-Anthracenedione, 1,4-dihydroxy-5,8-65271-80-9Formulation,Cancer,
bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-70476-82-9optimized, liposomesgeneral
[CAS]
MIV-210(3′-Fluoro-2′,3′-dideoxy guanosine)Antiviral, otherInfection,
hepatitis-
B virus
mivacuriumIsoquinolinium, 2,2′-[(1,8-dioxo-4-octene-106861-44-3EP181055Muscle relaxantAnaesthesia,
1,8-diyl)bis(oxy-3,1-]adjunct
propanediyl)bis[1,2,3,4-tetrahydro-6,7-
dimethoxy-2-methyl-1-[(3,4,5-
trimethoxyphenyl)methyl]-, dichloride, [R-
[R*,R*-(E)]]]-[CAS]
Mivazerol125472-02-8
mizolastine4(1H)-Pyrimidinone, 2-[[1-[1-[(4-108612-45-9EP217700Antiallergic,Rhinitis,
fluorophenyl)methyl]-1H-benzimidazol-2-non-asthmaallergic,
yl]-4-piperidinyl]methylamino]-[CAS]general
Mizoribine50924-49-7
MKC-733(R)-N-(3-quinuclidinyl)-7-oxo-4,7-194093-42-0JP09216888GastroprokineticGastro-
dihydrothieno[3,2-b]pyridine-6-oesophageal
carboxamide hydrochloridereflux
MLN-5196-Oxa-2-azabicyclo[3.2.0]heptane-3,7-211866-70-5WO9915183NeuroprotectiveIschaemia,
dione, 1-[(1S)-1-hydroxy-2-methylpropyl]-4-cerebral
propyl-, (1R,4R,5S)-[CAS]
MLN-5764-Methoxy-benzo[a]phenazine-11-Anticancer, otherCancer,
carboxylic acid (2-dimethylamino)-1-(R)-general
methylethyl)-amide
moclobemideBenzamide, 4-chloro-N-[2-(4-71320-77-9EP326023AntidepressantDepression,
morpholinyl)ethyl]-[CAS]general
modafinilAcetamide, 2-[(diphenylmethyl)sulfinyl]-68693-11-8DE2809625PsychostimulantNarcolepsy
[CAS]
moexipril3-Isoquinolinecarboxylic acid, 2-[2-[[1-103775-10-6U.S.4,344,949Antihypertensive,Hypertension,
(ethoxycarbonyl)-3-phenylpropyl]amino]-1-103775-14-0renin systemgeneral
oxopropyl]-1,2,3,4-tetrahydro-6,7-
dimethoxy-(3S-(2(R*(R*)),3R*))-[CAS]
Mofarotene125533-88-2
Mofebutazone2210-63-1
Mofegiline119386-96-8
mofezolac5-Isoxazoleacetic acid, 3,4-bis(4-78967-07-4EP26928Analgesic, NSAIDPain,
methoxyphenyl)-[CAS]post-operative
MOL-6131N-[4-(aminomethyl)benzyl]-8(S)-[1-[4-[2-(4-AntiasthmaAsthma
aminophenyl)-acetamido]butyryl]piperidin-
4-yl]-2-(naphthalen-1-ylmethyl)-1,3-dioxo-
2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2-a]-
pyridazine-5(R)-carboxamide
Molindone7416-34-4
molsidomineSydnone imine, N-(ethoxycarbonyl)-3-(4-25717-80-0U.S.3,769,283Vasodilator,
morpholinyl)-[CAS]coronary
mometasonePregna-1,4-diene-3,20-dione, 9,21-105102-22-5EP57401Antipruritic/inflamm,Psoriasis
dichloro-11,17-dihydroxy-16-methyl-,83919-23-7allergic
(11β,16Alpha)-[CAS]
Monatepil103377-41-9
Monobenzone103-16-2
monolaurinDodecanoic acid, monoester with 1,2,3-27215-38-9U.S.4,885,282DermatologicalIchthyosis
propanetriol [CAS]
montelukastCyclopropaneacetic acid, 1-[[[1-[3-[2-(7-151767-02-1AntiasthmaAsthma
Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-158966-92-8
hydroxy-1-
methylethyl)phenyl]propyl]thio]methyl]-,
[CAS]
Monteplase122007-85-6
Moperone1050-79-9
Mopidamol13665-88-8
Moprolol5741-22-0
moracizineCarbamic acid, [10-[3-(4-morpholinyl)-1-29560-58-5U.S.3,864,487AntiarrhythmicTachycardia,
oxopropyl]-10H-phenothiazin-2-yl]-, ethyl31883-05-3ventricular
ester [CAS]
Morazone6536-18-1
Moricizine31883-05-3
Moroxydine3731-59-7
Morphazinamide952-54-5
morphineMorphine-3,6-diol, 7,8-didehydro-4,5-57-27-2Formulation,Pain, cancer
epoxy-17-methyl-(5Alpha,6Alpha)-, [CAS]6055-06-7parenteral, other
64-31-3
morphine-6-morphine-6-glucuronideFormulation,Pain, general
glucuronideinhalable, systemic
mosapramineSpiro[imidazo[1,2-a]pyridine-3(2H),4′-89419-40-9U.S.4,337,260Neuroleptic
piperidin]-2-one, 1′-[3-(3-chloro-10,11-98043-60-8
dihydro-5H-dibenz[b,f]azepin-5-
yl)propyl]hexahydro-, (+/−)-[CAS]
mosaprideBenzamide, 4-amino-5-chloro-2-ethoxy-N-112885-41-3EP243959GI inflammatory/Gastritis
((4-((4-fluorophenyl)methyl)-2-112885-42-4bowel disorders
morpholinyl)methyl)-[CAS]
motexafinGadolinium, bis(acetetato-kappaO)(9,10-246252-06-2Radio/Cancer,
gadoliniumdiethyl-20,21-bis(2-(2-(2-chemosensitizerbrain
methoxy)ethoxy)ethoxy)-4,15-dimethyl-
8,11-imino-3,16:16,13-dinitrilo-1,18-
benzodiazacycloeicosine-5,14-
dipropanalato-kappaN1,kappaN18,
kappaN23, kappaN24, kappaN25), (PB-7-
11-233′2′4) [CAS]
Motretinide56281-36-8
Moveltipril85856-54-8
Moxalactam64952-97-2
Moxastine3572-74-5
Moxaverine10539-19-2
Moxestrol34816-55-2
moxifloxacin3-Quinolinecarboxylic acid, 1-cyclopropyl-6-186826-86-8DE19546249QuinoloneInfection,
fluoro-1,4-dihydro-8-methoxy-7-(octahydro-151096-09-2antibacterialrespiratory
6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-,tract, general
hydrochloride (4aS-cis)-[CAS]
moxisylytePhenol, 4-[2-(dimethylamino)ethoxy]-2-964-52-3Male sexualImpotence
methyl-5-(1-methylethyl)-, acetate (ester),54-32-0dysfunction
[CAS]
moxonidine5-Pyrimidinamine, 4-chloro-N-(4,5-dihydro-75438-57-2DE2849537Antihypertensive,Hypertension,
1H-imidazol-2-yl)-6-methoxy-2-methyl-othergeneral
[CAS]
M-PGA(−)-(S)-2-Methyl-2-(1-oxo-2,3-dihydro-1H-U.S.5,712,291Anticancer, otherCancer,
isoindol-2-yl)pentanedioic acidgeneral
MPI-5010Platinum diamminedichloro-, (SP-4-2) +U.S.6,224,883Formulation,Cancer, head
(R)-4-[1-hydroxy-2-(methylamino)-ethyl]-parenteral, otherand neck
1,2-benzenediol
MPI-50202,4(1H,3H)-Pyrimidinedione, 5-fluoro-51-21-8U.S.5,750,146Formulation,Cancer, breast
[CAS]parenteral, other
MPL198076-81-2Immunostimulant,Vaccine
otheradjunct
MRS-1754U.S.6,060,481AntiasthmaAsthma
MS-2091-Piperazineethanol, 4-(diphenylacetyl)-158681-49-3Radio/Cancer,
Alpha-[(5-quinolinyloxy)methyl]-, (2E)-2-chemosensitizerbreast
butenedioate(2:3) (salt) [CAS]
MS-275N-(2-Aminophenyl)-4-[N-(pyridin-3-yl-Anticancer,Cancer, lung,
methoxycarbonyl)aminomethyl]benzamideantimetabolitegeneral
MS-325201688-00-8
MS-377EP839805NeurolepticSchizophrenia
Mupirocin12650-69-0
Muscarin300-54-9
Muzolimine55294-15-0
MX-1013U.S.6,153,591HepatoprotectiveUnspecified
mycophenolate4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-116680-01-4WO9119498ImmunosuppressantTransplant
mofetil6-methoxy-7-methyl-3-oxo-5-128794-94-5rejection,
isobenzofuranyl)-4-methyl-, 2-(4-general
morpholinyl)ethyl ester, (E)-[CAS]
mycophenolic acid4-hexanoic acid, 6-(1,3-dihydro-4-hydroxy-37415-62-6Formulation, oral,Transplant
6-methoxy-7-methyl-3-oxo-5-24280-93-1enteric-coatedrejection,
isobenzofuranyl)-4-methyl-,general
Myrophine467-18-5
N-(Hydroxymethyl)-3569-99-1
nicotinamide
N,N,N′,N′-83-81-8
Tetraethylphthalamide
N2-Formyl-795-13-1
sulfisomidine
N4-β-D-53274-53-6
Glucosylsulfanilamide
N4-547-52-4
Sulfanilylsulf-
anilamide
Nabilone51022-71-0
nabumetone2-Butanone, 4-(6-methoxy-2-naphthalenyl)-42924-53-8GB1476721Anti-inflammatoryArthritis,
[CAS]osteo
N-acetylcysteineL-Cysteine, N-acetyl-[CAS]616-91-1Anticancer, otherCancer,
general
N-Acetylmethionine65-82-7
nadifloxacin1H,5H-Benzo[ij]quinolizine-2-carboxylic124858-35-1U.S.4,399,134QuinoloneAcne
acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-antibacterial
piperidinyl)-5-methyl-1-oxo-, (+/−)-[CAS]
nadolol2,3-Naphthalenediol, 5-[3-[(1,1-42200-33-9U.S.4,346,106Antihypertensive,
dimethylethyl)amino]-2-hydroxypropoxy]-adrenergic
1,2,3,4-tetrahydro-[CAS]
Nadoxolol54063-51-3
nafamostatBenzoic acid, 4-80251-32-7EP450232GI inflammatory/Pancreatitis
[(aminoiminomethyl)amino]-, 6-81525-10-2bowel disorders
(aminoiminomethyl)-2-naphthalenyl ester-82956-11-4
[CAS]
nafarelinLuteinizing hormone-releasing factor (pig),76932-56-4EP21234ReleasingEndometriosis
6-[3-(2-naphthalenyl)-D-alanine]-[CAS]86220-42-0hormones
Nafcillin147-52-4
Nafronyl31329-57-4
naftidofuryl2-Furanpropanoic acid, tetrahydro-Alpha-31329-57-4Formulation, Unspecified
(1-naphthalenylmethyl)-, 2-modified-
(diethylamino)ethyl esterrelease, other
naftifine1-Naphthalenemethanamine, N-methyl-N-65472-88-0U.S.4,282,251AntifungalInfection,
(3-phenyl-2-propenyl)-, (E)-[CAS]65473-14-5dermatological
naftopidil1-Piperazineethanol, 4-(2-methoxyphenyl)-57149-07-2U.S.3,997,666Antihypertensive,Hypertension,
Alpha-[(1-naphthalenyoxy)methyl]-[CAS]adrenergicgeneral
nalbuphineMorphinan-3,6,14-triol, 17-20594-83-6U.S.3,393,197Analgesic, otherPain, general
(cyclobutylmethyl)-4,5-epoxy-,23277-43-2
(5Alpha,6Alpha)-[CAS]
Nalidixic Acid389-08-2
nalmefeneMorphinan-3,14-diol, 17-55096-26-9JP56167687DependencePoisoning, drug
(cyclopropylmethyl)-4,5-epoxy-6-treatment
methylene-,(5Alpha)-[CAS]
Nalorphine62-67-9
naloxoneMorphinan-6-one, 17-allyl-4,5Alpha-epoxy-357-08-4Septic shock
3,14-dihydroxy-, hydrochloride [CAS]465-65-6treatment
naltrexoneMorphinan-6-one, 17-(cyclopropylmethyl)-16590-41-3U.S.3,332,950DependenceAddiction,
4,5-epoxy-3,14-dihydroxy-, (5Alpha)-[CAS]16676-29-2treatmentnarcotic/opiate
NAMIImidazoliumAnticancer, otherCancer, general
trans(imidazole)(dimethylsulfoxide)-
tetrachlororuthenate (III)
naminidilGuanidine, N-cyano-N′-(4-cyanophenyl)-220641-11-2DermatologicalAlopecia,
N″-[(1R)-1,2,2-trimethylpropyl]-[CAS]general
Nandrolone434-22-0
Naphazoline835-31-4
Naphthalene91-20-3
naproxen betainateMethanaminium, 1-carboxy-N,N,N-104124-26-7U.S..4,672,077Antiarthritic,Arthritis,
trimethyl-salt with (R)-6-methoxy-Alpha-otherrheumatoid
methyl-2-naphthaleneacetic acid (1:1),
sodium salt [CAS]
naproxen2-Naphthaleneacetic acid, 6-methoxy-26159-34-2GB1211134Analgesic, NSAIDPain, general
Alpha-methyl-, [CAS]22204-53-1
naratriptan1H-Indole-5-ethanesulfonamide, N-methyl-121679-13-8EP303507AntimigraineMigraine
3-(1-methyl-4-piperidinyl)-[CAS]
Narceine131-28-2
Narcobarbital125-55-3
Natamycin7681-93-8
nateglinideD-phenylalanine, N-((4-(1-105816-04-4EP196222AntidiabeticDiabetes,
methylethyl)cyclohexyl)carbonyl)-, trans-Type II
[CAS]
N-Butyldeoxy-72599-27-0
nojirimycin
N-Butylscopol-149-64-4
ammonium
Bromide
NC-503U.S.5,643,562Anti-inflammatoryAmyloidosis
NC-531U.S.5,643,562Cognition enhancerAlzheimer's
disease
NCX-1000WO0061604HepatoprotectiveCirrhosis,
hepatic
NCX-4016Benzoic acid, 2-(acetyloxy)-, 2-175033-36-0WO9716405SymptomaticInsulin-related
((nitrooxy)methyl)phenyl ester [CAS]antidiabeticmetabolic
syndrome
NCX-456Benzoic acid, 5-amino-2-hydroxy-, 4-256499-26-0GI inflammatory/Inflammatory
(nitrooxy)butyl ester [CAS]bowel disordersbowel disease
NCX-950Alpha′-[[(1,1-dimethylethyl)amino]methyl]-4AntiasthmaAsthma
hydroxy-1,3-benzenedimethanol nitrate
n-Docosanol661-19-8
NE-100Benzeneethanamine, 4-methoxy-3-(2-149409-57-4WO9307113NeurolepticSchizophrenia
phenylethoxy)-N,N-dipropyl-, hydrochloride
[CAS]
Nealbarbital561-83-1
nebivolol2H-1-Benzopyran-2-methanol,118457-14-0EP145067Antihypertensive,Hypertension,
Alpha,Alpha′-[iminobis(methylene)]bis[6-99200-09-6adrenergicgeneral
fluoro-3,4-dihydro]-, (2R*(R*(R*(S*))))-(1+)-
[CAS]
nebostinelN1-(4,4-Dimethylcyclohexyl)-L-163000-63-3EP0688312CognitionUnspecified
isoglutamineenhancer
Nebracetam97205-34-0
nedaplatinPlatinum, diammine[hydroxyacetato(2-)-95734-82-0EP216362Anticancer,
O1,O2]-, (SP-4-3)-[CAS]alkylating
nedocromil4H-Pyrano[3,2-g]quinoline-2,8-dicarboxylic69049-73-6EP555718Antiasthma,Rhinitis, allergic,
acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-69049-74-7Ophthalmologicalgeneral, Ocular
propyl-[CAS]disorder, general
nefazodone3H-1,2,4-Triazol-3-one, 2-[3-[4-(3-82752-99-6U.S.4,338,317AntidepressantDepression,
chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-83366-66-9general
2,4-dihydro-4-(2-phenoxyethyl)-, [CAS]
nefiracetam1-Pyrrolidineacetamide, N-(2,6-77191-36-7U.S.4,341,790CognitionDementia,
dimethylphenyl)-2-oxo-[CAS]enhancersenile, general
nefopam1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-13669-70-0U.S.3,487,153Analgesic, NSAID
5-methyl-1-phenyl-[CAS]23327-57-3
Negamycin33404-78-3
nelfinavir3-Isoquinolinecarboxamide, N-(1,1-159989-65-8Antiviral, anti-HIVInfection,
dimethylethyl)decahydro-2-(2-hydroxy-3-159989-64-7HIV/AIDS
((3-hydroxy-2-methylbenzoyl)amino)-4-
(phenylthio)butyl)-, (3S-
(2(2S*,3S*),3Alpha,4aβ,8aβ))-, [CAS]
Nemonapride75272-39-8
Neostigmine59-99-4
nepadutantCyclo[3-amino-L-alanyl-L-leucyl-N-[2-183747-35-5WO9628467AntiasthmaAsthma
(acetylamino)-2-deoxy-β-D-
glucopyranosyl]-L-asparaginyl-L-Alpha-
aspartyl-L-tryptophyl-L-phenylalanyl], (4-1)-
lactam [CAS]
neramexane1,3,3,5,5-pentamethylcyclohexylamine202807-80-5DependenceAddiction,
219810-59-0treatmentalcohol
neridronic acidPhosphonic acid, (6-amino-1-79778-41-9MusculoskeletalOsteogenesis
hydroxyhexylidene)bis-[CAS]imperfecta
Neriifolin466-07-9
N-Ethylamphetamine457-87-4
neticonazole1H-Imidazole, 1-[2-(methylthio)-1-[2-130773-02-3EP445540AntifungalInfection,
(pentyloxy)phenyl]ethenyl]-,130726-68-0Candida,
monohydrochloride, (E)-[CAS]general
netilmicinD-Streptamine, O-3-deoxy-4-C-methyl-3-56391-56-1GB1473733AminoglycosideInfection,
(methylamino)-β-L-arabinopyranosyl-(1-6)-56391-57-2antibioticgeneral
O-[2,6-diamino-2,3,4,6-tetradeoxy-Alpha-D
glycero-hex-4-enopyranosyl-(1-4)]-2-deoxy-
N1-ethyl-[CAS]
nevirapine6H-Dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-129618-40-2EP429987Antiviral,Infection,
one, 11-cyclopropyl-5,11-dihtdro-4-methyl-anti-HIVHIV/AIDS
[CAS]
NGD-98-2WO9635689AnxiolyticAnxiety,
general
Nialamide51-12-7
Niaprazine27367-90-4
Nicametate3099-52-3
nicaraven3-Pyridinecarboxamide, N,N′-(1-methyl-1,2-79455-30-4EP29602NeuroprotectiveHaemorrhage,
ethanediyl)bis-[CAS]subarachnoid
nicardipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-54527-84-3U.S.3,985,758NeuroprotectiveHypertension,
2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-55985-32-5general
[methyl(phenylmethyl)amino]ethyl ester
[CAS]
nicergolineErgoline-8-methanol, 10-methoxy-1,6-27848-84-6Formulation, Unspecified
dimethyl-, (8/b)-, 5-bromo-3-modified-
pyridinecarboxylate(ester)release, other
Niceritrol5868053
Niclosamide50-65-7
Nicoclonate10571-59-2
Nicofuranose15351-13-0
Nicomol27959-26-8
Nicomorphine639-48-5
nicorandil3-Pyridinecarboxamide, N-[2-65141-46-0U.S.4,792,564Vasodilator,Hypertension,
(nitrooxy)ethyl]-[CAS]coronarygeneral
Nicotinamide98-92-0
nicotinePyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-54-11-5Formulation,Addiction,
[CAS]inhalable, othernicotine
Nicotinic Acid59-67-6
Nicotinic Acid Benzyl94-44-0
Ester
Nicotinyl Alcohol100-55-0
nifedipine4-(2′-nitrophenyl)-2,6-dimethyl-3,5-21829-25-4GB1173862Vasodilator,Hypertension,
dicarbomethoxy-1,4-dihydropyridinecoronarygeneral
nifekalant2,4(1H,3H)-Pyrimidinedione, 6-[[2-[(2-130636-43-0EP369627AntiarrhythmicArrhythmia,
hydroxyethyl)[3-(4-130656-51-8general
nitrophenyl)propyl]amino]ethyl]amino]-1,3-
dimethyl-, [CAS]
Nifenalol7413-36-7
Niflumic Acid4394-00-7
Nifuratel4936-47-4
Nifurfoline3363-58-4
Nifuroxazide965-52-6
Nifuroxime6236051
Nifurpirinol13411-16-0
Nifurprazine1614-20-6
Nifurtimox23256-30-6
Nifurtoinol1088-92-2
nifurzide2-Thiophenecarboxylic acid, 5-nitro-, [3-(5-39978-42-2U.S.3,847,911AntidiarrhoealInfection,
nitro-2-furanyl)-2-propenylidene]hydrazideGI tract
[CAS]
NIK-254Gentamicin, sulfate (salt) [CAS]1405-41-0Formulation, otherInfection,
general
Nikethamide59-26-7
nilutamide2,4-Imidazolidinedione, 5,5-dimethyl-3-[4-63612-50-0U.S.4,472,382Anticancer,Cancer,
nitro-3-(trifluoromethyl)phenyl]-[CAS]hormonalprostate
nilvadipine3,5-Pyridinedicarboxylic acid, 2-cyano-1,4-75530-68-6U.S.4,338,322Antihypertensive,Hypertension,
dihydro-6-methyl-4-(3-nitrophenyl)-, 3-othergeneral
methyl 5-(1-methylethyl) ester [CAS]
nimesulideMethanesulfonamide, N-(4-nitro-2-51803-78-2U.S.3,840,597Anti-inflammatoryPain, general
phenoxyphenyl)-[CAS]
Nimetazepam2011-67-8
nimodipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-66085-59-4EP533014Neuroprotective
2,6-dimethyl-4-(3-nitrophenyl)-, 2-
methoxyethyl 1-methylethyl ester [CAS]
Nimorazole6506-37-2
nimustineUrea, N′-[(4-amino-2-methyl-5-103745-00-2GB1374344Anticancer,Cancer, brain
pyrimidinyl)methyl]-N-(2-chloroethyl)-N-42471-28-3alkylating
nitroso-[CAS]55661-38-6
Ninopterin2179-16-0
NIP-142N-[4(S)-(Cyclopropylamino)-3-(R)-hydroxy-WO9804542AntiarrhythmicFibrillation,
2,2-dimethyl-7-nitro-3,4-dihydro-2H-1-atrial
benzopyran-6-yl]-4-
methoxybenzeneacetamide
NIP-531N′-[3,5-Bis(trifluoromethyl)benzyl]-N-[3-[N-Antipruritic/inflamm,Eczema,
[1-(4-fluorobenzyl)benzimidazol-2-yl]-allergicatopic
amino]propyl-N-methylurea hydrochloride
niperotidineN-[2-[[5-84845-75-0GB2104071AntiulcerUlcer, GI,
[(dimethylamino)methyl]furfuryl]thio]ethyl]-general
2-nitro-N′-piperonyl-1,1-ethenediamine
nipradilol2H-1-Benzopyran-3-ol, 3,4-dihydro-8-[2-81486-22-8EP42299Formulation,Glaucoma
hydroxy-3-[(1-methylethyl)amino]propoxy]-,86247-86-1mucosal, topical
3-nitrate [CAS]
Niridazole61-57-4
nisoldipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-63675-72-9GB1516793Antihypertensive,Hypertension,
2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-othergeneral
methylpropyl ester-[CAS]
nitazoxanideBenzamide, 2-(acetyloxy)-N-(5-nitro-2-55981-09-4U.S.5,387,598ProtozoacideInfection, GI
thiazolyl)-[CAS]tract
nitisinone1,3-Cyclohexanedione, 2-[2-nitro-4-104206-65-7EP186118Metabolic andCirrhosis,
(trifluoromethyl)benzoyl]-[CAS]enzyme disordershepatic
nitracrine1,3-Propanediamine, N,N-dimethyl-N′-(1-4533-39-5FR1458183Anticancer, otherCancer,
nitro-9-acridinyl)-[CAS]6514-85-8ovarian
Nitrazepam146-22-5
nitrendipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-39562-70-4GB1358951Antihypertensive,Hypertension,
2,6-dimethyl-4-(3-nitrophenyl)-, ethylothergeneral
methyl ester-[CAS]
nitroflurbiprofen(1,1′-Biphenyl)-4-acetic acid, 2-fluoro-158836-71-6EP670825UrologicalIncontinence
Alpha-methyl-, 4-(nitrooxy)butyl ester
[CAS]
Nitrofurantoin67-20-9
Nitrofurazone59-87-0
nitroglycerin1,2,3-Propanetriol, trinitrate [CAS]55-63-0Formulation,Angina,
transdermal, patchgeneral
Nitromersol133-58-4
nitronaproxen2-Naphthaleneacetic acid, 6-methoxy-Alpha-163133-43-5WO9509831Analgesic, NSAIDPain, post-
methyl 4-(nitrooxy)butyl ester (AlphaS)-operative
[CAS]
nitroxazepineDibenz[b,f][1,4]oxazepin-11(10H)-one, 10-16398-39-3NL6608671Antidepressant
[3-(dimethylamino)propyl]-2-nitro-,
monohydrochloride [CAS]
Nitroxoline4008-48-4
nizatidine1,1-Ethenediamine, N-[2-[[[2-76963-41-2EP49618AntiulcerUlcer,
[(dimethylamino)methyl]-4-duodenal
thiazolyl]methyl]thio]ethyl]-N′-methyl-2-
nitro-[CAS]
Nizofenone54533-85-6
NM-33-(2-methylcarboxymethyl)-6-methoxy-8-JP08176138Anticancer, otherCancer,
hydroxy-isocoumaringeneral
NM-7024-Bromo-5-(3-pyridylmethylamino)-6-[3-(4-AntithromboticPeripheral
chlorophenyl)propoxy]-3(2H)pyridazinonevascular
hydrochloridedisease
N-Methylephedrine552-79-4
N-Methylepinephrine554-99-4
N-Methylglucamine6284-40-8
NN-4146-chloro-3-(1-methylcyclopropylamino)-4H-AntidiabeticDiabetes,
thieno[3,2-e]-[1,2,4]thiadiazine-1,1-dioxideType II
NNC-05-1869(R)-1-(3-(10,11-dihydro-5H-SymptomaticNeuropathy,
dibenzo[a,d]cyclohepten-5-ylidene)-1-antidiabeticdiabetic
propyl)-3-piperidine carboxylic acid
Nogalamycin1404-15-5
nolatrexed4(1H)-Quinazolinone, 2-amino-6-methyl-5-152946-68-4WO9320055Anticancer,
(4-pyridinylthio)-, [CAS]147149-76-6antimetaboliteCancer, liver
nolomirolePropanoic acid, 2-methyl-, 5,6,7,8-138531-51-8WO9529147CardiostimulantHeart failure
tetrahydro-6-(methylamino)-1,2-
naphthalenediyl ester, hydrochloride, (+/−)-
[CAS]
nolpitantium1-Azoniabicyclo[2.2.2]octane, 1-[2-[3-(3,4-153050-21-6EP591040GI inflammatory/Inflammatory
dichlorophenyl)-1-[[3-(1-bowel disordersbowel
methylethoxy)phenyl]acetyl]-3-disease
piperidinyl]ethyl]-4-phenyl-, chloride, (S)-
[CAS]
nomegestrol19-Norpregna-4,6-diene-3,20-dione, 17-58652-20-3DE2522533MenstruationMenstrual
(acetyloxy)-6-methyl-[CAS]disordersdisorder,
general
Nomifensine24526-64-5
Noprylsulfamide576-97-6
Norbolethone1235-15-0
Nordazepam1088-11-5
Nordefrin6539-57-7
(unspecified);
74812-63-8
(R*,S*)-(±)-
form
Nordihydroguaiaretic27686-84-6
Acid(meso-form);
500-38-9
(unspecified)
Norelgestromin,
Ethinyl Estradiol
Norepinephrine51-41-2
Norethandrolone52-78-8
Norethindrone68-22-4
Norethynodrel68-23-5
Norfenefrine536-21-0
norfloxacin3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-68077-27-0U.S.4,146,719QuinoloneInfection,
1,4-dihydro-4-oxo-7-(1-piperazinyl)-[CAS]70458-96-7antibacterialgeneral
Norgesterone13563-60-5
Norgestimate35189-28-7
Norgestrel6533-00-2
Norgestrienone848-21-5
Norlevorphanol1531-12-0
Normethadone467-85-6
Normethandrone514-61-4
Normorphine466-97-7
Norphenazone89-25-8
Norpipanone561-48-8
Norpseudoephedrine492-39-7
Nortriptyline72-69-5
Norvinisterone6795-60-4
Noscapine128-62-1
Novembichin1936-40-9
Novobiocin303-81-1
Noxiptillin3362-45-6
Noxythiolin15599-39-0
NS-1209Butanoic acid, 2-[[[5-[4-254751-28-5WO9426747AntiepilepticEpilepsy,
[(dimethylamino)sulfonyl]phenyl]-general
1,2,6,7,8,9-hexahydro-8-methyl-2-oxo-3H-
pyrrolo[3,2-h]isoquinolin-3-
ylidene]amino]oxy]-3-hydroxy-[CAS]
NS-12315-(4-chlorophenyl)-6,7,8,9-tetrahydro-1H-NeuroprotectiveIschaemia,
pyrolo-(3,2-h)naphthalene-2,3-dione-3-cerebral
oxime
NS-126U.S.5,063,222Antiallergic,Rhinitis,
non-asthmaallergic,
general
NS-2202-Methyl-c-5-[4-[5-methyl-2-(4-Hypolipaemic/Athero-
methylphenyl)-4-oxazolyl]butyl]-1,3-Antiatherosclerosissclerosis
dioxane-r-2-carboxylic acid
NS-2330NS 2330 [CAS]402856-42-2Cognition enhancerAlzheimer's
disease
NS5A inhibitorsU.S.6,030,785Antiviral, otherInfection,
hepatitis-
C virus
NS-7Pyrimidine, 4-(4-fluorophenyl)-2-methyl-6-178429-67-9WO9607641NeuroprotectiveIschaemia,
[[5-(1-piperidinyl)pentyl]oxy]-,cerebral
monohydrochloride [CAS]
NS-82-Amino-5-(2-fluorophenyl)-4-methyl-1H-UrologicalIncontinence
pyrrole-3-carbonitrile
NSC-33050717-AllylaminogeldanamycinAnticancer,Cancer,
antibioticgeneral
NSC-6195342-chloroethyl phenyl selenoneAnticancer,Cancer,
alkylatinggeneral
NSC-6977262,5-diazinidinyl-3-[hydroxymethyl]6-methyl-Anticancer,Cancer,
1,4-benzoquinoneantibioticgeneral
N-Sulfanilyl-3,4-120-34-3
xylamide
NU-60272,4-Pyrimidinediamine, 6-220036-08-8Anticancer, otherCancer,
(cyclohexylmethoxy)-5-nitroso-[CAS]general
NV-072,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-53745-16-7U.S.6,455,032Antipruritic/inflamm,Keratosis
5-sec-pentyl-, 2-oxime [CAS]non-allergic
NVP-SRA880([3R,4aR,10aR]-1,2,3,4,4a,5,10,10a-NeurologicalUnspecified
Octahydro-6-methoxy-1-methyl-
benz[g]quinoline-3-carboxylic acid-4-(4-
nitrophenyl)piperazine amide, hydrogen
maleate
NW-1029(S)-(+)-2-[4-(2-Analgesic, otherPain, general
fluorobenzyloxy)benzylamino]propanamide
methansulfonate
NXY-059CPI 22 [CAS]168021-79-2U.S.5,780,510NeuroprotectiveIschaemia,
cerebral
Nylidrin447-41-6
NZ-3141-Imidazolidineacetic acid, 3-[(3-128043-99-2EP353198SymptomaticNeuropathy,
nitrophenyl)methyl]-2,4,5-trioxo-[CAS]antidiabeticdiabetic
NZ-4195-hydroxy-1-methylimidazolidine-2,4-dioneEP412940UrologicalRenal failure
Obidoxime Chloride114-90-9
OC-108OC 108 [CAS]162602-62-2Vasoprotective,Venous
topicalinsufficiency
ocinaplonMethanone, 2-pyridinyl[7-(4-96604-21-6EP129847AnxiolyticGeneralized
pyridinyl)pyrazolo[1,5-a]pyrimidin-3-yl]-anxiety
[CAS]disorder
Octabenzone1843-05-6
Octacaine13912-77-1
Octamoxin4684-87-1
Octaverine549-68-8
octenidine1-Octanamine, N,N′-(1,10-decanediyldi-70775-75-6WO8705501StomatologicalPeriodontitis
1(4H)-pyridinyl-4-ylidene)bis-[CAS]71251-02-0
86767-75-1
Octodrine543-82-8
Octopamine104-14-3
Octotiamine137-86-0
octreotideL-Cysteinamide, D-phenylalanyl-L-83150-76-9Formulation, Cancer,
cysteinyl-L-phenylalanyl-D-tryptophy-L-fixed-dosegeneral
lysyl-L-threonyl-N-[2-hydroxy-1-combinations
(hydroxymethyl)propyl]-, cyclic (2-7)-
disulfide, [R-(R*,R*)]-[CAS]
Octyl5466-77-3
Methoxycinnamate
ofloxacin7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-82419-36-1EP47005Quinolone
carboxylic acid, 9-fluoro-2,3-dihydro-3-antibacterial
methyl-10-(4-methyl-1-piperazinyl)-7-oxo-,
(+/−)-[CAS]
o-lodohippurate133-17-5
loanzapine10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-132539-06-1EP454436NeurolepticSchizophrenia
methyl-4-(4-methyl-1-piperazinyl)-[CAS]
Oleandrin465-16-7
Oleic Acid112-80-1
olmesartan -1H-Imidazole-5-carboxylic acid, 4-(1-144689-63-4EP503785Antihypertensive,Hypertension,
medoxomilhydroxy-1-methylethyl)-2-propyl-1-((2′-(1H-renin systemgeneral
tetrazol-5-yl)(1,1′-biphenyl)-4-yl)methyl)-,
(5-methyl-2-oxo-1,3-dioxol-4-yl) methyl
ester [CAS]
olopatadine11-[(Z)-3-(Dimethylamino)propylidene]-113806-05-6EP235796OphthalmologicalConjunctivitis
6,11-dihydrodibenz[b,e]oxepin-2-acetic140462-76-6
acid, monohydrochloride
olpadronic acidMonosodium 3-dimethylamino-1-63132-39-8WO9619998OsteoporosisOsteoporosis
(hydroxypropylidene)-1,1-bisphosphonatetreatment
olsalazineBenzoic acid, 3,3′-azobis[6-hydroxy-[CAS]15722-48-2U.S.4,559,330GI inflammatory/Colitis,
53200-51-4bowel disordersulcerative
oltipraz3H-1,2-Dithiole-3-thione, 4-methyl-5-64224-21-1DE2705641Anticancer, otherCancer, general
pyrazinyl-[CAS]
OM-294DP2-[3(R)-(Dodecanoyloxy)tetradecanamido]-Anticancer,Unspecified
N-[4-[3(R)-hydroxytetradecanamido]-5-immunological
(phosphonooxy)pentyl]-4-
(phosphonooxy)butyramide
Omacorethyl (5Z,8Z,11Z,14Z,17Z)-eicosa-81926-94-5Hypolipaemic/Hypertrigly-
5,8,11,14,17-pentaenoate + ethyl86227-47-6Antiatherosclerosisceridaemia
(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-
4,7,10,13,16,19-hexaenoate
omapatrilat7H-Pyrido(2,1-b)(1,3)thiazepine-7-167305-00-2U.S.5,508,272Antihypertensive,Hypertension,
carboxylic acid, octahydro-4-((2-mercapto-renin systemgeneral
1-oxo-3-phenylpropyl)amino)-5-oxo, (4S-
(4Alpha(R*),7Alpha,10aβ))-[CAS]
omeprazole1H-Benzimidazole, 5-methoxy-2-[[(4-73590-58-6U.S.4,255,431AntiulcerUlcer, GI,
methoxy-3,5-dimethyl-2-general
pyridinyl)methyl]sulfinyl]-[CAS]
omiloxetineEthanone, 2-[(3R,4S)-3-[(1,3-benzodioxol-176894-09-0AntidepressantDepression,
5-yloxy)methyl]-4-(4-fluorophenyl)-1-general
piperidinyl]-1-(4-fluorophenyl)-, rel-[CAS]
omoconazole1H-Imidazole, 1-[2-[2-(4-74512-12-2EP8804AntifungalInfection,
chlorophenoxy)ethoxy]-2-(2,4-dermatological
dichlorophenyl)-1-methylethenyl]-, (Z)-
[CAS]
Onapristone96346-61-1
ondansetron4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-99614-01-4U.S.4,847,281AntiemeticChemotherapy-
methyl-3-[(2-methyl-1H-imidazol-1-99614-02-5induced nausea
yl)methyl]-[CAS]and vomiting
ONO-3403Benzoic acid, 4-[(1E)-3-[(2-ethoxy-2-181586-07-2GI inflammatory/Unspecified
oxoethyl)-2-propenylamino]-2-methyl-3-bowel disorders
oxo-1-propenyl]-, 4-
(aminoiminomethyl)phenyl ester,
monomethanesulfonate [CAS]
ONO-41281,4,9-Triazaspiro(5.5)undecane-2,5-dione,342394-93-8Antiviral, anti-HIVInfection,
1-butyl-3-(cyclohexylmethyl)-9-((2,3-HIV/AIDS
dihydro-1,4-benzodioxin-6-yl)methyl-
[CAS]
ONO-8815 LyL-lysine (Z)-7-[(1R,2R,3R,5R)-5-chloro-3-Labour inhibitorLabour,
hydroxy-2-[(E)-(S)-4-(1-ethylcyclobutyl)-4-preterm
hydroxy-1-butenyl]cyclopentyl]-5-
heptenoate
ONT-093U.S.5,756,527Radio/Cancer,
chemosensitizergeneral
OPC-145232(1H)-Quinolinone, 1-[3-[4-(3-145969-30-8EP512525AntidepressantDepression,
chlorophenyl)-1-piperazinyl]propyl]-3,4-general
dihydro-5-methoxy-[CAS]
OPC-31260Benzamide, N-[4-[[5-(dimethylamino)-137975-06-5WO9105549UrologicalUnspecified
2,3,4,5-tetrahydro-1H-1-benzazepin-1-
yl]carbonyl]phenyl]-2-methyl-
OPC-51803(5R)-2-[1-(2-chloro-4-(1-AntidiabeticDiabetes,
pyrolidinyl)benzoyl)-2,3,4,5-tetrahydro-1H-insipidus
1-benzazepin-5-yl]-N-isopropylacetamide
OPC-65352-Pyridinecarboxylic acid, 6-[2-(3,4-145739-56-6WO9209586GI inflammatory/Inflammatory
diethoxyphenyl)-4-thiazolyl]-[CAS]bowel disordersbowel
disease
Opiniazide2779-55-7
opioid analgesics2-(4-trifluoromethylphenyl)-N-methyl-[1-Analgesic, otherPain, general
phenyl-2-(1-pyrolidinyl)ethylacetamide]
Opipramol315-72-0
Orazamide2574-78-9
orazipone2,4-Pentanedione, 3-((4-137109-78-5EP440324AntiasthmaUnspecified
methylsulfonyl)phenyl)methylene)-[CAS]
Org-12962Piperazine, 1-[6-chloro-5-(trifluoromethyl)-210821-63-9AntidepressantDepression,
2-pyridinyl]-, monohydrochloride [CAS]general
Org-24448U.S.6,166,008NeurolepticSchizophrenia
oritavancinVancomycin, 22-O-(3-amino-2,3,6-trideoxy-171099-57-3U.S.5,840,684Peptide antibioticInfection,
3-C-methyl-Alpha-L-arabino-dermatological
hexopyranosyl)-N3″-[(4′-chloro[1,1′-
biphenyl]-4-yl)methyl]-,(4″R)-[CAS]
orlistatL-Leucine, N-formyl-, 1-[(3-hexyl-4-oxo-2-96829-58-2EP129748Anorectic/Obesity
oxetanyl)methyl]dodecyl ester, [2S-Antiobesity
[2Alpha(R*),3β]]-[CAS]
ormeloxifenePyrrolidine, 1-[2-(p-(7-methoxy-2,2-31477-60-8DE2329201FemaleContraceptive,
dimethyl-3-phenyl-4-contraceptivefemale
chromanyl)phenoxy)ethyl]-, trans-[CAS]
Ornidazole16773-42-5
Ornipressin3397-23-7
Ornithine70-26-8
ornoprostilProst-13-en-1-oic acid, 11,15-dihydroxy-70667-26-4U.S.4,278,688ProstaglandinUlcer, gastric
17,20-dimethyl-6,9-dioxo-, methyl ester,
(11Alpha,13E,15S,17S)-[CAS]
Orotic Acid65-86-1
Orphenadrine83-98-7
Orthocaine536-25-4
Osalmid526-18-1
osanetantAcetamide, N-[1-[3-[(3R)-1-benzoyl-3-(3,4-160492-56-8EP673928NeurolepticSchizophrenia
dichlorophenyl)-3-piperidinyl]propyl]-4-
phenyl-4-piperidinyl]-N-methyl-[CAS]
osaterone2-Oxapregna-4,6-diene-3,20-dione, 17-105149-00-6EP193871ProstateBenign prostatic
(acetyloxy)-6-chloro-[CAS]disordershyperplasia
oseltamivir1-Cyclohexene-1-carboxylic acid, 4-196618-13-0WO9626933Antiviral, otherInfection,
(acetylamino)5-amino-3-(1-ethylpropoxy)-,influenza virus
ethyl ester, (3R-(3Alpha,(4β,5Alpha))-
[CAS]
OSI-78364′-Thio-β-D-arabinofuranosylcytosineAnticancer,Cancer,
antimetabolitegeneral
OSI-7904Pentanedioic acid, 2-[5-[[(1,2-dihydro-3-139987-54-5WO9119700Formulation,Cancer,
methyl-1-oxobenzo[f]quinazolin-9-optimized, liposomesgeneral
yl)methyl]amino]-1,3-dihydro-1-oxo-2H-
isoindol-2-yl]-, (S)-[CAS]
ospemifeneEthanol, 2-[4-[(1Z)-4-chloro-1,2-diphenyl-1-128607-22-7WO9607402MenopausalOsteoporosis
butenyl]phenoxy]-[CAS]disorders
otilonium bromideEthanaminium, N,N-diethyl-N-methyl-2-[[4-26095-59-0GB1181406AntispasmodicIrritable bowel
[[2-(octyloxy)benzoyl]amino]benzoyl]oxy]-,syndrome
bromide [CAS]
Ouabain630-60-4
Oxaceprol33966-33-7
Oxacillin66-79-5
Oxaflozane26629-87-8
oxaliplatinPlatinum, (1,2-cyclohexanediamine-61825-94-3EP393575Anticancer,Cancer,
N,N′)[ethanedioato(2-)-O,O′]-, [SP-4-2-(1R-alkylatingcolorectal
trans)]-[CAS]
Oxalyt-C1,2,3-Propanetricarboxylic acid, 2-hydroxy-,28060-67-5DE2249274Urological
potassium sodium salt [CAS]
Oxamarin15301-80-1
Oxametacine27035-30-9
Oxamniquine21738-42-1
oxandrolone2-Oxaandrostan-3-one, 17-hydroxy-17-53-39-4U.S.3,128,283Reproductive/Sex-
methyl-, (5Alpha,17β)-[CAS]gonadal, generalchromosome
abnormality,
Turner's
syndrome
Oxantel36531-26-7
Oxapropanium541-66-2
oxaprozin2-Oxazolepropanoic acid, 4,5-diphenyl-21256-18-8GB1206403Antiarthritic, otherArthritis,
[CAS]osteo
oxatomide2H-Benzimidazol-2-one, 1-[3-[4-60607-34-3GB1579365Antiallergic, Rhinitis,
(diphenylmethyl)-1-piperazinyl]propyl]-1,3-non-asthmaallergic,
dihydro-[CAS]general
oxazepam7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-604-75-1Formulation, oral,Anxiety,
2H-1,4-benzodiazepin-2-oneorally-disintegratinggeneral
oxazolamOxazolo[3,2-d][1,4]benzodiazepin-6(5H)-27167-30-2U.S.3,772,371Anxiolytic
one, 10-chloro-2,3,7,11b-tetrahydro-2-
methyl-11b-phenyl-[CAS]
oxcarbazepine5H-Dibenz[b,f]azepine-5-carboxamide,28721-07-5DE2011087AntiepilepticEpilepsy,
10,11-dihydro-10-oxo-[CAS]29331-92-8general
Oxeladin468-61-1
Oxendolone33765-68-3
Oxethazaine126-27-2
Oxetoron26020-55-3
oxiconazoleEthanone, 1-(2,4-dichlorophenyl)-2-(1H-64211-45-6GB1514870AntifungalInfection,
imidazol-1-yl)-, O-[(2,4-fungal,
dichlorophenyl)methyl]oxime, (Z)-[CAS]general
Oxidronic Acid15468-10-7
Oxiniacic Acid2398-81-4
Oxiracetam62613-82-5
oxitropium3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,30286-75-0GB1178305Antiasthma
9-ethyl-7-(3-hydroxy-1-oxo-2-
phenylpropoxy)-9-methyl-, bromide, [7(S)-
(1Alpha,2β,4β,5Alpha,7β)]-[CAS]
Oxolamin959-14-8
Oxolinix Acid14698-29-4
Oxophenarsine538-03-4
Oxprenolol6452-71-7
Oxybenzone131-57-7
oxybutyninBenzeneacetic acid, Alpha-cyclohexyl-5633-20-5Formulation, Incontinence
Alpha-hydroxy-, 4-(diethylamino)-2-butynylmodified-
ester-[CAS]release, other
Oxycinchophen485-89-2
oxycodoneMorphinan-6-one, 4,5-epoxy-14-hydroxy-3-76-42-6Formulation,Pain, general
methoxy-17-methyl-, (5Alpha)-transmucosal, nasal
Oxytedrine15687-41-9
OxygentOctane, 1-bromo-423-55-2HaematologicalSurgery
1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-adjunct
heptadecfluoro-[CAS]
Oxymesterone145-12-0
Oxymetazoline1491-59-4
oxymetholoneAndrostan-3-one, 17-hydroxy-2-434-07-1HormoneAnaemia,
(hydroxymethylene)-17-methyl-,general
(5Alpha,17β)-[CAS]
Oxymethurea140-95-4
oxymorphone(5Alpha)-4,5-Epoxy-3,14-dihydroxy-17-76-41-5Formulation, Pain, general
methylmorphinan-6-one [CAS]modified-
release, immediate
Oxypendyl5585-93-3
Oxypertine153-87-7
Oxyphenbutazone129-20-4
Oxyphencyclimine125-53-1
Oxyphenisatin115-33-3
Oxyphenonium50-10-2
Oxypinocamphone10136-65-9
oxypurinol1H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-2465-59-0AntigoutHyper-
dione [CAS]uricaemia
Oxytetracycline79-57-2
ozagrel2-Propenoic acid, 3-[4-(1H-imidazol-1-78712-43-3GB2025946AntithromboticVasospasm,
ylmethyl)phenyl]-, (E)-[CAS]82571-53-7cerebral
p-(Benzyl-536-95-8
sulfonamido)-
benzoic Acid
P-100U.S.6,313,777Antiviral, anti-HIVInfection,
HIV/AIDS
P-1202Pentanoic acid, 5-amino-4-oxo, methyl79416-27-6U.S.6,034,267DermatologicalKeratosis
ester, hydrochloride [CAS]
P32/98Di-(3N-[(2S,3S)-2-amino-3-methyl-AntidiabeticDiabetes,
pentanoyl]-1,3-thiazolidine)fumarateType II
PA-824WO9701562AntimycobacterialInfection,
tuberculosis
PACAP 38Pituitary adenylate cyclase-activating128606-20-2U.S.5,128,242NeuroprotectiveNerve injury,
peptide-38 [CAS]general
pactitaxel5β,20-Epoxy-1,2Alpha,4,7β,10β,13Alpha-33069-62-4Formulation,Cancer,
hexahydroxytax-11-en-9-one-4,10-optimized, breast
diacetate-2-benzoate-13-(Alpha-nanoparticles
phenylhippurate)
PADREU.S.6,413,935Immunostimulant,Vaccine
otheradjunct
pagoclone1H-Isoindol-1-one, 2-(7-chloro-1,8-133737-32-3U.S.4,960,779AnxiolyticPanic
naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-disorder
2-oxohexyl)-(R)-[CAS]
PAI inhibsWO9404512AntithromboticThrombosis,
venous
palindore8H-1,4-dioxino[2,3-e]indol-8-one,2,3,7,9-189681-71-8NeurolepticSchizophrenia
tetrahydro-2-[(phenylmethyl)amino]methyl]-,
2(S)-, (2E)-2-butendioate (1:1)
Palivizumab188039-54-5
palonosetron3aS-2-[(S)-1-Azabicyclo[2.2.2]oct-3-yl]-135729-62-3U.S.5,202,333AntiemeticChemotherapy-
2,3,3a,4,5,6-hexahydro-1-oxo-1H-induced
benz[de]isoquinoline hydrochloridenausea and
vomiting
Pamabrom606-04-2
Pamaquine491-92-9
pamicogral1H-Pyrrole-1-acetic acid, 2-[4,5-bis(4-101001-34-7EP159677AntithromboticThrombosis,
methoxyphenyl)-2-thiazolyl]-, ethyl estercerebral
[CAS]
pamidronate(3-Amino-1-40391-99-9Formulation, Hyper-
hydroxypropylidene)diphosphonic acid-implantcalcaemia
[CAS]of malignancy
p-Aminobenzoic Acid150-13-0
p-Aminohippuric Acid61-78-9
p-Amino-70-69-9
propiophenone
p-Aminosalicylic 65-49-6
Acid
Panavir4,4′-isopropylidenedithiobis-2,6-di-t-NeuroprotectiveVasospasm,
butylphenolcerebral
Pancuronium15500-66-0
Panipenem87726-17-8
Pantethine16816-67-4
pantoprazole1H-Benzimidazole, 5-(difluoromethoxy)-2-102625-70-7EP166287AntiulcerUlcer,
[[(3,4-dimethyloxy-2-pyridinyl)methyl]-duodenal
sulfinyl]-[CAS]
Pantothenic Acid79-83-4
Papain
Papaverine58-74-2
paracetamolAcetamide, N-(4-hydroxyphenyl)-[CAS]103-90-2Formulation, oral,Pain, general
other, modified-
release
Paraflutizide1580-83-2
Paraldehyde123-63-7
Paramethadione115-67-3
Paramethasone53-33-8
Paranyline1729-61-9
Parathyroid Hormone9002-64-6
parecoxibPropanamide, N-((4-(5-methyl-3-phenyl-4-198470-85-8WO9738986Analgesic, NSAIDPain, post-
isoxazolyl)phenyl)sulfonyl)-, sodium saltoperative
[CAS]
Parethoxycaine94-23-5
Pargyline555-57-7
paricalcitol19-Nor-9,10-secoergosta-5,7,22-triene-131918-61-1EP387077HormoneHyperparathy-
1,3,25-triol, (1Alpha,3β,7E,22E)-[CAS]roidsm
paromomycinO-2-Amino-2-deoxy-Alpha-D-7542-37-2ProtozoacideInfection,
glucopyranosyl-(1-4)-O-[O-2,6-diamino-2,6-leishmaniasis
dideoxy-β-L-idopyranosyl-(1-3)-β-D-
ribofuranosyl-(1-5)]-2-deoxy-D-streptamine
paroxetinePiperidine, 3-[(1,3-benzodioxol-5-61869-08-7EP223403Antidepressant,Depression,
yloxy)methyl]-4-(4-fluorophenyl)-, (3S-formulation, oral,general
trans)-[CAS]orally-
disintegrating
Paroxypropione70-70-2
Parsalmide30653-83-9
PaTrin-24-BromothenylguanineRadio/Cancer,
chemosensitizermelanoma
Pazinaclone103255-66-9
pazufloxacin7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-127045-41-4DE3913245QuinoloneInfection,
carboxylic acid, 10-(1-aminocyclopropyl)-9-127046-45-1antibacterialgeneral
fluoro-2,3-dihydro-3-methyl-7-oxo-, (S)-136905-87-8
[CAS]
p-Bromoacetanilide103-88-8
PC-NSAIDsU.S.4,918,063Formulation, otherArthritis,
general
PD-01662856-(2,6-Dichlorophenyl)-2-[4-(diethylamino-Anticancer, otherCancer,
ethoxy)-phenylamino]-8-pyrido[2,3-general
D]pyrimidine-7-one
Pecilocin19504-77-9
pefloxacin3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-70458-92-3GB1598915QuinoloneInfection,
1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-antibacterialurinary tract
oxo-[CAS]
pegvisomantSomatotropin (18-aspartic acid, 21-218620-50-9SomatostatinAcromegaly
asparagine, 120-lysine, 167-asparagine,
168-alanine, 171-serine, 172-arginine, 174-
serine, 179-threonine (human), pegylated
[CAS]
Pelletierine4396-1-4
pemetrexedL-Glutamic acid, N-[4-[2-(2-amino-4,7-137281-23-3U.S.5,248,775Anticancer,Cancer,
dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-150399-23-8antimetabolitemesothel-
yl)ethyl]benzoyl]-, disodium salt [CAS]ioma
pemirolast4H-Pyrido[1,2-a]pyrimidin-4-one, 9-methyl-100299-08-9U.S.4,457,932AntiasthmaAsthma
3-(1H-tetrazol-5-yl)-[CAS]69372-19-6
Pemoline2152-34-3
Pempidine79-55-0
PEN-203U.S.5,955,446Antiviral, otherInfection,
human
papilloma
virus
Penamecillin983-85-7
penbutolol2-Propanol, 1-(2-cyclopentylphenoxy)-3-38363-32-5GB1215751Antihypertensive,
[(1,1-dimethylethyl)amino]-, (S)-, sulfate38363-40-5adrenergic
(2:1) (salt) [CAS]
penciclovir6H-Purin-6-one, 2-amino-1,9-dihydro-9-[4-39809-25-1JP60058982Antiviral, otherInfection,
hydroxy-3-(hydroxymethyl)butyl]-[CAS]herpes
simplex virus
Penethamate808-71-9
penfluridol4-Piperidinol, 1-[4,4-bis(4-26864-56-2DE2040231Neuroleptic
fluorophenyl)butyl]-4-[4-chloro-3-
(trifluoromethyl)phenyl]-[CAS]
Penicillamine52-67-5
Penicillin G61-33-6
Penicillin G 1538-09-6
Benzathine
Penicillin G Procaine6130-64-9
Penicillin N525-94-0
Penicillin O87-09-2
Penicillin V87-08-1
Penimepicycline4599-60-4
PenntussU.S.4,221,778Formulation, Rhinitis,
modified-allergic,
release, othergeneral
Pentaerythritol Chloral78-12-6
Pentaerythritol2209-86-1
Dichlorohydrin
Pentaerythritol597-71-7
Pentagastrin5534-95-2
Pentagestrone7001-56-1
PentaLyteStarch, 2-hydroxyethyl ether [CAS]9005-27-0U.S.5,407,428Plasma substituteSurgery
adjunct
Pentam thonium541-20-8
pentamidineBenzenecarboximidamide, 4,4′-[1,5-100-33-4Formulation,Infection,
pentanediylbis(oxy)]bis-[CAS]inhalable, systemicPneumocystis
jiroveci
prophylaxis
Pentazocine359-83-1
Pentetate12111-24-9
Pentetic Acid67-43-6
Pentetreotide138661-02-6
Penthienate60-44-6
Pentifyllin1028-33-7
Pentigetide62087-72-3
Pentisomide78833-03-1
Pentobarbital76-74-4
Pentolinium52-62-0
Pentorex434-43-5
pentosanXylan, [CAS]37319-17-8U.S.5,180,715UrologicalInflammation,
urinary tract
pentostatinImidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-53910-25-1U.S.3,923,785Anticancer,Cancer,
deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-antimetaboliteleukaemia,
tetrahydro-, (R)-[CAS]hairy cell
pentoxifylline1H-Purine-2,6-dione, 3,7-dihydro-3,7-NeuroprotectiveAmyotrophic
dimethyl-1-(5-oxohexyl)-[CAS]lateral sclerosis
Pentoxyl147-61-5
Pentrinitrol1607-17-6
Pentylenetetrazole54-95-5
peplomycinBieomycinamide, N1-[3-[(1-68247-85-8U.S.4,195,018Anticancer,
phenylethyl)amino]propyl]-, (S)-[CAS]antibiotic
Perazine84-97-9
Perflubron423-55-2
Perfosfamide62435-42-1;
39800-16-3
(unspecified)
pergolideErgoline, 8-[(methylthio)methyl]-6-propyl-,66104-22-1U.S.4,797,405AntiparkinsonianParkinson's
(8β)-, monomethanesulfonate-[CAS]66104-23-2disease
Perhexiline6621-47-2
Pericyazine2622-26-6
perifosinePiperidinium, 4-157716-52-4EP594999Anticancer, otherCancer,
[[hydroxy(octadecyloxy)phosphinyl]oxy]-prostate
1,1-dimethyl-, inner salt [CAS]
perillyl alcohol1-Cyclohexene-1-methanol, 4-(1-536-59-4U.S.5,110,832Anticancer, otherCancer,
methylethenyl)-[CAS]breast
Perimethazine13093-88-4
perindopril1H-Indole-2-carboxylic acid, 1-[2-[[1-107133-36-8EP49658Antihypertensive,Hypertension,
(ethoxycarbonyl)butyl],amino]-1-82834-16-0renin systemgeneral
oxopropyl]octahydro-, [2S-95153-31-4
[1-[R*(R*)],2Alpha,3aβ,7aβ]]-, compd. with
2-methyl-2-propanamine (1:1) [CAS]
Periodyl53586-99-5
perisoxal1-Piperidineethanol, Alpha-(5-phenyl-3-2139-25-5JP04217925Anti-inflammatory
isoxazolyl)-, 2-hydroxy-1,2,3-2055-44-9
propanetricarboxylate (2:1) (salt) [CAS]
Perlapine1977-11-3
Permethrin52645-53-1
perospirone1H-Isoindole-1,3(2H)-dione, 2-[4-[4-(1,2-129273-38-7CA2167004NeurolepticSchizophrenia
benzisothiazol-3-yl)-1-150915-41-6
piperazinyl]butyl]hexahydro-, cis-[CAS]
Perphenazine58-39-9
Petroleum Benzin8030-30-6
PH-10U.S.6,331,286AntipsoriasisPsoriasis
Phanquinone84-12-8
Pharmaprojects No. WO9638482ImmunologicalUnspecified
4994
Pharmaprojects No. WO9703986NeurolepticSchizophrenia
5325
Pharmaprojects No. WO0204426AntiasthmaAsthma
5972
Pharmaprojects No. U.S.6,057,346Antiviral, anti-HIVInfection,
6362HIV/AIDS
Pharmaprojects No. (R)-N-[4-[2-[[2-Hydroxy-2-(3-Anorectic/Obesity
6446pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-Antiobesity
(trifluoromethyl)phenyl]thiazo-2-yl]-
benzenesulfonamide
Pharmaprojects No. WO0206223PsychostimulantAttention
6590deficit
disorder
Pharmaprojects No. U.S.6,455,026Genomics-basedCancer, brain
6656drug discovery
Pharmaprojects No. U.S.6,299,900Formulation, otherPain, general
6691
Pharmaprojects No. 3-(6-Aminopyridin-3-yl)-N-methyl-N-[(1-Antibacterial, otherInfection,
6743methyl-1H-indol-2-yl)methyl]acrylamidegeneral
Pharmaprojects No. 1,2,3,4,10,14b-Hexahydro-6-methoxy-2-AntidepressantDepression,
6748methyldibenzo[c,f]pyrazino[1,2-a]azepingeneral
Phenacaine620-99-5
Phenacemide63-98-9
Phenacetin62-44-2
Phenadoxone467-84-5
Phenallymal115-43-5
Phenamet3819-34-9
Phenazocine127-35-5
Phenazopyridine136-40-3
Phenbutamide3149-00-6
Phencyclidine77-10-1
Phendimetrazine634-03-7
Phenelzine51-71-8
Phenesterine3546-10-9
Phenetharbital357-67-5
Phenethicillin132-93-4
Pheneturide90-49-3
Phenformin114-86-3
Phenglutarimide1156-05-4
Phenindamine82-88-2
Phenindione83-12-5
Pheniprazine55-52-7
Pheniramine86-21-5
Phenmetrazine134-49-6
Phenobarbital50-06-6
Phenobutiodil554-24-5
Phenocoll103-97-9
Phenoctide78-05-7
Phenolphthalein77-09-8
Phenolphthalol81-92-5
Phenolsulfonphthalein143-74-8
Phenol-639-44-1
tetrachlorophthalein
Phenoperidine562-26-5
Phenosulfazole515-54-8
Phenoxybenzamine59-96-1
Phenoxypropazine3818-37-9
Phenprobamate673-31-4
Phenprocoumon435-97-2
phenserinePyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-101246-66-6Cognition enhancerAlzheimer's
hexahydro-1,3a,8-trimethyl-,disease
phenylcarbamate (ester), (3aS-cis)-[CAS]
Phensuximide86-34-0
Phentermine122-09-8
Phentetiothalein18265-54-8
phentolaminePhenol, 3-(((4,5-dihydro-1H-imidazol-2-65-28-1Formulation,Impotence
yl)methyl)(4-methylphenyl)amino)-,50-60-2oral, other
monomethanesulfonate (salt) [CAS]
Phenyl Acetylsalicylate134-55-4
Phenyl Aminosalicylate133-11-9
Phenyl Salicylate118-55-8
Phenylbutazone50-33-9
Phenylephrine61-76-7
Phenylethanolamine7568-93-6
Phenylmercury102-98-7
Phenylmethylbarbituric76-94-8
Acid
phenylpropanolamineBenzenemethanol, Alpha-(1-aminoethyl)-,14838-15-4Anorectic/
(R*,S*)-(+/−)-[CAS]Antiobesity,
formulation,
optimized,
microparticles
Phenylpropyl-93-88-9
methylamine
Phenyltoloxamine92-12-6
Phenyramidol553-69-5
phenytoin2,4-Imidazolidinedione, 5,5-diphenyl-57-41-0Formulation,Epilepsy,
[CAS]oral, othergeneral
Phethenylate510-34-9
Phloroglucinol108-73-6
Pholcodine509-67-1
Pholedrine370-14-9
Phosphocreatine67-07-2
Phosphocysteamine5746-40-7
Phosphorylcholine107-73-3
Phthalysulfacetamide131-69-1
Phthalylsulfathiazole85-73-4
p-Hydroxyephedrine365-26-4
Phylloquinone84-80-0
Physostigmine57-47-6
Phytic Acid83-86-3
PI-88D-Mannose, O-6-O-phosphono-Alpha-D-185077-23-0Anticancer, otherCancer,
mannopyranosyl-(1-3)-O-Alpha-D-melanoma
mannopyranosyl-(1-3)-O-Alpha-D-
mannopyranosyl-(1-3)-O-Alpha-D-
mannopyranosyl-(1-2)-hydrogen sulphate
[CAS]
Piberaline39640-15-8
piboserod2H-(1,3)Oxazino(3,2-a)indole-10-152811-62-6WO9318036AntiarrhythmicFibrillation,
carboxamide, N-((1-butyl-4-atrial
piperidinyl)methyl)-3,4-dihydro-[CAS]
Picilorex62510-56-9
Picloxydine5636-92-0
Picoperine21755-66-8
Picosulfate10040-45-6
Picotamide32828-81-2
Picumast39577-19-0
pidotimod4-Thiazolidinecarboxylic acid, 3-[(5-oxo-2-121808-62-6EP276752ImmunomoInfection,
pyrrolidinyl)carbonyl]-[CAS]dulator,respiratory
anti-infectivetract, lower
Pifarnine56208-01-6
piketoprofenBenzeneacetamide, 3-benzoyl-Alpha-60576-13-8GB1436502Anti-inflammatory,
methyl-N-(4-methyl-2-pyridinyl)-[CAS]topical
Pildralazine64000-73-3
pilocarpine2(3H)-Furanone, 3-ethyldihydro-4-[(1-92-13-7Formulation,
methyl-1H-imidazol-5-yl)methyl]-, (3S-cis)-implant,
[CAS]Stomatological
Piloplex2-Propenoic acid, 2-methyl-, dodecyl62783-28-2DE2636559Formulation,Glaucome
ester, polymer with 2-propenoicacid,mucosal, topical
compd. with (3S-cis)-3-ethyldihydro-4-[(1-
methyl-1H-imidazol-5-yl)methyl]-2(3H)-
furanone [CAS]
pilsicainide1H-Pyrrolizine-7a(5H)-acetamide, N-(2,6-88069-49-2U.S.4,564,624AntiarrhythmicArrhythmia,
dimethylphenyl)tetrahydro-,88069-67-4general
monohydrochloride [CAS]
Pimeclone534-84-9
pimecrolimus15,19-Epoxy-3H-pyrido(2,1-137071-32-0EP626385Antipruritic/Eczema,
c)(1,4)oxaazacyclotricosine-inflamm, allergicatopic
1,7,20,21(4H,23H)-tetrone, 3-(2-(4-chloro-
3-methoxycyclohexyl)-1-methyletheny)-8-
ethyl-
5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,
26a-hexadecahydro-5,19-dihydroxy-14,16-
dimethoxy-4,10,12,18-tetramethyl-(3S-
(3R*E(1S*,3S*,4R*)),
4S*,5R*,8S*,9E*,12R*,14R*,5S*,16R*,18S
8,19S*,26aR*))-[CAS]
Pimefylline10001-43-1
pimilprostAcetic acid, [2-[octahydro-5-hydroxy-6-(3-139403-31-9DermatologicalUlcer,
hydroxy-5-methyl-1-nonenyl)-2-general
pentalenyl]ethoxy]-, methyl ester, [2R-
[2Alpha,3Alpha,4Alpha(1E,3S*,5S*),5β,6a
Alpha]]-[CAS]
Piminodine13495-09-5
Pimobendan74150-27-9
pimozide2H-Benzimidazol-2-one, 1-[1-[4,4-bis(4-2062-78-4FRM3695Neuroleptic
fluorophenyl)butyl]-4-piperidinyl]-1,3-
dihydro-[CAS]
Pinacidil85371-64-8
pinaveriumMorpholinium, 4-[(2-bromo-4,5-53251-94-8EP406743AntispasmodicIrritable
dimethoxyphenyl)methyl]-4-[2-[2-(6,6-59995-65-2bowel
dimethylbicyclo[3.1.1]hept-2-syndrome
yl)ethoxy]ethyl]-, [CAS]
pinazepam2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-52463-83-9DE2339790Anxiolytic
dihydro-5-phenyl-1-(2-propynyl)-[CAS]
Pindolol13523-86-9
pioglitazone2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-111025-46-8EP193256AntidiabeticDiabetes,
pyridinyl)ethoxy]phenyl]methyl]-,112529-15-4Type II
monohydrochloride (+/−)-[CAS]
Pipacycline1110-80-1
Pipamazine84-04-8
Pipamperone1893-33-0
Pipazethate2167-85-3
Pipebuzone27315-91-9
Pipecurium52212-02-9
pipecuroniumPiperazinium, 4,4′-52212-02-9GB1398050Muscle relaxantAnaesthesia,
[(2β,3Alpha,5Alpha,16β,17β)-3,17-68399-57-5adjunct
bis(acetyloxy)androstane-2,16-diyl]bis[1,1]-
dimethyl-, [CAS]
pipemidic acidPyrido[2,3-d]pyrimidine-6-carboxylic acid,51940-44-4GB1451911Antibacterial,Infection,
8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)-otherurinary tract
[CAS]
Pipenzolate Bromide125-51-9
Piperacetazine3819-00-9
piperacillin4-Thia-1-azabicyclo[3.2.0]heptane-2-59703-84-3GB1508062Penicillin,Infection,
carboxylic acid, 6-[[[[(4-ethyl-2,3-dioxo-1-61477-96-1injectablegeneral
piperazinyl)carbonyl]amino]phenylacetyl]-
amino]-3,3-dimethyl-7-oxo-,[2S-
[2Alpha,5Alpha,6β(S*)]]-[CAS]
Piperazine Adipate142-88-1
Piperidione77-03-2
Piperidolate82-98-4
Piperilate4546-39-8
piperine analoguesWO002544DermatologicalVitiligo
Piperocaine136-82-3
Piperonal120-57-0
Piperoxan59-39-2
Piperylone25 31-4-6
Pipobroman54-91-1
Piposulfan2608-24-4
pipotiazineHexadecanoic acid, 2-[1-[3-[2-37517-26-3U.S.4,782,077Neuroleptic
[(dimethylamino)sulfonyl]-10H-39860-99-6
phenothiazin-10-yl]propyl]-4-
piperidinyl]ethyl ester [CAS]
Pipoxolan18174-58-8
Pipradrol467-60-7
piprozolinAcetic acid, [3-ethyl-4-oxo-5-(1-piperidinyl)-17243-64-0U.S.3,971,794GI inflammatory/Motility
2-thiazolidinylidene]-, ethyl ester [CAS]bowel disordersdysfunction,
GI, general
Piracetam7491-74-9
pirarubicin5,12-Naphthacenedione, 10-[[3-amino-72496-41-4U.S.4,303,785Anticancer,Cancer, breast
2,3,6-trideoxy-4-O-(tetrahydro-2H-pyran-2-antibiotic
yl)-Alpha-L-lyxo-hexopyranosyl]oxy]-
7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-
(hydroxyacetyl)-1-methoxy-, [8S-
[8Alpha,10Alpha(S*)]]-[CAS]
Pirazolac71002-09-0
pirbuterol2,6-Pyridinedimethanol, Alpha6-[[(1,1-38029-10-6U.S.3,786,160AntiasthmaAsthma
dimethylethyl)amino]methyl]-3-hydroxy-,38677-81-5
monoacetate (salt) [CAS]65652-44-0
Pirenoxine1043-21-6
pirenzepine6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one,28797-61-7FR1505795Antiulcer
5,11-dihydro-11-[(4-methyl-1-29868-97-1
piperazinyl)acetyl]-[CAS]
piretanideBenzoic acid, 3-(aminosulfonyl)-4-phenoxy-55837-27-9U.S.4,010,273Antihypertensive,Hypertension,
5-(1-pyrrolidinyl)-[CAS]diureticgeneral
pirfenidone2(1H)-Pyridnone, 5-methyl-1-phenyl-53179-13-8RespiratoryFibrosis,
[CAS]pulmonary
piribedilPyrimidine, 2-[4-(1,3-benzodioxol-5-3605-01-4U.S.3,299,067Vasodilator,Parkinson's
ylmethyl)-1-piperazinyl]-[CAS]peripheraldisease
Piridocaine87-21-8
Pirifibrate55285-45-5
Piritramide302-41-0
Piritrexim72732-56-0
pirlindole1H-Pyrazine[3,2,1-jk]carbazole,16154-78-2SU276060AntidepressantDepression,
2,3,3a,4,5,6-hexahydro-8-methyl-[CAS]60762-57-4general
pirmenol(2-Pyridinemethanol, Alpha-[3-(2,6-61477-94-9U.S.4,112,103AntiarrhythmicTachycardia,
dimethyl-1-piperidinyl)propyl]-68252-19-7supra-
Alpha.phenyl-, cis-(+)-[CAS]ventricular
Piroctone50650-76-5
Piroheptine16378-21-5
Piromidic Acid19562-30-2
piroxicam2H-1,2-Benzothiazine-3-carboxamide, 4-36322-90-4U.S.3,862,319Anti-inflammatory
hydroxy-2-methyl-N-2-pyridinyl-, 1,1-
dioxide [CAS]
piroxicam betadexβ-Cyclodextrin, compd. with 4-hydroxy-2-121696-62-6EP153998Formulation, otherPain,
methyl-N-2-pyridinyl-2H-1,2-benzothiazine-96684-39-8musculo-
3-carboxamide 1,1-dioxide-[CAS]skeletal
piroxicam cinnamate2-Propenoic acid, 3-phenyl-, 2-methyl-3-87234-24-0EP79639Antiarthritic, otherInflammation,
[(2-pyridinylamino)carbonyl]-2H-1,2-general
benzothiazin-4-yl ester, S,S-dioxide [CAS]
Pirozadil54110-25-7
Pirprofen31793-07-4
pitavastatin6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-147526-32-7EP304063Hypolipaemic/Hyper-
fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-,Antiatherosclerosislipidaemia,
calcium salt (2:1), [S-[R*,S*-(E)]]-[CAS]general
pivagabineN-trimethylacetyl-4-aminobutyric acid69542-93-4NeurologicalAnxiety,
general
pivaloyloxymethylButanoic acid, (2,2-dimethyl-1-122110-53-6EP302349Anticancer, otherCancer, lung,
oxopropoxy)methyl ester [CAS]non-small cell
Pivalylbenzhydrazine306-19-4
Pivampicillin33817-20-8
pivampicillin/98445-47-7Penicillin, oralInfection,
pivmecillinamgeneral
Pivcefalexin63836-75-9
pivmecillinam4-Thia-1-azabicyclo[3.2.0]heptane-2-32886-97-8GB1293590Penicillin, oralInfection,
carboxylic acid, 6-[[(hexahydro-1H-azepin-1-general
yl)methylene]amino]-3,3-dimethyl-7-oxo-,
(2,2-dimethyl-1-oxopropoxy)methyl ester,
[2S-(2Alpha,5Alpha,6β)]-[CAS]
pixantroneBenz[g]isoquinoline-5,10-dione, 6,9-bis[(2-144675-97-8EP503537Anticancer, otherCancer,
aminoethyl)amino]-, (2Z)-2-lymphoma,
butenedioate(1:2) [CAS]non-Hodgkin's
pizotifen4-(9,10-dihydro-4H-15574-96-6DE2346747Antimigraine
benzo[4,5]cyclohepta[1,2-b]thien-4-
ylidene)-1-methylpiperidine
Pizotyline15574-96-6
PKI-166Phenol, 4-(4-(((1R)-1-phenylethyl)amino)-187724-61-4Anticancer, otherCancer,
1H-pyrrolo(2,3-d)pyrimidin-6-yl)-[CAS]general
p-Lactophenetide539-08-2
Plafibride63394-05-8
plasminogen activatorPlasminogen activator [CAS]105913-11-9EP151996FibrinolyticInfarction,
myocardial
Plasmocid551-01-9
Platonin3571-88-8
Plaunotol64218-02-6
PLD-118Cyclopentanecarboxylic acid, 2-amino-4-198022-65-0EP805145AntifungalInfection,
methylene-, (1R,2S)-[CAS]Candida,
general
PLD-147(OC-6-43)-Bis(acetato)(1-Anticancer,Cancer,
adamantylamine)ammine-dichloro-alkylatinggeneral
platinum (IV)
pleconaril1,2,4-Oxadiazole, 3-(3,5-dimethyl-4-(3-(3-153168-05-9U.S.5,464,848Antiviral, otherInfection,
methyl-5-isoxazolyl)propoxy)phenyl)-5-respiratory
(trifluoromethyl)-[CAS]tract, general
Plicamycin18379-89-7
p-Methyldiphen-19804-27-4
hydramine
PMS-601WO0001677Antiviral, Anti-HIVInfection,
HIV/AIDS
Pneumococcal
Vaccine, Diphtheria
Conjugate
Pneumococcal
Vaccine, Polyvalent
PNU-288034N-[[(5s)-3[4[(1,1-dioxido-4-Antibiotic, otherInfection,
thiomorpholinyl)3,5-difluorophenyl]-2-oxo-general
5-oxazolidinyl]methyl]acetamide]
Podophyllotoxin518-28-5
polaprezincZinc, bis(N-β-alanyl-L-histidinato-107667-60-7EP303380AntiulcerUlcer,
N3,OAlpha)-, (T-4)-[CAS]duodenal
Poldine Methylsulfate545-80-2
Policresulen9011-2-3
Polidexide9064-92-0
polidocanolPolyethylene glycol monododecyl ether3055-99-0Vasoprotective,Venous
9002-92-0systemicinsufficiency
Poliovirus Vaccine
Inactivated
poly-ADPRT inhibitorsWO9845253Anticancer, otherCancer,
general
Polyestradiol28014-46-2
Phosphate
Polyphenon EPolyphenon E [CAS]188265-33-0Antiviral, otherInfection,
human
papilloma
virus
Polythiazide346-18-9
porfimerPhotofrin [CAS]87806-31-3U.S.4,882,234Anticancer, otherCancer, lung,
non-small cell
Perfiromycin801-52-5
posaconazoleD-threo-Pentitol, 2,5-anhydro-1,3,4-171228-49-2U.S.5,714,490AntifungalInfection,
trideoxy-2-C-(2,4-difluorophenyl)-4-((4-(4-fungal,
(4-(1(1S,2S)-1-ethyl-2-hydroxypropyl)-1,5-general
dihydro-5-oxo-4H-1,2,4-triazol-4-yl)phenyl)-
1-piperazinyl)phenoxy)methyl)-1-(1H-1,2,4-
triazol-1-yl)-[CAS]
Posatirelin7866473-0
potassium chloridePotassium chloride (KCl) [CAS]7447-40-7Formulation, oral,
enteric-coated
Potassium Gluconate299-27-4
Potassium1321-14-8
Gualacolsulfonate
Potassium p-138-84-1
Aminobenzoate
Potassium7722-64-7
Permanganate
Povidone9003-39-8
Povidone-Iodine25655-41-8
PP-1173-Pyridinemethanol, hydrofluoride [CAS]62756-44-9DE2633028Formulation, oral,Unspecified
other
PR-2699(−)-(E)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-AntifungalInfection,
2-ylidene]-1-imidazolylacetonitrilefungal,
general
PR-608(S)-(−)-1-[4,4-bis(4-fluorophenyl)butyl]-4-(2-AntiparkinsonianParkinson's
hydroxy-3-phenylaminopropyl)piperazinedisease
trihydrochloride
Practolol6673-35-4
Prajmaline35080-11-6
Pralidoxime51-15-0
pralnacasan6H-Pyridazino(1,2-a)(1,2)diazepine-1-192755-52-5Antiarthritic,Arthritis,
carboxamide, N-((2R,3S)-2-immunologicalrheumatoid
ethoxytetrahydro-5-oxo-3-
furanyl)octahydro-9-((1-
isoquinolinylcarbonyl)amino)-6,10-dioxo-,
(1S,9S)-[CAS]
pramipexole2,6-Benzothiazolediamine, 4,5,6,7-104632-26-0EP186087AntiparkinsonianParkinson's
tetrahydro-N6-propyl-, (S)-[CAS]disease
pramiracetam1-Pyrrolidineacetamide, N-[2-[bis(1-68497-62-1U.S.4,145,347Cognition enhancerAmnesia
methylethyl)amino]ethyl]-2-oxo-,72869-16-0
monohydrochloride [CAS]75733-50-5
Pramiverin14334-40-8
pramlintide1,2-Dithia-5,8,11,14,17-151126-32-8U.S.5,124,314AntidiabeticDiabetes,
pentaazacycloeicosane, cyclic peptideType I
deriv. [CAS]
Pramoxine140-65-8
pranidipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-99522-79-9EP173126Antihypertensive,Hypertension,
2,6-dimethyl-4-(3-nitrophenyl)-, methyl 3-othergeneral
phenyl-2-propenyl ester, (E)-[CAS]
Pranlukast103177-37-3
pranoprofen5H-[1]Benzopyrano[2,3-b]pyridine-7-acetic52549-17-4Formulation, Ocular disorder,
acid, Alpha-methyl-[CAS]mucosal, topicalgeneral
prasteroneAndrost-5-en-17-one, 3-hydroxy-, (3β)-53-43-0Labour inducer
[CAS]
pratosartan4(3H)-Cycloheptimidazolone, 5,6,7,8-153804-05-8U.S.5,409,947Antihypertensive,Hypertension,
tetrahydro-2-propyl-3-[[2′-(1H-tetrazol-5-renin systemgeneral
yl)[1,1′-biphenyl]-4-yl]methyl]-[CAS]
pravastatin1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-81093-37-0U.S.4,346,227Hypolipaemic/Atherosclerosis
hexahydro-β,delta,6-trihydroxy-2-methyl-8-81131-70-6Antiatherosclerosis
(2-methyl-1-oxobutoxy)-, monosodium
salt, [1S-
[1Alpha(βS*,deltaS*),2Alpha,6Alpha,8β(R*),
8aAlpha]]-[CAS]
Prazepam2955-38-6
praziquantel4H-Pyrazino[2,1-a]isoquinolin-4-one, 2-55268-74-1U.S.4,001,411Schistosomicide
(cyclohexylcarbonyl)-1,2,3,6,7,11b-
hexahydro-[CAS]
prazosinPiperazine, 1-(4-amino-6,7-dimethoxy-2-19216-56-9U.S.4,092,315Antihypertensive,Hypertension,
quinazolinyl)-4-(2-furanylcarbonyl)-[CAS]19237-84-4adrenergicgeneral
Prednicarbate73771-04-7
prednimustinePregna-1,4-diene-3,20-dione, 21-[4-[4-29069-24-7GB1272841Anticancer,
[bis(2-chloroethyl)amino]phenyl]-1-alkylating
oxobutoxy]-11,17-dihydroxy-, (11β)-[CAS]
Prednisolone50-24-8
Prednisolone 21-5626-34-6
Diethylaminoacetate
prednisolone farnesilPregna-1,4-diene-3,20-dione, 11,17-118244-44-3EP332143Antiarthritic, otherArthritis,
dihydroxy-21-[(3,7,11-trimethyl-1-oxo-rheumatoid
2,6,10-dodecatrienyl)oxy]-,
[11β,21(2E,6E)]-[CAS]
Prednisolone Sodium125-02-0
Phosphate
Prednisone53-03-2
Prednival15180-00-4
Prednylidene599-33-7
pregabalinHexanoic acid, 3-(aminomethyl)-5-methyl,148553-50-8AntiepilepticEpilepsy,
(S)-[CAS]general
Pregnan-3α-ol-20-one128-20-1
Premarin +Estra-4,9-dien-3-one, 17-(2-hydroxy-1-74513-62-5MenopausalHormone
trimegestoneoxopropyl)-17-methyl-, [17β(S)]-[CAS]disordersreplacement
therapy
prenalterolPhenol, 4-[2-hydroxy-3-[(1-57526-81-5GB1470039Cardiostimulant
methylethyl)amino]propoxy]-,61260-05-7
hydrochloride, (S)-[CAS]
Prenoxdiazine982-43-4
Prenylamine390-64-7
prezatideCuprate(1-), (N2-(N-glycyl-L-histidyl)-L-130120-57-9VulneraryWound
lysinato)(N2-(N-glycyl-L-histidyl)-L-healing
lysinato(2-))-, hydrogen, [CAS]
Pridinol511-45-5
Prifinium4630-95-9
Prilocaine721-50-6
Primaquine90-34-6
Primidone125-33-7
Prinomastat192329-42-3
PRO-2000U.S.5,614,599Antiviral, anti-HIVInfection,
HIV
prophylaxis
Probenecid57-66-9
Probucol23288-49-5
procainamideBenzamide, 4-amino-N-[2-51-06-9Formulation, otherArrhythmia,
(diethylamino)ethyl]-[CAS]614-39-1general
Procaine59-46-1
Procarbazine671-16-9
procaterol2(1H)-Quinolinone, 8-hydroxy-5-[1-hydroxy-59828-07-8GB1496766Antiasthma
2-[(1-methylethyl)amino]butyl]-60443-17-6
monohydrochloride [CAS]72332-33-3
prochlorperazine10H-Phenothiazine,2-chloro-10-[3-(4-58-38-8Formulation, oral,Nausea and
methyl-1-piperazinyl)propyl]-, (Z)-2-84-02-6othervomiting,
butenedioategeneral
procodazol1H-Benzimidazole-2-propanoic acid [CAS]23249-97-0ES407882Anticancer,Cancer,
immunologicalgeneral
Procyclidine77-37-2
Procymate13931-64-1
Prodipine31314-38-2
Proflavine92-62-6
Progabide62666-20-0
progesteronePrefn-4-ene-3,20-dione [CAS]57-83-0Formulation,Amenorrhoea
transmucosal,
systemic
proglumetacin1H-Indole-3-acetic acid, 1-(4-57132-53-3GB1467568Anti-inflammatoryInflammation,
chlorobenzoyl)-5-methoxy-2-methyl-, 2-(4-59209-40-4general
(3-((4-(benzoylamino)-5-(dipropylamino)-
1,5-dioxopentyl)oxy)propyl)-1-
piperazinyl)ethylester, (+/−)-[CAS]
proglumidePentanoic acid, 4-(benzoylamino)-5-6620-60-6DE1518125AntiulcerUlcer, gastric
(dipropylamino)-5-oxo-, (+/−)-[CAS]
Proheptazine77-14-5
Prolactin9002-62-4
Prolintane493-92-5
Prolonium123-47-7
Promazine58-40-2
Promedol64-39-1
Promegestone34184-77-5
promestrieneEstra-1,3,5(10)-triene, 17-methoxy-3-39219-28-8GB1337198Reproductive/Acne
propoxy-, (17β)-[CAS]gonadal, general
Promethazine60-87-7
Pronethalol54-80-8
propacetamolGlycine, N,N-diethyl-, 4-66532-85-2U.S.4,127,671Formulation,
(acetylamino)phenyl ester [CAS]66532-86-3parenteral, other
propafenone1-Propanone, 1-[2-[2-hydroxy-3-54063-53-5GB1307455AntiarrhythmicFibrillation,
(propylamino)propoxy]phenyl]-3-phenyl-ventricular
[CAS]
Propagermanium12758-40-6
Propallylonal545-93-7
Propamidine104-32-5
propane-1,2-diol1,2-propanediol57-55-6Formulation,Infection,
fungal,
dermal, topicalgeneral
Propanidid1421-14-3
Propantheline50-34-0
Proparacaine499-67-2
Propatyl2921-92-8
propenidazoleethyl trans-Alpha-acetyl-1-methyl-5-76448-31-2AntifungalInfection,
nitroimidazole-2-acrylatetrichomoniasis
propentofylline1H-Purine-2,6-dione, 3,7-dihydro-3-methyl-55242-55-2GB1470220NeuroprotectiveIschaemia,
1-(5-oxohexyl)-7-propyl-[CAS]cerebral
Propicillin551-27-9
Propiomazine362-29-8
Propionic Acid79-09-4
propionyl L-carnitine1-Propanaminium, 3-carboxy-N,N,N-119793-66-7GB2008578Vasodilator,Peripheral
trimethyl-2-(1-oxopropoxy)-, chloride, (R)-20084-19-1peripheralvascular disease
[CAS]
Propipocaine3670-68-6
Propiram15686-91-6
propiverine2,2-diphenyl-2-(1-propoxy)acetic acid (1-54556-98-8UrologicalIncontinence
methylpiperid-4-yl) ester hydrochloride60569-19-9
Propizepine10321-12-7
propofolPhenol, 2,6-bis(1-methylethyl)-[CAS]2078-54-8U.S.4,056,635Anaesthetic,Anaesthesia
injectable
Propoxycaine550-83-4
Propoxyphene469-62-5
propranolol2-Propanol, 1-[(1-methylethyl)amino]-3-(1-318-98-9Formulation, Hypertension,
naphthalenyloxy)-[CAS]525-66-6modified-general
release, <=24 hr
Propylhexedrine101-40-6
Propyliodone587-61-1
Propylthiouracil51-25-5
Propyphenazone479-92-5
Proquazone22760-18-5
Proscillaridin466-06-8
Prostacyclin35121-78-9
Prostaglandin E1745-65-3
Prostaglandin E2363-24-6
Prostaglandin F551-11-1
Prosultiamine59-58-5
Protein C60202-16-6
Protheobromine50-39-5
Prothipendyl303-69-5
Protiofate58416-00-5
Protionamide14222-60-7
protizinic acid10H-Phenothiazine-2-acetic acid, 7-13799-03-6U.S.3,450,698Anti-
methoxy-Alpha,10-dimethyl-, (+/−)-[CAS]inflammatory
Protoanemonin108-28-1
Protoklol136-70-9
Protoporphyrin IX553-12-8
Protriptyline438-60-8
Pro-Urokinase82657-92-9
Proxazole5696-9-3
Proxibarbal2537-29-3
proxigermaniumPropanoic acid, 3,3′-(1,3-dioxo-1,3-12758-40-6FR2005110Antiviral, otherInfection,
digermoxanediyl)bis-[CAS]hepatitis-
B virus
Proxyphylline603-00-9
Prozapine3426-8-2
Prucalopride179474-81-8
prulifloxacin1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-123447-62-1EP315828Quinolone Infection,
carboxylic acid, 6-fluoro-1-methyl-7-[4-[(5-antibacterialrespiratory
methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-tract, general
piperazinyl]-4-oxo-[CAS]
Pseudococaine478-73-9
pseudoephedrine +Benzenemethanol, Alpha-[1-Formulation, Rhinitis,
triprolidine(methylamino)ethyl]-, hydrochloride, [S-modified-allergic,
(R*,R*)]-, mixt. with (E)-2-[1-(4-release, othergeneral
methylphenyl)-3-(1-pyrrolidinyl)-1-
propenyl]pyridine monohydrochloride
[CAS]
pseudoephedrineBenzenemethanol, Alpha-[1-90-82-4,Formulation, oral,Infection,
(methylamino)ethyl]-, [S-(R*,R*)]-[CAS]8054-27-1,otherrespiratory
345-78-8tract, general
Psilocybin520-52-5
PSK-3841Benzonitrile, 4-[3-(4-hydroxybutyl)-4,4-154992-24-2DermatologicalAlopecia,
dimethyl-2,5-dioxo-1-imidazolidinyl]-2-general
(trifluoromethyl)-[CAS]
p-Sulfanilyl-4393-19-5
benzylamine
PT-141U.S.6,051,555Male sexualImpotence
dysfunction
Pteropterin89-38-3
Puromycin53-79-2
PX-121-Methylpropyl 2-mercaptoimidazolylAnticancer, otherCancer,
disulfidegeneral
Pyrantel15686-83-6
Pyrazinamide98-96-4
Pyridinol Carbamate1882-26-4
Pyridostigmine 101-26-8
Bromide
Pyridoxal 5-Phosphate54-47-7
Pyridoxine58-56-0
Pyrilamine91-84-9
Pyrimethamine58-14-0
Pyrinoline1740-22-3
Pyrisuccideanol33605-94-6
Pyrithione1121-30-8
Pyrithyldione77-04-3
Pyritinol1098-97-1
Pyrocatechol120-80-9
Pyrogallol87-66-1
Pyronaridine74847-35-1
Pyrovalerone3563-49-3
Pyroxylin9004-70-0
Pyrrobutamine91-82-7
Pyrrocaine2210-77-7
Pyrrolntrin1018-71-9
Pyrvinium Pamoate3546-41-6
quazepam2H-1,4-Benzodiazepine-2-thione, 7-chloro-36735-22-5U.S.3,845,039Hypnotic/SedativeInsomnia
5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-
trifluoroethyl)-[CAS]
Quercetin117-39-5
quetiapineEthanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-111974-69-7EP240228NeurolepticSchizophrenia
11-yl-1-piperazinyl)ethoxy]-, (E)-2-111974-72-2
butenedioate (2:1) (salt) [CAS]
Quinacillin1596-63-0
quinacrineN-(6-Chloro-2-methoxy-9-acridinyl)-N,N-83-89-6NeurologicalCreutzfeldt-
diethyl-1,4-pentanediamine + 10H-Jakob disease
Phenothiazine-10-propanamine, 2-chloro-
N,N-dimethyl
quinagolideSulfamide, N,N-diethyl-N′-87056-78-8EP77754AntiprolactinHyperprolactin-
(1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-94424-50-7aemia
1-propylbenzo[g]quinolin-3-yl)-,97805-49-7
(3Alpha,4aAlpha,10aβ)-(+/−)-[CAS]
quinapril3-Isoquinolinecarboxylic acid, 2-[2-[[1-82586-55-8EP49605Antihypertensive,Hypertension,
(ethoxycarbonyl)-3-phenylpropyl]amino]-1-85441-61-8renin systemgeneral
oxopropyl]-1,2,3,4-tetrahydro-, [3S-90243-99-5
[2[R*(R*)],3R*]]-[CAS]
quinaprilat3-Isoquinolinecarboxylic acid, 2-[2-[(1-82768-85-2EP46953Antihypertensive,Hypertension,
carboxy-3-phenylpropyl)amino]-1-renin systemgeneral
oxopropyl]-1,2,3,4-tetrahydro-, [3S-
[2[R*(R*)],3R*]]-[CAS]
Quinapyramine20493-41-8
Quinbolone2487-63-0
Quinestradiol1169-79-5
Quinestrol152-43-2
Quinethazone73-49-4
quinfamide2-Furancarboxylic acid, 1-(dichloroacetyl)-62265-68-3U.S.3,997,542Amoebicide
1,2,3,4-tetrahydro-6-quinolinyl ester [CAS]
quinidineCinchonan-9-ol, 6′-methoxy-, (9S)-, sulfate747-45-5Formulation, Arrhythmia,
(1:1) (salt) [CAS]56-54-2modified-general
release, other
Quinine130-95-0
Quinocide525-61-1
Quinupramine31721-17-2
Quinupristin120138-50-3
R-107500cis-2,3,3a,8-tetrahydro-N,N-WO9614320AnxiolyticAnxiety,
dimethyldibenz[c,f]isoxazolo[2,3-a]azepine-general
2-methanamine
R-667WO0204439COPD treatmentEmphysema,
general
rabeprazole1H-Benzimidazole, 2-[[[4-(3-117976-89-3EP268956AntiulcerUlcer,
methoxypropoxy)-3-methyl-2-117976-90-6gastric
pyridinyl]methyl]sulfinyl]-, sodium salt-
[CAS]
racecadotrilGlycine, N-[2-[(acetylthio)methyl]-1-oxo-3-112573-72-5EP38758AntidiarrhoealDiarrhoea,
phenylpropyl]-, phenylmethyl ester, (+/−)-81110-73-8general
[CAS]
Racemethorphan510-53-2
raloxifeneMethanone, [6-hydroxy-2-(4-82640-04-8EP62503OsteoporosisOsteoporosis
hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-84449-90-1treatment
piperidinyl)ethoxy]phenyl]-, hydrochloride
[CAS]
raltitrexedL-glutamic acid, N-[[5-[[(1,4-dihydro-2-112887-68-0EP239362Anticancer,Cancer,
methyl-4-oxo-6-antimetabolitecolorectal
quinazolinyl)methyl]methylamino]-2-
thienyl]carbonyl]-[CAS]
ramatroban9H-Carbazole-9-propanoic acid, 3-[[(4-116649-85-5EP242518Antiallergic,Rhinitis,
fluorophenyl)sulfonyl]amino]-1,2,3,4-non-asthmaallergic,
tetrahydro-, (R)-[CAS]perennial
Ramifenazone3615-24-5
ramiprilCyclopenta[b]pyrrole-2-carboxylic acid, 1-87269-97-4EP79022Antihypertensive,Heart failure
[2-[[1-(ethoxycarbonyl)-3-87333-19-5renin system
phenylpropyl]amino]-1-
oxopropyl]octahydro-, [2S-
[1[R*(R*)],2Alpha,3aβ,6aβ]]-[CAS]
ramosetronMethanone, (1-methyl-1H-indol-3-132907-72-3EP381422AntiemeticNausea and
yl)(4,5,6,7-tetrahydro-1H-benzimidazol-5-132036-88-5vomitting,
yl)-, monohydrochloride, (R)-[CAS]general
Ramot project No. U.S.5,730,992DermatologicalUnspecified
1097
Ranimustine58994-96-0
ranitidine1,1-Ethenediamine, N-[2-[[[5-66357-35-5U.S.4,128,658AntiulcerUlcer,
[(dimethylamino)methyl]-2-duodenal
furanyl]methyl]thio]ethyl]-N′-methyl-2-nitro-
[CAS]
ranitidine bismuth1,2,3-Propanetricarboxylic acid, 2-hydroxy-128345-62-0EP533281AntiulcerUlcer,
citratebismuth(3+) salt (1:1), compd. with N-(2-duodenal
(((5-((dimethylamino)methyl)-2-
furanyl)methyl)thio)ethyl)-N′-methyl-2-ni1-
ethenediamine (1:1)-[CAS]
ranolazine1-Piperazineacetamide, N-(2,6-95635-55-5EP126449AntianginalAngina,
dimethylphenyl)-4-[2-hydroxy-3-(2-95635-56-6general
methoxyphenoxy)propyl]-, (+/−)-[CAS]
Ranpirnase133737-96-9
Rapacuronium156137-99-4
rasagiline1H-Inden-1-amine, 2,3-dihydro-N-2-161735-79-1U.S.5,457,133AntiparkinsonianParkinson's
propynyl-, (R)-, [CAS]disease
Raubasine483-04-5
ravuconazoleBenzonitrile, 4-[2-[(1R,2R)-2-(2,4-182760-06-1AntifungalInfection,
difluorophenyl)-2-hydroxy-1-methyl-3-(1H-meningitis,
1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-[CAS]general
raxofelast2-Benzofuranacetic acid, 5-(acetyloxy)-2,3-128232-14-4U.S.4,999,350SymptomaticNephropathy,
dihydro-4,6,7-trimethyl-, (+)-[CAS]antidiabeticdiabetic
razoxane2,6-Piperazinedione, 4,4′-(1-methyl-1,2-21416-67-1,GB1234935Anticancer, otherCancer,
ethanediyl)bis-[CAS]21416-87-5general
RC-529Tetradecanoic acid (1R)-1-(2-((2-((2-deoxy216014-46-9Immunostimulant,Vaccine
3-O-((3R)-1-oxo-3-((1-otheradjunct
oxotetradecyl)oxy)tetradecyl)amino-4-O-
phosphono-β-D-
glucopyranosyl)oxy)ethyl)amino)-2-
oxoethyl)dodecyl ester, compd. with N,N-
diethylethanamine (1:1) [CAS]
rebamipide4-Quinolinepropanoic acid, Alpha-[(4-90098-04-7DE3324034Antiulcer
chlorobenzoyl)amino]-1,2-dihydro-2-oxo-
[CAS]
rebimastatL-Valinamide, N-((2S)-2-mercapto-1-oxo-4-259188-38-0Anticancer, otherCancer, lung,
(3,4,4-trimethyl-2,5-dioxo-1-non-small cell
imidazolidinyl)butyl)-L-leucyl-N,3-dimethyl-
[CAS]
reboxetimeMorpholine, 2-[(2-71620-89-8,U.S.4,229,449AntidepressantDepression,
ethoxyphenoxy)phenylmethyl]-, (R*,S*)-98769-81-4general
[CAS]
Remacemide128298-28-2
remifentanil1-Piperidinepropanoic acid, 4-132539-07-2,EP383579Analgesic, otherPain, general
(methoxycarbonyl)-4-((1-132875-61-7
oxopropyl)phenylamino)-methyl ester-
[CAS]
reminetantTricyclo[3.3.1.13,7]decane-2-carboxylic146362-70-1EP699438NeurolepticSchizophrenia
acid, 2-[[[1-(7-chloro-4-quinolinyl)-5-(2,6-
dimethoxyphenyl)-1H-pyrazol-3-
yl]carbonyl]amino]-[CAS]
Remoxipride80125-14-0
renzaprideBenzamide, 4-amino-N-1-109872-41-5JP58188885GastroprokineticIrritable bowel
azabicyclo[3.3.1]non-4-yl-5-chloro-2-88721-77-1syndrome
methoxy-[CAS]
repaglinideBenzoic acid, 2-ethoxy-4-[2-[[3-methyl-1-[2-135062-02-1WO9300337AntidiabeticDiabetes,
(1-piperidinyl)phenyl]butyl]amino]-2-Type II
oxoethyl]-, (S)-[CAS]
repertaxin L-lysine salt2(R)-4-IsobutylphenylpropionylWO0024710CardiovascularReperfusion
methanesulfonamide L-lysine saltinjury
repinotan1,2-Benzisothiazol-3(2H)-one, 2-(4-(((3,4-144980-29-0U.S.5,137,901NeuroprotectiveIschaemia,
dihydro-2H-1-benzopyran-2-144980-77-8cerebral
yl)methyl)amino)butyl)-, 1,1-dioxide,
monohydrochloride [CAS]
repirinast4H-Pyrano[3,2-c]quinoline-2-carboxylic73080-51-0U.S.4,298,610Antiasthma
acid, 5,6-dihydro-7,8-dimethyl-4,5-dioxo-,
3-methylbutyl ester [CAS]
Reposal3625-25-0
reproterol1H-Purine-2,6-dione, 7-[3-[[2-(3,5-13055-82-8FRM5969AntiasthmaAsthma
dihydroxyethyl]amino]propyl]-3,7-dihydro-54063-54-6
1,3-dimethyl-[CAS]
Rescimetol73573-42-9
Rescinnamine24815-24-5
Reserpiline131-02-2
Reserpine50-55-5
Resibufogenin465-39-4
resiquimod1H-Imidazo(4,5-c)quinoline-1-144875-48-9U.S.5,389,640Antiviral, otherInfection,
ethanol(ethoxymethyl)-Alpha, Alpha-hepatitis-
dimethyl-[CAS]C virus
Resorcinol108-46-3
Reteplase133652-38-7
retigabineCarbamic acid, (2-amino-4-(((4-150812-12-7DE4200259AntiepilepticEpilepsy,
fluorophenyl)methyl)amino)phenyl)-, ethylgeneral
ester [CAS]
retinoic acidRetinoic acid [CAS]302-79-4Formulation, Cancer,
parenteral,leukaemia,
otheracute
myelogenous
RevimidU.S.6,281,230Anticancer, otherCancer,
myelome
R-flurbiprofen[1,1′-Biphenyl]-4-acetic acid, 2-fluoro-5104-49-4Anticancer, otherCancer,
Alpha-methylprostate
Rho (D) Immune
Globulin (Human)
Rho-kinase inhibitorsWO0156988AntiasthmaUnspcified
ribavirin1H-1,2,4-Triazole-3-carboxamide, 1-β-D-36791-04-5U.S.4,122,771Antiviral, otherInfection,
ribofuranosyl-[CAS]haemorrhagic
fever
Riboflavin146-17-8
ribostamycinD-Streptamine, O-2,6-diamono-2,6-dideoxy-25546-65-0GB1254883AminoglycosideInfection,
Alpha-D-glucopyranosyl-(1-4)-O-[β-D-antibioticgeneral
ribofuranosyl-(1-5)]-2-deoxy-[CAS]
Ricinoleic Acid141-22-0
Ridogrel110140-89-1
rifabutinRifamycin XIV, 1′,4-didehydro-1-deoxy-1,4-72559-06-9U.S.4,219,478AntimycobacterialInfection,
dihydro-5′-(2-methylpropyl)-1-oxo-[CAS]Mycobacterium
avium complex
rifalazilRifamycin VIII, 1′,4-didehydro-1-deoxy-1,4-129791-92-0EP366914AntimycobacterialInfection,
dihydro-3′-hydroxy-5′-[4-(2-methylpropyl)-129791-94-2tuberculosis
1-piperazinyl]-1-oxo-[CAS]133633-12-2
rifametaneRifamycin, 3-[[[1-94168-98-6EP119571AntimycobacterialInfection,
(diethylamino)ethylidene]hydrazono]methyl]-general
[CAS]
RifamideRifamycin, 3-[[(4-methyl-1-2750-76-7
rifampicin +piperazinyl)imino]methyl]-, mixt. with 5-61498-94-0Formulation, Infection,
trimethoprim[(3,4,5-trimethoxyphenyl)methyl]-2,4-fixed-dosegeneral
pyrimidinediamine [CAS]combinations
Rifampin13292-46-1
Rifamycin SV6998-60-3
rifapentineRifamycin, 3-[[(4-cyclopentyl-1-61379-65-5DE2608218Antibiotic, otherInfection,
piperazinyl)imino]methyl]-[CAS]tuberculosis
rifaximinEpoxypentadeca[1,11,13]trienimino)benzo80621-81-4GB2079270Antibiotic, otherInfection, GI
furo[4,5-e]-pyrido[1,2-a]benzimidazole-tract
1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-
tetrahydroxy-27-methoxy-
2,4,11,16,20,22,25,26-octamethyl-, [2S-
(2R*,16Z,18E,20R*,22S*,23S*,24S*,25R*,
26S*,27R*,28E)]
rifaximine cream4-deoxy-4′-methylpyrido[1′,2′-80621-81-4BE888895Formulation, Infection,
1,2]imidoazo[5,4-c]rifamycin SVdermal, topicaldermatological
Rilmazafone99593-25-6
rilmenidine2-Oxazolamine, N-(dicyclopropylmethyl)-54187-04-1DE2362754Antihypertensive,Hypertension,
4,5-dihydro-[CAS]54249-57-9adrenergicgeneral
riluzole2-Benzothiazolamine, 6-(trifluoromethoxy)-1744-22-5EP50551NeuroprotectiveAmyotrophic
[CAS]lateral
sclerosis
Rimantadine13392-28-4
rimazolium4H-Pyrido[1,2-a]pyrimidinium, 3-28610-84-6DE2461349Analgesic, NSAID
(ethoxycarbonyl)-6,7,8,9-tetrahydro-1,6-35615-72-6
dimethyl-4-oxo-, [CAS]
rimexoloneAndrosta-1,4-dien-3-one, 11-hydroxy-16,17-49697-38-3DE2301317OphthalmologicalInflammation,
dimethyl-17-(1-oxopropyl)-,ocular
(11β,16Alpha,17β)-[CAS]
Rimiterol32953-89-2
rimonabant1H-Pyrazole-3-carboxamide, 5-(4-158681-13-1U.S.5,624,941Anorectic/Obesity
chlorophenyl)-1-(2,4-dichlorophenyl)-4-Antiobesity
methyl-N-1-piperidinyl-,
monohydrochloride [CAS]
riodoxol1,3-Benzenediol, 2,4,6-triiodo-[CAS]19403-92-0U.S.3,755,251Antiviral, other
Rioprostil77287-05-9
risedronatePhosphonic acid, (1-hydroxy-2-(3-115436-72-1EP304961OsteoporosisPagets disease
pyridinyl)ethylidene)bis-, monosodium salttreatment
Risedronic Acid105492-24-6
risperidone4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-106266-06-2EP196132Neuroleptic,Schizophrenia
fluoro-1,2-benzisoxazol-3-yl)-1-formulation,
piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-optimized,
methyl-[CAS]microencapsulate
Ritanserin87051-43-2
Ritipenem84845-57-8
ritodrineBenzenemethanol, 4-hydroxy-Alpha-[1-[[2-23239-51-2U.S.3,410,944Labour inhibitorLabour, preterm
(4-hydroxyphenyl)ethyl]amino]ethyl]-,26652-09-5
(R*,S*)-[CAS]
ritonavir2,4,7,12-Tetraazatridecan-13-oic acid, 10-155213-67-5WO9414436Antiviral, anti-HIVInfection, HIV/
hydroxy-2-methyl-5-(1-methylethyl)-1-(2-(1-AIDS
methylethyl)-4-thiazolyl)-3,6-dioxo-8,11-
bis(phenylmethyl)-, 5-thiazolyl-methyl
ester, (5S-(5R*,8R*,10R*,11R*))-[CAS]
Rituximab174722-31-7
rivastigmineCarbamic acid, ethylmethyl-, 3[1-123441-03-2DE3805744Cognition enhancerAlzheimer's
(dimethylamino)ethyl]phenyl ester, (S)-129101-54-8disease
[CAS]
rizatriptan1H-Indole-3-ethanamine, N,N-dimethyl-5-145202-66-0EP497512AntimigraineMigraine
(1H-1,2,4-triazol-1-ylmethyl)-, [CAS]159776-67-7
144034-80-0
RJR-24033-Buten-1-amine, N-methyl-4-(3-pyridinyl)-,183288-99-5Cognition enhancerAlzheimer's
(3E)-, (2E)-2-butenedioate (1:1) [CAS]disease
RNA Stealth5-FormyluridineAntiviral, otherInfection,
Nucleosideshepatitis-
C virus
Ro-00948892′,3′-Di-O-acetyl-5′-vinylcytidineAnticancer,Cancer,
antimetabolitegeneral
Ro-61-17902-Pyridinesulfonamide, N-[6-(2-180384-56-9WO9619459CardiovascularHaemorrhage,
hydroxyethoxy)-5-(2-methoxyphenoxy)-2-subarachnoid
[2-(1H-tetrazol-5-yl)-4-pyridinyl]-4-
pyrimidinyl]-5-methyl-[CAS]
Rociverine53716-44-2
rocuroniumPyrrolidinium, 1-104855-17-6EP287150Muscle relaxantMuscle
[(2β,3Alpha,5Alpha,16β,17β)-17-104884-91-5spasm,
(acetyloxy)-3-hydroxy-2-(4-119302-91-9general
morphonlinyl)androstan-16-yl]-1-(2-143558-00-3
propenyl)-, bromide-[CAS]
rofecoxib2(5H)-Furanone, 4-(4-162011-90-7U.S.5,474,995Analgesic, NSAIDArthritis,
(methylsulfonyl)phenyl)-3-phenyl-[CAS]osteo
roflumilastBenzamide, 3-(cyclopropylmethoxy)-N-162401-32-3WO9501338COPD treatmentChronic
(3,5-dichloro-4-pyridinyl)-4-obstructive
(difluoromethoxy)-[CAS]pulmonary
disease
rokitamycinLeucomycin V, 4B-butanoate 3B-74014-51-0U.S.4,242,504Macrolide antibioticInfection,
propanoate [CAS]general
Rolipram61413-54-5
Rolitetracycline751-97-3
Romurtide78113-36-7
Ronifibrate42597-57-9
ropinirole2H-Indol-2-one, 4-[2-(dipropylamino)ethyl]-91374-20-8EP266033AntiparkinsonianParkinson's
1,3-dihydro-, monohydrochloride-[CAS]91374-21-9disease
ropivacaine2-Piperidinecarboxamide, N-(2,6-84057-95-4EP239710Anaesthetic, localAnaesthesia
dimethylphenyl)-1-propyl-, (S)-[CAS]98717-15-8
Roquinimex84088-42-6
rosaprostolCyclopentaneheptanoic acid, 2-hexyl-5-56695-65-9GB1523355Prostaglandin
hydroxy-[CAS]
Rosaramicin35834-26-5
Rose Bengal632-68-8
rosiglitazone2,4-Thiazolidinedione, 5-((4-(2-methyl-2-122320-73-4U.S.5,002,953AntidiabeticDiabetes,
pyridinylamino)ethoxy)phenyl)methyl)-, (Z)-155141-29-0Type II
2-butenedioate (1:1) [CAS]
rosoxacin3-Quinolinecarboxylic acid, 1-ethyl-1,4-40034-42-2U.S.3,753,993QuinoloneInfection,
dihydro-4-oxo-7-(4-pyridinyl)-[CAS]antibacterialgonorrhoea
rostaporfinTin, dichloro[ethyl 3,4,10,21-tetrahydro-114494-17-6OphthalmologicalMacular
4,9,14,19-tetraethyl-18.19-dihydro-degeneration
3,8,13,18-tetramethyl-20-
phorbinecarboxylato(2-)-
kappaN23,kappaN24,kappaN25,kappaN26]-,
(OC-6-13)-[CAS]
rosuvastatin6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-147098-20-2JP2648897Hypolipaemic/Hyper-
(1-methylethyl)-2-Antitherosclerosislipidaemia,
(methyl(methylsulfonyl)amino)-5-general
pyrimdinyl)-3,5-dihydroxy- (S-(R*,S*-(E)))
[CAS]
rotigotine1-Naphthalenol, 5,6,7,8-tetrahydro-6-99755-59-6U.S.4,564,628AntiparkinsonianParkinson's
[propyl[2-(2-thienyl)ethyl]amino]-, (S)-disease
[CAS]
Rotraxate92071-51-7
Roxarsone121-19-7
roxatidineAcetamide, 2-(acetyloxy)-N-[3-[3-(1-78628-28-1EP24510AntiulcerUlcer, gastric
piperidinylmethyl)phenoxy]propyl]-, [CAS]93793-83-0
roxifibanL-Alanine, 3-(((3-(4-176022-59-6U.S.5,849,736AntithromboticThrombosis,
(aminoiminomethyl)phenyl)-4,5-dihydro-5-general
isoxazolyl)acetyl)amino)-N-
(butoxycarbonyl)-, methyl ester, (R)-,
[CAS]
Roxindol112192-04-8
roxithromycinErythromycin, 9-[O-[(2-80214-83-1EP33255MacrolideInfection,
methoxyethoxy)methyl]oxime][CAS]80214-86-4antibioticgeneral
RPR-109881ABenzenepropanoic acid, β-(((1,1-192573-38-9Anticancer, otherCancer, lung,
dimethylethoxy)carbonyl)amino)-Alpha-general
hydroxy-
(1S,2S,4S,7R,8aR,9aS,10aR,12aS,12bR)-
7,12a-bis(acetyloxy)-1-(benzoyloxy)-
1,3,47,8,9,9a,10,10a,12,12a,12b-
dodecahydro-2-hydroxy-5,13,13-trimethyl-
8-oxo-2,6-methano-2H-cyclodeca(3,4)
cyclopropa (4,5) benz (1,2-b) oxet-4-yl
ester, dihydrate Alpha R, betaS [CAS]
RPR-1304014,9-Ethano-3aH-benz[f]isoindole-3a-210282-69-2WO9829390Anticancer, otherCancer,
carboxylicacid, 1,2,3,4,9,9a-hexahydro-2-general
[2-(2-methoxyphenyl)-1-oxo-2-propenyl]-9-
(4-methylphenyl)-, (3aR,4S,9S,9aR)-rel-
[CAS]
R-roscovitineU.S.6,316,456Anticancer, otherCancer, lung,
non-small cell
RS-0406N′N′-bis(3-hydroxyphenyl)pyridazine-3,6-NeuroprotectiveAlzheimer's
diaminedisease
RSR-13131179-95-8
Rubijervine79-58-3
rubitecan1H-Pyrano(3′,4′:6,7)indolizino(1,2-91421-42-0U.S.6,485,514Anticancer, otherCancer,
b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-pancreatic
hydroxy-10-nitro-, (S)-[CAS]
ruboxistaurin9H,18H-5,21:12,17-169939-94-0SymptomaticRetinopathy,
Dimethenodibenzo(e,k)pyrrolo(3,4-antidiabeticdiabetic
h)(1,4,13)oxadiazacyclohexadecine-
18,20(19H)-dione,9-
((dimethylamino)methyl)-6,7,10,11-
tetrahydro-, (S)-[CAS]
Rufinamide106308-44-5
rufloxacin7H-Pyrido[1,2,3-de]-1,4-benzothiazine-6-101363-10-4EP165375QuinoloneInfection,
carboxylic acid, 9-fluoro-2,3-dihydro-10-(4-102052-47-1antibacterialgeneral
methyl-1-piperazinyl)-7-oxo-[CAS]106017-08-7
rupatadine5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8-156611-76-6EP0577957Antiallergic,Rhinitis,
chloro-6,11-dihydro-11-[1-[(5-methyl-3-non-asthmaallergic,
pyridinyl)methyl]-4-piperidinylidene]-,seasonal
trihydrochloride-[CAS]
Rutin153-18-4
RWJ-544285-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-189448-35-9WO3713772Cephalosporin,Infection,
carboxylic acid, 7-[[(2Z)-(2-amino-5-chloro-injectablebeta-
4-thiazolyl)(hydroxyimino)acetyl]amino]-3-lactamase
[(3-[[(2-aminoethyl)thio]methyl]-4-resistant
pyridinyl]thio]methyl]-4-
pyridinyl]thio]-8-oxo-, (6R,7R)-[CAS]
S-0139Olean-12-en-28-oic acid, 27-[[3-[5-hydroxy-193969-54-9WO9727314CardiovascularIschaemia,
2-[(4-methoxy-1,4-dioxo-2-cerebral
butenyl)]amino]phenyl]-1-oxo-2-
propenyl]oxy]-3-oxo-[CAS]
S-15535Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-146998-34-7CognitionCognitive
5-yl)-4-(2,3-dihydro-1H-inden-2-yl)-[CAS]enhancerdisorder,
general
S-188861-Naphthalenepropanoic acid, 6-(((4-165537-73-5AntithromboticThrombosis,
chlorophenyl)sulfonyl)amino)-5,6,7,8-general
tetrahydro-2-methyl [CAS]
S-347307-chloro-6-sulfamoyl-2-(1H)-quinoleinone-NeuroprotectiveUnspecified
3-phosphonic acid
S-35787β-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-Cephalosporin,Infection,
ethoxyiminoacetamido]-3-(1-(N-injectablegeneral
methylaminopropyl)-1H-imidazo[4,5-
b]pyridinium-4-methyl-3-cephem-4-
carboxylate monosulfate
S-364962-[N-[4-(4-AntiasthmaAsthma
Chlorophenylsulfonylamino)butyl]-N-[3-[(4-
isopropylthiazol-2-
yl)methyloxy]benzyl]sulfamoyl]benzoic
acid
S-365272-[N-[4-(4-AntiasthmaAsthma
Chlorophenylsulfonylamino)butyl]-N-[3-[(4-
(4-cyclobutylthiazol-2-
yl)ethyl]benzyl]sulfamoyl]benzoic acid
S-5751(1R,2R,3S,5S)-7-[2-(5-Antiallergic,Allergy,
Hydroxybenzothiophen-3-ylcarboxamido)-non-asthmageneral
6,6-dimethylbicyclo[3.1.1]hept-3yl]-5(Z)-
heptenoic acid
S-8510Imidazo[4,5-d]pyrano[4,3-b]pyridine,151466-23-8EP556008CognitionAlzheimer's
1,6,7,9-tetrahydro-2-(3-isoxazolyl)-,enhancerdisease
phosphate (1:1) [CAS]
S-89212-Naphthalenecarboxylis acid, 1-(3,4-151165-96-7WO9308155Hypolipaemic/Hypercholest-
dimethoxyphenyl)-3-(3-ethyl-1-oxopentyl)-Antiatherosclerosiserolaemia
4-hydroxy-6,7,8-trimethoxy-, methyl ester
[CAS]
Sabcomeline159912-53-5
Sabeluzole104383-17-7
S-Adenosylmethionine29908-03-0
safinamide(S)-(+)-2-[4-(3-133865-89-1AU711309AntiepilepticEpilepsy,
fluorobenzyloxy)benzylamino]propanamidegeneral
methansulfonate
Salacetamide487-48-9
Salazosulfadimidine2315-8-4
salbutamol1,3-Benzenedimethanol,Alpha1-[[(1,1-18559-94-9EP451745Formulation, Asthma
dimethylethyl)amino]methyl]-4-hydroxy-inhalable,
[CAS]topical, dry powder
Salicin138-52-3
Salicyl Alcohol90-01-7
Salicylamide65-45-2
Salicylamide O-Acetic25395-22-6
Acid
Salicylanilide87-17-2
Salicylic Acid69-72-7
Salicylsilfuric Acid89-45-2
Salinazid495-84-1
salmeterol1,3-Benzenedimethanol, 4-hydroxy-Alpha1-89365-50-4WO9006775AntiasthmaAsthma
[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-,94749-08-3
(±)-1-hydroxy-2-naphthalenecarboxylate
[CAS]
Salsalate552-94-3
Salverine6376-26-7
Samarium 153Sm154427-83-5
Lexidronam
sampatrilatL-Tyrosine, N2-(methylsulfonyl)-L-lysyl-1-129981-36-8EP358398Antihypertensive,Hypertension,
[(2S)-3-amino-2-renin systemgeneral
carboxypropyl]cyclopentanecarbonyl-
[CAS]
Sancycline808-26-4
Saperconazole110588-57-3
sapropterin4(1H)-Pteridinone, 2-amino-6-(1,2-69056-38-8EP191335AntidepressantHyperphenyl-
dihydroxypropyl)-5,6,7,8-tetrahydro-,62989-33-7alaninaemia
dihydrochloride, [6R-[6R*(1R*,2S)]]-
[CAS]
saquinavirButanediamide, N1-[3-[3-[[(1,1-127779-20-8EP432695Antiviral, anti-HIVInfection,
dimethylethyl)amino]carbonyl]octahydro-HIV/AIDS
2(1H)-isoquinolinyl]-2-hydroxy-1-
(phenylmethyl)propyl]-2-[(2-
quinolinylcarbonyl)amino]-, [3S-
[2[1R*(R*),2S*],3Alpha,4aβ,8aβ]]-[CAS]
Saralasin34273-10-4
saredutantBenzamide, N-[4-[4-(acetylamino)-4-142001-63-6EP474561AntiasthmaAsthma
phenyl-1-piperidinyl]-2-(3,4-
dichloropenyl)butyl]-N-methyl-, (S)-[CAS]
sarizotan3-Pyridinemethanamine, N-((3,4-dihydro-177975-08-5AntiparkinsonianParkinson's
2H-1-benzopyran-2-yl)methyl)-5-(4-disease
fluorophenyl)-[CAS]
sarpogrelateButanedioic acid, mono[2-(dimethylamino)-125926-17-2EP398326Antithrombotic
1-[[2-[2-(3-
methoxyphenyl)ethyl]phenoxy]methyl]ethyl]
ester [CAS]
Satigrel111753-73-2
satraplatinPlatinum, bis(acetato-129580-63-8EP328274Anticancer,Cancer,
O)amminedichloro(cyclohexanamine)-,alkylatingprostate
(OC-6-43)-[CAS]
Satumomab144058-40-2
SB-237376N-[3-[[2-(3,4-AntiarrhythmicFibrillation,
dimethoxyphenyl)ethyl]amino]propyl]-4-atrial
nitrobenzamide, HCl
SB-238039(5-(-2-phenylamino-4-pyrimidinyl)-4-)(4-Anticancer, otherCancer,
fluorophenyl)-1-(4-piperidinyl)imidazolegeneral
SB-277011trans-N-[4-[2-(Cyano-1,2,3,4-NeurolepticSchizophrenia
tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-
4-quinolinecarboxamide
Scarlet Red85-83-6
SCH-00013Benzonitrile, 4-[2-[3,6-dihydro-4-(1,4,5,6-217963-18-3EP618204CardiostimulantHeart failure
tetrahydro-6-oxo-3-pyridazinyl)-1(2H)-
pyridinyl]-1-hydroxyethyl]-[CAS]
Sch-23863(2-[10,11-Dihydro-5-ethoxy-5H-dibenzoImmunosuppressantInflammation,
[a,d] cyclohepten-S-yl]-N,N-dimethyl-general
ethanamine
saredutantBenzamide, N-[4-[4-(acetylamino)-4-142001-63-6EP474561AntiasthmaAsthma
phenyl-1-piperidinyl]-2-(3,4-
dichlorophenyl)butyl]-N-methyl-, (S)-[CAS]
sarizotan3-Pyridinemethanamine, N-((3,4-dihydro-177975-08-5AntiparkinsonianParkinson's
2H-1-benzopyran-2-yl)methyl)-5-(4-disease
fluorophenyl)-[CAS]
sarpogrelateButanedioic acid, mono[2-(dimethylamino)-125926-17-2EP398326Antithrombotic
1-[[2-[2-(3-
methoxyphenyl)ethyl]phenoxy]methyl]-
ethyl] ester [CAS]
Satigrel111753-73-2
satraplatinPlatinum, bis(acetato-129580-63-8EP328274Anticancer,Cancer,
O)amminedichloro(cyclohexanamine)-,alkylatingprostate
(OC-6-43)-[CAS]
Satumomab144058-40-2
SB-237376N-[3-[[2-(3,4-AntiarrhythmicFibrillation,
dimethoxyphenyl)ethyl]amino]propyl]-4-atrial
nitrobenzamide, HCl
SB-238039(5-(-2-phenylamino-4-pyrimidinyl)-4-)(4-Anticancer, otherCancer,
fluorophenyl)-1-(4-piperidinyl)imidazolegeneral
SB-277011trans-N-[4-[2-(6-Cyano-1,2,3,4-NeurolepticSchizophrenia
tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-
4-quinolinecarboxamide
Scarlet Red85-83-6
SCH-00013Benzonitrile, 4-[2-[3,6-dihydro-4-(1,4,5,6-217963-18-3EP618204CardiostimulantHeart failure
tetrahydro-6-oxo-3-pyridazinyl)-1(2H)-
pyridinyl]-1-hydroxyethyl]-[CAS]
Sch-23863(2-[10,11-Dihydro-5-ethoxy-5H-dibenzoImmunosuppressantInflammation,
[a,d]cyclohepten-S-yl]-N,N-dimethyl-general
ethanamine
sertaconazole1H-Imidazole, 1-[2-[(7-chlorobenzo[b]thien-99592-32-2EP151477AntifungalInfection,
3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-dermatological
[CAS]
sertindole2-Imidazolidinone, 1-[2-[4-[5-chloro-1-(4-106516-24-9EP392959NeurolepticSchizophrenia
fluorophenyl)-1H-indol-3-yl]-1-
piperidinyl]ethyl]-[CAS]
sertraline1-Naphthalenamine, 4-(3,4-79559-97-0EP30081AntidepressantDepression,
dichlorophenyl)-1,2,3,4-tetrahydro-N-79617-96-2general
methyl-, (1S-cis)-[CAS]79617-97-3
Setastine64294-95-7
sevelamer2-Propen-1-amine polymer with152751-57-0U.S.5,496,545UrologicalRenal failure
(chloromethyl)oxirane, hydrochloride52757-95-6
[CAS]
sevofluranePropane, 1,1,1,3,3,3-hexafluoro-2-28523-86-6DE1954268Anaesthetic,Anaesthesia
(fluoromethoxy)-[CAS]inhalation
SG-2102H-1,4-Benzothiazine-2-acetic acid, 3,4-143162-65-6SymptomaticNeuropathy,
dihydro-3-oxo-4-((4,5,7-trifluoro-2-antidiabeticdiabetic
benzothiazolyl)methyl)-[CAS]
sibutramineCyclobutanemethanamine, 1-(4-106650-56-0GB2098602Anorectic/Obesity
chlorophenyl)-N,N-dimethyl-Alpha-(2-84485-00-7Antiobesity
methylpropyl)-[CAS]
siccanin(4aS-22733-60-4JP37003548Antifungal
(4aAlpha,6aAlpha,11bAlpha,13aR*,
13bAlpha))-1,2,3,4,4a,5,6a,11b,13b-
decahydro-4,4,6a,9-tetramethyl-13H-
benzo[a]furo[2,3,4-mn]xanthen-11-ol
sildenafilPiperazine, 1-((3-(4,7-dihydro-1-methyl-7-171599-83-0WO9428902Male sexualImpotence
oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-139755-83-2dysfunction
5-yl)-4-ethoxyphenyl)sulfonyl)-4-methyl, 2-
hydroxy-1,2,3-propanetricarboxylate-(1:1)
[CAS]
silodosin1H-Indole-7-carboxamide, 2,3-dihydro-1-160970-54-7EP600675UrologicalDysuria
(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-
trifluoroethoxy)phenoxy]ethyl]amino]-
propyl]-[CAS]
Silver Lactate128-00-7
Sch-577901-Piperazineacetonitrile, 4-cyclohexyl-221660-80-6Cognition enhancerAlzheimer's
alpha-[4-[(S)-(4-disease
methoxyphenyl)sulfinyl]phenyl]-[CAS]
Sch-633907H-Pyrazolo[4,3-e][1,2,4]triazolo[1,5-174648-45-4AntiparkinsonianParkinson's
c]pyrimidin-5-amine, 2-(2-furanyl)-7-(3-disease
phenylpropyl)-[CAS]
Scillarenin465-22-5
Scopolamine51-34-3
Scopolamine N-Oxide97-75-6
scopolamineBenzeneacetic acid, Alpha-51-34-3U.S.4,262,003Formulation,Nausea and
(hydroxymethyl)-, 9-methyl-3-oxa-9-transdermal, othervomitting,
azatricyclo[3.3.1.02,4]non-7-yl ester,general
[7(S)-(1Alpha,2β,4β,5Alpha,7β)]-[CAS]
SCS technologyU.S.6,046,188AntiasthmaUnspecified
secalciferol9,10-Secocholesta-5,7,10(19)-triene-55721-11-4EP301167OsteoporosisOsteo-
3,24,25-triol, (3β,5Z,7E,24R)-[CAS]treatmentdystrophy
secnidazole1H-Imidazole-1-ethanol, Alpha,2-dimethyl3366-95-8FRM3270ProtozoacideInfection,
5-nitro-[CAS]trichomoniasis
Secobarbital309-43-3
selegilineBenzeneethanamine, N,Alpha-dimethyl-N-14611-51-9GB1153578Antiparkinsonian
2-propynyl, (R)-[CAS]
Selenomethionine1464-42-2
Sematilide101526-83-4
Semotiadil116476-13-2
seocalcitol1,3-Cyclohexanediol, 5-((1-(6-ethyl-6-134404-52-7WO9100855Anticancer, otherCancer,
hydroxy-1-methyl-2,4-octadienyl)octahydro-liver
7a-methyl-4H-inden-4-ylidene)ethylidene)-
4-methylene-, (1R-
(1Alpha(1R*,2E,4E),3aβ,4E(1R*,3S*,5Z),
7aAlpha))-[CAS]
Sepimostat103926-64-3
seratrodastBenzeneheptanoic acid, zeta-(2,4,5-103187-07-1EP232089AntiasthmaAsthma
trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-,112665-43-7
(+/−)-[CAS]
sertaconazole1H-Imidazole, 1-[2-[(7-chlorobenzo[b]thien-99592-32-2EP151477AntifungalInfection,
3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-derma-
[CAS]tological
sertindole2-Imidazolidinone, 1-[2-[4-[5-chloro-1-(4-106516-24-9EP392959NeurolepticSchizophrenia
fluorophenyl)-1H-indol-3-yl]-1-
piperidinyl]ethyl]-[CAS]
sertraline1-Naphthalenamine, 4-(3,4-79559-97-0EP30081AntidepressantDepression,
dichlorophenyl)-1,2,3,4-tetrahydro-N-79617-96-2general
methyl-, (1S-cis)-[CAS]79617-97-3
Setastine64294-95-7
sevelamer2-Propen-1-amine polymer with152751-57-0U.S.5,496,545UrologicalRenal failure
(chloromethyl)oxirane, hydrochloride52757-95-6
[CAS]
sevofluranePropane, 1,1,1,3,3,3-hexafluoro-2-28523-86-6DE1954268Anaesthetic,Anaesthesia
(fluoromethoxy)-[CAS]inhalation
SG-2102H-1,4-Benzothiazine-2-acetic acid, 3,4-143162-65-6SymptomaticNeuropathy,
dihydro-3-oxo-4-((4,5,7-trifluoro-2-antidiabeticdiabetic
benzothiazolyl)methyl)-[CAS]
sibutramineCyclobutanemethanamine, 1-(4-106650-56-0GB2098602Anorectic/Obesity
chlorophenyl)-N,N-dimethyl-Alpha-(2-84485-00-7Antiobesity
methylpropyl)-[CAS]
siccanin(4aS-22733-60-4JP37003548Antifungal
(4aAlpha,6aAlpha,11bAlpha,13aR*,
13bAlpha))-1,2,3,4,4a,5,6a,11b,13b-
decahydro-4,4,6a,9-tetramethyl-13H-
benzo[a]furo[2,3,4-mn]xanthen-11-ol
sildenafilPiperazine, 1-((3-(4,7-dihydro-1-methyl-7-171599-83-0WO9428902Male sexualImpotence
oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-139755-83-2dysfunction
5-yl)-4-ethoxyphenyl)sulfonyl)-4-methyl, 2-
hydroxy-1,2,3-propanetricarboxylate-(1:1)
[CAS]
silodosin1H-Indole-7-carboxamide, 2,3-dihydro-1-160970-54-7EP600675UrologicalDysuria
(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-
trifluoroethoxy)phenoxy]ethyl]amino]-
propyl]-[CAS]
Silver Lactate128-00-7
Silver Picrate146-84-9
silver sulfadiazineN′-2-pyrimidinylsulfanilamide22199-08-2Anti-infective, otherInfection,
monosilver salt68-35-9general
Simetride154-82-5
Simfibrate14929-11-4
simvastatinButanoic acid, 2,2-dimethyl-, 1,2,3,7,8,8a-79902-63-9U.S.4,444,784Hypolipaemic/Hyper-
hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-Antiatherosclerosislipidaemia,
hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-general
naphthalenyl ester, [1S-
[1Alpha,3Alpha,7β,8β(2S*,4S*),8aβ]]-
[CAS]
Sincalide25126-32-3
Sintropium Bromide79467-19-9
Sisomicin32385-11-8
sitafloxacin3-Quinolinecarboxylic acid, 7-(7-amino-5-127254-12-0EP341493QuinoloneInfection,
azaspiro[2.4]hept-5-yl)-8-chloro-6-fluoro-1-antibacterialgeneral
(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-,
[1R-[1Alpha(S*),2Alpha]]-, hydrate
sitamaquine1,6-Hexanediamine, N,N-diethyl-N′-(6-5330-29-0
methoxy-4-methyl-8-quinolinyl)-[CAS]57695-04-2ProtozoacideInfection,
leishmaniasis
sitaxsentanN-(4-Chloro-3-methyl-5-isoxazolyl)-2-[[4,5-184036-34-8U.S.5,464,853Antihypertensive,Hypertension,
(methylenedioxy)-o-toly]acetyl]-3-otherpulmonary
thiophenesulfonamide
sivelestatGlycine, N-[2-[[[4-(2,2-dimethyl-1-127373-66-4EP347168RespiratorySystemic
oxopropoxy)phenyl]sulfonyl]amino]benzoyl]-inflammatory
[CAS]response
syndrome
SJA-6017Butanamide, 2-[[(4-190274-53-4EP771565OphthalmologicalCataract
fluorophenyl)sulfonyl]amino]-N-[(1S)-1-
formyl-3-methylbutyl,),-3-methyl-, (2S)-
[CAS]
SL-65-14986-Fluoro-9-methyl-2-phenyl-4-pyrrolidin-1-EP607076AnxiolyticAnxiety,
ylcarbonyl)-2,9-dihydro-1H-pyrido[3,4-general
b]indole-1-one
SLV-306(3S,2′R)-3-[1-[2′-(Ethoxycarbonyl)-4′-Antihypertensive,Hypertension,
phenyl-butyl-]cyclopentan-1-diureticgeneral
carbonylamino]-2,3,4,5-tetra-hydro-2-oxo-
1H-benzapin-1-acetic acid
SLV-3082(3H)-Benzoxazolone, 7-(4-methyl-1-269718-83-4AntiparkinsonianParkinson's
piperazinyl)-, monohydrochloridedisease
Sm153 lexidronamSamarate(5-)-153Sm, (((1,2-160369-78-8Analgesic, otherPain, cancer
ethanediylbis(nitrilobis(methylene)))-
tetrakis(phosphonato))(8-)-
N,N′,OP,OP′,OP′′′,OP′′′′)-, pentasodium,
(OC-6-21)-[CAS]
S-Methylmethionine4727-40-6
SMP-300N-(Aminoiminomethyl)-11-chloro-5,6,7,8-AntianginalAngina,
tetrahydro-8-oxo-4H-pyrrolo[3,2,1-general
k][1]benzazocine-2-carboxamide
monomethanesulfonate monohydrate
SN-38(4S)-4,7,11-triethyl-3,4,12,14-tetrahydro-100286-90-6Formulation,Cancer,
4,10-dihydroxy-3,14-dioxo-1H-optimized, colorectal
pyrano[3′,4′:6,7]indolizino[1,2-b]quindin-9-liposomes
yl
SNAP-7941((+)-methyl (4S)-3-[[(3-(4-[3-AnxiolyticAnxiety,
(acetylamino)phenyl]-1-general
piperidinyl)propyl)amino]carbonyl]-4-(3,4-
difluorophenyl)-6-(methoxymethyl)-2-oxo-
1,2,3,4-tetrahydro-5-pyrimidinecarboxylate
hydrochloride)
SOA-1322-Naphthalenecarboxamide, N-[2-[4-143964-80-1Formulation,Asthma
(diphenylmethoxy)-1-piperidinyl]ethyl]-3-inhalable, topical
hydroxy-5-(3-pyridinylmethoxy)-[CAS]
soblidotinL-valinamide, N,N-dimethyl-L-valyl-N-[2-149606-27-0WO9303054Anticancer,Cancer, lung,
methoxy-4-[2-[1-methoxy-2-methyl-2-oxo-othernon-small
3-((2-phenylethyl)amino]proply]-1-cell
pyrrolidinyl]-1-(2-methylpropyl)-4-oxobutyl]-
N-methyl-, [2S-
[1[1R*(R*),2S*],2R*(1S*,2S*)]]-[CAS]
Sobrerol498-71-5
sobuzoxaneCarbonic acid, 1,2-ethanediylbis[(2,6-dioxo98631-95-9EP140327Anticancer, otherCancer,
4,1-piperazinediyl)methylene]bis(2-lymphoma,
methylpropyl) ester [CAS]T-cell
Sodium Arsanilate127-85-5
Sodium Arsphenamine1936-28-3
Sodium Chloride
Sodium Dibunate14992-59-7
Sodium Folate6484-89-5
Sodium149-44-0
Formaldehy
desulfoxylate Sodium1334-74-3
Glycerophosphate
Sodium Hyaluronate
Sodium Iodomethamate519-26-6
Sodium Nitrite7632-00-0
Sodium Nitroprusside14402-89-2
sodium oxybateButyric acid, 4-hydroxy monosodium salt502-85-2PsychostimulantNarcolepsy
[CAS]
Sodium Phenol-1300-51-2
sulfonate
sodium phenylbutyrateButyric acid, 4-phenyl-, sodium salt-[CAS]1716-12-7Formulation, otherHyper-
ammonaemia
sodium phosphateSodium phosphate monobasicU.S.6,162,464Formulation,Surgery
monohydrate + sodium phosphate dibasicoral, otheradjunct
anhydrous
sodium prasterone3β-hydroxy-5-androsten-17-one(sodiumEP380036Formulation,Labour,
sulfatesulfate dihydrate)mucosal, topicalinduction
Sodium Propionate137-40-6
sodium salicylateBenzoic acid, 2-hydroxy-, monosodium54-21-7Formulation, oral,Pain, general
salt [CAS]solubility-enhanced
Sodium Tetradecyl139-88-8
Sulfate
sofalconeAcetic acid, [5-[(3-methyl-2-butenyl)oxy]-2-64506-49-6GB1523241Antiulcer
[3-[4-[(3-methyl-2-butenyl)oxy]phenyl]-1-
oxo-2-propenyl]phenoxy]-[CAS]
Solasulfone133-65-3
solifenacinButanedioic acid compd with (1S)-(3R)-1-242478-38-2UrologicalOveractive
azabicyclo(2.2.2)oct-3-yl 3,4-dihydro-1-bladder
phenyl-2(1H)-isoquinolinecarboxylate (1:1)
[CAS]
SorbinicateD-Glucitol, hexa-3-ptridinecarboxylate6184-06-1BE883352Hypolipaemic/
[CAS]Antiatherosclerosis
Sorbitol50-70-4
Sorivudine77181-69-2
sotalolMethanesulfonamide, N-[4-[1-hydroxy-2-3930-20-9Antiarrhythmic
[(1-methylethyl)amino]ethyl]phenyl]-[CAS]959-24-0
Soterenol13642-52-9
Sozoiodolic Acid554-71-2
spaglumic acidL-Glutamic acid, N-(N-acetyl-L-Alpha-3106-85-2Formulation,Conjunctivitis
aspartyl)-[CAS]80619-64-3mucosal, topical
sparfloxacin3-Quinolinecarboxylic acid, 5-amino-1-110871-86-8EP221463QuinoloneInfection,
cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-antibacterialrespiratory
6,8-difluoro-1,4-dihydro-4-oxo-, cis-[CAS]tract, general
Sparteine90-39-1
SPA-S-843Candicin D, 18-decarboxy-40-demethyl-202748-83-2U.S.5,298,495AntifungalInfection,
3,7-dideoxo-N3′-((dimethylamino)acetyl)-fungal,
18-(((2-general
(dimethylamino)ethyl)amino)carbonyl)-3,7-
dihydroxy-N47-methyl-5-oxo cyclic 15,19-
hemiacetal, comp with L-ascorbic acid
(1:2) [CAS]
Spasmolytol25333-96-4
SPD-7542(1H)-Pyrimidinone, 4-amino-1-(2-160707-69-7U.S.6,228,860Antiviral, anti-HIVInfection,
(hydroxymethyl)-1,3-oxathiolan-4-yl-(2R-HIV/AIDS
cis)-
Spectinomycin1695-77-8
SPI-3394-[3-(4-Oxo-4,5,6,7-tetrahydroindol-CognitionAlzheimer's
yl)propionylamino]benzoic acid ethyl esterenhancerdisease
Spiperone749-02-0
spirapril1,4-Dithia-7-azaspiro[4.4]nonane-8-83647-97-6EP50800Antihypertensive,Hypertension,
carboxylic acid, 7-[2-[[1-(ethoxycarbonyl)-3-renin systemgeneral
phenylpropyl]amino]-1-oxopropyl]-, [8S-
[7[R*(R*)],8R*]]-[CAS]
Spirogermanium41992-23-8
spironolactonePregn-4-ene-21-carboxylic acid, 7-52-01-7EP124147Formulation,Acne
(acetylthio)-17-hydroxy-3-oxo-, Gamma-dermal, topical
lactone,(7Alpha,17Alpha)-[CAS]
SR-121463Benzamide, N-(1,1-dimethylethyl)-4-[[cis-5′-185913-78-4WO9715556CardiostimulantHeart
ethoxy-4-[2-(4-morpholinyl)ethoxy]-2′-failure
oxospiro[cyclohexane-1,3′-[3H]indol]-
1′(2′H)-yl]sulfonyl]-3-methoxy-[CAS]
SR-144190Morpholine, 4-benzoyl-2-(3,4-201152-86-5WO9623787AnxiolyticAnxiety,
difluorophenyl)-2-[2-[4-general
[[(dimethylamino)carbonyl]amino]-4-phenyl-
1-piperidinyl]ethyl]-, (2R)-[CAS]
SR-1461311H-Indole-1-acetic acid, 2-[[[4-(4-chloro-221671-61-0WO9915525Anorectic/Obesity
2,5-dimethoxyphenyl)-5-(2-Antiobesity
cyclohexylethyl)-2-
thiazolyl]amino]carbonyl]-5,7-dimethyl-
[CAS]
SR-271425N-[1-[2-(diethylamino)ethylamino]-7-Anticancer,Cancer,
methoxy-9-oxo-9H-thioxanthen-4-alkylatinggeneral
ylmethyl]formamide
SR-278971H-Indole-1-acetic acid, 2-[[[4-(2-136381-85-6EP432040Anticancer, otherCancer,
chlorophenyl)-2-thiazolyl]amino]carbonyl]-pancreatic
[CAS]
SR-31747Cyclohexanamine, N-(3-(3-chloro-4-132173-07-0EP376850Anticancer, otherCancer,
cyclohexylphenyl)-2-propenyl)-N-ethyl-,myeloma
hydrochloride, (Z)-[CAS]
SR-58611Acetic acid, [[(7S)-7-[[(2R)-2-(3-121524-09-2EP303546GI inflammatory/Irritable
chlorophenyl)-2-hydroxyethyl]amino]-bowel disordersbowel
5,6,7,8-tetrahydro-2-naphthalenyl]oxy]-,syndrome
ethyl ester, hydrochloride [CAS]
SS732U.S.5,385,900Formulation,Infection,
mucosal, topicalocular
SS-750(R)-(−)-2-(2,4-difluorophenyl)-1-U.S.6,083,968AntifungalInfection,
(ethylsulfonyl)-1,1-difluoro-3-(1H-1,2,4-fungal,
triazol-1-yl)-2-propanolgeneral
β-alethinePropanamide, N,N′(dithiodi-2,1-646-08-2Anticancer,Cancer,
ethanediyl)bis(3-amino)-[CAS]immunologicalmyeloma
SSR-149415(2S,4R)-1-[5-chloro-1-[(2,4-WO0155130AntidepressantDepression,
dimethoxyphenyl)sulfonyl]-3-(2-methoxy-general
phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-
hydroxy-N,N-dimethyl-2-pyrrolidone
carboxamide
SSR-1805752-(7-chloro-5-methyl-4-oxo-3-phenyl-4,5-NeuroprotectiveUnspecified
dihydro-3H-pyridazino[4,5-6]indol-1-yl)-
N,N-dimethylacetamide
SSR-181507(3-Exo)-8-benzoyl-N-[[(2S)-7-chloro-2,3-U.S.6,221,879NeurolepticSchizophrenia
dihydro-1,4-benzodioxin-2-yl]methyl]-8-
azabicyclo[3.2.1]octane-3-methanamine
HCl
SSR-591813(5aS,8S,10aR)-5a,6,9,10-tetrahydro,DependenceAddiction,
7H,11H-8,10a-treatmentnicotine
methanopyrido[2′,3′:5,6]pyrano[2,3-
d]azepine
SST-101D-Glucitol, 1,4:3,6-dianhydro-, dinitrate87-33-2Formulation,Angina,
[CAS]transdermal, othergeneral
SSY-726(−)-(R)-3-Methyl-3-(methylsulfonyl)-1-U.S.5,147,886AntifungalInfection,
(1,2,4-triazol-1-yl)-2-[4-(trifluoromethyl)-fungal,
phenyl]-2-butanolgeneral
ST-2001-Propanaminium, 2-(acetyloxy)-3-carboxy-5080-50-2DE3015635Cognition Dementia,
N,N,N-trimethyl-, chloride, (R)-[CAS]enhancersenile,
general
stachyfilinWO9711947Antiviral, otherInfection,
influenza
virus
Stallimycin636-47-5
StampidineU.S.6,350,736Antiviral, anti-HIVInfection,
HIV/AIDS
Stannous15578-26-4
Pyrophosphate
stannsoporfin(OC-6-13)-Dihydrogen dichloro[7,12-106344-20-1HepatoprotectiveHyperbiliru-
diethyl-3,8,13,17-tetramethyl-21H,23H-binaemia
porphine-2,18-dipropanoato(4-)-
N21,N22,N23,N24]stannate(2-)
Stanolone521-18-6
Stanozolol10418-03-8
(2′H form);
302-96-5
(1′H form)
Staph aureus therU.S.6,376,652Genomics-basedInfection,
drug discoveryMRSA
STAT4 inhibitorsWO9629341ImmunosuppressantUnspecified
stavudineThymidine, 2′,3′-didehydro-3′-deoxy-[CAS]3056-17-5EP501511Antiviral, anti-HIVInfection,
HIV/AIDS
Stenbolone5197-58-0
stepronimGlycine, N-[1-oxo-2-[(2-72324-18-6U.S.4,242,354AntitussiveCough
thienylcarbonyl)thio]propyl]-[CAS]
Stibocaptate27279-76-1
Stibophen15489-16-4
Stilbamidine122-06-5
stiripentol1-Penten-3-ol, 1-(1,3-benzodioxol-5-yl)-4,4-49763-96-4AntiepilepticEpilepsy,
dimethyl-[CAS]general
Streptodornase37340-82-2
Streptomycin57-92-1
Streptonicozid5667-71-0
Streptonigrin3930-19-6
Streptozocin18883-66-4
strontium ranelate3-Thiopheneacetic acid, 5-135459-87-9EP415850OsteoporosisOsteoporosis
[bis(carboxymethyl)amino]-2-carboxy-4-treatment
cyano-, strontium salt (1:2)-[CAS]
strontium-89 chlorideStrontium chloride (89SrCl2) [CAS]38270-90-5Analgesic, otherPain, cancer
Succimer304-55-2
Succinimide123-56-8
Succinylcholine55-94-7
Succinylcholine71-27-2
Succinylsulfathiazole116-43-8
Succisulfone5934-14-5
Suclofenide30279-49-3
sucralfateAluminium, hexadeca-μ-54182-58-0JP58208233Antiulcer, Ulcer, general
hydroxytetracosahydroxy(μ8-(1,3,4,6-tetra-Formulation,
O-sulfo-β-D-fructofuranosyl-Alpha-D-oral, other
glucopyranoside tetrakis(hydrogen
sulfato)(8-)))hexadeca-[CAS]
sufentanilPropanamide, N-[4-(methoxymethyl)-1-[2-56030-54-7U.S.3,998,834Analgesic, other,Pain, general
(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl-formulation implant
[CAS]
sulbactam4-Thia-1-azabicyclo[3.2.0]heptane-2-68373-14-8GB2000138Antibiotic, otherInfection,
carboxylic acid, 3,3-dimethyl-7-oxo-, 4,4-general
dioxide, (2S-cis)-[CAS]
sulbactam + ampicillin117060-71-6U.S.4,234,579Antibiotic, otherInfection,
general
sulbenicillin4-Thia-1-azabicyclo[3.2.0]heptane-2-28002-18-8GB1289358Penicillin,Infection,
carboxylic acid, 3,3-dimethyl-7-oxo-6-41744-40-5injectablepseudomonal
[(phenylsulfoacetyl)amino]-, [2S-
[2Alpha,5Alpha,6β(S*)]]-[CAS]
Sulbentine350-12-9
sulbutiaminePropanoic acid, 2-methyl-, dithiobis[3-[1-3286-46-2NeurologicalUnspecified
[[(4-amino-2-methyl-5-67-16-3
pyrimidinyl)methyl]formylamino]-
ethylidene]-3,1-propanediyl] ester [CAS]
sulconazole1H-Imidazole, 1-[2-[[(4-61318-90-9U.S.4,055,652AntifungalInfection,
chlorophenyl)methyl]thio]-2-(2,4-61318-91-0fungal,
dichlorophenyl)ethyl]-, (+/−)-[CAS]general
Sulesomab167747-19-5
Sulfabenzamide127-71-9
Sulfacetamide144-80-9
Sulfachlorpyridazine80-32-0
Sulfachrysoidine485-41-6
Sulfacytine17784-12-2
Sulfadiazine68-35-9
Sulfadicramide115-68-4
Sulfadimethoxine122-11-2
Sulfadoxine2447-57-6
Sulfaethidole94-19-9
Sulfaguanidine57-67-0
Sulfaguanole27031-08-9
Sulfalene152-47-6
Sulfaloxic Acid14376-16-0
Sulfamerazine127-79-7
Sulfameter651-06-9
Sulfamethazine57-68-1
Sulfamethizole144-82-1
Sulfamethomidine3772-76-7
Sulfamethoxazole723-46-6
Sulfamethoxy-80-35-3
pyridazine
Sulfametrole32909-92-5
Sulfamidochrysoidine103-12-8
Sulfamoxole729-99-7
Sulfanilamide63-74-1
Sulfanilic Acid121-57-3
Sulfanilylurea547-44-4
Sulfaperine599-88-2
Sulfaphenazole526-08-9
Sulfaproxyline116-42-7
Sulfapyrazine116-44-9
Sulfapyridine144-83-2
Sulfarside1134-98-1
Sulfarsphenamine618-82-6
sulfasalazineBenzoic acid, 2-hydroxy-5-[[4-[(2-599-79-1Formulation, oral,Arthritis,
pyridinylamino)sulfonyl]phenyl]azo]-[CAS]enteric-coatedrheumatoid
Sulfasomizole632-00-8
Sulfasymazine1984-94-7
Sulfathiazole72-14-0
Sulfathiourea515-49-1
Sulfinalol66264-77-5
Sulfinpyrazone57-96-5
Sulfiram95-05-6
Sulfisomidine515-64-0
Sulfisoxazole127-69-5
Sulfobromophthalein71-67-0
Sulfonethylmethane76-20-0
Sulfoniazide3691-81-4
Sulfonmethane115-24-2
Sulforidazine14759-06-9
Sulfoxone144-75-2
sulindaccis-5-fluoro-2-methyl-1-[(p-38194-50-2U.S.3,725,548Anti-inflammatoryIn-
methylsulfinyl)benzylidene]indene-3-aceticflammation,
acidgeneral
Sulisatin54935-03-4
Sulisobenzone4065-45-6
Sulmarin29334-07-4
Sulmazole73384-60-8
Suloctidil54063-56-8
Sulphan Blue129-17-9
sulpirideBenzamide, 5-(aminosulfonyl)-N-[(1-ethyl-15676-16-1Alimentary/
2-pyrrolidinyl)methyl]-2-methoxy-[CAS]Metabolic, other
silprostone5-Heptenamide, 7-[3-hydroxy-2-(3-hydroxy-60325-46-4U.S.4,024,179ProstaglandinAbortion
4-phenoxy-1-butenyl)-5-oxocyclopentyl]-N-
(methylsulfonyl)-, [1R-
[1Alpha(Z),2β(1E,3R*),3Alpha]]-[CAS]
sultamicillin4-Thia-1-azabicyclo(3.2.0)heptane-2-117060-71-6GB2044255Penicillin, oralInfection,
carboxylic acid, 6-76497-13-7general
((aminophenylacetyl)amino)-3,3-dimethyl-
7-oxo-, (((3,3-dimethyl-7-oxo-4-thia-1-
azabicyclo(3.2.0)hept-2-
yl)carbonyl)oxy)methyl ester, S, S-dioxide,
(2S-
(2.alpha.(2R*,5S*),5,alpha.,6.beta.(S*)))-
[CAS]
Sulthiame61-56-3
sultoprideBenzamide, N-[(1-ethyl-2-53583-79-2FRM5916NeurolepticPsychosis,
pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-general
methoxy-[CAS]
Sultosilic Acid57775-26-5
sumanirole4H-Imidazo[4,5,1-ij]quinolin-2(1H)-one, 5,6-179386-44-8WO9514020AntiparkinsonianParkinson's
dihydro-5-(methylamino)-, (5R)-, (2Z)-2-disease
butenedioate (1:1) [CAS]
sumatriptan1H-Indole-5-methanesulfonamide, 3-[2-103628-46-2EP147107AntimigraineMigraine
(dimethylamino)ethyl]-N-methyl-,103628-48-4
butanedioate (1:1)-[CAS]
SUN-N80751-(4-amino-2,3,5-trimethylphenoxy)-3-(4-[4-NeuroprotectiveInfarction,
(4-fluorobenzyl)phenyl]piperazin-1-cerebral
yl)propan-2(s)-ol dimethanesulfonate
suplatastSulfonium, [3-[[4-(3-ethoxy-2-94055-76-2JP59167564AntiasthmaAsthma
hydroxypropoxy)phenyl]amino]-3-
oxopropyl]dimethyl-, [CAS]
Suprofen40828-46-4
Suramin129-46-4
surfactant TABeractant [CAS]108778-82-1WO9117766Lung SurfactantRespiratory
distress
syndrome,
general
Suriclone53813-83-5
Suxibuzone27470-51-5
SYM-1010U.S.5,830,998AntiapilepticEpilepsy,
general
SYM-2081L-Glutamic acid, 4-methyl-, (4R)-[CAS]31137-74-3Analgesic, otherPain, general
SYM-22074-(Aminophenyl)-1-methyl-6,7-NeuroprotectiveIschaemia,
(methylenedioxy)-N-butyl-1,2-cerebral
dihydrophthalazine-2-carboxamide
Symclosene87-90-1
Syn-12531-cyclopropyl-6-fluoro-8-methoxy-7-[3-(4-QuinoloneInfection,
methyl-1,2,3-triazol-1-yl)pyrrolidin-1-yl]-4-antibacterialperitoneum
oxo-1,4-dihydroquinoline 3-carboxylic acid
Syn-21901-Azetidinesulfonic acid, 3-[[(2E)-[[(1,4-214963-75-4WO9847895Antibacterial,Infection,
dihydro-1,5-dihydroxy-4-oxo-2-othergeneral
pyridinyl)methoxy]imino]-2-
thienylacetyl]amino]-2-methyl-4-oxo,
(2S,3S)-[CAS]
Syn-28693H-1,2,4-Triazol-3-one, 4-(4-(4-((1R,2R)-2-210562-98-4U.S.6,153,616AntifungalInfection,
(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-Aspergillus
(1H-1,2,4-triazol-1-yl)propyl)-1-
piperazinyl)phenyl)-2,4-dihydro-2((4-
(trifluoromethoxy)phenyl)methyl)-[CAS]
Synephrine94-07-5
Syrosingopine84-36-6
T-10951-Propanone, 3-(5-benzofuranyl)-1-(2-209746-59-8EP850948AntidiabeticDiabetes,
hydroxy-6-((6-O-methoxycarbonyl)-β-D-general
glucopyranosyl)oxy)-4-methylphenyl-
[CAS]
T-1249L-Phenylalaninamide, N-acetyl-L-251562-00-2WO9959615Antiviral,Infection,
tryptophyl-L-glutaminyl-L-Alpha-glutamyl-anti-HIVHIV/AIDS
L-tryptophyl-L-Alpha-glutamyl-L-
glutaminyl-L-lysyl-L-isoleucyl-L-threonyl-
L-alanyl-L-leucyl-L-leucyl-L-Alpha-
glutamyl-L-glutaminyl-
L-alanyl-L-glutaminyl-L-isoleucyl-
L-glutaminyl-L-glutaminyl-L-Alpha-
glutamyl-L-lysyl-L-Alpha-glutamyl-
asparaginyl-L-tyrosyl-L-Alpha-glutanyl-L-
leucyl-L-glutaminyl-L-lysyl-L-leucyl-L-
Alpha-aspartyl-L-lysyl-l-trytophyl-L-ananyl-
L-seryl-L-leucyl-L-trytophyl-L-Alpha-
glutamyl-L-tryptophyl-[CAS]
T-39121-cyclopropyl-8-methyl-7-[5-methyl-6-QuinoloneInfection,
(methylamino)-3-pyridinyl]-4-oxo-1,4-antibacterialderma-
dihydro-3-quinolinecarboxylic acidtological
T-588Benzo(b)thiophene-5-methanol, Alpha-((2-142935-03-3EP565965CognitionAlzheimer's
(diethylamino)ethoxy)methyl)-,enhancerdisease
hydrochloride, (R)-[CAS]
T-67Benzenesulfonamide, 2,3,4,5,6-195533-53-0Anticancer, otherCancer,
pentafluoro-N-(3-fluoro-4-methoxyphenyl)-liver
[CAS]
T-82U.S.5,190,951Cognition enhancerAlzheimer's
disease
TA-20052(1H)-Quinolinone, 8-hydroxy-5-[1-hydroxy137888-11-0U.S.4,579,854AntiasthmaAsthma
2-[[2-(4-methoxyphenyl)-1-
methylethyl]amino]ethyl]-,
monohydrochloride, [R-(R*,R*)]-[CAS]
TA-20052(1H)-Quinolinone, 8-hydroxy-5-[1-hydroxyWO189480Formulation, Asthma
2-[[2-(4-methoxyphenyl)-1-inhalable,
methylethyl]amino]ethyl]-,solution
monohydrochloride, [R-(R*,R*)]-[CAS]
TA-9931,5-Benzothiazepin-4(5H)-one, 3-122024-98-0JP01045376AntithromboticPeripheral
(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-vascular
dihydro-8-methyl-2-(4-methylphenyl)-,disease
(2R,3R)-rel-(−)-, (2Z)-2-butenedioate [CAS]
tabimorelin(R)-Alpha-[(E)-5-Amino-N,5-dimethyl-2-170851-70-4ReleasingGrowth
hexenamido]-N-methyl-N-[(R)-Alpha-193079-69-5hormoneshormone
(methylcarbamoyl)phenethyl]-2-deficiency
napthalenepropionamide
tacalcitol9,10-Secocholesta-5,7,10(19)-triene-57333-96-7EP129003AntipsoriasisKeratosis
1,3,24-triol, (1Alpha,3β,5Z,7E,24R)-[CAS]93129-94-3
tacedinalineBenzamide, 4-(acetylamino)-N-(2-112522-64-2DE3613571Anticancer, otherCancer,
aminophenyl)-[CAS]pancreatic
tacrine9-Acridinamine, 1,2,3,4-tetrahydro-[CAS]1684-40-8EP332147CognitionAlzheimer's
321-64-2enhancerdisease
Tacrolimus104987-11-3
tadalafilPyrazino(1′,2′:1,6)pyrido(3,4-b)indole 1,4-171596-29-5U.S.6,143,746Male sexualImpotence
dione, 6-(1,3-benzodioxol-5-yl)-dysfunction
2,3,6,7,12,12a-hexahydro-2-methyl-, (6R-
trans) [CAS]
tafenoquine1,4-Pentanediamine, N4-[2,6-dimethoxy-4-106635-80-7U.S.4,617,394AntimalarialInfection,
methyl-5-[3-(trifluoromethyl)phenoxy]-8-106635-81-8malaria
quinolinyl]-[CAS]80065-55-0
tafluposide179067-42-6WO9612727Anticancer, otherCancer,
general
TAK-375(S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-Hypnotic/Insomnia
[5,4-b]furan-8-yl)]propionamideSedative
TAK-4272-[6-[[3-[4-(Diphenylmethoxy)-Antipruritic/Eczema,
piperidino]imidazo[1,2-b]pyridazin-2-yl-2-allergicatopic
methylpropionic acid dihydrate
TAK-559(E)-4-[4-[5-Methyl-2-phenyl-1,3-oxazol-4-AntidiabeticDiabetes,
yl)methoxy]benzyloxyimino]-4-general
phenylbutyric acid
Taka-Diastase9001-19-8
talampanel7H-1,3-Dioxolo[4,5-161832-65-1U.S.5,639,751AntiepilepticEpilepsy,
h][2,3]benzodiazepine,7-acetyl-5-(4-general
aminophenyl)-8,9-dihydro-8-methyl-,(8R)-
[CAS]
Talampicillin47747-56-8
talaporfinN-[(2S,3S)-18-Carboxy-2-(2-carboxy-220201-34-3Radio/Cancer, lung,
ethyl)-13-ethyl-2,3-dihydro-3,7,12,17-chemosensitizergeneral
tetramethyl-8-vinyl porphyrin-20-yl]acetyl]-
L-aspartic acid
Talastine16188-61-7
Talbutal115-44-6
Talinolol57460-41-0
talipexole4H-Thiazolo[4,5-d]azepin-2-amine, 5,6,7,8-101626-70-4DE3503963AntiparkinsonianSchizophrenia
tetrahydro-6-(2-propenyl)-[CAS]36085-73-1
talnetant4-Quinolinecarboxamide, 3-hydroxy-2-174636-32-9WO9532948GI inflammatory/Irritable bowel
phenyl-N-[(1S)-1-phenylpropyl]-[CAS]bowel disorderssyndrome
talniflumate3-Pyridinecarboxylic acid, 2-[[3-66898-62-2BE858864Anti-inflammatoryInflammation,
(trifluoromethyl)phenyl]amino]-, 1,3-ocular
dihydro-3-oxo-1-isobenzofuranyl ester
[CAS]
taltirelinL-Prolinamide, N-[(hexahydro-1-methyl-2,6-103300-74-9JP61033197NeurologicalDyskinesia,
dioxo-4-pyrimidinyl)carbonyl]-L-histidyl-,general
(S)-[CAS]
tamoxifenEthanamine, 2-[4-(1,2-diphenyl-1-10540-29-1U.S.4,536,516Anticancer,
butenyl)phenoxy]-N,N-dimethyl-, (Z)-hormonal
[CAS]
tamsulosinBenzenesulfonamide, 5-[2-[[2-(2-106133-20-4EP34432Prostate disordersBenign
ethoxyphenoxy)ethyl]amino]propyl]-2-80223-99-0prostatic
methoxy-, (R)-[CAS]hyperplasia
tandospirone4,7-Methano-1H-isoindole-1,3(2H)-dione,112457-95-1EP82402AnxiolyticAnxiety,
hexahydro-2-[4-[4-(2-pyrimidinyl)-1-87760-53-0general
piperazinyl]butyl]-,
(3aAlpha,4β,7β,7aAlpha)-, 2-hydroxy-
1,2,3-propanetricarboxylate (1:1) [CAS]
Tannoform9010-29-1
Taprostene108945-35-3
tariquidar3-Quinolinecarboxamide, N-[2-[[[4-[2-(3,4-206873-63-4WO9817648Radio/Cancer, lung,
dihydro-6,7-dimethoxy-2(1H)-chemosensitizernon-small cell
isoquinolinyl)ethyl]phenyl]amino]carbonyl]-
4,5-dimethoxyphenyl]-[CAS]
TAS-1036-[[2-(Dimethyl-amino)ethyl]amino]-3-174634-09-4WO9532187Anticancer, otherCancer, lung,
hydroxy-7H-indeno[2,1-c]quinolin-7-onenon-small
dihydrochloridecell
Tasosartan145733-36-4
Taurocholic Acid81-24-3
Taurolidine19388-87-5
tazanolastAcetic acid, oxo[[3-(1H-tetrazol-5-82989-25-1U.S.4,778,816Antiasthma
yl)phenyl]amino]-, butyl ester [CAS]
tazarotene3-Pyridinecarboxylic acid, 6-[(3,4-dihydro-118292-40-3EP284288AntipsoriasisPsoriasis
4,4-dimethyl-2H-1-benzothiopyran-6-
yl)ethynyl]-, ethyl ester [CAS]
Tazobactam89786-04-9
tazobactam +JP58225091Antibiotic, otherInfection,
piperacillingeneral
TBC-3711374680-51-0CardiovascularHeart failure
TCH-346N-Methyl-N-propargyl-10-aminomethyl-NeuroprotectiveAmyotrophic
dibenzo(b,f)oxepinlateral
sclerosis
tebipenem5-Hexenoic acid, 4-hydroxy-, polymer with82200-24-6Beta-lactamInfection,
4-ethenyl-1H-imidazole [CAS]antibioticstreptococcal
tecadenosonAdenosine, N-[(3R)-tetrahydro-3-furanyl]-204512-90-3WO9808855AntiarrhythmicTachycardia,
[CAS]supra-
ventricular
tecastemizole1H-Benzimidazol-2-amine, 1-((4-75970-99-9U.S.4,219,559Antiallergic,Rhinitis,
fluorophenyl)methyl)-N-4-piperidinyl-non-asthmaallergic,
[CAS]seasonal
Technetium 99mTc121281-41-2
Bicisate
Technetium 99mTc125224-05-7;
Mertiatide104348-91-6
Technetium 99mTc109581-73-9
Sestamibi
Technetium 99mTc104716-22-5
Teboroxime
Teclothiazide4267-5-4
Teclozan5560-78-1
tedisamilSpiro[cyclopentane-1,9′-90961-53-8EP102833AntiarrhythmicFibrillation,
[3,7]diazabicyclo[3.3.1]nonane], 3′,7′-atrial
bis(cyclopropylmethyl)-[CAS]
Teflurane124-72-1
tegafur2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-17902-23-7GB1168391Anticancer,Cancer,
(tetrahydro-2-furanyl)-[CAS]antimetabolitegeneral
tegafur + uracil2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-74578-38-4EP224885Anticancer,Cancer,
(tetrahydro-2-furanyl)-, mixt. withantimetabolitebreast
2,4(1H,3H)-pyrimidinedione-[CAS]
tegaserodHydrazinecarboximidamine, 2-((5-methoxy-189188-57-6GI inflammatory/Irritable
1H-indol-3-yl)methylene)-N-pentyl-, (Z)-2-145158-71-0bowel disordersbowel
butenedioate [CAS]syndrome
Teicoplanin61036-64-4
telbivudineβ-L-2′-deoxythymidine3424-98-4Antiviral, otherInfection,
hepatitis-
B virus
Telenzepine80880-90-6
telithromycin3-De((2,6-dideoxy-3-C-methyl-3-O-methyl-191114-48-4EP680967Macrolide Infection,
Alpha-L-ribo-hexopyranosyl)oxy)-11,12-antibioticrespiratory
dideoxy-6-O-methyl-3-oxo-12,11-tract,
(oxycarbonyl((4-(4-(3-pyridinyl)-1H-general
imidazol-1-yl)butyl)imino))-[CAS]
telmesteine3,4-Thiazolidinedicarboxylic acid, 3-ethyl122946-43-4COPD treatmentBronchitis,
ester, (R)-[CAS]chronic
telmisartan(1,1′-Biphenyl)-2-carboxylic acid, 4′-((1,4-144701-48-4EP502314Antihypertensive,Hypertension,
dimethyl-2′-propyl(2,6′-bi-1H-renin systemgeneral
benzimidazol)-1′-yl)methyl)-[CAS]
telomerase inhibsWO9941261Anticancer, otherCancer,
general
temazepam7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-846-50-4U.S.3,197,467Hypnotic/Insomnia
phenyl-2H-1,4-benzodiazepin-2-oneSedative
temiverineBenzeneacetic acid, Alpha-cyclohexyl-129927-33-9GB2222828UrologicalPollakisuria
Alpha-hydroxy-, 4-(diethylamino)-1,1-
dimethyl-2-butyny ester, [CAS]
temocapril1,4-Thiazepine-4(5H)-acetic acid, 6-[[1-102090-90-4U.S.4,495,188Antihypertensive,Hypertension,
(ethoxycarbonyl)-3-110221-44-8renin systemgeneral
phenylpropyl]amino]tetrahydro-5-oxo-2-(2-111902-57-9
thienyl)-, [2S-[2Alpha,6β(R*)]]-[CAS]
Temocillin66148-78-5
temoporfinPhenol, 3,3′,3″,3′′′-(2,3-dihydro-21H,23H-122341-38-2EP337601Radio/Cancer, head
porphine-5,10,15,20-tetrayl)tetrakis-[CAS]chemosensitizerand neck
temozolomideImidazo[5,1-d]-1,2,3,5-tetrazine-8-85622-93-1DE3231255Anticancer,Cancer, brain,
carboxamide, 3,4-dihydro-3-methyl-4-oxo-alkylatinggeneral
[CAS]
tenatoprazole1H-Imidazo(4,5-b)pyridine, 5-methoxy-2-113712-98-4U.S.4,808,596AntiulcerUlcer, gastric
(((4-methoxy-3,5-dimethyl-2-
pyridinyl)methyl)sulfinyl)-[CAS]
Tenecteplase191588-94-0
Tenidap120210-48-2
teniposideFuro[3′,4′:6,7]naphtho[2,3-d]-1,3-dioxol-29767-20-2U.S.3,524,844Anticancer, otherCancer,
6(5aH)-one, 5,8,8a,9-tetrahydro-5-(4-lymphoma,
hydroxy-3,5-dimethoxyphenyl)-9-[[4,6-O-(2-non-
thienylmethylene)-β-D-glucopyranosyl]oxy]-,Hodgkin's
[5R-[5Alpha,5aβ,8aAlpha,9β(R*)]]-[CAS]
tenofovirPhosphonic acid, (((1R)-2-(6-amino-9H-147127-20-6Antiviral, anti-HIVInfection,
purin-9-yl)-1-methylethoxy)methyl)-[CAS]HIV/AIDS
tenofovir disoproxil2,4,6,8-tetraoxa-5-phosphanonanedioic202138-50-9Antiviral, anti-HIVInfection,
acid, 5-(2-(6-amino-9H-purin-9-yl)-1-HIV/AIDS
methylethoxymethyl) bis(1-
methylethyl)ester, 5-oxide (R)-, (E)-2-
butenedioate
Tenonitrozole3810-35-3
tenoxicam2H-Thieno[2,3-e]-1,2-thiazine-3-59804-37-4GB1519811Antiarthritic, other
carboxamide, 4-hydroxy-2-methyl-N-2-
pyridinyl-, 1,1-dioxide [CAS]
Tenuazonic Acid610-88-8
teprenone5,9,13,17-Nonadecatetraen-2-one,3796-63-2Antiulcer
6,10,14,18-tetramethyl-[CAS]6809-52-5
terazosinPiperazine, 1-(4-amino-6,7-dimethoxy-2-63074-08-8U.S.4,112,097Antihypertensive,Hypertension,
quinazolinyl)-4-[(tetrahydro-2-63590-64-7adrenergicgeneral
furanyl)carbonyl]-[CAS]70024-40-7
terbinafine1-Naphthalenemethanamine, N-(6,6-78628-80-5EP24587AntifungalInfection,
dimethyl-2-hepten-4-ynyl)-N-methyl-, (E)-91191-71-6derma-
[CAS]tological
terbutaline1,3-Benzenediol, 5-[2-[(1,1-23031-25-6Formulation,Dysmen-
dimethylethyl)amino]-1-hydroxyethyl]-mucosal, topicalorrhoea
[CAS]
terconazolePiperazine, 1-[4-[[2-(2,4-dichlorophenyl)-2-67915-31-5U.S.4,358,449AntifungalVaginitis
(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-
4-yl]methoxy]phenyl]-4-(1-methylethyl)-,
cis-[CAS]
terfenadine1-Piperidinebutanol, Alpha-[4-(1,1-50679-08-8U.S.3,878,217Antiallergic,
dimethylethyl)phenyl]-4-non-asthma
(hydroxydiphenylmethyl)-[CAS]
tergurideUrea, N,N-diethyl-N′-[(8Alpha)-6-37686-84-3EP159522AntiprolactinHyperpro-
methylergolin-8-yl]-[CAS]lactinaemia
Terlipressin14636-12-5
Terodiline15793-40-5
Terofenamate29098-15-5
Terpin80-53-5
tertalolol2-Propanol, 1-[(3,4-dihydro-2H-1-33580-30-2GB1308191Antihypertensive,Hypertension,
benzothiopyran-8-yl)oxy]-3-[(1,1-83688-84-0adrenergicgeneral
dimethylethyl)amino]-, hydrochloride,34784-64-0
(+/−)-[CAS]
tert-Pentyl Alcohol75-85-4
tesaglitazar(2S)-2-ethoxy-3-[4-[2-[4-AntidiabeticDiabetes,
[(methylsulfonyl)oxy]phenyl]ethoxy]phenyl]Type II
propanoic acid
tesmilifeneEthanamine, N,N-Diethyl-2-(4-92981-78-7Radio/Cancer,
(phenylmethyl)phenoxy)-[CAS]chemosensitizerbreast
Testolactone968-93-4
Testosteroneandrost-4-en-3-one, 17-hydroxy-,58-22-0Formulation,Hormone
(17β)-[CAS]5949-44-0transdermal, replacement
systemictherapy
tetrabamate60763-47-5DE2748794AnxiolyticAddiction,
alcohol
Tetrabarbital76-23-3
Tetrabenazine58-46-8
Tetracaine136-47-0
Tetrachloroethylene127-18-4
tetracineBenzoic acid, 4-(butylamino)-, 2-94-24-6Formulation,Pain, general
(dimethylamino)ethyl ester [CAS]transdermal,
systemic
tetracycline2-Naphthacenecarboxamide, 4-60-54-8Formulation, oral,Infection,
(dimethylamino)-1,4,4a,5,5a,6,11,12a-otheroral
octahydro-3,6,10,112,12a-pentahydroxy-6-
methyl-1,11-dioxo-, [4S-
(4Alpha,4aAlpha,5aAlpha,6β,12aAlpha)]-
[CAS]
Tetrahydrozoline84-22-0
Tetrandrine518-34-3
Tetrantoin52094-70-9
Tetrazepam10379-14-3
Tetrofosmin127502-06-1
tetroxoprim2,4-Pyrimidinediamine, 5-[[3,5-dimethoxy-53808-87-0U.S.3,992,379Trimethoprim andInfection,
4-(2-methoxyethoxy)phenyl]methyl]-[CAS]74515-38-1analoguesgeneral
Tevenel ®4302-95-8
tezacitabineCylidine, 2′-deoxy-2′-(fluoromethylene)-,130306-02-4U.S.5,616,702Anticancer,Cancer,
(2E)-[CAS]antimetabolitecolorectal
tezosentan2-Pyridinesulfonamide, N-(6-(2-180384-57-0CardiostimulantOedema,
hydroxyethanoxy)-5-(2-methoxyphenoxy)-2-general
(2-(1H-tetrazol-5-yl)-4-pyridinyl)-4-
pyrimidinyl)-5-(1-methylethyl)-[CAS]
thalidomide1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-50-35-1DermatologicalInfection,
piperidinyl)-[CAS]derma-
tological
Thenaldine86-12-4
Thenyldiamine91-79-2
Theobromine83-67-0
Theofibrate54504-70-0
theophylline1H-Purine-2,6-dione, 3,7-dihydro-1,3-58-55-9Formulation, Asthma
dimethyl-[CAS]5967-84-0modified-
release, other
Thiabendazole148-79-8
Thiacetazone104-06-3
thiacymserineCarbamic acid, [4-(1-methylethyl)phenyl]-,145209-51-4Cognition enhancerAlzheimer's
(3aS,8aS)-3,3a,8,8a-tetrahydro-3a,8-disease
dimethyl-2H-thieno[2,3-b]indol-5-yl ester
[CAS]
Thialbarbital467-36-7
Thiamine59-43-8
Thiamine154-87-0
Thiamine67-16-3
Thiamiprine5581-52-2
Thiamphenicol15318-45-3
Thiamylal77-27-0
Thiazesim5845-26-1
Thiazinamium58-34-4
Thiazolinobutazone54749-86-9
Thiazolsulfone473-30-3
Thibenzazoline6028-35-9
Thiethylperazine1420-55-9
Thimerfonate5964-24-9
Thimerosal54-64-8
Thiobarbital77-32-7
Thiobutabarbital2095-57-0
Thiocarbamizine91-71-4
Thiocarbarsone120-02-5
Thiocolchicine2730-71-4
Thiocresol26445-03-4
Thioctic Acid62-46-4
Thioglycerol96-27-5
Thioguanine154-42-7
ThioimragL-Thiolyrosinyl-glycinyl-glycineAnticancer,Cancer,
immunologicalgeneral
Thiopental71-73-8
Thiopropazate84-06-0
Thioproperazine316-81-4
Thioridazine50-52-2
Thiothixene5591-45-7
ThiovirThiophosphonoformic acidAntiviral, anti-HIVInfection,
HIV/AIDS
Thiphenamil82-99-5
Thiram137-26-8
Thonzylamine63-56-9
Thozalinone655-05-0
Thromboplastin9035-58-9
Thurfyl Nicotinate70-19-9
thymectacinU.S.6,245,750Anticancer, otherCancer,
colorectal
Thymol89-83-8
Thymopentin69558-55-0
Thymyl N-578-20-1
Isoamylcarbamate
Thyropropic Acid51-26-3
Thyroxine51-48-9
Tiadenol6964-20-1
tiagabine3-Piperidinecarboxylic acid, 1-[4,4-bis(3-115103-54-3WO8700171AntiepilepticEpilepsy,
methyl-2-thienyl)-3-butenyl]-, (R)-[CAS]general
Tiamenidine31428-61-2
tianeptineHeptanoic acid, 7-[(3-chloro-6,11-dihydro-72797-41-2GB1269551AntidepressantDepression,
6-methyldibenzo[c,f][1,2]thiazepin-11-66981-73-5general
yl)amino]-, S,S-dioxide [CAS]
tiaprideBenzamide, N-[2-(diethylamino)ethyl]-2-51012-32-9GB1394563Neuroleptic
methoxy-5-(methylsulfonyl)-[CAS]
tiaprofenic acid2-Thiopheneacetic acid, 5-benzoyl-Alpha-33005-95-7GB1331505Antiarthritic, other
methyl-[CAS]
Tiaramide32527-55-2
tiazofurin4-Thiazolecarboxamide, 2-β-D-60084-10-8EP54432Anticancer,Cancer,
ribofuranosyl-[CAS]antimetaboliteleukaemia,
chronic
myelogenous
Tibezonium54663-47-7
tibolone19-Norpregn-5(10)-en-20-yn-3-one, 17-5630-53-5EP389035MenopausalHormone
hydroxy-7-methyl-, (7Alpha,17Alpha)-disordersreplacement
[CAS]therapy
Ticarcillin34787-01-4
ticlopidineThieno[3,2-c]pyridine, 5-[(2-53885-35-1GB1554424Antithrombotic
chlorophenyl)methyl]-4,5,6,7-tetrahydro-55142-85-3
[CAS]
Ticrynafen40180-04-9
tiemonium4-(3-hydroxy-3-phenyl-3-thien-2-yl-propyl)-6252-92-2Antispasmodic
4-methylmorpholinium144-12-7
tigecycline2-Naphthacenecarboxamide, 4,7-220620-09-7EP582829TetracyclineInfection,
bis(dimethylamino)-9-[[[(1,1-general
dimethylethyl)amino]acetyl]amino]-
1,4,4a,5,5a,6,11,12a-octahydro-
3,10,12,12a-tetrahydroxy-1,11-dioxo-,
(4S,4aS,5aR,12aS)-[CAS]
Tigemonam102507-71-1
Tigloidine495-83-0
Tilidine20380-58-9
Tilisolol85136-71-6
tilmacoxibBenzenesulfonamide, 4-(4-cyclohexyl-2-180200-68-4WO9619463Alimentary/Polyp
methyl-5-oxazolyl)-2-fluoro-[CAS]Metabolic, other
tiludronic acidPhosphonic acid, [[(4-89987-06-4EP100718OsteoporosisPaget's
chlorophenyl)thio]methylene]bis-[CAS]treatmentdisease
Timentin86482-18-0Antibiotic, otherInfection,
general
timepidiumPiperidinium, 3-(di-2-thienylmethylene)-5-35035-05-3GB1358446Antispasmodic
methoxy-1,1-dimethyl-, [CAS]
Timiperone57648-21-2
timolol(−)-1-(t-butylamino)-3-[(4-morpholino-1,2,5-26839-75-8GB1253709Antihypertensive,
thiadiazol-3-yl)oxy]-2-propanolmaleate26921-17-5adrenergic,
(1:1) saltantiglaucoma
Timonacic444-27-9
Tin Ethyl Etiopurpurin113471-15-1
tinazoline1H-Indole, 3-[(4,5-dihydro-1H-imidazol-2-62882-99-9U.S.3,376,311Vasodilator,
yl)thio]-[CAS]peripheral
Tinidazole19387-91-8
Tinoridine24237-54-5
Tiocarlide910-86-1
Tioclomarol22619-35-8
tioconazole1H-Imidazole, 1-[2-[(2-chloro-3-61675-64-7U.S.4,062,966AntifungalInfection,
thienyl)methoxy]-2-(2,4-65899-73-2fungal,
dichlorophenyl)ethyl]-[CAS]general
tioproninGlycine, N-(2-mercapto-1-oxopropyl)-1953-02-2U.S.3,246,025UrologicalHomo-
[CAS]cystinuria
tiotropium3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane,136310-93-5EP418716COPD treatmentChronic
7-((hydroxydi-2-thienylacetyl)oxy)-9,9-obstructive
dimethyl-, [CAS]pulmonary
disease
Tioxolone4991-65-5
Tipepidine5169-78-8
tipifarnib2(1H)-Quinolone, 6-(amino(4-192185-68-5WO9716443Anticancer, otherCancer,
chlorophenyl)(1-methyl-1H-imidazol-5-192185-72-1breast
yl)methyl)-4-(3-chlorophenyl)-1-methyl
[CAS]
tipranavirN-[3-[1(R)-[4-Hydroxy-2-oxo-6(R)-(2-174484-41-4Antiviral, anti-HIVInfection,
phenylethyl)-6-propyl-5,6-dihydro-2H-HIV/AIDS
pyran-3-yl]propyl]phenyl]-5-
(trifluoromethyl)pyridine-2-sulfonamide
tiquizium2H-Quinolizinium, 3-(di-2-71731-58-3U.S.4,205,074Antispasmodic
thienylmethylene)octahydro-5-methyl-,
[CAS]
tirapazamine1,2,4-Benzotriazin-3-amine, 1,4-dioxide-20028-80-2DE2204574Radio/Cancer, lung,
[CAS]27314-97-2chemosensitizernon-small
5424-06-6cell
Tiratricol51-24-1
tirilazadPregna-1,4,9(11)-triene-3,20-dione, 21-[4-110101-65-0WO8701706NeuroprotectiveHaemorrhage,
(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-110101-67-2subarachnoid
piperazinyl]-16-methyl-, (16Alpha)-, [CAS]110101-66-1
tirofibanL-Tyrosine, N-(butylsulfonyl)-O-[4-(4-142373-60-2EP478363AntithromboticInfarction,
piperidinyl)butyl]-, [CAS]144494-65-5myocardial
tiropramideBenzenepropanamide, Alpha-55837-29-1DE2503992AntispasmodicMuscle spasm,
(benzoylamino)-4-[2-(diethylamino)ethoxy]-general
N,N-dipropyl-, (+/−)-[CAS]
Titanium Sulfate13825-74-6
tixocortolPregn-4-ene-3,20-dione, 21-[(2,2-dimethyl-55560-96-8
1-oxopropyl)thio]-11,17-dihydroxy-, (11β)-61951-99-3GB1475795Antiallergic, non-Rhinitis,
[CAS]asthma, mucosal,allergic,
topicalgeneral
tizanidine2,1,3-Benzothiadiazol-4-amine, 5-chloro-N-51322-75-9GB1429926Muscle relaxantSpastic
(4,5-dihydro-1H-imidazol-2-yl)-[CAS]paralysis
TLK-199Glycine, L-Gamma-glutamyl-S-168682-53-9U.S.5,679,643Immunostimulant,Myelo-
(phenylmethyl)-L-cysteinyl-2-phenyl-,otherdysplastic
diethyl ester, (2R)-[CAS]syndrome
TLK-286Glycine, L-Gamma-glutamyl-3-[[2-158382-37-7U.S.5,545,621Anticancer, otherCancer,
([bis[bis(2-ovarian
chloroethyl)amino]phosphinyl]oxy)ethyl]-
sulfonyl]-L-alanyl-2-phenyl-, (2R)-[CAS]
TNF-β analogueRU2035185Anticancer,Cancer,
immunologicalgeneral
TNP-470129298-91-5
TO-186Pregna-1,4-diene-3,20-dione, 9-fluoro-5534-02-1Antipruritic/inflamm,
11β,17,21-trihydroxy-16.beta.-methyl-, 17-allergic
butyrate 21-propionate [CAS]
tobramycinO-3-amino-3-deoxy-Alpha-D-32986-56-4Formulation,Infection,
glucopyranosyl-(1,6)-O-(2,6-diamino-2,3,6-inhalable,respiratory
trideoxy-Alpha-D-ribo-hexopyranosyl-(1-4)-topicaltract, general
2-deoxy-[CAS]
tocainidePropanamide, 2-amino-N-(2,6-41708-72-9U.S.4,218,477AntiarrhythmicFibrilation,
dimethylphenyl)-[CAS]ventricular
Tocamphyl5634-42-4
tocladesine8-Chloroadenosine 3′5′-cyclic phosphate41941-56-4Anticancer, otherCancer,
colorectal
Tocoretinate40516-48-1
Todralazine14679-73-3
Tofenacin15301-93-6
tofimilast5H-Pyrazolo[3,4-c]-1,2,4-triazolo[4,3-185954-27-2AntiasthmaAsthma
a]pyridine,9-cyclopentyl-7-ethyl-6,9-
dihydro-3-(2-thienyl)-
tofisopam5H-2,3-Benzodiazepine, 1-(3,4-22345-47-7GB1334271AnxiolyticAnxiety,
dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-general
methyl-[CAS]
Tolazamid1156-19-0
Tolazolin59-98-3
Tolbutamide64-77-7
tolcaponeMethanone, (3,4-dihydroxy-5-134308-13-7EP237929AntiparkinsonianParkinson's
nitrophenyl)(4-methylphenyl)-[CAS]disease
tolciclateCarbamothioic acid, methyl(3-50838-36-3GB1364407AntifungalInfection,
methylphenyl)-, O-(1,2,3,4-tetrahydro-1,4-derma-
methanonaphthalen-6-yl) ester [CAS]tological
Tolcyclamide664-95-9
tolevamerBenzenesulfonic acid, 4-ethenyl-,28038-50-8Antibacterial,Infection,
homopolymer.otherClostridium,
general
tolfenamic acidBenzoic acid, 2[(3-chloro-2-13710-19-5DE1543295Anti-inflammatoryInflammation,
methylphenyl)amino]-[CAS]general
Tolindate27877-51-6
Toliprolol2933-94-0
Tolmetin26171-23-3
Tolnaftate2398-96-1
Tolonidine4201-22-3
Tolonium92-31-9
toloxatone2-Oxazolidinone, 5-(hydroxymethyl)-3-(3-29218-27-7GB1250538Antidepressant
methylphenyl)-[CAS]
Tolperisone728-88-1
Tolpropamine5632-44-0
Tolrestat82964-04-3
tolserineCarbamic acid, (2-methylphenyl)-,145209-30-9CognitionAlzheimer's
(3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-enhancerdisease
trimethylpyrrolo[2,3-b]indol-5-yl ester
[CAS]
tolterodinePhenol, 2-(3-(bis(1-methylethyl)amino)-1-124937-51-5EP325571UrologicalIncontinence
phenylpropyl)-4-methyl-, (R)-[CAS]
tolvaptanBenzamide, N-[4-[(7-chloro-2,3,4,5-150683-30-0EP450097CardiovascularHeart failure
tetrahydro-5-hydroxy-1H-1-benzazepin-1-
yl)carbonyl]-3-methyl]phenyl]-2-methyl-
[CAS]
Tolycaine3686-58-6
TopiramateBeta-D-Fructopyranose, 2,3:4,5-97240-79-4EP533483AntiepilepticEpilepsy,
bis-O-(1-methylethylidene)-,generalized,
sulfamate [CAS]tonic-clonic
topoisomeraseU.S.5,733,880Anticancer, otherCancer,
inhibitorsgeneral
topotecan1H-Pyrano[3′,4′:6,7]indolizino[1,2-123948-87-8EP231122Anticancer,Cancer,
b]quinoline-3,14(4H,12H)-dione, 9-otherovarian
[(dimethylamino)methyl]-4-ethyl-4,10-
dihydroxy-, (S)-[CAS]
torasemide3-Pyridinesulfonamide, N-[[(1-56211-40-6U.S.4,018,929Antihypertensive,Hypertension,
methylethyl)amino]carbonyl]-4-[(3-diureticgeneral
methylphenyl)amino]-[CAS]
torcetapibethyl (2R,4S)-4-[[3,5-bis(trifluoromethyl)262352-17-0Hypolipaemic/Athero-
benzyl](methoxycarbonyl)amino]-2-ethyl-6-Antiatherosclerosissclerosis
(trifluoromethyl)-3,4-dihydroquinoline-
1(2H)-carboxylate
torcitabineβ-L-2′DeoxycytidineAntiviral, otherInfection,
hepatitis-
B virus
toremifeneEthanamine, 2-[4-(4-chloro-1,2-diphenyl-1-89778-26-7EP95875Anticancer,Cancer,
butenyl)phenoxy]-N,N-dimethyl-, (Z)-[CAS]89778-27-8hormonalbreast
Torsemide56211-40-6
Tositumomab208921-02-2
tosulfloxacin1,8-Naphthyridine-3-carboxylic acid, 7-(3-100490-36-6U.S.4,704,459QuinoloneInfection,
amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-115964-29-9antibacterialurinary tract
6-fluoro-1,4-dihydro-4-oxo-, [CAS]
tramadolCyclohexanol, 2-[(dimethylamino)methyl]-1-27203-92-5Analgesic, otherPain, general
(3-methoxyphenyl)-, cis-(+/−)-[CAS]36282-47-0
Tramazoline1082-57-1
trandolapril1H-Indole-2-carboxylic acid, 1-[2-[(1-87679-71-8DE3151690Antihypertensive,Hypertension,
carboxy-3-phenylpropyl)amino]-1-87679-37-6renin systemgeneral
oxopropyl]octahydro-, [2S-52-53-9
[1[R*(R*)],2Alpha,3aAlpha,7aβ]]-[CAS]
tranexamic acidCyclohexanecarboxylic acid, 4-1197-18-8U.S.3,950,405AntifibrinolyticMenstrual
(aminomethyl)-, trans-[CAS]disorder,
general
tranilastBenzoic acid, 2-[[3-(3,4-dimethoxyphenyl)-53902-12-8U.S.3,940,422VulneraryWound
1-oxo-2-propenyl]amino]-[CAS]healing
trans-retinoic acidRetinoic acid [CAS]302-79-4Anticancer, otherCancer,
general
Tranylcypromine155-09-9
trapidil[1,2,4]Triazolo[1,5-a]pyrimidin-7-amine,15421-84-8DD55956Vasodilator,
N,N-diethyl-5-methyl-[CAS]coronary
Trastuzumab180288-69-1
travoprost5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-157283-68-6Formulation,Glaucoma
hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-mucosal, topical
butenyl)cyclopentyl)-, 1-methylethylester
(1R(1Alpha(Z),2β(1E,3R*),3Alpha,5Alpha)
[CAS]
Traxanox58712-69-9
traxoprodil1-Piperidineethanol, 4-hydroxy-Alpha-(4-134234-12-1Analgesic, otherPain,
hydroxyphenyl)-β-methyl-4-phenyl-,188591-67-5general
(AlphaS,βS)-[CAS]
trazodone1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-19794-93-5U.S.4,215,104Antidepressant
[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-25332-39-2
[CAS]
Tremacamra155576-45-7
Trenbolone10161-33-8
Trengestone5192-84-7
treosulfan1,2,3,4-Butanetetrol, 1,4-299-75-2WO8401506Anticancer,
dimethanesulfonate, [S-(R*,R*)]-[CAS]alkylating
trepibutoneBenzenebutanoic acid, 2,4,5-triethoxy-41826-92-0GB1387733Antispasmodic
Gamma-oxo-[CAS]
treprostinolProsta-5,13-dien-1-oic acid, 6,9-epoxy-35121-78-9U.S.6,054,486Formulation,Hypertension,
11,15-dihydroxy-,61849-14-7parenteral, otherpulmonary
[5Z,9Alpha,11Alpha,13E,15S]-[CAS]
tretinoinRetinoic acid [CAS]302-79-4Formulation,Acne
dermal, topical
tretoquinol6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-18559-59-8ZA6802416Antiasthma
[(3,4,5-trimethoxyphenyl)methyl]-, (S)-30418-38-3
[CAS]21650-42-0
TRH24305-27-9
TRI-50bTRI 50b [CAS]226214-49-9AntithromboticThrombosis,
general
Triacetin102-76-1
Triamcinolone76-25-5
Acetonide
Triamcinolone31002-79-6
Benetonide
Triamcinolone5611-51-8
Hexacetonide
triamcinolonePregna-1,4-diene-3,20-dione, 9-fluoro-76-25-5Formulation,Asthma
11,21-dihydroxy-16,17-[(1-124-94-7inhalable, topical
methylethylidene)bis(oxy)]-, (11β,16Alpha)-
[CAS]
Triamterene396-01-0
triapineTriapine [CAS]236392-56-5U.S.6,458,816Anticancer,Cancer,
antimetaboliteleukaemia,
general
Triaziquone68-76-8
triazolam8-chloro-6-(2-chlorophenyl)-1-methyl-4H-28911-01-5U.S.3,980,790Hypnotic/Insomnia
[1,2,4]-triazolo[4,3-a][1,4]benzodiazepineSedative
Tribenoside10310-32-4
Trichlorfon52-68-6
Trichlormethiazide133-67-5
Trichlormethine555-77-1
Trichloroethylene79-01-6
Triclobisonium79-90-3
Triclocarban101-20-2
Triclofenol Piperazine5714-82-9
Triclofos306-52-5
Triclosan3380-34-5
Tricromyl85-90-5
Tridihexethyl Iodide125-99-5
trientine1,2-Ethanediamine, N,N2-bis(2aminoethyl)-,38260-01-4Metabolic andWilson's
[CAS]112-24-3enzyme disordersdisease
Triethanolamine102-71-6
Triethylenemelamine51-18-3
Triethylenephos-545-55-1
phoramide
Triethylene-52-24-4
thiophosphoramide
Trifluoperazine117-89-5
Trifluperidol749-13-3
Triflupromazine146-54-3
trifluridineThymidine, Alpha,Alpha,Alpha-trifluoro-70-00-8U.S.3,201,387Antiviral, otherInfection,
[CAS]herpes
virus, general
triflusalBenzoic acid, 2-(acetyloxy)-4-322-79-2U.S.4,096,252AntithromboticThrombosis,
(trifluoromethyl)-[CAS]general
Trihexyphenidyl52-49-3
triolstaneAndrost-2-ene-2-carbonitrile, 4,5-epoxy-13647-35-3U.S.3,296,255Anticancer,Cancer,
3,17-dihydroxy-, (4Alpha,5Alpha,17β)-hormonalbreast
[CAS]
Trimazosin35795-16-5
trimebutineBenzoic acid, 3,4,5-trimethoxy-, 2-34140-59-5DE2151716Antispasmodic
(dimethylamino)-2-phenylbutyl ester, (Z)-2-39133-31-8
butenedioate (1:1) [CAS]
Trimecaine616-68-2
Trimeprazine84-96-8
Trimetazidine5011-34-7
Trimethadione127-48-0
Trimethaphan68-91-7
Trimethobenzamide138-56-7
Trimethoprim738-70-5
Trimetozine635-41-6
trimetrexate2,4-Quinazolinediamine, 5-methyl-6-52128-35-5U.S.4,391,809AntifungalInfection,
[[(3,4,5-trimethoxyphenyl)amino]methyl]-82952-64-5Pneumocystis
[CAS]jiroveci
trimipramine5H-Dibenz[b,f]azepine-5-propanamine,521-78-8Antidepressant
10,11-dihydro-N,N,β-trimethyl-, (Z)-2-739-71-9
butenedioate (1:1) [CAS]
Trimoprostil69900-72-7
Trioxsalen3902-71-4
tripamideBenzamide, 3-(aminosulfonyl)-4-chloro-N-73803-48-2JP7305585Antihypertensive,Hypertension,
(octahydro-4,7-methano-2H-isoindol-2-yl)-,diureticgeneral
(3aAlpha,4Alpha,7Alpha,7aAlpha)-[CAS]
Triparanol78-41-1
Tripelennamine91-81-6
Triprolidine486-12-4
triptorelinLuteinizing hormone-releasing factor (pig),124508-66-3U.S.4,010,125Releasing hormonesCancer,
6-D-tryptophan-[CAS]57773-63-4prostate
tritiozineMorpholine, 4-[thioxo(3,4,5-35619-65-9U.S.3,862,138Antiulcer
trimethoxyphenyl)methyl]-[CAS]
Tritoqualine14504-73-5
TRK-530Phosphonic acid, [[[4-151425-92-2WO9410181Antiarthritic,Arthritis,
(methylthio)phenyl]thio]methylene]bis-,otherrheumatoid
disodium salt [CAS]
TRK-8202-Propenamide, N-[(5Alpha,6β)-17-152658-17-8WO9315081Antipruritic/Pruritus
(cyclopropylmethyl)-4,5-epoxy-3,14-inflamm,
dihydroxymorphinan-6-yl]-3-(3-furanyl)-N-non-allergic
methyl-, monohydrochloride, (2E)-[CAS]
Troclosene2244-21-5
trofosfamide3-2-(chloroethyl)-2-[bis(2-22089-22-1GB1188159Anticancer,
chloroethyl)amino]tetrahydro-2H-1,3,2-alkylating
oxazaphosphorin 2-oxide
Troglitazone97322-87-7
Troleandomycin2751-9-9
Trolnitrate588-42-1
tromantadineN-(1-adamantyl)-2-(2-dimethylamine53783-83-8DE1941218Antiviral, otherInfection,
ethoxy)acetamideherpes
simplex virus
Tromethamine77-86-1
Tropacine6878-98-4
Tropesin65189-78-8
Tropicamide1508-75-4
tropine1H-Indole-3-acetic acid, 1-(4-65189-78-8Antiarthritic, other
chlorobenzoyl)-5-methoxy-2-methyl-, 2-
carboxy-2-phenylethyl ester, (+/−)-[CAS]
tropisetron1H-Indole-3-carboxylic acid, 8-methyl-8-89565-68-4GB2125398AntiemeticChemotherapy-
azabicyclo[3.2.1]oct-3-yl ester, endo-[CAS]induced
nausea and
vomiting
Trospectomycin88669-04-9
trospium3Alpha-Hydroxyspiro[1AlphaH,5AlphaH-10405-02-4UrologicalPollakisuria
nortropane-8,1′-pyrrolidinium] benzilate
trovafloxacin1,8-Naphthyridine-3-carboxylic acid, 7-(6-147059-72-1U.S.5,164,402QuinoloneInfection,
amino-3-azabicyclo[3.1.0]hex-3-yl)-1-(2,4-147059-75-4antibacterialrespiratory
difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-,tract, general
(1Alpha,5Alpha,6Alpha)-, [CAS]
troxacitabine2(1H)-Pyrimidinone, 4-amino-1-(2-145918-75-8Anticancer,Cancer,
(hydroxymethyl)-1,3-dioxolan-4-yl)-, (2S-otherleukaemia,
cis)-[CAS]acute
myelogenous
Troxerutin7085-55-4
troxipideBenzamde, 3,4,5-trimethoxy-N-3-30751-05-4U.S.3,647,805AntiulcerUlcer, gastric
piperidinyl-, (+/−)-[CAS]99777-81-8
Trypan Red574-64-1
Tryparsamide554-72-3
Tryptophan73-22-3
TSH9002-71-5
TSN-096,14-Ethenomorphinan-7-methanol, 17-52485-79-7Formulation,Pain, cancer
(cyclopropylmethyl)-Alpha-(1,1-transdermal, patch
dimethylethyl)-, 5-epoxy-18,19-dihydro-3-
hydroxy-6-methoxy-Alpha-methyl-,
[5Alpha,7Alpha,(S)]-[CAS]
TU-2100Nonanedioic acid, bis[(2-U.S.6,180,669AntiacneAcne
(ethoxycarbonyl)phenyl] ester
Tuaminoheptane123-82-0
Tubercidin69-33-0
Tubocurarine Chloride57-94-3
tulobuterolBenzenemethanol, 2-chloro-Alpha-[[(1,1-41570-61-0DE2244737AntiasthmaAsthma
dimethylethyl)amino]methyl]-[CAS]
TV-3326N-(Propargyl-(3R)aminoindan-5-yl)-ethylCognitionAlzheimer's
methyl carbamateenhancerdisease
TY-11223Acetic acid, [2-[2,3,3a,6,7,7a-hexahydro-2-140694-43-5U.S.4,837,342AntithromboticUnspecified
hydroxy-1-(3-hydroxy-4,4-dimethyl-1,6-
nonadiynyl)-1H-inden-5-yl]ethoxy]-, [1S-
[1Alpha(R*),2β,3aAlpha,7aAlpha]]-[CAS]
TY-125336,7,8,9-Tetrahydro-2-methyl-5H-U.S.6,258,829AntiarrhythmicUnspecified
cyclohepta[b]pyridine-3-carbonylguanidine
maleate
TYB-3215D-Glucitol, 1,4:3,6-dianhydro-, dinitrate87-33-2Formulation, Angina,
[CAS]modified-general
release, other
Tybamate4268-36-4
tyloxapol4-(1,1,3,3-Tetramethylbutyl)phenol25301-02-4Formulation,Cystic fibrosis
polymer with formaldehyde and oxiraneinhalable, topical
[CAS]
Tymazoline24243-97-8
Tyramine51-67-2
Tyropanoate7246-21-1
Ubenimex58970-76-6
ufenamateBenzoic acid, 2-[[3-67330-25-0BE861852Antipruritic/
(trifluoromethyl)phenyl]amino]-, butyl esterinflamm,
[CAS]non-allergic
Undecylenic Acid112-38-9
Unoprostone12037-36-6
UR-88804-[4-Chloro-5-(3-fluoro-4-Anti-inflammatoryInflammation,
methoxyphenyl)imidazol-1-imidazol-1-general
yl]benzenesulfonamide-[CAS]
Uracil Mustard66-75-1
Uralyt-U1,2,3-Propanetricarboxylic acid, 2-hydroxy-,55049-48-4U.S.4,400,535Urological
potassium sodium salt (5:6,6), hydrate
[CAS]
urapidil2,4(1H,3H)-Pyrimidinedione, 6-[[3-[4-(2-34661-75-1GB1309324Antihypertensive,Hypertension,
methoxyphenyl)-1-adreergicgeneral
piperazinyl]propyl]amino]-1,3-dimethyl-
[CAS]
ureaUrea [CAS]57-13-6Antipsoriasis
Uredepa302-49-8
Urethan51-79-6
Uridine 5′-63-39-8
Triphosphate
Urinastatin80449-31-6
ursodeoxycholic acid3Alpha,7β-dihydroxy-5β-cholan-24-oic128-13-2Formulation, other,Cirrhosis,
acid [CAS]Cirrhosis, primaryprimary
biliary, hepaticbiliary
dysfunction, biliary
calcalus
Ursodiol128-13-2
UshercellU.S.6,063,773Formulation,Contraceptive,
mucosal, topicalfemale
Uzarin20231-81-6
valaciclovirL-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-124832-26-4EP308065Antiviral, otherInfection,
9H-purin-9-yl)methoxy]ethyl ester [CAS]herpes
simplex virus
Valacyclovir124832-26-4
valdecoxibBenzenesulfonamide, 4-(5-methyl-3-181695-72-7U.S.5,859,257Antiarthritic, otherArthritis,
phenyl-4-isoxazolyl)-[CAS]rheumatoid
Valdetamide512-48-1
Valethamate90-22-2
valganciclovirL-Valine, 2-((2-amino-1,6-dihydro-6-oxo-175865-59-5EP694547Antiviral, otherInfection,
9H-purin-9-yl)methoxy)-3-hydroxypropyl175865-60-8cytomegalo-
ester [CAS]virus
Valnoctamide4171-13-5
valomaciclovirL-Valine (3R)-3-((2-amino-1,6-dihydro-6-195156-77-5Antiviral, otherInfection,
oxo-9H-purin-9-yl)methyl)-4-((1-herpes
oxooctadecyl)oxy)butyl ester [CAS]simplex virus
valproatePentanoic acid, 2-propyl-, [CAS]76584-70-8U.S.4,988,731AntiepilepticEpilepsy,
1069-66-5generalized,
tonic-clonic
Valproic Acid99-66-1
Valpromide2430-27-5
valrocemidePentanamide, N-(2-amino-2-oxoethyl)-2-92262-58-3U.S.5,585,358AntiepilepticEpilepsy,
propyl-[CAS]general
valrubicinPentanoic acid, 2-(1,2,3,4,6,11-hexahydro-56124-62-0U.S.4,035,566Anticancer,Cancer,
2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-antibioticbladder
((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-
Alpha-L-lyxo-hexopyranosyl)oxy)-2-
naphthacenyl)-2-oxoethyl ester (2S-cis)-
[CAS]
valsartanL-Valine, N-(1-oxopentyl)-N-[[2′-(1H-137862-53-4EP443983Antihypertensive,Hypertension,
tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-renin systemgeneral
[CAS]
Valspodar121584-18-7
vardenafilPiperazine, 1-(3-(1,4-dihydro-5-methyl(-4-224785-90-4Male sexualSexual
oxo-7-propylimidazo(5,1-f)(1,2,4)-triazin-2-dysfunctiondysfunction,
yl)-4-ethoxyphenyl)sulfonyl)-4-ethyl-[CAS]male, general
varespladibAcetic acid, ((3-(aminooxoacetyl)-2-ethyl-1-172732-68-2EP675110Septic shockSepsis
(phenylmethyl)-1H-indol-4-yl)oxy)-[CAS]172733-42-5treatment
Varicella Virus
Vaccine
vatanidipine3,5-Pyridinedicarboxylic acid, 1,4-dihydro-116308-55-5EP257616NeuroprotectiveHypertension,
2,6-dimethyl-4-(3-nitrophenyl)-, 2-[4-[4-133743-71-2general
(diphenylmethyl)-1-piperazinyl]phenyl]ethyl
methyl ester, [CAS]
VEAU.S.6,007,817Radio/Cancer,
chemosensitizergeneral
vecuroniumPiperidinium, 1-50700-72-6U.S.4,237,126MuscleAnaesthesia,
[(2β,3Alpha,5Alpha,16β,17β)-3,17-relaxantadjunct
bis(acetyloxy)-2-(1-piperidinyl)androstan-
16-yl]-1-methyl-, [CAS]
Velnacrine104675-29-8
venlafaxineCyclohexanol, 1-[2-(dimethylamino)-1-(4-93413-69-5GB2227743AntidepressantDepression,
methoxyphenyl)ethyl]-, [CAS]99300-78-4general
Veralipride66644-81-3
verapamilBenzeneacetonitrile, Alpha-[3-[[2-(3,4-52-53-9Formulation, Hypertension,
dimethoxyphenyl)ethyl]methylamino]propyl]-modified-general
3,4-dimethoxy-Alpha-(1-methylethyl)-release, other
[CAS]
verteporfin23H,25H-Benzo[b]porphine-9,13-129497-78-5U.S.5,238,940OphthalmologicalMacular
dipropanoic acid, 18-ethenyl-4,4a-dihydro-degeneration
3,4-bis(methoxycarbonyl)-4a,8,14,19-
tetramethyl-, monomethyl ester, trans-
[CAS]
vesnarinonePiperazine, 1-(3,4-dimethoxybenzoyl)-4-81840-15-5GB2086896CardiostimulantHeart failure
(1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)-
[CAS]
Vetrabutine3735-45-3
VF-233Benzene carboximidamide, N,3,4,5-95933-74-7U.S.4,623,659CardiovascularReperfusion,
tetrahydroxy-[CAS]injury
VI-0134U.S.6,403,597Male sexualPremature
dysfunctionejaculation
vidarabine9H-Purin-6-amine, 9-β-D-arabinofuranosyl-24356-66-9GB1159290Antiviral, otherInfection,
[CAS]5536-17-4herpes
virus, general
vigabatrin5-Hexenoic acid, 4-amino-[CAS]68506-86-5GB1472525AntiepilepticEpilepsy,
60643-86-9partial
(focal, local)
vilazodone2-Benzofurancarboxamide, 5-[4-[4-(5-163521-12-8EP648767AntidepressantDepression,
cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-general
[CAS]
Viloxazine46817-91-8
Viminol21363-18-8
Vinbarbital125-44-0
Vinblastine865-21-4
vinburnineEburnamenin-14(15H)-one,474-00-0DE1932245Cognition
(3Alpha,16Alpha)-[CAS]4880-88-0enhancer
Vincamine1617-90-9
Vinconate70704-03-9
vincristineVincaleukoblastine, 22-oxo-, sulfate (1:1)2068-78-2EP207831Formulation,Cancer,
(salt)[CAS]57-22-7parenteral, othergeneral
vindesineVincaleukoblastine, 3-(aminocarbonyl)-O4-53643-48-4GB1463575Anticancer, otherCancer,
deacetyl-3-de(methoxycarbonyl)-[CAS]59917-39-4leulaemia,
acute
lymphocytic
vinflunineAspidospermidine-3-carboxylic acid, 4-162652-95-1FR2707988Anticancer, otherCancer,
(acetyloxy)-6,7-didehydro-15-general
[(2R,4R,6S,8S)-4-(1,1-difluoroethyl)-
1,3,4,5,6,7,8,9-octahydro-8-
(methoxycarbonyl)-2,6-methano-2H-
azecino[4,3-b]indol-8-yl]-3-hydroxy-16-
methoxy-1-methyl-, methyl ester,
(2β,3β,4β,5Alpha,12β,19Alpha)-[CAS]
vinorelbineC′-Norvincaleukoblastine, 3′,4′-didehydro-71486-22-1EP10458Anticancer, otherCancer, lung,
4′-deoxy-[CAS]non-small
cell
vinpocetineEburnamenine-14-carboxylic acid, ethyl42971-09-5GB1405127CognitionCognitive
ester, (3Alpha,16Alpha)-[CAS]enhancerdisorder,
general
Vinyl Ether109-93-3
Vinylbital2430-49-1
Viquidil84-55-9
Viridin3306-52-3
Visnadine477-32-7
Vitamin A68-26-8
vitamin B12Vitamin B12 [CAS]68-19-9Formulation,Anaemia,
transmucosal, nasalgeneral
vitamin CL-Ascorbic acid [CAS]50-81-7Formulation, Nutrition
modified-
release, <=24 hr
Vitamin D250-14-6
Vitamin D367-97-0
Vitamin K583-70-5
Vitamins, Prenatal
VLA-4 antagonists((R,S)-4-(4-(Amino-imino-methyl)-phenyl)-EP842943AntiasthmaAsthma
3-((4-biphenylyl)-methyl)-4-methyl-2,5-
dioxoimidazolidin-1-yl)-acetyl-L-N-methyl-
aspartyl-L-phenylglycine
VNP-4010M1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-U.S.6,040,338Anticancer,Cancer,
(methylamino)carbonylhydrazinealkylatinggeneral
vogliboseD-epi-Inositol, 3,4-dideoxy-4-[[2-hydroxy-1-83480-29-9EP56194AntidiabeticDiabetes,
(hydroxymethyl)ethyl]amino]-2-C-Type II
(hydroxymethyl)-[CAS]
voriconazole4-Pyrimidineethanol, Alpha-(2,4-137234-62-9EP440372AntifungalInfection,
difluorophenyl)-5-fluoro-β-methyl-Alpha-fungal,
(1H-1,2,4-triazol-1-ylmethyl)-, (R-(R*,S*))-general
[CAS]
Vorozole129731-10-8
VUF-K-87887-[3-[4-(2-Quinolinylmethyl)-1-AntiasthmaAsthma
piperazinyl]propoxy]-3,4-dihydro-2H-1,4-
benzothiazine-3-one
Warfarin81-81-2
WF-10Tetrachlorodecaoxide [CAS]92047-76-2Radio/Chemotherapy-
chemoprotectiveinduced injury,
bone marrow,
general
WMC-792-(3-[4-[3-(6-oxo-6H-2, 10b-diaza-Anticancer, otherCancer,
aceanthrenylen-5-ylamino)propyl]-colorectal
piperazin-1-yl]propyl)-5-nitro-2-aza-
phenalene-1,3-dione
wound healing matrixU.S.5,897,880Formulation,Ulcer, diabetic
transdermal, patch
WP-170U.S.6,531,121CytokineUnspecified
xaliprodenPyridine, 1,2,3,6-tetrahydro-1-[2-(2-90494-79-4
naphthalenyl)ethyl]-4-[3-135354-020-8EP101381NeuroprotectiveAmyotrophic
(trifluoromethyl)phenyl]-, [CAS]lateral
sclerosis
xamoterol4-Morpholinecarboxamide, N-[2-[[2-73210-73-8GB2002748CardiostimulantHeart failure
hydroxy-3-(4-81801-12-9
hydroxyphenoxy)propyl]amino]ethyl]-, (+/−)-
[CAS]
Xanomeline131986-45-3
Xanthinol Niacinate437-74-1
Xemilofiban149820-74-6
Xenbucin959-10-4
Xibenolol81584-06-7
xibornolPhenol, 4,5-dimethyl-2-(1,7,7-13741-18-9GB1206774Antibacterial, otherInfection,
trimethylbicyclo[2.2.1]hept-2-yl)-, exo-general
[CAS]
ximelagatranGlycine, N-((R)-cyclohexyl-2-((2S)-2-((((4-192939-46-1AntithromboticThrombosis,
(hydroxyamino)iminomethyl)phenyl)methyl)-venous
amino)carbonyl)-1-azetidinyl)2-oxoethyl
ethyl ester [CAS]
Ximoprofen56187-89-4
xipamideBenzamide, 5-(aminosulfonyl)-4-chloro-N-14293-44-8U.S.3,567,777Antihypertensive,
(2,6-dimethylphenyl)-2-hydroxy-[CAS]diuretic
xorphanolMorphinan-3-ol, 17-(cyclobutylmethyl)-8-77287-89-9Analgesic, otherPain, cancer
methyl-6-methylene-, (8β)-[CAS]
XR-51182,5-Piperazinedione, 3-[[5-[[2-174766-49-5WO9532190Anticancer, otherCancer,
(dimethylamino)ethyl]thio]-2-general
thienyl]methylene]-6-(phenylmethylene)-,
monohydrochloride, (3Z,6Z)-[CAS]
XR-5944N,N′-(1,2-Ethanediyl)bis(imino-2,1-EP934278Anticancer, otherCancer,
ethanediyl)bis(9-methylphenazine-1-general
carboxamide)
Xylometazoline526-36-3
Xylose58-86-6
YH-18852-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-178307-42-1WO9605177AntiulcerUlcer, GI,
2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-general
dimethyl-, monohydrochloride [CAS]
YM-511Benzonitrile, 4-[[(4-bromophenyl)methyl]-148869-05-0WO9305027Anticancer,Cancer,
4H-1,2,4-triazol-4-ylamino]-[CAS]hormonalbreast
YM-598potassium(E)-N-[6-methoxy-5-(2-Anticancer, otherCancer,
methoxyphenoxy)-2-(pyrimidin-2-prostate
yl)pyrimidin-4-yl]-2-
phenylethenesulfonamidate
Yohimbine146-48-5
YT-146Adenosine, 2-(1-octynyl)-[CAS]90596-75-1U.S.5,270,304Anti-inflammatoryInflammation,
general
Z-321Thiazolidine, 3-((2,3-dihydro-1H-inden-2-130849-58-0EP372484CognitionDementia,
yl)acetyl)-4-(1-pyrrolidinylcarbonyl)-, (R)-enhancersenile,
[CAS]general
Z-335(1H-Indene-5-acetic acid, 2[[[(4-146731-14-8JP92506077AntithromboticPeripheral
chlorophenyl)sulfonyl]amino]methyl]-2,3-vascular
dihydro, monosodium salt) [CAS]disease
zafirlukastCarbamin acid, [3-[[2-methoxy-4-[[[(2-107753-78-6EP199543AntiasthmaAsthma
methylphenyl)sulfonyl]amino]carbonyl]-
phenyl]methyl]-1-methyl-1H-indol-5-yl]-,
cyclopentyl ester [CAS]
zalcitabineCytidine, 2′,3′-dideoxy-[CAS]7481-89-2U.S.4,879,277Antiviral, anti-HIVInfection,
HIV/AIDS
Zaldaride109826-26-8
zaleplonAcetamide, N-[3-(3-cyanopyrazolo[1,5-151319-34-5EP776898Hypnotic/Insomnia
a]pyrimidin-7-yl)phenyl]-N-ethyl-[CAS]Sedative
zaltoprofenDibenzo[b,f]thiepin-2-acetic acid, 10,11-74711-43-6JP55053282Anti-
dihydro-Alpha-methyl-10-oxo-[CAS]inflammatory
zanamivir5-Acetamido-2,6-anhydro-3,4,5-trideoxy-4-139110-80-8WO9116320Antiviral, otherInfection,
guanidino-D-glycero-D-galacto-non-2-influenza
enonic acid [CAS]virus
zanapezil1-Propanone, 3-(1-(phenylmethyl)-4-142852-50-4EP487071CognitionAlzheimer's
piperidinyl)-1-(2,3,4,5-tetrahydro-1H-1-enhancerdisease
benzazepin-8-yl)-[CAS]
Zatebradine85175-67-3
ZD-0473Platinum, amminedichloro(2-181630-15-9EP727430Anticancer,Cancer,
methylpyridine)-(SP-4-3)-[CAS]alkylatingovarian
ZD-0947WO9528388UrologicalOveractive
bladder
ZD-6126N-acetylcolchinol-O-phosphateAnticancer, otherCancer,
general
ZD-93311H-Tetrazole-5-butanoic acid, Alpha-((4-153537-73-6GB2264946Anticancer,Cancer,
(((1,4-dihydro-2,7-dimethyl-4-oxo-6-antimetabolitepancreatic
quinazolinyl)methyl)-2-propynylamino)-2-
fluorobenzoyl)amino) (S)-[CAS]
zebularine2(1H)-Pyrimidinone, 1-β-D-ribofuranosyl-3690-10-6Anticancer, otherCancer,
[CAS]general
zelandopam7,8-Isoquinolinediol, 4-(3,4-138086-00-7JP03190818Vasodilator,Hypertension,
dihydroxyphenyl)-1,2,3,4-tetrahydro-,renalgeneral
[CAS]
Zenarestat112733-06-9
Ziconotide107452-89-1
zidovudineThymidine, 3′-azido-3′-deoxy-[CAS]30516-87-1U.S.4,724,232Antiviral,Infection,
anti-HIVHIV/AIDS
zileutonUrea, N-(1-benzo[b]thien-2-ylethyl)-N-111406-87-2EP279263AntiasthmaAsthma
hydroxy-[CAS]
Zimeldine56775-88-3
zinc acetatehexakis(\m-acetato)-\m4-oxotetrazinc12129-82-7Antiviral, otherInfection,
herpes
simplex virus
prophylaxis
zinc acexamateHexanoic acid, 6-(acetylamino)-, zinc salt70020-71-2EP369088AntiulcerUlcer,
(2:1)-[CAS]duodenal
zinc ibuprofenate78416-80-5Anti-inflammatory,Inflammation,
topicaldermal
Zinc p-Phenolsulfonate127-82-2
Zinc Salicylate16283-36-6
Zinostatin9014-2-2
zinostatin stimalamer123760-07-6EP136791Anticancer,Cancer,
antibioticliver
Zipeprol34758-83-3
ziprasidone2H-Indol-2-one, 5-(2-(4-(1,2-122883-93-6EP281309NeurolepticSchizophrenia
benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-146939-27-7
chloro-1,3-dihydro-[CAS]
zofenoprilL-Proline, 1-[3-(benzoylthio)-2-methyl-1-75176-37-3
oxopropyl]-4-(phenylthio)-,81872-10-8GB2028327Antihypertensive,Hypertension,
[1(R*),2Alpha,4Alpha]-[CAS]81972-10-8renin systemgeneral
81938-43-4
zofenpril + HCTZL-Proline, 1-[3-(benzoylthio)-2-methyl-1-Formulation, fixed-doseHypertension,
oxopropyl]-4-(phenylthio)-,combinationsgeneral
[1(R*),2Alpha,4Alpha]- + 6-Chloro-3,4-
dihydro-2H-1,2,4-benzothiazide-7-
sulfonamide 1,1-dioxide [CAS]
zoledronic acidPhosphonic acid, [1-hydroxy-2-(1H-118072-93-8EP531253OsteoporosisHyper-
imidazol-1-yl)ethylidene]bis-[CAS]165800-06-6treatmentcalcaemia
of malignancy
zolimidine2-(p-methylsulfonylphenyl)imidazo[1,2-1222-57-7U.S.3,318,880AntiulcerGastritis
a]pyridine
zolmitriptan2-Oxazokidinone, 4-((3-(2-139264-17-8WO9118897AntimigraineMigraine
(dimethylamino)ethyl)-1H-indol-5-
yl)methyl)-, (S)-[CAS]
zolpidemImidazol[1,2-a]pyridine-3-acetamide, N,N,6-99294-93-6EP50563Hypnotic/Insomnia
trimethyl-2-(4-methylphenyl)-(R-(R*,R*))-82626-48-0Sedative
2,3-dihydroxybutanediotade (2:1) [CAS]
Zomepirac33369-31-2
zonampanel1(2H)-Quinoxalineacetic acid, 3,4-dihydro-210245-80-0NeuroprotectiveIschaemia,
7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-cerebral
[CAS]
zoniporide1H-pyrazole-4-carboxamide,N-249296-45-5CardiovascularUnspecified
(aminoimino methyl)-5-cyclopropyl-1-(5-
quinolinyl)-,
zonisamide1,2-Benzisoxazole-3-methanesulfonamide68291-97-4GB2025931AntiepilepticEpilepsy,
[CAS]68291-98-5generalized,
tonic-clonic
zopiclone1-Piperazinecarboxylic acid, 4-methyl-, 6-43200-80-2GB1358680Hypnotic/Insomnia
(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-Sedative
pyrrolo[3,4-b]pyrazin-5-yl ester [CAS]
Zopolrestat110703-94-1
Zorubicin54083-22-6
zosuquidar1-Piperazineethanol, 4-(1,1-difluoro-167465-36-3Radio/Cancer,
1,1a,6,10b-chemosensitizerleukaemia,
tetrahydrodibenzo[a,e]cyclopropa[c]cyclo-acute
hepten-6-yl)-Alpha-[(5-quinolinyloxy)methyl]-,myelogenous
[6(R)-(1aAlpha,6Alpha,10bAlpha)]-[CAS]
zotepineEthanamine, 2-[(8-26615-21-4GB1247067NeurolepticSchizophrenia
chlorodibenzo[b,f]thiepin-10-yl)oxy]-N,N-
dimethyl-[CAS]
ZP-123WO0162775AntiarrhythmicArrhythmia,
general
Z-tamoxifenEthanamine, 2-[4-(1,2-diphenyl-1-10540-29-1Anticancer,Cancer,
butenyl)phenoxy]-N,N-dimethyl-, (Z)-hormonalcolorectal
[CAS]
zuclopenthixol1-Piperazineethanol, 4-[3-(2-chloro-9H-53772-83-1EP27082NeurolepticPsychosis,
thioxanthen-9-ylidene)propyl]-, (Z)-[CAS]982-24-1general
85721-05-7
64053-00-5

Full text: Click here
Patent 2011

Example 1

1.1 Using general procedure A, (R)-(+)-3-(tert-butyloxycarbonylamino)-pyrrolidine was alkylated with bromoacetic acid ethyl ester to give ((R)-3-tert-butoxycarbonylamino-pyrrolidin-1-yl)-acetic acid ethyl ester. Off-white solid. MS 273.1 ([M+H]+)

[Figure (not displayed)]

1.2 Using general procedure B, ((R)-3-tert-butoxycarbonylamino-pyrrolidin-1-yl)-acetic acid ethyl ester was converted to ((R)-3-amino-pyrrolidin-1-yl)-acetic acid ethyl ester dihydrochloride. Off-white amorphous solid. MS 173.4 ([M+H]+)

[Figure (not displayed)]

1.3 Using general method D, ((R)-3-amino-pyrrolidin-1-yl)-acetic acid ethyl ester dihydrochloride was coupled with 5-chlorothiophene-2-carboxylic acid to give {(R)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidin-1-yl}-acetic acid ethyl ester. Off-white amorphous solid. MS 317.0 ([M+H]+)

[Figure (not displayed)]

1.4 Using general method F, {(R)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidin-1-yl}-acetic acid ethyl ester was reacted with 1-(4-amino-3-fluoro-phenyl)-1H-pyridin-2-one (CAS 536747-52-1, prepared according to WO 2003045912) to give 5-chloro-thiophene-2-carboxylic acid ((R)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Off-white amorphous solid. Light yellow solid. MS 475.3 ([M+H]+)

[Figure (not displayed)]

Example 2

A solution of 200 mg {(R)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidin-1-yl}-acetic acid ethyl ester (Ex. 1.3) in 4 ml EtOH and 4 ml H2O was treated with 0.051 g NaOH. The reaction mixture was stirred for 4 hrs at r.t., then evaporated. The resulting crude acid was coupled with 1-(N-methylpiperidin-4-yl)piperazine according to general method D to give 5-chloro-thiophene-2-carboxylic acid ((R)-1-{2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-pyrrolidin-3-yl)-amide. Light yellow solid. MS 454.6 ([M+H]+)

[Figure (not displayed)]

Example 3

In analogy to example 1, [(S)-3-(tert-butyloxycarbonylamino)-pyrrolidine was converted to 5-chloro-thiophene-2-carboxylic acid ((S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Off-white amorphous solid. MS 475.3 ([M+H]+)

[Figure (not displayed)]

Example 4

In analogy to example 1.1, 1.2 and 2, [[(S)-3-(tert-butyloxycarbonylamino)-pyrrolidine was converted to 5-chloro-thiophene-2-carboxylic acid ((S)-1-{2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-pyrrolidin-3-yl)-amide. White solid. MS 454.6 ([M+H]+)

[Figure (not displayed)]

Example 5

5.1 Using general procedure D ((R)-3-amino-pyrrolidin-1-yl)-acetic acid ethyl ester dihydrochloride (example 1.2) was coupled with 4-chlorobenzoic acid to give [(R)-3-(4-chloro-benzoylamino)-pyrrolidin-1-yl]-acetic acid ethyl ester. Solid. MS 311.3 ([M+H]+)<

[Figure (not displayed)]

5.2 Using general procedure F [(R)-3-(4-chloro-benzoylamino)-pyrrolidin-1-yl]-acetic acid ethyl ester was reacted with 1-(4-amino-3-fluoro-phenyl)-1H-pyridin-2-one (CAS 536747-52-1, prepared according to WO 2003045912) to give 4-chloro-((R)-1-{[2-fluoro-4-(2-oxo-2-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-benzamide. Light yellow solid. MS 469.5 ([M+H]+)

[Figure (not displayed)]

Example 6

6.1 Using general procedure D (R)-1-Boc-3-aminopyrrolidine was coupled with 5-chlorothiophene-2-carboxylic acid to give (R)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1-carboxylic acid tert-butyl ester. Yellow solid. MS 329.3 ([M−H])

[Figure (not displayed)]

6.2 Using general procedure B (R)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1-carboxylic acid tert-butyl ester was deprotected to give 5-chloro-thiophene-2-carboxylic acid (R)-pyrrolidin-3-ylamide hydrochloride. Yellow solid. MS 231.4 ([M+H]+)

[Figure (not displayed)]

6.3 Using general procedure A 5-chloro-thiophene-2-carboxylic acid (R)-pyrrolidin-3-ylamide hydrochloride was reacted with ethyl-2-bromopropionate to give 2-{(R)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidin-1-yl}-propionic acid ethyl ester. Oil. MS 329.1 ([M−H])

[Figure (not displayed)]

6.4 Using general procedure F 2-{(R)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidin-1-yl}-propionic acid ethyl ester was reacted with 1-(4-amino-3-fluoro-phenyl)-1H-pyridin-2-one (CAS 536747-52-1, prepared according to WO 2003045912) to give 5-chloro-thiophene-2-carboxylic acid ((R)-1-{1-[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-ethyl}-pyrrolidin-3-yl)-amide. Yellow solid. MS 487.4 ([M−H])

[Figure (not displayed)]

Example 7

7.1 A solution of 400 mg 5-chloro-thiophene-2-carboxylic acid (R)-pyrrolidin-3-ylamide hydrochloride (example 6.2) in 5 ml THF was treated with 0.31 ml TEA and 0.16 ml bromo acetylbromide. The reaction mixture was stirred over night. The precipitate was filtered and washed with THF. The filtrate was concentrated. The crude product was purified by chromatography (silica gel; gradient: CH2Cl2 to CH2Cl2/MeOH 98:2) to give 250 mg 5-chloro-thiophene-2-carboxylic acid [(R)-1-(2-bromo-acetyl)-pyrrolidin-3-yl]-amide. Off-white amorphous solid. 353.1 ([M+H]+)

[Figure (not displayed)]

7.2 A solution of 250 mg 5-chloro-thiophene-2-carboxylic acid [(R)-1-(2-bromo-acetyl)-pyrrolidin-3-yl]-amide in 2 ml DMF was treated with 110 mg 1-(4-amino-phenyl)-1H-pyridin-2-one (CAS 13143-47-0), 0.12 ml TEA and 110 mg tetrabutylammonium iodide. The reaction mixture was stirred at r.t. for 2 days, then quenched with water and extracted with EtOAc. The organic layer was washed with water, dried over MgSO4 and filtrated. The crude product was purified by chromatography (silica gel; gradient: CH2Cl2 to CH2Cl2/MeOH 95:5) to give 72 mg 5-chloro-thiophene-2-carboxylic acid ((R)-1-{2-[4-(2-oxo-pyridin-1-yl)-phenylamino]-acetyl}-pyrrolidin-3-yl)-amide. MS 457.5 ([M+H]+)

[Figure (not displayed)]

Example 8

8.1 A suspension of 540 mg ((R)-3-amino-pyrrolidin-1-yl)-acetic acid ethyl ester dihydrochloride (example 1.2) in 5 ml THF was treated with 1.2 ml TEA and 530 mg 5-chlorothiophene-2-sulfonylchloride. The reaction mixture was stirred over night at r.t., then taken up in EtOAc and washed with water and brine. The organic layer was dried over MgSO4, filtered and concentrated to give 690 mg [(R)-3-(5-chloro-thiophene-2-sulfonylamino)-pyrrolidin-1-yl]-acetic acid ethyl ester. Oil. 353.1 ([M+H]+)

[Figure (not displayed)]

8.2 Using general procedure F [(R)-3-(5-chloro-thiophene-2-sulfonylamino)-pyrrolidin-1-yl]-acetic acid ethyl ester was reacted with 1-(4-amino-3-fluoro-phenyl)-1H-pyridin-2-one (CAS 536747-52-1, prepared according to WO 2003045912) to give 2-[(R)-3-(5-chloro-thiophene-2-sulfonylamino)-pyrrolidin-1-yl]-N-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-acetamide. White solid. MS 511.3 ([M+H]+)

[Figure (not displayed)]

Example 9

9.1 In analogy to examples 1.1-1.3 3-N-Boc-amino-piperidine was converted to {3-[(5-chloro-thiophene-2-carbonyl)-amino]-piperidin-1-yl}-acetic acid ethyl ester. Solid. 331.3 ([M+H]+)

[Figure (not displayed)]

9.2 To a stirred solution of {3-[(5-chloro-thiophene-2-carbonyl)-amino]-piperidin-1-yl}-acetic acid ethyl ester at r.t. in 5 ml ethanol were added 5 ml 1 N NaOH. The slurry slowly turned to a clear solution. Stirring at r.t. was then continued for 5 h. The mixture was neutralized by adding 5 ml of 1 N HCl (pH ˜7). The light orange solution was concentrated to leave an off-white solid. This residue was coevaporated several times with toluene to remove the remaining H2O, and dried overnight (r.t., 0.5 mbar) to give 1.07 g {3-[(5-chloro-thiophene-2-carbonyl)-amino]-piperidin-1-yl}-acetic acid (containing 2 mol equivalents of sodium chloride). Off-white solid. MS 301.3 ([M−H])

[Figure (not displayed)]

9.3 To a stirred suspension of 300 mg {3-[(5-chloro-thiophene-2-carbonyl)-amino]-piperidin-1-yl}-acetic acid (containing 2 mol equivalents of sodium chloride) at r.t. in 5 ml acetonitrile and 0.5 ml DMF under an argon atmosphere were added 0.5 ml N-ethyldiisopropylamine, 175 mg 1-(4-amino-3-fluoro-phenyl)-1H-pyridin-2-one (CAS 536747-52-1, prepared according to WO 2003045912) and 365 mg BOP-Cl. The compact slurry was then stirred at r.t. for 18 h. The mixture was concentrated. The residue was taken up with CH2Cl2, washed with 1 N NaOH, H2O and brine, dried (MgSO4), filtered and concentrated. The crude product was purified by chromatography (silica gel; gradient: cyclohexane to EtOAc) to give 98 mg 5-chloro-thiophene-2-carboxylic acid (1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-piperidin-3-yl)-amide. White solid. MS 489.5 ([M+H]+)

[Figure (not displayed)]

Example 10

Using general procedure D {3-[(5-chloro-thiophene-2-carbonyl)-amino]-piperidin-1-yl}-acetic acid (containing 2 mol equivalents of sodium chloride) was coupled with 1-(N-methyl-4-piperidyl)-piperazine to give 5-chloro-thiophene-2-carboxylic acid (1-{2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-piperidin-3-yl)-amide. Off-white solid. 468.5 ([M+H]+)

[Figure (not displayed)]

Example 11

11.1 Using general procedure D N-Boc-trans-4-amino-L-proline methyl ester hydrochloride was coupled with 5-chlorothiophene-2-carboxylic acid to give (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester. White solid. MS 389.4 ([M+H]+)

[Figure (not displayed)]

11.2 Using general procedure B (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester was deprotected to give (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-2-carboxylic acid methyl ester hydrochloride. White solid. MS 289.0 ([M+H]+)

[Figure (not displayed)]

11.3 A solution of 3 g 1-(4-amino-3-fluoro-phenyl)-1H-pyridin-2-one (CAS 536747-52-1, prepared according to WO 2003045912) in 90 ml THF was treated with 3.5 ml TEA and 2.3 ml bromoacetyl bromide. The suspension was stirred over night at r.t., then concentrated. The residue was taken up in CH2Cl2 and was washed with 1 N HCl and brine, dried (MgSO4), filtered and concentrated. The crude product was purified by chromatography (silica gel; gradient: CH2Cl2->CH2Cl2/MeOH 9:1). The product-containing fractions were concentrated. The remaining solid was triturated with diethyl ether to give 3.1 g 2-bromo-[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenyl]-acetamide as off-white solid. MS 325.0 ([M+H]+)

[Figure (not displayed)]

11.4 Using general procedure A with DMF as solvent (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-2-carboxylic acid methyl ester hydrochloride was reacted with 2-bromo-[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenyl]-acetamide to give (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid methyl ester. White solid. MS 533.2 ([M+H]+)

[Figure (not displayed)]

Example 12

A solution of 394 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid methyl ester (example 11.4) in 10 ml THF was treated with 1.5 ml 1N NaOH. The reaction mixture was stirred for 4 hrs at r.t., then brought to pH 7 with 3N HCl and concentrated. The crude product was purified by chromatography (silica gel; CH2Cl2/MeOH 4:1, then MeOH). The product-containing fractions were concentrated, triturated with water and dried to give 290 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid as an off-white solid. MS 519.3 ([M+H]+)

[Figure (not displayed)]

Example 13

Using general procedure D (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]—1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid (example 12) was coupled with 2-aminoethanol to give (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid (2-hydroxy-ethyl)-amide. White solid. MS 562.5 ([M+H]+)

[Figure (not displayed)]

Example 14

Using general procedure D (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid (example 12) was coupled with aminomethylcyclopropane to give (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]—1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid cyclopropylmethyl-amide and (2R,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid cyclopropylmethyl-amide. White solid (both products). MS 572.3 ([M+H]+)

[Figure (not displayed)]

Example 15

Using general procedure D (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid (example 12) was coupled with methylamine hydrochloride to give (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid methylamide. White solid. MS 532.3 ([M+H]+)

[Figure (not displayed)]

Example 16

To a solution of 44 mg cyanuric chloride in 1.5 ml 1,2-dimethoxyethane were added 0.03 ml N-methylmorpholine. The resulting white suspension was treated with 150 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-2-carboxylic acid (example 12) in 0.5 ml 1,2-dimethoxyethane and stirred at r.t for 3 hrs. The precipitate was filtered off. The filtrate was cooled to 0° C. A solution of 13 mg NaBH4 in 0.7 ml H2O was added dropwise. The mixture was stirred for 5 min at 0° C., then diluted with water and extracted with EtOAc. The organic layer was washed with water, dried over MgSO4, filtrated and concentrated. The crude product was purified by chromatography (silica gel; gradient: CH2Cl2->CH2Cl2/MeOH 9:1) to give 20 mg 5-chloro-thiophene-2-carboxylic acid ((3R,5S)-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-5-hydroxymethyl-pyrrolidin-3-yl)-amide. White solid. MS 505.4 ([M+H]+)

[Figure (not displayed)]

Example 17

17.1 To a stirred solution of 6.98 g (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester (example 11.1) at 0° C. in 125 ml methanol under an argon atmosphere were added 3.05 g lithium chloride (3.046 g, 4 eq.) and 1.36 g NaBH4 and stirring was continued for 1 h at 0° C. The ice bath was removed. The off-white slurry was stirred at r.t. for 6 hrs. The mixture was cooled to 0° C. and treated with 25 ml THF and 1.36 g NaBH4. The ice bath was removed and stirring was overnight. Then the mixture was filtered and the filtrate was concentrated to leave a light yellow sticky solid. The crude product was purified by column chromatography (silica gel, gradient: CH2Cl2->CH2Cl2/MeOH 95.5) to give—along with 1.12 g starting material—4.11 g (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-hydroxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester as white solid. MS 361.4 ([M+H]+)

[Figure (not displayed)]

17.2 To a stirred solution of 2.5 g (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-hydroxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester at 0° C. in 10 ml dichloromethane under an argon atmosphere were added 5.89 ml N-ethyldiisopropylamine and 0.65 ml methanesulfonyl chloride. The mixture was stirred at 0° C. for 4 h, then diluted with DCM and washed with H2O and brine, dried over MgSO4, filtered and concentrated. The crude product was isolated by column chromatography (silica gel, gradient: CH2Cl2->CH2Cl2/MeOH 95:5) to give 2.42 g (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methanesulfonyloxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester as off-white amorphous solid. MS 439.1 ([M+H]+)

[Figure (not displayed)]

17.3 To a stirred solution of 200 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methanesulfonyloxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester at r.t. in 5 ml THF under an argon atmosphere were added 0.38 ml pyrrolidine. The mixture was heated to reflux for 6 h, then cooled to r.t. and concentrated. The crude product was purified by column chromatography (silica gel, gradient CH2Cl2->CH2Cl2/MeOH 9:1) to give 138 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-pyrrolidin-1-ylmethyl-pyrrolidine-1-carboxylic acid tert-butyl ester as off-white amorphous solid. MS 414.4 ([M+H]+)

[Figure (not displayed)]

17.4 To a stirred solution of 134 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-pyrrolidin-1-ylmethyl-pyrrolidine-1-carboxylic acid tert-butyl ester at r.t. in 3.4 ml dioxane under an argon atmosphere were added 1.6 ml 4 M HCl in dioxane. The mixture was then stirred for 18 h. The resulting white suspension was concentrated to leave 139 mg 5-chloro-thiophene-2-carboxylic acid ((3R,5S)-5-pyrrolidin-1-ylmethyl-pyrrolidin-3-yl)-amide dihydrochloride as off-white solid. MS 314.3 ([M+H]+)

[Figure (not displayed)]

17.5 Using general procedure A 5-chloro-thiophene-2-carboxylic acid ((3R,5S)-5-pyrrolidin-1-ylmethyl-pyrrolidin-3-yl)-amide was reacted with 2-bromo-[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenyl]-acetamide (example 11.3) to give 5-chloro-thiophene-2-carboxylic acid ((3R,5S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-5-pyrrolidin-1-ylmethyl-pyrrolidin-3-yl)-amide. Light yellow solid. MS 558.2 ([M+H]+)

[Figure (not displayed)]

Example 18

18.1 To a stirred solution of 200 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methanesulfonyloxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (example 17.2) at r.t. in 5 ml THF under an argon atmosphere were added 78 mg sodium methylate. The resulting suspension was heated to reflux for 4 hrs, then treated again with 78 mg sodium methylate and 1.5 ml MeOH and refluxed overnight. The reaction mixture was cooled to r.t. and concentrated. The crude product was purified by column chromatography (silica gel, gradient: cyclohexane->cyclohexane/EtOAc 35:65) to give (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methoxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester as colorless gum. MS 375.0 ([M+H]+)

[Figure (not displayed)]

18.2 In analogy to examples 17.4 and 17.5 (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methoxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3R,5S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-5-methoxymethyl-pyrrolidin-3-yl)-amide. Off-white solid. MS 519.3 ([M+H]+)

[Figure (not displayed)]

Example 19

19.1 To a stirred, cooled (0° C.) suspension of 30 mg NaH (55% dispersion in mineral oil) in 1.5 ml DMF under an argon atmosphere were added a solution of 58 mg 2-pyrrolidinone in 1.5 ml DMF. The ice bath was removed and stirring at r.t. was continued for 1 h 30. The mixture was cooled again and a solution of 200 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methanesulfonyloxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (example 17.2) in 2 ml DMF was added. The temperature was elevated to 80° C. The reaction mixture was stirred over night, was cooled to r.t., diluted with EtOAc and washed with H2O. The aqueous phase was back-extracted with EtOAc. The combined organics were washed with H2O and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by column chromatography (silica gel, gradient: CH2Cl2->CH2Cl2/MeOH 95:5) to give 46 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-(2-oxo-pyrrolidin-1-ylmethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester as colorless gum. MS 428.3 ([M+H]+)

[Figure (not displayed)]

19.2 In analogy to examples 17.4 and 17.5 (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-(2-oxo-pyrrolidin-1-ylmethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid [(3R,5S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-5-(2-oxo-pyrrolidin-1-ylmethyl)-pyrrolidin-3-yl]-amide. Off-white amorphous solid. MS 572.3 ([M+H]+)

[Figure (not displayed)]

Example 20

20.1 To a stirred solution of 550 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methanesulfonyloxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (example 17.2) at r.t. in 5 ml DMF under an argon atmosphere were added 98 mg NaN3. The mixture was heated to 90° C. and stirred over night. The mixture was cooled to r.t., diluted with EtOAc and washed with H2O and brine. The combined organics were dried over MgSO4, filtered and concentrated to leave 552 mg of the crude azide as a light yellow viscous oil. It was dissolved in 7 ml THF. To the solution were added 986 mg triphenylphosphine and 0.5 ml H2O. The reaction mixture was stirred overnight, then concentrated. The crude product was purified by column chromatography (silica gel, gradient: CH2Cl2->CH2Cl2/MeOH 95:5) to give 326 mg (2S,4R)-2-aminomethyl-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1-car-boxylic acid tert-butyl ester as off-white amorphous solid. MS 360.3 ([M+H]+)

[Figure (not displayed)]

20.2 To a stirred, cooled solution of 150 mg (2S,4R)-2-aminomethyl-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1-carboxylic acid tert-butyl ester in 5 ml dichloromethane under an argon atmosphere were added 0.29 ml triethylamine and 0.04 ml methanesulfonyl chloride. The mixture was slowly warmed to r.t., stirred over night and then concentrated. The crude product was isolated by column chromatography (silica gel, gradient: CH2Cl2->CH2Cl2/MeOH 95:5) to give 165 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-(methanesulfonylamino-methyl)-pyrrolidine-1-carboxylic acid tert-butyl ester as off-white amorphous solid. MS 435.9 ([M−H])

[Figure (not displayed)]

20.3 In analogy to examples 17.4 and 17.5 (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-(methanesulfonylamino-methyl)-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid [(3R,5S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-5-(methanesulfonylamino-methyl)-pyrrolidin-3-yl]-amide. Off-white solid. MS 582.2 ([M+H]+)

[Figure (not displayed)]

Example 22

22.1 A solution of 19.6 g N-Boc-pyrroline in 200 ml CH2Cl2 was cooled to −10° C. and was treated in two portions with 30 g meta-chloroperbenzoic acid. The mixture was stirred for 17 h, slowly warming up to room temperature. Then, the white precipitate was filtered off and washed with dichloromethane. The filtrate was washed with 5% aq. NaHSO3, sat. aq. NaHCO3 and brine, dried (MgSO4), filtered and concentrated. The crude product was purified by chromatography (silica gel; gradient: cyclohexane->cyclohexane/EtOAc 65:35) to give 11.8 g 6-oxa-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester as a light yellow oil. MS 186.1 ([M+H]+)

[Figure (not displayed)]

22.2 A solution of 9.7 g 6-oxa-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester in 480 ml MeOH was thoroughly degassed and flushed with argon. It was treated with 660 mg (1R,2R)-(−)-[1,2-cyclohexanediamino-N,N′-bis(3,5-di-t-butylsalicylidene)]-chromium (III) chloride (CAS 164931-83-3; available from Strem). The resulting heterogenous mixture was again degassed, flushed with argon, cooled to 0° C. and treated with 7.2 ml trimethyl silyl azide. The dark red-brown slurry (slowly warming up to room temperature, and becoming more and more compact) was stirred at r.t. for 21 h. Then, the mixture was taken up in MeOH and treated with 7.71 g K2CO3. Stirring at r.t. under an argon atmosphere was continued for 24 h, the mixture slowly turning to a clear red/brown solution. The mixture was concentrated. The orange-brown residue was taken up in CH2Cl2 and washed with H2O. The organic layer was filtered, washed with brine, dried over MgSO4 and concentrated. The crude product was purified by chromatography (silica gel; gradient: cyclohexane->cyclohexane/EtOAc 1:1) to give 9.7 g (3S,4S)-3-azido-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester as yellow viscous oil. MS 287.1 ([M+AcO])

[Figure (not displayed)]

22.3 A solution of 2.0 g (3S,4S)-3-azido-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester in 25 MeOH was treated under an argon atmosphere with 100 mg PtO2. The reaction mixture was stirred over night under a hydrogen atmosphere. The catalyst was filtered off and washed with methanol. The filtrate was concentrated. The crude product was purified by chromatography (silica gel; gradient: CH2Cl2->CH2Cl2/MeOH 4:1) to give 1.5 g (3S,4S)-3-amino-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester as off-white solid. MS 202.9 ([M+H]+)

[Figure (not displayed)]

22.4 Using general procedure C (3S,4S)-3-amino-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester was reacted with 5-chlorothiophene-2-carboxylic acid to give (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester. Off-white solid. MS 347.3 ([M+H]+)

[Figure (not displayed)]

22.5 Using general procedure B (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester was deprotected to give 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-hydroxy-pyrrolidin-3-yl)-amide hydrochloride. Off-white solid. MS 247.1 ([M+H]+)

[Figure (not displayed)]

22.6 Using general procedure A with DMF as solvent 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-hydroxy-pyrrolidin-3-yl)-amide hydrochloride was reacted with 2-bromo-[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenyl]-acetamide to give 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide. Light-yellow solid. MS 491.3 ([M+H]+)

[Figure (not displayed)]

Example 23

Using analogous procedures as described in examples 22.4-22.6 (3S,4R)-3-amino-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (CAS 190792-75-7; prepared from (3S,4S)-3-amino-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (example 22.3) as described by S. E. Schaus, J. F. Larrow, E. N. Jacobsen in Journal of Organic Chemistry, 1997, 62(12), 4197) was converted to 5-chloro-thiophene-2-carboxylic acid ((3R,4S)-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide. White solid. MS 491.4 ([M+H]+)

[Figure (not displayed)]

Example 24

24.1 A solution of 1.0 g (3S,4S)-3-azido-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (example 22.2) in 15 ml acetonitrile and 3 ml THF was treated with 3.0 g silver(I) oxide and and 2.7 ml iodomethane. The reaction mixture was stirred over night at r.t., then again treated with 3.0 g silver(I) oxide and 2.7 ml iodomethane. The reaction was agitated over night at r.t., then filtrated. The filtrate was concentrated. The crude product was purified by chromatography (silica gel; cyclohexane/EtOAc 2:1) to give 1.0 g (3S,4S)-3-azido-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester as light yellow oil. MS 243.4 ([M+H]+)

[Figure (not displayed)]

24.2 Using analogous procedures as described in examples 17.3-17.6 (3S,4S)-3-azido-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-methoxy-pyrrolidin-3-yl)-amide. Light yellow amorphous solid. MS 505.3 ([M+H]+)

[Figure (not displayed)]

Example 25

25.1 Using analogous procedures as described in examples 22.3 and 22.4 (3S,4S)-3-azido-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester (example 24.1) was converted to (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester. White solid. MS 361.4 ([M+H]+)

[Figure (not displayed)]

25.2 Using analogous procedures as described in examples 6.2 and 6.3 (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to {(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidin-1-yl}-acetic acid ethyl ester. Oil. MS 347.1 ([M+H]+)

[Figure (not displayed)]

25.3 Using general procedure F {(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidin-1-yl}-acetic acid ethyl ester was reacted with 1-(4-amino-phenyl)-1H-pyridin-2-one (CAS 13143-47-0) to give 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-methoxy-1-{[4-(2-oxo-2-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Yellow solid. MS 487.1 ([M+H]+)

[Figure (not displayed)]

Example 26

Using general procedure F {(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidin-1-yl}-acetic acid ethyl ester (example 25.2) was reacted with 4-(4-amino-3-fluoro-phenyl)-morpholin-3-one (CAS 438056-69-0) to give 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(3-oxo-morpholin-4-yl)-phenylcar-bamoyl]-methyl}-4-methoxy-pyrrolidin-3-yl)-amide. Yellow solid. MS 511.3 ([M+H]+)

[Figure (not displayed)]

Example 27

Using general procedure F {(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidin-1-yl}-acetic acid ethyl ester (example 25.2) was reacted with 1-(4-amino-3-fluoro-phenyl)-1H-pyrazin-2-one (prepared from 2-fluoro-4-iodoaniline by reaction with 1H-pyrazin-2-one, Cu(I)I, N,N′-dimethylethylenediamine and cesium carbonate in dioxane at 120° C.) to give 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-pyrazin-1-yl)-phenylcarbamoyl]-methyl}-4-methoxy-pyrrolidin-3-yl)-amide. Yellow solid. MS 506.3 ([M+H]+)

[Figure (not displayed)]

Example 28

Using general procedure F {(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidin-1-yl}-acetic acid ethyl ester (example 25.2) was reacted with 4-(4-aminophenyl)-morpholin-3-one (CAS 438056-69-0) to give 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-methoxy-1-{[4-(3-oxo-morpholin-4-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Yellow solid. MS 493.0 ([M+H]+)

[Figure (not displayed)]

Example 29

29.1 A solution of 150 mg (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (example 22.4) in 3 ml MeCN and 1 ml THF was treated with 300 mg silver(I) oxide and 0.35 ml iodoethane. The reaction mixture was stirred over night, then was again treated with 300 mg silver(I) oxide and 0.35 ml iodoethane. The reaction mixture was agitated over night at r.t., then filtrated. The filtrate was concentrated. The crude product was purified by chromatography (silica gel; gradient: cyclohexane->EtOAc) to give 90 mg (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-ethoxy-pyrrolidine-1-carboxylic acid tert-butyl ester as light yellow oil. MS 373.1 ([M−H])

[Figure (not displayed)]

29.2 Using analogous procedures as described in examples 22.5 and 22.6 (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-ethoxy-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-ethoxy-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Yellow solid. MS 519.3 ([M+H]+)

[Figure (not displayed)]

Example 30

30.1 A suspension of 37 mg NaH (55% in oil) in 2 ml DMF was treated at 0° C. under an argon atmosphere with a solution of 270 mg (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (example 22.4). The reaction mixture was stirred for 1 hr at r.t. Then, 334 mg 2,2-difluoroethyl trifluoromethanesulfonate were added at 0° C. The reaction mixture was stirred for 2 days at r.t., then diluted with EtOAc and washed with water. The organic layer was dried over MgSO4, filtered and concentrated. The crude product was isolated by chromatography (silica gel; gradient: cyclohexane->cyclohexane/EtOAc 9:1) to give 157 mg (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-(2,2-difluoro-ethoxy)-pyrrolidine-1-carboxylic acid tert-butyl ester. Colorless solid. MS 409.0 ([M+H]+)

[Figure (not displayed)]

30.2 Using analogous procedures as described in examples 22.5 and 22.6 (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-(2,2-difluoro-ethoxy)-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-(2,2-difluoro-ethoxy)-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Yellow solid. MS 555.2 ([M+H]+)

[Figure (not displayed)]

Example 31

31.1 A suspension of 187 mgNaH (55% dispersion in mineral oil) in 3 ml DMF under an argon atmosphere was cooled to 0° C. and treated with a solution of 960 mg (3S,4S)-3-azido-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (example 22.2) in 6 ml DMF. The ice bath was removed and stirring at r.t. was continued for 90 min. The mixture was cooled to 0° C. and a solution 0.7 ml 2-(2-bromoethoxy)tetrahydro-2H-pyran in 1 ml DMF was added. The mixture (slowly warming up to room temperature) was then stirred for 18 h. The reaction mixture was diluted with EtOAc and washed with H2O. The aqueous phase was back extracted with EtOAc. The combined organics were washed with H2O and brine, dried over MgSO4, filtered and concentrated. The crude product was isolated by column chromatography (silica gel; gradient: cyclohexane->cyclohexane/EtOAc 3:2) to give 545 mg (3S,4S)-03-azido-4-[2-(tetrahydro-pyran-2-yloxy)-ethoxy]-pyrrolidine-1-carboxylic acid tert-butyl ester as light yellow viscous oil. MS 357.3 ([M+H]+)

[Figure (not displayed)]

31.2 Using analogous procedure as described in examples 22.3-22.6 (3S,4S)-3-azido-4-[2-(tetrahydro-pyran-2-yloxy)-ethoxy]-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid [(3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-(2-hydroxy-ethoxy)-pyrrolidin-3-yl]-amide. White amorphous solid. MS 535.5 ([M+H]+)

[Figure (not displayed)]

Example 32

32.1 A solution of 480 mg (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (example 22.4) in 14 ml DMSO/CH2Cl2 1:1 was cooled to 0° C. and treated with 1.34 ml TEA and 934 mg sulfur trioxide-pyridine complex. The reaction mixture was warmed to r.t., stirred for 2 hrs, then diluted with CH2Cl2 and washed with water. The organic layer was dried over MgSO4, filtrated and concentrated. The crude product was purified by column chromatography (silica gel, CH2Cl2/MeOH 95:5) to give 315 mg 5-chloro-thiophene-2-carboxylic acid ((S)-1-{[2-fluoro-4-(2-oxo-2-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-oxo-pyrrolidin-3-yl)-amide as off-white amorphous solid. MS 489.0 ([M−H])

[Figure (not displayed)]

32.2 A solution of 100 mg 5-chloro-thiophene-2-carboxylic acid ((S)-1-{[2-fluoro-4-(2-oxo-2-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-oxo-pyrrolidin-3-yl)-amide in 10 ml MeOH was treated with 1.58 g ammonium acetate and 14 mg NaBH3CN. The reaction mixture was stirred at r.t. overnight, then concentrated and taken up in CH2Cl2. The solids were filtered off. The filtrate was concentrated to leave the crude product which was isolated by column chromatography (silica gel, gradient: CH2Cl2->CH2Cl2/MeOH 4:1) to give 8 mg 5-chloro-thiophene-2-carboxylic acid ((S)-4-amino-1-{[2-fluoro-4-(2-oxo-2-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide as off-white solid. MS 490.1 ([M+H]+)

[Figure (not displayed)]

Example 33

A solution of 50 mg 5-chloro-thiophene-2-carboxylic acid ((S)-1-{[2-fluoro-4-(2-oxo-2-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-oxo-pyrrolidin-3-yl)-amide (example 32.1) in 2 ml THF was treated with 0.04 ml dimethylamine solution (33% in EtOH) and cooled to 0° C. The reaction mixture was brought to pH 5 by the addition of AcOH. Then, 7 mg of NaBH3CN were added. The reaction mixture was stirred at r.t. overnight, then concentrated. The crude product was isolated by column chromatography (silica gel, gradient: CH2Cl2->CH2Cl2/MeOH 9:1) to give 14 mg 5-chloro-thiophene-2-carboxylic acid ((S)-4-dimethylamino-1-{[2-fluoro-4-(2-oxo-2-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide as white solid. MS 518.5 ([M+H]+)

[Figure (not displayed)]

Example 34

In analogy to example 33 ((S)-1-{[2-fluoro-4-(2-oxo-2-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-oxo-pyrrolidin-3-yl)-amide (example 32.1) was reacted with 2,2-difluoro ethylamine to give 5-chloro-thiophene-2-carboxylic acid ((S)-4-(2,2-difluoro-ethylamino)-1-{[2-fluoro-4-(2-oxo-2-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide as light yellow amorphous solid. MS 552.3 ([M−H])

[Figure (not displayed)]

Example 35

35.1 Using the same procedure as described in example 32.1 (3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (example 22.4) was converted to (S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester. Light yellow solid. MS 345.0 ([M+H]+)

[Figure (not displayed)]

35.2 A solution of 500 mg (S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester in 20 ml EtOH was treated with 155 mg ammonium chloride, 0.49 ml Hünig's base and 0.86 ml tetraisopropyl orthotitanate. The reaction mixture was stirred for 5 hrs at 40° C. Then it was cooled to 0° C., treated with 110 mg NaBH4 and stirred at r.t. overnight. The mixture was diluted with EtOAc and washed with H2O. The organic layer was dried over MgSO4, filtered and concentrated. The crude product was purified by column chromatography (silica gel, gradient: CH2Cl2->CH2Cl2/MeOH 9:1) to give 180 mg (S)-3-amino-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1-carboxylic acid tert-butyl ester as yellow solid. MS 344.3 ([M−H])

[Figure (not displayed)]

35.3 In analogy to example 20.2 (S)-3-amino-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1-carboxylic acid tert-butyl ester was reacted with methane sulfonylchloride to give (S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methanesulfonylamino-pyrrolidine-1-carboxylic acid tert-butyl ester. White solid. MS 424.0 ([M+H]+)

[Figure (not displayed)]

35.4 In analogy to examples 17.4 and 17.5 (S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methanesulfonylamino-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-methanesulfonylamino-pyrrolidin-3-yl)-amide. Off-white solid. MS 568.2 ([M+H]+)

[Figure (not displayed)]

Example 36

In analogy to example 35.3 and 35.4 (S)-3-amino-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1-carboxylic acid tert-butyl ester (example 35.2) was reacted with acetyl chloride and then converted to 5-chloro-thiophene-2-carboxylic acid ((S)-4-acetylamino-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Off-white solid. MS 532.0 ([M+H]+)

[Figure (not displayed)]

Example 37

37.1 To stirred, cooled (−78° C.) solution of 695 mg (3S,4S)-3-azido-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (example 22.2) in 5 ml CH2Cl2 under an argon atmosphere were added 2.69 g bis(2-methoxyethyl)aminosulphur trifluoride (50% solution in THF). The dry ice bath was removed and the mixture was allowed to warm to r.t. and stirring was continued for 22 h. The mixture was poured into 10% aq. Na2CO3. The organic phase was washed with brine, dried (MgSO4), filtered and concentrated. The crude product was purified by chromatography (silica gel; gradient: cyclohexane->cyclohexane/EtOAc 3:2) to give 424 mg (S)-3-azido-4-fluoro-pyrrolidine-1-carboxylic acid tert-butyl ester as light yellow oil. MS 409.0 ([M+H]+)

[Figure (not displayed)]

37.2 Using analogous procedures as described in examples 22.3-22.6 (S)-3-azido-4-fluoro-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((S)-4-fluoro-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarba-moyl]-methyl}-pyrrolidin-3-yl)-amide. White solid. MS 493.3 ([M+H]+)

[Figure (not displayed)]

Example 38

38.1 A solution of 530 mg (3S,4S)-3-azido-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (example 22.2) in 5 ml pyridine was cooled to 0° C. under an argon atmosphere and treated with 664 mg 4-toluenesulfonyl chloride. The mixture was slowly warmed to room temperature and stirred for 6 hrs. The pyridine was distilled off. The residue was taken up in CH2Cl2 and 10% aq. Na2CO3. The organic phase was washed with H2O and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by column chromatography (silica gel, gradient: cyclohexane->cyclohexane/EtOAc 7:3) to give 628 mg (3S,4S)-3-azido-4-(toluene-4-sulfonyloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester as viscous yellow oil. MS 405.3 ([M+Na]+)

[Figure (not displayed)]

38.2 A solution of 440 mg (3S,4S)-3-azido-4-(toluene-4-sulfonyloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester in 8.6 ml 1M tetrabutylammonium fluoride solution in THF was stirred overnight at r.t. The reaction mixture was concentrated. The crude product was isolated by column chromatography (silica gel, gradient: cyclohexane->cyclohexane/EtOAc 1:1) to give 150 mg (3S,4R)-3-azido-4-fluoro-pyrrolidine-1-carboxylic acid tert-butyl ester as colorless liquid. MS 230 ([M])

[Figure (not displayed)]

38.3 Using analogous procedures as described in examples 22.3-22.6 (3S,4R)-3-azido-4-fluoro-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3S,4R)-4-fluoro-1-{[2-fluoro-4-(2-oxo-2-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. White solid. MS493.4 ([M+H]+)

[Figure (not displayed)]

Example 39

39.1 Using general procedure A 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-hydroxy-pyrrolidin-3-yl)-amide hydrochloride (example 22.5) was reacted with bromoacetic acid ethylester to give {(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-hydroxy-pyrrolidin-1-yl}-acetic acid ethyl ester. Light yellow solid. MS 333.3 ([M+H]+)

[Figure (not displayed)]

39.2 Using the same procedure as described in example 32.1 {(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-hydroxy-pyrrolidin-1-yl}-acetic acid ethyl ester was converted to {(S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-oxo-pyrrolidin-1-yl}-acetic acid ethyl ester. Amorphous gum. MS 333.1 ([M+H]+)

[Figure (not displayed)]

39.3 To a cooled (0° C.), stirred suspension of 44 mg potassium tert-butylate in 3 ml THF under an argon atmosphere were added 149 mg methyltriphenylphosphonium bromide. The yellow slurry was then stirred for 1 h 30, slowly warming up to room temperature. A solution of 100 mg {(S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-oxo-pyrrolidin-1-yl}-acetic acid ethyl ester in 2 ml THF was then added. The mixture was heated to reflux and stirred for 2 hrs. The mixture (dark brown slurry) was cooled to r.t., diluted with EtOAc, washed with sat. aq. NH4C1, H2O and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by column chromatography (silica gel, gradient: CH2Cl2->CH2Cl2/MeOH 95:5) to give 76 mg {(R)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methylene-pyrrolidin-1-yl}-acetic acid ethyl ester (contaminated with 43 w % triphenylphosphin oxide). Amorphous gum. MS 329.0 ([M+H]+)

[Figure (not displayed)]

39.4 Using general procedure F {(R)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methylene-pyrrolidin-1-yl}-acetic acid ethyl ester was reacted with 1-(4-amino-3-fluoro-phenyl)-1H-pyridin-2-one (CAS 536747-52-1, prepared according to WO 2003045912) to give 5-chloro-thiophene-2-carboxylic acid ((R)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-methylene-pyrrolidin-3-yl)-amide. Yellow solid. MS 487.2 ([M+H]+)

[Figure (not displayed)]

Example 40

40.1 (3R,4R)-Pyrrolidine-1,3,4-tricarboxylic acid 1-tert.-butyl ester 3-ethyl ester (CAS 595556-31-35 g; 17 mmol) was dissolved in toluene (50 ml), triethylamine (2.43 ml; 17 mmol) and diphenylphosphoryl azide (3.77 ml; 17 mmol) were added. The reaction mixture was stirred at 80° C. for 30 min. After that 2-(trimethylsilyl)ethanol (12.41 ml; 87 mmol) was added and the reaction mixture was stirred at 90° C. for 14 h. The reaction mixture was evaporated, dissolved in ethyl acetate and extracted with aqueous Na2CO3 and aqueous HCl (1N). The organic layers were combined and dried over Na2SO4. Flash chromatography over silica gel using DCM/MeOH/NH3 as eluent yielded 4.6 g (65.6%) (3S,4R)-4-(2-trimethylsilanyl-ethoxycarbonylamino)-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester. MS 403.5 [M+H+].

[Figure (not displayed)]

40.2 (3S,4R)-4-(2-Trimethylsilanylethoxycarbonylamino)-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester (1.4 g; 3 mmol) is dissolved in acetonitrile (15 ml) and TBAF (1.372 g; 4 mmol) is added under an argon atmosphere. The mixture is stirred for 18 h at 50° C. 5-Chlorothiophene-2-carboxylic acid (1.272 g; 8 mmol) is dissolved in THF (10 ml), N-methyl morpholine (0.86 ml; 8 mmol) followed by isobutyl chloroformate (1.03 ml; 8 mmol) is added at 0° C. to this solution. After 30 min stirring at 25° C. this solution is added to the reaction mixture above. After 18 h at 25° C. additional 0.5 equivalents of activated 5-chloro-thiophene-2-carboxylic acid is added. The whole mixture is stirred for 3 d at 25° C., evaporated to dryness, dissolved in DCM/THF and washed with 1N aq. HCl solution, 10% aq. Na2CO3 solution. The organic phase is dried over Na2SO4. Flash chromatography over silica gel using DCM/MeOH/NH3 as eluent yielded 0.522 g (37.2%) (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester. Light brown oil. MS 403.5 [M+H+].

[Figure (not displayed)]

40.3 Using general procedure B (3S,4R)-4-[(5-Chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester was converted into (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-3-carboxylic acid ethyl ester hydrochloride. Light yellow solid. MS 303.4 [M+H+].

[Figure (not displayed)]

40.4 Using general procedure A with THF as solvent (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-pyrrolidine-3-carboxylic acid ethyl ester hydrochloride was reacted with 2-bromo-[2-fluoro-4-(2-oxopyridin-1-yl)-phenyl]-acetamide to give (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl-carbamoyl]-methyl}-pyrrolidine-3-carboxylic acid ethyl ester. Light brown solid. MS 547.2 [M+H+].

[Figure (not displayed)]

Example 41

(3S,4R)-4-[(5-Chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-3-carboxylic acid ethyl ester (example 40.4; 0.11 g) is dissolved in THF/water (1:1; 3 ml) and LiOH hydrate (9 mg) is added to the suspension. The mixture is stirred for 2 h at 25° C. The solvent is evaporated to dryness to obtain 0.102 g (95%) lithium (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-3-carboxylate. White solid. MS 519.3 [M+H+].

[Figure (not displayed)]

Example 42

Lithium (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-3-carboxylate (example 41; 0.09 g) is dissolved in THF/DMF (1:1; 3 ml) and CDI (0.083 g) is added. The mixture is stirred for 1 h at 25° C., after that 2-(methylamino)-ethanol (0.03 ml) is added. The reaction mixture is stirred for 18 h at 25° C. and evaporated to dryness followed by flash chromatography over silica gel using DCM/MeOH/NH3 as eluent to yield 0.033 g (33.4%) (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-3-carboxylic acid (2-hydroxy-ethyl)-methyl-amide. White solid. MS 576.5 [M+H+].

[Figure (not displayed)]

Example 43

The preparation of (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-3-carboxylic acid (2,2-difluoro-ethyl)-amide is analogous to example 42 using 2,2-difluoroethylamine. White solid. MS 582.3 [M+H+].

[Figure (not displayed)]

Example 44

(3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidine-3-carboxylic acid ethyl ester (example 40.4; 1.2 g) is dissolved in ethanol (12 ml) under Ar-atmosphere. NaBH4 (4 equivalents) is added and the mixture is stirred for 18 h at 25° C. After that additional NaBH4 (5 equivalents) is added and the reaction mixture is stirred for further 24 h at 25° C. Further NaBH4 (11 equivalents) is added and the reaction mixture is stirred for 72 h at 25° C. to give 80% conversion of the ester to the alcohol. After that the reaction mixture is evaporated to dryness followed by flash chromatography over silica gel using DCM/MeOH/NH3 as eluent to yield 0.435 g (39.3%) 5-chloro-thiophene-2-carboxylic acid ((3R,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-methyl-pyrrolidin-3-yl)-amide. Pale yellow solid. MS 505.3 [M+H+].

[Figure (not displayed)]

Example 45

5-Chloro-thiophene-2-carboxylic acid ((3R,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxymethyl-pyrrolidin-3-yl)-amide (example 44; 2.0 g) is dissolved in dichloromethane (20 ml) under an argon atmosphere. Pyridine (0.48 ml) is dropped to this solution followed by mesylchloride (0.46 ml) at 0° C. The reaction mixture is stirred at 0° C. for 1 h. After that the reaction mixture is stirred at 25° C. for 48 h until conversion is complete. The reaction mixture is treated with SiO2 and evaporated to dryness followed by flash chromatography over silica gel using DCM/MeOH/NH3 as eluent to yield 1.75 g (75.8%) of methanesulfonic acid (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-ylmethyl ester. Off-white solid. MS 583.2 [M+H+].

[Figure (not displayed)]

Example 46

Methanesulfonic acid (3S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-ylmethyl ester (example 45; 50 mg) and azettidine (24 mg) are dissolved in DMF (1 ml) in a sealed tube. The reaction mixture is stirred for 72 h at 25° C. and purified with preparative HPLC to yield 16 mg (34.3%) 5-chloro-thiophene-2-carboxylic acid ((3R,4S)-4-azetidin-1-ylmethyl-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide diformiate as colorless gum. MS 544.3 [M+H+].

[Figure (not displayed)]

Example 47

5-Chloro-thiophene-2-carboxylic acid ((3R,4S)-4-cyclopropylaminomethyl-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide formiate was prepared according to the methods described for example 46 to yield 28 mg (30.0%) as light yellow solid. MS 544.3 [M+H+].

[Figure (not displayed)]

Example 48

5-Chloro-thiophene-2-carboxylic acid ((3R,4S)-4-cyclobutylaminomethyl-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide diformiate was prepared according to the methods described for example 46 to yield 39 mg (40.7%) as colorless amorphous solid. MS 558.2 [M+H+].

[Figure (not displayed)]

Example 49

5-Chloro-thiophene-2-carboxylic acid ((3R,4S)-4-[(cyclopropylmethyl-amino)-methyl]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide formiate was prepared according to the methods described for example 46 to yield 39 mg (40.7%) as light yellow amorphous solid. MS 558.2 [M+H+].

[Figure (not displayed)]

Example 50

(3R,4R)-4-[2-Fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-3-carboxylic acid ethyl ester hydrochloride (0.315 g; synthesis described in EP04101265.9 example 28 step 3) is suspended in acetonitrile (10 ml) and K2CO3 (0.425 g) is added as solid. 2-Bromo-N-(5-chloro-2-pyridinyl)-acetamide (0.23 g) is added and the reaction mixture is stirred at 25° C. for 18 h. After that the mixture is heated for 3 h to 80° C., cooled to 25° C. and filtered. The filtrate is evaporated to dryness followed by flash chromatography over silica gel using DCM/MeOH/NH3 as eluent to yield 0.203 g (46.3%) (3R,4R)-1-[(5-chloro-pyridin-2-ylcarbamoyl)-methyl]-4-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarba-moyl]-pyrrolidine-3-carboxylic acid ethyl ester. White solid. MS 542.3 [M+H+].

[Figure (not displayed)]

Example 51

Lithium (3R,4R)-1-[(5-chloro-pyridin-2-ylcarbamoyl)-methyl]-4-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-3-carboxylate is prepared from (3R,4R)-1-[(5-chloro-pyridin-2-ylcarbamoyl)-methyl]-4-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-3-carboxylic acid ethyl ester according to example 41. White solid. MS 514.3 [M+H+].

[Figure (not displayed)]

Example 54

50.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 5-chlorothiophene-2-carboxylic acid to give (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. Brown oil. MS 345.0 ([M+H]+)

[Figure (not displayed)]

50.2 Using general procedure C, (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Pale brown oil. MS 245.4 ([M+H]+)

[Figure (not displayed)]

50.3 Using general method G, 1-(4-amino-3-fluoro-phenyl)-1H-pyridin-2-one (prepared according to WO 2003045912) was activated with 4-nitrophenyl chloroformate to give [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester. Pale pink solid.

[Figure (not displayed)]

50.4 Using general method H, 5-chloro-thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester to give (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. White solid. MS 475.0 ([M+H]+)

[Figure (not displayed)]

Example 56

56.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 5-bromothiophene-2-carboxylic acid to give (R)-3-{[(5-bromo-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. Yellow oil. MS 389.0 ([M+H]+)

[Figure (not displayed)]

56.2 Using general procedure C, (R)-3-{[(5-bromo-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-bromo-thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoroacetate. Yellow oil. MS 288.9 ([M+H]+)

[Figure (not displayed)]

56.3 Using general method H. 5-bromo-thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (R)-3-{[(5-bromo-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. White solid. MS 521.3 ([M+H]+)

[Figure (not displayed)]

Example 57

57.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 5-bromo-4-methyl-thiophene-2-carboxylic acid (prepared according to M. Nemec et al., Collection of Czechoslovak Chemical Communications, 1974, 39, 3527) to give (R)-3-{[(5-bromo-4-methyl-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. White solid. MS 403.3 ([M−H])

[Figure (not displayed)]

57.2 Using general procedure C, (R)-3-{[(5-bromo-4-methyl-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-bromo-4-methyl-thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Colorless oil. MS 301.0 ([M−H])

[Figure (not displayed)]

57.3 Using general method H, 5-bromo-4-methyl-thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (R)-3-{[(5-bromo-4-methyl-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. White solid. MS 530.8 ([M−H])

[Figure (not displayed)]

Example 58

58.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 4,5-dibromothiophene-2-carboxylic acid to give (R)-3-{[(4,5-dibromo-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. White solid. MS 466.9 ([M−H])

[Figure (not displayed)]

58.2 Using general procedure C, (R)-3-{[(4,5-dibromo-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 4,5-dibromo-thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoroacetate. Pale yellow oil. MS 349.9 ([M+H]+)

[Figure (not displayed)]

58.3 Using general method H, 4,5-dibromo-thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (R)-3-{[(4,5-dibromo-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. Pale yellow solid. MS 598.8 ([M+H]+)

[Figure (not displayed)]

Example 59

59.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 5-bromo-furan-2-carboxylic acid to give (R)-3-{[(5-bromo-furan-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. Pale yellow solid. MS373.1 ([M−H])

[Figure (not displayed)]

59.2 Using general procedure C, (R)-3-{[(5-bromo-furan-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-bromo-furan-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Orange oil. MS 273.1 ([M+H]+) Br

[Figure (not displayed)]

59.3 Using general method H, 5-bromo-furan-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (R)-3-{[(5-bromo-furan-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. White solid. MS 504.9 ([M+H]+)

[Figure (not displayed)]

Example 60

60.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 4,5-dibromo-1H-pyrrole-2-carboxylic acid to give (R)-3-{[(4,5-dibromo-1H-pyrrole-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. Pale yellow solid. MS449.9 ([M−H])

[Figure (not displayed)]

60.2 Using general procedure C, (R)-3-{[(4,5-dibromo-1H-pyrrole-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 4,5-dibromo-1H-pyrrole-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoroacetate. Red oil. MS 349.9 ([M−H])

[Figure (not displayed)]

60.3 Using general method H, 4,5-dibromo-1H-pyrrole-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give 4,5-dibromo-1H-pyrrole-2-carboxylic acid {(R)-1-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidin-3-ylmethyl}-amide. White solid. MS 582.1 ([M+H]+)

[Figure (not displayed)]

Example 61

61.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 2-chloro-thiazole-4-carboxylic acid (prepared according to R. Walsh et al. Chimica Therapeutica, 1973, 8, 199) to give (R)-3-{[(2-chloro-thiazole-4-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. White solid. MS 343.9 ([M−H])

[Figure (not displayed)]

61.2 Using general procedure C, (R)-3-{[(2-chloro-thiazole-4-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 2-chloro-thiazole-4-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Pale yellow oil. MS 246.1 ([M+H]+)

[Figure (not displayed)]

61.3 Using general method H, 2-chloro-thiazole-4-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give 2-chloro-thiazole-4-carboxylic acid {(R)-1-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidin-3-ylmethyl}-amide. White solid. MS 476.0 ([M+H]+)

[Figure (not displayed)]

Example 62

62.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 4-chloro-benzoic acid to give (R)-3-[(4-chloro-benzoylamino)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester. Yellow oil. MS 339.3 ([M+H]+)

[Figure (not displayed)]

62.2 Using general procedure C, (R)-3-[(4-chloro-benzoylamino)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 4-chloro-N—(S)-1-pyrrolidin-3-ylmethyl-benzamide trifluoro acetate. Yellow oil. MS 239.3 ([M+H]+)

[Figure (not displayed)]

62.3 Using general method H, 4-chloro-N—(S)-1-pyrrolidin-3-ylmethyl-benzamide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (R)-3-[(4-chloro-benzoylamino)-methyl]-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. White solid. MS 469.0 ([M+H]+)

[Figure (not displayed)]

Example 63

63.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 6-chloro-nicotinic acid to give (R)-3-{[(6-chloro-pyridine-3-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. Yellow oil. MS 340.1 ([M+H]+)

[Figure (not displayed)]

63.2 Using general procedure C, (R)-3-{[(6-chloro-pyridine-3-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 6-chloro-N—(S)-1-pyrrolidin-3-ylmethyl-nicotinamide trifluoro acetate. Yellow oil. MS 240.3 ([M+H]+)

[Figure (not displayed)]

63.3 Using general method H, 6-chloro-N—(S)-1-pyrrolidin-3-ylmethyl-nicotinamide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give 6-chloro-N-{(R)-1-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidin-3-ylmethyl}-nicotinamide. White solid. MS 470.1 ([M+H]+)

[Figure (not displayed)]

Example 64

64.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 4-methoxy-benzoic acid to give (R)-3-[(4-methoxy-benzoylamino)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester. Yellow oil. MS 335.1 ([M+H]+)

[Figure (not displayed)]

64.2 Using general procedure C, (R)-3-[(4-methoxy-benzoylamino)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 4-methoxy-N—(S)-1-pyrrolidin-3-ylmethyl-benzamide trifluoro acetate. Yellow oil. MS 235.1 ([M+H]+)

[Figure (not displayed)]

64.3 Using general method H, 4-methoxy-N—(S)-1-pyrrolidin-3-ylmethyl-benzamide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (R)-3-[(4-methoxy-benzoylamino)-methyl]-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. White solid. MS 465.0 ([M+H]+)

[Figure (not displayed)]

Example 65

65.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 6-chloro-benzo[b]thiophene-2-carboxylic acid (prepared according to WO 2001007436) to give (R)-3-{[(6-chloro-benzo[b]thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. White solid. MS 392.9 ([M−H])

[Figure (not displayed)]

65.2 Using general procedure C, (R)-3-{[(6-chloro-benzo[b]thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 6-chloro-benzo[b]thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Colorless oil. MS 293.1 ([M−H])

[Figure (not displayed)]

65.3 Using general method H, 6-chloro-benzo[b]thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (R)-3-{[(6-chloro-benzo[b]thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. White solid. MS 523.2 ([M−H])

[Figure (not displayed)]

Example 66

66.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 5-chloro-benzo[b]thiophene-2-carboxylic acid to give (R)-3-{[(5-chloro-benzo[b]thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. White solid. MS 392.9 ([M−H])

[Figure (not displayed)]

66.2 Using general procedure C, (R)-3-{[(5-chloro-benzo[b]thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-benzo[b]thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Pale yellow oil. MS 293.0 ([M−H])

[Figure (not displayed)]

66.3 Using general method H, 5-chloro-benzo[b]thiophene-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (R)-3-{[(5-chloro-benzo[b]thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. Pale yellow solid. MS 523.0 ([M−H])

[Figure (not displayed)]

Example 67

67.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 5-chloro-benzofuran-2-carboxylic acid to give (R)-3-{[(5-chloro-benzofuran-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. White solid. MS377.3 ([M−H])

[Figure (not displayed)]

67.2 Using general procedure C, (R)-3-{[(5-chloro-benzofuran-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-benzofuran-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Pale yellow oil. MS 277.1 ([M−H])

[Figure (not displayed)]

67.3 Using general method H, 5-chloro-benzofuran-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (R)-3-{[(5-chloro-benzofuran-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. Pale yellow solid. MS 507.0 ([M−H])

[Figure (not displayed)]

Example 68

68.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 6-chloro-1H-indole-2-carboxylic acid to give (R)-3-{[(6-chloro-1H-indole-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. Pale yellow solid. MS376.1 ([M−H])

[Figure (not displayed)]

68.2 Using general procedure C, (R)-3-{[(6-chloro-1H-indole-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 6-chloro-1H-indole-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Pale yellow solid. MS 276.0 ([M−H])

[Figure (not displayed)]

68.3 Using general method H, 6-chloro-1H-indole-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give 6-chloro-1H-indole-2-carboxylic acid {(R)-1-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidin-3-ylmethyl}-amide. Pale yellow solid. MS 506.1 ([M−H])

[Figure (not displayed)]

Example 69

69.1 Using general procedure E, (R)-3-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 5-chloro-1H-indole-2-carboxylic acid to give (R)-3-{[(5-chloro-1H-indole-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. Pale yellow solid. MS 376.4 ([M−H])

[Figure (not displayed)]

69.2 Using general procedure C, (R)-3-{[(5-chloro-1H-indole-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-1H-indole-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Pale yellow solid. MS 276.0 ([M−H])

[Figure (not displayed)]

69.3 Using general method H, 5-chloro-1H-indole-2-carboxylic acid ((S)-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give 5-chloro-1H-indole-2-carboxylic acid {(R)-1-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidin-3-ylmethyl}-amide. Pale yellow solid. MS 506.1 ([M−H])

[Figure (not displayed)]

Example 73

73.1 To a solution of 10.96 g of 4-bromo-2-fluoro-benzoic acid in 40 ml of DMSO was added subsequently 6.67 g of 2-hydroxypyridine, 1.10 g of 8-hydroxyquinoline, 1.43 g of Cu(I)I and 7.61 g of K2CO3 and the mixture was heated to 150° C. for 18 h. The suspension was diluted with water, filtered, the residue was washed with AcOEt, triturated with MeOH, filtered and dried to give 5.77 g of 2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-benzoic acid. MS: 234.1 (M+H)+

[Figure (not displayed)]

73.2 Using general method E, rac-5-chloro-thiophene-2-carboxylic acid-1-pyrrolidin-3-ylmethyl)-amide trifluoro acetate (prepared according to example 54.1-54.2) was reacted with 2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-benzoic acid to give rac-5-chloro-thiophene-2-carboxylic acid {1-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-benzoyl]-pyrrolidin-3-ylmethyl}-amide. White solid. MS 460.3 ([M+H]+)

[Figure (not displayed)]

Example 74

74.1 Using the method described in example 73.1, 1,4-diiodobenzene was reacted with 2-hydroxypyridine to give 1-(4-iodo-phenyl)-1H-pyridin-2-one. Pale yellow solid. MS: 298.1 (M+H)+

[Figure (not displayed)]

74.2 According to M. Hepperle et al. (Tetrahedron Letters, 2002, 43, 3359), a mixture of rac-5-chloro-thiophene-2-carboxylic acid-1-pyrrolidin-3-ylmethyl)-amide (27 mg, prepared according to example 54.1-54.2) and 1-(4-iodo-phenyl)-1H-pyridin-2-one (30 mg), in toluene (0.5 ml) and THF (0.25 ml) was treated with rac-2,2′-bis-(diphenylphosphino)-1,1′-binaphtaline (4 mg), tris-(dibenzylideneacetone)-dipalladium chloroform complex (2.5 mg) and a solution of NaOt-Bu (17 mg) in THF (0.25 ml) and heated to reflux temperature for 5 h. The mixture was partitioned between 1 N HCl and AcOEt, the organic layer was dried and evaporated. The crude material was purified by preparative thin layer chromatography on silica using CH2Cl2/MeOH (9:1) to give rac-5-chloro-thiophene-2-carboxylic acid {1-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-pyrrolidin-3-ylmethyl}-amide. Yellow oil. MS 414.0 ([M+H]+)

[Figure (not displayed)]

Example 75

75.1 Using general procedure E, rac-2-aminomethyl-1-N-tert-butoxycarbonyl-pyrrolidine was coupled with 5-chlorothiophene-2-carboxylic acid to give rac-2-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. Brown oil. MS 345.0 ([M+H]+)

[Figure (not displayed)]

75.2 Using general procedure C, rac-2-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to rac-5-chloro-thiophene-2-carboxylic acid (pyrrolidin-2-ylmethyl)-amide trifluoro acetate. Red oil. MS 245.4 ([M+H]+)

[Figure (not displayed)]

75.3 Using general method H, rac-5-chloro-thiophene-2-carboxylic acid (pyrrolidin-2-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give rac-2-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. Pale yellow solid. MS 475.1 ([M+H]+)

[Figure (not displayed)]

Example 76

Using general method H, rac-5-chloro-thiophene-2-carboxylic acid (pyrrolidin-2-ylmethyl)-amide trifluoro acetate (example 75.2) was reacted with 2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-benzoic acid (prepared according to example 54.1) to give rac-5-chloro-thiophene-2-carboxylic acid {1-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-benzoyl]-pyrrolidin-2-ylmethyl}-amide. White solid. MS 460.0 ([M+H]+)

[Figure (not displayed)]

Example 77

77.1 Using general procedure H, (3S,4S)-(4-trifluoromethyl-pyrrolidin-3-ylmethyl)-carbamic acid tert-butyl ester (H. Fukui et al., Bioorganic & Medicinal Chemistry Letters, 1998, 8, 2833) was coupled with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give {(3R,4S)-1-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-4-trifluoromethyl-pyrrolidin-3-ylmethyl}-carbamic acid tert-butyl ester. Orange oil. MS 499.3 ([M+H]+)

[Figure (not displayed)]

77.2 Using general method C, {(3R,4S)-1-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-4-trifluoromethyl-pyrrolidin-3-ylmethyl}-carbamic acid tert-butyl ester was converted to (3R,4S)-3-aminomethyl-4-trifluoromethyl-pyrrolidine-1-carboxylic acid [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide trifluoro acetate. Red oil. MS 399.1 ([M+H]+)

[Figure (not displayed)]

77.3 Using general method E, (3R,4S)-3-aminomethyl-4-trifluoromethyl-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide trifluoro acetate was coupled with 5-chlorothiophene-2-carboxylic acid to give (3R,4S)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-trifluoromethyl-pyrrolidine-1-carboxy-lic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. White solid. MS 443.0 ([M+H]+)

[Figure (not displayed)]

Example 79

79.1 To a solution of 17.1 g (98.2% GC purity) of trans, rac-3-cyano-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (prepared according to C. Y. Hong et al. (Bioorganic Medicinal Chemistry Letters, 2003, 13, 4399), by D. J. Kim et al. (Journal of Medicinal Chemistry, 1997, 40, 3584) or by S. U. Hansen & M. Bols (Acta Chemica Scandinavica, 1997, 52, 1214)) in 765 ml of t-butylmethyl ether and 85 ml of vinyl acetate was added 21.3 g of Lipase AK (Amano Enzyme Inc.) and the suspension was stirred at 22° C. until ca. 54% conversion (as calculated from the ee-values of substrate and product according to C. J. Sih et al. (J. Am. Chem. Soc., 1982, 104, 7294)) was reached. The enzyme was filtered off, the filtrate evaporated in vacuo and the residual oil chromatographed on 400 g silicagel (0.040-0.063 mm; dichloromethane/diethyl ether 9:1→3:1) to give the formed optically enriched (S,S)-3-acetoxy-4-cyano-pyrrolidine-1-carboxylic acid tert-butyl ester (10.7 g; 84% ee, optically further enriched in example 60.2) and the retained (R,R)-3-cyano-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (6.9 g). Analytics: +EI-MS: 213.3 (M+H+); [α]D=+1.20° (c=1.00, CHCl3); 97.8% ee (GC on BGB-176; 30 m×0.25 mm; H2; 90 kPa; 130° C. to 200° C. with 2° C./min; inj. 200° C.).

79.2 The optically enriched (S,S)-3-acetoxy-4-cyano-pyrrolidine-1-carboxylic acid tert-butyl ester (10.4 g, 84% ee) was dissolved in 500 ml of t-butylmethyl ether (slow). The solution was emulsified under vigorous stirring with 4 l of 0.1M NaCl, 3.7 mM sodium phosphate buffer pH 7.0. Hydrolysis was started by adding 750 mg of Chirazyme L-2 (Roche Applied Sciences) and the pH was kept at 7.0 by the controlled addition of 0.1 M NaOH-solution

[Figure (not displayed)]
(pH-stat) under vigorous stirring at r.t. After a consumption of 51.3 ml 0.1M NaOH-solution (after 91 h) the reaction mixture was extracted with 4 l and 2×3 l of dichloromethane (uncomplete phase separation due to intermediate phase). The combined organic phases were concentrated and the residual oil chromatographed on 150 g silicagel (0.040-0.063 mm; dichloromethane/diethyl ether 9:1) to give the retained optically further enriched (S,S)-3-acetoxy-4-cyano-pyrrolidine-1-carboxylic acid tert-butyl ester (8.1 g). Analytics: +EI-MS: 255 (M+H+); [α]D=−11.88° (c=1.02, CHCl3); 98.7% ee (GC on BGB-176; 30 m×0.25 mm; H2; 90 kPa; 130° C. to 200° C. with 2° C./min; inj. 200° C.).

79.3 A suspension of (3S,4S)-3-acetoxy-4-cyano-pyrrolidine-1-carboxylic acid tert-butyl ester (89 mg) in 10 ml of AcOEt and 0.2 ml of chloroform, 0.2 ml of AcOH and 4 mg of PtO2 was hydrogenated at 22° C. and atmospheric pressure for 16 h. The suspension was filtered and the filtrate evaporated to give (3S,4R)-3-acetoxy-4-aminomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester acetate. Colorless semisolid. MS 259.3 ([M+H]+)

[Figure (not displayed)]

79.4 Using general procedure E, (3S,4R)-3-acetoxy-4-aminomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester acetate was coupled with 5-chlorothiophene-2-carboxylic acid to give (3S,4R)-3-acetoxy-4-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester. Brown oil. MS 347.0 ([M-iso-butene+H]+)

[Figure (not displayed)]

79.5 A solution of (3S,4R)-3-acetoxy-4-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester (20 mg) in 1 ml of a 2M NH3 solution in MeOH was stirred at 22° C. for 1 h and evaporated to give (3R,4S)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester. Pale brown oil. MS 305.1 ([M-isobutene+H]+)

[Figure (not displayed)]

79.6 Using general method C, (3R,4S)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to (3S,4S)-5-chloro-thiophene-2-carboxylic acid (4-hydroxy-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Yellow oil. MS 261.0 ([M+H]+)

[Figure (not displayed)]

79.7 Using general method H, to (3S,4S)-5-chloro-thiophene-2-carboxylic acid (4-hydroxy-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (3R,4S)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-hydroxy-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. Colorless solid. MS 491.0 ([M+H]+)

[Figure (not displayed)]

Example 80

80.1 A solution of (3S,4S)-3-acetoxy-4-cyano-pyrrolidine-1-carboxylic acid tert-butyl ester (1.00 g, prepared according to example 79.2) in 10 ml of a 2M NH3 solution in MeOH was stirred at 22° C. for 1 h and evaporated. The residue was chromatographed on silica (heptane/AcOEt, 2.5:1) to give (3S,4S)-3-cyano-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester. Colorless solid. MS 213.3 ([M+H]+)

[Figure (not displayed)]

80.2 A suspension of (3S,4S)-3-cyano-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (212 mg) in 10 ml of THF and 2.32 g of Ag2O and 0.62 ml of CH3I was heated in a sealed tube to 50° C. for 16 h. The suspension was filtered and the filtrate chromatographed on silica (heptane/AcOEt, 3:1) to give 161 mg of (3S,4S)-3-cyano-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester. Colorless oil. MS 171.4 ([M-isobutene+H]+)

[Figure (not displayed)]

80.3 A suspension of (3S,4S)-3-cyano-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester (150 mg) in 15 ml of EtOH, 0.3 ml of chloroform, 0.38 ml of AcOH and 8 mg of PtO2 was hydrogenated at 22° C. and atmospheric pressure for 16 h. The suspension was filtered and the filtrate evaporated to give 188 mg of (3R,4S)-3-aminomethyl-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester acetate. Colorless semisolid. MS 231.3 ([M+H]+)

[Figure (not displayed)]

80.4 Using general procedure E, (3R,4S)-3-aminomethyl-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester acetate was coupled with 5-chlorothiophene-2-carboxylic acid to give (3R,4S)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester. Colorless foam. MS 318.9 ([M−isobutene+H]+)

[Figure (not displayed)]

80.5 Using general method C, (3R,4S)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-methoxy-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Pale yellow oil. MS 275.1 ([M+H]+)

[Figure (not displayed)]

80.6 Using general method H, 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-methoxy-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (3R,4S)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-methoxy-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. Pale yellow solid. MS 505.1 ([M+H]+)

[Figure (not displayed)]

Example 81

81.1 To a solution of (3R,4S)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (600 mg, prepared according to example 79.5) in 10 ml of CH2Cl2 was added at 5° C. 2.30 ml of NEt3 and 1.59 g of SO3-pyridine complex, the solution was warmed to 22° C. and stirring was continued for 3 h. The mixture was washed with aqueous NH4Cl, the organic layer was dried and evaporated. The residue was chromatographed on silica (heptane/AcOEt, 2:1) to give 435 mg of (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester. Pale yellow solid. MS 303.0 ([M-isobutene+H]+)

[Figure (not displayed)]

81.2 Using general method C, (R)-3-1{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((S)-4-oxo-pyrrolidin-3-ylmethyl)-amide trifluoro acetate. Green oil. MS 259.0 ([M+H]+)

[Figure (not displayed)]

81.3 Using general method H, 5-chloro-thiophene-2-carboxylic acid ((S)-4-oxo-pyrrolidin-3-ylmethyl)-amide trifluoro acetate was reacted with [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-carbamic acid 4-nitro-phenyl ester (prepared according to example 54.3) to give (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-oxo-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. Pale brown solid. MS 489.0 ([M+H]+)

[Figure (not displayed)]

Example 82

To a solution of (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-oxo-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide (example 81.3; 50 mg) in 2 ml of THF was added at 22° C. 12 mg of NaBH4 and stirring was continued for 1.5 h. The mixture was partitioned between 1 N HCl and AcOEt, the organic layer was washed with brine, dried and evaporated to give (3R,4R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-hydroxy-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. White solid. MS491.3 ([M+H]+)

[Figure (not displayed)]

Example 83

A solution of the (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-oxo-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide (120 mg, example 81.3) and 12 ml of THF saturated with methylamine was treated at 5° C. with 3.5 ml of AcOH until pH=6 and the mixture was warmed to 22° C. After 1.5 h, the mixture was treated with 24 mg of Na(CN)BH3 and stirring was continued for 2.5 h. The mixture was diluted with 5 ml of water, the pH was adjusted to 14 using 3 N NaOH and the solution was extracted with THF. The organic layer was dried and evaporated to give (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-methylamino-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. Colorless foam. MS 504.0 ([M+H]+)

[Figure (not displayed)]

Example 84

To a solution of (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-methylamino-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide (example 83; 25 mg) in 0.8 ml of CH3CN and 19-II of N,N-diisopropylethylamine was added at 22° C. 6 mg of methylchloroformate and stirring was continued for 3 h. The mixture was diluted with 0.5 ml of MeOH, evaporated and the residue was chromatographed on silica (AcOEt/MeOH, 15:1) to give {(R)-4-1{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-1-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl-carbamoyl]-pyrrolidin-3-yl}-methyl-carbamic acid methyl ester. Colorless solid. MS 562.0 ([M+H]+)

[Figure (not displayed)]

Example 85

To a solution of (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-methylamino-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide (example 83; 26 mg) in 0.8 ml of CH3CN and 22 μl of N,N-diisopropylethylamine was added at 22° C. 6 μl of methanesulfonylchloride and stirring was continued for 3 h. The mixture was diluted with 0.5 ml of MeOH, evaporated and the residue was chromatographed on silica (AcOEt/MeOH, 15:1) to give (R)-3-{[(5-chloro-thiophene-2-carbonyl)-amino]-methyl}-4-(methanesulfonyl-methyl-amino)-pyrrolidine-1-carboxylic acid[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide. Colorless solid. MS 582.0 ([M+H]+)

[Figure (not displayed)]

Example 87

In analogy to examples 17.3-17.5 (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methanesulfonyloxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (example 17.2) was reacted with 3,3-difluoropyrrolidine and then converted to 5-chloro-thiophene-2-carboxylic acid ((3R,5S)-5-(3,3-difluoro-pyrrolidin-1-ylmethyl)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Light yellow amorphous solid. MS 594.3 ([M+H]+)

[Figure (not displayed)]

Example 88

In analogy to examples 17.3-17.5 (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methanesulfonyloxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (example 17.2) was reacted with cyclopropylamine and then converted to 5-chloro-thiophene-2-carboxylic acid ((3R,5S)-5-cyclopropylaminomethyl-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl-carbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Off-white amorphous solid. MS 544.2 ([M+H]+)

[Figure (not displayed)]

Example 89

89.1 To a stirred, cooled (0° C.) solution of 1.48 g (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-hydroxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (example 17.1) in 30 ml CH2Cl2/DMSO 1:1 under an argon atmosphere were added 5.7 ml triethylamine and 3.92 g SO3-pyridine complex in one portion. The clear solution (slowly warming up to room temperature) was then stirred for 3 h. The mixture was diluted with EtOAc and washed with 1 N HCl. The aqueous phase was back extracted with EtOAc. The combined organics were washed with 1 N HCl, H2O and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by chromatography (silica gel; cyclohexane/EtOAc 1:1) to give 985 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-formyl-pyrrolidine-1-carboxylic acid tert-butyl ester as white amorphous solid. MS 359.0 ([M+H]+)

[Figure (not displayed)]

89.2 A mixture of 200 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-formyl-pyrrolidine-1-carboxylic acid tert-butyl ester, 90 mg 2,2-difluorethyl amine (solution in 1 ml THF) and 0.33 ml tetraisopropyl orthotitanate was stirred at r.t. for 1 h 30. The mixture was diluted with 1.5 ml ethanol and 35 mg NaBH3CN was added. Stirring at r.t. was continued for 18 h. Then, 0.5 ml H2O was added and stirring was continued for 30 min. The mixture was concentrated. The crude product was purified by column chromatography (silica gel; gradient: cyclohexane->cyclohexane/EtOAc 3:7) to give 105 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-[(2,2-difluoro-ethylamino)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester as white amorphous solid. MS 424.0 ([M+H]+)

[Figure (not displayed)]

89.3 In analogy to examples 17.4 and 17.5 (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-[(2,2-difluoro-ethylamino)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3R,5S)-5-[(2,2-difluoro-ethylamino)-methyl]-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Light yellow amorphous solid. MS 568.2 ([M+H]+)

[Figure (not displayed)]

Example 90

90.1 To a stirred, cooled (0° C.) suspension of 55 mg NaH (55% dispersion in mineral oil) in 2 ml DMF under an argon atmosphere was added 84 mg 2,2-difluoroethanol (solution in 1 ml DMF). The ice bath was removed and stirring at r.t. was continued for 1 h. A solution of 150 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methanesulfonyloxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (example 17.2) in 2 ml DMF was then added. The mixture was heated to 80° C. and stirring at that temperature was continued for 21 h. The mixture was cooled to r.t., diluted with EtOAc and washed with H2O. The aqueous phase was back extracted with EtOAc. The combined organics were washed with H2O and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by column chromatography (silica gel; cyclohexane->cyclohexane/EtOAc 1:1) to give 12 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-(2,2-difluoro-ethoxymethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester as colorless gum. MS 425.0 ([M+H]+)

[Figure (not displayed)]

90.2 In analogy to examples 17.4 and 17.5 (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-(2,2-difluoro-ethoxymethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3R,5S)-5-(2,2-difluoro-ethoxymethyl)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Off-white solid. MS 569.2 ([M+H]+)

[Figure (not displayed)]

Example 91

91.1 To a stirred solution of 150 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-methanesulfonyloxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (example 17.2) at r.t. in 3.3 ml DMF under an argon atmosphere was added 1.71 ml tetrabutylammonium fluoride solution (1 M in THF). The mixture was heated to 80° C. and stirring at that temperature was continued for 19 h. The mixture was cooled to r.t., diluted with EtOAc and washed with H2O. The aqueous phase was back extracted with EtOAc. The combined organics were washed with H2O and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by column chromatography (silica gel; cyclohexane->cyclohexane/EtOAc 1:1) to give 44 mg (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-fluoromethyl-pyrrolidine-1-carboxylic acid tert-butyl ester as off-white amorphous solid. MS 361.0 ([M−H])

[Figure (not displayed)]

91.2 In analogy to examples 17.4 and 17.5 (2S,4R)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-2-fluoromethyl-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3R,5S)-5-fluoromethyl-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Light yellow amorphous solid. MS 507.3 ([M+H]+)

[Figure (not displayed)]

Example 92

In analogy to example 25.3 {(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidin-1-yl}-acetic acid ethyl ester (example 25.2) was reacted with 3-(4-amino-3-fluoro-phenyl)-oxazolidin-2-one (prepared from 2-fluoro-4-iodoaniline and 2-oxazolidinone in the presence of Cu(I)I, ethylenediamine and potassium phosphate in dioxane at 110° C.) to give 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-oxazolidin-3-yl)-phenylcarbamoyl]-methyl}-4-methoxy-pyrrolidin-3-yl)-amide as yellow solid. MS 497.5 ([M+H]+)

[Figure (not displayed)]

Example 93

In analogy to example 25.3 {(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidin-1-yl}-acetic acid ethyl ester (example 25.2) was reacted with 5-methyl-4,5,6,7-tetrahydro-thiazolo[5,4]pyridin-2-ylamine (CAS 17899-48-8) to give 5-chloro-thiophene-2-carboxylic acid {(3S,4S)-4-methoxy-1-[(5-methyl-4,5,6,7-tetrahydro-thiazolo[5,4]pyridin-2-ylcarbamoyl)-methyl]-pyrrolidin-3-yl}-amide as yellow solid. MS 470.5 ([M+H]+)

[Figure (not displayed)]

Example 94

94.1 In analogy to example 25.3 {(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidin-1-yl}-acetic acid ethyl ester (example 25.2) was reacted with 2-amino-6,7-dihydro-thiazolo[5,4]pyridine-5-carboxylic acid tert-butyl ester (CAS 365996-05-0) to give 2-(2-{(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidin-1-yl}-acetylamino)-6,7-dihydro-thiazolo[5,4-]pyridine-5-carboxylic acid tert-butyl ester as off-white solid. MS 556.3 ([M+H]+)

[Figure (not displayed)]

94.2 According to general procedure B 2-(2-{(3S,4S)-3-[(5-chloro-thiophene-2-carbonyl)-amino]-4-methoxy-pyrrolidin-1-yl}-acetylamino)-6,7-dihydro-thiazolo[5,4-]pyridine-5-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid {(3S,4S)-4-methoxy-1-[(4,5,6,7-tetrahydro-thiazolo[5,4]pyridin-2-ylcarbamoyl)-methyl]-pyrrolidin-3-yl}-amide dihydrochloride. Off-white solid. MS 456.4 ([M+H]+)

[Figure (not displayed)]

94.3 A suspension of 60 mg 5-chloro-thiophene-2-carboxylic acid {(3S,4S)-4-methoxy-1-[(4,5,6,7-tetrahydro-thiazolo[5,4]pyridin-2-ylcarbamoyl)-methyl]-pyrrolidin-3-yl}-amide dihydrochloride in 3 ml THF was treated with 0.03 ml TEA and 0.01 ml 2-iodopropane. After stirring at r.t. overnight, the reaction mixture was again treated with 0.03 ml TEA and 0.03 ml 2-iodopropane and heated to 70° C. overnight. Then, it was concentrated. The crude product was purified by column chromatography (silica gel; gradient: CH2Cl2->CH2Cl2/MeOH 9:1) to give 51 mg 5-chloro-thiophene-2-carboxylic acid {(3S,4S)-1-[(5-isopropyl-4,5,6,7-tetrahydro-thiazolo[5,4]pyridin-2-ylcarbamoyl)-methyl]-4-methoxy-pyrrolidin-3-yl}-amide as yellow solid. MS 498.4 ([M+H]+)

[Figure (not displayed)]

Example 95

In analogy to example 94.3 5-chloro-thiophene-2-carboxylic acid {(3S,4S)-4-methoxy-1-[(4,5,6,7-tetrahydro-thiazolo[5,4]pyridin-2-ylcarbamoyl)-methyl]-pyrrolidin-3-yl}-amide dihydrochloride (example 94.2) was reacted with 1-(bromomethyl)cyclopropane to give 5-chloro-thiophene-2-carboxylic acid {(3S,4S)-1-[(5-cyclopropylmethyl-4,5,6,7-tetrahydro-thiazolo[5,4]pyridin-2-ylcarbamoyl)-methyl]-4-methoxy-pyrrolidin-3-yl}-amide. Yellow solid. MS 510.5 ([M+H]+)

[Figure (not displayed)]

Example 96

96.1 A suspension of 210 mg NaH (55% in mineral oil) in 3 ml DMF was treated at 0° C. with 1.0 g (3S,4S)-3-azido-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester in 6 ml DMF. The reaction mixture was stirred at 0° C. for 90 min, then it was cooled to 0° C. A solution of 0.53 ml ethyl bromoacetate was added dropwise. The reaction mixture was slowly warmed to r.t., stirred overnight, then heated for 1 hr at 50° C. After cooling to r.t. the mixture was taken up in EtOAc and washed with H2O. The combined organics were dried over MgSO4, filtrated and concentrated. The crude product was purified by column chromatography (silica gel; cyclohexane->cyclohexane/EtOAc 3:2) to give 584 mg (3S,4S)-3-azido-4-ethoxycarbonylmethoxy-pyrrolidine-1-carboxylic acid tert-butyl ester as yellow liquid. MS 315.2 ([M+H]+)

[Figure (not displayed)]

96.2 In analogy to examples 22.3-22.6 (3S,4S)-3-azido-4-ethoxycarbonylmethoxy-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to ((3S,4S)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yloxy)-acetic acid ethyl ester. White amorphous solid. MS 577.5 ([M+H]+)

[Figure (not displayed)]

Example 97

A solution of 359 mg ((3S,4S)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yloxy)-acetic acid ethyl ester (example 96.2) in 10 ml THF was treated with 1.24 ml 1N NaOH and stirred for 5 hrs at r.t. The reaction mixture was concentrated. The crude product was purified by chromatography (silica gel; gradient: CH2Cl2->CH2Cl2/MeOH 7:3) to give 279 mg ((3S,4S)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yloxy)-acetic acid as white solid. MS 549.3 ([M+H]+)

[Figure (not displayed)]

Example 98

A solution of 50 mg ((3S,4S)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yloxy)-acetic acid (example 97) in 1 ml DMF was treated with 264 mg ammonium chloride, 21 mg EDCI, 3 mg DMAP and 0.04 ml TEA. The reaction mixture was stirred over night at r.t., then concentrated. The crude product was isolated by column chromatography (silica gel; gradient: CH2Cl2->CH2Cl2/MeOH 4:1) to give 23 mg 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-carbamoylmethoxy-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarba-moyl]-methyl}-pyrrolidin-3-yl)-amide as white solid. MS 548.0 ([M+H]+)

[Figure (not displayed)]

Example 99

According to general procedure D ((3S,4S)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yloxy)-acetic acid (example 97) was reacted with cyclopropylamine to give 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-cyclopropylcarbamoylmethoxy-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. White solid. MS588.5 ([M+H]+)

[Figure (not displayed)]

Example 100

According to general procedure D ((3S,4S)-4-[(5-chloro-thiophene-2-carbonyl)-amino]-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yloxy)-acetic acid (example 97) was reacted with dimethylamine hydrochloride to give 5-chloro-thiophene-2-carboxylic acid ((3S,4S)-4-dimethylcarbamoylmethoxy-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Off-white solid. MS576.3 ([M+H]+)

[Figure (not displayed)]

Example 101

101.1 To a stirred, cooled (0° C.) solution of 3.18 g N-benzyl-N-(methoxymethyl)trimethyl-silylmethylamine (CAS 93102-05-7) in 30 ml CH2Cl2 under an argon atmosphere was added dropwise a solution of 1.69 g (E)-3-cyclopropyl-acrylic acid methyl ester (CAS 59939-11-6; J. Org. Chem. 1990, 55(10), 3097) in 15 ml CH2Cl2 over a period of 20 min. Then a solution of 0.1 ml TFA in 5 ml CH2Cl2 was added dropwise within 10 min. When addition was complete, the mixture (slowly warming up to room temperature) was stirred overnight. Then, the mixture was diluted with CH2Cl2, washed with sat. aq. NaHCO3 and brine, dried over MgSO4, filtered and concentrated. The crude product was isolated by chromatography (silica gel; (gradient: cyclohexane->cyclohexane/EtOAc 7:3) to give 1.14 g (3RS,4RS)-1-benzyl-4-cyclopropyl-pyrrolidine-3-carboxylic acid methyl ester as light yellow oil. MS 260.3 ([M+H]+)

[Figure (not displayed)]

101.2 To a stirred solution of 1.13 g (3RS,4RS)-1-benzyl-4-cyclopropyl-pyrrolidine-3-carboxylic acid methyl ester at r.t. in 10 ml methanol under an argon atmosphere was added 113 mg 10% Pd/C. The mixture was then stirred at r.t. under a hydrogen atmosphere overnight. The catalyst was filtered off and rinsed with methanol. The filtrate was concentrated to leave 630 mg (3RS,4RS)-4-cyclopropyl-pyrrolidine-3-carboxylic acid methyl ester as a light yellow oil. MS170.3 ([M+H]+)

[Figure (not displayed)]

101.3 To a stirred, cooled (0° C.) solution of 625 mg (3RS,4RS)-4-cyclopropyl-pyrrolidine-3-carboxylic acid methyl ester in 6 ml dichloromethane under an argon atmosphere were added 0.51 ml triethylamine and 0.30 ml pyridine. To this was added a solution of 806 mg Boc2O in 4 ml CH2Cl2 over a period of 10 min. The ice bath was removed and stirring at r.t. was continued overnight. The mixture was diluted with CH2Cl2, washed with 0.5 N HCl, H2O and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by column chromatography (silica gel; cyclohexane->cyclohexane/EtOAc 3:1) to give 635 mg (3RS,4RS)-4-cyclopropyl-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-methyl ester as colorless viscous oil. MS 292.1 ([M+H]+)

[Figure (not displayed)]

101.4 To a stirred solution of 630 mg (3RS,4RS)-4-cyclopropyl-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-methyl ester at r.t. in 5 ml ethanol under an argon atmosphere was added 4.7 ml 1 N NaOH. The mixture was then stirred for 4 h, then concentrated, dissolved in 5 ml H2O, acidified to pH 1 by the addition of 1 N HCl, and extracted with EtOAc. The combined organics were washed with H2O and brine, dried over MgSO4, filtered and concentrated to leave the crude product as a colorless gum which turned to an off-white solid after standing one night at room temperature: 497 mg (3RS,4RS)-4-cyclopropyl-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester. MS 254.1 ([M−H])

[Figure (not displayed)]

101.5 To a stirred solution of 200 mg (3RS,4RS)-4-cyclopropyl-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester at 80° C. in 2 ml dioxane under an argon atmosphere were added 0.20 ml diphenylphosphoryl azide and 0.16 ml N-ethyldiisopropylamine. Stirring at 80° C. was continued for 4 hrs. Then, the hot mixture was poured onto 15 ml 1 N KOH and the product was extracted with EtOAc. The aqueous phase was back extracted with EtOAc. The combined organics were washed with H2O and brine, dried over MgSO4, filtered and concentrated. The crude product was purified by column chromatography (silica gel; gradient: CH2Cl2->CH2Cl2/MeOH 9:1) to give 34 mg (3RS,4SR)-3-amino-4-cyclopropyl-pyrrolidine-1-carboxylic acid tert-butyl ester as light brown gum. MS 227.3 ([M+H]+)

[Figure (not displayed)]

101.6 In analogy to example 11 (3RS,4SR)-3-amino-4-cyclopropyl-pyrrolidine-1-carboxylic acid tert-butyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3RS,4SR)-4-cyclopropyl-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-pyrrolidin-3-yl)-amide. Off-white amorphous solid. MS 515.3 ([M+H]+)

[Figure (not displayed)]

Example 102

102.1 In analogy to example 101.1 ethyl crotonate and N-benzyl-N-(methoxymethyl)tri-methylsilylmethylamine (CAS 93102-05-7) were reacted to give (3RS,4RS)-1-benzyl-4-methyl-pyrrolidine-3-carboxylic acid ethyl ester. Light yellow solid. MS 248.3 ([M+H]+)

[Figure (not displayed)]

102.2 In analogy to examples 101.2-101.6 (3RS,4RS)-1-benzyl-4-methyl-pyrrolidine-3-carboxylic acid ethyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3RS,4SR)-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-methyl-pyrrolidin-3-yl)-amide. White solid. MS489.4 ([M+H]+)

[Figure (not displayed)]

Example 103

103.1 In analogy to example 101.1 ethyl cinnamate and N-benzyl-N-(methoxymethyl)tri-methylsilylmethylamine (CAS 93102-05-7) were reacted to give (3RS,4SR)-1-benzyl-4-phenyl-pyrrolidine-3-carboxylic acid ethyl ester. Light yellow liquid. MS 310.1 ([M+H]+)

[Figure (not displayed)]

103.2 In analogy to examples 101.2-101.6 (3RS,4SR)-1-benzyl-4-phenyl-pyrrolidine-3-carboxylic acid ethyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3RS,4SR)-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-phenyl-pyrrolidin-3-yl)-amide. White solid. MS 551.2 ([M+H]+)

[Figure (not displayed)]

Example 104

104.1 In analogy to example 101.1 (E)-4-methyl-pent-2-enoic acid ethyl ester and N-benzyl-N-(methoxymethyl)tri-methylsilylmethylamine (CAS 93102-05-7) were reacted to give (3RS,4RS)-1-benzyl-4-isopropyl-pyrrolidine-3-carboxylic acid ethyl ester. Light yellow oil.

[Figure (not displayed)]

104.2 In analogy to examples 101.2-101.6 3RS,4RS)-1-benzyl-4-isopropyl-pyrrolidine-3-carboxylic acid ethyl ester was converted to 5-chloro-thiophene-2-carboxylic acid ((3RS,4SR)-1-{[2-fluoro-4-(2-oxo-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-isopropyl-pyrrolidin-3-yl)-amide. Off-white amorphous solid. MS 515.3 ([M+H]+)

[Figure (not displayed)]

Example 105

105.1 In analogy to example 101.1 ((E)-5-(tert-butyl-dimethyl-silanyloxy)-pent-2-enoic acid methyl ester (CAS 688801-64-1) and N-benzyl-N-(methoxymethyl)tri-methylsilylmethylamine (CAS 93102-05-7) were reacted to give (3RS,4RS)-1-benzyl-4-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-pyrrolidine-3-carboxylic acid methyl ester. Light yellow oil. MS 378.3 ([M+H]+)

[Figure (not displayed)]

105.2 In analogy to examples 101.2-101.6 (3RS,4RS)-1-benzyl-4-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-pyrrolidine-3-carboxylic acid methyl ester was converted to 5-chloro-thiophene-2-carboxylic acid [(3RS,4SR)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl-carbamoyl]-methyl}-4-(2-hydroxy-ethyl)-pyrrolidin-3-yl]-amide. Off-white amorphous solid. MS 519.3 ([M+H]+)

[Figure (not displayed)]

Example 107

107.1 Under an Ar atmosphere 1-benzyl-4-trifluoromethyl-pyrrolidine-3-carboxylic acid ethyl ester (10 g) (CAS152188-51-7P, synthesis described at Jean Pierre Begue et al. Tetrahedron Lett., 1993, 34(20), 3279-82) is dissolved in ethanol (100 ml). Acetic acid (0.19 ml), di-tert. butyl dicarbonate (7.6 g) and Pd/C (10%, 106 mg) were added to the solution. The argon atmosphere was changed to a hydrogen atmosphere. The mixture was stirred for 1 h at 25° C. and the hydrogen atmosphere was then refreshed. The mixture was afterwards stirred additional 7 h at 25° C., filtered then through a sartorius funnel and the filtrate was evaporated to dryness. The crude product as dissolved in THF (100 ml) and water (10 ml). DMAP (20 mg) was added to the solution and the mixture was stirred for 2 h at 25° C. After that the mixture was diluted with CH2Cl2 (100 ml) and extracted with water. The organic layer was dried over Na2SO4, filtered and evaporated to dryness to yield (3RS,4SR)-4-trifluoromethyl-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester (9.76 g) as colorless oil. MS 312.3 ([M+H]+).

107.2 (3RS,4SR)-4-Trifluoromethyl-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester (9.76 g) was dissolved in THF/water (1:1 10 ml) and LiOH (0.826 g) was added to the emulsion. The mixture was stirred for 18 h at 25° C. The reaction mixture was then diluted with CH2Cl2 (50 ml) and treated with HCl (1N, 20 ml). The aqueous phase was extracted twice with CH2Cl2 (20 ml) and the combined organic layers were dried over Na2SO4, filtered and evaporated to dryness to yield (3RS,4SR)-4-trifluoromethyl-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester (5.8 g) as light yellow solid. MS 284.3 ([M+H]+).

107.3 (3RS,4SR)-3-Trifluoromethyl-4-(2-trimethylsilanyl-ethoxycarbonylamino)-pyrro-lidine-1-carboxylic acid tert-butyl ester was prepared according to the methods described for example 40.1 to yield 3.1 g as a yellow oil. MS 399.5 ([M+H]+).

107.4 (3S,4R)-3-[(5-Chloro-thiophene-2-carbonyl)-amino]-4-trifluoromethyl-pyrrolidine-1-carboxylic acid tert-butyl ester was prepared according to the methods described for example 40.2 to yield 1.3 g as a yellow foam. MS 399.3 ([M+H]+, Cl-isotopes).

107.5 5-Chloro-thiophene-2-carboxylic acid ((3SR,4RS)-4-trifluoromethyl-pyrrolidin-3-yl)-amide; hydrochloride was prepared according to the methods described for example 40.3 to yield 0.98 g as a yellow foam. MS 299.3 ([M+H]+, Cl-isotopes).

107.6 5-Chloro-thiophene-2-carboxylic acid ((3SR,4RS)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-trifluoromethyl-pyrrolidin-3-yl)-amide was prepared according to the methods described for example 40.4 to yield 60 mg as a white solid. MS 543.2 ([M+H]), Cl-isotopes).

[Figure (not displayed)]

Example 108

5-Chloro-thiophene-2-carboxylic acid ((3RS,4RS)-1-{[4-(3-oxo-morpholin-4-yl)-phenylcarbamoyl]-methyl}-4-trifluoromethyl-pyrrolidin-3-yl)-amide was prepared starting from example 107.5 according to the methods described for examples 39.1 and 39.4 to yield 54 mg as a light yellow solid. MS 531.2 ([M+H]), Cl-isotopes).

[Figure (not displayed)]

Full text: Click here
Patent 2010

Most recents protocols related to «Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether»

Example 5

Preparation of methyl 2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methylene]-hydrazinecarboxylate (Compound 105)

To a mixture of 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzaldehyde (0.80 g, 3.30 mmol) in methanol (10 mL) was added methyl hydrazinocarboxylate (0.307 g, 3.30 mmol). The reaction mixture was stirred at ambient temperature, and then concentrated under reduced pressure. The resulting material was purified by MPLC silica gel chromatography (eluting with a gradient of 0 to 100% ethyl acetate in hexanes) to provide a white solid (0.84 g). The white solid was crystallized from ethanol to provide the title compound, a compound of the present invention, as colorless needles (549 mg) melting at 183-185° C.

1H NMR (CDCl3): δ 3.89 (br s, 3H), 7.83-7.85 (m, 2H), 7.9-8.0 (br s, 1H), 8.13-8.15 (m, 2H), 8.2-8.5 (br s, 1H);

19F NMR (CDCl3): δ−65.34.

Formulation/Utility

A compound of Formula 1 of this invention (including N-oxides, hydrates, and salts thereof) will generally be used as a fungicidal active ingredient in a composition, i.e. formulation, with at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, which serve as a carrier. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature.

Useful formulations include both liquid and solid compositions. Liquid compositions include solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like, which optionally can be thickened into gels. The general types of aqueous liquid compositions are soluble concentrate, suspension concentrate, capsule suspension, concentrated emulsion, microemulsion and suspo-emulsion. The general types of nonaqueous liquid compositions are emulsifiable concentrate, microemulsifiable concentrate, dispersible concentrate and oil dispersion.

The general types of solid compositions are dusts, powders, granules, pellets, pills, pastilles, tablets, filled films (including seed coatings) and the like, which can be water-dispersible (“wettable”) or water-soluble. Films and coatings formed from film-forming solutions or flowable suspensions are particularly useful for seed treatment. Active ingredient can be (micro)encapsulated and further formed into a suspension or solid formulation; alternatively the entire formulation of active ingredient can be encapsulated (or “overcoated”). Encapsulation can control or delay release of the active ingredient. An emulsifiable granule combines the advantages of both an emulsifiable concentrate formulation and a dry granular formulation. High-strength compositions are primarily used as intermediates for further formulation.

Sprayable formulations are typically extended in a suitable medium before spraying. Such liquid and solid formulations are formulated to be readily diluted in the spray medium, usually water, but occasionally another suitable medium like an aromatic or paraffinic hydrocarbon or vegetable oil. Spray volumes can range from about one to several thousand liters per hectare, but more typically are in the range from about ten to several hundred liters per hectare. Sprayable formulations can be tank mixed with water or another suitable medium for foliar treatment by aerial or ground application, or for application to the growing medium of the plant. Liquid and dry formulations can be metered directly into drip irrigation systems or metered into the furrow during planting. Liquid and solid formulations can be applied onto seeds of crops and other desirable vegetation as seed treatments before planting to protect developing roots and other subterranean plant parts and/or foliage through systemic uptake.

The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges which add up to 100 percent by weight.

Weight Percent
Active
IngredientDiluentSurfactant
Water-Dispersible0.001-900-99.9990-15
and Water-soluble
Granules, Tablets
and Powders.
Oil Dispersions,   1-5040-99   0-50
Suspensions,
Emulsions, Solutions
(including Emulsifiable
Concentrates)
Dusts   1-2570-99   0-5 
Granules and Pellets0.001-955-99.9990-15
High Strength Compositions  90-990-10   0-2 

Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, gypsum, cellulose, titanium dioxide, zinc oxide, starch, dextrin, sugars (e.g., lactose, sucrose), silica, talc, mica, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Typical solid diluents are described in Watkins et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, N.J.

Liquid diluents include, for example, water, N,N-dimethylalkanamides (e.g., N,N-dimethylformamide), limonene, dimethyl sulfoxide, N-alkylpyrrolidones (e.g., N-methylpyrrolidinone), alkyl phosphates (e.g., triethyl phosphate), ethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, propylene carbonate, butylene carbonate, paraffins (e.g., white mineral oils, normal paraffins, isoparaffins), alkylbenzenes, alkylnaphthalenes, glycerine, glycerol triacetate, sorbitol, aromatic hydrocarbons, dearomatized aliphatics, alkylbenzenes, alkylnaphthalenes, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, acetates such as isoamyl acetate, hexyl acetate, heptyl acetate, octyl acetate, nonyl acetate, tridecyl acetate and isobornyl acetate, other esters such as alkylated lactate esters, dibasic esters, alkyl and aryl benzoates and γ-butyrolactone, and alcohols, which can be linear, branched, saturated or unsaturated, such as methanol, ethanol, n-propanol, isopropyl alcohol, n-butanol, isobutyl alcohol, n-hexanol, 2-ethylhexanol, n-octanol, decanol, isodecyl alcohol, isooctadecanol, cetyl alcohol, lauryl alcohol, tridecyl alcohol, oleyl alcohol, cyclohexanol, tetrahydrofurfuryl alcohol, diacetone alcohol, cresol and benzyl alcohol. Liquid diluents also include glycerol esters of saturated and unsaturated fatty acids (typically C6-C22), such as plant seed and fruit oils (e.g., oils of olive, castor, linseed, sesame, corn (maize), peanut, sunflower, grapeseed, safflower, cottonseed, soybean, rapeseed, coconut and palm kernel), animal-sourced fats (e.g., beef tallow, pork tallow, lard, cod liver oil, fish oil), and mixtures thereof. Liquid diluents also include alkylated fatty acids (e.g., methylated, ethylated, butylated) wherein the fatty acids may be obtained by hydrolysis of glycerol esters from plant and animal sources, and can be purified by distillation. Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950.

The solid and liquid compositions of the present invention often include one or more surfactants. When added to a liquid, surfactants (also known as “surface-active agents”) generally modify, most often reduce, the surface tension of the liquid. Depending on the nature of the hydrophilic and lipophilic groups in a surfactant molecule, surfactants can be useful as wetting agents, dispersants, emulsifiers or defoaming agents.

Surfactants can be classified as nonionic, anionic or cationic. Nonionic surfactants useful for the present compositions include, but are not limited to: alcohol alkoxylates such as alcohol alkoxylates based on natural and synthetic alcohols (which may be branched or linear) and prepared from the alcohols and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof; amine ethoxylates, alkanolamides and ethoxylated alkanolamides; alkoxylated triglycerides such as ethoxylated soybean, castor and rapeseed oils; alkylphenol alkoxylates such as octylphenol ethoxylates, nonylphenol ethoxylates, dinonyl phenol ethoxylates and dodecyl phenol ethoxylates (prepared from the phenols and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); block polymers prepared from ethylene oxide or propylene oxide and reverse block polymers where the terminal blocks are prepared from propylene oxide; ethoxylated fatty acids; ethoxylated fatty esters and oils; ethoxylated methyl esters; ethoxylated tristyrylphenol (including those prepared from ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); fatty acid esters, glycerol esters, lanolin-based derivatives, polyethoxylate esters such as polyethoxylated sorbitan fatty acid esters, polyethoxylated sorbitol fatty acid esters and polyethoxylated glycerol fatty acid esters; other sorbitan derivatives such as sorbitan esters; polymeric surfactants such as random copolymers, block copolymers, alkyl peg (polyethylene glycol) resins, graft or comb polymers and star polymers; polyethylene glycols (pegs); polyethylene glycol fatty acid esters; silicone-based surfactants; and sugar-derivatives such as sucrose esters, alkyl polyglycosides and alkyl polysaccharides.

Useful anionic surfactants include, but are not limited to: alkylaryl sulfonic acids and their salts; carboxylated alcohol or alkylphenol ethoxylates; diphenyl sulfonate derivatives; lignin and lignin derivatives such as lignosulfonates; maleic or succinic acids or their anhydrides; olefin sulfonates; phosphate esters such as phosphate esters of alcohol alkoxylates, phosphate esters of alkylphenol alkoxylates and phosphate esters of styryl phenol ethoxylates; protein-based surfactants; sarcosine derivatives; styryl phenol ether sulfate; sulfates and sulfonates of oils and fatty acids; sulfates and sulfonates of ethoxylated alkylphenols; sulfates of alcohols; sulfates of ethoxylated alcohols; sulfonates of amines and amides such as N,N-alkyltaurates; sulfonates of benzene, cumene, toluene, xylene, and dodecyl and tridecylbenzenes; sulfonates of condensed naphthalenes; sulfonates of naphthalene and alkyl naphthalene; sulfonates of fractionated petroleum; sulfosuccinamates; and sulfosuccinates and their derivatives such as dialkyl sulfosuccinate salts.

Useful cationic surfactants include, but are not limited to: amides and ethoxylated amides; amines such as N-alkyl propanediamines, tripropylenetriamines and dipropylenetetramines, and ethoxylated amines, ethoxylated diamines and propoxylated amines (prepared from the amines and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); amine salts such as amine acetates and diamine salts; quaternary ammonium salts such as quaternary salts, ethoxylated quaternary salts and diquaternary salts; and amine oxides such as alkyldimethylamine oxides and bis-(2-hydroxyethyl)-alkylamine oxides.

Also useful for the present compositions are mixtures of nonionic and anionic surfactants or mixtures of nonionic and cationic surfactants. Nonionic, anionic and cationic surfactants and their recommended uses are disclosed in a variety of published references including McCutcheon's Emulsifiers and Detergents, annual American and International Editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964; and A. S. Davidson and B. Milwidsky, Synthetic Detergents, Seventh Edition, John Wiley and Sons, New York, 1987.

Compositions of this invention may also contain formulation auxiliaries and additives, known to those skilled in the art as formulation aids. Such formulation auxiliaries and additives may control: pH (buffers), foaming during processing (antifoams such polyorganosiloxanes (e.g., Rhodorsil® 416)), sedimentation of active ingredients (suspending agents), viscosity (thixotropic thickeners), in-container microbial growth (antimicrobials), product freezing (antifreezes), color (dyes/pigment dispersions (e.g., Pro-lzed® Colorant Red)), wash-off (film formers or stickers), evaporation (evaporation retardants), and other formulation attributes. Film formers include, for example, polyvinyl acetates, polyvinyl acetate copolymers, polyvinylpyrrolidone-vinyl acetate copolymer, polyvinyl alcohols, polyvinyl alcohol copolymers and waxes. Examples of formulation auxiliaries and additives include those listed in McCutcheon's Volume 2: Functional Materials, annual International and North American editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; and PCT Publication WO 03/024222.

The compound of Formula 1 and any other active ingredients are typically incorporated into the present compositions by dissolving the active ingredient in a solvent or by grinding in a liquid or dry diluent. Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. If the solvent of a liquid composition intended for use as an emulsifiable concentrate is water-immiscible, an emulsifier is typically added to emulsify the active-containing solvent upon dilution with water. Active ingredient slurries, with particle diameters of up to 2,000 m can be wet milled using media mills to obtain particles with average diameters below 3 μm. Aqueous slurries can be made into finished suspension concentrates (see, for example, U.S. Pat. No. 3,060,084) or further processed by spray drying to form water-dispersible granules. Dry formulations usually require dry milling processes, which produce average particle diameters in the 2 to 10 m range. Dusts and powders can be prepared by blending and usually grinding (such as with a hammer mill or fluid-energy mill). Granules and pellets can be prepared by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, “Agglomeration”, Chemical Engineering, Dec. 4, 1967, pp 147-48, Perry's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pp 8-57 and following, and WO 91/13546. Pellets can be prepared as described in U.S. Pat. No. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in U.S. Pat. Nos. 4,144,050, 3,920,442 and DE 3,246,493. Tablets can be prepared as taught in U.S. Pat. Nos. 5,180,587, 5,232,701 and 5,208,030. Films can be prepared as taught in GB 2,095,558 and U.S. Pat. No. 3,299,566.

One embodiment of the present invention relates to a method for controlling fungal pathogens, comprising diluting the fungicidal composition of the present invention (a compound of Formula 1 formulated with surfactants, solid diluents and liquid diluents or a formulated mixture of a compound of Formula 1 and at least one other fungicide) with water, and optionally adding an adjuvant to form a diluted composition, and contacting the fungal pathogen or its environment with an effective amount of said diluted composition.

Although a spray composition formed by diluting with water a sufficient concentration of the present fungicidal composition can provide sufficient efficacy for controlling fungal pathogens, separately formulated adjuvant products can also be added to spray tank mixtures. These additional adjuvants are commonly known as “spray adjuvants” or “tank-mix adjuvants”, and include any substance mixed in a spray tank to improve the performance of a pesticide or alter the physical properties of the spray mixture. Adjuvants can be anionic or nonionic surfactants, emulsifying agents, petroleum-based crop oils, crop-derived seed oils, acidifiers, buffers, thickeners or defoaming agents. Adjuvants are used to enhancing efficacy (e.g., biological availability, adhesion, penetration, uniformity of coverage and durability of protection), or minimizing or eliminating spray application problems associated with incompatibility, foaming, drift, evaporation, volatilization and degradation. To obtain optimal performance, adjuvants are selected with regard to the properties of the active ingredient, formulation and target (e.g., crops, insect pests).

The amount of adjuvants added to spray mixtures is generally in the range of about 2.5% to 0.1% by volume. The application rates of adjuvants added to spray mixtures are typically between about 1 to 5 L per hectare. Representative examples of spray adjuvants include: Adigor® (Syngenta) 47% methylated rapeseed oil in liquid hydrocarbons, Silwet® (Helena Chemical Company) polyalkyleneoxide modified heptamethyltrisiloxane and Assist® (BASF) 17% surfactant blend in 83% paraffin based mineral oil.

One method of seed treatment is by spraying or dusting the seed with a compound of the invention (i.e. as a formulated composition) before sowing the seeds. Compositions formulated for seed treatment generally comprise a film former or adhesive agent.

Therefore, typically a seed coating composition of the present invention comprises a biologically effective amount of a compound of Formula 1 and a film former or adhesive agent. Seeds can be coated by spraying a flowable suspension concentrate directly into a tumbling bed of seeds and then drying the seeds. Alternatively, other formulation types such as wetted powders, solutions, suspoemulsions, emulsifiable concentrates and emulsions in water can be sprayed on the seed. This process is particularly useful for applying film coatings on seeds. Various coating machines and processes are available to one skilled in the art. Suitable processes include those listed in P. Kosters et al., Seed Treatment: Progress and Prospects, 1994 BCPC Mongraph No. 57, and references listed therein.

For further information regarding the art of formulation, see T. S. Woods, “The Formulator's Toolbox-Product Forms for Modern Agriculture” in Pesticide Chemistry and Bioscience, The Food-Environment Challenge, T. Brooks and T. R. Roberts, Eds., Proceedings of the 9th International Congress on Pesticide Chemistry, The Royal Society of Chemistry, Cambridge, 1999, pp. 120-133. See also U.S. Pat. No. 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10-41; U.S. Pat. No. 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; U.S. Pat. No. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989; and Developments in formulation technology, PJB Publications, Richmond, U K, 2000.

In the following Examples, all percentages are by weight and all formulations are prepared in conventional ways. Compound numbers refer to compounds in Index Tables A-G. Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent. The following Examples are, therefore, to be constructed as merely illustrative, and not limiting of the disclosure in any way whatsoever.

Example A
High Strength Concentrate
Compound 1798.5%
silica aerogel0.5%
synthetic amorphous fine silica1.0%
Example B
Wettable Powder
Compound 6765.0%
dodecylphenol polyethylene glycol ether2.0%
sodium ligninsulfonate4.0%
sodium silicoaluminate6.0%
montmorillonite (calcined)23.0%
Example C
Granule
Compound 6310.0%
attapulgite granules (low90.0%
volatile matter, 0.71/0.30 mm;
U.S.S. No. 25-50 sieves)
Example D
Extruded Pellet
Compound 6125.0%
anhydrous sodium sulfate10.0%
crude calcium ligninsulfonate5.0%
sodium alkylnaphthalenesulfonate1.0%
calcium/magnesium bentonite59.0%
Example E
Emulsifiable Concentrate
Compound 5210.0%
polyoxyethylene sorbitol hexoleate20.0%
C6-C10 fatty acid methyl ester70.0%
Example F
Microemulsion
Compound 515.0%
polyvinylpyrrolidone-vinyl acetate copolymer30.0%
alkylpolyglycoside30.0%
glyceryl monooleate15.0%
water20.0%
Example G
Seed Treatment
Compound 4720.00%
polyvinylpyrrolidone-vinyl acetate copolymer5.00%
montan acid wax5.00%
calcium ligninsulfonate1.00%
polyoxyethylene/polyoxypropylene block copolymers1.00%
stearyl alcohol (POE 20)2.00%
polyorganosilane0.20%
colorant red dye0.05%
water65.75%
Example H
Fertilizer Stick
Compound 1172.50%
pyrrolidone-styrene copolymer4.80%
tristyrylphenyl 16-ethoxylate2.30%
talc0.80%
corn starch5.00%
slow-release fertilizer36.00%
kaolin38.00%
water10.60%
Example I
Suspension Concentrate
Compound 118 35%
butyl polyoxyethylene/polypropylene block copolymer4.0%
stearic acid/polyethylene glycol copolymer1.0%
styrene acrylic polymer1.0%
xanthan gum0.1%
propylene glycol5.0%
silicone based defoamer0.1%
1,2-benzisothiazolin-3-one0.1%
water53.7% 
Example J
Emulsion in Water
Compound 2010.0%
butyl polyoxyethylene/polypropylene block copolymer4.0%
stearic acid/polyethylene glycol copolymer1.0%
styrene acrylic polymer1.0%
xanthan gum0.1%
propylene glycol5.0%
silicone based defoamer0.1%
1,2-benzisothiazolin-3-one0.1%
aromatic petroleum based hydrocarbon20.0
water58.7%
Example K
Oil Dispersion
Compound 1725%
polyoxyethylene sorbitol hexaoleate15%
organically modified bentonite clay2.5% 
fatty acid methyl ester57.5%
Example L
Suspoemulsion
Compound 910.0%
imidacloprid5.0%
butyl polyoxyethylene/polypropylene block copolymer4.0%
stearic acid/polyethylene glycol copolymer1.0%
styrene acrylic polymer1.0%
xanthan gum0.1%
propylene glycol5.0%
silicone based defoamer0.1%
1,2-benzisothiazolin-3-one0.1%
aromatic petroleum based hydrocarbon20.0%
water53.7%

Water-soluble and water-dispersible formulations are typically diluted with water to form aqueous compositions before application. Aqueous compositions for direct applications to the plant or portion thereof (e.g., spray tank compositions) typically contain at least about 1 ppm or more (e.g., from 1 ppm to 100 ppm) of the compound(s) of this invention.

Seed is normally treated at a rate of from about 0.001 g (more typically about 0.1 g) to about 10 g per kilogram of seed (i.e. from about 0.0001 to 1% by weight of the seed before treatment). A flowable suspension formulated for seed treatment typically comprises from about 0.5 to about 70% of the active ingredient, from about 0.5 to about 30% of a film-forming adhesive, from about 0.5 to about 20% of a dispersing agent, from 0 to about 5% of a thickener, from 0 to about 5% of a pigment and/or dye, from 0 to about 2% of an antifoaming agent, from 0 to about 1% of a preservative, and from 0 to about 75% of a volatile liquid diluent.

The compounds of this invention are useful as plant disease control agents. The present invention therefore further comprises a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof to be protected, or to the plant seed to be protected, an effective amount of a compound of the invention or a fungicidal composition containing said compound. The compounds and/or compositions of this invention provide control of diseases caused by a broad spectrum of fungal plant pathogens in the Ascomycota, Basidiomycota, Zygomycota phyla, and the fungal-like Oomycata class. They are effective in controlling a broad spectrum of plant diseases, particularly foliar pathogens of ornamental, turf, vegetable, field, cereal, and fruit crops. These pathogens include but are not limited to those listed in Table 1-1. For Ascomycetes and Basidiomycetes, names for both the sexual/teleomorph/perfect stage as well as names for the asexual/anamorph/imperfect stage (in parentheses) are listed where known. Synonymous names for pathogens are indicated by an equal sign. For example, the sexual/teleomorph/perfect stage name Phaeosphaeria nodorum is followed by the corresponding asexual/anamorph/imperfect stage name Stagnospora nodorum and the synonymous older name Septoria nodorum.

TABLE 1-1
Ascomycetes in the order Pleosporales including Alternaria
solani, A. altemata and A. brassicae, Guignardia bidwellii,
Venturia inaequalis, Pyrenophora tritici-repentis
(Dreschlera tritici-repentis = Helminthosporium
tritici-repentis) and Pyrenophora teres (Dreschlera teres =
Helminthosporium teres), Corynespora cassiicola, Phaeosphaeria
nodorum (Stagonospora nodorum = Septoria nodorum),
Cochliobolus carbonum and C. heterostrophus, Leptosphaeria
biglobosa and L. maculans;
Ascomycetes in the order Mycosphaerellales including
Mycosphaerella graminicola (Zymoseptoria tritici = Septoria
tritici), M. berkeleyi (Cercosporidium personatum), M. arachidis
(Cercospora arachidicola), Passalora sojina (Cercospora sojina),
Cercospora zeae-maydis and C. beticola;
Ascomycetes in the order Erysiphales (the powdery mildews)
such as Blumeria graminis f.sp. tritici and Blumeria graminis
f.sp. hordei, Erysiphe polygoni, E. necator (=Uncinula necator),
Podosphaera fuliginea (=Sphaerotheca fuliginea), and
Podosphaera leucotricha (=Sphaerotheca fuliginea);
Ascomycetes in the order Helotiales such as Botryotinia
fuckeliana (Botrytis cinerea), Oculimacula yallundae (=Tapesia
yallundae; anamorph Helgardia herpotrichoides = Pseudocercosporella
herpetrichoides), Monilinia fructicola, Sclerotinia sclerotiorum,
Sclerotinia minor, and Sclerotinia homoeocarpa;
Ascomycetes in the order Hypocreales such as Giberella zeae
(Fusarium graminearum), G. monoliformis (Fusarium moniliforme),
Fusarium solani and Verticillium dahliae;
Ascomycetes in the order Eurotiales such as Aspergillus flavus
and A. parasiticus;
Ascomycetes in the order Diaporthales such as Cryptosphorella
viticola (=Phomopsis viticola), Phomopsis longicolla, and
Diaporthe phaseolorum;
Other Ascomycete pathogens including Magnaporthe grisea,
Gaeumannomyces graminis, Rhynchosporium secalis, and anthracnose
pathogens such as Glomerella acutata (Colletotrichum acutatum),
G. graminicola (C. graminicola) and G. lagenaria (C. orbiculare);
Basidiomycetes in the order Urediniales (the rusts) including
Puccinia recondita, P. striiformis, Puccinia hordei, P. graminis
and P. arachidis), Hemileia vastatrix and Phakopsora pachyrhizi;
Basidiomycetes in the order Ceratobasidiales such as Thanatophorum
cucumeris (Rhizoctonia solani) and Ceratobasidium oryzae-sativae
(Rhizoctonia oryzae);
Basidiomycetes in the order Polyporales such as Athelia rolfsii
(Sclerotium rolfsii);
Basidiomycetes in the order Ustilaginales such as Ustilago maydis;
Zygomycetes in the order Mucorales such as Rhizopus stolonifer,
Oomycetes in the order Pythiales, including Phytophthora
infestans, P. megasperma, P. parasitica, P. sojae, P. cinnamomi
and P. capsici, and Pythium pathogens such as Pythium
aphanidermatum, P. graminicola, P. irregulare, P. ultimum and
P. dissoticum;
Oomycetes in the order Peronosporales such as Plasmopara viticola,
P. halstedii, Peronospora hyoscyami (=Peronospora tabacina),
P. manshurica, Hyaloperonospora parasitica (=Peronospora
parasitica), Pseudoperonospora cubensis and Bremia lactucae;
and other genera and species closely related to all of the
above pathogens.

In addition to their fungicidal activity, the compositions or combinations also have activity against bacteria such as Erwinia amylovora, Xanthomonas campestris, Pseudomonas syringae, and other related species. By controlling harmful microorganisms, the compounds of the invention are useful for improving (i.e. increasing) the ratio of beneficial to harmful microorganisms in contact with crop plants or their propagules (e.g., seeds, corms, bulbs, tubers, cuttings) or in the agronomic environment of the crop plants or their propagules.

Compounds of the invention are useful in treating all plants, plant parts and seeds. Plant and seed varieties and cultivars can be obtained by conventional propagation and breeding methods or by genetic engineering methods. Genetically modified plants or seeds (transgenic plants or seeds) are those in which a heterologous gene (transgene) has been stably integrated into the plant's or seed's genome. A transgene that is defined by its particular location in the plant genome is called a transformation or transgenic event.

Genetically modified plant cultivars which can be treated according to the invention include those that are resistant against one or more biotic stresses (pests such as nematodes, insects, mites, fungi, etc.) or abiotic stresses (drought, cold temperature, soil salinity, etc.), or that contain other desirable characteristics. Plants can be genetically modified to exhibit traits of, for example, herbicide tolerance, insect-resistance, modified oil profiles or drought tolerance.

Treatment of genetically modified plants and seeds with compounds of the invention may result in super-additive or synergistic effects. For example, reduction in application rates, broadening of the activity spectrum, increased tolerance to biotic/abiotic stresses or enhanced storage stability may be greater than expected from just simple additive effects of the application of compounds of the invention on genetically modified plants and seeds.

Compounds of this invention are useful in seed treatments for protecting seeds from plant diseases. In the context of the present disclosure and claims, treating a seed means contacting the seed with a biologically effective amount of a compound of this invention, which is typically formulated as a composition of the invention. This seed treatment protects the seed from soil-borne disease pathogens and generally can also protect roots and other plant parts in contact with the soil of the seedling developing from the germinating seed. The seed treatment may also provide protection of foliage by translocation of the compound of this invention or a second active ingredient within the developing plant. Seed treatments can be applied to all types of seeds, including those from which plants genetically transformed to express specialized traits will germinate. Representative examples include those expressing proteins toxic to invertebrate pests, such as Bacillus thuringiensis toxin or those expressing herbicide resistance such as glyphosate acetyltransferase, which provides resistance to glyphosate. Seed treatments with compounds of this invention can also increase vigor of plants growing from the seed.

Compounds of this invention and their compositions, both alone and in combination with other fungicides, nematicides and insecticides, are particularly useful in seed treatment for crops including, but not limited to, maize or corn, soybeans, cotton, cereal (e.g., wheat, oats, barley, rye and rice), potatoes, vegetables and oilseed rape.

Furthermore, the compounds of this invention are useful in treating postharvest diseases of fruits and vegetables caused by fungi and bacteria. These infections can occur before, during and after harvest. For example, infections can occur before harvest and then remain dormant until some point during ripening (e.g., host begins tissue changes in such a way that infection can progress); also infections can arise from surface wounds created by mechanical or insect injury. In this respect, the compounds of this invention can reduce losses (i.e. losses resulting from quantity and quality) due to postharvest diseases which may occur at any time from harvest to consumption. Treatment of postharvest diseases with compounds of the invention can increase the period of time during which perishable edible plant parts (e.g., fruits, seeds, foliage, stems, bulbs, tubers) can be stored refrigerated or un-refrigerated after harvest, and remain edible and free from noticeable or harmful degradation or contamination by fungi or other microorganisms. Treatment of edible plant parts before or after harvest with compounds of the invention can also decrease the formation of toxic metabolites of fungi or other microorganisms, for example, mycotoxins such as aflatoxins.

Plant disease control is ordinarily accomplished by applying an effective amount of a compound of this invention either pre- or post-infection, to the portion of the plant to be protected such as the roots, stems, foliage, fruits, seeds, tubers or bulbs, or to the media (soil or sand) in which the plants to be protected are growing. The compounds can also be applied to seeds to protect the seeds and seedlings developing from the seeds. The compounds can also be applied through irrigation water to treat plants. Control of postharvest pathogens which infect the produce before harvest is typically accomplished by field application of a compound of this invention, and in cases where infection occurs after harvest the compounds can be applied to the harvested crop as dips, sprays, fumigants, treated wraps and box liners.

Rates of application for these compounds (i.e. a fungicidally effective amount) can be influenced by factors such as the plant diseases to be controlled, the plant species to be protected, ambient moisture and temperature and should be determined under actual use conditions. One skilled in the art can easily determine through simple experimentation the fungicidally effective amount necessary for the desired level of plant disease control.

Foliage can normally be protected when treated at a rate of from less than about 1 g/ha to about 5,000 g/ha of active ingredient. Seed and seedlings can normally be protected when seed is treated at a rate of from about 0.001 g (more typically about 0.1 g) to about 10 g per kilogram of seed.

Compounds of this invention can also be mixed with one or more other biologically active compounds or agents including fungicides, insecticides, nematocides, bactericides, acaricides, herbicides, herbicide safeners, growth regulators such as insect molting inhibitors and rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants, plant nutrients, other biologically active compounds or entomopathogenic bacteria, virus or fungi to form a multi-component pesticide giving an even broader spectrum of agricultural protection. Thus the present invention also pertains to a composition comprising a compound of Formula 1 (in a fungicidally effective amount) and at least one additional biologically active compound or agent (in a biologically effective amount) and can further comprise at least one of a surfactant, a solid diluent or a liquid diluent. The other biologically active compounds or agents can be formulated in compositions comprising at least one of a surfactant, solid or liquid diluent. For mixtures of the present invention, one or more other biologically active compounds or agents can be formulated together with a compound of Formula 1, to form a premix, or one or more other biologically active compounds or agents can be formulated separately from the compound of Formula 1, and the formulations combined together before application (e.g., in a spray tank) or, alternatively, applied in succession.

As mentioned in the Summary of the Invention, one aspect of the present invention is a fungicidal composition comprising (i.e. a mixture or combination of) a compound of Formula 1, an N-oxide, or a salt thereof (i.e. component a), and at least one other fungicide (i.e. component b). Of note is such a combination where the other fungicidal active ingredient has different site of action from the compound of Formula 1. In certain instances, a combination with at least one other fungicidal active ingredient having a similar spectrum of control but a different site of action will be particularly advantageous for resistance management. Thus, a composition of the present invention can further comprise a fungicidally effective amount of at least one additional fungicidal active ingredient having a similar spectrum of control but a different site of action.

Of note is a composition which in addition to the Formula 1 compound of component (a), includes as component (b) at least one fungicidal compound selected from the group consisting of the FRAC-defined mode of action (MOA) classes (A) nucleic acid synthesis, (B) mitosis and cell division, (C) respiration, (D) amino acid and protein synthesis, (E) signal transduction, (F) lipid synthesis and membrane integrity, (G) sterol biosynthesis in membranes, (H) cell wall biosynthesis in membranes, (I) melanin synthesis in cell wall, (P) host plant defense induction, multi-site contact activity and unknown mode of action.

FRAC-recognized or proposed target sites of action along with their FRAC target site codes belonging to the above MOA classes are (A1) RNA polymerase I, (A2) adenosine deaminase, (A3) DNA/RNA synthesis (proposed), (A4) DNA topoisomerase, (B1-B3) β-tubulin assembly in mitosis, (B4) cell division (proposed), (B5) delocalization of spectrin-like proteins, (C1) complex I NADH odxido-reductase, (C2) complex II: succinate dehydrogenase, (C3) complex III: cytochrome bcl (ubiquinol oxidase) at Qo site, (C4) complex III: cytochrome bcl (ubiquinone reductase) at Qi site, (C5) uncouplers of oxidative phosphorylation, (C6) inhibitors of oxidative phosphorylation, ATP synthase, (C7) ATP production (proposed), (C8) complex III: cytochrome bcl (ubiquinone reductase) at Qx (unknown) site, (D1) methionine biosynthesis (proposed), (D2-D5) protein synthesis, (E1) signal transduction (mechanism unknown), (E2-E3) MAP/histidine kinase in osmotic signal transduction, (F2) phospholipid biosynthesis, methyl transferase, (F3) lipid peroxidation (proposed), (F4) cell membrane permeability, fatty acids (proposed), (F6) microbial disrupters of pathogen cell membranes, (F7) cell membrane disruption (proposed), (G1) C14-demethylase in sterol biosynthesis, (G2) Δ14-reductase and Δ8→Δ7-isomerase in sterol biosynthesis, (G3) 3-keto reductase, C4-demethylation, (G4) squalene epoxidase in sterol biosynthesis, (H3) trehalase and inositol biosynthesis, (H4) chitin synthase, (H5) cellulose synthase, (I1) reductase in melanin biosynthesis and (I2) dehydratase in melanin biosynthesis.

Of particular note is a composition which in addition to the Formula 1 compound of component (a), includes as component (b) at least one fungicidal compound selected from the group consisting of the classes (b1) methyl benzimidazole carbamate (MBC) fungicides; (b2) dicarboximide fungicides; (b3) demethylation inhibitor (DMI) fungicides; (b4) phenylamide fungicides; (b5) amine/morpholine fungicides; (b6) phospholipid biosynthesis inhibitor fungicides; (b7) succinate dehydrogenase inhibitor fungicides; (b8) hydroxy(2-amino-)pyrimidine fungicides; (b9) anilinopyrimidine fungicides; (b10)N-phenyl carbamate fungicides; (b11) quinone outside inhibitor (QoI) fungicides; (b12) phenylpyrrole fungicides; (b13) azanaphthalene fungicides; (b14) lipid peroxidation inhibitor fungicides; (b15) melanin biosynthesis inhibitor-reductase (MBI-R) fungicides; (b16) melanin biosynthesis inhibitor-dehydratase (MBI-D) fungicides; (b17) sterol biosynthesis inhibitor (SBI): Class III fungicides; (b18) squalene-epoxidase inhibitor fungicides; (b19) polyoxin fungicides; (b20) phenylurea fungicides; (b21) quinone inside inhibitor (QiI) fungicides; (b22) benzamide and thiazole carboxamide fungicides; (b23) enopyranuronic acid antibiotic fungicides; (b24) hexopyranosyl antibiotic fungicides; (b25) glucopyranosyl antibiotic: protein synthesis fungicides; (b26) glucopyranosyl antibiotic: trehalase and inositol biosynthesis fungicides; (b27) cyanoacetamideoxime fungicides; (b28) carbamate fungicides; (b29) oxidative phosphorylation uncoupling fungicides; (b30) organo tin fungicides; (b31) carboxylic acid fungicides; (b32) heteroaromatic fungicides; (b33) phosphonate fungicides; (b34) phthalamic acid fungicides; (b35) benzotriazine fungicides; (b36) benzene-sulfonamide fungicides; (b37) pyridazinone fungicides; (b38) thiophene-carboxamide fungicides; (b39) complex I NADH oxidoreductase inhibitor fungicides; (b40) carboxylic acid amide (CAA) fungicides; (b41) tetracycline antibiotic fungicides; (b42) thiocarbamate fungicides; (b43) benzamide fungicides; (b44) microbial fungicides; (b45) QXI fungicides; (b46) plant extract fungicides; (b47) host plant defense induction fungicides; (b48) multi-site contact activity fungicides; (b49) fungicides other than fungicides of classes (b1) through (b48); and salts of compounds of classes (b1) through (b48).

Further descriptions of these classes of fungicidal compounds are provided below.

(b1) “Methyl benzimidazole carbamate (MBC) fungicides” (FRAC code 1) inhibit mitosis by binding to 1-tubulin during microtubule assembly. Inhibition of microtubule assembly can disrupt cell division, transport within the cell and cell structure. Methyl benzimidazole carbamate fungicides include benzimidazole and thiophanate fungicides. The benzimidazoles include benomyl, carbendazim, fuberidazole and thiabendazole. The thiophanates include thiophanate and thiophanate-methyl.

(b2) “Dicarboximide fungicides” (FRAC code 2) inhibit a MAP/histidine kinase in osmotic signal transduction. Examples include chlozolinate, iprodione, procymidone and vinclozolin.

(b3) “Demethylation inhibitor (DMI) fungicides” (FRAC code 3) (Sterol Biosynthesis Inhibitors (SBI): Class I) inhibit C14-demethylase, which plays a role in sterol production. Sterols, such as ergosterol, are needed for membrane structure and function, making them essential for the development of functional cell walls. Therefore, exposure to these fungicides results in abnormal growth and eventually death of sensitive fungi. DMI fungicides are divided between several chemical classes: azoles (including triazoles and imidazoles), pyrimidines, piperazines, pyridines and triazolinthiones. The triazoles include azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole (including diniconazole-M), epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, quinconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, uniconazole-P, α-(1-chlorocyclopropyl)-α-[2-(2,2-dichlorocyclopropyl)ethyl]-1H-1,2,4-triazole-1-ethanol, rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole, rel-2-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione, and rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-5-(2-propen-1-ylthio)-1H-1,2,4-triazole. The imidazoles include econazole, imazalil, oxpoconazole, prochloraz, pefurazoate and triflumizole. The pyrimidines include fenarimol, nuarimol and triarimol. The piperazines include triforine. The pyridines include buthiobate, pyrifenox, pyrisoxazole (3-[(3R)-5-(4-chlorophenyl)-2,3-dimethyl3-isoxazolidinyl]pyridine, mixture of 3R,5R- and 3R,5S-isomers) and (aS)-[3-(4-chloro-2-fluorophenyl)5-(2,4-difluorophenyl)-4-isoxazolyl]-3-pyridinemethanol. The triazolinthiones include prothioconazole and 2-[2-(1-chlorocyclopropyl)-4-(2,2-dichloro-cyclopropyl)-2-hydroxybutyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione. Biochemical investigations have shown that all of the above mentioned fungicides are DMI fungicides as described by K. H. Kuck et al. in Modern Selective Fungicides-Properties, Applications and Mechanisms of Action, H. Lyr (Ed.), Gustav Fischer Verlag: New York, 1995, 205-258.

(b4) “Phenylamide fungicides” (FRAC code 4) are specific inhibitors of RNA polymerase in Oomycete fungi. Sensitive fungi exposed to these fungicides show a reduced capacity to incorporate uridine into rRNA. Growth and development in sensitive fungi is prevented by exposure to this class of fungicide. Phenylamide fungicides include acylalanine, oxazolidinone and butyrolactone fungicides. The acylalanines include benalaxyl, benalaxyl-M (also known as kiralaxyl), furalaxyl, metalaxyl and metalaxyl-M (also known as mefenoxam). The oxazolidinones include oxadixyl. The butyrolactones include ofurace.

(b5) “Amine/morpholine fungicides” (FRAC code 5) (SBI: Class II) inhibit two target sites within the sterol biosynthetic pathway, Δ8→Δ7 isomerase and Δ14 reductase. Sterols, such as ergosterol, are needed for membrane structure and function, making them essential for the development of functional cell walls. Therefore, exposure to these fungicides results in abnormal growth and eventually death of sensitive fungi. Amine/morpholine fungicides (also known as non-DMI sterol biosynthesis inhibitors) include morpholine, piperidine and spiroketal-amine fungicides. The morpholines include aldimorph, dodemorph, fenpropimorph, tridemorph and trimorphamide. The piperidines include fenpropidin and piperalin. The spiroketal-amines include spiroxamine.

(b6) “Phospholipid biosynthesis inhibitor fungicides” (FRAC code 6) inhibit growth of fungi by affecting phospholipid biosynthesis. Phospholipid biosynthesis fungicides include phophorothiolate and dithiolane fungicides. The phosphorothiolates include edifenphos, iprobenfos and pyrazophos. The dithiolanes include isoprothiolane.

(b7) “Succinate dehydrogenase inhibitor (SDHI) fungicides” “(FRAC code 7) inhibit Complex II fungal respiration by disrupting a key enzyme in the Krebs Cycle (TCA cycle) named succinate dehydrogenase. Inhibiting respiration prevents the fungus from making ATP, and thus inhibits growth and reproduction. SDHI fungicides include phenylbenzamide, furan carboxamide, oxathiin carboxamide, thiazole carboxamide, pyrazole-4-carboxamide, pyridine carboxamide, phenyl oxoethyl thiophene amides and pyridinylethyl benzamides. The benzamides include benodanil, flutolanil and mepronil. The furan carboxamides include fenfuram. The oxathiin carboxamides include carboxin and oxycarboxin. The thiazole carboxamides include thifluzamide. The pyrazole-4-carboxamides include benzovindiflupyr (N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide), bixafen, fluxapyroxad (3-(difluoromethyl)-1-methyl-N-(3′,4′,5′-trifluoro[1,1′-biphenyl]-2-yl)-1H-pyrazole-4-carboxamide), furametpyr, isopyrazam (3-(difluoromethyl)-1-methyl-N-[1,2,3,4-tetrahydro9-(1-methylethyl)-1,4-methanonaphthalen-5-yl]-1H-pyrazole-4-carboxamnide), penflufen (N-[2-(1,3-dimethylbutyl)phenyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide), penthiopyrad, sedaxane (N-[2-[1,1′-bicyclopropyl]-2-ylphenyl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide), N-[2-(1S,2R)-[1,1′-bicyclopropyl]-2-ylphenyl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-N-(2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, N-[2-(2,4-dichlorophenyl)2-methoxy-1-methylethyl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide and N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[[2-(1-methyl-ethyl)phenyl]methyl]-1H-pyrazole-4-carboxamide. The pyridine carboxamides include boscalid. The phenyl oxoethyl thiophene amides include isofetamid (N-[1,1-dimethyl-2-[2-methyl-4-(1-methylethoxy)phenyl]-2-oxoethyl]-3-methyl-2-thiophenecarboxamide). The pyridinylethyl benzamides include fluopyram.

(b8) “Hydroxy-(2-amino-)pyrimidine fungicides” (FRAC code 8) inhibit nucleic acid synthesis by interfering with adenosine deaminase. Examples include bupirimate, dimethirimol and ethirimol.

(b9) “Anilinopyrimidine fungicides” (FRAC code 9) are proposed to inhibit biosynthesis of the amino acid methionine and to disrupt the secretion of hydrolytic enzymes that lyse plant cells during infection. Examples include cyprodinil, mepanipyrim and pyrimethanil.

(b10) “N-Phenyl carbamate fungicides” (FRAC code 10) inhibit mitosis by binding to β-tubulin and disrupting microtubule assembly. Inhibition of microtubule assembly can disrupt cell division, transport within the cell and cell structure. Examples include diethofencarb.

(b1) “Quinone outside inhibitor (QoI) fungicides” (FRAC code 11) inhibit Complex III mitochondrial respiration in fungi by affecting ubiquinol oxidase. Oxidation of ubiquinol is blocked at the “quinone outside” (Qo) site of the cytochrome bc1 complex, which is located in the inner mitochondrial membrane of fungi. Inhibiting mitochondrial respiration prevents normal fungal growth and development. Quinone outside inhibitor fungicides include methoxyacrylate, methoxycarbamate, oximinoacetate, oximinoacetamide and dihydrodioxazine fungicides (collectively also known as strobilurin fungicides), and oxazolidinedione, imidazolinone and benzylcarbamate fungicides. The methoxyacrylates include azoxystrobin, coumoxystrobin (methyl (αE)-2-[[(3-butyl-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]methyl]-α-(methoxymethylene)benzeneacetate), enoxastrobin (methyl (αE)-2-[[[(E)-[(2E)-3-(4-chlorophenyl)-1-methyl-2-propen-1-ylidene]amino]oxy]methyl]-α-(methoxymethylene)benzeneaceate) (also known as enestroburin), flufenoxystrobin (methyl (αE)-2-[[2-chloro-4-(trifluoromethyl)phenoxy]methyl]-α-(methoxymethylene)benzeneacetate), picoxystrobin, and pyraoxystrobin (methyl (αE)-2-[[[3-(4-chlorophenyl)-1-methyl-1H-pyrazol-5-yl]oxy]methyl]-α-(methoxymethylene)benzeneacetate). The methoxy-carbamates include pyraclostrobin, pyrametostrobin (methyl N-[2-[[(1,4-dimethyl-3-phenyl-1H-pyrazol-5-yl)oxy]methyl]phenyl]-N-methoxycarbamate) and triclopyricarb (methyl N-methoxy-N-[2-[[(3,5,6-trichloro-2-pyridinyl)oxy]methyl]phenyl]carbamate). The oximino-acetates include kresoxim-methyl, and trifloxystrobin. The oximinoacetamides include dimoxystrobin, fenaminstrobin ((αE)-2-[[[(E)-[(2E)-3-(2,6-dichlorophenyl)-1-methyl-2-propen-1-ylidene]amino]oxy]methyl]-α-(methoxyimino)-N-methylbenzeneacetamide), metominostrobin, orysastrobin and α-[methoxyimino]-N-methyl-2-[[[1-[3-(trifluoro-methyl)phenyl]ethoxy]imino]methyl]benzeneacetamide. The dihydrodioxazines include fluoxastrobin. The oxazolidinediones include famoxadone. The imidazolinones include fenamidone. The benzylcarbamates include pyribencarb. Class (b11) also includes mandestrobin (2-[(2,5-dimethylphenoxy)methyl]-α-methoxy-N-benzeneacetamide).

(b12) “Phenylpyrrole fungicides” (FRAC code 12) inhibit a MAP/histidine kinase associated with osmotic signal transduction in fungi. Fenpiclonil and fludioxonil are examples of this fungicide class.

(b13) “Azanaphthalene fungicides” (FRAC code 13) are proposed to inhibit signal transduction by a mechanism which is as yet unknown. They have been shown to interfere with germination and/or appressorium formation in fungi that cause powdery mildew diseases. Azanaphthalene fungicides include aryloxyquinolines and quinazolinones. The aryloxyquinolines include quinoxyfen. The quinazolinones include proquinazid.

(b14) “Lipid peroxidation inhibitor fungicides” (FRAC code 14) are proposed to inhibit lipid peroxidation which affects membrane synthesis in fungi. Members of this class, such as etridiazole, may also affect other biological processes such as respiration and melanin biosynthesis. Lipid peroxidation fungicides include aromatic hydrocarbon and 1,2,4-thiadiazole fungicides. The aromatic hydrocarboncarbon fungicides include biphenyl, chloroneb, dicloran, quintozene, tecnazene and tolclofos-methyl. The 1,2,4-thiadiazoles include etridiazole.

(b15) “Melanin biosynthesis inhibitors-reductase (MBI-R) fungicides” (FRAC code 16.1) inhibit the naphthal reduction step in melanin biosynthesis. Melanin is required for host plant infection by some fungi. Melanin biosynthesis inhibitors-reductase fungicides include isobenzofuranone, pyrroloquinolinone and triazolobenzothiazole fungicides. The isobenzofuranones include fthalide. The pyrroloquinolinones include pyroquilon. The triazolobenzothiazoles include tricyclazole.

(b16) “Melanin biosynthesis inhibitors-dehydratase (MBI-D) fungicides” (FRAC code 16.2) inhibit scytalone dehydratase in melanin biosynthesis. Melanin in required for host plant infection by some fungi. Melanin biosynthesis inhibitors-dehydratase fungicides include cyclopropanecarboxamide, carboxamide and propionamide fungicides. The cyclopropanecarboxamides include carpropamid. The carboxamides include diclocymet. The propionamides include fenoxanil.

(b17) “Sterol Biosynthesis Inhibitor (SBI): Class III fungicides (FRAC code 17) inhibit 3-ketoreductase during C4-demethylation in sterol production. SBI: Class III inhibitors include hydroxyanilide fungicides and amino-pyrazolinone fungicides. Hydroxyanilides include fenhexamid. Amino-pyrazolinones include fenpyrazamine (S-2-propen-1-yl 5-amino-2,3-dihydro-2-(1-methylethyl)-4-(2-methylphenyl)-3-oxo-1H-pyrazole-1-carbothioate).

(b18) “Squalene-epoxidase inhibitor fungicides” (FRAC code 18) (SBI: Class IV) inhibit squalene-epoxidase in the sterol biosynthesis pathway. Sterols such as ergosterol are needed for membrane structure and function, making them essential for the development of functional cell walls. Therefore, exposure to these fungicides results in abnormal growth and eventually death of sensitive fungi. Squalene-epoxidase inhibitor fungicides include thiocarbamate and allylamine fungicides. The thiocarbamates include pyributicarb. The allylamines include naftifine and terbinafine.

(b19) “Polyoxin fungicides” (FRAC code 19) inhibit chitin synthase. Examples include polyoxin.

(b20) “Phenylurea fungicides” (FRAC code 20) are proposed to affect cell division. Examples include pencycuron.

(b21) “Quinone inside inhibitor (QiI) fungicides” (FRAC code 21) inhibit Complex III mitochondrial respiration in fungi by affecting ubiquinone reductase. Reduction of ubiquinone is blocked at the “quinone inside” (Qi) site of the cytochrome bc1 complex, which is located in the inner mitochondrial membrane of fungi. Inhibiting mitochondrial respiration prevents normal fungal growth and development. Quinone inside inhibitor fungicides include cyanoimidazole and sulfamoyltriazole fungicides. The cyanoimidazoles include cyazofamid. The sulfamoyltriazoles include amisulbrom.

(b22) “Benzamide and thiazole carboxamide fungicides” (FRAC code 22) inhibit mitosis by binding to β-tubulin and disrupting microtubule assembly. Inhibition of microtubule assembly can disrupt cell division, transport within the cell and cell structure. The benzamides include zoxamide. The thiazole carboxamides include ethaboxam.

(b23) “Enopyranuronic acid antibiotic fungicides” (FRAC code 23) inhibit growth of fungi by affecting protein biosynthesis. Examples include blasticidin-S.

(b24) “Hexopyranosyl antibiotic fungicides” (FRAC code 24) inhibit growth of fungi by affecting protein biosynthesis. Examples include kasugamycin.

(b25) “Glucopyranosyl antibiotic: protein synthesis fungicides” (FRAC code 25) inhibit growth of fungi by affecting protein biosynthesis. Examples include streptomycin.

(b26) “Glucopyranosyl antibiotic: trehalase and inositol biosynthesis fungicides” (FRAC code 26) inhibit trehalase and inositol biosynthesis. Examples include validamycin.

(b27) “Cyanoacetamideoxime fungicides (FRAC code 27) include cymoxanil.

(b28) “Carbamate fungicides” (FRAC code 28) are considered multi-site inhibitors of fungal growth. They are proposed to interfere with the synthesis of fatty acids in cell membranes, which then disrupts cell membrane permeability. Propamacarb, iodocarb, and prothiocarb are examples of this fungicide class.

(b29) “Oxidative phosphorylation uncoupling fungicides” (FRAC code 29) inhibit fungal respiration by uncoupling oxidative phosphorylation. Inhibiting respiration prevents normal fungal growth and development. This class includes 2,6-dinitroanilines such as fluazinam, and dinitrophenyl crotonates such as dinocap, meptyldinocap and binapacryl.

(b30) “Organo tin fungicides” (FRAC code 30) inhibit adenosine triphosphate (ATP) synthase in oxidative phosphorylation pathway. Examples include fentin acetate, fentin chloride and fentin hydroxide.

(b31) “Carboxylic acid fungicides” (FRAC code 31) inhibit growth of fungi by affecting deoxyribonucleic acid (DNA) topoisomerase type II (gyrase). Examples include oxolinic acid.

(b32) “Heteroaromatic fungicides” (Fungicide Resistance Action Committee (FRAC) code 32) are proposed to affect DNA/ribonucleic acid (RNA) synthesis. Heteroaromatic fungicides include isoxazoles and isothiazolones. The isoxazoles include hymexazole and the isothiazolones include octhilinone.

(b33) “Phosphonate fungicides” (FRAC code 33) include phosphorous acid and its various salts, including fosetyl-aluminum.

(b34) “Phthalamic acid fungicides” (FRAC code 34) include teclofthalam.

(b35) “Benzotriazine fungicides” (FRAC code 35) include triazoxide.

(b36) “Benzene-sulfonamide fungicides” (FRAC code 36) include flusulfamide.

(b37) “Pyridazinone fungicides” (FRAC code 37) include diclomezine.

(b38) “Thiophene-carboxamide fungicides” (FRAC code 38) are proposed to affect ATP production. Examples include silthiofam.

(b39) “Complex I NADH oxidoreductase inhibitor fungicides” (FRAC code 39) inhibit electron transport in mitochondria and include pyrimidinamines such as diflumetorim, and pyrazole-5-carboxamides such as tolfenpyrad.

(b40) “Carboxylic acid amide (CAA) fungicides” (FRAC code 40) inhibit cellulose synthase which prevents growth and leads to death of the target fungus. Carboxylic acid amide fungicides include cinnamic acid amide, valinamide and other carbamate, and mandelic acid amide fungicides. The cinnamic acid amides include dimethomorph, flumorph and pyrimorph (3-(2-chloro-4-pyridinyl)-3-[4-(1,1-dimethylethyl)phenyl]-1-(4-morpholinyl)-2-propene-1-one). The valinamide and other carbamates include benthiavalicarb, benthiavalicarb-isopropyl, iprovalicarb, tolprocarb (2,2,2-trifluoroethyl N-[(1S)-2-methyl-1-[[(4-methylbenzoyl)amino]methyl]propyl]carbamate) and valifenalate (methyl N-[(1-methylethoxy)carbonyl]-L-valyl-3-(4-chlorophenyl)-3-alaninate) (also known as valiphenal). The mandelic acid amides include mandipropamid, N-[2-[4-[[3-(4-chloro-phenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)amino]-butanamide and N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamide.

(b41) “Tetracycline antibiotic fungicides” (FRAC code 41) inhibit growth of fungi by affecting protein synthesis. Examples include oxytetracycline.

(b42) “Thiocarbamate fungicides” (FRAC code 42) include methasulfocarb.

(b43) “Benzamide fungicides” (FRAC code 43) inhibit growth of fungi by delocalization of spectrin-like proteins. Examples include pyridinylmethyl benzamide fungicides such as fluopicolide (now FRAC code 7, pyridinylethyl benzamides).

(b44) “Microbial fungicides” (FRAC code 44) disrupt fungal pathogen cell membranes. Microbial fungicides include Bacillus species such as Bacillus amyloliquefaciens strains QST 713, FZB24, MB1600, D747 and the fungicidal lipopeptides which they produce.

(b45) “QXI fungicides” (FRAC code 45) inhibit Complex III mitochondrial respiration in fungi by affecting ubiquinone reductase at an unknown (Qx) site of the cytochrome bcl complex. Inhibiting mitochondrial respiration prevents normal fungal growth and development. QXI fungicides include triazolopyrimidylamines such as ametoctradin (5-ethyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine).

(b46) “Plant extract fungicides” are proposed to act by cell membrane disruption. Plant extract fungicides include terpene hydrocarbons and terpene alcohols such as the extract from Melaleuca alternifolia (tea tree).

(b47) “Host plant defense induction fungicides” (FRAC code P) induce host plant defense mechanisms. Host plant defense induction fungicides include benzothiadiazoles, benzisothiazole and thiadiazole-carboxamide fungicides. The benzothiadiazoles include acibenzolar-S-methyl. The benzisothiazoles include probenazole. The thiadiazole-carboxamides include tiadinil and isotianil.

(b48) “Multi-site contact fungicides” inhibit fungal growth through multiple sites of action and have contact/preventive activity. This class of fungicides includes: (b48.1) “copper fungicides” (FRAC code M1)”, (b48.2) “sulfur fungicides” (FRAC code M2), (b48.3) “dithiocarbamate fungicides” (FRAC code M3), (b48.4) “phthalimide fungicides” (FRAC code M4), (b48.5) “chloronitrile fungicides” (FRAC code M5), (b48.6) “sulfamide fungicides” (FRAC code M6), (b48.7) multi-site contact “guanidine fungicides” (FRAC code M7), (b48.8) “triazine fungicides” (FRAC code M8), (b48.9) “quinone fungicides” (FRAC code M9), (b48.10) “quinoxaline fungicides” (FRAC code M10) and (b48.11) “maleimide fungicides” (FRAC code M11). “Copper fungicides” are inorganic compounds containing copper, typically in the copper(II) oxidation state; examples include copper oxychloride, copper sulfate and copper hydroxide, including compositions such as Bordeaux mixture (tribasic copper sulfate). “Sulfur fungicides” are inorganic chemicals containing rings or chains of sulfur atoms; examples include elemental sulfur. “Dithiocarbamate fungicides” contain a dithiocarbamate molecular moiety; examples include mancozeb, metiram, propineb, ferbam, maneb, thiram, zineb and ziram. “Phthalimide fungicides” contain a phthalimide molecular moiety; examples include folpet, captan and captafol. “Chloronitrile fungicides” contain an aromatic ring substituted with chloro and cyano; examples include chlorothalonil. “Sulfamide fungicides” include dichlofluanid and tolyfluanid. Multi-site contact “guanidine fungicides” include, guazatine, iminoctadine albesilate and iminoctadine triacetate. “Triazine fungicides” include anilazine. “Quinone fungicides” include dithianon. “Quinoxaline fungicides” include quinomethionate (also known as chinomethionate). “Maleimide fungicides” include fluoroimide.

(b49) “Fungicides other than fungicides of classes (b1) through (b48)” include certain fungicides whose mode of action may be unknown. These include: (b49.1), “phenyl-acetamide fungicides” (FRAC code U6), (b49.2) “aryl-phenyl-ketone fungicides” (FRAC code U8), (b49.3) “guanidine fungicides” (FRAC code U12), (b49.4) “thiazolidine fungicides” (FRAC code U13), (b49.5) “pyrimidinone-hydrazone fungicides” (FRAC code U14) and (b49.6) compounds that bind to oxysterol-binding protein as described in PCT Patent Publication WO 2013/009971. The phenyl-acetamides include cyflufenamid and N-[[(cyclopropylmethoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]-methylene]-benzeneacetamide. The aryl-phenyl ketones include benzophenones such as metrafenone, and benzoylpyridines such as pyriofenone (5-chloro-2-methoxy-4-methyl-3-pyridinyl)(2,3,4-trimethoxy-6-methylphenyl)methanone). The quanidines include dodine. The thiazolidines include flutianil ((2Z)-2-[[2-fluoro-5-(trifluoromethyl)phenyl]thio]-2-[3-(2-methoxyphenyl)-2-thiazolidinylidene]acetonitrile). The pyrimidinonehydrazones include ferimzone. The (b49.6) class includes oxathiapiprolin (1-[4-[4-[5-(2,6-difluorophenyl)-4,5-dihydro-3-isoxazolyl]-2-thiazolyl]-1-piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone) and its R-enantiomer which is 1-[4-[4-[5R-(2,6-difluorophenyl)-4,5-dihydro-3-isoxazolyl]-2-thiazolyl]-1-piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-ethanone (Registry Number 1003319-79-6). The (b49) class also includes bethoxazin, flometoquin (2-ethyl-3,7-dimethyl-6-[4-(trifluoromethoxy)phenoxy]-4-quinolinyl methyl carbonate), fluoroimide, neo-asozin (ferric methanearsonate), picarbutrazox (1,1-dimethylethyl N-[6-[[[[((Z)1-methyl-1H-tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-pyridinyl]carbamate), pyrrolnitrin, quinomethionate, tebufloquin (6-(1,1-dimethylethyl)-8-fluoro-2,3-dimethyl-4-quinolinyl acetate), tolnifanide (N-(4-chloro-2-nitrophenyl)-N-ethyl-4-methylbenzenesulfonamide), 2-butoxy-6-iodo-3-propyl-4H-1-benzopyran-4-one, 3-butyn-1-yl N-[6-[[[[(1-methyl-1H-tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-pyridinyl]-carbamate, (N-(4-chloro-2-nitrophenyl)-N-ethyl-4-methylbenzenesulfonamide), N′-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide, N-[[(cyclopropylmethoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]-methylene]benzeneacetamide, 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetrone, 5-fluoro-2-[(4-methylphenyl)methoxy]-4-pyrimidinamine, 5-fluoro-2-[(4-fluorophenyl)methoxy]-4-pyrimidinamine and 4-fluorophenyl N-[1-[[[1-(4-cyano-phenyl)ethyl]sulfonyl]methyl]propyl]carbamate, pentyl N-[6-[[[[(1-methyl-1H-tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-pyridinyl]carbamate, pentyl N-[4-[[[[(1-methyl-1H-tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-thiazolyl]carbamate and pentyl N-[6-[[[[(Z)-(1-methyl-1H-tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-pyridinyl]-carbamate. The (b46) class further includes mitosis- and cell division-inhibiting fungicides besides those of the particular classes described above (e.g., (b1), (b10) and (b22)).

Additional “Fungicides other than fungicides of classes (1) through (46)” whose mode of action may be unknown, or may not yet be classified include a fungicidal compound selected from components (b49.7) through (b49.12), as shown below.

Component (b49.7) relates to a compound of Formula b49.7

[Figure (not displayed)]

[Figure (not displayed)]

    • wherein Rb1 is —OCH2 or
      Examples of a compound of Formula b49.7 include (b49.7a) (2-chloro-6-fluorophenyl)-methyl 2-[1-[2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl]-4-piperidinyl]-4-thiazolecarboxylate (Registry Number 1299409-40-7) and (b49.7b) (1R)-1,2,3,4-tetrahydro-1-naphthalenyl 2-[1-[2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl]-4-piperidinyl]-4-thiazolecarboxylate (Registry Number 1299409-42-9). Methods for preparing compounds of Formula b46.2 are described in PCT Patent Publications WO 2009/132785 and WO 2011/051243.

Component (b49.8) relates to a compound of Formula b49.8

[Figure (not displayed)]

    • wherein Rb2 is CH3, CF3 or CHF2; Rb3 is CH3, CF3 or CHF2; Rb4 is halogen or cyano; and n is 0, 1, 2 or 3.
      Examples of a compound of Formula b49.8 include (b49.8a) 1-[4-[4-[5-[(2,6-difluorophenoxy)methyl]-4,5-dihydro-3-isoxazolyl]-2-thiazolyl]-1-piperdinyl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone. Methods for preparing compounds of Formula b49.8 are described in PCT Patent Application PCT/US11/64324.

Component (b4799) relates to a compound of Formula b49.9

[Figure (not displayed)]

    • wherein Rb5 is —CH2OC(O)CH(CH3)2, —C(O)CH3, —CH2OC(O)CH3, —C(O)OCH2CH(CH3)2 or

[Figure (not displayed)]
Examples of a compound of Formula b49.9 include (b49.9a) [[4-methoxy-2-[[[(3S,7R,8R,9S)-9-methyl-8-(2-methyl-1-oxopropoxy)-2,6-dioxo-7-(phenylmethyl)-1,5-dioxonan-3-yl]amino]carbonyl]-3-pyridinyl]oxy]methyl 2-methylpropanoate (also known as fenpicoxamid) (Registry Number 517875-34-2), (b49.9b) (3S,6S,7R,8R)-3-[[[3-(acetyloxy)-4-methoxy-2-pyridinyl]carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl 2-methylpropanoate (Registry Number 234112-93-7), (b49.9c) (3S,6S,7R,8R)-3[[[3 [(acetyloxy)methoxy]-4-methoxy-2-pyridinyl]carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl 2-methylpropanoate (Registry Number 517875-31-9), (b49.9d) (3S,6S,7R,8R)-3-[[[4-methoxy-3-[[(2-methylpropoxy)carbonyl]oxy]-2-pyridinyl]-carbonyl]amino]6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl 2-methylpropanoate (Registry Number 328256-72-0), and (b49.9e)N-[[3-(1,3-benzodioxol-5-ylmethoxy)-4-methoxy-2-pyridinyl]carbonyl]-O-[2,5-dideoxy-3-O-(2-methyl-1-oxopropyl)-2-(phenylmethyl)L-arabinonoyl]-L-serine, (1→4′)-lactone (Registry Number 1285706-70-8). Methods for preparing compounds of Formula b49.9 are described in PCT Patent Publications WO 99/40081, WO 2001/014339, WO 2003/035617 and WO 2011044213.

Component (b49.10) relates to a compound of Formula b49.10

[Figure (not displayed)]
wherein Rb6 is H or F, and Rb7 is —CF2CHFCF3 or —CF2CF2H. Examples of a compound of Formula b49.10 are (b49.10a) 3-(difluoromethyl)-N-[4-fluoro-2-(1,1,2,3,3,3-hexafluoro-propoxy)phenyl]-1-methyl-1H-pyrazole-4-carboxamide (Registry Number 1172611-40-3) and (b49.10b) 3-(difluoromethyl)-1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-1H-pyrazole4-carboxamide (Registry Number 923953-98-4). Compounds of Formula 49.10 can be prepared by methods described in PCT Patent Publication WO 2007/017450.

Component b49.11 relates a compound of Formula b49.11

[Figure (not displayed)]

wherein

    • Rb8 is halogen, C1-C4 alkoxy or C2-C4 alkynyl;
    • Rb9 is H, halogen or C1-C4 alkyl;
    • Rb10 is C1-C12 alkyl, C1-C12 haloalkyl, C1-C12 alkoxy, C2-C12 alkoxyalkyl, C2-C12 alkenyl, C2-C12 alkynyl, C4-C12 alkoxyalkenyl, C4-C12 alkoxyalkynyl, C1-C12 alkylthio or C2-C12 alkylthioalkyl;
    • Rb11 is methyl or —Yb13—Rb12;
    • Rb12 is C1-C2 alkyl; and
    • Yb13 is CH2, O or S.

Examples of compounds of Formula b49.11 include (b49.11a) 2-[(3-bromo-6-quinolinyl)-oxy]-N-(1,1-dimethyl-2-butyn-1-yl)-2-(methylthio)acetamide, (b49.11b) 2[(3-ethynyl-6-quinolinyl)oxy]-N-[1-(hydroxymethyl)-1-methyl-2-propyn-1-yl]-2-(methylthio)acetamide, (b49.11c)N-(1,1-dimethyl-2-butyn-1-yl)-2-[(3-ethynyl-6-quinolinyl)oxy]-2-(methylthio)-acetamide, (b49.11d) 2-[(3-bromo-8-methyl-6-quinolinyl)oxy]-N-(1,1-dimethyl-2-propyn-1-yl)-2-(methylthio)acetamide and (b49.11e) 2-[(3-bromo-6-quinolinyl)oxy]-N-(1,1-di-methylethyl)butanamide. Compounds of Formula b49.11, their use as fungicides and methods of preparation are generally known; see, for example, PCT Patent Publications WO 2004/047538, WO 2004/108663, WO 2006/058699, WO 2006/058700, WO 2008/110355, WO 2009/030469, WO 2009/049716 and WO 2009/087098.

Component 49.12 relates to N-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide, which is believed to inhibit C24-methyl transferase involved in the biosynthesis of sterols.

Therefore of note is a mixture (i.e. composition) comprising a compound of Formula 1 and at least one fungicidal compound selected from the group consisting of the aforedescribed classes (1) through (49). Also of note is a composition comprising said mixture (in fungicidally effective amount) and further comprising at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. Of particular note is a mixture (i.e. composition) comprising a compound of Formula 1 and at least one fungicidal compound selected from the group of specific compounds listed above in connection with classes (1) through (49). Also of particular note is a composition comprising said mixture (in fungicidally effective amount) and further comprising at least one additional surfactant selected from the group consisting of surfactants, solid diluents and liquid diluents.

Examples of component (b) fungicides include acibenzolar-S-methyl, aldimorph, ametoctradin, amisulbrom, anilazine, azaconazole, azoxystrobin, benalaxyl (including benalaxyl-M), benodanil, benomyl, benthiavalicarb (including benthiavalicarb-isopropyl), benzovindiflupyr, bethoxazin, binapacryl, biphenyl, bitertanol, bixafen, blasticidin-S, boscalid, bromuconazole, bupirimate, buthiobate, captafol, captan, carbendazim, carboxin, carpropamid, chloroneb, chlorothalonil, chlozolinate, clotrimazole, copper hydroxide, copper oxychloride, copper sulfate, coumoxystrobin, cyazofamid, cyflufenamid, cymoxanil, cyproconazole, cyprodinil, dichlofluanid, diclocymet, diclomezine, dicloran, diethofencarb, difenoconazole, diflumetorim, dimethirimol, dimethomorph, dimoxystrobin, diniconazole (including diniconazole-M), dinocap, dithianon, dithiolanes, dodemorph, dodine, econazole, edifenphos, enoxastrobin (also known as enestroburin), epoxiconazole, etaconazole, ethaboxam, ethirimol, etridiazole, famoxadone, fenamidone, fenarimol, fenaminstrobin, fenbuconazole, fenfuram, fenhexamid, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, fenpyrazamine, fentin acetate, fentin chloride, fentin hydroxide, ferbam, ferimzone, flometoquin, fluazinam, fludioxonil, flufenoxystrobin, flumorph, fluopicolide, fluopyram, flouroimide, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutianil, flutolanil, flutriafol, fluxapyroxad, folpet, fthalide, fuberidazole, furalaxyl, furametpyr, guazatine, hexaconazole, hymexazole, imazalil, imibenconazole, iminoctadine albesilate, iminoctadine triacetate, iodocarb, ipconazole, iprobenfos, iprodione, iprovalicarb, isoconazole, isofetamid, isoprothiolane, isopyrazam, isotianil, kasugamycin, kresoxim-methyl, mancozeb, mandepropamid, mandestrobin, maneb, mepanipyrim, mepronil, meptyldinocap, metalaxyl (including metalaxyl-M/mefenoxam), metconazole, methasulfocarb, metiram, metominostrobin, metrafenone, miconazole, myclobutanil, naftifine, neo-asozin, nuarimol, octhilinone, ofurace, orysastrobin, oxadixyl, oxathiapiprolin, oxolinic acid, oxpoconazole, oxycarboxin, oxytetracycline, pefurazoate, penconazole, pencycuron, penflufen, penthiopyrad, phosphorous acid (including salts thereof, e.g., fosetyl-aluminum), picarbutrazox, picoxystrobin, piperalin, polyoxin, probenazole, prochloraz, procymidone, propamacarb, propiconazole, propineb, proquinazid, prothiocarb, prothioconazole, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyrazophos, pyribencarb, pyributicarb, pyrifenox, pyrimethanil, pyriofenone, pyrisoxazole, pyroquilon, pyrrolnitrin, quinconazole, quinomethionate, quinoxyfen, quintozene, sedaxane, silthiofam, simeconazole, spiroxamine, streptomycin, sulfur, tebuconazole, tebufloquin, teclofthalam, tecnazene, terbinafine, tetraconazole, thiabendazole, thifluzamide, thiophanate, thiophanate-methyl, thiram, tiadinil, tolclofos-methyl, tolnifanide, tolprocarb, tolyfluanid, triadimefon, triadimenol, triarimol, triticonazole, triazoxide, tribasic copper sulfate, tricyclazole, triclopyricarb, tridemorph, trifloxystrobin, triflumizole, triforine, trimorphamide, uniconazole, uniconazole-P, validamycin, valifenalate (also known as valiphenal), vinclozolin, zineb, ziram, zoxamide, (3S,6S,7R,8R)-3-[[[3-[(acetyloxy)methoxy]-4-methoxy-2-pyridinyl]carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl 2-methylpropanoate, (3S,6S,7R,8R)-3-[[[3-(acetyloxy)-4-methoxy-2-pyridinyl]carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl 2-methylpropanoate, N-[[3-(1,3-benzodioxol-5-ylmethoxy)-4-methoxy-2-pyridinyl]carbonyl]-O-[2,5-dideoxy-3-O-(2-methyl-1-oxopropyl)-2-(phenylmethyl)-L-arabinonoyl]-L-serine, (1→4′)-lactone, N-[2-(1S,2R)-[1,1′-bicyclopropyl]-2-ylphenyl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, 2-[(3-bromo-6-quinolinyl)oxy]-N-(1,1-dimethyl-2-butyn-1-yl)-2-(methylthio)acetamide, 2-[(3-bromo-6-quinolinyl)oxy]-N-(1,1-dimethylethyl)butanamide, 2-[(3-bromo-8-methyl-6-quinolinyl)oxy]-N-(1,1-dimethyl-2-propyn-1-yl)-2-(methylthio)acetamide, 2-butoxy-6-iodo-3-propyl-4H-1-benzopyran-4-one, 3-butyn-1-yl N-[6-[[[[(1-methyl-1H-tetrazol-5-yl)phenylmethylene]-amino]oxy]methyl]-2-pyridinyl]carbamate, α-(1-chlorocyclopopropyl)-α-[2-(2,2dichloro-cyclopropyl)ethyl]-1H-1,2,4-triazole-1-ethanol, 2-[2-(1-chlorocyclopropyl)-4-(2,2-dichloro-cyclopropyl)-2-hydroxybutyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione, (αS)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-4-isoxazolyl]-3-pyridinemethanol, rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole, rel-2-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione, rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-5-(2-propen-1-ylthio)-1H-1,2,4-triazole, 3-[5-(4-chlorophenyl)-2,3-di-methyl-3-isoxazolidinyl]pyridine, (2-chloro-6-fluorophenyl)methyl 2-[1-[2-[3,5-bis(di-fluoromethyl)-1H-pyrazol-1-yl]acetyl]-4-piperidinyl]-4-thiazolecarboxylate, N′-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide, N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]-ethyl]-3-methyl-2-[(methylsulfonyl)amino]butanamide, N-[2-[4-[[3-(4-chlorophenyl)-2-propyn-1-yl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(ethylsulfonyl)amino]butanamide, N′-[4-[4-chloro-3-(trifluoromethyl)phenoxy]-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide, N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[[2-(1-methyl-ethyl)phenyl]methyl]-1H-pyrazole-4-carboxamide, N-[[(cyclopropylmethoxy)amino][6-(difluoromethoxy)-2,3-difluorophenyl]methylene]benzeneacetamide, N-[2-(2,4-dichloro-phenyl)-2-methoxy-1-methylethyl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, N-(3′,4′-difluoro[1,1′-biphenyl]-2-yl)-3-(trifluoromethyl)-2-pyrazinecarboxamide, 3-(difluoromethyl)-N-(2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-N-[4-fluoro-2-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl]-1-methyl-1H-pyrazole-4-carboxamide, 5,8-difluoro-N-[2-[3-methoxy-4-[[4-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]ethyl]-4-quinazolinamine, 3-(difluoromethyl)-1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-1H-pyrazole-4-carboxamide, 1-[4-[4-[5R-[(2,6-difluorophenoxy)methyl]-4,5-dihydro-3-isoxazolyl]-2-thiazolyl]-1-piperdinyl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, N-(1,1-dimethyl-2-butyn-1-yl)-2-[(3-ethynyl-6-quinolinyl)oxy]-2-(methylthio)acetamide, 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetrone, 2-[(3-ethynyl-6-quinolinyl)oxy]-N-[1-(hydroxy-methyl)-1-methyl-2-propyn-1-yl]-2-(methylthio)acetamide, 4-fluorophenyl N-[1-[[[1-(4-cyanophenyl)ethyl]sulfonyl]methyl]propyl]carbamate, 5-fluoro-2-[(4-fluorophenyl)-methoxy]-4-pyrimidinamine, 5-fluoro-2-[(4-methylphenyl)methoxy]-4-pyrimidinamine, (3S,6S,7R,8R)-3-[[[4-methoxy-3-[[(2-methylpropoxy)carbonyl]oxy]-2-pyridinyl]-carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl-2-methylpropanoate, α-(methoxyimino)-N-methyl-2-[[[1-[3-(trifluoromethyl)phenyl]ethoxy]imino]-methyl]benzeneacetamide, [[4-methoxy-2-[[[(3S,7R,8R,9S)-9-methyl-8-(2-methyl-1-oxo-propoxy)-2,6-dioxo-7-(phenylmethyl)-1,5-dioxonan-3-yl]amino]carbonyl]-3-pyridinyl]oxy]methyl 2-methylpropanoate, pentyl N-[6-[[[[(1-methyl-1H-tetrazol-5-yl)-phenylmethylene]amino]oxy]methyl]-2-pyridinyl]carbamate, pentyl N-[4-[[[[(1-methyl-1H-tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-thiazolyl]carbamate, and pentyl N-[6-[[[[(Z)-(1-methyl-1H-tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-pyridinyl]-carbamate and (1R)-1,2,3,4-tetrahydro-1-naphthalenyl 2-[1-[2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl]-4-piperidinyl]-4-thiazolecarboxylate. Therefore of note is a fungicidal composition comprising as component (a) a compound of Formula 1 (or an N-oxide or salt thereof) and as component (b) at least one fungicide selected from the preceding list.

Of particular note are combinations of compounds of Formula 1 (or an N-oxide or salt thereof) (i.e. Component (a) in compositions) with azoxystrobin, benzovindiflupyr, bixafen, captan, carpropamid, chlorothalonil, copper hydroxide, copper oxychloride, copper sulfate, cymoxanil, cyproconazole, cyprodinil, diethofencarb, difenoconazole, dimethomorph, epoxiconazole, ethaboxam, fenarimol, fenhexamid, fluazinam, fludioxonil, fluopyram, flusilazole, flutianil, flutriafol, fluxapyroxad, folpet, iprodione, isofetamid, isopyrazam, kresoxim-methyl, mancozeb, mandestrobin, meptyldinocap, metalaxyl (including metalaxyl-M/mefenoxam), metconazole, metrafenone, myclobutanil, oxathiapiprolin, penflufen, penthiopyrad, phosphorous acid (including salts thereof, e.g., fosetyl-aluminum), picoxystrobin, propiconazole, proquinazid, prothioconazole, pyraclostrobin, pyrimethanil, sedaxane spiroxamine, sulfur, tebuconazole, thiophanate-methyl, trifloxystrobin, zoxamide, α-(1-chlorocyclopropyl)-α-[2-(2,2-dichlorocyclopropyl)ethyl]-1H-1,2,4-triazole-1-ethanol, 2-[2-(1chlorocyclopropyl)-4-(2,2-dichlorocyclopropyl)-2-hydroxybutyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione, N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methylethyl]-3-(difluoro-methyl)-1-methyl-1H-pyrazole-4-carboxamide, 3-(difluoromethyl)-N-(2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, 1-[4-[4-[5R-(2,6-difluoro-phenyl)-4,5-dihydro-3-isoxazolyl]-2-thiazolyl]-1-piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, 1,1-dimethylethyl N-[6-[[[[(1-methyl-1H-tetrazol-5-yl)phenylmethylene]amino]oxy]methyl]-2-pyridinyl]carbamate, 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetrone, 5-fluoro-2-[(4-fluoro-phenyl)methoxy]-4-pyrimidinamine, 5-fluoro-2-[(4-methylphenyl)methoxy]-4-pyrimidinamine, (aS)-[3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-4-isoxazolyl]-3-pyridinemethanol, rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole, rel-2-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]-methyl]-1,2-dihydro-3H-1,2,4-triazole-3-thione, and rel-1-[[(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-2-oxiranyl]methyl]-5-(2-propen-1-ylthio)-1H-1,2,4-triazole (i.e. as Component (b) in compositions).

Examples of other biologically active compounds or agents with which compounds of this invention can be formulated are: invertebrate pest control compounds or agents such as abamectin, acephate, acetamiprid, acrinathrin, afidopyropen ([(3S,4R,4aR,6S,6aS,12R, 12aS, 12bS)-3-[(cyclopropylcarbonyl)oxy]-1,3,4,4a,5,6,6a,12,12a, 12b-decahydro-6,12-dihydroxy-4,6a, 12b-trimethyl-11-oxo-9-(3-pyridinyl)-2H, 11H-naphtho[2,1-b]pyrano[3,4-e]pyran-4-yl]methyl cyclopropanecarboxy-late), amidoflumet (S-1955), avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, buprofezin, carbofuran, cartap, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clothianidin, cyantraniliprole (3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide), cyclaniliprole (3-bromo-N-[2-bromo-4-chloro-6-[[(1-cyclopropyl-ethyl) amino]carbonyl]phenyl]1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide), cycloxaprid ((5S,8R)-1-[(6-chloro-3-pyridinyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro-5,8-epoxy-1H-imidazo[1,2-a]azepine), cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, dimefluthrin, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flubendiamide, flucythrinate, flufenoxystrobin (methyl (αE)-2-[[2-chloro-4-(trifluoromethyl)phenoxy]methyl]-α-(methoxymethylene)benzeneacetate), flufensulfone (5-chloro-2-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]thiazole), flupiprole (1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[(2-methyl-2-propen-1-yl)amino]-4-[(trifluoro-methyl)sulfinyl]-1H-pyrazole-3-carbonitrile), flupyradifurone (4-[[(6-chloro-3-pyridinyl)-methyl](2,2-difluoroethyl)amino]-2(5H)-furanone), tau-fluvalinate, flufenerim (UR-50701), flufenoxuron, fonophos, halofenozide, heptafluthrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2-dimethyl-3-[(1Z)-3,3,3-trifluoro-1-propen-1-yl]cyclo-propanecarboxylate), hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, meperfluthrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1R,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate), metaflumizone, metaldehyde, methamidophos, methidathion, methomyl, methoprene, methoxychlor, methoxyfenozide, metofluthrin, milbemycin oxime, momfluorothrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl-3-(2-cyano-1-propen-1-yl)-2,2-dimethylcyclopropanecarboxylate), monocrotophos, nicotine, nitenpyram, nithiazine, novaluron, noviflumuron (XDE-007), oxamyl, pyflubumide (1,3,5-trimethyl-N-(2-methyl-1-oxopropyl)-N-[3-(2-methylpropyl)-4-[2,2,2-trifluoro-1-methoxy-1-(trifluoromethyl)ethyl]phenyl]-1H-pyrazole-4-carboxamide), parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, pymetrozine, pyrafluprole, pyrethrin, pyridalyl, pyrifluquinazon, pyriminostrobin (methyl (αE)-2-[[[2-[(2,4-dichlorophenyl)amino]-6-(trifluoromethyl)-4-pyrimidinyl]oxy]methyl]-α-(methoxy-methylene)benzeneacetate), pyriprole, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen (BSN 2060), spirotetramat, sulfoxaflor, sulprofos, tebufenozide, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, tetramethylfluthrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tolfenpyrad, tralomethrin, triazamate, trichlorfon and triflumuron; and biological agents including entomopathogenic bacteria, such as Bacillus thuringiensis subsp. aizawai, Bacillus thuringiensis subsp. kurstaki, and the encapsulated delta-endotoxins of Bacillus thuringiensis (e.g., Cellcap, MPV, MPVII); entomopathogenic fungi, such as green muscardine fungus; and entomopathogenic virus including baculovirus, nucleopolyhedro virus (NPV) such as HzNPV, AfNPV; and granulosis virus (GV) such as CpGV.

Compounds of this invention and compositions thereof can be applied to plants genetically transformed to express proteins toxic to invertebrate pests (such as Bacillus thuringiensis delta-endotoxins). The effect of the exogenously applied fungicidal compounds of this invention may be synergistic with the expressed toxin proteins.

General references for agricultural protectants (i.e. insecticides, fungicides, nematocides, acaricides, herbicides and biological agents) include The Pesticide Manual, 13th Edition, C. D. S. Tomlin, Ed., British Crop Protection Council, Farnham, Surrey, U. K., 2003 and The BioPesticide Manual, 2nd Edition, L. G. Copping, Ed., British Crop Protection Council, Farnham, Surrey, U. K., 2001.

For embodiments where one or more of these various mixing partners are used, the weight ratio of these various mixing partners (in total) to the compound of Formula 1 is typically between about 1:3000 and about 3000:1. Of note are weight ratios between about 1:300 and about 300:1 (for example ratios between about 1:30 and about 30:1). One skilled in the art can easily determine through simple experimentation the biologically effective amounts of active ingredients necessary for the desired spectrum of biological activity. It will be evident that including these additional components may expand the spectrum of diseases controlled beyond the spectrum controlled by the compound of Formula 1 alone.

In certain instances, combinations of a compound of this invention with other biologically active (particularly fungicidal) compounds or agents (i.e. active ingredients) can result in a greater-than-additive (i.e. synergistic) effect. Reducing the quantity of active ingredients released in the environment while ensuring effective pest control is always desirable. When synergism of fungicidal active ingredients occurs at application rates giving agronomically satisfactory levels of fungal control, such combinations can be advantageous for reducing crop production cost and decreasing environmental load.

Also in certain instances, combinations of a compound of the invention with other biologically active compounds or agents can result in a less-than-additive (i.e. safening) effect on organisms beneficial to the agronomic environment. For example, a compound of the invention may safen a herbicide on crop plants or protect a beneficial insect species (e.g., insect predators, pollinators such as bees) from an insecticide.

Fungicides of note for formulation with compounds of Formula 1 to provide mixtures useful in seed treatment include but are not limited to amisulbrom, azoxystrobin, boscalid, carbendazim, carboxin, cymoxanil, cyproconazole, difenoconazole, dimethomorph, fluazinam, fludioxonil, flufenoxystrobin, fluquinconazole, fluopicolide, fluoxastrobin, flutriafol, fluxapyroxad, ipconazole, iprodione, metalaxyl, mefenoxam, metconazole, myclobutanil, paclobutrazole, penflufen, picoxystrobin, prothioconazole, pyraclostrobin, sedaxane, silthiofam, tebuconazole, thiabendazole, thiophanate-methyl, thiram, trifloxystrobin and triticonazole.

Invertebrate pest control compounds or agents with which compounds of Formula 1 can be formulated to provide mixtures useful in seed treatment include but are not limited to abamectin, acetamiprid, acrinathrin, afidopyropen, amitraz, avermectin, azadirachtin, bensultap, bifenthrin, buprofezin, cadusafos, carbaryl, carbofuran, cartap, chlorantraniliprole, chlorfenapyr, chlorpyrifos, clothianidin, cyantraniliprole, cyclaniliprole, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, dieldrin, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenothiocarb, fenoxycarb, fenvalerate, fipronil, flonicamid, flubendiamide, fluensulfone, flufenoxuron, flufiprole, flupyradifurone, fluvalinate, formetanate, fosthiazate, heptafluthrin, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, lufenuron, meperfluthrin, metaflumizone, methiocarb, methomyl, methoprene, methoxyfenozide, momfluorothrin, nitenpyram, nithiazine, novaluron, oxamyl, pyflubumide, pymetrozine, pyrethrin, pyridaben, pyriminostrobin, pyridalyl, pyriproxyfen, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, sulfoxaflor, tebufenozide, tetramethrin, tetramethylfluthrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, triflumuron, Bacillus thuringiensis delta-endotoxins, strains of Bacillus thuringiensis and strains of Nucleo polyhydrosis viruses.

Compositions comprising compounds of Formula 1 useful for seed treatment can further comprise bacteria and fungi that have the ability to provide protection from the harmful effects of plant pathogenic fungi or bacteria and/or soil born animals such as nematodes. Bacteria exhibiting nematicidal properties may include but are not limited to Bacillus firmus, Bacillus cereus, Bacillius subtilis and Pasteuria penetrans. A suitable Bacillus firmus strain is strain CNCM I-1582 (GB-126) which is commercially available as BioNem™. A suitable Bacillus cereus strain is strain NCMM 1-1592. Both Bacillus strains are disclosed in U.S. Pat. No. 6,406,690. Other suitable bacteria exhibiting nematicidal activity are B. amyloliquefaciens IN937a and B. subtilis strain GB03. Bacteria exhibiting fungicidal properties may include but are not limited to B. pumilus strain GB34. Fungal species exhibiting nematicidal properties may include but are not limited to Myrothecium verrucaria, Paecilomyces lilacinus and Purpureocillium lilacinum.

Seed treatments can also include one or more nematicidal agents of natural origin such as the elicitor protein called harpin which is isolated from certain bacterial plant pathogens such as Erwinia amylovora. An example is the Harpin-N-Tek seed treatment technology available as N-Hibit™ Gold CST.

Seed treatments can also include one or more species of legume-root nodulating bacteria such as the microsymbiotic nitrogen-fixing bacteria Bradyrhizobium japonicum. These inocculants can optionally include one or more lipo-chitooligosaccharides (LCOs), which are nodulation (Nod) factors produced by rhizobia bacteria during the initiation of nodule formation on the roots of legumes. For example, the Optimize® brand seed treatment technology incorporates LCO Promoter Technology™ in combination with an inocculant.

Seed treatments can also include one or more isoflavones which can increase the level of root colonization by mycorrhizal fungi. Mycorrhizal fungi improve plant growth by enhancing the root uptake of nutrients such as water, sulfates, nitrates, phosphates and metals. Examples of isoflavones include, but are not limited to, genistein, biochanin A, formononetin, daidzein, glycitein, hesperetin, naringenin and pratensein. Formononetin is available as an active ingredient in mycorrhizal inocculant products such as PHC Colonize® AG.

Seed treatments can also include one or more plant activators that induce systemic acquired resistance in plants following contact by a pathogen. An example of a plant activator which induces such protective mechanisms is acibenzolar-S-methyl.

The following TESTS demonstrate the control efficacy of compounds of this invention on specific pathogens. The pathogen control protection afforded by the compounds is not limited, however, to these species. See Index Tables A-G below for compound descriptions. The following abbreviations are used in the Index Tables: Me means methyl, Et means ethyl, n-Pr means n-propyl, i-Pr means iso-propyl, c-Pr means cyclopropyl, t-Bu means tert-butyl, Ph means phenyl, MeO means methoxy and EtO means ethoxy. The abbreviation “Cmpd. No.” stands for “Compound Number”, and the abbreviation “Ex.” stands for “Example” and is followed by a number indicating in which example the compound is prepared. 19F NMR spectra are reported in ppm relative to trichlorofluoromethane in CDCl3 solution unless indicated otherwise. The numerical value reported in the column “MS” is the molecular weight of the highest isotopic abundance positively charged parent ion (M+1) formed by addition of H+ (molecular weight of 1) to the molecule having the highest isotopic abundance, or the highest isotopic abundance negatively charged ion (M−1) formed by loss of H+(molecular weight of 1). The presence of molecular ions containing one or more higher atomic weight isotopes of lower abundance (e.g., 37Cl, 81Br) is not reported. The reported MS peaks were observed by mass spectrometry using electrospray ionization (ESI) or atmospheric pressure chemical ionization (APCI).

INDEX TABLE A
[Figure (not displayed)]
A dash “—” in the R3c column means that no R3c substituent is present and the remaining carbon valences are
occupied by hydrogen atoms. In the Z2 column, the bond projecting to the left is attached to C═O, and the
bond projecting to the right is attached to the phenyl ring.
19FMP
Cmpd.R1Z1Z2R3cNMR° C.MS
1PhNH—OCH2−65.42
2CH3CH2NH—OCH2−65.37 99-101
3i-PrNH—OCH2−65.36
4EtOC(═O)CH2NH—OCH2−65.36
5CH3CH2NH—OCH2CH(OMe)—−65.35
6CH3N(Me)—OCH2−65.35
7ClCH2CH2NH—OCH2−65.35
9CH3NH—OCH2−65.36
10CH3CH2CH2NH—OCH2−65.36
11MeOCH2CH2NH—OCH2−65.36
12CH≡CCH2NH—OCH2−65.3594-96
13PhCH2NH—OCH2−65.35
14CH3CH2CH(Me)NH—OCH2−65.36
15n-BuNH—OCH2−65.36
16t-BuNH—OCH2−65.37
17 (Ex. 4)HNH—OCH2−65.35142-144
19CH3CH2NH—OCH(Me)—−65.44
20CH3CH2NH—OCH2CH2CH2−65.36344 (M + 1)
223-pyridinylNH—OCH2−65.33365 (M + 1)
23 (Ex. 3)3-pyridinylNH—OCH(Me)—−65.35379 (M + 1)
244-(MeOC(═O))PhCH2NH—OCH2−65.35436 (M + 1)
254-(MeOC(═O))PhCH2NH—OCH(Me)—−65.35450 (M + 1)
264-(EtOC(═O))PhCH2NH—OCH2−65.39450 (M + 1)
274-(EtOC(═O))PhCH2NH—OCH(Me)—−65.35464 (M + 1)
28CH3N(Me)—OCH2CH2CH2−65.38344 (M + 1)
29CH2═CHCH2NH—OCH2CH2CH2−65.39356 (M + 1)
30CH≡CCH2NH—OCH2CH2CH2−65.39354 (M + 1)
31CH3NH—OCH2CH2CH2−65.44330 (M + 1)
32CH≡CCH2N(Me)—OCH2−65.36340 (M + 1)
33CH≡CCH2CH2NH—OCH2−65.40340 (M + 1)
343-pyridinylNH—OCH2CH2−65.36379 (M + 1)
353-pyridinylNH—OCH2CH2CH2−65.40393 (M + 1)
36CH3C≡CCH2NH—OCH2−65.42340 (M + 1)
41HNH—OCH2CH2−64.72a
42CH3NH—OCH2CH2−65.37
43 (Ex. 2)CH3CH2NH—OCH2CH2−65.39
44CH3N(Me)—OCH2CH2−65.39
45CH≡CCH2NH—OCH2CH2−65.37
474-(MeOC(═O))PhNH—OCH2−65.34422 (M − 1)
484-(MeOC(═O))PhNH—OCH(Me)—−65.34436 (M + 1)
494-(MeOC(═O))PhNH—OCH2CH2−65.36436 (M + 1)
504-(MeOC(═O))PhNH—OCH2CH2CH2−65.38450 (M + 1)
51CH2═CHCH2NH—OCH2−65.36
52CH3CH2N(Me)—OCH2−65.36
53CH3CH2N(Et)—OCH2−65.36
54c-PrNH—OCH2−65.36
55N≡CCH2NH—OCH2−65.35
574-(EtOC(═O))PhNH—OCH2−65.35434 (M − 1)
584-(EtOC(═O))PhNH—OCH(Me)—−65.36448 (M − 1)
594-(EtOC(═O))PhNH—OCH2CH2−65.37448 (M − 1)
604-(EtOC(═O))PhNH—OCH2CH2CH2−65.38462 (M − 1)
62CH3C≡CCH2NH—OCH(Me)—−65.35
63CH3C≡CCH2NH—OCH2CH2−65.41
64CH3C≡CCH2NH—OCH2CH2CH2−65.44
65CH≡CCH2CH2NH—OCH2CH2CH2−65.48368 (M + 1)
66CH≡CCH2CH2NH—OCH2CH2−65.42354 (M + 1)
67CH≡CCH2CH2NH—OCH(Me)—−65.39
684-(EtOC(═O))PhCH2NH—OCH2CH2−65.37464 (M + 1)
694-(EtOC(═O))PhCH2NH—OCH2CH2CH2−65.38478 (M + 1)
71CH3NH—OCH(Me)—−65.35
72CH3N(Me)—OCH(Me)—−65.61
73CH3CH2CH2NH—OCH(Me)—−65.3365-67
75CH3CH2NHOCH(CH2OMe)CH2−65.39
76CH≡CCH2NH—OCH(Me)—−65.43
77c-PrNH—OCH(Me)—−65.3790-92342 (M + 1)
78CH3CH2OC(═O)NH—OCH2CH2−65.35
79CH3CH2OC(═O)NH—OCH2−65.35
84HNH—OCH(Me)—−65.35
85HNH—OCH23-F−65.33,
−115.99
86HNH—OCH23-Cl−65.33
87HNH—OC(Me)2−65.34
89HNH—OCH22-F−65.21,149-150
−106.66
90HNH—OCH23-Me−65.35108-109
105 (Ex. 5)CH3O—NHN═CH—−65.34183-185315 (M + 1)
106t-BuO—NHN═CH—−65.35356 (M − 1)
107CH3CH2O—NHN═CH—−65.34329 (M + 1)
108CH3O—NHN═C(Me)—−65.35329 (M + 1)
109t-BuO—N(Me)N═CH—−65.36
136HN(OMe)—OCH2−65.34316 (M − 1)
a19F NMR in DMSO-d6 solution.

INDEX TABLE B
[Figure (not displayed)]
A dash “—” in the R13 column means that no R13 substituent is present
and the remaining carbon valences are occupied by hydrogen atoms.
Cmpd.R1Z1R1319F NMRMS
101HNH3-Cl −65.33
102CH3NH3-C1 −65.34
103CH3CH2NH3-Cl −65.35
104CH≡CCH2NH3-Cl −65.34
110CH3CH2NH −65.35
112HNH4-F −65.34,381 (M − 1)
−113.6
113CH3NH4-F −65.34,395 (M − 1)
−113.64
114CH3CH2NH4-F −65.35,409 (M − 1)
−113.69
115CH≡CCH2NH4-F −65.34,381 (M − 1)
−113.38
116CH3CH2CH2NH4-F −65.35,321 (M + 1)
−113.69
117HNH −65.35362 (M − 1)
118CH≡CCH2NH −65.35400 (M − 1)
1194-(MeOC(═O))NH −65.35511 (M − 1)
PhCH2
120CH≡CCH2CH2NH −65.35414 (M − 1)
121CH3N(Me) −65.35
122CH3OCH2CH2NH −65.35
128HNH2-CH3 −65.35
129CH3NH2-CH3 −65.35
130CH3CH2NH2-CH3 −65.35317 (M − 1)
131HNH3-F −65.34,380 (M − 1)
−112.10
132CH3NH3-F −65.34,
−112.21
133CH3CH2NH3-F −65.35,
−112.22
134CH3N(Me)3-F −65.35,
−112.22
135CH≡CCH2NH3-F −65.34,418 (M − 1)
−112.05
137CH3NH −65.35
138CH2═CHCH2NH −65.35
139CH3CH2CH2NH −65.35
140(CH3)2CHCH2NH −65.35
143HNH4-CH3 −65.35
144CH3NH4-CH3 −65.35
145CH3CH2NH4-CH3 −65.35
146CH2═C(Me)CH2NH4-CH3 −65.35

INDEX TABLE C
[Figure (not displayed)]
Cmpd.Z219F NMRMS
 8—OCH2−65.33
21—OCH2CH2CH2−65.34365 (M − 1)
40—OCH2CH2−65.38
(Ex. 1)
70—OCH(Me)—−65.32351 (M − 1)

INDEX TABLE D
[Figure (not displayed)]
A dash “—” in the R13 column means that no R13 substituent
is present and the remaining carbon valences are occupied
by hydrogen atoms.
Cmpd.R1319F NMRMS
 834-CH3O −65.41
1004-CH3 −65.37
111 −65.33414 (M − 1)
1274-F −65.31,431 (M − 1)
−111.68
1422-CH3 −65.33427 (M − 1)
1253-F −65.32,431 (M − 1)
−111.12
1263-Cl −65.31447 (M − 1)

INDEX TABLE E
[Figure (not displayed)]
Cmpd.R1Z1Z2A19F NMR
37CH≡CCH2NH—OCH2S−65.42
38CH3NH—OCH2S−65.41
39CH3CH2NH—OCH2S−65.40
46CH3CH2CH2NH—OCH2S−65.39
61CH≡CCH2NH—OCH(Me)—S−65.43
74CH3CH2CH2NH—OCH(Me)—S−65.41
80HNH—OCH2O−65.30
81CH≡CCH2NH—OCH2O−65.31
124CH3CH2O—NHN═CH—S−65.39
141CH3O—NHN═CH—S−65.39

INDEX TABLE F
[Figure (not displayed)]
Cmpd.R1Z1Z219F NMR
93HNH—OCH2−65.37
94CH3NH—OCH2−65.35
95CH3CH2NH—OCH2−65.37
96CH≡CCH2NH—OCH2−65.36
97CH2═CHCH2NH—OCH2−65.36
98CH2═C(Me)CH2NH—OCH2−65.34
99CH3N(Me)—OCH2−65.37

INDEX TABLE G
[Figure (not displayed)]
Cmpd.R1—Z1—C(═W)—Z2—J—19F NMRM.P.
18[Figure (not displayed)]
−65.44
82[Figure (not displayed)]
−65.27
88[Figure (not displayed)]
−65.18159-160
91[Figure (not displayed)]
−65.35107-108
123[Figure (not displayed)]
−65.32

Full text: Click here
Patent 2023

Example 1

[Figure (not displayed)]

Step a: 6,8-difluoro-1,2,3,4-tetrahydronaphthalen-1-one (500 mg, 2.74 mmol) was dissolved in CH2Cl2 (11 ml, 0.25 M) and the resulting solution was sparged with nitrogen gas for minutes. Triethylamine (574 μL, 1.5 equiv.) was added, and the solution was cooled to 0° C. before the addition of Tf2O (691 μL, 1.5 equiv.). The reaction was allowed to warm to room temperature and was stirred overnight. The solution was quenched with water, extracted with CH2Cl2, and the resulting organics were dried over Na2SO4 and concentrated onto Celite. The crude material was flashed on silca gel (gradient, 0% to 20% ethyl acetate in hexanes) to yield the desired 5,7-difluoro-4-(trifluoromethylsulfonyloxy)-1,2-dihydronaphthalene (470 mg, 54% yield) as an oil.

Step b: A vial was charged with alkenyl triflate from step a (2.50 g, 7.96 mmol, 1.0 equiv.), PdCl2(dppf) (872 mg, 1.19 mmol, 15 mol %), B2pin2 (2.82 g, 11.1 mmol, 1.4 equiv.), KOAc (1.72 g, 17.5 mmol, 2.2 equiv.) and 1,4-dioxane (20 ml). The vial was capped, and the reaction mixture was purged with N2 for 2 minutes. The reaction was heated at 80° C. and stirred for 30 min. The reaction was cooled, filtered, and concentrated onto Celite. Purification by flash chromatography (SiO2, hexane to 10% EtOAc) furnished the alkenyl pinacol boronic ester as a brown oil (1.16 g, 3.97 mmol, 50%).

Step c: To a vial containing the product from step b (100 mg, 0.342 mmol, 1.0 equiv.) was added 3-bromo-2-chloro-6-(methylsulfonyl)benzonitrile (100 mg, 0.342 mmol, 1.0 equiv.), PdCl2(dppf) (25 mg, 0.034 mmol, 10 mol %), 1,4-dioxane (1 mL) and 1M aq. Na2CO3 solution (0.7 mL). The vial was capped and purged with N2 for 2 minutes. The reaction was heated at 80° C. and stirred for 1.5 h. Once complete, the reaction was cooled, diluted with sat. aq. NH4Cl solution (20 mL) and extracted with DCM (20 mL). The aqueous layer was separated and back extracted with additional DCM (2×20 mL). The organic layers were combined, washed with brine (40 mL), and dried over MgSO4. Concentration under reduced pressure and purification by flash chromatography (SiO2, hexane to 50% EtOAc gradient) furnished the cross-coupled product as a white solid that was taken onto the next step (58.6 mg, 0.154 mmol, 45%, ESI MS [M+H]+ for C18H12ClF2NO2S, calcd 380.0, found 380.1).

Step d: To a vial containing the product from step c (58.6 mg, 0.154 mmol, 1.0 equiv.) was added Pd/C (10% Pd, 25 mg). The vial was evacuated and back-filled with N2 (×3). MeOH (1 mL) and EtOAc (1 mL) were added, and the reaction mixture was purged with H2 for 2 min, then stirred at room temperature under 1 atm H2 for 16 h. The reaction vessel was flushed with N2 and the mixture filtered through Celite, rinsing with EtOAc. Concentration under reduced pressure and purification by preparative reverse phase HPLC (20 to 100% gradient of acetonitrile and water with 0.1% TFA) furnished the product as a white solid. 1H NMR (400 MHz, DMSO-d6) δ 7.95 (d, J=8.2 Hz, 1H), 7.31 (d, J=8.2 Hz, 1H), 7.10-6.98 (m, 2H), 4.79-4.72 (m, 1H), 3.43 (s, 3H), 2.99-2.88 (m, 1H), 2.88-2.75 (m, 1H), 2.19-2.08 (m, 1H), 1.87-1.75 (m, 1H), 1.75-1.63 (m, 1H), 1.62-1.47 (m, 1H). ESI MS [M+H]+ for C18H14ClF2NO2S, calcd 382.0, found 382.1.

Example 2

[Figure (not displayed)]

Step a: To a suspension of 7-fluoro-2,3-dihydro-1H-inden-1-one (10.0 g, 66.6 mmol) and aluminum trichloride (22.2 g, 166.5 mmol, 2.5 equiv.) in 1,2-dichloroethane (190 ml, 0.35M) was added bromine (3.58 ml, 70 mmol, 1.05 equiv.) dropwise. The resulting solution was heated to 60° C. for three hours, after which the reaction was cooled to room temperature and poured onto ice. The reaction was extracted with MTBE, dried over magnesium sulfate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:1 solution of CH2Cl2:hexanes) to yield 4-bromo-7-fluoro-2,3-dihydro-1H-inden-1-one.

Step b: To a suspension of 4-bromo-7-fluoro-2,3-dihydro-1H-inden-1-one (17.0 g, 74.3 mmol) and Cs2CO3 (26.6 g, 81.7 mmol, 1.1 equiv.) in DMF (372 ml, 0.2M) was added benzyl mercaptan (9.24 g, 8.71 ml, 1.0 equiv.). The reaction was stirred at room temperature for 90 minutes. The desired product was precipitated from solution through the addition of 1.5 L of water and was dried under high vacuum overnight. The resulting crude product (23.1 g, 93% yield) was taken on without further purification.

Step c: The crude thioether from the step b (23.1 g, 69.2 mmol) was suspended in toluene (692 ml, 0.1M). Aluminum trichloride (10.2 g, 1.1 equiv.) was added at room temperature. An additional portion of aluminum trichloride (3.6 g, 27 mmol, 0.4 equiv.) was added after three hours. After an additional three hours, the reaction was quenched with water, extracted with ethyl acetate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the desired thiophenol as a yellow solid (13.4 g, 80% yield).

Step d: A solution of the thiophenol product from step c (6.7 g, 27.6 mmol) and methyl viologen dichloride hydrate (710 mg, 0.1 equiv.) in DMF (55 ml, 0.5M) was carefully degassed via three freeze-pump-thaw cycles under nitrogen. The resulting solution was cooled to −10 to −5° C. in a brine ice bath, and an excess of CF3I was sparged through the reaction mixture. The reaction was then stirred overnight under an atmosphere of CF3I. The reaction was carefully quenched at room temperature with water (off-gassing of residual CF3I occurs, use caution), extracted with ethyl acetate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in hexanes) to yield the desired thioether (5.21 g, 61% yield).

Step e: To a solution of the product from step d (10.45 g, 33.6 mmol) in MeCN (129 ml, 0.26 M with respect to starting material), CCl4 (129 ml, 0.26 M with respect to starting material), and H2O (258 ml, 0.13M with respect to starting material) was added ruthenium trichloride (697 mg, 3.36 mmol, 0.1 equiv.) followed by sodium periodate (29.6 g, 138.4 mmol, 4.12 equiv.). The reaction was stirred at room temperature for one hour, and upon completion was extracted with CH2Cl2 (×2). The combined organics were washed with saturated Na2S2O3, washed with brine, and dried over sodium sulfate before concentrating. The crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the product sulfone as a white solid (10.53 g, 91% yield). ESI MS [M+H]+ for C10H6BrF3O3S; calc 342.9, found 342.9.

Step f: A solution of the product sulfone from step e (3.5 g, 10.2 mmol) and Selectfluor (4.32 g, 12.2 mmol, 1.2 equiv.) in methanol (102 ml, 0.1M) was heated to 50° C. Sulfuric acid (27 μl, 5 mol %) was added, and the reaction was stirred at 50° C. for 48 hours. The solution was then diluted with diethyl ether, and the resulting white precipitate was filtered off and discarded. The organic solution was concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the product dimethyl acetal as a white solid (3.57 g, 87% yield).

Step g: A solution of the product acetal from step f (3.18 g, 7.8 mmol) and wet Amberlyst 15 (4.77 g, 150 wt %) in dioxane (31 ml, 0.2 M) was heated to 90° C. overnight. Upon completion, the polymeric beads were removed by filtration, and the concentrated crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the desired fluorinated ketone (2.33 g, 83% yield).

Step h: A solution of the indanone product of step g (2.5 g, 6.93 mmol) in dichloromethane (28 ml, 0.25M) was sparged with nitrogen gas before the addition of formic acid (783 μL, 956 mg, 20.8 mmol, 3 equiv.) and triethylamine (1.94 ml, 1.41 g, 13.9 mmol, 2 equiv.) at 0° C. under nitrogen. RuCl(p-cymene)[(R,R)-Ts-DPEN] (44.5 mg, 0.07 mmol, 0.01 equiv.) was added, and the reaction was stirred for a minimum of 12 hours at 0 to 5° C. Upon full conversion, the reaction was quenched with saturated NaHCO3 and extracted with CH2Cl2. The combined organics were concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in a 1:1 solution of CH2Cl2:hexanes) to yield the desired indanol (2.0 g, 80% yield) as a single diastereomer. The enantiomeric excess of this material was found to be 98% by chiral HPLC (Chiralpak AD-H, 20% iPrOH/hexanes, isocratic, 20 minutes) as compared to a racemic sample, which was obtained through reduction of the 2-fluoroindanone with sodium borohydride.

Step i: To a solution of the chiral indanol from step h (1.01 g, 2.75 mmol) in CH2Cl2 (11 ml, 0.25M) was added 2,6-lutidine (800 μL, 6.9 mmol, 2.5 equiv.) and TBSOTf (791 μL, 3.44 mmol, 1.25 equiv.) at 0° C. The reaction was allowed to warm to room temperature and was stirred overnight. Upon completion, the reaction was concentrated directly onto Celite and purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in hexanes) to yield the TBS ether (1.35 g, 100% yield).

Step j: The TBS ether product of step i (674 mg, 1.41 mmol) was combined with B2Pin2 (457 mg, 1.8 mmol, 1.3 equiv.) Pd(dppf)Cl2 (103 mg, 0.14 mmol, 0.1 equiv.) and potassium acetate (213 mg, 3 mmol, 2.2 equiv.) in dioxane (14 ml, 0.1M), and the resulting solution was heated to 100° C. for three hours. The reaction solution was concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 30% ethyl acetate in hexanes) to yield the desired boronic pinacol ester (638 mg, 86% yield) as a colorless oil.

Step k: The boronic ester product of step j (1.64 g, 3.13 mmol) was combined with 5,7-difluoro-4-(trifluoromethylsulfonyloxy)-1,2-dihydronaphthalene (1.18 g, 3.75 mmol, 1.2 equiv.), Pd(dppf)Cl2 (227 mg, 0.31 mmol, 0.1 equiv.) and sodium carbonate (2M, aq., 3.13 ml, 2.0 equiv.) in dioxane (31 ml, 0.1M) and heated to 75° C. for three hours. Upon completion, the reaction was concentrated onto Celite and purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in hexanes) to yield the desired alkene product (1.42 g, 86% yield) as a colorless resin.

Step l: TBAF (0.1M in THF, 0.3 mmol, 1.5 equiv.) was added to a cooled solution of the product of step k (113 mg, 0.2 mmol) at 0° C., and the reaction was allowed to warm to ambient temperature. After 2 hours the reaction was concentrated onto Celite and purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in hexanes) to yield the free indanol (1S,2R)-4-(6,8-difluoro-3,4-dihydronaphth-1-yl)-2-fluoro-7-(trifluoromethylsulfonyl)-1-indanol (33.7 mg, 37% yield). 1H NMR (400 MHz, CDCl3): 7.92 (d, J=8.1 Hz, 1H), 7.49 (d, J=8.1 Hz, 1H), 6.81 (d, J=8.3 Hz, 1H), 6.56 (ddd, J=11.3, 8.7, 2.6 Hz, 1H), 6.15 (dd, J=4.9, 4.9 Hz, 1H), 5.58-5.51 (br m, 1H), 5.28-5.08 (m, 1H), 3.14-3.00 (m, 2H), 2.92-2.79 (m, 2H), 2.48-2.37 (m, 2H). ESI MS [M+Na]+ for C20H14F6O3S; calcd 471.0, found 471.0.

Step m: The product indanol of step 1 was dissolved in methanol (700 μL, 0.1M) and added to palladium on carbon (3 mg, 10% Pd by weight) under an atmosphere of nitrogen. The reaction mixture was placed under an atmosphere of hydrogen at 55 psi and agitated in a Parr shaker overnight. The resulting diastereomers were separated by column chromatography (silica gel, 100% toluene) to yield (1S,2R)-4-[R-6,8-difluoro-1,2,3,4-tetrahydronaphth-1-yl]-2-fluoro-7-(trifluoromethylsulfonyl)-1-indanol (example 2a) as the less polar diastereomer. 1H NMR (400 MHz, CDCl3): δ 7.76 (d, J=8.1 Hz, 1H), 6.98 (d, J=8.1 Hz, 1H), 6.75 (br d, J=10.0 Hz, 1H), 6.58 (dd, J=9.8 Hz, 1H), 5.59-5.55 (m, 1H), 5.41-5.23 (m, 1H), 4.41-4.36 (br m, 1H), 3.51-3.41 (m, 1H), 3.25-3.16 (m, 1H), 3.12 (d, J=4.1 Hz, 1H), 2.94-2.78 (m, 2H), 2.17-2.07 (m, 1H), 1.78-1.67 (m, 2H). ESI MS [M+Na]+ for C20H16F6O3S; calcd 473.1, found 473.1. (1S,2R)-4-[S-6,8-difluoro-1,2,3,4-tetrahydronaphth-1-yl]-2-fluoro-7-(trifluoromethylsulfonyl)-1-indanol (example 2b) was isolated as the more polar diastereomer. 1H NMR (400 MHz, CDCl3): δ 7.75 (d, J=8.3 Hz, 1H), 6.92 (d, J=8.3 Hz, 1H), 6.79-6.72 (m, 1H), 6.62-6.54 (m, 1H), 5.60 (td, J=5.0, 3.7 Hz, 1H), 5.47-5.24 (m, 1H), 4.38-4.34 (m, 1H), 3.50-3.27 (m, 2H), 3.08 (d, 1H), 2.98-2.75 (m, 2H), 2.16-2.07 (m, 1H), 1.86-1.62 (m, 2H). ESI MS [M+Na]+ for C20H16F6O3S; calcd 473.1, found 473.1.

Example 3

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 2. 1H NMR (400 MHz, Chloroform-d) δ 7.71-7.67 (d, J=8.1 Hz, 1H), 6.81 (d, J=8.1 Hz, 1H), 6.73 (d, J=9.1, Hz, 1H), 6.55 (ddd, J=2.1, 9.2, 18.4 Hz, 1H), 5.67 (dt, J=4.7, 12.4 Hz, 1H), 5.51-5.33 (dq, J=4.7, 52.4 Hz, 1H), 4.32 (m, 1H), 3.59 (dd, J=4.4, 1.4 Hz, 1H), 3.31 (dd, J=21.2, 4.9 Hz, 2H), 3.23 (s, 3H), 2.94-2.76 (m, 2H), 2.14-2.05 (m, 1H), 1.83 (m, 1H), 1.75-1.65 (m, 2H). ESI MS [M−H2O+H]+ for C20H19F3O3S calcd 379.1, found 379.1.

Example 4

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 2. 1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J=8.1 Hz, 1H), 6.84 (d, J=8.1 Hz, 1H), 6.73 (d, J=9.1 Hz, 1H), 6.56 (ddd, J=2.4, 9.1, 18.0 Hz, 1H), 5.65 (dt, J=4.8, 14.4 Hz, 1H), 5.49-5.31 (m, 1H), 4.36 (m, 1H), 3.66 (dd, J=5.1, 1.8 Hz, 1H), 3.40 (ddd, J=21.6, 16.9, 3.2 Hz, 1H), 3.25 (s, 3H), 3.16-2.99 (m, 1H), 2.95-2.74 (m, 2H), 2.13-2.00 (m, 1H), 1.76-1.62 (m, 3H). ESI MS [M−H2O+H]+ for C20H19F3O3S calcd 379.1, found 379.1.

Example 8

[Figure (not displayed)]

Step a: To a solution of 5,7-difluorochroman-4-one (500 mg, 2.71 mmol) in CH2Cl2 (12 mL, 0.2M) at 0° C. was added 2,6-di-tert-butylmethylpyridine (1.17 g, 5.69 mmol, 2.1 equiv.) followed by trifluoromethanesulfonic anhydride (860 μL, 5.14 mmol, 1.9 equiv.) dropwise. Reaction was stirred at 0° C. for 1 h and then warmed to rt for another 1 h. At this point, hexane (5 mL) was added to precipitate the pyridinium salt and the reaction mixture was filtered over a pad of Celite. Solvent was removed in vacuo and the crude residue was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in hexanes) to yield the desired vinyl triflate (754 mg, 88%) as a yellow oil. ESI MS [M+H]+ for C10H5F5O4S calcd 316.9, found 317.2.

Step b: The title compound was synthesized in a similar fashion to Example 1. 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J=8.2 Hz, 1H), 7.17 (d, J=8.2 Hz, 1H), 6.59-6.45 (m, 1H), 6.45-6.35 (m, 1H), 5.60 (dd, J=6.6, 5.1 Hz, 1H), 5.51-5.22 (m, 1H), 4.45-4.34 (m, 1H), 4.29-4.14 (m, 1H), 4.08-3.98 (m, 1H), 3.61-3.42 (m, 1H), 3.28-3.16 (m, 1H), 2.43-2.33 (m, 1H), 1.96-1.80 (m, 1H). ESI MS [M+Na]+ for C19H14F6O4SNa calcd 475.0, found 475.0.

Example 9

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 1. 1H NMR (400 MHz, Methanol-d4) δ 7.78 (dt, J=8.1, 1.7 Hz, 1H), 7.13 (dd, J=15.1, 8.1 Hz, 1H), 6.89 (ddd, J=9.8, 2.7, 1.1 Hz, 1H), 6.83-6.64 (m, 2H), 5.56-5.49 (m, 1H), 4.32-4.25 (m, 1H), 3.63-3.06 (m, 3H), 2.97-2.78 (m, 2H), 2.21-2.06 (m, 1H), 1.97-1.76 (m, 1H), 1.80-1.68 (m, 1H). ESI MS [M+H]+ for C20H19F3O3S, calcd 380.4, found 380.1.

Example 10

[Figure (not displayed)]

Step a: A suspension of the 3-bromo-2-chloro-6-fluorobenzaldehyde (25 g, 105.3 mmol), NH2OH×HCl (8.8 g, 126.4 mmol, 1.2 equiv.) and NaOAc (10.4 g, 126.4 mmol, 1.2 equiv.) in anhydrous EtOH (100 mL) was stirred under reflux for overnight. Reaction was cooled to room temperature, evaporated and the residue was diluted with H2O (300 mL). White solid was filtered off, washed with H2O and dried under vacuum (24.3 g, 91%). Crude product was used in the next step without further purification. ESI MS [M+H]+ for C7H4BrClFNO, calcd 251.9, found 251.9.

Step b: Oxime from step a was diluted with acetic anhydride (150 mL) and stirred at 120° C. for overnight, then cooled down and concentrated in vacuo to give brown solid (22.5 g, 99%). Crude product was used in the next step without further purification.

Step c: Product from step b (20 g, 85.3 mmol) was dissolved in anhydrous DMF (100 mL), cooled to 0° C. and anhydrous Na2S (6.6 g, 85.3 mmol) was added in one portion. Reaction mixture was stirred for 2 h at 0° C., then quenched with H2O (500 mL) and extracted with CH2Cl2 (3×200 mL). Organics were discarded and aqueous layer was neutralized with 10% KHSO4 solution to pH˜2 and extracted again with CH2Cl2 (3×150 mL). The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo to give yellow solid that was used in the next step without further purification (19.1 g, 90%). ESI MS [M−H] for C7H3BrClNS, calcd 245.9, found 245.9.

Step d: Product from step c (33.6 g, 135.2 mmol) was dissolved in anhydrous DMF (300 mL) and paraquat dichloride hydrate (3.5 g, 13.5 mmol, 10% mol.) was added. The mixture was cooled to 0° C. and trifluoroiodomethane×TMG reagent (33.6 mL, 162.2 mmol, 1.2 equiv.) was added followed by TEA (18.8 mL, 135.2 mmol). Reaction was stirred at 0° C. for 15 min. then warmed up to room temperature and stirred for overnight. Quenched with H2O (1500 mL) and extracted with EtOAc (3×300 mL). Combined organics were washed with brine (2×100 mL), dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by column chromatography (silica gel, hex→30% EtOAc in hexanes) to afford the product as yellow solid (19.3 g, 45%).

Step e: The product from step d (18.5 g, 58.4 mmol) was dissolved in CH2Cl2:CH3CN:H2O (1:1:2; 300 mL) and NaIO4 (50 g, 233.6 mmol, 4 equiv.) was added followed by RuCl3×H2O (394 mg, 1.75 mmol, 3% mol.). The reaction was stirred at room temperature for 1.5 h then diluted with H2O (1000 mL) and 10% Na2S2O3 solution (100 mL) and extracted with EtOAc (3×300 mL). Combined organics were dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by column chromatography (silica gel, hex→40% EtOAc in hexanes) to afford the product as white solid (19.4 g, 95%). 1H NMR (400 MHz, CDCl3) δ 8.17 (d, J=8.6 Hz, 1H), 7.98 (d, J=8.6, 1H).

Step f: The mixture of 8-bromo-6-fluoroquinoline (15.7 g, 69.5 mmol), Zn(CN)2 (4.9 g, 41.7 mmol, 0.8 equiv.) and Pd(PPh3)4 (8 g, 6.9 mmol, 10% mol) in anhydrous DMF (100 mL) was stirred at 100° C. for overnight. Then reaction was cooled to room temperature and diluted with H2O (500 mL). Yellow solid was filtered off, washed with H2O and dried under vacuum. Crude product was used in the next step without further purification.

Step g: The product from step f was placed in a Parr bottle and dissolved in MeOH (300 mL) and concentrated HCl (50 mL). The mixture was purged with N2 and PtO2 (1.56 g, 6.9 mmol, 10% mol) was added. The reaction was shaken under H2 atmosphere (50 psi) for 5 h, then filtered through Celite, washed with MeOH and evaporated. Crude residue was purified by column chromatography (silica gel, hex→30% EtOAc in hexanes) to afford the product as a yellow solid (5.9 g, 48% over 2 steps). 1H NMR (400 MHz, CDCl3) δ 6.90-6.81 (m, 2H), 4.63 (brs, 1H), 3.41-3.33 (m, 2H), 2.77-2.68 (m, 2H), 1.96-1.85 (m, 2H).

Step h: The mixture of bromide from step g (200 mg, 0.57 mmol), tetrahydroquinoline from step g (100 mg, 0.57 mmol), Pd(OAc)2 (25 mg, 0.22 mmol, 20% mol.), rac-BINAP (87 mg, 0.14 mmol, 25% mol.) and Cs2CO3 (372 mg, 1.14 mmol, 2 equiv.) in anhydrous, degassed toluene (2 mL) was stirred at 100 C for 5 h. Whole reaction mixture was loaded on a silica gel cartridge and purified by column chromatography (silica gel, hex→30% EtOAc in hexanes) to afford the product as a yellow solid (44 mg, 17%). 1H NMR (400 MHz, CDCl3) δ 8.02 (d, J=8.7 Hz, 1H), 7.34 (d, J=8.7 Hz, 1H), 7.19-7.13 (m, 1H), 7.11-7.07 (m, 1H), 3.90-3.57 (m, 2H), 3.06-2.82 (m, 2H), 2.20-1.78 (m, 2H). ESI MS [M+H]+ for C18H10ClF4N3O2S, calcd 444.0, found 444.0.

Example 11

[Figure (not displayed)]

Step a: A solution of the 3-bromo-2-chloro-6-fluorobenzonitrile (5 g, 21.3 mmol) in anhydrous CH3CN (100 mL) was cooled to 0° C. and then CH3SNa (1.64 g, 23.4 mmol, 1.1 equiv.) was added in one portion. The mixture was stirred at 0° C. for 15 min. then the cooling batch was removed, and reaction was stirred at room temperature for overnight. Diluted with H2O (300 mL) and the product was filtered off, (white solid, 4.6 g, 82%).

Step b was done in a similar fashion to Example 10. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J=8.5 Hz, 1H), 7.95 (d, J=8.5 Hz, 1H), 3.30 (s, 3H).

Step c was done in a similar fashion to Example 10 (brown solid, 3.5 mg, 1%). 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J=8.5 Hz, 1H), 7.29 (d, J=8.5 Hz, 1H), 7.16-7.10 (m, 1H), 7.08-7.03 (m, 1H), 3.72-3.57 (m, 2H), 3.31 (s, 3H), 3.00-2.81 (m, 2H), 2.10-1.79 (m, 2H). ESI MS [M+H]+ for C18H13ClFN3O2S, calcd 390.0, found 390.0.

Example 12

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 10. (yellow solid, 130 mg, 50%). 1H NMR (400 MHz, CDCl3) δ 7.90 (d, J=8.8 Hz, 1H), 7.06 (d, J=8.8 Hz, 1H), 7.00-6.93 (m, 1H), 6.93-6.86 (m, 1H), 3.91-3.82 (m, 1H), 3.66-3.53 (m, 1H), 3.02-2.86 (m, 2H), 2.06-1.93 (m, 1H), 1.89-1.75 (m, 1H). ESI MS [M+H]+ for C17H10Cl2F4N2O2S, calcd 453.0, found 453.0.

Example 13

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 10. (yellow solid, 172 mg, 69%). 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J=8.8 Hz, 1H), 7.28 (d, J=8.8 Hz, 1H), 6.79-6.73 (m, 1H), 6.70-6.59 (m, 1H), 3.77-3.67 (m, 2H), 2.95-2.87 (m, 2H), 1.99-1.89 (m, 2H). ESI MS [M+H]+ for C17H10ClF5N2025, calcd 437.0, found 437.0.

Example 14

[Figure (not displayed)]

Step a: To a 40 mL vial was added 6-fluoro-1,2,3,4-tetrahydroquinoline-8-carbonitrile (61 mg, 0.344 mmol, 1.2 equiv.), 5-bromo-3-fluoro-2-(trifluoromethyl)-pyridine (70 mg, 0.287 mmol, 1.0 equiv.), Pd(OAc)2 (13 mg, 0.057 mmol, 20 mol %), rac-BINAP (45 mg, 0.072 mmol, 25 mol %), Cs2CO3 (190 mg, 0.574 mmol, 2.0 equiv.) and toluene (1.5 mL). The reaction vessel was capped, and the mixture purged with N2 for 2 min. The reaction was stirred at 100° C. for 2 h. The reaction mixture was cooled, concentrated onto Celite and purified by flash column chromatography (SiO2, hexane→40% EtOAc in hexanes) to afford the product as a white solid (65 mg, 0.192 mmol, 55%, ESI MS [M+H]+ for C16H10F5N3, calcd 340.3, found 340.0).

Step b: A vial was charged with the product from step a (30 mg, 0.088 mmol, 1.0 equiv.), KCN (7.0 mg, 0.097 mmol, 1.1 equiv.), and NMP (0.3 mL). The reaction mixture was stirred at 100° C. for 4 h. The reaction was diluted with sat. aq. NaHCO3 solution (10 mL) and extracted with EtOAc (10 mL). The aqueous layer was separated and back extracted with additional EtOAc (15 mL). The organic layers were combined, washed with H2O (2×20 mL), brine (20 mL), and dried over MgSO4. Concentration under reduced pressure and purification by flash chromatography furnished the product as a yellow solid (4.0 mg, 0.012 mmol, 13%). 1H NMR (400 MHz, DMSO-d6) δ 8.70-8.63 (m, 1H), 8.31-8.25 (m, 1H), 7.70-7.64 (m, 1H), 7.61-7.54 (m, 1H), 3.86-3.80 (m, 2H), 2.80 (t, J=6.4 Hz, 2H), 1.95-1.87 (m, 2H). ESI MS [M+H]+ for C17H10F4N4, calcd 347.1, found 347.0.

Example 15

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 14 using 1-bromo-2-chloro-3-fluoro-4-(trifluoromethyl)-benzene. 1H NMR (400 MHz, DMSO-d6) δ 7.74-7.67 (m, 1H), 7.53-7.43 (m, 2H), 7.13-7.04 (m, 1H), 3.74-3.48 (m, 2H), 3.07-2.77 (m, 2H), 2.06-1.64 (m, 2H). ESI MS [M+H]+ for C17H10ClF5N2, calcd 373.0, found 373.0.

Example 16

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 10. 1H NMR (400 MHz, Chloroform-d) δ 10.24 (s, 1H), 8.87 (d, J=6.1 Hz, 1H), 8.43 (d, J=8.2 Hz, 1H), 8.26 (dd, J=6.2, 0.9 Hz, 1H), 7.29 (d, J=8.2 Hz, 1H), 7.26-7.22 (m, 1H), 7.15-7.11 (m, 1H), 3.87-3.76 (m, 2H), 3.16-2.94 (m, 2H), 2.08-1.85 (m, 2H). ESI MS [M+H]+ for C20H13F4N3O25 calcd 436.1, found 436.1.

Example 17

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 19. 1H NMR (400 MHz, Chloroform-d) δ 7.77 (d, J=8.4 Hz, 1H), 7.00 (s, OH), 6.83 (d, J=8.8 Hz, 1H), 6.70 (ddd, J=11.0, 8.3, 2.6 Hz, 1H), 5.51 (s, 1H), 5.18 (d, J=50.8 Hz, 1H), 3.69 (s, 2H), 3.00 (br m, 2H), 2.84 (p, J=6.4 Hz, 1H), 2.12-1.99 (m, 1H), 1.81 (br m, 2H), 1.60 (dq, J=14.5, 7.5 Hz, 1H), 0.98 (t, J=7.4 Hz, 3H). ESI MS [M+H]+ for C21H19F6NO3S calcd 480.1, found 480.1.

Example 18

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 10. 1H NMR (400 MHz, CDCl3) δ 7.84 (dd, J=8.8, 0.4 Hz, 1H), 7.13 (d, J=8.9 Hz, 1H), 6.54 (dd, J=8.6, 2.7 Hz, 1H), 6.43 (dd, J=10.2, 2.8 Hz, 1H), 3.74 (br. s, 2H), 3.51 (s, 3H), 2.95-2.79 (m, 2H), 1.91 (br. s, 2H). 19F NMR (376 MHz, CDCl3) δ −77.11, −115.53. ESI MS [M+H]+ for C18H13ClF4N2O3S; calcd 449.0, found 449.1.

Example 19

[Figure (not displayed)]

Step a: Chloroacetyl chloride (8.3 mL, 110 mmol) was added dropwise to a stirred suspension of 2-amino-5-fluorophenol (9.5 g, 75 mmol) and potassium carbonate (41.4 g, 300 mmol) in THF (120 mL) at 0° C. The reaction was stirred at ambient temperature for 30 min before it was maintained at 66° C. for 48 h. The mixture was cooled, filtered through Celite pad to remove inorganic solids and the filtrate was concentrated to dryness. The residue was fractionated by column chromatography (SiO2, hexanes/EtOAc gradient) to yield 7-fluoro-2H-benzo[b][1,4]oxazin-3(4H)-one (5.5 g, 32.9 mmol, 44% yield) as a brown solid. 1H NMR (400 MHz, CDCl3) δ 8.73 (s, 1H), 6.90-6.53 (m, 3H), 4.60 (s, 2H). 19F NMR (376 MHz, CDCl3) δ 117.25.

Step b: Lithium aluminum hydride (1.2 g, 3.2 mmol) was carefully added in portions to a solution of 7-fluoro-2H-benzo[b][1,4]oxazin-3(4H)-one (3.5 g, 2.1 mmol) in THE (30 mL) at 0° C. Once the addition was complete, the cooling bath was removed, and the mixture was stirred at ambient temperature for 4 h. After TLC analysis indicated complete reaction, the mixture was quenched using Fieser protocol and the product was extracted diethyl ether. After all solvent was removed under reduced pressure, the crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce 7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine (2.9 g, 18.9 mmol, 90% yield) as a brown solid. 1H NMR (400 MHz, CDCl3) δ 6.63-6.22 (m, 3H), 4.30-4.18 (m, 2H), 3.59 (s, 1H), 3.44-3.32 (m, 2H). 19F NMR (376 MHz, CDCl3) δ −124.56.

Step c: Bromine (0.4 mL, 7.5 mmol) was added dropwise to a solution of 7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine (1 g, 6.5 mmol) in acetic acid (26 mL), that was placed in a water bath in order to maintain the reaction temperature below 25° C. Once the addition was complete, the reaction was stirred at ambient temperature for 10 min and poured in 5% aqueous NaHSO3 (100 mL). The crude product was extracted with a mixture of EtOAc and hexanes (v/v 1:1, 3×35 mL), then combined extracts were washed with water (3×100 mL), aqueous NaHCO3 (2×100 mL) and brine (50 mL). The solution was dried over Na2SO4 and the solvent was evaporated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to yield 5-bromo-7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine (1.05 g, 4.5 mmol, 70% yield) as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 6.79 (dd, J=8.0, 2.8 Hz, 1H), 6.52 (dd, J=9.5, 2.8 Hz, 1H), 4.32-4.14 (m, 2H), 4.14-3.88 (br. s, 1H), 3.53-3.34 (m, 2H). 19F NMR (376 MHz, CDCl3) δ −124.82 (d, J=8.3 Hz).

Step d: A mixture of 5-bromo-7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine (1.05 g, 4.5 mmol), zinc cyanide (0.43 g, 3.6 mmol) and Pd(PPh3)4 (0.52 g, 0.45 mmol) in DMF (11 mL) was heated at 100° C. under nitrogen atmosphere for 4 hours. Once complete disappearance of starting material was observed by TLC analysis (30% EtOAc in hexanes as an eluent), the solution was cooled to ambient temperature and poured in a mixture of EtOAc (50 mL) and water (50 mL). The resulting suspension was filtered through a Celite plug. The organic phase was separated, and the aqueous solution was additionally extracted with EtOAc (2×25 mL). Combined organic phase was washed with water (2×75 mL) and brine (75 mL), dried over Na2SO4 and concentrated to dryness. The dry residue was fractionated by column chromatography (SiO2, hexanes/EtOAc gradient) to provide 7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carbonitrile (0.75 g, 4.2 mmol, 94% yield) as a white powder. 1H NMR (400 MHz, CDCl3) δ 6.78-6.54 (m, 2H), 4.51 (br. s, 1H), 4.33-4.17 (m, 2H), 3.60-3.40 (m, 2H). 19F NMR (376 MHz, CDCl3) δ −124.17. ESI MS [M+Na]+ for C9H7FN2O; calcd 179.1, found 179.1.

Step e: The mixture of (1S,2R)-4-bromo-2-fluoro-1-(tertbutyl-dimethysilyl)-7-(trifluoromethylsulfonyl)indan (100 mg, 0.21 mmol), 7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carbonitrile (38 mg, 0.21 mmol), Pd(OAc)2 (9.5 mg, 0.042 mmol), rac-BINAP (33 mg, 0.053 mmol) and Cs2CO3 (137 mg, 0.42 mmol) in anhydrous, degassed toluene (1 mL) was stirred at 100° C. for 6 h. Then the mixture was cooled to ambient temperature, diluted with EtOAc and filtered through a Celite pad to remove inorganic solids. The filtrate was concentrated on Celite and purified by column chromatography (SiO2, hexanes/EtOAc gradient) to a mixture of product and unreacted benzomorpholine (55 mg). This mixture was submitted to step f without additional purification.

Step f: The mixture of TBS-protected indanol and unreacted benzomorpholine from previous step was dissolved in CH3CN (1 mL) and placed in a 3 mL vial equipped with a magnetic stirrer, then HF.Py complex (hydrogen fluoride ˜70%, pyridine ˜30%, 0.1 mL) was added. The resulting solution was stirred overnight at ambient temperature. After TLC analysis indicated complete consumption of the starting material the reaction was diluted with EtOAc (20 mL) and 1M aqueous HCl solution (20 mL). The product was extracted with EtOAc (2×10 mL), combined organic extracts were washed with aqueous NaHCO3 (20 mL) and brine (20 mL), dried over Na2SO4 and concentrated to dryness. The residue was fractionated by column chromatography (SiO2, hexanes/EtOAc gradient) to yield 7-fluoro-4-((1S,2R)-2-fluoro-1-hydroxy-7-((trifluoromethyl)sulfonyl)-2,3-dihydro-1H-inden-4-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carbonitrile (25 mg, 0.054 mmol, 26% yield over two steps) as a yellowish oil. 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J=8.6 Hz, 1H), 7.05-6.93 (m, 2H), 6.89 (dd, J=7.5, 2.8 Hz, 1H), 5.59 (br. s, 1H), 5.28 (br. d, J=49.6 Hz, 1H), 4.39 (d, J=11.5 Hz, 1H), 4.10 (br. s, 1H), 3.76-3.57 (m, 2H), 3.34 (br. s, 2H), 3.03 (s, 1H). 19F NMR (376 MHz, CDCl3) δ −78.08, −113.95, −199.41 (d, J=51.0 Hz). ESI MS [M+Na]+ for C19H13F5N2O4S; calcd 483.0, found 483.1.

Example 20

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 19. 1H NMR (400 MHz, CDCl3) δ 7.80 (d, J=8.4 Hz, 1H), 6.99-6.79 (m, 3H), 5.68-5.61 (m, 1H), 5.37 (br. d, J=52.1, 1H), 4.38-4.23 (m, 1H), 4.18-4.02 (m, 1H), 3.72-3.48 (m, 3H), 3.43-2.93 (m, 5H). 19F NMR (376 MHz, CDCl3) δ −115.26, −199.17. ESI MS [M-OH]+ for C19H16F2N2O4S; calcd 389.1, found 389.1.

Example 21

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 10. 1H NMR (400 MHz, CDCl3) δ 9.15 (dd, J=4.3, 1.7 Hz, 1H), 8.61 (dd, J=8.6, 1.7 Hz, 1H), 8.44 (d, J=8.3 Hz, 1H), 7.60 (dd, J=8.6, 4.2 Hz, 1H), 7.08 (dd, J=8.3, 0.9 Hz, 1H), 6.85-6.76 (m, 1H), 6.71-6.61 (m, 1H), 3.86-3.69 (m, 2H), 3.04-2.96 (m, 2H), 1.99-1.82 (m, 2H). ESI MS [M+H]+ for C19H13F5N2O2S calcd 429.1, found 429.1.

Example 22

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 19. 1H NMR (400 MHz, Methanol-d4) δ 7.76 (d, J=8.6 Hz, 1H), 7.03 (d, J=8.6 Hz, 1H), 6.85-6.80 (m, 1H), 6.77-6.69 (m, 1H), 5.50-5.44 (m, 1H), 3.66-3.57 (m, 3H), 3.22 (s, 3H), 3.18-3.03 (m, 1H), 2.93-2.84 (t, J=6.6 Hz, 2H), 1.96-1.84 (m, 2H). ESI MS [M+H]+ for C19H17F4NO3S calcd 416.1, found 416.0.

Example 23

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 24. 1H NMR (400 MHz, CDCl3) δ 8.46 (d, J=2.2 Hz, 1H), 7.94 (dd, J=8.9, 2.3 Hz, 1H), 7.33 (dd, J=8.9, 1.7 Hz, 1H), 6.82-6.76 (m, 1H), 6.76-6.63 (m, 1H), 3.77-3.50 (m, 2H), 2.92-2.81 (m, 2H), 2.15-1.99 (m, 2H). ESI MS [M+H]+ for C16H11F5N2O4S calcd 423.0, found 423.1.

Example 24

[Figure (not displayed)]

4-Bromo-3-nitrobenotrifluoride (270 mg, 1 mmol), 6,8-difluoro-1,2,3,4-tetrahydroquinoline (324 mg, 1.2 mmol), Pd(OAc)2 (45 mg, 0.2 mmol), rac-BINAP (187 mg, 0.3 mmol), and Cs2CO3 (652 mg, 2 mmol), were suspended in PhMe (5 mL). The suspension was degassed with N2 for 5 minutes at ambient temperature and heated to 100° C. for 1.5 hours. The mixture was cooled to room temperature, diluted with EtOAc, filtered, and concentrated onto Celite®. Purification by column chromatography (0-10% EtOAc/hexanes) afforded the title compound as an orange oil (125 mg, 35% yield). 41 NMR (400 MHz, CDCl3) δ 8.13 (dd, J=2.2, 0.9 Hz, 1H), 7.68-7.61 (m, 1H), 7.26-7.22 (m, 1H), 6.73 (dddt, J=8.4, 2.6, 1.7, 0.9 Hz, 1H), 6.63 (dddd, J=11.3, 8.4, 2.8, 0.7 Hz, 1H), 3.57 (s, 2H), 2.88 (tt, J=6.6, 0.8 Hz, 2H), 2.00 (q, J=6.2 Hz, 2H). 19F NMR (376 MHz, CDCl3) δ −62.3 (3 F), −117.3 (1 F), −116.7 (1 F). ESI MS [M+H]+ for C16H11F5N2O2, calcd 359.1, found 359.1.

Example 121

[Figure (not displayed)]

Step a: A flask was charged with 2-chloro-4-fluoroaniline (18.2 g, 15 mL, 1.0 mol. equiv.) and excess acrylic acid (46 g, 5.0 mol. equiv.) and the resulting mixture was stirred at 45° C. for 15 h. During this time, the product solidified from the reaction mixture and was collected by filtration, rinsing with hexanes, to afford the aniline product that was used crude in the next step (25.4 g, 93%).

Step b: The product from step a (25.4 g) was then added portion-wise to Eaton's reagent (100 mL) at 0° C. The resulting mixture was warmed to room temperature and then heated at 80° C. for 3 h. After this time, the reaction was cooled, and carefully poured onto ice, after which the product precipitated out of solution as a yellow solid (17.4 g, 75%).

Step c: A flask containing the product from the previous step (15 g, 75.3 mmol, 1.0 mol. equiv.) in MeOH (250 mL) was cooled to 0° C. under N2. NaBH4 (3.41 g, 90.4 mmol, 1.2 mol. equiv.) was added slowly in portions, after which the reaction was stirred at room temperature for 30 min. At this time, the reaction was placed in an ice bath, quenched with H2O, and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with water, brine, and dried over MgSO4. Concentration under reduced pressure furnished tetrahydroquinoline intermediate that was taken onto the next step without further purification.

Step d: To the crude intermediate from step c was added DCM (250 mL) and imidazole (7.70 g, −1.5 mol. equiv.). The resulting mixture was cooled to 0° C. and TBSCl (17.0 g, −1.5 equiv.) was added. The reaction was warmed to room temperature and stirred for 2 h. The reaction was filtered to remove imidazole hydrochloride and concentrated onto Celite. Purification by flash column chromatography (SiO2, hexanes to 10% EtOAc/hexanes) furnished the TBS protected alcohol as a colorless oil (16.7 g, 70% over 2 steps).

Step e: A flask was charged with TBS alcohol from the previous step (6.0 g, 19 mmol, 1.0 mol. equiv.), K4Fe(CN)6.3H2O (5.61 g, 13.3 mmol, 0.7 mol. equiv.), Pd XPhos gen III (0.803 g, 0.95 mmol, 5 mol %), XPhos (0.452 g, 0.95 mmol, 5 mol %), KOAc (0.242 g, 2.47 mmol, 0.13 mol. equiv.), H2O (40 mL) and 1,4-dioxane (40 mL). The resulting mixture was purged with N2, heated at 100° C., and stirred vigorously under N2. After 3 h, the reaction was cooled, and diluted with EtOAc and H2O. The aqueous layer was separated and back extracted with additional EtOAc. Filtration through Celite to remove solids may improve the distinction of layers. The organic layers were combined and dried over MgSO4. Purification by flash column chromatography (SiO2, hexanes to 20% EtOAc) furnished the benzonitrile product as a yellow solid (5.68 g, 98%).

Step f: To a flask containing 6-bromo-2-fluoro-3-(trifluoromethyl)benzoic acid (10 g, 34.8 mmol, 1.0 mol. equiv.) was added DMF (70 mL), followed by EDC.HCl (9.98 g, 52.2 mmol, 1.5 mol. equiv.), HOBt.H2O (7.0 g, 52.2 mmol, 1.5 mol. equiv.), ammonium carbonate (16.7 g, 174 mmol, 5.0 mol. equiv.), and DIPEA (18 mL, 3.0 mol. equiv.). The resulting mixture was stirred overnight at 40° C. The reaction was partitioned between EtOAc and H2O. The aqueous layer was separated and extracted with additional EtOAc. The organic layers were combined, washed with H2O to remove DMF, and dried over MgSO4. Concentration under reduced pressure furnished crude amide that was taken onto the next step without purification.

Step g: To a flask containing crude amide from the previous step was added DMF (100 mL) and cyanuric trichloride (2.55 g, 13.9 mmol, ˜0.6 mol. equiv.). The resulting mixture was stirred under N2 at room temperature for 16 h. The reaction was partitioned between EtOAc and H2O. The aqueous layer was separated and extracted with additional EtOAc. The organic layers were combined, washed with H2O to remove DMF, and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 20% EtOAc) furnished the nitrile product as a white solid (2.68 g, 26% over 2 steps).

Step h: A vial was charged with benzonitrile from the previous step (1.0 g, 3.73 mmol, 1.0 mol. equiv.), 4-[tert-butyl(dimethyl)silyl]oxy-6-fluoro-1,2,3,4-tetrahydroquinoline-8-carbonitrile (1.10 g, 3.73 mmol, 1.0 mol. equiv.), Pd(OAc)2 (0.167 g, 0.746 mmol, 20 mol %), rac-BINAP (0.580 g, 0.925 mmol, 25 mol %), Cs2CO3 (2.42 g, 7.46 mmol, 2.0 mol. equiv.) and toluene (15 mL). N2 was bubbled through the reaction mixture for 3 min, the vial capped, and heated at 100° C. for 15 h. The reaction was monitored by TLC and NMR analysis. The reaction was cooled, filtered, and concentrated onto Celite. Purification by flash column chromatography (SiO2, hexanes to 10 to 20% EtOAc) furnished the coupled product as a yellow solid (1.00 g, 54%). ESI MS [M+H]+ for C24H24F5N3OSi, calcd 494.2, found 494.2.

Step is A flask containing the product from the previous step (1.0 g, 2.02 mmol, 1.0 mol. equiv.) and THF (10 mL) was cooled to 0° C. and TBAF (1 M in THF, 3.0 mL, 1.5 mol. equiv.) was added. The reaction mixture was warmed to room temperature and stirred for 15 min. After this time, the reaction was quenched with sat. aq. NH4Cl solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with brine, and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 20% to 50% to 80% EtOAc) furnished the alcohol product as a white solid (0.694 g, 91%).

Step j: A vial containing the alcohol product from the previous step (35 mg, 0.093 mmol, 1.0 mol. equiv.) in DCM (1 mL) was cooled to −78° C. DAST (20 μL, 0.149 mmol, 1.6 mol. equiv.) was added, and the reaction was allowed to warm to room temperature and stirred for 5 min. The reaction was quenched at 0° C. with sat. aq. NaHCO3 solution and diluted with DCM. The aqueous layer was separated and back extracted with additional DCM. The organic layers were combined and dried over MgSO4. Concentration under reduced pressure and purification by column chromatography (SiO2, hexanes to 20% EtOAc) furnished racemic 1-[2-cyano-3-fluoro-4-(trifluoromethyl)phenyl]-4,6-difluoro-3,4-dihydro-2H-quinoline-8-carbonitrile as a white solid (13 mg, 37%). The enantiomers could be separated by preparative SFC chiral purification (2.0×25.0 cm ChromegaChiral CC4 from ES Industries (West Berlin, NJ), CO2 co-solvent Isopropanol/Hexane (1:9), 15% co-solvent at 100 mL/min) to furnish the title compound (4S′)-1-[2-cyano-3-fluoro-4-(trifluoromethyl)phenyl]-4,6-difluoro-3,4-dihydro-2H-quinoline-8-carbonitrile as a white solid (98.8% ee, tR=1.5 min). Absolute stereochemistry was confirmed by single crystal X-ray analysis. 1H NMR (400 MHz, DMSO-d6, appears as a 2:1 mixture of rotamers) δ 8.11 (t, J=8.6 Hz, 1H), 8.03 (t, J=8.6 Hz, 2H), 7.94-7.79 (m, 6H), 7.43 (d, J=8.8 Hz, 1H), 7.12 (d, J=8.7 Hz, 2H), 5.82 (dt, J=49.7, 2.9 Hz, 1H), 5.70 (dt, J=49.8, 2.9 Hz, 2H), 4.08-3.67 (m, 6H), 2.38-2.02 (m, 6H). ESI MS [(M−HF)+H]+ for C18H8F5N3, calcd 362.0, found 362.0.

Example 123

[Figure (not displayed)]

This compound was prepared in a similar fashion to Example 121 from 6-bromo-2-chloro-3-(trifluoromethyl)benzoic acid. 1H NMR (400 MHz, DMSO-d6, appears as a 2:1 mixture of rotamers) δ 8.15 (d, J=8.8 Hz, 1H), 8.05 (d, J=8.8 Hz, 2H), 7.93-7.86 (m, 4H), 7.86-7.77 (m, 2H), 7.57 (d, J=8.8 Hz, 1H), 7.26 (d, J=8.7 Hz, 2H), 5.82 (dt, J=49.7, 2.9 Hz, 1H), 5.70 (dt, J=49.8 Hz, 2.9 Hz, 2H), 4.05-3.91 (m, 3H), 3.88-3.66 (m, 3H), 2.32-2.00 (m, 6H). ESI MS [M+H]+ for C18H9ClF5N3, calcd 398.0, found 397.9.

Example 125

[Figure (not displayed)]

Step a: A solution of 1-[2-cyano-3-fluoro-4-(trifluoromethyl)phenyl]-6-fluoro-4-oxo-2,3-dihydroquinoline-8-carbonitrile (100 mg, 0.265 mmol) in 1 ml of a 50 wt % solution of Deoxo-Fluor® in toluene was heated to 70° C. overnight. Upon completion the reaction was cooled to 0° C. in an ice bath and quenched with water. The resulting solution was extracted with ethyl acetate and methylene chloride, and the crude concentrated material was purified by flash chromatography on silica gel (0% to 30% ethyl acetate in hexanes) to yield 1-[2-cyano-3-fluoro-4-(trifluoromethyl)phenyl]-4,4,6-trifluoro-2,3-di hydroquinoline-8-carbonitrile. 1H NMR (400 MHz, CDCl3): δ 7.75 (dd, J=8.2, 8.2 Hz, 1H), 7.68 (dd, J=7.8, 3.0 Hz, 1H), 7.27 (dd, J=7.2, 3.0 Hz, 1H), 6.92 (d, J=8.6 Hz, 1H), 4.16-4.09 (m, 1H), 3.99-3.92 (m, 1H), 2.53-2.39 (m, 2H). ESI MS [M+H]+ for C18H8F7N3, calcd. 400.1, found 400.0.

Example 126

[Figure (not displayed)]

Step a: A flask containing 2,5-dibromo-3-fluoropyridine (6.00 g, 23.6 mmol, 1.0 mol. equiv.) in THF (100 mL) was cooled to −78° C. under N2. A solution of LDA (2.0 M in heptane/THF/ethylbenzene, 17.7 mL, 1.5 mol. equiv.) was added slowly, and the resulting mixture stirred for 15 min. MeI (2.9 mL, 2.0 mol. equiv.) was added and the reaction mixture was allowed to warm to room temperature and stirred for 30 min. The reaction was cooled to 0° C. and quenched with sat. aq. NH4Cl solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 15% EtOAc) furnished the methylated product as a yellow oil (3.64 g, 57%).

Step b: A flask containing the product from the previous step (3.00 g, 11.2 mmol, 1.0 mol. equiv.) in dry toluene (30 mL) was cooled to −78° C. under N2. nBuLi (2.5 M in hexanes, 5.4 mL, 1.2 mol. equiv.) was added, and the reaction stirred for 30 min. After this time, the organolithium was trapped with anhydrous DMA (3.2 mL, 33.6 mmol, 2.0 mol. equiv.) and the reaction stirred for an additional 20 min. The reaction was quenched with sat. aq. NH4Cl solution at −78° C. After warming, the mixture was diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 30% EtOAc) furnished the ketone product (906 mg, 35%).

Step c: To the ketone product from the previous step (400 mg, 1.72 mmol, 1.0 mol. equiv.) was added Deoxo-Fluor (2.7 M in toluene, 3.0 mL, 4.0 mol. equiv.) and the resulting mixture was stirred at 70° C. for 9 h. The reaction mixture was poured onto ice, quenched with sat. aq. NaHCO3 solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 20% EtOAc) furnished the difluorinated product as a yellow oil (342 mg, 78%). ESI MS [M+H]+ for C8H7BrF3N, calcd 253.9, found 253.8.

The title compound 1-[6-(1,1-difluoroethyl)-5-fluoro-4-methylpyridin-3-yl]-4,4,6-trifluoro-2,3-dihydroquinoline-8-carbonitrile was prepared in 4 additional steps from 5-bromo-2-(1,1-difluoroethyl)-3-fluoro-4-methylpyridine, in a similar fashion to Example 125. 1H NMR (400 MHz, Chloroform-d) δ 7.96 (d, J=0.6 Hz, 1H), 7.67-7.62 (m, 1H), 7.31-7.27 (m, 1H), 3.90-3.79 (m, 1H), 3.55-3.46 (m, 1H), 2.59-2.40 (m, 2H), 2.38 (d, J=2.3 Hz, 3H), 2.05 (td, J=18.8, 0.7 Hz, 3H). ESI MS [M+H]+ for C18H13F6N3, calcd 386.1, found 386.0.

Example 127

[Figure (not displayed)]

Step a: A flask containing 5-bromo-3-fluoro-2-(trifluoromethyl)pyridine (1.00 g, 4.09 mmol, 1.0 mol. equiv.) in THF (10 mL) was cooled to −78° C. under N2. A solution of LDA (2.0 M in heptane/THF/ethylbenzene, 17.7 mL, 1.5 mol. equiv.) was added slowly, and the resulting mixture stirred for 15 min. A solution of hexachloroethane (1.93 g, 8.18 mmol, 2.0 mol. equiv.) in THF (3 mL) was added and the reaction mixture was warmed to room temperature and stirred for 15 min. The reaction was cooled to 0° C. and quenched with sat. aq. NH4Cl solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 15% EtOAc) furnished the chlorinated product as a yellow oil (824 mg, 72%).

The title compound 1-[4-chloro-5-fluoro-6-(trifluoromethyl)pyridin-3-yl]-4,4,6-trifluoro-2,3-dihydroquinoline-8-carbonitrile was prepared in 4 additional steps from 5-bromo-4-chloro-3-fluoro-2-(trifluoromethyl)pyridine, in a similar fashion to Example 125. 1H NMR (400 MHz, Chloroform-d) δ 8.18 (s, 1H), 7.69 (ddt, J=7.7, 3.0, 0.8 Hz, 1H), 7.34 (ddt, J=7.2, 3.1, 0.9 Hz, 1H), 4.07-3.90 (m, 1H), 3.83-3.70 (m, 1H), 2.63-2.41 (m, 2H). ESI MS [M+H]+ for C16H7F7N3, calcd 410.0, found 409.9.

Example 129

[Figure (not displayed)]

The title compound 4,4,6-trifluoro-1-[5-fluoro-4-methyl-6-(trifluoromethyl)pyridin-3-yl]-2,3-dihydroquinoline-8-carbonitrile was prepared in 3 additional steps in a similar fashion to Example 125. 1H NMR (400 MHz, DMSO-d6) δ 8.40 (s, 1H), 7.96-7.90 (m, 1H), 7.87 (dd, J=8.0, 2.9 Hz, 1H), 3.95-3.80 (m, 1H), 3.78-3.65 (m, 1H), 2.70-2.52 (m, 2H), 2.33 (d, J=2.1 Hz, 3H). ESI MS [M+H]+ for C17H10F7N3, calcd 390.0, found 390.0.

Example 134

[Figure (not displayed)]

Step a: A solution of 4-bromo-7-methylsulfonyl-2,3-dihydroinden-1-one (25.0 g, 86.5 mmol) in 500 mL of dry methanol was loaded in 1 L single-neck round-bottom flask equipped with a stirring bar and a reflux condenser with a drying tube. SelectFluor (38.2 g, 104 mmol) and concentrated sulfuric acid (0.5 mL) were added sequentially, and the mixture was refluxed for 5 h. Once TLC analysis indicates complete disappearance of the starting material the reaction was cooled to ambient temperature. Aqueous sulfuric acid (0.3 M, 130 mL) was added, and the mixture was refluxed for 3 h to transform the corresponding dimethylacetal to the desired α-fluoroketone. The resulting clear solution was cooled to an ambient temperature and methanol was distilled off under reduced pressure. The residual mixture was diluted with dichloromethane (1 L) and water (500 mL). The organic phase was separated, and the aqueous solution was extracted with dichloromethane (2×100 mL). Combined organic extract was washed with brine (500 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness producing α-fluoroketone (25.9 g, 84.3 mmol, 97% yield) as a white solid.

Step b: The product from step a (25.9 g, 84.3 mmol) was placed in 1 L single-neck round-bottom flask equipped with a stirring bar. The flask was charged with dichloromethane (700 mL), formic acid (20.0 mL, 0.50 mol) and triethylamine (47.0 mL, 0.34 mol). The resulting solution was cooled to 0° C. and RuCl(p-cymene)[(R,R)-TsDPEN] (2.2 g, 3.4 mmol) was added. The resulting brownish solution was stirred at 0° C. for 16 h. Once TLC analysis shows complete conversion of the starting material the reaction was concentrated to about a half of its original volume under reduced pressure. The residual solution was sequentially washed with an aqueous 1M NaOH (400 mL) and brine (500 ml). The organic phase was separated, dried over Na2SO4 and concentrated to dryness to produce the crude product with sufficient purity for the next step.

Enantiopurity of this material (96% ee) was determined using HPLC-UV chromatography [Chiralpak®AD-H (4.6×250 mm; 90% i-PrOH-hexanes; flow rate=1 mL/min; 10 μL injection of a 1 mg/mL solution; detection at 254 nm; t1=4.89 min. (minor), t2=5.26 min. (major)]

Step c: The crude material from the previous step was dissolved in dichloromethane (700 mL) and placed in 2 L three-neck round-bottom flask equipped with a thermometer, an addition funnel, a stirring bar and a reflux condenser with a drying tube. Triethylamine (105.0 mL, 0.81 mmol) was added to the mixture in one portion and the addition funnel was charged with TBSOTf (96.4 g, 0.37 mmol). Then TBSOTf was added dropwise causing an exothermic reaction with the rate required to maintain continuous reflux. Once the addition was complete the reaction mixture was reflux for additional 15 min upon which TLC analysis shows complete conversion of the starting material to the product. The solution was allowed to cool to ambient temperature, transferred into separatory funnel and sequentially washed with saturated aqueous NH4Cl (500 mL) and brine (500 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The obtained crude product was purified by flash chromatography (SiO2, hexanes/EtOAc gradient) to provide TBS ether as a white solid (26.5 g, 62.6 mmol, 74% yield over two steps).

Step d: The TBS ether product from the previous step (29.5 g, 70.0 mmol) was combined with B2Pin2 (23.0 g, 91.0 mmol, 1.3 equiv.), Pd(dppf)Cl2 (5.1 g, 7.0 mmol, 0.1 equiv.) and potassium acetate (13.8 g, 0.14 mmol, 2.0 equiv.) in dioxane (230 ml) in 500 mL single-neck round-bottom flask equipped with a magnetic stirring bar and reflux condenser with nitrogen inlet adapter. The mixture was degassed under vacuum, backfilled with nitrogen and heated to 100° C. for 2 h. After 1H NMR analysis of an aliquot indicated complete consumption of the starting material the reaction mixture was allowed to cool to ambient temperature and concentrated to dryness under reduced pressure. The residue was partitioned between EtOAc (500 mL) and water (300 mL). Organic layer was separated, and the aqueous phase was additionally extracted with EtOAc (2×100 mL). The combined organic extract was dried over Na2SO4 and the solvent was evaporated under reduced pressure to yield crude boronic pinacol ester that was used for the next step without further purification.

Step e: A solution of crude product from step d (70 mmol) and 8-cyano-6-fluoro-3,4-dihydronaphthalen-1-yl trifluoromethanesulfonate (22.5 g, 70.0 mmol) in dioxane (230 mL) was placed in 500 mL single-neck round-bottom flask equipped with a magnetic stirring bar and reflux condenser with nitrogen inlet. Then Pd(dppf)Cl2 (5.1 g, 7.0 mmol) and aqueous sodium carbonate (2M solution, 70.0 ml, 40.0 mmol) were sequentially added. The mixture was degassed under vacuum, backfilled with nitrogen and heated to 100° C. for 1 h. Upon reaction completion, dioxane was removed under reduced pressure. The residue was partitioned between EtOAc (500 mL) and water (500 mL). Organic layer was separated, and the aqueous phase was additionally extracted with EtOAc (2×100 mL). The combined organic extract was washed with brine (500 mL), dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to yield the desired alkene (28.5 g, 55.3 mmol, 79% yield) as a white foam.

Step f: The alkene of step e (28.0 g, 54.0 mmol) was dissolved in dry methanol (540 mL) and added to palladium on carbon (5.0 g, 10% Pd by weight) under an atmosphere of nitrogen. The reaction mixture was placed under an atmosphere of hydrogen at 50 psi and agitated in a Parr shaker for 4 hours. The excess hydrogen was vented out and the mixture was sparged with nitrogen to remove residual hydrogen gas. The resulting suspension was filtered through a celite pad, and the filtrate was concentrated to dryness under reduced pressure producing crude mixture of epimers (1:1 dr). In order to isolate the more polar (S)-epimer the crude mixture was subjected to column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired tetralin derivative (9.6 g, 18.5 mmol, 34% yield) as a white foam.

Step g: To a solution of the TBS ether from the step fin THF (93 mL) TBAF (37.2 mL, 37.2 mmol, 1 M solution in THF) was added dropwise at ambient temperature. The resulting brown solution was stirred for 20 min before TLC analysis indicated complete conversion of the starting material. The mixture was diluted with EtOAc (200 mL) and sequentially washed with water (200 mL) and brine (150 mL). The organic extract was dried over Na2SO4, concentrated to dryness and the crude product was submitted to acylation reaction without purification.

The dry material obtained in the previous transformation was dissolved in dichloromethane (50 mL), then DMAP (0.7 g, 5.8 mmol) and Et3N (8.0 mL, 77.0 mmol) were added. The reaction mixture was cooled to 0° C. and acetic anhydride (7.3 mL, 77.0 mmol) was added dropwise over 1 min period. The cooling bath was removed, and the reaction was stirred at room temperature for 30 min. Once TLC and LCMS analysis indicated complete transformation the solution was diluted with dichloromethane (150 mL) and sequentially washed with water (200 mL), saturated aqueous NaHCO3 (100 mL) and brine (100 mL). The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired acetate ester (8.3 g, 18.5 mmol, 100% yield) as a white powder.

Step h: The acetate ester (8.3 g, 18.6 mmol) from step g, MnO2 (6.5 g, 75 mmol) and dichloromethane (93 mL) were loaded in 500 mL flask single-neck round-bottom flask equipped with a magnetic stirring bar and a reflux condenser. The mixture was cooled to 0° C. and tBuO2H (34 mL, 186 mmol, 5.5 M solution in decane) was added dropwise over 5 min. The reaction was stirred at 0° C. for 10 min, then it was allowed to warm to ambient temperature and stirred until gas formation ceased. The resulting black suspension was reflux for 24 h, then it was cooled to room temperature and additional amount of MnO2 (6.5 g, 75 mmol) and tBuO2H (34 mL, 186 mmol, 5.5 M solution in decane) were added sequentially. The mixture was refluxed for additional 48 h, cooled to room temperature. Inorganic solids were removed by filtration. The filtrate was passed through a plug of celite, washed with water (100 mL), dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce the corresponding α-tetralone (6.2 g, 13.5 mmol, 72% yield) as a white powder.

Step is A solution of α-tetralone (1.5 g, 3.3 mmol) from step h in dichloromethane (33 mL) was placed in 100 mL single-neck round bottom flask equipped with magnetic stirring bar and drying tube. The mixture was charged with formic acid (0.37 mL, 9.8 mmol), Et3N (0.91 mL, 6.5 mmol) and RuCl(p-cymene)[(R,R)-Ts-DPEN) (62 mg, 0.1 mmol) at ambient temperature and stirred for 1 h. The resulting brown solution was diluted with dichloromethane (70 mL) and washed with aqueous saturated NaHCO3. The organic extract was dried over Na2SO4 and concentrated to dryness under reduced pressure. The crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the corresponding 1,2,3,4-tetrahydro-1-naphthol (1.43 g, 3.1 mmol, 95% yield, single epimer) as white powder.

Step j: A solution of Deoxo-Fluor (3.4 ml, 9.1 mmol, 2.7 M in toluene) in dichloromethane (52 mL) was placed in 100 ml single-neck round bottom flask equipped with a magnetic stirring bar and nitrogen inlet and cooled to −78° C., then TMS-morpholine (1.65 mL, 9.2 mmol) was added dropwise. The reaction was stirred at −78° C. for 5 min, then the mixture was allowed to warm to room temperature and stirred for 2 h. The resulting transparent solution was cooled to −78° C. and solid 1,2,3,4-tetrahydro-1-naphthol (1.2 g, 2.6 mmol) from step i was added in one portion. The cooling bath was removed, and the reaction was stirred 30 min at room temperature. Once TLC analysis indicated complete consumption of the starting material the mixture was diluted with DCM (50 mL) and quenched with aqueous saturated NaHCO3 (50 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The dry residue was dissolved in 1,2-dimethoxyethane (60 mL) and AgClO4.xH2O (0.20 g) was added. The mixture was heated at 70° C. for 1 h, concentrated to dryness and the crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) followed by trituration with 30 mL of MTBE and filtration to yield the desired α-fluorotetralin (1.1 g, 2.4 mmol, 92% yield, single epimer) as a white solid.

Step k: α-Fluorotetralin from step j (1.1 g, 2.4 mmol) was suspended in 7M NH3 solution in MeOH (90 mL) and the mixture was stirred at ambient temperature for 36 h. The resulting clear solution was concentrated to dryness under reduced pressure and the crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) followed by trituration with 30 mL of hexanes and filtration to yield the desired product (0.85 g, 2.0 mmol, 85% yield). 1H NMR (400 MHz, CDCl3) δ 7.69 (d, J=8.1 Hz, 1H), 7.51 (d, J=8.4, 1H), 7.39 (d, J=7.5 Hz, 1H), 6.43 (d, J=8.1 Hz, 1H), 5.69 (dt, J=13.5, 5.1 Hz, 1H), 5.65-5.33 (m, 2H), 4.67-4.60 (m, 1H), 3.58 (ddd, J=20.8, 16.8, 3.4 Hz, 1H), 3.44 (dd, J=5.7, 2.9 Hz, 1H), 3.28 (s, 3H), 3.28-3.10 (m, 1H), 2.56-2.38 (m, 1H), 2.24-2.04 (m, 1H), 2.02-1.79 (m, 1H), 1.76-1.65 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −110.92 (m), −157.06 (m), −199.18 (m). ESI MS [M+Na]+ for C21H18F3NO3SNa, calcd 444.1, found 444.0).

Example 135

[Figure (not displayed)]

Step a: A mixture of [(1S,2R)-4-[(1R)-8-cyano-6-fluoro-4-oxo-2,3-dihydro-1H-naphthalen-1-yl]-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (145 mg, 0.31 mmol) prepared by the protocol from the Example 134, 1,2-ethanedithiol (0.38 mL, 4.6 mmol) and p-toluenesulfonic acid monohydrate (12.0 mg, 0.06 mmol) in benzene (25 mL) was placed in a single-neck round bottom flask equipped with Dean-Stark apparatus and a reflux condenser with nitrogen inlet adapter. The reaction was refluxed for 16 h, cooled to ambient temperature and washed with 1 M NaOH (25 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness under reduced pressure. The crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the desired product (0.17 g, 0.31 mmol, 100% yield) as a colorless oil.

Step b: To a cooled to −78° C. suspension of N-iodosuccinimide (71.0 mg, 0.32 mmol) in dichloromethane (1 mL) HF.Py (0.19 mL, 0.80 mmol) was added. The resulting dark suspension was stirred for 5 min before a solution of 1,3-dithiolane from step a (85 mg, 0.16 mmol) in dichloromethane (1 mL) was added dropwise over 1 min. The reaction mixture was stirred at −78° C. for 20 min followed by additional 20 min at 0° C. Once TLC analysis indicated complete conversion of 1,3-dithiolane the reaction was diluted with dichloromethane (15 mL) and washed with a mixture of aqueous saturated NaHCO3 and Na2S2O3 (1:1, v/v). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The crude material was fractionated by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the desired product (33.0 mg, 0.07 mmol, 43% yield) as a white solid.

Step c: 1,1-Difluorotetraline from step b (33.0 mg, 0.07 mmol) was dissolved in THE (1 mL) and a solution of LiOH·H2O (8.5 mg, 0.2 mmol) in water (0.2 mL) was added at 0° C. The reaction was stirred at room temperature for 3 h and monitored by LCMS analysis. Once complete conversion was achieved the reaction was diluted with EtOAc (20 mL) and washed with 1M aqueous HCl (15 mL). The organic phase was separated, and the aqueous solution was additionally extracted with EtOAc (15 mL). The combined organic extract was washed with brine, dried over Na2SO4 and concentrated to dryness under reduced pressure. The crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the desired product (27.0 mg, 0.06 mmol, 90% yield) as a white solid. 1H NMR (400 MHz, CDCl3) δ 7.84-7.65 (m, 2H), 7.51-7.38 (m, 1H), 6.56 (d, J=8.3 Hz, 1H), 5.68 (dt, J=13.5, 5.0 Hz, 1H), 5.51-5.32 (m, 1H), 4.64 (br. s, 1H), 3.68-3.42 (m, 2H), 3.27 (s, 3H), 3.23-3.03 (m, 1H), 2.62-2.38 (m, 1H), 2.38-2.08 (m, 2H), 1.95-1.85 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −85.85 (d, J=5260.8 Hz), −109.12 (m), −199.20 (dtd, J=52.8, 22.4, 13.5 Hz). ESI MS [M+Na]+ for C2H17F4NNaO3S, calcd 462.1, found 462.0).

Example 136

[Figure (not displayed)]

Step a: To a suspension of 7-fluoro-2,3-dihydro-1H-inden-1-one (10.0 g, 66.6 mmol) and aluminum trichloride (22.2 g, 166.5 mmol, 2.5 equiv.) in 1,2-dichloroethane (190 ml, 0.35M) was added bromine (3.58 ml, 70 mmol, 1.05 equiv.) dropwise. The resulting solution was heated to 60° C. for three hours, after which the reaction was cooled to room temperature and poured onto ice. The reaction was extracted with MTBE, dried over magnesium sulfate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:1 solution of CH2Cl2:hexanes) to yield 4-bromo-7-fluoro-2,3-dihydro-1H-inden-1-one.

Step b: To a suspension of 4-bromo-7-fluoro-2,3-dihydro-1H-inden-1-one (17.0 g, 74.3 mmol) and Cs2CO3 (26.6 g, 81.7 mmol, 1.1 equiv.) in DMF (372 ml, 0.2M) was added benzyl mercaptan (9.24 g, 8.71 ml, 1.0 equiv.). The reaction was stirred at room temperature for 90 minutes. The desired product was precipitated from solution through the addition of 1.5 L of water and was dried under high vacuum overnight. The resulting crude product (23.1 g, 93% yield) was taken on without further purification.

Step c: The crude thioether from the step b (23.1 g, 69.2 mmol) was suspended in toluene (692 ml, 0.1M). Aluminum trichloride (10.2 g, 1.1 equiv.) was added at room temperature. An additional portion of aluminum trichloride (3.6 g, 27 mmol, 0.4 equiv.) was added after three hours. Upon completion, the reaction was quenched with water, extracted with ethyl acetate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the desired thiophenol as a yellow solid (13.4 g, 80% yield).

Step d: A solution of the thiophenol product from step c (6.7 g, 27.6 mmol) and methyl viologen dichloride hydrate (710 mg, 0.1 equiv.) in DMF (55 ml, 0.5M) was carefully degassed via three freeze-pump-thaw cycles under nitrogen. The resulting solution was cooled to −10 to −5° C. in a brine ice bath, and an excess of CF3I was sparged through the reaction mixture. The reaction was then stirred overnight under an atmosphere of CF3I. The reaction was carefully quenched at room temperature with water (off-gassing of residual CF3I occurs, use caution), extracted with ethyl acetate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in hexanes) to yield the desired thioether (5.21 g, 61% yield).

Step e: To a solution of the product from step d (10.45 g, 33.6 mmol) in MeCN (129 ml, 0.26 M with respect to starting material), CCl4 (129 ml, 0.26 M with respect to starting material), and H2O (258 ml, 0.13M with respect to starting material) was added ruthenium trichloride (697 mg, 3.36 mmol, 0.1 equiv.) followed by sodium periodate (29.6 g, 138.4 mmol, 4.12 equiv.). The reaction was stirred at room temperature for one hour, and upon completion was extracted with CH2Cl2 (×2). The combined organics were washed with saturated Na2S2O3, washed with brine, and dried over sodium sulfate before concentrating. The crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the product sulfone as a white solid (10.53 g, 91% yield). ESI MS [M+H]+ for C10H6BrF3O3S; calc 342.9, found 342.9.

Step f: A solution of the product sulfone from Step e (3.5 g, 10.2 mmol) and Selectfluor (4.32 g, 12.2 mmol, 1.2 equiv.) in methanol (102 ml, 0.1M) was heated to 50° C. Sulfuric acid (27 μl, 5 mol %) was added, and the reaction was stirred at 50° C. for 48 hours. The solution was then diluted with diethyl ether, and the resulting white precipitate was filtered off and discarded. The organic solution was concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the product dimethyl acetal as a white solid (3.57 g, 87% yield).

Step g: A solution of the product acetal from Step f (3.18 g, 7.8 mmol) and wet Amberlyst 15 (4.77 g, 150 wt %) in dioxane (31 ml, 0.2 M) was heated to 90° C. overnight. Upon completion, the polymeric beads were removed by filtration, and the concentrated crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the desired fluorinated ketone (2.33 g, 83% yield).

Step h: A solution of the indanone product of Step g (2.5 g, 6.93 mmol) in dichloromethane (28 ml, 0.25M) was sparged with nitrogen gas before the addition of formic acid (783 μL, 956 mg, 20.8 mmol, 3 equiv.) and triethylamine (1.94 ml, 1.41 g, 13.9 mmol, 2 equiv.) at 0° C. under nitrogen. RuCl(p-cymene)[(R,R)-Ts-DPEN] (44.5 mg, 0.07 mmol, 0.01 equiv.) was added, and the reaction was stirred for a minimum of 12 hours at 0 to 5° C. Upon full conversion, the reaction was quenched with saturated NaHCO3 and extracted with CH2Cl2. The combined organics were concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in a 1:1 solution of CH2Cl2:hexanes) to yield the desired indanol (2.0 g, 80% yield) as a single diastereomer. The enantiomeric excess of this material was found to be 98% by chiral HPLC (Chiralpak AD-H, 20% iPrOH/hexanes, isocratic, 20 minutes) as compared to a racemic sample, which was obtained through reduction of the 2-fluoroindanone with sodium borohydride.

Step i: To a solution of the chiral indanol from Step h (1.01 g, 2.75 mmol) in CH2Cl2 (11 ml, 0.25M) was added 2,6-lutidine (800 μL, 6.9 mmol, 2.5 equiv.) and TBSOTf (791 μL, 3.44 mmol, 1.25 equiv.) at 0° C. The reaction was allowed to warm to room temperature and was stirred overnight. Upon completion, the reaction was concentrated directly onto celite and purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in hexanes) to yield the TBS ether (1.35 g, 100% yield).

Step j: The TBS ether product of Step i (674 mg, 1.41 mmol) was combined with B2Pin2 (457 mg, 1.8 mmol, 1.3 equiv.) Pd(dppf)Cl2 (103 mg, 0.14 mmol, 0.1 equiv.) and potassium acetate (213 mg, 3 mmol, 2.2 equiv.) in dioxane (14 ml, 0.1M), and the resulting solution was heated to 100° C. for three hours. The reaction solution was concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 30% ethyl acetate in hexanes) to yield the desired boronic pinacol ester (638 mg, 86% yield) as a colorless oil.

The protocols for the following steps were identical to the Example 134. 1H NMR (400 MHz, CDCl3) δ 7.75 (d, J=8.2 Hz, 1H), 7.52 (ddd, J=8.3, 2.8, 1.4 Hz, 1H), 7.40 (ddd, J=7.5, 2.7, 1.7 Hz, 1H), 6.60 (d, J=8.2 Hz, 1H), 5.73-5.50 (m, 2H), 5.46-5.23 (m, 1H), 4.74-4.60 (m, 1H), 3.79-3.51 (m, 1H), 3.36-3.20 (m, 1H), 3.02 (d, J=4.2 Hz, 1H), 2.61-2.43 (m, 1H), 2.22-2.09 (m, 1H), 1.97-1.86 (m, 1H), 1.81-1.73 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −77.43, −110.37 (d, J=1.6 Hz), −157.81 (d, J=45.0 Hz), −197.41-−202.71 (m). ESI MS [M+Na]+ for C21H15F6NNaO3S, calcd 498.1, found 498.0.

Example 138

[Figure (not displayed)]

Step a: A solution of Deoxo-Fluor (26.0 μl, 0.07 mmol, 2.7 M in toluene) in toluene (0.25 mL) was cooled to 0° C. under nitrogen, then TMS-morpholine (13.0 μL, 0.072 mmol) was added. The reaction was stirred at 0° C. for 5 min, then it was allowed to warm to room temperature and stirred for 2 h. The resulting solution was cooled back to 0° C. and a suspension of 1,2,3,4-tetrahydro-1-naphthol (8.0 mg, 0.02 mmol, prepared by analogy to Example 134) in dry toluene (0.5 mL) was added. The cooling bath was removed, and the reaction was stirred 30 min at room temperature. Once TLC analysis indicated complete consumption of the starting material the mixture was diluted with EtOAc (10 mL) and quenched with aqueous saturated NaHCO3 (3 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The dry residue was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) to yield the title compound (7.0 mg, 0.018 mmol, 87% yield, single epimer) as a white solid. 1H NMR (400 MHz, CDCl3) δ 7.74 (d, J=8.3 Hz, 1H), 7.58 (dd, J=8.5, 2.8 Hz, 1H), 7.37 (dd, J=7.6, 2.5 Hz, 1H), 6.68 (d, J=8.3 Hz, 1H), 5.62 (ddd, J=49.8, 8.4, 4.7 Hz, 1H), 4.89 (s, 1H), 2.51-2.31 (m, 1H), 2.34-2.07 (m, 2H), 2.03-1.86 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −63.03, −109.89, −169.86 (d, J=50.8 Hz). ESI MS [M+Na]+ for C19H10ClF5N2Na, calcd 419.0, found 419.0).

Example 139

[Figure (not displayed)]

Step a: A mixture of LDA (30 mL, 59.3 ml, 2 M solution in THF/heptane/ethylbenzene) and dry THF (240 mL) was placed under an atmosphere of nitrogen in 500 mL single-neck round bottom flask equipped with a magnetic stirring bar and nitrogen inlet adapter with rubber septum. The solution was cooled to −78° C. under nitrogen and 2,5-dibromo-3-fluoropyridine (12.1 g, 47.4 mmol) solution in dry THF (40 mL) was added via syringe dropwise over 20 min. The resulting mixture was stirred for 30 min and MeI (5 mL, 81 mmol) was added dropwise over 5 min at −78° C. Then cooling bath was removed and the reaction was allowed to warm to ambient temperature and stirred for 1 h followed by quench with aqueous saturated NH4Cl (200 mL). The mixture was transferred into separatory funnel, diluted with water (100 mL) and EtOAc (200 mL). The organic phase was separated, and the aqueous phase was additionally extracted with EtOAc (2×100 mL), Combined organic extracts were washed with brine, dried over Na2SO4, and the solvent was removed under reduced pressure. The crude material was purified by flash chromatography (silica gel, 0% to 30% ethyl acetate in hexanes) to yield 2,5-dibromo-3-fluoro-4-methyl-pyridine (12.0 g, 44.6 mmol, 94% yield) as a colorless crystallizing oil.

Step b: A solution of 2,5-dibromo-3-fluoro-4-methyl-pyridine (6.0 g, 22.3 mmol) in toluene (110 mL) was placed in 250 mL single-necked round bottom flask equipped with magnetic stirring bar and nitrogen inlet adapter with rubber septum. This solution was cooled to −78° C. and nBuLi (9.8 mL, 24.5 mmol) was added dropwise via syringe over 10 min. The resulting heterogenous solution was stirred at −78° C. for 20 min before N,N-dimethylacetamide (3.2 mL) was added dropwise over 1 min. The reaction mixture was stirred for 30 min and quenched with aqueous saturated NH4Cl (50 mL) at −78° C. The resulting biphasic mixture was diluted with water (50 mL) and EtOAc (100 mL). The organic phase was separated, and the aqueous phase was additionally extracted with EtOAc (2×100 mL). The combined organic extract was washed with brine, dried over Na2SO4, and the solvent was removed under reduced pressure. The crude material was purified by flash chromatography (silica gel, 0% to 40% ethyl acetate in hexanes) to yield corresponding 2-acetylpyridine (2.8 g, 12.1 mmol, 54% yield) as a colorless crystallizing oil.

Step c: A mixture of 2-acetylpyridine from step b (2.8 g, 12.0 mmol) and deoxo-fluor (6.7 mL, 36 mmol) in toluene (60 mL) was placed in 250 mL single-neck round bottom flask equipped with stirring bar and reflux condenser with drying tube. The mixture was maintained at 70° C. for 24 h. Despite incomplete conversion the biphasic reaction was cooled to ambient temperature and poured in aqueous saturated NaHCO3 (200 mL) under vigorous stirring. Then the mixture was diluted with EtOAc (200 mL) and filtered through a pad of celite. The organic phase was separated, and the aqueous phase was additionally extracted with EtOAc (2×70 mL). Combined organic extracts were washed with brine, dried over Na2SO4 and concentrated to dryness. The crude material was fractionated by flash chromatography (silica gel, 0% to 30% ethyl acetate in hexanes) to yield 5-bromo-2-(1,1-difluoroethyl)-3-fluoro-4-methylpyridine (1.9 g, 7.5 mmol, 63% yield) as a yellowish liquid.

The protocols for the following steps were identical to the Example 134. The title compounds characterization data: 1H NMR (400 MHz, CDCl3) δ 7.53-7.42 (m, 1H), 7.42-7.32 (m, 1H), 7.22 (s, 1H), 5.56 (dt, J=49.9, 3.3 Hz, 1H), 4.69 (br. s, 1H), 2.64-2.36 (m, 4H), 2.27-2.09 (m, 1H), 2.08-1.85 (m, 4H), 1.83-1.67 (m, 1H). 19F NMR (376 MHz, CDCl3) δ 89.77 (m), −110.97 (m), −125.45, −156.81 (m). ESI MS [M+H]+ for C19H16F5N2, calcd 367.1, found 367.2).

Example 140

[Figure (not displayed)]

Step a: To an ice-cold solution of (1S,2R)-4-bromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-ol (11.5 g, 37.3 mmol) in dichloromethane (190 ml, 0.2M) was added DMAP (1.4 g, 11.2 mmol) and triethylamine (10.4 ml, 75 mmol, 2 equiv.) followed by the dropwise addition of acetic anhydride (7.1 ml, 75 mmol, 2 equiv.). The solution was allowed to warm to room temperature and was stirred for one hour. Upon completion the reaction was quenched with saturated aq. NaHCO3, the resulting solution was extracted with dichloromethane (2×), dried over Na2SO4, and concentrated onto celite. The crude material was purified by flash chromatography on silica gel (0-10% ethyl acetate in hexanes) to yield [(1S,2R)-4-bromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (13.1 g, 100% yield). ESI MS [M+H]+ for C12H12BrFO4S, calcd. 351.0, found 351.0.

Step b: A solution of dichloroethane (0.2M, 190 ml) containing [(1S,2R)-4-bromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (13.5 g, 38.5 mmol), 2,2′-Azobis(2-methylpropionitrile) (40 mg, 1 mol %), and N-bromosuccinimide (7.54 g, 1.1 equiv) was heated to reflux for 90 minutes. Upon completion, the reaction was cooled and partitioned between ethyl acetate and saturated NaHCO3. The organics were collected, washed with dilute Na2S2O3, dried over Na2SO4, and concentrated onto celite. The crude material was purified by flash chromatography on silica gel (5% ethyl acetate in a 1:3 ratio of CH2Cl2:hexanes) to provide two brominated diastereomers, [(1S,2S,3R)-3,4-dibromo-2-fluoro-7-methyl sulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (6.83 g, 41% yield) and [(1S,2S,3S)-3,4-dibromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (2.5 g, 15% yield). The diastereomeric products elute in the order listed.

Step c: To a solution of [(1S,2S,3R)-3,4-dibromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (6.73 g, 15.6 mmol) in THF (0.08M, 195 ml) at 0° C. was added a 0.5 M aqueous solution of LiOH (5.93 ml, 1.5 equiv.) and the reaction was allowed to stir at 0° C. for three hours, at which time the reaction was quenched at 0° C. with 1N HCl. The resulting solution was extracted three times with methylene chloride, the organics were dried over Na2SO4, and flashed 0 to 20% ethyl acetate in [1:1 hexanes:dichloromethane] to yield (1S,2S,3S)-3,4-dibromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-ol (3.68 g, 61% yield).

Step d: Sodium hydride (60% dispersion in mineral oil, 440 mg, 10.5 mmol, 1.1 equiv.) was added slowly at 0° C. to a solution of (1S,2S,3S)-3,4-dibromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-ol (3.68 g, 9.5 mmol) and benzyl bromide (6.77 ml, 9.75 g, 57 mmol, 6 equiv.) in THF (38 ml, 0.25M with respect to indanol) and DMF (9.5 ml, 1M with respect to indanol). The reaction was allowed to warm to room temperature and was stirred overnight. The next day, 3 additional equivalents of BnBr and 0.55 equivalents of NaH were added, and the reaction went to completion within two hours. The solution was quenched with 1N HCl, extracted with ethyl acetate, dried over Na2SO4, and concentrated. The crude material was purified by flash chromatography on silica gel, 0 to 20% ethyl acetate in hexanes, to yield (1S,2S,3S)-1,7-dibromo-2-fluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-indene as a white foam (2.46 g, 54% yield).

Step e: To a solution of (1S,2S,3S)-1,7-dibromo-2-fluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-indene (2.46 g, 5.1 mmol) in sulfolane (28.4 ml) and water (5.6 ml) was added silver perchlorate hydrate (unknown hydrate stoichiometry) (2.13 g, −10.3 mmol), and the reaction was heated to 75° C. overnight with the exclusion of light. After 23 hours, the starting material was almost fully consumed, and the reaction was quenched with H2O. Upon dilution with MTBE silver salts can be filtered out of the biphasic mixture, and the organics were collected and dried over sodium sulfate. Purification by flash chromatography (0 to 5% to 50% ethyl acetate in dichloromethane) yielded the diastereomeric alcohol products (1R,2R,3S)-7-bromo-2-fluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-inden-1-ol (750 mg, 35% yield) and (1S,2R,3S)-7-bromo-2-fluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-inden-1-ol (470 mg, 22% yield). The diastereomeric products elute in the order listed, and the latter was taken on through further steps. ESI MS [M+Na]+ for C17H16BrFO4S, calcd. 437.0, found 437.0.

Step f: To an ice-cold solution of (1S,2R,3S)-7-bromo-2-fluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-inden-1-ol (386 mg, 0.93 mmol) in dichloromethane (0.1M, 9.3 ml) was added (diethylamino)sulfur trifluoride (492 μl, 600 mg, 3.7 mmol, 4 equiv.), and the resulting solution was stirred at temperatures between 0 and 10° C. for three hours, at which time it was quenched with saturated NaHCO3. The organics were extracted with ethyl acetate, dried over Na25O4, and purified by flash chromatography on silica gel (10% ethyl acetate in hexanes, isocratic) to yield two fluorinated products: (1S,2S,3S)-7-bromo-1,2-difluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-indene (undesired, less polar, 158 mg, 40% yield) and (1R,2S,3S)-7-bromo-1,2-difluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-indene (desired, more polar, 234 mg, 60% yield).

Step g: (1R,2S,3S)-7-bromo-1,2-difluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-indene (234 mg, 0.56 mmol), B2Pin2 (185 mg, 0.73 mmol, 1.3 equiv.), KOAc (121 mg, 1.23 mmol, 2.2 equiv.) and PdCl2(dppf) (44 mg, 0.06 mmol, 10 mol %) were combined in dioxane (5.6 ml, 0.1M). The resulting solution was sparged with nitrogen and heated to 100° C. until all starting material was consumed (2.5 h). The crude reaction mixture was filtered over celite, concentrated, taken up in ethyl acetate, and washed with water to remove remaining KOAc. The resulting solid was taken on to the Suzuki cross-coupling step without further purification.

The title compound was completed in a similar fashion to Example 134. 1H NMR (400 MHz, CDCl3): δ 7.96 (dd, J=8.1, 2.0 Hz, 1H), 7.23-7.17 (m, 2H), 6.86 (d, J=8.1 Hz, 1H), 5.91-5.75 (m, overlap, 2H), 5.20-5.02 (m, 1H), 4.95-4.91 (m, 1H), 3.02-2.84 (m, 3H), 2.28-2.19 (m, 1H), 1.93-1.85 (m, 1H), 1.79-1.58 (m, 2H).

Example 141

[Figure (not displayed)]

Step a: Performed in similar fashion to step a of Example 134

Step b: To a solution of the product from step a (10 g, 38 mmol, 1 equiv.) in CH2Cl2 (190 mL, 0.2 M) at 0° C. was added Et3N (32 mL, 228 mmol, 6 equiv.) followed by TBSOTf (17.5 mL, 76 mmol, 2 equiv). The reaction was left to warm to room temperature overnight. The reaction mixture was concentrated then dried under vacuum for 45 minutes. The crude silyl enol ether was dissolved in MeCN (190 mL, 0.2 M), then Selectfluor (20.2 g, 57 mmol, 1.5 equiv.) was added and the reaction was stirred at room temperature for 2 hours or until judged complete by TLC. The reaction mixture was diluted with EtOAc, washed with 0.2 M aqueous HCl, followed by brine. The organic layer was dried with MgSO4 and concentrated. The crude product was purified by flash column chromatography (SiO2, 0 to 50% EtOAc/hexanes) to yield the difluoroketone as a light-yellow solid (7.0 g, 24.9 mmol, 66%). 1H NMR (400 MHz, Chloroform-d) δ 7.79 (d, J=8.4 Hz, 1H), 7.36 (dt, J=8.4, 0.9 Hz, 1H), 3.48 (td, J=12.6, 0.8 Hz, 2H).

Step c: Performed in similar fashion to step b of Example 134. 1H NMR (400 MHz, Chloroform-d) δ 7.45 (d, J=8.5 Hz, 1H), 7.19 (d, J=8.5 Hz, 1H), 5.22 (d, J=12.4 Hz, 1H), 3.61-3.33 (m, 2H), 1.11 (t, J=7.1 Hz, 2H).

Step d: Performed in similar fashion to step c of Example 134. ESI MS [M+H]+ for C15H20BrClF2OSi calcd. 397.0, found 397.0.

Step e: Performed in similar fashion to step d of Example 134. The crude product was used in step f without column chromatographic purification.

Step f: Performed in similar fashion to step e of Example 134. ESI MS [M+H]+ for C26H27ClF3NOSi calcd. 490.2, found 490.2.

Step g: Performed in similar fashion to step f of Example 134 with 5 equivalents of Et3N added to the reaction mixture. Diastereomers were not separated at this stage. ESI MS [M+H]+ for C26H29ClF3NOSi calcd. 492.2, found 492.2.

Step h: Aryl chloride (100 mg, 0.20 mmol, 1 equiv.), K4Fe(CN)6.3H2O (59 mg, 0.14 mmol, 0.7 equiv.), XPhos Pd G3 (17 mg, 0.02 mmol, 0.1 equiv.), XPhos (10 mg, 0.02 mmol, 0.1 equiv.), and KOAc (4 mg, 0.04 mmol, 0.2 equiv.) were dissolved in 1:1 water/dioxane (2 mL, 0.1 M). The reaction mixture was sparged with nitrogen for 10 minutes and then heated to 100° C. After 2 hours, the reaction was judged complete by LCMS. The reaction mixture was let to cool to room temperature and then partitioned between EtOAc and water. The layers were separated and the aqueous was extracted three times with EtOAc. The combined organics were dried over Na2SO4 and concentrated. The crude product was purified by flash column chromatography (SiO2, 0 to 50% EtOAc/hexanes) to afford the aryl nitrile product. ESI MS [M+H]+ for C27H29F3N2OSi calcd. 483.2, found 483.2.

Step i: The product from step h was treated with an excess of HF-pyridine in acetonitrile. After stirring overnight the mixture was quenched with saturated NaHCO3 and extracted with EtOAc. The product was purified by flash column chromatography. The final product was isolated as a 1:1 mixture of diastereomers (40 mg, 0.11 mmol. 54% over two steps). ESI MS [M]+ for C21H15F3N2O calcd. 369.1, found 369.1. 1H NMR (400 MHz, Chloroform-d) δ 7.47 (dd, J=8.0, 2.9 Hz, 1H), 7.18 (d, J=8.6 Hz, 2H), 6.60 (dd, J=14.3, 8.0 Hz, 1H), 5.33 (m, 1H), 4.45 (dt, J=9.0, 4.1 Hz, 1H), 3.88-3.27 (m, 2H), 3.10-2.80 (m, 3H), 2.23-2.08 (m, 1H), 1.89-1.70 (m, 2H).

Example 143

[Figure (not displayed)]

Step a: From 8-[(1)-1-[tert-butyl(dimethyl)silyl]oxy-7-chloro-2,2-difluoro-1,3-dihydroinden-4-yl]-3-fluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile, followed the same procedure described in Example 134 to prepare compound 8-[(1S)-1-[tert-butyl(dimethyl)silyl] oxy-7-chloro-2,2-difluoro-1,3-dihydroinden-4-yl]-3-fluoro-5-oxo-7,8-dihydro-6H-naphthalene-1-carbonitrile. 1H NMR (400 MHz, Chloroform-d) δ 8.04 (dddd, J=8.4, 2.9, 1.6, 0.5 Hz, 1H), 7.53 (dt, J=7.3, 2.9 Hz, 1H), 7.09 (d, J=8.3 Hz, 1H), 6.35 (dd, J=13.2, 8.3 Hz, 1H), 5.29-5.01 (m, 1H), 4.62 (m, 1H), 3.80-3.33 (m, 2H), 2.80-2.30 (m, 2H), 2.20-2.10 (m, 1H), 1.60-1.50 (m, 1H), 1.00-0.72 (m, 9H), 0.36-0.11 (m, 6H).

Step b: A vial was charged with 8-[(1S)-1-[tert-butyl(dimethyl)silyl]oxy-7-chloro-2,2-difluoro-1,3-dihydroinden-4-yl]-3-fluoro-5-oxo-7,8-dihydro-6H-naphthalene-1-carbonitrile from step a (30 mg, 0.06 mmol, 1.0 equiv.) and mixture solvent (MeOH 0.2 ml, THF 0.3 ml). The reaction mixture was cooled to 0° C. and NaBH4 (2.2 mg, 0.06 mmol, 1.0 equiv.) was added. The reaction mixture was stirred at 0° C. for 30 min. Once complete, purification by flash chromatography (SiO2, hexane to 30% EtOAc) furnished the (5R)-8-[(1S)-1-[tert-butyl(dimethyl)silyl]oxy-7-chloro-2,2-difluoro-1,3-dihydroinden-4-yl]-3-fluoro-5-hydroxy-5,6,7,8-tetrahydronaphthalene-1-carbonitrile. (18 mg, 0.035 mmol, 59%). ESI MS [M+H]+ for C26H29ClF3NO2Si, calcd 509.1, found 525.1.

Step c: To a vial containing the product from step b (18 mg, 0.035 mmol, 1.0 equiv.) was added 0.4 ml DCM. The reaction was cooled at −40° C. and DAST (11 mg, 0.071 mmol, 2.0 equiv.) was added. The reaction mixture was stirred at −40° C. for 30 min. Once complete, purification by flash chromatography (SiO2, hexane to 10% EtOAc gradient) to yield the (5S)-8[(1 S)-1-[tert-butyl(dimethyl)silyl]oxy-7-chloro-2,2-difluoro-1,3-dihydroinden-4-yl]-3,5-difluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (12 mg, 0.024 mmol, 67%). ESI MS [M+H]+ for C26H28ClF4NOSi, calcd 511.0, found 527.0.

Step d: To a vial containing the product from step c (12 mg, 0.024 mmol, 1.0 equiv.) was added 1-Methyl-1H-pyrazole-5-boronic acid pinacol ester (6.4 mg, 0.031 mmol, 1.3 equiv.), Pd-Sphos-G2 (1.7 mg, 0.0024 mmol, 0.1 equiv.). The vial was evacuated and back-filled with N2 (×3). 1M aq. Na2CO3 solution (0.1 ml, 0.096 mmol, 4.0 equiv.) and Dioxane (0.25 mL) were added. The reaction was heated at 100° C. and stirred for overnight. Once complete, purification by flash chromatography (SiO2, hexane to 30% EtOAc gradient) to yield (5S)-8-[(1S)-1-[tert-butyl(dimethyl)silyl] oxy-2,2-difluoro-7-(2-methylpyrazol-3-yl)-1,3-dihydroinden-4-yl]-3,5-difluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (13 mg, 0.023 mmol, 97%). ESI MS [M+H]+ for C30H33F4N3OSi, calcd 556.7, found 556.2.

Step e: A solution of the product from step d (13 mg, 0.023 mmol) in CH3CN (0.4 mL) was placed in a 3 mL vial equipped with a magnetic stirrer, then HF.Py complex (hydrogen fluoride ˜70%, pyridine ˜30%, 0.2 mL) was added. The resulting colorless solution was stirred for 1 hr at ambient temperature. Once complete, purification by HPLC to yield (5S,8R)-8-[(1S)-2,2-difluoro-1-hydroxy-7-(2-methylpyrazol-3-yl)-1,3-dihydroinden-4-yl]-3,5-difluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (2.2 mg, 0.005 mmol, 22%). 1H NMR (400 MHz, Methanol-d4) δ 7.69-7.57 (m, 2H), 7.54 (d, J=2.0 Hz, 1H), 7.16 (d, J=8.0 Hz, 1H), 6.55-6.46 (m, 2H), 5.73-5.60 (m, 2H), 4.84-4.80 (m, 1H), 4.68-4.61 (m, 1H), 3.84-3.67 (m, 1H), 3.47 (td, J=16.6, 4.7 Hz, 1H), 2.52-2.40 (m, 1H), 2.16-1.95 (m, 2H), 1.84-1.73 (m, 1H). ESI MS [M+H]+ for C30H33F4N3OSi, calcd 442.4, found 442.0.

Example 144

[Figure (not displayed)]

Step a: Into a 50-L reactor purged and maintained with an inert atmosphere of nitrogen, was placed 3,5-difluorobenzaldehyde (1500.00 g, 10555.57 mmol, 1.00 equiv), tetrahydrofuran (15 L), (2-carboxyethyl)triphenylphosphanium bromide (5260.06 g, 12666.69 mmol, 1.20 equiv). This was followed by the addition of a solution of tert-butoxypotassium (2961.18 g, 26388.93 mmol, 2.50 equiv) in THF (15 L) dropwise with stirring at 0° C. in 2 h. The resulting solution was stirred for 1 overnight at room temperature. The reaction was repeated 1 time. The reaction was then quenched by the addition of 20 L of water. The resulting mixture was concentrated under vacuum. The resulting solution was extracted with 2×8 L of ethyl acetate and the aqueous layers combined. HCl (3 mol/L) was employed to adjust the pH to 4-5. The resulting solution was extracted with 3×6 L of ethyl acetate and the organic layers combined and dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1:10-1:5). This resulted in 2500 g (59.76%) of (3E)-4-(3,5-difluorophenyl)but-3-enoic acid as a white solid.

Step b: Into a 20-L High-Pressure autoclave was placed (3E)-4-(3,5-difluorophenyl)but-3-enoic acid (2500.00 g, 12615.49 mmol, 1.00 equiv), EA (12.5 L), 10% Pd/C (125 g). The reaction was then purged with nitrogen and pressurized with hydrogen gas to 150 psi, The mixture was stirred 4 h at room temperature. The solids were filtered out. Rinsed with EA (2.5 L), The resulting mixture was concentrated under vacuum. This resulted in 2318 g (91.79%) of 4-(3,5-difluorophenyl)butanoic acid as colorless oil.

Step c: Into a 20-L 4-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen, was placed sulfuric acid (6.6 L), 4-(3,5-difluorophenyl)butanoic acid (2318.00 g, 11579.28 mmol, 1.00 equiv). The resulting solution was stirred for 4 h at 40-45° C. The reaction mixture was cooled to 0° C. with a water/ice bath. The reaction mixture was transferred onto 30 L of water/ice. The resulting solution was extracted with 3×8 L of MTBE and the organic layers combined. The resulting mixture was washed with 1×5 L of H2O and 1×5 L of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The crude product was re-crystallized from MTBE:hexane (5V) in the ratio of 1:3. This resulted in 1600 g (75.85%) of 6,8-difluoro-3,4-dihydro-2H-naphthalen-1-one as a off-white solid. 500.4000 g was submitted to QC and other was used to TG2. LCMS-PH-ACS-002-TG1-0: (ES, m/z): [M+H]+=183. 1H-NMR-PH-ACS-002-TG1-0: (300 MHz, DMSO-d6, ppm) δ 7.24-7.07 (m, 2H), 2.97 (t, J=6.1 Hz, 2H), 2.57 (dd, J=7.2, 5.8 Hz, 2H), 2.07-1.93 (m, 2H).

Step d: Into a 50-L reactor purged and maintained with an inert atmosphere of nitrogen, was placed dioxane (13.50 L), trimethyl(sodiooxy)silane (1661.00 g, 14806.69 mmol, 3.00 equiv). This was followed by the addition of a solution of 6,8-difluoro-3,4-dihydro-2H-naphthalen-1-one (900.00 g, 4940.440 mmol, 1.00 equiv) in dioxane (4.5 L) dropwise with stirring at 80-90° C. in 2 h. The resulting solution was stirred for 1 h at 80-90° C. The reaction mixture was cooled to 20° C. with a water/ice bath. The reaction was then quenched by the addition of 10 L of HCl (1 mol/L). The resulting solution was extracted with 1×6 L of ethyl acetate. The organic layer was washed with 1×8 L of H2O and 1×8 L of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1:20-1:10). This resulted in 720 g (80.88%) of 6-fluoro-8-hydroxy-3,4-dihydro-2H-naphthalen-1-one as a yellow solid.

Step e: Into a 20-L reactor purged and maintained with an inert atmosphere of nitrogen, was placed 6-fluoro-8-hydroxy-3,4-dihydro-2H-naphthalen-1-one (720.00 g, 3996.04 mmol, 1.00 equiv), DCM (10.00 L), TEA (1010.00 g, 9981.22 mmol, 2.50 equiv), LiCl (185.00 g, 4363.82 mmol, 1.09 equiv). The reactor was cooled to 0° C. This was followed by the addition of Tf2O (1128.00 g, 3998.02 mmol, 1.00 equiv) dropwise with stirring at 0° C. in 1.5 hrs. The resulting solution was stirred for 3 h at room temperature. The reaction was then quenched by the addition of 10 L of water. The resulting solution was extracted with 2×5 L of dichloromethane and the organic layers combined. The resulting mixture was washed with 1×5 L of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1:10). This resulted in 1025 g (82.15%) of 3-fluoro-8-oxo-6,7-dihydro-5H-naphthalen-1-yl trifluoromethanesulfonate as a brown solid.

Step f: Into a 20-L 4-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen, was placed 3-fluoro-8-oxo-6,7-dihydro-5H-naphthalen-1-yl trifluoromethanesulfonate (1025.00 g, 3282.83 mmol, 1.00 equiv), DMF (10.00 L), Zn(CN)2 (304.00 g, 2588.46 mmol, 0.79 equiv), Pd(PPh3)4 (150.00 g, 129.80 mmol, 0.04 equiv). The resulting solution was stirred for 4 h at 100° C. The reaction mixture was cooled with a water/ice bath. The reaction was then quenched by the addition of 30 L of water/ice. The resulting solution was extracted with 3×8 L of ethyl acetate and the organic layers combined. The resulting mixture was washed with 2×8 L of H2O and 1×8 L of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with dichloromethane/petroleum ether (1:2-1:1). This resulted in 501.4000 g (80.83%) of 3-fluoro-8-oxo-6,7-dihydro-5H-naphthalene-1-carbonitrile as a yellow solid. LC-MS: (ES, m/z): [M+H]+=190. 1H-NMR (300 MHz, CDCl3) δ 7.40 (dd, J=8.0, 2.6 Hz, 1H), 7.23 (ddd, J=8.4, 2.2, 1.2 Hz, 1H), 3.04 (t, J=6.1 Hz, 2H), 2.74 (dd, J=7.3, 5.9 Hz, 2H), 2.19 (p, J=6.5 Hz, 2H).

Step g: To a mixture of the product from step f (25 g, 132 mmol) and ethylene glycol (5 eq.) and benzene (330 mL) was added pTsOH·H2O (2.51 g, 13.2 mmol, 0.1 equiv). The reaction mixture was refluxed overnight with Dean Stark apparatus and quenched with saturated NaHCO3. The mixture was extracted with EtOAc, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 5-15% gradient to afford the acetal as a yellow solid (31.9 g, 100%).

Step h: To a stirred solution of the product from step g (6.0 g, 25.7 mmol) in acetone (68 mL) and water (17 mL), MgSO4 (6.50 g, 54.0 mmol, 2.1 equiv) was added in one portion. A reflux condenser was fitted to the reaction vessel and KMnO4 (21.1 g, 133.6 mmol, 5.2 equiv) was added in portions over the course of 20 minutes (probably use ice bath for higher scale) and the resulting strongly purple reaction mixture was stirred at 45° C. for 20 h. The reaction mixture was quenched with saturated Na2S2O3 and water. The mixture was extracted with EtOAc, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 10-40% gradient to afford the ketone as a yellow solid (3.24 g, 51%).

Step i: To a mixture of the product from step h (3.80 g, 15.4 mmol) and DCM (77 mL) was added formic acid (1.7 mL, 46.2 mmol, 3 equiv) and Et3N (4.2 mL, 30.8 mmol, 2 equiv). The reaction mixture was cooled to 0° C. and catalyst (293 mg, 0.46 mmol, 0.03 equiv) was added. After stirring overnight at 4° C. (fridge) the reaction was quenched with saturated NaHCO3. The mixture was extracted with DCM, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 20-50% gradient to afford the alcohol as a yellow solid (3.74 g, 98%).

Step j: To a mixture of the product from step i (3.72 g, 14.9 mmol) and acetone (149 mL) was added I2 (379 mg, 1.49 mmol, 0.1 equiv). The reaction mixture was stirred at rt for 30 minutes and quenched with Na2S2O3 in water. The mixture was extracted with EtOAc, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 20-50% gradient to afford the ketone as a yellow solid (2.72 g, 89%).

Step k: To a mixture of the product from step j (2.72 g, 13.3 mmol) and DCM (89 mL) was added Et3N (2.7 mL, 20.0 mmol, 1.5 equiv) at 0° C. followed by TBSOTf (3.7 mL, 15.9 mmol, 1.2 equiv) and the mixture was stirred at 0° C. for 1 h. The reaction mixture was washed with NaHCO3 sat., extracted with DCM, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 0-20% gradient to afford the protected alcohol as a yellow solid (3.79 g, 89%).

Step l: To a mixture of product from step k (2.51 g, 7.86 mmol) and THF (52 mL) was added ArNTf2 (9.2 g, 23.6 mmol, 3 equiv). The reaction mixture was cooled to −78° C. and LiHMDS (1M in THF, 11.8 mL, 11.8 mmol, 1.5 equiv) was added and the mixture was stirred 20 minutes at −78° C. As the conversion was incomplete LiHMDS (3.9 mL, 3.9 mmol, 0.5 equiv) was added and the reaction was stirred for another 20 minutes. The mixture was quenched with NaHCO3 sat., extracted with THF, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 0-10% gradient to afford the triflate as a white solid (2.14 g, 60%).

[Figure (not displayed)]

Step m: To a solution of 4-bromo-7-chloro-1-indanone (40.0 g, 163 mmol, 1.0 equiv.) in MeOH (800 mL) was added Selectfluor (63.5 g, 179 mmol, 1.1 equiv.) and concentrated H2SO4 (1.0 mL). The resulting mixture was heated at reflux for 3 h. After cooling to room temperature, 0.3 M H2SO4 (aq., 200 mL) was added to the reaction mixture. The resulting mixture was heated at reflux for another 1 h. After cooling to room temperature, large amount of the product was precipitated out and collected via filtration. The filtrate was concentrated and diluted with DCM (500 mL) and washed with H2O and brine. The organic phase was dried over Na2SO4 and concentrated. Combining the previous filtering cake, 40.4 g (153 mmol, 94% yield) of the desired product was obtained as pale brown solid.

Step n: To a solution of the product from step m (40.4 g, 153 mmol, 1.0 equiv.) and Et3N (92.9 g, 128 mL, 918 mmol, 6.0 equiv.) in DCM (380 mL) was added TBSOTf (80.9 g, 70.3 mL, 306 mmol, 2.0 equiv.) dropwise at 0° C. The resulting solution was stirred at 0° C. for 1.5 h, and then quenched with saturated NaHCO3 (aq.) and kept stirring for 1 h. The resulting mixture was then separated, and the aqueous phase was extracted with DCM (3×150 mL). The combined organic phase was then washed with brine, dried over Na2SO4 and concentrated to afford the crude silyl enol ether. The crude product was then dissolved in MeCN (750 mL). Selectfluor (81.3 g, 230 mmol, 1.5 equiv.) was added portion-wise at room temperature. The resulting mixture was stirred at room temperature for 30 min and then filtered to remove the precipitated salts. The filtrate was concentrated and diluted with DCM (500 mL) and H2O (500 mL). The aqueous phase was extracted with DCM (2×200 mL). The combined organic phase was then washed with brine, dried over Na2SO4 and concentrated to afford crude solid. Trituration with hexanes (3×150 mL) and drying under vacuum afforded 42.4 g (151 mmol, 99% yield) of desired product that was obtained as light yellow powdery solid.

Step o: HCO2H (34.8 g, 28 mL, 755 mmol, 5.0 equiv.) was added to a solution of Et3N (45.8 g, 63 mL, 453 mmol, 3.0 equiv.) in DCM (100 mL) dropwise. The resulting solution was stirred at room temperature for 30 min, and then added to a solution of the product from step n (42.4 g, 151 mmol, 1.0 equiv.) and RuCl(p-cymene)[(R,R)-TsDPEN] (1.92 g, 3.02 mmol, 2.0 mol %) in DCM (400 mL) at 0° C. The resulting mixture was kept stirring at this temperature for 1.5 h and then concentrated. The crude product was directly used in the next step.

Step p: Chloromethyl methyl ether (32.6 g, 34 mL, 454 mmol, 3.0 equiv.) was added dropwise to a solution of the crude product from step o (151 mmol) and diisopropylethylamine (58.7 g, 79 mL, 454 mmol, 3.0 equiv.) in DCM (300 mL). The resulting solution was then heated at reflux overnight, cooled to room temperature and then directly concentrated on Celite and purified by flash chromatography (SiO2, 10 to 20% EtOAc/Hex) to afford the protected indanol product (31.4 g, 95.9 mmol, 64% yield over 2 steps) and recovered free indanol (97% ee, 6.2 g, 21.9 mmol, 14% yield).

Step q: A 250-mL flask was charged with the product from step p (15.0 g, 45.8 mmol, 1.0 equiv.), B2Pin2 (12.2 g, 48.1 mmol, 1.05 equiv.), Pd(dppf)Cl2 (3.35 g, 4.58 mmol, 10 mol %), KOAc (8.99 g, 91.6 mmol, 2.0 equiv.) and 1,4-dioxane (120 mL). The reaction mixture was degassed with N2 bubbling for 10 min before being heated. After stirring at 100° C. overnight, the reaction mixture was cooled, concentrated on Celite and purified by flash chromatography (SiO2, 0 to 15% EtOAc/Hex) to afford the product (14.2 g, 37.9 mmol, 83% yield) as pale-yellow liquid.

Step r: A 500-mL flask was charged with the product from i (22.8 g, 50.4 mmol, 1.0 equiv.), the product from step q (20.8 g, 55.4 mmol, 1.1 equiv.), Pd(dppf)Cl2 (3.66 g, 5.04 mmol, 10 mol %), Na2CO3 (10.6 g, 100 mmol, 2.0 equiv.), 1,4-dioxane (200 mL) and H2O (50 mL). The reaction mixture was degassed with N2 bubbling for 10 min before being heated to 80° C. and stirred overnight. The reaction mixture was cooled, concentrated onto Celite and purified by flash chromatography (SiO2, 0 to 15% EtOAc/Hex) to afford the desired product (19.3 g, 35.1 mmol, 70% yield).

Step s: A mixture of the product from step r (8.20 g, 14.9 mmol, 1.0 equiv.), Pd/C (10 wt % Pd, 1.58 g, 10 mol %) in MeOH (75 mL) was shaken in parr hydrogenator under H2 (50 psi) for 2 h. After this time LCMS showed no remaining starting material. The reaction mixture was then filtered through Celite and concentrated to afford the product (7.25 g, 13.1 mmol, 88% yield).

Step t: To a solution of the product from step s (7.25 g, 13.1 mmol, 1.0 equiv.) in THF (65 mL) was added TBAF (1M in THF, 14 mL, 1.1 equiv.) at 0° C. The resulting solution was stirred at 0° C. for 15 min, and then quenched by saturated NH4Cl (aq.). The aqueous phase was extracted with EtOAc×2. The combined organic layer was then washed with brine, dried over Na2SO4, concentrated and purified by flash chromatography (SiO2, 10 to 15% EtOAc/Hex) to afford the product (3.78 g, 8.6 mmol, 66% yield).

Step u: To a solution of 4-(trimethylsilyl)morpholine (6.28 g, 39.4 mmol, 3.55 equiv.) in DCM (70 mL) was added deoxofluor (2.7M in toluene, 14 mL, 3.5 equiv.) dropwise at −78° C. The resulting solution was then stirred at this temperature for 5 min and warmed to room temperature for 1 h. The reaction mixture was then cooled back to −78° C. and a solution of the product from step t (4.88 g, 11.1 mmol, 1.0 equiv.) in DCM (15 mL) was added dropwise. The resulting solution was then stirred at this temperature for 5 min, after which the reaction vessel was warmed to room temperature and stirred for an additional 1 h. The reaction was quenched with saturated NaHCO3 (aq.). The aqueous layer was extracted with DCM×2. The combined organic layer was then washed with brine, dried over Na2SO4, concentrated and purified by flash chromatography (SiO2, 0 to 20% EtOAc/Hex) to afford the product (3.33 g, 7.6 mmol, 68% yield).

Step v: A flask containing the product from step u (50 mg, 0.114 mmol), o-Tolylboronic acid (0.14 mmol), and Pd-SPhos-G2 (9 mg, 0.011 mmol) was evacuated and backfilled with nitrogen. Degassed dioxane (1.1 mL) and 1.0M Na2CO3 (0.46 mL) were added and mixture heated to 100° C. for two hours. After cooling to room temperature, the reaction was partition between EtOAc and water. The organics were dried over MgSO4 and concentrated.

Step w: The crude product from step v was dissolved in CH2Cl2 (1 mL) and TFA (0.2 mL) was added. After stirring at room temperature for 4 hours, the reaction was diluted with toluene and evaporate under reduced pressure. The product was reconstituted in DMSO and purified by reverse phase HPLC (gradient MeCN/H2O) to afford the desired product (39 mg, 71% yield) as a white solid after lyophilization. 1H NMR (400 MHz, Chloroform-d) δ 7.51 (d, J=8.6 Hz, 1H), 7.40 (dd, J=7.7, 2.2 Hz, 1H), 7.32-7.17 (m, 4H), 6.96 (d, J=7.9 Hz, 1H), 6.36 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.1, 3.7 Hz, 1H), 4.81 (d, J=85.0 Hz, 1H), 4.53 (s, 1H), 3.83 (ddd, J=21.6, 16.7, 10.0 Hz, 1H), 3.41 (t, J=16.7 Hz, 1H), 2.61-2.40 (m, 1H), 2.26-2.11 (m, 2H), 2.10 (s, 3H), 1.97-1.81 (m, 1H). ESI MS [M+H]+ for C27H21F4NO, calcd 452.2, found 452.3.

Example 145

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 7.85 (s, 1H), 7.53 (d, J=8.9 Hz, 1H), 7.41 (dt, J=7.6, 2.2 Hz, 1H), 7.06 (d, J=7.8 Hz, 1H), 6.44 (d, J=8.0 Hz, 1H), 5.62 (dt, J=50.0, 3.7 Hz, 1H), 5.28-5.12 (m, 1H), 4.54 (app. s, 1H), 3.98-3.76 (m, 1H), 3.71 (s, 3H), 3.60-3.40 (m, 1H), 2.59-2.41 (m, 1H), 2.34-1.93 (m, 2H), 1.86 (d, J=14.2 Hz, 1H). ESI MS [M+H]+ for C25H18F4N4O, calcd 467.1, found 467.3.

Example 146

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3): δ 7.83 (s, 1H), 7.53-7.48 (m, 1H), 7.41-7.36 (m, 1H), 7.06 (d, J=7.9 Hz, 1H), 6.46 (d, J=7.9 Hz, 1H), 5.60 (dt, J=50.0, 3.7 Hz, 1H), 4.83 (dd, J=11.9, 5.0 Hz, 1H), 4.56-4.49 (m, 1H), 3.93 (s, 3H), 3.91-3.78 (m, 1H), 3.42 (td, J=16.9, 2.6 Hz, 1H), 2.96 (dd, J=5.2, 1.9 Hz, 1H), 2.56-2.44 (m, 1H), 2.23-2.04 (m, 2H), 1.87-1.76 (m, 1H). ESI MS [M+H]+ for C23H18F4N4O, calcd 442.1, found 442.1.

Example 147

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 7.87 (s, 1H), 7.53 (d, J=7.6 Hz, 1H), 7.42-7.38 (m, 1H), 7.08 (d, J=8.0 Hz, 1H), 6.48 (d, J=7.9 Hz, 1H), 5.62 (dt, J=49.9, 3.7 Hz, 1H), 4.83 (d, J=11.7 Hz, 1H), 4.55 (s, 1H), 3.96 (s, 3H), 3.94-3.81 (m, 1H), 3.52-3.38 (m, 1H), 2.59-2.44 (m, 1H), 2.27-1.97 (m, 2H), 1.90-1.79 (m, 1H). ESI MS [M+H]+ for C23H18F4N4O, calcd 443.1, found 443.3.

Example 148

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 7.51 (d, J=6.7 Hz, 1H), 7.46 (s, 1H), 7.42 (d, J=8.2 Hz, 1H), 7.38 (dt, J=7.7, 2.3 Hz, 1H), 6.39 (d, J=8.1 Hz, 1H), 5.61 (dt, J=50.1, 3.7 Hz, 1H), 5.14 (d, J=12.8 Hz, 1H), 4.54-4.40 (m, 1H), 3.95-3.77 (m, 1H), 3.43 (t, J=17.3 Hz, 1H), 2.53 (s, 3H), 2.52-2.41 (m, 1H), 2.26-1.95 (m, 2H), 1.86-1.73 (m, 1H). ESI MS [M+H]+ for C24H18F4N2O2, calcd 443.1, found 443.2.

Example 149

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. H NMR (400 MHz, Chloroform-d) δ 8.38 (s, 1H), 7.51 (d, J=7.7 Hz, 1H), 7.44-7.36 (m, 1H), 7.12 (d, J=8.0 Hz, 1H), 6.78 (s, 1H), 6.38 (d, J=8.0 Hz, 1H), 5.61 (dt, J=49.9, 3.3 Hz, 1H), 5.10 (dd, J=11.0, 3.5 Hz, 1H), 4.80 (s, 2H), 4.58-4.50 (m, 1H), 3.96-3.79 (m, 1H), 3.54-3.39 (m, 1H), 2.55-2.43 (m, 1H), 2.23-1.98 (m, 2H), 1.84 (d, J=13.1 Hz, 1H). ESI MS [M+H]+ for C26H18F4N4O, calcd 479.1, found 479.3.

Example 150

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.89 (s, 1H), 7.77 (d, J=0.8 Hz, 1H), 7.50 (d, J=8.8 Hz, 1H), 7.37 (dt, J=7.4, 2.4 Hz, 1H), 7.23 (d, J=8.1 Hz, 1H), 6.33 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.2, 3.7 Hz, 1H), 4.93 (d, J=12.3 Hz, 1H), 4.50-4.45 (m, 1H), 3.96 (s, 3H), 3.93-3.78 (m, 1H), 3.43 (t, J=17.3 Hz, 1H), 2.53-2.41 (m, 1H), 2.20-1.99 (m, 2H), 1.81 (dd, J=13.9, 4.1 Hz, 1H). ESI MS [M+H]+ for C24H19F4N3O, calcd 442.2, found 442.3.

Example 151

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.91 (s, 1H), 7.51 (d, J=7.7 Hz, 1H), 7.39 (dt, J=7.7, 2.2 Hz, 1H), 7.23 (d, J=8.1 Hz, 1H), 6.39 (d, J=8.0 Hz, 1H), 5.60 (dt, J=50.0, 3.5 Hz, 1H), 5.33 (d, J=12.4 Hz, 1H), 4.56-4.48 (m, 1H), 3.95-3.76 (m, 1H), 3.42 (td, J=16.6, 4.1 Hz, 1H), 2.57-2.38 (m, 1H), 2.24-1.96 (m, 2H), 1.87-1.76 (m, 1H). ESI MS [M+H]+ for C24H18F64N2O2, calcd 443.4, found 443.2.

Example 152

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.51-7.48 (m, 1H), 7.40-7.39 (m, 1H), 7.35-7.34 (m, 1H), 6.96-6.92 (m, 1H), 6.40-6.36 (m, 1H), 5.59 (ddd, J=50.1, 3.7, 3.7 Hz, 1H), 5.39-5.22 (m, 1H), 5.08-4.97 (m, 1H), 4.62-4.60 (m, 1H), 3.61-3.60 (m, 3H), 3.59-3.46 (m, 1H), 3.24-3.04 (m, 1H), 2.51-2.42 (m, 1H), 2.19-1.99 (m, 3H), 1.89-1.78 (m, 5H). ESI MS [M+H]+ for C25H22F3N3O, calcd 438.2, found 438.1.

Example 153

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.01 (s, 1H), 7.51 (dt, J=8.2, 2.0 Hz, 1H), 7.46-7.29 (m, 2H), 7.03 (d, J=7.9 Hz, 1H), 6.76 (s, 1H), 6.42 (d, J=7.9 Hz, 1H), 5.61 (dt, J=50.0, 3.7 Hz, 1H), 4.91 (s, 1H), 4.49 (d, J=35.4 Hz, 2H), 3.85 (ddd, J=21.8, 16.6, 9.5 Hz, 1H), 3.48-3.29 (m, 1H), 2.49 (td, J=12.7, 5.6 Hz, 1H), 2.28-2.07 (m, 2H), 1.85 (dq, J=13.8, 3.9 Hz, 1H). ESI MS [M+H]+ for C25H19F4N3O calcd. 454.1, found 454.1.

Example 154

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.53-7.48 (m, 1H), 7.47 (s, 1H), 7.38 (dt, J=7.8, 2.3 Hz, 1H), 7.29 (d, J=8.0 Hz, 1H), 6.38 (d, J=8.0 Hz, 1H), 5.77-5.45 (m, 1H), 4.93 (d, J=15.8 Hz, 1H), 4.60-4.45 (m, 1H), 3.93 (ddd, J=25.9, 16.6, 9.2 Hz, 1H), 3.47 (t, J=17.5 Hz, 1H), 2.50 (ddt, J=17.7, 11.7, 5.2 Hz, 1H), 2.22 (s, 3H), 2.19-2.04 (m, 1H), 1.94-1.80 (m, 1H). ESI MS [M+H]+ for C24H19F4N3O calcd. 442.1, found 442.1.

Example 155

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.69-7.60 (m, 1H), 7.61-7.47 (m, 2H), 7.47-7.28 (m, 2H), 6.92 (t, J=7.1 Hz, 1H), 6.40 (d, J=7.9 Hz, 1H), 5.72-5.52 (m, 1H), 4.73 (ddd, J=68.1, 11.7, 6.0 Hz, 1H), 4.52 (s, 1H), 3.83 (td, J=19.2, 17.8, 9.7 Hz, 1H), 3.42 (t, J=17.1 Hz, 1H), 2.59-2.43 (m, 1H), 2.30 (s, 3H), 2.28-2.04 (m, 3H), 1.93-1.79 (m, 1H). ESI MS [M+NH4]+ for C28H20F4N2O calcd. 494.2, found 494.2.

Example 156

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.67-8.62 (m, 2H), 7.66-7.49 (m, 2H), 7.24-7.14 (m, 3H), 6.61 (d, J=8.0 Hz, 1H), 4.95 (d, J=11.0 Hz, 1H), 4.47 (dd, J=6.1, 3.2 Hz, 1H), 3.89 (ddd, J=24.5, 16.6, 8.9 Hz, 1H), 3.40 (t, J=16.9 Hz, 1H), 3.11-2.81 (m, 2H), 2.16 (dddd, J=13.4, 10.7, 6.1, 4.0 Hz, 1H), 1.97-1.73 (m, 2H). ESI MS [M+OH]+ for C25H18F4N2O calcd. 420.1, found 420.1.

Example 157

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.56-7.47 (m, 2H), 7.40 (ddd, J=7.6, 2.7, 1.7 Hz, 1H), 7.04 (d, J=7.9 Hz, 1H), 6.43-6.35 (m, 2H), 5.61 (dt, J=50.1, 3.7 Hz, 1H), 5.38 (dt, J=5.8, 4.6 Hz, OH), 5.24 (dt, J=5.8, 4.5 Hz, OH), 5.11 (dd, J=10.0, 4.7 Hz, 1H), 4.66-4.59 (m, 1H), 3.76 (s, 3H), 3.65-3.49 (m, 1H), 3.20 (ddd, J=18.8, 16.4, 6.0 Hz, 1H), 2.48 (tdd, J=12.5, 5.8, 3.3 Hz, 1H), 2.26 (s, 1H), 2.20-1.98 (m, 2H), 1.87-1.76 (m, 1H). ESI MS [M+H]+ for C24H20F3N3O calcd. 424.2, found 424.1.

Example 158

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 14. BFI NMR (400 MHz, Chloroform-d) δ 8.85 (s, 1H), 8.33 (s, 1H), 7.57-7.48 (m, 1H), 7.43-7.35 (m, 1H), 7.28 (s, 1H), 6.39 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.0, 3.6 Hz, 1H), 5.01 (dd, J=11.7, 4.4 Hz, 1H), 4.58-4.47 (m, 1H), 3.91 (ddd, J=25.2, 16.7, 8.6 Hz, 1H), 3.44 (t, J=17.1 Hz, 1H), 3.31 (s, 1H), 2.50 (ddd, J=18.7, 13.3, 4.4 Hz, 1H), 2.25-1.96 (m, 2H), 1.87-1.74 (m, 1H), 0.96-0.77 (m, 1H). ESI MS [M+H]+ for C23H16F4N2O5 calcd. 445.1, found 445.1.

Example 159

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.39 (dd, J=4.9, 1.8 Hz, 1H), 7.57 (br s, 1H) 7.51 (ddd, J=8.4, 2.8, 1.3 Hz, 1H), 7.40 (dt, J=7.7, 2.3 Hz, 1H), 7.15 (ddd, J=7.7, 4.9, 0.7 Hz, 1H), 6.95 (d, J=7.8 Hz, 1H), 6.38 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.1, 3.7 Hz, 1H), 4.80 (s, 1H), 4.62-4.43 (m, 1H), 3.84 (ddd, J=20.8, 16.8, 10.1 Hz, 1H), 3.41 (td, J=16.6, 4.0 Hz, 1H), 2.63-2.39 (m, 1H), 2.25 (s, 3H), 2.22-2.01 (m, 1H), 1.96-1.62 (m, 2H). ESI MS [M+H]+ for C26H20F4N2O calcd. 452.2, found 452.2.

Example 160

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.89 (s, 1H), 8.61 (s, 1H) 7.99 (d, J=8.0 Hz, 1H), 7.58-7.47 (m, 1H), 7.39 (dt, J=7.2, 2.2 Hz, 2H), 7.16 (d, J=8.0 Hz, 1H), 6.43 (d, J=8.0 Hz, 1H), 5.63 (dt, J=50.2, 3.6 Hz, 1H), 4.93 (d, J=10.9 Hz, 1H), 4.56 (s, 1H), 3.93 (ddd, J=24.4, 16.5, 8.7 Hz, 1H), 3.57 (s, 1H), 3.43 (t, J=16.7 Hz, 1H), 2.58-2.43 (m, 1H), 2.28-2.02 (m, 1H), 1.92-1.76 (m, 1H). ESI MS [M+H]+ for C25H18F4N2O calcd. 439.1, found 439.1.

Example 161

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, DMSO-d6): δ 11.76 (bs, 1H), 7.95 (dd, J=8.2, 2.3 Hz, 1H), 7.84 (d, J=8.7 Hz, 1H), 7.35 (d, J=9.3 Hz, 1H), 6.94 (d, J=7.9 Hz, 1H), 6.33 (d, J=7.9 Hz, 1H), 6.17 (d, J=9.3 Hz, 1H), 5.77 (d, J=49.7 Hz, 1H), 4.82 (d, J=12.0 Hz, 1H), 4.59 (s, 1H), 3.73-3.32 (m, 2H), 2.31 (d, J=11.3 Hz, 1H), 2.16-1.77 (m, 5H), 1.68 (d, J=13.8 Hz, 1H).

Example 162

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, DMSO-d6): δ 7.97 (dt, J=8.3, 2.3 Hz, 1H), 7.93-7.84 (m, 2H), 7.73 (td, J=7.7, 1.3 Hz, 1H), 7.67-7.62 (m, 1H), 7.55 (td, J=7.6, 1.2 Hz, 1H), 7.15 (d, J=7.9 Hz, 1H), 6.43 (d, J=7.9 Hz, 1H), 6.00 (d, J=6.9 Hz, 1H), 5.79 (d, J=49.7 Hz, 1H), 5.16 (dt, J=12.4, 6.5 Hz, 1H), 4.65 (s, 1H), 3.64 (tq, J=29.8, 15.5, 14.6 Hz, 2H), 2.32 (dd, J=16.9, 6.1 Hz, 1H), 2.15-1.79 (m, 2H), 1.74 (d, J=13.8 Hz, 1H).

Example 163

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.95 (d, J=7.9 Hz, 1H), 8.74 (t, J=6.0 Hz, 1H), 7.56-7.38 (m, 3H), 7.15 (d, J=8.0 Hz, 1H), 6.82 (s, br., 1H), 6.44 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.0, 3.5 Hz, 1H), 5.18 (dd, J=10.8, 6.1 Hz, 1H), 4.59-4.52 (m, 1H), 3.82 (ddd, J=16.9, 14.0, 11.1 Hz, 1H), 3.43 (m, 1H), 2.51 (tdd, J=13.4, 6.2, 3.1 Hz, 1H), 2.21-1.95 (m, 2H), 1.86-1.77 (m, 1H). ESI MS [M+H]+ for C25H18F5N2O, calcd 457.1, found 457.0.

Example 164

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.40 (s, 1H), 7.55-7.47 (m, 1H), 7.39 (dt, J=7.6, 2.1 Hz, 1H), 7.22 (t, J=7.8 Hz, 1H), 7.06 (d, J=8.0 Hz, 1H), 7.01 (d, J=7.6 Hz, 1H), 6.79 (d, J=7.7 Hz, 1H), 6.36 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.0, 3.7 Hz, 1H), 4.91 (dd, J=11.5, 6.4 Hz, 1H), 4.55-4.48 (m, 1H), 3.83 (ddd, J=21.3, 16.7, 10.0 Hz, 1H), 3.48-3.34 (m, 2H), 3.26 (d, J=22.8 Hz, 1H), 3.11 (d, J=6.5 Hz, 1H), 2.56-2.42 (m, 1H), 2.21-2.04 (m, 2H), 1.90-1.81 (m, 1H). ESI MS [M+H]+ for C28H21F4N2O2, calcd 493.2, found 493.0.

Example 165

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.55-7.47 (m, 1H), 7.32-7.42 (m, 3H), 7.30-7.18 (m, 2H), 6.88 (d, J=7.8 Hz, 1H), 6.33 (d, J=7.8 Hz, 1H), 5.62 (dt, J=50.0, 4.0 Hz, 1H), 4.75 (dd, J=11.9, 1.8 Hz, 1H), 4.51 (m, 1H), 3.83 (ddd, J=22.8, 16.4, 9.1 Hz, 1H), 3.62 (d, J=12.2 Hz, 1H), 3.49 (d, J=12.2 Hz, 1H), 3.38 (td, J=16.3, 3.1 Hz, 1H), 2.51 (td, J=14.4, 13.8, 7.5 Hz, 1H), 2.26-2.04 (m, 2H), 2.01 (s, 2H), 1.90 (dq, J=13.1, 4.0 Hz, 1H). ESI MS [M+H]+ for C27H23F4N2O, calcd 467.2, found 467.0.

Example 166

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d, appearing as ˜2:1 rotamers) δ 8.14-7.27 (m, 3H), 6.99 (d, J=8.0 Hz, 1H), 6.40 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.0, 3.7 Hz, 1H), 4.95-4.85 (m, 1H), 4.82 (d, J=11.6 Hz, 1H), 4.51 (m, 1H), 4.05-3.14 (m, 5H), 2.98-1.68 (m, 7H). ESI MS [M+H]+ for C25H22F4N3O, calcd 456.2, found 456.1.

Example 167

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.71 (s, 1H), 7.51 (dt, J=8.5, 2.0 Hz, 1H), 7.40 (dt, J=7.6, 2.2 Hz, 1H), 7.09 (d, J=7.9 Hz, 1H), 6.37 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.0, 3.6 Hz, 1H), 5.02-4.92 (m, 1H), 4.56-4.49 (m, 1H), 3.84 (ddd, J=21.0, 16.8, 10.2 Hz, 1H), 3.42 (td, J=16.7, 3.8 Hz, 1H), 2.87 (dd, J=6.4, 1.6 Hz, 1H), 2.50 (tq, J=13.2, 5.4, 4.5 Hz, 1H), 2.33 (s, 3H), 2.25-2.02 (m, 2H), 2.00 (s, 3H), 1.89-1.80 (m, 1H). ESI MS [M+H]+ for C24H19F4N2OS, calcd 459.1, found 459.0.

Example 168

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, DMSO-d6) δ 8.02 (s, 1H), 7.95 (d, J=7.7 Hz, 1H), 7.85 (d, J=9.0 Hz, 1H), 6.96 (d, J=7.9 Hz, 1H), 6.54 (s, 2H), 6.36 (d, J=7.9 Hz, 1H), 5.98 (d, J=6.5 Hz, 1H), 5.87-5.63 (m, 1H), 4.85-4.75 (m, 1H), 4.63-4.57 (m, 1H), 3.62 (td, J=17.3, 11.7 Hz, 1H), 3.47 (td, J=16.6, 8.3 Hz, 1H), 2.34-2.25 (m, 1H), 2.10-1.80 (m, 5H), 1.75-1.66 (m, 1H). ESI MS [M+H]+ for C25H21F4N4O, calcd 469.2, found 469.3.

Example 169

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.55-7.48 (m, 1H), 7.39 (dt, J=7.8, 2.2 Hz, 1H), 7.07 (d, J=8.0 Hz, 1H), 6.41 (d, J=8.0 Hz, 1H), 6.25 (s, 1H), 5.73-5.51 (m, 1H), 4.93 (d, J=11.6 Hz, 1H), 4.58-4.48 (m, 2H), 3.86 (ddd, J=22.8, 16.9, 9.8 Hz, 1H), 3.67 (s, 3H), 3.49-3.35 (m, 1H), 2.57-2.43 (m, 1H), 2.30 (s, 3H), 2.23-2.03 (m, 2H), 1.90-1.78 (m, 1H). ESI MS [M+H]+ for C25H22F4N3O3, calcd 456.2, found 456.3.

Example 170

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144 and isolated as a 2:1 mixture of rotational isomers. 1H NMR (400 MHz, Chloroform-d) δ 7.56-7.49 (m, 1H), 7.44-7.39 (m, 1H), 7.37 (s, 1H), 7.04-6.96 (m, 1H), 6.50-6.40 (m, 1H), 5.63 (dt, J=49.9, 3.5 Hz, 1H), 4.85-4.76 (m, 1H), 4.56-4.50 (m, 1H), 3.93-3.74 (m, 1H), 3.60 (s, 3H), 3.51-3.32 (m, 1H), 2.59-2.44 (m, 1H), 2.26-2.02 (m, 2H), 1.96-1.83 (m, 4H). ESI MS [M+H]+ for C25H22F4N3O3, calcd 456.2, found 456.3.

Example 171

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144 and isolated as a 3:2 mixture of rotational isomers. 1H NMR (400 MHz, Chloroform-d) δ 7.57-7.48 (m, 1H), 7.44-7.37 (m, 1H), 7.38-7.30 (m, 1H), 7.05 (d, J=7.9 Hz, 0.4H), 7.01 (d, J=8.0 Hz, 0.6H), 6.61 (d, J=9.1 Hz, 1H), 6.49-6.39 (m, 1H), 6.26 (dd, J=6.9, 1.2 Hz, 0.4H), 6.05 (dd, J=6.7, 1.2 Hz, 0.6H), 5.71-5.53 (m, 1H), 5.05 (d, J=12.9 Hz, 0.6H), 4.93-4.83 (m, 0.4H), 4.58-4.48 (m, 1H), 3.94-3.74 (m, 1H), 3.54-3.33 (m, 1H), 3.27 (s, 1H), 3.23 (s, 2H), 2.61-2.44 (m, 1.5H), 2.27-1.96 (m, 1.5H), 1.92-1.78 (m, 1H). ESI MS [M+H]+ for C26H21F4N2O2, calcd 469.2, found 469.3.

Example 173

[Figure (not displayed)]

Step a: (3-bromopyridin-2-yl)methanol (500 mg, 2.66 mmol) was dissolved in CH2Cl2 (13.3 ml). The solution was cooled to 0° C., and (Diethylamino)sulfur trifluoride (414 ul, 472 mg, 1.1 equiv.) was added dropwise. The solution was allowed to warm to room temperature. Upon completion, the reaction was quenched with saturated NaHCO3, extracted with methylene chloride, dried over Na2SO4, and concentrated. The crude residue was purified by flash column chromatography (SiO2, 0% to 20% ethyl acetate in hexanes) to provide 3-bromo-2-(fluoromethyl)pyridine as a clear oil (196 mg, 39% yield).

Step b: 3-bromo-2-(fluoromethyl)pyridine (196 mg, 1 mmol) was combined with Pd(dppf)Cl2 (73.2 mg, 0.1 mmol), KOAc (216 mg, 2.2 mmol) and B2Pin2 (330 mg, 1.3 mmol) in dioxane (5 ml). The resulting solution was heated to 100° C. Upon completion, the reaction was cooled, filtered over celite, and concentrated to a crude residue which was taken on without further purification.

Step c: The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.68 (dd, J=4.7, 1.6 Hz, 1H), 7.90-7.50 (br. m, 1H), 7.52-7.48 (m, 1H), 7.40-7.36 (m, 2H), 7.84 (d, J=7.9 Hz, 1H), 5.68-5.54 (m, 1H), 5.29 (br s, 1H), 5.16 (br s, 1H) 4.76 (br s, 1H), 4.53-4.51 (m, 1H), 3.90-3.78 (m, 1H), 3.46-3.36 (m, 1H), 2.55-2.45 (m, 1H), 2.23-2.05 (m, 3H), 1.88-1.81 (m, 1H), ESI MS [M+H]+ for C26H19F5N2O, calcd 471.1, found 471.1.

Example 174

[Figure (not displayed)]

Step a: A flask was charged with (5S,8R)-8-[(1S)-7-chloro-2,2-difluoro-1-(methoxymethoxy)-1,3-dihydroinden-4-yl]-3,5-difluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (489 mg, 1.11 mmol, 1.0 equiv.), B2Pin2 (846 mg, 3.33 mmol, 3.0 equiv.), K3PO4 (707 mg, 3.33 mmol, 3.0 equiv.), XPhos Pd G3 (51 mg, 0.06 mmol, 0.05 equiv.), and 1,4-dioxane (11 mL, 0.1 M). The reaction mixture was sparged with N2 for 10 minutes, heated to 90° C., and stirred under N2 overnight. The reaction was quenched with water and extracted with EtOAc (2×50 mL). The combined organics were washed with brine (50 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by column chromatography (silica gel, 0→40% EtOAc in hexanes) to afford the product (374 mg, 63% yield).

Step b: A flask was charged with (5S,8R)-8-[(1S)-2,2-difluoro-1-(methoxymethoxy)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-dihydroinden-4-yl]-3,5-difluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (45 mg, 0.08 mmol, 1.0 equiv.), 5-bromo-1-methyl-1,2,4-triazole (17 mg, 0.10 mmol, 1.2 equiv.), and XPhos Pd G3 (7 mg, 0.008 mmol, 0.1 equiv.). The reagents were dissolved in 1,4-dioxane (0.8 mL, 0.1 M) and 1M Na2CO3 in H2O (0.32 mL, 0.32 mmol, 4.0 equiv) was added. The reaction mixture was sparged with N2 for 10 minutes, heated to 100° C., and stirred under N2 for 1 hour. The reaction was quenched into saturated aqueous NaCl and extracted with EtOAc (3×10 mL). The combined organics were dried over MgSO4, filtered, and concentrated in vacuo. The crude residue was moved directly into step c without further purification.

Step c: The crude residue from step b (0.08 mmol) was dissolved in DCM (1.0 mL). TFA (0.2 mL) was added and the reaction mixture was stirred for 16 hours at 20° C. The reaction mixture was azeotroped with PhMe and the crude residue was dissolved in DCM, filtered over celite, and concentrated in vacuo. The crude residue was purified by prep-HPLC (40-100% MeCN in water) to afford the product was a white solid (8 mg, 23% yield over 2 steps). 1H NMR (400 MHz, Chloroform-d) δ 7.97 (s, 1H), 7.52 (d, J=7.4 Hz, 1H), 7.40 (dt, J=7.6, 2.2 Hz, 1H), 7.28 (d, J=8.4 Hz, 1H), 6.49 (d, J=8.0 Hz, 1H), 5.60 (dt, J=50.0, 3.6 Hz, 1H), 4.94 (d, J=16.4 Hz, 1H), 4.62-4.54 (m, 1H), 4.03 (s, 3H), 3.98-3.80 (m, 1H), 3.42 (t, J=17.3 Hz, 1H), 2.58-2.45 (m, 1H), 2.28-1.92 (m, 2H), 1.90-1.81 (m, 1H). ESI MS [M+H]+ for C23H18F4N40, calcd 443.1, found 443.3.

Example 175

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.75 (s, 1H), 7.52-7.48 (m, 1H), 7.40-7.37 (m, 1H), 7.01 (d, J=7.9 Hz, 1H), 6.41 (d, J=7/9 Hz, 1H), 5.59 (ddd, J=50.0, 3.7, 3.7 Hz, 1H), 5.30 (ddd, J=52.6, 8.8, 4.5 Hz, 1H), 5.05 (ddd, J=10.3, 7.2, 4.7 Hz, 1H), 4.62-4.60 (m, 1H), 3.94 (s, 3H), 3.57 (ddd, J=20.4, 16.5, 4.3 Hz, 1H), 3.20 (ddd, J=19.7, 16.5, 5.8 Hz, 1H), 2.53-2.40 (m, 2H), 2.20-1.95 (m, 2H), 1.82-1.75 (m, 1H). ESI MS [M+H]+ for C25H19F3N4O, calcd 425.2, found 425.1.

Example 176

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.53 (d, J=2.5 Hz, 1H), 8.44 (d, J=2.2 Hz, 1H), 7.51 (d, J=7.9 Hz, 1H), 7.39 (dt, J=7.6, 2.2 Hz, 1H), 7.24 (d, J=8.2 Hz, 1H), 6.40 (d, J=8.0 Hz, 1H), 5.62 (dt, J=50.1, 3.5 Hz, 1H), 4.81 (d, J=14.3 Hz, 1H), 4.63-4.53 (m, 1H), 4.05-3.83 (m, 1H), 3.45 (t, J=17.1 Hz, 1H), 2.66 (s, 3H), 2.59-2.46 (m, 1H), 2.30-1.99 (m, 2H), 1.94-1.83 (m, 1H). ESI MS [M+H]+ for C25H19F4N3O, calcd 454.2, found 454.3.

Example 177

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.57 (s, 1H), 8.18 (s, 1H), 7.53 (d, J=6.1 Hz, 1H), 7.40 (dt, J=7.3, 2.2 Hz, 1H), 7.07 (d, J=7.8 Hz, 1H), 6.48 (d, J=7.9 Hz, 1H), 5.74-5.51 (m, 1H), 5.04-4.85 (m, 3H), 4.53 (s, 1H), 3.96-3.78 (m, 1H), 3.43 (t, J=17.4 Hz, 1H), 2.56-2.45 (m, 1H), 2.32-2.00 (m, 2H), 1.91-1.79 (m, 1H). ESI MS [M+H]+ for C24H18F4N4O, calcd 455.1, found 455.2.

Example 178

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 8.62 (s, 1H), 8.47 (s, 1H), 8.01 (d, J=8.2 Hz, 1H), 7.91 (d, J=8.5 Hz, 1H), 7.09 (d, J=7.9 Hz, 1H), 6.40 (d, J=7.9 Hz, 1H), 6.13 (s, 2H), 5.97 (d, J=7.1 Hz, 1H), 5.81 (d, J=49.5 Hz, 1H), 5.18-5.03 (m, 1H), 4.68 (s, 1H), 3.79-3.48 (m, 2H), 2.40-2.28 (m, 1H), 2.17-1.85 (m, 2H), 1.73 (d, J=13.7 Hz, 1H). ESI MS [M+H]+ for C24H18F4N4O, calcd 455.1, found 455.3.

Example 179

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.83 (s, 1H), 7.50 (d, J=8.6 Hz, 1H), 7.38 (dt, J=7.6, 2.3 Hz, 1H), 7.14 (d, J=8.1 Hz, 1H), 6.32 (d, J=8.0 Hz, 1H), 4.79 (d, J=14.8 Hz, 1H), 4.68 (s, 2H), 4.60-4.52 (m, 1H), 4.00-3.84 (m, 1H), 3.43 (t, J=17.3 Hz, 1H), 2.54-2.43 (m, 1H), 2.47 (s, 3H), 2.24-2.00 (m, 2H), 1.87 (d, J=13.7 Hz, 1H). ESI MS [M+H]+ for C25H20F4N4O, calcd 469.2, found 469.3.

Example 180

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.25 (s, 1H), 7.52 (d, J=7.6 Hz, 1H), 7.39 (dt, J=7.6, 2.2 Hz, 1H), 7.29 (d, J=8.1 Hz, 1H), 7.13 (s, 1H), 6.42 (d, J=8.0 Hz, 1H), 5.72-5.49 (m, 2H), 5.04 (d, J=11.8 Hz, 1H), 4.56-4.47 (m, 1H), 3.91 (ddd, J=24.9, 16.8, 8.8 Hz, 1H), 3.47 (t, J=17.1 Hz, 1H), 2.51 (td, J=15.0, 13.1, 4.3 Hz, 1H), 2.25-1.98 (m, 2H), 1.88-1.74 (m, 1H). ESI MS [M+H]+ for C24H17F4N3O2S, calcd 488.1, found 488.2.

Example 181

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.72 (s, 1H), 8.46 (s, 1H), 7.56-7.47 (m, 2H), 7.40 (d, J=7.4 Hz, 1H), 6.50 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.0, 3.0 Hz, 1H), 4.98 (d, J=13.9 Hz, 1H), 4.62-4.53 (m, 1H), 3.98-3.81 (m, 1H), 3.41 (t, J=17.0 Hz, 1H), 2.58-2.46 (m, 1H), 2.25-1.96 (m, 2H), 1.84 (d, J=15.5 Hz, 1H). ESI MS [M+H]+ for C24H18F4N40, calcd 455.1, found 455.3.

Example 182

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.11 (s, 1H), 7.81 (d, J=8.1 Hz, 1H), 7.51 (d, J=9.0 Hz, 1H), 7.38 (dt, J=7.6, 2.3 Hz, 1H), 6.36 (d, J=8.1 Hz, 1H), 5.60 (dt, J=50.0, 3.5 Hz, 1H), 5.31 (d, J=17.4 Hz, 1H), 4.60-4.49 (m, 1H), 4.00 (s, 3H), 3.94-3.80 (m, 1H), 3.45 (td, J=17.1, 4.1 Hz, 1H), 2.54-2.41 (m, 1H), 2.23-1.91 (m, 2H), 1.87-1.76 (m, 1H). ESI MS [M+H]+ for C23H18F4N4O, calcd 443.1, found 443.3.

Example 184

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.72 (dd, J=4.7, 1.6 Hz, 1H), 8.07 (dd, J=8.0, 1.6 Hz, 1H), 7.58 (dd, J=8.0, 4.7 Hz, 1H), 7.55-7.50 (m, 1H), 7.40 (ddd, J=7.5, 2.7, 1.7 Hz, 1H), 7.20 (d, J=7.8 Hz, 1H), 6.44 (d, J=8.0 Hz, 1H), 5.62 (dt, J=50.0, 3.5 Hz, 1H), 5.06 (d, J=10.9 Hz, 1H), 4.55 (t, J=3.9 Hz, 1H), 3.99-3.76 (m, 1H), 3.49 (td, J=16.1, 7.7 Hz, 1H), 2.59-2.42 (m, 2H), 2.25-2.11 (m, 2H), 1.94-1.76 (m, 1H). ESI MS [M+H]+ for C26H17F4N3O calcd. 464.1, found 464.1.

Example 185

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 8.01-7.91 (m, 1H), 7.85 (d, J=9.1 Hz, 1H), 7.26 (d, J=7.4 Hz, 1H), 6.98 (d, J=7.9 Hz, 1H), 6.47 (d, J=7.5 Hz, 1H), 6.35 (d, J=7.9 Hz, 1H), 5.93 (d, J=6.3 Hz, 1H), 5.78 (d, J=49.7 Hz, 1H), 5.25 (s, 2H), 4.89 (s, 1H), 4.60 (s, 1H), 3.72-3.53 (m, 1H), 3.52-3.38 (m, 1H), 2.32 (q, J=1.9 Hz, 1H), 2.27 (s, 3H), 2.06 (d, J=15.3 Hz, 1H), 1.70 (d, J=13.7 Hz, 1H). ESI MS [M+H]+ for C26H21F4N3O calcd. 468.2, found 468.2.

Example 186

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.04 (d, J=2.7 Hz, 1H), 7.98 (d, J=2.7 Hz, 1H), 7.56-7.49 (m, 2H), 7.39 (ddd, J=7.5, 2.8, 1.7 Hz, 1H), 6.43 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.1, 3.6 Hz, 1H), 5.24 (s, 1H), 4.93-4.80 (m, 3H), 4.61-4.53 (m, 1H), 4.00-3.79 (m, 1H), 3.40 (t, J=17.2 Hz, 1H), 2.51 (ddq, J=16.5, 9.4, 3.5 Hz, 1H), 2.26-2.06 (m, 2H), 1.91-1.79 (m, 1H), 1.63 (s, 1H). ESI MS [M+H]+ for C24H18F4N4O calcd. 455.1, found 455.1.

Example 187

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J=0.9 Hz, 1H), 7.76 (dd, J=8.0, 1.0 Hz, 1H), 7.52 (ddd, J=8.4, 2.9, 1.2 Hz, 1H), 7.39 (ddd, J=7.6, 2.8, 1.7 Hz, 1H), 7.34 (dd, J=7.1, 1.0 Hz, 1H), 7.22 (dt, J=8.0, 3.6 Hz, 2H), 6.48 (d, J=8.0 Hz, 1H), 5.64 (dt, J=50.1, 3.5 Hz, 1H), 4.89 (d, J=9.3 Hz, 1H), 4.71-4.44 (m, 1H), 4.08-3.94 (m, 1H), 3.41 (t, J=16.6 Hz, 1H), 2.52 (td, J=14.7, 14.1, 6.2 Hz, 1H), 2.28-2.08 (m, 2H), 1.95-1.75 (m, 1H). ESI MS [M+H]+ for C27H20F4N30, calcd 478.2, found 478.0.

Example 188

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.70 (s, 1H), 7.51 (d, J=7.2 Hz, 1H), 7.38 (d, J=7.2 Hz, 1H), 7.05 (d, J=8.0 Hz, 1H), 6.38 (d, J=8.0 Hz, 1H), 5.59 (d, J=49.9 Hz, 1H), 4.98 (d, J=11.7 Hz, 1H), 4.48 (s, 1H), 3.89-3.69 (m, 1H), 3.48-3.32 (m, 1H), 2.46 (m, 1H), 2.18 (s, 3H), 2.12-1.90 (m, 2H), 1.77 (s, 1H). ESI MS [M+H]+ for C24H20F4N3OS, calcd 474.1, found 474.0.

Example 189

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.92 (d, J=0.4 Hz, 1H), 8.08 (dd, J=8.1, 1.2 Hz, 1H), 7.64 (ddd, J=7.4, 1.2, 0.5 Hz, 1H), 7.57 (dd, J=8.0, 7.4 Hz, 1H), 7.52 (ddd, J=8.4, 2.8, 1.3 Hz, 1H), 7.41 (ddd, J=7.6, 2.7, 1.7 Hz, 1H), 7.31 (d, J=8.0 Hz, 1H), 6.43 (d, J=7.9 Hz, 1H), 5.63 (dt, J=50.1, 3.6 Hz, 1H), 4.98 (dd, J=11.1, 1.4 Hz, 1H), 4.68-4.29 (m, 1H), 4.00-3.74 (m, 1H), 3.40 (td, J=16.4, 3.0 Hz, 1H), 2.56-2.39 (m, 1H), 2.28-2.00 (m, 2H), 1.95-1.77 (m, 1H). ESI MS [M+H]+ for C27H19F4N2OS, calcd 495.1, found 495.0.

Example 190

[Figure (not displayed)]

The title compound was prepared in a similar fashion to example 174. 1H NMR (400 MHz, CDCl3) δ 9.19 (s, 1H), 8.02 (dd, J=8.0, 1.2 Hz, 1H), 7.57 (t, J=7.7 Hz, 1H), 7.54-7.47 (m, 2H), 7.39 (ddd, J=7.6, 2.7, 1.7 Hz, 1H), 7.14 (d, J=8.0 Hz, 1H), 6.44 (d, J=7.9 Hz, 1H), 5.62 (dt, J=49.6, 3.5 Hz, 1H), 5.13-4.69 (m, 1H), 4.59 (dd, J=6.0, 2.9 Hz, 1H), 4.01-3.78 (m, 1H), 3.41 (td, J=16.4, 3.0 Hz, 1H), 2.57-2.36 (m, 1H), 2.21-2.04 (m, 2H), 1.93-1.75 (m, 1H). ESI MS [M+H]+ for C27H19F4N2OS, calcd 495.1, found 495.0.

Example 191

[Figure (not displayed)]

Step a: The reaction was performed in a similar fashion to step b of Example 174. The crude product was purified by flash column chromatography (SiO2, 0 to 100% EtOAc/hexanes) to yield the product as a yellow solid (28 mg, 0.051 mmol, 51%).

Step b: The reaction was performed in a similar fashion to step c of Example 174. The crude product was carried forward without further purification (20 mg).

Step c: To a 40-mL scintillation vial containing the product from step b (20 mg, 0.40 mmol, 1.0 equiv.) dissolved in THE (1 mL) was added sodium borohydride (15.1 mg, 0.40 mmol, 10.0 equiv.) in one portion. The resulting mixture was kept stirring at 23° C. for 2 h when TLC showed the reaction was complete. The reaction mixture was then quenched with sat. aq. brine solution (4 mL), and then extracted with EtOAc (5 mL×3). The organic layers were combined and dried over Na2SO4. Concentration under reduced pressure and purification by HPLC afforded a white solid (5 mg, 0.009 mmol, 23%). 1H NMR (400 MHz, CDCl3) δ 9.09 (s, 1H), 7.56-7.49 (m, 1H), 7.43-7.37 (m, 1H), 7.18 (d, J=8.1, 1H), 6.45 (d, J=8.0 Hz, 1H), 5.83-5.42 (m, 1H), 5.00-4.86 (m, 1H), 4.69 (d, J=13.2 Hz, 1H), 4.58 (d, J=13.3 Hz, 1H), 4.53 (dd, J=5.7, 2.6 Hz, 1H), 3.94-3.78 (m, 1H), 3.40 (td, J=16.4, 4.9 Hz, 1H), 2.56-2.41 (m, 1H), 2.26-1.97 (m, 2H), 1.87-1.74 (m, 1H). ESI MS [M+H]+ for C24H19F4N2O2S, calcd 475.1, found 475.0.

Example 192

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.68 (s, 1H), 7.50 (dt, J=8.4, 2.2 Hz, 1H), 7.42-7.32 (m, 1H), 7.17 (d, J=7.9 Hz, 1H), 6.36 (d, J=8.0 Hz, 1H), 5.60 (dt, J=50.1, 3.5 Hz, 1H), 4.84 (d, J=16.0 Hz, 1H), 4.60-4.41 (m, 1H), 3.90 (ddd, J=26.1, 16.6, 8.7 Hz, 1H), 3.42 (t, J=17.4 Hz, 1H), 2.58 (s, 3H), 2.54-2.36 (m, 1H), 2.17-1.97 (m, 2H), 1.93-1.78 (m, 1H). ESI MS [M+H]+ for C24H19F4N2OS, calcd 459.1, found 459.0.

Example 193

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 7.51 (dt, J=8.4, 2.0 Hz, 1H), 7.39 (ddd, J=7.6, 2.7, 1.7 Hz, 1H), 7.06 (d, J=8.0 Hz, 1H), 6.35 (d, J=8.0 Hz, 1H), 5.60 (dt, J=50.1, 3.6 Hz, 1H), 5.04-4.98 (m, 1H), 4.57-4.44 (m, 1H), 3.93-3.73 (m, 1H), 3.41 (td, J=16.7, 4.0 Hz, 1H), 2.66 (s, 3H), 2.49 (ddd, J=18.5, 11.3, 4.2 Hz, 1H), 2.23 (s, 3H), 2.20-2.06 (m, 2H), 1.89-1.75 (m, 1H). ESI MS [M+H]+ for C25H20F4N2OS, calcd 473.1, found 473.0.

Example 194

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.55-7.48 (m, 1H), 7.38 (dt, J=7.6, 2.1 Hz, 1H), 7.18-6.91 (m, 2H), 6.63 (t, J=7.4 Hz, 1H), 6.56 (d, J=9.1 Hz, 1H), 6.41 (d, J=7.7 Hz, 1H), 5.62 (dt, J=50.0, 3.7 Hz, 1H), 4.72 (d, J=12.4 Hz, 1H), 4.56-4.50 (m, 1H), 4.06-3.75 (m, 1H), 3.39 (t, J=16.8 Hz, 1H), 2.57-2.43 (m, 1H), 2.25-2.07 (m, 2H), 1.93-1.81 (m, 1H). ESI MS [M+H]+ for C26H20F5N2O, calcd 471.1, found 471.3.

Example 195

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.54-7.47 (m, 1H), 7.38 (dt, J=7.6, 2.2 Hz, 1H), 6.96 (d, J=7.8 Hz, 2H), 6.78 (d, J=7.5 Hz, 1H), 6.69 (s, 1H), 6.38 (d, J=7.8 Hz, 1H), 5.61 (dt, J=50.0, 3.7 Hz, 1H), 4.69 (d, J=12.7 Hz, 1H), 4.56-4.51 (m, 1H), 3.88 (ddd, J=25.1, 16.1, 7.8 Hz, 1H), 3.38 (t, J=16.6 Hz, 1H), 2.56-2.42 (m, 1H), 2.33 (s, 3H), 2.22-2.01 (m, 2H), 1.91-1.81 (m, 1H). ESI MS [M+H]+ for C27H23F4N20, calcd 467.2, found 467.3.

Example 196

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.55-7.48 (m, 1H), 7.42-7.34 (m, 1H), 7.23-7.14 (m, 1H), 7.03 (d, J=7.9 Hz, 1H), 6.71-6.59 (m, 2H), 6.41 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.2, 3.7 Hz, 1H), 4.84-4.76 (m, 1H), 4.55-4.50 (m, 1H), 3.88 (ddd, J=22.4, 16.5, 9.0 Hz, 1H), 3.61 (bs, 2H), 3.44 (td, J=16.4, 3.1 Hz, 1H), 2.58-2.43 (m, 1H), 2.24-2.11 (m, 2H), 1.95-1.83 (m, 1H). ESI MS [M+H]+ for C26H20F5N2O, calcd 471.1, found 471.3.

Example 197

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.56-7.49 (m, 1H), 7.39 (dt, J=7.3, 2.2 Hz, 1H), 7.24-7.12 (m, 2H), 7.10-7.02 (m, 1H), 6.98 (d, J=7.8 Hz, 1H), 6.46 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.1, 3.9 Hz, 1H), 4.76 (d, J=12.0 Hz, 1H), 4.56-4.50 (m, 1H), 3.97-3.62 (m, 3H), 3.42 (t, J=16.7 Hz, 1H), 2.58-2.44 (m, 1H), 2.30-2.00 (m, 2H), 1.90-1.80 (m, 1H), 0.08 (d, J=4.5 Hz, 1H). ESI MS [M+H]+ for C27H20F3N30, calcd 478.2, found 478.3.

Example 198

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.97 (d, J=7.6 Hz, 1H), 7.75-7.67 (m, 1H), 7.57-7.49 (m, 1H), 7.44-7.37 (m, 1H), 6.96 (d, J=7.9 Hz, 1H), 6.44 (d, J=7.9 Hz, 1H), 5.63 (dt, J=49.6, 3.3 Hz, 1H), 4.56-4.51 (m, 1H), 4.28-4.16 (m, 2H), 3.86 (ddd, J=20.8, 16.9, 10.3 Hz, 1H), 3.45 (t, J=16.9 Hz, 1H), 3.28 (s, 3H), 2.59-2.47 (m, 1H), 2.43 (s, 3H), 2.17-1.98 (m, 2H), 1.91-1.83 (m, 1H). ESI MS [M+H]+ for C27H23F4N2O3S, calcd 531.1, found 531.2.

Example 200

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 11.89 (s, 1H), 7.88 (ddd, J=6.2, 1.8, 0.8 Hz, 1H), 7.84-7.75 (m, 1H), 7.51 (ddd, J=8.9, 2.8, 1.2 Hz, 1H), 7.45-7.35 (m, 1H), 7.16-7.06 (m, 2H), 6.90 (ddd, J=7.2, 6.2, 1.0 Hz, 1H), 6.43 (d, J=8.2 Hz, 1H), 5.71-5.44 (m, 1H), 5.28-5.22 (m, 1H), 4.52 (d, J=4.1 Hz, 1H), 3.88-3.64 (m, 1H), 3.38-3.12 (m, 1H), 2.56-2.39 (m, 1H), 2.24-2.05 (m, 1H), 2.05-1.91 (m, 2H), 1.82-1.64 (m, 1H). ESI MS [M+H]+ for C25H20F4N3O, calcd 454.2, found 454.2.

Example 202

[Figure (not displayed)]

Step a: To a mixture of 3-chloro-4-fluorobenzylaldehyde (20.0 g, 126 mmol, 1.0 equiv.) in 1,2-DCE/TFA (5:1 v/v, 420 mL) was added NBS (26.9 g, 151 mmol, 1.2 equiv.), 2-amino-5-chlorobenzotrifluoride (4.93 g, 25.2 mmol, 20 mol %) and Pd(OAc)2 (2.83 g, 12.6 mmol, 10 mol %), under N2. The resulting mixture was heated at 60° C. for 40 h, after which the substrate was fully consumed, confirmed by NMR monitoring. After cooling to room temperature, the reaction mixture was concentrated under vacuum and then diluted with EtOAc. The resulting mixture was washed with water then brine, dried over MgSO4, and purified by flash chromatography (SiO2, 10 to 20% EtOAc/Hex) to afford the product 2-bromo-5-chloro-4-fluorobenzylaldehyde (19.5 g, 82.1 mmol, 65%).

Step b: NEt3 (16.2 mL, 115 mmol, 2.5 mol. equiv.) was added to HCO2H (10.6 mL, 278 mmol, 6.0 mol. equiv.) at 0° C. A separate flask was charged with 2-bromo-5-chloro-4-fluorobenzylaldehyde (11 g, 46.3 mmol, 1.0 mol. equiv.), DMF (50 mL) and Meldrum's acid (6.68 g, 46.3 mmol, 1.0 mol. equiv.), and the mixture was cooled to 0° C. The cooled NEt3-HCO2H mixture was added slowly to the DMF mixture at 0° C. The reaction was allowed to warm to room temperature, followed by heating to reflux at 100° C. and was stirred for 12 h. The reaction was cooled and decanted onto ice. The mixture was diluted with EtOAc and acidified with 2M aq. HCl. The aqueous layer was separated and back extracted with EtOAc. The organic layers were combined, washed with 2M aq. HCl, H2O and brine, and dried over MgSO4. Concentration under reduced pressure and azeotropic removal of residual DMF with toluene afforded 3-(2-bromo-5-chloro-4-fluorophenyl)propanoic acid (12.2 g) that was of sufficient purity to use in the next step.

Step c: The crude material from step b was placed in an ice-bath and thionyl chloride (20 mL) was added, and the reaction was heated to 80° C. for 1 h. The reaction was cooled, and residual thionyl chloride was removed upon concentration under reduced pressure in a fume-hood. This furnished 3-(2-bromo-5-chloro-4-fluorophenyl)propanoyl chloride that was used directly in the next step.

Step d: Crude 3-(2-bromo-5-chloro-4-fluorophenyl)propanoyl chloride from the previous step was dissolved in DCM (100 mL) and cooled to 0° C. AlCl3 (14.5 g, 108 mmol, 2.5 mol. equiv.) was added and the resulting mixture was heated to 40° C. and stirred for 15 h. The reaction mixture was cooled and decanted carefully onto ice. The mixture was acidified with 2M aq. HCl and diluted with additional DCM. The aqueous layer was separated and extracted with DCM. The organic layers were combined and washed with additional 2M aq. HCl, water, brine, and dried over MgSO4. Concentration under reduced pressure and purification by flash chromatography (SiO2, 20 to 60% hexanes/DCM) furnished 4-bromo-7-chloro-6-fluoro-2,3-dihydroinden-1-one (5.22 g, 19.8 mmol, 43% over 3 steps) as a yellow solid.

The title compound was prepared from 4-bromo-7-chloro-6-fluoro-2,3-dihydroinden-1-one in a similar fashion to the sequence described for Example 144. 1H NMR (400 MHz, CDCl3) δ 7.88 (s, 1H), 7.58-7.52 (m, 1H), 7.43 (ddd, J=7.5, 2.8, 1.7 Hz, 1H), 6.22 (d, J=10.5 Hz, 1H), 5.63 (dt, J=49.8, 3.6 Hz, 1H), 4.81 (dd, J=11.8, 4.7 Hz, 1H), 4.57-4.50 (m, 1H), 3.94 (d, J=1.4 Hz, 3H), 3.90-3.75 (m, 1H), 3.41 (t, J=16.8 Hz, 1H), 2.70 (d, J=4.7 Hz, 1H), 2.54 (tdd, J=13.4, 6.2, 3.2 Hz, 1H), 2.29-1.98 (m, 2H), 1.85 (ddd, J=12.2, 6.3, 3.4 Hz, 1H). ESI MS [M+H]+ for C23H17F5N4O, calcd 461.1, found 461.0.

Example 203

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 202. 1H NMR (400 MHz, CDCl3, appears as a 1.2:1 mixture of rotamers with mostly overlapping peaks) δ 7.56-7.48 (m, 1H), 7.46-7.38 (m, 1.4H), 7.22 (d, J=8.3 Hz, 0.5H), 6.41 (d, J=8.3 Hz, 0.5H), 6.36-6.33 (m, 0.4H), 6.08 (d, J=10.3 Hz, 1H), 5.61 (dt, J=50.0, 3.6 Hz, 1H), 4.97 (dd, J=11.9, 2.5 Hz, 0.5H), 4.79 (d, J=11.7 Hz, 0.4H), 4.59-4.39 (m, 3H), 3.88-3.71 (m, 1H), 3.45-3.30 (m, 1H), 2.57-2.42 (m, 1H), 2.27-2.11 (m, 2H), 2.08 (s, 1.2H), 2.04 (s, 1.5H), 1.93-1.80 (m, 1H). ESI MS [M+H]+ for C26H20F5N3O, calcd 486.2, found 486.0.

Example 204

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 202. 1H NMR (400 MHz, DMSO-d6, appears as a 3.5:1 rotamers) δ 8.00-7.93 (m, 1H), 7.88-7.81 (m, 1H), 7.17 (d, J=7.8 Hz, 0.2H), 7.14 (d, J=7.7 Hz, 0.8H), 7.09 (d, J=1.5 Hz, 0.8H), 7.04 (d, J=1.5 Hz, 0.2H), 7.00 (dd, J=7.7, 1.7 Hz, 0.8H), 6.93 (dd, J=7.8, 1.7 Hz, 0.2H), 6.33 (d, J=10.7 Hz, 0.8H), 6.24 (d, J=10.8 Hz, 0.2H), 6.05 (d, J=6.4 Hz, 0.8H), 5.96 (d, J=6.6 Hz, 0.2H), 5.79 (dt, J=49.4, 3.1 Hz, 1H), 5.23 (s, 0.4H), 4.99 (s, 1.6H), 4.92-4.76 (m, 1H), 4.67-4.57 (m, 1H), 3.70-3.38 (m, 2H), 2.41-2.23 (m, 1H), 2.15-1.88 (m, 2H), 1.83-1.65 (m, 1H). ESI MS [M+H]+ for C27H18F5N3O, calcd 496.1, found 496.0.

Example 205

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 202. 1H NMR (400 MHz, CDCl3, appears as a 1.5:1 mixture of rotamers) δ 8.27 (s, 0.4H), 8.01 (s, 0.6H), 7.62-7.50 (m, 1H), 7.48-7.36 (m, 1H), 6.26 (d, J=10.3 Hz, 0.4H), 6.16 (d, J=10.1 Hz, 0.6zH), 5.63 (dt, J=50.2, 2.5 Hz, 1H), 5.04-4.75 (m, 3H), 4.55-4.47 (m, 4H), 3.91-3.69 (m, 1H), 3.66-3.52 (m, 1H), 3.50-3.21 (m, 1H), 2.67-2.44 (m, 4H), 2.31-1.98 (m, 2H), 1.94-1.79 (m, 1H). ESI MS [M+H]+ for C25H19F5N4O, calcd 487.2, found 487.0.

Example 206

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 202. 1H NMR (400 MHz, CDCl3, appears as a 1:1 mixture of rotamers) δ 8.84 (s, 0.5H), 8.55 (s, 0.5H), 7.58-7.48 (m, 1H), 7.49-7.37 (m, 1H), 6.22 (t, J=9.8 Hz, 0.5H), 6.12 (d, J=9.9 Hz, 0.5H), 5.72-5.51 (m, 1H), 5.24-5.14 (m, 0.5H), 4.98-4.60 (m, 0.5H), 4.58-4.49 (m, 1H), 4.47-4.40 (m, 1H), 3.89-3.72 (m, 1H), 3.51-3.29 (m, 1H), 2.68-2.34 (m, 4H), 2.30-1.94 (m, 2H), 1.92-1.72 (m, 1H). ESI MS [M+H]+ for C26H17F5N4O, calcd 497.1, found 497.0.

Example 208

[Figure (not displayed)]

Step a: To a solution of (5R,8R)-8-[(1S)-7-chloro-2,2,6-trifluoro-1-(methoxymethoxy)-1,3-dihydroinden-4-yl]-3-fluoro-5-hydroxy-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (accessed during the preparation of example 202, 1.17 g, 2.57 mmol, 1.0 equiv.) in DCM (26 mL) was added DMP (1.64 g, 3.86 mmol, 1.5 mol. equiv.) at 0° C. The resulting mixture was then stirred at room temperature for 1 h, and then quenched with saturated NaHCO3 (aq.) and saturated Na2S2O3 (aq.). The aqueous layer was extracted with DCM×2. The combined organic layer was then washed with brine, dried over Na2SO4, concentrated and purified by flash chromatography (SiO2, 10 to 40% EtOAc/hexanes) to afford the product (1.16 g, 2.56 mmol, 100%) as a white solid.

Step b: To a solution of the crude product from step a (1.16 g, 2.56 mmol, 1.0 equiv.) in DCM (10 mL) was added Et3N (1.55 g, 2.1 mL, 15.3 mmol, 6.0 equiv.) then TBSOTf (2.03 g, 1.8 mL, 7.68 mmol, 2.0 equiv.) dropwise at 0° C. The resulting solution was stirred at room temperature for 6 h, and then quenched with saturated NaHCO3 (aq.). The resulting mixture was then separated, and the aqueous phase was extracted with DCM. The combined organic phase was then washed with brine, dried over Na2SO4 and concentrated to afford the crude product which was used directly in the next step.

Step c: The crude product from step b (˜2.56 mmol) was then dissolved in MeCN (15 mL). Selectfluor (2.00 g, 5.63 mmol, 2.2 equiv.) was added at room temperature. The resulting mixture was stirred at 60° C. for 15 min upon which TLC analysis showed the full consumption of starting material. The reaction was concentrated under reduced pressure to remove MeOH. The residue was treated with DCM and washed with water. The aqueous phase was extracted with DCM. The combined organic phase was then washed with brine, dried over Na2SO4, concentrated and purified by flash column chromatography (SiO2, 0 to 30% EtOAc/hexanes) to afford the product as an off-white foam (dr 6:1, 0.945 g, 2.06 mmol, 78% yield over 2 steps).

Step d: A solution of the product from step c (0.945 g, 2.06 mmol, 1.0 equiv.), RuCl(p-cymene)[(S,S)-TsDPEN] (63.6 mg, 0.10 mmol, 5 mol %), HCO2H (0.184 g, 0.15 mL, 4.0 mmol, 2.0 equiv.) and Et3N (0.607 g, 0.84 mL, 6.0 mmol, 3.0 equiv.) in DCM (20 mL) was stirred at 0° C. overnight. The reaction mixture was then quenched with saturated NaHCO3 (aq.). The resulting mixture was then separated, and the aqueous phase was extracted with DCM. The combined organic phase was then washed with brine, dried over Na2SO4, concentrated and purified by flash column chromatography (SiO2, 0 to 30% EtOAc/hexanes) to afford the product as an off-white foam (dr 6:1, 0.888 g, 1.87 mmol, 94% yield).

Step e: To a solution of the product from step d (0.888 g, 1.87 mmol, 1.0 equiv.) in THE (18 mL) was added m-nitrobenzoic acid (0.938 g, 5.61 mmol, 3.0 equiv.), DIAD (0.908 g, 0.88 mL, 4.49 mmol, 2.4 equiv.) and PPh3 (1.18 g, 4.49 mmol, 2.4 equiv.) at 0° C. The resulting mixture was stirred at this temperature for 1 h, and then quenched by the addition of water. The aqueous phase was extracted with EtOAc. The combined organic phase was then washed with brine, dried over Na2SO4, concentrated and purified by flash column chromatography (SiO2, 0 to 30% EtOAc/hexanes) to afford the ester intermediate. The ester was then dissolved in THF/MeOH (2:1, 15 mL). A solution of LiOH·H2O (0.118 g, 2.80 mmol, 1.5 equiv.) in H2O (3 mL) was added at room temperature. The resulting mixture was stirred at room temperature for 10 min and then concentrated under vacuum. The residue was treated with EtOAc and H2O. The aqueous phase was extracted with EtOAc. The combined organic phase was then washed with brine, dried over Na2SO4 and concentrated to afford the product which was directly used in the next step.

Step f: To a solution of the product from step e (˜1.87 mmol) in DCM (18 mL) was added DAST (1.51 g, 1.2 mL, 9.35 mmol, 5.0 equiv.) dropwise at −40° C. The reaction temperature was gradually raised to −10° C. in 1 h, upon which TLC analysis showed full conversion of the substrate. The reaction mixture was then quenched with saturated NaHCO3 (aq.). The resulting mixture was then separated, and the aqueous phase was extracted with DCM. The combined organic phase was then washed with brine, dried over Na2SO4, concentrated and purified by flash column chromatography (SiO2, 0 to 20% EtOAc/hexanes) to afford the single diastereomer product as an off-white foam (0.418 g, 0.878 mmol, 47% yield over 2 steps).

Step g: A 40-mL vial was charged with the product from step f (60.0 mg, 0.126 mmol, 1.0 equiv.), 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-imidazole (28.9 mg, 0.139 mmol, 1.1 equiv.), SPhos-Pd-G2 (9.4 mg, 13 μmol, 10 mol %), 1M Na2CO3 aqueous solution (0.25 mL, 0.25 mmol, 2.0 equiv.) and 1,4-dioxane (1.3 mL). The resulting mixture was heated at 100° C. and stirred overnight. After cooling to room temperature, the reaction mixture was diluted with EtOAc and washed with H2O. The aqueous layer was separated and extracted with EtOAc. The combined organic phase was then washed with brine, dried over Na2SO4 and concentrated. The residue was treated with TFA/DCM (1:10, 2.0 mL) and heated to 40° C. for 1 h. The mixture was then concentrated and purified by HPLC to afford the title compound as a white solid (5.5 mg, 11.5 μmol, 9% yield). 1H NMR (400 MHz, CDCl3) δ 7.61-7.57 (m, 2H), 7.44 (ddd, J=7.7, 2.8 Hz, 1H), 7.39 (s, 1H), 6.38 (d, J=10.6 Hz, 1H), 5.70 (dd, J=50.3, 15.8 Hz, 1H), 5.35-5.13 (m, 1H), 4.73 (d, J=11.5 Hz, 1H), 4.66 (t, J=6.8 Hz, 1H), 3.75 (ddd, J=24.3, 16.2, 8.1 Hz, 1H), 3.54 (d, J=1.7 Hz, 3H), 3.13 (t, J=16.6 Hz, 1H), 2.93-2.80 (m, 1H), 2.05 (ddd, J=26.0, 14.7, 6.7 Hz, 1H). ESI MS [M+H]+ for C24H17F6N3O, calcd 478.1, found 478.0.

Example 209

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 208. 1H NMR (400 MHz, DMSO-d6) δ 7.97 (ddd, J=8.3, 2.9, 1.1 Hz, 1H), 7.87 (dd, J=9.0, 2.8 Hz, 1H), 6.57 (d, J=11.2 Hz, 1H), 6.25 (d, J=5.9 Hz, 1H), 6.03 (ddd, J=51.0, 15.9, 2.1 Hz, 1H), 5.46-5.18 (m, 1H), 4.71 (t, J=6.3 Hz, 1H), 4.64 (dd, J=12.0, 5.9 Hz, 1H), 3.78 (s, 3H), 3.57 (ddd, J=24.7, 16.6, 9.4 Hz, 1H), 3.25 (t, J=17.0 Hz, 1H), 2.85-2.64 (m, 1H), 2.11 (d, J=2.1 Hz, 3H), 2.06-1.88 (m, 1H). ESI MS [M+H]+ for C25H19F6N3O, calcd 492.2, found 492.0.

Example 210

[Figure (not displayed)]

Step a: To a solution 4-bromo-7-chloro-6-fluoro-2,3-dihydroinden-1-one (5.20 g, 21.9 mmol, 1.0 equiv.) in MeOH (100 mL) was added SelectFluor (9.31 g, 26.3 mmol, 1.2 equiv.) and concentrated H2SO4 (5 drops). The resulting mixture was heated at reflux for 2 h. After cooling to room temperature, 0.3 M H2SO4 (aq., 220 mL) was added to the reaction mixture. The resulting mixture was heated at reflux for another 1 h. After cooling to room temperature, the reaction was partitioned between EtOAc (200 mL) and H2O (200 mL). The aqueous layer was separated and back extracted with additional EtOAc (200 mL). The organic layers were combined, washed with water, then brine and dried over MgSO4. Concentration under reduced pressure gave mono-fluoro indanone that was taken crude onto the next step without purification (4.60 g, 75%).

Step b: To a solution of 4-bromo-7-chloro-2,6-difluoro-2,3-dihydroinden-1-one (4.6 g, 21.9 mmol, 1.0 mol. equiv.) in DMF (60 mL) was added HCO2H (1.9 mL, 48.9 mmol, 3.0 mol. equiv.) and NEt3 (4.6 mL, 32.6 mmol, 2.0 mol. equiv.) at 0° C. RuCl(p-cymene)[(R,R)-TsDPEN] (418 mg, 0.652 mmol, 4.0 mol %) was added and the reaction was stirred in the fridge for 48 h. The reaction was poured onto sat. aq. NaHCO3 solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with H2O (3×100 mL), brine, and dried over MgSO4. Concentration under reduced pressure and purification by column chromatography (SiO2, hexanes to 30% EtOAc) furnished the alcohol product as a single diastereomer (2.94 g, 64%, 75% ee as determined via analytical chiral HPLC using an AD-H column).

Step c: To a solution of indanol product from step b (2.94 g, 10.37 mmol, 1.0 mol. equiv.) in DCM (35 mL) was added DIPEA (3.7 mL, 20.7 mmol, 2.0 mol. equiv.) and MOMBr (1.3 mL, 15.6 mmol, 1.5 mol. equiv.) at 0° C. The reaction was allowed to warm to room temperature and was then heated at 40° C. overnight. The reaction was poured onto sat. aq. NaHCO3 solution and diluted with DCM. The aqueous layer was separated and back extracted with additional DCM. The organic layers were combined, washed with H2O, brine, and dried over MgSO4. Concentration under reduced pressure and purification by column chromatography (SiO2, hexanes to 70% DCM) furnished the MOM protected indanol (2.3 g, 68%).

The title compound was prepared from (1S,2R)-4-bromo-7-chloro-2,6-difluoro-1-(methoxymethoxy)-2,3-dihydro-1H-indene in analogous fashion to the sequence described for Example 144. 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J=1.9 Hz, 1H), 7.55-7.50 (m, 1H), 7.43 (dt, J=7.6, 2.3 Hz, 1H), 6.40 (s, 1H), 6.13 (d, J=10.4 Hz, 1H), 5.61 (dt, J=50.0, 3.6 Hz, 1H), 5.32 (d, J=52.4 Hz, 1H), 5.07 (s, 1H), 4.60 (s, 1H), 3.73 (d, J=1.3 Hz, 3H), 3.61-3.44 (m, 1H), 3.24-3.10 (m, 1H), 2.49 (tdd, J=13.4, 6.0, 3.1 Hz, 1H), 2.34-2.01 (m, 3H), 1.88-1.77 (m, 1H). ESI MS [M+H]+ for C24H19F4N3O, calcd 442.1, found 442.0.

Example 211

[Figure (not displayed)]

Step a: To a mixture of 4-bromo-6,7-difluoro-2,3-dihydroinden-1-one (5.0 g, 20.2 mmol, 1.0 mol. equiv.) in CH3CN (60 mL) was added NaSMe (1.84 g, 26.3 mmol, 1.3 mol. equiv.) at 0° C. The reaction was allowed to warm to room temperature and stirred for 1 h. The reaction was quenched with sat. aq. NH4Cl solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with water, brine and dried over MgSO4. Concentration under reduced pressure furnished crude thioether that was taken directly onto the next step without additional purification.

Step b: The crude thioether product of step a was dissolved in DCM (100 mL) and cooled to 0° C. mCPBA (9.50 g, 42.4 mmol, 2.1 mol. equiv.) was added portion-wise and the reaction was allowed to warm to room temperature and stirred for 2 h. The reaction was cooled in an ice-bath and carefully quenched by the addition of sat. aq. Na2S2O3 solution and sat. aq. NaHCO3 solution. After vigorous stirring, the aqueous layer was separated and extracted with additional DCM. The organic layers were combined, washed with brine and dried over MgSO4. Concentration under reduced pressure furnished crude sulfone that was taken onto the next step without additional purification.

Step c: To a solution of crude 4-bromo-6-fluoro-7-methylsulfonyl-2,3-dihydroinden-1-one from the previous step (˜20.2 mmol, 1.0 equiv.) in MeOH (120 mL) was added SelectFluor (8.58 g, 24.2 mmol, 1.2 equiv.) and concentrated H2SO4 (5 drops). The resulting mixture was heated at reflux for 2 h. After cooling to room temperature, 0.3 M H2SO4 (aq., 200 mL) was added to the reaction mixture. The resulting mixture was heated at reflux for another 1 h. After cooling to room temperature, the reaction was partitioned between EtOAc (200 mL) and H2O (200 mL). The aqueous layer was separated and back extracted with additional EtOAc (200 mL). The organic layers were combined, washed with water, then brine and dried over MgSO4. Concentration under reduced pressure furnished the mono-fluoroindanone as a white solid (5.98 g, 91% over 3 steps).

The title compound was prepared in a similar fashion to the sequence described for the preparation of Example 144 from the product of step c. 1H NMR (400 MHz, DMSO-d6) δ 7.97 (ddd, J=8.3, 2.8, 1.6 Hz, 1H), 7.91-7.84 (m, 1H), 6.40 (d, J=11.8 Hz, 1H), 5.85-5.67 (m, 2H), 5.62 (q, J=5.4 Hz, 1H), 5.37-5.18 (m, 1H), 4.74-4.63 (m, 1H), 3.35 (s, 3H), 3.31-3.16 (m, 2H), 2.30 (qd, J=11.2, 10.0, 5.4 Hz, 1H), 2.08-1.66 (m, 3H). ESI MS [M+Na]+ for C21H17F4NO3S, calcd 462.1, found 462.0.

Example 213

[Figure (not displayed)]

Step a: To a solution of 4-bromo-7-hydroxy-2,3-dihydroinden-1-one (12.0 g, 52.8 mmol, 1.0 mol. equiv.) in AcOH (120 mL) was added N-chlorosuccinimide (7.41 g, 55.4 mmol, 1.05 mol. equiv.). The reaction was warmed to 70° C. and stirred for 18 h. After this time, the reaction was poured onto ice and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layer was combined, washed with sat. aq. NaHCO3 solution, water, brine, and dried over MgSO4. Concentration under reduced pressure furnished the chloroindanone product (13.0 g, 94%) which was used in the next step without purification.

Step b: To a solution of 4-bromo-6-chloro-7-hydroxy-2,3-dihydroinden-1-one (11.5 g, 43.9 mmol, 1.0 mol. equiv.) in DCM (300 mL) was added NEt3 (13 mL, 87.8 mmol, 2.0 mol. equiv.) and triflic anhydride (8.1 mL, 48.3 mmol, 1.1 mol. equiv.) at 0° C. Upon completion, the reaction was carefully poured onto sat. aq. NaHCO3 solution at 0° C. The aqueous layer was separated and back extracted with additional DCM. The organic layer was combined, washed with sat. aq. NaHCO3 solution, brine, and dried over MgSO4. Concentration under reduced and purification by column chromatography (SiO2, hexane to 20% EtOAc) furnished the triflate product (11.2 g, 65%).

Step c: To a solution of (7-bromo-5-chloro-3-oxo-1,2-dihydroinden-4-yl) trifluoromethanesulfonate (11.2 g, 28.4 mmol, 1.0 mol equiv.) in CH3CN (120 mL) at 0° C. was added NaSMe (2.98 g, 42.6 mmol, 1.5 mol. equiv.) at 0° C. The reaction was allowed to warm to room temperature and stirred for 1 h. The reaction was quenched with sat. aq. NH4Cl solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with water, brine and dried over MgSO4. Concentration under reduced pressure furnished crude thioether that was taken directly onto the next step without additional purification.

Step d: The crude thioether product of step c was dissolved in DCM (140 mL) and cooled to 0° C. mCPBA (13.7 g, 59.6 mmol, 2.1 mol. equiv.) was added portion-wise and the reaction warmed to room temperature and stirred for 2 h. The reaction was cooled in an ice-bath and carefully quenched by the addition of sat. aq. Na2S2O3 solution and sat. aq. NaHCO3 solution. After vigorous stirring, the aqueous layer was separated and extracted with additional DCM. The organic layers were combined, washed with brine and dried over MgSO4. Concentration under reduced and purification by column chromatography (SiO2, hexane to 50% EtOAc) furnished the sulfone product (5.16 g, 56% over 2 steps).

The title compound was prepared from the product of step d in a similar fashion to Example 211. 1H NMR (400 MHz, DMSO-d6) δ 8.01-7.95 (m, 1H), 7.91-7.85 (m, 1H), 6.54 (s, 1H), 5.92-5.67 (m, 3H), 5.27 (dq, J=52.2, 6.2 Hz, 1H), 4.72-4.66 (m, 1H), 3.36 (s, 3H), 3.32-3.17 (m, 2H), 2.38-2.24 (m, 1H), 2.07-1.66 (m, 3H). ESI MS [M+Na]+ for C21H17ClF3NO3S, calcd 478.0, found 477.9.

Example 214

[Figure (not displayed)]

Step a: To a mixture of (5R)-5-[tert-butyl(dimethyl)silyl]oxy-8-[(1S,2R)-6-chloro-2-fluoro-1-(methoxymethoxy)-7-methylsulfonyl-2,3-dihydro-1H-inden-4-yl]-3-fluoro-5,6-dihydronaphthalene-1-carbonitrile (190 mg, 0.310 mmol, 1.0 mol. equiv.) in NMP (1.8 mL) was added CuCN (110 mg, 1.24 mmol, 4.0 mol. equiv.). The reaction was heated to 180° C. and stirred for 1.5 h. The reaction was poured onto sat. aq. NaHCO3 solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with H2O, brine and dried over MgSO4. Concentration under reduced pressure and purification by column chromatography (SiO2, hexane to 40% EtOAc) furnished the benzonitrile adduct (71 mg, 38%).

The title compound was accessed from the product of step a in a similar fashion to that described for Example 144. 1H NMR (400 MHz, DMSO-d6) δ 8.00-7.95 (m, 1H), 7.92-7.87 (m, 1H), 7.01 (s, 1H), 6.07 (d, J=6.7, 1.0 Hz, 1H), 5.78 (d, J=49.9 Hz, 1H), 5.62 (ddd, J=11.4, 6.7, 4.9 Hz, 1H), 5.33 (dq, J=52.7, 5.0 Hz, 1H), 4.81-4.75 (m, 1H), 3.48 (s, 3H), 3.44-3.30 (m, 2H), 2.37-2.23 (m, 1H), 2.06-1.65 (m, 3H). ESI MS [M+Na]+ for C22H17F3N2O3S, calcd 469.1, found 469.0.

Example 215

[Figure (not displayed)]

Step a. A round-bottomed flask was charged with triflate (10.0 g, 22.15 mmol, 1.0 equiv.), and boronate (9.75 g, 24.37 mmol, 1.1 equiv.), Pd(dppf)Cl2 (1.62 g, 2.21 mmol, 0.1 equiv.), Na2CO3 (4.67 g, 44.30 mmol, 2.0 equiv.), 1,4-dioxane (80 mL) and H2O (20 mL). The reaction mixture was degassed with N2 bubbling for 10 min before it was stirred at 80° C. for 16 h. The reaction mixture was then quenched with saturated NaCl (aq) and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→32%) to afford the product (10.0 g, 78%) as an off-white foam.

Step b: Product of step a (10.0 g, 17.37 mmol, 1.0 equiv.) was dissolved in degassed MeOH (110 mL) and Pd/C (20 wt % Pd, 2.00 g, 10 mol %) was added. The reaction was then shaken in parr hydrogenator under H2 (50 psi) for 2 h or until LCMS showed no starting material remaining. The reaction mixture was then filtered through Celite, concentrated and the residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→35%) to afford to afford the product (8.0 g, 80%) as an off-white foam.

Step c. TBAF (25.0 mL, 1M in THF, 1.8 equiv.) was added to a solution of product of step b (8.00 g, 13.85 mmol, 1.0 equiv.) in THF (100 mL) at 0° C. The reaction was slowly warmed to 23° C., stirred for 30 min and quenched with H2O. The solution was extracted with EtOAc and the combined organic extract was washed with sat. sol. NaCl. The solvent was evaporated, and the residue was used in the next step without further purification.

Step d. Oxalyl chloride (1.31 mL, 15.24 mmol, 1.1 equiv.) was dissolved in dry CH2Cl2 (30 mL) and cooled to −78° C. DMSO (2.36 mL, 33.24 mmol, 2.4 equiv.) was added dropwise to the reaction mixture and the reaction was stirred for 15 minutes at −78° C. Next, product of step e was dissolved in dry CH2Cl2 (20 mL) and was added dropwise. The reaction was stirred for 30 minutes. Et3N (9.60 mL, 69.25 mmol, 5.0 equiv.) was then added and the reaction was stirred at −78° C. for 1 h. The dry-ice bath was removed, and the reaction mixture was allowed to warm to room temperature and quenched with sat. sol. NaCl. The solution was extracted with EtOAc and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→60%) to afford to afford the product (6.14 g, 96%) as an off-white foam.

Step e. Product of step d (6.40 g, 13.9 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (100 mL) and Et3N (15.5 mL, 110 mmol, 8.0 equiv.) and TBSOTf (10.7 mL, 55.5 mmol, 4.0 equiv.) were added sequentially. The mixture was stirred for 2 h at 23° C. The reaction mixture was then quenched with sat. sol. NaHCO3 and extracted with CH2Cl2. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→14%) to afford the product (7.11 g, 89%) as an off-white foam.

Step f. Product of step e (7.11 g, 12.4 mmol, 1.0 equiv.) was dissolved in MeCN (100 mL) and SelectFluor (9.63 g, 27.2 mmol, 2.2 equiv.) was added. The mixture was stirred for 15 min at 60° C. The reaction mixture was then quenched with sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%-30%) to afford the product (5.21 g, 88%) as an off-white foam.

Step g. Product of step f (5.21 g, 10.87 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (55 mL) and cooled to 0° C. Et3N (3.03 mL, 21.74 mmol, 3.0 equiv.) and HCO2H (1.23 mL, 32.61 mmol, 2.0 equiv.) were then added and the solution was degassed for 10 min before RuCl(p-cymene)[(S,S)-Ts-DPEN] (104 mg, 0.163 mmol, 0.015 equiv.) was added. The reaction flask was sealed with a septum and the reaction was stirred at 4° C. for 16 h. The reaction mixture was poured into a sat. sol. NaHCO3 and extracted with CH2Cl2. The organic layer was washed with brine, dried over Na2SO4, filtered, and concentrated. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→55%) to afford the product as a separable mixture of diastereosiomer (6:1 dr, 4.31 g, 83%) with the cis-isomer (0.61 g, 12%) and trans-isomer (3.70 g, 71%) obtained as off-white foams.

Step h. Product of step g (3.60 g, 7.48 mmol, 1.0 equiv.) was dissolved in THE (80 mL) at 0° C. and 3-nitrobenzoic acid (3.37 g, 22.43 mmol, 3.0 equiv.), triphenylphosphine (4.71 g, 17.94 mmol, 2.4 equiv.) and DIAD (3.53 mL, 17.94 mmol, 2.4 equiv.) were added sequentially. The reaction mixture was stirred at 23° C. for 2 h and then quenched with H2O. The mixture was extracted with EtOAc, the combined organic extract was washed with sat. sol. NaHCO3 and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%-65%) to afford the desired product (4.70 g, 99%) as an off-white foam. The residue was dissolved in THF/MeOH (2:1, 60 mL) and LiOH·H2O (471 mg, 11.22 mmol, 1.5 equiv.) in H2O (20 mL) was added dropwise. The reaction was stirred at 23° C. for 45 minutes. The solution was extracted with EtOAc, the combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→55%) to afford the product (2.80 g, 78%) as an off-white foam.

Step i. Product of step h (1.20 g, 2.49 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (25 mL) and the solution was cooled to −40° C. under an atmosphere of nitrogen. DAST (1.65 mL, 12.46 mmol, 5.0 equiv.) was then added dropwise at −40° C. The reaction mixture was slowly warmed from −40° C. to −10° C. over a period of 2 h. When the reaction reached completion, the solution was poured in a cold sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→50%) to afford the product (0.98 g, 82%) as an off-white foam.

Step j. Product of step i (0.98 g, 2.03 mmol, 1.0 equiv.) was dissolved in THE (12 mL) at 23° C. A solution of hydrochloric acid (12 mL, 6M) was added dropwise, and the mixture was stirred at 30° C. for 2 h. When the reaction reached completion, the solution was poured in an ice-cold sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→50%) to afford the desired product (0.845 g, 95%) as an off-white foam. The material was dissolved in CH2Cl2 at 50° C., cooled to 0° C. and hexanes was added. The precipitate was collected by filtration to afford a white solid (0.714 g, 80%, >96% purity according to 1H and 19F NMR). 1H NMR (400 MHz, DMSO-d6) δ 7.96 (ddd, J=8.3, 2.7, 1.3 Hz, 1H), 7.89 (dd, J=8.9, 2.7 Hz, 1H), 7.57 (d, J=8.1 Hz, 1H), 6.66 (d, J=8.1 Hz, 1H), 5.95 (ddd, J=51.2, 13.5, 2.2 Hz, 1H), 5.89 (d, J=5.6 Hz, 1H), 5.47 (ddd, J=10.0, 6.2, 4.9 Hz, 1H), 5.26 (qd, J=52.5, 5.4 Hz, 1H), 5.12 (tddd, J=47.4, 18.7, 10.3, 2.7 Hz, 1H), 4.83 (t, J=5.4 Hz, 1H), 3.30 (s, 3H), 3.28-3.13 (m, 2H), 2.71-2.60 (m, 1H), 2.02-1.85 (m, 1H). 19F NMR (376 MHz, DMSO-d6) δ −112.3, −179.6, −196.7, −199.4. ESI MS [M+Na]+ for C21H17F4NO3SNa, calcd 462.0, found 461.9.

Example 216

[Figure (not displayed)]

Steps a and b were performed under similar conditions as previously described using starting material previously prepared according to Example 215.

Step c. Tetrabutylammonium fluoride [4.5 mL, 1M in THF] was added to a solution of product of step b (1.2 g, 2.17 mmol, 1.0 equiv.) in THF [0.15M] at 0° C. The reaction was slowly warmed to 23° C., stirred for 30 min and quenched with H2O. The solution was extracted with EtOAc and the combined organic extract was washed with sat. sol. NaCl. The solvent was evaporated, and the residue was used in the next step without further purification.

Step d. Oxalyl chloride (0.205 mL, 2.39 mmol, 1.1 equiv.) was dissolved in dry CH2Cl2 (5 mL) and cooled to −78° C. DMSO (0.37 mL, 5.22 mmol, 2.4 equiv.) was added dropwise to the reaction mixture and the reaction was stirred for 15 minutes at −78° C. Next, product of step c was dissolved in dry CH2Cl2 (4 mL) and was added dropwise, and the reaction was stirred for 15 minutes. Et3N (1.51 mL, 10.87 mmol, 5.0 equiv.) was then added and the reaction was stirred at −78° C. for 1 h. The dry-ice bath was removed, and the reaction mixture was allowed to warm to room temperature and quenched with sat. sol. NaCl. The solution was extracted with EtOAc and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→30%) to afford to afford the product (852 mg, 90%) as an off-white foam.

Step e. Product of step d (650 mg, 1.49 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (6.0 mL) and Et3N (1.25 mL, 8.94 mmol, 6.0 equiv.) and TBSOTf (1.03 mL, 4.47 mmol, 3.0 equiv.) were added sequentially. The mixture was stirred for 2 h at 23° C. The reaction mixture was then quenched with sat. sol. NaHCO3 and extracted with CH2Cl2. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→14%) to afford the product (720 mg, 88%) as an off-white foam.

Step f. Product of step e (720 mg, 1.31 mmol, 1.0 equiv.) was dissolved in MeCN (8.0 mL) and SelectFluor (1.02 g, 2.88 mmol, 2.2 equiv.) was added. The mixture was stirred for 45 min at 60° C. The reaction mixture was then quenched with sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→30%) to afford the product (403 mg, 68%) as an off-white foam.

Step g. Product of step f (402 mg, 0.89 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (4.5 mL) and cooled to 0° C. Et3N (0.25 mL, 1.77 mmol, 3.0 equiv.) and HCO2H (0.1 mL, 2.66 mmol, 2.0 equiv.) were then added and the solution was degassed for 10 min before RuCl(p-cymene)[(S,S)-Ts-DPEN] (8.5 mg, 0.013 mmol, 0.015 equiv.) was added. The reaction flask was sealed with a septum and the reaction was stirred at 4° C. for 16 h. The reaction mixture was poured into saturated NaHCO3 and extracted with CH2Cl2. The organic layer was washed with brine, dried over Na2SO4, filtered, and concentrated. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→30%) to afford the product as a separable mixture of diastereosiomer (6:1 dr, 368 mg, 92%) with the cis-isomer (56 mg, 14%) and trans-isomer (312 mg, 78%) obtained as off-white foams.

Step h. Product of step g (312 mg, 0.68 mmol, 1.0 equiv.) was dissolved in THE (6.5 mL) at 0° C. and 3-nitrobenzoic acid (0.34 g, 2.05 mmol, 3.0 equiv.), triphenylphosphine (0.43 g, 1.64 mmol, 2.4 equiv.) and DIAD (0.32 mL, 1.64 mmol, 2.4 equiv.) were added sequentially. The reaction mixture was stirred at 0° C. for 2 h and then quenched with H2O. The solution was extracted with EtOAc, the combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→35%) to afford product (414 mg, 97%) as an off-white foam. The residue was dissolved in THF/MeOH (2:1, 5.0 mL) and LiOH (43 mg, 1.03 mmol, 1.5 equiv.) in H2O (1.5 mL) was added dropwise. The reaction was stirred at 23° C. for 1 h. The solution was extracted with EtOAc, the combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→25%) to afford the product (250 mg, 80%) as an off-white foam.

Step i. Product of step h (305 mg, 0.67 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (6.5 mL) and the solution was cooled to −40° C. under an atmosphere of nitrogen. DAST (0.44 mL, 3.35 mmol, 5.0 equiv.) was then added dropwise at −40° C. The reaction mixture was stirred and slowly warmed from −40° C. to −10° C. over a period of 2 h. When the reaction reached completion, the solution was poured in a cold sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→20%) to afford the product (250 mg, 82%) as an off-white foam.

Step j. A vial was charged with product of step i (50 mg, 0.11 mmol, 1.0 equiv.), 6-amino-2-methylpyridin-3-ylboronic acid pinacol ester (38 mg, 0.163 mmol, 1.5 equiv.), SPhos Pd G2 (16 mg, 0.022 mmol, 0.2 equiv.), aq. Na2CO3 (46 mg, 0.44 mmol, 4.0 equiv., 1M), and dioxane (1.2 mL). The reaction mixture was then sparged with N2 for 10 minutes before being heated to 100° C. for 2 h. The solution was extracted with EtOAc, the combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→80%) to afford the product (45 mg, 78%) as an off-white foam.

Step k. Hydrochloric acid [2.0 mL, 6M] was added to previous product (1.0 equiv.) dissolved in THE [2.0 mL, 0.02M], and the mixture was stirred at 30° C. for 2 h. When the reaction reached completion, the solution was poured in a cold sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→90%) to afford the product (25 mg, 50%) as an off-white foam. 1H NMR (400 MHz, DMSO-d6) δ 7.93 (dd, J=8.2, 1.9 Hz, 1H), 7.83 (dd, J=9.0, 2.7 Hz, 1H), 7.20 (d, J=8.2 Hz, 1H), 6.91 (d, J=7.9 Hz, 1H), 6.54 (d, J=7.9 Hz, 1H), 6.25 (d, J=8.3 Hz, 1H), 6.11-5.90 (m, 1H), 5.87-5.79 (m, 3H), 5.23 (ddd, J=48.3, 17.2, 9.6 Hz, 1H), 4.70-4.57 (m, 2H), 3.55 (ddd, J=22.0, 16.8, 10.3 Hz, 1H), 3.28-3.18 (m, 1H), 2.75-2.63 (m, 1H), 1.99 (s, 3H), 1.96-1.86 (m, 1H). 19F NMR (376 MHz, DMSO-d6) δ −102.59, −112.72, −113.45, −180.54, −200.09. ESI MS [M+H]+ for C26H21F5N3O1, calcd 486.1, found 486.0.

Example 217

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 216. 1H NMR (400 MHz, DMSO-d6) δ 7.94 (dd, J=8.2, 1.7 Hz, 1H), 7.85 (dd, J=9.0, 2.7 Hz, 1H), 7.44 (d, J=1.9 Hz, 1H), 7.18 (d, J=8.0 Hz, 1H), 6.64 (d, J=8.0 Hz, 1H), 6.44 (d, J=1.9 Hz, 1H), 6.10 (d, J=6.0 Hz, 1H), 6.09-5.91 (m, 1H), 5.40-5.00 (m, 1H), 4.82-4.74 (m, 1H), 4.72 (t, J=5.7 Hz, 1H), 3.64 (s, 3H), 3.63-3.53 (m, 1H), 3.40-3.31 (m, 1H), 2.76-2.65 (m, 1H), 2.02-1.84 (m, 1H). 19F NMR (376 MHz, DMSO-d6) δ −102.6, −112.5, −113.3, −180.3, −200.0. ESI MS [M+H]+ for C24H19F5N3O1, calcd 460.1, found 460.0.

Example 218

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 216. 1H NMR (400 MHz, DMSO-d6) δ 7.97-7.93 (m, 1H), 7.87 (d, J=2.8 Hz, 1H), 7.85 (s, 1H), 7.25 (d, J=8.0 Hz, 1H), 6.65 (d, J=8.0 Hz, 1H), 6.15 (d, J=6.5 Hz, 1H), 6.00 (dd, J=51.1, 14.7 Hz, 1H), 5.35-5.09 (m, 1H), 4.89 (dt, J=11.5, 5.4 Hz, 1H), 4.74 (s, 1H), 3.86 (s, 3H), 3.62 (td, J=17.0, 12.5 Hz, 1H), 3.47-3.33 (m, 1H), 2.75-2.62 (m, 1H), 2.00-1.82 (m, 1H). 19F NMR (376 MHz, DMSO-d6) δ −102.9, −112.5, −112.6, −180.2, −200.0. ESI MS [M+H]+ for C23H18F5N4O1, calcd 461.1, found 461.0.

Example 219

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 216. 1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J=8.3, 2.8 Hz, 1H), 7.40-7.35 (m, 1H), 7.17 (d, J=8.3 Hz, 1H), 6.42 (d, J=8.3 Hz, 1H), 5.66 (ddd, J=50.3, 16.8, 2.7 Hz, 1H), 5.31-5.08 (m, 2H), 4.54 (t, J=6.8 Hz, 1H), 3.84-3.69 (m, 1H), 3.30 (td, J=16.9, 2.6 Hz, 1H), 2.88-2.73 (m, 1H), 2.50 (d, J=5.9 Hz, 1H), 2.00-1.83 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −101.8, −110.5, −114.8, 182.4, −202.9. ESI MS [M+Na]+ for C20H13C11F5N1O1Na, calcd 436.0, found 436.0.

Example 220

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 216. 1H NMR (400 MHz, CD3OD) δ 8.69 (s, 1H), 7.70 (dd, J=8.7, 2.8 Hz, 1H), 7.68-7.60 (m, 1H), 7.13 (d, J=8.0 Hz, 1H), 6.70 (d, J=8.0 Hz, 1H), 5.94-5.75 (m, 1H), 5.29-5.08 (m, 1H), 5.00-4.91 (m, 1H), 4.82-4.76 (m, 1H), 3.70 (dt, J=17.0, 13.5 Hz, 1H), 3.50-3.31 (m, 1H), 2.87-2.76 (m, 1H), 2.39 (s, 3H), 2.08-1.94 (m, 1H). 19F NMR (376 MHz, CD3OD) δ −102.6, −111.3, −113.9, 183.6, −203.6. ESI MS [M+H]+ for C26H18F5N4O1, calcd 497.1, found 497.1.

Example 221

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 216. 1H NMR (400 MHz, DMSO-d6) δ 7.97 (ddd, J=8.3, 2.9, 1.5 Hz, 1H), 7.90-7.86 (m, 2H), 6.97 (d, J=7.9 Hz, 1H), 6.43 (d, J=7.9 Hz, 1H), 6.27 (s, 1H), 6.05-5.86 (m, 2H), 5.29-5.04 (m, 1H), 4.92 (dt, J=12.3, 6.1 Hz, 1H), 4.75 (s, 1H), 3.65-3.52 (m, 1H), 3.47-3.32 (m, 1H), 2.70-2.58 (m, 1H), 2.31 (s, 3H), 2.00-1.87 (m, 1H). 19F NMR (376 MHz, DMSO-d6) δ −103.1, −111.6, −112.6, 177.8, −198.8. ESI MS [M+H]+ for C25H20F5N4O1, calcd 487.1, found 487.0.

Example 222

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.47 (ddd, J=8.3, 2.7, 1.4 Hz, 1H), 7.36 (ddd, J=7.6, 2.8, 1.8 Hz, 1H), 7.05 (d, J=8.1 Hz, 1H), 6.22 (d, J=8.1 Hz, 1H), 5.55 (ddd, J=50.0, 3.6, 3.6 Hz, 1H), 5.41-5.24 (m, 2H), 4.53-4.51 (m, 1H), 3.56-3.46 (m, 1H), 3.12 (ddd, J=21.6, 16.7, 5.7 Hz, 1H), 2.53-2.50 (m, 1H), 2.46-2.36 (m, 1H), 2.15-1.89 (m, 2H), 1.72-1.66 (m, 1H). ESI MS [M+Na]+ for C20H15ClF3NO, calcd 400.1, found 400.0.

Example 223

[Figure (not displayed)]

Step a: The starting material [(1S)-7-chloro-4-[(1R,4S)-8-cyano-4,6-difluoro-1,2,3,4-tetrahydronaphthalen-1-yl]-2,2-difluoro-1,3-dihydroinden-1-yl] acetate (42.0 mg, 0.106 mmol, 1.0 mol. equiv.) was dissolved in 1 mL dioxane. Vinylboronic acid pinacol ester (19.6 mg, 0.127 mmol, 1.2 mol. equiv.), SPhos-Pd gen. II (7.9 mg, 0.011 mmol, 0.1 mol. equiv.), and 0.42 mL 1 M Na2CO3 aqueous solution (0.42 mmol, 4.0 mol. equiv.) were added. The mixture was sparged with N2 for 10 min and then heated at 100° C. for 70 min. The reaction mixture was partitioned between ethyl acetate and water. The organic phase was separated and dried using Na2SO4. The drying agent was filtered off and the organic solution was evaporated and chromatographed (SiO2, hexanes to 30% EtOAc/hexanes). The desired product (20.2 mg, 0.047 mmol, 44% yield) was obtained.

Step b: The product from step a (20.2 mg, 0.047 mmol, 1.0 mol. equiv.) was dissolved in 0.2 mL CCl4 and 0.2 mL acetonitrile, then 0.2 mL water was added. RuCl3.3H2O (6.7 mg, 0.026 mmol, 0.55 mol. equiv.) and Na1O4 (53 mg, 0.25 mmol, 5.3 mol. equiv.) were added. The reaction mixture was stirred for 1 h. The reaction was quenched by acetic acid and water. The organic phase was separated and dried over Na2SO4. Prep-TLC (SiO2, hexanes/EtOAc=1:1, with a few drops of acetic acid) gave the desired product (14 mg, 0.031 mmol, 66% yield).

Step c: The product from step b (14 mg, 0.031 mmol) was dissolved in the mixture of 1 mL THF, 1 mL dioxane and 1 mL water. LiOH·H2O (20 mg, excess) was added. The reaction mixture was stirred for 2 h before being quenched by acetic acid. All the volatiles were evaporated, then DCM was added. The DCM solution was dried over Na2SO4. HPLC (acetonitrile/water=10/90 to 90/10, with 0.1% TFA, 20 mL/min for 36 min) gave the desired product (3 S)-7-[(1R,4S)-8-cyano-4,6-difluoro-1,2,3,4-tetrahydronaphthalen-1-yl]-2,2-difluoro-3-hydroxy-1,3-dihydroindene-4-carboxylic acid (6.2 mg, 0.015 mmol, 49%).

1H NMR (400 MHz, Chloroform-d) δ 9.99 (s, br, 2H), 7.63 (d, J=8.0 Hz, 1H), 7.48 (dt, J=8.8, 1.7 Hz, 1H), 7.35 (dt, J=7.7, 2.0 Hz, 1H), 6.28 (d, J=8.0 Hz, 1H), 5.56 (d, J=49.8 Hz, 1H), 5.34-5.26 (m, 1H), 4.45 (s, 1H), 3.81-3.64 (m, 1H), 3.31 (td, J=16.7, 4.7 Hz, 1H), 2.40 (d, J=14.7 Hz, 1H), 2.13-1.89 (m, 2H), 1.72 (d, J=13.4 Hz, 1H). ESI MS [M+H]+ for C21H16F4NO3, calcd 406.1, found 406.0.

Example 224

[Figure (not displayed)]

Step a: The starting material (3S)-7-[(1R,4S)-8-cyano-4,6-difluoro-1,2,3,4-tetrahydronaphthalen-1-yl]-2,2-difluoro-3-hydroxy-1,3-dihydroindene-4-carboxylic acid (12.6 mg, 0.031 mmol, 1.0 mol. equiv.), prepared according to example 223, was dissolved in 0.5 mL DMF. HATU (95 mg, 0.25 mmol, 8 mol. equiv.), i-Pr2NEt (74 mg, 0.10 mL, 0.57 mmol, 19 mol. equiv.), and dimethylamine (2.0 Min THE solution, 0.09 mL, 0.18 mmol, 6 mol. equiv.) were added. The reaction mixture was stirred for 18 h. The reaction mixture was quenched by aqueous HCl (1 M) and extracted with EtOAc. The organic phase was separated and dried over Na2SO4. After filtration and evaporation, the residue was purified by HPLC (acetonitrile/water=20/80 to 80/20, with 0.1% TFA, 20 mL/min for 25 min). The desired product (3S)-7-[(1R,4S)-8-cyano-4,6-difluoro-1,2,3,4-tetrahydronaphthalen-1-yl]-2,2-difluoro-3-hydroxy-N,N-dimethyl-1,3-dihydroindene-4-carboxamide was obtained (7.1 mg, 0.016 mmol, 53% yield).

1H NMR (400 MHz, Chloroform-d) δ 7.50 (dt, J=8.4, 2.0 Hz, 1H), 7.38 (dt, J=7.6, 2.2 Hz, 1H), 7.06 (d, J=7.9 Hz, 1H), 6.34 (d, J=7.9 Hz, 1H), 5.58 (dt, J=50.0, 3.7 Hz, 1H), 5.14 (dd, J=13.7, 2.6 Hz, 1H), 4.55-4.48 (m, 1H), 3.77 (td, J=15.6, 7.6 Hz, 1H), 3.33 (td, J=16.4, 6.3 Hz, 1H), 3.12 (s, 3H), 3.01 (s, 3H), 2.65 (s, br, 1H), 2.46 (tdd, J=13.3, 6.1, 3.2 Hz, 1H), 2.29-2.12 (m, 1H), 2.12-1.90 (m, 1H), 1.78 (ddt, J=13.9, 5.8, 3.3 Hz, 1H). ESI MS [M+H]+ for C23H21F4N2O2, calcd 433.2, found 433.0.

Example 225

[Figure (not displayed)]

Synthesis of the title compound was performed in a similar fashion to Example 144 using methyl boronic acid. The crude product was purified by flash column chromatography (SiO2, 0 to 100% EtOAc/hexanes) to afford a white solid (11 mg, 0.029 mmol, 35%). 1H NMR (400 MHz, CDCl3) δ 7.53-7.42 (m, 1H), 7.36 (dt, J=7.7, 2.2 Hz, 1H), 6.92 (d, J=7.8 Hz, 1H), 6.19 (d, J=7.8 Hz, 1H), 5.58 (dt, J=50.1, 3.6 Hz, 1H), 5.14-4.99 (m, 1H), 4.48-4.38 (m, 1H), 3.76 (td, J=18.0, 11.8 Hz, 1H), 3.36 (td, J=16.9, 5.7 Hz, 1H), 2.47-2.40 (m, 1H), 2.39 (s, 3H), 2.19-1.93 (m, 2H), 1.75 (dq, J=13.5, 3.5 Hz, 1H). ESI MS [M+H]+ for C21H18F4NO, calcd 376.1, found 376.0.

Example 228

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) (4:1 mixture of rotamers) δ 8.30 (d, J=2.2 Hz, 1H), 8.13 (s, 1H), 7.92 (s, 1H), 7.53-7.48 (m, 1H), 7.42-7.37 (m, 1H), 7.04-6.989 (m, 3H), 6.45-6.37 (m, 1H), 5.70-5.51 (m, 1H), 4.95-4.85 (m, 1H), 4.55-4.48 (m, 1H), 3.97-3.76 (m, 1H), 3.43 (t, J=16.9 Hz, 1H), 2.56-2.42 (m, 1H), 2.22-2.05 (m, 2H), 1.88-1.79 (m, 1H). ESI MS [M+H]+ for C27H18F4N2O2, calcd 479.1, found 479.0.

Example 229

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.53-7.47 (m, 1H), 7.39-7.35 (m, 1H), 7.09-6.93 (m, 2H), 6.90-6.77 (m, 2H), 6.40 (d, J=7.9 Hz, 1H), 5.69-5.51 (m, 1H), 5.15 (s, 1H), 4.70 (d, J=12.4 Hz, 1H), 4.55-4.49 (m, 1H), 3.95-3.75 (m, 1H), 3.66-3.56 (m, 2H), 3.37 (t, J=16.5 Hz, 1H), 2.54-2.43 (m, 1H), 2.19-1.98 (m, 2H), 1.88-1.80 (m, 1H). ESI MS [M+H]+ for C26H19F5N2O, calcd 471.1, found 471.0.

Example 230

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.87 (s, 1H), 7.58 (dd, J=6.8, 1.0 Hz, 1H), 7.54-7.47 (m, 1H), 7.41-7.37 (m, 1H), 7.29 (dd, J=7.1, 6.8 Hz, 1H), 6.59 (t, J=7.1 Hz, 1H), 6.45 (d, J=8.0 Hz, 1H), 6.32 (d, J=7.3 Hz, 1H), 5.69-5.52 (m, 1H), 4.99 (d, J=11.8 Hz, 1H), 4.62 (s, 2H), 4.59 (m, 1H), 4.01-3.86 (m, 1H), 3.39 (t, J=16.9 Hz, 1H), 2.56-2.44 (m, 1H), 2.24-2.03 (m, 2H), 1.91-1.79 (m, 1H). ESI MS [M+H]+ for C27H20F4N4O, calcd 493.2, found 493.0.

Example 231

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) (2:1 mixture of rotamers) δ 7.74-7.61 (m, 1H), 7.55-7.38 (m, 2H), 7.19-7.09 (m, 1H), 7.06-7.01 (m, 1H), 6.99-6.91 (m, 1H), 6.80-6.57 (m, 1H), 6.47-6.40 (m, 1H), 5.70-5.49 (m, 1H), 5.05-4.87 (m, 1H), 4.59 (s, 1H), 3.97-3.76 (m, 1H), 3.53-3.36 (m, 1H), 2.57-2.43 (m, 1H), 2.25-2.02 (m, 2H), 2.21-1.91 (s, 3H), 1.96-1.85 (m, 1H). ESI MS [M+H]+ for C28H21F4N3O, calcd 492.2, found 492.0.

Example 232

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) (3:1 mixture of rotamers) δ 7.52-7.47 (m, 1H), 7.40-7.35 (m, 1H), 7.24 (s, 1H), 6.99-6.90 (m, 1H), 6.46-6.34 (m, 1H), 5.68-5.52 (m, 1H), 4.91-4.75 (m, 1H), 4.56-5.49 (m, 1H), 3.89-3.73 (m, 1H), 3.48-3.24 (m, 1H), 3.34 (s, 3H), 2.55-2.42 (m, 1H), 2.19-2.03 (m, 2H), 1.98 (s, 3H), 1.91-1.83 (m, 1H). ESI MS [M+H]+ for C25H21F4N3O, calcd 456.2, found 456.0.

Example 233

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 8.90-8.86 (m, 1H), 8.84 (dd, J=6.9, 1.8 Hz, 1H), 8.26 (s, 1H), 7.98-7.93 (m, 1H), 7.88-7.82 (m, 1H), 7.41 (dd, J=6.9, 4.3 Hz, 1H), 7.36 (d, J=8.0 Hz, 1H), 6.50 (d, J=8.0 Hz, 1H), 5.86-5.68 (s, 1H), 5.09 (dd, J=11.8, 6.0 Hz, 1H), 4.70-4.62 (m, 1H), 3.76-3.47 (m, 3H), 2.39-2.27 (m, 1H), 2.08-1.82 (m, 2H), 1.72-1.65 (m, 1H). ESI MS [M+H]+ for C26H18F4N4O, calcd 479.1, found 479.0.

Example 234

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 9.19 (d, J=1.4 Hz, 1H), 8.32 (dd, J=4.7, 1.5 Hz, 1H), 8.11 (s, 1H), 7.97-7.91 (m, 2H), 7.87-7.81 (m, 1H), 7.37 (d, J=8.0 Hz, 1H), 6.47 (d, J=8.0 Hz, 1H), 5.84-5.68 (m, 1H), 5.05 (dd, J=11.7, 5.2 Hz, 1H), 4.68-4.63 (m, 1H), 3.76-3.47 (m, 3H), 2.37-2.26 (m, 1H), 2.08-1.83 (m, 2H), 1.73-1.66 (m, 1H). ESI MS [M+H]+ for C26H18F4N4O, calcd 479.1, found 479.0.

Example 235

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 7.95-7.91 (m, 1H), 7.85-7.80 (m, 1H), 7.08-6.83 (m, 4H), 6.37 (d, J=7.9 Hz, 1H), 5.84-5.67 (m, 1H), 4.85 (d, J=11.9 Hz, 1H), 4.60 (s, 1H), 3.70-3.55 (m, 1H), 3.53-3.40 (m, 1H), 2.34-2.23 (m, 1H), 2.05-1.87 (m, 2H), 1.70-1.61 (m, 1H). ESI MS [M+H]+ for C26H19F5N2O, calcd 471.1, found 471.0.

Example 236

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 7.96-7.91 (m, 1H), 7.87-7.82 (m, 1H), 7.61 (s, 1H), 7.16 (d, J=7.9 Hz, 1H), 6.47 (d, J=7.9 Hz, 1H), 6.19 (s, 1H), 5.82-5.67 (m, 1H), 5.08-4.97 (m, 1H), 4.65-4.61 (m, 1H), 3.72-3.47 (m, 2H), 3.45 (s, 3H), 2.60 (s, 3H), 2.36-2.24 (m, 1H), 2.06-1.80 (m, 2H), 1.71-1.61 (m, 1H). ESI MS [M+H]+ for C25H21F4N3O, calcd 456.2, found 456.0.

Example 237

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 8.51 (dd, J=4.4, 1.6 Hz, 1H), 8.17 (dd, J=9.2, 1.6 Hz, 1H), 7.96-7.91 (m, 1H), 7.86-7.80 (m, 1H), 7.57 (d, J=8.1 Hz, 1H), 7.25 (dd, J=9.2, 4.4 Hz, 1H), 6.43 (d, J=8.1 Hz, 1H), 6.04 (d, J=6.6 Hz, 1H), 5.84-5.68 (m, 1H), 5.14-5.06 (m, 1H), 4.65-4.59 (m, 1H), 3.73-3.47 (m, 2H), 2.36-2.24 (m, 1H), 2.05-1.80 (m, 2H), 1.74-1.65 (m, 1H). ESI MS [M+H]+ for C26H18F4N4O, calcd 479.1, found 479.0.

Example 238

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.51-7.46 (m, 1H), 7.39-7.34 (m, 1H), 7.17 (d, J=8.0 Hz, 1H), 7.10 (d, J=1.3 Hz, 1H), 6.96 (d, J=1.3 Hz, 1H), 6.40 (d, J=8.0 Hz, 1H), 5.66-5.50 (m, 1H), 4.89 (d, J=17.4 Hz, 1H), 4.57-4.52 (m, 1H), 3.93-3.79 (m, 1H), 3.78 (s, 3H), 3.42-3.31 (m, 1H), 2.52-2.42 (m, 1H), 2.20-2.00 (m, 2H), 1.87-1.79 (m, 1H). ESI MS [M+H]+ for C24H19F4N3O, calcd 442.1, found 442.0.

Example 239

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.25 (s, 1H), 8.20 (d, J=7.0 Hz, 1H), 7.96 (s, 1H), 7.71 (d, J=9.1 Hz, 1H), 7.53-7.47 (m, 1H), 7.41-7.36 (m, 1H), 7.31 (d, J=8.0 Hz, 1H), 7.21 (ddd, J=9.1, 6.7, 1.2 Hz, 1H), 6.77 (td, J=6.8, 1.2 Hz, 1H), 6.50 (d, J=8.0 Hz, 1H), 5.70-5.53 (m, 1H), 4.81 (d, J=11.9 Hz, 1H), 4.65-4.58 (m, 1H), 4.07-3.91 (m, 1H), 3.35 (t, J=16.8 Hz, 1H), 2.56-2.43 (m, 1H), 2.24-2.03 (m, 2H), 1.93-1.83 (m, 1H). ESI MS [M+H]+ for C27H19F4N3O, calcd 478.1, found 478.0.

Example 240

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.55 (s, 1H), 7.52-7.47 (m, 1H), 7.39-7.35 (m, 1H), 7.33 (s, 1H), 7.04 (d, J=7.9 Hz, 1H), 6.41 (d, J=8.0 Hz, 1H), 5.68-5.51 (m, 1H), 4.83 (d, J=11.8 Hz, 1H), 4.53 (s, 1H), 3.85 (ddd, J=24.5, 16.6, 9.0 Hz, 1H), 3.54 (s, 3H), 3.33 (t, J=16.7 Hz, 1H), 2.52-2.40 (m, 1H), 2.18-1.99 (m, 2H), 1.86-1.77 (m, 1H). ESI MS [M+H]+ for C24H19F4N30, calcd 442.1, found 442.1.

Example 241

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 8.74 (s, 1H), 8.61 (d, J=5.8 Hz, 1H), 7.67 (d, J=5.8 Hz, 1H), 7.52 (m, 1H), 7.40 (dt, J=7.5, 2.2 Hz, 1H), 6.96 (d, J=7.9 Hz, 1H), 6.46 (d, J=8.0 Hz, 1H), 5.71-5.49 (m, 1H), 4.92-4.78 (m, 1H), 4.55-4.51 (m, 1H), 3.89-3.76 (m, 1H), 3.51-3.36 (m, 1H), 2.55-2.46 (m, 2H), 2.39 (s, 3H), 2.21-2.14 (m, 1H), 2.10-2.02 (m, 1H), 1.87-1.80 (m, 1H). ESI MS [M+H]+ for C26H21F4N2O, calcd 453.16, found 453.1.

Example 242

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 8.60 (s, 1H), 8.52 (d, J=5.6 Hz, 1H), 7.62-7.52 (m, 1H), 7.52 (d, J=2.8 Hz, 1H), 7.39 (dt, J=7.5, 2.3 Hz, 1H), 6.93 (d, J=7.9 Hz, 1H), 6.45 (d, J=7.9 Hz, 1H), 5.6 (dt, J=50.0, 3.7 Hz, 1H), 4.91-4.78 (m, 1H), 4.55-4.50 (m, 1H), 3.81 (td, J=17.3, 11.5 Hz, 1H), 3.41 (td, J=16.2, 6.7 Hz, 1H), 2.56-2.45 (m, 1H), 2.22 (s, 3H), 2.21-1.98 (m, 2H), 1.88-1.80 (m, 1H). ESI MS [M+H]+ for C26H21F4N2O, calcd 453.16, found 453.1.

Example 243

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 13.83 (s, 1H), 8.50 (dd, J=7.9, 1.1 Hz, 1H), 8.19 (dd, J=5.8, 1.2 Hz, 1H), 7.99 (d, J=1.9 Hz, 1H), 7.52 (ddd, J=8.2, 2.8, 1.1 Hz, 1H), 7.42-7.36 (m, 2H), 7.30 (d, J=8.0 Hz, 1H), 6.50 (d, J=8.0 Hz, 1H), 5.62 (dt, J=50.1, 3.6 Hz, 1H), 4.79 (d, J=11.7 Hz, 1H), 4.56-4.51 (m, 1H), 3.90 (ddd, J=25.1, 16.7, 8.5 Hz, 1H), 3.43 (t, J=17.1 Hz, 1H), 2.57-2.45 (m, 1H), 2.23-2.03 (m, 2H), 1.89-1.79 (m, 1H). ESI MS [M+H]+ for C28H21F4N2O, calcd 477.16, found 478.1.

Example 244

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.51 (d, J=5.0 Hz, 1H), 8.02 (d, J=8.0 Hz, 1H), 7.57 (dd, J=7.9, 5.3 Hz, 1H), 7.51 (d, J=8.5 Hz, 1H), 7.37 (ddd, J=7.5, 2.8, 1.5 Hz, 1H), 7.12 (d, J=7.9 Hz, 1H), 6.58 (d, J=7.9 Hz, 1H), 5.59 (dt, J=52.0, 4.0 Hz, 1H), 4.92 (d, J=12.7 Hz, 1H), 4.54 (m, 1H), 3.77-3.62 (m, 1H), 3.27-3.13 (m, 1H), 2.62-2.34 (m, 2H), 2.35 (s, 3H), 2.21-2.03 (m, 2H), 1.90-1.79 (m, 1H). ESI MS [M+H]+ for C26H20F4N20, calcd 453.16, found 453.1.

Example 245

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.31 (dd, J=6.8, 1.1 Hz, 1H), 7.84 (s, 1H), 7.74 (d, J=1.6 Hz, 1H), 7.66 (d, J=7.0 Hz, 1H), 7.56-7.46 (m, 1H), 7.37 (dt, J=7.4, 2.3 Hz, 1H), 7.29 (t, J=7.0 Hz, 1H), 7.20 (d, J=7.9 Hz, 1H), 6.67-6.60 (m, 1H), 5.59 (dt, J=50.1, 4.0 Hz, 1H), 4.98-4.87 (m, 1H), 4.57-4.52 (m, 1H), 3.77-3.62 (m, 1H), 3.21-3.08 (m, 1H), 2.57-2.23 (m, 3H), 2.23-2.06 (m, 2H), 1.91-1.81 (m, 1H). ESI MS [M+H]+ for C27H20F4N3O, calcd 478.15, found 478.1.

Example 246

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, MeOD) δ 8.73 (dd, J=5.8, 1.6 Hz, 1H), 8.54 (dd, J=8.0, 1.6 Hz, 1H), 7.93 (dd, J=7.9, 5.9 Hz, 1H), 7.77 (s, 1H), 7.71-7.63 (m, 2H), 5.70 (dt, J=49.8, 3.9 Hz, 1H), 5.36 (d, J=1.9 Hz, 1H), 5.31 (d, J=4.2 Hz, 0.5H), 5.23 (m, 0.5H), 4.83-4.78 (m, 1H), 3.53-3.40 (m, 1H), 3.24-3.12 (m, 1H), 2.62 (s, 3H), 2.58-2.46 (m, 1H), 2.20-1.94 (m, 2H), 1.91-1.82 (m, 1H). ESI MS [M+H]+ for C25H21F3N3O, calcd 436.16, found 436.1.

Example 247

[Figure (not displayed)]

Step a: A suspension of NaH (1.4 g, 35.1 mmol, 60% in mineral oil) in THF (120 mL) was loaded in 250 ml single-neck round-bottom flask equipped with a stirring bar and a reflux condenser with a drying tube. Dimethyl carbonate (2.0 mL, 23.3 mmol) was added in one portion and the mixture was cooled to 0° C. Then solid 4-bromo-7-methylsulfanyl-2,3-dihydroinden-1-one (3.0 g, 11.7 mmol) was added in one portion. The reaction was allowed to warm to ambient temperature and stirred for 10 min. The resulting suspension was reflux for 3 h. Once TLC analysis indicated complete consumption of the starting material the reaction was cooled to room temperature and poured in 1M aqueous HCl solution (200 mL). The mixture was diluted with EtOAc (200 mL), the organic phase was separated, and the aqueous solution was extracted with EtOAc (2×70 mL). Combined organic extract was washed with brine (500 mL), dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the desired product (3.4 g, 10.8 mmol, 93% yield) as a yellow solid.

Step b: The solution of indanone from step a (2.6 g, 8.3 mmol) in THF (82 mL) was loaded in 250 ml single-neck round-bottom flask equipped with a stirring bar and a drying tube. The reaction mixture was cooled to 0° C., and NaH (0.35 g, 8.7 mmol, 60% in mineral oil) was added in one portion. The cooling bath was removed, and the mixture was stirred at ambient temperature for 30 min. Upon complete dissolution of NaH the reaction was cooled back to 0° C. and NFSI (3.1 g, 9.9 mmol) was added. The cooling bath was removed, and the reaction was stirred at room temperature for 30 min. Upon complete disappearance of the starting material by TLC analysis the mixture was quenched with saturated aqueous NH4Cl (70 mL) and diluted with EtOAc (150 ml) and water (100 mL). The organic phase was separated, and the aqueous solution was extracted with EtOAc (2×50 mL). Combined organic extract was dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired product (2.5 g, 7.5 mmol, 92% yield) as a yellowish solid.

Step c: The α-fluoroindanone from step b (5.1 g, 15.4 mmol) in dichloromethane (80 mL) was placed in 250 ml single-neck round-bottom flask equipped with a stirring bar and a drying tube. The solution was cooled to 0° C., then formic acid (1.75 mL, 46.2 mmol), triethylamine (4.1 mL, 30.8 mmol) and RuCl(p-cymene)[R,R-TsDPEN] (0.5 g, 0.77 mmol) were sequentially added. The reaction was stirred at 0° C. and monitored by 1H NMR every 30 min until it reached 52% conversion. Then the resulting brown solution was diluted with dichloromethane (100 mL) and washed with aqueous saturated NaHCO3 solution (100 mL). The organic phase was separated, and the aqueous solution was extracted with dichloromethane (2×30 mL). Combined organic extract was dried over Na2SO4 and concentrated to dryness. The crude residue was fractionated by column chromatography (SiO2, hexanes/EtOAc gradient) to produce enantioenriched α-fluoroindane-1-ol (2.7 g, 8.1 mmol, 53% yield) as a colorless oil and recovered α-fluoroindanone (2.1 g, 6.3 mmol, 41% yield) as a yellowish solid. The enantiopurity of indane-1-ol product was determined (88% ee) using 1H NMR after hydrolysis and amide coupling with enantiopure (R)-4-methoxy-α-methylbenzylamine.

Step d: To a solution of α-fluoroindane-1-ol from step c (1.0 g, 3.0 mmol) in tetrahydrofuran (20 mL) a solution of LiOH·H2O (1.25 g, 30 mmol) in water (20 mL) was added at ambient temperature. The resulting biphasic mixture was vigorously stirred for 20 min. Once TLC analysis indicated complete consumption of the starting material, the mixture was slowly acidified with 1M aqueous HCl to pH=3. The resulting mixture was diluted with EtOAc (40 mL), and the organic layer was separated. The aqueous phase was additionally extracted with EtOAc (20 mL). Combined organic extract was washed with brine, dried over Na2SO4 and concentrated to dryness. The crude product was used for the step e without additional purification.

Step e: β-Hydroxy acid step d (3.0 mmol) was dissolved in DMF (15 mL) and (R)-4-methoxy-α-methylbenzylamine (0.68 mL, 4.5 mmol), 1-hydroxybenzotriazole hydrate (0.86 g, 4.5 mmol, contains 20 wt. % of water) and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.86 g, 4.5 mmol) were added sequentially. After 24 h of stirring at room temperature the mixture was diluted with water (100 mL), and the crude product was extracted with EtOAc (3×40 mL). Combined organic extract was thoroughly washed with water (3×70 mL), dried over Na2SO4 and concentrated to dryness. The crude residue was fractionated by column chromatography (SiO2, hexanes/EtOAc gradient) to produce corresponding amide (1.1 g, 2.4 mmol, 81% yield) as a single diastereomer in a form of white foam.

Step f: Amide from step e (1.7 g, 3.7 mmol) was dissolved in dichloromethane (37 mL) and m-CPBA (2.2 g, 9.4 mmol, contained 25 wt. % of water) was added in one portion. The resulting solution was stirred at ambient temperature for 1 h. The resulting mixture was diluted with dichloromethane (50 mL) and sequentially washed with 2M aqueous NaOH (2×30 mL) and brine (90 mL). The organic extract was dried over Na2SO4 and concentrated to dryness. The crude sulfone-containing product was used for step g without purification.

Step g: The crude material from step f was dissolved in 35 ml of trifluoroacetic acid. The obtained solution was stirred at 65° C. for 2 h. The bright red solution was diluted with water (300 mL). The formed precipitate was removed by filtration, washed with MTBE and dried on filter for 2 h to produce the desired primary amide as a white solid (1.08 g, 3.1 mmol, 84% yield over two steps).

Step h: The primary amide product from the previous step (0.4 g, 1.1 mmol) was combined with B2Pin2 (0.35 g, 1.4 mmol), Pd(dppf)Cl2 (83.0 g, 0.11 mmol) and potassium acetate (0.2 g, 2.2 mmol) in dioxane (6 ml) in 40 mL screw cap vial equipped with a magnetic stirring bar. The mixture was degassed under vacuum, backfilled with nitrogen and heated to 100° C. for 1.5 h. After 1H NMR analysis of an aliquot indicated complete consumption of the starting material the reaction mixture was allowed to cool to ambient temperature and concentrated to dryness under reduced pressure. The residue was partitioned between EtOAc (70 mL) and water (40 mL). Organic layer was separated, and the aqueous phase was additionally extracted with EtOAc (2×20 mL). The combined organic extract was dried over Na2SO4 and the solvent was evaporated under reduced pressure to yield crude boronic pinacol ester that was used for the next step without further purification.

Step is A solution of crude boronic pinacol ester (1.1 mmol) from the previous step and (4R)-4-[tert-butyl(dimethyl)silyl] oxy-8-cyano-6-fluoro-3,4-dihydronaphthalen-1-yl]trifluoromethanesulfonate (0.51 g, 1.1 mmol) in dioxane (6 mL) was placed in 40 mL screw cap vial equipped with a magnetic stirring bar. Then Pd(dppf)Cl2 (83 mg, 0.11 mmol) and aqueous sodium carbonate (2M solution, 1.2 ml, 2.3 mmol) were sequentially added. The mixture was degassed under vacuum, backfilled with nitrogen and heated to 100° C. for 0.5 h. Upon reaction completion, dioxane was removed under reduced pressure. The residue was partitioned between EtOAc (70 mL) and water (50 mL). Organic layer was separated, and the aqueous phase was additionally extracted with EtOAc (2×15 mL). The combined organic extract was washed with brine (50 mL), dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to yield the desired alkene (0.65 g, 1.1 mmol, 100% yield over two steps) as a brownish foam.

Step j: The alkene of step i (0.65 g, 1.1 mmol) was dissolved in dry methanol (15 mL) and added to palladium on carbon (0.25 g, 10% Pd by weight) under an atmosphere of nitrogen. The reaction mixture was placed under an atmosphere of hydrogen at 50 psi and agitated in a Parr shaker for 1 h. The excess hydrogen was vented out and the mixture was sparged with nitrogen to remove residual hydrogen gas. TLC analysis indicated incomplete reaction. Additional 0.25 g of palladium on carbon was added and the reaction was agitated under an atmosphere of hydrogen at 50 psi for additional hour. The resulting suspension was filtered through a celite pad, and the filtrate was concentrated to dryness under reduced pressure. The crude residue was subjected to column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired tetralin derivative (0.5 g, 0.9 mmol, 77% yield) as a colorless oil.

Step k: A mixture of tetralin from previous step (0.5 g, 0.9 mmol) and triethylamine (0.6 mL, 4.4 mmol) in dichloromethane (9 mL) was place in 100 mL single-neck round-bottom flask equipped with a stirring bar and a drying tube. The mixture was cooled to 0° C. and trifluoroacetic anhydride (0.4 mL, 2.6 mmol) was added dropwise over 5 min. The resulting yellow solution was stirred at 0° C. for 10 min, diluted with dichloromethane (40 mL) and sequentially washed with water (50 mL) and saturated aqueous NaHCO3 (50 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired α-fluoronitrile derivative (0.27 g, 0.5 mmol, 55% yield) as a colorless oil.

Step 1: The α-fluoronitrile from step k (100.0 mg, 0.18 mmol) was dissolved in acetonitrile (2 mL) and HF.Py (0.2 mL, HF—70%, pyridine—30%) was added in one portion at ambient temperature. The reaction mixture was stirred for 1 h, diluted with EtOAc (30 mL) and carefully washed with aqueous saturated NaHCO3 (20 mL). The organic extract was washed with brine (30 mL), dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired hydroxytetralin derivative (73.0 mg, 0.16 mmol, 92% yield) as a white powder.

Step m: A solution of Deoxo-Fluor (106 μl, 0.57 mmol) in toluene (3.3 mL) was placed in 40 ml screw cap vial equipped with a magnetic stirring bar and nitrogen balloon. The solution was cooled to 0° C., then TMS-morpholine (103 μl, 0.58 mmol) was added dropwise. The reaction was stirred at 0° C. for 5 min, then the mixture was allowed to warm to room temperature and stirred for 2 h. The resulting cloudy solution was cooled to 0° C. and a solution of 1,2,3,4-tetrahydro-1-naphthol from step 1 (73.0 mg, 0.16 mmol) in dichloromethane (1 mL) was added dropwise over 1 min. The resulting mixture was stirred for 5 min and immediately diluted with dichloromethane (20 mL) and quenched with aqueous saturated NaHCO3 (20 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The dry residue was fractionated by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the product that was further purified by reversed phase HPLC (C18 column, water with 1% TFA/CH3CN gradient, 20 mL/min) to yield the title compound (26 mg, 0.06 mmol, 36% yield, single epimer) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.72 (d, J=8.0 Hz, 1H), 7.53 (ddd, J=8.2, 2.7, 1.3 Hz, 1H), 7.39 (ddd, J=7.5, 2.8, 1.7 Hz, 1H), 6.56 (d, J=8.1 Hz, 1H), 5.80 (dd, J=15.3, 5.0 Hz, 1H), 5.60 (dt, J=49.8, 3.6 Hz, 1H), 4.60-4.48 (m, 1H), 4.08 (ddd, J=31.8, 17.4, 1.0 Hz, 1H), 3.94 (d, J=5.2 Hz, 1H), 3.61 (dd, J=21.2, 17.4 Hz, 1H), 3.16 (s, 3H), 2.60-2.42 (m, 1H), 2.29-2.08 (m, 1H), 2.07-1.87 (m, 1H), 1.82-1.70 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −110.39 (t, J=7.8 Hz), −151.11 (ddd, J=31.8, 21.3, 15.5 Hz), −157.85. ESI MS [M+Na]+ for C22H17F3N2SO3Na, calcd 469.1, found 469.1).

Example 248

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 247. 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J=8.1 Hz, 1H), 7.53 (ddd, J=8.3, 2.8, 1.4 Hz, 1H), 7.39 (ddd, J=7.5, 2.7, 1.7 Hz, 1H), 6.51 (d, J=8.1 Hz, 1H), 5.93 (ddd, J=11.9, 6.1, 0.6 Hz, 1H), 5.58 (dt, J=49.8, 3.5 Hz, 1H), 4.69-4.51 (m, 1H), 4.07 (d, J=6.1 Hz, 1H), 3.96 (dd, J=18.4, 17.3 Hz, 1H), 3.58 (dd, J=21.7, 16.9 Hz, 1H), 3.24 (s, 3H), 2.65-2.40 (m, 1H), 2.24-2.08 (m, 1H), 1.98-1.79 (m, 1H), 1.74-1.62 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −110.4 (t, J=8.7 Hz), −157.3 (m), −170.6 (m). ESI MS [M+Na]+ for C22H17F3N2SO3Na, calcd 469.1, found 469.1.

Analytical Methods:

LC: Agilent 1100 series; Mass spectrometer: Agilent G6120BA, single quad

LC-MS method: Agilent Zorbax Eclipse Plus C18, 4.6×100 mm, 3.5 μM, 35° C., 1.5 mL/min flow rate, a 2.5 min gradient of 0% to 100% B with 0.5 min wash at 100% B; A=0.1% of formic acid/5% acetonitrile/94.9% water; B=0.1% of formic acid/5% water/94.9% acetonitrile

Flash column: ISCO Rf+

Reverse phase HPLC: ISCO-EZ or Agilent 1260; Column: Kinetex 5 μm EVO C18 100 A; 250×21.2 mm (Phenomenex)

Full text: Click here
Patent 2023

Example 2

Due to air-sensitive nature of ligand the organic phase is prepared under a nitrogen atmosphere. The organic phase is formed from Pd(OAc)2 (0.94 g, 98%) dissolved in chloroform (27 g) and then stirred for 10 minutes followed by addition of 2-dicyclohexylphosphino-2′, 4′,6′-triisopropyl-1,1′-biphenyl (2.0 g, 98%, 1:1 Pd:P). To this mixture is added polymethylene polyphenylene di-isocyanate (PMPPI) (10.0 g) and the contents stirred for a further 120 minutes. This organic phase mixture is then added to an aqueous phase, cooled to 1° C., containing 40% REAX 100 M solution (7.99 g), 20% TERGITOL XD solution (3.99 g) and 25% Poly Vinyl Alcohol (PVOH) solution (6.39 g) in deionised water (67.10 ml) while shearing (using a FISHER 4-blade retreat-curve stirrer) at 500 rpm for 8 minutes. The reaction was maintained under inert atmosphere (N2) throughout. After 8 minutes the shear rate was reduced to 160 rpm and few drops of de-foamer (DrewPLus S-4382) were added during the onset of polymerisation (detected by carbon dioxide evolution). The suspension thus obtained was stirred at 1° C. for a further 30 minutes, then maintained at 5° C. for 18 hours, warmed to 45° C. and maintained at this temperature for a further 2 hours. The microcapsules were then filtered though a polyethylene frit (20 micron porosity) and the capsules washed on a filter bed according to the following sequence: deionised water (5×100 ml), DMF (2×50 ml), ethanol (2×50 ml), toluene (2×50 ml), hexane (2×50 ml), and finally dried in a vacuum oven at 50° C.

Example of Library Synthesis Utilizing Multicomponent Reactions

96 different oligonucleotide tags, A1-A96 were synthesized using the protocol above, maintained on solid-support and deprotected on the terminal amine using the following protocol (in this example 96 different oligonucleotides are used).

However, the protocol is not fixed and can easily be scaled to any number between 1 and 10.000 or beyond 10.000 in a high-throughput format at any desired scale suitable for the experimenter.

Deprotection

Protected oligonucleotides A1-A96 maintained on solid-support

To each column add 0.3 ml Dichloromethane (DCM).

Incubate at RT for 15 min

Add 0.3 ml 2% DCA in DCM Incubate 1 min and drain

Add 0.3 ml 2% DCA in DMF. Incubate 5 min and drain (turn yellow)

Repeat until no color development

Wash ×3 with 0.3 ml DCM and inc. 5 min.

Each of the tags A1-A96 on solid support was reacted with a unique building block (BBa1-a96) using an acylation reaction as shown elsewhere in the examples. Building blocks were selected as suitably protected NH—R—COOH, NR′—R—COOH, NH—CH(R)—COOH, NR′—CH(R)—COOH, NR′—R—COOH or NH—R′—NR—CH2—COOH reactants where R or R′ can be any chemical entity f.ex a chemical entity listed elsewhere in this application.

The protection group used in this example is preferable Fmoc, which was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Orthogonal protection groups on R-groups are present whenever relevant for the feasibility of the overall library chemistry.

Multicomponent Reactions for Generation of Position 2 Building Blocks (BBb1-b96)

Multicomponent Reactions (MCRs) are convergent reactions, in which three or more starting materials react to form a product, where basically all or most of the atoms contribute to the newly formed product (A. Dömling, I. Ugi, Angew. Chem. Intl. Ed. 2000, 39, 3168).

In an MCR, a product is assembled according to a cascade of elementary chemical reactions. Thus, there is a network of reaction equilibria, which all finally flow into an irreversible step yielding the product. The challenge is to conduct an MCR in such a way that the network of pre-equilibrated reactions channel into the main product and do not yield side products.

The result is clearly dependent on the reaction conditions: solvent, temperature, catalyst, concentration, the kind of starting materials and functional groups. (A. Dömling in: Multicomponent Reactions (J. Zhu, H. Bienayme) Wiley-VCH, Weinheim 2005, p. 76).

More than 500 different scaffolds have been described in the literature so far, where 18 of these scaffolds are shown herein below. Many of these reactions are base catalyzed which works well in combination with DNA.

Other MCR's requires acidic catalysis which is known to be troublesome in combination with DNA. In these cases a mild lewis catalysis like NH4Cl, LiBr in aprotic solvents, should be used.

Some of the procedures described below require an alternative protection strategy for the phosphate backbone or the nucleobases. The phosphate groups in the DNA backbone are usually protected with cyanoethyl group, but alternative protection groups for the phosphates like the methyl and other more stable groups are known from the literature.

Multicomponent reaction can be combined with a reaction where suitable R groups react and thus forms a ring structure. One example of this is ring closure metathesis (Chem. Commun. 2003 596) where 2 of the R groups contain an alkene functionality.

[Figure (not displayed)]
[Figure (not displayed)]

The above formulas are illustrative of 18 examples of scaffolds generated by multicomponent reactions.

Uqi 4 component reaction used for generation of position 2 building blocks (BBb1-b96): After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, an array of 3 isonitrils and 4 aldehydes were mixed with 8 acids, each mixture transferred to one individual oligonucleotide and allowed to react at ambient temperature ranging from 20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position 2.

Add the acid 25 μl 0.5 M in DCM, add isonitrile 25 μl 0.5M in DCM, add aldehyde 25 μl 0.5 M in DCM and add 25 μl alcohol (methanol, ethanol, isopropanol, trifluoroethanol, hexaisofluoroisopropanol or the likes). Heated in a sealed multiposition plate in the microwave oven for 15 min or allowed to react at ambient temperature for 24-48 hours.

Aldehydes selected from the list of: aldehydes list No. 2

Acids selected from the list of: Acids list No. 4

Isonitriles selected from the list of: isonitrile (methyl ester) list No. 1

Protection groups was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

TOSMIC van Leusen 3 Component Reaction Used for Generation of Position 2 Building Blocks (BBb1-b96):

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, an array of 8 isonitriles and 12 aldehydes were created, each mixture transferred to one individual oligonucleotide and allowed to react at ambient temperature ranging from 20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position 2. (M. van Leusen, J. Wildeman, O. H. Oldenziel, J. Org. Chem. 1977, 42, 1153. A. M. van Leusen, Heterocycl. Chem. 1980, 5, S-111)

Add the aldehyde 25 μl 0.5 M in DMF incubate for 30 minutes, add isonitrile (TOSMIC reagent) 25 μl 0.5M in DCM and add triethylamine, diisopropylethylamine or morpholine 25 μl 2 M in DCM. Heated in a sealed multiposition plate in the microwave oven for 15 min or allowed to react at ambient temperature for 24-48 hours.

Aldehydes selected from the list of: aldehydes list No. 2

Isonitrile selected from the list of: isonitrile(tosmic) list No. 1

Protection groups was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Petasis 3 Component Reaction Used for Generation of Position 2 Building Blocks (BBb1-b96):

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, an array of 8 aldehydes and 12 boronic acids were created and allowed to react at ambient temperature ranging from 20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position 2.

Add the aldehyde 25 μl 0.5 M in DCM incubate for 10 minutes mix with boronic acid 25 μl 1 M in DCM. Heated in a sealed multiposition plate in the microwave oven for 15 min or allowed to react at ambient temperature for 24-48 hours.

Aldehydes selected from the list of: aldehydes list No. 2

Boronic acids selected from the list of: Boronic acids list No. 3

Protection groups was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Example of Library Synthesis Utilizing Organocatalytic Reactions

96 different oligonucleotide tags, A1-A96 were synthesized using the protocol above, maintained on solid-support and deprotected on the terminal amine using the following protocol (in this example 96 different oligonucleotides are used). However, the protocol is not fixed and can easily be scaled to any number between 1 and 10.000 or beyond 10.000 in a high-throughput format at any desired scale suitable for the experimenter.

Deprotection

Protected oligonucleotides A1-A96 maintained on solid-support To each column add 0.3 ml Dichloromethane (DCM). Incubate at RT for 15 min Add 0.3 ml 2% DCA in DCM Incubate 1 min and drain Add 0.3 ml 2% DCA in DMF. Incubate 5 min and drain (turn yellow) Repeat until no color development Wash ×3 with 0.3 ml DCM and inc. 5 min. Each of the tags A1-A96 on solid support was reacted with a unique building block (BBa1-a96) using an acylation reaction as shown elsewhere in the examples. Building blocks were selected as suitably protected NH—R—COOH, NR′—R—COOK NH—CH(R)—COOH, NR′—CH(R)—COOH, NR′—R—COOH or NH—R′—NR—CH2—COOH reactants where R or R′ can be any chemical entity f.ex a chemical entity listed elsewhere in this application. The protection group used in this example is Fmoc, was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Orthogonal protection groups on R-groups are present whenever relevant for the feasibility of the overall library chemistry.

Organocatalytic Reactions for Generation of Position 2 Building Blocks (BBb1-b96)

Organocatalytic reaction have in the past ten years received an increasingly interest. Iminium-, enamine- and recently SOMO catalysis open a wide range of chemical reactions performed in the presence of DNA since all three types of activation lowers the activation energy of the chemical reactions and conditions are mild compared to traditional activation like Lewis acid catalysis. If the catalyst responsible for the organocatalytic reactions are carefully selected these types of reaction all runs with high enantioselectivity or diastereoselectivity, if stereoselectivity in the reaction, is undesired an achiral catalyst is chosen.

1,4-Addition of Electron-Rich Benzenes to α,β-Unsaturated Aldehydes.

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, 12 different anilines were attached to the oligonucleotide complexes using an acylation reaction as shown elsewhere in the examples, each aniline added to 8 positions. An array of reactions are created by addition of 8 different croton aldehydes, preactivated with the catalyst, to each of the 12 anilines, attached to different oligonucleotides and allowed to react at ambient temperature ranging from +20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position2. J. Am. Chem. Soc. 2002, 7894.

Add the aniline 25 μl 0.1 M in DMF, add HATU (2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and 24 μl 0.1 M, 25 μl 0.2 M Dipea (diisopropylamine) in DMF.

Incubate for 1 hour at 25° C.

Washed with 3×DMF, 3×DCM.

A mixture of the crotonaldehyde 25 μl 0.5 M in DCM, catalyst ((2S,5S)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one) 25 μl 0.05M in DCM and 24 μl 0.05 M HCl (made from 4N HCl in dioxane, pH are carefully checked in a test mixture of catalyst and HCl). Incubate 30 min and transfer to oligonucleotide, allow to react at ambient temperature for 24 48 hours

Anilines selected from the list of: anilines List No. 6

Crotonaldehydes selected from the list of: crotonaldehydes List No. 7

Protection groups was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Orpanocatalytical Cyclopropanations of α,β-Unsaturated Aldehydes.

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, 12 different methylketones were attached to the oligonucleotide complexes using an acylation reaction as shown elsewhere in the examples, transformed into the corresponding dimethylsulfonylide as described below, each ylide is present in 8 positions. An array of reactions are created by addition of 8 different crotonaldehydes, preactivated with the catalyst, to each of the 12 ylides formed from the methylketones, attached to different oligonucleotides and allowed to react at ambient temperature ranging from +20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position 2. J. Am. Chem. Soc. 2005, 3240.

Add the methylketone 25 μl 0.1 M in DMF, add HATU (2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and 24 μl 0.1 M, 25 μl 0.2 M Dipea (diisopropylamine) in DMF.

Incubate for 1 hour at 25° C.

Washed with 3×DMF, 3×DCM.

Methylketones are transformed into α-keto bromides or iodides by reaction with NBS (N-bromo-succinimide) or NIS (N-iodo-succinimide), respectively. Other reagents with similar reactivity is also possible.

Add 100 μl 0.1 M NBS in CHCl3.

Incubate for 60 min at ambient temperature.

Washed with 3×DCM.

Add 100 μl 0.5 M dimethylsulfide in DCM.

Incubate for 60 min at ambient temperature.

Washed with 3×DCM.

A mixture of the crotonaldehyde 25 μl 0.5 M in CHCl3 and catalyst ((S)-(−)-indoline-2-carboxylic acid) 25 μl 0.05M in DCM

Incubate 30 min and transfer to oligonucleotide, allow to react at ambient temperature for 24 48 hours.

Crotonaldehydes selected from the list of: crotonaldehydes List No. 7

Methylketones selected from the list of: Methylketones List No. 8

Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Cross-Aldol Reaction of Aldehydes.

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, 12 different carboxylic acid-aldehydes were attached to the oligonucleotide complexes using an acylation reaction as shown elsewhere in the examples, An array of reactions are created by addition of 8 different aldehydes, premixed with the catalyst, to each of the 12 aldehydes attached to different oligonucleotides and allowed to react at ambient temperature ranging from +20-150° C. giving rise to 9216 formed compounds as a combination of position 1 and position 2. J. Am. Chem. Soc. 2002, 6798.

Add the carboxylic acid—aldehyde 25 μl 0.1 M in DMF, add HATU (2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and 24 μl 0.1 M, 25 μl 0.2 M Dipea (diisopropylamine) in DMF.

Incubate for 1 hour at 25° C.

Washed with 3×DMF, 3×DCM.

A mixture of the aldehyde 25 μl 0.5 M in DMF and catalyst ((S)-proline) 25 μl 0.05M in DMF.

Transfer to oligonucleotide, allow to react at ambient temperature for 24-48 hours

Aldehydes selected from the list of: aldehydes list No. 2

Carboxylic acid-aldehydes selected from the list of: Carboxylic acids—aldehydes List No. 5

Washed with 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Examples of Library Synthesis Utilizing Heterocycle Generating Reactions.

96 different oligonucleotide tags, A1-A96 were synthesized using the protocol above, maintained on solid-support and deprotected on the terminal amine using the following protocol (in this example 96 different oligonucleotides are used). However, the protocol is not fixed and can easily be scaled to any number between 1 and 10.000 or beyond 10.000 in a high-throughput format at any desired scale suitable for the experimenter.

Deprotection

Protected oligonucleotides A1-A96 maintained on solid-support To each column add 0.3 ml Dichloromethane (DCM). Incubate at RT for 15 min Add 0.3 ml 2% DCA in DCM Incubate 1 min and drain Add 0.3 ml 2% DCA in DMF. Incubate 5 min and drain (turn yellow) Repeat until no color development Wash ×3 with 0.3 ml DCM and inc. 5 min. Each of the tags A1-A96 on solid support was reacted with a unique building block (BBa1-a96) using an acylation reaction as shown elsewhere in the examples. Building blocks were selected as suitably protected NH—R—COOH, NR′—R—COOH, NH—CH(R)—COOH, NR′—CH(R)—COOH, NR′—R—COOH or NH—R′—NR—CH2—COOH reactants where R or R′ can be any chemical entity f.ex a chemical entity listed elsewhere in this application. The protection group used in this example is Fmoc, was removed using standard conditions chosen from Greene, “Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999). Orthogonal protection groups on R-groups are present whenever relevant for the feasibility of the overall library chemistry.

Reactions Between Di-Nucleophiles and Di-Electrophiles for Generation of Position 2 Building Blocks (BBb1-b96)

Several reactions which generates heterocycles are known, most of these reactions can be used in connection with protected DNA when conditions are carefully selected. Obvious strong protic acid must be avoided, but mild Lewis acids like NH4Cl, LiBr or similar can be used as alternatives when the right solvent and temperature is applied (Name Reactions in Heterocyclic Chemistry, Lie Jack Li, 2005

Knorr Pyrazole Synthesis.

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, 12 different carboxylic acid-aldehydes were attached to the oligonucleotide complexes using an acylation reaction as shown elsewhere in the examples, each aldehyde added to 8 positions. These aldehydes were transformed into the corresponding hydrazines by reductive amination using either trifluoroacetic acid hydrazide, Fmoc hydrazide (9-fluorenylmethyl carbazate) or hydrazine hydrochloride followed by subsequent deprotection. An array of reactions are created by addition of 8 different dicarbonyls or β-ketoesters, to each of the 12 hydrazines aldehydes attached to different oligonucleotides and allowed to react at ambient temperature ranging from 20-150° C., using standard heating or microwave heating, giving rise to 9216 formed compounds as a combination of position 1 and position2. Add the carboxylic acid-aldehydes 25 μl 0.1 M in DMF, add HATU (2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and 24 μl 0.1 M, 25 μl 0.2 M Dipea (diisopropylamine) in DMF.

Incubate for 1 hour at 25° C.

Washed with 3×DMF, 3×DCM.

Add Fmoc hydrazide 25 μl 0.1 M in THF, and 25 μl trimethyl orthoformate, incubate for 1 h at rt., add sodiumcyanoborohydride 25 μl 0.1 M in DMF/MeOH 3:1 incubate for 16 h at rt.

Wash with 3×DMF

Add piperidine/DMF 1:4 wait 5 minutes drain and repeat treatment.

Washed with 3×Methanol, 3×DMF, 3×DCM.

Add a mixture of the dicarbonyl 25 μl 0.5 M in THF, catalyst Lithium bromide 25 μl 0.05M in THF to oligonucleotide, allow to react at ambient temperature for 24 48 hours

Carboxylic acid-aldehydes selected from the list: Carboxylic acid-aldehydes List No. 5

Dicarbonyls selected from the list: dicarbonyls List No. 9

Washed with 3×THF, 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Bioinelli Reaction.

After a mix and a split step into 96 different positions of the oligonucleotides (A1-A96)-(BBa1-96) complexes, 12 different carboxylic acid-aldehydes were attached to the oligonucleotide complexes using an acylation reaction as shown elsewhere in the examples, each aldehyde added to 8 positions. An array of reactions are created by addition, of 8 different β-ketoesters or β-ketoamides mixed with either urea or thiourea, to each of the 12 aldehydes attached to different oligonucleotides and allowed to react at ambient temperature ranging from 20-150° C., using standard heating or microwave heating, giving rise to 9216 formed compounds as a combination of position 1 and position2.

Add the carboxylic acid-aldehydes 25 μl 0.1 M in DMF, add HATU (2-(7-Aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) and 24 μl 0.1 M, 25 μl 0.2 M Dipea (diisopropylamine) in DMF.

Incubate for 1 hour at 25° C.

Washed with 3×DMF, 3×DCM.

Add a mixture of urea 25 μl 0.5 M in THF, β-ketoester 25 μl 0.5 M in THF and catalyst Lithium bromide 25 μl 0.05M in THF to oligonucleotide, allow to react at ambient temperature for 24 48 hours.

Carboxylic acid-aldehydes selected from the list: Carboxylic acid-aldehydes List No. 5

Dicarbonyls selected from the list: dicarbonyls List No. 9 Washed with 3×THF, 3×DMF, 3×DCM.

Deprotect oligonucleotide and cleave from resin using standard methods for the selected protection and attachment strategy (“Protective Groups In Organic Synthesis,” (John Wiley & Sons, New York (1999)) followed by purification on either a spin column or by reverse phase chromatography described elsewhere in this patent application and 96 different oligonucleotide tags, B1-B96 are enzymatically attached using the protocol described elsewhere in this application.

Reverse Phase Chromatography Purification of Oligonucleotides:

Deprotected Oligoes:

Each oligonucleotide are dissolved in 20 μl solvent A and placed in a sealed 96 well plate and placed in the Waters ACQUITY autosampler. All samples are run through the Waters ACQUITY UPLC System with SQD-MS, controlled by MassLynx 4.1 and collected according to their target mass. MaxEnt is used to deconvolute massspec and compare with target mass (oligo-small molecule complex).

Column: Acquity UPLC BEH C18 1.7 μm 2.1×50 mm (Waters part 186002350)

Method used:

Solvent A: 200 mM HFIP 8.4 mM TEA 5% MeOH in water

Solvent B: 200 mM HFIP 8.4 mM TEA 60% MeOH in water

TimeFlow
(min)(ml/min)% A% B
Gradient:Initial0.99010
0.700.99010
4.500.90100
5.000.90100
5.100.99010
6.000.99010

Column Oven Temperature: 65° C.

UV Detection: 254 nm

MS Detection: ESi(−), 6 min, 550-1300 Da; Cone 35 V; Source Temp 130° C.

Use spilt flow between MS and Fraction Collector (1:9)

Fractions containing the target mass were evaporated furnishing pure oligonucleotide.

Protected Oligoes:

The method outlined above for the Waters ACQUITY equipment can also be used applying protected oligonucleotide. Preferable the buffer content are lowered in both solvent A and B with a factor 10 or simply changed to solvent A: water and solvent B: acetonitrile.

Alternatively:

Full or partial protected oligonucleotides can also be purified using reverse phase cartridges in a single column or a parallel format using one of the different commercial available products such as the Glen-Pack from Glen research or “Discovery DSC-18Lt SPE 96-well Plate” from supelco.

The protected oligonucleotide must be applied on the column dissolved in a solvent composition with a moderate organic solvent strength. Therefore the oligonucleotides needs to be concentrated in a vacuum evaporator if dissolved in pure organics.

Dissolve the protected oligonucleotide in a mixture of water and acetonitrile (preferable with a content of acetonitril below 20%) apply the solution to a preconditioned cartridge water/acetonitrile 9:1 and wash with more water/acetonitrile 9:1. The protected oligonucleotide is eluated with a higher content of acetonitrile in the solvent used. Preferable a stepwise gradient is used starting with water/acetonitril 90:10 up to 90:10, raising 10% per 100 μl, 100 μl solvent per 100 μl adsorbent used.

Examples above from the multicomponent, organocatalytic or heterocyclic generating reactions could be carried out using oligoes detached from the solid support if a photolabile linker is used as the support. Only difference is that the wash procedures must be substituted with the purification protocol above.

Through all following lists, protection groups are applied when necessary, selected from “Protection Groups” 3rd edition 2004 Philip J. Kocienski).

List No. 1—Isonitriles:

Tosmic-isonitriles: (1-PHENYL-1-TOSYL)METHYL ISOCYANIDE; (2,4-DIMETHYLPHENYL)(ISOCYANO)METHYL 4-METHYLPHENYL SULFONE; (3-METHOXYPHENYL)[(4-METHYLPHENYL)SULFONYL]ACETONITRILE; (4-METHOXYPHENYL)[(4-METHYLPHENYL)SULFONYL]ACETONITRILE; [1-(2-FLUOROPHENYL)-1-TOSYL]METHYL ISOCYANIDE; [1-(2-TRIFLUOROMETHYLPHENYL)-1-TOSYL]METHYL ISOCYANIDE; [1-(3-CHLOROPHENYL)-1-TOSYL]METHYL ISOCYANIDE; [1-(3-FLUOROPHENYL)-1-TOSYL]METHYL ISOCYANIDE; [1-(3-TRIFLUOROMETHYLPHENYL)-1-TOSYL]METHYL ISOCYANIDE; [1-(4-TRIFLUOROMETHYLPHENYL)-1-TOSYL]METHYL ISOCYANIDE; 1-(2,3-DICHLOROPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,3-DIMETHOXYPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,4-DIMETHOXYPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,5-DIBROMOPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,5-DICHLOROPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,5-DIMETHOXYPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,6-DICHLOROPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2,6-DIMETHOXYPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(2-CYCLOPROPYL-1-ISOCYANOETHYLSULFONYL)-4-METHYLBENZENE; 1-(3,4-DIBROMOPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(3,4-DICHLOROPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(3,5-DIBROMOPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1-(4-DIMETHYLAMINOPHENYL)-1-TOSYLMETHYL ISOCYANIDE; 1,3-DICHLORO-5-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 1-[(1-ISOCYANO-3-METHYLBUTYL)SULFONYL]-4-METHYL-BENZENE; 1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-NAPHTHALENE; 1-ALLYL-1-TOSYLMETHYL ISOCYANIDE; 1-BENZYL-1-TOSYLMETHYL ISOCYANIDE; 1-CYCLOBUTYL-1-TOSYLMETHYL ISOCYANIDE; 1-CYCLOHEXYL-1-TOSYLMETHYL ISOCYANIDE; 1-CYCLOPENTYL-1-TOSYLMETHYL ISOCYANIDE; 1-CYCLOPROPYL-1-TOSYLMETHYL ISOCYANIDE; 1-ETHOXYCARBONYL-1-TOSYLMETHYL ISOCYANIDE; 1-ETHYL-1-TOSYLMETHYL ISOCYANIDE; 1-FURAN-2-YL-1-TOSYLMETHYL ISOCYANIDE; 1-ISOCYANO-2-PHENYL-1-TOSYLETHENE; 1-ISOPROPYL-1-TOSYLMETHYL ISOCYANIDE; 1-METHYL-1-TOSYLMETHYL ISOCYANIDE; 1-M-TOLYL-1-TOSYLMETHYL ISOCYANIDE; 1-N-BUTYL-1-TOSYLMETHYL ISOCYANIDE; 1-N-PENTYL-1-TOSYLMETHYL ISOCYANIDE; 1-N-PROPYL-1-TOSYLMETHYL ISOCYANIDE; 1-O-TOLYL-1-TOSYLMETHYL ISOCYANIDE; 1-P-TOLYL-1-TOSYLMETHYL ISOCYANIDE; 1-PYRIDIN-2-YL-1-TOSYLMETHYL ISOCYANIDE; 1-PYRIDIN-3-YL-1-TOSYLMETHYL ISOCYANIDE; 1-PYRIDIN-4-YL-1-TOSYLMETHYL ISOCYANIDE; 1-PYRROL-2-YL-1-TOSYLMETHYL ISOCYANIDE; 1-THIOPHEN-2-YL-1-TOSYLMETHYL ISOCYANIDE; 2,4-DICHLORO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 2-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-NAPHTHALENE; 2-CHLORO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 2-CHLORO-4-FLUORO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 3-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZOIC ACID METHYL ESTER; 3-BROMO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 4-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-1,2-DIMETHOXY-BENZENE; 4-[ISOCYANO(TOLUENE-4-SULPHONYL)METHYL]BIPHENYL; 4-BROMO-1-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZENE; 5-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-1,2,3-TRIMETHOXY-BENZENE; 5-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-BENZO[1,3]DIOXOLE; 6-[ISOCYANO-(TOLUENE-4-SULFONYL)-METHYL]-2,3-DIHYDRO-BENZO[1,4]DIOXINE; A-(P-TOLYLSULFONYL)-A-((THIEN-3-YL)METHYL)ISOCYANIDE; ALPHA-(P-TOLUENESULFONYL)-4-FLUOROBENZYLISONITRILE; A-TOSYL-(2,3-DIFLUOROBENZYL)ISOCYANIDE; A-TOSYL-(2,4-DIFLUOROBENZYL)ISOCYANIDE; A-TOSYL-(2,5-DIFLUOROBENZYL) ISOCYANIDE; A-TOSYL-(2,6-DIFLUOROBENZYL)ISOCYANIDE; A-TOSYL-(2-BROMOBENZYL) ISOCYANIDE; A-TOSYL-(2-NITROBENZYL) ISOCYANIDE; A-TOSYL-(3,4-DIFLUOROBENZYL) ISOCYANIDE; A-TOSYL-(3,5-DIFLUOROBENZYL) ISOCYANIDE; A-TOSYL-(3-IODOMETHYLBENZYL)ISOCYANIDE; A-TOSYL-(3-NITROBENZYL) ISOCYANIDE; A-TOSYL-(4-CHLOROBENZYL) ISOCYANIDE; A-TOSYL-(4-IODOMETHYLBENZYL)ISOCYANIDE; A-TOSYL-(4-NITROBENZYL) ISOCYANIDE; ISOCYANO(2-METHOXYPHENYL)METHYL-4-METHYLPHENYL SULFONE; ISOCYANO(2-TERT-BUTYLSULFANYLPHENYL)METHYL-4-METHYLPHENYL SULFONE; PHENYLSULFONYLMETHYL ISOCYANIDE; TERT-BUTYL-3-ISOCYANO-3-TOSYLPROPANOATE; TOSYL-(2-FLUORBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-BROMBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-CHLORBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-CYANOBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-FLUORBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-METHYLBENZYL)-METHYL-ISOCYANIDE; TOSYL-(3-TRIFLUORMETHYLBENZYL)-METHYLISOCYANIDE; TOSYL-(4-BROMBENZYL)-METHYL-ISOCYANIDE; TOSYL-(4-CHLORBENZYL)-METHYL-ISOCYANIDE; TOSYL-(4-CYANOBENZYL)-METHYL-ISOCYANIDE; TOSYL-(4-FLUORBENZYL)-METHYL-ISOCYANIDE; TOSYL-(4-METHYLBENZYL)-METHYL-ISOCYANIDE; TOSYL-(4-TRIFLUORMETHYLBENZYL)-METHYLISOCYANIDE; TOSYLMETHYL ISOCYANIDE
Methyl esters; METHYL ISOCYANOACETATE; 6-ISOCYANOHEXANOICACIDMETHYL-ESTER; 5-ISOCYANOVALERIC ACID METHYL ESTER; TRANS-4-(ISOCYANOMETHYL)CYCLOHEXANE CARBOXYLIC ACID METHYL ESTER; 11-ISOCYANOUNDECANOIC ACID METHYL ESTER; D,L-3-ISOCYANO-N-BUTYRIC ACID METHYL ESTER; 4-ISOCYANOBUTYRIC ACID METHYL ESTER; 2-ISOCYANO-2-(4-FLUOROPHENYL) ACETIC ACID METHYL ESTER; 2-ISOCYANO-2-(4-CHLOROPHENYL)PROPIONIC ACID METHYL ESTER; 2-ISOCYANO-4-BENZYLOXYCARBONYLBUTYRIC ACID METHYL ESTER; 2,6-DIISOCYANOHEPTANEDIOIC ACID DIMETHYL ESTER; 2-ISOCYANO-2-(4-FLUOROPHENYL)-PROPIONIC ACID METHYL ESTER; 2-ISOCYANO-(INDOL-3-YL)-ACETIC ACID METHYL ESTER; 2-ISOCYANO-4-METHYLPENTANOIC ACID METHYL ESTER; 2-ISOCYANOHEXANOIC ACID METHYL ESTER; 2-ISOCYANOADIPIC ACID DIMETHYL ESTER; 2,5-DIISOCYANOVALERIC ACID METHYL ESTER; 2-(1′-ISOCYANOCYCLOHEXYL) ACETIC ACID METHYL ESTER; METHYL 3-ISOCYANO-3-(3-NITROPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(4-METHYLPHENYL)PROPIONATE; METHYL-3-ISOCYANO-3-(4-BENZYLOXYPHENYL)PROPIONATE; 2-ISOCYANOOCTANOIC ACID METHYL ESTER; 2-ISOCYANOSUCCINIC ACID DIMETHYL ESTER; 2-ISOCYANOVALERIC ACID METHYL ESTER; METHYL 3-ISOCYANO-3-(3-FLUOROPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(4-FLUOROPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(4-ISOPROPYLPHENYL)PROPIONATE; 2-ISOCYANO-3-(BENZYLTHIO)PROPIONIC ACID METHYL ESTER; 2-ISOCYANO-2,4-DIMETHYLPENTANOIC ACID METHYL ESTER; 2-ISOCYANO-4-(METHYLTHIO)BUTYRIC ACID METHYL ESTER; METHYL-2-ISOCYANO-3-(METHYLTHIO)-PROPIONATE; 2-ISOCYANO-3,3-DIMETHYLBUTYRIC ACID METHYL ESTER; METHYL 3-ISOCYANO-3-(2-FLUOROPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(3,4-METHYLENEDIOXYPHENYL)PROPIONATE; 3-DIMETHYLAMINO-2-ISOCYANOACRYLIC ACID METHYL ESTER; 2-ISOCYANO-3-PHENYLPROPIONIC ACID METHYL ESTER; METHYL 3-ISOCYANO-3-(4-HEXYLOXYPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(2,3-DICHLOROPHENYL)PROPIONATE; METHYL-3-ISOCYANO-3-(4-CYANOPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(4-METHYLTHIOPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-PHENYLPROPIONATE; METHYL-3-ISOCYANO-3-(4-BENZALDEHYDEDIETHYLACETAL)PROPIONATE; METHYL-3-ISOCYANO-3-(4-BROMOPHENYL)PROPIONATE; 2-ISOCYANOGLUTARIC ACID METHYL ESTER; METHYL 2-ISOCYANO-3-METHYLPENTANOATE; METHYL 3-ISOCYANO-3-(4-TRIFLUOROMETHYLPHENYL)PROPIONATE; METHYL 3-ISOCYANO-3-(4-METHOXYPHENYL)PROPIONATE; METHYL-3-ISOCYANO-4-CHLOROBENZOATE; METHYL-3-ISOCYANO-2-METHYLBENZOATE; METHYL 3-ISOCYANO-4-METHYLBENZOATE; METHYL-4-ISOCYANOBENZOATE; METHYL-1-ISOCYANOCYCLOHEXYL-CARBOXYLATE; METHYL 3-ISOCYANOPROPANOATE; METHYL-3-ISOCYANOBENZOATE; METHYL 2-ISOCYANOISOVALERATE; 2-ISOCYANOPROPIONIC ACID METHYL ESTER; METHYL-2-ISOCYANO-ISOBUTYRATE; (S,R)-METHYL-2-ISOCYANO-3-METHYL-3-PHENYLPROPIONATE; METHYL-3-ISOCYANO-(3-METHOXYPHENYL)PROPIONATE; 8-ISOCYANO-OCTANOIC ACID METHYL ESTER; METHYL-4-ISOCYANO-5-CHLORO-2-METHOXYBENZOATE; METHYL-3,5-DIISOCYANOBENZOATE; METHYL-3-METHYLCARBOXYMETHYL-THIO-2-ISOCYANOPROPIONATE; METHYL-2-ISOCYANO-5-CHLORO-BENZOATE; METHYL-2-ISOCYANO-3-METHYL-BENZOATE; METHYL-2-ISOCYANO-6-CHLORO-BENZOATE; METHYL-2-ISOCYANO-6-FLUOR-BENZOATE; METHYL-2-ISOCYANO-5-BROMO-BENZOATE; METHYL-2-ISOCYANO-4,5-DIMETHOXY-BENZOATE; METHYL-3-ISOCYANO-2-NAPHTHALINOATE; METHYL-4-(ISOCYANOMETHYL)-BENZOATE; METHYL-2-ISOCYANO-3,5-DICHLORO-BENZOATE; METHYL-2-ISOCYANO-5-METHYL-BENZOATE; METHYL-2-ISOCYANO-6-METHYL-BENZOATE; METHYL-2-ISOCYANO-5-NITRO-BENZOATE; METHYL-2-ISOCYANO-4-FLUOR-BENZOATE; METHYL-3-ISOCYANOHEXANOATE; METHYL-2-ISOCYANO-3-(4-IMIDAZOLYL)PROPIONATE; METHYL-1-ISOCYANO-1-CYCLOPENTAN-CARBOXYLATE; 2-ISOCYANO-4-(METHYLSELENO) BUTYRIC ACID METHYL ESTER; METHYL-2-ISOCYANOBENZOATE; DIMETHYL 2-ISOCYANOTEREPHTHALATE; METHYL-2-ISOCYANO-4-CHLORO-BENZOATE; SCHOLLKOPF ISOCYANIDE; METHYL-3-[3,5-BIS(TRIFLUOROMETHYL)-PHENYL]-2-ISOCYANO-PROPIONATE; METHYL-2-ISOCYANO-3-(4-CHLORO-PHENYL)-PROPIONATE; METHYL 3-(1H-INDOL-3-YL)-2-ISOCYANOPROPANOATE; METHYL 2-ISOCYANO-3-(4-BENZYLOXY-PHENYL)-PROPIONATE; METHYL-2-ISOCYANO-3-(4-FLUORO-PHENYL)-PROPIONATE; METHYL-4-ISOCYANO-3-METHYL-BENZOATE; METHYL-(−1-ISOCYANOCYCLOPROPYL)-CARBOXYLATE; METHYL-3-ISOCYANO-4-METHOXY-BENZOATE; METHYL 4-ISOCYANOPHENYLACETATE; 2-ISOCYANO-3-ACETYL PROPIONIC ACID METHYL ESTER; METHYL-2-ISOCYANONAPHTHALENE CARBOXYLATE; 2-ISOCYANOPHENYL ACETIC ACID METHYL ESTER; METHYL (2R)-2-AMINO-3-(4,6-DIAMINO-3-ISOCYANO(2-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(4,6-DIAMINO-3-ISOCYANO(2-PYRIDYL))PROPANOATE; METHYL-4-ISOCYANO-3-(TRIFLUOROMETHOXY)-BENZOATE; METHYL-2-ISOCYANO-3-(TRIFLUOROMETHYL)-BENZOATE; METHYL-3-ISOCYANO-5-(TRIFLUOROMETHYL)-BENZOATE; METHYL-2-ISOCYANO-6-(TRIFLUOROMETHYL)-BENZOATE; METHYL-2-HYDROXYMETHYL-ISOCYANO-ACETATE; METHYL-3-(4-T-BUTOXYPHENYL)-2-ISOCYANO-PROPIONATE; METHYL-3-(N—BOC-AMINO)-5-ISOCYANO-BENZOATE; CN-GLY-PRO-OME; METHYL-2-FLUORO-4-ISOCYANOBUTYRATE; METHYL-3-ISOCYANO-4-FLUOROBENZOATE; METHYL-2-ISOCYANO-5-FLUOROBENZOATE; METHYL-2-FLUORO-4-ISOCYANOBENZOATE; METHYL-3-FLUORO-4-ISOCYANOBENZOATE; METHYL-2-FLUORO-5-ISOCYANOBENZOATE; 2-ISOCYANO-BUTANOIC ACID METHYL ESTER
Without methyl ester functionality; TERT-BUTYL ISOCYANIDE; 1,1,3,3-TETRAMETHYLBUTYL ISOCYANIDE; BENZYL ISOCYANIDE; N-BUTYLISOCYANIDE; CYCLOHEXYL ISOCYANIDE; 1,6-DIISOCYANOHEXANE; 1,4-DIISOCYANOBENZENE; 2,6-DIMETHYLPHENYL ISOCYANIDE; I-PROPYLISOCYANIDE; 2-MORPHOLINOETHYL ISOCYANIDE; 3-ISCYANOPROPYLTOSYLATE; (ISOCYANOMETHYL)TRIMETHYLSILANE; DIETHYL ISOCYANOMETHYLPHOSPHONATE; 3-ISOCYANATOPROPYLTRIMETHOXYSILANE; HEXYL ISOCYANIDE; 1-(ISOCYANOMETHYL)-1H-BENZOTRIAZOLE; 4-ETHYLPHENYL ISOCYANIDE; TRIPHENYLMETHYLISOCYANIDE; XANTHOASCIN; XANTOCILLIN; XANTHOCILLIN X MONOMETHYL ETHER; ETHYL ISOCYANIDE; 6-OXABICYCLO(3.1.0)HEX-3-ENE-2-METHANOL, 2-HYDROXY-4-ISOCYANO-ALPHA-METHYL-, (1-ALPHA,2-BETA,2(R*),5-ALPHA)-(−)-; BIS-(4-ISOCYANOPHENYL)METHANE; 3,5-BIS(TRIFLUOROMETHYL)PHENYLISOCYANIDE; 4-CHLORO-2-ISOCYANO-1-METHOXY-BENZENE; 2-ISOCYANO-5-CHLORBENZOTRIFLUORIDE; 2,3-DICHLOROPHENYLISOCYANIDE; 1,3-DICHLORO-5-ISOCYANOBENZENE; 1-ISOCYANO-2,5-DIMETHOXY-4-NITRO-BENZENE; 2-METHOXY-5-NITRO-PHENYL-ISOCYANIDE; 4-NITROPHENYLISOCYANIDE; 2-METHOXY-4-NITROPHENYL ISOCYANIDE; 2-METHYL-5-NITROPHENYL ISOCYANIDE; 4-METHYL-3-NITRO-PHENYLISOCYANIDE; 3-NITROPHENYLISOCYANIDE; CARDIO-SPECT; 1-ADAMANTANEISOCYANIDE; 4-METHOXYBENZYL ISOCYANIDE; 1-ETHOXY-4-(ISOCYANOMETHYL)BENZENE; 3-FLUOROBENZYLISOCYANIDE; 3-CHLOROBENZYLISOCYANIDE; 3-METHOXYBENZYLISOCYANIDE; 2-CHLOROBENZYLISOCYANIDE; 2-METHOXYBENZYLISOCYANIDE; 2-TRIFLUOROMETHYLBENZYLISOCYANIDE; 1-(2-ISOCYANOETHYL)-4-METHOXYBENZENE; 2-METHYLBENZYLISOCYANIDE; 3-METHYLBENZYLISOCYANIDE; 1-(ISOCYANOMETHYL)-4-METHYLBENZENE; 3,4-DIMETHOXYBENZYL ISOCYANIDE; 1,3-BENZODIOXOL-5-YLMETHYL ISOCYANIDE; (1-ISOCYANOETHYL)BENZENE; 2-PHENOXYPHENYLISOCYANIDE; 3-PHENYLPROPYL ISOCYANIDE; (2-ISOCYANOETHYL)BENZENE; 1,3-DICHLORO-2-(2-ISOCYANOETHYL)BENZENE; 4-FLUOROPHENETHYLISOCYANIDE; BETA-METHYLPHENYLETHYLISOCYANIDE; 2-(4-CHLOROPHENYL)ETHYLISOCYANIDE; 1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL ISOCYANIDE; ISOAMYLISOCYANIDE; 2-ISOCYANOMETHYLTETRAHYDRO-FURANE; OCTYL ISOCYANIDE; 3-TRIFLUOROMETHYLBENZYLISOCYANIDE; 2-FLUOROBENZYLISOCYANIDE; 2-METHOXYPHENYL ISOCYANIDE; 3-METHOXYPHENYL ISOCYANIDE; 1-BENZYL-4-ISOCYANOPIPERIDINE; 1-BENZYL-4-(ISOCYANOMETHYL)-4-PHENYLPIPERIDINE; 9-ETHYL-3-ISOCYANO-9H-CARBAZOLE; 2,2-DIPHENYLETHYLISOCYANIDE; 1-ISOCYANO-3,3-DIPHENYLPROPANE; 4-PHENYLBUT-1-YLISOCYANIDE; 2-PENTYL ISOCYANIDE; 2-ISOCYANOBUTANE; 1-PENTYL ISOCYANIDE; DIPHENYLMETHYL ISOCYANIDE; 3,4-DICHLOROPHENYLISOCYANIDE; 3-ISOCYANOBENZONITRILE; 2,2-DIMETHOXYETHYL ISOCYANIDE; CYCLOPENTYL ISOCYANIDE; 2-CYANOPHENYLISONITRILE; 4-ISOCYANOBENZONITRILE; 1-ISOCYANO-2-(TRIFLUOROMETHYL)BENZENE; 3-ISOCYANO-4-CHLOROBENZOTRIFLUORIDE; 3-ISOCYANOBENZOTRIFLUORIDE; 5-ISOCYANO-2-CHLOROBENZOTRIFLUORIDE; 3-(ISOCYANOMETHYL)PYRIDINE; 4-(ISOCYANOMETHYL)PYRIDINE; 5-METHYLHEX-2-YLISOCYANIDE; 2-(ISOCYANOMETHYL)PYRIDINE; 1-BENZOYL-4-(2-ISOCYANOETHYL)PIPERAZINE; 1-(2-ISOCYANOETHYL)-PIPERIDINE; 1-METHYL-3-PHENYLPROPYLISOCYANIDE; 2-BROMOBENZYLISOCYANIDE; 3-BROMOBENZYLISOCYANIDE; 4-METHOXYPHENYL ISOCYANIDE; 4-BENZYLOXYPHENYLISOCYANIDE; 2,4-DICHLOROPHENYL ISOCYANIDE; 1-CHLORO-2-ISOCYANOBENZENE; 2,5-DICHLOROPHENYL ISOCYANIDE; 2,6-DICHLOROPHENYL ISOCYANIDE; 3-CHLORO-4-FLUOROPHENYLISOCYANIDE; 4-CHLORO-2-FLUORO-1-ISOCYANOBENZENE; 5-CHLORO-2-METHYLPHENYL ISOCYANIDE; 3-CHLORO-4-METHYLPHENYLISOCYANIDE; 3-CHLORO-2-METHYL-PHENYL-ISOCYANIDE; 4-SEC-BUTYLPHENYL ISOCYANIDE; 4-TERT-BUTYLPHENYLISOCYANIDE; 2-SEC-BUTYLPHENYL ISOCYANIDE; 2-ISOPROPYL-PHENYLISOCYANIDE; 2-ETHYLPHENYL ISOCYANIDE; 4-ISOPROPYL-PHENYLISOCYANIDE; 4-(TRIFLUORMETHOXY)-PHENYL-ISOCYANIDE; 2,3-DIMETHYLPHENYLISOCYANIDE; 2,4-DIMETHYLPHENYL ISOCYANIDE; 2,5-DIMETHYLPHENYL ISOCYANIDE; 3,5-DIMETHYLPHENYL ISOCYANIDE; 3,4-DIMETHYLPHENYL ISOCYANIDE; N-(4-ISOCYANOPHENYL)-N,N-DIMETHYLAMINE; 1-ISOCYANONAPHTHALENE; CYCLOHEPTYL ISOCYANIDE; CYCLOCTYLISOCYANIDE; 2-CYCLOHEXEN-1-YLETHYLISOCYANIDE; 2-(3,4-DIMETHOXYPHENYL)ETHYLISOCYANIDE; 3,4-DIFLUORPHENYLISOCYANIDE; 2,4-DIFLUOROPHENYL ISOCYANIDE; 1,4-DIISOCYANOBUTANE; 1,3-DIISOCYANOPROPANE; N-(3-ISOCYANOPROPYL)-N,N-DIMETHYLAMINE; N,N-DIETHYL-N-(3-ISOCYANOPROPYL)AMINE; 2-ISOCYANO-N,N-DIMETHYLETHANAMINE; 4-(3-ISOCYANOPROPYL)MORPHOLINE; 3-METHOXYPROPYL ISOCYANIDE; 3-BUTOXYPROP-1-YLISOCYANIDE; 1-ISOCYANO-3-ISOPROPOXYPROPANE; 3-ISOCYANOOCTANE; TERT-AMYLISOCYANIDE; 2-ISOCYANOOCTANE; 5-ISOCYANOMETHYL-2-DIMETHYL-DIOXOLANE; 4-BROMOBENZYLISOCYANIDE; 4-FLUOROBENZYLISOCYANIDE; 4-CHLOROBENZYLISOCYANIDE; (S)-(−)-ALPHA-METHYLBENZYL ISOCYANIDE; ISONITRILOMETHYL PS RESIN; TUNGSTEN(0) PENTACARBONYL-N-PENTYLISONITRILE; 5-CHLORO-2-ISOCYANOPYRIDINE; 5-BROMO-2-ISOCYANOPYRIDINE; 1-ISOCYANO-4-PHENOXYBENZENE; 1-(3-ISOCYANOPHENYL)ETHANONE; 1-FLUORO-3-ISOCYANOBENZENE; 2,6-DIBROMO-4-FLUOROPHENYLISOCYANIDE; 3-BROMO-4-FLUOROBENZYLISOCYANIDE; 5-BROMO-2-FLUOROBENZYLISOCYANIDE; 1-(4-CHLOROPHENYL)ETHYL ISOCYANIDE; 2-CHLORO-6-FLUOROBENZYLISOCYANIDE; 3,4,5-TRIMETHOXYBENZYLISOCYANIDE; 3,5-BIS(TRIFLUOROMETHYL)BENZYLISOCYANIDE; 2,4-DIFLUOROBENZYLISOCYANIDE; 2,5-DIFLUOROBENZYLISOCYANIDE; 2,5-DIMETHYLBENZYLISOCYANIDE; D-(+)-ALPHA-METHYLBENZYLISOCYANIDE; 1-(4-BROMOPHENYL)ETHYLISOCYANIDE; 2-PHENYLPROP-2-YLISOCYANIDE; 4-(TRIFLUOROMETHOXY)BENZYLISOCYANIDE; 2,6-DIFLUORBENZYLISOCYANIDE; 3-(METHYLTHIO)PHENYLISOCYANIDE; 1-BROMO-4-ISOCYANOBENZENE; 3-NITROBENZYLISOCYANIDE; 4-ISOCYANOBENZOPHENONE; 4-ETHOXYPHENYLISOCYANIDE; 2-CHLORO-4-NITROPHENYLISOCYANIDE; 2-ETHOXYPHENYLISOCYANIDE; CYCLOPROPYL ISOCYANIDE; (S)-(+)-1-ISOCYANOINDANE; (R)-(−)-1-ISOCYANOINDANE; 4-BROMO-2-FLUOROBENZYLISOCYANIDE; 4-CHLORO-2-FLUOROBENZYLISOCYANIDE; 1-FLUORO-2-ISOCYANOBENZENE; 4-METHYLPHENYLISOCYANIDE; 4-ISOCYANO-3-NITROBENZOTRIFLUORIDE; 2-METHYLPHENYLISOCYANIDE; 2-METHYL-6-ISOPROPYLPHENYLISOCYANIDE; (S)-3,3-DIMETHYLBUTY-2-YLISOCYANIDE; 4-TERT-BUTYLBENZYLISOCYANIDE; 2,2-DIPHENYLPROPYLISOCYANIDE; 2,4-DIMETHOXYPHENYLISOCYANIDE; 2,5-DIMETHOXYPHENYLISOCYANIDE; 4-BROMO-2-FLUOROPHENYLISOCYANIDE; 3,3-DIMETHYLBUT-1-YLISOCYANIDE; (R)-3,3-DIMETHYLBUT-2-YLISOCYANIDE; 2,2-DIMETHYLPROPYLISOCYANIDE; CYCLODODECYLISOCYANIDE; 1-ISOCYANOINDANE; 2-(3-METHOXYPHENYL)ETHYL-ISOCYANIDE; 3,5-DIMETHYLBENZYLISOCYANIDE; 3-ISOCYANO-4-METHOXY-1,1′-BIPHENYL; 2-ISOCYANO-5-CHLORO-2′-FLUOROBENZOPHENONE; 2-ISOCYANO-2′-FLUORO-5-BROMO-BENZOPHENONE; 2-BROMOPHENYLISOCYANIDE; 3,4-DIMETHOXYPHENYLISOCYANIDE; 3-ISOCYANO-PHENYLFORMAMIDE; 4-FLUOROPHENYL ISOCYANIDE; 4-ISOCYANOACETOPHENONE; 1-ISOCYANO-2-PHENYLBENZENE; 1-CYANO-4-ISOCYANONAPHTHALENE; 2-FLUOROPHENETHYLISOCYANIDE; 2-(3-BROMOPHENYL)ETHYLISOCYANIDE; 2-(4-BROMOPHENYL)ETHYLISOCYANIDE; 2-(2-CHLOROPHENYL)ETHYLISOCYANIDE; 3,4-DICHLOROBENZYLISOCYANIDE; 2,4-DICHLORBENZYLISOCYANIDE; 2-(4-ISOCYANOPHENYL)ETHYL-ISOCYANIDE; 3-METHYLPHENETHYLISOCYANIDE; 4-CHLORO-2-METHOXY-5-METHYLPHENYL ISOCYANIDE; 2,4-DIBROMO-6-METHYLPHENYL-ISOCYANIDE; 2-BROMO-4-METHYLPHENYLISOCYANIDE; 2,5-DIBROMOPHENYLISOCYANIDE; 2-FLUOR-5-NITROPHENYLISOCYANIDE; 2,4,6-TRICHLOROPHENYLISOCYANIDE; 4-BROMO-2-CHLOROPHENYLISOCYANIDE; 2-METHYLPHENETHYLISOCYANIDE; 3-FLUOROPHENETHYLISOCYANIDE; 2,4-DICHLOROPHENETHYLISOCYANIDE; 2-(3-CHLORO-PHENYL)ETHYLISOCYANIDE; 3-CHLORO-2-METHOXYPHENYL-ISOCYANIDE; 1-ISOCYANO-4-(TRIFLUOROMETHYL)BENZENE; 3-BROMOPHENYLISOCYANIDE; 2,6-DIBROMO-4-NITROPHENYLISOCYANIDE; 2,6-DIBROMO-4-METHYLISOCYANIDE; 4-FLUORO-2-METHYLPHENYLISOCYANIDE; 2-METHOXY-5-METHYLPHENYL-ISOCYANIDE; 1-ISOCYANOBENZENE; 1-(2-ISOCYANOETHYL)-PYRROLIDINE; 1-(2-ISOCYANO-ETHYL)-4-METHYL-PIPERAZINE; (5-CHLORO-2-THIENYL)METHYLISOCYANIDE; 2-(THIEN-2-YL)ETHYLISOCYANIDE; 1-(2-ISOCYANOETHYL)-2,2-DIMETHYLPYRROLIDINE; 1-(3-CHLOROPHENYL)ETHYL ISOCYANIDE; 3-(1-ISOCYANO-ETHYL)-PYRIDINE; 4-(1-ISOCYANOETHYL)PYRIDINE; 4-BENZYL-1-(2-ISOCYANO-ETHYL)PIPERIDINE; 1-(2-ISOCYANO-ETHYL)-4-PYRIDIN-2-YL-PIPERAZINE; 1-CYCLOHEXYL-4-(2-ISOCYANO-ETHYL)-PIPERAZINE; 4-(TRIFLUOROMETHYL)BENZYL-ISOCYANIDE; 1-(2-CHLOROPHENYL)ETHYL ISOCYANIDE; 1-(1-ISOCYANO-ETHYL)-2-METHOXY-BENZENE; 1-(5-METHYL-2-THIENYL)ETHYL ISOCYANIDE; 1-(4-FLUOROPHENYL)ETHYLISOCYANIDE; 1-(2-ISOCYANO-ETHYL)-4-PHENYL-PIPERAZINE; 1-(2-ISOCYANOETHYL)-4-(2-PYRROLIDINOETHYL)-PIPERIDINE; N-2-ISOCYANOETHYL-2,3-DIHYDROINDOLE; 1-(2-ISOCYANOETHYL)-1,2,3,4-TETRAHYDROQUINOLINE; 1-(2-ISOCYANOETHYL)-6,7-DIEMTHOXY-1,2,3,4-TETRAHYDROQUINOLINE; 1-(2-ISOCYANO-ETHYL)-4-PHENYL-PIPERIDINE; 1-(3-CHLORO-PROPYL)-4-(2-ISOCYANO-ETHYL)-PIPERAZINE; 1-ALLYL-4-(2-ISOCYANO-ETHYL)-PIPERAZINE; 1-BUTYL-4-(2-ISOCYANOETHYL)PIPERAZINE; 1-(2-ISOCYANO-ETHYL)-4-ISOPROPYL-PIPERAZINE; 4-[4-(2-ISOCYANO-ETHYL)-PIPERAZIN-1-YL]-MORPHOLINE; 1-(2-ISOCYANO-ETHYL)-4-PYRROLIDIN-1-YL-PIPERAZINE; 1-(2-ISOCYANO-ETHYL)-4-(2-METHOXY-ETHYL)-PIPERAZINE; 1-(2-ISOCYANO-ETHYL)-4-(2-DIMETHYLAMINOETHYL)-PIPERAZINE; 1-(2-ISOCYANO-ETHYL)-4-(2-PYRIMIDINO)-PIPERAZINE; 1-(2-ISOCYANO-ETHYL)-4-(2-PYRAZINYL)-PIPERAZINE; 1-CHLORO-4-ISOCYANOBENZENE; 4-(DIETHYLAMINO)PHENYL ISOCYANIDE; 2-ISOCYANO-1-PHENYLETHANOLE; 1-(2-ISOCYANO-ETHYL)-4-PYRIDIN-4-YL-PIPERAZINE; 2-CHLORO-6-METHYLPHENYL ISOCYANIDE; METHYL ISOCYANIDE; 4-(2-DIMETHYLAMINO)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4,4′-DIISOCYANO-BIPHENYL; 4-(ISOCYANOMETHYL)BENZYL-ISOCYANIDE; 1,4-BIS(3-ISOCYANOPROPYL)PIPERAZINE; 3-ISOCYANOPHENYLISOCYANIDE; 1,2-DIISOCYANOCYCLOHEXANE; 1,4-DIISOCYANOCYCLOHEXANE; 1,3-DIISOCYANO-2,2-DIMETHYL-PROPANE; 3-(2-ISOCYANOETHYL)-1H-INDOLE; 4-(3-CHLOROPROPYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-N-BUTYL-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-(2-PYRIMIDINO)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-(2-PYRAZINYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-(2-PYRIDYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-(4-PYRIDYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; N-METHYLPIPERAZINO-ISOCYANO-ACETAMIDE; 6-ISOCYANOQUINOLINE; 3-(ISOCYANOMETHYL)BENZYL-ISOCYANIDE; 1,2-DIISOCYANO-2-METHYLPROPANE; 1,5-DIISOCYANOPENTANE; 1,7-DIISOCYANOHEPTANE; 4,4′-DIISOCYANO-3,3′-DIMETHOXY-BIPHENYL; 1,2-BIS-(2-ISOCYANOETHOXY)-ETHANE; 1,3-BIS(ISOCYANOMETHYL)CYCLO-HEXANE; 4-ALLYL-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-ISOPROPYL-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-CYCLOHEXYL-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-[((2-MORPHOLINO-4-YL)ETHYL)]-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-(2-PYRROLIDINOETHYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; 1,2-DIISOCYANOETHANE; 4-(2-METHOXYETHYL)-PIPERAZINO-ISOCYANO-ACETAMIDE; 4-CHLORO-2-METHYLPHENYL ISOCYANIDE; (S,S)-1,2-DIISOCYANOCYCLO-HEXANE; 4-(2-PYRROLIDINOETHYL)-1-PIPERIDINO-2-ISOCYANOACETAMIDE; 1-PYRROLIDINO-2-ISOCYANOACETAMIDE; 4-(1-PYRROLIDINO)-PIPERIDINO-ISOCYANO-ACETAMIDE; 4-METHYL-PIPERIDINO-ISOCYANO-ACETAMIDE; 1-CYCLOHEXENYLISOCYANIDE; 1,10-DIISOCYANODECANE; 2-(2-ISOCYANOETHYL)PYRIDINE; N-MORPHOLINO-2-ISOCYANOACET-AMIDE; N-PIPERIDINO-2-ISOCYANOACETAMIDE; 4-BENZYL-PIPERIDINO-ISOCYANO-ACETAMIDE; 2,6-DIMETHYL-PIPERIDINO-ISOCYANO-ACETAMIDE; 4-PHENYL-PIPERIDINO-ISOCYANO-ACETAMIDE; (5-METHYL-2-FURYL)METHYL ISOCYANIDE; 1,3-DIMETHYLBUT-1-YLISOCYANIDE; 6-METHYLHEPT-2-YLISOCYANIDE; 2-NAPHTHYL ISOCYANIDE; 2-ISOCYANO-3-PHENYL-PROPIONIC-ACIDMORPHOLINAMIDE; 3,5-DIFLUORBENZYLISOCYANIDE; 4-FORMYLAMINOPHENYLISOCYANIDE; 2-(ISOCYANOMETHYL)FURAN; 2-ISOCYANOPYRIDINE; 2,3-DIHYDRO-6-ISOCYANO-1,4-BENZODIOXINE; 1-CHLORO-3-ISOCYANOBENZENE; 2-CHLORO-5-NITROPHENYLISOCYANIDE; 2,4-DIBROMPHENYLISOCYANIDE; 1-CHLORO-5-ISOCYANO-2,4-DIMETHOXYBENZENE; 3-PHENOXY-PHENYLISOCYANIDE; 3-CHLORO-2-FLUOROPHENYLISOCYANIDE; 1-ISOCYANO-2-METHOXYETHANE; 1-(3-ISOCYANOPROPYL)-1H-IMIDAZOLE; 3,4,5-TRIMETHOXYPHENYLISOCYANIDE; 1-ISOCYANO-3,3-DIETHOXYPROPANE; 1,8-DIISOCYANOOCTANE; 2,2-DIETHOXY-1-ISOCYANOETHANE; 1-(2-ISOCYANOPHENYL)PYRROLE; (R)-(+)-ALPHA-(1-NAPHTHYL)-ETHYL-ISOCYANIDE; (S)-(−)-ALPHA-(1-NAPHTHYL)-ETHYL-ISOCYANIDE; 4-(4-ISOCYANOPHENYL)MORPHOLINE; 4-NITROPHENYLETHYLISOCYANIDE; 5-ISOCYANOMETHYLINDOLE; 3-ISOCYANOPROPYLTRIETHOXYSILANE; 1-(3-ISOCYANOPROPYL)-2-PYRROLIDINONE; 2-(2-ISOCYANOETHOXY)PROPANE; 1-(2-ISOCYANOETHOXY)PROPANE; 1-ETHOXY-2-ISOCYANOETHANE; 2-TERT-BUTOXYETHYL ISOCYANIDE; 1,3-BENZODIOXOL-5-YLISOCYANIDE; 2-ISOCYANO-1,3,5-TRIMETHYLBENZENE; 4-ISOCYANO-1,3,5-TRIMETHYL-1H-PYRAZOLE; 8-ISOCYANOQUINOLINE; (1-ISOCYANO-2-PHENYLETHYL)BENZENE; 1-(ISOCYANOMETHYL)NAPHTHALENE; 4-PHENYLCYCLOHEXENYLISOCYANIDE; 3-CHLORO-5-METHOXYPHENYLISOCYANIDE; 2-IODOPHENYL ISOCYANIDE; 3-CHLORO-4-METHOXYPHENYLISOCYANIDE; 2-(3,4-DIETHOXYPHENYL)ETHYL ISOCYANIDE; 2,4-DIMETHOXYBENZYL ISOCYANIDE; 3-METHYLPHENYL ISOCYANIDE; 2-CHLORO-5-(TRIFLUOROMETHYL)BENZYL-ISOCYANIDE; 1,3-DIETHYL-2-ISOCYANO-BENZENE; 2,3-DICHLOROBENZYLISOCYANIDE; 4-CHLORO-3-(TRIFLUOROMETHYL)BENZYL-ISOCYANIDE; 2,3-DIMETHYLBENZYLISOCYANIDE; 4-METHYL-3-CHLOROBENZYL-ISOCYANIDE; 2,4,6-TRIMETHYLBENZYLISOCYANIDE; 3-CHLORO-4-FLUOROBENZYLISOCYANIDE; 2,6-DICHLOROBENZYLISOCYANIDE; 4-PHENOXY-BENZYLISOCYANIDE; 3-PHENOXYBENZYL ISOCYANIDE; 2-METHYL-3-NITROPHENYL ISOCYANIDE; 2-METHYL-4-NITROPHENYL ISOCYANIDE; ALLYLISOCYANIDE; CYCLOBUTYL ISOCYANIDE; 4-BROMO-2-METHYLPHENYL ISOCYANIDE; 1-ISOPROPYL-2-METHYLPROPYL ISOCYANIDE; 1,7,7-TRIMETHYLBICYCLO[2.2.1]HEPT-2-YL ISOCYANIDE; 4-(2-ISOCYANOETHYL)PYRIDINE; 2-NITROPHENYL ISOCYANIDE; 2-ISOCYANO-N,N-DIMETHYL-2-PYRIDIN-4-YLETHYLENAMINE; 1,2,3,4-TETRAHYDRO-CHINOLINO-1-ISOCYANOACETAMIDE; 4-(METHYLTHIO)PHENYLISOCYANIDE; 2-ISOCYANO-2-METHYLPROPANE HYDROCHLORIDE; 5-ISOCYANO-PYRIDINE-2,4-DIAMINE; 5-BROMO-2-ISOCYANO-1,3-DIMETHYLBENZENE; 2,5-DIFLUORO-PHENYLISOCYANIDE; 2,6-DIFLUORO-PHENYLISOCYANIDE; 2,4,6-TRIFLUORO-PHENYLISOCYANIDE; 2-ETHYL-6-METHYL-PHENYLISOCYANIDE; 2-ISOCYANO-9-FLUORENONE; 2-(TRIFLUORMETHOXY)-PHENYLISOCYANIDE; 2-ISOCYANOBENZOPHENONE; 2-ISOCYANO-5-CHLORBENZO-PHENONE; 2-ISOCYANO-2′,5-DICHLORBENZO-PHENONE; 2-NITRO-4-METHOXYPHENYL-ISOCYANIDE; 2-ISOPROPENYL-PHENYLISOCYANIDE; 2,3,4-TRIFLUORO-PHENYLISOCYANIDE; 2-CHLORO-4-FLUORO-5-METHYL-PHENYLISOCYANIDE; 4-BUTOXY-PHENYLISOCYANIDE; 4-METHOXY-2-METHYL-PHENYL-ISOCYANIDE; 2-METHOXYISOBUTYL ISOCYANIDE; PROPANE, 2-ISOCYANO-2-METHYL-, ZINC COMPLEX; 2-(4-ISOCYANOPHENYL)ACETONITRILE; 5-FLUORO-2-METHYL-PHENYL-ISOCYANIDE; 3,5-DIMETHOXY-PHENYLISOCYANIDE; 4-ISOCYANO-3-CHLOROBENZOTRI-FLUORIDE; 4-OCTYLOXY-PHENYLISOCYANIDE; 5-BROMO-2-METHYL-PHENYL-ISOCYANIDE; 2,4,5-TRIFLUORO-PHENYLISOCYANIDE; 4-VINYL-PHENYLISOCYANIDE; 3,3-DIFLUORO-PHENYLISOCYANIDE; 3-ETHYL-PHENYLISOCYANIDE; 3-FLUORO-2-METHYL-PHENYL-ISOCYANIDE; 4-PROPYL-PHENYLISOCYANIDE; 2-BROMO-4-TRIFLUOROMETHOXY-PHENYLISOCYANIDE; 3-BROMO-4-METHYL-PHENYL-ISOCYANIDE; 1-ISOCYANO-3-(TRIFLUOROMETHOXY)BENZENE; 1,2-DIFLUORO-3-ISOCYANO-BENZENE; 4-HEXYL-PHENYLISOCYANIDE; 2-FLUORO-5-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 2-METHOXY-5-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 4-BROMO-5-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; (3-ISOCYANOPHENYL)(PHENYL)METHANONE; 2-TERT-BUTYL-PHENYLISOCYANIDE; 5-ISOCYANO-1H-INDOLE; 2-FLUORO-5-METHYL-PHENYLISOCYANIDE; 3-FLUORO-4-METHYL-PHENYLISOCYANIDE; 3-TRIFLUOROMETHYL-4-FLUORO-PHENYLISOCYANIDE; 2-METHOXYDIBENZO[B,D]FURAN-3-YL ISOCYANIDE; 1-(ISOCYANOMETHYL)-2,3-DIMETHOXYBENZENE; 6-ISOCYANO-1-METHYL-1H-INDOLE; 5-ISOCYANO-1-METHYL-1H-INDOLE; 6-BROMO-5-ISOCYANO-PYRIDINE-2,4-DIAMINE; 5-ISOCYANO-1H-INDAZOLE; 1-BENZYL-5-ISOCYANO-1H-INDAZOLE; 1-(ISOCYANOMETHYL)-3-(TRIFLUOROMETHOXY)BENZENE; 5-FLUORO-2-ISOCYANO-1,3-DIMETHYL-BENZENE; 1-(2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYL)-3-ISOCYANO-1H-PYRAZOL-5-AMINE; 1-ISOCYANO-3,5-DIMETHYLADAMANTANE; 2,3-DIHYDRO-6-ISOCYANOBENZO[E][1,3]OXAZIN-4-ONE; N-(4-ISOCYANOPHENYL)ACETAMIDE; 3-((1S,3S)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 3-((1R,3R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 4-((1S,3S)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 4-((1R,3R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; (R)-1-(4-ISOCYANOPHENYL)ETHANOL; (S)-1-(4-ISOCYANOPHENYL)ETHANOL; 3-((1R)-1-AMINO-2-HYDROXY-ISOPROPYL)BENZENISOCYANIDE; 3-((1S)-1-AMINO-2-HYDROXY-ISOPROPYL)BENZENISOCYANIDE; 4-((1R)-1-AMINO-2-HYDROXY-ISOPROPYL)BENZENISOCYANIDE; 4-((1S)-1-AMINO-2-HYDROXY-ISOPROPYL)BENZENISOCYANIDE; 4-((1S,3R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 3-((3S,1R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 3-((1S,3R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 4-((3S,1R)-3-AMINO-1,4-DIHYDROXYBUTYL)BENZENISOCYANIDE; 2-ISOCYANO-1-METHOXY-3-METHYL-BENZENE; 1-(2-ISOCYANOETHYL)-3-TRIFLUOROMETHOXYBENZENE; 4-PHENYL-PIPERAZINO-ISOCYANO-ACETAMIDE; 2-CHLORO-4-ISOCYANOMETHYL-PYRIDINE; 2,4′-DIISOCYANO-BIPHENYL; 2,4-DIBROMO-6-FLUORPHENYLISOCYANIDE; 2,6-DIBROMO-4-(TRIFLUOROMETHOXY)PHENYL-ISOCYANIDE; 2,4-DIBROMO-6-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 2,6-DICHLORO-4-(TRIFLUOROMETHOXY)PHENYL-ISOCYANIDE; 2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYL-ISOCYANIDE; 3-(DIFLUOROMETHOXY)PHENYLISOCYANIDE; 1,5-BIS-ISOCYANOMETHYL-2,4-DIMETHYL-BENZENE; R-1-ISOCYANO-1,2,3,4-TETRA-HYDRONAPHTHALENE; 4-BROMO-3,5-DIFLUORO-PHENYLISOCYANIDE; 5-BROMO-2,4-DIFLUORO-PHENYLISOCYANIDE; 2-BROMO-4-FLUOROPHENYLISOCYANIDE; 2-BROMO-5-FLUOROPHENYLISOCYANIDE; 3-BROMO-4-FLUOROPHENYLISOCYANIDE; 4-BROMO-3-FLUOROPHENYLISOCYANIDE; 2-CHLORO-4,6-DIFLUORO-PHENYLISOCYANIDE; 2-CHLORO-4-FLUOROPHENYLISOCYANIDE; 2-CHLORO-5-FLUOROPHENYLISOCYANIDE; 2-CHLORO-6-FLUOROPHENYLISOCYANIDE; 4-CHLORO-3-FLUOROPHENYLISOCYANIDE; 5-CHLORO-2-FLUOROPHENYLISOCYANIDE; 2-CHLORO-5-FLUORO-4-NITROPHENYL-ISOCYANIDE; 4-(DIFLUOROMETHOXY)PHENYLISOCYANIDE; (1S,2R,5R)6,6-DIMETHYLBICYCLO-[3.1.1]HEPT-2-YLMETHYL-ISOCYANIDE; 3-FLUORO-4-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 2-(2-METHOXYPHENOXY)-5-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 3-TRIFLUOROMETHOXY-4-ISOCYANOBENZONITRIL; 2,4-BIS(TRIFLUOROMETHYL)PHENYLISOCYANIDE; 2,5-BIS(TRIFLUOROMETHYL)PHENYLISOCYANIDE; 3,5-BIS(TRIFLUOROMETHYL)-2-METHYL-PHENYLISOCYANIDE; 4-[3,5-DI(TRIFLUOROMETHYL)PHENOXY]-PHENYLISOCYANIDE; 2-BROMO-4-CHLORO-6-FLUOROPHENYLISOCYANIDE; 2-BROMO-5-CHLORO-4-FLUOROPHENYLISOCYANIDE; 2-BROMO-6-CHLORO-4-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 2-BROMO-4,6-DIFLUORO-PHENYLISOCYANIDE; 4-BROMO-2,6-DIFLUORO-PHENYLISOCYANIDE; 5-BROMO-2-FLUOROPHENYLISOCYANIDE; 3-BROMO-4-(TRIFLUOROMETHOXY)-PHENYLISOCYANIDE; 4-BROMO-2-(TRIFLUOROMETHOXY)-PHENYLISOCYANIDE; 4-BROMO-3-(TRIFLUOROMETHOXY)-PHENYLISOCYANIDE; 5-CHLORO-4-FLUORO-2-NITROPHENYL-ISOCYANIDE; 2-CHLORO-4-TRIFLUOROMETHOXY-PHENYLISOCYANIDE; 3-CHLORO-4-TRIFLUOROMETHOXY-PHENYLISOCYANIDE; 3-ISOCYANO-4-(METHYLTHIO)BENZOTRIFLUORIDE; 2-ISOCYANO-5-NITRO-BENZOTRIFLUORIDE; 3-ISOCYANO-4-NITRO-BENZOTRIFLUORIDE; 5-ISOCYANO-2-NITRO-BENZOTRIFLUORIDE; 4-ISOCYANO-NONAFLUOROBIPHENYL; 3-(TRIFLUOROMETHYLTHIO)-PHENYLISOCYANIDE; 4-(TRIFLUOROMETHYLTHIO)PHENYLISOCYANIDE; 4-[(3-(TRIFLUOROMETHYL)PHENYL)SULFANYL]-PHENYLISOCYANIDE; 3-ISOCYANO-4-(4-MORPHOLINO)BENZOTRIFLUORIDE; 3-ISOCYANO-4-(1-PIPERIDINO)-BENZOTRIFLUORIDE; 1,5-DIISOCYANO-NAPHTHALENE; 2-ISOCYANO-9H-FLUORENE; 2-BROMO-4-(TRIFLUOROMETHYL)-6-NITROPHENYL-ISOCYANIDE; 3-CHLORO-4-(TRIFLUOROMETHYL)PHENYL-ISOCYANIDE; 2-ISOCYANO-4-(4-CHLORO-3,5-DIMETHYLPHENOXY)-BENZOTRIFLUORIDE; 2-ISOCYANO-4-CHLORO-2′-FLUOROBENZOPHENONE; 3-CHLORO-5-NITRO-4-(TRIFLUOROMETHYL)-PHENYL-ISOCYANIDE; 2-CHLORO-5-NITRO-4-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 4-ISOCYANO-2-CYANO-3′-(TRIFLUOROMETHYL)DIPHENYL THIOETHER; 4-ISOCYANO-2,5-DIFLUOROBENZONITRILE; 2-ISOCYANO-5-(TRIFLUOROMETHYL)PYRIDINE; 2-ISOCYANO-6-(TRIFLUOROMETHYL)PYRIDINE; 3-ISOCYANO-4-(TRIFLUOROMETHYL)PYRIDINE; 3-ISOCYANO-6-(TRIFLUOROMETHYL)PYRIDINE; 4-BROMO-2-(TRIFLUORMETHYL)PHENYL-ISOCYANIDE; 2-BROMO-5-(TRIFLUORMETHYL)PHENYLISOCYANIDE; 3-BROM-5-(TRIFLUORMETHYL)PHENYL-ISOCYANIDE; 2,2′-DIISOCYANO-BIPHENYL; 2-BROMO-4-(TRIFLUOROMETHYL)PHENYL-ISOCYANIDE; 3-(4-ISOCYANOBENZYLTHIO)-BENZOTRIFLUORIDE; 3-CHLORO-2-FLUOROBENZYLISOCYANIDE; 5-CHLORO-2-FLUOROBENZYLISOCYANIDE; 6-CHLORO-2-FLUORO-3-METHYLBENZYLISOCYANIDE; 2,3-DIFLUORBENZYLISOCYANIDE; 3,4-DIFLUOROBENZYLISOCYANIDE; 2-(DIFLUOROMETHOXY)BENZYLISOCYANIDE; 1,4-DIISOCYANO-2-METHOXY-BENZENE; N-ALLYL-2-ISOCYANO-ACETAMIDE; N-ALLYL-2-ISOCYANO-N-METHYL-ACETAMIDE; N-ALLYL-2-BENZYL-2-ISOCYANO-ACETAMIDE; 2-ISOCYANO-4-METHYL-PENTANOIC ACID ALLYLAMIDE; 2-ISOCYANO-3-(5-IMIDAZO)-PROPIONIC ACID MORPHOLINAMIDE; N-PROPYLISOCYANIDE; 2-HYDROXY-CYCLOHEXYLISOCYANIDE; 3-(DIFLUOROMETHOXY)BENZYLISOCYANIDE; 3-ISOCYANO-2-(2-FLUOROPHENOXY)PYRIDINE; 5-FLUORO-2-ISOCYANOPYRIDINE; 2-ISOCYANO-4-(TRIFLUOROMETHYL)PYRIDINE; N-ALLYL-2-ISOCYANO-N-ETHYL-ACETAMIDE; 2-ISOCYANO-PROPIONIC ACID MORPHOLINAMIDE; PRIAXON 01648; 2-ISOCYANO-CYCLOHEXYLOXY-TRIMETHYLSILANE; 2-(TRIFLUOROMETHOXY)BENZYL-ISOCYANIDE; 5-ISOCYANO-2-CYANOBENZO-TRIFLUORIDE; 1-ETHYL-2-ISOCYANO-3-METHOXY-BENZENE; 4-ISOCYANO-3-P-TOLYL-1H-PYRAZOLE; 1,6-DICHLORO-4-FLUOROPHENYL-ISOCYANIDE; 2-(METHYLTHIO)ETHYLISOCYANIDE; 4-ISOCYANOBIPHENYL; 2-(2-CHLORO-6-FLUOROBENZYLTHIO)ETHYL-ISOCYANIDE; 2-CHLORO-3,6-DIFLUOROBENZYLISOCYANIDE; 3-CHLORO-2,6-DIFLUOROBENZYLISOCYANIDE; 2-CHLORO-4-FLUOROBENZYLISOCYANIDE; DIETHYL-(4-ISOCYANO-PENTYL)-AMINE; 2,6-DINITRO-4-(TRIFLUOROMETHYL)PHENYL-ISOCYANIDE; 2-FLUORO-5-ISOCYANOBENZONITRILE; 2-FLUORO-3-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; 3-FLUORO-5-(TRIFLUOROMETHYL)-PHENYLISOCYANIDE; BUTYL-(3-ISOCYANO-PROPYL)-(1-ISOCYANO-PROPYL)-AMINE; 4-ISOCYANO-1-METHOXY-2-NITRO-BENZENE; 2-ISOCYANO-5-NITRO-1H-PYRROLE; 2-ISOCYANO-5-NITRO-PYRIDINE; 2-ISOCYANO-3-PHENYL-1-(PYRROLIDIN-1-YL)PROPAN-1-ONE; 2-ISOCYANO-3-PHENYL-1-(PIPERIDIN-1-YL)PROPAN-1-ONE; 1-AMINO-5-ISOCYANOINDOLE; 2-ISOCYANOETHYLTOSYLATE; (E)-3-CHLORO-4,4,4-TRIFLUORO-2-ISOCYANOBUT-2-ENENITRILE; 2-ISOCYANO-3-METHYL-PYRIDINE; 5-ISOCYANO-PYRIDIN-3-OL; 4-ISOCYANOBENZOIC ACID MORPHOLIDE; P-TOLYLTHIOMETHYL ISOCYANIDE; 1-(2-ISOCYANO-ETHYL)-1,2,3,4-TETRAHYDRO-NAPHTHALENE; 2-ISOCYANOETHYL O-TOLYLSULFAMATE; (E)-4,4,4-TRIFLUORO-2-ISOCYANO-3-METHOXYBUT-2-ENENITRILE; 3-BROMO-5-ISOCYANOPYRIDIN-2-AMINE

List No. 2—aldehydes: including aldehydes from list no. 5; (−)-CITRONELLAL; (+)-CITRONELLAL; (1-FORMYL-2-OXO-2-PHENYLETHYL)SODIUM; (1-METHYL-1H-IMIDAZOL-4-YL)-ACETALDEHYDE; (1-METHYLPIPERIDIN-4-YL)ACETALDEHYDE; (1R,3S,5S)-8-METHYL-8-AZABICYCLO[3.2.1]OCTANE-3-CARBALDEHYDE; (1R,4R)-METHYL 4-FORMYLCYCLOHEXANECARBOXYLATE; (1S)-1,3,4-TRIMETHYL-3-CYCLOHEXENE-1-CARBALDEHYDE; (1S,2S)-2-(TRIFLUOROMETHYL)CYCLOPROPANE-1-CARBALDEHYDE; (1S,4R)-BICYCLO[2.2.1]HEPTANE-2-CARBALDEHYDE; (2,2,3-TRIMETHYL-CYCLOPENT-3-ENYL)-ACETALDEHYDE; (2,3,6-TRIFLUOROPHENYL)ACETALDEHYDE; (2,3-DIFLUORO-4-METHYLPHENYL)ACETALDEHYDE; (2,3-DIFLUOROPHENYL)ACETALDEHYDE; (2,4-DIFLUOROPHENYL)ACETALDEHYDE; (2,5-DIFLUORO-PHENYL)-ACETALDEHYDE; (2,6-DIFLUORO-3-METHYLPHENYL)ACETALDEHYDE; (2-CHLORO-5-FLUOROPHENYL)ACETALDEHYDE; (2-CYANO-5-FORMYLPHENYL)BORONIC ACID; (2-FLUORO-3-METHYLPHENYL)ACETALDEHYDE; (2-FORMYL-IMIDAZOL-1-YL)-ACETIC ACID METHYL ESTER; (2-FORMYLPHENOXY)ACETONITRILE; (2-FORMYL-PHENYL)-ACETONITRILE; (2-HYDROXY-PHENYL)-ACETALDEHYDE; (2-METHOXYPHENYL)ACETALDEHYDE; (2-METHYLPHENYL)ACETALDEHYDE; (2-NITROPHENYL)ACETALDEHYDE; (3,4,5-TRIMETHYL-1H-PYRAZOL-1-YL)ACETALDEHYDE; (3,4-DIFLUOROPHENYL)ACETALDEHYDE; (3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETALDEHYDE; (3,5-DIMETHYL-1H-PYRAZOL-4-YL)ACETALDEHYDE COMPOUND WITH METHANOL (1:1); (3AR,3BS,4S,4AS,5AS)-2-OXOOCTAHYDROCYCLOPROPA[3,4]CYCLOPENTA[1,2-B]FURAN-4-CARBALDEHYDE; (3-CHLORO-4-METHYLPHENYL)ACETALDEHYDE; (3-CHLORO-5-FLUOROPHENYL)ACETALDEHYDE; (3-CHLORO-PHENYL)-ACETALDEHYDE; (3-FLUORO-4-METHOXYPHENYL)ACETALDEHYDE; (3-FLUORO-PHENYL)-ACETALDEHYDE; (3-HYDROXY-4-METHOXY-PHENYL)-ACETALDEHYDE; (3-HYDROXY-PHENYL)-ACETALDEHYDE; (3-METHYLPHENYL)ACETALDEHYDE; (3-NITRO-1H-PYRAZOL-1-YL)ACETALDEHYDE; (3-NITRO-PHENYL)-ACETALDEHYDE; (3S)-3-ISOPROPYL-6-OXOHEPTANAL; (4-CHLORO-2-FLUOROPHENYL)ACETALDEHYDE; (4-CHLORO-PHENYL)-ACETALDEHYDE; (4-CHLORO-PHENYL)-OXO-ACETALDEHYDE; (4-ETHYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-FLUORO-2-FORMYLPHENYL)BORONIC ACID; (4-FLUORO-3-METHYL-PHENYL)-OXO-ACETALDEHYDE; (4-FLUORO-PHENYL)-ACETALDEHYDE; (4-FLUORO-PHENYL)-OXO-ACETALDEHYDE; (4-FORMYL-3-METHOXYPHENOXYMETHYL)POLYSTYRENE; (4-ISOPROPYLPHENYL)ACETALDEHYDE; (4-METHOXY-PHENYL)-OXO-ACETALDEHYDE; (4-METHYLPHENYL)(OXO)ACETALDEHYDE; (4-METHYL-PIPERAZIN-1-YL)-ACETALDEHYDE; (4-METHYL-PYRAZOL-1-YL)-ACETALDEHYDE; (4-METHYLSULFANYLPHENYL)ACETALDEHYDE; (4-NITRO-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-NITRO-PHENYL)-ACETALDEHYDE; (4R,5S)-5-(HYDROXYMETHYL)-2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBALDEHYDE; (4S)-2,2-DIMETHYL-1,3-DIOXOLANE-4-ACETALDEHYDE; (5-CHLORO-2-FLUOROPHENYL)ACETALDEHYDE; (5-CHLOROPYRIMIDIN-2-YL)ACETALDEHYDE; (5-FORMYLPYRIDIN-3-YL)BORONIC ACID; (5-METHYL-3-NITRO-PYRAZOL-1-YL)-ACETALDEHYDE; (5-PYRIMIDINYLOXY)-ACETALDEHYDE; (5S)-5,6-DIHYDRO-5-INDOLIZINECARBOXALDEHYDE; (8R)-5,6,7,8-TETRAHYDRO-8-INDOLIZINEACETALDEHYDE; (AR)-A-METHYL-2-FURANACETALDEHYDE; (AR)-A-METHYL-3-FURANACETALDEHYDE; (AS,BS)-A,B-DIMETHYL-1H-PYRROLE-1-PROPANAL; (BR)-A,B-DIMETHYL-1H-PYRROLE-1-PROPANAL; (BR)-B, 1-DIMETHYL-1H-PYRROLE-2-PROPANAL; (BR)-B-METHYL-2,5-DIOXO-1-PYRROLIDINEPROPANAL; (BS)-B,1-DIMETHYL-1H-PYRROLE-2-PROPANAL; (DIMETHYLHYDRAZONO)ACETALDEHYDE; (E)-2-ALLYL-2-ETHYLHEX-3-ENAL; (M-TOLYL)GLYOXAL HYDRATE; (PHENYLSULFANYL)ACETALDEHYDE; (R)-(−)-3-HYDROXYNONANAL; (R)-(+)-2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBOXALDEHYDE; (R)-1,4-DIOXASPIRO[4,5]DECANE-2-CARBOXALDEHYDE; (R)-CYCLOHEX-3-ENECARBALDEHYDE; (S)-2-(1H-PYRROL-1-YL)PROPANAL; (S)-2-(2,5-DIMETHYL-1H-PYRROL-1-YL)PROPANAL; (S)-2-(BENZYLOXY)PROPIONAL; (S)-GLYCERALDEHYDE ACETONIDE; (S,E)-1-(BUT-1-ENYL)-5-OXOPYRROLIDINE-2-CARBALDEHYDE; (TERT-BUTYLDIMETHYLSILYLOXY)ACETALDEHYDE; (TETRAHYDRO-THIOPYRAN-4-YL)-ACETALDEHYDE; [1,2,4]TRIAZINE-3-CARBALDEHYDE; [1,2,4]TRIAZOLO[4,3-A]PYRAZINE-3-CARBALDEHYDE; [1,3]DIOXOLO[4,5-B]PYRIDINE-6-CARBALDEHYDE; [1,3]DIOXOLO[4,5-B]PYRIDINE-7-CARBALDEHYDE; [1,6]NAPHTHYRIDINE-8-CARBALDEHYDE; [1,8]NAPHTHYRIDIN-2-YL-ACETALDEHYDE; [1,8]NAPHTHYRIDINE-2-CARBALDEHYDE; [1,8]NAPHTHYRIDINE-3-CARBALDEHYDE; [4-(2-OXO-ETHYL)-PHENYL]-ACETALDEHYDE; 1-([ETHYL(METHYL)AMINO]METHYL)CYCLOPENTANE-1-CARBALDEHYDE; 1-(1,1-DIMETHYLPROPYL)-2-FORMYLIMIDAZOLE; 1-(1,2-DIMETHYLPROPYL)-2-FORMYLIMIDAZOLE; 1-(1-ETHYLPROPYL)-2-FORMYLIMIDAZOLE; 1-(2,3-DIHYDROXY-PROPYL)-2-FORMYLIMIDAZOLE; 1-(2-CHLOROETHYL)-2-FORMYLIMIDAZOLE; 1-(2-FORMYLIMIDAZOL-1-YL)-PROPAN-2-OL; 1-(2-HYDROXY-1,1-DIMETHYLETHYL)-2-FORMYLIMIDAZOLE; 1-(2-HYDROXY-1-METHYL-ETHYL)-2-FORMYLIMIDAZOLE; 1-(2-HYDROXYETHYL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-HYDROXYETHYL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-HYDROXYETHYL)PIPERIDINE-4-CARBALDEHYDE; 1-(2-HYDROXYPROPYL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-HYDROXYPROPYL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-HYDROXYPROPYL)PIPERIDINE-4-CARBALDEHYDE; 1-(2-METHOXYETHYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-(2-METHOXYETHYL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-METHOXYETHYL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-METHOXYETHYL)PIPERIDINE-4-CARBALDEHYDE; 1-(2-METHYLPROP-2-EN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-METHYLPROP-2-EN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-METHYLPROP-2-EN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(2-METHYLPROPYL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-METHYLPROPYL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-METHYLPROPYL)PIPERIDINE-4-CARBALDEHYDE; 1-(3-CHLORO-PROPYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-(3-HYDROXYPROPYL)PIPERIDINE-2-CARBALDEHYDE; 1-(3-HYDROXYPROPYL)PIPERIDINE-3-CARBALDEHYDE; 1-(3-HYDROXYPROPYL)PIPERIDINE-4-CARBALDEHYDE; 1-(3-METHOXY-PROPYL)-2-FORMYL-1H-IMIDAZOLE; 1-(3-METHYLBUTYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-(BUT-2-YN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(BUT-2-YN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(BUT-2-YN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(BUT-3-EN-2-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(BUT-3-EN-2-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(BUT-3-EN-2-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(BUT-3-YN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(BUT-3-YN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(BUT-3-YN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(BUTAN-2-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(BUTAN-2-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(CYCLOPROPYLMETHYL)PIPERIDINE-2-CARBALDEHYDE; 1-(CYCLOPROPYLMETHYL)PIPERIDINE-3-CARBALDEHYDE; 1-(CYCLOPROPYLMETHYL)PIPERIDINE-4-CARBALDEHYDE; 1-(DIFLUOROMETHYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-(DIFLUOROMETHYL)PIPERIDINE-2-CARBALDEHYDE; 1-(DIFLUOROMETHYL)PIPERIDINE-3-CARBALDEHYDE; 1-(DIFLUOROMETHYL)PIPERIDINE-4-CARBALDEHYDE; 1-(DIMETHYLAMINOMETHYL)CYCLOPENTANECARBOXALDEHYDE; 1-(METHOXYMETHYL)-1H-PYRAZOLE-3-CARBALDEHYDE; 1-(PROP-2-EN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(PROP-2-EN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(PROP-2-EN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(PROP-2-YN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(PROP-2-YN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(PROP-2-YN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(PROPAN-2-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(PROPAN-2-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(PYRIDIN-2-YL)CYCLOBUTANECARBALDEHYDE; 1-(TETRAHYDROPYRANYLOXY)CYCLOPROPANECARBALDEHYDE; 1-(TRIFLUOROMETHYL)CYCLOPROPANECARBALDEHYDE; 1,1-DIOXO-HEXAHYDRO-1LAMBDA6-THIOPYRAN-4-CARBALDEHYDE; 1,2,3,4-TETRAHYDRONAPHTHALENE-1-CARBALDEHYDE; 1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1,2,3-BENZOTHIADIAZOLE-5-CARBOXALDEHYDE; 1,2,4-OXADIAZOLE-3-CARBOXALDEHYDE; 1,2,4-OXADIAZOLE-5-CARBOXALDEHYDE; 1,2,4-THIADIAZOLE-3-CARBOXALDEHYDE; 1,2,4-THIADIAZOLE-3-CARBOXALDEHYDE, 5-METHYL-; 1,2,4-THIADIAZOLE-5-CARBOXALDEHYDE; 1,2,4-THIADIAZOLE-5-CARBOXALDEHYDE, 3-METHYL-; 1,2,4-TRIAZOLO[4,3-A]PYRIDINE-3-CARBOXALDEHYDE; 1,2-BENZENEDICARBOXALDEHYDE, 3-FLUORO; 1,2-BENZISOXAZOLE-3-CARBOXALDEHYDE; 1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 1,3,4-OXADIAZOLE-2-CARBOXALDEHYDE, 5-METHYL-; 1,3,4-THIADIAZOLE-2,5-DICARBOXALDEHYDE; 1,3,4-THIADIAZOLE-2-CARBOXALDEHYDE; 1,3,4-TRIMETHYL-3-CYCLOHEXEN-1-CARBOXALDEHYDE; 1,3,5-TRIAZINE-2-CARBALDEHYDE; 1,3-BENZENEDICARBOXALDEHYDE, 2-CHLORO-; 1,3-BENZENEDICARBOXALDEHYDE, 5-HYDROXY-; 1,3-BENZODIOXOLE-5-CARBOXALDEHYDE, 6-HYDROXY-; 1,3-BENZOTHIAZOLE-2-CARBALDEHYDE; 1,3-DIHYDRO-1-OXO-5-ISOBENZOFURANCARBOXALDEHYDE; 1,3-DIHYDRO-2,1,3-BENZOXADIAZOLE-5-CARBOXALDEHYDE; 1,3-DIHYDRO-FURO[3,4-C]PYRIDINE-6-CARBOXALDEHYDE; 1,3-DIMETHYLPIPERIDINE-4-CARBALDEHYDE; 1,3-DIOXOLANE-2,2-DIACETALDEHYDE; 1,3-DIOXOLANE-2-ACETALDEHYDE, 2-METHYL-; 1,3-DIOXOLANE-4-CARBOXALDEHYDE, 5-(HYDROXYMETHYL)-2,2-DIMETHYL-, (4R,5R)-; 1,3-OXAZOL-2-YLACETALDEHYDE; 1,3-THIAZOL-2-YLACETALDEHYDE; 1,4,5,6-TETRAHYDRO-CYCLOPENTAPYRAZOLE-3-CARBALDEHYDE; 1,4,5-TRIMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1,4,6,7-TETRAHYDROPYRANO[4,3-C]PYRAZOLE-3-CARBALDEHYDE; 1,4,7-TRIOXASPIRO[4.4]NONANE-9-CARBALDEHYDE; 1,4-BENZODIOXAN-6-CARBOXALDEHYDE; 1,4-BENZODIOXIN-5-CARBOXALDEHYDE; 1,4-DIMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1,4-DIMETHYL-5-NITRO-1H-IMIDAZOLE-2-CARBALDEHYDE; 1,4-DIMETHYLPIPERAZINE-2-CARBALDEHYDE; 1,4-DIMETHYLPIPERIDINE-4-CARBALDEHYDE; 1,4-DIOXANE-2-CARBOXALDEHYDE; 1,4-DIOXASPIRO[4.5]DECANE-8-CARBALDEHYDE; 1,5-DIMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 1,5-DIMETHYL-2-BENZIMIDAZOLECARBOXALDEHYDE; 1,5-NAPHTHYRIDINE-2-CARBOXALDEHYDE; 1,5-NAPHTHYRIDINE-3-CARBALDEHYDE; 1,5-NAPHTHYRIDINE-4-CARBOXALDEHYDE; 1,6-DIHYDRO-6-OXO-3-PYRIDAZINECARBOXALDEHYDE; 1,6-NAPHTHYRIDINE-2-CARBOXALDEHYDE; 1,6-NAPHTHYRIDINE-4-CARBOXALDEHYDE; 1,7-NAPHTHYRIDINE-3-CARBALDEHYDE; 1,8-NAPHTHYRIDINE-4-CARBALDEHYDE; 1,8-NAPHTHYRIDINE-4-CARBOXALDEHYDE, 3-HYDROXY-; 1-[(DIMETHYLAMINO)METHYL]CLOHEXANE-1-CARBALDEHYDE; 10-UNDECENAL; 1-ACETYL-2-PIPERIDINECARBOXALDEHYDE; 1-ACETYLAZETIDINE-3-CARBALDEHYDE; 1-ACETYLPIPERIDINE-3-CARBALDEHYDE; 1-ACETYLPIPERIDINE-4-CARBALDEHYDE; 1-ADAMANTANE CARBOXALDEHYDE; 1-ALLYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ALLYLCYCLOHEXANECARBALDEHYDE; 1-AZABICYCLO[2.2.2]OCTANE-2-CARBOXALDEHYDE; 1-AZA-BICYCLO[2.2.2]OCTANE-3-CARBALDEHYDE; 1-AZABICYCLO[2.2.2]OCTANE-4-CARBOXALDEHYDE; 1-BENZOFURAN-3-YLACETALDEHYDE; 1-BENZOFURAN-5-CARBALDEHYDE; 1-BENZOFURAN-6-CARBALDEHYDE; 1-BENZOTHIOPHENE-5-CARBALDEHYDE; 1-BUTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-BUTYLPIPERIDINE-2-CARBALDEHYDE; 1-BUTYLPIPERIDINE-3-CARBALDEHYDE; 1-BUTYLPIPERIDINE-4-CARBALDEHYDE; 1-CYCLOBUTYLMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-CYCLOPENTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-CYCLOPROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ETHYL-1H-1,2,4-TRIAZOLE-5-CARBALDEHYDE; 7; 1-ETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ETHYL-1H-INDOLE-4-CARBALDEHYDE; 1-ETHYL-1H-INDOLE-5-CARBALDEHYDE; 1-ETHYL-1H-INDOLE-6-CARBALDEHYDE; 1-ETHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 1-ETHYL-4-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ETHYL-4-OXOCYCLOHEXANECARBALDEHYDE; 1-ETHYL-AZEPANE-4-CARBALDEHYDE; 1-ETHYLPIPERIDINE-2-CARBALDEHYDE; 1-ETHYLPIPERIDINE-3-CARBALDEHYDE; 1-ETHYLPIPERIDINE-4-CARBALDEHYDE; 1-FLUORONAPHTHALENE-2-CARBALDEHYDE; 1-FLUORONAPHTHALENE-3-CARBOXALDEHYDE; 1-FLUORONAPHTHALENE-7-CARBOXALDEHYDE; 1-FLUORONAPHTHALENE-8-CARBOXALDEHYDE; 1-FORMYL-2-(4-METHOXYPHENYL)-ETHYL; 1-FORMYL-CYCLOBUTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPENTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPROPANECARBOXYLIC ACID METHYL ESTER; 1H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 1H-BENZIMIDAZOLE-1-ACETALDEHYDE; 1H-BENZO[D][1,2,3]TRIAZOLE-5-CARBALDEHYDE; 1H-INDAZOL-3-YLACETALDEHYDE; 1H-INDAZOLE-1-PROPANAL; 1H-INDAZOLE-3,4-DICARBOXALDEHYDE; 1H-INDAZOLE-3,5-DICARBOXALDEHYDE; 1H-INDAZOLE-3-CARBALDEHYDE; 1H-INDAZOLE-4-CARBALDEHYDE; 1H-INDAZOLE-5-CARBALDEHYDE; 1H-INDAZOLE-6-CARBALDEHYDE; 1H-INDAZOLE-7-CARBALDEHYDE; 1H-INDENE-1-CARBOXALDEHYDE, 2,3-DIHYDRO-; 1H-INDENE-2-CARBOXALDEHYDE,2,3-DIHYDRO-; 1H-INDOLE-1-PROPANAL; 1H-PYRAZOL-1-YLACETALDEHYDE; 1H-PYRAZOLE-3-CARBALDEHYDE; 1H-PYRAZOLE-3-CARBALDEHYDE, HYDROCHLORIDE; 1H-PYRAZOLE-3-CARBOXALDEHYDE, 1,4-DIMETHYL-; 1H-PYRAZOLO[3,4-B]PYRIDINE-3-CARBALDEHYDE; 1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBALDEHYDE; 1H-PYRAZOLO[3,4-C]PYRIDINE-4-CARBALDEHYDE; 1H-PYRAZOLO[3,4-C]PYRIDINE-5-CARBALDEHYDE; 1H-PYRAZOLO[3,4-C]PYRIDINE-7-CARBALDEHYDE; 1H-PYRAZOLO[4,3-B]PYRIDINE-5-CARBALDEHYDE; 1H-PYRAZOLO[4,3-B]PYRIDINE-6-CARBALDEHYDE; 1H-PYRAZOLO[4,3-B]PYRIDINE-7-CARBALDEHYDE; 1H-PYRAZOLO[4,3-C]PYRIDINE-4-CARBALDEHYDE; 1H-PYRROLE-1-BUTANAL; 1H-PYRROLE-1-PROPANAL; 1H-PYRROLO[2,3-B]PYRIDINE-1-PROPANAL; 1-HYDROXY-2-NAPHTHALDEHYDE; 1-ISOBUTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ISOPROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-ISOPROPYL-AZEPANE-4-CARBALDEHYDE; 1-ISOPROPYLPIPERIDINE-4-CARBALDEHYDE; 1-METHYL-1H-1,2,3-BENZOTRIAZOLE-5-CARBALDEHYDE; 1-METHYL-1H-BENZIMIDAZOLE-5-CARBOXALDEHYDE; 1-METHYL-1H-BENZO[D]IMIDAZOLE-6-CARBALDEHYDE; 1-METHYL-1H-IMIDAZO[4,5-B]PYRIDINE-2-CARBALDEHYDE; 1-METHYL-1H-IMIDAZO[4,5-C]PYRIDINE-2-CARBALDEHYDE; 1-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-METHYL-1H-INDAZOLE-3-CARBALDEHYDE; 1-METHYL-1H-INDAZOLE-4-CARBALDEHYDE; 1-METHYL-1H-INDAZOLE-5-CARBALDEHYDE; 1-METHYL-1H-INDAZOLE-6-CARBALDEHYDE; 1-METHYL-1H-INDAZOLE-7-CARBALDEHYDE; 1-METHYL-1H-INDOLE-3-ACETALDEHYDE; 1-METHYL-1H-INDOLE-4-CARBALDEHYDE; 1-METHYL-1H-INDOLE-5-ACETALDEHYDE; 1-METHYL-1H-INDOLE-5-CARBALDEHYDE; 1-METHYL-1H-INDOLE-6-CARBALDEHYDE; 1-METHYL-1H-INDOLE-7-CARBALDEHYDE; 1-METHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 1-METHYL-1H-PYRAZOLO[3,4-C]PYRIDINE-4-CARBALDEHYDE; 1-METHYL-1H-PYRROLE-2-ACETALDEHYDE; 1-METHYL-1H-PYRROLE-2-PROPANAL; 1-METHYL-2,3-DIHYDRO-1H-PYRROLIZINE-2-CARBALDEHYDE; 1-METHYL-2-FORMYLBENZIMIDAZOLE; 1-METHYL-2-OXO-3-PIPERIDINEACETALDEHYDE; 1-METHYL-3,4-DIHYDROISOQUINOLINE-7-CARBALDEHYDE; 1-METHYL-3-CYCLOHEXENE-1-CARBOXALDEHYDE; 1-METHYL-3-PIPERIDINEACETALDEHYDE; 1-METHYL-4-OXOCYCLOHEXANECARBALDEHYDE; 1-METHYL-4-PIPERIDINECARBALDEHYDE HYDROCHLORIDE; 1-METHYL-5-NITRO-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-METHYL-8-NAPHTHALDEHYDE; 1-METHYL-AZEPANE-4-CARBALDEHYDE; 1-METHYLBENZIMIDAZOLE-4-CARBOXALDEHYDE; 1-METHYLCYCLOHEXANE-1-CARBOXALDEHYDE; 1-METHYL-CYCLOPENTANECARBOXALDEHYDE; 1-METHYLINDOLINE-5-CARBALDEHYDE; 1-METHYLNAPHTHALENE-2-CARBOXALDEHYDE; 1-METHYLNAPHTHALENE-3-CARBOXALDEHYDE; 1-METHYLNAPHTHALENE-5-CARBOXALDEHYDE; 1-METHYLNAPHTHALENE-6-CARBOXALDEHYDE; 1-METHYLNAPHTHALENE-7-CARBOXALDEHYDE; 1-METHYLPIPERIDINE-2-CARBALDEHYDE; 1-METHYLPIPERIDINE-3-CARBALDEHYDE; 1-METHYLPIPERIDINE-4-CARBALDEHYDE; 1-NAPHTHALDEHYDE; 1-NAPHTHALENECARBOXALDEHYDE, 5,6,7,8-TETRAHYDRO; 1-OXO-1,2,3,4-TETRAHYDRONAPHTHALENE-2-CARBALDEHYDE; 1-PENTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-PHENYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-PHENYLCYCLOPENTANECARBALDEHYDE; 1-PHENYLCYCLOPROPANECARBALDEHYDE; 1-PIPERIDINEPROPANAL; 1-PROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-PROPYL-1H-PYRAZOLE-3-CARBALDEHYDE; 1-PROPYLPIPERIDINE-2-CARBALDEHYDE; 1-PROPYLPIPERIDINE-3-CARBALDEHYDE; 1-PROPYLPIPERIDINE-4-CARBALDEHYDE; 1-PYRIDIN-3-YL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-SEC-BUTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-TERT-BUTYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-VINYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 2-([(2-HYDROXYETHYL)(METHYL)AMINO]METHYL)-2-METHYLBUTANAL; 2-([2-(DIMETHYLAMINO)ETHYL](PROPYL)AMINO)ACETALDEHYDE; 2-([CYCLOPROPYL(METHYL)AMINO]METHYL)-2-METHYLBUTANAL; 2-([ETHYL(METHYL)AMINO]METHYL)-2-METHYLBUTANAL; 2-([ETHYL(METHYL)AMINO]METHYL)-2-METHYLPENTANAL; 2-(1-(2-OXOETHYL)-1H-PYRAZOL-4-YL)ACETONITRILE; 2-(1,2,4-OXADIAZOL-3-YL)BENZALDEHYDE; 2-(1,3,4-THIADIAZOL-2-YLSULFANYL)ACETALDEHYDE; 2-(1,3-DIOXOLAN-2-YL)ACETALDEHYDE; 2-(1,3-THIAZOL-2-YLSULFANYL)ACETALDEHYDE; OXAZEPAN-4-YL)ACETALDEHYDE; 2-(1-ACETYLAZETIDIN-2-YL)ACETALDEHYDE; 2-(1H-1,2,3-BENZOTRIAZOL-1-YL)ACETALDEHYDE; 2-(1H-1,2,4-TRIAZOL-1-YL)ACETALDEHYDE; 2-(1H-1,2,4-TRIAZOL-5-YLSULFANYL)ACETALDEHYDE; 2-(1H-IMIDAZOL-1-YL)PYRIMIDINE-5-CARBALDEHYDE; 2-(1H-INDOL-1-YL)ACETALDEHYDE; 2-(1H-PYRAZOL-1-YL)BENZALDEHYDE; 2-(1H-PYRAZOL-1-YL)PYRIMIDINE-5-CARBALDEHYDE; 2-(1H-PYRAZOL-3-YL)BENZALDEHYDE; 2-(1H-PYRROL-1-YL)BENZALDEHYDE; 2-(1H-PYRROL-1-YL)PROPANAL; 2-(1-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)ACETALDEHYDE; 2-(1-METHYL-2-OXOPYRROLIDIN-3-YL)ACETALDEHYDE; 2-(1-METHYLETHYL)-3-PYRIDINECARBOXALDEHYDE; 2-(1-METHYLETHYL)-4-PYRIDINECARBOXALDEHYDE; 2-(2-(3-OXOPROPYL)PHENYL)ACETONITRILE; 2-(2,2,2-TRIFLUOROETHOXY)ACETALDEHYDE; 2-(2,2,3,3-TETRAFLUOROPROPOXY)ACETALDEHYDE; 2-(2,2-DIMETHYLMORPHOLIN-4-YL)ACETALDEHYDE; 2-(2,2-DIMETHYLPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(2,3,5-TRIFLUOROPHENYL)ACETALDEHYDE; 2-(2,3-DIFLUOROPHENOXY)ACETALDEHYDE; 2-(2,3-DIHYDRO-1H-INDOL-1-YL)ACETALDEHYDE; 2-(2,3-DIHYDRO-1H-ISOINDOL-2-YL)ACETALDEHYDE; 2-(2,3-DIHYDROBENZOFURAN-5-YL)ACETALDEHYDE; 2-(2,3-DIHYDROBENZOFURAN-6-YL)ACETALDEHYDE; 2-(2,3-DIMETHYLPHENOXY)ACETALDEHYDE; DIMETHYLPHENYL)ACETALDEHYDE; 2-(2,3-DIMETHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(2,4,5-TRIFLUOROPHENYL)ACETALDEHYDE; 2-(2,4,6-TRIFLUOROPHENYL)ACETALDEHYDE; DIFLUOROPHENOXY)ACETALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-2-OXOACETALDEHYDE; 2-(2,4-DIMETHYLPHENOXY)ACETALDEHYDE; 2-(2,4-DIMETHYLPHENYL)ACETALDEHYDE; 2-(2,4-DIMETHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(2,4-DIOXO-1,3-THIAZOLIDIN-3-YL)ACETALDEHYDE; 2-(2,5-DIFLUOROPHENOXY)ACETALDEHYDE; 2-(2,5-DIMETHYLPHENOXY)ACETALDEHYDE; 2-(2,5-DIMETHYLPHENYL)ACETALDEHYDE; 2-(2,5-DIOXOPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(2,6-DIFLUOROPHENYL)ACETALDEHYDE; 2-(2,6-DIMETHYLPHENOXY)ACETALDEHYDE; 2-(2,6-DIMETHYLPHENYL)ACETALDEHYDE; 2-(2,6-DIOXOPIPERIDIN-1-YL)ACETALDEHYDE; 2-(2,7-DIOXOAZEPAN-1-YL)ACETALDEHYDE; 2-(2-[(DIMETHYLAMINO)METHYL]PYRROLIDIN-1-YL)ACETALDEHYDE; 2-(2-AZABICYCLO[2.2.1]HEPTAN-2-YL)ACETALDEHYDE; 2-(2-BUTOXYETHOXY)ACETALDEHYDE; 2-(2-CHLORO-4-FLUOROPHENYL)ACETALDEHYDE; 2-(2-CHLORO-6-FLUOROPHENYL)ACETALDEHYDE; 2-(2-CHLOROPHENOXY)ACETALDEHYDE; 2-(2-CHLOROPHENYL)ACETALDEHYDE; 2-(2-ETHOXYETHOXY)ACETALDEHYDE; 2-(2-ETHOXYPHENYL)ACETALDEHYDE; 2-(2-ETHYL-1H-IMIDAZOL-1-YL)ACETALDEHYDE; 2-(2-ETHYLPHENOXY)ACETALDEHYDE; 2-(2-FLUORO-3-FORMYLPHENYL)ACETONITRILE; 2-(2-FLUORO-5-FORMYLPHENYL)ACETONITRILE; 2-(2-FLUORO-5-METHYLPHENYL)ACETALDEHYDE; 2-(2-FLUOROETHOXY)-BENZALDEHYDE; 2-(2-FLUOROPHENOXY)ACETALDEHYDE; 2-(2-FLUOROPHENYL)-3-OXOPROPANENITRILE; 2-(2-FLUOROPHENYL)ACETALDEHYDE; 2-(2-FORMYL-IMIDAZOL-1-YL)-BUTAN-1-OL; 2-(2-FORMYLIMIDAZOL-1-YL)-PROPANE-1,3-DIOL; 2-(2-FORMYLPIPERIDIN-1-YL)ACETONITRILE; 2-(2-FORMYLPIPERIDIN-1-YL)PROPANENITRILE; 2-(2-FURYL)-2-OXO-ACETALDEHYDE; 2-(2-FURYL)-5-PYRIMIDINECARBALDEHYDE; 2-(2-HYDROXYETHOXY)ACETALDEHYDE; 2-(2-HYDROXYETHOXY)BENZALDEHYDE; 2-(2-METHOXY-5-METHYLPHENYL)ACETALDEHYDE; 2-(2-METHOXYETHOXY)ACETALDEHYDE; 2-(2-METHOXYETHYL)PYRIMIDINE-4-CARBALDEHYDE; 2-(2-METHOXYETHYL)PYRIMIDINE-5-CARBALDEHYDE; 2-(2-METHOXYPHENOXY)ACETALDEHYDE; 2-(2-METHYL-1,4-OXAZEPAN-4-YL)ACETALDEHYDE; 2-(2-METHYL-1H-IMIDAZOL-1-YL)ACETALDEHYDE; 2-(2-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(2-METHYLFURAN-3-YL)ACETALDEHYDE; 2-(2-METHYLPHENOXY)ACETALDEHYDE; 2-(2-METHYLPHENYL)-3-OXOPROPANENITRILE; 2-(2-METHYLPROPOXY)ACETALDEHYDE; 2-(2-METHYLPROPYL)PYRIMIDINE-4-CARBALDEHYDE; 2-(2-METHYLPROPYL)PYRIMIDINE-5-CARBALDEHYDE; 2-(2-METHYLTHIAZOL-5-YL)ACETALDEHYDE; 2-(2-OXO-1,2-DIHYDROPYRIDIN-1-YL)ACETALDEHYDE; 2-(2-OXO-1,2-DIHYDROPYRIMIDIN-1-YL)ACETALDEHYDE; 2-(2-OXO-1,3-THIAZOLIDIN-3-YL)ACETALDEHYDE; 2-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-3-YL)ACETALDEHYDE; 2-(2-OXOAZEPAN-1-YL)ACETALDEHYDE; 2-(2-OXOAZOCAN-1-YL)ACETALDEHYDE; 2-(2-OXOETHOXY)BENZONITRILE; 2-(2-OXOPIPERIDIN-1-YL)ACETALDEHYDE; 2-(2-OXOPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(2-PHENYLHYDRAZONO)ACETALDEHYDE; 2-(2-PROPYNYLOXY)BENZENECARBALDEHYDE; 2-(2-PYRAZINYL)MALONDIALDEHYDE; 2-(2-PYRIDINYLOXY)-ACETALDEHYDE; 2-(2-PYRIDYL)MALONDIALDEHYDE; 2-(3-(DIMETHYLAMINO)PHENYL)ACETALDEHYDE; 2-(3-(NITROMETHYL)OXETAN-3-YL)ACETALDEHYDE; 2-(3,3-DIMETHYLMORPHOLIN-4-YL)ACETALDEHYDE; 2-(3,4,5-TRIFLUOROPHENYL)ACETALDEHYDE; 2-(3,4-DIFLUOROPHENOXY)ACETALDEHYDE; 2-(3,4-DIMETHYLPHENOXY)ACETALDEHYDE; 2-(3,4-DIMETHYLPHENYL)-3-OXOPROPANENITRILE; 2-(3,4-DIMETHYLPHENYL)ACETALDEHYDE; 2-(3,5-DIFLUOROPHENOXY)ACETALDEHYDE; 2-(3,5-DIFLUOROPHENYL)ACETALDEHYDE; 2-(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)ACETALDEHYDE; 2-(3,5-DIMETHYLPHENOXY)ACETALDEHYDE; DIMETHYLPHENYL)ACETALDEHYDE; 2-(3,5-DIOXOMORPHOLIN-4-YL)ACETALDEHYDE; 2-(3,6-DIOXO-1,2,3,6-TETRAHYDROPYRIDAZIN-1-YL)ACETALDEHYDE; 2-(3-CHLORO-2-FLUOROPHENYL)ACETALDEHYDE; 2-(3-CHLORO-4-FLUOROPHENYL)ACETALDEHYDE; 2-(3-CHLOROPHENOXY)ACETALDEHYDE; 2-(3-ETHYLPHENOXY)ACETALDEHYDE; 2-(3-FLUORO-4-FORMYLPHENYL)ACETONITRILE; 2-(3-FLUORO-4-HYDROXYPHENYL)ACETALDEHYDE; 2-(3-FLUORO-4-METHYLPHENYL)ACETALDEHYDE; 2-(3-FLUORO-5-FORMYLPHENYL)ACETONITRILE; 2-(3-FLUORO-5-METHYLPHENYL)ACETALDEHYDE; 2-(3-FLUOROPHENOXY)ACETALDEHYDE; 2-(3-FLUOROPHENYL)-3-OXOPROPANENITRILE; 2-(3-FLUORO-PHENYL)-CYCLOPROPANECARBALDEHYDE; 2-(3-FLUORO-PHENYL)-MALONALDEHYDE; 2-(3-FORMYLPHENOXY)ACETONITRILE; 2-(3-FORMYLPHENYL)ACETONITRILE; 2-(3-FORMYLPIPERIDIN-1-YL)ACETONITRILE; 2-(3-FORMYLPIPERIDIN-1-YL)PROPANENITRILE; 2-(3-HYDROXYPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(3-METHOXYPHENOXY)ACETALDEHYDE; 2-(3-METHOXYPHENYL)ACETALDEHYDE; 2-(3-METHOXYPROPOXY)ACETALDEHYDE; 2-(3-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(3-METHYL-2,4,5-TRIOXIOIMIDAZOLIDIN-1-YL)ACETALDEHYDE; 2-(3-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ACETALDEHYDE; 2-(3-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)ACETALDEHYDE; 2-(3-METHYL-2-OXOIMIDAZOLIDIN-1-YL)ACETALDEHYDE; 2-(3-METHYLBUTOXY)ACETALDEHYDE; 2-(3-METHYLPHENYL)-3-OXOPROPANENITRILE; 2-(3-METHYLPHENYL)MALONDIALDEHYDE; 2-(3-NITRO-1H-1,2,4-TRIAZOL-1-YL)ACETALDEHYDE; 2-(3-OXOPROPANOYL)BENZONITRILE; 2-(4-(DIMETHYLAMINO)PHENYL)ACETALDEHYDE; 2-(4,4-DIMETHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4,5-DIMETHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-3-YL)ACETALDEHYDE; 2-(4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIMIDIN-1-YL)ACETALDEHYDE; 2-(4-ACETYLPIPERAZIN-1-YL)ACETALDEHYDE; 2-(4-CHLORO-3-FLUOROPHENYL)ACETALDEHYDE; 2-(4-CHLOROPHENOXY)ACETALDEHYDE; 2-(4-CHLORO-PHENYL)-PROPIONALDEHYDE; 2-(4-CYCLOPROPYLPIPERAZIN-1-YL)ACETALDEHYDE; 2-(4-ETHOXYPHENYL)ACETALDEHYDE; 2-(4-ETHOXYPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-ETHYL-4-METHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-ETHYLPHENOXY)ACETALDEHYDE; 2-(4-ETHYL-PHENYL)-3-OXO-PROPIONITRILE; 2-(4-ETHYLPHENYL)ACETALDEHYDE; 2-(4-ETHYLPIPERAZIN-1-YL)ACETALDEHYDE; 2-(4-ETHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-FLUORO-2-METHYLPHENYL)ACETALDEHYDE; 2-(4-FLUORO-3-METHOXYPHENYL)ACETALDEHYDE; 2-(4-FLUORO-3-METHYLPHENYL)ACETALDEHYDE; 2-(4-FLUOROPHENOXY)ACETALDEHYDE; 2-(4-FLUOROPHENYL)-3-OXOPROPANENITRILE; 2-(4-FLUOROPHENYL)CYCLOPROPANECARBALDEHYDE; 2-(4-FLUOROPHENYL)MALONDIALDEHYDE; 2-(4-FORMYLPHENOXY)ACETONITRILE; 2-(4-FORMYLPHENYL)ACETONITRILE; 2-(4-FORMYLPIPERIDIN-1-YL)ACETONITRILE; 2-(4-FORMYLPIPERIDIN-1-YL)PROPANENITRILE; 2-(4-HYDROXY-3-METHOXYPHENYL)ACETALDEHYDE; 2-(4-HYDROXYPHENYL)ACETALDEHYDE; 2-(4-HYDROXYPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-METHOXY-2-METHYLPHENYL)ACETALDEHYDE; 2-(4-METHOXY-3-METHYLPHENYL)ACETALDEHYDE; 2-(4-METHOXYPHENOXY)ACETALDEHYDE; 2-(4-METHOXYPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(4-METHYL-2,3-DIOXOPIPERAZIN-1-YL)ACETALDEHYDE; 2-(4-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-3-YL)ACETALDEHYDE; 2-(4-METHYL-2-OXOPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(4-METHYL-6-OXO-1,6-DIHYDROPYRIMIDIN-1-YL)ACETALDEHYDE; 2-(4-METHYLPHENYL)-3-OXOPROPANENITRILE; 2-(4-METHYLPHENYL)MALONDIALDEHYDE; 2-(4-METHYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-NITRO-1H-IMIDAZOL-1-YL)ACETALDEHYDE; 2-(4-OXOCYCLOHEXYL)ACETALDEHYDE; 2-(4-OXOPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-PROPYLPHENYL)ACETALDEHYDE; 2-(4-PROPYLPIPERAZIN-1-YL)ACETALDEHYDE; 2-(4-PROPYLPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-PYRIDYL)MALONDIALDEHYDE; 2-(4-PYRIMIDYL)MALONDIALDEHYDE; DIMETHYL-1,3-DIOXAN-2-YL)ACETALDEHYDE; 2-(5-ETHYLPYRIDIN-2-YL)ACETALDEHYDE; 2-(5-FLUORO-2-METHYLPHENYL)ACETALDEHYDE; 2-(5-FLUOROPYRIDIN-3-YL)ACETALDEHYDE; 2-(5-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(5-METHYL-2-OXO-1,2-DIHYDROPYRIMIDIN-1-YL)ACETALDEHYDE; 2-(5-METHYLFURAN-2-YL)-2-OXOACETALDEHYDE; 2-(5-NITROFURAN-2-YL)-2-OXOACETALDEHYDE; 2-(6-CHLOROPYRIDIN-3-YL)ACETALDEHYDE; 2-(6-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)ACETALDEHYDE; 2-(6-METHYLPYRIDIN-3-YL)ACETALDEHYDE; 2-(7-METHYL-1H-INDAZOL-5-YL)ACETALDEHYDE; 2-(AZEPAN-1-YL)ACETALDEHYDE; 2-(AZOCAN-1-YL)ACETALDEHYDE; 2-(BENZO[D]OXAZOL-2-YL)ACETALDEHYDE; 2-(BENZOFURAN-5-YL)ACETALDEHYDE; 2-(BENZOFURAN-6-YL)ACETALDEHYDE; 2-(BENZYLSULFANYL)ACETALDEHYDE; 2-(BUT-2-YN-1-YLOXY)BENZALDEHYDE; 2-(BUT-3-EN-1-YLOXY)ACETALDEHYDE; 2-(BUT-3-YN-1-YLOXY)BENZALDEHYDE; 2-(BUTYLSULFANYL)ACETALDEHYDE; 2-(CHLOROMETHYL)NICOTINALDEHYDE; 2-(CHLOROMETHYL)PYRIMIDINE-4-CARBALDEHYDE; 2-(CHLOROMETHYL)PYRIMIDINE-5-CARBALDEHYDE; 2-(CYCLOHEPTYLOXY)ACETALDEHYDE; 2-(CYCLOHEXYLMETHOXY)ACETALDEHYDE; 2-(CYCLOHEXYLOXY)ACETALDEHYDE; 2-(CYCLOHEXYLSULFANYL)ACETALDEHYDE; 2-(CYCLOPENTYLOXY)ACETALDEHYDE; 2-(CYCLOPENTYLSULFANYL)ACETALDEHYDE; 2-(CYCLOPROPYLMETHOXY)ACETALDEHYDE; 2-(CYCLOPROPYLMETHYL)PYRIMIDINE-5-CARBALDEHYDE; 2-(DIBUTYLAMINO)ACETALDEHYDE; 2-(DIETHYLAMINO)ACETALDEHYDE; 2-(DIFLUOROMETHOXY)BENZALDEHYDE; 2-(DIFLUOROMETHOXY)PYRAZINE-6-CARBOXALDEHYDE; 2-(DIFLUOROMETHYL)-4-FLUOROBENZALDEHYDE; 2-(DIFLUOROMETHYL)BENZALDEHYDE; 2-(DIMETHYLAMINO)-3-HYDROXYBENZALDEHYDE; 2-(DIMETHYLAMINO)-4-HYDROXYBENZALDEHYDE; 2-(DIMETHYLAMINO)-5-FLUOROBENZALDEHYDE; 2-(DIMETHYLAMINO)-5-HYDROXYBENZALDEHYDE; 2-(DIMETHYLAMINO)-6-HYDROXYBENZALDEHYDE; 2-(DIMETHYLAMINO)-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-(DIMETHYLAMINO)ACETALDEHYDE; 2-(DIMETHYLAMINO)ISONICOTINALDEHYDE; 2-(DIMETHYLAMINO)NICOTINALDEHYDE; 2-(DIMETHYLAMINO)PYRIMIDINE-4-CARBOXALDEHYDE; 2-(DIPROPYLAMINO)ACETALDEHYDE; 2-(ETHYLSULFANYL)ACETALDEHYDE; 2-(FURAN-2-YL)-2-METHYLPROPANAL; 2-(FURAN-2-YL)-2-OXOACETALDEHYDE HYDRATE; 2-(FURAN-2-YL)ACETALDEHYDE; 2-(FURAN-2-YL)BUTANAL; 2-(FURAN-2-YL)PROPANAL; 2-(FURAN-2-YL)PYRIMIDINE-4-CARBALDEHYDE; 2-(FURAN-2-YLMETHOXY)ACETALDEHYDE; 2-(HEPTYLOXY)ACETALDEHYDE; 2-(HEXYLOXY)ACETALDEHYDE; 2-(HYDROXYMETHYL)-4-PYRIDINECARBOXALDEHYDE; 2-(HYDROXYMETHYL)-5-PYRIMIDINECARBOXALDEHYDE; 2-(HYDROXYMETHYL)-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-(HYDROXYMETHYL)PYRIMIDINE-4-CARBALDEHYDE; 2-(ISOQUINOLIN-5-YL)ACETALDEHYDE; 2-(ISOQUINOLIN-6-YL)ACETALDEHYDE; 2-(ISOQUINOLIN-7-YL)ACETALDEHYDE; 2-(METHOXYMETHOXY)BENZALDEHYDE; 2-(METHOXYMETHYL)-5-PYRIMIDINECARBALDEHYDE; 2-(METHOXYMETHYL)-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-(METHOXYMETHYL)PYRIMIDINE-4-CARBALDEHYDE; 2-(METHYL[(1-METHYL-1H-PYRAZOL-4-YL)METHYL]AMINO)ACETALDEHYDE; 2-(METHYL[(1-METHYLPYRROLIDIN-3-YL)METHYL]AMINO)ACETALDEHYDE; 2-(METHYL[(2-METHYLFURAN-3-YL)METHYL]AMINO)ACETALDEHYDE; 2-(METHYL[(5-METHYLFURAN-2-YL)METHYL]AMINO)ACETALDEHYDE; 2-(METHYL[2-(PYRROLIDIN-1-YL)ETHYL]AMINO)ACETALDEHYDE; 2-(METHYLDITHIO)-ISOBUTYRALDEHYDE; 2-(METHYLTHIO)BENZALDEHYDE; 2-(METHYLTHIO)NICOTINALDEHYDE; 2-(METHYLTHIO)PYRIMIDINE-4-CARBALDEHYDE; 2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE; 2-(N,N-DIMETHYLAMINO)BENZALDEHYDE; 2-(NAPHTHALEN-1-YL)ACETALDEHYDE; 2-(OXAN-4-YLMETHOXY)ACETALDEHYDE; 2-(OXAN-4-YLSULFANYL)ACETALDEHYDE; 2-(OXOLAN-3-YL)ACETALDEHYDE; 2-(OXOLAN-3-YLOXY)ACETALDEHYDE; 2-(PENTYLOXY)ACETALDEHYDE; 2-(PIPERIDIN-1-YL)ACETALDEHYDE; 2-(PIPERIDIN-1-YL)BUTANAL; 2-(PROP-2-EN-1-YLOXY)ACETALDEHYDE; 2-(PROPAN-2-YLOXY)ACETALDEHYDE; 2-(PROPAN-2-YLSULFANYL)ACETALDEHYDE; 2-(PROPYLSULFANYL)ACETALDEHYDE; 2-(PYRAZIN-2-YL)ACETALDEHYDE; 2-(PYRIDIN-2-YL)ACETALDEHYDE; 2-(PYRIDIN-2-YL)ACETALDEHYDE N-OXIDE; 2-(PYRIDIN-2-YLSULFANYL)ACETALDEHYDE; 2-(PYRIDIN-3-YL)ACETALDEHYDE; 2-(PYRIDIN-4-YL)ACETALDEHYDE; 2-(PYRIMIDIN-2-YL)ACETALDEHYDE; 2-(PYRIMIDIN-2-YLSULFANYL)ACETALDEHYDE; 2-(PYRIMIDIN-4-YL)ACETALDEHYDE; 2-(PYRIMIDIN-5-YL)ACETALDEHYDE; 2-(PYRROLIDIN-1-YL)ACETALDEHYDE; 2-(QUINOLIN-2-YL)ACETALDEHYDE; 2-(QUINOLIN-3-YL)ACETALDEHYDE; 2-(QUINOLIN-4-YL)ACETALDEHYDE; 2-(QUINOLIN-5-YL)ACETALDEHYDE; 2-(QUINOLIN-6-YL)ACETALDEHYDE; 2-(QUINOLIN-7-YL)ACETALDEHYDE; 2-(QUINOLIN-8-YL)ACETALDEHYDE; 2-(TERT-BUTOXY)ACETALDEHYDE; 2-(TERT-BUTYLSULFANYL)ACETALDEHYDE; 2-(TETRAHYDRO-2H-PYRAN-4-YL)-2-METHYLPROPANAL; 2-(TETRAHYDRO-2H-THIOPYRAN-4-YL)-2-METHYLPROPANAL; 2-(THIOMORPHOLIN-4-YL)ACETALDEHYDE; 2-(THIOPHEN-2-YL)ACETALDEHYDE; 2-(THIOPHEN-2-YLMETHOXY)ACETALDEHYDE; 2-(THIOPHEN-2-YLSULFANYL)ACETALDEHYDE; 2-(THIOPHEN-3-YL)ACETALDEHYDE; 2-(TRIFLUOROMETHYL)BENZALDEHYDE; 2-(TRIFLUOROMETHYL)PROPIONALDEHYDE; 2,2 DIMETHYL-4-CYANOBUTYRALDEHYDE; 2,2,3,3,3-PENTAFLUOROPROPANAL; 2,2,3-TRIMETHYLCYCLOPENT-3-ENE-1-CARBOXALDEHYDE; 2,2,4-TRIMETHYL-3-HYDROXYPENTANAL; 2,2,5-TRIMETHYLHEX-4-ENAL; 2,2,5-TRIMETHYLHEXANAL; 2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-CARBALDEHYDE; 2,2-BIS(ETHYLTHIO)ACETALDEHYDE; 2,2-DICHLOROHEXANAL; 2,2-DICHLOROPENTANAL; 2,2-DIFLUOROACETALDEHYDE; 2,2-DIFLUORO-CYCLOPROPANECARBALDEHYDE; 2,2-DIMETHYL-1,3-DIOXANE-5-CARBALDEHYDE; 2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBOXALDEHYDE; 2,2-DIMETHYL-3-(2-METHYLPYRROLIDIN-1-YL)PROPANAL; 2,2-DIMETHYL-3-(3-METHYLPYRROLIDIN-1-YL)PROPANAL; 2,2-DIMETHYL-3,4-OCTADIENAL; 2,2-DIMETHYL-3-[METHYL(2-METHYLPROPYL)AMINO]PROPANAL; 2,2-DIMETHYL-3-[METHYL(PROPAN-2-YL)AMINO]PROPANAL; 2,2-DIMETHYL-3-[METHYL(PROPYL)AMINO]PROPANAL; 2,2-DIMETHYL-3-MORPHOLIN-4-YLPROPANAL; 2,2-DIMETHYL-3-OXOHEPT-6-ENAL; 2,2-DIMETHYL-3-OXOHEPTANAL; 2,2-DIMETHYL-3-OXOHEXANAL; 2,2-DIMETHYL-3-OXOCTANAL; 2,2-DIMETHYL-3-OXOPENTANAL; 2,2-DIMETHYL-3-PHENYLPROPIONALDEHYDE; 2,2-DIMETHYL-3-PIPERIDIN-1-YLPROPANAL; 2,2-DIMETHYL-3-PYRROLIDIN-1-YLPROPANAL; 2,2-DIMETHYL-4-HEXEN-1-ALDEHYDE; 2,2-DIMETHYL-4-PENTENAL; 2,2-DIMETHYL-5-VINYL-[1,3]DIOXOLANE-4-CARBALDEHYDE; 2,2-DIMETHYLBUTANAL; 2,2-DIMETHYLNONANAL; 2,2-DIMETHYL-SUCCINALDEHYDONITRILE; 2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-CARBALDEHYDE; 2,2-DIMETHYL-TETRAHYDROTHIOPHENE-3-CARBOXALDEHYDE; 2,2′-OXYBISACETALDEHYDE; 2,3-(METHYLENEDIOXY)BENZALDEHYDE; 2,3,4,5-TETRAHYDROXY-PENTANAL; 2,3,4-TRIFLUOROBENZALDEHYDE; 2,3,4-TRIFLUOROBENZENEYL ACETALDEHYDE; 2,3,4-TRIHYDROXY-6-METHYL-BENZALDEHYDE; 2,3,4-TRIHYDROXYBENZALDEHYDE; 2,3,5,6-TETRAMETHYLBENZALDEHYDE; 2,3,5-TRIFLUORO-4-PYRIDINECARBOXALDEHYDE; 2,3,5-TRIFLUOROBENZALDEHYDE; 2,3,6-TRIFLUOROBENZALDEHYDE; 2,3,6-TRIFLUOROPYRIDINE-4-CARBOXALDEHYDE; 2,3,6-TRIMETHYLCYCLOHEXYLMETHANAL; 2,3-DICHLORO-2-METHYLPROPANAL; 2,3-DICHLOROPROPIONALDEHYDE; 2,3-DIFLUORO-4-HYDROXYBENZALDEHYDE; 2,3-DIFLUORO-4-METHOXYBENZALDEHYDE; 2,3-DIFLUORO-4-METHYLBENZALDEHYDE; 2,3-DIFLUORO-5-METHYLBENZALDEHYDE; 2,3-DIFLUORO-6-HYDROXYBENZALDEHYDE; 2,3-DIFLUORO-6-METHOXYBENZALDEHYDE; 2,3-DIFLUORO-6-METHYLBENZALDEHYDE; 2,3-DIFLUOROBENZALDEHYDE; 2,3-DIFLUORO-BENZENEPROPANAL; 2,3-DIFLUOROISONICOTINALDEHYDE; 2,3-DIHYDRO-[1,4]DIOXINO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 2,3-DIHYDRO-[1,4]DIOXINO[2,3-B]PYRIDINE-7-CARBALDEHYDE; 2,3-DIHYDRO-[1,4]DIOXINO[2,3-C]PYRIDINE-7-CARBALDEHYDE; 2,3-DIHYDRO-1,4-BENZODIOXINE-5-CARBALDEHYDE; 2,3-DIHYDRO-1-BENZOFURAN-2-CARBALDEHYDE; 2,3-DIHYDRO-1-BENZOFURAN-7-CARBALDEHYDE; 2,3-DIHYDRO-2,5-DIMETHYL-2-FORMYL-1,4-PYRAN; 2,3-DIHYDRO-2-OXO-3-FURANCARBOXALDEHYDE; 2,3-DIHYDRO-4-BENZOFURANCARBOXALDEHYDE; 2,3-DIHYDRO-BENZO[1,4]DIOXINE-2-CARBALDEHYDE; 2,3-DIHYDROBENZO[B]FURAN-5-CARBOXALDEHYDE; 2,3-DIHYDRO-BENZOFURAN-6-CARBALDEHYDE; 2,3-DIHYDROXY-4-METHOXYBENZALDEHYDE; 2,3-DIHYDROXYBENZALDEHYDE; 2,3-DIMETHOXYBENZALDEHYDE; 2,3-DIMETHOXYISONICOTINALDEHYDE; 2,3-DIMETHYLANISALDEHYDE; 2,3-DIMETHYLBENZALDEHYDE; 2,3-DIMETHYL-BENZENEPROPANAL; 2,3-DIMETHYLISONICOTINALDEHYDE; 2,3-DIMETHYLPENTANAL; 2,3-EPOXYDECANAL; 2,3-EPOXYHEPTANAL; 2,3-EPOXYOCTANAL; 2,3-O-(3-PENTYLIDENE)-D-GLYCERALDEHYDE; 2,3-O-(3-PENTYLIDENE)-L-GLYCERALDEHYDE; 2,3-PYRIDINEDICARBOXALDEHYDE; 2,4,5-TRIFLUORO-3-METHYLBENZALDEHYDE; 2,4,5-TRIFLUOROBENZALDEHYDE; 2,4,5-TRIHYDROXYBENZALDEHYDE; 2,4,5-TRIMETHYLBENZALDEHYDE; 2,4,6-PYRIDINETRICARBOXALDEHYDE; 2,4,6-TRIFLUOROBENZALDEHYDE; 2,4,6-TRIHYDROXYBENZALDEHYDE; 2,4,6-TRIHYDROXYPYRIMIDINE-5-CARBOXALDEHYDE; 2,4,6-TRIIFLUOROPYRIDINE-3-CARBOXALDEHYDE; 2,4,6-TRIMETHYL-3-CYCLOHEXENE-1-CARBOXALDEHYDE; 2,4,6-TRIMETHYLBENZALDEHYDE; 2,4,6-TRIMETHYL-PYRIDINE-3-CARBALDEHYDE; 2,4-DIFLUORO-3-FORMYLBENZONITRILE; 2,4-DIFLUORO-3-HYDROXYBENZALDEHYDE; 2,4-DIFLUORO-3-METHOXYBENZALDEHYDE; 2,4-DIFLUORO-3-METHYLBENZALDEHYDE; 2,4-DIFLUORO-5-METHYLBENZALDEHYDE; 2,4-DIFLUORO-6-HYDROXYBENZALDEHYDE; 2,4-DIFLUORO-6-METHYLBENZALDEHYDE; 2,4-DIFLUOROBENZALDEHYDE; 2,4-DIFLUORONICOTINALDEHYDE; 2,4-DIHYDROXY-3-METHYLBENZALDEHYDE; 2,4-DIHYDROXY-5-METHOXYBENZALDEHYDE; 2,4-DIHYDROXY-6-METHYLBENZALDEHYDE; 2,4-DIHYDROXYBENZALDEHYDE; 2,4-DIHYDROXY-BENZENE-1,3-DICARB-ALDEHYDE; 2,4-DIMETHOXY-5-FORMYLPYRIMIDINE; 2,4-DIMETHOXYBENZALDEHYDE; 2,4-DIMETHOXYNICOTINALDEHYDE; 2,4-DIMETHYL-3-CYCLOHEXENECARBOXALDEHYDE; 2,4-DIMETHYL-3-FLUOROBENZALDEHYDE; 2,4-DIMETHYLBENZALDEHYDE; 2,4-DIMETHYLNICOTINALDEHYDE; 2,4-DIMETHYLPYRIMIDINE-5-CARBALDEHYDE; 2,4-DIOXOTETRAHYDROFURAN-3-CARBALDEHYDE; 2,4-O-ETHYLIDENE-D-ERYTHROSE; 2,4-PYRIDINEDICARBOXALDEHYDE; 2,4-PYRIDINEDICARBOXALDEHYDE, 6-METHYL-; 2,5-ANHYDRO-D-MANNOSE; 2,5-DIFLUORO-3-METHYLBENZALDEHYDE; 2,5-DIFLUORO-4-HYDROXYBENZALDEHYDE; 2,5-DIFLUORO-4-METHOXYBENZALDEHYDE; 2,5-DIFLUORO-4-METHYLBENZALDEHYDE; 2,5-DIFLUORO-6-METHYLBENZALDEHYDE; 2,5-DIFLUOROBENZALDEHYDE; 2,5-DIFLUOROPYRIDINE-3-CARBOXALDEHYDE; 2,5-DIFLUOROPYRIDINE-4-CARBOXALDEHYDE; 2,5-DIHYDRO-1-METHYL-5-OXO-1H-PYRROLE-2-PROPANAL; 2,5-DIHYDRO-5-OXO-2-FURANCARBOXALDEHYDE; 2,5-DIHYDROXY-3-METHOXYBENZENECARBALDEHYDE; 2,5-DIHYDROXYBENZALDEHYDE; 2,5-DIMETHOXY-3-TETRAHYDROFURANCARBOXALDEHYDE; 2,5-DIMETHOXYBENZALDEHYDE; 2,5-DIMETHOXYISONICOTINALDEHYDE; 2,5-DIMETHOXYNICOTINALDEHYDE; 2,5-DIMETHYL-1H-PYRROLE-1-ACETALDEHYDE; 2,5-DIMETHYL-4-METHOXYBENZALDEHYDE; 2,5-DIMETHYLBENZALDEHYDE; 2,5-DIMETHYL-BENZENEPROPANAL; 2,5-DIMETHYLISONICOTINALDEHYDE; 2,5-DIMETHYLPYRIDINE-3-CARBOXALDEHYDE; 2,5-DIMETHYLTEREPHTHALALDEHYDE; 2,5-DIOXO-1-PYRROLIDINEBUTANAL; 2,5-PYRAZINEDICARBOXALDEHYDE; 2,5-PYRIDINEDICARBOXALDEHYDE; 2,6,6-TRIMETHYL-1-CYCLOHEXENE-1-ACETALDEHYDE; 2,6-DIETHYLBENZALDEHYDE; 2,6-DIFLUORO-3-HYDROXYBENZALDEHYDE; 2,6-DIFLUORO-3-METHOXYBENZALDEHYDE; 2,6-DIFLUORO-3-METHYLBENZALDEHYDE; 2,6-DIFLUORO-4-FORMYLBENZONITRILE; 2,6-DIFLUORO-4-HYDROXYBENZALDEHYDE; 2,6-DIFLUORO-4-METHOXYBENZALDEHYDE; 2,6-DIFLUORO-4-METHYLBENZALDEHYDE; 2,6-DIFLUOROBENZALDEHYDE; 2,6-DIFLUOROPYRIDINE-3-CARBOXALDEHYDE; 2,6-DIFLUOROPYRIDINE-4-CARBOXALDEHYDE; 2,6-DIFORMYLPHENOL; 2,6-DIHYDROXY-4-METHYLBENZALDEHYDE; 2,6-DIHYDROXYBENZALDEHYDE; 2,6-DIMETHOXY-3-FORMYLPYRIDINE; 2,6-DIMETHOXYBENZALDEHYDE; 2,6-DIMETHOXYISONICOTINALDEHYDE; 2,6-DIMETHYL-3-HYDROXYBENZALDEHYDE; 2,6-DIMETHYL-3-METHOXYBENZALDEHYDE; 2,6-DIMETHYL-4-FLUOROBENZALDEHYDE; 2,6-DIMETHYL-4-HYDROXYBENZALDEHYDE; 2,6-DIMETHYL-5-HEPTENAL; 2,6-DIMETHYLBENZALDEHYDE; 2,6-DIMETHYL-BENZENEPROPANAL; 2,6-DIMETHYLPHENYLGLYOXAL; 2,6-DIMETHYL-PYRIDINE-3-CARBALDEHYDE; 2,6-DIMETHYLPYRIDINE-4-CARBOXALDEHYDE; 2,6-DIMETHYLPYRIMIDINE-4-CARBALDEHYDE; 2,6-PYRIDINEDICARBOXALDEHYDE; 2,7-NAPHTHYRIDINE-4-CARBALDEHYDE; 2-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]ACETALDEHYDE; 2-[(1-METHYL-1H-PYRAZOL-4-YL)SULFANYL]ACETALDEHYDE; 2-[(2,2-DIMETHYLPROPYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(2-FLUOROPHENYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(2-FLUOROPHENYL)SULFANYL]ACETALDEHYDE; 2-[(2-HYDROXYETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(2-HYDROXYETHYL)(PENTAN-3-YL)AMINO]ACETALDEHYDE; 2-[(2-HYDROXYETHYL)(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[(2-HYDROXYETHYL)(PROPYL)AMINO]ACETALDEHYDE; 2-[(2-HYDROXYETHYL)SULFANYL]ACETALDEHYDE; 2-[(2-HYDROXYPROPYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(2-METHOXYETHYL)(2-METHYLPROPYL)AMINO]ACETALDEHYDE; 2-[(2-METHOXYETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(2-METHOXYETHYL)SULFANYL]ACETALDEHYDE; 2-[(2-METHYLBUTAN-2-YL)OXY]ACETALDEHYDE; 2-[(2-METHYLPHENYL)SULFANYL]ACETALDEHYDE; 2-[(2-METHYLPROPYL)(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[(2-METHYLPROPYL)SULFANYL]ACETALDEHYDE; 2-[(3-FLUOROPHENYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(3-HYDROXYPROPYL)(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[(3-METHOXYPROPYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(3-METHYLCYCLOHEXYL)SULFANYL]ACETALDEHYDE; 2-[(3-METHYLPHENYL)SULFANYL]ACETALDEHYDE; 2-[(4,5-DIMETHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]ACETALDEHYDE; 2-[(4-FLUOROPHENYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(4-FLUOROPHENYL)SULFANYL]ACETALDEHYDE; 2-[(4-HYDROXYPYRIMIDIN-2-YL)SULFANYL]ACETALDEHYDE; 2-[(4-METHYL-1,3-THIAZOL-2-YL)SULFANYL]ACETALDEHYDE; 2-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]ACETALDEHYDE; 2-[(4-METHYLCYCLOHEXYL)OXY]ACETALDEHYDE; 2-[(4-METHYLPENTYL)OXY]ACETALDEHYDE; 2-[(4-METHYLPHENYL)SULFANYL]ACETALDEHYDE; 2-[(4-METHYLPYRIMIDIN-2-YL)SULFANYL]ACETALDEHYDE; 2-[(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]ACETALDEHYDE; 2-[(5-METHYL-1,3,4-THIADIAZOL-2-YL)SULFANYL]ACETALDEHYDE; 2-[(5-METHYLPYRIMIDIN-2-YL)SULFANYL]ACETALDEHYDE; 2-[(CYANOMETHYL)(2-OXOETHYL)AMINO]ACETONITRILE; 2-[(CYANOMETHYL)(3-OXOPROPYL)AMINO]ACETONITRILE; 2-[(CYCLOBUTYLMETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(CYCLOHEXYLMETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(CYCLOPENTYLMETHYL)SULFANYL]ACETALDEHYDE; 2-[(CYCLOPROPYLMETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(CYCLOPROPYLMETHYL)(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[(CYCLOPROPYLMETHYL)(PROPYL)AMINO]ACETALDEHYDE; 2-[(DIETHYLAMINO)METHYL]-2-METHYLBUTANAL; 2-[(DIMETHYLAMINO)METHYL]-2-ETHYLBUTANAL; 2-[(DIMETHYLAMINO)METHYL]-2-METHYLBUTANAL; 2-[(DIMETHYLAMINO)METHYL]-2-METHYLPENTANAL; 2-[(FURAN-2-YLMETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(FURAN-2-YLMETHYL)SULFANYL]ACETALDEHYDE; 2-[(FURAN-3-YLMETHYL)(METHYL)AMINO]ACETALDEHYDE; 2-[(METHYLSULFANYL)METHYL]PYRIMIDINE-4-CARBALDEHYDE; 2-[(METHYLSULFANYL)METHYL]PYRIMIDINE-5-CARBALDEHYDE; 2-[1,2,4]TRIAZOL-1-YL-BENZALDEHYDE; 2-[2-(3-HYDROXYPROPYL)PYRROLIDIN-1-YL]ACETALDEHYDE; 2-[2-(HYDROXYMETHYL)PYRROLIDIN-1-YL]ACETALDEHYDE; 2-[2-(PROPAN-2-YL)-1H-IMIDAZOL-1-YL]ACETALDEHYDE; 2-[2-(PROPAN-2-YLOXY)ETHOXY]ACETALDEHYDE; 2-[2-(PYRIDIN-2-YL)ETHOXY]ACETALDEHYDE; 2-[2-(THIOPHEN-2-YL)ETHOXY]ACETALDEHYDE; 2-[3-(DIMETHYLAMINO)PYRROLIDIN-1-YL]ACETALDEHYDE; 2-[3-(HYDROXYMETHYL)PHENOXY]ACETALDEHYDE; 2-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]ACETALDEHYDE; 2-[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]ACETALDEHYDE; 2-[4-(HYDROXYMETHYL)PHENOXY]ACETALDEHYDE; 2-[4-(HYDROXYMETHYL)PIPERIDIN-1-YL]ACETALDEHYDE; 2-[4-(PROPAN-2-YL)PIPERAZIN-1-YL]ACETALDEHYDE; 2-[BENZYL(METHYL)AMINO]ACETALDEHYDE; 2-[BIS(2-HYDROXYETHYL)AMINO]ACETALDEHYDE; 2-[BIS(2-METHYLPROPYL)AMINO]ACETALDEHYDE; 2-[BUTYL(2-HYDROXYETHYL)AMINO]ACETALDEHYDE; 2-[BUTYL(CYCLOPROPYL)AMINO]ACETALDEHYDE; 2-[BUTYL(ETHYL)AMINO]ACETALDEHYDE; 2-[BUTYL(METHYL)AMINO]ACETALDEHYDE; 2-[CYCLOHEPTYL(METHYL)AMINO]ACETALDEHYDE; 2-[CYCLOHEXYL(ETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOHEXYL(METHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPENTYL(2-HYDROXYETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPENTYL(ETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPENTYL(METHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(2-HYDROXYETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(2-METHOXYETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(2-METHYLPROPYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(ETHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(METHYL)AMINO]ACETALDEHYDE; 2-[CYCLOPROPYL(PROPYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2,2,2-TRIFLUOROETHYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2-ETHYLBUTYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2-HYDROXYETHYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2-METHOXYETHYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2-METHYLPROPYL)AMINO]ACETALDEHYDE; 2-[ETHYL(2-OXOETHYL)AMINO]-N,N-DIMETHYLACETAMIDE; 2-[ETHYL(FURAN-2-YLMETHYL)AMINO]ACETALDEHYDE; 2-[ETHYL(METHYL)AMINO]ACETALDEHYDE; 2-[ETHYL(METHYL)AMINO]BENZALDEHYDE; 2-[ETHYL(PHENYL)AMINO]ACETALDEHYDE; 2-[ETHYL(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[ETHYL(PROPYL)AMINO]ACETALDEHYDE; 2-[METHYL(1,3-THIAZOL-4-YLMETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(1-METHYLPIPERIDIN-3-YL)AMINO]ACETALDEHYDE; 2-[METHYL(1-METHYLPIPERIDIN-4-YL)AMINO]ACETALDEHYDE; 2-[METHYL(2,2,2-TRIFLUOROETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(2-METHYLPHENYL)AMINO]ACETALDEHYDE; 2-[METHYL(2-METHYLPROPYL)AMINO]ACETALDEHYDE; 2-[METHYL(3-METHYLBUTYL)AMINO]ACETALDEHYDE; 2-[METHYL(3-METHYLPHENYL)AMINO]ACETALDEHYDE; 2-[METHYL(4-METHYLCYCLOHEXYL)AMINO]ACETALDEHYDE; 2-[METHYL(4-METHYLPHENYL)AMINO]ACETALDEHYDE; 2-[METHYL(PENTAN-3-YL)AMINO]ACETALDEHYDE; 2-[METHYL(PENTYL)AMINO]ACETALDEHYDE; 2-[METHYL(PHENYL)AMINO]ACETALDEHYDE; 2-[METHYL(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[METHYL(PROPYL)AMINO]ACETALDEHYDE; 2-[METHYL(PYRIDIN-2-YLMETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(PYRIDIN-3-YLMETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(PYRIDIN-4-YLMETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(THIOPHEN-2-YLMETHYL)AMINO]ACETALDEHYDE; 2-[METHYL(THIOPHEN-3-YLMETHYL)AMINO]ACETALDEHYDE; 2-[PENTYL(PROPAN-2-YL)AMINO]ACETALDEHYDE; 2-[PROPAN-2-YL(PROPYL)AMINO]ACETALDEHYDE; 2-ACETYL-3-PYRIDINECARBOXALDEHYDE; 2-ACETYL-5-OXO-PENTANOIC ACID METHYL ESTER; 2-ACETYLBENZALDEHYDE; 2-ACETYLPYRIDINE-4-CARBALDEHYDE; 2-ALLYL-3-HYDROXYBENZALDEHYDE; 2-ALLYLOXYBENZALDEHYDE; 2-BENZOFURANGLYOXYLALDEHYDE; 2-BENZOFURANPROPANAL; 2-BROMO-2-METHYL-PROPIONALDEHYDE; 2-BROMO-3-METHYLBUTYRALDEHYDE; 2-BROMOBUTANAL; 2-BROMOMALONALDEHYDE; 2-BROMO-PROPIONALDEHYDE; 2-BUTOXYACETALDEHYDE; 2-BUTYLPYRIMIDINE-4-CARBALDEHYDE; 2-BUTYL-PYRIMIDINE-5-CARBALDEHYDE; 2-BUTYNAL; 2-CHLORO-2-METHYLPROPANAL; 2-CHLORO-3,4-DIHYDROXYBENZALDEHYDE; 2-CHLORO-3,5-DIMETHYLBENZALDEHYDE; 2-CHLORO-3-CYANOBENZALDEHYDE; 2-CHLORO-3-FLUORO-4-FORMYLPYRIDINE; 2-CHLORO-3-FLUORO-4-HYDROXYBENZALDEHYDE; 2-CHLORO-3-FLUORO-6-HYDROXY-BENZALDEHYDE; 2-CHLORO-3-FLUOROBENZALDEHYDE; 2-CHLORO-3-FLUOROMETHYLBENZALDEHYDE; 2-CHLORO-3-FORMYL-4-PICOLINE; 2-CHLORO-3-FORMYL-6-PICOLINE; 2-CHLORO-3-HYDROXYBENZALDEHYDE; 2-CHLORO-3-HYDROXYISONICOTINALDEHYDE; 2-CHLORO-3-METHOXYBENZALDEHYDE; 2-CHLORO-3-METHOXYPYRIDINE-4-CARBOXALDEHYDE; 2-CHLORO-3-METHYLBENZALDEHYDE; 2-CHLORO-3-METHYLPYRIDINE-4-CARBOXALDEHYDE; 2-CHLORO-3-PHENYLPROPANAL; 2-CHLORO-3-PYRIDINECARBOXALDEHYDE; 2-CHLORO-4,6-DIMETHYLPYRIDINE-3-CARBOXALDEHYDE; 2-CHLORO-4-FLUORO-3-METHYLBENZALDEHYDE; 2-CHLORO-4-FLUOROBENZALDEHYDE; 2-CHLORO-4-FLUORO-PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-4-HYDROXYBENZALDEHYDE; 2-CHLORO-4-HYDROXYNICOTINALDEHYDE; 2-CHLORO-4-METHOXYBENZALDEHYDE; 2-CHLORO-4-METHOXYNICOTINALDEHYDE; 2-CHLORO-4-METHOXYPYRIDINE-5-CARBOXALDEHYDE; 2-CHLORO-4-METHYLBENZALDEHYDE; 2-CHLORO-5-FLUORO-3-FORMYLPYRIDINE; 2-CHLORO-5-FLUORO-4-FORMYLPYRIDINE; 2-CHLORO-5-FLUORO-6-FORMYLPYRIDINE; 2-CHLORO-5-FLUOROBENZALDEHYDE; 2-CHLORO-5-FORMYL-4-PICOLINE; 2-CHLORO-5-FORMYL-NICOTINONITRILE; 2-CHLORO-5-HYDROXY-3-PYRIDINECARBOXALDEHYDE; 2-CHLORO-5-HYDROXYBENZALDEHYDE; 2-CHLORO-5-HYDROXYISONICOTINALDEHYDE; 2-CHLORO-5-METHOXYBENZALDEHYDE; 2-CHLORO-5-METHOXYISONICOTINALDEHYDE; 2-CHLORO-5-METHOXYPYRIDINE-3-CARBOXALDEHYDE; 2-CHLORO-5-METHYLBENZALDEHYDE; 2-CHLORO-5-METHYLPYRIDINE-3-CARBALDEHYDE; 2-CHLORO-5-METHYLPYRIDINE-4-CARBOXALDEHYDE; 2-CHLORO-6-CYANOBENZALDEHYDE; 2-CHLORO-6-CYANOISONICOTINALDEHYDE; 2-CHLORO-6-FLUORO-3-METHYLBENZALDEHYDE; 2-CHLORO-6-FLUOROBENZALDEHYDE; 2-CHLORO-6-FLUOROISONICOTINALDEHYDE; 2-CHLORO-6-FLUORONICOTINALDEHYDE; 2-CHLORO-6-FORMYLBENZONITRILE; 2-CHLORO-6-HYDROXYBENZALDEHYDE; 2-CHLORO-6-HYDROXYISONICOTINALDEHYDE; 2-CHLORO-6-HYDROXYNICOTINALDEHYDE; 2-CHLORO-6-METHOXY-4-PYRIDINECARBOXALDEHYDE; 2-CHLORO-6-METHOXYBENZALDEHYDE; 2-CHLORO-6-METHOXYNICOTINALDEHYDE; 2-CHLORO-6-METHYLBENZALDEHYDE; 2-CHLORO-6-METHYLPYRIDINE-4-CARBOXALDEHYDE; 2-CHLOROBENZALDEHYDE; 2-CHLORO-HEXANAL; 2-CHLOROISONICOTINALDEHYDE; 2-CHLOROISONICOTINALDEHYDE HYDRATE; 2-CHLOROMALONALDEHYDE; 2-CHLOROPHENYLGLYOXAL; 2-CHLOROPROPIONALDEHYDE; 2-CHLORO-PYRIDINE-3,5-DICARBALDEHYDE; 2-CHLOROPYRIMIDINE-4,6-DICARBALDEHYDE; 2-CHLOROPYRIMIDINE-4-CARBALDEHYDE; 2-CHLOROPYRIMIDINE-5-CARBALDEHYDE; 2-CYANO-3-FLUOROBENZALDEHYDE; 2-CYANO-3-HYDROXYBENZALDEHYDE; 2-CYANO-4-FLUOROBENZALDEHYDE; 2-CYANO-4-METHOXYBENZALDEHYDE; 2-CYANO-4-METHYLBENZALDEHYDE; 2-CYANO-5-FLUOROBENZALDEHYDE; 2-CYANO-5-HYDROXYBENZALDEHYDE; 2-CYANO-5-METHOXYBENZALDEHYDE; 2-CYANO-5-METHYLBENZALDEHYDE; 2-CYANO-6-FLUOROBENZALDEHYDE; 2-CYANO-6-HYDROXYBENZALDEHYDE; 2-CYANO-6-METHOXYBENZALDEHYDE; 2-CYANO-6-METHYLBENZALDEHYDE; 2-CYANOBENZALDEHYDE; 2-CYANOPYRIDINE-4-CARBOXALDEHYDE; 2-CYCLOBUTOXYACETALDEHYDE; 2-CYCLOHEXYL PROPANAL; 2-CYCLOHEXYLACETALDEHYDE; 2-CYCLOPROPOXYBENZALDEHYDE; 2-CYCLOPROPYL-2-OXOACETALDEHYDE; 2-CYCLOPROPYL-3-PYRIDINECARBOXALDEHYDE; 2-CYCLOPROPYL-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-CYCLOPROPYLACETALDEHYDE; 2-CYCLOPROPYLBENZALDEHYDE; 2-CYCLOPROPYLETHYNYL-BENZALDEHYDE; 2-CYCLOPROPYLPYRIMIDINE-4-CARBALDEHYDE; 2-CYCLOPROPYLPYRIMIDINE-5-CARBALDEHYDE; 2-DECYNAL; 2-DEOXY-D-GLUCOSE; 2-DEOXY-D-RIBOSE; 2-DEOXY-L-GLUCOSE; 2-DEOXY-L-RIBOSE; 2-DIMETHYLAMINO-1,3-DIOXOHEXANE; 2-DIMETHYLAMINO-5-FORMYLBENZONITRILE; 2-DIMETHYLAMINOMETHYL-BENZALDEHYDE; 2-DIMETHYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-ETHENYLBENZALDEHYDE; 2-ETHOXY-3-METHYLPYRIDINE-5-CARBOXALDEHYDE; 2-ETHOXY-4-FLUOROBENZALDEHYDE; 2-ETHOXY-5-FLUOROBENZALDEHYDE; 2-ETHOXY-5-METHYLBENZALDEHYDE; 2-ETHOXYBENZALDEHYDE; 2-ETHOXYNICOTINALDEHYDE; 2-ETHYL-1,3-DITHIOLANE-2-CARBALDEHYDE; 2-ETHYL-2-([ETHYL(METHYL)AMINO]METHYL)BUTANAL; 2-ETHYL-2,3-DIHYDRO-1H-INDENE-2-CARBALDEHYDE; 2-ETHYL-3-HYDROXYBENZALDEHYDE; 2-ETHYL-3-HYDROXYHEXANAL; 2-ETHYL-3-METHYLBUTANAL; 2-ETHYL-3-PYRIDINECARBOXALDEHYDE; 2-ETHYL-4-HYDROXYBENZALDEHYDE; 2-ETHYL-4-PYRIDINECARBOXALDEHYDE; 2-ETHYL-5-HYDROXYBENZALDEHYDE; 2-ETHYL-5-METHYLCYCLOPENTANAL; 2-ETHYL-6-HYDROXYBENZALDEHYDE; 2-ETHYL-6-METHYL-4-PYRIDINECARBOXALDEHYDE; 2-ETHYL-6-METHYLBENZALDEHYDE; 2-ETHYL-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-ETHYLBENZALDEHYDE; 2-ETHYLBUTYRALDEHYDE; 2-ETHYLHEPTANAL; 2-ETHYLHEXANAL; 2-ETHYLHEXENAL; 2-ETHYLPYRIMIDINE-4-CARBALDEHYDE; 2-ETHYLPYRIMIDINE-5-CARBALDEHYDE; 2-ETHYLSULFANYL-PYRIMIDINE-5-CARBALDEHYDE; 2-ETHYNYL-5-PYRIMIDINECARBOXALDEHYDE; 2-ETHYNYLBENZALDEHYDE; 2-FLUORO-3-(CHLOROMETHYL)BENZALDEHYDE; 2-FLUORO-3-(DIFLUOROMETHYL)BENZALDEHYDE; 2-FLUORO-3,4-DIHYDROXY-BENZALDEHYDE; 2-FLUORO-3-FORMYL-4-PICOLINE; 2-FLUORO-3-FORMYLPHENYLBORONIC ACID; 2-FLUORO-3-FORMYLPYRIDINE; 2-FLUORO-3-HYDROXY-4-METHOXYBENZALDEHYDE; 2-FLUORO-3-HYDROXY-6-METHOXYBENZALDEHYDE; 2-FLUORO-3-HYDROXYBENZALDEHYDE; 2-FLUORO-3-HYDROXYISONICOTINALDEHYDE; 2-FLUORO-3-METHOXY-5-METHYLBENZALDEHYDE; 2-FLUORO-3-METHOXYBENZALDEHYDE; 2-FLUORO-3-METHOXYISONICOTINALDEHYDE; 2-FLUORO-3-METHYL-5-METHOXYBENZALDEHYDE; 2-FLUORO-3-METHYLBENZALDEHYDE; 2-FLUORO-3-METHYL-BENZENEPROPANAL; 2-FLUORO-3-METHYLISONICOTINALDEHYDE; 2-FLUORO-3-NITROBENZALDEHYDE; 2-FLUORO-4-(CHLOROMETHYL)BENZALDEHYDE; 2-FLUORO-4,5-DIHYDROXYBENZALDEHYDE; 2-FLUORO-4-FORMYLBENZONITRILE; 2-FLUORO-4-FORMYLPHENYLBORONIC ACID; 2-FLUORO-4-FORMYLPYRIDINE; 2-FLUORO-4-HYDROXYBENZALDEHYDE; 2-FLUORO-4-MERCAPTOBENZALDEHYDE; 2-FLUORO-4-METHOXYBENZALDEHYDE; 2-FLUORO-4-METHYLBENZALDEHYDE; 2-FLUORO-4-NITROBENZALDEHYDE; 2-FLUORO-5-FORMYL-3-PICOLINE; 2-FLUORO-5-FORMYLBENZONITRILE; 2-FLUORO-5-FORMYLPHENYLBORONIC ACID; 2-FLUORO-5-FORMYLPYRIDINE; 2-FLUORO-5-HYDROXYBENZALDEHYDE; 2-FLUORO-5-HYDROXYISONICOTINALDEHYDE; 2-FLUORO-5-HYDROXYNICOTINALDEHYDE; 2-FLUORO-5-MERCAPTOBENZALDEHYDE; 2-FLUORO-5-METHOXYBENZALDEHYDE; 2-FLUORO-5-METHOXYISONICOTINALDEHYDE; 2-FLUORO-5-METHOXYNICOTINALDEHYDE; 2-FLUORO-5-METHYLBENZALDEHYDE; 2-FLUORO-5-METHYLISONICOTINALDEHYDE; 2-FLUORO-5-METHYLPYRIDINE-3-CARBOXALDEHYDE; 2-FLUORO-5-NITROBENZALDEHYDE; 2-FLUORO-6-FORMYLPYRIDINE; 2-FLUORO-6-HYDROXY-3-METHOXYBENZALDEHYDE; 2-FLUORO-6-HYDROXYBENZALDEHYDE; 2-FLUORO-6-HYDROXYISONICOTINALDEHYDE; 2-FLUORO-6-HYDROXYNICOTINALDEHYDE; 2-FLUORO-6-METHOXYBENZALDEHYDE; 2-FLUORO-6-METHOXYISONICOTINALDEHYDE; 2-FLUORO-6-METHOXYNICOTINALDEHYDE; 2-FLUORO-6-METHYLBENZALDEHYDE; 2-FLUORO-6-METHYLISONICOTINALDEHYDE; 2-FLUORO-6-METHYLNICOTINALDEHYDE; 2-FLUORO-6-NITROBENZALDEHYDE; 2-FLUOROBENZALDEHYDE; 2-FLUORONAPHTHALENE-1-CARBOXALDEHYDE; 2-FLUORONAPHTHALENE-3-CARBOXALDEHYDE; 2-FLUORONAPHTHALENE-4-CARBOXALDEHYDE; 2-FLUORONAPHTHALENE-5-CARBOXALDEHYDE; 2-FLUORONAPHTHALENE-6-CARBOXALDEHYDE; 2-FLUORONAPHTHALENE-7-CARBOXALDEHYDE; 2-FLUOROPHENYLGLYOXAL HYDRATE; 2-FORMYL-1,3-BENZOXAZOLE-6-CARBONITRILE; 2-FORMYL-1,3-BENZOXAZOLE-7-CARBONITRILE; 2-FORMYL-1-PIPERIDINECARBOXYLIC ACID METHYL ESTER; 2-FORMYL-3,4-DIHYDRO-2H-PYRAN; 2-FORMYL-3-METHYL-3H-IMIDAZOLE-4-CARBOXYLIC ACID METHYL ESTER; 2-FORMYL-3-METHYLBUTANENITRILE; 2-FORMYL-3-OXO-BUTYRIC ACID ETHYL ESTER; 2-FORMYL-3-PHENYL-PROPIONITRILE; 2-FORMYL-4-METHYLPENTANENITRILE; 2-FORMYL-4-METHYLPHENYLBORONIC ACID; 2-FORMYL-4-PICOLINE; 2-FORMYL-5,6,7,8-TETRAHYDROQUINAZOLINE; 2-FORMYL-5-HYDROXYBENZONITRILE; 2-FORMYL-5-METHYLPHENYLBORONIC ACID; 2-FORMYL-6-METHOXYBENZONITRILE; 2-FORMYL-6-METHYLBENZONITRILE; 2-FORMYL-6-METHYL-CYCLOPENTAIMIDAZOLE; 2-FORMYL-6-METHYLISONICOTINONITRILE; 2-FORMYL-6-METHYLPYRIDINE-4-BORONIC ACID; 2-FORMYLAZULENE; 2-FORMYL-BENZOYL CHLORIDE; 2-FORMYLBUTANENITRILE; 2-FORMYLNICOTINONITRILE; 2-FORMYLPHENYLBORONIC ACID; 2-FORMYLPROPIONIC ACID ETHYL ESTER; 2-FORMYLPYRIDINE-4-BORONIC ACID; 2-FORMYLPYRIMIDINE-4-CARBONITRILE; 2-FURAN-2-YL-BENZALDEHYDE; 2-FURANBUTANAL; 2-FURANPENTANAL; 2H-1,2,3-TRIAZOLE-4-CARBOXALDEHYDE, 5-[(DIMETHYLAMINO)METHYL]-; 2-HEPTYNAL; 2-HEXYNAL; 2H-PYRAN-4-CARBOXALDEHYDE, 4-FLUOROTETRAHYDRO-; 2H-TETRAZOLE-5-CARBALDEHYDE; 2-HYDROXY-1-NAPHTHALDEHYDE; 2-HYDROXY-3-(METHYLTHIO)BENZALDEHYDE; 2-HYDROXY-3,4-DIMETHYL-BENZALDEHYDE; 2-HYDROXY-3,5-DIMETHYL-BENZALDEHYDE; 2-HYDROXY-3,6-DIMETHYLBENZALDEHYDE; 2-HYDROXY-3-ISOPROPYLBENZALDEHYDE; 2-HYDROXY-3-METHOXY-5-METHYL-BENZALDEHYDE; 2-HYDROXY-3-METHOXYBENZALDEHYDE; 2-HYDROXY-3-METHYLBENZALDEHYDE; 2-HYDROXY-3-METHYLISONICOTINALDEHYDE; 2-HYDROXY-4-(METHYLTHIO)BENZALDEHYDE; 2-HYDROXY-4,5-DIMETHYL-BENZALDEHYDE; 2-HYDROXY-4,6-DIMETHYL-BENZALDEHYDE; 2-HYDROXY-4-ISOPROPYLBENZALDEHYDE; 2-HYDROXY-4-METHOXY-6-METHYLBENZALDEHYDE; 2-HYDROXY-4-METHOXYBENZALDEHYDE; 2-HYDROXY-4-METHYLBENZALDEHYDE; 2-HYDROXY-4-METHYLNICOTINALDEHYDE; 2-HYDROXY-4-NITROBENZALDEHYDE; 2-HYDROXY-4-PYRIDINECARBOXALDEHYDE; 2-HYDROXY-5-(HYDROXYMETHYL)BENZALDEHYDE; 2-HYDROXY-5-(METHYLSULFANYL)BENZALDEHYDE; 2-HYDROXY-5-CHLOROMETHYLBENZALDEHYDE; 2-HYDROXY-5-ISOPROPYL-BENZALDEHYDE; 2-HYDROXY-5-METHOXY-3-METHYL-BENZALDEHYDE; 2-HYDROXY-5-METHOXY-4-METHYL-BENZALDEHYDE; 2-HYDROXY-5-METHOXYBENZALDEHYDE; 2-HYDROXY-5-METHYLBENZALDEHYDE; 2-HYDROXY-5-METHYLISONICOTINALDEHYDE; 2-HYDROXY-5-METHYLISOPHTHALALDEHYDE; 2-HYDROXY-5-METHYLNICOTINALDEHYDE; 2-HYDROXY-5-NITROBENZALDEHYDE; 2-HYDROXY-5-NITRONICOTINALDEHYDE; 2-HYDROXY-5-PROPYL-BENZALDEHYDE; 2-HYDROXY-6-(METHYLTHIO)BENZALDEHYDE; 2-HYDROXY-6-ISOPROPYLBENZALDEHYDE; 2-HYDROXY-6-METHOXYBENZALDEHYDE; 2-HYDROXY-6-METHYLBENZALDEHYDE; 2-HYDROXY-6-METHYLISONICOTINALDEHYDE; 2-HYDROXY-6-METHYL-PYRIDINE-3-CARBALDEHYDE; 2-HYDROXY-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-HYDROXY-6-NITROBENZALDEHYDE; 2-HYDROXYHEXANEDIAL; 2-HYDROXYNICOTINALDEHYDE; 2-HYDROXYPYRAZINE-6-CARBOXALDEHYDE; 2-HYDROXYPYRIMIDINE-5-CARBALDEHYDE; 2-HYDROXYQUINOLINE-3-CARBALDEHYDE; 2-HYDROXYQUINOLINE-4-CARBOXALDEHYDE; 2-HYDROXYQUINOLINE-5-CARBOXALDEHYDE; 2-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 2-HYDROXYQUINOLINE-7-CARBOXALDEHYDE; 2-HYDROXYQUINOLINE-8-CARBOXALDEHYDE; 2-HYDROXYTEREPHTHALALDEHYDE; 2-IMIDAZOL-1-YL-BENZALDEHYDE; 2-IMIDAZOL-1-YL-PYRIDINE-3-CARBALDEHYDE; 2-IMIDAZOL-1-YL-PYRIDINE-4-CARBALDEHYDE; 2-ISOPROPOXYBENZALDEHYDE; 2-ISOPROPOXY-PYRIDINE-3-CARBALDEHYDE; 2-ISOPROPYL-6-METHYLBENZALDEHYDE; 2-ISOPROPYLBENZALDEHYDE; 2-ISOPROPYLPYRIMIDINE-4-CARBALDEHYDE; 2-ISOPROPYL-PYRIMIDINE-5-CARBALDEHYDE; 2-MERCAPTO-4-METHOXYBENZALDEHYDE; 2-MERCAPTOBENZALDEHYDE; 2-MESITYLACETALDEHYDE; 2-METHOXY-3,5-DIMETHYLBENZALDEHYDE; 2-METHOXY-3-METHYLBENZALDEHYDE; 2-METHOXY-3-METHYLISONICOTINALDEHYDE; 2-METHOXY-3-PYRIDINECARBOXALDEHYDE; 2-METHOXY-4-MERCAPTOBENZALDEHYDE; 2-METHOXY-4-METHYLBENZALDEHYDE; 2-METHOXY-4-METHYLNICOTINALDEHYDE; 2-METHOXY-5-METHYLBENZALDEHYDE; 2-METHOXY-5-METHYLISONICOTINALDEHYDE; 2-METHOXY-5-METHYLNICOTINALDEHYDE; 2-METHOXY-6-METHYL-3-PYRIDINECARBOXALDEHYDE; 2-METHOXY-6-METHYLBENZALDEHYDE; 2-METHOXY-6-METHYLISONICOTINALDEHYDE; 2-METHOXY-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-METHOXY-PENT-4-YNAL; 2-METHOXYPHENYLGLYOXAL; 2-METHOXYPYRAZINE-6-CARBOXALDEHYDE; 2-METHOXYPYRIDINE-4-CARBOXALDEHYDE; 2-METHOXYPYRIMIDINE-4,6-DICARBALDEHYDE; 2-METHOXYPYRIMIDINE-4-CARBALDEHYDE; 2-METHOXYPYRIMIDINE-5-CARBALDEHYDE; 2-METHYL DECANAL; 2-METHYL OCTANAL; 2-METHYL-1-NAPHTHALDEHYDE; 2-METHYL-1-OXOPENTAN-3-YL ETHANETHIOATE; 2-METHYL-1-OXOPENTAN-3-YL-ETHANETHIOATE; 2-METHYL-2-([METHYL(PROPAN-2-YL)AMINO]METHYL)BUTANAL; 2-METHYL-2-([METHYL(PROPYL)AMINO]METHYL)BUTANAL; 2-METHYL-2-(PYRROLIDIN-1-YLMETHYL)BUTANAL; 2-METHYL-2,3-DIHYDRO-1-BENZOFURAN-5-CARBALDEHYDE; 2-METHYL-2H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 2-METHYL-2-METHYLSULFANYL-PROPIONALDEHYDE; 2-METHYL-2-MORPHOLINOPROPANAL; 2-METHYL-2-PHENYLPROPANAL; 2-METHYL-2-PIPERIDINOPROPANAL; 2-METHYL-3-(1H-PYRROL-1-YL)PROPANAL; 2-METHYL-3-[METHYL(3-OXOPROPYL)AMINO]PROPANENITRILE; 2-METHYL-3-NITROBENZALDEHYDE; 2-METHYL-3-OXO-3-(THIOPHEN-2-YL)PROPANAL; 2-METHYL-3-OXO-BUTANAL; 2-METHYL-3-OXOPROPANENITRILE; 2-METHYL-3-PHENYLPROPANAL; 2-METHYL-3-TOLYLPROPIONALDEHYDE; 2-METHYL-4,5,6,7-TETRAHYDROBENZOFURAN-4-CARBALDEHYDE; 2-METHYL-4,5-DIFLUOROBENZALDEHYDE; 2-METHYL-4-NITROBENZALDEHYDE; 2-METHYL-5-NITROBENZALDEHYDE; 2-METHYL-6-NITROBENZALDEHYDE; 2-METHYL-6-QUINOLINECARBALDEHYDE; 2-METHYLBENZALDEHYDE; 2-METHYLBUTYRALDEHYDE; 2-METHYLCYCLOPROPANE-1-CARBALDEHYDE; 2-METHYLHEPTANAL; 2-METHYLHEXANAL; 2-METHYLISONICOTINALDEHYDE; 2-METHYLISONICOTINALDEHYDE HYDROCHLORIDE; 2-METHYLNAPHTHALENE-3-CARBOXALDEHYDE; 2-METHYLNAPHTHALENE-4-CARBOXALDEHYDE; 2-METHYLNAPHTHALENE-5-CARBOXALDEHYDE; 2-METHYLNAPHTHALENE-6-CARBOXALDEHYDE; 2-METHYLNAPHTHALENE-8-CARBOXALDEHYDE; 2-METHYLNICOTINALDEHYDE; 2-METHYLNONANAL; 2-METHYL-PENT-4-ENAL; 2-METHYLPYRIMIDINE-4,6-DICARBALDEHYDE; 2-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-METHYLPYRIMIDINE-5-CARBALDEHYDE; 2-METHYLQUINOLINE-4-CARBOXALDEHYDE; 2-METHYLTHIOACETALDEHYDE; 2-METHYLVALERALDEHYDE; 2-NAPHTHALDEHYDE; 2-NAPHTHALENECARBOXALDEHYDE, 3-HYDROXY-; 2-NAPHTHYLACETALDEHYDE; 2-NITROBENZALDEHYDE; 2-NITRONICOTINALDEHYDE; 2-NONYNAL; 2-OCTYNAL; 2-OXAZOLECARBOXALDEHYDE, 4-METHYL-; 2-OXAZOLECARBOXALDEHYDE, 5-(1,1-DIMETHYLETHYL)-; 2-OXAZOLECARBOXALDEHYDE, 5-ETHYL-; 2-OXO-2-(PIPERIDIN-1-YL)ACETALDEHYDE; 2-OXO-2-(PYRIDIN-2-YL)ACETALDEHYDE; 2-OXO-2-(PYRIDIN-3-YL)ACETALDEHYDE; 2-OXO-2-(PYRIDIN-4-YL)ACETALDEHYDE; 2-OXO-2H-CHROMENE-7-CARBALDEHYDE; 2-OXO-2-O-TOLYLACETALDEHYDE HYDRATE; 2-OXO-3-OXAZOLIDINEPROPANAL; 2-OXO-3-PHENYL-PROPANAL; 2-OXO-5-(PROPAN-2-YL)CYCLOHEXANE-1-CARBALDEHYDE; 2-OXOBUTANALDEHYDE; 2-OXOHEXAHYDRO-2H-CYCLOPENTA[B]FURAN-4-CARBALDEHYDE; 2-PENTYNAL; 2-PHENYL-2H-1,2,3-TRIAZOLE-4-CARBALDEHYDE; 2-PHENYLBUTANAL; 2-PHENYLCYCLOPROPANECARBALDEHYDE; 2-PHENYLMALONDIALDEHYDE; 2-PHENYLPROPIONALDEHYDE; 2-PROPOXYACETALDEHYDE; 2-PROPOXYBENZALDEHYDE; 2-PROPOXY-PYRIDINE-3-CARBALDEHYDE; 2-PROPYL VALERALDEHYDE; 2-PROPYL-4-PYRIDINECARBOXALDEHYDE; 2-PROPYLHEXANAL; 2-PROPYL-PYRIMIDINE-4-CARBALDEHYDE; 2-PROPYL-PYRIMIDINE-5-CARBALDEHYDE; 2-P-TOLYL-CYCLOPROPANECARBALDEHYDE; 2-PYRAZINEBUTANAL; 2-PYRAZINECARBOXALDEHYDE, 3-METHYL-; 2-PYRAZINECARBOXALDEHYDE, 5-METHYL-; 2-PYRIDAZIN-4-YLMALONALDEHYDE; 2-PYRIDIN-4-YLCYCLOPROPANECARBOXALDEHYDE; 2-PYRIDINECARBOXALDEHYDE; 2-PYRIDINECARBOXALDEHYDE, 1-OXIDE; 2-PYRIDINECARBOXALDEHYDE, 3,4-DIMETHYL-; 2-PYRIDINECARBOXALDEHYDE, 3-ETHENYL-; 2-PYRIDINECARBOXALDEHYDE, 4-ETHYL-; 2-PYRIDINECARBOXALDEHYDE, 6-(METHOXYMETHYL)-; 2-PYRIDINECARBOXALDEHYDE,6-(1-METHYLETHOXY)-; 2-PYRIMIDINECARBONITRILE, 5-FORMYL-; 2-PYRIMIDINECARBOXALDEHYDE; 2-PYRIMIDINECARBOXALDEHYDE, 5-METHYL-; 2-QUINOLINECARBOXALDEHYDE; 2-QUINOLINECARBOXALDEHYDE, 1-OXIDE; 2-QUINOXALINECARBALDEHYDE; 2-QUINOXALINECARBALDEHYDE 4-OXIDE; 2-QUINOXALINECARBOXALDEHYDE, 6-METHYL-; 2-TERT-BUTYLBENZALDEHYDE; 2-TERT-BUTYLISONICOTINALDEHYDE; 2-TERT-BUTYLPYRIMIDINE-4-CARBALDEHYDE; 2-TERT-BUTYLPYRIMIDINE-5-CARBALDEHYDE; 2-THIAZOLECARBOXALDEHYDE; 2-THIENYLGLYOXAL; 2-THIOGLYCERALDEHYDE; 2-THIOPHENEBUTANAL; 2-THIOPHENEGLYOXAL HYDRATE; 3-([ETHYL(METHYL)AMINO]METHYL)OXOLANE-3-CARBALDEHYDE; 3-(1,2,4-OXADIAZOL-3-YL)BENZALDEHYDE; 3-(1,3,4-THIADIAZOL-2-YLSULFANYL)PROPANAL; 3-(1,3-THIAZOL-2-YLSULFANYL)PROPANAL; 3-(1,4-OXAZEPAN-4-YL)PROPANAL; 3-(1,4-THIAZEPAN-4-YL)PROPANAL; 3-(1-ETHYL-1H-PYRAZOL-4-YL)-3-OXOPROPANAL; 3-(1H-1,2,4-TRIAZOL-1-YL)BENZALDEHYDE; 3-(1H-1,2,4-TRIAZOL-5-YLSULFANYL)PROPANAL; 3-(1H-IMIDAZOL-1-YL)BENZALDEHYDE; 3-(1H-PYRAZOL-1-YL)BENZALDEHYDE; 3-(1H-PYRAZOL-1-YL)PROPANAL; 3-(1H-PYRAZOL-3-YL)BENZALDEHYDE; 3-(1H-PYRAZOL-4-YL)BENZALDEHYDE; 3-(1H-PYRROL-1-YL)BENZALDEHYDE; 3-(1H-TETRAZOL-5-YL)BENZALDEHYDE; 3-(1-METHYL-1H-IMIDAZOL-4-YL)-PROPIONALDEHYDE; 3-(1-METHYL-1H-PYRAZOL-4-YL)-3-OXOPROPANAL; 3-(1-METHYL-2-OXO-ETHYL)-BENZONITRILE; 3-(2,2,2-TRIFLUOROETHOXY)PROPANAL; 3-(2,2-DIMETHYLMORPHOLIN-4-YL)PROPANAL; 3-(2,2-DIMETHYLPYRROLIDIN-1-YL)PROPANAL; 3-(2,3-DIMETHYLPIPERIDIN-1-YL)PROPANAL; 3-(2,4-DIFLUORO-PHENYL)-PROPIONALDEHYDE; 3-(2,4-DIMETHYL-PHENYL)-PROPIONALDEHYDE; 3-(2,4-DIMETHYLPIPERIDIN-1-YL)PROPANAL; 3-(2,4-DIOXO-1,3-THIAZOLIDIN-3-YL)PROPANAL; 3-(2,5-DIFLUORO-PHENYL)-PROPIONALDEHYDE; 3-(2,5-DIMETHYLFURAN-3-YL)-3-OXOPROPANAL; 3-(2,5-DIMETHYLMORPHOLIN-4-YL)PROPANAL; 3-(2,5-DIOXOPYRROLIDIN-1-YL)-2-METHYLPROPANAL; 3-(2,5-DIOXOPYRROLIDIN-1-YL)PROPANAL; 3-(2,6-DIFLUORO-PHENYL)-PROPIONALDEHYDE; 3-(2,6-DIMETHYLMORPHOLIN-4-YL)PROPANAL; 3-(2,6-DIMETHYLPIPERIDIN-1-YL)PROPANAL; 3-(2,6-DIOXOPIPERIDIN-1-YL)PROPANAL; 3-(2-BUTOXYETHOXY)PROPANAL; 3-(2-CHLORO-PHENYL)-PROPIONALDEHYDE; 3-(2-CHLORO-PYRIMIDIN-5-YL)-PROPIONALDEHYDE; 3-(2-ETHOXYETHOXY)PROPANAL; 3-(2-ETHYLMORPHOLIN-4-YL)PROPANAL; 3-(2-ETHYLPIPERIDIN-1-YL)PROPANAL; 3-(2-ETHYLPYRROLIDIN-1-YL)PROPANAL; 3-(2-FLUOROPHENOXY)PROPANAL; 3-(2-FLUOROPHENYL)-3-OXOPROPANAL; 3-(2-FLUORO-PHENYL)-PROPIONALDEHYDE; 3-(2-FORMYLIMIDAZOL-1-YL)-PROPAN-1-OL; 3-(2-FORMYL-IMIDAZOL-1-YL)-PROPIONITRILE; 3-(2-FURYL)-3-OXOPROPANAL; 3-(2-FURYL)BENZALDEHYDE; 3-(2H-TETRAZOL-5-YL)BENZALDEHYDE; 3-(2-HYDROXYETHOXY)BENZALDEHYDE; 3-(2-HYDROXYETHYL)BENZALDEHYDE; 3-(2-HYDROXYMETHYL-PHENYL)-PROPIONALDEHYDE; 3-(2-HYDROXYPHENYL)-3-OXOPROPANAL; 3-(2-HYDROXY-PHENYL)-PROPIONALDEHYDE; 3-(2-METHOXY-PHENYL)-PROPIONALDEHYDE; 3-(2-METHOXYPYRIDIN-4-YL)PROPANAL; 3-(2-METHYL-1,4-OXAZEPAN-4-YL)PROPANAL; 3-(2-METHYLMORPHOLIN-4-YL)PROPANAL; 3-(2-METHYLPHENOXY)PROPANAL; 3-(2-METHYLPHENYL)-3-OXOPROPANAL; 3-(2-METHYLPHENYL)PROPANAL; 3-(2-METHYLPIPERIDIN-1-YL)PROPANAL; 3-(2-METHYLPROPOXY)PROPANAL; 3-(2-METHYLPYRROLIDIN-1-YL)PROPANAL; 3-(2-OXO-1,3-THIAZOLIDIN-3-YL)PROPANAL; 3-(2-OXO-2,3-DIHYDRO-1,3-THIAZOL-3-YL)PROPANAL; 3-(2-OXO-ACETYL)-BENZONITRILE; 3-(2-OXOAZEPAN-1-YL)PROPANAL; 3-(2-OXOETHOXY)BENZALDEHYDE; 3-(2-OXOETHOXY)BENZONITRILE; 3-(2-OXOPIPERIDIN-1-YL)PROPANAL; 3-(2-OXOPYRROLIDIN-1-YL)PROPANAL; 3-(2-PROPEN-1-YL)-BENZALDEHYDE; 3-(3,3-DIMETHYLMORPHOLIN-4-YL)PROPANAL; 3-(3,4-DIFLUORO-PHENYL)-PROPIONALDEHYDE; 3-(3,4-DIHYDROXY-PHENYL)-PROPIONALDEHYDE; 3-(3,5-DIFLUORO-PHENYL)-PROPIONALDEHYDE; 3-(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)PROPANAL; 3-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PROPANAL; 3-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PROPANALHYDRATE; 3-(3,5-DIMETHYLPIPERIDIN-1-YL)PROPANAL; 3-(3,5-DIOXOMORPHOLIN-4-YL)PROPANAL; 3-(3-ALLYL)-5-HEXEN-1-AL; 3-(3-CHLORO-PHENYL)-PROPIONALDEHYDE; 3-(3-CHLOROPYRIDIN-2-YL)PROPANAL; 3-(3-ETHYLMORPHOLIN-4-YL)PROPANAL; 3-(3-ETHYLPIPERIDIN-1-YL)PROPANAL; 3-(3-FLUORO-4-METHYL-PHENYL)-PROPIONALDEHYDE; 3-(3-FLUOROPHENOXY)PROPANAL; 3-(3-FLUOROPHENYL)-3-OXOPROPANAL; 3-(3-FLUOROPHENYL)PROPANAL; 3-(3-HYDROXY-PHENYL)-PROPIONALDEHYDE; 3-(3-HYDROXYPIPERIDIN-1-YL)PROPANAL; 3-(3-HYDROXY-PROP-1-YNYL)-BENZALDEHYDE; 3-(3-HYDROXYPYRROLIDIN-1-YL)-2,2-DIMETHYLPROPANAL; 3-(3-HYDROXYPYRROLIDIN-1-YL)PROPANAL; 3-(3-METHOXYPHENYL)PROPANAL; 3-(3-METHOXYPROPOXY)PROPANAL; 3-(3-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(3-METHYL-2,5-DIOXOPYRROLIDIN-1-YL)PROPANAL; 3-(3-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)PROPANAL; 3-(3-METHYL-2-OXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(3-METHYL-3H-IMIDAZOL-4-YL)-PROPIONALDEHYDE; 3-(3-METHYLBUTOXY)PROPANAL; 3-(3-METHYLMORPHOLIN-4-YL)PROPANAL; 3-(3-METHYLPHENOXY)PROPANAL; 3-(3-METHYLPHENYL)PROPANAL; 3-(3-METHYLPIPERIDIN-1-YL)PROPANAL; 3-(3-METHYLPYRROLIDIN-1-YL)PROPANAL; 3-(3-OXOPROPANOYL)BENZONITRILE; 3-(3-OXO-PROPYL)-BENZONITRILE; 3-(4,4-DIMETHYLPIPERIDIN-1-YL)PROPANAL; 3-(4-CHLORO-PHENYL)-PROPIONALDEHYDE; 3-(4-ETHYL-PHENYL)-PROPIONALDEHYDE; 3-(4-ETHYLPIPERAZIN-1-YL)PROPANAL; 3-(4-ETHYLPIPERIDIN-1-YL)PROPANAL; 3-(4-FLUOROPHENOXY)PROPANAL; 3-(4-FLUOROPHENYL)-3-OXOPROPANAL; 3-(4-FLUOROPHENYL)PROPIONALDEHYDE; 3-(4-HYDROXYMETHYL-PHENYL)-PROPIONALDEHYDE; 3-(4-HYDROXY-PHENYL)-PROPIONALDEHYDE; 3-(4-HYDROXYPIPERIDIN-1-YL)PROPANAL; 3-(4-METHOXYPHENYL)PROPANAL; 3-(4-METHOXYPIPERIDIN-1-YL)PROPANAL; 3-(4-METHYL-1,4-DIAZEPAN-1-YL)PROPANAL; 3-(4-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-3-YL)PROPANAL; 3-(4-METHYL-2-OXOPYRROLIDIN-1-YL)PROPANAL; 3-(4-METHYLPHENOXY)PROPANAL; 3-(4-METHYLPHENYL)-3-OXOPROPANAL; 3-(4-METHYLPHENYL)PROPIONALDEHYDE; 3-(4-METHYLPIPERAZIN-1-YL)PROPANAL; 3-(4-METHYLPIPERIDIN-1-YL)PROPANAL; 3-(4-OXOPIPERIDIN-1-YL)PROPANAL; 3-(5-CHLOROTHIOPHEN-2-YL)PROPANAL; 3-(5-ETHYLTHIOPHEN-2-YL)PROPANAL; 3-(5-METHYL-2-FURYL)BUTYRALDEHYDE; 3-(5-METHYL-2-OXO-1,2-DIHYDROPYRIMIDIN-1-YL)PROPANAL; 3-(5-METHYLFURAN-2-YL)-3-OXOPROPANAL; 3-(5-METHYLTHIEN-2-YL)-3-OXOPROPANAL; 3-(6-CHLORO-PYRIDAZIN-3-YL)-PROPIONALDEHYDE; 3-(ALLYLOXY)BENZALDEHYDE; 3-(AZEPAN-1-YL)PROPANAL; 3-(AZOCAN-1-YL)PROPANAL; 3-(BENZOFURAN-5-YL)PROPANAL; 3-(BENZOFURAN-6-YL)PROPANAL; 3-(BUT-2-YN-1-YLOXY)BENZALDEHYDE; 3-(BUT-3-EN-1-YLOXY)PROPANAL; 3-(BUT-3-YN-1-YLOXY)BENZALDEHYDE; 3-(BUTAN-2-YLOXY)PROPANAL; 3-(BUTAN-2-YLSULFANYL)PROPANAL; 3-(BUTYLSULFANYL)PROPANAL; 3-(CYCLOHEPTYLOXY)PROPANAL; 3-(CYCLOHEXYLMETHOXY)PROPANAL; 3-(CYCLOHEXYLOXY)PROPANAL; 3-(CYCLOHEXYLSULFANYL)PROPANAL; 3-(CYCLOPENTYLOXY)PROPANAL; 3-(CYCLOPENTYLSULFANYL)PROPANAL; 3-(CYCLOPROPYLMETHOXY)PROPANAL; 3-(DIETHYLAMINO)PROPANAL; 3-(DIFLUOROMETHOXY)BENZALDEHYDE; 3-(DIFLUOROMETHOXY)PYRAZINE-2-CARBOXALDEHYDE; 3-(DIMETHYLAMINO)-2-HYDROXYBENZALDEHYDE; 3-(DIMETHYLAMINO)-4-HYDROXYBENZALDEHYDE; 3-(DIMETHYLAMINO)-5-HYDROXYBENZALDEHYDE; 3-(DIMETHYLAMINO)BENZALDEHYDE; 3-(DIMETHYLAMINO)PROPANAL; 3-(DIPROPYLAMINO)PROPANAL; 3-(ETHYLSULFANYL)PROPANAL; 3-(ETHYLTHIO)BUTANAL; 3-(FURAN-2-YL)-2-METHYL-3-OXOPROPANAL; 3-(FURAN-2-YL)PROPANAL; 3-(FURAN-2-YLMETHOXY)PROPANAL; 3-(HEPTYLOXY)PROPANAL; 3-(HEXYLOXY)PROPANAL; 3-(HYDROXYMETHYL)BENZALDEHYDE; 3-(METHOXYMETHOXY)BENZALDEHYDE; 3-(METHYLTHIO)BENZALDEHYDE; 3-(METHYLTHIO)BUTANAL; 3-(METHYLTHIO)HEXANAL; 3-(METHYLTHIO)PROPIONALDEHYDE; 3-(OXAN-2-YLMETHOXY)PROPANAL; 3-(OXAN-4-YL)PROPANAL; 3-(OXAN-4-YLMETHOXY)PROPANAL; 3-(OXAN-4-YLOXY)PROPANAL; 3-(OXAN-4-YLSULFANYL)PROPANAL; 3-(OXOLAN-2-YL)PROPANAL; 3-(OXOLAN-2-YLMETHOXY)PROPANAL; 3-(OXOLAN-3-YLMETHOXY)PROPANAL; 3-(OXOLAN-3-YLOXY)PROPANAL; 3-(PENTYLOXY)PROPANAL; 3-(PHENYLSULFANYL)PROPANAL; 3-(PROP-2-EN-1-YLOXY)PROPANAL; 3-(PROP-2-YNYL)BENZALDEHYDE; 3-(PROPAN-2-YLOXY)PROPANAL; 3-(PROPAN-2-YLSULFANYL)PROPANAL; 3-(PROPYLSULFANYL)PROPANAL; 3-(PYRAZIN-2-YL)BUTANAL; 3-(PYRAZIN-2-YL)PROPANAL; 3-(PYRIDIN-2-YL)PROPANAL; 3-(PYRIDIN-2-YLSULFANYL)PROPANAL; 3-(PYRIDIN-3-YL)PROPANAL; 3-(PYRIMIDIN-2-YL)PROPANAL; 3-(PYRIMIDIN-2-YLSULFANYL)PROPANAL; 3-(PYRIMIDIN-4-YL)PROPANAL; 3-(PYRIMIDIN-5-YL)PROPANAL; 3-(PYRROLIDIN-1-YL)PROPANAL; 3-(TERT-BUTOXY)PROPANAL; 3-(TERT-BUTYLSULFANYL)PROPANAL; 3-(TETRAHYDRO-2H-PYRAN-4-YL)-2,2-DIMETHYLPROPANAL; 3-(TETRAHYDRO-FURAN-3-YL)-PROPIONALDEHYDE; 3-(THIOMORPHOLIN-4-YL)PROPANAL; 3-(THIOPHEN-2-YL)PROPANAL; 3-(THIOPHEN-2-YLMETHOXY)PROPANAL; 3-(THIOPHEN-2-YLSULFANYL)PROPANAL; 3-(THIOPHEN-3-YL)PROPANAL; 3-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-(TRIFLUOROMETHYL)BENZALDEHYDE; 3-(TRIFLUOROMETHYL)BUTYRALDEHYDE; 3(Z)-NONENAL; 3,3,3-TRIFLUOROPROPANAL; 3,3,3-TRIFLUOROPROPIONALDEHYDE HYDRATE; 3,3,4,4,4-PENTAFLUOROBUTANAL; 3,3-DIMETHOXY-2-(HYDROXYMETHYLENE)PROPIONITRILE SODIUM SALT; 3,3-DIMETHYLBUTYRALDEHYDE; 3,4,5-TRIFLUOROBENZALDEHYDE; 3,4,5-TRIHYDROXYBENZALDEHYDE; 3,4,5-TRIHYDROXYBENZALDEHYDE MONOHYDRATE; 3,4,5-TRIMETHYLBENZALDEHYDE; 3,4-DIFLUORO-2-HYDROXYBENZALDEHYDE; 3,4-DIFLUORO-2-METHYLBENZALDEHYDE; 3,4-DIFLUORO-5-METHOXYBENZALDEHYDE; 3,4-DIFLUORO-5-METHYLBENZALDEHYDE; 3,4-DIFLUOROBENZALDEHYDE; 3,4-DIFLUOROPHENYLGLYOXAL; 3,4-DIHYDRO-1H-2-BENZOPYRAN-1-CARBOXALDEHYDE; 3,4-DIHYDRO-1H-2-BENZOPYRAN-3-CARBOXALDEHYDE; 3,4-DIHYDRO-1H-2-BENZOPYRAN-4-CARBOXALDEHYDE; 3,4-DIHYDRO-1H-2-BENZOPYRAN-5-CARBOXALDEHYDE; 3,4-DIHYDRO-1H-2-BENZOPYRAN-6-CARBOXALDEHYDE; 3,4-DIHYDRO-2H-CHROMENE-4-CARBALDEHYDE; 3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 3,4-DIHYDROPHENYLGLYOXAL; 3,4-DIHYDROXY PHENYL GLYOXAL; 3,4-DIHYDROXY-5-METHOXYBENZALDEHYDE; 3,4-DIHYDROXYBENZALDEHYDE; 3,4-DIMETHOXYBENZALDEHYDE; 3,4-DIMETHYL-3-CYCLOHEXENYLMETHANAL; 3,4-DIMETHYLBENZALDEHYDE; 3,4-DIMETHYL-BENZENEPROPANAL; 3,4-PYRIDINEDICARBOXALDEHYDE; 3,5,5-TRIMETHYLHEXANAL; 3,5,6-TRIMETHYL-2-PYRAZINECARBALDEHYDE; 3,5,6-TRIMETHYL-3-CYCLOHEXENE-1-CARBOXALDEHYDE; 3,5-DIETHYLBENZALDEHYDE; 3,5-DIFLUORO-2-HYDROXYBENZALDEHYDE; 3,5-DIFLUORO-2-METHOXYBENZALDEHYDE; 3,5-DIFLUORO-2-METHYLBENZALDEHYDE; 3,5-DIFLUORO-4-HYDROXYBENZALDEHYDE; 3,5-DIFLUORO-4-METHOXYBENZALDEHYDE; 3,5-DIFLUORO-4-PYRIDINECARBOXALDEHYDE; 3,5-DIFLUOROBENZALDEHYDE; 3,5-DIFLUOROPYRIDINE-2-CARBALDEHYDE; 3,5-DIHYDROXYBENZALDEHYDE; 3,5-DIMETHOXYBENZALDEHYDE; 3,5-DIMETHOXY-HEXANAL; 3,5-DIMETHOXYPYRAZINE-2-CARBALDEHYDE; 3,5-DIMETHOXYPYRIDINE-4-CARBOXALDEHYDE; 3,5-DIMETHYL-4-HYDROXYBENZALDEHYDE; 3,5-DIMETHYL-4-METHOXYBENZALDEHYDE; 3,5-DIMETHYLBENZALDEHYDE; 3,5-DIMETHYL-BENZENEPROPANAL; 3,5-DIMETHYLPYRAZINE-2-CARBALDEHYDE; 3,5-DIMETHYLPYRIDINE-2-CARBOXALDEHYDE; 3,5-DIMETHYLPYRIDINE-4-CARBOXALDEHYDE; 3,6-DIFLUORO-2-HYDROXYBENZALDEHYDE; 3,6-DIFLUORO-2-METHOXYBENZALDEHYDE; 3,6-DIFLUOROPICOLINALDEHYDE; 3,7-DIMETHYL-7-HYDROXYOCTANAL; 3,7-DIMETHYLOCTANAL; 3-[(1-CYCLOPROPYLETHYL)(METHYL)AMINO]PROPANAL; 3-[(1-METHOXYPROPAN-2-YL)(METHYL)AMINO]PROPANAL; 3-[(2,2-DIMETHYLPROPYL)(METHYL)AMINO]PROPANAL; 3-[(2-HYDROXYETHYL)(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[(2-HYDROXYETHYL)(METHYL)AMINO]PROPANAL; 3-[(2-HYDROXYETHYL)(PROPAN-2-YL)AMINO]PROPANAL; 3-[(2-HYDROXYETHYL)(PROPYL)AMINO]PROPANAL; 3-[(2-HYDROXYETHYL)SULFANYL]PROPANAL; 3-[(2-HYDROXYPROPYL)(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[(2-HYDROXYPROPYL)(METHYL)AMINO]PROPANAL; 3-[(2-METHOXYETHYL)(2-OXOETHYL)AMINO]PROPANENITRILE; 3-[(2-METHOXYETHYL)(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[(2-METHOXYETHYL)(METHYL)AMINO]PROPANAL; 3-[(2-METHOXYETHYL)SULFANYL]PROPANAL; 3-[(2-METHYLBUTAN-2-YL)OXY]PROPANAL; 3-[(2-METHYLCYCLOHEXYL)OXY]PROPANAL; 3-[(2-METHYLPROPYL)(2-OXOETHYL)AMINO]PROPANENITRILE; 3-[(2-METHYLPROPYL)(PROPAN-2-YL)AMINO]PROPANAL; 3-[(2-METHYLPROPYL)SULFANYL]PROPANAL; 3-[(2-OXOETHYL)(PROPAN-2-YL)AMINO]PROPANENITRILE; 3-[(3,3-DIMETHYLBUTAN-2-YL)(METHYL)AMINO]PROPANAL; 3-[(3-HYDROXYPROPYL)(PROPAN-2-YL)AMINO]PROPANAL; 3-[(3-METHOXYPROPYL)(METHYL)AMINO]PROPANAL; 3-[(3-METHYLCYCLOHEXYL)OXY]PROPANAL; 3-[(3-OXOPROPYL)(PROPAN-2-YL)AMINO]PROPANENITRILE; 3-[(4-METHYLCYCLOHEXYL)OXY]PROPANAL; 3-[(4-METHYLPENTAN-2-YL)OXY]PROPANAL; 3-[(4-METHYLPENTYL)OXY]PROPANAL; 3-[(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]PROPANAL; 3-[(CYCLOBUTYLMETHYL)(METHYL)AMINO]PROPANAL; 3-[(CYCLOPENTYLMETHYL)SULFANYL]PROPANAL; 3-[(CYCLOPROPYLMETHYL)(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[(CYCLOPROPYLMETHYL)(METHYL)AMINO]PROPANAL; 3-[(CYCLOPROPYLMETHYL)(PROPAN-2-YL)AMINO]PROPANAL; 3-[(CYCLOPROPYLMETHYL)(PROPYL)AMINO]PROPANAL; 3-[(DIMETHYLAMINO)METHYL]BENZALDEHYDE; 3-[(DIMETHYLAMINO)METHYL]OXOLANE-3-CARBALDEHYDE; 3-[(FURAN-2-YLMETHYL)(METHYL)AMINO]PROPANAL; 3-[(FURAN-2-YLMETHYL)SULFANYL]PROPANAL; 3-[(FURAN-3-YLMETHYL)(METHYL)AMINO]PROPANAL; 3-[2-(HYDROXYMETHYL)PIPERIDIN-1-YL]PROPANAL; 3-[2-(HYDROXYMETHYL)PYRROLIDIN-1-YL]PROPANAL; 3-[2-(PROPAN-2-YLOXY)ETHOXY]PROPANAL; 3-[3-(DIMETHYLAMINO)PYRROLIDIN-1-YL]PROPANAL; 3-[3-(HYDROXYMETHYL)PIPERIDIN-1-YL]PROPANAL; 3-[4-(HYDROXYMETHYL)PIPERIDIN-1-YL]PROPANAL; 3-[BIS(2-HYDROXYETHYL)AMINO]PROPANAL; 3-[BUTAN-2-YL(ETHYL)AMINO]PROPANAL; 3-[BUTAN-2-YL(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[BUTAN-2-YL(METHYL)AMINO]PROPANAL; 3-[BUTYL(2-HYDROXYETHYL)AMINO]PROPANAL; 3-[BUTYL(CYCLOPROPYL)AMINO]PROPANAL; 3-[BUTYL(ETHYL)AMINO]PROPANAL; 3-[BUTYL(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[BUTYL(METHYL)AMINO]PROPANAL; 3-[CYCLOHEXYL(METHYL)AMINO]PROPANAL; 3-[CYCLOPENTYL(ETHYL)AMINO]PROPANAL; 3-[CYCLOPENTYL(METHYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(2-HYDROXYETHYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(2-METHOXYETHYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(2-METHYLPROPYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(2-OXOETHYL)AMINO]PROPANENITRILE; 3-[CYCLOPROPYL(3-OXOPROPYL)AMINO]PROPANENITRILE; 3-[CYCLOPROPYL(ETHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[CYCLOPROPYL(ETHYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[CYCLOPROPYL(METHYL)AMINO]PROPANAL; 3-[CYCLOPROPYL(PROPYL)AMINO]PROPANAL; 3-[ETHYL(1-METHOXYPROPAN-2-YL)AMINO]PROPANAL; 3-[ETHYL(2-HYDROXYETHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[ETHYL(2-HYDROXYETHYL)AMINO]PROPANAL; 3-[ETHYL(2-METHOXYETHYL)AMINO]PROPANAL; 3-[ETHYL(2-METHYLPROPYL)AMINO]PROPANAL; 3-[ETHYL(2-OXOETHYL)AMINO]PROPANENITRILE; 3-[ETHYL(3-OXOPROPYL)AMINO]-2-METHYLPROPANENITRILE; 3-[ETHYL(3-OXOPROPYL)AMINO]PROPANENITRILE; 3-[ETHYL(METHYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[ETHYL(METHYL)AMINO]PROPANAL; 3-[ETHYL(PROPAN-2-YL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[ETHYL(PROPAN-2-YL)AMINO]PROPANAL; 3-[ETHYL(PROPYL)AMINO]-2,2-DIMETHYLPROPANAL; 3-[ETHYL(PROPYL)AMINO]PROPANAL; 3-[METHYL(2,2,2-TRIFLUOROETHYL)AMINO]PROPANAL; 3-[METHYL(2-METHYLBUTYL)AMINO]PROPANAL; 3-[METHYL(2-METHYLPROPYL)AMINO]PROPANAL; 3-[METHYL(2-OXOETHYL)AMINO]BENZONITRILE; 3-[METHYL(2-OXOETHYL)AMINO]BUTANENITRILE; 3-[METHYL(2-OXOETHYL)AMINO]PROPANENITRILE; 3-[METHYL(3-METHYLBUTAN-2-YL)AMINO]PROPANAL; 3-[METHYL(3-METHYLBUTYL)AMINO]PROPANAL; 3-[METHYL(3-OXOPROPYL)AMINO]BUTANENITRILE; 3-[METHYL(3-OXOPROPYL)AMINO]PROPANENITRILE; 3-[METHYL(4-METHYLPENTAN-2-YL)AMINO]PROPANAL; 3-[METHYL(OXAN-4-YL)AMINO]PROPANAL; 3-[METHYL(OXOLAN-2-YLMETHYL)AMINO]PROPANAL; 3-[METHYL(PENTAN-2-YL)AMINO]PROPANAL; 3-[METHYL(PENTAN-3-YL)AMINO]PROPANAL; 3-[METHYL(PENTYL)AMINO]PROPANAL; 3-[METHYL(PHENYL)AMINO]PROPANAL; 3-[METHYL(PROPAN-2-YL)AMINO]PROPANAL; 3-[METHYL(PROPYL)AMINO]PROPANAL; 3-[METHYL(THIOLAN-3-YL)AMINO]PROPANAL; 3-[PROPAN-2-YL(PROPYL)AMINO]PROPANAL; 3-ACETOXYBENZALDEHYDE; 3-ACETYL-4-FLUORO-BENZALDEHYDE; 3-ACETYLBENZALDEHYDE; 3-ALLYL-4-HYDROXYBENZALDEHYDE; 3-ALLYLSALICYLALDEHYDE; 3-BENZYLOXY-PROPIONALDEHYDE; 3-BUTOXYPROPANAL; 3-BUTYNAL; 3-CHLORO-2-FLUORO-4-HYDROXYBENZALDEHYDE; 3-CHLORO-2-FLUOROBENZALDEHYDE; 3-CHLORO-2-FLUOROPYRIDINE-4-CARBOXALDEHYDE; 3-CHLORO-2-FORMYL-4-PICOLINE; 3-CHLORO-2-HYDROXY-5-FORMYLPYRIDINE; 3-CHLORO-2-HYDROXY-5-METHYL-BENZALDEHYDE; 3-CHLORO-2-HYDROXY-6-METHYL-BENZALDEHYDE; 3-CHLORO-2-HYDROXYBENZALDEHYDE; 3-CHLORO-2-HYDROXYISONICOTINALDEHYDE; 3-CHLORO-2-METHOXYBENZALDEHYDE; 3-CHLORO-2-METHOXYPYRIDINE-6-CARBOXALDEHYDE; 3-CHLORO-2-METHYLBENZALDEHYDE; 3-CHLORO-2-METHYLPYRIDINE-4-CARBOXALDEHYDE; 3-CHLORO-2-METHYLPYRIDINE-5-CARBOXALDEHYDE; 3-CHLORO-2-METHYLPYRIDINE-6-CARBOXALDEHYDE; 3-CHLORO-4,5-DIHYDROXYBENZALDEHYDE; 3-CHLORO-4-CYANOBENZALDEHYDE; 3-CHLORO-4-FLUORO-2-HYDROXYBENZALDEHYDE; 3-CHLORO-4-FLUOROBENZALDEHYDE; 3-CHLORO-4-FORMYL-2-METHOXYPYRIDINE; 3-CHLORO-4-FORMYLBENZONITRILE; 3-CHLORO-4-HYDROXYBENZALDEHYDE; 3-CHLORO-4-METHOXYBENZALDEHYDE; 3-CHLORO-4-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 3-CHLORO-4-METHYLBENZALDEHYDE; 3-CHLORO-5-CYANOBENZALDEHYDE; 3-CHLORO-5-FLUORO-2-HYDROXYBENZALDEHYDE; 3-CHLORO-5-FLUORO-4-HYDROXYBENZALDEHYDE; 3-CHLORO-5-FLUOROBENZALDEHYDE; 3-CHLORO-5-FLUOROISONICOTINALDEHYDE; 3-CHLORO-5-FLUOROPICOLINALDEHYDE; 3-CHLORO-5-FORMYL-2-METHOXYPYRIDINE; 3-CHLORO-5-HYDROXYBENZALDEHYDE; 3-CHLORO-5-HYDROXYPICOLINALDEHYDE; 3-CHLORO-5-METHOXYBENZALDEHYDE; 3-CHLORO-5-METHOXYPYRAZINE-2-CARBALDEHYDE; 3-CHLORO-5-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 3-CHLORO-5-METHOXYPYRIDINE-4-CARBOXALDEHYDE; 3-CHLORO-5-METHYLBENZALDEHYDE; 3-CHLORO-5-METHYLPYRIDINE-2-CARBOXALDEHYDE; 3-CHLORO-5-METHYLPYRIDINE-4-CARBOXALDEHYDE; 3-CHLORO-6-FLUOROPICOLINALDEHYDE; 3-CHLORO-6-HYDROXYPICOLINALDEHYDE; 3-CHLORO-6-METHOXYPICOLINALDEHYDE; 3-CHLORO-6-METHYL-PYRIDINE-2-CARBALDEHYDE; 3-CHLOROBENZALDEHYDE; 3-CHLOROISONICOTINALDEHYDE; 3-CHLOROMETHYL-4-HYDROXY-BENZALDEHYDE; 3-CHLOROPROPANAL; 3-CHLORO-PYRAZINE-2-CARBALDEHYDE; 3-CHLOROPYRIDINE-2-CARBOXALDEHYDE; 3-CINNOLINECARBOXALDEHYDE; 3-CYANO-2-FLUOROBENZALDEHYDE; 3-CYANO-2-HYDROXYBENZALDEHYDE; 3-CYANO-2-METHOXYBENZALDEHYDE; 3-CYANO-2-METHYLBENZALDEHYDE; 3-CYANO-4-HYDROXYBENZALDEHYDE; 3-CYANO-4-METHOXYBENZALDEHYDE; 3-CYANO-5-FLUOROBENZALDEHYDE; 3-CYANO-5-HYDROXYBENZALDEHYDE; 3-CYANO-5-METHOXYBENZALDEHYDE; 3-CYANO-5-METHYLBENZALDEHYDE; 3-CYANOBENZALDEHYDE; 3-CYCLOBUTOXYPROPANAL; 3-CYCLOHEPTYLPROPIONALDEHYDE; 3-CYCLOHEXENE-1-CARBOXALDEHYDE; 3-CYCLOHEXYL-3-OXOPROPANAL; 3-CYCLOHEXYLPROPIONALDEHYDE; 3-CYCLOPENTYL-3-OXOPROPANAL; 3-CYCLOPENTYLPROPANAL; 3-CYCLOPROPOXYBENZALDEHYDE; 3-CYCLOPROPOXYISONICOTINALDEHYDE; 3-CYCLOPROPOXYPICOLINALDEHYDE; 3-CYCLOPROPYL-3-OXOPROPANAL; 3-CYCLOPROPYL-4-FLUOROBENZALDEHYDE; 3-CYCLOPROPYLBENZALDEHYDE; 3-DECYNAL; 3-DEOXYGLUCOSONE; 3-DIETHYLAMINO-2,2-DIMETHYL-PROPIONALDEHYDE; 3-DIMETHYLAMINO-2,2-DIMETHYLPROPIONALDEHYDE; 3-ETHOXY-4-FLUOROBENZALDEHYDE; 3-ETHOXY-4-HYDROXYBENZALDEHYDE; 3-ETHOXY-4-METHYLBENZALDEHYDE; 3-ETHOXY-5-FLUOROBENZALDEHYDE; 3-ETHOXYBENZALDEHYDE; 3-ETHOXYPICOLINALDEHYDE; 3-ETHOXYPROPIONALDEHYDE; 3-ETHOXYSALICYLALDEHYDE; 3-ETHYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-ETHYL-1H-INDAZOLE-6-CARBALDEHYDE; 3-ETHYL-2-HYDROXYBENZALDEHYDE; 3-ETHYL-2-PYRAZINECARBOXALDEHYDE; 3-ETHYL-4-FLUOROBENZALDEHYDE; 3-ETHYL-4-FORMYL-BENZONITRILE; 3-ETHYL-4-HYDROXYBENZALDEHYDE; 3-ETHYL-4-METHOXYBENZALDEHYDE; 3-ETHYL-4-PYRIDINECARBOXALDEHYDE; 3-ETHYL-5-HYDROXYBENZALDEHYDE; 3-ETHYLBENZALDEHYDE; 3-ETHYLHEPTANAL; 3-ETHYL-OXETANE-3-CARBALDEHYDE; 3-ETHYNYL-4-METHOXY-BENZALDEHYDE; 3-ETHYNYLBENZALDEHYDE; 3-ETHYNYL-PYRIDINE-4-CARBALDEHYDE; 3-FLUORO-2-FORMYL-4-PICOLINE; 3-FLUORO-2-FORMYL-6-PICOLINE; 3-FLUORO-2-FORMYLPHENYLBORONIC ACID; 3-FLUORO-2-FORMYLPYRIDINE; 3-FLUORO-2-HYDROXY-4-METHYL-BENZALDEHYDE; 3-FLUORO-2-HYDROXY-5-METHYL-BENZALDEHYDE; 3-FLUORO-2-HYDROXY-6-METHOXYBENZALDEHYDE; 3-FLUORO-2-HYDROXY-6-METHYL-BENZALDEHYDE; 3-FLUORO-2-HYDROXYISONICOTINALDEHYDE; 3-FLUORO-2-METHOXYBENZALDEHYDE; 3-FLUORO-2-METHOXYISONICOTINALDEHYDE; 3-FLUORO-2-METHYLBENZALDEHYDE; 3-FLUORO-2-METHYLISONICOTINALDEHYDE; 3-FLUORO-2-NITROBENZALDEHYDE; 3-FLUORO-3-FORMYLOXOLANE; 3-FLUORO-4-FORMYLPHENYLBORONIC ACID; 3-FLUORO-4-HYDROXY-5-METHOXYBENZALDEHYDE; 3-FLUORO-4-HYDROXYBENZALDEHYDE; 3-FLUORO-4-METHOXYBENZALDEHYDE; 3-FLUORO-4-METHYLBENZALDEHYDE; 3-FLUORO-4-NITRO-BENZALDEHYDE; 3-FLUORO-5-(CHLOROMETHYL)BENZALDEHYDE; 3-FLUORO-5-FORMYL-2-METHOXYPYRIDINE; 3-FLUORO-5-FORMYLPHENYLBORONIC ACID; 3-FLUORO-5-FORMYLPYRIDINE; 3-FLUORO-5-HYDROXY-2-PYRIDINECARBOXYLIC ACID; 3-FLUORO-5-HYDROXYBENZALDEHYDE; 3-FLUORO-5-METHOXYBENZALDEHYDE; 3-FLUORO-5-METHOXYPICOLINALDEHYDE; 3-FLUORO-5-METHYLBENZALDEHYDE; 3-FLUORO-5-NITROBENZALDEHYDE; 3-FLUORO-6-FORMYL-2-PICOLINE; 3-FLUORO-6-HYDROXYPYRIDINE-2-CARBOXALDEHYDE; 3-FLUORO-6-METHOXYPICOLINALDEHYDE; 3-FLUOROBENZALDEHYDE; 3-FLUOROISONICOTINALDEHYDE; 3-FLUOROPHENYLGLYOXAL; 3-FLUOROPHENYLGLYOXAL HYDRATE; 3-FLUOROSALICYLALDEHYDE; 3-FORMYL-1H-INDAZOLE-4-CARBONITRILE; 3-FORMYL-1H-INDAZOLE-6-CARBONITRILE; 3-FORMYL-1H-PYRAZOLE-4-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-1-PHENYL-1H-PYRAZOLE; 3-FORMYL-2,2-DIMETHYL-CYCLOPROPANECARBOXYLIC ACID ETHYL ESTER; 3-FORMYL-2-PYRIDINECARBONITRILE; 3-FORMYL-4-HYDROXYBENZONITRILE; 3-FORMYL-4-HYDROXYPHENYLBORONIC ACID; 3-FORMYL-4-METHOXYPYRIDINE; 3-FORMYL-4-METHYLPHENYLBORONIC ACID; 3-FORMYL-4-NITROPYRIDINE 1-OXIDE; 3-FORMYL-5-METHYLPHENYLBORONIC ACID; 3-FORMYL-BENZOYL CHLORIDE; 3-FORMYL-CYCLOPENTANECARBONITRILE; 3-FORMYLISONICOTINONITRILE; 3-FORMYLPHENYLBORONIC ACID; 3-FORMYLPYRIDINE-4-BORONIC ACID; 3-FURAN-3-YL-PROPIONALDEHYDE; 3-FURANBUTANAL; 3-FURANPENTANAL; 3-HEPTYNAL; 3-HEXENAL; 3-HEXYNAL; 3-HYDROXY-2-(METHYLTHIO)BENZALDEHYDE; 3-HYDROXY-2,5-DIMETHYLPYRIDINE-4-CARBOXALDEHYDE; 3-HYDROXY-2-ISOPROPYLBENZALDEHYDE; 3-HYDROXY-2-METHOXYBENZALDEHYDE; 3-HYDROXY-2-METHYL-4-PYRIDINECARBOXALDEHYDE; 3-HYDROXY-2-METHYLBENZALDEHYDE; 3-HYDROXY-2-NITROBENZALDEHYDE; 3-HYDROXY-4(HYDROXYMETHYL)-2-METHYL-5-PYRIDINE-CARBOXALDEHYDE; 3-HYDROXY-4-(METHYLTHIO)BENZALDEHYDE; 3-HYDROXY-4-ISOPROPYLBENZALDEHYDE; 3-HYDROXY-4-METHOXYBENZALDEHYDE; 3-HYDROXY-4-METHYL-BENZALDEHYDE; 3-HYDROXY-4-NITROBENZALDEHYDE; 3-HYDROXY-5-(METHYLTHIO)BENZALDEHYDE; 3-HYDROXY-5-ISOPROPYLBENZALDEHYDE; 3-HYDROXY-5-METHOXYBENZALDEHYDE; 3-HYDROXY-5-METHYLBENZALDEHYDE; 3-HYDROXY-5-NITROBENZALDEHYDE; 3-HYDROXY-6-METHOXY-PYRIDINE-2-CARBALDEHYDE; 3-HYDROXY-6-METHYLPYRIDINE-2-CARBOXALDEHYDE; 3-HYDROXYAMINO-BENZALDEHYDE; 3-HYDROXYBENZALDEHYDE; 3-HYDROXY-BENZO[D]ISOXAZOLE-5-CARBALDEHYDE; 3-HYDROXYMETHYL-4-METHOXY-BENZALDEHYDE; 3-HYDROXYNAPHTHALENE-1-CARBOXALDEHYDE; 3-HYDROXYPHENYLGLYOXAL; 3-HYDROXYPHTHALALDEHYDE; 3-HYDROXYPROPANAL; 3-HYDROXYPYRAZINE-2-CARBOXALDEHYDE; 3-HYDROXYPYRIDINE-2-CARBOXALDEHYDE; 3-HYDROXYPYRIDINE-4-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-2-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-4-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-5-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-7-CARBOXALDEHYDE; 3-HYDROXYQUINOLINE-8-CARBOXALDEHYDE; 3-IMIDAZOL-1-YL-PROPIONALDEHYDE; 3-ISOCYANATOBENZALDEHYDE; 3-ISOPROPOXYBENZALDEHYDE; 3-ISOPROPYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-ISOPROPYLBENZALDEHYDE; 3-ISOPROPYLPYRIDINE-2-CARBALDEHYDE; 3-ISOTHIAZOLECARBOXALDEHYDE; 3-ISOTHIAZOLECARBOXALDEHYDE, 4-METHYL-; 3-ISOTHIAZOLECARBOXALDEHYDE, 5-METHYL-; 3-ISOXAZOLECARBOXALDEHYDE, 4-METHYL-; 3-ISOXAZOLECARBOXALDEHYDE, 5-(1-HYDROXY-1-METHYLETHYL)-; 3-MERCAPTO-2-METHYLPENTANAL; 3-MERCAPTOBENZALDEHYDE; 3-METHOXY BUTYRALDEHYDE; 3-METHOXY-2-METHYLBENZALDEHYDE; 3-METHOXY-2-METHYLISONICOTINALDEHYDE; 3-METHOXY-4-METHYLBENZALDEHYDE; 3-METHOXY-4-SULFANYLBENZALDEHYDE; 3-METHOXY-5-METHYLBENZALDEHYDE; 3-METHOXY-5-METHYLPYRAZINE-2-CARBALDEHYDE; 3-METHOXY-6-METHYL-PYRAZINECARBOXALDEHYDE; 3-METHOXYBENZALDEHYDE; 3-METHOXYPHENYLGLYOXAL; 3-METHOXY-PROPIONALDEHYDE; 3-METHOXYPYRAZINE-2-CARBALDEHYDE; 3-METHOXY-PYRIDINE-2-CARBALDEHYDE; 3-METHOXYPYRIDINE-4-CARBOXALDEHYDE; 3-METHYL-[1,2,4]TRIAZINE-5-CARBALDEHYDE; 3-METHYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-METHYL-1H-INDAZOLE-5-CARBALDEHYDE; 3-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBALDEHYDE; 3-METHYL-1-PENTANAL; 3-METHYL-2,3-DIHYDRO-BENZOFURAN-4-CARBALDEHYDE; 3-METHYL-2-NITROBENZALDEHYDE; 3-METHYL-2-PYRIDINECARBOXALDEHYDE; 3-METHYL-2-QUINOXALINECARBALDEHYDE; 3-METHYL-3H-IMIDAZO[4,5-B]PYRIDINE-2-CARBALDEHYDE; 3-METHYL-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBALDEHYDE; 3-METHYL-3-PHENYLBUTYRALDEHYDE; 3-METHYL-4-NITROBENZALDEHYDE; 3-METHYL-4-NITRO-BUTYRALDEHYDE; 3-METHYL-4-PYRIDINECARBOXALDEHYDE; 3-METHYL-5-NITROBENZALDEHYDE; 3-METHYLBENZENE-1,2-DICARBOXALDEHYDE; 3-METHYLHEPTAN-1-AL; 3-METHYLNITROSAMINOPROPIONALDEHYDE; 3-METHYLOCTANAL; 3-METHYLOXETANE-3-CARBALDEHYDE; 3-METHYLPENTANEDIAL; 3-METHYLPYRIDINE-2,5-DICARBALDEHYDE; 3-METHYLQUINOLINE-2-CARBOXALDEHYDE; 3-MORPHOLIN-4-YL-PROPIONALDEHYDE; 3-NITRO-6-PYRIDINECARBOXALDEHYDE; 3-NITROBENZALDEHYDE; 3-NITROISONICOTINALDEHYDE; 3-NITROPROPANAL; 3-NITROPYRIDINE-2-CARBOXALDEHYDE; 3-NITROSALICYLALDEHYDE; 3-NONYNAL; 3-OCTYNAL; 3-OXO-2-(2-THIENYL)PROPANENITRILE; 3-OXO-2-PHENYLPROPANENITRILE; 3-OXO-3-(PYRIDIN-2-YL)PROPANAL; 3-OXO-3-(PYRIDIN-3-YL)PROPANAL; 3-OXO-3-(PYRIDIN-4-YL)PROPANAL; 3-OXO-3-(THIOPHEN-2-YL)PROPANAL; 3-OXO-3-(THIOPHEN-3-YL)PROPANAL; 3-OXO-3-PHENYL-PROPIONALDEHYDE; 3-OXO-BUTANAL; 3-OXOPROPANENITRILE; 3-OXO-PROPIONIC ACID ETHYL ESTER; 3-PENTYNAL; 3-PHENOXYPROPANAL; 3-PHENYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-PHENYL-2H-AZIRENE-2-CARBALDEHYDE; 3-PHENYL-4-PENTENAL; 3-PHENYLBUTYRALDEHYDE; 3-PHENYLPROPIONALDEHYDE; 3-PROP-2-YNYLOXY-BENZALDEHYDE; 3-PROPOXYBENZALDEHYDE; 3-PROPOXYPROPANAL; 3-PROPYLBICYCLO(2.2.1)HEPT-5-ENE-2-CARBALDEHYDE; 3-PROPYLENECARBOXYALDEHYDE; 3-PROPYLSALICYLALDEHYDE; 3-PYRIDAZINECARBOXALDEHYDE, 4-METHYL-; 3-PYRIDAZINECARBOXALDEHYDE, 5-METHYL-; 3-PYRIDIN-4-YL-PROPIONALDEHYDE; 3-PYRIDINECARBOXALDEHYDE; 3-PYRIDINECARBOXALDEHYDE, 1-OXIDE; 3-PYRIDINECARBOXALDEHYDE, 6-(2-HYDROXYETHOXY)-; 3-PYRIDINECARBOXALDEHYDE, 6-ETHYNYL-; 3-PYRIDINECARBOXALDEHYDE, 6-PROPOXY-; 3-QUINOLINECARBOXALDEHYDE; 3-TERT-BUTYL-1,2,4-OXADIAZOLE-5-CARBALDEHYDE; 3-TERT-BUTYLBENZALDEHYDE; 3-TERT-BUTYLDIMETHYLSILYLPROPYNAL; 3-TRIETHYLSILYLPROPYNAL; 3-TRIMETHYLSILYLPROPYNAL; 3-VINYLBENZALDEHYDE; 4-(1,1-DIFLUORO-ETHYL)-BENZALDEHYDE; 4-(1,2,4-OXADIAZOL-3-YL)BENZALDEHYDE; 4-(1,3-DIOXOLAN-2-YL)BUTANAL; 4-(1,3-OXAZOL-4-YL)BENZALDEHYDE; 4-(1-AZIRIDINYL)-BENZALDEHYDE; 4-(1H-1,2,4-TRIAZOL-1-YL)BENZALDEHYDE; 4-(1H-IMIDAZOL-1-YL)BENZALDEHYDE; 4-(1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-(1H-PYRAZOL-3-YL)BENZALDEHYDE; 4-(1H-PYRAZOL-4-YL)BENZALDEHYDE; 4-(1H-PYRROL-1-YL)BENZALDEHYDE; 4-(1H-TETRAZOL-1-YL)-BENZALDEHYDE; 4-(1H-TETRAZOL-5-YL)BENZALDEHYDE; 4-(1-METHYL-2-OXO-PYRROLIDIN-3-YL)-BUTYRALDEHYDE; 4-(1-METHYLETHYL)-3-PYRIDINECARBOXALDEHYDE; 4-(1-METHYLVINYL)BENZALDEHYDE; 4-(2,2,2-TRIFLUOROETHOXY)BUTANAL; 4-(2-FLUOROETHOXY)-BENZALDEHYDE; 4-(2-FURYL)BENZALDEHYDE; 4-(2H-1,2,3-TRIAZOL-2-YL)BENZALDEHYDE; 4-(2H-TETRAZOL-5-YL)BENZALDEHYDE; 4-(2-HYDROXYETHOXY)BENZALDEHYDE; 4-(2-HYDROXYETHYL)BENZALDEHYDE; 4-(2-OXOACETYL)BENZONITRILE; 4-(2-OXOETHOXY)BENZALDEHYDE; 4-(2-OXOETHOXY)BENZONITRILE; 4-(2-PROPEN-1-YL)-3-PYRIDINECARBOXALDEHYDE; 4-(3-BUTEN-1-YL)-5-METHYL-1H-PYRAZOLE-3-CARBOXALDEHYDE; 4-(3-HYDROXYPROP-1-YNYL)BENZALDEHYDE; 4-(3-METHYLBUTOXY)BUTANAL; 4-(3-OXOPROPANOYL)BENZONITRILE; 4-(3-OXO-PROPYL)-BENZONITRILE; 4-(4-HYDROXYBUT-1-YN-1-YL)BENZALDEHYDE; 4-(BUT-2-YN-1-YLOXY)BENZALDEHYDE; 4-(BUT-3-YN-1-YLOXY)BENZALDEHYDE; 4-(BUTAN-2-YL)-1,3-THIAZOLE-2-CARBALDEHYDE; 4-(CHLOROMETHYL)BENZALDEHYDE; 4-(CHLOROMETHYL)NICOTINALDEHYDE; 4-(DIFLUOROMETHOXY)BENZALDEHYDE; 4-(DIMETHYLAMINO)-2-PYRIDINECARBOXALDEHYDE; 4-(DIMETHYLAMINO)-3-FLUOROBENZALDEHYDE; 4-(DIMETHYLAMINO)-3-HYDROXYBENZALDEHYDE; 4-(DIMETHYLAMINO)-3-METHYLBENZALDEHYDE; 4-(DIMETHYLAMINO)-3-PYRIDINECARBOXALDEHYDE; 4-(DIMETHYLAMINO)BUTANAL; 4-(DIMETHYLAMINO)SALICYLALDEHYDE; 4-(ETHYLTHIO)BENZALDEHYDE; 4-(FLUOROMETHYL)BENZALDEHYDE; 4-(FURAN-2-YL)-4-HYDROXYBUTANAL; 4-(FURAN-2-YL)-4-OXOBUTANAL; 4-(HYDROXY(METHYL)AMINO)BENZALDEHYDE; 4-(HYDROXYMETHYL)-2-PYRIDINECARBOXALDEHYDE; 4-(HYDROXYMETHYL)BENZALDEHYDE; 4-(METHYLSULFINYL)BENZALDEHYDE; 4-(METHYLTHIO)BENZALDEHYDE; 4-(METHYLTHIO)BUTYRALDEHYDE; 4-(OXAZOL-5-YL)BENZALDEHYDE; 4-(PROP-2-YN-1-YLOXY)BENZALDEHYDE; 4-(PROP-2-YNYL)BENZALDEHYDE; 4-(PROPAN-2-YLOXY)BUTANAL; 4-(TRIFLUOROMETHYL)BENZALDEHYDE; 4,4,4-TRIFLUOROBUT-2-YNAL; 4,4,4-TRIFLUOROBUTYRALDEHYDE; 4,4-DIETHOXY-2-BUTYN-1-AL; 4,4-DIFLUORO-CYCLOHEXANECARBALDEHYDE; 4,4-DIMETHOXYBUTANAL; 4,4-DIMETHYL-2,6-DIOXOCYCLOHEXANECARBALDEHYDE; 4,4-DIMETHYL-3-OXO-PENTANAL; 4,5,6,7-TETRAHYDRO-1,3-BENZOTHIAZOLE-2-CARBALDEHYDE; 4,5,6,7-TETRAHYDRO-4-BENZOFURANCARBOXALDEHYDE; 4,5,6,7-TETRAHYDRO-4-OXO-5-BENZOFURANCARBOXALDEHYDE; 4,5,6,7-TETRAHYDROBENZO[D]ISOXAZOLE-3-CARBALDEHYDE; 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIDINE-2-CARBALDEHYDE; 4,5-DIFLUORO-2-HYDROXYBENZALDEHYDE; 4,5-DIFLUORO-2-METHOXYBENZALDEHYDE; 4,5-DIFLUORO-3-HYDROXYBENZALDEHYDE; 4,5-DIFLUOROPYRIDINE-2-CARBALDEHYDE; 4,5-DIMETHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4,5-DIMETHYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 4,5-DIMETHYLPYRIDINE-2-CARBALDEHYDE; 4,6,6-TRIMETHYLHEPTANAL; 4,6-DIFLUORO-5-PYRIMIDINE FORMALDEHYDE; 4,6-DIHYDROXY-2-METHYL-PYRIMIDINE-5-CARBALDEHYDE; 4,6-DIHYDROXY-5-FORMYLPYRIMIDINE; 4,6-DIHYDROXY-PYRIDINE-3-CARBALDEHYDE; 4,6-DIMETHOXYPYRIMIDINE-2YL-CARBALDEHYDE; 4,6-DIMETHOXYPYRIMIDINE-5-CARBALDEHYDE; 4,6-DIMETHYL-2-PYRIMIDINECARBOXALDEHYDE; 4,6-DIMETHYL-3-(1H)INDAZOLE CARBOXALDEHYDE; 4,6-DIMETHYL-3-PYRIDINECARBOXALDEHYDE; 4,6-DIMETHYLCYCLOHEX-3-ENECARBALDEHYDE; 4,6-DIMETHYLPYRIDINE-2-CARBALDEHYDE; 4,7-DIMETHYL-1H-INDAZOLE-3-CARBALDEHYDE; 4,8-DIMETHYLNONANAL; 4-[(DIMETHYLAMINO)METHYL]OXANE-4-CARBALDEHYDE; 4-[1,2,3]TRIAZOL-1-YL-BENZALDEHYDE; 4-[ETHYL(METHYL)AMINO]BENZALDEHYDE; 4-[METHYL(2-OXOETHYL)AMINO]BENZONITRILE; 4-ACETOXY-4-METHYL-1-PENTANAL; 4-ACETOXYBENZALDEHYDE; 4-ACETYL-2-PYRIDINECARBOXALDEHYDE; 4-ACETYLBENZALDEHYDE; 4-ALLYLOXYBENZALDEHYDE; 4-BENZOFURANCARBOXALDEHYDE; 4-BROMOBUTYRALDEHYDE; 4-BUTOXYBUTANAL; 4-BUTYLBENZALDEHYDE; 4-BUTYLCYCLOHEXANE-1-CARBALDEHYDE; 4-CARBOXALDEHYDEBENZOCYCLOBUTENE; 4-CHLORO-2,5-DIMETHYLBENZALDEHYDE; 4-CHLORO-2,6-DIMETHYLBENZALDEHYDE; 4-CHLORO-2,6-DIMETHYLPYRIDINE-3-CARBOXALDEHYDE; 4-CHLORO-2-ETHYL-BENZALDEHYDE; 4-CHLORO-2-FLUOROBENZALDEHYDE; 4-CHLORO-2-FLUOROPYRIDINE-3-CARBOXALDEHYDE; 4-CHLORO-2-FORMYLBENZONITRILE; 4-CHLORO-2-HYDROXYBENZALDEHYDE; 4-CHLORO-2-MERCAPTOBENZALDEHYDE; 4-CHLORO-2-METHOXYBENZALDEHYDE; 4-CHLORO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-2-METHOXYPYRIDINE-5-CARBOXALDEHYDE; 4-CHLORO-2-METHYL-5-PYRIMIDINECARBOXALDEHYDE; 4-CHLORO-2-METHYLBENZALDEHYDE; 4-CHLORO-2-METHYL-PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-2-METHYLPYRIDINE-5-CARBOXALDEHYDE; 4-CHLORO-3,5-DIMETHYLBENZALDEHYDE; 4-CHLORO-3-CYANOBENZALDEHYDE; 4-CHLORO-3-ETHYLBENZALDEHYDE; 4-CHLORO-3-FLUOROBENZALDEHYDE; 4-CHLORO-3-FLUOROPICOLINALDEHYDE; 4-CHLORO-3-FORMYLBENZONITRILE; 4-CHLORO-3-HYDROXYBENZALDEHYDE; 4-CHLORO-3-HYDROXYMETHYL-BENZALDEHYDE; 4-CHLORO-3-METHOXYBENZALDEHYDE; 4-CHLORO-3-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 4-CHLORO-3-METHYLBENZALDEHYDE; 4-CHLORO-3-METHYL-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-5-FLUORO-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-5-FLUORO-PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-5-HYDROXY-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-5-HYDROXY-PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-5-METHOXY-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-5-METHOXYPYRIDINE-3-CARBOXALDEHYDE; 4-CHLORO-5-METHYL-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-5-METHYL-PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-6-FORMYL-NICOTINONITRILE; 4-CHLORO-6-METHOXY-PYRIDINE-2-CARBALDEHYDE; 4-CHLORO-6-METHOXYPYRIMIDINE-2-CARBALDEHYDE; 4-CHLORO-6-METHYL-PYRIDINE-2-CARBALDEHYDE; 4-CHLOROBENZALDEHYDE; 4-CHLORO-BUTYRALDEHYDE; 4-CHLOROPICOLINALDEHYDE; 4-CHLOROPYRIDINE-2,6-DICARBOXALDEHYDE; 4-CHLOROPYRIDINE-3-CARBOXALDEHYDE; 4-CHLOROPYRIMIDINE-2-CARBALDEHYDE; 4-CHLOROPYRIMIDINE-5-CARBALDEHYDE; 4-CINNOLINECARBOXALDEHYDE; 4-CYANO-2,5-DIFLUOROBENZALDEHYDE; 4-CYANO-2,6-DIFLUOROBENZALDEHYDE; 4-CYANO-2-FLUOROBENZALDEHYDE; 4-CYANO-2-METHOXYBENZALDEHYDE; 4-CYANO-2-METHYLBENZALDEHYDE; 4-CYANO-3-HYDROXYBENZALDEHYDE; 4-CYANO-3-METHOXY-BENZALDEHYDE; 4-CYANO-3-METHYLBENZALDEHYDE; 4-CYANOBENZALDEHYDE; 4-CYANOPYRIDINE-2-CARBOXALDEHYDE; 4-CYCLOHEXYLBUTYRALDEHYDE; 4-CYCLOPENTYL-BENZALDEHYDE; 4-CYCLOPROPOXYBENZALDEHYDE; 4-CYCLOPROPOXYNICOTINALDEHYDE; 4-CYCLOPROPOXYPICOLINALDEHYDE; 4-CYCLOPROPYL-2-FLUOROBENZALDEHYDE; 4-CYCLOPROPYLBENZALDEHYDE; 4-DIMETHYLAMINO-2-METHYLBENZALDEHYDE; 4-DIMETHYLAMINOBENZALDEHYDE; 4-DIMETHYLAMINOMETHYL-BENZALDEHYDE; 4-ETHOXY-2-HYDROXY-BENZALDEHYDE; 4-ETHOXY-2-METHYLBENZALDEHYDE; 4-ETHOXY-3-FLUOROBENZALDEHYDE; 4-ETHOXY-3-HYDROXYBENZALDEHYDE; 4-ETHOXY-3-METHYLBENZALDEHYDE; 4-ETHOXY-3-METHYL-PYRIDINE-2-CARBALDEHYDE; 4-ETHOXYBENZALDEHYDE; 4-ETHOXYBUTANAL; 4-ETHOXYNICOTINALDEHYDE; 4-ETHOXYPYRIDINE-2-CARBALDEHYDE; 4-ETHYL-2-HYDROXYBENZALDEHYDE; 4-ETHYL-2-THIAZOLECARBOXALDEHYDE; 4-ETHYL-3-HYDROXYBENZALDEHYDE; 4-ETHYL-4-FORMYLHEXANENITRILE; 4-ETHYL-4-FORMYL-TETRAHYDROPYRAN; 4-ETHYL-5-METHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4-ETHYLBENZALDEHYDE; 4-ETHYLOCTANAL; 4-ETHYL-TETRAHYDRO-2H-THIOPYRAN-4-CARBALDEHYDE; 4-ETHYNYLBENZALDEHYDE; 4-ETHYNYL-PYRIDINE-2-CARBALDEHYDE; 4-ETHYNYL-PYRIDINE-3-CARBALDEHYDE; 4-FLUORO-1H-INDAZOLE-3-CARBALDEHYDE; 4-FLUORO-1-NAPHTHALDEHYDE; 4-FLUORO-2-(METHYLTHIO)BENZALDEHYDE; 4-FLUORO-2,3-DIMETHYLBENZALDEHYDE; 4-FLUORO-2-FORMYLPYRIDINE; 4-FLUORO-2-HYDROXYBENZALDEHYDE; 4-FLUORO-2-MERCAPTOBENZALDEHYDE; 4-FLUORO-2-METHOXYBENZALDEHYDE; 4-FLUORO-2-METHYLBENZALDEHYDE; 4-FLUORO-2-METHYL-PYRIDINE-3-CARBALDEHYDE; 4-FLUORO-2-NITROBENZALDEHYDE; 4-FLUORO-3-(CHLOROMETHYL)BENZALDEHYDE; 4-FLUORO-3,5-DIMETHYLBENZALDEHYDE; 4-FLUORO-3-FORMYLPHENYLBORONIC ACID; 4-FLUORO-3-FORMYLPYRIDINE; 4-FLUORO-3-HYDROXYBENZALDEHYDE; 4-FLUORO-3-ISOPROPYLBENZALDEHYDE; 4-FLUORO-3-METHOXYBENZALDEHYDE; 4-FLUORO-3-METHYLBENZALDEHYDE; 4-FLUORO-3-NITROBENZALDEHYDE; 4-FLUORO-4-FORMYLTHIANE; 4-FLUOROBENZALDEHYDE; 4-FLUOROBENZENE-1,2-DICARBOXALDEHYDE; 4-FLUOROBENZO[D]OXAZOLE-2-CARBALDEHYDE; 4-FLUOROBENZOFURAN-7-CARBALDEHYDE; 4-FLUOROBUTYRALDEHYDE; 4-FLUOROPHENYLGLYOXAL HYDRATE; 4-FORMYL-1-PIPERIDINECARBOXYLIC ACID METHYL ESTER; 4-FORMYL-2-METHYLPHENYLBORONIC ACID; 4-FORMYL-3-HYDROXYPHENYLBORONIC ACID; 4-FORMYL-3-METHYLPHENYLBORONIC ACID; 4-FORMYL-4-METHYL-TETRAHYDROPYRAN; 4-FORMYL-4-METHYLTHIANE; 4-FORMYLBENZALDEHYDE-O-METHYL ALDOXIME; 4-FORMYL-BENZENEPROPANAL; 4-FORMYL-BENZOYL CHLORIDE; 4-FORMYL-HEXANOIC ACID METHYL ESTER; 4-FORMYLNICOTINONITRILE; 4-FORMYLPHENYLBORONIC ACID; 4-FORMYLPYRIMIDINE-2-CARBONITRILE; 4-FORMYLTETRAHYDROPYRAN; 4-FORMYL-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID METHYL ESTER; 4H-CYCLOPENTA[D]THIAZOLE-2-CARBOXALDEHYDE, 5,6-DIHYDRO-; 4-HYDROXY-1H-INDAZOLE-3-CARBOXALDEHYDE; 4-HYDROXY-1-METHYL-2,5-CYCLOHEXADIENE-1-CARBALDEHYDE; 4-HYDROXY-1-NAPHTHALDEHYDE; 4-HYDROXY-2-(METHYLTHIO)BENZALDEHYDE; 4-HYDROXY-2,5-DIMETHYLBENZALDEHYDE; 4-HYDROXY-2-ISOPROPYLBENZALDEHYDE; 4-HYDROXY-2-METHOXYBENZALDEHYDE; 4-HYDROXY-2-METHYLBENZALDEHYDE; 4-HYDROXY-2-NITROBENZALDEHYDE; 4-HYDROXY-2-QUINOLINECARBALDEHYDE; 4-HYDROXY-3-(METHYLTHIO)BENZALDEHYDE; 4-HYDROXY-3-ISOPROPYLBENZALDEHYDE; 4-HYDROXY-3-METHOXY-5-METHYLBENZENECARBALDEHYDE; 4-HYDROXY-3-METHYLBENZALDEHYDE; 4-HYDROXY-3-NITROBENZALDEHYDE; 4-HYDROXY-4-METHYL-HEX-2-YNAL; 4-HYDROXY-5-BENZOFURANCARBOXALDEHYDE; 4-HYDROXY-5-METHOXY-2-PYRIDINECARBALDEHYDE; 4-HYDROXY-5-METHYL-1,3-DIALDEHYDE; 4-HYDROXY-5-NITRONICOTINALDEHYDE; 4-HYDROXYBENZALDEHYDE; 4-HYDROXYBENZALDEHYDE POTASSIUM SALT; 4-HYDROXY-BICYCLO[2.2.2]OCTANE-1-CARBOXALDEHYDE; 4-HYDROXYINDANE-5-CARBALDEHYDE; 4-HYDROXYISOPHTHALALDEHYDE; 4-HYDROXYNAPHTHALENE-2-CARBOXALDEHYDE; 4-HYDROXYPHENYL GLYOXAL; 4-HYDROXYPHENYLGLYOXAL HYDRATE; 4-HYDROXYPHTHALALDEHYDE; 4-HYDROXY-PYRIDINE-2-CARBALDEHYDE; 4-HYDROXYPYRIDINE-3-CARBOXALDEHYDE; 4-HYDROXY-QUINOLINE-3-CARBALDEHYDE; 4-HYDROXYQUINOLINE-5-CARBOXALDEHYDE; 4-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 4-HYDROXYQUINOLINE-7-CARBOXALDEHYDE; 4-HYDROXYQUINOLINE-8-CARBOXALDEHYDE; 4-IMIDAZOL-1-YL-BUTYRALDEHYDE; 4-ISOBUTYLBENZALDEHYDE; 4-ISOCYANATOBENZALDEHYDE; 4-ISOPROPOXYBENZALDEHYDE; 4-ISOPROPYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4-ISOPROPYLBENZALDEHYDE; 4-MERCAPTOBENZALDEHYDE; 4-METHOXY-2,6-DIMETHYLBENZALDEHYDE; 4-METHOXY-2-METHYLBENZALDEHYDE; 4-METHOXY-2-PYRIMIDINECARBOXALDEHYDE; 4-METHOXY-3,5-DIMETHYLPICOLINALDEHYDE; 4-METHOXY-3-METHYLBENZALDEHYDE; 4-METHOXY-3-METHYL-PYRIDINE-2-CARBALDEHYDE; 4-METHOXYBUTANAL; 4-METHOXYISOPHTHALALDEHYDE; 4-METHOXYMETHYLBENZALDEHYDE; 4-METHOXYPHENYLACETALDEHYDE; 4-METHOXYPHTHALALDEHYDE; 4-METHOXYPICOLINALDEHYDE; 4-METHOXYPYRIDINE-2,6-DICARBALDEHYDE; 4-METHYL-1,2,5-OXADIAZOLE-3-CARBOXALDEHYDE; 4-METHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4-METHYL-1-NAPHTHALDEHYDE; 4-METHYL-2-(PROP-2-YN-1-YLOXY)BENZALDEHYDE; 4-METHYL-2,6-PYRIDINEDICARBOXALDEHYDE; 4-METHYL-2-NITROBENZALDEHYDE; 4-METHYL-2-PYRIMIDINECARBOXALDEHYDE; 4-METHYL-2-THIAZOLECARBOXALDEHYDE 3-OXIDE; 4-METHYL-3-(1H)INDAZOLE CARBOXALDEHYDE; 4-METHYL-3-NITROBENZALDEHYDE; 4-METHYL-3-NITROPICOLINALDEHYDE; 4-METHYL-3-OXOPENTANAL; 4-METHYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 4-METHYL-4-NITROVALERALDEHYDE; 4-METHYL-5-OXO-PENTANOIC ACID METHYL ESTER; 4-METHYL-5-THIAZOLEACETALDEHYDE; 4-METHYLHEPTANAL; 4-METHYLHEXANAL; 4-METHYLNICOTINALDEHYDE; 4-METHYLPENTALDEHYDE; 4-METHYLPHENYLGLYOXAL HYDRATE; 4-METHYLPYRIDINE-2,5-DICARBALDEHYDE; 4-METHYLPYRIMIDINE-5-CARBALDEHYDE; 4-METHYQUINOLINE-2-CARBOXALDEHYDE; 4-NITRO-2-FORMYLPYRIDINE N-OXIDE; 4-NITROBENZALDEHYDE; 4-NITRONICOTINALDEHYDE; 4-NITRO-PYRIDINE-2-CARBALDEHYDE; 4-N-PROPOXYBENZALDEHYDE; 4-N-PROPYLBENZALDEHYDE; 4-OXO-4-(3-PYRIDYL)-BUTANAL; 4-OXO-4-(PIPERIDIN-1-YL)BUTANAL; 4-OXO-6,7-DIHYDRO-4H-PYRAZOLO[5,1-C][1,4]OXAZINE-2-CARBALDEHYDE; 4-OXOBUTANOIC ACID METHYL ESTER; 4-OXO-TETRAHYDROFURAN-3-CARBOXALDEHYDE; 4-PENTENAL; 4-PHENOXYBUTANAL; 4-PHENYLBUTYRALDEHYDE; 4-PROPYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4-PROPYL-3-PYRIDINECARBOXALDEHYDE; 4-PYRIDAZINECARBOXALDEHYDE, 3-METHYL-; 4-PYRIDAZINECARBOXALDEHYDE, 5-METHYL-; 4-PYRIDAZINECARBOXALDEHYDE, 6-METHYL-; 4-PYRIDIN-2-YLBUTANAL; 4-PYRIDIN-3-YLBUTANAL; 4-PYRIDIN-4-YLBUTANAL; 4-PYRIDINECARBOXALDEHYDE; 4-PYRIDINECARBOXALDEHYDE N-OXIDE; 4-PYRIMIDINECARBOXALDEHYDE, 5-METHYL-; 4-QUINOLINECARBOXALDEHYDE; 4-QUINOLINECARBOXALDEHYDE, 8-HYDROXY-; 4-TERT-BUTYL-1,3-THIAZOLE-2-CARBALDEHYDE; 4-TERT-BUTYLBENZALDEHYDE; 4-TERT-BUTYLCYCLOHEXANE-1-CARBALDEHYDE; 4-TETRAHYDROPYRANYLOXY-BUTANAL; 4-THIAZOLEPROPANAL; 4-VINYL-BENZALDEHYDE; 5-(1,1-DIMETHYLETHYL)-3-ISOXAZOLECARBOXALDEHYDE; 5-(1-METHYLETHYL)-2-PYRIDINECARBOXALDEHYDE; 5-(2-FURYL)ISOXAZOLE-3-CARBALDEHYDE; 5-(2-FURYL)PYRIDINE-2-CARBALDEHYDE; 5-(2-METHYL-PROPENYL)-PYRIDINE-2-CARBALDEHYDE; 5-(CHLOROMETHYL)NICOTINALDEHYDE; 5-(CHLOROMETHYL)PICOLINALDEHYDE; 5-(DIFLUOROMETHOXY)PYRAZINE-2-CARBOXALDEHYDE; 5-(DIMETHYLAMINO)-2-PYRIDINECARBOXALDEHYDE; 5-(DIMETHYLAMINO)PYRAZINE-2-CARBALDEHYDE; 5-(DIMETHYLAMINO)SALICYLALDEHYDE; 5-(FURAN-2-YL)PYRIDINE-3-CARBALDEHYDE; 5-(HYDROXYMETHYL)-2-PYRIDINECARBOXALDEHYDE; 5-(METHOXYMETHYL)-4-METHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 5-(METHYLTHIO)-1H-PYRAZOLE-3-CARBALDEHYDE; 5-(PYRIDIN-2-YL)OXAZOLE-2-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-3-CARBALDEHYDE; 5,5-DIETHOXYPENTANAL; 5,5-DIMETHOXYPENTANAL; 5,5-DIMETHYL-1,3-DIOXANE-2-PROPIONALDEHYDE; 5,5-DIMETHYLHEXANAL; 5,6,7,8-TETRAHYDRO-7-INDOLIZINECARBOXALDEHYDE; 5,6,7,8-TETRAHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 5,6-DIFLUORONICOTINALDEHYDE; 5,6-DIFLUOROPICOLINALDEHYDE; 5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOLE-2-CARBALDEHYDE; 5,6-DIHYDRO-5-INDOLIZINECARBOXALDEHYDE; 5,6-DIMETHOXYNICOTINALDEHYDE; 5,6-DIMETHOXYPICOLINALDEHYDE; 5,6-DIMETHYLPYRIDINE-2-CARBALDEHYDE; 5,7-DIHYDRO-5-OXO-FURO[3,4-B]PYRIDINE-2-CARBOXALDEHYDE; 5-[(DIMETHYLAMINO)METHYL]ISOXAZOLE-3-CARBALDEHYDE; 5-ACETYL-2-PYRIDINECARBOXALDEHYDE; 5-ACETYL-PYRAZINECARBOXALDEHYDE; 5-BENZOTHIAZOLECARBOXALDEHYDE; 5-CHLORO-2,2-DIMETHYLPENTANAL; 5-CHLORO-2,4-DIHYDROXY-BENZALDEHYDE; 5-CHLORO-2-FLUORO-3-FORMYL-4-PICOLINE; 5-CHLORO-2-FLUOROBENZALDEHYDE; 5-CHLORO-2-FLUOROISONICOTINALDEHYDE; 5-CHLORO-2-FLUOROMETHYLBENZALDEHYDE; 5-CHLORO-2-FLUORONICOTINALDEHYDE; 5-CHLORO-2-FORMYLBENZONITRILE; 5-CHLORO-2-FORMYLPYRIDINE; 5-CHLORO-2-HYDROXY-3-METHYLBENZALDEHYDE; 5-CHLORO-2-HYDROXY-4-METHYL-BENZALDEHYDE; 5-CHLORO-2-HYDROXYISONICOTINALDEHYDE; 5-CHLORO-2-HYDROXYNICOTINALDEHYDE; 5-CHLORO-2-MERCAPTOBENZALDEHYDE; 5-CHLORO-2-METHOXYBENZALDEHYDE; 5-CHLORO-2-METHOXYNICOTINALDEHYDE; 5-CHLORO-2-METHOXY-PYRIDINE-4-CARBALDEHYDE; 5-CHLORO-2-METHYLBENZALDEHYDE; 5-CHLORO-2-METHYL-PYRIDINE-3-CARBALDEHYDE; 5-CHLORO-2-METHYL-PYRIDINE-4-CARBALDEHYDE; 5-CHLORO-3-FLUORO-2-HYDROXY-BENZALDEHYDE; 5-CHLORO-3-FLUOROPICOLINALDEHYDE; 5-CHLORO-3-METHOXYPYRAZINE-2-CARBALDEHYDE; 5-CHLORO-3-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 5-CHLORO-3-METHYLPYRIDINE-2-CARBOXALDEHYDE; 5-CHLORO-4-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 5-CHLORO-4-METHOXYPYRIDINE-3-CARBOXALDEHYDE; 5-CHLORO-4-METHYL-PYRIDINE-2-CARBALDEHYDE; 5-CHLORO-4-METHYLPYRIDINE-3-CARBOXALDEHYDE; 5-CHLORO-6-FLUORONICOTINALDEHYDE; 5-CHLORO-6-FLUOROPICOLINALDEHYDE; 5-CHLORO-6-HYDROXYPICOLINALDEHYDE; 5-CHLOROISOPHTHALALDEHYDE; 5-CHLORO-PENTANAL; 5-CHLOROPYRAZINE-2-CARBALDEHYDE; 5-CHLOROPYRIDINE-3-CARBALDEHYDE; 5-CHLOROPYRIMIDINE-2-CARBALDEHYDE; 5-CHLOROPYRIMIDINE-4-CARBOXALDEHYDE; 5-CHLOROSALICYLALDEHYDE; 5-CHLOROTHIAZOLE-2-CARBALDEHYDE; 5-CYANOINDAZOLE-3-CARBOXALDEHYDE; 5-CYANO-2-FLUOROBENZALDEHYDE; 5-CYANO-2-METHOXY BENZALDEHYDE; 5-CYANO-2-METHYLBENZALDEHYDE; 5-CYANOISOPHTHALALDEHYDE; 5-CYCLOPROPOXYNICOTINALDEHYDE; 5-CYCLOPROPOXYPICOLINALDEHYDE; 5-CYCLOPROPYL-1H-PYRAZOLE-3-CARBALDEHYDE; 5-CYCLOPROPYL-2-FLUOROBENZALDEHYDE; 5-CYCLOPROPYL-2-HYDROXYBENZALDEHYDE; 5-CYCLOPROPYLPYRAZINE-2-CARBALDEHYDE; 5-DEOXY-3,4-D1-O-METHYL-D-RIBOSE; 5-DEOXY-3,4-DI-O-METHYL-L-ARABINOSE; 5-DEOXY-D-RIBOSE; 5-DEOXY-L-ARABINOSE; 5-ETHOXY-2-HYDROXY-BENZALDEHYDE; 5-ETHOXYPYRIDINE-2-CARBALDEHYDE; 5-ETHYL-1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 5-ETHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 5-ETHYL-2-HYDROXYBENZENECARBALDEHYDE; 5-ETHYL-2-METHOXYBENZALDEHYDE; 5-ETHYL-2-PYRIDINECARBOXALDEHYDE; 5-ETHYL-3-METHYLBENZALDEHYDE; 5-ETHYL-3-PYRIDINECARBOXALDEHYDE; 5-ETHYLISOXAZOLE-3-CARBALDEHYDE; 5-ETHYNYL-2-METHOXYBENZALDEHYDE; 5-ETHYNYL-2-PYRIDINECARBOXALDEHYDE; 5-ETHYNYLNICOTINALDEHYDE; 5-FLUORO-1H-INDAZOLE-3-CARBALDEHYDE; 5-FLUORO-1-NAPHTHALDEHYDE; 5-FLUORO-2,3-DIHYDROBENZOFURAN-7-CARBOXALDEHYDE; 5-FLUORO-2-FORMYLPHENYLBORONIC ACID; 5-FLUORO-2-FORMYLPYRIDINE; 5-FLUORO-2-HYDROXY-3-METHYLBENZALDEHYDE; 5-FLUORO-2-HYDROXY-4-PYRIDINECARBOXALDEHYDE; 5-FLUORO-2-HYDROXYBENZALDEHYDE; 5-FLUORO-2-HYDROXYNICOTINALDEHYDE; 5-FLUORO-2-MERCAPTOBENZALDEHYDE; 5-FLUORO-2-METHOXYBENZALDEHYDE; 5-FLUORO-2-METHOXYNICOTINALDEHYDE; 5-FLUORO-2-METHYL-3-PYRIDINECARBOXALDEHYDE; 5-FLUORO-2-METHYLBENZALDEHYDE; 5-FLUORO-2-NITROBENZALDEHYDE; 5-FLUORO-4-FORMYL-2-METHOXYPYRIDINE; 5-FLUORO-4-HYDROXYISOPHTHALALDEHYDE; 5-FLUORO-6-HYDROXYNICOTINALDEHYDE; 5-FLUORO-6-HYDROXYPICOLINALDEHYDE; 5-FLUORO-6-METHOXYPICOLINALDEHYDE; 5-FLUORO-6-METHYLNICOTINALDEHYDE; 5-FLUOROBENZO[D]OXAZOLE-2-CARBALDEHYDE; 5-FLUOROISOPHTHALALDEHYDE; 5-FLUORONAPHTHALENE-2-CARBOXALDEHYDE; 5-FLUORO-PYRIMIDINE-2-CARBALDEHYDE; 5-FORMYL-1-INDANONE; 5-FORMYL-2H-PYRAZOLE-3-CARBOXYLIC ACID METHYL ESTER; 5-FORMYL-2-ISOPROXYPYRIDINE; 5-FORMYL-2-METHOXY-4-PICOLINE; 5-FORMYL-2-METHYL-BENZONITRILE; 5-FORMYL-2-METHYLPHENYLBORONIC ACID; 5-FORMYLFURO[2,3-B]PYRIDINE; 5-FORMYL-PYRAZINE-2-CARBOXYLIC ACID METHYL ESTER; 5-FORMYLPYRIDINE-2-BORONIC ACID; 5-FORMYLPYRIDINE-2-BORONIC ACIDHYDRATE; 5-FORMYLPYRIDINE-2-CARBONITRILE; 5-FORNYL-3-PYRIDINECARBONITRILE; 5-FURAN-2-YL-[1,2,4]OXADIAZOLE-3-CARBALDEHYDE; 5-FURAN-2-YL-OXAZOLE-2-CARBALDEHYDE; 5-HEXYNAL; 5-HYDROXY-1H-INDAZOLE-3-CARBOXALDEHYDE; 5-HYDROXY-1H-INDAZOLE-4-CARBALDEHYDE; 5-HYDROXY-2-(METHYLTHIO)BENZALDEHYDE; 5-HYDROXY-2-ISOPROPYLBENZALDEHYDE; 5-HYDROXY-2-METHOXYBENZALDEHYDE; 5-HYDROXY-2-METHOXY-PYRIDINE-4-CARBALDEHYDE; 5-HYDROXY-2-METHYLBENZALDEHYDE; 5-HYDROXY-2-METHYL-BENZENEPROPANAL; 5-HYDROXY-2-NITROBENZALDEHYDE; 5-HYDROXY-4,6-DIMETHYL-3-PYRIDINECARBOXALDEHYDE; 5-HYDROXY-4-BENZOFURANCARBOXALDEHYDE; 5-HYDROXY-6-BENZOFURANCARBOXALDEHYDE; 5-HYDROXY-6-METHYL-2-PYRIDINECARBOXALDEHYDE; 5-HYDROXY-6-NITRONICOTINALDEHYDE; 5-HYDROXYNAPHTHALENE-1-CARBOXALDEHYDE; 5-HYDROXYNAPHTHALENE-2-CARBOXALDEHYDE; 5-HYDROXYNICOTINALDEHYDE; 5-HYDROXYPENTANAL; 5-HYDROXYPYRAZINE-2-CARBOXALDEHYDE; 5-HYDROXYPYRIDINE-2-CARBALDEHYDE; 5-HYDROXYPYRIMIDINE-2-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-2-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-3-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-4-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-7-CARBOXALDEHYDE; 5-HYDROXYQUINOLINE-8-CARBOXALDEHYDE; 5-IMIDAZOL-1-YL-PENTANAL; 5-ISOBENZOFURANCARBOXALDEHYDE, 1,3-DIHYDRO-; 5-ISOBUTYL-1H-PYRAZOLE-3-CARBALDEHYDE; 5-ISOBUTYLPYRAZINE-2-CARBALDEHYDE; 5-ISOPROPYL-1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 5-ISOPROPYL-1,3,4-THIADIAZOLE-2-CARBALDEHYDE; 5-ISOPROPYL-3-METHYLBENZALDEHYDE; 5-ISOPROPYLISOXAZOLE-3-CARBALDEHYDE; 5-ISOPROPYLPYRAZINE-2-CARBALDEHYDE; 5-METHANESULFONYLPENTANAL; 5-METHOXY-2-METHYLBENZALDEHYDE; 5-METHOXY-2-PYRIMIDINECARBOXALDEHYDE; 5-METHOXY-3-PYRIDINECARBOXALDEHYDE; 5-METHOXY-6-METHYL-PYRIDINE-2-CARBALDEHYDE; 5-METHOXYISOPHTHALALDEHYDE; 5-METHOXYPENTANAL; 5-METHOXYPYRAZINE-2-CARBALDEHYDE; 5-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 5-METHYL-1,3,4-THIADIAZOLE-2-CARBALDEHYDE; 5-METHYL-1,3-BENZOXAZOLE-2-CARBALDEHYDE; 5-METHYL-1,3-THIAZOLE-2-CARBALDEHYDE; 5-METHYL-1H-INDAZOLE-3-CARBALDEHYDE; 5-METHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 5-METHYL-2-(PROP-2-YN-1-YLOXY)BENZALDEHYDE; 5-METHYL-2-NITROBENZALDEHYDE; 5-METHYL-3-NITROPICOLINALDEHYDE; 5-METHYL-4-(PROPAN-2-YL)-1,3-THIAZOLE-2-CARBALDEHYDE; 5-METHYLFURAN-2-PROPIONALDEHYDE; 5-METHYLHEXANAL; 5-METHYLISOPHTHALALDEHYDE; 5-METHYLISOXAZOLE-3-CARBOXALDEHYDE; 5-METHYLNICOTINALDEHYDE; 5-METHYL-OXAZOLE-2-CARBALDEHYDE; 5-METHYLPYRIDINE-2-CARBOXALDEHYDE; 5-METHYLQUINOLINE-2-CARBALDEHYDE; 5-NITRO-6-METHYL-2-PYRIDINECARBALDEHYDE; 5-NITRONICOTINALDEHYDE; 5-NORBORNENE-2-CARBOXALDEHYDE; 5-OXO-PENTANOIC ACID METHYL ESTER; 5-OXOPENTYL ACETATE; 5-PHENYL-[1,2,4]OXADIAZOLE-3-CARBALDEHYDE; 5-PHENYL-1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 5-PHENYL-1H-PYRAZOLE-3-CARBALDEHYDE; 5-PHENYLISOXAZOLE-3-CARBALDEHYDE; 5-PHENYL-OXAZOLE-2-CARBALDEHYDE; 5-PHENYLPENTANAL; 5-PYRIDIN-3-YL-OXAZOLE-2-CARBALDEHYDE; 5-QUINAZOLINECARBOXALDEHYDE; 5-TERT-BUTYL-1,3,4-OXADIAZOLE-2-CARBALDEHYDE; 5-TERT-BUTYL-1H-PYRAZOLE-3-CARBALDEHYDE; 6-(1-HYDROXY-1-METHYL-ETHYL)-PYRIDINE-3-CARBALDEHYDE; 6-(1-METHYLETHYL)-2-PYRIDINECARBOXALDEHYDE; 6-(1-METHYLETHYL)-3-PYRIDINECARBOXALDEHYDE; 6-(2-FURYL)NICOTINALDEHYDE; 6-(2-HYDROXYPROPAN-2-YL)PICOLINALDEHYDE; 6-(4H-1,2,4-TRIAZOL-4-YL)PYRIDINE-2-CARBOXALDEHYDE; 6-(CHLOROMETHYL)NICOTINALDEHYDE; 6-(CHLOROMETHYL)PYRIDINE-2-CARBALDEHYDE; 6-(DIMETHYLAMINO)-4-METHYLNICOTINALDEHYDE; 6-(DIMETHYLAMINO)NICOTINALDEHYDE; 6-(FLUOROMETHYL)PYRIDINE-2-CARBALDEHYDE; 6-(FURAN-2-YL)PYRIDINE-2-CARBALDEHYDE; 6-(HYDROXYMETHYL)-3-PYRIDINECARBOXALDEHYDE; 6,6-DIMETHOXYHEXANAL; 6,7-DIHYDRO-4H-PYRAZOLO[5,1-C][1,4]OXAZINE-2-CARBALDEHYDE; 6,7-DIHYDRO-4H-PYRAZOLO[5,1-C][1,4]THIAZINE-2-CARBALDEHYDE; 6,7-DIHYDRO-5H-CYCLOPENTA[C]PYRIDINE-3-CARBOXALDEHYDE; 6,7-DIHYDRO-5H-PYRANO[2,3-D]PYRIMIDINE-2-CARBALDEHYDE; 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBALDEHYDE; 6,7-DIMETHYL-1H-INDAZOLE-3-CARBALDEHYDE; 6-[ETHYL(METHYL)AMINO]NICOTINALDEHYDE; 6-ACETYL-NICOTINALDEHYDE; 6-ACETYLPYRIDINE-2-CARBALDEHYDE; 6-BENZOTHIAZOLECARBOXALDEHYDE; 6-CHLORO-1,2,4-TRIAZINE-5-CARBALDEHYDE; 6-CHLORO-2-FLUORO-3-METHYLBENZALDEHYDE; 6-CHLORO-2-FLUOROPYRIDINE-3-CARBOXALDEHYDE; 6-CHLORO-2-METHOXY-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-METHYLPYRIMIDINE-4-CARBALDEHYDE; 6-CHLORO-3-FORMYL-2-PICOLINE; 6-CHLORO-3-METHOXYPYRIDINE-2-CARBOXALDEHYDE; 6-CHLORO-3-METHYLPYRIDINE-2-CARBOXALDEHYDE; 6-CHLORO-4-FLUORO-PYRIDINE-2-CARBALDEHYDE; 6-CHLORO-4-FLUORO-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-4-HYDROXY-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-4-METHOXY-PYRIDINE-2-CARBALDEHYDE; 6-CHLORO-4-METHYLPICOLINALDEHYDE; 6-CHLORO-5-FLUORONICOTINALDEHYDE; 6-CHLORO-5-FLUOROPICOLINALDEHYDE; 6-CHLORO-5-HYDROXY-3-PYRIDINECARBOXALDEHYDE; 6-CHLORO-5-METHOXYPICOLINALDEHYDE; 6-CHLORO-5-METHOXY-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-5-METHYLNICOTINALDEHYDE; 6-CHLOROHEXANAL; 6-CHLORONICOTINALDEHYDE; 6-CHLOROPYRAZINE-2-CARBALDEHYDE; 6-CHLOROPYRIDAZINE-3-CARBALDEHYDE; 6-CHLOROPYRIDINE-2-CARBALDEHYDE; 6-CHLOROPYRIMIDINE-4-CARBALDEHYDE; 6-CYANOPYRIDINE-2-CARBOXALDEHYDE; 6-CYCLOPROPYL-2-FORMYLPYRIMIDINE; 6-CYCLOPROPYL-PYRIDINE-3-CARBALDEHYDE; 6-DEOXY-D-GALACTOSE; 6-DEOXY-L-TALOSE; 6-DIMETHYLAMINO-PYRIDINE-2-CARBALDEHYDE; 6-ETHOXY-5-FLUORO-PYRIDINE-3-CARBALDEHYDE; 6-ETHOXYNICOTINALDEHYDE; 6-ETHOXYPYRIDINE-2-CARBOXALDEHYDE; 6-ETHYL-3-PYRIDINECARBOXALDEHYDE; 6-ETHYNYLPICOLINALDEHYDE; 6-FLUORO-1H-INDAZOLE-5-CARBALDEHYDE; 6-FLUORO-3-(1H)INDAZOLE CARBOXALDEHYDE; 6-FLUORO-3-FORMYL-2-PICOLINE; 6-FLUORO-5-METHOXYNICOTINALDEHYDE; 6-FLUORO-5-METHYLPYRIDINE-2-CARBALDEHYDE; 6-FLUOROBENZO[D]OXAZOLE-2-CARBALDEHYDE; 6-FORMYL NICOTINONITRILE; 6-FORMYL-2-METHYLPYRIDINE-3-BORONIC ACID; 6-FORMYL-2-PYRIDINE CARBOXYLIC ACID METHYL ESTER; 6-FORMYL-4-METHYLPYRIDINE-3-BORONIC ACID; 6-FORMYLFURO[3,2-C]PYRIDINE; 6-FORMYLPYRIDINE-2-BORONIC ACID; 6-FORMYLPYRIDINE-3-BORONIC ACID; 6-HYDROXY-1H-INDAZOLE-3-CARBOXALDEHYDE; 6-HYDROXY-2-METHYLNICOTINALDEHYDE; 6-HYDROXY-2-METHYLPYRIMIDINE-4-CARBALDEHYDE; 6-HYDROXY-2-NAPHTHALDEHYDE; 6-HYDROXY-5-NITRONICOTINALDEHYDE; 6-HYDROXY-5-QUINOLINECARBOXALDEHYDE; 6-HYDROXYISOQUINOLINE-5-CARBALDEHYDE; 6-HYDROXYMETHYL-2-PYRIDINECARBOXALDEHYDE; 6-HYDROXYNAPHTHALENE-1-CARBOXALDEHYDE; 6-HYDROXYNICOTINALDEHYDE; 6-HYDROXYPYRIDAZINE-3-CARBOXALDEHYDE; 6-HYDROXYPYRIDINE-2-CARBOXALDEHYDE; 6-HYDROXYPYRIMIDINE-4-CARBALDEHYDE; 6-HYDROXYQUINOLINE-2-CARBOXALDEHYDE; 6-HYDROXYQUINOLINE-3-CARBOXALDEHYDE; 6-HYDROXYQUINOLINE-4-CARBOXALDEHYDE; 6-HYDROXYQUINOLINE-7-CARBOXALDEHYDE; 6-HYDROXYQUINOLINE-8-CARBOXALDEHYDE; 6-IMIDAZOL-1-YL-HEXANAL; 6-IMIDAZOL-1-YL-PYRIDINE-2-CARBALDEHYDE; 6-METHOXY-2,6-DIMETHYL HEPTANAL; 6-METHOXY-2-METHYLPYRIDINE-3-CARBOXALDEHYDE; 6-METHOXY-2-PYRIDINECARBOXALDEHYDE; 6-METHOXY-3-METHYLPYRIDINE-2-CARBALDEHYDE; 6-METHOXY-3-PYRIDINECARBOXALDEHYDE; 6-METHOXY-5-METHYLNICOTINALDEHYDE; 6-METHOXY-5-METHYLPYRIDINE-2-CARBALDEHYDE; 6-METHOXYPYRIDAZINE-3-CARBALDEHYDE; 6-METHYL-1,3-BENZOXAZOLE-2-CARBALDEHYDE; 6-METHYL-2-(PROPAN-2-YL)PYRIMIDINE-4-CARBALDEHYDE; 6-METHYL-2-PROPYLPYRIMIDINE-4-CARBALDEHYDE; 6-METHYL-2-PYRIDINECARBOXALDEHYDE; 6-METHYL-2-QUINOLINECARBOXALDEHYDE; 6-METHYL-3-(1H)INDAZOLE CARBOXALDEHYDE; 6-METHYL-3-CYCLOHEXENE-1-CARBOXALDEHYDE; 6-METHYL-3-NITROPICOLINALDEHYDE; 6-METHYL-5-QUINOLINECARBALDEHYDE; 6-METHYL-BENZO[1,3]DIOXOLE-5-CARBALDEHYDE; 6-METHYLISOVANILLIN; 6-METHYLNICOTINALDEHYDE; 6-METHYLPYRAZINE-2-CARBOXALDEHYDE; 6-METHYLPYRIDAZINE-3-CARBALDEHYDE; 6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 6-METHYLQUINOLINE-8-CARBOXALDEHYDE; 6-NITROPICOLINALDEHYDE; 6-OXO-HEXANOIC ACID ETHYL ESTER; 6-QUINOLINECARBALDEHYDE; 6-TERT-BUTYL-PYRIDINE-3-CARBALDEHYDE; 7,7-DIMETHOXYHEPTANAL; 7,7-DIMETHYL-2-OXOBICYCLO[2.2.1]HEPTANE-1-CARBALDEHYDE; 7,8-DIHYDRO-5H-PYRANO[4,3-B]PYRIDINE-3-CARBALDEHYDE; 7,8-DIHYDRO-5H-PYRANO[4,3-D]PYRIDINE-4-CARBALDEHYDE; 7,8-DIHYDRO-5H-PYRANO[4,3-D]PYRIMIDINE-2-CARBALDEHYDE; 7,8-DIHYDRO-5H-PYRANO[4,3-D]PYRIMIDINE-4-CARBALDEHYDE; 7-ETHYL-1H-INDAZOLE-5-CARBALDEHYDE; 7-FLUORO-1H-INDAZOLE-3-CARBOXALDEHYDE; 7-FLUORO-1H-INDAZOLE-4-CARBALDEHYDE; 7-FLUOROBENZO[D]OXAZOLE-2-CARBALDEHYDE; 7-FLUORONAPHTHALENE-1-CARBOXALDEHYDE; 7-FORMYL-8-QUINOLINOL; 7-HYDROXY-1,3-BENZODIOXOLE-5-CARBOXALDEHYDE; 7-HYDROXY-3-QUINOLINECARBOXALDEHYDE; 7-HYDROXYISOQUINOLINE-8-CARBALDEHYDE; 7-HYDROXYNAPHTHALENE-1-CARBOXALDEHYDE; 7-HYDROXYNAPHTHALENE-2-CARBOXALDEHYDE; 7-HYDROXYQUINOLINE-2-CARBOXALDEHYDE; 7-HYDROXYQUINOLINE-4-CARBOXALDEHYDE; 7-HYDROXYQUINOLINE-5-CARBOXALDEHYDE; 7-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 7-HYDROXYQUINOLINE-8-CARBALDEHYDE; 7-METHYL-1H-INDAZOLE-3-CARBALDEHYDE; 7-METHYL-1H-INDAZOLE-5-CARBALDEHYDE; 7-METHYL-2-NAPHTHALDEHYDE; 7-METHYLQUINOLINE-3-CARBALDEHYDE; 7-OXO-HEPTANOIC ACID ETHYL ESTER; 7-OXOHEPTYL ACETATE; 8-HYDROXYNAPHTHALENE-1-CARBOXALDEHYDE; 8-HYDROXYNAPHTHALENE-2-CARBOXALDEHYDE; 8-HYDROXYQUINOLINE-2-CARBOXALDEHYDE; 8-HYDROXYQUINOLINE-3-CARBOXALDEHYDE; 8-HYDROXY-QUINOLINE-5-CARBALDEHYDE; 8-HYDROXYQUINOLINE-6-CARBOXALDEHYDE; 8-METHYLQUINOLINE-5-CARBALDEHYDE; 8-OXOOCTANENITRILE; 8-QUINOLINECARBALDEHYDE; 9-DECENAL; A,A-DIMETHYL-2-PYRIDINEACETALDEHYDE; ACETALDEHYDE; ACETALDEHYDE, (3-METHYLPHENOXY)-; ACETALDEHYDE, 2-NITRO-; ACETALDEHYDE, IODO-; ACETALDEHYDE, PARA-METHYL PHENOXY; ACETIC ACID 2-FORMYL-PHENYL ESTER; ACETIC ACID 3-METHYL-6-OXO-HEX-2-ENYL ESTER; ACETYLOXYACETALDEHYDE; ADIPALDEHYDE; A-FORMYL-2-PYRIDINEACETONITRILE; A-FORMYL-3-PYRIDINEACETONITRILE; A-FORMYL-4-PYRIDINEACETONITRILE; ALDENAL C-11; ALDOL; ALPHA-CYCLOCIRAL; A-METHYL-3-PYRIDINEPROPANAL; A-METHYL-4-PYRIDINEACETALDEHYDE; BENZALDEHYDE; BENZALDEHYDE ON POLYSTYRENE; BENZALDEHYDE-180; BENZENE-1,2,4-TRICARBALDEHYDE; BENZENE-1,3,5-TRICARBALDEHYDE; BENZENEACETALDEHYDE, 2-FLUORO-4-METHOXY-; BENZENEACETALDEHYDE, A,A-DIFLUORO-; BENZENEACETALDEHYDE, A-FLUORO-; BENZENEBUTANAL, 2-METHYL-; BENZENEBUTANAL, 4-FLUORO-; BENZENEBUTANAL, 4-METHYL-; BENZO[B]FURAN-7-CARBALDEHYDE; BENZO[B]THIOPHENE-4-CARBALDEHYDE; BENZO[B]THIOPHENE-7-CARBALDEHYDE; BENZO[D]ISOXAZOLE-5-CARBALDEHYDE; BENZO[D]OXAZOLE-6-CARBALDEHYDE; BENZONITRILE, 4-(2-OXOETHYL)-; BENZONITRILE, 4-FORMYL-3-HYDROXY-; BENZOOXAZOLE-2-CARBALDEHYDE; BENZYLGLYOXYLATE; BENZYLOXYACETALDEHYDE; BETA-CYANOPROPIONALDEHYDE; BETAINE ALDEHYDE; BETAINE ALDEHYDE CHLORIDE; BICYCLO[2,2,1]HEPTANE-2-CARBOXALDEHYDE; BICYCLO[4.2.0]OCTA-1,3,5-TRIENE-7-CARBALDEHYDE; BROMOACETALDEHYDE; BUTANAL, 2,2-DIETHYL-; BUTANAL, 3-METHOXY-3-METHYL-; BUTYL GLYOXYLATE; BUTYLMALONDIALDEHYDE; BUTYRALDEHYDE; BUTYRALDEHYDE,-BTA-BROMO-ALPHA-OXO-; CAMPHOLENIC ALDEHYDE; CHLORAL; CHLOROACETALDEHYDE; CHROMAN-3-CARBALDEHYDE; CHROMAN-6-CARBALDEHYDE; CHROMAN-8-CARBALDEHYDE; CIS-3-HEXENYL OXY-ACETALDEHYDE; CIS-4-DECENAL; CIS-4-HEPTENAL; CIS-6-NONENAL; CIS-7-DECEN-1-AL; CIS-8-UNDECEN-1-AL; CITRONELLAL; COUMARIN-6-CARBOXALDEHYDE; CYCLOBUTANECARBOXALDEHYDE; CYCLOBUTYL(PHENYL)ACETALDEHYDE; CYCLOBUTYLACETALDEHYDE; CYCLOHEPTANECARBALDEHYDE; CYCLOHEXANECARBOXALDEHYDE; CYCLOHEXANONE-4-CARBOXALDEHYDE; CYCLOOCTANECARBALDEHYDE; CYCLOPENTANECARBALDEHYDE; CYCLOPENTYL ACETALDEHYDE; CYCLOPENTYLMALONDIALDEHYDE; CYCLOPROPANECARBOXALDEHYDE; CYCLOPROPANECARBOXALDEHYDE, 2-PHENYL-, (1R,2R)-; CYCLOPROPYLMALONDIALDEHYDE; DECANAL; DIAZOACETALDEHYDE; DICHLOROACETALDEHYDE; DICHLOROACETALDEHYDE HYDRATE; DIMETHYLMALONDIALDEHYDE; DI-N-BUTYLACETALDEHYDE; ETHOXYACETALDEHYDE; ETHYL 1-FORMYLCYCLOBUTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPENTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPROPANECARBOXYLATE; ETHYL 2-[(2-OXOETHYL)SULFANYL]ACETATE; ETHYL 2-CHLORO-3-OXOPROPANOATE; ETHYL 2-FORMYL-1-CYCLOPROPANECARBOXYLATE; ETHYL 2-FORMYLBUTANOATE; ETHYL 3-FORMYL-1H-PYRAZOLE-5-CARBOXYLATE; ETHYL 4-OXOBUTANOATE; ETHYL ALLYL FORMYLMETHYLCARBAMATE; ETHYL GLYOXALATE; ETHYL-2-FORMYL-3-OXOPROPIONATE; ETHYLMALONDIALDEHYDE; FLUOROACETALDEHYDE; FLUOROMALONALDEHYDE; FORMALDEHYDE/GLUTARALDEHYDE; FURO[2,3-C]PYRIDINE-5-CARBALDEHYDE; FURO[3,2-B]PYRIDINE-6-CARBALDEHYDE; GLUTARALDEHYDE; GLUTARALDEHYDEMONOACETAL; GLYCIDALDEHYDE; GLYCOLALDEHYDE; GLYOXAL; GLYOXAL DIETHYL ACETAL; GLYOXAL DIMETHYL ACETAL; HEPT-6-ENAL; HEPTALDEHYDE; HEX-4-YNAL; HEX-5-ENAL; HEXAHYDRO-4,7-METHANOINDAN-1-CARBOXALDEHYDE; HEXANAL; HEXYL GLYOXYLATE; HYDROXYPIVALDEHYDE; HYDROXYPROPANEDIAL; IMIDAZO[1,2-A]PYRIMIDINE-7-CARBALDEHYDE; IMIDAZO[1,2-B]PYRIDAZINE-6-CARBOXALDEHYDE; IMIDAZO[1,5-A]PYRIDINE-3-CARBALDEHYDE; IMIDAZO[2,1,5-CD]INDOLIZINE-2-CARBOXALDEHYDE; IMIDAZOL-1-YL-ACETALDEHYDE; INDAN-5-CARBALDEHYDE; ISOBUTYRALDEHYDE; ISOPHTHALALDEHYDE; ISOPROPYL GLYOXYLATE; ISOPROPYLMALONDIALDEHYDE; ISOQUINOLINE-1-CARBALDEHYDE; ISOQUINOLINE-3-CARBALDEHYDE; ISOQUINOLINE-4-CARBALDEHYDE; ISOQUINOLINE-5-CARBALDEHYDE; ISOQUINOLINE-6-CARBALDEHYDE; ISOQUINOLINE-7-CARBALDEHYDE; ISOQUINOLINE-8-CARBALDEHYDE; ISOVALERALDEHYDE; ISOXAZOLE-3-CARBALDEHYDE; ISOXAZOLO[4,5-C]PYRIDINE-4-CARBALDEHYDE; MALONDIALDEHYDE; METHOXYACETALDEHYDE; METHYL 2-[(2-OXOETHYL)SULFANYL]ACETATE; METHYL 2-[(3-OXOPROPYL)SULFANYL]ACETATE; METHYL 2-CHLORO-2-FORMYLACETATE; METHYL 2-FORMYLBENZOATE; METHYL 2-FORMYLNICOTINATE; METHYL 2-FORMYLPYRIDINE-4-CARBOXYLATE; METHYL 2-METHYL-3-OXOPROPIONATE; METHYL 3-[(2-OXOETHYL)SULFANYL]PROPANOATE; METHYL 3-FORMYL-2-PYRIDINECARBOXYLATE; METHYL 3-FORMYLBENZOATE; METHYL 3-OXOPROPANOATE; METHYL 4-FORMYLBENZOATE; METHYL 4-FORMYLPYRIDINE-2-CARBOXYLATE; METHYL 4-FORMYLPYRIMIDINE-2-CARBOXYLATE; METHYL 5-FORMYLNICOTINATE; METHYL 5-FORMYLPICOLINATE; METHYL 5-FORMYLPYRIMIDINE-2-CARBOXYLATE; METHYL 6-FORMYLNICOTINATE; METHYL 6-OXOHEXANOATE; METHYL 7-OXOHEPTANOATE; METHYL DIFORMYLACETATE; METHYL GLYOXYLATE; METHYLMALONDIALDEHYDE; MONO METHOXY PEG ALDEHYDE; MORPHOLIN-4-YL-ACETALDEHYDE; MORPHOLIN-4-YL-ACETALDEHYDE HCL; M-TOLUALDEHYDE; N,N-DIMETHYL-2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; N,N-DIMETHYL-2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-BOC-(METHYLAMINO)ACETALDEHYDE; NITROACETALDEHYDE POTASSIUM SALT; NITROMALONALDEHYDE; NITROMALONALDEHYDE SODIUM SALT; NITROMALONALDEHYDE SODIUM SALT HYDRATE; NON-8-ENAL; NONANAL; O-ANISALDEHYDE; OCT-7-ENAL; OCTANAL; OCTANAL, 8-CHLORO-; OCTANEDIAL; OCTYL OXY-ACETALDEHYDE; O-PHTHALALDEHYDE; OXAZOLE-2-CARBALDEHYDE; OXOPENTANAL(4-); P-ANISALDEHYDE; P-AZIDOBENZALDEHYDE; PENT-4-YNAL; PENTAFLUOROPROPIONALDEHYDE HYDRATE; PENTANAL, 5-BROMO-; PENTANOIC ACID, 5-OXO-, ETHYL ESTER; PHENOXY ACETALDEHYDE; PHENYLACETALDEHYDE; PHENYLETHYL OXYACETALDEHYDE; PHENYLGLYOXAL; PHENYLGLYOXAL MONOHYDRATE; PHENYLPROPARGYL ALDEHYDE; P-HYDROXY PHENYL BUTANONE; PINONALDEHYDE; PIPERONAL; PIPERONYL FORMALDEHYDE; P-METHYLPHENYLACETALDEHYDE; PROPANAL, 3-BROMO-; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (R)—; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (S)—; PROPIONALDEHYDE; PROPYLMALONDIALDEHYDE; PROPYNAL; P-TOLUALDEHYDE; PYRAZINE-2,6-DICARBALDEHYDE; PYRAZINE-2-CARBALDEHYDE; PYRAZOLO[1,5-A]PYRIDINE-2-CARBALDEHYDE; PYRIDAZINE-3,6-DICARBALDEHYDE; PYRIDAZINE-3-CARBALDEHYDE; PYRIDAZINE-4-CARBALDEHYDE; PYRIDINE-3,5-DICARBOXALDEHYDE; PYRIDINE-4-ALDEHYDE HYDRATE; PYRIDINIUM, 2-FORMYL-5-HYDROXY-1-PROPYL-, INNER SALT; PYRIDO[2,3-B]PYRAZINE-3-CARBALDEHYDE; PYRIDO[2,3-B]PYRAZINE-6-CARBALDEHYDE; PYRIDO[2,3-B]PYRAZINE-7-CARBOXALDEHYDE; PYRIDO[2,3-E]PYRAZINE-8-CARBALDEHYDE; PYRIDOXAL; PYRIMIDINE-2,4,6-TRICARBALDEHYDE; PYRIMIDINE-2,4-DICARBALDEHYDE; PYRIMIDINE-4,6-DICARBALDEHYDE; PYRIMIDINE-4-CARBOXALDEHYDE; PYRIMIDINE-5-CARBOXALDEHYDE; PYRROLO[1,2-C]PYRIMIDINE-1-CARBOXALDEHYDE; PYRUVIC ALDEHYDE; QUINAZOLINE-2-CARBALDEHYDE; QUINAZOLINE-4-CARBALDEHYDE; QUINAZOLINE-6-CARBALDEHYDE; QUINOLINE-5-CARBALDEHYDE; QUINOLINE-7-CARBALDEHYDE; QUINOXALINE-5-CARBALDEHYDE; QUINOXALINE-6-CARBALDEHYDE; QUINUCLIDINE-2-CARBALDEHYDE; QUINUCLIDINE-3-CARBALDEHYDE; QUINUCLIDINE-4-CARBALDEHYDE; S-2-METHYLBUTANAL; SALICYLALDEHYDE; SALICYLALDEHYDE, SODIUM SALT; SODIUM GLYOXYLATE; SODIUM GLYOXYLATE MONOHYDRATE; SPIROCYCLOHEXYLBUTANE-1,3-DIONE; SUCCINALDEHYDE; TEREPHTHALALDEHYDE; TERT-BUTYL 4-OXOBUTANOATE; TERT-BUTYL 5-OXOPENTANOATE; TERT-BUTYLGLYOXAL; TERT-BUTYLMALONDIALDEHYDE; TETRAHYDRO-2,5-DIMETHOXY-5-METHYLFURAN-3-CARBALDEHYDE; TETRAHYDRO-2-FURANCARBOXALDEHYDE; TETRAHYDRO-2H-PYRAN-2-CARBALDEHYDE; TETRAHYDROFURAN-3-CARBOXALDEHYDE; TETRAHYDRO-PYRAN-3-CARBALDEHYDE; TETRAHYDROPYRAN-4-YLACETALDEHYDE; TETRAHYDRO-THIOPYRAN-3-CARBALDEHYDE; TETRAHYDROTHIOPYRAN-4-CARBALDEHYDE; TRANS-1,4-CYCLOHEXANE DICARBOXALDEHYDE; TRANS-2,2-DIMETHYL-4-HEPTENAL; TRANS-4-DECEN-1-AL; TRANS-4-ETHYL-CYCLOHEXANECARBALDEHYDE; TRANS-4-HEPTENAL; TRIFLUOROACETALDEHYDE; TRIFLUOROACETALDEHYDE HYDRATE; TRIFLUOROPYRUVIC ALDEHYDE; TRIFORMYLMETHANE; TRIMETHYLACETALDEHYDE; TRIPLAL; TRIVERTAL; UNDECANAL; VALERALDEHYDE; VANILLIN; Halogens: (2-BROMO-5-FORMYL-IMIDAZOL-1-YL)-ACETIC ACID METHYL ESTER; (2-CHLORO-3-FORMYL-INDOL-1-YL)-ACETIC ACID METHYL ESTER; (2-CHLORO-5-FORMYL-IMIDAZOL-1-YL)-ACETIC ACID METHYL ESTER; (2E)-2-BROMO-3-(DIMETHYLAMINO)-2-PROPENAL; (2E)-3-(4-BROMOPHENYL)-3-CHLOROACRYLALDEHYDE; (2E)-3-CHLORO-3-(2,4-DIMETHYLPHENYL)-2-METHYLACRYLALDEHYDE; (2Z)-2-CHLORO-2-BUTENAL; (2Z)-3-(4-BROMOPHENYL)-3-CHLOROACRYLALDEHYDE; (4-BROMO-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-CHLORO-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-ACETALDEHYDE; (4-CHLORO-5-FORMYL-2-OXO-THIAZOL-3-YL)-ACETIC ACID ETHYL ESTER; (4-IODO-1H-PYRAZOL-1-YL)ACETALDEHYDE; (4-IODO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETALDEHYDE; (8-BROMO-3-METHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL)ACETALDEHYDE; (E)-3-CHLORO-2-METHYL-3-(2-THENYL) ACROLEIN; (Z)-2-(2-(4-BROMOPHENYL)HYDRAZONO)-2-CHLOROACETALDEHYDE; (Z)-2-BROMO-4-OXO-BUT-2-ENOIC ACID ETHYL ESTER; (Z)-3-CHLORO-2-METHYL-3-(2-THENYL) ACROLEIN; (Z)-3-CHLORO-2-METHYL-3-PHENYL-ACRYLALDEHYDE; (Z)-3-CHLORO-3-(3-CHLOROPHENYL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-(4-FLUOROPHENYL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-(4-METHOXYPHENYL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-(4-NITROPHENYL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-(THIOPHEN-3-YL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-PHENYLACRYLALDEHYDE; (Z)-3-CHLORO-3-P-TOLYLACRYLALDEHYDE; (Z)-3-HYDROXY-2-IODOACROLEIN; (Z)-N-(4-CHLORO-3-ETHYL-5-FORMYLTHIAZOL-2(3H)-YLIDENE)BENZENESULFONAMIDE; 1-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)CYCLOHEXANE-1-CARBALDEHYDE; 1-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)CYCLOPENTANE-1-CARBALDEHYDE; 1-((6-CHLOROIMIDAZO[1,2-A]PYRIDIN-2-YL)METHYL)PIPERIDINE-2-CARBALDEHYDE; 1-((6-CHLOROIMIDAZO[1,2-A]PYRIDIN-2-YL)METHYL)PIPERIDINE-3-CARBALDEHYDE; 1-((6-CHLOROIMIDAZO[1,2-A]PYRIDIN-2-YL)METHYL)PIPERIDINE-4-CARBALDEHYDE; 1-((BENZYLOXY)METHYL)-4-IODO-1H-IMIDAZOLE-5-CARBALDEHYDE; 1-(2-BROMO-ALLYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-BROMOPHENYL)-3-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPHENYL)-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPROP-2-EN-1-YL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-BROMOPROP-2-EN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-BROMOPROP-2-EN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-BROMOPROP-2-EN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(2-CHLORO-4-FLUOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLORO-4-FLUOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLORO-5-FLUOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLORO-5-FLUOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLORO-ALLYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-CHLOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(2-CHLOROPROP-2-EN-1-YL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(2-CHLOROPROP-2-EN-1-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(2-CHLOROPROP-2-EN-1-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(2-CHLOROPROP-2-EN-1-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(3-BROMOPHENYL)-3-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-BROMOPHENYL)-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(3-CHLORO-4-FLUOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(3-CHLORO-4-FLUOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(3-CHLOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(3-CHLOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(4-BROMOPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-2-(DIMETHYLAMINO)-1H-IMIDAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-BROMOPHENYL)-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(4-CHLOROPHENYL)-3,5-DIBROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(4-CHLOROPHENYL)-3,5-DICHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1-(BUTAN-2-YL)-3-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-CYCLOPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(BUTAN-2-YL)-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(PHENYLSULFONYL)-2-IODO-4-AZAINDOLE-6-CARBOXALDEHYDE; 1-(PHENYLSULFONYL)-2-IODO-7-AZAINDOLE-5-CARBALDEHYDE; 1-(PHENYLSULPHONYL)-2-IODO-7-AZAINDOLE-6-CARBALDEHYDE; 1,3-BIS(2,4-DIFLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(2,5-DIFLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(2-CHLOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(2-FLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(2-FLUOROPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(3,4-DIFLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(3,5-DIFLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(3-CHLOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(3-FLUOROPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(4-FLUOROPHENYL)-5-BROMO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-BIS(4-FLUOROPHENYL)-5-CHLORO-1H-PYRAZOLE-4-CARBOXALDEHYDE; 1,3-DI-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-[(3-BROMOTHIOPHEN-2-YL)METHYL]-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-[(3-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[(3-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[(3-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[(3-CHLORO-1-BENZOTHIOPHEN-2-YL)METHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[(3-CHLORO-1-BENZOTHIOPHEN-2-YL)METHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[(3-CHLORO-1-BENZOTHIOPHEN-2-YL)METHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[(4-BROMOTHIOPHEN-2-YL)METHYL]-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-[(4-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[(4-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[(4-BROMOTHIOPHEN-2-YL)METHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[(5-CHLORO-1,3-DIMETHYL-1H-PYRAZOL-4-YL)METHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[(5-CHLORO-1,3-DIMETHYL-1H-PYRAZOL-4-YL)METHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[(5-CHLORO-1,3-DIMETHYL-1H-PYRAZOL-4-YL)METHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHYL]-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-[4-(3-CHLORO-2-THIENYL)-6-METHYL-2-PYRIMIDINYL]-1H-PYRROLE-2-CARBALDEHYDE; 11-CHLORO-13-OXO-8-OXA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 11-CHLORO-13-OXO-8-THIA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 1-ACETYL-3-CHLORO-1H-INDOLE-2-CARBOXALDEHYDE; 1-ALLYL-2-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 1-BENZYL-2-BROMO-1H-IMIDAZOLE-5-CARBALDEHYDE; 1-BENZYL-2-CHLORO-1H-IMIDAZOLE-5-CARBALDEHYDE; 1-BENZYL-3-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-4-IODO-1H-PYRROLE-2-CARBALDEHYDE; 1-BENZYL-5-CHLORO-2,3,6,7-TETRAHYDRO-1H-AZEPINE-4-CARBALDEHYDE HYDROCHLORIDE; 1-BENZYL-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BENZYL-5-CHLORO-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 1-BOC-2-CHLORO-3-FORMYL-INDOLE; 1-BOC-4-CHLORO-5-FORMYL-3,6-DIHYDRO-2H-PYRIDINE; 1-BUTYL-3-TERT-BUTYL-5-CHLORO-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-4-CHLORO-3-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-CYCLOPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-BUTYL-6-CHLORO-5-FORMYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 1-CHLORO-2-FORMYL-3-METHYL-BENZO[4,5]IMIDAZO[1,2-A]PYRIDINE-4-CARBONITRILE; 1-CHLORO-3,4-DIHYDRO-2-NAPHTHALENECARBALDEHYDE; 1-CHLORO-5,7-DIMETHYL-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1-CHLORO-5-METHOXY-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1-CHLORO-6,7-DIMETHOXY-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1-CHLORO-6-METHOXY-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1-CHLORO-7-METHOXY-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 1-CHLORO-FORMYL-3H-BENZO[F]CHROMENE; 1H-IMIDAZOLE-4-BROMO-2-CARBOXYALDEHYDE; 1H-INDOLE-1-CARBOXYLIC ACID, 3-BROMO-4-FORMYL-, 1,1-DIMETHYLETHYL ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 4-FORMYL-3-IODO-, 1,1-DIMETHYLETHYL ESTER; 1H-INDOLE-3-ACETALDEHYDE, 2-IODO-1-(PHENYLSULFONYL)-; 1H-INDOLE-3-ACETALDEHYDE, 2-IODO-1-METHYL-; 1H-INDOLE-3-CARBOXALDEHYDE, 2-CHLORO-5-METHOXY-1,6-DIMETHYL-; 1H-INDOLE-3-CARBOXALDEHYDE, 2-CHLORO-5-METHOXY-6-METHYL-; 1H-INDOLE-3-CARBOXALDEHYDE, 2-IODO-; 1H-INDOLE-3-CARBOXALDEHYDE, 2-IODO-1-(METHOXYMETHYL)-; 1H-INDOLE-3-CARBOXALDEHYDE, 2-IODO-1-METHOXY-; 1H-PYRAZOLE-1-PROPANAL, 4-BROMO-BETA-CYCLOPENTYL-, (BETAR)-; 1H-PYRAZOLO[3,4-C]PYRIDINE-7-CARBOXALDEHYDE, 3-CHLORO-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 2-CHLORO-; 1-SEC-BUTYL-4-CHLORO-3-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 1-SEC-BUTYL-6-CHLORO-5-FORMYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 1-TERT-BUTYL-5-CHLORO-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-CYCLOPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 1-TERT-BUTYL-5-CHLORO-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 2-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)-2-ETHYLBUTANAL; 2-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)-2-METHYLBUTANAL; 2-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)-2-METHYLPENTANAL; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-4-ETHYL-1,3-THIAZOLE-5-CARBALDEHYDE; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-4-METHYL-1,3-THIAZOLE-5-CARBALDEHYDE; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-5-FLUOROBENZALDEHYDE; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)ACETALDEHYDE; 2-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)BENZALDEHYDE; 2-([5-CHLORO-1-(4-METHYLPHENYL)-6-OXO-1,6-DIHYDROPYRIDAZIN-4-YL]OXY)BENZALDEHYDE; 2-(1-((BENZYLOXY)METHYL)-4-IODO-1H-IMIDAZOL-5-YL)ACETALDEHYDE; 2-(2H-1,3-BENZODIOXOL-5-YL)-6-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(3-BENZYL-5-BROMO-2,6-DIOXO-2,3-DIHYDROPYRIMIDIN-1(6H)-YL)ACETALDEHYDE; 2-(3-BROMO-1H-INDOL-1-YL)ACETALDEHYDE; 2-(3-BROMO-2-METHYL-1H-INDOL-1-YL)ACETALDEHYDE; 2-(3-BROMO-FURAN-2-YL)-4-FORMYL-IMIDAZOLE; 2-(3-BROMO-PHENYL)-6-CHLORO-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(3-BROMO-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(3-CHLORO-1H-INDOL-1-YL)ACETALDEHYDE; 2-(4,5-DIBROMOFURAN-2-YL)-1,3-THIAZOLE-4-CARBALDEHYDE; 2-(4,5-DIBROMOFURAN-2-YL)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)-5-FLUOROBENZALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)-5-NITROBENZALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)-6-CHLOROBENZALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(4-BROMO-1H-PYRAZOL-1-YL)QUINOLINE-3-CARBALDEHYDE; 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-5-FLUOROBENZALDEHYDE; 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-5-NITROBENZALDEHYDE; 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-6-CHLOROBENZALDEHYDE; 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(4-BROMO-3-NITRO-1H-PYRAZOL-1-YL)ACETALDEHYDE; 2-(4-BROMO-FURAN-2-YL)-4-FORMYL-IMIDAZOLE; 2-(4-BROMOPHENYL)-6-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(4-BROMOPHENYL)-7-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(4-BROMOTHIOPHEN-2-YL)-1,3-THIAZOLE-4-CARBALDEHYDE; 2-(4-BROMOTHIOPHEN-2-YL)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-(4-BROMO-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-CHLORO-1H-PYRAZOL-1-YL)-5-FLUOROBENZALDEHYDE; 2-(4-CHLORO-1H-PYRAZOL-1-YL)-5-NITROBENZALDEHYDE; 2-(4-CHLORO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 2-(4-CHLORO-1H-PYRAZOL-1-YL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(4-CHLORO-1H-PYRAZOL-1-YL)QUINOLINE-3-CARBALDEHYDE; 2-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-5-FLUOROBENZALDEHYDE; 2-(5-BROMO-1H-PYRAZOL-1-YL)ACETALDEHYDE; 2-(5-BROMO-2,6-DIOXO-3-PHENETHYL-2,3-DIHYDROPYRIMIDIN-1(6H)-YL)ACETALDEHYDE; 2-(5-BROMO-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)ACETALDEHYDE; 2-(5-BROMO-3-ETHYL-2,6-DIOXO-2,3-DIHYDROPYRIMIDIN-1(6H)-YL)ACETALDEHYDE; 2-(5-BROMO-3-METHYL-2,6-DIOXO-2,3-DIHYDROPYRIMIDIN-1(6H)-YL)ACETALDEHYDE; 2-(5-BROMO-3-NITRO-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)ACETALDEHYDE; 2-(5-CHLORO-1H-PYRAZOL-1-YL)ACETALDEHYDE; 2,2′-DIFORMYL-4,4′-DIBROMO-3,3′-BITHIOPHENE; 2,3,3-TRICHLOROPROPENAL; 2,3-DICHLORO-4,4,4-TRIFLUOROBUT-2-ENAL; 2,4-DIBROMOTHIAZOLE-5-CARBOXALDEHYDE; 2,4-DICHLORO-1H-INDOLE-3-CARBALDEHYDE; 2,4-DICHLORO-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2,4-DICHLORO-1-PHENYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2,4-DICHLORO-5-THIAZOLECARBOXALDEHYDE; 2,5,6-TRICHLORO-1H-INDOLE-3-CARBALDEHYDE; 2,5-DICHLORO-1H-INDOLE-3-CARBALDEHYDE; 2,5-DICHLORO-1-PHENYL-1H-PYRROLE-3,4-DICARBALDEHYDE; 2,6-DICHLORO-1,4-DIDIHYDROPYRIDINE-3,5-DICARBOXYALDEHYDE; 2,6-DICHLORO-1H-INDOLE-3-CARBALDEHYDE; 2,6-DICHLORO-3-FORMYLPYRIDAZINE; 2,6-DICHLORO-IMIDAZO[1,2-A]PYRIDINE-3-CARBOXALDEHYDE; 2,6-DICHLORO-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXALDEHYDE; 2,7-DICHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-3,5-DICHLOROBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-ETHOXYBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-METHOXYBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-4-METHOXYBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-4-PROPOXYBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-CHLOROBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-METHOXYBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-METHYLBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-NITROBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]-6-CHLOROBENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 2-[(2-BROMOPROP-2-EN-1-YL)OXY]NAPHTHALENE-1-CARBALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3-ETHOXYBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3-METHOXYBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-4-METHOXYBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-4-PROPOXYBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-METHOXYBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-METHYLBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-NITROBENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 2-[(2-CHLOROPROP-2-EN-1-YL)OXY]NAPHTHALENE-1-CARBALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-ETHOXYBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-5-CHLOROBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-5-METHOXYBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-5-NITROBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-6-CHLOROBENZALDEHYDE; 2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-ETHOXYBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-5-CHLOROBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-5-METHOXYBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-5-NITROBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-6-CHLOROBENZALDEHYDE; 2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-5-METHOXYBENZALDEHYDE; 2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 2-[(5-CHLORO-6-OXO-1-PHENYL-1,6-DIHYDROPYRIDAZIN-4-YL)OXY]BENZALDEHYDE; 2-AMINO-4-CHLORO-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-AMINO-4-CHLORO-1-PHENYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-AMINO-4-CHLORO-3-CYANO-5-FORMYLTHIOPHENE; 2-AMINO-4-CHLORO-6-OXO-1H-PYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-CHLOROTHIAZOLE-5-CARBALDEHYDE; 2-AMINO-6-CHLORO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2-AMINO-7-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-5-CARBOXALDEHYDE; 2-AZEPAN-1-YL-4-CHLORO-THIAZOLE-5-CARBALDEHYDE; 2-BIPHENYL-4-YL-6-BROMOIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-BIPHENYL-4-YL-6-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-BROMO-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-BROMO-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-BROMO-2-BUTENAL; 2-BROMO-3-DIMETHYLAMINOACROLEIN; 2-BROMO-3-HYDROXY-2-BUTENE-1,4-DIONE; 2-BROMO-3-HYDROXY-PROPENAL; 2-BROMO-3-ISOPROPOXYACRYLALDEHYDE; 2-BROMO-3-METHYLBUT-2-ENAL; 2-BROMO-4-(4-FLUORO-PHENYL)-5-NITRO-CYCLOHEX-1-ENECARBALDEHYDE; 2-BROMO-5,5-DIMETHYL-CYCLOHEX-1-ENECARBALDEHYDE; 2-BROMO-CYCLOHEX-1-ENECARBALDEHYDE; 2-BROMO-CYCLOPENT-1-ENECARBALDEHYDE; 2-BROMO-PROPENAL; 2-BUTENAL, 3-CHLORO-4-OXO-4-PHENYL-, (E)-; 2-BUTYL-4-CHLORO-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-BUTYL-5-CHLORO-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-BUTYL-5-IODO-3H-IMIDAZOLE-4-CARBALDEHYDE; 2-CHLORO-1-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-1-ETHYL-5-FORMYL-4-METHYL-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBONITRILE; 2-CHLORO-1H-BENZIMIDAZOLE-5-CARBOXALDEHYDE; 2-CHLORO-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-INDOLE-3,5-DICARBALDEHYDE; 2-CHLORO-1-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-1-METHYL-5-PHENYL-1H-PYRROLE-3,4-DICARBALDEHYDE; 2-CHLORO-1-PHENYL-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-1-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 2-CHLORO-3-FORMYL-N,N-DIMETHYL-1H-INDOLE-5-SULFONAMIDE; 2-CHLORO-3-HYDROXY-2-PROPENAL; 2-CHLORO-3-PHENYLPROP-2-ENAL; 2-CHLORO-4-IODO-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-5-(MORPHOLIN-4-YLSULFONYL)-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-(PYRROLIDIN-1-YLSULFONYL)-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-ETHYLCYCLOHEX-1-ENE-1-CARBALDEHYDE; 2-CHLORO-5-HYDROXY-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-HYDROXY-6-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-METHOXY-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-METHOXY-1-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-CHLORO-5-METHYLCYCLOHEX-1-ENE-1-CARBALDEHYDE; 2-CHLORO-5-PHENYLCYCLOHEX-1-ENE-1-CARBALDEHYDE; 2-CHLORO-6-(4-CHLORO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 2-CHLORO-6-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 2-CHLORO-6-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 2-CHLORO-6-METHYL-4A,8A-DIHYDRO-3-QUINOLINECARBALDEHYDE; 2-CHLORO-6-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-8-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLOROACROLEIN; 2-CHLOROCYCLOHEX-1-ENECARBALDEHYDE; 2-CHLOROCYCLOPENT-1-ENECARBALDEHYDE; 2-CHLORO-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-ETHOXY-4-FORMYLPHENYL 4-CHLORO-1-ETHYLPYRAZOLE-3-CARBOXYLATE; 2-ETHYL-5-CHLORO-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-IODO-4-AZAINDOLE-6-CARBOXALDEHYDE; 3-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)OXOLANE-3-CARBALDEHYDE; 3-([(4-BROMOTHIOPHEN-2-YL)METHYL]METHYL)AMINO)-2,2-DIMETHYLPROPANAL; 3-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)PROPANAL; 3-([4-BROMO-3,5-BIS(DIFLUOROMETHYL)-1H-PYRAZOL-1-YL]METHYL)-4-METHOXYBENZALDEHYDE; 3-(2-BROMO-4-CHLOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(2-BROMO-4-FLUOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(2-BROMO-5-CHLOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(2-BROMO-5-FLUOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(2-BROMOPHENYL)-5-CHLORO-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(2-BROMOPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(3-BROMO-1H-INDOL-1-YL)PROPANAL; 3-(3-BROMOPHENYL)-5-CHLORO-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(3-BROMOPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(1-CYCLOPROPYLETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(BUTAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-BUTYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-CYCLOHEXYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-CYCLOPENTYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)-1-TERT-BUTYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(3-BROMOTHIOPHEN-2-YL)PROPANAL; 3-(3-CHLORO-1H-INDOL-1-YL)PROPANAL; 3-(3-TERT-BUTYL-5-CHLORO-4-FORMYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(4-[(2-CHLOROPROP-2-EN-1-YL)OXY]PHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(4-[(2-CHLOROPROP-2-EN-1-YL)OXY]PHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(4-BROMO-2-CHLOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(4-BROMO-2-FLUOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(4-BROMO-3-NITRO-1H-PYRAZOL-1-YL)PROPANAL; 3-(4-BROMOPHENYL)-5-CHLORO-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(4-BROMOPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(4-BROMOTHIOPHEN-2-YL)PROPANAL; 3-(4-CHLORO-3-NITRO-PYRAZOL-1-YLMETHYL)-4-METHOXY-BENZALDEHYDE; 3-(4-CHLORO-PYRAZOL-1-YLMETHOXY)-BENZALDEHYDE; 3-(5-BROMO-1H-PYRAZOL-1-YL)PROPANAL; 3-(5-BROMO-2-CHLOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(5-BROMO-2-FLUOROPHENYL)-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3-(5-BROMO-3-NITRO-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)PROPANAL; 3-(5-CHLORO-1H-PYRAZOL-1-YL)PROPANAL; 3-(5-CHLORO-3-CYCLOPROPYL-4-FORMYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(5-CHLORO-3-ETHYL-4-FORMYL-1H-PYRAZOL-1-YL)BENZONITRILE; 3-(5-CHLORO-3-ETHYL-4-FORMYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(5-CHLORO-4-FORMYL-3-METHYL-1H-PYRAZOL-1-YL)BENZONITRILE; 3-(5-CHLORO-4-FORMYL-3-METHYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(5-CHLORO-4-FORMYL-3-PHENYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(5-CHLORO-4-FORMYL-3-PROPYL-1H-PYRAZOL-1-Yl)BENZONITRILE; 3-(5-CHLORO-4-FORMYL-3-PROPYL-1H-PYRAZOL-1-YL)PROPANENITRILE; 3-(DIMETHYLAMINO)-2-IODOACROLEIN; 3,4-DIBROMO-5-METHYL-2-PYRROLECARBOXALDEHYDE; 3,4-DIBROMOTHIOPHENE-2,5-DICARBOXALDEHYDE; 3,4-DIBROMOTHIOPHENE-2-CARBOXALDEHYDE; 3,4-DICHLORO-2,5-PYRROLEDICARBOXALDEHYDE; 3,5-DIBROMO-1-(2,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(2,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DIBROMO-1H-PYRAZOLE-4-CARBALDEHYDE; 3,5-DIBROMO-2-THIOPHENECARBOXALDEHYDE; 3,5-DICHLORO-1-(2-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(4-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 3,5-DICHLORO-1H-PYRROLE-2,4-DICARBALDEHYDE; 3,5-DICHLORO-1-PHENYL-1H-PYRROLE-2,4-DICARBALDEHYDE; 3,5-DICHLORO-2-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3,5-DICHLORO-2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 3,5-DICHLORO-2-FURANCARBOXALDEHYDE; 3,5-DIIODO-4-METHYL-2-PYRROLECARBOXALDEHYDE; 3-[(2-BROMOPROP-2-EN-1-YL)OXY]-4-METHOXYBENZALDEHYDE; 3-[(2-BROMOPROP-2-EN-1-YL)OXY]-4-NITROBENZALDEHYDE; 3-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-[(2-CHLOROPROP-2-EN-1-YL)OXY]-4-METHOXYBENZALDEHYDE; 3-[(2-CHLOROPROP-2-EN-1-YL)OXY]-4-NITROBENZALDEHYDE; 3-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 3-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-4-NITROBENZALDEHYDE; 3-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-[(4-BROMO-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-BROMO-5-METHYL-3-NITRO-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 3-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-4-NITROBENZALDEHYDE; 3-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-[(4-CHLORO-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-CHLORO-3-NITRO-1H-PYRAZOL-1-YL)METHOXY]BENZALDEHYDE; 3-[(4-CHLORO-5-METHYL-3-NITRO-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-IODO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(5-BROMO-2-OXO-1,2-DIHYDROPYRIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-4-METHOXYBENZALDEHYDE; 3-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 3-[2-(3-BROMOTHIOPHEN-2-YL)-2-OXOETHOXY]BENZALDEHYDE; 3-[5-CHLORO-3-(DIFLUOROMETHYL)-4-FORMYL-1H-PYRAZOL-1-YL]BENZONITRILE; 3-[5-CHLORO-4-FORMYL-3-(PROPAN-2-YL)-1H-PYRAZOL-1-YL]BENZONITRILE; 3-[5-CHLORO-4-FORMYL-3-(PROPAN-2-YL)-1H-PYRAZOL-1-YL]PROPANENITRILE; 3-[5-CHLORO-4-FORMYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]PROPANENITRILE; 3-ALLYL-4-CHLORO-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 3-BENZYL-4-CHLORO-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 3-BENZYLOXYMETHYL-2-BUTYL-5-IODO-3H-IMIDAZOLE-4-CARBALDEHYDE; 3-BROMO INDAZOLE-6-CARBOXALDEHYDE; 3-BROMO-1-(TERT-BUTYLDIMETHYLSILYL)-1H-INDOLE-4-CARBALDEHYDE; 3-BROMO-1H-INDAZOLE-5-CARBALDEHYDE; 3-BROMO-1H-INDOLE-2-CARBALDEHYDE; 3-BROMO-1H-INDOLE-4-CARBALDEHYDE; 3-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 3-BROMO-1-METHYL-1H-INDOLE-2-CARBALDEHYDE; 3-BROMO-2-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-BROMO-2-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-BROMO-2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-2-FORMYLFURAN; 3-BROMO-2-FORMYLPYRROLE; 3-BROMO-4-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-ETHOXYBENZALDEHYDE; 3-BROMO-4-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-METHOXYBENZALDEHYDE; 3-BROMO-4-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-BROMO-4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-ETHOXYBENZALDEHYDE; 3-BROMO-4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-METHOXYBENZALDEHYDE; 3-BROMO-4-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-BROMO-4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-4-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 3-BROMO-4-CHLORO-2-METHYL-1-(4-METHYLPHENYL)-6,7-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 3-BROMO-4-FLUORO-6-AZAINDOLE-7-CARBOXALDEHYDE; 3-BROMO-4-FORMYLTHIOPHENE; 3-BROMO-5-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 3-BROMO-5-FLUORO-1-METHYL-1H-INDOLE-2-CARBALDEHYDE; 3-BROMO-5-FORMYLFURAN-2-YLBORONIC ACID; 3-BROMO-5-ISOXAZOLECARBOXALDEHYDE; 3-BROMO-5-METHYL-2-THIOPHENECARBOXALDEHYDE; 3-BROMO-6-AZAINDOLE-7-CARBOXALDEHYDE; 3-BROMO-BENZO[B]THIOPHENE-2-CARBOXALDEHYDE; 3-BROMO-BENZOFURAN-2-CARBALDEHYDE; 3-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 3-BROMOIMIDAZO[1,2-A]PYRIDINE-6-CARBALDEHYDE; 3-BROMO-IMIDAZO[1,2-A]PYRIDINE-8-CARBOXALDEHYDE; 3-BROMO-PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXALDEHYDE; 3-BROMOTHIOPHENE-2-CARBOXALDEHYDE; 3-CHLORO INDAZOLE-6-CARBOXALDEHYDE; 3-CHLORO-1-BENZOFURAN-2-CARBALDEHYDE; 3-CHLORO-1-BENZOTHIOPHENE-2-CARBALDEHYDE; 3-CHLORO-1-ETHYL-1H-PYRROLE-2-CARBALDEHYDE; 3-CHLORO-1H-INDAZOLE-5-CARBALDEHYDE; 3-CHLORO-1H-INDOLE-2-CARBALDEHYDE; 3-CHLORO-1H-INDOLE-4-CARBALDEHYDE; 3-CHLORO-1H-PYRAZOLO[4,3-C]PYRIDINE-7-CARBALDEHYDE; 3-CHLORO-1H-PYRROLE-2,4-DICARBALDEHYDE; 3-CHLORO-1H-PYRROLE-2-CARBALDEHYDE; 3-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 3-CHLORO-1-METHYL-1H-INDOLE-2-CARBALDEHYDE; 3-CHLORO-1-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 3-CHLORO-1-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 3-CHLORO-2-(4-CHLOROPHENYL)-4,4,4-TRIFLUORBUT-2-ENAL; 3-CHLORO-2-(4-CHLORO-PHENYL)-4,4,4-TRIFLUORO-BUT-2-ENAL; 3-CHLORO-2,3-BIS(4-METHOXYPHENYL)ACRYLALDEHYDE; 3-CHLORO-3-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)ACRYLALDEHYDE; 3-CHLORO-3-(2′-FLUORO[1,1-BIPHENYL]-4-YL)-2-METHYLACRYLALDEHYDE; 3-CHLORO-3-(4-CHLOROPHENYL)ACROLEIN; 3-CHLORO-3-(4-NITROPHENYL)ACRYLALDEHYDE; 3-CHLORO-3-(P-CHLOROPHENYL)ACROLEIN; 3-CHLORO-3-PHENYL-PROPENAL; 3-CHLORO-3-TRIFLUOROMETHYL-2-PHENYL-2-PROPENAL; 3-CHLORO-4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-METHOXYBENZALDEHYDE; 3-CHLORO-4-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 3-CHLORO-4-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 3-CHLORO-5-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 3-CHLORO-5-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-CHLORO-5-PHENYL-5H-PYRAZOLO[4,3-C]PYRIDINE-7-CARBALDEHYDE; 3-CHLORO-6-AZAINDOLE-7-CARBOXALDEHYDE; 3-CHLORO-6-METHOXY-1-BENZOFURAN-2-CARBALDEHYDE; 3-CHLORO-6-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-CHLOROIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 3-CHLOROTHIOPHENE-2-CARBALDEHYDE; 3-CHLOROTHIOPHENE-4-CARBOXALDEHYDE; 3-FORMYL-4-IODOTHIOPHENE; 3-FORMYLPHENYL 3-CHLORO-1-BENZOTHIOPHENE-2-CARBOXYLATE; 3-FORMYLPHENYL 4-CHLORO-1-ETHYLPYRAZOLE-3-CARBOXYLATE; 3-FORMYLPHENYL 4-IODO-1-METHYL-1H-PYRAZOLE-5-CARBOXYLATE; 3-IODO-1H-INDAZOLE-4-CARBALDEHYDE; 3-IODO-1H-INDAZOLE-5-CARBALDEHYDE; 3-IODO-1H-INDAZOLE-6-CARBALDEHYDE; 3-IODO-1H-INDAZOLE-7-CARBALDEHYDE; 3-IODO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-IODO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 3-IODO-4,5-DIMETHYLTHIOPHENE-2-CARBALDEHYDE; 3-IODO-6-AZAINDOLE-7-CARBOXALDEHYDE; 3-IODO-6-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-IODO-IMIDAZO[1,2-A]PYRIDINE-7-CARBALDEHYDE; 3-IODO-IMIDAZO[1,2-A]PYRIDINE-8-CARBALDEHYDE; 3-IODOTHIOPHENE-2-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(1,1-DIOXO-LAMBDA(6)-THIOLAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(1-CYCLOPROPYLETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(2-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(4-METHYLPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(6-METHYLPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(6-METHYLPYRIMIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-CYCLOHEPTYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-CYCLOHEXYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-CYCLOPENTYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-TERT-BUTYL-5-CHLORO-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 4-(([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)METHYL)OXANE-4-CARBALDEHYDE; 4-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-2-METHYLBENZALDEHYDE; 4-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-3,5-DIFLUOROBENZALDEHYDE; 4-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-3-FLUOROBENZALDEHYDE; 4-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-3-METHYLBENZALDEHYDE; 4-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)BENZALDEHYDE; 4-(2-BUTYL-5-FORMYL-4-IODO-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID METHYL ESTER; 4-(3-BROMOTHIEN-2-YL)BENZALDEHYDE; 4-(4-BROMO-1H-PYRAZOL-1-YL)-3-FLUOROBENZALDEHYDE; 4-(4-BROMO-1H-PYRAZOL-1-YL)-3-NITROBENZALDEHYDE; 4-(4-BROMO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-2-METHYLBENZALDEHYDE; 4-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3,5-DIFLUOROBENZALDEHYDE; 4-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3-FLUOROBENZALDEHYDE; 4-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3-METHYLBENZALDEHYDE; 4-(4-CHLORO-1H-PYRAZOL-1-YL)-3-FLUOROBENZALDEHYDE; 4-(4-CHLORO-1H-PYRAZOL-1-YL)-3-NITROBENZALDEHYDE; 4-(4-CHLORO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-2-METHYLBENZALDEHYDE; 4-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3-FLUOROBENZALDEHYDE; 4-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3-METHYLBENZALDEHYDE; 4-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-3-NITROBENZALDEHYDE; 4-(4-CHLORO-PYRAZOL-1-YLMETHYL)-5-METHYL-THIOPHENE-2-CARBALDEHYDE; 4-(4-CHLORO-PYRAZOL-1-YLMETHYL)-THIOPHENE-2-CARBALDEHYDE; 4-(5-CHLORO-3-ETHYL-4-FORMYL-1H-PYRAZOL-1-YL)BENZONITRILE; 4-(5-CHLORO-4-FORMYL-3-METHYL-1H-PYRAZOL-1-YL)BENZONITRILE; 4-(5-CHLORO-4-FORMYL-3-PROPYL-1H-PYRAZOL-1-YL)BENZONITRILE; 4,5-DIBROMO-1H-PYRROLE-2-CARBOXALDEHYDE; 4,5-DIBROMO-1-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4,5-DIBROMO-2-FURALDEHYDE; 4,5-DIBROMO-3-METHYLTHIOPHENE-2-CARBALDEHYDE; 4,5-DIBROMOTHIOPHENE-2-CARBOXALDEHYDE; 4,5-DICHLORO-3-THIOPHENECARBOXALDEHYDE; 4,6,8-TRICHLORO-3-FORMYLCOUMARIN; 4,6-DICHLORO-2H-1-BENZOTHIINE-3-CARBALDEHYDE; 4,6-DICHLORO-2H-BENZOPYRAN-3-CARBOXALDEHYDE; 4,6-DICHLORO-2-METHYL-2H-1-BENZOTHIINE-3-CARBALDEHYDE; 4,6-DICHLORO-3-FORMYL-7-METHYLCOUMARIN; 4,6-DICHLORO-3-FORMYLCOUMARIN; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3,5-DIMETHOXYBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3,5-DIMETHYLBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-CHLORO-5-METHOXYBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-CHLOROBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-ETHOXYBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-METHOXYBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-3-NITROBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]-5-METHOXY-2-NITROBENZALDEHYDE; 4-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3,5-DIMETHOXYBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3,5-DIMETHYLBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3-ETHOXYBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3-METHOXYBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-3-NITROBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]-5-METHOXY-2-NITROBENZALDEHYDE; 4-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-CHLORO-5-METHOXYBENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-CHLOROBENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-ETHOXYBENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]-3-NITROBENZALDEHYDE; 4-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-CHLORO-5-METHOXYBENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-CHLOROBENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-ETHOXYBENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-3-NITROBENZALDEHYDE; 4-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 4-[(4-CHLORO-1H-PYRAZOL-1-YL)METHOXY]BENZALDEHYDE; 4-[(4-CHLORO-3-NITRO-1H-PYRAZOL-1-YL)METHOXY]BENZALDEHYDE; 4-[(4-CHLORO-3-NITRO-1H-PYRAZOL-1-YL)METHYL]-3-METHOXYBENZALDEHYDE; 4-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-3,5-DIMETHYLBENZALDEHYDE; 4-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]-3-METHOXYBENZALDEHYDE; 4-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 4-[2-(3-BROMOTHIOPHEN-2-YL)-2-OXOETHOXY]-3-CHLOROBENZALDEHYDE; 4-[2-(3-BROMOTHIOPHEN-2-YL)-2-OXOETHOXY]BENZALDEHYDE; 4-[5-CHLORO-3-(DIFLUOROMETHYL)-4-FORMYL-1H-PYRAZOL-1-YL]BENZONITRILE; 4-[5-CHLORO-4-FORMYL-3-(PROPAN-2-YL)-1H-PYRAZOL-1-YL]BENZONITRILE; 4-AMINO-5-CHLORO-1H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-1-(4-CHLOROBENZYL)-1H-PYRAZOLE-5-CARBALDEHYDE; 4-BROMO-1-(4-CHLOROPHENYL)-1H-PYRAZOLE-5-CARBOXALDEHYDE; 4-BROMO-1-(4-METHYLBENZYL)-1H-PYRAZOLE-5-CARBOXALDEHYDE; 4-BROMO-1-ETHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-1H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-1H-PYRAZOLE-5-CARBALDEHYDE; 4-BROMO-1H-PYRROLE-2-CARBALDEHYDE; 4-BROMO-1-METHYL-1H-IMIDAZOLE-5-CARBOXALDEHYDE; 4-BROMO-1-METHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-1-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-BROMO-1-PROPYL-1H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-2-(4-BROMO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-BROMO-2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-BROMO-2-(4-CHLORO-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-BROMO-2-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)BENZALDEHYDE; 4-BROMO-2,3-THIOPHENEDICARBOXALDEHYDE; 4-BROMO-2,5-BIS(ETHYLSULFANYL)-3-THIOPHENECARBALDEHYDE; 4-BROMO-2-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 4-BROMO-2-ETHYL-2H-PYRAZOLE-3-CARBALDEHYDE; 4-BROMO-2-FORMYLTHIAZOLE; 4-BROMO-2-FORMYLTHIOPHEN-3-YLBORONIC ACID; 4-BROMO-2-FURALDEHYDE; 4-BROMO-3,5-DIMETHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-BROMO-3-FORMYL-PYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER; 4-BROMO-3-FORMYLTHIOPHEN-2-YLBORONIC ACID; 4-BROMO-3-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-BROMO-3-METHYLTHIOPHENE-2-CARBALDEHYDE; 4-BROMO-5-(4-METHYL-PYRIMIDIN-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE; 4-BROMO-5,6-DIHYDRO-2H-PYRAN-3-CARBALDEHYDE; 4-BROMO-5-[(4-CHLOROPHENYL)THIO]-2-FURALDEHYDE; 4-BROMO-5-[(4-METHYLPHENYL)THIO]-2-FURALDEHYDE; 4-BROMO-5-ETHYL-THIOPHENE-2-CARBALDEHYDE; 4-BROMO-5-FORMYL-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXYLIC ACID BENZYL ESTER; 4-BROMO-5-METHYLTHIOPHENE-2-CARBALDEHYDE; 4-BROMO-5-MORPHOLIN-4-YL-2-FURALDEHYDE; 4-BROMO-5-NITRO-2-THIOPHENECARBOXALDEHYDE; 4-BROMO-5-PROPYLTHIOPHENE-2-CARBALDEHYDE; 4-BROMO-PENT-4-ENAL; 4-BROMOTHIAZOLE-5-CARBALDEHYDE; 4-BROMOTHIOPHENE-2-CARBOXALDEHYDE; 4-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 4-CHLORO-1,3-DIMETHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-1-ETHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 4-CHLORO-1-ETHYL-1H-PYRAZOLE-5-CARBOXALDEHYDE; 4-CHLORO-1-ETHYL-3-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-1-ETHYLPYRAZOLE-3-CARBALDEHYDE; 4-CHLORO-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-1-METHYL-1H-PYRAZOLE-3-CARBALDEHYDE; 4-CHLORO-1-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-1-PROPYL-1H-PYRAZOLE-3-CARBALDEHYDE; 4-CHLORO-2-(1-ACETYL-4-PIPERAZINYL)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(1-METHYL-4-PIPERAZINYL)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(1-METHYLIMIDAZOLYL-2-THIO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(1-PHENYL-ETHYLAMINO)-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(1-PIPERIDIN-4-OL)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(1-PIPERIDINO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(1-PYRROLIDINO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(2,4-DICHLOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(2,4-DIFLUOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(2,6-DIMETHYLPHENYL)-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(2-BENZOXAZOLYLTHIO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(2-CHLOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(2-FLUOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3,4-DICHLOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3,4-DIFLUOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL)-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(3,4-DIMETHOXYPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3,4-DIMETHYLPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3-CHLOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3-FLUOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(3-NITROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(4-BROMOHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-CARBOMETHOXYL-1-PIPERIDINYL)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-CHLOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-FLUOROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-FLUOROPHENYL)THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(4-METHOXYPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-METHYLPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-METHYLPYRIMIDINYL-2-THIO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-MORPHOLINO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-NITROPHENOXY)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-OXO-PIPERIDINYL)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-(4-PHENYL-PIPERAZIN-1-YL)-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(DIETHYLAMINO)-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(DIMETHYLAMINO)-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(PHENYLTHIO)-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-(TERT-BUTYLAMINO)-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-[(2,6-DIETHYLPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(2-CHLOROPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(2-METHOXYPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(2-METHYLPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(3-CHLORO-4-METHYLPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(4-CHLOROPHENYL)SULFANYL]-1-PHENYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(4-METHOXYPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(4-METHYLPHENYL)AMINO]-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-[(N-METHYL-N′-3-PHENYLPROPYL)AMINO]-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-[2-(TRIFLUOROMETHYL)PHENOXY]-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-[3-(TRIFLUOROMETHYL)PHENOXY]-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-[4-(TRIFLUOROMETHYL)PHENOXY]-5-THIAZOLECARBOXALDEHYDE; 4-CHLORO-2-ETHOXY-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-FORMYLPHENYL 4-BROMO-1-METHYL-1H-PYRAZOLE-3-CARBOXYLATE; 4-CHLORO-2-FURANCARBOXALDEHYDE; 4-CHLORO-2H-THIOCHROMENE-3-CARBALDEHYDE; 4-CHLORO-2-METHOXY-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-METHOXY-1-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-METHYL-1-(3-TRIFLUOROMETHYL-PHENYL)-6,7-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 4-CHLORO-2-METHYL-1-(4-METHYLPHENYL)-6,7-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 4-CHLORO-2-MORPHOLIN-1YL-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-OXO-2,3-DIHYDROTHIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-2-OXO-3-PHENYL-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-OXO-3-PROPYL-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-PHENOXY-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-PHENYLAMINO-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-2-PHENYLTHIAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-(2-CHLOROETHYL)-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-(3-METHYLPHENYL)-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-(4-METHYLPHENYL)-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-ETHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-FORMYL-2H-BENZO[H]CHROMENE; 4-CHLORO-3-FORMYL-2-THIOPHENEBORONIC ACID; 4-CHLORO-3-FORMYL-6-METHYLCOUMARIN; 4-CHLORO-3-FORMYLPYRAZOLE; 4-CHLORO-3-METHYL-1,6-DIPHENYL-6,7-DIHYDRO-1H-INDAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-METHYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-CHLORO-3-METHYL-1-PROPYL-1H-PYRAZOLE-5-CARBALDEHYDE; 4-CHLORO-3-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-CHLORO-5-FORMYL-3,6,6-TRIMETHYL-6,7-DIHYDRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER; 4-CHLORO-5-FORMYL-3-METHYL-6,7-DIHYDRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER; 4-CHLORO-5-NITRO-2-FURANCARBOXALDEHYDE; 4-CHLORO-6-FLUORO-2H-1-BENZOTHIINE-3-CARBALDEHYDE; 4-CHLORO-6-FLUORO-2H-BENZOPYRAN-3-CARBOXALDEHYDE; 4-CHLORO-6-FLUORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-6-METHYL-2H-THIOCHROMENE-3-CARBALDEHYDE; 4-CHLORO-9-METHYL-2,9-DIHYDRO-1H-CARBAZOLE-3-CARBOXALDEHYDE; 4-CHLOROTHIAZOLE-5-CARBOXALDEHYDE; 4-CHLOROTHIOPHENE-2-CARBALDEHYDE; 4-FORMYL-2-METHOXYPHENYL 3-CHLORO-1-BENZOTHIOPHENE-2-CARBOXYLATE; 4-FORMYL-2-METHOXYPHENYL 4-CHLORO-1-ETHYLPYRAZOLE-3-CARBOXYLATE; 4-FORMYLPHENYL 4-BROMO-1-METHYL-1H-PYRAZOLE-3-CARBOXYLATE; 4-FORMYLPHENYL 4-CHLORO-1-ETHYLPYRAZOLE-3-CARBOXYLATE; 4-FORMYLPHENYL 4-IODO-1-METHYL-1H-PYRAZOLE-3-CARBOXYLATE; 4-IODO-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-IODO-1H-PYRROLE-2-CARBALDEHYDE; 4-IODO-1-METHYL-1H-IMIDAZOLE-5-CARBOXALDEHYDE; 4-IODO-2,5-DIMETHYLTHIOPHENE-3-CARBALDEHYDE; 4-IODO-2-THIOPHENECARBALDEHYDE; 5-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)FURAN-2-CARBALDEHYDE; 5-(1-CHLOROETHENYL)-1H-PYRROLE-2-CARBOXALDEHYDE; 5-(4-BROMO-1H-PYRAZOL-1-YL)-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-(4-BROMO-3,5-BIS-DIFLUOROMETHYL-PYRAZOL-1-YLMETHYL)-FURAN-2-CARBALDEHYDE; 5-(4-BROMO-3-NITRO-PYRAZOL-1-YLMETHYL)-FURAN-2-CARBALDEHYDE; 5-(4-CHLORO-1H-PYRAZOL-1-YL)-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-(4-CHLORO-PYRAZOL-1-YLMETHYL)-FURAN-2-CARBALDEHYDE; 5-[(4-CHLORO-3-NITRO-1H-PYRAZOL-1-YL)METHYL]-2-FURALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2,6-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUORO-4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUORO-5-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(3,5-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(3-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-ETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-FLUORO-3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-[4-(1-METHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(1,1-DIMETHYLETHYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DICHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(2,6-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,4-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DICHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(2,6-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2,5-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLORO-4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLORO-5-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLORO-6-FLUOROBENZYL)-1,6-DIHYDRO-6-OXOPYRIDINE-3-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(2,3-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(2,6-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-CHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-FLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(2-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DICHLOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-BROMO-1-(3,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DICHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,4-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DICHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3,5-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLORO-4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(2,3-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(2,6-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-CHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-FLUOROPHENYL)-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(3-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(2,3-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(2,6-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-CHLOROPHENYL)-3-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-FLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-METHOXYBENZYL)PYRROLE-2-CARBALDEHYDE; 5-BROMO-1-(4-METHYLBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-BROMO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-(4-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1H-PYRAZOLE-3-CARBALDEHYDE; 5-BROMO-1H-PYRROLE-2-CARBALDEHYDE; 5-BROMO-1H-PYRROLE-3-CARBALDEHYDE; 5-BROMO-1-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-BROMO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-BROMO-1-METHYL-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-[4-(1-METHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-METHYL-3-PROPYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-PHENYL-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-PHENYL-3-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-PHENYL-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-PHENYL-3-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-1-PHENYL-3-PROPYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-2-[(2-BROMOPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 5-BROMO-2-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 5-BROMO-2-[(3-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 5-BROMO-2-[(4-BROMOTHIOPHEN-2-YL)METHOXY]BENZALDEHYDE; 5-BROMO-2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 5-BROMO-2-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 5-BROMO-2-METHYL-2H-INDAZOLE-3-CARBALDEHYDE; 5-BROMO-2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 5-BROMO-3-(2,3,4-TRIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,3-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,4-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,5-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2,6-DIMETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMO-4-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMO-4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMO-5-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMO-5-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMOPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-BROMOPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-4-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-5-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLORO-6-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-ETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-ETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUORO-4-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUORO-4-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUORO-5-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUORO-5-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-METHYLPROPYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(2-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,4-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DICHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIMETHYLPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3,5-DIMETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-BROMOPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-BROMOPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUORO-4-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUORO-4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(3-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-BROMO-2-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-BROMO-2-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-BROMOPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-BROMOPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLORO-3-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLORO-3-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-ETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-ETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-ETHYLPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-ETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUORO-3-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUORO-3-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(4-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(5-BROMO-2-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-(5-BROMO-2-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-[4-(1-METHYLETHYL)PHENYL]-1H-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-CHLORO-1-BENZOFURAN-2-CARBALDEHYDE; 5-BROMO-3-ETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-ETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-ETHYL-4-METHYL-PYRROLE-2-CARBOXALDEHYDE; 5-BROMO-3-ETHYL-IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 5-BROMO-3-FORMYL-PYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER; 5-BROMO-3H-IMIDAZOLE-4-CARBALDEHYDE; 5-BROMO-3-METHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-PHENYL-1-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-PHENYL-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-3-PHENYL-1-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-BROMO-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2,6-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUORO-4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUORO-5-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(3,5-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(3-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-ETHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-FLUORO-3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-[4-(1-METHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIMETHYLETHYL)-3-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(1,1-DIOXIDOTETRAHYDROTHIEN-3-YL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1,1-DIOXO-1LAMBDA(6)-THIOLAN-3-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1,1-DIOXO-1LAMBDA(6)-THIOLAN-3-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1,1-DIOXO-LAMBDA(6)-THIOLAN-3-YL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(1-CYCLOPROPYLETHYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DICHLOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,4-DIFLUOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHOXY-BENZYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHYLPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHYLPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHYLPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,4-DIMETHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2,5-DIMETHYLPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,5-DIMETHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,5-DIMETHYLPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,5-DIMETHYLPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2,5-DIMETHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLORO-4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLORO-5-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLORO-6-FLUOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-CHLOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; CHLORO-1-(2-FLUOROPHENYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; CHLORO-1-(2-FLUOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-FLUOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHOXYPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHOXYPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHOXYPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; CHLORO-1-(2-METHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; CHLORO-1-(2-METHYLPROPYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHYLPROPYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHYLPROPYL)-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-METHYLPROPYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(2-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; CHLORO-1-(3,4-DICHLOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,4-DICHLOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,4-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DICHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIFLUOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIFLUOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIFLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIFLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3,5-DIMETHYLPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,5-DIMETHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,5-DIMETHYLPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,5-DIMETHYLPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3,5-DIMETHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLORO-4-METHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-CHLOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-FLUOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHOXYBENZYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYL-1,1-DIOXO-1LAMBDA6-THIOLAN-3-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYL-1,1-DIOXO-1LAMBDA6-THIOLAN-3-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLBUTYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLBUTYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLBUTYL)-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLBUTYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-METHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(3-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4,6-DIMETHOXYPYRIMIDIN-2-YL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-CHLOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-FLUOROBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-FLUOROPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLBENZYL)-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-1-(4-METHYLPHENYL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLPHENYL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLPYRIDIN-2-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLPYRIDIN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-METHYLPYRIDIN-2-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(4-NITROPHENYL)-3-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-CHLOROPYRIDAZIN-3-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIDAZIN-3-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIDAZIN-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIDAZIN-3-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIMIDIN-4-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIMIDIN-4-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(6-METHYLPYRIMIDIN-4-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PENTAN-3-YL)-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PENTAN-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PENTAN-3-YL)-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PENTAN-3-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PROPAN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PROPAN-2-YL)-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PYRIDIN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PYRIDIN-4-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-(PYRIMIDIN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1,3-BIS(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1,3-DIETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1,3-DIMETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1,3-DIMETHYL-2,4,7-TRIOXO-8-PHENYL-1,2,3,4,7,8-HEXAHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXALDEHYDE; 5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1,3-DIPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[(4-METHYLPHENYL)METHYL]-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[(4-METHYLPHENYL)METHYL]-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(DIMETHYLAMINO)ETHYL]-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEPTYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOHEXYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-(DIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-CYCLOPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-CYCLOPENTYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-(METHOXYMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-ETHYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1H-PYRROLE-2,4-DICARBALDEHYDE; 5-CHLORO-1H-PYRROLE-2-CARBALDEHYDE; 5-CHLORO-1-ISOBUTYL-3-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-1H-PYRROLE-2,4-DICARBALDEHYDE; 5-CHLORO-1-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-([(4-METHYLPHENYL)SULFANYL]METHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-[(PHENYLSULFANYL)METHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-[2-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-[4-(1-METHYLETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-[4-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-METHYL-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-METHYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-PHENYL-3-(2,3,4-TRIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-PHENYL-3-(4-PROPYLPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-1-PHENYL-3-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-PHENYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-PHENYL-3-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-1-PROPYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-(DIMETHYLAMINO)-1-(4-FLUOROPHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-(DIMETHYLAMINO)-1-(4-METHYLPHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-(DIMETHYLAMINO)-1-PHENYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-[(2-CHLOROPROP-2-EN-1-YL)OXY]BENZALDEHYDE; 5-CHLORO-2-[(5-CHLORO-1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE; 5-CHLORO-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-2-OXO-3-PHENYL-2,3-DIHYDRO-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-PHENYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-PHENYL-3H-IMIDAZOLE-4-CARBALDEHYDE; 5-CHLORO-2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 5-CHLORO-3-([(4-CHLOROPHENYL)SULFANYL]METHYL)-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(2,3-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,3-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,4-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,5-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2,6-DIMETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-4-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-4-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-4-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-4-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-5-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-5-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-5-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-5-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-5-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-6-FLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-6-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLORO-6-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-ETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-ETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUORO-4-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUORO-4-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUORO-5-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUORO-5-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-METHYLPROPYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(2-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,4-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DICHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DICHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIFLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIMETHOXYPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIMETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIMETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIMETHYLPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3,5-DIMETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUORO-4-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUORO-4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(3-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLORO-3-NITROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLORO-3-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-(1,1-DIMETHYLETHYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-CHLOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-ETHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-ETHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-ETHYLPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-ETHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUORO-3-NITROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUORO-3-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUOROPHENYL)-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUOROPHENYL)-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUOROPHENYL)-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-METHOXYPHENYL)-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-METHYLPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(4-NITROPHENYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2,4-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2,5-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(3,5-DIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(4,6-DIMETHYLPYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(4-METHYLPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(6-METHYLPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(6-METHYLPYRIMIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-[(4-METHYLPHENYL)METHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-[2-(DIMETHYLAMINO)ETHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(DIFLUOROMETHYL)-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(2-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(4-METHYLPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(6-METHYLPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(6-METHYLPYRIMIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-[(4-METHYLPHENYL)METHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(METHOXYMETHYL)-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(PROPAN-2-YL)-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(PROPAN-2-YL)-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(PROPAN-2-YL)-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(PROPAN-2-YL)-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-[2-(DIMETHYLAMINO)-1-FORMYLVINYL]-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1-METHYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-[4-(1,1-DIMETHYLETHYL)PHENYL]-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-[4-(1-METHYLETHYL)PHENYL]-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-(1-CYCLOPROPYLETHYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-[2-(DIMETHYLAMINO)ETHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-CYCLOPROPYL-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2,4,6-TRIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2-METHYLPROPYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(3-METHYL-1,1-DIOXO-1LAMBDA6-THIOLAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(4-METHYLPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(6-METHYLPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(6-METHYLPYRIMIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(7H-PURIN-6-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-[(4-METHYLPHENYL)METHYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-ETHYL-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(2,4,6-TRIMETHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(2-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(3-METHYL-1,1-DIOXO-1LAMBDA6-THIOLAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(3-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(3-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(4-METHYLBENZYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(4-METHYLPYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(6-METHYLPYRIDAZIN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(6-METHYLPYRIMIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(7H-PURIN-6-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(PENTAN-3-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-[5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-METHYL-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PHENYL-1-(PROPAN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PHENYL-1-PROPYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PROPYL-1-(PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PROPYL-1-(PYRIDIN-4-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PROPYL-1-(PYRIMIDIN-2-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-CHLORO-3-PROPYLIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 5-CHLORO-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 5-IODO-1H-PYRROLE-2-CARBALDEHYDE; 5-IODO-6-OXO-1,6-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-TERT-BUTYL-2-CHLORO-3-HYDROXYMETHYLENE-CYCLOHEX-1-ENE CARBOXALDEHYDE; 5-TERT-BUTYL-2-CHLOROCYCLOHEX-1-ENE-1-CARBALDEHYDE; 6-([(4-BROMOTHIOPHEN-2-YL)METHYL](METHYL)AMINO)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE; 6-(4-BROMO-1H-PYRAZOL-1-YL)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE; 6-(4-CHLORO-1H-PYRAZOL-1-YL)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE; 6,8-DIBROMOIMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE; 6,8-DICHLORO-IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 6-[(2-BROMOPROP-2-EN-1-YL)OXY]-2H-1,3-BENZODIOXOLE-5-CARBALDEHYDE; 6-[(2-CHLOROPROP-2-EN-1-YL)OXY]-2H-1,3-BENZODIOXOLE-5-CARBALDEHYDE; 6-[(4-BROMOTHIOPHEN-2-YL)METHOXY]-2H-1,3-BENZODIOXOLE-5-CARBALDEHYDE; 6-BROMO-2-(3,4-DIMETHOXYPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(3-METHOXY-PHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(3-NITROPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(4-BROMOPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(4-CHLOROPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(4-FLUOROPHENYL)-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(4-METHOXYPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(4-NITROPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 6-BROMO-2-METHYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-METHYLPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBALDEHYDE; 6-BROMO-2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-P-TOLYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBOXALDEHYDE; 6-BROMO-3-FORMYL-PYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER; 6-BROMO-4-CHLORO-3-FORMYLCOUMARIN; 6-BROMO-7-METHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-8-(DIMETHYLAMINO)IMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE; 6-BROMO-8-FLUOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMOIMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE; 6-BROMO-IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 6-BROMOIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-BROMOIMIDAZO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 6-BROMO-IMIDAZO[1,2-B]PYRIDAZINE-2-CARBOXYALDEHYDE; 6-CHLORO-1,3-BIS(2-METHOXYETHYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-1,3-DIISOBUTYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-2-(2,4-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(2,5-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3,4-DIMETHOXY-PHENYL)-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3,4-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3-CHLORO-PHENYL)-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3-FLUORO-PHENYL)-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3-METHOXY-PHENYL)-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(3-NITRO-PHENYL)-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(4-CHLOROPHENYL)IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(4-FLUORO-PHENYL)-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(4-METHOXY-PHENYL)-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-(4-NITRO-PHENYL)-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2,3-DIMETHYL-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXALDEHYDE; 6-CHLORO-2-CYCLOBUTYL-IMIDAZO[1,2-B]PYRIDAZINE-3-CARBALDEHYDE; 6-CHLORO-2-CYCLOPROPYL-IMIDAZO[1,2-B]PYRIDAZINE-3-CARBALDEHYDE; 6-CHLORO-2-METHYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-METHYL-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXALDEHYDE; 6-CHLORO-2-M-TOLYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-PHENYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-P-TOLYL-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-3-METHYL-5-PHENYL-5H-ISOXAZOLO[5,4-B]PYRROLO[2,3-E]PYRIDINE-7-CARBALDEHYDE; 6-CHLORO-3-METHYL-IMIDAZO[2,1-B]THIAZOLE-5-CARBOXALDEHYDE; 6-CHLORO-5-FORMYL-1-(2-METHOXY-ETHYL)-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-1-(3-METHOXY-PROPYL)-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-1,3-DIMETHYLURACIL; 6-CHLORO-5-FORMYL-1,4-DIMETHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-1-ISOBUTYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-1-ISOPROPYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-4-METHYL-1-(3-METHYL-BUTYL)-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-4-METHYL-2-OXO-1-(TETRAHYDRO-FURAN-2-YLMETHYL)-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-5-FORMYL-4-METHYL-2-OXO-1-PROPYL-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-CHLORO-IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 6-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 6-CHLOROIMIDAZO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 6-CHLORO-IMIDAZO[1,2-B]PYRIDAZINE-2-CARBOXALDEHYDE; 6-CHLOROIMIDAZO[1,2-B]PYRIDAZINE-3-CARBALDEHYDE; 6-CHLOROIMIDAZO[2,1-B]THIAZOLE-5-CARBOXALDEHYDE; 7-BROMO-1-CHLORO-3,4-DIHYDRO-NAPHTHALENE-2-CARBALDEHYDE; 7-BROMO-2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-BROMO-2-CHLORO-8-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-BROMO-2-METHYL-2H-INDAZOLE-3-CARBALDEHYDE; 7-BROMO-2-METHYL-H-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 7-BROMO-2-PHENYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 7-BROMO-3-FORMYL-PYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER; 7-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 7-BROMO-IMIDAZO[1,5-A]PYRIDINE-1-CARBALDEHYDE; 7-CHLORO-2-(4-CHLOROPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 7-CHLORO-2-METHYL-H-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 7-CHLORO-5-OXO-5H-THIAZOLO[3,2-A]PYRIMIDINE-6-CARBALDEHYDE; 8-BROMO-6-CHLOROIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 8-BROMO-6-METHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 8-BROMOIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 8-CHLORO-6-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; 8-CHLORO-IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE; ALPHA-BROMO-5-NITRO-2-THIOPHENEACROLEIN; ALPHA-BROMOCINNAMALDEHYDE; ALPHA-BROMOCINNAMALDEHYDE; ALPHA-CHLOROCINNAMALDEHYDE; ETHYL (4-CHLORO-5-FORMYL-2-PHENYL-1H-IMIDAZOL-1-YL)ACETATE; ETHYL 2-(5-CHLORO-4-FORMYL-3-METHYL-1H-PYRAZOL-1-YL)-3,3-BIS(METHYLSULFANYL)ACRYLATE; ETHYL 2-(5-CHLORO-4-FORMYL-3-METHYL-1H-PYRAZOL-1-YL)ACETATE; ETHYL 2-ANILINO-4-CHLORO-5-FORMYL-3-THIOPHENECARBOXYLATE; ETHYL 4-CHLORO-5-FORMYL-2-(METHYLAMINO)-3-THIOPHENECARBOXYLATE; ETHYL 4-CHLORO-5-FORMYL-2-METHYL-3-THIOPHENECARBOXYLATE; ETHYL 4-CHLORO-5-FORMYL-3-(METHYLTHIO)-6,7-DIHYDRO-2-BENZOTHIOPHENE-1-CARBOXYLATE; ETHYL 4-CHLORO-5-FORMYL-3-METHYL-6,7-DIHYDRO-1-BENZOFURAN-2-CARBOXYLATE; ETHYL 4-CHLORO-7-FORMYL-5-METHYLPYRROLO[2,1-F][1,2,4]TRIAZINE-6-CARBOXYLATE; ETHYL 5-CHLORO-4-FORMYL-1-METHYL-1H-PYRAZOLE-3-CARBOXYLATE; ETHYL 5-CHLORO-4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLATE; ETHYL 6-CHLORO-4-(4-CHLOROPHENYL)-5-FORMYL-2-METHYL-1,4-DIHYDRO-3-PYRIDINECARBOXYLATE; METHYL 4-BROMO-5-FORMYL-2-THIOPHENECARBOXYLATE; METHYL 5-CHLORO-4-FORMYL-1-METHYL-1H-PYRAZOLE-3-CARBOXYLATE; METHYL 5-CHLORO-4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLATE; N-[(2E)-3-ALLYL-4-CHLORO-5-FORMYL-1,3-THIAZOL-2(3H)-YLIDENE]BENZENESULFONAMIDE; N-[(2E)-3-ALLYL-4-CHLORO-5-FORMYL-1,3-THIAZOL-2(3H)-YLIDENE]THIOPHENE-2-SULFONAMIDE; N-PHENYL-3-FORMYL-4-CHLORO-5-(2-CHLOROETHYL)-6-OXO-1,6-DIHYDROPYRIDINE; TERT-BUTYL 4-FORMYL-3-IODO-1H-INDAZOLE-1-CARBOXYLATE; TERT-BUTYL 5-FORMYL-3-IODO-1H-INDAZOLE-1-CARBOXYLATE; TERT-BUTYL 6-FORMYL-3-IODO-1H-INDAZOLE-1-CARBOXYLATE; TERT-BUTYL 7-FORMYL-3-IODO-1H-INDAZOLE-1-CARBOXYLATE; Primary amine: (2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETYL)UREA; (2-AMINO-1H-IMIDAZOL-4-YL)-ACETALDEHYDE HCL; (2-AMINO-6-METHOXY-PHENYL)-ACETALDEHYDE; (2-AMINOPHENYL)CYCLOHEXYL-METHANONE; (2R)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)ACETIC ACID; (2R)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)ACETIC ACID; (2R)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOIC ACID; (2R)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANOIC ACID; (2S)-1-(3-FORMYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)PYRROLIDINE-2-CARBOXAMIDE; (2S)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)ACETIC ACID; (2S)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)ACETIC ACID; (2S)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOIC ACID; (2S)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANOIC ACID; (3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)UREA; (3R)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANENITRILE; (3R)-3-AMINO-3-(4-FORMYL(2-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(5-FORMYL(2-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(5-FORMYL(3-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(6-FORMYL(2-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANENITRILE; (3R)-3-AMINO-3-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANENITRILE; (3S)-3-AMINO-3-(4-FORMYL(2-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(5-FORMYL(2-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(5-FORMYL(3-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(6-FORMYL(2-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANENITRILE; (3S)-3-AMINO-3-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANENITRILE; (4-AMINO-PHENYL)-ACETALDEHYDE; (4R)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOIC ACID; (4S)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOIC ACID; (5-FORMYLPYRIMIDIN-2-YL)METHANAMINIUM CHLORIDE; (5R)-5-AMINO-5-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PENTANOIC ACID; (5S)-5-AMINO-5-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PENTANOIC ACID; (E)-3-(5-AMINOFURAN-2-YL)ACRYLALDEHYDE; (S)-4-N-CBZ-AMINO-4-FORMYL BUTYLAMIDE; (Z)-B-AMINOACROLEIN; [2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETYL]UREA; [2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)ACETYL]UREA; [2-(2-CHLORO-4-FORMYLPHENOXY)ACETYL]UREA; [2-(2-ETHOXY-4-FORMYLPHENOXY)ACETYL]UREA; [2-(2-ETHOXY-6-FORMYLPHENOXY)ACETYL]UREA; [2-(2-FORMYL-4-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-4-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYL-4-NITROPHENOXY)ACETYL]UREA; [2-(2-FORMYL-5-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-5-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYL-6-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-6-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYLPHENOXY)ACETYL]UREA; [2-(2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(3-CHLORO-2-FORMYLPHENOXY)ACETYL]UREA; [2-(3-CHLORO-2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(3-FORMYLPHENOXY)ACETYL]UREA; [2-(3-FORMYLPHENOXY)PROPANOYL]UREA; [2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(3-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(4-CHLORO-2-FORMYLPHENOXY)ACETYL]UREA; [2-(4-CHLORO-2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETYL]UREA; [2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2-METHOXYPHENOXY)ACETYL]UREA; [2-(4-FORMYL-2-METHOXYPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2-NITROPHENOXY)ACETYL]UREA; [2-(4-FORMYLPHENOXY)ACETYL]UREA; [2-(4-FORMYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(4-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(5-FORMYL-2-METHOXYPHENOXY)ACETYL]UREA; [2-(5-FORMYL-2-METHOXYPHENOXY)PROPANOYL]UREA; [2-(5-FORMYL-2-NITROPHENOXY)ACETYL]UREA; [3-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [3-(3-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [3-(4-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; 1-(2,6-DIFLUORO-4-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(2,6-DIFLUORO-4-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(2,6-DIFLUORO-4-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(2,6-DIFLUORO-4-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(2-AMINOETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(2-FLUORO-4-FORMYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(2-FLUORO-4-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(2-FLUORO-4-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(2-FLUORO-4-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(2-FLUORO-4-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(2-FORMYL-4-NITROPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(2-FORMYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(2-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(2-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(2-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(2-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(2-OXOETHYL)PIPERIDINE-3-CARBOXAMIDE; 1-(2-OXOETHYL)PIPERIDINE-4-CARBOXAMIDE; 1-(2-OXOETHYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(3-AMINO-PROPYL)-1H-IMIDAZOLE-2-CARBALDEHYDE HCL; 1-(3-CHLORO-2-FORMYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(3-CHLORO-2-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(3-CHLORO-2-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(3-CHLORO-2-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(3-CHLORO-2-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL)PYRROLIDINE-2-CARBOXAMIDE; 1-(3-OXOPROPYL)PIPERIDINE-2-CARBOXAMIDE; 1-(3-OXOPROPYL)PIPERIDINE-3-CARBOXAMIDE; 1-(3-OXOPROPYL)PIPERIDINE-4-CARBOXAMIDE; 1-(3-OXOPROPYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FLUORO-2-FORMYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(4-FLUORO-2-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(4-FLUORO-2-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(4-FLUORO-2-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(4-FLUORO-2-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)PIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)PIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-2-NITROPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYLPHENYL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYLPHENYL)PIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYLPHENYL)PIPERIDINE-3-CARBOXAMIDE; 1-(4-FORMYLPHENYL)PIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(5-BROMO-2-FORMYLPHENYL)PYRROLIDINE-2-CARBOXAMIDE; 1-(5-FORMYL-2-METHOXYBENZYL)PIPERIDINE-4-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)-6-METHYLPIPERIDINE-3-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)PIPERIDINE-2-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)PIPERIDINE-3-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)PIPERIDINE-4-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)PYRROLIDINE-2-CARBOXAMIDE; 1-(5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)PIPERIDINE-2-CARBOXAMIDE; 1-(5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)PIPERIDINE-3-CARBOXAMIDE; 1-(5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)PIPERIDINE-4-CARBOXAMIDE; 1-(5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)PYRROLIDINE-2-CARBOXAMIDE; 1-(5-FORMYLPYRIMIDIN-2-YL)ETHANAMINIUM CHLORIDE; 1-[(5-FORMYL-2-METHOXYPHENYL)METHYL]PYRROLIDINE-2-CARBOXAMIDE; 1-AMINO-9,10-DIOXO-9,10-DIHYDRO-2-ANTHRACENECARBALDEHYDE; 1-AMINONAPHTHALENE-2-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-3-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-4-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-5-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-6-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-7-CARBOXALDEHYDE; 1-AMINONAPHTHALENE-8-CARBOXALDEHYDE; 1H-INDOLE-3-CARBOXALDEHYDE, 1-[2-(DIMETHYLAMINO)PROPANAMINE]-2-METHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-AMINO-6,7-DIHYDRO-2,3-DIMETHYL-6-OXO-; 2-((1R)-1,2-DIAMINOETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINO-2-METHYLPROPYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINOBUTYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINOETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINOPENTYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINOPROP-2-ENYL)PYRIDINE-4-CARBALDEHYDE; 2-((1R)-1-AMINOPROPYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1,2-DIAMINOETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINO-2-METHYLPROPYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINOBUTYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINOETHYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINOPENTYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINOPROP-2-ENYL)PYRIDINE-4-CARBALDEHYDE; 2-((1S)-1-AMINOPROPYL)PYRIDINE-4-CARBALDEHYDE; 2-((3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL)(METHYL)AMINO)ACETAMIDE; 2-((3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL)(PROPAN-2-YL)AMINO)ACETAMIDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(2-METHYLPROPYL)AMINO)ACETAMIDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(METHYL)AMINO)ACETAMIDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(PROPAN-2-YL)AMINO)ACETAMIDE; 2-([(5-FORMYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)ACETAMIDE; 2-([(5-FORMYL-2-METHOXYPHENYL)METHYL](PROPAN-2-YL)AMINO)ACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)BUTANAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)PROPANAMIDE; 2-(2-AMINO-ETHYL)-1H-IMIDAZOLE-4-CARBALDEHYDE 2HCL; 2-(2-AMINOETHYL)PYRIMIDINE-5-CARBALDEHYDE HYDROCHLORIDE; 2-(2-AMINO-PHENYL)-OXAZOLE-4-CARBALDEHYDE; 2-(2-AMINO-PHENYL)-THIAZOLE-4-CARBALDEHYDE; 2-(2-AMINOPYRIMIDIN-5-YL)BENZALDEHYDE; 2-(2-BROMO-4-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)ACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)BUTANAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)PROPANAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)ACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)BUTANAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)PROPANAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)BUTANAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)BUTANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)PROPANAMIDE; 2-(2-CHLORO-6-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)BUTANAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)PROPANAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)ACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)BUTANAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)PROPANAMIDE; 2-(2-FLUORO-4-FORMYLPHENOXY)BENZAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)BUTANAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; 2-(2-FORMYL-4-METHYLPHENOXY)ACETAMIDE; 2-(2-FORMYL-4-METHYLPHENOXY)BUTANAMIDE; 2-(2-FORMYL-4-METHYLPHENOXY)PROPANAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)ACETAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)BUTANAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)PROPANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)BUTANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)ACETAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)BUTANAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)PROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)BUTANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; 2-(2-FORMYLPHENOXY)ACETAMIDE; 2-(2-FORMYLPHENOXY)BENZAMIDE; 2-(2-FORMYLPHENOXY)BUTANAMIDE; 2-(2-FORMYLPHENOXY)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-4,6-DIMETHYLPYRIDINE-3-CARBOXAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)BUTANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)PYRIDINE-3-CARBOXAMIDE; 2-(2-OXOETHOXY)BENZAMIDE; 2-(3-AMINO-PHENYL)-OXAZOLE-4-CARBALDEHYDE; 2-(3-AMINO-PHENYL)-THIAZOLE-4-CARBALDEHYDE; 2-(3-AMINOPYRROLIDIN-1-YL)ACETALDEHYDE; 2-(3-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)BENZAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)BUTANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; 2-(3-FORMYL-1H-INDOL-1-YL)ACETAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-2-METHYLPROPANAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)ACETAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PROPANAMIDE; 2-(3-FORMYL-2-METHYL-INDOL-1-YL)-ACETAMIDE; 2-(3-FORMYL-5-METHOXY-INDOL-1-YL)-ACETAMIDE; 2-(3-FORMYLPHENOXY)ACETAMIDE; 2-(3-FORMYLPHENOXY)BUTANAMIDE; 2-(3-FORMYLPHENOXY)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-4,6-DIMETHYLPYRIDINE-3-CARBOXAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)BUTANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)PYRIDINE-3-CARBOXAMIDE; 2-(3-OXOPROPOXY)BENZAMIDE; 2-(4-(AMINOMETHYL)PHENYL)-2-OXOACETALDEHYDE; 2-(4-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 2-(4-AMINO-PHENYL)-THIAZOLE-4-CARBALDEHYDE; 2-(4-AMINOPIPERIDIN-1-YL)ACETALDEHYDE; 2-(4-BROMO-2-FORMYLPHENOXY)ACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)BUTANAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)BUTANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; 2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)BUTANAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; 2-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)ACETAMIDE; 2-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)PROPANAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)BUTANAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; 2-(4-FORMYL-2-METHYLPHENOXY)BENZAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)ACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)BUTANAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)PROPANAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; 2-(4-FORMYL-3-METHOXY-PHENOXY)-ACETAMIDE; 2-(4-FORMYL-3-METHYLPHENOXY)BENZAMIDE; 2-(4-FORMYL-3-PHENYL-1H-PYRAZOL-1-YL)ACETAMIDE; 2-(4-FORMYL-6-METHYLPYRIMIDIN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)ACETAMIDE; 2-(4-FORMYLPHENOXY)BENZAMIDE; 2-(4-FORMYLPHENOXY)BUTANAMIDE; 2-(4-FORMYLPHENOXY)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-4,6-DIMETHYLPYRIDINE-3-CARBOXAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)BUTANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)PYRIDINE-3-CARBOXAMIDE; 2-(4-FORMYLPYRIMIDIN-2-YL)ACETAMIDE; 2-(5-AMINO-6-CHLOROPYRIMIDIN-4-YLOXY)-4-METHYLBENZALDEHYDE; 2-(5-AMINO-6-CHLOROPYRIMIDIN-4-YLOXY)-5-METHYLBENZALDEHYDE; 2-(5-AMINO-6-CHLOROPYRIMIDIN-4-YLOXY)BENZALDEHYDE; 2-(5-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 2-(5-BROMO-3-FORMYL-1H-INDOL-1-YL)ACETAMIDE; 2-(5-BROMO-4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; 2-(5-CHLORO-2-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; 2-(5-CHLORO-4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)BUTANAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)ACETAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)BUTANAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)PROPANAMIDE; 2-(5-FORMYLPYRIMIDIN-2-YL)ACETAMIDE; 2-(6-AMINO-9H-PURIN-9-YL)ACETALDEHYDE; 2-(6-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 2-(AMINOMETHYL)-3-CYCLOPROPOXYBENZALDEHYDE; 2-(AMINOMETHYL)-3-CYCLOPROPOXYISONICOTINALDEHYDE; 2-(AMINOMETHYL)-3-HYDROXYBENZALDEHYDE; 2-(AMINOMETHYL)-3-PYRIDINECARBOXALDEHYDE; 2-(AMINOMETHYL)-4-CYCLOPROPOXYBENZALDEHYDE; 2-(AMINOMETHYL)-4-CYCLOPROPOXYNICOTINALDEHYDE; 2-(AMINOMETHYL)-4-HYDROXYBENZALDEHYDE; 2-(AMINOMETHYL)-4-PYRIDINECARBOXALDEHYDE; 2-(AMINOMETHYL)-5-CYCLOPROPOXYBENZALDEHYDE; 2-(AMINOMETHYL)-5-CYCLOPROPOXYISONICOTINALDEHYDE; 2-(AMINOMETHYL)-5-CYCLOPROPOXYNICOTINALDEHYDE; 2-(AMINOMETHYL)-5-HYDROXYBENZALDEHYDE; 2-(AMINOMETHYL)-5-PYRIMIDINECARBOXALDEHYDE; 2-(AMINOMETHYL)-6-CYCLOPROPOXYBENZALDEHYDE; 2-(AMINOMETHYL)-6-HYDROXYBENZALDEHYDE; 2,3-DIAMINOBENZALDEHYDE; 2,3-DIFLUORO-4-AMINO-PHENYLACETALDEHYDE; 2,3-DIFLUORO-6-AMINO-PHENYLACETALDEHYDE; 2,4,6-TRIAMINO-5-PYRIMIDINECARBOXALDEHYDE; 2,4-DIAMINO-5-METHOXYBENZALDEHYDE; 2,4-DIAMINO-6-HYDROXY-5-PYRIMIDINECARBALDEHYDEHYDRATE; 2,4-DIAMINO-6-HYDROXY-PYRIMIDINE-5-CARBALDEHYDE; 2,4-DIAMINO-6-OXO-1,6-DIHYDRO-5-PYRIMIDINECARBALDEHYDE; 2,4-DIAMINO-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBALDEHYDE; 2,4-DIAMINOBENZALDEHYDE; 2,4-DIAMINOPTERIDINE-6-CARBALDEHYDE; 2,4-DIAMINOPYRIDO[2,3-D]PYRIMIDINE-6-CARBALDEHYDE; 2,4-DIAMINOPYRIMIDINE-5-CARBOXALDEHYDE; 2,4-DIAMINOQUINAZOLINE-6-CARBALDEHYDE; 2,4-HEXADIENOIC ACID, 2-AMINO-5-METHYL-6-OXO-, (E,Z)-; 2,6-DIAMINO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2,6-DIAMINO-4-PHENYLPYRIDINE-3,5-DICARBALDEHYDE; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]ACETAMIDE; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]BUTANAMIDE; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]PROPANAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(2-FORMYL-4-NITROPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(2-FORMYL-4-NITROPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(2-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(2-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(2-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 2-[(2-METHYLPROPYL)(2-OXOETHYL)AMINO]ACETAMIDE; 2-[(2-METHYLPROPYL)(3-OXOPROPYL)AMINO]ACETAMIDE; 2-[(2-OXOETHYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(CYCLOPENTYL)AMINO]ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(3-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 2-[(3-FORMYLQUINOLIN-2-YL)(METHYL)AMINO]ACETAMIDE; 2-[(3-OXOPROPYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)OXY]BENZAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYL-2-NITROPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-2-NITROPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYLPHENYL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(4-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(4-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 2-[(5-BROMO-2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; 2-[(5-BROMO-2-FORMYLPHENYL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(5-FORMYL-2-FURYL)METHOXY]BENZAMIDE; 2-[(5-FORMYL-2-METHOXYBENZYL)OXY]BENZAMIDE; 2-[(5-FORMYLFURAN-2-YL)(2-METHYLPROPYL)AMINO]ACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]ACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(PROPAN-2-YL)AMINO]ACETAMIDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETAMIDE; 2-[(CARBAMOYLMETHYL)((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL))AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(2,6-DIFLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(2-FLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(2-OXOETHYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(3-CHLORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(3-OXOPROPYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(4-FLUORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(4-FORMYL-2-METHYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(4-FORMYL-3-METHYLPHENYL)AMINO]ACETAMIDE; 2-[(CARBAMOYLMETHYL)(4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[1-(2-FLUORO-4-FORMYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(2-FORMYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(2-OXOETHYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(3-CHLORO-2-FORMYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(3-OXOPROPYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(4-FLUORO-2-FORMYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(4-FORMYL-2-METHYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(4-FORMYL-3-METHYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(4-FORMYLPHENYL)PIPERIDIN-4-YL]ACETAMIDE; 2-[1-(5-FORMYLFURAN-2-YL)PIPERIDIN-4-YL]ACETAMIDE; 2-[15N]AMINO-2-DEOXY-D-GLUCOSE HYDROCHLORIDE; 2-[3-(AMINOMETHYL)PYRROLIDIN-1-YL]ACETALDEHYDE; 2-[BUTYL((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL))AMINO]ACETAMIDE; 2-[BUTYL(2,6-DIFLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(2-FLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(2-OXOETHYL)AMINO]ACETAMIDE; 2-[BUTYL(3-CHLORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(3-OXOPROPYL)AMINO]ACETAMIDE; 2-[BUTYL(4-FLUORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]ACETAMIDE; 2-[BUTYL(4-FORMYL-2-METHYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(4-FORMYL-3-METHYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[BUTYL(5-FORMYLFURAN-2-YL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(2-FLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(2-OXOETHYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(3-OXOPROPYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(4-FLUORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(4-FORMYL-2-METHYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(4-FORMYL-3-METHYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(4-FORMYLPHENYL)AMINO]ACETAMIDE; 2-[CYCLOPENTYL(5-FORMYLFURAN-2-YL)AMINO]ACETAMIDE; 2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; 2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; 2-AMINO-1H-IMIDAZOLE-4-CARBALDEHYDE HCL; 2-AMINO-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-AMINO-1-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-AMINO-1-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-AMINO-1-PROPANAL; 2-AMINO-3-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-5-CARBOXALDEHYDE; 2-AMINO-3-(2,3-DIFLUOROPHENYL)PYRIDINE-5-CARBOXALDEHYDE; 2-AMINO-3-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-5-CARBOXALDEHYDE; 2-AMINO-3-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-5-CARBOXALDEHYDE; 2-AMINO-3-(PERFLUOROPHENYL)PYRIDINE-5-CARBOXALDEHYDE; 2-AMINO-3-(TRIFLUOROMETHOXY)BENZALDEHYDE; 2-AMINO-3-(TRIFLUOROMETHYL)ISONICOTINALDEHYDE; 2-AMINO-3,4,5,6-TETRAHYDROXYHEXANAL HYDROCHLORIDE; 2-AMINO-3,4,5-TRIFLUOROBENZALDEHYDE; 2-AMINO-3,4,6-TRIFLUORO-5-METHYLBENZALDEHYDE; 2-AMINO-3,5-DIBROMOBENZALDEHYDE; 2-AMINO-3,5-DICHLOROBENZALDEHYDE; 2-AMINO-3,5-DIFLUOROBENZALDEHYDE; 2-AMINO-3,6-DIMETHOXYBENZENECARBALDEHYDE; 2-AMINO-3-BROMOBENZALDEHYDE; 2-AMINO-3-CHLOROBENZALDEHYDE; 2-AMINO-3-CYCLOPROPOXYBENZALDEHYDE; 2-AMINO-3-CYCLOPROPOXYISONICOTINALDEHYDE; 2-AMINO-3-FLUOROBENZALDEHYDE; 2-AMINO-3-FORMYL-6,7-DIMETHYLCHROMONE; 2-AMINO-3-FORMYL-6-METHYLCHROMONE; 2-AMINO-3-FORMYLBENZOIC ACID; 2-AMINO-3-FORMYLCHROMONE; 2-AMINO-3-FORMYLPYRIDINE; 2-AMINO-3-HYDROXY-4-METHOXYBENZALDEHYDE; 2-AMINO-3-HYDROXYBENZALDEHYDE; 2-AMINO-3-IODOBENZALDEHYDE; 2-AMINO-3-METHOXYBENZALDEHYDE; 2-AMINO-3-METHYLBENZALDEHYDE; 2-AMINO-3-METHYLISONICOTINALDEHYDE; 2-AMINO-3-NITROBENZALDEHYDE; 2-AMINO-3-PYRIDINECARBOXALDEHYDE HCL; 2-AMINO-4-(TRIFLUOROMETHOXY)BENZALDEHYDE; 2-AMINO-4-(TRIFLUOROMETHYL)BENZALDEHYDE; 2-AMINO-4-(TRIFLUOROMETHYL)NICOTINALDEHYDE; 2-AMINO-4-(TRIFLUOROMETHYL)PYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4,5-DIMETHOXYBENZALDEHYDE; 2-AMINO-4,6-DICHLOROPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4,6-DIFLUOROBENZALDEHYDE; 2-AMINO-4,6-DIPIPERIDINO-5-PYRIMIDINECARBALDEHYDE; 2-AMINO-4-[BENZYL(METHYL)AMINO]-6-CHLORO-5-PYRIMIDINECARBALDEHYDE; 2-AMINO-4-BENZYLOXYBENZALDEHYDE; 2-AMINO-4-BRBOMOPYRIDINE-6-CARBOXALDEHYDE; 2-AMINO-4-BROMOBENZALDEHYDE; 2-AMINO-4-CHLORO-6-METHYL-PYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-CHLORO-6-MORPHOLIN-4-YLPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-CHLORO-6-PIPERIDINO-5-PYRIMIDINECARBALDEHYDE; 2-AMINO-4-CHLORO-6-PYRROLIDIN-1-YLPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-CHLOROBENZALDEHYDE; 2-AMINO-4-CHLORO-PYRIDINE-3-CARBALDEHYDE; 2-AMINO-4-CHLOROPYRIMIDINE-5-CARBOXALDEHYDE; 2-AMINO-4-CYCLOPROPOXYBENZALDEHYDE; 2-AMINO-4-CYCLOPROPOXYNICOTINALDEHYDE; 2-AMINO-4-ETHOXYBENZALDEHYDE; 2-AMINO-4-FLUOROBENZALDEHYDE; 2-AMINO-4-HYDROXY-3-METHOXY-BENZALDEHYDE; 2-AMINO-4-HYDROXYBENZALDEHYDE; 2-AMINO-4-HYDROXY-PTERIDINE-6-CARBALDEHYDE; 2-AMINO-4-IODOBENZALDEHYDE; 2-AMINO-4-METHOXY-3-PENTYLOXY-BENZALDEHYDE; 2-AMINO-4-METHOXY-6-MORPHOLIN-4-YLPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-METHOXY-6-PYRROLIDIN-1-YLPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-4-METHOXYBENZALDEHYDE; 2-AMINO-4-METHYL-5-THIAZOLECARBOXALDEHYDE; 2-AMINO-4-METHYLBENZALDEHYDE; 2-AMINO-4-METHYLNICOTINALDEHYDE; 2-AMINO-4-NITRO-5-METHOXYBENZALDEHYDE; 2-AMINO-4-NITROBENZALDEHYDE; 2-AMINO-4-OXOBUTANOIC ACID; 2-AMINO-5-(2-(TRIFLUOROMETHOXY)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(2-(TRIFLUOROMETHOXY)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(2-(TRIFLUOROMETHYL)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(2-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(2,3-DIFLUOROPHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(2,3-DIFLUOROPHENYL)NICOTINALDEHYDE; 2-AMINO-5-(2-FLUOROPHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(2-FLUOROPHENYL)NICOTINALDEHYDE; 2-AMINO-5-(2-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(2-FORMYLPHENYL)NICOTINIC ACID; 2-AMINO-5-(2-OXOPIPERIDIN-1-YL)-BENZALDEHYDE; 2-AMINO-5-(2-OXOPYRROLIDIN-1-YL)BENZALDEHYDE; 2-AMINO-5-(3-(TRIFLUOROMETHOXY)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(3-(TRIFLUOROMETHOXY)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(3-(TRIFLUOROMETHYL)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(3-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(3-FLUOROPHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(3-FLUOROPHENYL)NICOTINALDEHYDE; 2-AMINO-5-(3-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(3-FORMYLPHENYL)NICOTINIC ACID; 2-AMINO-5-(3-OXO-MORPHOLIN-4-YL)-BENZALDEHYDE; 2-AMINO-5-(4-(TRIFLUOROMETHOXY)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(4-(TRIFLUOROMETHOXY)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(4-(TRIFLUOROMETHYL)PHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(4-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 2-AMINO-5-(4-FLUOROPHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(4-FLUOROPHENYL)NICOTINALDEHYDE; 2-AMINO-5-(4-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(4-FORMYLPHENYL)NICOTINIC ACID; 2-AMINO-5-(PERFLUOROPHENYL)ISONICOTINALDEHYDE; 2-AMINO-5-(PERFLUOROPHENYL)NICOTINALDEHYDE; 2-AMINO-5-(PHENYLETHYNYL)NICOTINALDEHYDE; 2-AMINO-5-(PYRIDIN-3-YL)ISONICOTINALDEHYDE; 2-AMINO-5-(PYRIDIN-3-YL)NICOTINALDEHYDE; 2-AMINO-5-(PYRIDIN-4-YL)ISONICOTINALDEHYDE; 2-AMINO-5-(PYRIDIN-4-YL)NICOTINALDEHYDE; 2-AMINO-5-(TRIFLUOROMETHOXY)BENZALDEHYDE; 2-AMINO-5-(TRIFLUOROMETHYL)ISONICOTINALDEHYDE; 2-AMINO-5-(TRIFLUOROMETHYL)NICOTINALDEHYDE; 2-AMINO-5-BENZYLOXY-4-METHOXYBENZALDEHYDE; 2-AMINO-5-BENZYLOXYBENZALDEHYDE; 2-AMINO-5-BROMOBENZALDEHYDE; 2-AMINO-5-BROMOISONICOTINALDEHYDE; 2-AMINO-5-BROMONICOTINALDEHYDE; 2-AMINO-5-BROMOPYRIMIDINE-4-CARBALDEHYDE; 2-AMINO-5-CHLOROBENZALDEHYDE; 2-AMINO-5-CHLOROBENZALDEHYDE HYDROBROMIDE; 2-AMINO-5-CHLOROBENZALDEHYDE HYDROCHLORIDE; 2-AMINO-5-CHLOROISONICOTINALDEHYDE; 2-AMINO-5-CHLORONICOTINALDEHYDE; 2-AMINO-5-CYCLOPROPOXY-2,3-DIHYDROPYRIDINE-3-CARBALDEHYDE; 2-AMINO-5-CYCLOPROPOXYISONICOTINALDEHYDE; 2-AMINO-5-ETHOXY-4-METHOXYBENZALDEHYDE; 2-AMINO-5-ETHOXYBENZALDEHYDE; 2-AMINO-5-FLUOROBENZALDEHYDE; 2-AMINO-5-FLUOROISONICOTINALDEHYDE; 2-AMINO-5-FLUORO-PYRIDINE-3-CARBALDEHYDE; 2-AMINO-5-FORMYL-4-(TRIFLUOROMETHYL)THIAZOLE; 2-AMINO-5-FORMYLBENZONITRILE; 2-AMINO-5-FORMYLTHIAZOLE; 2-AMINO-5-FORMYLTHIAZOLE HCL; 2-AMINO-5-HYDROXY-4-METHOXYBENZALDEHYDE; 2-AMINO-5-HYDROXYBENZALDEHYDE; 2-AMINO-5-IODOBENZALDEHYDE; 2-AMINO-5-IODOPYRIDINE-3-CARBOXALDEHYDE; 2-AMINO-5-METHOXY-4-(PHENYLMETHOXY)BENZALDEHYDE; 2-AMINO-5-METHOXYBENZALDEHYDE; 2-AMINO-5-METHYLBENZALDEHYDE; 2-AMINO-5-METHYLISONICOTINALDEHYDE; 2-AMINO-5-METHYLNICOTINALDEHYDE; 2-AMINO-5-NITROBENZALDEHYDE; 2-AMINO-5-PHENYLISONICOTINALDEHYDE; 2-AMINO-5-PHENYLNICOTINALDEHYDE; 2-AMINO-5-PYRIMIDINECARBOXYALDEHYDE; 2-AMINO-6-(1-PIPERIDINYL)-3,5-PYRIDINEDICARBALDEHYDE; 2-AMINO-6-(DIMETHYLAMINO)-4-HYDROXYPYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-6-(TRIFLUOROMETHOXY)BENZALDEHYDE; 2-AMINO-6-(TRIFLUOROMETHYL)ISONICOTINALDEHYDE; 2-AMINO-6-(TRIFLUOROMETHYL)NICOTINALDEHYDE; 2-AMINO-6,7-DICHLORO-3-FORMYLCHROMONE; 2-AMINO-6,8-DICHLORO-3-FORMYLCHROMONE; 2-AMINO-6,8-DIMETHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2-AMINO-6-BROMO-3-FORMYLCHROMONE; 2-AMINO-6-BROMO-PYRIDINE-3-CARBALDEHYDE; 2-AMINO-6-CHLORO-3-FORMYLCHROMONE; 2-AMINO-6-CHLORO-7-METHYL-3-FORMYL CHROMONE; 2-AMINO-6-CHLOROBENZALDEHYDE; 2-AMINO-6-CHLOROISONICOTINALDEHYDE; 2-AMINO-6-CHLORO-PYRIDINE-3-CARBALDEHYDE; 2-AMINO-6-CYCLOPROPOXYBENZALDEHYDE; 2-AMINO-6-ETHYL-3-FORMYLCHROMONE; 2-AMINO-6-FLUORO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2-AMINO-6-FLUOROBENZALDEHYDE; 2-AMINO-6-HYDROXYBENZALDEHYDE; 2-AMINO-6-IODOBENZALDEHYDE; 2-AMINO-6-ISOPROPYL-4-OXO-4H-BENZOPYRAN-3-CARBOXALDEHYDE; 2-AMINO-6-METHOXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2-AMINO-6-METHOXYBENZALDEHYDE; 2-AMINO-6-METHYLBENZALDEHYDE; 2-AMINO-6-METHYLISONICOTINALDEHYDE; 2-AMINO-6-METHYL-PYRIDINE-3-CARBALDEHYDE; 2-AMINO-6-METHYLPYRIMIDINE-4-CARBALDEHYDE; 2-AMINO-6-NITROBENZALDEHYDE; 2-AMINO-6-PYRIDINE CARBOXALDEHYDE; 2-AMINO-6-TERT-BUTYL-3-FORMYLCHROMONE; 2-AMINOBENZALDEHYDE; 2-AMINOBENZALDEHYDE HCL; 2-AMINOBENZO[D]THIAZOLE-6-CARBALDEHYDE; 2′-AMINO-BIPHENYL-4-CARBALDEHYDE; 2-AMINONAPHTHALENE-1-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-3-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-4-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-5-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-6-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-7-CARBOXALDEHYDE; 2-AMINONAPHTHALENE-8-CARBOXALDEHYDE; 2-AMINOOXAZOLE-5-CARBALDEHYDE; 2-AMINOPYRIDINE-4-CARBALDEHYDE; 2-AMINOPYRIMIDINE-4-CARBOXALDEHYDE; 2-AMINO-THIAZOLE-4-CARBOXALDEHYDE; 2-AMINOTHIOPHENE-3-CARBOXALDEHYDE; 2-AMINOTHIOPHENE-4-CARBOXALDEHYDE; 2-AMINOTHIOPHENE-5-CARBOXALDEHYDE; 2-CHLORO-3-FORMYL-QUINOLINE-8-CARBOXYLIC ACID AMIDE; 2-CYCLOPROPOXY-3-FORMYLBENZAMIDE; 2-CYCLOPROPOXY-4-FORMYLBENZAMIDE; 2-CYCLOPROPOXY-5-FORMYLBENZAMIDE; 2-CYCLOPROPOXY-6-FORMYLBENZAMIDE; 2-FLUORO-3-AMINOBENZALDEHYDE; 2-FLUORO-6-(2-OXOETHOXY)BENZAMIDE; 2-FLUORO-6-(3-OXOPROPOXY)BENZAMIDE; 2-FORMYL-3-HYDROXYBENZAMIDE; 2-FORMYL-4-HYDROXYBENZAMIDE; 2-FORMYL-5-HYDROXYBENZAMIDE; 2-FORMYL-6-HYDROXYBENZAMIDE; 2-FORMYLBENZYLAMINE; 2-FORMYLBENZYLAMINE HYDROCHLORIDE; 2-NAPHTHALENECARBOXALDEHYDE, 5-AMINO-5,6,7,8-TETRAHYDRO-,(5R)-; 2-THIOPHENECARBOXALDEHYDE, 3-AMINO-5-METHYL-; 3-((1R)-1,2-DIAMINOETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-2-(4-PYRIDYL)ETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-2-HYDROXYETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-2-METHYLPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-3-HYDROXYPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-4-HYDROXYBUTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINO-5-HYDROXYPENTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINOBUTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINOETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINOPROP-2-ENYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)-1-AMINOPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R)AMINOCYCLOPROPYLMETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1R,2R)-1-AMINO-2-HYDROXYPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1,2-DIAMINOETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-2-(4-PYRIDYL)ETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-2-HYDROXYETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-2-METHYLPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-3-HYDROXYPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-4-HYDROXYBUTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINO-5-HYDROXYPENTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINOBUTYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINOETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)-1-AMINOPROP-2-ENYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S)AMINOCYCLOPROPYLMETHYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((1S,2R)-1-AMINO-2-HYDROXYPROPYL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-([3-(AMINOMETHYL)PYRROLIDIN-1-YL]METHYL)-4-METHOXYBENZALDEHYDE; 3-(2,4-DICHLORO-6-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2,4-DICHLORO-6-FORMYLPHENOXY)PROPANAMIDE; 3-(2-AMINOETHYLAMINO)-5-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(2-BROMO-4-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-BROMO-4-FORMYLPHENOXY)PROPANAMIDE; 3-(2-BROMO-6-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-BROMO-6-FORMYLPHENOXY)PROPANAMIDE; 3-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)PROPANAMIDE; 3-(2-ETHOXY-4-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-ETHOXY-4-FORMYLPHENOXY)PROPANAMIDE; 3-(2-ETHOXY-6-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-ETHOXY-6-FORMYLPHENOXY)PROPANAMIDE; 3-(2-FORMYL-4-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; 3-(2-FORMYL-4-METHYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-4-METHYLPHENOXY)PROPANAMIDE; 3-(2-FORMYL-4-NITROPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-4-NITROPHENOXY)PROPANAMIDE; 3-(2-FORMYL-5-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; 3-(2-FORMYL-5-PROPOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-5-PROPOXYPHENOXY)PROPANAMIDE; 3-(2-FORMYL-6-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; 3-(2-FORMYL-IMIDAZOL-1-YL)-PROPIONAMIDE; 3-(2-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(2-FORMYLPHENOXY)PROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)-2-METHYLPROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 3-(2-FORMYLTHIOPHEN-4-YL)-6-AMINOPICOLINIC ACID; 3-(2-OXOETHOXY)BENZAMIDE; 3-(3-AMINO-4-ETHYLPHENYL)PROPANAL; 3-(3-AMINOPIPERIDIN-1-YL)PROPANAL; 3-(3-AMINOPYRROLIDIN-1-YL)PROPANAL; 3-(3-CHLORO-2-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(3-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; 3-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PROPANAMIDE; 3-(3-FORMYL-2-HYDROXYPHENYL)BENZAMIDE; 3-(3-FORMYL-4-HYDROXYPHENYL)BENZAMIDE; 3-(3-FORMYL-INDOL-1-YL)-PROPIONAMIDE; 3-(3-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(3-FORMYLPHENOXY)PROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)-2-METHYLPROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 3-(3-OXOPROPOXY)BENZAMIDE; 3-(4-AMINO-IMIDAZOL-1-YL)-PROPIONALDEHYDE 2HCL; 3-(4-AMINOPHENYL)-2-HYDROXYBENZALDEHYDE; 3-(4-AMINOPHENYL)-4-HYDROXYBENZALDEHYDE; 3-(4-AMINOPHENYL)PYRIDINE-4-CARBALDEHYDE; 3-(4-AMINOPIPERIDIN-1-YL)PROPANAL; 3-(4-BROMO-2-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-BROMO-2-FORMYLPHENOXY)PROPANAMIDE; 3-(4-CHLORO-2-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHOXYPHENOXY)PROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; 3-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)PROPANAMIDE; 3-(4-FORMYL-2-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; 3-(4-FORMYL-2-NITROPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-FORMYL-2-NITROPHENOXY)PROPANAMIDE; 3-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE; 3-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)PROPANAMIDE; 3-(4-FORMYLPHENOXY)-2-METHYLPROPANAMIDE; 3-(4-FORMYLPHENOXY)PROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)-2-METHYLPROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; 3-(4-FORMYLPYRIDIN-3-YL)BENZAMIDE; 3-(5-AMINO-PYRIDIN-2-YLOXY)BENZALDEHYDE; 3-(5-FORMYL-2-HYDROXYPHENYL)BENZAMIDE; 3-(5-FORMYL-2-METHOXYPHENOXY)-2-METHYLPROPANAMIDE; 3-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; 3-(5-FORMYL-2-NITROPHENOXY)-2-METHYLPROPANAMIDE; 3-(5-FORMYL-2-NITROPHENOXY)PROPANAMIDE; 3-(5-FORMYL-FURAN-2-YL)-BENZOIC ACID CARBAMOYLMETHYL ESTER; 3-(5-FORMYLPYRIDIN-3-YL)BENZAMIDE; 3-(5-FORMYLTHIOPHEN-2-YL)-6-AMINOPICOLINIC ACID; 3-(AMINOMETHYL)-2-CYCLOPROPOXYBENZALDEHYDE; 3-(AMINOMETHYL)-2-HYDROXYBENZALDEHYDE; 3-(AMINOMETHYL)-4-CYCLOPROPOXYBENZALDEHYDE; 3-(AMINOMETHYL)-4-CYCLOPROPOXYPICOLINALDEHYDE; 3-(AMINOMETHYL)-4-HYDROXYBENZALDEHYDE; 3-(AMINOMETHYL)-5-CYCLOPROPOXYISONICOTINALDEHYDE; 3-(AMINOMETHYL)-5-CYCLOPROPOXYPICOLINALDEHYDE; 3-(AMINOMETHYL)-5-HYDROXYBENZALDEHYDE; 3-[(1-FORMYLNAPHTHALEN-2-YL)OXY]-2-METHYLPROPANAMIDE; 3-[(1-FORMYLNAPHTHALEN-2-YL)OXY]PROPANAMIDE; 3-[(2-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-[(3-AMINOPIPERIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(3-AMINOPYRROLIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(3-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-[(4-AMINOPIPERIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]PROPANAMIDE; 3-[3-(AMINOMETHYL)PYRROLIDIN-1-YL]PROPANAL; 3-ALLYL-4-AMINO-2-THIOXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 3-AMINO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-AMINO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-AMINO-2-(TRIFLUOROMETHOXY)BENZALDEHYDE; 3-AMINO-2-(TRIFLUOROMETHYL)ISONICOTINALDEHYDE; 3-AMINO-2,6-DIMETHYLBENZALDEHYDE; 3-AMINO-2-BROMOBENZALDEHYDE; 3-AMINO-2-BROMOPYRIDINE-4-CARBOXALDEHYDE; 3-AMINO-2-BUTENAL; 3-AMINO-2-CHLOROBENZALDEHYDE; 3-AMINO-2-CHLOROPYRIDINE-4-CARBOXALDEHYDE; 3-AMINO-2-CYCLOPROPOXYBENZALDEHYDE; 3-AMINO-2-ETHYLACROLEIN; 3-AMINO-2-HYDROXYBENZALDEHYDE; 3-AMINO-2-IODOBENZALDEHYDE; 3-AMINO-2-IODOPYRIDINE-4-CARBOXALDEHYDE; 3-AMINO-2-ISOPROPYLACROLEIN; 3-AMINO-2-METHOXYBENZALDEHYDE; 3-AMINO-2-METHYLACRYLALDEHYDE; 3-AMINO-2-METHYLBENZALDEHYDE; 3-AMINO-2-METHYLISONICOTINALDEHYDE; 3-AMINO-2-NITROBENZALDEHYDE; 3-AMINO-2-QUINOLINECARBOXALDEHYDE; 3-AMINO-2-QUINOXALINECARBOXALDEHYDE; 3-AMINO-3-DEOXY-D-MANNOSE, HYDROCHLORIDE; 3-AMINO-4-(4-OXOQUINAZOLIN-3(4H)-YL)BENZALDEHYDE; 3-AMINO-4-(TRIFLUOROMETHOXY)BENZALDEHYDE; 3-AMINO-4-BROMOBENZALDEHYDE; 3-AMINO-4-BROMO-BENZALDEHYDE HYDROCHLORIDE; 3-AMINO-4-CHLOROBENZALDEHYDE; 3′-AMINO-4′-CHLORO-BIPHENYL-4-CARBALDEHYDE; 3-AMINO-4-CYCLOPROPOXYBENZALDEHYDE; 3-AMINO-4-CYCLOPROPOXYPICOLINALDEHYDE; 3-AMINO-4-FLUOROBENZALDEHYDE; 3-AMINO-4-HYDROXYBENZALDEHYDE; 3-AMINO-4-IODOBENZALDEHYDE; 3-AMINO-4-METHOXYBENZALDEHYDE; 3-AMINO-4-METHYL-BENZALDEHYDE; 3-AMINO-4-NITROBENZALDEHYDE; 3-AMINO-4-PYRIDINECARBOXYALDEHYDE HYDROCHLORIDE; 3-AMINO-5-(2-FORMYLPHENYL)BENZOIC ACID; 3-AMINO-5-(3-FORMYLPHENYL)BENZOIC ACID; 3-AMINO-5-(4-FORMYLPHENYL)BENZOIC ACID; 3-AMINO-5-(TRIFLUOROMETHOXY)BENZALDEHYDE; 3-AMINO-5-(TRIFLUOROMETHYL)ISONICOTINALDEHYDE; 3-AMINO-5-(TRIFLUOROMETHYL)PICOLINALDEHYDE; 3-AMINO-5,6,7,8-TETRAHYDROTHIENO[2,3-B]QUINOLINE-2-CARBALDEHYDE; 3-AMINO-5-BROMOBENZALDEHYDE; 3-AMINO-5-BROMOBENZOTHIOPHENE-2-CARBOXALDEHYDE; 3-AMINO-5-BROMOPYRAZINE-2-CARBALDEHYDE; 3-AMINO-5-CHLOROBENZALDEHYDE; 3-AMINO-5-CHLOROBENZOTHIOPHENE-2-CARBOXALDEHYDE; 3-AMINO-5-CHLOROPYRAZINE-2-CARBALDEHYDE; 3-AMINO-5-CYCLOPROPOXYBENZALDEHYDE; 3-AMINO-5-CYCLOPROPOXYISONICOTINALDEHYDE; 3-AMINO-5-CYCLOPROPOXYPICOLINALDEHYDE; 3-AMINO-5-FLUOROBENZOTHIOPHENE-2-CARBOXALDEHYDE; 3-AMINO-5-HYDROXYBENZALDEHYDE; 3-AMINO-5-IODOBENZALDEHYDE; 3-AMINO-5-METHOXYBENZALDEHYDE; 3-AMINO-5-METHYL-2-FURANCARBOXALDEHYDE; 3-AMINO-5-METHYLBENZALDEHYDE; 3-AMINO-5-NITROBENZALDEHYDE; 3-AMINO-6,7,8,9-TETRAHYDROBENZALDEHYDE; 3-AMINO-6-BROMOPYRAZINE-2-CARBALDEHYDE; 3-AMINO-6-CHLOROPYRAZINE-2-CARBALDEHYDE; 3-AMINO-6-FORMYL-2-PYRAZINECARBONITRILE; 3-AMINO-6-TRIFLUOROMETHYL-PYRIDINE-2-CARBALDEHYDE; 3-AMINOBENZALDEHYDE; 3-AMINOBENZALDEHYDE HYDROCHLORIDE; 3′-AMINO-BIPHENYL-4-CARBALDEHYDE; 3-AMINOFURAN-2-CARBALDEHYDE; 3-AMINO-IMIDAZO[1,2-A]PYRIDINE-2-CARBOXALDEHYDE; 3-AMINOISONICOTINALDEHYDE; 3-AMINOPYRAZINE-2-CARBALDEHYDE; 3-AMINO-PYRIDINE-2-CARBALDEHYDE; 3-AMINO-PYRIDINE-4-CARBALDEHYDE DIHYDROCHLORIDE; 3-AMINOTHIOPHENE-2-CARBALDEHYDE; 3-AMINOTHIOPHENE-4-CARBOXALDEHYDE; 3-AMINOTHIOPHENE-5-CARBOXALDEHYDE; 3-BROMO-2-FORMYLANILINE; 3-CYCLOHEXYL-4-METHOXY-1-OXO-2-PROPANAMINIUM CHLORIDE; 3-CYCLOPROPOXY-2-FORMYLBENZAMIDE; 3-CYCLOPROPOXY-2-FORMYLISONICOTINAMIDE; 3-CYCLOPROPOXY-4-FORMYLBENZAMIDE; 3-CYCLOPROPOXY-4-FORMYLPICOLINAMIDE; 3-CYCLOPROPOXY-5-FORMYLBENZAMIDE; 3-CYCLOPROPOXY-5-FORMYLISONICOTINAMIDE; 3-CYCLOPROPOXY-5-FORMYLPICOLINAMIDE; 3-CYCLOPROPOXY-6-FORMYLPICOLINAMIDE; 3-FLUORO-4-(4-FORMYLPHENOXY)BENZAMIDE; 3-FLUORO-4-[(2-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-FLUORO-4-[(3-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-FLUORO-4-[(4-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 3-FORMYL BENZAMIDINE HYDROCHLORIDE; 3-FORMYL-2-HYDROXYBENZAMIDE; 3-FORMYL-4-HYDROXYBENZAMIDE; 3-FORMYL-5-HYDROXYBENZAMIDE; 3-FORMYLBENZAMIDE; 3-FORMYLBENZYLAMINE; 3-FORMYLBENZYLAMINE HYDROCHLORIDE; 3-METHOXY-4-(2-OXOETHOXY)BENZAMIDE; 3-METHOXY-4-(3-OXOPROPOXY)BENZAMIDE; 3-NITRO-4-(2-OXOETHOXY)BENZAMIDE; 3-NITRO-4-(3-OXOPROPOXY)BENZAMIDE; 4-((6-AMINOPYRIDIN-2-YL)OXY)BUTANAL; 4-([4-((1R)-1-AMINO-2-CYCLOPROPYLETHYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1R)-1-AMINO-2-METHYLPROPYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1R)-1-AMINOBUTYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1R)-1-AMINOETHYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1R)-1-AMINOPENTYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1R)-1-AMINOPROPYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1S)-1-AMINO-2-CYCLOPROPYLETHYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1S)-1-AMINO-2-METHYLPROPYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1S)-1-AMINOBUTYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1S)-1-AMINOETHYL)PHENYL]METHYL)BENZALDEHYDE; 4-([4-((1S)-1-AMINOPENTYL)PHENYL]METHYL)BENZALDEHYDE; 4-(2-AMINO-1H-IMIDAZOL-4-YL)-BUTYRALDEHYDE HCL; 4-(2-AMINOETHYL)BENZALDEHYDE, [ETHYL-2-14C]-; 4-(2-AMINO-IMIDAZOL-1-YL)-BUTYRALDEHYDE HCL; 4-(2-FLUORO-4-FORMYLPHENOXY)BENZAMIDE; 4-(2-FORMYLPHENOXY)BENZAMIDE; 4-(2-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; 4-(2-METHOXYETHYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE; 4-(2-OXOETHOXY)BENZAMIDE; 4-(3-AMINOPHENYL)-2-FORMYLPHENOL; 4-(3-CARBAMOYL-4-CHLOROPHENYL)-2-FORMYLPHENOL; 4-(3-CHLORO-2-FORMYLPHENOXY)BENZAMIDE; 4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)BENZAMIDE; 4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)BUTANAMIDE; 4-(3-FORMYL-2-HYDROXYPHENYL)BENZAMIDE; 4-(3-FORMYL-4-HYDROXYPHENYL)BENZAMIDE; 4-(3-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; 4-(3-OXOPROPOXY)BENZAMIDE; 4-(4-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 4-(4-FLUORO-2-FORMYLPHENOXY)BENZAMIDE; 4-(4-FORMYL-2-METHYLPHENOXY)BENZAMIDE; 4-(4-FORMYL-3-METHYLPHENOXY)BENZAMIDE; 4-(4-FORMYLPHENOXY)BENZAMIDE; 4-(4-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; 4-(4-FORMYL-PYRIDIN-2-YL)-BENZAMIDE; 4-(4-FORMYLPYRIDIN-3-YL)BENZAMIDE; 4-(5-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 4-(5-FORMYL-2-HYDROXYPHENYL)BENZAMIDE; 4-(5-FORMYLFURAN-2-YL)BENZAMIDE; 4-(5-FORMYL-PYRIDIN-3-YL)-BENZAMIDE; 4-(5-FORMYLTHIOPHEN-2-YL)BENZAMIDE; 4-(6-AMINO-BENZOOXAZOL-2-YL)-BENZALDEHYDE; 4-(AMINOMETHYL)-2-CYCLOPROPOXYBENZALDEHYDE; 4-(AMINOMETHYL)-2-HYDROXYBENZALDEHYDE; 4-(AMINOMETHYL)-3-CYCLOPROPOXYBENZALDEHYDE; 4-(AMINOMETHYL)-3-CYCLOPROPOXYPICOLINALDEHYDE; 4-(AMINOMETHYL)-3-HYDROXYBENZALDEHYDE; 4-(AMINOMETHYL)-5-CYCLOPROPOXYNICOTINALDEHYDE; 4-(AMINOMETHYL)-5-CYCLOPROPOXYPICOLINALDEHYDE; 4,5-DIAMINO-2,3-DIFLUOROBENZALDEHYDE; 4,5-DIAMINO-2-BROMOBENZALDEHYDE; 4,5-DIAMINO-2-CHLOROBENZALDEHYDE; 4,5-DIAMINO-2-FLUOROBENZALDEHYDE; 4,6-DIAMINONICOTINALDEHYDE; 4,6-DIAMINOPYRIMIDINE-5-CARBALDEHYDE; 4-[(2-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4-[(3-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)OXY]BENZAMIDE; 4-[(4-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4′-AMINO-[1,1′-BIPHENYL]-3-CARBALDEHYDE; 4-AMINO-1,2-DIHYDRO-2-OXO-5-PYRIMIDINECARBOXALDEHYDE; 4-AMINO-1-BENZYLIMIDAZOLE-5-CARBALDEHYDE; 4-AMINO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-AMINO-1H-PYRROLO[3,2-C]PYRIDINE-2-CARBALDEHYDE; 4-AMINO-1-METHYL-1H-PYRROLE-2-CARBOXALDEHYDE; 4-AMINO-2-(TRIFLUOROMETHOXY)BENZALDEHYDE; 4-AMINO-2-(TRIFLUOROMETHYL)BENZALDEHYDE; 4-AMINO-2,3-DIFLUORO-5-NITROBENZALDEHYDE; 4-AMINO-2,6-DICHLOROPYRIDINE-3-CARBALDEHYDE; 4-AMINO-2,6-DICHLOROPYRIMIDINE-5-CARBOXALDEHYDE; 4-AMINO-2,6-DIFLUOROBENZALDEHYDE; 4-AMINO-2,6-DIHYDROXYPYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-2,6-DIMETHYL-3-PYRIDINECARBOXALDEHYDE; 4-AMINO-2,6-DIMETHYL-5-PYRIMIDINECARBOXALDEHYDE; 4-AMINO-2-BENZYLSULFANYL-PYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-2-BROMO-5-NITROBENZALDEHYDE; 4-AMINO-2-BROMOBENZALDEHYDE; 4-AMINO-2-CHLORO-5-NITROBENZALDEHYDE; 4-AMINO-2-CHLORO-BENZALDEHYDE; 4-AMINO-2-CHLORONICOTINALDEHYDE; 4-AMINO-2-CYCLOPROPOXYBENZALDEHYDE; 4-AMINO-2-FLUORO-5-NITROBENZALDEHYDE; 4-AMINO-2-FLUOROBENZALDEHYDE; 4-AMINO-2′-FORMYL[1,1′-BIPHENYL]-3-CARBOXYLIC ACID; 4′-AMINO-2′-HYDROXY-[1,1′-BIPHENYL]-3-CARBALDEHYDE; 4-AMINO-2-HYDROXYBENZALDEHYDE; 4-AMINO-2-IODOBENZALDEHYDE; 4-AMINO-2-MERCAPTOPYRIMIDINE-5-CARBALDEHYDE; 4′-AMINO-2′-METHOXY-[1,1′-BIPHENYL]-3-CARBALDEHYDE; 4-AMINO-2-METHOXY-5-PYRIMIDINECARBOXALDEHYDE; 4-AMINO-2-METHOXYBENZALDEHYDE; 4-AMINO-2-METHOXYNICOTINALDEHYDE; 4-AMINO-2-METHYL-6-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-2-METHYLBENZALDEHYDE; 4-AMINO-2-METHYL-PYRIDINE-3-CARBALDEHYDE; 4-AMINO-2-METHYLPYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-2-METHYLTHIO-PYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-2-NITROBENZALDEHYDE; 4-AMINO-2-PYRROLIDINECARBALDEHYDE; 4-AMINO-3-(TRIFLUOROMETHOXY)BENZALDEHYDE; 4-AMINO-3,5-DIBROMOBENZALDEHYDE; 4-AMINO-3,5-DICHLOROBENZALDEHYDE; 4-AMINO-3,5-DIMETHYLBENZALDEHYDE; 4-AMINO-3-BROMOBENZALDEHYDE; 4-AMINO-3-CHLORO-5-(TRIFLUOROMETHYL)BENZALDEHYDE; 4-AMINO-3-CHLOROBENZALDEHYDE; 4-AMINO-3-CYCLOPROPOXYBENZALDEHYDE; 4-AMINO-3-CYCLOPROPOXYPICOLINALDEHYDE; 4′-AMINO-3′-FLUORO[1,1-BIPHENYL]-2-CARBALDEHYDE; 4′-AMINO-3′-FLUORO[1,1-BIPHENYL]-3-CARBALDEHYDE; 4′-AMINO-3′-FLUORO[1,1-BIPHENYL]-4-CARBALDEHYDE; 4-AMINO-3-FORMYL-BENZOIC ACID METHYL ESTER; 4-AMINO-3-FORMYLPYRIDINE; 4-AMINO-3-HYDROXYBENZALDEHYDE; 4-AMINO-3-IODOBENZALDEHYDE; 4-AMINO-3-METHOXYBENZALDEHYDE; 4-AMINO-3-METHYLBENZALDEHYDE; 4-AMINO-3-NITROBENZALDEHYDE; 4-AMINO-3-PYRIDINECARBOXYALDEHYDE HYDROCHLORIDE; 4-AMINO-4,6-DIDEOXY-D-MANNOSE; 4-AMINO-4′-FORMYL[1,1′-BIPHENYL]-3-CARBOXYLIC ACID; 4-AMINO-5-BROMO-2-CHLOROPYRIDINE-3-CARBALDEHYDE; 4-AMINO-5-CYCLOPROPOXYNICOTINALDEHYDE; 4-AMINO-5-CYCLOPROPOXYPICOLINALDEHYDE; 4-AMINO-5-FORMYL-2-METHOXYPHENYL ACETATE; 4-AMINO-5-IODOPYRIDINE-3-CARBOXALDEHYDE; 4-AMINO-6-(2-OXO-ETHYL)-2-TRIFLUOROMETHYL-QUINOLINE-3-CARBONITRILE; 4-AMINO-6-BROMO-PYRIDINE-2-CARBALDEHYDE; 4-AMINO-6-BROMO-PYRIDINE-3-CARBALDEHYDE; 4-AMINO-6-CHLORO-2-METHYLSULFANYL-PYRIMIDINE-5-CARBALDEHYDE; 4-AMINO-6-CHLORO-5-PYRIMIDINECARBALDEHYDE; 4-AMINO-6-CHLOROPICOLINALDEHYDE; 4-AMINO-6-CHLORO-PYRIDINE-3-CARBALDEHYDE; 4-AMINO-6-FLUORO-3-INDAZOLECARBOXALDEHYDE; 4-AMINO-6-FORMYL-2-TRIFLUOROMETHYL-QUINOLINE-3-CARBONITRILE; 4-AMINOBENZALDEHYDE; 4′-AMINO-BIPHENYL-4-CARBALDEHYDE; 4-AMINOINDOLE-3-CARBOXALDEHYDE; 4-AMINO-N-(4-FORMYL-3-METHYL-PHENYL)-BUTYRAMIDE HYDROCHLORIC ACID; 4-AMINO-PYRIDINE-2-CARBALDEHYDE; 4-AMINO-PYRIDINE-3-CARBALDEHYDE DIHYDROCHLORIDE; 4-AMINO-PYRIDINE-3-CARBALDEHYDE TRIFLUOROACETATE; 4-AMINO-PYRIMIDINE-5-CARBALDEHYDE; 4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZINE-6-CARBALDEHYDE; 4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZINE-7-CARBALDEHYDE; 4-CHLORO-6-AMINO-3-(1H)INDAZOLE CARBOXALDEHYDE; 4-CYCLOPROPOXY-2-FORMYLBENZAMIDE; 4-CYCLOPROPOXY-2-FORMYLNICOTINAMIDE; 4-CYCLOPROPOXY-3-FORMYLBENZAMIDE; 4-CYCLOPROPOXY-3-FORMYLPICOLINAMIDE; 4-CYCLOPROPOXY-5-FORMYLNICOTINAMIDE; 4-CYCLOPROPOXY-5-FORMYLPICOLINAMIDE; 4-CYCLOPROPOXY-6-FORMYLNICOTINAMIDE; 4-CYCLOPROPOXY-6-FORMYLPICOLINAMIDE; 4-FLUORO-3-[(2-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4-FLUORO-3-[(3-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4-FLUORO-3-[(4-FORMYLPIPERIDIN-1-YL)METHYL]BENZAMIDE; 4-FLUORO-3-FORMYLBENZAMIDE; 4-FORMYL BENZAMIDINE HYDROCHLORIDE; 4-FORMYL-1H-PYRAZOLE-1-CARBOTHIOAMIDE; 4-FORMYL-1H-PYRAZOLE-3-CARBOXAMIDE; 4-FORMYL-2H-PYRAZOLE-3-CARBOXYLIC ACID AMIDE; 4-FORMYL-2-HYDROXYBENZAMIDE; 4-FORMYL-3-HYDROXYBENZAMIDE; 4-FORMYLBENZAMIDE; 4-FORMYL-BENZAMIDINE; 4-FORMYLBENZYLAMINE; 4-FORMYLBENZYLAMINE HYDROCHLORIDE; 4-PYRIMIDINECARBOXALDEHYDE, 6-AMINO-2-CYCLOPROPYL-5-FLUORO-; 4-PYRIMIDINECARBOXALDEHYDE, 6-AMINO-5-CHLORO-2-CYCLOPROPYL-; 5-((1R)-1,2-DIAMINOETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1,2-DIAMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1,2-DIAMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2-HYDROXYETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2-HYDROXY-ISOPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINO-2-METHYLPROPYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINO-2-METHYLPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINO-2-METHYLPROPYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOBUTYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOBUTYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINOBUTYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOETHYL)THIOPHENE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPENTYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPENTYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINOPENTYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPROP-2-ENYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPROP-2-ENYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINOPROP-2-ENYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPROPYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1R)-1-AMINOPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1R)-1-AMINOPROPYL)PYRIDINE-3-CARBALDEHYDE; 5-((1R)AMINOCYCLOPROPYLMETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1,2-DIAMINOETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1,2-DIAMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1,2-DIAMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2-HYDROXYETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2-HYDROXY-ISOPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINO-2-METHYLPROPYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINO-2-METHYLPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINO-2-METHYLPROPYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOBUTYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOBUTYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINOBUTYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOETHYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOETHYL)THIOPHENE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPENTYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPENTYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINOPENTYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPROP-2-ENYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPROP-2-ENYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINOPROP-2-ENYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPROPYL)-2-AMINOPYRIDINE-3-CARBALDEHYDE; 5-((1S)-1-AMINOPROPYL)PYRIDINE-2-CARBALDEHYDE; 5-((1S)-1-AMINOPROPYL)PYRIDINE-3-CARBALDEHYDE; 5-((1S)AMINOCYCLOPROPYLMETHYL)PYRIDINE-2-CARBALDEHYDE; 5-(2-FORMYLTHIOPHEN-4-YL)-2-AMINOISONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-AMINONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-3-AMINOBENZOIC ACID; 5-(3-AMINOCARBONYLPHENYL)-2-FORMYLPHENOL; 5-(3-AMINOPHENYL)-2-FORMYLPHENOL; 5-(3-AMINOPHENYL)PENTANAL; 5-(3-CARBAMOYL-4-CHLOROPHENYL)-2-FORMYLPHENOL; 5-(3-FORMYL-PHENYL)-NICOTINAMIDE; 5-(4-AMINOPHENYL)-2-HYDROXYBENZALDEHYDE; 5-(4-AMINOPHENYL)PYRIDINE-3-CARBALDEHYDE; 5-(5-AMINO-4-FORMYL-PYRAZOL-1-YL)-2-METHOXY-BENZONITRILE; 5-(5-FORMYLTHIOPHEN-2-YL)-2-AMINOISONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-AMINONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-3-AMINOBENZOIC ACID; 5-(AMINOMETHYL)-2-CYCLOPROPOXYBENZALDEHYDE; 5-(AMINOMETHYL)-2-HYDROXYBENZALDEHYDE; 5-(AMINOMETHYL)-3-CYCLOPROPOXYCYCLOHEXA-1,3-DIENECARBALDEHYDE; 5-(AMINOMETHYL)-3-CYCLOPROPOXYPICOLINALDEHYDE; 5-(AMINOMETHYL)-3-PYRIDINECARBOXALDEHYDE; 5-(AMINOMETHYL)-4-CYCLOPROPOXYNICOTINALDEHYDE; 5-(AMINOMETHYL)-4-CYCLOPROPOXYPICOLINALDEHYDE; 5-AMINO-[1,3,4]THIADIAZOLE-2-CARBALDEHYDE; 5-AMINO-1-BENZYL-1,2,3,6-TETRAHYDROPYRIDINE-4-CARBALDEHYDE; 5-AMINO-1-CYCLOPROPYL-6,7-DIFLUORO-8-METHYL-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 5-AMINO-1H-INDAZOLE-3-CARBOXALDEHYDE; 5-AMINO-1H-PYRAZOLE-3-CARBALDEHYDE; 5-AMINO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-AMINO-1-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-AMINO-1-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 5-AMINO-2-(4-ETHYLPIPERAZIN-1-YL)BENZALDEHYDE; 5-AMINO-2-(4-METHYLPIPERAZIN-1-YL)BENZALDEHYDE; 5-AMINO-2-(TRIFLUOROMETHOXY)BENZALDEHYDE; 5-AMINO-2,4-DIFLUOROBENZALDEHYDE; 5-AMINO-2-BROMOBENZALDEHYDE; 5-AMINO-2-CHLORO-4-FLUOROBENZALDEHYDE; 5-AMINO-2-CHLOROBENZALDEHYDE; 5-AMINO-2-CHLORO-PYRIDINE-3-CARBALDEHYDE; 5-AMINO-2-CHLORO-PYRIDINE-4-CARBALDEHYDE; 5-AMINO-2-CYCLOPROPOXYBENZALDEHYDE; 5-AMINO-2-FLUOROBENZALDEHYDE; 5-AMINO-2-FLUOROISONICOTINALDEHYDE; 5-AMINO-2-FORMYL-BENZENESULFONIC ACID; 5-AMINO-2-HYDROXYBENZALDEHYDE; 5-AMINO-2-IODOBENZALDEHYDE; 5-AMINO-2-METHOXYBENZALDEHYDE; 5-AMINO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-AMINO-2-METHYLBENZALDEHYDE; 5-AMINO-2-NITROBENZALDEHYDE; 5-AMINO-2-TRIFLUOROMETHYL-PYRIDINE-3-CARBALDEHYDE; 5-AMINO-2-TRIFLUOROMETHYL-PYRIDINE-4-CARBALDEHYDE; 5-AMINO-3-CYCLOPROPOXYPICOLINALDEHYDE; 5-AMINO-4-BROMO-2-CHLOROBENZALDEHYDE; 5-AMINO-4-BROMO-2-FLUOROBENZALDEHYDE; 5-AMINO-4-BROMO-3-FLUOROBENZALDEHYDE; 5-AMINO-4-CHLORO-PYRIDINE-2-CARBALDEHYDE; 5-AMINO-4-CHLORO-PYRIDINE-3-CARBALDEHYDE; 5-AMINO-4-CYCLOPROPOXYNICOTINALDEHYDE; 5-AMINO-4-CYCLOPROPOXYPICOLINALDEHYDE; 5-AMINO-4-NITROTHIOPHENE-2-CARBALDEHYDE; 5-AMINO-6-CHLORO-PYRIDINE-3-CARBALDEHYDE; 5-AMINOBENZO[B]THIOPHENE-2-CARBALDEHYDE; 5-AMINOINDOLE-3-CARBOXALDEHYDE; 5-AMINOISOPHTHALALDEHYDE; 5-AMINONICOTINALDEHYDE; 5-AMINOPICOLINALDEHYDE; 5-AMINO-PYRAZINE-2-CARBALDEHYDE; 5-AMINOPYRIMIDINE-2-CARBALDEHYDE; 5-CYCLOPROPOXY-2-FORMYLBENZAMIDE; 5-CYCLOPROPOXY-2-FORMYLISONICOTINAMIDE; 5-CYCLOPROPOXY-2-FORMYLNICOTINAMIDE; 5-CYCLOPROPOXY-3-FORMYLPICOLINAMIDE; 5-CYCLOPROPOXY-4-FORMYLNICOTINAMIDE; 5-CYCLOPROPOXY-4-FORMYLPICOLINAMIDE; 5-CYCLOPROPOXY-6-FORMYLNICOTINAMIDE; 5-CYCLOPROPOXY-6-FORMYLPICOLINAMIDE; 5-FORMYL-1,4-DIMETHYL-1H-PYRROLE-2-CARBOXAMIDE; 5-FORMYL-2-FURANCARBOXAMIDE; 5-FORMYL-2-HYDROXY-BENZAMIDE; 5-FORMYL-2-METHOXY-BENZAMIDE; 5-FORMYL-2-PYRIDINECARBOXAMIDE; 5-FORMYLTHIOPHENE-2-CARBOXAMIDE; 6-((1R)-1,2-DIAMINOETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1,2-DIAMINOETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1,2-DIAMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1,2-DIAMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINO-2-HYDROXYETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-HYDROXYETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINO-2-METHYLPROPYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-METHYLPROPYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-METHYLPROPYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINO-2-METHYLPROPYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINOBUTYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOBUTYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOBUTYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOBUTYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINOETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 64(1R)-1-AMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINOPENTYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPENTYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPENTYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPENTYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINOPROP-2-ENYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROP-2-ENYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROP-2-ENYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROP-2-ENYL)PYRIDINE-3-CARBALDEHYDE; 6-((1R)-1-AMINOPROPYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROPYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROPYL)PYRIDINE-2-CARBALDEHYDE; 6-((1R)-1-AMINOPROPYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1,2-DIAMINOETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1,2-DIAMINOETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 64(1S)-1,2-DIAMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1,2-DIAMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((18)-1-AMINO-2,2,2-TRIFLUOROETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2,2,2-TRIFLUOROETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINO-2-HYDROXYETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-HYDROXYETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-HYDROXYETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINO-2-METHYLPROPYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-METHYLPROPYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-METHYLPROPYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINO-2-METHYLPROPYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINOBUTYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOBUTYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOBUTYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOBUTYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINOETHYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOETHYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOETHYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOETHYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINOPENTYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPENTYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPENTYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPENTYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINOPROP-2-ENYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROP-2-ENYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROP-2-ENYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROP-2-ENYL)PYRIDINE-3-CARBALDEHYDE; 6-((1S)-1-AMINOPROPYL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROPYL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROPYL)PYRIDINE-2-CARBALDEHYDE; 6-((1S)-1-AMINOPROPYL)PYRIDINE-3-CARBALDEHYDE; 6-(3-AMINOPHENYL)-2-FORMYLPHENOL; 6-(3-AMINOPHENYL)HEXANAL; 6-(3-CARBAMOYL-4-CHLOROPHENYL)-2-FORMYLPHENOL; 6-(4-AMINOPHENOXY)PYRIDINE-3-CARBOXALDEHYDE; 6-(AMINOMETHYL)-3-CYCLOPROPOXYPICOLINALDEHYDE; 6-(AMINOMETHYL)-4-CYCLOPROPOXY-1,6-DIHYDROPYRIDINE-2-CARBALDEHYDE; 6-(AMINOMETHYL)-4-CYCLOPROPOXYNICOTINALDEHYDE; 6-(AMINOMETHYL)-5-CYCLOPROPOXYNICOTINALDEHYDE; 6-(AMINOMETHYL)-5-CYCLOPROPOXYPICOLINALDEHYDE; 6-AMINO-(1H)INDAZOLE-3-CARBOXALDEHYDE; 6-AMINO-1-(2-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-FURYLMETHYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(2-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(3-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1,3-DIETHYL-5-FORMYLURACIL; 6-AMINO-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-BENZYL-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-BUTYL-5-FORMYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-AMINO-1-ISOBUTYL-3-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-SEC-BUTYL-5-FORMYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-2-(TRIFLUOROMETHYL)NICOTINALDEHYDE; 6-AMINO-2,3,4-TRIFLUOROBENZALDEHYDE; 6-AMINO-2,3-DIFLUOROBENZALDEHYDE; 6-AMINO-2,4-DIOXO-1-(2-PHENYLETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1-(PYRIDIN-3-YLMETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2-BROMO-PYRIDINE-3-CARBALDEHYDE; 6-AMINO-2-METHYLNICOTINALDEHYDE; 6-AMINO-3-(2-(TRIFLUOROMETHOXY)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(2-(TRIFLUOROMETHYL)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(2,3-DIFLUOROPHENYL)PICOLINALDEHYDE; 6-AMINO-3-(2-FLUOROPHENYL)PICOLINALDEHYDE; 6-AMINO-3-(2-FORMYLPHENYL)PICOLINIC ACID; 6-AMINO-3-(3-(TRIFLUOROMETHOXY)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(3-(TRIFLUOROMETHYL)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(3-FLUOROPHENYL)PICOLINALDEHYDE; 6-AMINO-3-(3-FORMYLPHENYL)PICOLINIC ACID; 6-AMINO-3-(4-(TRIFLUOROMETHOXY)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(4-(TRIFLUOROMETHYL)PHENYL)PICOLINALDEHYDE; 6-AMINO-3-(4-FLUOROPHENYL)PICOLINALDEHYDE; 6-AMINO-3-(4-FORMYLPHENYL)PICOLINIC ACID; 6-AMINO-3-(PERFLUOROPHENYL)PICOLINALDEHYDE; 6-AMINO-3-(PYRIDIN-3-YL)PICOLINALDEHYDE; 6-AMINO-3-(PYRIDIN-4-YL)PICOLINALDEHYDE; 6-AMINO-3,5-DIBROMOPICOLINALDEHYDE; 6-AMINO-3-BROMO-2,4-DIFLUOROBENZALDEHYDE; 6-AMINO-3-BROMOPICOLINALDEHYDE; 6-AMINO-3-CYCLOPROPOXYCYCLOHEXA-2,4-DIENECARBALDEHYDE; 6-AMINO-3-CYCLOPROPOXYPICOLINALDEHYDE; 6-AMINO-3-PHENYLPICOLINALDEHYDE; 6-AMINO-4-CHLORONICOTINALDEHYDE; 6-AMINO-4-CYCLOPROPOXYNICOTINALDEHYDE; 6-AMINO-4-CYCLOPROPOXYPICOLINALDEHYDE; 6-AMINO-4-FLUORO-3-(1H)INDAZOLE CARBOXALDEHYDE; 6-AMINO-4-METHYL-3-PYRIDINECARBOXALDEHYD; 6-AMINO-4-OXO-1-PHENYL-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-5-(2-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 6-AMINO-5-(2-FLUOROPHENYL)NICOTINALDEHYDE; 6-AMINO-5-(3-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 6-AMINO-5-(3-FLUOROPHENYL)NICOTINALDEHYDE; 6-AMINO-5-(4-(TRIFLUOROMETHYL)PHENYL)NICOTINALDEHYDE; 6-AMINO-5-(4-FLUOROPHENYL)NICOTINALDEHYDE; 6-AMINO-5-(PYRIDIN-3-YL)NICOTINALDEHYDE; 6-AMINO-5-(PYRIDIN-4-YL)NICOTINALDEHYDE; 6-AMINO-5-BROMONICOTINALDEHYDE; 6-AMINO-5-CYCLOPROPOXYNICOTINALDEHYDE; 6-AMINO-5-CYCLOPROPOXYPICOLINALDEHYDE; 6-AMINO-5-FORMYL-1-(2-METHOXY-ETHYL)-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-1-(3-METHOXY-PROPYL)-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-1,4-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-1-ISOBUTYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-1-ISOPROPYL-4-METHYL-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-4-METHYL-1-(3-METHYL-BUTYL)-2-OXO-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-4-METHYL-2-OXO-1-(TETRAHYDRO-FURAN-2-YLMETHYL)-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-FORMYL-4-METHYL-2-OXO-1-PROPYL-1,2-DIHYDRO-PYRIDINE-3-CARBONITRILE; 6-AMINO-5-NITRONICOTINALDEHYDE; 6-AMINO-5-NITROPICOLINALDEHYDE; 6-AMINO-5-PHENYLNICOTINALDEHYDE; 6-AMINO-BENZO[1,3]DIOXOLE-5-CARBALDEHYDE; 6-AMINOINDOLE-3-CARBOXALDEHYDE; 6-AMINONICOTINALDEHYDE; 6-AMINOPYRIMIDINE-4-CARBOXALDEHYDE; 6-FORMYLPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE; 6-METHYL-1-(2-OXOETHYL)PIPERIDINE-3-CARBOXAMIDE; 6-METHYL-1-(3-OXOPROPYL)PIPERIDINE-3-CARBOXAMIDE; 7-AMINO[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-6-CARBALDEHYDE; 7-AMINO[1,8]NAPHTHYRIDINE-2-CARBALDEHYDE; 7-AMINO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-AMINO-2-CYCLOPROPYL-5-METHYL-PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBALDEHYDE; 7-AMINO-2-CYCLOPROPYL-PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBALDEHYDE; 7-AMINO-8-METHYLQUINOLINE-3-CARBALDEHYDE; 7-AMINOBENZO[C][1,2,5]THIADIAZOLE-4-CARBALDEHYDE; 7-AMINOINDOLE-3-CARBOXALDEHYDE; 8-AMINOQUINOLINE-7-CARBALDEHYDE; 9-(3-OXOPROP-1-ENYL)ADENINE; ACETALDEHYDE, AMINOBENZOYL-; ADENOSINE, PERIODATE OXIDIZED; ALAHOPCIN; ALPHA-AMINO-BENZENEACETALDEHYDE; BENZALDEHYDE, 3-AMINO-4-HYDROXY-5-METHOXY-; BENZOOXAZOLE-2-CARBALDEHYDE-4-YLAMINE; BENZOOXAZOLE-2-CARBALDEHYDE-5-YLAMINE; BENZOOXAZOLE-2-CARBALDEHYDE-6-YLAMINE; BENZYL (2R)-5-AMINO-4-METHYL-1-OXOPENTAN-2-YLCARBAMATE; CYTOSINE PROPENAL; DAUNOSAMINE; D-GALACTOSAMINE; D-GALACTOSAMINE HYDROCHLORIDE; D-GLUCOSAMINE 6-SULFATE; D-GLUCOSAMINE HYDROCHLORIDE; D-GLUCOSAMINE HYDROCHLORIDE, [1-14C]-; D-GLUCOSAMINE HYDROCHLORIDE, [6-3H]-; D-GLUCOSAMINE SULFATE; DL-CYSTINE-3,3,3′,3′-D4; D-LYXOSYLAMINE; D-MANNOSAMINE HYDROCHLORIDE; D-MANNOSAMINE HYDROCHLORIDE, [1-14C]-; EPSILON-PYRROLE-LYSINE; ETHYL 2-AMINO-5-(3-OXOPROP-1-ENYL)-3-FUROATE; ETHYL 2-AMINO-6-FORMYLPYRIMIDINE-4-CARBOXYLATE; FORPHENICINE; GALACTOSAMINE HYDROCHLOR-IDE-D-[1-14C]; GLUCOSAMINE; GLUCOSAMINE HYDROCHLORIDE D-[1-14C]; GLUCOSAMINE HYDROCHLORIDE, D-[14C(U)]; GLUCOSAMINE HYDROCHLORIDE, D-[6-3H]; GLUCURONAMIDE; GUANOSINE PERIODATE OXIDIZED; H-LEU-NHOH ACOH; L-2-AMINOADIPATE 6-SEMIALDEHYDE; L-GLUCOSAMINE; MANNOSAMINE HYDROCHLORIDE D [6-3H]; METHYL (2R)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(2-CHLORO-3-FORMYL(4-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(2-FORMYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(3-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(3-FORMYL-2-METHYL(4-HYDROIMIDAZO[1,2-A]PYRIDIN-6-YL))PROPANOATE; METHYL (2R)-2-AMINO-3-(3-FORMYL-4-HYDROXYPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(3-FORMYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(4-FLUORO-3,5-DIFORMYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(4-FLUORO-3-FORMYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(4-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(4-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(4-FORMYLPHENYL)PROPANOATE; METHYL (2R)-2-AMINO-3-(5-BROMO-4-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(5-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(5-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(5-FORMYL-6-METHOXY(3-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(6-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2R)-2-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(2-CHLORO-3-FORMYL(4-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(2-FORMYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(3-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(3-FORMYL-2-METHYL(4-HYDROIMIDAZO[1,2-A]PYRIDIN-6-YL))PROPANOATE; METHYL (2S)-2-AMINO-3-(3-FORMYL-4-HYDROXYPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(3-FORMYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(4-FLUORO-3,5-DIFORMYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(4-FLUORO-3-FORMYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(4-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(4-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(4-FORMYLPHENYL)PROPANOATE; METHYL (2S)-2-AMINO-3-(5-BROMO-4-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(5-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(5-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(5-FORMYL-6-METHOXY(3-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(6-FORMYL(2-PYRIDYL))PROPANOATE; METHYL (2S)-2-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (3R)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOATE; METHYL (3R)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (3R)-3-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (3S)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOATE; METHYL (3S)-3-AMINO-3-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PROPANOATE; METHYL (3S)-3-AMINO-3-(6-FORMYL(3-PYRIDYL))PROPANOATE; METHYL (4R)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOATE; METHYL (4S)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOATE; METHYL 3-((1R)-1-AMINO-2-HYDROXYETHYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1R)-1-AMINO-3-HYDROXYPROPYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1R)-1-AMINO-4-HYDROXYBUTYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1R)-1-AMINO-5-HYDROXYPENTYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1R)-1-AMINOETHYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1S)-1-AMINO-2-HYDROXYETHYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1S)-1-AMINO-3-HYDROXYPROPYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1S)-1-AMINO-4-HYDROXYBUTYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1S)-1-AMINO-5-HYDROXYPENTYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((1S)-1-AMINOETHYL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-AMINO-5-FORMYLBENZOATE; METHYL 4-AMINO-5-FORMYLPYRIDINE-2-CARBOXYLATE; METHYL 5-((1R)-1-AMINO-2-CYANOETHYL)-3-FORMYL-4-HYDROXYBENZOATE; METHYL 5-((1S)-1-AMINO-2-CYANOETHYL)-3-FORMYL-4-HYDROXYBENZOATE; METHYL 6-AMINO-5-FORMYLPYRIDINE-2-CARBOXYLATE; MURAMIC ACID; MURAMIC ACID HYDRATE; P-AMINOETHYLBENZALDEHYDE HCL; SODIUM, 2-AMINO-4-FORMYL-BENZENESULFONATE; SODIUM, 2-AMINO-5-FORMYL-BENZENESULFONATE; TERT-BUTYL 3-AMINO-4-(4-FORMYLPYRIDIN-3-YL)BENZOATE; TERT-BUTYL 3-AMINO-4-(5-FORMYLPYRIDIN-3-YL)BENZOATE; TERT-BUTYL 5-(AMINOMETHYL)-3-FORMYL-1H-INDOLE-1-CARBOXYLATE; Secondary amine: ((1,3-DIMETHYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)THIO)ACETALDEHYDE; (11-OXO-UNDECYL)-CARBAMIC ACID TERT-BUTYL ESTER; (1-FORMYL-CYCLOPROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (1-FORMYL-VINYL)-CARBAMIC ACID TERT-BUTYL ESTER; (1H-IMIDAZOL-2-YL)-ACETALDEHYDE; (1H-IMIDAZOL-4-YL)-ACETALDEHYDE; (2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ACETALDEHYDE; (2,6-DIOXO-PIPERIDIN-4-YL)-ACETALDEHYDE; (2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETYL)UREA; (2-AMINO-1H-IMIDAZOL-4-YL)-ACETALDEHYDE HCL; (2-CHLORO-4-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-CHLORO-4-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-CHLORO-5-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-CHLORO-5-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-CHLORO-6-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2E)-2-METHYL-3-(1H-PYRROL-2-YL)-2-PROPENAL; (2E)-3-(1H-INDOL-3-YL)-2-PROPENAL; (2E)-3-(1H-PYRROL-2-YL)-2-PROPENAL; (2E)-3-(1H-PYRROLO[2,3-B]PYRIDIN-3-YL)-2-PROPENAL; (2-FLUORO-4-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FLUORO-5-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FLUORO-5-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-1,4-DIMETHYL-1H-INDOL-5-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-1H-PYRROL-3-YL)METHYL ACETATE; (2-FORMYL-3-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-3-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-4,5-DIMETHOXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-4-HYDROXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-4-METHOXY-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-4-METHOXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-4-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-4-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-4-NITRO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-5-METHOXY-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-5-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-5-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-6-METHOXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-6-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-CYCLOHEXYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (2-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-PYRIDIN-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-FORMYL-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-METHYL-3-OXO-PROPYL)-CARBAMIC ACID BENZYL ESTER; (2-METHYL-3-OXO-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-OXO-1-THIOPHEN-3-YL-ETHYL)-CARBAMIC ACID BENZYL ESTER; (2-OXO-1-THIOPHEN-3-YL-ETHYL)-CARBAMIC ACID TERT-BUTYL ESTER; (2-PHENYL-1H-INDOL-3-YL)-ACETALDEHYDE; (2R)-3-HYDROXY-2-([(1R)-2-OXO-1-(6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)ETHYL]OXY)PROPANAL; (2R,12BS)-2-ETHYL-1,2,6,7,12,12B-HEXAHYDRO-INDOLO[2,3-A]QUINOLIZINE-3-CARBALDEHYDE; (2S)-2-PYRROLIDINECARBOXALDEHYDE; (2Z)-3-(1H-PYRROL-2-YL)-2-PROPENAL; (3-CHLORO-4-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-CHLORO-4-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-CHLORO-5-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-CHLORO-5-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FLUORO-2-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FLUORO-4-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-FLUORO-4-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FLUORO-5-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-FLUORO-5-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-1H-INDAZOL-6-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-2-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-2-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-4-METHYL-1H-INDOL-7-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-4-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-4-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-BENZYL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-PYRAZIN-2-YL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-PYRAZIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID BENZYL ESTER; (3-FORMYL-PYRIDIN-4-YL)-CARBAMIC ACID BENZYL ESTER; (3-OXO-1-PHENYL-PROPYL)-CARBAMIC ACID BENZYL ESTER; (3-OXO-1-PHENYL-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (3-OXO-3,4-DIHYDRO-2-QUINOXALINYL)(PHENYLHYDRAZONO)ACETALDEHYDE; (3-OXO-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4,4,8-TRIMETHYL-2-OXO-1,2,3,4-TETRAHYDRO-QUINOLIN-6-YL)-ACETALDEHYDE; (4,5-DIFLUORO-2-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-CHLORO-2-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-CHLORO-3-FORMYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-CHLORO-6-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FLUORO-2-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FLUORO-3-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FLUORO-3-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-1H-PYRAZOL-3-YL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-1H-PYRAZOL-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-2-HYDROXY-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-2-HYDROXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-2-METHOXY-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-2-METHOXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-2-METHYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-2-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-2-NITRO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-3-NITRO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-BICYCLO[2.2.2]OCT-1-YL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-OXAZOL-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (4-FORMYL-PYRIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER; (4-FORMYLTHIAZOL-2-YL)CARBAMIC ACID TERT-BUTYL ESTER; (5-CHLORO-2-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (5-CHLORO-2-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FLUORO-2-FORMYL-PHENYL)-CARBAMIC ACID BENZYL ESTER; (5-FLUORO-2-FORMYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-2,4-DIMETHYL-1H-PYRROL-3-YL)-ACETIC ACID; (5-FORMYL-2H-[1,2,4]TRIAZOL-3-YL)-CARBAMIC ACID BENZYL ESTER; (5-FORMYL-2H-[1,2,4]TRIAZOL-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-2-HYDROXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-2-METHOXY-PHENYL)-CARBAMIC ACID BENZYL ESTER; (5-FORMYL-2-METHOXY-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-2-METHYL-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-PYRAZIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID BENZYL ESTER; (5-FORMYL-PYRIDIN-3-YL)-CARBAMIC ACID BENZYL ESTER; (5-FORMYL-PYRIDIN-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-FORMYL-THIAZOL-2-YL)-CARBAMIC ACID BENZYL ESTER; (5-FORMYL-THIAZOL-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (5-OXO-PENTYL)-CARBAMIC ACID TERT-BUTYL ESTER; (6-CHLORO-4-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (6-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID BENZYL ESTER; (6-FORMYL-PYRIDIN-2-YL)-CARBAMIC ACID TERT-BUTYL ESTER; (6-TRIFLUOROMETHYL)-7-AZAINDOLE-3-CARBOXALDEHYDE; (7-OXO-HEPTYL)-CARBAMIC ACID BENZYL ESTER; (7-OXO-HEPTYL)-CARBAMIC ACID TERT-BUTYL ESTER; (9H-FLUOREN-9-YL)METHYL 2-OXOETHYLCARBAMATE; (E)-3-(1H-INDOL-2-YL)-2-PROPENAL; (R)-(+)-2-(BENZYLCARBONYLAMINO)-3-PHENYLPROPANAL; (R)-(1-ETHYL-3-OXO-PROPYL)-CARBAMIC ACID BENZYL ESTER; (R)-(1-ETHYL-3-OXO-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (R)-(3-OXO-1-PHENYL-PROPYL)-CARBAMIC ACID BENZYL ESTER; (R)-(3-OXO-1-PHENYL-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (R)-[1-(4-CHLORO-PHENYL)-3-OXO-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; (R)-[1-(4-METHOXY-PHENYL)-3-OXO-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; (R)-2-OXO-IMIDAZOLIDINE-4-CARBALDEHYDE; (R)-5,6-DIOXO-PIPERAZINE-2-CARBALDEHYDE; (R)-BENZYL 1-OXOPROPAN-2-YLCARBAMATE; (R)-N-(1-ETHYL-3-OXO-PROPYL)-ACETAMIDE; (R)—N-(3-OXO-1-PHENYL-PROPYL)-ACETAMIDE; (R)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)-2-METHYLPROPYLCARBAMATE; (R)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)BUTYLCARBAMATE; (R)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)ETHYLCARBAMATE; (R)-TERT-BUTYL 1-OXOPROPAN-2-YLCARBAMATE; (R)-TERT-BUTYL 3-METHYL-1-OXOBUTAN-2-YLCARBAMATE; (S)-(1-ETHYL-3-OXO-PROPYL)-CARBAMIC ACID BENZYL ESTER; (S)-(1-ETHYL-3-OXO-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER; (S)-[1-(4-CHLORO-PHENYL)-3-OXO-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; (S)-[1-(4-METHOXY-PHENYL)-3-OXO-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; (S)-2-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-4-YL)ACETALDEHYDE; (S)-2-PIPERIDINECARBOXALDEHYDE HYDROCHLORIDE; (S)-4-(1-BENZYL-2-HYDROXYETHYLAMINO)BENZALDEHYDE; (S)-4-(1-HYDROXYMETHYL-PROPYLAMINO)BENZALDEHYDE; (S)-4-(2-HYDROXY-1-PHENYL-ETHYLAMINO)BENZALDEHYDE; (S)-4-N-CBZ-AMINO-4-FORMYL BUTYLAMIDE; (S)-BENZYL 1-OXOPROPAN-2-YLCARBAMATE; (S)—N-(1-ETHYL-3-OXO-PROPYL)-ACETAMIDE; (S)—N-(2-(2-FORMYL-1-PYRROLIDINYL)-2-OXOETHYL)ACETAMIDE; (S)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)-2-METHYLPROPYLCARBAMATE; (S)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)BUTYLCARBAMATE; (S)-TERT-BUTYL 1-(5-FORMYLOXAZOL-2-YL)ETHYLCARBAMATE; (S)-TERT-BUTYL 2-OXO-1-PHENYLETHYLCARBAMATE; (S)-TERT-BUTYL 3-OXO-1-PHENYLPROPYLCARBAMATE; (Z)-2-(3,4-DIHYDROPYRROLO[1,2-A]PYRAZIN-1(2H)-YLIDENE)ACETALDEHYDE; (Z)-2-(PYRROLO[1,2-A]PYRAZIN-1(2H)-YLIDENE)PROPANAL; (Z)-2-METHYL-3-(1H-PYRROL-2-YL)-2-PROPENAL; [1-(2-FORMYL-PHENYL)-AZETIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL ESTER; [1-(3-FORMYL-PHENYL)-AZETIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL ESTER; [1-(3-FORMYL-PHENYL)-PYRROLIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL-ESTER; [1-(4-FORMYL-PHENYL)-AZETIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL ESTER; [1-(4-FORMYL-PHENYL)-PYRROLIDIN-3-YL]-CARBAMIC ACID TERT-BUTYL-ESTER; [2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETYL]UREA; [2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)ACETYL]UREA; [2-(2-CHLORO-4-FORMYLPHENOXY)ACETYL]UREA; [2-(2-ETHOXY-4-FORMYLPHENOXY)ACETYL]UREA; [2-(2-ETHOXY-6-FORMYLPHENOXY)ACETYL]UREA; [2-(2-FORMYL-4-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-4-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYL-4-NITROPHENOXY)ACETYL]UREA; [2-(2-FORMYL-5-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-5-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYL-6-METHOXYPHENOXY)ACETYL]UREA; [2-(2-FORMYL-6-METHOXYPHENOXY)PROPANOYL]UREA; [2-(2-FORMYLPHENOXY)ACETYL]UREA; [2-(2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(2-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(2-OXO-ETHYL)-BENZYL]-CARBAMIC ACID BENZYL ESTER; [2-(3-CHLORO-2-FORMYLPHENOXY)ACETYL]UREA; [2-(3-CHLORO-2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(3-FORMYLPHENOXY)ACETYL]UREA; [2-(3-FORMYLPHENOXY)PROPANOYL]UREA; [2-(3-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(3-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(4-CHLORO-2-FORMYLPHENOXY)ACETYL]UREA; [2-(4-CHLORO-2-FORMYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETYL]UREA; [2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2-METHOXYPHENOXY)ACETYL]UREA; [2-(4-FORMYL-2-METHOXYPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-2-NITROPHENOXY)ACETYL]UREA; [2-(4-FORMYLPHENOXY)ACETYL]UREA; [2-(4-FORMYLPHENOXY)PROPANOYL]UREA; [2-(4-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; [2-(4-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [2-(5-FORMYL-2-METHOXYPHENOXY)ACETYL]UREA; [2-(5-FORMYL-2-METHOXYPHENOXY)PROPANOYL]UREA; [2-(5-FORMYL-2-NITROPHENOXY)ACETYL]UREA; [2-(5-FORMYL-FURAN-2-YL)-PHENYL]-CARBAMIC ACID TERT-BUTYL ESTER; [2,2-DIMETHYL-1-(2-OXO-ETHYL)-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; [2,4′-BI-1H-IMIDAZOLE]-4-CARBOXALDEHYDE; [2,4′-BI-1H-IMIDAZOLE]-5-CARBOXALDEHYDE, 1-METHYL; [2-METHYL-1-(2-OXO-ETHYL)-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER; [3-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [3-(3-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [3-(4-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; [3-(5-FORMYL-FURAN-2-YL)-PHENYL]-CARBAMIC ACID TERT-BUTYL ESTER; [4-(2-OXO-ETHYL)-PHENYL]-CARBAMIC ACID BENZYL ESTER; [4-(2-OXO-ETHYL)-THIAZOL-2-YL]-CARBAMIC ACID BENZYL ESTER; [4-(2-OXO-ETHYL)-THIAZOL-2-YL]-CARBAMIC ACID TERT-BUTYL ESTER; [4-(5-FORMYL-FURAN-2-YL)-PHENYL]-CARBAMIC ACID TERT-BUTYL ESTER; [4-(6-FORMYLPYRIDIN-2-YL)PHENYL]CARBAMIC ACID TERT-BUTYL ESTER; 1-((2R,4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 14(4-OXO-3H,4H-THIENO[3,2-D]PYRIMIDIN-2-YL)METHYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-((4-OXO-3H,4H-THIENO[3,2-D]PYRIMIDIN-2-YL)METHYL)PIPERIDINE-4-CARBALDEHYDE; 1-(1H-IMIDAZOL-2-YL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 1-(1H-IMIDAZOL-2-YL)-PIPERIDINE-3-CARBALDEHYDE; 1-(1H-IMIDAZOL-2-YL)-PIPERIDINE-4-CARBALDEHYDE HCL; 1-(1-OXO-1,2-DIHYDROISOQUINOLIN-3-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(2,6-DIFLUORO-4-FORMYLPHENYL)-N-METHYLPYRROLIDINE-2-CARBOXAMIDE; 1-(2-BENZYLAMINOETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(2-FLUORO-4-FORMYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(2-FORMYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(2-PIPERAZIN-1-YLETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(3,5-ANHYDRO-2-DEOXY-BETA-D-THREO-PENTAFURANOSYL)THIMINE; 1-(3-CHLORO-2-FORMYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(3-FORMYLPHENYL)PIPERAZINE; 1-(4-ANILINOPHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 1-(4-FLUORO-2-FORMYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)-N-METHYLPIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-1H-IMIDAZOL-2-YL)-NAPHTHALEN-2-OL; 1-(4-FORMYL-2-METHYLPHENYL)-N-METHYLPIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-2-METHYLPHENYL)-N-METHYLPYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)-N-METHYLPIPERIDINE-2-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(4-FORMYL-3-METHYLPHENYL)-N-METHYLPYRROLIDINE-2-CARBOXAMIDE; 1-(4-FORMYLPHENYL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(4-PIPERIDINYL)-1H-1,2,3-TRIAZOLE-4-CARBOXALDEHYDE; 1-(5-FORMYLFURAN-2-YL)-N-METHYLPIPERIDINE-2-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE; 1-(5-FORMYLFURAN-2-YL)-N-METHYLPYRROLIDINE-2-CARBOXAMIDE; 1-(5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)-N-METHYLPYRROLIDINE-2-CARBOXAMIDE; 1-(7H-PURIN-6-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1-(7H-PURIN-6-YL)PIPERIDINE-2-CARBALDEHYDE; 1-(7H-PURIN-6-YL)PIPERIDINE-3-CARBALDEHYDE; 1-(7H-PURIN-6-YL)PIPERIDINE-4-CARBALDEHYDE; 1-(FURAN-2-CARBONYL)-3-(2-OXO-1-PHENYL-ETHYL)-UREA; 1-(N-BOC-2-AMINOETHYL)-2-FORMYLIMIDAZOLE; 1-(N-BOC-3-AMINOPROPYL)-2-FORMYLIMIDAZOLE; 1-(PIPERIDIN-2-YLMETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(PIPERIDIN-3-YLMETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(PIPERIDIN-4-YL)-2-FORMYLIMIDAZOLE HCL; 1-(PIPERIDIN-4-YLMETHYL)-2-FORMYLIMIDAZOLE HCL; 1-(PYRROLIDIN-3-YLMETHYL)-2-FORMYLIMIDAZOLE HCL; 1′,2′,3′,4′,5′,6′-HEXAHYDRO-[2,4′]BIPYRIDINYL-5-CARBALDEHYDE; 1,2,3,4-TETRAHYDRO-1-OXOISOQUINOLINE-6-CARBALDEHYDE; 1,2,3,4-TETRAHYDRO-2-OXO-5-QUINOLINECARBOXALDEHYDE; 1,2,3,4-TETRAHYDRO-2-OXO-6-QUINOLINECARBOXALDEHYDE; 1,2,3,4-TETRAHYDRO-8-QUINOLINECARBOXALDEHYDE; 1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOLE-5-CARBALDEHYDE; 1,2,3,4-TETRAHYDROISOQUINOLINE-6-CARBALDEHYDE HYDROCHLORIDE; 1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBALDEHYDE HYDROCHLORIDE; 1,2-DIHYDRO-2-OXO-4-PYRIDINECARBOXALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6,8-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6-METHYL-2-OXO-3-PYRIDINECARBOXALDEHYDE; 1,2-DIHYDRO-7,8-DIMETHYL-2-OXO-QUINOLINE-3-CARBOXALDEHYDE; 1,2-DIHYDRO-7-METHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-8-METHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDROISOQUINOLINE-4-CARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-(PROPYLAMINO)-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-5-(3-OXOPIPERAZIN-1-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1,3-DIMETHYL-5-(5-OXO-1,4-DIAZEPAN-1-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 1,3-DIMETHYL-6-(METHYLAMINO)-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,4,5,6-TETRAHYDRO-4-IMINO-6-OXO-S-TRIAZINE-2-CARBOXALDEHYDE; 1,4-DIHYDRO-3-HYDROXY-2-QUINOXALINECARBOXALDEHYDE; 1,4-DIHYDRO-4-OXO-2-PYRIDINECARBOXALDEHYDE; 1,4-DIHYDRO-5-METHYL-4-OXO-3-PYRIDINECARBOXALDEHYDE; 1,4-DIHYDRO-6-METHYL-4-OXO-3-PYRIDINECARBOXALDEHYDE; 1,4-DIMETHYL-3-FORMYLCARBAZOLE; 1,6-DIHYDRO-4-METHYL-6-OXO-PYRANO[4,3-B]PYRROLE-2-CARBOXALDEHYDE; 1-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[(4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL)METHYL]-1H-IMIDAZOLE-2-CARBALDEHYDE; 1-[2-(1H-INDOL-3-YL)-ETHYL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 1-[2-(1H-INDOL-3-YL)-ETHYL]-2-FORMYLIMIDAZOLE; 1-[2-(2-FORMYLPHENOXY)PROPANOYL]-3-METHYLUREA; 1-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHOXYETHYL)UREA; 1-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHYLPROPYL)UREA; 1-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(PROP-2-EN-1-YL)UREA; 1-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(PROPAN-2-YL)UREA; 1-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]-3-METHYLUREA; 1-[2-(3-CHLORO-2-FORMYLPHENOXY)PROPANOYL]-3-METHYLUREA; 1-[2-(3-FORMYLPHENOXY)PROPANOYL]-3-METHYLUREA; 1-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHOXYETHYL)UREA; 1-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHYLPROPYL)UREA; 1-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]-3-METHYLUREA; 1-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]-3-PROPYLUREA; 1-[2-(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ETHYL]PIPERIDINE-2-CARBALDEHYDE; 1-[2-(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ETHYL]PIPERIDINE-3-CARBALDEHYDE; 1-[2-(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ETHYL]PIPERIDINE-4-CARBALDEHYDE; 1-[2-(4-CHLORO-2-FORMYLPHENOXY)PROPANOYL]-3-METHYLUREA; 1-[2-(4-FORMYLPHENOXY)PROPANOYL]-3-METHYLUREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHOXYETHYL)UREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(2-METHYLPROPYL)UREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(PROP-2-EN-1-YL)UREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-(PROPAN-2-YL)UREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-METHYLUREA; 1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]-3-PROPYLUREA; 1-[2-(IMIDAZOL-4-YL)ETHYL]-2-FORMYLIMIDAZOLE; 1-[3-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]-3-METHYLUREA; 1-[3-(4-FORMYLPIPERIDIN-1-YL)PROPANOYL]-3-METHYLUREA; 1-CYCLOOCTYL-6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 1H-BENZIMIDAZOL-2-YL(METHYLSULFONYL)ACETALDEHYDE; 1H-BENZIMIDAZOL-2-YLMALONALDEHYDE; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-CHLORO-; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-IODO-; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-METHYL-; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-NITRO-; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-TRIFLUOROMETHOXY-; 1H-BENZIMIDAZOLE-2-CARBOXALDEHYDE, 5-TRIFLUOROMETHYL-; 1H-BENZIMIDAZOLE-5-CARBALDEHYDE; 1H-BENZO[D]IMIDAZOLE-4-CARBALDEHYDE; 1H-BENZO[D]IMIDAZOLE-6-CARBALDEHYDE; 1H-BENZO[G]INDOLE-3-CARBOXALDEHYDE; 1H-BENZOIMIDAZOLE-2-CARBOXALDEHYDE; 1H-IMIDAZOLE-4-CARBALDEHYDE; 1H-IMIDAZOLE-5-ACETALDEHYDE; 1H-IMIDAZOLE-5-CARBALDEHYDE; 1H-IMIDAZOLE-5-CARBOXALDEHYDE, 4-(1-METHYLETHYL)-; 1H-IMIDAZOLE-5-CARBOXALDEHYDE, 4-ETHYL-; 1H-IMIDAZOLE-5-CARBOXALDEHYDE, 4-PROPYL-; 1H-IMIDAZOLE-5-CARBOXYLIC ACID, 4-FORMYL-, METHYL ESTER; 1H-INDAZOLE-3-CARBOXALDEHYDE, 5-[(CYCLOHEXYLMETHYL)AMINO]-; 1H-INDAZOLE-6-CARBOXAMIDE, 3-FORMYL-N-(4-HYDROXYPHENYL)-; 1H-INDOLE-1-ACETAMIDE, 3-FORMYL-N-2-PROPEN-1-YL-; 1H-INDOLE-1-ACETAMIDE, 3-FORMYL-N-PROPYL-; 1H-INDOLE-1-ACETAMIDE, N-(1,1-DIMETHYLETHYL)-3-FORMYL-; 1H-INDOLE-2,3-DICARBALDEHYDE; 1H-INDOLE-2-CARBALDEHYDE; 1H-INDOLE-2-CARBOXALDEHYDE, 4-METHOXY-; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-5-METHOXY-6-METHYL-, ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 5-ETHOXY-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-4-METHYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-5,6-DIMETHOXY-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-5-METHYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-6-METHOXY-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-6-METHYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 3-FORMYL-7-METHYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 4-BROMO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 4-FLUORO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 5-ETHOXY-3-FORMYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 5-FORMYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 6-BROMO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 6-BROMO-3-FORMYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 6-CHLORO-3-FORMYL-,METHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 6-CHLORO-4-FLUORO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 6-FLUORO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-2-CARBOXYLIC ACID, 7-BROMO-3-FORMYL-,ETHYL ESTER; 1H-INDOLE-3-CARBOXALDEHYDE,2-CYCLOPENTYL-5-(TRIFLUOROMETHYL)-; 1H-INDOLE-3-PROPANAL; 1H-INDOLE-3-PROPANOIC ACID, 2-FORMYL-4,5,6,7-TETRAHYDRO-; 1H-INDOLE-4-CARBOXYLIC ACID, 3-FORMYL-, ETHYL ESTER; 1H-INDOLE-5-ACETALDEHYDE; 1H-INDOLE-5-CARBOXALDEHYDE, 2-METHYL-; 1H-INDOLE-5-CARBOXALDEHYDE, RADICAL ION(1+); 1H-PURINE-8-CARBOXALDEHYDE, 2,3,6,9-TETRAHYDRO-2,6-DIOXO-; 1H-PYRROLE-2,3,5-TRICARBOXALDEHYDE; 1H-PYRROLE-2,3-DICARBALDEHYDE; 1H-PYRROLE-2,4-DICARBALDEHYDE; 1H-PYRROLE-2,5-DICARBALDEHYDE; 1H-PYRROLE-2-CARBOXALDEHYDE, 4-(CHLOROACETYL)-3,5-DIMETHYL-; 1H-PYRROLE-2-CARBOXALDEHYDE, 4-FLUORO-3,5-DIMETHYL-; 1H-PYRROLE-2-CARBOXALDEHYDE, 5-(METHYLTHIO)-; 1H-PYRROLE-2-CARBOXYLIC ACID, 4-FORMYL-2,3-DIHYDRO-, METHYL ESTER; 1H-PYRROLE-2-PROPANAL; 1H-PYRROLE-3-CARBALDEHYDE; 1H-PYRROLE-3-CARBOXALDEHYDE, 4-PHENYL-; 1H-PYRROLE-3-PROPANAL; 1H-PYRROLO[2,3-B]PYRIDINE-2-CARBALDEHYDE; 1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID, 3-FORMYL-, METHYL ESTER; 1H-PYRROLO[2,3-B]PYRIDINE-3,4-DICARBALDEHYDE; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 2-METHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 4-METHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 5-CHLORO-2-ETHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 5-CHLORO-2-METHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 5-METHOXY-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 6-BROMO-; 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE, 6-CHLORO-4-METHYL-; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-(4-FLUOROPHENYL)-6-(1-METHYLETHYL)-; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-AMINO-6,7-DIHYDRO-2,3-DIMETHYL-6-OXO-; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-CHLORO-3-METHYL; 1H-PYRROLO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 1H-PYRROLO[2,3-C]PYRIDINE-2-CARBALDEHYDE; 1H-PYRROLO[2,3-C]PYRIDINE-5-CARBALDEHYDE; 1H-PYRROLO[3,2-B]PYRIDINE-2-CARBALDEHYDE; 1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 1H-PYRROLO[3,2-B]PYRIDINE-5-CARBOXALDEHYDE; 1H-PYRROLO[3,2-B]PYRIDINE-6-CARBALDEHYDE; 1H-PYRROLO[3,2-B]PYRIDINE-7-CARBOXALDEHYDE; 1H-PYRROLO[3,2-C]PYRIDINE-2-CARBALDEHYDE; 1H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXALDEHYDE; 1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBALDEHYDE; 1-METHYL-4-OXO-4,5-DIHYDRO-1H-PYRAZOLO[3,4-D]PYRIMIDINE-3-CARBALDEHYDE; 1-METHYL-4-OXO-4,5-DIHYDRO-1H-PYRROLO[3,2-C]PYRIDINE-2-CARBALDEHYDE; 1-OXO-1,2,3,4-TETRAHYDROISOQUINOLINE-5-CARBALDEHYDE; 1-OXO-1,2-DIHYDROISOQUINOLINE-4-CARBALDEHYDE; 1-OXO-1,2-DIHYDROISOQUINOLINE-5-CARBALDEHYDE; 1-OXO-1,2-DIHYDROISOQUINOLINE-6-CARBALDEHYDE; 1-OXO-1,2-DIHYDROISOQUINOLINE-7-CARBALDEHYDE; 1-OXOISOINDOLINE-4-CARBALDEHYDE; 1-OXOISOINDOLINE-5-CARBALDEHYDE; 2-((2-HYDROXYETHYL)AMINO)-9-ME-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-((2-METHOXYETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-((2R)-2-PIPERIDYL)PYRIDINE-4-CARBALDEHYDE; 2-((2R)AZETIDIN-2-YL)PYRIDINE-4-CARBALDEHYDE; 2-((2R)PYRROLIDIN-2-YL)PYRIDINE-4-CARBALDEHYDE; 2-((2S)-2-PIPERIDYL)PYRIDINE-4-CARBALDEHYDE; 2-((2S)AZETIDIN-2-YL)PYRIDINE-4-CARBALDEHYDE; 2-((2S)PYRROLIDIN-2-YL)PYRIDINE-4-CARBALDEHYDE; 2-((3,4-DIHYDRO-1(2H)-ISOQUINOLINYLIDENE)-ACETALDEHYDE); 2-((3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL)(METHYL)AMINO)-N-METHYLACETAMIDE; 2-((3R)MORPHOLIN-3-YL)PYRIDINE-4-CARBALDEHYDE; 2-((3S)MORPHOLIN-3-YL)PYRIDINE-4-CARBALDEHYDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(METHYL)AMINO)-N-(PROPAN-2-YL)ACETAMIDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(METHYL)AMINO)-N-METHYLACETAMIDE; 2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(PROPYL)AMINO)-N-METHYLACETAMIDE; 2-((FURAN-2-YLMETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-((TETRAHYDROFURAN-2-YLMETHYL)AMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-([(5-FORMYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)-N-METHYLACETAMIDE; 2-(1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL)ACETALDEHYDE HYDROCHLORIDE; 2-(1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)ACETALDEHYDE HYDROCHLORIDE; 2-(1-ADAMANTYL)-5-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 2-(1-ADAMANTYL)-5-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-(1-ETHYL-PENTYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(1H-BENZOIMIDAZOL-2-YLSULFANYL)-3-PHENYL-PROPENAL; 2-(1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 2-(1H-IMIDAZOL-2-YL)-MALONALDEHYDE; 2-(1H-IMIDAZOL-4-YLMETHYL)-BENZALDEHYDE; 2-(1H-INDOL-3-YL)-2-OXOACETALDEHYDE; 2-(1H-INDOL-3-YL)ACETALDEHYDE; 2-(1H-INDOL-3-YL)PROPANAL; 2-(1H-INDOL-4-YLOXY)-ACETALDEHYDE; 2-(1H-INDOL-5-YL)-BENZALDEHYDE; 2-(1H-PYRROL-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(1H-PYRROL-2-YL)OXAZOLE-5-CARBALDEHYDE; 2-(1H-PYRROL-2-YL)PROPANAL; 2-(1H-PYRROL-3-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(1H-PYRROL-3-YL)PROPANAL; 2-(1-METHYL-1H-PYRROL-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(1-METHYL-BUTYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(1-PIPERAZINYL)-3-PYRIDINECARBOXALDEHYDE; 2-(2,3-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(2,3-DIFLUORO-4-METHYL-PHENYL)-4-FORMYLIMIDAZOLE; 2-(2,3-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,3-DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 2-(2,3-DIHYDRO-BENZOFURAN-5-YL)-4-FORMYL-IMIDAZOLE; 2-(2,3-DIMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2,3-DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,3-DIOXO-2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 2-(2,4,6-TRIMETHYL-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(2,4-DICHLORO-5-FLUORO-PHENYL)-4-FORMYLIMIDAZOLE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; DICHLORO-6-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(2,4-DICHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2,4-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,4-DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,4-DIMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2,4-DIMETHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,4-DIOXO-1,3-DIAZASPIRO[4.4]NONAN-3-YL)ACETALDEHYDE; 2-(2,4-DIOXO-1,3-DIAZASPIRO[4.5]DECAN-3-YL)ACETALDEHYDE; 2-(2,4-DIOXO-1,3-DIAZASPIRO[4.7]DODECAN-3-YL)ACETALDEHYDE; 2-(2,5-DICHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2,5-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,5-DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,5-DIMETHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2,5-DIMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2,5-DIMETHYL-1H-PYRROL-3-YL)-4-FORMYLIMIDAZOLE; 2-(2,5-DIMETHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2,5-DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,5-DIMETHYLTHIEN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; DIOXOIMIDAZOLIDIN-1-YL)ACETALDEHYDE; 2-(2,6-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(2,6-DIFLUORO-4-METHOXYPHENYL)-4-FORMYLIMIDAZOLE; 2-(2,6-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2,6-DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2,6-DIMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2,6-DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(2-AMINO-ETHYL)-1H-IMIDAZOLE-4-CARBALDEHYDE 2HCL; 2-(2-BROMO-4-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-BROMO-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-BROMO-4-METHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-BROMO-5-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-BROMO-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-BROMO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-CHLORO-4,5-DIFLUOROPHENYL)-4-FORMYLIMIDAZOLE; 2-(2-CHLORO-4-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-CHLORO-4-FLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-4-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-4-FLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-4-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-ETHYLACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-ETHYLPROPANAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-PROP-2-YNYLACETAMIDE; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2-CYANOETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(CYCLOPROPYLMETHYL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-CYCLOPENTYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-PHENYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(2-CHLORO-4-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(2-CHLORO-5-FLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-5-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-5-FLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-5-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-5-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-CHLORO-6-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-CHLORO-6-FLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-6-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-6-FLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-6-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROANILINO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(2-CHLORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-CHLOROPHENYL)-4,6-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-4,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5-ETHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-6,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-CHLORO-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-PHENYLACETAMIDE; 2-(2-ETHOXY-4-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-ETHOXY-6-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(2-ETHOXY-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(2-FLUORO-3-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUORO-4-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUORO-4-NITROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUORO-4-NITROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUORO-5-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUORO-5-METHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUORO-5-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUORO-5-NITROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUORO-5-NITROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUORO-6-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-FLUOROANILINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(2-FLUORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-FLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FLUOROPHENYL)-7-METHYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-FORMYL-1H-IMIDAZOL-1-YL)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYL-1H-IMIDAZOL-1-YL)-N-(3-METHOXYPHENYL)ACETAMIDE; 2-(2-FORMYL-1H-IMIDAZOL-1-YL)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(2-FURYLMETHYL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-(TETRAHYDROFURAN-2-YLMETHYL)ACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(2-FORMYL-4-METHOXYPHENOXY)-N-PROPYLPROPANAMIDE; 2-(2-FORMYL-4-METHYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-4-METHYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-4-NITROPHENOXY)-N-PROPYLACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(2-FORMYL-5-METHOXYPHENOXY)-N-PROPYLPROPANAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-5-PROPOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-(TETRAHYDROFURAN-2-YLMETHYL)ACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(2-FORMYL-6-METHOXYPHENOXY)-N-PROPYLPROPANAMIDE; 2-(2-FORMYL-6-METHOXY-PHENOXY)-N-P-TOLYL-ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-FURYLMETHYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHOXYPHENYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(2-PHENYLETHYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHOXYPHENYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(OXAN-4-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PENTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-(TETRAHYDRO-2-FURANYLMETHYL)ACETAMIDE; 2-(2-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-PENTYLPROPANAMIDE; 2-(2-FORMYLPHENOXY)-N-PHENYLACETAMIDE; 2-(2-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(2-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(1,3-THIAZOL-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYL-4-OXOPENTAN-3-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLCYCLOHEXYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHYL-1,2-OXAZOL-5-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(4-METHYL-1,3-THIAZOL-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLCYCLOHEXYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,3,4-OXADIAZOL-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(5-METHYLHEXAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(HEPTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(OXAN-4-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(OXOLAN-2-YLMETHYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(PYRIMIDIN-2-YL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-(THIOPHEN-2-YLMETHYL)ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-[1-(FURAN-2-YL)ETHYL]ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-[1-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-[2-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-[3-(PROPAN-2-YLOXY)PROPYL]ACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-METHYLACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-PENTYLPROPANAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-PHENYLACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-PROPYLACETAMIDE; 2-(2-FORMYLPIPERIDIN-1-YL)-N-PROPYLPROPANAMIDE; 2-(2-IODO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-METHOXY-5-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2-METHOXY-NAPHTHALEN-1-YL)-4-FORMYLIMIDAZOLE; 2-(2-METHOXY-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-METHOXY-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(2-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(2-METHYLSULFANYL-ETHYL)-4-FORMYLIMIDAZOLE; 2-(2-NAPHTHYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(2-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(2-OXOPROPYL)-1H-PYRROLE-3-CARBALDEHYDE; 2-(2-PYRIDINYL)-1H-INDOLE-3-CARBALDEHYDE HYDROCHLORIDE; 2-(2-TRIFLUOROMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(2-TRIFLUOROMETHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-(TRIFLUOROMETHYL)PHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(3,4-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,4-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(3,4-DIMETHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(3,4-DIMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3,4-DIMETHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(3,5-DICHLORO-PHENYL)-IMIDAZOLE-4-CARBALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(3,5-DIMETHOXY-PHENYL)-4-FORMYL-1H-IMIDAZOLE; DIMETHYLPHENYL)IMIDAZOLE-4-CARBALDEHYDE; 2-(3-AZETIDINYLOXY)-BENZALDEHYDE; 2-(3-BROMO-4-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-BROMO-4-METHOXYPHENYL)-4-FORMYLIMIDAZOLE; 2-(3-BROMO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-BROMOPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(3-CHLORO-2-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-CYANOETHYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(CYCLOPROPYLMETHYL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPENTYLACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(3-CHLORO-2-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(3-CHLORO-4-FLUORO-PHENYL)-4-FORMYLIMIDAZOLE; 2-(3-CHLORO-4-FLUOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLORO-4-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLORO-4-FLUOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLORO-4-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-4,6-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-4,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5-ETHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-6,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-CHLORO-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(3-FLUORO-2-METHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-FLUORO-4-METHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(3-FLUORO-4-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-FLUORO-4-METHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-FLUORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-FLUOROPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(3-FLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FLUOROPHENYL)-7-METHYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-FORMYL-1H-INDOL-1-YL)-N-(2-THIENYLMETHYL)ACETAMIDE; 2-(3-FORMYL-1H-PYRROL-2-YL)ACETONITRILE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-N-(PROPAN-2-YL)ACETAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-N-METHYLACETAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-N-METHYLPROPANAMIDE; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-N-PROPYLPROPANAMIDE; 2-(3-FORMYL-2-METHYL-1H-INDOL-1-YL)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-(2-METHOXY-ETHYL)-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-(TETRAHYDRO-FURAN-2-YLMETHYL)-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-FURAN-2-YLMETHYL-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-ISOPROPYL-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-M-TOLYLACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-O-TOLYL-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-PHENYL-ACETAMIDE; 2-(3-FORMYL-INDOL-1-YL)-N-P-TOLYLACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHOXYPHENYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(4-METHOXYPHENYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(OXAN-4-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PENTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(3-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-MESITYLACETAMIDE; 2-(3-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(3-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-PENTYLPROPANAMIDE; 2-(3-FORMYLPHENOXY)-N-PHENYLACETAMIDE; 2-(3-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(3-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(1,3-THIAZOL-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYL-4-OXOPENTAN-3-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLCYCLOHEXYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHYL-1,2-OXAZOL-5-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(4-METHYL-1,3-THIAZOL-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLCYCLOHEXYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,3,4-OXADIAZOL-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(5-METHYLHEXAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(HEPTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(OXAN-4-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(OXOLAN-2-YLMETHYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(PYRIMIDIN-2-YL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-(THIOPHEN-2-YLMETHYL)ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-[1-(FURAN-2-YL)ETHYL]ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-[1-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-[2-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-[3-(PROPAN-2-YLOXY)PROPYL]ACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-METHYLACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-PENTYLPROPANAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-PHENYLACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-PROPYLACETAMIDE; 2-(3-FORMYLPIPERIDIN-1-YL)-N-PROPYLPROPANAMIDE; 2-(3-IODO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-METHOXY-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-METHOXYPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(3-METHOXY-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(3-METHYLBENZO[B]THIOPHEN-2-YL)4-FORMYLIMIDAZOLE; 2-(3-METHYLPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(3-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-METHYL-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(3-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-1-YL)ACETALDEHYDE; 2-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-1-YL)BENZALDEHYDE; 2-(3-OXOPIPERAZIN-1-YL)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-(3-OXOPIPERAZIN-1-YL)ACETALDEHYDE; 2-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 2-(3-OXOPIPERAZIN-1-YL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(3-OXOPIPERAZIN-1-YL)QUINOLINE-3-CARBALDEHYDE; 2-(3-PYRIDINYL)-5-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(3-TRIFLUOROMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(3-TRIFLUOROMETHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-(TRIFLUOROMETHYL)PHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ACETALDEHYDE; 2-(4,5-DIMETHOXY-2-NITRO-PHENYL)-4-FORMYLIMIDAZOLE; 2-(4,5-DIMETHYL-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-BROMO-2-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-BROMO-2-FORMYLPHENOXY)-N-PROP-2-YNYLACETAMIDE; 2-(4-BROMO-3-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-BROMO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-BROMOPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(4-BROMO-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-CYANOETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(CYANOMETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(CYCLOPROPYLMETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PENTAN-2-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-(TETRAHYDROFURAN-2-YLMETHYL)ACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPENTYLACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-ETHYLACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(4-CHLORO-2-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(4-CHLORO-3-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-CHLORO-3-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-CHLORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-CHLOROPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(4-CHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-CHLOROPHENYL)-4,6-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-4,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5-ETHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-6,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-CHLORO-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-ETHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-ETHOXY-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-ETHOXY-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-ETHYL-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-ETHYLPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYLPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-ETHYL-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-FLUORO-3-METHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-FLUORO-3-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-FLUORO-3-NITROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUORO-3-NITROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-1,2-DIHYDROQUINOLINE-4-CARBALDEHYDE; 2-(4-FLUORO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-FLUOROPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-FLUOROPHENYL)-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FLUOROPHENYL)-7-METHYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-3-METHOXY-PHENOL; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-4-METHOXY-PHENOL; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-4-NITRO-PHENOL; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-5-METHOXY-PHENOL; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-6-METHOXY-PHENOL; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZONITRILE; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-PHENOL; 2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(TETRAHYDROFURAN-2-YLMETHYL)ACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-ISOBUTYLACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-PROPYLACETAMIDE; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYL-2-METHOXY-6-NITROPHENOXY)-N-PROP-2-YNYLACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(5-METHYLISOXAZOL-3-YL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-(TETRAHYDROFURAN-2-YLMETHYL)ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-ISOBUTYLACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-FORMYL-2-METHOXY-PHENOXY)-N-O-TOLYL-ACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-PHENYLACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(4-FORMYL-2-METHOXYPHENOXY)-N-PROPYLPROPANAMIDE; 2-(4-FORMYL-2-METHOXY-PHENOXY)-N-P-TOLYL-ACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-FORMYL-2-NITROPHENOXY)-N-PROPYLACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(OXAN-4-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(PENTAN-3-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-METHYLACETAMIDE; 2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-PHENYLACETAMIDE; 2-(4-FORMYLIMIDAZOL-2-YL)-4-TRIFLUOROMETHOXYPHENOL; 2-(4-FORMYL-IMIDAZOL-2-YL)-5-METHOXY-4-NITROPHENOL; 2-(4-FORMYLPHENOXY)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-FURYLMETHYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHYLCYCLOHEXYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHOXYPHENYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(4-METHOXYPHENYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(4-METHYLBENZYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(OXAN-4-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PENTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(PENTAN-3-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(4-FORMYL-PHENOXY)-N-(TETRAHYDRO-FURAN-2-YLMETHYL)-ACETAMIDE; 2-(4-FORMYL-PHENOXY)-N-[2-(1H-IMIDAZOL-4-YL)-ETHYL]-ACETAMIDE; 2-(4-FORMYLPHENOXY)-N-1,3-THIAZOL-2-YLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-2-PYRIDINYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-ISOBUTYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-MESITYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-METHYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-PENTYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-PENTYLPROPANAMIDE; 2-(4-FORMYLPHENOXY)-N-PHENYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-PROPYLACETAMIDE; 2-(4-FORMYLPHENOXY)-N-PROPYLPROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(1,3-THIAZOL-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(1-METHOXYPROPAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHOXYETHYL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYL-4-OXOPENTAN-3-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLBUTAN-2-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLCYCLOHEXYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(2-METHYLPROPYL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHOXYPROPYL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHYL-1,2-OXAZOL-5-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLBUTYL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(3-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(4-METHYL-1,3-THIAZOL-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLCYCLOHEXYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(4-METHYLPHENYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,3,4-OXADIAZOL-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(5-METHYLHEXAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(FURAN-2-YLMETHYL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(HEPTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(OXAN-4-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(OXOLAN-2-YLMETHYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-2-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PENTAN-3-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(PYRIMIDIN-2-YL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-(THIOPHEN-2-YLMETHYL)ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-[1-(FURAN-2-YL)ETHYL]ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-[1-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-[2-(THIOPHEN-2-YL)ETHYL]ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-[3-(PROPAN-2-YLOXY)PROPYL]ACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-METHYLACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-PENTYLPROPANAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-PHENYLACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-PROPYLACETAMIDE; 2-(4-FORMYLPIPERIDIN-1-YL)-N-PROPYLPROPANAMIDE; 2-(4H-1,2,4-TRIAZOL-3-YL)-1,3-THIAZOLE-4-CARBALDEHYDE; 2-(4H-1,2,4-TRIAZOL-3-YL)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBALDEHYDE; 2-(4-IODO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-ISOPROPOXY-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-ISOPROPYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-ISOPROPYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-METHOXY-2-NITRO-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-METHOXY-3-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-METHOXY-NAPHTHALEN-1-YL)-4-FORMYL-IMIDAZOLE; 2-(4-METHOXY-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-METHOXYPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(4-METHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-METHOXY-PHENYLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-METHYL-3-NITRO-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-METHYLPHENYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(4-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-(4-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-(4-TERT-BUTYL-PHENYL)-4-FORMYL-1H-IMIDAZOLE; 2-(4-TRIFLUOROMETHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(4-TRIFLUOROMETHYL-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-3-YL)-BENZALDEHYDE; 2-(5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)-1H-INDOLE-3-CARBALDEHYDE; 2-(5-BROMO-2-FLUORO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(5-BROMO-2-METHOXY-PHENYL)-4-FORMYLIMIDAZOLE; 2-(5-BROMO-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-BROMO-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-CHLORO-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-CHLORO-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-ETHYL-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-ETHYL-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-FLUORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-1-YL)ACETALDEHYDE; 2-(5-FLUORO-2-METHOXY-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(5-FLUORO-2-NITRO-PHENYL)-4-FORMYL-IMIDAZOLE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(2,2,2-TRIFLUOROETHYL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(2-METHOXYETHYL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(2-METHYLPROPYL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-EN-1-YL)PROPANAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROP-2-YN-1-YL)PROPANAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-METHYLACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-PROPYLACETAMIDE; 2-(5-FORMYL-2-METHOXYPHENOXY)-N-PROPYLPROPANAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-(PROPAN-2-YL)ACETAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-METHYLACETAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-METHYLPROPANAMIDE; 2-(5-FORMYL-2-NITROPHENOXY)-N-PROPYLACETAMIDE; 2-(5-HYDROXY-1H-INDOL-3-YL)ACETALDEHYDE; 2-(5-IODO-FURAN-2-YL)-4-FORMYL-IMIDAZOLE; 2-(5-ISOPROPYL-2-METHOXY-PHENYL)-4-FORMYLIMIDAZOLE; 2-(5-METHYL-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-METHYL-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-NITRO-FURAN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-NITRO-THIOPHEN-2-YL)-4-FORMYL-1H-IMIDAZOLE; 2-(5-NITRO-THIOPHEN-3-YL)-4-FORMYL-IMIDAZOLE; 2-(5-OXO-1,4-DIAZEPAN-1-YL)-1,3-THIAZOLE-5-CARBALDEHYDE; 2-(5-OXO-1,4-DIAZEPAN-1-YL)ACETALDEHYDE; 2-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 2-(5-OXO-1,4-DIAZEPAN-1-YL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE; 2-(6,10-DIMETHYL-2,4-DIOXO-1,3-DIAZASPIRO[4.5]DECAN-3-YL)ACETALDEHYDE; 2-(6-METHOXY-NAPHTHALEN-2-YL)-4-FORMYL-IMIDAZOLE; 2-(8-METHYL-2,4-DIOXO-1,3-DIAZASPIRO[4.5]DECAN-3-YL)ACETALDEHYDE; 2-(9H-PURIN-6-YLSULFANYL)ACETALDEHYDE; 2-(ALLYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)NICOTINALDEHYDE; 2-(BENZYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(BENZYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(BUTYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(CYCLOHEXYLAMINO)-BENZALDEHYDE; 2-(DIMETHYLAMINO)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 2-(ETHYL[(5-FORMYL-2-METHOXYPHENYL)METHYL]AMINO)-N-METHYLACETAMIDE; 2-(ETHYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(ETHYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(ETHYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(HEXYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(HYDROXYMETHYL)-1H-INDOLE-3-CARBALDEHYDE; 2-(HYDROXYMETHYL)-1H-PYRROLE-3-CARBALDEHYDE; 2-(ISOBUTYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(ISOPROPYLAMINO)-4-METHYLBENZALDEHYDE; 2-(ISOPROPYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(ISOPROPYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(METHYLAMINO)NICOTINALDEHYDE; 2-(METHYLAMINO)PYRIMIDINE-4-CARBOXALDEHYDE; 2-(METHYLTHIO)-4-[(2-METHOXYPHENYL)AMINO]-5-PYRIMIDINECARBOXALDEHYDE; 2-(METHYLTHIO)-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE-4-CARBALDEHYDE; 2-(NAPHTHALEN-1-YLAMINO)-PYRIMIDINE-5-CARBALDEHYDE; 2-(PHENYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(PIPERAZIN-1-YL)ACETALDEHYDE; 2-(PIPERAZIN-1-YL)PYRIMIDINE-5-CARBALDEHYDE; 2-(PROPYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(PROPYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(PYRROLIDIN-2-YL)PYRIMIDINE-4-CARBALDEHYDE; 2-(SEC-BUTYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 2-(TERT-BUTYLAMINO)PYRIMIDINE-4-CARBALDEHYDE; 2-(TRIFLUOROMETHYL)-1H-BENZO[D]IMIDAZOLE-4-CARBALDEHYDE; 2-(TRIFLUOROMETHYL)-1H-IMIDAZOLE-5-CARBALDEHYDE; 2,2,2-TRIFLUORO-N-(3-FORMYLPHENYL)ACETAMIDE; 2,3,4,5-TETRAHYDRO-1,4-BENZOXAZEPINE-7-CARBALDEHYDE; 2,3,4,9-TETRAHYDRO-1-H-CARBAZOL-3-CARBALDEHYDE; 2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-8-CARBALDEHYDE; 2,3-DIHYDRO-1H-INDOLE-4-CARBALDEHYDE; 2,3-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 2,3-DIHYDRO-1H-INDOLE-6-CARBALDEHYDE; 2,3-DIHYDRO-1H-PYRIDO[3,4-B][1,4]OXAZINE-8-CARBALDEHYDE; 2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 2,3-DIHYDRO-2-OXOBENZO[D]OXAZOLE-5-CARBALDEHYDE; 2,3-DIHYDRO-3,3-DIMETHYL-2-OXO-1H-PYRROLO[3,2-C]PYRIDINE-4-CARBALDEHYDE; 2,3-DIHYDRO-4-METHYL-2-OXO-5-THIAZOLECARBOXALDEHYDE; 2,3-DIHYDRO-5-METHOXY-3-PHENYL-2-INDOLECARBOXALDEHYDE; 2,3-DIMETHYL-1H-INDOLE-5-CARBALDEHYDE; 2,3-DIMETHYL-1H-INDOLE-7-CARBALDEHYDE; 2,3-DIMETHYL-1H-PYRROLO[2,3-C]PYRIDINE-7-CARBALDEHYDE; 2,3-DIOXO-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE-7-CARBALDEHYDE; 2,3-FORMYL PIPERIDINE; 2,4,5-TRIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 2,4,6-TRIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2,4,6-TRIOXO-HEXAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 2,4,7-TRIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2,4-DIAMINO-6-OXO-1,6-DIHYDRO-5-PYRIMIDINECARBALDEHYDE; 2,4-DIAMINO-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBALDEHYDE; 2,4-DICHLORO-N-(3-FORMYL-PHENYL)-BENZAMIDE; 2,4-DIFLUORO-6-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 2,4-DIHYDROXYMETHYL-3-METHYL PYRROL-5-CARBALDEHYDE; 2,4-DIMETHYL PYRROL-3-CARBALDEHYDE; 2,4-DIMETHYL-3-HYDROXYMETHYL PYRROL-5-CARBALDEHYDE; 2,4-DIMETHYL-5-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,4-DIMETHYL-5-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,4-DIMETHYL-5-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,4-DIMETHYL-5-[5-(4-METHYLPHENYL)-1,3,4-OXADIAZOL-2-YL]-1H-PYRROLE-3-CARBALDEHYDE; 2,5,7-TRIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2,5-DIFORMYL-1H-PYRROLE-3-CARBONITRILE; 2,5-DIMETHYL-1-(2-OXOPIPERIDIN-3-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-1H-IMIDAZOLE-4-CARBOXALDEHYDE; 2,5-DIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2,5-DIMETHYL-1H-PYRROLE-3,4-DICARBALDEHYDE; 2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-(3-PHENYL-1,2,4-OXADIAZOL-5-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-[3-(4-METHYLPHENYL)-1,2,4-OXADIAZOL-5-YL]-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIMETHYL-4-[5-(4-METHYLPHENYL)-1,3,4-OXADIAZOL-2-YL]-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DIOXO-3-PYRROLIDINEACETALDEHYDE; 2,5-DIPHENYL-1H-PYRROLE-3-CARBALDEHYDE; 2,5-DITERT-BUTYL-1H-INDOLE-3-CARBALDEHYDE; 2,6-DIAMINO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2,6-DIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2,7-DIMETHYL-1H-INDOLE-3-CARBALDEHYDE; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]-N-METHYLACETAMIDE; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]-N-METHYLPROPANAMIDE; 2-[(2,3-DIMETHYLPHENYL)AMINO]-1,3-THIAZOLE-4-CARBALDEHYDE; 2-[(2,6-DICHLOROPHENYL)AMINO]BENZALDEHYDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(ETHYL)AMINO]-N-ETHYLACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(ETHYL)AMINO]-N-METHYLACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-ETHYLACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-CHLOROPHENYL)AMINO]-BENZALDEHYDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(2-FLUORO-4-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-FORMYL-4-NITROPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-FORMYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(2-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(2-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(2-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(2-FURYLMETHYL)AMINO]-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[(2-FURYLMETHYL)AMINO]PYRIMIDINE-5-CARBALDEHYDE; 2-[(2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-6-YL)OXY]ACETALDEHYDE; 2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 2-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(ETHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(ETHYL)AMINO]-N-ETHYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(ETHYL)AMINO]-N-METHYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-CYCLOPROPYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-ETHYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(3-CHLORO-2-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(3-FORMYLQUINOLIN-2-YL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(4-FLUORO-2-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(4-FORMYL-2-METHYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-2-NITROPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(4-FORMYL-3-METHYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYLPHENYL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(4-FORMYLPHENYL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(4-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-FORMYLPHENYL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(4-FORMYLPHENYL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(4-OXO-6-PROPYL-1,4-DIHYDROPYRIMIDIN-2-YL)SULFANYL]ACETALDEHYDE; 2-[(5-BROMO-2-FORMYLPHENYL)(ETHYL)AMINO]-N-METHYLACETAMIDE; 2-[(5-BROMO-2-FORMYLPHENYL)(METHYL)AMINO]-N-ETHYLACETAMIDE; 2-[(5-BROMO-2-FORMYLPHENYL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]-N-(2-METHOXYETHYL)ACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]-N-METHYLACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]-N-PROPYLACETAMIDE; 2-[(5-FORMYLFURAN-2-YL)(PROPYL)AMINO]-N-METHYLACETAMIDE; 2-[(5-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]ACETALDEHYDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-(PROP-2-EN-1-YL)ACETAMIDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-(PROP-2-YN-1-YL)ACETAMIDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-(PROPAN-2-YL)ACETAMIDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-METHYLACETAMIDE; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-PROPYLACETAMIDE; 2-[(6-METHYL-4-OXO-1,4-DIHYDROPYRIMIDIN-2-YL)SULFANYL]ACETALDEHYDE; 2-[(BENZOYLAMINO)METHYL]-4-FORMYLPHENYL ACETATE; 2-[(CYCLOHEXYLAMINO)(PHENYL)METHYLENE]MALONALDEHYDE; 2-[1-(1H-IMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 2-[2-(1H-IMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 2-[2-(1H-IMIDAZOL-4-YL)-VINYL]-BENZALDEHYDE; 2-[2-(2-METHYLIMIDAZOL-4-YL)-ETHYL]BENZALDEHYDE; 2-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 2-[3-(2-OXO-PYRROLIDIN-1-YL)-PROPYLAMINO]-PYRIMIDINE-4-CARBALDEHYDE; 2-[4-(1,1-DIMETHYLETHYL)PHENYL]-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-[4-(1,1-DIMETHYLETHYL)PHENYL]-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-[4-(1,1-DIMETHYLETHYL)PHENYL]-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-[4-(1,1-DIMETHYLETHYL)PHENYL]-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-[4-(PHENYLAMINO)PHENOXY]ACETALDEHYDE; 2-[ETHYL((3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL))AMINO]-N-METHYLACETAMIDE; 2-[ETHYL((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL))AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(2-FLUORO-4-FORMYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(2-FLUORO-4-FORMYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(2-FORMYL-4-NITROPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(2-FORMYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(2-FORMYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(2-OXOETHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(2-OXOETHYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(3-OXOPROPYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(3-OXOPROPYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FLUORO-2-FORMYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(4-FLUORO-2-FORMYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FORMYL-2-METHYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(4-FORMYL-2-METHYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FORMYL-2-NITROPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FORMYL-3-METHYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(4-FORMYL-3-METHYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(4-FORMYLPHENYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(4-FORMYLPHENYL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(5-FORMYLFURAN-2-YL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[ETHYL(5-FORMYLFURAN-2-YL)AMINO]-N-METHYLACETAMIDE; 2-[ETHYL(PIPERIDIN-4-YL)AMINO]ACETALDEHYDE; 2-[METHYL(2-OXOETHYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[METHYL(3-OXOPROPYL)AMINO]-N-(PROPAN-2-YL)ACETAMIDE; 2-[METHYL(3-OXOPROPYL)AMINO]-N-PROPYLACETAMIDE; 2-[METHYL(PIPERIDIN-4-YL)AMINO]ACETALDEHYDE; 2-[PIPERIDIN-4-YL(PROPYL)AMINO]ACETALDEHYDE; 2-ACETAMIDO-2-DEOXY-DEXTRO-GALACTOPYRANOSE HYDRATE; 2-ACETAMIDO-4-HYDROXY-6-PTERIDINECARBOXALDEHYDE; 2-AMINO-1H-IMIDAZOLE-4-CARBALDEHYDE HCL; 2-AMINO-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-ANILINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-ANILINOPYRIMIDINE-5-CARBALDEHYDE; 2-BENZAMIDOCINNAMALDEHYDE; 2-BENZO[B]THIOPHEN-2-YL-4-FORMYL-IMIDAZOLE; 2-BENZYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-BROMO-4-FORMYLPIPERIDINE; 2-BROMO-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXALDEHYDE; 2-BUTYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-BUTYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-CHLORO-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE-4-CARBALDEHYDE; 2-CHLORO-6-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 2-CHLORO-6-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 2-CHLORO-6-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 2-CHLORO-6-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 2-CHLORO-6-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 2-CHLORO-N-(3-FORMYL-PHENYL)-BENZAMIDE; 2-CYCLOHEX-3-ENYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-CYCLOHEXYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-CYCLOHEXYL-4,6-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-4,6-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-4,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-4,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-(1,1-DIMETHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-ETHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-6,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-6,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYL-7-METHYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOHEXYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-CYCLOPENTYL-1H-INDOLE-3-CARBALDEHYDE; 2-CYCLOPROPOXY-3-(METHYLAMINO)BENZALDEHYDE; 2-CYCLOPROPOXY-3-FORMYL-N-METHYLBENZAMIDE; 2-CYCLOPROPOXY-4-(METHYLAMINO)BENZALDEHYDE; 2-CYCLOPROPOXY-4-FORMYL-N-METHYLBENZAMIDE; 2-CYCLOPROPOXY-5-(METHYLAMINO)BENZALDEHYDE; 2-CYCLOPROPOXY-5-FORMYL-N-METHYLBENZAMIDE; 2-CYCLOPROPOXY-6-(METHYLAMINO)BENZALDEHYDE; 2-CYCLOPROPOXY-6-FORMYL-N-METHYLBENZAMIDE; 2-CYCLOPROPYL-4,6-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-4,6-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-4,6-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-4,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-4,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-4,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-(1,1-DIMETHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-(1-METHYLETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-ETHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-6,7-DICHLORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-6,7-DIFLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-6,7-DIMETHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-FLUORO-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-METHOXY-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-METHOXY-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYL-7-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-CYCLOPROPYLAMINO-PYRIMIDINE-4-CARBALDEHYDE; 2-ETHENYL-1H-INDOLE-3-CARBOXALDEHYDE; 2-ETHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 2-ETHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 2-ETHYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 2-ETHYL-4-FORMYLIMIDAZOLE; 2-ETHYL-4-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-ETHYL-5-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-ETHYL-5-OXO-5,6-DIHYDRO-IMIDAZO[1,2-C]PYRIMIDINE-3-CARBALDEHYDE; 2-FLUORO-4-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 2-FLUORO-4-(PIPERIDIN-3-YL)BENZALDEHYDE HCL; 2-FLUORO-4-(PIPERIDIN-4-YL)BENZALDEHYDE HYDROCHLORIDE; 2-FLUORO-4-(PYRROLIDIN-3-YL)BENZALDEHYDE HCL; 2-FLUORO-5-(1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 2-FLUORO-5-(4-FORMYL-IMIDAZOL-2-YL)-BENZONITRILE; 2-FLUORO-6-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 2-FORMYL-1,4,6,7-TETRAHYDRO-PYRROLO[3,2-C]PYRIDINE-5-CARBOXYLIC ACID TERT-BUTYL ESTER; 2-FORMYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID METHYL ESTER; 2-FORMYL-1H-IMIDAZOLE-4-CARBONITRILE; 2-FORMYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-FORMYL-1H-INDOLE-6-CARBONITRILE; 2-FORMYL-1H-PYRROLE-3-CARBONITRILE; 2-FORMYL-3-HYDROXY-N-METHYLBENZAMIDE; 2-FORMYL-3-METHYL-1-OXO-1,5-DIHYDRO-BENZO[4,5]IMIDAZO[1,2-A]PYRIDINE-4-CARBONITRILE; 2-FORMYL-4-(5-BROMOTHIOPHEN-2-YL)IMIDAZOLE; 2-FORMYL-4-(5-CHLOROTHIOPHEN-2-YL)IMIDAZOLE; 2-FORMYL-4-(5-METHYLTHIOPHEN-2-YL)IMIDAZOLE; 2-FORMYL-4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDINE HYDROCHLORIDE; 2-FORMYL-4-[3-(N-METHYLAMINOCARBONYL)PHENYL]PHENOL; 2-FORMYL-4-HYDROXY-N-METHYLBENZAMIDE; 2-FORMYL-4-METHOXY-N-METHYL-BENZAMIDE; 2-FORMYL-5-[3-(N-METHYLAMINOCARBONYL)PHENYL]PHENOL; 2-FORMYL-5-HYDROXY-N-METHYLBENZAMIDE; 2-FORMYL-5-METHOXY-N-METHYL-BENZAMIDE; 2-FORMYL-5-METHYL-1H-IMIDAZO[4,5-C]PIPERIDINE; 2-FORMYL-5-METHYL-1H-PYRROLE-3,4-DICARBONITRILE; 2-FORMYL-6-[3-(N-METHYLAMINOCARBONYL)PHENYL]PHENOL; 2-FORMYL-6H-FURO[2,3-B]PYRROLE-5-CARBOXYLIC ACID; 2-FORMYL-6-HYDROXY-N-METHYLBENZAMIDE; 2-FORMYL-6-METHOXY-1H-INDOLE; 2-FORMYL-7-METHYL-4,5,6,7-TETRAHYDROBENZOIMIDAZOLE; 2-FORMYL-N-ISOPROPYLTHIAZOLE-4-CARBOXAMIDE; 2-FORMYLPIPERIDINE; 2-FORMYLPIPERIDINE HCL; 2-FURAN-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-FURAN-3-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-FURANCARBOXALDEHYDE, 5-(1H-INDOL-5-YL)-; 2-HEPTYL-1,4-DIHYDRO-4-OXO-3-QUINOLINECARBOXALDEHYDE; 2-HYDROXY-3-(METHYLAMINO)BENZALDEHYDE; 2-HYDROXY-4-(METHYLAMINO)BENZALDEHYDE; 2-HYDROXY-5-(METHYLAMINO)BENZALDEHYDE; 2-HYDROXY-5-METHYL-3-(PIPERIDIN-3-YL)BENZALDEHYDE; 2-HYDROXY-5-METHYL-3-(PIPERIDIN-4-YL)BENZALDEHYDE; 2-HYDROXY-5-METHYL-3-(PYRROLIDIN-3-YL)BENZALDEHYDE; 2-HYDROXY-6-(METHYLAMINO)BENZALDEHYDE; 2-ISOBUTYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-ISOPROPYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-MERCAPTO-1H-INDOLE-3-CARBALDEHYDE; 2-METHOXY-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-METHYL-1H-BENZO[D]IMIDAZOLE-4-CARBALDEHYDE; 2-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-METHYL-1H-INDOLE-3-ACETALDEHYDE; 2-METHYL-1H-INDOLE-4-CARBALDEHYDE; 2-METHYL-1H-INDOLE-7-CARBALDEHYDE; 2-METHYL-1H-PYRROLE-3-CARBALDEHYDE; 2-METHYL-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 2-METHYL-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 2-METHYL-4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 2-METHYL-4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 2-METHYL-4-(METHYLAMINO)BENZALDEHYDE; 2-METHYL-4H-FURO[3,2-B]PYRROLE-5-CARBALDEHYDE; 2-METHYL-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 2-METHYL-5-NITRO-1H-INDOLE-3-CARBALDEHYDE; 2-METHYL-5-OXO-5,6-DIHYDRO-IMIDAZO[1,2-C]PYRIMIDINE-3-CARBALDEHYDE; 2-METHYL-9-OXO-4H,9H-PYRAZOLO[3,2-B]QUINAZOLINE-3-CARBALDEHYDE; 2-METHYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-METHYLAMINO-THIAZOLE-5-CARBALDEHYDE; 2-METHYLIMIDAZOLE-5-CARBOXALDEHYDE; 2-METHYLINDOLE-3-CARBOXALDEHYDE; 2-METHYLSULFANYL-3H-IMIDAZOLE-4-CARBALDEHYDE; 2-METHYLSULFANYL-4-PHENYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-METHYLSULFANYL-5-TRIMETHYLSILANYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-METHYLTHIO-4-ISOAMYLAMINO-5-PYRIMIDINECARBOXALDEHYDE; 2-MORPHOLINECARBOXALDEHYDE; 2-M-TOLYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-M-TOLYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-NAPHTHALEN-1-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-NAPHTHALEN-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-N-BOC-AMINO-3-FORMYLPYRIDINE; 2-O-TOLYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-O-TOLYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-OXO-1,2,6,7,8,9-HEXAHYDROBENZO[G]QUINOLINE-3-CARBALDEHYDE; 2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 2-OXO-1,2-DIHYDROQUINOLINE-7-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-1H-PYRIDO[2,3-B][1,4]OXAZINE-7-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBALDEHYDE; 2-OXO-2,3-DIHYDRO-BENZOOXAZOLE-6-CARBALDEHYDE; 2-OXO-2-PHENYLETHYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; 2-OXO-4-(PROPYLAMINO)-2H-CHROMENE-3-CARBALDEHYDE; 2-OXO-5-PROPYLINDOLINE-3-CARBALDEHYDE; 2-OXO-IMIDAZOLIDINE-4-CARBALDEHYDE; 2-OXOINDOLINE-3-CARBALDEHYDE; 2-PHENETHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-PHENYL-1H-BENZO[D]IMIDAZOLE-4-CARBALDEHYDE; 2-PHENYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-PHENYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXALDEHYDE; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBOXALDEHYDE; 2-PHENYLINDOLE-3-CARBOXALDEHYDE; 2-PIPERAZIN-1-YL-5-TRIFLUOROMETHYLBENZALDEHYDE; 2-PIPERAZIN-1-YL-BENZALDEHYDE; 2-PIPERAZINECARBOXALDEHYDE; 2-PROPENAL, 3-[(4-METHYLPHENYL)AMINO]-2-NITRO-; 2-PROPYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-P-TOLYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-P-TOLYLAMINO-PYRIMIDINE-5-CARBALDEHYDE; 2-PYRIDIN-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-PYRIDIN-2-YL-1H-INDOLE-3-CARBALDEHYDE; 2-PYRIDIN-3-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-PYRIDIN-3-YL-1H-INDOLE-3-CARBALDEHYDE; 2-PYRIDIN-4-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-PYRIDIN-4-YL-1H-INDOLE-3-CARBALDEHYDE; 2-PYRIDINECARBOXALDEHYDE, 4-[4-(METHYLAMINO)-3-NITROPHENOXY]-; 2-PYRIDONE-6-CARBOXALDEHYDE; 2-PYRROLECARBAMIC ACID, 4-FORMYL-3,5-DIMETHYL-; 2-QUINOLIN-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-SEC-BUTYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-STYRYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-TERT-BUTYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-TERT-BUTYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 2-TERT-BUTYL-3-FORMYL-1H-INDOLE-5-CARBONITRILE; 2-TERT-BUTYL-4-CHLORO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-4-FLUORO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5,7-DIFLUORO-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5-CHLORO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5-ISOPROPYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-5-PHENYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-7-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-7-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 2-TERT-BUTYL-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 2-THIAZOL-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-THIEN-2-YL-1H-INDOLE-3-CARBALDEHYDE; 2-THIOPHEN-2-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-THIOPHEN-3-YL-1H-IMIDAZOLE-4-CARBALDEHYDE; 2-THIOPHENECARBOXALDEHYDE, 5-(1H-INDOL-5-YL)-; 2-THIOXO-1,2-DIHYDROPYRIDINE-3-CARBALDEHYDE; 2-VINYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 3-((2R)(2-PIPERIDYL))-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2R)AZETIDIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2R)PIPERAZIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2R)PYRROLIDIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2S)(2-PIPERIDYL))-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2S)AZETIDIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2S)PIPERAZIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((2S)PYRROLIDIN-2-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((3R)MORPHOLIN-3-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-((3S)MORPHOLIN-3-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-(1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL)PROPANAL HYDROCHLORIDE; 3-(1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)PROPANAL HYDROCHLORIDE; 3-(1,4-DIAZEPAN-1-YL)PROPANAL; 3-(1H-BENZOIMIDAZOL-2-YLSULFANYL)-3-PHENYL-PROPENAL; 3-(1H-BENZOIMIDAZOL-2-YLSULFANYLMETHYL)-4-METHOXY-BENZALDEHYDE; 3-(1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 3-(1H-IMIDAZOL-2-YL)-PROPIONALDEHYDE; 3-(1H-IMIDAZOL-4-YL)BENZALDEHYDE; 3-(1H-IMIDAZOL-4-YL)-PROPIONALDEHYDE; 3-(1H-IMIDAZOL-4-YLMETHYL)-BENZALDEHYDE; 3-(1H-INDOL-5-YL)BENZALDEHYDE; 3-(1-METHYL-1,2,3,6-TETRAHYDRO-PYRIDIN-4-YL)-1H-INDOLE-5-CARBALDEHYDE; 3-(2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 3-(2,3-DIOXO-2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 3-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(2,4-DICHLORO-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2,4-DIMETHYL-5-FORMYL-1H-PYRROLE-3-YL)PROPANOIC ACID; 3-(2,4-DIOXO-1,3-DIAZASPIRO[4.4]NONAN-3-YL)PROPANAL; 3-(2,4-DIOXO-1,3-DIAZASPIRO[4.5]DECAN-3-YL)PROPANAL; 3-(2,4-DIOXO-1,3-DIAZASPIRO[4.7]DODECAN-3-YL)PROPANAL; 3-(2,5-DIOXO-4-PROPYLIMIDAZOLIDIN-1-YL)PROPANAL; 3-(2,5-DIOXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(2-AMINOETHYLAMINO)-5-METHYL-1H-PYRAZOLE-4-CARBALDEHYDE; 3-(2-BROMO-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-BROMO-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-ETHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(2-CHLORO-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-ETHOXY-4-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(2-ETHOXY-4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-ETHOXY-6-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(2-ETHOXY-6-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-ETHOXYCARBONYLETHYL)-2,4-DIMETHYL-5-FORMYLPYRROLE; 3-(2-FORMYL-4-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-FORMYL-4-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYL-4-METHYL-1H-PYRROL-3-YL)-PROPIONIC ACID; 3-(2-FORMYL-4-METHYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYL-4-NITROPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYL-5-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-FORMYL-5-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYL-5-PROPOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYL-6-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-FORMYL-6-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)PROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 3-(2-FORMYLPIPERIDIN-1-YL)-N-PHENYLPROPANAMIDE; 3-(3-[(METHYLAMINO)METHYL]PIPERIDIN-1-YL)PROPANAL; 3-(3-AZETIDINYLOXY)-BENZALDEHYDE; 3-(3-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(3-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 3-(3-CHLORO-2-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(3-CHLORO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(3-FORMYL-1H-INDOL-5-YL)BENZOIC ACID; 3-(3-FORMYL-1H-INDOL-5-YL)BENZONITRILE; 3-(3-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(3-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)PROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 3-(3-FORMYLPIPERIDIN-1-YL)-N-PHENYLPROPANAMIDE; 3-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-1-YL)PROPANAL; 3-(3-OXOPIPERAZIN-1-YL)PROPANAL; 3-(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(4-BROMO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-BUTYL-4-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(4-CHLORO-2-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-CHLORO-2-FORMYLPHENOXY)-N-CYCLOPROPYLPROPANAMIDE; 3-(4-CHLORO-2-FORMYLPHENOXY)-N-ETHYLPROPANAMIDE; 3-(4-CHLORO-2-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-ETHYL-4-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)PROPANAL; 3-(4-FORMYL-1H-IMIDAZOL-2-YL)-4-NITRO-PHENOL; 3-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 3-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZONITRILE; 3-(4-FORMYL-1H-IMIDAZOL-2-YL)-PHENOL; 3-(4-FORMYL-2,6-DIMETHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-FORMYL-2,6-DIMETHYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-FORMYL-2-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-FORMYL-2-NITROPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-FORMYLPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-FORMYLPHENOXY)-N-METHYLPROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)-N-(5-METHYL-1,2-OXAZOL-3-YL)PROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)-N-METHYLPROPANAMIDE; 3-(4-FORMYLPIPERIDIN-1-YL)-N-PHENYLPROPANAMIDE; 3-(4-PHENYL-1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 3-(5-CHLORO-1H-INDOL-3-YL)PROPANAL; 3-(5-FLUORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-1-YL)PROPANAL; 3-(5-FORMYL-2-METHOXYPHENOXY)-N-(PROPAN-2-YL)PROPANAMIDE; 3-(5-FORMYL-2-METHOXYPHENOXY)-N-METHYLPROPANAMIDE; 3-(5-FORMYL-2-NITROPHENOXY)-N-METHYLPROPANAMIDE; 3-(5-FORMYL-4H-1,2,4-TRIAZOL-3-YL)BENZONITRILE; 3-(5-FORMYL-4-METHYL-1H-PYRROL-3-YL)PROPANENITRILE; 3-(5-OXO-1,4-DIAZEPAN-1-YL)PROPANAL; 3-(5-OXO-PYRROLIDIN-3-YL)-BENZALDEHYDE; 3-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)BENZALDEHYDE; 3-(8-METHYL-2,4-DIOXO-1,3-DIAZASPIRO[4.5]DECAN-3-YL)PROPANAL; 3-(9H-PURIN-6-YLSULFANYL)PROPANAL; 3-(AZETIDIN-3-YL)-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-(BOC-AMIDINO)-BENZALDEHYDE; 3-(CHLOROMETHYL)-2-FORMYL-1-OXO-1,5-DIHYDROPYRIDO[1,2-A]BENZIMIDAZOLE-4-CARBONITRILE; 3-(CYCLOHEXYLAMINO)-2-ISOPROPYL-3-PHENYLACRYLALDEHYDE; 3-(PIPERAZIN-1-YL)PROPANAL; 3,3-DIMETHYL-2-OXO-2,3-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 3,4,5,6-TETRAHYDROXY-2-(METHYLAMINO)HEXANAL; 3,4,5-TRIMETHYL-1H-PYRROLE-2-CARBOXALDEHYDE; 3,4-BIS(4-FLUOROPHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 3,4-BIS(TRIFLUOROMETHYL)-1H-PYRROLE-2,5-DICARBALDEHYDE; 3,4-BIS(TRIFLUOROMETHYL)-1H-PYRROLE-2-CARBALDEHYDE; 3,4-DIHYDRO-2,3-DIOXO-2H-BENZO[B][1,4]OXAZINE-6-CARBALDEHYDE; 3,4-DIHYDRO-3-OXO-2H-BENZO[B][1,4]OXAZINE-8-CARBALDEHYDE; 3,4-DIHYDRO-3-OXO-2-QUINOXALINECARBOXALDEHYDE; 3,4-DIMETHYL-1H-PYRROLE-2-CARBOXALDEHYDE; 3,4-DIMETHYL-2,5-PYRROLEDICARBOXALDEHYDE; 3,4-DIMETHYL-5-FORMYLPYRROLE-2-CARBOXYLIC ACID; 3,5-DIBROMO-4-(METHYLAMINO)BENZALDEHYDE; 3,5-DICHLORO-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3,5-DICHLORO-4-(METHYLAMINO)BENZALDEHYDE; 3,5-DIFLUORO-4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 3,5-DIFLUORO-4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 3,5-DIMETHYL-1-(7H-PURIN-6-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 3,5-DIMETHYL-1H-INDOLE-2-CARBALDEHYDE; 3,5-DIMETHYL-1H-PYRROLE-2-CARBOXALDEHYDE; 3,5-DIMETHYL-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3,5-DIMETHYL-4-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 3,5-DIMETHYL-4-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 3,5-DIMETHYL-PYRROLE-2,4-DICARBOXALDEHYDE; 3,7-DIMETHYL-1H-INDOLE-2-CARBALDEHYDE; 3,7-DIMETHYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURINE-8-CARBALDEHYDE; 3-[(1-FORMYLNAPHTHALEN-2-YL)OXY]-N-METHYLPROPANAMIDE; 3-[(1R)-1-(METHYLAMINO)ETHYL]-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-[(1S)-1-(METHYLAMINO)ETHYL]-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-[(1S)-2-HYDROXY-1-(METHYLAMINO)ETHYL]-2-HYDROXY-5-METHYLBENZALDEHYDE; 3-[(2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(2,5-DIOXOIMIDAZOLIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-6-YL)OXY]PROPANAL; 3-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 3-[(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)METHYL]-4-METHOXYBENZALDEHYDE; 3-[(4-NITROPHENYL)AMINO]-1H-INDOLE-2-CARBALDEHYDE; 3-[(5-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]PROPANAL; 3-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]-N-METHYLPROPANAMIDE; 3-[(BENZYLOXYCARBONYL)AMINO]-1-PROPANAL; 3-[1-(1H-IMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 3-[2-(1H-IMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 3-[2-(1H-IMIDAZOL-4-YL)-VINYL]-BENZALDEHYDE; 3-[2-(2-METHYLIMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 3-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 3-[4-(FURAN-2-YL)-4-METHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL]PROPANAL; 3-[4-(PHENYLAMINO)PHENOXY]PROPANAL; 3-[ETHYL(PIPERIDIN-4-YL)AMINO]PROPANAL; 3-[METHYL(PIPERIDIN-4-YL)AMINO]PROPANAL; 3-[PIPERIDIN-4-YL(PROPYL)AMINO]PROPANAL; 3-ACETAMIDOPHENYLGLYOXAL HYDRATE; 3-ACETYL-4-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 3-AMINO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-ANILINO-2-NITROACRYLALDEHYDE; 3-BUTYL-1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; 3-CHLORO-4-(METHYLAMINO)BENZALDEHYDE; 3-CHLORO-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-CHLORO-4-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 3-CHLORO-5-METHOXY-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-CYANO-4-METHYL-7-AZAINDOLE-4-CARBALDEHYDE; 3-CYCLOPROPOXY-2-(METHYLAMINO)BENZALDEHYDE; 3-CYCLOPROPOXY-2-(METHYLAMINO)ISONICOTINALDEHYDE; 3-CYCLOPROPOXY-2-FORMYL-N-METHYLBENZAMIDE; 3-CYCLOPROPOXY-2-FORMYL-N-METHYLISONICOTINAMIDE; 3-CYCLOPROPOXY-4-(METHYLAMINO)BENZALDEHYDE; 3-CYCLOPROPOXY-4-(METHYLAMINO)PICOLINALDEHYDE; 3-CYCLOPROPOXY-4-FORMYL-N-METHYLBENZAMIDE; 3-CYCLOPROPOXY-4-FORMYL-N-METHYLPICOLINAMIDE; 3-CYCLOPROPOXY-5-(METHYLAMINO)CYCLOHEXA-1,3-DIENECARBALDEHYDE; 3-CYCLOPROPOXY-5-(METHYLAMINO)ISONICOTINALDEHYDE; 3-CYCLOPROPOXY-5-(METHYLAMINO)PICOLINALDEHYDE; 3-CYCLOPROPOXY-5-FORMYL-N-METHYLBENZAMIDE; 3-CYCLOPROPOXY-5-FORMYL-N-METHYLISONICOTINAMIDE; 3-CYCLOPROPOXY-5-FORMYL-N-METHYLPICOLINAMIDE; 3-CYCLOPROPOXY-6-(METHYLAMINO)PICOLINALDEHYDE; 3-CYCLOPROPOXY-6-FORMYL-N-METHYLPICOLINAMIDE; 3-CYCLOPROPYL-1-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; 3-CYCLOPROPYL-1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; 3-DIMETHYLAMINOMETHYL-1H-INDOLE-2-CARBALDEHYDE; 3-ET-5((4-ET-5-FORMYL-3-ME-2H-PYRROL-2-YLIDENE)ME)-4-ME-1H-PYRROLE-2-CARBALDEHYDE; 3-ETHOXY-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-ETHOXY-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-ETHYL-1-[2-(2-FORMYLPHENOXY)PROPANOYL]UREA; 3-ETHYL-1-[2-(2-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; 3-ETHYL-1-[2-(3-FORMYLPHENOXY)PROPANOYL]UREA; 3-ETHYL-1-[2-(3-FORMYLPIPERIDIN-1-YL)PROPANOYL]UREA; 3-ETHYL-1-[2-(4-FORMYLPHENOXY)PROPANOYL]UREA; 3-ETHYL-1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; 3-ETHYL-1H-INDOLE-2-CARBALDEHYDE; 3-ETHYL-4,5-DIMETHYLPYRROLE-2-CARBOXALDEHYDE; 3-ETHYL-4-METHYL-1H-PYRROLE-2,5-DICARBOXALDEHYDE; 3-ETHYL-4-METHYL-1H-PYRROLE-2-CARBOXALDEHYDE; 3-ETHYL-5-METHYL-1H-INDOLE-2-CARBALDEHYDE; 3-ETHYL-5-OXO-5,6-DIHYDRO-IMIDAZO[1,2-C]PYRIMIDINE-2-CARBALDEHYDE; 3-FLUORO-2-(1-PIPERAZINO)-BENZALDEHYDE; 3-FLUORO-2-(1-PIPERAZINO)-BENZALDEHYDE HYDROCHLORIDE; 3-FLUORO-4-(1-PIPERAZINO)-BENZALDEHYDE HYDROCHLORIDE; 3-FLUORO-4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 3-FLUORO-4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 3-FLUORO-5-(1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 3-FORMALDEHYDE PIPERIDINE; 3-FORMYL-1,6-DIHYDROXYCARBAZOLE; 3-FORMYL-1H-INDOLE-2-CARBONITRILE; 3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-4-CARBONITRILE; 3-FORMYL-1H-INDOLE-4-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-4-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-1H-INDOLE-5-CARBOXYLIC ACID ETHYL ESTER; 3-FORMYL-1H-INDOLE-6-CARBONITRILE; 3-FORMYL-1H-INDOLE-6-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-6-CARBOXYLIC ACID ETHYL ESTER; 3-FORMYL-1H-INDOLE-7-CARBONITRILE; 3-FORMYL-1H-INDOLE-7-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER; 3-FORMYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBONITRILE; 3-FORMYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBONITRILE; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-4-CARBONITRILE; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-4-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-7-CARBONITRILE; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-7-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[3,2-B]PYRIDINE-5-CARBONITRILE; 3-FORMYL-1H-PYRROLO[3,2-B]PYRIDINE-5-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBONITRILE; 3-FORMYL-1H-PYRROLO[3,2-B]PYRIDINE-7-CARBONITRILE; 3-FORMYL-2-HYDROXY-N-METHYLBENZAMIDE; 3-FORMYL-4(1H)-PYRIDONE; 3-FORMYL-4,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-4,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-4-AZAINDOLE-5-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-4-AZAINDOLE-6-CARBOXYLIC ACID; 3-FORMYL-4-AZAINDOLE-6-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-4-HYDROXY-N-METHYLBENZAMIDE; 3-FORMYL-4-METHYL-1H-INDOLE-7-CARBONITRILE; 3-FORMYL-4-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID; 3-FORMYL-4-METHYLINDOLE; 3-FORMYL-4-NITRO-7-AZAINDOLE; 3-FORMYL-5,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-5,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-5-AZAINDOLE; 3-FORMYL-5-HYDROXY-N-METHYLBENZAMIDE; 3-FORMYL-5-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-5-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-5-NITRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER; 3-FORMYL-6-(TRIFLUOROMETHYL)-1H-INDOLE-5-CARBONITRILE; 3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHYL-5-NITRO-7-AZAINDOLE; 3-FORMYL-6-METHYL-7-AZAINDOLE; 3-FORMYLINDOLE-4-BORONIC ACID PINACOL ESTER; 3-FORMYLINDOLE-5-CARBOXYLIC ACID; 3-FORMYLINDOLE-7-CARBOXYLIC ACID ETHYL ESTER; 3-FORMYLINDOLE-7-CARBOXYLIC ACID METHYL ESTER; 3-FORMYL-N,N-DIMETHYL-1H-INDOLE-5-SULFONAMIDE; 3-FORMYL-N-METHYL-BENZAMIDE; 3-FORMYLPHENYL PHENYLCARBAMATE; 3H-BENZO[D]IMIDAZOLE-4-CARBALDEHYDE; 3H-IMIDAZO[4,5-B]PYRIDINE-2-CARBOXALDEHYDE; 3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBALDEHYDE; 3H-IMIDAZO[4,5-B]PYRIDINE-7-CARBALDEHYDE; 3-HYDROXY-2-(METHYLAMINO)BENZALDEHYDE; 3-HYDROXY-4-(METHYLAMINO)BENZALDEHYDE; 3-HYDROXY-5-(METHYLAMINO)BENZALDEHYDE; 3-METHOXY-1H-PYRROLE-2-CARBALDEHYDE; 3-METHOXY-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-METHOXY-2-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 3-METHOXY-2-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 3-METHOXY-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-METHOXY-4-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 3-METHOXY-4-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 3-METHYL-1H-PYRROLE-2,4-DICARBALDEHYDE; 3-METHYL-1H-PYRROLE-2,5-DICARBALDEHYDE; 3-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 3-METHYL-3-PHENYLAMINO-BUTYRALDEHYDE; 3-METHYL-4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 3-METHYL-4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 3-METHYL-5-OXO-5,6-DIHYDRO-IMIDAZO[1,2-C]PYRIMIDINE-2-CARBALDEHYDE; 3-N-BOC-AMINO-4-FORMYL-5-METHOXYPYRIDINE; 3-NITRO-1H-PYRROLE-2-CARBALDEHYDE; 3-NITRO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 3-NITRO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 3-NITRO-4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 3-NITRO-4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 3-NITRO-4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 3-OXO-1,3-DIHYDRO-ISOINDOLE-4-CARBALDEHYDE; 3-OXO-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE-6-CARBALDEHYDE; 3-OXO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-7-CARBALDEHYDE; 3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]OXAZINE-6-CARBALDEHYDE; 3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]THIAZINE-6-CARBALDEHYDE; 3-OXOISOINDOLINE-5-CARBALDEHYDE; 3-PHENYL-1H-INDOLE-2-CARBALDEHYDE; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXALDEHYDE; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXALDEHYDE; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBOXALDEHYDE; 3-TERT-BUTYL-1-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]UREA; 4-((2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL)BENZALDEHYDE; 4-((4-[(1R)-1-(METHYLAMINO)ETHYL]PHENYL)METHYL)BENZALDEHYDE; 4-((4-[(1S)-1-(METHYLAMINO)ETHYL]PHENYL)METHYL)BENZALDEHYDE; 4-((4-[(1S)-2-HYDROXY-1-(METHYLAMINO)ETHYL]PHENYL)METHYL)BENZALDEHYDE; 4-(1,1-DIMETHYLETHYL)-1H-PYRROLE-2-CARBOXALDEHYDE; 4-(1H-BENZIMIDAZOL-6-YLOXY)-3-CHLORO-BENZALDEHYDE; 4-(1H-BENZIMIDAZOL-6-YLOXY)-BENZALDEHYDE; 4-(1H-BENZOIMIDAZOL-2-YLMETHOXY)-3-METHOXY-BENZALDEHYDE; 4′-(1H-IMIDAZOL-2-YL)-[1,1′-BIPHENYL]-3-CARBOXALDEHYDE; 4-(1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 4-(1H-IMIDAZOL-2-YL)-B-OXO-BENZENEPROPANAL; 4-(1H-IMIDAZOL-2-YL)-BUTYRALDEHYDE; 4-(1H-IMIDAZOL-4-YL)BENZALDEHYDE; 4-(1H-IMIDAZOL-4-YL)-BUTYRALDEHYDE; 4-(1H-IMIDAZOL-4-YLMETHYL)-BENZALDEHYDE; 4-(1H-INDOL-3-YL)BUTANAL; 4-(1H-INDOL-4-YL)BENZALDEHYDE; 4-(1H-INDOL-5-YL)BENZALDEHYDE; 4-(2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 4-(2,3-DIOXO-2,3-DIHYDRO-1H-INDOL-5-YL)BENZALDEHYDE; 4-(2,4-DIFLUOROPHENYL)-4-PIPERIDINYLMETHANONE HYDROCHLORIDE; 4-(2-[4-(TRIFLUOROMETHYL)PIPERIDINO]ACETYL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(2-AMINO-1H-IMIDAZOL-4-YL)-BUTYRALDEHYDE HCL; 4-(2-CHLOROACETYL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(2-CHLOROPYRIMIDIN-5-YL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 4-(2-FORMYLPIPERIDIN-1-YL)-N-METHYLPYRIDINE-2-CARBOXAMIDE; 4-(2-FORMYLVINYL)-ACETANILIDE; 4-(2-HYDROXY-ETHYLAMINO)-BENZALDEHYDE; 4-(2-PIPERIDIN-4-YLETHYL)IMIDAZOLE-2-CARBALDEHYDE; 4-(2-PROPEN-1-YL)-1H-PYRROLE-2-CARBOXALDEHYDE; 4-(2-PYRROLIDIN-1-YLETHYL)IMIDAZOLE-2-CARBALDEHYDE; 4-(3,9-DIAZASPIRO[5.5]UNDEC-3-YL)BENZALDEHYDE; 4-(3-ACETYLAMINOPHENYL)-2-FORMYLPHENOL; 4-(3-AZETIDINYLOXY)-BENZALDEHYDE; 4-(3-BROMOPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(3-CHLOROPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(3-FLUOROPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 4-(3-FORMYL-1H-INDOL-5-YL)BENZOIC ACID; 4-(3-FORMYL-1H-INDOL-5-YL)BENZONITRILE; 4-(3-FORMYLPIPERIDIN-1-YL)-N-METHYLPYRIDINE-2-CARBOXAMIDE; 4-(3-METHOXYPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-1-YL)BENZALDEHYDE; 4-(3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]OXAZIN-6-YLOXY)BUTANAL; 4-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 4-(4-BROMOPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(4-BROMOPHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(4-CHLOROPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(4-CHLOROPHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(4-DIMETHOXYMETHYLIMIDAZOL-2-YL)-BENZALDEHYDE; 4-(4-FLUORO-PHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 4-(4-FLUOROPHENYL)-2-THIOXO-2,3-DIHYDRO-1,3-THIAZOLE-5-CARBALDEHYDE; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-2-NITRO-PHENOL; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-3-METHOXY-PHENOL; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZONITRILE; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-NAPHTHALEN-1-OL; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-PHENOL; 4-(4-FORMYLIMIDAZOL-2-YL)-2,6-DIMETHOXY-PHENOL; 4-(4-FORMYLIMIDAZOL-2-YL)-2,6-DIMETHYL-PHENOL; 4-(4-FORMYLIMIDAZOL-2-YL)-2-METHOXY-6-NITROPHENOL; 4-(4-FORMYLIMIDAZOL-2-YL)-2-METHOXY-PHENOL; 4-(4-FORMYLPIPERIDIN-1-YL)-N-METHYLPYRIDINE-2-CARBOXAMIDE; 4-(4-METHOXYPHENYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(4-METHYL-7-OXO-7,8-DIHYDRO-PYRIDO[2,3-D]PYRIMIDIN-2-YLOXY)BUTYRALDEHYDE; 4-(4-PHENYL-1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 4-(4-PIPERIDINYLOXY)BENZALDEHYDE; 4-(4-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 4-(4-PYRIDIN-3-YL-1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 4-(4-PYRIDIN-4-YL-1H-IMIDAZOL-2-YL)-BENZALDEHYDE; 4-(5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-3-YL)-BENZALDEHYDE; 4-(5-ETHYL-1,3,4-OXADIAZOL-2-YL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-(5-FLUORO-1H-INDOL-3-YL)BUTANAL; 4-(5-FORMYL-4H-1,2,4-TRIAZOL-3-YL)BENZONITRILE; 4-(5-ISOPROPYL-1,3,4-OXADIAZOL-2-YL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 4-(5-OXO-PYRROLIDIN-3-YL)-BENZALDEHYDE; 4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)BENZALDEHYDE; 4-(7-OXO-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-YLOXY)BUTANAL; 4-(BENZYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE; 4-(BENZYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(BENZYLAMINO)-6-CHLORO-5-PYRIMIDINECARBALDEHYDE; 4-(BENZYLOXY)-6-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 4-(BENZYLOXY)-7-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 4-(BOC-AMIDINO)-BENZALDEHYDE; 4-(BUTYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(CYCLOBUTYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBALDEHYDE; 4-(CYCLOHEPTYLAMINO)-2-(METHYLSULFANYL)-5-PYRIMIDINECARBALDEHYDE; 4-(CYCLOHEXYLAMINO)-3-NITROBENZALDEHYDE; 4-(CYCLOPENTYLAMINO)-2-(METHYLSULFANYL)-5-PYRIMIDINECARBALDEHYDE; 4-(CYCLOPENTYLAMINO)-6-METHYL-2-(METHYLSULFANYL)-5-PYRIMIDINECARBALDEHYDE; 4-(ETHYLAMINO)-2-(METHYLSULFANYL)-5-PYRIMIDINECARBALDEHYDE; 4-(ETHYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(ETHYLAMINO)-6-METHYL-2-(METHYLSULFANYL)-5-PYRIMIDINECARBALDEHYDE; 4-(METHYLAMINO)-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 4-(METHYLAMINO)-3-NITROBENZALDEHYDE; 4-(N-BOC-AMINO)CYCLOHEXYLETHANAL; 4-(PIPERIDIN-4-YLOXY)BENZALDEHYDE HYDROCHLORIDE; 4-(PROP-1-YNYL)-1H-PYRROLE-2-CARBALDEHYDE; 4-(PYRIDIN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; 4-(PYRIDIN-4-YL)-1H-INDOLE-3-CARBALDEHYDE; 4-(TRIFLUOROMETHYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-(TRIFLUOROMETHYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-(TRIFLUOROMETHYL)-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-(TRIFLUOROMETHYL)INDOLE-3-CARBOXALDEHYDE; 4-(TRIMETHYLSILYL)-1H-PYRROLE-2-CARBOXALDEHYDE; 4,4′-DIFORMYLDIPHENYLAMINE; 4,5,6,7,8,9-HEXAHYDRO-1H-CYCLOOCTA[B]PYRROLE-2-CARBALDEHYDE; 4,5,6,7-TETRAFLUOROINDOLE-3-CARBOXALDEHYDE; 4,5,6,7-TETRAHYDRO-1H-INDOLE-2-CARBALDEHYDE; 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINE-3-CARBALDEHYDE; 4,5,6,7-TETRAHYDRO-2H-ISOINDOLE-1,3-DICARBALDEHYDE; 4,5,6,7-TETRAHYDRO-2H-ISOINDOLE-1-CARBALDEHYDE; 4,5,6,7-TETRAHYDRO-4-OXO-2H-PYRROLO[3,4-C]PYRIDINE-1-CARBOXALDEHYDE; 4,5,6,7-TETRAHYDRO-5-OXO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBOXALDEHYDE; 4,5,6,7-TETRAHYDRO-7,7-DIMETHYL-1H-INDOLE-2-CARBOXALDEHYDE; 4,5,6,7-TETRAHYDROBENZOIMIDAZOLE-2-CARBALDEHYDE; 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBALDEHYDE; 4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBALDEHYDE; 4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDINE-2-CARBALDEHYDE; 4,5-DICHLOROINDOLE-3-CARBOXALDEHYDE; 4,5-DIETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4,5-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 4,5-DIHYDRO-4-OXO-3H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXALDEHYDE; 4,5-DIHYDRO-4-OXO-FURO[3,2-C]PYRIDINE-2-CARBOXALDEHYDE; 4,5-DIMETHOXY-1H-INDOLE-3-CARBALDEHYDE; 4,5-DIMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4,5-DIMETHYLPYRROLE-2-CARBOXALDEHYDE; 4,6-DICHLOROINDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 4,6-DIMETHYL-3-INDOLE CARBOXALDEHYDE; 4,7-DICHLOROINDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHOXY-1H-INDOLE-3-CARBALDEHYDE; 4,7-DIMETHYL-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 4,7-DIMETHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 4-[(2,4-DINITROPHENYL)AMINO]BENZALDEHYDE; 4-[(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]BENZALDEHYDE; 4-[(2-METHOXY)ETHYLAMINO]-2-METHYLTHIO-5-PYRIMIDINECARBOXALDEHYDE; 4-[(2-METHOXYBENZYL)AMINO]-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXALDEHYDE; 4-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 4-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 4-[(3-METHOXYBENZYL)AMINO]-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXALDEHYDE; 4-[2-(1H-BENZIMIDAZOL-2-YLTHIO)ETHOXY]BENZALDEHYDE; 4-[2-(1H-IMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 4-[2-(1H-IMIDAZOL-4-YL)-VINYL]BENZALDEHYDE; 4-[2-(2-METHYLIMIDAZOL-4-YL)-ETHYL]-BENZALDEHYDE; 4-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 4-[2-HYDROXY-3-[(1-METHYLETHYL)AMINO]PROPOXY]BENZALDEHYDE; 4-[3-(4-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-[3-(4-METHOXYPHENYL)-1,2,4-OXADIAZOL-5-YL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-[3-(CYCLOPROPYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 4-[3-(N-ETHYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 4-[4-(ETHYLCARBAMOYL)-3-FLUOROPHENYL]-2-FORMYLPHENOL; 4-[5-(4-FLUOROPHENYL)-1,3,4-OXADIAZOL-2-YL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-[5-(4-METHOXYPHENYL)-1,3,4-OXADIAZOL-2-YL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-[N-(2-PYRIDYLAMINO)ETHOXY]BENZALDEHYDE; 4-ACETAMIDOBENZALDEHYDE; 4-ACETAMIDOPHENYLGLYOXAL HYDRATE; 4-ACETYL-1H-PYRROLE-2-CARBALDEHYDE; 4-ACETYL-3,5-DIMETHYL-PYRROLE-2-CARBOXALDEHYDE; 4-ACETYL-3-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-ACETYL-5-FORMYL-3-METHYL-PYRROLE-2-CARBOXYLIC ACID; 4-ACETYL-5-METHYL-PYRROLE-3-CARBOXALDEHYDE; 4-AMINO-1,2-DIHYDRO-2-OXO-5-PYRIMIDINECARBOXALDEHYDE; 4-AMINO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-AMINO-1H-PYRROLO[3,2-C]PYRIDINE-2-CARBALDEHYDE; 4-AMINO-2-PYRROLIDINECARBALDEHYDE; 4-AMINOINDOLE-3-CARBOXALDEHYDE; 4-AMINO-N-(4-FORMYL-3-METHYL-PHENYL)-BUTYRAMIDE HYDROCHLORIC ACID; 4-BENZYLOXYINDOLE-3-CARBOXALDEHYDE; 4-BENZYLOXYMETHYL-1H-INDOLE-3-CARBALDEHYDE; 4-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-BROMO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-BROMO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-BROMO-2-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 4-BROMO-2-(4-FORMYL-1H-IMIDAZOL-2-YL)-PHENOL; 4-BROMO-2-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 4-BROMO-2-(DIMETHYLAMINO)-1H-INDOLE-3-CARBALDEHYDE; 4-BROMO-5-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-BROMO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-BROMO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-BROMO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-BROMO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-BROMO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-BROMO-7-CHLORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-BROMO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-BROMO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-BROMO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-BROMOINDOLE-3-CARBOXALDEHYDE; 4-BROMO-N-(1-METHYL-3-OXOPROPYL)BENZAMIDE; 4-BUTYL-5-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-CARBOXALDEHYDE-N-ISOPROPYLBENZAMIDE; 4-CHLORO-1H-INDOLE-2-CARBALDEHYDE; 4-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBALDEHYDE; 4-CHLORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-CHLORO-2-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 4-CHLORO-2-CYCLOPROPYL-6-(CYCLOPROPYLAMINO)PYRIMIDINE-5-CARBALDEHYDE; 4-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 4-CHLORO-5-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 4-CHLORO-5-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBALDEHYDE; 4-CHLORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-CHLORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-CHLOROINDOLE-3-CARBALDEHYDE; 4-CHLORO-N-(1-METHYL-3-OXOPROPYL)BENZAMIDE; 4-CHLORO-N-(3-FORMYL-PHENYL)-BENZAMIDE; 4-CYCLOHEXYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-CYCLOHEXYL-5-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-CYCLOPROPOXY-2-(METHYLAMINO)BENZALDEHYDE; 4-CYCLOPROPOXY-2-(METHYLAMINO)NICOTINALDEHYDE; 4-CYCLOPROPOXY-2-FORMYL-N-METHYLBENZAMIDE; 4-CYCLOPROPOXY-2-FORMYL-N-METHYLNICOTINAMIDE; 4-CYCLOPROPOXY-3-(METHYLAMINO)BENZALDEHYDE; 4-CYCLOPROPOXY-3-(METHYLAMINO)PICOLINALDEHYDE; 4-CYCLOPROPOXY-3-FORMYL-N-METHYLBENZAMIDE; 4-CYCLOPROPOXY-3-FORMYL-N-METHYLPICOLINAMIDE; 4-CYCLOPROPOXY-5-(METHYLAMINO)NICOTINALDEHYDE; 4-CYCLOPROPOXY-5-(METHYLAMINO)PICOLINALDEHYDE; 4-CYCLOPROPOXY-5-FORMYL-N-METHYLNICOTINAMIDE; 4-CYCLOPROPOXY-5-FORMYL-N-METHYLPICOLINAMIDE; 4-CYCLOPROPOXY-6-(METHYLAMINO)-1,6-DIHYDROPYRIDINE-2-CARBALDEHYDE; 4-CYCLOPROPOXY-6-(METHYLAMINO)NICOTINALDEHYDE; 4-CYCLOPROPOXY-6-ETHYL-1,6-DIHYDROPYRIDINE-2-CARBALDEHYDE; 4-CYCLOPROPOXY-6-FORMYL-N-METHYLNICOTINAMIDE; 4-CYCLOPROPOXY-6-FORMYL-N-METHYLPICOLINAMIDE; 4-CYCLOPROPOXY-6-METHOXY-1,6-DIHYDROPYRIDINE-2-CARBALDEHYDE; 4-CYCLOPROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-ETHENYL-1H-PYRROLE-2-CARBOXALDEHYDE; 4-ETHOXY-1H-INDOLE-3-CARBALDEHYDE; 4-ETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-ETHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-ETHYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-ETHYL-3-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-ETHYL-3-METHYL-5-OXO-3-PYRROLINE-2-CARBOXALDEHYDE; 4-ETHYL-5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-ETHYL-5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER; 4-ETHYLINDOLE-3-CARBOXALDEHYDE; 4-ETHYNYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-ETHYNYL-3-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 4-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 4-FLUORO-1H-INDOLE-7-CARBALDEHYDE; 4-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-FLUORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-FLUORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-FLUORO-2-(4-FORMYL-IMIDAZOL-2-YL)-6-METHYLPHENOL; 4-FLUORO-2-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 4-FLUORO-5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FLUORO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-FLUORO-N-(1-METHYL-3-OXOPROPYL)BENZAMIDE; 4-FORMYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-FORMYL-1H-INDOLE-6-CARBOXYLIC ACID ETHYL ESTER; 4-FORMYL-1H-PYRROLE-2-CARBONITRILE; 4-FORMYL-1H-PYRROLE-2-CARBOTHIOIC ACID O-ETHYL ESTER; 4-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2-HYDROXY-N-METHYLBENZAMIDE; 4-FORMYL-2-METHOXYPHENYL METHYLCARBAMATE; 4-FORMYL-2-METHOXYPHENYL PHENYLCARBAMATE; 4-FORMYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-3-HYDROXY-N-METHYLBENZAMIDE; 4-FORMYL-5-METHOXY-N-PHENYLNICOTINAMIDE; 4-FORMYL-5-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER; 4-FORMYL-5-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID METHYL ESTER; 4-FORMYL-7-AZAINDOLE-3-CARBOXYLIC ACID METHYL ESTER; 4-FORMYL-IMIDAZOLE-2-CARBOXYLIC ACID ETHYL ESTER; 4-FORMYL-IMIDAZOLE-2-CARBOXYLIC ACID METHYL ESTER; 4-FORMYL-N-METHYL-BENZAMIDE; 4-FORMYL-N-PHENYL-BENZAMIDE; 4-FORMYLPHENYL 2-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YL)ACETATE; 4-FORMYLPHENYL N-PHENYLCARBAMATE; 4-FORMYLPIPERIDINE; 4-FORMYLPIPERIDINE HCL; 4H-FURO[3,2-B]PYRROLE-2-CARBALDEHYDE; 4-HYDROXY-1H-INDOLE-3-CARBALDEHYDE; 4-HYDROXY-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-HYDROXY-2-(METHYLAMINO)BENZALDEHYDE; 4-HYDROXY-3-(METHYLAMINO)BENZALDEHYDE; 4-HYDROXY-5-AZAINDOLE-3-CARBALDEHYDE; 4-HYDROXYMETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE HCL; 4-IMIDAZOLIDINEACETALDEHYDE, 4-[(2S)-2,3-DIHYDROXYPROPYL]-A-HYDROXY-2,5-DIOXO-, (AR,4R)-; 4-IMIDAZOLIDINEACETALDEHYDE, A-HYDROXY-2,5-DIOXO-4-(1,2,3-TRIHYDROXYPROPYL)-, [4S-[AS*,4R*(1R*,2S*)]]-; 4-IODO-7-AZAINDOLE-3-CARBALDEHYDE; 4-ISOPROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBALDEHYDE; 4-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-METHOXY-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 4-METHOXY-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 4-METHOXY-2-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 4-METHOXY-2-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 4-METHOXY-3-([(5-METHYL-4H-1,2,4-TRIAZOL-3-YL)SULFANYL]METHYL)BENZALDEHYDE; 4-METHOXY-3-([METHYL(PIPERIDIN-4-YL)AMINO]METHYL)BENZALDEHYDE; 4-METHOXY-3-(PIPERAZIN-1-YLMETHYL)BENZALDEHYDE; 4-METHOXY-3-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 4-METHOXY-3-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 4-METHOXY-3-[(3-OXOPIPERAZIN-1-YL)METHYL]BENZALDEHYDE; 4-METHOXY-3-[(5-OXO-1,4-DIAZEPAN-1-YL)METHYL]BENZALDEHYDE; 4-METHOXY-3-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 4-METHOXY-5-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-METHOXY-7-METHYLINDOLE-3-CARBOXALDEHYDE; 4-METHOXYCARBONYL-7-AZAINDOLE-3-CARBALDEHYDE; 4-METHOXYINDOLE-3-CARBOXALDEHYDE; 4-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-METHYL-1H-IMIDAZOLE-5-CARBALDEHYDE; 4-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 4-METHYL-1H-PYRROLE-3-CARBALDEHYDE; 4-METHYL-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-METHYL-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 4-METHYL-5-AZAINDOLE-3-CARBOXALDEHYDE; 4-METHYL-5-METHOXY-7-AZAINDOLE-3-CARBALDEHYDE; 4-METHYL-7-NITRO-1H-INDOLE-3-CARBALDEHYDE; 4-METHYLAMINO-2-METHYLSULFANYL-6-(TRIFLUOROMETHYL)PYRIMIDIN-5-CARBALDEHYDE; 4-METHYLAMINO-2-METHYLSULFANYL-PYRIMIDINE-5-CARBALDEHYDE; 4-METHYLINDOLE-2-CARBALDEHYDE; 4-METHYL-INDOLE-6-CARBOXALDEHYDE; 4-N-BOC-AMINO-3-FLUOROBENZALDEHYDE; 4-NITRO-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-NITRO-1H-PYRROLE-2-CARBALDEHYDE; 4-NITRO-1H-PYRROLE-3-CARBALDEHYDE; 4-NITRO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 4-NITRO-3-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 4-NITROINDOLE-3-CARBOXALDEHYDE; 4-OXO-1H-QUINOLINE-3-CARBALDEHYDE; 4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBOXALDEHYDE; 4-OXO-2,4,6,7-TETRAHYDROPYRANO[3,4-C]PYRROLE-1-CARBALDEHYDE; 4-OXO-3,4-DIHYDROQUINAZOLINE-2-CARBALDEHYDE; 4-OXO-3,4-DIHYDRO-QUINAZOLINE-8-CARBALDEHYDE; 4-OXO-4-(1H-PYRROL-2-YL)BUTANAL; 4-OXO-4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-A]PYRAZINE-2-CARBALDEHYDE; 4-OXO-5,6,7,8-TETRAHYDRO-4H-1,5,8A-TRIAZA-AZULENE-2-CARBALDEHYDE; 4-PHENETHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-PHENYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXALDEHYDE; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBOXALDEHYDE; 4-PHENYL-4-PIPERIDINECARBOXALDEHYDE; 4-PHENYLAMINOBENZALDEHYDE; 4-PIPERAZIN-1-YL-BENZALDEHYDE; 4-PIPERAZIN-1-YLBENZALDEHYDE HCL; 4-PIPERIDIN-4-YLMETHYLIMIDAZOLE-2-CARBALDEHYDE HCL; 4-PIPERIDINECARBOXYLIC ACID, 4-FORMYL-; 4-PYRIDIN-2-YL-1H-PYRROLE-2-CARBALDEHYDE; 4-STYRYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 4-TERTBUTYLOXYCARBONYL-AMINOPHENYLACETALDEHYDE; 4-THIOPHEN-2-YL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-((1H-PYRROL-2-YL)METHYL)-1H-PYRROLE-2-CARBALDEHYDE; 5-((2R)-2-PIPERIDYL)PYRIDINE-2-CARBALDEHYDE; 5-((2R)-2-PIPERIDYL)PYRIDINE-3-CARBALDEHYDE; 5-((2R)AZETIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2R)AZETIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 5-((2R)PIPERAZIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2R)PYRROLIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2R)PYRROLIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 5-((2S)-2-PIPERIDYL)PYRIDINE-2-CARBALDEHYDE; 5-((2S)-2-PIPERIDYL)PYRIDINE-3-CARBALDEHYDE; 5-((2S)AZETIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2S)AZETIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 5-((2S)PIPERAZIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2S)PYRROLIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 5-((2S)PYRROLIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 5-((3R)MORPHOLIN-3-YL)PYRIDINE-2-CARBALDEHYDE; 5-((3R)MORPHOLIN-3-YL)PYRIDINE-3-CARBALDEHYDE; 5-((3S)MORPHOLIN-3-YL)PYRIDINE-2-CARBALDEHYDE; 5-((3S)MORPHOLIN-3-YL)PYRIDINE-3-CARBALDEHYDE; 5-(1,1-DIMETHYLETHYL)-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1,1-DIMETHYLETHYL)-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1,1-DIMETHYLETHYL)-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1,1-DIMETHYLETHYL)-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1,1-DIMETHYLETHYL)-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1,3-DIOXO-2,3-DIHYDRO-1H-ISOINDOL-5-YL)-2-FURALDEHYDE; 5-(1-BENZOTHIEN-2-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(1-BENZOTHIEN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE; 5-(1H-IMIDAZOL-2-YL)-PENTANAL; 5-(1H-IMIDAZOL-4-YL)-PENTANAL; 5-(1H-INDOL-2-YL)-2,4-DIMETHOXYBENZALDEHYDE; 5-(1H-INDOL-2-YL)-3-METHOXY-1H-PYRROLE-2-CARBALDEHYDE; 5-(1-METHYLETHYL)-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1-METHYLETHYL)-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(1-METHYLETHYL)-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(2,2,6,6-TETRAMETHYL-1,2,3,6-TETRAHYDRO-PYRIDIN-4-YL)-THIOPHENE-2-CARBALDEHYDE; DIHYDRO-1-BENZOFURAN-5-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2,3-DIHYDRO-1H-INDOL-5-YL)-2-FURALDEHYDE; 5-(2,3-DIHYDRO-1H-INDOL-5-YL)-2-THIOPHENECARBALDEHYDE; 5-(2,3-DIOXO-2,3-DIHYDRO-1H-INDOL-5-YL)-2-FURALDEHYDE; 5-(2,3-DIOXO-2,3-DIHYDRO-1H-INDOL-5-YL)-2-THIOPHENE CARBALDEHYDE; 5-(2-BROMOPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(2-CHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2-FLUOROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(2-FURYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2-METHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2-METHOXYPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(2-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(2-PROPEN-1-YL)-1H-PYRROLE-2-CARBOXALDEHYDE; 5-(2-THIENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-ACETYLAMINOPHENYL)-2-FORMYLPHENOL; 5-(3-BROMOPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-CHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-CHLORO-PHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 5-(3-CHLOROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-FLUOROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-METHOXYPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-METHOXYPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-1-YL)FURAN-2-CARBALDEHYDE; 5-(3-OXOPIPERAZIN-1-YL)FURAN-2-CARBALDEHYDE; 5-(3-QUINOLINYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(3-THIENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-BROMOPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-CHLORO-3-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-CHLOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-CHLOROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-FLUOROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-FORMYLIMIDAZOL-2-YL)-2-METHOXY-PHENOL; 5-(4H-1,2,4-TRIAZOL-3-YLTHIO)-2-FURALDEHYDE; 5-(4-METHOXY-PHENYL)-1H-PYRROLE-2-CARBALDEHYDE; 5-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(4-METHYLPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-NITROPHENYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(4-TERT-BUTYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(5-ETHYL-1,3,4-OXADIAZOL-2-YL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 5-(5-ISOPROPYL-1,3,4-OXADIAZOL-2-YL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 5-(5-OXO-1,4-DIAZEPAN-1-YL)FURAN-2-CARBALDEHYDE; 5-(5-PYRIMIDINYL)-1H-INDOLE-3-CARBALDEHYDE; 5-(6-METHYL-1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE; 5-(AZETIDIN-3-YL)PICOLINALDEHYDE; 5-(BENZYLOXY)-1H-PYRROLO[3,2-B]PYRIDINE-2-CARBALDEHYDE; 5-(METHYLAMINO)-2-PYRIDINECARBOXALDEHYDE; 5-(N1-PIPERAZINYL)THIOPHENE-2-CARBOXALDEHYDE; 5-(PIPERAZIN-1-YL)FURAN-2-CARBALDEHYDE; 5-(PIPERIDIN-3-YL)PICOLINALDEHYDE; 5-(PIPERIDIN-4-YL)PICOLINALDEHYDE; 5-(PYRIDIN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(PYRIDIN-4-YL)-1H-INDOLE-3-CARBALDEHYDE; 5-(PYRROLIDIN-3-YL)PICOLINALDEHYDE; 5-(TRIFLUOROMETHOXY)INDOLE-3-CARBOXALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-(TRIMETHYLSILYL)-1H-PYRROLE-2-CARBOXALDEHYDE; 5,5′-METHYLENEBIS(1H-PYRROLE-2-CARBALDEHYDE); 5,5′-METHYLENEBIS(3,4-DIMETHYL-1H-PYRROLE-2-CARBALDEHYDE); 5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE-3-CARBALDEHYDE; 5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDINE-2-CARBALDEHYDE; 5,6,7,8-TETRAHYDRO-7-OXO-PYRIDO[2,3-D]PYRIMIDINE-2-CARBOXALDEHYDE; 5,6,7,8-TETRAHYDRO-IMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE; 5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE-2-CARBALDEHYDE; 5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE-4-CARBALDEHYDE; 5,6-DICHLORO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 5,6-DICHLORO-1H-INDOLE-2-CARBALDEHYDE; 5,6-DICHLOROINDOLE-3-CARBOXALDEHYDE; 5,6-DIFLUORO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 5,6-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 5,6-DIMETHOXY-1H-INDOLE-3-CARBALDEHYDE; 5,6-DIMETHYL-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 5,6-DIOXO-PIPERAZINE-2-CARBALDEHYDE; 5,7-DICHLORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 5,7-DICHLORO-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5,7-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 5,8-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 5-[(2,2,6,6-TETRAMETHYL-4-OXO-3-PIPERIDINYLIDENE)METHYL]-2-THIOPHENECARBALDEHYDE; 5-[(4-METHYLPHENYL)SULFANYL]-2-PHENYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-[(5-METHYL-1H-BENZIMIDAZOL-2-YL)THIO]-2-FURALDEHYDE; 5-[(7-CHLORO-4-QUINOLINYL)AMINO]-2-HYDROXYBENZALDEHYDE; 5-[3-(1,3-DIOXOLAN-2-YL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[3-(CYCLOPROPYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 5-[3-(N-ETHYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 5-[3-(TRIFLUOROMETHYL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[4-(1,3-DIOXOLAN-2-YL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[4-(DIMETHYLAMINO)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[4-(ETHYLCARBAMOYL)-3-FLUOROPHENYL]-2-FORMYLPHENOL; 5-[4-(METHYLSULFANYL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[4-(METHYLSULFONYL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[4-(TRIFLUOROMETHYL)PHENYL]-1H-INDOLE-3-CARBALDEHYDE; 5-[5-(4-FLUOROPHENYL)-1,3,4-OXADIAZOL-2-YL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 5-[5-(4-METHOXYPHENYL)-1,3,4-OXADIAZOL-2-YL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE; 5-ACETYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-AMINO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-AMINO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-AMINOINDOLE-3-CARBOXALDEHYDE; 5-ANILINO-3-PHENYL-4-ISOXAZOLECARBALDEHYDE; 5-BENZOYL-1H-INDOLE-3-CARBALDEHYDE; 5-BENZYLOXY-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBOXALDEHYDE; 5-BENZYLOXYINDOLE-3-CARBOXALDEHYDE; 5-BENZYLOXYMETHYL-1H-INDOLE-3-CARBALDEHYDE; 5-BROMO-1H-INDOLE-2-CARBALDEHYDE; 5-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-BROMO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 5-BROMO-2-(2-FLUOROANILINO)BENZALDEHYDE; 5-BROMO-2-(4-FLUOROANILINO)BENZALDEHYDE; 5-BROMO-2-(DIMETHYLAMINO)-1H-INDOLE-3-CARBALDEHYDE; 5-BROMO-2-(METHYLAMINO)NICOTINALDEHYDE; 5-BROMO-2-[(2-FURYLMETHYL)AMINO]BENZALDEHYDE; 5-BROMO-2-CYCLOPROPYL-1H-INDOLE-3-CARBOXALDEHYDE; 5-BROMO-2-CYCLOPROPYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 5-BROMO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-BROMO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-BROMO-2-TERT-BUTYL-1H-INDOLE-3-CARBALDEHYDE; 5-BROMO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5-BROMO-3-FORMYL-6-METHYL-7-AZAINDOLE; 5-BROMO-3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 5-BROMO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-BROMO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-4-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-BROMO-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-BROMO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-BROMO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-BROMO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-BROMO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-BROMOBENZIMIDAZOLE-2-CARBOXALDEHYDE; 5-BROMOINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-1H-INDOLE-2-CARBALDEHYDE; 5-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 5-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 5-CHLORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 5-CHLORO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 5-CHLORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2,5-DIMETHYLANILINO)BENZALDEHYDE; 5-CHLORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2-FLUOROANILINO)BENZALDEHYDE; 5-CHLORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(3-CHLORO-4-METHYLANILINO)BENZALDEHYDE; 5-CHLORO-2-(3-CHLOROANILINO)BENZALDEHYDE; 5-CHLORO-2-(3-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(4-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(4-ETHOXYANILINO)BENZALDEHYDE; 5-CHLORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-(5-CHLORO-2-METHYLANILINO)BENZALDEHYDE; 5-CHLORO-2-(METHYLAMINO)NICOTINALDEHYDE; 5-CHLORO-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 5-CHLORO-2-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 5-CHLORO-2-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 5-CHLORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-CYCLOHEXYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-CYCLOPROPYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-CHLORO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-CHLORO-2-PHENYL-1H-INDOLE-3-CARBALDEHYDE; 5-CHLORO-3-ETHYLAMINO-PYRIDINE-2-CARBALDEHYDE; 5-CHLORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5-CHLORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER; 5-CHLORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID METHYL ESTER; 5-CHLORO-3-FORMYL-6-METHYL-7-AZAINDOLE; 5-CHLORO-3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 5-CHLORO-3-METHYLAMINO-PYRIDINE-2-CARBALDEHYDE; 5-CHLORO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-6-FLUORO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 5-CHLORO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-CHLORO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-CHLOROINDOLE-3-CARBOXALDEHYDE; 5-CYANO-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXALDEHYDE; 5-CYANOINDOLE-3-CARBOXALDEHYDE; 5-CYCLOPROPOXY-2-(METHYLAMINO)BENZALDEHYDE; 5-CYCLOPROPOXY-2-(METHYLAMINO)ISONICOTINALDEHYDE; 5-CYCLOPROPOXY-2-(METHYLAMINO)NICOTINALDEHYDE; 5-CYCLOPROPOXY-2-FORMYL-N-METHYLBENZAMIDE; 5-CYCLOPROPOXY-2-FORMYL-N-METHYLISONICOTINAMIDE; 5-CYCLOPROPOXY-2-FORMYL-N-METHYLNICOTINAMIDE; 5-CYCLOPROPOXY-3-(METHYLAMINO)PICOLINALDEHYDE; 5-CYCLOPROPOXY-3-FORMYL-N-METHYLPICOLINAMIDE; 5-CYCLOPROPOXY-4-(METHYLAMINO)NICOTINALDEHYDE; 5-CYCLOPROPOXY-4-(METHYLAMINO)PICOLINALDEHYDE; 5-CYCLOPROPOXY-4-FORMYL-N-METHYLNICOTINAMIDE; 5-CYCLOPROPOXY-4-FORMYL-N-METHYLPICOLINAMIDE; 5-CYCLOPROPOXY-6-(METHYLAMINO)NICOTINALDEHYDE; 5-CYCLOPROPOXY-6-(METHYLAMINO)PICOLINALDEHYDE; 5-CYCLOPROPOXY-6-FORMYL-N-METHYLNICOTINAMIDE; 5-CYCLOPROPOXY-6-FORMYL-N-METHYLPICOLINAMIDE; 5-CYCLOPROPYL-1H-INDOLE-3-CARBALDEHYDE; 5′-DEOXYINOSINE DIALDEHYDE; 5-DIETHYLAMINO-2-(4-FORMYLIMIDAZOL-2-YL)-PHENOL; 5-ETHOXY-1H-INDOLE-3-CARBALDEHYDE; 5-ETHOXY-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-ETHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 5-ETHYL-2-FORMYL-1H-PYRROLE-3-CARBONITRILE; 5-ETHYL-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-ETHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ETHYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-ETHYL-4-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-ETHYNYL-3,4-DIMETHYL-1H-PYRROLE-2-CARBALDEHYDE; 5-FLUORO-1,2-DIHYDRO-2-OXO-4-PYRIDINECARBOXALDEHYDE; 5-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 5-FLUORO-1H-PYRROLE-2-CARBALDEHYDE; 5-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 5-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBALDEHYDE; 5-FLUORO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 5-FLUORO-2-(2,3,4-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(2,4,5-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 5-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(4-FORMYL-IMIDAZOL-2-YL)-PHENOL; 5-FLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 5-FLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5-FLUORO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-FLUORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5-FLUORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER; 5-FLUORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID METHYL ESTER; 5-FLUORO-3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 5-FLUORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-6-IODO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 5-FLUORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-7-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-FLUOROBENZIMIDAZOLE-2-CARBOXALDEHYDE; 5-FLUOROINDOLE-3-CARBOXALDEHYDE; 5-FLUORO-INDOLE-7-CARBOXALDEHYDE; 5-FORMYL-1H-PYRROL-2-YLBORONIC ACID; 5-FORMYL-1H-PYRROLE-2-CARBONITRILE; 5-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-1H-PYRROLE-3-CARBONITRILE; 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-FORMYL-2,4-DIMETHYLPYRROLE-3-PROPIONIC ACID, METHYL ESTER; 5-FORMYL-2-HYDROXY-N-METHYLBENZAMIDE; 5-FORMYL-2-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID METHYL ESTER; 5-FORMYL-3,4-DIMETHYL-1H-PYRROLE-2-CARBONITRILE; 5-FORMYL-3,4-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER; 5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-4-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-4-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID ETHYL ESTER; 5-FORMYL-4-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID METHYL ESTER; 5-FORMYL-4-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-FORMYLIMIDAZOLE-4-CARBOXYLIC ACID METHYL ESTER; 5-FORMYLPYRROLE-2-CARBOXYLIC ACID METHYL ESTER; 5-FORMYLURACIL; 5-FORMYLURIDINE; 5H-PYRIMIDO[5,4-B]INDOLE-8-CARBOXALDEHYDE; 5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXALDEHYDE; 5-HYDROXY-1H-INDOLE-3-CARBALDEHYDE; 5-HYDROXY-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-HYDROXY-2-(METHYLAMINO)BENZALDEHYDE; 5-HYDROXY-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-HYDROXY-4-AZAINDOLE-3-CARBALDEHYDE; 5-HYDROXY-4-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-IODO-7-AZAINDOLE-3-CARBOXALDEHYDE; 5-ISOPROPYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ISOPROPYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-METHOXY INDOLE-3-CARBOXALDEHYDE, [3-14C]; 5-METHOXY-1H-INDOLE-2-CARBALDEHYDE; 5-METHOXY-1H-INDOLE-4-CARBALDEHYDE; 5-METHOXY-1H-PYRROLE-2-CARBOXALDEHYDE; 5-METHOXY-1H-PYRROLO[2,3-C]PYRIDINE-2-CARBALDEHYDE; 5-METHOXY-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 5-METHOXY-1H-PYRROLO[3,2-B]PYRIDINE-2-CARBALDEHYDE; 5-METHOXY-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 5-METHOXY-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 5-METHOXY-2-[(2-OXOAZEPAN-3-YL)OXY]BENZALDEHYDE; 5-METHOXY-2-[2-(2-OXOIMIDAZOLIDIN-1-YL)ETHOXY]BENZALDEHYDE; 5-METHOXY-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHOXY-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 5-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 5-METHOXY-3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 5-METHOXY-4-METHYLINDOLE-3-CARBOXALDEHYDE; 5-METHOXY-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-METHOXYBENZIMIDAZOLE-2-CARBOXALDEHYDE; 5-METHOXYINDOLE-3-CARBOXALDEHYDE; 5-METHOXYINDOLE-7-CARBOXALDEHYDE; 5-METHYL-1-(7H-PURIN-6-YL)-1H-PYRAZOLE-4-CARBALDEHYDE; 5-METHYL-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE HYDROCHLORIDE; 5-METHYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-METHYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-METHYL-1H-INDOLE-2-CARBALDEHYDE; 5-METHYL-1H-INDOLE-7-CARBOXALDEHYDE; 5-METHYL-1H-PYRROLE-2,4-DICARBALDEHYDE; 5-METHYL-1H-PYRROLE-2-CARBALDEHYDE; 5-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-METHYL-2-(2,3,4-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(2,4,5-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 5-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRROLE-2-CARBALDEHYDE; 5-METHYL-4-AZAINDOLE-3-CARBALDEHYDE; 5-METHYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-METHYL-4-NITRO-1H-PYRROLE-2-CARBALDEHYDE; 5-METHYL-4-NITRO-1H-PYRROLE-3-CARBALDEHYDE; 5-METHYL-4-PROPYL-1H-IMIDAZOLE-2-CARBALDEHYDE; 5-METHYLINDOLE-3-CARBOXALDEHYDE; 5-NITRO-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-NITRO-1H-INDOLE-2-CARBALDEHYDE; 5-NITRO-1H-INDOLE-3-CARBALDEHYDE; 5-NITRO-1H-PYRROLE-2-CARBALDEHYDE; 5-NITRO-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBALDEHYDE; 5-NITRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 5-NITRO-2-(3-OXOPIPERAZIN-1-YL)BENZALDEHYDE; 5-NITRO-2-(5-OXO-1,4-DIAZEPAN-1-YL)BENZALDEHYDE; 5-NITRO-2-[(2-OXO-1,3-OXAZOLIDIN-5-YL)METHOXY]BENZALDEHYDE; 5-OXO-4,5-DIHYDROPYRAZINE-2-CARBALDEHYDE; 5-PHENYL-1H-INDOLE-3-CARBALDEHYDE; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXALDEHYDE; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXALDEHYDE; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBOXALDEHYDE; 5-PHENYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-PHENYLPYRROLE-2-CARBOXALDEHYDE; 5-P-TOLYL-1H-PYRROLE-2-CARBALDEHYDE; 5-TERT-BUTYL-1H-IMIDAZOLE-4-CARBALDEHYDE; 5-TERT-BUTYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 5-TERT-BUTYL-2-CYCLOPENTYL-1H-INDOLE-3-CARBALDEHYDE; 5-TERT-BUTYL-4H-1,2,4-TRIAZOLE-3-CARBALDEHYDE; 5-TERT-BUTYL-PYRROLE-2-CARBALDEHYDE; 5-THIEN-2-YL-1H-PYRROLE-2-CARBALDEHYDE; 6-((2R)-2-PIPERIDYL)PYRIDINE-2-CARBALDEHYDE; 6-((2R)-2-PIPERIDYL)PYRIDINE-3-CARBALDEHYDE; 6-((2R)AZETIDIN-2-YL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((2R)AZETIDIN-2-YL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((2R)AZETIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 6-((2R)AZETIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 6-((2R)PYRROLIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 6-((2R)PYRROLIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 6-((2S)-2-PIPERIDYL)PYRIDINE-2-CARBALDEHYDE; 6-((2S)-2-PIPERIDYL)PYRIDINE-3-CARBALDEHYDE; 6-((2S)AZETIDIN-2-YL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((2S)AZETIDIN-2-YL)-5-METHOXYPYRIDINE-2-CARBALDEHYDE; 6-((2S)AZETIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 6-((2S)AZETIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 6-((2S)PYRROLIDIN-2-YL)PYRIDINE-2-CARBALDEHYDE; 6-((2S)PYRROLIDIN-2-YL)PYRIDINE-3-CARBALDEHYDE; 6-((3R)MORPHOLIN-3-YL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((3R)MORPHOLIN-3-YL)PYRIDINE-2-CARBALDEHYDE; 6-((3R)MORPHOLIN-3-YL)PYRIDINE-3-CARBALDEHYDE; 6-((3S)MORPHOLIN-3-YL)-5-(PHENYLMETHOXY)PYRIDINE-2-CARBALDEHYDE; 6-((3S)MORPHOLIN-3-YL)PYRIDINE-2-CARBALDEHYDE; 6-((3S)MORPHOLIN-3-YL)PYRIDINE-3-CARBALDEHYDE; 6-(1H-IMIDAZOL-2-YL)-HEXANAL; 6-(1H-IMIDAZOL-4-YL)-HEXANAL; 6-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 6-(2-METHOXYBENZYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-2-CARBALDEHYDE; 6(3,9-DIAZASPIRO[5.5]UNDEC-3-YL)NICOTINALDEHYDE; 6-(3-ACETYLAMINOPHENYL)-2-FORMYLPHENOL; 6-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 6-(3-OXOPIPERAZIN-1-YL)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE; 6-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 6-(4-FORMYL-1H-IMIDAZOL-2-YL)-NAPHTHALEN-2-OL; 6-(4-FORMYLIMIDAZOL-2-YL)2,3-DIMETHOXYBENZOIC ACID; 6-(5-OXO-1,4-DIAZEPAN-1-YL)IMIDAZO[2,1-B][1,3]THIAZOLE-5-CARBALDEHYDE; 6-(AMINOMETHYL)-4-CYCLOPROPOXY-1,6-DIHYDROPYRIDINE-2-CARBALDEHYDE; 6-(BENZYLAMINO)-5-NITRONICOTINALDEHYDE; 6-(BENZYLAMINO)NICOTINALDEHYDE; 6-(BENZYLOXY)-5-METHYL-1H-INDOLE-3-CARBALDEHYDE; 6-(BUTYLAMINO)NICOTINALDEHYDE; 6-(CYCLOPROPYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-2-CARBALDEHYDE; 6-(CYCLOPROPYLAMINO)NICOTINALDEHYDE; 6-(ETHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-2-CARBALDEHYDE; 6-(ETHYLAMINO)NICOTINALDEHYDE; 6-(ISOPENTYLAMINO)-5-NITRONICOTIN-ALDEHYDE; 6-(ISOPROPYLAMINO)-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-(ISOPROPYLAMINO)NICOTINALDEHYDE; 6-(METHYLAMINO)NICOTINALDEHYDE; 6-(PHENYLAMINO)NICOTINALDEHYDE; 6-(PIPERIDIN-4-YLOXY)NICOTINALDEHYDE; 6-(PROPYLAMINO)NICOTINALDEHYDE; 6-(PYRIDIN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; 6-(PYRIDIN-4-YL)-1H-INDOLE-3-CARBALDEHYDE; 6-(PYRROLIDIN-3-YL)NICOTINALDEHYDE; 6-(TERT-BUTYLAMINO)NICOTINALDEHYDE; 6-(TRIFLUOROMETHOXY)-1H-INDOLE-3-CARBALDEHYDE; 6-(TRIFLUOROMETHYL)-1H-IMIDAZO[4,5-B]PYRIDINE-2-CARBALDEHYDE; 6-(TRIFLUOROMETHYL)-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-(TRIFLUOROMETHYL)-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-(TRIFLUOROMETHYL)INDOLE-3-CARBOXALDEHYDE; 6,7-DICHLOROINDOLE-3-CARBOXALDEHYDE; 6,7-DIETHOXY-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 6,7-DIFLUORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIFLUOROINDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6,7-DIMETHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 6-[(1-BENZYL-4-PIPERIDYL)AMINO]NICOTINALDEHYDE; 6-[(2-METHOXYETHYL)AMINO]-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-[3-(CYCLOPROPYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 6-[3-(N-ETHYLAMINOCARBONYL)PHENYL]-2-FORMYLPHENOL; 6-[4-(ETHYLCARBAMOYL)-3-FLUOROPHENYL]-2-FORMYLPHENOL; 6-ACETAMIDOHEXANAL; 6-AMINO-1-(2-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-FURYLMETHYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(2-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(3-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-BENZYL-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-AMINO-1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-2,4-DIOXO-1-(2-PHENYLETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1-(PYRIDIN-3-YLMETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-4-OXO-1-PHENYL-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINOINDOLE-3-CARBOXALDEHYDE; 6-AZAINDOLE-3-CARBOXALDEHYDE; 6-BENZOYL-1H-INDOLE-3-CARBALDEHYDE; 6-BENZYLOXYINDOLE-3-CARBOXALDEHYDE; 6-BENZYLOXYMETHYL-1H-INDOLE-3-CARBALDEHYDE; 6-BROMO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-BROMO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-BROMO-1H-INDOLE-2-CARBALDEHYDE; 6-BROMO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-BROMO-2-(DIMETHYLAMINO)-1H-INDOLE-3-CARBALDEHYDE; 6-BROMO-2-OXO-1,2,3,4-TETRAHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-BROMO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-BROMO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-BROMO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-BROMO-4-OXO-3,4-DIHYDROQUINAZOLINE-2-CARBALDEHYDE; 6-BROMO-5-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-BROMO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-BROMO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-BROMO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-BROMOINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-CHLORO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-CHLORO-1H-INDOLE-2-CARBALDEHYDE; 6-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-2-CYCLOHEXYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-2-CYCLOPROPYL-7-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-2-METHYL-1H-BENZO[D]IMIDAZOLE-5-CARBALDEHYDE; 6-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 6-CHLORO-4-(METHYLAMINO)NICOTINALDEHYDE; 6-CHLORO-4-AZAINDOLE-3-CARBALDEHYDE; 6-CHLORO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 6-CHLORO-5-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-5-METHOXY-1H-INDOLE-3-CARBALDEHYDE; 6-CHLORO-7-FLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-CHLORO-7-METHYL-1H-INDOLE-2-CARBALDEHYDE; 6-CHLOROINDOLE-3-CARBOXALDEHYDE; 6-ETHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-ETHOXYINDOLE-3-CARBOXALDEHYDE; 6-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-ETHYLINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-FLUORO-1H-INDOLE-2-CARBALDEHYDE; 6-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 6-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 6-FLUORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-FLUORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-3-CARBALDEHYDE; 6-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 6-FLUORO-4,5-DIHYDRO-IMIDAZOL[1,5-A]QUINOXALIN-3-CARBALDEHYDE; 6-FLUORO-4-AZAINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-4-HYDROXY-1H-INDOLE-2-CARBALDEHYDE; 6-FLUORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-4-METHOXY-1H-INDOLE-2-CARBALDEHYDE; 6-FLUORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-7-METHOXYINDOLE-3-CARBOXALDEHYDE; 6-FLUORO-7-METHYL-1H-INDOLE-2-CARBALDEHYDE; 6-FLUOROINDOLE-3-CARBOXALDEHYDE; 6-FORMYL-2,3-DIHYDRO-1H-INDOLE HYDROCHLORIDE; 6-FORMYL-2-THIOURACIL; 6-FORMYL-2-THIOURACIL HYDRATE; 6-FORMYL-3-IMINO-4-METHYL-N-PHENYL-3,4-DIHYDRO-2-PYRAZINECARBOXAMIDE; 6-FORMYL-8-FLUORO-2H-1,4-BENZOXAZIN-3(4H)-ONE; 6-FORMYL-N-ISOPROPYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2-CARBOXAMIDE; 6-FORMYL-URACIL MONOHYDRATE; 6H-THIENO[2,3-B]PYRROLE-3-CARBOXALDEHYDE; 6-HYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBALDEHYDE; 6-HYDROXY-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-HYDROXY-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-HYDROXY-4-AZAINDOLE-3-CARBALDEHYDE; 6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 6-HYDROXYNICOTINALDEHYDE; 6-IODO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-METHOXY-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-METHOXY-1H-INDOLE-3-CARBALDEHYDE; 6-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 6-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBALDEHYDE; 6-METHOXY-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-METHOXY-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 6-METHOXY-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 6-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 6-METHOXY-9H-PURINE-8-CARBALDEHYDE; 6-METHYL-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-METHYL-1H-INDOLE-2-CARBALDEHYDE; 6-METHYL-1H-INDOLE-4-CARBALDEHYDE; 6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-METHYL-2-OXO-1,2-DIHYDROQUINOLIN-3-CARBALDEHYDE; 6-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 6-METHYL-5,6-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE; 6-METHYL-5-AZAINDOLE-3-CARBOXALDEHYDE; 6-METHYLINDOLE-3-CARBOXALDEHYDE; 6-NITRO-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-NITRO-1H-INDOLE-3-CARBALDEHYDE; 6-NITRO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 6-NITRO-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 6-OXO-5,6,7,8-TETRAHYDRO-IMIDAZO[1,2-A]PYRAZINE-3-CARBALDEHYDE; 6-OXO-5,6-DIHYDRO-[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBALDEHYDE; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-CARBOXALDEHYDE; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXALDEHYDE; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXALDEHYDE; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE; 6-PIPERAZIN-1-YLNICOTINALDEHYDE; 6-QUINOXALINECARBOXALDEHYDE, 3,4-DIHYDRO-3-OXO-; 6-TRIFLUOROMETHOXY-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 6-TRIFLUOROMETHYL-1H-BENZOIMIDAZOLE-2-CARBALDEHYDE; 7-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 7-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 7-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBALDEHYDE; 7-(PYRIDIN-3-YL)-1H-INDOLE-3-CARBALDEHYDE; 7-(PYRIDIN-4-YL)-1H-INDOLE-3-CARBALDEHYDE; 7-(TRIFLUOROMETHYL)-1H-INDOLE-2-CARBALDEHYDE; 7-(TRIFLUOROMETHYL)-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-(TRIFLUOROMETHYL)INDOLE-3-CARBOXALDEHYDE; 7-AMINO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-AMINOINDOLE-3-CARBOXALDEHYDE; 7-AZAINDOLE-4-CARBOXALDEHYDE; 7-BENZYLOXYINDOLE-3-CARBALDEHYDE; 7-BENZYLOXYMETHYL-1H-INDOLE-3-CARBALDEHYDE; 7-BROMO-1H-INDOLE-2-CARBALDEHYDE; 7-BROMO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-BROMO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-BROMO-2-CYCLOPROPYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-BROMO-2-CYCLOPROPYL-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 7-BROMO-3-FORMYL-1H-INDOLE; 7-BROMO-4-CHLORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 7-BROMO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 7-BROMO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-BROMO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-BROMO-4-METHYL-1H-INDOLE-3-CARBALDEHYDE; 7-BROMO-5-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 7-BROMO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-BROMO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-BROMO-5-METHYL-1H-INDOLE-2-CARBOXALDEHYDE; 7-BROMO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 7-BROMO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-BROMO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-CHLORO-1H-INDOLE-2-CARBALDEHYDE; 7-CHLORO-1H-INDOLE-3-CARBALDEHYDE; 7-CHLORO-1H-INDOLE-4-CARBALDEHYDE; 7-CHLORO-1H-INDOLE-5-CARBALDEHYDE; 7-CHLORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-CHLORO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-CHLORO-2-(2,3-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2,6-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(3,4-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(3,5-DIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(3-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(4-CHLOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(4-ETHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-CYCLOHEXYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-CYCLOHEXYL-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-CYCLOPROPYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-CYCLOPROPYL-5-FLUORO-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-2-CYCLOPROPYL-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-3,3-DIMETHYL-2,3-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 7-CHLORO-3-METHYL-1H-INDOLE-2-CARBALDEHYDE; 7-CHLORO-4-(TRIFLUOROMETHYL)-1H-INDOLE-2-CARBALDEHYDE; 7-CHLORO-4-FLUOROINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-4-METHYL-1H-INDOLE-3-CARBALDEHYDE; 7-CHLORO-5-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 7-CHLORO-5-FLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-FLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-FLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-FLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-FLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-5-METHYL-1H-INDOLE-2-CARBOXALDEHYDE; 7-CHLORO-6-FLUOROINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-CHLORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-ETHOXY-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-ETHOXYINDOLE-3-CARBOXALDEHYDE; 7-ETHYL-1H-INDOLE-3-CARBALDEHYDE; 7-FLUORO-1H-INDOLE-3-CARBALDEHYDE; 7-FLUORO-1H-INDOLE-5-CARBALDEHYDE; 7-FLUORO-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-FLUORO-1H-PYRROLO[3,2-C]PYRIDINE-3-CARBALDEHYDE; 7-FLUORO-2-(2,3,4-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(2,4,5-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(2-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(2-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(3-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(3-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(4-FLUOROPHENYL)-5-METHYL-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-3,3-DIMETHYL-2,3-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 7-FLUORO-3,3-DIMETHYL-2-OXO-2,3-DIHYDRO-1H-INDOLE-5-CARBALDEHYDE; 7-FLUORO-4-HYDROXY-1H-INDOLE-2-CARBALDEHYDE; 7-FLUORO-4-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-FLUORO-4-METHOXY-1H-INDOLE-2-CARBALDEHYDE; 7-FLUORO-4-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-5-METHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 7-FLUORO-6-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-FLUORO-6-METHOXYINDOLE-3-CARBOXALDEHYDE; 7-FORMYLGRAMINE; 7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBALDEHYDE; 7-HYDROXY-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-HYDROXY-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-HYDROXYINDOLE-3-CARBOXALDEHYDE; 7-INDOLINECARBOXALDEHYDE; 7-METHOXY-1H-INDOLE-2-CARBALDEHYDE; 7-METHOXY-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-METHOXY-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-METHOXY-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHOXY-2-METHYL-1H-INDOLE-3-CARBALDEHYDE; 7-METHOXY-2-OXO-1,2-D1HYDRO-QUINOLINE-3-CARBALDEHYDE; 7-METHOXY-3-INDOLECARBOXALDEHYDE; 7-METHYL-1H-INDOLE-2-CARBALDEHYDE; 7-METHYL-1H-PYRROLO[2,3-C]PYRIDINE-3-CARBALDEHYDE; 7-METHYL-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-METHYL-2-(2,3,4-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(2,4,5-TRIFLUOROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(2-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(2-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(2-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(3-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(3-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(3-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(4-METHYLPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(4-METHYLPHENYL)-5-NITRO-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-(4-NITROPHENYL)-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-[4-(1-METHYLETHYL)PHENYL]-1H-INDOLE-3-CARBOXALDEHYDE; 7-METHYL-2-PHENYL-1H-INDOLE-3-CARBALDEHYDE; 7-METHYL-4-OXO-2-P-TOLYLAMINO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-5-AZAINDOLE-3-CARBOXALDEHYDE; 7-METHYLINDOLE-3-CARBOXALDEHYDE; 7-METHYLSULFANYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 7-NITRO-1H-PYRROLO[3,2-B]PYRIDINE-3-CARBALDEHYDE; 7-NITROINDOLE-3-CARBOXALDEHYDE; 7-OXO-2,3,6,7-TETRAHYDRO-[1,4]DIOXINO[2,3-G]QUINOLINE-8-CARBALDEHYDE; 8-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 8-CHLORO-5-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-4-CARBALDEHYDE; 8-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 8-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 8-METHYL-3-OXO-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE-6-CARBALDEHYDE; 8-OXO-3,4,8,9-TETRAHYDRO-2H,7H-[1,4]DIOXEPINO[2,3-F]INDOLE-9-CARBALDEHYDE; 9H-CARBAZOLE-2-CARBALDEHYDE; 9H-CARBAZOLE-3-CARBALDEHYDE; 9H-PYRIDO[3,4-B]INDOLE-1-CARBOXALDEHYDE; 9-METHYL-4-OXO-2-(2-PYRIMIDINYLAMINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; ACETAMIDE, N-(2-FORMYL-1H-INDOL-5-YL)-; ACETAMIDE, N-[4-(2-FORMYL-1H-PYRROL-1-YL)PHENYL]-; ACETYL D-MANNOSAMINE N-[MANNOSAMINE-1-14C]; ACETYL-D-GALACTOSAMINE, N-[GALACTOSAMINE-1-14C]; ACETYL-D-GLUCOSAMINE N-[GLUCOSAMINE-6-3H]; ACETYL-D-GLUCOSAMINE, N-[GLUCOSAMINE-1-14C]; ACETYL-D-MANNOSAMINE, N-[MANNOSAMINE-6-3H]; ALAHOPCIN; ALLYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; ALORACETAM; AZETIDINE-2-CARBOXALDEHYDE; AZETIDINE-3-CARBOXALDEHYDE; BENZAMIDE, N-(4,6-DIMETHYL-2-PYRIDINYL)-4-FORMYL-; BENZYL (2R)-5-AMINO-4-METHYL-1-OXOPENTAN-2-YLCARBAMATE; BENZYL (4-FORMYL-1H-IMIDAZOL-2-YL)METHYLCARBAMATE; BENZYL (4-FORMYL-6-METHYLPYRIMIDIN-2-YL)METHYLCARBAMATE; BENZYL (4-FORMYLPYRIMIDIN-2-YL)METHYLCARBAMATE; BENZYL (5-FORMYLPYRIMIDIN-2-YL)METHYLCARBAMATE; BENZYL 2-(4-FORMYL-1H-IMIDAZOL-2-YL)ETHYLCARBAMATE; BENZYL 2-(5-FORMYLPYRIMIDIN-2-YL)ETHYLCARBAMATE; BENZYL 2-(FORMYLMETHYL)PHENYLCARBAMATE; BENZYL 2-OXOETHYLCARBAMATE; BENZYL 3-FORMYL-1H-INDOLE-2-CARBOXYLATE; BENZYL 3-FORMYLBICYCLO[2.2.1]HEPT-5-EN-2-YLCARBAMATE; BENZYL 4-ETHYL-5-FORMYL-3-METHYL-2-PYRROLECARBOXYLATE; BENZYL 4-FORMYLBENZYLCARBAMATE; BENZYL 4-FORMYLPYRIDIN-2-YLCARBAMATE; BENZYL 4-OXOBUTYLCARBAMATE; BENZYL 5-FORMYL-2-HYDROXYPHENYLCARBAMATE; BENZYL 6-FORMYLPYRIDIN-3-YLCARBAMATE; BENZYL CIS-4-FORMYLCYCLOHEXYLCARBAMATE; BENZYL FORMYL(4-HYDROXYPHENYL)METHYLCARBAMATE; BENZYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; BENZYL N-[(5-FORMYL-2-THIENYL)METHYL]CARBAMATE; BML-244; BOC-1-AMINO-1-CYCLOPENTANECARBOXALDEHYDE; BOC-ALA-ALDEHYDE; BOC-L-CYSTEINAL; BOC-L-ISOLEUCINAL; BOC-L-METHIONINAL; BOC-L-VALINAL; BUTYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; BUTYRAMIDO-MALONALDEHYDIC ACID; CALPAIN INHIBITOR III; CARBAMIC ACID, (1-FORMYLPROPYL)-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, (2,2-DIMETHYL-3-OXOPROPYL)-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, (3-OXOPROPYL)-, ETHYL ESTER; CARBAMIC ACID, (3-OXOPROPYL)-, METHYL ESTER; CARBAMIC ACID, (5-OXOPENTYL)-, PHENYLMETHYL ESTER; CARBAMIC ACID, [(1S)-1-FORMYL-2-(PHENYLMETHOXY)ETHYL]-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, [(1S)-1-FORMYLPROPYL]-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, N-(1,1-DIMETHYL-2-OXOETHYL)-, PHENYLMETHYL ESTER; CARBAMIC ACID, N-(3-OXOPROPYL)-, 9H-FLUOREN-9-YLMETHYL ESTER; CARBAMIC ACID, N-(4-OXOBUTYL)-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, N-(6-OXOHEXYL)-, 1,1-DIMETHYLETHYL ESTER; CARBAMIC ACID, N-(6-OXOHEXYL)-, PHENYLMETHYL ESTER; CARBAMIC ACID, N-(8-OXOOCTYL)-, PHENYLMETHYL ESTER; CHROMOGEN I; CIS-N-(4-FORMYL-CYCLOHEXYL)-ACETAMIDE; DIETHYL-[4-(4-FORMYLIMIDAZOL-2-YL)-PHENYL]-AMINE; ETHOXY-N-(2-FORMYL(3-THIENYL))FORMAMIDE; ETHYL (1S,2S)-2-FORMYL-1-(4-METHOXYPHENYL)-3-METHYLBUTYLCARBAMATE; ETHYL (3-FORMYL-1H-INDOL-2-YL)ACETATE; ETHYL 2-(4-FORMYLPHENYL)IMIDAZOLE-4-CARBOXYLATE; ETHYL 2-(ACETYLAMINO)-2-CYANO-3-METHYL-5-OXOPENTANOATE; ETHYL 2-CYANO-3-(5-FORMYL-1H-PYRROL-2-YL)-2-PROPENOATE; ETHYL 3,5-DIMETHYL-4-(3-OXOPROP-1-ENYL)-1H-PYRROLE-2-CARBOXYLATE; ETHYL 3-FORMYL-1H-INDOLE-2-CARBOXYLATE; ETHYL 3-FORMYL-5-METHOXY-1H-INDOLE-2-CARBOXYLATE; ETHYL 3-FORMYL-5-METHYL-1H-INDOLE-2-CARBOXYLATE; ETHYL 3-FORMYL-7-(METHYLSULFANYL)-1H-INDOLE-2-CARBOXYLATE; ETHYL 3-FORMYL-7-NITRO-1H-INDOLE-2-CARBOXYLATE; ETHYL 4,6-DICHLORO-3-FORMYL-1H-INDOLE-2-CARBOXYLATE; ETHYL 4-FORMYL-1H-PYRROLE-2-CARBOXYLATE; ETHYL 4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE; ETHYL 4-FORMYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLATE; ETHYL 4-FORMYL-5-METHYL-1H-PYRROLE-3-CARBOXYLATE; ETHYL 5-(ACETYLAMINO)-4-FORMYL-3-METHYLTHIOPHENE-2-CARBOXYLATE; ETHYL 5-BROMO-3-FORMYL-1H-INDOLE-2-CARBOXYLATE; ETHYL 5-ETHYL-3-FORMYL-1H-INDOLE-2-CARBOXYLATE; ETHYL 5-FORMYL-1H-PYRROLE-2-CARBOXYLATE; ETHYL 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE; ETHYL 5-FORMYL-2-OXO-2,3-DIHYDRO-1H-IMIDAZOLE-4-CARBOXYLATE; ETHYL 5-FORMYLIMIDAZOLE-4-CARBOXYLATE; ETHYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; ETHYL N-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; ETHYL N-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; ETHYL N-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; FMOC-ALA-ALDEHYDE; FMOC-D-ALA-ALDEHYDE; GLUCOSAMIDE HCL; GUANOSINE PERIODATE OXIDIZED; HEXYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; IMIDAZOLE-2-CARBOXALDEHYDE; INDOLE-3,4-DICARBOXALDEHYDE; INDOLE-3,5-DICARBOXALDEHYDE; INDOLE-3,6-DICARBOXALDEHYDE; INDOLE-3,7-DICARBOXALDEHYDE; INDOLE-3-CARBOXALDEHYDE; INDOLE-4-CARBOXALDEHYDE; INDOLE-5-CARBOXALDEHYDE; INDOLE-6-CARBOXALDEHYDE; INDOLE-7-CARBOXALDEHYDE; ISOBUTYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; ISOINDOLINE-4-CARBALDEHYDE HCL; METHYL 2-FLUORO-4-FORMYLPHENYLCARBAMATE; METHYL 3-((2R)AZETIDIN-2-YL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-((2S)AZETIDIN-2-YL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-(3-FORMYL-1H-INDOL-5-YL)BENZOATE; METHYL 3-(AZETIDIN-3-YL)-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-[(1R)-1-(METHYLAMINO)ETHYL]-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-[(1S)-1-(METHYLAMINO)ETHYL]-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-[(1S)-2-HYDROXY-1-(METHYLAMINO)ETHYL]-5-FORMYL-4-HYDROXYBENZOATE; METHYL 3-FLUORO-4-FORMYLPHENYLCARBAMATE; METHYL 3-FORMYL-1H-INDOLE-2-CARBOXYLATE; METHYL 3-FORMYL-1H-INDOLE-5-CARBOXYLATE; METHYL 3-FORMYL-4-HYDROXY-5-(PIPERIDIN-3-YL)BENZOATE; METHYL 3-FORMYL-4-HYDROXY-5-(PIPERIDIN-4-YL)BENZOATE; METHYL 3-FORMYL-4-HYDROXY-5-(PYRROLIDIN-3-YL)BENZOATE; METHYL 3-FORMYL-4-METHOXY-1H-INDOLE-2-CARBOXYLATE; METHYL 3-FORMYL-5-METHANESULFONYL-1H-INDOLE-2-CARBOXYLATE; METHYL 3-FORMYL-5-METHOXY-1H-INDOLE-2-CARBOXYLATE; METHYL 3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLATE; METHYL 3-FORMYLINDOLE-6-CARBOXYLATE; METHYL 3-FORMYLPHENYLCARBAMATE; METHYL 4-(3-FORMYL-1H-INDOL-5-YL)BENZOATE; METHYL 4-FORMYL-1H-PYRROLE-2-CARBOXYLATE; METHYL 4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE; METHYL 4-FORMYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLATE; METHYL 4-FORMYLPHENYLCARBAMATE; METHYL 5-(2-FORMYL-1H-PYRROL-1-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXYLATE; METHYL 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE; METHYL 5-FORMYLPYRROLE-3-CARBOXYLATE; METHYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; METHYL N-[2-(2-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; METHYL N-[2-(3-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; METHYL N-[2-(4-FORMYLPIPERIDIN-1-YL)ACETYL]CARBAMATE; METHYL3-FORMYL-4,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLATE; N-((5-FORMYLFURAN-2-YL)METHYL)ACETAMIDE; N-(1,1-DIMETHYLETHYL)-N′-(3-FORMYL-1H-INDAZOL-4-YL)-UREA; N-(1,1-DIMETHYLETHYL)-N′-(3-FORMYL-1H-INDAZOL-5-YL)-UREA; N-(1,1-DIMETHYLETHYL)-N′-(3-FORMYL-1H-INDAZOL-7-YL)-UREA; N-(11-OXO-UNDECYL)-ACETAMIDE; N-(1-CYCLOPROPYLETHYL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(1-METHYL-3-OXOPROPYL)-1-BENZOTHIOPHENE-2-CARBOXAMIDE; N-(1-METHYL-3-OXOPROPYL)BENZAMIDE; N-(2-(DIETHYLAMINO)ETHYL)-5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE; N-(2-(FORMYLMETHYL)BENZYL)ACETAMIDE; N-(2-(FORMYLMETHYL)PHENYOACETAMIDE; N-(2,3-DIMETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2,3-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2,3-DIMETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2,4-DIMETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2,4-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2,4-DIMETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2,5-DIMETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2,5-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2,5-DIMETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2,6-DICHLORO-4-FORMYLPHENYL)ACETAMIDE; N-(2,6-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2-ACETAMIDOETHYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-ACETAMIDOETHYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-ACETAMIDOETHYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-BROMO-5-FORMYLPYRIDIN-3-YL)PIVALAMIDE; N-(2-CHLORO-3-FORMYLPYRIDIN-4-YL)PIVALAMIDE; N-(2-CHLORO-6-FORMYLPYRIDIN-3-YL)PIVALAMIDE; N-(2-CHLOROPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2-CHLOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CHLOROPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2-CHLOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CHLOROPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2-CHLOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CYANO-5-FORMYLPYRIDIN-3-YL)PIVALAMIDE; N-(2-CYANOETHYL)-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CYANOETHYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CYANOETHYL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-(2-CYANOETHYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2-CYANOETHYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-CYANOETHYL)-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(2-ETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(2-ETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(2-ETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(2-FLUOROPHENYL)-2-(2-FORMYL-1H-IMIDAZOL-1-YL)ACETAMIDE; N-(2-FLUOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-FLUOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(2-FLUOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N′-(2-FORMYL-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE; N-(2-FORMYL-3-METHOXYPHENYL)-2,2-DIMETHYLPROPANAMIDE; N-(2-FORMYL-3-METHOXYPYRIDIN-4-YL)PIVALAMIDE; N-(2-FORMYL-4,5-DIMETHOXY-PHENYL)-ACETAMIDE; N-(2-FORMYL-4-METHOXY-PHENYL)-ACETAMIDE; N-(2-FORMYL-4-METHYL-PHENYL)-ACETAMIDE; N-(2-FORMYL-4-NITROPHENYL)ACETAMIDE; N-(2-FORMYL-5,8-DIOXO-5,8-DIHYDROQUINOLIN-7-YL)ACETAMIDE; N′-(2-FORMYL-5-METHOXY-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE; N-(2-FORMYL-5-METHOXY-PHENYL)-ACETAMIDE; N′-(2-FORMYL-5-METHYL-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE; N′-(2-FORMYL-5-METHYL-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE HYDROCHLORIDE; N-(2-FORMYL-5-METHYL-PHENYL)-ACETAMIDE; N′-(2-FORMYL-6-METHYL-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE; N-(2-FORMYL-6-METHYL-PHENYL)-ACETAMIDE; N-(2-FORMYLFURO[3,2-B]PYRIDIN-7-YL)PIVALAMIDE; N-(2-FORMYLPHENYL)-3-NITROBENZAMIDE; N-(2-FORMYL-PHENYL)-ACETAMIDE; N-(2-FORMYLPHENYL)CYCLOPROPANECARBOXAMIDE; N-(2-FORMYLPHENYL)FORMAMIDE; N-(2-FORMYLQUINOLIN-6-YL)ACETAMIDE; N-(2-METHOXYETHYL)-2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; N-(2-METHOXYETHYL)-2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-(2-METHYL-3-OXO-PROPYL)-ACETAMIDE; N-(2-OXO-1-THIOPHEN-3-YL-ETHYL)-ACETAMIDE; N-(3,4-DIFLUORO-2-FORMYLPHENYL)PIVALAMIDE; N-(3,4-DIMETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(3,4-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(3,4-DIMETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3,5-DIMETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(3,5-DIMETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(2-FORMYL-1H-IMIDAZOL-1-YL)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(3-CHLOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-CYANOTHIOPHEN-2-YL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-CYANOTHIOPHEN-2-YL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-CYANOTHIOPHEN-2-YL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-DIMETHYLAMINO-PROPYL)-4-FORMYL-BENZAMIDE; N′-(3-ETHYL-5-FORMYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-PYRIMIDIN-4-YL)-N,N-DIMETHYL-FORMAMIDINE; N-(3-FLUOROPHENYL)-2-(2-FORMYL-1H-IMIDAZOL-1-YL)ACETAMIDE; N-(3-FLUOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-FLUOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3-FLUOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(3′-FORMYL[1,1′-BIPHENYL]-3-YL)ACETAMIDE; N-(3′-FORMYL[1,1′-BIPHENYL]-4-YL)ACETAMIDE; N-(3-FORMYL-2-METHYL-PHENYL)-ACETAMIDE; N-(3-FORMYL-2-PYRIDINYL)-2,2-DIMETHYLPROPANAMIDE; N-(3-FORMYL-4-METHYL-PHENYL)-ACETAMIDE; N-(3-FORMYL-4-PYRIDINYL)-2,2-DIMETHYLPROPANAMIDE; N-(3-FORMYL-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)PIVALAMIDE; N-(3-FORMYL-5-METHYLPYRIDIN-2-YL)PIVALAMIDE; N-(3-FORMYL-BENZYL)-ACETAMIDE; N-(3-FORMYLPHENYL)-4-METHOXYBENZAMIDE; N-(3-FORMYL-PHENYL)-4-METHYL-BENZAMIDE; N-(3-FORMYL-PYRAZIN-2-YL)-ACETAMIDE; N-(3-FORMYL-PYRIDIN-2-YL)-ACETAMIDE; N-(3-FORMYL-PYRIDIN-4-YL)-ACETAMIDE; N-(3-FORMYLQUINOLIN-7-YL)ACETAMIDE; N-(3-OXO-1-PHENYLPROPYL)ACETAMIDE; N-(4-((5-FORMYL-2-METHOXYBENZYL)OXY)PHENYL)ACETAMIDE; N-(4-(2-OXOACETYL)PHENYL)ACETAMIDE; N-(4-[(2-FORMYLPIPERIDIN-1-YL)METHYL]-1,3-THIAZOL-2-YL)ACETAMIDE; N-(4-[(2-OXOETHYL)SULFANYL]PHENYL)ACETAMIDE; N-(4-[(3-FORMYLPIPERIDIN-1-YL)METHYL]-1,3-THIAZOL-2-YL)ACETAMIDE; N-(4-[(3-OXOPROPYL)SULFANYL]PHENYL)ACETAMIDE; N-(4-[(4-FORMYLPIPERIDIN-1-YL)METHYL]-1,3-THIAZOL-2-YL)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(2-FORMYL-1H-IMIDAZOL-1-YL)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(4-CHLOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4-ETHOXYPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(4-ETHOXYPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(4-ETHOXYPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(4-ETHYLPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(4-ETHYLPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(4-ETHYLPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(4-FLUOROPHENYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(4-FLUOROPHENYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4-FLUORO-PHENYL)-2-(3-FORMYL-INDOL-1-YL)-ACETAMIDE; N-(4-FLUOROPHENYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(4-FLUOROPHENYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4-FLUOROPHENYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(4-FLUOROPHENYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(4′-FORMYL[1,1-BIPHENYL]-2-YL)ACETAMIDE; N-(4′-FORMYL[1,1-BIPHENYL]-3-YL)ACETAMIDE; N-(4′-FORMYL[1,1′-BIPHENYL]-4-YL)ACETAMIDE; N-(4-FORMYL-1,3-THIAZOL-2-YL)ACETAMIDE; N-(4-FORMYL-1H-PYRAZOL-3-YL)-ACETAMIDE; N-(4-FORMYL-2-HYDROXY-PHENYL)-ACETAMIDE; N-(4-FORMYL-2-METHOXY-PHENYL)-ACETAMIDE; N-(4-FORMYL-2-METHOXYPYRIDIN-3-YL)PIVALAMIDE; N-(4-FORMYL-2-METHYL-PHENYL)-ACETAMIDE; N-(4-FORMYL-2-TRIFLUOROMETHOXY-PHENYL)-ACETAMIDE; N-(4-FORMYL-3-METHYLPHENYL)ACETAMIDE; N-(4-FORMYL-3-NITRO-PHENYL)-ACETAMIDE; N-(4-FORMYL-PYRIDIN-2-YL)-ACETAMIDE; N-(4-FORMYL-PYRIDIN-3-YL)-2,2-DIMETHYL-PROPIONAMIDE; N-(4-FORMYLPYRIDIN-3-YL)ACETAMIDE; N′-(5-[(5-FORMYL-1H-PYRROL-3-YL)CARBONYL]-1,3-THIAZOL-2-YL)-N,N-DIMETHYLIMINOFORMAMIDE; N-(5-BROMO-2-FORMYL-QUINOLIN-6-YL)-ACETAMIDE; N-(5-BROMO-2-FORMYL-QUINOLIN-8-YL)-ACETAMIDE; N-(5-BROMO-4-FORMYL-1,3-THIAZOL-2-YL)ACETAMIDE; N′-(5-CHLORO-2-FORMYL-1H-INDOL-3-YL)-N,N-DIMETHYLIMIDOFORMAMIDE; N-(5-CHLORO-3-FORMYLPYRIDIN-2-YL)PIVALAMIDE; N-(5-FLUORO-3-FORMYLPYRIDIN-2-YL)PIVALAMIDE; N-(5-FORMYL-1H-IMIDAZOL-2-YL)-ACETAMIDE; N-(5-FORMYL-2H-[1,2,4]TRIAZOL-3-YL)-ACETAMIDE; N-(5-FORMYL-2-HYDROXYPHENYL)ACETAMIDE; N-(5-FORMYL-2-METHOXY-PHENYL)-ACETAMIDE; N-(5-FORMYL-2-METHYLPHENYL)ACETAMIDE; N-(5-FORMYL-2-THIENYL)ACETAMIDE; N-(5-FORMYL-FURAN-2-YLMETHYL)-BENZAMIDE; N-(5-FORMYL-PYRIDIN-2-YL)-ACETAMIDE; N-(5-FORMYL-PYRIDIN-3-YL)-ACETAMIDE; N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINE; N-(5-FORMYL-THIAZOL-2-YL)-ACETAMIDE; N-(5-OXO-PENTYL)-ACETAMIDE; N-(6-CHLORO-3-FORMYL-PYRIDIN-2-YL)-2,2-DIMETHYL-PROPIONAMIDE; N-(6-FLUORO-3-FORMYLPYRIDIN-2-YL)PIVALAMIDE; N-(6-FORMYL-BENZO[1,3]DIOXOL-5-YL)-ACETAMIDE; N-(6-FORMYL-PYRIDIN-2-YL)-ACETAMIDE; N-(6-FORMYLPYRIDIN-2-YL)PIVALAMIDE; N-(7-FORMYL-[1,8]NAPHTHYRIDIN-2-YL)-ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(BUTAN-2-YL)-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-(BUTAN-2-YL)-2-(3-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(3-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-(BUTAN-2-YL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-(BUTAN-2-YL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(BUTAN-2-YL)-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-(BUTAN-2-YL)-2-(4-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(BUTAN-2-YL)-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-(BUTAN-2-YL)-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(BUTAN-2-YL)-3-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PROPANAMIDE; N-(CYANOMETHYL)-2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-ETHOXY-6-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYL-4-NITROPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYANOMETHYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYANOMETHYL)-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-(5-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-(CYANOMETHYL)-2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(2-FORMYLPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(3-FORMYLPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-(CYCLOPROPYLMETHYL)-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(TERT-BUTYL)-2-(2-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; N-(TERT-BUTYL)-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-(TERT-BUTYL)-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-(TERT-BUTYL)-2-(4-FORMYLPHENOXY)ACETAMIDE; N-[2-(2-FORMYLPHENOXY)PHENYL]ACETAMIDE; N-[2-(2-FORMYLPIPERIDIN-1-YL)ETHYL]ACETAMIDE; N-[2-(2-OXOETHOXY)PHENYL]ACETAMIDE; N-[2-(3-FORMYL-2-HYDROXYPHENYL)PHENYL]-2,2-DIMETHYLPROPANAMIDE; N-[2-(3-FORMYL-4-HYDROXYPHENYL)PHENYL]-2,2-DIMETHYLPROPANAMIDE; N-[2-(3-FORMYLPIPERIDIN-1-YL)ETHYL]ACETAMIDE; N-[2-(3-OXOPROPOXY)PHENYL]ACETAMIDE; N-[2-(4-FORMYLPHENOXY)PHENYL]ACETAMIDE; N-[2-(4-FORMYLPIPERIDIN-1-YL)ETHYL]ACETAMIDE; N-[2-(4-FORMYLPYRIDIN-3-YL)PHENYL]-2,2-DIMETHYLPROPANAMIDE; N-[2-(5-FORMYL-2-FURYL)PHENYL]ACETAMIDE; N-[2-(5-FORMYL-2-HYDROXYPHENYL)PHENYL]-2,2-DIMETHYLPROPANAMIDE; N-[2-(5-FORMYLPYRIDIN-3-YL)PHENYL]-2,2-DIMETHYLPROPANAMIDE; N-[2-OXO-1-(2-OXO-1,2-DIHYDRO-QUINOLIN-4-YLMETHYL)-ETHYL]-ACETAMIDE; N-[3-(2-OXOETHOXY)PHENYL]ACETAMIDE; N-[3-(3-OXOPROPOXY)PHENYL]ACETAMIDE; N-[3-(5-FORMYL-2-FURYL)PHENYL]ACETAMIDE; N-[3-(BENZYLOXY)-4-FORMYLPHENYL]ACETAMIDE; N-[4-(2-FORMYLPHENOXY)PHENYL]ACETAMIDE; N-[4-(2-OXOETHOXY)PHENYL]ACETAMIDE; N-[4-(2-OXO-ETHYL)-PHENYL]-ACETAMIDE; N-[4-(2-OXO-ETHYL)-THIAZOL-2-YL]-ACETAMIDE; N-[4-(2-OXO-ETHYL)-THIAZOL-2-YL]-FORMAMIDE; N-[4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PHENYL]ACETAMIDE; N-[4-(3-OXOPROPOXY)PHENYL]ACETAMIDE; N-[4-(3-OXO-PROPYL)-PHENYL]-ACETAMIDE; N-[4-(5-FORMYL-2-FURYL)PHENYL]ACETAMIDE; N-ACETYL-D-GALACTOSAMINE; N-ACETYL-D-GLUCOSAMINE; N-ACETYL-D-GLUCOSAMINE-2-3H; N-ACETYL-D-MANNOSAMINE; N-ACETYL-D-MANNOSAMINE MONOHYDRATE; N-ACETYLMURAMIC ACID; N-BENZYL-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-BENZYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-BENZYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BENZYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-BENZYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BENZYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-BENZYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BENZYLAMINOACETALDEHYDE; N-BOC-D-PHENYLALANINAL; N-BOC-L-PHENYLALANINAL; N-BUTYL-2-(2-CHLORO-4-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(2-CHLORO-4-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-BUTYL-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-BUTYL-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-BUTYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BUTYL-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-BUTYL-2-(3-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(3-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BUTYL-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-BUTYL-2-(4-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(4-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-BUTYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-BUTYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-BUTYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-BUTYL-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-BUTYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-BUTYL-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-BUTYL-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-CYCLOHEPTYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEPTYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEPTYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-CYCLOHEPTYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEXYL-2-(2-FORMYL-1H-IMIDAZOL-1-YL)ACETAMIDE; N-CYCLOHEXYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-CYCLOHEXYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEXYL-2-(3-FORMYL-2-METHYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOHEXYL-2-(3-FORMYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOHEXYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-CYCLOHEXYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEXYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-CYCLOHEXYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-CYCLOHEXYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-CYCLOHEXYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOHEXYL-3-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOHEXYL-3-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOHEXYL-3-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPENTYL-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPENTYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPENTYL-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPENTYL-2-(3-FORMYL-2-METHYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOPENTYL-2-(3-FORMYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOPENTYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPENTYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPENTYL-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPENTYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-CYCLOPENTYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPENTYL-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPENTYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPENTYL-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(METHYL)AMINO)ACETAMIDE; N-CYCLOPROPYL-2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-ETHOXY-4-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-ETHOXY-6-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-4-NITROPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-5-PROPOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPROPYL-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)ACETAMIDE; N-CYCLOPROPYL-2-(3-FORMYL-2-METHYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOPROPYL-2-(3-FORMYL-INDOL-1-YL)-ACETAMIDE; N-CYCLOPROPYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPROPYL-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-CYCLOPROPYL-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-2-(5-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-CYCLOPROPYL-2-[(2,6-DIFLUORO-4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETAMIDE; N-CYCLOPROPYL-2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-CYCLOPROPYL-3-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(2-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-3-(3-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-3-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(4-FORMYLPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-3-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-CYCLOPROPYL-3-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-CYCLOPROPYL-4-FORMYLBENZAMIDE; N-ETHYL-2-((3-FORMYLIMIDAZO[1,2-A]PYRIDIN-2-YL)(METHYL)AMINO)ACETAMIDE; N-ETHYL-2-((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL)(METHYL)AMINO)ACETAMIDE; N-ETHYL-2-([(5-FORMYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)ACETAMIDE; N-ETHYL-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-2-(2-FORMYL-4-METHYLPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-4-NITROPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-4-NITROPHENOXY)PROPANAMIDE; N-ETHYL-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-2-(2-FORMYL-5-PROPOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-ETHYL-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-ETHYL-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)ACETAMIDE; N-ETHYL-2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PROPANAMIDE; N-ETHYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-ETHYL-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-ETHYL-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; N-ETHYL-2-(4-FORMYL-2-METHOXY-6-NITROPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-2-(4-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYL-2-NITROPHENOXY)PROPANAMIDE; N-ETHYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-ETHYL-2-(4-FORMYLPHENOXY)ACETAMIDE; N-ETHYL-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-ETHYL-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; N-ETHYL-2-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-2-(5-FORMYL-2-NITROPHENOXY)ACETAMIDE; N-ETHYL-2-(5-FORMYL-2-NITROPHENOXY)PROPANAMIDE; N-ETHYL-2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]ACETAMIDE; N-ETHYL-2-[(2-FLUORO-4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(2-FORMYL-4-NITROPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FLUORO-2-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FORMYL-2-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FORMYL-2-NITROPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FORMYL-3-METHYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(4-FORMYLPHENYL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(5-FORMYLFURAN-2-YL)(METHYL)AMINO]ACETAMIDE; N-ETHYL-2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETAMIDE; N-ETHYL-2-[ETHYL((5-FORMYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL))AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(2-FLUORO-4-FORMYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(2-FORMYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(2-OXOETHYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(4-FLUORO-2-FORMYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(4-FORMYL-2-METHYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(4-FORMYL-3-METHYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(4-FORMYLPHENYL)AMINO]ACETAMIDE; N-ETHYL-2-[ETHYL(5-FORMYLFURAN-2-YL)AMINO]ACETAMIDE; N-ETHYL-2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; N-ETHYL-2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-ETHYL-3-(2-FORMYL-4-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-3-(2-FORMYL-4-NITROPHENOXY)PROPANAMIDE; N-ETHYL-3-(2-FORMYL-5-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-3-(2-FORMYL-6-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-3-(2-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-3-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-3-(3-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-3-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-3-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANAMIDE; N-ETHYL-3-(4-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-3-(4-FORMYL-2-NITROPHENOXY)PROPANAMIDE; N-ETHYL-3-(4-FORMYLPHENOXY)PROPANAMIDE; N-ETHYL-3-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-ETHYL-3-(5-FORMYL-2-METHOXYPHENOXY)PROPANAMIDE; N-ETHYL-3-(5-FORMYL-2-NITROPHENOXY)PROPANAMIDE; N-ETHYL-3-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]PROPANAMIDE; N-ETHYL-4-(2-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; N-ETHYL-4-(3-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; N-ETHYL-4-(4-FORMYLPIPERIDIN-1-YL)PYRIDINE-2-CARBOXAMIDE; N-ETHYLGLUCOSAMINE; N-METHYL-1-(2-OXOETHYL)PIPERIDINE-4-CARBOXAMIDE; N-METHYL-1-(3-OXOPROPYL)PIPERIDINE-2-CARBOXAMIDE; N-METHYL-1-(3-OXOPROPYL)PIPERIDINE-4-CARBOXAMIDE; N-METHYL-1-(3-OXOPROPYL)PYRROLIDINE-2-CARBOXAMIDE; N-METHYL-2-[(2-OXOETHYL)(PROPYL)AMINO]ACETAMIDE; N-METHYL-2-[(3-OXOPROPYL)(PROPYL)AMINO]ACETAMIDE; N-METHYL-2-[METHYL(2-OXOETHYL)AMINO]ACETAMIDE; N-METHYL-2-[METHYL(3-OXOPROPYL)AMINO]ACETAMIDE; N-NITROSO-4-METHYLAMINOBENZALDEHYDE; N-OCTYL-D-GLUCOSAMINE; N-PROPANOYL-D-GLUCOSAMINE; N-TERT-BOC-2-(4-FORMYL-2-METHOXYPHENOXY)ETHYLAMINE-D3; N-TERT-BUTYL-2-(2-CHLORO-4-FORMYLPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(2-CHLORO-4-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(2-FORMYL-4-METHOXYPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(2-FORMYL-5-METHOXYPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(2-FORMYL-6-METHOXYPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(2-FORMYLPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(2-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(2-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-TERT-BUTYL-2-(2-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-TERT-BUTYL-2-(3-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(3-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(3-FORMYLPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(3-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(3-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-TERT-BUTYL-2-(3-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-TERT-BUTYL-2-(4-CHLORO-2-FORMYLPHENOXY)ACETAMIDE; N-TERT-BUTYL-2-(4-CHLORO-2-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETAMIDE; N-TERT-BUTYL-2-(4-FORMYLPHENOXY)PROPANAMIDE; N-TERT-BUTYL-2-(4-FORMYLPIPERIDIN-1-YL)ACETAMIDE; N-TERT-BUTYL-2-(4-FORMYLPIPERIDIN-1-YL)PROPANAMIDE; N-TERT-BUTYL-2-(5-FORMYL-2-METHOXYPHENOXY)ACETAMIDE; OROTALALDEHYDE; PHENACETURIC ACID,-ALPHA-FORMYL-ALPHA-METHYL-; PIPERIDINE-3-CARBALDEHYDE; PRINCETON PBMR041959; PROPANAMIDE, N-(2-FORMYLPHENYL)-2,2-DIMETHYL; PROPYL N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINATE; PYRROLE-2-CARBOXALDEHYDE; PYRROLIDINE-2-CARBALDEHYDE; RARECHEM AQ NN 0175; RO 08-2750; T-BUTYL N-(2-OXOETHYL)CABAMATE; TERT-BUTYL (1S,2R)-1-(5-FORMYLOXAZOL-2-YL)-2-METHYLBUTYLCARBAMATE; TERT-BUTYL (1S,2S)-1-(5-FORMYLOXAZOL-2-YL)-2-METHYLBUTYLCARBAMATE; TERT-BUTYL (2S)-1-OXO-3-PHENYLBUTAN-2-YLCARBAMATE; TERT-BUTYL (4-FORMYL-2-METHOXYPYRIDIN-3-YL)CARBAMATE; TERT-BUTYL (4-FORMYL-5-METHYLISOXAZOL-3-YL)CARBAMATE; TERT-BUTYL (5-FORMYL-2-NAPHTHYL)CARBAMATE; TERT-BUTYL (5-FORMYLPYRIDIN-2-YL)CARBAMATE; TERT-BUTYL (6-CHLORO-3-FORMYLPYRIDIN-2-YL)CARBAMATE; TERT-BUTYL (R)-1-FORMYL-3-METHYLBUTYL CARBAMATE; TERT-BUTYL (S)-1-FORMYL-2-(4-HYDROXYPHENYL)ETHYLCARBAMATE; TERT-BUTYL (S)1-FORMYL-3-METHYLBUTYLCARBAMATE; TERT-BUTYL [(1S)-2-CYCLOHEXYL-1-FORMYLETHYL]CARBAMATE; TERT-BUTYL [(1S,3S)-1-FORMYL-3-METHYLPENTYL]CARBAMATE; TERT-BUTYL 1-(FORMYLMETHYL)CYCLOHEXYL CARBAMATE; TERT-BUTYL 1-FORMYL-2-(3-HYDROXYPHENYL)ETHYLCARBAMATE; TERT-BUTYL 1-FORMYLPENTYLCARBAMATE; TERT-BUTYL 1-OXOPROPAN-2-YLCARBAMATE; TERT-BUTYL 2-(5-FORMYLPYRIMIDIN-2-YLAMINO)ACETATE; TERT-BUTYL 2-(FORMYLMETHYL)BENZYLCARBAMATE; TERT-BUTYL 2-(FORMYLMETHYL)PHENYLCARBAMATE; TERT-BUTYL 2,6-DICHLORO-4-FORMYLPHENYLCARBAMATE; TERT-BUTYL 2-CHLORO-3-FORMYLPYRIDIN-4-YLCARBAMATE; TERT-BUTYL 2-FLUORO-6-FORMYLPHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-3-METHOXYPHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-4-(TRIFLUOROMETHYL)PHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-4,6-DIMETHYLPHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-5-(TRIFLUOROMETHYL)PHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-5-METHOXYPHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-6-(TRIFLUOROMETHYL)PHENYLCARBAMATE; TERT-BUTYL 2-FORMYL-6,7-DIHYDROTHIAZOLO[5,4-C]PYRIDINE-5(4H)-CARBOXYLATE; TERT-BUTYL 2-FORMYL-6-METHYLPHENYLCARBAMATE; TERT-BUTYL 2-FORMYLFURAN-3-YLCARBAMATE; TERT-BUTYL 2-FORMYLPROPAN-2-YLCARBAMATE; TERT-BUTYL 2-FORMYLQUINOLIN-6-YLCARBAMATE; TERT-BUTYL 2-FORMYLQUINOLIN-8-YLCARBAMATE; TERT-BUTYL 2-METHYL-5-OXOPENT-3-YN-2-YLCARBAMATE; TERT-BUTYL 3-(2-OXOETHYL)PYRIDIN-2-YLCARBAMATE; TERT-BUTYL 3,4,5-TRIFLUORO-2-FORMYLPHENYLCARBAMATE; TERT-BUTYL 3,4-DIFLUORO-2-FORMYLPHENYLCARBAMATE; TERT-BUTYL 3-CHLORO-2-FORMYLPHENYLCARBAMATE; TERT-BUTYL 3-FORMYL-1H-INDOL-4-YLCARBAMATE; TERT-BUTYL 3-FORMYL-5-(TRIFLUOROMETHYL)THIEN-2-YLCARBAMATE; TERT-BUTYL 3-FORMYLBENZYLCARBAMATE; TERT-BUTYL 3-FORMYLPYRIDIN-4-YLCARBAMATE; TERT-BUTYL 3-METHYL-1-OXOBUTAN-2-YLCARBAMATE; TERT-BUTYL 4-(2-OXOETHYL)PYRIDIN-2-YLCARBAMATE; TERT-BUTYL 4-CHLORO-2-FORMYLBENZYLCARBAMATE; TERT-BUTYL 4-CHLORO-2-FORMYLPHENYLCARBAMATE; TERT-BUTYL 4-CHLORO-3-FORMYLPYRIDIN-2-YLCARBAMATE; TERT-BUTYL 4-CHLORO-5-FORMYLPYRIDIN-2-YLCARBAMATE; TERT-BUTYL 4-FLUORO-2-FORMYLPHENYLCARBAMATE; TERT-BUTYL 4-FORMYL-3-(TRIFLUOROMETHYL)PHENYLCARBAMATE; TERT-BUTYL 4-FORMYLBENZO[D]THIAZOL-2-YLCARBAMATE; TERT-BUTYL 4-FORMYLPYRIDIN-2-YLCARBAMATE; TERT-BUTYL 4-FORMYLPYRIDIN-3-YLCARBAMATE; TERT-BUTYL 4-OXOBUT-2-YNYLCARBAMATE; TERT-BUTYL 5-(5-FORMYLOXAZOL-2-YL)-1-METHYL-1H-PYRROL-3-YLCARBAMATE; TERT-BUTYL 5-CHLORO-4-FORMYLPYRIDIN-2-YLCARBAMATE; TERT-BUTYL 5-FLUORO-4-FORMYLPYRIDIN-2-YLCARBAMATE; TERT-BUTYL 5-FORMYL-3,4-DIMETHYL-1H-PYRROLE-2-CARBOXYLATE; TERT-BUTYL 6-(2-OXOETHYL)PYRIDIN-2-YLCARBAMATE; TERT-BUTYL 6-FORMYL-2,3-DIMETHYLPHENYLCARBAMATE; TERT-BUTYL 6-FORMYLPYRIDIN-3-YLCARBAMATE; TERT-BUTYL 6-FORMYLPYRIMIDIN-4-YLCARBAMATE; TERT-BUTYL CIS-4-(2-OXOETHYL)CYCLOHEXYLCARBAMATE; TERT-BUTYL CIS-4-FORMYLCYCLOHEXYLCARBAMATE; TERT-BUTYL FORMYL(4-HYDROXYPHENYL)METHYLCARBAMATE; TERT-BUTYL N-(1-BENZYL-2-OXOETHYL)CARBAMATE; TERT-BUTYL N-(2-FORMYL-1-BENZOFURAN-5-YL)CARBAMATE; TERT-BUTYL N-(4-FORMYLBENZYL)CARBAMATE; TERT-BUTYL TRANS-4-(2-OXOETHYL)CYCLOHEXYLCARBAMATE; TERT-BUTYL TRANS-4-FORMYLCYCLOHEXYLCARBAMATE; TERT-BUTYL(S)-2-(4-FLUOROCYCLOHEXYL)-1-FORMYLETHYLCARBAMATE; THEOPHYLLINEACETIC ALDEHYDE; TRANS-3-(2,4-DIFLUOROPHENYL)PYRROLIDINE-2-CARBALDEHYDE; TRANS-4-(BENZYLOXYCARBONYLAMINO)CYCLOHEXANECARBALDEHYDE; TRANS-BENZYL (-4-FORMYLCYCLOHEXYL)METHYLCARBAMATE; TRANS-TERT-BUTYL (4-FORMYLCYCLOHEXYL)METHYLCARBAMATE; TRIAZOLAL;

List No. 3—Boronic Acids:

(1-([2-(TRIMETHYLSILYL)ETHOXY]METHYL)-1H-IMIDAZOL-4-YL)BORONIC ACID; (1-([2-(TRIMETHYLSILYL)ETHOXY]METHYL)-1H-IMIDAZOL-5-YL)BORONIC ACID; (1-(2-(DIMETHYLAMINO)ETHOXY)-1H-PYRAZOL-4-YL)BORONIC ACID; (1-(3-METHOXYPROPYL)-1H-PYRAZOL-4-YL)BORONIC ACID; (1,2,3,4-TETRAHYDRO-1-OXO-6-ISOQUINOLINYL)-BORONIC ACID; (1,2-DIHYDRO-2-OXO-5-PYRIMIDINYL)-BORONIC ACID; (1,2-DIHYDRO-4,8-DIMETHOXY-2-OXO-3-QUINOLINYL)-BORONIC ACID; (1-[(4-METHYLPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDIN-3-YL)BORONIC ACID; (1-[(BENZYLOXY)CARBONYL]-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)BORONIC ACID; (1-[TERT-BUTYL(DIMETHYL)SILYL]-1H-INDOL-3-YL)BORONIC ACID; (1-[TERT-BUTYL(DIMETHYL)SILYL]-1H-PYRROLO[2,3-B]PYRIDIN-5-YL)BORONIC ACID; (10-PHENYLANTHRACEN-9-YL)BORONIC ACID; (1-ACETYL-2,3-DIHYDRO-1H-INDOL-5-YL)BORONIC ACID; (1-BENZYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)BORONIC ACID; (1-BENZYLINDAZOL-5-YL)BORONIC ACID; (1-CYCLOPROPYL-1H-PYRAZOL-4-YL)BORONIC ACID; (1-METHYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)BORONIC ACID; (1-METHYL-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)BORONIC ACID; (1-METHYLBENZIMIDAZOLE-2-YL)BORONIC ACID; (1-OXO-1,3-DIHYDROISOBENZOFURAN-4-YL)BORONIC ACID; (1-OXO-1,3-DIHYDROISOBENZOFURAN-5-YL)BORONIC ACID; (1-OXO-1,3-DIHYDROISOBENZOFURAN-6-YL)BORONIC ACID; (1-OXO-1,3-DIHYDROISOBENZOFURAN-7-YL)BORONIC ACID; (1-OXO-2-PHENYLISOINDOLIN-4-YL)BORONIC ACID; (1-OXO-2-PHENYLISOINDOLIN-5-YL)BORONIC ACID; (1-OXO-2-PHENYLISOINDOLIN-6-YL)BORONIC ACID; (1-OXO-2-PHENYLISOINDOLIN-7-YL)BORONIC ACID; (1-OXO-2-PROPYLISOINDOLIN-4-YL)BORONIC ACID; (1-OXO-2-PROPYLISOINDOLIN-5-YL)BORONIC ACID; (1-OXO-2-PROPYLISOINDOLIN-6-YL)BORONIC ACID; (1-OXO-2-PROPYLISOINDOLIN-7-YL)BORONIC ACID; (1-OXOISOINDOLIN-7-YL)BORONIC ACID; (1R)-1-(2-THIENYLACETYLAMINO)-1-(3-CARBOXYPHENYL)METHYLBORONIC ACID; (1R,2S)-2-METHYLCYCLOPROPYLBORONIC ACID; (1S)-1,7,7-TRIMETHYLBICYCLO[2.2.1]HEPT-2-EN-2-YLBORONIC ACID; (1S,2S)-2-(CHLOROMETHYL)CYCLOPROPYLBORONIC ACID; (1S,2S)-2-METHYLCYCLOPROPYLBORONIC ACID; (1S,2S)-2-PHENYLCYCLOPROPYLBORONIC ACID; (1S,2S)-2-PROPYLCYCLOPROPYLBORONIC ACID; (1-TRITYL-1H-1,2,3-BENZOTRIAZOL-5-YL)BORONIC ACID; (1-TRITYL-1H-IMIDAZOL-4-YL)BORONIC ACID; (2-([(1,3-DIMETHYL-1H-PYRAZOL-5-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(2,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(2,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(2,5-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(2,5-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(2-CHLOROPHENYL)METHOXY]METHYL)PHENYL)BORANEDIOL; (2-([(2-CHLOROPHENYL)SULFANYL]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([(2E)-3-PHENYLPROP-2-EN-1-YL]OXY)PHENYL)BORANEDIOL; (2-([(2-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(3,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(3,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(3-CHLOROPHENYL)SULFANYL]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([(3-CHLOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(3-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([(4,6-DIMETHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(4-CHLOROPHENYL)SULFANYL]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([(4-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([(CYCLOHEXYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([(CYCLOPROPYLMETHYL)(PROPYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([3-(1H-IMIDAZOL-1-YL)PROPYL]AMINO)PYRIMIDIN-5-YL)BORONIC ACID; (2-([4-(DIMETHYLAMINO)PIPERIDIN-1-YL]METHYL)PHENYL)BORANEDIOL; (2-([4-(PROPAN-2-YL)PIPERAZIN-1-YL]METHYL)PHENYL)BORANEDIOL; (2-([BENZYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([BIS(2-METHOXYETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([BIS(2-METHYLPROPYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([BUTYL(CYCLOPROPYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([CYCLOHEPTYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([CYCLOHEXYL(ETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([CYCLOHEXYL(METHYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([CYCLOPENTYL(ETHYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([CYCLOPROPYL(2-METHOXYETHYL)AMINO]METHYL)-5-FLUOROPHENYL)BORANEDIOL; (2-([ETHYL(2-ETHYLBUTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([ETHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([METHYL(1-METHYLPIPERIDIN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([METHYL(4-METHYLCYCLOHEXYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([METHYL(PYRIDIN-2-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([METHYL(PYRIDIN-3-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-([METHYL(PYRIDIN-4-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-(2-(DIMETHYLAMINO)ETHOXY)PYRIDIN-4-YL)BORONIC ACID; (2-(2-HYDROXYETHYL)-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-(2-HYDROXYETHYL)-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-(2-HYDROXYETHYL)-1-OXOISOINDOLIN-6-YL)BORONIC ACID; (2-(2-HYDROXYETHYL)-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-(2-METHOXYETHYL)PYRIDIN-4-YL)BORONIC ACID; (2-(3-(DIMETHYLAMINO)PROPYL)PYRIDIN-4-YL)BORONIC ACID; (2-(3-METHOXYPROPYL)PYRIDIN-4-YL)BORONIC ACID; (2-(4-CHLORO-BENZYL)-AMINOPYRIMIDIN-5-YL)BORONIC ACID; (2-(CYANOMETHYL)-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-(CYANOMETHYL)-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-(CYANOMETHYL)-1-OXOISOINDOLIN-6-YL)BORONIC ACID; (2-(CYANOMETHYL)-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-(N-(3,4-DIMETHYLISOXAZOL-5-YL)-N-((2-METHOXYETHOXY)METHYL)SULFAMOYL)PHENYL)BORONIC ACID; (2-(N-(3,4-DIMETHYLISOXAZOL-5-YL)SULFAMOYL)PHENYL)BORONIC ACID; (2-(N-(TERT-BUTYL)SULFAMOYL)-5-ISOBUTYLTHIOPHEN-3-YL)BORONIC ACID; (2,2-DIMETHYL-2,3-DIHYDRO-1-BENZOFURAN-5-YL)BORANEDIOL; (2,3,5,6-TETRACHLOROPHENYL)BORANEDIOL; (2,3-DIFLUORO-4-PROPYLPHENYL)-BORONIC ACID; (2,3-DIMETHOXY-5-METHYLPHENYL)BORONIC ACID; (2,4-DIFLUORO-5-METHYLPHENYL)BORONIC ACID; (2,4-DIMETHYLTHIAZOLE)-5-BORONIC ACID; (2,6-DIETHYLPHENYL)BORONIC ACID; (2,6-DIMETHOXY-4-METHYLPHENYL)BORONIC ACID; (2,6-DIMETHOXY-4-PYRIMIDINYL)-BORONIC ACID; (2,6-DIMETHYL-4-METHOXYPHENYL)BORONIC ACID; (2-[(1-BENZYLPIPERIDIN-4-YL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(1-ETHYL-1H-PYRAZOL-4-YL)METHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[(1-ETHYL-1H-PYRAZOL-4-YL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(1-ETHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (2-[(1-METHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (2-[(1-PHENYLETHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(2,2-DIMETHYLMORPHOLIN-4-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(2,3-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2,3-DIMETHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(2,4-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2,4-DIMETHYLPIPERIDIN-1-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(2,5-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2,6-DICHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2-BUTOXYETHOXY)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(2-CHLORO-6-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2-CHLOROPHENYL)METHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[(2-CHLOROPHENYL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(2E)-BUT-2-EN-1-YLOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[(2E)-BUT-2-EN-1-YLOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(2E)-BUT-2-EN-1-YLOXY]NAPHTHALEN-1-YL)BORANEDIOL; (2-[(2E)-BUT-2-EN-1-YLOXY]PHENYL)BORANEDIOL; (2-[(2-FLUOROPHENYL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(2-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2-FURYLMETHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(2-METHOXYETHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(2-METHYLPENTYL)OXY]PHENYL)BORANEDIOL; (2-[(2-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(2-METHYLPROP-2-EN-1-YL)OXY]NAPHTHALEN-1-YL)BORANEDIOL; (2-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (2-[(2-PHENYLETHOXY)METHYL]PHENYL)BORANEDIOL; (2-[(2-PHENYLETHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(3,3-DIMETHYLMORPHOLIN-4-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(3,4-DICHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(3,4-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(3,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(3-CHLOROPHENYL)METHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[(3-CHLOROPHENYL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(3-FLUOROPHENYL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(3-HYDROXYPROPYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(3-METHOXYPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(3-METHYLBUT-2-EN-1-YL)OXY]NAPHTHALEN-1-YL)BORANEDIOL; (2-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (2-[(3-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(3-MORPHOLIN-4-YLPROPYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(3-PHENYLPROP-2-YN-1-YL)OXY]PHENYL)BORANEDIOL; (2-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(4-CHLOROPHENYL)METHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[(4-CHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(4-CYCLOPROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(4-ETHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(4-ETHYLPIPERIDIN-1-YL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(4-FLUOROPHENYL)METHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[(4-METHOXYBENZOYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(4-METHOXYPHENYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(4-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (2-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)BORONIC ACID DIHYDROCHLORIDE; (2-[(4-PROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(4-PROPYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-[(BENZYLOXY)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(BENZYLSULFANYL)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(CYCLOHEPTYLOXY)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(CYCLOHEXYLMETHOXY)METHYL]-5-FLUOROPHENYL)BORANEDIOL; (2-[(CYCLOHEXYLMETHOXY)METHYL]PHENYL)BORANEDIOL; (2-[(CYCLOPENTYLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-[(DIBUTYLAMINO)METHYL]PHENYL)BORANEDIOL; (2-[(DIISOPROPYLAMINO)CARBONYL]-3-METHOXYPHENYL)BORONIC ACID; (2-[(METHYLAMINO)SULFONYL]PHENYL)BORONIC ACID; (2-[(OCTYLOXY)METHYL]PHENYL)BORANEDIOL; (2-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (2-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-[(OXOLAN-3-YLOXY)METHYL]PHENYL)BORANEDIOL; (2-[(PYRIDIN-4-YLMETHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-[(TERT-BUTOXYCARBONYL)AMINO]-5-FLUOROPHENYL)BORONIC ACID; (2-[2-(DIETHYLAMINO)ETHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[2-(DIETHYLAMINO)ETHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[2-(DIETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(DIMETHYLAMINO)ETHOXY]-5-FLUOROPHENYL)BORANEDIOL; (2-[2-(DIMETHYLAMINO)ETHOXY]-5-METHYLPHENYL)BORANEDIOL; (2-[2-(DIMETHYLAMINO)ETHOXY]NAPHTHALEN-1-YL)BORANEDIOL; (2-[2-(DIMETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(MORPHOLIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(PYRIDIN-2-YL)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(PYRIDIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (2-[2-(PYRROLIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (2-[3-(2,2,2-TRIFLUOROETHOXY)PROPOXY]PHENYL)BORANEDIOL; (2-[BENZYL(METHYL)AMINO]PYRIMIDIN-5-YL)BORONIC ACID; (2-ACETYL-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-ACETYL-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-ACETYL-1-OXOISOINDOLIN-6-YL)BORONIC ACID; (2-ACETYL-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-AMINO-4-CARBOXYPHENYL)BORONIC ACID; (2-AMINO-4-CYANO)BENZENEBORONIC ACID, HYDROCHLORIDE; (2-AMINO-4-METHOXYCARBONYLPHENYL)BORONIC ACID HYDROCHLORIDE; (2-AMINOPHENYL)BORONIC ACID HYDROCHLORIDE; (2-ANILINOPYRIMIDIN-5-YL)BORONIC ACID; (2-BENZYLPHENYL)BORANEDIOL; (2-BOC-AMINOMETHYL-5-FLUOROPHENYL)BORONIC ACID; (2-BOC-AMINOPHENYL)BORONIC ACID; (2-BUTOXYNAPHTHALEN-1-YL)BORANEDIOL; (2-CHLORO-3-HYDROXYPHENYL)-BORONIC ACID; (2-CHLORO-5-ISOPROPYLPHENYL)BORONIC ACID; (2-CHLORO-8-METHOXY-3-QUINOLINYL)-BORONIC ACID; (2-CYCLOHEXYLAMINOPYRIMIDIN-5-YL)BORONIC ACID; (2-ETHYL-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-ETHYL-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-ETHYL-1-OXOISOINDOLIN-6-YL)BORONIC ACID; (2-ETHYL-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-ETHYNYLPHENYL)BORONIC ACID; (2-FLUORO-5-([(2-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(2-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(3-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(4-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(4-METHYLCYCLOHEXYL)OXY]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(4-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([(5-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([METHYL(OXAN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-([METHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-FLUORO-5-[(2,2,3,3-TETRAFLUOROPROPOXY)METHYL]PHENYL)BORANEDIOL; (2-FLUORO-5-[(4-METHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-FLUORO-5-[(4-METHYL-1,4-DIAZEPAN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-FLUORO-5-[(HEPTYLOXY)METHYL]PHENYL)BORANEDIOL; (2-FLUORO-5-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (2-FLUORO-5-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-ISOPROPOXY-5-TRIFLUOROMETHYLPHENYL)BORONIC ACID; (2-ISOPROPYL-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-ISOPROPYL-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-ISOPROPYL-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-ISOPROPYLPYRIMIDIN-5-YL)BORONIC ACID; (2-METHOXY-5-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([(4-METHYLPENTYL)OXY]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([2-(PROPAN-2-YLOXY)ETHOXY]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([METHYL(2,2,2-TRIFLUOROETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([METHYL(3-METHYLBUTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([METHYL(PENTAN-3-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([METHYL(PENTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-([PROPAN-2-YL(PROPYL)AMINO]METHYL)PHENYL)BORANEDIOL; (2-METHOXY-5-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(4-METHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(OXAN-4-YLOXY)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(PHENYLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(PYRIDIN-2-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-[(PYRIMIDIN-2-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (2-METHOXY-5-NITROPHENYL)BORONIC ACID; (2-METHOXY-5-PYRIDINYL)BORONIC ACID HYDROCHLORIDE; (2-METHOXY-6-METHYLPHENYL)BORONIC ACID; (2-METHYL-1,3-BENZOXAZOL-6-YL)BORONIC ACID; (2-METHYL-1-OXOISOINDOLIN-4-YL)BORONIC ACID; (2-METHYL-1-OXOISOINDOLIN-5-YL)BORONIC ACID; (2-METHYL-1-OXOISOINDOLIN-6-YL)BORONIC ACID; (2-METHYL-1-OXOISOINDOLIN-7-YL)BORONIC ACID; (2-METHYL-2,3-DIHYDRO-1-BENZOFURAN-5-YL)BORANEDIOL; (2-METHYL-3-CARBOXYPHENYL)BORONIC ACID; (2-METHYL-4-CARBOXYPHENYL)BORONIC ACID; (2-METHYL-5-NITROPHENYL)BORONIC ACID; (2-METHYL-5-PHENYL-3-THIENYL)-BORONIC ACID; (2-METHYL-5-QUINOLINYL)BORONIC ACID HYDRATE; (2-METHYLPYRIMIDIN-5-YL)BORONIC ACID; (2-METHYLQUINOLIN-5-YL)BORONIC ACID; (2-METHYLQUINOLIN-8-YL)BORANEDIOL; (2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL)BORONIC ACID; (2-OXO-2,3-DIHYDRO-1H-PYRIDO[2,3-B][1,4]OXAZIN-7-YL)BORONIC ACID; (2-PHENOXYPYRIMIDIN-5-YL)BORONIC ACID; (2-PIPERAZIN-1-YLPYRIMIDIN-5-YL)BORONIC ACID; (2-PIPERIDIN-1-YLPYRIMIDIN-5-YL)BORONIC ACID; (2-PROPOXYNAPHTHALEN-1-YL)BORANEDIOL; (2-PROPOXYPYRIMIDIN-5-YL)BORONIC ACID; (2-PYRROLIDIN-1-YLPYRIMIDIN-5-YL)BORONIC ACID; (2-TERT-BUTYLPYRIMIDIN-5-YL)BORONIC ACID; (3-([(2,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(2,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(2,5-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(2,5-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(2-CHLOROPHENYL)METHOXY]METHYL)PHENYL)BORANEDIOL; (3-([(2E)-3-PHENYLPROP-2-EN-1-YL]OXY)PHENYL)BORANEDIOL; (3-([(2-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(3,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(3,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(3-CHLOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(3-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([(4,6-DIMETHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(4-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([CYCLOHEXYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([4-(DIMETHYLAMINO)PIPERIDIN-1-YL]METHYL)PHENYL)BORANEDIOL; (3-([4-(PROPAN-2-YL)PIPERAZIN-1-YL]METHYL)PHENYL)BORANEDIOL; (3-([BENZYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([BIS(2-METHOXYETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([BIS(2-METHYLPROPYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([BUTYL(ETHYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([CYCLOHEPTYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([CYCLOHEXYL(ETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([CYCLOPENTYL(METHYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([CYCLOPROPYL(PROPYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([ETHYL(2-ETHYLBUTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([ETHYL(2-METHOXYETHYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([ETHYL(2-METHYLPROPYL)AMINO]METHYL)-4-METHOXYPHENYL)BORANEDIOL; (3-([ETHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([METHYL(1-METHYLPIPERIDIN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([METHYL(4-METHYLCYCLOHEXYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([METHYL(PYRIDIN-2-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([METHYL(PYRIDIN-3-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-([METHYL(PYRIDIN-4-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-(2-[(3-METHOXYPROPYL)(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[(4-METHYLPENTYL)OXY]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[(CYCLOBUTYLMETHYL)(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL)PHENYL)BORONIC ACID; (3-(2-[2-(PROPAN-2-YLOXY)ETHOXY]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[BUTYL(ETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[CYCLOPENTYL(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[CYCLOPROPYL(PROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[ETHYL(2-METHOXYETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[ETHYL(2-METHYLPROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[METHYL(2,2,2-TRIFLUOROETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[METHYL(3-METHYLBUTYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[METHYL(PENTAN-3-YL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[METHYL(PENTYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(2-[PROPAN-2-YL(PROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (3-(3-BENZYOXY)PROPOXY)PHENYL BORONIC ACID; (3,4-DIETHOXYPHENYL)BORANEDIOL; (3,4-DIPROPOXYPHENYL)BORANEDIOL; (3,5-DIMETHOXY-D6)-PHENYLBORONIC ACID; (3,5-DIMETHOXYPHENYL)METHANOL-4-BORONIC ACID; (3,5-DIMETHYL-1-PHENYL-1H-PYRAZOL-4-YL)BORANEDIOL; (3,5-DIMETHYL-D6)-PHENYLBORONIC ACID; (3,5-DINITRO-2-METHYLPHENYL)BORONIC ACID; (3,5-DIPHENYLPHENYL)BORONIC ACID; (3,6-DIAMINO-9-ACRIDINYL)-BORONIC ACID; (3-[(1-METHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (3-[(1-METHYLPIPERIDIN-2-YL)METHOXY]PHENYL)BORONIC ACID; (3-[(2,3-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2,4-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2,5-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2-CHLORO-4-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2-CHLORO-6-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2E)-BUT-2-EN-1-YLOXY]PHENYL)BORANEDIOL; (3-[(2-METHYL-1,4-OXAZEPAN-4-YL)METHYL]PHENYL)BORANEDIOL; (3-[(2-METHYLPENTYL)OXY]PHENYL)BORANEDIOL; (3-[(2-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (3-[(2-PHENYLETHOXY)METHYL]PHENYL)BORANEDIOL; (3-[(3,4-DICHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(3,4-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(3,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (3-[(3-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(3-PHENYLPROP-2-YN-1-YL)OXY]PHENYL)BORANEDIOL; (3-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4,5-DIMETHYL-1H-IMIDAZOL-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4-CYCLOPROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4-ETHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (3-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)BORONIC ACID DIHYDROCHLORIDE; (3-[(4-PROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(4-PROPYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-[(CYCLOHEXYLMETHOXY)METHYL]PHENYL)BORANEDIOL; (3-[(CYCLOHEXYLOXY)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(CYCLOHEXYLSULFANYL)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(CYCLOPENTYLSULFANYL)METHYL]PHENYL)BORANEDIOL; (3-[(DIBUTYLAMINO)METHYL]PHENYL)BORANEDIOL; (3-[(DIPROPYLAMINO)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(HEXYLOXY)METHYL]-4-METHOXYPHENYL)BORANEDIOL; (3-[(OCTYLOXY)METHYL]PHENYL)BORANEDIOL; (3-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (3-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (3-[(OXOLAN-3-YLOXY)METHYL]PHENYL)BORANEDIOL; (3-[(TERT-BUTOXYCARBONYL)AMINO]-5-METHYLISOXAZOL-4-YL)BORONIC ACID; (3-[(TRIMETHYLSILYL)ETHYNYL]PHENYL)BORONIC ACID; (3-[1-(DIMETHYLAMINO)ETHYL]PHENYL)BORONIC ACID; (3-[2-(1,4-OXAZEPAN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(1,4-THIAZEPAN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(4,5-DIMETHYL-1H-IMIDAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(4-METHYLPIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(AZEPAN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(CYCLOHEXYLOXY)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(CYCLOHEXYLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(DIETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(DIMETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(DIPROPYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(HEXYLOXY)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(OXAN-4-YLOXY)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(OXAN-4-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PHENYLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PYRIDIN-2-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PYRIDIN-2-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PYRIDIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PYRIMIDIN-2-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (3-[2-(PYRROLIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (3-[3-(2,2,2-TRIFLUOROETHOXY)PROPOXY]PHENYL)BORANEDIOL; (3-[4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL]PHENYL)BORONIC ACID; (3-ACETAMIDO-2-NITRO)BENZENEBORONIC ACID; (3-ACETAMIDOMETHYLPHENYL)BORONIC ACID; (3-ALLYLAMINOCARBONYL)BENZENEBORONIC ACID; (3-AMINO-4-CHLOROPHENYL)BORONIC ACID HYDROCHLORIDE; (3-AMINO-5-METHOXYCARBONYLPHENYL)BORONIC ACID; (3-AMINO-5-NITROPHENYL)BORONIC ACID; (3-AMINO-5-NITROPHENYL)BORONIC ACID HYDROCHLORIDE; (3-AMINOMETHYLPHENYL)BORONIC ACID; (3-AMINOMETHYLPHENYL)BORONIC ACID HYDROCHLORIDE; (3-BENZYLOXYCARBONYL-5-NITROPHENYL)BORONIC ACID; (3-BOC-AMINO-4-METHYLPHENYL)BORONIC ACID; (3-BOC-AMINO-5-NITROPHENYL)BORONIC ACID; (3-BOC-AMINOPHENYL)BORONIC ACID; (3-CARBAMOTHIOYL)BENZENEBORONIC ACID; (3-CHLORO-4-ETHOXYCARBONYL)BENZENEBORONIC ACID; (3-CHLORO-4-METHOXYCARBONYL)BENZENEBORONIC ACID; (3-CHLORO-5-CYANOPHENYL)BORONIC ACID; (3-CYCLOHEXYLPROPYL)BORONIC ACID; (3-ETHOXYCARBONYL-5-NITROPHENYL)BORONIC ACID; (3-ETHYL-1H-INDAZOL-4-YL)BORONIC ACID; (3-FLUORO-4-([(2-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(2-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(3-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(4-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(4-METHYLCYCLOHEXYL)OXY]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(4-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([(5-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([METHYL(OXAN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-([METHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (3-FLUORO-4-[(2,2,3,3-TETRAFLUOROPROPOXY)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-4-[(4-METHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-4-[(4-METHYL-1,4-DIAZEPAN-1-YL)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-4-[(HEPTYLOXY)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-4-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-4-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (3-FLUORO-5-METHOXYCARBONYLPHENYL)BORONIC ACID; (3-FLUORO-5-TRIFLUOROMETHYLPHENYL)BORONIC ACID; (3-FORMYLOXYPHENYL)BORONIC ACID; (3-METHANESULFONYLAMINOMETHYLPHENYL)BORONIC ACID; (3-METHYL-4-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (3-METHYL-4-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (3-METHYL-4-CARBOXYPHENYL)BORONIC ACID; (3-METHYL-5-METHOXY-D6)-PHENYLBORONIC ACID; (3-NITRO-4-ISOBUTYLPHENYL)BORONIC ACID; (3-PHENYLAMINOCARBONYLPHENYL)BORONIC ACID; (3-T-BUTYL-5-METHYLPHENYL)BORONIC ACID; (3-TERT-BUTOXYPHENYL)BORONIC ACID; (4-((1-METHYL-1H-IMIDAZOL-4-YL)METHOXY)PHENYL)BORONIC ACID; (4-([(1,3-DIMETHYL-1H-PYRAZOL-5-YL)SULFANYL]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(2,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(2,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(2,5-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(2,5-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(2-CHLOROPHENYL)METHOXY]METHYL)PHENYL)BORANEDIOL; (4-([(2-CHLOROPHENYL)SULFANYL]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(2-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(3,4-DIFLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(3,4-DIMETHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(3-CHLOROPHENYL)SULFANYL]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(3-CHLOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(3-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([(3-METHYLCYCLOHEXYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(4,6-DIMETHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(4-CHLOROPHENYL)SULFANYL]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(4-METHOXYPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([(CYCLOHEXYLMETHYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([(CYCLOPROPYLMETHYL)(PROPYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([(TERT-BUTOXYCARBONYL)(METHYL)AMINO]METHYL)PHENYL)BORONIC ACID; (4-([4-(DIMETHYLAMINO)PIPERIDIN-1-YL]METHYL)PHENYL)BORANEDIOL; (4-([4-(PROPAN-2-YL)PIPERAZIN-1-YL]METHYL)PHENYL)BORANEDIOL; (4-([BENZYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([BIS(2-METHOXYETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([BIS(2-METHYLPROPYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([BUTYL(CYCLOPROPYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([CYCLOHEPTYL(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([CYCLOHEXYL(ETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([CYCLOHEXYL(METHYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([CYCLOPENTYL(ETHYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([CYCLOPROPYL(2-METHOXYETHYL)AMINO]METHYL)-3-FLUOROPHENYL)BORANEDIOL; (4-([ETHYL(2-ETHYLBUTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([ETHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(1-METHYLPIPERIDIN-3-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(1-METHYLPIPERIDIN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(4-METHYLCYCLOHEXYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(PYRIDIN-2-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(PYRIDIN-3-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-([METHYL(PYRIDIN-4-YLMETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-(2-[(3-METHOXYPROPYL)(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[(4-METHYLPENTYL)OXY]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[(CYCLOBUTYLMETHYL)(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[(TERT-BUTOXYCARBONYL)AMINO]ETHYL)PHENYL)BORONIC ACID; (4-(2-[2-(PROPAN-2-YLOXY)ETHOXY]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[BUTYL(ETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[CYCLOPENTYL(METHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[CYCLOPROPYL(PROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[ETHYL(2-METHOXYETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[ETHYL(2-METHYLPROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[METHYL(2,2,2-TRIFLUOROETHYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[METHYL(3-METHYLBUTYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[METHYL(PENTAN-3-YL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[METHYL(PENTYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-[PROPAN-2-YL(PROPYL)AMINO]ETHOXY)PHENYL)BORANEDIOL; (4-(2-AMINO-2-OXOETHOXY)PHENYL)BORONIC ACID; (4-(2-HYDROXYETHYL)PIPERAZIN-1-YL)(3-BORONOPHENYL)METHANONE, HCL; (4-(2-MORPHOLINO-2-OXOETHOXY)PHENYL)BORONIC ACID; (4-(2-OXO-2-THIOMORPHOLINOETHOXY)PHENYL)BORONIC ACID; (4-(2S)-3-AMINO-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-OXOPROPYLPHENYL)BORONIC ACID; (4-(4-(2-(DIMETHYLAMINO)ACETYL)PIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(4-(2-HYDROXYETHYL)PIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(4-BENZYLPIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(4-ETHYLPIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(4-ISOPROPYLPIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(4-PROPYLPIPERAZIN-1-YL)PHENYL)BORONIC ACID; (4-(5H,6H,7H,8H-IMIDAZO[1,2-A]PYRAZIN-7-YLMETHYL)PHENYL)BORANEDIOL; (4-[(1-METHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (4-[(1-METHYLPIPERIDIN-2-YL)METHOXY]PHENYL)BORONIC ACID; (4-[(2,2-DIMETHYLMORPHOLIN-4-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(2,3-DIMETHYLPIPERIDIN-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(2,4-DICHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2,4-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2,5-DIFLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2-BUTOXYETHOXY)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(2-CHLORO-4-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2-CHLORO-6-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2-CHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2E)-BUT-2-EN-1-YLOXY]PHENYL)BORANEDIOL; (4-[(2-METHYL-1,4-OXAZEPAN-4-YL)METHYL]PHENYL)BORANEDIOL; (4-[(2-METHYLPENTYL)OXY]PHENYL)BORANEDIOL; (4-[(2-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (4-[(2-PHENYLETHOXY)METHYL]PHENYL)BORANEDIOL; (4-[(3,3-DIMETHYLMORPHOLIN-4-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(3,4-DICHLOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(3,4-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(3,5-DIMETHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (4-[(3-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (4-[(3-PHENYLPROP-2-YN-1-YL)OXY]PHENYL)BORANEDIOL; (4-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(4,5-DIMETHYL-1H-IMIDAZOL-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(4-CHLORO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(4-CYCLOPROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(4-ETHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(4-ETHYLPIPERIDIN-1-YL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)BORONIC ACID; (4-[(4-PROPYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(4-PROPYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-[(BENZYLOXY)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(BENZYLSULFANYL)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(CYCLOHEPTYLOXY)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(CYCLOHEXYLMETHOXY)METHYL]-3-FLUOROPHENYL)BORANEDIOL; (4-[(CYCLOHEXYLMETHOXY)METHYL]PHENYL)BORANEDIOL; (4-[(CYCLOPENTYLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-[(DIBUTYLAMINO)METHYL]PHENYL)BORANEDIOL; (4-[(DIMETHYLAMINO)METHYL]PHENYL)BORONIC ACID HYDROCHLORIDE; (4-[(OCTYLOXY)METHYL]PHENYL)BORANEDIOL; (4-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (4-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-[(OXOLAN-3-YLOXY)METHYL]PHENYL)BORANEDIOL; (4-[(TERT-BUTOXYCARBONYL)AMINO]PYRIDIN-3-YL)BORONIC ACID; (4-[(TRIMETHYLSILYL)ETHYNYL]PHENYL)BORONIC ACID; (4-[[TERT-BUTYL(DIMETHYL)SILYL]OXY]-2-METHOXYPHENYL)BORONIC ACID; (4-[1-(1-PIPERIDINYL)ETHYL]PHENYL)BORONIC ACID; (4-[1-(1-PYRROLIDINYL)ETHYL]PHENYL)BORONIC ACID; (4-[1-(4-MORPHOLINYL)ETHYL]PHENYL)BORONIC ACID; (4-[1-(DIMETHYLAMINO)ETHYL]PHENYL)BORONIC ACID; (4-[2-(1,4-OXAZEPAN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(1,4-THIAZEPAN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(4,5-DIMETHYL-1H-IMIDAZOL-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(4-METHYLPIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(AZEPAN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(CYCLOHEXYLOXY)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(CYCLOHEXYLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(DIETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(DIMETHYLAMINO)ETHOXY]-3-METHYLPHENYL)BORANEDIOL; (4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(DIPROPYLAMINO)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(HEXYLOXY)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(MORPHOLIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(OXAN-4-YLOXY)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(OXAN-4-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PHENYLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PYRIDIN-2-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PYRIDIN-2-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PYRIDIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (4-[2-(PYRIMIDIN-2-YLSULFANYL)ETHOXY]PHENYL)BORANEDIOL; (4-[2,2′:6′,2″-TERPYRIDIN]-4′-YLPHENYL)-4′-BORONIC ACID; (4-[3-(2,2,2-TRIFLUOROETHOXY)PROPOXY]PHENYL)BORANEDIOL; (4-[3-(PIPERIDIN-1-YL)PROPOXY]PHENYL)BORANEDIOL; (4-[4-(DIMETHYLAMINO)BUTYL]PHENYL)BORONIC ACID; (4-ACETAMIDOMETHYLPHENYL)BORONIC ACID; (4-ALLYLAMINOCARBONYL)BENZENEBORONIC ACID; (4-AMINO-2-FLUOROPHENYL)BORONIC ACID; (4-AMINOSULFONYLPHENYL)BORONIC ACID; (4-BENZYLOXYCARBONYL-2-NITRO)BENZENEBORONIC ACID; (4-BOC-AMINOPHENYL)BORONIC ACID; (4-BUTOXY-3-METHYLPHENYL)BORANEDIOL; (4-CBZ-AMINOPHENYL)BORONIC ACID; (4-CHLORO-2-ETHOXYCARBONYL)BENZENEBORONIC ACID; (4-CHLORO-2-METHYLTHIAZOLO[4,5-C]PYRIDIN-7-YL)BORONIC ACID; (4-CHLORO-3-HYDROXYPHENYL)BORONIC ACID; (4-CYANO-2-NITROPHENYL)BORONIC ACID; (4-ETHOXY-2-ETHYLPHENYL)BORONIC ACID; (4-ETHOXY-3,5-DIMETHOXYPHENYL)BORONIC ACID; (4-ETHOXY-3-TRIFLUOROMETHYLPHENYL)BORONIC ACID; (4-FLUORO-5-ISOPROPYL-2-METHOXYPHENYL)BORONIC ACID; (4-FLUOROPHENYLAMINOMETHYL)-4-BENZENEBORONIC ACID; (4-FLUOROPHENYLAMINOMETHYLENE)-4-BENZENEBORONIC ACID; (4-HEXYL-2-THIENYL)-BORONIC ACID; (4-HYDROXY-2-METHYL)PHENYLBORONIC ACID; (4-HYDROXY-3-NITROPHENYL)BORONIC ACID; (4-ISOPROPYL-2-METHOXYPHENYL)BORONIC ACID; (4-METHANESULFONYLAMINOMETHYLPHENYL)BORONIC ACID; (4-METHOXY-2,6-DIMETHYLPHENYL)BORONIC ACID HYDRATE; (4-METHOXY-3-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([(4-METHYLPENTYL)OXY]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([2-(PROPAN-2-YLOXY)ETHOXY]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([METHYL(2,2,2-TRIFLUOROETHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([METHYL(3-METHYLBUTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([METHYL(PENTAN-3-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([METHYL(PENTYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-([PROPAN-2-YL(PROPYL)AMINO]METHYL)PHENYL)BORANEDIOL; (4-METHOXY-3-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(4-METHYLPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(OXAN-4-YLOXY)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(PHENYLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(PYRIDIN-2-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-[(PYRIMIDIN-2-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (4-METHOXY-3-TRIFLUOROMETHYLPHENYL)BORONIC ACID; (4-METHOXYCARBONYLMETHYL)PHENYLBORONIC ACID; (4-METHYL-1-NAPHTHALENE)BORONIC ACID; (4-METHYL-2-NITROPHENYL)BORONIC ACID; (4-OXO-1,4-DIHYDROQUINAZOLIN-6-YL)BORONIC ACID; (4-PHENYLAMINOCARBONYLPHENYL)BORONIC ACID; (4-PROPOXY-3-METHYLPHENYL)BORONIC ACID; (4-PYRROLIDIN-1-YLPHENYL)BORONIC ACID; (4-SEC-BUTYLPHENYL)BORONIC ACID; (4-TERT-BUTYL-2-METHOXYPHENYL)BORONIC ACID; (4-THIOMORPHOLINOPHENYL)BORONIC ACID; (5-([(1,3-DIMETHYL-1H-PYRAZOL-5-YL)SULFANYL]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(2-CHLOROPHENYL)SULFANYL]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(3-CHLOROPHENYL)SULFANYL]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(4-CHLOROPHENYL)SULFANYL]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(CYCLOBUTYLMETHYL)(METHYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-([(CYCLOPROPYLMETHYL)(PROPYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([(TERT-BUTOXYCARBONYL)AMINO]METHYL)PYRIDIN-3-YL)BORONIC ACID; (5-([BUTYL(CYCLOPROPYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([BUTYL(ETHYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-([CYCLOHEXYL(METHYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([CYCLOPENTYL(ETHYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([CYCLOPENTYL(METHYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-([CYCLOPROPYL(2-M ETHOXYETHYL)AMINO]METHYL)-2-FLUOROPHENYL)BORANEDIOL; (5-([CYCLOPROPYL(PROPYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-([ETHYL(2-METHOXYETHYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-([ETHYL(2-METHYLPROPYL)AMINO]METHYL)-2-METHOXYPHENYL)BORANEDIOL; (5-(METHYLTHIO)PYRIDIN-3-YLTHIO)METHYLBORONIC ACID; (5′-(PIPERIDIN-2-YL)-[3,3′-BIPYRIDIN]-5-YL)BORONIC ACID; (5′-(PROP-1-YN-1-YL)[3,3′-BIPYRIDIN]-5-YL)BORONIC ACID; (5,7-DICHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINYL)-BORONIC ACID; (5-[(2,2-DIMETHYLMORPHOLIN-4-YL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(2-BUTOXYETHOXY)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(3,3-DIMETHYLMORPHOLIN-4-YL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(3,5-DIMETHYL-1H-1,2,4-TRIAZOL-1-YL)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-[(3,5-DIMETHYL-1H-PYRAZOL-1-YL)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(4-ETHYLPIPERAZIN-1-YL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(4-ETHYLPIPERIDIN-1-YL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(ACETYLAMINO)METHYL]PYRIDIN-3-YL)BORONIC ACID; (5-[(BENZYLOXY)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(BENZYLSULFANYL)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(CYCLOHEPTYLOXY)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(CYCLOHEXYLMETHOXY)METHYL]-2-FLUOROPHENYL)BORANEDIOL; (5-[(CYCLOHEXYLOXY)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-[(CYCLOHEXYLSULFANYL)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-[(DIPROPYLAMINO)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-[(HEXYLOXY)METHYL]-2-METHOXYPHENYL)BORANEDIOL; (5-ACETAMIDO-2-NITRO)BENZENEBORONIC ACID; (5-AMINO-1-NAPHTHALENYL)-BORONIC ACID; (5-AMINO-2-HYDROXYMETHYLPHENYL)BORONIC ACID, HCL, DIHYDRATE; (5-CHLORO-2-[(2,2-DIMETHYLPROPOXY)CARBONYL]PHENYL)BORONIC ACID; (5-CHLORO-2-METHOXYPYRIDIN-4-YL)BORONIC ACID; (5-CHLOROBENZO[B]THIOPHEN-2-YL)BORONIC ACID; (5-FLUORO-2-([(2-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(2-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(3-METHOXYPROPYL)(METHYL)AMINO]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(3-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(4-FLUOROPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(4-METHYLCYCLOHEXYL)OXY]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(4-METHYLPHENYL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(4-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(5-METHYL-1,3,4-OXADIAZOL-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([(5-METHYLPYRIMIDIN-2-YL)SULFANYL]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([METHYL(OXAN-4-YL)AMINO]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-([METHYL(PHENYL)AMINO]METHYL)PHENYL)BORANEDIOL; (5-FLUORO-2-[(1-METHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(2,2,3,3-TETRAFLUOROPROPOXY)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[(2-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(3-FLUOROPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(4-METHOXYPIPERIDIN-1-YL)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[(4-METHYL-1,4-DIAZEPAN-1-YL)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[(4-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[(HEPTYLOXY)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[(OXAN-4-YLMETHOXY)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[(OXAN-4-YLSULFANYL)METHYL]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(2,2,2-TRIFLUOROETHOXY)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(3-METHYLBUTOXY)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(MORPHOLIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(PYRIDIN-2-YL)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(PYRIDIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[2-(PYRROLIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-[3-(PYRROLIDIN-1-YL)PROPOXY]PHENYL)BORANEDIOL; (5-FLUORO-2-THIENYL)BORONIC ACID; (5-HYDROXYPYRIDIN-2-YL)BORONIC ACID; (5-ISOPROPYL-1H-INDAZOL-4-YL)BORONIC ACID; (5-METHYL-2-[(1-METHYL-1H-PYRAZOL-4-YL)METHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(2-METHYLPENTYL)OXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(2-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(2-METHYLPROP-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(3-METHYLBUT-2-EN-1-YL)OXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(3-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[(4-METHYLPHENYL)METHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(2,2,2-TRIFLUOROETHOXY)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(3-METHYLBUTOXY)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(MORPHOLIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(PYRIDIN-2-YL)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(PYRIDIN-4-YL)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[2-(PYRROLIDIN-1-YL)ETHOXY]PHENYL)BORANEDIOL; (5-METHYL-2-[3-(PYRROLIDIN-1-YL)PROPOXY]PHENYL)BORANEDIOL; (5-PHENOXY-3-PYRIDINYL)BORONIC ACID; (5-TRIFLUOROMETHYLBENZO[B]THIOPHEN-2-YL)BORONIC ACID; (6-(TERT-BUTOXYCARBONYL)-5,6,7,8-TETRAHYDRO-1,6-NAPHTHYRIDIN-3-YL)BORONIC ACID; (6-AMINOPYRIDIN-3-YL)BORONIC ACID; (6-ETHOXY-5-FLUOROPYRIDIN-3-YL)BORONIC ACID; (7-BUTYL-2-NAPHTHALENYL)BORONIC ACID; (7-CHLORO-1-BENZOTHIOPHEN-2-YL)BORANEDIOL; (7-HEPTYL-2-NAPHTHALENYL)BORONIC ACID; (8-METHOXY-2-METHYL-5-QUINOLINYL)BORONIC ACID TRIHYDRATE; (8-METHOXY-2-METHYLQUINOLIN-5-YL)BORONIC ACID; (8-METHOXY-2-METHYLQUINOLIN-5-YL)BORONIC ACID TRIHYDRATE; (8-METHOXYQUINOLIN-5-YL)BORONIC ACID; (8-METHYL-5-QUINOLINYL)BORONIC ACID HYDRATE; (9-ETHYL-9H-CARBAZOL-3-YL)BORONIC ACID; (9-METHYL-9H-CARBAZOL-3-YL)BORONIC ACID; (E)-(2-(FURAN-2-YL)VINYL)BORONIC ACID; (E)-(2-CYCLOPENTYLETHENYL)BORONIC ACID; (E)-3-((1H-PYRROL-2-YL)METHYLENE)-2-OXOINDOLIN-5-YLBORONIC ACID; (E)-3-(3-ETHOXY-3-OXOPROP-1-ENYL)-2-FLUOROPHENYLBORONIC ACID; (E)-3-(TRIFLUOROMETHYL)STYRYLBORONIC ACID; (E)-3-ACETOXYPROP-1-ENYLBORONIC ACID; (E)-3-METHOXYSTYRYLBORONIC ACID; (E)-3-PHENOXYPROP-1-ENYLBORONIC ACID; (E)-4-(N′-HYDROXYCARBAMIMIDOYL)PHENYLBORONIC ACID; (E)-4-AMINOBUT-2-ENYLBORONIC ACID HYDROCHLORIDE; (E)-5-(2-ETHOXYCARBONYLETHEN-1-YL)-2-FLUOROPHENYLBORONIC ACID; (E)-5-CHLORO-1-PENTENEBORONIC ACID; (E)-BUT-2-EN-2-YLBORONIC ACID; (FURAN-2-YLMETHYL)BORONIC ACID; (M-ACRYLAMIDOPHENYL)BORONIC ACID; (PYRIDIN-2-YLTHIO)METHYLBORONIC ACID; (PYRIDINE-D4)-4-BORONIC ACID; (PYRIMIDINE-2-D1)-5-BORONIC ACID; (S)-4-(2-AMINO-3-TERT-BUTOXY-3-OXOPROPYL)PHENYLBORONIC ACID; (Z)-CYCLOOCTENYLBORONIC ACID; [1-(TERT-BUTOXYCARBONYL)-1H-PYRROLO[2,3-B]PYRIDIN-2-YL]BORONIC ACID; [1,2,4]TRIAZOLO[1,5-A]PYRIDINE-6-BORONIC ACID; [1,2,5]OXADIAZOLO[3,4-B]PYRIDIN-6-YLBORONIC ACID; [1,3]DIOXOLO[4,5-B]PYRIDINE-6-BORONIC ACID; [10-(1-NAPHTHALENYL)-9-ANTHRACENYL]BORONIC ACID; [10-[4-(2-NAPHTHALENYL)PHENYL]-9-ANTHRACENYL]-BORONIC ACID; [2-(([(2-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [2-(([(3-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [2-((METHYL[(1-METHYL-1H-IMIDAZOL-2-YL)METHYL]AMINO)METHYL)PHENYL]BORANEDIOL; [2-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [2-(1H-INDAZOL-1-YLMETHYL)PHENYL]BORANEDIOL; [2-(1H-PYRAZOL-1-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(1H-PYRROL-1-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(2,2,2-TRIFLUOROETHOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(2,2,2-TRIFLUOROETHOXY)PYRIMIDIN-5-YL]BORONIC ACID; [2-(2,3-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,3-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,3-DIHYDRO-1H-INDOL-1-YLMETHYL)PHENYL]BORANEDIOL; [2-(2,3-DIHYDRO-1H-ISOINDOL-2-YLMETHYL)PHENYL]BORANEDIOL; [2-(2,3-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [242,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,5-DIMETHYL-1H-PYRROL-1-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(2,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,6-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2,6-DIMETHYLMORPHOLIN-4-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(2,6-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-CHLORO-4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-CHLORO-4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-CHLORO-5-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-CHLOROPHENOXYMETHYL)-5-FLUOROPHENYL]BORANEDIOL; [2-(2-ETHOXYETHOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(2-ETHOXYETHOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(2-ETHOXYETHOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(2-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-METHOXYETHOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(2-METHOXYETHOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(2-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [2-(2-METHYLPROPOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(2-PHENOXYETHOXY)PHENYL]BORANEDIOL; [2-(2-PHENYLETHOXY)PHENYL]BORANEDIOL; [2-(3,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [243,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(3,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [243,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)-4-METHOXYPHENYL]BORONIC ACID; [2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)-4-METHOXYPHENYL]BORONIC ACID HYDROCHLORIDE; [2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)-4-METHYLPHENYL]BORONIC ACID; [2-(3,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(3-CHLOROPHENOXYMETHYL)-5-FLUOROPHENYL]BORANEDIOL; [2-(3-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(3-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(3-METHOXYPROPOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(3-METHYLBUTOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(3-METHYLBUTOXY)PHENYL]BORANEDIOL; [2-(3-PHENYLPROPOXY)PHENYL]BORANEDIOL; [2-(4-CHLORO-2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(4-CHLORO-3-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(4-CHLOROPHENOXYMETHYL)-5-FLUOROPHENYL]BORANEDIOL; [2-(4-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(4-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-(4-N-BOC-PIPERAZIN-1-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(ALLYLAMINO)PYRIMIDIN-5-YL]BORONIC ACID; [2-(AZEPAN-1-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [2-(AZOCAN-1-YLMETHYL)-5-FLUOROPHENYL]BORANEDIOL; [2-(BENZYLAMINO)PYRIMIDIN-5-YL]BORONIC ACID; [2-(BUT-3-EN-2-YLOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(BUT-3-EN-2-YLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(BUT-3-EN-2-YLOXY)PHENYL]BORANEDIOL; [2-(BUTAN-2-YLOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(BUTAN-2-YLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(BUTAN-2-YLOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(BUTAN-2-YLOXY)PHENYL]BORANEDIOL; [2-(CYCLOBUTOXYMETHYL)-5-FLUOROPHENYL]BORANEDIOL; [2-(CYCLOBUTOXYMETHYL)PHENYL]BORANEDIOL; [2-(CYCLOHEXYLMETHOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(CYCLOHEXYLMETHOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(CYCLOHEXYLMETHOXY)PHENYL]BORANEDIOL; [2-(CYCLOHEXYLOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(CYCLOHEXYLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(CYCLOHEXYLOXY)PHENYL]BORANEDIOL; [2-(CYCLOPENTYLMETHOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(CYCLOPENTYLMETHOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(CYCLOPENTYLOXY)-5-FLUOROPHENYL]BORANEDIOL; [2-(CYCLOPENTYLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(CYCLOPENTYLOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(CYCLOPENTYLOXY)PHENYL]BORANEDIOL; [2-(CYCLOPROPYLMETHOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(DIBENZYLAMINO)PYRIMIDIN-5-YL]BORONIC ACID; [2-(DIETHYLAMINO)PYRIMIDIN-5-YL]BORONIC ACID; [2-(DIMETHYLAMINO)PHENYL]BORONIC ACID HYDROCHLORIDE HYDRATE; [2-(E-3-METHOXY-3-OXO-1-PROPEN-1-YL)PHENYL]BORONIC ACID; [2-(HEPTYLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(HEPTYLOXY)PHENYL]BORANEDIOL; [2-(HEXYLOXY)-5-METHYLPHENYL]BORANEDIOL; [2-(HEXYLOXY)PHENYL]BORANEDIOL; [2-(MORPHOLIN-4-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [2-(NONYLOXY)PHENYL]BORANEDIOL; [2-(OCTAHYDROQUINOLIN-1(2H)-YL)PYRIMIDIN-5-YL]BORONIC ACID; [2-(OCTYLOXY)PHENYL]BORANEDIOL; [2-(OXAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [2-(OXAN-4-YLMETHOXY)PHENYL]BORANEDIOL; [2-(OXOLAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [2-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [2-(PENTYLOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(PENTYLOXY)PHENYL]BORANEDIOL; [2-(PIPERIDIN-1-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [2-(PROP-2-EN-1-YLOXY)NAPHTHALEN-1-YL]BORANEDIOL; [2-(PYRIDIN-3-YLMETHOXY)PHENYL]BORANEDIOL; [2-(PYRIMIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [2-(PYRROLIDIN-1-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [2-(TRIFLUOROMETHOXY)PYRIMIDIN-5-YL]BORONIC ACID; [2-(TRIFLUOROMETHYL)QUINAZOLIN-4-YL]BORONIC ACID; [2-(TRIFLUOROMETHYL)QUINOLIN-5-YL]BORONIC ACID; [2-(TRIFLUOROMETHYL)QUINOLIN-6-YL]BORONIC ACID; [2,4-BIS(PROPAN-2-YL)PHENYL]BORANEDIOL; [2-[(TERT-BUTOXYCARBONYL)AMINO]PYRIMIDIN-5-YL]BORONIC ACID; [2-[2-(TRIPHENYLMETHYL)-2H-TETRAZOL-5-YL]PHENYL]BORONIC ACID; [2-AMINO-5-(TRIFLUOROMETHYL)PHENYL]BORONIC ACID; [2-FLUORO-3-(METHOXYCARBONYL)PHENYL]BORONIC ACID; [2-FLUORO-3-(TRIFLUOROMETHOXY)PHENYL]BORONIC ACID; [2-FLUORO-5-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(2-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(3-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(3-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-FLUORO-5-(4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [2-METHOXY-5-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [2-METHOXY-5-(1,4-THIAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [2-METHOXY-5-(PHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(([(2-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [3-(([(3-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [3-(1,3-DIOXOLAN-2-YL)-2-FLUOROPHENYL]BORONIC ACID; [3-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [3-(1H-INDAZOL-1-YLMETHYL)PHENYL]BORANEDIOL; [3-(1H-PYRAZOL-3-YL)PHENYL]BORONIC ACID; [3-(1H-PYRAZOL-5-YL)PHENYL]BORONIC ACID HYDRATE; [3-(1-METHOXYETHYL)PHENYL]BORONIC ACID; [3-(2,3-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,3-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,3-DIHYDRO-1H-INDOL-1-YLMETHYL)PHENYL]BORANEDIOL; [3-(2,3-DIHYDRO-1H-ISOINDOL-2-YLMETHYL)PHENYL]BORANEDIOL; [3-(2,3-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,6-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2,6-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-CARBOXYETHYL)PHENYL]BORONIC ACID; [3-(2-CHLORO-4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-CHLORO-4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-CHLORO-5-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-CYCLOBUTOXYETHOXY)PHENYL]BORANEDIOL; [3-(2-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [3-(2-PHENYLETHOXY)PHENYL]BORANEDIOL; [3-(3,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3,5-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3-HYDROXYPROPYL)PHENYL]BORONIC ACID; [3-(3-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(3-METHYLBUTOXY)PHENYL]BORANEDIOL; [3-(3-PHENYLPROPOXY)PHENYL]BORANEDIOL; [3-(4-CHLORO-1H-BENZOTHIAZOL-2-YL)PHENYL]-BORONIC ACID; [3-(4-CHLORO-2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(4-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(4-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-(AZEPAN-1-YLMETHYL)-4-METHOXYPHENYL]BORANEDIOL; [3-(AZEPAN-1-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [3-(BUT-3-EN-2-YLOXY)PHENYL]BORANEDIOL; [3-(BUTAN-2-YLOXY)PHENYL]BORANEDIOL; [3-(CYCLOBUTOXYMETHYL)-4-METHOXYPHENYL]BORANEDIOL; [3-(CYCLOBUTOXYMETHYL)PHENYL]BORANEDIOL; [3-(CYCLOPENTYLOXY)PHENYL]BORANEDIOL; [3-(E-3-METHOXY-3-OXO-1-PROPEN-1-YL)PHENYL]BORONIC ACID; [3-(HEPTYLOXY)PHENYL]BORANEDIOL; [3-(HEXYLOXY)PHENYL]BORANEDIOL; [3-(ISOBUTYLAMINOCARBONYL)PHENYL]BORONIC ACID; [3-(MORPHOLIN-4-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [3-(N-ISOPROPYLAMINOCARBONYL)PHENYL]BORONIC ACID; [3-(NONYLOXY)PHENYL]BORANEDIOL; [3-(OCTYLOXY)PHENYL]BORANEDIOL; [3-(OXAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [3-(OXOLAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [3-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [3-(PENTYLOXY)PHENYL]BORANEDIOL; [3-(PYRIDIN-3-YLMETHOXY)PHENYL]BORANEDIOL; [3-(PYRIDIN-4-YLMETHOXY)PHENYL]BORANEDIOL; [3-(PYRIMIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [3-(PYRROLIDIN-1-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [3,3′-BIPYRIDIN]-5-YLBORONIC ACID; [3-FLUORO-4-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(2-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(3-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(3-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-FLUORO-4-(4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(2-METHYLPROPOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(3-METHYLBUTOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(PENTYLOXY)PHENYL]BORANEDIOL; [3-METHYL-4-(PROP-2-EN-1-YLOXY)PHENYL]BORANEDIOL; [4-(([(2-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [4-(([(3-METHYLPHENYL)METHYL]SULFANYL)METHYL)PHENYL]BORANEDIOL; [4-(1′(3′-AMINOPROPYLL)IMIDAZOLE-1-CARBONYL)PHENYL] BORONIC ACID; [4-(1,3,4-OXADIAZOL-2-YL)PHENYL]BORONIC ACID; [4-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [4-(1-AMINO-4′-METHYLPIPERAZINE-1-CARBONYL)PHENYL]BORONIC ACID; [4-(1-ETHOXYETHYL)PHENYL]BORONIC ACID; [4-(1-ETHOXYETHYL)PHENYL]BORONIC ACID HYDRATE; [4-(1H-INDAZOL-1-YLMETHYL)PHENYL]BORANEDIOL; [4-(1H-PYRAZOL-1-YL)PHENYL]BORONIC ACID; [4-(1H-PYRAZOL-5-YL)PHENYL]BORONIC ACID; [4-(1-METHOXYETHYL)PHENYL]BORONIC ACID; [4-(2,3-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,3-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,3-DIHYDRO-1H-INDOL-1-YLMETHYL)PHENYL]BORANEDIOL; [4-(2,3-DIHYDRO-1H-ISOINDOL-2-YLMETHYL)PHENYL]BORANEDIOL; [4-(2,3-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,6-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2,6-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-CHLORO-4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-CHLORO-4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-CHLORO-5-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-CHLOROPHENOXYMETHYL)-3-FLUOROPHENYL]BORANEDIOL; [4-(2-CYCLOBUTOXYETHOXY)PHENYL]BORANEDIOL; [4-(2-ETHOXYCARBONYLETHYL)PHENYL]BORONIC ACID; [4-(2-ETHOXYETHOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(2-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-METHOXYETHOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(2-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [4-(2-PHENYL-1H-BENZIMIDAZOL-1-YL)PHENYL]BORONIC ACID; [4-(2-PHENYLETHOXY)PHENYL]BORANEDIOL; [4-(2-PIPERIDIN-1-YLETHYL)PHENYL]BORONIC ACID; [4-(3,4-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3,4-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3,4-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3,5-DICHLOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3,5-DIFLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PHENYL]BORONIC ACID; [4-(3,5-DIMETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3-CHLOROPHENOXYMETHYL)-3-FLUOROPHENYL]BORANEDIOL; [4-(3-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(3-METHOXYPROPOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(3-PHENYLPROPOXY)PHENYL]BORANEDIOL; [4-(4′-AMINOMORPHOLINE-1-CARBONYL)PHENYL] BORONIC ACID; [4-(4-CHLORO-2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(4-CHLOROPHENOXYMETHYL)-3-FLUOROPHENYL]BORANEDIOL; [4-(4-ETHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(4-METHOXYPHENOXYMETHYL)PHENYL]BORANEDIOL; [4-(4-TERT-BUTYLPHENYL)PHENYL]BORANEDIOL; [4-(AZEPAN-1-YLMETHYL)PHENYL]BORONIC ACID; [4-(AZOCAN-1-YLMETHYL)-3-FLUOROPHENYL]BORANEDIOL; [4-(BUT-2-EN-1-YLOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(BUT-3-EN-2-YLOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(BUT-3-EN-2-YLOXY)PHENYL]BORANEDIOL; [4-(BUTAN-2-YLOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(BUTAN-2-YLOXY)PHENYL]BORANEDIOL; [4-(CYCLOBUTOXYMETHYL)-3-FLUOROPHENYL]BORANEDIOL; [4-(CYCLOBUTOXYMETHYL)PHENYL]BORANEDIOL; [4-(CYCLOHEXYLOXY)PHENYL]BORANEDIOL; [4-(CYCLOPENTYLOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(CYCLOPROPYLMETHOXY)-3-METHYLPHENYL]BORANEDIOL; [4-(DIFLUOROMETHOXY)-2-METHOXYPHENYL]BORONIC ACID; [4-(E-3-METHOXY-3-OXO-1-PROPEN-1-YL)PHENYL]BORONIC ACID; [4-(MORPHOLIN-4-YLMETHYL)PHENYL]BORONIC ACID HYDROCHLORIDE; [4-(OXOLAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [4-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [4-(PIPERAZIN-1-YL)PHENYL]BORONIC ACID; [4-(PIPERAZIN-1-YLMETHYL)PHENYL]BORONIC ACID DIHYDROCHLORIDE; [4-(PYRIMIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [4-(TRANS-4-N-PROPYLCYCLOHEXYL)PHENYL]BORONIC ACID; [4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [4-(TRIPHENYLSILYL)PHENYL]BORONIC ACID; [4-CHLORO-2-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PHENYL]BORONIC ACID; [4-FLUORO-3-(HYDROXYMETHYL)PHENYL]BORONIC ACID; [4-METHOXY-2-(1H-PYRAZOL-1-YL)PHENYL]BORONIC ACID; [4-METHOXY-3-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [4-METHOXY-3-(1,4-THIAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [4-METHOXY-3-(PHENOXYMETHYL)PHENYL]BORANEDIOL; [4-METHYL-2-(1H-PYRAZOL-1-YL)PHENYL]BORONIC ACID; [4-TRIFLUOROMETHYL-6-[3-(TRIFLUOROMETHYL)PHENYL]PYRIMIDIN-2-YL]BORONIC ACID; [4-TRIFLUOROMETHYL-6-[4-(TRIFLUOROMETHYL)PHENYL]PYRIMIDIN-2-YL]BORONIC ACID; [5-(1,3-DIOXOLAN-2-YL)-2-FLUOROPHENYL]BORONIC ACID; [5-(2-CHLOROPHENOXYMETHYL)-2-FLUOROPHENYL]BORANEDIOL; [5-(3-CHLOROPHENOXYMETHYL)-2-FLUOROPHENYL]BORANEDIOL; [5-(4-CHLOROPHENOXYMETHYL)-2-FLUOROPHENYL]BORANEDIOL; [5-(AZEPAN-1-YLMETHYL)-2-METHOXYPHENYL]BORANEDIOL; [5-(AZOCAN-1-YLMETHYL)-2-FLUOROPHENYL]BORANEDIOL; [5-(BUTYLCARBAMOYL)-2-FLUOROPHENYL]BORONIC ACID; [5-(CYCLOBUTOXYMETHYL)-2-FLUOROPHENYL]BORANEDIOL; [5-(CYCLOBUTOXYMETHYL)-2-METHOXYPHENYL]BORANEDIOL; [5-(DIMETHYLCARBAMOYL)-2-FLUOROPHENYL]BORONIC ACID; [5,6,7,8-TETRAHYDROQUINAZOLIN-2-YL]BORONIC ACID; [5-BENZYLOXY-1-TOSYLINDOL-3-YL]BORONIC ACID; [5-FLUORO-2-(1,4-OXAZEPAN-4-YLMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-METHOXYETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-METHYLPROPOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(2-PHENYLETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(3-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(3-METHYLBUTOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(3-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(4-FLUOROPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(4-METHYLPHENOXYMETHYL)PHENYL]BORANEDIOL; [5-FLUORO-2-(HEPTYLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(HEXYLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(OCTYLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(OXAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(OXAN-4-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(OXOLAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PENTYLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PROP-2-EN-1-YLOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PYRIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PYRIDIN-3-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PYRIDIN-4-YLMETHOXY)PHENYL]BORANEDIOL; [5-FLUORO-2-(PYRIMIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(2,2,2-TRIFLUOROETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(2-METHYLBUTOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(2-PHENYLETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(3-METHYLBUTOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(OCTYLOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(OXAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(OXAN-4-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(OXOLAN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(OXOLAN-3-YLOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PENTYLOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PROP-2-EN-1-YLOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PYRIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PYRIDIN-3-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PYRIDIN-4-YLMETHOXY)PHENYL]BORANEDIOL; [5-METHYL-2-(PYRIMIDIN-2-YLMETHOXY)PHENYL]BORANEDIOL; [6-(1-NAPHTHYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-3-YL]BORONIC ACID; [6-(2-METHOXYETHOXY)NAPHTHALEN-2-YL]BORANEDIOL; [6-(2-METHYLBUTOXY)NAPHTHALEN-2-YL]BORANEDIOL; [6-(2-METHYLPROPOXY)NAPHTHALEN-2-YL]BORANEDIOL; [6-(2-NAPHTHYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(3-METHYLBUTOXY)NAPHTHALEN-2-YL]BORANEDIOL; [6-(4-ETHYLPHENYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL]BORONIC ACID; [6-(M-TOLYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(O-TOLYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(P-TOLYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2YL]BORONIC ACID; [6-(TERT-BUTYL)-4-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL]BORONIC ACID; [6-(TRIFLUOROMETHOXY)PYRIDIN-3-YL]BORONIC ACID; [6-CYCLOPROPYLPYRIMIDIN-2-YL]BORONIC ACID; [6-METHOXY-1-TOSYLINDOL-3-YL]BORONIC ACID; 1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)PYRAZOLE-5-BORONIC ACID; 1-([2-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([2-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-4-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE; 1-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-4,6-DIMETHYL-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-4-METHYL-1,2,3,4-TETRAHYDROPYRAZINE-2,3-DIONE; 1-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-4-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)-4-METHOXYPHENYL]METHYL)-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-4,6-DIMETHYL-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-4-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([4-(DIHYDROXYBORANYL)-2-FLUOROPHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE; 1-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-1,2-DIHYDROPYRIDIN-2-ONE; 1-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-4,6-DIMETHYL-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-4-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-1,2-DIHYDROPYRIDIN-2-ONE; 1-([5-(DIHYDROXYBORANYL)-2-METHOXYPHENYL]METHYL)-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-(1-BOC-PIPERIDINO)PYRAZOLE-4-BORONIC ACID; 1-(1-ETHOXYETHYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(2-(DIMETHYLAMINO)ETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-(PYRROLIDIN-1-YL)ETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-(TERT-BUTYLDIMETHYLSILYLOXY)ETHYL)-1H-PYRAZOL-3-YLBORONIC ACID; 1-(2-(TERT-BUTYLDIMETHYLSILYLOXY)ETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2,2,2-TRIFLUOROETHYL)-1H-PYRAZOLE-4-BORONIC ACID; 1-(2,2,2-TRIFLUOROETHYL)-1H-PYRAZOLE-5-BORONIC ACID; 1-(2,2-DIETHOXYETHYL)PYRAZOLE-4-BORONIC ACID; 1-(2,2-DIFLUOROETHYL)-PYRROL-2-YLBORONIC ACID; 1-(2,2-DIFLUOROETHYL)-PYRROL-3-YLBORONIC ACID; 1-(2,2-DIMETHYLPROPANOYL)-1H-PYRROL-2-YLBORONIC ACID; 1-(2-[4-(DIHYDROXYBORANYL)PHENOXY]ETHYL)-1,2-DIHYDROPYRIMIDIN-2-ONE; 1-(2-AMINO-2-OXOETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-AMINOETHY)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-CHLOROPHENYL)PYRAZOLE-4-BORONIC ACID; 1-(2-HYDROXYETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-METHOXYETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(2-METHOXYETHYL)-PYRROL-2-YLBORONIC ACID; 1-(2-METHOXYETHYL)-PYRROL-3-YLBORONIC ACID; 1-(3-(DIMETHYLAMINO)PROPYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(3,3-DIETHOXYPROPYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(3,3-DIETHOXYPROPYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(3-CHLOROPHENYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(3-CHLOROPHENYL)-1H-PYRAZOLE-3-BORONIC ACID; 1-(3-CHLOROPHENYL)-4-(ETHOXYCARBONYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(3-HYDROXYPROPYL)-1H-PYRROL-3-YLBORONIC ACID; 1-(3-METHYLBUTYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-BORONIC ACID; 1-(3-PYRIDINYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(4-BORONOBENZOYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(4-BORONOPHENYLSULFONYL)AZETIDINE; 1-(4-CARBOXYBUTYL)INDOLE-5-BORONIC ACID; 1-(4-CHLOROBENZOYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YLBORONIC ACID; 1-(4-CHLOROPHENYL)-4-(ETHOXYCARBONYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(4-FLUOROPHENYL)PYRAZOLE-4-BORONIC ACID; 1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(4-PYRIDINOMETHYL)PYRAZOLE-4-BORONIC ACID; 1-(4-PYRIDINYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(5-METHOXY-5-OXOPENTYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(6-CHLOROPYRIMIDIN-4-YL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(BENZYL)-5-INDOLINEBORONIC ACID; 1-(CYCLOPROPYLMETHYL)-1H-PYRAZOLE-5-BORONIC ACID; 1-(CYCLOPROPYLMETHYL)-PYRROL-2-YLBORONIC ACID; 1-(CYCLOPROPYLMETHYL)-PYRROL-3-YLBORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-2-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-3-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-4-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-5-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-6-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-7-BORONIC ACID; 1-(DIFLUOROMETHOXY)NAPHTHALENE-8-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-2-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-3-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-4-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-5-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-6-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-7-BORONIC ACID; 1-(DIFLUOROMETHYL)NAPHTHALENE-8-BORONIC ACID; 1-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 1-(METHOXYMETHYL)-2-(PHENYLTHIO)-1H-IMIDAZOL-5-YLBORONIC ACID; 1-(METHYLSULFONYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(METHYLSULFONYL)-PYRROL-2-YLBORONIC ACID; 1-(METHYLSULFONYL)-PYRROL-3-YLBORONIC ACID; 1-(N,N-DIMETHYLSULFAMOYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(N,N-DIMETHYLSULFAMOYL)-3-(PYRIDIN-2-YL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(N,N-DIMETHYLSULFAMOYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(N,N-DIMETHYLSULFAMOYL)-3-ETHYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-(N,N-DIMETHYLSULFAMOYL)-3-METHYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-(PHENYLSULFONYL)-1H-INDOL-3-YLBORONIC ACID; 1-(PHENYLSULFONYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(PHENYLSULFONYL)-1H-PYRROLO[3,2-C]PYRIDINE-2-YLBORONIC ACID; 1-(PHENYLSULFONYL)-2-INDOLEBORONIC ACID; 1-(PHENYLSULFONYL)PYRROLE-2-BORONIC ACID; 1-(PHENYLSULPHONYL)-1H-INDOLE-5-BORONIC ACID; 1-(P-TOLUENESULFONYL)-INDOLE-2-BORONIC ACID; 1-(PYRIDIN-2-YLMETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(PYRIDIN-3-YLMETHYL)PYRAZOLE-4-BORONIC ACID; 1-(T-BUTOXYCARBONYL)PYRAZOLE-5-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDRO-4,4-DIMETHYLQUINOLIN-7-YL-7-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-1H-INDOL-5-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-1H-PYRROLO[3,2-C]PYRIDIN-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-2-OXOINDOLIN-5-YLBORONIC ACID; 1′-(TERT-BUTOXYCARBONYL)-2-OXOSPIRO[INDOLINE-3,4′-PIPERIDINE]-5-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYLINDOLIN-5-YL-5-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYLINDOLIN-6-YL-6-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-3-METHYL-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-4-CHLORO-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-4-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-4-METHYL-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-(PENT-4-ENYL)-1H-PYRROL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-(TRIFLUOROMETHOXY)INDOLE-2-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-(TRIISOPROPYLSILYLOXY)-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5,7-DIMETHOXY-1H-INDOL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-FLUORO-1H-INDOL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-INDOLINEBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-METHOXY-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-METHOXY-1H-INDOL-3-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-METHOXY-1H-PYRROLO[3,2-B]PYRIDIN-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-5-METHYL-1H-PYRROL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-6-CHLORO-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-6-ETHYL-5-FLUORO-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-7-CHLORO-5-METHOXY-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-7-METHOXY-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)-7-METHYL-1H-INDOL-2-YLBORONIC ACID; 1-(TERT-BUTOXYCARBONYL)INDOLE-2-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)INDOLE-3-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)INDOLIN-6-YL-6-BORONIC ACID; 1-(TERT-BUTOXYCARBONYL)PYRROLE-2-BORONIC ACID; 1-(TERT-BUTOXYCARBONYLAMINO)NAPHTHALEN-2-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-1H-INDOL-5-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-1H-INDOL-6-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-4-CHLORO-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-4-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-4-METHYL-PYRROL-3-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-7-CHLORO-1H-INDOL-3-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-7-FLUORO-1H-INDOL-3-YLBORONIC ACID; 1-(TERT-BUTYLDIMETHYLSILYL)-PYRROL-3-YLBORONIC ACID; 1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-INDAZOLE-5-BORONIC ACID; 1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(TETRAHYDRO-2H-PYRAN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-(TETRAHYDRO-2H-PYRAN-2-YL)PYRAZOLE-4-BORONIC ACID; 1-(TETRAHYDRO-2H-PYRAN-4-YL)VINYLBORONIC ACID; 1-(THIAZOL-2-YLMETHYL)-1H-PYRAZOL-4-YLBORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-2-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-3-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-4-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-5-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-6-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-7-BORONIC ACID; 1-(TRIFLUOROMETHOXY)NAPHTHALENE-8-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-2-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-3-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-4-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-5-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-6-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-7-BORONIC ACID; 1-(TRIFLUOROMETHYL)NAPHTHALENE-8-BORONIC ACID; 1-(TRIISOPROPYLSILYL)-1H-INDOLE-3-BORONIC ACID; 1-(TRIISOPROPYLSILYL)-1H-PYRAZOL-3-YLBORONIC ACID; 1-(TRIISOPROPYLSILYL)-PYRROL-2-YLBORONIC ACID; 1-(TRIISOPROPYLSILYL)PYRROLE-3-BORONIC ACID; 1-(TRIMETHYLSILYL)-1H-PYRROL-3-YLBORONIC ACID; 1,1-(ETHYLENEDITHIO)-INDANE-5-BORONIC ACID; 1,10-PHENANTHROLIN-2-YLBORONIC ACID; 1,2,2-TRIMETHYL-CYCLOPROPYL BORONIC ACID; 1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL-6-BORONIC ACID HCL; 1,2,3,4-TETRAHYDROISOQUINOLIN-6-YLBORONIC ACID; 1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL-7-BORONIC ACID HYDROCHLORIDE; 1,2,3,6-TETRAHYDROPYRIDIN-4-YLBORONIC ACID HYDROCHLORIDE; 1,2,3,6-TETRAHYDROPYRIDINE-4-YL-BORONIC ACID; 1,2,3-TRIAZOLE-5-BORONIC ACID; 1,2,5,6-TETRAHYDROPYRIDIN-3-YLBORONIC ACID; 1,2-DIHYDRO-NAPHTHALENE-3-BORONIC ACID; 1,2-DIMETHYL-1H-IMIDAZOL-5-YLBORONIC ACID; 1,2-DIMETHYL-1H-INDOLE-7-BORONIC ACID; 1,3,4-THIADIAZOL-2-YLBORONIC ACID; 1,3,4-TRIMETHYL-1H-PYRAZOLE-5-BORONIC ACID; 1,3,5-TRIMETHYL-1H-PYRAZOL-4-YLBORONIC ACID; 1,3,5-TRIMETHYL-1H-PYRAZOLE-4-BORONIC ACID, HYDROCHLORIDE; 1,3-BENZOTHIAZOL-2-YLBORONIC ACID; 1,3-BENZOTHIAZOL-6-YLBORONIC ACID; 1,3-BENZOXAZOLE-5-BORONIC ACID; 1,3-BENZOXAZOLE-6-BORONIC ACID; 1,3-BIS(METHOXYMETHYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-BORONIC ACID; 1,3-DICHLORO-4-METHOXY-BENZENE-2-YLBORONIC ACID; 1,3-DIHYDRO-2-BENZOFURAN-5-YLBORANEDIOL; 1,3-DIHYDRO-2H-PYRROLO[2,3-B]PYRIDIN-2-ONE-4-BORONIC ACID; 1,3-DIMETHYL-1H-INDAZOLE-4-BORONIC ACID; 1,3-DIMETHYL-1H-INDAZOLE-5-BORONIC ACID; 1,3-DIMETHYL-1H-INDAZOLE-6-BORONIC ACID; 1,3-DIMETHYL-1H-INDAZOLE-7-BORONIC ACID; 1,3-DIMETHYL-1H-PYRAZOL-4-YLBORONIC ACID; 1,3-DIMETHYLPYRAZOLE-5-BORONIC ACID; 1,3-DIMETHYLPYRIMIDINE-2,4-DIONE-5-BORONIC ACID; 1,3-OXAZOL-5-YLBORONIC ACID; 1,4-BENZODIOXANE-5-BORONIC ACID; 1,4-BENZODIOXANE-6-BORONIC ACID; 1,4-BENZODIOXIN-2-YLBORONIC ACID; 1,4-DIHYDROQUINAZOLIN-5-YLBORONIC ACID; 1,4-DIMETHOXYNAPHTHALEN-2-YLBORONIC ACID; 1,4-DIMETHYL-1H-INDAZOLE-5-BORONIC ACID; 1,4-DIMETHYL-1H-INDAZOLE-6-BORONIC ACID; 1,4-DIOXA-SPIRO[4,5]DEC-7-EN-8-BORONIC ACID; 1,5-DIMETHYL-1H-INDAZOLE-4-BORONIC ACID; 1,5-DIMETHYL-1H-INDAZOLE-6-BORONIC ACID; 1,5-DIMETHYL-1H-INDOL-2-YLBORONIC ACID; 1,5-DIMETHYLPYRAZOLE-4-BORONIC ACID; 1,5-DIMETHYL-PYRROL-3-YLBORONIC ACID; 1,6-DIMETHYL-1H-INDAZOLE-4-BORONIC ACID; 1,6-DIMETHYL-1H-INDAZOLE-5-BORONIC ACID; 1,7-DIMETHYL-1H-INDAZOLE-4-BORONIC ACID; 1,7-DIMETHYL-1H-INDAZOLE-5-BORONIC ACID; 1,7-NAPHTHYRIDIN-4-YLBORONIC ACID; 1,7-NAPHTHYRIDINE-3-BORONIC ACID; 1,8-NAPHTHALIC ANHYDRIDE-4-BORONIC ACID; 1,8-NAPHTHYRIDIN-2-YLBORONIC ACID; 1,8-NAPHTHYRIDIN-4-YLBORONIC ACID; 1-[1,3]-DIOXOLAN-2-YLMETHYL-1H-PYRAZOLE-4-BORONIC ACID; 1-[5-(DIHYDROXYBORYL)PYRIMIDIN-2-YLPIPERIDINE-3-CARBOXYLIC ACID; 10-(2-NAPHTHYL)ANTHRACENE-9-BORONIC ACID; 1-ACETYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YLBORONIC ACID; 1-ACETYL-4-CHLORO-PYRROL-3-YLBORONIC ACID; 1-ACETYL-4-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 1-ACETYL-4-METHYL-PYRROL-3-YLBORONIC ACID; 1-ACETYL-PYRROL-3-YLBORONIC ACID; 1-ACETYLPYRROLIDIN-2-YLBORONIC ACID; 1-ALLYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-AMINONAPHTHALENE-2-BORONIC ACID; 1-AMINONAPHTHALENE-3-BORONIC ACID; 1-AMINONAPHTHALENE-4-BORONIC ACID; 1-AMINONAPHTHALENE-6-BORONIC ACID; 1-AMINONAPHTHALENE-7-BORONIC ACID; 1-AMINONAPHTHALENE-8-BORONIC ACID; 1-BENZENESULFONYL-1H-INDOLE-4-BORONIC ACID; 1-BENZENESULFONYL-1H-INDOLE-7-BORONIC ACID; 1-BENZOTHIEN-7-YLBORONIC ACID; 1-BENZYL-1,2,3,4-TETRAHYDRO-6-QUINOLINYLBORONIC ACID; 1-BENZYL-1H-PYRAZOLE-4-BORONIC ACID; 1-BENZYL-4-CHLORO-PYRROL-3-YLBORONIC ACID; 1-BENZYL-4-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 1-BENZYL-4-METHYL-PYRROL-3-YLBORONIC ACID; 1-BENZYL-PIPERIDINE-4-BORONIC ACID; 1-BENZYL-PYRROL-2-YLBORONIC ACID; 1-BENZYL-PYRROL-3-YLBORONIC ACID; 1-BIPHENYLENYLBORONIC ACID; 1-BOC-1,2,3,4-TETRAHYDRO-QUINOLINE-6-BORONIC ACID; 1-BOC-3,5-DIMETHYLPYRAZOLE-4-BORONIC ACID; 1-BOC-3-TRIFLUOROMETHYLPYRAZOLE-5-BORONIC ACID; 1-BOC-5,6-DICHLORO-1H-INDOLE-2-BORONIC ACID; 1-BOC-5-CHLORO-1H-INDOLE-2-BORONIC ACID; 1-BOC-5-CYANO-1H-INDOLE-2-BORONIC ACID; 1-BOC-5-FLUOROINDOLE-2-BORONIC ACID; 1-BOC-5-METHYL-1H-INDOLE-2-BORONIC ACID; 1-BOC-5-TBDMSO-INDOLE-2-BORONIC ACID; 1-BOC-6-CYANOINDOLE-2-BORONIC ACID; 1-BOC-6-METHOXYINDOLE-2-BORONIC ACID; 1-BOC-6-METHYLINDOLE-2-BORONIC ACID; 1-BOC-PIPERIDINE-4-BORONIC ACID; 1-BOC-PYRROLO[2,3-C]PYRIDINE-3-YLBORONIC ACID; 1-BUTENYLBORONIC ACID; 1-CARBOXYLMETHYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-CHLOROISOQUINOLINE-4-BORONIC ACID; 1-CHLORONAPHTHALENE-2-BORONIC ACID; 1-CHLORONAPHTHALENE-3-BORONIC ACID; 1-CHLORONAPHTHALENE-4-BORONIC ACID; 1-CHLORONAPHTHALENE-5-BORONIC ACID; 1-CHLORONAPHTHALENE-6-BORONIC ACID; 1-CHLORONAPHTHALENE-7-BORONIC ACID; 1-CHLORONAPHTHALENE-8-BORONIC ACID; 1-CYCLOHEXEN-1-YL-BORONIC ACID; 1-CYCLOHEXYL-1H-PYRAZOLE-5-BORONIC ACID; 1-CYCLOHEXYLVINYLBORONIC ACID; 1-CYCLOPENTYL-1H-PYRAZOLE-4-BORONIC ACID; 1-CYCLOPENTYL-PYRROL-3-YLBORONIC ACID; 1-ETHYL-1H-PYRAZOL-5-YLBORONIC ACID; 1-ETHYL-1H-PYRAZOLE-4-BORONIC ACID; 1-ETHYL-3-METHYL-1H-PYRAZOLE-5-BORONIC ACID; 1-ETHYL-3-PHENYL-1H-INDOL-2-YLBORONIC ACID; 1-ETHYL-PYRROL-3-YLBORONIC ACID; 1-FLUORONAPHTHALENE-2-BORONIC ACID; 1-FLUORONAPHTHALENE-3-BORONIC ACID; 1-FLUORONAPHTHALENE-5-BORONIC ACID; 1-FLUORONAPHTHALENE-6-BORONIC ACID; 1-FLUORONAPHTHALENE-7-BORONIC ACID; 1-FLUORONAPHTHALENE-8-BORONIC ACID; 1H-1,2,3-BENZOTRIAZOL-5-YLBORONIC ACID; 1H-1,2,3-BENZOTRIAZOL-6-YLBORONIC ACID; 1H-BENZIMIDAZOL-4-YLBORONIC ACID; 1H-BENZIMIDAZOL-5-YLBORONIC ACID; 1H-BENZIMIDAZOLE-5-BORONIC ACID, HYDROCHLORIDE SALT; 1H-BENZO[D]IMIDAZOL-6-YLBORONIC ACID; 1H-IMIDAZOL-2-YLBORONIC ACID HYDROCHLORIDE; 1H-IMIDAZOL-4-YLBORONIC ACID; 1H-IMIDAZOL-5-YLBORONIC ACID; 1H-INDAZOLE-4-BORONIC ACID; 1H-INDAZOLE-5-BORONIC ACID; 1H-INDAZOLE-5-BORONIC ACID HYDROCHLORIDE; 1H-INDAZOLE-7-BORONIC ACID; 1H-INDENE-2-BORONIC ACID; 1H-INDOL-2-YLBORONIC ACID; 1H-INDOL-4-YLBORONIC ACID HYDROCHLORIDE; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-4-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-4-METHOXY-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(1-METHYLETHOXY)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(1-PIPERIDINYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(1-PIPERIDINYLCARBONYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(1-PIPERIDINYLMETHYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(4-METHYL-1-PIPERAZINYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(CYCLOHEXYLAMINO)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(DIETHYLAMINO)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(DIMETHYLAMINO)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-(METHYLTHIO)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[(4,4-DIMETHOXY-1-PIPERIDINYL)METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[(4-METHYL-1-PIPERAZINYL)CARBONYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[(4-METHYL-1-PIPERAZINYL)SULFONYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[(DIETHYLAMINO)METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[(DIMETHYLAMINO)METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[[[2-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]ETHYL]AMINO]METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[[[3-(DIMETHYLAMINO)-2,2-DIMETHYLPROPYL]AMINO]METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[[[DIMETHYL(1-METHYLETHYL)SILYL]OXY]METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[[4-(2-HYDROXYETHYL)-1-PIPERAZINYL]METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[2-(1-PIPERIDINYL)ETHOXY]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[2-(4-MORPHOLINYL)ETHOXY]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[3-(1,3-DIOXOLAN-2-YL)PROPYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-[3-(DIMETHYLAMINO)PROPYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-HYDROXY-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-5-NITRO-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-(TRIFLUOROMETHOXY)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-(TRIFLUOROMETHYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-[[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]METHYL]-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-ETHOXY-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-6-HYDROXY-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-7-CHLORO-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 2-BORONO-7-HYDROXY-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 4-[[BIS(1-METHYLETHYL)AMINO]CARBONYL]-2-BORONO-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-INDOLE-1-CARBOXYLIC ACID, 5-BORONO-2,3-DIHYDRO-7-NITRO-, 1-(1,1-DIMETHYLETHYL) ESTER; 1H-PYRAZOLE-1-BENZYL-4-BORONIC ACID; 1H-PYRAZOLE-3-BORONIC ACID; 1H-PYRAZOLE-3-BORONIC ACID HYDRATE; 1H-PYRAZOLE-4-BORONIC ACID; 1H-PYRAZOLE-4-BORONIC ACID HCL; 1H-PYRAZOLE-5-BORONIC ACID; 1H-PYRAZOLO[3,4-B]PYRIDINE-5-BORONIC ACID; 1H-PYRAZOLO[3,4-C]PYRIDINE-4-BORONIC ACID; 1H-PYRAZOLO[4,3-B]PYRIDINE-6-BORONIC ACID; 1H-PYRAZOLO[4,3-B]PYRIDINE-7-BORONIC ACID; 1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 1H-PYRROLO[2,3-B]PYRIDIN-5-YLBORONIC ACID; 1H-PYRROLO[2,3-B]PYRIDINE-2-BORONIC ACID; 1H-PYRROLO[2,3-B]PYRIDINE-3-BORONIC ACID; 1H-PYRROLO[2,3-B]PYRIDINE-6-BORONIC ACID; 1H-PYRROLO[2,3-C]PYRIDINE-3-YLBORONIC ACID; 1H-PYRROLO[3,2-B]PYRIDIN-5-YLBORONIC ACID; 1H-PYRROLO[3,2-B]PYRIDIN-6-YLBORONIC ACID; 1H-PYRROLO[3,2-B]PYRIDINE-2-BORONIC ACID; 1H-PYRROLO[3,2-B]PYRIDINE-3-BORONIC ACID; 1H-PYRROLO[3,2-B]PYRIDINE-7-BORONIC ACID; 1-HYDROXYL-2-NAPHTHALENEBORONIC ACID; 1-ISOBUTYL-1H-PYRAZOL-5-YLBORONIC ACID; 1-ISOBUTYL-1H-PYRAZOLE-4-BORONIC ACID; 1-ISOPROPYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-ISOPROPYL-1H-PYRAZOLE-5-BORONIC ACID; 1-ISOPROPYL-1H-PYRROL-3-YLBORONIC ACID; 1-ISOPROPYL-3-METHYL-1H-PYRAZOLE-5-BORONIC ACID; 1-ISOPROPYL-PYRROL-2-YLBORONIC ACID; 1-ISOQUINOLYLBORONIC ACID; 1-METHOXYNAPHTHALENE-2-BORONIC ACID; 1-METHOXYNAPHTHALENE-3-BORONIC ACID; 1-METHOXYNAPHTHALENE-5-BORONIC ACID; 1-METHOXYNAPHTHALENE-6-BORONIC ACID; 1-METHOXYNAPHTHALENE-7-BORONIC ACID; 1-METHOXYNAPHTHALENE-8-BORONIC ACID; 1-METHYL-1,2,3-TRIAZOLE-4-BORONIC ACID; 1-METHYL-1H-BENZOIMIDAZOLE-6-BORONIC ACID; 1-METHYL-1H-IMIDAZOL-5-YLBORONIC ACID; 1-METHYL-1H-INDAZOLE-4-BORONIC ACID HYDROCHLORIDE; 1-METHYL-1H-INDAZOLE-5-BORONIC ACID; 1-METHYL-1H-PYRAZOL-3-YLBORONIC ACID; 1-METHYL-1H-PYRAZOL-5-YLBORONIC ACID; 1-METHYL-1H-PYRAZOLE-4-BORONIC ACID; 1-METHYL-1H-PYRAZOLE-4-BORONIC ACID HYDROCHLORIDE; 1-METHYL-1H-PYRROL-2-YL BORONIC ACID; 1-METHYL-1H-PYRROL-3-YLBORONIC ACID; 1-METHYL-2-(TRIPHENYL-METHYL)ISOINDOLE-5-BORONIC ACID; 1-METHYL-2-OXOINDOLIN-6-YLBORONIC ACID; 1-METHYL-3-CYCLOPROPYL-1H-PYRAZOLE-5-BORONIC ACID; 1-METHYL-3-ETHYL-1H-PYRAZOLE-5-BORONIC ACID; 1-METHYL-3-ISOPROPYL-1H-PYRAZOLE-5-BORONIC ACID; 1-METHYL-3-TERT-BUTYL-1H-PYRAZOLE-5-BORONIC ACID; 1-METHYL-3-TRIFLUOROMETHYLPYRAZOLE-5-BORONIC ACID; 1-METHYL-4-CHLORO-1H-PYRAZOLE-5-BORONIC ACID; 1-METHYL-5-PHENYL-PYRROL-3-YLBORONIC ACID; 1-METHYLINDAZOLE-4-BORONIC ACID; 1-METHYLINDAZOLE-6-BORONIC ACID; 1-METHYLINDAZOLE-7-BORONIC ACID; 1-METHYLINDOLE-5-BORONIC ACID; 1-METHYLNAPHTHALENE-2-BORONIC ACID; 1-METHYLNAPHTHALENE-3-BORONIC ACID; 1-METHYLNAPHTHALENE-5-BORONIC ACID; 1-METHYLNAPHTHALENE-6-BORONIC ACID; 1-METHYLNAPHTHALENE-7-BORONIC ACID; 1-METHYLNAPHTHALENE-8-BORONIC ACID; 1-METHYL-PIPERIDINE-4-BORONIC ACID; 1-NAPHTHALENEBORONIC ACID; 1-NAPHTHALENECARBOXYLIC ACID, 5-BORONIC ACID; 1-N-BOC-PYRROLE-3-BORONIC ACID; 1-N-BOC-PYRROLIDIN-2-YLBORONIC ACID; 1-NEOPENTYL-1H-PYRAZOLE-5-BORONIC ACID; 1-NONANEBORONIC ACID; 1-N-THP-PYRAZOL-3-YLBORONIC ACID; 1-PENTEN-YL BORONIC ACID; 1-PENTENYLBORONIC ACID; 1-PHENYL-1H-INDOL-2-YLBORONIC ACID; 1-PHENYL-1H-PYRAZOLE-4-BORONIC ACID; 1-PHENYL-1H-PYRROL-2-YLBORONIC ACID; 1-PHENYL-3,4-DIHYDROPYRROLO[1,2-A]PYRAZIN-6-YLBORONIC ACID; 1-PHENYL-CYCLOPROPYL-1-BORONIC ACID; 1-PHENYL-PYRROL-3-YLBORONIC ACID; 1-PHENYLSULFONYLINDOLE-6-BORONIC ACID; 1-PHENYLVINYLBORONIC ACID; 1-PIPERIDINECARBOXYLIC ACID, 4-(4-BORONOPHENYL)-4-(4-CHLOROPHENYL)-, 1-(1,1-DIMETHYLETHYL) ESTER; 1-PROPYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-PROPYL-1H-PYRAZOL-5-YLBORONIC ACID; 1-P-TOLYL-1H-PYRAZOL-4-YLBORONIC ACID; 1-PYRENEBORONIC ACID; 1-TBDMS-INDOLE-4-BORONIC ACID; 1-TERT-BUTOXYCARBONYL-1H-PYRAZOLE-4-BORONIC ACID; 1-TERT-BUTYL-1H-PYRAZOLE-4-BORONIC ACID; 1-TERT-BUTYL-1H-PYRAZOLE-5-BORONIC ACID; 1-TERT-BUTYL-4-(ETHOXYCARBONYL)-1H-PYRAZOL-5-YLBORONIC ACID; 1-TERT-BUTYLOXYCARBONYL-PYRRAZOLE-3-BORIC ACID; 1-TERT-BUTYRONYCARBONYL-3-BORIC INDAZOLE; 1-TOSYL-1H-PYRROLO[2,3-B]PYRIDIN-3-YLBORONIC ACID; 2-((1-(TERT-BUTOXYCARBONYL)AZEPAN-3-YL)METHYL)PHENYLBORONIC ACID; 2-((1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 2-((1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 2-((2′-CHLORO-5′-(TRIFLUOROMETHYL)PHENOXY)METHYL)PHENYLBORONIC ACID; 2-((3-(TRIFLUOROMETHYL)PHENOXY)METHYL)PHENYLBORONIC ACID; 2-((3-CYCLOPROPYLUREIDO)METHYL)PHENYLBORONIC ACID; 2-((3-ETHYLUREIDO)METHYL)PHENYLBORONIC ACID; 2-((3-METHYLUREIDO)METHYL)PHENYLBORONIC ACID; 2-((4′-(TRIFLUOROMETHOXY)PHENOXY)METHYL)PHENYLBORONIC ACID; 2-((BENZYLOXY)CARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL-6-BORONIC ACID; 2-((BENZYLOXYCARBONYLAMINO)METHYL)PHENYLBORONIC ACID; 2-((DIETHYLAMINO)METHYL)PHENYLBORONIC ACID; 2-((DIISOPROPYLAMINO)METHYL)PHENYLBORONIC ACID; 2-((DIMETHYLAMINO)METHYL)-5-NITROPHENYLBORONIC ACID; 2-((DIMETHYLAMINO)METHYL)THIAZOL-5-YLBORONIC ACID; 2-((TERT-BUTOXYCARBONYLAMINO)METHYL)-5-NITROPHENYLBORONIC ACID; 2-((TERT-BUTOXYCARBONYLAMINO)METHYL)PYRIMIDIN-5-YLBORONIC ACID; 2-([2-(DIHYDROXYBORANYL)-4-FLUOROPHENYL]METHYL)-2,3-DIHYDROPYRIDAZIN-3-ONE; 2-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-2,3-DIHYDROPYRIDAZIN-3-ONE; 2-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-2,3-METHYLPYRIDINE-4-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(2,4,5-TRICHLOROPHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(2,4-DICHLOROPHENYLMETHOXY)PHENYLBORONIC ACID; 2-(2,5-DIHYDRO-1H-PYRROL-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(2,5-DIMETHYL-1H-PYRROL-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(2,5-DIMETHYLPYRROL-1-YL)-5-CHLOROPYRIDINE-4-BORONIC ACID; 2-(2-[3-(DIHYDROXYBORANYL)PHENOXY]ETHYL)-2,3-DIHYDROPYRIDAZIN-3-ONE; 2-(2-AMINO-2-OXOETHYL)PHENYLBORONIC ACID; 2-(2-BORONOPHENOXYMETHYL)BENZONITRILE; 2-(2-BORONOPHENYL)ACETIC ACID; 2-(2-CARBOXYVINYL)BENZENEBORONIC ACID; 2-(2′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 2-(2-CHLOROETHYL)-4,5-DIMETHOXYPHENYLBORONIC ACID; 2-(2-CHLOROETHYL)PHENYLBORONIC ACID; 2-(2-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 2-(2-CHLOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(2-FLUOROPHENOXY)PHENYLBORONIC ACID; 2-(2-FLUOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(2-FURYL)PYRIMIDINE-5-BORONIC ACID; 2-(2H-TETRAZOL-5-YL)-PHENYLBORONIC ACID; 2-(2-HYDROXYETHYL)PHENYLBORONIC ACID; 2-(2′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 2-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 2-(2-METHOXYPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(2-METHYL-1,3-DIOXOLAN-2-YL)PHENYLBORONIC ACID; 2-(2-METHYLIMIDAZOL-1-YL)PYRIMIDINE-4-BORONIC ACID; 2-(2-METHYLIMIDAZOL-1-YL)PYRIMIDINE-5-BORONIC ACID; 2-(2-METHYLPIPERIDIN-1-YL)THIAZOLE-4-BORONIC ACID; 2-(2-OXOPYRROLIDIN-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(2-PYRIDYL)PYRIMIDINE-5-BORONIC ACID; 2-(2-TERT-BUTYLPHENOXY)PYRIDIN-3-YLBORONIC ACID; 2-(2-THIENYL)PYRIMIDINE-5-BORONIC ACID; 2-(2-TOLYL)PYRIMIDINE-5-BORONIC ACID; 2-(2-TRIFLUOROMETHYL-PHENYL)-ETHENEBORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(3-(TRIFLUOROMETHOXY)PHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(3,3-DIETHOXYPROPOXY)PHENYLBORONIC ACID; 2-(3-BORONOPHENOXYMETHYL)BENZONITRILE; 2-(3-BORONOPHENYL)-2-METHYL-1,3-DIOXOLANE; 2-(3-BORONOPHENYL)-5-METHYL-1,3,4-OXADIAZOLE; 2-(3-BORONOPHENYL)ACETIC ACID; 2-(3′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 2-(3-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 2-(3-CHLOROPHENYL)ETHENEBORONIC ACID; 2-(3-CHLOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(3-CYANOPHENYLMETHOXY)PHENYLBORONIC ACID; 2-(3′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 2-(3-FLUOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(3-FLUORO-PROPOXY)-BENZENEBORONIC ACID; 2-(3-FURYL)PYRIMIDINE-5-BORONIC ACID; 2-(3-HYDROXYPROPOXY)PYRIMIDIN-5-YLBORONIC ACID; 2-(3-HYDROXYPYRROLIDIN-1-YL)PYRIMIDINE-4-BORONIC ACID; 2-(3-METHOXYPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(3-METHOXYPROPOXY)PHENYLBORONIC ACID; 2-(3-METHYL-1H-PYRAZOL-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(3-METHYL-1H-PYRAZOL-1-YL)PYRIMIDINE-4-BORONIC ACID; 2-(3-METHYL-1H-PYRAZOL-1-YL)THIAZOLE-4-BORONIC ACID; 2-(3-METHYLPIPERIDIN-1-YL)THIAZOLE-4-BORONIC ACID; 2-(3-PHENYLBORONIC ACID)-2-METHYL-OXETANE; 2-(3-PYRIDYL)PYRIMIDINE-5-BORONIC ACID; 2-(3-THIENYL)PYRIMIDINE-5-BORONIC ACID; 2-(3-TOLYL)PYRIMIDINE-5-BORONIC ACID; 2-(4-(CYCLOHEXYLOXY)PIPERIDIN-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-(T-BUTOXYCARBONYL)PIPERAZIN-1-YL)PYRIDINE-3-BORONIC ACID; 2-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(4-(TRIFLUOROMETHOXY)PHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YLBORONIC ACID; 2-(4-ACETYLPIPERAZIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(4-BENZYLOXYPHENYL)PYRIMIDINE-5-BORONIC ACID; 2-(4-BORONOBENZOYL)HYDRAZINECARBOTHIOAMIDE; 2-(4-BORONOBENZOYL)-N-METHYLHYDRAZINECARBOTHIOAMIDE; 2-(4-BORONOPHENOXYMETHYL)BENZONITRILE; 2-(4-BORONOPHENYL)-2-METHYLPROPANENITRILE; 2-(4-BORONOPHENYL)-2-METHYLPROPANOIC ACID; 2-(4-BORONOPHENYL)-5,6-DIHYDRO-4H-1,3-OXAZINE; 2-(4-BORONOPHENYL)ACETIC ACID; 2-(4-CBZ-PIPERAZIN-1-YL)PYRIDINE-5-BORONIC ACID; 2-(4-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 2-(4-CHLOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-CYANOPHENYLMETHOXY)PHENYLBORONIC ACID; 2-(4-DIHYDROXYBORANE)PHENYL-4-CARBOXY-6-METHYLQUINOLINE; 2-(4-DIHYDROXYBORANE)PHENYL-4-CARBOXYQUINOLINE; 2-(4′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 2-(4-FLUOROPHENYL)CYCLOPROPYLBORONIC ACID; 2-(4-FLUOROPHENYL)PYRIDIN-4-YLBORONIC ACID; 2-(4-FLUOROPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-HYDROXYPIPERIDIN-1-YL)-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-(4′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 2-(4-METHOXYBENZYLOXY)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-METHOXYPHENYL)PYRIDIN-4-YLBORONIC ACID; 2-(4-METHOXYPHENYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-METHYL-1H-PYRAZOL-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-METHYL-1H-PYRAZOL-1-YL)PYRIMIDINE-4-BORONIC ACID; 2-(4-METHYL-1H-PYRAZOL-1-YL)THIAZOLE-4-BORONIC ACID; 2-(4-METHYLIMIDAZOL-1-YL)PYRIMIDINE-5-BORONIC ACID; 2-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(4-METHYLPIPERAZIN-1-YL)PYRIMIDIN-5-YLBORONIC ACID; 2-(4-METHYLPIPERIDIN-1-YL)THIAZOLE-4-BORONIC ACID; 2-(4-NITROPHENYL)ETHENYLBORONIC ACID; 2-(4-PENTYLOXYPHENYL)PYRIMIDINE-5-BORONIC ACID; 2-(4-PENTYLPHENYL)PYRIMIDINE-5-BORONIC ACID; 2-(4-PYRIDYL)PYRIMIDINE-5-BORONIC ACID; 2-(4-TERT-BUTYLPHENYL)ACETYLENE-1-BORONIC ACID; 2-(4-TOLYL)PYRIMIDINE-5-BORONIC ACID; 2-(5-(3,3,3-TRIFLUOROPROPYL)-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-(DIMETHYLAMINO)-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-[1,3]DIOXOLAN-2-YL-2,4-DIMETHOXY-PHENYL)-BORONIC ACID; 2-(5-ETHOXY-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-ISOBUTYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-ISOPROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(5-PROPYL-1,3,4-THIADIAZOL-2-YL)PHENYLBORONIC ACID; 2-(ALLYLOXY)-5-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 2-(AMINOMETHYL)-5-FLUOROBENZENEBORONIC ACID HYDROCHLORIDE; 2-(AMINOMETHYL)-5-FLUOROPHENYLBORONIC ACID; 2-(AMINOMETHYL)-5-NITROPHENYLBORONIC ACID; 2-(AMINOMETHYL)PHENYL BORONIC ACID; 2-(AMINOMETHYL)PHENYLBORONIC ACID, HCL; 2-(AMINOMETHYL)THIAZOL-5-YLBORONIC ACID; 2-(AZETIDIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(AZETIDINE-1-CARBONYL)PHENYLBORONIC ACID; 2-(AZIRIDINE-1-CARBONYL)PHENYLBORONIC ACID; 2-(BENZYL(METHYL)AMINO)QUINOLIN-6-YLBORONIC ACID; 2-(BENZYLAMINO)PYRIDIN-4-YLBORONIC ACID; 2-(BENZYLOXY)-3,5-DIFLUOROPHENYLBORONIC ACID; 2-(BENZYLOXY)-3-CHLOROPHENYLBORONIC ACID; 2-(BENZYLOXY)-3-METHYLPHENYLBORONIC ACID; 2-(BENZYLOXY)-4-(DIMETHYLAMINO)PYRIMIDINE-5-BORONIC ACID; 2-(BENZYLOXY)-4-METHOXYPHENYLBORONIC ACID; 2-(BENZYLOXY)-4-METHYLPHENYLBORONIC ACID; 2-(BENZYLOXY)-5-BORONOBENZOIC ACID; 2-(BENZYLOXY)-5-ETHOXYPHENYLBORONIC ACID; 2-(BENZYLOXY)-5-FLUOROPYRIDIN-3-YLBORONIC ACID; 2-(BENZYLOXY)-5-METHOXYPHENYLBORONIC ACID; 2-(BENZYLOXY)-5-TERT-BUTYLPHENYLBORONIC ACID; 2-(BENZYLOXY)NAPHTHALEN-1-YLBORONIC ACID; 2-(BENZYLOXY)PYRIDINE-4-BORONIC ACID; 2-(BENZYLOXY)PYRIMIDIN-5-YLBORONIC ACID; 2-(BENZYLOXYCARBONYLAMINO)ETHYLBORONIC ACID; 2-(BIPHENYL)PHENYLBORONIC ACID; 2-(BOC-AMINO)THIAZOLE-5-BORONIC ACID; 2-(BOC-AMINOMETHYL)PYRIDINE-4-BORONIC ACID; 2-(BUTOXYCARBONYLAMINO)PYRIDIN-3-YLBORONIC ACID; 2-(CHLOROMETHYL)-5-NITROPHENYLBORONIC ACID; 2-(CYANOMETHYL)PHENYLBORONIC ACID; 2-(CYCLOBUTOXY)PYRIMIDINE-5-BORONIC ACID; 2-(CYCLOBUTYL)PYRIMIDINE-5-BORONIC ACID; 2-(CYCLOBUTYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(CYCLOHEXYL)PYRIMIDINE-5-BORONIC ACID; 2-(CYCLOHEXYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(CYCLOHEXYLETHYL)BORONIC ACID; 2-(CYCLOHEXYLOXY)METHYLPHENYLBORONIC ACID; 2-(CYCLOHEXYLOXY)PYRIMIDIN-5-YLBORONIC ACID; 2-(CYCLOPENTOXY)PYRIMIDINE-5-BORONIC ACID; 2-(CYCLOPENTYL)PYRIDINE-4-BORONIC ACID; 2-(CYCLOPENTYL)PYRIMIDINE-5-BORONIC ACID; 2-(CYCLOPENTYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(CYCLOPROPANECARBOXAMIDO)PHENYLBORONIC ACID; 2-(CYCLOPROPYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(CYCLOPROPYLCARBAMOYL)-5-METHYLPYRIDIN-4-YLBORONIC ACID; 2-(CYCLOPROPYLCARBAMOYL)PYRIDIN-4-YLBORONIC ACID; 2-(CYCLOPROPYLMETHOXY)-4-TRIFLUOROMETHYLPHENYLBORONIC ACID; 2-(CYCLOPROPYLMETHOXY)PHENYLBORONIC ACID; 2-(CYCLOPROPYLMETHOXY)PYRIDINE-5-BORONIC ACID; 2-(DICYCLOHEXYLPHOSPHINO)PHENYLBORONIC ACID; 2-(DIETHYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(DIFLUOROMETHOXY)-5-FLUOROPHENYLBORONIC ACID; 2-(DIFLUOROMETHOXY)-6-FLUOROPHENYLBORONIC ACID; 2-(DIFLUOROMETHOXY)-BENZENEBORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-1-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-3-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-4-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-5-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-6-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-7-BORONIC ACID; 2-(DIFLUOROMETHOXY)NAPHTHALENE-8-BORONIC ACID; 2-(DIFLUOROMETHOXY)PYRAZINE-6-BORONIC ACID; 2-(DIFLUOROMETHYL)-5-FLUOROPHENYLBORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-1-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-3-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-4-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-5-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-6-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-7-BORONIC ACID; 2-(DIFLUOROMETHYL)NAPHTHALENE-8-BORONIC ACID; 2-(DIHYDROXYBORYL)-3-THIOPHENECARBOXYLIC ACID; 2-(DIHYDROXYBORYL)-4-METHOXYBENZOIC ACID; 2-(DIHYDROXYBORYL)-5-METHOXYBENZOIC ACID; 2-(DIISOPROPYLCARBANOYL) PHENYLBORONIC ACID; 2-(DIMETHYLAMINE)PHENYLBORONIC ACID; 2-(DIMETHYLAMINO)-4,6-DIMETHYLPYRIMIDIN-5-YLBORONIC ACID; 2-(DIMETHYLAMINO)-4-METHOXYPYRIMIDIN-5-YLBORONIC ACID; 2-(DIMETHYLAMINO)-5-METHYLPHENYLBORONIC ACID; 2-(DIMETHYLAMINO)-5-PYRIDINYL BORONIC ACID HYDROCHLORIDE; 2-(DIMETHYLAMINO)-6-OXO-1,6-DIHYDROPYRIMIDIN-5-YLBORONIC ACID; 2-(DIMETHYLAMINO)BENZENEBORONIC ACID HYDROCHLORIDE; 2-(DIMETHYLAMINO)PYRIDINE-3-BORONIC ACID; 2-(DIMETHYLAMINO)PYRIDINE-5-BORONIC ACID HYDRATE; 2-(DIMETHYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(DIMETHYLAMINOCARBONYL)BENZENEBORONIC ACID; 2-(E-CYANOVINYL)PHENYLBORONIC ACID; 2-(ETHOXYCARBONYL)-1H-IMIDAZOL-5-YLBORONIC ACID; 2-(ETHOXYCARBONYL)-1-METHYL-1H-IMIDAZOL-5-YLBORONIC ACID; 2-(ETHOXYCARBONYL)-4-FLUOROPHENYLBORONIC ACID; 2-(ETHOXYCARBONYL)FURAN-3-BORONIC ACID; 2-(ETHOXYCARBONYL)PYRIDINE-4-BORONIC ACID; 2-(ETHOXYCARBONYL)THIOPHEN-3-YLBORONIC ACID; 2-(ETHOXY-D5)-PHENYLBORONIC ACID; 2-(ETHOXY-D5)-PYRIMIDINE-5-BORONIC ACID; 2-(ETHYL-D5)-PHENYLBORONIC ACID; 2-(ETHYL-D5)-PYRIMIDINE-5-BORONIC ACID; 2-(FURAN-2-YL)PYRIDINE-4-BORONIC ACID; 2-(HYDROXY)PYRIDINE-4-BORONIC ACID; 2-(HYDROXYMETHYL)-6-METHOXYPHENYLBORONIC ACID; 2-(HYDROXYMETHYL)FURAN-3-YLBORONIC ACID; 2-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 2-(HYDROXYMETHYL)PHENYLBORONIC ACID; 2-(HYDROXYMETHYL)THIOPHEN-3-YLBORONIC ACID; 2-(IMIDAZOL-1-YL)PYRIMIDINE-4-BORONIC ACID; 2-(IMIDAZOL-1-YL)PYRIMIDINE-5-BORONIC ACID; 2-(IMIDAZOL-1-YL)THIAZOLE-4-BORONIC ACID; 2-(ISOBUTOXY)PYRIDINE-3-BORONIC ACID; 2-(ISOBUTYLTHIO)-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(ISOPROPOXY)PYRIDINE-4-BORONIC ACID; 2-(ISO-PROPOXY-D7)-PHENYLBORONIC ACID; 2-(ISO-PROPOXY-D7)-PYRIMIDINE-5-BORONIC ACID; 2-(ISOPROPYL)PYRIDINE-4-BORONIC ACID; 2-(ISO-PROPYL-D7)-PHENYLBORONIC ACID; 2-(ISO-PROPYL-D7)-PYRIDINE-4-BORONIC ACID; 2-(ISO-PROPYL-D7)-PYRIMIDINE-5-BORONIC ACID; 2-(METHANESULFONYLAMINO)PHENYLBORONIC ACID; 2-(METHOXYCARBONYL)-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(METHOXYCARBONYL)-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(METHOXYCARBONYL)-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-(METHOXYCARBONYL)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(METHOXYCARBONYL)-5-PHENYLTHIOPHEN-3-YLBORONIC ACID; 2-(METHOXYCARBONYL)PYRIDINE-4-BORONIC ACID; 2-(METHOXYCARBONYL)QUINOLIN-8-YLBORONIC ACID; 2-(METHOXY-D3)-PHENYLBORONIC ACID; 2-(METHOXY-D3)-PYRIDINE-4-BORONIC ACID; 2-(METHOXY-D3)-PYRIMIDINE-5-BORONIC ACID; 2-(METHOXYMETHOXY)-5-METHYLPHENYLBORONIC ACID; 2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 2-(METHYL-13C,D3)PYRIDINE-4-BORONIC ACID; 2-(METHYLAMINO)-6-OXO-1,6-DIHYDROPYRIMIDIN-5-YLBORONIC ACID; 2-(METHYLAMINO)PYRIDIN-4-YLBORONIC ACID; 2-(METHYLAMINO)PYRIMIDIN-5-YLBORONIC ACID; 2-(METHYL-D3)-PHENYLBORONIC ACID; 2-(METHYL-D3)-PYRIDINE-4-BORONIC ACID; 2-(METHYL-D3)-PYRIMIDINE-5-BORONIC ACID; 2-(METHYLSULFINYL)PHENYLBORONIC ACID; 2-(METHYLSULFONAMIDO)PYRIMIDIN-5-YLBORONIC ACID; 2-(METHYLSULFONYL)PHENYLBORONIC ACID; 2-(METHYLSULFONYL)PYRIDINE-5-BORONIC ACID; 2-(METHYLTHIO)PHENYLBORONIC ACID; 2-(METHYLTHIO)PYRIDINE-3-BORONIC ACID; 2-(METHYLTHIO)PYRIMIDINE-5-BORONIC ACID; 2-(METHYLTHIOL-D3)-PHENYLBORONIC ACID; 2-(MORPHOLIN-1-YL)PHENYLBORONIC ACID HCL; 2-(MORPHOLIN-1YL)PYRIMIDIN-5-YLBORONIC ACID HCL; 2-(MORPHOLIN-4-YL)PYRIDINE-4-BORONIC ACID; 2-(MORPHOLIN-4-YLCARBONYL)BENZENEBORONIC ACID; 2-(MORPHOLINO)PHENYLBORONIC ACID; 2-(MORPHOLINOMETHYL)PHENYLBORONIC ACID; 2-(MORPHOLINOMETHYL)PYRIDIN-4-YLBORONIC ACID; 2-(MORPHOLINOSULFONYL)PHENYLBORONIC ACID; 2-(N,N-DIETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 2-(N,N-DIMETHYLAMINO)PYRIDINE-5-BORONIC ACID 2HCL; 2-(N,N-DIMETHYLAMINOMETHYL)PHENYLBORONIC ACID; 2-(N,N-DIMETHYLSULFAMOYL)PYRIDIN-3-YLBORONIC ACID; 2-(N,N-DIMETHYLSULFAMOYLOXY)PHENYLBORONIC ACID; 2-(N,N-DIMETHYLSULPHAMOYL)BENZENEBORONIC ACID; 2-(N,N-METHYLETHYLAMINO)THIAZOLE-4-BORONIC ACID; 2-(NAPHTHALEN-1-YL)PHENYLBORONIC ACID; 2-(NAPHTHALEN-1-YL)PYRIDINE-4-BORONIC ACID; 2-(NAPHTHALEN-2-YL)PHENYLBORONIC ACID; 2-(N-BENZYLSULFAMOYL)-5-METHYLPHENYLBORONIC ACID; 2-(N-BOC-AMINOMETHYL)-4-FLUOROPHENYLBORONIC ACID; 2-(N-ETHYLSULFAMOYL)PHENYLBORONIC ACID; 2-(N-METHYL-N-PHENYL)AMINOMETHYLBENZENEBORONIC ACID; 2-(N-PHENYLAMINOMETHYL)PHENYLBORONIC ACID; 2-(N-PROPOXY-D7)-PYRIMIDINE-5-BORONIC ACID; 2-(N-PROPYL)PYRIMIDINE-5-BORONIC ACID; 2-(N-PROPYL-D7)-PYRIDINE-4-BORONIC ACID; 2-(N-PROPYL-D7)-PYRIDINE-5-BORONIC ACID; 2-(N-PROPYL-D7)-PYRIMIDINE-5-BORONIC ACID; 2-(N-PROPYLSULFAMOYL)PHENYLBORONIC ACID; 2-(N-TERT-BUTYLSULFAMOYL)-5-PROPYLTHIOPHEN-3-YLBORONIC ACID; 2-(PERFLUOROPHENYL)-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(PERFLUOROPHENYL)-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(PERFLUOROPHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(PERFLUOROPHENYL)-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(PERFLUOROPHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(PERFLUOROPHENYL)-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(PIPERAZIN-1-YL)PYRIDIN-3-YLBORONIC ACID; 2-(PIPERAZIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(PIPERAZIN-1-YL)THIAZOLE-4-BORONIC ACID-HCL; 2-(PIPERAZIN-1-YLMETHYL)PHENYLBORONIC ACID; 2-(PIPERIDIN-1-YL)-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-(PIPERIDIN-1-YL)PYRIDIN-4-YLBORONIC ACID; 2-(PIPERIDIN-1-YLMETHYL)PHENYLBORONIC ACID; 2-(PIPERIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 2-(PIPERIDINO)PHENYLBORONIC ACID HCL; 2-(PROP-1-YNYL)PYRIDIN-4-YLBORONIC ACID; 2-(PROPAN-2-YLOXY)NAPHTHALENE-1-BORONIC ACID; 2-(PYRIDIN-2-YL)PHENYLBORONIC ACID; 2-(PYRIDIN-2-YLMETHOXY)PHENYLBORONIC ACID; 2-(PYRIDIN-4-YLMETHOXY)PHENYLBORONIC ACID; 2-(PYRIDINE-3-YL)PHENYLBORONIC ACID; 2-(PYRIDINE-4-YL)PHENYLBORONIC ACID; 2-(PYRROLIDIN-1-YL)-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-(PYRROLIDIN-1-YL)PHENYLBORONIC ACID HYDROCHLORIDE; 2-(PYRROLIDIN-1-YL)PYRIDINE-3-BORONIC ACID; 2-(PYRROLIDINO)PHENYLBORONIC ACID; 2-(PYRROLIDINYLSULFONYL)PHENYLBORONIC ACID; 2-(TERT-BUTOXY)PYRIDINE-4-BORONIC ACID; 2-(TERT-BUTOXYCARBONYL(METHYL)AMINO)PYRIMIDIN-5-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-5-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-6-YL-6-BORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-2,3,4,5-TETRAHYDRO-1H-BENZO[C]AZEPIN-7-YL-7-BORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-2,3,4,5-TETRAHYDRO-1H-BENZO[C]AZEPIN-8-YL-8-BORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-5-CHLOROPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)-5-METHOXYPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)PHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYL)PYRIDIN-3-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-3-FLUOROPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-4-CYANOPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-5-CHLOROPYRIDIN-4-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-5-METHOXYPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-6-METHOXYPHENYLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)BIPHENYL-3-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)PYRIDIN-3-YLBORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-THIOPHENE-3-BORONIC ACID; 2-(TERT-BUTOXYCARBONYLAMINO)-THIOPHENE-4-BORONIC ACID; 2-(TERT-BUTOXYMETHYL)PHENYLBORONIC ACID; 2-(TERT-BUTYL)PYRIDINE-4-BORONIC ACID; 2-(TERT-BUTYLAMINO)SULFONYLPHENYLBORONIC ACID; 2-(TERT-BUTYLCARBAMOYL)-5-ISOBUTYLTHIOPHEN-3-YLBORONIC ACID; 2-(TERT-BUTYLCARBONYLAMINO)-6-CHLOROPHENYLBORONIC ACID; 2-(TERT-BUTYLCARBONYLAMINO)PHENYLBORONIC ACID; 2-(TETRAHYDRO-2H-PYRAN-4-YLOXY)PYRIDIN-4-YLBORONIC ACID; 2-(TETRAHYDRO-FURAN-3-YLOXY)PYRIMIDINE-5-BORONIC ACID; 2-(TETRAHYDROPYRAN-2-YLOXY)PHENYLBORONIC ACID; 2-(TETRAHYDROPYRAN-4-YLOXYMETHY)PHENYLBORONIC ACID; 2-(TETRAZOL-5-YL)PHENYLBORONIC ACID; 2-(THIOMORPHOLINOMETHYL)PHENYLBORONIC ACID; 2-(THIOPHEN-2-YL)PYRIDINE-4-BORONIC ACID; 2-(THIOPHEN-2-YLMETHOXYMETHYL)PHENYLBORONIC ACID; 2-(THIOPHEN-3-YL)PHENYLBORONIC ACID; 2-(TOLYL-D7)-BORONIC ACID; 2-(TRIETHYLSILYL)BENZOTHIOPHENE-7-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-1-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-3-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-4-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-5-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-6-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-7-BORONIC ACID; 2-(TRIFLUOROMETHOXY)NAPHTHALENE-8-BORONIC ACID; 2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-(TRIFLUOROMETHOXY)PYRAZINE-6-BORONIC ACID; 2-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-6-BORONIC ACID; 2-(TRIFLUOROMETHYL)-1H-BENZIMIDAZOLE-5-BORONIC ACID, HYDROCHLORIDE SALT; 2-(TRIFLUOROMETHYL)-1H-INDOL-5-YLBORONIC ACID; 2-(TRIFLUOROMETHYL)-1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 2-(TRIFLUOROMETHYL)-3-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-3-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-3-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-3-FLUORO-PHENYLBORONIC ACID; 2-(TRIFLUOROMETHYL)-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)-6-NITROPHENYLBORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-1-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-3-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-5-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-6-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-7-BORONIC ACID; 2-(TRIFLUOROMETHYL)NAPHTHALENE-8-BORONIC ACID; 2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-(TRIFLUOROMETHYL)PYRIMIDIN-5-YLBORONIC ACID; 2-(TRIFLUOROMETHYLTHIO)-BENZENEBORONIC ACID; 2-(TRIMETHYLSILYL)BENZO[B]THIOPHEN-7-YLBORONIC ACID; 2,1,3-BENZOTHIADIAZOL-4-YLBORONIC ACID; 2,2,4,4-TETRAFLUORO-4H-BENZO[1,3]DIOXINE-6-BORONIC ACID; 2,2,4,4-TETRAMETHYL-3,4-DIHYDROBENZOTHIOPYRANYL-6-BORONIC ACID; 2,2′:6′,2″-TERPYRIDINE-4′-BORONIC ACID; 2,2′-BIPYRIDIN-4-YLBORONIC ACID; 2,2′-BITHIOPHENE-5-BORONIC ACID; 2,2-DIFLUOROBENZO[1,3]DIOXOLE-4-BORONIC ACID; 2,2-DIFLUORO-BENZO[1,3]DIOXOLE-5-BORONIC ACID; 2,2-DIMETHYL-2,3-DIHYDRO-1-BENZOFURAN-4-BORONIC ACID; 2,2-DIMETHYL-2,3-DIHYDRO-1-BENZOFURAN-6-BORONIC ACID; 2,2-DIMETHYL-3,4-DIHYDRO-2H-CHROMEN-6-YLBORONIC ACID; 2,2-DIMETHYLETHENYLBORONIC ACID; 2,2-DIMETHYLPROPYL-4′-(TRIFLUOROMETHYL)BENZOATE-2′-BORONIC ACID; 2,2-DIMETHYLPROPYL-4′-METHOXYBENZOATE-2′-BORONIC ACID; 2,2-DIPHENYLVINYLBORONIC ACID; 2,3,4,5,6-PENTAFLUOROBENZENEBORONIC ACID; 2,3,4,5,6-PENTAMETHYLPHENYLBORONIC ACID; 2,3,4,5-TETRAFLUOROPHENYLBORONIC ACID; 2,3,4,6-TETRAFLUOROPHENYLBORONIC ACID; 2,3,4-TRICHLORO-5-NITROPHENYLBORONIC ACID; 2,3,4-TRICHLOROPHENYLBORONIC ACID; 2,3,4-TRIFLUOROPHENYLBORONIC ACID; 2,3,4-TRIMETHOXYPHENYLBORONIC ACID; 2,3,4-TRIS(BENZYLOXY)PHENYLBORONIC ACID; 2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 2,3,5,6-TETRAMETHYLPHENYLBORONIC ACID; 2,3,5-TRICHLOROPHENYLBORONIC ACID; 2,3,5-TRIFLUOROPHENYLBORONIC ACID; 2,3,6-TRICHLOROPHENYLBORONIC ACID; 2,3,6-TRIFLUOROPHENYLBORONIC ACID; 2,3,6-TRIMETHOXYPHENYLBORONIC ACID; 2,3-DICHLORO-4-METHOXYPHENYLBORONIC ACID; 2,3-DICHLORO-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2,3-DICHLORO-6-FLUOROPHENYLBORONIC ACID; 2,3-DICHLOROPHENYLBORONIC ACID; 2,3-DICHLOROPYRIDINE-4-BORONIC ACID; 2,3-DICHLOROPYRIDINE-5-BORONIC ACID; 2,3-DIFLUORO-4-(5-NONYL-1,3-DIOXAN-2-YL)PHENYLBORONIC ACID; 2,3-DIFLUORO-4-(HEPTYLOXY)PHENYLBORONIC ACID; 2,3-DIFLUORO-4-(N-HEXYLOXY)PHENYLBORONIC ACID; 2,3-DIFLUORO-4-BENZYLPHENYLBORONIC ACID; 2,3-DIFLUORO-4-ETHOXYPHENYLBORONIC ACID; 2,3-DIFLUORO-4-ETHYLPHENYLBORONIC ACID; 2,3-DIFLUORO-4′-HEPTYLBIPHENYL-4-BORONIC ACID; 2,3-DIFLUORO-4-HEPTYLPHENYL BORONIC ACID; 2,3-DIFLUORO-4-HEXYLPHENYL BORONIC ACID; 2,3-DIFLUORO-4-HYDROXYPHENYLBORONIC ACID; 2,3-DIFLUORO-4-ISOBUTYLPHENYLBORONIC ACID; 2,3-DIFLUORO-4-METHOXYPHENYLBORONIC ACID; 2,3-DIFLUORO-4-METHYLPHENYLBORONIC ACID; 2,3-DIFLUORO-4-N-BUTYLPHENYLBORONIC ACID; 2,3-DIFLUORO-4′-PENTYLBIPHENYL-4-BORONIC ACID; 2,3-DIFLUORO-4-PENTYLOXYPHENYLBORONIC ACID; 2,3-DIFLUORO-4-PENTYLPHENYLBORONIC ACID; 2,3-DIFLUORO-5-NITROPHENYLBORONIC ACID; 2,3-DIFLUORO-6-BENZYLOXYPHENYLBORONIC ACID; 2,3-DIFLUORO-6-ETHOXYPHENYLBORONIC ACID; 2,3-DIFLUORO-6-METHOXYPHENYLBORONIC ACID; 2,3-DIFLUOROPHENYLBORONIC ACID; 2,3-DIFLUOROPYRIDINE-4-BORONIC ACID; 2,3-DIHYDRO-1,4-BENZODIOXIN-2-YLBORONIC ACID; 2,3-DIHYDRO-1-BENZOFURAN-7-BORONIC ACID; 2,3-DIHYDRO-1H-INDEN-5-YLBORANEDIOL; 2,3-DIHYDRO-5-FURYLBORONIC ACID; 2,3-DIHYDRO-8-METHOXYBENZO[B][1,4]DIOXIN-5-YL-5-BORONIC ACID; 2,3-DIHYDROBENZOFURAN-5-BORONIC ACID; 2,3-DIHYDROTHIENO[3,4-B][1,4]DIOXIN-5-YLBORONIC ACID; 2,3-DIMETHOXY-1-TERT-BUTYL-PHENYL-5-BORONIC ACID; 2,3-DIMETHOXYPHENYLBORONIC ACID; 2,3-DIMETHOXYPYRIDINE-4-BORONIC ACID; 2,3-DIMETHYL-2H-INDAZOL-6-YLBORONIC ACID; 2,3-DIMETHYL-4-HYDROXYMETHYLPHENYLBORONIC ACID; 2,3-DIMETHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-7-YLBORONIC ACID; 2,3-DIMETHYLANTHRACEN-10-YL-10-BORONIC ACID; 2,3-DIMETHYLBENZO[B]THIOPHENE-7-BORONIC ACID; Z,3′-DIMETHYLBIPHENYL-2-YLBORONIC ACID; 2,3-DIMETHYLINDAZOLE-5-BORONIC ACID; 2,3-DIMETHYLPHENYLBORONIC ACID; 2,3-DIMETHYLPYRIDIN-4-YLBORONIC ACID; 2,3-METHYLENEDIOXYPHENYLBORONIC ACID; 2,4-(DIMETHYL)PYRIMIDINE-5-BORONIC ACID; 2,4,5-TRICHLOROPHENYLBORONIC ACID; 2,4,5-TRIFLUOROPHENYLBORONIC ACID; 2,4,5-TRIMETHYLPHENYLBORONIC ACID; 2,4,6-(TRIMETHYL)PYRIMIDINE-5-BORONIC ACID; 2,4,6-TRICHLOROPHENYLBORONIC ACID; 2,4,6-TRIFLUORO-3-HYDROXYPHENYLBORONIC ACID; 2,4,6-TRIFLUORO-3-METHYLPHENYLBORONIC ACID; 2,4,6-TRIFLUOROPHENYLBORONIC ACID; 2,4,6-TRIISOPROPYLBENZENEBORONIC ACID; 2,4,6-TRIMETHOXYPHENYLBORONIC ACID; 2,4,6-TRIMETHYLPHENYLBORONIC ACID; 2,4,6-TRIMETHYLPYRIDIN-3-YLBORONIC ACID; 2,4,6-TRICHLOROPYRIDINE-3-BORONIC ACID; 2,4-BIS(BENZYLOXY)PHENYLBORONIC ACID; 2,4-BIS(BENZYLOXY)PYRIMIDINE-5-BORONIC ACID; 2,4-BIS(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2,4-DI(TERT-BUTOXY)PYRIMIDIN-5-YLBORONIC ACID HYDRATE; 2,4-DIAMINOPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIBUTOXYPHENYLBORONIC ACID; 2,4-DICHLORO-3-CYANOPHENYLBORONIC ACID; 2,4-DICHLORO-3-METHOXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-(2-(DIMETHYLAMINO)ETHOXY)PHENYLBORONIC ACID; 2,4-DICHLORO-5-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 2,4-DICHLORO-5-(CYCLOPENTYLOXY)PHENYLBORONIC ACID; 2,4-DICHLORO-5-(CYCLOPROPYLMETHOXY)PHENYLBORONIC ACID; 2,4-DICHLORO-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2,4-DICHLORO-5-ETHOXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-HYDROXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-ISOBUTOXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-ISOPROPOXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-METHOXYPHENYLBORONIC ACID; 2,4-DICHLORO-5-NITROPHENYLBORONIC ACID; 2,4-DICHLORO-5-PROPOXYPHENYLBORONIC ACID; 2,4-DICHLORO-6-ETHYLPHENYLBORONIC ACID; 2,4-DICHLORO-6-HYDROXYPHENYLBORONIC ACID; 2,4-DICHLORO-6-METHOXYPHENYLBORONIC ACID; 2,4-DICHLOROPHENYLBORONIC ACID; 2,4-DICHLOROPYRIDINE-3-BORONIC ACID; 2,4-DICHLOROPYRIDINE-5-BORONIC ACID HYDRATE; 2,4-DICHLOROPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIETHOXYPHENYLBORONIC ACID; 2,4-DIETHOXYPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIFLUORO-3-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2,4-DIFLUORO-3-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 2,4-DIFLUORO-3-CYANOPHENYLBORONIC ACID; 2,4-DIFLUORO-5-NITROPHENYLBORONIC ACID; 2,4-DIFLUORO-6-HYDROXYPHENYLBORONIC ACID; 2,4-DIFLUOROPHENYLBORONIC ACID; 2,4-DIFLUOROPYRIDINE-3-BORONIC ACID; 2,4-DIFLUOROPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIHYDROXYPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIISOPROPOXYPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIMETHOXY-6-METHYLPHENYLBORONIC ACID; 2,4-DIMETHOXYPHENYLBORONIC ACID; 2,4-DIMETHOXYPYRIDIN-3-YLBORONIC ACID; 2,4-DIMETHOXYPYRIMIDINE-5-BORONIC ACID; 2,4-DIMETHYL-3-METHOXYBENZENEBORONIC ACID; 2,4-DIMETHYL-6-METHOXYPHENYLBORONIC ACID; 2′,4′-DIMETHYLBIPHENYL-2-YLBORONIC ACID; 2,4-DIMETHYLPHENYLBORONIC ACID; 2,4-DIMETHYLPYRIDINE-3-BORONIC ACID; 2,4-DIOXOHEXAHYDROPYRIMIDIN-5-YLBORONIC ACID; 2,4-DIPHENYL-5-PYRIMIDINYLBORONIC ACID; 2,4-DIPROPOXYPHENYLBORONIC ACID; 2,4-DITERT-BUTOXYPYRIMIDIN-5-YLBORONIC ACID; 2,5-BIS(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 2,5-DICHLORO-4-METHOXY-BENZENEBORONIC ACID; 2,5-DICHLORO-4-METHYL-BENZENEBORONIC ACID; 2,5-DICHLOROPHENYLBORONIC ACID; 2,5-DICHLOROPYRIDINE-3-BORONIC ACID; 2,5-DICHLOROPYRIDINE-4-BORONIC ACID; 2,5-DICHLOROTHIOPHENE-3-BORONIC ACID; 2,5-DIFLUORO-4-BENZYLOXYPHENYLBORONIC ACID; 2,5-DIFLUORO-4-ETHOXYPHENYLBORONIC ACID; 2,5-DIFLUORO-4-HYDROXYPHENYLBORONIC ACID; 2,5-DIFLUORO-4-METHOXYPHENYLBORONIC ACID; 2,5-DIFLUORO-6-ETHOXYPHENYLBORONIC ACID; 2,5-DIFLUOROPHENYLBORONIC ACID; 2,5-DIFLUOROPYRIDINE-3-BORONIC ACID; 2,5-DIFLUOROPYRIDINE-4-BORONIC ACID; 2,5-DIMETHOXYPHENYLBORONIC ACID; 2,5-DIMETHOXYPYRIMIDIN-4-YLBORONIC ACID; 2,5-DIMETHYL-4-ETHOXYPHENYLBORONIC ACID; 2,5-DIMETHYL-4-METHOXYPHENYLBORONIC ACID; 2′,5′-DIMETHYLBIPHENYL-2-YLBORONIC ACID; 2,5-DIMETHYLPHENYLBORONIC ACID; 2,5-DIMETHYLPYRIDIN-3-YLBORONIC ACID; 2,5-DIMETHYLTHIOPHENE-3-BORONIC ACID; 2,6-BIS(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2,6-DICHLORO-3-METHYLPHENYLBORONIC ACID; 2,6-DICHLORO-3-NITROPHENYLBORONIC ACID; 2,6-DICHLORO-4-METHYLPHENYLBORONIC ACID; 2,6-DICHLOROBENZYLBORONIC ACID; 2,6-DICHLOROPHENYLBORONIC ACID; 2,6-DICHLOROPYRIDINE-3-BORONIC ACID; 2,6-DICHLOROPYRIDINE-4-BORONIC ACID; 2,6-DICYANOPYRIDINE-4-BORONIC ACID; 2,6-DIETHOXYPYRIDINE-3-BORONIC ACID; 2,6-DIETHYLPYRIDINE-4-BORONIC ACID; 2,6-DIFLUORO-3-(2′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 2,6-DIFLUORO-3-(2′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 2,6-DIFLUORO-3-(3′,5-DIMETHOXYBENZYLOXY)PHENYLBORONIC ACID; 2,6-DIFLUORO-3-ETHOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-3-HYDROXYPHENYLBORONIC ACID; 2,6-DIFLUORO-3-ISOPROPOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-3-METHOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-3-NITROPHENYLBORONIC ACID; 2,6-DIFLUORO-3-PROPOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-4-(3-FLUOROPHENOXY)PHENYLBORONIC ACID; 2,6-DIFLUORO-4-ETHOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-4-HYDROXYPHENYLBORONIC ACID; 2,6-DIFLUORO-4-METHOXYPHENYLBORONIC ACID; 2,6-DIFLUORO-4-METHYLPHENYLBORONIC ACID; 2,6-DIFLUORO-4-MORPHOLIN-4-YL-PHENYL BORONIC ACID; 2,6-DIFLUOROPHENYLBORONIC ACID; 2,6-DIFLUOROPYRIDINE-3-BORONIC ACID; 2,6-DIFLUOROPYRIDINE-3-BORONIC ACID HYDRATE; 2,6-DIFLUOROPYRIDINE-4-BORONIC ACID; 2,6-DIHYDROXYBENZENEBORONIC ACID; 2,6-DIISOPROPYLPHENYLBORONIC ACID; 2,6-DIMETHOXYPHENYLBORONIC ACID; 2,6-DIMETHOXYPYRIDIN-4-YLBORONIC ACID; 2,6-DIMETHOXYPYRIDINE-3-BORONIC ACID; 2,6-DIMETHYL-4-CHLOROPHENYLBORONIC ACID; 2,6-DIMETHYL-4-ETHOXYPHENYLBORONIC ACID; 2,6-DIMETHYLPHENYLBORONIC ACID; 2,6-DIMETHYLPYRIDINE-3-BORONIC ACID; 2,6-DIMETHYL-PYRIDINE-4-BORONIC ACID; 2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YLBORONIC ACID; 2,6-DIPHENYLPYRIDIN-4-YLBORONIC ACID; 2,6-DIPHENYLPYRIMIDIN-4-YLBORONIC ACID; 2,7-NAPHTHYRIDINE-4-BORONIC ACID; 2-[(1,2′,3′,4′-TETRAHYDRO-5-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 2-[(1-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 2-[(2,2-DIMETHYLPROPANOYL)AMINO]PYRIDINE-3-BORONIC ACID; 2-[(2′,6′-DIISOPROPYLPHENOXY)METHYL]PHENYLBORONIC ACID; 2-[(2-ISOPROPYL-5-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 2-[(2-METHYLPHENOXY)METHYL]BENZENEBORONIC ACID; 2-[(3′,5′-DIFLUOROPHENOXY)METHYL]PHENYLBORONIC ACID; 2-[(3-DIMETHYLANILINO)METHYL]BENZENEBORONIC ACID; 2-[(4′-(2-METHOXYETHYL)PHENOXY)METHYL]PHENYLBORONIC ACID; 2-[(4′-CHLORO-1-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 2-[(4′-TERT-BUTYL-2′-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 2-[2-(4-METHYL-PIPERAZIN-1-YL)-ETHOXY]-PHENYLBORONIC ACID; 2-[2-(4-METHYL-PIPERIDIN-1-YL)-ETHOXY]-PHENYLBORONIC ACID; 2-ACETAMIDO-5-AMINOPHENYLBORONIC ACID; 2-ACETAMIDO-5-CHLOROPHENYLBORONIC ACID; 2-ACETAMIDOBENZO[D]OXAZOL-5-YLBORONIC ACID; 2-ACETAMIDOBENZO[D]OXAZOL-6-YLBORONIC ACID; 2-ACETAMIDOPHENYLBORONIC ACID; 2-ACETAMIDOPYRIDINE-5-BORONIC ACID; 2-ACRYLAMIDOPHENYLBORONIC ACID; 2-ALLYLOXYPHENYLBORONIC ACID; 2-AMINO-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-AMINO-3-(TRIFLUOROMETHYL)-PYRIDINE-5-BORONIC ACID; 2-AMINO-3,4,5-TRIFLUOROPHENYLBORONIC ACID; 2-AMINO-3,5-DIFLUOROPHENYLBORONIC ACID; 2-AMINO-3-FLUOROPYRIDINE-4-BORONIC ACID; 2-AMINO-3-METHYLPYRIDINE-4-BORONIC ACID; 2-AMINO-4-(2-METHYLPROPYL)PHENYLBORONIC ACID; 2-AMINO-4-(ETHOXYCARBONYL)BENZENEBORONIC ACID HYDROCHLORIDE; 2-AMINO-4-(IMINO(METHOXY)METHYL)PHENYLBORONIC ACID HCL; 2-AMINO-4-(ISOPROPOXYCARBONYL)PHENYLBORONIC ACID, HCL; 2-AMINO-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-AMINO-4-(TRIFLUOROMETHYL)PYRIMIDIN-5-YLBORONIC ACID; 2-AMINO-4,5-DIFLUOROPHENYLBORONIC ACID; 2-AMINO-4-BORONOBUTANOIC ACID; 2-AMINO-4-CARBOXYBENZENEBORONIC ACID HYDROCHLORIDE; 2-AMINO-4-CHLOROPHENYL BORONIC ACID; 2-AMINO-4-METHOXYCARBONYL PHENYLBORONIC ACID; 2-AMINO-4-METHOXYPYRIMIDIN-5-YLBORONIC ACID; 2-AMINO-4-METHYLPYRIDINE-3-BORONIC ACID; 2-AMINO-4-METHYLPYRIMIDIN-5-YLBORONIC ACID; 2-AMINO-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-AMINO-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-AMINO-5-CHLOROPHENYLBORONIC ACID; 2-AMINO-5-CHLORO-PYRIDINE-4-BORONIC ACID; 2-AMINO-5-FLUOROBENZENEBORONIC ACID HYDROCHLORIDE; 2-AMINO-5-FLUOROPHENYLBORONIC ACID; 2-AMINO-5-METHOXYPHENYLBORONIC ACID; 2-AMINO-5-METHYLPYRIDINE-3-BORONIC ACID; 2-AMINO-5-METHYLPYRIDINE-4-BORONIC ACID; 2-AMINO-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-AMINO-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-AMINO-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-AMINO-6-FLUOROPYRIDIN-3-YLBORONIC ACID; 2-AMINO-6-FLUOROPYRIDIN-4-YLBORONIC ACID; 2-AMINO-6-METHOXYPYRIDINE-3-BORONIC ACID; 2-AMINO-6-METHYL-5-NITROPHENYLBORONIC ACID; 2-AMINO-6-METHYLPYRIDINE-3-BORONIC ACID; 2-AMINO-6-METHYLPYRIDINE-4-BORONIC ACID; 2-AMINO-6-METHYLPYRIMIDINE-4-BORONIC ACID; 2-AMINOBENZO[D]OXAZOL-5-YLBORONIC ACID; 2-AMINOCARBONYLPHENYLBORONIC ACID; 2-AMINOETHYL BORONIC ACID; 2-AMINOMETHYL-4-FLUOROPHENYLBORONIC ACID, HCL; 2-AMINONAPHTHALENE-1-BORONIC ACID; 2-AMINONAPHTHALENE-3-BORONIC ACID; 2-AMINONAPHTHALENE-4-BORONIC ACID; 2-AMINONAPHTHALENE-5-BORONIC ACID; 2-AMINONAPHTHALENE-6-BORONIC ACID; 2-AMINONAPHTHALENE-7-BORONIC ACID; 2-AMINONAPHTHALENE-8-BORONIC ACID; 2-AMINOPHENYLBORONIC ACID; 2-AMINOPYRIDINE-3-BORONIC ACID; 2-AMINOPYRIDINE-4-BORONIC ACID; 2-AMINOPYRIMIDIN-4-YLBORONIC ACID; 2-AMINOPYRIMIDINE-5-BORONIC ACID; 2-AMINOPYRIMIDINE-5-BORONIC ACID HCL; 2-AMINOQUINAZOLIN-6-YLBORONIC ACID; 2-ANTHRACENYLBORONIC ACID; 2-BENZYL-1,3-DIOXOISOINDOLIN-5-YLBORONIC ACID; 2-BENZYL-1-OXO-1,2-DIHYDROISOQUINOLIN-6-YLBORONIC ACID; 2-BENZYL-2H-INDAZOL-6-YLBORONIC ACID; 2-BENZYLCYCLOPROPYLBORONIC ACID; 2-BENZYLOXY-3-FLUOROPHENYLBORONIC ACID; 2-BENZYLOXY-4-FLUOROPHENYLBORONIC ACID; 2-BENZYLOXY-5-CHLOROPHENYLBORONIC ACID; 2-BENZYLOXY-5-CHLOROPYRIDINE-3-BORONIC ACID; 2-BENZYLOXY-5-FLUOROPHENYLBORONIC ACID; 2-BENZYLOXY-5-METHYLPHENYLBORONIC ACID; 2-BENZYLOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 2-BENZYLOXY-6-FLUOROPHENYLBORONIC ACID; 2-BENZYLOXYPHENYLBORONIC ACID; 2-BENZYLOXYPYRIDINE-3-BORONIC ACID; 2-BENZYLTHIOPHENYLBORONIC ACID; 2-BIPHENYLBORONIC ACID; 2-BOC-AMINOMETHYL-PHENYLBORONIC ACID; 2-BORONO-1-METHYL-1H-INDOLE-5-CARBOXYLIC ACID; 2-BORONO-1-METHYL-1H-INDOLE-6-CARBOXYLIC ACID; 2-BORONO-4,5-DIMETHOXYBENZOIC ACID; 2-BORONO-4-CHLOROBENZOIC ACID; 2-BORONO-5-FLUOROBENZOIC ACID; 2-BORONO-5-TERT-BUTOXYBENZOIC ACID; 2-BORONO-6-(TRIFLUOROMETHYL)BENZOIC ACID; 2-BORONO-6-METHOXYBENZOIC ACID; 2-BORONO-6-METHOXYISONICOTINIC ACID; 2-BORONO-7-METHOXYBENZO[B]THIOPHENE-4-CARBOXYLIC ACID; 2-BORONOBENZENESULFONAMIDE; 2-BORONOBENZO[B]THIOPHENE-5-CARBOXYLIC ACID; 2-BORONOBENZO[B]THIOPHENE-6-CARBOXYLIC ACID; 2-BORONOBENZO[B]THIOPHENE-7-CARBOXYLIC ACID; 2-BUTOXY-3,5-DIMETHYLPHENYLBORONIC ACID; 2-BUTOXY-4-CHLOROPHENYLBORONIC ACID; 2-BUTOXY-4-FLUOROPHENYLBORONIC ACID; 2-BUTOXY-5-CHLOROPHENYLBORONIC ACID; 2-BUTOXY-5-CHLOROPYRIDINE-3-BORONIC ACID; 2-BUTOXY-5-FLUOROPHENYLBORONIC ACID; 2-BUTOXY-5-METHYLPHENYLBORONIC ACID; 2-BUTOXY-6-FLUOROPHENYLBORONIC ACID; 2-BUTOXYPHENYLBORONIC ACID; 2-BUTYLBORONIC ACID; 2-BUTYLTHIO-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-CARBAMOYL-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CARBAMOYL-4-FLUOROPHENYLBORONIC ACID; 2-CARBAMOYL-5-CHLOROPHENYLBORONIC ACID; 2-CARBAMOYLTHIAZOL-5-YLBORONIC ACID; 2-CARBOXY-4-CHLOROPHENYLBORONIC ACID; 2-CARBOXY-5-FLUOROPHENYLBORONIC ACID; 2-CARBOXY-6-METHOXYPYRIDINE-3-BORONIC ACID; 2-CARBOXYPHENYLBORONIC ACID; 2-CARBOXYPYRIDINE-4-BORONIC ACID; 2-CARBOXYTHIOPHENE-3-BORONIC ACID; 2-CARBOXYTHIOPHENE-4-BORONIC ACID; 2-CHLORO-1-METHYL-1H-IMIDAZOL-5-YLBORONIC ACID; 2-CHLORO-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-CHLORO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CHLORO-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-CHLORO-3,4-DIFLUOROPHENYLBORONIC ACID; 2-CHLORO-3,5-DIFLUOROPHENYLBORONIC ACID; 2-CHLORO-3,6-DIFLUOROPHENYLBORONIC ACID; 2-CHLORO-3-CYANOPHENYLBORONIC ACID; 2-CHLORO-3-CYANOPYRIDINE-4-BORONIC ACID; 2-CHLORO-3-ETHOXY-6-FLUOROPHENYLBORONIC ACID; 2-CHLORO-3-ETHOXYPHENYLBORONIC ACID; 2-CHLORO-3-FLUORO-5-PICOLINE-4-BORONIC ACID; 2-CHLORO-3-FLUOROPHENYLBORONIC ACID; 2-CHLORO-3-FLUOROPYRIDINE-4-BORONIC ACID; 2-CHLORO-3-FLUOROPYRIDINE-4-BORONIC ACID HYDRATE; 2-CHLORO-3-FLUOROPYRIDINE-5-BORONIC ACID; 2-CHLORO-3-HYDROXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-3-METHOXYPHENYLBORONIC ACID; 2-CHLORO-3-METHOXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-3-METHYLPHENYLBORONIC ACID; 2-CHLORO-3-METHYLPYRIDINE-4-BORONIC ACID; 2-CHLORO-3-METHYLPYRIDINE-5-BORONIC ACID; 2-CHLORO-3-PROPOXYPHENYLBORONIC ACID; 2-CHLORO-4-(2-METHOXY-2-OXOETHYL)PHENYLBORONIC ACID; 2-CHLORO-4-(ETHOXYCARBONYL)BENZENEBORONIC ACID; 2-CHLORO-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CHLORO-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-CHLORO-4,5-DIFLUOROPHENYLBORONIC ACID; 2-CHLORO-4,6-DIFLUOROPHENYLBORONIC ACID; 2-CHLORO-4,6-DIMETHOXYPYRIMIDIN-5-YLBORONIC ACID; 2-CHLORO-4-[((1,1-DIMETHYLETHYL)DIMETHYLSILYL)OXY]PHENYLBORONIC ACID; 2-CHLORO-4-CYANOPHENYLBORONIC ACID; 2-CHLORO-4-CYANOPYRIDIN-3-YLBORONIC ACID; 2-CHLORO-4-ETHOXYPHENYLBORONIC ACID; 2-CHLORO-4-FLUORO-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-CHLORO-4-FLUORO-5-METHOXYPHENYLBORONIC ACID; 2-CHLORO-4-FLUORO-5-METHYLPHENYLBORONIC ACID; 2-CHLORO-4-FLUOROPHENYLBORONIC ACID; 2-CHLORO-4-FLUOROPYRIDINE-3-BORONIC ACID; 2-CHLORO-4-HYDROXYPHENYLBORONIC ACID; 2-CHLORO-4-ISOPROPROXYPHENYLBORONIC ACID; 2-CHLORO-4-METHOXY-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-CHLORO-4-METHOXY-5-METHYL-BENZENEBORONIC ACID; 2-CHLORO-4-METHOXYPHENYLBORONIC ACID; 2-CHLORO-4-METHOXYPYRIDINE-3-BORONIC ACID; 2-CHLORO-4-METHOXYPYRIDINE-5-BORONIC ACID; 2-CHLORO-4-METHYLPHENYLBORONIC ACID; 2-CHLORO-4-METHYLPYRIDINE-3-BORONIC ACID; 2-CHLORO-4-METHYLPYRIDINE-5-BORONIC ACID; 2-CHLORO-4-METHYLPYRIMIDINE-5-BORONIC ACID; 2-CHLORO-4-PHENYLPYRIDINE-3-BORONIC ACID; 2-CHLORO-4-TRIFLUOROMETHOXYPHENYLBORONIC ACID; 2-CHLORO-5-(1,3-DIOXOLAN-2-YL)PYRIDIN-3-YLBORONIC ACID; 2-CHLORO-5-(4-FLUOROPHENYL)THIOPHEN-3-YLBORONIC ACID; 2-CHLORO-5-(ETHOXYCARBONYL)BENZENEBORONIC ACID; 2-CHLORO-5-(ETHYLSULFONYL)PHENYLBORONIC ACID; 2-CHLORO-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-CHLORO-5-(OXAZOL-2-YL)PHENYLBORONIC ACID; 2-CHLORO-5-(THIAZOL-2-YL)PHENYLBORONIC ACID; 2-CHLORO-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-CHLORO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CHLORO-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-CHLORO-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-CHLORO-5-(TRIFLUOROMETHYL)THIOPHENE-3-BORONIC ACID; 2-CHLORO-5-BORONOBENZAMIDE; 2-CHLORO-5-CYANOPHENYLBORONIC ACID; 2-CHLORO-5-CYANOPYRIDINE-3-BORONIC ACID; 2-CHLORO-5-ETHOXYBENZENEBORONIC ACID; 2-CHLORO-5-FLUORO-3-PICOLINE-4-BORONIC ACID; 2-CHLORO-5-FLUORO-6-METHYLPHENYLBORONIC ACID; 2-CHLORO-5-FLUOROPHENYLBORONIC ACID; 2-CHLORO-5-FLUOROPYRIDINE-3-BORONIC ACID; 2-CHLORO-5-FLUOROPYRIDINE-4-BORONIC ACID; 2-CHLORO-5-HYDROXYMETHYLPHENYLBORONIC ACID; 2-CHLORO-5-HYDROXYPHENYLBORONIC ACID; 2-CHLORO-5-HYDROXYPYRIDINE-3-BORONIC ACID; 2-CHLORO-5-HYDROXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-5-ISOBUTOXYPHENYLBORONIC ACID; 2-CHLORO-5-ISOPROPOXYPHENYLBORONIC ACID; 2-CHLORO-5-METHOXY-4-METHYLBENZENEBORONIC ACID; 2-CHLORO-5-METHOXYPHENYLBORONIC ACID; 2-CHLORO-5-METHOXYPYRIDINE-3-BORONIC ACID; 2-CHLORO-5-METHOXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-5-METHOXYPYRIDINE-4-BORONIC ACID, MONOLITHIUM SALT; 2-CHLORO-5-METHYLPHENYLBORONIC ACID; 2-CHLORO-5-METHYLPYRIDINE-3-BORONIC ACID; 2-CHLORO-5-METHYLPYRIDINE-4-BORONIC ACID; 2-CHLORO-5-NITROPHENYLBORONIC ACID; 2-CHLORO-5-PHENYLPYRIDIN-3-YLBORONIC ACID; 2-CHLORO-5-PROPOXYPHENYLBORONIC ACID; 2-CHLORO-6-(1H-PYRAZOL-1-YL)PYRIDINE-3-BORONIC ACID; 2-CHLORO-6-(METHOXYMETHOXY)PHENYLBORONIC ACID; 2-CHLORO-6-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-CHLORO-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CHLORO-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-CHLORO-6-CYANOPHENYLBORONIC ACID; 2-CHLORO-6-FLUORO-3-(METHOXYMETHOXY)PHENYLBORONIC ACID; 2-CHLORO-6-FLUORO-3-HYDROXYPHENYLBORONIC ACID; 2-CHLORO-6-FLUORO-3-METHOXYPHENYLBORONIC ACID; 2-CHLORO-6-FLUORO-3-METHYLPHENYLBORONIC ACID; 2-CHLORO-6-FLUORO-5-METHYLPHENYLBORONIC ACID; 2-CHLORO-6-FLUOROPHENYLBORONIC ACID; 2-CHLORO-6-HYDROXYPHENYLBORONIC ACID; 2-CHLORO-6-HYDROXYPYRIDINE-3-BORONIC ACID; 2-CHLORO-6-HYDROXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-6-ISOPROPYLPYRIDINE-3-BORONIC ACID; 2-CHLORO-6-ISOPROPYLPYRIDINE-4-BORONIC ACID; 2-CHLORO-6-METHOXY-4-(METHOXYMETHYL)PHENYLBORONIC ACID; 2-CHLORO-6-METHOXYPHENYLBORONIC ACID; 2-CHLORO-6-METHOXYPYRIDINE-3-BORONIC ACID; 2-CHLORO-6-METHOXYPYRIDINE-4-BORONIC ACID; 2-CHLORO-6-METHYLPHENYLBORONIC ACID; 2-CHLORO-6-METHYLPYRIDINE-3-BORONIC ACID; 2-CHLORO-6-PHENYLPYRIDIN-3-YLBORONIC ACID; 2-CHLOROFURAN-3-YLBORONIC ACID; 2-CHLORONAPHTHALENE-1-BORONIC ACID; 2-CHLORONAPHTHALENE-3-BORONIC ACID; 2-CHLORONAPHTHALENE-4-BORONIC ACID; 2-CHLORONAPHTHALENE-5-BORONIC ACID; 2-CHLORONAPHTHALENE-6-BORONIC ACID; 2-CHLORONAPHTHALENE-7-BORONIC ACID; 2-CHLORONAPHTHALENE-8-BORONIC ACID; 2-CHLOROPHENYLBORONIC ACID; 2-CHLOROPYRIDINE-3-BORONIC ACID; 2-CHLOROPYRIDINE-4-BORONIC ACID; 2-CHLOROPYRIDINE-5-BORONIC ACID; 2-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-CHLOROPYRIMIDINE-5-BORONIC ACID; 2-CHLOROQUINOLINE-3-BORONIC ACID; 2-CHLOROTHIOPHENE-3-BORONIC ACID; 2′-CYANO-2-FLUOROBIPHENYL-3-YLBORONIC ACID; 2-CYANO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CYANO-3-FLUOROPHENYLBORONIC ACID; 2-CYANO-3-HYDROXYPHENYLBORONIC ACID; 2-CYANO-3-METHOXYPHENYLBORONIC ACID; 2-CYANO-3-METHYLPHENYLBORONIC ACID; 2-CYANO-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CYANO-4-FLUOROPHENYLBORONIC ACID; 2-CYANO-4-HYDROXYPHENYLBORONIC ACID; 2-CYANO-4-METHOXYPHENYLBORONIC ACID; 2-CYANO-4-METHYLPHENYLBORONIC ACID; 2-CYANO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-CYANO-5-FLUOROPHENYLBORONIC ACID; 2-CYANO-5-HYDROXYPHENYLBORONIC ACID; 2-CYANO-5-METHOXYPHENYLBORONIC ACID; 2-CYANO-5-METHYLPHENYLBORONIC ACID; 2-CYANO-6-FLUOROPHENYLBORONIC ACID; 2-CYANO-6-HYDROXYPHENYLBORONIC ACID; 2-CYANO-6-METHOXYPHENYLBORONIC ACID; 2-CYANO-6-METHYLPHENYLBORONIC ACID; 2-CYANO-6-METHYLPYRIMIDINE-4-BORONIC ACID; 2-CYANOMETHOXYPHENYLBORONIC ACID; 2-CYANOPHENYLBORONIC ACID; 2-CYANOPYRIDINE-3-BORONIC ACID; 2-CYANOPYRIDINE-4-BORONIC ACID; 2-CYANOPYRIMIDIN-5-YLBORONIC ACID; 2-CYANOPYRIMIDINE-4-BORONIC ACID; 2-CYANOTHIAZOL-5-YLBORONIC ACID; 2-CYANOTHIOPHEN-3-YLBORONIC ACID; 2-CYCLOBUTYLPHENYLBORONIC ACID; 2-CYCLOHEXYL-CYCLOPROPYL-1-BORONIC ACID; 2-CYCLOHEXYLETHENYLBORONIC ACID; 2-CYCLOHEXYLOXY-5-METHYLPYRIDINE-3-BORONIC ACID; 2-CYCLOPROPOXYPHENYLBORONIC ACID; 2-CYCLOPROPYL-1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 2-CYCLOPROPYLPHENYLBORONIC ACID; 2-CYCLOPROPYLPYRIDINE-4-BORONIC ACID; 2-CYCLOPROPYLPYRIMIDIN-5-YLBORONIC ACID; 2-DIFLUOROMETHOXY-3-FLUORO-BENZENEBORONIC ACID; 2-DIFLUOROMETHOXY-3-METHYL-BENZENEBORONIC ACID; 2-DIFLUOROMETHOXY-4-FLUORO-BENZENEBORONIC ACID; 2-DIFLUOROMETHOXY-5-METHYL-BENZENEBORONIC ACID; 2-DIFLUOROMETHOXY-5-TRIFLUOROMETHYL-BENZENEBORONIC ACID; 2-DIFLUOROMETHYL-PHENYLBORONIC ACID; 2-DIMETHYLAMINO-6-METHOXYPHENYLBORONIC ACID; 2-DIMETHYLAMINOPYRIDINE-4-BORONIC ACID; 2-DIMETHYLAMINOPYRIMIDINYL-5-BORONIC ACID; 2-ETHOXY-1-NAPHTHALENEBORONIC ACID; 2-ETHOXY-3-FLUOROPHENYLBORONIC ACID; 2-ETHOXY-4-FLUOROPHENYLBORONIC ACID; 2-ETHOXY-4-METHYL-5-PYRIDINYLBORONIC ACID; 2-ETHOXY-4-METHYLPYRIDINE-3-BORONIC ACID; 2-ETHOXY-4-TRIFLUOROMETHYLPHENYLBORONIC ACID; 2-ETHOXY-5-(TRIFLUOROMETHOXY)BENZENEBORONIC ACID; 2-ETHOXY-5-FLUOROPHENYLBORONIC ACID; 2-ETHOXY-5-FLUOROPYRIDINE-4-BORONIC ACID; 2-ETHOXY-5-HYDROXYPHENYLBORONIC ACID; 2-ETHOXY-5-METHOXYPHENYLBORONIC ACID; 2-ETHOXY-5-METHYLPHENYLBORONIC ACID; 2-ETHOXY-5-METHYLPYRIDIN-3-YLBORONIC ACID; 2-ETHOXY-5-PYRIDINEBORONIC ACID; 2-ETHOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 2-ETHOXY-6-FLUOROPHENYLBORONIC ACID; 2-ETHOXY-6-METHYLPYRIDINE-3-BORONIC ACID; 2-ETHOXYCARBONYL-5-FLUOROPHENYLBORONIC ACID; 2-ETHOXYCARBONYLMETHYLPHENYLBORONIC ACID; 2-ETHOXYCARBONYLPHENYLBORONIC ACID; 2-ETHOXYMETHYLPHENYLBORONIC ACID; 2-ETHOXYPHENYLBORONIC ACID; 2-ETHOXYPYRIDINE-3-BORONIC ACID; 2-ETHOXYPYRIDINE-4-BORONIC ACID; 2-ETHOXYPYRIMIDINE-5-BORONIC ACID; 2-ETHOXYQUINOLIN-3-YLBORONIC ACID; 2-ETHOXYQUINOLIN-6-YLBORONIC ACID; 2-ETHYL-3,5-DIMETHYLPHENYLBORONIC ACID; 2-ETHYLBENZOFURAN-3-YLBORONIC ACID; 2-ETHYLPHENYLBORONIC ACID; 2-ETHYLPYRIDINE-3-BORONIC ACID; 2-ETHYLPYRIDINE-4-BORONIC ACID; 2-ETHYLPYRIMIDIN-5-YLBORONIC ACID; 2-ETHYLSULFINYLPHENYLBORONIC ACID; 2-ETHYLSULFONYLPHENYLBORONIC ACID; 2-ETHYLTHIO-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-ETHYLTHIOPHENYLBORONIC ACID; 2-ETHYLTHIOPYRIDINE-5-BORONIC ACID; 2-FLUORO-3-(ETHOXYCARBONYL)PHENYLBORONIC ACID; 2-FLUORO-3-(HYDROXYMETHYL)PHENYLBORONIC ACID; 2-FLUORO-3-(N,N-DIMETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 2-FLUORO-3-(PIPERIDIN-1-YLMETHYL)PHENYLBORONIC ACID; 2-FLUORO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-FLUORO-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-FLUORO-3,4-METHYLENEDIOXYPHENYLBORONIC ACID; 2-FLUORO-3-HYDROXYPHENYLBORONIC ACID; 2-FLUORO-3-HYDROXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-3-ISOBUTOXYPHENYLBORONIC ACID; 2-FLUORO-3-ISOPROPOXYPHENYLBORONIC ACID; 2-FLUORO-3-METHOXYPHENYLBORONIC ACID; 2-FLUORO-3-METHOXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-3-METHOXYPYRIDINE-5-BORONIC ACID; 2-FLUORO-3-METHYLPHENYLBORONIC ACID; 2-FLUORO-3-METHYLPYRIDINE-4-BORONIC ACID; 2-FLUORO-3-METHYLPYRIDINE-5-BORONIC ACID; 2-FLUORO-3-NITROPHENYLBORONIC ACID; 2-FLUORO-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 2-FLUORO-4-(3-(PYRROLIDIN-1-YL)PHENOXY)PHENYLBORONIC ACID; 2-FLUORO-4-(3-FLUOROPHENOXY)PHENYLBORONIC ACID; 2-FLUORO-4-(5-FLUOROPYRIDIN-3-YLOXY)PHENYLBORONIC ACID; 2-FLUORO-4-(6-FLUOROPYRIDIN-3-YLOXY)PHENYLBORONIC ACID; 2-FLUORO-4-(METHOXY-D3)-PHENYLBORONIC ACID; 2-FLUORO-4-(METHYLSULFONYL)PHENYLBORONIC ACID; 2-FLUORO-4-(N-ETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 2-FLUORO-4-(PHENYLAMINO)PHENYLBORONIC ACID; 2-FLUORO-4-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 2-FLUORO-4-(PYRIDIN-3-YLOXY)PHENYLBORONIC ACID; 2-FLUORO-4-(TERT-BUTOXYCARBONYLAMINO)PHENYLBORONIC ACID; 2-FLUORO-4-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PHENYLBORONIC ACID; 2-FLUORO-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-FLUORO-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-FLUORO-4-BIPHENYLYLBORONIC ACID; 2-FLUORO-4-ETHOXYCARBONYLPHENYLBORONIC ACID; 2-FLUORO-4-HYDROXYPHENYLBORONIC ACID; 2-FLUORO-4-ISOPROPOXYPHENYLBORONIC ACID; 2-FLUORO-4-METHOXYCARBONYLPHENYLBORONIC ACID; 2-FLUORO-4-METHOXYPHENYLBORONIC ACID; 2-FLUORO-4-METHYLPHENYLBORONIC ACID; 2-FLUORO-4-METHYLPYRIDINE-3-BORONIC ACID; 2-FLUORO-4-METHYLPYRIDINE-5-BORONIC ACID; 2-FLUORO-4-PHENYLPYRIDIN-3-YLBORONIC ACID; 2-FLUORO-4-PROPOXYPHENYLBORONIC ACID; 2-FLUORO-4-TRIFLUOROMETHOXYPHENYLBORONIC ACID; 2-FLUORO-5-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 2-FLUORO-5-(1-MORPHOLINOETHYL)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-5-(4-(METHYLTHIO)BENZYL)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-5-(HYDRAZINOCARBONYL)BENZENEBORONIC ACID; 2-FLUORO-5-(ISOPROPYLCARBAMOYL)BENZENEBORONIC ACID; 2-FLUORO-5-(METHOXY(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 2-FLUORO-5-(METHOXYCARBAMOYL)BENZENEBORONIC ACID; 2-FLUORO-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-FLUORO-5-(METHOXY-D3)-PHENYLBORONIC ACID; 2-FLUORO-5-(METHYLCARBAMOYL)BENZENEBORONIC ACID; 2-FLUORO-5-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 2-FLUORO-5-(MORPHOLINOMETHYL)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-5-(PHENYLCARBAMOYL)BENZENEBORONIC ACID; 2-FLUORO-5-(PIPERIDIN-1-YLCARBONYL)BENZENEBORONIC ACID; 2-FLUORO-5-(PROPYLCARBAMOYL)BENZENEBORONIC ACID; 2-FLUORO-5-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 2-FLUORO-5-(THIOMORPHOLINOMETHYL)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-FLUORO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-FLUORO-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-FLUORO-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-FLUORO-5-HYDROXYMETHYLPHENYLBORONIC ACID; 2-FLUORO-5-HYDROXYPHENYLBORONIC ACID; 2-FLUORO-5-HYDROXYPYRIDINE-3-BORONIC ACID; 2-FLUORO-5-HYDROXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-5-ISOBUTOXYPHENYLBORONIC ACID; 2-FLUORO-5-ISOPROPOXYPHENYLBORONIC ACID; 2-FLUORO-5-ISOPROPYLPHENYLBORONIC ACID; 2-FLUORO-5-METHOXYPHENYLBORONIC ACID; 2-FLUORO-5-METHOXYPYRIDINE-3-BORONIC ACID; 2-FLUORO-5-METHOXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-5-METHYLPHENYLBORONIC ACID; 2-FLUORO-5-METHYLPYRIDINE-3-BORONIC ACID; 2-FLUORO-5-METHYLPYRIDINE-4-BORONIC ACID; 2-FLUORO-5-NITROPHENYLBORONIC ACID; 2-FLUORO-5-PHENOXYPHENYLBORONIC ACID; 2-FLUORO-5-PROPOXYPHENYLBORONIC ACID; 2-FLUORO-5-VINYLPYRIDIN-3-YLBORONIC ACID; 2-FLUORO-6-(2-METHOXYETHOXY)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-6-(HYDROXYMETHYL)PHENYLBORONIC ACID; 2-FLUORO-6-(METHYLTHIOMETHOXY)PHENYLBORONIC ACID; 2-FLUORO-6-(PROP-1-YNYL)PYRIDIN-3-YLBORONIC ACID; 2-FLUORO-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-FLUORO-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-FLUORO-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-FLUORO-6-HYDROXYPHENYLBORONIC ACID; 2-FLUORO-6-HYDROXYPYRIDINE-3-BORONIC ACID; 2-FLUORO-6-HYDROXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-6-ISOPROPOXYPHENYLBORONIC ACID; 2-FLUORO-6-METHOXY-3-METHYLPHENYLBORONIC ACID; 2-FLUORO-6-METHOXYPHENYLBORONIC ACID; 2-FLUORO-6-METHOXYPYRIDINE-3-BORONIC ACID; 2-FLUORO-6-METHOXYPYRIDINE-4-BORONIC ACID; 2-FLUORO-6-METHYLPHENYLBORONIC ACID; 2-FLUORO-6-METHYLPYRIDINE-3-BORONIC ACID; 2-FLUORO-6-METHYLPYRIDINE-4-BORONIC ACID; 2-FLUORO-6-MORPHOLINOPYRIDIN-3-YLBORONIC ACID; 2-FLUORO-6-PHENOXYPHENYLBORONIC ACID; 2-FLUORO-6-PHENYLPYRIDINE-3-BORONIC ACID; 2-FLUORO-6-PICOLINE-5-BORONIC ACID; 2-FLUORO-6-PROPOXYPHENYLBORONIC ACID; 2-FLUOROBENZO[B]THIOPHEN-3-YLBORONIC ACID; 2-FLUORONAPHTHALENE-1-BORONIC ACID; 2-FLUORONAPHTHALENE-3-BORONIC ACID; 2-FLUORONAPHTHALENE-4-BORONIC ACID; 2-FLUORONAPHTHALENE-5-BORONIC ACID; 2-FLUORONAPHTHALENE-6-BORONIC ACID; 2-FLUORONAPHTHALENE-7-BORONIC ACID; 2-FLUORONAPHTHALENE-8-BORONIC ACID; 2-FLUOROPHENYLBORONIC ACID; 2-FLUOROPYRIDINE-3-BORONIC ACID; 2-FLUOROPYRIDINE-3-BORONIC ACID HYDRATE; 2-FLUOROPYRIDINE-3-BORONIC ACID TRIHYDRATE; 2-FLUOROPYRIDINE-4-BORONIC ACID; 2-FLUOROPYRIDINE-5-BORONIC ACID; 2-FLUOROPYRIMIDIN-5-YLBORONIC ACID; 2-FLUOROQUINOLINE-3-BORONIC ACID; 2-HEPTYLCYCLOPROPYLBORONIC ACID; 2-HEXYL-CYCLOPROPYL-1-BORONIC ACID; 2-HEXYLTHIOPHENE-3-BORONIC ACID; 2H-ISOQUINOLIN-1-ONE-6-BORONIC ACID; 2H-ISOQUINOLIN-1-ONE-7-BORONIC ACID; 2H-PYRANO[3,2-B]PYRIDIN-7-YLBORONIC ACID; 2-HYDROXY-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-HYDROXY-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-HYDROXY-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-HYDROXY-3-METHYLPHENYLBORONIC ACID; 2-HYDROXY-3-METHYLPYRIDINE-4-BORONIC ACID; 2-HYDROXY-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-HYDROXY-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-HYDROXY-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-HYDROXY-4-METHOXYPHENYLBORONIC ACID; 2-HYDROXY-4-METHYLPHENYLBORONIC ACID; 2-HYDROXY-4-METHYLPYRIDINE-3-BORONIC ACID; 2-HYDROXY-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-HYDROXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-HYDROXY-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-HYDROXY-5-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-HYDROXY-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-HYDROXY-5-METHOXYPHENYLBORONIC ACID; 2-HYDROXY-5-METHYLPHENYLBORONIC ACID; 2-HYDROXY-5-METHYLPYRIDINE-3-BORONIC ACID; 2-HYDROXY-5-METHYLPYRIDINE-4-BORONIC ACID; 2-HYDROXY-6-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-HYDROXY-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-HYDROXY-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-HYDROXY-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-HYDROXY-6-METHOXYPHENYLBORONIC ACID; 2-HYDROXY-6-METHYLPHENYLBORONIC ACID; 2-HYDROXY-6-METHYLPYRIDINE-3-BORONIC ACID; 2-HYDROXY-6-METHYLPYRIDINE-4-BORONIC ACID; 2-HYDROXYL-1-NAPHTHALENEBORONIC ACID; 2-HYDROXYMETHYL-4-METHOXYPHENYLBORONIC ACID; 2-HYDROXYPHENYLBORONIC ACID; 2-HYDROXYPYRAZINE-6-BORONIC ACID; 2-HYDROXYPYRIDIN-3-YLBORONIC ACID; 2-HYDROXYPYRIMIDINE-5-BORONIC ACID; 2-HYDROXYQUINOLIN-3-YLBORONIC ACID; 2-HYDROXYQUINOLINE-4-BORONIC ACID; 2-HYDROXYQUINOLINE-5-BORONIC ACID; 2-HYDROXYQUINOLINE-6-BORONIC ACID; 2-HYDROXYQUINOLINE-7-BORONIC ACID; 2-HYDROXYQUINOLINE-8-BORONIC ACID; 2-ISOBUTOXY-5-METHYLPHENYLBORONIC ACID; 2-ISOBUTOXY-6-METHOXYPHENYLBORONIC ACID; 2-ISOBUTOXYPHENYLBORONIC ACID; 2-ISOPROPOXY-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-ISOPROPOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-ISOPROPOXY-5-METHYLPHENYLBORONIC ACID; 2-ISOPROPOXY-6-METHOXYPHENYLBORONIC ACID; 2-ISOPROPOXYPHENYLBORONIC ACID; 2-ISOPROPOXYPYRIDINE-3-BORONIC ACID; 2-ISOPROPOXYPYRIMIDIN-5-YLBORONIC ACID; 2-ISOPROPYL-1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 2-ISOPROPYL-6-METHOXYPYRIDIN-3-YLBORONIC ACID; 2-ISOPROPYL-7-METHOXYPYRAZOLO[1,5-A]PYRIDIN-3-YLBORONIC ACID; 2-ISOPROPYLPHENYLBORONIC ACID; 2-ISOPROPYLTHIO-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-ISOPROXYPYRIDINE-5-BORONIC ACID; 2-METHOXY-1-NAPHTHALENEBORONIC ACID; 2-METHOXY-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHOXY-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHOXY-3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-METHOXY-3-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 2-METHOXY-3-METHYLPHENYL BORONIC ACID; 2-METHOXY-3-METHYLPYRIDINE-4-BORONIC ACID; 2-METHOXY-4-(METHOXYCARBONYL)PHENYLBORONIC ACID; 2-METHOXY-4-(TRIFLUOROMETHOXY)-PHENYLBORONIC ACID; 2-METHOXY-4-(TRIFLUOROMETHYL)-PHENYLBORONIC ACID; 2-METHOXY-4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-METHOXY-4-METHYLPHENYLBORONIC ACID; 2-METHOXY-4-METHYLPYRIDINE-3-BORONIC ACID; 2-METHOXY-4-METHYL-PYRIDINE-5-BORONIC ACID; 2-METHOXY-4-PHENYLPYRIDINE-3-BORONIC ACID; 2-METHOXY-5-(PYRIDINE-4-YL)PHENYLBORONIC ACID; 2-METHOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHOXY-5-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-METHOXY-5-METHYLPHENYLBORONIC ACID; 2-METHOXY-5-METHYLPYRIDINE-3-BORONIC ACID; 2-METHOXY-5-METHYLPYRIDINE-4-BORONIC ACID; 2-METHOXY-5-METHYLTHIOPHEN-3-YLBORONIC ACID; 2-METHOXY-5-PHENYLPYRIDIN-3-YLBORONIC ACID; 2-METHOXY-5-PROPYLPHENYLBORONIC ACID; 2-METHOXY-5-PYRIDINEBORONIC ACID; 2-METHOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 2-METHOXY-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-METHOXY-6-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHOXY-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHOXY-6-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 2-METHOXY-6-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 2-METHOXY-6-CARBOXYPYRIDINE-4-BORONIC ACID; 2-METHOXY-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-METHOXY-6-ISOPROPYLPYRIDINE-3-BORONIC ACID; 2-METHOXY-6-METHYLPYRIDIN-3-YLBORONIC ACID; 2-METHOXY-6-METHYLPYRIDINE-4-BORONIC ACID; 2-METHOXY-6-METHYLTHIOPHENYLBORONIC ACID; 2-METHOXY-6-PHENYLPYRIDINE-3-BORONIC ACID; 2-METHOXYCARBONYL-1,3-BENZOXAZOLE-5-BORONIC ACID; 2-METHOXYCARBONYL-1,3-BENZOXAZOLE-6-BORONIC ACID; 2-METHOXYCARBONYL-3,5-DIFLUOROPHENYLBORONIC ACID; 2-METHOXYCARBONYL-3-FLUOROPHENYLBORONIC ACID; 2-METHOXYCARBONYL-3-METHOXYPHENYLBORONIC ACID; 2-METHOXYCARBONYL-3-METHYLPHENYLBORONIC ACID; 2-METHOXYCARBONYL-4-METHOXYPHENYLBORONIC ACID; 2-METHOXYCARBONYL-4-METHYLPHENYLBORONIC ACID; 2-METHOXYCARBONYLINDOLE-5-BORONIC ACID; 2-METHOXYCARBONYLPHENYLBORONIC ACID; 2-METHOXYMETHOXY-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHOXYMETHYLPHENYLBORONIC ACID; 2-METHOXYNAPHTHALENE-4-BORONIC ACID; 2-METHOXYNAPHTHALENE-5-BORONIC ACID; 2-METHOXYNAPHTHALENE-7-BORONIC ACID; 2-METHOXYNAPHTHALENE-8-BORONIC ACID; 2-METHOXYPHENYLBORONIC ACID; 2-METHOXYPYRAZINE-6-BORONIC ACID; 2-METHOXYPYRIDINE-3-BORONIC ACID; 2-METHOXYPYRIDINE-3-BORONIC ACID HYDRATE; 2-METHOXYPYRIDINE-3-BORONIC ACID-HCL; 2-METHOXYPYRIDINE-4-BORONIC ACID; 2-METHOXYPYRIDINE-6-BORONIC ACID, HYDROCHLORIDE SALT; 2-METHOXYPYRIMIDINE-4-BORONIC ACID; 2-METHOXYPYRIMIDINE-5-BORONIC ACID; 2-METHOXYQUINOLIN-6-YLBORONIC ACID; 2-METHOXYQUINOLINE-3-BORONIC ACID; 2-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-6-BORONIC ACID; 2-METHYL-1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 2-METHYL-1,3-BENZOXAZOLE-5-BORONIC ACID; 2-METHYL-1-[(4-METHYLPHENYL)SULFONYL]-1H-INDOLE-3-BORONIC ACID; 2-METHYL-1H-BENZIMIDAZOLE-5-BORONIC ACID, HYDROCHLORIDE SALT; 2-METHYL-1-OXO-1,2-DIHYDROISOQUINOLIN-6-YLBORONIC ACID; 2-METHYL-2-(4-BORONOPHENYL)PROPYLAMINE, HCL; 2-METHYL-2H-INDAZOLE-6-BORONIC ACID; 2-METHYL-2H-INDAZOLE-7-BORONIC ACID; 2-METHYL-3-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(2,4,5-TRICHLOROPHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(PERFLUOROPHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHYL-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHYL-3-NITROPHENYLBORONIC ACID; 2-METHYL-4-(METHOXYMETHOXY)PHENYLBORONIC ACID; 2-METHYL-4-(MORPHOLINOSULFONYL)PHENYLBORONIC ACID; 2-METHYL-4-(N-METHYLSULFAMOYL)PHENYLBORONIC ACID; 2-METHYL-4-(N-PROPYLSULFAMOYL)PHENYLBORONIC ACID; 2-METHYL-4-(PIPERIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-4-(PYRROLIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-4-(TRIFLUOROMETHOXY)BENZENEBORONIC ACID; 2-METHYL-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHYL-4-CYANOPHENYLBORONIC ACID; 2-METHYL-4-FLUORO-PYRAZOLE-3-BORONIC ACID; 2-METHYL-4-NITROPHENYLBORONIC ACID; 2-METHYL-5-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 2-METHYL-5-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 2-METHYL-5-(5-METHYL-4H-1,2,4-TRIAZOL-3-YL)PHENYLBORONIC ACID; 2-METHYL-5-(N-MORPHOLINYLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-5-(OXAZOL-2-YL)PHENYLBORONIC ACID; 2-METHYL-5-(PIPERIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-5-(PYRROLIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-5-(THIAZOL-2-YL)PHENYLBORONIC ACID; 2-METHYL-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHYL-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHYL-5-(TRIFLUOROMETHYLSULFONYL)PHENYLBORONIC ACID; 2-METHYL-5-AMINOPYRIDINE-4-BORONIC ACID; 2-METHYL-5-CHLOROPYRIDINE-4-BORONIC ACID; 2-METHYL-5-HYDROXYCABONYL-3-BORONIC ACID; 2-METHYL-5-METHOXYPYRIDINE-4-BORONIC ACID; 2-METHYL-6-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(2,4,5-TRICHLOROPHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(2,4,5-TRICHLOROPHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(PERFLUOROPHENYL)PYRIDINE-3-BORONIC ACID; 2-METHYL-6-(PERFLUOROPHENYL)PYRIDINE-4-BORONIC ACID; 2-METHYL-6-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 2-METHYL-6-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 2-METHYL-6-METHOXYPYRIDINE-3-BORONIC ACID; 2-METHYLBENZO[B]THIOPHEN-3-YLBORONIC ACID; 2-METHYLBENZOTHIAZOLE-4-BORONIC ACID; 2-METHYLBENZOTHIAZOLE-5-BORONIC ACID; 2-METHYLBENZOTHIAZOLE-6-BORONIC ACID; 2-METHYLBENZOTHIAZOLE-7-BORONIC ACID; 2′-METHYLBIPHENYL-2-YLBORONIC ACID; 2-METHYLFURAN-3-BORONIC ACID; 2-METHYLINDAZOLE-4-BORONIC ACID; 2-METHYLINDAZOLE-5-BORONIC ACID; 2-METHYLNAPHTHALENE-1-BORONIC ACID; 2-METHYLNAPHTHALENE-3-BORONIC ACID; 2-METHYLNAPHTHALENE-4-BORONIC ACID; 2-METHYLNAPHTHALENE-5-BORONIC ACID; 2-METHYLNAPHTHALENE-7-BORONIC ACID; 2-METHYLPHENYLBORONIC ACID; 2-METHYLPYRIDINE-3-BORONIC ACID; 2-METHYLPYRIDINE-4-BORONIC ACID; 2-METHYLPYRIMIDIN-4-YLBORONIC ACID; 2-METHYLQUINOLIN-4-YLBORONIC ACID; 2-METHYLQUINOLINE-6-BORONIC ACID; 2-METHYLQUINOLINE-7-BORONIC ACID; 2-METHYLTHIAZOL-5-YLBORONIC ACID; 2-METHYLTHIAZOLE-4-BORONIC ACID; 2-METHYLTHIO-5-TRIFLUOROMETHOXYPHENYLBORONIC ACID; 2-METHYLTHIO-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-METHYLTHIO-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-METHYLTHIOPHENE-3-BORONIC ACID; 2-METHYLTHIOPYRIDINE-5-BORONIC ACID; 2-MORPHOLINO-6-CHLOROPYRIMIDINE-4-BORONIC ACID; 2-MORPHOLINOPYRIDINE-3-BORONIC ACID; 2-MORPHOLINOPYRIDINE-3-BORONIC ACID-HCL; 2-MORPHOLINOPYRIMIDIN-5-YLBORONIC ACID; 2-MORPHOLINOPYRIMIDINE-4-BORONIC ACID; 2-N,N-DIETHYLSULFAMOYLPHENYLBORONIC ACID; 2-NAPHTHALENEBORONIC ACID; 2-NITRO-5-AMINOPHENYLBORIC ACID; 2-NITRO-5-CARBOXYPHENYLBORONIC ACID; 2-NITROPHENYLBORONIC ACID; 2-NORBORNEN-2-YLBORONIC ACID; 2-OXO-1,2-DIHYDROPYRIDIN-3-YLBORONIC ACID; 2-OXO-1,2-DIHYDROQUINOLIN-3-YLBORONIC ACID; 2-OXO-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOL-5-YLBORONIC ACID; 2-OXO-2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDIN-5-YLBORONIC ACID; 2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-6-YL-BORONIC ACID; 2-PHENOXYPHENYLBORONIC ACID; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-BORONIC ACID; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-BORONIC ACID; 2-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-BORONIC ACID; 2-PHENYLCYCLOPROPYLBORONIC ACID; 2-PHENYLFURAN-3-YLBORONIC ACID; 2-PHENYLIMIDAZO[1,2-A]PYRIDIN-6-YLBORONIC ACID; 2-PHENYLOXAZOL-5-YLBORONIC ACID; 2-PHENYLPYRIDIN-4-YLBORONIC ACID; 2-PHENYLPYRIDINE-3-BORONIC ACID; 2-PHENYLPYRIMIDINE-4-BORONIC ACID; 2-PHENYLPYRIMIDINE-5-BORONIC ACID; 2-PHENYLTHIAZOL-5-YLBORONIC ACID; 2-PHENYLTHIOPHEN-3-YLBORONIC ACID; 2-PICOLINE-3-BORONIC ACID HCL; 2-PICOLINE-4-BORONIC ACID HCL; 2-PICOLINE-5-BORONIC ACID HYDRATE; 2-PROPEN-1-YL-BORONIC ACID; 2-PROPOXYPHENYLBORONIC ACID; 2-PROPOXYPYRIDINE-3-BORONIC ACID; 2-PROPYLBENZO[D]OXAZOL-6-YLBORONIC ACID; 2-PROPYLTHIO-5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 2-P-TERPHENYLBORONIC ACID; 2-P-TOLYLPYRIDIN-4-YLBORONIC ACID; 2-PYRAZOL-1-YL-PHENYL-BORONIC ACID; 2-PYRIDINEBORONIC ACID; 2-PYRROLIDIN-1-YLPYRIDINE-3-BORONIC ACID HYDROCHLORIDE; 2-PYRROLYLBORONIC ACID; 2-QUINOXALINYLBORONIC ACID; 2-SEC-BUTOXY-5-CHLOROPYRIDIN-3-YLBORONIC ACID; 2-TERT-BUTOXY-PYRIMIDINE-5-BORONIC ACID; 2-TERT-BUTYL-1H-PYRROLO[2,3-B]PYRIDIN-4-YLBORONIC ACID; 2-TRIFLUOROACETYLAMINOPHENYLBORONIC ACID; 2-TRIFLUOROMETHYL-5-PYRIDINEBORIC ACID; 2-TRIFLUOROMETHYL-6-CHLORO-5-PYRIDINEBORIC ACID; 2-TRIPHENYLENYLBORONIC ACID; 2-VINYLPHENYLBORONIC ACID; 3-((1-(TERT-BUTOXYCARBONYL)AZEPAN-3-YL)METHYL)PHENYLBORONIC ACID; 3-((1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 34(1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 3-((2-(MESITYLSULFONYL)HYDRAZONO)METHYL)PHENYLBORONIC ACID; 3-((2′-CHLORO-5′-(TRIFLUOROMETHYL)PHENOXY)METHYL)PHENYLBORONIC ACID; 3-((4′-(2-METHOXYETHYL)PHENOXY)METHYL)PHENYLBORONIC ACID; 3-((4′-(TRIFLUOROMETHOXY)PHENOXY)METHYL)PHENYLBORONIC ACID; 3-((BUTOXYCARBONYLAMINO)METHYL)PHENYLBORONIC ACID; 3-((DIETHYLCARBAMOYL)OXY)PYRIDINE-4-BORONIC ACID; 3-((DIMETHYLAMINO)METHYL)PHENYLBORONIC ACID; 3-((PHENYLAMINO)METHYL)PHENYLBORONIC ACID; 34(TETRAHYDROFURAN-2-YL)METHYLCARBAMOYL)PHENYLBORONIC ACID; 3-([2-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-3,4-DIHYDROPYRIMIDIN-4-ONE; 3-([3-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-3,4-DIHYDROPYRIMIDIN-4-ONE; 3-([4-(DIHYDROXYBORANYL)PHENYL]METHYL)-6-METHYL-3,4-DIHYDROPYRIMIDIN-4-ONE; 3-(1-(PYRROLIDIN-1-YL)ETHYL)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)-4-CYANOPIPERIDIN-4-YL)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YL)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YLOXY)PHENYLBORONIC ACID; 3-(1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)PHENYLBORONIC ACID; 3-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YLOXY)-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(1,2,4-OXADIAZOL-3-YL)-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-(1,3-DIOXOLAN-2-YL)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(1-ADAMANTYL)-4-METHOXYPHENYLBORONIC ACID; 3-(1H-1,2,3-TRIAZOL-4-YL)PHENYLBORONIC ACID; 3-(1H-1,2,4-TRIAZOL-3-YL-CARBAMOYL)PHENYLBORONIC ACID; 3-(1H-IMIDAZOL-2-YL)PHENYLBORONIC ACID; 3-(1H-PYRAZOL-4-YL)PHENYLBORONIC ACID; 3-(1H-PYRAZOL-5-YL)PHENYLBORONIC ACID; 3-(1H-PYRROL-1-YL)PHENYLBORONIC ACID; 3-(1H-PYRROLE-1-CARBONYL)PHENYLBORONIC ACID; 3-(1H-TETRAZOL-5-YLCARBAMOYL)BENZENEBORONIC ACID HYDROCHLORIDE; 3-(1-HYDROXYETHYL)PHENYLBORONIC ACID; 3-(1-ISOPROPYLPIPERIDIN-4-YLCARBAMOYL)PHENYLBORONIC ACID; 3-(1-METHYLETHYLSULFONAMIDO)PHENYLBORONIC ACID; 3-(1-PROPYLTHIO)-BENZENEBORONIC ACID; 3-(1-PYRROLIDINO)PHENYLBORONIC ACID HCL; 3-(2-(DIMETHYLAMINO)ETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-(2-(PIPERIDIN-1-YL)ETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-(2-(PIPERIDIN-1-YL)ETHYLCARBAMOYL)PHENYLBORONIC ACID HYDROCHLORIDE; 3-(2-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(2,2,2-TRICHLOROACETAMIDO)BENZENEBORONIC ACID; 3-(2,2,2-TRIFLUOROACETAMIDO)BENZENEBORONIC ACID; 3-(2,2,2-TRIFLUORO-ETHOXY)-4,5-DIFLUORO-BENZENEBORONIC ACID; 3-(2,2,2-TRIFLUOROETHOXY)PHENYLBORONIC ACID; 3-(2,2,2-TRIFLUOROETHYLTHIO)-BENZENEBORONIC ACID; 3-(2,2-DICYANOVINYL)PHENYLBORONIC ACID; 3-(2,2-DIFLUORO-ETHOXY)-4,5-DIFLUORO-BENZENEBORONIC ACID; 3-(2,2-DIFLUOROETHOXY)PHENYLBORONIC ACID; 3-(2,2-DIFLUOROETHYLTHIO)-BENZENEBORONIC ACID; 3-(2,2-DIMETHOXYETHOXY)PHENYLBORONIC ACID; 3-(2,3-DIFLUOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(2,3-DIFLUOROPHENYL)-2-METHYLPYRIDINE-4-BORONIC ACID; 3-(2,4,5-TRICHLOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(2,4-DICHLOROPHENYLMETHOXY)PHENYLBORONIC ACID; 3-(2,5-DIOXOIMIDAZOLIDIN-4-YL)PHENYLBORONIC ACID; 3-(2,6-DICHLOROPHENYLMETHOXY)PHENYLBORONIC ACID; 3-(2-AMINOETHYL)PHENYLBORONIC ACID HYDROCHLORIDE; 3-(2-CARBOXYVINYL)BENZENEBORONIC ACID; 3-(2′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 3-(2-CHLOROETHYLCARBAMOYL)BENZENEBORONIC ACID; 3-(2-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 3-(2-CYANOETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(2-ETHOXY-2-OXOETHOXY)PHENYLBORONIC ACID; 3-(2-ETHOXYCARBONYLETHYL)PHENYLBORONIC ACID; 3-(2′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 3-(2H-TETRAZOL-5-YL)-PHENYL-BORONIC ACID; 3-(2-HYDROXYETHYL)PHENYLBORONIC ACID; 3-(2-HYDROXYETHYLAMINO)PYRIDIN-2-YLBORONIC ACID; 3-(2-HYDROXYETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-(2-HYDROXYPROPAN-2-YL)PYRIDINE-2-BORONIC ACID; 3-(2-METHOXY-2-OXOETHOXY)PHENYLBORONIC ACID; 3-(2-METHOXY-2-OXOETHYL)PHENYLBORONIC ACID; 3-(2′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 3-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 3-(2-METHOXYETHOXY)THIOPHEN-2-YLBORONIC ACID; 3-(2-METHOXYETHYLAMINOCARBONYL)BENZENEBORONIC ACID; 3-(2-MORPHOLINOETHOXY)PHENYLBORONIC ACID; 3-(2-N,N-DIETHYLAMINOETHYLAMINOCARBONYL)PHENYLBORONIC ACID, HCL; 3-(2-NITRO-4-TRIFLUOROMETHYLPHENOXY)PHENYLBORONIC ACID; 3-(2-NITROETHYL)PHENYLBORONIC ACID; 3-(2-NITROPHENOXY)PHENYLBORONIC ACID; 3-(2-THIAZOLYL)AMINOCARBONYLPHENYLBORONIC ACID; 3-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(3-(METHOXYCARBONYL)PYRROLIDIN-1-YL)PHENYLBORONIC ACID; 3-(3-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(3′-(TRIFLUOROMETHYL)PHENOXYMETHYL)PHENYLBORONIC ACID; 3-(3,3-DIETHOXYPROPOXY)PHENYLBORONIC ACID; 3-(3,5-DICHLOROPHENYLCARBAMOYL)-4-FLUOROPHENYLBORONIC ACID; 3-(3′,5′-DIMETHOXYBENZYLOXY)PHENYLBORONIC ACID; 3-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PHENYLBORONIC ACID; 3-(3,5-DIMETHYLISOXAZOL-4-YL)PHENYLBORONIC ACID; 3-(3,7-DIMETHYLOCTYLOXY)BENZENEBORONIC ACID; 3-(3-BORONOPHENYL)ACRYLONITRILE; 3-(3-CARBOXYPROPIONYLAMINO)PHENYLBORONIC ACID; 3-(3-CHLORO-4-FLUOROPHENYLCARBAMOYL)-4-FLUOROPHENYLBORONIC ACID; 3-(3′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 3-(3-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 3-(3-CHLOROPROPYLCARBAMOYL)BENZENEBORONIC ACID; 3-(3-CHLOROPROPYLSULPHONAMIDO)BENZENEBORONIC ACID; 3-(3-ETHOXY-3-OXOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-(3-ETHYLTHIOUREIDO)PHENYLBORONIC ACID; 3-(3′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 3-(3-FLUOROPHENYLCARBAMOYL)PHENYLBORONIC ACID; 3-(3-FLUOROPROPYLOXY)-BENZENEBORONIC ACID; 3-(3-ISOPROPYLTHIOUREIDO)PHENYLBORONIC ACID; 3-(3′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 3-(3-METHOXYPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-(3-METHYLTHIOUREIDO)PHENYLBORONIC ACID; 3-(4-(TERT-BUTOXYCARBONYL)PIPERAZINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(4-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(4-ACETAMIDOPHENYLAMINO)PHENYLBORONIC ACID; 3-(4-ACETYLPIPERAZIN-1-YL)PHENYLBORONIC ACID; 3-(4-AMINOBENZYL)PHENYLBORONIC ACID; 3-(4-AMINOPHENYLAMINO)PHENYLBORONIC ACID; 3-(4-BORONOPHENOXYMETHYL)BENZONITRILE; 3-(4-BORONOPHENYL)CYCLOBUTANONE ETHYLENE KETAL; 3-(4-CARBOETHOXYBUTYL)PHENYLBORONIC ACID; 3-(4-CARBOXYBUTOXY)-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-(4′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 3-(4-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 3-(4-CYANOPHENYL)AMINOCARBONYLPHENYLBORONIC ACID; 3-(4-CYANOPHENYLMETHOXY)PHENYLBORONIC ACID; 3-(4-CYCLOPROPYLPIPERAZIN-1-YL)PHENYLBORONIC ACID; 3-(4-ETHOXYCARBONYLBUTYLOXY)-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-(4-FLUORO-2-NITROPHENOXY)PHENYLBORONIC ACID; 3-(4′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YLBORONIC ACID; 3-(4-FLUOROPHENYL)AMINOCARBONYLPHENYLBORONIC ACID; 3-(4′-HEPTYLOXYPHENOXYMETHYL)PHENYLBORONIC ACID; 3-(4-METHOXY)BENZYLOXY-5-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 3-(4′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 3-(4-METHYLPIPERAZIN-1-YL)PHENYLBORONIC ACID; 3-(4-METHYLPIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(4-NITROPHENOXY)PHENYLBORONIC ACID; 3-(5-(TRIFLUOROMETHYL)PYRIDIN-2-YLOXY)PHENYLBORONIC ACID; 3-(5-METHYL-1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-(9H-CARBAZOL-9-YL)PHENYLBORONIC ACID; 3-(ACETOXYMETHYL)PHENYLBORONIC ACID; 3-(ALLYLOXY)-4,5-DIFLUOROPHENYLBORONIC ACID; 3-(ALLYLOXYMETHYL)-4-METHOXYPHENYLBORONIC ACID; 3-(ALLYLOXYMETHYL)PHENYLBORONIC ACID; 3-(ALLYLTHIO)-BENZENEBORONIC ACID; 3-(AMINOCARBONYL)-4-FLUOROBENZENEBORONIC ACID; 3-(AMINOCARBONYL)-5-FLUOROBENZENEBORONIC ACID; 3-(AMINOMETHYL)-2-FLUOROPHENYLBORONIC ACID, HCL; 3′-(AMINOMETHYL)BIPHENYL-3-YLBORONIC ACID; 3-(AZETIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(AZIRIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(BENZYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 3-(BENZYLAMINO)-5-CHLOROPHENYLBORONIC ACID; 3-(BENZYLAMINO)-5-NITROBENZENEBORONIC ACID HYDROCHLORIDE; 3-(BENZYLCARBAMOYL)-4-FLUOROPHENYLBORONIC ACID; 3-(BENZYLCARBAMOYL)-5-FLUOROBENZENEBORONIC ACID; 3-(BENZYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(BENZYLOXY)-2,4-DICHLOROPHENYLBORONIC ACID; 3-(BENZYLOXY)-2,6-DIFLUOROPHENYLBORONIC ACID; 3-(BENZYLOXY)-4-FLUOROPHENYLBORONIC ACID; 3-(BENZYLOXY)-4-METHOXYPHENYLBORONIC ACID; 3-(BENZYLOXY)-4-METHYLPHENYLBORONIC ACID; 3-(BENZYLOXY)-5-CHLOROPHENYLBORONIC ACID; 3-(BENZYLOXY)-5-METHYLPHENYLBORONIC ACID; 3-(BENZYLOXYCARBONYLAMINO)-5-NITROPHENYLBORONIC ACID; 3-(BIS(2-HYDROXYETHYL)AMINO)PYRIDIN-2-YLBORONIC ACID; 3-(BOC-AMINOMETHYL)-PYRIDINE-4-BORONIC ACID; 3-(BUT-3-ENYLOXY)-4-METHOXYPHENYLBORONIC ACID; 3-(BUT-3-ENYLOXY)PHENYLBORONIC ACID; 3-(BUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(BUTYLSULFONAMIDO)PHENYLBORONIC ACID; 3-(CARBOXYMETHOXY)-5-FLUOROBENZENEBORONIC ACID; 3-(CBZ-AMINO)-5-FLUOROPHENYLBORONIC ACID; 3-(CHLOROMETHYL)BENZENEBORONIC ACID; 3-(CYCLOBUTYL)FURAN-2-BORONIC ACID; 3-(CYCLOBUTYL)THIOPHENE-2-BORONIC ACID; 3-(CYCLOBUTYLTHIO)PHENYLBORONIC ACID; 3-(CYCLOHEXYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 3-(CYCLOHEXYL)FURAN-2-BORONIC ACID; 3-(CYCLOHEXYL)THIOPHENE-2-BORONIC ACID; 3-(CYCLOHEXYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(CYCLOHEXYLCARBAMOYL)-4-FLUOROBENZENEBORONIC ACID; 3-(CYCLOHEXYLCARBAMOYL)-5-FLUOROBENZENEBORONIC ACID; 3-(CYCLOHEXYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(CYCLOHEXYLMETHOXY)PHENYLBORONIC ACID; 3-(CYCLOHEXYLOXY)METHYLPHENYLBORONIC ACID; 3-(CYCLOHEXYLOXY)PHENYLBORONIC ACID; 3-(CYCLOHEXYLSULFONYL)PHENYLBORONIC ACID; 3-(CYCLOPENTYL)FURAN-2-BORONIC ACID; 3-(CYCLOPENTYL)THIOPHENE-2-BORONIC ACID; 3-(CYCLOPENTYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(CYCLOPENTYLOXY)-4-METHOXYBENZENEBORONIC ACID; 3-(CYCLOPENTYLOXY)-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-(CYCLOPENTYLOXY)-5-METHYLPHENYLBORONIC ACID; 3-(CYCLOPROPANESULFONAMIDO)PHENYLBORONIC ACID; 3-(CYCLOPROPYL)FURAN-2-BORONIC ACID; 3-(CYCLOPROPYL)THIOPHENE-2-BORONIC ACID; 3-(CYCLOPROPYLAMINO)BENZO[D]ISOXAZOL-5-YLBORONIC ACID; 3-(CYCLOPROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(CYCLOPROPYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(CYCLOPROPYLMETHOXY)-5-METHYLPHENYLBORONIC ACID; 3-(CYCLOPROPYLMETHOXY)PHENYLBORONIC ACID; 3-(CYCLOPROPYLMETHYL)THIOPHENYLBORONIC ACID; 3-(CYCLOPROPYLSULFONYL)PHENYLBORONIC ACID; 3-(DANSYLAMINO)PHENYLBORONIC ACID; 3-(DIETHYLCARBAMOYL)-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 3-(DIETHYLCARBAMOYL)-2-FLUOROPHENYLBORONIC ACID; 3-(DIETHYLCARBAMOYL)-4-FLUOROBENZENEBORONIC ACID; 3-(DIETHYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(DIETHYLCARBAMOYL)FURAN-2-YLBORONIC ACID; 3-(DIETHYLCARBAMOYL)THIOPHEN-2-YLBORONIC ACID; 3-(DIFLUOROMETHOXY)-2-FLUOROPHENYLBORONIC ACID; 3-(DIFLUOROMETHOXY)-5-FLUOROPHENYLBORONIC ACID; 3-(DIFLUOROMETHOXY)-BENZENEBORONIC ACID; 3-(DIFLUOROMETHOXY)PYRAZINE-2-BORONIC ACID; 3-(DIFLUOROMETHYL)-4-FLUOROPHENYLBORONIC ACID; 3-(DIHYDROXYBORYL)-4-METHOXYPYRIDINIUM; 3-(DIISOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-(DIMETHOXYMETHYL)-4-NITROPHENYLBORONIC ACID; 3-(DIMETHYLCARBAMOYL)-4-FLUOROBENZENEBORONIC ACID; 3-(DIMETHYLCARBAMOYL)-5-NITROBENZENEBORONIC ACID; 3-(DIMETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-(DIPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-(ETHOXYCARBONYL)-5-METHOXYBENZOFURAN-2-YLBORONIC ACID; 3-(ETHOXYCARBONYL)THIOPHEN-2-YLBORONIC ACID; 3-(ETHOXY-D5)-PHENYLBORONIC ACID; 3-(ETHYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 3-(ETHYLCARBAMOYL)-4-FLUOROBENZENEBORONIC ACID; 3-(ETHYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(ETHYL-D5)-PHENYLBORONIC ACID; 3-(ETHYLSULFONAMIDO)PHENYLBORONIC ACID; 3-(FURFURYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(HYDROXYIMINO)METHYLPHENYLBORONIC ACID; 3-(HYDROXYMETHYL)-5-METHYLPHENYLBORONIC ACID; 3-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 3-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 3-(HYDROXYMETHYL)PHENYLBORONIC ACID; 3-(ISOBUTYRAMIDO)BENZENEBORONIC ACID; 3-(ISOPROPOXYCARBONYL)PHENYLBORONIC ACID; 3-(ISO-PROPOXY-D7)-PHENYLBORONIC ACID; 3-(ISO-PROPYL)FURAN-2-BORONIC ACID; 3-(ISO-PROPYL)THIOPHENE-2-BORONIC ACID; 3-(ISO-PROPYL-D7)-PHENYLBORONIC ACID; 3-(METHOXYCARBAMOYL)PHENYLBORONIC ACID; 3-(METHOXYCARBONYL)FURAN-2-BORONIC ACID; 3-(METHOXYCARBONYL)PYRIDINE-2-BORONIC ACID; 3-(METHOXY-D3)-PHENYLBORONIC ACID; 3-(METHOXYMETHOXY)PHENYLBORONIC ACID; 3-(METHYLAMINO)BENZO[D] ISOXAZOL-5-YLBORONIC ACID; 3-(METHYLAMINO)PYRIDIN-2-YLBORONIC ACID; 3-(METHYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(METHYL-D3)-5-FLUOROPHENYLBORONIC ACID; 3-(METHYL-D3)-PHENYLBORONIC ACID; 3′-(METHYLSULFONYL)BIPHENYL-3-YLBORONIC ACID; 3-(METHYLSULFONYL)PHENYLBORONIC ACID; 3-(METHYLSULFONYLAMINO)PHENYLBORONIC ACID; 3-(METHYLTHIO)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(METHYLTHIO)PHENYLBORONIC ACID; 3-(METHYLTHIO)THIOPHEN-2-YLBORONIC ACID; 3-(METHYLTHIOL-D3)-PHENYLBORONIC ACID; 3-(MORPHOLIN-4-YLSULPHONYL)BENZENEBORONIC ACID; 3-(MORPHOLINE-4-CARBONYL)-5-NITROPHENYLBORONIC ACID; 3-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 3-(MORPHOLINO)PHENYLBORONIC ACID; 3-(MORPHOLINOMETHYL)PHENYLBORONIC ACID; 3-(N,N-DIETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(N,N-DIETHYLSULPHAMOYL)BENZENEBORONIC ACID; 3-(N,N-DIMETHYLAMINO)PHENYLBORONIC ACID; 3-(N,N-DIMETHYLSULFAMOYLAMINO)PHENYLBORONIC ACID; 3-(N,N-DIMETHYLSULPHONAMIDO)BENZENEBORONIC ACID; 3-(N,O-DIMETHYLHYDROXYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(NAPHTHALEN-2-YL)PHENYLBORONIC ACID; 3-(N-BENZYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(N-BENZYLSULFAMOYL)-4-METHOXYPHENYLBORONIC ACID; 3-(N-BOC-AMINOMETHYL)PHENYLBORONIC ACID; 3-(N-BUTYLCARBAMOYL)-4-FLUOROPHENYLBORONIC ACID; 3-(N-BUTYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(N-CYCLOPROPYLSULPHAMOYL)BENZENEBORONIC ACID; 3-(NEOPENTYLOXY)PHENYLBORONIC ACID; 3-(NEOPENTYLOXYSULFONYL)PHENYLBORONIC ACID; 3-(N-ETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(N-ETHYLSULFAMOYL)PHENYLBORONIC ACID; 3-(N-ISOPROPYLAMINOCARBONYL)-5-NITROPHENYLBORONIC ACID; 3-(N-ISOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 3-(N-METHYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(N-PROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(N-T-BUTYL-N-METHYLSULFAMOYL)PHENYLBORONIC ACID; 3-(OXETAN-3-YL)PHENYLBORONIC ACID; 3-(PERFLUOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(PHENYLAMINO)PHENYLBORONIC ACID; 3-(PHENYLAMINOCARBONYL)-5-NITROPHENYLBORONIC ACID; 3-(PIPERIDIN-1-YL)-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(PIPERIDIN-1-YL)PHENYLBORONIC ACID; 3-(PIPERIDIN-1-YLMETHYL)PHENYLBORONIC ACID; 3-(PIPERIDIN-1-YLMETHYL)PHENYLBORONIC ACID, HCL; 3-(PIPERIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 3-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(PIPERIDINO)PHENYLBORONIC ACID HCL; 3-(PROPOXYCARBONYL)PHENYLBORONIC ACID; 3-(PROPYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(PROPYLSULFONAMIDO)PHENYLBORONIC ACID; 3-(P-TOLYLCARBAMOYL)PHENYLBORONIC ACID; 3-(PYRIDIN-2-YL)PHENYL BORONIC ACID; 3-(PYRIDIN-2-YLAMINO)PHENYLBORONIC ACID; 3-(PYRIDIN-2-YLMETHOXY)PHENYLBORONIC ACID; 3-(PYRIDIN-4-YLAMINO)PHENYLBORONIC ACID; 3-(PYRIDINE-3-YL)PHENYLBORONIC ACID; 3-(PYRIDINE-4-YL)PHENYLBORONIC ACID; 3-(PYRROLIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 3-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-(PYRROLIDINO)PHENYLBORONIC ACID; 3-(T-BUTOXYCARBONYLAMINO)-4-CHLOROPHENYLBORONIC ACID; 3-(T-BUTYLCARBAMOYL)-5-NITROPHENYLBORONIC ACID; 3-(T-BUTYLDIMETHYLSILYLOXY)-4-CHLORO-2-FLUOROPHENYLBORONIC ACID; 3-(T-BUTYLDIMETHYLSILYLOXY)-4-METHOXYPHENYLBORONIC ACID; 3-(T-BUTYLDIMETHYLSILYLOXY)PHENYLBORONIC ACID; 3-(T-BUTYLTHIO)PHENYLBORONIC ACID; 3-(TERT-BUTOXYCARBONYL)-2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPIN-7-YL-7-BORONIC ACID; 3-(TERT-BUTOXYCARBONYL)PHENYLBORONIC ACID; 3-(TERT-BUTOXYCARBONYLAMINO)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(TERT-BUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 3-(TERT-BUTYLCARBAMOYL)-4-FLUOROPHENYLBORONIC ACID; 3-(TERT-BUTYLDIMETHYLSILYLOXY)-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-(TETRAHYDRO-2H-PYRAN-2-YLOXY)PHENYLBORONIC ACID; 3-(TETRAHYDRO-2H-PYRAN-4-YL)METHOXYPHENYLBORONIC ACID; 3-(TETRAHYDROPYRAN-4-YLOXYMETHY)PHENYLBORONIC ACID; 3-(TETRAZOL-5-YL)PHENYLBORONIC ACID; 3-(THIOMORPHOLIN-4-YLCARBONYL)BENZENEBORONIC ACID; 3-(THIOPHEN-2-YLMETHOXYMETHYL)PHENYLBORONIC ACID; 3-(TOLYL-D7)-BORONIC ACID; 3-(TRANS-4-HYDROXYCYCLOHEXYLCARBAMOYL)PHENYLBORONIC ACID; 3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-(TRIFLUOROMETHOXY)PYRAZINE-2-BORONIC ACID; 3-(TRIFLUOROMETHYL)-1-TRITYL-1H-PYRAZOL-4-YLBORONIC ACID; 3-(TRIFLUOROMETHYL)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-(TRIFLUOROMETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-(TRIFLUOROMETHYL)-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-(TRIFLUOROMETHYL)-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(ETHOXY-D5)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(ETHYL-D5)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(ISO-PROPOXY-D7)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(ISO-PROPYL-D7)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(METHOXY-D3)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-(METHYL-D3)-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-METHYL-PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)-5-VINYLPHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-(TRIFLUOROMETHYLTHIO)-BENZENEBORONIC ACID; 3,3-DIMETHYL-1-BUTENYLBORONIC ACID; 3,3-DIMETHYL-2-OXOINDOLIN-6-YLBORONIC ACID; 3,4-(METHYLENE-D2)-DIOXYPHENYLBORONIC ACID; 3,4,5-TRICHLORO-2-METHYLPHENYLBORONIC ACID; 3,4,5-TRICHLOROPHENYLBORONIC ACID; 3,4,5-TRIFLUOROPHENYLBORONIC ACID; 3,4,5-TRIMETHOXYPHENYLBORONIC ACID; 3,4,5-TRIS(BENZYLOXY)PHENYLBORONIC ACID; 3,4-BIS(2-METHYLBUTYLOXY)BENZENEBORONIC ACID; 3,4-BIS(2-METHYLPROPYLOXY)BENZENEBORONIC ACID; 3,4-BIS(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3,4-DIAMINOPHENYLBORONIC ACID; 3,4-DICHLORO-2-METHYLPHENYLBORONIC ACID; 3′,4′-DICHLORO-4-BIPHENYLBORONIC ACID; 3,4-DICHLORO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3,4-DICHLOROPHENYLBORONIC ACID; 3,4-DIFLUORO-2-ISOPROPOXYPHENYLBORONIC ACID; 3,4-DIFLUORO-5-(METHOXYCARBONYL)PHENYLBORONIC ACID; 3,4-DIFLUORO-5-(TRIFLUOROMETHYL)-PHENYLBORONIC ACID; 3,4-DIFLUORO-5-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 3,4-DIFLUORO-5-METHOXYBENZENEBORONIC ACID; 3,4-DIFLUORO-5-NITROPHENYLBORONIC ACID; 3,4-DIFLUOROPHENYLBORONIC ACID; 3,4-DIHYDRO-1H-2-BENZOPYRAN-1-BORONIC ACID; 3,4-DIHYDRO-1H-2-BENZOPYRAN-3-BORONIC ACID; 3,4-DIHYDRO-1H-2-BENZOPYRAN-4-BORONIC ACID; 3,4-DIHYDRO-1H-2-BENZOPYRAN-5-BORONIC ACID; 3,4-DIHYDRO-1H-2-BENZOPYRAN-6-BORONIC ACID; 3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-6-YLBORONIC ACID; 3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YLBORONIC ACID; 3,4-DIHYDRO-2H-1-BENZOPYRAN-6-YLBORANEDIOL; 3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZIN-7-YLBORONIC ACID; 3,4-DIHYDRO-2H-PYRAN-6-YLBORONIC ACID; 3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-6-BORONIC ACID; 3,4-DIMETHOXYPHENYLBORONIC ACID; 3,4-DIMETHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-6-YLBORONIC ACID; 3,4-DIMETHYL-5-FLUORO-PHENYLBORONIC ACID; 3′,4′-DIMETHYLBIPHENYL-2-YLBORONIC ACID; 3,4-DIMETHYLPHENYLBORONIC ACID; 3,4-METHYLENEDIOXYPHENYLBORONIC ACID; 3,5,5,8,8-PENTAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YLBORONIC ACID; 3,5,5,8,8-PENTAMETHYL-5,8-DIHYDRONAPHTHALEN-2-BORONIC ACID; 3,5-BIS((TERT-BUTYLSILYLOXY)METHYL)PHENYLBORONIC ACID; 3,5-BIS(TERT-BUTYLDIMETHYLSILYLOXY)PHENYLBORONIC ACID; 3,5-BIS(TRIFLUOROMETHYL)BENZYLBORONIC ACID; 3,5-BIS(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3,5-DIAMINOPHENYL BORONIC ACID; 3,5-DICHLORO-2-FLUOROPYRIDIN-4-YLBORONIC ACID; 3,5-DICHLORO-2-METHOXYPHENYLBORONIC ACID; 3,5-DICHLORO-2-METHYLPHENYLBORONIC ACID; 3,5-DICHLORO-4-CYANOPHENYLBORONIC ACID; 3,5-DICHLORO-4-ETHOXYPHENYLBORONIC ACID; 3,5-DICHLORO-4-METHOXYPHENYLBORONIC ACID; 3,5-DICHLOROPHENYLBORONIC ACID; 3,5-DICHLOROPYRIDINE-2-BORONIC ACID; 3,5-DICHLOROPYRIDINE-4-BORONIC ACID; 3,5-DICHLOROTHIOPHEN-2-YLBORONIC ACID; 3,5-DICYANOPHENYLBORONIC ACID; 3,5-DIFLUORO-2-HYDROXYPHENYLBORONIC ACID; 3,5-DIFLUORO-2-METHOXYPHENYLBORONIC ACID; 3,5-DIFLUORO-2-NITROPHENYLBORONIC ACID; 3,5-DIFLUORO-4-(HYDROXYMETHYL)PHENYLBORONIC ACID; 3,5-DIFLUORO-4-(METHOXYCARBONYL)PHENYLBORONIC ACID; 3,5-DIFLUORO-4-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 3,5-DIFLUORO-4-CHLOROPHENYLBORONIC ACID; 3,5-DIFLUORO-4-DIFLUOROMETHOXY-BENZENEBORONIC ACID; 3,5-DIFLUORO-4-HYDROXYPHENYLBORONIC ACID; 3,5-DIFLUORO-4-METHOXY-PHENYLBORONIC ACID; 3,5-DIFLUOROPHENYLBORONIC ACID; 3,5-DIFLUOROPYRIDINE-4-BORONIC ACID; 3,5-DIFLUOROPYRIDINE-4-BORONIC ACID HYDRATE; 3,5-DIMETHOXYPHENYLBORONIC ACID; 3,5-DIMETHYL-1-(THP)PYRAZOLE-4-BORONIC ACID; 3,5-DIMETHYL-1H-PYRAZOL-4-YLBORONIC ACID HYDROCHLORIDE; 3,5-DIMETHYL-4-(3′,5′-DIMETHOXYBENZYLOXY)PHENYLBORONIC ACID; 3,5-DIMETHYL-4-CHLOROPHENYLBORONIC ACID; 3,5-DIMETHYL-4-ETHOXYPHENYLBORONIC ACID; 3,5-DIMETHYL-4-FLUORO-PHENYLBORONIC ACID; 3,5-DIMETHYL-4-ISOPROPOXYPHENYLBORONIC ACID; 3,5-DIMETHYL-4-METHOXYPHENYLBORONIC ACID; 3,5-DIMETHYL-4-PROPOXYPHENYLBORONIC ACID; 3,5-DIMETHYLBENZO[B]THIOPHEN-2-YLBORONIC ACID; 3,5-DIMETHYLISOXAZOLE-4-BORONIC ACID; 3,5-DIMETHYLPHENYLBORONIC ACID; 3,5-DIMETHYLTHIOPHEN-2-YLBORONIC ACID; 3,5-DINITRO-4-METHYLPHENYLBORONIC ACID; 3,5-DINITROPHENYL BORONIC ACID; 3,5-DI-T-BUTYLPHENYLBORONIC ACID; 3,6-DIFLUORO-2-HYDROXYPHENYLBORONIC ACID; 3,6-DIFLUORO-2-METHOXYPHENYLBORONIC ACID; 3,6-DIHYDRO-2H-PYRAN-4-BORONIC ACID; 3,6-DIMETHOXYLPYRIDAZINE-4-BORONIC ACID; 3,6-DIMETHYLPYRAZIN-2-YLBORONIC ACID; 3,6-DIMETHYLPYRIDINE-2-BORONIC ACID; 3-[(1-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 3-[(2-FLUOROPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 3-[(2-ISOPROPYL-5-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 3-[(2-MORPHOLIN-4-YLETHYL)CARBAMOYL]BENZENEBORONIC ACID HYDROCHLORIDE; 3-[(2-PYRROLIDIN-1-YLETHYL)CARBAMOYL]BENZENEBORONIC ACID HYDROCHLORIDE; 3-[(3-METHOXY-3-OXOPROPYL)CARBAMOYL]BENZENEBORONIC ACID; 3-[(4′-CHLORO-1-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 3-[(4-CHLORO-3-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 3-[(4-CHLOROPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 3-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]BENZENEBORONIC ACID HYDROCHLORIDE; 3-[(4′-TERT-BUTYL-2′-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 3-[(BENZYLOXY)METHYL]PYRIDINE-2-BORONIC ACID; 3-[(E)-2-NITROVINYL]PHENYLBORONIC ACID; 3-[2-(DIHYDROXYBORANYL)PHENOXYMETHYL]PYRIDINE-2-CARBONITRILE; 3-[3-(DIHYDROXYBORANYL)PHENOXYMETHYL]BENZONITRILE; 3-[3-(DIHYDROXYBORANYL)PHENOXYMETHYL]PYRIDINE-2-CARBONITRILE; 3-[4-(DIHYDROXYBORANYL)PHENOXYMETHYL]PYRIDINE-2-CARBONITRILE; 3-[METHOXY(METHYL)CARBAMOYL]-5-NITROPHENYLBORONIC ACID; 3-[N-(4-METHOXYBENZYL)SULFAMOYL]PHENYLBORONIC ACID; 3-[N-CYCLOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL]PHENYLBORONIC ACID; 3-ACETAMIDO-4-NITROPHENYLBORONIC ACID; 3-ACETAMIDO-5-BORONOBENZOIC ACID; 3-ACETAMIDOBENZO[D]ISOXAZOL-5-YLBORONIC ACID; 3-ACETAMIDOBENZO[D]ISOXAZOL-6-YLBORONIC ACID; 3-ACETAMIDOPHENYLBORONIC ACID; 3-ACETOXY-4-METHOXYPHENYLBORONIC ACID; 3-ALLYLOXYPHENYLBORONIC ACID; 3-AMINO-1H-INDAZOL-6-YLBORONIC ACID; 3-AMINO-2-(METHOXYCARBONYL)PYRIDINE-5-BORONIC ACID; 3-AMINO-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-AMINO-2-CYANOPYRIDINE-5-BORONIC ACID; 3-AMINO-2-FLUOROPYRIDINE-5-BORONIC ACID; 3-AMINO-2-METHYLPYRIDINE-4-BORONIC ACID; 3-AMINO-2-METHYLPYRIDINE-5-BORONIC ACID; 3-AMINO-3-(2-BORONOPHENYL)PROPANOIC ACID; 3-AMINO-3-(3-BORONOPHENYL)PROPANOIC ACID; 3-AMINO-3-(4-BORONOPHENYL)PROPANOIC ACID; 3-AMINO-4,5-DIFLUOROPHENYLBORONIC ACID; 3-AMINO-4-CHLOROPHENYLBORONIC ACID; 3-AMINO-4-FLUOROPHENYLBORONIC ACID; 3-AMINO-4-FLUOROPHENYLBORONIC ACID HYDROCHLORIDE; 3-AMINO-4-METHOXYPHENYLBORONIC ACID; 3-AMINO-4-METHOXYPHENYLBORONIC ACID HCL; 3-AMINO-4-METHYLPHENYLBORONIC ACID; 3-AMINO-4-METHYLPHENYLBORONIC ACID HYDROCHLORIDE; 3-AMINO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-AMINO-5-CARBOXYLPHENYLBORONIC ACID; 3-AMINO-5-CHLOROPYRIDIN-2-YLBORONIC ACID; 3-AMINO-5-CYANOBENZENEBORONIC ACID HYDROCHLORIDE; 3-AMINO-5-CYANOPHENYLBORONIC ACID; 3-AMINO-5-DIETHYLCARBAMOYLPHENYLBORONIC ACID, HCL; 3-AMINO-5-ETHOXYCARBONYLPHENYLBORONIC ACID; 3-AMINO-5-FLUOROPHENYLBORONIC ACID; 3-AMINO-5-METHOXYCARBONYLPHENYLBORONIC ACID, HCL; 3-AMINO-5-METHOXYPYRIDIN-2-YLBORONIC ACID; 3-AMINO-6,7′[7′,8′,8′-TRICYANOQUINODIMETHANEPHENYLBORONIC ACID; 3-AMINO-6-METHOXYPYRAZIN-2-YLBORONIC ACID; 3-AMINO-8-HYDROXY-1,10-PHENANTHROLIN-2-YLBORONIC ACID; 3-AMINOCARBONYL-2-FLUOROPHENYLBORONIC ACID; 3-AMINOCARBONYLPHENYLBORONIC ACID; 3-AMINOPHENYLBORONIC ACID; 3-AMINOPHENYLBORONIC ACID HYDROCHLORIDE; 3-AMINOPHENYLBORONIC ACID MONOHYDRATE; 3-AMINOPYRAZIN-2-YLBORONIC ACID; 3-AMINOPYRIDINE-2-BORONIC ACID; 3-AMINOPYRIDINE-4-BORONIC ACID; 3-AMINOPYRIDINE-5-BORONIC ACID; 3-AMINOQUINOLIN-6-YLBORONIC ACID; 3-BENYLOXY-4-CHLORO-PHENYLBORONIC ACID; 3-BENZYLOXY-2-CHLORO-6-FLUOROPHENYLBORONIC ACID; 3-BENZYLOXY-4-CHLORO-2-FLUOROPHENYLBORONIC ACID; 3-BENZYLOXY-5-FLUOROPHENYLBORONIC ACID; 3-BENZYLOXYCARBONYLPHENYLBORONIC ACID; 3-BENZYLOXYPHENYLBORONIC ACID; 3-BIPHENYLBORONIC ACID; 3-BORONO-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-BORONO-2-METHOXYBENZOIC ACID; 3-BORONO-4-FLUOROBENZOIC ACID ETHYL ESTER; 3-BORONO-4-METHOXYBENZOIC ACID; 3-BORONO-5-CHLOROBENZAMIDE; 3-BORONO-5-METHOXY-BENZOIC ACID, 1-METHYL ESTER; 3-BORONO-A,A-DIMETHYL-BENZENEACETIC ACID; 3-BORONOBENZENESULFONAMIDE; 3-BORONOBENZOHYDRAZIDE; 3-BORONOISONICOTINIC ACID; 3-BORONO-N-(2,3-DIMETHYLPHENYL)BENZAMIDE; 3-BORONO-N-(2,4-DIMETHYLPHENYL)BENZAMIDE; 3-BORONO-N-(2,5-DIMETHYLPHENYL)BENZAMIDE; 3-BORONO-N-(2-CHLORO-4-METHYLPHENYL)BENZAMIDE; 3-BUTOXY-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-BUTOXY-2,6-DIFLUOROPHENYLBORONIC ACID; 3-BUTOXY-2-CHLOROPHENYLBORONIC ACID; 3-BUTOXY-4-CHLORO-2-FLUOROPHENYLBORONIC ACID; 3-BUTOXY-4-CHLOROPHENYLBORONIC ACID; 3-BUTOXY-4-METHOXYPHENYLBORONIC ACID; 3-BUTOXY-5-CHLOROPHENYLBORONIC ACID; 3-BUTOXY-5-METHOXYPHENYLBORONIC ACID; 3-BUTOXY-5-METHYLPHENYLBORONIC ACID; 3-BUTOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 3-BUTOXYCARBONYLAMINOPHENYLBORONIC ACID; 3-BUTOXYCARBONYLPHENYLBORONIC ACID; 3-BUTOXYPHENYLBORONIC ACID; 3-CARBAMOYL-5-NITROPHENYLBORONIC ACID; 3′-CARBAMOYLBIPHENYL-3-YLBORONIC ACID; 3-CARBOXY-2,4-DIFLUOROPHENYLBORONIC ACID; 3-CARBOXY-2-FLUOROPHENYLBORONIC ACID; 3-CARBOXY-4,5-DIFLUOROPHENYLBORONIC ACID; 3-CARBOXY-4-CHLOROPHENYLBORONIC ACID; 3-CARBOXY-4-FLUOROPHENYLBORONIC ACID; 3-CARBOXY-4-METHOXYPHENYLBORONIC ACID; 3-CARBOXY-5-CHLOROBENZENEBORONIC ACID; 3-CARBOXY-5-FLUOROPHENYLBORONIC ACID; 3-CARBOXY-5-FLUOROPYRIDINE-4-BORONIC ACID; 3-CARBOXY-5-METHOXYPHENYLBORONIC ACID; 3-CARBOXY-5-METHYLPHENYLBORONIC ACID; 3-CARBOXY-5-NITROPHENYLBORONIC ACID; 3-CARBOXYFURAN-2-BORONIC ACID; 3-CARBOXYMETHYL-6-FLUOROPHENYLBORONIC ACID; 3-CARBOXYPHENYLBORONIC ACID; 3-CHLORO-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 3-CHLORO-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-CHLORO-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-CHLORO-2-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 3-CHLORO-2,4-DIFLUOROBENZENEBORONIC ACID; 3-CHLORO-2,5-DIFLUOROPHENYLBORONIC ACID; 3-CHLORO-2,6-DIFLUOROPHENYLBORONIC ACID; 3-CHLORO-2-CYANOPHENYLBORONIC ACID; 3-CHLORO-2-FLUOROPHENYLBORONIC ACID; 3-CHLORO-2-FLUOROPYRIDINE-4-BORONIC ACID; 3-CHLORO-2-HYDROXYMETHYLPHENYLBORONIC ACID; 3-CHLORO-2-HYDROXYPHENYLBORONIC ACID; 3-CHLORO-2-HYDROXYPYRIDINE-4-BORONIC ACID; 3-CHLORO-2-ISOBUTOXYPYRIDINE-5-BORONIC ACID; 3-CHLORO-2-METHOXYPHENYLBORONIC ACID; 3-CHLORO-2-METHOXYPYRIDINE-4-BORONIC ACID; 3-CHLORO-2-METHOXYPYRIDINE-5-BORONIC ACID; 3-CHLORO-2-METHOXYPYRIDINE-6-BORONIC ACID; 3-CHLORO-2-METHYLPHENYLBORONIC ACID; 3-CHLORO-2-METHYLPYRIDINE-4-BORONIC ACID; 3-CHLORO-2-METHYLPYRIDINE-5-BORONIC ACID; 3-CHLORO-2-METHYLPYRIDINE-6-BORONIC ACID; 3-CHLORO-2-MORPHOLINOPYRIDINE-4-BORONIC ACID; 3-CHLORO-4-(2,2,2-TRIFLUOROETHOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(2,2-DIFLUOROETHOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(2′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(2′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(3′,5′-DIMETHOXYBENZYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(3′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(4′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(CYCLOHEXYLCARBAMOYL)BENZENEBORONIC ACID; 3-CHLORO-4-(CYCLOPENTYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(CYCLOPENTYLOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(CYCLOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(CYCLOPROPYLMETHOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(HYDRAZINOCARBONYL)BENZENEBORONIC ACID; 3-CHLORO-4-(HYDROXYMETHYL)PHENYLBORONIC ACID; 3-CHLORO-4-(MORPHOLINE-4-CARBONYL)BENZENEBORONIC ACID; 3-CHLORO-4-(N,N-DIETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(N,N-DIMETHYLCARBAMOYL)BENZENEBORONIC ACID; 3-CHLORO-4-(N-BENZYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(N-ETHYLCARBAMOYL)BENZENEBORONIC ACID; 3-CHLORO-4-(N-ISOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(N-METHYLCARBAMOYL)BENZENEBORONIC ACID; 3-CHLORO-4-(N-TERT-BUTYLCARBAMOYL)PHENYLBORONIC ACID; 3-CHLORO-4-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-CHLORO-4-(PYRROLIDINYL-1-CARBONYL)PHENYLBORONIC ACID; 3-CHLORO-4-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PHENYLBORONIC ACID; 3-CHLORO-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-CHLORO-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-CHLORO-4,5-DIFLUOROPHENYLBORONIC ACID; 3-CHLORO-4-CYANOPHENYLBORONIC ACID; 3-CHLORO-4-ETHOXYPHENYLBORONIC ACID; 3-CHLORO-4-FLUORO-5-NITROPHENYLBORONIC ACID; 3-CHLORO-4-FLUOROPHENYLBORONIC ACID; 3-CHLORO-4-HYDROXYPHENYLBORONIC ACID; 3-CHLORO-4-ISOPROPOXYPHENYLBORONIC ACID; 3-CHLORO-4-METHOXY-5-METHYLPHENYLBORONIC ACID; 3-CHLORO-4-METHOXYPHENYLBORONIC ACID; 3-CHLORO-4-METHOXYPYRIDINE-2-BORONIC ACID; 3-CHLORO-4-METHYLPHENYLBORONIC ACID; 3-CHLORO-4-METHYLPYRIDINE-2-BORONIC ACID; 3-CHLORO-4-MORPHOLINOPHENYLBORONIC ACID; 3-CHLORO-4-PROPOXYPHENYLBORONIC ACID; 3-CHLORO-4-PYRIDINEBORONIC ACID; 3-CHLORO-4-PYRIDINEBORONIC ACID HYDRATE; 3-CHLORO-4-PYRIDINEBORONIC ACID PENTAHYDRATE; 3-CHLORO-5-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 3-CHLORO-5-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-CHLORO-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-CHLORO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YLBORONIC ACID; 3-CHLORO-5-ETHOXYPHENYLBORONIC ACID; 3-CHLORO-5-FLUORO-4-METHYLPHENYLBORONIC ACID; 3-CHLORO-5-FLUOROPHENYLBORONIC ACID; 3-CHLORO-5-FLUOROPYRIDINE-4-BORONIC ACID; 3-CHLORO-5-HYDROXYPYRIDINE-2-BORONIC ACID; 3-CHLORO-5-ISOBUTOXYPHENYLBORONIC ACID; 3-CHLORO-5-METHOXYCARBONYL-PHENYL-BORONIC ACID; 3-CHLORO-5-METHOXYPHENYLBORONIC ACID; 3-CHLORO-5-METHOXYPYRIDINE-2-BORONIC ACID; 3-CHLORO-5-METHOXYPYRIDINE-4-BORONIC ACID; 3-CHLORO-5-METHYLPHENYLBORONIC ACID; 3-CHLORO-5-METHYLPYRIDINE-2-BORONIC ACID; 3-CHLORO-5-METHYLPYRIDINE-4-BORONIC ACID; 3-CHLORO-5-PROPOXYPHENYLBORONIC ACID; 3-CHLORO-5-VINYLPHENYLBORONIC ACID; 3-CHLORO-6-METHOXYPYRIDIN-2-YLBORONIC ACID; 3-CHLORO-6-METHYLPYRIDINE-2-BORONIC ACID; 3′-CHLORO-BIPHENYL-4-BORONIC ACID; 3-CHLOROCARBONYLPHENYLBORONIC ACID; 3-CHLOROPHENYLBORONIC ACID; 3-CHLOROPYRIDINE-2-BORONIC ACID; 3-CHLOROTHIOPHENE-2-BORONIC ACID; 3-CHLOROTHIOPHENE-4-BORONIC ACID; 3-CYANO-2-FLUOROPHENYLBORONIC ACID; 3-CYANO-2-HYDROXYPHENYLBORONIC ACID; 3-CYANO-2-METHOXYPHENYLBORONIC ACID; 3-CYANO-2-METHYLPHENYLBORONIC ACID; 3-CYANO-4-FLUOROPHENYLBORONIC ACID; 3-CYANO-4-HYDROXYPHENYLBORONIC ACID; 3-CYANO-4-ISOPROPOXYPHENYLBORONIC ACID; 3-CYANO-4-METHOXYPHENYLBORONIC ACID; 3-CYANO-4-METHYLPHENYLBORONIC ACID; 3-CYANO-4-PROPOXYPHENYLBORONIC ACID; 3-CYANO-5-(PROP-1-YNYL)PHENYLBORONIC ACID; 3-CYANO-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-CYANO-5-FLUOROPHENYLBORONIC ACID; 3-CYANO-5-HYDROXYPHENYLBORONIC ACID; 3-CYANO-5-METHOXYPHENYLBORONIC ACID; 3-CYANO-5-METHYLPHENYLBORONIC ACID; 3-CYANO-5-NITROPHENYLBORONIC ACID; 3′-CYANOBIPHENYL-3-YLBORONIC ACID; 3-CYANOMETHOXYPHENYLBORONIC ACID; 3-CYANOMETHYLPHENYLBORONIC ACID; 3-CYANOPHENYLBORONIC ACID; 3-CYANOPYRAZIN-2-YLBORONIC ACID; 3-CYANOPYRIDINE-2-BORONIC ACID; 3-CYANOPYRIDINE-4-BORONIC ACID; 3-CYANOTHIOPHEN-2-YLBORONIC ACID; 3-CYCLOBUTYLPHENYLBORONIC ACID; 3-CYCLOPROPOXYPHENYLBORONIC ACID; 3-CYCLOPROPYLL-1H-PYRAZOLE-5-BORONIC ACID; 3-CYCLOPROPYLPHENYLBORONIC ACID; 3-CYCLOPROPYLPYRIDIN-4-YLBORONIC ACID; 3-DIFLUOROMETHOXY-4-FLUORO-BENZENEBORONIC ACID; 3-DIFLUOROMETHOXY-4-METHYL-BENZENEBORONIC ACID; 3-DIFLUOROMETHYL-PHENYLBORONIC ACID; 3-DIMETHYLAMINOPHENYLBORONIC ACID HCL; 3-ETHOXY-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-ETHOXY-2-FLUOROPHENYLBORONIC ACID; 3-ETHOXY-4-FLUOROPHENYLBORONIC ACID; 3-ETHOXY-4-METHOXYPHENYLBORONIC ACID; 3-ETHOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-ETHOXY-5-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 3-ETHOXY-5-AMINOPYRIDINE-4-BORONIC ACID; 3-ETHOXY-5-FLUOROPHENYLBORONIC ACID; 3-ETHOXY-5-METHYLPHENYLBORONIC ACID; 3-ETHOXY-5-METHYLPYRIDINE-4-BORONIC ACID; 3-ETHOXYCARBONYL-4-FLUOROPHENYLBORONIC ACID; 3-ETHOXYCARBONYLMETHYLPHENYLBORONIC ACID; 3-ETHOXYCARBONYLPHENYLBORONIC ACID; 3-ETHOXYNAPHTHALEN-2-YLBORONIC ACID; 3-ETHOXYPHENYLBORONIC ACID; 3-ETHOXYPYRIDINE-4-BORONIC ACID; 3-ETHYLAMINOPHENYLBORONIC ACID; 3-ETHYLFURAN-2-BORONIC ACID; 3-ETHYLPHENYLBORONIC ACID; 3-ETHYLSULFINYLPHENYLBORONIC ACID; 3-ETHYLSULFONYLPHENYLBORONIC ACID; 3-ETHYLTHIOPHENE-2-BORONIC ACID; 3-ETHYLTHIOPHENYLBORONIC ACID; 3-FLUORO-1H-PYRROLO[2,3-B]PYRIDIN-5-YLBORONIC ACID; 3-FLUORO-1-METHYL-1H-PYRROLE-2-BORONIC ACID; 3-FLUORO-2-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 3-FLUORO-2-(METHYLTHIOMETHOXY)PHENYLBORONIC ACID; 3-FLUORO-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-FLUORO-2-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 3-FLUORO-2-HYDROXYPHENYLBORONIC ACID; 3-FLUORO-2-HYDROXYPYRIDINE-4-BORONIC ACID; 3-FLUORO-2-METHOXY-5-(METHYLTHIO)BENZENEBORONIC ACID; 3-FLUORO-2-METHOXYPHENYLBORONIC ACID; 3-FLUORO-2-METHOXYPYRIDINE-4-BORONIC ACID; 3-FLUORO-2-METHOXYPYRIDINE-5-BORONIC ACID; 3-FLUORO-2-METHYLPHENYLBORONIC ACID; 3-FLUORO-2-METHYLPYRIDINE-4-BORONIC ACID; 3-FLUORO-2-MORPHOLINOPYRIDINE-4-BORONIC ACID; 3-FLUORO-4-((4-METHOXYBENZYLOXY)CARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-FLUORO-4-(2,2,2-TRIFLUOROETHOXY)PHENYLBORONIC ACID; 3-FLUORO-4-(2-HYDROXYETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-4-(4-METHOXYBENZYLTHIO)PHENYLBORONIC ACID; 3-FLUORO-4-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 3-FLUORO-4-(ISOPROPYLCARBAMOYL)BENZENEBORONIC ACID; 3-FLUORO-4-(METHOXY(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-4-(METHOXYCARBAMOYL)BENZENEBORONIC ACID; 3-FLUORO-4-(METHOXYMETHOXY)PHENYLBORONIC ACID; 3-FLUORO-4-(METHYLCARBAMOYL)BENZENEBORONIC ACID; 3-FLUORO-4-(METHYLSULFONYL)PHENYLBORONIC ACID; 3-FLUORO-4-(METHYLTHIO)PHENYLBORONIC ACID; 3-FLUORO-4-(PHENYLCARBAMOYL)BENZENEBORONIC ACID; 3-FLUORO-4-(PIPERIDIN-1-YLCARBONYL)BENZENEBORONIC ACID; 3-FLUORO-4-(PROPYLCARBAMOYL)BENZENEBORONIC ACID; 3-FLUORO-4-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 3-FLUORO-4-(THIOPHEN-2-YLMETHOXYMETHYL)PHENYLBORONIC ACID; 3-FLUORO-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-FLUORO-4-BIPHENYLBORONIC ACID; 3-FLUORO-4′-HEPTYLBIPHENYL-4-BORONIC ACID; 3-FLUORO-4-HYDRAZINOCARBONYLPHENYLBORONIC ACID; 3-FLUORO-4-HYDROXYPHENYLBORONIC ACID; 3-FLUORO-4-ISOPROPOXYPHENYLBORONIC ACID; 3-FLUORO-4-METHOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 3-FLUORO-4-METHOXYCARBONYLPHENYLBORONIC ACID; 3-FLUORO-4-METHOXYPHENYLBORONIC ACID; 3-FLUORO-4-METHYLPHENYLBORONIC ACID; 3-FLUORO-4-MORPHOLINOPHENYLBORONIC ACID; 3-FLUORO-4-N-METHYL, N-ETHYLAMIDYL PHENYLBORONIC ACID; 3-FLUORO-4′-PENTYLBIPHENYL-4-BORONIC ACID; 3-FLUORO-4-PROPOXYPHENYLBORONIC ACID; 3-FLUORO-4-TRIFLUOROMETHYL-PHENYLBORONIC ACID; 3-FLUORO-5-(2,2,2-TRIFLUOROETHOXY)BENZENEBORONIC ACID; 3-FLUORO-5-(DIETHYLCARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-5-(ETHOXY-D5)-PHENYLBORONIC ACID; 3-FLUORO-5-(ETHYL-D5)-PHENYLBORONIC ACID; 3-FLUORO-5-(HYDRAZINECARBONYL)PHENYLBORONIC ACID; 3-FLUORO-5-(ISO-PROPOXY-D7)-PHENYLBORONIC ACID; 3-FLUORO-5-(ISO-PROPYL-D7)-PHENYLBORONIC ACID; 3-FLUORO-5-(METHOXY-D3)-PHENYLBORONIC ACID; 3-FLUORO-5-(METHYLCARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-5-(MORPHOLIN-4-YLCARBONYL)BENZENEBORONIC ACID; 3-FLUORO-5-(PIPERIDIN-1-YLCARBONYL)BENZENEBORONIC ACID; 3-FLUORO-5-(PROPYLCARBAMOYL)PHENYLBORONIC ACID; 3-FLUORO-5-ETHOXYCARBONYLPHENYLBORONIC ACID; 3-FLUORO-5-HYDROXYPHENYLBORONIC ACID; 3-FLUORO-5-HYDROXYPYRIDINE-2-BORONIC ACID; 3-FLUORO-5-ISOBUTOXYPHENYLBORONIC ACID; 3-FLUORO-5-ISOPROPOXYPHENYLBORONIC ACID; 3-FLUORO-5-METHOXYPHENYLBORONIC ACID; 3-FLUORO-5-METHOXYPYRIDINE-2-BORONIC ACID; 3-FLUORO-5-METHYLPHENYLBORONIC ACID; 3-FLUORO-5-METHYLPYRIDINE-4-BORONIC ACID; 3-FLUORO-5-MORPHOLINOPHENYLBORONIC ACID; 3-FLUORO-5-PYRROLIDINOPHENYLBORONIC ACID; 3-FLUORO-5-VINYLPHENYLBORONIC ACID; 3-FLUOROBENZYLBORONIC ACID; 3′-FLUORO-BIPHENYL-4-BORONIC ACID; 3-FLUOROISOQUINOLIN-7-YLBORONIC ACID; 3-FLUOROPHENYLBORONIC ACID; 3-FLUOROPYRIDINE-2-BORONIC ACID; 3-FLUOROPYRIDINE-4-BORONIC ACID; 3-FLUOROPYRIDINE-4-BORONIC ACID HYDRATE; 3-HEXYLTHIOPHENE-2-BORONIC ACID; 3-HYDROXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-HYDROXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-HYDROXY-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-HYDROXY-2-METHOXYPHENYLBORONIC ACID; 3-HYDROXY-2-METHYLPHENYLBORONIC ACID; 3-HYDROXY-2-METHYLPYRIDINE-4-BORONIC ACID; 3-HYDROXY-4-(METHOXYCARBONYL)PHENYLBORONIC ACID; 3-HYDROXY-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-HYDROXY-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-HYDROXY-4-METHOXYPHENYLBORONIC ACID; 3-HYDROXY-4-METHYLPHENYLBORONIC ACID; 3-HYDROXY-4-MORPHOLINOPHENYLBORONIC ACID; 3-HYDROXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-HYDROXY-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-HYDROXY-5-METHOXYPHENYLBORONIC ACID; 3-HYDROXY-5-METHYLPHENYLBORONIC ACID; 3-HYDROXY-5-NITROPHENYLBORONIC ACID; 3-HYDROXYMETHYL-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-HYDROXYMETHYL-4-METHYLPHENYLBORONIC ACID; 3-HYDROXYMETHYLTHIOPHENE-2-BORONIC ACID; 3-HYDROXYNAPHTHALENE-1-BORONIC ACID; 3-HYDROXYNAPHTHALENE-2-BORONIC ACID; 3-HYDROXYPHENYLBORONIC ACID; 3-HYDROXYPYRAZINE-2-BORONIC ACID; 3-HYDROXYPYRIDINE-2-BORONIC ACID; 3-HYDROXYPYRIDINE-4-BORONIC ACID; 3-HYDROXYQUINOLINE-2-BORONIC ACID; 3-HYDROXYQUINOLINE-4-BORONIC ACID; 3-HYDROXYQUINOLINE-5-BORONIC ACID; 3-HYDROXYQUINOLINE-6-BORONIC ACID; 3-HYDROXYQUINOLINE-7-BORONIC ACID; 3-HYDROXYQUINOLINE-8-BORONIC ACID; 3-ISOBUTOXY-4-METHOXYPHENYLBORONIC ACID; 3-ISOBUTOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-ISOBUTOXY-5-METHYLPHENYLBORONIC ACID; 3-ISOBUTOXYPHENYLBORONIC ACID; 3-ISOPROPOXY-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-ISOPROPOXY-4-METHOXYPHENYLBORONIC ACID; 3-ISOPROPOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-ISOPROPOXY-5-METHYLPHENYLBORONIC ACID; 3-ISOPROPOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 3-ISOPROPOXYPHENYLBORONIC ACID; 3-ISOPROPROXY-4-METHYLPHENYLBORONIC ACID; 3-ISOPROPYLPHENYLBORONIC ACID; 3-ISOTHIOCYANOPHENYLBORONIC ACID; 3-MALEIMIDOPHENYL BORONIC ACID; 3-MERCAPTOPHENYLBORONIC ACID; 3-METHACRYLAMIDOPHENYLBORONIC ACID; 3-METHOXY-1-PROPENYLBORONIC ACID; 3-METHOXY-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-METHOXY-2-(TRIFLUOROMETHYL)PYRIDINE-4-BORONIC ACID; 3-METHOXY-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-METHOXY-2,5-DIMETHYLPHENYLBORONIC ACID; 3-METHOXY-2-HYDROXYPHENYLBORONIC ACID; 3-METHOXY-2-METHYLPHENYLBORONIC ACID; 3-METHOXY-2-METHYLPYRIDINE-4-BORONIC ACID; 3-METHOXY-3-OXOPROP-1-EN-2-YLBORONIC ACID; 3-METHOXY-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-METHOXY-4-(PYRIDIN-3-YLMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-4-(PYRIDIN-4-YLMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-4-CARBOXYPHENYLBORONIC ACID; 3-METHOXY-4-METHOXYCARBONYLPHENYLBORONIC ACID; 3-METHOXY-4-METHYLPHENYLBORONIC ACID; 3-METHOXY-4-MORPHOLINOPHENYLBORONIC ACID; 3-METHOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-METHOXY-5-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 3-METHOXY-5-AMINOPYRIDINE-4-BORONIC ACID; 3-METHOXY-5-METHYLPHENYLBORONIC ACID; 3-METHOXY-5-METHYLPYRIDINE-4-BORONIC ACID; 3-METHOXY-5-PROPOXYPHENYLBORONIC ACID; 3-METHOXY-6-(4-METHOXYPHENYL)PYRIDAZIN-4-YLBORONIC ACID; 3′-METHOXY-BIPHENYL-4-BORONIC ACID; 3-METHOXYCARBONYL-5-METHYLPHENYLBORONIC ACID; 3-METHOXYCARBONYL-5-NITROPHENYLBORONIC ACID; 3-METHOXYCARBONYLPHENYLBORONIC ACID; 3-METHOXYMETHOXY-4-METHYLPHENYLBORONIC ACID; 3-METHOXYMETHYLPHENYLBORONIC ACID; 3-METHOXYNAPHTHALENE-2-BORONIC ACID; 3-METHOXYPHENYLBORONIC ACID; 3-METHOXYPYRAZINE-2-BORONIC ACID; 3-METHOXYPYRIDINE-2-BORONIC ACID; 3-METHOXYPYRIDINE-4-BORONIC ACID; 3-METHOXYPYRIDINE-4-BORONIC ACID HYDRATE; 3-METHOXYTHIOPHENE-2-BORONIC ACID; 3-METHYL-1-(TETRAHYDROPYRAN-2-YL)-1H-INDAZOLE-4-BORONIC ACID; 3-METHYL-1-BUTYLBORONIC ACID; 3-METHYL-1H-INDAZOLE-4-BORONIC ACID; 3-METHYL-1H-INDAZOLE-5-BORONIC ACID; 3-METHYL-1H-INDAZOLE-6-BORONIC ACID; 3-METHYL-1H-INDAZOLE-7-BORONIC ACID; 3-METHYL-1H-PYRAZOL-4-YLBORONIC ACID; 3-METHYL-1-PROPYL-1H-PYRAZOL-5-YLBORONIC ACID; 3-METHYL-2-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(2,4,5-TRICHLOROPHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(PERFLUOROPHENYL)PYRIDINE-4-BORONIC ACID; 3-METHYL-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-METHYL-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 3-METHYL-2-BUTEN-2-YLBORONIC ACID; 3-METHYL-2-PROPOXYPYRIDINE-5-BORONIC ACID; 3-METHYL-3H-QUINAZOLIN-4-ONE-6-BORONIC ACID; 3-METHYL-4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 3-METHYL-4-MORPHOLINOPHENYLBORONIC ACID; 3-METHYL-4-TRIFLUOROMETHOXYPHENYLBORONIC ACID; 3-METHYL-4-TRIFLUOROMETHYL-PHENYLBORONIC ACID; 3-METHYL-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-METHYL-5-NITROPYRIDIN-2-YLBORONIC ACID; 3-METHYL-5-PROPOXYPHENYLBORONIC ACID; 3-METHYLBENZO[B]THIOPHENE-2-BORONIC ACID; 3-METHYLBENZOFURAN-2-YLBORONIC ACID; 3′-METHYLBIPHENYL-2-YLBORONIC ACID; 3-METHYLFURAN-2-YLBORONIC ACID; 3-METHYLPHENYLBORONIC ACID; 3-METHYLPYRAZINE-2-BORONIC ACID; 3-METHYLPYRIDINE-2-BORONIC ACID; 3-METHYLPYRIDINE-4-BORONIC ACID; 3-METHYLSULFAMOYLPHENYLBORONIC ACID; 3-METHYLSULFINYLPHENYLBORONIC ACID; 3-METHYLTHIOPHENE-2-BORONIC ACID; 3-MORPHOLINOPHENYLBORONIC ACID HYDROCHLORIDE; 3-MORPHOLINOPYRIDINE-2-BORONIC ACID; 3-N-CYCLOHEXYLSULFAMOYLPHENYLBORONIC ACID; 3-NITRO-5-(PIPERIDIN-1-YLCARBONYL)BENZENEBORONIC ACID; 3-NITRO-5-(PYRROLIDIN-1-YLCARBONYL)BENZENEBORONIC ACID; 3-NITRO-5-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 3-NITRO-5-VINYLPHENYLBORONIC ACID; 3′-NITRO-BIPHENYL-4-BORONIC ACID; 3-NITROPHENYLBORONIC ACID; 3-NITROPYRIDINE-2-BORONIC ACID; 3-OXO-2,3-DIHYDROPYRIDAZIN-4-YLBORONIC ACID; 3-OXO-6-(TRIFLUOROMETHYL)ISOINDOLIN-5-YLBORONIC ACID; 3-OXO-6-PHENYLISOINDOLIN-5-YLBORONIC ACID; 3-OXOISOINDOLIN-5-YLBORONIC ACID; 3-PHENOXYPHENYLBORONIC ACID; 3-PHENYL-1H-PYRAZOLE-5-BORONIC ACID; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-BORONIC ACID; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-BORONIC ACID; 3-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-BORONIC ACID; 3-PHENYLISOXAZOLE-5-BORONIC ACID; 3-PHENYLPROPYLBORONIC ACID; 3-PHENYLPYRIDINE-2-BORONIC ACID; 3-PHENYLPYRIDINE-4-BORONIC ACID; 3-PHENYLTHIOPHENE-2-BORONIC ACID; 3-PICOLINE-4-BORONIC ACID HCL; 3-PICOLINE-5-BORONIC ACIDHYDRATE; 3-PROPOXY-2,4,6-TRIFLUOROPHENYLBORONIC ACID; 3-PROPOXY-5-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 3-PROPOXY-5-TRIFLUOROMETHYLPHENYLBORONIC ACID; 3-PROPOXYPHENYLBORONIC ACID; 3-P-TOLYLISOXAZOL-5-YLBORONIC ACID; 3-PYRAZOL-1-YL-PHENYLBORONIC ACID; 3-PYRIDINECARBOXYLIC ACID-6-BORONIC ACID; 3-PYRROLIDINYLBORONIC ACID; 3-PYRROLIDINYLPYRIDINE-2-BORONIC ACID; 3-PYRROLYLBORONIC ACID; 3-QUINOLINEBORONIC ACID; 3-QUINOLINEBORONIC ACID, HCL; 3-T-BDMSTHIOPHENYLBORONIC ACID; 3-T-BUTOXYCARBOXYPHENYLBORONIC ACID; 3-T-BUTYL-5-CARBOXYPHENYLBORONIC ACID; 3-TERT-BUTOXYMETHYLPHENYLBORONIC ACID; 3-TERT-BUTYL-1H-PYRAZOLE-5-BORONIC ACID; 3-TERT-BUTYLPHENYLBORONIC ACID; 3-TRIFLUOROMETHYLBENZYLBORONIC ACID; 3′-TRIFLUOROMETHYL-BIPHENYL-4-BORONIC ACID; 3-TRIMETHYLSILYLPHENYLBORONIC ACID; 3-VINYLPHENYLBORONIC ACID; 4-((1-(TERT-BUTOXYCARBONYL)AZEPAN-3-YL)METHYL)PHENYLBORONIC ACID; 4-((1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 4-((1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)METHYL)PHENYLBORONIC ACID; 4-((1-NAPHTHYLOXY)METHYL)PHENYLBORONIC ACID; 4-((3,3-DIFLUOROPYRROLIDIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((3,3-DIMETHYLPYRROLIDIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((3-HYDROXYPYRROLIDIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((4-(TRIFLUOROMETHYL)PIPERIDIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((4H-1,2,4-TRIAZOL-3-YL)METHOXY)PHENYLBORONIC ACID; 4-((4H-1,2,4-TRIAZOL-4-YL)CARBAMOYL)PHENYLBORONIC ACID, HCL; 4-((4-METHOXYPIPERIDIN-1-YL)METHYL)PHENYLBORONIC ACID; 4-((BENZYLOXYCARBONYLAMINO)METHYL)PHENYLBORONIC ACID; 4-((DIETHYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 4-((DIMETHOXYPHOSPHORYL)METHYL)PHENYLBORONIC ACID; 4-((DIMETHYLAMINO)METHYL)PHENYLBORONIC ACID; 4-((DI-TERT-BUTOXYPHOSPHORYL)METHYL)PHENYLBORONIC ACID; 4-((N,N-DIMETHYLSULFAMOYL)METHYL)PHENYLBORONIC ACID; 4-((N-BOC-AMINO)METHYL)PHENYLBORONIC ACID; 4-((N-METHYLACETAMIDO)METHYL)PHENYLBORONIC ACID; 4-((PHENYLAMINO)METHYL)PHENYLBORONIC ACID; 4-((PYRIDIN-4-YLOXY)METHYL)PHENYLBORONIC ACID; 4-((TETRAHYDROFURAN-2-YL)METHYLCARBAMOYL)PHENYLBORONIC ACID; 4-([1,3]DIOXOLAN-2-YLMETHOXY)-PHENYLBORONIC ACID; 4-(1-(BENZYLOXYCARBONYLAMINO)CYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-(HYDROXYMETHYL)CYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-(METHOXYCARBONYL)CYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-(MORPHOLINE-4-CARBONYL)CYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YL)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YLOXY)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)PHENYLBORONIC ACID; 4-(1-(TERT-BUTOXYCARBONYLAMINO)CYCLOPROPYL)PHENYLBORONIC ACID; 4-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 4-(1,3-DIOXOLAN-2-YL)-2,6-DIFLUOROPHENYLBORONIC ACID; 4-(1,3-DIOXOLAN-2-YL)-2,6-DIMETHOXYPHENYLBORONIC ACID; 4-(1-ALLYL-PIPERIDIN-2-YL)-BENZENEBORONIC ACID; 4-(1-ALLYL-PYRROLIDIN-2YL)BENZENEBORONIC ACID; 4-(1-AMINOCYCLOPROPYL)PHENYLBORONIC ACID HYDROCHLORIDE; 4-(1-AMINOETHYL)PHENYLBORONIC ACID; 4-(1-BENZYL-1H-PYRAZOL-4-YL)-2-FLUOROPHENYLBORONIC ACID; 4-(1-BENZYL-1H-PYRAZOL-4-YL)PHENYLBORONIC ACID; 4-(1-BENZYLPIPERIDIN-4-YL)PHENYLBORONIC ACID; 4-(1-BOC-PIPERIDIN-4-YLOXY)-2-METHOXYPHENYLBORONIC ACID; 4(1-BOC-PIPERIDIN-4-YLOXY)-3-METHOXYPHENYLBORONIC ACID; 4-(1-BOC-PIPERIDIN-4-YLOXY)PHENYLBORONIC ACID; 4-(1-BOC-PYRROLIDIN-2-YL)BENZENEBORONIC ACID; 4-(1-BOC-PYRROLIDIN-3-YLOXY)PHENYLBORONIC ACID; 4-(1-CARBAMOYLCYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-CARBOXYCYCLOPROPYL)PHENYLBORONIC ACID; 4-(1-CYANOCYCLOPROPYL)PHENYLBORONIC ACID; 4-(1H-1,2,3-TRIAZOL-4-YL)PHENYLBORONIC ACID; 4-(1H-IMIDAZOL-1-YL)PHENYLBORONIC ACID; 4-(1H-PYRAZOL-1-YLSULFONYL)PHENYLBORONIC ACID; 4-(1H-PYRROL-1-YL)PHENYLBORONIC ACID; 4-(1H-PYRROL-1-YLSULFONYL)PHENYLBORONIC ACID; 4-(1H-TETRAZOL-5-YL)BUTYLBORONIC ACID; 4-(1H-TETRAZOL-5-YLCARBAMOYL)BENZENEBORONIC ACID HYDROCHLORIDE; 4-(1-HYDROXY-1-PHENYL)METHYLPHENYLBORONIC ACID; 4-(1-HYDROXYETHYL)PHENYLBORONIC ACID; 4-(1-METHYL-1H-IMIDAZOL-2-YL)PHENYLBORONIC ACID; 4-(1-PHENYL-1H-BENZO[D]IMIDAZOL-2-YL)PHENYLBORONIC ACID; 4-(1-PYRROLIDINYLMETHYL)PHENYLBORONIC ACID; 4-(2-(1,3-DIOXOISOINDOLIN-2-YL)ETHOXY)PHENYLBORONIC ACID; 4-(2-(1H-IMIDAZOL-1-YL)ETHOXY)PHENYLBORONIC ACID; 4-(2-(1H-PYRAZOL-1-YL)ETHOXY)PHENYLBORONIC ACID; 4-(2-(BENZYLOXYCARBONYLAMINO)ETHYL)PHENYLBORONIC ACID; 4-(2-(DIETHYLAMINO)ETHYLCARBAMOYL)PHENYLBORONIC ACID, HCL; 4-(2-(DIMETHYLAMINO)-2-OXOETHYL)PHENYLBORONIC ACID; 4-(2-(DIMETHYLAMINO)ETHOXY)-3-METHOXYPHENYLBORONIC ACID; 4-(2-(DIMETHYLAMINO)ETHYLCARBAMOYL)PHENYLBORONIC ACID, HCL; 4-(2-(DIMETHYLAMINO)ETHYLSULFONYL)PHENYLBORONIC ACID; 4-(2-(METHYLAMINO)-2-OXOETHOXY)PHENYLBORONIC ACID; 4-(2-(METHYLAMINO)-2-OXOETHYL)PHENYLBORONIC ACID; 4-(2-(METHYLAMINO)ACETAMIDO)PHENYLBORONIC ACID; 4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYLBORONIC ACID; 4-(2-(T-BUTOXYCARBONYLAMINO)ETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-(2,2,2-TRIFLUOROACETAMIDO)NAPHTHALEN-1-YLBORONIC ACID; 4-(2,2,2-TRIFLUOROETHOXY)PHENYLBORONIC ACID; 4-(2,2,2-TRIFLUOROETHYLAMINOCARBONYL)BENZENEBORONIC ACID; 4-(2,2-DIFLUOROETHOXY)PHENYLBORONIC ACID; 4-(2,2-DIMETHOXYETHOXY)PHENYLBORONIC ACID; 4-(2,2-DIMETHYLPROPANOYL)-4H-1,4-BENZOXAZIN-3-YLBORONIC ACID; 4-(2,2-DIPHENYLVINYL)PHENYLBORONIC ACID; 4-(2,4-DIFLUOROPHENOXY)PHENYLBORONIC ACID; 4-(2,4-DIOXOIMIDAZOLIDIN-5-YL)PHENYBORONIC ACID; 4-(2,5-DIMETHYL-1H-PYRROL-1-YL)PHENYLBORONIC ACID; 4-(2,6-DICHLOROPHENYLMETHOXY)PHENYLBORONIC ACID; 4-(2-ACETAMIDOETHOXY)PHENYLBORONIC ACID; 4-(2-ACETAMIDOETHYL)PHENYLBORONIC ACID; 4-(2-AMINOPHENOXY)PHENYLBORONIC ACID, HCL; 4-(2-CARBOXYETHYL)PHENYLBORONIC ACID; 4-(2-CARBOXYVINYL)BENZENEBORONIC ACID; 4-(2′-CHLOROBENZYLOXY)-3,5-DIMETHYLPHENYLBORONIC ACID; 4-(2-CHLOROETHOXY)PHENYLBORONIC ACID; 4-(2-CHLOROETHYLCARBAMOYL)BENZENEBORONIC ACID; 4-(2-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 4-(2-CYANOETHYL)PHENYLBORONIC ACID; 4-(2-CYANOETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(2-CYANOVINYL)PHENYLBORONIC ACID; 4-(2-ETHOXY-2-OXOETHOXY)BENZENEBORONIC ACID; 4-(2-ETHOXY-2-OXOETHYLTHIO)PHENYLBORONIC ACID; 4-(2′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 4-(2-FLUOROETHOXY)PHENYLBORONIC ACID; 4-(2-FLUOROPHENOXY)PHENYLBORONIC ACID; 4-(2-FLUOROPHENYL)FURAN-2-BORONIC ACID; 4-(2-FLUOROPHENYL)THIOPHENE-2-BORONIC ACID; 4-(2-FURYL)PYRIDINE-2-BORONIC ACID; 4-(2H-TETRAZOL-5-YL)-PHENYLBORONIC ACID; 4-(2-HYDROXYETHOXY)-3-METHOXYPHENYLBORONIC ACID; 4-(2-HYDROXYETHYL)PHENYLBORONIC ACID; 4-(2-HYDROXYETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-(2-HYDROXYPROPAN-2-YL)PYRIDINE-2-BORONIC ACID; 4-(2-HYDROXYPROPAN-2-YL)PYRIDINE-3-BORONIC ACID; 4-(2-METHOXY-2-OXOETHOXY)PHENYLBORONIC ACID; 4-(2-METHOXY-2-OXOETHYL)-2-METHYLPHENYLBORONIC ACID; 4-(2′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 4-(2-METHOXYCARBONYLETHYL)PHENYLBORONIC ACID; 4-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 4-(2-METHOXYETHYL)PHENYLBORONIC ACID; 4-(2-METHOXYETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-(2-METHOXYPHENYL)FURAN-2-BORONIC ACID; 4-(2-METHOXYPHENYL)THIOPHENE-2-BORONIC ACID; 4-(2-METHYL-1,3-DIOXOLAN-2-YL)PHENYLBORONIC ACID; 4-(2-METHYLTHIAZOL-5-YL)PHENYLBORONIC ACID; 4-(2-MORPHOLINOETHOXY)PHENYLBORONIC ACID, HCL; 4-(2-MORPHOLINOETHYL)PHENYLBORONIC ACID; 4-(2-MORPHOLINOETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-(2-NITRO-4-(TRIFLUOROMETHYL)PHENOXY)PHENYLBORONIC ACID; 4-(2-NITROETHYL)PHENYLBORONIC ACID; 4-(2-NITROPHENOXY)BENZENEBORONIC ACID; 4-(2-O-THP-HYDROXY-ETHYL)-PHENYL-BORONIC ACID; 4-(2-OXO-2-(PROPYLAMINO)ETHYL)PHENYLBORONIC ACID; 4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYLBORONIC ACID; 4-(2-OXOPYRROLIDIN-1-YL)PHENYLBORONIC ACID; 4-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)PHENYLBORONIC ACID; 4-(2-PYRIDYL)PHENYLBORONIC ACID; 4-(2-TETRAHYDROPYRANYLOXY)PHENYLBORONIC ACID; 4-(2-THIAZOLYL)AMINOCARBONYLPHENYLBORONIC ACID; 4-(2-THIAZOLYL)THIOPHENE-2-BORONIC ACID; 4-(2-THIENYL)PHENYLBORONIC ACID; 4-(2-THIENYL)PYRIDINE-2-BORONIC ACID; 4-(2-TOLYL)FURAN-2-BORONIC ACID; 4-(2-TOLYL)THIOPHENE-2-BORONIC ACID; 4-(3-(2-ACETYLHYDRAZINYL)-3-OXOPROPYL)PHENYLBORONIC ACID; 4-(3-(DIMETHYLAMINO)PHENOXY)PHENYLBORONIC ACID; 4-(3-(ETHOXYCARBONYL)PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(3′-(TRIFLUOROMETHYL)PHENOXYMETHYL)PHENYLBORONIC ACID; 4-(3,3-DIETHOXYPROPOXY)PHENYLBORONIC ACID; 4-(3,4,4-TRIFLUORO-BUT-3-EN-1-YL-OXY)-PHENYLBORONIC ACID; 4-(3,5-DIMETHOXYBENZYLOXY)PHENYLBORONIC ACID; 4-(3,7-DIMETHYLOCTYLOXY)BENZENEBORONIC ACID; 4-(3-CHLOROBENZYLAMINO)PHENYLBORONIC ACID; 4-(3′-CHLOROBENZYLOXY)-3,5-DIMETHYLPHENYLBORONIC ACID; 4-(3-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 4-(3-CHLOROPHENOXY)-3-METHOXYPHENYLBORONIC ACID; 4-(3-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 4-(3-CHLOROPROPYLCARBAMOYL)BENZENEBORONIC ACID; 4-(3-ETHYLUREIDO)-3-METHOXYPHENYLBORONIC ACID; 4-(3-ETHYLUREIDO)PHENYLBORONIC ACID; 4-(3′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 4-(3-FLUOROPHENOXY)-2-METHYLPHENYLBORONIC ACID; 4-(3-FLUOROPHENOXY)-2-NITROPHENYLBORONIC ACID; 4-(3-FLUOROPHENYL)FURAN-2-BORONIC ACID; 4-(3-FLUOROPHENYL)THIOPHENE-2-BORONIC ACID; 4-(3-FLUOROPHENYLCARBAMOYL)PHENYLBORONIC ACID; 4-(3-FLUORO-PROPOXY)-BENZENEBORONIC ACID; 4-(3-HYDRAZINYL-3-OXOPROPYL)PHENYLBORONIC ACID; 4-(3-HYDROXYPROPYL)PHENYLBORONIC ACID; 4-(3-HYDROXYPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-(3-ISOPROPYL-2-OXOIMIDAZOLIDIN-1-YL)PHENYLBORONIC ACID; 4-(3-METHOXYPHENYL)FURAN-2-BORONIC ACID; 4-(3-METHOXYPHENYL)THIOPHENE-2-BORONIC ACID; 4-(3-METHOXYPROPOXY)PHENYLBORONIC ACID; 4-(3-METHOXYPROPYLCARBAMOYL)BENZENEBORONIC ACID; 4-(3-METHYL-2-OXOIMIDAZOLIDIN-1-YL)PHENYLBORONIC ACID; 4-(3-METHYL-2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)PHENYLBORONIC ACID; 4-(3-METHYLOXETAN-3-YL)METHOXYPHENYLBORONIC ACID; 4-(3-METHYLTHIOUREIDO)PHENYLBORONIC ACID; 4-(3-PROPYL-1,2,4-OXADIAZOL-5-YL)PHENYLBORONIC ACID; 4-(3-TOLYL)FURAN-2-BORONIC ACID; 4-(3-TOLYL)THIOPHENE-2-BORONIC ACID; 4-(4-(2-HYDROXYETHYL)PIPERAZINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(4′-(2-PENTYLOXY)PHENYL)PHENYLBORONIC ACID; 4-(4-(BENZYLOXY)PHENOXY)PHENYLBORONIC ACID; 4-(4-(DIMETHYLAMINO)PIPERAZIN-1-YL)PHENYLBORONIC ACID; 4-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)PHENYLBORONIC ACID; 4-(4,4,6-TRIMETHYL-1,3-DIOXAN-2-YL)PHENYLBORONIC ACID; 4-(4-BENZYLOXYPHENYL)BENZENEBORONIC ACID; 4-(4-BOC-PIPERAZINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(4-BORONOPHENOXYMETHYL)BENZONITRILE; 4-(4-BUTYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(4-CHLORO-2-FLUOROBENZYL)PHENYLBORONIC ACID; 4-(4′-CHLOROBENZYLOXY)-3,5-DIMETHYLPHENYLBORONIC ACID; 4-(4′-CHLOROBENZYLOXY)PHENYLBORONIC ACID; 4-(4-CHLOROPHENOXYMETHYL)PHENYLBORONIC ACID; 4-(4-CHLOROPHENYLCARBAMOYL)PHENYLBORONIC ACID; 4-(4-ETHYLCYCLOHEXYL)-2-FLUOROPHENYLBORONIC ACID; 4-(4-ETHYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(4-FLUORO-2-NITROPHENOXY)PHENYLBORONIC ACID; 4-(4′-FLUOROBENZYLOXY)PHENYLBORONIC ACID; 4-(4-FLUOROPHENYL)FURAN-2-BORONIC ACID; 4-(4-FLUOROPHENYL)PHENYLBORONIC ACID; 4-(4-FLUOROPHENYL)THIOPHENE-2-BORONIC ACID; 4-(4′-ISOPENTYLOXYPHENYL)PHENYLBORONIC ACID; 4-(4′-ISOPROPOXYPHENYL)PHENYLBORONIC ACID; 4-(4′-METHOXYBENZYLOXY)PHENYLBORONIC ACID; 4-(4-METHOXYPHENYL)FURAN-2-BORONIC ACID; 4-(4-METHOXYPHENYL)THIOPHENE-2-BORONIC ACID; 4-(4-METHOXYPIPERIDIN-1-YL)PHENYLBORONIC ACID; 4-(4-METHYLBENZYLOXY)PHENYLBORONIC ACID; 4-(4-METHYLPIPERAZIN-1-YL)PHENYLBORONIC ACID; 4-(4-METHYLPIPERAZINE-1-CARBONYL)PHENYLBORONIC ACID, HCL; 4-(4-METHYL-PIPERAZINESULFONYL)PHENYL BORONIC ACID; 4-(4-METHYLPIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(4-NITROPHENOXY)PHENYLBORONIC ACID; 4-(4-PENTYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(4-PENTYLOXYPHENYL)BENZENEBORONIC ACID; 4-(4-PENTYLPHENYL)BENZENEBORONIC ACID; 4-(4′-PROPOXYPHENYL)PHENYLBORONIC ACID; 4-(4-TOLYL)FURAN-2-BORONIC ACID; 4-(4-TOLYL)THIOPHENE-2-BORONIC ACID; 4-(5-(ETHOXYMETHYL)-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-(METHOXYMETHYL)-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-(METHYLAMINO)-1,3,4-THIADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-AMINO-1,3,4-THIADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-BENZYLOXYPYRIMID-2-YL)PHENYLBORONIC ACID; 4-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-METHYLPYRIDIN-3-YL)PHENYLBORONIC ACID; 4-(5-OXOPYRAZOLIDIN-3-YL)PHENYLBORONIC ACID; 4-(5-PENTYLOXYPYRIMID-2-YL)PHENYLBORONIC ACID; 4-(5-PENTYLOXYTHIEN-2-YL)BENZENEBORONIC ACID; 4-(5-PENTYLPYRIMID-2-YL)PHENYLBORONIC ACID; 4-(5-PENTYLTHIEN-2-YL)BENZENEBORONIC ACID; 4-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-(6-METHOXYPYRIDIN-3-YL)PHENYLBORONIC ACID; 4-(9H-CARBOZOL-9-YL)PHENYLBORONIC ACID; 4-(9H-FLUOREN-9-YL)PHENYLBORONIC ACID; 4-(ACETAMIDOMETHYL)-3-METHOXYPHENYLBORONIC ACID; 4-(ACETOXYMETHYL)BENZENEBORONIC ACID; 4-(AMINOMETHYL)-3-FLUOROPHENYLBORONIC ACID, HCL; 4-(AMINOMETHYL)BENZENEBORONIC ACID; 4-(AZIRIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(BENZYL(ETHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-(BENZYL(METHYL)AMINO)PHENYLBORONIC ACID; 4-(BENZYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-(BENZYLAMINO)PHENYLBORONIC ACID; 4-(BENZYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(BENZYLOXY)-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(BENZYLOXY)-2,3-DIFLUOROPHENYLBORONIC ACID; 4-(BENZYLOXY)-2-CHLOROPHENYLBORONIC ACID; 4-(BENZYLOXY)-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(BENZYLOXY)-3,5-DICHLOROPHENYLBORONIC ACID; 4-(BENZYLOXY)-3,5-DIMETHOXYPHENYLBORONIC ACID; 4-(BOC-AMINOMETHYL)PYRIDINE-3-BORONIC ACID; 4-(BUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(BUTYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(BUTYLSULFINYL)PHENYLBORONIC ACID; 4-(BUTYLSULFONAMIDO)PHENYLBORONIC ACID; 4-(BUTYLSULFONYL)PHENYLBORONIC ACID; 4-(CARBOXYMETHOXY)PHENYLBORONIC ACID; 4-(CYANOMETHYL)BENZENEBORONIC ACID; 4-(CYCLOBUTYL)FURAN-2-BORONIC ACID; 4-(CYCLOBUTYL)THIOPHENE-2-BORONIC ACID; 4-(CYCLOHEXYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-(CYCLOHEXYL)FURAN-2-BORONIC ACID; 4-(CYCLOHEXYL)THIOPHENE-2-BORONIC ACID; 4-(CYCLOHEXYLAMINO)PHENYLBORONIC ACID; 4-(CYCLOHEXYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(CYCLOHEXYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(CYCLOHEXYLMETHOXY)PHENYLBORONIC ACID; 4-(CYCLOHEXYLOXY)METHYLPHENYLBORONIC ACID; 4-(CYCLOHEXYLSULFONYL)PHENYLBORONIC ACID; 4-(CYCLOPENTYL)FURAN-2-BORONIC ACID; 4-(CYCLOPENTYL)THIOPHENE-2-BORONIC ACID; 4-(CYCLOPENTYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(CYCLOPENTYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(CYCLOPROPANECARBOXAMIDO)PHENYLBORONIC ACID; 4-(CYCLOPROPANESULFONAMIDO)PHENYLBORONIC ACID; 4-(CYCLOPROPYL)FURAN-2-BORONIC ACID; 4-(CYCLOPROPYL)PYRIDINE-2-BORONIC ACID; 4-(CYCLOPROPYL)THIOPHENE-2-BORONIC ACID; 4-(CYCLOPROPYLAMINO)PHENYLBORONIC ACID; 4-(CYCLOPROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(CYCLOPROPYLMETHOXY)-2-FLUOROPHENYLBORONIC ACID; 4-(CYCLOPROPYLMETHOXY)BENZENEBORONIC ACID; 4-(CYCLOPROPYLMETHYLSULFINYL)PHENYLBORONIC ACID; 4-(CYCLOPROPYLMETHYLSULFONYL)PHENYLBORONIC ACID; 4-(CYCLOPROPYLMETHYLTHIO)PHENYLBORONIC ACID; 4-(CYCLOPROPYLSULFINYL)PHENYLBORONIC ACID; 4-(CYCLOPROPYLSULFONYL)PHENYLBORONIC ACID; 4-(DIBENZYLAMINO)NAPHTHALEN-1-YLBORONIC ACID; 4-(DIBENZYLAMINO)PHENYLBORONIC ACID; 4-(DIETHYLAMINO)PHENYLBORONIC ACID; 4-(DIETHYLCARBAMOYL)-2-METHOXYBENZENEBORONIC ACID; 4-(DIETHYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(DIFLUOROMETHOXY)-2-FLUOROPHENYLBORONIC ACID; 4-(DIFLUOROMETHOXY)BENZOTHIAZOLE-2-BORONIC ACID; 4-(DIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-(DIFLUOROMETHYL)-3-FLUOROPHENYLBORONIC ACID; 4-(DIHYDROXYBORANYL)-2,3-DIFLUOROBENZOIC ACID; 4-(DIHYDROXYBOROPHENYL)ACETYLENE; 4-(DIHYDROXYBORYL)-2-NITROBENZOIC ACID; 4-(DIHYDROXYBORYL)-3-METHOXYBENZOIC ACID; 4-(DIISOPROPYLCARBAMOYL)-2-ETHOXYPYRIDIN-3-YLBORONIC ACID; 4-(DIISOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-(DIISOPROPYLCARBAMOYL)PYRIDIN-3-YLBORONIC ACID; 4-(DIMETHYLAMINO)-2-METHYLPHENYLBORONIC ACID; 4-(DIMETHYLAMINO)PHENYLBORONIC ACID; 4-(DIMETHYLCARBAMOYL)-2-(PROP-1-YNYL)PHENYLBORONIC ACID; 4-(DIMETHYLCARBAMOYL)-2-FLUOROPHENYLBORONIC ACID; 4-(DIMETHYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(DIPHENYLAMINO)PHENYLBORONIC ACID; 4-(DIPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(2-NITROPHENYL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(4-FLUOROPHENYL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(4-NITROPHENYL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(PYRAZIN-2-YL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(PYRIDIN-2-YL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(PYRIDIN-4-YL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-1-(PYRIMIDIN-2-YL)-1H-PYRAZOL-5-YLBORONIC ACID; 4-(ETHOXYCARBONYL)-2-FURANBORONIC ACID; 4-(ETHOXYCARBONYLDIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(ETHOXY-D5)-PHENYLBORONIC ACID; 4-(ETHOXYMETHOXY)PHENYLBORONIC ACID; 4-(ETHOXYPHENYL-D9)-BORONIC ACID; 4-(ETHYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-(ETHYLAMINO)-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(ETHYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(ETHYL-D5)-PHENYLBORONIC ACID; 4-(ETHYLPHENYL-D9)-BORONIC ACID; 4-(ETHYLSULFONAMIDO)PHENYLBORONIC ACID; 4-(ETHYLSULFONYL)PHENYLBORONIC ACID; 4-(FURAN-2-YL)PHENYLBORONIC ACID; 4-(FURFURYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(HYDROXYIMINO)METHYLPHENYLBORONIC ACID; 4-(HYDROXYMETHYL)-3-(METHYLSULFONYL)PHENYLBORONIC ACID; 4-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 4-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 4-(HYDROXYMETHYL)PHENYLBORONIC ACID; 4-(HYDROXYMETHYL)THIOPHEN-3-YLBORONIC ACID; 4-(ISOBUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(ISOBUTYLSULFINYL)PHENYLBORONIC ACID; 4-(ISOBUTYLSULFONYL)PHENYLBORONIC ACID; 4-(ISOBUTYLTHIO)PHENYLBORONIC ACID; 4-(ISOPENTYLOXY)PHENYLBORONIC ACID; 4-(ISOPENTYLSULFINYL)PHENYLBORONIC ACID; 4-(ISOPENTYLSULFONYL)PHENYLBORONIC ACID; 4-(ISOPENTYLTHIO)PHENYLBORONIC ACID; 4-(ISOPROPOXYCARBONYL)-2-NITROPHENYLBORONIC ACID; 4-(ISOPROPOXYCARBONYLAMINO)PHENYLBORONIC ACID; 4-(ISO-PROPOXY-D7)-PHENYLBORONIC ACID; 4-(ISOPROPYL(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-(ISO-PROPYL)FURAN-2-BORONIC ACID; 4-(ISO-PROPYL)PYRIDINE-2-BORONIC ACID; 4-(ISO-PROPYL)THIOPHENE-2-BORONIC ACID; 4-(ISOPROPYLAMINO)-3-METHOXYPHENYLBORONIC ACID; 4-(ISOPROPYLAMINO)-5-(METHOXYCARBONYL)THIOPHEN-2-YLBORONIC ACID; 4-(ISOPROPYLAMINO)PHENYLBORONIC ACID; 4-(ISO-PROPYL-D7)-PHENYLBORONIC ACID; 4-(ISO-PROPYLPHENYL-D11)-BORONIC ACID; 4-(ISOPROPYLSULFONYLPHENYL)BORONIC ACID; 4-(METHANESULFINYL)BENZENEBORONIC ACID; 4-(METHANESULFONYLAMINO)PHENYLBORONIC ACID; 4-(METHOXYCARBONYL)-1H-INDOL-2-YLBORONIC ACID; 4-(METHOXYCARBONYL)-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-(METHOXYCARBONYL)-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4′-(METHOXYCARBONYL)BIPHENYL-4-YLBORONIC ACID; 4-(METHOXYCARBONYL)NAPHTHALENE-1-BORONIC ACID; 4-(METHOXYCARBONYL)PYRIDINE-3-BORONIC ACID; 4-(METHOXYCARBONYLAMINO)BENZENEBORONIC ACID; 4-(METHOXY-D3)-PHENYL-BORONIC ACID; 4-(METHOXYMETHOXY)-3,5-DIMETHYLPHENYLBORONIC ACID; 4-(METHOXYMETHOXY)PHENYLBORONIC ACID; 4-(METHOXYMETHYL)-2,6-DIMETHYLPHENYLBORONIC ACID; 4-(METHOXYMETHYL)PHENYLBORONIC ACID; 4-(METHOXYMETHYLTHIO)PHENYLBORONIC ACID; 4-(METHOXYPHENYL-D7)-BORONIC ACID; 4-(METHYL-D3)-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(METHYL-D3)-PHENYLBORONIC ACID; 4-(METHYLSULFONYL)-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(METHYLSULFONYL)PHENYLBORONIC ACID; 4-(METHYLSULFONYLOXY)PHENYLBORONIC ACID; 4-(METHYLTHIO)-1-(PHENYLSULFONYL)-1H-INDOL-2-YLBORONIC ACID; 4-(METHYLTHIO)-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(METHYLTHIO)PHENYLBORONIC ACID; 4-(METHYLTHIOL-D3)-PHENYLBORONIC ACID; 4-(MORPHOLIN-1-YL)PHENYLBORONIC ACID HCL; 4-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 4-(MORPHOLINOMETHYL)PHENYLBORONIC ACID; 4-(MORPHOLINOSULFONYL)PHENYLBORONIC ACID; 4-(N-(1-METHYLPIPERIDIN-4-YL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(2-(TBDMSO)ETHYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(3-CHLORO-2-METHYLPHENYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(3-CHLOROPHENYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(3-CHLOROPROPYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(3-METHYLBUTANOYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(4-FLUORO-3-METHOXYPHENYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(4-HYDROXYCYCLOHEXYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-(TERT-BUTOXYCARBONYL)METHYLSULFONAMIDO)PHENYLBORONIC ACID; 4-(N,N-BIS(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N,N-DIETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N,N-DIETHYLAMINOMETHYL)BENZENEBORONIC ACID; 4-(N,N-DIETHYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 4-(N,N-DIMETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N,N-DIMETHYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 4-(N,N-DIMETHYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N,O-DIMETHYLHYDROXYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N-ACETYLSULFAMOYL)PHENYLBORONIC ACID; 4-(NAPHTHALEN-1-YL)PHENYLBORONIC ACID; 4-(NAPHTHALEN-2-YL)PHENYLBORONIC ACID; 4-(NAPHTHALENE-1-YL)-1-NAPHTHALENE BORONIC ACID; 4-(N-BENZYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N-BENZYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-BENZYLSULPHONAMIDO)BENZENEBORONIC ACID; 4-(N-BUTOXYCARBONYL)AMINOPHENYLBORONIC ACID; 4-(N-BUTYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-BUTYLSULPHONAMIDO)BENZENEBORONIC ACID; 4-(N-CYCLOHEXYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-CYCLOHEXYL-N-METHYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-CYCLOHEXYLSULPHONAMIDO)BENZENEBORONIC ACID; 4-(N-CYCLOPENTYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-CYCLOPROPYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 4-(N-CYCLOPROPYLSULFAMOYL)PHENYLBORONIC ACID; 4-(NEOPENTYLOXY)PHENYLBORONIC ACID; 4-(NEOPENTYLOXYSULFONYL)PHENYLBORONIC ACID; 4-(N-ETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N-ETHYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 4-(N-ETHYLSULPHONAMIDO)BENZENEBORONIC ACID; 4-(N′-HYDROXYCARBAMIMIDOYL)BENZENEBORONIC ACID; 4-(N-ISOBUTYRYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-ISOPROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N-ISOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-ISOPROPYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 4-(N-ISOPROPYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-METHYLAMINOCARBONYL)-2-FLUOROPHENYLBORONIC ACID; 4-(N-METHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(N-METHYL-N-(1-METHYLPIPERIDIN-4-YL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-METHYL-N-(4-METHOXYBENZYL)SULFAMOYL)PHENYLBORONIC ACID; 4-(N-METHYLSULFAMOYLMETHYL)PHENYLBORONIC ACID; 4-(N-NAPHTHALEN-1-YLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-NONYLOXY)BENZENEBORONIC ACID; 4-(N-OCTYL)BENZENEBORONIC ACID; 4-(N-PIPERIDIN-4-YLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-PROPIONYLSULFAMOYL)PHENYLBORONIC ACID; 4-(N-PROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(O-METHYLHYDROXYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(OXAZOL-5-YL)PHENYLBORONIC ACID; 4-(PENTAN-3-YLOXY)PHENYLBORONIC ACID; 4-(PHENETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-(PHENOXYMETHYL)PHENYLBORONIC ACID; 4-(PIPERIDIN-1-YLMETHYL)PHENYLBORONIC ACID; 4-(PIPERIDIN-1-YLSULFONYL)PHENYLBORONIC ACID; 4-(PIPERIDIN-4-YLSULFONYL)PHENYLBORONIC ACID; 4-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(PIPERIDINO)PHENYLBORONIC ACID; 4-(PIPERIDINO)PHENYLBORONIC ACID HCL; 4-(PROP-1-YNYL)PYRIDIN-3-YLBORONIC ACID; 4-(PROP-2-YNYL)PHENYLBORONIC ACID; 4-(PROPYLSULFONYL)PHENYLBORONIC ACID; 4-(PYRIDIN-2-YL-AMINOCARBONYL)BENZENEBORONIC ACID; 4-(PYRIDIN-2-YLMETHOXY)PHENYLBORONIC ACID; 4-(PYRIDIN-2-YLOXY)PHENYLBORONIC ACID; 4-(PYRIDIN-3-YLMETHOXY)PHENYLBORONIC ACID; 4-(PYRIDIN-4-YL)PHENYL BORONIC ACID; 4-(PYRIDIN-4-YLAMINO)PHENYLBORONIC ACID; 4-(PYRIDIN-4-YLMETHOXY)PHENYLBORONIC ACID; 4-(PYRIDIN-4-YLOXY)PHENYLBORONIC ACID; 4-(PYRIDINE-3-YL)PHENYLBORONIC ACID; 4-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-(PYRROLIDINO)PHENYLBORONIC ACID HCL; 4-(PYRROLIDINYLSULFONYL)PHENYLBORONIC ACID; 4-(T-BOC-(PHENYL)AMINO)PHENYLBORONIC ACID; 4-(TERT-BUTOXY)PYRIDINE-2-BORONIC ACID; 4-(TERT-BUTOXYCARBONYL)-2,3,4,5-TETRAHYDROBENZO[F][1,4]OXAZEPIN-7-YLBORONIC ACID; 4-(TERT-BUTOXYCARBONYL)-3-METHYLPHENYLBORONIC ACID; 4-(TERT-BUTOXYCARBONYL)PHENYLBORONIC ACID; 4-(TERT-BUTOXYCARBONYLAMINO)-2,6-DIMETHYLPHENYLBORONIC ACID; 4-(TERT-BUTOXYCARBONYL-ISOPROPYLAMINO)-BENZENEBORONIC ACID; 4(TERT-BUTOXYCARBONYL-N-METHYLAMINO)-PHENYLBORONIC ACID; 4-(TERT-BUTYL)PYRIDINE-2-BORONIC ACID; 4-(TERT-BUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-(TERT-BUTYLAMINOSULPHONYL)BENZENEBORONIC ACID; 4-(TERT-BUTYLCARBAMOYL)-3-FLUOROBENZENEBORONIC ACID; 4-(TERT-BUTYLDIMETHYLSILYLOXY)-2-(PROP-1-YNYL)PHENYLBORONIC ACID; 4-(TERT-BUTYLDIMETHYLSILYLOXY)-3,5-DICHLOROPHENYLBORONIC ACID; 4-(TERT-BUTYLDIMETHYLSILYLOXY)-3-METHOXYPHENYLBORONIC ACID; 4-(TERT-BUTYLDIMETHYLSILYLOXY)CYCLOHEX-1-ENYLBORONIC ACID; 4-(TERT-BUTYLDIMETHYLSILYLOXY)PHENYLBORONIC ACID; 4-(TERT-BUTYLTHIO)PHENYLBORONIC ACID; 4-(TETRAHYDRO-2H-PYRAN-2-YL)METHOXYPHENYLBORONIC ACID; 4-(TETRAHYDRO-2H-PYRAN-2-YLSULFANYL)PHENYLBORONIC ACID; 4-(TETRAHYDRO-2H-PYRAN-4-YL)METHOXYPHENYLBORONIC ACID; 4-(TETRAHYDROPYRAN-4-YLOXYMETHY)PHENYLBORONIC ACID; 4-(TETRAZOL-5-YL)PHENYLBORONIC ACID; 4-(THIAZOL-2-YL)FURAN-2-BORONIC ACID; 4-(THIAZOLINE-3-CARBONYL)PHENYLBORONIC ACID; 4-(THIOMORPHOLIN-4-YLCARBONYL)BENZENEBORONIC ACID; 4-(THIOMORPHOLINYLSULFONYL)PHENYLBORONIC ACID; 4-(THIOPHEN-2-YLCARBAMOYL)PHENYLBORONIC ACID; 4-(TOLYL-D7)-BORONIC ACID; 4-(TRANS-4-BUTYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(TRANS-4-ETHYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(TRANS-4-HYDROXYCYCLOHEXYLCARBAMOYL)PHENYLBORONIC ACID; 4-(TRANS-4-PENTYLCYCLOHEXYL)PHENYLBORONIC ACID; 4-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)-2-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-(TRIFLUOROMETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-(TRIFLUOROMETHYL)-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-(TRIFLUOROMETHYL)-2-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)-2-FURANBORONIC ACID; 4-(TRIFLUOROMETHYL)-2-THIOPHENEBORONIC ACID; 4′-(TRIFLUOROMETHYL)-4-BIPHENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)CYCLOHEX-1-ENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-(TRIFLUOROMETHYL)PYRIDINE-2-BORONIC ACID; 4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 4-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID HYDRATE; 4-(TRIFLUOROMETHYL)PYRIMIDINE-5-BORONIC ACID; 4-(TRIFLUOROMETHYLTHIO)-BENZENEBORONIC ACID; 4-(TRIFLUOROVINYLOXYPHENYL)BORONIC ACID; 4-(TRIISOPROPYLSILYLOXY)PHENYL BORONIC ACID; 4-(TRIMETHYLAMMONIUM)METHYLPHENYLBORONIC ACID BROMIDE SALT; 4-(TRIMETHYLAMMONIUM)METHYLPHENYLBORONIC ACID IODIDE SALT; 4-(TRIMETHYLSILYL)THIOPHEN-2-YLBORONIC ACID; 4,4-DIMETHYL-2-OXO-2,4-DIHYDRO-1H-BENZO[D][1,3]OXAZIN-6-YLBORONIC ACID; 4,4-DIMETHYLCYCLOHEXEN-1-YLBORONIC ACID; 4,5,6,7-TETRAHYDRO-3-PYRAZOLO[1,5-A]PYRIDINE BORONIC ACID; 4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDIN-2-YL BORONIC ACID; 4,5-BIS(BENZYLOXY)-2-CHLOROPHENYLBORONIC ACID; 4,5-DICHLORO-2-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 4,5-DICHLORO-2-METHOXYPHENYLBORONIC ACID; 4,5-DICHLOROPYRIDINE-3-BORONIC ACID; 4,5-DICHLOROTHIOPHEN-2-YLBORONIC ACID; 4,5-DIFLUORO-2-ETHOXYPHENYLBORONIC ACID; 4,5-DIFLUORO-2-ISOPROPOXYPHENYLBORONIC ACID; 4,5-DIFLUORO-2-METHOXYPHENYLBORONIC ACID; 4,5-DIFLUORO-2-METHYLPHENYLBORONIC ACID; 4,5-DIFLUORO-2-NITROPHENYLBORONIC ACID; 4,5-DIMETHOXY-2-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4,5-DIMETHYLPYRIDINE-2-BORONIC ACID; 4,5-DIMETHYLPYRIDINE-3-BORONIC ACID; 4,6-DICHLORO-PYRIDINE-2-BORONIC ACID; 4,6-DICHLOROPYRIDINE-3-BORONIC ACID; 4,6-DICHLOROPYRIMIDIN-2-YLBORONIC ACID; 4,6-DIMETHOXYBENZOFURAN-2-YLBORONIC ACID; 4,6-DIMETHOXYPYRIDINE-3-BORONIC ACID; 4,6-DIMETHOXYPYRIMIDIN-5-YLBORONIC ACID; 4,6-DIMETHYLPYRIDINE-2-BORONIC ACID; 4,6-DIMETHYLPYRIDINE-3-BORONIC ACID; 4-[(1,1-DIMETHYLETHOXY)CARBONYL]PHENYLMETHYL)AMINOPHENYLBORONIC ACID; 4-[(2,3-DIFLUOROPHENYL)METHOXY]PHENYLBORONIC ACID; 4-[(2,3-DIMETHYLPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(2,4-DIMETHYLPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(2,5-DIMETHYLPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(2′,6′-DIISOPROPYLPHENOXY)METHYL]PHENYLBORONIC ACID; 4-[(2-CHLORO-4-METHYLPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(2′-CHLORO-5′-(TRIFLUOROMETHYL)PHENOXY)METHYL]PHENYLBORONIC ACID; 4-[(2-FLUOROPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(2-HYDROXYETHYL)THIO]PHENYLBORONIC ACID; 4-[(2-ISOPROPYL-5-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 4-[(2-PIPERIDIN-1-YLETHYL)CARBAMOYL]BENZENEBORONIC ACID HYDROCHLORIDE; 4-[(2-PYRROLIDIN-1-YLETHYL)CARBAMOYL]BENZENEBORONIC ACID HYDROCHLORIDE; 4-[(3-CHLORO-4-METHYLPHENYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(3-ETHOXY-3-OXOPROPYL)CARBAMOYL]BENZENEBORONIC ACID; 4-[(4′-(2-METHOXYETHYL)PHENOXY)METHYL]PHENYLBORONIC ACID; 4-[(4′-CHLORO-1-NAPHTHYLOXY)METHYL]PHENYLBORONIC ACID; 4-[(4-FLUOROPHENYL)AMINOCARBONYL]BENZENEBORONIC ACID; 4-[(4-METHOXYBENZYL)SULPHAMOYL]BENZENEBORONIC ACID; 4-[(4-TERT-BUTYL-2-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID; 4-[(BENZYLOXY)METHYL]PYRIDINE-2-BORONIC ACID; 4-[(FURAN-2-YLMETHOXY)METHYL]PHENYLBORONIC ACID; 4-[(METHYLSULFONYL)METHYL]PHENYLBORONIC ACID; 4-[(THIEN-2-YLMETHOXY)METHYL]BENZENEBORONIC ACID; 4-[4′-(3-PENTYLOXY)PHENYL]PHENYLBORONIC ACID; 4-[4′-(TRIFLUOROMETHOXY)PHENOXYMETHYL]PHENYLBORONIC ACID; 4-[5-(4-DIMETHYLAMINOPHENYL)OXAZOL-2-YL]PHENYLBORONIC ACID; 4-[N-CYCLOPROPYL-N-(4-METHOXYBENZYL)SULFAMOYL]PHENYLBORONIC ACID; 4-[N-ETHYL-N-(4-METHOXYBENZYL)SULPHAMOYL]BENZENEBORONIC ACID; 4-[TERT-BUTYL(4-METHOXYBENZYL)SULPHAMOYL]BENZENEBORONIC ACID; 4-ACETAMIDO-2-CYANOPHENYLBORONIC ACID; 4-ACETAMIDO-2-METHYLPHENYLBORONIC ACID; 4-ACETAMIDO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-ACETAMIDO-3-CYANOPHENYLBORONIC ACID; 4-ACETAMIDO-3-METHOXYPHENYLBORONIC ACID; 4-ACETAMIDOPHENYLBORONIC ACID; 4-ACETOXY-3-NITROPHENYLBORONIC ACID; 4-ACETOXYBENZENEBORONIC ACID; 4-ALLYLOXY PHENYL BORONIC ACID; 4-AMINO-3-CYANO-2-(TRIFLUOROMETHYL)QUINOLIN-6-YLBORONIC ACID; 4-AMINO-3-FLUOROBENZENEBORONIC ACID, N-CBZ PROTECTED; 4-AMINO-3-FLUOROPHENYLBORONIC ACID; 4-AMINO-3-FLUOROPHENYLBORONIC ACID HYDROCHLORIDE; 4-AMINO-3-NITROPHENYLBORONIC ACID; 4-AMINO-6-METHOXYPYRIDIN-2-YLBORONIC ACID; 4-AMINO-6-METHYLPYRIDINE-3-BORONIC ACID; 4-AMINOBENZYLBORONIC ACID; 4-AMINOCARBONYLPHENYLBORONIC ACID; 4-AMINOMETHYLPHENYLBORONIC ACID HYDROCHLORIDE; 4-AMINOPHENYLBORONIC ACID; 4-AMINOPHENYLBORONIC ACID HYDROCHLORIDE; 4-AMINOPYRIDIN-3-YLBORONIC ACID; 4-AMINOPYRIDINE-2-BORONIC ACID; 4-BENZAMIDOPHENYLBORONIC ACID; 4-BENZOFURANYL-BORONIC ACID; 4-BENZYLOXY-1H-INDOLE-BORONIC ACID; 4-BENZYLOXY-1-TERT-BUTOXYCARBONYLINDOLE-2-BORONIC ACID; 4-BENZYLOXY-2,5-DIMETHOXYPHENYLBORONIC ACID; 4-BENZYLOXY-2,6-DIFLUOROPHENYLBORONIC ACID; 4-BENZYLOXY-2-DIMETHYLAMINO-PYRIMIDINE-5-BORONIC ACID; 4-BENZYLOXY-2-FLUOROPHENYLBORONIC ACID; 4-BENZYLOXY-2-METHYLPHENYLBORONIC ACID; 4-BENZYLOXY-2-PIPERIDINE-1-YL-PYRIMIDINE-5-BORONIC ACID; 4-BENZYLOXY-3,5-DIFLUOROPHENYLBORONIC ACID; 4-BENZYLOXY-3,5-DIMETHYLPHENYLBORONIC ACID; 4-BENZYLOXY-3-CHLORO-5-METHYLPHENYLBORONIC ACID; 4-BENZYLOXY-3-CHLOROPHENYLBORONIC ACID; 4-BENZYLOXY-3-FLUOROPHENYLBORONIC ACID; 4-BENZYLOXY-3-METHOXYBENZENEBORONIC ACID; 4-BENZYLOXY-3-METHYLPHENYLBORONIC ACID; 4′-BENZYLOXYCARBONYLAMINO-BIPHENYL-4-BORONIC ACID; 4-BENZYLOXYCARBONYLPHENYLBORONIC ACID; 4-BENZYLOXYPHENYLBORONIC ACID; 4-BENZYLTHIOPHENYLBORONIC ACID; 4-BIPHENYLBORONIC ACID; 4′-BORONIC ACID-BIPHENYL-3-CARBOXYLIC ACID METHYL ESTER; 4-BORONO-2-(CYCLOHEXYLOXY)BENZOIC ACID; 4-BORONO-2-(TRIFLUOROMETHYL)BENZOIC ACID; 4-BORONO-2-ISOBUTYLBENZOIC ACID; 4-BORONO-3,5-DIFLUOROBENZOIC ACID; 4-BORONO-3-FLUOROTHIOANISOLE; 4-BORONO-5-FLUORO-2-METHOXYBENZOIC ACID; 4-BORONOBENZENESULFONIC ACID; 4-BORONOBENZOHYDRAZIDE; 4-BORONO-DL-PHENYLALANINE; 4-BORONO-DL-PHENYLALANINE B10 ENRICHED; 4-BORONO-D-PHENYLALANINE; 4-BORONO-D-PHENYLALANINE B10 ENRICHED; 4-BORONO-L-PHENYLALANINE; 4-BORONO-L-PHENYLALANINE B10 ENRICHED; 4-BORONONICOTINIC ACID; 4-BORONOPYRIDINE 1-OXIDE; 4-BUTOXY-2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 4-BUTOXY-2-METHYLPHENYLBORONIC ACID; 4-BUTOXY-3,5-DIMETHYLPHENYLBORONIC ACID; 4-BUTOXY-3-CHLOROPHENYLBORONIC ACID; 4-BUTOXY-3-FLUOROPHENYLBORONIC ACID; 4-BUTOXYPHENYLBORONIC ACID; 4′-BUTYL-3-FLUOROBIPHENYL-4-BORONIC ACID; 4′-BUTYL-4-BIPHENYLBORONIC ACID; 4-BUTYLPHENYLBORONIC ACID; 4-BUTYLPYRIMIDINE-5-BORONIC ACID; 4-BUTYLTHIOPHENYLBORONIC ACID; 4-CARBAMOYL-2-FLUOROBENZENEBORONIC ACID; 4-CARBAMOYL-3-CHLOROPHENYLBORONIC ACID; 4-CARBAMOYL-3-FLUOROPHENYLBORONIC ACID; 4-CARBOXY-2,6-DICHLOROPHENYLBORONIC ACID; 4-CARBOXY-2-CHLOROPHENYLBORONIC ACID; 4-CARBOXY-2-FLUOROPHENYLBORONIC ACID; 4-CARBOXY-2-NITROPHENYLBORONIC ACID; 4-CARBOXY-3-CHLOROPHENYLBORONIC ACID; 4-CARBOXY-3-FLUOROPHENYLBORONIC ACID; 4-CARBOXY-6-CHLOROPYRIDINE-3-BORONIC ACID; 4-CARBOXYNAPHTHALENE-1-BORONIC ACID; 4-CARBOXYPHENYLBORONIC ACID; 4-CHLORO-1-(2,2-DIFLUOROETHYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-(2-METHOXYETHYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-(CYCLOPROPYLMETHYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-(METHYLSULFONYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-(TRIMETHYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-CYCLOPENTYL-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-ETHYL-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1H-INDOLE-2-BORONIC ACID; 4-CHLORO-1-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 4-CHLORO-1-METHYL-1H-PYRROLE-2-BORONIC ACID; 4-CHLORO-1-METHYL-PYRROL-3-YLBORONIC ACID; 4-CHLORO-1-PHENYL-PYRROL-3-YLBORONIC ACID; 4-CHLORO-2-((TETRAHYDRO-2H-PYRAN-2-YL)METHOXY)PHENYLBORONIC ACID; 4-CHLORO-2-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 4-CHLORO-2-(CYCLOPENTYLOXY)PHENYLBORONIC ACID; 4-CHLORO-2-(METHOXYMETHYL)PHENYLBORONIC ACID; 4-CHLORO-2-(PIPERIDIN-1-YL)PHENYLBORONIC ACID; 4-CHLORO-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-CHLORO-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-CHLORO-2,3-DIFLUOROPHENYLBORONIC ACID; 4-CHLORO-2,5-DIFLUOROPHENYLBORONIC ACID; 4-CHLORO-2,6-DIFLUOROPHENYLBORONIC ACID; 4-CHLORO-2,6-DIMETHOXYPHENYLBORONIC ACID; 4-CHLORO-2,6-DIMETHYLPYRIDINE-3-BORONIC ACID; 4-CHLORO-2-CYANOPHENYLBORONIC ACID; 4-CHLORO-2-ETHOXYPHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-3-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-3-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-3-ISOPROPOXYPHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-3-METHOXYPHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-3-PROPOXYPHENYLBORONIC ACID; 4-CHLORO-2-FLUORO-5-METHOXYPHENYLBORONIC ACID; 4-CHLORO-2-FLUOROPHENYLBORONIC ACID; 4-CHLORO-2-FURANBORONIC ACID; 4-CHLORO-2-HYDROXY-6-METHYLPHENYLBORONIC ACID; 4-CHLORO-2-HYDROXYPHENYLBORONIC ACID; 4-CHLORO-2-ISOBUTOXYPHENYLBORONIC ACID; 4-CHLORO-2-ISOPROPOXYPHENYLBORONIC ACID; 4-CHLORO-2-METHOXYPHENYLBORONIC ACID; 4-CHLORO-2-METHOXYPYRIDINE-3-BORONIC ACID; 4-CHLORO-2-METHOXYPYRIDINE-5-BORONIC ACID; 4-CHLORO-2-METHYLPHENYLBORONIC ACID; 4-CHLORO-2-METHYLPYRIDINE-3-BORONIC ACID; 4-CHLORO-2-METHYLPYRIDINE-5-BORONIC ACID; 4-CHLORO-2-PROPOXYPHENYLBORONIC ACID; 4-CHLORO-3-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YLOXY)PHENYLBORONIC ACID; 4-CHLORO-3-(2-DIMETHYLAMINOETHOXY)PHENYLBORONIC ACID; 4-CHLORO-3-(2-METHOXYETHOXY)PHENYLBORONIC ACID; 4-CHLORO-3-(CYCLOHEXYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(CYCLOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(DIMETHYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(ETHOXYCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(ETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(ISOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(N,N-DIETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(N-BUTYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(N-METHYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(N-MORPHOLINECARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(N-PROPYLAMINOCARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-CHLORO-3-(T-BUTYLCARBAMOYL)PHENYLBORONIC ACID; 4-CHLORO-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-CHLORO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-CHLORO-3-CYANOPHENYLBORONIC ACID; 4-CHLORO-3-ETHOXY-2-FLUOROPHENYLBORONIC ACID; 4-CHLORO-3-ETHOXYPHENYLBORONIC ACID; 4-CHLORO-3-ETHYLPHENYLBORONIC ACID; 4-CHLORO-3-FLUOROPHENYLBORONIC ACID; 4-CHLORO-3-ISOBUTOXYPHENYLBORONIC ACID; 4-CHLORO-3-ISOPROPOXYPHENYLBORONIC ACID; 4-CHLORO-3-METHOXYPHENYLBORONIC ACID; 4-CHLORO-3-METHOXYPYRIDINE-2-BORONIC ACID; 4-CHLORO-3-METHYLPHENYLBORONIC ACID; 4-CHLORO-3-METHYLPYRIDINE-2-BORONIC ACID; 4-CHLORO-3-NITROPHENYLBORONIC ACID; 4-CHLORO-3-PROPOXYPHENYLBORONIC ACID; 4′-CHLORO-4-BIPHENYLBORONIC ACID; 4-CHLORO-5-(METHOXYCARBONYL)THIOPHENE-2-BORONIC ACID; 4-CHLORO-5-METHOXYPYRIDINE-2-BORONIC ACID; 4-CHLORO-5-METHOXYPYRIDINE-3-BORONIC ACID; 4-CHLORO-5-METHYLPYRIDINE-2-BORONIC ACID; 4-CHLORO-5-METHYLPYRIDINE-3-BORONIC ACID; 4-CHLORO-6-(TRIFLUOROMETHYL)PYRIDIN-2-YLBORONIC ACID; 4-CHLORO-6-METHOXYPYRIDIN-2-YLBORONIC ACID; 4-CHLOROCARBONYL-3-FLUOROPHENYLBORONIC ACID; 4-CHLOROCARBONYLPHENYLBORONIC ACID; 4-CHLOROMETHYLPHENYLBORONIC ACID; 4-CHLORO-N-(BOC)-INDOLE-2-BORONIC ACID; 4-CHLOROPHENYLBORONIC ACID; 4-CHLOROPYRIDINE-2-BORONIC ACID; 4-CHLOROPYRIDINE-3-BORONIC ACID; 4-CHLOROPYRIDINE-3-BORONIC ACID, HCL; 4-CHLOROPYRIMIDINE-2-BORONIC ACID; 4-CHLOROPYRIMIDINE-5-BORONIC ACID; 4-CHLORO-PYRROL-3-YLBORONIC ACID; 4-CHLOROQUINOLINE-3-BORONIC ACID; 4-CHLOROTHIOPHEN-2-YLBORONIC ACID; 4-CYANO-1H-INDOL-2-YLBORONIC ACID; 4-CYANO-2,3-DIFLUOROPHENYLBORONIC ACID; 4-CYANO-2,5-DIFLUOROPHENYLBORONIC ACID; 4-CYANO-2,6-DIFLUOROPHENYLBORONIC ACID; 4-CYANO-2-FLUOROPHENYLBORONIC ACID; 4-CYANO-2-HYDROXYPHENYLBORONIC ACID; 4-CYANO-2-METHOXYPHENYLBORONIC ACID; 4-CYANO-2-METHOXYPYRIDIN-3-YLBORONIC ACID; 4-CYANO-2-THIOPHENEBORONIC ACID; 4-CYANO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-CYANO-3,5-DIFLUOROPHENYLBORONIC ACID; 4-CYANO-3-FLUOROPHENYLBORONIC ACID; 4-CYANO-3-HYDROXYPHENYLBORONIC ACID; 4-CYANO-3-METHOXYPHENYLBORONIC ACID; 4-CYANO-3-METHYLBENZO[B]THIOPHEN-2-YLBORONIC ACID; 4-CYANO-3-METHYLPHENYLBORONIC ACID; 4-CYANOBENZO[B]THIOPHEN-2-YLBORONIC ACID; 4-CYANOMETHOXYPHENYLBORONIC ACID; 4-CYANONAPHTHALEN-2-YLBORONIC ACID; 4-CYANOPHENYLBORONIC ACID; 4-CYANOPYRIDINE-2-BORONIC ACID; 4-CYANOPYRIDINE-3-BORONIC ACID; 4-CYANOTHIOPHEN-3-YLBORONIC ACID; 4-CYCLOBUTYL(PHENYL-D4)-BORONIC ACID; 4-CYCLOBUTYLPHENYLBORONIC ACID; 4-CYCLOHEXYLBENZENEBORONIC ACID; 4-CYCLOPENTENYLPHENYLBORONIC ACID; 4-CYCLOPENTOXYPHENYLBORONIC ACID; 4-CYCLOPENTYLPHENYLBORONIC ACID; 4-CYCLOPENTYLPYRIMIDINE-5-BORONIC ACID; 4-CYCLOPROPOXYPHENYLBORONIC ACID; 4-CYCLOPROPYL(PHENYL-D4)-BORONIC ACID; 4-CYCLOPROPYL-BENZENEBORONIC ACID; 4-CYCLOPROPYL-PYRROL-3-YLBORONIC ACID; 4-CYCLOPROPYLTHIOPHENYLBORONIC ACID; 4-DIFLUOROMETHOXY-3-FLUORO-BENZENEBORONIC ACID; 4-DIFLUOROMETHOXY-3-METHYL-BENZENEBORONIC ACID; 4-DIFLUOROMETHOXY-3-TRIFLUOROMETHYL-BENZENEBORONIC ACID; 4-DIFLUOROMETHYL-PHENYLBORONIC ACID; 4-DIMETHYLAMINONAPHTHALENE-1-BORONIC ACID; 4-DIMETHYLAMINOPHENYLBORONIC ACID HYDROCHLORIDE; 4-DIPHENYL-1-NAPHTHALENE BORONIC ACID; 4-ETHOXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-ETHOXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-ETHOXY-2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 4-ETHOXY-2-FLUOROPHENYLBORONIC ACID; 4-ETHOXY-2-METHOXYPHENYLBORONIC ACID; 4-ETHOXY-2-METHYLPHENYLBORONIC ACID; 4-ETHOXY-3-FLUOROPHENYLBORONIC ACID; 4-ETHOXY-3-METHYLPHENYLBORONIC ACID; 4-ETHOXYBIPHENYL-4′-BORONIC ACID; 4-ETHOXYCARBONYL-2-NITROPHENYLBORONIC ACID; 4-ETHOXYCARBONYL-3-FLUOROPHENYLBORONIC ACID; 4-ETHOXYCARBONYL-3-METHOXYPHENYLBORONIC ACID; 4-ETHOXYCARBONYLMETHYLPHENYLBORONIC ACID; 4-ETHOXYCARBONYLPHENYLBORONIC ACID; 4-ETHOXYMETHYLPHENYLBORONIC ACID; 4-ETHOXYPHENYLBORONIC ACID; 4-ETHOXYPYRIDINE-3-BORONIC ACID; 4-ETHYL-3,5-DIMETHYLPHENYLBORONIC ACID; 4′-ETHYL-3-FLUOROBIPHENYL-4-BORONIC ACID; 4′-ETHYL-4-BIPHENYLBORONIC ACID; 4-ETHYL-6-(ETHYL(METHYL)AMINO)PYRIDIN-3-YLBORONIC ACID; 4-ETHYLCYCLOHEXEN-1-YLBORONIC ACID; 4-ETHYLFURAN-2-BORONIC ACID; 4-ETHYLPHENYLBORONIC ACID; 4-ETHYLPYRIDINE-3-BORONIC ACID; 4-ETHYL-PYRROL-3-YLBORONIC ACID; 4-ETHYLSULFINYLPHENYLBORONIC ACID; 4-ETHYLTHIOPHEN-2-YLBORONIC ACID; 4-ETHYLTHIOPHENYLBORONIC ACID; 4-ETHYNYL-2-METHYLPYRIDIN-3-YLBORONIC ACID; 4-FLUORO(PHENYL-D4)-BORONIC ACID; 4-FLUORO-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-FLUORO-1H-INDAZOL-6-YLBORONIC ACID; 4-FLUORO-1H-INDOL-3-YLBORONIC ACID; 4-FLUORO-1H-PYRAZOL-5-YLBORONIC ACID; 4-FLUORO-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 4-FLUORO-1-METHYL-1H-PYRROLE-2-BORONIC ACID; 4-FLUORO-2-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 4-FLUORO-2-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-FLUORO-2-(METHYLSULFONYL)PHENYLBORONIC ACID; 4-FLUORO-2-(METHYLTHIO)PHENYLBORONIC ACID; 4-FLUORO-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-FLUORO-2,3-DIMETHYLPHENYLBORONIC ACID; 4-FLUORO-2,5-DIMETHYLPHENYLBORONIC ACID; 4-FLUORO-2-FURANBORONIC ACID; 4-FLUORO-2-HYDROXYPHENYLBORONIC ACID; 4-FLUORO-2-ISOPROPOXYPHENYLBORONIC ACID; 4-FLUORO-2-METHOXY-5-METHYLPHENYLBORONIC ACID; 4-FLUORO-2-METHOXYCARBONYLPHENYLBORONIC ACID; 4-FLUORO-2-METHOXYPHENYLBORONIC ACID; 4-FLUORO-2-METHYLPHENYLBORONIC ACID; 4-FLUORO-2-PROPOXYPHENYLBORONIC ACID; 4-FLUORO-2-THIOPHENEBORONIC ACID; 4-FLUORO-3-(2,2,2-TRIFLUOROETHOXY)PHENYLBORONIC ACID; 4-FLUORO-3-(2-CHLORO-PHENYLCARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(2-HYDROXYETHYLCARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(ISOPROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(METHOXY(METHYL)CARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4-FLUORO-3-(METHYLCARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 4-FLUORO-3-(N-PROPYLCARBAMOYL)PHENYLBORONIC ACID; 4-FLUORO-3-(PHENYLCARBAMOYL)BENZENEBORONIC ACID; 4-FLUORO-3-(PIPERIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-FLUORO-3-(PYRROLIDINE-1-CARBONYL)PHENYLBORONIC ACID; 4-FLUORO-3-(TETRAHYDRO-2H-PYRAN-2-YLOXY)PHENYLBORONIC ACID; 4-FLUORO-3-(TETRAZOL-5-YL)PHENYLBORONIC ACID; 4-FLUORO-3-(THIOMORPHOLINOMETHYL)PHENYLBORONIC ACID; 4-FLUORO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-FLUORO-3-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 4-FLUORO-3,5-BIS(TRIMETHYLSILYL)PHENYLBORONIC ACID; 4-FLUORO-3-[(METHOXYAMINO)CARBONYL]BENZENEBORONIC ACID; 4-FLUORO-3-HYDROXYPHENYLBORONIC ACID; 4-FLUORO-3-METHOXYPHENYLBORONIC ACID; 4-FLUORO-3-METHYLPHENYLBORONIC ACID; 4-FLUORO-3-NITROPHENYLBORONIC ACID; 4-FLUOROBENZOFURAN-7-BORONIC ACID; 4-FLUOROBENZYLBORONIC ACID; 4-FLUORONAPHTHALENE-1-BORONIC ACID; 4-FLUOROPHENYLBORONIC ACID; 4-FLUOROPYRIDINE-2-BORONIC ACID; 4-FLUOROPYRIDINE-3-BORONIC ACID; 4-FLUORO-PYRROL-3-YLBORONIC ACID; 4-FLUOROQUINOLINE-3-BORONIC ACID; 4-HEPTYLOXYPHENYLBORONIC ACID; 4-HEXYLOXYPHENYLBORONIC ACID; 4-HEXYLTHIOPHENE-3-BORONIC ACID; 4-HYDROXY-2-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4-HYDROXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-HYDROXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-HYDROXY-2-METHOXYPHENYLBORONIC ACID; 4-HYDROXY-3-(METHOXYCARBONYL)PHENYLBORONIC ACID; 4-HYDROXY-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-HYDROXY-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-HYDROXY-3,5-DIMETHYLPHENYLBORONIC ACID; 4-HYDROXY-3-METHOXYPHENYLBORONIC ACID; 4-HYDROXY-3-METHYLBENZENEBORONIC ACID; 4-HYDROXYBENZOTHIAZOLE-2-BORONIC ACID; 4-HYDROXYL-1-NAPHTHALENEBORONIC ACID; 4-HYDROXYMETHYL-2-METHOXYPHENYLBORONIC ACID; 4-HYDROXYMETHYL-3-METHYLPHENYLBORONIC ACID; 4-HYDROXYNAPHTHALENE-2-BORONIC ACID; 4-HYDROXYPHENYLBORONIC ACID; 4-HYDROXYPYRIDINE-2-BORONIC ACID; 4-HYDROXYPYRIDINE-3-BORONIC ACID; 4-HYDROXYQUINOLINE-2-BORONIC ACID; 4-HYDROXYQUINOLINE-3-BORONIC ACID; 4-HYDROXYQUINOLINE-5-BORONIC ACID; 4-HYDROXYQUINOLINE-6-BORONIC ACID; 4-HYDROXYQUINOLINE-7-BORONIC ACID; 4-HYDROXYQUINOLINE-8-BORONIC ACID; 4′-ISOBUTOXYBIPHENYL-4-YLBORONIC ACID; 4-ISOBUTOXYPHENYLBORONIC ACID; 4′-ISOBUTYL-3′-NITROBIPHENYL-4-YLBORONIC ACID; 4-ISOBUTYLPHENYLBORONIC ACID; 4-ISOBUTYRAMIDOBENZENEBORONIC ACID; 4-ISOPROPOXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-ISOPROPOXY-2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 4-ISOPROPOXY-2,6-DIMETHYLPHENYLBORONIC ACID; 4-ISOPROPOXY-2-METHYLPHENYLBORONIC ACID; 4-ISOPROPOXY-3-(TRIFLUOROMETHYL)BENZENEBORONIC ACID; 4-ISOPROPOXY-3-METHYLPHENYLBORONIC ACID; 4-ISOPROPOXYCARBONYLPHENYLBORONIC ACID; 4-ISOPROPOXYPHENYLBORONIC ACID; 4-ISOPROPOXYPHENYLBORONIC ACID HYDRATE; 4-ISOPROPYL-1-(METHYLSULFONYL)-PYRROL-3-YLBORONIC ACID; 4-ISOPROPYL-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-ISOPROPYL-1-(TRIMETHYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-ISOPROPYLPHENYLBORONIC ACID; 4-ISOPROPYLPYRIMIDINE-5-BORONIC ACID; 4-ISOPROPYL-PYRROL-3-YLBORONIC ACID; 4-ISOPROPYLTHIOPHENYLBORONIC ACID; 4-JULOLIDINE BORONIC ACID; 4-MERCAPTOPHENYLBORONIC ACID; 4-METHOXY-1H-INDOL-2-YLBORONIC ACID; 4-METHOXY-2-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 4-METHOXY-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 4-METHOXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-METHOXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-METHOXY-2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 4-METHOXY-2,3-DIMETHYLPHENYLBORONIC ACID; 4-METHOXY-2-METHYLPHENYLBORONIC ACID; 4-METHOXY-2-NITROPHENYLBORONIC ACID; 4-METHOXY-3-(METHOXYMETHOXY)PHENYLBORONIC ACID; 4-METHOXY-3-(MORPHOLIN-4-YLSULPHONYL)BENZENEBORONIC ACID; 4-METHOXY-3-(N,N-DIETHYLSULFAMOYL)PHENYLBORONIC ACID; 4-METHOXY-3-(PIPERIDIN-1-YLSULPHONYL)BENZENEBORONIC ACID; 4-METHOXY-3-(PYRROLIDIN-1-YLSULPHONYL)BENZENEBORONIC ACID; 4-METHOXY-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-METHOXY-3-METHYLPHENYLBORONIC ACID; 4-METHOXY-3-NITROPHENYLBORONIC ACID; 4-METHOXY-3-PROPOXYPHENYLBORONIC ACID; 4-METHOXY-3-PYRIDINE BORONIC ACID HYDROCHLORIDE; 4-METHOXY-3-PYRIDINEBORONIC ACID; 4′-METHOXY-4-BIPHENYLBORONIC ACID; 4-METHOXY-6-METHYLPYRIDINE-3-BORONIC ACID; 4-METHOXYBENZO[B]THIOPHEN-2-YLBORONIC ACID; 4-METHOXYBENZOTHIAZOLE-2-BORONIC ACID; 4-METHOXYCARBONYL-2-NITROPHENYLBORONIC ACID; 4-METHOXYCARBONYL-3,5-DIMETHYLPHENYLBORONIC ACID; 4-METHOXYCARBONYL-3-METHYLPHENYLBORONIC ACID; 4-METHOXYCARBONYL-3-NITROPHENYLBORONIC ACID; 4-METHOXYCARBONYLPHENYLBORONIC ACID; 4-METHOXYNAPHTHALENE-1-BORONIC ACID; 4-METHOXYPHENYLBORONIC ACID; 4-METHOXYPYRIDINE-2-BORONIC ACID; 4-METHOXYPYRIDINE-3-BORONIC ACID HYDRATE; 4-METHOXYPYRIMIDIN-5-YLBORONIC ACID; 4-METHOXY-QUINOLINE-2-BORONIC ACID; 4-METHYL(PHENYL-D4)-BORONIC ACID; 4-METHYL-1-(METHYLSULFONYL)-PYRROL-3-YLBORONIC ACID; 4-METHYL-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-METHYL-1-(TRIMETHYLSILYL)-PYRROL-3-YLBORONIC ACID; 4-METHYL-1-CYCLOHEXEN-1-YLBORONIC ACID; 4-METHYL-1H-INDAZOLE-5-BORONIC ACID; 4-METHYL-1H-INDAZOLE-6-BORONIC ACID; 4-METHYL-1H-INDOL-3-YLBORONIC ACID; 4-METHYL-1H-INDOLE-2-BORONIC ACID; 4-METHYL-1-PENTENYLBORONIC ACID; 4-METHYL-1-PHENYL-1H-PYRAZOL-3-YLBORONIC ACID; 4-METHYL-2-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(2,4,5-TRICHLOROPHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOL-5-YLBORONIC ACID; 4-METHYL-2-(PERFLUOROPHENYL)PYRIDINE-3-BORONIC ACID; 4-METHYL-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-METHYL-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4′-METHYL-2,2′-BITHIOPHEN-5-YLBORONIC ACID; 4-METHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-6-YLBORONIC ACID; 4-METHYL-2-PHENYLTHIAZOL-5-YLBORONIC ACID; 4-METHYL-3-(4-(PYRIDIN-2-YLMETHOXY)BENZAMIDO)PHENYLBORONIC ACID; 4-METHYL-3-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 4-METHYL-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-7-YLBORONIC ACID; 4-METHYL-3-NITROPHENYLBORONIC ACID; 4-METHYL-3-THIOPHENEBORONIC ACID; 4′-METHYL-4-BIPHENYLBORONIC ACID; 4-METHYL-6-(1H-PYRAZOL-1-YL)PYRIDIN-3-YLBORONIC ACID; 4-METHYL-6-(1H-PYRROL-1-YL)PYRIDIN-3-YLBORONIC ACID; 4-METHYLFURAN-2-BORONIC ACID; 4-METHYLPHENYLBORONIC ACID; 4-METHYLPYRIDINE-2-BORONIC ACID; 4-METHYLPYRIDINE-3-BORONIC ACID; 4-METHYLPYRIDINE-3-BORONIC ACID, HYDROCHLORIDE; 4-METHYLPYRIMIDINE-5-BORONIC ACID; 4-METHYL-PYRROL-3-YLBORONIC ACID; 4-METHYLTHIOPHENE-2-BORONIC ACID; 4-MORPHOLINOPHENYLBORONIC ACID; 4-MORPHOLINOQUINOLIN-6-YLBORONIC ACID; 4-N-BOC-AMINO-3-FLUOROPHENYLBORONIC ACID; 4-N-BOC-AMINO-3-METHOXY-PHENYLBORONIC ACID; 4-N-BUTOXY-2-FLUOROPHENYLBORONIC ACID; 4-N-HEPTYLPHENYLBORONIC ACID; 4-N-HEXYLPHENYLBORONIC ACID; 4-NITRO-3-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 4′-NITRO-BIPHENYL-4-BORONIC ACID; 4-NITROPHENYLBORONIC ACID; 4-NITROPYRIDINE-2-BORONIC ACID; 4-N-NONYLBENZENEBORONIC ACID; 4-N-PENTYLPHENYLBORONIC ACID; 4-OCTYLOXYPHENYLBORONIC ACID; 4-OXO-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YLBORONIC ACID; 4-PENT-1-YNYLPHENYLBORONIC ACID; 4-PENTENYLBORONIC ACID; 4-PENTYL-2-FLUOROPHENYLBORONIC ACID; 4-PENTYL-3-FLUOROPHENYLBORONIC ACID; 4-PENTYLCYCLOHEX-1-ENYLBORONIC ACID; 4-PENTYLOXY-2-FLUOROPHENYLBORONIC ACID; 4-PENTYLOXY-3-FLUOROPHENYLBORONIC ACID; 4-PENTYLOXYPHENYLBORONIC ACID; 4-PHENOXYPHENYLBORONIC ACID; 4-PHENOXYPYRIDIN-3-YLBORONIC ACID; 4-PHENYL(NAPHTHALENE-1-YL)BORONIC ACID; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-BORONIC ACID; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-BORONIC ACID; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-BORONIC ACID; 4-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-BORONIC ACID; 4-PHENYLFURAN-2-BORONIC ACID; 4-PHENYLPYRIDINE-3-BORONIC ACID; 4-PHENYLPYRIMIDINE-2-BORONIC ACID; 4-PHENYLPYRIMIDINE-5-BORONIC ACID; 4-PHENYL-PYRROL-3-YLBORONIC ACID; 4-PHENYLTHIOPHENE-2-BORONIC ACID; 4-PIVALAMIDOPHENYLBORONIC ACID; 4-PROPOXY-2,3,5,6-TETRAFLUOROPHENYLBORONIC ACID; 4-PROPOXY-2-METHYLPHENYLBORONIC ACID; 4-PROPOXYCARBONYLPHENYLBORONIC ACID; 4-PROPOXYPHENYLBORONIC ACID; 4′-PROPYL-3-FLUOROBIPHENYL-4-BORONIC ACID; 4′-PROPYL-4-BIPHENYLBORONIC ACID; 4-PROPYLCYCLOHEX-1-ENYLBORONIC ACID; 4-PROPYLPHENYLBORONIC ACID; 4-PROPYLPYRIDIN-3-YLBORONIC ACID; 4-PROPYLSULFANYLPHENYLBORONIC ACID; 4-PROPYLTHIOPHEN-2-YLBORONIC ACID; 4-TBDMS-HYDROXYMETHYLPHENYLBORONIC ACID; 4-T-BUTOXYPHENYLBORONIC ACID; 4-T-BUTYLCYCLOHEXEN-1-YLBORONIC ACID; 4-TERT-BUTOXY-2-CHLOROPYRIMIDIN-5-YLBORONIC ACID; 4′-TERT-BUTOXYCARBONYLAMINO-BIPHENYL-4-BORONIC ACID; 4-TERT-BUTOXYCARBOXYPHENYLBORONIC ACID; 4-TERT-BUTOXYMETHYLPHENYLBORONIC ACID; 4-TERT-BUTYL-2-FURANBORONIC ACID; 4-TERT-BUTYL-2-METHYLPHENYLBORONIC ACID; 4-TERT-BUTYL-3-NITROBENZENEBORONIC ACID; 4′-TERT-BUTYLBIPHENYL-2-YLBORONIC ACID; 4-TERT-BUTYLPHENYLBORONIC ACID; 4-TRIFLUOROACETYL AMINOPHENYLBORONIC ACID; 4-TRIFLUOROMETHOXYPHENYL 4-BORONOBENZENESULFONAMIDE; 4-TRIMETHYLSILYLPHENYLBORONIC ACID; 4-VINYLPHENYLBORONIC ACID; 5-((1-PHENYLETHYL)CARBAMOYL)THIOPHEN-2-YLBORONIC ACID; 5-((4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)METHYL)-2-FLUOROPHENYLBORONIC ACID; 5-((BENZYLOXYCARBONYLAMINO)METHYL)THIOPHENE-2-BORONIC ACID; 5-((BOC-AMINO)METHYL)FURAN-2-BORONIC ACID; 5-((CYCLOPENTYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 5-((CYCLOPROPYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 5-((DIETHYLAMINO)METHYL)FURAN-2-YLBORONIC ACID; 5-((DIMETHYLAMINO)METHYL)FURAN-2-YLBORONIC ACID; 5-((DIMETHYLAMINO)METHYL)PYRIDIN-3-YLBORONIC ACID; 5-((DIMETHYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 5-((ETHYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 5-((ISOPROPYLAMINO)METHYL)THIOPHEN-2-YLBORONIC ACID; 5-((METHYLAMINO)METHYL)FURAN-3-YLBORONIC ACID; 5-((METHYLAMINO)METHYL)THIOPHEN-3-YLBORONIC ACID; 5-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-([TERT-BUTYL(DIMETHYL)SILYL]OXY)PYRIDINE-3-BORONIC ACID; 5-(1-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)ETHYL)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-(1-(TERT-BUTYLDIMETHYLSILYLOXY)-2-METHYLPROPAN-2-YL)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-(1-(TERT-BUTYLDIMETHYLSILYLOXY)PROPAN-2-YL)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-(1,3-DIOXOLAN-2-YL)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-(1,3-DIOXOLAN-2-YL)FURAN-2-YLBORONIC ACID; 5-(1,3-DIOXOLAN-2-YL)PYRIDINE-BORONIC ACID; 5-(1-CYANOCYCLOPROPYL)-2-FLUOROPHENYLBORONIC ACID; 5-(1H-INDOL-4-YL)PYRIDIN-3-YLBORONIC ACID; 5-(1H-PYRAZOL-1-YL)PYRAZINE-2-BORONIC ACID; 5-(1H-PYRIDIN-2-ONE)PYRAZINE-2-BORONIC ACID; 5-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(2-FLUOROPHENYL)FURAN-2-BORONIC ACID; 5-(2-FLUOROPHENYL)THIOPHENE-2-BORONIC ACID; 5-(2-FURYL)THIOPHENE-2-BORONIC ACID; 5-(2-HYDROXYPROPAN-2-YL)PYRIDINE-2-BORONIC ACID; 5-(2-HYDROXYPROPAN-2-YL)PYRIDINE-3-BORONIC ACID; 5-(2-METHOXYETHOXY)PYRIDINE-3-BORONIC ACID; 5-(2-METHOXYPHENYL)FURAN-2-BORONIC ACID; 5-(2-METHOXYPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(2-METHOXYPHENYL)THIOPHENE-2-BORONIC ACID; 5-(2-METHYLIMIDAZOL-1-YL)PYRAZINE-2-BORONIC ACID; 5-(2-METHYLPIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(2-THIAZOLYL)THIOPHENE-2-BORONIC ACID; 5-(2-TOLYL)FURAN-2-BORONIC ACID; 5-(2-TOLYL)THIOPHENE-2-BORONIC ACID; 5-(2-TRIFLUOROMETHYLPHENYL)FURAN-2-BORONIC ACID; 5-(2-TRIFLUOROMETHYLPHENYL)THIOPHENE-2-BORONIC ACID; 5-(3-((TERT-BUTOXYCARBONYL)AMINO)PROPANAMIDO)PYRIDINE-3-BORONIC ACID; 5-(3-(AMINOMETHYL)PHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(3-(METHYLSULFONYL)PHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(3,5-DIMETHYLISOXAZOL-4-YL)BENZO[B]THIOPHEN-2-YLBORONIC ACID; 5-(3,5-DIMETHYLISOXAZOL-4-YL)THIOPHEN-2-YLBORONIC ACID; 5-(3-BORONOPHENYL)PENTANOIC ACID; 5-(3-ETHOXYPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(3-METHOXYPHENYL)PYRIDIN-2-YLBORONIC ACID; 5-(3-METHYL-1H-PYRAZOL-1-YL)PYRAZINE-2-BORONIC ACID; 5-(3-METHYLPIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(3-MORPHOLINOPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(3-SULFAMOYLPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(4-(DIMETHYLAMINO)PHENYL)THIOPHEN-2-YLBORONIC ACID; 5-(4-(METHYLSULFONYL)PHENYL)PYRIMIDIN-2-YLBORONIC ACID; 5-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(4,4-DIMETHYL-4,5-DIHYDROOXAZOL-2-YL)PYRIDIN-3-YLBORONIC ACID; 5-(4-CHLOROPHENYL)THIOPHEN-2-YLBORONIC ACID; 5-(4-FLUOROPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(4-FLUOROPHENYL)THIOPHEN-2-YLBORONIC ACID; 5-(4-METHOXYPHENYL)PYRIDIN-2-YLBORONIC ACID; 5-(4-METHOXYPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(4-METHOXYPHENYL)THIOPHEN-2-YLBORONIC ACID; 5-(4-METHYL-1H-PYRAZOL-1-YL)PYRAZINE-2-BORONIC ACID; 5-(4-METHYLPHENYL)THIOPHENE-2-BORONIC ACID; 5-(4-METHYLPIPERAZIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YLBORONIC ACID; 5-(4-METHYLPIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(4-MORPHOLINOPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-(4-PENTYLOXYPHENYL)THIOPHENE-2-BORONIC ACID; 5-(4-PENTYLPHENYL)THIOPHENE-2-BORONIC ACID; 5-(5-CHLOROPYRIDIN-3-YLOXY)PYRIDIN-3-YLBORONIC ACID; 5-(5-CYCLOPROPYL-1,3,4-OXADIAZOL-2-YL)-2-METHYLPHENYLBORONIC ACID; 5-(AMINOMETHYL)-2-FLUOROPHENYLBORONIC ACID, HCL; 5-(AMINOMETHYL)THIOPHEN-2-YLBORONIC ACID; 5-(BENZO[D]THIAZOL-2-YL)THIOPHENE-2-BORONIC ACID; 5-(BENZYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID; 5-(BENZYLOXY)-1H-INDOL-2-YLBORONIC ACID; 5-(BENZYLOXY)-2-(DIETHOXYMETHYL)PHENYLBORONIC ACID; 5-(BENZYLOXY)-2,4-DICHLOROPHENYLBORONIC ACID; 5-(BENZYLOXY)-2-BORONOBENZOIC ACID; 5-(BENZYLOXY)-2-CHLOROPHENYLBORONIC ACID; 5-(BENZYLOXY)-2-FLUOROPHENYLBORONIC ACID; 5-(BENZYLOXY)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 5-(BENZYLOXY)-2-METHYLPHENYLBORONIC ACID; 5-(BENZYLOXY)PYRIDINE-3-BORONIC ACID-HCL; 5-(BENZYLOXYCARBONYLAMINO)-2-FLUOROPHENYLBORONIC ACID; 5-(BOC-AMINO)PYRIDINE-3-BORONIC ACID; 5-(BOC-AMINOMETHYL)THIOPHENE-2-BORONIC ACID; 5-(CYANOMETHYL)THIOPHEN-3-YLBORONIC ACID; 5-(CYCLOBUTYL)FURAN-2-BORONIC ACID; 5-(CYCLOBUTYL)THIOPHENE-2-BORONIC ACID; 5-(CYCLOHEXYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID; 5-(CYCLOPENTOXY)PYRAZINE-2-BORONIC ACID; 5-(CYCLOPROPYL)FURAN-2-BORONIC ACID; 5-(CYCLOPROPYL)THIOPHENE-2-BORONIC ACID; 5-(CYCLOPROPYLCARBAMOYL)-2-FLUOROPHENYLBORONIC ACID; 5-(DIETHOXYMETHYL)FURAN-2-YLBORONIC ACID; 5-(DIETHYLAMINO)PYRAZINE-2-BORONIC ACID; 5-(DIETHYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID; 5-(DIETHYLCARBAMOYL)THIOPHEN-2-YLBORONIC ACID; 5-(DIFLUOROMETHOXY)-2-FLUOROPHENYLBORONIC ACID; 5-(DIFLUOROMETHOXY)BENZOTHIAZOLE-2-BORONIC ACID; 5-(DIFLUOROMETHOXY)PYRAZINE-2-BORONIC ACID; 5-(DIHYDROXYBORYL)-2-THIOPHENECARBOXYLIC ACID; 5-(DIMETHOXYMETHYL)FURAN-2-BORONIC ACID; 5-(DIMETHOXYMETHYL)PYRIDINE-3-BORONIC ACID; 5-(DIMETHYLAMINO)-2-METHYLPHENYLBORONIC ACID; 5-(DIMETHYLAMINO)-3-METHYLPYRIDIN-2-YLBORONIC ACID HYDROCHLORIDE; 5-(DIMETHYLAMINO)BENZO[B]THIOPHEN-2-YLBORONIC ACID; 5-(DIMETHYLAMINO)PYRAZINE-2-BORONIC ACID; 5-(DIMETHYLAMINO)PYRIDIN-2-YLBORONIC ACID; 5-(DIMETHYLAMINO)PYRIDIN-3-YLBORONIC ACID; 5-(DIMETHYLAMINO-D6)-PYRIDINE-3-BORONIC ACID; 5-(DIMETHYLCARBAMOYL)-3-FLUOROPHENYLBORONIC ACID; 5-(DIMETHYLCARBAMOYL)PYRIDINE-3-BORONIC ACID; 5-(ETHOXYCARBONYL)-1H-INDOL-2-YLBORONIC ACID; 5-(ETHOXYCARBONYL)-1H-PYRROL-2-YLBORONIC ACID; 5-(ETHOXYCARBONYL)-2-HYDROXYPHENYLBORONIC ACID; 5-(ETHOXYCARBONYL)-2-METHOXYPHENYLBORONIC ACID; 5-(ETHOXYCARBONYL)-3-PYRIDINYL BORONIC ACID; 5-(ETHOXYCARBONYL)-6-METHYLPYRIDINE-3-BORONIC ACID; 5-(ETHOXYCARBONYL)FURAN-2-BORONIC ACID; 5-(ETHOXYCARBONYL)THIOPHENE-2-BORONIC ACID; 5-(ETHOXYCARBONYL)THIOPHENE-3-BORONIC ACID; 5-(ETHOXYMETHYL)PYRIDINE-3-BORONIC ACID; 5-(ETHYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID; 5-(ETHYLCARBAMOYL)-3-FLUOROPHENYLBORONIC ACID; 5-(ETHYL-D5)-PYRIDINE-3-BORONIC ACID; 5-(ETHYLTHIO)FURAN-3-YLBORONIC ACID; 5-(FURAN-2-YL)FURAN-2-BORONIC ACID; 5-(HYDROXYMETHYL)-3-PYRIDINYL BORONIC ACID; 5-(HYDROXYMETHYL)FURAN-2-YLBORONIC ACID; 5-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 5-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 5-(HYDROXYMETHYL)PYRIDIN-3-YLBORONIC ACID HYDROCHLORIDE; 5-(HYDROXYMETHYL)PYRIDINE-2-BORONIC ACID; 5-(IMIDAZOL-1-YL)PYRAZINE-2-BORONIC ACID; 5-(ISOPROPOXY)PYRAZINE-2-BORONIC ACID; 5-(ISO-PROPYL)FURAN-2-BORONIC ACID; 5-(ISO-PROPYL)THIOPHENE-2-BORONIC ACID; 5-(ISO-PROPYL-D7)-PYRIDINE-3-BORONIC ACID; 5-(METHOXY(METHYL)CARBAMOYL)FURAN-2-YLBORONIC ACID; 5-(METHOXYCARBONYL)-1H-PYRAZOL-3-YLBORONIC ACID; 5-(METHOXYCARBONYL)-1H-PYRROL-3-YLBORONIC ACID; 5-(METHOXYCARBONYL)-1-TOSYL-1H-PYRROL-3-YLBORONIC ACID; 5-(METHOXYCARBONYL)-4-METHYLTHIOPHEN-2-YLBORONIC ACID; 5-(METHOXYCARBONYL)-6-(METHYLTHIO)PYRIDIN-3-YLBORONIC ACID; 5-(METHOXYCARBONYL)FURAN-2-BORONIC ACID; 5-(METHOXYCARBONYL)PYRIDINE-2-BORONIC ACID; 5-(METHOXYCARBONYL)PYRIDINE-3-BORONIC ACID; 5-(METHOXYCARBONYL)THIOPHENE-3-BORONIC ACID; 5-(METHOXY-D3)-PYRAZINE-2-BORONIC ACID; 5-(METHOXY-D3)-PYRIDINE-3-BORONIC ACID; 5-(METHOXYMETHOXY)-2-METHYLPHENYLBORONIC ACID; 5-(METHOXYMETHOXY)-2-METHYLPYRIDIN-4-YLBORONIC ACID; 5-(METHOXYMETHYL)-3-PYRIDINYL BORONIC ACID; 5-(METHOXYMETHYL)THIOPHEN-3-YLBORONIC ACID; 5-(METHYL-D3)-PYRIDINE-3-BORONIC ACID; 5-(METHYLSULFANYL)-2-THIENYLBORONIC ACID; 5-(METHYLSULPHONYL)PYRIDINE-3-BORONIC ACID; 5-(METHYLTHIO)PYRAZINE-2-BORONIC ACID; 5-(METHYLTHIO)PYRIDINE-3-BORONIC ACID; 5-(MORPHOLINOMETHYL)THIOPHEN-2-YLBORONIC ACID; 5-(N,N-DIETHYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 5-(N,N-DIMETHYLSULFAMOYL)-2-METHYLPHENYLBORONIC ACID; 5-(N,N-METHYLETHYLAMINO)PYRAZINE-2-BORONIC ACID; 5-(N-PROPOXY)PYRAZINE-2-BORONIC ACID; 5-(N-PROPYL-D7)-PYRIDINE-3-BORONIC ACID; 5-(N-TERT-BUTYLSULFAMOYL)-2-METHYLBENZENEBORONIC ACID; 5-(N-TERT-BUTYLSULFAMOYL)THIOPHEN-2-YLBORONIC ACID; 5-(O-TBDMS)OXYMETHYLFURAN-2-BORONIC ACID; 5-(OXAZOL-5-YL)FURAN-2-YLBORONIC ACID; 5-(OXAZOL-5-YL)THIOPHEN-2-YLBORONIC ACID; 5-(PERFLUOROETHYL)PYRIDIN-3-YLBORONIC ACID; 5-(PIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(PIPERIDIN-2-YL)PYRIDIN-3-YLBORONIC ACID; 5-(PROP-1-YNYL)PYRIDIN-3-YLBORONIC ACID; 5-(PYRIDIN-3-YLOXY)PYRIDINE-3-BORONIC ACID; 5-(PYRROLIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 5-(T-BUTYLDIMETHYLSILYLOXY)-2,3-DIFLUOROPHENYLBORONIC ACID; 5-(T-BUTYLDIMETHYLSILYLOXY)-2-FLUOROPHENYLBORONIC ACID; 5-(T-BUTYLDIMETHYLSILYLOXY)-2-METHOXYPHENYLBORONIC ACID; 5-(TERT-BUTOXY)PYRAZINE-2-BORONIC ACID; 5-(TERT-BUTOXY)PYRIDINE-2-BORONIC ACID; 5-(TERT-BUTOXYCARBONYL)-4,5,6,7-TETRAHYDROTHIENO[3,4-C]PYRIDIN-3-YLBORONIC ACID; 5-(TERT-BUTOXYCARBONYL)-5,6-DIHYDRO-4H-THIENO[3,2-C]PYRROL-2-YLBORONIC ACID; 5-(TERT-BUTOXYCARBONYL)-5,6-DIHYDRO-4H-THIENO[3,4-C]PYRROL-1-YL BORONIC ACID; 5-(TERT-BUTOXYCARBONYLAMINO)-2-(DIMETHYLAMINO)PHENYLBORONIC ACID; 5-(TERT-BUTOXYCARBONYLAMINO)-2-CHLOROPYRIDIN-4-YLBORONIC ACID; 5-(TERT-BUTOXYCARBONYLAMINO)NAPHTHALEN-1-YLBORONIC ACID; 5-(TERT-BUTYL)PYRAZINE-2-BORONIC ACID; 5-(TERT-BUTYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID; 5-(TERT-BUTYLCARBAMOYL)-4-METHYLTHIOPHEN-2-YLBORONIC ACID; 5-(TERT-BUTYLCARBAMOYL)PYRIDINE-3-BORONIC ACID; 5-(THIAZOL-2-YL)FURAN-2-BORONIC ACID; 5-(THIOPHEN-2-YL)FURAN-2-BORONIC ACID; 5-(TRIFLUOROMETHOXY)PYRAZINE-2-BORONIC ACID; 5-(TRIFLUOROMETHOXY)PYRIDINE-3-BORONIC ACID; 5-(TRIFLUOROMETHYL)-1H-PYRROL-2-YLBORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-(TRIFLUOROMETHYL)-2-(TRIMETHYLSILYL)PHENYLBORONIC ACID; 5-(TRIFLUOROMETHYL)FURAN-2-BORONIC ACID; 5-(TRIFLUOROMETHYL)PYRIDINE-2-BORONIC ACID; 5-(TRIFLUOROMETHYL)THIOPHENE-2-BORONIC ACID; 5-(TRIFLUOROMETHYL)THIOPHENE-3-BORONIC ACID; 5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-2-NAPHTHALENYLBORONIC ACID; 5,6,7,8-TETRAHYDRO-2-NAPHTHALENYLBORONIC ACID; 5,6,7,8-TETRAHYDROISOQUINOLINE-3-BORONIC ACID; 5,6,7,8-TETRAHYDRONAPHTHALEN-1-YLBORONIC ACID; 5,6,7,8-TETRAHYDROQUINOLINE-2-BORONIC ACID; 5,6-DIFLUOROBENZO[B]THIOPHEN-3-YLBORONIC ACID; 5,6-DIMETHOXY-1H-INDOL-3-YLBORONIC ACID; 5,6-DIMETHOXYPYRAZIN-2-YLBORONIC ACID; 5,6-DIMETHYLPYRIDINE-2-BORONIC ACID; 5,6-DIMETHYLPYRIDINE-3-BORONIC ACID; 5-[(BENZYLOXY)METHYL]PYRIDINE-2-BORONIC ACID; 5-[(TRIMETHYLSILANYL)ETHYNYL]PYRIDINE-3-BORONIC ACID; 5-ACETAMIDO-2-(AMINOMETHYL)PHENYLBORONIC ACID; 5-ACETAMIDO-2-METHYLPHENYLBORONIC ACID; 5-ACRYLAMIDO-2-((DIMETHYLAMINO)METHYL)PHENYLBORONIC ACID; 5-ACRYLAMIDO-2-(AMINOMETHYL)PHENYLBORONIC ACID; 5-ACRYLAMIDO-2-(HYDROXYMETHYL)PHENYLBORONIC ACID; 5-ALLYL-2-METHOXYPHENYLBORONIC ACID; 5-AMINO-2-((TERT-BUTOXYCARBONYLAMINO)METHYL)PHENYLBORONIC ACID; 5-AMINO-2-(HYDROXYMETHYL)BENZENEBORONIC ACID HYDROCHLORIDE; 5-AMINO-2,3-DIFLUOROPHENYLBORONIC ACID; 5-AMINO-2,4-DIFLUOROPHENYLBORONIC ACID; 5-AMINO-2-CHLOROPHENYLBORONIC ACID HYDROCHLORIDE; 5-AMINO-2-CHLOROPYRIDINE-3-BORONIC ACID; 5-AMINO-2-FLUOROPHENYLBORONIC ACID; 5-AMINO-2-FLUOROPHENYLBORONIC ACID HYDROCHLORIDE; 5-AMINO-3-FLUORO-6-(METHOXYCARBONYL)PYRIDIN-2-YLBORONIC ACID; 5-AMINO-6-(2,2,2-TRIFLUOROETHOXY)PYRAZIN-2-YLBORONIC ACID; 5-AMINO-6-(2-METHOXYETHOXY)PYRAZIN-2-YLBORONIC ACID; 5-AMINO-6-(4-(METHOXYCARBONYL)PIPERIDIN-1-YL)PYRAZIN-2-YLBORONIC ACID; 5-AMINO-6-(METHOXYCARBONYL)-3-METHYLPYRIDIN-2-YLBORONIC ACID; 5-AMINO-6-CHLOROPYRIDINE-3-BORONIC ACID; 5-AMINO-6-ETHOXYPYRIDINE-3-BORONIC ACID; 5-AMINO-6-METHOXYPYRAZIN-2-YLBORONIC ACID; 5-AMINO-6-METHOXYPYRIDINE-3-BORONIC ACID; 5-AMINOBENZO[B]THIOPHEN-2-YLBORONIC ACID; 5-AMINOCARBONYLPYRIDINE-2-BORONIC ACID; 5-AMINOPYRAZINE-2-BORONIC ACID; 5-AMINOPYRIDINE-2-BORONIC ACID; 5-AMINOPYRIDINE-3-BORONIC ACID-HCL; 5-AMINOTHIOPHEN-3-YLBORONIC ACID; 5-BENZOTHIOPHENEBORONIC ACID; 5-BENZYLOXY-1-BOC-INDOLE-2-BORONIC ACID; 5-BENZYLOXY-3-PYRIDINYLBORONIC ACID; 5-BORONO-2-(2-HYDROXYPROPAN-2-YL)PYRIDINE 1-OXIDE; 5-BORONO-2,3-DIHYDRO-3-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-1-CARBOXYLIC ACID 1-(1,1-DIMETHYLETHYL) ESTER; 5-BORONO-3-METHYLTHIOPHENE-2-CARBOXYLIC ACID; 5-BORONO-4-CHLORO-2-FLUOROBENZOIC ACID; 5-BORONO-6-FLUOROPICOLINIC ACID; 5-BORONOFURAN-2-CARBOXYLIC ACID; 5-BORONOFURAN-3-CARBOXYLIC ACID; 5-BUTOXY-2,4-DICHLOROPHENYLBORONIC ACID; 5-BUTOXY-2-CHLOROPHENYLBORONIC ACID; 5-BUTOXY-2-FLUOROPHENYLBORONIC ACID; 5-BUTYL-2-(N-TERT-BUTYLSULFAMOYL)THIOPHEN-3-YLBORONIC ACID; 5-BUTYLFURAN-2-YLBORONIC ACID; 5-BUTYLPYRIDIN-2-YLBORONIC ACID; 5-CARBAMOYL-2-CHLOROPHENYLBORONIC ACID; 5-CARBAMOYL-2-FLUOROBENZENEBORONIC ACID; 5-CARBAMOYL-2-HYDROXYPHENYLBORONIC ACID; 5-CARBAMOYLFURAN-3-YLBORONIC ACID; 5-CARBAMOYLTHIOPHEN-2-YLBORONIC ACID; 5-CARBAMOYLTHIOPHEN-3-YLBORONIC ACID; 5-CARBOXY-2-CHLORO-4-METHOXYPHENYLBORONIC ACID; 5-CARBOXY-2-CHLOROPHENYLBORONIC ACID; 5-CARBOXY-2-ETHOXYPHENYLBORONIC ACID; 5-CARBOXY-2-FLUOROPHENYLBORONIC ACID; 5-CARBOXY-2-FLUOROPYRIDINE-3-BORONIC ACID; 5-CARBOXY-6-CHLOROPYRIDINE-3-BORONIC ACID; 5-CARBOXY-6-FLUOROPYRIDINE-3-BORONIC ACID; 5-CARBOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 5-CHLORO-1H-INDOL-3-YLBORONIC ACID; 5-CHLORO-1H-INDOLE-2-BORONIC ACID; 5-CHLORO-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 5-CHLORO-1-METHYL-PYRROL-3-YLBORONIC ACID; 5-CHLORO-2-(ETHOXYCARBONYL)PHENYLBORONIC ACID; 5-CHLORO-2-(METHOXYCARBONYL)PHENYLBORONIC ACID; 5-CHLORO-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 5-CHLORO-2-(MORPHOLINE-4-CARBONYL)PHENYLBORONIC ACID; 5-CHLORO-2-(PIVALOYLAMINO)PHENYLBORONIC ACID; 5-CHLORO-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 5-CHLORO-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5′-CHLORO-2,2′-BITHIOPHEN-5-YLBORONIC ACID; 5-CHLORO-2,3-DIFLUOROPYRIDIN-4-YLBORONIC ACID; 5-CHLORO-2,4-DIFLUOROPHENYLBORONIC ACID; 5-CHLORO-2-CYANOPHENYLBORONIC ACID; 5-CHLORO-2-ETHOXYPHENYLBORONIC ACID; 5-CHLORO-2-ETHOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-FLUORO-3-METHYLPHENYLBORONIC ACID; 5-CHLORO-2-FLUORO-4-METHOXYPHENYLBORONIC ACID; 5-CHLORO-2-FLUORO-4-METHYLPHENYLBORONIC ACID; 5-CHLORO-2-FLUORO-4-PICOLINE-3-BORONIC ACID; 5-CHLORO-2-FLUOROPHENYLBORONIC ACID; 5-CHLORO-2-FLUOROPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-FLUOROPYRIDINE-4-BORONIC ACID; 5-CHLORO-2-HYDROXYPHENYLBORONIC ACID; 5-CHLORO-2-HYDROXYPYRIDINE-4-BORONIC ACID; 5-CHLORO-2-ISOBUTOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-ISOPROPOXYPHENYLBORONIC ACID; 5-CHLORO-2-ISOPROPOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-METHOXYPHENYLBORONIC ACID; 5-CHLORO-2-METHOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-METHYL-3-NITROBENZENEBORONIC ACID; 5-CHLORO-2-METHYL-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-CHLORO-2-METHYLPHENYLBORONIC ACID; 5-CHLORO-2-METHYLPYRIDINE-3-BORONIC ACID; 5-CHLORO-2-NITROPHENYLBORONIC ACID; 5-CHLORO-2-PROPOXYPHENYLBORONIC ACID; 5-CHLORO-2-PROPOXYPYRIDIN-4-YLBORONIC ACID; 5-CHLORO-2-PROPOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-3-METHOXYPYRIDINE-2-BORONIC ACID; 5-CHLORO-3-METHYLBENZO[B]THIOPHEN-2-YLBORONIC ACID; 5-CHLORO-3-METHYLPYRIDIN-2-YLBORONIC ACID; 5-CHLORO-4-METHOXY-2-METHYLPHENYLBORONIC ACID; 5-CHLORO-4-METHOXYPYRIDINE-2-BORONIC ACID; 5-CHLORO-4-METHOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-4-METHYLPYRIDINE-2-BORONIC ACID; 5-CHLORO-4-METHYLPYRIDINE-3-BORONIC ACID; 5-CHLORO-6-(4-CHLOROPHENYL)PYRIDIN-3-YLBORONIC ACID; 5-CHLORO-6-(4-CHLOROPHENYLAMINO)PYRIDIN-3-YLBORONIC ACID; 5-CHLORO-6-ETHOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-6-HYDROXYPYRIDIN-3-YLBORONIC ACID; 5-CHLORO-6-ISOPROPOXYPYRIDINE-3-BORONIC ACID; 5-CHLORO-6-OXO-1,6-DIHYDROPYRIDIN-3-YLBORONIC ACID; 5-CHLORO-6-PROPOXYPYRIDINE-3-BORONIC ACID; 5-CHLOROBENZOFURAN-2-YLBORONIC ACID; 5-CHLOROBIPHENYL-3-YLBORONIC ACID; 5-CHLOROPYRAZINE-2-BORONIC ACID; 5-CHLOROPYRIDINE-2-BORONIC ACID; 5-CHLOROPYRIDINE-3-BORONIC ACID; 5-CHLOROPYRIMIDINE-2-BORONIC ACID; 5-CHLOROPYRIMIDINE-4-BORONIC ACID; 5-CHLORO-PYRROL-3-YLBORONIC ACID; 5-CHLOROTHIOPHENE-2-BORONIC ACID; 5-CHLOROTHIOPHENE-3-BORONIC ACID; 5-CYANO-1H-INDOLE-2-BORONIC ACID; 5-CYANO-1-METHYL-1H-PYRROL-2-YLBORONIC ACID; 5-CYANO-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 5-CYANO-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 5-CYANO-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-CYANO-2-FLUOROPHENYLBORONIC ACID; 5-CYANO-2-HYDROXYPHENYLBORONIC ACID; 5-CYANO-2-HYDROXYPYRIDIN-3-YLBORONIC ACID; 5-CYANO-2-METHOXYPHENYLBORONIC ACID; 5-CYANO-2-METHOXYPYRIDIN-3-YLBORONIC ACID; 5-CYANO-2-METHYLPHENYLBORONIC ACID; 5-CYANO-2-METHYLTHIOPHEN-3-YL-BORONIC ACID; 5-CYANO-2-OXO-1,2-DIHYDROPYRIDIN-3-YLBORONIC ACID; 5-CYANO-3-METHYLPYRIDIN-2-YLBORONIC ACID; 5-CYANO-3-METHYLTHIOPHENE-2-BORONIC ACID; 5-CYANO-3-PYRIDINYL BORONIC ACID; 5-CYANO-4-METHYLTHIOPHENE-2-BORONIC ACID; 5-CYANO-6-ETHOXYPYRIDINE-3-BORONIC ACID; 5-CYANOBENZOFURAN-2-YLBORONIC ACID; 5-CYANOPYRAZINE-2-BORONIC ACID; 5-CYANOPYRIDIN-2-YL-2-BORONIC ACID; 5-CYANOTHIOPHEN-3-YLBORONIC ACID; 5-CYANOTHIOPHENE-2-BORONIC ACID; 5-CYCLOPROPYLPYRIDIN-3-YLBORONIC ACID; 5-ETHOXY-2-FLUOROPHENYLBORONIC ACID; 5-ETHOXYPYRAZINE-2-BORONIC ACID; 5-ETHOXYPYRIDIN-2-YLBORONIC ACID; 5-ETHOXYPYRIDINE-3-BORONIC ACID; 5-ETHOXYTHIOPHEN-2-YLBORONIC ACID; 5-ETHYL-1,3,4-THIADIAZOL-2-YLBORONIC ACID; 5-ETHYL-1H-INDAZOL-4-YL BORONIC ACID; 5-ETHYLFURAN-2-BORONIC ACID; 5-ETHYLPYRIDIN-3-YLBORONIC ACID; 5-ETHYLTHIOPHENYLBORONIC ACID; 5-FLUORO-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 5-FLUORO-1H-INDAZOL-6-YLBORONIC ACID; 5-FLUORO-1H-INDOL-2-YLBORONIC ACID; 5-FLUORO-1-METHYL-1H-INDAZOLE-6-BORONIC ACID; 5-FLUORO-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 5-FLUORO-1-METHYL-PYRROL-3-YLBORONIC ACID; 5-FLUORO-2-(1,2,4-OXADIAZOL-3-YL)PHENYLBORONIC ACID; 5-FLUORO-2-(4-FLUOROPHENYLMETHOXY)PHENYLBORONIC ACID; 5-FLUORO-2-(5-PROPYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID; 5-FLUORO-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 5-FLUORO-2-(MORPHOLINOCARBONYL)PHENYLBORONIC ACID; 5-FLUORO-2-(TRIFLUOROETHOXY)PHENYLBORONIC ACID; 5-FLUORO-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-FLUORO-2,3-DIMETHOXYPHENYLBORONIC ACID; 5-FLUORO-2-HYDROXYMETHYLPHENYLBORONIC ACID; 5-FLUORO-2-HYDROXYPHENYLBORONIC ACID; 5-FLUORO-2-HYDROXYPYRIDINE-4-BORONIC ACID; 5-FLUORO-2-ISOPROPOXYPHENYLBORONIC ACID; 5-FLUORO-2-ISOPROPOXYPYRIDINE-4-BORONIC ACID; 5-FLUORO-2-METHOXYCARBONYLPHENYLBORONIC ACID; 5-FLUORO-2-METHOXYPHENYLBORONIC ACID; 5-FLUORO-2-METHOXYPYRIDINE-3-BORONIC ACID; 5-FLUORO-2-METHOXYPYRIDINE-4-BORONIC ACID; 5-FLUORO-2-METHYLPHENYLBORONIC ACID; 5-FLUORO-2-METHYLPYRIDINE-4-BORONIC ACID; 5-FLUORO-2-NITROBENZENEBORONIC ACID; 5-FLUORO-2-PROPOXYPHENYLBORONIC ACID; 5-FLUORO-3-METHYLBENZO[B]THIOPHEN-2-YLBORONIC ACID; 5-FLUORO-3-NITROPYRIDIN-2-YLBORONIC ACID; 5-FLUORO-4-METHOXYPYRIMIDIN-2-YLBORONIC ACID; 5-FLUORO-6-HYDROXYPYRIDIN-3-YLBORONIC ACID; 5-FLUORO-6-METHYLPYRIDINE-2-BORONIC ACID; 5-FLUOROBENZOFURAN-2-YLBORONIC ACID; 5-FLUOROBENZOTHIOPHENE-2-BORONIC ACID; 5-FLUOROPYRAZINE-2-BORONIC ACID; 5-FLUOROPYRIDINE-2-BORONIC ACID; 5-FLUOROPYRIDINE-3-BORONIC ACID; 5-FLUORO-PYRROL-3-YLBORONIC ACID; 5-FLUOROQUINOLINE-8-BORONIC ACID; 5H-[1,3]DIOXOLO[4,5-F]INDOL-7-YLBORONIC ACID; 5-HEXENYLBORONIC ACID; 5-HEXYLTHIOPHENE-2-BORONIC ACID; 5-HEXYLTHIOPHENE-3-BORONIC ACID; 5-HYDROXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 5-HYDROXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-HYDROXY-2-METHOXYPHENYLBORONIC ACID; 5-HYDROXY-2-METHYLPHENYLBORONIC ACID; 5-HYDROXYBENZOTHIAZOLE-2-BORONIC ACID; 5-HYDROXYMETHYL-2-METHOXYPHENYLBORONIC ACID; 5-HYDROXYMETHYLTHIOPHENE-2-BORONIC ACID; 5-HYDROXYNAPHTHALENE-1-BORONIC ACID; 5-HYDROXYNAPHTHALENE-2-BORONIC ACID; 5-HYDROXYPYRAZINE-2-BORONIC ACID; 5-HYDROXYPYRIDINE-3-BORONIC ACID; 5-HYDROXYQUINOLINE-2-BORONIC ACID; 5-HYDROXYQUINOLINE-3-BORONIC ACID; 5-HYDROXYQUINOLINE-4-BORONIC ACID; 5-HYDROXYQUINOLINE-6-BORONIC ACID; 5-HYDROXYQUINOLINE-7-BORONIC ACID; 5-HYDROXYQUINOLINE-8-BORONIC ACID; 5-INDOLYLBORONIC ACID; 5-ISOPROPYL-2-METHOXYPHENYLBORONIC ACID; 5-ISOPROPYL-2-METHOXYQUINOLIN-3-YLBORONIC ACID; 5-ISOPROPYLTHIOPHENE-3-BORONIC ACID; 5-METHOXY-1-(PHENYLSULFONYL)-1H-PYRROLO[3,2-B]PYRIDIN-2-YLBORONIC ACID; 5-METHOXY-1-[(4-METHYLPHENYL)SULFONYL]-1H-INDOL-3-YLBORONIC ACID; 5-METHOXY-1H-INDOL-3-YLBORONIC ACID; 5-METHOXY-1H-INDOLE-2-BORONIC ACID; 5-METHOXY-1H-PYRROLO[3,2-B]PYRIDIN-6-YLBORONIC ACID; 5-METHOXY-1-METHYL-1H-INDOL-3-YLBORONIC ACID; 5-METHOXY-2-(METHOXYMETHOXY)PHENYLBORONIC ACID; 5-METHOXY-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 5-METHOXY-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-METHOXY-2-METHYLPHENYLBORONIC ACID; 5-METHOXYBENZO[B]THIOPHENE-2-BORONIC ACID; 5-METHOXYBENZOFURAN-2-BORONIC ACID; 5-METHOXYBENZOTHIAZOLE-2-BORONIC ACID; 5-METHOXYCARBONYL-1H-INDOLE-2-BORONIC ACID; 5-METHOXYCARBONYL-2-METHYLPHENYLBORONIC ACID; 5-METHOXYFURAN-2-YLBORONIC ACID; 5-METHOXYPYRAZINE-2-BORONIC ACID; 5-METHOXYPYRIDINE-2-BORONIC ACID; 5-METHOXYPYRIDINE-3-BORONIC ACID; 5-METHOXYTHIOPHENE-2-BORONIC ACID; 5-METHYL-1-(TRIISOPROPYLSILYL)-PYRROL-3-YLBORONIC ACID; 5-METHYL-1-HEXENYLBORONIC ACID; 5-METHYL-1H-INDAZOLE-4-BORONIC ACID; 5-METHYL-1H-INDAZOLE-6-BORONIC ACID; 5-METHYL-1H-INDOL-4-YLBORONIC ACID; 5-METHYL-1H-INDOLE-2-BORONIC ACID; 5-METHYL-1-PHENYL-1H-PYRAZOL-4-YLBORONIC ACID; 5-METHYL-2-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(2,4,5-TRICHLOROPHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(2,4,5-TRICHLOROPHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(METHYLTHIO)PHENYLBORONIC ACID; 5-METHYL-2-(PERFLUOROPHENYL)PYRIDINE-3-BORONIC ACID; 5-METHYL-2-(PERFLUOROPHENYL)PYRIDINE-4-BORONIC ACID; 5-METHYL-2-(TRIFLUOROMETHOXY)PHENYLBORONIC ACID; 5-METHYL-2-(TRIFLUOROMETHYL)PHENYLBORONIC ACID; 5-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YLBORONIC ACID; 5-METHYL-2-PENTYLOXYPYRIDINE-3-BORONIC ACID; 5-METHYL-2-PROPOXYPHENYLBORONIC ACID; 5-METHYL-3-PHENYL-4-ISOXAZOLYLBORONIC ACID; 5-METHYL-5H-PYRROLO[2,3-B]PYRAZIN-3-YLBORONIC ACID; 5-METHYL-6-(METHYL-D3)-PYRIDINE-3-BORONIC ACID; 5-METHYL-6-(METHYLTHIO)PYRIDIN-3-YLBORONIC ACID; 5-METHYL-6-(MORPHOLIN-4-YL)PYRIDINE-3-BORONIC ACID; 5-METHYL-6-MORPHOLINOPYRIDIN-3-YLBORONIC ACID HYDROCHLORIDE; 5-METHYL-6-THIOMORPHOLINOPYRIDIN-3-YLBORONIC ACID; 5-METHYLBENZO[B]THIOPHEN-3-YLBORONIC ACID; 5-METHYLBENZO[B]THIOPHENE-2-BORONIC ACID; 5-METHYLFURAN-2-BORONIC ACID; 5-METHYLFURAN-3-YLBORONIC ACID; 5-METHYLISOXAZOL-4-YLBORONIC ACID; 5-METHYLPYRAZINE-2-BORONIC ACID; 5-METHYLPYRIDINE-2-BORONIC ACID; 5-METHYLPYRIDINE-3-BORONIC ACID; 5-METHYL-PYRROL-3-YLBORONIC ACID; 5-METHYLTHIOPHENE-2-BORONIC ACID; 5-METHYLTHIOPHENE-3-BORONIC ACID; 5-MORPHOLINOPYRAZINE-2-BORONIC ACID; 5-MORPHOLINOPYRIDIN-2-YLBORONIC ACID; 5-MORPHOLINOPYRIDIN-3-YLBORONIC ACID; 5-NITRO-1H-INDOL-2-YLBORONIC ACID; 5-NITROISOQUINOLINE-8-BORONIC ACID; 5-NITROPYRIDIN-2-YLBORONIC ACID; 5-PENTYLOXYTHIOPHENE-2-BORONIC ACID; 5-PENTYLTHIOPHENE-2-BORONIC ACID; 5-PENTYLTHIOSELENOPHENE-2-BORONIC ACID; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-BORONIC ACID; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-BORONIC ACID; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID; 5-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-6-BORONIC ACID; 5-PHENYL-2-THIENYLBORONIC ACID; 5-PHENYL-3-PYRIDINYL BORONIC ACID; 5-PHENYLFURAN-2-BORONIC ACID; 5-PHENYLPYRIDINE-2-BORONIC ACID; 5-PHENYLPYRIMIDINE-2-BORONIC ACID; 5-PHENYLPYRIMIDINE-4-BORONIC ACID; 5-PHENYL-PYRROL-3-YLBORONIC ACID; 5-PHENYLTHIOPHEN-3-YLBORONIC ACID; 5-PROPOXYBENZOFURAN-2-YLBORONIC ACID; 5-PROPYLPYRIMIDIN-2-YLBORONIC ACID; 5-PROPYLTHIOPHENE-2-BORONIC ACID; 5-SULFAMOYLPYRIDINE-3-BORONIC ACID; 5-SULFAMOYLTHIOPHEN-2-YLBORONIC ACID; 5-TERT-BUTOXYCARBONYLTHIOPHENE-2-BORONIC ACID; 5-TERT-BUTYL-2-CHLOROPHENYLBORONIC ACID; 5-TERT-BUTYL-2-ETHOXYPHENYLBORONIC ACID; 5-TERT-BUTYL-2-FURANBORONIC ACID; 5-TERT-BUTYL-2-METHOXYBENZENEBORONIC ACID; 5-TERT-BUTYLTHIOPHENE-2-BORONIC ACID; 5-TERT-BUTYLTHIOPHENE-3-BORONIC ACID; 5-TRIFLUOROMETHYL-1H-PYRAZOL-3-YLBORONIC ACID; 5-TRIFLUOROMETHYL-1H-PYRAZOL-4-YLBORONIC ACID; 5-TRIFLUOROMETHYLPYRIDINE-3-BORONIC ACID; 5-TRIFLUOROMETHYLQUINOLINE-8-BORONIC ACID; 5-TRIMETHYLSILYLTHIOPHENE-2-BORONIC ACID; 6-(1,4-DIOZA-8-AZASPIRO[4.5]DEC-8-YL)PYRIDINE-3-BORONIC ACID; 6-(1-CYANOCYCLOPROPYL)PYRIDINE-3-BORONIC ACID; 6-(1H-1,2,4-TRIAZOL-1-YL)PYRIDIN-3-YLBORONIC ACID; 6-(1H-IMIDAZOL-2-YL)PYRIDIN-3-YLBORONIC ACID; 6-(1H-PYRIDIN-2-ONE)PYRIDINE-2-BORONIC ACID; 6-(1-METHYL-1H-TETRAZOL-5-YL)PYRIDIN-3-YLBORONIC ACID; 6-(2-(METHOXYMETHOXY)PROPAN-2-YL)PYRIDIN-2-YLBORONIC ACID; 6-(2-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(2,3-DIFLUOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(2,3-DIFLUOROPHENYL)-2-METHYLPYRIDINE-3-BORONIC ACID; 6-(2,4,5-TRICHLOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(2,4-DIMETHYLPHENOXY)PYRIDIN-3-YLBORONIC ACID; 6-(2-CYANOPROPAN-2-YL)PYRIDIN-3-YLBORONIC ACID; 6-(2-ETHYLIMIDAZOL-1-YL)PYRIDINE-2-BORONIC ACID; 6-(2-FURYL)PYRIDINE-2-BORONIC ACID; 6-(2-HYDROXYPROPAN-2-YL)PYRIDINE-2-BORONIC ACID; 6-(2-HYDROXYPROPAN-2-YL)PYRIDINE-3-BORONIC ACID; 6-(2-METHOXY-2-OXOETHOXY)PYRIDINE-3-BORONIC ACID; 6-(2-METHYL-2H-TETRAZOL-5-YL)PYRIDIN-3-YLBORONIC ACID; 6-(2-METHYLIMIDAZOL-1-YL)PYRIDINE-2-BORONIC ACID; 6-(2-METHYLPHENYL)PYRIDINE-2-BORONIC ACID; 6-(2-METHYLPIPERIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(2-MORPHOLINOETHOXY)PYRIDINE-3-BORONIC ACID; 6-(2-THIENYL)PYRIDINE-2-BORONIC ACID; 6-(3-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(3-FURAN)PYRIDINE-2-BORONIC ACID; 6-(3-HYDROXYOXETAN-3-YL)PYRIDIN-3-YLBORONIC ACID; 6-(3-HYDROXYPYRROLIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(3-METHYL-1H-PYRAZOL-1-YL)PYRIDINE-2-BORONIC ACID; 6-(3-METHYLPHENYL)PYRIDINE-2-BORONIC ACID; 6-(3-METHYLPIPERIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(3-THIENYL)PYRIDINE-2-BORONIC ACID; 6-(4-(TRIFLUOROMETHOXY)PHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(4-ACETYLPIPERAZIN-1-YL)PYRIDIN-3-YLBORONIC ACID; 6-(4-CHLOROPHENOXY)PYRIDIN-3-YLBORONIC ACID; 6-(4-FLUOROPHENYL)PYRIDINE-3-BORONIC ACID; 6-(4-HYDROXYPIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 6-(4-METHOXYBENZYLCARBAMOYL)PYRIDINE-3-BORONIC ACID; 6-(4-METHOXYBENZYLOXY)PYRIDIN-3-YLBORONIC ACID; 6-(4-METHOXYPHENOXY)PYRIDIN-3-YLBORONIC ACID; 6-(4-METHYL-1H-PYRAZOL-1-YL)PYRIDINE-2-BORONIC ACID; 6-(4-METHYLPHENOXY)PYRIDIN-3-YLBORONIC ACID; 6-(4-METHYLPHENYL)PYRIDINE-2-BORONIC ACID; 6-(4-METHYLPIPERAZIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(4-METHYLPIPERIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(4-MORPHOLINYL)-3-PYRIDINYLBORONIC ACID; 6-(4-MORPHOLINYLMETHYL)-3-PYRIDINYL BORONIC ACID; 6-(4-N-BOC-PIPERAZINE-1-YL)-3-PYRIDINYL BORONIC ACID; 6-(5-CHLOROPYRIDIN-3-YLOXY)PYRIDIN-3-YLBORONIC ACID; 6-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PYRIDIN-3-YLBORONIC ACID; 6-(6-CHLOROPYRIDIN-3-YLOXY)PYRIDIN-3-YLBORONIC ACID; 6-(AMINOCARBONYL)PYRIDINE-3-BORONIC ACID; 6-(AZEPAN-1-YL)PYRIDIN-3-YLBORONIC ACID; 6-(BENZYLOXY)-2-NAPHTHYLBORONIC ACID; 6-(BENZYLOXY)-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YLBORONIC ACID; 6-(BOC-METHYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(CYCLOBUTOXY)PYRIDINE-2-BORONIC ACID; 6-(CYCLOBUTYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(CYCLOHEXYL)PYRIDINE-2-BORONIC ACID; 6-(CYCLOHEXYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(CYCLOHEXYLOXY)PYRIDINE-2-BORONIC ACID; 6-(CYCLOPENTOXY)PYRIDINE-2-BORONIC ACID; 6-(CYCLOPENTYL)PYRIDINE-2-BORONIC ACID; 6-(CYCLOPENTYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(CYCLOPROPYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(CYCLOPROPYLMETHOXY)PYRAZIN-2-YLBORONIC ACID; 6-(DIETHYLAMINO)-4-ETHYLPYRIDIN-3-YLBORONIC ACID; 6-(DIETHYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(DIETHYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(DIFLUOROMETHOXY)BENZOTHIAZOLE-2-BORONIC ACID; 6-(DIMETHOXYMETHYL)PYRIDIN-2-YLBORONIC ACID; 6-(DIMETHYLAMINO)-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 6-(DIMETHYLAMINO)-2-METHYLPYRIDINE-3-BORONIC ACID; 6-(DIMETHYLAMINO)-4-ETHYLPYRIDINE-3-BORONIC ACID; 6-(DIMETHYLAMINO)-4-ISOPROPOXYPYRIDIN-3-YLBORONIC ACID; 6-(DIMETHYLAMINO)-4-METHOXYPYRIDIN-3-YLBORONIC ACID; 6-(DIMETHYLAMINO)-4-METHYLPYRIDINE-3-BORONIC ACID; 6-(DIMETHYLAMINO)-5-METHYLPYRIDIN-3-YLBORONIC ACID; 6-(DIMETHYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(DIMETHYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(DIMETHYLCARBAMOYL)PYRIDINE-3-BORONIC ACID; 6-(ETHANESULFONYL)PYRIDINE-3-BORONIC ACID; 6-(ETHYL(METHYL)AMINO)PYRIDINE-3-BORONIC ACID; 6-(ETHYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(ETHYLCARBAMOYL)PYRIDIN-3-YLBORONIC ACID; 6-(ETHYLTHIO)-5-METHYLPYRIDIN-3-YLBORONIC ACID; 6-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 6-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 6-(HYDROXYMETHYL)PYRIDINE-2-BORONIC ACID; 6-(HYDROXYMETHYL)PYRIDINE-3-BORONIC ACID; 6-(IMIDAZOL-1-YL)PYRIDINE-2-BORONIC ACID; 6-(ISO-PROPOXY)PYRIDINE-2-BORONIC ACID; 6-(ISOPROPYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(ISO-PROPYL-D7)-PYRIDINE-3-BORONIC ACID; 6-(ISOPROPYLTHIO)PYRIDINE-3-BORONIC ACID; 6-(METHOXYCARBONYL)INDOLE-2-BORONIC ACID; 6-(METHOXYCARBONYL)PYRIDINE-2-BORONIC ACID; 6-(METHOXYCARBONYL)PYRIDINE-3-BORONIC ACID; 6-(METHOXYMETHOXY)PYRIDIN-3-YLBORONIC ACID; 6-(METHYLAMINO)PYRIDIN-3-YLBORONIC ACID; 6-(METHYLAMINO)PYRIDIN-3-YLBORONIC ACID HYDROCHLORIDE; 6-(METHYLCARBAMOYL)PYRIDIN-3-YLBORONIC ACID; 6-(METHYL-D3)-PYRIDINE-3-BORONIC ACID; 6-(MORPHOLINOMETHYL)PYRIDIN-3-YLBORONIC ACID; 6-(N,N-METHYLETHYLAMINO)PYRIDINE-2-BORONIC ACID; 6-(NEOPENTYLOXY)PYRIDINE-3-BORONIC ACID; 6-(N-PROPOXY)PYRIDINE-2-BORONIC ACID; 6-(PERFLUOROPHENYL)-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-(PHENYLTHIO)PYRIDIN-3-YLBORONIC ACID; 6-(PIPERAZIN-1-YL)PYRIDINE-3-BORONIC ACID; 6-(PIPERIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 6-(PIPERIDIN-1-YL)PYRIDIN-3-YLBORONIC ACID; 6-(PIPERIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(PIVALAMIDO)PYRIDINE-3-BORONIC ACID; 6-(PROP-1-YNYL)PYRAZIN-2-YLBORONIC ACID; 6-(PROP-1-YNYL)PYRIMIDIN-4-YLBORONIC ACID; 6-(PROPYLAMINO)PYRIDINE-3-BORONIC ACID; 6-(PYRIDIN-3-YLOXY)PYRIDINE-3-BORONIC ACID; 6-(PYRROL-1-YL)-3-PYRIDINYL BORONIC ACID; 6-(PYRROLIDIN-1-YL)PYRAZINE-2-BORONIC ACID; 6-(PYRROLIDIN-1-YL)PYRIDINE-2-BORONIC ACID; 6-(PYRROLIDIN-1-YL)PYRIDINE-3-BORONIC ACID; 6-(QUINOLIN-3-YL)PYRIDIN-3-YLBORONIC ACID; 6-(TERT-BUTOXY)PYRIDINE-2-BORONIC ACID; 6-(TERT-BUTOXYCARBONYLAMINO)PYRIDIN-3-YLBORONIC ACID; 6-(TERT-BUTOXYMETHYL)PYRIDIN-3-YLBORONIC ACID; 6-(TERT-BUTYL)PYRIDINE-2-BORONIC ACID; 6-(TERT-BUTYLDIMETHYLSILYLOXY)-1H-INDOL-2-YLBORONIC ACID; 6-(TETRAHYDRO-2H-PYRAN-2-YLOXY)-2-NAPHTHYLBORONIC ACID; 6-(TETRAHYDRO-2H-PYRAN-4-YLOXY)PYRIDIN-3-YLBORONIC ACID; 6-(TETRAHYDRO-FURAN-3-YLOXY)PYRIDINE-2-BORONIC ACID; 6-(TRIFLUOROMETHYL)-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-(TRIFLUOROMETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-(TRIFLUOROMETHYL)-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-(TRIFLUOROMETHYL)PYRIDINE-2-BORONIC ACID; 6,6,6-TRIFLUOROHEXANEBORONIC ACID; 6,7-DIHYDRO-5H-CYCLOPENTA[B]PYRIDINE-2-BORONIC ACID; 6,7-DIMETHOXY-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 6-[(4-CHLOROPHENYL)THIO]PYRIDIN-3-YLBORONIC ACID; 6-[(4-METHYLPHENYL)THIO]PYRIDIN-3-YLBORONIC ACID; 6-[(BENZYLOXY)METHYL]PYRIDINE-2-BORONIC ACID; 6-[(DIETHYLAMINO)CARBONYL]PYRIDINE-3-BORONIC ACID; 6-[4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL]PYRIDINE-2-BORONIC ACID; 6-ACETAMIDO-4-METHYLPYRIDINE-3-BORONIC ACID; 6-ACETAMIDO-5-METHYLPYRIDIN-3-YLBORONIC ACID; 6-ACETOXYNAPHTHALEN-2-YLBORONIC ACID; 6-AMINO-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-AMINO-2-FLUOROPYRIDIN-3-YLBORONIC ACID; 6-AMINO-2-METHOXYPYRIDINE-3-BORONIC ACID; 6-AMINO-2-METHOXYPYRIDINE-4-BORONIC ACID; 6-AMINO-2-METHYLPYRIDINE-3-BORONIC ACID; 6-AMINO-2-METHYLPYRIMIDIN-4-YLBORONIC ACID; 6-AMINO-4-(TRIFLUOROMETHYL)PYRIDIN-3-YLBORONIC ACID; 6-AMINO-4-CHLOROPYRIDIN-3-YLBORONIC ACID; 6-AMINO-5-FLUOROPYRIDINE-3-BORONIC ACID; 6-AMINO-5-METHOXYPYRIDIN-3-YLBORONIC ACID; 6-AMINO-5-METHYLPYRIDINE-3-BORONIC ACID; 6-AMINO-5-SULFAMOYLPYRIDINE-3-BORONIC ACID; 6-AMINOPYRAZINE-2-BORONIC ACID; 6-AMINOPYRIDAZIN-3-YL-3-BORONIC ACID; 6-AMINOPYRIDINE-2-BORONIC ACID; 6-AMINOPYRIDINE-3-BORONIC ACID-HCL; 6-BENZOXY-5-FLUOROPYRIDINE-3-BORONIC ACID; 6-BENZYLOXY-1-BOC-INDOLE-2-BORONIC ACID; 6-BENZYLOXY-1H-INDOLE-2-BORONIC ACID; 6-BENZYLOXY-2-FLUORO-3-METHYLPHENYLBORONIC ACID; 6-BENZYLOXYPYRIDINE-3-BORONIC ACID; 6-BORONOBENZO[D][1,3]DIOXOLE-5-CARBOXYLIC ACID; 6-BUTOXY-5-CHLOROPYRIDINE-3-BORONIC ACID; 6-BUTOXY-5-METHYLPYRIDINE-3-BORONIC ACID; 6-BUTOXYPYRIDINE-3-BORONIC ACID; 6-CARBOXY-2-NAPHTHALENEBORONIC ACID; 6-CARBOXYPYRIDINE-3-BORONIC ACID; 6-CHLORO-(4-TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-CHLORO(PYRAZINE-D2)-2-BORONIC ACID; 6-CHLORO-1-METHYL-1H-PYRROLO[2,3-B]PYRIDIN-2-YLBORONIC ACID; 6-CHLORO-1-METHYLINDOLE-2-BORONIC ACID; 6-CHLORO-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6′-CHLORO-2,3′-BIPYRIDIN-5-YLBORONIC ACID; 6-CHLORO-2,3-DIFLUOROPHENYLBORONIC ACID; 6-CHLORO-2-FLUORO-3-METHOXYPHENYLBORONIC ACID; 6-CHLORO-2-FLUOROPYRIDINE-3-BORONIC ACID; 6-CHLORO-2-METHOXYPYRIDINE-3-BORONIC ACID; 6-CHLORO-2-METHYLPYRIDINE-3-BORONIC ACID; 6-CHLORO-2-METHYLPYRIMIDINE-4-BORONIC ACID; 6-CHLORO-3-METHOXYPYRIDINE-2-BORONIC ACID; 6-CHLORO-3-METHYLPYRIDINE-2-BORONIC ACID; 6-CHLORO-3-OXOISOINDOLIN-5-YLBORONIC ACID; 6-CHLORO-4-(TRIFLUOROMETHYL)PYRIDINE-2-BORONIC ACID; 6-CHLORO-4-FLUOROPYRIDINE-3-BORONIC ACID; 6-CHLORO-4-METHOXYPYRIDINE-2-BORONIC ACID; 6-CHLORO-4-METHYLPYRIDINE-2-BORONIC ACID; 6-CHLORO-5-METHOXYPYRIDINE-3-BORONIC ACID; 6-CHLOROBENZO[B]THIOPHEN-3-YLBORONIC ACID; 6-CHLOROPYRAZINE-2-BORONIC ACID; 6-CHLOROPYRIDAZIN-3-YL-3-BORONIC ACID; 6-CHLOROPYRIDINE-2-BORONIC ACID; 6-CHLOROPYRIMIDINE-4-BORONIC ACID; 6-CYANO-3-METHYLBENZO[B]THIOPHEN-2-YLBORONIC ACID; 6-CYANO-3-OXOISOINDOLIN-5-YLBORONIC ACID; 6-CYANOBENZO[B]THIOPHEN-2-YLBORONIC ACID; 6-CYANOPYRAZINE-2-BORONIC ACID; 6-CYANOPYRIDIN-3-YLBORONIC ACID; 6-CYANOPYRIDINE-2-BORONIC ACID; 6-CYCLOPROPYLPYRIDIN-3-YLBORONIC ACID; 6-CYCLOPROPYLPYRIDINE-2-BORONIC ACID; 6-ETHOXY-2-METHYLPYRIDINE-3-BORONIC ACID; 6-ETHOXY-2-NAPHTHALENEBORONIC ACID; 6-ETHOXYPYRIDINE-2-BORONIC ACID; 6-ETHYL-1,6-DIHYDROPYRIMIDIN-5-YLBORONIC ACID; 6-ETHYLPYRIDINE-2-BORONIC ACID; 6-FLUORO-1H-INDOLE-2-BORONIC ACID; 6-FLUORO-1-METHYL-1H-INDOL-2-YLBORONIC ACID; 6-FLUORO-2-(2-METHOXYETHOXY)PYRIDIN-3-YLBORONIC ACID; 6-FLUORO-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-FLUORO-2,3′-BIPYRIDIN-5-YLBORONIC ACID; 6-FLUORO-3-OXOISOINDOLIN-5-YLBORONIC ACID; 6-FLUOROBENZO[B]THIEN-2-YL BORONIC ACID; 6-FLUOROPYRIDAZIN-3-YLBORONIC ACID; 6-FLUOROPYRIDINE-2-BORONIC ACID; 6-FLUOROQUINOLINE-8-BORONIC ACID; 6-HYDROXY-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-HYDROXY-2-METHYLPYRIDINE-3-BORONIC ACID; 6-HYDROXY-2-NAPHTHALENEBORONIC ACID; 6-HYDROXY-5-(TETRAHYDROPYRAN-2-YL)NAPHTHALENE-2-BORONIC ACID; 6-HYDROXYBENZOTHIAZOLE-2-BORONIC ACID; 6-HYDROXYNAPHTHALENE-1-BORONIC ACID; 6-HYDROXYPYRIDIN-3-YLBORONIC ACID; 6-HYDROXYPYRIDINE-2-BORONIC ACID; 6-HYDROXYQUINOLINE-2-BORONIC ACID; 6-HYDROXYQUINOLINE-3-BORONIC ACID; 6-HYDROXYQUINOLINE-4-BORONIC ACID; 6-HYDROXYQUINOLINE-5-BORONIC ACID; 6-HYDROXYQUINOLINE-7-BORONIC ACID; 6-HYDROXYQUINOLINE-8-BORONIC ACID; 6-INDAZOLYBORONIC ACID; 6-INDAZOLYBORONIC ACID HCL; 6-ISOBUTOXY-5-METHYLPYRIDINE-3-BORONIC ACID; 6-ISOPROPOXYBENZO[B]THIOPHEN-2-YLBORONIC ACID; 6-ISOPROPYL-2-METHYLBENZENEBORONIC ACID; 6-ISO-PROPYLPYRIDINE-2-BORONIC ACID; 6-METHOXY-1,5-NAPHTHYRIDINE-4-BORONIC ACID; 6-METHOXY-1,7-NAPHTHYRIDIN-4-YLBORONIC ACID; 6-METHOXY-1H-INDOL-2-YLBORONIC ACID; 6-METHOXY-1H-INDOL-3-YLBORONIC ACID; 6-METHOXY-2-(TRIFLUOROMETHYL)PYRIDINE-3-BORONIC ACID; 6-METHOXY-2-ETHYLPYRIDINE-3-BORONIC ACID; 6-METHOXY-2-NAPHTHALENEBORONIC ACID; 6-METHOXY-3-OXOISOINDOLIN-5-YLBORONIC ACID; 6-METHOXY-5-METHYLPYRIDINE-3-BORONIC ACID; 6-METHOXYBENZO[B]THIOPHENE-2-BORONIC ACID; 6-METHOXYBENZOFURAN-2-BORONIC ACID; 6-METHOXYBENZOTHIAZOLE-2-BORONIC ACID; 6-METHOXYPYRIDAZIN-3-YL-3-BORONIC ACID; 6-METHOXYPYRIDINE-2-BORONIC ACID; 6-METHYL-1H-INDAZOLE-4-BORONIC ACID; 6-METHYL-1H-INDAZOLE-5-BORONIC ACID; 6-METHYL-1H-INDOL-3-YLBORONIC ACID; 6-METHYL-1H-INDOLE-2-BORONIC ACID; 6-METHYL-2-(2-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(2,4,5-TRICHLOROPHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(3-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(4-(TRIFLUOROMETHOXY)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-(PERFLUOROPHENYL)PYRIDINE-3-BORONIC ACID; 6-METHYL-2-NAPHTHALENEBORONIC ACID; 6-METHYLBENZO[B]THIEN-2-YL BORONIC ACID; 6-METHYLBENZOFURAN-2-YLBORONIC ACID; 6-METHYLPYRAZINE-2-BORONIC ACID; 6-METHYLPYRIDINE-2-BORONIC ACID; 6-METHYLPYRIDINE-3-BORONIC ACID; 6-METHYLQUINOLINE-8-BORONIC ACID; 6-MORPHOLINOPYRAZINE-2-BORONIC ACID; 6-MORPHOLINOPYRIDINE-2-BORONIC ACID; 6-NITROPYRIDIN-3-YLBORONIC ACID; 6-OXO-1,6-DIHYDROPYRAZIN-2-YLBORONIC ACID; 6-PENTYLNAPTHALENE-2-BORONIC ACID; 6-PENTYLOXYNAPHTHALENE-2-BORONIC ACID; 6-PHENOXYPYRIDIN-3-YLBORONIC ACID; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-2-BORONIC ACID; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-3-BORONIC ACID; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID; 6-PHENYL-1H-PYRROLO[2,3-B]PYRIDINE-5-BORONIC ACID; 6-PHENYLPYRIDINE-2-BORONIC ACID; 6-PHENYLPYRIDINE-3-BORONIC ACID; 6-PHENYLPYRIMIDINE-4-BORONIC ACID; 6-PROPOXYBENZOFURAN-2-YLBORONIC ACID; 6-PROPOXYPYRIDINE-3-BORONIC ACID; 6-PROPYLPYRIDIN-3-YLBORONIC ACID; 6-QUINAZOLINEBORONIC ACID; 6-QUINOLINYLBORONIC ACID HYDRATE; 6-SEC-BUTYLPYRAZIN-2-YLBORONIC ACID; 6-T-BUTYLDIMETHYLSILYLOXY-2-NAPHTHALENEBORONIC ACID; 6-TERT-BUTYLNAPHTHALEN-2-YLBORONIC ACID; 6-TERT-BUTYLPYRIDIN-3-YLBORONIC ACID; 6-THIOMORPHOLINOPYRIDIN-3-YLBORONIC ACID; 7-(DIFLUOROMETHOXY)BENZOTHIAZOLE-2-BORONIC ACID; 7-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 7-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 7-(TERT-BUTYLDIMETHYLSILYLOXY)-1H-INDOL-2-YLBORONIC ACID; 7-(TRIFLUOROMETHYL)PYRIDO[2,3-D]PYRIMIDIN-4-YLBORONIC ACID; 7-CHLORO-1H-PYRAZOLO[3,4-C]PYRIDINE-4-BORONIC ACID; 7-CHLOROBENZO[B]THIOPHEN-3-YLBORONIC ACID; 7-CHLOROQUINOLINE-4-BORONIC ACID; 7-CYANOBENZO[B]THIOPHEN-2-YLBORONIC ACID; 7-FLUORO-2-METHYLQUINOLINE-8-BORONIC ACID; 7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLBORONIC ACID; 7-HYDROXYBENZOTHIAZOLE-2-BORONIC ACID; 7-HYDROXYNAPHTHALENE-1-BORONIC ACID; 7-HYDROXYNAPHTHALENE-2-BORONIC ACID; 7-HYDROXYQUINOLINE-2-BORONIC ACID; 7-HYDROXYQUINOLINE-3-BORONIC ACID; 7-HYDROXYQUINOLINE-4-BORONIC ACID; 7-HYDROXYQUINOLINE-5-BORONIC ACID; 7-HYDROXYQUINOLINE-6-BORONIC ACID; 7-HYDROXYQUINOLINE-8-BORONIC ACID; 7-METHOXY-1H-INDOL-2-YLBORONIC ACID; 7-METHOXY-1H-INDOL-3-YLBORONIC ACID; 7-METHOXY-2-METHYLQUINOLIN-4-YLBORONIC ACID; 7-METHOXYBENZO[B]THIOPHENE-2-BORONIC ACID; 7-METHOXYBENZOFURAN-2-BORONIC ACID; 7-METHOXYBENZOFURAN-3-YLBORONIC ACID; 7-METHOXYBENZOTHIAZOLE-2-BORONIC ACID; 7-METHOXYQUINOLIN-4-YLBORONIC ACID; 7-METHYL-1-(TRIISOPROPYLSILYL)-1H-INDOL-3-YLBORONIC ACID; 7-METHYL-1H-INDAZOLE-4-BORONIC ACID; 7-METHYL-1H-INDAZOLE-5-BORONIC ACID; 7-METHYL-1H-INDOL-2-YLBORONIC ACID; 7-METHYL-1-NAPHTHALENEBORONIC ACID; 7-METHYLIMIDAZO[1,2-A]PYRIDINE-6-BORONIC ACID; 7-PHENYL-1H-INDOL-2-YLBORONIC ACID; 7-PROPOXYBENZOFURAN-2-YLBORONIC ACID; 8-(HYDROXYMETHYL)NAPHTHALENE-1-BORONIC ACID; 8-(HYDROXYMETHYL)NAPHTHALENE-2-BORONIC ACID; 8-CHLORO-1,7-NAPHTHYRIDINE-3-BORONIC ACID; 8-CHLORO-2-METHYL-1,7-NAPHTHYRIDIN-5-YLBORONIC ACID; 8-FLUORO-2-METHYLQUINOLINE-7-BORONIC ACID; 8-FLUORO-7-HYDROXYQUINOXALIN-6-YLBORONIC ACID; 8-FLUOROQUINOLIN-3-YLBORONIC ACID; 8-FLUOROQUINOLIN-6-YLBORONIC ACID; 8-FLUOROQUINOLINE-7-BORONIC ACID; 8-FLUOROQUINOXALIN-6-YLBORONIC ACID; 8-HYDROXYNAPHTHALENE-1-BORONIC ACID; 8-HYDROXYNAPHTHALENE-2-BORONIC ACID; 8-HYDROXYQUINOLINE-2-BORONIC ACID; 8-HYDROXYQUINOLINE-3-BORONIC ACID; 8-HYDROXYQUINOLINE-4-BORONIC ACID; 8-HYDROXYQUINOLINE-5-BORONIC ACID; 8-HYDROXYQUINOLINE-6-BORONIC ACID; 8-HYDROXYQUINOLINE-7-BORONIC ACID; 8-ISOQUINOLINEBORONIC ACID; 8-METHOXYQUINOLINE-7-BORONIC ACID; 8-METHYL-5-QUINOLINYLBORONIC ACID; 8-OXATRICYCLO[7.4.0.0(2,7)]TRIDECA-1(9),2(7),3,5,10,12-HEXAEN-4-YLBORANEDIOL; 8-TRIFLUOROMETHOXYQUINOLINE-5-BORONIC ACID; 8-TRIFLUOROMETHYLQUINOLINE-6-BORONIC ACID; 9,9-DIETHYLFLUORENE-2-BORONIC ACID; 9,9-DIMETHYL-9H-FLUOREN-2-YL-BORONIC ACID; 9-ACRIDINYL-BORONIC ACID; 9-ANTHRACENEBORONIC ACID; 9H-CARBAZOL-3-YLBORONIC ACID; 9H-FLUOREN-9-YLBORONIC ACID; 9-PHENANTHRENEBORONIC ACID; 9-PHENYLCARBAZOLE-3-BORONIC ACID; ABH; ACENAPHTHENE-5-BORONIC ACID; ACETAMIDOMETHYLBORONIC ACID; ACETYL BOROARGININE TRIFLUOROACETATE; ALLENYLBORONIC ACID; ALPHA-(TRIFLUOROMETHYL)ETHENYL BORONIC ACID; AMINO[4-(DIHYDROXYBORYL)PHENYL]ACETIC ACID; B-(1,6-DIHYDRO-6-OXO-3-PYRIDINYL)-BORONIC ACID; B-(1-METHYL-1H-INDOL-4-YL)-BORONIC ACID; B-(2′-CHLORO[2,4′-BIPYRIDIN]-4-YL)-BORONIC ACID; B-(3,6-DIHYDRO-1,1-DIOXIDO-2H-THIOPYRAN-4-YL)-BORONIC ACID; B-(3-ETHYNYLPHENYL)-BORONIC ACID; B-(4-AMINO-3-PYRIDINYL)-BORONIC ACID HYDROCHLORIDE; B-(4′-CYANO[1,1′-BIPHENYL]-4-YL)-BORONIC ACID; B-(5-FLUORO-1,6-DIHYDRO-6-OXO-3-PYRIDINYL)-BORONIC ACID; B-(5-METHOXY-1-METHYL-1H-PYRROLO[3,2-B]PYRIDIN-6-YL)-BORONIC ACID; B-(9,10-DIPHENYL-2-ANTHRACENYL)BORONIC ACID; B-[1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-BORONIC ACID; B-[2-(DIFLUOROMETHYL)-1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-BORONIC ACID; B-[2,6-DIMETHYL-4-(PHENYLMETHOXY)PHENYL]-BORONIC ACID; B-[3-(1-PROPYN-1-YL)PHENYL]-BORONIC ACID; B-[3,4-BIS[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]METHYLPHENYL]-BORONIC ACID; B-[3,5-BIS[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]PHENYL]-BORONIC ACID; B-[4,2′:6′,4″-TERPYRIDIN]-4′-YL-BORONIC ACID; B-[4-[(TETRAHYDRO-1,1-DIOXIDO-2H-THIOPYRAN-4-YL)AMINO]PHENYL]-BORONIC ACID; B-[4-[[(TETRAHYDRO-1,1-DIOXIDO-2H-THIOPYRAN-4-YL)AMINO]SULFONYL]PHENYL]-BORONIC ACID; B-[4-[BIS(4-METHYLPHENYL)AMINO]PHENYL]-BORONIC ACID; B-[5-(3-METHOXYPHENYL)-3-PYRIDINYL]-BORONIC ACID; B-[5-[(PHENYLSULFONYL)AMINO]-3-PYRIDINYL]BORONIC ACID; B-5H-PYRROLO[3,2-B:4,5-B′]DIPYRIDIN-3-YL-BORONIC ACID; B-6-BENZOFURANYL-BORONIC ACID; BEC; BEC AMMONIUM SALT; BEC, HYDROCHLORIDE; BENZAMIDOMETHYLBORONIC ACID; BENZENE-1,4-DIBORONIC ACID MONO-MIDA ESTER; BENZIMIDAZOLE-2-BORONIC ACID; BENZO[B]THIOPHENE-2-BORONIC ACID; BENZO[C][1,2,5]OXADIAZOLE-5-BORONIC ACID; BENZO[D]ISOXAZOL-4-YLBORONIC ACID; BENZO[D]ISOXAZOL-5-YLBORONIC ACID; BENZO[D]ISOXAZOL-6-YLBORONIC ACID; BENZO[D]OXAZOL-7-YLBORONIC ACID; BENZOCYCLOBUTENE-4-BORONIC ACID; BENZOFURAN-2-BORONIC ACID; BENZOFURAN-3-BORONIC ACID; BENZOFURAN-5-BORONIC ACID; BENZOPYRAZINE-6-BORONIC ACID HCL; BENZOTHIOPHENE-3-BORONIC ACID; BENZYLBORONIC ACID; BIPHENYL-2-YLBORONIC ACID HYDRATE; BOC-3-AMINOPYRIDINE-4-BORONIC ACID; BOC-4-AMINO-6-METHYLPYRIDINE-3-BORONIC ACID; BOC-L-PROLINEBORONIC ACID; BORONIC ACID, (2,3,4,5-TETRAHYDRO-3-METHYL-1H-3-BENZAZEPIN-7-YL)-; BORONIC ACID, [2-(1-PIPERIDINYLCARBONYL)PHENYL]-; BORONIC ACID, [2-(1-PYRROLIDINYLCARBONYL)PHENYL]-; BORONIC ACID, [3-(1-METHYLETHYL)-1H-INDAZOL-4-YL]-; BORONIC ACID, [3-(1-NAPHTHALENYL)PHENYL]-; BORONIC ACID, [3-(1-PYRROLIDINYLMETHYL)PHENYL]-, HYDROCHLORIDE, PROPAN-2-OL; BORONIC ACID, [3-(PHENYLMETHYL)PHENYL]-; BORONIC ACID, [4-(1-PIPERIDINYLMETHYL)PHENYL]-, HYDROCHLORIDE; BORONIC ACID, [4-(1-PYRROLIDINYLMETHYL)PHENYL]-, HYDROCHLORIDE; BORONIC ACID, [4-(2-AMINO-3-HYDROXYPROPYL)PHENYL]-; BORONIC ACID, [4-(MERCAPTOMETHYL)PHENYL]-; BORONIC ACID, [4-(PHENYLMETHYL)PHENYL]-; BORONIC ACID, [4-[(2R)-2-AMINO-3-HYDROXYPROPYL]PHENYL]-; BORONIC ACID, [4-[(2S)-2-AMINO-3-HYDROXYPROPYL]PHENYL]-; BORONIC ACID, [4-CHLORO-1-[TRIS(1-METHYLETHYL)SILYL]-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-; BORONIC ACID, B-(1,2,3,4-TETRAHYDRO-7-ISOQUINOLINYL)-; BORONIC ACID, B-(3-METHOXY-6-PHENYL-4-PYRIDAZINYL)-; BORONIC ACID, B-(5-HYDROXYBENZO[B]THIEN-2-YL)-; BORONIC ACID, B-[2-[1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL]PHENYL]-; BORONIC ACID, B-[3,5-DICHLORO-2-(2,2-DIFLUOROETHOXY)PHENYL]-; BORONIC ACID, B-[3-METHOXY-6-(6-METHOXY-3-PYRIDINYL)-4-PYRIDAZINYL]-; BORONIC ACID, B-[5-(2-METHYLPHENYL)-3-PYRIDINYL]-; BORONIC ACID, B-[5-[(E)-[4-OXO-3-(2-PROPEN-1-YL)-2-THIOXO-5-THIAZOLIDINYLIDENE]METHYL]-2-THIENYL]-; BORONIC ACID, B-[6-(6-FLUORO-3-PYRIDINYL)-3-METHOXY-4-PYRIDAZINYL]-; BORTEZOMIB; BORTEZOMIB-D8; B-PYRIDO[2,3-B]PYRAZIN-7-YL-BORONIC ACID; BUT-1-ENE-4-BORONIC ACID; BZ-PHE-BOROLEU; CARBAZOL-4-YLBORONIC ACID; CARBAZOLE-1-BORONIC ACID; CEP-18770; CHROMABORA II; CHROMAN-8-BORONIC ACID; CIS-1-PROPENE-1-BORONIC ACID; CIS-2-METHYL-CYCLOPROPYL BORONIC ACID; COMBI-BLOCKS BB-2570; CYCLOBUTYLBORONIC ACID; CYCLOHEPTANEBORONIC ACID; CYCLOHEPTEN-1-YLBORONIC ACID; CYCLOHEXYLBORONIC ACID; CYCLOHEXYLMETHYLBORONIC ACID; CYCLOPENTEN-1-YLBORONIC ACID; CYCLOPENTYLBORONIC ACID; CYCLOPROPYLBORONIC ACID; CYCLOPROPYLBORONIC ACID MONOHYDRATE; DIBENZOFURAN-1-BORONIC ACID; DIBENZOFURAN-4-BORONIC ACID; DIBENZOTHIOPHENE-2-BORONIC ACID; DIBENZOTHIOPHENE-4-BORONIC ACID; DITHIENO[3,2-B:2′,3′-D]THIOPHENE-2-BORONIC ACID; E-(4-BUTYLPHENYL)ETHENYLBORONIC ACID; E-1-OCTENYLBORONIC ACID; E-HEXEN-1-YLBORONIC ACID; E-PENTADECENE-1-BORONIC ACID; E-PHENYLETHENYLBORONIC ACID; ETHYL (3-BORONOBENZOYLAMINO)ACETATE; ETHYL (4-BORONOBENZOYLAMINO)ACETATE; ETHYL 3-BORONOCINNAMATE; ETHYL 4-BORONOCINNAMATE; ETHYLBORONIC ACID; ETHYL-D5-BORONIC ACID; FERROCENEBORONIC ACID; FLUORANTHENE-3-BORONIC ACID; FLUORENE-2-BORONIC ACID; FURAN-2-BORONIC ACID; FURAN-3-BORONIC ACID; FURO[2,3-C]PYRIDINE-7-BORONIC ACID; FURO[3,2-C]PYRIDINE-4-BORONIC ACID; HEPT-6-ENYLBORONIC ACID; HEPTYLBORONIC ACID; HEX-5-EN-2-YLBORONIC ACID; HEXADECYLBORONIC ACID; H-PYRAZOLO[3,4-B]PYRIDINE-4-BORONIC ACID; IMIDAZO[1,2-A]PYRAZINE-6-BORONIC ACID; IMIDAZO[1,2-A]PYRIDIN-3-YLBORONIC ACID; IMIDAZO[1,2-A]PYRIDIN-8-YLBORONIC ACID; IMIDAZO[1,2-A]PYRIDINE-6-BORONIC ACID; IMIDAZO[1,2-A]PYRIMIDIN-3-YLBORONIC ACID; IMIDAZO[1,2-A]PYRIMIDIN-6-YLBORONIC ACID; IMIDAZO[1,5-A]PYRIDIN-5-YLBORONIC ACID; IMIDAZOLE-2-BORONIC ACID; INDAZOLE-3-BORONIC ACID; INDAZOLE-4-BORONIC ACID HYDROCHLORIDE; INDOLE-3-BORONIC ACID; INDOLE-4-BORONIC ACID; INDOLE-6-BORONIC ACID; INDOLE-7-BORONIC ACID; INDOLIN-6-YLBORONIC ACID; ISOBUTYLBORONIC ACID; ISOINDOLIN-1-ONE-4-BORONIC ACID; ISOINDOLIN-1-ONE-5-BORONIC ACID; ISOPROPYLBORONIC ACID; ISO-PROPYL-D7-BORONIC ACID; ISOQUINOLIN-4-YLBORONIC ACID HYDROCHLORIDE; ISOQUINOLIN-5-YLBORONIC ACID HYDROCHLORIDE; ISOQUINOLIN-6-YLBORONIC ACID HYDROCHLORIDE; ISOQUINOLINE-3-BORONIC ACID; ISOQUINOLINE-4-BORONIC ACID; ISOQUINOLINE-5-BORONIC ACID; ISOQUINOLINE-6-BORONIC ACID; ISOQUINOLINE-7-BORONIC ACID; ISOTHIAZOLE-4-BORONIC ACID; ISOTHIAZOLE-5-BORONIC ACID; ISOXAZOL-3-YLBORONIC ACID; ISOXAZOLE-4-BORONIC ACID; ISOXAZOLE-5-BORONIC ACID; LITHIUM (3-FLUORO-6-METHYLPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (3-METHYLPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (4-(1,3-DIOXOLAN-2-YL)PYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (4-METHYLPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (5-CHLOROPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (5-CYANOPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (5-FLUOROPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (5-METHOXYPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (6-(1,3-DIOXOLAN-2-YL)PYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (6-METHOXYPYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (PYRAZIN-2-YL)TRIHYDROXYBORATE; LITHIUM (PYRIDIN-2-YL)TRIHYDROXYBORATE; LITHIUM (QUINOLIN-2-YL)TRIHYDROXYBORATE; LITHIUM TRIHYDROXY(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)BORATE; LITHIUM TRIHYDROXY(5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)BORATE; LITHIUM TRIHYDROXY(6-(TRIFLUOROMETHYL)PYRIDIN-2-YL)BORATE; LITHIUM TRIHYDROXY(6-METHYLPYRIDIN-2-YL)BORATE; LITHIUM TRIHYDROXY(ISOQUINOLIN-1-YL)BORATE; L-PHENYLALANINE, 4-BORONO-, HYDROCHLORIDE; M-AMINOPHENYLBORONIC ACID-AGAROSE; METHYL (4-BORONOBENZOYLAMINO)ACETATE; METHYL 3-(3-BORONOPHENYL)PROPIONATE; METHYL 3-(4-BORONOBENZAMIDO)PROPIONATE; METHYL 3-BORONO-4-METHOXYBENZOATE; METHYL 4-BORONO-3-CHLOROBENZOATE; METHYL 4-BORONOBENZENESULFONAMIDE; METHYL PYRIDINE-2-BORONIC ACID-4-CARBOXYLATE; METHYLBORONIC ACID; METHYL-D3-BORONIC ACID; MLN-2238; N-(2-DIHYDROXYBORYLBENZYL)-N-METHYLM-TOLYLAMINE; N-(2-HYDROXYETHYL) 3-BORONOBENZENESULFONAMIDE; N-(2-HYDROXYETHYL) 4-BORONOBENZENESULFONAMIDE; N-(3,4-DIFLUOROPHENYL) 3-BORONOBENZAMIDE; N-(3-CHLORO-2-METHYLPHENYL) 3-BORONOBENZAMIDE; N-(3-CHLORO-4-FLUOROPHENYL) 3-BORONOBENZAMIDE; N-(4-FLUOROPHENYL) 4-BORONOBENZENESULFONAMIDE; N-(4-METHOXYBENZYL) 4-BORONOBENZAMIDE; N-(4-PHENYLBORONIC)SUCCINAMIC ACID; N-(BOC)-4-FLUOROINDOLE-2-BORONIC ACID; N-(BOC)-6-FLUOROINDOLE-2-BORONIC ACID; N-(BOC)-7-FLUOROINDOLE-2-BORONIC ACID; N-(METHYL-D3)-INDAZOLE-5-BORONIC ACID; N-(METHYL-D3)-INDAZOLE-6-BORONIC ACID; N-(P-TOLUENESULFONYL)INDOLE-3-BORONIC ACID; N-(TERT-BUTOXYCARBONYL)-4-METHYLINDOLE-2-BORONIC ACID; N-(THIAZOLINE-2-YL) 3-BORONOBENZAMIDE; N-(THIAZOLINE-2-YL) 4-BORONOBENZAMIDE; N,N,2-TRIMETHYLANILINE-4-BORONIC ACID; N,N-DIETHYL 4-BORONOBENZENESULFONAMIDE; N-[4-METHOXY-3-(4-METHYLPIPERAZIN-1-YL)-PHENYL]-4-CARBAMIDOBENZENEBORONIC ACID; N-2-TRIFLUOROMETHYLPHENYL 4-BORONOBENZAMIDE; N-BENZYL 3-BORONO-4-METHYLBENZENESULFONAMIDE; N-BENZYL 3-BORONOBENZENESULFONAMIDE; N-BOC-5-(DIETHOXYMETHYL)PYRROLE-2-BORONIC ACID; N-BOC-5-CHLORO-INDOL-3-YL BORONIC ACID; N-BOC-PYRROLIDIN-2-(S)-YLBORONIC ACID; N-BOC-PYRROLIDINYL-3-BORONIC ACID; N-BUTYL 3-BORONOBENZENESULFONAMIDE; N-BUTYLBORONIC ACID; N-CYCLOPROPYL 4-BORONO-2-FLUOROBENZAMIDE; N-DECYLBORONIC ACID; N-DIETHYL 3-BORONO-5-CHLOROBENZAMIDE; N-DIMETHYL 3-BORONO-5-CHLOROBENZAMIDE; N-DODECYLBORONIC ACID; NEOPENTYLBORONIC ACID; N-ETHYL 3-BORONO-5-CHLOROBENZAMIDE; N-ETHYL-5-INDOLE BORONIC ACID; N-HEXYLBORONIC ACID; N-ISOPROPYL 3-BORONOBENZENESULFONAMIDE; N-METHYL 2-BORONO-4-FLUOROBENZAMIDE; N-METHYL 3-BORONO-5-CHLOROBENZAMIDE; N-METHYL-4-PYRIDINEBORONIC ACID IODIDE; N-METHYLINDOLE-2-BORONIC ACID; N-PENTYLBORONIC ACID; N-PROPYLBORONIC ACID; N-PROPYL-D7-BORONIC ACID; N-P-TOLYL 4-BORONOBENZENESULFONAMIDE; N-TETRADECYLBORONIC ACID; N-TRIDECANEBORONIC ACID; N-UNDECANEBORONIC ACID; OCT-7-ENYLBORONIC ACID; OCTADECYLBORONIC ACID; OCTYLBORONIC ACID; OXAZOL-2-YLBORONIC ACID; OXINDOLE-6-BORONIC ACID; P-(4-PROPYLCYCLOHEXYL)PHENYLBORONIC ACID; PERYLENE-3-BORONIC ACID; PHENANTHREN-2-YL-2-BORONIC ACID; PHENANTHREN-3-YL-3-BORONIC ACID; PHENETHYLBORONIC ACID; PHENOXATHIIN-4-BORONIC ACID; PHENYLALANINE, 4-BORONO-, HYDROCHLORIDE; PHENYLBORONIC ACID; PHENYLBORONIC ACID, [RING-14C]-; PHENYL-D5-BORONIC ACID; PIPERIDIN-4-YLBORONIC ACID HYDROCHLORIDE; PIPERIDINE-4-BORONIC ACID; PIVALAMIDOMETHYLBORONIC ACID; PROP-1-EN-2-YLBORONIC ACID; PROPIONAMIDOMETHYLBORONIC ACID; PYRAZIN-2-YLBORONIC ACID; PYRAZOLE-3-BORONIC ACID, HYDROCHLORIDE; PYRAZOLO[1,5-A]PYRIDIN-3-YLBORONIC ACID; PYRAZOLO[1,5-A]PYRIDIN-5-YLBORONIC ACID; PYRAZOLO[1,5-A]PYRIDIN-7-YLBORONIC ACID; PYRIDAZIN-3-YLBORONIC ACID; PYRIDAZIN-4-YLBORONIC ACID; PYRIDINE-3-BORONIC ACID; PYRIDINE-3-BORONIC ACID HCL; PYRIDINE-4-BORONIC ACID; PYRIDINE-4-BORONIC ACID HYDRATE; PYRIDINE-4-BORONIC ACID HYDROCHLORIDE; PYRIDO[3,4-D]PYRIDAZINE-5-BORONIC ACID; PYRIMIDIN-2-YLBORONIC ACID; PYRIMIDIN-5-YL-5-BORONIC ACID MONOHYDRATE; PYRIMIDINE-4-BORONIC ACID; PYRIMIDINE-5-BORONIC ACID; QUINAZOLIN-4-YLBORONIC ACID; QUINAZOLIN-7-YLBORONIC ACID; QUINOLINE-2-BORONIC ACID; QUINOLINE-4-BORONIC ACID; QUINOLINE-5-BORONIC ACID; QUINOLINE-6-BORONIC ACID; QUINOLINE-6-BORONIC ACID HYDROCHLORIDE; QUINOLINE-7-BORONIC ACID; QUINOLINE-8-BORONIC ACID; QUINOXALINE-6-BORONIC ACID; RACEMIC, TRANS-1-CHLOROMETHYL-CYCLOPROPYL-2-BORONIC ACID; RACEMIC, TRANS-1-PROPYL-CYCLOPROPYL-2-BORONIC ACID; S-(2-BORONOETHYL)-L-CYSTEINE HYDROCHLORIDE; SELENOPHENE-2-BORONIC ACID; SODIUM (TRIHYDROXY)PHENYLBORATE; SODIUM PYRIDINE-3-TRIHYDROXYBORATE; SODIUM THIOPHENE-2-TRIHYDROXYBORATE; SODIUM THIOPHENE-3-TRIHYDROXYBORATE; TALABOSTAT; T-BUTYL 3-BORONOBENZENESULFONAMIDE; TERT-BUTYLBORONIC ACID; TETRAHYDROFURAN-3-BORONIC ACID; TETRAHYDROPYRAN-3-BORONIC ACID; TETRAHYDROPYRAN-4-BORONIC ACID; THIANTHRENE-1-BORONIC ACID; THIANTHRENE-2-BORONIC ACID; THIAZOL-5-YLBORONIC ACID; THIAZOLE-2-BORONIC ACID; THIAZOLE-4-BORONIC ACID; THIENO[2,3-B]PYRIDIN-2-YLBORONIC ACID; THIENO[2,3-C]PYRIDINE-7-BORONIC ACID; THIENO[3,2-B]THIOPHENE-2-BORONIC ACID; THIENO[3,2-C]PYRIDIN-2-YL BORONIC ACID; THIENO[3,2-C]PYRIDINE-4-BORONIC ACID; THIOPHENE-2-BORONIC ACID; THIOPHENE-2-CARBOXYLIC ACID METHYL ESTER-5-BORIC ACID; THIOPHENE-3-BORONIC ACID; TRANS-(4-PENTYLCYCLOHEXYL)CYCLOHEX-1-ENYLBORONIC ACID; TRANS-(4-PROPYLCYCLOHEXYL)CYCLOHEX-1-ENYLBORONIC ACID; TRANS-1-PROPEN-1-YLBORONIC ACID; TRANS-2-(3-CHLOROPHENYL)CYCLOPROPANEBORONIC ACID; TRANS-2-(3-FLUOROPHENYL)CYCLOPROPANEBORONIC ACID; TRANS-2-(3-FLUOROPHENYL)VINYLBORONIC ACID; TRANS-2-(3-METHOXYPHENYL)CYCLOPROPANEBORONIC ACID; TRANS-2-(4-BIPHENYL)VINYLBORONIC ACID; TRANS-2-(4-CHLOROPHENYL)VINYLBORONIC ACID; TRANS-2-(4-FLUOROPHENYL)CYCLOPROPANEBORONIC ACID; TRANS-2-(4-FLUOROPHENYL)VINYLBORONIC ACID; TRANS-2-(4-METHOXYPHENYL)VINYLBORONIC ACID; TRANS-2-(4-METHYLPHENYL)CYCLOPROPANEBORONIC ACID; TRANS-2-(4-METHYLPHENYL)VINYLBORONIC ACID; TRANS-2-(6-CHLOROPYRIDIN-3-YL)CYCLOPROPANEBORONIC ACID; TRANS-2-(6-METHOXYPYRIDIN-3-YL)CYCLOPROPANEBORONIC ACID; TRANS-2-(6-METHYLPYRIDIN-3-YL)CYCLOPROPANEBORONIC ACID; TRANS-2-[4-(TRIFLUOROMETHYL)PHENYL]CYCLOPROPANEBORONIC ACID; TRANS-2-[4-(TRIFLUOROMETHYL)PHENYL]VINYLBORONIC ACID; TRANS-2-[6-(TRIFLUOROMETHYL)PYRIDIN-3-YL]CYCLOPROPANEBORONIC ACID; TRANS-2-CHLOROMETHYLVINYLBORONIC ACID; TRANS-2-METHYL-CYCLOPROPYL BORONIC ACID; TRANS-2-PHENYLCYCLOPROPYLBORONIC ACID; TRANS-2-PYRIDIN-3-YLCYCLOPROPANEBORONIC ACID; TRANS-3,3,3-TRIFLUOROPROPENE-1-BORONIC ACID; TRANS-3-PHENYLPROPEN-1-YL-BORONIC ACID; TRANS-4-(BETA-NITROVINYL)BENZENEBORONIC ACID; TRANS-HEPTENYLBORONIC ACID; TRANS-NONENYLBORONIC ACID; TRIMETHYLSILYLETHYNYLBORONIC ACID; URACIL-5-BORONIC ACID; VILDAGLIPTIN-BORONIC ACID; VINYL BORONIC ACID; Z-1-HEXENYLBORONIC ACID

List No. 4—Acids: ((AMINOCARBONYL)AMINO)ACETIC ACID HYDRATE; (−)-(1S,4R)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID; (+)-4-AMINO-2-FLUOROBUTYRIC ACID; (+/−)-2-ACETOXYPROPIONIC ACID; (+/−)-2-AMINO-CYCLOHEXANECARBOXYLIC ACID; (+/−)-CIS-3-METHYL-2-PIPERIDINECARBOXYLIC ACID; (+/−)-THREO-3-METHYLASPARTIC ACID; (+/−)-TRANS-AZETIDINE-2,4-DICARBOXYLIC ACID; (+/−)-TRANS-EPOXYSUCCINIC ACID; (1-AMINO-1H-IMIDAZOL-2-YL)-ACETIC ACID; (1-AMINOCYCLOPENTYL)ACETIC ACID; (1H-[1,2,3]TRIAZOL-4-YL)-ACETIC ACID; (1H-IMIDAZOL-2-YL)-ACETIC ACID; (1H-PYRAZOL-3-YL)-ACETIC ACID; (1H-PYRROL-2-YL)-ACETIC ACID; (1-METHYL-1H-IMIDAZOL-2-YL)-ACETIC ACID; (1-METHYL-1H-IMIDAZOL-4-YL)-ACETIC ACID; (1-METHYL-1H-PYRAZOL-3-YL)ACETIC ACID; (1-METHYL-1H-PYRAZOL-4-YL)-ACETIC ACID; (1-METHYL-1H-PYRAZOL-5-YL)ACETIC ACID; (1-METHYL-1H-PYRROL-3-YL)ACETIC ACID; (1-METHYLHYDRAZINO)ACETIC ACID; (1-METHYLPYRROLIDIN-2-YL)ACETIC ACID; (1R,2R)-(+2-AMINO-1-CYCLOPENTANECARBOXYLIC ACID; (1R,2R)-2-(CHLOROMETHYL)CYCLOPROPANECARBOXYLIC ACID; (1R,2R)-2-AMINOCYCLOHEXANECARBOXYLIC ACID; (1R,2R)-CYCLOBUTANE-1,2-DICARBOXYLIC ACID; (1R,2R,4R)-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID; (1R,2S)-(−)-2-AMINO-CYCLOHEMNECARBOXYLIC ACID; (1R,2S)-2-AMINO-4-METHYLENECYCLOPENTANECARBOXYLIC ACID; (1R,2S)-2-AMINO-CYCLOHEX-3-ENECARBOXYLIC ACID; (1R,2S)-2-AMINO-CYCLOPENTANECARBOXYLIC ACID; (1R,2S)-2-METHYLCYCLOPROPANECARBOXYLIC ACID; (1R,2S)-2-PROPYLCYCLOPROPANECARBOXYLIC ACID; (1R,2S,4R)-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID; (1R,3R)-(3-AMINOCYCLOPENTYL)-ACETIC ACID; (1R,3R)-3-AMINOCYCLOHEXANECARBOXYLIC ACID; (1R,3R)-3-AMINO-CYCLOPENTANE CARBOXYLIC ACID; (1R,3S)-(3-AMINOCYCLOPENTYL)-ACETIC ACID; (1R,3S)-1-AMINO-3-HYDROXYCYCLOPENTANECARBOXYLIC ACID; (1R,3S)-3-AMINO-CYCLOHEXANECARBOXYLIC ACID; (1R,3S)-3-AMINOCYCLOPENTANECARBOXYLIC ACID; (1R,3S,4R)-2-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID; (1R,3S,4S)-2-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID; (1R,3S,4S)-3-AMINO-4-FLUOROCYCLOPENTANECARBOXYLIC ACID; (1R,4R)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID; (1R,4S)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID; (1R,4S,5R)-BICYCLO[2.1.1]HEXANE-5-CARBOXYLIC ACID; (1R,4S,5S)-BICYCLO[2.1.1]HEXANE-5-CARBOXYLIC ACID; (1R,5S,6R)-BICYCLO[3.1.1]HEPTANE-6-CARBOXYLIC ACID; (1R,5S,6S)-BICYCLO[3.1.1]HEPTANE-6-CARBOXYLIC ACID; (1R,6R)-6-AMINOCYCLOHEX-3-ENE-1-CARBOXYLIC ACID; (1S)-1-METHYL-2-CYCLOHEXENE-1-CARBOXYLIC ACID; (1S)-3-OXO-CYCLOPENTANEACETIC ACID; (1S,2R)-(−)-2-AMINOCYCLOHEX-3-ENECARBOXYLIC ACID; (1S,2R)-2-(METHOXYCARBONYL)CYCLOPROPANECARBOXYLIC ACID; (1S,2R)-2-AMINO-2-METHYLCYCLOPENTANECARBOXYLIC ACID; (1S,2R)-2-AMINOCYCLOPENTANECARBOXYLIC ACID; (1S,2R)-2-PROPYLCYCLOPROPANECARBOXYLIC ACID; (1S,2S)-2-(HYDROXYMETHYL)CYCLOPROPANECARBOXYLIC ACID; (1S,2S)-2-AMINOCYCLOHEXANECARBOXYLIC ACID; (1S,2S)-2-AMINO-CYCLOPETANECARBOXYLIC ACID; (1S,2S)-3-METHYLENECYCLOPROPANE-1,2-DICARBOXYLIC ACID; (1S,2S)-CYCLOPROPANE-1,2-DICARBOXYLIC ACID; (1S,2S,5R)-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID; (1S,3R)-(3-AMINOCYCLOPENTYL)-ACETIC ACID; (1S,3R)-1-AMINO-3-HYDROXYCYCLOPENTANECARBOXYLIC ACID; (1S,3R)-3-AMINO-CYCLOHEXANECARBOXYLIC ACID; (1S,3R)-3-AMINOCYCLOPENTANECARBOXYLIC ACID; (1S,3R)-3-AMINOMETHYL-CYCLOPENTANECARBOXYLIC ACID; (1S,3S)-(3-AMINOCYCLOPENTYL)-ACETIC ACID; (1S,3S)-3-AMINOCYCLOHEXANECARBOXYLIC ACID; (1S,3S)-3-AMINOCYCLOPENTANECARBOXYLIC ACID; (1S,3S)-3-AMINOMETHYL-CYCLOPENTANECARBOXYLIC ACID; (1S,3S)-3-HYDROXY-CYCLOPENTANECARBOXYLIC ACID; (1S,5R)-2-AZABICYCLO[3.1.0]HEXANE-1-CARBOXYLIC ACID; (1-VINYL-CYCLOBUTYL)-ACETIC ACID; (2-AMINO-1H-IMIDAZOL-4-YL)-ACETIC ACID; (2-AMINO-2-METHYL-PROPOXY)-ACETIC ACID; (2-AMINO-2-OXOETHOXY)ACETIC ACID; (2-AMINO-ETHOXY)-ACETIC ACID; (2E)-((AMINOCARBONOTHIOYL)HYDRAZONO)ACETIC ACID; (2E)-2-(HYDROXYIMINO)HEXANOIC ACID; (2E)-2-[(AMINOCARBONYL)HYDRAZONO]PROPANOIC ACID; (2E)-3-(1H-PYRROL-3-YL)-2-PROPENOIC ACID; (2E)-3-(DIMETHYLCARBAMOYL)PROP-2-ENOIC ACID; (2E)-3-(ETHYLCARBAMOYL)PROP-2-ENOIC ACID; (2E)-3,4-DIMETHYLHEX-2-ENOIC ACID; (2E)-3,4-DIMETHYLPENT-2-ENOIC ACID; (2E)-3,5-DIMETHYLHEX-2-ENOIC ACID; (2E)-3-CYCLOPROPYLBUT-2-ENOIC ACID; (2E)-3-ETHYL-4-METHYLPENT-2-ENOIC ACID; (2E)-3-METHOXY-2-METHYL-2-PROPENOIC ACID; (2E)-4-(DIMETHYLAMINO)BUT-2-ENOIC ACID; (2E,4E)-2-CYANO-2,4-HEXADIENOIC ACID; (2-FURYL)GLYOXYLIC ACID; (2-METHYL-1H-IMIDAZOL-1-YL)ACETIC ACID; (2-METHYL-1H-IMIDAZOL-4-YL)-ACETIC ACID; (2-METHYL-ALLYLOXY)-ACETIC ACID; (2-METHYLAMINO-ETHOXY)-ACETIC ACID; (2-METHYL-CYCLOPENTYL)-ACETIC ACID; (2-OXO-1,3-OXAZOLIDIN-3-YL)ACETIC ACID; (2-OXO-IMIDAZOLIDIN-1-YL)-ACETIC ACID; (2-OXO-PYRROLIDIN-1-YL)-ACETIC ACID; (2-PYRROLIDINYLIDENEAMINO)ACETIC ACID; (2R)-1-FORMYLPYRROLIDINE-2-CARBOXYLIC ACID; (2R)-1-METHYL-2-PIPERIDINECARBOXYLIC ACID; (2R)-2-(ACETYLOXY)-PROPANOIC ACID; (2R)-2-(ISOPROPYLAMINO)PROPANOIC ACID; (2R)-2,5-DIHYDRO-5-OXO-2-FURANACETIC ACID; (2R)-2-AMINO-2-(3-FURYL)ACETIC ACID; (2R)-2-AMINO-2-CYCLOBUTYLPROPANOIC ACID; (2R)-2-AMINO-2-CYCLOPROPYLPROPANOIC ACID; (2R)-2-AMINO-4-METHYLHEXANOIC ACID; (2R)-2-AZIDO-3-HYDROXY-2-METHYL-PROPANOIC ACID; (2R)-2-METHYL-2-PIPERIDINECARBOXYLIC ACID; (2R)-2-PROPANAMIDOPROPANOIC ACID; (2R)-4-AMINO-2-HYDROXY-4-OXOBUTANOIC ACID; (2R)-HYDROXYBUTANEDIOIC ACID 1-METHYL ESTER; (2R)-OXIRANE-2-CARBOXYLIC ACID; (2R,3R)-3-AMINO-2-OXETANECARBOXYLIC ACID; (2R,3S)-3-AMINO-2-OXETANECARBOXYLIC ACID; (2R,3R)-(−)-EPOXYSUCCINIC ACID; (2R,3R)-2-AMINO-3-HYDROXY-4-METHYL-VALERIC ACID; (2R,3R)-2-AMINO-3-HYDROXY-HEXANOIC ACID; (2R,3R)-2-AMINO-3-HYDROXY-PENTANOIC ACID; (2R,3R)-2-AMINO-3-HYDROXY-SUCCINIC ACID; (2R,3R)-2-AMINO-3-METHYLOXYBUTANOIC ACID; (2R,3R)-3-AMINO-2-HYDROXYHEXANOIC ACID; (2R,3R)-3-AMINO-2-METHYL-BUTANOIC ACID; (2R,3R)-3-HYDROXY-D-ISOVALINE; (2R,3R)-3-METHYL-PYRROLINE-2-CARBOXYLIC ACID; (2R,3S)-(+2-AMINO-3-HYDROXY-4-METHYLPENTANOIC ACID; (2R,3S)-2-AMINO-3-HYDROXY-PENTANOIC ACID; (2R,3S)-2-AMINO-3-HYDROXY-SUCCINIC ACID; (2R,3S)-2-AMINO-3-METHYLSUCCINIC ACID; (2R,3S)-3-AMINO-2-HYDROXYHEXANOIC ACID; (2R,3S)-3-AMINO-2-METHYL-BUTANOIC ACID; (2R,3S)-3-HYDROXY-D-ISOVALINE; (2R,4R)-(+)-AZETIDINE-2,4-DICARBOXYLIC ACID; (2R,4R)-4-(METHYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID; (2R,4R)-4-FLUOROPYRROLIDINE-2-CARBOXYLIC ACID; (2R,4R)-4-METHYL-2-PYROOLIDINE CARBOXYLIC ACID; (2R,4R)-4-METHYLPIPERIDINE-2-CARBOXYLIC ACID; (2R,4S)-4-(METHYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID; (2R,4S)-4-FLUOROPYRROLIDINE-2-CARBOXYLIC ACID; (2R,4S)-4-HYDROXY-1-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; (2R,4S)-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID; (2S)-2-(1H-PYRROL-1-YL)PROPANOIC ACID; (2S)-2-(1H-TETRAZOL-1-YL)PROPANOIC ACID; (2S)-2-(CARBAMOYLAMINO)-3-HYDROXYPROPANOIC ACID; (2S)-2-(CARBAMOYLAMINO)PROPANOIC ACID; (2S)-2,3-DIHYDROXYPROPANOIC ACID; (2S)-2-[(METHOXYCARBONYL)AMINO]PROPANOIC ACID; (2S)-2-[(METHYLCARBAMOYL)AMINO]PROPANOIC ACID; (2S)-2-AMINO-2-(3-FURYL)ACETIC ACID; (2S)-2-AMINO-2,3-DIMETHYLBUTANOIC ACID; (2S)-2-AMINO-2-CYCLOBUTYLPROPANOIC ACID; (2S)-2-AMINO-2-CYCLOPROPYLPROPANOIC ACID; (2S)-2-AMINO-3-(2-METHYLENECYCLOPROPYL)PROPANOIC ACID; (2S)-2-AMINO-4-FLUORO-BUTANOIC ACID; (2S)-2-AMINO-4-METHYLHEXANOIC ACID; (2S)-2-AMINO-5-HEXENOIC ACID; (2S)-2-AMINOPENT-4-ENOIC ACID; (2S)-2-BUTOXYPROPANOIC ACID; (2S)-2-METHYL-3-(METHYLSULFANYL)PROPANOIC ACID; (2S)-2-PROPANAMIDOPROPANOIC ACID; (2S)-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID; (2S)-5-HYDROXY-2-PIPERIDINECARBOXYLIC ACID; (2S)-5-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; (2S)AZETIDINE-2-CARBOXYLIC ACID; (2S)-HYDROXYBUTANEDIOIC ACID 1-METHYL ESTER; (2S)-NORBORNANE-2-CARBOXYLIC ACID; (2S)-OXIRANE-2-CARBOXYLIC ACID; (2S)PIPERIDINE-2-CARBOXYLIC ACID; (2S,3S)-3-AMINO-2-OXETANECARBOXYLIC ACID; (2S,3R)-(+)-2-AMINO-3-HYDROXY-4-METHYLPENTANOIC ACID; (2S,3R)-2-AMINO-3-HYDROXY-PENTANOIC ACID; (2S,3R)-2-AMINO-3-METHYLSUCCINIC ACID; (2S,3R)-3-AMINO-2-HYDROXYHEXANOIC ACID; (2S,3R)-3-HYDROXY-L-ISOVALINE; (2S,3S)-(+)-2-AMINO-3-METHYLPENTANOIC-UL-14C ACID HYDROCHLORIDE; (2S,3S)-2-AMINO-3-ETHOXYBUTANOIC ACID; (2S,3S)-2-AMINO-3-HYDROXY-4-METHYL-VALERIC ACID; (2S,3S)-2-AMINO-3-HYDROXY-HEXANOIC ACID; (2S,3S)-2-AMINO-3-HYDROXY-PENTANOIC ACID; (2S,3S)-2-AMINO-3-METHOXYBUTANOIC ACID; (2S,3S)-2-HYDROXY-3-METHYLPENTANOIC ACID; (2S,3S)-3-AMINO-2-HYDROXYHEXANOIC ACID; (2S,3S)-3-HYDROXY-L-ISOVALINE; (2S,3S)-3-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; (2S,3S)-DIAMINOSUCCINIC ACID; (2S,4R)-4-(AMINOMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-(HYDROXYMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-(METHYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-AMINOPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-CYANOPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-FLUOROPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-HYDROXY-1-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4R)-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID; (2S,4S)-(−)-AZETIDINE-2,4-DICARBOXYLIC ACID; (2S,4S)-4-(AMINOMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-4-(METHYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-4-AMINOPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-4-CYANOPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-4-FLUOROPYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID; (2Z)-3-([AMINO(IMINO)METHYL]SULFANYL)-2-PROPENOIC ACID; (2Z)-3-CYCLOPROPYL-2-PROPENOIC ACID; (2Z)-3-THIOCYANATO-2-PROPENOIC ACID; (2Z,4E)-HEXA-2,4-DIENOIC ACID; (3-AMINO-1H-1,2,4-TRIAZOL-1-YL)ACETIC ACID; (3-AMINO-1H-1,2,4-TRIAZOL-5-YL)ACETIC ACID; (3-AMINO-PROPOXY)-ACETIC ACID; (3-AMINOPYRAZOL-1-YL)ACETIC ACID; (3-AMINO-PYRROLIDIN-1-YL)-ACETIC ACID; (3-AMINO-TETRAHYDRO-FURAN-2-YL)-ACETIC ACID; (3-HYDROXY-1H-PYRAZOL-4-YL)ACETIC ACID; (3-HYDROXY-PYRROLIDIN-1-YL)-ACETIC ACID; (3-METHYL)PYRROLIDIN-2-YL ACETIC ACID; (3-METHYL-[1,2,4]OXADIAZOL-5-YL)-ACETIC ACID; (3-METHYL-1H-PYRAZOL-1-YL)ACETIC ACID; (3-METHYL-1H-PYRROL-2-YL)-ACETIC ACID; (3-METHYL-3H-IMIDAZOL-4-YL)-ACETIC ACID; (3-METHYL-4,5-DIHYDRO-1H-PYRAZOL-1-YL)ACETIC ACID; (3-METHYLBUTOXY)ACETIC ACID; (3-OXO-PYRROLIDIN-1-YL)-ACETIC ACID; (3R)-3-(ACETYLAMINO)BUTANOIC ACID; (3R)-3-AMINO-3-HYDROXYPROPANOIC ACID; (3R)-3-AMINO-4-METHYLHEXANOIC ACID; (3R)-3-AMINOPYRROLIDINE-3-CARBOXYLIC ACID; (3R)-THIOMORPHOLINECARBOXYLIC ACID; (3R,2R)-2,3-DIAMINOBUTYRIC ACID; (3R,4R)-3-AMINO-4-HYDROXYPENTANOIC ACID; (3R,4S)-1-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID; (3S)-1,3-DIOXANE-2-METHYL-4-CARBOXYLIC ACID; (3S)-1-METHYL-3-PIPERIDINECARBOXYLIC ACID; (3S)-3-(ACETYLAMINO)BUTANOIC ACID; (3S)-3-AMINO-4-METHYLHEXANOIC ACID; (3S)-3-AMINOPYRROLIDINE-3-CARBOXYLIC ACID; (3S,2R)-2,3-DIAMINOBUTYRIC ACID; (3S,2S)-2,3-DIAMINOBUTYRIC ACID; (3S,4S)-4-METHYLPYRROLIDINE-3-CARBOXYLIC ACID; (4,5-DIHYDRO-1H-IMIDAZOL-2-YLAMINO)-ACETIC ACID; (4,5-DIHYDRO-3H-PYRROL-2-YLAMINO)-ACETIC ACID; (4-AMINO-1H-PYRAZOL-1-YL)ACETIC ACID; (4E)-2-AMINOHEX-4-ENOIC ACID; (4-METHYL-[1,2,3]TRIAZOL-1-YL)-ACETIC ACID; (4-METHYL-1H-IMIDAZOL-2-YL)-ACETIC ACID; (4-METHYL-1H-PYRAZOL-1-YL)ACETIC ACID; (4-METHYL-FURAZAN-3-YL)-ACETIC ACID; (4R)-1,3-THIAZINANE-4-CARBOXYLIC ACID; (4R)-2-AMINO-4,5-DIHYDRO-1,3-THIAZOLE-4-CARBOXYLIC ACID; (4R)-3-METHYL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID; (4S)-1,3-THIAZINANE-4-CARBOXYLIC ACID; (4S)-4-AMINO-D-PROLINE; (4S)-4-METHYLHEPTANOIC ACID; (4S)-4-METHYL-L-PROLINE; (4S)-4-METHYL-NORLEUCINE; (4S,2RS)-2-METHYLTHIAZOLIDINE-4-CARBOXYLIC ACID; (5-AMINO-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; (5-AMINO-1H-TETRAZOL-1-YL)ACETIC ACID; (5-AMINO-2H-TETRAZOL-2-YL)ACETIC ACID; (5-AMINO-4H-[1,2,4]TRIAZOL-3-YL)-ACETIC ACID; (5-METHYL-1H-PYRAZOL-3-YL)-ACETIC ACID; (5-METHYL-1H-TETRAZOL-1-YL)ACETIC ACID; (5-METHYL-2H-[1,2,4]TRIAZOL-3-YL)-ACETIC ACID; (5-METHYL-4,5-DIHYDRO-1H-PYRAZOL-1-YL)ACETIC ACID; (5-METHYL-4H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; (5-METHYL-FURAN-2-YL)-ACETIC ACID; (5-METHYL-IMIDAZOL-1-YL)-ACETIC ACID; (5-METHYL-PYRAZOL-1-YL)-ACETIC ACID; (5-OXO-2,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; (5-OXO-2,5-DIHYDRO-1H-PYRAZOL-3-YL)ACETIC ACID; (5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; (ALLYLSULFINYL)ACETIC ACID; (ALLYLTHIO)ACETIC ACID; (ALPHAR)-ALPHA-HYDROXY-CYCLOPROPANEPROPANOIC ACID; (ALPHAS)-ALPHA-HYDROXY-CYCLOBUTANEPROPANOIC ACID; (ALPHAS)-ALPHA-HYDROXY-CYCLOPROPANEPROPANOIC ACID; (AMIDINOTHIO)ACETIC ACID; (AMINOSULFONYL)ACETIC ACID; (AR)-A-HYDROXY-2-FURANACETIC ACID; (BUTYLTHIO)ACETIC ACID; (BUTYRYLAMINO)ACETIC ACID; (CYCLOBUTYLCARBAMOYL)FORMIC ACID; (CYCLOPENTYLAMINO)ACETIC ACID; (D,L)-2-AMINO-HEPT-6-ENOIC ACID; (DIETHYLAMINO)(OXO)ACETIC ACID; (E)-2-(METHOXYIMINO)ACETIC ACID; (E)-3-(1H-IMIDAZOL-5-YL)-2-PROPENOIC ACID; (E)-3-(1H-PYRROL-1-YL)-2-PROPENOIC ACID; (E)-3-(1H-PYRROL-2-YL)ACRYLIC ACID; (E)-3,4,4-TRIMETHYLPENT-2-ENOIC ACID; (E)-3-CYANO-3-(METHYLIMINO)-2-OXOPROPANOIC ACID; (E)-3-CYCLOBUTYLACRYLIC ACID; (E)-3-CYCLOPENTYLACRYLIC ACID; (E)-3-CYCLOPROPYLACRYLIC ACID; (E)-3-METHOXY-2-BUTENOIC ACID; (E)-4,4-DIMETHYL-2-PENTENOIC ACID; (E)-5-(METHYLTHIO)PENT-2-ENOIC ACID; (E)-5-METHYL-HEX-2-ENOIC ACID; (ETHYLTHIO)ACETIC ACID; (ISOBUTYLAMINO)(OXO)ACETIC ACID; (ISOBUTYLTHIO)ACETIC ACID; (ISOBUTYRYLAMINO)ACETIC ACID; (ISOPROPENYLAMINO)ACETIC ACID; (ISOPROPYLTHIO)ACETIC ACID; (METHYLTHIO)ACETIC ACID; (N′-ACETYL-N-METHYL-HYDRAZINO)-ACETIC ACID; (N-CARBOXYMETHYL-HYDRAZINO)-ACETIC ACID; (N-HYDROXYCARBAMIMIDOYL)-ACETIC ACID; (PROP-2-YNYLTHIO)ACETIC ACID; (PROPYLAMINO)ACETIC ACID; (PROPYLTHIO)ACETIC ACID; (PYRROL-3-YL)-ACETIC ACID; (R)-(−)-2-AMINO-2-METHYLBUTANEDIOIC ACID; (R)-(+2-METHYLGLUTARIC ACID; (R)-(−)-5-OXOTETRAHYDROFURAN-2-CARBOXYLIC ACID; (R)-(−)-CITRAMALIC ACID; (R)-(−)-NIPECOTIC ACID; (R)-(+)-2,2-DIMETHYL-1,3-DIOXOLAN-4-CARBOXYLATE; (R)-(+)-2-CHLOROPROPIONIC ACID; (R)-(+)-2-METHOXYPROPIONIC ACID; (R)-(+)-2-TETRAHYDROFUROIC ACID; (R)-(+)-3-CYCLOHEXENECARBOXYLIC ACID; (R)-(+)-3-METHYLSUCCINIC ACID 1-MONOMETHYL ESTER; (R)-(+)-4-OXO-2-AZETIDINECARBOXYLIC ACID; (R)-(+)-METHYLSUCCINIC ACID; (R)-(2-HYDROXYPYRROLIDIN-1-YL)-ACETIC ACID; (R)-(3-AMINO-PYRROLIDIN-1-YL)-ACETIC ACID; (R)-(3-HYDROXYPYRROLIDIN-1-YL)-ACETIC ACID; (R)-1,2,3,6-TETRAHYDROPYRIDINE-2-CARBOXYLIC ACID; (R)-1-AMINO-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID; (R)-1-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; (R)-2-(PIPERIDIN-2-YL)ACETIC ACID; (R)-2-(PIPERIDIN-3-YL)ACETIC ACID; (R)-2-(PYRROLIDIN-3-YL)ACETIC ACID; (R)-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID; (R)-2,3-DIMETHYLBUTANOIC ACID; (R)-2,5-DIMETHYLHEX-5-ENOIC ACID; (R)-2-AMINO-2-METHYL-4-PENTENOIC ACID; (R)-2-AMINO-2-METHYL-PENTANOIC ACID; (R)-2-AMINO-3-(CARBAMOYLOXY)PROPANOIC ACID; (R)-2-AMINO-3-CYANOPROPANOIC ACID; (R)-2-AMINO-3-HYDROXY-3-METHYLBUTANOIC ACID; (R)-2-AMINO-3-METHOXYLPROPANOIC ACID; (R)-2-AMINO-4-METHOXYBUTYRIC ACID; (R)-2-AMINO-5-METHYLHEXANOIC ACID; (R)-2-AMINO-BUTYRIC ACID HYDROCHLORIDE; (R)-2-AMINOHEPT-6-YNOIC ACID; (R)-2-AMINOHEX-5-YNOIC ACID; (R)-2-AMINOMETHYL-3-METHYL-BUTYRIC ACID; (R)-2-AMINOMETHYL-4-METHYL-PENTANOIC ACID; (R)-2-AMINO-N-METHYL-SUCCINAMIC ACID; (R)-2-CHLORO-3-METHYLBUTYRIC ACID; (R)-2-CHLOROBUTYRIC ACID; (R)-2-HYDROXY-2-METHYLBUTYRIC ACID; (R)-2-HYDROXY-4-METHYLPENTANOIC ACID; (R)-2-HYDROXYBUTYRIC ACID; (R)-2-HYDROXYMETHYLBUTANOIC ACID; (R)-2-HYDROXYMETHYLHEXANOIC ACID; (R)-2-HYDROXYMETHYL-PENTANOIC ACID; (R)-2-HYDROXYMETHYLPROPANOIC ACID; (R)-2-METHYL-4-NITROBUTANOIC ACID; (R)-2-METHYLHEPT-6-ENOIC ACID; (R)-2-METHYLPENTANOIC ACID; (R)-2-METHYLPROLINE; (R)-2-MORPHOLINEACETIC ACID; (R)-2-OXOHEXAHYDROPYRIMIDINE-4-CARBOXYLIC ACID; (R)-2-OXO-IMIDAZOLIDINE-4-CARBOXYLIC ACID; (R)-2-VINYLHEX-5-ENOIC ACID; (R)-2-VINYLHEXANOIC ACID; (R)-2-VINYLPENT-4-ENOIC ACID; (R)-2-VINYLPENTANOIC ACID; (R)-3-(HYDROXYMETHYL)PENT-4-ENOIC ACID; (R)-3,3,3-TRIFLUORO-2-HYDROXYPROPIONIC ACID; (R)-3,4-DIAMINOBUTYRIC ACID; (R)-3,5-DIAMINOPENTANOIC ACID; (R)-3-AMINO-2-(HYDROXYMETHYL)PROPANOIC ACID; (R)-3-AMINO-2-METHYLPROPANOIC ACID-HCL; (R)-3-AMINO-2-METHYL-PROPIONIC ACID; (R)-3-AMINO-3-CYCLOBUTYL-PROPIONIC ACID; (R)-3-AMINO-3-CYCLOPROPYL-PROPIONIC ACID; (R)-3-AMINO-3-METHYLPENTANOIC ACID; (R)-3-AMINO-4-METHYL-PENTANOIC ACID; (R)-3-AMINO-5-METHYL-HEXANOIC ACID; (R)-3-AMINO-BUTANOIC ACID HYDROCHLORIDE SALT; (R)-3-AMINOBUTYRIC ACID; (R)-3-AMINO-HEPT-6-ENOIC ACID; (R)-3-AMINOHEX-5-ENOIC ACID; (R)-3-AMINO-L-PROLINE; (R)-3-AMINO-PENTANOIC ACID; (R)-3-AMINOTETRAHYDRO-2H-PYRAN-3-CARBOXYLIC ACID; (R)-3-AMINOTETRAHYDROFURAN-3-CARBOXYLIC ACID; (R)-3-AMINOTETRAHYDROTHIOPHENE-3-CARBOXYLIC ACID; (R)-3-CHLOROLACTIC ACID; (R)-3-HYDROXYBUTYRIC ACID; (R)-3-METHYLHEPTANOIC ACID; (R)-3-METHYLHEMNOIC ACID; (R)-3-METHYL-PENTANOIC ACID; (R)-4-AMINO-2-HYDROXYBUTYRIC ACID; (R)-4-AMINO-3-HYDROXYBUTANOIC ACID; (R)-4-AMINOHEX-5-ENOIC ACID; (R)-4-OXO-2-PIPERRIDINE CARBOXYLIC ACID; (R)-4-OXOPYRROLIDINE-2-CARBOXYLIC ACID; (R)-5-AMINO-4-HYDROXYPENTANOIC ACID; (R)-5-OXO-PIPERAZINE-2-CARBOXYLIC ACID; (R)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; (R)-6-OXO-PIPERAZINE-2-CARBOXYLIC ACID; (R)-ALPHA-ALLYLALANINE H2O; (R)-ALPHA-ETHYLALANINE H2O; (R)-ALPHA-PROPARGYLALANINE; (R)-AMINO-FURAN-2-YL-ACETIC ACID; (R)-HEXAHYDRO-1H-AZEPINE-2-CARBOXYLIC ACID; (R)-ISOSERINE; (R)-MORPHOLIN-3-YL-ACETIC ACID; (R)-MORPHOLINE-2-CARBOXYLIC ACID; (R)-MORPHOLINE-3-CARBOXYLIC ACID; (R)-PIPERAZINE-2-CARBOXYLIC ACID; (R)-PIPERIDINE-2-CARBOXYLIC ACID; (R)-PYRROLIDINE-3-CARBOXYLIC ACID; (R)-TETRAHYDRO-3-FURANCARBOXYLIC ACID; (R)-TRIMETHYLLACTIC ACID; (R,S)-2-AMINO-3-HYDROXY-2-METHYLPROPIONIC ACID HYDRATE; (R,S)-2-AMINO-3-HYDROXY-3-METHYLBUTANOIC ACID; (R,S)-2-AMINOPENT-4-YNOIC ACID HYDROCHLORIDE; (RS)-(TETRAZOL-5-YL)GLYCINE; (S)-(+2-ACETOXYPROPIONIC ACID; (S)-(−)-2-AMINO-2-METHYL-4-PENTENOIC ACID HYDRATE; (S)-(−)-2-CHLOROPROPIONIC ACID; (S)-(−)-2-HYDROXY-3,3-DIMETHYLBUTYRIC ACID; (S)-(−)-2-METHOXYPROPIONIC ACID; (S)-(+3,3,3-TRIFLUORO-2-HYDROXYPROPANOIC ACID; (S)-(−)-3-CYCLOHEXENECARBOXYLIC ACID; (S)-(+4-AMINO-2-HYDROXYBUTYRIC ACID; (S)-(−)-4-OXO-2-AZETIDINECARBOXYLIC ACID; (S)-(−)-METHYLSUCCINIC ACID; (S)-(−)-TETRAHYDRO-2-FUROIC ACID; (S)-(−)-THIOLACTIC ACID; (S)-(+)-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID; (S)-(+)-2-AMINO-2-METHYLBUTANOIC ACID MONOHYDRATE; (S)-(+)-2-AMINO-3-HYDROXY-3-METHYLBUTANOIC ACID; (S)-(+)-2-HYDROXY-3-METHYLBUTYRIC ACID; (S)-(+)-2-METHYLBUTYRIC ACID; (S)-(+)-2-METHYLGLUTARIC ACID; (S)-(+)-5-OXOTETRAHYDROFURAN-2-CARBOXYLIC ACID; (S)-(+)-CITRAMALIC ACID; (S)-(+)-NIPECOTIC ACID; (S)-(+)-SERINE-UL-14C HYDROCHLORIDE; (S)-(+)-VALINE-UL-14C HYDROCHLORIDE; (S)-(2-HYDROXYPYRROLIDIN-1-YL)-ACETIC ACID; (S)-(3-AMINO-PYRROLIDIN-1-YL)-ACETIC ACID; (S)-(3-HYDROXYPYRROLIDIN-1-YL)-ACETIC ACID; (S)-1,2,3,4-TETRAHYDRO-PYRIDINE-2-CARBOXYLIC ACID; (S)-1,4-OXAZEPANE-3-CARBOXYLIC ACID; (S)-1-AMINO-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID; (S)-1-ISOPROPYL-AZETIDINE-2-CARBOXYLIC ACID; (S)-2-(2-PYRROLIDINYL)ACETIC ACID; (S)-2-(PIPERIDIN-2-YL)ACETIC ACID; (S)-2-(PIPERIDIN-3-YL)ACETIC ACID; (S)-2-(PYRROLIDIN-3-YL)ACETIC ACID; (S)-2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBOXYLIC ACID; (S)-2,3-DIMETHYLBUTANOIC ACID; (S)-2,4-DIHYDROXYBUTYRIC ACID; (S)-2,5-DIMETHYLHEX-5-ENOIC ACID; (S)-2-AMINO-2-(MERCAPTOMETHOXY)ACETIC ACID; (S)-2-AMINO-2-FURANACETIC ACID; (S)-2-AMINO-2-METHYL-4-PENTENOIC ACID; (S)-2-AMINO-2-METHYL-PENTANOIC ACID; (S)-2-AMINO-3-METHOXYPROPANOIC ACID; (S)-2-AMINO-4-(METHYLAMINO)-4-OXOBUTANOIC ACID; (S)-2-AMINO-4-CYANOBUTYRIC ACID; (S)-2-AMINO-4-METHOXYBUTYRIC ACID; (S)-2-AMINO-5-METHYLHEXANOIC ACID; (S)-2-AMINO-6-HEPTENOIC ACID; (S)-2-AMINOHEPT-6-YNOIC ACID; (S)-2-AMINOHEX-5-YNOIC ACID; (S)-2-AMINOMETHYL-3-METHYL-BUTYRIC ACID; (S)-2-AMINOMETHYL-4-METHYL-PENTANOIC ACID; (S)-2-CHLORO-3-METHYLBUTYRIC ACID; (S)-2-CHLORO-N-BUTYRIC ACID; (S)-2-FLUORO-4-METHYLPENTANOIC ACID; (S)-2-HYDROXY-2,3-DIMETHYLBUTANOIC ACID; (S)-2-HYDROXY-2-METHYLBUTYRIC ACID; (S)-2-HYDROXYBUTYRIC ACID; (S)-2-HYDROXYMETHYL-HEXANOIC ACID; (S)-2-HYDROXYMETHYL-PENTANOIC ACID; (S)-2-HYDROXYPENTANOIC ACID; (S)-2-MERCAPTOBUTANOIC ACID; (S)-2-METHYL-1,4,5,6-TETRAHYDROPYRIMIDINE-4-CARBOXYLIC ACID; (S)-2-METHYLHEPT-6-ENOIC ACID; (S)-2-METHYLPENTENOIC ACID; (S)-2-METHYLPIPERIDINE-2-CARBOXYLIC ACID; (S)-2-METHYLSUCCINIC ACID 1-METHYL ESTER; (S)-2-MORPHOLINEACETIC ACID; (S)-2-OXOHEXAHYDROPYRIMIDINE-4-CARBOXYLIC ACID; (S)-2-PIPERIDINONE-6-CARBOXYLIC ACID; (S)-2-PYRROLIDIN-1-YL-PROPIONIC ACID; (S)-2-VINYLHEX-5-ENOIC ACID; (S)-2-VINYLHEXANOIC ACID; (S)-2-VINYLPENT-4-ENOIC ACID; (S)-2-VINYLPENTANOIC ACID; (S)-3-(HYDROXYMETHYL)PENT-4-ENOIC ACID; (S)-3,4-DIAMINOBUTYRIC ACID; (S)-3,5-DIAMINOPENTANOIC ACID; (S)-3-AMINO-2-(HYDROXYMETHYL)PROPANOIC ACID; (S)-3-AMINO-2-METHYLPROPANOIC ACID-HCL; (S)-3-AMINO-2-METHYL-PROPIONIC ACID; (S)-3-AMINO-3-CYCLOBUTYL-PROPIONIC ACID; (S)-3-AMINO-3-CYCLOPROPYL-PROPIONIC ACID; (S)-3-AMINO-3-METHYLPENTANOIC ACID; (S)-3-AMINO-4,4-DIMETHYL-PENTANOIC ACID; (S)-3-AMINO-4-METHYL-PENTANOIC ACID; (S)-3-AMINO-5-METHYL-HEXANOIC ACID; (S)-3-AMINOBUTANOIC ACID; (S)-3-AMINO-HEPT-6-ENOIC ACID; (S)-3-AMINO-HEX-5-ENOIC ACID; (S)-3-AMINO-PENTANOIC ACID; (S)-3-AMINOTETRAHYDRO-2H-PYRAN-3-CARBOXYLIC ACID; (S)-3-AMINOTETRAHYDROFURAN-3-CARBOXYLIC ACID; (S)-3-AMINOTETRAHYDROTHIOPHENE-3-CARBOXYLIC ACID; (S)-3-HYDROXY-2-METHYL-PROPIONIC ACID; (S)-3-HYDROXY-4-METHOXY-4-OXOBUTANOIC ACID; (S)-3-HYDROXYBUTYRIC ACID; (S)-3-METHYLHEPTANOIC ACID; (S)-3-METHYLHEXANOIC ACID; (S)-3-METHYL-PENTANOIC ACID; (S)-4,4-DIMETHYL-PYRROLIDINE-2-CARBOXYLIC ACID; (S)-4,5-DIDEHYDROPIPECOLIC ACID; (S)-4-AMINO-3-HYDROXYBUTANOIC ACID; (S)-4-AMINOHEX-5-ENOIC ACID; (S)-4-METHYLHEXANOIC ACID; (S)-4-OXO-2-PIPERIDINE CARBOXYLIC ACID; (S)-5-AMINO-4-HYDROXYPENTANOIC ACID; (S)-5-METHYLHEPTANOIC ACID; (S)-5-OXO-PIPERAZINE-2-CARBOXYLIC ACID; (S)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; (S)-6-OXO-PIPERAZINE-2-CARBOXYLIC ACID; (S)-A-AMINO-2-HYDROXYBUTANOIC ACID; (S)-ALPHA-METHYLCYSTEINE; (S)-ALPHA-PROPARGYLALANINE; (S)-AMINO-(1H-IMIDAZOL-2-YL)-ACETIC ACID; (S)-HEXAHYDRO-1H-AZEPINE-2-CARBOXYLIC ACID; (S)-ISOSERINE; (S)-MORPHOLIN-3-YL-ACETIC ACID; (S)-MORPHOLINE-2-CARBOXYLIC ACID; (S)-MORPHOLINE-3-CARBOXYLIC ACID; (S)-OXAZOLIDINE-4-CARBOXYLIC ACID; (S)-PIPERAZINE-2-CARBOXYLIC ACID; (S)-PYRROLIDINE-3-CARBOXYLIC ACID; (S)-TETRAHYDRO-3-FURANCARBOXYLIC ACID; (S)-THIOMORPHOLINE-3-CARBOXYLIC ACID; (SEC-BUTYLAMINO)(OXO)ACETIC ACID; (TERT-BUTYLAMINO)(OXO)ACETIC ACID; (TERT-BUTYLTHIO)ACETIC ACID; (TETRAHYDRO-FURAN-2-YL)-ACETIC ACID; (TETRAHYDRO-FURAN-3-YL)-ACETIC ACID; (TETRAHYDRO-PYRAN-2-YL)-ACETIC ACID; (TETRAHYDRO-PYRAN-4-YLIDENE)-ACETIC ACID; (TRIFLUOROMETHOXY)ACETIC ACID; (TRIMETHYLSILYL)ACETIC ACID; (Z)-3-(1H-PYRROL-2-YL)-2-PROPENOIC ACID; (Z)-3-(2-FURANYL)-2-PROPENOIC ACID; (Z)-3-CYCLOPROPYLBUT-2-ENOIC ACID; (Z)-HEX-2-ENOIC ACID; [(2-AMINO-2-OXOETHYL)THIO]ACETIC ACID; [(2-METHOXYETHYL)(METHYL)AMINO]ACETIC ACID; [(2-METHOXYETHYL)CARBAMOYL]FORMIC ACID; [(2-METHYLBUTYL)AMINO]ACETIC ACID; [(2-METHYLCYCLOPROPYL)CARBAMOYL]FORMIC ACID; [(3-METHYLBUTYL)AMINO]ACETIC ACID; [(CYCLOPROPYLMETHYL)THIO]ACETIC ACID; [(PROP-2-EN-1-YL)CARBAMOYL]FORMIC ACID; [(PROP-2-YN-1-YL)CARBAMOYL]FORMIC ACID; [ETHYL(METHYL)AMINO]ACETIC ACID; 1-(2-AMINOETHYL)CYCLOPROPANECARBOXYLIC ACID; 1-(2-PROPYN-1-YL)-1H-PYRROLE-2-CARBOXYLIC ACID; 1-(AMINOMETHYL)CYCLOBUTANE-1-CARBOXYLIC ACID; 1-(AMINOMETHYL)CYCLOPENTANECARBOXYLIC ACID; 1-(AMINOMETHYL)CYCLOPROPANECARBOXYLIC ACID; 1-(CARBOXYMETHYL)PYRIDINIUM; 1-(CHLOROCARBONYL)-CYCLOPROPANECARBOXYLIC ACID; 1-(CYCLOPROPYLMETHYL)CYCLOPROPANECARBOXYLIC ACID; 1-(DIMETHYLAMINO)CYCLOBUTANE-1-CARBOXYLIC ACID; 1-(DIMETHYLAMINO)CYCLOPROPANECARBOXYLIC ACID; 1-(ETHYLAMINO)CYCLOBUTANE-1-CARBOXYLIC ACID; 1-(HYDROXYMETHYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(HYDROXYMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-(HYDROXYMETHYL)-CYCLOPENTANECARBOXYLIC ACID; 1-(HYDROXYMETHYL)CYCLOPROPANECARBOXYLIC ACID; 1-(METHOXYMETHYL)CYCLOBUTANECARBOXYLIC ACID; 1-(METHOXYMETHYL)CYCLOPROPANECARBOXYLIC ACID; 1-(METHYLAMINO)CYCLOBUTANE-1-CARBOXYLIC ACID; 1-(METHYLAMINO)CYCLOPENTANE-1-CARBOXYLIC ACID; 1-(METHYLCARBAMOYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 1,1-CYCLOBUTANEDICARBOXYLIC ACID; 1,1-CYCLOPROPANEDICARBOXYLIC ACID; 1,1-CYCLOPROPANEDICARBOXYLIC ACID MONOMETHYL ESTER; 1,1-DICYCLOPROPANECARBOXYLIC ACID; 1,2,3,6-TETRAHYDRO-PYRIDINE-2-CARBOXYLIC ACID; 1,2,3,6-TETRAHYDRO-PYRIDINE-4-CARBOXYLIC ACID; 1,2,3-THIADIAZOLE-4-CARBOXYLIC ACID; 1,2,3-THIADIAZOLE-5-CARBOXYLIC ACID; 1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 1,2,4-OXADIAZOLE-3-CARBOXYLIC ACID; 1,2,4-OXADIAZOLE-5-CARBOXYLIC ACID; 1,2,4-TRIAZINE-3-CARBOXYLIC ACID; 1,2,4-TRIAZINE-5-CARBOXYLIC ACID; 1,2,4-TRIAZOLE-1-ACETIC ACID; 1,2,5,6-TETRAHYDROPYRIDINE-3-CARBOXYLIC ACID; 1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID; 1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID, 4-(METHYLAMINO)-; 1,2,5-THIADIAZOLE-3-CARBOXYLIC ACID; 1,2-CYCLOPROPANEDICARBOXYLIC ACID, (1R,2R)-REL-; 1,2-CYCLOPROPANEDICARBOXYLIC ACID, (1R,2S)-REL-; 1,2-DIMETHYL-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 1,3,4-OXADIAZOLE-2-CARBOXYLIC ACID; 1,3,4-THIADIAZOLE-2-CARBOXYLIC ACID; 1,3,5,7-CYCLOOCTATETRAENECARBOXYLIC ACID; 1,3,5-TRIAZINE-2-CARBOXYLIC ACID; 1,3-ACETONEDICARBOXYLIC ACID; 1,3-DIHYDRO-IMIDAZOL-2-ONE-5-METHYL-4-CARBOXYLIC ACID; 1,3-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1,3-DIMETHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 1,3-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 1,3-DIMETHYL-PYRROLIDINE-3-CARBOXYLIC ACID; 1,3-METHYLENECYCLOBUTANE CARBOXYLIC ACID; 1,3-OXATHIOLANE-2-CARBOXYLIC ACID, 5-OXO-; 1,3-THIAZINANE-4-CARBOXYLIC ACID; 1,3-THIAZOL-4-YLACETIC ACID; 1,4,5,6-TETRAHYDRO-PYRIDAZINE-3-CARBOXYLIC ACID; 1,4-DIHYDRO-2-METHYLBENZOIC ACID; 1,4-DIHYDRO-4-OXO-2-PYRIDINECARBOXYLIC ACID; 1,4-DIHYDROBENZOIC ACID; 1,4-DIOXANE-2-CARBOXYLIC ACID; 1,4-OXAZEPANE-3-CARBOXYLIC ACID; 1,5-DIMETHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 1,5-DIMETHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 1,6-DIHYDRO-6-OXOPYRIMIDINE-4-CARBOXYLIC ACID; 1-ACETYL-2-AZETIDINECARBOXYLIC ACID; 1-ACETYL-3-AZETIDINECARBOXYLIC ACID; 1-ACETYLCYCLOPROPANECARBOXYLIC ACID; 1-ALLYL-AZETIDINE-2-CARBOXYLIC ACID; 1-ALLYLCYCLOPROPANECARBOXYLIC ACID; 1-AMINO-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 1-AMINO-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID; 1-AMINO-2-ETHENYLCYCLOPROPANECARBOXYLIC ACID; 1-AMINO-2-METHYLCYCLOPENTANECARBOXYLIC ACID; 1-AMINO-2-METHYLENE-CYCLOPROPANECARBOXYLIC ACID; 1-AMINO-3,3-DIMETHYL-CYCLOBUTANECARBOXYLIC ACID; 1-AMINO-3-HYDROXYCYCLOBUTANECARBOXYLIC ACID; 1-AMINO-3-METHYLCYCLOPENTANECARBOXYLIC ACID; 1-AMINOAZETIDINE-2-CARBOXYLIC ACID; 1-AMINOCYCLOBUTANECARBOXYLIC ACID; 1-AMINOCYCLOHEXANECARBOXYLIC ACID; 1-AMINOCYCLOPENT-3-ENECARBOXYLIC ACID; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; 1-AMINO-CYCLOPROPANE-1-CARBOXYLIC ACID HYDROCHLORIDE; 1-AZABICYCLO[2.2.1]HEPTANE-4-CARBOXYLIC ACID; 1-AZETIDINEACETIC ACID; 1-CARBAMOYL-AZETIDINE-3-CARBOXYLIC ACID; 1-CARBOXYCYCLOPROPANECARBOXAMIDE; 1-CUBANECARBOXYLIC ACID; 1-CYANO-1-CYCLOPROPANECARBOXYLIC ACID; 1-CYANOCYCLOBUTANECARBOXYLIC ACID; 1-CYANOCYCLOPENTANECARBOXYLIC ACID; 1-CYCLOBUTENE-1-CARBOXYLIC ACID; 1-CYCLOHEXENE-1-CARBOXYLIC ACID; 1-CYCLOHEXENYLACETIC ACID; 1-CYCLOPENTENE-1-CARBOXYLIC ACID, 2-AMINO-; 1-CYCLOPENTENECARBOXYLIC ACID; 1-CYCLOPROPYL-2-AZETIDINECARBOXYLIC ACID; 1-ETHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 1-ETHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 1-ETHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-ETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-ETHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 1-ETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 1-ETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 1-ETHYL-4-OXO-2-AZETIDINECARBOXYLIC ACID; 1-ETHYL-AZETIDINE-3-CARBOXYLIC ACID; 1-ETHYLCYCLOBUTANECARBOXYLIC ACID; 1-ETHYLCYCLOPENTANE-1-CARBOXYLIC ACID; 1-ETHYLCYCLOPROPANECARBOXYLIC ACID; 1-ETHYLPYRROLIDINE-2-CARBOXYLIC ACID; 1-ETHYLPYRROLIDINE-3-CARBOXYLIC ACID; 1-FLUOROCYCLOHEXANECARBOXYLIC ACID; 1-FLUORO-CYCLOPROPANECARBOXYLIC ACID; 1-FORMYLPYRROLIDINE-2-CARBOXYLIC ACID; 1-FORMYLPYRROLIDINE-3-CARBOXYLIC ACID; 1H-[1,2,3]TRIAZOLE-4-CARBOXYLIC ACID; 1H-1,2,3-TRIAZOLE-1-ACETIC ACID; 1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID, 5-METHYL-; 1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID, 1-AMINO-; 1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID, 5-AMINO-2,3-DIHYDRO-; 1H-1,2,4-TRIAZOLE-5-CARBOXYLIC ACID; 1H-IMIDAZOL-1-YL(OXO)ACETIC ACID; 1H-IMIDAZOL-4-YL(OXO)ACETIC ACID; 1H-IMIDAZOLE-1-ACETIC ACID, ALPHA-METHYL-, (R)-; 1H-IMIDAZOLE-1-ACETIC ACID,-ALPHA-FLUORO-; 1H-IMIDAZOLE-2-CARBOXYLIC ACID; 1H-IMIDAZOLE-2-CARBOXYLIC ACID HYDROCHLORIDE; 1H-IMIDAZOLE-2-CARBOXYLIC ACID, 4,5-DIHYDRO-5-OXO-; 1H-IMIDAZOLE-4-CARBOXYLIC ACID; 1H-IMIDAZOLE-5-CARBOXYLIC ACID; 1H-PYRAZOL-1-YLACETIC ACID; 1H-PYRAZOLE-3-CARBOXYLIC ACID; 1H-PYRAZOLE-4-CARBOXYLIC ACID; 1H-PYRAZOLE-4-CARBOXYLIC ACID HYDRATE; 1H-PYRROL-1-YLACETIC ACID; 1H-PYRROLE-2-CARBOXYLIC ACID, 3,4-DIFLUORO-; 1H-TETRAZOLE-1-ACETIC ACID; 1H-TETRAZOLE-5-ACETIC ACID; 1H-TETRAZOLE-5-CARBOXYLIC ACID; 1-HYDROXY-1-CYCLOPROPANECARBOXYLIC ACID; 1-HYDROXY-2-PIPERIDINECARBOXYLIC ACID; 1-HYDROXY-3-METHYLCYCLOPENTANE-1-CARBOXYLIC ACID; 1-HYDROXY-CYCLOBUTANECARBOXYLIC ACID; 1-HYDROXY-CYCLOHEXANECARBOXYLIC ACID; 1-HYDROXY-CYCLOPENTANECARBOXYLIC ACID; 1-ISOPROPYL-AZETIDINE-2-CARBOXYLIC ACID; 1-ISOPROPYLAZETIDINE-3-CARBOXYLIC ACID; 1-METHOXYCYCLOPENTANE-1-CARBOXYLIC ACID; 1-METHYL-1-CYCLOHEXANECARBOXYLIC ACID; 1-METHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 1-METHYL-1H-1,2,3-TRIAZOLE-5-CARBOXYLIC ACID; 1-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 1-METHYL-1H-1,2,4-TRIAZOLE-5-CARBOXYLIC ACID; 1-METHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 1-METHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 1-METHYL-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 1-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 1-METHYL-2,5-DIHYDRO-1H-PYRROLE-2-CARBOXYLIC ACID; 1-METHYL-2-CYCLOHEXENE-1-CARBOXYLIC ACID; 1-METHYL-2-IMIDAZOLINE-4-CARBOXYLIC ACID; 1-METHYL-3-AZETIDINECARBOXYLIC ACID; 1-METHYL-3-CYCLOHEXENECARBOXYLIC ACID; 1-METHYL-4-OXO-2-AZETIDINECARBOXYLIC ACID; 1-METHYL-5-OXO-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-METHYL-5-OXOPYRROLIDINE-2-CARBOXYLIC ACID; 1-METHYL-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; 1-METHYLCYCLOBUTANECARBOXYLIC ACID; 1-METHYLCYCLOPENTANECARBOXYLIC ACID; 1-METHYLCYCLOPROPANE-1-CARBOXYLIC ACID; 1-METHYLIMIDAZOLE-2-CARBOXYLIC ACID HYDRATE; 1-METHYLPIPERAZINE-2-CARBOXYLIC ACID; 1-METHYL-PIPERIDINE-2-CARBOXYLIC ACID; 1-METHYLPIPERIDINE-3-CARBOXYLIC ACID; 1-METHYLPIPERIDINE-4-CARBOXYLIC ACID; 1-METHYL-PYRROLE-2-ACETIC ACID; 1-METHYLPYRROLIDINE-2-CARBOXYLIC ACID; 1-METHYLPYRROLIDINE-2-CARBOXYLIC ACID HYDRATE; 1-METHYLPYRROLIDINE-3-CARBOXYLIC ACID; 1-NITRO-3-AZETIDINECARBOXYLIC ACID; 1-PROPYL-AZETIDINE-2-CARBOXYLIC ACID; 1-PROPYLCYCLOBUTANECARBOXYLIC ACID; 1-VINYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-VINYL-1H-PYRROLE-2-CARBOXYLIC ACID; 2-([(2E)-3-CHLOROPROP-2-EN-1-YL]AMINO)ACETIC ACID; 2-([(METHYLCARBAMOYL)METHYL]AMINO)ACETIC ACID; 2-([2-(DIMETHYLAMINO)ETHYL]AMINO)ACETIC ACID; 2-(1-(HYDROXYMETHYL)CYCLOPROPYL)ACETIC ACID; 2-(1,2,4-OXADIAZOL-5-YL)ACETIC ACID; 2-(1,2-OXAZOL-4-YL)ACETIC ACID; 2-(1H-1,2,4-TRIAZOL-1-YL)PROPANOIC ACID; 2-(1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; 2-(1H-IMIDAZOL-1-YL)PROPANOIC ACID; 2-(1H-PYRAZOL-1-YL)PROPANOIC ACID; 2-(1H-PYRROL-1-YL)PROPANOIC ACID; 2-(1H-PYRROL-2-YL)PROPANOIC ACID; 2-(1-HYDROXYCYCLOBUTYL)ACETIC ACID; 2-(1-HYDROXYCYCLOBUTYL)PROPANOIC ACID; 2-(1-HYDROXYCYCLOPENTYL)ACETIC ACID; 2-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; 2-(1-METHYL-3-PYRROLIDINYL)ACETIC ACID; 2-(1-METHYLHYDRAZINO)PROPANOIC ACID; 2-(2-AMINOACETAMIDO)ACETIC ACID-15N2; 2-(2-CH LOROETHOXY)ACETIC ACID; 2-(2-CYANO-ETHYLAMINO)-PROPIONIC ACID; 2-(2-ETHOXYETHOXY)ACETIC ACID; 2-(2H-TETRAZOL-5-YL)ACETIC ACID; 2-(2-HYDROXYETHOXY)ACETIC ACID; 2-(2-HYDROXYETHOXY)BUTANOIC ACID; 2-(2-HYDROXYETHOXY)PROPANOIC ACID; 2-(2-METHOXYETHOXY)ACETIC ACID; 2-(2-METHOXYETHOXY)PROPANOIC ACID; 2-(2-METHYL-1H-IMIDAZOL-5-YL)ACETIC ACID; 2-(2-METHYLENECYCLOPROPYL)ACETIC ACID; 2-(2-METHYLPROPOXY)PROPANOIC ACID; 2-(2-METHYLPROPYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 2-(2-METHYLPYRROLIDIN-1-YL)ACETIC ACID; 2-(3-AMINO-1H-PYRAZOL-5-YL)ACETIC ACID; 2-(3H-IMIDAZOL-4-YL)ACETIC ACID; 2-(3-HYDROXYAZETIDIN-1-YL)ACETIC ACID; 2-(3-HYDROXYAZETIDIN-1-YL)PROPANOIC ACID; 2-(3-HYDROXYOXOLAN-3-YL)ACETIC ACID; 2-(3-HYDROXYPROPOXY)ACETIC ACID; 2-(3-HYDROXYPROPOXY)PROPANOIC ACID; 2-(3-METHOXYPROPOXY)ACETIC ACID; 2-(3-METHYL-1H-PYRROL-1-YL)ACETIC ACID; 2-(3-METHYLPYRROLIDIN-1-YL)ACETIC ACID; 2-(3-OXOCYCLOPENTYL)ACETIC ACID; 2-(3-PYRROLIDINYLIDENE)ACETIC ACID; 2-(4-METHYL)PYRROLIDINYL ACETIC ACID; 2-(5-AMINO-1H-1,2,4-TRIAZOL-1-YL)ACETIC ACID; 2-(5-AMINO-1H-PYRAZOL-1-YL)ACETIC ACID; 2-(5-METHYL-1,3,4-OXADIAZOL-2-YL)ACETIC ACID; 2-(5-METHYL-1H-1,2,4-TRIAZOL-3-YL)ACETIC ACID; 2-(5-METHYLPYRROLIDIN-2-YL)ACETIC ACID; 2-(5-OXO-4,5-DIHYDRO-1H-PYRAZOL-3-YL)ACETIC ACID; 2-(5-OXOPYRROLIDIN-2-YL)ACETIC ACID; 2-(ALLYLAMINO)ACETIC ACID; 2-(ALLYLTHIO)PROPANOIC ACID; 2-(AMINOAMINOCARBONYLAMINO)ACETIC ACID; 2-(AMINOMETHYL)-2-ETHYLBUTANOIC ACID; 2-(AMINOMETHYL)-3-METHYLBUTANOIC ACID; 2-(AMINOMETHYL)-4-METHYLPENTANOIC ACID; 2-(AMINOMETHYL)BUTANOIC ACID; 2-(AMINOMETHYL)CYCLOPROPANECARBOXYLIC ACID; 2-(AMINOMETHYL)PENTANOIC ACID; 2-(AMINOOXY)ACETIC ACID; 2-(AZETIDIN-1-YL)-2-OXOACETIC ACID; 2-(BUT-2-EN-1-YLOXY)ACETIC ACID; 2-(BUT-3-EN-1-YLOXY)ACETIC ACID; 2-(BUT-3-EN-1-YLOXY)PROPANOIC ACID; 2-(BUT-3-EN-2-YLAMINO)ACETIC ACID; 2-(BUT-3-EN-2-YLAMINO)PROPANOIC ACID; 2-(BUT-3-EN-2-YLSULFANYL)ACETIC ACID; 2-(BUT-3-ENAMIDO)ACETIC ACID; 2-(BUT-3-YN-1-YLAMINO)ACETIC ACID; 2-(BUT-3-YN-1-YLAMINO)PROPANOIC ACID; 2-(BUT-3-YN-1-YLSULFANYL)ACETIC ACID; 2-(BUTAN-2-YLAMINO)ACETIC ACID; 2-(BUTAN-2-YLAMINO)PROPANOIC ACID; 2-(BUTAN-2-YLOXY)ACETIC ACID; 2-(BUTAN-2-YLSULFANYL)ACETIC ACID; 2-(BUTYLAMINO)ACETIC ACID; 2-(BUTYLAMINO)PROPANOIC ACID; 2-(CYANOMETHYLTHIO)ACETIC ACID; 2-(CYCLOBUTYLAMINO)ACETIC ACID; 2-(CYCLOBUTYLAMINO)PROPANOIC ACID; 2-(CYCLOBUTYLMETHOXY)-ACETIC ACID; 2-(CYCLOBUTYLMETHYL)ACRYLIC ACID; 2-(CYCLOPENTYLOXY)ACETIC ACID; 2-(CYCLOPROPYLAMINO)-2-METHYLPROPANOIC ACID; 2-(CYCLOPROPYLAMINO)-2-OXOACETIC ACID; 2-(CYCLOPROPYLAMINO)ACETIC ACID; 2-(CYCLOPROPYLAMINO)BUTANOIC ACID; 2-(CYCLOPROPYLAMINO)PROPANOIC ACID; 2-(CYCLOPROPYLCARBAMOYL)ACETIC ACID; 2-(CYCLOPROPYLMETHOXY)-ACETIC ACID; 2-(CYCLOPROPYLMETHOXY)PROPANOIC ACID; 2-(DIETHYLAMINO)PROPANOIC ACID; 2-(DIMETHYLAMINO)-2-METHYLBUTANOIC ACID; 2-(DIMETHYLAMINO)-2-METHYLPROPANOIC ACID; 2-(DIMETHYLAMINO)BUTANOIC ACID; 2-(DIMETHYLAMINO)PENTANOIC ACID; 2-(DIMETHYLAMINO)PROPANOIC ACID; 2-(DIMETHYLCARBAMOYL)ACETIC ACID; 2-(ETHANESULFINYL)ACETIC ACID; 2-(ETHOXYCARBONYLAMINO)ACETIC ACID; 2-(ETHYLAMINO)-2-METHYLBUTANOIC ACID; 2-(ETHYLAMINO)-2-METHYLPROPANOIC ACID; 2-(ETHYLAMINO)-3-METHOXYPROPANOIC ACID; 2-(ETHYLAMINO)-3-METHYLBUTANOIC ACID; 2-(ETHYLAMINO)ACETIC ACID HYDROCHLORIDE; 2-(ETHYLAMINO)BUTANOIC ACID; 2-(ETHYLAMINO)PENTANOIC ACID; 2-(ETHYLAMINO)PROPANOIC ACID; 2-(ETHYLCARBAMOYL)ACETIC ACID; 2-(ETHYLSULFANYL)-2-METHYLPROPANOIC ACID; 2-(ETHYLSULFANYL)BUTANOIC ACID; 2-(ETHYLTHIO)PROPANOIC ACID; 2-(FORMYLOXY)PROPANOIC ACID; 2-(FURAN-2-YL)PROPANOIC ACID; 2-(FURAN-3-YL)-2-HYDROXYACETIC ACID; 2-(HYDROXYMETHYL)-BUTANOIC ACID; 2-(HYDROXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-(ISOPROPYLIDENEAMINOOXY)PROPIONIC ACID; 2-(ISOPROPYLTHIO)PROPANOIC ACID; 2-(METHOXY(METHYL)AMINO)-2-OXOACETIC ACID; 2-(METHOXYCARBONYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 2-(METHYLAMINO)-3-(METHYLSULFANYL)PROPANOIC ACID; 2-(METHYLAMINO)BUTANOIC ACID; 2-(METHYLAMINO)HEXANOIC ACID; 2-(METHYLAMINO)PENTANOIC ACID; 2-(METHYLCARBAMOYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 2-(METHYLSULFANYL)BUTANOIC ACID; 2-(METHYLTHIO)PROPANOIC ACID; 2-(N-CYCLOBUTYL-N-METHYLAMINO)ACETIC ACID; 2-(N-ETHYLACETAMIDO)ACETIC ACID; 2-(N-METHYLACETAMIDO)ACETIC ACID; 2-(N-METHYLACETAMIDO)PROPANOIC ACID; 2-(N-METHYLFORMAMIDO)PROPANOIC ACID; 2-(N-METHYL-HYDRAZINO)-BUTYRIC ACID; 2-(N-METHYL-N-PROPYLAMINO)ACETIC ACID; 2-(N-METHYLPROP-2-YNAMIDO)ACETIC ACID; 2-(N-PROPYLFORMAMIDO)ACETIC ACID; 2-(OXETAN-3-YLIDENE)ACETIC ACID; 2-(OXOLAN-3-YLAMINO)ACETIC ACID; 2-(OXOLAN-3-YLIDENE)ACETIC ACID; 2-(OXOLAN-3-YLOXY)ACETIC ACID; 2-(PENT-4-ENYLOXY)ACETIC ACID; 2-(PENTAN-2-YLAMINO)ACETIC ACID; 2-(PENTAN-3-YLAMINO)ACETIC ACID; 2-(PENTAN-3-YLOXY)ACETIC ACID; 2-(PENTYLAMINO)ACETIC ACID; 2-(PENTYLOXY)ACETIC ACID; 2-(PROP-2-EN-1-YLAMINO)BUTANOIC ACID; 2-(PROP-2-EN-1-YLAMINO)PROPANOIC ACID; 2-(PROP-2-EN-1-YLOXY)ACETIC ACID; 2-(PROP-2-EN-1-YLOXY)BUTANOIC ACID; 2-(PROP-2-EN-1-YLOXY)PROPANOIC ACID; 2-(PROP-2-YN-1-YLAMINO)ACETIC ACID; 2-(PROP-2-YN-1-YLAMINO)PROPANOIC ACID; 2-(PROP-2-YN-1-YLOXY)ACETIC ACID; 2-(PROP-2-YN-1-YLOXY)BUTANOIC ACID; 2-(PROP-2-YN-1-YLOXY)PROPANOIC ACID; 2-(PROP-2-YN-1-YLSULFANYL)PROPANOIC ACID; 2-(PROP-2-YNAMIDO)ACETIC ACID; 2-(PROP-2-YNAMIDO)PROPANOIC ACID; 2-(PROPAN-2-YL)PENTANOIC ACID; 2-(PROPAN-2-YLAMINO)ACETIC ACID; 2-(PROPAN-2-YLAMINO)BUTANOIC ACID; 2-(PROPAN-2-YLOXY)BUTANOIC ACID; 2-(PROPYLAMINO)BUTANOIC ACID; 2-(PROPYLAMINO)PROPANOIC ACID; 2-(PROPYLCARBAMOYL)ACETIC ACID; 2-(PROPYLSULFANYL)PROPANOIC ACID; 2(S),3(R)-2-AMINO-3-HYDROXYPENT-4-YNOIC ACID; 2(S)-AMINO-4-AZIDO-BUTANOIC ACID; 2-(TERT-BUTOXY)PROPANOIC ACID; 2-(TERT-BUTYLAMINO)ACETIC ACID; 2-(TRIFLUOROMETHYL)ACRYLIC ACID; 2,2,3,3-TETRAMETHYLCYCLOPROPANECARBOXYLIC ACID; 2,2,3-TRIMETHYL-3-BUTENOIC ACID; 2,2,3-TRIMETHYLBUTANOIC ACID; 2,2,3-TRIMETHYLPENTANOIC ACID; 2,2,4-TRIMETHYL-4-PENTENOIC ACID; 2,2,4-TRIMETHYLPENTANOIC ACID; 2,2-BIS(HYDROXYMETHYL)BUTYRIC ACID; 2,2-BIS(HYDROXYMETHYL)PROPIONIC ACID; 2,2-DIAMINO-3-MERCAPTO-PROPIONIC ACID; 2,2-DICHLOROPROPIONIC ACID; 2,2-DICYCLOPROPYLACETIC ACID; 2,2-DIETHYLBUTYRIC ACID; 2,2-DIETHYLCYCLOPROPANECARBOXYLIC ACID; 2,2-DIFLUORO-3-HYDROXYBUTANOIC ACID; 2,2-DIFLUORO-3-METHYLBUTYRIC ACID; 2,2-DIFLUOROBUTYRIC ACID; 2,2-DIFLUOROCYCLOBUTANECARBOXYLIC ACID; 2,2-DIFLUOROCYCLOPROPANECARBOXYLIC ACID; 2,2-DIFLUOROPENT-4-ENOIC ACID; 2,2-DIFLUOROPENTANOIC ACID; 2,2-DIFLUOROPROPIONIC ACID; 2,2-DIMETHYL CYCLOPROPYL CARBOXYLIC ACID; 2,2-DIMETHYL-1,3-DIOXOLANE-4-CARBOXYLIC ACID; 2,2-DIMETHYL-3-(METHYLSULFANYL)PROPANOIC ACID; 2,2-DIMETHYL-3-HYDROXYPROPIONIC ACID; 2,2-DIMETHYL-3-OXOBUTANOIC ACID; 2,2-DIMETHYL-4-OXO-PENTANOIC ACID; 2,2-DIMETHYL-4-PENTENOIC ACID; 2,2-DIMETHYL-5-HEXENOIC ACID; 2,2-DIMETHYL-5-HEXYNOIC ACID; 2,2-DIMETHYLBUT-3-ENOIC ACID; 2,2-DIMETHYL-BUT-3-YNOIC ACID; 2,2-DIMETHYLBUTYRIC ACID; 2,2-DIMETHYL-CYCLOPENTANECARBOXYLIC ACID; 2,2-DIMETHYLHEXANOIC ACID; 2,2-DIMETHYL-MALONAMIC ACID; 2,2-DIMETHYL-MALONIC ACID MONOMETHYL ESTER; 2,2-DIMETHYLSUCCINIC ACID; 2,2-DIMETHYLVALERIC ACID; 2,3,3,3-TETRAFLUOROPROPANOIC ACID; 2,3,3-TRIMETHYLBUTANOIC ACID; 2,3,3-TRIMETHYLPROPIONIC ACID; 2,3,4-TRIHYDROXYBUTANOIC ACID; 2,3:4,5-DIEPOXY-HEXANOIC ACID; 2,3-ANHYDRO-4-DEOXY-PENTARIC ACID; 2,3-DIAMINOBUTYRIC ACID; 2,3-DIAMINOPROPIONIC ACID; 2,3-DICHLOROPROPIONIC ACID; 2,3′-DIENE-VALPROIC ACID; 2,3-DIENEVALPROIC ACID; 2,3-DIETHYLCYCLOPROP-2-ENE-1-CARBOXYLIC ACID; 2,3-DIHYDRO-2-OXO-4-PYRIDINECARBOXYLIC ACID; 2,3-DIHYDRO-3-OXO-5-1SOTHIAZOLECARBOXAMIDE; 2,3-DIHYDRO-4-METHYL-3-OXO-5-1SOXAZOLECARBOXYLIC ACID; 2,3-DIHYDROXYISOVALERIC ACID; 2,3-DIMERCAPTOPROPIONIC ACID; 2,3-DIMETHYL-2-(METHYLAMINO)BUTANOIC ACID; 2,3-DIMETHYLPENTANOIC ACID; 2,3-DIMETHYLSUCCINIC ACID; 2,3-EPOXYPROPANOIC ACID; 2,4,4-TRIMETHYLPENTANOIC ACID; 2,4,6-OCTATRIENOIC ACID; 2,4-DIAMINO-2-METHYL-BUTYRIC ACID; 2,4-DIAMINO-BUTYRIC ACID; 2,4-DIENE VALPROIC ACID; 2,4-DIMETHYL-2-PENTENOIC ACID; 2,4-DIMETHYL-3-FUROIC ACID; 2,4-DIMETHYLHEXANOIC ACID; 2,4-DIMETHYL-OXAZOLE-5-CARBOXYLIC ACID; 2,4-DIMETHYLPENTANOIC ACID; 2,4-DIMETHYLPYRROLE-3-CARBOXYLIC ACID; 2,5-DIHYDRO-4-METHYL-5-OXO-3-FURANCARBOXYLIC ACID; 2,5-DIHYDRO-5-OXO-2-FURANACETIC ACID; 2,5-DIHYDRO-5-OXO-3-FURANCARBOXYLIC ACID; 2,5-DIHYDRO-FURAN-2-CARBOXYLIC ACID; 2,5-DIMETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID; 2,5-DIMETHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2,5-DIMETHYL-3-FUROIC ACID; 2,5-DIMETHYL-HEX-4-ENOIC ACID; 2,5-DIMETHYLHEXANOIC ACID; 2,5-DIMETHYLPYRROLE-3-CARBOXYLIC ACID; 2,5-DIOXO-PYRROLIDINE-3-CARBOXYLIC ACID; 2,6-HEPTADIENOIC ACID; 2-[(1-CARBAMOYLETHYL)AMINO]ACETIC ACID; 2-[(1-CYANOETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(1-CYANOETHYL)SULFANYL]ACETIC ACID; 2-[(1-CYANOPROPYL)AMINO]ACETIC ACID; 2-[(1-CYCLOPROPYLETHYL)AMINO]ACETIC ACID; 2-[(1-HYDROXY-2-METHYLPROPAN-2-YL)AMINO]ACETIC ACID; 2-[(1-HYDROXYBUTAN-2-YL)AMINO]ACETIC ACID; 2-[(1-HYDROXYPROPAN-2-YL)AMINO]ACETIC ACID; 2-[(1-HYDROXYPROPAN-2-YL)AMINO]PROPANOIC ACID; 2-[(1-METHOXYPROPAN-2-YL)AMINO]ACETIC ACID; 2-[(2,2-DIFLUOROETHYL)AMINO]ACETIC ACID; 2-[(2,2-DIMETHYLCYCLOPROPYL)AMINO]ACETIC ACID; 2-[(2,2-DIMETHYLPROPYL)AMINO]ACETIC ACID; 2-[(2-AMINOETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(2-AMINOETHYL)(METHYL)AMINO]PROPANOIC ACID; 2-[(2-AMINOETHYL)AMINO]-2-METHYLPROPANOIC ACID; 2-[(2-AMINOETHYL)CARBAMOYL]ACETIC ACID; 2-[(2-AMINOETHYL)SULFANYL]ACETIC ACID; 2-[(2-AMINOETHYL)SULFANYL]PROPANOIC ACID; 2-[(2-CARBAMOYLETHYL)AMINO]ACETIC ACID; 2-[(2-CHLOROPROP-2-EN-1-YL)AMINO]ACETIC ACID; 2-[(2-CYANOETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(2E)-BUT-2-EN-1-YL(METHYL)AMINO]ACETIC ACID; 2-[(2E)-BUT-2-EN-1-YLAMINO]PROPANOIC ACID; 2-[(2E)-BUT-2-EN-1-YLSULFANYL]ACETIC ACID; 2-[(2E)-BUT-2-ENAMIDO]ACETIC ACID; 2-[(2-ETHOXYETHYL)AMINO]ACETIC ACID; 2-[(2-HYDROXY-2-METHYLPROPYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYBUTYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYETHYL)(METHYL)AMINO]PROPANOIC ACID; 2-[(2-HYDROXYETHYL)AMINO]-2-METHYLPROPANOIC ACID; 2-[(2-HYDROXYETHYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYETHYL)AMINO]PROPANOIC ACID; 2-[(2-HYDROXYETHYL)CARBAMOYL]ACETIC ACID; 2-[(2-HYDROXYETHYL)SULFANYL]ACETIC ACID; 2-[(2-HYDROXYPROPYL)(METHYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYPROPYL)AMINO]ACETIC ACID; 2-[(2-HYDROXYPROPYL)AMINO]PROPANOIC ACID; 2-[(2-METHOXY-2-OXOETHYL)AMINO]ACETIC ACID; 2-[(2-METHOXYACETYL)AMINO]ACETIC ACID; 2-[(2-METHOXYETHYL)AMINO]ACETIC ACID; 2-[(2-METHOXYETHYL)AMINO]PROPANOIC ACID; 2-[(2-METHYLBUTAN-2-YL)AMINO]ACETIC ACID; 2-[(2-METHYLBUTAN-2-YL)OXY]ACETIC ACID; 2-[(2-METHYLCYCLOPROPYL)AMINO]ACETIC ACID; 2-[(2-METHYLCYCLOPROPYL)AMINO]PROPANOIC ACID; 2-[(2-METHYLPROP-2-EN-1-YL)AMINO]ACETIC ACID; 2-[(2-METHYLPROP-2-EN-1-YL)AMINO]PROPANOIC ACID; 2-[(2-METHYLPROP-2-EN-1-YL)SULFANYL]ACETIC ACID; 2-[(2-METHYLPROPYL)AMINO]ACETIC ACID; 2-[(3-AMINOPROPYL)AMINO]ACETIC ACID; 2-[(3-CYANOPROPYL)AMINO]ACETIC ACID; 2-[(3E)-THIOLAN-3-YLIDENE]ACETIC ACID; 2-[(3-HYDROXYPROPYL)(METHYL)AMINO]ACETIC ACID; 2-[(3-HYDROXYPROPYL)AMINO]ACETIC ACID; 2-[(3-HYDROXYPROPYL)AMINO]PROPANOIC ACID; 2-[(3-METHOXYPROPYL)AMINO]ACETIC ACID; 2-[(3-METHYLBUT-2-EN-1-YL)AMINO]ACETIC ACID; 2-[(3-METHYLBUTAN-2-YL)AMINO]ACETIC ACID; 2-[(4-HYDROXYBUTYL)AMINO]ACETIC ACID; 2-[(AMINOCARBONYL)AMINO]-3-HYDROXYPROPANOIC ACID; 2-[(AMINOCARBONYL)AMINO]BUTANOIC ACID; 2-[(AMINOTHIOXOMETHYL)AMINO]ACETIC ACID; 2-[(CARBAMOYLMETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(CARBAMOYLMETHYL)AMINO]ACETIC ACID; 2-[(CARBAMOYLMETHYL)AMINO]PROPANOIC ACID; 2-[(CYANOMETHANE)SULFINYL]ACETIC ACID; 2-[(CYANOMETHYL)(ETHYL)AMINO]ACETIC ACID; 2-[(CYANOMETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(CYANOMETHYL)(METHYL)AMINO]PROPANOIC ACID; 2-[(CYANOMETHYL)AMINO]ACETIC ACID; 2-[(CYANOMETHYL)AMINO]PROPANOIC ACID; 2-[(CYANOMETHYL)CARBAMOYL]ACETIC ACID; 2-[(CYANOMETHYL)SULFANYL]PROPANOIC ACID; 2-[(CYCLOBUTYLMETHYL)AMINO]ACETIC ACID; 2-[(CYCLOPROPYLCARBONYL)AMINO]ACETIC ACID; 2-[(CYCLOPROPYLMETHYL)(METHYL)AMINO]ACETIC ACID; 2-[(CYCLOPROPYLMETHYL)AMINO]ACETIC ACID; 2-[(CYCLOPROPYLMETHYL)AMINO]PROPANOIC ACID; 2-[(ETHYLCARBAMOYL)AMINO]ACETIC ACID; 2-[(METHOXYCARBONYL)(METHYL)AMINO]ACETIC ACID; 2-[(METHOXYCARBONYL)AMINO]ACETIC ACID; 2-[(METHOXYCARBONYL)AMINO]PROPANOIC ACID; 2-[(METHYLCARBAMOYL)AMINO]ACETIC ACID; 2-[(METHYLCARBAMOYL)AMINO]PROPANOIC ACID; 2-[(METHYLCARBAMOYL)METHOXY]ACETIC ACID; 2-[(PROP-2-EN-1-YL)CARBAMOYL]ACETIC ACID; 2-[(PROP-2-YN-1-YL)CARBAMOYL]ACETIC ACID; 2-[(PROPAN-2-YL)AMINO]PROPANOIC ACID; 2-[(PROPAN-2-YL)CARBAMOYL]ACETIC ACID; 2-[1-(MERCAPTOMETHYL)CYCLOPROPYL]ACETIC ACID; 2-[2-(DIAMINOMETHYLIDENE)HYDRAZONO]PROPANOIC ACID; 2-[BUT-2-YN-1-YL(METHYL)AMINO]ACETIC ACID; 2-[BUT-3-YN-1-YL(METHYL)AMINO]ACETIC ACID; 2-[BUTAN-2-YL(METHYL)AMINO]ACETIC ACID; 2-[BUTYL(METHYL)AMINO]ACETIC ACID; 2-[CARBAMOYL(ETHYL)AMINO]ACETIC ACID; 2-[CYCLOPROPYL(ETHYL)AMINO]ACETIC ACID; 2-[CYCLOPROPYL(METHYL)AMINO]ACETIC ACID; 2-[CYCLOPROPYL(METHYL)AMINO]PROPANOIC ACID; 2-[ETHYL(2-HYDROXYETHYL)AMINO]ACETIC ACID; 2-[ETHYL(METHYL)AMINO]-2-METHYLPROPANOIC ACID; 2-[ETHYL(METHYL)AMINO]BUTANOIC ACID; 2-[ETHYL(METHYL)AMINO]PROPANOIC ACID; 2-[ETHYL(METHYL)CARBAMOYL]ACETIC ACID; 2-[ETHYL(PROP-2-EN-1-YL)AMINO]ACETIC ACID; 2-[ETHYL(PROP-2-YN-1-YL)AMINO]ACETIC ACID; 2-[ETHYL(PROPAN-2-YL)AMINO]ACETIC ACID; 2-[ETHYL(PROPYL)AMINO]ACETIC ACID; 2-[METHOXY(METHYL)CARBAMOYL]ACETIC ACID; 2-[METHYL(2-METHYLPROP-2-EN-1-YL)AMINO]ACETIC ACID; 2-[METHYL(2-METHYLPROPYL)AMINO]ACETIC ACID; 2-[METHYL(METHYLCARBAMOYL)AMINO]ACETIC ACID; 2-[METHYL(PROP-2-EN-1-YL)AMINO]ACETIC ACID; 24METHYL(PROP-2-EN-1-YL)AMINOPROPANOIC ACID; 2-[METHYL(PROP-2-YN-1-YL)AMINO]ACETIC ACID; 2-[METHYL(PROP-2-YN-1-YL)AMINO]PROPANOIC ACID; 2-[METHYL(PROPAN-2-YL)AMINO]PROPANOIC ACID; 2-[METHYL(PROPIONYL)AMINO]ACETIC ACID; 2-[METHYL(PROPYL)AMINO]PROPANOIC ACID; 2-ACETAMIDO-2-METHYLPROPANOIC ACID; 2-ACETAMIDOACRYLIC ACID; 2-ACETAMIDOBUTYRIC ACID; 2-ACETYL-3-OXO-BUTANOIC ACID; 2-ACETYLAMINO-2-HYDROXY-ACETIC ACID; 2-ALLYL-4-PENTENOIC ACID; 2-AMINO-1,3-OXAZOLE-4-CARBOXYLIC ACID; 2-AMINO-1-ETHOXY-CYCLOPROPANECARBOXYLIC ACID; 2-AMINO-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-AMINO-2-(1-METHYLCYCLOPROPYL)PROPIONIC ACID; 2-AMINO-2-(OXETAN-3-YL)ACETIC ACID; 2-AMINO-2-CYCLOBUTYLPROPIONIC ACID; 2-AMINO-2-CYCLOPROPYLPROPIONIC ACID; 2-AMINO-2-HYDROXY-ACETIC ACID; 2-AMINO-2-METHYL-3-(METHYLSULFANYL)PROPANOIC ACID; 2-AMINO-2-METHYL-3-METHOXY-PROPANOIC ACID; 2-AMINO-2-METHYL-3-METHYLAMINO-PROPANOIC ACID; 2-AMINO-2-METHYL-4-METHOXY-BUTYRIC ACID; 2-AMINO-2-METHYL-4-PENTENOIC ACID; 2-AMINO-2-METHYL-5-HYDROXY-PENTANOIC ACID; 2-AMINO-2-METHYLBUT-3-YNOIC ACID; 2-AMINO-2-METHYLBUTYRIC ACID; 2-AMINO-2-METHYL-CYCLOPENTANECARBOXYLIC ACID; 2-AMINO-2-METHYLPENTANOIC ACID; 2-AMINO-2-METHYLSUCCINIC ACID; 2-AMINO-3-(DIMETHYLAMINO)-2-METHYLPROPANOIC ACID; 2-AMINO-3-(ETHYLSULFANYL)PROPANOIC ACID; 2-AMINO-3-(METHYLAMINO)PROPANOIC ACID; 2-AMINO-3-[ETHYL(METHYL)AMINO]PROPANOIC ACID; 2-AMINO-3-[METHYLTHIO]BUTYRIC ACID; 2-AMINO-3-BUTENOIC ACID; 2-AMINO-3-CYANOPROPANOIC ACID; 2-AMINO-3-ETHOXY-2-METHYLPROPANOIC ACID; 2-AMINO-3-ETHOXYPROPANOIC ACID; 2-AMINO-3-ETHYL-PENTANOIC ACID; 2-AMINO-3-FLUOROBUTYRIC ACID; 2-AMINO-3-HYDROXY-2-METHYLBUTANOIC ACID; 2-AMINO-3-HYDROXY-4-METHYL-VALERIC ACID; 2-AMINO-3-HYDROXYBUTANOIC ACID; 2-AMINO-3-METHOXY-2-METHYLPROPANOIC ACID; 2-AMINO-3-METHYLENE-CYCLOBUTANECARBOXYLIC ACID; 2-AMINO-3-METHYL-HEXANOIC ACID; 2-AMINO-3-METHYLPENT-4-ENOIC ACID; 2-AMINO-3-METHYLPENTANOIC ACID; 2-AMINO-3-PROPOXYPROPANOIC ACID; 2-AMINO-4(5)-IMIDAZOLEACETIC ACID; 2-AMINO-4-(DIMETHYLAMINO)BUTANOIC ACID; 2-AMINO-4,4-DIFLUOROBUTANOIC ACID; 2-AMINO-4-BORONOBUTANOIC ACID; 2-AMINO-4-ETHOXYBUTANOIC ACID; 2-AMINO-4-FLUORO-BUTANOIC ACID; 2-AMINO-4-HEXYNOIC ACID; 2-AMINO-4-METHOXY-2-METHYLBUTANOIC ACID; 2-AMINO-4-METHOXYBUTANOIC ACID; 2-AMINO-4-METHYL-1,3-OXAZOLE-5-CARBOXYLIC ACID; 2-AMINO-4-METHYL-3-PENTENOIC ACID; 2-AMINO-4-METHYLENE-CYCLOBUTANECARBOXYLIC ACID; 2-AMINO-4-METHYLENE-CYCLOPENTANECARBOXYLIC ACID; 2-AMINO-4-METHYLHEXANOIC ACID; 2-AMINO-4-METHYL-PENT-4-ENOIC ACID; 2-AMINO-4-OXOBUTANOIC ACID; 2-AMINO-4-THIAZOLINIC ACID; 2-AMINO-5-HYDROXYLEVULINIC ACID; 2-AMINO-5-HYDROXYVALERIC ACID; 2-AMINO-5-METHOXYPENTANOIC ACID; 2-AMINO-5-METHYLHEX-4-ENOIC ACID; 2-AMINOBICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID; 2-AMINOCYCLOHEX-1-ENECARBOXYLIC ACID; 2-AMINOCYCLOPENTANEACETIC ACID; 2-AMINO-CYCLOPENTANECARBOXYLIC ACID; 2-AMINO-CYCLOPROPANECARBOXYLIC ACID; 2-AMINOHEPTANOIC ACID; 2-AMINOHEX-5-ENOIC ACID; 2-AMINOHEX-5-YNOIC ACID; 2-AMINOISOBUTYRIC ACID; 2-AMINOISOBUTYRIC-15N ACID; 2-AMINOISONICOTINIC ACID; 2-AMINOMETHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-AMINONICOTINIC ACID; 2-AMINOOXAZOLE-5-CARBOXYLIC ACID; 2-AMINOPYRIMIDINE-4-CARBOXYLIC ACID; 2-AMINOPYRIMIDINE-5-CARBOXYLIC ACID; 2-AMINOTHIAZOLE-4-CARBOXYLIC ACID; 2-AMINOTHIAZOLE-5-CARBOXYLIC ACID; 2-AMINOTHIOPHENE-3-CARBOXYLIC ACID; 2-AZABICYCLO[2.1.1]HEXANE-1-CARBOXYLIC ACID; 2-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID; 2-AZETIDINECARBOXYLIC ACID, 3-AMINO-4-OXO-; 2-AZIDO-2-METHYLPROPIONIC ACID; 2-AZIDOACETIC ACID; 2-AZIDOPROPANOIC ACID; 2-BUTOXYACETIC ACID; 2-BUTOXYPROPANOIC ACID; 2-BUTYLCYCLOPROPANECARBOXYLIC ACID; 2-BUTYNOIC ACID; 2-CARBAMOYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-CARBOXYETHYL ACRYLATE; 2-CARBOXYL MALONIC ACID; 2-CHLORO-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 2-CHLORO-2-FLUORO-CYCLOPROPANECARBONIC ACID; 2-CHLORO-3-FUROIC ACID; 2-CHLORO-3-HYDROXYBUTANOIC ACID; 2-CHLORO-3-METHOXYPROPIONIC ACID; 2-CHLORO-3-METHYLBUTANOIC ACID; 2-CHLOROACRYLIC ACID; 2-CHLOROBUTYRIC ACID; 2-CHLOROCYCLOPENT-1-ENE-1-CARBOXYLIC ACID; 2-CHLOROFURAN-4-CARBOXYLIC ACID; 2-CHLOROOXAZOLE-4-CARBOXYLIC ACID; 2-CHLOROPROPIONIC ACID; 2-CHLOROPROPIONIC ACID, [1-14C]; 2-CYANO-2-ETHYLBUTANOIC ACID; 2-CYANO-2-HEXENOIC ACID; 2-CYANO-2-METHYLACETIC ACID; 2-CYANO-2-METHYLPROPANOIC ACID; 2-CYANO-3-METHYL-BUT-2-ENOIC ACID; 2-CYANO-3-METHYLBUTANOIC ACID; 2-CYANO-4-METHYLPENTANOIC ACID; 2-CYANO-4-PYRIDINE CARBOXYLIC ACID; 2-CYANOBENZOIC ACID; 2-CYANOBUTANOIC ACID; 2-CYANO-OXAZOLE-4-CARBOXYLIC ACID; 2-CYANOPYRIDINE-3-CARBOXYLIC ACID; 2-CYANOPYRIMIDINE-5-CARBOXYLIC ACID; 2-CYCLOHEXYLIDENEACETIC ACID; 2-CYCLOPENTANONE CARBOXYLATE; 2-CYCLOPENTENE-1-ACETIC ACID; 2-CYCLOPENTENE-1-CARBOXYLIC ACID; 2-CYCLOPENTENE-1-CARBOXYLIC ACID, 4-AMINO-; 2-CYCLOPENTYL-2-HYDROXYACETIC ACID; 2-CYCLOPENTYLIDENEACETIC ACID; 2-CYCLOPENTYLIDENEPROPANOIC ACID; 2-CYCLOPENTYLPROPANOIC ACID; 2-CYCLOPROPYL-2-(ETHYLAMINO)ACETIC ACID; 2-CYCLOPROPYL-2-(METHYLAMINO)ACETIC ACID; 2-CYCLOPROPYL-2-(METHYLAMINO)PROPANOIC ACID; 2-CYCLOPROPYL-2-FORMAMIDOACETIC ACID; 2-CYCLOPROPYL-2-HYDROXYACETIC ACID; 2-CYCLOPROPYL-2-HYDROXYPROPANOIC ACID; 2-CYCLOPROPYL-2-METHOXYPROPANOIC ACID; 2-CYCLOPROPYL-2-METHYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-CYCLOPROPYL-2-OXOACETIC ACID; 2-CYCLOPROPYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-CYCLOPROPYLPROPANOIC ACID; 2-ENEVALPROIC ACID; 2-ETHOXY-2,2-DIFLUOROACETIC ACID; 2-ETHOXY-2-METHYLBUTANOIC ACID; 2-ETHOXY-2-METHYLPROPANOIC ACID; 2-ETHOXY-2-OXOACETIC ACID; 2-ETHOXY-3-HYDROXYPROPANOIC ACID; 2-ETHOXY-3-METHOXYPROPANOIC ACID; 2-ETHOXY-3-METHYLBUTANOIC ACID; 2-ETHOXY-3-METHYLCYCLOPROPANECARBOXYLIC ACID; 2-ETHOXY-4-HYDROXYBUTANOIC ACID; 2-ETHOXYBUTANOIC ACID; 2-ETHOXYCYCLOPROPANE-1-CARBOXYLIC ACID; 2-ETHOXYPROPANOIC ACID; 2-ETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID; 2-ETHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-ETHYL-2-(METHYLAMINO)BUTANOIC ACID; 2-ETHYL-2-HEXENOIC ACID; 2-ETHYL-2-HEXENOIC ACID, PREDOMINANTLY TRANS; 2-ETHYL-2-HYDROXYBUTYRIC ACID; 2-ETHYL-2-METHOXYBUTANOIC ACID; 2-ETHYL-2-METHYLPENTANOIC ACID; 2-ETHYL-3,3-DIMETHYL-2-OXIRANECARBOXYLIC ACID; 2-ETHYL-3H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-ETHYL-3-HYDROXY-3-METHYLBUTANOIC ACID; 2-ETHYL-3-HYDROXYBUTANOIC ACID; 2-ETHYL-3-HYDROXYPENTANOIC ACID; 2-ETHYL-3-METHYLBUTANOIC ACID; 2-ETHYL-3-METHYLPENTANOIC ACID; 2-ETHYL-4-METHOXYBUTANOIC ACID; 2-ETHYL-4-METHYLPENTANOIC ACID; 2-ETHYLACRYLIC ACID; 2-ETHYLBUTYRIC ACID; 2-ETHYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-ETHYLHEXANOIC ACID; 2-ETHYLPENTANOIC ACID; 2-ETHYLPROLINE; 2-ETHYLSUCCINIC ACID; 2-ETHYNYL-BENZOIC ACID; 2-FLUORO-1,3-THIAZOLE-4-CARBOXYLIC ACID; 2-FLUORO-3-METHYLBUTYRIC ACID; 2-FLUORO-3-OXOBUTANOIC ACID; 2-FLUOROACRYLIC ACID; 2-FLUOROBENZOIC ACID; 2-FLUORO-BETA-ALANINE HYDROCHLORIDE; 2-FLUOROISOBUTYRIC ACID; 2-FLUORO-L-PROLINE; 2-FLUORONICOTINIC ACID; 2-FLUORO-OXAZOLE-4-CARBOXYLIC ACID; 2-FLUOROPROPIONIC ACID; 2-FLUOROPYRIDINE-4-CARBOXYLIC ACID; 2-FLUORO-THIAZOLE-5-CARBOXYLIC ACID; 2-FORMAMIDO-2-METHYLPROPANOIC ACID; 2-FORMYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-FORMYLCYCLOPENT-2-ENECARBOXYLIC ACID; 2-FURANACETIC ACID, TETRAHYDRO-5-OXO-; 2-FUROIC ACID; 2-FURYLACETIC ACID; 2-GUANIDINOPROPIONIC ACID; 2-GUANIDINO-PROPIONIC ACID; 2H-1,2,3-TRIAZOLE-2-ACETIC ACID; 2-HEPTENOIC ACID; 2-HEPTYNOIC ACID; 2-HEXYNOIC ACID; 2H-PYRAN-2-ONE-6-CARBOXYLIC ACID; 2H-PYRAZOLE-3-CARBOXYLIC ACID; 2H-PYRROLE-2-CARBOXYLIC ACID, 5-AMINO-3,4-DIHYDRO-4-METHYLENE-, (2S)-; 2H-PYRROLE-2-CARBOXYLIC ACID, 5-AMINO-3,4-DIHYDRO-; 2H-PYRROLE-2-CARBOXYLIC ACID, 5-AMINO-3,4-DIHYDRO-,(2R)-; 2H-TETRAZOL-2-YLACETIC ACID; 2H-TETRAZOLE-5-CARBOXYLIC ACID; 2-HYDRAZINO-3-METHYLBUTANOIC ACID; 2-HYDRAZINOBUTANOIC ACID; 2-HYDRAZINYLACETIC ACID; 2-HYDROXY-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-HYDROXY-2,3-DIMETHYLBUTANOIC ACID; 2-HYDROXY-2,4-DIMETHYLPENTANOIC ACID; 2-HYDROXY-2-METHYL-3-OXOBUTANOIC ACID; 2-HYDROXY-2-METHYL-BUT-3-ENOIC ACID; 2-HYDROXY-2-METHYLBUTYRIC ACID; 2-HYDROXY-2-METHYLPENTANOIC ACID; 2-HYDROXY-3,3-DIMETHYLBUTANOIC ACID; 2-HYDROXY-3-BUTENOIC ACID; 2-HYDROXY-3-BUTYNOIC ACID; 2-HYDROXY-3-METHYL-3-BUTEN-1-OIC ACID; 2-HYDROXY-3-METHYLBUTYRIC ACID; 2-HYDROXY-3-METHYLHEXANOIC ACID; 2-HYDROXY-3-METHYLPENTANOIC ACID; 2-HYDROXY-3-NITRO-PROPANOIC ACID; 2-HYDROXY-3-PYRAZINECARBOXYLIC ACID; 2-HYDROXY-4,4-DIMETHYLPENTANOIC ACID; 2-HYDROXY-4-AMINO BUTANOIC ACID; 2-HYDROXY-4-METHOXY-2-METHYLBUTANOIC ACID; 2-HYDROXY-5-THIAZOLECARBOXYLIC ACID; 2-HYDROXYAMINO-BUTYRIC ACID; 2-HYDROXYAMINO-PENTANOIC ACID; 2-HYDROXYCYCLOHEXANECARBOXYLIC ACID; 2-HYDROXYHEPTANOIC ACID; 2-HYDROXYIMINO-BUTYRIC ACID; 2-HYDROXYISOBUTYRIC ACID; 2-HYDROXYISONICOTINIC ACID; 2-HYDROXYNICOTINIC ACID; 2-HYDROXY-PENT-4-ENOIC ACID; 2-HYDROXYPYRIMIDINE-4-CARBOXYLIC ACID; 2-HYDROXYPYRIMIDINE-5-CARBOXYLIC ACID; 2-HYDROXYVALERIC ACID; 2-IMIDAZOLIDONE-4-CARBOXYLIC ACID; 2-ISOBUTOXYACETIC ACID; 2-ISOBUTYLAMINO-PROPIONIC ACID; 2-ISOPROPOXYPROPANOIC ACID; 2-KETOGLUTARIC ACID; 2-MERCAPTO-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 2-MERCAPTOBUTYRIC ACID; 2-MERCAPTOISOBUTYRIC ACID; 2-MERCAPTOPROPIONIC ACID; 2-METHANESULFINYLACETIC ACID; 2-METHANESULFINYLPROPANOIC ACID; 2-METHOXY-2-METHYLBUTANOIC ACID; 2-METHOXY-2-METHYLPENTANOIC ACID; 2-METHOXY-2-METHYLPROPANOIC ACID; 2-METHOXYBUTANOIC ACID; 2-METHOXYCROTONIC ACID; 2-METHOXYPENTANOIC ACID; 2-METHOXYPROPANOIC ACID; 2-METHYL CYCLOBUTANECARBOXYLIC ACID; 2-METHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID; 2-METHYL-1,3-OXAZOLE-5-CARBOXYLIC ACID; 2-METHYL-1,3-THIAZOLE-4-CARBOXYLIC ACID; 2-METHYL-1,3-THIAZOLE-5-CARBOXYLIC ACID; 2-METHYL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID; 2-METHYL-1,4,5,6-TETRAHYDROPYRIMIDINE-4-CARBOXYLIC ACID; 2-METHYL-1-CYCLOHEXANECARBOXYLIC ACID; 2-METHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-METHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID HYDRATE; 2-METHYL-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 2-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 2-METHYL-2-(METHYLAMINO)BUTANOIC ACID; 2-METHYL-2-(METHYLAMINO)PENTANOIC ACID; 2-METHYL-2-(METHYLSULFANYL)BUTANOIC ACID; 2-METHYL-2-(METHYLSULFANYL)PROPANOIC ACID; 2-METHYL-2-(N-METHYLFORMAMIDO)PROPANOIC ACID; 2-METHYL-2-(PROP-2-EN-1-YLAMINO)PROPANOIC ACID; 2-METHYL-2-(PROP-2-EN-1-YLOXY)PROPANOIC ACID; 2-METHYL-2-(PROP-2-YN-1-YLAMINO)PROPANOIC ACID; 2-METHYL-2-(PROPAN-2-YL)CYCLOPROPANE-1-CARBOXYLIC ACID; 2-METHYL-2-(PROPAN-2-YLAMINO)PROPANOIC ACID; 2-METHYL-2-(PROPAN-2-YLOXY)PROPANOIC ACID; 2-METHYL-2-(PROPYLAMINO)PROPANOIC ACID; 2-METHYL-2-ETHYLBUTYRIC ACID; 2-METHYL-2-HEPTENOIC ACID; 2-METHYL-2-HEXENOIC ACID; 2-METHYL-2-PENTENOIC ACID; 2-METHYL-2-PIPERIDINECARBOXYLIC ACID; 2-METHYL-2-PROPOXYPROPANOIC ACID; 2-METHYL-2-PROPYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-METHYL-2-THIAZOLIDINECARBOXYLIC ACID; 2-METHYL-3-(METHYLAMINO)PROPANOIC ACID; 2-METHYL-3-(METHYLSULFANYL)PROPANOIC ACID; 2-METHYL-3-(PROP-2-EN-1-YLAMINO)PROPANOIC ACID; 2-METHYL-3-(PROP-2-YN-1-YLAMINO)PROPANOIC ACID; 2-METHYL-3-(PROPAN-2-YLAMINO)PROPANOIC ACID; 2-METHYL-3-(PROPYLAMINO)PROPANOIC ACID; 2-METHYL-3-BUTENOIC ACID; 2-METHYL-3-CYCLOHEXENE-1-CARBOXYLIC ACID; 2-METHYL-3-FUROIC ACID; 2-METHYL-3-HYDROXYBUTYRIC ACID; 2-METHYL-3-PENTENOIC ACID; 2-METHYL-4,5-DIHYDRO-FURAN-3-CARBOXYLIC ACID; 2-METHYL-4,5-DIHYDROOXAZOLE-4-CARBOXYLIC ACID; 2-METHYL-4,5-DIHYDROTHIOPHENE-3-CARBOXYLIC ACID; 2-METHYL-4-OXOHEXANOIC ACID; 2-METHYL-4-OXOPENTANOIC ACID; 2-METHYL-4-PENTENOIC ACID; 2-METHYLACETOACETIC ACID; 2-METHYLBUTYRIC ACID; 2-METHYLCYCLOPENTANECARBOXYLIC ACID; 2-METHYLCYCLOPROPANECARBOXYLIC ACID; 2-METHYL-CYSTEINE; 2-METHYL-D-SERINE; 2-METHYLENECYCLOPROPANECARBOXYLIC ACID; 2-METHYLENE-PENTANEDIOIC ACID; 2-METHYLENE-SUCCINIC ACID 1-METHYL ESTER; 2-METHYLGLUTARIC ACID; 2-METHYLHEPTANOIC ACID; 2-METHYLHEXANOIC ACID; 2-METHYLISONICOTINIC ACID; 2-METHYLISOXAZOLE-4-CARBOXYLIC ACID; 2-METHYL-L-SERINE; 2-METHYLNICOTINIC ACID; 2-METHYL-PIPERIDINE-3-CARBOXYLIC ACID; 2-METHYLPROLINE; 2-METHYLPYRIMIDINE-4-CARBOXYLIC ACID; 2-METHYLPYRIMIDINE-5-CARBOXYLIC ACID; 2-METHYLTETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID; 2-METHYL-TETRAHYDRO-FURAN-2-CARBOXYLIC ACID; 2-METHYLTHIOPHENE-3-CARBOXYLIC ACID; 2-METHYLVALERIC ACID; 2-MORPHOLINEACETIC ACID; 2-NITROCYCLOPROPANECARBOXYLIC ACID; 2-OCTYNOIC ACID; 2-OXA-BICYCLO[2.1.1]HEXANE-5-CARBOXYLIC ACID; 2-OXA-BICYCLO[3.1.0]HEX-3-ENE-6-CARBOXYLIC ACID; 2-OXABICYCLO[3.1.0]HEXANE-6-CARBOXYLIC ACID; 2-OXABICYCLO[4.1.0]HEPTANE-7-CARBOXYLIC ACID; 2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 2-OXO-1,2-DIHYDROPYRIDINE-4-CARBOXYLIC ACID; 2-OXO-1,3-OXAZOLIDINE-4-CARBOXYLIC ACID; 2′-OXO-1H-PYRROLE-3-ACETIC ACID; 2-OXO-2-(1H-PYRROL-2-YL)ACETIC ACID; 2-OXO-2,3-DIHYDRO-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-OXO-2H-PYRAN-3-CARBOXYLIC ACID; 2-OXO-3H-PYRIMIDINE-4-CARBOXYLIC ACID; 2-OXO-3-OXA-BICYCLO[3.1.0]HEXANE-1-CARBOXYLIC ACID; 2-OXOBUTYRIC ACID; 2-OXOCYCLOHEXANECARBOXYLIC ACID; 2-OXOCYCLOPENTANEACETIC ACID; 2-OXOPENTANOIC ACID; 2-OXO-PIPERIDINE-3-CARBOXYLIC ACID; 2-OXOPIPERIDINE-4-CARBOXYLIC ACID; 2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; 2-PENTYNOIC ACID; 2-PIPERIDINE ACETIC ACID; 2-PROPOXYACETIC ACID; 2-PROPOXYBUTANOIC ACID; 2-PROPOXYPROPANOIC ACID; 2-PROPYL-3-PENTENOIC ACID; 2-PROPYL-3-PENTYNOIC ACID; 2-PROPYL-4-PENTENOIC ACID; 2-PROPYLACRYLIC ACID; 2-PROPYLCYCLOPROPANE-1-CARBOXYLIC ACID; 2-PYRAZINE ACETIC ACID; 2-PYRAZINECARBOXYLIC ACID; 2-PYRAZINECARBOXYLIC ACID 4-OXIDE; 2-PYRAZINECARBOXYLIC ACID, 5-FLUORO-; 2-PYRIDINECARBOXYLIC ACID, HYDRATE; 2-PYRIDINECARBOXYLIC ACID, 6-AMINO-2,3-DIHYDRO-; 2-PYRIDYLACETIC ACID; 2-PYRIMIDINEACETIC ACID; 2-PYRROLIDIN-1-YLPROPANOIC ACID; 2-PYRROLIDINYL ACETIC ACID; 2R,3R-2-METHYL-PIPERIDINE-3-CARBOXYLIC ACID; 2S,3R-2-METHYL-PIPERIDINE-3-CARBOXYLIC ACID; 2S,3S-2-METHYL-PIPERIDINE-3-CARBOXYLIC ACID; 2-SULFANYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-SULFANYLCYCLOPENTANE-1-CARBOXYLIC ACID; 2-TETRAHYDROFUROIC ACID; 2-THIABICYCLO[3.1.0]HEX-3-ENE-6-CARBOXYLIC ACID; 2-THIOPHENEACETIC ACID; 2-THIOPHENECARBOXYLIC ACID; 2-THIOPHENECARBOXYLIC ACID, [CARBOXYL-14C]; 2-THIOPHENECARBOXYLIC ACID, 4-FLUORO-; 2-THIOPHENECARBOXYLIC ACID, 5-AMINO-; 3-(1,2,3,4-TETRAAZOL-2-YL)PROPANOIC ACID; 3-(1,2,4-OXADIAZOL-3-YL)PROPANOIC ACID; 3-(1,2,4-OXADIAZOL-5-YL)PROPANOIC ACID; 3-(1,2,5-OXADIAZOL-3-YL)PROPANOIC ACID; 3-(1,3-OXAZOL-2-YL)PROPANOIC ACID; 3-(1H-[1,2,3]TRIAZOL-4-YL)-PROPIONIC ACID; 3-(1H-1,2,3-TRIAZOL-1-YL)PROPANOIC ACID; 3-(1H-1,2,4-TRIAZOL-1-YL)PROPANOIC ACID; 3-(1H-1,2,4-TRIAZOL-3-YL)PROPANOIC ACID; 3-(1H-IMIDAZOL-1-YL)PROPANOIC ACID; 3-(1H-IMIDAZOL-2-YL)-ACRYLIC ACID; 3-(1H-IMIDAZOL-2-YL)-PROPIONIC ACID; 3-(1H-PYRAZOL-1-YL)PROPANOIC ACID; 3-(1H-PYRAZOL-4-YL)-ACRYLIC ACID; 3-(1H-PYRAZOL-4-YL)PROPANOIC ACID; 3-(1H-PYRAZOL-5-YL)PROPANOIC ACID; 3-(1H-PYRROL-1-YL)PROPANOIC ACID; 3-(1H-PYRROL-2-YL)PROPANOIC ACID; 3-(1H-TETRAZOL-1-YL)PROPANOIC ACID; 3-(1H-TETRAZOL-5-YL)PROPANOIC ACID; 3-(1-METHYLCYCLOPROPYL)PROPANOIC ACID; 3-(2-FURYL)ACRYLIC ACID; 3-(2-FURYL)PROP-2-YNOIC ACID; 3-(2-FURYL)PROPANOIC ACID; 3-(2-HYDROXYETHOXY)PROPANOIC ACID; 3-(2-METHOXYETHOXY)PROPANOIC ACID; 3-(2-METHYLPROPOXY)PROPANOIC ACID; 3-(2-PYRIDYL)ACRYLIC ACID; 3-(2-PYRIDYL)PROP-2-YNOIC ACID; 3-(3,3-DIMETHYL-2-OXIRANYLIDENE)-PROPANOIC ACID; 3-(3-FURYL)ACRYLIC ACID; 3-(3-HYDROXYAZETIDIN-1-YL)PROPANOIC ACID; 3-(3-HYDROXYPROPOXY)PROPANOIC ACID; 3-(3-PYRIDYL)ACRYLIC ACID; 3-(4H-1,2,4-TRIAZOL-4-YL)PROPANOIC ACID; 3-(4-PYRIDYL)ACRYLIC ACID; 3-(ACETYLOXY)-2-AMINOPROPANOIC ACID; 3-(ACETYLTHIO)PROPIONIC ACID; 3-(AMINOMETHYL)-OXOLANE-3-CARBOXYLIC ACID; 3-(BUT-2-EN-1-YLOXY)PROPANOIC ACID; 3-(BUT-3-EN-1-YLOXY)PROPANOIC ACID; 3-(BUT-3-EN-2-YLAMINO)PROPANOIC ACID; 3-(BUT-3-YN-1-YLAMINO)PROPANOIC ACID; 3-(BUTAN-2-YLAMINO)PROPANOIC ACID; 3-(BUTAN-2-YLOXY)PROPANOIC ACID; 3-(BUTYLAMINO)PROPANOIC ACID; 3-(CARBAMOYLAMINO)-2-METHYLPROPANOIC ACID; 3-(CARBAMOYLAMINO)BUTANOIC ACID; 3-(CARBOXYMETHYL)-1,2,3-OXADIAZOL-3-IUM-5-OLATE; 3-(CARBOXYMETHYL)-1,3-THIAZOL-3-IUM; 3-(CYCLOBUTYLAMINO)PROPANOIC ACID; 3-(CYCLOPROPYLAMINO)-2-METHYLPROPANOIC ACID; 3-(CYCLOPROPYLAMINO)-2-PROPENOIC ACID; 3-(CYCLOPROPYLAMINO)BUTANOIC ACID; 3-(CYCLOPROPYLMETHOXY)PROPANOIC ACID; 3-(DIETHYLAMINO)PROPANOIC ACID; 3-(DIMETHYLAMINO)-2-(METHYLAMINO)PROPANOIC ACID; 3-(DIMETHYLAMINO)-2-METHYLPROPANOIC ACID; 3-(DIMETHYLAMINO)BUTANOIC ACID; 3-(DIMETHYLAMINO)PENTANOIC ACID; 3-(DIMETHYLAMINO)PROPANOIC ACID; 3-(ETHYLAMINO)-2-METHYLPROPANOIC ACID; 3-(ETHYLAMINO)BUTANOIC ACID; 3-(ETHYLAMINO)PROPANOIC ACID; 3-(ETHYLCARBAMOYL)PROPANOIC ACID; 3-(ETHYLSULFANYL)-2-METHYLPROPANOIC ACID; 3-(ETHYLSULFANYL)BUTANOIC ACID; 3-(ETHYLTHIO)PROPANOIC ACID; 3-(FURAN-3-YL)PROPANOIC ACID; 3-(HYDROXYAMINO)ALANINE-15N; 3-(HYDROXYMETHYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-(HYDROXYMETHYL)CYCLOBUTANECARBOXYLIC ACID; 3-(HYDROXYMETHYL)-CYCLOPENTANECARBOXYLIC ACID; 3-(HYDROXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-(IMIDAZOL-4-YL)PROPIONIC ACID; 3-(ISOBUTYLAMINO)PROPANOIC ACID; 3-(ISOPROPYLAMINO)PROPANOIC ACID; 3-(ISOPROPYL-METHYL-AMINO)-PROPIONIC ACID; 3-(ISOPROPYLTHIO)PROPANOIC ACID; 3-(ISOXAZOL-4-YL)PROPANOIC ACID; 3-(METHYLAMINO)-3-OXOPROPANOIC ACID; 3-(METHYLAMINO)BUTANOIC ACID; 3-(METHYLAMINO)OXOLANE-3-CARBOXYLIC ACID; 3-(METHYLAMINO)PROPANOIC ACID HYDROCHLORIDE; 3-(METHYLAMINO)PROPIONIC ACID; 3-(METHYLCARBAMOYL)PROP-2-ENOIC ACID; 3-(METHYLSULFANYL)BUTANOIC ACID; 3-(METHYLSULFANYL)PENTANOIC ACID; 3-(N-METHYLAMINO)-L-ALANINE; 3-(N-METHYLFORMAMIDO)PROPANOIC ACID; 3-(N-METHYL-HYDRAZINO)-PROPIONIC ACID; 3-(PROP-2-EN-1-YLAMINO)BUTANOIC ACID; 3-(PROP-2-EN-1-YLAMINO)PROPANOIC ACID; 3-(PROP-2-EN-1-YLSULFANYL)PROPANOIC ACID; 3-(PROP-2-YN-1-YLAMINO)BUTANOIC ACID; 3-(PROP-2-YN-1-YLAMINO)PROPANOIC ACID; 3-(PROP-2-YN-1-YLOXY)PROPANOIC ACID; 3-(PROP-2-YN-1-YLSULFANYL)PROPANOIC ACID; 3-(PROP-2-YNAMIDO)PROPANOIC ACID; 3-(PROPAN-2-YLAMINO)BUTANOIC ACID; 3-(PROPIONYLAMINO)PROPANOIC ACID; 3-(PROPYLAMINO)BUTANOIC ACID; 3-(PROPYLAMINO)PROPANOIC ACID; 3-(PROPYLSULFANYL)PROPANOIC ACID; 3-(PYRROL-3-YL)-PROPIONIC ACID; 3-(TETRAHYDRO-FURAN-2-YL)-PROPIONIC ACID; 3-(TRIMETHYLSILYL)PROPIOLIC ACID; 3,3,3-TRIFLUORO-DL-ALANINE; 3,3,3-TRIFLUOROLACTIC ACID; 3,3,3-TRIFLUOROPROPIONIC ACID; 3,3-DICHLOROACRYLIC ACID; 3,3-DIFLUOROCYCLOBUTANECARBOXYLIC ACID; 3,3-DIFLUOROPROPANOIC ACID; 3,3-DIMETHOXYPROPANOIC ACID; 3,3-DIMETHYL-2-(METHYLAMINO)BUTANOIC ACID; 3,3-DIMETHYL-4-OXOVALERIC ACID; 3,3-DIMETHYL-4-PENTENOIC ACID; 3,3-DIMETHYLACRYLIC ACID; 3,3-DIMETHYLBUTYRIC ACID; 3,3-DIMETHYLCYCLOBUTANECARBOXYLIC ACID; 3,3-DIMETHYLHEXANOIC ACID; 3,3-DIMETHYLPENTANOIC ACID; 3,3-DITHIOPROPIONIC ACID; 3,4,4-TRIMETHYLPENTANOIC ACID; 3,4-DEHYDRO-DL-PROLINE; 3,4-DEHYDRO-D-PROLINE; 3,4-DEHYDRO-L-PROLINE; 3,4-DEHYDRO-L-PROLINE HYDROCHLORIDE; 3,4-DIAMINOBUTYRIC ACID; 3,4-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID; 3,4-DIHYDRO-2H-PYRAN-5-CARBOXYLIC ACID; 3,4-DIHYDRO-2H-PYRROLE-2-CARBOXYLIC ACID; 3,4-DIHYDRO-3-OXO-2-PYRAZINECARBOXYLIC ACID; 3,4-DIHYDRO-4-OXO-2-PYRIMIDINECARBOXYLIC ACID; 3,4-DIMETHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3,4-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 3,4-DIMETHYLHEXANOIC ACID; 3,4-DIMETHYLISOXAZOLE-5-CARBOXYLIC ACID; 3,4-DIMETHYLPENTANOIC ACID; 3,4-EPOXY-2-HYDROXY-VALERIC ACID; 3,4-METHYLENEDIOXYBUTANOIC ACID; 3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 3,5-DIMETHYL-3H-IMIDAZOLE-4-CARBOXYLIC ACID; 3,5-DIMETHYL-4,5-DIHYDROISOXAZOLE-5-CARBOXYLIC ACID; 3,5-DIMETHYL-FURAN-2-CARBOXYLIC ACID; 3,5-DIMETHYLHEXANOIC ACID; 3,5-DIMETHYLISOXAZOLE-4-CARBOXYLIC ACID; 3,6-DIHYDRO-6-OXO-3-PYRIDAZINECARBOXYLIC ACID; 3-[(1-HYDROXYPROPAN-2-YL)AMINO]PROPANOIC ACID; 3-[(2-AMINOETHYL)(METHYL)AMINO]PROPANOIC ACID; 3-[(2-AMINOETHYL)AMINO]PROPANOIC ACID; 3-[(2-AMINOETHYL)SULFANYL]PROPANOIC ACID; 3-[(2-CYANOETHYL)AMINO]PROPANOIC ACID; 3-[(2E)-BUT-2-EN-1-YLAMINO]PROPANOIC ACID; 3-[(2-HYDROXYETHYL)(METHYL)AMINO]PROPANOIC ACID; 3-[(2-HYDROXYETHYL)AMINO]-2-METHYLPROPANOIC ACID; 3-[(2-HYDROXYETHYL)AMINO]BUTANOIC ACID; 3-[(2-HYDROXYETHYL)AMINO]PROPANOIC ACID; 3-[(2-HYDROXYPROPYL)AMINO]PROPANOIC ACID; 3-[(2-METHOXYETHYL)AMINO]PROPANOIC ACID; 3-[(2-METHYLCYCLOPROPYL)AMINO]PROPANOIC ACID; 3-[(2-METHYLPROP-2-EN-1-YL)AMINO]PROPANOIC ACID; 3-[(3-AMINOPROPYL)AMINO]PROPANOIC ACID; 3-[(3-HYDROXYPROPYL)AMINO]PROPANOIC ACID; 3-[(CARBAMOYLMETHYL)AMINO]PROPANOIC ACID; 3-[(CYANOMETHYL)(METHYL)AMINO]PROPANOIC ACID; 3-[(CYANOMETHYL)AMINO]PROPANOIC ACID; 3-[(CYANOMETHYL)SULFANYL]PROPANOIC ACID; 3-[(CYCLOPROPYLMETHYL)AMINO]PROPANOIC ACID; 3-[(METHOXYCARBONYL)AMINO]PROPANOIC ACID; 3-[(METHYLCARBAMOYL)AMINO]PROPANOIC ACID; 3-[1,3]DIOXOLAN-2-YL-PROPIONIC ACID; 3-[ACETYL(METHYL)AMINO]PROPANOIC ACID; 3-[CARBAMOYL(METHYL)AMINO]PROPANOIC ACID; 3-[CYCLOPROPYL(METHYL)AMINO]PROPANOIC ACID; 3-[ETHYL(METHYL)AMINO]-2-METHYLPROPANOIC ACID; 3-[ETHYL(METHYL)AMINO]BUTANOIC ACID; 3-[ETHYL(METHYL)AMINO]PROPANOIC ACID; 3-[METHYL(PROP-2-EN-1-YL)AMINO]PROPANOIC ACID; 3-[METHYL(PROP-2-YN-1-YL)AMINO]PROPANOIC ACID; 3-[METHYL(PROPYL)AMINO]PROPANOIC ACID; 3-ACETAMIDO-2-METHYLPROPANOIC ACID; 3-ACETAMIDOBUTANOIC ACID; 3-ACETYLACRYLIC ACID; 3-ALLYLOXYPROPIONIC ACID; 3-AMINO-1,2,4-TRIAZOLE-5-CARBOXYLIC ACID; 3-AMINO-1,2,4-TRIAZOLE-5-CARBOXYLIC ACID HYDRATE; 3-AMINO-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-AMINO-1H-PYRROLE-2-CARBOXYLIC ACID; 3-AMINO-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-AMINO-1-METHYLPYRROLIDINE-3-CARBOXYLIC ACID; 3-AMINO-2-(CYCLOPROPYLMETHYL)PROPANOIC ACID; 3-AMINO-2,2-DIFLUORO-PROPIONIC ACID; 3-AMINO-2,2-DIMETHYL-PROPANOIC ACID; 3-AMINO-2-CYANOBUT-2-ENOIC ACID; 3-AMINO-2-CYANOPROPIONIC ACID; 3-AMINO-2-HYDROXY-HEXANOIC ACID; 3-AMINO-2-METHYLPROPANOIC ACID HYDROCHLORIDE; 3-AMINO-2-METHYL-PROPIONIC ACID HYDRATE; 3-AMINO-3,6-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID; 3-AMINO-3-CYCLOBUTYL-PROPIONIC ACID; 3-AMINO-3-CYCLOPROPYL-PROPIONIC ACID; 3-AMINO-3-METHYL-BUTYRIC ACID; 3-AMINO-3-METHYLPENTANOIC ACID; 3-AMINO-3-OXOPROPANOIC ACID; 3-AMINO-4-(CARBOXYMETHYL)FURAZANE; 3-AMINO-4-(METHYLTHIO)-BUTANOIC ACID; 3-AMINO-4,4-DIMETHYL-PENTANOIC ACID; 3-AMINO-4-HYDROXYBUTYRIC ACID; 3-AMINO-4-METHYLHEXANOIC ACID; 3-AMINO-4-METHYL-PENT-4-ENOIC ACID; 3-AMINO-4-METHYLPENTANOIC ACID; 3-AMINO-4-OXO-PENTANOIC ACID; 3-AMINO-4-PYRIDAZINECARBOXYLIC ACID; 3-AMINO-4-PYRROLECARBOXYLIC ACID; 3-AMINO-5-ISOXAZOLECARBOXYLIC ACID; 3-AMINO-5-METHYLHEXANOIC ACID; 3-AMINOAZETIDINE-3-CARBOXYLIC ACID; 3-AMINOBENZOIC ACID; 3-AMINOCYCLOBUTANECARBOXYLIC ACID; 3-AMINOCYCLOHEXANECARBOXYLIC ACID; 3-AMINOCYCLOPENTANECARBOXYLIC ACID; 3-AMINOFURAN-2-CARBOXYLIC ACID; 3-AMINOHEPTANOIC ACID; 3-AMINO-HEXANOIC ACID; 3-AMINOISONICOTINIC ACID; 3-AMINOISOTHIAZOLE-4-CARBOXYLIC ACID; 3-AMINO-L-ALANINE HYDROCHLORIDE; 3-AMINOMETHYL-FURAN-2-CARBOXYLIC ACID; 3-AMINOOXETANE-3-CARBOXYLIC ACID; 3-AMINOPENTANE-3-CARBOXYLIC ACID; 3-AMINOPENTANEDIOIC ACID; 3-AMINO-PENTANOIC ACID; 3-AMINOPYRAZINE-2-CARBOXYLIC ACID; 3-AMINOPYRAZOLE-4-CARBOXYLIC ACID; 3-AMINOPYRIDINE-2-CARBOXYLIC ACID; 3-AMINOPYRROLIDINE-3-CARBOXYLIC ACID; 3-AMINOTETRAHYDRO-2H-PYRAN-3-CARBOXYLIC ACID; 3-AMINO-TETRAHYDRO-FURAN-2-CARBOXYLIC ACID; 3-AMINOTETRAHYDROFURAN-3-CARBOXYLIC ACID; 3-AMINO-TETRAHYDRO-THIOPHENE-2-CARBOXYLIC ACID; 3-AMINO-TETRAHYDRO-THIOPHENE-3-CARBOXYLIC ACID; 3-AMINOTHIETANE-3-CARBOXYLIC ACID; 3-AMINOTHIOPHENE-2-CARBOXYLIC ACID; 3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID; 3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLIC ACID; 3-AZIDO-2-METHYLPROPANOIC ACID; 3-AZIDO-3-METHYLBUTYRIC ACID; 3-AZIDOBUTANOIC ACID; 3-AZIDOPROPANOIC ACID; 3-BUTOXYPROPANOIC ACID; 3-BUTYNOIC ACID; 3-CARBAMOYL-2,3-DIMETHYLPROP-2-ENOIC ACID; 3-CARBAMOYLPROP-2-ENOIC ACID; 3-CARBOXY-1,1-DIMETHYL-, (E)-2-PROPENYL; 3-CARBOXY-1-METHYLPYRIDINIUM; 3-CHLORO-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-CHLORO-1H-PYRROLE-2-CARBOXYLIC ACID; 3-CHLORO-2,2-DIMETHYLBUT-3-ENOIC ACID; 3-CHLORO-2,2-DIMETHYLPROPIONIC ACID; 3-CHLORO-2-OXOPROPANOIC ACID; 3-CHLOROBUTYRIC ACID; 3-CHLOROCROTONIC ACID; 3-CHLOROCYCLOBUTANECARBOXYLIC ACID; 3-CHLOROFURAN-2-CARBOXYLIC ACID; 3-CHLOROFURAN-4-CARBOXYLIC ACID; 3-CHLOROISOXAZOLE-5-CARBOXYLIC ACID; 3-CHLORO-L-ALANINE; 3-CHLOROPROPIONIC ACID; 3-CYANOBENZOIC ACID; 3-CYANOISONICOTINIC ACID; 3-CYANOPROPANOIC ACID; 3-CYANOPYRIDINE-2-CARBOXYLIC ACID; 3-CYCLOHEXENE-1-CARBOXYLIC ACID; 3-CYCLOPENT-1-ENYL-ACRYLIC ACID; 3-CYCLOPENTENE-1-CARBOXYLIC ACID; 3-CYCLOPENTYLPROPIONIC ACID; 3-CYCLOPROPYL-2,2-DIMETHYL-PROPIONIC ACID; 3-CYCLOPROPYL-2-METHYL-PROPIONIC ACID; 3-CYCLOPROPYL-3-HYDROXY-2-METHYLPROPANOIC ACID; 3-CYCLOPROPYL-3-HYDROXYBUTANOIC ACID; 3-CYCLOPROPYL-3-HYDROXYPROPANOIC ACID; 3-CYCLOPROPYL-3-OXO-PROPIONIC ACID; 3-CYCLOPROPYLBUTANOIC ACID; 3-CYCLOPROPYLPROP-2-YNOIC ACID; 3-CYCLOPROPYLPROPIONIC ACID; 3-ETHOXY-2-(METHYLAMINO)PROPANOIC ACID; 3-ETHOXY-2-BUTENOIC ACID; 3-ETHOXYACRYLIC ACID; 3-ETHOXYPROPIONIC ACID; 3-ETHYL CYCLOBUTANECARBOXYLIC ACID; 3-ETHYL-1,2,4-OXADIAZOLE-5-CARBOXYLIC ACID; 3-ETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-ETHYL-2-HEXENOIC ACID; 3-ETHYL-2-HYDROXYPENTANOIC ACID; 3-ETHYL-3-HYDROXYPENTANOIC ACID; 3-ETHYL-4,5-DIHYDROISOXAZOLE-5-CARBOXYLIC ACID; 3-ETHYL-4-METHYLPENTANOIC ACID; 3-ETHYLHEXANOIC ACID; 3-ETHYLOXETANE-3-CARBOXYLIC ACID; 3-ETHYLOXOLANE-3-CARBOXYLIC ACID; 3-ETHYLPENT-2-ENOIC ACID; 3-ETHYLPENTANOIC ACID; 3-ETHYLPYRROLIDINE-3-CARBOXYLIC ACID; 3-ETHYNYL-BENZOIC ACID; 3-ETHYNYLPICOLINIC ACID; 3-FLUORO-2,2-DIMETHYLPROPANOIC ACID; 3-FLUORO-2-THIOPHENECARBOXYLIC ACID; 3-FLUOROBENZOIC ACID; 3-FLUOROCYCLOBUTANECARBOXYLIC ACID; 3-FLUORO-DL-ALANINE; 3-FLUORO-DL-NORLEUCINE; 3-FLUORO-DL-VALINE; 3-FLUOROISONICOTINIC ACID; 3-FLUOROPROPANOIC ACID; 3-FLUOROPYRIDINE-2-CARBOXYLIC ACID; 3-FORMAMIDO-2-METHYLPROPANOIC ACID; 3-FORMAMIDOPROPANOIC ACID; 3-FORMYL-2-FUROIC ACID; 3-FUROIC ACID; 3-FURYL(OXO)ACETIC ACID; 3-GUANIDINOPROPIONIC ACID; 3H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID, 5-AMINO-; 3-HEPTENOIC ACID; 3H-TETRAFLUOROPROPIONIC ACID; 3-HYDROXY-1H-PYRROLE-2-CARBOXYLIC ACID; 3-HYDROXY-1-METHYLPYRROLIDINE-3-CARBOXYLIC ACID; 3-HYDROXY-2-(PROPAN-2-YL)BUTANOIC ACID; 3-HYDROXY-2,2,3-TRIMETHYLBUTANOIC ACID; 3-HYDROXY-2,2-DIMETHYLBUTANOIC ACID; 3-HYDROXY-2,2-DIMETHYLPENTANOIC ACID; 3-HYDROXY-2,3-DIMETHYLBUTANOIC ACID; 3-HYDROXY-2,3-DIMETHYLPENTANOIC ACID; 3-HYDROXY-2,4-DIMETHYLPENTANOIC ACID; 3-HYDROXY-2-METHYLHEXANOIC ACID; 3-HYDROXY-2-METHYLPENTANOIC ACID; 3-HYDROXY-2-METHYLPROPANOIC ACID; 3-HYDROXY-2-OXOPROPANOIC ACID; 3-HYDROXY-3,4-DIMETHYLPENTANOIC ACID; 3-HYDROXY-3-METHYLCYCLOBUTANECARBOXYLIC ACID; 3-HYDROXY-3-METHYL-N-VALERIC ACID; 3-HYDROXY-4,4-DIMETHYLPENTANOIC ACID; 3-HYDROXY-4-METHYLHEXANOIC ACID; 3-HYDROXY-4-METHYLPENTANOIC ACID; 3-HYDROXY-4-PYRIDINECARBOXYLIC ACID; 3-HYDROXY-5-METHYLHEXANOIC ACID; 3-HYDROXYASPARTIC ACID; 3-HYDROXYBENZOIC ACID; 3-HYDROXYBUTYRIC ACID; 3-HYDROXYCYCLOBUTANECARBOXYLIC ACID; 3-HYDROXY-CYCLOPENTANECARBOXYLIC ACID; 3-HYDROXYGLUTARIC ACID; 3-HYDROXYHEXANOIC ACID; 3-HYDROXYISOXAZOLE-5-CARBOXYLIC ACID; 3-HYDROXY-N-METHYLVALINE; 3-HYDROXYOXOLANE-3-CARBOXYLIC ACID; 3-HYDROXYPENT-4-ENOIC ACID; 3-HYDROXYPICOLINIC ACID; 3-HYDROXYPROPIONIC ACID; 3-HYDROXYTETRAHYDRO-3-THIOPHENECARBOXYLIC ACID; 3-HYDROXYTHIOPHENE-2-CARBOXYLIC ACID; 3-ISOPROPOXY-3-OXOPROPANOIC ACID; 3-ISOPROPOXYPROPANOIC ACID; 3-ISOPROPYL-CYCLOBUTANECARBOXYLIC ACID; 3-ISOTHIOUREIDOPROPIONIC ACID; 3-ISOXAZOL-3-YLPROPANOIC ACID; 3-ISOXAZOL-5-YLPROPANOIC ACID; 3-ISOXAZOLEACETIC ACID; 3-ISOXAZOLEACETIC ACID, 5-HYDROXY-; 3-ISOXAZOLECARBOXYLIC ACID; 3-ISOXAZOLIDIN-2-YLPROPANOIC ACID; 3-MERCAPTOISOBUTYRIC ACID; 3-MERCAPTOPROPIONIC ACID; 3-METHANESULFINYLPROPANOIC ACID; 3-METHOXY-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-METHOXY-2-(METHYLAMINO)PROPANOIC ACID; 3-METHOXY-2,2-DIMETHYLPROPANOIC ACID; 3-METHOXY-2-FUROIC ACID; 3-METHOXY-2-METHYL-2-(METHYLAMINO)PROPANOIC ACID; 3-METHOXY-2-METHYL-3-OXOPROPANOIC ACID; 3-METHOXY-2-METHYLPROPANOIC ACID; 3-METHOXYBUT-2-ENOIC ACID; 3-METHOXYBUTYRIC ACID; 3-METHOXYCYCLOBUTANECARBOXYLIC ACID; 3-METHOXY-ISOXAZOLE-5-CARBOXYLIC ACID; 3-METHOXYPROPIONIC ACID; 3-METHOXYVALINE; 3-METHYL-1,2,4-OXADIAZOLE-5-CARBOXYLIC ACID; 3-METHYL-1-CYCLOHEXANECARBOXYLIC ACID; 3-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 3-METHYL-2-(METHYLAMINO)PENTANOIC ACID; 3-METHYL-2-(METHYLSULFANYL)BUTANOIC ACID; 3-METHYL-2-FUROIC ACID; 3-METHYL-2-HEXENOIC ACID; 3-METHYL-2-OXO-2,3-DIHYDRO-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 3-METHYL-2-OXOBUTYRIC ACID; 3-METHYL-2-OXOVALERIC ACID; 3-METHYL-2-PENTENOIC ACID; 3-METHYL-2-SULFANYLBUTANOIC ACID; 3-METHYL-2-THIOPHENECARBOXYLIC ACID; 3-METHYL-4,5-DIHYDROISOXAZOLE-5-CARBOXYLIC ACID; 3-METHYL-4-ISOXAZOLECARBOXYLIC ACID; 3-METHYL-4-OXO-2-PENTENOIC ACID; 3-METHYL-4-OXOHEXANOIC ACID; 3-METHYL-4-PENTENOIC ACID; 3-METHYL-4-PIPERIDINECARBOXYLIC ACID; 3-METHYL-4-PYRIDAZINECARBOXYLIC ACID; 3-METHYL-4-PYRIDINECARBOXYLIC ACID; 3-METHYL-5,6-DIHYDRO-1,4-DIOXINE-2-CARBOXYLIC ACID; 3-METHYL-5-ISOXAZOLEACETIC ACID; 3-METHYL-5-OXO-4,5-DIHYDRO-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-METHYL-5-OXO-PYRROLIDINE-2-CARBOXYLIC ACID; 3-METHYLBUT-3-ENOIC ACID; 3-METHYL-CYCLOBUTANEACETIC ACID; 3-METHYLCYCLOBUTYLCARBOXYLIC ACID; 3-METHYLENECYCLOBUTANECARBOXYLIC ACID; 3-METHYLENECYCLOPROPANE-TRANS-1,2-DICARBOXYLIC ACID; 3-METHYLENEPENTANEDIOIC ACID; 3-METHYLGLUTACONIC ACID; 3-METHYLGLUTARIC ACID; 3-METHYLHEPTANOIC ACID; 3-METHYLHEXANOIC ACID; 3-METHYLIDENECYCLOPROPANE-1,2-DICARBOXYLIC ACID; 3-METHYLISOTHIAZOLE-4-CARBOXYLIC ACID; 3-METHYLISOTHIAZOLE-5-CARBOXYLIC ACID; 3-METHYLISOXAZOLE-5-CARBOXYLIC ACID; 3-METHYLOXANE-3-CARBOXYLIC ACID; 3-METHYLOXETANE-3-CARBOXYLIC ACID; 3-METHYL-OXOLANE-3-CARBOXYLIC ACID; 3-METHYL-PENT-2-ENOIC ACID; 3-METHYLPENTANOIC ACID; 3-METHYLPICOLINIC ACID; 3-METHYLPIPERAZINE-2-CARBOXYLIC ACID; 3-METHYL-PIPERIDINE-3-CARBOXYLIC ACID; 3-METHYLPROLINE; 3-METHYLPYRAZINE-2-CARBOXYLIC ACID; 3-METHYL-PYRROLIDINE-3-CARBOXYLIC ACID; 3-METHYLTHIOPROPIONIC ACID; 3-MORPHOLINECARBOXYLIC ACID; 3-NITROPROPIONIC ACID; 3-OCTENOIC ACID; 3-OXABICYCLO[3.1.0]HEXANE-6-CARBOXYLIC ACID; 3-OXALURIC ACID; 3-OXAZOL-5-YL-PROPIONIC ACID; 3-OXO-1-CYCLOHEXANECARBOXYLIC ACID; 3-OXO-2,3-DIHYDROISOXAZOLE-5-CARBOXYLIC ACID; 3-OXO-2,3-DIHYDRO-PYRIDAZINE-4-CARBOXYLIC ACID; 3-OXO-2,3-DIHYDROPYRIDINE-5-CARBOXYLIC ACID; 3-OXOCYCLOBUTANECARBOXYLIC ACID; 3-OXOCYCLOPENT-1-ENECARBOXYLIC ACID; 3-OXOCYCLOPENTANECARBOXYLIC ACID; 3-OXOPENTANOIC ACID; 3-OXO-PIPERAZINE-2-CARBOXYLIC ACID; 3-OXO-PIPERIDINE-2-CARBOXYLIC ACID; 3-OXOPROPANOIC ACID; 3-PENTENOIC ACID; 3-PIPERIDINE ACETIC ACID; 3-PROPOXY-PROPIONIC ACID; 3-PYRIDAZINEACETIC ACID; 3-PYRIDIN-3-YLPROP-2-YNOIC ACID; 3-PYRIDIN-4-YLPROP-2-YNOIC ACID; 3-PYRIDINECARBOXYLIC ACID, 5-ETHYNYL-; 3-PYRIDINECARBOXYLIC ACID, HYDRATE; 3-PYRIDYLACETIC ACID; 3-PYRROLIDIN-1-YL-PROPIONIC ACID; 3-PYRROLIDIN-2-YL-PROPIONIC ACID; 3-PYRROLIDINEACETIC ACID; 3-PYRROLIDINECARBOXYLIC ACID, 4-AMINO-; 3-SULFANYLPENTANOIC ACID; 3-TERT-BUTOXYPROPIONIC ACID; 3-TERT-BUTYL-DL-ALANINE; 3-THIOLNORVALINE; 3-THIOPHENEACETIC ACID; 3-THIOPHENECARBOXYLIC ACID; 3-THIOPHENECARBOXYLIC ACID, 2-FLUORO-; 3-THIOPHENECARBOXYLIC ACID, 5-AMINO-; 3-TRIMETHYLSILYLPROPIONIC ACID; 3-UREIDOPROPIONIC ACID; 3-VINYLBENZOIC ACID; 4-(1-METHYLCYCLOPROPYL)BUTANOIC ACID; 4-(2-HYDROXYETHOXY)BUTANOIC ACID; 4-(ALLYLOXY)BUTANOIC ACID; 4-(AMINOMETHYL)-1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID; 4-(CYCLOPROPYLAMINO)BUTANOIC ACID; 4-(DIMETHYLAMINO)-3-HYDROXYBUTANOIC ACID; 4-(DIMETHYLAMINO)BUTANOIC ACID; 4-(DIMETHYLAMINO)PENTANOIC ACID; 4-(ETHYLAMINO)BUTANOIC ACID; 4-(ETHYLSULFANYL)BUTANOIC ACID; 4-(HYDROXYMETHYL)FURAN-2-CARBOXYLIC ACID; 4-(ISOPROPYLAMINO)BUTANOIC ACID; 4-(METHYLAMINO)BUTYRIC ACID; 4-(METHYLAMINO)PYRROLIDINE-2-CARBOXYLIC ACID; 4-(METHYLCARBAMOYL)BUTANOIC ACID; 4-(METHYLSULFANYL)BUTANOIC ACID; 4-(METHYLSULFANYL)PENTANOIC ACID; 4-(PROP-2-EN-1-YLAMINO)BUTANOIC ACID; 4-(PROP-2-YN-1-YLAMINO)BUTANOIC ACID; 4-(PROP-2-YN-1-YLOXY)BUTANOIC ACID; 4-(PROPAN-2-YLOXY)BUTANOIC ACID; 4-(PROPYLAMINO)BUTANOIC ACID; 4,4,4-TRIFLUOROBUT-2-YNOIC ACID; 4,4,4-TRIFLUOROBUTYRIC ACID; 4,4,4-TRIFLUOROCROTONIC ACID; 4,4-DIAMINO-3-OXOPENTANOIC ACID; 4,4-DIFLUORO-2-METHYLBUTANOIC ACID; 4,4-DIFLUORO-BUT-2-ENOIC ACID; 4,4-DIFLUOROBUTANOIC ACID; 4,4-DIFLUOROPENTANOIC ACID; 4,4-DIMETHOXY-BUT-2-ENOIC ACID; 4,4-DIMETHOXYBUTANOIC ACID; 4,4-DIMETHYL-2-OXO-PENTANOIC ACID; 4,4-DIMETHYL-3-OXOPENTANOIC ACID; 4,4-DIMETHYLHEXANOIC ACID; 4,4-DIMETHYLPENTANOIC ACID; 4,4-DIMETHYL-PYRROLIDINE-3-CARBOXYLIC ACID; 4,5-DEHYDRO-LEUCINE; 4,5-DIHYDRO-FURAN-3-CARBOXYLIC ACID; 4,5-DIHYDRO-OXAZOLE-4-CARBOXYLIC ACID; 4,5-DIHYDROTHIAZOLE-5-CARBOXYLIC ACID; 4,5-DIMETHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4,5-DIMETHYL-2-FUROIC ACID; 4,5-DIMETHYL-ISOXAZOLE-3-CARBOXYLIC ACID; 4,5-DIOXOVALERIC ACID; 4,5-EPOXY-2-HEXENOIC ACID; 4-[(2-HYDROXYETHYL)AMINO]BUTANOIC ACID; 4-[(CYANOMETHYL)AMINO]BUTANOIC ACID; 4-[ETHYL(METHYL)AMINO]BUTANOIC ACID; 4-ACETAMIDOBUTYRIC ACID; 4-ACETYLBUTYRIC ACID; 4-AMINO-[1,2,5]THIADIAZOLE-3-CARBOXYLIC ACID; 4-AMINO-1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID; 4-AMINO-1-CYCLOHEXENE-1-CARBOXYLIC ACID; 4-AMINO-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-AMINO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-AMINO-1H-PYRAZOLE-5-CARBOXYLIC ACID; 4-AMINO-1H-PYRROLE-2-CARBOXYLIC ACID; 4-AMINO-1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-AMINO-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 4-AMINO-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-AMINO-2,2-DIFLUOROBUTYRIC ACID; 4-AMINO-2,2-DIMETHYL-BUTYRIC ACID; 4-AMINO-2,4-DIMETHYL-PENTANOIC ACID; 4-AMINO-2-HYDROXY-3,3-DIMETHYLBUTANOIC ACID; 4-AMINO-3,3-DIFLUOROBUTANOIC ACID; 4-AMINO-3,3-DIMETHYLBUTANOIC ACID; 4-AMINO-3,4-DIMETHYL-PENTANOIC ACID; 4-AMINO-3-METHYLISOXAZOLE-5-CARBOXYLIC ACID; 4-AMINO-4-METHYLPENTANOIC ACID; 4-AMINO-5-FLUOROPENTANOIC ACID; 4-AMINO-5-IMIDAZOLECARBOXYLIC ACID; 4-AMINO-5-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-AMINO-5-METHYLFURAN-2-CARBOXYLIC ACID; 4-AMINO-5-METHYLHEXANOIC ACID; 4-AMINOBENZOIC ACID; 4-AMINOBUTANOIC ACID HYDROCHLORIDE; 4-AMINOBUTYRIC ACID; 4-AMINOCYCLOHEMNECARBOXYLIC ACID; 4-AMINO-ISOTHIAZOLE-3-CARBOXYLIC ACID; 4-AMINOMETHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-AMINONICOTINIC ACID; 4-AMINOPIPERIDINE-3-CARBOXYLIC ACID; 4-AMINOPIPERIDINE-4-CARBOXYLIC ACID; 4-AMINO-PYRIDAZINE-3-CARBOXYLIC ACID; 4-AMINOPYRIDINE-2-CARBOXYLIC ACID; 4-AMINOPYRIMIDINE-2-CARBOXYLIC ACID; 4-AMINOPYRIMIDINE-5-CARBOXYLIC ACID; 4-AMINO-TETRAHYDRO-FURAN-3-CARBOXYLIC ACID; 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID; 4-AMINO-TETRAHYDRO-THIOPHENE-3-CARBOXYLIC ACID; 4-AMINOTHIOPHENE-2-CARBOXYLIC ACID; 4-AMINOTHIOPHENE-3-CARBOXYLIC ACID; 4-CARBOXYL BENZOCYCLOBUTENE; 4-CHLORO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-CHLORO-1H-PYRAZOLE-5-CARBOXYLIC ACID; 4-CHLORO-1H-PYRROLE-2-CARBOXYLIC ACID; 4-CHLOROBUTYRIC ACID; 4-CHLOROBUTYRIC ACID, [1-14C]; 4-CHLOROFURAN-2-CARBOXYLIC ACID; 4-CYANO-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-CYANO-1H-PYRROLE-2-CARBOXYLIC ACID; 4-CYANO-2-PYRIDINECARBOXYLIC ACID; 4-CYANO-3-PYRIDINECARBOXYLIC ACID; 4-CYANOBENZOIC ACID; 4-CYANOBENZOIC ACID, [CYANO-14C]; 4-CYANOBUTANOIC ACID; 4-CYCLOHEPTENE-1-CARBOXYLIC ACID; 4-CYCLOPROPYL-4-HYDROXYBUTANOIC ACID; 4-CYCLOPROPYL-4-OXOBUTYRIC ACID; 4-ETHOXY-2-METHYLBUTANOIC ACID; 4-ETHOXY-4-OXOBUTANOIC ACID; 4-ETHOXYBUTANOIC ACID; 4-ETHOXYPENTANOIC ACID; 4-ETHYLHEXANOIC ACID; 4-ETHYNYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-ETHYNYL-BENZOIC ACID; 4-FLUORO-2-AZABICYCLO[2.1.1]HEXANE-1-CARBOXYLIC ACID; 4-FLUORO-2-PYRROLIDINECARBOXYLIC ACID; 4-FLUORO-3-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 4-FLUORO-4-PIPERIDINECARBOXYLIC ACID; 4-FLUOROBENZOIC ACID; 4-FLUOROBUTYRIC ACID; 4-FLUORO-CYCLOHEXANECARBOXYLIC ACID; 4-FLUORO-L-THREONINE; 4-FLUORONICOTINIC ACID; 4-FLUOROPYRIDAZINE-3-CARBOXYLIC ACID; 4-FLUOROPYRIDINE-2-CARBOXYLIC ACID; 4-FLUORO-TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID; 4-FORMAMIDOBUTYRIC ACID; 4-FORMYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-GUANIDINOBUTYRIC ACID; 4H-1,2,4-TRIAZOL-4-YLACETIC ACID; 4H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 4-HEXENOIC ACID; 4-HEXYNOIC ACID, 2-AMINO-, (2R)-; 4-HEXYNOIC ACID, 2-AMINO-, (2S)-; 4H-IMIDAZOLE-5-CARBOXYLIC ACID; 4-HYDROXY-2-METHYLHEXANOIC ACID; 4-HYDROXY-2-METHYLPENTANOIC ACID; 4-HYDROXY-2-PYRROLINE-2-CARBOXYLIC ACID; 4-HYDROXY-2-THIOPHENECARBOXYLIC ACID; 4-HYDROXY-3-METHYLHEXANOIC ACID; 4-HYDROXY-3-METHYLPENTANOIC ACID; 4-HYDROXY-4-METHYLPENT-2-YNOIC ACID; 4-HYDROXY-5-METHYLHEXANOIC ACID; 4-HYDROXYBENZOIC ACID; 4-HYDROXYBENZOIC ACID [CARBOXYL-14C]; 4-HYDROXY-BUT-2-ENOIC ACID; 4-HYDROXY-BUT-2-YNOIC ACID; 4-HYDROXYBUTYRIC ACID; 4-HYDROXYBUTYRIC ACID, [2,3-3H]-; 4-HYDROXYCYCLOHEXANE CARBOXYLIC ACID, [CARBOXYL-14C]; 4-HYDROXYCYCLOHEXANECARBOXYLIC ACID; 4-HYDROXY-DL-PROLINE; 4-HYDROXY-FURAZAN-3-CARBOXYLIC ACID; 4-HYDROXYHEPTANOIC ACID; 4-HYDROXYHEXANOIC ACID; 4-HYDROXYIMINO-PENTANOIC ACID; 4-HYDROXYISOLEUCINE; 4-HYDROXY-L-ISOLEUCINE; 4-HYDROXYMETHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-HYDROXYMETHYL-PYRROLIDINE-3-CARBOXYLIC ACID; 4-HYDROXYNICOTINIC ACID; 4-HYDROXYOXANE-4-CARBOXYLIC ACID; 4-HYDROXYPENTANOIC ACID; 4-HYDROXYPIPECOLIC ACID; 4-HYDROXYPIPERIDINE-4-CARBOXYLIC ACID; 4-HYDROXYPYRIDAZINE-3-CARBOXYLIC ACID; 4-HYDROXYPYRIDINE-2-CARBOXYLIC ACID; 4-HYDROXYPYRIMIDINE-5-CARBOXYLIC ACID; 4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID; 4-HYDROXY-TETRAHYDRO-2-FUROIC ACID; 4-ISOTHIAZOLECARBOXYLIC ACID; 4-MERCAPTO-2-PYRROLIDINECARBOXYLIC ACID; 4-MERCAPTOBUTYRIC ACID; 4-MERCAPTO-PENTANOIC ACID; 4-METHOXY-2-(METHYLAMINO)BUTANOIC ACID; 4-METHOXY-2,2-DIMETHYLBUTANOIC ACID; 4-METHOXY-2-METHYLBUTANOIC ACID; 4-METHOXYBUTANOIC ACID; 4-METHOXYPENTANOIC ACID; 4-METHOXY-PYRROLIDINE-3-CARBOXYLIC ACID; 4-METHYL HYDROGEN L-ASPARTATE; 4-METHYL PYRIDINE-2-CARBOXYLIC ACID, [CARBOXYL-14C]; 4-METHYL-1,2,3-THIADIAZOLE-5-CARBOXYLIC ACID; 4-METHYL-1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID; 4-METHYL-1,3-OXAZOLE-5-CARBOXYLIC ACID; 4-METHYL-1-CYCLOHEXANECARBOXYLIC ACID; 4-METHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-METHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID HYDRATE; 4-METHYL-1H-IMIDAZOLE-5-CARBOXYLIC ACID; 4-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-METHYL-2,5-CYCLOHEXADIENE-1-CARBOXYLIC ACID; 4-METHYL-2-OXOVALERIC ACID; 4-METHYL-2-PENTENOIC ACID; 4-METHYL-2-PENTYNOIC ACID; 4-METHYL-2-PYRIMIDINECARBOXYLIC ACID; 4-METHYL-2-PYRROLIDINE CARBOXYLIC ACID; 4-METHYL-2-THIOPHENECARBOXYLIC ACID; 4-METHYL-3-FURANCARBOXYLIC ACID; 4-METHYL-3-PENTENOIC ACID; 4-METHYL-3-PYRIDAZINECARBOXYLIC ACID; 4-METHYL-3-PYRROLIDINECARBOXYLIC ACID; 4-METHYL-4H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 4-METHYL-5-ISOTHIAZOLECARBOXYLIC ACID; 4-METHYL-5-OXO-2,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-METHYL-5-OXO-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-METHYL-5-OXOTETRAHYDRO-3-FURANCARBOXYLIC ACID; 4-METHYL-5-OXY-FURAZAN-3-CARBOXYLIC ACID; 4-METHYLBICYCLO[3.1.0]HEX-2-ENE-6-CARBOXYLIC ACID; 4-METHYLENE-5-OXO-4,5-DIHYDROFURAN-3-CARBOXYLIC ACID; 4-METHYLENE-L-PROLINE; 4-METHYLHEPTANOIC ACID; 4-METHYLHEXANOIC ACID; 4-METHYLIDENECYCLOHEXANE-1-CARBOXYLIC ACID; 4-METHYLISOXAZOLE-3-CARBOXYLIC ACID; 4-METHYLISOXAZOLE-5-CARBOXYLIC ACID; 4-METHYL-MORPHOLINE-2-CARBOXYLIC ACID; 4-METHYL-MORPHOLINE-3-CARBOXYLIC ACID; 4-METHYLNICOTINIC ACID; 4-METHYLOXAZOLE-2-CARBOXYLIC ACID; 4-METHYLPENT-4-ENOIC ACID; 4-METHYLPENTANOIC ACID; 4-METHYLPIPERAZINE-2-CARBOXYLIC ACID; 4-METHYL-PIPERIDINE-2-CARBOXYLIC ACID; 4-METHYLPIPERIDINE-4-CARBOXYLIC ACID; 4-METHYLPYRAZOLE-3-CARBOXYLIC ACID; 4-METHYLPYRIDINE-2-CARBOXYLIC ACID; 4-METHYLPYRIMIDINE-5-CARBOXYLIC ACID; 4-METHYLPYRROLE-2-CARBOXYLIC ACID; 4-METHYLTETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID; 4-METHYLTHIAZOLE-2-CARBOXYLIC ACID; 4-METHYLTHIAZOLE-5-CARBOXYLIC ACID; 4-METHYLTHIOPHENE-3-CARBOXYLIC ACID; 4-NITROBUTANOIC ACID; 4-OXAZOLEACETIC ACID; 4-OXAZOLEACETIC ACID, 2-METHYL-; 4-OXAZOLECARBOXYLIC ACID; 4-OXAZOLIDINECARBOXYLIC ACID; 4-OXO-1,4-DIHYDRO-PYRIMIDINE-5-CARBOXYLIC ACID; 4-OXOAZETIDINE-2-CARBOXYLIC ACID; 4-OXOCYCLOHEXANECARBOXYLIC ACID; 4-OXOHEPTANOIC ACID; 4-OXOHEXANOIC ACID; 4-OXOPIPERIDINE-2-CARBOXYLIC ACID; 4-OXO-PIPERIDINE-3-CARBOXYLIC ACID; 4-OXO-PROLINE; 4-OXOPYRROLIDINE-3-CARBOXYLIC ACID; 4-OXO-TETRAHYDROFURAN-3-CARBOXYLIC ACID; 4-OXOTETRAHYDROTHIOPHENE-3-CARBOXYLIC ACID; 4-PENTENOIC ACID; 4-PENTYNOIC ACID; 4-PROPOXYBUTANOIC ACID; 4-PYRIDINEACETIC ACID; 4-PYRIDINEACRYLIC ACID; 4-PYRIMIDINEACETIC ACID; 4-PYRIMIDINECARBOXYLIC ACID, 5-HYDROXY-; 4-UREIDO-BUTYRIC ACID; 4-VINYLBENZOIC ACID; 4-YN-VPA; 5-(AMINOMETHYL)-2-FUROIC ACID; 5-(DIMETHYLAMINO)PENTANOIC ACID; 5-(HYDROXYMETHYL)-1H-PYRROLE-2-CARBOXYLIC ACID; 5-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID; 5-(HYDROXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 5-(METHYLAMINO)FURAN-2-CARBOXYLIC ACID; 5-(METHYLSULFANYL)PENTANOIC ACID; 5,5-DIMETHYLHEXANOIC ACID; 5,5-DIMETHYL-PYRROLIDINE-2-CARBOXYLIC ACID; 5,6-DIHYDRO-[1,4]DIOXINE-2-CARBOXYLIC ACID; 5,6-DIHYDRO-1,4-OXATHIINE-2-CARBOXYLIC ACID; 5,6-DIHYDRO-2H-PYRAN-3-CARBOXYLIC ACID; 5,6-DIHYDRO-4H-PYRAN-2-CARBOXYLIC ACID; 5,6-DIHYDRO-5-OXO-2-PYRAZINECARBOXYLIC ACID; 5-ACETYLVALERIC ACID; 5-AMINO CAPROIC ACID; 5-AMINO-1H-[1,2,3]TRIAZOLE-4-CARBOXYLIC ACID; 5-AMINO-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-AMINO-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 5-AMINO-1H-PYRAZOLE-3-ACETIC ACID; 5-AMINO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-AMINO-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-AMINO-1H-PYRROLE-2-CARBOXYLIC ACID; 5-AMINO-1-METHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 5-AMINO-1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-AMINO-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-AMINO-2-PYRAZINECARBOXYLIC ACID; 5-AMINO-2-PYRIDINECARBOXYLIC ACID; 5-AMINO-3-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-AMINO-3-METHYL-ISOXAZOLE-4-CARBOXYLIC ACID; 5-AMINO-3-OXO-2,3-DIHYDRO-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-AMINO-4,5-DIHYDRO-3H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-AMINO-4H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID MONOHYDRATE; 5-AMINO-4H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-AMINO-5-OXOPENTANOIC ACID; 5-AMINO-FURAN-2-CARBOXYLIC ACID; 5-AMINOLEVULINIC ACID; 5-AMINONICOTINIC ACID; 5-AMINOPENTANOIC ACID HYDRATE; 5-AMINO-PYRIDAZINE-4-CARBOXYLIC ACID; 5-AMINOPYRIMIDINE-2-CARBOXYLIC ACID; 5-AMINO-PYRIMIDINE-4-CARBOXYLIC ACID; 5-AMINOVALERIC ACID; 5-AZASPIRO[2.4]HEPTANE-1-CARBOXYLIC ACID; 5-AZIDO-PENTANOIC ACID; 5-CHLORO-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 5-CHLORO-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-CHLORO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-CHLORO-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-CHLORO-2H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID; 5-CHLORO-5-HEXENOIC ACID; 5-CHLOROFURAN-2-CARBOXYLIC ACID; 5-CHLORO-ISOXAZOLE-3-CARBOXYLIC ACID; 5-CHLOROVALERIC ACID; 5-CYANO-1H-PYRROLE-2-CARBOXYLIC ACID; 5-CYANO-2-FURANCARBOXYLIC ACID; 5-CYANO-3-PYRIDINECARBOXYLIC ACID; 5-CYANOPENTANOIC ACID; 5-CYANOPYRIDINE-2-CARBOXYLIC ACID; 5-ETHENYL-2-FURANCARBOXYLIC ACID; 5-ETHENYL-2-PYRIDINECARBOXYLIC ACID; 5-ETHENYL-3-PYRIDINECARBOXYLIC ACID; 5-ETHOXYPENTANOIC ACID; 5-ETHYL-1,2,4-OXADIAZOLE-3-CARBOXYLIC ACID; 5-ETHYL-1,3,4-OXADIAZOLE-2-CARBOXYLIC ACID; 5-ETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID; 5-ETHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 5-ETHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-ETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-ETHYL-4H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-ETHYL-FURAN-2-CARBOXYLIC ACID; 5-ETHYL-ISOXAZOLE-3-CARBOXYLIC ACID; 5-ETHYL-ISOXAZOLE-4-CARBOXYLIC ACID; 5-ETHYNYLPICOLINIC ACID; 5-FLUORO-2-THIOPHENECARBOXYLIC ACID; 5-FLUORO-3-THIOPHENECARBOXYLIC ACID; 5-FLUORO-L-PROLINE; 5-FLUORONICOTINIC ACID; 5-FLUOROPIPERIDINE-3-CARBOXYLIC ACID; 5-FLUOROPYRIDINE-2-CARBOXYLIC ACID; 5-FLUOROPYRIMIDINE-2-CARBOXYLIC ACID; 5-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-2-FURANCARBOXYLIC ACID; 5-HEXENOIC ACID; 5-HEXYNOIC ACID; 5H-TETRAAZOL-5-YLACETIC ACID; 5-HYDROXY-1,2,4-TRIAZINE-6-CARBOXYLIC ACID; 5-HYDROXY-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-HYDROXY-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-HYDROXY-1-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-HYDROXY-2-PYRIMIDINECARBOXYLIC ACID; 5-HYDROXY-3-PIPERIDINECARBOXYLIC ACID; 5-HYDROXYFURAN-2-CARBOXYLIC ACID; 5-HYDROXYHEXANOIC ACID; 5-HYDROXY-L-NORVALINE; 5-HYDROXYMETHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 5-HYDROXYMETHYL-2-FURANCARBOXYLIC ACID; 5-HYDROXYNICOTINIC ACID; 5-HYDROXYPENTANOIC ACID; 5-HYDROXYPICOLINIC ACID; 5-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID; 5-HYDROXYPYRAZINE-2-CARBOXYLIC ACID; 5-HYDROXYPYRAZINE-3-CARBOXYLIC ACID; 5-METHOXY-2-FUROIC ACID; 5-METHOXY-2-METHYLPENTANOIC ACID; 5-METHOXY-3-METHYLPENT-2-ENOIC ACID; 5-METHOXY-3-METHYLPENTANOIC ACID; 5-METHOXY-ISOXAZOLE-4-CARBOXYLIC ACID; 5-METHOXYPENTANOIC ACID; 5-METHYL-[1,3,4]OXADIAZOLE-2-CARBOXYLIC ACID; 5-METHYL-1,2,3-OXADIAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1,2,3-THIADIAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1,2,4-OXADIAZOLE-3-CARBOXYLIC ACID; 5-METHYL-1,3,4-THIADIAZOLE-2-CARBOXYLIC ACID; 5-METHYL-1,3-DIOXANE-5-CARBOXYLIC ACID; 5-METHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 5-METHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-METHYL-2-FUROIC ACID; 5-METHYL-2H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID; 5-METHYL-2H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 5-METHYL-2-OXO-2,3-DIHYDRO-OXAZOLE-4-CARBOXYLIC ACID; 5-METHYL-2-PYRAZINECARBOXYLIC ACID; 5-METHYL-2-THIOPHENECARBOXYLIC ACID; 5-METHYL-3,4-DIHYDRO-2H-PYRROLE-2-CARBOXYLIC ACID; 5-METHYL-4H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-METHYL-4-HEXENOIC ACID; 5-METHYL-4-OXOHEXANOIC ACID; 5-METHYL-5-HEXENOIC ACID; 5-METHYLFURAN-3-CARBOXYLIC ACID; 5-METHYLHEPT-4-ENOIC ACID; 5-METHYLHEPTANOIC ACID; 5-METHYLHEXANOIC ACID; 5-METHYLISOTHIAZOLE-4-CARBOXYLIC ACID; 5-METHYLISOXAZOLE-3-CARBOXYLIC ACID; 5-METHYLISOXAZOLE-4-CARBOXYLIC ACID; 5-METHYLNICOTINIC ACID; 5-METHYLOXAZOLE-2-CARBOXYLIC ACID; 5-METHYLPICOLINIC ACID; 5-METHYLPROLINE; 5-METHYL-PYRIDAZINE-4-CARBOXYLIC ACID; 5-METHYLPYRIMIDINE-2-CARBOXYLIC ACID; 5-METHYLPYRIMIDINE-4-CARBOXYLIC ACID; 5-METHYLTHIAZOLE-2-CARBOXYLIC ACID; 5-METHYLTHIAZOLE-4-CARBOXYLIC ACID; 5-METHYLTHIOPHENE-3-CARBOXYLIC ACID; 5-NORBORNENE-2-CARBOXYLIC ACID; 5-NORBORNENE-2-CARBOXYLIC ACID, PREDOMINANTLY ENDO; 5-OXASPIRO[2.4]HEPTANE-1-CARBOXYLIC ACID; 5-OXO-2,5-DIHYDRO-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID; 5-OXO-2,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-OXO-2-HEXENOIC ACID; 5-OXO-4,5-DIHYDRO-1H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID; 5-OXO-4,5-DIHYDRO-1H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID HYDRATE; 5-OXO-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-OXO-4,5-DIHYDROPYRAZINE-2-CARBOXYLIC ACID; 5-OXO-CYCLOHEX-1-ENECARBOXYLIC ACID; 5-OXO-HEPTANOIC ACID; 5-OXOPIPERAZINE-2-CARBOXYLIC ACID; 5-OXOPIPERIDINE-2-CARBOXYLIC ACID; 5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; 5-OXOTETRAHYDROTHIOPHENE-3-CARBOXYLIC ACID; 5-PYRIMIDINEACETIC ACID; 5-SULFANYLFURAN-2-CARBOXYLIC ACID; 5-SULFANYLPENTANOIC ACID; 5-THIAZOLEACETIC ACID; 6-AMINO-[1,2,4]TRIAZINE-5-CARBOXYLIC ACID; 6-AMINO-2,3,4,5-TETRAHYDRO-3-PYRIDINECARBOXYLIC ACID; 6-AMINO-6-OXO-HEXANOIC ACID; 6-AMINOCAPROIC ACID; 6-AMINONICOTINIC ACID; 6-AMINOPYRAZINE-2-CARBOXYLIC ACID; 6-AMINOPYRIDAZINE-3-CARBOXYLIC ACID; 6-AMINOPYRIDINE-2-CARBOXYLIC ACID; 6-AMINO-PYRIMIDINE-4-CARBOXYLIC ACID; 6-CYANONICOTINIC ACID; 6-CYANOPYRIDINE-2-CARBOXYLIC ACID; 6-ETHYNYLNICOTINIC ACID; 6-FLUORONICOTINIC ACID; 6-FLUOROPYRIDINE-2-CARBOXYLIC ACID; 6-HEPTENOIC ACID; 6-HEPTYNOIC ACID; 6-HYDROXYCAPROIC ACID; 6-HYDROXYNICOTINIC ACID; 6-HYDROXYPICOLINIC ACID; 6-HYDROXYPYRIDAZINE-3-CARBOXYLIC ACID; 6-HYDROXYPYRIMIDINE-4-CARBOXYLIC ACID; 6-MERCAPTOHEXANOIC ACID; 6-METHOXYHEXANOIC ACID; 6-METHYL-1,2,3,4-TETRAHYDROPYRIDINE-3-CARBOXYLIC ACID; 6-METHYL-2-PIPERIDINE CARBOXYLIC ACID; 6-METHYL-3,4-DIHYDRO-2H-PYRAN-5-CARBOXYLIC ACID; 6-METHYL-3-PIPERIDINECARBOXYLIC ACID; 6-METHYL-6-HEPTENOIC ACID; 6-METHYLHEPTANOIC ACID; 6-METHYLNICOTINIC ACID; 6-METHYLPICOLINIC ACID; 6-METHYLPYRAZINE-2-CARBOXYLIC ACID; 6-METHYLPYRIDAZINE-3-CARBOXYLIC ACID; 6-METHYLPYRIMIDINE-4-CARBOXYLIC ACID; 6-OXABICYCLO[3.1.0]HEXANE-3-CARBOXYLIC ACID; 6-OXO-1,4,5,6-TETRAHYDROPYRIDAZINE-3-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDROPYRAZINE-2-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDRO-PYRIDAZINE-3-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDROPYRIDAZINE-4-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDROPYRIDINE-2-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 6-OXO-1,6-DIHYDRO-PYRIMIDINE-5-CARBOXYLIC ACID; 6-OXO-3H-PYRIMIDINE-4-CARBOXYLIC ACID; 6-OXO-HEXAHYDRO-PYRIDAZINE-3-CARBOXYLIC ACID; 6-OXO-PIPERAZINE-2-CARBOXYLIC ACID; 6-OXO-PIPERIDINE-2-CARBOXYLIC ACID; 6-OXOPIPERIDINE-3-CARBOXYLIC ACID; 7-AMINOHEPTANOIC ACID; 7-HYDROXYHEPTANOIC ACID; 7-OCTENOIC ACID; 7-OXA-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID; 7-OXOHEPTANOIC ACID; AC-ALA-OH; AC-D-ALA-OH; ACETAMIDINE ACETATE; ACETATE BUFFER; ACETIC ACID; ACETIC ACID-ACETONITRILE; ACETIC ACID-AMMONIUM ACETATE; ACETOACETIC ACID; ACETONE CARBOXYMETHOXIME; ACETONITRILE WITH AMMONIUM ACETATE; ACETOXYACETIC ACID; ACETYL-D-2-AMINOBUTYRIC ACID; ACETYLENEDICARBOXYLIC ACID; ACETYLPYRUVIC ACID; ACONIC ACID; ACRYLAMIDO BUFFER; ACRYLATE, AMMONIUM; ACRYLIC ACID; ADIPIC ACID; A-FLUORO-B-ALANINE; ALA-GLY; ALANINE-NH2 ACETATE SALT; ALANOSINE; ALBIZZIIN; ALFA-NITRO ACETIC ACID; ALLO-DL-3-THIOBUTYRINE; ALLO-O-ETHYL-D-THR; ALLYLMALONIC ACID; ALPHA-(METHYLAMINO)ISOBUTYRIC ACID; ALPHA-AMINO-2-CYCLOPENTENYLACETIC ACID; ALPHA-METHYL-D-ALLYLGLYCINE; ALPHA-METHYL-DL-SERINE; ALPHA-METHYL-D-PROPARGYLGLYCINE; ALPHA-METHYL-D-VALINE; ALPHA-METHYL-L-ALLYLGLYCINE; ALPHA-METHYL-L-ASP; ALPHA-METHYL-L-PROLINE; ALPHA-METHYL-L-PROPARGYLGLYCINE; AMINO-(1H-IMIDAZOL-2-YL)-ACETIC ACID; AMINO-(PYRROLIDIN-3-YL)-ACETIC ACID; AMINO-(TETRAHYDRO-FURAN-3-YL)-ACETIC ACID; AMINO-CYCLOPROPYL-ACETIC ACID; AMINO-FURAN-2-YL-ACETIC ACID; AMINO-FURAN-3-YL-ACETIC ACID; AMINOMALONIC ACID; AMINOOXYACETIC ACID, HYDROCHLORIDE SALT; AMINO-PYRROL-2-YL-ACETIC ACID; AMMONIUM ACETATE; AMMONIUM ACETATE BUFFER; AMMONIUM BENZOATE; AMMONIUM BIOXALATE MONOHYDRATE; AMMONIUM HYDROGEN MALEATE; AMMONIUM HYDROGEN SUCCINATE; AMMONIUM HYDROGENOXALATE HEMIHYDRATE; AMMONIUM ISOVALERATE; AMMONIUM LACTATE; AMMONIUM OXALATE; AMMONIUM OXALATE MONOHYDRATE; AMMONIUM PROPIONATE; AMMONIUM TRIFLUOROACETATE; ANGELIC ACID; ANTHRANILIC ACID; ATROPIC ACID; AZALEUCINE; AZEPANE-2-CARBOXYLIC ACID; AZEPANE-3-CARBOXYLIC ACID; AZEPANE-4-CARBOXYLIC ACID; AZETIDIN-3-YLACETIC ACID; AZETIDIN-3-YLIDENEACETIC ACID; AZETIDIN-3-YLIDENEACETIC ACID HYDROCHLORIDE; AZETIDINE-2-CARBOXYLIC ACID; AZETIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE; AZETIDINE-3-CARBOXYLIC ACID; AZETIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE; AZIRIDINE-2-CARBOXYLIC ACID; BENZOCYCLOBUTYL-1-CARBOXYLIC ACID; BENZOIC ACID; BENZOIC ACID, 2-ETHENYL-; BENZOIC ACID-12C7; BETA-ALANINE; BETA-ASPARTYL HYDRAZIDE; BETA-CHLORO-DL-ALANINE; BETA-CHLOROLACTIC ACID; BETA-CYANO-L-ALANINE; BETA-FLUOROLACTIC ACID; BETA-HOMOALANINE HYDROCHLORIDE; BETA-HYDROXYISOVALERIC ACID; BETA-HYDROXYLEUCINE; BETA-HYDROXYNORLEUCINE; BETA-HYDROXYNORVALINE; BETA-METHOXYVALINE; BETA-METHYLGUANADINOPROPIONIC ACID; BETA-METHYLLEVULINIC ACID; BETA-N,N-DIMETHYLAMINO-D-ALA; BETA-N,N-DIMETHYLAMINO-L-ALA; BETA-N-ETHANOLAMINO-D-ALA; BETA-N-ETHANOLAMINO-L-ALA; BETA-N-METHYLAMINO-D-ALA; BETA-T-BUTYL-D-ALANINE; BETA-THIOLNORVALINE; BICYCLO[2.2.1]HEPTANE-1-CARBOXYLIC ACID; BICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID; BICYCLO[3.1.0]HEX-2-ENE-6-CARBOXYLIC ACID; BICYCLO[3.1.0]HEXANE-3-CARBOXYLIC ACID; BICYCLO[3.2.0]HEPTANE-3-CARBOXYLIC ACID; BICYCLO[4.1.0]HEPTANE-7-CARBOXYLIC ACID; BICYCLO[4.2.0]OCTA-1(6),2,4-TRIENE-2-CARBOXYLIC ACID; BROMOACETIC ACID; BROMOPROPIOLIC ACID; BUTANOIC ACID, 2-AMINO-3-OXO-; BUTYRAMIDINE HOAC; BUTYRIC ACID; CARBAMIMIDOYL-ACETIC ACID; CARBAMOYL-DL-ALA-OH; CARBOXYMETHYLNITROSOUREA; CHLOROACETIC ACID; CHLORODIFLUOROACETIC ACID; CHLOROFLUOROACETIC ACID; CIS,CIS-MUCONIC ACID; CIS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID; CIS-2-AMINO-1-CYCLOPENTANECARBOXYLIC ACID; CIS-2-AMINO-2-METHYL-CYCLOPENTANECARBOXYLIC ACID; CIS-2-AMINO-4-CYCLOHEXENE-1-CARBOXYLIC ACID; CIS-2-AMINO-CYCLOHEX-3-ENECARBOXYLIC ACID; CIS-2-FLUORO-CYCLOPROPANECARBOXYLIC ACID; CIS-2-HYDROXY-1-CYCLOPENTANECARBOXYLIC ACID; CIS-2-METHYLCYCLOPROPANECARBOXYLIC ACID; CIS-3-(1H-IMIDAZOL-4-YL)-2-PROPENOIC ACID; CIS-3-AMINOCYCLOBUTANECARBOXYLIC ACID; CIS-3-AMINOCYCLOHEXANECARBOXYLIC ACID; CIS-3-AMINO-TETRAHYDROPYRAN-4-CARBOXYLIC ACID; CIS-3-CHLOROACRYLIC ACID; CIS-3-CHLOROCYCLOBUTANECARBOXYLIC ACID; CIS-3-FLUOROCYCLOBUTANECARBOXYLIC ACID; CIS-3-HEXENOIC ACID; CIS-3-HYDROXYCYCLOBUTANECARBOXYLIC ACID; CIS-3-HYDROXY-DL-PROLINE; CIS-3-METHYL-2-HEXENOIC ACID; CIS-3-METHYL-CYCLOBUTANEACETIC ACID; CIS-3-METHYLCYCLOBUTANECARBOXYLIC ACID; CIS-4-AMINOCROTONIC ACID; CIS-4-AMINOCYCLOHEXANECARBOXYLIC ACID; CIS-4-HYDROXYCYCLOHEXANECARBOXYLIC ACID; CIS-4-HYDROXY-DL-PROLINE; CIS-4-HYDROXY-D-PROLINE; CIS-4-HYDROXY-L-PROLINE; CIS-4-HYDROXY-TETRAHYDRO-2-FUROIC ACID; CIS-4-MERCAPTO-L-PROLINE; CIS-AZETIDINE-2,4-DICARBOXYLIC ACID; CIS-CYCLOBUTANE-1,2-DICARBOXYLIC ACID; CIS-CYCLOBUTANE-1,3-DICARBOXYLIC ACID; CIS-EPOXYSUCCINIC ACID; CIS-L-3-HYDROXYPROLINE; CITRACONIC ACID; COMANIC ACID; COUMALIC ACID; CREATINE; CROTONIC ACID; CROTYL GLYCINE; CYANO(METHOXYIMINO)ACETIC ACID; CYANO(METHOXYIMINO)ACETIC ACID; CYANOACETIC ACID; CYANOACRYLIC ACID; CYCLOBUTANE-1,1-DICARBOXYLIC ACID MONOAMIDE; CYCLOBUTANE-1,3-DICARBOXYLIC ACID; CYCLOBUTANECARBOXYLIC ACID; CYCLOBUTANEPROPANOIC ACID; CYCLOBUTYL-ACETIC ACID; CYCLOBUTYLIDENEACETIC ACID; CYCLOBUTYL-OXO-ACETIC ACID; CYCLOBUTYLPROPIONIC ACID; CYCLOCREATINE; CYCLOHEPTANECARBOXYLIC ACID; CYCLOHEXANECARBOXYLIC ACID; CYCLOHEXYLACETIC ACID; CYCLOLEUCINE; CYCLOPENTANECARBOXYLIC ACID; CYCLOPENTENYL ACETIC ACID; CYCLOPENTYLACETIC ACID; CYCLOPROPANE-1,2-DICARBOXYLIC ACID; CYCLOPROPANECARBOXYLIC ACID; CYCLOPROPANECARBOXYLIC ACID HYDRAZINE; CYCLOPROPANECARBOXYLIC ACID, 1-AMINO-2-ETHENYL-, (1R,2S)-; CYCLOPROPANECARBOXYLIC ACID, 2-(CHLOROCARBONYL)-, TRANS-; CYCLOPROPYLACETIC ACID; CYCLOPROPYL-HYDROXYIMINO-ACETIC ACID; CYCLOPROPYLIDENE-ACETIC ACID; D(−)-ISOVALINE; D-(+)-MALIC ACID; D,L-2-AMINO-3-(HYDROXY-15N2-AMINO)PROPIONIC ACID; D,L-2-AMINO-3-(HYDROXYAMINO)PROPIONIC ACID; D,L-ALANOSINE; D-2,3-DIAMINOPROPIONIC ACID; D-2,4-DIAMINOBUTYRIC ACID; D-2-AMINO-5-METHYLHEX-4-ENOIC ACID; D-2-AMINOBUTYRIC ACID; D-2-AZIRIDINECARBOXYLIC ACID; D-2-HYDROXYPENTANEDIOIC ACID; D-3-METHYLASPARTIC ACID; D-3-THIOBUTYRINE; D-3-THIOLNORVALINE; D-6-HYDROXYNORLEUCINE; D-6-OXO-PIPECOLINIC ACID; D-ALA-3-CL; D-ALANINE; D-ALBIZZIIN; D-ALLOISOLEUCINE; D-ALLYLGLYCINE; D-ALPHA-HYDROXYISOVALERIC ACID; D-ASPARAGINE; D-ASPARTIC ACID; D-ASPARTIC ACID BETA-HYDROXAMATE; D-ASPARTIC ACID-BETA-METHYL ESTER; D-AZETIDINE-2-CARBOXYLIC ACID; D-BETA,BETA-DIETHYLALANINE; D-BETA-HOMOSERINE; D-CANALINE; D-CYCLOBUTYLALANINE; D-CYCLOBUTYLGLYCINE; D-CYCLOPENTYLGLYCINE; D-CYCLOPROPYLALANINE; D-CYCLOPROPYLGLYCINE; D-CYSTEINE; D-D-HYDROXYNORVALINE; D-GLUTAMIC ACID; D-GLUTAMINE; D-GLYCERIC ACID; D-HOMOCYSTEINE; D-HOMOSERINE; DICHLOROACETIC ACID; DICHLOROFLUOROACETIC ACID; DIETHYLAMINE ACETATE; DIETHYLAMINO-ACETIC ACID; DIFLUOROACETIC ACID; DIFLUOROMETHYLTHIOACETIC ACID; DIFLUORO-PROPANEDIOIC ACID; DIGLYCOLIC ACID; DIHYDROXYACETIC ACID; DIHYDROXYFUMARIC ACID; DIMETHYLMALONIC ACID; D-ISOASPARAGINE; D-ISOGLUTAMINE; D-ISOLEUCINE; D-ISOTHREONINE; DL-2,3-DIAMINOPROPIONIC ACID HYDROCHLORIDE; DL-2,3-DIAMINOSUCCINIC ACID; DL-2-AMINO-4-PENTENOIC ACID; DL-2-AMINOBUTYRIC ACID; DL-2-FLUORO-3-ALANINE; DL-2-HYDROXY-N-BUTYRIC ACID; DL-2-ISOPROPYLSERINE; DL-3-AMINOBUTYRIC ACID; DL-3-AMINOISOBUTYRIC ACID; DL-3-METHYLASPARTIC ACID; DL-3-THIOBUTYRINE; DL-4-AMINO-2-FLUOROBUTYRIC ACID; DL-4-AMINO-3-HYDROXYBUTYRIC ACID; DL-6-HYDROXYNORLEUCINE; D-LACTIC ACID; DL-ALANINE; DL-ALANYL-GLYCINE; DL-ALLO-ISOLEUCINE; DL-ALLO-THREONINE; DL-ALPHA-HYDROXYCAPROIC ACID; DL-ALPHA-METHYLLEUCINE; DL-ASPARAGINE; DL-ASPARTIC ACID; DL-BETA-HYDROXYNORVALINE; DL-CIS-4-FLUORO-5-PYRROLIDONE-2-CARBOXYLIC ACID; DL-CITRAMALIC ACID; DL-CYCLOBUTYLALANINE; DL-CYCLOBUTYLGLYCINE; DL-CYCLOPENTYLGLYCINE; DL-CYCLOPROPYLALANINE; DL-CYSTEINE; D-LEUCINE; DL-GLUTAMIC ACID; DL-GLUTAMIC ACID ALPHA-AMIDE; DL-GLUTAMINE; DL-GLYCERIC ACID; DL-HOMOCYSTEINE; DL-HOMOLEUCINE; DL-HOMOSERINE; DL-ISOLEUCINE; DL-ISOSERINE; DL-LEUCIC ACID; DL-LEUCINE; DL-LYSINE; DL-MALIC ACID; DL-METHIONINE; DL-METHYLTARTRONIC ACID; DL-NORLEUCINE; DL-NORVALINE; DL-O-METHYLSERINE; DL-ORNITHINE; DL-PENICILLAMINE; DL-PIPECOLINIC ACID; DL-PROLINE; DL-PROPARGYLGLYCINE; DL-PYROGLUTAMIC ACID; DL-SERINE; DL-S-METHYL-CYS-OH; DL-TERT-LEUCINE; DL-THREO-BETA-HYDROXYASPARTIC ACID; DL-THREONINE; DL-TRANS-2,6-DIAMINO-4-HEXENOIC ACID; DL-TRANS-4-FLUORO-5-PYRROLIDONE-2-CARBOXYLIC ACID; DL-TRANS-HYDROXYPROLINE; DL-VALINE; D-LYSINE; D-METHALLYLGLYCINE; D-METHIONINE; D-NORLEUCINE; D-NORVALINE; D-ORNITHINE; D-PENICILLAMINE; D-PROLINE; D-PROPARGYLGLYCINE; D-PYROGLUTAMIC ACID; D-SERINE; D-S-METHYL-CYS-OH; D-TERT-LEUCINE; D-THIAZOLIDINE-4-CARBOXYLIC ACID; D-THREONINE; D-TRANS-4-FLUORO-5-PYRROLIDONE-2-CARBOXYLIC ACID; D-VALINE; D-VINYLGLYCINE; EPOXY METHACRYLATE; ERYTHRO-BETA-HYDROXY-L-ASPARTIC ACID; ERYTHRO-DL-BETA-HYDROXYNORLEUCINE; ERYTHRO-DL-BETA-HYDROXYNORVALINE; ETHOXYACETIC ACID; ETHOXYMETHYLENECYANOACETIC ACID; ETHYL HYDROGEN MALONATE; ETHYLMALONIC ACID; FLUOROACETIC ACID; FOR-D-ALA-OH; FOR-D-VAL-OH; FORMIMINOGLYCINE; FUMARIC ACID; FUMARIC ACID MONOETHYL ESTER; FURAN-3-YL-ACETIC ACID; GABA; GABACULINE; GAMMA-ACETYLENIC GABA; GAMMA-CHLORO-ALPHA-AMINOBUTYRIC ACID; GAMMA-METHYL-L-LEUCINE; GAMMA-METHYLPROLINE; GLUTACONIC ACID; GLUTARIC ACID; GLYCINE; GLYCINE AMIDE ACETATE; GLYCINE HYDROCHLORIDE; GLYCOLIC ACID; GLYCYLDEHYDROALANINE; GLYCYL-DL-ALANINE; GLYCYLGLYCINE; GLYCYL-L-ALANINE; GLYCYL-SARCOSINE; GLY-D-ALA; GLYOXILIC ACID OXIME; GLYOXYLIC ACID; GLYOXYLIC ACID MONOHYDRATE; GLYOXYLIC ACID SEMICARBAZONE; GUANIDINE ACETATE; GUANIDINE OXALATE; HADACIDIN; H-ALPHA-ME-D-LEU-OH; H-ALPHA-ME-DL-VAL-OH; H-ALPHA-ME-LEU-OH; H-ASP-NH2; H-ASP-OME; H-BETA-ALA-GLY-OH; HCL/ACOH; H-D-ALA-GLY-OH; H-D-ALLO-THR-OH; H-D-ASP-OME; H-D-DAP-OH HCL; H-DL-ASP-OME; H-DL-GLU-OH; H-DL-MELEU-OH; H-D-MEALA-OH HCL; H-D-PRA-OH HCL; H-D-SER(AC)-OH; H-D-THR(ME)-OH; HEPT-4-EN-6-YNOIC ACID; HEPT-5-ENOIC ACID; HEPTA-4,6-DIENOIC ACID; HEPTANOIC ACID; HEXA-4,5-DIENOIC ACID; HEXAHYDROPYRIDAZINE-3-CARBOXYLIC ACID; HEXAHYDROPYRIMIDINE-2-CARBOXYLIC ACID; HEXANOIC ACID; H-GLU-2-CHLOROTRITYL RESIN; H-GLY-BETA-ALA-OH; H-L-DAB-OH; H-MEILE-OH; H-MEVAL-OH; H-PRA-OH HCL; HYDANTOIC ACID; HYDRAZINE ACETATE; HYDRAZINE MONOOXALATE; HYDROCHLORIC ACID-PROPIONIC ACID; HYDROXYIMINO-ACETIC ACID; HYDROXYLAMINE ACETATE; HYPOGLYCIN; IMIDAZOL-1-YL-ACETIC ACID; IMIDAZOLE-4-ACETIC ACID; IMINODIACETIC ACID; IMMOBILIZED IMINODIACETIC ACID; ISOBUTYL ACRYLIC ACID; ISOBUTYRIC ACID; ISOCROTONIC ACID; ISONICOTINIC ACID; ISONICOTINIC ACID N-OXIDE; ISONIPECOTIC ACID; ISOPROPOXYACETIC ACID; ISOPROPYLMALONIC ACID; ISOTHIAZOLE-3-CARBOXYLIC ACID; ISOTHIAZOLE-5-CARBOXYLIC ACID; ISOVALERIC ACID; ISOXAZOLE-4-CARBOXYLIC ACID; ISOXAZOLE-5-CARBOXYLIC ACID; ITACONIC ACID; ITACONIC ACID MONOMETHYL ESTER; KETOMALONIC ACID; KETOMALONIC ACID MONOHYDRATE; L-(−)-MALIC ACID; L-(−)-THREO-3-HYDROXYASPARTIC ACID; L-(+)-LACTIC ACID; L-2,3-DIAMINOPROPIONIC ACID; L-2-ACETAMIDOBUTYRIC ACID; L-2-AMINO-5-METHYLHEX-4-ENOIC ACID; L-2-AMINOADIPATE 6-SEMIALDEHYDE; L-2-AMINOBUTYRIC ACID; L-2-AMINOBUTYRIC ACID HYDROCHLORIDE; L-2-AZIRIDINECARBOXYLIC ACID; L-2-METHYLCYSTEINE; L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID; L-3-METHYLASPARTIC ACID; L-3-THIOBUTYRINE; L-3-THIOLNORVALINE; L-6-HYDROXYNORLEUCINE; LACTIC ACID; L-ALANINE; L-ALANINE HYDROCHLORIDE; L-ALLO-ISOLEUCINE; L-ALLO-THREONINE; L-ALLYLGLYCINE; L-ASPARAGINE; L-ASPARTIC ACID; L-ASPARTIC ACID BETA-HYDROXAMATE; L-ASPARTIC ACID-AGAROSE; L-AZETIDINE-2-CARBOXYLIC ACID; L-AZETIDINE-2-CARBOXYLIC ACID HCL; L-BETA,BETA-DIETHYLALANINE; L-BETA-HOMOALANINE HYDROCHLORIDE; L-BETA-HOMOSERINE; L-BETA-HOMOTHREONINE; L-CANALINE; L-CYCLOBUTYLALANINE; L-CYCLOBUTYLGLYCINE; L-CYCLOPENTYLGLYCINE; L-CYCLOPROPYLALANINE; L-CYCLOPROPYLGLYCINE; L-CYSTEINE; LEVULINIC ACID; L-GLUTAMIC ACID; L-GLUTAMINE; L-HOMOCYSTEINE; L-HOMOSERINE; L-HYDROXYPROLINE; L-ISOGLUTAMINE; L-ISOLEUCINE; L-ISOTHREONINE; L-ISOVALINE; LITHIUM SUCCINATE; L-LEUCIC ACID; L-LEUCINE; L-LYSINE; L-METHIONINE; L-NORLEUCINE; L-NORVALINE; L-ORNITHINE; L-PENICILLAMINE; L-PIPECOLIC ACID; L-PROLINE; L-PROLINE HYDRATE; L-PROPARGYLGLYCINE; L-PYROGLUTAMIC ACID; L-SERINE; L-SERINE [G-3 H]; L-SERINE HYDROCHLORIDE; L-TERT-LEUCINE; L-THIAZOLIDINE-4-CARBOXYLIC ACID; L-THREONIC ACID; L-THREONINE; L-THREONINE-AGAROSE; L-TRANS-4-FLUORO-5-PYRROLIDONE-2-CARBOXYLIC ACID; L-VALINE; L-VINYLGLYCINE; MALEAMIC ACID; MALEIC ACID; MALEIC ACID MONOETHYL ESTER; MALEIC ACID MONOMETHYL ESTER; MALEIC ACID MONOSODIUM SALT; MALONIC ACID; MERCAPTOACETIC ACID; MESACONIC ACID; MESO-2,3-DIAMINOSUCCINIC ACID; MESO-2,3-DIMETHYLSUCCINIC ACID; METHACRYLATE, AMMONIUM; METHACRYLIC ACID; METHANESULFONYLACETIC ACID; METHOXYACETIC ACID; METHOXYCARBONYLOXY-ACETIC ACID; METHYL HYDROGEN GLUTARATE; METHYLMALONIC ACID; METHYLSUCCINIC ACID; MONO-AMMONIUM CITRACONATE; MONOMETHYL AMINOMALONATE; MONOMETHYL FUMARATE; MONOMETHYL MALONATE; MONO-METHYL SUCCINATE; MORPHOLIN-3-YL-ACETIC ACID; MORPHOLIN-4-YL-ACETIC ACID; MORPHOLINE-2-CARBOXYLIC ACID; M-TOLUIC ACID; N-(1-CYANO-1-METHYLETHYL)GLYCINE; N-(2-AMINOETHYL)GLYCINE; N-(2CT RESIN)-L-MET-OH; N-(2-CYANOETHYL)-ALANINE; N-(2-CYANOETHYL)GLYCINE; N-(4-AMINOBUTYL)-GLYCINE; N-(TERT-BUTYL)HYDROXYLAMINE ACETATE; N,N-DIMETHYL(2-HYDROXYETHYL)AMMONIUM ACETATE; N,N-DIMETHYLGLYCINE; N,N-DIMETHYLGLYCINE HYDROCHLORIDE; N,N-DIMETHYL-L-ALA-OH; N,N-DIMETHYL-L-VALINE; N,N-DIMETHYLOXAMIC ACID; N,N-DIMETHYLSUCCINAMIC ACID; N,N-DIMETHYLVALINE; N-[(DIMETHYLAMINO)CARBONYL]GLYCINE; N-ACETYL-BETA-ALANINE; N-ACETYL-DL-ALANINE; N-ACETYL-DL-SERINE; N-ACETYLGLYCINE; N-ACETYL-L-SERINE; N-ALPHA-METHYL-L-2-AMINO PENTANOIC ACID; N-ALPHA-METHYL-L-2-AMINO-CAPROIC ACID; N-ALPHA-METHYL-L-ALANINE HYDROCHLORIDE; N-ALPHA-METHYL-L-THREONINE; N-AMINO-D-PROLINE; N-CARBAMYL-ALPHA-AMINO-ISOBUTYRIC ACID; N-ETHYLGLYCINE; N-ETHYL-L-PROLINE; N-ETHYLMALEAMIC ACID; N-FORMYL CYSTEINE; N-FORMYL-DL-2-AMINO-N-BUTYRIC ACID; N-FORMYL-DL-ALANINE; N-FORMYL-DL-VALINE; N-FORMYLGLYCINE; N-FORMYL-L-ALANINE; N-FORMYL-L-PROLINE; N-FORMYL-L-VALINE; NH2-L-ILE-OH; NH2-L-LEU-OH; NH2-L-PRO-OH; NICOTINIC ACID; NICOTINIC ACID N-OXIDE; NIPECOTIC ACID; N-ISOPROPYL-N-METHYLGLYCINE; NITRAMINOACETIC ACID; N-ME-CIS-HYDROXYPROLINE; N-ME-DL-VAL-OH; N-METHACRYLOYLGLYCINE; N-METHYL-2-METHYLENE-SUCCINAMIC ACID; N-METHYL-D-ALANINE; N-METHYL-D-ASPARTIC ACID; N-METHYL-D-ISOLEUCINE; N-METHYL-DL-ALANINE; N-METHYL-DL-ASPARTIC ACID; N-METHYL-DL-ISOLEUCINE; N-METHYL-D-PROLINE MONOHYDRATE; N-METHYLHYDROXYLAMINE OXALATE; N-METHYLIMINODIACETIC ACID; N-METHYL-L-ALANINE; N-METHYL-L-ASPARTIC ACID; N-METHYL-L-CYSTEINE; N-METHYL-L-LEUCINE; N-METHYL-L-PROLINE; N-METHYL-L-PROLINE MONOHYDRATE; N-METHYL-L-SERINE; N-METHYLMALEAMIC ACID; N-METHYLSUCCINAMIC ACID; N-NITROSARCOSINE; N-NITROSO-D-PROLINE; N-NITROSO-L-AZETIDINE-2-CARBOXYLIC ACID; N-NITROSO-L-PROLINE; N-NITROSO-N-METHYL-3-AMINOPROPIONIC ACID; N-NITROSO-N-METHYL-4-AMINOBUTYRIC ACID; N-NITROSOSARCOSINE; NORVALINE, 4-OXO-; N-OXALYLGLYCINE; N-PROPIONYLALANINE; N-PROPIONYLGLYCINE; O-(AMINOCARBONYL)SERINE; O-ACETYL-L-SERINE; OCTANOIC ACID; O-METHYLISOUREA ACETATE; O-METHYL-L-THREONINE; O-TBU-(S)-LACTIC ACID; O-TOLUIC ACID; OXALACETIC ACID; OXALIC ACID; OXALIC ACID DIHYDRATE; OXALIC ACID MONO-(N-METHYL)-AMIDE; OXALYL MONOGUANYLHYDRAZIDE; OXALYSINE; OXAMIC ACID; OXAMIC ACID AMMONIUM SALT; OXAZOLE-2-CARBOXYLIC ACID; OXAZOLE-5-CARBOXYLIC ACID; OXETANE-2-CARBOXYLIC ACID; OXETANE-2-CARBOXYLIC ACID AMMONIASALT; OXETANE-3-CARBOXYLIC ACID; OXETIN; OXIRANE-(2S,3S)-DICARBOXYLIC ACID MONOMETHYL ESTER; OXIRANE-2,3-DICARBOXYLIC ACID; OXIRANE-2,3-DICARBOXYLIC ACID MONOMETHYL ESTER; OXO(PROPYLAMINO)ACETIC ACID; OXO-PYRROLIDIN-1-YL-ACETIC ACID; PENT-3-YNOIC ACID; PEROXYMALEIC ACID; PHENYLACETIC ACID; PHENYLPROPIOLIC ACID; PHOSPHONOACETIC ACID; PICOLINIC ACID; PICOLINIC ACID N-OXIDE; PICOLINIC ACID, [3H]-; PIPERAZIN-1-YL-ACETIC ACID; PIPERAZIN-2-YLACETIC ACID; PIPERAZINE-2-CARBOXYLIC ACID; PIPERIDAZINE-3-(R)-CARBOXYLIC ACID; PIPERIDIN-1-YL-ACETIC ACID; PIPERIDIN-4-YLACETIC ACID; PIPERIDIN-4-YLIDENE-ACETIC ACID; PIPERIDINIUM ACETATE; PIVALIC ACID; POTASSIUM BINOXALATE; PROPANEDIOIC ACID MONOPOTASSIUM SALT; PROPANOIC ACID, 2-HYDRAZINO-2-METHYL-; PROPIOLIC ACID; PROPIONIC ACID; PROPYLMALONIC ACID; P-TOLUIC ACID; PYRIDAZIN-4-YLACETIC ACID; PYRIDAZINE-3-CARBOXYLIC ACID; PYRIDAZINE-4-CARBOXYLIC ACID; PYRIDINE 2-CARBOXYLIC ACID, [CARBOXY-14C]; PYRIDINIUM ACETATE; PYRIMIDINE-2-CARBOXYLIC ACID; PYRIMIDINE-4-CARBOXYLIC ACID; PYRIMIDINE-5-CARBOXYLIC ACID; PYRROLE-2-CARBOXYLIC ACID; PYRROLE-3-CARBOXYLIC ACID; PYRROLE-3-CARBOXYLIC ACID HYDRATE; PYRROLIDIN-1-YL-ACETIC ACID; PYRROLIDINE-3-CARBOXYLIC ACID; PYRUVIC ACID; R-2-AMINOBUTYRIC ACID [CARBOXYL-14C]; R-2-AMINOHEPTANOIC ACID; S-2-AMINOBUTYRIC ACID [CARBOXYL-14C]; S-2-AMINOHEPTANOIC ACID; S-2-CHLOROVALERIC ACID; S-ACETYLTHIOACETIC ACID; SALICYLIC ACID; SARCOSINE; SAR-GLY-OH; S-CYANOCYSTEINE; S-ETHYL-L-CYSTEINE; S-HYPOGLYCINE A; SIGLURE ACID; S-METHYL-L-CYSTEINE; SODIUM ACID OXALATE; SODIUM HYDROGEN FUMARATE; SODIUM HYDROGEN OXALATE; SORBIC ACID; SPIRO[2.2]PENTANE-1-CARBOXYLIC ACID; SPIRO[2.3]HEXANE-1-CARBOXYLIC ACID; SPIRO[2.4]HEPTANE-1-CARBOXYLIC ACID; SQUARAIN-CARBOXYLATE; SUCCINAMIC ACID; SUCCINIC ACID; SUCCINIC ACID MONOSODIUM SALT; SUCCINIC SEMIALDEHYDE; SULFOACETIC ACID; TARTRONIC ACID; TERT-BUTOXY ACETIC ACID; TETRAHYDRO-2H-PYRAN-3-CARBOXYLIC ACID; TETRAHYDRO-2H-PYRAN-3-YLACETIC ACID; TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID; TETRAHYDRO-2H-THIOPYRAN-3-CARBOXYLIC ACID; TETRAHYDRO-3-FUROIC ACID; TETRAHYDRO-5-OXO-2-FURANCARBOXYLIC ACID; TETRAHYDROPYRANYL-4-ACETIC ACID; TETRAHYDROTHIOPHENE-2-CARBOXYLIC ACID; TETRAHYDROTHIOPHENE-3-CARBOXYLIC ACID; TETRAHYDROTHIOPYRAN-4-CARBOXYLIC ACID; THIAZOL-2-YL-ACETIC ACID; THIAZOLE-2-CARBOXYLIC ACID; THIAZOLE-4-CARBOXYLIC ACID; THIAZOLE-5-CARBOXYLIC ACID; THIAZOLIDINE-2-CARBOXYLIC ACID; THIAZOLIDINE-4-CARBOXYLIC ACID; THIOMORPHOLINE-2-CARBOXYLIC ACID; THIOMORPHOLINE-3-CARBOXYLIC ACID; THREO-D-BETA-HYDROXYNORLEUCINE; THREO-DL-BETA-HYDROXYNORLEUCINE; THREO-DL-BETA-HYDROXYNORVALINE; THREO-L-BETA-HYDROXYNORLEUCINE; THREONINE, L-[14C(U)]; TIGLIC ACID; TRANS,TRANS-MUCONIC ACID; TRANS-2,4-PENTADIENOIC ACID; TRANS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID; TRANS-2-AMINO-4-CYCLOHEXENE-1-CARBOXYLIC ACID; TRANS-2-AMINO-CYCLOPENTANECARBOXYLIC ACID; TRANS-2-BUTENE-1,4-DICARBOXYLIC ACID; TRANS-2-CHLOROMETHYL-1-CYCLOPROPANECARBOXYLIC ACID; TRANS-2-FLUORO-CYCLOPROPANECARBOXYLIC ACID; TRANS-2-HEXENOIC ACID; TRANS-2-HYDROXYMETHYL-1-CYCLOPROPANECARBOXYLIC ACID; TRANS-2-OCTENOIC ACID; TRANS-2-PENTENOIC ACID; TRANS-3-AMINOCYCLOBUTANECARBOXYLIC ACID; TRANS-3-CHLOROACRYLIC ACID; TRANS-3-CHLOROCYCLOBUTANECARBOXYLIC ACID; TRANS-3-FLUOROCYCLOBUTANECARBOXYLIC ACID; TRANS-3-HEXENOIC ACID; TRANS-3-HYDROXYCYCLOBUTANECARBOXYLIC ACID; TRANS-3-HYDROXYHEPT-4-ENOIC ACID; TRANS-3-HYDROXYHEX-4-ENOIC ACID; TRANS-3-HYDROXY-L-PROLINE; TRANS-3-METHYL-CYCLOBUTANEACETIC ACID; TRANS-3-METHYLCYCLOBUTANECARBOXYLIC ACID; TRANS-4-AMINOCROTONIC ACID HYDROCHLORIDE; TRANS-4-AMINOCYCLOHEXANECARBOXYLIC ACID; TRANS-4-HYDROXYCYCLOHEXANECARBOXYLIC ACID; TRANS-4-HYDROXY-D-PROLINE; TRANS-4-HYDROXY-TETRAHYDRO-2-FUROIC ACID; TRANS-4-METHYLCYCLOHEXANECARBOXYLIC ACID; TRANS-CINNAMIC ACID; TRANS-CYCLOBUTANE-1,2-DICARBOXYLIC ACID; TRANS-CYCLOBUTANE-1,3-DICARBOXYLIC ACID; TRIFLUOROACETIC ACID; TRIMETHYLAMMONIUM ACETATE; TRIMETHYLPYRUVIC ACID; UROCANIC ACID; VALERIC ACID; VALPROIC ACID; VIGABATRIN; VINYLACETIC ACID

List No. 5—Carboxylic Acids Aldehydes

((2-FORMYL-3-THIENYL)THIO)ACETIC ACID; ([2-(2-FORMYLPHENOXY)ETHYL]THIO)ACETIC ACID; ([2-(4-FORMYL-2-METHOXYPHENOXY)ETHYL]THIO)ACETIC ACID; ([2-(4-FORMYLPHENOXY)ETHYL]THIO)ACETIC ACID; ([3-(2-FORMYLPHENOXY)PROPYL]THIO)ACETIC ACID; ([3-(4-FORMYLPHENOXY)PROPYL]THIO)ACETIC ACID; ([4-(2-FORMYL-1H-PYRROL-1-YL)PHENYL]THIO)ACETIC ACID; ([4-FORMYL-3-METHYL-1-(4-METHYLBENZYL)-1H-PYRAZOL-5-YL]THIO)ACETIC ACID; (2-BROMO-4-CHLORO-6-FORMYLPHENOXY)ACETIC ACID; (2-BROMO-4-FORMYL-6-METHOXYPHENOXY)ACETIC ACID; (2-BROMO-4-FORMYLPHENOXY)ACETIC ACID; (2-BROMO-6-CHLORO-4-FORMYLPHENOXY)ACETIC ACID; (2-BROMO-6-ETHOXY-4-FORMYLPHENOXY)ACETIC ACID; (2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)ACETIC ACID; (2-CHLORO-4-FORMYLPHENOXY)ACETIC ACID; (2-CHLORO-6-ETHOXY-4-FORMYLPHENOXY)ACETIC ACID; (2E)-2,3-DIBROMO-4-OXOBUT-2-ENOIC ACID; (2-ETHOXY-4-FORMYLPHENOXY)ACETIC ACID; (2-ETHOXY-6-FORMYLPHENOXY)ACETIC ACID; (2-FORMYL-1H-PYRROL-1-YL)(PHENYL)ACETIC ACID; (2-FORMYL-1H-PYRROL-1-YL)ACETIC ACID; (2-FORMYL-6-METHOXY-4-NITROPHENOXY)ACETIC ACID; (2-FORMYL-IMIDAZOL-1-YL)-PHENYL-ACETIC ACID; (2R)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)ACETIC ACID; (2R)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)ACETIC ACID; (2R)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOIC ACID; (2R)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2R)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))ACETIC ACID; (2R)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANOIC ACID; (2RS)-2-(4-FORMYLPHENYL)PROPANOIC ACID; (2S)-2-(2-FORMYL-1H-PYRROL-1-YL)-3-PHENYLPROPANOIC ACID; (2S)-2-(2-FORMYL-1H-PYRROL-1-YL)-4-METHYLPENTANOIC ACID; (2S)-2-(2-FORMYL-1H-PYRROL-1-YL)PROPANOIC ACID; (2S)-2-AMINO-2-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)ACETIC ACID; (2S)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)ACETIC ACID; (2S)-2-AMINO-2-(4-[(4-FORMYLPHENYL)METHYL]PHENYL)PROPANOIC ACID; (2S)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(4-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(5-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-AMINO-5-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL(2-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL(3-PYRIDYL))PROPANOIC ACID; (2S)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))ACETIC ACID; (2S)-2-AMINO-2-(6-FORMYL-3-METHOXY(2-PYRIDYL))PROPANOIC ACID; (2S,3R)-2-BENZYL-5-FORMYL-2,3-DIHYDROBENZOFURAN-3-CARBOXYLIC ACID; (2S,3R)-5-FORMYL-2-METHYL-2,3-DIHYDROBENZOFURAN-3-CARBOXYLIC ACID; (2Z)-2,3-DICHLORO-4-OXOBUT-2-ENOIC ACID; (3-FORMYL-2-METHYL-INDOL-1-YL)-ACETIC ACID; (3-FORMYL-4-NITROPHENOXY)ACETIC ACID; (3-FORMYL-5-METHOXY-1H-INDOL-1-YL)ACETIC ACID; (4-BROMO-2-FORMYL-6-METHOXYPHENOXY)ACETIC ACID; (4-BROMO-2-FORMYLPHENOXY)ACETIC ACID; (4-CHLORO-2-FORMYL-6-METHOXYPHENOXY)ACETIC ACID; (4-CHLORO-2-FORMYLPHENOXY)ACETIC ACID; (4-FORMYL-2,6-DIMETHOXYPHENOXY)ACETIC ACID; (4-FORMYL-2-IODO-6-METHOXYPHENOXY)ACETIC ACID; (4-FORMYL-2-IODOPHENOXY)ACETIC ACID; (4-FORMYL-2-M ETHOXYPHENOXY)ACETIC ACID; (4-FORMYL-3,5-DIMETHOXYPHENOXY)ACETIC ACID; (4-FORMYL-3-METHOXYPHENYL)ACETIC ACID; (4-FORMYL-3-PHENYL-1H-PYRAZOL-1-YL)ACETIC ACID; (4-FORMYL-BENZENESULFONYLAMINO)-ACETIC ACID; (4′-FORMYL-BIPHENYL-2-YL)-ACETIC ACID; (4′-FORMYL-BIPHENYL-3-YL)-ACETIC ACID; (4′-FORMYL-BIPHENYL-4-YL)-ACETIC ACID; (4R)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOIC ACID; (4S)-4-AMINO-4-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)BUTANOIC ACID; (5-BROMO-2-ETHOXY-4-FORMYLPHENOXY)ACETIC ACID; (5-BROMO-4-FORMYL-2-METHOXYPHENOXY)ACETIC ACID; (5-CHLORO-2-ETHOXY-4-FORMYLPHENOXY)ACETIC ACID; (5-CHLORO-4-FORMYL-2-METHOXYPHENOXY)ACETIC ACID; (5-FORMYL-2,4-DIMETHYL-1H-PYRROL-3-YL)-ACETIC ACID; (5-FORMYL-2-METHOXYPHENOXY)ACETIC ACID; (5-FORMYL-4-HYDROXY-6-OXO-3-PHENYLPYRIDAZIN-1(6H)-YL)ACETIC ACID; (5-FORMYL-IMIDAZO[2,1-B]THIAZOL-6-YLSULFANYL)-ACETIC ACID; (5R)-5-AMINO-5-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PENTANOIC ACID; (5S)-5-AMINO-5-(3-FORMYL-2-HYDROXY-5-METHYLPHENYL)PENTANOIC ACID; (R)-3-((R)-2-((R)-2-ACETAMIDO-3-METHYLBUTANAMIDO)PROPANAMIDO)-4-OXOBUTANOIC ACID; [(2-FORMYL-1-METHYL-1H-INDOL-3-YL)THIO]ACETIC ACID; [(3-ETHOXY-5-FORMYL-2-HYDROXY-BENZYL)-METHYL-AMINO]-ACETIC ACID; [(3-FORMYL-1-METHYL-1H-INDOL-2-YL)THIO]ACETIC ACID; [(3-FORMYL-6-METHOXYQUINOLIN-2-YL)THIO]ACETIC ACID; [(4-FORMYL-2-NITROPHENYL)THIO]ACETIC ACID; [(4-FORMYL-3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)THIO]ACETIC ACID; [(5-FORMYL-2-HYDROXY-3-METHOXY-BENZYL)-METHYL-AMINO]-ACETIC ACID; [[1-(2-CHLOROBENZYL)-4-FORMYL-3-METHYL-1H-PYRAZOL-5-YL]THIO]ACETIC ACID; [[1-(4-CHLOROBENZYL)-4-FORMYL-3-METHYL-1H-PYRAZOL-5-YL]THIO]ACETIC ACID; [2-(2-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(3-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(4-FORMYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)PHENOXY]ACETIC ACID; [4-FORMYL-3-(4-METHOXYPHENYL)-1H-PYRAZOL-1-YL]ACETIC ACID; [5-(4-FORMYLBENZYLIDENE)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-3-YL]ACETIC ACID; 1-(2,4-DICHLOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(2,5-DICHLOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(2,5-DIMETHYLBENZYL)-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-(2-BROMOPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(2-CHLORO-4-FLUOROBENZYL)-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-(2-CHLORO-4-FORMYLPHENOXY)CYCLOHEXANE-1-CARBOXYLIC ACID; 1-(2-CHLORO-4-FORMYLPHENOXY)CYCLOPENTANE-1-CARBOXYLIC ACID; 1-(2-CHLOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(2-FLUOROBENZYL)-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-(2-FLUOROBENZYL)-3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 1-(2-FLUOROBENZYL)-3-FORMYL-6-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-(3,4-DIMETHYLPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(3-BROMOPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(3-CHLOROBENZYL)-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-(3-CHLOROBENZYL)-4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 1-(3-CHLOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(3-FORMYL-4-HYDROXY-BENZYL)-PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)-2-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)-3-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)-4-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)CYCLOHEPTANE-1-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)CYCLOHEXANE-1-CARBOXYLIC ACID; 1-(3-FORMYLPHENOXY)CYCLOPENTANE-1-CARBOXYLIC ACID; 1-(4-BROMOPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(4-CHLOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(4-ETHOXYPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(4-ETHYLPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(4-FLUOROBENZYL)-3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 1-(4-FLUOROBENZYL)-4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 1-(4-FLUOROPHENYL)-4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 1-(4-FORMYL-2-PHENYL-1,3-THIAZOL-5-YL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(4-FORMYL-BENZENESULFONYL)-PIPERIDINE-4-CARBOXYLIC ACID; 1-(4-FORMYL-BENZENESULFONYL)-PYRROLIDINE-2-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)-2-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)-3-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)-4-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)CYCLOHEPTANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)CYCLOHEXANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENOXY)CYCLOPENTANE-1-CARBOXYLIC ACID; 1-(4-FORMYLPHENYL)-4-PIPERIDINECARBOXYLIC ACID; 1-(5-FORMYL-2-METHOXYBENZYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1,8-NAPHTHALALDEHYDIC ACID; 1-[(5-FORMYL-2-FURYL)METHYL]PYRAZOLE-4-CARBOXYLIC ACID; 1-[2-(3-FORMYLPHENOXY)ETHYL]-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 1-[2-(4-FORMYLPHENOXY)ETHYL]-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID; 12-OXO-9(Z)-DODECENOIC ACID; 1-BENZYL-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-BENZYL-3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 1-BENZYL-4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 1-ETHYL-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 1-ETHYL-3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 1H-INDOLE-1-BUTANOIC ACID, 5-BROMO-3-FORMYL-; 1H-INDOLE-1-BUTANOIC ACID, 7-ETHYL-3-FORMYL-; 1H-INDOLE-3-PROPANOIC ACID, 2-FORMYL-4,5,6,7-TETRAHYDRO-; 1H-PYRAZOLE-3-CARBOXYLIC ACID, 5-FORMYL-1-METHYL-; 1H-PYRROLE-1-ACETIC ACID, 3-FORMYL-; 1-PIPERIDINECARBOXYLIC ACID, 2-(2-FORMYLETHYL)-; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)ACETIC ACID; 2-(2,4-DICHLORO-6-FORMYLPHENOXY)PROPANOIC ACID; 2-(2,6-DIBROMO-4-FORMYLPHENOXY)ACETIC ACID; 2-(2,6-DICHLORO-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-BROMO-4-FORMYL-6-METHOXYPHENOXY)PROPANOIC ACID; 2-(2-BROMO-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-BROMO-6-ETHOXY-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-BROMO-6-FORMYLPHENOXY)ACETIC ACID; 2-(2-BROMO-6-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)PROPANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2,2-DIFLUOROACETIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2,4-DIMETHYLPENTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2-CYCLOPROPYLPROPANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2-ETHYLBUTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2-METHYLBUTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2-METHYLPENTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-2-METHYLPROPANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-3-METHOXY-2-METHYLPROPANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-3-METHYLBUTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)-4-METHOXY-2-METHYLBUTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)BUTANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-CHLORO-4-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-(2-CHLORO-6-ETHOXY-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-ETHOXY-4-FORMYL-6-NITROPHENOXY)PROPANOIC ACID; 2-(2-ETHOXY-4-FORMYLPHENOXY)PENTANOIC ACID; 2-(2-ETHOXY-4-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-ETHOXY-6-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-1H-PYRROL-1-YL)BENZOIC ACID; 2-(2-FORMYL-4-M ETHOXYPHENOXY)ACETIC ACID; 2-(2-FORMYL-4-METHOXYPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-4-METHYLPHENOXY)ACETIC ACID; 2-(2-FORMYL-4-METHYLPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-4-NITROPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-5-METHOXYPHENOXY)ACETIC ACID; 2-(2-FORMYL-5-METHOXYPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-5-PROPOXYPHENOXY)ACETIC ACID; 2-(2-FORMYL-5-PROPOXYPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-6-METHOXY-4-NITROPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-6-METHOXYPHENOXY)ACETIC ACID; 2-(2-FORMYL-6-METHOXYPHENOXY)PROPANOIC ACID; 2-(2-FORMYL-IMIDAZOL-1-YL)-3-PHENYL-PROPIONIC ACID; 2-(2-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID; 2-(2-FORMYLPHENOXY)PENTANOIC ACID; 2-(2-FORMYLPHENOXY)PROPANOIC ACID; 2-(2-FORMYLPHENYL)-4-NITROBENZOIC ACID; 2-(2-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 2-(2-FORMYLPHENYL)-5-METHYLBENZOIC ACID; 2-(2-FORMYLPHENYL)-6-METHYLBENZOIC ACID; 2-(2-FORMYLPHENYL)-ISONICOTINIC ACID; 2-(2-FORMYLPHENYL)NICOTINIC ACID; 2-(2-FORMYL-PYRROL-1-YL)-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHENE-3-CARBOXYLIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-4-CHLOROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-4-FLUOROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-4-NITROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-5-FLUOROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-5-METHOXYBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-5-METHYLBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-6-CHLOROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-6-FLUOROBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)-6-METHYLBENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)BENZOIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)ISONICOTINIC ACID; 2-(2-FORMYLTHIOPHEN-4-YL)NICOTINIC ACID; 2-(2-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2-(3-CARBOXYPHENOXY)-4-CHLORO-5-THIAZOLECARBOXALDEHYDE; 2-(3-CHLORO-2-FORMYLPHENOXY)ACETIC ACID; 2-(3-CHLORO-2-FORMYLPHENOXY)PROPANOIC ACID; 2-(3-FORMYL-1H-INDOL-1-YL)BUTANOIC ACID; 2-(3-FORMYL-1H-INDOL-1-YL)PROPANOIC ACID; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-4,5-DIMETHYL-3-THIOPHENECARBOXYLIC ACID; 2-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-BENZOIC ACID; 2-(3-FORMYL-2-METHOXYPHENOXY)PROPANOIC ACID; 2-(3-FORMYL-4-HYDROXY-5-METHOXYPHENYL)ACETIC ACID; 2-(3-FORMYLPHENOXY)-2,4-DIMETHYLPENTANOIC ACID; 2-(3-FORMYLPHENOXY)-2,5-DIMETHYLHEXANOIC ACID; 2-(3-FORMYLPHENOXY)-2-METHYLBUTANOIC ACID; 2-(3-FORMYLPHENOXY)-2-METHYLPENTANOIC ACID; 2-(3-FORMYLPHENOXY)-2-METHYLPROPANOIC ACID; 2-(3-FORMYLPHENOXY)-2-PHENYLACETIC ACID; 2-(3-FORMYLPHENOXY)-2-PROPYLPENTANOIC ACID; 2-(3-FORMYLPHENOXY)-3-METHOXY-2-METHYLPROPANOIC ACID; 2-(3-FORMYLPHENOXY)-3-METHYLBUTANOIC ACID; 2-(3-FORMYLPHENOXY)-4-METHOXY-2-METHYLBUTANOIC ACID; 2-(3-FORMYLPHENOXY)BUTANOIC ACID; 2-(3-FORMYLPHENOXY)PROPANOIC ACID; 2-(3-FORMYLPHENOXYMETHYL)BENZOIC ACID; 2-(3-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-(3-FORMYLPHENYL)-4-NITROBENZOIC ACID; 2-(3-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 2-(3-FORMYLPHENYL)-5-METHYLBENZOIC ACID; 2-(3-FORMYLPHENYL)-6-METHYLBENZOIC ACID; 2-(3-FORMYLPHENYL)ISONICOTINIC ACID; 2-(3-FORMYLPHENYL)NICOTINIC ACID; 2-(3-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(3-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2-(4-BROMO-2-FORMYLPHENOXY)PROPANOIC ACID; 2-(4-CHLORO-2-FORMYL-6-METHOXYPHENOXY)PROPANOIC ACID; 2-(4-CHLORO-2-FORMYLPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-1H-IMIDAZOL-1-YL)ACETIC ACID; 2-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 2-(4-FORMYL-2,6-DIMETHOXYPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)ACETIC ACID; 2-(4-FORMYL-2,6-DIMETHYLPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)ACETIC ACID; 2-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-2-METHOXY-6-NITROPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-2-METHOXYPHENOXY)PROPANOIC ACID; 2-(4-FORMYL-2-NITROPHENOXY)ACETIC ACID; 2-(4-FORMYL-2-NITROPHENOXY)PROPANOIC ACID; 2-(4-FORMYLPHENOXY)-2,4-DIMETHYLPENTANOIC ACID; 2-(4-FORMYLPHENOXY)-2,5-DIMETHYLHEXANOIC ACID; 2-(4-FORMYLPHENOXY)-2-METHYLBUTANOIC ACID; 2-(4-FORMYLPHENOXY)-2-METHYLPENTANOIC ACID; 2-(4-FORMYLPHENOXY)-2-METHYLPROPANOIC ACID; 2-(4-FORMYLPHENOXY)-2-PHENYLACETIC ACID; 2-(4-FORMYLPHENOXY)-2-PROPYLPENTANOIC ACID; 2-(4-FORMYLPHENOXY)-3-METHOXY-2-METHYLPROPANOIC ACID; 2-(4-FORMYLPHENOXY)-3-METHYLBUTANOIC ACID; 2-(4-FORMYLPHENOXY)-4-METHOXY-2-METHYLBUTANOIC ACID; 2-(4-FORMYLPHENOXY)BUTANOIC ACID; 2-(4-FORMYLPHENOXY)PENTANOIC ACID; 2-(4-FORMYLPHENOXY)PROPANOIC ACID; 2-(4-FORMYLPHENOXYMETHYL)BENZOIC ACID; 2-(4-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-(4-FORMYLPHENYL)-4-NITROBENZOIC ACID; 2-(4-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 2-(4-FORMYLPHENYL)-5-METHYLBENZOIC ACID; 2-(4-FORMYLPHENYL)-6-METHYLBENZOIC ACID; 2-(4-FORMYLPHENYL)ISONICOTINIC ACID; 2-(4-FORMYLPHENYL)NICOTINIC ACID; 2-(4-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(5-(BENZYLOXY)-2-FORMYLPHENOXY)PROPANOIC ACID; 2-(5-FORMYL-1H-BENZIMIDAZOL-1-YL)ACETIC ACID; 2-(5-FORMYL-2-METHOXYPHENOXY)-2-PHENYLACETIC ACID; 2-(5-FORMYL-2-METHOXYPHENOXY)PROPANOIC ACID; 2-(5-FORMYL-2-NITROPHENOXY)ACETIC ACID; 2-(5-FORMYL-2-NITROPHENOXY)PROPANOIC ACID; 2-(5-FORMYLFURAN-2-YL)ACETIC ACID; 2-(5-FORMYL-FURAN-2-YL)-BENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-4-CHLOROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-4-FLUOROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-4-NITROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-5-FLUOROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-5-METHOXYBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-5-METHYLBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-6-CHLOROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-6-FLUOROBENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)-6-METHYLBENZOIC ACID; 2-(5-FORMYL-THIOPHEN-2-YL)-BENZOIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)ISONICOTINIC ACID; 2-(5-FORMYLTHIOPHEN-2-YL)NICOTINIC ACID; 2-(5-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(5-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE MONOHYDRATE; 2-(5-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2,2-DIFLUORO-2-(3-FORMYLPHENOXY)ACETIC ACID; 2,2-DIFLUORO-2-(4-FORMYLPHENOXY)ACETIC ACID; 2,3-DIBROMO-4-OXO-BUTYRIC ACID; 2,4-DICHLORO-5-FLUORO-3-FORMYL-BENZOIC ACID; 2,4-DIFLUORO-5-FORMYLBENZOIC ACID; 2,4-HEXADIENOIC ACID, 2-AMINO-5-METHYL-6-OXO-, (E,Z)-; 2,6-DIFLUORO-4-FORMYLBENZOIC ACID; 2-[(1-FORMYL-2-NAPHTHYL)OXY]PROPANOIC ACID; 2-[(1-FORMYLNAPHTHALEN-2-YL)OXY]ACETIC ACID; 2-[(4-FORMYL-1,3-DIMETHYL-1H-PYRAZOL-5-YL)SULFANYL]ACETIC ACID; 2-[(5-FORMYL-2-METHOXYBENZYL)THIO]NICOTINIC ACID; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]ACETIC ACID; 2-[(6-FORMYL-2H-1,3-BENZODIOXOL-5-YL)OXY]PROPANOIC ACID; 2-[2-(3-FORMYL-INDOL-1-YL)-ACETYLAMINO]-BENZOIC ACID; 2-[4-(2-FORMYL-1H-PYRROL-1-YL)PHENOXY]PROPANOIC ACID; 2-[4-(3-FORMYL-2,5-DIMETHYL-1H-1-PYRROLYL)PHENOXY]PROPANOIC ACID; 2-AMINO-3-FORMYLBENZOIC ACID; 2-AMINO-4-OXOBUTANOIC ACID; 2-AMINO-5-(2-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(2-FORMYLPHENYL)NICOTINIC ACID; 2-AMINO-5-(3-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(3-FORMYLPHENYL)NICOTINIC ACID; 2-AMINO-5-(4-FORMYLPHENYL)ISONICOTINIC ACID; 2-AMINO-5-(4-FORMYLPHENYL)NICOTINIC ACID; 2-BROMO-3-CHLORO-4-OXO-2-BUTENOIC ACID; 2-CARBOXY-3-CHLORO-BENZENALDEHYDE; 2-CARBOXYBENZALDEHYDE; 2-CHLORO-4-(2-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-4-(3-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-4-(4-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-4-(5-FORMYL-FURAN-2-YL)-BENZOIC ACID; 2-CHLORO-4-FORMYLBENZOIC ACID; 2-CHLORO-5-(2-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-5-(2-FORMYLPHENYL)ISONICOTINIC ACID; 2-CHLORO-5-(2-FORMYLPHENYL)NICOTINIC ACID; 2-CHLORO-5-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)BENZOIC ACID; 2-CHLORO-5-(3-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-5-(3-FORMYLPHENYL)ISONICOTINIC ACID; 2-CHLORO-5-(3-FORMYLPHENYL)NICOTINIC ACID; 2-CHLORO-5-(4-FORMYLPHENYL)BENZOIC ACID; 2-CHLORO-5-(4-FORMYLPHENYL)ISONICOTINIC ACID; 2-CHLORO-5-(4-FORMYLPHENYL)NICOTINIC ACID; 2-CHLORO-5-(5-FORMYL-2-FURYL)BENZOIC ACID; 2-CHLORO-5-FORMYL-BENZOIC ACID; 2-CHLORO-6-FLUORO-3-FORMYL-BENZOIC ACID; 2-CYCLOPROPOXY-3-FORMYLBENZOIC ACID; 2-CYCLOPROPOXY-4-FORMYLBENZOIC ACID; 2-CYCLOPROPOXY-5-FORMYLBENZOIC ACID; 2-CYCLOPROPOXY-6-FORMYLBENZOIC ACID; 2-CYCLOPROPYL-2-(3-FORMYLPHENOXY)PROPANOIC ACID; 2-CYCLOPROPYL-2-(4-FORMYLPHENOXY)PROPANOIC ACID; 2-ETHYL-2-(3-FORMYLPHENOXY)BUTANOIC ACID; 2-ETHYL-2-(4-FORMYLPHENOXY)BUTANOIC ACID; 2-FLUORO-4-(2-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-4-(3-FORMYL-2-HYDROXYPHENYL)BENZOIC ACID; 2-FLUORO-4-(3-FORMYL-4-HYDROXYPHENYL)BENZOIC ACID; 2-FLUORO-4-(3-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-4-(4-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-4-(4-FORMYLPYRIDIN-3-YL)BENZOIC ACID; 2-FLUORO-4-(5-FORMYL-2-HYDROXYPHENYL)BENZOIC ACID; 2-FLUORO-4-(5-FORMYLPYRIDIN-3-YL)BENZOIC ACID; 2-FLUORO-4-FORMYLBENZOIC ACID; 2-FLUORO-5-(2-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-5-(3-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-5-(4-FORMYLPHENYL)BENZOIC ACID; 2-FLUORO-5-FORMYLBENZOIC ACID; 2′-FORMYL[1,1′-BIPHENYL]-2-CARBOXYLIC ACID; 2-FORMYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 2-FORMYL-1H-PYRROLE-1-PROPANOIC ACID; 2-FORMYL-3-HYDROXYBENZOIC ACID; 2-FORMYL-3-NITRO-BENZOIC ACID; 2-FORMYL-4,5-DIMETHOXY-BENZOIC ACID; 2-FORMYL-4-HYDROXY-3-METHOXYBENZOIC ACID; 2-FORMYL-4-HYDROXYBENZOIC ACID; 2-FORMYL-4-NITROPHENOXYACETIC ACID; 2-FORMYL-5-HYDROXYBENZOIC ACID; 2-FORMYL-5-IODO-BENZOIC ACID; 2-FORMYL-5-METHOXY-BENZOIC ACID; 2-FORMYL-5-NITROBENZOIC ACID; 2-FORMYL-6H-FURO[2,3-B]PYRROLE-5-CARBOXYLIC ACID; 2-FORMYL-6-HYDROXYBENZOIC ACID; 2-FORMYL-6-METHOXYBENZOIC ACID; 2′-FORMYL-BIPHENYL-3-CARBOXYLIC ACID; 2′-FORMYL-BIPHENYL-4-CARBOXYLIC ACID; 2-FORMYLCINNAMIC ACID; 2-FORMYLCYCLOPENT-2-ENECARBOXYLIC ACID; 2-FORMYLPHENOXYACETIC ACID; 2-FORMYLQUINOLINE-6-CARBOXYLIC ACID; 2-FORMYLQUINOLINE-8-CARBOXYLIC ACID; 2-FORMYLTHIOPHENE-3-CARBOXYLIC ACID; 2-HYDROXYISOPHTHALALDEHYDE ACID HYDRATE; 2-NAPHTHALENECARBOXYLIC ACID, 5-FORMYL-4-HYDROXY-6,7-DIMETHOXY-; 2-PYRROLECARBAMIC ACID, 4-FORMYL-3,5-DIMETHYL-; 3-(2,4-DIMETHYL-5-FORMYL-1H-PYRROLE-3-YL)PROPANOIC ACID; 3-(2-CHLORO-4-FORMYL-6-METHOXY-PHENOXYMETHYL)-BENZOIC ACID; 3-(2-CHLORO-4-FORMYLPHENOXY)PROPANOIC ACID; 3-(2-CHLORO-4-FORMYLPHENOXY)THIANE-3-CARBOXYLIC ACID; 3-(2-CHLORO-4-FORMYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-(2-ETHOXY-4-FORMYLPHENOXY)PROPANOIC ACID; 3-(2-FORMYL-1H-PYRROL-1-YL)-4-METHYL-BENZOIC ACID; 3-(2-FORMYL-1H-PYRROL-1-YL)BENZOIC ACID; 3-(2-FORMYL-4-METHYL-1H-PYRROL-3-YL)-PROPIONIC ACID; 3-(2-FORMYL-IMIDAZOL-1-YL)-PROPIONIC ACID; 3-(2-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID; 3-(2-FORMYLPHENOXY)PROPANOIC ACID; 3-(2-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 3-(2-FORMYLPHENYL)-2-METHYLBENZOIC ACID; 3-(2-FORMYLPHENYL)-5-HYDROXYBENZOIC ACID; 3-(2-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 3-(2-FORMYLPHENYL)-5-NITROBENZOIC ACID; 3-(2-FORMYLPHENYL)-5-TRIFLUOROMETHYLBENZOIC ACID; 3-(2-FORMYLPHENYL)ISONICOTINIC ACID; 3-(2-FORMYLPHENYL)PICOLINIC ACID; 3-(2-FORMYLPHENYL)PROPANOIC ACID; 3-(2-FORMYLTHIOPHEN-3-YL)PROPIOLIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-2-METHOXYBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-2-METHYLBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-4-CHLOROBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-4-FLUOROBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-CHLOROBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-FLUOROBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-HYDROXYBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-METHOXYBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-NITROBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-5-TRIFLUOROMETHYLBENZOIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)-6-AMINOPICOLINIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)ISONICOTINIC ACID; 3-(2-FORMYLTHIOPHEN-4-YL)PICOLINIC ACID; 3-(3-FORMYL-1H-INDOL-1-YL)PROPANOIC ACID; 3-(3-FORMYL-1H-INDOL-5-YL)BENZOIC ACID; 3-(3-FORMYL-1H-PYRROL-1-YL)PROPANOIC ACID; 3-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-4-METHYLBENZOIC ACID; 3-(3-FORMYL-2,5-DIMETHYL-PYRROL-1-YL)-2-METHYL-BENZOIC ACID; 3-(3-FORMYL-2,5-DIMETHYL-PYRROL-1-YL)-BENZOIC ACID; 3-(3-FORMYLPHENOXY)PROPANOIC ACID; 3-(3-FORMYLPHENOXY)THIANE-3-CARBOXYLIC ACID; 3-(3-FORMYLPHENOXY)THIOLANE-3-CARBOXYLIC ACID; 3-(3-FORMYLPHENOXYMETHYL)BENZOIC ACID; 3-(3-FORMYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-(3-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 3-(3-FORMYLPHENYL)-2-METHYLBENZOIC ACID; 3-(3-FORMYLPHENYL)-5-HYDROXYBENZOIC ACID; 3-(3-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 3-(3-FORMYLPHENYL)-5-NITROBENZOIC ACID; 3-(3-FORMYLPHENYL)-5-TRIFLUOROMETHYLBENZOIC ACID; 3-(3-FORMYLPHENYL)ISONICOTINIC ACID; 3-(3-FORMYLPHENYL)PICOLINIC ACID; 3-(3-FORMYLPHENYL)PROPANOIC ACID; 3-(3-OXOPROPYL)-BENZOIC ACID; 3-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 3-(4-FORMYL-2-METHOXY-5-NITROPHENOXY)PROPANOIC ACID; 3-(4-FORMYL-2-METHOXYPHENOXY)PROPANOIC ACID; 3-(4-FORMYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)PROPANOIC ACID; 3-(4-FORMYLPHENOXY)PROPANOIC ACID; 3-(4-FORMYLPHENOXY)THIANE-3-CARBOXYLIC ACID; 3-(4-FORMYLPHENOXY)THIOLANE-3-CARBOXYLIC ACID; 3-(4-FORMYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-(4-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 3-(4-FORMYLPHENYL)-2-METHYLBENZOIC ACID; 3-(4-FORMYLPHENYL)-3-METHYLBUTANOIC ACID; 3-(4-FORMYLPHENYL)-5-HYDROXYBENZOIC ACID; 3-(4-FORMYLPHENYL)-5-METHOXYBENZOIC ACID; 3-(4-FORMYLPHENYL)-5-NITROBENZOIC ACID; 3-(4-FORMYLPHENYL)-5-TRIFLUOROMETHYLBENZOIC ACID; 3-(4-FORMYLPHENYL)ISONICOTINIC ACID; 3-(4-FORMYLPHENYL)PICOLINIC ACID; 3-(4-FORMYLPHENYL)PROPANOIC ACID; 3-(5-FORMYL-2-FURYL)BENZOIC ACID; 3-(5-FORMYL-3-THIENYL)BENZOIC ACID; 3-(5-FORMYL-FURAN-2-YL)-2-METHYL-BENZOIC ACID; 3-(5-FORMYL-FURAN-2-YL)-4-METHYL-BENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-2-METHOXYBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-2-METHYLBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-4-CHLOROBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-4-FLUOROBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-CHLOROBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-FLUOROBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-HYDROXYBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-METHOXYBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-NITROBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-5-TRIFLUOROMETHYLBENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)-6-AMINOPICOLINIC ACID; 3-(5-FORMYL-THIOPHEN-2-YL)-BENZOIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)ISONICOTINIC ACID; 3-(5-FORMYLTHIOPHEN-2-YL)PICOLINIC ACID; 3-(5-FORMYLTHIOPHEN-3-YL)PROPIOLIC ACID; 3-(7-FORMYL-8-HYDROXY-QUINOLIN-5-YL)-PROPIONIC ACID; 3,4-DIFORMYL-5-(4-METHOXY-3-NITROPHENYL)PENTANOIC ACID; 3,4-DIMETHYL-5-FORMYLPYRROLE-2-CARBOXYLIC ACID; 3-[(1-FORMYL-2-NAPHTHYL)OXY]PROPANOIC ACID; 3-[(2-CHLORO-6-ETHOXY-4-FORMYLPHENOXY)METHYL]BENZOIC ACID; 3-[(4-FORMYL-2-METHOXYPHENOXY)METHYL]BENZOIC ACID; 3-[(4-FORMYLPHENOXY)METHYL]BENZOIC ACID; 3-[2-(3-FORMYL-INDOL-1-YL)-ACETYLAMINO]-BENZOIC ACID; 3-[4-FORMYL-3-(4-METHOXYPHENYL)-1H-PYRAZOL-1-YL]PROPANOIC ACID; 3-AMINO-5-(2-FORMYLPHENYL)BENZOIC ACID; 3-AMINO-5-(3-FORMYLPHENYL)BENZOIC ACID; 3-AMINO-5-(4-FORMYLPHENYL)BENZOIC ACID; 3-BROMO-2-FORMYL-5-NITRO-BENZOIC ACID; 3-CARBOXYBENZALDEHYDE; 3-CARBOXYLIC ACID-1H-INDAZOLE-4-CARBOXALDEHYDE; 3-CHLORO-2-FORMYL-5-NITRO-BENZOIC ACID; 3-CHLORO-2-FORMYLBENZOIC ACID; 3-CHLORO-5-FORMYLPYRIDINE-2-CARBOXYLIC ACID; 3-CYCLOPROPOXY-2-FORMYLBENZOIC ACID; 3-CYCLOPROPOXY-2-FORMYLISONICOTINIC ACID; 3-CYCLOPROPOXY-4-FORMYLBENZOIC ACID; 3-CYCLOPROPOXY-4-FORMYLPICOLINIC ACID; 3-CYCLOPROPOXY-5-FORMYLBENZOIC ACID; 3-CYCLOPROPOXY-5-FORMYLISONICOTINIC ACID; 3-CYCLOPROPOXY-5-FORMYLPICOLINIC ACID; 3-CYCLOPROPOXY-6-FORMYLPICOLINIC ACID; 3-FLUORO-4-(2-FORMYLPHENYL)BENZOIC ACID; 3-FLUORO-4-(3-FORMYLPHENYL)BENZOIC ACID; 3-FLUORO-4-(4-FORMYLPHENYL)BENZOIC ACID; 3′-FORMYL(1,1′-BIPHENYL)-3-CARBOXYLIC ACID; 3′-FORMYL(1,1′-BIPHENYL)-4-CARBOXYLIC ACID; 3′-FORMYL[1,1-BIPHENYL]-2-CARBOXYLIC ACID; 3-FORMYL-1-(2-METHYLBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1-(4-METHOXYBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1-(4-VINYLBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1H-INDAZOLE-4-CARBOXYLIC ACID; 3-FORMYL-1H-INDAZOLE-5-CARBOXYLIC ACID; 3-FORMYL-1H-INDAZOLE-6-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-4-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-6-CARBOXYLIC ACID; 3-FORMYL-1H-INDOLE-7-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-4-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[2,3-C]PYRIDINE-7-CARBOXYLIC ACID; 3-FORMYL-1H-PYRROLO[3,2-B]PYRIDINE-5-CARBOXYLIC ACID; 3-FORMYL-1-ISOBUTYL-1H-INDOLE-4-CARBOXYLIC ACID; 3-FORMYL-1-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-1-METHYL-1H-INDOLE-4-CARBOXYLIC ACID; 3-FORMYL-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-FORMYL-2-FUROIC ACID; 3-FORMYL-2-THIOPHENECARBOXYLIC ACID; 3-FORMYL-4,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-4-AZAINDOLE-6-CARBOXYLIC ACID; 3′-FORMYL-4′-HYDROXY[1,1′-BIPHENYL]-3-CARBOXYLIC ACID; 3′-FORMYL-4-HYDROXY[1,1-BIPHENYL]-3-CARBOXYLIC ACID; 3′-FORMYL-4′-HYDROXY[1,1-BIPHENYL]-4-CARBOXYLIC ACID; 3-FORMYL-4-HYDROXYBENZOIC ACID; 3-FORMYL-4-METHOXY-BENZOIC ACID; 3-FORMYL-4-METHYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID; 3-FORMYL-5,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-5-HYDROXYBENZOIC ACID; 3-FORMYL-5-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-5-METHOXY-BENZOIC ACID; 3-FORMYL-5-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1-(2-METHYLBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1-(4-METHOXYBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1-(4-METHYLBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1-(4-VINYLBENZYL)-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYL-6-METHOXY-1-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 3-FORMYLINDOL-1-YL-ACETIC ACID; 3-FORMYLINDOLE-5-CARBOXYLIC ACID; 3-FORMYLPHENOXYACETIC ACID; 3-FORMYLPICOLINIC ACID; 3-FORMYLSALICYLIC ACID; 3-OXOPROPANOIC ACID; 4-([(4-FORMYL-2-METHOXYPHENOXY)ACETYL]AMINO)BENZOIC ACID; 4-([2-(1,3-BENZOXAZOL-2-YL)-3-OXO-1-PROPENYL]AMINO)-2-HYDROXYBENZOIC ACID; 4-(2,6-DIHYDROXYBENZOYL)-3-FORMYL-5-HYDROXYBENZOIC ACID; 4-(2-BUTYL-5-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID; 4-(2-CARBOXYTHIOPHEN-3-YL)BENZALDEHYDE; 4-(2-CARBOXYTHIOPHENE-4-YL)-2-FORMYLPHENOL; 4-(2-CHLORO-4-FORMYLPHENOXY)BUTANOIC ACID; 4-(2-CHLORO-4-FORMYLPHENOXY)OXANE-4-CARBOXYLIC ACID; 4-(2-CHLORO-4-FORMYLPHENOXY)PENTANOIC ACID; 4-(2-CHLORO-4-FORMYLPHENOXY)THIANE-4-CARBOXYLIC ACID; 4-(2-CHLORO-4-FORMYLPHENOXYMETHYL)-1,3-THIAZOLE-2-CARBOXYLIC ACID; 4-(2-ETHOXY-4-FORMYLPHENOXYMETHYL)BENZOIC ACID; 4-(2-FORMYL-1H-PYRROL-1-YL)-3-METHYL-BENZOIC ACID; 4-(2-FORMYL-1H-PYRROL-1-YL)BENZOIC ACID; 4-(2-FORMYL-IMIDAZOL-1-YL)-BUTYRIC ACID; 4-(2-FORMYL-IMIDAZOL-1-YLMETHYL)-BENZOIC ACID; 4-(2-FORMYLPHENYL)-2-HYDROXYBENZOIC ACID; 4-(2-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 4-(2-FORMYLPHENYL)-2-NITROBENZOIC ACID; 4-(2-FORMYLPHENYL)-3-HYDROXYBENZOIC ACID; 4-(2-FORMYLPHENYL)-3-METHOXYBENZOIC ACID; 4-(2-FORMYLPHENYL)-3-METHYLBENZOIC ACID; 4-(2-FORMYLPHENYL)NICOTINIC ACID; 4-(2-FORMYLPHENYL)PICOLINIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-2-CHLOROBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-2-FLUOROBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-2-HYDROXYBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-2-METHOXYBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-2-NITROBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-3-FLUOROBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-3-HYDROXYBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-3-METHOXYBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)-3-METHYLBENZOIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)NICOTINIC ACID; 4-(2-FORMYLTHIOPHEN-4-YL)PICOLINIC ACID; 4-(2-OXOACETYL)BENZOIC ACID; 4-(3-CARBOXY-4-CHLOROPHENYL)-2-FORMYLPHENOL; 4-(3-CARBOXY-5-FLUOROPHENYL)-2-FORMYLPHENOL; 4-(3-FORMYL-1H-INDOL-5-YL)BENZOIC ACID; 4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)-BENZENEACETIC ACID; 4-(3-FORMYL-2,5-DIMETHYL-1H-PYRROL-1-YL)BENZENECARBOXYLIC ACID; 4-(3-FORMYL-2,5-DIMETHYL-PYRROL-1-YL)-3-METHYL-BENZOIC ACID; 4-(3-FORMYL-4-NITRO-PHENOXY)-BUTYRIC ACID; 4-(3-FORMYLPHENOXY)BUTANOIC ACID; 4-(3-FORMYLPHENOXY)OXANE-4-CARBOXYLIC ACID; 4-(3-FORMYLPHENOXY)PENTANOIC ACID; 4-(3-FORMYLPHENOXY)THIANE-4-CARBOXYLIC ACID; 4-(3-FORMYLPHENOXYMETHYL)-1,3-THIAZOLE-2-CARBOXYLIC ACID; 4-(3-FORMYLPHENOXYMETHYL)-5-METHYLFURAN-2-CARBOXYLIC ACID; 4-(3-FORMYLPHENOXYMETHYL)BENZOIC ACID; 4-(3-FORMYLPHENYL)-2-HYDROXYBENZOIC ACID; 4-(3-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 4-(3-FORMYLPHENYL)-2-NITROBENZOIC ACID; 4-(3-FORMYLPHENYL)-3-HYDROXYBENZOIC ACID; 4-(3-FORMYLPHENYL)-3-METHOXYBENZOIC ACID; 4-(3-FORMYLPHENYL)-3-METHYLBENZOIC ACID; 4-(3-FORMYLPHENYL)NICOTINIC ACID; 4-(3-FORMYLPHENYL)PICOLINIC ACID; 4-(3-FORMYL-PYRIDIN-2-YL)-BENZOIC ACID; 4-(3-METHOXY-4-FORMYL)PHENOXYBUTYRIC ACID; 4-(3-OXOPROPYL)-BENZOIC ACID; 4-(4-FORMYL-1H-IMIDAZOL-2-YL)-BENZOIC ACID; 4-(4-FORMYL-2-METHOXYPHENOXY)BUTANOIC ACID; 4-(4-FORMYL-3,5-DIMETHOXYPHENOXY)BUTYRIC ACID; 4-(4-FORMYLPHENOXY)BENZOIC ACID; 4-(4-FORMYLPHENOXY)BUTANOIC ACID; 4-(4-FORMYLPHENOXY)OXANE-4-CARBOXYLIC ACID; 4-(4-FORMYLPHENOXY)PENTANOIC ACID; 4-(4-FORMYLPHENOXY)THIANE-4-CARBOXYLIC ACID; 4-(4-FORMYLPHENOXYMETHYL)-1,3-THIAZOLE-2-CARBOXYLIC ACID; 4-(4-FORMYLPHENOXYMETHYL)-5-METHYLFURAN-2-CARBOXYLIC ACID; 4-(4-FORMYLPHENOXYMETHYL)BENZOIC ACID; 4-(4-FORMYLPHENYL)-2-HYDROXYBENZOIC ACID; 4-(4-FORMYLPHENYL)-2-METHOXYBENZOIC ACID; 4-(4-FORMYLPHENYL)-2-NITROBENZOIC ACID; 4-(4-FORMYLPHENYL)-3-HYDROXYBENZOIC ACID; 4-(4-FORMYLPHENYL)-3-METHOXYBENZOIC ACID; 4-(4-FORMYLPHENYL)-3-METHYLBENZOIC ACID; 4-(4-FORMYLPHENYL)NICOTINIC ACID; 4-(4-FORMYLPHENYL)PICOLINIC ACID; 4-(5-CARBOXY-2-FLUOROPHENYL)-2-FORMYLPHENOL; 4-(5-FORMYL-2-FURYL)BENZOIC ACID; 4-(5-FORMYL-2-FURYL)THIOPHENE-2-CARBOXYLIC ACID; 4-(5-FORMYL-3-THIENYL)BENZOIC ACID; 4-(5-FORMYL-FURAN-2-YL)-2-HYDROXY-BENZOIC ACID; 4-(5-FORMYL-FURAN-2-YL)-3-METHYL-BENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-2-CHLOROBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-2-FLUOROBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-2-HYDROXYBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-2-METHOXYBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-2-NITROBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-3-FLUOROBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-3-HYDROXYBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-3-METHOXYBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)-3-METHYLBENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)BENZOIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)NICOTINIC ACID; 4-(5-FORMYLTHIOPHEN-2-YL)PICOLINIC ACID; 4′-(BENZYLOXY)-3′-FORMYL[1,1-BIPHENYL]-3-CARBOXYLIC ACID; 4′-(BENZYLOXY)-3′-FORMYL[1,1-BIPHENYL]-4-CARBOXYLIC ACID; 4,5-DIOXOVALERIC ACID; 4-[(2,6-DICHLORO-4-FORMYLPHENOXY)METHYL]BENZOIC ACID; 4-[(2-BROMO-4-FORMYLPHENOXY)METHYL]BENZOIC ACID; 4-[(2-CHLORO-4-FORMYL-6-METHOXYPHENOXY)METHYL]BENZOIC ACID; 4-[(2-CHLORO-6-ETHOXY-4-FORMYLPHENOXY)METHYL]BENZOIC ACID; 4-[(2-FORMYL-6-METHOXYPHENOXY)METHYL]BENZOIC ACID; 4-[(2-FORMYLPHENOXY)METHYL]BENZOIC ACID; 4-[(3-FORMYLPHENOXY)METHYL]-5-METHYLISOXAZOLE-3-CARBOXYLIC ACID; 4-[(4-BROMO-2-FORMYLPHENOXY)METHYL]BENZOIC ACID; 4-[(4-FORMYL-2-METHOXYPHENOXY)METHYL]BENZOIC ACID; 4-[(4-FORMYL-3-HYDROXYPHENOXY)METHYL]BENZENECARBOXYLIC ACID; 4-[(4-FORMYLPHENOXY)METHYL]-5-METHYLISOXAZOLE-3-CARBOXYLIC ACID; 4-[(Z)-2-(3-FORMYL-4-HYDROXYPHENYL)DIAZENYL]BENZENECARBOXYLIC ACID; 4-[1-(HYDROXYMETHYLENE)-2-OXOETHYL]-3-NITROBENZOIC ACID; 4-[2-(3-FORMYL-INDOL-1-YL)-ACETYLAMINO]-BENZOIC ACID; 4-[3-(2-CHLOROPHENYL)-4-FORMYL-1H-PYRAZOL-1-YL]BENZOIC ACID; 4-[4-FORMYL-3-(4-METHOXYPHENYL)-1H-PYRAZOL-1-YL]BENZOIC ACID; 4-ACETYL-5-FORMYL-3-METHYL-PYRROLE-2-CARBOXYLIC ACID; 4-AMINO-2′-FORMYL[1,1-BIPHENYL]-3-CARBOXYLIC ACID; 4-AMINO-4′-FORMYL[1,1-BIPHENYL]-3-CARBOXYLIC ACID; 4-AMINO-PYRIDINE-3-CARBALDEHYDE TRIFLUOROACETATE; 4-BROMO-2-FORMYL-5-NITRO-BENZOIC ACID; 4-BROMO-2-FORMYLBENZOIC ACID; 4-BROMO-3-FORMYL-6-INDAZOLECARBOXYLIC ACID; 4-CARBONYLCYCLOHEXANECARBOXYLIC ACID; 4-CARBONYLPHENYLACETIC ACID; 4-CARBOXY-2,6-DIFLUOROBENZALDEHYDE; 4-CARBOXYBENZALDEHYDE; 4-CHLORO-2-(2-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-2-(3-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-2-(4-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-2-FORMYL-5-NITRO-BENZOIC ACID; 4-CHLORO-3-(2-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-3-(3-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-3-(4-FORMYLPHENYL)BENZOIC ACID; 4-CHLORO-3-(5-FORMYL-FURAN-2-YL)-BENZOIC ACID; 4-CHLORO-6-CARBOXYLIC ACID-3-(1H)INDAZOLE CARBOXALDEHYDE; 4-CYANO-2-FORMYLBENZOIC ACID; 4-CYCLOPROPOXY-2-FORMYLBENZOIC ACID; 4-CYCLOPROPOXY-2-FORMYLNICOTINIC ACID; 4-CYCLOPROPOXY-3-FORMYLBENZOIC ACID; 4-CYCLOPROPOXY-3-FORMYLPICOLINIC ACID; 4-CYCLOPROPOXY-5-FORMYLNICOTINIC ACID; 4-CYCLOPROPOXY-5-FORMYLPICOLINIC ACID; 4-CYCLOPROPOXY-6-FORMYLNICOTINIC ACID; 4-CYCLOPROPOXY-6-FORMYLPICOLINIC ACID; 4-ETHYL-5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FLUORO-2-(2-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-2-(3-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-2-(4-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-3-(2-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-3-(3-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-3-(4-FORMYLPHENYL)BENZOIC ACID; 4-FLUORO-3-FORMYL-6-INDAZOLECARBOXYLIC ACID; 4-FLUORO-3-FORMYL-BENZOIC ACID; 4-FLUORO-5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-[1,1-BIPHENYL]-2-CARBOXYLIC ACID; 4-FORMYL-1-(2-METHOXYPHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(2-METHYLPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(3-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(3-METHOXYPHENYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(3-METHYLPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(4-ISOPROPYLPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(4-METHOXYBENZYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(4-METHYLPHENYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1-(MESITYLMETHYL)-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1,2,5-TRIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1H-IMIDAZOLE-2-CARBOXYLIC ACID; 4-FORMYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-1-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(2-METHYLBENZYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(2-METHYLPHENYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(3-METHYLBENZYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(3-METHYLPHENYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(4-METHYLBENZYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-(4-METHYLPHENYL)-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2,5-DIMETHYL-1-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-FORMYL-2-HYDROXYBENZOIC ACID; 4′-FORMYL-2′ETHYLBIPHENYL-4-CARBOXYLIC ACID; 4-FORMYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-FORMYL-3-HYDROXYBENZOIC ACID; 4-FORMYL-3-METHOXY-PHENOXYACETIC ACID; 4-FORMYL-3-THIOPHENECARBOXYLIC ACID; 4′-FORMYL-4-HYDROXY[1,1′-BIPHENYL]-3-CARBOXYLIC ACID; 4-FORMYLBICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID; 4′-FORMYL-BIPHENYL-2-CARBOXYLIC ACID; 4′-FORMYLBIPHENYL-3-CARBOXYLIC ACID; 4′-FORMYL-BIPHENYL-4-CARBOXYLIC ACID; 4-FORMYLCINNAMIC ACID; 4-FORMYLNAPHTHALENE-1-CARBOXYLIC ACID; 4-FORMYLNICOTINIC ACID; 4-FORMYLPHENOXYACETIC ACID; 4-FORMYLQUINOLINE-6-CARBOXYLIC ACID; 4-FORMYLQUINOLINE-8-CARBOXYLIC ACID; 4-PIPERIDINECARBOXYLIC ACID, 4-FORMYL-; 4-PYRIMIDINECARBOXYLIC ACID, 5-FORMYL-; 5-((3-FORMYL-1H-INDOL-1-YL)METHYL)FURAN-2-CARBOXYLIC ACID; 5-(2-CARBOXYTHIOPHENE-4-YL)-2-FORMYLPHENOL; 5-(2-CHLORO-4-FORMYLPHENOXY)PENTANOIC ACID; 5-(2-CHLORO-4-FORMYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 5-(2-CHLORO-4-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 5-(2-CHLORO-4-FORMYLPHENOXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 5-(2-FORMYL-1H-PYRROL-1-YL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 5-(2-FORMYLPHENYL)-2-FUROIC ACID; 5-(2-FORMYLPHENYL)-2-HYDROXYISONICOTINIC ACID; 5-(2-FORMYLPHENYL)-2-HYDROXYNICOTINIC ACID; 5-(2-FORMYLPHENYL)-2-METHOXYNICOTINIC ACID; 5-(2-FORMYLPHENYL)-2-THIOPHENECARBOXYLIC ACID; 5-(2-FORMYLPHENYL)-6-HYDROXYNICOTINIC ACID; 5-(2-FORMYLPHENYL)NICOTINIC ACID; 5-(2-FORMYLPHENYL)-PICOLINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-AMINOISONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-AMINONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-CHLOROBENZOIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-CHLOROISONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-CHLORONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-FLUOROBENZOIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-HYDROXYISONICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-HYDROXYNICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-2-METHOXYNICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-3-AMINOBENZOIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)-6-HYDROXYNICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)NICOTINIC ACID; 5-(2-FORMYLTHIOPHEN-4-YL)PICOLINIC ACID; 5-(3-ALLYLOXY-4-FORMYL-PHENOXY)-PENTANOIC ACID; 5-(3-CARBOXY-4-CHLOROPHENYL)-2-FORMYLPHENOL; 5-(3-CARBOXY-5-FLUOROPHENYL)-2-FORMYLPHENOL; 5-(3-CARBOXYPHENYL)-2-FORMYLPHENOL; 5-(3-FORMYL-1H-INDOL-1-YL)THIOPHENE-2-CARBOXYLIC ACID; 5-(3-FORMYLPHENOXY)PENTANOIC ACID; 5-(3-FORMYLPHENOXYMETHYL)-1,2-OXAZOLE-3-CARBOXYLIC ACID; 5-(3-FORMYLPHENOXYMETHYL)-2-METHYLFURAN-3-CARBOXYLIC ACID; 5-(3-FORMYLPHENOXYMETHYL)-3-METHYLFURAN-2-CARBOXYLIC ACID; 5-(3-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 5-(3-FORMYLPHENOXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 5-(3-FORMYLPHENYL)-2-FUROIC ACID; 5-(3-FORMYLPHENYL)-2-HYDROXYISONICOTINIC ACID; 5-(3-FORMYLPHENYL)-2-HYDROXYNICOTINIC ACID; 5-(3-FORMYLPHENYL)-2-METHOXYNICOTINIC ACID; 5-(3-FORMYLPHENYL)-6-HYDROXYNICOTINIC ACID; 5-(3-FORMYLPHENYL)NICOTINIC ACID; 5-(3-FORMYLPHENYL)PICOLINIC ACID; 5-(4-CARBOXY-3-FLUOROPHENYL)-2-FORMYLPHENOL; 5-(4-CARBOXYPHENYL)-2-FORMYLPHENOL; 5-(4-FORMYL-3,5-DIMETHOXYPHENOXY)PENTANOIC ACID; 5-(4-FORMYL-3-HYDROXY-PHENOXY)-PENTANOIC ACID; 5-(4-FORMYLPHENOXY)PENTANOIC ACID; 5-(4-FORMYLPHENOXYMETHYL)-1,2-OXAZOLE-3-CARBOXYLIC ACID; 5-(4-FORMYLPHENOXYMETHYL)-2-METHYLFURAN-3-CARBOXYLIC ACID; 5-(4-FORMYLPHENOXYMETHYL)-3-METHYLFURAN-2-CARBOXYLIC ACID; 5-(4-FORMYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 5-(4-FORMYLPHENOXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 5-(4-FORMYLPHENYL)-2-FUROIC ACID; 5-(4-FORMYLPHENYL)-2-HYDROXYISONICOTINIC ACID; 5-(4-FORMYLPHENYL)-2-HYDROXYNICOTINIC ACID; 5-(4-FORMYLPHENYL)-2-METHOXYNICOTINIC ACID; 5-(4-FORMYLPHENYL)-6-HYDROXYNICOTINIC ACID; 5-(4-FORMYLPHENYL)NICOTINIC ACID; 5-(4-FORMYLPHENYL)-PICOLINIC ACID; 5-(5-CARBOXY-2-FLUOROPHENYL)-2-FORMYLPHENOL; 5-(5-FORMYL-2-FURYL)-2-HYDROXYBENZOIC ACID; 5-(5-FORMYL-2-FURYL)-2-METHYLBENZOIC ACID; 5-(5-FORMYL-2-THIENYL)-2-HYDROXYBENZOIC ACID; 5-(5-FORMYL-FURAN-2-YL)-THIOPHENE-2-CARBOXYLIC ACID; 5-(5-FORMYLPYRIDIN-2-YL)THIOPHENE-2-CARBOXYLIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-AMINOISONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-AMINONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-CHLOROBENZOIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-CHLOROISONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-CHLORONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-FLUOROBENZOIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-HYDROXYISONICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-HYDROXYNICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-2-METHOXYNICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-3-AMINOBENZOIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)-6-HYDROXYNICOTINIC ACID; 5-(5-FORMYL-THIOPHEN-2-YL)-FURAN-2-CARBOXYLIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)NICOTINIC ACID; 5-(5-FORMYLTHIOPHEN-2-YL)PICOLINIC ACID; 5-(5-FORMYL-THIOPHEN-3-YL)-FURAN-2-CARBOXYLIC ACID; 5-(6-FORMYLPYRIDIN-2-YL)THIOPHENE-2-CARBOXYLIC ACID; 5-[(2-FORMYL-6-METHOXYPHENOXY)METHYL]-2-FUROIC ACID; 5-[(2-FORMYLPHENOXY)METHYL]-2-FUROIC ACID; 5-[(3-FORMYLPHENOXY)METHYL]-2-FUROIC ACID; 5-[(4-FORMYLPHENOXY)METHYL]-2-FUROIC ACID; 5-BROMO-2-FORMYL-BENZOIC ACID; 5-BROMO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5-CARBOXYVANILLIN; 5-CHLORO-2-(3-OXOPROPYL)-BENZOIC ACID; 5-CHLORO-2-FORMYL-BENZOIC ACID; 5-CHLORO-3-(2-FORMYLPHENYL)BENZOIC ACID; 5-CHLORO-3-(3-FORMYLPHENYL)BENZOIC ACID; 5-CHLORO-3-(4-FORMYLPHENYL)BENZOIC ACID; 5-CHLORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5-CHLORO-4-FORMYL-1-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-CHLORO-4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-CYCLOPROPOXY-2-FORMYLBENZOIC ACID; 5-CYCLOPROPOXY-2-FORMYLISONICOTINIC ACID; 5-CYCLOPROPOXY-2-FORMYLNICOTINIC ACID; 5-CYCLOPROPOXY-3-FORMYLPICOLINIC ACID; 5-CYCLOPROPOXY-4-FORMYLNICOTINIC ACID; 5-CYCLOPROPOXY-4-FORMYLPICOLINIC ACID; 5-CYCLOPROPOXY-6-FORMYLNICOTINIC ACID; 5-CYCLOPROPOXY-6-FORMYLPICOLINIC ACID; 5-FLUORO-2-(2-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-2-(3-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-2-(4-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-2-FORMYLBENZOIC ACID; 5-FLUORO-3-(2-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-3-(3-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-3-(4-FORMYLPHENYL)BENZOIC ACID; 5-FLUORO-3-FORMYL-1H-INDOLE-2-CARBOXYLIC ACID; 5′-FORMYL-[2,2′]BIFURANYL-5-CARBOXYLIC ACID; 5′-FORMYL-[2,2]BITHIOPHENYL-5-CARBOXYLIC ACID; 5′-FORMYL-[2,3′]BITHIOPHENYL-5-CARBOXYLIC ACID; 5-FORMYL-1-BENZOFURAN-2-CARBOXYLIC ACID; 5-FORMYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-2,4-DIMETHOXY-BENZOIC ACID; 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-FORMYL-2-FURANCARBOXYLIC ACID; 5-FORMYL-2-METHOXYBENZOIC ACID; 5-FORMYL-2-PYRIDINECARBOXYLIC ACID; 5-FORMYL-2-THIOPHENECARBOXYLIC ACID; 5′-FORMYL-3,3′-BITHIOPHENE-5-CARBOXYLIC ACID; 5-FORMYL-3-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-4-HYDROXYPICOLINIC ACID; 5-FORMYL-4-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-FORMYL-4-METHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-FORMYL-4-METHYLTHIOPHENE-2-CARBOXYLIC ACID; 5-FORMYL-4-PHENANTHRENECARBOXYLIC ACID; 5-FORMYLNICOTINIC ACID; 5-FORMYLSALICYLIC ACID; 5-FORMYL-THIAZOLE-4-CARBOXYLIC ACID; 5-FORMYLTHIOPHENE-3-CARBOXYLIC ACID; 5-THIAZOLECARBOXYLIC ACID, 2-FORMYL; 6-(2-CARBOXYTHIOPHENE-4-YL)-2-FORMYLPHENOL; 6-(2-FORMYLPHENYL)NICOTINIC ACID; 6-(2-FORMYLPHENYL)PICOLINIC ACID; 6-(2-FORMYLTHIOPHEN-4-YL)NICOTINIC ACID; 6-(2-FORMYLTHIOPHEN-4-YL)PICOLINIC ACID; 6-(3-CARBOXY-4-CHLOROPHENYL)-2-FORMYLPHENOL; 6-(3-CARBOXY-5-FLUOROPHENYL)-2-FORMYLPHENOL; 6-(3-CARBOXYPHENYL)-2-FORMYLPHENOL; 6-(3-FORMYLPHENYL)NICOTINIC ACID; 6-(3-FORMYLPHENYL)PICOLINIC ACID; 6-(4-CARBOXYPHENYL)-2-FORMYLPHENOL; 6-(4-FORMYLIMIDAZOL-2-YL)2,3-DIMETHOXYBENZOIC ACID; 6-(4-FORMYLPHENYL)NICOTINIC ACID; 6-(4-FORMYLPHENYL)PICOLINIC ACID; 6-(5-CARBOXY-2-FLUOROPHENYL)-2-FORMYLPHENOL; 6-(5-FORMYLTHIOPHEN-2-YL)NICOTINIC ACID; 6-(5-FORMYLTHIOPHEN-2-YL)PICOLINIC ACID; 6-AMINO-3-(2-FORMYLPHENYL)PICOLINIC ACID; 6-AMINO-3-(3-FORMYLPHENYL)PICOLINIC ACID; 6-AMINO-3-(4-FORMYLPHENYL)PICOLINIC ACID; 6-BROMO-3-FORMYL-4-INDAZOLECARBOXYLIC ACID; 6-CHLORO-2-(2-FORMYLPHENYL)BENZOIC ACID; 6-CHLORO-2-(3-FORMYLPHENYL)BENZOIC ACID; 6-CHLORO-2-(4-FORMYLPHENYL)BENZOIC ACID; 6-CHLORO-3-CARBOXALDEHYDE-(1H)INDAZOLE-4-CARBOXYLIC ACID; 6-FLUORO-2-(2-FORMYLPHENYL)BENZOIC ACID; 6-FLUORO-2-(3-FORMYLPHENYL)BENZOIC ACID; 6-FLUORO-2-(4-FORMYLPHENYL)BENZOIC ACID; 6-FLUORO-3-FORMYL-4-INDAZOLECARBOXYLIC ACID; 6-FORMYL-2,3-DIMETHOXYBENZOIC ACID; 6-FORMYLPYRIDINE-2-CARBOXYLIC ACID; 7-OXOHEPTANOIC ACID; 8-FORMYL-4H-1,3-BENZODIOXINE-6-CARBOXYLIC ACID; 9-OXONONANOIC ACID; AC-VAD-CHO; ALAHOPCIN; BUTYRAMIDO-MALONALDEHYDIC ACID; CHEMDIV-BB BB01-2130; D-(+)GLUCURONIC ACID; D-GLUCURONIC ACID, [6-14C]; EPSILON-PYRROLE-LYSINE; FORPHENICINE; GLYOXYLIC ACID; GLYOXYLIC ACID MONOHYDRATE; L-2-AMINOADIPATE 6-SEMIALDEHYDE; LABOTEST-BB LT00441298; L-IDURONIC ACID, SODIUM SALT; MORPHOLIN-4-YL-ACETALDEHYDE CF3CO2H; MUCOBROMIC ACID; MUCOCHLORIC ACID; MURAMIC ACID; MURAMIC ACID HYDRATE; N-(5-FORMYLPYRIMIDIN-2-YL)GLYCINE; N-(5-FORMYLPYRIMIDIN-2-YL)-N-METHYLGLYCINE; N-ACETYLMURAMIC ACID; PHENACETURIC ACID,-ALPHA-FORMYL-ALPHA-METHYL-; SUCCINIC SEMIALDEHYDE; TRAUMATIN; TUCARESOL; VELARESOL

List No. 6 anilines: Anilines selected from the list of: 2-((5-[3-(DIMETHYLAMINO)PHENYL]-1,3,4-OXADIAZOL-2-YL)SULFANYL)ACETIC ACID; (3-DIMETHYLAMINO-PHENOXY)-ACETIC ACID; 5-OXO-(+/−)-TRANS-4-(2-(N,N-DIMETHYLAMINO)PHENYL)-PYRROLIDINE-2-CARBOXYLIC ACID; 5-OXO-(+/−)-TRANS-4-(3-(N,N-DIMETHYLAMINO)PHENYL)-PYRROLIDINE-2-CARBOXYLIC ACID; (2S,4S)-1-(TERT-BUTOXYCARBONYL)-4-[3-(DIMETHYL-AMINO)PHENOXY]-2-PYRROLIDINECARBOXYLIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]PROPANOIC ACID; 2-[3-(DIMETHYLAMINO)PHENOXY]PROPANOIC ACID; 2-[3-(DIMETHYLAMINO)PHENOXY]-3-METHYLBUTANOIC ACID; 4-[3-(DIMETHYLAMINO)PHENOXY]BUTANOIC ACID; 2-AMINO-3-[2-(DIMETHYLAMINO)PHENYL]PROPANOIC ACID; 3-[2-(DIMETHYLAMINO)PHENYL]-2-[(TERT-BUTOXY)CARBONYLAMINO]PROPANOIC ACID; (2S,4R)-4-[3-(DIMETHYLAMINO)PHENOXY]-1-[(1-TERT-BUTOXY)CARBONYL]PYRROLIDINE-2-CARBOXYLIC ACID; 2-(2-(DIMETHYLAMINO)PHENYL)ACETIC ACID; 2-(3-(DIMETHYLAMINO)PHENYL)ACETIC ACID; 3-(DIMETHYLAMINO)-BENZENEPROPANOIC ACID; (4S)-4-AMINO-4-[2-(DIMETHYLAMINO)PHENYL]BUTANOIC ACID; (5S)-5-AMINO-5-[2-(DIMETHYLAMINO)PHENYL]PENTANOIC ACID; (5R)-5-AMINO-5-[2-(DIMETHYLAMINO)PHENYL]PENTANOIC ACID; (4R)-4-AMINO-4-[2-(DIMETHYLAMINO)PHENYL]BUTANOIC ACID; 3-[2-(DIMETHYLAMINO)PHENYL]PROP-2-ENOIC ACID; 3-[2-CHLORO-6-(DIMETHYLAMINO)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[4-BROMO-2-(DIMETHYLAMINO)PHENYL]PROP-2-ENOIC ACID; 1-(4-AMINO-2-DIMETHYLAMINO-PHENYL)-ACETIC ACID; 2-([2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)ACETIC ACID; 3-([2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)PROPANOIC ACID; 2-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)ACETIC ACID; 4-([2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)BUTANOIC ACID; 2-((5-[3-(DIMETHYLAMINO)PHENYL]-4H-1,2,4-TRIAZOL-3-YL)SULFANYL)ACETIC ACID; 3-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)PROPANOIC ACID; (2E)-3-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)PROP-2-ENOIC ACID; 2-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 2-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)CYCLOPROPANE-1-CARBOXYLIC ACID; 3-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)PROPANOIC ACID; 5-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)PENTANOIC ACID; (2E)-3-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)PROP-2-ENOIC ACID; 4-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)BUTANOIC ACID; 3-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)PROPANOIC ACID; 4-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)BUTANOIC ACID; 5-[3-(DIMETHYLAMINO)PHENOXY]PENTANOIC ACID; 2-(([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)METHOXY)ACETIC ACID; 2-(([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)METHOXY)ACETIC ACID; (2S)-2-AMINO-2-[2-(DIMETHYLAMINO)PHENYL]ACETIC ACID; (2R)-2-AMINO-2-[2-(DIMETHYLAMINO)PHENYL]ACETIC ACID; (2S)-2-AMINO-2-[3-(DIMETHYLAMINO)PHENYL]ACETIC ACID; (2R)-2-AMINO-2-[3-(DIMETHYLAMINO)PHENYL]ACETIC ACID; 2-[3-(DIMETHYLAMINO)PHENOXY]BUTANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-2-(METHYLAMINO)PROPANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-2-(ETHYLAMINO)PROPANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-2-(PROPYLAMINO)PROPANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-2-(PROPAN-2-YLAMINO)PROPANOIC ACID; 2-(CYCLOPROPYLAMINO)-3-[3-(DIMETHYLAMINO)PHENOXY]PROPANOIC ACID; [5-(3-DIMETHYLAMINO-PHENYL)-4-METHYL-4H-[1,2,4]TRIAZOL-3-YLSULFANYL]-ACETIC ACID; 2-AMINO-3-[3-(DIMETHYLAMINO)PHENOXY]PROPANOIC ACID; 2-([2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)PROPANOIC ACID; 2-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]SULFAMOYL)PROPANOIC ACID; 2-([2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)ACETIC ACID; 4-[3-(DIMETHYLAMINO)PHENOXY]-2-(ETHYLAMINO)BUTANOIC ACID; 2-[3-(DIMETHYLAMINO)PHENOXY]CYCLOPENTANE-1-CARBOXYLIC ACID; 2-AMINO-4-[3-(DIMETHYLAMINO)PHENOXY]BUTANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]PENTANOIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-2-ETHOXYPROPANOIC ACID; 4-[3-(DIMETHYLAMINO)PHENOXY]-2-(METHYLAMINO)BUTANOIC ACID; 5-[3-(DIMETHYLAMINO)PHENOXYMETHYL]OXOLANE-2-CARBOXYLIC ACID; 4-[3-(DIMETHYLAMINO)PHENOXY]PENTANOIC ACID; 2-([3-CHLORO-2-(DIMETHYLAMINO)PHENYL]CARBAMOYL)ACETIC ACID; 3-[3-(DIMETHYLAMINO)PHENOXY]-4,4,4-TRIFLUOROBUTANOIC ACID; 4-[3-(DIMETHYLAMINO)PHENOXY]-2-ETHOXYBUTANOIC ACID; 2-[3-(DIMETHYLAMINO)PHENOXY]CYCLOHEXANE-1-CARBOXYLIC ACID; [3-BENZOYL-2-(DIMETHYLAMINO)PHENYL]ACETIC ACID; 4-(2-PYRROLIDIN-1-YL-PHENYLCARBAMOYL)-BUTYRIC ACID; 2-AMINO-3-(2-PYRROLIDINYLPHENYL)PROPANOIC ACID; 2-[(TERT-BUTOXY)CARBONYLAMINO]-3-(2-PYRROLIDINYLPHENYL)PROPANOIC ACID; 1-PHENYLPYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-FLUOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-METHOXYPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-[3-(TRIFLUOROMETHYL)PHENYL]PYRROLIDINE-3-CARBOXYLIC ACID; 3-(1-PYRROLIDINYL)-BENZENEPROPANOIC ACID; 2-(1-PYRROLIDINYL)-BENZENEPROPANOIC ACID; (5R)-5-AMINO-5-(2-PYRROLIDINYLPHENYL)PENTANOIC ACID; (5S)-5-AMINO-5-(2-PYRROLIDINYLPHENYL)PENTANOIC ACID; (4R)-4-AMINO-4-(2-PYRROLIDINYLPHENYL)BUTANOIC ACID; (4S)-4-AMINO-4-(2-PYRROLIDINYLPHENYL)BUTANOIC ACID; 3-PYRROLIDINECARBOXYLIC ACID, 1-(2-CHLORO-3-HYDROXYPHENYL)-; (2E)-3-[2-CHLORO-6-(PYRROLIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 3-[2-(PYRROLIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[4-BROMO-2-(PYRROLIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 3-(([2-(PYRROLIDIN-1-YL)PHENYL]METHYL)AMINO)PROPANOIC ACID; 2-(([2-(PYRROLIDIN-1-YL)PHENYL]METHYL)AMINO)ACETIC ACID; 2-([2-(PYRROLIDIN-1-YL)PHENYL]SULFAMOYL)ACETIC ACID; (2E)-3-([2-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)PROP-2-ENOIC ACID; (2E)-3-([3-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)PROP-2-ENOIC ACID; 2-([3-(PYRROLIDIN-1-YL)PHENYL]SULFAMOYL)ACETIC ACID; 4-(([2-(PYRROLIDIN-1-YL)PHENYL]METHYL)AMINO)BUTANOIC ACID; 3-([3-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)PROPANOIC ACID; 3-([2-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)PROPANOIC ACID; 3-[2-CHLORO-6-(3-METHYLPYRROLIDIN-1-YL)PHENYL]DROP-2-ENOIC ACID; 3-[4-BROMO-2-(3-METHYLPYRROLIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 3-[2-(3-METHYLPYRROLIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (R)-[1-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-PYRROLIDIN-3-YLOXY]-ACETIC ACID; 4-([3-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)BUTANOIC ACID; 5-OXO-1-(2-PYRROLIDIN-1-YL-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID; 5-OXO-1-(3-PYRROLIDIN-1-YL-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-METHYL-3-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-FLUORO-5-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-[2-(TRIFLUOROMETHYL)PHENYL]PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-SULFAMOYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-[2-(METHYLSULFAMOYL)PHENYL]PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-METHYL-5-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CYANOPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-FLUORO-2-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYL-5-METHYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYL-3-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYL-5-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 2-([2-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)ACETIC ACID; 1-(5-FLUORO-2-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2,3-DIFLUORO-6-NITROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(5-CHLORO-2-CYANOPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 2-([3-(PYRROLIDIN-1-YL)PHENYL]CARBAMOYL)ACETIC ACID; 1-(2-CYANO-5-METHYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID; 1-(3-CHLORO-2-CYANOPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID N-(2-PIPERIDIN-1-YL-PHENYL)-SUCCINAMIC ACID; 4-(2-PIPERIDIN-1-YL-PHENYLCARBAMOYL)-BUTYRIC ACID; 1-(2-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 2-AMINO-2-(1-PHENYLPIPERIDIN-4-YL)ACETIC ACID; TERT-BUTOXYCARBONYLAMINO-(1-PHENYL-PIPERIDIN-4-YL)-ACETIC ACID; [(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)]-(1-PHENYL-PIPERIDIN-4-YL)-ACETIC ACID; 2-(4-AMINO-1-(3-METHOXYPHENYL)PIPERIDIN-4-YL)ACETIC ACID; 2-(4-AMINO-1-PHENYLPIPERIDIN-4-YL)ACETIC ACID; 1-(2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-[2-(METHYLSULFONYL)PHENYL]PIPERIDINE-3-CARBOXYLIC ACID; 1-[2-(METHYLSULFONYL)PHENYL]PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CYANOPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-PHENYL-4-PIPERIDINECARBOXYLIC ACID; 2-AMINO-3-(2-PIPERIDYLPHENYL)PROPANOIC ACID; 2-[(TERT-BUTOXY)CARBONYLAMINO]-3-[2-(4-HYDROXYPIPERIDYL)PHENYL]PROPANOIC ACID; 2-[(TERT-BUTOXY)CARBONYLAMINO]-3-(2-PIPERIDYLPHENYL)PROPANOIC ACID; (S,S)-3-METHYL-1-(2-PIPERIDINOPHENYL)BUTYLAMINE, N-ACETYL-GLUTAMATE SALT; 2-(1-PHENYLPIPERIDIN-4-YLIDENE)ACETIC ACID; (E)-3-(2-(PIPERIDIN-1-YL)PHENYL)ACRYLIC ACID; 2-(1-PHENYLPIPERIDIN-4-YL)ACETIC ACID; 1-[(2-ISOPROPYLSULFONYL-5-TRIFLUOROMETHYL)PHENYL]PIPERIDINE-4-CARBOXYLIC ACID; 1-[(2-ISOPROPYLSULFONYL-5-TRIFLUOROMETHYL)PHENYL]PIPERIDINE-3-CARBOXYLIC ACID; 2-(1-(3-METHOXYPHENYL)PIPERIDIN-4-YLIDENE)ACETIC ACID; 2-(1-(3-METHOXYPHENYL)PIPERIDIN-4-YL)ACETIC ACID; 3-(1-PIPERIDINYL)-BENZENEPROPANOIC ACID; 2-(1-PIPERIDINYL)-BENZENEPROPANOIC ACID; (5R)-5-AMINO-5-(2-PIPERIDYLPHENYL)PENTANOIC ACID; (5S)-5-AMINO-5-(2-PIPERIDYLPHENYL)PENTANOIC ACID; (5R)-5-AMINO-5-[2-(4-HYDROXYPIPERIDYL)PHENYL]PENTANOIC ACID; (5S)-5-AMINO-5-[2-(4-HYDROXYPIPERIDYL)PHENYL]PENTANOIC ACID; 1-(5-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(5-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(5-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(3-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(3-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(3-BROMO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(5-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(5-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(5-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-CYANO-3-FLUOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-CHLORO-2-CYANOPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CYANO-3-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(2-CYANO-3-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(2-CYANO-3-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(3-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(3-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(5-CHLORO-2-CYANOPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(5-BROMO-2-CYANOPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-BROMO-2-CYANOPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-CHLORO-2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(5-CYANO-2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (S)-1-(5-CYANO-2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (5)-1-(2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(2-CYANOPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(5-CYANO-2-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; (S)-1-(2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (R)-1-(5-CYANO-2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (4R)-4-AMINO-4-(2-PIPERIDYLPHENYL)BUTANOIC ACID; (4S)-4-AMINO-4-(2-PIPERIDYLPHENYL)BUTANOIC ACID; (4R)-4-AMINO-4-[2-(4-HYDROXYPIPERIDYL)PHENYL]BUTANOIC ACID; (4S)-4-AMINO-4-[2-(4-HYDROXYPIPERIDYL)PHENYL]BUTANOIC ACID; (2E)-3-[4-BROMO-2-(PIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 1-(2-CARBAMOYLPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYLPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(5-CHLORO-2-NITROPHENYL)-4-PIPERIDINECARBOXYLIC ACID; (2E)-3-[2-CHLORO-6-(PIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(3-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(4-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 1-PHENYL-4-PIPERIDINAMINEACETATE; 1-(3-METHYLPHENYL)-4-PIPERIDINAMINEACETATE; 1-(2-FLUOROPHENYL)-4-PIPERIDINAMINEACETATE; 1-(3-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-SULFAMOYLPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; (2E)-3-[4-BROMO-2-(3-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(4-METHOXYPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(3-ETHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(3,5-DIMETHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[4-BROMO-2-(4-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 1-(2-SULFAMOYLPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; (2E)-3-[2-CHLORO-6-(4-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-CHLORO-6-(3-METHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 1-(3-FLUORO-2-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(3-FLUORO-2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(3-FLUORO-5-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(3-FLUORO-5-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-AMINO-PHENYL)-PIPERIDINE-4-CARBOXYLIC ACID; 3-[2-(4-ETHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 3-[1-(2-CYANOPHENYL)PIPERIDIN-3-YL]PROPANOIC ACID; 1-[2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID; 5-OXO-1-(2-PIPERIDIN-1-YL-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYL-5-METHYLPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 2-[1-(3-CHLORO-2-CYANOPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 2-[1-(2-NITROPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 1-(2-CARBAMOYL-5-CHLOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 2-([2-(PIPERIDIN-1-YL)PHENYL]CARBAMOYL)ACETIC ACID; 1-(5-FLUORO-2-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CYANO-5-METHYLPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-[2-(TRIFLUOROMETHYL)PHENYL]PIPERIDINE-4-CARBOXYLIC ACID; 2-[1-(2-CYANOPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 2-[1-(2-CYANO-5-METHYLPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 2-[1-(5-CHLORO-2-CYANOPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 3-[2-(4,4-DIMETHYLPIPERIDIN-1-YL)PHENYL]PROP-2-ENOIC ACID; 1-(2-CARBAMOYL-5-METHYLPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-METHYL-3-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-METHYL-5-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 2-[1-(3-NITROPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 1-(2-CYANO-5-METHYLPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-CARBAMOYL-3-CHLOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 2-[1-(2-CARBAMOYLPHENYL)PIPERIDIN-3-YL]ACETIC ACID; 3-[1-(2-CYANOPHENYL)PIPERIDIN-4-YL]PROPANOIC ACID; 1-(5-FLUORO-2-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-METHYL-3-NITROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID; 1-[2-(TRIFLUOROMETHYL)PHENYL]PIPERIDINE-3-CARBOXYLIC ACID; 1-(2-METHYL-5-NITROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CARBAMOYL-3-CHLOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-(2-CARBAMOYL-5-CHLOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID; 1-PHENYL-3-PIPERIDINECARBOXYLIC ACID 3-(HEXAHYDRO-1H-AZEPIN-1-YL)-BENZENEPROPANOIC ACID; 2-(HEXAHYDRO-1H-AZEPIN-1-YL)-BENZENEPROPANOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)-4-BROMOPHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)-6-CHLOROPHENYL]PROP-2-ENOIC ACID

List No. 7—crotonaldehydes: ALL-TRANS-RETINAL; 3-(2-FURYL)ACROLEIN; 2-NITROCINNAMALDEHYDE; CITRAL; TRANS-CINNAMALDEHYDE; 2-METHOXYCINNAMALDEHYDE; 4-DIMETHYLAMINOCINNAMALDEHYDE; CROTONALDEHYDE; 2,4-HEXADIENAL; TRANS,TRANS-2,4-HEPTADIENAL; TRANS,TRANS-2,4-NONADIENAL; TRANS,TRANS-2,4-DECADIENAL; TRANS-2-HEXENAL; TRANS-2-HEPTENAL; TRANS-2-OCTENAL; 4-NITROCINNAMALDEHYDE; TRANS-2-NONENAL; 3,3-DIPHENYLACROLEIN; TRANS-2-PENTENAL; 3-(5-NITRO-2-FURYL)ACROLEIN; 3-METHYL-2-BUTENAL; TRANS,TRANS-5-(4-(DIMETHYLAMINO)PHENYL)-2,4-PENTADIENAL; (2E,4E)-5-(4-NITRO-PHENYL)-PENTA-2,4-DIENAL; TRANS-2-DODECENAL; FEMA 3082; 2,4-OCTADIENAL; TRANS,TRANS-2,4-UNDECADIENAL; TRANS,TRANS-2,4-DODECADIENAL; TRANS-2-DECENAL; TRANS-2-UNDECENAL; 2-TRANS-6-CIS-DODECADIENAL; 4-METHOXYCINNAMALDEHYDE; 3-(THIOPHEN-2-YL)ACRYLALDEHYDE; (4-OXO-2-BUTEN-1-YL)TRIPHENYLPHOSPHONIUM BROMIDE; (1,3,3-TRIMETHYL-1,3-DIHYDRO-INDOL-2-YLIDENE)-ACETALDEHYDE; FARNESAL; TETRABUTYLAMMONIUM GLUTACONALDEHYDE ENOLATE; 3-CHLORO-3-PHENYL-PROPENAL; 2-BENZAMIDOCINNAMALDEHYDE; 2-(1,3,3-TRIMETHYLINDOLIN-2-YLIDENE)ACETALDEHYDE; METHYL-(5S,6S)-EPOXY-11-OXO-(7E,9E)-UNDECADIENOATE; 4-HYDROXY-3-METHOXYCINNAMALDEHYDE; TRANS-4-(DIETHYLAMINO)CINNAMALDEHYDE; SINAPINALDEHYDE; 13-CIS-RETINAL; (Z)-3-CHLORO-3-PHENYLACRYLALDEHYDE; (Z)-3-CHLORO-3-(4-FLUOROPHENYL)ACRYLALDEHYDE; (Z)-3-CHLORO-3-(4-METHOXYPHENYL)ACRYLALDEHYDE; 9-CIS-RETINAL; 11-CIS RETINAL; 3-NITROCINNAMALDEHYDE; TRANS-2-TETRADECENAL; 4-CHLOROCINNAMALDEHYDE; BETA-(4-PYRIDYL)ACROLEIN OXALATE; FUMARALDEHYDE MONO(DIMETHYL ACETAL); 3-CHLORO-3-(P-CHLOROPHENYL)ACROLEIN; FUMARALDEHYDIC ACID METHYL ESTER; TRANS,TRANS-2,6-NONADIENAL; (Z)-3,7-DIMETHYLOCTA-2,6-DIENAL; TRANS,TRANSMUCONALDEHYDE; ETHYL TRANS-4-OXO-2-BUTENOATE; DIMETHYL DECADIENAL; 4-ACETOXY-3-METHOXYCINNAMALDEHYDE; DECA-2,4,6,8-TETRAENAL; 3,3-DIMETHYLCYCLOHEXYLIDENEACETALDEHYDE; 11-(2-FURYL)UNDECA-2,4,6,8,10-PENTAENAL; 3-(1-ACETYL-1H-INDOL-3-YL)ACRYLALDEHYDE; ETHYL CITRAL; 4-OXO-3-(3-OXOPROP-1-ENYL)-4H-CHROMEN-6-YL ACETATE; 3-(7-METHYL-4-OXO-4H-CHROMEN-3-YL)ACRYLALDEHYDE; 4-OXO-3-(3-OXOPROP-1-ENYL)-4H-CHROMEN-7-YL ACETATE; 3-(1-OXO-1H-BENZO[F]CHROMEN-2-YL)ACRYLALDEHYDE; 3-(4-TERT-BUTYL-PHENYL)-PROPENAL; LIMONENAL; (2E,4E,6E)-6-(3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE)HEXA-2,4-DIENAL; (E)-3,7-DIMETHYL-4-(3-METHYLBUT-2-EN-1-YL)OCTA-2,6-DIENAL; 3,4,5-TRIMETHOXYCINNAMALDEHYDE; 4-HYDROXYCINNAMALDEHYDE; 4-METHYL-2-PENTENAL; CIS-2-HEXENAL; 3-CHLORO-3-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)ACRYLALDEHYDE; 4-KETORETINAL; (E)-4-HYDROXYHEXENAL; 1-(3-OXO-1-PROPENYL)-2-NAPHTHYL ACETATE; 3-BROMOCINNAMALDEHYDE; 2-CHLOROCINNAMALDEHYDE; ETHYL 3,5-DIMETHYL-4-(3-OXOPROP-1-ENYL)-1H-PYRROLE-2-CARBOXYLATE; 2-[(1E)-3-OXOPROP-1-EN-1-YL]PHENYL ACETATE; 3-CHLORO-3-(4-NITROPHENYL)ACRYLALDEHYDE; (2E)-3-(4-BROMOPHENYL)-3-CHLOROACRYLALDEHYDE; 3-CHLORO-3-(4-CHLOROPHENYL)ACROLEIN; 2-HYDROXYCINNAMALDEHYDE; 4-HYDROPEROXY-2-NONENAL; ETHYL 2-AMINO-5-(3-OXOPROP-1-ENYL)-3-FUROATE; 2-HEXENAL; 3-AMINO-2-BUTENAL; 3-(3-PYRIDYL)ACROLEIN; (Z)-3-CHLORO-3-(4-NITROPHENYL)ACRYLALDEHYDE; (5-METHYL-2,4-DIPHENYL-6H-1,3-OXAZIN-6-YLIDENE)ACETALDEHYDE; (2E,4E)-5-(4-FLUOROPHENYL)-2,4-PENTADIENAL; 4-BROMOCINNAMALDEHYDE; AURORA KA-3085; (1-CHLORO-2-FORMYLVINYL)FERROCENE; 4-DIBUTYLAMINOCINNAMALDEHYDE; 4-FLUOROCINNAMALDEHYDE; (E)-3-[3′-(4″-FLUOROPHENYL)-1′-(1″-METHYLETHYL)-1H-INDOL-2″-YL]-2-PROPNAL; (2E)-3-(1H-PYRROL-2-YL)-2-PROPENAL; 4-HYDROXYRETINAL; GRANDLURE; 3-(5-METHYL-2-PHENYL-3-INDOLIZINYL)-3-PHENYLACRYLALDEHYDE; 3-(5-METHYL-2-PHENYL-3-INDOLIZINYL)ACRYLALDEHYDE; 3-(4-[6-(3-OXO-1-PROPENYL)IMIDAZO[1,2-A]PYRIDIN-2-YL]PHENYL)ACRYLALDEHYDE; (2E,4E)-5-(4-CHLOROPHENYL)-2,4-PENTADIENAL; TRAUMATIN; (Z)-3,5-DIMETHYLHEX-2-ENAL; (E)-3,4,8-TRIMETHYL-NONA-2,7-DIENAL; (Z)-3,7-DIMETHYL-OCTA-2,7-DIENAL; (2E)-3-(1-BENZYL-1H-1,2,3-TRIAZOL-4-YL)ACRYLALDEHYDE; 4-ISOPROPYLCINNAMALDEHYDE; 2,4,6-TRIMETHYLCINNAMALDEHYDE; (2E)-3-[5-(4-METHYL-3-NITROPHENYL)-2-FURYL]ACRYLALDEHYDE; (2Z)-3-(2-MERCAPTO-1H-BENZIMIDAZOL-1-YL)-3-PHENYLACRYLALDEHYDE; (2E)-3-[5-(3-NITROPHENYL)-2-FURYL]ACRYLALDEHYDE; (2E)-3-[5-(2-CHLOROPHENYL)-2-FURYL]ACRYLALDEHYDE; (2E)-3-[5-(3-CHLORO-4-METHYLPHENYL)-2-FURYL]ACRYLALDEHYDE; (2E)-3-[5-(4-CHLOROPHENYL)-2-FURYL]ACRYLALDEHYDE; 2,6-DIFLUOROCINNAMIC ALDEHYDE; 4-(TRIFLUOROMETHOXY)CINNAMIC ALDEHYDE; 2-CHLORO-4-FLUOROCINNAMALDEHYDE; ALL-TRANS-3-HYDROXYRETINAL; CINNAMALDEHYDE-UL (RING-14C); 3-[(2R,3R)-3-PENTYLOXIRANYL]-2E-PROPENAL; 4-OXO 2-NONENAL-D3; 4-(2-FORMYLVINYL)BENZONITRILE; (+/−)-4-HYDROXY-9,9,9-D3-NON-2E-ENAL; 4-OXO-2-NONENAL; 2-CHLORO-6-FLUOROCINNAMALDEHYDE; 3-CHLOROCINNAMALDEHYDE; 2,3-DIMETHOXYCINNAMALDEHYDE; 2,3-DICHLOROCINNAMALDEHYDE; 2,4-DIFLUOROCINNAMALDEHYDE; 4-PHENYLCINNAMALDEHYDE; 2-FLUOROCINNAMALDEHYDE; 2-PROPENAL, 3-(3-METHYLPHENYL)-,(2E); 3-FLUOROCINNAMALDEHYDE; 2-PROPENAL, 3-(4-METHYLPHENYL)-,(2E); 2-METHYLCINNAMALDEHYDE; 2-PROPENAL, 3-(4-(ACETYLOXY)PHENYL)-,(2E); 4-OXO-2-HEXENAL; 3-(2-HYDROXY-NAPHTHALEN-1-YL)-PROPENAL; (2Z)-3-(4-BROMOPHENYL)-3-CHLOROACRYLALDEHYDE; 3-METHYL-HEX-2-ENAL; (E)-3,6-DIMETHYL-HEPTA-2,5-DIENAL; 3-(NAPHTHALEN-2-YL)ACRYLALDEHYDE; 2-BROMOCINNAMALDEHYDE; (2E,13Z)-OCTADECA-2,13-DIENAL; (2E)-OCTADEC-2-ENAL; 3-(TRIFLUOROMETHYL)CINNAMALDEHYDE; (E)-3-[5-TERT-BUTYLDIMETHYLSILYLOXYMETHYL-2,6-DIISOPROPYL-4-(4-FLUOROPHENYL)-PYRID-3-YL]-PROP-2-ENAL; 3-(9-ANTHRYL)ACROLEIN; (E,E,E)-2,4,6-OCTATRIENAL; 4-(TRIFLUOROMETHYL)CINNAMALDEHYDE; 5-PROP-2-ENAL-1,2:3,4-DI-O-ISOPROPYLIDENE-A-D-GALACTOPYRANOSE; (E)-3-((3AR,6S,6AR)-6-(BENZYLOXY)-TETRAHYDRO-2,2-DIMETHYLFURO[3,2-D][1,3]DIOXOL-5-YL)ACRYLALDEHYDE; (2Z)-3-[(4S)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]PROP-2-ENAL; (2Z)-3-[(4R)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]PROP-2-ENAL; (2E)-3-[6-(BENZYLOXY)-2,2-DIMETHYLTETRAHYDROFURO[3,4-D][1,3]DIOXOL-4-YL]PROP-2-ENAL; (E)-4-(METHYL-PHENYL-AMINO)-BUT-2-ENAL; 3-METHYL-5-[(2,6,6-TRIMETHYLCYCLOHEX-3,3,7,7,7-D5)-1-ENYL]PENTA-2,4-DIENAL; 3-HYDROXYRETINAL-D5; 3-(4-AZIDOPHENYL)ACRYLALDEHYDE; (E)-5,9-ANHYDRO-6,7-O-CYCLOHEXYLIDENE-2,3,4,8-TETRADEOXY-8-C-(ETHOXYCARBONYL)METHYL-3-METHYL-D-ALLO-NON-2-ENAL; (E)-3-[2-CYCLOPROPYL-4-(4-FLUOROPHENYL)-3-QUINOLINYL]-2-PROPENAL; 3-(3-METHOXYPHENYL)ACRYLALDEHYDE; 3-(2-(TRIFLUOROMETHYL)PHENYL)ACRYLALDEHYDE; 4,4-DIMETHYLPENT-2-ENAL; (2E,4E)-7-[(4-METHOXYBENZYL)OXY]-2,4-HEPTADIENAL; (E)-2-HEXADECENAL; (2E,4E)-5-(4-METHOXY-2,3,6-TRIMETHYLPHENYL)-3-METHYLPENTA-2,4-DIENAL; (2E)-3-(5-CHLORO-2-FURYL)ACRYLALDEHYDE; (2E)-3-(5-BROMO-2-FURYL)ACRYLALDEHYDE; 2-(THIETAN-3-YLIDENE)ACETALDEHYDE; 2-(OXETAN-3-YLIDENE)ACETALDEHYDE; 2,4-PENTADIENAL; NONA-2,4,6-TRIENAL; (2Z)-3-(1H-PYRROL-2-YL)-2-PROPENAL; (2E)-3-(3-INDOLIZINYL)-2-PROPENAL; (2E)-3-(1-METHYL-1H-PYRROL-2-YL)-2-PROPENAL; (2E)-3-(1-INDOLIZINYL)-2-PROPENAL; (E)-3-(1-METHYL-5-OXO-2,5-DIHYDRO-1H-PYRROL-3-YL)ACRYLALDEHYDE; (2E)-3-(1H-INDOL-3-YL)-2-PROPENAL; (2E)-3-(1H-PYRROLO[2,3-B]PYRIDIN-3-YL)-2-PROPENAL; (Z)-2-(3,4-DIHYDROPYRROLO[1,2-A]PYRAZIN-1(2H)-YLIDENE)ACETALDEHYDE; (E)-3-(1H-INDOL-2-YL)-2-PROPENAL; (2E)-(3,5,5-TRIMETHYLCYCLOHEX-2-EN-1-YLIDENE)ACETALDEHYDE; 2-BUTENAL, 3-CHLORO-4-OXO-4-PHENYL-, (E)-; 3-(2-PYRIDINYL)-2-PROPENAL; (2E)-3-(2-PYRIDINYL)-2-PROPENAL; (Z)-3-CHLORO-3-(THIOPHEN-3-YL)ACRYLALDEHYDE; (Z)-3-(2,5-DIHYDRO-1-METHYL-5-OXO-1H-PYRROL-3-YL)-2-PROPENAL; 2-((3,4-DIHYDRO-1(2H)-ISOQUINOLINYLIDENE)-ACETALDEHYDE); 2-CYCLOHEPTYLIDENEACETALDEHYDE; (E)-(1-METHYL-2-PIPERIDINYLIDENE)-ACETALDEHYDE; 3-(3-TERT-BUTYL-5-ISOPROPYLPHENYL)BUT-2-ENAL; (Z)-2-BROMO-4-OXO-BUT-2-ENOIC ACID ETHYL ESTER; TRANS,TRANS-5-BROMO-2,4-PENTADIENAL; 3-(5-CHLORO-2-HYDROXY-3-METHOXY-PHENYL)-PROPENAL; 3-(2,3-DICHLORO-6-HYDROXY-5-METHOXY-PHENYL)-PROPENAL; DIBROMO-5-ETHOXY-6-HYDROXY-PHENYL)-PROPENAL; 3-(5-CHLORO-2-HYDROXY-3-NITRO-PHENYL)-PROPENAL; 3-(5-BROMO-2-HYDROXY-3-NITRO-PHENYL)-PROPENAL; 3-(5-BENZYL-3-BROMO-2-HYDROXY-PHENYL)-PROPENAL; 3-(3-BROMO-5-CHLORO-2-HYDROXY-PHENYL)-PROPENAL; 3-(5-BENZYL-2-HYDROXY-3-NITRO-PHENYL)-PROPENAL; 3-(2-HYDROXY-5-NITRO-PHENYL)-PROPENAL; 3-(3,5-DICHLORO-2-HYDROXY-PHENYL)-PROPENAL; 3-(3-BROMO-2-HYDROXY-5-NITRO-PHENYL)-PROPENAL; 3-(5-CHLORO-2-HYDROXY-PHENYL)-PROPENAL; 3-(5-BROMO-2-HYDROXY-PHENYL)-PROPENAL; 3-(3,5-DIBROMO-2-HYDROXY-PHENYL)-PROPENAL; 3-(5-BROMO-2-HYDROXY-3-METHOXY-PHENYL)-PROPENAL; 3-(2-HYDROXY-3-NITRO-PHENYL)-PROPENAL; 3-(5-BENZYL-3-CHLORO-2-HYDROXY-PHENYL)-PROPENAL; 3-(5-BROMO-3-CHLORO-2-HYDROXY-PHENYL)-PROPENAL; 3-(2-HYDROXY-3-METHOXY-5-NITRO-PHENYL)-PROPENAL; 3-(5-BENZYL-2-HYDROXY-PHENYL)-PROPENAL; (E)-3-[2-CYCLOPROPYL-4-(4-FLUOROPHENYL)-3-QUINOLYL]-ACROLEIN; (2E)-3-(2-FURANYL)-2-BUTENAL; (2Z)-3-(3-FURANYL)-2-BUTENAL; (E)-5-(3-OXOPROP-1-ENYL)FURAN-2-CARBALDEHYDE; (E)-3-(5-AMINOFURAN-2-YL)ACRYLALDEHYDE; (2Z)-3-(2-FURANYL)-2-BUTENAL; (2E)-3-(2,5-DIHYDRO-5-OXO-2-FURANYL)-2-PROPENAL; (2E)-3-(4-NITRO-2-FURANYL)-2-PROPENAL; (2Z)-3-(2-FURANYL)-2-PROPENAL; (2E)-3-(3-BENZOFURANYL)-2-PROPENAL; (2E)-3-(5-METHYL-2-FURANYL)-2-PROPENAL; (2E)-3-(2-CHLORO-4-METHOXYPHENYL)-2-PROPENAL; (2E)-3-CYCLOPENTYL-2-PROPENAL; (2Z,4E)-4-(3′,4′-DIHYDRO-1′(2′H)-NAPHTHALEN-1′YLIDENE)-3-METHYL-2-BUTENAL; 3-(1H-BENZOIMIDAZOL-2-YLSULFANYL)-3-PHENYL-PROPENAL; (Z)-3-CHLORO-3-P-TOLYLACRYLALDEHYDE; TERT-BUTYL 4-(2-OXOETHYLIDENE)PIPERIDINE-1-CARBOXYLATE; TERT-BUTYL 3-[(1E)-3-OXOPROP-1-ENYL]AZETIDINE-1-CARBOXYLATE; (Z)-3-CHLORO-3-(3-CHLOROPHENYL)ACRYLALDEHYDE; 4-(2-FORMYLVINYL)-ACETANILIDE; N-[4-(4-FLUOROPHENYL)-6-(1-METHYLETHYL)-5-[(1E)-3-OXO-1-PROPEN-1-YL]-2-PYRIMIDINYL]-N-METHYLMETHANESULFONAMIDE; (E)-2-(2-FURANYL)-2-BUTENEDIAL; (E)-2-(5-METHYL-2-FURANYL)-2-BUTENEDIAL; 4-HYDROXY NONENAL ALKYNE; 3-(2-PYRIDINYL)-2-BUTENAL; (2E)-3-(4-PYRIDINYL)-2-PROPENAL; 3-(HEXAHYDRO-1H-AZEPIN-1-YL)-BENZENEPROPANOIC ACID; 2-(HEXAHYDRO-1H-AZEPIN-1-YL)-BENZENEPROPANOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)PHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)-4-BROMOPHENYL]PROP-2-ENOIC ACID; (2E)-3-[2-(AZEPAN-1-YL)-6-CHLOROPHENYL]PROP-2-ENOIC ACID

List No. 8—Methylketones: CIS-PINONIC ACID; 2-ACETYLBENZOIC ACID; 4-ACETYLBENZOIC ACID; LEVULINIC ACID; 4,6-DIOXOHEPTANOIC ACID; 4-ACETYLBUTYRIC ACID; N-(ACETOACETYL)GLYCINE; DIACETONEAMINE HYDROGEN OXALATE; 5-ACETYLSALICYLIC ACID; 3-ACETYLACRYLIC ACID; 4-ACETYLPHENOXYACETIC ACID; (4-ACETYLPHENYL)ACETIC ACID; 2-PHENYLLEVULINIC ACID; 4-ACETYL-3,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 5-CARBOXYDEHYDROACETIC ACID; 3,3-DIMETHYL-4-OXOVALERIC ACID; 5-[(4-ACETYLPHENYL)AMINO]-5-OXOPENTANOIC ACID; 3-ACETYLBENZOIC ACID; 5-ACETYLVALERIC ACID; A-ACETYLMANDELIC ACID; ACETOACETIC ACID; 5-ACETYLTHIOPHENE-2-CARBOXYLIC ACID; ACETYLPYRUVIC ACID; 2-(3-ACETYL-2,2-DIMETHYLCYCLOBUTYL)ACETIC ACID; 7-OXOOCTANOIC ACID; 5,7-DIOXOOCTANOIC ACID; N-(ACETOACETYL)ANTHRANILIC ACID; 10-OXOUNDECANOIC ACID; 4-[(2-ACETYL-3-THIENYL)AMINO]-4-OXOBUT-2-ENOIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL]SULFANYL)ACETIC ACID; 2-(([(2-ACETYLPHENYL)CARBAMOYL]METHYL)SULFANYL)ACETIC ACID; 2-(1-ACETYL-2-OXOPROPYL)-5-METHOXYBENZOIC ACID; 2-ACETYLPHENOXY ACETIC ACID; 3-METHYL-4-OXO-2-PENTENOIC ACID; BETA-METHYLLEVULINIC ACID; 2-METHYL-4-OXOPENTANOIC ACID; DIACETONAMINE HYDROGEN OXALATE HYDRATE; 5-[(3-ACETYLPHENYL)AMINO]-5-OXOPENTANOIC ACID; 2-ACETYL-3,6-DIMETHYLBENZOIC ACID; 2-((3-OXO-2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]-1-BUTENYL)AMINO)ACETIC ACID; 2-(4-ACETYL-2,3-DIHYDRO-5-METHYL-2-OXO-1H-PYRROL-3-YL)ACETIC ACID; 4-(4-ACETYLANILINO)-4-OXO-2-BUTENOIC ACID; 9-OXODEC-2-ENOIC ACID; 2-ACETYLTHIAZOLE-4-CARBOXYLIC ACID; 5-ACETYL-2-AMINO-4-HYDROXYBENZOIC ACID; 5-ACETYL-4-HYDROXY-3-METHOXY-FURAN-2-CARBOXYLIC ACID; 4′-ACETYL-BIPHENYL-4-CARBOXYLIC ACID; 1-(4-ACETYLPHENYL)-4-PIPERIDINECARBOXYLIC ACID; (2-ACETYL-4,5-DIMETHOXYPHENYL)ACETIC ACID; 3-(2-OXO-PROPYL)-BENZOIC ACID; 4-(2-OXOPROPYL)BENZOIC ACID; 2-(1,1-DIMETHYL-2-OXO-PROPYL)-MALONIC ACID; 4-(4-ACETYLANILINO)-4-OXOBUTANOIC ACID; 5-OXO-3-PHENYL-HEXANOIC ACID; 4-(4-ACETYLPHENOXY)BENZOIC ACID; (E)-3-(5-ACETYL-FURAN-2-YL)ACRYLIC ACID; 3-ACETYL-4-HYDROXYBENZOIC ACID; [2-(2-OXOPROPOXY)PHENOXY]ACETIC ACID; 2-CYANO-3,3-DIMETHYL-4-OXO-PENTANOIC ACID; 4-ACETYL-1-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 3-ACETYL-2-OXO-1,2-DIHYDRO-QUINOLINE-4-CARBOXYLIC ACID; 3-ACETYL-4,5-DIMETHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 2-[(4-ACETYLPHENYL)SULFANYL]ACETIC ACID; 2-ISOPROPYL-5-OXOHEXANOIC ACID; 4-KETOVALPROIC ACID; 5-OXO-2-PROPYL-HEXANOIC ACID; 2-ACETYL-3,6-DIFLUOROBENZOIC ACID; 3-ACETYL-2-METHYL-QUINOLINE-4-CARBOXYLIC ACID; 5-ACETYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 4-[(3-ACETYLPHENYL)AMINO]-4-OXOBUTANOIC ACID; (2E)-4-[(3-ACETYLPHENYL)AMINO]-4-OXOBUT-2-ENOIC ACID; 4-HYDROXY-2-METHYL-3-(3-OXO-BUTYL)-QUINOLINE-6-CARBOXYLIC ACID; 8-ACETYL-3A,4,5,9B-TETRAHYDRO-3H-CYCLOPENTA[C]QUINOLINE-4-CARBOXYLIC ACID; 3-METHYL-5-(2-OXO-PROPYL)-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 3-CARBOXY-4-HYDROXYPHENYLACETONE; 4-ACETYL-3,5-DIOXO-1-METHYLCYCLOHEXANECARBOXYLIC ACID; (4-ACETYL-2-METHOXYPHENOXY)ACETIC ACID; 1-(4-ACETYL-PHENYL)-5-METHYL-1H-[1,2,3]TRIAZOLE-4-CARBOXYLIC ACID; 2-ACETYL-1H-INDOLE-3-CARBOXYLIC ACID; 5-ACETYL-2-ACETYLAMINO-4-METHYL-THIOPHENE-3-CARBOXYLIC ACID; 1-(4-ACETYLPHENYL)-5-OXOPYRROLIDINE-3-CARBOXYLIC ACID; 4-(2-ACETYL-3-OXO-1-BUTENYL)BENZENECARBOXYLIC ACID; N-(M-ACETYLPHENYL)ANTHRANILIC ACID; 2-(4-ACETYLPHENOXY)-2-METHYLPROPANOIC ACID; 4-[(2-ACETYLPHENYL)AMINO]-4-OXOBUTANOIC ACID; 3-ACETYLTHIOPHENE-2-CARBOXYLIC ACID; 9-OXODECANOIC ACID; 3-ACETYL-1H-INDOLE-2-CARBOXYLIC ACID; 2-(([(4-ACETYLPHENYL)CARBAMOYL]METHYL)SULFANYL)ACETIC ACID; 2′-ACETYL-2-BIPHENYLCARBOXYLIC ACID; 4-ACETYL-7-METHOXY-1-BENZOFURAN-2-CARBOXYLIC ACID; 2-(3-OXOBUTANAMIDO)PROPANOIC ACID; 4-METHYL-2-(3-OXOBUTANAMIDO)PENTANOIC ACID; 3-(3-OXOBUTANAMIDO)BENZOIC ACID; 4-(3-OXOBUTANAMIDO)BENZOIC ACID; (3-ACETYLPHENOXY)ACETIC ACID; 2-(2-OXOPROPYL)HEXANOIC ACID; 2-(2-OXOPROPYL)BENZOIC ACID; 2-METHYL-3-ACETYLBENZOIC ACID; 4-ACETYL-1H-PYRROLE-2-CARBOXYLIC ACID; 3-(2-HYDROXY-4,4-DIMETHYL-6-OXO-1-CYCLOHEXENYL)-4-OXOPENTANOIC ACID; 3-((4-OXOPENTANOYL)OXY)-2-PHENYLPROPANOIC ACID; MONO-(2-ETHYL-5-OXOHEXYL)-ADIPATE; (S)-2-TERT-BUTOXYCARBONYLAMINO-4-OXO-PENTANOIC ACID; 3-ACETYL-QUINOLINE-4-CARBOXYLIC ACID; 6-ACETYL-7-METHYL-PYRAZOLO[1,5-A]PYRIMIDINE-2-CARBOXYLIC ACID; 6-ACETYL-7-METHYL-PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID; (2-ACETYL-4-METHYLPHENOXY)ACETIC ACID; 4-((5-ACETYL-4-METHYL-1,3-THIAZOL-2-YL)AMINO)-4-OXOBUTANOIC ACID; 3-(2-CARBOXYPHENYL)PENTANE-2,4-DIONE; 4-ACETYL-1-CYCLOPROPYL-2,5-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID; 5-[(4-ACETYLPHENOXY)METHYL]-2-FUROIC ACID; 3-([(5-ACETYL-2-METHOXYPHENYL)METHYL]SULFANYL)PROPANOIC ACID; 1-(3-ACETYLPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID; 4-(4-ACETYL-PHENOXY)-BUTYRIC ACID; [(5-ACETYL-3-CYANO-6-METHYLPYRIDIN-2-YL)THIO]ACETIC ACID; 3-(4-ACETYLPHENOXY)PROPANOIC ACID; 3-(3-ACETYL-6-METHYL-4-OXO-4H-PYRAN-2-YLAMINO)-PROPIONIC ACID; 3′-ACETYL-BIPHENYL-2-CARBOXYLIC ACID; (3′-ACETYL-BIPHENYL-3-YL)-ACETIC ACID; 3′-ACETYL-BIPHENYL-3-CARBOXYLIC ACID; 3′-ACETYL-BIPHENYL-4-CARBOXYLIC ACID; (3′-ACETYL-BIPHENYL-4-YL)-ACETIC ACID; 3-METHYL-5-(3-OXOBUTYL)-1-BENZOFURAN-2-CARBOXYLIC ACID; O-(3-OXOBUTYL)-N-PROPYLHYDROXYLAMINE OXALATE SALT; (5-ACETYL-3-THIENYL)ACETIC ACID; 3-(3-ACETYL-BENZENESULFONYLAMINO)-PROPIONIC ACID; 4′-ACETYL-BIPHENYL-3-CARBOXYLIC ACID; (4-ACETYL-PIPERIDIN-1-YL)-ACETIC ACID; 2-[(5-ACETYL-4-METHYL-2-PYRIMIDINYL)SULFANYL]ACETIC ACID; 2,6-DIMETHOXY-4-GLYCOLIC ACID PHENYL ACETONE; (2S)-2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; (2S)-2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; (3-ACETYL-INDOL-1-YL)-ACETIC ACID; 1-(1,2-DIOXOPROPYL)-S-PROLINE; 2-ACETYL-3,4,5,6-TETRAFLUOROBENZOIC ACID; LABOTEST-BB LT03330740; 4-ACETYL-1-BENZYL-PYRROLIDINE-3-CARBOXYLIC ACID; 4-ACETYL-PYRROLIDINE-3-CARBOXYLIC ACID; 2-ACETONICOTINIC ACID; (3-ACETYL-2-METHYL-INDOL-1-YL)-ACETIC ACID; (3-ACETYL-7-ETHYL-INDOL-1-YL)-ACETIC ACID; 6-ACETYL-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID; 3-ACETYL-1H-PYRAZOLE-5-CARBOXYLIC ACID; 4-[(4-ACETYLPHENYL)CARBAMOYL]-3-METHYLBUTANOIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL]METHOXY)ACETIC ACID; 2-(([(3-ACETYLPHENYL)CARBAMOYL]METHYL)SULFANYL)ACETIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL]METHOXY)ACETIC ACID; 3-(4-ACETYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)BUTANOIC ACID; 3-(3-ACETYL-2,4-DIMETHYL-PYRROL-1-YL)-PROPIONIC ACID; 3-(4-ACETYL-3,5-DIMETHYL-PYRAZOL-1-YL)-PROPIONIC ACID; 3-AMINO-4-OXO-PENTANOIC ACID; 5-ACETYL-6-METHYL-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBOXYLIC ACID; 2-(4-ACETYLPHENOXY)PROPANOIC ACID; 2-([(4-ACETYLPHENYL)SULFONYL]AMINO)PROPANOIC ACID; ([(3-ACETYLPHENYL)SULFONYL]AMINO)ACETIC ACID; (5-ACETYL-2-METHOXYPHENYL)ACETIC ACID; 2-(2-OXOPROPYLTHIO)BENZOIC ACID; 2-[(4-ACETYL-2-FLUOROPHENYL)SULFANYL]ACETIC ACID; ([(4-ACETYLPHENYL)SULFONYL]AMINO)ACETIC ACID; 5-(4-ACETYLPHENYL)-2-FUROIC ACID; 3-([(4-ACETYLPHENYL)SULFONYL]AMINO)PROPANOIC ACID; 2-(4-ACETYLPHENOXY)-2-PHENYLACETIC ACID; L-4-ACETYLPHE; (4-ACETYL-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ACETIC ACID; 3-(4-ACETYL-3,5-DIMETHYL-PYRAZOL-1-YL)-2-METHYL-PROPIONIC ACID; (4-ACETYLANILINO)ACETIC ACID; 5-ACETYL-3-METHYL-1H-INDOLE-2-CARBOXYLIC ACID; 7-ACETYL-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID; 2-(2-ACETYL-4-ETHYLPHENOXY)ACETIC ACID; 2′-ACETYLBIPHENYL-3-CARBOXYLIC ACID; 2′-ACETYL[1,1′-BIPHENYL]-4-CARBOXYLIC ACID; 4-(5-ACETYL-2-THIENYL)BENZOIC ACID; 3-(5-ACETYL-2-THIENYL)BENZOIC ACID; 3-(3-ACETYL-INDOL-1-YL)-PROPIONIC ACID; 2-(3-ACETYL-1H-INDOL-1-YL)PROPANOIC ACID; [5-ACETYL-3-(METHOXYCARBONYL)-4-METHYL-1H-PYRROL-2-YL]ACETIC ACID; 4-[(5-ACETYL-4-METHYL-1,3-THIAZOL-2-YL)AMINO]BUTANOIC ACID; (S)-2-AMINO-5-OXO-HEXANOIC ACID, HYDROBROMIDE; (2Z)-4-((4-ACETYLPHENYL)AMINO)-3-METHYL-4-OXOBUT-2-ENOIC ACID; 3-(4-ACETYL-5-METHYL-2-FURYL)PROPANOIC ACID; 5-ACETYLTHIOPHENE-3-CARBOXYLIC ACID; 3-(3-ACETYL-2,5-DIMETHYL-PYRROL-1-YLMETHYL)-BENZOIC ACID; 4-(3-ACETYL-2,5-DIMETHYL-PYRROL-1-YLMETHYL)-BENZOIC ACID; (1-(4-ACETYLPHENYL)-2-OXOHYDRAZINO)ACETIC ACID; DL-3-(P-ACETYLPHENYL)-ALANINE; 2-METHYLACETOACETIC ACID; (3AR,4S,9BS)-8-ACETYL-3A,4,5,9B-TETRAHYDRO-3H-CYCLOPENTA[C]QUINOLINE-4-CARBOXYLIC ACID; 2-ACETYL-3-(4-ETHYLPHENYL)BUTANOIC ACID; 3-(4-ACETYL-PHENYL)-2-AMINO-PROPIONIC ACID HYDROCHLORIDE; [(4-ACETYLBENZYL)OXY]ACETIC ACID; 3-ACETYL-5-NITROBENZOIC ACID; 3-ACETYLADAMANTANE-1-CARBOXYLIC ACID; 2-(3-ACETYL-1H-INDOL-1-YL)BUTANOIC ACID; 4-(3-ACETYL-2,5-DIMETHYL-1H-PYRROL-1-YL)BENZOIC ACID; [2-(2-ACETYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(3-ACETYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; [2-(4-ACETYL-PHENYL)-1H-IMIDAZOL-4-YL]-ACETIC ACID; 2-ACETYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID; 5-ACETYL-1H-INDOLE-2-CARBOXYLIC ACID; 7-ACETYL-2-INDOLE CARBOXYLIC ACID; (S)-3-(3-ACETYL-4-HYDROXY-PHENYL)-2-HYDROXY-PROPIONIC ACID; (2S)-3-(3-ACETYL-4-HYDROXYPHENYL)-2-AMINOPROPANOIC ACID; 3-ACETYL-1H-INDOLE-5-CARBOXYLIC ACID; 2-METHYL-6-OXO-HEPTANOIC ACID; (3-ACETYL-2-METHYL-5-PHENYL-1H-PYRROL-1-YL)ACETIC ACID; 5-ACETYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 4-(2-ACETYL-PHENOXY)-BUTYRIC ACID; 1-(3-ACETYL-PHENYL)-5-METHYL-1H-[1, 2, 3]TRIAZOLE-4-CARBOXYLIC ACID; 1-(3-ACETYL-PHENYL)-5-ISOPROPYL-1H-[1, 2, 3]TRIAZOLE-4-CARBOXYLIC ACID; 1-(3-ACETYL-PHENYL)-5-ETHYL-1H-[1, 2, 3]TRIAZOLE-4-CARBOXYLIC ACID; 1-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]PYRROLIDINE-2-CARBOXYLIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]-3-METHYLBUTANOIC ACID; 6-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]HEXANOIC ACID; 2-(4-ACETYL-2-METHOXYPHENOXY)PROPANOIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 2-[4-(3-OXOBUTYL)PHENOXY]PROPANOIC ACID; 3-(3-ACETYLPHENOXY)PROPANOIC ACID; 2-(3-ACETYLPHENOXY)PROPANOIC ACID; 2-[4-(3-OXOBUTYL)PHENOXY]Acetic ACID; 4-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]BUTANOIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-4-METHYLPENTANOIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3-METHYLBUTANOIC ACID; 1-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]PIPERIDINE-3-CARBOXYLIC ACID; 3-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]BUTANOIC ACID; 4-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]BUTANOIC ACID; 3-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID; 3-(4-ACETYL-2-METHOXYPHENOXY)PROPANOIC ACID; 1-(4-ACETYL-1H-PYRROLE-2-CARBONYL)PIPERIDINE-2-CARBOXYLIC ACID; 3-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]BUTANOIC ACID; 2-(2-ACETYLPHENOXY)-PROPANOIC ACID; 2-[(4-ACETYLBENZENE)(METHYL)SULFONAMIDO]ACETIC ACID; 4′-ACETYL-BIPHENYL-4-ACETIC ACID; 3-[4-(3-OXOBUTYL)PHENOXY]PROPANOIC ACID; 5-(3-ACETYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-ACETYL-2,6-DIMETHYLISONICOTINIC ACID; 2-ACETYL-3-(4-HYDROXYLPHENYL)-ACRYLIC ACID; 3-ACETYL-1H-PYRROLE-2-CARBOXYLIC ACID; (5-ACETYLTHIEN-2-YL)ACETIC ACID; 5-([(4-ACETYLPHENYL)AMINO]METHYL)-2-FUROIC ACID; 5-([(3-ACETYLPHENYL)AMINO]METHYL)-2-FUROIC ACID; 6-ACETYLPICOLINIC ACID; 5-ACETYL-1H-PYRROLE-2-CARBOXYLIC ACID; 2-(4-ACETYL-2-METHOXYPHENOXY)-3-METHYLBUTANOIC ACID; 4-[4-(3-OXOBUTYL)PHENOXY]BUTANOIC ACID; 4-(3-ACETYLPHENOXY)BUTANOIC ACID; 2-(4-ACETYLPHENOXY)-3-METHYLBUTANOIC ACID; 3-METHYL-2-[4-(3-OXOBUTYL)PHENOXY]BUTANOIC ACID; 2-(3-ACETYLPHENOXY)-3-METHYLBUTANOIC ACID; 2-([[1-(2-AMINO-1,3-THIAZOL-4-YL)-2-OXOPROPYLIDENE]AMINO]OXY)-2-METHYLPROPANOIC ACID; (1S,6R)-6-ACETYL-1-METHYL-3-CYCLOHEXENE-1-CARBOXYLIC ACID; 4-(4-ACETYL-2-METHOXYPHENOXY)BUTANOIC ACID; (2S)-2-([(4-ACETYLPHENYL)SULFONYL]AMINO)PROPANOIC ACID; 2-((1S,3S)-3-ACETYL-2,2-DIMETHYLCYCLOBUTYL)ACETIC ACID; 7-ACETYL-4-HYDROXY-QUINOLINE-3-CARBOXYLIC ACID; 2-ACETYL-3-OXO-BUTANOIC ACID; [1-(4-ACETYL-PHENYL)-PIPERIDIN-4-YL]-ACETIC ACID; 4-ACETYLBENZOIC ACID HYDRATE; 2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)ACETIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)ACETIC ACID; 5-ACETYL-2-PYRIDINECARBOXYLIC ACID; 5-ACETYL-2-HYDROXY-3-METHOXY-BENZOIC ACID; 3-ACETYL-6-AMINO-4-METHYLPICOLINIC ACID; 3-ACETYL-6-AMINO-5-METHYLPICOLINIC ACID; 3-[(3-ACETYLPHENYL)SULFAMOYL]PROPANOIC ACID; 3-[(4-ACETYLPHENYL)SULFAMOYL]PROPANOIC ACID; ETHYL 2-ACETYL-4′-NITROCINNAMATE; N-ACETOACETYLANTHRANILIC ACID HYDRATE; 3-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; 3-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; 4-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 4-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 5-ACETYL-3-METHYLTHIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID; 2-ACETYLISONICOTINIC ACID; (4R)-4-(2-ACETYLPHENYL)-4-AMINOBUTANOIC ACID; (4S)-4-(2-ACETYLPHENYL)-4-AMINOBUTANOIC ACID; (4R)-4-(3-ACETYLPHENYL)-4-AMINOBUTANOIC ACID; (4S)-4-(3-ACETYLPHENYL)-4-AMINOBUTANOIC ACID; 3-ISOXAZOLECARBOXYLIC ACID, 5-ACETYL-; (5R)-5-(2-ACETYLPHENYL)-5-AMINOPENTANOIC ACID; (5S)-5-(2-ACETYLPHENYL)-5-AMINOPENTANOIC ACID; (5R)-5-(3-ACETYLPHENYL)-5-AMINOPENTANOIC ACID; (5S)-5-(3-ACETYLPHENYL)-5-AMINOPENTANOIC ACID; BENZOIC ACID, 3-ACETYL-2-AMINO-6-METHOXY-; 3-ACETYL-1-BUTYLINDOLE-6-CARBOXYLIC ACID; 2-[(3-ACETYLBENZENE)(METHYL)SULFONAMIDO]ACETIC ACID; 1-ACETYLCYCLOPROPANECARBOXYLIC ACID; 5-(4-ACETYLPHENOXY)PENTANOIC ACID; 5-(3-ACETYLPHENOXY)PENTANOIC ACID; 2-([(5-ACETYL-2-ETHOXYPHENYL)METHYL]SULFANYL)ACETIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3-HYDROXYBUTANOIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]-3-HYDROXYPROPANOIC ACID; 4-[(4-ACETYL-1H-PYRROL-2-YL)-N-METHYLFORMAMIDO]BUTANOIC ACID; 3-([2-(2-ACETYLPHENOXY)ETHYL]SULFANYL)PROPANOIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL]SULFANYL)PROPANOIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL]SULFANYL)PROPANOIC ACID; 2-[(3-ACETYLBENZENE)SULFONAMIDO]PROPANOIC ACID; 3-(2-ACETYLPHENOXY)PROPANOIC ACID; 3-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 3-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)-N-METHYLFORMAMIDO]ACETIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3-HYDROXYPROPANOIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL]SULFANYL)ACETIC ACID; 2-[(3-ACETYLPHENYL)SULFAMOYL]ACETIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)SULFANYL)PROPANOIC ACID; 4-ACETYL-5-OXO-HEX-2-ENOIC ACID; (S)-3-(3-ACETYL-4-HYDROXY-PHENYL)-2-AMINO-PROPIONIC ACID HYDROCHLORIDE; 2-(2-ACETYL-5-METHOXYPHENYL)ACETIC ACID; N-(((2-ACETYLPHENYL)AMINO)CARBONYL)GLYCINE; N-(((2-ACETYLPHENYL)AMINO)CARBONYL)-BETA-ALANINE; N-(((2-ACETYLPHENYL)AMINO)CARBONYL)-L-ALANINE; BUTANOIC ACID, 2-AMINO-3-OXO-; 2-[(4-ACETYLPHENYL)SULFAMOYL]ACETIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)SULFANYL)ACETIC ACID; 3-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)SULFANYL)PROPANOIC ACID; (2R)-3-(3-ACETYL-4-HYDROXYPHENYL)-2-AMINOPROPANOIC ACID; D-4-ACETYLPHE; AC-THZ-OH; AC-D-THZ-OH; 3′-ACETYL-BIPHENYL-2-ACETIC ACID; 3-[4-(3-OXOBUTYL)PHENOXY]BUTANOIC ACID; 3-(4-ACETYL-2-METHOXYPHENOXY)BUTANOIC ACID; 2-METHYL-3-[4-(3-OXOBUTYL)PHENOXY]PROPANOIC ACID; 3-(4-ACETYL-2-METHOXYPHENOXY)-2-METHYLPROPANOIC ACID; 2-(([(2-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)ACETIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL]AMINO)PROPANOIC ACID; 3-([(5-ACETYL-2-METHOXYPHENYL)METHYL]AMINO)PROPANOIC ACID; 2-(([(4-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)ACETIC ACID; 3-([2-(2-ACETYLPHENOXY)ETHYL]AMINO)PROPANOIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL](METHYL)AMINO)ACETIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)ACETIC ACID; 3-[(4-ACETYLPHENYL)SULFANYL]PROPANOIC ACID; 2-[(4-ACETYLPHENYL)SULFANYL]PROPANOIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL]AMINO)PROPANOIC ACID; 2-[4-(3-OXOBUTYL)PHENOXY]BUTANOIC ACID; 2-(3-ACETYLPHENOXY)BUTANOIC ACID; 4-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)BUTANOIC ACID; 2-(([(3-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)ACETIC ACID; 2-([(5-ACETYL-2-ETHOXYPHENYL)METHYL]AMINO)ACETIC ACID; 3-[(4-ACETYL-2-FLUOROPHENYL)SULFANYL]PROPANOIC ACID; 2-[(4-ACETYL-2-FLUOROPHENYL)SULFANYL]PROPANOIC ACID; ABAMACHEM ABA-1038178; 3-(3-ACETYL-2-METHYL-5-PHENYL-1H-PYRROL-1-YL)PROPANOIC ACID; 2-(3-ACETYLPHENOXY)-2,2-DIFLUOROACETIC ACID; 2,2-DIFLUORO-2-[4-(3-OXOBUTYL)PHENOXY]ACETIC ACID; 2-(4-ACETYLPHENOXY)-2,2-DIFLUOROACETIC ACID; 2-(4-ACETYL-2-METHOXYPHENOXY)-2,2-DIFLUOROACETIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)ACETIC ACID; 4-ACETYL-5-METHYL-3-PROPYL-1H-PYRROLE-2-CARBOXYLIC ACID; 2-(4-ACETYLPHENOXY)BUTANOIC ACID; 2-([(5-ACETYL-2-ETHOXYPHENYL)METHYL](METHYL)AMINO)ACETIC ACID; FCHGROUP FCH243829; 3-METHYL-2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)BUTANOIC ACID; 3-(([(4-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 2-(([(4-ACETYLPHENYL)CARBAMOYL]METHYL)(METHYL)AMINO)ACETIC ACID; (2-ACETYL-1H-IMIDAZOL-1-YL)ACETIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL]AMINO)ACETIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL]AMINO)ACETIC ACID; 4′-ACETYL-2′-METHYLBIPHENYL-4-CARBOXYLIC ACID; 2-(4-ACETYL-2-METHOXYPHENOXY)BUTANOIC ACID; 2-[(4-ACETYLPHENYL)CARBAMOYL]CYCLOPROPANE-1-CARBOXYLIC ACID; 2-[(3-ACETYLPHENYL)CARBAMOYL]CYCLOPROPANE-1-CARBOXYLIC ACID; 3-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 2-[METHYL(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]ACETIC ACID; 2-([(5-ACETYL-2-ETHOXYPHENYL)METHYL]AMINO)PROPANOIC ACID; 4-([2-(2-ACETYLPHENOXY)ETHYL]AMINO)BUTANOIC ACID; 3-(([(2-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 1-([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)PYRROLIDINE-2-CARBOXYLIC ACID; 1-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)CARBONYL]PYRROLIDINE-2-CARBOXYLIC ACID; 3-CARBAMOYL-2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 2-CYCLOPROPYL-2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 1-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]PIPERIDINE-4-CARBOXYLIC ACID; 2-[(4-ACETYLPHENYL)SULFANYL]PYRIDINE-3-CARBOXYLIC ACID; 2-[N-(CYCLOPROPYLMETHYL)(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]ACETIC ACID; 2-(([(2-ACETYLPHENYL)CARBAMOYL]METHYL)(METHYL)AMINO)ACETIC ACID; 3-[N-CYCLOPROPYL-1-(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]PROPANOIC ACID; 5-[4-(3-OXOBUTYL)PHENOXY]PENTANOIC ACID; 5-(4-ACETYL-2-METHOXYPHENOXY)PENTANOIC ACID; 2-(3-ACETYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 3-(3-ACETYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 3-(4-ACETYLPHENOXYMETHYL)FURAN-2-CARBOXYLIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3,3-DIMETHYLBUTANOIC ACID; 3-(([(3-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 3-([(5-ACETYL-2-ETHOXYPHENYL)METHYL]AMINO)PROPANOIC ACID; 2-(([(2-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 4-([(5-ACETYL-2-METHOXYPHENYL)METHYL]AMINO)BUTANOIC ACID; 5-[(3-ACETYLPHENYL)CARBAMOYL]PENTANOIC ACID; 5-[(4-ACETYLPHENYL)CARBAMOYL]PENTANOIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3-METHYLPENTANOIC ACID; 1-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID; 1-[(4-ACETYL-1H-PYRROLE-2-)AMIDO]CYCLOPENTANE-1-CARBOXYLIC ACID; 2-(4-ACETYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)AMINO)PENTANOIC ACID; 4-[(4-ACETYLPHENYL)SULFANYL]BENZOIC ACID; 2-[(4-ACETYLPHENYL)SULFANYL]BENZOIC ACID; 2-(([(3-ACETYLPHENYL)CARBAMOYL]METHYL)(METHYL)AMINO)ACETIC ACID; 2-[CYCLOPROPYL(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]ACETIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)-N-(PROPAN-2-YL)FORMAMIDO]ACETIC ACID; 2-[N-(BUTAN-2-YL)(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]ACETIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)(PROPAN-2-YL)AMINO)ACETIC ACID; 2-ACETYL-3-HYDROXYTHIOPHENE-5-CARBOXYLIC ACID; 2-(([(4-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 2-(([(3-ACETYLPHENYL)CARBAMOYL]METHYL)AMINO)PROPANOIC ACID; 5-ACETYL-2-METHOXYBENZOIC ACID; 3-([2-(2-ACETYLPHENOXY)ETHYL](METHYL)AMINO)PROPANOIC ACID; 3-([(5-ACETYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)PROPANOIC ACID; 2-(3-ACETYL-1H-PYRROL-2-YL)ACETIC ACID; 2,2-DIMETHYL-4-OXO-PENTANOIC ACID; 7-METHYL-8-OXONONANOIC ACID; 4-ACETYL-3-ETHYL-5-METHYL-1H-PYRROLE-2-CARBOXYLIC ACID; 4-ACETYL PHENYLALANINE HYDROCHLORIDE; 1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID, 2-ACETYL-; GLYCINE, N-(1-METHYL-3-OXOBUTYLIDENE)-; 2-ACETYL-ALPHA-AMINO-CYCLOPROPANEACETIC ACID; 3-[METHYL(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]PROPANOIC ACID; 4-(2-ACETYLPHENYL)-4-OXOBUTANOIC ACID; 3-[(4-ACETYL-1H-PYRROL-2-YL)-N-ETHYLFORMAMIDO]PROPANOIC ACID; 3-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)-N-ETHYLFORMAMIDO]PROPANOIC ACID; 3-ACETYL-7-BENZOFURANACETIC ACID; 5-OXO-2-HEXENOIC ACID; (2S)-2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-3-METHYLPENTANOIC ACID; 2-[ETHYL([((2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]ACETIC ACID; 3-[ETHYL(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]PROPANOIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL](ETHYL)AMINO)ACETIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL](ETHYL)AMINO)ACETIC ACID; 2-(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL)(PROPYL)AMINO)ACETIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)-N-ETHYLFORMAMIDO]ACETIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-4-HYDROXYBUTANOIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]-4-HYDROXYBUTANOIC ACID; 4-METHYL-3-(3-OXOBUTANAMIDO)BENZOIC ACID; 3-(3-OXOBUTANAMIDO)-3-(THIOPHEN-2-YL)PROPANOIC ACID; 2-FLUORO-5-(3-OXOBUTANAMIDO)BENZOIC ACID; 4-FLUORO-3-(3-OXOBUTANAMIDO)BENZOIC ACID; 2,4-DIFLUORO-5-(3-OXOBUTANAMIDO)BENZOIC ACID; 2-METHYL-3-(3-OXOBUTANAMIDO)BENZOIC ACID; 3-METHYL-4-(3-OXOBUTANAMIDO)BENZOIC ACID; 2-CHLORO-5-(3-OXOBUTANAMIDO)BENZOIC ACID; 2-[(4-ACETYL-1H-PYRROL-2-YL)FORMAMIDO]-2-METHYLPROPANOIC ACID; 2-[(4-ACETYL-1-METHYL-1H-PYRROL-2-YL)FORMAMIDO]-2-METHYLPROPANOIC ACID; 3-(4-ACETYLPHENYL)-2-BROMOPROPANOIC ACID; 2-PYRIDINECARBOXYLIC ACID, 3-(2-OXOPROPOXY)-; 2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)-2-METHYLPROPANOIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL](METHYL)AMINO)ACETIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)-3-HYDROXYPROPANOIC ACID; 3-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 3-([(3-ACETYLPHENYL)CARBAMOYL](METHYL)AMINO)PROPANOIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL](ETHYL)AMINO)ACETIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)-2-METHYLPROPANOIC ACID; 6-[(4-ACETYLPHENYL)SULFANYL]PYRIDINE-3-CARBOXYLIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL](METHYL)AMINO)ACETIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)-3-HYDROXYPROPANOIC ACID; 3-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)BUTANOIC ACID; 3-([(4-ACETYLPHENYL)CARBAMOYL](METHYL)AMINO)PROPANOIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL](ETHYL)AMINO)ACETIC ACID; 2-[(4-ACETYLPHENYL)SULFANYL]PYRIDINE-4-CARBOXYLIC ACID; 2-(4-ACETYLPHENOXY)-2,4-DIMETHYLPENTANOIC ACID; 2-(4-ACETYLPHENOXY)-2-METHYLPENTANOIC ACID; 2-CYCLOPROPYL-2-(3-ACETYLPHENOXY)PROPANOIC ACID; 2-(3-ACETYLPHENOXY)-2-ETHYLBUTANOIC ACID; 1-(3-ACETYLPHENOXY)CYCLOHEXANE-1-CARBOXYLIC ACID; 1-(4-ACETYLPHENOXY)CYCLOPENTANE-1-CARBOXYLIC ACID; 2-CYCLOPROPYL-2-(4-ACETYLPHENOXY)PROPANOIC ACID; 2-(4-ACETYLPHENOXY)-2-ETHYLBUTANOIC ACID; 1-(4-ACETYLPHENOXY)CYCLOHEXANE-1-CARBOXYLIC ACID; 4-(4-ACETYLPHENOXY)OXANE-4-CARBOXYLIC ACID; 2-(4-ACETYLPHENOXY)-2-METHYLBUTANOIC ACID; 3-(3-ACETYLPHENOXY)THIOLANE-3-CARBOXYLIC ACID; 2-(3-ACETYLPHENOXY)-2,4-DIMETHYLPENTANOIC ACID; 1-(3-ACETYLPHENOXY)CYCLOPENTANE-1-CARBOXYLIC ACID; 4-(3-ACETYLPHENOXY)OXANE-4-CARBOXYLIC ACID; 2-(3-ACETYLPHENOXY)-2-METHYLPENTANOIC ACID; 2-(3-ACETYLPHENOXY)-2-METHYLBUTANOIC ACID; 2-METHYL-2-[4-(3-OXOBUTYL)PHENOXY]PROPANOIC ACID; 2-METHYL-2-[4-(3-OXOBUTYL)PHENOXY]BUTANOIC ACID; 3-(4-ACETYLPHENOXY)THIOLANE-3-CARBOXYLIC ACID; 2-(4-ACETYL-2-METHOXYPHENOXY)-2-METHYLPROPANOIC ACID; 2-(4-ACETYL-2-M ETHOXYPHENOXY)-2-METHYLBUTANOIC ACID; 2-ACETYL-4-BROMOPHENYLHYDROGENCARBONATE; 3-(2-FURYL)-1-(2-OXOPROPYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID; 3-(2-OXOPROPYL)-3H-IMIDAZO[4,5-B]PYRIDINE-2-CARBOXYLIC ACID; 2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; 4-(METHOXYCARBONYL)-1-(2-OXOPROPYL)-1H-IMIDAZOLE-5-CARBOXYLIC ACID; (2S)-2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)-3-HYDROXYPROPANOIC ACID; (2S)-2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)-3-HYDROXYPROPANOIC ACID; 5-ACETYL-1,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 5-ACETYL-1-ETHYL-6-METHYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 6-ACETYL-5-METHYL-3-OXO-3,4-DIHYDROPYRAZINE-2-CARBOXYLIC ACID; 5-ACETYL-4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 5-ACETYL-6-METHYL-2-OXO-1-PROPYL-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID; 2-(1-[(4-ACETYL-1H-PYRROL-2-YL)CARBONYL]PYRROLIDIN-2-YL)ACETIC ACID; 4-(3-OXOBUTANAMIDO)BUTANOIC ACID; 2-[(4-ACETYL-2-METHOXYPHENYL)SULFANYL]ACETIC ACID; 2-(3-ACETYLPHENOXY)-2-METHYLPROPANOIC ACID; 2-(ACETYL-METHOXYCARBONYLAMINO)BENZOIC ACID; 5-(2-ACETYL-PHENOXYMETHYL)-FURAN-2-CARBOXYLIC ACID; 3-(3-OXOBUTANAMIDO)PROPANOIC ACID; 2-(5-ACETYLFURAN-2-YL)ACETIC ACID; 2-(4-ACETYLPHENOXY)-4-METHOXY-2-METHYLBUTANOIC ACID; 2-(3-ACETYLPHENOXY)-4-METHOXY-2-METHYLBUTANOIC ACID; 5-[2-(3-ACETYL-PHENYL)-PROPYL]-FURAN-2-CARBOXYLIC ACID; 2-[(2-ACETYLNAPHTHALEN-1-YL)OXY]PROPANOIC ACID; 2-(4-ACETYL-3-METHOXYPHENYL)ACETIC ACID; BENZENEACETIC ACID, 3-ACETYL; 4-ACETYL-5-BROMONICOTINIC ACID; 4-ACETYLNICOTINIC ACID; 3-ACETYLISONICOTINIC ACID; 4-(ETHOXYCARBONYL)-3,5-DIMETHYL-1-(2-OXOPROPYL)-1H-PYRROLE-2-CARBOXYLIC ACID; 3-METHYL-2-(3-OXOBUTANAMIDO)BUTANOIC ACID; (2S)-2-(2-ACETYLPHENYL)-2-HYDROXYACETIC ACID; 2-[(3-ACETYLPHENYL)SULFAMOYL]PROPANOIC ACID; 3-ACETYL-2-PYRIDINECARBOXYLIC ACID; 3-ACETYL-5-CHLORO-2-PYRIDINECARBOXYLIC ACID; 2-(2-ACETYL-4-METHYLPHENOXY)PROPANOIC ACID; 2-[(4-ACETYLPHENYL)SULFAMOYL]PROPANOIC ACID; (2R)-2-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; (2R)-2-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)PROPANOIC ACID; 3-(4-ACETYLPHENOXY)BENZOIC ACID; 2-(4-ACETYLPHENOXY)BENZOIC ACID; 3-(4-ACETYLPHENOXY)PYRIDINE-2-CARBOXYLIC ACID; 1-(4-ACETYLPHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-(4-ACETYL-2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID; 1-(4-ACETYLPHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID; 2-(2-ACETYL-4-CHLOROPHENOXY)PROPANOIC ACID; 4-ACETYLPYRIMIDINE-5-CARBOXYLIC ACID; 5-ACETYL-2-MERCAPTOBENZOIC ACID; 3-[(6-ACETYL-2-NAPHTHALENYL)AMINO]ALANINE; 5-ACETYLPYRIMIDINE-4-CARBOXYLIC ACID; 5-ACETYL-1-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXYLIC ACID; 5-ACETYL-4-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID; 2,2-DIMETHYL-3-OXOBUTANOIC ACID; 3-ACETYL-1H-INDOLE-6-CARBOXYLIC ACID; 2-[(4-ACETYLPHENYL)CARBAMOYL]ACETIC ACID; 2-[(3-ACETYLPHENYL)CARBAMOYL]ACETIC ACID; 5-(2-ACETYLPHENYL)-PICOLINIC ACID; 5-(4-ACETYLPHENYL)-PICOLINIC ACID; 5-(3-ACETYLPHENYL)-PICOLINIC ACID; 2-FLUORO-3-OXOBUTANOIC ACID; 2-HYDROXY-2-METHYL-3-OXOBUTANOIC ACID; 5-ACETYL-INDOLE-3-CARBOXYLIC ACID; 2,2-DICHLORO-ACETOACETIC ACID; 5-CHLORO-6-OXO-HEPTANOIC ACID; 4-ACETAMIDO-5-OXO-HEXANOIC ACID; 1-PYRROLIDINECARBOXYLIC ACID, 3-ACETYL-2,4-DIMETHYL-; 1,4-BENZODIOXIN-2-CARBOXYLIC ACID, 2,3-DIHYDRO-6-(2-OXOPROPYL)-; 5-(2-ACETYLPHENYL)-NICOTINIC ACID; 5-(4=ACETYLPHENYL)-NICOTINIC ACID; 4-(4-ACETYL-2-METHOXYPHENOXY)PENTANOIC ACID; 4-(4-ACETYLPHENOXY)PENTANOIC ACID; 5-(5-ACETYLTHIOPHEN-2-YL)-NICOTINIC ACID; 2-(2-ACETYLPHENYL)-ISONICOTINIC ACID; 2-(3-ACETYLPHENYL)-ISONICOTINIC ACID; 2-(4-ACETYLPHENYL)-ISONICOTINIC ACID; 2-([2-(2-ACETYLPHENOXY)ETHYL](METHYL)AMINO)PROPANOIC ACID; 2-METHYL-2-[METHYL(([(2-METHYL-4-OXOPENTAN-3-YL)CARBAMOYL]METHYL))AMINO]PROPANOIC ACID; 2-ACETYL-5-THIAZOLECARBOXYLIC ACID; 2-(4-ACETYLPHENYL)BENZOIC ACID; 5-ACETYL-2-METHYL-NICOTINIC ACID; GLYCINE, N-(4-ACETYL-2-NITROPHENYL)-; BETA-ALANINE, N-(4-ACETYL-2-NITROPHENYL)-; 4-[4-(3-OXOBUTYL)PHENOXY]BUT-2-ENOIC ACID; 2-(2-ACETYL-5-FLUOROPHENOXY)PROPANOIC ACID; 5-(3-ACETYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 3-([(3-ACETYLPHENYL)CARBAMOYL]AMINO)-2-METHYLPROPANOIC ACID; 5-(4-ACETYLPHENOXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 4-(3-ACETYLPHENOXY)PENTANOIC ACID; 3-([(4-ACETYLPHENYL)CARBAMOYL]AMINO)-2-METHYLPROPANOIC ACID; 5-(3-ACETYLPHENOXYMETHYL)OXOLANE-2-CARBOXYLIC ACID; 5-(4-ACETYLPHENOXYMETHYL)FURAN-3-CARBOXYLIC ACID; 2-([(3-ACETYLPHENYL)CARBAMOYL](METHYL)AMINO)PROPANOIC ACID; 2-([(5-ACETYL-2-METHOXYPHENYL)METHYL](METHYL)AMINO)PROPANOIC ACID; 4-[4-(3-OXOBUTYL)PHENOXY]PENTANOIC ACID; 2-(4-ACETYLPHENOXY)-3-METHOXY-2-METHYLPROPANOIC ACID; 2-(3-ACETYLPHENOXY)-3-METHOXY-2-METHYLPROPANOIC ACID; 2-(2-ACETYLPHENYL)-5-FLUOROPYRIDINE-4-CARBOXYLIC ACID; 3-(2-ACETYLPHENYL)PYRIDINE-2-CARBOXYLIC ACID; 4-(2-ACETYLPHENYL)PYRIDINE-2-CARBOXYLIC ACID; 4-(4-ACETYL-2-METHOXYPHENOXY)BUT-2-ENOIC ACID; 2-(2-ACETYLPHENYL)PYRIDINE-3-CARBOXYLIC ACID; 4-ACETYLTHIOPHENE-2-CARBOXYLIC ACID; 5-(2-ACETYLPHENYL)-2-AMINOPYRIDINE-3-CARBOXYLIC ACID; 3-(2-ACETYLPHENYL)-6-AMINOPYRIDINE-2-CARBOXYLIC ACID; 3-(2-ACETYLPHENYL)PYRIDINE-4-CARBOXYLIC ACID; 6-(2-ACETYLPHENYL)PYRIDINE-3-CARBOXYLIC ACID; 5-(2-ACETYLPHENYL)-2-HYDROXYBENZOIC ACID; 3-(2-ACETYLPHENYL)-4-HYDROXYBENZOIC ACID; 3-(2-ACETYLPHENYL)-5-HYDROXYBENZOIC ACID; 3-(2-ACETYLPHENYL)-2-HYDROXYBENZOIC ACID; (2S)-2-(5-ACETYL-2-CHLORO-6-METHYL(3-PYRIDYL))-2-AMINOPROPANOIC ACID; (2R)-2-(5-ACETYL-2-CHLORO-6-METHYL(3-PYRIDYL))-2-AMINOPROPANOIC ACID; (2S)-2-(5-ACETYL-6-CHLORO(3-PYRIDYL))-2-AMINOPROPANOIC ACID; (2R)-2-(5-ACETYL-6-CHLORO(3-PYRIDYL))-2-AMINOPROPANOIC ACID; (2S)-2-(6-ACETYL(2-PYRIDYL))-2-AMINOPROPANOIC ACID; (2R)-2-(6-ACETYL(2-PYRIDYL))-2-AMINOPROPANOIC ACID; (2R)-2-(6-ACETYL(2-PYRIDYL))-2-AMINOACETIC ACID; (2S)-2-(5-ACETYL-2-CHLORO-6-METHYL(3-PYRIDYL))-2-AMINOACETIC ACID; (2R)-2-(5-ACETYL-2-CHLORO-6-METHYL(3-PYRIDYL))-2-AMINOACETIC ACID; (2S)-2-(5-ACETYL-6-CHLORO(3-PYRIDYL))-2-AMINOACETIC ACID; (2R)-2-(5-ACETYL-6-CHLORO(3-PYRIDYL))-2-AMINOACETIC ACID; (2S)-2-(5-ACETYL(2-PYRIDYL))-2-AMINOPROPANOIC ACID; (2R)-2-(5-ACETYL(2-PYRIDYL))-2-AMINOPROPANOIC ACID; (2S)-2-(5-ACETYL(2-PYRIDYL))-2-AMINOACETIC ACID; (2R)-2-(5-ACETYL(2-PYRIDYL))-2-AMINOACETIC ACID; (2S)-2-(6-ACETYL(2-PYRIDYL))-2-AMINOACETIC ACID; 3-(5-ACETYLTHIOPHEN-3-YL)PROPIOLIC ACID; 3-(2-ACETYLTHIOPHEN-3-YL)PROPIOLIC ACID; 2-(4-ACETYL-5-METHYL-1H-PYRAZOL-1-YL)ACETIC ACID; 5-(4-ACETYLPHENYL)-3-AMINOBENZOIC ACID; 4-(4-ACETYLPHENYL)-3-FLUOROBENZOIC ACID; 5-(3-ACETYLPHENYL)-2-CHLOROBENZOIC ACID; 4-(3-ACETYLPHENYL)-2-CHLOROBENZOIC ACID; 3-(3-ACETYLPHENYL)-5-CHLOROBENZOIC ACID; 2-(3-ACETYLPHENYL)-4-CHLOROBENZOIC ACID; 2-(3-ACETYLPHENYL)-6-CHLOROBENZOIC ACID; 3-(3-ACETYLPHENYL)-4-CHLOROBENZOIC ACID; 2-(4-ACETYLPHENYL)-6-METHYLBENZOIC ACID; 4-(4-ACETYLPHENYL)-3-METHYLBENZOIC ACID; 3-(4-ACETYLPHENYL)-2-METHYLBENZOIC ACID; 2-(4-ACETYLPHENYL)-5-METHYLBENZOIC ACID; 4-(4-ACETYLPHENYL)-3-HYDROXYBENZOIC ACID; 3-(4-ACETYLPHENYL)-5-HYDROXYBENZOIC ACID; 4-(4-ACETYLPHENYL)-2-HYDROXYBENZOIC ACID; 2-(4-ACETYLPHENYL)-4-FLUOROBENZOIC ACID; 2-(4-ACETYLPHENYL)-5-FLUOROBENZOIC ACID; 3-(4-ACETYLPHENYL)-4-FLUOROBENZOIC ACID; 4-(4-ACETYLPHENYL)-2-FLUOROBENZOIC ACID; 5-(4-ACETYLPHENYL)-2-FLUOROBENZOIC ACID; 3-(4-ACETYLPHENYL)-5-FLUOROBENZOIC ACID; 2-(4-ACETYLPHENYL)-6-FLUOROBENZOIC ACID; 4-(4-ACETYLPHENYL)-3-METHOXYBENZOIC ACID; 3-(4-ACETYLPHENYL)-2-METHOXYBENZOIC ACID; 2-(3-ACETYLPHENYL)-6-METHYLBENZOIC ACID; 4-(3-ACETYLPHENYL)-3-METHYLBENZOIC ACID; 3-(3-ACETYLPHENYL)-2-METHYLBENZOIC ACID; 4-(3-ACETYLPHENYL)-2-HYDROXYBENZOIC ACID; 2-(3-ACETYLPHENYL)-4-FLUOROBENZOIC ACID; 2-(3-ACETYLPHENYL)-5-FLUOROBENZOIC ACID; 3-(3-ACETYLPHENYL)-5-FLUOROBENZOIC ACID; 2-(3-ACETYLPHENYL)-6-FLUOROBENZOIC ACID; 4-(3-ACETYLPHENYL)-3-METHOXYBENZOIC ACID; 3-(3-ACETYLPHENYL)-2-METHOXYBENZOIC ACID; 2-(3-ACETYLPHENYL)-5-METHOXYBENZOIC ACID; 3-(3-ACETYLPHENYL)-5-METHOXYBENZOIC ACID; 4-(3-ACETYLPHENYL)-2-METHOXYBENZOIC ACID; 4-(3-ACETYLPHENYL)NICOTINIC ACID; 3-(3-ACETYLPHENYL)-6-AMINOPICOLINIC ACID; 2-(3-ACETYLPHENYL)-5-METHYLBENZOIC ACID; 5-(3-ACETYLPHENYL)-3-AMINOBENZOIC ACID; 4-(3-ACETYLPHENYL)-3-HYDROXYBENZOIC ACID; 3-(3-ACETYLPHENYL)-5-HYDROXYBENZOIC ACID; 3-(3-ACETYLPHENYL)-4-FLUOROBENZOIC ACID; 4-(3-ACETYLPHENYL)-3-FLUOROBENZOIC ACID; 4-(3-ACETYLPHENYL)-2-FLUOROBENZOIC ACID; 5-(3-ACETYLPHENYL)-2-FLUOROBENZOIC ACID; 4-(4-ACETYLPHENYL)NICOTINIC ACID; 3-(4-ACETYLPHENYL)-6-AMINOPICOLINIC ACID; 3-(3-ACETYLPHENYL)ISONICOTINIC ACID; 2-(3-ACETYLPHENYL)NICOTINIC ACID; 5-(3-ACETYLPHENYL)NICOTINIC ACID; 2-(4-ACETYLPHENYL)-5-METHOXYBENZOIC ACID; 3-(4-ACETYLPHENYL)-5-METHOXYBENZOIC ACID; 2-(4-ACETYLPHENYL)-6-CHLOROBENZOIC ACID; 3-(4-ACETYLPHENYL)-4-CHLOROBENZOIC ACID; 4-(4-ACETYLPHENYL)-2-METHOXYBENZOIC ACID; 5-(4-ACETYLPHENYL)-2-CHLOROBENZOIC ACID; 4-(4-ACETYLPHENYL)-2-CHLOROBENZOIC ACID; 3-(4-ACETYLPHENYL)-5-CHLOROBENZOIC ACID; 2-(4-ACETYLPHENYL)-4-CHLOROBENZOIC ACID; 6-(3-ACETYLPHENYL)NICOTINIC ACID; 3-(3-ACETYLPHENYL)PICOLINIC ACID; 4-(3-ACETYLPHENYL)PICOLINIC ACID; 6-(3-ACETYLPHENYL)PICOLINIC ACID; 5-(3-ACETYLPHENYL)-6-HYDROXYNICOTINIC ACID; 5-(3-ACETYLPHENYL)-2-METHOXYNICOTINIC ACID; 4-(4-ACETYLPHENYL)PICOLINIC ACID; 6-(4-ACETYLPHENYL)PICOLINIC ACID; 5-(4-ACETYLPHENYL)-2-AMINOISONICOTINIC ACID; 5-(4-ACETYLPHENYL)-2-AMINONICOTINIC ACID; 5-(4-ACETYLPHENYL)-2-HYDROXYNICOTINIC ACID; 5-(4-ACETYLPHENYL)-2-HYDROXYISONICOTINIC ACID; 5-(4-ACETYLPHENYL)-2-METHOXYNICOTINIC ACID; 5-(3-ACETYLPHENYL)-2-AMINOISONICOTINIC ACID; 5-(3-ACETYLPHENYL)-2-AMINONICOTINIC ACID; 5-(3-ACETYLPHENYL)-2-HYDROXYNICOTINIC ACID; 5-(3-ACETYLPHENYL)-2-HYDROXYISONICOTINIC ACID; 3-(4-ACETYLPHENYL)ISONICOTINIC ACID; 2-(4-ACETYLPHENYL)NICOTINIC ACID; 6-(4-ACETYLPHENYL)NICOTINIC ACID; 3-(4-ACETYLPHENYL)PICOLINIC ACID; 5-(4-ACETYLPHENYL)-6-HYDROXYNICOTINIC ACID; 5-(3-ACETYL-PHENOXY)-FURAN-2-CARBOXYLIC ACID; 5-(4-ACETYL-PHENOXY)-FURAN-2-CARBOXYLIC ACID; 3-ACETYL-4-AZAINDOLE-5-CARBOXYLIC ACID; 3-ACETYL-7-AZAINDOLE-6-CARBOXYLIC ACID; 3-ACETYL-4-AZAINDOLE-7-CARBOXYLIC ACID; 3-ACETYL-4-METHYL-2-PYRROLECARBOXYLIC ACID; 4-ACETYL-5-FORMYL-3-METHYL-PYRROLE-2-CARBOXYLIC ACID; 2-ACETYL-6-NITROBENZOIC ACID; (2-ACETYL-3-HYDROXYPHENOXY)ACETIC ACID; 2,2-DIMETHYL-5-OXOHEXANOIC ACID; 2-BUTYL-5-OXOHEXANOIC ACID; 5-ACETYL-2-FUROIC ACID

List No. 9—Dicarbonyls: FORMYL-2-OXO-2-PHENYLETHYL)SODIUM; (2S)-1-(3-FORMYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)PYRROLIDINE-2-CARBOXAMIDE; (5-FORMYL-6-OXO-3-TRIFLUOROMETHYL-6H-PYRIDAZIN-1-YL)-ACETIC ACID ETHYL ESTER; 1-(3,4-DIMETHYLPHENYL)-3-METHYL-5-OXO-3-PYRAZOLIN-4-CARBALDEHYDE; 1,2-DIHYDRO-6-METHYL-2-OXO-3-PYRIDINECARBOXALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-(PROPYLAMINO)-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-6-(METHYLAMINO)-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,4-DIHYDRO-5-METHYL-4-OXO-3-PYRIDINECARBOXALDEHYDE; 1,4-DIHYDRO-6-METHYL-4-OXO-3-PYRIDINECARBOXALDEHYDE; 11-CHLORO-13-OXO-8-OXA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 11-CHLORO-13-OXO-8-THIA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 1-BENZYL-3-OXOPIPERIDINE-4-CARBALDEHYDE; 1-CYCLOPROPYL-7-FLUORO-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-CYCLOPROPYL-7-FLUORO-8-METHYL-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-ETHOXYCARBONYL-3-FORMYL-4-PIPERIDONE; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-AMINO-6,7-DIHYDRO-2,3-DIMETHYL-6-OXO-; 2-((2-METHOXYETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(2-(METHYLTHIO)PYRIMIDIN-4-YL)MALONALDEHYDE; 2-(3-FLUORO-PHENYL)-6-METHOXY-3-OXO-2,3-DIHYDRO-ISOQUINOLINE-4-CARBALDEHYDE; 2-(4-IODOPHENOXY)MALONDIALDEHYDE; 2-(ALLYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2,2-DIMETHYL-3-OXOHEPT-6-ENAL; 2,2-DIMETHYL-3-OXOHEPTANAL; 2,2-DIMETHYL-3-OXOHEXANAL; 2,2-DIMETHYL-3-OXOOCTANAL; 2,2-DIMETHYL-3-OXOPENTANAL; 2,6-DIAMINO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2,7-DICHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-AMINO-6-CHLORO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2-CHLORO-6-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIMETHYLAMINO-1,3-DIOXOHEXANE; 2-HEPTYL-1,4-DIHYDRO-4-OXO-3-QUINOLINECARBOXALDEHYDE; 2-IODOMALONALDEHYDE; 2-METHYL-3-(3-NITROPHENYL)-3-OXOPROPANAL; 2-METHYL-3-OXO-3-(THIOPHEN-2-YL)PROPANAL; 2-METHYL-3-OXO-BUTANAL; 2-METHYL-5-(MORPHOLIN-4-YL)-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBALDEHYDE; 2-OXO-1-[1-(TRIMETHYLSILYL)-2-PROPENYL]CYCLOHEXANECARBALDEHYDE; 2-OXO-5-(PROPAN-2-YL)CYCLOHEXANE-1-CARBALDEHYDE; 2-OXO-5-PROPYLINDOLINE-3-CARBALDEHYDE; 3-(1,1-BIPHENYL-4-YL)-3-OXOPROPANAL; 3-(1,3-BENZODIOXOL-5-YL)-3-OXOPROPANAL; 3-(1,3-BENZOTHIAZOL-2-YL)-3-OXOPROPANAL; 3-(1-BENZOFURAN-2-YL)-3-OXOPROPANAL; 3-(1-ETHYL-1H-PYRAZOL-4-YL)-3-OXOPROPANAL; 3-(1-ETHYL-3,5-DIMETHYL-1H-PYRAZOL-4-YL)-3-OXOPROPANAL; 3-(1-METHYL-1H-1,3-BENZODIAZOL-2-YL)-3-OXOPROPANAL; 3-(1-METHYL-1H-PYRAZOL-4-YL)-3-OXOPROPANAL; 3-(1-NAPHTHYL)-3-OXOPROPANAL; 3-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-OXOPROPANAL; 3-(2,4-DICHLORO-5-FLUOROPHENYL)-3-OXOPROPANAL; DICHLOROPHENYL)-3-OXOPROPANAL; 3-(2,4-DIFLUOROPHENYL)-3-OXOPROPANAL; 3-(2,5-DICHLOROPHENYL)-3-OXOPROPANAL; 3-(2,5-DIFLUOROPHENYL)-3-OXOPROPANAL; 3-(2,5-DIMETHYLFURAN-3-YL)-3-OXOPROPANAL; 3-(2,6-DICHLORO-3-FLUOROPHENYL)-3-OXOPROPANAL; DIFLUOROPHENYL)-3-OXOPROPANAL; 3-(2-BROMOPHENYL)-3-OXOPROPANAL; 3-(2-CHLOROPHENYL)-3-OXOPROPANAL; 3-(2-ETHOXYPHENYL)-3-OXOPROPANAL; 3-(2-FLUOROPHENYL)-3-OXOPROPANAL; 3-(2-FURYL)-3-OXOPROPANAL; 3-(2-METHOXY-5-METHYLPHENYL)-3-OXOPROPANAL; 3-(2-METHYLPHENYL)-3-OXOPROPANAL; 3-(2-NAPHTHYL)-3-OXOPROPANAL; 3-(2-NITROPHENYL)-3-OXOPROPANAL; 3-(3,4-DICHLOROPHENYL)-3-OXOPROPANAL; 3-(3,4-DIFLUOROPHENYL)-3-OXOPROPANAL; 3-(3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YL)-3-OXOPROPANAL; 3-(3,4-DIMETHOXYPHENYL)-3-OXOPROPANAL; 3-(3,4-DIPROPOXYPHENYL)-3-OXOPROPANAL; 3-(3-BROMOPHENYL)-3-OXOPROPANAL; 3-(3-CHLORO-4-FLUOROPHENYL)-3-OXOPROPANAL; 3-(3-CHLOROPHENYL)-3-OXOPROPANAL; 3-(3-ETHYL-1-BENZOFURAN-2-YL)-3-OXOPROPANAL; 3-(3-FLUOROPHENYL)-3-OXOPROPANAL; 3-(3-NITROPHENYL)-3-OXOPROPANAL; 3-(4-BROMOPHENYL)-3-OXOPROPANAL; 3-(4-ETHOXYPHENYL)-3-OXOPROPANAL; 3-(4-FLUOROPHENYL)-3-OXOPROPANAL; 3-(4-ISOPROPYLPHENYL)-3-OXOPROPANAL; 3-(4-METHYL-3-NITROPHENYL)-3-OXOPROPANAL; 3-(4-METHYLPHENYL)-3-OXOPROPANAL; 3-(4-NITROPHENYL)-3-OXOPROPANAL; 3-(5-BROMO-1-BENZOFURAN-2-YL)-3-OXOPROPANAL; 3-(5-BROMOTHIOPHEN-2-YL)-3-OXOPROPANAL; 3-(5-CHLOROTHIOPHEN-2-YL)-3-OXOPROPANAL; 3-(5-ETHYLTHIOPHEN-2-YL)-3-OXOPROPANAL; 3-(5-METHYLFURAN-2-YL)-3-OXOPROPANAL; 3-(5-METHYLTHIEN-2-YL)-3-OXOPROPANAL; 3-(6-METHOXYNAPHTHALEN-2-YL)-3-OXOPROPANAL; 3-(9H-FLUOREN-2-YL)-3-OXOPROPANAL; 3-(ADAMANTAN-1-YL)-3-OXOPROPANAL; 3-(FURAN-2-YL)-2-METHYL-3-OXOPROPANAL; 3,4-DIHYDRO-3-OXO-2-QUINOXALINECARBOXALDEHYDE; 3-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-3-OXOPROPANAL; 3-[4-(BENZYLOXY)PHENYL]-3-OXOPROPANAL; 3-[4-(METHYLSULFANYL)PHENYL]-3-OXOPROPANAL; 3-CYCLOHEXYL-3-OXOPROPANAL; 3-CYCLOPENTYL-3-OXOPROPANAL; 3-CYCLOPROPYL-3-OXOPROPANAL; 3-FORMYL-2-(METHYLPHENYLAMINO)CHROMONE; 3-FORMYL-4(1H)-PYRIDONE; 3-MESITYL-3-OXOPROPANAL; 3-OXO-3-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)PROPANAL; 3-OXO-3-(4-PROPOXYPHENYL)PROPANAL; 3-OXO-3-(4-PROPYLPHENYL)PROPANAL; 3-OXO-3-(PYRIDIN-3-YL)PROPANAL; 3-OXO-3-(PYRIDIN-4-YL)PROPANAL; 3-OXO-3-(THIOPHEN-3-YL)PROPANAL; 3-OXO-BUTANAL; 4,5,6,7-TETRAHYDRO-4-OXO-5-BENZOFURANCARBOXALDEHYDE; 4-METHYL-3-OXOPENTANAL; 4-OXO-1H-QUINOLINE-3-CARBALDEHYDE; 4-OXO-6-PHENYL-4H-1-BENZOPYRAN-3-CARBOXALDEHYDE; 4-OXO-TETRAHYDROFURAN-3-CARBOXALDEHYDE; 5-(TERT-BUTYLDIMETHYLSILYLOXY)-2-OXOCYCLOHEXANECARBALDEHYDE; 5,6,7-TRIFLUORO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 5-AMINO-1-CYCLOPROPYL-6,7-DIFLUORO-8-METHYL-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 5-BROMO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-CHLORO-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-ETHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ETHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-HYDROXY-3-OXO-2,3-DIHYDRO-1-BENZOXEPINE-4-CARBALDEHYDE; 5-ISOPROPYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 6-(3-OXOPROPANOYL)PYRIDINE-3-BORONIC ACID; 6-(BROMOMETHYL)-1,3-DIETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-(ISOPROPYLAMINO)-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6,7-DICHLORO-3-FORMYLCHROMONE; 6-[(2-METHOXYETHYL)AMINO]-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-BROMO-2-OXO-1,2,3,4-TETRAHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-CHLORO-1,3-BIS(2-METHOXYETHYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-1,3-DIISOBUTYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-8-NITRO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 6-DIMETHYLAMINO-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXALDEHYDE; 6-ISOPROPOXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 6-METHYL-8-NITRO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7,8-DIHYDROXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-BROMO-2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-BROMO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-CHLORO-5-OXO-5H-THIAZOLO[3,2-A]PYRIMIDINE-6-CARBALDEHYDE; 7-FLUORO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-HYDROXY-8-METHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-METHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-NITRO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 8-BROMO-6-METHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 8-NITRO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 8-OXO-3,4,8,9-TETRAHYDRO-2H,7H-[1,4]DIOXEPINO[2,3-F]INDOLE-9-CARBALDEHYDE; ACETALDEHYDE, AMINOBENZOYL-; ALPHA,ALPHA-DICHLORO-BETA-OXO-BENZENEPROPANAL; ALPHA-CHLORO-BETA-OXO-BENZENEPROPANAL; ALPHA-FLUORO-4-METHYL-BETA-OXO-BENZENEPROPANAL; BUTYLMALONDIALDEHYDE; CYCLOPENTYLMALONDIALDEHYDE; CYCLOPROPYLMALONDIALDEHYDE; DIMETHYLMALONDIALDEHYDE; ETHYLMALONDIALDEHYDE; ISOPROPYLMALONDIALDEHYDE; METHYLMALONDIALDEHYDE; N,N-DIMETHYL-4-(3-OXOPROPANOYOBENZENE-1-SULFONAMIDE; PROPYLMALONDIALDEHYDE; TERT-BUTYLMALONDIALDEHYDE; 4-ANTIPYRINECARBOXALDEHYDE; CHROMONE-3-CARBOXALDEHYDE; 4,4-DIMETHYL-3-OXO-PENTANAL; 5,7-DIMETHYL-3-FORMYLCHROMONE; 6,8-DICHLORO-3-FORMYLCHROMONE; 2,4-DIPHENYL-3-OXOBUTYRALDEHYDE; 6-AMINO-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1,3-DIETHYL-5-FORMYLURACIL; 1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-FLUORO-3-FORMYLCHROMONE; 2-AMINO-6-FLUORO-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 6-CHLORO-3-FORMYLCHROMONE; 2-AMINO-6-CHLORO-3-FORMYLCHROMONE; 3-FORMYL-6-METHYLCHROMONE; 2-AMINO-3-FORMYL-6-METHYLCHROMONE; AURORA KA-3767; 2-AMINO-6-BROMO-3-FORMYLCHROMONE; 2-AMINO-3-FORMYLCHROMONE; 6-CHLORO-3-FORMYL-7-METHYLCHROMONE; 6-BROMO-3-FORMYLCHROMONE; 3-FORMYL-6-NITROCHROMONE; 5-FORMYLURACIL; 6,7-DIMETHYL-3-FORMYLCHROMONE; 6,8-DIMETHYL-3-FORMYLCHROMONE; 3-FORMYL-6-ISOPROPYLCHROMONE; 6-ETHYL-3-FORMYLCHROMONE; 2-AMINO-3-FORMYL-6,7-DIMETHYLCHROMONE; 2-(2-BENZOXAZOLYL)MALONDIALDEHYDE; 2-(4-PYRIMIDYL)MALONDIALDEHYDE; 2-(4-CHLORO-2-NITROPHENYL)MALONDIALDEHYDE; 2-(3-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(2-NITROPHENYL)MALONDIALDEHYDE; 2-(4-METHOXYPHENYL)MALONDIALDEHYDE; 2-(4-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(4-CHLOROPHENYL)MALONDIALDEHYDE; 2-(4-METHYLPHENYL)MALONDIALDEHYDE; 2-(5-METHOXY-2-NITROPHENYL)MALONDIALDEHYDE MONOHYDRATE; 2-(5-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE MONOHYDRATE; 2-(4-METHYLSULFONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(2-PYRAZINYL)MALONDIALDEHYDE; 2-(2-QUINOXALINYL)MALONDIALDEHYDE; 2-(2-PYRIDYL)MALONDIALDEHYDE; 2-(2-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2-(3-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2-(4-PYRIDYL)MALONDIALDEHYDE; 1,3-DIMETHYL-2,4,6-TRIOXO-HEXAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-HYDROXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 7-HYDROXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2-BROMOMALONALDEHYDE; 1,2-DIHYDRO-7-METHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-ETHOXY-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 4,4-DIMETHYL-2,6-DIOXOCYCLOHEXANECARBALDEHYDE; 2-AMINO-4-CHLORO-6-OXO-1H-PYRIMIDINE-5-CARBALDEHYDE; 2-OXOINDOLINE-3-CARBALDEHYDE; 2-HYDROXY-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 2-(DIMETHYLAMINO)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBALDEHYDE; 2-(4-NITRO-1H-PYRAZOL-1-YL)MALONALDEHYDE; 1-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 2-OXO-1-PHENYLINDOLINE-3-CARBALDEHYDE; 4-OXO-5-PHENYL-4H-PYRAN-3-CARBOXALDEHYDE; 2-CHLORO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BUTYLTHIO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-(4-METHYLPIPERIDIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLTHIO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 3-OXO-2,5-DIPHENYL-PENT-4-ENAL; 7-METHYL-4-OXO-2-P-TOLYLAMINO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-(METHYLOXY)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-8-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[(CYCLOHEXYLAMINO)(PHENYL)METHYLENE]MALONALDEHYDE; 4-OXO-2-(PHENYLTHIO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBOXALDEHYDE; 4-OXO-2-P-TOLYLSULFANYL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; MALONDIALDEHYDE; 6-CHLORO-5-FORMYL-1,3-DIMETHYLURACIL; 2-[2-(4-METHOXYPHENYL)HYDRAZONO]-3-OXO-3-(2-THIENYL)PROPANAL; 2-[2-(4-CHLOROPHENYL)HYDRAZONO]-3-OXO-3-(2-THIENYL)PROPANAL; 2-[2-(3-METHYLPHENYL)HYDRAZONO]-3-OXO-3-(2-THIENYL)PROPANAL; 3-OXO-2-(2-PHENYLHYDRAZONO)-3-(2-THIENYL)PROPANAL; 3-(2-FURYL)-3-OXO-2-(2-PHENYLHYDRAZONO)PROPANAL; 2-[2-(4-CHLOROPHENYL)HYDRAZONO]-3-(2-FURYL)-3-OXOPROPANAL; 3-(2-FURYL)-2-[2-(4-METHOXYPHENYL)HYDRAZONO]-3-OXOPROPANAL; 3-(2-FURYL)-2-[2-(3-METHYLPHENYL)HYDRAZONO]-3-OXOPROPANAL; 2-[2-(2,3-DIMETHYLPHENYL)HYDRAZONO]-3-(4-METHYLPHENYL)-3-OXOPROPANAL; 2-[2-(2-CHLOROPHENYL)HYDRAZONO]-3-OXO-3-PHENYLPROPANAL; 2-[2-(4-METHOXYPHENYL)HYDRAZONO]-3-OXO-3-PHENYLPROPANAL; 3-(4-METHOXYPHENYL)-3-OXO-2-(2-PHENYLHYDRAZONO)PROPANAL; 3-OXO-3-PHENYL-2-(2-PHENYLHYDRAZONO)PROPANAL; 2-[2-(4-METHYLPHENYL)HYDRAZONO]-3-OXO-3-(4-PYRIDINYL)PROPANAL; 2-[2-(4-FLUOROPHENYL)HYDRAZONO]-3-OXO-3-(4-PYRIDINYL)PROPANAL; 3-(4-CHLOROPHENYL)-3-OXO-2-(2-PHENYLHYDRAZONO)PROPANAL; 2-[2-(4-CHLOROPHENYL)HYDRAZONO]-3-OXO-3-(4-PYRIDINYL)PROPANAL; 3-OXO-2-(2-PHENYLHYDRAZONO)-3-(4-PYRIDINYL)PROPANAL; 9-METHYL-4-OXO-2-(PHENYLTHIO)-4H-PYRIDO[1,2-A]PYRIMDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-PYRROLIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(2,6-DIMETHYL-4-MORPHOLINYL)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(2-CHLOROANILINO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-PYRROLIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-METHYL-1-PIPERIDINYL)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[BENZYL(METHYL)AMINO]-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 6-(BROMOMETHYL)-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 2-[(2-FURYLMETHYL)AMINO]-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 6-AMINO-1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 2-(2-FLUOROANILINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-ANILINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 3-METHYL-5-OXO-1-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-4-CARBALDEHYDE; 3-OXO-3-(THIOPHEN-2-YL)PROPANAL; 3-FORMYL-4-OXO-4H-CHROMEN-7-YL ACETATE; 2-AMINO-6,8-DICHLORO-3-FORMYLCHROMONE; 2-CHLOROMALONALDEHYDE; 6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 5-OXO-2,3-DIHYDRO-1H,5H-PYRIDO[3,2,1-IJ]QUINOLINE-6-CARBALDEHYDE; 4-OXO-1,2-DIHYDRO-4H-PYRROLO[3,2,1-IJ]QUINOLINE-5-CARBALDEHYDE; 2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(2-QUINOLYL)MALONDIALDEHYDE; 1-((2R,4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; HYDROXYPROPANEDIAL; 1-CYCLOOCTYL-6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 2-(AZEPAN-1-YL)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-((2-HYDROXYETHYL)AMINO)-9-ME-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-PYRIDAZIN-4-YLMALONALDEHYDE; 1,2-DIHYDRO-6,8-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 2-(4-QUINOLYL)MALONDIALDEHYDE SESQUIHYDRATE; 2-[ISOPROPYL(METHYL)AMINO]-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; METHYL ((3-FORMYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDIN-2-YL)THIO)ACETATE; 6-METHYL-2-OXO-1,2-DIHYDROQUINOLIN-3-CARBALDEHYDE; 6-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 5,7-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 7-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 8-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 5,8-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 1,2-DIHYDRO-7,8-DIMETHYL-2-OXO-QUINOLINE-3-CARBOXALDEHYDE; 6-ETHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 2-(3-FLUORO-PHENYL)-MALONALDEHYDE; 2-(2-METHOXY-PHENYL)-MALONALDEHYDE; 2-(3-METHOXYPHENYL)MALONDIALDEHYDE; 2-(2-CHLOROPHENYL)MALONDIALDEHYDE; 2-(DIMETHYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-FLUOROPHENYL)MALONDIALDEHYDE; 2-(3,4-DICHLOROPHENYL)MALONDIALDEHYDE; 2-(3-CHLOROPHENYL)MALONDIALDEHYDE; 2-(2-BROMO-PHENYL)-MALONALDEHYDE; 2-(4-BROMOPHENYL)MALONDIALDEHYDE; 2-(4-NITROPHENYL)MALONDIALDEHYDE; 2-(2,4-DINITROPHENYL)MALONDIALDEHYDE; 2-(3,4-DIMETHYL-PHENYL)-MALONALDEHYDE; 8-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-OXO-5,6-DIHYDRO-[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBALDEHYDE; 8-BROMO-6-CHLORO-3-FORMYLCHROMONE; SODIUM 5-FORMYL-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-4-PYRIMIDINOLATE; 2-AMINO-6-CHLORO-7-METHYL-3-FORMYL CHROMONE; 6-METHOXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 2-(4-ETHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 1,3,6-TRIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 2-(ETHYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(2-PYRIMIDINYLAMINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 6-FLUORO-8-NITROCHROMONE-3-CARBOXALDEHYDE; 7-METHYL-2-(4-METHYL-PIPERIDIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-2-(4-METHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-THIOMORPHOLIN-4-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-METHYLPIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7,7-DIMETHYL-2-OXOBICYCLO[2.2.1]HEPTANE-1-CARBALDEHYDE; 9-METHYL-4-OXO-2-THIOMORPHOLIN-4-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; NITROMALONALDEHYDE; NITROMALONALDEHYDE SODIUM SALT; FLUOROMALONALDEHYDE; 7-CHLORO-3-FORMYLCHROMONE; 2-(4-TRIFLUOROMETHOXYPHENYL)MALONDIALDEHYDE; 2-(4-TRIFLUOROMETHYLPHENYL)MALONDIALDEHYDE; 2-(3-TRIFLUOROMETHYLPHENYL)MALONDIALDEHYDE; 2-AMINO-6-ETHYL-3-FORMYLCHROMONE; 2-AMINO-6-ISOPROPYL-4-OXO-4H-BENZOPYRAN-3-CARBOXALDEHYDE; 2-(3,5-DIFLUOROPHENYL)MALONDIALDEHYDE; 2,3-DIHYDRO-5-METHYL-3-OXO-2-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 2-(3-BROMOPHENYL)MALONDIALDEHYDE; 2-(4-ETHOXYPHENYL)MALONDIALDEHYDE; 2-(4-PHENYLPHENYL)MALONDIALDEHYDE; 2-PHENYLMALONDIALDEHYDE; 2-(3-METHYLPHENYL)MALONDIALDEHYDE; 2-(4-CHLOROPHENOXY)MALONDIALDEHYDE; 2-(3-CHLOROPHENOXY)MALONDIALDEHYDE; 2-(3,5-DIMETHYLPIPERIDIN-1-YL)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-(4-METHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; (5-FORMYL-4-HYDROXY-6-OXO-3-PHENYLPYRIDAZIN-1(6H)-YL)ACETIC ACID; 5-FORMYLURIDINE; 7-OXO-2,3,6,7-TETRAHYDRO-[1,4]DIOXINO[2,3-G]QUINOLINE-8-CARBALDEHYDE; 4-OXO-4H-BENZO[H]CHROMENE-3-CARBALDEHYDE; 2-FORMYL-3-METHYL-1-OXO-1,5-DIHYDRO-BENZO[4,5]IMIDAZO[1,2-A]PYRIDINE-4-CARBONITRILE; 2-NAPHTHALEN-1-YL-MALONALDEHYDE; 3-(CHLOROMETHYL)-2-FORMYL-1-OXO-1,5-DIHYDROPYRIDO[1,2-A]BENZIMIDAZOLE-4-CARBONITRILE; 6-CHLORO-8-CHLOROMETHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; SPIROCYCLOHEXYLBUTANE-1,3-DIONE; 2-(5-HYDROXYCARBONYL-2-NITROPHENYL)MALONDIALDEHYDE; 2-(2-THIENYLMETHYLENE)MALONALDEHYDE; 2-DIMETHYLAMINO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-((FURAN-2-YLMETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-FLUOROPHENOXY)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(M-TOLYLOXY)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(AZEPAN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 6-AMINO-1-ISOBUTYL-3-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; N′-(3-ETHYL-5-FORMYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-PYRIMIDIN-4-YL)-N,N-DIMETHYL-FORMAMIDINE; 2-AZEPAN-1-YL-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIMETHYLAMINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 2,4,6-TRIOXO-HEXAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 2-(4-METHOXYPHENOXY)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-AMINO-6-METHOXY-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2,4-DIOXO-3,4-DIHYDRO-2H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 1-ISOBUTYL-6-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-BOC-3-FORMYL-4-OXO-PIPERIDINE; 1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-ISOBUTYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-(4-METHOXY-BENZYL)-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-ISOBUTYL-6-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 3-BENZYLIDENE-2-OXO-CYCLOHEXANECARBALDEHYDE; 4-QUINOLINYLMALONALDEHYDE; 1-(3,5-ANHYDRO-2-DEOXY-BETA-D-THREO-PENTAFURANOSYL)THIMINE; 2-(5-HYDROXYCARBONYL-6-PYRIDYL)MALONDIALDEHYDE; 2-CHLORO-1-ETHYL-5-FORMYL-4-METHYL-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBONITRILE; 2-OXO-1,2,6,7,8,9-HEXAHYDROBENZO[G]QUINOLINE-3-CARBALDEHYDE; 6-METHOXY-1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 6-AMINO-4-OXO-1-PHENYL-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 3-FORMYL-8-METHOXYCHROMONE; 3-FORMYL-7-METHOXYCHROMONE; 6-METHOXY-1-OXO-1,2,3,4-TETRAHYDRO-[2]-NAPHTHALDEHYDE; 3-FORMYL-5-METHOXYCHROMONE; 2-(1H-IMIDAZOL-2-YL)-MALONALDEHYDE; 6-AMINO-1-BENZYL-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 7-CHLORO-3,5-DIOXO-2,3,4,5-TETRAHYDRO-BENZO[B]OXEPINE-4-CARBALDEHYDE; 2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6,7-DIETHOXY-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-ETHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 6-AMINO-1-(2-FURYLMETHYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 2-(5-CHLORO-1,3-BENZOXAZOL-2-YL)MALONALDEHYDE; 6-AMINO-1-(3-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-HYDROXY-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 3-FORMYL-4-OXO-4H-CHROMEN-6-YL ACETATE; 1-OXO-1,2,3,4-TETRAHYDRONAPHTHALENE-2-CARBALDEHYDE; 2,4-DIAMINO-6-OXO-1,6-DIHYDRO-5-PYRIMIDINECARBALDEHYDE; 5-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 6-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 6-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 4-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 1H-BENZIMIDAZOL-2-YLMALONALDEHYDE; 6-AMINO-2,4-DIOXO-1-(PYRIDIN-3-YLMETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 7-METHYLSULFANYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-ETHYL-7-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 7-METHOXY-1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; TRIFORMYLMETHANE; 3-OXO-3-PHENYL-PROPIONALDEHYDE; 2-AMINO-6-TERT-BUTYL-3-FORMYLCHROMONE; 6-AMINO-2,4-DIOXO-1-(2-PHENYLETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-TERT-BUTYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 3-(4-CHLOROPHENYL)-3-OXOPROPANAL; 3-(4-METHOXYPHENYL)-3-OXOPROPANAL; 2-AMINO-6,8-DIMETHYL-4-OXO-4H-CHROMENE-3-CARBALDEHYDE; 2-AMINO-6,7-DICHLORO-3-FORMYLCHROMONE; 3-(5-FLUORO-2-HYDROXYPHENYL)-3-OXOPROPANAL; 3-(2-HYDROXYPHENYL)-3-OXOPROPANAL; 3-(2-HYDROXY-5-METHYLPHENYL)-3-OXOPROPANAL; 3-(5-CHLORO-2-HYDROXYPHENYL)-3-OXOPROPANAL; 3-(5-BROMO-2-HYDROXYPHENYL)-3-OXOPROPANAL; 3-OXO-2-PHENOXY-BUTYRALDEHYDE; 8-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-8-METHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-BROMO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1-OXO-1,2,3,4-TETRAHYDRO-2-PHENANTHRENECARBALDEHYDE; 2,2-DIMETHYL-3-OXO-3-PHENYLPROPANAL; NITROMALONALDEHYDE SODIUM SALT HYDRATE; 5-CHLORO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 6-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 6-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 4-(1H-IMIDAZOL-2-YL)-B-OXO-BENZENEPROPANAL; 3-(2,5-DIMETHOXYPHENYL)-3-OXOPROPANAL; 3-(2,4-DIMETHOXYPHENYL)-3-OXOPROPANAL; 3-OXO-3-[2-(TRIFLUOROMETHYL)PHENYL]PROPANAL; 3-OXO-3-[3-(TRIFLUOROMETHYL)PHENYL]PROPANAL; 3-OXO-3-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAL; 3-(2-METHOXYPHENYL)-3-OXOPROPANAL; 3-(3-METHOXYPHENYL)-3-OXOPROPANAL; 3-(3,4-DIMETHYLPHENYL)-3-OXOPROPANAL; 3-(4-ETHYLPHENYL)-3-OXOPROPANAL; 3-(4-TERT-BUTYLPHENYL)-3-OXOPROPANAL; 3-[4-(2-METHYLPROPYL)PHENYL]-3-OXOPROPANAL; 3-OXO-3-[4-(PROPAN-2-YLOXY)PHENYL]PROPANAL; 3-OXO-3-(PYRIDIN-2-YL)PROPANAL; 3-(2,4-DIMETHYLPHENYL)-3-OXOPROPANAL; 3-(2,5-DIMETHYLPHENYL)-3-OXOPROPANAL; 3-(3-FLUORO-4-METHOXYPHENYL)-3-OXOPROPANAL; 2-(3-OXOPROPANOYL)BENZONITRILE; 4-(3-OXOPROPANOYL)BENZONITRILE; 3-(3-OXOPROPANOYL)BENZONITRILE; 3-(3-BROMO-4-FLUOROPHENYL)-3-OXOPROPANAL; (2-CHLORO-1-ETHOXY-1,3-DIOXOPROPAN-2-YL)POTASSIUM; 10-OXO-2,3,5,6-TETRAHYDRO-1H,4H,10H-11-OXA-3A-AZA-BENZO[DE]ANTHRACENE-9-CARBALDEHYDE; 1-FORMYL-CYCLOBUTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPENTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPROPANECARBOXYLIC ACID METHYL ESTER; 1-TERT-BUTYL 4-ETHYL 4-FORMYLPIPERIDINE-1,4-DICARBOXYLATE; 2,3-DIHYDRO-2-OXO-3-FURANCARBOXALDEHYDE; 2,4-DIOXOTETRAHYDROFURAN-3-CARBALDEHYDE; 2,5-DIHYDRO-2-OXO-3-FURANCARBOXALDEHYDE; 2-DIMETHYLAMINO-6-OXO-4-PHENYL-6H-[1,3]OXAZINE-5-CARBALDEHYDE; 2-FORMYL-3-OXO-BUTYRIC ACID ETHYL ESTER; 2-FORMYLPROPIONIC ACID ETHYL ESTER; 2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 2-OXO-4-(PROPYLAMINO)-2H-CHROMENE-3-CARBALDEHYDE; 3-ETHYL-4-FLUOROPHENYL-3-OXOPROPANOATE; 3-OXOPROPANOIC ACID; 3-OXO-PROPIONIC ACID ETHYL ESTER; 4-(BENZYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(BUTYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(ETHYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4,6,8-TRICHLORO-3-FORMYLCOUMARIN; 4,6-DICHLORO-3-FORMYL-7-METHYLCOUMARIN; 4,6-DICHLORO-3-FORMYLCOUMARIN; 4-[(4-METHYLPHENYL)SULFANYL]-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-3-FORMYL-6-METHYLCOUMARIN; 4-CHLORO-6-FLUORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-FORMYL-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID METHYL ESTER; 4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-3-FORMYL-6-METHYLCOUMARIN; 4-HYDROXY-5,7-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6,7-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6,8-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6-CHLORO-3-FORMYLCOUMARIN; 4-PIPERIDINECARBOXYLIC ACID, 4-FORMYL-; 5-(ETHOXYCARBONYL)-2-FORMYL-4-METHYL-1H-PYRROLE-3-PROPANOIC ACID METHYL ESTER; 6,8-DICHLORO-3-FORMYLCOUMARIN; 6-BROMO-4-CHLORO-3-FORMYLCOUMARIN; 6-BROMO-4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 6-CHLORO-4-HYDROXY-7-METHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 6-FLUORO-4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 7-(DIETHYLAMINO)-4-HYDROXY-2-OXOCHROMENE-3-CARBALDEHYDE; 7-DIETHYLAMINO-3-FORMYLCOUMARIN; 8-METHYL-10-OXO-2,3,5,6-TETRAHYDRO-1H,4H, 10H-11-OXA-3A-AZA-BENZO[DE]ANTHRACENE-9-CARBALDEHYDE; BENZYL 3-OXOPROPANOATE; BUTYRAMIDO-MALONALDEHYDIC ACID; DIETHYL FORMYLSUCCINATE; DIMETHYL 2-FORMYLSUCCINATE; ETHYL 1-FORMYLCYCLOBUTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOHEXANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPENTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPROPANECARBOXYLATE; ETHYL 2-(4-BROMOPHENYL)-3-OXOPROPANOATE; ETHYL 2-CHLORO-3-OXOPROPANOATE; ETHYL 2-FORMYLBUTANOATE; ETHYL 3-DIMETHYLAMINO-2-FORMYLACRYLATE; ETHYL 3-OXO-2-PHENYLPROPANOATE; MALONALDEHYDIC ACID, N-METHYLACETAMIDO-, ETHYL ESTER; METHYL 2-(2-BROMOPHENYL)-2-FORMYLACETATE; METHYL 2-CHLORO-2-FORMYLACETATE; METHYL 2-METHYL-3-OXOPROPIONATE; METHYL 3-N,N-DIMETHYLAMINO-2-FORMYLACRYLATE; METHYL 3-OXOPROPANOATE; METHYL A-FORMYLPHENYLACETATE; PHENACETURIC ACID,-ALPHA-FORMYL-ALPHA-METHYL-; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (R)—; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (S)—; ZINC(II) 2-(CARBOXYMETHYL)-2-FORMYLSUCCINATE;

β-keto-esters: (2-CHLORO-1-ETHOXY-1,3-DIOXOPROPAN-2-YL)POTASSIUM; 10-OXO-2,3,5,6-TETRAHYDRO-1H,4H,10H-11-OXA-3A-AZA-BENZO[DE]ANTHRACENE-9-CARBALDEHYDE; 1-FORMYL-CYCLOBUTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPENTANECARBOXYLIC ACID METHYL ESTER; 1-FORMYL-CYCLOPROPANECARBOXYLIC ACID METHYL ESTER; 1-TERT-BUTYL 4-ETHYL 4-FORMYLPIPERIDINE-1,4-DICARBOXYLATE; 2,3-DIHYDRO-2-OXO-3-FURANCARBOXALDEHYDE; 2,4-DIOXOTETRAHYDROFURAN-3-CARBALDEHYDE; 2,5-DIHYDRO-2-OXO-3-FURANCARBOXALDEHYDE; 2-DIMETHYLAMINO-6-OXO-4-PHENYL-6H-[1,3]OXAZINE-5-CARBALDEHYDE; 2-FORMYL-3-OXO-BUTYRIC ACID ETHYL ESTER; 2-FORMYLPROPIONIC ACID ETHYL ESTER; 2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 2-OXO-4-(PROPYLAMINO)-2H-CHROMENE-3-CARBALDEHYDE; 3-ETHYL-4-FLUOROPHENYL-3-OXOPROPANOATE; 3-OXOPROPANOIC ACID; 3-OXO-PROPIONIC ACID ETHYL ESTER; 4-(BENZYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(BUTYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-(ETHYLAMINO)-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4,6,8-TRICHLORO-3-FORMYLCOUMARIN; 4,6-DICHLORO-3-FORMYL-7-METHYLCOUMARIN; 4,6-DICHLORO-3-FORMYLCOUMARIN; 4-[(4-METHYLPHENYL)SULFANYL]-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-CHLORO-3-FORMYL-6-METHYLCOUMARIN; 4-CHLORO-6-FLUORO-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-FORMYL-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID METHYL ESTER; 4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-3-FORMYL-6-METHYLCOUMARIN; 4-HYDROXY-5,7-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6,7-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6,8-DIMETHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 4-HYDROXY-6-CHLORO-3-FORMYLCOUMARIN; 4-PIPERIDINECARBOXYLIC ACID, 4-FORMYL-; 5-(ETHOXYCARBONYL)-2-FORMYL-4-METHYL-1H-PYRROLE-3-PROPANOIC ACID METHYL ESTER; 6,8-DICHLORO-3-FORMYLCOUMARIN; 6-BROMO-4-CHLORO-3-FORMYLCOUMARIN; 6-BROMO-4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 6-CHLORO-4-HYDROXY-7-METHYL-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 6-FLUORO-4-HYDROXY-2-OXO-2H-CHROMENE-3-CARBALDEHYDE; 7-(DIETHYLAMINO)-4-HYDROXY-2-OXOCHROMENE-3-CARBALDEHYDE; 7-DIETHYLAMINO-3-FORMYLCOUMARIN; 8-METHYL-10-OXO-2,3,5,6-TETRAHYDRO-1H,4H,10H-11-OXA-3A-AZA-BENZO[DE]ANTHRACENE-9-CARBALDEHYDE; BENZYL 3-OXOPROPANOATE; BUTYRAMIDO-MALONALDEHYDIC ACID; DIETHYL FORMYLSUCCINATE; DIMETHYL 2-FORMYLSUCCINATE; ETHYL 1-FORMYLCYCLOBUTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOHEXANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPENTANECARBOXYLATE; ETHYL 1-FORMYLCYCLOPROPANECARBOXYLATE; ETHYL 2-(4-BROMOPHENYL)-3-OXOPROPANOATE; ETHYL 2-CHLORO-3-OXOPROPANOATE; ETHYL 2-FORMYLBUTANOATE; ETHYL 3-DIMETHYLAMINO-2-FORMYLACRYLATE; ETHYL 3-OXO-2-PHENYLPROPANOATE; MALONALDEHYDIC ACID, N-METHYLACETAMIDO-, ETHYL ESTER; METHYL 2-(2-BROMOPHENYL)-2-FORMYLACETATE; METHYL 2-CHLORO-2-FORMYLACETATE; METHYL 2-METHYL-3-OXOPROPIONATE; METHYL 3-N,N-DIMETHYLAMINO-2-FORMYLACRYLATE; METHYL 3-OXOPROPANOATE; METHYL A-FORMYLPHENYLACETATE; PHENACETURIC ACID,-ALPHA-FORMYL-ALPHA-METHYL-; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (R)—; PROPANOIC ACID, 2-METHYL-3-OXO-, METHYL ESTER, (S)—; ZINC(II) 2-(CARBOXYMETHYL)-2-FORMYLSUCCINATE;
β-keto-amides: (2S)-1-(3-FORMYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)PYRROLIDINE-2-CARBOXAMIDE; (5-FORMYL-4-HYDROXY-6-OXO-3-PHENYLPYRIDAZIN-1(6H)-YL)ACETIC ACID; (5-FORMYL-6-OXO-3-TRIFLUOROMETHYL-6H-PYRIDAZIN-1-YL)-ACETIC ACID ETHYL ESTER; 1-((2R,4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; DIMETHYLPHENYL)-3-METHYL-5-OXO-3-PYRAZOLIN-4-CARBALDEHYDE; 1-(4-METHOXY-BENZYL)-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6,7-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6,8-DIMETHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-6-METHYL-2-OXO-3-PYRIDINECARBOXALDEHYDE; 1,2-DIHYDRO-7,8-DIMETHYL-2-OXO-QUINOLINE-3-CARBOXALDEHYDE; 1,2-DIHYDRO-7-METHYL-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,2-DIHYDRO-8-METHOXY-2-OXO-3-QUINOLINECARBOXALDEHYDE; 1,3,6-TRIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 1,3-DIMETHYL-2,4,6-TRIOXO-HEXAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-(PROPYLAMINO)-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-2,4-DIOXO-6-[(TETRAHYDRO-2-FURANYLMETHYL)AMINO]-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 1,3-DIMETHYL-6-(METHYLAMINO)-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 11-CHLORO-13-OXO-8-OXA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 11-CHLORO-13-OXO-8-THIA-1,10-DIAZATRICYCLO[7.4.0.02,7]TRIDECA-2(7),3,5,9,11-PENTAENE-12-CARBALDEHYDE; 1-CYCLOOCTYL-6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 1-ETHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-ETHYL-7-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXALDEHYDE, 4-AMINO-6,7-DIHYDRO-2,3-DIMETHYL-6-OXO-; 1-ISOBUTYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-ISOBUTYL-6-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-ISOBUTYL-6-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 1-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 2-((2-HYDROXYETHYL)AMINO)-9-ME-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-((2-METHOXYETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-((FURAN-2-YLMETHYL)AMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(2,6-DIMETHYL-4-MORPHOLINYL)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(2-CHLOROANILINO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(2-FLUOROANILINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(3,5-DIMETHYLPIPERIDIN-1-YL)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(3-FLUORO-PHENYL)-6-METHOXY-3-OXO-2,3-DIHYDRO-ISOQUINOLINE-4-CARBALDEHYDE; 2-(4-ETHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-FLUOROPHENOXY)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-METHOXYPHENOXY)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(4-METHYL-1-PIPERIDINYL)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(4-METHYLPIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(ALLYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(AZEPAN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(AZEPAN-1-YL)-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(BENZYLTHIO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(BUTYLTHIO)-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2-(DIMETHYLAMINO)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-(ETHYLAMINO)-9-METHYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 2,3-DIHYDRO-5-METHYL-3-OXO-2-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE; 2,4,6-TRIOXO-HEXAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 2,4-DIAMINO-6-OXO-1,6-DIHYDRO-5-PYRIMIDINECARBALDEHYDE; 2,4-DIOXO-3,4-DIHYDRO-2H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2,6-DIAMINO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2,7-DICHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[(2-FURYLMETHYL)AMINO]-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[BENZYL(METHYL)AMINO]-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-[ISOPROPYL(METHYL)AMINO]-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-AMINO-4-CHLORO-6-OXO-1H-PYRIMIDINE-5-CARBALDEHYDE; 2-AMINO-6-CHLORO-1,4-DIHYDRO-4-OXO-5-PYRIMIDINECARBOXALDEHYDE; 2-ANILINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-AZEPAN-1-YL-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-1-ETHYL-5-FORMYL-4-METHYL-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBONITRILE; 2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-6-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-8-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-CHLORO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIETHYLAMINO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIMETHYLAMINO-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-DIMETHYLAMINO-9-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-FORMYL-3-METHYL-1-OXO-1,5-DIHYDRO-BENZO[4,5]IMIDAZO[1,2-A]PYRIDINE-4-CARBONITRILE; 2-HYDROXY-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-METHYL-5-(MORPHOLIN-4-YL)-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBALDEHYDE; 2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 2-OXO-1,2,6,7,8,9-HEXAHYDROBENZO[G]QUINOLINE-3-CARBALDEHYDE; 2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 2-OXO-1-PHENYLINDOLINE-3-CARBALDEHYDE; 2-OXO-5-PROPYLINDOLINE-3-CARBALDEHYDE; 2-OXOINDOLINE-3-CARBALDEHYDE; (CHLOROMETHYL)-2-FORMYL-1-OXO-1,5-DIHYDROPYRIDO[1,2-A]BENZIMIDAZOLE-4-CARBONITRILE; 3,4-DIHYDRO-3-OXO-2-QUINOXALINECARBOXALDEHYDE; 3-METHYL-5-OXO-1-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-4-CARBALDEHYDE; 4-ANTIPYRINECARBOXALDEHYDE; 4-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 4-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 4-OXO-1,2-DIHYDRO-4H-PYRROLO[3,2,1-IJ]QUINOLINE-5-CARBALDEHYDE; 4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBOXALDEHYDE; 4-OXO-2-(PHENYLTHIO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-P-TOLYLSULFANYL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-PYRROLIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 4-OXO-2-THIOMORPHOLIN-4-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 5,7-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 5,8-DIMETHYL-2-OXO-1,2-DIHYDRO-3-QUINOLINECARBALDEHYDE; 5-BROMO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-CHLORO-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBALDEHYDE; 5-CHLORO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ETHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 5-ETHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 5-FORMYLURACIL; 5-FORMYLURIDINE; 5-ISOPROPYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 5-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 5-OXO-2,3-DIHYDRO-1H,5H-PYRIDO[3,2,1-IJ]QUINOLINE-6-CARBALDEHYDE; 6-(BROMOMETHYL)-1,3-DIETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-(BROMOMETHYL)-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-(ISOPROPYLAMINO)-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6,7-DIETHOXY-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 6-[(2-METHOXYETHYL)AMINO]-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(2-FURYLMETHYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(2-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(3-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-CHLOROPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-(4-METHOXYPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1-(4-METHYLPHENYL)-4-OXO-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-1,3-DIETHYL-5-FORMYLURACIL; 6-AMINO-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-BENZYL-2,4-DIOXOTETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-ISOBUTYL-3-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-AMINO-2,4-DIOXO-1-(2-PHENYLETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1-(PYRIDIN-3-YLMETHYL)TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-AMINO-4-OXO-1-PHENYL-2-THIOXO-1,2,3,4-TETRAHYDRO-5-PYRIMIDINECARBALDEHYDE; 6-BROMO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-BROMO-2-OXO-1,2,3,4-TETRAHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-CHLORO-1,3-BIS(2-METHOXYETHYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-1,3-DIISOBUTYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-CHLORO-2-OXO-3-INDOLINECARBALDEHYDE; 6-CHLORO-5-FORMYL-1,3-DIMETHYLURACIL; 6-DIMETHYLAMINO-1,3-DIMETHYL-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXALDEHYDE; 6-ETHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 6-FLUORO-2-OXOINDOLINE-3-CARBALDEHYDE; 6-HYDROXY-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBALDEHYDE; 6-METHOXY-1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 6-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 6-METHOXY-2-OXOINDOLINE-3-CARBALDEHYDE; 6-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDINE-5-CARBALDEHYDE; 6-METHYL-2-OXO-1,2-DIHYDROQUINOLIN-3-CARBALDEHYDE; 6-METHYL-2-OXOINDOLINE-3-CARBALDEHYDE; 6-OXO-5,6-DIHYDRO-[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBALDEHYDE; 7-BROMO-2-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-CHLORO-5-OXO-5H-THIAZOLO[3,2-A]PYRIMIDINE-6-CARBALDEHYDE; 7-ETHOXY-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 7-METHOXY-1-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 7-METHOXY-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 7-METHYL-2-(4-METHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-2-(4-METHYL-PIPERIDIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 7-METHYL-4-OXO-2-P-TOLYLAMINO-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 7-METHYLSULFANYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE; 7-OXO-2,3,6,7-TETRAHYDRO-[1,4]DIOXINO[2,3-G]QUINOLINE-8-CARBALDEHYDE; 8-CHLORO-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 8-ETHYL-1,2-DIHYDRO-2-OXO-3-QUINOLINECARBOXALDEHYDE; 8-METHYL-2-OXO-1,2-DIHYDROQUINOLINE-3-CARBALDEHYDE; 8-OXO-3,4,8,9-TETRAHYDRO-2H,7H-[1,4]DIOXEPINO[2,3-F]INDOLE-9-CARBALDEHYDE; 9-METHYL-2-(4-METHYL-PIPERAZIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-(4-METHYLPIPERIDIN-1-YL)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-(METHYLOXY)-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-2-MORPHOLIN-4-YL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(2-PYRIMIDINYLAMINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(4-TOLUIDINO)-4H-PYRIDO(1,2-A)PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(M-TOLYLOXY)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-(PHENYLTHIO)-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-PIPERIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-PYRROLIDIN-1-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; 9-METHYL-4-OXO-2-THIOMORPHOLIN-4-YL-4H-PYRIDO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE; METHYL ((3-FORMYL-4-OXO-4H-PYRIDO(1,2-A)PYRIMIDIN-2-YL)THIO)ACETATE; N′-(3-ETHYL-5-FORMYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-PYRIMIDIN-4-YL)-N,N-DIMETHYL-FORMAMIDINE; SODIUM 5-FORMYL-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-4-PYRIMIDINOLATE

Full text: Click here
Patent 2022

Example 1

[Figure (not displayed)]

Step a: 6,8-difluoro-1,2,3,4-tetrahydronaphthalen-1-one (500 mg, 2.74 mmol) was dissolved in CH2Cl2 (11 ml, 0.25 M) and the resulting solution was sparged with nitrogen gas for 5 minutes. Triethylamine (574 μL, 1.5 equiv.) was added, and the solution was cooled to 0° C. before the addition of Tf2O (691 μL, 1.5 equiv.). The reaction was allowed to warm to room temperature and was stirred overnight. The solution was quenched with water, extracted with CH2Cl2, and the resulting organics were dried over Na2SO4 and concentrated onto Celite. The crude material was flashed on silca gel (gradient, 0% to 20% ethyl acetate in hexanes) to yield the desired 5,7-difluoro-4-(trifluoromethylsulfonyloxy)-1,2-dihydronaphthalene (470 mg, 54% yield) as an oil.

Step b: A vial was charged with alkenyl triflate from step a (2.50 g, 7.96 mmol, 1.0 equiv.), PdCl2(dppf) (872 mg, 1.19 mmol, 15 mol %), B2pin2 (2.82 g, 11.1 mmol, 1.4 equiv.), KOAc (1.72 g, 17.5 mmol, 2.2 equiv.) and 1,4-dioxane (20 ml). The vial was capped, and the reaction mixture was purged with N2 for 2 minutes. The reaction was heated at 80° C. and stirred for 30 min. The reaction was cooled, filtered, and concentrated onto Celite. Purification by flash chromatography (SiO2, hexane to 10% EtOAc) furnished the alkenyl pinacol boronic ester as a brown oil (1.16 g, 3.97 mmol, 50%).

Step c: To a vial containing the product from step b (100 mg, 0.342 mmol, 1.0 equiv.) was added 3-bromo-2-chloro-6-(methylsulfonyl)benzonitrile (100 mg, 0.342 mmol, 1.0 equiv.), PdCl2(dppf) (25 mg, 0.034 mmol, 10 mol %), 1,4-dioxane (1 mL) and 1M aq. Na2CO3 solution (0.7 mL). The vial was capped and purged with N2 for 2 minutes. The reaction was heated at 80° C. and stirred for 1.5 h. Once complete, the reaction was cooled, diluted with sat. aq. NH4Cl solution (20 mL) and extracted with DCM (20 mL). The aqueous layer was separated and back extracted with additional DCM (2×20 mL). The organic layers were combined, washed with brine (40 mL), and dried over MgSO4. Concentration under reduced pressure and purification by flash chromatography (SiO2, hexane to 50% EtOAc gradient) furnished the cross-coupled product as a white solid that was taken onto the next step (58.6 mg, 0.154 mmol, 45%, ESI MS [M+H]+ for C18H12ClF2NO2S, calcd 380.0, found 380.1).

Step d: To a vial containing the product from step c (58.6 mg, 0.154 mmol, 1.0 equiv.) was added Pd/C (10% Pd, 25 mg). The vial was evacuated and back-filled with N2 (×3). MeOH (1 mL) and EtOAc (1 mL) were added, and the reaction mixture was purged with H2 for 2 min, then stirred at room temperature under 1 atm H2 for 16 h. The reaction vessel was flushed with N2 and the mixture filtered through Celite, rinsing with EtOAc. Concentration under reduced pressure and purification by preparative reverse phase HPLC (20 to 100% gradient of acetonitrile and water with 0.1% TFA) furnished the product as a white solid. 1H NMR (400 MHz, DMSO-d6) δ 7.95 (d, J=8.2 Hz, 1H), 7.31 (d, J=8.2 Hz, 1H), 7.10-6.98 (m, 2H), 4.79-4.72 (m, 1H), 3.43 (s, 3H), 2.99-2.88 (m, 1H), 2.88-2.75 (m, 1H), 2.19-2.08 (m, 1H), 1.87-1.75 (m, 1H), 1.75-1.63 (m, 1H), 1.62-1.47 (m, 1H). ESI MS [M+H]+ for C18H14ClF2NO2S, calcd 382.0, found 382.1.

Example 2

[Figure (not displayed)]

Step a: To a suspension of 7-fluoro-2,3-dihydro-1H-inden-1-one (10.0 g, 66.6 mmol) and aluminum trichloride (22.2 g, 166.5 mmol, 2.5 equiv.) in 1,2-dichloroethane (190 ml, 0.35M) was added bromine (3.58 ml, 70 mmol, 1.05 equiv.) dropwise. The resulting solution was heated to 60° C. for three hours, after which the reaction was cooled to room temperature and poured onto ice. The reaction was extracted with MTBE, dried over magnesium sulfate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:1 solution of CH2Cl2:hexanes) to yield 4-bromo-7-fluoro-2,3-dihydro-1H-inden-1-one.

Step b: To a suspension of 4-bromo-7-fluoro-2,3-dihydro-1H-inden-1-one (17.0 g, 74.3 mmol) and Cs2CO3 (26.6 g, 81.7 mmol, 1.1 equiv.) in DMF (372 ml, 0.2M) was added benzyl mercaptan (9.24 g, 8.71 ml, 1.0 equiv.). The reaction was stirred at room temperature for 90 minutes. The desired product was precipitated from solution through the addition of 1.5 L of water and was dried under high vacuum overnight. The resulting crude product (23.1 g, 93% yield) was taken on without further purification.

Step c: The crude thioether from the step b (23.1 g, 69.2 mmol) was suspended in toluene (692 ml, 0.1M). Aluminum trichloride (10.2 g, 1.1 equiv.) was added at room temperature. An additional portion of aluminum trichloride (3.6 g, 27 mmol, 0.4 equiv.) was added after three hours. After an additional three hours, the reaction was quenched with water, extracted with ethyl acetate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the desired thiophenol as a yellow solid (13.4 g, 80% yield).

Step d: A solution of the thiophenol product from step c (6.7 g, 27.6 mmol) and methyl viologen dichloride hydrate (710 mg, 0.1 equiv.) in DMF (55 ml, 0.5M) was carefully degassed via three freeze-pump-thaw cycles under nitrogen. The resulting solution was cooled to −10 to −5° C. in a brine ice bath, and an excess of CF3I was sparged through the reaction mixture. The reaction was then stirred overnight under an atmosphere of CF3I. The reaction was carefully quenched at room temperature with water (off-gassing of residual CF3I occurs, use caution), extracted with ethyl acetate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in hexanes) to yield the desired thioether (5.21 g, 61% yield).

Step e: To a solution of the product from step d (10.45 g, 33.6 mmol) in MeCN (129 ml, 0.26 M with respect to starting material), CCl4 (129 ml, 0.26 M with respect to starting material), and H2O (258 ml, 0.13M with respect to starting material) was added ruthenium trichloride (697 mg, 3.36 mmol, 0.1 equiv.) followed by sodium periodate (29.6 g, 138.4 mmol, 4.12 equiv.). The reaction was stirred at room temperature for one hour, and upon completion was extracted with CH2Cl2 (×2). The combined organics were washed with saturated Na2S2O3, washed with brine, and dried over sodium sulfate before concentrating. The crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the product sulfone as a white solid (10.53 g, 91% yield). ESI MS [M+H]+ for C10H6BrF3O3S; calc 342.9, found 342.9.

Step f: A solution of the product sulfone from step e (3.5 g, 10.2 mmol) and Selectfluor (4.32 g, 12.2 mmol, 1.2 equiv.) in methanol (102 ml, 0.1M) was heated to 50° C. Sulfuric acid (27 μl, 5 mol %) was added, and the reaction was stirred at 50° C. for 48 hours. The solution was then diluted with diethyl ether, and the resulting white precipitate was filtered off and discarded. The organic solution was concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the product dimethyl acetal as a white solid (3.57 g, 87% yield).

Step g: A solution of the product acetal from step f (3.18 g, 7.8 mmol) and wet Amberlyst 15 (4.77 g, 150 wt %) in dioxane (31 ml, 0.2 M) was heated to 90° C. overnight. Upon completion, the polymeric beads were removed by filtration, and the concentrated crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the desired fluorinated ketone (2.33 g, 83% yield).

Step h: A solution of the indanone product of step g (2.5 g, 6.93 mmol) in dichloromethane (28 ml, 0.25M) was sparged with nitrogen gas before the addition of formic acid (783 μL, 956 mg, 20.8 mmol, 3 equiv.) and triethylamine (1.94 ml, 1.41 g, 13.9 mmol, 2 equiv.) at 0° C. under nitrogen. RuCl(p-cymene)[(R,R)-Ts-DPEN] (44.5 mg, 0.07 mmol, 0.01 equiv.) was added, and the reaction was stirred for a minimum of 12 hours at 0 to 5° C. Upon full conversion, the reaction was quenched with saturated NaHCO3 and extracted with CH2Cl2. The combined organics were concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in a 1:1 solution of CH2Cl2:hexanes) to yield the desired indanol (2.0 g, 80% yield) as a single diastereomer. The enantiomeric excess of this material was found to be 98% by chiral HPLC (Chiralpak AD-H, 20% iPrOH/hexanes, isocratic, 20 minutes) as compared to a racemic sample, which was obtained through reduction of the 2-fluoroindanone with sodium borohydride.

Step i: To a solution of the chiral indanol from step h (1.01 g, 2.75 mmol) in CH2Cl2 (11 ml, 0.25M) was added 2,6-lutidine (800 μL, 6.9 mmol, 2.5 equiv.) and TBSOTf (791 μL, 3.44 mmol, 1.25 equiv.) at 0° C. The reaction was allowed to warm to room temperature and was stirred overnight. Upon completion, the reaction was concentrated directly onto Celite and purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in hexanes) to yield the TBS ether (1.35 g, 100% yield).

Step j: The TBS ether product of step i (674 mg, 1.41 mmol) was combined with B2Pin2 (457 mg, 1.8 mmol, 1.3 equiv.) Pd(dppf)Cl2 (103 mg, 0.14 mmol, 0.1 equiv.) and potassium acetate (213 mg, 3 mmol, 2.2 equiv.) in dioxane (14 ml, 0.1M), and the resulting solution was heated to 100° C. for three hours. The reaction solution was concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 30% ethyl acetate in hexanes) to yield the desired boronic pinacol ester (638 mg, 86% yield) as a colorless oil.

Step k: The boronic ester product of step j (1.64 g, 3.13 mmol) was combined with 5,7-difluoro-4-(trifluoromethylsulfonyloxy)-1,2-dihydronaphthalene (1.18 g, 3.75 mmol, 1.2 equiv.), Pd(dppf)Cl2 (227 mg, 0.31 mmol, 0.1 equiv.) and sodium carbonate (2M, aq., 3.13 ml, 2.0 equiv.) in dioxane (31 ml, 0.1M) and heated to 75° C. for three hours. Upon completion, the reaction was concentrated onto Celite and purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in hexanes) to yield the desired alkene product (1.42 g, 86% yield) as a colorless resin.

Step l: TBAF (0.1M in THF, 0.3 mmol, 1.5 equiv.) was added to a cooled solution of the product of step k (113 mg, 0.2 mmol) at 0° C., and the reaction was allowed to warm to ambient temperature. After 2 hours the reaction was concentrated onto Celite and purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in hexanes) to yield the free indanol (1S,2R)-4-(6,8-difluoro-3,4-dihydronaphth-1-yl)-2-fluoro-7-(trifluoromethylsulfonyl)-1-indanol (33.7 mg, 37% yield). 1H NMR (400 MHz, CDCl3): δ 7.92 (d, J=8.1 Hz, 1H), 7.49 (d, J=8.1 Hz, 1H), 6.81 (d, J=8.3 Hz, 1H), 6.56 (ddd, J=11.3, 8.7, 2.6 Hz, 1H), 6.15 (dd, J=4.9, 4.9 Hz, 1H), 5.58-5.51 (br m, 1H), 5.28-5.08 (m, 1H), 3.14-3.00 (m, 2H), 2.92-2.79 (m, 2H), 2.48-2.37 (m, 2H). ESI MS [M+Na]+ for C20H14F6O3S; calcd 471.0, found 471.0.

Step m: The product indanol of step l was dissolved in methanol (700 μL, 0.1M) and added to palladium on carbon (3 mg, 10% Pd by weight) under an atmosphere of nitrogen. The reaction mixture was placed under an atmosphere of hydrogen at 55 psi and agitated in a Parr shaker overnight. The resulting diastereomers were separated by column chromatography (silica gel, 100% toluene) to yield (1S,2R)-4-[R-6,8-difluoro-1,2,3,4-tetrahydronaphth-1-yl]-2-fluoro-7-(trifluoromethylsulfonyl)-1-indanol (example 2a) as the less polar diastereomer. 1H NMR (400 MHz, CDCl3): δ 7.76 (d, J=8.1 Hz, 1H), 6.98 (d, J=8.1 Hz, 1H), 6.75 (br d, J=10.0 Hz, 1H), 6.58 (dd, J=9.8 Hz, 1H), 5.59-5.55 (m, 1H), 5.41-5.23 (m, 1H), 4.41-4.36 (br m, 1H), 3.51-3.41 (m, 1H), 3.25-3.16 (m, 1H), 3.12 (d, J=4.1 Hz, 1H), 2.94-2.78 (m, 2H), 2.17-2.07 (m, 1H), 1.78-1.67 (m, 2H). ESI MS [M+Na]+ for C20H16F6O3S; calcd 473.1, found 473.1. (1S,2R)-4-[S-6,8-difluoro-1,2,3,4-tetrahydronaphth-1-yl]-2-fluoro-7-(trifluoromethylsulfonyl)-1-indanol (example 2b) was isolated as the more polar diastereomer. 1H NMR (400 MHz, CDCl3): δ 7.75 (d, J=8.3 Hz, 1H), 6.92 (d, J=8.3 Hz, 1H), 6.79-6.72 (m, 1H), 6.62-6.54 (m, 1H), 5.60 (td, J=5.0, 3.7 Hz, 1H), 5.47-5.24 (m, 1H), 4.38-4.34 (m, 1H), 3.50-3.27 (m, 2H), 3.08 (d, 1H), 2.98-2.75 (m, 2H), 2.16-2.07 (m, 1H), 1.86-1.62 (m, 2H). ESI MS [M+Na]+ for C20H16F6O3S; calcd 473.1, found 473.1.

Example 3

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 2. 1H NMR (400 MHz, Chloroform-d) δ 7.71-7.67 (d, J=8.1 Hz, 1H), 6.81 (d, J=8.1 Hz, 1H), 6.73 (d, J=9.1, Hz, 1H), 6.55 (ddd, J=2.1, 9.2, 18.4 Hz, 1H), 5.67 (dt, J=4.7, 12.4 Hz, 1H), 5.51-5.33 (dq, J=4.7, 52.4 Hz, 1H), 4.32 (m, 1H), 3.59 (dd, J=4.4, 1.4 Hz, 1H), 3.31 (dd, J=21.2, 4.9 Hz, 2H), 3.23 (s, 3H), 2.94-2.76 (m, 2H), 2.14-2.05 (m, 1H), 1.83 (m, 1H), 1.75-1.65 (m, 2H). ESI MS [M−H2O+H]+ for C20H19F3O3S calcd 379.1, found 379.1.

Example 4

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 2. 1H NMR (400 MHz, Chloroform-d) δ 7.70 (d, J=8.1 Hz, 1H), 6.84 (d, J=8.1 Hz, 1H), 6.73 (d, J=9.1 Hz, 1H), 6.56 (ddd, J=2.4, 9.1, 18.0 Hz, 1H), 5.65 (dt, J=4.8, 14.4 Hz, 1H), 5.49-5.31 (m, 1H), 4.36 (m, 1H), 3.66 (dd, J=5.1, 1.8 Hz, 1H), 3.40 (ddd, J=21.6, 16.9, 3.2 Hz, 1H), 3.25 (s, 3H), 3.16-2.99 (m, 1H), 2.95-2.74 (m, 2H), 2.13-2.00 (m, 1H), 1.76-1.62 (m, 3H). ESI MS [M−H2O+H]+ for C20H19F3O3S calcd 379.1, found 379.1.

Example 8

[Figure (not displayed)]

Step a: To a solution of 5,7-difluorochroman-4-one (500 mg, 2.71 mmol) in CH2Cl2 (12 mL, 0.2M) at 0° C. was added 2,6-di-tert-butylmethylpyridine (1.17 g, 5.69 mmol, 2.1 equiv.) followed by trifluoromethanesulfonic anhydride (860 μL, 5.14 mmol, 1.9 equiv.) dropwise. Reaction was stirred at 0° C. for 1 h and then warmed to rt for another 1 h. At this point, hexane (5 mL) was added to precipitate the pyridinium salt and the reaction mixture was filtered over a pad of Celite. Solvent was removed in vacuo and the crude residue was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in hexanes) to yield the desired vinyl triflate (754 mg, 88%) as a yellow oil. ESI MS [M+H]+ for C10H5F5O4S calcd 316.9, found 317.2.

Step b: The title compound was synthesized in a similar fashion to Example 1. 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J=8.2 Hz, 1H), 7.17 (d, J=8.2 Hz, 1H), 6.59-6.45 (m, 1H), 6.45-6.35 (m, 1H), 5.60 (dd, J=6.6, 5.1 Hz, 1H), 5.51-5.22 (m, 1H), 4.45-4.34 (m, 1H), 4.29-4.14 (m, 1H), 4.08-3.98 (m, 1H), 3.61-3.42 (m, 1H), 3.28-3.16 (m, 1H), 2.43-2.33 (m, 1H), 1.96-1.80 (m, 1H). ESI MS [M+Na]+ for C19H14F6O4SNa calcd 475.0, found 475.0.

Example 9

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 1. 1H NMR (400 MHz, Methanol-d4) δ 7.78 (dt, J=8.1, 1.7 Hz, 1H), 7.13 (dd, J=15.1, 8.1 Hz, 1H), 6.89 (ddd, J=9.8, 2.7, 1.1 Hz, 1H), 6.83-6.64 (m, 2H), 5.56-5.49 (m, 1H), 4.32-4.25 (m, 1H), 3.63-3.06 (m, 3H), 2.97-2.78 (m, 2H), 2.21-2.06 (m, 1H), 1.97-1.76 (m, 1H), 1.80-1.68 (m, 1H). ESI MS [M+H]+ for C20H19F3O3s, calcd 380.4, found 380.1.

Example 10

[Figure (not displayed)]

Step a: A suspension of the 3-bromo-2-chloro-6-fluorobenzaldehyde (25 g, 105.3 mmol), NH2OH×HCl (8.8 g, 126.4 mmol, 1.2 equiv.) and NaOAc (10.4 g, 126.4 mmol, 1.2 equiv.) in anhydrous EtOH (100 mL) was stirred under reflux for overnight. Reaction was cooled to room temperature, evaporated and the residue was diluted with H2O (300 mL). White solid was filtered off, washed with H2O and dried under vacuum (24.3 g, 91%). Crude product was used in the next step without further purification. ESI MS [M+H]+ for C7H4BrClFNO, calcd 251.9, found 251.9.

Step b: Oxime from step a was diluted with acetic anhydride (150 mL) and stirred at 120° C. for overnight, then cooled down and concentrated in vacuo to give brown solid (22.5 g, 99%). Crude product was used in the next step without further purification.

Step c: Product from step b (20 g, 85.3 mmol) was dissolved in anhydrous DMF (100 mL), cooled to 0° C. and anhydrous Na2S (6.6 g, 85.3 mmol) was added in one portion. Reaction mixture was stirred for 2 h at 0° C., then quenched with H2O (500 mL) and extracted with CH2Cl2 (3×200 mL). Organics were discarded and aqueous layer was neutralized with 10% KHSO4 solution to pH ˜ 2 and extracted again with CH2Cl2 (3×150 mL). The combined organic layers were dried over MgSO4, filtered and concentrated in vacuo to give yellow solid that was used in the next step without further purification (19.1 g, 90%). ESI MS [M−H]— for C7H3BrClNS, calcd 245.9, found 245.9.

Step d: Product from step c (33.6 g, 135.2 mmol) was dissolved in anhydrous DMF (300 mL) and paraquat dichloride hydrate (3.5 g, 13.5 mmol, 10% mol.) was added. The mixture was cooled to 0° C. and trifluoroiodomethane×TMG reagent (33.6 mL, 162.2 mmol, 1.2 equiv.) was added followed by TEA (18.8 mL, 135.2 mmol). Reaction was stirred at 0° C. for 15 min. then warmed up to room temperature and stirred for overnight. Quenched with H2O (1500 mL) and extracted with EtOAc (3×300 mL). Combined organics were washed with brine (2×100 mL), dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by column chromatography (silica gel, hex→30% EtOAc in hexanes) to afford the product as yellow solid (19.3 g, 45%).

Step e: The product from step d (18.5 g, 58.4 mmol) was dissolved in CH2Cl2:CH3CN:H2O (1:1:2; 300 mL) and NaIO4 (50 g, 233.6 mmol, 4 equiv.) was added followed by RuCl3×H2O (394 mg, 1.75 mmol, 3% mol.). The reaction was stirred at room temperature for 1.5 h then diluted with H2O (1000 mL) and 10% Na2S2O3 solution (100 mL) and extracted with EtOAc (3×300 mL). Combined organics were dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by column chromatography (silica gel, hex→40% EtOAc in hexanes) to afford the product as white solid (19.4 g, 95%). 1H NMR (400 MHz, CDCl3) δ 8.17 (d, J=8.6 Hz, 1H), 7.98 (d, J=8.6, 1H).

Step f: The mixture of 8-bromo-6-fluoroquinoline (15.7 g, 69.5 mmol), Zn(CN)2 (4.9 g, 41.7 mmol, 0.8 equiv.) and Pd(PPh3)4 (8 g, 6.9 mmol, 10% mol) in anhydrous DMF (100 mL) was stirred at 100° C. for overnight. Then reaction was cooled to room temperature and diluted with H2O (500 mL). Yellow solid was filtered off, washed with H2O and dried under vacuum. Crude product was used in the next step without further purification.

Step g: The product from step f was placed in a Parr bottle and dissolved in MeOH (300 mL) and concentrated HCl (50 mL). The mixture was purged with N2 and PtO2 (1.56 g, 6.9 mmol, 10% mol) was added. The reaction was shaken under H2 atmosphere (50 psi) for 5 h, then filtered through Celite, washed with MeOH and evaporated. Crude residue was purified by column chromatography (silica gel, hex→30% EtOAc in hexanes) to afford the product as a yellow solid (5.9 g, 48% over 2 steps). 1H NMR (400 MHz, CDCl3) δ 6.90-6.81 (m, 2H), 4.63 (brs, 1H), 3.41-3.33 (m, 2H), 2.77-2.68 (m, 2H), 1.96-1.85 (m, 2H).

Step h: The mixture of bromide from step g (200 mg, 0.57 mmol), tetrahydroquinoline from step g (100 mg, 0.57 mmol), Pd(OAc)2 (25 mg, 0.22 mmol, 20% mol.), rac-BINAP (87 mg, 0.14 mmol, 25% mol.) and Cs2CO3 (372 mg, 1.14 mmol, 2 equiv.) in anhydrous, degassed toluene (2 mL) was stirred at 100 C for 5 h. Whole reaction mixture was loaded on a silica gel cartridge and purified by column chromatography (silica gel, hex→30% EtOAc in hexanes) to afford the product as a yellow solid (44 mg, 17%). 1H NMR (400 MHz, CDCl3) δ 8.02 (d, J=8.7 Hz, 1H), 7.34 (d, J=8.7 Hz, 1H), 7.19-7.13 (m, 1H), 7.11-7.07 (m, 1H), 3.90-3.57 (m, 2H), 3.06-2.82 (m, 2H), 2.20-1.78 (m, 2H). ESI MS [M+H]+ for C18H10ClF4N3O2S, calcd 444.0, found 444.0.

Example 11

[Figure (not displayed)]

Step a: A solution of the 3-bromo-2-chloro-6-fluorobenzonitrile (5 g, 21.3 mmol) in anhydrous CH3CN (100 mL) was cooled to 0° C. and then CH3SNa (1.64 g, 23.4 mmol, 1.1 equiv.) was added in one portion. The mixture was stirred at 0° C. for 15 min. then the cooling batch was removed, and reaction was stirred at room temperature for overnight. Diluted with H2O (300 mL) and the product was filtered off, (white solid, 4.6 g, 82%).

Step b was done in a similar fashion to Example 10. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J=8.5 Hz, 1H), 7.95 (d, J=8.5 Hz, 1H), 3.30 (s, 3H).

Step c was done in a similar fashion to Example 10 (brown solid, 3.5 mg, 1%). 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J=8.5 Hz, 1H), 7.29 (d, J=8.5 Hz, 1H), 7.16-7.10 (m, 1H), 7.08-7.03 (m, 1H), 3.72-3.57 (m, 2H), 3.31 (s, 3H), 3.00-2.81 (m, 2H), 2.10-1.79 (m, 2H). ESI MS [M+H]+ for C18H13ClFN3O2S, calcd 390.0, found 390.0.

Example 12

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 10. (yellow solid, 130 mg, 50%). 1H NMR (400 MHz, CDCl3) δ 7.90 (d, J=8.8 Hz, 1H), 7.06 (d, J=8.8 Hz, 1H), 7.00-6.93 (m, 1H), 6.93-6.86 (m, 1H), 3.91-3.82 (m, 1H), 3.66-3.53 (m, 1H), 3.02-2.86 (m, 2H), 2.06-1.93 (m, 1H), 1.89-1.75 (m, 1H). ESI MS [M+H]+ for C17H10Cl2F4N2O2S, calcd 453.0, found 453.0.

Example 13

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 10. (yellow solid, 172 mg, 69%). 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J=8.8 Hz, 1H), 7.28 (d, J=8.8 Hz, 1H), 6.79-6.73 (m, 1H), 6.70-6.59 (m, 1H), 3.77-3.67 (m, 2H), 2.95-2.87 (m, 2H), 1.99-1.89 (m, 2H). ESI MS [M+H]+ for C17H10ClF5N2O2S, calcd 437.0, found 437.0.

Example 14

[Figure (not displayed)]

Step a: To a 40 mL vial was added 6-fluoro-1,2,3,4-tetrahydroquinoline-8-carbonitrile (61 mg, 0.344 mmol, 1.2 equiv.), 5-bromo-3-fluoro-2-(trifluoromethyl)-pyridine (70 mg, 0.287 mmol, 1.0 equiv.), Pd(OAc)2 (13 mg, 0.057 mmol, 20 mol %), rac-BINAP (45 mg, 0.072 mmol, 25 mol %), Cs2CO3 (190 mg, 0.574 mmol, 2.0 equiv.) and toluene (1.5 mL). The reaction vessel was capped, and the mixture purged with N2 for 2 min. The reaction was stirred at 100° C. for 2 h. The reaction mixture was cooled, concentrated onto Celite and purified by flash column chromatography (SiO2, hexane→40% EtOAc in hexanes) to afford the product as a white solid (65 mg, 0.192 mmol, 55%, ESI MS [M+H]+ for C16H10F5N3, calcd 340.3, found 340.0).

Step b: A vial was charged with the product from step a (30 mg, 0.088 mmol, 1.0 equiv.), KCN (7.0 mg, 0.097 mmol, 1.1 equiv.), and NMP (0.3 mL). The reaction mixture was stirred at 100° C. for 4 h. The reaction was diluted with sat. aq. NaHCO3 solution (10 mL) and extracted with EtOAc (10 mL). The aqueous layer was separated and back extracted with additional EtOAc (15 mL). The organic layers were combined, washed with H2O (2×20 mL), brine (20 mL), and dried over MgSO4. Concentration under reduced pressure and purification by flash chromatography furnished the product as a yellow solid (4.0 mg, 0.012 mmol, 13%). 1H NMR (400 MHz, DMSO-d6) δ 8.70-8.63 (m, 1H), 8.31-8.25 (m, 1H), 7.70-7.64 (m, 1H), 7.61-7.54 (m, 1H), 3.86-3.80 (m, 2H), 2.80 (t, J=6.4 Hz, 2H), 1.95-1.87 (m, 2H). ESI MS [M+H]+ for C17H10F4N4, calcd 347.1, found 347.0.

Example 15

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 14 using 1-bromo-2-chloro-3-fluoro-4-(trifluoromethyl)-benzene. 1H NMR (400 MHz, DMSO-d6) δ 7.74-7.67 (m, 1H), 7.53-7.43 (m, 2H), 7.13-7.04 (m, 1H), 3.74-3.48 (m, 2H), 3.07-2.77 (m, 2H), 2.06-1.64 (m, 2H). ESI MS [M+H]+ for C17H10ClF5N2, calcd 373.0, found 373.0.

Example 16

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 10. 1H NMR (400 MHz, Chloroform-d) δ 10.24 (s, 1H), 8.87 (d, J=6.1 Hz, 1H), 8.43 (d, J=8.2 Hz, 1H), 8.26 (dd, J=6.2, 0.9 Hz, 1H), 7.29 (d, J=8.2 Hz, 1H), 7.26-7.22 (m, 1H), 7.15-7.11 (m, 1H), 3.87-3.76 (m, 2H), 3.16-2.94 (m, 2H), 2.08-1.85 (m, 2H). ESI MS [M+H]+ for C20H13F4N3O2S calcd 436.1, found 436.1.

Example 17

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 19. 1H NMR (400 MHz, Chloroform-d) δ 7.77 (d, J=8.4 Hz, 1H), 7.00 (s, 0H), 6.83 (d, J=8.8 Hz, 1H), 6.70 (ddd, J=11.0, 8.3, 2.6 Hz, 1H), 5.51 (s, 1H), 5.18 (d, J=50.8 Hz, 1H), 3.69 (s, 2H), 3.00 (br m, 2H), 2.84 (p, J=6.4 Hz, 1H), 2.12-1.99 (m, 1H), 1.81 (br m, 2H), 1.60 (dq, J=14.5, 7.5 Hz, 1H), 0.98 (t, J=7.4 Hz, 3H). ESI MS [M+H]+ for C21H19F6NO3S calcd 480.1, found 480.1.

Example 18

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 10. 1H NMR (400 MHz, CDCl3) δ 7.84 (dd, J=8.8, 0.4 Hz, 1H), 7.13 (d, J=8.9 Hz, 1H), 6.54 (dd, J=8.6, 2.7 Hz, 1H), 6.43 (dd, J=10.2, 2.8 Hz, 1H), 3.74 (br. s, 2H), 3.51 (s, 3H), 2.95-2.79 (m, 2H), 1.91 (br. s, 2H). 19F NMR (376 MHz, CDCl3) δ −77.11, −115.53. ESI MS [M+H]+ for C18H13ClF4N2O3S; calcd 449.0, found 449.1.

Example 19

[Figure (not displayed)]

Step a: Chloroacetyl chloride (8.3 mL, 110 mmol) was added dropwise to a stirred suspension of 2-amino-5-fluorophenol (9.5 g, 75 mmol) and potassium carbonate (41.4 g, 300 mmol) in THF (120 mL) at 0° C. The reaction was stirred at ambient temperature for 30 min before it was maintained at 66° C. for 48 h. The mixture was cooled, filtered through Celite pad to remove inorganic solids and the filtrate was concentrated to dryness. The residue was fractionated by column chromatography (SiO2, hexanes/EtOAc gradient) to yield 7-fluoro-2H-benzo[b][1,4]oxazin-3(4H)-one (5.5 g, 32.9 mmol, 44% yield) as a brown solid. 1H NMR (400 MHz, CDCl3) δ 8.73 (s, 1H), 6.90-6.53 (m, 3H), 4.60 (s, 2H). 19F NMR (376 MHz, CDCl3) δ −117.25.

Step b: Lithium aluminum hydride (1.2 g, 3.2 mmol) was carefully added in portions to a solution of 7-fluoro-2H-benzo[b][1,4]oxazin-3(4H)-one (3.5 g, 2.1 mmol) in THF (30 mL) at 0° C. Once the addition was complete, the cooling bath was removed, and the mixture was stirred at ambient temperature for 4 h. After TLC analysis indicated complete reaction, the mixture was quenched using Fieser protocol and the product was extracted diethyl ether. After all solvent was removed under reduced pressure, the crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce 7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine (2.9 g, 18.9 mmol, 90% yield) as a brown solid. 1H NMR (400 MHz, CDCl3) δ 6.63-6.22 (m, 3H), 4.30-4.18 (m, 2H), 3.59 (s, 1H), 3.44-3.32 (m, 2H). 19F NMR (376 MHz, CDCl3) δ −124.56.

Step c: Bromine (0.4 mL, 7.5 mmol) was added dropwise to a solution of 7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine (1 g, 6.5 mmol) in acetic acid (26 mL), that was placed in a water bath in order to maintain the reaction temperature below 25° C. Once the addition was complete, the reaction was stirred at ambient temperature for 10 min and poured in 5% aqueous NaHSO3 (100 mL). The crude product was extracted with a mixture of EtOAc and hexanes (v/v 1:1, 3×35 mL), then combined extracts were washed with water (3×100 mL), aqueous NaHCO3 (2×100 mL) and brine (50 mL). The solution was dried over Na2SO4 and the solvent was evaporated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to yield 5-bromo-7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine (1.05 g, 4.5 mmol, 70% yield) as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 6.79 (dd, J=8.0, 2.8 Hz, 1H), 6.52 (dd, J=9.5, 2.8 Hz, 1H), 4.32-4.14 (m, 2H), 4.14-3.88 (br. s, 1H), 3.53-3.34 (m, 2H). 19F NMR (376 MHz, CDCl3) δ −124.82 (d, J=8.3 Hz).

Step d: A mixture of 5-bromo-7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine (1.05 g, 4.5 mmol), zinc cyanide (0.43 g, 3.6 mmol) and Pd(PPh3)4 (0.52 g, 0.45 mmol) in DMF (11 mL) was heated at 100° C. under nitrogen atmosphere for 4 hours. Once complete disappearance of starting material was observed by TLC analysis (30% EtOAc in hexanes as an eluent), the solution was cooled to ambient temperature and poured in a mixture of EtOAc (50 mL) and water (50 mL). The resulting suspension was filtered through a Celite plug. The organic phase was separated, and the aqueous solution was additionally extracted with EtOAc (2×25 mL). Combined organic phase was washed with water (2×75 mL) and brine (75 mL), dried over Na2SO4 and concentrated to dryness. The dry residue was fractionated by column chromatography (SiO2, hexanes/EtOAc gradient) to provide 7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carbonitrile (0.75 g, 4.2 mmol, 94% yield) as a white powder. 1H NMR (400 MHz, CDCl3) δ 6.78-6.54 (m, 2H), 4.51 (br. s, 1H), 4.33-4.17 (m, 2H), 3.60-3.40 (m, 2H). 19F NMR (376 MHz, CDCl3) δ −124.17. ESI MS [M+Na]+ for C9H7FN2O; calcd 179.1, found 179.1.

Step e: The mixture of (1S,2R)-4-bromo-2-fluoro-1-(tertbutyl-dimethysilyl)-7-(trifluoromethylsulfonyl)indan (100 mg, 0.21 mmol), 7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carbonitrile (38 mg, 0.21 mmol), Pd(OAc)2 (9.5 mg, 0.042 mmol), rac-BINAP (33 mg, 0.053 mmol) and Cs2CO3 (137 mg, 0.42 mmol) in anhydrous, degassed toluene (1 mL) was stirred at 100° C. for 6 h. Then the mixture was cooled to ambient temperature, diluted with EtOAc and filtered through a Celite pad to remove inorganic solids. The filtrate was concentrated on Celite and purified by column chromatography (SiO2, hexanes/EtOAc gradient) to a mixture of product and unreacted benzomorpholine (55 mg). This mixture was submitted to step f without additional purification.

Step f: The mixture of TBS-protected indanol and unreacted benzomorpholine from previous step was dissolved in CH3CN (1 mL) and placed in a 3 mL vial equipped with a magnetic stirrer, then HF.Py complex (hydrogen fluoride ˜70%, pyridine ˜30%, 0.1 mL) was added. The resulting solution was stirred overnight at ambient temperature. After TLC analysis indicated complete consumption of the starting material the reaction was diluted with EtOAc (20 mL) and 1M aqueous HCl solution (20 mL). The product was extracted with EtOAc (2×10 mL), combined organic extracts were washed with aqueous NaHCO3 (20 mL) and brine (20 mL), dried over Na2SO4 and concentrated to dryness. The residue was fractionated by column chromatography (SiO2, hexanes/EtOAc gradient) to yield 7-fluoro-4-((1S,2R)-2-fluoro-1-hydroxy-7-((trifluoromethyl)sulfonyl)-2,3-dihydro-1H-inden-4-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-5-carbonitrile (25 mg, 0.054 mmol, 26% yield over two steps) as a yellowish oil. 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J=8.6 Hz, 1H), 7.05-6.93 (m, 2H), 6.89 (dd, J=7.5, 2.8 Hz, 1H), 5.59 (br. s, 1H), 5.28 (br. d, J=49.6 Hz, 1H), 4.39 (d, J=11.5 Hz, 1H), 4.10 (br. s, 1H), 3.76-3.57 (m, 2H), 3.34 (br. s, 2H), 3.03 (s, 1H). 19F NMR (376 MHz, CDCl3) δ −78.08, −113.95, −199.41 (d, J=51.0 Hz). ESI MS [M+Na]+ for C19H13F5N2O4S; calcd 483.0, found 483.1.

Example 20

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 19. 1H NMR (400 MHz, CDCl3) δ 7.80 (d, J=8.4 Hz, 1H), 6.99-6.79 (m, 3H), 5.68-5.61 (m, 1H), 5.37 (br. d, J=52.1, 1H), 4.38-4.23 (m, 1H), 4.18-4.02 (m, 1H), 3.72-3.48 (m, 3H), 3.43-2.93 (m, 5H). 19F NMR (376 MHz, CDCl3) δ −115.26, −199.17. ESI MS [M-OH]+ for C19H16F2N2O4S; calcd 389.1, found 389.1.

Example 21

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 10. 1H NMR (400 MHz, CDCl3) δ 9.15 (dd, J=4.3, 1.7 Hz, 1H), 8.61 (dd, J=8.6, 1.7 Hz, 1H), 8.44 (d, J=8.3 Hz, 1H), 7.60 (dd, J=8.6, 4.2 Hz, 1H), 7.08 (dd, J=8.3, 0.9 Hz, 1H), 6.85-6.76 (m, 1H), 6.71-6.61 (m, 1H), 3.86-3.69 (m, 2H), 3.04-2.96 (m, 2H), 1.99-1.82 (m, 2H). ESI MS [M+H]+ for C19H13F5N2O2S calcd 429.1, found 429.1.

Example 22

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 19. 1H NMR (400 MHz, Methanol-d4) δ 7.76 (d, J=8.6 Hz, 1H), 7.03 (d, J=8.6 Hz, 1H), 6.85-6.80 (m, 1H), 6.77-6.69 (m, 1H), 5.50-5.44 (m, 1H), 3.66-3.57 (m, 3H), 3.22 (s, 3H), 3.18-3.03 (m, 1H), 2.93-2.84 (t, J=6.6 Hz, 2H), 1.96-1.84 (m, 2H). ESI MS [M+H]+ for C19H17F4NO3S calcd 416.1, found 416.0.

Example 23

[Figure (not displayed)]

The title compound was synthesized in a similar fashion to Example 24. 1H NMR (400 MHz, CDCl3) δ 8.46 (d, J=2.2 Hz, 1H), 7.94 (dd, J=8.9, 2.3 Hz, 1H), 7.33 (dd, J=8.9, 1.7 Hz, 1H), 6.82-6.76 (m, 1H), 6.76-6.63 (m, 1H), 3.77-3.50 (m, 2H), 2.92-2.81 (m, 2H), 2.15-1.99 (m, 2H). ESI MS [M+H]+ for C16H11F5N2O4S calcd 423.0, found 423.1.

Example 24

[Figure (not displayed)]

4-Bromo-3-nitrobenotrifluoride (270 mg, 1 mmol), 6,8-difluoro-1,2,3,4-tetrahydroquinoline (324 mg, 1.2 mmol), Pd(OAc)2 (45 mg, 0.2 mmol), rac-BINAP (187 mg, 0.3 mmol), and Cs2CO3 (652 mg, 2 mmol), were suspended in PhMe (5 mL). The suspension was degassed with N2 for 5 minutes at ambient temperature and heated to 100° C. for 1.5 hours. The mixture was cooled to room temperature, diluted with EtOAc, filtered, and concentrated onto Celite®. Purification by column chromatography (0-10% EtOAc/hexanes) afforded the title compound as an orange oil (125 mg, 35% yield). 1H NMR (400 MHz, CDCl3) δ 8.13 (dd, J=2.2, 0.9 Hz, 1H), 7.68-7.61 (m, 1H), 7.26-7.22 (m, 1H), 6.73 (dddt, J=8.4, 2.6, 1.7, 0.9 Hz, 1H), 6.63 (dddd, J=11.3, 8.4, 2.8, 0.7 Hz, 1H), 3.57 (s, 2H), 2.88 (tt, J=6.6, 0.8 Hz, 2H), 2.00 (q, J=6.2 Hz, 2H). 19F NMR (376 MHz, CDCl3) δ −62.3 (3F), −117.3 (1F), −116.7 (1F). ESI MS [M+H]+ for C16H11F5N2O2, calcd 359.1, found 359.1.

Example 121

[Figure (not displayed)]

Step a: A flask was charged with 2-chloro-4-fluoroaniline (18.2 g, 15 mL, 1.0 mol. equiv.) and excess acrylic acid (46 g, 5.0 mol. equiv.) and the resulting mixture was stirred at 45° C. for 15 h. During this time, the product solidified from the reaction mixture and was collected by filtration, rinsing with hexanes, to afford the aniline product that was used crude in the next step (25.4 g, 93%).

Step b: The product from step a (25.4 g) was then added portion-wise to Eaton's reagent (100 mL) at 0° C. The resulting mixture was warmed to room temperature and then heated at 80° C. for 3 h. After this time, the reaction was cooled, and carefully poured onto ice, after which the product precipitated out of solution as a yellow solid (17.4 g, 75%).

Step c: A flask containing the product from the previous step (15 g, 75.3 mmol, 1.0 mol. equiv.) in MeOH (250 mL) was cooled to 0° C. under N2. NaBH4 (3.41 g, 90.4 mmol, 1.2 mol. equiv.) was added slowly in portions, after which the reaction was stirred at room temperature for 30 min. At this time, the reaction was placed in an ice bath, quenched with H2O, and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with water, brine, and dried over MgSO4. Concentration under reduced pressure furnished tetrahydroquinoline intermediate that was taken onto the next step without further purification.

Step d: To the crude intermediate from step c was added DCM (250 mL) and imidazole (7.70 g, ˜1.5 mol. equiv.). The resulting mixture was cooled to 0° C. and TBSCl (17.0 g, ˜1.5 equiv.) was added. The reaction was warmed to room temperature and stirred for 2 h. The reaction was filtered to remove imidazole hydrochloride and concentrated onto Celite. Purification by flash column chromatography (SiO2, hexanes to 10% EtOAc/hexanes) furnished the TBS protected alcohol as a colorless oil (16.7 g, 70% over 2 steps).

Step e: A flask was charged with TBS alcohol from the previous step (6.0 g, 19 mmol, 1.0 mol. equiv.), K4Fe(CN)6.3H2O (5.61 g, 13.3 mmol, 0.7 mol. equiv.), Pd XPhos gen III (0.803 g, 0.95 mmol, 5 mol %), XPhos (0.452 g, 0.95 mmol, 5 mol %), KOAc (0.242 g, 2.47 mmol, 0.13 mol. equiv.), H2O (40 mL) and 1,4-dioxane (40 mL). The resulting mixture was purged with N2, heated at 100° C., and stirred vigorously under N2. After 3 h, the reaction was cooled, and diluted with EtOAc and H2O. The aqueous layer was separated and back extracted with additional EtOAc. Filtration through Celite to remove solids may improve the distinction of layers. The organic layers were combined and dried over MgSO4. Purification by flash column chromatography (SiO2, hexanes to 20% EtOAc) furnished the benzonitrile product as a yellow solid (5.68 g, 98%).

Step f: To a flask containing 6-bromo-2-fluoro-3-(trifluoromethyl)benzoic acid (10 g, 34.8 mmol, 1.0 mol. equiv.) was added DMF (70 mL), followed by EDC.HCl (9.98 g, 52.2 mmol, 1.5 mol. equiv.), HOBt.H2O (7.0 g, 52.2 mmol, 1.5 mol. equiv.), ammonium carbonate (16.7 g, 174 mmol, 5.0 mol. equiv.), and DIPEA (18 mL, 3.0 mol. equiv.). The resulting mixture was stirred overnight at 40° C. The reaction was partitioned between EtOAc and H2O. The aqueous layer was separated and extracted with additional EtOAc. The organic layers were combined, washed with H2O to remove DMF, and dried over MgSO4. Concentration under reduced pressure furnished crude amide that was taken onto the next step without purification.

Step g: To a flask containing crude amide from the previous step was added DMF (100 mL) and cyanuric trichloride (2.55 g, 13.9 mmol, ˜0.6 mol. equiv.). The resulting mixture was stirred under N2 at room temperature for 16 h. The reaction was partitioned between EtOAc and H2O. The aqueous layer was separated and extracted with additional EtOAc. The organic layers were combined, washed with H2O to remove DMF, and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 20% EtOAc) furnished the nitrile product as a white solid (2.68 g, 26% over 2 steps).

Step h: A vial was charged with benzonitrile from the previous step (1.0 g, 3.73 mmol, 1.0 mol. equiv.), 4-[tert-butyl(dimethyl)silyl]oxy-6-fluoro-1,2,3,4-tetrahydroquinoline-8-carbonitrile (1.10 g, 3.73 mmol, 1.0 mol. equiv.), Pd(OAc)2 (0.167 g, 0.746 mmol, 20 mol %), rac-BINAP (0.580 g, 0.925 mmol, 25 mol %), Cs2CO3 (2.42 g, 7.46 mmol, 2.0 mol. equiv.) and toluene (15 mL). N2 was bubbled through the reaction mixture for 3 min, the vial capped, and heated at 100° C. for 15 h. The reaction was monitored by TLC and NMR analysis. The reaction was cooled, filtered, and concentrated onto Celite. Purification by flash column chromatography (SiO2, hexanes to 10 to 20% EtOAc) furnished the coupled product as a yellow solid (1.00 g, 54%). ESI MS [M+H]+ for C24H24F5N3OSi, calcd 494.2, found 494.2.

Step i: A flask containing the product from the previous step (1.0 g, 2.02 mmol, 1.0 mol. equiv.) and THF (10 mL) was cooled to 0° C. and TBAF (1 M in THF, 3.0 mL, 1.5 mol. equiv.) was added. The reaction mixture was warmed to room temperature and stirred for 15 min. After this time, the reaction was quenched with sat. aq. NH4Cl solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with brine, and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 20% to 50% to 80% EtOAc) furnished the alcohol product as a white solid (0.694 g, 910%).

Step j: A vial containing the alcohol product from the previous step (35 mg, 0.093 mmol, 1.0 mol. equiv.) in DCM (1 mL) was cooled to −78° C. DAST (20 μL, 0.149 mmol, 1.6 mol. equiv.) was added, and the reaction was allowed to warm to room temperature and stirred for 5 min. The reaction was quenched at 0° C. with sat. aq. NaHCO3 solution and diluted with DCM. The aqueous layer was separated and back extracted with additional DCM. The organic layers were combined and dried over MgSO4. Concentration under reduced pressure and purification by column chromatography (SiO2, hexanes to 20% EtOAc) furnished racemic 1-[2-cyano-3-fluoro-4-(trifluoromethyl)phenyl]-4,6-difluoro-3,4-dihydro-2H-quinoline-8-carbonitrile as a white solid (13 mg, 37%). The enantiomers could be separated by preparative SFC chiral purification (2.0×25.0 cm ChromegaChiral CC4 from ES Industries (West Berlin, N.J.), CO2 co-solvent Isopropanol/Hexane (1:9), 15% co-solvent at 100 mL/min) to furnish the title compound (4S)-1-[2-cyano-3-fluoro-4-(trifluoromethyl)phenyl]-4,6-difluoro-3,4-dihydro-2H-quinoline-8-carbonitrile as a white solid (98.8% ee, tR=1.5 min). Absolute stereochemistry was confirmed by single crystal X-ray analysis. 1H NMR (400 MHz, DMSO-d6, appears as a 2:1 mixture of rotamers) δ 8.11 (t, J=8.6 Hz, 1H), 8.03 (t, J=8.6 Hz, 2H), 7.94-7.79 (m, 6H), 7.43 (d, J=8.8 Hz, 1H), 7.12 (d, J=8.7 Hz, 2H), 5.82 (dt, J=49.7, 2.9 Hz, 1H), 5.70 (dt, J=49.8, 2.9 Hz, 2H), 4.08-3.67 (m, 6H), 2.38-2.02 (m, 6H). ESI MS [(M−HF)+H]+ for C18H8F5N3, calcd 362.0, found 362.0.

Example 123

[Figure (not displayed)]

This compound was prepared in a similar fashion to Example 121 from 6-bromo-2-chloro-3-(trifluoromethyl)benzoic acid. 1H NMR (400 MHz, DMSO-d6, appears as a 2:1 mixture of rotamers) δ 8.15 (d, J=8.8 Hz, 1H), 8.05 (d, J=8.8 Hz, 2H), 7.93-7.86 (m, 4H), 7.86-7.77 (m, 2H), 7.57 (d, J=8.8 Hz, 1H), 7.26 (d, J=8.7 Hz, 2H), 5.82 (dt, J=49.7, 2.9 Hz, 1H), 5.70 (dt, J=49.8 Hz, 2.9 Hz, 2H), 4.05-3.91 (m, 3H), 3.88-3.66 (m, 3H), 2.32-2.00 (m, 6H). ESI MS [M+H]+ for C18H9ClF5N3, calcd 398.0, found 397.9.

Example 125

[Figure (not displayed)]

Step a: A solution of 1-[2-cyano-3-fluoro-4-(trifluoromethyl)phenyl]-6-fluoro-4-oxo-2,3-dihydroquinoline-8-carbonitrile (100 mg, 0.265 mmol) in 1 ml of a 50 wt % solution of Deoxo-Fluor® in toluene was heated to 70° C. overnight. Upon completion the reaction was cooled to 0° C. in an ice bath and quenched with water. The resulting solution was extracted with ethyl acetate and methylene chloride, and the crude concentrated material was purified by flash chromatography on silica gel (0% to 30% ethyl acetate in hexanes) to yield 1-[2-cyano-3-fluoro-4-(trifluoromethyl)phenyl]-4,4,6-trifluoro-2,3-dihydroquinoline-8-carbonitrile. 1H NMR (400 MHz, CDCl3): δ 7.75 (dd, J=8.2, 8.2 Hz, 1H), 7.68 (dd, J=7.8, 3.0 Hz, 1H), 7.27 (dd, J=7.2, 3.0 Hz, 1H), 6.92 (d, J=8.6 Hz, 1H), 4.16-4.09 (m, 1H), 3.99-3.92 (m, 1H), 2.53-2.39 (m, 2H). ESI MS [M+H]+ for C18H8F7N3, calcd. 400.1, found 400.0.

Example 126

[Figure (not displayed)]

Step a: as containing 2,5-dibromo-3-fluoropyridine (6.00 g, 23.6 mmol, 1.0 mol. equiv.) in THF (100 mL) was cooled to −78° C. under N2. A solution of LDA (2.0 M in heptane/THF/ethylbenzene, 17.7 mL, 1.5 mol. equiv.) was added slowly, and the resulting mixture stirred for 15 min. Mel (2.9 mL, 2.0 mol. equiv.) was added and the reaction mixture was allowed to warm to room temperature and stirred for 30 min. The reaction was cooled to 0° C. and quenched with sat. aq. NH4Cl solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 15% EtOAc) furnished the methylated product as a yellow oil (3.64 g, 57%).

Step b: A flask containing the product from the previous step (3.00 g, 11.2 mmol, 1.0 mol. equiv.) in dry toluene (30 mL) was cooled to −78° C. under N2. nBuLi (2.5 M in hexanes, 5.4 mL, 1.2 mol. equiv.) was added, and the reaction stirred for 30 min. After this time, the organolithium was trapped with anhydrous DMA (3.2 mL, 33.6 mmol, 2.0 mol. equiv.) and the reaction stirred for an additional 20 min. The reaction was quenched with sat. aq. NH4Cl solution at −78° C. After warming, the mixture was diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 30% EtOAc) furnished the ketone product (906 mg, 35%).

Step c: To the ketone product from the previous step (400 mg, 1.72 mmol, 1.0 mol. equiv.) was added Deoxo-Fluor (2.7 M in toluene, 3.0 mL, 4.0 mol. equiv.) and the resulting mixture was stirred at 70° C. for 9 h. The reaction mixture was poured onto ice, quenched with sat. aq. NaHCO3 solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 20% EtOAc) furnished the difluorinated product as a yellow oil (342 mg, 78%). ESI MS [M+H]+ for C8H7BrF3N, calcd 253.9, found 253.8.

The title compound 1-[6-(1,1-difluoroethyl)-5-fluoro-4-methylpyridin-3-yl]-4,4,6-trifluoro-2,3-dihydroquinoline-8-carbonitrile was prepared in 4 additional steps from 5-bromo-2-(1,1-difluoroethyl)-3-fluoro-4-methylpyridine, in a similar fashion to Example 125. 1H NMR (400 MHz, Chloroform-d) δ 7.96 (d, J=0.6 Hz, 1H), 7.67-7.62 (m, 1H), 7.31-7.27 (m, 1H), 3.90-3.79 (m, 1H), 3.55-3.46 (m, 1H), 2.59-2.40 (m, 2H), 2.38 (d, J=2.3 Hz, 3H), 2.05 (td, J=18.8, 0.7 Hz, 3H). ESI MS [M+H]+ for C18H13F6N3, calcd 386.1, found 386.0.

Example 127

[Figure (not displayed)]

Step a: A flask containing 5-bromo-3-fluoro-2-(trifluoromethyl)pyridine (1.00 g, 4.09 mmol, 1.0 mol. equiv.) in THF (10 mL) was cooled to −78° C. under N2. A solution of LDA (2.0 M in heptane/THF/ethylbenzene, 17.7 mL, 1.5 mol. equiv.) was added slowly, and the resulting mixture stirred for 15 min. A solution of hexachloroethane (1.93 g, 8.18 mmol, 2.0 mol. equiv.) in THF (3 mL) was added and the reaction mixture was warmed to room temperature and stirred for 15 min. The reaction was cooled to 0° C. and quenched with sat. aq. NH4Cl solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined and dried over MgSO4. Concentration under reduced pressure and purification by flash column chromatography (SiO2, hexanes to 15% EtOAc) furnished the chlorinated product as a yellow oil (824 mg, 72%).

The title compound 1-[4-chloro-5-fluoro-6-(trifluoromethyl)pyridin-3-yl]-4,4,6-trifluoro-2,3-dihydroquinoline-8-carbonitrile was prepared in 4 additional steps from 5-bromo-4-chloro-3-fluoro-2-(trifluoromethyl)pyridine, in a similar fashion to Example 125. 1H NMR (400 MHz, Chloroform-d) δ 8.18 (s, 1H), 7.69 (ddt, J=7.7, 3.0, 0.8 Hz, 1H), 7.34 (ddt, J=7.2, 3.1, 0.9 Hz, 1H), 4.07-3.90 (m, 1H), 3.83-3.70 (m, 1H), 2.63-2.41 (m, 2H). ESI MS [M+H]+ for C16H7F7N3, calcd 410.0, found 409.9.

Example 129

[Figure (not displayed)]

The title compound 4,4,6-trifluoro-1-[5-fluoro-4-methyl-6-(trifluoromethyl)pyridin-3-yl]-2,3-dihydroquinoline-8-carbonitrile was prepared in 3 additional steps in a similar fashion to Example 125. 1H NMR (400 MHz, DMSO-d6) δ 8.40 (s, 1H), 7.96-7.90 (m, 1H), 7.87 (dd, J=8.0, 2.9 Hz, 1H), 3.95-3.80 (m, 1H), 3.78-3.65 (m, 1H), 2.70-2.52 (m, 2H), 2.33 (d, J=2.1 Hz, 3H). ESI MS [M+H]+ for C17H10F7N3, calcd 390.0, found 390.0.

Example 134

[Figure (not displayed)]

Step a: A solution of 4-bromo-7-methylsulfonyl-2,3-dihydroinden-1-one (25.0 g, 86.5 mmol) in 500 mL of dry methanol was loaded in 1 L single-neck round-bottom flask equipped with a stirring bar and a reflux condenser with a drying tube. SelectFluor (38.2 g, 104 mmol) and concentrated sulfuric acid (0.5 mL) were added sequentially, and the mixture was refluxed for 5 h. Once TLC analysis indicates complete disappearance of the starting material the reaction was cooled to ambient temperature. Aqueous sulfuric acid (0.3 M, 130 mL) was added, and the mixture was refluxed for 3 h to transform the corresponding dimethylacetal to the desired α-fluoroketone. The resulting clear solution was cooled to an ambient temperature and methanol was distilled off under reduced pressure. The residual mixture was diluted with dichloromethane (1 L) and water (500 mL). The organic phase was separated, and the aqueous solution was extracted with dichloromethane (2×100 mL). Combined organic extract was washed with brine (500 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness producing α-fluoroketone (25.9 g, 84.3 mmol, 97% yield) as a white solid.

Step b: The product from step a (25.9 g, 84.3 mmol) was placed in 1 L single-neck round-bottom flask equipped with a stirring bar. The flask was charged with dichloromethane (700 mL), formic acid (20.0 mL, 0.50 mol) and triethylamine (47.0 mL, 0.34 mol). The resulting solution was cooled to 0° C. and RuCl(p-cymene)[(R,R)-TsDPEN] (2.2 g, 3.4 mmol) was added. The resulting brownish solution was stirred at 0° C. for 16 h. Once TLC analysis shows complete conversion of the starting material the reaction was concentrated to about a half of its original volume under reduced pressure. The residual solution was sequentially washed with an aqueous 1M NaOH (400 mL) and brine (500 ml). The organic phase was separated, dried over Na2SO4 and concentrated to dryness to produce the crude product with sufficient purity for the next step.

Enantiopurity of this material (96% ee) was determined using HPLC-UV chromatography [Chiralpak®AD-H (4.6×250 mm; 90% i-PrOH-hexanes; flow rate=1 mL/min; 10 μL injection of a 1 mg/mL solution; detection at 254 nm; t1=4.89 min. (minor), t2=5.26 min. (major)]

Step c: The crude material from the previous step was dissolved in dichloromethane (700 mL) and placed in 2 L three-neck round-bottom flask equipped with a thermometer, an addition funnel, a stirring bar and a reflux condenser with a drying tube. Triethylamine (105.0 mL, 0.81 mmol) was added to the mixture in one portion and the addition funnel was charged with TBSOTf (96.4 g, 0.37 mmol). Then TBSOTf was added dropwise causing an exothermic reaction with the rate required to maintain continuous reflux. Once the addition was complete the reaction mixture was reflux for additional 15 min upon which TLC analysis shows complete conversion of the starting material to the product. The solution was allowed to cool to ambient temperature, transferred into separatory funnel and sequentially washed with saturated aqueous NH4Cl (500 mL) and brine (500 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The obtained crude product was purified by flash chromatography (SiO2, hexanes/EtOAc gradient) to provide TBS ether as a white solid (26.5 g, 62.6 mmol, 74% yield over two steps).

Step d: The TBS ether product from the previous step (29.5 g, 70.0 mmol) was combined with B2Pin2 (23.0 g, 91.0 mmol, 1.3 equiv.), Pd(dppf)Cl2 (5.1 g, 7.0 mmol, 0.1 equiv.) and potassium acetate (13.8 g, 0.14 mmol, 2.0 equiv.) in dioxane (230 ml) in 500 mL single-neck round-bottom flask equipped with a magnetic stirring bar and reflux condenser with nitrogen inlet adapter. The mixture was degassed under vacuum, backfilled with nitrogen and heated to 100° C. for 2 h. After 1H NMR analysis of an aliquot indicated complete consumption of the starting material the reaction mixture was allowed to cool to ambient temperature and concentrated to dryness under reduced pressure. The residue was partitioned between EtOAc (500 mL) and water (300 mL). Organic layer was separated, and the aqueous phase was additionally extracted with EtOAc (2×100 mL). The combined organic extract was dried over Na2SO4 and the solvent was evaporated under reduced pressure to yield crude boronic pinacol ester that was used for the next step without further purification.

Step e: A solution of crude product from step d (70 mmol) and 8-cyano-6-fluoro-3,4-dihydronaphthalen-1-yl trifluoromethanesulfonate (22.5 g, 70.0 mmol) in dioxane (230 mL) was placed in 500 mL single-neck round-bottom flask equipped with a magnetic stirring bar and reflux condenser with nitrogen inlet. Then Pd(dppf)Cl2 (5.1 g, 7.0 mmol) and aqueous sodium carbonate (2M solution, 70.0 ml, 40.0 mmol) were sequentially added. The mixture was degassed under vacuum, backfilled with nitrogen and heated to 100° C. for 1 h. Upon reaction completion, dioxane was removed under reduced pressure. The residue was partitioned between EtOAc (500 mL) and water (500 mL). Organic layer was separated, and the aqueous phase was additionally extracted with EtOAc (2×100 mL). The combined organic extract was washed with brine (500 mL), dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to yield the desired alkene (28.5 g, 55.3 mmol, 79% yield) as a white foam.

Step f: The alkene of step e (28.0 g, 54.0 mmol) was dissolved in dry methanol (540 mL) and added to palladium on carbon (5.0 g, 10% Pd by weight) under an atmosphere of nitrogen. The reaction mixture was placed under an atmosphere of hydrogen at 50 psi and agitated in a Parr shaker for 4 hours. The excess hydrogen was vented out and the mixture was sparged with nitrogen to remove residual hydrogen gas. The resulting suspension was filtered through a celite pad, and the filtrate was concentrated to dryness under reduced pressure producing crude mixture of epimers (1:1 dr). In order to isolate the more polar (S)-epimer the crude mixture was subjected to column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired tetralin derivative (9.6 g, 18.5 mmol, 34% yield) as a white foam.

Step g: To a solution of the TBS ether from the step f in THF (93 mL) TBAF (37.2 mL, 37.2 mmol, 1 M solution in THF) was added dropwise at ambient temperature. The resulting brown solution was stirred for 20 min before TLC analysis indicated complete conversion of the starting material. The mixture was diluted with EtOAc (200 mL) and sequentially washed with water (200 mL) and brine (150 mL). The organic extract was dried over Na2SO4, concentrated to dryness and the crude product was submitted to acylation reaction without purification.

The dry material obtained in the previous transformation was dissolved in dichloromethane (50 mL), then DMAP (0.7 g, 5.8 mmol) and Et3N (8.0 mL, 77.0 mmol) were added. The reaction mixture was cooled to 0° C. and acetic anhydride (7.3 mL, 77.0 mmol) was added dropwise over 1 min period. The cooling bath was removed, and the reaction was stirred at room temperature for 30 min. Once TLC and LCMS analysis indicated complete transformation the solution was diluted with dichloromethane (150 mL) and sequentially washed with water (200 mL), saturated aqueous NaHCO3 (100 mL) and brine (100 mL). The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired acetate ester (8.3 g, 18.5 mmol, 100% yield) as a white powder.

Step h: The acetate ester (8.3 g, 18.6 mmol) from step g, MnO2 (6.5 g, 75 mmol) and dichloromethane (93 mL) were loaded in 500 mL flask single-neck round-bottom flask equipped with a magnetic stirring bar and a reflux condenser. The mixture was cooled to 0° C. and tBuO2H (34 mL, 186 mmol, 5.5 M solution in decane) was added dropwise over 5 min. The reaction was stirred at 0° C. for 10 min, then it was allowed to warm to ambient temperature and stirred until gas formation ceased. The resulting black suspension was reflux for 24 h, then it was cooled to room temperature and additional amount of MnO2 (6.5 g, 75 mmol) and tBuO2H (34 mL, 186 mmol, 5.5 M solution in decane) were added sequentially. The mixture was refluxed for additional 48 h, cooled to room temperature. Inorganic solids were removed by filtration. The filtrate was passed through a plug of celite, washed with water (100 mL), dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce the corresponding α-tetralone (6.2 g, 13.5 mmol, 72% yield) as a white powder.

Step i: A solution of α-tetralone (1.5 g, 3.3 mmol) from step h in dichloromethane (33 mL) was placed in 100 mL single-neck round bottom flask equipped with magnetic stirring bar and drying tube. The mixture was charged with formic acid (0.37 mL, 9.8 mmol), Et3N (0.91 mL, 6.5 mmol) and RuCl(p-cymene)[(R,R)-Ts-DPEN) (62 mg, 0.1 mmol) at ambient temperature and stirred for 1 h. The resulting brown solution was diluted with dichloromethane (70 mL) and washed with aqueous saturated NaHCO3. The organic extract was dried over Na2SO4 and concentrated to dryness under reduced pressure. The crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the corresponding 1,2,3,4-tetrahydro-1-naphthol (1.43 g, 3.1 mmol, 95% yield, single epimer) as white powder.

Step j: A solution of Deoxo-Fluor (3.4 ml, 9.1 mmol, 2.7 M in toluene) in dichloromethane (52 mL) was placed in 100 ml single-neck round bottom flask equipped with a magnetic stirring bar and nitrogen inlet and cooled to −78° C., then TMS-morpholine (1.65 mL, 9.2 mmol) was added dropwise. The reaction was stirred at −78° C. for 5 min, then the mixture was allowed to warm to room temperature and stirred for 2 h. The resulting transparent solution was cooled to −78° C. and solid 1,2,3,4-tetrahydro-1-naphthol (1.2 g, 2.6 mmol) from step i was added in one portion. The cooling bath was removed, and the reaction was stirred 30 min at room temperature. Once TLC analysis indicated complete consumption of the starting material the mixture was diluted with DCM (50 mL) and quenched with aqueous saturated NaHCO3 (50 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The dry residue was dissolved in 1,2-dimethoxyethane (60 mL) and AgClO4 xH2O (0.20 g) was added. The mixture was heated at 70° C. for 1 h, concentrated to dryness and the crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) followed by trituration with 30 mL of MTBE and filtration to yield the desired α-fluorotetralin (1.1 g, 2.4 mmol, 92% yield, single epimer) as a white solid.

Step k: α-Fluorotetralin from step j (1.1 g, 2.4 mmol) was suspended in 7M NH3 solution in MeOH (90 mL) and the mixture was stirred at ambient temperature for 36 h. The resulting clear solution was concentrated to dryness under reduced pressure and the crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) followed by trituration with 30 mL of hexanes and filtration to yield the desired product (0.85 g, 2.0 mmol, 85% yield). 1H NMR (400 MHz, CDCl3) δ 7.69 (d, J=8.1 Hz, 1H), 7.51 (d, J=8.4, 1H), 7.39 (d, J=7.5 Hz, 1H), 6.43 (d, J=8.1 Hz, 1H), 5.69 (dt, J=13.5, 5.1 Hz, 1H), 5.65-5.33 (m, 2H), 4.67-4.60 (m, 1H), 3.58 (ddd, J=20.8, 16.8, 3.4 Hz, 1H), 3.44 (dd, J=5.7, 2.9 Hz, 1H), 3.28 (s, 3H), 3.28-3.10 (m, 1H), 2.56-2.38 (m, 1H), 2.24-2.04 (m, 1H), 2.02-1.79 (m, 1H), 1.76-1.65 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −110.92 (m), −157.06 (m), −199.18 (m). ESI MS [M+Na]+ for C21H18F3NO3SNa, calcd 444.1, found 444.0).

Example 135

[Figure (not displayed)]

Step a: A mixture of [(1S,2R)-4-[(1R)-8-cyano-6-fluoro-4-oxo-2,3-dihydro-1H-naphthalen-1-yl]-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (145 mg, 0.31 mmol) prepared by the protocol from the Example 134, 1,2-ethanedithiol (0.38 mL, 4.6 mmol) and p-toluenesulfonic acid monohydrate (12.0 mg, 0.06 mmol) in benzene (25 mL) was placed in a single-neck round bottom flask equipped with Dean-Stark apparatus and a reflux condenser with nitrogen inlet adapter. The reaction was refluxed for 16 h, cooled to ambient temperature and washed with 1 M NaOH (25 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness under reduced pressure. The crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the desired product (0.17 g, 0.31 mmol, 100% yield) as a colorless oil.

Step b: To a cooled to −78° C. suspension of N-iodosuccinimide (71.0 mg, 0.32 mmol) in dichloromethane (1 mL) HF Py (0.19 mL, 0.80 mmol) was added. The resulting dark suspension was stirred for 5 min before a solution of 1,3-dithiolane from step a (85 mg, 0.16 mmol) in dichloromethane (1 mL) was added dropwise over 1 min. The reaction mixture was stirred at −78° C. for 20 min followed by additional 20 min at 0° C. Once TLC analysis indicated complete conversion of 1,3-dithiolane the reaction was diluted with dichloromethane (15 mL) and washed with a mixture of aqueous saturated NaHCO3 and Na2S2O3 (1:1, v/v). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The crude material was fractionated by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the desired product (33.0 mg, 0.07 mmol, 43% yield) as a white solid.

Step c: 1,1-Difluorotetraline from step b (33.0 mg, 0.07 mmol) was dissolved in THF (1 mL) and a solution of LiOH H2O (8.5 mg, 0.2 mmol) in water (0.2 mL) was added at 0° C. The reaction was stirred at room temperature for 3 h and monitored by LCMS analysis. Once complete conversion was achieved the reaction was diluted with EtOAc (20 mL) and washed with 1M aqueous HCl (15 mL). The organic phase was separated, and the aqueous solution was additionally extracted with EtOAc (15 mL). The combined organic extract was washed with brine, dried over Na2SO4 and concentrated to dryness under reduced pressure. The crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the desired product (27.0 mg, 0.06 mmol, 90% yield) as a white solid. 1H NMR (400 MHz, CDCl3) δ 7.84-7.65 (m, 2H), 7.51-7.38 (m, 1H), 6.56 (d, J=8.3 Hz, 1H), 5.68 (dt, J=13.5, 5.0 Hz, 1H), 5.51-5.32 (m, 1H), 4.64 (br. s, 1H), 3.68-3.42 (m, 2H), 3.27 (s, 3H), 3.23-3.03 (m, 1H), 2.62-2.38 (m, 1H), 2.38-2.08 (m, 2H), 1.95-1.85 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −85.85 (d, J=5260.8 Hz), −109.12 (m), −199.20 (dtd, J=52.8, 22.4, 13.5 Hz). ESI MS [M+Na]+ for C21H17F4NNaO3S, calcd 462.1, found 462.0).

Example 136

[Figure (not displayed)]

Step a: To a suspension of 7-fluoro-2,3-dihydro-1H-inden-1-one (10.0 g, 66.6 mmol) and aluminum trichloride (22.2 g, 166.5 mmol, 2.5 equiv.) in 1,2-dichloroethane (190 ml, 0.35M) was added bromine (3.58 ml, 70 mmol, 1.05 equiv.) dropwise. The resulting solution was heated to 60° C. for three hours, after which the reaction was cooled to room temperature and poured onto ice. The reaction was extracted with MTBE, dried over magnesium sulfate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:1 solution of CH2Cl2:hexanes) to yield 4-bromo-7-fluoro-2,3-dihydro-1H-inden-1-one.

Step b: To a suspension of 4-bromo-7-fluoro-2,3-dihydro-1H-inden-1-one (17.0 g, 74.3 mmol) and Cs2CO3 (26.6 g, 81.7 mmol, 1.1 equiv.) in DMF (372 ml, 0.2M) was added benzyl mercaptan (9.24 g, 8.71 ml, 1.0 equiv.). The reaction was stirred at room temperature for 90 minutes. The desired product was precipitated from solution through the addition of 1.5 L of water and was dried under high vacuum overnight. The resulting crude product (23.1 g, 93% yield) was taken on without further purification.

Step c: The crude thioether from the step b (23.1 g, 69.2 mmol) was suspended in toluene (692 ml, 0.1M). Aluminum trichloride (10.2 g, 1.1 equiv.) was added at room temperature. An additional portion of aluminum trichloride (3.6 g, 27 mmol, 0.4 equiv.) was added after three hours. Upon completion, the reaction was quenched with water, extracted with ethyl acetate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the desired thiophenol as a yellow solid (13.4 g, 80% yield).

Step d: A solution of the thiophenol product from step c (6.7 g, 27.6 mmol) and methyl viologen dichloride hydrate (710 mg, 0.1 equiv.) in DMF (55 ml, 0.5M) was carefully degassed via three freeze-pump-thaw cycles under nitrogen. The resulting solution was cooled to −10 to −5° C. in a brine ice bath, and an excess of CF3I was sparged through the reaction mixture. The reaction was then stirred overnight under an atmosphere of CF3I. The reaction was carefully quenched at room temperature with water (off-gassing of residual CF3I occurs, use caution), extracted with ethyl acetate, and concentrated. The crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in hexanes) to yield the desired thioether (5.21 g, 61% yield).

Step e: To a solution of the product from step d (10.45 g, 33.6 mmol) in MeCN (129 ml, 0.26 M with respect to starting material), CCl4 (129 ml, 0.26 M with respect to starting material), and H2O (258 ml, 0.13M with respect to starting material) was added ruthenium trichloride (697 mg, 3.36 mmol, 0.1 equiv.) followed by sodium periodate (29.6 g, 138.4 mmol, 4.12 equiv.). The reaction was stirred at room temperature for one hour, and upon completion was extracted with CH2Cl2 (×2). The combined organics were washed with saturated Na2S2O3, washed with brine, and dried over sodium sulfate before concentrating. The crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the product sulfone as a white solid (10.53 g, 91% yield). ESI MS [M+H]+ for C10H6BrF3O3S; calc 342.9, found 342.9.

Step f: A solution of the product sulfone from Step e (3.5 g, 10.2 mmol) and Selectfluor (4.32 g, 12.2 mmol, 1.2 equiv.) in methanol (102 ml, 0.1M) was heated to 50° C. Sulfuric acid (27 μl, 5 mol %) was added, and the reaction was stirred at 50° C. for 48 hours. The solution was then diluted with diethyl ether, and the resulting white precipitate was filtered off and discarded. The organic solution was concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the product dimethyl acetal as a white solid (3.57 g, 87% yield).

Step g: A solution of the product acetal from Step f (3.18 g, 7.8 mmol) and wet Amberlyst 15 (4.77 g, 150 wt %) in dioxane (31 ml, 0.2 M) was heated to 90° C. overnight. Upon completion, the polymeric beads were removed by filtration, and the concentrated crude material was purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in a 1:3 solution of CH2Cl2 in hexanes) to yield the desired fluorinated ketone (2.33 g, 83% yield).

Step h: A solution of the indanone product of Step g (2.5 g, 6.93 mmol) in dichloromethane (28 ml, 0.25M) was sparged with nitrogen gas before the addition of formic acid (783 μL, 956 mg, 20.8 mmol, 3 equiv.) and triethylamine (1.94 ml, 1.41 g, 13.9 mmol, 2 equiv.) at 0° C. under nitrogen. RuCl(p-cymene)[(R,R)-Ts-DPEN] (44.5 mg, 0.07 mmol, 0.01 equiv.) was added, and the reaction was stirred for a minimum of 12 hours at 0 to 5° C. Upon full conversion, the reaction was quenched with saturated NaHCO3 and extracted with CH2Cl2. The combined organics were concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 20% ethyl acetate in a 1:1 solution of CH2Cl2:hexanes) to yield the desired indanol (2.0 g, 80% yield) as a single diastereomer. The enantiomeric excess of this material was found to be 98% by chiral HPLC (Chiralpak AD-H, 20% iPrOH/hexanes, isocratic, 20 minutes) as compared to a racemic sample, which was obtained through reduction of the 2-fluoroindanone with sodium borohydride.

Step i: To a solution of the chiral indanol from Step h (1.01 g, 2.75 mmol) in CH2Cl2 (11 ml, 0.25M) was added 2,6-lutidine (800 μL, 6.9 mmol, 2.5 equiv.) and TBSOTf (791 μL, 3.44 mmol, 1.25 equiv.) at 0° C. The reaction was allowed to warm to room temperature and was stirred overnight. Upon completion, the reaction was concentrated directly onto celite and purified by flash chromatography (silica gel, 0% to 10% ethyl acetate in hexanes) to yield the TBS ether (1.35 g, 100% yield).

Step j: The TBS ether product of Step i (674 mg, 1.41 mmol) was combined with B2Pin2 (457 mg, 1.8 mmol, 1.3 equiv.) Pd(dppf)Cl2 (103 mg, 0.14 mmol, 0.1 equiv.) and potassium acetate (213 mg, 3 mmol, 2.2 equiv.) in dioxane (14 ml, 0.1M), and the resulting solution was heated to 100° C. for three hours. The reaction solution was concentrated, and the crude material was purified by flash chromatography (silica gel, 0% to 30% ethyl acetate in hexanes) to yield the desired boronic pinacol ester (638 mg, 86% yield) as a colorless oil.

The protocols for the following steps were identical to the Example 134. 1H NMR (400 MHz, CDCl3) δ 7.75 (d, J=8.2 Hz, 1H), 7.52 (ddd, J=8.3, 2.8, 1.4 Hz, 1H), 7.40 (ddd, J=7.5, 2.7, 1.7 Hz, 1H), 6.60 (d, J=8.2 Hz, 1H), 5.73-5.50 (m, 2H), 5.46-5.23 (m, 1H), 4.74-4.60 (m, 1H), 3.79-3.51 (m, 1H), 3.36-3.20 (m, 1H), 3.02 (d, J=4.2 Hz, 1H), 2.61-2.43 (m, 1H), 2.22-2.09 (m, 1H), 1.97-1.86 (m, 1H), 1.81-1.73 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −77.43, −110.37 (d, J=1.6 Hz), −157.81 (d, J=45.0 Hz), −197.41-−202.71 (m). ESI MS [M+Na]+ for C21H15F6NNaO3S, calcd 498.1, found 498.0.

Example 138

[Figure (not displayed)]

Step a: A solution of Deoxo-Fluor (26.0 μl, 0.07 mmol, 2.7 M in toluene) in toluene (0.25 mL) was cooled to 0° C. under nitrogen, then TMS-morpholine (13.0 μL, 0.072 mmol) was added. The reaction was stirred at 0° C. for 5 min, then it was allowed to warm to room temperature and stirred for 2 h. The resulting solution was cooled back to 0° C. and a suspension of 1,2,3,4-tetrahydro-1-naphthol (8.0 mg, 0.02 mmol, prepared by analogy to Example 134) in dry toluene (0.5 mL) was added. The cooling bath was removed, and the reaction was stirred 30 min at room temperature. Once TLC analysis indicated complete consumption of the starting material the mixture was diluted with EtOAc (10 mL) and quenched with aqueous saturated NaHCO3 (3 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The dry residue was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) to yield the title compound (7.0 mg, 0.018 mmol, 87% yield, single epimer) as a white solid. 1H NMR (400 MHz, CDCl3) δ 7.74 (d, J=8.3 Hz, 1H), 7.58 (dd, J=8.5, 2.8 Hz, 1H), 7.37 (dd, J=7.6, 2.5 Hz, 1H), 6.68 (d, J=8.3 Hz, 1H), 5.62 (ddd, J=49.8, 8.4, 4.7 Hz, 1H), 4.89 (s, 1H), 2.51-2.31 (m, 1H), 2.34-2.07 (m, 2H), 2.03-1.86 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −63.03, −109.89, −169.86 (d, J=50.8 Hz). ESI MS [M+Na]+ for C19H10ClF5N2Na, calcd 419.0, found 419.0).

Example 139

[Figure (not displayed)]

Step a: A mixture of LDA (30 mL, 59.3 ml, 2 M solution in THF/heptane/ethylbenzene) and dry THF (240 mL) was placed under an atmosphere of nitrogen in 500 mL single-neck round bottom flask equipped with a magnetic stirring bar and nitrogen inlet adapter with rubber septum. The solution was cooled to −78° C. under nitrogen and 2,5-dibromo-3-fluoropyridine (12.1 g, 47.4 mmol) solution in dry THF (40 mL) was added via syringe dropwise over 20 min. The resulting mixture was stirred for 30 min and Mel (5 mL, 81 mmol) was added dropwise over 5 min at −78° C. Then cooling bath was removed and the reaction was allowed to warm to ambient temperature and stirred for 1 h followed by quench with aqueous saturated NH4Cl (200 mL). The mixture was transferred into separatory funnel, diluted with water (100 mL) and EtOAc (200 mL). The organic phase was separated, and the aqueous phase was additionally extracted with EtOAc (2×100 mL), Combined organic extracts were washed with brine, dried over Na2SO4, and the solvent was removed under reduced pressure. The crude material was purified by flash chromatography (silica gel, 0% to 30% ethyl acetate in hexanes) to yield 2,5-dibromo-3-fluoro-4-methyl-pyridine (12.0 g, 44.6 mmol, 94% yield) as a colorless crystallizing oil.

Step b: A solution of 2,5-dibromo-3-fluoro-4-methyl-pyridine (6.0 g, 22.3 mmol) in toluene (110 mL) was placed in 250 mL single-necked round bottom flask equipped with magnetic stirring bar and nitrogen inlet adapter with rubber septum. This solution was cooled to −78° C. and nBuLi (9.8 mL, 24.5 mmol) was added dropwise via syringe over 10 min. The resulting heterogenous solution was stirred at −78° C. for 20 min before N,N-dimethylacetamide (3.2 mL) was added dropwise over 1 min. The reaction mixture was stirred for 30 min and quenched with aqueous saturated NH4Cl (50 mL) at −78° C. The resulting biphasic mixture was diluted with water (50 mL) and EtOAc (100 mL). The organic phase was separated, and the aqueous phase was additionally extracted with EtOAc (2×100 mL). The combined organic extract was washed with brine, dried over Na2SO4, and the solvent was removed under reduced pressure. The crude material was purified by flash chromatography (silica gel, 0% to 40% ethyl acetate in hexanes) to yield corresponding 2-acetylpyridine (2.8 g, 12.1 mmol, 54% yield) as a colorless crystallizing oil.

Step c: A mixture of 2-acetylpyridine from step b (2.8 g, 12.0 mmol) and deoxo-fluor (6.7 mL, 36 mmol) in toluene (60 mL) was placed in 250 mL single-neck round bottom flask equipped with stirring bar and reflux condenser with drying tube. The mixture was maintained at 70° C. for 24 h. Despite incomplete conversion the biphasic reaction was cooled to ambient temperature and poured in aqueous saturated NaHCO3 (200 mL) under vigorous stirring. Then the mixture was diluted with EtOAc (200 mL) and filtered through a pad of celite. The organic phase was separated, and the aqueous phase was additionally extracted with EtOAc (2×70 mL). Combined organic extracts were washed with brine, dried over Na2SO4 and concentrated to dryness. The crude material was fractionated by flash chromatography (silica gel, 0% to 30% ethyl acetate in hexanes) to yield 5-bromo-2-(1,1-difluoroethyl)-3-fluoro-4-methylpyridine (1.9 g, 7.5 mmol, 63% yield) as a yellowish liquid.

The protocols for the following steps were identical to the Example 134. The title compounds characterization data: 1H NMR (400 MHz, CDCl3) δ 7.53-7.42 (m, 1H), 7.42-7.32 (m, 1H), 7.22 (s, 1H), 5.56 (dt, J=49.9, 3.3 Hz, 1H), 4.69 (br. s, 1H), 2.64-2.36 (m, 4H), 2.27-2.09 (m, 1H), 2.08-1.85 (m, 4H), 1.83-1.67 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −89.77 (m), −110.97 (m), −125.45, −156.81 (m). ESI MS [M+H]+ for C19H16F5N2, calcd 367.1, found 367.2).

Example 140

[Figure (not displayed)]

Step a: To an ice-cold solution of (1S,2R)-4-bromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-ol (11.5 g, 37.3 mmol) in dichloromethane (190 ml, 0.2M) was added DMAP (1.4 g, 11.2 mmol) and triethylamine (10.4 ml, 75 mmol, 2 equiv.) followed by the dropwise addition of acetic anhydride (7.1 ml, 75 mmol, 2 equiv.). The solution was allowed to warm to room temperature and was stirred for one hour. Upon completion the reaction was quenched with saturated aq. NaHCO3, the resulting solution was extracted with dichloromethane (2×), dried over Na2SO4, and concentrated onto celite. The crude material was purified by flash chromatography on silica gel (0-10% ethyl acetate in hexanes) to yield [(1S,2R)-4-bromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (13.1 g, 100% yield). ESI MS [M+H]+ for Cl2H12BrFO4S, calcd. 351.0, found 351.0.

Step b: A solution of dichloroethane (0.2M, 190 ml) containing [(1S,2R)-4-bromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (13.5 g, 38.5 mmol), 2,2′-Azobis(2-methylpropionitrile) (40 mg, 1 mol %), and N-bromosuccinimide (7.54 g, 1.1 equiv) was heated to reflux for 90 minutes. Upon completion, the reaction was cooled and partitioned between ethyl acetate and saturated NaHCO3. The organics were collected, washed with dilute Na2S2O3, dried over Na2SO4, and concentrated onto celite. The crude material was purified by flash chromatography on silica gel (5% ethyl acetate in a 1:3 ratio of CH2Cl2:hexanes) to provide two brominated diastereomers, [(1S,2S,3R)-3,4-dibromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (6.83 g, 41% yield) and [(1S,2S,3S)-3,4-dibromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (2.5 g, 15% yield). The diastereomeric products elute in the order listed.

Step c: To a solution of [(1S,2S,3R)-3,4-dibromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-yl] acetate (6.73 g, 15.6 mmol) in THF (0.08M, 195 ml) at 0° C. was added a 0.5 M aqueous solution of LiOH (5.93 ml, 1.5 equiv.) and the reaction was allowed to stir at 0° C. for three hours, at which time the reaction was quenched at 0° C. with 1N HCl. The resulting solution was extracted three times with methylene chloride, the organics were dried over Na2SO4, and flashed 0 to 20% ethyl acetate in [1:1 hexanes:dichloromethane] to yield (1S,2S,3S)-3,4-dibromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-ol (3.68 g, 61% yield).

Step d: Sodium hydride (60% dispersion in mineral oil, 440 mg, 10.5 mmol, 1.1 equiv.) was added slowly at 0° C. to a solution of (1S,2S,3S)-3,4-dibromo-2-fluoro-7-methylsulfonyl-2,3-dihydro-1H-inden-1-ol (3.68 g, 9.5 mmol) and benzyl bromide (6.77 ml, 9.75 g, 57 mmol, 6 equiv.) in THF (38 ml, 0.25M with respect to indanol) and DMF (9.5 ml, 1M with respect to indanol). The reaction was allowed to warm to room temperature and was stirred overnight. The next day, 3 additional equivalents of BnBr and 0.55 equivalents of NaH were added, and the reaction went to completion within two hours. The solution was quenched with 1N HCl, extracted with ethyl acetate, dried over Na2SO4, and concentrated. The crude material was purified by flash chromatography on silica gel, 0 to 20% ethyl acetate in hexanes, to yield (1S,2S,3S)-1,7-dibromo-2-fluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-indene as a white foam (2.46 g, 54% yield).

Step e: To a solution of (1S,2S,3S)-1,7-dibromo-2-fluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-indene (2.46 g, 5.1 mmol) in sulfolane (28.4 ml) and water (5.6 ml) was added silver perchlorate hydrate (unknown hydrate stoichiometry) (2.13 g, −10.3 mmol), and the reaction was heated to 75° C. overnight with the exclusion of light. After 23 hours, the starting material was almost fully consumed, and the reaction was quenched with H2O. Upon dilution with MTBE silver salts can be filtered out of the biphasic mixture, and the organics were collected and dried over sodium sulfate. Purification by flash chromatography (0 to 5% to 50% ethyl acetate in dichloromethane) yielded the diastereomeric alcohol products (1R,2R,3S)-7-bromo-2-fluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-inden-1-ol (750 mg, 35% yield) and (1S,2R,3S)-7-bromo-2-fluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-inden-1-ol (470 mg, 22% yield). The diastereomeric products elute in the order listed, and the latter was taken on through further steps. ESI MS [M+Na]+ for C17H16BrFO4S, calcd. 437.0, found 437.0.

Step f: To an ice-cold solution of (1S,2R,3S)-7-bromo-2-fluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-inden-1-ol (386 mg, 0.93 mmol) in dichloromethane (0.1M, 9.3 ml) was added (diethylamino)sulfur trifluoride (492 μl, 600 mg, 3.7 mmol, 4 equiv.), and the resulting solution was stirred at temperatures between 0 and 10° C. for three hours, at which time it was quenched with saturated NaHCO3. The organics were extracted with ethyl acetate, dried over Na2SO4, and purified by flash chromatography on silica gel (10% ethyl acetate in hexanes, isocratic) to yield two fluorinated products: (1S,2S,3S)-7-bromo-1,2-difluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-indene (undesired, less polar, 158 mg, 40% yield) and (1R,2S,3S)-7-bromo-1,2-difluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-indene (desired, more polar, 234 mg, 60% yield).

Step g: (1R,2S,3S)-7-bromo-1,2-difluoro-4-methylsulfonyl-3-phenylmethoxy-2,3-dihydro-1H-indene (234 mg, 0.56 mmol), B2Pin2 (185 mg, 0.73 mmol, 1.3 equiv.), KOAc (121 mg, 1.23 mmol, 2.2 equiv.) and PdCl2(dppf) (44 mg, 0.06 mmol, 10 mol %) were combined in dioxane (5.6 ml, 0.1M). The resulting solution was sparged with nitrogen and heated to 100° C. until all starting material was consumed (2.5 h). The crude reaction mixture was filtered over celite, concentrated, taken up in ethyl acetate, and washed with water to remove remaining KOAc. The resulting solid was taken on to the Suzuki cross-coupling step without further purification.

The title compound was completed in a similar fashion to Example 134. 1H NMR (400 MHz, CDCl3): δ 7.96 (dd, J=8.1, 2.0 Hz, 1H), 7.23-7.17 (m, 2H), 6.86 (d, J=8.1 Hz, 1H), 5.91-5.75 (m, overlap, 2H), 5.20-5.02 (m, 1H), 4.95-4.91 (m, 1H), 3.02-2.84 (m, 3H), 2.28-2.19 (m, 1H), 1.93-1.85 (m, 1H), 1.79-1.58 (m, 2H).

Example 141

[Figure (not displayed)]

Step a: Performed in similar fashion to step a of Example 134.

Step b: To a solution of the product from step a (10 g, 38 mmol, 1 equiv.) in CH2Cl2 (190 mL, 0.2 M) at 0° C. was added Et3N (32 mL, 228 mmol, 6 equiv.) followed by TBSOTf (17.5 mL, 76 mmol, 2 equiv). The reaction was left to warm to room temperature overnight. The reaction mixture was concentrated then dried under vacuum for 45 minutes. The crude silyl enol ether was dissolved in MeCN (190 mL, 0.2 M), then Selectfluor (20.2 g, 57 mmol, 1.5 equiv.) was added and the reaction was stirred at room temperature for 2 hours or until judged complete by TLC. The reaction mixture was diluted with EtOAc, washed with 0.2 M aqueous HCl, followed by brine. The organic layer was dried with MgSO4 and concentrated. The crude product was purified by flash column chromatography (SiO2, 0 to 50% EtOAc/hexanes) to yield the difluoroketone as a light-yellow solid (7.0 g, 24.9 mmol, 66%). 1H NMR (400 MHz, Chloroform-d) δ 7.79 (d, J=8.4 Hz, 1H), 7.36 (dt, J=8.4, 0.9 Hz, 1H), 3.48 (td, J=12.6, 0.8 Hz, 2H).

Step c: Performed in similar fashion to step b of Example 134. 1H NMR (400 MHz, Chloroform-d) δ 7.45 (d, J=8.5 Hz, 1H), 7.19 (d, J=8.5 Hz, 1H), 5.22 (d, J=12.4 Hz, 1H), 3.61-3.33 (m, 2H), 1.11 (t, J=7.1 Hz, 2H).

Step d: Performed in similar fashion to step c of Example 134. ESI MS [M+H]+ for C15H20BrClF2OSi calcd. 397.0, found 397.0.

Step e: Performed in similar fashion to step d of Example 134. The crude product was used in step f without column chromatographic purification.

Step f: Performed in similar fashion to step e of Example 134. ESI MS [M+H]+ for C26H27ClF3NOSi calcd. 490.2, found 490.2.

Step g: Performed in similar fashion to step f of Example 134 with 5 equivalents of Et3N added to the reaction mixture. Diastereomers were not separated at this stage. ESI MS [M+H]+ for C26H29ClF3NOSi calcd. 492.2, found 492.2.

Step h: Aryl chloride (100 mg, 0.20 mmol, 1 equiv.), K4Fe(CN)6 3H2O (59 mg, 0.14 mmol, 0.7 equiv.), XPhos Pd G3 (17 mg, 0.02 mmol, 0.1 equiv.), XPhos (10 mg, 0.02 mmol, 0.1 equiv.), and KOAc (4 mg, 0.04 mmol, 0.2 equiv.) were dissolved in 1:1 water/dioxane (2 mL, 0.1 M). The reaction mixture was sparged with nitrogen for 10 minutes and then heated to 100° C. After 2 hours, the reaction was judged complete by LCMS. The reaction mixture was let to cool to room temperature and then partitioned between EtOAc and water. The layers were separated and the aqueous was extracted three times with EtOAc. The combined organics were dried over Na2SO4 and concentrated. The crude product was purified by flash column chromatography (SiO2, 0 to 50% EtOAc/hexanes) to afford the aryl nitrile product. ESI MS [M+H]+ for C27H29F3N2OSi calcd. 483.2, found 483.2.

Step i: The product from step h was treated with an excess of HF-pyridine in acetonitrile. After stirring overnight the mixture was quenched with saturated NaHCO3 and extracted with EtOAc. The product was purified by flash column chromatography. The final product was isolated as a 1:1 mixture of diastereomers (40 mg, 0.11 mmol. 54% over two steps). ESI MS [M]+ for C21H15F3N2O calcd. 369.1, found 369.1. 1H NMR (400 MHz, Chloroform-d) δ 7.47 (dd, J=8.0, 2.9 Hz, 1H), 7.18 (d, J=8.6 Hz, 2H), 6.60 (dd, J=14.3, 8.0 Hz, 1H), 5.33 (m, 1H), 4.45 (dt, J=9.0, 4.1 Hz, 1H), 3.88-3.27 (m, 2H), 3.10-2.80 (m, 3H), 2.23-2.08 (m, 1H), 1.89-1.70 (m, 2H).

Example 143

[Figure (not displayed)]

Step a: From 8-[(1S)-1-[tert-butyl(dimethyl)silyl]oxy-7-chloro-2,2-difluoro-1,3-dihydroinden-4-yl]-3-fluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile, followed the same procedure described in Example 134 to prepare compound 8-[(1S)-1-[tert-butyl(dimethyl)silyl]oxy-7-chloro-2,2-difluoro-1,3-dihydroinden-4-yl]-3-fluoro-5-oxo-7,8-dihydro-6H-naphthalene-1-carbonitrile. 1H NMR (400 MHz, Chloroform-d) δ 8.04 (dddd, J=8.4, 2.9, 1.6, 0.5 Hz, 1H), 7.53 (dt, J=7.3, 2.9 Hz, 1H), 7.09 (d, J=8.3 Hz, 1H), 6.35 (dd, J=13.2, 8.3 Hz, 1H), 5.29-5.01 (m, 1H), 4.62 (m, 1H), 3.80-3.33 (m, 2H), 2.80-2.30 (m, 2H), 2.20-2.10 (m, 1H), 1.60-1.50 (m, 1H), 1.00-0.72 (m, 9H), 0.36-0.11 (m, 6H).

Step b: A vial was charged with 8-[(1S)-1-[tert-butyl(dimethyl)silyl]oxy-7-chloro-2,2-difluoro-1,3-dihydroinden-4-yl]-3-fluoro-5-oxo-7,8-dihydro-6H-naphthalene-1-carbonitrile from step a (30 mg, 0.06 mmol, 1.0 equiv.) and mixture solvent (MeOH 0.2 ml, THF 0.3 ml). The reaction mixture was cooled to 0° C. and NaBH4 (2.2 mg, 0.06 mmol, 1.0 equiv.) was added. The reaction mixture was stirred at 0° C. for 30 min. Once complete, purification by flash chromatography (SiO2, hexane to 30% EtOAc) furnished the (5R)-8-[(1S)-1-[tert-butyl(dimethyl)silyl]oxy-7-chloro-2,2-difluoro-1,3-dihydroinden-4-yl]-3-fluoro-5-hydroxy-5,6,7,8-tetrahydronaphthalene-1-carbonitrile. (18 mg, 0.035 mmol, 59%). ESI MS [M+H]+ for C26H29ClF3NO2Si, calcd 509.1, found 525.1.

Step c: To a vial containing the product from step b (18 mg, 0.035 mmol, 1.0 equiv.) was added 0.4 ml DCM. The reaction was cooled at −40° C. and DAST (11 mg, 0.071 mmol, 2.0 equiv.) was added. The reaction mixture was stirred at −40° C. for 30 min. Once complete, purification by flash chromatography (SiO2, hexane to 10% EtOAc gradient) to yield the (5S)-8-[(1S)-1-[tert-butyl(dimethyl)silyl]oxy-7-chloro-2,2-difluoro-1,3-dihydroinden-4-yl]-3,5-difluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (12 mg, 0.024 mmol, 67%). ESI MS [M+H]+ for C26H28ClF4NOSi, calcd 511.0, found 527.0.

Step d: To a vial containing the product from step c (12 mg, 0.024 mmol, 1.0 equiv.) was added 1-Methyl-1H-pyrazole-5-boronic acid pinacol ester (6.4 mg, 0.031 mmol, 1.3 equiv.), Pd-Sphos-G2 (1.7 mg, 0.0024 mmol, 0.1 equiv.). The vial was evacuated and back-filled with N2 (×3). 1M aq. Na2CO3 solution (0.1 ml, 0.096 mmol, 4.0 equiv.) and Dioxane (0.25 mL) were added. The reaction was heated at 100° C. and stirred for overnight. Once complete, purification by flash chromatography (SiO2, hexane to 30% EtOAc gradient) to yield (5S)-8-[(1S)-1-[tert-butyl(dimethyl)silyl]oxy-2,2-difluoro-7-(2-methylpyrazol-3-yl)-1,3-dihydroinden-4-yl]-3,5-difluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (13 mg, 0.023 mmol, 97%). ESI MS [M+H]+ for C30H33F4N3OSi, calcd 556.7, found 556.2.

Step e: A solution of the product from step d (13 mg, 0.023 mmol) in CH3CN (0.4 mL) was placed in a 3 mL vial equipped with a magnetic stirrer, then HF.Py complex (hydrogen fluoride ˜70%, pyridine ˜30%, 0.2 mL) was added. The resulting colorless solution was stirred for 1 hr at ambient temperature. Once complete, purification by HPLC to yield (5S,8R)-8-[(1S)-2,2-difluoro-1-hydroxy-7-(2-methylpyrazol-3-yl)-1,3-dihydroinden-4-yl]-3,5-difluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (2.2 mg, 0.005 mmol, 22%). 1H NMR (400 MHz, Methanol-d4) δ 7.69-7.57 (m, 2H), 7.54 (d, J=2.0 Hz, 1H), 7.16 (d, J=8.0 Hz, 1H), 6.55-6.46 (m, 2H), 5.73-5.60 (m, 2H), 4.84-4.80 (m, 1H), 4.68-4.61 (m, 1H), 3.84-3.67 (m, 1H), 3.47 (td, J=16.6, 4.7 Hz, 1H), 2.52-2.40 (m, 1H), 2.16-1.95 (m, 2H), 1.84-1.73 (m, 1H). ESI MS [M+H]+ for C30H33F4N3OSi, calcd 442.4, found 442.0.

Example 144

[Figure (not displayed)]

Step a: Into a 50-L reactor purged and maintained with an inert atmosphere of nitrogen, was placed 3,5-difluorobenzaldehyde (1500.00 g, 10555.57 mmol, 1.00 equiv), tetrahydrofuran (15 L), (2-carboxyethyl)triphenylphosphanium bromide (5260.06 g, 12666.69 mmol, 1.20 equiv). This was followed by the addition of a solution of tert-butoxypotassium (2961.18 g, 26388.93 mmol, 2.50 equiv) in THF (15 L) dropwise with stirring at 0° C. in 2 h. The resulting solution was stirred for 1 overnight at room temperature. The reaction was repeated 1 time. The reaction was then quenched by the addition of 20 L of water. The resulting mixture was concentrated under vacuum. The resulting solution was extracted with 2×8 L of ethyl acetate and the aqueous layers combined. HCl (3 mol/L) was employed to adjust the pH to 4-5. The resulting solution was extracted with 3×6 L of ethyl acetate and the organic layers combined and dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1:10-1:5). This resulted in 2500 g (59.76%) of (3E)-4-(3,5-difluorophenyl)but-3-enoic acid as a white solid.

Step b: Into a 20-L High-Pressure autoclave was placed (3E)-4-(3,5-difluorophenyl)but-3-enoic acid (2500.00 g, 12615.49 mmol, 1.00 equiv), EA (12.5 L), 10% Pd/C (125 g). The reaction was then purged with nitrogen and pressurized with hydrogen gas to 150 psi, The mixture was stirred 4 h at room temperature. The solids were filtered out. Rinsed with EA (2.5 L), The resulting mixture was concentrated under vacuum. This resulted in 2318 g (91.79%) of 4-(3,5-difluorophenyl)butanoic acid as colorless oil.

Step c: Into a 20-L 4-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen, was placed sulfuric acid (6.6 L), 4-(3,5-difluorophenyl)butanoic acid (2318.00 g, 11579.28 mmol, 1.00 equiv). The resulting solution was stirred for 4 h at 40-45° C. The reaction mixture was cooled to 0° C. with a water/ice bath. The reaction mixture was transferred onto 30 L of water/ice. The resulting solution was extracted with 3×8 L of MTBE and the organic layers combined. The resulting mixture was washed with 1×5 L of H2O and 1×5 L of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The crude product was re-crystallized from MTBE:hexane (5V) in the ratio of 1:3. This resulted in 1600 g (75.85%) of 6,8-difluoro-3,4-dihydro-2H-naphthalen-1-one as a off-white solid. 500.4000 g was submitted to QC and other was used to TG2. LCMS-PH-ACS-002-TG1-0: (ES, m/z): [M+H]+=183. 1H-NMR-PH-ACS-002-TG1-0: (300 MHz, DMSO-d6, ppm) δ 7.24-7.07 (m, 2H), 2.97 (t, J=6.1 Hz, 2H), 2.57 (dd, J=7.2, 5.8 Hz, 2H), 2.07-1.93 (m, 2H).

Step d: Into a 50-L reactor purged and maintained with an inert atmosphere of nitrogen, was placed dioxane (13.50 L), trimethyl(sodiooxy)silane (1661.00 g, 14806.69 mmol, 3.00 equiv). This was followed by the addition of a solution of 6,8-difluoro-3,4-dihydro-2H-naphthalen-1-one (900.00 g, 4940.440 mmol, 1.00 equiv) in dioxane (4.5 L) dropwise with stirring at 80-90° C. in 2 h. The resulting solution was stirred for 1 h at 80-90° C. The reaction mixture was cooled to 20° C. with a water/ice bath. The reaction was then quenched by the addition of 10 L of HCl (1 mol/L). The resulting solution was extracted with 1×6 L of ethyl acetate. The organic layer was washed with 1×8 L of H2O and 1×8 L of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1:20-1:10). This resulted in 720 g (80.88%) of 6-fluoro-8-hydroxy-3,4-dihydro-2H-naphthalen-1-one as a yellow solid.

Step e: Into a 20-L reactor purged and maintained with an inert atmosphere of nitrogen, was placed 6-fluoro-8-hydroxy-3,4-dihydro-2H-naphthalen-1-one (720.00 g, 3996.04 mmol, 1.00 equiv), DCM (10.00 L), TEA (1010.00 g, 9981.22 mmol, 2.50 equiv), LiCl (185.00 g, 4363.82 mmol, 1.09 equiv). The reactor was cooled to 0° C. This was followed by the addition of Tf2O (1128.00 g, 3998.02 mmol, 1.00 equiv) dropwise with stirring at 0° C. in 1.5 hrs. The resulting solution was stirred for 3 h at room temperature. The reaction was then quenched by the addition of 10 L of water. The resulting solution was extracted with 2×5 L of dichloromethane and the organic layers combined. The resulting mixture was washed with 1×5 L of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1:10). This resulted in 1025 g (82.15%) of 3-fluoro-8-oxo-6,7-dihydro-5H-naphthalen-1-yl trifluoromethanesulfonate as a brown solid.

Step f: Into a 20-L 4-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen, was placed 3-fluoro-8-oxo-6,7-dihydro-5H-naphthalen-1-yl trifluoromethanesulfonate (1025.00 g, 3282.83 mmol, 1.00 equiv), DMF (10.00 L), Zn(CN)2 (304.00 g, 2588.46 mmol, 0.79 equiv), Pd(PPh3)4 (150.00 g, 129.80 mmol, 0.04 equiv). The resulting solution was stirred for 4 h at 100° C. The reaction mixture was cooled with a water/ice bath. The reaction was then quenched by the addition of 30 L of water/ice. The resulting solution was extracted with 3×8 L of ethyl acetate and the organic layers combined. The resulting mixture was washed with 2×8 L of H2O and 1×8 L of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with dichloromethane/petroleum ether (1:2-1:1). This resulted in 501.4000 g (80.83%) of 3-fluoro-8-oxo-6,7-dihydro-5H-naphthalene-1-carbonitrile as a yellow solid. LC-MS: (ES, m/z): [M+H]+=190. 1H-NMR (300 MHz, CDCl3) δ 7.40 (dd, J=8.0, 2.6 Hz, 1H), 7.23 (ddd, J=8.4, 2.2, 1.2 Hz, 1H), 3.04 (t, J=6.1 Hz, 2H), 2.74 (dd, J=7.3, 5.9 Hz, 2H), 2.19 (p, J=6.5 Hz, 2H).

Step g: To a mixture of the product from step f (25 g, 132 mmol) and ethylene glycol (5 eq.) and benzene (330 mL) was added pTsOH.H2O (2.51 g, 13.2 mmol, 0.1 equiv). The reaction mixture was refluxed overnight with Dean Stark apparatus and quenched with saturated NaHCO3. The mixture was extracted with EtOAc, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 5-15% gradient to afford the acetal as a yellow solid (31.9 g, 100%).

Step h: To a stirred solution of the product from step g (6.0 g, 25.7 mmol) in acetone (68 mL) and water (17 mL), MgSO4 (6.50 g, 54.0 mmol, 2.1 equiv) was added in one portion. A reflux condenser was fitted to the reaction vessel and KMnO4 (21.1 g, 133.6 mmol, 5.2 equiv) was added in portions over the course of 20 minutes (probably use ice bath for higher scale) and the resulting strongly purple reaction mixture was stirred at 45° C. for 20 h. The reaction mixture was quenched with saturated Na2S2O3 and water. The mixture was extracted with EtOAc, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 10-40% gradient to afford the ketone as a yellow solid (3.24 g, 51%).

Step i: To a mixture of the product from step h (3.80 g, 15.4 mmol) and DCM (77 mL) was added formic acid (1.7 mL, 46.2 mmol, 3 equiv) and Et3N (4.2 mL, 30.8 mmol, 2 equiv). The reaction mixture was cooled to 0° C. and catalyst (293 mg, 0.46 mmol, 0.03 equiv) was added. After stirring overnight at 4° C. (fridge) the reaction was quenched with saturated NaHCO3. The mixture was extracted with DCM, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 20-50% gradient to afford the alcohol as a yellow solid (3.74 g, 98%).

Step j: To a mixture of the product from step i (3.72 g, 14.9 mmol) and acetone (149 mL) was added I2 (379 mg, 1.49 mmol, 0.1 equiv). The reaction mixture was stirred at rt for 30 minutes and quenched with Na2S2O3 in water. The mixture was extracted with EtOAc, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 20-50% gradient to afford the ketone as a yellow solid (2.72 g, 89%).

Step k: To a mixture of the product from step j (2.72 g, 13.3 mmol) and DCM (89 mL) was added Et3N (2.7 mL, 20.0 mmol, 1.5 equiv) at 0° C. followed by TBSOTf (3.7 mL, 15.9 mmol, 1.2 equiv) and the mixture was stirred at 0° C. for 1 h. The reaction mixture was washed with NaHCO3 sat., extracted with DCM, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 0-20% gradient to afford the protected alcohol as a yellow solid (3.79 g, 89%).

Step l: To a mixture of product from step k (2.51 g, 7.86 mmol) and THF (52 mL) was added ArNTf2 (9.2 g, 23.6 mmol, 3 equiv). The reaction mixture was cooled to −78° C. and LiHMDS (1M in THF, 11.8 mL, 11.8 mmol, 1.5 equiv) was added and the mixture was stirred 20 minutes at −78° C. As the conversion was incomplete LiHMDS (3.9 mL, 3.9 mmol, 0.5 equiv) was added and the reaction was stirred for another 20 minutes. The mixture was quenched with NaHCO3 sat., extracted with THF, dried over Na2SO4, and concentrated. The crude material was purified by column chromatography (hexanes/EtOAc), 0-10% gradient to afford the triflate as a white solid (2.14 g, 60%).

[Figure (not displayed)]

Step m: To a solution of 4-bromo-7-chloro-1-indanone (40.0 g, 163 mmol, 1.0 equiv.) in MeOH (800 mL) was added Selectfluor (63.5 g, 179 mmol, 1.1 equiv.) and concentrated H2SO4 (1.0 mL). The resulting mixture was heated at reflux for 3 h. After cooling to room temperature, 0.3 M H2SO4 (aq., 200 mL) was added to the reaction mixture. The resulting mixture was heated at reflux for another 1 h. After cooling to room temperature, large amount of the product was precipitated out and collected via filtration. The filtrate was concentrated and diluted with DCM (500 mL) and washed with H2O and brine. The organic phase was dried over Na2SO4 and concentrated. Combining the previous filtering cake, 40.4 g (153 mmol, 94% yield) of the desired product was obtained as pale brown solid.

Step n: To a solution of the product from step m (40.4 g, 153 mmol, 1.0 equiv.) and Et3N (92.9 g, 128 mL, 918 mmol, 6.0 equiv.) in DCM (380 mL) was added TBSOTf (80.9 g, 70.3 mL, 306 mmol, 2.0 equiv.) dropwise at 0° C. The resulting solution was stirred at 0° C. for 1.5 h, and then quenched with saturated NaHCO3 (aq.) and kept stirring for 1 h. The resulting mixture was then separated, and the aqueous phase was extracted with DCM (3×150 mL). The combined organic phase was then washed with brine, dried over Na2SO4 and concentrated to afford the crude silyl enol ether. The crude product was then dissolved in MeCN (750 mL). Selectfluor (81.3 g, 230 mmol, 1.5 equiv.) was added portion-wise at room temperature. The resulting mixture was stirred at room temperature for 30 min and then filtered to remove the precipitated salts. The filtrate was concentrated and diluted with DCM (500 mL) and H2O (500 mL). The aqueous phase was extracted with DCM (2×200 mL). The combined organic phase was then washed with brine, dried over Na2SO4 and concentrated to afford crude solid. Trituration with hexanes (3×150 mL) and drying under vacuum afforded 42.4 g (151 mmol, 99% yield) of desired product that was obtained as light yellow powdery solid.

Step o: HCO2H (34.8 g, 28 mL, 755 mmol, 5.0 equiv.) was added to a solution of Et3N (45.8 g, 63 mL, 453 mmol, 3.0 equiv.) in DCM (100 mL) dropwise. The resulting solution was stirred at room temperature for 30 min, and then added to a solution of the product from step n (42.4 g, 151 mmol, 1.0 equiv.) and RuCl(p-cymene)[(R,R)-TsDPEN] (1.92 g, 3.02 mmol, 2.0 mol %) in DCM (400 mL) at 0° C. The resulting mixture was kept stirring at this temperature for 1.5 h and then concentrated. The crude product was directly used in the next step.

Step p: Chloromethyl methyl ether (32.6 g, 34 mL, 454 mmol, 3.0 equiv.) was added dropwise to a solution of the crude product from step o (151 mmol) and diisopropylethylamine (58.7 g, 79 mL, 454 mmol, 3.0 equiv.) in DCM (300 mL). The resulting solution was then heated at reflux overnight, cooled to room temperature and then directly concentrated on Celite and purified by flash chromatography (SiO2, 10 to 20% EtOAc/Hex) to afford the protected indanol product (31.4 g, 95.9 mmol, 64% yield over 2 steps) and recovered free indanol (97% ee, 6.2 g, 21.9 mmol, 14% yield).

Step q: A 250-mL flask was charged with the product from step p (15.0 g, 45.8 mmol, 1.0 equiv.), B2Pin2 (12.2 g, 48.1 mmol, 1.05 equiv.), Pd(dppf)Cl2 (3.35 g, 4.58 mmol, 10 mol %), KOAc (8.99 g, 91.6 mmol, 2.0 equiv.) and 1,4-dioxane (120 mL). The reaction mixture was degassed with N2 bubbling for 10 min before being heated. After stirring at 100° C. overnight, the reaction mixture was cooled, concentrated on Celite and purified by flash chromatography (SiO2, 0 to 15% EtOAc/Hex) to afford the product (14.2 g, 37.9 mmol, 83% yield) as pale-yellow liquid.

Step r: A 500-mL flask was charged with the product from i (22.8 g, 50.4 mmol, 1.0 equiv.), the product from step q (20.8 g, 55.4 mmol, 1.1 equiv.), Pd(dppf)Cl2 (3.66 g, 5.04 mmol, 10 mol %), Na2CO3 (10.6 g, 100 mmol, 2.0 equiv.), 1,4-dioxane (200 mL) and H2O (50 mL). The reaction mixture was degassed with N2 bubbling for 10 min before being heated to 80° C. and stirred overnight. The reaction mixture was cooled, concentrated onto Celite and purified by flash chromatography (SiO2, 0 to 15% EtOAc/Hex) to afford the desired product (19.3 g, 35.1 mmol, 70% yield).

Step s: A mixture of the product from step r (8.20 g, 14.9 mmol, 1.0 equiv.), Pd/C (10 wt % Pd, 1.58 g, 10 mol %) in MeOH (75 mL) was shaken in parr hydrogenator under H2 (50 psi) for 2 h. After this time LCMS showed no remaining starting material. The reaction mixture was then filtered through Celite and concentrated to afford the product (7.25 g, 13.1 mmol, 88% yield).

Step t: To a solution of the product from step s (7.25 g, 13.1 mmol, 1.0 equiv.) in THF (65 mL) was added TBAF (1M in THF, 14 mL, 1.1 equiv.) at 0° C. The resulting solution was stirred at 0° C. for 15 min, and then quenched by saturated NH4Cl (aq.). The aqueous phase was extracted with EtOAc×2. The combined organic layer was then washed with brine, dried over Na2SO4, concentrated and purified by flash chromatography (SiO2, 10 to 15% EtOAc/Hex) to afford the product (3.78 g, 8.6 mmol, 66% yield).

Step u: To a solution of 4-(trimethylsilyl)morpholine (6.28 g, 39.4 mmol, 3.55 equiv.) in DCM (70 mL) was added deoxofluor (2.7M in toluene, 14 mL, 3.5 equiv.) dropwise at −78° C. The resulting solution was then stirred at this temperature for 5 min and warmed to room temperature for 1 h. The reaction mixture was then cooled back to −78° C. and a solution of the product from step t (4.88 g, 11.1 mmol, 1.0 equiv.) in DCM (15 mL) was added dropwise. The resulting solution was then stirred at this temperature for 5 min, after which the reaction vessel was warmed to room temperature and stirred for an additional 1 h. The reaction was quenched with saturated NaHCO3 (aq.). The aqueous layer was extracted with DCM×2. The combined organic layer was then washed with brine, dried over Na2SO4, concentrated and purified by flash chromatography (SiO2, 0 to 20% EtOAc/Hex) to afford the product (3.33 g, 7.6 mmol, 68% yield).

Step v: A flask containing the product from step u (50 mg, 0.114 mmol), o-Tolylboronic acid (0.14 mmol), and Pd-SPhos-G2 (9 mg, 0.011 mmol) was evacuated and backfilled with nitrogen. Degassed dioxane (1.1 mL) and 1.0M Na2CO3 (0.46 mL) were added and mixture heated to 100° C. for two hours. After cooling to room temperature, the reaction was partition between EtOAc and water. The organics were dried over MgSO4 and concentrated.

Step w: The crude product from step v was dissolved in CH2Cl2 (1 mL) and TFA (0.2 mL) was added. After stirring at room temperature for 4 hours, the reaction was diluted with toluene and evaporate under reduced pressure. The product was reconstituted in DMSO and purified by reverse phase HPLC (gradient MeCN/H2O) to afford the desired product (39 mg, 71% yield) as a white solid after lyophilization. 1H NMR (400 MHz, Chloroform-d) δ 7.51 (d, J=8.6 Hz, 1H), 7.40 (dd, J=7.7, 2.2 Hz, 1H), 7.32-7.17 (m, 4H), 6.96 (d, J=7.9 Hz, 1H), 6.36 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.1, 3.7 Hz, 1H), 4.81 (d, J=85.0 Hz, 1H), 4.53 (s, 1H), 3.83 (ddd, J=21.6, 16.7, 10.0 Hz, 1H), 3.41 (t, J=16.7 Hz, 1H), 2.61-2.40 (m, 1H), 2.26-2.11 (m, 2H), 2.10 (s, 3H), 1.97-1.81 (m, 1H). ESI MS [M+H]+ for C27H21F4NO, calcd 452.2, found 452.3.

Example 145

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 7.85 (s, 1H), 7.53 (d, J=8.9 Hz, 1H), 7.41 (dt, J=7.6, 2.2 Hz, 1H), 7.06 (d, J=7.8 Hz, 1H), 6.44 (d, J=8.0 Hz, 1H), 5.62 (dt, J=50.0, 3.7 Hz, 1H), 5.28-5.12 (m, 1H), 4.54 (app. s, 1H), 3.98-3.76 (m, 1H), 3.71 (s, 3H), 3.60-3.40 (m, 1H), 2.59-2.41 (m, 1H), 2.34-1.93 (m, 2H), 1.86 (d, J=14.2 Hz, 1H). ESI MS [M+H]+ for C25H18F4N4O, calcd 467.1, found 467.3.

Example 146

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3): δ 7.83 (s, 1H), 7.53-7.48 (m, 1H), 7.41-7.36 (m, 1H), 7.06 (d, J=7.9 Hz, 1H), 6.46 (d, J=7.9 Hz, 1H), 5.60 (dt, J=50.0, 3.7 Hz, 1H), 4.83 (dd, J=11.9, 5.0 Hz, 1H), 4.56-4.49 (m, 1H), 3.93 (s, 3H), 3.91-3.78 (m, 1H), 3.42 (td, J=16.9, 2.6 Hz, 1H), 2.96 (dd, J=5.2, 1.9 Hz, 1H), 2.56-2.44 (m, 1H), 2.23-2.04 (m, 2H), 1.87-1.76 (m, 1H). ESI MS [M+H]+ for C23H18F4N4O, calcd 442.1, found 442.1.

Example 147

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 7.87 (s, 1H), 7.53 (d, J=7.6 Hz, 1H), 7.42-7.38 (m, 1H), 7.08 (d, J=8.0 Hz, 1H), 6.48 (d, J=7.9 Hz, 1H), 5.62 (dt, J=49.9, 3.7 Hz, 1H), 4.83 (d, J=11.7 Hz, 1H), 4.55 (s, 1H), 3.96 (s, 3H), 3.94-3.81 (m, 1H), 3.52-3.38 (m, 1H), 2.59-2.44 (m, 1H), 2.27-1.97 (m, 2H), 1.90-1.79 (m, 1H). ESI MS [M+H]+ for C23H18F4N4O, calcd 443.1, found 443.3.

Example 148

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 7.51 (d, J=6.7 Hz, 1H), 7.46 (s, 1H), 7.42 (d, J=8.2 Hz, 1H), 7.38 (dt, J=7.7, 2.3 Hz, 1H), 6.39 (d, J=8.1 Hz, 1H), 5.61 (dt, J=50.1, 3.7 Hz, 1H), 5.14 (d, J=12.8 Hz, 1H), 4.54-4.40 (m, 1H), 3.95-3.77 (m, 1H), 3.43 (t, J=17.3 Hz, 1H), 2.53 (s, 3H), 2.52-2.41 (m, 1H), 2.26-1.95 (m, 2H), 1.86-1.73 (m, 1H). ESI MS [M+H]+ for C24H18F4N2O2, calcd 443.1, found 443.2.

Example 149

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.38 (s, 1H), 7.51 (d, J=7.7 Hz, 1H), 7.44-7.36 (m, 1H), 7.12 (d, J=8.0 Hz, 1H), 6.78 (s, 1H), 6.38 (d, J=8.0 Hz, 1H), 5.61 (dt, J=49.9, 3.3 Hz, 1H), 5.10 (dd, J=11.0, 3.5 Hz, 1H), 4.80 (s, 2H), 4.58-4.50 (m, 1H), 3.96-3.79 (m, 1H), 3.54-3.39 (m, 1H), 2.55-2.43 (m, 1H), 2.23-1.98 (m, 2H), 1.84 (d, J=13.1 Hz, 1H). ESI MS [M+H]+ for C26H18F4N4O, calcd 479.1, found 479.3.

Example 150

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.89 (s, 1H), 7.77 (d, J=0.8 Hz, 1H), 7.50 (d, J=8.8 Hz, 1H), 7.37 (dt, J=7.4, 2.4 Hz, 1H), 7.23 (d, J=8.1 Hz, 1H), 6.33 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.2, 3.7 Hz, 1H), 4.93 (d, J=12.3 Hz, 1H), 4.50-4.45 (m, 1H), 3.96 (s, 3H), 3.93-3.78 (m, 1H), 3.43 (t, J=17.3 Hz, 1H), 2.53-2.41 (m, 1H), 2.20-1.99 (m, 2H), 1.81 (dd, J=13.9, 4.1 Hz, 1H). ESI MS [M+H]+ for C24H19F4N3O, calcd 442.2, found 442.3.

Example 151

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.91 (s, 1H), 7.51 (d, J=7.7 Hz, 1H), 7.39 (dt, J=7.7, 2.2 Hz, 1H), 7.23 (d, J=8.1 Hz, 1H), 6.39 (d, J=8.0 Hz, 1H), 5.60 (dt, J=50.0, 3.5 Hz, 1H), 5.33 (d, J=12.4 Hz, 1H), 4.56-4.48 (m, 1H), 3.95-3.76 (m, 1H), 3.42 (td, J=16.6, 4.1 Hz, 1H), 2.57-2.38 (m, 1H), 2.24-1.96 (m, 2H), 1.87-1.76 (m, 1H). ESI MS [M+H]+ for C24H18F64N2O2, calcd 443.4, found 443.2.

Example 152

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.51-7.48 (m, 1H), 7.40-7.39 (m, 1H), 7.35-7.34 (m, 1H), 6.96-6.92 (m, 1H), 6.40-6.36 (m, 1H), 5.59 (ddd, J=50.1, 3.7, 3.7 Hz, 1H), 5.39-5.22 (m, 1H), 5.08-4.97 (m, 1H), 4.62-4.60 (m, 1H), 3.61-3.60 (m, 3H), 3.59-3.46 (m, 1H), 3.24-3.04 (m, 1H), 2.51-2.42 (m, 1H), 2.19-1.99 (m, 3H), 1.89-1.78 (m, 5H). ESI MS [M+H]+ for C25H22F3N3O, calcd 438.2, found 438.1.

Example 153

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.01 (s, 1H), 7.51 (dt, J=8.2, 2.0 Hz, 1H), 7.46-7.29 (m, 2H), 7.03 (d, J=7.9 Hz, 1H), 6.76 (s, 1H), 6.42 (d, J=7.9 Hz, 1H), 5.61 (dt, J=50.0, 3.7 Hz, 1H), 4.91 (s, 1H), 4.49 (d, J=35.4 Hz, 2H), 3.85 (ddd, J=21.8, 16.6, 9.5 Hz, 1H), 3.48-3.29 (m, 1H), 2.49 (td, J=12.7, 5.6 Hz, 1H), 2.28-2.07 (m, 2H), 1.85 (dq, J=13.8, 3.9 Hz, 1H). ESI MS [M+H]+ for C25H19F4N3O calcd. 454.1, found 454.1.

Example 154

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.53-7.48 (m, 1H), 7.47 (s, 1H), 7.38 (dt, J=7.8, 2.3 Hz, 1H), 7.29 (d, J=8.0 Hz, 1H), 6.38 (d, J=8.0 Hz, 1H), 5.77-5.45 (m, 1H), 4.93 (d, J=15.8 Hz, 1H), 4.60-4.45 (m, 1H), 3.93 (ddd, J=25.9, 16.6, 9.2 Hz, 1H), 3.47 (t, J=17.5 Hz, 1H), 2.50 (ddt, J=17.7, 11.7, 5.2 Hz, 1H), 2.22 (s, 3H), 2.19-2.04 (m, 1H), 1.94-1.80 (m, 1H). ESI MS [M+H]+ for C24H19F4N3O calcd. 442.1, found 442.1.

Example 155

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.69-7.60 (m, 1H), 7.61-7.47 (m, 2H), 7.47-7.28 (m, 2H), 6.92 (t, J=7.1 Hz, 1H), 6.40 (d, J=7.9 Hz, 1H), 5.72-5.52 (m, 1H), 4.73 (ddd, J=68.1, 11.7, 6.0 Hz, 1H), 4.52 (s, 1H), 3.83 (td, J=19.2, 17.8, 9.7 Hz, 1H), 3.42 (t, J=17.1 Hz, 1H), 2.59-2.43 (m, 1H), 2.30 (s, 3H), 2.28-2.04 (m, 3H), 1.93-1.79 (m, 1H). ESI MS [M+NH4]+ for C28H20F4N2O calcd. 494.2, found 494.2.

Example 156

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.67-8.62 (m, 2H), 7.66-7.49 (m, 2H), 7.24-7.14 (m, 3H), 6.61 (d, J=8.0 Hz, 1H), 4.95 (d, J=11.0 Hz, 1H), 4.47 (dd, J=6.1, 3.2 Hz, 1H), 3.89 (ddd, J=24.5, 16.6, 8.9 Hz, 1H), 3.40 (t, J=16.9 Hz, 1H), 3.11-2.81 (m, 2H), 2.16 (dddd, J=13.4, 10.7, 6.1, 4.0 Hz, 1H), 1.97-1.73 (m, 2H). ESI MS [M+OH]+ for C25H18F4N2O calcd. 420.1, found 420.1.

Example 157

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.56-7.47 (m, 2H), 7.40 (ddd, J=7.6, 2.7, 1.7 Hz, 1H), 7.04 (d, J=7.9 Hz, 1H), 6.43-6.35 (m, 2H), 5.61 (dt, J=50.1, 3.7 Hz, 1H), 5.38 (dt, J=5.8, 4.6 Hz, 0H), 5.24 (dt, J=5.8, 4.5 Hz, 0H), 5.11 (dd, J=10.0, 4.7 Hz, 1H), 4.66-4.59 (m, 1H), 3.76 (s, 3H), 3.65-3.49 (m, 1H), 3.20 (ddd, J=18.8, 16.4, 6.0 Hz, 1H), 2.48 (tdd, J=12.5, 5.8, 3.3 Hz, 1H), 2.26 (s, 1H), 2.20-1.98 (m, 2H), 1.87-1.76 (m, 1H). ESI MS [M+H]+ for C24H20F3N3O calcd. 424.2, found 424.1.

Example 158

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.85 (s, 1H), 8.33 (s, 1H), 7.57-7.48 (m, 1H), 7.43-7.35 (m, 1H), 7.28 (s, 1H), 6.39 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.0, 3.6 Hz, 1H), 5.01 (dd, J=11.7, 4.4 Hz, 1H), 4.58-4.47 (m, 1H), 3.91 (ddd, J=25.2, 16.7, 8.6 Hz, 1H), 3.44 (t, J=17.1 Hz, 1H), 3.31 (s, 1H), 2.50 (ddd, J=18.7, 13.3, 4.4 Hz, 1H), 2.25-1.96 (m, 2H), 1.87-1.74 (m, 1H), 0.96-0.77 (m, 1H). ESI MS [M+H]+ for C23H16F4N2OS calcd. 445.1, found 445.1.

Example 159

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.39 (dd, J=4.9, 1.8 Hz, 1H), 7.57 (br s, 1H) 7.51 (ddd, J=8.4, 2.8, 1.3 Hz, 1H), 7.40 (dt, J=7.7, 2.3 Hz, 1H), 7.15 (ddd, J=7.7, 4.9, 0.7 Hz, 1H), 6.95 (d, J=7.8 Hz, 1H), 6.38 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.1, 3.7 Hz, 1H), 4.80 (s, 1H), 4.62-4.43 (m, 1H), 3.84 (ddd, J=20.8, 16.8, 10.1 Hz, 1H), 3.41 (td, J=16.6, 4.0 Hz, 1H), 2.63-2.39 (m, 1H), 2.25 (s, 3H), 2.22-2.01 (m, 1H), 1.96-1.62 (m, 2H). ESI MS [M+H]+ for C26H20F4N2O calcd. 452.2, found 452.2.

Example 160

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.89 (s, 1H), 8.61 (s, 1H) 7.99 (d, J=8.0 Hz, 1H), 7.58-7.47 (m, 1H), 7.39 (dt, J=7.2, 2.2 Hz, 2H), 7.16 (d, J=8.0 Hz, 1H), 6.43 (d, J=8.0 Hz, 1H), 5.63 (dt, J=50.2, 3.6 Hz, 1H), 4.93 (d, J=10.9 Hz, 1H), 4.56 (s, 1H), 3.93 (ddd, J=24.4, 16.5, 8.7 Hz, 1H), 3.57 (s, 1H), 3.43 (t, J=16.7 Hz, 1H), 2.58-2.43 (m, 1H), 2.28-2.02 (m, 1H), 1.92-1.76 (m, 1H). ESI MS [M+H]+ for C25H18F4N2O calcd. 439.1, found 439.1.

Example 161

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, DMSO-d6): δ 11.76 (bs, 1H), 7.95 (dd, J=8.2, 2.3 Hz, 1H), 7.84 (d, J=8.7 Hz, 1H), 7.35 (d, J=9.3 Hz, 1H), 6.94 (d, J=7.9 Hz, 1H), 6.33 (d, J=7.9 Hz, 1H), 6.17 (d, J=9.3 Hz, 1H), 5.77 (d, J=49.7 Hz, 1H), 4.82 (d, J=12.0 Hz, 1H), 4.59 (s, 1H), 3.73-3.32 (m, 2H), 2.31 (d, J=11.3 Hz, 1H), 2.16-1.77 (m, 5H), 1.68 (d, J=13.8 Hz, 1H).

Example 162

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, DMSO-d6): δ 7.97 (dt, J=8.3, 2.3 Hz, 1H), 7.93-7.84 (m, 2H), 7.73 (td, J=7.7, 1.3 Hz, 1H), 7.67-7.62 (m, 1H), 7.55 (td, J=7.6, 1.2 Hz, 1H), 7.15 (d, J=7.9 Hz, 1H), 6.43 (d, J=7.9 Hz, 1H), 6.00 (d, J=6.9 Hz, 1H), 5.79 (d, J=49.7 Hz, 1H), 5.16 (dt, J=12.4, 6.5 Hz, 1H), 4.65 (s, 1H), 3.64 (tq, J=29.8, 15.5, 14.6 Hz, 2H), 2.32 (dd, J=16.9, 6.1 Hz, 1H), 2.15-1.79 (m, 2H), 1.74 (d, J=13.8 Hz, 1H).

Example 163

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.95 (d, J=7.9 Hz, 1H), 8.74 (t, J=6.0 Hz, 1H), 7.56-7.38 (m, 3H), 7.15 (d, J=8.0 Hz, 1H), 6.82 (s, br., 1H), 6.44 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.0, 3.5 Hz, 1H), 5.18 (dd, J=10.8, 6.1 Hz, 1H), 4.59-4.52 (m, 1H), 3.82 (ddd, J=16.9, 14.0, 11.1 Hz, 1H), 3.43 (m, 1H), 2.51 (tdd, J=13.4, 6.2, 3.1 Hz, 1H), 2.21-1.95 (m, 2H), 1.86-1.77 (m, 1H). ESI MS [M+H]+ for C25H18F5N20, calcd 457.1, found 457.0.

Example 164

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.40 (s, 1H), 7.55-7.47 (m, 1H), 7.39 (dt, J=7.6, 2.1 Hz, 1H), 7.22 (t, J=7.8 Hz, 1H), 7.06 (d, J=8.0 Hz, 1H), 7.01 (d, J=7.6 Hz, 1H), 6.79 (d, J=7.7 Hz, 1H), 6.36 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.0, 3.7 Hz, 1H), 4.91 (dd, J=11.5, 6.4 Hz, 1H), 4.55-4.48 (m, 1H), 3.83 (ddd, J=21.3, 16.7, 10.0 Hz, 1H), 3.48-3.34 (m, 2H), 3.26 (d, J=22.8 Hz, 1H), 3.11 (d, J=6.5 Hz, 1H), 2.56-2.42 (m, 1H), 2.21-2.04 (m, 2H), 1.90-1.81 (m, 1H). ESI MS [M+H]+ for C28H21F4N2O2, calcd 493.2, found 493.0.

Example 165

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.55-7.47 (m, 1H), 7.32-7.42 (m, 3H), 7.30-7.18 (m, 2H), 6.88 (d, J=7.8 Hz, 1H), 6.33 (d, J=7.8 Hz, 1H), 5.62 (dt, J=50.0, 4.0 Hz, 1H), 4.75 (dd, J=11.9, 1.8 Hz, 1H), 4.51 (m, 1H), 3.83 (ddd, J=22.8, 16.4, 9.1 Hz, 1H), 3.62 (d, J=12.2 Hz, 1H), 3.49 (d, J=12.2 Hz, 1H), 3.38 (td, J=16.3, 3.1 Hz, 1H), 2.51 (td, J=14.4, 13.8, 7.5 Hz, 1H), 2.26-2.04 (m, 2H), 2.01 (s, 2H), 1.90 (dq, J=13.1, 4.0 Hz, 1H). ESI MS [M+H]+ for C27H23F4N2O, calcd 467.2, found 467.0.

Example 166

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d, appearing as ˜2:1 rotamers) δ 8.14-7.27 (m, 3H), 6.99 (d, J=8.0 Hz, 1H), 6.40 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.0, 3.7 Hz, 1H), 4.95-4.85 (m, 1H), 4.82 (d, J=11.6 Hz, 1H), 4.51 (m, 1H), 4.05-3.14 (m, 5H), 2.98-1.68 (m, 7H). ESI MS [M+H]+ for C25H22F4N3O, calcd 456.2, found 456.1.

Example 167

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.71 (s, 1H), 7.51 (dt, J=8.5, 2.0 Hz, 1H), 7.40 (dt, J=7.6, 2.2 Hz, 1H), 7.09 (d, J=7.9 Hz, 1H), 6.37 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.0, 3.6 Hz, 1H), 5.02-4.92 (m, 1H), 4.56-4.49 (m, 1H), 3.84 (ddd, J=21.0, 16.8, 10.2 Hz, 1H), 3.42 (td, J=16.7, 3.8 Hz, 1H), 2.87 (dd, J=6.4, 1.6 Hz, 1H), 2.50 (tq, J=13.2, 5.4, 4.5 Hz, 1H), 2.33 (s, 3H), 2.25-2.02 (m, 2H), 2.00 (s, 3H), 1.89-1.80 (m, 1H). ESI MS [M+H]+ for C24H19F4N2OS, calcd 459.1, found 459.0.

Example 168

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, DMSO-d6) δ 8.02 (s, 1H), 7.95 (d, J=7.7 Hz, 1H), 7.85 (d, J=9.0 Hz, 1H), 6.96 (d, J=7.9 Hz, 1H), 6.54 (s, 2H), 6.36 (d, J=7.9 Hz, 1H), 5.98 (d, J=6.5 Hz, 1H), 5.87-5.63 (m, 1H), 4.85-4.75 (m, 1H), 4.63-4.57 (m, 1H), 3.62 (td, J=17.3, 11.7 Hz, 1H), 3.47 (td, J=16.6, 8.3 Hz, 1H), 2.34-2.25 (m, 1H), 2.10-1.80 (m, 5H), 1.75-1.66 (m, 1H). ESI MS [M+H]+ for C25H21F4N4O, calcd 469.2, found 469.3.

Example 169

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.55-7.48 (m, 1H), 7.39 (dt, J=7.8, 2.2 Hz, 1H), 7.07 (d, J=8.0 Hz, 1H), 6.41 (d, J=8.0 Hz, 1H), 6.25 (s, 1H), 5.73-5.51 (m, 1H), 4.93 (d, J=11.6 Hz, 1H), 4.58-4.48 (m, 2H), 3.86 (ddd, J=22.8, 16.9, 9.8 Hz, 1H), 3.67 (s, 3H), 3.49-3.35 (m, 1H), 2.57-2.43 (m, 1H), 2.30 (s, 3H), 2.23-2.03 (m, 2H), 1.90-1.78 (m, 1H). ESI MS [M+H]+ for C25H22F4N3O3, calcd 456.2, found 456.3.

Example 170

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144 and isolated as a 2:1 mixture of rotational isomers. 1H NMR (400 MHz, Chloroform-d) δ 7.56-7.49 (m, 1H), 7.44-7.39 (m, 1H), 7.37 (s, 1H), 7.04-6.96 (m, 1H), 6.50-6.40 (m, 1H), 5.63 (dt, J=49.9, 3.5 Hz, 1H), 4.85-4.76 (m, 1H), 4.56-4.50 (m, 1H), 3.93-3.74 (m, 1H), 3.60 (s, 3H), 3.51-3.32 (m, 1H), 2.59-2.44 (m, 1H), 2.26-2.02 (m, 2H), 1.96-1.83 (m, 4H). ESI MS [M+H]+ for C25H22F4N3O3, calcd 456.2, found 456.3.

Example 171

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144 and isolated as a 3:2 mixture of rotational isomers. 1H NMR (400 MHz, Chloroform-d) δ 7.57-7.48 (m, 1H), 7.44-7.37 (m, 1H), 7.38-7.30 (m, 1H), 7.05 (d, J=7.9 Hz, 0.4H), 7.01 (d, J=8.0 Hz, 0.6H), 6.61 (d, J=9.1 Hz, 1H), 6.49-6.39 (m, 1H), 6.26 (dd, J=6.9, 1.2 Hz, 0.4H), 6.05 (dd, J=6.7, 1.2 Hz, 0.6H), 5.71-5.53 (m, 1H), 5.05 (d, J=12.9 Hz, 0.6H), 4.93-4.83 (m, 0.4H), 4.58-4.48 (m, 1H), 3.94-3.74 (m, 1H), 3.54-3.33 (m, 1H), 3.27 (s, 1H), 3.23 (s, 2H), 2.61-2.44 (m, 1.5H), 2.27-1.96 (m, 1.5H), 1.92-1.78 (m, 1H). ESI MS [M+H]+ for C26H21F4N2O2, calcd 469.2, found 469.3.

Example 173

[Figure (not displayed)]

Step a: (3-bromopyridin-2-yl)methanol (500 mg, 2.66 mmol) was dissolved in CH2Cl2 (13.3 ml). The solution was cooled to 0° C., and (Diethylamino)sulfur trifluoride (414 ul, 472 mg, 1.1 equiv.) was added dropwise. The solution was allowed to warm to room temperature. Upon completion, the reaction was quenched with saturated NaHCO3, extracted with methylene chloride, dried over Na2SO4, and concentrated. The crude residue was purified by flash column chromatography (SiO2, 0% to 20% ethyl acetate in hexanes) to provide 3-bromo-2-(fluoromethyl)pyridine as a clear oil (196 mg, 39% yield).

Step b: 3-bromo-2-(fluoromethyl)pyridine (196 mg, 1 mmol) was combined with Pd(dppf)Cl2 (73.2 mg, 0.1 mmol), KOAc (216 mg, 2.2 mmol) and B2Pin2 (330 mg, 1.3 mmol) in dioxane (5 ml). The resulting solution was heated to 100° C. Upon completion, the reaction was cooled, filtered over celite, and concentrated to a crude residue which was taken on without further purification.

Step c: The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 8.68 (dd, J=4.7, 1.6 Hz, 1H), 7.90-7.50 (br. m, 1H), 7.52-7.48 (m, 1H), 7.40-7.36 (m, 2H), 7.84 (d, J=7.9 Hz, 1H), 5.68-5.54 (m, 1H), 5.29 (br s, 1H), 5.16 (br s, 1H) 4.76 (br s, 1H), 4.53-4.51 (m, 1H), 3.90-3.78 (m, 1H), 3.46-3.36 (m, 1H), 2.55-2.45 (m, 1H), 2.23-2.05 (m, 3H), 1.88-1.81 (m, 1H), ESI MS [M+H]+ for C26H19F5N2O, calcd 471.1, found 471.1.

Example 174

[Figure (not displayed)]

Step a: A flask was charged with (5S,8R)-8-[(1S)-7-chloro-2,2-difluoro-1-(methoxymethoxy)-1,3-dihydroinden-4-yl]-3,5-difluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (489 mg, 1.11 mmol, 1.0 equiv.), B2Pin2 (846 mg, 3.33 mmol, 3.0 equiv.), K3PO4 (707 mg, 3.33 mmol, 3.0 equiv.), XPhos Pd G3 (51 mg, 0.06 mmol, 0.05 equiv.), and 1,4-dioxane (11 mL, 0.1 M). The reaction mixture was sparged with N2 for 10 minutes, heated to 90° C., and stirred under N2 overnight. The reaction was quenched with water and extracted with EtOAc (2×50 mL). The combined organics were washed with brine (50 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by column chromatography (silica gel, 0→40% EtOAc in hexanes) to afford the product (374 mg, 63% yield).

Step b: A flask was charged with (5S,8R)-8-[(1S)-2,2-difluoro-1-(methoxymethoxy)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-dihydroinden-4-yl]-3,5-difluoro-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (45 mg, 0.08 mmol, 1.0 equiv.), 5-bromo-1-methyl-1,2,4-triazole (17 mg, 0.10 mmol, 1.2 equiv.), and XPhos Pd G3 (7 mg, 0.008 mmol, 0.1 equiv.). The reagents were dissolved in 1,4-dioxane (0.8 mL, 0.1 M) and 1M Na2CO3 in H2O (0.32 mL, 0.32 mmol, 4.0 equiv) was added. The reaction mixture was sparged with N2 for 10 minutes, heated to 100° C., and stirred under N2 for 1 hour. The reaction was quenched into saturated aqueous NaCl and extracted with EtOAc (3×10 mL). The combined organics were dried over MgSO4, filtered, and concentrated in vacuo. The crude residue was moved directly into step c without further purification.

Step c: The crude residue from step b (0.08 mmol) was dissolved in DCM (1.0 mL). TFA (0.2 mL) was added and the reaction mixture was stirred for 16 hours at 20° C. The reaction mixture was azeotroped with PhMe and the crude residue was dissolved in DCM, filtered over celite, and concentrated in vacuo. The crude residue was purified by prep-HPLC (40→100% MeCN in water) to afford the product was a white solid (8 mg, 23% yield over 2 steps). 1H NMR (400 MHz, Chloroform-d) δ 7.97 (s, 1H), 7.52 (d, J=7.4 Hz, 1H), 7.40 (dt, J=7.6, 2.2 Hz, 1H), 7.28 (d, J=8.4 Hz, 1H), 6.49 (d, J=8.0 Hz, 1H), 5.60 (dt, J=50.0, 3.6 Hz, 1H), 4.94 (d, J=16.4 Hz, 1H), 4.62-4.54 (m, 1H), 4.03 (s, 3H), 3.98-3.80 (m, 1H), 3.42 (t, J=17.3 Hz, 1H), 2.58-2.45 (m, 1H), 2.28-1.92 (m, 2H), 1.90-1.81 (m, 1H). ESI MS [M+H]+ for C23H18F4N4O, calcd 443.1, found 443.3.

Example 175

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.75 (s, 1H), 7.52-7.48 (m, 1H), 7.40-7.37 (m, 1H), 7.01 (d, J=7.9 Hz, 1H), 6.41 (d, J=7/9 Hz, 1H), 5.59 (ddd, J=50.0, 3.7, 3.7 Hz, 1H), 5.30 (ddd, J=52.6, 8.8, 4.5 Hz, 1H), 5.05 (ddd, J=10.3, 7.2, 4.7 Hz, 1H), 4.62-4.60 (m, 1H), 3.94 (s, 3H), 3.57 (ddd, J=20.4, 16.5, 4.3 Hz, 1H), 3.20 (ddd, J=19.7, 16.5, 5.8 Hz, 1H), 2.53-2.40 (m, 2H), 2.20-1.95 (m, 2H), 1.82-1.75 (m, 1H). ESI MS [M+H]+ for C25H19F3N4O, calcd 425.2, found 425.1.

Example 176

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.53 (d, J=2.5 Hz, 1H), 8.44 (d, J=2.2 Hz, 1H), 7.51 (d, J=7.9 Hz, 1H), 7.39 (dt, J=7.6, 2.2 Hz, 1H), 7.24 (d, J=8.2 Hz, 1H), 6.40 (d, J=8.0 Hz, 1H), 5.62 (dt, J=50.1, 3.5 Hz, 1H), 4.81 (d, J=14.3 Hz, 1H), 4.63-4.53 (m, 1H), 4.05-3.83 (m, 1H), 3.45 (t, J=17.1 Hz, 1H), 2.66 (s, 3H), 2.59-2.46 (m, 1H), 2.30-1.99 (m, 2H), 1.94-1.83 (m, 1H). ESI MS [M+H]+ for C25H19F4N3O, calcd 454.2, found 454.3.

Example 177

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.57 (s, 1H), 8.18 (s, 1H), 7.53 (d, J=6.1 Hz, 1H), 7.40 (dt, J=7.3, 2.2 Hz, 1H), 7.07 (d, J=7.8 Hz, 1H), 6.48 (d, J=7.9 Hz, 1H), 5.74-5.51 (m, 1H), 5.04-4.85 (m, 3H), 4.53 (s, 1H), 3.96-3.78 (m, 1H), 3.43 (t, J=17.4 Hz, 1H), 2.56-2.45 (m, 1H), 2.32-2.00 (m, 2H), 1.91-1.79 (m, 1H). ESI MS [M+H]+ for C24H18F4N4O, calcd 455.1, found 455.2.

Example 178

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 8.62 (s, 1H), 8.47 (s, 1H), 8.01 (d, J=8.2 Hz, 1H), 7.91 (d, J=8.5 Hz, 1H), 7.09 (d, J=7.9 Hz, 1H), 6.40 (d, J=7.9 Hz, 1H), 6.13 (s, 2H), 5.97 (d, J=7.1 Hz, 1H), 5.81 (d, J=49.5 Hz, 1H), 5.18-5.03 (m, 1H), 4.68 (s, 1H), 3.79-3.48 (m, 2H), 2.40-2.28 (m, 1H), 2.17-1.85 (m, 2H), 1.73 (d, J=13.7 Hz, 1H). ESI MS [M+H]+ for C24H18F4N4O, calcd 455.1, found 455.3.

Example 179

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.83 (s, 1H), 7.50 (d, J=8.6 Hz, 1H), 7.38 (dt, J=7.6, 2.3 Hz, 1H), 7.14 (d, J=8.1 Hz, 1H), 6.32 (d, J=8.0 Hz, 1H), 4.79 (d, J=14.8 Hz, 1H), 4.68 (s, 2H), 4.60-4.52 (m, 1H), 4.00-3.84 (m, 1H), 3.43 (t, J=17.3 Hz, 1H), 2.54-2.43 (m, 1H), 2.47 (s, 3H), 2.24-2.00 (m, 2H), 1.87 (d, J=13.7 Hz, 1H). ESI MS [M+H]+ for C25H20F4N4O, calcd 469.2, found 469.3.

Example 180

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.25 (s, 1H), 7.52 (d, J=7.6 Hz, 1H), 7.39 (dt, J=7.6, 2.2 Hz, 1H), 7.29 (d, J=8.1 Hz, 1H), 7.13 (s, 1H), 6.42 (d, J=8.0 Hz, 1H), 5.72-5.49 (m, 2H), 5.04 (d, J=11.8 Hz, 1H), 4.56-4.47 (m, 1H), 3.91 (ddd, J=24.9, 16.8, 8.8 Hz, 1H), 3.47 (t, J=17.1 Hz, 1H), 2.51 (td, J=15.0, 13.1, 4.3 Hz, 1H), 2.25-1.98 (m, 2H), 1.88-1.74 (m, 1H). ESI MS [M+H]+ for C24H17F4N3O2S, calcd 488.1, found 488.2.

Example 181

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.72 (s, 1H), 8.46 (s, 1H), 7.56-7.47 (m, 2H), 7.40 (d, J=7.4 Hz, 1H), 6.50 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.0, 3.0 Hz, 1H), 4.98 (d, J=13.9 Hz, 1H), 4.62-4.53 (m, 1H), 3.98-3.81 (m, 1H), 3.41 (t, J=17.0 Hz, 1H), 2.58-2.46 (m, 1H), 2.25-1.96 (m, 2H), 1.84 (d, J=15.5 Hz, 1H). ESI MS [M+H]+ for C24H18F4N4O, calcd 455.1, found 455.3.

Example 182

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.11 (s, 1H), 7.81 (d, J=8.1 Hz, 1H), 7.51 (d, J=9.0 Hz, 1H), 7.38 (dt, J=7.6, 2.3 Hz, 1H), 6.36 (d, J=8.1 Hz, 1H), 5.60 (dt, J=50.0, 3.5 Hz, 1H), 5.31 (d, J=17.4 Hz, 1H), 4.60-4.49 (m, 1H), 4.00 (s, 3H), 3.94-3.80 (m, 1H), 3.45 (td, J=17.1, 4.1 Hz, 1H), 2.54-2.41 (m, 1H), 2.23-1.91 (m, 2H), 1.87-1.76 (m, 1H). ESI MS [M+H]+ for C23H18F4N4O, calcd 443.1, found 443.3.

Example 183

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.50 (d, J=8.2, 2.2 Hz, 1H), 7.38 (dt, J=7.5, 2.6 Hz, 1H), 7.11 (d, J=8.0 Hz, 1H), 6.39 (d, J=8.0 Hz, 1H), 5.59 (dt, J=50.1, 3.7 Hz, 1H), 4.96 (d, J=16.6 Hz, 1H), 4.62-4.53 (m, 1H), 4.04 (s, 3H), 3.97-3.80 (m, 1H), 3.39 (d, J=17.0 Hz, 1H), 2.54-2.42 (m, OH), 2.45 (s, 3H), 2.22-1.98 (m, 2H), 1.89-1.81 (m, 1H). ESI MS [M+H]+ for C24H20F4N4O, calcd 457.2, found 457.3.

Example 184

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.72 (dd, J=4.7, 1.6 Hz, 1H), 8.07 (dd, J=8.0, 1.6 Hz, 1H), 7.58 (dd, J=8.0, 4.7 Hz, 1H), 7.55-7.50 (m, 1H), 7.40 (ddd, J=7.5, 2.7, 1.7 Hz, 1H), 7.20 (d, J=7.8 Hz, 1H), 6.44 (d, J=8.0 Hz, 1H), 5.62 (dt, J=50.0, 3.5 Hz, 1H), 5.06 (d, J=10.9 Hz, 1H), 4.55 (t, J=3.9 Hz, 1H), 3.99-3.76 (m, 1H), 3.49 (td, J=16.1, 7.7 Hz, 1H), 2.59-2.42 (m, 2H), 2.25-2.11 (m, 2H), 1.94-1.76 (m, 1H). ESI MS [M+H]+ for C26H17F4N3O calcd. 464.1, found 464.1.

Example 185

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 8.01-7.91 (m, 1H), 7.85 (d, J=9.1 Hz, 1H), 7.26 (d, J=7.4 Hz, 1H), 6.98 (d, J=7.9 Hz, 1H), 6.47 (d, J=7.5 Hz, 1H), 6.35 (d, J=7.9 Hz, 1H), 5.93 (d, J=6.3 Hz, 1H), 5.78 (d, J=49.7 Hz, 1H), 5.25 (s, 2H), 4.89 (s, 1H), 4.60 (s, 1H), 3.72-3.53 (m, 1H), 3.52-3.38 (m, 1H), 2.32 (q, J=1.9 Hz, 1H), 2.27 (s, 3H), 2.06 (d, J=15.3 Hz, 1H), 1.70 (d, J=13.7 Hz, 1H). ESI MS [M+H]+ for C26H21F4N3O calcd. 468.2, found 468.2.

Example 186

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.04 (d, J=2.7 Hz, 1H), 7.98 (d, J=2.7 Hz, 1H), 7.56-7.49 (m, 2H), 7.39 (ddd, J=7.5, 2.8, 1.7 Hz, 1H), 6.43 (d, J=8.0 Hz, 1H), 5.61 (dt, J=50.1, 3.6 Hz, 1H), 5.24 (s, 1H), 4.93-4.80 (m, 3H), 4.61-4.53 (m, 1H), 4.00-3.79 (m, 1H), 3.40 (t, J=17.2 Hz, 1H), 2.51 (ddq, J=16.5, 9.4, 3.5 Hz, 1H), 2.26-2.06 (m, 2H), 1.91-1.79 (m, 1H), 1.63 (s, 1H). ESI MS [M+H]+ for C24H18F4N4O calcd. 455.1, found 455.1.

Example 187

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.07 (d, J=0.9 Hz, 1H), 7.76 (dd, J=8.0, 1.0 Hz, 1H), 7.52 (ddd, J=8.4, 2.9, 1.2 Hz, 1H), 7.39 (ddd, J=7.6, 2.8, 1.7 Hz, 1H), 7.34 (dd, J=7.1, 1.0 Hz, 1H), 7.22 (dt, J=8.0, 3.6 Hz, 2H), 6.48 (d, J=8.0 Hz, 1H), 5.64 (dt, J=50.1, 3.5 Hz, 1H), 4.89 (d, J=9.3 Hz, 1H), 4.71-4.44 (m, 1H), 4.08-3.94 (m, 1H), 3.41 (t, J=16.6 Hz, 1H), 2.52 (td, J=14.7, 14.1, 6.2 Hz, 1H), 2.28-2.08 (m, 2H), 1.95-1.75 (m, 1H). ESI MS [M+H]+ for C27H20F4N3O, calcd 478.2, found 478.0.

Example 188

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.70 (s, 1H), 7.51 (d, J=7.2 Hz, 1H), 7.38 (d, J=7.2 Hz, 1H), 7.05 (d, J=8.0 Hz, 1H), 6.38 (d, J=8.0 Hz, 1H), 5.59 (d, J=49.9 Hz, 1H), 4.98 (d, J=11.7 Hz, 1H), 4.48 (s, 1H), 3.89-3.69 (m, 1H), 3.48-3.32 (m, 1H), 2.46 (m, 1H), 2.18 (s, 3H), 2.12-1.90 (m, 2H), 1.77 (s, 1H). ESI MS [M+H]+ for C24H20F4N3OS, calcd 474.1, found 474.0.

Example 189

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.92 (d, J=0.4 Hz, 1H), 8.08 (dd, J=8.1, 1.2 Hz, 1H), 7.64 (ddd, J=7.4, 1.2, 0.5 Hz, 1H), 7.57 (dd, J=8.0, 7.4 Hz, 1H), 7.52 (ddd, J=8.4, 2.8, 1.3 Hz, 1H), 7.41 (ddd, J=7.6, 2.7, 1.7 Hz, 1H), 7.31 (d, J=8.0 Hz, 1H), 6.43 (d, J=7.9 Hz, 1H), 5.63 (dt, J=50.1, 3.6 Hz, 1H), 4.98 (dd, J=11.1, 1.4 Hz, 1H), 4.68-4.29 (m, 1H), 4.00-3.74 (m, 1H), 3.40 (td, J=16.4, 3.0 Hz, 1H), 2.56-2.39 (m, 1H), 2.28-2.00 (m, 2H), 1.95-1.77 (m, 1H). ESI MS [M+H]+ for C27H19F4N20S, calcd 495.1, found 495.0.

Example 190

[Figure (not displayed)]

The title compound was prepared in a similar fashion to example 174. 1H NMR (400 MHz, CDCl3) δ 9.19 (s, 1H), 8.02 (dd, J=8.0, 1.2 Hz, 1H), 7.57 (t, J=7.7 Hz, 1H), 7.54-7.47 (m, 2H), 7.39 (ddd, J=7.6, 2.7, 1.7 Hz, 1H), 7.14 (d, J=8.0 Hz, 1H), 6.44 (d, J=7.9 Hz, 1H), 5.62 (dt, J=49.6, 3.5 Hz, 1H), 5.13-4.69 (m, 1H), 4.59 (dd, J=6.0, 2.9 Hz, 1H), 4.01-3.78 (m, 1H), 3.41 (td, J=16.4, 3.0 Hz, 1H), 2.57-2.36 (m, 1H), 2.21-2.04 (m, 2H), 1.93-1.75 (m, 1H). ESI MS [M+H]+ for C27H19F4N2OS, calcd 495.1, found 495.0.

Example 191

[Figure (not displayed)]

Step a: The reaction was performed in a similar fashion to step b of Example 174. The crude product was purified by flash column chromatography (SiO2, 0 to 100% EtOAc/hexanes) to yield the product as a yellow solid (28 mg, 0.051 mmol, 51%).

Step b: The reaction was performed in a similar fashion to step c of Example 174. The crude product was carried forward without further purification (20 mg).

Step c: To a 40-mL scintillation vial containing the product from step b (20 mg, 0.40 mmol, 1.0 equiv.) dissolved in THF (1 mL) was added sodium borohydride (15.1 mg, 0.40 mmol, 10.0 equiv.) in one portion. The resulting mixture was kept stirring at 23° C. for 2 h when TLC showed the reaction was complete. The reaction mixture was then quenched with sat. aq. brine solution (4 mL), and then extracted with EtOAc (5 mL×3). The organic layers were combined and dried over Na2SO4. Concentration under reduced pressure and purification by HPLC afforded a white solid (5 mg, 0.009 mmol, 23%). 1H NMR (400 MHz, CDCl3) δ 9.09 (s, 1H), 7.56-7.49 (m, 1H), 7.43-7.37 (m, 1H), 7.18 (d, J=8.1, 1H), 6.45 (d, J=8.0 Hz, 1H), 5.83-5.42 (m, 1H), 5.00-4.86 (m, 1H), 4.69 (d, J=13.2 Hz, 1H), 4.58 (d, J=13.3 Hz, 1H), 4.53 (dd, J=5.7, 2.6 Hz, 1H), 3.94-3.78 (m, 1H), 3.40 (td, J=16.4, 4.9 Hz, 1H), 2.56-2.41 (m, 1H), 2.26-1.97 (m, 2H), 1.87-1.74 (m, 1H). ESI MS [M+H]+ for C24H19F4N2O2S, calcd 475.1, found 475.0.

Example 192

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.68 (s, 1H), 7.50 (dt, J=8.4, 2.2 Hz, 1H), 7.42-7.32 (m, 1H), 7.17 (d, J=7.9 Hz, 1H), 6.36 (d, J=8.0 Hz, 1H), 5.60 (dt, J=50.1, 3.5 Hz, 1H), 4.84 (d, J=16.0 Hz, 1H), 4.60-4.41 (m, 1H), 3.90 (ddd, J=26.1, 16.6, 8.7 Hz, 1H), 3.42 (t, J=17.4 Hz, 1H), 2.58 (s, 3H), 2.54-2.36 (m, 1H), 2.17-1.97 (m, 2H), 1.93-1.78 (m, 1H). ESI MS [M+H]+ for C24H19F4N2OS, calcd 459.1, found 459.0.

Example 193

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 7.51 (dt, J=8.4, 2.0 Hz, 1H), 7.39 (ddd, J=7.6, 2.7, 1.7 Hz, 1H), 7.06 (d, J=8.0 Hz, 1H), 6.35 (d, J=8.0 Hz, 1H), 5.60 (dt, J=50.1, 3.6 Hz, 1H), 5.04-4.98 (m, 1H), 4.57-4.44 (m, 1H), 3.93-3.73 (m, 1H), 3.41 (td, J=16.7, 4.0 Hz, 1H), 2.66 (s, 3H), 2.49 (ddd, J=18.5, 11.3, 4.2 Hz, 1H), 2.23 (s, 3H), 2.20-2.06 (m, 2H), 1.89-1.75 (m, 1H). ESI MS [M+H]+ for C25H20F4N2OS, calcd 473.1, found 473.0.

Example 194

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.55-7.48 (m, 1H), 7.38 (dt, J=7.6, 2.1 Hz, 1H), 7.18-6.91 (m, 2H), 6.63 (t, J=7.4 Hz, 1H), 6.56 (d, J=9.1 Hz, 1H), 6.41 (d, J=7.7 Hz, 1H), 5.62 (dt, J=50.0, 3.7 Hz, 1H), 4.72 (d, J=12.4 Hz, 1H), 4.56-4.50 (m, 1H), 4.06-3.75 (m, 1H), 3.39 (t, J=16.8 Hz, 1H), 2.57-2.43 (m, 1H), 2.25-2.07 (m, 2H), 1.93-1.81 (m, 1H). ESI MS [M+H]+ for C26H20F5N2O, calcd 471.1, found 471.3.

Example 195

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.54-7.47 (m, 1H), 7.38 (dt, J=7.6, 2.2 Hz, 1H), 6.96 (d, J=7.8 Hz, 2H), 6.78 (d, J=7.5 Hz, 1H), 6.69 (s, 1H), 6.38 (d, J=7.8 Hz, 1H), 5.61 (dt, J=50.0, 3.7 Hz, 1H), 4.69 (d, J=12.7 Hz, 1H), 4.56-4.51 (m, 1H), 3.88 (ddd, J=25.1, 16.1, 7.8 Hz, 1H), 3.38 (t, J=16.6 Hz, 1H), 2.56-2.42 (m, 1H), 2.33 (s, 3H), 2.22-2.01 (m, 2H), 1.91-1.81 (m, 1H). ESI MS [M+H]+ for C27H23F4N20, calcd 467.2, found 467.3.

Example 196

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.55-7.48 (m, 1H), 7.42-7.34 (m, 1H), 7.23-7.14 (m, 1H), 7.03 (d, J=7.9 Hz, 1H), 6.71-6.59 (m, 2H), 6.41 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.2, 3.7 Hz, 1H), 4.84-4.76 (m, 1H), 4.55-4.50 (m, 1H), 3.88 (ddd, J=22.4, 16.5, 9.0 Hz, 1H), 3.61 (bs, 2H), 3.44 (td, J=16.4, 3.1 Hz, 1H), 2.58-2.43 (m, 1H), 2.24-2.11 (m, 2H), 1.95-1.83 (m, 1H). ESI MS [M+H]+ for C26H20F5N2O, calcd 471.1, found 471.3.

Example 197

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.56-7.49 (m, 1H), 7.39 (dt, J=7.3, 2.2 Hz, 1H), 7.24-7.12 (m, 2H), 7.10-7.02 (m, 1H), 6.98 (d, J=7.8 Hz, 1H), 6.46 (d, J=7.9 Hz, 1H), 5.62 (dt, J=50.1, 3.9 Hz, 1H), 4.76 (d, J=12.0 Hz, 1H), 4.56-4.50 (m, 1H), 3.97-3.62 (m, 3H), 3.42 (t, J=16.7 Hz, 1H), 2.58-2.44 (m, 1H), 2.30-2.00 (m, 2H), 1.90-1.80 (m, 1H), 0.08 (d, J=4.5 Hz, 1H). ESI MS [M+H]+ for C27H20F3N3O, calcd 478.2, found 478.3.

Example 198

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.97 (d, J=7.6 Hz, 1H), 7.75-7.67 (m, 1H), 7.57-7.49 (m, 1H), 7.44-7.37 (m, 1H), 6.96 (d, J=7.9 Hz, 1H), 6.44 (d, J=7.9 Hz, 1H), 5.63 (dt, J=49.6, 3.3 Hz, 1H), 4.56-4.51 (m, 1H), 4.28-4.16 (m, 2H), 3.86 (ddd, J=20.8, 16.9, 10.3 Hz, 1H), 3.45 (t, J=16.9 Hz, 1H), 3.28 (s, 3H), 2.59-2.47 (m, 1H), 2.43 (s, 3H), 2.17-1.98 (m, 2H), 1.91-1.83 (m, 1H). ESI MS [M+H]+ for C27H23F4N2O3S, calcd 531.1, found 531.2.

Example 200

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 11.89 (s, 1H), 7.88 (ddd, J=6.2, 1.8, 0.8 Hz, 1H), 7.84-7.75 (m, 1H), 7.51 (ddd, J=8.9, 2.8, 1.2 Hz, 1H), 7.45-7.35 (m, 1H), 7.16-7.06 (m, 2H), 6.90 (ddd, J=7.2, 6.2, 1.0 Hz, 1H), 6.43 (d, J=8.2 Hz, 1H), 5.71-5.44 (m, 1H), 5.28-5.22 (m, 1H), 4.52 (d, J=4.1 Hz, 1H), 3.88-3.64 (m, 1H), 3.38-3.12 (m, 1H), 2.56-2.39 (m, 1H), 2.24-2.05 (m, 1H), 2.05-1.91 (m, 2H), 1.82-1.64 (m, 1H). ESI MS [M+H]+ for C25H20F4N3O, calcd 454.2, found 454.2.

Example 202

[Figure (not displayed)]

Step a: To a mixture of 3-chloro-4-fluorobenzylaldehyde (20.0 g, 126 mmol, 1.0 equiv.) in 1,2-DCE/TFA (5:1 v/v, 420 mL) was added NBS (26.9 g, 151 mmol, 1.2 equiv.), 2-amino-5-chlorobenzotrifluoride (4.93 g, 25.2 mmol, 20 mol %) and Pd(OAc)2 (2.83 g, 12.6 mmol, 10 mol %), under N2. The resulting mixture was heated at 60° C. for 40 h, after which the substrate was fully consumed, confirmed by NMR monitoring. After cooling to room temperature, the reaction mixture was concentrated under vacuum and then diluted with EtOAc. The resulting mixture was washed with water then brine, dried over MgSO4, and purified by flash chromatography (SiO2, 10 to 20% EtOAc/Hex) to afford the product 2-bromo-5-chloro-4-fluorobenzylaldehyde (19.5 g, 82.1 mmol, 65%).

Step b: NEt3 (16.2 mL, 115 mmol, 2.5 mol. equiv.) was added to HCO2H (10.6 mL, 278 mmol, 6.0 mol. equiv.) at 0° C. A separate flask was charged with 2-bromo-5-chloro-4-fluorobenzylaldehyde (11 g, 46.3 mmol, 1.0 mol. equiv.), DMF (50 mL) and Meldrum's acid (6.68 g, 46.3 mmol, 1.0 mol. equiv.), and the mixture was cooled to 0° C. The cooled NEt3-HCO2H mixture was added slowly to the DMF mixture at 0° C. The reaction was allowed to warm to room temperature, followed by heating to reflux at 100° C. and was stirred for 12 h. The reaction was cooled and decanted onto ice. The mixture was diluted with EtOAc and acidified with 2M aq. HCl. The aqueous layer was separated and back extracted with EtOAc. The organic layers were combined, washed with 2M aq. HCl, H2O and brine, and dried over MgSO4. Concentration under reduced pressure and azeotropic removal of residual DMF with toluene afforded 3-(2-bromo-5-chloro-4-fluorophenyl)propanoic acid (12.2 g) that was of sufficient purity to use in the next step.

Step c: The crude material from step b was placed in an ice-bath and thionyl chloride (20 mL) was added, and the reaction was heated to 80° C. for 1 h. The reaction was cooled, and residual thionyl chloride was removed upon concentration under reduced pressure in a fume-hood. This furnished 3-(2-bromo-5-chloro-4-fluorophenyl)propanoyl chloride that was used directly in the next step.

Step d: Crude 3-(2-bromo-5-chloro-4-fluorophenyl)propanoyl chloride from the previous step was dissolved in DCM (100 mL) and cooled to 0° C. AlCl3 (14.5 g, 108 mmol, 2.5 mol. equiv.) was added and the resulting mixture was heated to 40° C. and stirred for 15 h. The reaction mixture was cooled and decanted carefully onto ice. The mixture was acidified with 2M aq. HCl and diluted with additional DCM. The aqueous layer was separated and extracted with DCM. The organic layers were combined and washed with additional 2M aq. HCl, water, brine, and dried over MgSO4. Concentration under reduced pressure and purification by flash chromatography (SiO2, 20 to 60% hexanes/DCM) furnished 4-bromo-7-chloro-6-fluoro-2,3-dihydroinden-1-one (5.22 g, 19.8 mmol, 43% over 3 steps) as a yellow solid.

The title compound was prepared from 4-bromo-7-chloro-6-fluoro-2,3-dihydroinden-1-one in a similar fashion to the sequence described for Example 144. 1H NMR (400 MHz, CDCl3) δ 7.88 (s, 1H), 7.58-7.52 (m, 1H), 7.43 (ddd, J=7.5, 2.8, 1.7 Hz, 1H), 6.22 (d, J=10.5 Hz, 1H), 5.63 (dt, J=49.8, 3.6 Hz, 1H), 4.81 (dd, J=11.8, 4.7 Hz, 1H), 4.57-4.50 (m, 1H), 3.94 (d, J=1.4 Hz, 3H), 3.90-3.75 (m, 1H), 3.41 (t, J=16.8 Hz, 1H), 2.70 (d, J=4.7 Hz, 1H), 2.54 (tdd, J=13.4, 6.2, 3.2 Hz, 1H), 2.29-1.98 (m, 2H), 1.85 (ddd, J=12.2, 6.3, 3.4 Hz, 1H). ESI MS [M+H]+ for C23H17F5N4O, calcd 461.1, found 461.0.

Example 203

[Figure (not displayed)]

The title compound was prepared m a similar fashion to Example 202. 1H NMR (400 MHz, CDCl3, appears as a 1.2:1 mixture of rotamers with mostly overlapping peaks) δ 7.56-7.48 (m, 1H), 7.46-7.38 (m, 1.4H), 7.22 (d, J=8.3 Hz, 0.5H), 6.41 (d, J=8.3 Hz, 0.5H), 6.36-6.33 (m, 0.4H), 6.08 (d, J=10.3 Hz, 1H), 5.61 (dt, J=50.0, 3.6 Hz, 1H), 4.97 (dd, J=11.9, 2.5 Hz, 0.5H), 4.79 (d, J=11.7 Hz, 0.4H), 4.59-4.39 (m, 3H), 3.88-3.71 (m, 1H), 3.45-3.30 (m, 1H), 2.57-2.42 (m, 1H), 2.27-2.11 (m, 2H), 2.08 (s, 1.2H), 2.04 (s, 1.5H), 1.93-1.80 (m, 1H). ESI MS [M+H]+ for C26H20F5N3O, calcd 486.2, found 486.0.

Example 204

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 202. 1H NMR (400 MHz, DMSO-d6, appears as a 3.5:1 rotamers) δ 8.00-7.93 (m, 1H), 7.88-7.81 (m, 1H), 7.17 (d, J=7.8 Hz, 0.2H), 7.14 (d, J=7.7 Hz, 0.8H), 7.09 (d, J=1.5 Hz, 0.8H), 7.04 (d, J=1.5 Hz, 0.2H), 7.00 (dd, J=7.7, 1.7 Hz, 0.8H), 6.93 (dd, J=7.8, 1.7 Hz, 0.2H), 6.33 (d, J=10.7 Hz, 0.8H), 6.24 (d, J=10.8 Hz, 0.2H), 6.05 (d, J=6.4 Hz, 0.8H), 5.96 (d, J=6.6 Hz, 0.2H), 5.79 (dt, J=49.4, 3.1 Hz, 1H), 5.23 (s, 0.4H), 4.99 (s, 1.6H), 4.92-4.76 (m, 1H), 4.67-4.57 (m, 1H), 3.70-3.38 (m, 2H), 2.41-2.23 (m, 1H), 2.15-1.88 (m, 2H), 1.83-1.65 (m, 1H). ESI MS [M+H]+ for C27H18F5N3O, calcd 496.1, found 496.0.

Example 205

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 202. 1H NMR (400 MHz, CDCl3, appears as a 1.5:1 mixture of rotamers) δ 8.27 (s, 0.4H), 8.01 (s, 0.6H), 7.62-7.50 (m, 1H), 7.48-7.36 (m, 1H), 6.26 (d, J=10.3 Hz, 0.4H), 6.16 (d, J=10.1 Hz, 0.6zH), 5.63 (dt, J=50.2, 2.5 Hz, 1H), 5.04-4.75 (m, 3H), 4.55-4.47 (m, 4H), 3.91-3.69 (m, 1H), 3.66-3.52 (m, 1H), 3.50-3.21 (m, 1H), 2.67-2.44 (m, 4H), 2.31-1.98 (m, 2H), 1.94-1.79 (m, 1H). ESI MS [M+H]+ for C25H19F5N4O, calcd 487.2, found 487.0.

Example 206

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 202. 1H NMR (400 MHz, CDCl3, appears as a 1:1 mixture of rotamers) δ 8.84 (s, 0.5H), 8.55 (s, 0.5H), 7.58-7.48 (m, 1H), 7.49-7.37 (m, 1H), 6.22 (t, J=9.8 Hz, 0.5H), 6.12 (d, J=9.9 Hz, 0.5H), 5.72-5.51 (m, 1H), 5.24-5.14 (m, 0.5H), 4.98-4.60 (m, 0.5H), 4.58-4.49 (m, 1H), 4.47-4.40 (m, 1H), 3.89-3.72 (m, 1H), 3.51-3.29 (m, 1H), 2.68-2.34 (m, 4H), 2.30-1.94 (m, 2H), 1.92-1.72 (m, 1H). ESI MS [M+H]+ for C26H17F5N4O, calcd 497.1, found 497.0.

Example 208

[Figure (not displayed)]

Step a: To a solution of (5R,8R)-8-[(1S)-7-chloro-2,2,6-trifluoro-1-(methoxymethoxy)-1,3-dihydroinden-4-yl]-3-fluoro-5-hydroxy-5,6,7,8-tetrahydronaphthalene-1-carbonitrile (accessed during the preparation of example 202, 1.17 g, 2.57 mmol, 1.0 equiv.) in DCM (26 mL) was added DMP (1.64 g, 3.86 mmol, 1.5 mol. equiv.) at 0° C. The resulting mixture was then stirred at room temperature for 1 h, and then quenched with saturated NaHCO3 (aq.) and saturated Na2S2O3 (aq.). The aqueous layer was extracted with DCM×2. The combined organic layer was then washed with brine, dried over Na2SO4, concentrated and purified by flash chromatography (SiO2, 10 to 40% EtOAc/hexanes) to afford the product (1.16 g, 2.56 mmol, 100%) as a white solid.

Step b: To a solution of the crude product from step a (1.16 g, 2.56 mmol, 1.0 equiv.) in DCM (10 mL) was added Et3N (1.55 g, 2.1 mL, 15.3 mmol, 6.0 equiv.) then TBSOTf (2.03 g, 1.8 mL, 7.68 mmol, 2.0 equiv.) dropwise at 0° C. The resulting solution was stirred at room temperature for 6 h, and then quenched with saturated NaHCO3 (aq.). The resulting mixture was then separated, and the aqueous phase was extracted with DCM. The combined organic phase was then washed with brine, dried over Na2SO4 and concentrated to afford the crude product which was used directly in the next step.

Step c: The crude product from step b (˜2.56 mmol) was then dissolved in MeCN (15 mL). Selectfluor (2.00 g, 5.63 mmol, 2.2 equiv.) was added at room temperature. The resulting mixture was stirred at 60° C. for 15 min upon which TLC analysis showed the full consumption of starting material. The reaction was concentrated under reduced pressure to remove MeOH. The residue was treated with DCM and washed with water. The aqueous phase was extracted with DCM. The combined organic phase was then washed with brine, dried over Na2SO4, concentrated and purified by flash column chromatography (SiO2, 0 to 30% EtOAc/hexanes) to afford the product as an off-white foam (dr 6:1, 0.945 g, 2.06 mmol, 78% yield over 2 steps).

Step d: A solution of the product from step c (0.945 g, 2.06 mmol, 1.0 equiv.), RuCl(p-cymene)[(S,S)-TsDPEN] (63.6 mg, 0.10 mmol, 5 mol %), HCO2H (0.184 g, 0.15 mL, 4.0 mmol, 2.0 equiv.) and Et3N (0.607 g, 0.84 mL, 6.0 mmol, 3.0 equiv.) in DCM (20 mL) was stirred at 0° C. overnight. The reaction mixture was then quenched with saturated NaHCO3 (aq.). The resulting mixture was then separated, and the aqueous phase was extracted with DCM. The combined organic phase was then washed with brine, dried over Na2SO4, concentrated and purified by flash column chromatography (SiO2, 0 to 30% EtOAc/hexanes) to afford the product as an off-white foam (dr 6:1, 0.888 g, 1.87 mmol, 94% yield).

Step e: To a solution of the product from step d (0.888 g, 1.87 mmol, 1.0 equiv.) in THF (18 mL) was added m-nitrobenzoic acid (0.938 g, 5.61 mmol, 3.0 equiv.), DIAD (0.908 g, 0.88 mL, 4.49 mmol, 2.4 equiv.) and PPh3 (1.18 g, 4.49 mmol, 2.4 equiv.) at 0° C. The resulting mixture was stirred at this temperature for 1 h, and then quenched by the addition of water. The aqueous phase was extracted with EtOAc. The combined organic phase was then washed with brine, dried over Na2SO4, concentrated and purified by flash column chromatography (SiO2, 0 to 30% EtOAc/hexanes) to afford the ester intermediate. The ester was then dissolved in THF/MeOH (2:1, 15 mL). A solution of LiOH.H2O (0.118 g, 2.80 mmol, 1.5 equiv.) in H2O (3 mL) was added at room temperature. The resulting mixture was stirred at room temperature for 10 min and then concentrated under vacuum. The residue was treated with EtOAc and H2O. The aqueous phase was extracted with EtOAc. The combined organic phase was then washed with brine, dried over Na2SO4 and concentrated to afford the product which was directly used in the next step.

Step f: To a solution of the product from step e (˜1.87 mmol) in DCM (18 mL) was added DAST (1.51 g, 1.2 mL, 9.35 mmol, 5.0 equiv.) dropwise at −40° C. The reaction temperature was gradually raised to −10° C. in 1 h, upon which TLC analysis showed full conversion of the substrate. The reaction mixture was then quenched with saturated NaHCO3 (aq.). The resulting mixture was then separated, and the aqueous phase was extracted with DCM. The combined organic phase was then washed with brine, dried over Na2SO4, concentrated and purified by flash column chromatography (SiO2, 0 to 20% EtOAc/hexanes) to afford the single diastereomer product as an off-white foam (0.418 g, 0.878 mmol, 47% yield over 2 steps).

Step g: A 40-mL vial was charged with the product from step f (60.0 mg, 0.126 mmol, 1.0 equiv.), 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-imidazole (28.9 mg, 0.139 mmol, 1.1 equiv.), SPhos-Pd-G2 (9.4 mg, 13 μmol, 10 mol %), 1M Na2CO3 aqueous solution (0.25 mL, 0.25 mmol, 2.0 equiv.) and 1,4-dioxane (1.3 mL). The resulting mixture was heated at 100° C. and stirred overnight. After cooling to room temperature, the reaction mixture was diluted with EtOAc and washed with H2O. The aqueous layer was separated and extracted with EtOAc. The combined organic phase was then washed with brine, dried over Na2SO4 and concentrated. The residue was treated with TFA/DCM (1:10, 2.0 mL) and heated to 40° C. for 1 h. The mixture was then concentrated and purified by HPLC to afford the title compound as a white solid (5.5 mg, 11.5 μmol, 9% yield). 1H NMR (400 MHz, CDCl3) δ 7.61-7.57 (m, 2H), 7.44 (ddd, J=7.7, 2.8 Hz, 1H), 7.39 (s, 1H), 6.38 (d, J=10.6 Hz, 1H), 5.70 (dd, J=50.3, 15.8 Hz, 1H), 5.35-5.13 (m, 1H), 4.73 (d, J=11.5 Hz, 1H), 4.66 (t, J=6.8 Hz, 1H), 3.75 (ddd, J=24.3, 16.2, 8.1 Hz, 1H), 3.54 (d, J=1.7 Hz, 3H), 3.13 (t, J=16.6 Hz, 1H), 2.93-2.80 (m, 1H), 2.05 (ddd, J=26.0, 14.7, 6.7 Hz, 1H). ESI MS [M+H]+ for C24H17F6N3O, calcd 478.1, found 478.0.

Example 209

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 208. 1H NMR (400 MHz, DMSO-d6) δ 7.97 (ddd, J=8.3, 2.9, 1.1 Hz, 1H), 7.87 (dd, J=9.0, 2.8 Hz, 1H), 6.57 (d, J=11.2 Hz, 1H), 6.25 (d, J=5.9 Hz, 1H), 6.03 (ddd, J=51.0, 15.9, 2.1 Hz, 1H), 5.46-5.18 (m, 1H), 4.71 (t, J=6.3 Hz, 1H), 4.64 (dd, J=12.0, 5.9 Hz, 1H), 3.78 (s, 3H), 3.57 (ddd, J=24.7, 16.6, 9.4 Hz, 1H), 3.25 (t, J=17.0 Hz, 1H), 2.85-2.64 (m, 1H), 2.11 (d, J=2.1 Hz, 3H), 2.06-1.88 (m, 1H). ESI MS [M+H]+ for C25H19F6N3O, calcd 492.2, found 492.0.

Example 210

[Figure (not displayed)]

Step a: To a solution 4-bromo-7-chloro-6-fluoro-2,3-dihydroinden-1-one (5.20 g, 21.9 mmol, 1.0 equiv.) in MeOH (100 mL) was added SelectFluor (9.31 g, 26.3 mmol, 1.2 equiv.) and concentrated H2SO4 (5 drops). The resulting mixture was heated at reflux for 2 h. After cooling to room temperature, 0.3 M H2SO4 (aq., 220 mL) was added to the reaction mixture. The resulting mixture was heated at reflux for another 1 h. After cooling to room temperature, the reaction was partitioned between EtOAc (200 mL) and H2O (200 mL). The aqueous layer was separated and back extracted with additional EtOAc (200 mL). The organic layers were combined, washed with water, then brine and dried over MgSO4. Concentration under reduced pressure gave mono-fluoro indanone that was taken crude onto the next step without purification (4.60 g, 75%).

Step b: To a solution of 4-bromo-7-chloro-2,6-difluoro-2,3-dihydroinden-1-one (4.6 g, 21.9 mmol, 1.0 mol. equiv.) in DMF (60 mL) was added HCO2H (1.9 mL, 48.9 mmol, 3.0 mol. equiv.) and NEt3 (4.6 mL, 32.6 mmol, 2.0 mol. equiv.) at 0° C. RuCl(p-cymene)[(R,R)-TsDPEN] (418 mg, 0.652 mmol, 4.0 mol %) was added and the reaction was stirred in the fridge for 48 h. The reaction was poured onto sat. aq. NaHCO3 solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with H2O (3×100 mL), brine, and dried over MgSO4. Concentration under reduced pressure and purification by column chromatography (SiO2, hexanes to 30% EtOAc) furnished the alcohol product as a single diastereomer (2.94 g, 64%, 75% ee as determined via analytical chiral HPLC using an AD-H column).

Step c: To a solution of indanol product from step b (2.94 g, 10.37 mmol, 1.0 mol. equiv.) in DCM (35 mL) was added DIPEA (3.7 mL, 20.7 mmol, 2.0 mol. equiv.) and MOMBr (1.3 mL, 15.6 mmol, 1.5 mol. equiv.) at 0° C. The reaction was allowed to warm to room temperature and was then heated at 40° C. overnight. The reaction was poured onto sat. aq. NaHCO3 solution and diluted with DCM. The aqueous layer was separated and back extracted with additional DCM. The organic layers were combined, washed with H2O, brine, and dried over MgSO4. Concentration under reduced pressure and purification by column chromatography (SiO2, hexanes to 70% DCM) furnished the MOM protected indanol (2.3 g, 68%).

The title compound was prepared from (1S,2R)-4-bromo-7-chloro-2,6-difluoro-1-(methoxymethoxy)-2,3-dihydro-1H-indene in analogous fashion to the sequence described for Example 144. 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J=1.9 Hz, 1H), 7.55-7.50 (m, 1H), 7.43 (dt, J=7.6, 2.3 Hz, 1H), 6.40 (s, 1H), 6.13 (d, J=10.4 Hz, 1H), 5.61 (dt, J=50.0, 3.6 Hz, 1H), 5.32 (d, J=52.4 Hz, 1H), 5.07 (s, 1H), 4.60 (s, 1H), 3.73 (d, J=1.3 Hz, 3H), 3.61-3.44 (m, 1H), 3.24-3.10 (m, 1H), 2.49 (tdd, J=13.4, 6.0, 3.1 Hz, 1H), 2.34-2.01 (m, 3H), 1.88-1.77 (m, 1H). ESI MS [M+H]+ for C24H19F4N3O, calcd 442.1, found 442.0.

Example 211

[Figure (not displayed)]

Step a: To a mixture of 4-bromo-6,7-difluoro-2,3-dihydroinden-1-one (5.0 g, 20.2 mmol, 1.0 mol. equiv.) in CH3CN (60 mL) was added NaSMe (1.84 g, 26.3 mmol, 1.3 mol. equiv.) at 0° C. The reaction was allowed to warm to room temperature and stirred for 1 h. The reaction was quenched with sat. aq. NH4Cl solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with water, brine and dried over MgSO4. Concentration under reduced pressure furnished crude thioether that was taken directly onto the next step without additional purification.

Step b: The crude thioether product of step a was dissolved in DCM (100 mL) and cooled to 0° C. mCPBA (9.50 g, 42.4 mmol, 2.1 mol. equiv.) was added portion-wise and the reaction was allowed to warm to room temperature and stirred for 2 h. The reaction was cooled in an ice-bath and carefully quenched by the addition of sat. aq. Na2S2O3 solution and sat. aq. NaHCO3 solution. After vigorous stirring, the aqueous layer was separated and extracted with additional DCM. The organic layers were combined, washed with brine and dried over MgSO4. Concentration under reduced pressure furnished crude sulfone that was taken onto the next step without additional purification.

Step c: To a solution of crude 4-bromo-6-fluoro-7-methylsulfonyl-2,3-dihydroinden-1-one from the previous step (˜20.2 mmol, 1.0 equiv.) in MeOH (120 mL) was added SelectFluor (8.58 g, 24.2 mmol, 1.2 equiv.) and concentrated H2SO4 (5 drops). The resulting mixture was heated at reflux for 2 h. After cooling to room temperature, 0.3 M H2SO4 (aq., 200 mL) was added to the reaction mixture. The resulting mixture was heated at reflux for another 1 h. After cooling to room temperature, the reaction was partitioned between EtOAc (200 mL) and H2O (200 mL). The aqueous layer was separated and back extracted with additional EtOAc (200 mL). The organic layers were combined, washed with water, then brine and dried over MgSO4. Concentration under reduced pressure furnished the mono-fluoroindanone as a white solid (5.98 g, 91% over 3 steps).

The title compound was prepared in a similar fashion to the sequence described for the preparation of Example 144 from the product of step c. 1H NMR (400 MHz, DMSO-d6) δ 7.97 (ddd, J=8.3, 2.8, 1.6 Hz, 1H), 7.91-7.84 (m, 1H), 6.40 (d, J=11.8 Hz, 1H), 5.85-5.67 (m, 2H), 5.62 (q, J=5.4 Hz, 1H), 5.37-5.18 (m, 1H), 4.74-4.63 (m, 1H), 3.35 (s, 3H), 3.31-3.16 (m, 2H), 2.30 (qd, J=11.2, 10.0, 5.4 Hz, 1H), 2.08-1.66 (m, 3H). ESI MS [M+Na]+ for C21H17F4NO3S, calcd 462.1, found 462.0.

Example 213

[Figure (not displayed)]

Step a: To a solution of 4-bromo-7-hydroxy-2,3-dihydroinden-1-one (12.0 g, 52.8 mmol, 1.0 mol. equiv.) in AcOH (120 mL) was added N-chlorosuccinimide (7.41 g, 55.4 mmol, 1.05 mol. equiv.). The reaction was warmed to 70° C. and stirred for 18 h. After this time, the reaction was poured onto ice and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layer was combined, washed with sat. aq. NaHCO3 solution, water, brine, and dried over MgSO4. Concentration under reduced pressure furnished the chloroindanone product (13.0 g, 94%) which was used in the next step without purification.

Step b: To a solution of 4-bromo-6-chloro-7-hydroxy-2,3-dihydroinden-1-one (11.5 g, 43.9 mmol, 1.0 mol. equiv.) in DCM (300 mL) was added NEt3 (13 mL, 87.8 mmol, 2.0 mol. equiv.) and triflic anhydride (8.1 mL, 48.3 mmol, 1.1 mol. equiv.) at 0° C. Upon completion, the reaction was carefully poured onto sat. aq. NaHCO3 solution at 0° C. The aqueous layer was separated and back extracted with additional DCM. The organic layer was combined, washed with sat. aq. NaHCO3 solution, brine, and dried over MgSO4. Concentration under reduced and purification by column chromatography (SiO2, hexane to 20% EtOAc) furnished the triflate product (11.2 g, 65%).

Step c: To a solution of (7-bromo-5-chloro-3-oxo-1,2-dihydroinden-4-yl) trifluoromethanesulfonate (11.2 g, 28.4 mmol, 1.0 mol equiv.) in CH3CN (120 mL) at 0° C. was added NaSMe (2.98 g, 42.6 mmol, 1.5 mol. equiv.) at 0° C. The reaction was allowed to warm to room temperature and stirred for 1 h. The reaction was quenched with sat. aq. NH4Cl solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with water, brine and dried over MgSO4. Concentration under reduced pressure furnished crude thioether that was taken directly onto the next step without additional purification.

Step d: The crude thioether product of step c was dissolved in DCM (140 mL) and cooled to 0° C. mCPBA (13.7 g, 59.6 mmol, 2.1 mol. equiv.) was added portion-wise and the reaction warmed to room temperature and stirred for 2 h. The reaction was cooled in an ice-bath and carefully quenched by the addition of sat. aq. Na2S2O3 solution and sat. aq. NaHCO3 solution. After vigorous stirring, the aqueous layer was separated and extracted with additional DCM. The organic layers were combined, washed with brine and dried over MgSO4. Concentration under reduced and purification by column chromatography (SiO2, hexane to 50% EtOAc) furnished the sulfone product (5.16 g, 56% over 2 steps).

The title compound was prepared from the product of step d in a similar fashion to Example 211. 1H NMR (400 MHz, DMSO-d6) δ 8.01-7.95 (m, 1H), 7.91-7.85 (m, 1H), 6.54 (s, 1H), 5.92-5.67 (m, 3H), 5.27 (dq, J=52.2, 6.2 Hz, 1H), 4.72-4.66 (m, 1H), 3.36 (s, 3H), 3.32-3.17 (m, 2H), 2.38-2.24 (m, 1H), 2.07-1.66 (m, 3H). ESI MS [M+Na]+ for C21H17ClF3NO3S, calcd 478.0, found 477.9.

Example 214

[Figure (not displayed)]

Step a: To a mixture of (5R)-5-[tert-butyl(dimethyl)silyl]oxy-8-[(1S,2R)-6-chloro-2-fluoro-1-(methoxymethoxy)-7-methylsulfonyl-2,3-dihydro-1H-inden-4-yl]-3-fluoro-5,6-dihydronaphthalene-1-carbonitrile (190 mg, 0.310 mmol, 1.0 mol. equiv.) in NMP (1.8 mL) was added CuCN (110 mg, 1.24 mmol, 4.0 mol. equiv.). The reaction was heated to 180° C. and stirred for 1.5 h. The reaction was poured onto sat. aq. NaHCO3 solution and diluted with EtOAc. The aqueous layer was separated and back extracted with additional EtOAc. The organic layers were combined, washed with H2O, brine and dried over MgSO4. Concentration under reduced pressure and purification by column chromatography (SiO2, hexane to 40% EtOAc) furnished the benzonitrile adduct (71 mg, 38%).

The title compound was accessed from the product of step a in a similar fashion to that described for Example 144. 1H NMR (400 MHz, DMSO-d6) δ 8.00-7.95 (m, 1H), 7.92-7.87 (m, 1H), 7.01 (s, 1H), 6.07 (d, J=6.7, 1.0 Hz, 1H), 5.78 (d, J=49.9 Hz, 1H), 5.62 (ddd, J=11.4, 6.7, 4.9 Hz, 1H), 5.33 (dq, J=52.7, 5.0 Hz, 1H), 4.81-4.75 (m, 1H), 3.48 (s, 3H), 3.44-3.30 (m, 2H), 2.37-2.23 (m, 1H), 2.06-1.65 (m, 3H). ESI MS [M+Na]+ for C22H17F3N2O3S, calcd 469.1, found 469.0.

Example 215

[Figure (not displayed)]

Step a. A round-bottomed flask was charged with triflate (10.0 g, 22.15 mmol, 1.0 equiv.), and boronate (9.75 g, 24.37 mmol, 1.1 equiv.), Pd(dppf)Cl2 (1.62 g, 2.21 mmol, 0.1 equiv.), Na2CO3 (4.67 g, 44.30 mmol, 2.0 equiv.), 1,4-dioxane (80 mL) and H2O (20 mL). The reaction mixture was degassed with N2 bubbling for 10 min before it was stirred at 80° C. for 16 h. The reaction mixture was then quenched with saturated NaCl (aq) and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→32%) to afford the product (10.0 g, 78%) as an off-white foam.

Step b: Product of step a (10.0 g, 17.37 mmol, 1.0 equiv.) was dissolved in degassed MeOH (110 mL) and Pd/C (20 wt % Pd, 2.00 g, 10 mol %) was added. The reaction was then shaken in parr hydrogenator under H2 (50 psi) for 2 h or until LCMS showed no starting material remaining. The reaction mixture was then filtered through Celite, concentrated and the residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→35%) to afford to afford the product (8.0 g, 80%) as an off-white foam.

Step c. TBAF (25.0 mL, 1M in THF, 1.8 equiv.) was added to a solution of product of step b (8.00 g, 13.85 mmol, 1.0 equiv.) in THF (100 mL) at 0° C. The reaction was slowly warmed to 23° C., stirred for 30 min and quenched with H2O. The solution was extracted with EtOAc and the combined organic extract was washed with sat. sol. NaCl. The solvent was evaporated, and the residue was used in the next step without further purification.

Step d. Oxalyl chloride (1.31 mL, 15.24 mmol, 1.1 equiv.) was dissolved in dry CH2Cl2 (30 mL) and cooled to −78° C. DMSO (2.36 mL, 33.24 mmol, 2.4 equiv.) was added dropwise to the reaction mixture and the reaction was stirred for 15 minutes at −78° C. Next, product of step e was dissolved in dry CH2Cl2 (20 mL) and was added dropwise. The reaction was stirred for 30 minutes. Et3N (9.60 mL, 69.25 mmol, 5.0 equiv.) was then added and the reaction was stirred at −78° C. for 1 h. The dry-ice bath was removed, and the reaction mixture was allowed to warm to room temperature and quenched with sat. sol. NaCl. The solution was extracted with EtOAc and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→60%) to afford to afford the product (6.14 g, 96%) as an off-white foam.

Step e. Product of step d (6.40 g, 13.9 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (100 mL) and Et3N (15.5 mL, 110 mmol, 8.0 equiv.) and TBSOTf (10.7 mL, 55.5 mmol, 4.0 equiv.) were added sequentially. The mixture was stirred for 2 h at 23° C. The reaction mixture was then quenched with sat. sol. NaHCO3 and extracted with CH2Cl2. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→14%) to afford the product (7.11 g, 89%) as an off-white foam.

Step f. Product of step e (7.11 g, 12.4 mmol, 1.0 equiv.) was dissolved in MeCN (100 mL) and SelectFluor (9.63 g, 27.2 mmol, 2.2 equiv.) was added. The mixture was stirred for 15 min at 60° C. The reaction mixture was then quenched with sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→30%) to afford the product (5.21 g, 88%) as an off-white foam.

Step g. Product of step f (5.21 g, 10.87 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (55 mL) and cooled to 0° C. Et3N (3.03 mL, 21.74 mmol, 3.0 equiv.) and HCO2H (1.23 mL, 32.61 mmol, 2.0 equiv.) were then added and the solution was degassed for 10 min before RuCl(p-cymene)[(S,S)-Ts-DPEN] (104 mg, 0.163 mmol, 0.015 equiv.) was added. The reaction flask was sealed with a septum and the reaction was stirred at 4° C. for 16 h. The reaction mixture was poured into a sat. sol. NaHCO3 and extracted with CH2Cl2. The organic layer was washed with brine, dried over Na2SO4, filtered, and concentrated. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→55%) to afford the product as a separable mixture of diastereoisomer (6:1 dr, 4.31 g, 83%) with the cis-isomer (0.61 g, 12%) and trans-isomer (3.70 g, 71%) obtained as off-white foams.

Step h. Product of step g (3.60 g, 7.48 mmol, 1.0 equiv.) was dissolved in THF (80 mL) at 0° C. and 3-nitrobenzoic acid (3.37 g, 22.43 mmol, 3.0 equiv.), triphenylphosphine (4.71 g, 17.94 mmol, 2.4 equiv.) and DIAD (3.53 mL, 17.94 mmol, 2.4 equiv.) were added sequentially. The reaction mixture was stirred at 23° C. for 2 h and then quenched with H2O. The mixture was extracted with EtOAc, the combined organic extract was washed with sat. sol. NaHCO3 and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→65%) to afford the desired product (4.70 g, 99%) as an off-white foam. The residue was dissolved in THF/MeOH (2:1, 60 mL) and LiOH.H2O (471 mg, 11.22 mmol, 1.5 equiv.) in H2O (20 mL) was added dropwise. The reaction was stirred at 23° C. for 45 minutes. The solution was extracted with EtOAc, the combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→55%) to afford the product (2.80 g, 78%) as an off-white foam.

Step i. Product of step h (1.20 g, 2.49 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (25 mL) and the solution was cooled to −40° C. under an atmosphere of nitrogen. DAST (1.65 mL, 12.46 mmol, 5.0 equiv.) was then added dropwise at −40° C. The reaction mixture was slowly warmed from −40° C. to −10° C. over a period of 2 h. When the reaction reached completion, the solution was poured in a cold sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→50%) to afford the product (0.98 g, 82%) as an off-white foam.

Step j. Product of step i (0.98 g, 2.03 mmol, 1.0 equiv.) was dissolved in THF (12 mL) at 23° C. A solution of hydrochloric acid (12 mL, 6M) was added dropwise, and the mixture was stirred at 30° C. for 2 h. When the reaction reached completion, the solution was poured in an ice-cold sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→50%) to afford the desired product (0.845 g, 95%) as an off-white foam. The material was dissolved in CH2C2 at 50° C., cooled to 0° C. and hexanes was added. The precipitate was collected by filtration to afford a white solid (0.714 g, 80%, >96% purity according to 1H and 19F NMR). 1H NMR (400 MHz, DMSO-d6) δ 7.96 (ddd, J=8.3, 2.7, 1.3 Hz, 1H), 7.89 (dd, J=8.9, 2.7 Hz, 1H), 7.57 (d, J=8.1 Hz, 1H), 6.66 (d, J=8.1 Hz, 1H), 5.95 (ddd, J=51.2, 13.5, 2.2 Hz, 1H), 5.89 (d, J=5.6 Hz, 1H), 5.47 (ddd, J=10.0, 6.2, 4.9 Hz, 1H), 5.26 (qd, J=52.5, 5.4 Hz, 1H), 5.12 (tddd, J=47.4, 18.7, 10.3, 2.7 Hz, 1H), 4.83 (t, J=5.4 Hz, 1H), 3.30 (s, 3H), 3.28-3.13 (m, 2H), 2.71-2.60 (m, 1H), 2.02-1.85 (m, 1H). 19F NMR (376 MHz, DMSO-d6) δ −112.3, −179.6, −196.7, −199.4. ESI MS [M+Na]+ for C21H17F4NO3SNa, calcd 462.0, found 461.9.

Example 216

[Figure (not displayed)]

Steps a and b were performed under similar conditions as previously described using starting material previously prepared according to Example 215.

Step c. Tetrabutylammonium fluoride [4.5 mL, 1M in THF] was added to a solution of product of step b (1.2 g, 2.17 mmol, 1.0 equiv.) in THF [0.15M] at 0° C. The reaction was slowly warmed to 23° C., stirred for 30 min and quenched with H2O. The solution was extracted with EtOAc and the combined organic extract was washed with sat. sol. NaCl. The solvent was evaporated, and the residue was used in the next step without further purification.

Step d. Oxalyl chloride (0.205 mL, 2.39 mmol, 1.1 equiv.) was dissolved in dry CH2Cl2 (5 mL) and cooled to −78° C. DMSO (0.37 mL, 5.22 mmol, 2.4 equiv.) was added dropwise to the reaction mixture and the reaction was stirred for 15 minutes at −78° C. Next, product of step c was dissolved in dry CH2Cl2 (4 mL) and was added dropwise, and the reaction was stirred for 15 minutes. Et3N (1.51 mL, 10.87 mmol, 5.0 equiv.) was then added and the reaction was stirred at −78° C. for 1 h. The dry-ice bath was removed, and the reaction mixture was allowed to warm to room temperature and quenched with sat. sol. NaCl. The solution was extracted with EtOAc and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→30%) to afford to afford the product (852 mg, 90%) as an off-white foam.

Step e. Product of step d (650 mg, 1.49 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (6.0 mL) and Et3N (1.25 mL, 8.94 mmol, 6.0 equiv.) and TBSOTf (1.03 mL, 4.47 mmol, 3.0 equiv.) were added sequentially. The mixture was stirred for 2 h at 23° C. The reaction mixture was then quenched with sat. sol. NaHCO3 and extracted with CH2Cl2. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→14%) to afford the product (720 mg, 88%) as an off-white foam.

Step f. Product of step e (720 mg, 1.31 mmol, 1.0 equiv.) was dissolved in MeCN (8.0 mL) and SelectFluor (1.02 g, 2.88 mmol, 2.2 equiv.) was added. The mixture was stirred for 45 min at 60° C. The reaction mixture was then quenched with sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→30%) to afford the product (403 mg, 68%) as an off-white foam.

Step g. Product of step f (402 mg, 0.89 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (4.5 mL) and cooled to 0° C. Et3N (0.25 mL, 1.77 mmol, 3.0 equiv.) and HCO2H (0.1 mL, 2.66 mmol, 2.0 equiv.) were then added and the solution was degassed for 10 min before RuCl(p-cymene)[(S,S)-Ts-DPEN] (8.5 mg, 0.013 mmol, 0.015 equiv.) was added. The reaction flask was sealed with a septum and the reaction was stirred at 4° C. for 16 h. The reaction mixture was poured into saturated NaHCO3 and extracted with CH2Cl2. The organic layer was washed with brine, dried over Na2SO4, filtered, and concentrated. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→30%) to afford the product as a separable mixture of diastereoisomer (6:1 dr, 368 mg, 92%) with the cis-isomer (56 mg, 14%) and trans-isomer (312 mg, 78%) obtained as off-white foams.

Step h. Product of step g (312 mg, 0.68 mmol, 1.0 equiv.) was dissolved in THF (6.5 mL) at 0° C. and 3-nitrobenzoic acid (0.34 g, 2.05 mmol, 3.0 equiv.), triphenylphosphine (0.43 g, 1.64 mmol, 2.4 equiv.) and DIAD (0.32 mL, 1.64 mmol, 2.4 equiv.) were added sequentially. The reaction mixture was stirred at 0° C. for 2 h and then quenched with H2O. The solution was extracted with EtOAc, the combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→35%) to afford product (414 mg, 97%) as an off-white foam. The residue was dissolved in THF/MeOH (2:1, 5.0 mL) and LiOH (43 mg, 1.03 mmol, 1.5 equiv.) in H2O (1.5 mL) was added dropwise. The reaction was stirred at 23° C. for 1 h. The solution was extracted with EtOAc, the combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→25%) to afford the product (250 mg, 80%) as an off-white foam.

Step i. Product of step h (305 mg, 0.67 mmol, 1.0 equiv.) was dissolved in CH2Cl2 (6.5 mL) and the solution was cooled to −40° C. under an atmosphere of nitrogen. DAST (0.44 mL, 3.35 mmol, 5.0 equiv.) was then added dropwise at −40° C. The reaction mixture was stirred and slowly warmed from −40° C. to −10° C. over a period of 2 h. When the reaction reached completion, the solution was poured in a cold sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→20%) to afford the product (250 mg, 82%) as an off-white foam.

Step j. A vial was charged with product of step i (50 mg, 0.11 mmol, 1.0 equiv.), 6-amino-2-methylpyridin-3-ylboronic acid pinacol ester (38 mg, 0.163 mmol, 1.5 equiv.), SPhos Pd G2 (16 mg, 0.022 mmol, 0.2 equiv.), aq. Na2CO3 (46 mg, 0.44 mmol, 4.0 equiv., 1M), and dioxane (1.2 mL). The reaction mixture was then sparged with N2 for 10 minutes before being heated to 100° C. for 2 h. The solution was extracted with EtOAc, the combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→80%) to afford the product (45 mg, 78%) as an off-white foam.

Step k. Hydrochloric acid [2.0 mL, 6M] was added to previous product (1.0 equiv.) dissolved in THF [2.0 mL, 0.02M], and the mixture was stirred at 30° C. for 2 h. When the reaction reached completion, the solution was poured in a cold sat. sol. NaHCO3 and extracted with EtOAc. The combined organic extract was washed with sat. sol. NaCl and the solvent was evaporated. The residue was purified using column chromatography on silica gel (Hexane/EtOAc—0%→90%) to afford the product (25 mg, 50%) as an off-white foam. 1H NMR (400 MHz, DMSO-d6) δ 7.93 (dd, J=8.2, 1.9 Hz, 1H), 7.83 (dd, J=9.0, 2.7 Hz, 1H), 7.20 (d, J=8.2 Hz, 1H), 6.91 (d, J=7.9 Hz, 1H), 6.54 (d, J=7.9 Hz, 1H), 6.25 (d, J=8.3 Hz, 1H), 6.11-5.90 (m, 1H), 5.87-5.79 (m, 3H), 5.23 (ddd, J=48.3, 17.2, 9.6 Hz, 1H), 4.70-4.57 (m, 2H), 3.55 (ddd, J=22.0, 16.8, 10.3 Hz, 1H), 3.28-3.18 (m, 1H), 2.75-2.63 (m, 1H), 1.99 (s, 3H), 1.96-1.86 (m, 1H). 19F NMR (376 MHz, DMSO-d6) δ −102.59, −112.72, −113.45, −180.54, −200.09. ESI MS [M+H]+ for C26H21F5N3O1, calcd 486.1, found 486.0.

Example 217

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 216. 1H NMR (400 MHz, DMSO-d6) δ 7.94 (dd, J=8.2, 1.7 Hz, 1H), 7.85 (dd, J=9.0, 2.7 Hz, 1H), 7.44 (d, J=1.9 Hz, 1H), 7.18 (d, J=8.0 Hz, 1H), 6.64 (d, J=8.0 Hz, 1H), 6.44 (d, J=1.9 Hz, 1H), 6.10 (d, J=6.0 Hz, 1H), 6.09-5.91 (m, 1H), 5.40-5.00 (m, 1H), 4.82-4.74 (m, 1H), 4.72 (t, J=5.7 Hz, 1H), 3.64 (s, 3H), 3.63-3.53 (m, 1H), 3.40-3.31 (m, 1H), 2.76-2.65 (m, 1H), 2.02-1.84 (m, 1H). 19F NMR (376 MHz, DMSO-d6) δ −102.6, −112.5, −113.3, −180.3, −200.0. ESI MS [M+H]+ for C24H19F5N3O1, calcd 460.1, found 460.0.

Example 218

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 216. 1H NMR (400 MHz, DMSO-d6) δ 7.97-7.93 (m, 1H), 7.87 (d, J=2.8 Hz, 1H), 7.85 (s, 1H), 7.25 (d, J=8.0 Hz, 1H), 6.65 (d, J=8.0 Hz, 1H), 6.15 (d, J=6.5 Hz, 1H), 6.00 (dd, J=51.1, 14.7 Hz, 1H), 5.35-5.09 (m, 1H), 4.89 (dt, J=11.5, 5.4 Hz, 1H), 4.74 (s, 1H), 3.86 (s, 3H), 3.62 (td, J=17.0, 12.5 Hz, 1H), 3.47-3.33 (m, 1H), 2.75-2.62 (m, 1H), 2.00-1.82 (m, 1H). 19F NMR (376 MHz, DMSO-d6) δ −102.9, −112.5, −112.6, −180.2, −200.0. ESI MS [M+H]+ for C23H18F5N401, calcd 461.1, found 461.0.

Example 219

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 216. 1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J=8.3, 2.8 Hz, 1H), 7.40-7.35 (m, 1H), 7.17 (d, J=8.3 Hz, 1H), 6.42 (d, J=8.3 Hz, 1H), 5.66 (ddd, J=50.3, 16.8, 2.7 Hz, 1H), 5.31-5.08 (m, 2H), 4.54 (t, J=6.8 Hz, 1H), 3.84-3.69 (m, 1H), 3.30 (td, J=16.9, 2.6 Hz, 1H), 2.88-2.73 (m, 1H), 2.50 (d, J=5.9 Hz, 1H), 2.00-1.83 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −101.8, −110.5, −114.8, −182.4, −202.9. ESI MS [M+Na]+ for C20H13Cl1F5N1O1Na, calcd 436.0, found 436.0.

Example 220

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 216. 1H NMR (400 MHz, CD3OD) δ 8.69 (s, 1H), 7.70 (dd, J=8.7, 2.8 Hz, 1H), 7.68-7.60 (m, 1H), 7.13 (d, J=8.0 Hz, 1H), 6.70 (d, J=8.0 Hz, 1H), 5.94-5.75 (m, 1H), 5.29-5.08 (m, 1H), 5.00-4.91 (m, 1H), 4.82-4.76 (m, 1H), 3.70 (dt, J=17.0, 13.5 Hz, 1H), 3.50-3.31 (m, 1H), 2.87-2.76 (m, 1H), 2.39 (s, 3H), 2.08-1.94 (m, 1H). 19F NMR (376 MHz, CD3OD) δ −102.6, −111.3, −113.9, −183.6, −203.6. ESI MS [M+H]+ for C26H18F5N401, calcd 497.1, found 497.1.

Example 221

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 216. 1H NMR (400 MHz, DMSO-d6) δ 7.97 (ddd, J=8.3, 2.9, 1.5 Hz, 1H), 7.90-7.86 (m, 2H), 6.97 (d, J=7.9 Hz, 1H), 6.43 (d, J=7.9 Hz, 1H), 6.27 (s, 1H), 6.05-5.86 (m, 2H), 5.29-5.04 (m, 1H), 4.92 (dt, J=12.3, 6.1 Hz, 1H), 4.75 (s, 1H), 3.65-3.52 (m, 1H), 3.47-3.32 (m, 1H), 2.70-2.58 (m, 1H), 2.31 (s, 3H), 2.00-1.87 (m, 1H). 19F NMR (376 MHz, DMSO-d6) δ −103.1, −111.6, −112.6, −177.8, −198.8. ESI MS [M+H]+ for C25H20F5N4O1, calcd 487.1, found 487.0.

Example 222

[Figure (not displayed)]

The title compound was prepare in a similar as ion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.47 (ddd, J=8.3, 2.7, 1.4 Hz, 1H), 7.36 (ddd, J=7.6, 2.8, 1.8 Hz, 1H), 7.05 (d, J=8.1 Hz, 1H), 6.22 (d, J=8.1 Hz, 1H), 5.55 (ddd, J=50.0, 3.6, 3.6 Hz, 1H), 5.41-5.24 (m, 2H), 4.53-4.51 (m, 1H), 3.56-3.46 (m, 1H), 3.12 (ddd, J=21.6, 16.7, 5.7 Hz, 1H), 2.53-2.50 (m, 1H), 2.46-2.36 (m, 1H), 2.15-1.89 (m, 2H), 1.72-1.66 (m, 1H). ESI MS [M+Na]+ for C20H15ClF3NO, calcd 400.1, found 400.0.

Example 223

[Figure (not displayed)]

Step a: The starting material [(1S)-7-chloro-4-[(1R,4S)-8-cyano-4,6-difluoro-1,2,3,4-tetrahydronaphthalen-1-yl]-2,2-difluoro-1,3-dihydroinden-1-yl] acetate (42.0 mg, 0.106 mmol, 1.0 mol. equiv.) was dissolved in 1 mL dioxane. Vinylboronic acid pinacol ester (19.6 mg, 0.127 mmol, 1.2 mol. equiv.), SPhos-Pd gen. II (7.9 mg, 0.011 mmol, 0.1 mol. equiv.), and 0.42 mL 1 M Na2CO3 aqueous solution (0.42 mmol, 4.0 mol. equiv.) were added. The mixture was sparged with N2 for 10 min and then heated at 100° C. for 70 min. The reaction mixture was partitioned between ethyl acetate and water. The organic phase was separated and dried using Na2SO4. The drying agent was filtered off and the organic solution was evaporated and chromatographed (SiO2, hexanes to 30% EtOAc/hexanes). The desired product (20.2 mg, 0.047 mmol, 44% yield) was obtained.

Step b: The product from step a (20.2 mg, 0.047 mmol, 1.0 mol. equiv.) was dissolved in 0.2 mL CCl4 and 0.2 mL acetonitrile, then 0.2 mL water was added. RuCl3-3H2O (6.7 mg, 0.026 mmol, 0.55 mol. equiv.) and NaIO4 (53 mg, 0.25 mmol, 5.3 mol. equiv.) were added. The reaction mixture was stirred for 1 h. The reaction was quenched by acetic acid and water. The organic phase was separated and dried over Na2SO4. Prep-TLC (SiO2, hexanes/EtOAc=1:1, with a few drops of acetic acid) gave the desired product (14 mg, 0.031 mmol, 66% yield).

Step c: The product from step b (14 mg, 0.031 mmol) was dissolved in the mixture of 1 mL THF, 1 mL dioxane and 1 mL water. LiOH.H2O (20 mg, excess) was added. The reaction mixture was stirred for 2 h before being quenched by acetic acid. All the volatiles were evaporated, then DCM was added. The DCM solution was dried over Na2SO4. HPLC (acetonitrile/water=10/90 to 90/10, with 0.1% TFA, 20 mL/min for 36 min) gave the desired product (3S)-7-[(1R,4S)-8-cyano-4,6-difluoro-1,2,3,4-tetrahydronaphthalen-1-yl]-2,2-difluoro-3-hydroxy-1,3-dihydroindene-4-carboxylic acid (6.2 mg, 0.015 mmol, 49%).

1H NMR (400 MHz, Chloroform-d) δ 9.99 (s, br, 2H), 7.63 (d, J=8.0 Hz, 1H), 7.48 (dt, J=8.8, 1.7 Hz, 1H), 7.35 (dt, J=7.7, 2.0 Hz, 1H), 6.28 (d, J=8.0 Hz, 1H), 5.56 (d, J=49.8 Hz, 1H), 5.34-5.26 (m, 1H), 4.45 (s, 1H), 3.81-3.64 (m, 1H), 3.31 (td, J=16.7, 4.7 Hz, 1H), 2.40 (d, J=14.7 Hz, 1H), 2.13-1.89 (m, 2H), 1.72 (d, J=13.4 Hz, 1H). ESI MS [M+H]+ for C21H16F4NO3, calcd 406.1, found 406.0.

Example 224

[Figure (not displayed)]

Step a: The starting material (3S)-7-[(1R,4S)-8-cyano-4,6-difluoro-1,2,3,4-tetrahydronaphthalen-1-yl]-2,2-difluoro-3-hydroxy-1,3-dihydroindene-4-carboxylic acid (12.6 mg, 0.031 mmol, 1.0 mol. equiv.), prepared according to example 223, was dissolved in 0.5 mL DMF. HATU (95 mg, 0.25 mmol, 8 mol. equiv.), i-Pr2NEt (74 mg, 0.10 mL, 0.57 mmol, 19 mol. equiv.), and dimethylamine (2.0 M in THF solution, 0.09 mL, 0.18 mmol, 6 mol. equiv.) were added. The reaction mixture was stirred for 18 h. The reaction mixture was quenched by aqueous HCl (1 M) and extracted with EtOAc. The organic phase was separated and dried over Na2SO4. After filtration and evaporation, the residue was purified by HPLC (acetonitrile/water=20/80 to 80/20, with 0.1% TFA, 20 mL/min for 25 min). The desired product (3S)-7-[(1R,4S)-8-cyano-4,6-difluoro-1,2,3,4-tetrahydronaphthalen-1-yl]-2,2-difluoro-3-hydroxy-N,N-dimethyl-1,3-dihydroindene-4-carboxamide was obtained (7.1 mg, 0.016 mmol, 53% yield).

1H NMR (400 MHz, Chloroform-d) δ 7.50 (dt, J=8.4, 2.0 Hz, 1H), 7.38 (dt, J=7.6, 2.2 Hz, 1H), 7.06 (d, J=7.9 Hz, 1H), 6.34 (d, J=7.9 Hz, 1H), 5.58 (dt, J=50.0, 3.7 Hz, 1H), 5.14 (dd, J=13.7, 2.6 Hz, 1H), 4.55-4.48 (m, 1H), 3.77 (td, J=15.6, 7.6 Hz, 1H), 3.33 (td, J=16.4, 6.3 Hz, 1H), 3.12 (s, 3H), 3.01 (s, 3H), 2.65 (s, br, 1H), 2.46 (tdd, J=13.3, 6.1, 3.2 Hz, 1H), 2.29-2.12 (m, 1H), 2.12-1.90 (m, 1H), 1.78 (ddt, J=13.9, 5.8, 3.3 Hz, 1H). ESI MS [M+H]+ for C23H21F4N2O2, calcd 433.2, found 433.0.

Example 225

[Figure (not displayed)]

Synthesis of the title compound was performed in a similar fashion to Example 144 using methyl boronic acid. The crude product was purified by flash column chromatography (SiO2, 0 to 100% EtOAc/hexanes) to afford a white solid (11 mg, 0.029 mmol, 35%). 1H NMR (400 MHz, CDCl3) δ 7.53-7.42 (m, 1H), 7.36 (dt, J=7.7, 2.2 Hz, 1H), 6.92 (d, J=7.8 Hz, 1H), 6.19 (d, J=7.8 Hz, 1H), 5.58 (dt, J=50.1, 3.6 Hz, 1H), 5.14-4.99 (m, 1H), 4.48-4.38 (m, 1H), 3.76 (td, J=18.0, 11.8 Hz, 1H), 3.36 (td, J=16.9, 5.7 Hz, 1H), 2.47-2.40 (m, 1H), 2.39 (s, 3H), 2.19-1.93 (m, 2H), 1.75 (dq, J=13.5, 3.5 Hz, 1H). ESI MS [M+H]+ for C21H18F4NO, calcd 376.1, found 376.0.

Example 228

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) (4:1 mixture of rotamers) δ 8.30 (d, J=2.2 Hz, 1H), 8.13 (s, 1H), 7.92 (s, 1H), 7.53-7.48 (m, 1H), 7.42-7.37 (m, 1H), 7.04-6.989 (m, 3H), 6.45-6.37 (m, 1H), 5.70-5.51 (m, 1H), 4.95-4.85 (m, 1H), 4.55-4.48 (m, 1H), 3.97-3.76 (m, 1H), 3.43 (t, J=16.9 Hz, 1H), 2.56-2.42 (m, 1H), 2.22-2.05 (m, 2H), 1.88-1.79 (m, 1H). ESI MS [M+H]+ for C27H18F4N2O2, calcd 479.1, found 479.0.

Example 229

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.53-7.47 (m, 1H), 7.39-7.35 (m, 1H), 7.09-6.93 (m, 2H), 6.90-6.77 (m, 2H), 6.40 (d, J=7.9 Hz, 1H), 5.69-5.51 (m, 1H), 5.15 (s, 1H), 4.70 (d, J=12.4 Hz, 1H), 4.55-4.49 (m, 1H), 3.95-3.75 (m, 1H), 3.66-3.56 (m, 2H), 3.37 (t, J=16.5 Hz, 1H), 2.54-2.43 (m, 1H), 2.19-1.98 (m, 2H), 1.88-1.80 (m, 1H). ESI MS [M+H]+ for C26H19F5N2O, calcd 471.1, found 471.0.

Example 230

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.87 (s, 1H), 7.58 (dd, J=6.8, 1.0 Hz, 1H), 7.54-7.47 (m, 1H), 7.41-7.37 (m, 1H), 7.29 (dd, J=7.1, 6.8 Hz, 1H), 6.59 (t, J=7.1 Hz, 1H), 6.45 (d, J=8.0 Hz, 1H), 6.32 (d, J=7.3 Hz, 1H), 5.69-5.52 (m, 1H), 4.99 (d, J=11.8 Hz, 1H), 4.62 (s, 2H), 4.59 (m, 1H), 4.01-3.86 (m, 1H), 3.39 (t, J=16.9 Hz, 1H), 2.56-2.44 (m, 1H), 2.24-2.03 (m, 2H), 1.91-1.79 (m, 1H). ESI MS [M+H]+ for C27H20F4N4O, calcd 493.2, found 493.0.

Example 231

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) (2:1 mixture of rotamers) δ 7.74-7.61 (m, 1H), 7.55-7.38 (m, 2H), 7.19-7.09 (m, 1H), 7.06-7.01 (m, 1H), 6.99-6.91 (m, 1H), 6.80-6.57 (m, 1H), 6.47-6.40 (m, 1H), 5.70-5.49 (m, 1H), 5.05-4.87 (m, 1H), 4.59 (s, 1H), 3.97-3.76 (m, 1H), 3.53-3.36 (m, 1H), 2.57-2.43 (m, 1H), 2.25-2.02 (m, 2H), 2.21-1.91 (s, 3H), 1.96-1.85 (m, 1H). ESI MS [M+H]+ for C28H21F4N3O, calcd 492.2, found 492.0.

Example 232

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) (3:1 mixture of rotamers) δ 7.52-7.47 (m, 1H), 7.40-7.35 (m, 1H), 7.24 (s, 1H), 6.99-6.90 (m, 1H), 6.46-6.34 (m, 1H), 5.68-5.52 (m, 1H), 4.91-4.75 (m, 1H), 4.56-5.49 (m, 1H), 3.89-3.73 (m, 1H), 3.48-3.24 (m, 1H), 3.34 (s, 3H), 2.55-2.42 (m, 1H), 2.19-2.03 (m, 2H), 1.98 (s, 3H), 1.91-1.83 (m, 1H). ESI MS [M+H]+ for C25H21F4N3O, calcd 456.2, found 456.0.

Example 233

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 8.90-8.86 (m, 1H), 8.84 (dd, J=6.9, 1.8 Hz, 1H), 8.26 (s, 1H), 7.98-7.93 (m, 1H), 7.88-7.82 (m, 1H), 7.41 (dd, J=6.9, 4.3 Hz, 1H), 7.36 (d, J=8.0 Hz, 1H), 6.50 (d, J=8.0 Hz, 1H), 5.86-5.68 (s, 1H), 5.09 (dd, J=11.8, 6.0 Hz, 1H), 4.70-4.62 (m, 1H), 3.76-3.47 (m, 3H), 2.39-2.27 (m, 1H), 2.08-1.82 (m, 2H), 1.72-1.65 (m, 1H). ESI MS [M+H]+ for C26H18F4N4O, calcd 479.1, found 479.0.

Example 234

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 9.19 (d, J=1.4 Hz, 1H), 8.32 (dd, J=4.7, 1.5 Hz, 1H), 8.11 (s, 1H), 7.97-7.91 (m, 2H), 7.87-7.81 (m, 1H), 7.37 (d, J=8.0 Hz, 1H), 6.47 (d, J=8.0 Hz, 1H), 5.84-5.68 (m, 1H), 5.05 (dd, J=11.7, 5.2 Hz, 1H), 4.68-4.63 (m, 1H), 3.76-3.47 (m, 3H), 2.37-2.26 (m, 1H), 2.08-1.83 (m, 2H), 1.73-1.66 (m, 1H). ESI MS [M+H]+ for C26H18F4N4O, calcd 479.1, found 479.0.

Example 235

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 7.95-7.91 (m, 1H), 7.85-7.80 (m, 1H), 7.08-6.83 (m, 4H), 6.37 (d, J=7.9 Hz, 1H), 5.84-5.67 (m, 1H), 4.85 (d, J=11.9 Hz, 1H), 4.60 (s, 1H), 3.70-3.55 (m, 1H), 3.53-3.40 (m, 1H), 2.34-2.23 (m, 1H), 2.05-1.87 (m, 2H), 1.70-1.61 (m, 1H). ESI MS [M+H]+ for C26H19F5N2O, calcd 471.1, found 471.0.

Example 236

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 7.96-7.91 (m, 1H), 7.87-7.82 (m, 1H), 7.61 (s, 1H), 7.16 (d, J=7.9 Hz, 1H), 6.47 (d, J=7.9 Hz, 1H), 6.19 (s, 1H), 5.82-5.67 (m, 1H), 5.08-4.97 (m, 1H), 4.65-4.61 (m, 1H), 3.72-3.47 (m, 2H), 3.45 (s, 3H), 2.60 (s, 3H), 2.36-2.24 (m, 1H), 2.06-1.80 (m, 2H), 1.71-1.61 (m, 1H). ESI MS [M+H]+ for C25H21F4N3O, calcd 456.2, found 456.0.

Example 237

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, DMSO-d6) δ 8.51 (dd, J=4.4, 1.6 Hz, 1H), 8.17 (dd, J=9.2, 1.6 Hz, 1H), 7.96-7.91 (m, 1H), 7.86-7.80 (m, 1H), 7.57 (d, J=8.1 Hz, 1H), 7.25 (dd, J=9.2, 4.4 Hz, 1H), 6.43 (d, J=8.1 Hz, 1H), 6.04 (d, J=6.6 Hz, 1H), 5.84-5.68 (m, 1H), 5.14-5.06 (m, 1H), 4.65-4.59 (m, 1H), 3.73-3.47 (m, 2H), 2.36-2.24 (m, 1H), 2.05-1.80 (m, 2H), 1.74-1.65 (m, 1H). ESI MS [M+H]+ for C26H18F4N4O, calcd 479.1, found 479.0.

Example 238

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 7.51-7.46 (m, 1H), 7.39-7.34 (m, 1H), 7.17 (d, J=8.0 Hz, 1H), 7.10 (d, J=1.3 Hz, 1H), 6.96 (d, J=1.3 Hz, 1H), 6.40 (d, J=8.0 Hz, 1H), 5.66-5.50 (m, 1H), 4.89 (d, J=17.4 Hz, 1H), 4.57-4.52 (m, 1H), 3.93-3.79 (m, 1H), 3.78 (s, 3H), 3.42-3.31 (m, 1H), 2.52-2.42 (m, 1H), 2.20-2.00 (m, 2H), 1.87-1.79 (m, 1H). ESI MS [M+H]+ for C24H19F4N3O, calcd 442.1, found 442.0.

Example 239

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, Chloroform-d) δ 8.25 (s, 1H), 8.20 (d, J=7.0 Hz, 1H), 7.96 (s, 1H), 7.71 (d, J=9.1 Hz, 1H), 7.53-7.47 (m, 1H), 7.41-7.36 (m, 1H), 7.31 (d, J=8.0 Hz, 1H), 7.21 (ddd, J=9.1, 6.7, 1.2 Hz, 1H), 6.77 (td, J=6.8, 1.2 Hz, 1H), 6.50 (d, J=8.0 Hz, 1H), 5.70-5.53 (m, 1H), 4.81 (d, J=11.9 Hz, 1H), 4.65-4.58 (m, 1H), 4.07-3.91 (m, 1H), 3.35 (t, J=16.8 Hz, 1H), 2.56-2.43 (m, 1H), 2.24-2.03 (m, 2H), 1.93-1.83 (m, 1H). ESI MS [M+H]+ for C27H19F4N3O, calcd 478.1, found 478.0.

Example 240

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, Chloroform-d) δ 7.55 (s, 1H), 7.52-7.47 (m, 1H), 7.39-7.35 (m, 1H), 7.33 (s, 1H), 7.04 (d, J=7.9 Hz, 1H), 6.41 (d, J=8.0 Hz, 1H), 5.68-5.51 (m, 1H), 4.83 (d, J=11.8 Hz, 1H), 4.53 (s, 1H), 3.85 (ddd, J=24.5, 16.6, 9.0 Hz, 1H), 3.54 (s, 3H), 3.33 (t, J=16.7 Hz, 1H), 2.52-2.40 (m, 1H), 2.18-1.99 (m, 2H), 1.86-1.77 (m, 1H). ESI MS [M+H]+ for C24H19F4N3O, calcd 442.1, found 442.1.

Example 241

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 8.74 (s, 1H), 8.61 (d, J=5.8 Hz, 1H), 7.67 (d, J=5.8 Hz, 1H), 7.52 (m, 1H), 7.40 (dt, J=7.5, 2.2 Hz, 1H), 6.96 (d, J=7.9 Hz, 1H), 6.46 (d, J=8.0 Hz, 1H), 5.71-5.49 (m, 1H), 4.92-4.78 (m, 1H), 4.55-4.51 (m, 1H), 3.89-3.76 (m, 1H), 3.51-3.36 (m, 1H), 2.55-2.46 (m, 2H), 2.39 (s, 3H), 2.21-2.14 (m, 1H), 2.10-2.02 (m, 1H), 1.87-1.80 (m, 1H). ESI MS [M+H]+ for C26H21F4N2O, calcd 453.16, found 453.1.

Example 242

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 8.60 (s, 1H), 8.52 (d, J=5.6 Hz, 1H), 7.62-7.52 (m, 1H), 7.52 (d, J=2.8 Hz, 1H), 7.39 (dt, J=7.5, 2.3 Hz, 1H), 6.93 (d, J=7.9 Hz, 1H), 6.45 (d, J=7.9 Hz, 1H), 5.6 (dt, J=50.0, 3.7 Hz, 1H), 4.91-4.78 (m, 1H), 4.55-4.50 (m, 1H), 3.81 (td, J=17.3, 11.5 Hz, 1H), 3.41 (td, J=16.2, 6.7 Hz, 1H), 2.56-2.45 (m, 1H), 2.22 (s, 3H), 2.21-1.98 (m, 2H), 1.88-1.80 (m, 1H). ESI MS [M+H]+ for C26H21F4N2O, calcd 453.16, found 453.1.

Example 243

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 144. 1H NMR (400 MHz, CDCl3) δ 13.83 (s, 1H), 8.50 (dd, J=7.9, 1.1 Hz, 1H), 8.19 (dd, J=5.8, 1.2 Hz, 1H), 7.99 (d, J=1.9 Hz, 1H), 7.52 (ddd, J=8.2, 2.8, 1.1 Hz, 1H), 7.42-7.36 (m, 2H), 7.30 (d, J=8.0 Hz, 1H), 6.50 (d, J=8.0 Hz, 1H), 5.62 (dt, J=50.1, 3.6 Hz, 1H), 4.79 (d, J=11.7 Hz, 1H), 4.56-4.51 (m, 1H), 3.90 (ddd, J=25.1, 16.7, 8.5 Hz, 1H), 3.43 (t, J=17.1 Hz, 1H), 2.57-2.45 (m, 1H), 2.23-2.03 (m, 2H), 1.89-1.79 (m, 1H). ESI MS [M+H]+ for C28H21F4N2O, calcd 477.16, found 478.1.

Example 244

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.51 (d, J=5.0 Hz, 1H), 8.02 (d, J=8.0 Hz, 1H), 7.57 (dd, J=7.9, 5.3 Hz, 1H), 7.51 (d, J=8.5 Hz, 1H), 7.37 (ddd, J=7.5, 2.8, 1.5 Hz, 1H), 7.12 (d, J=7.9 Hz, 1H), 6.58 (d, J=7.9 Hz, 1H), 5.59 (dt, J=52.0, 4.0 Hz, 1H), 4.92 (d, J=12.7 Hz, 1H), 4.54 (m, 1H), 3.77-3.62 (m, 1H), 3.27-3.13 (m, 1H), 2.62-2.34 (m, 2H), 2.35 (s, 3H), 2.21-2.03 (m, 2H), 1.90-1.79 (m, 1H). ESI MS [M+H]+ for C26H20F4N2O, calcd 453.16, found 453.1.

Example 245

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, CDCl3) δ 8.31 (dd, J=6.8, 1.1 Hz, 1H), 7.84 (s, 1H), 7.74 (d, J=1.6 Hz, 1H), 7.66 (d, J=7.0 Hz, 1H), 7.56-7.46 (m, 1H), 7.37 (dt, J=7.4, 2.3 Hz, 1H), 7.29 (t, J=7.0 Hz, 1H), 7.20 (d, J=7.9 Hz, 1H), 6.67-6.60 (m, 1H), 5.59 (dt, J=50.1, 4.0 Hz, 1H), 4.98-4.87 (m, 1H), 4.57-4.52 (m, 1H), 3.77-3.62 (m, 1H), 3.21-3.08 (m, 1H), 2.57-2.23 (m, 3H), 2.23-2.06 (m, 2H), 1.91-1.81 (m, 1H). ESI MS [M+H]+ for C27H20F4N3O, calcd 478.15, found 478.1.

Example 246

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 174. 1H NMR (400 MHz, MeOD) δ 8.73 (dd, J=5.8, 1.6 Hz, 1H), 8.54 (dd, J=8.0, 1.6 Hz, 1H), 7.93 (dd, J=7.9, 5.9 Hz, 1H), 7.77 (s, 1H), 7.71-7.63 (m, 2H), 5.70 (dt, J=49.8, 3.9 Hz, 1H), 5.36 (d, J=1.9 Hz, 1H), 5.31 (d, J=4.2 Hz, 0.5H), 5.23 (m, 0.5H), 4.83-4.78 (m, 1H), 3.53-3.40 (m, 1H), 3.24-3.12 (m, 1H), 2.62 (s, 3H), 2.58-2.46 (m, 1H), 2.20-1.94 (m, 2H), 1.91-1.82 (m, 1H). ESI MS [M+H]+ for C25H21F3N3O, calcd 436.16, found 436.1.

Example 247

[Figure (not displayed)]

Step a: A suspension of NaH (1.4 g, 35.1 mmol, 60% in mineral oil) in THF (120 mL) was loaded in 250 ml single-neck round-bottom flask equipped with a stirring bar and a reflux condenser with a drying tube. Dimethyl carbonate (2.0 mL, 23.3 mmol) was added in one portion and the mixture was cooled to 0° C. Then solid 4-bromo-7-methylsulfanyl-2,3-dihydroinden-1-one (3.0 g, 11.7 mmol) was added in one portion. The reaction was allowed to warm to ambient temperature and stirred for 10 min. The resulting suspension was reflux for 3 h. Once TLC analysis indicated complete consumption of the starting material the reaction was cooled to room temperature and poured in 1M aqueous HCl solution (200 mL). The mixture was diluted with EtOAc (200 mL), the organic phase was separated, and the aqueous solution was extracted with EtOAc (2×70 mL). Combined organic extract was washed with brine (500 mL), dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the desired product (3.4 g, 10.8 mmol, 93% yield) as a yellow solid.

Step b: The solution of indanone from step a (2.6 g, 8.3 mmol) in THF (82 mL) was loaded in 250 ml single-neck round-bottom flask equipped with a stirring bar and a drying tube. The reaction mixture was cooled to 0° C., and NaH (0.35 g, 8.7 mmol, 60% in mineral oil) was added in one portion. The cooling bath was removed, and the mixture was stirred at ambient temperature for 30 min. Upon complete dissolution of NaH the reaction was cooled back to 0° C. and NFSI (3.1 g, 9.9 mmol) was added. The cooling bath was removed, and the reaction was stirred at room temperature for 30 min. Upon complete disappearance of the starting material by TLC analysis the mixture was quenched with saturated aqueous NH4Cl (70 mL) and diluted with EtOAc (150 ml) and water (100 mL). The organic phase was separated, and the aqueous solution was extracted with EtOAc (2×50 mL). Combined organic extract was dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired product (2.5 g, 7.5 mmol, 92% yield) as a yellowish solid.

Step c: The α-fluoroindanone from step b (5.1 g, 15.4 mmol) in dichloromethane (80 mL) was placed in 250 ml single-neck round-bottom flask equipped with a stirring bar and a drying tube. The solution was cooled to 0° C., then formic acid (1.75 mL, 46.2 mmol), triethylamine (4.1 mL, 30.8 mmol) and RuCl(p-cymene)[R,R-TsDPEN] (0.5 g, 0.77 mmol) were sequentially added. The reaction was stirred at 0° C. and monitored by 1H NMR every 30 min until it reached 52% conversion. Then the resulting brown solution was diluted with dichloromethane (100 mL) and washed with aqueous saturated NaHCO3 solution (100 mL). The organic phase was separated, and the aqueous solution was extracted with dichloromethane (2×30 mL). Combined organic extract was dried over Na2SO4 and concentrated to dryness. The crude residue was fractionated by column chromatography (SiO2, hexanes/EtOAc gradient) to produce enantioenriched α-fluoroindane-1-ol (2.7 g, 8.1 mmol, 53% yield) as a colorless oil and recovered α-fluoroindanone (2.1 g, 6.3 mmol, 41% yield) as a yellowish solid. The enantiopurity of indane-1-ol product was determined (88% ee) using 1H NMR after hydrolysis and amide coupling with enantiopure (R)-4-methoxy-α-methylbenzylamine.

Step d: To a solution of α-fluoroindane-1-ol from step c (1.0 g, 3.0 mmol) in tetrahydrofuran (20 mL) a solution of LiOH.H2O (1.25 g, 30 mmol) in water (20 mL) was added at ambient temperature. The resulting biphasic mixture was vigorously stirred for 20 min. Once TLC analysis indicated complete consumption of the starting material, the mixture was slowly acidified with 1M aqueous HCl to pH=3. The resulting mixture was diluted with EtOAc (40 mL), and the organic layer was separated. The aqueous phase was additionally extracted with EtOAc (20 mL). Combined organic extract was washed with brine, dried over Na2SO4 and concentrated to dryness. The crude product was used for the step e without additional purification.

Step e: β-Hydroxy acid step d (3.0 mmol) was dissolved in DMF (15 mL) and (R)-4-methoxy-α-methylbenzylamine (0.68 mL, 4.5 mmol), 1-hydroxybenzotriazole hydrate (0.86 g, 4.5 mmol, contains 20 wt. % of water) and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.86 g, 4.5 mmol) were added sequentially. After 24 h of stirring at room temperature the mixture was diluted with water (100 mL), and the crude product was extracted with EtOAc (3×40 mL). Combined organic extract was thoroughly washed with water (3×70 mL), dried over Na2SO4 and concentrated to dryness. The crude residue was fractionated by column chromatography (SiO2, hexanes/EtOAc gradient) to produce corresponding amide (1.1 g, 2.4 mmol, 81% yield) as a single diastereomer in a form of white foam.

Step f: Amide from step e (1.7 g, 3.7 mmol) was dissolved in dichloromethane (37 mL) and m-CPBA (2.2 g, 9.4 mmol, contained 25 wt. % of water) was added in one portion. The resulting solution was stirred at ambient temperature for 1 h. The resulting mixture was diluted with dichloromethane (50 mL) and sequentially washed with 2M aqueous NaOH (2×30 mL) and brine (90 mL). The organic extract was dried over Na2SO4 and concentrated to dryness. The crude sulfone-containing product was used for step g without purification.

Step g: The crude material from step f was dissolved in 35 ml of trifluoroacetic acid. The obtained solution was stirred at 65° C. for 2 h. The bright red solution was diluted with water (300 mL). The formed precipitate was removed by filtration, washed with MTBE and dried on filter for 2 h to produce the desired primary amide as a white solid (1.08 g, 3.1 mmol, 84% yield over two steps).

Step h: The primary amide product from the previous step (0.4 g, 1.1 mmol) was combined with B2Pin2 (0.35 g, 1.4 mmol), Pd(dppf)Cl2 (83.0 g, 0.11 mmol) and potassium acetate (0.2 g, 2.2 mmol) in dioxane (6 ml) in 40 mL screw cap vial equipped with a magnetic stirring bar. The mixture was degassed under vacuum, backfilled with nitrogen and heated to 100° C. for 1.5 h. After 1H NMR analysis of an aliquot indicated complete consumption of the starting material the reaction mixture was allowed to cool to ambient temperature and concentrated to dryness under reduced pressure. The residue was partitioned between EtOAc (70 mL) and water (40 mL). Organic layer was separated, and the aqueous phase was additionally extracted with EtOAc (2×20 mL). The combined organic extract was dried over Na2SO4 and the solvent was evaporated under reduced pressure to yield crude boronic pinacol ester that was used for the next step without further purification.

Step i: A solution of crude boronic pinacol ester (1.1 mmol) from the previous step and (4R)-4-[tert-butyl(dimethyl)silyl]oxy-8-cyano-6-fluoro-3,4-dihydronaphthalen-1-yl]trifluoromethanesulfonate (0.51 g, 1.1 mmol) in dioxane (6 mL) was placed in 40 mL screw cap vial equipped with a magnetic stirring bar. Then Pd(dppf)Cl2 (83 mg, 0.11 mmol) and aqueous sodium carbonate (2M solution, 1.2 ml, 2.3 mmol) were sequentially added. The mixture was degassed under vacuum, backfilled with nitrogen and heated to 100° C. for 0.5 h. Upon reaction completion, dioxane was removed under reduced pressure. The residue was partitioned between EtOAc (70 mL) and water (50 mL). Organic layer was separated, and the aqueous phase was additionally extracted with EtOAc (2×15 mL). The combined organic extract was washed with brine (50 mL), dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to yield the desired alkene (0.65 g, 1.1 mmol, 100% yield over two steps) as a brownish foam.

Step j: The alkene of step i (0.65 g, 1.1 mmol) was dissolved in dry methanol (15 mL) and added to palladium on carbon (0.25 g, 10% Pd by weight) under an atmosphere of nitrogen. The reaction mixture was placed under an atmosphere of hydrogen at 50 psi and agitated in a Parr shaker for 1 h. The excess hydrogen was vented out and the mixture was sparged with nitrogen to remove residual hydrogen gas. TLC analysis indicated incomplete reaction. Additional 0.25 g of palladium on carbon was added and the reaction was agitated under an atmosphere of hydrogen at 50 psi for additional hour. The resulting suspension was filtered through a celite pad, and the filtrate was concentrated to dryness under reduced pressure. The crude residue was subjected to column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired tetralin derivative (0.5 g, 0.9 mmol, 77% yield) as a colorless oil.

Step k: A mixture of tetralin from previous step (0.5 g, 0.9 mmol) and triethylamine (0.6 mL, 4.4 mmol) in dichloromethane (9 mL) was place in 100 mL single-neck round-bottom flask equipped with a stirring bar and a drying tube. The mixture was cooled to 0° C. and trifluoroacetic anhydride (0.4 mL, 2.6 mmol) was added dropwise over 5 min. The resulting yellow solution was stirred at 0° C. for 10 min, diluted with dichloromethane (40 mL) and sequentially washed with water (50 mL) and saturated aqueous NaHCO3 (50 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired α-fluoronitrile derivative (0.27 g, 0.5 mmol, 55% yield) as a colorless oil.

Step l: The α-fluoronitrile from step k (100.0 mg, 0.18 mmol) was dissolved in acetonitrile (2 mL) and HF.Py (0.2 mL, HF—70%, pyridine—30%) was added in one portion at ambient temperature. The reaction mixture was stirred for 1 h, diluted with EtOAc (30 mL) and carefully washed with aqueous saturated NaHCO3 (20 mL). The organic extract was washed with brine (30 mL), dried over Na2SO4 and concentrated to dryness. The crude product was purified by column chromatography (SiO2, hexanes/EtOAc gradient) to produce the desired hydroxytetralin derivative (73.0 mg, 0.16 mmol, 92% yield) as a white powder.

Step m: A solution of Deoxo-Fluor (106 μl, 0.57 mmol) in toluene (3.3 mL) was placed in 40 ml screw cap vial equipped with a magnetic stirring bar and nitrogen balloon. The solution was cooled to 0° C., then TMS-morpholine (103 μl, 0.58 mmol) was added dropwise. The reaction was stirred at 0° C. for 5 min, then the mixture was allowed to warm to room temperature and stirred for 2 h. The resulting cloudy solution was cooled to 0° C. and a solution of 1,2,3,4-tetrahydro-1-naphthol from step l (73.0 mg, 0.16 mmol) in dichloromethane (1 mL) was added dropwise over 1 min. The resulting mixture was stirred for 5 min and immediately diluted with dichloromethane (20 mL) and quenched with aqueous saturated NaHCO3 (20 mL). The organic phase was separated, dried over Na2SO4 and concentrated to dryness. The dry residue was fractionated by column chromatography (SiO2, dichloromethane/EtOAc gradient) to produce the product that was further purified by reversed phase HPLC (C18 column, water with 1% TFA/CH3CN gradient, 20 mL/min) to yield the title compound (26 mg, 0.06 mmol, 36% yield, single epimer) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.72 (d, J=8.0 Hz, 1H), 7.53 (ddd, J=8.2, 2.7, 1.3 Hz, 1H), 7.39 (ddd, J=7.5, 2.8, 1.7 Hz, 1H), 6.56 (d, J=8.1 Hz, 1H), 5.80 (dd, J=15.3, 5.0 Hz, 1H), 5.60 (dt, J=49.8, 3.6 Hz, 1H), 4.60-4.48 (m, 1H), 4.08 (ddd, J=31.8, 17.4, 1.0 Hz, 1H), 3.94 (d, J=5.2 Hz, 1H), 3.61 (dd, J=21.2, 17.4 Hz, 1H), 3.16 (s, 3H), 2.60-2.42 (m, 1H), 2.29-2.08 (m, 1H), 2.07-1.87 (m, 1H), 1.82-1.70 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −110.39 (t, J=7.8 Hz), −151.11 (ddd, J=31.8, 21.3, 15.5 Hz), −157.85. ESI MS [M+Na]+ for C22H17F3N2SO3Na, calcd 469.1, found 469.1).

Example 248

[Figure (not displayed)]

The title compound was prepared in a similar fashion to Example 247. 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J=8.1 Hz, 1H), 7.53 (ddd, J=8.3, 2.8, 1.4 Hz, 1H), 7.39 (ddd, J=7.5, 2.7, 1.7 Hz, 1H), 6.51 (d, J=8.1 Hz, 1H), 5.93 (ddd, J=11.9, 6.1, 0.6 Hz, 1H), 5.58 (dt, J=49.8, 3.5 Hz, 1H), 4.69-4.51 (m, 1H), 4.07 (d, J=6.1 Hz, 1H), 3.96 (dd, J=18.4, 17.3 Hz, 1H), 3.58 (dd, J=21.7, 16.9 Hz, 1H), 3.24 (s, 3H), 2.65-2.40 (m, 1H), 2.24-2.08 (m, 1H), 1.98-1.79 (m, 1H), 1.74-1.62 (m, 1H). 19F NMR (376 MHz, CDCl3) δ −110.4 (t, J=8.7 Hz), −157.3 (m), −170.6 (m). ESI MS [M+Na]+ for C22H17F3N2SO3Na, calcd 469.1, found 469.1.

Analytical Methods:

LC: Agilent 1100 series; Mass spectrometer: Agilent G6120BA, single quad

LC-MS method: Agilent Zorbax Eclipse Plus C18, 4.6×100 mm, 3.5 μM, 35° C., 1.5 mL/min flow rate, a 2.5 min gradient of 0% to 100% B with 0.5 min wash at 100% B; A=0.1% of formic acid/5% acetonitrile/94.9% water; B=0.1% of formic acid/5% water/94.9% acetonitrile

Flash column: ISCO Rf+

Reverse phase HPLC: ISCO-EZ or Agilent 1260; Column: Kinetex 5 μm EVO C18 100 A; 250×21.2 mm (Phenomenex)

Full text: Click here
Patent 2022
Not available on PMC !

Example 1

The 7-aza-thienylpyridine compounds in Table 1 can be synthesized using methods described in Example 1. For some compounds, some of the reactions described in Example 2 and/or Example 3, below, can be used to prepare the compounds.

[Figure (not displayed)]

To dry N-isopropylpropan-2-amine (1.2 equiv.) in THE (0.3 M) at 0° C. is added n-butyllithium (2.5 M in hexane) (1.2 equiv.) slowly and the mixture is stirred for 10 min. The LDA solution in THE is used directly. To a solution of 3-bromo-2-chloro-5-fluoro-pyridine (A, 1 equiv.) in THE (0.3 M) at −78° C. is added the LDA solution and the resulting dark mixture is stirred for 45 min. Chloro(trimethyl)silane (1.7 equiv.) is added and the mixture is allowed to warm to rt within ca. 15 h. The reaction mixture is quenched with water, the layers separated, and the aqueous layer extracted with ethylacetate. The organic layers are combined, evaporated with silica gel and the free-flowing silica gel is loaded on a column and (3-bromo-2-chloro-5-fluoro-6-methyl-4-pyridyl)-trimethyl-silane (B) is purified by silica gel chromatography.

To a solution of (3-bromo-2-chloro-5-fluoro-4-pyridyl)-trimethyl-silane (B, 1 equiv.) in THE (0.25 M) at −78° C. is added LDA solution (1.2 equiv.) prepared as above and the resulting dark mixture is stirred for 45 min. Iodomethane (10 equiv.) is added and the mixture is allowed to warm to rt within ca. 15 h. The reaction mixture is quenched with water, the layers separated, and the aqueous layer further extracted with ethylacetate. The organic layers are combined, evaporated with silica gel and the free-flowing silica gel loaded on a column and (3-bromo-2-chloro-5-fluoro-6-methyl-4-pyridyl)-trimethyl-silane (C) is purified via silica gel chromatography.

(3-bromo-2-chloro-5-fluoro-6-methyl-4-pyridyl)-trimethyl-silane (C, 1 equiv.) is dissolved in THE (0.67 M), cooled to 0° C., and tetrabutylammonium fluoride (in THF) (1.2 equiv.) is added and the mixture stirred at 0° C. After 10 min the reaction is quenched with NH4Cl(aq) and diluted with EtOAc. The organic phase is washed with water twice, dried, filtered, concentrated, and loaded on a column and 3-bromo-2-chloro-5-fluoro-6-methylpyridine (D) is purified via silica gel chromatography.

[Figure (not displayed)]

To a solution of 3-bromo-2-chloro-5-fluoro-6-methylpyridine (A, 1 equiv.) in tetrahydrofuran (0.40 M) at −96° C. (internal temperature), lithium diisopropylamide solution (1.2 equiv.; 2 M in tetrahydrofuran) is added over a period of 60 min, maintaining internal temperature between −96 to −84° C. and the reaction mixture is maintained at −96 to −90° C. for 2 h. Carbon dioxide gas is purged into the reaction mixture for 35 minutes, maintaining internal temperature at −95 to −78° C. Progress of the reaction is monitored by TLC and the reaction mixture is warmed to −50 to −45° C., quenched with saturated aqueous ammonium chloride solution, and stirred for 10 min. The solution is acidified to pH 2.0-1.5 with 6 N hydrochloric acid, diluted with ethyl acetate and the organic layer washed with water. The aqueous layer is extracted with ethyl acetate and the combined organic layers are concentrated under reduced pressure, stirred in dichloromethane and the solid precipitated is filtered, washed with dichloromethane, and dried under vacuum to afford 3-bromo-2-chloro-5-fluoro-6-methylisonicotinic acid (B).

To a solution of 3-bromo-2-chloro-5-fluoro-6-methylisonicotinic acid (B, 1 equiv.) in N,N-dimethylformamide (0.32 M), acetamidine hydrochloride (C, 1.4 equiv.) is added and reaction mixture is cooled at 0° C. N,N-di-isopropylethylamine (5 equiv.) and HATU (1.1 equiv.) are added and reaction mixture is stirred at room temperature for 1 h. The reaction mixture is diluted with water, extracted with ethyl acetate and the combined organic layers are dried over anhydrous sodium sulphate, filtered and concentrated to afford 3-bromo-2-chloro-5-fluoro-N-(1-iminoethyl)-6-methylisonicotinamide (D).

To a stirred solution of 3-bromo-2-chloro-5-fluoro-N-(1-iminoethyl)-6-methylisonicotinamide (D, 1 equiv.) in tetrahydrofuran (2 M), sodium hydride (60%) (1 equiv.) is added at 0° C. and stirred for 1 h at 0° C. The reaction mass is slowly warmed to room temperature and stirred for 16 h. The reaction mass is cooled to 0° C., acidified with 2 N hydrochloric acid (pH˜2), and the resulting solid filtered, washed with 10% methanol in diethyl ether and dried to afford 5-bromo-6-chloro-2,8-dimethylpyrido[3,4-d]pyrimidin-4(3H)-one (E).

To a stirred solution of 5-bromo-6-chloro-2,8-dimethylpyrido[3,4-d]pyrimidin-4(3H)-one (E, 1 equiv.) in N,N-dimethylformamide (0.056 M), copper(I) cyanide (1.2 equiv.) is added at room temperature. The reaction is heated to 100° C. and stirred for 16 h. The reaction is quenched with 1 N hydrochloric acid, and the solid is filtered, washed with diethyl ether, and purified by via chromatography to afford 6-chloro-2,8-dimethyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (F).

5-bromo-6-chloro-2,8-dimethylpyrido[3,4-d]pyrimidin-4(3H)-one (E, 1 equiv.), copper(I) cyanide (1.2 equiv.), and NMP (0.072 M) are combined in a sealable vessel with a stir bar. The resulting mixture is sealed, stirred, and heated at 90° C. for 20 h. Upon cooling to room temperature, the reaction mixture is diluted with 1% TFA in acetonitrile, filtered, and purified via chromatography to afford 6-chloro-2,8-dimethyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (F).

To a solution of 5-bromo-6-chloro-2,8-dimethylpyrido[3,4-d]pyrimidin-4(3H)-one (E, 1 equiv.) in N,N-dimethylacetoamide (0.07 M) is added dicyanozinc (1.4 equiv.) and tetrakis(triphenylphosphine)palladium (2.0 equiv.) at room temperature. The mixture is degassed with argon for 5 min, and stirred for 5 h at 130° C. Upon cooling to room temperature, the mixture is diluted with dimethyl sulfoxide and acetonitrile and purified by chromatography to afford 6-chloro-2,8-dimethyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (F).

[Figure (not displayed)]

A solution of 6-chloro-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (A, 1 equiv.) in dimethyl sulfoxide (0.23 M) is purged with argon gas for 10 minutes. 18-Crown-6 ether (1.5 equiv.) and potassium fluoride (5 equiv.) are added to the reaction mixture and purging is continued for 5 minutes and stirred in a preheated oil bath at 160° C. for 2 h. The reaction mixture is cooled, poured on to ice cold water, extracted with ethyl acetate, and the ethyl acetate layer washed with brine solution, dried over anhydrous sodium sulphate, concentrated, and triturated with diethyl ether to get 6-fluoro-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (B).

[Figure (not displayed)]

To a solution of tert-butyl methyl(piperidin-4-yl)carbamate (A, 1 equiv.) and N,N-diisopropylethylamine (10 equiv.) in acetonitrile (0.35 M), 2,2,2-trifluoroethyl trifluoromethanesulfonate (2, 1.25 equiv.) is added dropwise and the mixture stirred at room temperature for 16 h. The reaction mixture is diluted with water, extracted with dichloromethane, and the organic layer dried over anhydrous sodium sulphate, filtered, concentrated, and purified by flash column chromatography to afford tert-butyl methyl(1-(2,2,2-trifluoroethyl)piperidin-4-yl)carbamate (C).

A solution of tert-butyl methyl(1-(2,2,2-trifluoroethyl)piperidin-4-yl)carbamate (C, 1 equiv.) in hydrochloride (4 M solution in 1,4-dioxane, 0.34 M) is stirred at room temperature for 4 h. The reaction mixture is concentrated to afford N-methyl-1-(2,2,2-trifluoroethyl)piperidin-4-amine hydrochloride (D).

A solution of 6-chloro-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (E, 1 equiv.) and N-methyl-1-(2,2,2-trifluoroethyl)piperidin-4-amine hydrochloride (D, 3 equiv.) in N,N-dimethylacetamide (0.24 M), potassium fluoride (8 equiv.) and 18-crown-6 (1 equiv.) are added and the reaction mixture heated at 130° C. for 16 h. The reaction mixture is cooled, diluted with water, extracted with ethyl acetate, and the organic layer washed with water, dried over anhydrous sodium sulphate, filtered, concentrated, and purified by flash column chromatography to afford 2-methyl-6-(methyl(1-(2,2,2-trifluoroethyl)piperidin-4-yl)amino)-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (F).

[Figure (not displayed)]

1,4-Dioxane (24 mL) and water (8 mL) is added to a mixture of 2,3-dibromo-5-fluoropyridine (A, 3000 mg, 11.8 mmol), cyclopropylboronic acid (1112 mg, 12.9 mmol), and cesium carbonate (8436 mg, 25.9 mmol). The mixture is bobbled with argon bubbling for 5 min. Tetrakis(triphenylphosphine)palladium (680 mg, 0.590 mmol) is added to the mixture, and the mixture is vacuumed and backfilled with argon three times. The resulting clear yellow reaction mixture is stirred for 72 h at 110° C. The mixture is diluted with ethyl acetate, and washed with brine, dried over anhydrous magnesium sulfate, and concentrated in vacuo after filtration. Purification by silica gel column chromatography (0 to 5% ethyl acetate in hexane) gave 3-bromo-2-cyclopropyl-5-fluoropyridine (B).

n-Butyllithium (2.5 M in hexane, 2.1 mL, 5.30 mmol) is added to a stirred solution of diisopropylamine (0.81 mL, 5.80 mmol) in THE (5 mL) at 0° C. under argon. The resulting light yellow solution is stirred for 10 min at 0° C. and then added slowly to a stirred solution of 3-bromo-2-cyclopropyl-5-fluoropyridine (B, 1000 mg, 4.60 mmol) in tetrahydrofuran (20 mL) at −78° C. under argon. The resulting yellow reaction mixture is stirred at −78° C. under argon for 30 min and then carbon dioxide gas is bubbled in for 2 min. The mixture is stirred at −78° C. for 10 min and then warmed to room temperature over 5 min. The reaction is diluted with 0.1 N sodium hydroxide, and extracted with diethyl ether. Water layer is acidified by 3 M hydrogen chloride, and extracted with ethyl acetate twice, dried over anhydrous magnesium sulfate, and concentrated in vacuo after filtration to afford 3-bromo-2-cyclopropyl-5-fluoroisonicotinic acid (C).

To a N,N-dimethylformamide (14 mL) solution of 3-bromo-2-cyclopropyl-5-fluoroisonicotinic acid (C, 730. mg, 2.81 mmol) is added 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (1387 mg, 3.60 mmol) and N,N-diisopropylethylamine (2.0 mL, 11.2 mmol) at 0° C. The mixture is stirred for 5 min at room temperature, and acetamidine hydrochloride (D, 345 mg, 3.60 mmol) is added to the mixture. After stirring the mixture for 17 h at room temperature, ice-cold water is added to the mixture, and extracted with ethyl acetate twice. The combined extracts are washed with aqueous solution of ammonium chloride, aqueous solution of sodium bicarbonate, and brine, dried over anhydrous magnesium sulfate, and concentrated in vacuo after filtration. The residue is dissolved tetrahydrofuran (18 mL), and sodium hydride (60% in mineral oil, 225 mg, 5.60 mmol) is added to the mixture at 0° C. After stirring the mixture for 18 h, ice-cold water is added to the mixture, and extracted with ethyl acetate three times, dried over anhydrous magnesium sulfate, and concentrated in vacuo after filtration. The residue is triturated with dichloromethane, and filtered to afford 5-bromo-6-cyclopropyl-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (E).

[Figure (not displayed)]

To a solution of ethyl 3-amino-6-chloro-5-cyano-2-methylisonicotinate (A, 0.90 g, 3.75 mmol) in 1,4-dioxane and water (4:1, 10.0 mL), phenylboronic acid (B, 0.68 g, 5.62 mmol) and potassium carbonate (1.53 g 11.25 mmol) are added. The reaction mixture is purged with argon for 5 min. Then, [1,1-bis(diphenylphospino)ferrocene] dichloropaladium(II) (complex with dichloromethane, 0.031 g, 0.037 mmol) is added and the reaction mixture is heated at 90° C. for 5 h. After this time, the reaction mixture is cooled, diluted with water, and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to obtain the crude product. This is purified by silica gel (100-200 mesh) column chromatography using 30-40% ethyl acetate in hexane to afford ethyl 3-amino-5-cyano-2-methyl-6-phenylisonicotinate (C).

To a solution of ethyl 3-amino-5-cyano-2-methyl-6-phenylisonicotinate (C, 0.6 g, 2.13 mmol) in tetrahydrofuran and water (4:1, 6 mL) at room temperature, lithium hydroxide (0.44 g, 10.67 mmol) is added. This reaction mixture is stirred at room temperature for 2 h. After this time, the reaction mixture is diluted with water, acidified with 1 N hydrochloric acid, and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to obtain the crude product. This is washed with diethyl ether to afford 3-amino-5-cyano-2-methyl-6-phenylisonicotinic acid (D).

To a solution of 3-amino-5-cyano-2-methyl-6-phenylisonicotinic acid (D, 0.5 g, 1.97 mmol) in N,N-dimethylformamide (5.0 mL), ammonium chloride (0.31 g, 5.92 mmol) and 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (0.840 g, 2.21 mmol) are added. This reaction mixture is cooled to 0° C., N,N-di-isopropylethylamine (2.7 mL, 14.70 mmol) is added, and the reaction mixture is stirred at 0° C. for 10 min. Then, the reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to obtain the crude product. This is purified by silica gel (100-200 mesh) column chromatography using 30-40% ethyl acetate in hexanes to afford 3-amino-5-cyano-2-methyl-6-phenylisonicotinamide (E).

A solution of 3-amino-5-cyano-2-methyl-6-phenylisonicotinamide (E, 0.4 g, 1.19 mmol), in triethylorthoacetate and acetic acid (4:1, 4 mL) is heated at 130° C. for 2 h under microwave. After this time, the reaction mixture is cooled, diluted with hexanes, and filtered to afford 2,8-dimethyl-4-oxo-6-phenyl-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (F).

[Figure (not displayed)]

To a stirred mixture of 3-chloro-5-fluoroisonicotinic acid (A, 1 equiv.) in diethyl carbonate (0.29 M) and water (0.44 M) under argon is added sodium 4,4-difluorocyclohexane-1-sulfinate (B, 3 equiv.) and the mixture is cooled to 0° C. tert-Butyl hydroperoxide (70 wt. % in water) (10 equiv.) is added and the mixture is stirred for 5 min then heated at 90° C. under argon with an oil bath for 3 h. Volatiles are removed on a rotary evaporator. The residue is taken up in a mixture of water, acetonitrile and TFA, filtered, and purified via preparatory HPLC to afford a mixture of 3-chloro-2-(4,4-difluorocyclohexyl)-5-fluoroisonicotinic acid (C) and 5-chloro-2-(4,4-difluorocyclohexyl)-3-fluoroisonicotinic acid (D).

HATU (1.1 equiv.) is added to a stirred solution of 3-chloro-2-(4,4-difluorocyclohexyl)-5-fluoroisonicotinic acid (C) and 5-chloro-2-(4,4-difluorocyclohexyl)-3-fluoroisonicotinic acid (D 1 equiv.) in DMF (0.46 M) at room temperature under argon. After 2 min N,N-diisopropylethylamine (1.1 equiv.) is added. After stirring at room temperature for 35 min a solution of acetamidine hydrochloride (2 equiv.) and N,N-diisopropylethylamine (2.2 equiv.) in DMF (5.6 M) (this is heated with a heat gun and sonicated to get all of the acetamidine dissolved) is added. The resulting solution is stirred vigorously at room temperature under argon for 1.5 h. The reaction mixture is diluted with ethyl acetate and washed three times with brine. The organics are dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and dried under high vacuum to afford a viscous amber oil. The oil is dissolved in THE (0.046 M) with stirring under argon. Sodium hydride (2.2 equiv.) is added and the reaction mixture is stirred vigorously at room temperature under argon for 21 h. A solution of ammonium chloride (5 equiv.) in water (0.14 M) is added with vigorous stirring. The resulting mixture is partitioned between ethyl acetate and brine. The organics are dried over magnesium sulfate, filtered, and concentrated on a rotary evaporator. The residue is taken up in NMP, acetonitrile, and TFA, filtered, and purified via preparatory HPLC to afford 5-chloro-6-(4,4-difluorocyclohexyl)-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (E) and 5-chloro-8-(4,4-difluorocyclohexyl)-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (F)

[Figure (not displayed)]

4-Methoxybenzyl chloride (1.27 mL, 9.38 mmol) is added to a stirred mixture of 5-bromo-6-chloro-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (A, 1.98 g, 7.21 mmol) and cesium carbonate (3.29 g, 10.1 mmol) in DMA (14 mL) at room temperature under argon. The resulting mixture is stirred vigorously and heated at 50° C. under argon for 2 h. The reaction mixture is diluted with ethyl acetate (1.5 L), washed once with water, and twice with brine. The organics are dried over magnesium sulfate, filtered, concentrated on a rotary evaporator with silica gel, and purified via silica gel chromatography (0-40% ethyl acetate in dichloromethane) to afford 5-bromo-6-chloro-3-(4-methoxybenzyl)-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (B).

5-Bromo-6-chloro-3-(4-methoxybenzyl)-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (B, 1.24 g, 3.14 mmol) is dissolved in DMF (20 mL) with stirring at 90° C. under argon. Copper(I) cyanide (338 mg, 3.77 mmol) is added and the resulting clear red solution is stirred and heated at 90° C. under argon for 1 h 40 min. While still hot the reaction mixture is diluted with ethyl acetate and filtered through Celite into ethyl acetate (600 mL). The filter cake is washed with ethyl acetate. The filtrate is shaken with water to give an emulsion which is filtered. The filtrate is partitioned between ethyl acetate and brine. The organics are washed twice with brine, dried over magnesium sulfate, filtered, concentrated on a rotary evaporator with silica gel, and purified via silica gel chromatography (0-100% ethyl acetate in dichloromethane) to afford 6-chloro-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (C).

6-Chloro-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (C, 100 mg, 0.293 mmol), 1-(2-fluoroethyl)piperazine bis HCl salt (D, 120 mg, 0.587 mmol), potassium carbonate (183 mg, 1.32 mmol), and NMP (1.5 mL) are combined in a sealable vessel with a stir bar. The resulting mixture is sealed, stirred vigorously, and heated at 70° C. with an oil bath for 40 min. N,N-diisopropylethylamine (0.26 mL, 1.47 mmol) is added and the resulting mixture is sealed, stirred vigorously, and heated at 100° C. with an oil bath for 1 h. After cooling to room temperature, the reaction mixture is diluted with methanol and acetic acid (0.34 mL, 5.87 mmol). The resulting mixture is filtered and purified via preparatory HPLC (10-45% acetonitrile in water with 0.1% TFA). Fractions containing the desired product are combined and concentrated on a rotary evaporator down to ˜20 mL and then lyophilized to dryness to afford a yellow oil. The oil is dissolved in acetonitrile and loaded onto a 2-gram Strata X-C ion exchange column from Phenomenex. The column is washed sequentially with water, acetonitrile, methanol, and then 5% ammonium hydroxide in methanol. Eluent containing the desired product is concentrated on a rotary evaporator and dried under high vacuum to afford 6-(4-(2-fluoroethyl)piperazin-1-yl)-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (E).

To a stirred mixture of 6-(4-(2-fluoroethyl)piperazin-1-yl)-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (E, 28.2 mg, 0.065 mmol) in diethyl carbonate (0.4 mL) and water (0.2 mL) under argon is added bis((isopropylsulfinyl)oxy)zinc (F, 54.2 mg, 0.194 mmol) followed by tert-butyl hydroperoxide (70 wt. % in water) (0.092 mL, 0.666 mmol). The mixture is stirred and heated at 90° C. under argon with an oil bath for 10 min. The reaction mixture is diluted with NMP, acetic acid, and methanol, filtered, and purified via preparatory HPLC (15-65% acetonitrile in water with 0.1% TFA). Fractions containing the desired product are loaded onto a Strata X-C ion exchange column from Phenomenex. The column is washed sequentially with water, acetonitrile, methanol, and then 5% ammonium hydroxide in methanol. Eluent containing the desired product is concentrated on a rotary evaporator and dried under high vacuum to afford 6-(4-(2-fluoroethyl)piperazin-1-yl)-8-isopropyl-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (G).

6-(4-(2-Fluoroethyl)piperazin-1-yl)-8-isopropyl-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (G, 23.8 mg, 0.050 mmol), TFA (2 mL), and water (0.1 mL) are combined in a sealable vessel with a stir bar, sealed, stirred, and heated at 70° C. for 1 h. Volatiles are removed on a rotary evaporator. The residue is taken up in NMP and methanol, filtered, and purified via preparatory HPLC (10-40% acetonitrile in water with 0.1% TFA). Fractions containing the desired product are loaded onto a Strata X-C ion exchange column from Phenomenex. The column is washed sequentially with water, acetonitrile, methanol, and then 5% ammonium hydroxide in methanol. Eluent containing the desired product is concentrated on a rotary evaporator and dried under high vacuum to afford 6-(4-(2-fluoroethyl)piperazin-1-yl)-8-isopropyl-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (H).

[Figure (not displayed)]

To a 1,4-dioxane (5.6 mL) solution of 6-chloro-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (A, 192 mg, 0.560 mmol) is added 1-(2,2,2-trifluoroethyl)piperidin-4-ol (B, 206 mg, 1.13 mmol), cesium carbonate (367 mg, 1.13 mmol), 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (105 mg, 0.169 mmol), and tris(dibenzylideneacetone)dipalladium (103 mg, 0.113 mmol) at room temperature. The mixture is bubbled with argon for 5 min, and stirred for 2 h at 100° C. The mixture is diluted with ethyl acetate and filtered through a pad of Celite. The filtrate is concentrated in vacuo. Purification by silica gel column chromatography (0-80% ethyl acetate in hexane) gave crude 3-(4-methoxybenzyl)-2-methyl-4-oxo-6-((1-(2,2,2-trifluoroethyl)piperidin-4-yl)oxy)-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (C).

[Figure (not displayed)]

To a 1,4-dioxane (3.9 mL) solution of 6-chloro-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (1, 134 mg, 0.390 mmol) is added phenylmethanethiol (1a, 0.09 mL, 0.790 mmol), cesium carbonate (256 mg, 0.790 mmol), 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (73 mg, 0.118 mmol), and tris(dibenzylideneacetone)dipalladium (72 mg, 0.0790 mmol) at room temperature. The mixture is bubbled with argon for 5 min, and stirred for 2 h at 100° C. The mixture is diluted with ethyl acetate, and washed with 5% breech in water, dried over anhydrous magnesium sulfate, and concentrated in vacuo after filtration. Purification by preparative HPLC (C18 column, 15-85% acetonitrile in water+0.1% trifluoroacetic acid) gave 6-(benzylthio)-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (2).

To a dichloromethane (2 mL) and water (0.4 mL) solution of 6-(benzylthio)-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (2, 74 mg, 0.173 mmol) is added sulfuryl chloride (0.1 mL, 1.21 mmol) at 0° C. The mixture is stirred for 1 h at room temperature. Organic layer is separated and dried over anhydrous magnesium sulfate, and concentrated in vacuo after filtration to give crude 5-cyano-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-6-sulfonyl chloride (3).

To a dichloromethane (1.7 mL) solution of 5-cyano-3-(4-methoxybenzyl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-6-sulfonyl chloride (3, 70 mg, 0.173 mmol) is added 1-methylpiperazine (0.06 mL, 0.520 mmol) and diisopropylethylamine (0.09 mL, 0.520 mmol) at 0° C. After stirring the mixture for 1 h at room temperature, the mixture is diluted with aqueous sodium bicarbonate. Organic materials are extracted with ethyl acetate twice, dried over anhydrous magnesium sulfate, and concentrated in vacuo after filtration. Purification by preparative IPLC (C18 column, 15-60% acetonitrile in water+0.1% trifluoroacetic acid) gave 3-(4-methoxybenzyl)-2-methyl-6-((4-methylpiperazin-1-yl)sulfonyl)-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (4).

[Figure (not displayed)]

A solution of 5-bromo-2-chloro-3-fluoropyridine (1, 30.0 g, 143.6 mmol) in tetrahydrofuran (300 mL) is cooled to −78° C. and lithiumdisopropylamide (2 M in THF, 78.9 mL, 157.9 mmol) is added dropwise. This reaction mixture is stirred at −78° C. for 1 h. Then, the reaction mixture is purged with carbon dioxide gas for 15 min allowed to warm at room temperature. The reaction mixture is quenched with ammonium chloride solution and diluted with water. The aqueous layer is washed with ethyl acetate, acidified with 6 N hydrochloric acid solution, and extracted with 15% methanol in dichloromethane. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to afford 5-bromo-2-chloro-3-fluoroisonicotinic acid (2).

To solution of 5-bromo-2-chloro-3-fluoroisonicotinic acid (2, 18.0 g, 71.1 mmol) in N,N-dimethylformamide (30 mL) at 0° C., acetamidine hydrochloride (2a, 13.4 g, 142.3 mmol) is added. Then N,N-diisopropylethylamine (110 mL, 711.0 mmol) and 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (40.5 g, 106.6 mmol) are added and the reaction mixture is stirred at room temperature for 2 h. After this time, reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to afford crude 5-bromo-2-chloro-3-fluoro-N-(1-iminoethyl)isonicotinamide (3).

A solution of crude 5-bromo-2-chloro-3-fluoro-N-(1-iminoethyl)isonicotinamide (3, 18.0 g) in tetrahydrofuran (200 mL) is cooled to 0° C., then 60% sodium hydride in mineral oil (7.30 g NaH, 184.3 mmol) is added portionwise and the reaction mixture is stirred at room temperature for 12 h. After this time, the reaction mixture is poured into ice-cold water. The aqueous layer is washed with 5% methanol in dichloromethane, acidified with 6 N hydrochloric acid solution, and extracted with 10% methanol in dichloromethane. The organic layer from this extraction is dried over anhydrous sodium sulfate, filtered, and concentrated to obtain the crude product which is washed with diethyl ether to afford 5-bromo-8-chloro-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (4).

To a solution of 5-bromo-8-chloro-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (4, 8.0 g, 29.3 mmol) in N,N-dimethylformamide (80.0 mL), copper(I) cyanide (4.1 g, 46.8 mmol) is added. The reaction mixture is heated at 90° C. for 3 h. After this time, the reaction mixture is cooled, diluted with water, acidified with 6 N hydrochloric acid solution, and extracted with ethyl acetate. The organic layer is concentrated to obtain the crude product which is purified by silica gel (100-200 mesh) column chromatography using 40-50% ethyl acetate in hexanes as eluent to afford 8-chloro-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (5).

To a solution of 8-chloro-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (5, 1.0 g, 4.55 mmol) in 1,4-dioxane (15.0 mL) at room temperature, 2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane (5a, 1.0 mL, 7.5 mmol), potassium carbonate (2.0 g, 15.0 mmol), and water (2 mL) are added. This reaction mixture is degassed with nitrogen for 10 min. Then, [1,1-bis(diphenylphospino)ferrocene] dichloropaladium(II),complex with dichloromethane (0.183 g, 0.225 mmol) is added and reaction mixture is heated at 95° C. for 12 h. After this time, the reaction mixture is cooled and concentrated under reduced pressure to obtain the crude product which is purified by silica gel (100-200 mesh) column chromatography using 10% methanol in dichloromethane as eluent to afford 2,8-dimethyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (6).

[Figure (not displayed)]

Diethylaminosulfur trifluoride (1.44 mL, 10.4 mmol) is added to a stirred solution of 5-bromo-3-fluoropicolinaldehyde (1, 0.97 g, 4.75 mmol) in DCM (20 mL) at −78° C. under argon. The cold bath is removed, and the reaction mixture is allowed to warm to room temperature under argon for 1.5 h. The reaction mixture is poured into a stirred mixture of saturated aqueous sodium bicarbonate and ice. The resulting mixture is stirred vigorously at room temperature for 1 h to fully quench the reaction mixture. The phases are separated, and the aqueous phase extracted with dichloromethane. The combined organics are dried over sodium sulfate, filtered, concentrated on a rotary evaporator, and purified via silica gel chromatography (0-10% ethyl acetate in hexanes) Fractions containing the desired product are combined and concentrated on a rotary evaporator at room temperature. The residue is diluted with dry THE (5 mL) and concentrated on a rotary evaporator. The residue is dried under high vacuum for 2 min to afford 5-bromo-2-(difluoromethyl)-3-fluoropyridine (2).

[Figure (not displayed)]

A solution of 3-fluoropyridin-2-ol (1, 20.0 g, 176.9 mmol) in N,N-dimethylformamide (220.0 mL) is cooled at 0° C., bromine (10.30 mL, 194.6 mmol) is added drop wise and reaction mixture is stirred at 0° C. for 2 h. After completion reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is washed with sodium bicarbonate and brine, dried over anhydrous sodium sulphate, filtered and concentrated to get crude compound. Crude compound is purified by column chromatography using silica gel (100-200 mesh) and 2-3% methanol in dichloromethane to afford 5-bromo-3-fluoropyridin-2-ol (2).

To a solution of 5-bromo-3-fluoropyridin-2-ol (2, 11.0 g, 57.29 mmol) in N,N-dimethylformamide (110 mL), cesium carbonate (24.59 g 74.47 mmol) and sodium 2-bromo-2,2-difluoroacetate (17.04 g, 85.93 mmol) are added and reaction mixture is heated at 55° C. After completion, reaction mixture is diluted with water and extracted with diethyl ether. The organic layer is dried over anhydrous sodium sulphate, filtered and concentrated to get crude compound. Crude compound obtained is concentrated under reduced pressure to obtain crude product which is purified by column chromatography using silica gel (100-200 mesh) and 1-2% ethyl acetate in hexane to afford 5-bromo-2-(difluoromethoxy)-3-fluoropyridine (3).

[Figure (not displayed)]

To a solution of 2,8-dimethyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (1, 0.16 g, 0.8 mmol) and zinc difluoromethanesulpfinate (0.472 g, 1.6 mmol) in a mixture of dichloromethane and water (4:1, 2 mL), trifluoroaceticacid (0.06 mL, 0.8 mmol) and tert-butyl hydroperoxide (0.23 mL, 2.4 mmol) are added. This mixture is stirred at room temperature for 16 h. After this time, the reaction mixture is concentrated under reduced pressure, diluted with water, and extracted with dichloromethane. The combined organic layer is washed with water and then brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product is purified by silica gel (100-200 mesh) flash chromatography using 40% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 6-(difluoromethyl)-2,8-dimethyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (2).

[Figure (not displayed)]

A solution of 2,8-dimethyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (1, 0.200 g, 0.99 mmol) and bis(((trifluoromethyl)sulfinyl)oxy)zinc (1a, 0.662 g 1.99 mmol) is stirred in chloroform (2.0 mL) and water (2.0 mL), tert-butyl hydrogen peroxide (70%) (0.38 mL, 2.99 mmol) is added at 0° C. The reaction mixture is stirred at room temperature for 15 h. After this time, the reaction mixture is diluted water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to obtain the crude product. The crude is purified by silica gel (100-200 mesh) column chromatography using 70-80% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 2,8-dimethyl-4-oxo-6-(trifluoromethyl)-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (2).

[Figure (not displayed)]

To a solution of 6-chloro-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (1, 1.0 g, 4.54 mmol), in dichloromethane:water (1:1) (20.0 mL) is added 2,2,2-trifluoroacetic acid (10.4 mL, 13.63 mmol). Reaction mixture is stirred at room temperature for 15 min before the addition of phenylboronic acid (1a, 1.65 g, 13.63 mmol) and stirred for 40 min. Silver nitrate (0.154 g, 0.90 mmol) and Potassium persulfate (2.45 g, 9.09 mmol). is added and reaction mixture is stirred for 24 h at room temperature. After completion, reaction mixture is diluted with water and extracted with dichloromethane. The organic layer is dried over anhydrous sodium sulphate, filtered and concentrated to get crude compound. The crude is washed with 30% diethyl ether in pentene to afford 6-chloro-2-methyl-4-oxo-8-phenyl-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (2).

[Figure (not displayed)]

Zinc powder (<10 micron) (37.7 mg, 0.58 mmol) is weighed out in a dry 1 dram vial and placed under argon. DMA (0.4 mL) is added followed by iodine (3.6 mg, 0.014 mmol). The resulting mixture is stirred vigorously at room temperature under argon until the red color of iodine faded (5 min). 4-(bromomethyl)tetrahydro-2H-pyran (2a, 0.072 mL, 0.56 mmol) is added and the resulting mixture is sealed, stirred vigorously, and heated at 80° C. for 23 h. After cooling to room temperature the reaction mixture is placed under argon and 6-chloro-3-(4-methoxybenzyl)-2,8-dimethyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (2, 49.9 mg, 0.14 mmol) and bis(triphenylphosphine)nickel(II) dichloride (9.2 mg, 0.014 mmol) are added. The resulting mixture is stirred vigorously at room temperature under argon for 2.5 h and then at 50° C. for 2 h. The reaction mixture is diluted with NMP and methanol, filtered, and purified via preparatory HPLC (15-70% acetonitrile in water with 0.1% TFA). Fractions containing the desired product are combined and lyophilized to dryness to afford 3-(4-methoxybenzyl)-2,8-dimethyl-4-oxo-6-((tetrahydro-2H-pyran-4-yl)methyl)-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (3).

[Figure (not displayed)]

2,3-Dibromo-5-fluoropyridine (1, 3.15 g, 12.4 mmol), 4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane (1a, 1.93 mL, 13.6 mmol), cesium carbonate (8.86 g, 27.2 mmol), 1,4-dioxane (24 mL) and water (6 mL) are combined in a 100 mL round bottom flask with a stirbar. The atmosphere in the flask is removed under vacuum and replaced with argon twice. Tetrakis(triphenylphosphine)palladium(0) (0.71 g, 0.62 mmol) is added and the atmosphere in the flask is removed under vacuum and replaced with argon twice. The resulting clear yellow reaction mixture is stirred vigorously and heated at 100° C. under argon for 12 h. After cooling to room temperature the reaction mixture is partitioned between brine and ethyl acetate. The organics are dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and purified via silica gel chromatography (2-15% ethyl acetate in hexanes) to afford 3-bromo-5-fluoro-2-vinylpyridine (2).

Dimethylamine (40 wt. % in water) (34.1 mL, 108 mmol) is added to a stirred solution of 3-bromo-5-fluoro-2-vinylpyridine (2, 2.18 g, 10.8 mmol) in acetic acid (14.2 mL, 248 mmol). The resulting mixture is sealed, stirred vigorously, and heated at 110° C. for 68 h. After cooling to room temperature the reaction mixture is poured onto a stirred mixture of sodium hydroxide (9.93 g, 248 mmol) and sodium bicarbonate (4.53 g, 54.0 mmol) in ice water. The resulting mixture is extracted three times with dichloromethane. The combined organics are dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and purified via silica gel chromatography (0-20% methanol in dichloromethane). Fractions containing the desired product are combined and concentrated on a rotary evaporator. The residue is concentrated down from THE twice and dried under high vacuum to afford 2-(3-bromo-5-fluoropyridin-2-yl)-N,N-dimethylethan-1-amine (3).

[Figure (not displayed)]

A solution of 2,3-dibromo-5-fluoropyridine (1, 10.0 g, 39.2 mmol), tributyl(1-ethoxyvinyl)stannane (1a, 15.5 mL, 43.1 mmol) and lithium chloride (4.9 g, 117.6 mmol) in N,N-dimethylformamide (100 mL) is degassed under nitrogen for 10 minutes. Then, bis(triphenylphosphine)palladium(II) dichloride (1.3 g, 1.9 mmol) is added and the mixture is heated at 100° C. for 4 h. The reaction mixture is cooled, diluted with water and extracted with diethyl ether. The combined organic layer is washed with water, dried over anhydrous sodium sulphate, filtered and concentrated. The crude product is purified by column chromatography using silica gel (100-200 mesh) and 0-2% ethyl acetate in hexane to afford 3-bromo-2-(1-ethoxyvinyl)-5-fluoropyridine (2).

A solution of 3-bromo-2-(1-ethoxyvinyl)-5-fluoropyridine (2, 5.7 g, 23.1 mmol) in dichloromethane (60 mL) is cooled to 0° C., hydrochloric acid in 1,4-dioxane (4 m, 10 mL) is added and the mixture is stirred at room temperature for 3 h. The reaction mixture is poured into ice cold water, neutralized with sodium bicarbonate and extracted with dichloromethane. The organic layer is dried over anhydrous sodium sulphate, filtered and concentrated. The crude product is purified by column chromatography using silica gel (100-200 mesh) and 0-5% ethyl acetate in hexane to afford 1-(3-bromo-5-fluoropyridin-2-yl)ethan-1-one (3).

A solution of 1-(3-bromo-5-fluoropyridin-2-yl)ethan-1-one (3, 3.8 g, 17.4 mmol) in dichloromethane (40 mL) is cooled to 0° C., diethylaminosulfur trifluoride (23.3 mL, 174.0 mmol) is added; the mixture is stirred at room temperature for 48 h and then heated at 40° C. for 72 h. The reaction mixture is cooled, poured into crushed ice (very slowly, in portions), neutralized with sodium bicarbonate and extracted with dichloromethane. The organic layer is dried over anhydrous sodium sulphate, filtered and concentrated. The crude is purified by column chromatography using silica gel (100-200 mesh) and 0-1% ethyl acetate in hexane to afford 3-bromo-2-(1,1-difluoroethyl)-5-fluoropyridine (4).

[Figure (not displayed)]

(Trimethylsilyl)diazomethane (2 M in diethyl ether) (19.5 mL, 39.1 mmol) is added slowly to a stirred mixture (not all dissolved) of 3,5-difluoroisonicotinic acid (1, 5.18 g, 32.6 mmol) in wet Methanol (200 mL) at 0° C. The resulting cloudy mixture is stirred vigorously at 0° C. under air. Bubbling is observed during the addition and continued for 45 min. Dichloromethane (100 mL) is added followed by more (trimethylsilyl)diazomethane (2 M in diethyl ether) (19.5 mL, 39.1 mmol). The resulting clear solution is stirred vigorously at 0° C. under air for 30 min. More (trimethylsilyl)diazomethane (2 M in diethyl ether) (19.5 mL, 39.1 mmol) is added and then more (trimethylsilyl)diazomethane (2 M in diethyl ether) (19.5 mL, 39.1 mmol) is added again until LCMS indicated complete conversion of the starting material. Volatiles are removed on a rotary evaporator. The residue is taken up in dichloromethane and purified via silica gel chromatography (0-50% ethyl acetate in hexanes) (dried under high vacuum for only a few seconds) to afford methyl 3,5-difluoroisonicotinate (2).

A solution of piperidine-4-carboxylic acid (2a 1.20 g, 9.27 mmol), ammonium persulfate (2.33 g, 10.2 mmol), and silver nitrate (590 mg, 3.47 mmol) in water (8 mL) is added to a stirred mixture of methyl 3,5-difluoroisonicotinate (2, 802 mg, 4.63 mmol) in 3% sulfuric acid in water (8 mL) at 70° C. The resulting brown mixture is heated at 70° C. with vigorous stirring for 10 min (bubbling is observed) and then cooled to room temperature. The reaction mixture is heated at 70° C. and more piperidine-4-carboxylic acid (1.20 g, 9.27 mmol), ammonium persulfate (2.33 g, 10.2 mmol), and silver nitrate (590 mg, 3.47 mmol) in water (8 mL) is added. The reaction mixture is heated at 70° C. for 10 min and then cooled to room temperature. Repeat this a total of four times. The reaction mixture is basified with potassium carbonate. All volatiles are removed on a rotary evaporator. The residue is slurried with 20% methanol in dichloromethane and filtered through Celite. The filter cake is washed thoroughly with 20% methanol in dichloromethane. The filtrate is concentrated on a rotary evaporator with silica gel and purified via silica gel chromatography (0-20% methanol in dichloromethane) to afford methyl 3,5-difluoro-2-(piperidin-4-yl)isonicotinate (3).

2,2,2-Trifluoroethyl trifluoromethanesulfonate (3a, 1.05 mL, 7.32 mmol) is added to a stirred solution of methyl 3,5-difluoro-2-(piperidin-4-yl)isonicotinate (3, 625 mg, 2.44 mmol) and N,N-diisopropylethylamine (3.40 mL, 19.5 mmol) in NMP (10 mL) at room temperature under argon. The resulting mixture is stirred at room temperature under argon for 3 h. The reaction mixture is diluted with ethyl acetate, washed three times with brine, dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and purified via silica gel chromatography (0-50% ethyl acetate in hexanes) to afford methyl 3,5-difluoro-2-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)isonicotinate (4).

Methyl 3,5-difluoro-2-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)isonicotinate (4, 505 mg, 1.49 mmol), trimethyltin hydroxide (1.08 g, 5.97 mmol), and DCE (10 mL) are combined in a 100 mL round bottom flask with a stirbar. The resulting mixture is stirred vigorously and heated at 80° C. under a reflux condenser under argon for 1 h and then at 85° C. for 3 h. Volatiles are removed on a rotary evaporator. The residue is taken up in 20% methanol in dichloromethane and purified via silica gel chromatography (0-20% methanol in dichloromethane) to afford 3,5-difluoro-2-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)isonicotinic acid (5).

[Figure (not displayed)]

Lithium bis(trimethylsilyl)amide (1M in toluene) (2.23 mL, 2.23 mmol) is added slowly to a stirred solution of tert-butyl 4-cyanopiperidine-1-carboxylate (1, 469 mg, 2.23 mmol) and 3-bromo-2,5-difluoropyridine (2, 433 mg, 2.23 mmol) in toluene (5 mL) at −78° C. under argon. The cold bath is removed and the resulting orange solution is allowed to warm to room temperature with stirring under argon and allowed to stir at room temperature for 2 h. 0.2 M HCl in water (22.3 mL, 4.46 mmol) is added with vigorous stirring. The resulting mixture is extracted with ethyl acetate. The organics are washed with brine, dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and purified via silica gel chromatography (0-50% ethyl acetate in hexanes) to afford tert-butyl 4-(3-bromo-5-fluoropyridin-2-yl)-4-cyanopiperidine-1-carboxylate (3).

n-Butyllithium (2.5 M in hexane) (0.48 mL, 1.20 mmol) is added to a stirred solution of diisopropylamine (0.18 mL, 1.30 mmol) in THF (4 mL) at 0° C. under argon. The resulting light yellow solution is stirred for 10 min at 0° C. and then added slowly to a stirred solution of tert-butyl 4-(3-bromo-5-fluoropyridin-2-yl)-4-cyanopiperidine-1-carboxylate (3, 401 mg, 1.04 mmol) in THF (7 mL) at −78° C. under argon. The resulting orange reaction mixture is stirred at −78° C. under argon for 30 min and then carbon dioxide gas is bubbled in for ˜1 min. (orange color fades) After 10 min 0.1 N sodium hydroxide in water (1 mL) is added to quench the reaction mixture. The resulting mixture is partitioned between 0.1 N sodium hydroxide in water (20 mL) and diethyl ether. The organics are extracted twice more with 0.1 N sodium hydroxide in water (5 mL). The organics are discarded. The water layer is acidified with 1 N HCl in water and then extracted four times with ethyl acetate. The organics are washed with brine, dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and dried under high vacuum to afford 3-bromo-2-(1-(tert-butoxycarbonyl)-4-cyanopiperidin-4-yl)-5-fluoroisonicotinic acid (4).

HATU (366 mg, 0.964 mmol) is added to a stirred solution of 3-bromo-2-(1-(tert-butoxycarbonyl)-4-cyanopiperidin-4-yl)-5-fluoroisonicotinic acid (4, 393 mg, 0.918 mmol) in DMF (6 mL) at room temperature under argon. After 2 min N,N-diisopropylethylamine (0.19 mL, 1.10 mmol) is added. The resulting orange mixture is stirred at room temperature under argon for 20 min. A solution of acetamidine hydrochloride (174 mg, 1.84 mmol) and N,N-diisopropylethylamine (0.80 mL, 4.59 mmol) in DMF (3 mL) (this is heated with a heat gun and sonicated to get all of the acetamidine dissolved) is added. The resulting orange mixture is stirred vigorously at room temperature under argon for 2 h. The reaction mixture is diluted with ethyl acetate, washed four times with brine, dried over magnesium sulfate, filtered, and concentrated on a rotary evaporator. Dry THE (10 mL) is added and volatiles are removed on a rotary evaporator again. The residue is dried under high vacuum for 10 min. The residue is dissolved with stirring in THE (15 mL) and cooled to 0° C. under argon. Sodium hydride (44.1 mg, 1.84 mmol) is added. The cold bath is removed and the resulting cloudy orange mixture is stirred vigorously at room temperature under argon for 2.5 h. A solution of ammonium chloride (147 mg, 2.75 mmol) in water (2 mL) is added and then the resulting mixture is partitioned between ethyl acetate and brine. The organics are dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and purified via silica gel chromatography (20-100% ethyl acetate in hexanes) to afford tert-butyl 4-(5-bromo-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-6-yl)-4-cyanopiperidine-1-carboxylate (5).

tert-Butyl 4-(5-bromo-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-6-yl)-4-cyanopiperidine-1-carboxylate (5, 313 mg, 0.698 mmol), ethanol (17 mL), and lithium hydroxide (1 M in water) (6.98 mL, 6.98 mmol) are combined in a sealable vessel with a stirbar. The resulting mixture is sealed, stirred vigorously, and heated at 120° C. with an oil bath for 44 h. After cooling to room temperature the reaction mixture is diluted with methanol and concentrated on a rotary evaporator. The residue is taken up in NMP, methanol, and acetic acid (0.60 mL, 10.5 mmol), filtered, and purified via preparatory HPLC (15-60% acetonitrile in water with 0.1% TFA). Fractions containing the desired product are combined and lyophilized to dryness to afford tert-butyl 4-(5-bromo-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-6-yl)-4-carbamoylpiperidine-1-carboxylate (6).

A stirred mixture of tert-butyl 4-(5-bromo-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-6-yl)-4-carbamoylpiperidine-1-carboxylate TFA salt (6, 186 mg, 0.321 mmol) in 6 M HCl in water (7 mL) is heated at 140° C. with an oil bath for 2 min and then sealed, stirred vigorously, and heated at 140° C. with an oil bath for 2 h. More 6 M HCl in water (3 mL) is added and heating at 140° C. with an oil bath continued for another 21 h. After cooling to room temperature the reaction mixture is diluted with methanol, filtered, and purified via preparatory HPLC (5-18% acetonitrile in water with 0.1% TFA). Fractions containing the desired product are loaded onto a Strata X-C ion exchange column from Phenomenex. The column is washed sequentially with water, acetonitrile, methanol, and then 5% ammonium hydroxide in methanol. Eluent containing the desired product is concentrated on a rotary evaporator and dried under high vacuum to afford 5-bromo-2-methyl-6-(piperidin-4-yl)pyrido[3,4-d]pyrimidin-4(3H)-one (7).

[Figure (not displayed)]

To a solution of 5-fluoropyridin-2-ol (1, 9.00 g, 0.079 mol) in tetrahydrofuran (290 mL) at 0° C., Trimethylphenylammonium tribromide (29.9 g, 0.079 mol) is added slowly and reaction mixture is stirred at room temperature for 16 h. After 16 h, the reaction mixture is partitioned between ethyl acetate and water. Aqueous layer is separated and re-extracted with ethyl acetate. The combined organic layer is washed with 5% sodium metabisulphite solution, saturated brine solution, dried over anhydrous sodium sulphate, filtered and concentrated to get crude product. The crude product is purified by column chromatography using silica gel (100-200 mesh) and 0-30% ethyl acetate in hexanes afford 3-bromo-5-fluoropyridin-2-ol (2) as off white solid. Yield: 4.90 g, 27%; MS (ESI) m/z 189.99 [M−1].

To a solution of 3-bromo-5-fluoropyridin-2-ol (2, 4.10 g, 0.021 mol) in N,N-dimethylformamide (40 mL), cesium carbonate (3.48 g, 0.031 mol) and sodium 2-bromo-2,2-difluoroacetate (2a, 5.05 g, 0.025 mmol) are added and the reaction mixture is heated at 70° C. for 4 h. After completion, reaction mixture cooled down and partitioned between diethyl ether and water. Aqueous layer is separated and re-extracted with diethyl ether. The combined organic layer is washed with water, saturated brine solution, dried over anhydrous sodium sulphate, filtered and concentrated to get crude product. The crude product is purified by column chromatography using silica gel (100-200 mesh) and hexane as eluent to afford 3-bromo-2-(difluoromethoxy)-5-fluoropyridine (3)

[Figure (not displayed)]
[Figure (not displayed)]

A solution of 2,2-dimethyl-1,3-dioxane-4,6-dione (B, 1.1 equiv.) and 1,1,1-triethoxyethane (C, 0.7 M) is stirred and heated at 90° C. for 2 h. methyl 4-aminothiophene-3-carboxylate (A, 1 equiv.) is added portionwise at 90° C. under argon atmosphere and heating at 90° C. continued for 6 h. The reaction mixture is cooled to room temperature, water added, and the mixture extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The crude product is triturated with diethyl ether to afford methyl 4-((1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)ethyl)amino)thiophene-3-carboxylate (D).

A solution of methyl 4-((1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)ethyl)amino)thiophene-3-carboxylate (D, 1 equiv.) in Dowtherm A (0.5 M), is heated at 235° C. for 4 h. After completion, the reaction mass is cooled to room temperature, the precipitated solid isolated by filtration and dried in vacuo. The solid obtained is washed with diethyl ether to afford methyl 7-hydroxy-5-methylthieno[3,2-b]pyridine-3-carboxylate (E).

To a solution of methyl 7-hydroxy-5-methylthieno[3,2-b]pyridine-3-carboxylate (E, 1 equiv.) in 1,2-dichloroethane (0.22 M) are added phosphoryl trichloride (3 equiv.) and a catalytic amount of N,N-dimethylformamide at room temperature and the reaction mixture heated at 90° C. for 6 h. The reaction mixture is concentrated under reduced pressure, diluted with ice cold water, and the solution basified with 10% aqueous sodium hydroxide solution to pH ˜7-8 followed by extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered, concentrated, and purified by column chromatography to afford methyl 7-chloro-5-methylthieno[3,2-b]pyridine-3-carboxylate (F1).

To a solution of methyl 7-chloro-5-methylthieno[3,2-b]pyridine-3-carboxylate (F1, 1 equiv.) in mixture of methanol (1.7 M), water (1.7 M) and tetrahydrofuran (0.64 M) is added lithium hydroxide monohydrate (2 equiv.) at room temperature and the resulting mixture is stirred for 2 h. The solid is filtered, the filtrate is concentrated and combined with the solid. The combined solids are acidified with saturated citric acid solution (up to pH=1) and filtered. The resulting solid is washed with methanol followed by diethyl ether and dried under high vacuum to afford 7-chloro-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (F2).

To a solution of 7-chloro-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (F2, 1 equiv.) in tert-butyl alcohol (0.4 M) is added 4-dimethylaminopyridine (1 equiv.) and Boc-anhydride (3 equiv.) at room temperature. The mixture is stirred for 48 h at 90° C. and the reaction mixture is concentrated under reduced pressure. The crude product is purified by column chromatography over silica gel to afford tert-butyl 7-chloro-5-methylthieno[3,2-b]pyridine-3-carboxylate (F3).

To a solution of tert-butyl 7-chloro-5-methylthieno[3,2-b]pyridine-3-carboxylate (F3, 1 equiv.) and (5-chloro-2-hydroxyphenyl)boronic acid (G, 1.2 equiv.), in 1,4-dioxane (0.5 M) and water (1.2 M) is added potassium carbonate solution (2 equiv.) at room temperature and the reaction mixture degassed with argon for 20 minutes. [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloride (0.05 equiv.) is added and mixture heated at 90° C. for 2 h. The reaction mixture is cooled to room temperature and filtered and the solid, washed with water followed by methanol, and dried under vacuum to afford tert-butyl 7-(5-chloro-2-hydroxyphenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (H).

To a solution of tert-butyl 7-(5-chloro-2-hydroxyphenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (H, 1 equiv.) in acetone (0.28 M) are added potassium carbonate (3.5 equiv.) and 1,2-dibromoethane (I, 5.0 equiv.) at room temperature and the reaction mixture heated at 40° C. for 12 h. An additional 5.0 equiv. of 1,2-dibromoethane is then added at room temperature and the mixture heated to 45° C. The reaction mixture is filtered through a sintered funnel, washed with acetone, and the filtrate concentrated and purified by column chromatography to afford tert-butyl 7-(2-(2-bromoethoxy)-5-chlorophenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (J).

[Figure (not displayed)]

A solution of 2-bromo-4-chloro-1-iodobenzene (A, 1 equiv.) and prop-2-yn-1-ol (B, 1.3 equiv.) in triethylamine (0.3 M) is degassed with argon for 10 min. Copper(I) iodide (0.15 equiv.) and bis(triphenylphosphine)palladium chloride (0.08 equiv.) are added and the reaction mixture stirred at room temperature for 16 h. The reaction mass is concentrated under reduced pressure and the crude compound purified by Combi-flash to afford 3-(2-bromo-4-chlorophenyl)prop-2-yn-1-ol (C).

To a solution of 3-(2-bromo-4-chlorophenyl)prop-2-yn-1-ol (C, 1 equiv.) in tetrahydrofuran (0.8 M) are added imidazole (3 equiv.), 4-dimethylaminopyridine (0.045 equiv.) and tert-butyldimethylchlorosilane (1.2 equiv.) at room temperature and the reaction mixture stirred for 24 h. The reaction mass is diluted with water, extracted with ethyl acetate and the organic layer separated, dried over anhydrous sodium sulphate, and purified by Combi-flash to afford ((3-(2-bromo-4-chlorophenyl)prop-2-yn-1-yl)oxy)(tert-butyl)dimethylsilane (D).

To a solution of ((3-(2-bromo-4-chlorophenyl)prop-2-yn-1-yl)oxy)(tert-butyl)dimethylsilane (D, 1 equiv.) in tetrahydrofuran (0.14 M) is added dropwise n-butyllithium (1.23 M in hexanes, 1.3 equiv.) at −78° C. and the mixture stirred at −78° C. for 1 h. 2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (E, 1.2 equiv.) is added dropwise at −78° C. and stirring continued for 1 h. The reaction is quenched with chilled water, extracted with ethyl acetate, and the organic layer separated, dried over anhydrous sodium sulphate, concentrated, and purified by Combi-flash to afford tert-butyl((3-(4-chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)prop-2-yn-1-yl)oxy)dimethylsilane (F).

[Figure (not displayed)]

To a solution of methyl 7-(2-(3-((tert-butyldimethylsilyl)oxy)prop-1-yn-1-yl)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.) in tetrahydrofuran (0.21 M) is added tetra-n-butylammonium fluoride (1.2 equiv.) at room temperature and the mixture stirred for 2 h. The reaction mass is diluted with ethyl acetate, washed with cold water and the organic layer separated, dried over anhydrous sodium sulphate, concentrated, and triturated with diethyl ether to afford methyl 7-(5-chloro-2-(3-hydroxyprop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylate (B).

To a solution of methyl 7-(5-chloro-2-(3-hydroxyprop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylate (B, 1 equiv.) in dichloromethane (10.0 mL) is added triphenylphosphine (1.5 equiv.) at room temperature and the reaction mixture cooled to 0° C. Carbontetrabromide (1.5 equiv.) is added and the reaction mixture stirred for 3 h at room temperature. The reaction mass is concentrated and purified by Combi-flash to afford methyl 7-(2-(3-bromoprop-1-yn-1-yl)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (C).

[Figure (not displayed)]

A solution of methyl 7-hydroxy-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.) and phosphorous oxybromide (10 equiv.) in 1,2 dichloroethane (0.45 M) is heated at 80° C. for 16 h. The reaction mixture is cooled to room temperature, quenched with aqueous solution of sodium bicarbonate, extracted with dichloromethane, and the combined organic layer washed with brine, dried over anhydrous sodium sulphate, filtered, concentrated, and purified by column chromatography to afford methyl 7-bromo-5-methylthieno[3,2-b]pyridine-3-carboxylate (B).

A solution of methyl 7-bromo-5-methylthieno[3,2-b]pyridine-3-carboxylate (B, 1 equiv.) and lithium hydroxide (3 equiv.) in methanol:tetrahydrofuran:water solvent mixture (1:2:1, 0.25 M) is stirred at room temperature for 16 h. The reaction is diluted with water, cooled to 0° C. and acidified with 1 N hydrochloric acid to pH ˜5. The precipitate is filtered, washed with pentane and dried to afford 7-bromo-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (C)

To a solution of 7-bromo-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (C, 1 equiv.) and methanesulfonamide (D, 1.5 equiv.) in dichloromethane (0.16 M), N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride (2 equiv.) and N,N-dimethylpyridin-4-amine (2.5 equiv.) are added at room temperature and the mixture stirred for 16 h. The reaction is diluted with water, cooled to 0° C., acidified with 1 N hydrochloric acid to pH ˜2 and extracted with dichloromethane. The combined organic layer is dried over anhydrous sodium sulphate, concentrated, and purified by column chromatography to afford 7-bromo-5-methyl-N-(methylsulfonyl)thieno[3,2-b]pyridine-3-carboxamide (E).

[Figure (not displayed)]

To a solution of tert-butyl 7-bromo-5-methylthieno[3,2-b]pyridine-3-carboxylate (1, 1.50 g, 4.5 mmol) in 1,4-dioxane is added selenium dioxide (0.55 g, 5.02 mmol) and reaction mixture is heated at 95° C. for 8 h. After completion, the reaction mixture is filtered over Celite bed and washed with ethyl acetate. The filtrate obtained is concentrated under reduced pressure to get crude product. The crude product obtained is purified by column chromatography using silica gel (100-200 mesh) and 10% ethyl acetate in hexanes to afford tert-butyl 7-bromo-5-formylthieno[3,2-b]pyridine-3-carboxylate (2).

To a solution of tert-butyl 7-bromo-5-formylthieno[3,2-b]pyridine-3-carboxylate (2, 0.55 g, 1.62 mmol) in methanol (6 mL) at 0° C. is added sodium borohydride (0.12 g, 3.25 mmol) and reaction mixture is stirred at same temperature for 1 hour. After completion, the reaction mixture is quenched with ice water and concentrated under reduced pressure. The crude material is dissolved in ethyl acetate, washed with water, brine solution, dried over anhydrous sodium sulphate, filtered and concentrated to get crude compound. The crude compound obtained is purified by column chromatography using silica gel (100-200 mesh) and 20% ethyl acetate in hexanes to afford tert-butyl 7-bromo-5-(hydroxymethyl)thieno[3,2-b]pyridine-3-carboxylate (3).

To a solution of tert-butyl 7-bromo-5-(hydroxymethyl)thieno[3,2-b]pyridine-3-carboxylate (3, 0.325 g, 0.94 mmol) in dichloromethane (5 mL) at −78° C., DAST (0.18 mL, 1.41 mmol) is added and reaction mixture is stirred at −78° C. for 1 hour. After completion, reaction mixture is quenched with ice cold water and extracted with dichloromethane. The organic layer is washed saturated solution of sodium bicarbonate, dried over anhydrous sodium sulphate, filtered and concentrated to get crude compound. The crude compound obtained is purified by column chromatography using silica gel (100-200 mesh) and 10% ethyl acetate in hexane to get tert-butyl 7-bromo-5-(fluoromethyl)thieno[3,2-b]pyridine-3-carboxylate (4).

[Figure (not displayed)]

A solution of tert-butyl 7-bromo-5-methylthieno[3,2-b]pyridine-3-carboxylate (1, 500.0 mg, 1.523 mmol), Azobisisobutyronitrile (24.98 mg, 0.152 mmol) and N-Bromosuccinimide (271.13 mg, 1.523 mmol) in carbon tetrachloride (10 mL) is stirred at 90° C. for 5 h. After completion, reaction mixture is concentrated under reduced pressure and is diluted with dichloromethane and silica gel is added. The solvent is evaporated. The crude silica mixture is purified by Isco column chromatography using 0-10% methanol in dichloromethane as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 7-bromo-5-(bromomethyl)thieno[3,2-b]pyridine-3-carboxylate (2)

To a stirred solution of tert-butyl 7-bromo-5-(bromomethyl)thieno[3,2-b]pyridine-3-carboxylate (2, 0.200 g, 0.491 mmol) in methanol (0.2 mL) and N-methylpyrrolidone (2.0 mL) is added cesium carbonate (0.480 g, 1.474 mmol) at RT and reaction mixture is stirred at room temperature for 8 h. After completion, the reaction mixture is diluted with dichloromethane and then silica gel is added. The solvent is then evaporated and the free flow silica gel is then loaded on the column and purified via silica gel chromatography eluting with methanol in dichloromethane to afford tert-butyl 7-bromo-5-(methoxymethyl)thieno[3,2-b]pyridine-3-carboxylate (3).

[Figure (not displayed)]
[Figure (not displayed)]

To a stirred solution of 4-methoxybenzyl alcohol (8.1 g, 59.1 mmol) in N,N-dimethylformamide (100 mL) at 0° C., sodium hydride (3.1 g, 65.0 mmol) is added. This reaction mixture is stirred at 0° C. for 30 min. Then, 7-chlorothieno[3,2-b]pyridine (1, 10 g, 59.1 mmol) is added at 0° C. and reaction mixture is stirred for 16 h at room temperature. After this time, the mixture is poured into ice. The resulting precipitate is collected by filtration and dried under reduced pressure to afford 7-((4-methoxybenzyl)oxy)thieno[3,2-b]pyridine (2).

To a stirred solution of 7-((4-methoxybenzyl)oxy)thieno[3,2-b]pyridine (2, 8.0 g, 29.5 mmol) in dry tetrahydrofuran (250 mL), n-butyllithium (2.3 M in hexanes, 38.0 mL, 64.9 mmol) is added dropwise at −78° C. This reaction mixture is stirred at the same temperature for 45 min. Then, carbon tetrabromide (9.7 g, 29.5 mmol) is added at −78° C. and the mixture is stirred at same temperature for 1 h. After this time, the reaction is quenched with saturated aqueous ammonium chloride solution and extracted with ethyl acetate. The organic layer is washed with water, dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product is purified by silica gel (100-200 mesh) column chromatography using 15% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 2-bromo-7-((4-methoxybenzyl)oxy)thieno[3,2-b]pyridine (3).

A solution of 2-bromo-7-((4-methoxybenzyl)oxy)thieno[3,2-b]pyridine (3, 6.5 g, 18.62 mmol) in a mixture of trifluoroacetic acid and dichloromethane (1:1, 40 mL) is stirred at room temperature for 8 h. After this time, the reaction mixture is concentrated under reduced pressure. The crude product is recrystallized with ether and pentanes to afford 2-bromothieno[3,2-b]pyridin-7-ol (4).

To a solution of 2-bromothieno[3,2-b]pyridin-7-ol (4, 3.5 g, 15.28 mmol) in methanol (30 mL), 30% sodium methoxide in methanol (14.0 g, in methanol, 76.4 mmol) and copper(I) bromide (0.200 g, 1.5 mmol) are added. This reaction mixture is stirred at 120° C. for 30 h. After this time, the reaction mixture is concentrated under reduced pressure, acidified with 2 N hydrochloric acid to pH-6, and extracted with 10% methanol in dichloromethane. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to afford 2-methoxythieno[3,2-b]pyridin-7-ol (5).

A mixture of 2-methoxythieno[3,2-b]pyridin-7-ol (5, 1.7 g, 9.39 mmol) and phosphoryl chloride (10 mL) is heated and stirred at 900° C. for 6 h. After this time, the reaction mixture is quenched with ice, treated with aqueous 50% sodium hydroxide solution, and extracted with ethyl acetate. The organic layer is washed with water and then saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The crude product is purified by Combiflash using 30% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 7-chloro-2-methoxythieno[3,2-b]pyridine (6).

To a solution of 3-bromo-7-chloro-2-methoxythieno[3,2-b]pyridine (6, 0.8 g, 4.02 mmol) in N,N-dimethylformamide (10 mL) at room temperature, N-bromosuccinimide (1.4 g, 8.04 mmol) is added. This reaction mixture is stirred for 30 min. Then, the reaction mixture is poured into ice and extracted with ethyl acetate. The organic layer is washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated to dryness under reduced pressure. The crude product is purified by Combiflash (12 g, RediSep column) using 10% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 3-bromo-7-chloro-2-methoxythieno[3,2-b]pyridine (7).

To a stirred solution of 3-bromo-7-chloro-2-methoxythieno[3,2-b]pyridine (7, 0.7 g, 2.52 mmol) in dry tetrahydrofuran (10 mL), n-butyllithium (2.3 M in hexanes, 1.97 mL, 4.54 mmol) is added dropwise at −78° C. This reaction mixture is stirred at the same temperature for 45 min. Dry carbon dioxide gas is bubbled through the reaction mixture, which is slowly warmed up to room temperature and stirred for 16 h. The reaction mixture is quenched with 10% aqueous citric acid solution and extracted with 10% methanol in dichloromethane. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to afford 7-chloro-2-methoxythieno[3,2-b]pyridine-3-carboxylic acid (8).

To a solution of 7-chloro-2-methoxythieno[3,2-b]pyridine-3-carboxylic acid (8, 0.5 g, 2.05 mmol) in N,N-dimethylformamide (5.0 mL) at room temperature, potassium carbonate (0.85 g, 6.17 mmol) and methyl iodide (0.32 g, 2.26 mmol) are added. This reaction mixture is stirred for 16 h. After this time, the reaction mixture is poured into ice and extracted with ethyl acetate. The organic layer is washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated to dryness under reduced pressure. The crude product is purified by Combiflash (12 g, RediSep column) using 2% methanol in dichloromethane as eluent. The desired fractions are concentrated under reduced pressure to afford methyl 7-chloro-2-methoxythieno[3,2-b]pyridine-3-carboxylate (9).

[Figure (not displayed)]

To a stirred solution of 3-bromobenzoic acid (1, 100.0 g, 497.5 mmol) in N,N-dimethylformamide (800 mL), carbodiimidazole (112.9 gm, 696.5 mmol) is added at room temperature and the reaction mixture is heated and stirred at 50° C. for 1 h. 1,8-Diazabicyclo[5.4.0]undec-7-ene (105.8 gm, 696.5 mmol) and tert-butanol (184.37 gm, 2487.5 mmol) are added at 50° C. and the reaction mixture is continued to stir at 50° C. for 16 h. After completion, the reaction mass is quenched with water and extracted with ethyl acetate. The organic layer is separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure. The crude product obtained is purified by column chromatography using 100-200 silica gel and 2% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 3-bromobenzoate (2).

A stirred solution of tert-butyl 3-bromobenzoate (2, 113.0 g, 439.4 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (3, 167.43 gm, 659.1 mmol) and potassium acetate (107.65 gm, 1098.5 mmol) in dioxane (600 mL) is degassed with argon for 30 min. Then [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) is added and the reaction mixture is heated and stirred at 85° C. for 16 h. After completion, the reaction mass is quenched with water and extracted with ethyl acetate. The organic layer is separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain the crude mass. This crude compound is purified by column chromatography using 100-200 silica gel and 3% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate (4).

A stirred solution of 4-chloro-2-iodophenol (5, 60.0 g, 235.8 mmol), tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate (4, 100.37 g, 330.1 mmol) and potassium carbonate (97.76 g, 707.4 mmol) in a mixture of dioxane and water (4:1, 1.0 Lit) is degassed with argon for 30 min. Palladium(II)bis(triphenylphosphine) dichloride is added at room temperature and stirred the reaction mixture at 100° C. for 6 h. After completion, the reaction mass is quenched with water and extracted with ethyl acetate. The organic layer is separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure. The crude compound obtained is purified by column chromatography using 100-200 silica gel and 4% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 5′-chloro-2′-hydroxy-[1,1′-biphenyl]-3-carboxylate (6).

To a stirred solution of tert-butyl 5′-chloro-2′-hydroxy-[1,1′-biphenyl]-3-carboxylate (6, 55.0 g, 180.5 mmol) in 1 N aqueous solution of sodium hydroxide (1.1 Lit), tetrabutylammoniumbromide (8.72 g, 27.07 mmol) and potassium iodide (4.49 g, 27.07 mmol) are added at room temperature and the reaction mass is heated to 90° C. 1,2-Dibromoethane (7, 57.82 mL, 667.89 mmol) is added slowly at 90° C. and the reaction mixture is stirred at 90° C. for 16 h. After completion, the reaction mass is extracted with dichloromethane. The organic layer is dried over sodium sulfate, filtered and concentrated under reduced pressure to obtain the crude mass. The crude compound is purified by column chromatography using 100-200 silica gel and 2% ethyl acetate in hexanes to afford tert-butyl 2′-(2-bromoethoxy)-5′-chloro-[1,1′-biphenyl]-3-carboxylate (8).

[Figure (not displayed)]

To a stirred solution of ethyl 2-(diethoxyphosphoryl)acetate (2, 23.01 g, 102.7 mmol) in tetrahydrofuran (100 mL) at 0° C., sodium hydride (60%) (5.47 g, 136.9 mmol) is added and the reaction mixture is stirred at 0° C. for 1 h. 2-bromo-4-chlorobenzaldehyde (1, 15.0 g, 68.4 mmol) in tetrahydrofuran (3 mL) is added slowly and the reaction mixture is stirred at 0° C. for 2 h. After completion, the reaction mass is quenched with water and extracted with ethyl acetate. The organic layer is separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to get the crude mass. The crude material is purified by Combi-flash using 3% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford ethyl (E)-3-(2-bromo-4-chlorophenyl)acrylate (3).

To a stirred solution of ethyl (E)-3-(2-bromo-4-chlorophenyl)acrylate (3, 2.0 g, 17.3 mmol) in dichloromethane (15.0 mL), diisobutylaluminium hydride (1 M in toluene) (31.1 mL, 31.1 mmol) is added and stirred at −78° C. for 1 h. The reaction mixture is slowly allowed to room temperature and stirred for 1 h. After completion, the reaction mass is quenched with aqueous ammonium chloride solution and extracted with dichloromethane. The organic layer is separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to get the crude mass which is purified by Combi-flash using 13% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford (E)-3-(2-bromo-4-chlorophenyl)prop-2-en-1-ol (4).

A stirred solution of (E)-3-(2-bromo-4-chlorophenyl)prop-2-en-1-ol (4, 1.5 g, 6.07 mmol), tert-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate (5, 2.03 g, 6.68 mmol), and potassium carbonate (2.51 g, 18.2 mmol) in a mixture of dioxane and water (4:1) (24.0 mL) is degassed with argon for 30 min. [1,1′-Bis(diphenylphosphino)ferrocene]palladium(II) dichloride (0.222 g, 0.3 mmol) is added and the reaction mixture is heated at 90° C. for 12 h. After completion, the reaction mass is quenched with water and extracted with ethyl acetate. The organic layer is separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to get the crude mass. The crude compound is purified by Combi-flash using 15% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl (E)-5′-chloro-2′-(3-hydroxyprop-1-en-1-yl)-[1,1′-biphenyl]-3-carboxylate (6).

To a stirred solution of tert-butyl (E)-5′-chloro-2′-(3-hydroxyprop-1-en-1-yl)-[1,1′-biphenyl]-3-carboxylate (6, 1.5 g, 4.34 mmol) and triethylamine (1.82 mL, 13.04 mmol) in dichloromethane at 0° C., methanesulfonyl chloride (0.67 mL, 8.69 mmol) is added and the reaction mixture is slowly allowed to room temperature and stirred for 16 h. After completion, the reaction mass is quenched with water and extracted with dichloromethane. The organic layer is separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to get the crude material. The crude compound is purified by Combi-flash using 10% ethyl acetate in hexanes as eluent to afford tert-butyl (E)-5′-chloro-2′-(3-chloroprop-1-en-1-yl)-[1,1′-biphenyl]-3-carboxylate (7).

[Figure (not displayed)]

A stirred solution of 2-bromo-4-chloro-1-iodobenzene (1, 1.0 g, 3.15 mmol), prop-2-yn-1-ol (2, 0.2 mL, 3.47 mmol) & copper(I) iodide (0.024 g, 0.126 mmol) in triethyl amine (30 mL) is degassed with argon for 20 min. Dichlorobis(triphenylphosphine)palladium(II) (0.110 g, 0.15 mmol) is added and the reaction mixture is stirred at room temperature for 16 h. After completion, the reaction mass is quenched with water and extracted with ethyl acetate. The organic layer is separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain the crude material. This crude compound is purified by Combi-flash using 10% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 3-(2-bromo-4-chlorophenyl)prop-2-yn-1-ol (3) as yellow solid. Yield: 0.725 g, 93%, MS no ionization.

To a stirred solution of 3-(2-bromo-4-chlorophenyl)prop-2-yn-1-ol (3, 0.72 g, 2.93 mmol) in dichloromethane (10 mL), thionyl chloride (0.85 mL, 11.75 mmol) is added at 0° C. and the reaction mixture is heated and stirred at 50° C. for 16 h. After completion, the reaction mass concentrated under reduced pressure to obtain the crude which is purified by Combi-flash using 3% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 2-bromo-4-chloro-1-(3-chloroprop-1-yn-1-yl) benzene (4)

[Figure (not displayed)]

To a solution of 6-chloro-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (A, 1 equiv.) in N,N-dimethylformamide (0.2 M solution) is added potassium carbonate (3 equiv.) and tert-butyl 7-(2-(2-bromoethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (B, 1 equiv.) and the reaction mixture is heated at 60° C. for 16 h. The reaction mixture is then cooled, diluted with water, and extracted 2× with ethyl acetate. The combined organic layer is washed with water, dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. Purification by silica gel column chromatography affords tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (C).

To a solution of 6-chloro-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (A, 1 equiv.) in N,N-dimethylformamide (0.14 M) is added tert-butyl 7-(2-(2-bromoethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (B, 1.3 equiv.), potassium iodide (0.2 equiv.), and ground potassium carbonate (3 equiv.) at room temperature. The mixture is stirred for 16 h at 50° C., diluted with water, and extracted 2× with ethyl acetate with ethyl acetate. The combined organic layer is washed with water, dried over anhydrous magnesium sulfate, and concentrated in vacuo. Purification by silica gel column chromatography gives tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (C).

[Figure (not displayed)]
[Figure (not displayed)]

To a solution of 3-bromo-5-fluoroisonicotinic acid (A, 5.0 g, 21.92 mmol) in dimethylformamide (15 mL), potassium carbonate (6.07 g, 43.84 mmol) and iodomethane (2.05 mL, 32.88 mmol) are added at room temperature and stirred the reaction mixture for 2 h at room temperature. After completion, the reaction mass is diluted with ethyl acetate and washed with cold water. The organic layer is separated, dried over anhydrous sodium sulphate, filtered and concentrated to give crude. The crude is purified by flash chromatography eluting the compound with ethyl acetate in hexanes (1-10%). The desired fractions are concentrated under reduced pressure to afford methyl 3-bromo-5-fluoroisonicotinate (B).

To a solution of methyl 3-bromo-5-fluoroisonicotinate (B, 4.0 g, 17.17 mmol) in dimethylformamide (15 mL), potassium carbonate (7.0 g, 51.51 mmol) is added followed by drop wise addition of 4-methoxy benzyl amine (3.52 mL, 25.0 mmol at room temperature The reaction mixture is stirred for 16 h at 50° C. After completion, the reaction mass is diluted with ethyl acetate and washed with cold water. The organic layer is separated and dried over anhydrous sodium sulphate, filtered and concentrated to give crude. The crude is purified by flash column chromatography eluting the compound with ethyl acetate in hexanes (10-20%). The desired fractions are concentrated under reduced pressure to afford methyl 3-bromo-5-((4-methoxybenzyl)amino)isonicotinate (C).

To a solution of methyl 3-bromo-5-((4-methoxybenzyl)amino)isonicotinate (C, 2.8 g, 8.0 mmol) in methanol (5.0 mL) and water (5.0 mL) is added sodium hydroxide (0.64 g, 26.0 mmol) and stirred the reaction mixture for 6 h at room temperature. After completion, the reaction mass is concentrated to evaporate methanol. The aqueous layer is cooled to 0° C. and acidified with 2 N hydrochloric acid (pH ˜4). The precipitated solid is filtered and dried to afford 3-bromo-5-((4-methoxybenzyl)amino)isonicotinic acid (D).

To a solution of 3-bromo-5-((4-methoxybenzyl)amino)isonicotinic acid (D, 0.9 g, 26.0 mmol) in dimethylformamide (15 mL), methyl 7-(2-(2-aminoethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (E, 1.16 g, 32.0 mmol) and 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (1.48 g, 39.0 mmol) are added at 0° C. Diisopropylethylamine is added drop wise at 0° C. and stirred the reaction mixture at room temperature for 3 h. After completion, the reaction mass is diluted with ethyl acetate and washed with cold water. The organic layer is separated, dried over anhydrous sodium sulphate, filtered and concentrated under reduced pressure to give crude. The crude is purified by flash column chromatography eluting the compound with methanol in dichloromethane (2-5%). The desired fractions are concentrated under reduced pressure to afford methyl 7-(2-(2-(3-bromo-5-((4-methoxybenzyl)amino)isonicotinamido)ethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (F).

To a solution of methyl 7-(2-(2-(3-bromo-5-((4-methoxybenzyl)amino)isonicotinamido)ethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (F, 1.8 g, 26.0 mmol) in dichloromethane (10 mL) is added triflouroacetic acid (10 mL) at 0° C. and is stirred the reaction mixture at room temperature for 2 h. After completion, the reaction mass is concentrated to give crude. The crude is triturated with diethyl ether to afford methyl 7-(2-(2-(3-amino-5-bromoisonicotinamido)ethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (G).

To a solution of methyl 7-(2-(2-(3-amino-5-bromoisonicotinamido)ethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (G, 1.2 g, 2.1 mmol) in tetrahydofuran (10 mL), 2,2-difluoroacetic anhydride (H, 0.26 mL, 2.1 mmol) is added at 0° C. and stirred the reaction mixture at room temperature for 1 h. After completion, the reaction mass is concentrated to give crude. The crude is purified by washing and triturating with diethyl ether to afford methyl 7-(2-(2-(3-bromo-5-(2,2-difluoroacetamido)isonicotinamido)ethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (I).

A solution of methyl 7-(2-(2-(3-bromo-5-(2,2-difluoroacetamido)isonicotinamido)ethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (I, 1.0 g, 1.56 mmol) in acetic acid (10 mL) is heated and stirred at 110° C. for 24 h. After completion, acetic acid is removed under reduced pressure to give crude. The crude is purified by flash column chromatography eluting the compound with ethyl acetate in hexanes (50-70%). The desired fractions are concentrated under reduced pressure to afford methyl 7-(2-(2-(5-bromo-2-(difluoromethyl)-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (J).

[Figure (not displayed)]

To a solution of cyclopropanol (B, 2.5 equiv.) in tetrahydrofuran (0.6 M), sodium hydride (3 equiv.) is added and the reaction mixture stirred at 0° C. for 10 min. tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.) is added to the reaction mixture at room temperature and heated at 120° C. for 6 h. The reaction mixture is cooled to room temperature, diluted with water, extracted with ethyl acetate, and the ethyl acetate layer dried over sodium sulfate, concentrated, and purified over a plug of silica gel to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-6-cyclopropoxy-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (C1).

To a solution of tert-butyl 7-(5-chloro-2-(2-(5-cyano-6-cyclopropoxy-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (C1, 1 equiv.) in dichloromethane (0.1 M), triflouroacetic acid (0.1 M) is added at 0° C. The reaction is slowly brought to room temperature and stirred for 16 h. The reaction is concentrated under reduced pressure, washed with diethyl ether, and purified by preparative HPLC to afford 7-(5-chloro-2-(2-(5-cyano-6-cyclopropoxy-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (C2)

[Figure (not displayed)]

To a solution of tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.), and azetidin-3-ol hydrochloride (B, 2 equiv.) in DMF (0.16 M), potassium carbonate (5 equiv.) is added at room temperature followed by heating at 100° C. with stirring for 16 h. The reaction mixture is diluted with water, extracted with ethyl acetate, and the organic layers washed with water and brine solution, dried over sodium sulfate, concentrated, and purified by flash chromatography to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-6-(3-hydroxyazetidin-1-yl)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (C).

[Figure (not displayed)]

A solution of tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.), and cesium hydroxide (3 equiv.) in 1,4-dioxane (0.12 M) is degassed under nitrogen for 5 minutes. Tris(dibenzylideneacetone)dipalladium(0) (0.05 equiv.) and 5-(di-tert-butylphosphino)-1′, 3′, 5′-triphenyl-1′H-[1,4′]bipyrazole (0.03 equiv.) are added and the mixture heated at 90° C. for 16 h. The reaction mixture is cooled, diluted with water, extracted with ethyl acetate, and the combined organic layer, dried over anhydrous sodium sulphate, filtered and concentrated to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-6-hydroxy-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (B).

[Figure (not displayed)]

A solution tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.) in methanolic ammonia (20%, 0.05 M) is heated in a sealed tube at 120° C. for 16 h. The reaction mixture is concentrated to afford tert-butyl 7-(2-(2-(6-amino-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-5-chlorophenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (B).

[Figure (not displayed)]

To a solution tert-butyl 7-(5-chloro-2-(2-(5-cyano-2-methyl-6-(methylamino)-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.) in acetic anhydride (B, 0.06 M), acetic acid (0.24 M) is added at room temperature and the mixture is heated at 120° C. for 27 h. The reaction mixture is quenched on ice, extracted with ethyl acetate, and the organic layer dried over anhydrous sodium sulfate, filtered, concentrated, and purified by preparative HPLC to afford 7-(5-chloro-2-(2-(5-cyano-2-methyl-6-(N-methylacetamido)-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (C).

[Figure (not displayed)]

A solution tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.) in methanolic ammonia (20%, 0.05 M) is heated in a sealed tube at 120° C. for 16 h. The reaction mixture is concentrated to afford tert-butyl 7-(2-(2-(6-amino-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-5-chlorophenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (B).

[Figure (not displayed)]

To a solution of tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-ethylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.) in N,N-dimethylformamide (0.05 M), 1-methylpiperazine (B, 3 equiv.), potassium fluoride (5 equiv.) and 18 crown-6 (1 equiv.) are added and the mixture heated at 90° C. for 3 h. The reaction mixture is cooled, diluted with water, extracted with ethyl acetate, and the combined organic layer dried over anhydrous sodium sulphate, filtered, and concentrated to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-2-methyl-6-(4-methylpiperazin-1-yl)-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-ethylthieno[3,2-b]pyridine-3-carboxylate (C).

[Figure (not displayed)]

To a solution 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (A, 1 equiv.) and tert-butyl azetidin-3-yl(methyl)carbamate hydrochloride (B, 2 equiv.) in 1,4-dioxane (0.088 M) is added caesium carbonate (0.172 g, 0.530 mmol) and the reaction mixture heated at 90° C. for 3 h. The reaction mixture is diluted with water, extracted with ethyl acetate, and the organic layer dried over anhydrous sodium sulphate, filtered, concentrated, and purified by column chromatography to afford 7-(2-(2-(6-(3-((tert-butoxycarbonyl)(methyl)amino)azetidin-1-yl)-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-5-chlorophenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (C1).

To a solution of 7-(2-(2-(6-(3-((tert-butoxycarbonyl)(methyl)amino)azetidin-1-yl)-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-5-chlorophenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (C1, 1 equiv.) in dichloromethane (0.045 M), 2,2,2-trifluoroacetic acid (0.14 M) is added at 0° C. and the reaction mixture stirred for 16 h at room temperature. The reaction mixture is concentrated and purified by preparative HPLC to afford 7-(5-chloro-2-(2-(5-cyano-2-methyl-6-(3-(methylamino)azetidin-1-yl)-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (C2)

[Figure (not displayed)]

tert-Butyl 7-(2-(2-(6-bromo-5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)-5-chlorophenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.), 3-aminopyridine (B, 1.1 equiv.), xantphos (0.2 equiv.), cesium carbonate (3 equiv.), and tris(dibenzylideneacetone)dipalladium(0) (0.2 equiv.) are suspended in 1,4-dioxane (0.047 M) in a screw capped vial equipped with a stir bar. The reaction mixture is sparged with argon for 3 min, then sealed and heated at 100° C. in a heating block for 75 min. The reaction mixture is cooled to room temperature and taken up in a 1:1 N,N dimethylformamide:methanol solution and filtered through a syringe filter. Preparatory HPLC affords tert-butyl 7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-6-(pyridin-3-ylamino)-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (C).

[Figure (not displayed)]

To a stirred solution of oxetan-3-amine (B, 1 equiv.), sodium carbonate (3.5 equiv.) in methanol (0.68 M) and 1,5-dichloropentan-3-one (A, 1 equiv.) are added at room temperature and the reaction mixture is heated at 75° C. for 3 h. The reaction mixture is cooled to room temperature, diluted with water, extracted with ethyl acetate, and the ethyl acetate layer is dried over sodium sulfate, concentrated, and purified over a plug of silica gel to afford 1-(oxetan-3-yl)piperidin-4-one (C).

To a solution of 1-(oxetan-3-yl)piperidin-4-one (C, 0.8 g, 5.16 mmol) in dichloromethane (0.5 M) are added ethylamine (2 M in tetrahydrofuran, 1.3 equiv.) and acetic acid (10 M) at room temperature. The reaction mixture is stirred for 60 min and sodium triacetoxyborohydride (1.3 equiv.) is added at 0° C. and stirred for 16 h at room temperature. The reaction is quenched with 10% aqueous sodium hydroxide solution, extracted with methanol in dichloromethane (5%), and the organic layer washed with sodium chloride solution, dried over anhydrous sodium sulfate, filtered and concentrated to afford N-ethyl-1-(oxetan-3-yl)piperidin-4-amine (D).

To a solution of tert-butyl 7-(5-chloro-2-(3-(5-cyano-6-fluoro-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylate (E, 1 equiv.) in acetonitrile (0.1 M), are added N-ethyl-1-(oxetan-3-yl)piperidin-4-amine (D, 2 equiv.) and N,N-diisopropylethylamine (3 equiv.) at room temperature and the reaction mixture is stirred for 30 h at 100° C. The reaction is cool to room temperature, quenched with water, extracted with ethyl acetate, and the organic layer washed with sodium chloride solution, dried over anhydrous sodium sulfate, filtered, concentrated and purified by Combi flash to afford tert-butyl 7-(5-chloro-2-(3-(5-cyano-6-(ethyl(1-(oxetan-3-yl)piperidin-4-yl)amino)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylate (F).

[Figure (not displayed)]

To a solution of tert-butyl (2-(difluoromethyl)pyridin-4-yl)(methyl)carbamate (A, 1 equiv.) and acetic acid (10 equiv.) in methanol (0.029 M), 5% rhodium on carbon (0.5 equiv.) is added at room temperature and the mixture heated at 80° C. under 80 psi for 15 hr. The reaction mixture is filtered and concentrated to afford tert-butyl (2-(difluoromethyl)piperidin-4-yl)(methyl)carbamate (B).

To a solution of tert-butyl (2-(difluoromethyl)piperidin-4-yl)(methyl)carbamate (B, 1 equiv.) in THE (0.19 M) are added formaldehyde (37% solution in water, 10 equiv.), acetic acid (9 equiv.) and molecular sieves (˜3× by weight). The mixture is stirred for 30 min at room temperature, sodium triacetoxyboranuide (361 mg, 1.7 mmol) is added and the mixture stirred for 30 min. The reaction mixture is diluted with methanol and the residue passed through a strata ion exchange column, eluting with water three times, then acetonitrile three times, then methanol three times. tert-Butyl (2-(difluoromethyl)-1-methylpiperidin-4-yl)(methyl)carbamate (C) is eluted by washing the column with a solution of dichloromethane, methanol, and ammonium hydroxide (50:40:10).

tert-Butyl (2-(difluoromethyl)-1-methylpiperidin-4-yl)(methyl)carbamate (C, 1 equiv.) in trifluoroacetic acid (0.006 M) is stirred at room temperature for 30 min and the reaction mixture is concentrated to afford 2-(difluoromethyl)-N,1-dimethylpiperidin-4-amine (D).

A mixture of 7-(5-chloro-2-(2-(5-cyano-8-fluoro-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylic acid (E, 1 equiv.), 2-(difluoromethyl)-N,1-dimethylpiperidin-4-amine (D, 5 equiv.) and NMP (0.037 M) in DIPEA (7 equiv.) is stirred at room temperature for 30 min. The reaction mixture is filtered and purified by HPLC to afford 7-(5-chloro-2-(2-(5-cyano-8-((2-(difluoromethyl)-1-methylpiperidin-4-yl)(methyl)amino)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylic acid (F).

[Figure (not displayed)]

To a dichloromethane (40 mL) solution of tert-butyl 7-(5-chloro-2-(3-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.) is added trifluoroacetic acid (0.25 M) at 0° C. and stirred for 17 h at room temperature. The mixture is concentrated in vacuo, aqueous sodium bicarbonate solution added, and washed with diethyl ether. The water layer is acidified with 3 N hydrogen chloride solution and stirred for 15 min. Filtration affords 7-(5-chloro-2-(3-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylic acid (B).

To a 7-(5-chloro-2-(3-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylic acid (B, 1160 mg, 2.12 mmol) solution in dichloromethane (0.11 M) and methanol (0.42 M) is added trimethylsilyldiazomethane (4 equiv.) at 0° C. Upon stirring for 10 min at 0° C., the reaction is quenched with acetic acid (3.5 M), concentrated and purified by silica gel column chromatography to afford methyl 7-(5-chloro-2-(3-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylate (C).

To a methyl 7-(5-chloro-2-(3-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylate (C, 433 mg, 0.770 mmol) in N-methyl-2-pyrrolidone (0.21 M) is added 1-(2-(trifluoromethoxy)ethyl)piperazine dihydrochloride (D, 1.5 equiv.) at room temperature and the mixture stirred for 2 h at 50° C. followed by 17 h at room temperature. The mixture is diluted with methanol, filtered, and the filtrate purified by preparative HPLC to give methyl 7-(5-chloro-2-(3-(5-cyano-2-methyl-4-oxo-6-(4-(2-(trifluoromethoxy)ethyl)piperazin-1-yl)pyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylate (E).

[Figure (not displayed)]

To a solution of tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.) and potassium trifluoro(2-((tetrahydro-2H-pyran-2-yl)oxy)ethyl)borate (B, 1.4 equiv.) in a mixture of toluene and water (2:1, 0.7 M) is added cesium carbonate (2 equiv.) and the reaction mixture degassed with argon for 15 min. [1,1′-Bis(diphenylphosphino)ferrocene]palladium(II) dichloride (0.1 equiv.) is added and heated at 100° C. for 16 h. The reaction mass is filtered through Celite, washed with ethyl acetate, and the filtrate dried over anhydrous sodium sulfate, concentrated, and purified by Combiflash to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-6-(2-((tetrahydro-2H-pyran-2-yl)oxy)ethyl)pyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (C).

To a stirred solution of tert-butyl 7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-6-(2-((tetrahydro-2H-pyran-2-yl)oxy)ethyl)pyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (C, 1 equiv.) in a mixture of acetonitrile and water (3:1, 0.018 M), selectfluor-II (2 equiv.) is added at 0° C. and the mixture stirred at room temperature for 48 h. The reaction mixture is partitioned between water and ethyl acetate and the organic layer dried over sodium sulfate and concentrated to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-6-(2-hydroxyethyl)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (D).

To a solution of tert-butyl 7-(5-chloro-2-(2-(5-cyano-6-(2-hydroxyethyl)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (D, 1 equiv.) in dichloromethane (0.4 M), diethylaminosulfur trifluoride (1.5 equiv.) is added at 0° C. and the mixture stirred at room temperature for 3 h. The reaction mass is quenched with 10% aqueous sodium hydroxide solution at 0° C., extracted with dichloromethane, and the organic layer dried over anhydrous sodium sulfate and concentrated to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-6-(2-fluoroethyl)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (E).

[Figure (not displayed)]
[Figure (not displayed)]

tert-Butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.), PdCl2(PPh3)2 (0.18 equiv.), and (E)-4,4,5,5-tetramethyl-2-(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-en-1-yl)-1,3,2-dioxaborolane (B, 1.6 equiv.) are suspended in 1,4-dioxane (0.054 M) in an oven dried microwave vial equipped with a stir bar. Aqueous potassium carbonate (2.0 M, 4 equiv.) is added, and the sealed vial is sparged with argon for 5 min and heated at 100° C. in a microwave reactor for 4 h. The reaction mixture is diluted with saturated aqueous sodium bicarbonate and ethyl acetate and the aqueous phase extracted with ethyl acetate three times. The combined organic material is washed with brine, dried over magnesium sulfate, filtered, and purified via silica gel chromatography to afford tert-butyl (E)-7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-6-(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-en-1-yl)pyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (C).

tert-Butyl (E)-7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-6-(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-en-1-yl)pyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (C, 1 equiv.) is suspended in methanol (0.05 M) and tetrahydrofuran (0.05 M) and water (0.05 M) in a screw capped vial equipped with a stir bar and the reaction mixture stirred at room temperature while p-toluenesulfonic acid (0.35 equiv.) is added in 1 portion. After 30 min the temperature is raised to 55° C. and stirred an additional 1 h. Water (0.1 M) is added and, after 1 h, the temperature raised to 80° C. and heated at this temperature for 8 h. The reaction mixture is cooled to room temperature and volatile solvent is then removed in vacuo. The reaction mixture is diluted with saturated aqueous sodium bicarbonate and ethyl acetate, the layers separated, and the aqueous phase extracted with ethyl acetate three times. The combined organic material is washed with brine, dried over magnesium sulfate, and the solids filtered and concentrated to afford tert-butyl (E)-7-(5-chloro-2-(2-(5-cyano-6-(3-hydroxyprop-1-en-1-yl)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (D).

tert-Butyl (E)-7-(5-chloro-2-(2-(5-cyano-6-(3-hydroxyprop-1-en-1-yl)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (D, 1 equiv.) is dissolved in dichloromethane (0.086 M) in an oven-dried screw capped vial equipped with a stir bar. The reaction mixture is stirred at 0° C. while N,N-diisopropylethylamine (6 equiv.) is added slowly. Methanesulfonyl chloride (2.6 equiv.) is then added dropwise at which time the ice bath is removed. After 30 min the reaction mixture is diluted with dichloromethane, washed with saturated aqueous sodium bicarbonate and brine, dried over magnesium sulfate, filtered and the solvent removed in vacuo, affording tert-butyl (E)-7-(5-chloro-2-(2-(5-cyano-2-methyl-6-(3-((methylsulfonyl)oxy)prop-1-en-1-yl)-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (E).

tert-Butyl (E)-7-(5-chloro-2-(2-(5-cyano-2-methyl-6-(3-((methylsulfonyl)oxy)prop-1-en-1-yl)-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (E, 54.5 mg, 0.07 mmol) is dissolved in 1,2-dichloroethane (0.05 M) in a screw capped vial equipped with a stir bar and the reaction mixture stirred at 10° C. while 4,4-difluoropiperidine (F, 3.3 equiv.) is added dropwise. N,N-Diisopropylethylamine (6.6 equiv.) is added dropwise and after 5 min the reaction mixture is warmed to room temperature. After 15 min the temperature is raised to 45° C. and stirring continued for 3 h. The reaction mixture is cooled to room temperature and the solvent is then removed in vacuo. The residue is taken up in DMF and filtered through a syringe filter. Preparatory HPLC afforded the desired product, which is isolated by passing HPLC fractions through a strata ion exchange column, then washing with a solution of dichloromethane, methanol, and ammonium hydroxide. The solvent is to afford tert-butyl (E)-7-(5-chloro-2-(2-(5-cyano-6-(3-(4,4-difluoropiperidin-1-yl)prop-1-en-1-yl)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (G).

[Figure (not displayed)]

To a solution of tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.), tributyl(methoxymethyl)stannane (B, 1.5 equiv.) in 1-methyl-2-pyrrolidinone (0.1 M) is degassed using argon for 10 min and tetrakis(triphenylphosphine)palladium (0) (0.055 g, 0.048 mmol) is added at room temperature and heated at 130° C. for 10 h. The reaction mixture is cooled to room temperature, diluted with water and, extracted with ethyl acetate, and the ethyl acetate layer dried over sodium sulfate, concentrated, and purified by preparative HPLC to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-6-(methoxymethyl)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (C).

[Figure (not displayed)]

To a solution of tert-butyl 7-(5-chloro-2-(2-(6-chloro-5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (A, 1 equiv.) and (2-fluorophenyl)boronic acid (B, 1.5 equiv.) in 1,4-dioxane is added 2 M aqueous potassium carbonate solution (3 equiv.) and reaction mixture degassed with argon gas for 10 min. [1,1′-Bis(diphenylphosphino)ferrocene] dichlopalladium(II)dichlomethane complex (0.05 equiv.) is added and degassed with argon gas for 5 min and the reaction mixture is heated at 90° C. for 3 h. The reaction mixture is diluted with water, extracted with ethyl acetate, and the organic layer dried over anhydrous sodium sulphate, filtered, concentrated, and purified by column chromatography to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-6-(2-fluorophenyl)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (C).

[Figure (not displayed)]

To a solution of 7-(5-chloro-2-(3-(5-cyano-6-((1-(2,2-difluoropropyl)piperidin-4-yl)(methyl)amino)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)thieno[3,2-b]pyridine-3-carboxylic acid (A, 1 equiv.) and oxetane-3-sulfonamide (B, 2.5 equiv.) in dichloromethane (0.07 M) is added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (2 equiv.) and 4-(dimethylamino)pyridine (2.5 equiv.) at 0° C. and stirred at room temperature for 12 h. The reaction mixture is diluted with water, extracted with dichloromethane, and the organic layer dried over anhydrous sodium sulphate, filtered, concentrated, and purified by preparative HPLC to afford 7-(5-chloro-2-(3-(5-cyano-6-((1-(2,2-difluoropropyl)piperidin-4-yl)(methyl)amino)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)-N-(oxetan-3-ylsulfonyl)thieno[3,2-b]pyridine-3-carboxamide (C).

[Figure (not displayed)]

To a stirred solution of 5-bromo-3-(3-(2-bromo-4-chlorophenyl)prop-2-yn-1-yl)-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (6, 0.6 g, 1.28 mmol) in N,N-dimethylformamide, copper(I) cyanide (0.138 g, 1.53 mmol) is added and the reaction mixture is heated and stirred at 90° C. for 16 h. After completion, the reaction mass is diluted with ethyl acetate and washed with cold water. The organic layer is separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure. The crude compound is purified by Combi-flash using 50% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 3-(3-(2-bromo-4-chlorophenyl)prop-2-yn-1-yl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (7).

A stirred solution of 3-(3-(2-bromo-4-chlorophenyl)prop-2-yn-1-yl)-2-methyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine-5-carbonitrile (7, 0.1 g, 0.24 mmol), 4-boronophthalic acid (8, 0.075 g, 0.36 mmol) and potassium carbonate (0.099 g, 0.72 mmol) in a mixture of dioxane, N,N-dimethylformamide and water (1.2 mL, 0.6 mL, 0.2 mL respectively) is degassed with argon for 25 min. Dichlorobis(triphenylphosphine)palladium(II) is added and the reaction mixture is heated and stirred at 90° C. for 2 h. After completion, volatiles are removed under reduced pressure to obtain the residue. This residue is diluted with water, acidified with 1 N aqueous hydrochloric acid and extracted with ethyl acetate. The organic layer is separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to obtain the compound. This compound is purified by preparative HPLC to afford 5′-chloro-2′-(3-(5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)-[1,1′-biphenyl]-3,4-dicarboxylic acid (9).

[Figure (not displayed)]

To a solution of methyl 2-amino-5′-chloro-2′-(2-(5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-[1,1′-biphenyl]-3-carboxylate (3, 1.5 g, 3.06 mmol) in acetonitrile (40 mL), tert-butyl nitrite (0.50 g, 4.8 mmol) is added at room temperature. Suspension of copper(I) iodide (0.93 g, 3.06 mmol) in acetonitrile (10 mL) is added drop wise over a period of 10 min at room temperature. The reaction mixture is stirred at 60° C. for 4 h. After completion, the reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is washed with aqueous sodium thiosulphate, dried over anhydrous sodium sulphate, filtered and concentrated under reduced pressure to afford crude. The crude is purified by flash column chromatography using 0-40% ethyl acetate in hexane to afford methyl 5′-chloro-2′-(2-(5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-2-iodo-[1,1′-biphenyl]-3-carboxylate (4).

A solution of methyl 5′-chloro-2′-(2-(5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-2-iodo-[1,1′-biphenyl]-3-carboxylate (4, 0.57 g, 0.95 mmol) in dioxane (20 mL) is degassed for 10 min using argon. Tributyl(ethynyl)stannane (5, 0.6 g, 1.86 mmol) and tetrakis(triphenylphosphine)palladium(0) (0.076 g, 0.066 mmol) are added and the reaction mixture is stirred at 90° C. for 16 h. After completion, reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate filtered and concentrated to dryness under reduced pressure. The crude is purified by flash column chromatography using 0-40% ethyl acetate in hexanes to afford methyl 5′-chloro-2′-(2-(5-cyano-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-2-ethynyl-[1,1′-biphenyl]-3-carboxylate (6).

Compounds made using one or more of the general methods described above are shown in Table 1. Where provided, characterization data is to the right of the compounds.

TABLE 1
7-Aza-Thienylpyridine and Derivative Compounds
Com-
poundCharacterization
34[Figure (not displayed)]
MS (ESI) m/z 447.30 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.98 (s, 1H), 9.23 (s, 1H), 9.07 (s, 1H), 8.20 (s, 1H), 7.88 (s, 1H), 7.84 (d, J = 7.68, 1H), 7.61 (d, J = 7.72, 1H), 7.45- 7.39 (m, 2H), 7.33 (d, J = 2.5 Hz, 1H), 7.21 (d, J = 8.84Hz, 1H), 4.35 (s, 4H)
35[Figure (not displayed)]
MS (ESI) m/z 462.39 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.19 (s, 1H), 9.03 (s, 1H), 8.63 (d, J = 4.8 Hz, 1H), 7.94 (d, J = 0.8 Hz, 1H), 7.59 (dd, J = 4.8 Hz, 1H), 7.48 (dd, J = 4.4 Hz, 1H), 7.409 (d, J = 2.8 Hz, 1H), 7.249 (d, J = 8.8 Hz, 1H), 4.386 (s, 4H), 2.22 (s, 3H)
36[Figure (not displayed)]
MS (ESI) m/z 486.38 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.16 (s, 1H), 7.87 (d, J = 7.68 Hz, 1H), 7.83 (s, 1H), 7.49 (d, J = 7.68 Hz, 1H), 7.43-7.38 (m, 2H), 7.27 (d, J = 2.6 Hz, 1H), 7.20 (d, J = 8.88 Hz, 1H), 4.39-4.35 (dd, J = 12.52 Hz, 4H), 2.29 (s, 3H)
38[Figure (not displayed)]
MS (ESI) m/z 529.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.98 (s, 1H), 9.13 (s, 1H), 7.87-7.85 (m, 2H), 7.56 (d, J = 7.76 Hz, 1H), 7.42-7.38 (m, 2H), 7.29 (d, J = 2.64 Hz, 1H), 7.21 (d, J = 8.92 Hz, 1H), 4.37 (m, 4H), 2.24 (s, 3H)
39[Figure (not displayed)]
MS (ESI) m/z 554.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.22 (s, 1H), 9.19 (s, 1H), 8.79 (d, J = 4.8 Hz, 1H), 8.45 (s, 1H), 7.61 (dd, J = 2.64, 8.88, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.45 (d, J = 2.68 Hz, 1H), 7.37 (d, J = 8.96 Hz, 1H), 6.72-6.46 (t, J = 51.6 Hz, 1H), 4.41 (d, J = 4.64 Hz, 2H), 4.36 (d, J = 4.52 Hz, 2H)
44[Figure (not displayed)]
MS (ESI) m/z 457.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.06 (s, 1H), 9.18 (s, 1H), 9.04 (s, 1H), 7.9-7.83 (m, 1H), 7.76 (s, 1H), 7.72 (d, J = 8.4 Hz, 1H), 7.52-7.44 (m, 3H), 7.36 (d, J = 2.2 Hz, 1H), 6.42-6.35 ( m, 1H), 6.22 (d, J = 16.04 Hz, 1H), 4.82 (d, J = 4.8 Hz, 2H), 2.58 (s, 3H)
45[Figure (not displayed)]
MS (ESI) m/z 510.44 [M − 1]−; 1H NMR (400 MHz, DMSO-d6) δ 9.01 (s, 1H), 8.98 (s, 1H), 8.96 (d, J = 4.56 Hz, 1H), 8.17 (d, J = 7.52 Hz, 1H), 7.64 (s, 1H), 7.56 (dd, J = 8.92 Hz, 1H), 7.44 (d, J = 4.56 Hz, 1H), 7.30 (d, J = 2.56 Hz, 1H), 7.26 (d, J = 8.96 Hz, 1H), 7.19 (d, J = 7.6 Hz, 1H), 4.33-4.29 (m, 2H), 4.24-4.17 (m, 1H), 4.12-4.06 (m, 1H), 1.84 (s, 3H)
48[Figure (not displayed)]
MS (ESI) m/z 475.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.16 (s, 1H), 9.18 (s, 1H), 9.05 (s, 1H), 7.36 (dd, J = 8.8 Hz, 1H), 7.28 (t, 2H), 7.24-7.18 (m, 5 H), 4.57 (t, 2H), 4.33 (t, 2H), 2.87 (t, 2H) 2.57 (t, 2H)
49[Figure (not displayed)]
MS (ESI) m/z 553.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) d 12.17 (bs, 1H), 8.84 (d, J = 4.76 Hz, 1H), 8.41 (s, 1H), 7.72 (dd, J = 10.68 Hz, 7.56 Hz, 1H),7.60 (dd, J = 8.08, 2.60 Hz, 1H), 7.48 (d, J = 4.76 Hz, 1H), 7.41 (d, J = 2.52 Hz, 1H), 7.36 (d, J = 8.08 Hz, 1H), 4.39 (t, J = 4.64 Hz, 2H). 4.23 (t, J = 4.68 Hz, 2H), 1.77 (s, 3H)
50[Figure (not displayed)]
MS (ESI) m/z 619.07 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.86 (d, J = 4.4 Hz, 1H), 8.24 (s, 1H), 8.08 (s, 1H), 7.60 (dd, J = 8.8, 2.6 Hz, 1H), 7.51 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.41 (t, J = 4.7 Hz, 2H), 4.25 (t, J = 4.7 Hz, 2H), 1.69 (s, 3H)
140[Figure (not displayed)]
MS (ESI) m/z 518.50 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.029 (d, J = 1.24 Hz, 2H), 8.835 (d, J = 4.76 Hz, 1H), 8.379 (s, 1H), 7.596 (dd, J = 2.6, 8.96 Hz, 1H), 7.48 (d, J = 4.72 Hz, 1H), 7.439 (d, J = 2.52 Hz, 1H), 7.35 (d, J = 9.0 Hz, 1H), 4.403 (t, J = 4.68 Hz, 2H), 4.255 (t, J = 6.04 Hz, 2H), 1.787 (s, 3H)
147[Figure (not displayed)]
MS (ESI) m/z 505 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.16 (s, 1H), 9.00 (s, 1H), 8.139 (m, J = 8.04 Hz, 2H), 7.44 (m, J = 7.92 Hz, 2H), 7.28 (d, J = 2.76 Hz, 1H), 7.19 (d, J = 8.92 Hz, 1H), 4.35 (s, 4H), 2.22 (s, 3H)
149[Figure (not displayed)]
MS (ESI) m/z 497.38 [M − 1]−; 1H NMR (400 MHz, DMSO-d6) δ 9.158 (s, 1H), 9.033 (s, 1H), 8.291 (s, 1H), 8.117 (d, J = 8.2 Hz, 1H), 7.63 (d, J = 8.28 Hz, 1H), 7.6 (dd, J = 1.96, 8.12 Hz, 1H), 7.53 (d, J = 1.96 Hz, 1H), 7.49 (dd, J = 2.2, 8.4 Hz, 1H), 5.05 (s, 2H), 2.35 (s, 3H)
150FA[Figure (not displayed)]
MS (ESI) m/z 497 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.20 (s, 1H), 9.03 (s, 1H), 7.68- 7.63 (m, 2H), 7.47-7.38 (m, 3H), 7.23 (d, J = 2.6 Hz, 1H), 7.18 (d, J = 8.88 Hz, 1H), 4.37- 4.22 (m, 4H), 2.25 (s, 3H)
150FB[Figure (not displayed)]
MS (ESI) m/z 539 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.19 (s, 1H), 9.03 (s, 1H), 7.25 (d, J = 2.6 Hz, 1H), 7.19 (d, J = 8.8 Hz, 1H),7.63- 7.67 (m, 2H), 7.50 (d, J = 6.5 Hz, 1H), 7.41- 7.44 (m, 1H), 7.41 (dd, J = 2.8 Hz, J'= 2.6 Hz, 1H), 4.36 (s, 4H), 4.41-4.48 (m, 1H), 2.24 (s, 3H), 1.19 (d, J = 6.2 Hz, 6H)
150FC[Figure (not displayed)]
MS (ESI) m/z 472 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.9 (s, 1H), 8.62 (d, J = 5.2 Hz, 1H), 7.91 (d, J = 5.16 Hz, 1H), 7.63-7.72 (m, 2H), 7.40-7.44 (m, 3H), 7.24 (d, J = 2.64 Hz, 1H), 7.19 (d, J = 8.84, 1H), 4.33-4.37 (m, 4H), 2.28 (s, 3H)
151[Figure (not displayed)]
MS (ESI) m/z 696.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.69 (bs, 1H), 68.92 (d, J = 4.4 Hz, 1H), 6 8.34 (s, 1H), 6 8.09 (s, 1H), 6 7.63-7.57 (m, 2H), 67.45 (d, J = 2.0 Hz, 1H), 6 7.36 (d, J = 8.8 Hz, 1H), 6 4.42 (t, 4.8 Hz, 2H), 6 4.24 (t, J = 4.8, 2H), 6 3.56 (s, 3H), 6 1.65 (s, 3H)
152[Figure (not displayed)]
MS (ESI) m/z 579.03 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.96 (b, 1H), 8.74(d, J = 4.72 Hz, 1H), 8.62 (s, 1H), 8.13 (d, J = 9.76 Hz, 1H), 7.76 (d, J = 9.76 Hz, 1H), 7.68 (t, J = 2.04 Hz, 1H), 7.53 (d, J = 4.72 Hz, 1H), 7.3 (t, J = 53.68 Hz, 1H), 4.88 (s, 2H), 2.22(s, 3H)
155[Figure (not displayed)]
MS (ESI) m/z 485.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.89 (bs, 1H), 9.17 (s, 1H), 9.00 (s, 1H), 7.88 (m, 1H), 7.46-7.36 (m, 3H), 7.16-7.12 (m, 2H), 4.32 (bs, 4H), 3.67 (s, 1H), 1.98 (s, 3H)
157[Figure (not displayed)]
MS (ESI) m/z 511.48 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.87 (s, 1H), 9.23 (s, 1H), 7.88-7.86 (dd, J = 1.28, J = 6.8 Hz, 1H), 7.80 (d, J = 1.6 Hz, 1H), 7.53 (d, J = 7.6 Hz, 1H), 7.45-7.17 (m, 5H), 4.36 (s, 4H), 2.19 (s, 3H)
183[Figure (not displayed)]
MS (ESI) m/z 690.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.15 (s, 1H), 8.79 (d, J = 4.8 Hz, 1H), 8.59 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.38 (d, J = 9.0 Hz, 1H), 4.89 (dt, J = 47.1, 4.7 Hz, 2H), 4.44-4.33 (m, 3H), 4.23 (t, J = 5.1 Hz, 2H), 3.93 (hept, J = 6.8 Hz, 1H), 3.79-3.52 (m, 7H), 1.87 (s, 3H), 1.25 (d, J = 6.8 Hz, 6H)
184[Figure (not displayed)]
MS (ESI) m/z 561.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.26 (s, 1H), 9.08 (s, 1H), 8.32 (s, 1H), 7.63 (d, J = 8.4 Hz, 1H), 7.39-7.16 (m, 5H), 4.34 (d, J = 3.6 Hz, 6H), 3.25-3.18 (m, 3H), 2.89 (s, 2H), 1.42 (d, J = 15 Hz, 4H), 1.27- 1.18 (m, 2H)
260[Figure (not displayed)]
MS (ESI) m/z 636.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.99 (s, 1H), 8.82 (d, J = 4.9 Hz, 1H), 8.40 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 3.50- 3.41 (m, 1H), 2.24-1.94 (m, 8H), 1.83 (s, 3H)
284[Figure (not displayed)]
MS (ESI) m/z 636.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.94 (s, 1H), 8.80 (d, J = 4.8 Hz, 1H), 8.60 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.45 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 4.9 Hz, 2H), 4.25 (t, J = 4.9 Hz, 2H), 3.94- 3.82 (m, 1H), 2.23-1.94 (m, 6H), 1.86 (td, J = 12.7, 12.1, 4.2 Hz, 2H), 1.80 (s, 3H)
338[Figure (not displayed)]
MS (ESI) m/z 560.1 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) d/ppm = 8.89 (s, 1H), 8.49 (s, 1H), 7.59 (dd, J = 8.9, 2.6 Hz, 1H), 7.43- 7.41 (m, 2H), 7.36 (d, J = 8.9 Hz, 1H), 4.43 (t, J = 4.8 Hz, 2H), 4.26 (t, J = 4.8 Hz, 2H), 3.19 (q, J = 7.5 Hz, 2H), 2.69 (s, 3H), 1.93 (s, 3H), 1.27 (t, J = 7.5 Hz, 3H)
339[Figure (not displayed)]
MS (ESI) m/z 572.1; 1H-NMR (400 MHz, d6- DMSO) d/ppm = 8.77 (s, 1H), 8.59 (s, 1H), 7.59 (dd, J = 8.9, 2.6 Hz, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.41 (s, 1H), 7.36 (d, J = 8.9 Hz, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.27 (t, J = 5.0 Hz, 2H), 3.21-3.11 (m, 1H), 2.68 (s, 3H), 1.92 (s, 3H), 1.33-1.26 (m, 1H), 1.21-1.15 (m, 1H)
340[Figure (not displayed)]
MS (ESI) m/z 600.2 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) d/ppm = 9.11 (s, 1H), 8.63 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46- 7.44 (m, 2H), 7.36 (d, J = 8.9 Hz, 1H), 4.44 (t, J = 4.9 Hz, 2H), 4.30 (t, J = 4.9 Hz, 2H), 2.70 (s, 3H), 2.05 (s, 3H)
365[Figure (not displayed)]
MS (ESI) m/z 603.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.58 (s, 1H), 8.96 (s, 1H), 8.34 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.42 (s, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.41 (t, J = 5.0 Hz, 2H), 4.28 (t, J = 5.1 Hz, 2H), 3.69-3.61 (m, 2H), 3.58-3.50 (m, 2H), 2.93 (s, 3H), 2.92 (s, 3H), 2.72 (s, 3H), 1.92 (s, 3H)
372[Figure (not displayed)]
MS (ESI) m/z 582.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.12 (s, 1H), 8.59 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.52 (t, J = 53.5 Hz, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.40 (s, 1H), 7.35 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.27 (t, J = 5.0 Hz, 2H), 2.66 (s, 3H), 1.90 (s, 3H)
384[Figure (not displayed)]
MS (ESI) m/z 552.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.99 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.62 (s, 1H), 7.80-7.73 (m, 1H), 7.72- 7.65 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.86 (s, 2H), 2.67-2.61 (m, 1H), 2.09 (s, 3H), 1.29- 1.15 (m, 4H)
385[Figure (not displayed)]
MS (ESI) m/z 649.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.91 (s, 1H), 8.84 (s, 1H), 8.56 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.40 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.41 (t, J = 5.1 Hz, 2H), 4.25 (t, J = 5.1 Hz, 2H), 3.57 (s, 3H), 2.68 (s, 3H), 2.61 (tt, J = 7.6, 4.9 Hz, 1H), 1.87 (s, 3H), 1.31-1.13 (m, 4H)
400[Figure (not displayed)]
MS (ESI) m/z 644.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.47 (s, 1H), 7.59 (dd, J = 8.9, 2.6 Hz, 1H), 7.44-7.38 (m, 2H), 7.37 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 3.87-3.78 (m, 2H), 3.26 (td, J = 11.7, 2.1 Hz, 2H), 2.96 (d, J = 7.1 Hz, 2H), 2.73 (s, 3H), 2.69 (s, 3H), 2.15-2.02 (m, 1H), 1.92 (s, 3H), 1.56-1.47 (m, 2H), 1.33 (qd, J = 12.0, 4.4 Hz, 2H)
418[Figure (not displayed)]
MS (ESI) m/z 572.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (s, 1H), 8.42 (s, 1H), 7.59 (dd, J = 8.8, 2.6 Hz, 1H), 7.42 (s, 1H), 7.41 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 2.70 (s, 3H), 2.65-2.56 (m, 1H), 1.86 (s, 3H), 1.27-1.14 (m, 4H)
419[Figure (not displayed)]
MS (ESI) m/z 546.7 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.89 (s, 1H), 8.38 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.42 (s, 1H), 7.41 (d, J = 2.6 Hz, 1H), 7.35 (d, J = 8.9 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 2.79 (s, 3H), 2.71 (s, 3H), 1.88 (s, 3H)
420[Figure (not displayed)]
MS (ESI) m/z 588.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.92 (s, 1H), 8.46 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.42 (d, J = 2.5 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.39 (t, J = 5.1 Hz, 2H), 4.24 (t, J = 5.1 Hz, 2H), 2.71 (s, 3H), 1.86 (s, 3H), 1.58 (s, 9H)
432[Figure (not displayed)]
MS (ESI) m/z 574.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.98 (s, 1H), 8.42 (s, 1H), 7.59 (dd, J = 8.9, 2.6 Hz, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.42 (s, 1H), 7.35 (d, J = 9.0 Hz, 1H), 4.39 (t, J = 4.9 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 3.64 (hept, J = 6.8 Hz, 1H), 2.70 (s, 3H), 1.87 (s, 3H), 1.33 (d, J = 6.7 Hz, 6H)
435[Figure (not displayed)]
MS (ESI) m/z 587.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.52-8.47 (m, 2H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.40-7.35 (m, 2H), 7.31 (d, J = 9.0 Hz, 1H), 4.37-4.29 (m, 6H), 4.16 (t, J = 5.1 Hz, 3H), 2.68 (s, 3H), 2.40- 2.28 (m, 2H), 1.79 (s, 3H)
441[Figure (not displayed)]
MS (ESI) m/z 655.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.65 (d, J = 2.7 Hz, 1H), 8.48 (s, 1H), 8.06 (dd, J = 9.1, 2.8 Hz, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.49-7.34 (m, 3H), 4.46 (t, J = 5.0 Hz, 2H), 4.30 (t, J = 5.1 Hz, 2H), 2.79 (s, 3H), 2.72 (s, 3H), 2.35 (s, 3H), 2.00 (s, 3H)
448[Figure (not displayed)]
MS (ESI) m/z 630.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.89 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.48 (s, 1H), 7.61 (dd, J = 9.0, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.41-7.37 (m, 2H), 4.43 (t, J = 5.1 Hz, 2H), 4.33 (d, J = 14.1 Hz, 2H), 4.24 (t, J = 5.1 Hz, 2H), 3.60 (d, J = 11.9 Hz, 2H), 3.33-3.19 (m, 2H), 2.91 (d, J = 3.1 Hz, 3H), 2.66 (s, 3H), 1.89 (s, 3H)
450[Figure (not displayed)]
MS (ESI) m/z 638.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.86 (s, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69 (dd, J = 8.4, 2.2 Hz, 1H), 7.63 (d, J = 2.1 Hz, 1H), 7.46 (s, 1H), 4.81 (s, 2H), 4.35 (d, J = 14.1 Hz, 2H), 3.62 (d, J = 12.0 Hz, 2H), 3.48-3.23 (m, 6H), 2.92 (d, J = 3.5 Hz, 3H), 2.74 (s, 3H), 2.66 (s, 3H), 2.17 (s, 3H)
459[Figure (not displayed)]
MS (ESI) m/z 560.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.73 (d, J = 4.8 Hz, 1H), 8.63 (s, 1H), 7.76 (d, J = 8.2 Hz, 1H), 7.72- 7.63 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.85 (s, 2H), 2.78 (d, J = 10.6 Hz, 6H), 2.15 (s, 3H)
474[Figure (not displayed)]
LCMS: 640.2 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.50 (s, 1H), 7.99-7.89 (m, 2H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48-7.31 (m, 5H), 4.45 (t, J = 5.0 Hz, 2H), 4.28 (t, J = 5.1 Hz, 2H), 2.79 (s, 3H), 2.71 (s, 3H), 1.97 (s, 3H)
475[Figure (not displayed)]
LCMS: 640.2 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.48 (s, 1H), 7.79-7.68 (m, 2H), 7.66-7.57 (m, 2H), 7.45-7.34 (m, 4H), 4.45 (t, J = 5.1 Hz, 2H), 4.29 (t, J = 5.0 Hz, 2H), 2.80 (s, 3H), 2.71 (s, 3H), 1.99 (s, 3H)
476[Figure (not displayed)]
LCMS: 640.2 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.57 (s, 1H), 7.72 (td, J = 7.7, 1.9 Hz, 1H), 7.67-7.57 (m, 2H), 7.47-7.34 (m, 5H), 4.44 (t, J = 5.0 Hz, 2H), 4.28 (t, J = 5.0 Hz, 2H), 2.80 (s, 3H), 2.71 (s, 3H), 1.96 (s, 3H)
477[Figure (not displayed)]
LCMS: 636.7 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.52 (s, 1H), 7.81-7.75 (m, 2H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46-7.32 (m, 5H), 4.45 (t, J = 5.0 Hz, 2H), 4.28 (t, J = 5.1 Hz, 2H), 2.78 (d, J = 0.7 Hz, 3H), 2.71 (s, 3H), 2.42 (s, 3H), 1.94 (s, 3H)
478[Figure (not displayed)]
LCMS: 636.8 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.50 (s, 1H), 7.70-7.63 (m, 2H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48-7.33 (m, 5H), 4.45 (t, J = 5.0 Hz, 2H), 4.28 (t, J = 5.0 Hz, 2H), 2.79 (s, 3H), 2.71 (s, 3H), 2.43 (s, 3H), 1.94 (s, 3H)
479[Figure (not displayed)]
LCMS: 636.8 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.52 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.44 (dq, J = 3.9, 2.0 Hz, 4H), 7.42- 7.31 (m, 3H), 4.44 (t, J = 5.0 Hz, 2H), 4.28 (d, J = 4.9 Hz, 2H), 2.77 (s, 3H), 2.71 (s, 3H), 2.18 (s, 3H), 1.90 (s, 3H)
480[Figure (not displayed)]
LCMS: 656.4 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.49 (s, 1H), 7.92 (d, J = 2.1 Hz, 1H), 7.91 (d, J = 2.1 Hz, 1H), 7.68-7.63 (m, 2H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.45-7.36 (m, 3H), 4.45 (t, J = 5.0 Hz, 2H), 4.29 (t, J = 4.9 Hz, 2H), 2.79 (s, 3H), 2.70 (s, 3H), 1.97 (s, 3H)
481[Figure (not displayed)]
LCMS: 656.6 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.46 (s, 1H), 7.94 (td, J = 1.9, 0.6 Hz, 1H), 7.85 (dt, J = 7.1, 1.7 Hz, 1H), 7.67- 7.57 (m, 3H), 7.45-7.36 (m, 3H), 4.46 (t, J = 5.1 Hz, 2H), 4.29 (t, J = 5.0 Hz, 2H), 2.79 (s, 3H), 2.72 (s, 3H), 1.99 (s, 3H)
482[Figure (not displayed)]
LCMS: 656.7 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.54 (s, 1H), 7.70-7.63 (m, 2H), 7.62-7.52 (m, 3H), 7.46-7.41 (m, 2H), 7.38 (d, J = 9.0 Hz, 1H), 4.44 (t, J = 5.0 Hz, 2H), 4.28 (s, 2H), 2.79 (s, 3H), 2.71 (s, 3H), 1.94 (s, 3H)
491[Figure (not displayed)]
MS (ESI) m/z 574.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.92 (s, 1H), 8.59 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.50-7.41 (m, 2H), 7.35 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.26 (t, J = 5.1 Hz, 2H), 4.12-4.00 N (m, 1H), 2.68 (s, 3H), 1.94 (s, 3H), 1.26 (d, J = 6.8 Hz, 6H)
492[Figure (not displayed)]
MS (ESI) m/z 560.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.48 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.42-7.35 (m, 4H), 4.43 (t, J = 5.1 Hz, 2H), 4.26 (t, J = 5.1 Hz, 2H), 2.72 (d, J = 3.2 Hz, 6H), 2.70 (s, 3H), 1.96 (s, 3H)
597[Figure (not displayed)]
MS (ESI) m/z 532.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.0 (d, J = 5.6 Hz, 1H), 8.38 (s, 1H), 7.59 (dd, J = 8.8, 2.5 Hz, 1H), 7.41 (d, J = 2.1 Hz, 2H), 7.35 (d, J = 9.0 Hz, 1H), 4.4 (t, J = 4.2 Hz, 2H), 4.26 (t, J = 4.8 Hz, 2H), 2.7 (s, 3H), 1.85 (s, 3H)
600[Figure (not displayed)]
MS (ESI) m/z 609.11 [M + 1; 1H NMR (400 MHz, DMSO-d6) δ 12.94 (s, 1H), 9.01 (d, J = 5.44, 1H), 8.51 (s, 1H), 7.62-7.56 (m, 1H), 7.49-7.31 (m, 3H), 4.41 (s, 2H), 4.26 (s, 2H), 3.58 (s, 3H), 2.69 (s, 3H), 1.91 (s, 3H)
601[Figure (not displayed)]
MS (ESI) m/z 526.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.14 (s, 1H), 9.08 (s, 1H), 8.61 (s, 1H), 7.75 (d, J = 8.2 Hz, 1H), 7.69-7.66 (m, 2H), 7.46 (s, 1H), 4.87 (s, 2H), 2.61 (s, 3H), 2.16 (s, 3H)
602[Figure (not displayed)]
MS (ESI) m/z 598.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (s, 1H), 8.40 (s, 1H), 7.85 (t, J = 72.0 Hz, 1H), 7.59 (d, J = 8.92 Hz, 1H), 7.42 (bs, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.40 (t, J = 5.12 Hz, 2H), 4.25 (t, J = 4.44 Hz, 2H), 2.71 (s, 3H), 1.82 (s, 3H)
603[Figure (not displayed)]
MS (ESI) m/z 642.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.85 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.53 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.7 Hz 1H), 7.39 (d, J = 9.0 Hz 1H), 4.55- 4.38 (m, 3H), 4.30-4.15 (m, 2H), 3.66-3.44 (m, 4H), 3.27-3.12 (m, 1H), 3.05-2.83 (m, 4H), 2.64 (s, 3H), 1.85 (s, 3H), 1.44-1.22 (m, 2H)
604[Figure (not displayed)]
MS (ESI) m/z 598.18 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.66 (s ,1H), 8.54 (s, 1H), 7.82 (t, J = 71.4 Hz, 1H), 7.60 (dd, J = 2.52, 8.84 Hz, 1H), 7.42 (d, J = 2.5 Hz, 1H), 7.40 (s, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.42 (t, J = 5.46 Hz, 2H), 4.29 (t, J = 5.46 Hz, 2H), 2.71 (s, 3H), 2.01 (s, 3H)
624[Figure (not displayed)]
MS (ESI) m/z 512.02 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.15 (s, 1H), 9.06 (s, 1H), 8.74 (d, J = 4.76 Hz, 1H), 8.61 (s, 1H), 7.76 (d, J = 8.96, 1H), 7.70-7.65 (m, 2H), 7.54 (d, J = 4.76, 1H), 4.87 (s, 2H), 2.13 (s, 3H)
656[Figure (not displayed)]
MS (ESI) m/z 636.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.83 (s, OH), 8.78 (d, J = 4.8 Hz, 1H), 8.67 (s, 1H), 7.76 (d, J = 8.3 Hz, 1H), 7.69 (dd, J = 8.3, 2.2 Hz, 1H), 7.66 (d, J = 2.1 Hz, 1H), 7.54 (d, J = 4.8 Hz, 1H), 4.91- 4.76 (m, 2H), 4.57 (d, J = 14.5 Hz, 1H), 3.73- 3.12 (m, 4H), 3.08-2.87 (m, 4H), 2.71 (s, 3H), 2.10 (s, 3H), 1.51 (s, 1H), 1.41-1.29 (m, 1H)
673[Figure (not displayed)]
LCMS (ESI) m/z 546.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.80 (s, 1H), 8.44 (s, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.41-7.35 (m, 2H), 7.33 (d, J = 9.0 Hz, 1H), 4.40 (s, 2H), 4.23 (s, 2H), 2.72 (s, 3H), 2.67 (s, 3H), 1.88 (s, 3H)
674[Figure (not displayed)]
LCMS (ESI) m/z 531.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.85 (s, 1H), 8.82 (dd, J = 4.8, 1.0 Hz, 1H), 8.48 (d, J = 2.0 Hz, 1H), 7.64- 7.56 (m, 1H), 7.52-7.40 (m, 2H), 7.36 (dd, J = 9.0, 4.8 Hz, 1H), 4.43 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 4.9 Hz, 2H), 2.76 (s, 3H), 1.85- 1.78 (m, 3H)
707[Figure (not displayed)]
MS (ESI) m/z 616.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.89 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.43 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 4.9 Hz, 2H), 4.32 (d, J = 14.2 Hz, 2H), 4.24 (t, J = 5.0 Hz, 2H), 3.61 (d, J = 12.0 Hz, 2H), 3.45 (t, J = 13.1 Hz, 2H), 3.32- 3.21 (m, 2H), 2.91 (d, J = 3.5 Hz, 3H), 1.84 (s, 3H)
721[Figure (not displayed)]
MS (ESI) m/z 560.99 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.73 (bs, 1H), 8.85 (s, 1H), 7.68 (s, 1H), 7.47 (dd, J = 2.64, 8.88 Hz, 1H), 7.28 (d, J = 2.60 Hz, 1H), 7.24 (d, J = 8.88 Hz, 1H), 7.19 (d, J = 8.00 Hz, 1H), 6.98 (d, J = 8.16 Hz, 1H), 4.34 (t, J = 4.60 Hz, 2H), 4.24 (t, J = 4.32 Hz, 2H), 3.93 (s, 3H), 2.79 (s, 3H), 1.86 (s, 3H)
722[Figure (not displayed)]
MS (ESI) m/z 544.96 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.92 (s, 1H), 8.84 (s, 1H), 7.92 (s, 1H), 7.49 (dd, J = 2.48 Hz, J = 8.84 Hz, 1H), 7.28-7.24 (m, 3H), 7.13 (d, J = 7.32 Hz, 1H), 4.35 (t, J = 4.56 Hz, 2H), 4.21 (t, J = 4.48 Hz, 2H), 2.79 (s, 3H), 2.67 (s, 3H), 1.76 (s, 3H)
723[Figure (not displayed)]
MS (ESI) m/z 564.90 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.15 (bs, 1H), 8.52 (s, 1H), 7.97 (s, 1H), 7.53-7.48 (m, 2H), 7.34 (d, J = 2.4Hz , 1H), 7.28 (d, J = 8.8 Hz, 1H), 7.23 (d, J = 7.6 Hz, 1H), 4.36 (t, J = 4.44 Hz, 2H), 4.22 (t, J = 4.4 Hz, 2H), 2.81 (s, 3H), 1.79 (s, 3H)
725[Figure (not displayed)]
MS (ESI) m/z 574 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.92 (bs, 1H), 8.35 (s, 1H), 7.96 (s, 1H), 7.49 (dd, J = 8.84, 2.48 Hz, 1H), 7.27- 7.21 (m, 3H), 7.12 (d, J = 7.32 Hz, 1H), 4.33 (t, J = 4.56 Hz, 2H), 4.17 (t, J = 4.44 Hz, 2H) 3.41 (s, 6H), 2.65 (s, 3H), 1.67 ( s, 3H)
726[Figure (not displayed)]
MS (ESI) m/z 560.99 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.83 (s, 1H), 8.58 (s, 1H), 7.94 (s, 1H), 7.48 (dd, J = 8.88, 2.64 Hz, 1H), 7.28-7.22 (m, 3H), 7.37 (d, J = 7.36 Hz, 1H), 4.34 (s, 2H), 4.20 (s, 2H), 4.09 (s, 3H), 2.67 (s, 3H), 1.80 (s, 3H)
727[Figure (not displayed)]
MS (ESI) m/z 574.98 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.98 (s, 1H), 8.96 (s, 1H), 7.93 (s, 1H), 7.48 (dd, J = 8.88, 2.56 Hz, 1H), 7.28-7.24 (m, 3H), 7.12 (d, J = 7.36, 1H), 4.95 (s, 2H), 4.34 (t, J = 4.4 Hz, 2H), 4.20 (t, J = 4.84 Hz, 2H), 3.41 (s, 3H), 2.66 (s, 3H), 1.74 (s, 3H)
728[Figure (not displayed)]
MS (ESI) m/z 595.96 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.49 (s, 1H) 7.60 (dd, J = 8.88, 2.76 1H), 7.42-7.08 (m, 4H), 4.43 (t, J = 4.68 Hz, 2H), 4.27 (t, J = 4.44 Hz, 2H), 2.79 (s, 3H), 2.70 (s, 3H), 1.91 (s, 3H)
730[Figure (not displayed)]
MS (ESI) m/z 614.03 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.50 (bs, 1H), 8.48 (s, 1H), 7.59 (d, J = 8.72 Hz, 1H), 7.42 (d, J = 4.8 Hz, 2H), 7.37 (d, J = 8.8 Hz, 1H), 4.44 (bs, 2H), 4.29 (bs, 2H), 2.80 (s, 3H), 2.71 (s, 1H), 1.94 (s, 1H
731[Figure (not displayed)]
MS (ESI) m/z 622.99 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.89 (s, 1H), 8.83 (s, 1H), 8.63 (s, 1H), 7.61 (dd, J = 2.44, 8.84 Hz, 1H), 7.45 (s,1H), 7.39 (d, J = 9.4 Hz, 2H), 4.43 (t, J = 4.48 Hz, 2H), 4.28 (t, J = 4.6 Hz, 2H), 3.56 (s, 3H), 2.75 (s, 3H), 2.69 (s, 3H), 2.01 (s, 3H)
732[Figure (not displayed)]
MS (ESI) m/z 616.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 at high temperature) 6 8.96 (s, 1H), 8.75 (s, 1H), 7.56-7.52 (dd, J = 6.4 Hz, 9.2 Hz, 1H), 7.38 (d, J = 2.8 Hz, 1H), 7.36 (s, 1H), 7.27 (bs, 1H), 4.43 (t, J = 5.2 Hz, 2H), 4.28 (t, J = 4.8 Hz, 2H), 2.73 (s, 3H), 2.63 (s, 3H), 2.00 (s, 3H)
733[Figure (not displayed)]
MS (ESI) m/z 599.99 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.51 (s, 1H), 8.11 (s, 1H), 7.55-7.52 (dd, J = 2.4, 8.8 Hz, 1H), 7.41 (d, J = 2.4 Hz, 1H), 7.31 (d, J = 9.2 Hz, 1H), 7.19 (s, 1H), 5.74-5.69 (m, 1H), 4.38 (t, J = 4.4 Hz, 2H), 4.26 (t, J = 4.4 Hz, 2H), 2.79 (s, 3H), 2.57 (s, 3H), 1.79 (s, 3H)
734[Figure (not displayed)]
MS (ESI) m/z 644.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.48 (s, 1H), 7.59 (dd, J = 8.88, 2.44 Hz, 1H), 7.41 (s, 2H), 7.36 (d, J = 8.96, 1H), 4.42 (t, J = 4.52 Hz, 2H), 4.25 (t, J = 4.4 Hz, 2H), 3.79 (t, J = 10.28 Hz, 2H), 3.26 (t, J = 11.36 Hz, 2H), 2.96 (d, J = 6.92 Hz, 2H), 2.73 (s, 3H), 2.69 (s, 3H), 2.09 (bs, 1H), 1.92 (s, 3H), 1.51 (d, J = 11.16 Hz, 2H), 1.39-1.28 (m, 2H)
737[Figure (not displayed)]
MS (ESI) m/z 622.05 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.51 (bs, 1H), 8.50 (s, 1H), 7.55 (bs, 2H), 7.64-7.7.45 (m, 4H), 7.42-7.36 (m, 3H), 4.44 (bs, 2H), 4.28 (bs, 2H), 2.78 (s, 3H), 2.69 (s, 3H), 1.94 (s, 3H)
742[Figure (not displayed)]
MS (ESI) m/z 586.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6): 6 13.5 (bs, 1H), 8.49 (s, 1H), 7.60-7.57 (dd, J = 2.4, 8.8 Hz, 1H), 7.39-7.35 (m, 3H), 4.42 (t, J = 4.4 Hz, 2H), 4.25 (t, J = 3.6 Hz), 2.68 (s, 3H), 2.66 (s, 3H), 1.90 (s, 3H), 1.18-1.16 (m, 4H)
749[Figure (not displayed)]
MS (ESI) m/z 668.00 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 611.6 (bs, 1H), 8.86 (s, 1H), 8.47 (s, 1H), 7.58-7.55 (m, 1H), 7.51 (d, J = 2.4 Hz, 1H), 7.39 (s, 1H), 7.34 (d, J = 8.8 Hz, 1H), 4.41 (t, J = 4.8 Hz, 2H), 4.27 (t, J = 5.20 Hz, 2H), 2.77 (s, 3H), 2.59 (s, 3H), 1.73 (s, 3H)
756[Figure (not displayed)]
MS (ESI) m/z 541.2 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.42 (bs, 1H), 9.11 (bs, 1H), 8.89 (s, 1H), 7.76 (d, J = 2.16 Hz, 1H), 7.74-7.62 (m, 2H), 7.53-7.38 (m, 2H), 7.11 (t, J = 7.80 Hz, 1H), 4.46 (s, 2H), 4.23 (s, 2H), 2.62- 2.57 (m, 1H), 1.89 (s, 3H), 1.29-1.08 (m, 4H)
757[Figure (not displayed)]
MS (ESI) m/z 548.02 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.54 (bs, 1H), 9.02 (s, 1H), 8.44 (d, J = 4.8 Hz 1H), 7.45 (dd, J = 2.8, 8.8 Hz, 1H), 7.26-7.20 (m, 3H), 4.31 (s, 4H), 2.62- 2.58 (m, 1H), 2.02 (s, 3H), 1.93 ( s, 3H), 1.20 (d, J = 8.0 Hz ,2H), 1.12 (s, 2H)
762[Figure (not displayed)]
MS (ESI) m/z 607.99 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.93 (s, 1H), 9.16 (s, 1H), 8.84 (d, J = 5.80, 2H), 7.91 (d, J = 5.92 Hz, 2H), 7.80 (s, 1H), 7.50 (dd, J = 8.84, 2.56 Hz, 1H), 7.29-7.26 (m, 3H), 7.15 (d, J = 7.32 Hz, 1H), 4.36 (t, J = 5.64, 2H), 4.25 (t, J = 3.80, 2H), 2.68 (s, 3H), 1.79 (s, 3H)
763[Figure (not displayed)]
MS (ESI) m/z 622.01 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.9 (bs, 1H), 9.19 (s, 1H), 8.76 (d, J = 5.24, 1H), 7.89 (s, 1H), 7.85 (s, 1H), 7.77 (s, 1H), 7.51 (dd, J = 8.84, 2.52 Hz, 1H), 7.29-7.26 (m, 3H), 7.15 (d, J = 7.32 Hz, 1H), 4.36 (t, J = 3.96 Hz, 2H), 4.25 (t, J = 4.96 Hz 2H), 2.68 (s, 3H), 2.65 (s, 3H), 1.78 (s, 3H)
770[Figure (not displayed)]
MS (ESI) m/z 588.72 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.25 (s, 1H), 8.88 (d, J = 5.64 Hz, 2H), 8.79 (d, J = 4.76 Hz, 1H), 8.63 (s, 1H), 8.00 (d, J = 5.72 Hz, 2H), 7.77 (d, J = 8.08 Hz, 1H), 7.70-7.68 (m, J = 8.0 Hz, 2H) 7.55 (d, J = 4.76 Hz, 1H), 4.89 (s, 2H), 2.22 (s, 3H)
771[Figure (not displayed)]
MS (ESI) m/z 585.00 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.94 (bs, 1H), 8.94 (s, 1H), 7.76 (s, 1H), 7.48 (dd, J = 2.52, 8.76 Hz, 1H), 7.26-7.24 (m, 2H), 7.06 (s, 1H), 4.32 (t, J = 4.48 Hz, 2H), 4.20 (t, J = 5.08 Hz, 2H), 2.62- 2.59 (m, 1H), 2.49 (s, 3H), 2.33 (s, 3H), 1.75 (s, 3H), 1.22 (bs, 2H), 1.14 (bs, 2H)
772[Figure (not displayed)]
MS (ESI) m/z 588.02 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (s, 1H), 8.70 (d, J = 5.12 Hz, 1H), 7.59 (dd, J = 8.88, 2.48 Hz, 1H), 7.42- 7.39 (m, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.44 (t, J = 4.25 Hz, 2H), 4.29 (t, J = 4.28 Hz, 2H), 3.66 (s, 3H), 2.62-2.59 (m, 1H), 1.87 (s, 3H), 1.24- 1.19 (m, 4H)
773[Figure (not displayed)]
MS (ESI) m/z 590.98 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.16 (bs, 1H), 8.98 (s, 1H), 7.83 (s, 1H), 7.53-7.49 (m, 2H), 7.33-7.22 (m, 3H), 4.34 (t, J = 4.8 Hz, 2H), 4.22 (t, J = 4.4 Hz, 2H), 2.60-2.58 (m, 1H), 1.77 (s, 3H), 1.22-1.15 (m, 4H)
791[Figure (not displayed)]
MS (ESI) m/z 574.95 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.57 (bs, 1H), 8.56 (s, 1H), 8.48 (s, 1H), 7.58 (dd, J = 8.8, 2.48 Hz, 1H), 7.41 (d, J = 2.52 Hz, 1H), 7.38 (s, 1H), 7.35 (d, J = 9.4 Hz, 1H), 4.39-4.36 (m, 2H), 4.21-4.18 (m, 2H), 3.25 (s, 6H), 2.70 (s, 3H), 1.80 (s, 3H)
792[Figure (not displayed)]
MS (ESI) m/z 565.91 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (s, 1H), 8.39 (s, 1H), 7.59 (dd, J = 8.84, 2.52 Hz, 1H), 7.42 (s, 2H), 7.34 (d, J = 8.96 Hz, 1H), 4.42-4.37 (m, 2H), 4.29-4.24 (m, 2H), 2.71 (s, 3H),.1.81(s, 3H)
793[Figure (not displayed)]
MS (ESI) m/z 585.97 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (s, 1H), 8.39 (s, 1H), 7.61 (dd, J = 8.88, 2.68 Hz, 1H), 7.45-7.43 (m, 2H), 7.37 (d, J = 8.96 Hz, 1H), 4.41 (t, J = 5.08 Hz, 2H), 4.25 (t, J = 5.24 Hz, 2H), 3.02 (q, J = 7.56,7.52 Hz, 2H), 2.67 (bs, 1H), 1.83 (s, 3H), 1.35 (t, J = 7.52 Hz, 3H), 1.24-1.19 (m, 4H)
794[Figure (not displayed)]
MS (ESI) m/z 571.07 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.00 (bs, 1H), 8.94 (s, 1H), 7.80 (s, 1H), 7.50 (dd, J = 8.84, 2.4 Hz, 1H), 7.26-7.21 (m, 3H), 7.12 (d, J = 7.32 Hz, 1H), 4.34 (t, J = 4.8 Hz, 2H), 4.21 (t, J = 4.44 Hz, 2H), 2.66 (s, 3H), 2.62-2.57 (m, 1H), 1.73 (s, 3H), 1.22-1.15 (m, 4H)
807[Figure (not displayed)]
MS (ESI) m/z 608.7 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.97 (s, 1H), 8.41 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.45-7.40 (m, 2H), 7.35 (d, J = 9.0 Hz, 1H), 4.45-4.35 (m, 2H), 4.26 (dtt, J = 14.9, 10.4, 5.0 Hz, 2H), 3.54 (td, J = 11.5, 7.9 Hz, 1H), 2.70 (s, 3H), 2.54- 2.44 (m,1H), 2.37-2.23 (m, 1H), 1.86 (s, 3H)
809[Figure (not displayed)]
MS (ESI) m/z 558.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.97 (d, J = 0.6 Hz, 1H), 8.41 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.42 (s, 1H), 7.35 (d, J = 9.0 Hz, 1H), 7.33-7.24 (m, 1H), 6.66 (dd, J = 16.7, 1.9 Hz, 1H), 5.88 (dd, J = 10.6, 1.9 Hz, 1H), 4.40 (t, J = 5.1 Hz, 2H), 4.26 (t, J = 5.0 Hz, 2H), 2.70 (s, 3H), 1.83 (s, 3H)
813[Figure (not displayed)]
MS (ESI) m/z 546.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.96 (s, 1H), 8.83 (d, J = 4.9 Hz, 1H), 8.41 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 3.11 (q, J = 7.5 Hz, 2H), 1.81 (s, 3H), 1.34 (t, J = 7.5 Hz, 3H)
814[Figure (not displayed)]
MS (ESI) m/z 600.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.06 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.43 (s, 1H), 7.60 (dd, J = 9.0, 2.6 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.35 (d, J = 8.9 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.27 (t, J = 5.0 Hz, 2H), 4.16 (q, J = 10.7 Hz, 2H), 1.83 (s, 3H)
815[Figure (not displayed)]
MS (ESI) m/z 644.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.71 (s, 1H), 8.37 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.23 (t, J = 5.0 Hz, 2H), 4.20- 4.24 (m, 2H), 3.60-3.40 (m, 2H), 3.30 (d, J = 14.1 Hz, 2H), 2.81 (d, J = 4.7 Hz, 3H), 1.79 (s, 3H), 1.43 (s, 3H), 1.38 (s, 3H)
816[Figure (not displayed)]
MS (ESI) m/z 644.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.58 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46 (s, 1H), 7.46 (d, J = 2.2 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.45-4.38 (m, 2H), 4.37- 4.28 (m, 2H), 4.22 (t, J = 5.1 Hz, 2H), 3.29-3.08 (m, 4H), 2.96 (d, J = 3.9 Hz, 3H), 1.76 (s, 3H), 1.68 (s, 3H), 1.48 (s, 3H)
817[Figure (not displayed)]
MS (ESI) m/z 660.8 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (d, J = 4.8 Hz, 1H), 8.47 (d, J = 9.3 Hz, 2H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.38 (d, J = 9.0 Hz, 1H), 4.91 (bs, 2H), 4.78 (bs, 2H), 4.49-4.38 (m, 2H), 4.30- 4.14 (m, 2H), 3.55-2.82 (br, 4H), 1.79 (s, 3H), 1.32-0.83 (m, 4H)
818[Figure (not displayed)]
MS (ESI) m/z 678.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (d, J = 4.8 Hz, 1H), 8.49 (s, 1H), 8.40 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.9 Hz, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 6.26 (tt, J = 55.6, 4.2 Hz, 1H), 4.49-4.35 (m, 2H), 4.29- 4.12 (m, 2H), 3.25-2.72 (m, 8H), 1.75 (s, 3H), 0.64-0.53 (m, 2H)
819[Figure (not displayed)]
MS (ESI) m/z 617.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 4.8 Hz, 1H), 8.60 (s, 1H), 8.36 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.59-4.58 (m, 2H), 4.40 (t, J = 5.1 Hz, 2H), 4.20 (t, J = 5.1 Hz, 2H), 3.84-3.76 (m, 1H), 3.66-3.54 (m, 2H), 1.91-1.84 (m, 2H), 1.78 (s, 3H), 1.53-1.41 (m, 2H)
820[Figure (not displayed)]
MS (ESI) m/z 699.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (dd, J = 4.9, 0.9 Hz, 1H), 8.71 (s, 1H), 8.42 (d, J = 1.5 Hz, 1H), 7.60 (dd, J = 9.0, 2.7 Hz, 1H), 7.50 (dd, J = 4.9, 2.6 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 5.37-5.27 (m, 1H), 4.39 (t, J = 5.0 Hz, 2H), 4.22 (t, J = 5.0 Hz, 2H), 3.43-3.26 (m, 2H), 3.02-2.90 (m, 2H), 2.81-2.69 (m, 2H), 2.12-2.01 (m, 2H), 1.90-1.79 (m, 2H), 1.75 (s, 3H)
821[Figure (not displayed)]
MS (ESI) m/z 680.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.04 (s, 1H), 8.85 (d, J = 4.8 Hz, 1H), 8.39 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.50 (d, J = 4.8 Hz, 1H), 7.46 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.29 (t, J = 5.0 Hz, 2H), 4.05 (br, 2H), 3.62-3.16 (br, 6H), 2.89 (s, 3H), 1.77 (s, 3H)
822[Figure (not displayed)]
MS (ESI) m/z 648.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76-8.71 (m, 2H), 8.66 (s, 1H), 7.75 (dd, J = 8.0, 0.9 Hz, 1H), 7.71-7.64 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.81 (s, 2H), 4.59 (bd, J = 16.5 Hz, 4H), 4.41 (s, 4H), 3.08 (br, 1H), 2.09 (s, 3H), 0.81-0.76 (m, 4H)
823[Figure (not displayed)]
MS (ESI) m/z 706.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 6.22 (t, J = 53.9 Hz, 1H), 4.56 (br, 6H), 4.38 (t, J = 5.0 Hz, 2H), 4.25 (br, 2H), 4.20 (t, J = 5.0 Hz, 2H), 1.79 (s, 3H), 1.32 (s, 6H)
824[Figure (not displayed)]
MS (ESI) m/z 678.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.85 (d, J = 4.9 Hz, 1H), 8.60 (s, 1H), 8.50 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.51 (d, J = 4.9 Hz, 1H), 7.45 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 6.26 (tt, J = 55.5, 4.2 Hz, 1H), 4.44-4.37 (m, 2H), 4.26- 4.14 (m, 2H), 3.44 (dd, J = 7.8, 6.6, 4.1 Hz, 2H), 3.19-2.84 (m, 6H), 1.74 (s, 3H), 0.81 (q, J = 6.6 Hz, 1H), 0.69-0.63 (m, 1H)
825[Figure (not displayed)]
MS (ESI) m/z 686.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (d, J = 4.8 Hz, 1H), 8.57 (s, 1H), 8.44 (s, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (d, J = 4.8 Hz, 1H), 7.39 (d, J = 2.7 Hz, 1H), 7.32 (d, J = 9.0 Hz, 1H), 4.65 (d, J = 48.5 Hz, 2H), 4.45 (br, 4H), 4.35 (t, J = 5.2 Hz, 2H), 4.27 (br, 4H), 4.17 (t, J = 5.2 Hz, 2H), 1.76 (s, 3H), 1.29 (br, 2H), 0.97 (br, 2H)
826[Figure (not displayed)]
MS (ESI) m/z 688.7 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.9 Hz, 1H), 8.61 (s, 1H), 8.48 (s, 1H), 7.64-7.58 (dd, J = 8.9, 2.6 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 4.4 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.71-4.42 (m, 8H), 4.38 (t, J = 5.2 Hz, 2H), 4.28-4.16 (m, 4H), 1.80 (s, 3H), 1.26 (s, 6H)
827[Figure (not displayed)]
MS (ESI) m/z 718.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.66 (s, 1H), 7.76 (d, J = 9.0 Hz, 1H), 7.71-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.59-4.47 (m, 2H), 4.33- 3.54 (br, 8H), 3.14 (s, 3H), 2.63 (br, 1H), 2.06 (s, 3H)
828[Figure (not displayed)]
MS (ESI) m/z 710.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.65 (s, 1H), 7.78-7.74 (m, 1H), 7.71-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.53-4.45 (m, 1H), 4.49 (d, J = 47.2 Hz, 2H), 4.42-4.36 (m, 1H), 4.31-4.24 (m, 1H), 4.15-4.07 (m, 1H), 3.99-3.92 (m, 1H), 3.15 (s, 3H), 2.79-2.40 (m, 4H), 2.06 (s, 3H), 1.24 (d, J = 1.9 Hz, 6H)
829[Figure (not displayed)]
MS (ESI) m/z 682.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.58 (s, 1H), 8.46 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.35 (d, J = 9.0 Hz, 1H), 4.45 (s, 2H), 4.37 (t, J = 5.1 Hz, 2H), 4.34 (s, 2H), 4.19 (t, J = 5.1 Hz, 2H), 3.98-3.87 (m, 1H), 2.76 (s, 3H), 2.69-2.42 (m, 4H), 1.76 (s, 3H), 1.10- 0.99 (m, 1H), 0.93-0.72 (m, 4H)
830[Figure (not displayed)]
MS (ESI) m/z 676.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.8 Hz, 1H), 8.71 (s, 1H), 8.66 (s, 1H), 7.77-7.74 (m, 1H), 7.71-7.66 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.80 (s, 2H), 4.48 (s, 2H), 4.36 (s, 2H), 3.99- 3.88 (m, 1H), 2.76 (s, 3H), 2.70-2.42 (m, 4H), 2.08 (s, 3H), 1.09-0.99 (m, 1H), 0.92-0.72 (m, 4H)
831[Figure (not displayed)]
MS (ESI) m/z = 586.3 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.89 (s, 1H), 8.40 (s, 1H), 7.59 (dd, J = 9.0, 2.6, 1H), 7.43-7.41 (m, 2H), 7.35 (d, J = 9.0 Hz, 1H), 4.39 (t, J = 5.2 Hz, 2H), 4.39 (t, J = 5.2 Hz, 2H), 2.71 (s, 3H), 1.86 (s, 3H), 1.47 (s, 3H), 1.12-1.07 (m, 2H), 0.92-0.88 (m, 2H)
837[Figure (not displayed)]
MS (ESI) m/z = 652.1 [M + 1]+; 1H;-NMR (400 MHz, d6-DMSO) δ/ppm = 8.79 (d, J = 4.8 Hz, 1H), 8.48 (s, 1H), 8.46 (s, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.44 (d, J = 4.8 Hz, 1H), 7.38 (d, J = 2.7 Hz, 1H), 7.35 (d, J = 8.9 Hz, 1H), 4.94-4.81 (m, 2H), 4.40 (t, J = 4.6 Hz, 2H), 4.28-4.19 (m, 4H), 3.88-3.77 (m, 2H), 1.80 (s, 3H) [remaining CH2-protons presumably obscured by water-peak]
838[Figure (not displayed)]
MS (ESI) m/z = 666.4 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.81 (d, J = 4.8 Hz, 1H), 8.53 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 8.8, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.38 (d, J = 8.8 Hz, 1H), 4.85 (bt, J = 12.4 Hz, 2H), 4.42 (t, J = 5.0 Hz, 2H), 4.24 (t, J = 5.0 Hz, 2H), 4.24-4.14 (b, 2H), 2.87-2.71 (b, 3H), 1.83 (s, 3H), remaining protons appear to be obscured by water peak
839[Figure (not displayed)]
MS (ESI) m/z = 640.0 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 9.00 (s, 1H), 8.38 (s, 1H), 7.59 (dd, J = 8.9, 2.8 Hz, 1H), 7.42 (d, J = 2.8 Hz, 1H), 7.41 (s, 1H), 7.35 (d, J = 8.9 Hz, 1H), 4.40 (t, J = 4.9 Hz, 2H), 4.26 (t, J = 4.9 Hz, 2H), 2.70 (s, 3H), 1.90 (s, 3H), 1.63-1.58 (m, 2H), 1.54-1.48 (m, 2H)
840[Figure (not displayed)]
MS (ESI) m/z = 696.3 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.78 (d, J = 4.8 Hz, 1H), 8.55 (s, 1H), 8.44 (s, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.42 (d, J = 4.8 Hz, 1H), 7.39 (d, J = 8.9 Hz, 1H), 4.44 (s, 4H), 4.34 (t, J = 5.0 Hz, 2H), 4.15 (t, J = 5.0 Hz, 2H), 3.89-3.51 (b), 3.12-2.76 (b), 1.73 (s, 3H)
842[Figure (not displayed)]
MS (ESI) m/z = 610.3 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 9.98-9.88 (b, 1H), 8.84 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.71-7.65 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.36 (bd, J = 14 Hz, 2H), 3.36-3.24 (m, 2H), 2.91 (s, 3H), 2.13 (s, 3H); remaining signals are obscured by water peak
843[Figure (not displayed)]
MS (ESI) m/z = 712.5 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 9.98-9.79 (b, 1H), 8.81 (d, J = 4.9 Hz, 1H), 8.52 (s, 1H), 8.49 (s, 1H), 7.61 (dd, J = 8.9, 2.8 Hz, 1H), 7.48 (d, J = 4.9 Hz, 1H), 7.42 (d, J = 2.8 Hz, 1H), 7.39 (d, J = 8.9 Hz, 1H), 5.21-5.08 (m, 2H), 4.43 (t, J = 5.0 Hz, 2H), 4.23 (t, J = 5.0 Hz, 2H), 3.76-3.62 (m, partially obscured by water peak), 3.38- 3.14 (m, partially obscured by water peak), 2.49-2.36 (m, 2H), 2.03-1.93 (m, 2H), 1.83 (s, 3H)
844[Figure (not displayed)]
MS (ESI) m/z = 712.3 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 9.98-9.78 (b, 1H), 8.83 (d, J = 4.9 Hz, 1H), 8.70 (s, 1H), 8.43 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.9 Hz, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.38 (d, J = 8.9 Hz, 1H), 4.41 (t, J = 4.8 Hz, 2H), 4.38- 4.28 (m, 2H), 4.24 (t, J = 4.8 Hz, 2H), 3.32-3.21 (m, partially obscured by water peak), 2.47- 2.33 (m, 2H), 2.02-1.91 (m,2 H), 1.85 (s, 3H); remaining signals obscured by water peak
845[Figure (not displayed)]
MS (ESI) m/z = 726.3 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 10.29-9.70 (b, 1H), 8.83 (d, J = 4.7 Hz, 1H), 8.71 (s, 1H), 8.44 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.7 Hz, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 4.41 (t, J = 4.5 Hz, 2H), 4.24 (t, J = 4.5 Hz, 2H), 4.50-3.20 (broad signals, partially obscured by water peak), 2.99 (bq, J = 11 Hz, 2H), 1.85 (s, 3H), 1.52 (s, 6H)
846[Figure (not displayed)]
MS (ESI) m/z 631.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.31 (s, 1H), 9.85 (s, 1H), 8.73 (d,J = 8.1 Hz, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.42 (s, 1H), 7.40-7.33 (m, 2H), 5.69 (d, J = 7.2 Hz, 1H), 5.60-5.42 (m, 1H), 4.78 (s, 1H), 4.59-4.46 (m, 2H), 4.41 (t, J = 5.2 Hz, 2H), 4.29 (q, J = 5.9, 5.4 Hz, 3H), 3.04-2.96 (m, 3H), 2.71 (s, 3H), 2.54 (d, J = 6.4 Hz, 3H), 2.11 (d, J = 22.1 Hz, 3H)
848[Figure (not displayed)]
MS (ESI) m/z 671.9 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.55 (s, 1H), 7.56 (dd,J = 8.9, 2.7 Hz, 1H), 7.38-7.29 (m, 4H), 4.61- 4.42 (m, 1H), 4.36 (t, J = 5.0 Hz, 2H), 4.20 (t, J = 5.0 Hz, 2H), 3.18-3.09 (m, 2H), 3.04 (s, 3H), 2.78 (d, J = 4.6 Hz, 3H), 2.67 (s, 4H), 2.17- 1.94 (m, 3H), 1.92 (s, 3H)
850[Figure (not displayed)]
LCMS: 574.6 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.46 (s, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.40-7.28 (m, 3H), 4.39 (t, J = 5.1 Hz, 2H), 4.22 (t, J = 5.0 Hz, 2H), 3.00 (q, J = 7.6 Hz, 2H), 2.70 (s, 3H), 2.66 (s, 3H), 1.90 (s, 3H), 1.28 (t, J = 7.5 Hz, 3H)
851[Figure (not displayed)]
LCMS: 560.4 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (d, J = 4.8 Hz, 1H), 8.46 (s, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (d, J = 4.8 Hz, 1H), 7.39 (d, J = 2.7 Hz, 1H), 7.33 (d, J = 9.0 Hz, 1H), 4.39 (t, J = 5.0 Hz, 2H), 4.21 (t, J = 5.0 Hz, 2H), 3.01 (q, J = 7.5 Hz, 2H), 2.71 (s, 3H), 1.80 (s, 3H), 1.28 (t, J = 7.5 Hz, 3H)
854[Figure (not displayed)]
MS (ESI) m/z 644.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.40 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.39 (t, J = 5.0 Hz, 2H), 4.21 (s, 2H), 3.08 (s, 3H), 2.81 (d, J = 4.7 Hz, 3H), 2.07 (d, J = 8.4 Hz, 5H), 1.77 (s, 3H)
857[Figure (not displayed)]
LCMS: 642.7 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 9.57 (s, 1H), 8.80 (d, J = 4.8 Hz, 1H), 8.59 (s, 1H), 8.46 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.49-7.34 (m, 3H), 4.43 (t, J = 5.0 Hz, 2H), 4.24 (d, J = 5.0 Hz, 2H), 3.35 (t, J = 10.8 Hz, 3H), 2.79 (d, J = 3.4 Hz, 3H), 2.23 (s, 2H), 2.08 (d, J = 8.1 Hz, 2H), 1.86 (s, 3H)
860[Figure (not displayed)]
LCMS: 678.5 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81-8.73 (m, 2H), 8.66 (s, 1H), 7.76 (d, J = 9.0 Hz, 1H), 7.69 (dd, J = 6.2, 2.3 Hz, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 3.69 (t, J = 4.7 Hz, 4H), 3.30 (q, J = 10.2 Hz, 2H), 2.84 (t, J = 4.8 Hz, 4H), 2.07 (s, 3H)
861[Figure (not displayed)]
LCMS: 712.7 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 4.8 Hz, 1H), 8.50 (s, 1H), 8.37 (s, 1H), 7.60 (dd, J = 9.0, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.69 (s, 1H), 4.43 (t, J = 5.1 Hz, 2H), 4.22 (d, J = 5.1 Hz, 2H), 3.22 (s, 1H), 3.13 (s, 3H), 3.04 (d, J = 11.2 Hz, 2H), 2.00-1.81 (m, 1H), 1.78 (s, 3H)
862[Figure (not displayed)]
LCMS: 662.5 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 9.80 (s, 1H), 8.80 (d, J = 4.8 Hz, 1H), 8.45 (d, J = 9.3 Hz, J = 8.9, 2.7 Hz, 1H), 7.48-7.41 (m, 2H), 7.39 (d, J = 9.0 Hz, 1H), 5.50 (s, 1H),J = 11.4 Hz, 1H), 5.02 (d, J = 12.3 Hz, 1H), 4.44 (q, J = 4.8 Hz, 2H), J = 5.1 Hz, 2H), 3.85 (d, J = 12.3 Hz, 1H), 3.26 (d, J = 1.6 Hz, 3H), 2.87 (d, J = 4.1. 12H), 7.61 (dd, 5.38 (s, 1H), 5.10 (d, 4.25 (t, Hz, 3H), 2.20-2.03 (m, 1H), 1.80 (s, 3H)
863[Figure (not displayed)]
LCMS: 670.2 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 9.64 (s, 1H), 9.51 (s, 1H), 8.82- 8.75 (m, 1H), 8.44-8.38J = 8.9, 2.6 Hz, 1H), 7.49 (t, J = 5.0 Hz, 1H), 7.44 (dd, J = 9.0, 2.7 Hz, 1H),J = 9.0 Hz, 1H), 5.18 (dq, J = 11.7, 5.8 Hz, 1H), 5.05 (s, 1H), 4.44 (q, J = 5.2 Hz, 2H), J = 5.0 Hz, 2H), 4.05-3.78 (m, 2H), 3.17 (d, J = 9.9 Hz, 1H), 3.07 (s, 3H), 2.72-J = 3.4 Hz, 5H)
864[Figure (not displayed)]
LCMS: 694.5 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.9 Hz, 1H), 8.40 (d, J = 2.3 Hz, 2H), 7.58 (dd, J = 8.9, 2.7 Hz, 1H), 7.44 (d, J = 4.8 Hz, 1H), 7.40-7.32 (m, 2H), 6.55 (t, J = 52.5 Hz, 2H), 4.89 (s, 1H), 4.48- 4.32 (m, 2H), 4.21 (t, J = 5.3 Hz, 2H), 3.10 (s, 3H), 2.91 (s, 4H), 2.33-2.08 (m, 4H), 2.05- 1.88 (m, 3H), 1.74 (s, 3H)
865[Figure (not displayed)]
LCMS: 712.6 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.60 (s, 1H), 8.45 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.38 (t, J = 5.0 Hz, 2H), 4.33-4.13 (m, 3H), 3.07 (s, 3H), 2.73-2.52 (m, 3H), 2.03-1.82 (m, 2H), 1.77 (d, J = 28.9 Hz, 5H), 1.25 (d, J = 16.2 Hz, 1H)
866[Figure (not displayed)]
LCMS: 694.5 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.63 (s, 1H), 8.42 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 6.49 (d, J = 52.7 Hz, 1H), 4.64 (d, J = 15.0 Hz, 1H), 4.39 (t, J = 5.0 Hz, 2H), 4.22 (t, J = 5.1 Hz, 2H), 3.09 (s, 3H), 2.94 (s, 3H), 1.76 (s, 3H)
868[Figure (not displayed)]
MS (ESI) m/z 670.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.50 (s, 1H), 8.64 (s, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.38-7.30 (m, 3H), 4.90 (s, 2H), 4.36 (t, J = 5.1 Hz, 2H), 4.22 (t, J = 5.1 Hz, 2H), 3.56 (d, J = 12.1 Hz, 2H), 3.30 (t, J = 10.9 Hz, 2H), 2.80 (s, 2H), 2.67 (s, 3H), 2.02 (d, J = 2.5 Hz, 4H), 1.93 (s, 3H)
869[Figure (not displayed)]
LCMS: 1.54 Min, 617.5 [M + H]-; 1H NM:R (400 MHz, DMSO-d6) δ 9.07 (s, 1H), 8.80 (s, 1H), 8.72 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.44-7.33 (m, 3H), 5.62 (p, J = 6.2 Hz, 1H), 4.58-4.45 (m, 2H), 4.41 (t, J = 5.1 Hz, 2H), 4.25 (dt, J = 20.4, 5.8 Hz, 4H), 2.71 (s, 3H), 2.54 (s, 3H), 2.11 (s, 3H)
871[Figure (not displayed)]
LCMS (ESI) m/z 654.8 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.50 (s, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.51-7.39 (m, 3H), 7.34 (d, J = 9.0 Hz, 1H), 7.26-7.14 (m, 2H), 4.43 (td, J = 8.9, 7.7, 3.7 Hz, 1H), 4.37 (dd, J = 10.3, 4.5 Hz, 1H), 4.23 (t, J = 5.1 Hz, 2H), 2.75 (s, 3H), 2.68 (s, 3H), 2.12 (s, 3H), 1.83 (s, 3H)
872[Figure (not displayed)]
LCMS (ESI) m/z 650.8 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.47 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.49-7.45 (m, 2H), 7.38 (d, J = 9.0 Hz, 1H), 7.30 (dd, J = 8.2, 6.9 Hz, 1H), 7.21-7.16 (m, 2H), 4.45 (t, J = 5.0 Hz, 2H), 4.26 (t, J = 5.0 Hz, 2H), 2.77 (s, 3H), 2.72 (s, 3H), 2.00 (s, 6H), 1.84 (s, 3H)
873[Figure (not displayed)]
LCMS (ESI) m/z 637.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.48 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.49-7.43 (m, 2H), 7.38 (d, J = 9.0 Hz, 1H), 7.30 (dd, J = 8.2, 6.9 Hz, 1H), 7.19 (d, J = 8.0 Hz, 2H), 4.45 (t, J = 5.0 Hz, 2H), 4.26 (t, J = 4.9 Hz, 2H), 2.77 (s, 3H), 2.72 (s, 3H), 2.00 (s, 6H)
874[Figure (not displayed)]
LCMS (ESI) m/z 656.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.36 (s, 1H), 8.54 (s, 1H), 8.30 (dd, J = 9.3, 5.7 Hz, 1H), 7.66-7.57 (m, 2H), 7.48-7.33 (m, 3H), 6.96 (ddd, J = 8.2, 5.8, 2.3 Hz, 1H), 4.43 (t, J = 5.0 Hz, 2H), 4.24 (t, J = 5.0 Hz, 2H), 2.72 (d, J = 4.6 Hz, 6H), 1.87 (s, 3H)
875[Figure (not displayed)]
LCMS (ESI) m/z 644.1 [M + 1]+; 1H NMR (400 MHz, Chloroform-d) δ 8.48 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.42-7.37 (m, 2H), 4.42 (d, J = 5.3 Hz, 2H), 4.33 (s, 1H), 4.30 (s, 1H), 4.25 (d, J = 5.0 Hz, 2H), 3.61 (d, J = 12.2 Hz, 2H), 3.44 (d, J = 13.6 Hz, 4H), 3.24 (d, J = 11.0 Hz, 1H), 2.92 (d, J = 4.4 Hz, 3H), 2.73 (s, 3H), 2.66 (s, 4H), 1.98 (s, 3H)
878[Figure (not displayed)]
LCMS (ESI) m/z 630.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (s, 1H), 8.44 (s, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.41-7.31 (m, 2H), 4.39 (d, J = 10.4 Hz, 1H), 4.39 (s, 1H), 4.20 (s, 1H), 3.79 (t, J = 4.9 Hz, 2H), 3.28 (s, 2H), 2.68 (s, 2H), 2.62 (s, 2H), 1.94 (s, 2H)
882[Figure (not displayed)]
LCMS (ESI) m/z 634.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.91 (s, 1H), 8.80 (d, J = 4.8 Hz, 1H), 8.35 (s, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.47-7.38 (m, 2H), 7.32 (d, J = 9.0 Hz, 1H), 6.27 (s, 1H), 4.37 (t, J = 5.0 Hz, 2H), 4.21 (t, J = 4.9 Hz, 2H), 2.87-2.75 (m, 4H), 2.22 (dq, J = 14.1, 6.8 Hz, 2H), 1.75 (s, 3H).
883[Figure (not displayed)]
LCMS (ESI) m/z 617.1 [M + 1]+.; 1H NMR (400 MHz, DMSO-d6) δ 8.53 (s, 1H), 8.47 (d, J = 0.8 Hz, 1H), 7.55 (dd, J = 8.9, 2.7 Hz, 1H), 7.41- 7.34 (m, 2H), 7.39-7.28 (m, 2H), 7.44-4.40 (m, 2H), 4.34 (t, J = 5.1 Hz, 2H), 4.16 (t, J = 5.1 Hz, 2H), 3.86 (dd, J = 11.5, 4.8 Hz, 2H), 3.73 (ddd, J = 11.1, 8.1, 3.4 Hz, 1H), 3.54 (d, J = 11.6 Hz, 1H), 2.67 (s, 3H), 2.05-1.94 (m, 1H), 1.90 (s, 2H), 1.76 (s, 3H)
884[Figure (not displayed)]
LCMS (ESI) m/z 614.9 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.61 (s, 1H), 8.45 (s, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.39-7.29 (m, 3H), 4.36 (t, J = 5.1 Hz, 2H), 4.24 (s, 2H), 4.22 − 4.14 (m, 4H), 2.71 (t, J = 7.7 Hz, 2H), 2.68 (s, 3H), 1.86 (s, 3H)
885[Figure (not displayed)]
LCMS (ESI) m/z 662.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 4.8 Hz, 1H), 8.46 (s, 1H), 7.57 (dd, J = 9.0, 2.6 Hz, 1H), 7.44 (d, J = 4.8 Hz, 1H), 7.39-7.32 (m, 2H), 4.98-4.74 (m, 2H), 4.40 (t, J = 5.1 Hz, 2H), 4.29 (s, 2H), 4.21 (t, J = 5.1 Hz, 2H), 3.64 (s, 2H), 3.56 (s, 2H), 3.47 (s, 2H), 3.31 (s, 2H), 2.66 (s, 3H), 1.86 (s, 3H)
886[Figure (not displayed)]
LCMS (ESI) m/z 698.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.9 Hz, 1H), 8.54 (s, 1H), 7.60 (dd, J = 8.8, 2.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.41 (s, 2H), 4.21 (s, 2H), 3.65 (s, 5H), 3.29 (q, J = 10.2 Hz, 2H), 2.82 (s, 4H), 2.64 (s, 3H), 1.80 (s, 3H)
888[Figure (not displayed)]
LCMS (ESI) m/z 613.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.92 (s, 1H), 8.98 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.36 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46 (dd, J = 13.2, 3.7 Hz, 2H), 7.36 (d, J = 9.0 Hz, 1H), 6.51 (s, 1H), 4.40 (d, J = 5.3 Hz, 2H), 4.27 (d, J = 5.0 Hz, 2H), 4.14 (d, J = 17.9 Hz, 1H), 3.91 (s, 1H), 3.69 (d, J = 11.9 Hz, 1H), 3.35 (s, 1H), 2.95 (d, J = 4.5 Hz, 6H), 1.81 (s, 3H)
889[Figure (not displayed)]
1H NMR (400 MHz, DMSO-d6) δ 8.91 (s, 1H), 8.80 (d, J = 4.8 Hz, 1H), 8.37 (s, 1H), 7.56 (d, J = 8.8 Hz, 1H), 7.43 (d, J = 15.4 Hz, 2H), 7.32 (d, J = 9.0 Hz, 1H), 6.40 (s, 1H), 4.37 (s, 2H), 4.21 (s, 2H), 3.35 (d, J = 9.9 Hz, 1H), 2.91 (s, 3H), 2.66 (s, 1H), 1.75 (s, 3H)
890[Figure (not displayed)]
LCMS (ESI) m/z 469.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.87 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 7.76 (d, J = 8.2 Hz, 1H), 7.76-7.65 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.51 (t, J = 54 Hz, 1H), 5.43 (s, 1H), 4.84 (s, 2H), 2.28 (s, 2H), 2.18 (s, 1H), 2.12 (s, 3H)
891[Figure (not displayed)]
LCMS (ESI) m/z 528.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.80 (d, J = 4.8 Hz, 1H), 8.69 (s, 1H), 7.76 (d, J = 9.1 Hz, 1H), 7.72- 7.64 (m, 2H), 7.56 (d, J = 4.8 Hz, 1H), 4.78 (s, 2H), 1.92 (s, 3H)
892[Figure (not displayed)]
LCMS (ESI) m/z 654.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 610.05 (s, 1H), 8.73-8.67 (m, 2H), 8.63 (s, 1H), 7.72 (dd, J = 8.1, 0.8 Hz, 1H), 7.73-7.61 (m, 2H), 7.51 (d, J = 4.8 Hz, 1H), 4.78 (s, 2H), 4.74-4.67 (m, 1H), 4.64- 4.55 (m, 3H), 4.49 (s, 2H), 4.40 (t, J = 6.9 Hz, 4H), 3.59 (d, J = 4.6 Hz, 1H), 3.52 (s, 1H), 2.07 (s, 3H), 1.21 (s, 1H)
893[Figure (not displayed)]
LCMS (ESI) m/z 672.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75-8.67 (m, 2H), 8.63 (s, 1H), 7.72 (dd, J = 8.1, 0.8 Hz, 1H), 7.69-7.61 (m, 2H), 7.51 (d, J = 4.8 Hz, 1H), 6.34 (t, J = 52 Hz, 1 H), 4.78 (s, 2H), 4.50 (s, 5H), 4.45 (s, 3H), 3.81 (s, 1H), 2.94 (s, 2H), 2.35 (s, 6H), 2.07 (s, 3H)
894[Figure (not displayed)]
LCMS (ESI) m/z 720.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.05(s, 1H), 8.75-8.71 (m, 2H), 8.66 (s, 1H), 7.78-7.73 (m, 1H), 7.72- 7.64 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.81 (s, 2H), 4.65 (s, 2H), 4.52 (s, 2H), 4.44 (d, J = 3.7 Hz, 4H), 4.37-4.29 (m, 2H), 3.61 (s, 2H), 2.10 (s, 3H)
895[Figure (not displayed)]
MS (ESI) m/z 650.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.78 (s, 1H), 8.85 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69 (dd, J = 8.4, 2.2 Hz, 1H), 7.66 (d, J = 2.1 Hz, 1H), 7.53 (d, J = 4.8 Hz, 1H), 4.84 (s, 2H), 4.38 (d, J = 14.1 Hz, 2H), 3.75 (d, J = 12.0 Hz, 2H), 3.60-3.48 (m, 2H), 3.33-3.23 (m, 2H), 3.17-3.11 (m, 2H), 2.14 (s, 3H), 1.18-1.08 (m, 1H), 0.72-0.66 (m, 2H), 0.45-0.37 (m, 2H)
897[Figure (not displayed)]
MS (ESI) m/z 562.07 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.59 (bs, 1H), 8.72 (s, 1H), 8.42 (s, 1H), 7.58 (dd, J = 2.56, 8.72 Hz, 1H), 7.40 (bs, 2H), 7.34 (d, J = 8.92 Hz, 1H), 4.39 (t, J = 4.00 Hz, 2H), 4.39 (t, J = 4.52 Hz, 2H), 4.11 (s, 3H), 2.70 (s, 3H), 1.85 (s, 3H)
898[Figure (not displayed)]
MS (ESI) m/z 586.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.5 (bs, 1H), 8.49 (s, 1H), 7.60-7.57 (dd, J = 4.0, 8.8 Hz, 1H), 7.39 (m, 3H), 4.44 (t, J = 6.0 Hz, 2H), 4.25 (t, J = 3.6 Hz, 2H), 2.68 (s, 6H), 1.90 (s, 3H), 1.18-1.16 (m, 4H)
900[Figure (not displayed)]
MS (ESI) m/z 572.02 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.39 (bs, 1H), 8.91 (s, 1H), 8.35 (s, 1H), 8.07 (s, 1H), 7.60-7.57 (dd, J = 7.48, 2.56 Hz, 1H), 7.41 (d, J = 2.52 Hz, 1H), 7.33 (d, J = 8.92 Hz, 1H), 4.41-4.35 (m, 2H), 4.30-4.20 (m, 2H), 3.01 (s, 3H), 2.67-2.60 (m, 1H), 1.81 (s, 3H), 1.28-1.12 (m, 4H)
910[Figure (not displayed)]
MS (ESI) m/z 648.05 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.41 (bs, 1H), 8.64 (s, 1H), 8.08 (d, J = 3.32 Hz, 2H), 7.58 (dd, J = 2.48, 8.84 Hz, 1H), 7.53 (d, J = 2.48 Hz, 3H), 7.42- 7.35 (d, J = 2.48 Hz, 1H), 7.35-7.38 (m, 2H), 4.43 (t, J = 5.80 Hz, 2H), 4.28 (t, J = 4.52 Hz, 2H), 2.66-2.55 (m, 1H), 2.55 (s, 3H), 1.95 (s, 3H), 1.23 (d, J = 4.28 Hz, 4H)
911[Figure (not displayed)]
MS (ESI) m/z 637.07 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.72 (d, J = 5.2 Hz, 1H), 8.47 (s, 1H), 7.83 (s, 1H), 7.79 (d, J = 4.48 Hz, 1H), 7.60 (dd, J = 2.52, 8.84 Hz, 1H), 7.42-7.34 (m, 3H), 4.45 (t, J = 6.12 Hz, 2H), 4.30 (t, J = 5.72 Hz, 2H), 2.80 (s, 3H), 2.71 (s, 3H), 2.65 (s, 3H), 2.01 (s, 3H)
912[Figure (not displayed)]
MS (ESI) m/z 586.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.90 (s, 1H), 8.54 (s, 1H), 7.58 (dd, J = 8.92, 2.44 Hz, 1H), 7.42 (d, J = 2.52 Hz, 1H), 7.40 (s, 1H), 7.35 (d, J = 8.92 Hz, 1H), 4.95 (t, J = 8.68, 1H), 4.41 (t, J = 5.8 Hz, 2H), 4.24 (t, J = 5.84, 2H), 2.68 (s, 3H), 2.37- 2.32 (m, 3H), 2.13-2.08 (m, 2H), 1.91 (s, 3H), 1.91 (bs, 2H)
913[Figure (not displayed)]
MS (ESI) m/z 596.04 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.55 (bs, 1H), 9.00 (s, 1H), 8.42 (s, 1H), 7.58 (d, J = 8.68 Hz, 1H), 7.41 (s, 2H), 7.35 (d, J = 8.88 Hz, 1H), 4.40 (t, J = 4.88 Hz, 2H), 4.27 (t, J = 5.4 Hz, 2H), 2.70 (s, 3H), 2.16 (t, J = 19.28 Hz, 3H), 1.89 (s, 3H)
914[Figure (not displayed)]
MS (ESI) m/z 582.03 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.06 (s, 1H), 8.40 (s, 1H), 7.59 (dd, J = 8.8, 2.5 Hz, 1H), 7.43-7.16 (m, 4H), 4.40 (t, J = 6.0 Hz, 2H), 4.28 (t, J = 2.6 Hz, 2H), 2.70 (s, 2H), 1.84 (s, 3H)
915[Figure (not displayed)]
MS (ESI) m/z 617.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.53 (bs, 1H), 9.02 (s, 1H), 8.36 (s, 1H), 7.59 (dd, J = 8.88 Hz, 2.52 Hz, 1H), 7.41-7.39 (m, 2H), 7.34 (d, J = 8.96 Hz, 1H), 5.72 (d, J = 47.16 Hz, 2H), 4.40 (t, J = 7.44 Hz, 2H), 4.27 (t, J = 4.48 Hz, 2H), 2.69 (s, 3H), 1.88 (s, 3H)
916[Figure (not displayed)]
MS (ESI) m/z 585.97 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (s, 1H), 8.39 (s, 1H), 7.61 (dd, J = 8.88Hz, J = 2.68 Hz, 1H), 7.45- 7.43 (m, 2H), 7.37 (d, J = 8.96 Hz, 1H), 4.42- 4.39 (m, 2H), 4.26- 4.23 (m, 2H), 3.02 (q, J = 7.56 Hz, J = 7.52 Hz, 2H), 2.67 (s, 1H), 1.83 (s, 3H), 1.35 (t, J = 7.52 Hz, 3H), 1.24-1.19 (m, 4H)
917[Figure (not displayed)]
MS (ESI) m/z 590.02 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.01 (s, 1H), 8.86 (s, 1H), 8.43 (s, 1H), 7.60 (dd, J = 2.48, 8.88 Hz, 1H), 7.51 (s, 1H), 7.43 (d, J = 2.52 Hz, 1H), 7.35 (d, J = 8.96, 1H), 5.69 (d, J = 46.8 Hz, 2H), 4.40 (t, J = 3.96 Hz, 2H), 4.23 (t, J = 4.40 Hz, 2H), 2.61-2.57 (m, 1H), 1.77 (s, 3H), 1.23-1.15 (m, 4H)
922[Figure (not displayed)]
MS (ESI) m/z 540.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.96 (s, 1H), 8.87 (s, 1H), 7.74 (s, 1H) 7.67 (d, J = 2.3 Hz, 1H), 7.62 (dd, J = 8.84, 2.40 Hz, 1H), 7.35 (d, J = 8.92 Hz, 1H), 4.44 (s, 4H), 2.68 (s, 3H), 2.58-2.57 (m, 1H), 1.20-1.14 (m, 4H)
923[Figure (not displayed)]
MS (ESI) m/z 560.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.95 (s, 1H), 8.35 (s, 1H), 7.59-7.56 (dd, J = 2.4, 8.4 Hz, 1H), 7.41-7.33 (m, 3H), 4.40 (t, J = 4.8 Hz, 2H), 4.26 (t, J = 4.8 Hz, 2H), 3.12 (m, 2H), 2.68 (s, 3H), 1.88 (s, 3H), 1.35 (t, J = 7.2 Hz, 3H)
924[Figure (not displayed)]
MS (ESI) m/z 690 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.4 (s, 1H), 8.50 (s, 1H), 7.94 (d, J = 7.8 Hz, 1H), 7.89 (t, J = 7.2 Hz, 1H), 7.81 (t, J = 8.4 Hz, 1H), 7.61 (dd, J = 2.4, 8.8 Hz, 1H), 7.43 (s, 2H), 7.38 (d, J = 8.82 Hz, 1H), 4.44 (bs, 2H), 4.27 (bs, 2H), 2.80 (s, 3H), 2.71 (s, 3H), 1.92 (s, 3H)
925[Figure (not displayed)]
MS (ESI) m/z 690.02 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.45 (s, 1H), 8.24 (s, 1H), 8.19 (d, J = 7.76 Hz, 1H), 7.94 (d, J = 7.6 Hz, 1H), 7.84 (t, J = 7.8 Hz, 1H), 7.60 (dd, J = 2.56, 8.8 Hz, 1H), 7.43 (s, 1H), 7.39 (d, J = 2.2 Hz, 2H), 4.46 (t, J = 3.6 Hz, 2H), 4.30 (t, J = 4.4 Hz, 2H), 2.80 (s, 3H), 2.71 (s, 3H), 2.00 (s, 3H)
926[Figure (not displayed)]
MS (ESI) m/z 690.02 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.44 (bs, 1H), 8.49 (s, 1H), 8.10 (d, J = 8.08 Hz, 2H), 7.95 (d, J = 8.20 Hz, 2H), 7.60 (dd, J = 8.88, 2.60 Hz, 1H), 7.43 (s, 1H), 7.42-7.37 (m, 2H), 4.45 (t, J = 4.64 Hz, 2H), 4.30 (t, J = 4.36 Hz, 2H), 2.80 (s, 3H), 2.71 (s, 3H), 1.99 (s, 3H)
927[Figure (not displayed)]
MS (ESI) m/z 654.03 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.50 (bs, 1H), 8.48 (s, 1H), 7.60 (dd, J = 2.4, 8.7 Hz, 1H), 7.43-7.37 (m, 5H), 7.30-7.26 (m, 1H), 4.44 (t, J = 5.2 Hz, 2H), 4.27 (t, J = 5.8 Hz, 2H), 2.77 (s, 3H), 2.71 (s, 3H), 2.13 (s, 3H), 1.93 (s, 3H)
928[Figure (not displayed)]
MS (ESI) m/z 622.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.03 (s, 1H), 8.35 (s, 1H), 7.58 (dd, J = 2.52, 8.8 Hz, 1H), 7.39 (t, J = 2.68 Hz, 2H), 7.35 (d, J = 9 Hz, 1H), 4.39 (t, J = 4.4 Hz, 2H), 4.26 (t, J = 4.28 Hz, 2H), 4.04-3.95 (m, 1H), 3.11-3.05 (m, 4H), 2.70 (s, 3H), 1.91 (s, 3H)
929[Figure (not displayed)]
MS (ESI) m/z 636.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.20 (bs, 1H), 9.04 (s, 1H), 8.37 (s, 1H), 7.61-7.56 (m, 1H), 7.44-7.38 (m, 2H), 7.34 (d, J = 8.96 Hz, 1H), 4.40-4.36 (m, 2H), 4.27-4.15 (m, 3H), 2.68 (s, 3H), 2.59-2.56 (m, 1H), 2.32-2.17 (m, 3H), 2.07-2.03 (m, 1H), 1.93-1.83 (m, 4H)
930[Figure (not displayed)]
MS (ESI) m/z 636.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.50 (bs, 1H), 8.99 (s, 1H), 8.38 (s, 1H), 7.59 (dd, J = 8.88, 2.52 Hz, 1H),7.40 (s, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.41-4.36 (m, 2H), 4.31-4.23 (m, 2H), 4.08-4.02 (m, 1H), 2.70 (s, 3H), 2.63-2.57 (m, 2H), 2.38- 2.32 (m, 1H), 2.29-2.26 (m, 2H), 2.09-2.05 (m, 1H), 1.91 (s, 3H)
931[Figure (not displayed)]
MS (ESI) m/z 650.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.96 (s, 1H), 8.35 (s, 1H), 7.59 (dd, J = 8.88, 2.56 Hz, 1H), 7.44-7.40 (m, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.40 (t, J = 4.68 Hz, 2H), 4.25 (t, J = 4.68, 2H), 3.60-3.50 (bs, 1H), 2.70 (s, 3H), 2.40-2.21 (m, 2H), 2.20-2.09 (m, 1H), 2.00.1.80 (m, 6H), 1.68-1.63 (m, 2H)
940[Figure (not displayed)]
MS (ESI) m/z 534.16 [M + 1]+;1H NMR (400 MHz, DMSO-d6) δ 13.08 (bs, 1H), 8.82 (s, 1H), 7.61-7.56 (m, 2H), 7.36-7.26 (m, 3H), 6.73 (d, J = 7.88 Hz, 1H), 4.46-4.30 (m, 4H), 2.60-2.59 (m, merged, 1H), 2.57 (s, 3H), 1.28-1.10 (m, 4H)
941[Figure (not displayed)]
MS (ESI) m/z 626.17 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.56 (bs, 1H), 9.09 (s, 1H), 8.48 (s, 1H), 7.74-7.71 (m, 1H), 7.65-7.58 (m, 2H), 7.45-7.34 (m, 4H), 7.35 (d, J = 8.8 Hz, 1H), 4.41 (t, J = 4.60 Hz, 2H), 4.28 (t, J = 4.60 Hz, 2H), 2.70 (s, 3H),1.90 (s, 3H)
942[Figure (not displayed)]
MS (ESI) m/z 626.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.55 (bs, 1H), 9.04 (s, 1H), 8.38 (s, 1H), 7.74 (t, J = 6.92 Hz, 2H), 7.67- 7.58 (m, 2H), 7.45-7.41 (m, 3H), 7.36 (d, J = 8.76 Hz, 1H), 4.42 (t, J = 4.68 Hz, 2H), 4.28 (t, J = 4.08, Hz, 2H), 2.66 (s, 3H), 1.98 (s, 3H)
943[Figure (not displayed)]
MS (ESI) m/z 626.05 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.55 (bs, 1H), 9.03 (s, 1H), 8.41 (s, 1H), 7.99-7.95 (m, 2H), 7.59 (dd, J = 2.56, 8.88 Hz, 1H), 7.45-7.41 (m, 4H), 7.36 (d, J = 8.96 Hz, 1H), 4.42 (t, J = 4.76 Hz, 2H), 4.28 (t, J = 4.52 Hz, 2H), 2.70 (s, 3H), 1.90 (s, 3H)
944[Figure (not displayed)]
MS (ESI) m/z 622.08 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.03 (s, 1H), 8.43 (s, 1H), 7.60 (dd, J = 8.92 Hz, 2.64 Hz, 1H), 7.47-7.35 (m, 7H), 4.42 (t, J = 5.64 Hz, 2H), 4.27 (t, J = 4.4 Hz, 2H), 2.73 (s, 3H), 2.19 (s, 3H), 1.86 (s, 3H)
945[Figure (not displayed)]
MS (ESI) m/z 622.05 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.02 (s, 1H), 8.41 (s, 1H), 7.90 (s, 1H), 7.68 (s, 1H), 7.58 (dd, J = 8.2, 2.12 Hz, 1H), 7.48-7.35 (m, 5H), 4.42 (t, J = 4.48, 2H), 4.27 (t, J = 5.68, 2H), 2.71 (s, 3H), 2.43 (s, 3H), 1.88 (s, 3H)
946[Figure (not displayed)]
MS (ESI) m/z 622.08 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.5 (s, 1H), 9.027 (s, 1H), 8.40 (s, 1H), 7.80 (d, J = 8.0 Hz, 2H), 7.58 (dd, J = 2.56 Hz, J = 2.52 Hz, 1H), 7.34- 7.42 (m, 5H), 4.40-4.42 (bs, 2H), 4.26- 4.28 (bs, 2H), 2.70 (s, 3H), 2.42 (s, 3H), 1.87 (s, 3H)
947[Figure (not displayed)]
MS (ESI) m/z 642.01 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.54 (bs, 1H), 9.07 (s, 1H), 8.43 (s, 1H), 7.70-7.68 (m, 2H), 7.66-7.54 (m, 3H), 7.43-7.42 (m, 2H), 7.35 (d, J = 9.0 Hz, 1H), 4.41 (t, J = 6.16 Hz, 2H), 4.27 (t, J = 4.48 Hz, 2H), 2.71 (s, 3H), 1.88 (s, 3H)
948[Figure (not displayed)]
MS (ESI) m/z 642.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.50 (bs, 1H), 9.03 (s, 1H), 8.37 (s, 1H), 7.97 (t, J = 2.0 Hz 1H), 7.90-7.84 (m, 1H), 7.67-7.58 (m, 3H), 7.42-7.40 (m, 2H), 7.41 (d, J = 2.6 Hz, 1H), 4.42 (t, J = 5.48 Hz, 2H), 4.28 (t, J = 4.40 Hz, 2H), 2.71 (s, 3H), 1.91 (s, 3H)
949[Figure (not displayed)]
MS (ESI) m/z 642.01 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.04 (s, 1H), 8.40 (s, 1H), 7.94 (d, J = 8.5 Hz, 2H), 7.67 (d, J = 8.5 Hz, 2H), 7.59 (dd, J = 8.9, 2.6 Hz, 1H), 7.45-7.40 (m, 2H), 7.36 (d, J = 8.9 Hz, 1H), 4.42 (t, J = 8.3 Hz, 2H), 4.28 (t, J = 4.4 Hz, 2H), 2.70 (s, 3H), 1.90 (s, 3H)
950[Figure (not displayed)]
MS (ESI) m/z 676 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.03 (s, 1H), 8.41 (s, 1H), 7.97 (d, J = 7.6 Hz, 1H), 7.91 (t, J = 7.6 Hz, 1H), 7.83 (t, J = 8.0 Hz, 2H), 7.61 (dd, J = 2.8, 8.8 Hz, 1H), 7.44 (s, 1H), 7.36 (d, J = 9.2 Hz) 1H), 4.42 (bs, 1H), 4.27 (bs, 1H), 2.72 (s, 3H), 1.87 (s, 3H)
951[Figure (not displayed)]
MS (ESI) m/z 676.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.06 (s, 1H), 8.37 (s, 1H), 8.27 (s, 1H), 8.22 (d, J = 7.6 Hz ,1H), 7.96 (d, J = 7.4 Hz, 1H), 7.84 (t, J = 7.8 Hz, 1H), 7.60 (dd, J = 2.52, 8.8 Hz, 1H), 7.43 (s, 1H), 7.41 (d, J = 2.5 Hz ,1H), 7.37 (d, J = 8.9 Hz, 1H), 4.43 (t, J = 5.4 Hz, 2H), 4.29 (t, J = 4.96 Hz, 2H), 2.75 (s, 3H), 1.92 (s, 1H)
952[Figure (not displayed)]
MS (ESI) m/z 676.01 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.49 (bs, 1H), 9.07 (s, 1H), 8.41 (s, 1H), 8.13 (d, J = 8.16 Hz, 2H), 7.98 (d, J = 8.28 Hz, 2H), 7.60 (dd, J = 8.92, 2.60 Hz 1H), 7.43-7.40 (m, 2H), 7.36 (d, J = 8.96 Hz 1H), 4.42 (t, J = 6.48 Hz 2H), 4.29 (t, J = 4.48 Hz 2H), 2.71 (s, 3H), 1.92 (s, 3H)
953[Figure (not displayed)]
MS (ESI) m/z 655.99 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 6, 9.03(s, 1H), 8.33 (s, 1H), 7.62-7.58 ( m, 2H), 7.52 (dd, J = 2.16, 8.24 Hz, 1H), 7.47-7.42 (m, 3H), 7.37 (d, J = 8.92 Hz, 1H), 4.43 (t, J = 4.96 Hz, 2H), 4.29 (t, J = 3.88 Hz, 2H), 2.72 (s, 3H), 2.15 (s, 3H), 1.85 (s, 3H)
954[Figure (not displayed)]
MS (ESI) m/z 675.95 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.06 (s, 1H), 8.36 (s, 1H), 7.90 (s, 1H), 7.74-7.68 (m, 2H), 7.59 (d, J = 6.6 Hz, 1H), 7.42 (s, 2H), 7.35 (d, J = 8.8 Hz, 1H), 4.42 (s, 2H), 4.28 (s, 2H), 2.72 (s, 3H), 1.89 (s, 3H)
970[Figure (not displayed)]
MS (ESI) m/z 521.01 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.47 (bs, 1H), 8.96 (s, 1H), 7.70 (s, 1H), 7.29 (d, J = 8.8 Hz, 1H), 7.17 (s, 1H), 7.10 (d, J = 8.8 Hz, 1H), 6.83 (s, 1H), 4.53 (t, J = 6.4 Hz, 2H), 4.39 (t, J = 4.8 Hz, 2H), 3.99 (s, 2H), 2.65 (s, 3H), 2.57 (bs, 1H), 1.20 (d, J = 7.6 Hz, 2H), 0.93 (d, J = 6.4 Hz, 2H)
971[Figure (not displayed)]
MS (ESI) m/z 643.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.38 (bs, 1H), 8.63 (s, 1H), 8.46 (s, 1H), 7.59 (dd, J = 2.5, 8.9 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (s, 1H), 7.34 (s, 1H), 4.76-4.69 (m, 2H), 4.38 (t, J = 4.3 Hz, 2H), 4.21 (t, J = 6.2 Hz, 2H), 3.43 (s, 3H), 2.69 (s, 3H), 1.81 (s, 3H)
972[Figure (not displayed)]
MS (ESI) m/z 629.09 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.65 (s, 1H), 8.43 (s, 1H), 7.77 (t, J = 6.0 Hz, 1H), 7.57 (d, J = 9.0 Hz, 1H), 7.41 (s, 1H), 7.35 (t, J = 5.3 Hz, 2H), 4.37- 4.30 (m, 4H), 4.20 (bs, 2H), 2.68 (s, 3H), 1.78 (s, 3H)
973[Figure (not displayed)]
MS (ESI) m/z 625.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.59 (s, 1H), 8.44 (s, 1H), 7.59 (dd, J = 2.56, 6.28 Hz, 1H), 7.40 (bs, 2H), 7.35 (d, J = 8.96 Hz, 1H), 6.38 (tt, J = 4.08, 59.88 Hz, 1H), 4.38 (t, J = 6.20 Hz, 2H), 4.21 (t, J = 4.48 Hz, 2H), 4.16-4.12 (m, 2H), 3.39 (s, 3H), 2.71 (s, 3H), 1.84 (s, 3H)
974[Figure (not displayed)]
MS (ESI) m/z 611.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.60 (s, 1H), 8.47 (s, 1H), 7.60-7.55 (m, 2H), 7.40 (s, 2H), 7.34 (d, J = 8.96 Hz 1H), 6.21 (tt, J = 5.28, 57.68 Hz, 1H), 4.36 (t, J = 4.60 Hz, 2H), 4.20 (t, J = 4.60 Hz, 2H), 3.93-3.86 (m, 2H), 2.70 (s, 3H), 1.80 (s, 3H)
975[Figure (not displayed)]
MS (ESI) m/z 560.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.14 (s, 1H), 8.61 (s, 1H), 7.62-7.59 (dd, J = 2.4, 8.4 Hz, 1H), 7.46 (s, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.37 (d, J = 9.2 Hz, 1H), 4.88 (t, J = 9.6 Hz, 2H), 4.40 (t, J = 4.4 Hz, 2H), 4.23 (t, J = 4.8 Hz, 2H), 4.17 (t, J = 9.6 Hz, 2H), 3.52 (s, 1H), 2.66 (s, 3H), 1.86 (s, 3H)
976[Figure (not displayed)]
MS (ESI) m/z 591.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (s, 1H), 8.23 (bs, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.38 (s, 1H), 7.33 (m, 2H), 4.37 (t, J = 5.2 Hz, 2H), 4.22 (t, J = 4.0 Hz, 2H), 3.84 (s, 3H), 3.26 (s, 3H), 2.66 (s, 3H), 1.63 (s, 3H)
977[Figure (not displayed)]
MS (ESI) m/z 615.03 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.92 (s, 1H), 8.44 (s, 1H), 7.59 (dd, J1 = 2.5 Hz, J2 = 8.8 Hz, 1H), 7.41- 7.40 (m, 2H), 7.35 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 8.8 Hz, 2H), 4.25 (t, J = 9.1 Hz, 2H), 4.08, (t, J = 13.6 Hz, 2H), 2.70 (s, 3H), 2.60-2.58 (m, 2H), 2.20 (t, J = 14.3 Hz, 2H), 1.87 (s, 3H)
978[Figure (not displayed)]
MS (ESI) m/z 604.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.54 (s, 1H), 8.48 (s, 1H), 7.59 (dd, J = 8.8 Hz, 2.48 Hz, 1H), 7.42-7.39 (m, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.37 (d, J = 4.48 Hz, 2H), 4.19 (d, J = 4.8 Hz, 2H), 3.05 (s, 3H), 2.70 (s, 3H), 2.53 (s, 6H), 1.78 (s, 3H)
979[Figure (not displayed)]
MS (ESI) m/z 590.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.69 (bs, 1H), 8.57 (s, 1H), 8.46 (s, 1H), 7.59 (dd, J = 8.88 Hz, 2.44 Hz, 1H), 7.43-7.41 (m, 2H), 7.34 (d, J = 8.96 Hz, 1H), 4.36 (t, J = 4.28 Hz, 2H), 4.18 (t, J = 4.6 Hz, 2H), 2.70 (s, 9H), 1.71 (s, 3H)
980[Figure (not displayed)]
MS (ESI) m/z 716.23 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 3.60 Hz, 1H), 8.68 (s, 1H), 8.59 (s, 1H), 7.74 (d, J = 8.40 Hz, 1H), 7.67-7.64 (m, 2H), 7.43 (d, J = 3.60 Hz, 1H), 4.80 (s, 2H), 4.25 (bs, 1H), 3.83 (s, 3H), 3.10 (s, 3H), 3.02 (d, J = 9.6 Hz, 2H), 2.78-2.71 (m, 2H), 2.39-2.34 (m, 2H), 2.03 (s, 3H), 1.93- 1.91 (m, 2H), 1.76-1.05 (m, 5H)
981[Figure (not displayed)]
MS (ESI) m/z 554.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.22 (s, 1H), 9.19 (s, 1H), 8.79 (d, J = 4.8 Hz, 1H), 8.45 (s, 1H), 7.61 (dd, J = 2.64, 8.88, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.45 (d, J = 2.68 Hz, 1H), 7.37 (d, J = 8.96 Hz, 1H), 6.72-6.46 (t, J = 51.6 Hz, 1H), 4.41 (d, J = 4.64 Hz, 2H), 4.36 (d, J = 4.52 Hz, 2H)
982[Figure (not displayed)]
MS (ESI) m/z 649.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.60 (s, 1H), 8.69 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 2.56 Hz, J = 8.88 Hz, 1H), 7.42-7.35 (m, 4H), 7.29 (d, J = 7.25 Hz, 1H), 7.12 (t, J = 7.52 Hz, 1H), 6.96 (t J = 7.24 Hz, 1H), 4.41 (t, J = 5.04 Hz, 2H), 4.34 (t, J = 8.04 Hz, 2H), 4.24 (t, J = 4.76 Hz, 2H), 3.22 (t, J = 7.88 Hz, 2H), 2.71 (s, 3H), 1.83 (s, 3H)
983[Figure (not displayed)]
MS (ESI) m/z 647.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.99 (s, 1H), 8.43 (s, 1H), 7.92 (d, J = 3.36 Hz, 1H), 7.74 (d, J = 8.12 Hz 1H), 7.69 (s, J = 7.60 Hz 1H), 7.61 (dd, J = 8.88, 2.48 Hz 1H), 7.45 (s, 1H), 7.43 (d, J = 2.48 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 7.29- 7.20 (m, 2H), 6.84 (d, J = 3.28 Hz, 1H), 4.44 (d, J = 4.48 Hz, 2H), 4.29 (d, J = 4.48 Hz, 2H), 2.70 (s, 3H), 1.87 (s, 3H)
984[Figure (not displayed)]
MS (ESI) m/z 598.05 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.91 (s, 1H), 8.58 (s, 1H), 8.44 (s, 1H), 7.96 (s, 1H), 7.59 (d, J = 8.76 Hz, 1H), 7.42 (s, 2H), 7.35 (d, J = 8.88 Hz, 1H), 6.70 (s, 1H), 4.41 (t, J = 4.12 Hz, 2H), 4.27 (t, J = 4.00 Hz, 2H), 2.71 (s, 3H), 1.83 (s, 3H)
985[Figure (not displayed)]
MS (ESI) m/z 561.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.52 (bs, 1H), 8.59 (s, 1H), 8.47 (s, 1H), 7.58 (dd, J = 8.8, 2.12 Hz, 1H), 7.41 (s, 1H), 7.381H), 7.33 (d, J = 8.96 Hz, 1H), 7.28-7.20 (m, 1H), 4.36 (t, J = 5.68 Hz, 2H), 4.18 (t, J = 6.16 Hz, 2H), 2.97 (d, J = 4.24 Hz, 3H), 2.69 (s, 3H), 1.75 (s, 3H)
986[Figure (not displayed)]
MS (ESI) m/z 637.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.59 (bs, 1H), 8.76 (s, 1H), 8.52 (s, 1H), 7.58 (dd, J = 8.84, 2.48 Hz, 1H), 7.43-7.32 (m, 5H), 7.18 (d, J = 8.00 Hz, 2H), 7.12 (t, J = 7.20 Hz, 1H), 4.35 (t, J = 5.48 Hz, 2H), 4.18 (t, J = 3.64 Hz, 2H), 3.53 (s, 3H), 2.72 (s, 3H), 1.78 (s, 3H)
987[Figure (not displayed)]
MS (ESI) m/z 651.29 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.45 (bs, 1H), 8.69 (s, 1H), 8.62 (s, 1H), 8.13 (t, J = 3.36 Hz, 2H), 7.58 (dd, J = 2.52, 8.84 Hz, 1H), 7.53-7.51 (m, 3H), 7.42 (d, J = 2.52 Hz, 1H), 7.39-7.36 (m, 2H), 4.41 (t, J = 4.60 Hz, 2H), 4.25 (t, J = 4.4 Hz, 2H), 3.31 (s, 6H), 2.56 (s, 3 H) 1.88 (s, 3H)
988[Figure (not displayed)]
MS (ESI) m/z 590.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.01 (s, 1H), 8.40 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.43-7.42 (m, 2H), 7.35 (d, J = 8.9 Hz, 1H), 4.95-4.90 (m, 1H), 4.39 (s, 2H), 4.23-4.20 (m, 2H), 3.22 (s, 3H), 2.70 (s, 3H), 1.84 (s, 3H), 1.50 (s, 3H)
989[Figure (not displayed)]
MS (ESI) m/z 626.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 with D2O) 6 9.14 (s, 1H), 7.79 (s, 1H), 7.50 (dd, J = 8.64 Hz, 1.96 Hz, 1H), 7.31 (d, J = 2.56 Hz, 1H), 7.25 (d, J = 8.68 Hz, 1H), 7.04 (s, 1H), 6.63 (s, 1H), 6.41 (s, 1H), 4.33 (s, 2H), 4.25 (s, 2H), 2.66 (s, 3H), 1.82 (s, 3H)
993[Figure (not displayed)]
MS (ESI) m/z 665.02 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.53 (bs, 1H), 9.56 (s, 1H), 9.11 (s, 1H), 8.72 (s, 1H), 8.32 (bs, 1H), 8.28 (d, J = 8.56 Hz, 1H), 8.06 (d, J = 8.48 Hz,1H), 7.59 (dd, J = 8.92Hz, 2.36 Hz, 1H), 7.41 (d, J = 2.28 Hz, 1H), 7.37-7.35 (m, 2H), 4.42 (t, J = 6.24 Hz, 2H), 4.30 (t, J = 4.56 Hz, 2H), 2.70 (s, 3H), 1.90 (s, 3H)
994[Figure (not displayed)]
MS (ESI) m/z 640.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.88 (s, 1H), 8.39 (s, 1H), 7.59 (dd, J = 8.88, 2.62 Hz, 1H), 7.41 (t, J = 2.8 Hz, 2H), 7.36 (d, J = 8.8 Hz, 1H), 4.40 (t, J 5.2 Hz, 2H), 4.27 (t, J = 5.2 Hz, 2H), 2.94 (d, 4.4 Hz, 1H), 2.70 (s, 3H), 2.66- 2.60 (m, 1H), 1.91 (s, 3H), 1.68 (t, J = 7.2 Hz, 2H)
997[Figure (not displayed)]
MS (ESI) m/z 673.99 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.50 (s, 1H), 8.50 (s, 1H), 7.86 (dd, J = 2.56, 6.08 Hz, 1H), 7.70 (dd, J = 4.60, 8.60 Hz, 1H), 7.58 (dd, J = 2.52, 8.92 Hz, 1H), 7.49 (t, J = 9.28 Hz, 2H), 7.42-7.36 (m, 2H), 4.44 (t, J = 4.40 Hz, 2H), 4.29 (t, J = 4.40 Hz, 2H), 2.79 (s, 3H), 2.70 (s, 3H), 2.00 (s, 3H)
998[Figure (not displayed)]
MS (ESI) m/z 658.03 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.50 (s, 1H), 8.52 (s, 1H), 7.64-7.61 (m, 1H), 7.60 (dd, J = 2.4, 8.92 Hz, 1H), 7.50-7.47 (m, 2H), 7.42 (bs, 1H), 7.40 (d, J = 2.56 Hz, 1H), 7.37 (d, J = 9.00 Hz, 1H), 4.44 (t, J = 4.72 Hz, 2H), 4.29 (t, J = 4.52 Hz, 2H) 2.79 (s, 3H), 2.70 (s, 3H), 2.06 (s, 3H)
999[Figure (not displayed)]
MS (ESI) m/z 674.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.50 (bs, 1H), 8.50 (s, 1H), 7.72-7.68 (m, 2H), 7.59 (dd, J = 2.56, 8.92 Hz, 1H), 7.53-7.45 (m, 1H), 7.43-7.41 (m, 2H), 7.34 (d, J = 9.2 Hz, 1H), 4.45 (t, J = 4.96 Hz, 2H), 4.29 (bs, 2H), 2.78 (s, 3H), 2.70 (s, 3H), 1.98 (s, 3H)
1004[Figure (not displayed)]
MS (ESI) m/z 548.02 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.62 (bs, 2H), 8.51 (s, 1H), 8.30 (bs, 1H), 7.59 (dd, J = 8.88, 2.52 Hz, 1H), 7.42 (s, 2H), 7.34 (d, J = 9.00 Hz 1H), 4.35 (t, J = 5.48 Hz, 2H), 4.15 (t, J = 3.64 Hz, 2H), 2.71 (s, 3H), 1.65 (s, 3H)
1008[Figure (not displayed)]
MS (ESI) m/z 663.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.68 (s, 1H), 8.10-8.08 (m, 2H), 7.60 (dd, J = 2.4, 6.8 Hz, 2H), 7.51-7.50 (m, 3H), 7.41-7.36 (m, 3H), 4.42 (t, J = 4.8 Hz, 6H), 4.24 (t, J = 4.4 Hz, 2H), 2.57 (s, 3H), 2.42- 2.32 (m, 2H), 1.97 (s, 3H)
1010[Figure (not displayed)]
MS (ESI) m/z 617.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.59 (s, 1H), 8.55 (s, 1H), 8.47 (s, 1H), 7.58 (d, J = 8.72 Hz ,1H), 7.40- 7.38 (m, 2H), 7.34 (d, J = 8.76 Hz, 1H), 4.55 (t, J = 6.76 Hz, 2H), 4.36 (m, 3H), 4.18-4.13 (m, 4H), 3.28 (s, 3H), 2.70 (s, 3H), 1.80 (s, 3H)
1011[Figure (not displayed)]
MS (ESI) m/z 603.09 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.55 (s, 1H), 8.48 (s, 1H), 7.59 (dd, J = 2.4, 8.8 Hz 1H), 7.41 (d, J = 2.4 Hz, 1H), 7.39 (s, 1H ), 7.35 (d, J = 9.2 Hz 1H), 5.79 (d, J = 5.2 Hz, 1H), 4.58 (m, 3H), 4.36 (bs, 2H), 4.19 (bs, 2H), 4.07 (d, J = 6.8 Hz, 2H), 2.70 (s, 3H), 1.78 (s, 3H)
1015[Figure (not displayed)]
MS (ESI) m/z 636.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.67 (bs, 1H), 8.50 (s, 1H), 7.87 (m, 2H), 7.61-7.55 (m, 4H), 7.46 (s, 1H), 7.42 (d, J = 2.5 Hz, 1H), 7.37 (s, 1H), 4.45 (t, J = 5.3 Hz, 2H), 4.27 (t, J = 4.6 Hz, 2H), 3.04- 2.98 (m, 2H), 2.78 (s, 3H), 1.35 (s, 3H), 1.08 (t, J = 7.5 Hz, 3H)
1016[Figure (not displayed)]
MS (ESI) m/z 622.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.73 (bs, 1H), 9.02 (s, 1H), 8.39 (s, 1H) 7.94-7.87 (m, 2H), 7.61-7.58 (m, 4H), 7.46-7.43 (m, 2H), 7.36 (d, J = 8.96 Hz, 1H), 4.42 (t, J = 5.6 Hz, 2H), 4.27 (t, J = 4.32 Hz, 2H), 3.02 (q, J = 7.52 Hz, 2H), 1.83 (s, 3H) 1.35 (t, J = 7.56 Hz, 3H)
1037[Figure (not displayed)]
MS (ESI) m/z 688.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.86 (bs, 1H), 8.87 (s, 1H), 8.11 (s, 1H), 7.54 (d, J = 8.72 Hz, 1H), 7.36 (s, 1H), 7.30 (d, J = 8.88 Hz, 1H), 7.23 (s, 1H), 4.48 (t, J = 4.4 Hz, 1H), 4.35 (t, J = 4.08, 2H), 4.22 (t, J = 3.24, 2H), 2.66 (s, 3H), 1.80 (s, 3H), 0.86 (d, J = 5.56 Hz, 2H), 0.81 (s, 2H)
1038[Figure (not displayed)]
MS (ESI) m/z 624.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.57 (bs, 1H), 8.62 (s, 1H), 8.44 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz 1H), 7.54-7.46 (m, 2H), 7.45-7.40 (m, 2H), 7.36 (d, J = 8.8 Hz, 1H), 7.35-7.28 m, 3H), 4.41 (t, J = 4.4 Hz, 2H), 4.26 (t, J = 5.2 Hz, 2H), 2.71 (s, 3H), 1.82 (s, 3H)
1039[Figure (not displayed)]
MS (ESI) m/z 639.08 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.62 (bs, 1H), 8.71 (s, 1H), 8.59 (d, J = 4 Hz, 1H), 8.43 (s, 1H), 7.89 (t, J = 7.08 Hz, 1H), 7.60-7.57 (m, 2H), 7.40 (s, 2H), 7.39-7.34 (m, 2H), 5.68 (s, 2H), 4.40 (t, J = 5.36 Hz, 2H), 4.24 (t, J = 4.36 Hz,2H), 2.70 (s, 3H), 1.85 (s, 3H)
1041[Figure (not displayed)]
MS (ESI) m/z 653.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) ) 68.58 (s, 1H), 8.46 (s, 1H), 7.58 (dd, J = 2.4, 8.8 Hz, 1H), 7.40 (t, J = 2.4 Hz, 2H), 7.35 (d, J = 8.8 Hz, 1H), 7.03-6.65 (m, 1H), 5.12 (t, J = 3.6 Hz, 1H), 4.72 (m, 2H), 4.38 (t, J = 5.2 Hz, 2H), 4.32 (m, 2H), 4.21 (t, J = 4.4 Hz, 2H), 3.40 (s, 1H), 2.71 (s, 3H), 1.83 (s, 3H)
1042[Figure (not displayed)]
MS (ESI) m/z 671.16 [M + 1]-; 1H NMR (400 MHz, DMSO-d6) δ 8.60 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 2.8, 8.8 Hz, 1H), 7.41-7.40 (m, 2H), 7.36 (d, J = 8.8 Hz, 1H), 5.36-5.33 (m, 1H), 4.79-4.75 (m, 2H), 4.43 (t, J = 3.2 Hz, 2H), 4.40 (t, J = 7.6 Hz, 2H), 4.21 (d, J = 4.4 Hz, 2H), 2.17 (s, 3H), 1.85 (s, 3H)
1043[Figure (not displayed)]
MS (ESI) m/z 667.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.56 (s, 1H), 8.47 (s, 1H), 7.57 (dd, J = 2.52, 8.8 Hz ,1H), 7.40 (t, J = 2.4 Hz, 2H), 7.34 (d, J = 8.84 Hz, 1H), 6.35-6.06 (m, 1H), 4.59 (t, J = 6.24 Hz, 2H), 4.36 (t, J = 4.8 Hz, 2H), 4.18 (d, J = 6.8 Hz, 4H), 3.84-3.75 (m, 2H), 2.70 (s, 3H), 1.80 (s, 3H)
1044[Figure (not displayed)]
MS (ESI) m/z 685.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.58 (bs, 1H), 8.57 (s, 1H), 8.47 (s, 1H), 7.58 (dd, J = 2.48, 8.88 Hz ,1H), 7.40 (d, J = 2.56 Hz, 1H), 7.39 (s, 1H), 7.34 (d, J = 9.00 Hz, 1H), 4.65-4.58 (m, 3H), 4.37 (t, J = 6.08 Hz, 2H), 4.25-4.19 (m, 6H), 2.70 (s, 3H), 1.81 (s, 3H)
1045[Figure (not displayed)]
MS (ESI) m/z 659.25 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.59 (bs, 1H), 8.55 (s, 1H), 8.47 (s, 1H), 7.59 (dd, J = 2.48, 8.84 Hz, 1H), 7.41 (d, J = 2.52 Hz, 1H), 7.39 (s, 1H), 7.34 (d, J = 8.96 Hz, 1H), 4.68-4.65 (m, 1H), 4.61-4.57 (m, 2H), 4.34 (t, J = 4.68 Hz, 2H), 4.16 (t, J = 3.72 Hz, 2H), 4.06-4.03 (m, 2H), 2.67 (s, 3H), 1.82 (s, 3H), 1.15 (s, 9H)
1051[Figure (not displayed)]
MS (ESI) m/z 641.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.52 (s, 1H), 9.06 (s, 1H), 8.67 (d, J = 2.76 Hz, 1H), 8.36 (s, 1H), 8.06 (dd, J = 2.64, 9.0 Hz, 1H), 7.60 (dd, J = 2.52, 8.8 Hz ,1H), 7.43 (s, 2H), 7.36 (d, J = 8.96 Hz, 1H), 4.43 (t, J = 5.0 Hz, 2H), 4.29 (t, J = 5.5 Hz, 2H), 2.72 (s, 3H), 2.36 (s, 3H), 1.91 (s, 3H)
1052[Figure (not displayed)]
MS (ESI) m/z, 640.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.51 (bs, 1H), 9.03 (s, 1H), 8.37 (s, 1H), 7.60 (dd, J = 2.40, 8.84 Hz, 1H), 7.43 (bs, 4H), 7.34 (d, J = 8.92 Hz, 1H), 7.32- 7.28 (m, 1H), 4.42 (t, J = 4.72 Hz, 2H), 4.27 (t, J = 4.76 Hz, 2H), 2.72 (s, 3H), 2.14 (s, 3H), 1.86 (s, 3H)
1053[Figure (not displayed)]
MS (ESI) m/z 603.17 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.94 (s, 1H), 8.38 (s, 1H), 7.59 (d, J = 8.72 Hz, 1H), 7.42 (s, J = 2.76, 2H), 7.36 (d, J = 8.96 Hz, 1H), 4.41 (s, 2H), 4.26 (s, 2H), 3.34 (s, 3H), 2.71 (s, 3H), 2.00 (bs, 3H), 1.84 (s, 3H)
1056[Figure (not displayed)]
MS (ESI) m/z 617.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.55 (s, 1H), 8.50 (s, 1H), 7.59 (dd, J = 8.8 Hz, 2.44 Hz, 1H), 7.42-7.40 (m, 2H), 7.35 (d, J = 9 Hz, 1H), 4.38 (bs, 1H), 4.36 (m, 2H), 4.21-4.18 (m, 2H), 3.93-3.87 (m, 3H), 3.78-3.73 (m,1H), 3.56 (d, J = 11.68 Hz, 1H), 2.70 (s, 3H), 2.04-2.02 (m, 1H), 1.94-1.92 (m, 1H), 1.79 (s, 3H)
1057[Figure (not displayed)]
MS (ESI) m/z 617.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.59 (bs, 1H), 8.56 (s, 1H), 8.47 (s, 1H), 7.58 (d, J = 8.64 Hz, 1H), 7.40 (d, J = 8.84 Hz, 2H), 7.34 (d, J = 8.88 Hz, 1H), 5.70 (bs, 1H) 4.36 (t, J = 6.56 Hz, 2H), 4.20 (m, 6H), 2.70 (s, 3H), 1.77 (s, 3H), 1.47 (s, 3H)
1062[Figure (not displayed)]
MS (ESI) m/z 574.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.7 (bs, 1H), 8.92 (s, 1H), 8.35 (s, 1H), 7.60 (d, J = 8.4 Hz, 1H), 7.44-7.43 (m, 2H), 7.36 (d, J = 8.8 Hz, 1H), 4.40 (t, J = 4.4 Hz, 2H), 4.25 (t, J = 4.0 Hz, 2H), 3.12- 3.07(m, 2H), 3.03-2.97 (m, 2H), 1.83 (s, 3H), 1.36 (t, J = 7.2 Hz, 6H)
1063[Figure (not displayed)]
MS (ESI) m/z 573.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.86 (s, 1H), 8.30 (s, 1H), 7.55 (dd, J = 8.88 Hz, 2.32 Hz, 1H), 7.35-7.30 (m, 3H), 4.36 (t, J = 6.6 Hz, 2H), 4.22 (t, J = 5.12 Hz, 2H), 3.02 (t, J = 7.36 Hz, 2H), 2.71 (s, 3H), 1.90 (s, 3H), 1.80-1.74 (m, 2H),0.93 (t, J = 14.6Hz, 3H)
1064[Figure (not displayed)]
MS (ESI) m/z 578.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.98 (s, 1H), 8.40 (s, 1H), 7.59 (dd, J = 8.88 Hz, 2.62 Hz, 1H), 7.41 (s, 2H), 7.35 (d, J = 8.89 Hz, 1H), 4.94 (dt, J = 48 Hz, 6.0 Hz, 2H), 4.40 (t, J = 5.2 Hz, 2H), 4.26 (t, J = 4.8 Hz, 2H), 3.49 (dt, J = 25 Hz, 6.0 Hz, 2H), 2.70 (s, 3H), 1.89 (s, 3H)
1065[Figure (not displayed)]
MS (ESI) m/z 578.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.50 (bs, 1H), 9.03 (s, 1H), 8.39 (s, 1H), 7.59 (dd, J = 8.8, 2.2 Hz 1H), 7.45-7.38 (m, 2H), 7.35 (d, J = 8.92 Hz, 1H), 6.24-6.15 (dq, J = 47.20, 6.80 Hz, 1H), 4.47- 4.35 (m, 2H), 4.35-4.29 (m, 2H), 2.69 (s, 3H), 1.87 (s, 3H), 1.78 (dd, J = 24.4, 6.32 Hz, 3H)
1066[Figure (not displayed)]
MS (ESI) m/z 576.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.58 (s, 1H), 8.98 (s, 1H), 8.35 (s, 1H), 7.58 (s, 1H), 7.41-7.35 (m, 3H), 4.74 (s, 2H), 4.39 (s, 2H), 4.26 (s, 2H), 3.38 (s, 3H) 2.69 (s, 3H), 1.85 (s, 3H)
1067[Figure (not displayed)]
MS (ESI) m/z 576.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.69 (s, 1H), 8.42 (s, 1H), 7.57 (dd, J = 2.52, 8.8 Hz, 1H), 7.41 (s, 2H), 7.35 (d, J = 8.92 Hz, 1H), 4.59-4.54 (m, 2H), 4.39 (t, J = 4.4 Hz, 2H), 4.23 (t, J = 4.3 Hz, 2H), 2.71 (s, 3H), 1.84 (s, 3H)
1068[Figure (not displayed)]
MS (ESI) m/z 602.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.70 (bs, 1H), 8.69 (s, 1H), 8.37 (s, 1H), 7.59 (dd, J = 8.88, 2.64 Hz, 1H), 7.40 (d, J = 2.60 Hz, 1H), 7.38 (s, 1H), 7.34 (d, J = 8.96 Hz, 1H), 4.41-4.31 (m, 4H), 4.23 (t, J = 4.60 Hz, 2H), 2.70 (s, 3H), 1.83 (s, 3H), 1.40- 1.40 (m, 1H), 0.65-0.58 (m, 2H), 0.46-0.39 (m, 2H)
1068[Figure (not displayed)]
MS (ESI) m/z 561.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.59 (bs, 1H), 8.55 (s, 1H), 7.58 (d, J = 8.0 Hz, 1H), 7.40-7.34 (m, 3H), 7.03 (s, 2H), 4.38 (t, J = 5.9 Hz, 2H), 4.17 (t, J = 4.0 Hz, 2H), 2.69 (s, 3H), 2.56 (s, 3H), 1.72 (s, 3H)
1070[Figure (not displayed)]
MS (ESI) m/z 575.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.56 (s, 1H), 7.60 (dd, J = 2.0, 8.8 Hz, 1H), 7.44 (t, J = 3.6 Hz, 2H), 7.36 (d, J = 9.2 Hz, 1H), 7.03 (bs, 2H), 4.40 (bs, 2H), 4.17 (bs, 2H), 3.03 (m, 2H), 2.55 (s, 3H), 1.69 (s, 3H), 2.96 (t, J = 7.6 Hz, 3H)
1071[Figure (not displayed)]
MS (ESI) m/z 561.21 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.80 (bs, 1H), 8.47 (s, 1H), 8.44 (s, 1H) 7.59 (d, J = 9.20 Hz, 1H), 7.44 (s, 2H), 7.33 (d, J = 9.0 Hz, 1H), 7.21 (bs, 2H), 4.35 (t, J = 5.48 Hz, 2H), 4.16 (t, J = 6.28 Hz, 2H), 3.01 (q, J = 7.52 Hz, 2H), 1.64 (s, 3H), 1.34 (t, J = 7.48 Hz, 3H)
1072[Figure (not displayed)]
MS (ESI) m/z 547.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.49 (s, 1H), 8.47 (s, 1H) 7.59 (dd, J = 8.92, 2.44 Hz, 1H), 7.45-7.39 (m, 2H), 7.33 (d, J = 8.92 Hz 1H), 7.21 (bs, 2H), 4.36 (t, J = 6.0 Hz, 2H), 4.17 (t, J = 6.04 Hz, 2H), 2.70 (s, 3H), 1.68 (s, 3H)
1076[Figure (not displayed)]
MS (ESI) m/z 600.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.71 (s, 1H), 8.81 (s, 1H), 8.35 (s, 1H), 7.60 (dd, J = 2.4, 8.8 Hz, 1H), 7.43 (s, 1H), 7.36 (d, J = 9.2 Hz, 1H), 4.41 (t, J = 4.8 Hz, 2H), 4.24 (t, J = 4.4 Hz, 2H), 2.96 (t, J = 7.2 Hz, 2H), 2.66 (m, 1H), 1.85-1.75 (m, 5H), 1.23-1.18 (m, 2H), 1.10-1.06 (m, 2H), 1.00 (t, J = 7.2 Hz, 3H)
1086[Figure (not displayed)]
MS (ESI) m/z 644.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.70 (bs, 1H), 9.90 (bs, 1H), 8.66 (s, 1H), 8.38 (s, 1H) 7.60 (dd, J = 8.88, 2.36 Hz, 1H), 7.46 (s, 1H), 7.41 (d, J = 2.36 Hz 1H), 7.37 (d, J = 8.96 Hz, 1H), 4.40 (t, J = 4.88 Hz, 2H), 4.31 (d, J = 13.92 Hz, 2H), 4.22 (t, J = 5.84 Hz, 2H), 3.61 (d, J = 11.36 Hz, 2H), 3.44 (t, J = 11.92 Hz, 2H), 3.30-3.28 (m, 2H), 3.02 (q, J = 7.44 Hz, 2H), 2.91 (s, 3H), 1.84 (s, 3H), 1.37 (t, J = 7.52 Hz, 3H)
1089[Figure (not displayed)]
MS (ESI) m/z 586.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 8.75 (s, 1H), 7.68 (s, 1H), 7.52 (d, J = 7.0 Hz, 1H), 7.34-7.28 (m, 3H), 7.09 (s, 1H), 4.34(5, 2H), 4.20 (s, 2H), 3.65 (s, 4H), 2.58 (s, 4H), 2.49 (s, 3H), 2.24 (s, 3H), 1.8 (s, 3H)
1091[Figure (not displayed)]
MS (ESI) m/z 644.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 14.39 (bs, 1H), 8.62 (s, 1H), 7.59 (dd, J = 2.48, 8.88 Hz ,1H), 7.40-7.38 (m, 2H), 7.35 (d, J = 8.92 Hz, 1H), 4.63-4.59 (m, 2H), 4.47 (bs, 2H), 4.39 (t, J = 4.64 Hz, 2H), 4.23 (t, J = 4.64 Hz, 3H), 2.82 (bs, 6H), 2.70 (s, 3H), 2.54 (s, 3H), 1.94 (s, 3H)
1092[Figure (not displayed)]
MS (ESI) m/z 670.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.58 (s, 1H), 7.55 (d, J = 8.8 Hz, 1H), 7.33-7.30 (m, 3H), 4.88 (s, 2H), 4.35 (s, 2H), 4.22 (s, 2H), 3.53 (d, J = 12 Hz, 2H), 3.31 (d, J = 11.6 Hz, 2H), 2.79 (s, 3H), 2.66 (s, 3H), 2.46 (s, 3H), 2.05 (s, 7H)
1097[Figure (not displayed)]
MS (ESI) m/z 651.21 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.64 (s, 1H), 8.42 (s, 1H), 7.59 (dd, J = 8.8, 2.56 Hz, 1H), 7.41 (s, 2H), 7.36 (d, J = 8.95 Hz, 1H), 4.39 (t, J = 6.9 Hz, 2H), 4.22 (t, J = 4.56 Hz, 2H), 3.87-3.75 (m, 4H), 2.71 (s, 3H), 2.21-2.15 (m, 4H) 1.87 (s, 3H)
1099[Figure (not displayed)]
MS (ESI) m/z 325.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 7.39-7.28 (m, 5H), 7.19 (d, J = 7.9 Hz, 1H), 4.99 (s, 2H), 3.50 (t, J = 12.4 Hz, 4H), 3.29-3.17 (m, 1H), 2.04 (t, J = 10.8 Hz, 2H), 1.77 (d, J = 12.4 Hz, 2H), 1.70 (d, J = 12.8 Hz, 2H), 1.15 (dq, J = 12.9, 3.2 Hz, 2H), 0.99 (q, J = 13.3 Hz, 2H)
1100[Figure (not displayed)]
MS (ESI) m/z 714.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.7 Hz, 1H), 8.71 (s, 1H), 8.66 (s, 1H), 7.78-7.74 (m, 1H), 7.69 (dd, J = 6.4, 2.2 Hz, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.92 (br, 4H), 4.82 (s, 2H), 4.33 (br, 2H), 3.13 (s, 3H), 2.07 (s, 3H), 2.03-1.61 (m, 8H)
1101[Figure (not displayed)]
MS (ESI) m/z 670.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.77 (s, 1H), 8.36 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.40 (br, 2H), 4.23 (br, 2H), 3.81-3.03 (br, 6H), 1.79 (s, 3H), 1.62 (br, 3H), 1.31 (br, 4H), 0.96-0.75 (m, 4H)
1102[Figure (not displayed)]
MS (ESI) m/z 664.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.90 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.63 (s, 1H), 7.78-7.73 (m, 1H), 7.69 (dd, J = 6.6, 2.2 Hz, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.85 (d, J = 7.1 Hz, 2H), 3.83-2.97 (br, 6H), 2.12 (s, 3H), 1.63 (br 3H), 1.34 (br, 3H), 1.23-0.78 (m, 5H)
1103[Figure (not displayed)]
MS (ESI) m/z 738.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.66 (s, 1H), 7.78-7.73 (m, 1H), 7.71-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.79-6.41 (m, 1H), 4.82 (s, 2H), 4.36 (br, 1H), 3.11 (s, 3H), 2.07 (s, 3H), 2.05-1.82 (br, 2H). Protons on piperidine were not seen
1104[Figure (not displayed)]
MS (ESI) m/z 722.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (s, 1H), 8.74 (d, J = 4.7 Hz, 1H), 8.62 (s, 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.71-7.61 (m, 2H), 7.43 (d, J = 4.7 Hz, 1H), 4.82 (s, 2H), 4.54 (bs, 2H), 3.86 (s, 3H), 3.68- 3.23 (br, 2H), 2.15 (s, 3H). Some aliphatic protons were not seen
1105[Figure (not displayed)]
MS (ESI) m/z 829.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.9 Hz, 1H), 8.82 (s, 1H), 8.75 (s, 1H), 7.78 (d, J = 9.1 Hz, 1H), 7.71 (dd, J = 6.6, 2.2 Hz, 2H), 7.64 (d, J = 4.9 Hz, 1H), 7.26-6.94 (m, 1H), 6.59 (tt, J = 54.1, 4.3 Hz, 2H), 4.84 (s, 2H), 4.56 (br, 1H), 4.48 (td, J = 14.7, 4.3 Hz, 2H), 3.12 (s, 3H), 2.34-1.97 (br, 8H), 1.95 (s, 3H), 1.76 (t, J = 19.4 Hz, 3H)
1106[Figure (not displayed)]
MS (ESI) m/z 710.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.06 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.73 (s, 1H), 8.66 (s, 1H), 7.76 (d, J = 9.0 Hz, 1H), 7.71-7.66 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 5.00-4.86 (m, 1H), 4.83 (s, 2H), 4.81-4.68 (m, 1H), 3.78-3.29 (m, 2H), 3.19 (s, 3H), 2.87 (s, 3H), 2.44-2.11 (m, 5H), 2.08 (s, 3H), 2.06-1.77 (m, 5H)
1107[Figure (not displayed)]
MS (ESI) m/z 752.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.8 Hz, 1H), 8.73 (s, 1H), 8.66 (s, 1H), 7.78-7.74 (m, 1H), 7.71-7.67 (m, 2H), 7.55 (d, J = 4.9 Hz, 1H), 4.82 (s, 2H), 4.38 (br, 1H), 3.11 (s, 3H), 2.08 (s, 3H), 2.07-1.92 (br, 2H), 1.84 (t, J = 20.0 Hz, 3H). Piperidine protons were not seen
1108[Figure (not displayed)]
MS (ESI) m/z 791.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.47 (s, 1H), 8.82-8.78 (m, 2H), 8.76 (s, 1H), 7.77 (dd, J = 8.3, 0.6 Hz, 1H), 7.73-7.66 (m, 2H), 7.62 (d, J = 4.9 Hz, 1H), 4.83 (s, 2H), 4.78 (br, 4H), 4.36-4.22 (m, 2H), 3.54 (s, 3H), 3.09 (s, 3H), 2.12-2.02 (m, 2H), 1.98 (s, 3H), 1.80-1.67 (m, 3H), 1.46-1.32 (m, 3H)
1109[Figure (not displayed)]
MS (ESI) m/z 854.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.01 (s, 1H), 8.89 (d, J = 4.8 Hz, 1H), 8.72 (ddd, J = 4.6, 1.7, 0.9 Hz, 1H), 8.66 (s, 1H), 8.59 (s, 1H), 8.27 (dt, J = 8.0, 1.1 Hz, 1H), 8.25-8.18 (m, 1H), 7.79-7.72 (m, 2H), 7.72-7.68 (m, 2H), 7.66 (d, J = 4.9 Hz, 1H), 4.82 (s, 2H), 4.76 (br, 4H), 4.34-4.23 (m, 1H), 3.24 (br, 1H), 3.07 (s, 3H), 2.13-2.01 (m, 2H), 1.97 (br, 2H), 1.94 (s, 3H), 1.71 (q, J = 12.1 Hz, 2H), 1.38 (q, J = 12.0 Hz, 2H)
1110[Figure (not displayed)]
MS (ESI) m/z 854.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.29 (dd, J = 2.4, 0.8 Hz, 1H), 8.92 (dd, J = 4.8, 1.6 Hz, 1H), 8.83 (d, J = 4.9 Hz, 1H), 8.69 (s, 1H), 8.54 (ddd, J = 8.2, 2.4, 1.6 Hz, 1H), 8.47 (s, 1H), 7.77-7.67 (m, 3H), 7.66 (dd, J = 2.2, 0.5 Hz, 1H), 7.62 (dd, J = 4.8, 0.4 Hz, 1H), 4.84 (br, 4H), 4.80 (s, 2H), 4.39-4.27 (m, 1H), 3.28 (br, 1H), 3.09 (s, 3H), 2.14-2.05 (m, 2H), 2.02-1.94 (m, 2H), 1.91 (s, 3H), 1.74 (q, J = 12.2 Hz, 2H), 1.42 (q, J = 11.9 Hz, 2H)
1111[Figure (not displayed)]
MS (ESI) m/z 854.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.98-8.93 (m, 2H), 8.84 (d, J = 4.9 Hz, 1H), 8.70 (s, 1H), 8.48 (s, 1H), 8.11- 7.70 (dd, J = 8.4, 2.2 Hz, 1H), 7.66 (dd, J = 2.2, 0.5 Hz, 1H), 7.64 (dd, J = 4.9, 0.4 Hz, 1H), 4.84 (br, 4H), 4.81 (s, 2H), 4.38-4.25 (m, 1H), 3.28 (br, 1H), 3.08 (s, 3H), 2.15-2.06 (m, 2H), 2.01-1.94 (m, 2H), 1.92 (s, 3H), 1.73 (q, J = 12.1 Hz, 2H), 1.41 (q, J = 11.8 Hz, 2H)
1112[Figure (not displayed)]
MS (ESI) m/z 688.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.74 (s, 1H), 8.65 (s, 1H), 7.77-7.74 (m, 1H), 7.71-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.52 (t, J = 53.4 Hz, 1H), 4.83 (s, 2H), 4.50 (bs, 1H), 3.11 (s, 3H), 2.25-1.98 (m, 7H)
1113[Figure (not displayed)]
MS (ESI) m/z 702.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.7 Hz, 1H), 8.69 (s, 1H), 8.59 (s, 1H), 7.74 (dd, J = 8.1, 0.8 Hz, 1H), 7.68-7.64 (m, 2H), 7.44 (d, J = 4.7 Hz, 1H), 6.15 (tt, J = 55.8, 4.4 Hz, 1H), 4.81 (s, 2H), 4.26 (ddt, J = 11.6, 7.7, 4.0 Hz, 1H), 3.84 (s, 3H), 3.10 (s, 3H), 3.03 (d, J = 11.2 Hz, 2H), 2.76 (td, J = 15.7, 4.3 Hz, 2H), 2.33 (t, J = 11.5 Hz, 2H), 2.03 (s, 3H), 1.92 (qd, J = 12.1, 3.9 Hz, 2H), 1.79 (d, J = 11.7 Hz, 2H); 19F NMR (377 MHz, DMSO-d6) 6-118.73 (dt, J = 55.8, 15.7 Hz, 2F)
1115[Figure (not displayed)]
MS (ESI) m/z 683.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.94 (s, 1H), 8.79 (d, J = 4.8 Hz, 1H), 8.59 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.45 (d, J = 2.7 Hz, 1H), 7.35 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 4.9 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 3.82- 3.70 (m, 1H), 3.20-3.09 (m, 2H), 2.78-2.67 (m, 2H), 1.92-1.79 (m, 7H)
1116[Figure (not displayed)]
MS (ESI) m/z 677.1 [M + 1]+; 1H NMR (400 MHz, Chloroform-d) δ 9.16 (s, 1H), 8.78 (d, J = 4.9 Hz, 1H), 8.56 (s, 1H), 7.59 (d, J = 8.4 Hz, 1H), 7.51 (dd, J = 8.4, 2.1 Hz, 1H), 7.46-7.41 (m, 2H), 4.81 (s, 2H), 3.66-3.38 (m, 5H), 3.01 I (t, J = 11.8 Hz, 2H), 2.50-2.31 (m, 5H), 2.13 (d, J = 14.0 Hz, 2H)
1117[Figure (not displayed)]
MS (ESI) m/z 683.3 [M + 1]+; 1H NMR (400 MHz, Chloroform-d) δ 9.12 (s, 1H), 8.78 (d, J = 4.8 Hz, 1H), 8.45 (s, 1H), 7.48 (dd, J = 8.9, 2.6 Hz, 1H), 7.32-7.27 (m, 2H), 7.03 (d, J = 8.9 Hz, 1H), 4.41 (t, J = 4.9 Hz, 2H), 4.29 (t, J = 4.9 Hz, 2H), 3.64-3.48 (m, 6H), 3.13-3.01 (m, 2H), 2.46-2.32 (m, 2H), 1.89 (s, 3H)
1118[Figure (not displayed)]
MS (ESI) m/z 694.3 [M + 1]+; 1H NMR (400 MHz, Chloroform-d) δ 8.75 (s, 1H), 8.71 (d, J = 4.8 Hz, 1H), 8.49 (s, 1H), 7.59 (d, J = 8.4 Hz, 1H), 7.52 (dd, J = 8.4, 2.1 Hz, 1H), 7.40 (d, J = 2.1 Hz, 1H), 7.38 (d, J = 4.9 Hz, 1H), 5.36 (d, J = 7.0 Hz, 2H), 4.77-4.64 (m, 3H), 4.34 (d, J = 7.0 Hz, 2H), 3.37 (d, J = 11.5 Hz, 2H), 3.28 (t, J = 12.1 Hz, 2H), 3.19 (s, 3H), 2.84-2.70 (m, 2H), 2.44 (s, 3H), 2.34 (d, J = 13.5 Hz, 2H), 1.85 (s, 3H)
1119[Figure (not displayed)]
MS (ESI) m/z 756.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.66 (s, 1H), 7.76 (d, J = 9.0 Hz, 1H), 7.71-7.66 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.35-4.24 (m, 1H), 3.38- 3.22 (m, 2H), 3.12-3.00 (m, 5H), 2.63-2.52 (m, 2H), 2.06 (s, 3H), 2.00-1.86 (m, 2H), 1.85- 1.75 (m, 2H)
1120[Figure (not displayed)]
MS (ESI) m/z 623.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.80-8.58 (m, 3H), 7.78- 7.63 (m, 3H), 7.53 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.27 (t, J = 11.8 Hz, 1H), 3.09 (s, 3H), 2.04 (s, 3H), 1.89-1.75 (m, 4H), 1.71-1.56 (m, 3H), 1.38 (q, J = 12.8, 12.2 Hz, 2H), 1.16 (q, J = 13.1 Hz, 1H)
1121[Figure (not displayed)]
LCMS (ESI) m/z 677.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.01 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.36 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.44 (s, 1H), 7.42 4.41 (t, J = 4.9 Hz, 2H), 4.33-4.09 (m, 4H), 2.08 (d, J = 4.4 Hz, 3H), 1.80 (s, 3H)
1122[Figure (not displayed)]
LCMS (ESI) m/z 631.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.00 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.37 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 2H), 7.05 (dt, J = 14.5, 6.8 Hz, 1H), 5.46 (d, J = 57.5 Hz, 1H), 4.56 (s, 2H), 4.46-4.32 (m, 4H), 4.26 (t, J = 5.0 Hz, 4H), 1.79 (s, 3H)
1123[Figure (not displayed)]
LCMS (ESI) m/z 627.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.01 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.38 (s, 1H), 7.67-7.58 (m, 2H), 7.48 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.1 Hz, 1H), 7.04 (d, J = 15.0 Hz, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.28 (t, J = 5.0 Hz, 2H), 2.98 (s, 6H), 1.86 (s, 3H), 1.53 (s, 2H), 1.35 (s, 2H)
1124[Figure (not displayed)]
LCMS (ESI) m/z 677.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.92 (s, 1H), 8.84 (dd, J = 4.8, 1.4 Hz, 1H), 8.38 (d, J = 2.2 Hz, 1H), 7.60 (ddd, J = 9.0, 2.7, 0.8 Hz, 1H), 7.50 (s, 1H), 7.51-7.41 (m, 1H), 7.35 (d, J = 9.0 Hz, 1H), 7.11 (d, J = 15.4 Hz, 1H), 6.93 (d, J = 15.4 Hz, 1H), 6.06 (tt, J = 56.0, 4.2 Hz, 1H), 4.40 (t, J = 4.9 Hz, 2H), 4.24 (t, J = 4.9 Hz, 2H), 3.19 (td, J = 15.5, 4.2 Hz, 2H), 2.61 (s, 3H), 1.73 (d, J = 1.3 Hz, 3H), 1.16-1.13 (m, 2H), 1.12-1.01 (m, 2H)
1125[Figure (not displayed)]
LCMS (ESI) m/z 728.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78-8.71 (m, 2H), 8.64 (s, 1H), 7.75 (dd, J = 7.9, 1.0 Hz, 1H), 7.71-7.64 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 2.09 (s, 3H), 0.70 (s, 2H), 0.65 (s, 2H)
1126[Figure (not displayed)]
LCMS (ESI) m/z 734.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 4.8 Hz, 1H), 8.58 (s, 1H), 8.38 (s, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.47-7.37 (m, 2H), 7.33 (d, J = 9.0 Hz, 1H), 4.49 (bs, 1H), 4.36 (t, J = 4.9 Hz, 2H), 4.18 (t, J = 4.9 Hz, 2H), 2.99 (s, 3 H), 1.73 (s, 3H), 1.51 (ddd, J = 13.2, 8.1, 4.9 Hz, 1H), 0.71- 0.60 (m, 4H)
1127[Figure (not displayed)]
LCMS (ESI) m/z 714.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 4.8 Hz, 1H), 8.54 (s, 1H), 8.34 (s, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.44 (d, J = 4.8 Hz, 1H), 7.39-7.29 (m, 2H), 4.51 (s, 1H), 4.46-4.30 (m, 4H), 4.19 (t, J = 5.1 Hz, 2H), 3.50 (d, J = 11.8 Hz, 2H), 3.26-3.11 (m, 2H), 3.08 (s, 3H), 2.75-2.66 (m, 1H), 2.25 (d, J = 12.7 Hz, 2H), 2.03 (d, J = 12.8 Hz, 2H), 1.79 (s, 3H), 1.07 (d, J = 6.9 Hz, 6H)
1128[Figure (not displayed)]
LCMS (ESI) m/z 712.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 4.8 Hz, 1H), 8.53 (s, 1H), 8.33 (s, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.44 (d, J = 4.9 Hz, 1H), 7.38-7.30 (m, 2H), 4.58-4.43 (m, 3H), 4.36 (t, J = 5.1 Hz, 2H), 4.19 (t, J = 5.0 Hz, 2H), 3.52 (d, J = 11.8 Hz, 3H), 3.18 (t, J = 12.7 Hz, 2H), 3.07 (s, 3H), 2.24 (d, J = 12.7 Hz, 2H), 2.17-1.95 (m, 3H), 1.80 (s, 3H), 1.06 (dd, J = 23.8, 2.3 Hz, 4H)
1129[Figure (not displayed)]
LCMS (ESI) m/z 730.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81-8.71 (m, 2H), 8.65 (s, 1H), 7.76 (dd, J = 7.9, 1.0 Hz, 1H), 7.72-7.66 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 3.11 (s, 3H), 2.40-2.18 (m, 2H), 2.11 (s, 4H), 1.03 (d, J = 6.9 Hz, 6H)
1130[Figure (not displayed)]
LCMS (ESI) m/z 469.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76-8.69 (m, 4H), 8.62 (s, 2H), 7.76-7.61 (m, 7H), 7.52 (d, J = 4.8 Hz, 2H), 4.79 (s, 5H), 4.51 (s, 1H), 3.71 (s, 1H), 3.34 (s, 1H), 2.07 (s, 8H), 2.01 (s, 1H), 1.22 (s, 14H)
1131[Figure (not displayed)]
LCMS (ESI) m/z 744.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.68 (d, J = 14.8 Hz, 2H), 7.76 (d, J = 9.0 Hz, 1H), 7.73-7.66 (m, 2H), 7.55 (d, J = 4.7 Hz, 1H), 4.82 (s, 2H), 4.21 (d, J = 6.9 Hz, 1H), 3.75 (s, 1H), 3.07 (s, 3H), 3.00 (s, 2H), 2.05 (s, 3H), 1.77 (s, 4H), 0.85 (s, 4H)
1132[Figure (not displayed)]
LCMS (ESI) m/z 718.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.73 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.61 (s, 1H), 7.72 (d, J = 8.9 Hz, 1H), 7.68-7.63 (m, 2H), 7.51 (d, J = 4.8 Hz, 1H), 4.79 (s, 2H), 4.50 (s, 1H), 3.71 (t, J = 13.7 Hz, 7H), 3.08 (s, 3H), 2.22 (s, 2H), 2.06 (s, 3H), 2.03-1.91 (m, 2H)
1133[Figure (not displayed)]
LCMS (ESI) m/z 732.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79-8.71 (m, 2H), 8.65 (s, 1H), 7.79-7.72 (m, 1H), 7.72-7.65 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 3.76 (s, 2H), 3.11 (s, 3H), 2.08 (s, 3H)
1134[Figure (not displayed)]
LCMS (ESI) m/z 720.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76-8.68 (m, 2H), 8.62 (s, 1H), 7.76-7.69 (m, 1H), 7.69-7.62 (m, 2H), 7.52 (d, J = 4.8 Hz, 1H), 4.86-4.58 (m, 2H), 4.79 (s, 3H), 4.42 (s, 1H), 2.05 (s, 3H), 1.92 (bs, 3H)
1135[Figure (not displayed)]
LCMS (ESI) m/z 744.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 1.8 Hz, 2H), 8.65 (s, 1H), 7.76 (d, J = 8.2 Hz, 1H), 7.69 (d, J = 8.9 Hz, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.72 (t, J = 75.2 Hz, 1H), 4.83 (s, 2H), 4.78 (s, 1H), 4.56 (s, 1H), 3.94 (d, J = 8.4 Hz, 1H), 3.57 (d, J = 11.9 Hz, 2H), 3.12 (s, 3H), 3.06 (d, J = 10.5 Hz, 2H), 2.77-2.64 (m, 2H), 2.54 (s, 1H), 2.11 (s, 7H). 19F NMR (377 MHz, DMSO-d6) 6- 73.82-82.25 (d, J = 75.1 Hz)
1136[Figure (not displayed)]
LCMS: 1.77 Min, 700.2. [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 610.73 (s, 1H), 8.78-8.72 (m, 2H), 8.64 (s, 1H), 7.81-7.73 (m, 1H), 7.72 J = 53.2 Hz, 1H), 4.82 (s, 2H), 4.12 (s, 4H), 3.92 (t, J = 16.0 Hz, 2H), 3.64 (d, J = 31.4 Hz, 4H), 2.06 (s, 3H)
1137[Figure (not displayed)]
LCMS: 1.71 Min, 714.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.61 (s, 1H), 8.81-8.72 (m, 2H), 8.64 (s, 1H), 7.79-7.72 (m, 1H), 7.71 (s, 2H), 4.32-3.89 (m, 6H), 3.64 (m, 4H), 2.07 (d, J = 1.6 Hz, 6H), 2.00 (s, 3H), 1.74 (t, J = 19.6 Hz, 3H)
1139[Figure (not displayed)]
MS (ESI) m/z 708.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.41 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.39 (t, J = 5.0 Hz, 2H), 4.21 (t, J = 5.0 Hz, 2H), 3.75- 3.30 (m, 10H), 3.09 (s, 3H), 1.75 (s, 6H)
1140[Figure (not displayed)]
MS (ESI) m/z 706.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.8 Hz, 1H), 8.69 (d, J = 22.6 Hz, 2H), 7.76 (d, J = 9.0 Hz, 1H), 7.71-7.66 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.31 (s, 1H), 3.34 (s, 1H), 3.10 (s, 5H), 2.61 (s, 2H), 2.06 (s, 3H), 1.96 (q, J = 11.8 Hz, 2H), 1.82 (d, J = 12.1 Hz, 2H)
1141[Figure (not displayed)]
MS (ESI) m/z 702.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.74 (s, 1H), 8.65 (s, 1H), 7.78-7.74 (m, 1H), 7.71-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 3.11 (s, 3H), 2.09 (s, 3H), 1.78 (t, J = 19.5 Hz, 3H)
1142[Figure (not displayed)]
MS (ESI) m/z 698.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78-8.73 (m, 2H), 8.65 (s, 1H), 7.76 (dd, J = 8.1, 0.8 Hz, 1H), 7.72-7.66 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.57 (d, J = 12.1 Hz, 1H), 3.67 (d, J = 12.6 Hz, 2H), 3.48 (dd, J = 22.6, 5.0 Hz, 2H), 3.33 (d, J = 11.5 Hz, 1H), 3.12 (s, 3H), 2.40-2.26 (m, 2H), 2.15-1.98 (m, 5H), 1.50 (d, J = 21.4 Hz, 6H)
1143[Figure (not displayed)]
MS (ESI) m/z 842.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 1H NMR (400 MHz, DMSO- d6) 613.21 (bs, 1H), 9.97 (s, 1H), 8.97-8.93 (m, 2H), 8.85 (d, J = 4.9 Hz, 1H), 8.69 (s, 1H), 8.50 (s, 1H), 8.10-8.05 (m, 2H), 7.77 (dd, J = 8.4, 0.5 Hz, 1H), 7.70 (dd, J = 8.4, 2.2 Hz, 1H), 7.66 (dd, J = 2.2, 0.5 Hz, 1H), 7.64 (dd, J = 4.9, 0.4 Hz, 1H), 4.82 (s, 2H), 4.57 (s, 1H), 3.96- 3.26 (m, 4H), 3.11 (s, 3H), 2.26 (s, 2H), 2.04 (dd, J = 20.6, 10.2 Hz, 2H), 1.92 (s, 3H), 1.78 (t, J = 19.5 Hz, 3H)
1144[Figure (not displayed)]
MS (ESI) m/z 842.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.12 (s, 1H), 9.28 (d, J = 2.3 Hz, 1H), 8.92 (d, J = 4.6 Hz, 1H), 8.84 (d, J = 4.9 Hz, 1H), 8.67 (s, 1H), 8.56-8.51 (m, 1H), 8.48 (s, 1H), 7.73 (ddd, J = 16.1, 10.9, 8.4 Hz, 3H), 7.66 (d, J = 2.2 Hz, 1H), 7.63 (d, J = 4.9 Hz, 1H), 4.81 (s, 2H), 3.11 (s, 3H), 1.90 (s, 3H)
1145[Figure (not displayed)]
MS (ESI) m/z 630.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.89 (s, 1H), 8.69 (s, 1H), 8.41 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.42 (s, 1H), 7.40 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.1 Hz, 2H), 4.31 (d, J = 14.2 Hz, 2H), 4.24 (t, J = 5.1 Hz, 2H), 3.61 (d, J = 12.0 Hz, 2H), 3.45 (t, J = 13.1 Hz, 2H), 3.24 (q, J = 10.2 Hz, 2H), 2.91 (d, J = 3.4 Hz, 3H), 2.72 (s, 3H), 1.90 (s, 3H)
1146[Figure (not displayed)]
MS (ESI) m/z 842.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 1H NMR (400 MHz, DMSO- d6) δ 13.03 (s, 1H), 8.90 (d, J = 4.9 Hz, 1H), 8.72 (ddd, J = 4.6, 1.7, 0.9 Hz, 1H), 8.65 (s, 1H), 8.60 (s, 1H), 8.30-8.25 (m, 1H), 8.21 (td, J = 7.7, 1.7 Hz, 1H), 7.80-7.72 (m, 2H), 7.72- 7.68 (m, 2H), 7.66 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 3.09 (s, 3H), 1.94 (s, 3H), 1.77 (t, J = 18.9 Hz, 2H)
1148[Figure (not displayed)]
MS (ESI) m/z 676.21. [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.22 (bs, 1H), 8.83 (d, J = 4.6 Hz, 1H), 8.49 (s, 1H), 7.94 (d, J = 7.8 Hz, 1H), 7.87 (t, J = 7.4 Hz, 1H), 7.77 (m, 2H), 7.60 (dd, J = 2.4, 8.8 Hz, 1H), 7.47 (d, J = 4.7 Hz, 1H), 7.44 (d, J = 2.4 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 4.44 (s, 2H), 4.27 (s, 2H), 2.77 (s, 3H), 1.85 (s, 3H)
1149[Figure (not displayed)]
MS (ESI) m/z 631.26 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.60 (bs, 1H), 8.56 (s, 1H), 7.58 (dd, J = 8.8, 2.4 Hz, 1H), 7.40-7.35 (m, 3H), 5.02 (bs, 1H), 4.39 (s, 2H), 4.19 (s, 2H), 3.90-3.82 (m, 2H), 3.74 (t, J = 8.0 Hz, 1H), 3.54 (d, J = 11.6 Hz 1H), 2.70 (s, 3H), 2.59 (s, 3H), 2.05-1.85 (m, 2H), 1.84 (s, 3H)
1152[Figure (not displayed)]
MS (ESI) m/z 616.24 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.56 (bs, 1H), 9.01 (s, 1H), 8.39 (s, 1H), 7.59 (dd, J = 2.8, 9.2 Hz, 1H), 7.41 (d, J = 2.4 Hz, 1H), 7.39 (s 1H), 7.34 (d, J = 8.8 Hz, 1H), 4.38 (s, 2H) 4.24 (s, 2H), 4.0-3.9 (m, 1H), 3.67-3.61 (m, 1H), 3.19 (s, 3H), 2.69 (bs, 5H), 2.35-2.31 (m, 2H), 1.86 (s, 3H)
1157[Figure (not displayed)]
MS (ESI) m/z 789.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.66 (s, 1H), 8.87 (d, J = 4.8 Hz, 1H), 8.60 (m, 1H), 8.58 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.54 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.38 (d, J = 9.2 Hz, 1H), 4.39 (t, J = 6.0 Hz, 2H), 4.35-4.25 (m, 1H), 4.19 (t, J = 6.0 Hz, 2H), 3.58 (s, 3H), 3.40- 3.20 (m, 2H), 3.07 (s, 5H), 2.65-2.55 (m, 2H), 1.99-1.90 (m, 2H), 1.85-1.79 (m, 2H), 1.74 (s,
1160[Figure (not displayed)]
MS (ESI) m/z 692.45 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.05 (bs, 1H), 8.83 (s, 1H), 8.75 (d, J = 4.6 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.2 Hz, 1H), 7.69 (s, 1H), 7.66 (s, 1H), 7.52 (d, J = 4.5 Hz, 1H), 4.83 (s, 2H), 4.31 (bs, 1H), 3.43 (bs, 7H), 2.85 (s, 4H), 2.11 (s, 3H)
1161[Figure (not displayed)]
MS (ESI) m/z 708.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.76 (dd, J = 8.3, 0.5 Hz, 1H), 7.71-7.65 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.84 (s, 2H), 4.53 (s, 2H), 4.06-2.83 (m, 8H), 2.13 (s, 3H)
1162[Figure (not displayed)]
MS (ESI) m/z 636.25 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.18 (bs, 1H), 8.84 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.65 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.84 (s, 2H), 4.38 (m, 2H), 3.79 (m, 2H,), 3.49 (m, 4H), 3.03 (m, 1H), 2.14 (s, 3H), 0.93 (m, 4H)
1163[Figure (not displayed)]
MS (ESI) m/z 686.0 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.03 (s, 1H), 8.83 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.66 (m, 1H), 7.53 (d, J = 4.8 Hz, 1H), 4.72 (s, 2H), 3.80 (bs, 4H), 3.39 (bs, 4H), 3.05-3.02 (m, 5H), 2.16 (s, 3H)
1164[Figure (not displayed)]
MS (ESI) m/z 694.52 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.68 (s, 1H), 8.45 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.72- 4.54 (m, 2H), 4.39 (bs, 2H), 4.22 (bs, 2H), 3.25- 2.78 (m, 10H), 1.81 (s, 3H), 1.45 (bs, 3H)
1165[Figure (not displayed)]
MS (ESI) m/z, 714.50 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 9.80 (bs, 1H), 8.76 (s, 1H), 8.75 (s, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.56 (bs, 1H), 3.56 (bs, 4H), 3.11 (bs, 1H), 3.06 (s, 3H), 3.05 (bs, 4H), 2.13 (bs, 4H), 2.11 (s, 3H)
1166[Figure (not displayed)]
MS (ESI) m/z 714.58 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.76-8.74 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.58-4.38 (m, 2H), 3.11 (s, 3H), 2.90-2.88 (m, 2H), 2.50-2.32 (m, 4H), 2.20-2.15 (m, 5H), 2.12-2.10 (m, 2H)
1167[Figure (not displayed)]
MS (ESI) m/z 668.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.08 (bs, 1H), 10.22 (bs, 1H), 8.85 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.69-7.66 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.39 (d, J = 11.6 Hz, 2H), 3.76 (bs, 6H), 3.43 (bs, 2H), 2.14 (s, 3H), 1.29 (d, J = 18.8 Hz, 2H), 0.99 (d, J = 7.6 Hz, 2H)
1168[Figure (not displayed)]
MS (ESI) m/z 722.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.41 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 4.52 (bs, 1H), 4.39 (s, 2H), 4.21 (s, 2H), 3.90-3.82 (m, 1H), 3.36-3.31 (m, 6H), 3.09 (s, 3H), 2.33- 2.27 (m, 1H), 2.02-2.07 (m, 4H), 1.79 (s, 3H), 0.99 (t, J = 7.2 Hz, 3H)
1169[Figure (not displayed)]
MS (ESI) m/z 696.24 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.76-8.75 (m, 2H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.54 (s, 1H), 3.74-3.72 (m, 4H), 3.31-3.29 (m, 2H), 3.12 (s, 3H), 2.28-2.22 (m, 2H), 2.13-2.10 (m, 5H), 1.25 (d, J = 19.6 Hz, 2H), 0.96 (d, J = 8.0 Hz, 2H)
1170[Figure (not displayed)]
MS (ESI) m/z 736.43 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.76-.8.74 (m, 2H), 8.64 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.70-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.56-4.52 (m, 3H), 3.67-3.55 (m, 4H), 3.25-3.19 (m, 2H), 3.11 (s, 3H), 2.23-2.20 (m, 2H), 2.17- 2.10 (m, 5H)
1171[Figure (not displayed)]
MS (ESI) m/z 664.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 6.0 Hz, 2H), 8.65 (s, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.60-4.59 (m, 1H), 3.66 (d, J = 11.6 Hz, 2H), 3.43-3.22 (m, 2H), 3.09 (s, 3H), 2.85 (bs, 1H), 2.10 (s, 7H), 0.95-0.85 (m, 4H)
1172[Figure (not displayed)]
MS (ESI) m/z 744.02 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.76-8.74 (m, 2H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 6.89-6.52 (m, 1H), 4.82 (s, 2H), 4.58-4.45 (m, 2H), 3.48-3.38 (m, 5H), 3.10 (s, 3H), 3.08-3.06 (m, 2H), 2.40.2.38 (m, 2H), 2.20-2.10 (m, 5H)
1173a[Figure (not displayed)]
MS (ESI) m/z 762.47 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.77-8.75 (m, 2H), 8.65 (s, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.70 (d, J = 2.0 Hz, 1H), 7.68 (s, 1H), 7.56 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.73 (quin, J = 7.2 Hz, 1H), 4.59 (bs, 1H), 3.62 (bs, 4H), 3.41 (bs, 1H), 3.12 (bs, 5H), 2.89 (bs, 2H), 2.11 (bs, 7H)
1173b[Figure (not displayed)]
MS (ESI) m/z 671.41 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.68 (d, J = 1.6 Hz, 2H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 3H), 3.38-3.28 (m, 4H), 3.11 (s, 9H), 2.02 (s, 3H), 1.97-1.91 (m, 2H), 1.89-1.83 (m, 2H)
1174[Figure (not displayed)]
MS (ESI) m/z 710.42 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 9.40 (bs, 1H), 8.76-8.74 (m, 2H), 8.64 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.56-4.53 (m, 1H), 3.94-3.80 (m, 4H), 3.66-3.59 (m, 4H), 3.11 (s, 3H), 2.40-2.34 (m, 3H), 2.27-2.24 (m, 1H), 2.10-2.01 (m, 5H), 1.91-1.88(m, 1H), 1.70-1.63(m, 1H)
1175[Figure (not displayed)]
MS (ESI) m/z 732.40 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77-8.74 (m, 2H), 8.65 (s, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.69 (d, J = 1.6 Hz, 1H), 7.68 (s, 1H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.48 (bs, 1H), 3.65 (m, 4H), 3.10 (s, 3H), 2.50-2.39 (m, 2H), 2.09 (s, 3H), 2.04 (bs, 4H), 1.44-1.33 (m, 2H)
1176[Figure (not displayed)]
MS (ESI) m/z 720.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.4 Hz, 1H), 8.74 (s, 1H), 8.67 (s, 1H), 7.76 (d, J = 8.8 Hz, 1H), 7.69-7.67 (m, 2H), 7.56 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.18-4.15 (m, 1H), 3.67-3.64 (m, 2H), 3.29 (bs, 2H), 3.07 (d, J = 9.2 Hz, 2H), 2.60-2.55 (m, 2H), 2.06 (s, 3H), 1.96-1.94 (m, 2H), 1.85-1.82 (m, 2H), 1.11 (t, J = 6.8 Hz, 3H)
1177[Figure (not displayed)]
MS (ESI) m/z 716.60 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.14 (bs, 1H), 8.77 (d, J = 4.4 Hz, 2H), 8.66 (s, 1H), 7.77-7.74 (m, 1H), 7.69-7.68 (m, 2H), 7.56 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.39 (bs, 1H), 3.63 (bs, 4H), 3.30 (bs, 4H), 2.34 (bs, 2H), 2.08 (s, 5H), 1.75 (t, J = 18.0 Hz, 3H), 1.13 (t, J = 6.8 Hz, 3H)
1180[Figure (not displayed)]
MS (ESI) m/z 713.37 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.62 (bs, 1H), 8.79 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.70-7.68 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.41-4.39 (d, J = 12.8 Hz, 2H), 3.83-3.69 (m, 4H), 3.23-3.14 (m, 4H), 2.43 (m, 2H), 2.33-2.25 (m, 3H), 2.10 (s, 3H), 1.91-1.88 (m, 2H)
1181[Figure (not displayed)]
MS (ESI) m/z 696.32 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.74 (bs, 1H), 8.78-8.72 (m, 2H), 8.64 (s, 1H), 7.75 (d, J = 8.1 Hz, 1H), 7.70-7.62 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 5.35-5.18 (m, 1H), 4.82 (s, 2H), 4.60-4.52 (m, 1H), 4.04-3.98 (m, 1H), 3.60-3.50 (m, 2H), 3.15-2.95 (m, 5H), 2.80-2.45 (m, 4H), 2.20-2.00 (m, 7H)
1182[Figure (not displayed)]
MS (ESI) m/z 730.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz 1H), 8.71 (s, 1H), 8.65 (s, 1H), 7.76-7.74 (m, 1H), 7.69-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.46 (t, J = 54.4 Hz, 1H), 4.81 (s, 2H), 4.50 (d, J = 6.8 Hz, 2H), 4.44 (d, J = 6.4 Hz, 2H), 4.32- 4.28 (m, 1H), 3.16 (s, 3H), 2.91-2.89 (m, 2H), 2.59-2.53 (m, 2H), 2.05 (s, 3H), 1.89-1.86 (m, 4H)
1183[Figure (not displayed)]
MS (ESI) m/z 821.52 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 12.71 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.75 (d, J = 2.4 Hz, 2H), 7.77 (d, J = 8.8 Hz, 1H), 7.71-7.68 (m, 2H), 7.62 (d, J = 4.8 Hz, 1H), 5.21 (quin, J = 7.6 Hz, 1H), 4.97- 4.90 (m, 4H), 4.82 (s, 2H), 4.59 (m, 1H), 3.69- 3.49 (m, 4H), 3.11 (bs, 5H), 2.32 (m, 2H), 1.98 (m, 2H), 1.93 (s, 3H), 1.76 (t, J = 19.6 Hz, 3H)
1184[Figure (not displayed)]
MS (ESI) m/z 728.48 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) 613.11 (bs, 1H), 8.78-8.76 (m, 2H), 8.65 (s, 1H), 7.76 (d, J = 9.2 Hz, 1H), 7.70-7.68 (m, 2H), 7.56 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.37 (bs, 1H), 3.75- 3.59 (m, 5H), 3.05 (bs, 6H), 2.15 (bs, 4H), 2.10 (s, 3H), 1.16 (t, J = 6.4 Hz, 3H)
1185[Figure (not displayed)]
MS (ESI) m/z 712.32 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.09 (bs, 1H), 8.76-8.74 (m, 2H), 8.64 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.70-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82-4.75 (m, 6H), 4.55 (bs, 1H), 3.91-3.85 (m, 2H), 3.52-3.35 (m, 4H), 3.10 (s, 3H), 2.32-2.21 (m, 2H), 2.09 (bs, 5H)
1186[Figure (not displayed)]
MS (ESI) m/z 694.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (d, J = 2.8 Hz, 1H), 8.76 (s, 1H), 8.65 (s, 1H), 7.76 (d, J = 9.2 Hz, 1H), 7.69 (d, J = 6.8 Hz, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.75 (bs, 4H), 4.38 (bs, 2H), 3.61 (d, J = 6.8 Hz, 2H), 3.52 (bs, 2H), 3.16 (bs, 2H), 2.16-2.10 (m, 7H), 1.15 (t, J = 6.8 Hz, 3H)
1187[Figure (not displayed)]
MS (ESI) m/z 715.47 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.8 Hz, 1H), 8.73 (s, 1H), 8.63 (s, 1H), 7.75 (d, J = 8.8, 1H), 7.68-7.68 (m, 2H), 7.63 (d, J = 4.8 Hz, 1H), 6.69 (t, J = 75.2 Hz, 1H), 4.81 (s, 2H), 4.70 (t, J = 5.6 Hz, 1H), 4.04 (d, J = 13.2 Hz, 2H), 3.60 (t, J = 6.4 Hz, 2H), 3.32-3.27 (m, 2H), 3.00 (t, J = 6.8 Hz, 2H), 2.37 (bs, 1H), 2.05 (s, 3H), 1.80 (d, J = 10.4 Hz, 2H), 1.39-1.32 (m, 2H)
1188[Figure (not displayed)]
MS (ESI) m/z 791.62 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.47 (s, 1H), 8.81-8.78 (m, 3H), 7.77 (d, J = 8.40 Hz, 1H), 7.71-7.67 (m, 2H), 7.62 (d, J = 4.80 Hz, 1H), 4.83 (s, 2H), 4.59 (bs, 1H), 3.74-3.54 (m, 6H), 3.08 (s, 3H), 2.98-2.88 (m, 6H), 2.11-2.05 (m, 4H), 2.00 (s, 3H)
1189[Figure (not displayed)]
MS (ESI) m/z 758.56 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76-8.74 (m, 2H), 8.64 (s, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.65 (t, J = 74.4 Hz, 1H), 4.82 (s, 2H), 4.57-4.47 (m, 2H), 3.53 (d, J = 11.6 Hz, 2H), 3.23-3.10 (m, 7H), 2.54- 2.49 (m, 2H), 2.32-2.28 (m, 1H), 2.16-2.09 (m, 7H), 2.06-1.91 (m, 2H)
1190[Figure (not displayed)]
MS (ESI) m/z 716.53 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.09 (bs, 1H), 9.32 (bs, 1H), 8.76-8.74 (m, J = 7.8 Hz, 2H), 8.64 (s, 1H) 7.75 (d, J = 8.2 Hz, 1H), 7.71-7.65 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.60-4.50 (m, 1H), 3.69 (d, J = 10.4 Hz, 2H), 3.30-311 (m, 4H), 3.10 (s, 3H), 2.50-2.32 (merged, 2H), 2.20-2.05 (m, 7H), 1.70 (t, J = 19.2 Hz, 3H)
1191[Figure (not displayed)]
MS (ESI) m/z 752.52 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.15 (s, 1H), 8.77-8.741 (m, 2H), 8.66 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.68 (d, J = 6.0 Hz, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.57 (t, J = 52.0 Hz, 1H), 4.81 (s, 2H), 4.29 (bs, 1H), 3.64 (d, J = 6.8 Hz, 2H), 3.03 (bs, 4H), 2.50 (s, 2H), 2.06 (s, 3H), 1.98-1.84 (m, 4H), 1.13-1.08 (m, 3H)
1194[Figure (not displayed)]
MS (ESI) m/z 602.22 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.62 (bs, 1H), 9.01 (s, 1H), 8.41 (s, 1H), 7.62-7.57 (m, 2H), 7.41 (d, J = 2.4 Hz, 1H), 7.39 (s, 1H), 7.34 (d, J = 8.0 Hz, 1H), 4.38 (s, 2H), 4.24 (s, 2H), 4.19-4.15 (m, 1H), 3.56 (bs, 1H), 2.68-2.62 (m, 5H), 2.32- 2.27 (m, 2H), 1.84 (s, 3H)
1195[Figure (not displayed)]
MS (ESI) m/z 720.41 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.56 Hz, 1H), 8.68 (s, 1H), 8.59 (s, 1H), 7.74 (d, J = 8.12 Hz, 1H), 7.67-7.64 (m, 2H), 7.43 (d, J = 4.64 Hz, 1H), 4.80 (s, 2H), 4.29-4.23 (m, 1H), 3.83 (s, 3H), 3.21 (q, J = 10.08 Hz, 2H), 3.10 (s, 3H), 3.04 (d, J = 11.4 Hz, 2H), 2.54 (bs, 2H), 2.03 (s, 3H), 1.98-1.89 (m, 2H), 1.78 (d, J = 10.52 Hz, 2H)
1196[Figure (not displayed)]
MS (ESI) m/z 644.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 14.39 (bs, 1H), 8.62 (s, 1H), 7.59 (dd, J = 2.48, 8.88 Hz ,1H), 7.40-7.38 (m, 2H), 7.35 (d, J = 8.92 Hz, 1H), 4.63-4.59 (m, 2H), 4.47 (bs, 2H), 4.39 (t, J = 4.64 Hz, 2H), 4.23 (t, J = 4.64 Hz, 3H), 2.82 (bs, 6H), 2.70 (s, 3H), 2.54 (s, 3H), 1.94 (s, 3H)
1198[Figure (not displayed)]
MS (ESI) m/z 620.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.63 (bs, 1H) 8.55 (s, 1H), 7.59 (dd, J = 8.88, 2.62 Hz, 1H), 7.42 (t, J = 6.0 Hz, 2H), 7.35 (d, J = 8.8 Hz, 1H), 4.40 (d, J = 4.4 Hz, 2H), 4.26 (s, 2H), 4.26 (t, J = 4.8 Hz, 2H), 2.98- 3.04 (m, 2H), 2.55 (d, J = 4.0 Hz, 1H), 1.93 (s, 3H), 1.13-1.36 (m, 7H)
1199[Figure (not displayed)]
MS (ESI) m/z 629.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.69 (bs, 1H), 8.49 (s, 1H), 7.59 (dd, J = 8.88, 2.62 Hz, 1H), 7.36- 7.43 (m, 3H), 4.41 (t, J = 6.0 Hz, 2H), 4.20 (t, J = 6.0 Hz, 2H), 4.26 (t, J = 4.8 Hz, 2H), 3.34 (s, 6H), 2.96- 3.01 (m, 2H), 2.40 (d, J = 4.0 Hz, 1H), 1.81 (s, 3H), 1.31 (t, J = 12.8 Hz, 3H), 1.03- 1.12 (m, 4H)
1202[Figure (not displayed)]
MS (ESI) m/z 656.33 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 14.39 (bs, 1H), 10.23 (bs, 1H), 8.68 (s, 1H), 7.59 (d, J = 8.0, 2.4 Hz, 1H), 7.45-7.38 (m, 2H), 7.39 (d, J = 8.8 Hz, 1H), 4.87 (d, J = 4.8 Hz, 2H), 4.39 (bs, 2H), 4.23 (bs, 2H), 3.91-3.82 (m, 2H), 3.60-3.49 (m, 2H), 3.00-2.88 (m, 2H), 2.75 (s, 3H), 2.70 (s, 3H), 2.53 (s, 3H), 1.86 (s, 3H)
1203[Figure (not displayed)]
MS (ESI) m/z 656.33 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 14.39 (bs, 1H), 10.23 (bs, 1H), 8.68 (s, 1H), 7.59 (d, J = 8.0, 2.4 Hz, 1H), 7.45-7.38 (m, 2H), 7.39 (d, J = 8.8 Hz, 1H), 4.87 (d, J = 4.8 Hz, 2H), 4.39 (bs, 2H), 4.23 (bs, 2H), 3.91-3.82 (m, 2H), 3.60-3.49 (m, 2H), 3.00-2.88 (m, 2H), 2.75 (s, 3H), 2.70 (s, 3H), 2.53 (s, 3H), 1.86 (s, 3H)
1204[Figure (not displayed)]
MS (ESI) m/z 554.23 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 11.14 (s, 1H), 8.99 (s, 1H), 7.37 (s, 1H), 7.31-7.28 (m, 2H), 7.21 (d, J = 2.4 Hz, 1H), 7.14 (d, J = 9.2 Hz, 1H), 6.92 (s, 1H), 6.38 (bs 1H), 4.33 (bs, 2H), 4.30 (bs, 2H), 3.80 (s, 2H), 2.60 (t, J = 3.6 Hz, 1H), 2.18 (s, 3H), 1.21 (d, J = 7.6 Hz, 2H), 1.12 (bs, 2H)
1216[Figure (not displayed)]
MS (ESI) m/z 641.37 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.75 (bs, 1H), 8.84 (s, 1H), 8.31 (s, 1H), 7.60 (dd, J = 2.52, 8.88 Hz, 1H), 7.45 (s, 1H), 7.41 (d, J = 2.48 Hz, 1H), 7.36 (d, J = 8.96 Hz, 1H), 4.39 (t, J = 4.40 Hz, 2H), 4.26 (t, J = 4.44 Hz, 2H), 3.84 (bs, 2H), 3.52 (bs, 2H), 3.31 (s, 3H), 3.01 (q, J = 7.48 Hz, 2H), 2.97 (bs, 1H), 2.91 (bs, 2H), 1.97 (s, 3H), 1.36 (t, J = 7.56 Hz, 3H)
1217[Figure (not displayed)]
MS (ESI) m/z 706.31 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.43 (bs, 1H), 8.59 (s, 1H), 8.16 (d, J = 3.6 Hz, 2H), 7.59 (dd, J = 2.0, 7.2 Hz, 1H), 7.54 (bs, 3H), 7.41 (bs, 3H), 4.45 (bs, 4H), 4.27 (bs, 2H), 3.60 (bs, 2H), 3.48 (bs, 2H), 3.33 (bs, 2H), 2.90 (s, 3H), 2.66 (bs, 3H), 2.008 (s, 3H)
1219[Figure (not displayed)]
MS (ESI) m/z 656.26 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.56 (s, 1H), 8.41 (s, 1H), 7.58 (dd, J = 2.48, 8.92 Hz, 1H), 7.42 (m, 2H), 7.35 (d, J = 8.9 Hz, 1H), 4.39-4.37 (m, 2H), 4.20-4.19 (m, 2H), 3.36-3.33 (m, 1H), 3.13-3.07 (m, 1H), 3.01 (q, J 7.5 Hz, 2H), 2.75-2.72 (m, 2H), 2.32 (s, 3 H), 2.20-2.15 (m, 1H), 1.75 (s, 3H), 1.34 (t, J = 7.5 Hz, 3H), 0.70-0.65 (m, 2H), 0.55-0.70 (m, 2H)
1220[Figure (not displayed)]
MS (ESI) m/z 642.25 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.76 (bs, 1H), 9.42 (bs, 2H), 8.62 (s, 1H), 8.41 (s, 1H), 7.60 (dd, J = 2.4, 8.8 Hz, 1H), 7.46 (s, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 4.44-4.40 (m, 3H), 4.22 (s, 2H), 3.51-3.38 (m, 1H), 3.41- 319 (m, 2H), 3.04 (m, 3H), 1.83 (s, 3H), 1.36 (m, 4H), 0.84 (m, 1H)
1227[Figure (not displayed)]
MS (ESI) m/z 638.14 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.56 (bs, 1H), 9.65 (bs, 1H), 9.01 (s, 1H), 8.45 (s, 1H), 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 2H), 7.36-7.32 (m, 2H), 7.28-7.23 (m, 2H), 4.41 (bs, 2H), 4.26 (bs, 2H), 2.70 (s, 3H), 2.16 (s, 3H), 1.38 (s, 3H)
1229[Figure (not displayed)]
MS (ESI) m/z 698.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.59 (bs, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.65 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.70-7.65 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.90-4.79 (m, 4H), 4.40-4.29 (m, 1H), 3.65-3.35 (m, 3H), 3.09 (s, 3H), 2.85-2.80 (m, 3H), 2.18-1.65 (m, 11H)
1231[Figure (not displayed)]
MS (ESI) m/z 592.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79-8.77 (m, 2H), 8.15 (s, 1H), 7.57 (dd, J = 2.60, 8.84 Hz, 1H), 7.34-7.32 (m, 3H), 4.38 (t, J = 4.60 Hz, 2H), 4.26 (t, J = 4.56 Hz, 2H), 1.77 (s, 3H), 1.63 (s, 9H)
1232[Figure (not displayed)]
MS (ESI) m/z 615.03 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.96 (s, 1H), 8.34 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.47 (s, 1H), 7.44 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.40-3.79 (m, 10H), 3.05-3.00 (m, 2H), 2.95 (s, 3H). 1.83 (s, 3H), 1.38-1.34 (t, J = 7.6 Hz, 3H)
1233[Figure (not displayed)]
MS (ESI) m/z 586.32 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.94 (s, 1H), 8.68 (d, J = 4.80 Hz, 1H), 8.51 (s, 1H), 7.74 (d, J = 8.40 Hz, 1H), 7.67-7.63 (m, 3H), 7.40 (d, J = 4.80 Hz, 1H), 4.88 (s, 2H), 2.18 (s, 3H), 1.59 (s, 9H)
1234[Figure (not displayed)]
MS (ESI) m/z 631.23 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.56 (s, 1H), 8.49 (s, 1H), 7.59 (dd, J = 8.88, 2.50 Hz, 1H), 7.41 (d, J = 2.60 Hz, 1H), 7.40 (s, 1H), 7.35 (d, J = 8.96 Hz, 1H), 4.37 (t, J = 5.00 Hz, 2H), 4.19 (t, J = 5.00 Hz, 2H), 4.11 (bs, 1H), 3.92-3.70 (m, 4H), 3.29 (s, 3H), 2.70 (s, 3H), 2.11-2.04 (m, 2H), 1.81 (s, 3H)
1235[Figure (not displayed)]
MS (ESI) m/z 631.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.76 (s, 1H), 8.54 (s, 1H), 8.48 (s, 1H), 7.59 (dd, J = 8.8 Hz, 2.4 Hz, 1H) 7.43 (s, 2H), 7.35 (d, J = 8.8 Hz, 1H), 5.07 (d, J = 2.8 Hz, 1H), 4.41 (bs, 1H), 4.37-4.36 (m, 2H), 4.42 (m, 2H), 3.93-3.87 (m, 2H), 3.79-3.75 (m, 1H), 3.59 (d, J = 11.2 Hz, 1H), 3.01 (q, J = 7.6 Hz, 2H), 2.04-2.01 (m, 1H), 1.93 (bs, 1H), 1.75 (s, 3H),1.35 (t, J = 7.6 Hz, 3H)
1236[Figure (not displayed)]
MS (ESI) m/z 631.23 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 14.35 (bs, 1H), 8.53 (s, 1H), 7.58 (dd, J = 8.96, 2.36 Hz, 1H), 7.39-7.34 (m, 3H), 4.45-4.36 (m, 3H), 4.21 (t, J = 4.24 Hz, 2H), 3.92-3.86 (m, 2H), 3.78-3.68 (m, 2H), 3.56 (d, J = 12.04 Hz, 1H), 2.70 (s, 3H), 2.53 (s, 3H), 2.22-1.86 (m, 5H)
1257[Figure (not displayed)]
MS (ESI) m/z 572.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.86 (s, 1H), 8.65 (d, J = 4.8 Hz, 1H), 7.71 (d, J = 5.2 Hz, 1H), 7.55 (dd, J = 8.8, 2.8 Hz, 1H), 7.44 (d, J = 5.2 Hz, 1H), 7.39 (d, J = 2.4 Hz, 1H), 7.31 (d, J = 9.2 Hz, 1H), 7.21 (d, J = 4.4 Hz, 1H), 4.36-4.23 (m, 6H), 3.60 (d, J = 12.0 Hz, 2H), 3.41 (t, J = 11.6 Hz, 2H), 3.29-3.16 (m, 2H), 2.90 (s, 3H), 1.81 (s, 3H)
1258[Figure (not displayed)]
MS (ESI) m/z 559.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.69 (s, 1H), 8.65 (d, J = 3.8, 1H), 7.75 (d, J = 4.76, 1H), 7.55-7.53 (m, 1H), 7.47 (d, J = 5.0 Hz, 1H), 7.39 (s, 1H), 7.31 (d, J = 8.6 Hz, 1H), 7.21 (d, J = 3.6 Hz, 1H), 5.07 (s, 1H), 4.41 (s, 1H), 4.35 (t, J = 3.6 Hz, 2H), 4.19 (t, J = 5.6 Hz, 2H), 3.89 (t, J = 5.9 Hz, 2H), 3.77-3.73 (m, 1H), 3.58 (d, J = 11.4 Hz, 1H), 2.00-1.98 (m, 1H), 1.93 (bs, 1H), 1.74 (s, 3H)
1264[Figure (not displayed)]
MS (ESI) m/z 633.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.99 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.37 (s, 1H), 7.61 (d, J = 9.2 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.44 (s, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.41 (t, J = 5.2 Hz, 2H), 4.27 (t, J = 4.0 Hz, 2H), 3.52 (bs, 6H), 3.77-3.25 (m, 2H), 2.92 ( d, J = 3.2 Hz, 3H), 1.82 (s, 3H)
1265[Figure (not displayed)]
MS (ESI) m/z 642.16 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 9.54 (s, 1H), 8.80 (d, J = 4.8 Hz,1H), 8.55 (s, 1H), 7.57 (dd, J = 2.4, 8.8 Hz, 1H), 7.45 (d, J = 4.8 Hz, 1H), 7.40-7.36 (m, 2H), 4.55 (s, 2H), 4.48 (d, J = 14 Hz, 4H), 4.40 (s, 2H), 4.22 (d, J = 14.4 Hz, 4H), 2.85 (d, J = 4 Hz, 3H), 2.60 (s, 3H), 1.86 (s, 3H)
1266[Figure (not displayed)]
MS (ESI) m/z 629.0 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.80 (d, J = 4.8 Hz, 1H), 8.55 (s, 1H), 8.49 (bs, 2H), 7.57 (dd, J = 2.4, 8.8 Hz ,1H), 7.45 (d, J = 4.8 Hz, 1H), 7.40-7.36 (m, 2H), 4.52 (s, 4H), 4.39 (d, J = 4.8 Hz, 2H), 4.22 (d, J = 5.2 Hz, 6H), 2.60 (s, 3H), 1.85 (s, 3H)
1268[Figure (not displayed)]
MS (ESI) m/z 678.28 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.82 (bs, 1H), 8.74 (d, J = 4.8 Hz, 1H), 8.48 (s, 1H), 8.05 (d, J = 8.4 Hz, 2H), 7.76 (s, 1H), 7.56 (dd, J = 8.8, 2.4 Hz, 1H), 7.41 (d, J = 2.8 Hz, 1H), 7.34 (d, J = 8.9 Hz, 1H), 7.28 (d, J = 4.4 Hz, 1H), 7.10 (d, J = 8.8 Hz, 2H), 4.43-4.36 (m, 2H), 4.27-4.17 (m, 4H), 3.86 (s, 3H), 3.62-3.53 (m, 2H), 3.41-3.29 (m, 2H), 3.21-3.10 (m, 2H), 2.90 (s, 3H), 1.78 (s, 3H)
1273[Figure (not displayed)]
MS (ESI) m/z 624.30 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.00 (bs, 1H), 8.76 (d, J = 4.80 Hz, 1H), 8.66 (s, 1H), 7.76-7.64 (m, 3H), 7.53 (d, J = 4.80 Hz, 1H), 4.82 (s, 2H), 4.38- 4.35 (m, 2H), 3.63-3.60 (m, 2H), 3.48-3.25 (m, 4H), 2.91 (s, 3H), 2.73 (s, 3H), 2.14 (s, 3H)
1274[Figure (not displayed)]
MS (ESI) m/z 680.33 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (d, J = 4.72 Hz, 1H), 8.52 (s, 1H), 7.59 (dd, J = 8.88, 2.44 Hz, 1H), 7.44 (d, J = 4.68, 1H), 7.40 (d, J = 2.4 Hz, 1H), 7.36 (d J = 9.0 Hz, 1H), 6.35-6.05 (m, 1H), 4.40 (t, J = 4.48 Hz, 2H), 4.20 (t, J = 4.72 Hz, 2H), 3.64 (s, 4H), 2.87-2.878 (m, 2H), 2.71 (s, 4H), 2.63 (s, 3H), 1.78 (s, 3H)
1279[Figure (not displayed)]
MS (ESI) m/z 622.22 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.01 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.39 (s, 1H), 7.59 (dd, J = 8.8, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.45-4.36 (m, 2H), 4.30-4.20 (m, 2H), 4.15-4.00 (m, 1H), 2.70-2.50 (m, 2H), 2.44-2.20 (m, 3H), 2.14-2.01 (m, 1H), 1.84 (s, 3H)
1281[Figure (not displayed)]
MS (ESI) m/z 687.47 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 10.05 (bs, 1H), 8.87 (d, J = 3.2 Hz, 1H), 8.74 (s, 1H), 8.72 (d, J = 4.8 Hz, 1H), 8.47 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.69 (d, J = 2.0 Hz, 2H), 7.66 (s, 1H), 7.49 (d, J = 4.4 Hz, 1H), 6.53 (tt, J = 5.2, 51.2 Hz, 1H), 4.82 (s, 2H), 4.49 (bs, 1H), 3.64 (bs, 4H), 3.38 (bs, 2H), 3.16 (s, 3H), 2.17 (bs, 2H), 2.04 (bs, 5H)
1282[Figure (not displayed)]
MS (ESI) m/z 630.28 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 14.09 (bs, 1H), 8.77 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 7.59 (dd, J = 8.8, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.40 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 9.2 Hz, 1H), 4.39 (s, 2H), 4.21 (s, 2H), 3.64 (s, 4H), 2.55-2.35 (m, 7H), 2.23 (s, 3H), 1.83 (s, 3H)
1297[Figure (not displayed)]
MS (ESI) m/z 644.30 [M + 1]+; 1 H NMR (400 MHz, DMSO-d6) δ 13.46 (bs, 1H), 8.66 (d, J = 4.8 Hz, 1H), 7.55 (dd, J = 8.8, 2.4 Hz, 1H), 7.37-7.28 (m, 3H), 4.42-4.34 (m, 2H), 4.21 (s, 2H), 3.63 (bs, 4H), 2.64 (s, 3H), 2.49-2.35 (m, 7H), 2.22 (s, 3H), 1.84 (s, 3H)
1301[Figure (not displayed)]
MS (ESI) m/z 628.33 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.82 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.67 (s, 1H), 8.46 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.8 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 4.48- 4.40 (m, 3H), 4.29-4.19 (m, 2H), 3.45-3.19 (m, 3H), 3.10-2.89 (m, 5H), 1.80 (s, 3H), 1.48-1.27 (m, 2H)
1302[Figure (not displayed)]
MS (ESI) m/z 648.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.15 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.43 (s, 1H), 7.57 (dd, J = 2.4, 8.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.41-7.36 (m, 2H), 4.95 (s, 1H), 4.84 (s, 1H), 4.39 (d, J = 4.4 Hz, 2H), 4.30 (d, J = 7.6 Hz, 2H), 4.23 (s, 2H), 3.83-3.59 (m, 4H), 3.53- 3.34 (m, 4H), 1.83 (s, 3H)
1303[Figure (not displayed)]
MS (ESI) m/z 666.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.68 (s, 1H), 8.46 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.37-7.35 (m, 1H), 6.46 (t, J = 54.8 Hz, 1H), 4.41-4.38 (m, 2H), 4.28-4.22 (m, 2H), 3.87-3.83 (m, 4H), 3.38-3.32 (m, 2H), 3.24-3.11 (m, 4H), 1.80 (s, 3H)
1304[Figure (not displayed)]
MS (ESI) m/z 684.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 11.77 (bs, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.66 (s, 1H), 8.40 (s, 1H), 7.58 (dd, J = 9.2, 6.8 Hz, 1H), 7.45-7.40 (m, 2H), 7.34 (d, J = 8.8 Hz, 1H), 4.37 (s, 2H), 4.20 (s, 2H), 3.65 (s, 4H), 3.35-3.20 (m, 2H), 2.81 (s, 4H), 1.75 (s, 3H)
1305[Figure (not displayed)]
MS (ESI) m/z 666 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz , 1H), 8.70 (s, 1H), 8.43 (s, 1H), 7.61 (dd, J = 2.4, 8.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.8 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 6.73-6.46 (m, 1H), 4.39 (s, 2H), 4.34 (s, 1H), 4.23 (s, 2H), 4.18 (s, 1H), 3.56-3.15 (m, 5H), 2.83 (s, 3H), 1.82 (s, 3H)
1306[Figure (not displayed)]
MS (ESI) m/z 642.35 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.43 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.44 (s, 1H), 7.61 (dd, J = 8.8 Hz, J = 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.41-7.38 (m, 2H), 4.41-4.40 (m, 4H), 4.31 (t, J = 2.4 Hz, 2H), 3.47 (bs, 6H), 3.01 (bs, 1H), 1.85 (s, 3H), 1.00-0.88 (bs, 2H)
1307[Figure (not displayed)]
MS (ESI) m/z 692.28 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.31 (bs, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.68 (s, 1H), 8.43 (s, 1H), 7.59 (dd, J = 2.40, 8.8 Hz, 1H), 7.46 (d, J = 4.4 Hz, 1H), 7.41 (d, J = 2.0 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.39 (s, 2H), 4.22 (s, 2H), 3.76 (m, 4H), 3.19-2.93 (m, 8H), 2.32 (m, 1H), 1.80 (s, 3H)
1308[Figure (not displayed)]
MS (ESI) m/z 698.28 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.33 (bs, 1H), 8.82 (d, J = 4.76 Hz, 1H), 8.69 (s, 1H), 8.43 (s, 1H), 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.46 (d, J = 4.7 Hz, 1H), 7.41 (d, J = 2.5 Hz, 1H), 7.35 (d, J = 8.9 Hz, 1H) , 4.39 (t, J = 4.8 Hz, 2H), 4.22 (t, J = 4.4 Hz, 2H), 3.38 (bs, 8H), 2.82 (s, 4H), 1.81 (s, 3H)
1309[Figure (not displayed)]
MS (ESI) m/z 694.37 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.67 (s, 1H), 8.45 (s, 1H), 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.0 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 6.22 (m, 1H), 4.39 (s, 2H), 4.21 (s, 2H), 3.72 (m, 4H), 2.96 (s, 4H), 1.79 (s, 3H), 1.23 (s, 6H)
1310[Figure (not displayed)]
MS (ESI) m/z 692.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 8.48 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.49 (d, J = 4.80, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 6.04 (t, J = 55.6 Hz, 1H), 4.38 (s, 2H), 4.20 (s, 2H), 3.55 (s, 4H), 3.01 (s, 4H), 1.75 (s, 3H), 0.90-078 (m, 4H)
1311[Figure (not displayed)]
MS (ESI) m/z 678.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.66 (s, 1H), 8.45 (s, 1H) 7.60 (dd, J = 9.2 Hz, 2.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 4.39 (bs, 2H), 4.32 (d, J = 12.8 Hz, 2H), 4.22 (bs, 4H), 3.64 (bs, 1H), 3.38 (bs, 1H), 3.19 (bs, 2H), 2.93 (bs, 2H), 2.15 (bs, 1H), 1.759 (s, 3H)
1312[Figure (not displayed)]
MS (ESI) m/z 680.29 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.22 (bs, 1H), 8.82 (d, J = 4.8 Hz 1H), 8.66 (s, 1H), 8.44 (s, 1H), 7.598 (dd, J = 2.4, 8.8 Hz, 1H), 7.47 (d, J = 4.4 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 6.25 (m, 1H), 4.38 (s, 2H), 4.21 (s, 2H), 3.64 (m, 4H), 2.97 (m, 4H), 2.63 (s, 1H), 1.77 (s, 3H), 1.16 (s, 3H)
1313[Figure (not displayed)]
MS (ESI) m/z 658.37 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.43 (bs, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.41 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.47 (d, J = 4.4 Hz, 1H), 7.41-7.36 (m, 2H), 4.42-4.39 (m, 4H), 4.24 (s, 2H), 3.72 (d, J = 12 Hz, 2H), 3.51 (t, J = 12.4 Hz, 2H), 3.19 (d, J = 9.6 Hz, 2H), 1.86 (s, 3H), 1.39 (s, 9H)
1314[Figure (not displayed)]
MS (ESI) m/z 654.34 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.22 (bs, 1H), 8.82 (d, J = 4.7 Hz, 1H), 8.57 (s, 1H), 8.46 (s, 1H), 7.59 (dd, J = 8.8, 2.5 Hz, 1H), 7.45 (d, J = 4.7 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.34 (d, J = 9.0 Hz, 1H), 4.41 (s, 4H), 4.36 (s, 2H), 4.18 (s, 2H), 3.49 (bs, 4H), 1.90 (bs, 1H), 1.73 (s, 3H), 0.42- 0.20 (m, 4H)
1315[Figure (not displayed)]
MS (ESI) m/z 698.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.4 Hz, 1H), 8.65 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.42-4.34 (m, 2H), 4.20 (s, 2H), 3.63-3.57 (m, 5H), 2.90- 2.80 (m, 4H), 1.76 (s, 3H), 1.21 (d, J = 6.8 Hz, 3H)
1316[Figure (not displayed)]
MS (ESI) m/z 712.41 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 8.47 (s, 1H), 7.59 (dd, J = 8.8, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.41-4.35 (m, 2H), 4.23-4.16 (m, 2H), 3.61 (s, 4H), 2.93 (s, 4H), 1.75 (s, 3H), 1.32 (s, 6H)
1317[Figure (not displayed)]
MS (ESI) m/z 676.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.23 (bs, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 8.45 (s, 1H), 7.59- 7.57 (m, 1H), 7.45 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.0 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.38 (s, 2H), 4.20 (s, 2H), 3.65 (s, 4H), 2.67 (s, 4H), 2.60-2.48 (m, 2H), 1.74 (s, 3H), 1.35 (J = 21.6 Hz, 6H)
1318[Figure (not displayed)]
MS (ESI) m/z 7694.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (d, J = 4.8 Hz, 1H), 8.51 (s, 1H), 8.31 (s, 1H), 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.45 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 6.54 (t, J = 57.2 Hz, 1H), 4.49 (bs, 2H), 4.39 (bs, 2H), 4.21 (bs, 2H), 3.60 (bs, 4H), 3.08 (t, J = 12.0 Hz, 2H), 3.08 (s, 3H), 2.17 (bs, 1H), 2.03 (bs, 4H) 1.76 (s, 3H)
1319[Figure (not displayed)]
MS (ESI) m/z 670.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.76 Hz, 1H), 8.62 (s, 1H), 8.41 (s, 1H), 7.60 (dd, J = 8.9 Hz, 2.4 Hz, 1H), 7.47 (d, J = 4.7 Hz, 1H), 7.42 (d, J = 2.5 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.57- 4.52 (m, 1H), 4.39 (d, J = 5.6 Hz, 2H), 4.17 (d, J = 5.28, 2H), 3.65 (d, J = 11.44, 2H), 3.95 (bs, 2H), 3.07 (s, 3H), 2.83 (bs, 1H), 2.07 (s, 4H), 1.76 (s, 3H), 0.94-0.85 (m, 4H)
1320[Figure (not displayed)]
MS (ESI) m/z 686.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.32 (s, 1H), 8.82 (d, J = 4.8, 1H), 8.61 (s, 1H), 8.40 (s, 1H), 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.77-4.76 (m, 4H), 4.55 (bs, 1H), 4.39 (s, 3H), 4.21 (s, 2H), 3.26-3.15 (m, 2H), 3.09-2.97 (m, 5H), 2.21-2.08 (m, 4H), 1.77 (s, 3H)
1321[Figure (not displayed)]
MS (ESI) m/z 652.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (s, 1H), 6 8.74 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69-7.66 (m, 2H), 7.53 (d, J = 4.4 Hz, 1H), 4.83 (s, 2H), 4.76 (s, 4H), 4.37 (bs, 4H), 4.04 (bs, 1H), 3.34-2.82 (m, 4H), 2.12 (s, 3H)
1322[Figure (not displayed)]
MS (ESI) m/z 664.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.74 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.64 (s, 1H), 7.76-7.73 (m, 1H), 7.69-7.66 (m, 2H), 7.52 (d, J = 4.8 Hz, 1H), 4.80 (s, 2H), 4.54 (t, J = 6.4 Hz, 2H), 4.47 (s, 4H), 4.35 (t, J = 6 Hz, 2H), 3.69 (t, J = 5.6 Hz, 1H), 3.42 (s, 4H), 2.0 (s, 3H)
1323[Figure (not displayed)]
MS (ESI) m/z 630.32 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.62 (s, 1H), 8.80 (d, J = 4.8 Hz, 1H), 8.59 (s, 1H), 8.50 (s, 1H), 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.45 (d, J = 4.8 Hz, 1H), 7.40 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 7.19 (s, 1H), 4.41 (t, J = 4.8 Hz, 2H), 4.24 (t, J = 4.8 Hz, 2H), 3.64 (s, 2H), 2.96 (m, 5H), 2.5 (m, 3H), 2.10 (m, 2H), 1.85 (s, 3H)
1324[Figure (not displayed)]
MS (ESI) m/z 652.29 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.17 (s, 1H), 8.85 (d, J = 4.81 Hz, 1H), 8.36 (s, 1H), 7.62-7.59 (m, 2H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 7.06 (bs, 1H), 4.44 (s, 2H), 4.33 (s, 2H), 3.29 (s, 6H), 2.60 (s, 3H), 1.92 (s, 3H)
1325[Figure (not displayed)]
MS (ESI) m/z 652.36 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.23 (bs, 1H), 9.09 (s, 1H), 9.00 (s, 1H), 8.85 (d, J = 4.4 Hz, 1H), 8.38 (s, 1H), 8.31 (d, J = 8.0 Hz, 1H), 7.65 (d, J = 8.0 Hz, 1H), 7.60 ( dd, J = 8.8, 2.4 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.42 (s, 2H), 4.28 (s, 2H), 3.66 (s, 2H), 2.26 (s, 6H), 1.83 (s, 3H)
1326[Figure (not displayed)]
MS (ESI) m/z 631.39 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.23 (bs, 1H), 8.97 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.36 (s, 1H), 7.60 (dd, J = 9.2, 2.0 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.81 (d, J = 46.4 Hz, 2H), 4.47-4.38 (m, 4H), 4.26 (s, 2H), 3.65-3.30 (m, 2H), 2.86 (s, 3H), 1.77 (s, 3H)
1327[Figure (not displayed)]
MS (ESI) m/z 667.38 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.16 (bs, 1H), 8.94 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.38 (s, 1H), 7.59 (dd, J = 9.2, 2.4 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.34 (d, J = 8.8 Hz, 1H), 4.39 (s, 2H), 4.25 (s, 2H), 3.88 (s, 2H), (q, J = 10.0 Hz, 2H), 2.54 (s, 3H), 1.73 (s, 3H)
1328[Figure (not displayed)]
MS (ESI) m/z 633.40 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.40 (bs, 1H), 10.08 (bs, 1H), (9.01 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.36 (s, 1H), 7.60 (dd, J = 8.9, 2.5 Hz, 1H), 7.48 (d, J = 4.7 Hz, 1H), 7.45-7.33 (m, 3H), 7.21-7.18 (m, 1H), 4.88 (d, J = 47.2 Hz, 2H), 4.41 (t, J = 4.9 Hz, 2H), 4.27-4.13 (m, 4H), 3.70-3.55 (m, merged, 2H), 2.90 (s, 3H), 1.81 (s, 3H)
1329[Figure (not displayed)]
MS (ESI) m/z 625.37 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.92 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.34 (s, 1H), 7.59 (dd, J = 8.8, 2.4 Hz, 1H), 7.48 (d, J = 4.4 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.40 (bs, 2H), 4.25 (bs, 2H), 2.74 (bs, 6H), 1.75 (s, 3H), 1.36 (bs, 4H)
1330[Figure (not displayed)]
MS (ESI) m/z 617.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.38 (bs, 1H), 10.15 (bs, 1H), 9.02 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.34 (s, 1H), 7.60 (dd, J = 2.4, 8.8 Hz, 1H), 7.46 (d, J = 4.4 Hz, 1H), 7.43 (d, J = 2.8 Hz, 1H), 7.35 (d, J = 9.2 Hz, 1H), 5.27 (d, J = 8.0 Hz, 1H), 4.40 (bs, 2H), 4.32-4.23 (m, 2H), 3.94 (t, J = 12.4 Hz, 1H), 3.78 (bs, 2H), 3.49 (bs, 2H), 3.24 (bs, 1H), 2.99 (s, 3H), 1.81 (s, 3H)
1332[Figure (not displayed)]
MS (ESI) m/z 655.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.98 (s, 1H), 8.84 (d, J = 4.8 Hz, 1H), 8.23 (s, 1H), 7.61 (dd, J = 9.2, 2.8 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.37 (d, J = 9.2 Hz, 1H), 4.42 (bs, 2H), 4.30 (bs, 2H), 2.82 (bs, 2H), 2.72 (s, 6H), 2.61 (bs, 2H) 1.30 (s, 9H)
1333[Figure (not displayed)]
MS (ESI) m/z 676.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.33 (bs, 1H), 9.75 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.71 (s, 1H), 8.38 (s, 1H), 7.61-7.58 (dd, J = 2.8, 9.2 Hz, 1H), 7.47 (d, J = 4.4 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.37 (d, J = 9.2 Hz, 1H), 4.97-4.79 (m, 2H), 4.39 (bs, 2H), 4.22 (bs, 2H), 3.88-3.48 (m, 6H), 1.79 (s, 3H), 1.45 (s, 3H), 1.40 (s, 3H)
1334[Figure (not displayed)]
MS (ESI) m/z 684.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.38 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.67 (s, 1H), 8.43 (s, 1H), 7.59 (d, J = 7.2 Hz, 1H), 7.47 (d, J = 4.4 Hz, 1H), 7.43 (s, 1H), 7.35 (d, J = 9.2 Hz, 1H), 4.38 (s, 2H), 4.21 (s, 2H), 4.08 (d, J = 11.2 Hz, 1H), 3.82- 3.05 (m, 5H), 2.67 (s, 1H), 2.50 (s, 3H), 1.76 (s, 3H)
1335[Figure (not displayed)]
MS (ESI) m/z 630.46 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.85 (s, 1H), 8.85 (d, J = 8.4 Hz, 1H), 8.67 (s, 1H), 8.40 (s, 1H), 7.61 (d, J = 8.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.41 (m, 2H), 4.74 (bs, 1H), 4.42 (m, 2H), 4.23 (m, 4H), 3.52 (m, 2H), 3.32 (m, 2H). 2.91 (s, 3H), 1.78 (s, 3H), 1.49 (d, J = 6.8 Hz, 3H), 1.04 (d, J = 5.6 Hz, 1H)
1336[Figure (not displayed)]
MS (ESI) m/z 674.50 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.67 (s, 1H), 8.45 (s, 1H), 7.60 (dd, J = 9.2, 2.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.62 (d, J = 49.6 Hz, 2H), 4.40-4.35 (m, 2H), 4.25-4.15 (m, 2H), 3.75-3.55 (m, 4H), 3.30-3.00 (m, 4H), 1.79 (s, 3H), 1.15-.0.80 (m, 4H)
1337[Figure (not displayed)]
MS (ESI) m/z 642.53 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.37 (bs, 1H), 8.82 (d, J = 4.4 Hz, 1H), 8.70 (s, 1H), 8.38 (s, 1H), 7.60 (t, J = 6.8 Hz, 1H), 7.47-7.21 (m, 3H), 4.39 (s, 2H), 4.23 (s, 2H), 4.05 (bs, 2H), 3.93 (bs, 2H), 3.52 (bs, 2H), 2.99 (s, 3H), 1.79 (s, 3H), 1.26- 1.07 (m, 4H)
1338[Figure (not displayed)]
MS (ESI) m/z 674.53 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.21 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.68 (s, 1H), 8.39 (s, 1H), 7.60 (dd, J = 8.8, 2.0 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.83-4.72 (m, 2H), 4.39 (s, 2H), 4.23 (s, 2H), 3.98-3.53 (m, 8H), 1.77 (s, 3H), 1.03 (bs, 4H)
1339[Figure (not displayed)]
MS (ESI) m/z 708.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.27 (bs, 1H), 8.82 (d, J = 8.0 Hz, 1H), 8.67 (s, 1H), 8.43 (s, 1H), 7.59 (d, J = 6.8 Hz, 1H), 7.46 (d, J = 4.4 Hz, 1H), 7.42 (s, 1H), 7.36 (d, J = 9.2 Hz, 1H), 4.39 (s, 2H), 4.22 (s, 2H), 3.59-3.30 (m, 12H), 3.10 (s, 3H), 1.79 (s, 3H)
1340[Figure (not displayed)]
MS (ESI) m/z 692.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.63 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 2.4, 8.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.57 (t, J = 8.0 Hz, 2H), 4.38 (bs, 4H), 4.20 (bs, 2H), 3.94 (bs, 1H), 3.07 (bs, 4H), 2.20 (bs, 4H), 1.76 (s, 3H)
1341[Figure (not displayed)]
MS (ESI) m/z 664.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.58 (s, 1H), 8.47 (s, 1H), 8.48 (s, 1H), 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.35 (d, J = 9.2 Hz, 1H), 4.47-4.42 (m, 2H), 4.37 (bs, 2H), 4.18 (bs, 2H), 4.13-4.10 (m, 2H), 3.95-3.74 (m, 5H), 1.74 (s, 3H)
1342[Figure (not displayed)]
MS (ESI) m/z 655.35 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.27 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.67 (s, 1H), 8.43 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.46 (d, J = 4.0 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 9.2 Hz, 1H), 4.43-4.35 (m, 2H), 4.25-4.15 (m, 2H), 4.13- 4.00 (m, 2H), 3.16- 3.10 (m, 1H), 2.97- 2.83 (m, 4H), 2.48-2.33 (m, 2H), 2.30 (s, 3H), 1.74 (s, 3H)
1343[Figure (not displayed)]
MS (ESI) m/z 683.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.69 (s, 1H), 8.43 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 4.40 (s, 2H), 4.23 (s, 2H), 3.95 (s, 2H), 3.57-3.40 (m, 4H), 3.30-3.15 (m, 4H), 1.83 (s, 3H), 1.46 (s, 6H)
1344[Figure (not displayed)]
MS (ESI) m/z 651.48 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.96 (s, 1H), 8.83 (d, J = 4.4 Hz, 1H), 8.36 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.48 (d, J = 4.4 Hz, 1H), 7.44 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 9.2 Hz, 1H), 4.80-4.60 (m, 1H), 4.40 (s, 2H), 4.25 (s, 2H), 3.55-3.30 (m, merged, 2H), 2.50-2.30 (m, 1H), 2.22-1.91 (m, 4H), 1.75 (s, 3H), 1.04-0.61 (m, 4H)
1345[Figure (not displayed)]
MS (ESI) m/z 635.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.40 (bs. 1H), 9.67 (bs, 1H), 8.96 (s, 1H), 8.82 (d, J = 4.7 Hz, 1H), 8.32 (s, 1H), 7.60 (dd, J = 8.92, 2.36 Hz, 1H), 7.47 (d, J = 4.7 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.9 Hz, 1H), 4.92-4.76 (m, 1H), 4.40 (t, J = 4.4 Hz, 2H), 4.26 (t, J = 5.0 Hz, 2H), 3.62-3.52 (m, 2H), 3.40-3.20 (m, 2H), 3.18 (t, J = 7.24 Hz, 2H), 2.88 (s, 3H), 2.31-2.17 (m, 2H), 1.82 (s, 3H)
1346[Figure (not displayed)]
MS (ESI) m/z 639.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.97 (s, 1H), 8.83 (d, J = 4.7 Hz, 1H), 8.37 (s, 1H), 7.59 (dd, J = 8.9, 2.4 Hz, 1H), 7.47 (d, J = 4.7 Hz, 1H), 7.44 (d, J = 2.4 Hz, 1H ), 7.34 (d, J = 9.0 Hz, 1H), 4.65-4.35 (m, 4H), 4.25 (t, J = 3.8 Hz, 2H), 2.85 (bs, 3H), 1.75 (s, 3H), 1.36 (s, 3H), 1.03 (bs, 2H), 0.72 (bs, 2H)
1347[Figure (not displayed)]
MS (ESI) m/z 624.49 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.08 (bs, 1H), 8.86 (s, 1H), 8.79 (d, J = 4.4 Hz, 1H), 8.66 (s, 1H), 7.88 (d, J = 8.4 Hz, 1H), 7.61 (d, J = 8.8 Hz, 1H), 7.52 (s, 1H), 7.42 (d, J = 4.8 Hz, 1H), 6.52-6.38 (m, 1H), 5.89 (d, J = 16.0 Hz, 1H), 4.68 (d, J = 4.0 Hz, 2H), 4.39 (d, J = 13.2 Hz, 1H), 3.11 (t, J = 12.4 Hz, 2H), 2.82-2.65 (m, 1H), 2.40-2.10 (m, 8H), 0.72-0.45 (m, 2H)
1348[Figure (not displayed)]
MS (ESI) m/z 628.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6), 68.81 (d, J = 4.8 Hz, 1H), 6 8.62 (s, 1H), 8.43 (s, 1H), 7.59 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.45-7.42 (m, 2H), 7.35 (d, J = 8.8 Hz, 1H), 4.78 (bs, 1H), 4.37 (t, J = 5.1 Hz, 2H), 4.27 (t, J = 4.5 Hz, 2H), 3.45-3.43 (m, 2H), 3.32-2.8 (m, 4H), 2.75-2.56 (m, 2H), 1.93-1.90 (m, 2H), 1.74 (s, 3H)
1349[Figure (not displayed)]
MS (ESI) m/z 715.66 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.89 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.41 (s, 1H), 7.58 (dd, J = 8.8 Hz, 2.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.34 (d, J = 8.8 Hz, 1H), 4.38 (s, 2H), 4.22 (s, 2H), 4.05 (s, 1H), 3.40-3.32 (m, 2H), 2.93 (s, 2H), 2.66-2.61 (m, 2H), 2.11-2.09 (m, 2H), 1.74 (s, 5H)
1350[Figure (not displayed)]
MS (ESI) m/z 694.59 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 8.41 (s, 1H), 7.59 (dd, J = 2.0, 8.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.0 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 6.15 (bs, 1H), 4.39 (s, 2H), 4.21-4.16 (m, 2H), 4.14 (bs, 2H), 3.01 (bs, 6H), 1.77 (s, 3H), 1.21 (s, 6H)
1351[Figure (not displayed)]
MS (ESI) m/z 658.47 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 2.36 Hz, 1H), 8.74 (s, 1H), 8.40 (s, 1H), 7.60 (dd, J = 8.9, 2.5 Hz, 1H), 7.47 (d, J = 4.7 Hz, 1H), 7.42 (d, J = 2.5 Hz, 2H), 7.37 (d, J = 9.0 Hz, 2H), 4.66 (d, J = 7.5 Hz, 2H), 4.40 (s, 2H), 4.24 (s, 2H), 4.14 (bs, 4H), 3.40 (s, 2H), 3.06 (s, 3H), 1.82 (s, 3H)
1352[Figure (not displayed)]
MS (ESI) m/z 652.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (s, 1H), 6 8.74 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69-7.66 (m, 2H), 7.53 (d, J = 4.4 Hz, 1H), 4.83 (s, 2H), 4.76 (s, 4H), 4.37 (bs, 4H), 4.04 (bs, 1H), 3.34-2.82 (m, 4H), 2.12 (s, 3H)
1353[Figure (not displayed)]
MS (ESI) m/z 692.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.05 (bs, 1H), 8.83 (s, 1H), 8.75 (d, J = 4.6 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.2 Hz, 1H), 7.69 (s, 1H), 7.66 (s, 1H), 7.52 (d, J = 4.6 Hz, 1H), 4.83 (s, 2H), 4.31 (bs, 1H), 3.43 (bs, 7H), 2.85 (s, 4H), 2.11 (s, 3H)
1354[Figure (not displayed)]
MS (ESI) m/z 636.25 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.18 (bs, 1H), 8.84 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.65 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.84 (s, 2H), 4.38 (m, 2H), 3.79 (m, 2H,), 3.49 (m, 4H), 3.03 (m, 1H), 2.14 (s, 3H), 0.93 (m, 4H)
1355[Figure (not displayed)]
MS (ESI) m/z 686.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.03 (s, 1H), 8.83 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.66 (m, 1H), 7.53 (d, J = 4.8 Hz, 1H), 4.72 (s, 2H), 3.80 (bs, 4H), 3.39 (bs, 4H), 3.05-3.02 (m, 5H), 2.16 (s, 3H)
1356[Figure (not displayed)]
MS (ESI) m/z 660.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.05 (bs, 1H), 8.79 (s, 1H), 8.75 (d, J = 4.6 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.1 Hz, 1H), 7.68 (m, 2H), 7.53 (d, J = 4.6 Hz, 1H), 6.34 (m, 1H), 4.82 (s, 2H), 3.76-2.66 (m, 10H), 2.09 (s, 1H)
1357[Figure (not displayed)]
MS (ESI) m/z 658.37 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.46 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 6.33 (t, J = 53.6 Hz, 1H), 5.09 (s, 1H), 4.38 (t, J = 4.3 Hz, 2H), 4.21 (t, J = 5.7, 2H), 4.15-3.80 (m, 7H), 2.21 (bs, 2H), 1.76 (s, 3H)
1358[Figure (not displayed)]
MS (ESI) m/z 716.50 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.68 (s, 1H), 8.45 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.37-7.33 (m, 2H), 5.77 (d, J = 46 Hz, 1H), 4.39 (s, 2H), 4.22 (s, 2H), 3.24 (bs, 2H), 3.29-3.15 (m, 8H), 1.79 (s, 3H)
1359[Figure (not displayed)]
MS (ESI) m/z 766.56 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4 Hz, 1H), 8.66 (s, 1H), 8.46 (s, 1H), 7.60 (dd, J = 2.4, 8.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.39 (bs, 2H), 4.21 (bs, 2H), 3.68 (bs, 4H), 2.96 (bs, 2H), 2.78 (bs, 4H), 2.46 (s, 1H) 1.77 (s, 3H)
1360[Figure (not displayed)]
MS (ESI) m/z 726.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.53 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.40 (s, 1H), 7.59 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.47 (d, J = 4.4 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.49 (bs, 1H), 4.52 (bs, 1H), 4.21 (bs, 2H), 3.69 (d, J = 10.4 Hz, 2H), 3.50 (bs, 2H), 3.40 (bs, 2H), 3.21 (s, 3H), 2.89-2.85 (m, 2H), 2.11 (bs, 4H), 1.78 (s, 3H)
1361[Figure (not displayed)]
MS (ESI) m/z 724.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 8.46 (s, 1H), 7.60 (dd, J = 8.8, 2.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.37 (s, 2H), 4.20 (s, 2H), 3.63 (bs, 4H), 2.84 (bs, 4H), 2.70-2.50 (m, 2H), 1.77 (s, 3H), 0.84-0.74 (m, 4H)
1362[Figure (not displayed)]
MS (ESI) m/z 755.45 [M + 1]+; 1H NMR (400 MHz, DMSO- d6) δ 12.44 (s, 1H), 8.83-8.79 (m, 3H), 7.76 (d, J = 8.4 Hz, 1H), 7.71- 7.67 (m, 2H), 7.61 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 3.75- 3.60 (m, 4H), 3.56 (s, 3H), 3.31 (q, J = 10.0 Hz, 2H), 2.90-2.80 (m, 4H), 2.00 (s, 3H)
1363[Figure (not displayed)]
MS (ESI) m/z 668.48 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.21 (bs, 1H), 9.37 (bs, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.67 (s, 1H), 8.37 (s, 1H), 7.59 (dd, J = 8.8, 2.4 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.41 (d, J = 2.0 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 4.38 (s, 2H), 4.21 (s, 2H), 3.80-3.50 (m, 2H), 3.20-2.90 (m, 2H), 2.61 (s, 3H), 1.78 (s, 3H), 1.40-0.80 (m, 8H)
1364[Figure (not displayed)]
MS (ESI) m/z 642.35 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.68 (s, 1H), 8.45 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.87-4.75 (m, 4H), 4.39 (bs, 2H), 4.22 (bs, 2H), 3.56-3.14 (m, 8H), 2.41 (s, 1H), 1.78 (s, 3H)
1365[Figure (not displayed)]
MS (ESI) m/z 656.52 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.30 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.69 (s, 1H), 8.41 (s, 1H), 7.62- 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.41-7.36 (m, 2H), 4.40 (bs, 4H), 4.24 (bs, 2H), 3.48 (bs, 6H), 1.85 (s, 3H), 1.39 (s, 3H), 1.19 (bs, 2H), 0.82 (bs, 2H)
1366[Figure (not displayed)]
MS (ESI) m/z 686.46 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79-8.73 (m, 2H), 8.66 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.72-7.66 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.04 (t, J = 55.6 Hz, 1H), 4.82 (s, 2H), 3.59 (s, 4H), 3.02 (s, 4H), 2.06 (s, 3H), 0.90-0.78 (m, 4H)
1367[Figure (not displayed)]
MS (ESI) m/z 677.49 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.05 (bs, 1H), 9.99 (bs, 1H), 8.82 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.71-7.66 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.45 (bs, 2H), 3.62 (bs, 4H), 3.27 (bs, 4H), 2.13 (s, 3H), 1.46 (bs, 6H)
1368[Figure (not displayed)]
MS (ESI) m/z 661.35 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (s, 1H), 8.77 (d, J = 3.2 Hz, 1H), 8.67 (s, 1H), 7.76 (d, J = 8.8 Hz, 1H), 7.71-7.65 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 3.67 (s, 4H), 2.82 (s, 4H) 2.07 (s, 3H), 1.32-1.27 (m, 2H), 1.17-1.09 (m, 2H)
1369[Figure (not displayed)]
MS (ESI) m/z 682.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (d, J = 4.4 Hz, 1H), 8.60 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 9.2, 2.4 Hz, 1H), 7.46 (d, J = 4.4 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 9.2 Hz, 1H), 4.60 (s, 2H), 4.52 (s, 2H), 4.43-4.38 (m, 4H), 4.33-4.28 (m, 2H), 4.20 (bs, 2H), 3.79 (bs, 1H), 1.89 (t, J = 6.8 Hz, 2H), 1.80 (s, 3H), 1.67-1.58 (m, 4H), 1.47 (t, J = 6.4 Hz, 2H)
1370[Figure (not displayed)]
MS (ESI) m/z 684.53 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.9 Hz, 1H), 8.61 (s, 1H), 8.40 (s, 1H), 7.60 (dd, J = 2.4, 8.8 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.51 (bs, 1H), 4.39 (s, 2H), 4.21 (s, 2H), 3.68 (d, J = 10.4 Hz, 2H), 3.21-3.16 (m, 2H), 3.09 (s, 3H), 3.01 (t, J = 5.6 Hz, 2H), 2.21-2.15 (m, 2H), 2.12-2.06 (m, 2H), 1.77 (s, 3H), 1.10 (bs, 1H), 0.67 (d, J = 7.2 Hz , 2H), 0.44-0.38 (m, 2H)
1371[Figure (not displayed)]
MS (ESI) m/z 654.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.48 (bs, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 8.44 (s, 1H), 7.60 (dd, J = 9.2, 2.4 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 5.25-4.89 (m, 2H), 4.63 (d, J = 10.4 Hz, 2H), 4.38 (s, 2H), 4.21 (s, 2H), 3.98 (bs, 2H), 3.18 (bs, 1H), 2.75 (bs, 2H), 1.78 (s, 3H), 0.86 (bs, 4H)
1378[Figure (not displayed)]
MS (ESI) m/z 608.1
1382[Figure (not displayed)]
MS (ESI) m/z 608.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 1H NMR (400 MHz, DMSO- d6) δ 9.05 (s, 1H), 8.44 (s, 1H), 7.94-7.86 (m, 2H), 7.64-7.54 (m, 4H), 7.46-7.40 (m, 2H), 7.37 (d, J = 9.0 Hz, 1H), 4.42 (d, J = 4.9 Hz, 2H), 4.29 (d, J = 4.9 Hz, 2H), 2.71 (s, 3H), 1.89 (s, 3H)
1390[Figure (not displayed)]
MS (ESI) m/z 650.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.93 (s, 1H), 8.39 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.42 (d, J = 2.8 Hz, 2H), 7.35 (d, J = 9.0 Hz, 1H), 6.29 (s, 1H), 4.39 (d, J = 5.0 Hz, 2H), 4.26 (d, J = 4.9 Hz, 2H), 2.91-2.78 (m, 4H), 2.71 (s, 3H), 2.35- 2.15 (m, 2H), 1.85 (s, 3H)
1395[Figure (not displayed)]
MS (ESI) m/z 714.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (d, J = 4.8 Hz, 1H), 8.54 (s, 1H), 8.48 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.39 (d, J = 9.0 Hz, 1H), 4.54 (s, 2H), 4.43 (t, J = 5.1 Hz, 2H), 4.24 (t, J = 5.1 Hz, 2H), 3.82-3.40 (m, 10H), 1.83 (s, 3H)
1396[Figure (not displayed)]
MS (ESI) m/z 708.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.76 (dd, J = 8.3, 0.5 Hz, 1H), 7.71-7.65 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.84 (s, 2H), 4.53 (s, 2H), 4.06-2.83 (m, 8H), 2.13 (s, 3H)
1397[Figure (not displayed)]
MS (ESI) m/z 708.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.60 (s, 1H), 8.40 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.51-7.47 (m, 1H), 7.44 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 6.46 (t, J = 54.6 Hz, 1H), 4.54 (s, 4H), 4.41 (t, J = 4.9 Hz, 2H), 4.21 (t, J = 4.8 Hz, 2H), 4.10 (s, 4H), 2.75 (t, J = 4.7 Hz, 4H), 1.75 (s, 3H)
1398[Figure (not displayed)]
MS (ESI) m/z 650.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.93 (s, 1H), 8.39 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.42 (d, J = 2.8 Hz, 2H), 7.35 (d, J = 9.0 Hz, 1H), 6.29 (s, 1H), 4.39 (d, J = 5.0 Hz, 2H), 4.26 (d, J = 4.9 Hz, 2H), 2.91-2.78 (m, 4H), 2.71 (s, 3H), 2.35- 2.15 (m, 2H), 1.85 (s, 3H)
1399[Figure (not displayed)]
MS (ESI) m/z 842.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.03 (s, 1H), 8.90 (d, J = 4.9 Hz, 1H), 8.72 (ddd, J = 4.6, 1.7, 0.9 Hz, 1H), 8.65 (s, 1H), 8.60 (s, 1H), 8.30-8.25 (m, 1H), 8.21 (td, J = 7.7, 1.7 Hz, 1H), 7.80-7.72 (m, 2H), 7.72-7.68 (m, 2H), 7.66 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 3.09 (s, 3H), 1.94 (s, 3H), 1.77 (t, J = 18.9 Hz, 2H)
1400[Figure (not displayed)]
MS (ESI) m/z = 740.3 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 6 9.59-9.49 (b, 1H), 8.83 (d, J = 4.6 Hz, 1H), 8.70 (s, 1H), 8.42 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.38 (d, J = 8.9 Hz, 1H), 4.43-4.36 (m, 2H), 4.24 (t, J = 4.8 Hz, 2H), 3.61-3.49 (m, 2H), 3.34-3.20 (m, 2H), 2.49-2.39 (m, 2H), 2.00-1.92 (m, 2H), 1.85 (s, 3H), 1.39 (s, 6H). Remaining protons partially obscured by water peak
1401[Figure (not displayed)]
MS (ESI) m/z = 738.3 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 6 8.83 (d, J = 4.9 Hz, 1H), 8.67 (s, 1H), 8.42 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.7 Hz, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 4.40 (t, J = 4.9 Hz, 2H), 4.23 (t, J = 4.9 Hz, 2H), 2.39- 2.25 (m, 2H), 1.82 (s, 3H), 1.40-0.45 (b, 4H). Remaining protons appear as very broad signals and/or are partially obscured by water peak
1402[Figure (not displayed)]
MS (ESI) m/z = 627.3 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 6 10.20-10.10 ppm (b, 1H), 9.15 (s, 1H), 8.74 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 7.78-7.75 (m, 1H), 7.71-7.68 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 15 Hz, 1H), 7.19 (dt, J = 7.3, 15 Hz, 1H), 4.97-4.79 (m, 2H), 4.88 (s, 2H), 4.35-4.13 (m, 2H), 3.75-3.53 (m, 2H), 2.91 (s, 3H), 2.15 (s, 3H)
1403[Figure (not displayed)]
MS (ESI) m/z = 686.2 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 68.77 (d, J = 4.8 Hz, 1H), 8.71 (s, 1H), 8.65 (s, 1H), 7.77-7.73 (m, 1H), 7.71-7.66 (m, 2H), 7.53 (d, J = 4.8 HZ, 1H), 6.37 (bt, J = 55 Hz, 1H), 4.81 (s, 2H), 3.25 (s, 3H), 2.37-2.18 (b, 2H), 2.11 (s, 3H). Remaining protons are (partially) obscured by water peak
1404[Figure (not displayed)]
MS (ESI) m/z = 674.4 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 68.75 (s, 1H), 8.75 (d, J = 4.7 Hz, 1H), 8.59 (s, 1H), 7.74 (dd, J = 8.1, 0.5 Hz, 1H), 7.69-7.64 (m, 2H), 7.43 (dd, J = 4.7, 0.3 Hz, 1H), 6.22 (tt, J = 55.7, 4.4 Hz, 1H), 4.81 (s, 2H), 3.85 (s, 3H), 3.71-3.67 (m, 4H), 2.84 (dt, J = 15.7, 4.2 Hz, 2H), 2.78-2.72 (m, 4H), 2.06 (s, 3H)
1405[Figure (not displayed)]
MS (ESI) m/z = 722.5 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 68.82 (s, 1H), 8.74 (d, J = 4.7 Hz, 1H), 8.62 (s, 1H), 7.73 (d, J = 8.4 Hz, 1H), 7.67 (dd, J = 8.4, 2.2 Hz, 1H), 7.61 (dd, J = 2.2, 0.4, 1H), 7.43 (d, J = 4.7 Hz, 1H), 4.82 (s, 2H), 4.59-4.53 (m, 2H), 3.86 (s, 3H), 3.69-3.62 (m, 2H), 2.16 (s, 3H). Remaining protons appear as very broad signals and/or are partially obscured by water peak
1406[Figure (not displayed)]
MS (ESI) m/z = 714.5 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 6 10.38-10.18 (b, 1H), 8.76 (d, J = 4.7 Hz, 1H), 8.75 (s, 1H), 8.66 (s, 1H), 7.78-7.66 (m, 3H), 7.55 (d, J = 4.7 Hz, 1H), 6.59 (t, J = 52.6 Hz, 1H), 4.82 (s, 2H), 4.78- 4.68 (m, 1H), 4.24-4.14 (m, overlapping with water peak), 3.76-3.58 (m, overlapping with water peak), 3.12 (s, 3H), 2.47-2.37 (m, 2H), 2.37-2.26 (m, 2H), 2.21-2.13 (m, 2H), 2.10-2.01 (m, 2H)
1407[Figure (not displayed)]
MS (ESI) m/z = 686.1 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 68.79 (b, 1H), 8.77 (d, J = 4.7 Hz, 1H), 8.67 (s, 1H), 7.79-7.74 (m, 1H), 7.71- 7.67 (m, 2H), 7.54 (d, J = 4.7 Hz, 1H), 6.58- 5.69 (b, 1H), 4.84 (s, 2H), 3.33 (t, J = 6.6 Hz, 1H), 3.28 (s, 3H), 2.08 (s, 3H). Remaining protons appear as broad signals and/or are (partially) obscured by water peak
1408[Figure (not displayed)]
MS (ESI) m/z = 819.2 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 6 12.98 (bs, 1H), 10.80-10.54 (b, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.79 (s, 1H), 8.75 (s, 1H), 7.77 (dd, J = 8.3, 0.5 Hz, 1H), 7.72-7.66 (m, 2H), 7.63 (d, J = 4.8 Hz, 1H), 6.40 (tt, J = 53.6, 2.8 Hz, 1H), 5.27-5.17 (m, 1H), 5.00-4.90 (m, 4H), 4.82 (s, 2H), 4.12 (bs, 2H), 3.99-3.85 (m, 2H), 3.76-3.55 (m, 4H), 2.11-1.93 (m, 4H), 1.96 (s, 3H)
1409[Figure (not displayed)]
MS (ESI) m/z = 840.5 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 6 13.15-12.95 (b, 1H), 10.75- 10.55 (b, 1H), 9.26 (dd, J = 2.4, 0.7 Hz, 1H), 8.89 (dd, J = 4.8, 1.6 Hz, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.52 (ddd, J = 8.1, 2.4, 1.6 Hz, 1H), 8.46 (s, 1H), 7.74-7.64 (m, 3H), 7.62 (dd, J = 2.2, 0.5 Hz, 1H), 7.59 (d, J = 4.8 Hz, 1H), 6.37 (tt, J = 53.7, 3.1 Hz, 1H), 4.77 (s, 2H), 4.10 (bs, 4H), 3.97-3.82 (m, 2H), 3.72- 3.50 (m, 4H), 2.07-1.94 (m, 4H), 1.87 (s, 3H)
1410[Figure (not displayed)]
MS (ESI) m/z = 791.4 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 6 12.44 (s, 1H), 10.60-10.50 (b, 1H), 8.80 (s, 1H), 8.80 (d, J = 4.8 Hz, 1H), 8.78 (s, 1H), 7.77 (dd, J = 8.3, 0.5 Hz, 1H), 7.70 (dd, J = 8.3, 2.1 Hz, 1H), 7.67 (dd, J = 2.1, 0.5 Hz, 1H), 7.62 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.27-3.90 (m, 6H), 3.79-3.56 (m, 4H expected; partially obscured by water peak), 3.55 (s, 3H expected; partially obscured by water peak), 2.12-1.95 (m, 4H), 2.00 (s, 3H), 1.73 (t, J = 19 Hz, 3H)
1411[Figure (not displayed)]
MS (ESI) m/z = 833.3 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) 6 12.65 (bs, 1H), 10.59 (bs, 1H), 8.78 (d, J = 4.8 Hz, 1H), 8.75 (s, 1H), 8.71 (s, 1H), 7.74 (dd, J = 8.3, 0.5 Hz, 1H), 7.67 (dd, J = 8.3, 2.1, 1H), 7.64 (dd, J = 2.1, 0.5 Hz, 1H), 7.59 (d, J = 4.8 Hz, 1H), 5.24-5.15 (m, 1H), 4.98-4.85 (m, 4H), 4.79 (s, 2H), 4.21-3.87 (m, 4H), 3.74-3.54 (m, 4H), 2.10-1.91 (m, 4H), 1.92 (s, 3H), 1.70 (t, J = 19.3 Hz, 3H)
1412[Figure (not displayed)]
MS (ESI) m/z = 854.4 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) d/ppm = 13.13-13.93 (b, 1H), 10.65-10.49 (b, 1H), 9.26 (dd, J = 2.4, 0.8 Hz, 1H), 8.89 (dd, J = 4.9, 1.6 Hz, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.52 (ddd, J = 8.1, 2.4, 1.6 Hz, 1H), 8.46 (s, 1H), 7.73 (dd, J = 8.4, 0.4 Hz, 1H), 7.69 (ddd, J = 8.1, 3.3, 0.8 Hz, 1H), 7.66 (dd, J = 8.4, 2.2 Hz, 1H), 7.62 (dd, J = 2.2, 0.4 Hz, 1H), 7.59 (d, J = 4.8 Hz, 1H), 4.77 (s, 2H), 4.24-3.90 (m, 6H expected, overlapping with water peak), 3.71-3.51 (m, 4H), 2.08-1.93 (m, 4H), 1.87 (s, 3H), 1.70 (t, J = 19.4 Hz, 3H)
1413[Figure (not displayed)]
MS (ESI) m/z 702.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.61 (s, 1H), 8.81-8.72 (m, 2H), 8.64 (s, 1H), 7.79-7.72 (m, 1H), 7.71 −7.64 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.32-3.89 (m, 6H), 3.64 (m, 4H), 2.07 (d, J = 1.6 Hz, 6H), 2.00 (s, 3H), 1.74 (t, J = 19.6 Hz, 3H)
1414[Figure (not displayed)]
LCMS (ESI) m/z 702.5 [M + 1]+
1415[Figure (not displayed)]
MS (ESI) m/z 629.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.23 (d, J = 22.2 Hz, 1H), 8.78 (m, 1H), 8.44 (d, J = 17.1 Hz, 1H), 8.11 (d, J = 57.3 Hz, 1H), 7.57 (m, 1H), 7.48-7.40 (m, 2H), 7.34 (dd, J = 12.2, 9.0 Hz, 1H), 4.39 (m, 2H), 4.26 (d, J = 5.4 Hz, 2H), 3.47-3.31 (m, 2H), 3.25 (dd, J = 13.1, 9.7 Hz, 1H), 2.29 (m, 1H), 2.22-2.11 (m, 1H), 2.11-2.01 (m, 1H), 1.99 (d, J = 2.0 Hz, 3H), 1.82 (d, J = 14.3 Hz, 1H), 1.46 (s, 1H), 1.26 (s, 3H)
1418[Figure (not displayed)]
MS (ESI) m/z 644.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.86 (s, 1H), 8.71 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.40 (s, 1H), 7.39 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.1 Hz, 2H), 4.31-4.22 (m, 4H), 3.62 (d, J = 12.1 Hz, 2H), 3.40 (t, J = 13.0 Hz, 2H), 3.20 (q, J = 11.4 Hz, 2H), 2.90 (s, 3H), 2.70 (s, 3H), 2.53 (s, 3H), 2.00 (s, 3H)
1419[Figure (not displayed)]
MS (ESI) m/z 588.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.90 (s, 1H), 8.63 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.41 (s, 1H), 7.36 (d, J = 9.0 Hz, 1H), 6.33 (q, J = 1.6 Hz, 1H), 5.97 (q, J = 1.9 Hz, 1H), 4.54-4.48 (m, 2H), 4.42 (t, J = 5.0 Hz, 2H), 4.28 (t, J = 5.1 Hz, 2H), 2.67 (s, 3H), 1.99 (s, 3H)
1421[Figure (not displayed)]
MS (ESI) m/z 619.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.17 (bs, 1H), 7.92 (bs, 1H), 7.52 (d, J = 5.2 Hz, 1H), 7.34-7.27 (m, 2H), 7.14 (bs, 1H), 4.35 (bs, 2H), 4.26 (bs, 2H), 4.04-3.97 (m, 2H), 3.74-3.67 (m, 2H), 2.34 (s, 3H), 1.82 (s, 3H), 1.78 (s, 3H)
1422[Figure (not displayed)]
MS (ESI) m/z 676.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.23 (bs, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 8.45 (s, 1H), 7.59- 7.57 (m, 1H), 7.45 (d, J = 4.80, 1H), 7.42 (d, J = 2.0 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.38 (s, 2H), 4.20 (s, 2H), 3.65 (s, 4H), 2.67 (s, 4H), 2.60-2.48 (m, 2H), 1.74 (s, 3H), 1.35 (J = 21.6 Hz, 6H)
1423[Figure (not displayed)]
MS (ESI) m/z 660.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.05 (bs, 1H), 8.79 (s, 1H), 8.75 (d, J = 4.64 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.12 Hz, 1H), 7.68 (m, 2H), 7.53 (d, J = 4.64 Hz, 1H), 6.34 (m, 1H), 4.82 (s, 2H), 3.76- 2.66 (m, 10H), 2.09 (s, 1H)
1424[Figure (not displayed)]
MS (ESI) m/z 662.41 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.42 (s, 1H), 7.61 (dd, J = 8.8 Hz, 2.8 Hz, 1H), 7.47 (d, J = 4.4 Hz, 1H), 7.41 (d, J = 2.8 Hz, 1H), 7.37 (d, J = 9.2 Hz, 1H), 4.96- 4.67 (m, 2H), 4.40-4.21 (m, 5H), 3.57-3.36 (m, 8H), 1.84 (s, 3H), 1.37 (d, J = 6.0 Hz, 3H)
1425[Figure (not displayed)]
MS (ESI) m/z 688.50 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz,1H), 8.67 (s, 1H), 8.44 (s, 1H), 7.60 (dd, J = 2.8, 8.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.41 (d, J = 2.8 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 4.58-4.48 (m, 1H), 4.44-4.41 (m, 2H), 4.39-4.36 (m, 2H), 3.56-3.53 (m, 4H), 3.30-3.28 (m, 1H), 3.17-2.95 (m, 4H), 2.22-2.19 (m, 2H), 1.84 (s, 3H), 1.14- 0.77 (m, 4H)
1427[Figure (not displayed)]
MS (ESI) m/z 697.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.01 (s, 1H), 8.82 (d, J = 4.4 Hz, 1H), 8.41 (s, 1H), 7.59 (dd, J = 8.8, 2.8 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.39 (t, J = 4.4 Hz, 2H), 4.24 (t, J = 4.4 Hz, 2H), 3.81-3.75 (m, 1H), 3.31 (bs, 3H), 2.45 (s, 3H), 2.32-2.23 (m, 1H), 2.11-1.93 (m, 3H), 1.92-1.66 (m, 5H)
1428[Figure (not displayed)]
MS (ESI) m/z 702.53 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.59 (s, 1H), 8.42 (s, 1H), 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.8 Hz, 1H) 7.36 (d, J = 9.2 Hz, 1H), 4.52 (s, 2H), 4.37-4.40 (m, 2H), 4.23-4.26 (m, 1H), 4.18-4.21 (m, 2H), 3.03 (s, 3H), 2.94-2.97 (m, 2H), 2.66-2.72 (m, 2H), 1.71-1.75 (m, 7H), 0.64-0.68 (m, 4H)
1426[Figure (not displayed)]
MS (ESI) m/z 724.56 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.66 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 2.4, 8.8 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.41 (d, J = 2.8 Hz, 1H), 7.35 (d, J = 9.2 Hz, 1H), 4.74 (s, 1H), 4.63 (s, 1H), 4.39 (t, J = 4.4 Hz, 2H), 4.21 (t, J = 4.4 Hz, 2H), 3.69 (bs, 4H), 2.88 (bs, 4H), 2.72 (bs, 4H), 1.7(s, 3H)
1430[Figure (not displayed)]
MS (ESI) m/z 720.50 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.8 Hz, 1H), 8.59 (s, 1H), 8.44 (s, 1H), 7.60 (dd, J = 2.4, 6.4 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.8 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 6.08 (t, J = 55.6 Hz, 1H), 4.38 (d, J = 4.4 Hz, 2H), 4.25 (bs, 1H), 4.19 (bs, 2H), 3.08 (bs, 2H), 3.03 (s, 3H), 2.92 (bs, 2H), 1.77 (bs, 7H), 0.48-0.78 (m, 4H)
1431[Figure (not displayed)]
MS (ESI) m/z 722.55 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.39 (s, 1H) 7.61 (dd, J = 2.4, 9.2 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42-7.35 (m, 2H), 6.52 (t, J = 52 Hz, 1H), 4.62-4.56 (m, 1H), 4.39 (bs, 2H), 4.21 (bs, 2H,), 3.38-3.34 (m, 4H), 3.09 (s, 3H), 2.32-2.26 (m, 2H), 2.12-2.09 (m, 2H), 1.76 (s, 3H), 1.44 (s, 6H)
1429[Figure (not displayed)]
MS (ESI) m/z 704.54 [M − F1]; 1H NMR (400 MHz, DMSO-d6) 613.2 (bs, 1H), 9.11 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.38 (s, 1H), 7.60 (dd, J = 2.8, 8.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.8 Hz, 1H) 7.36 (d, J = 8.8 Hz, 1H), 4.74-4.62 (d, J = 46.8 Hz, 2H), 4.60-4.57 (m, 1H), 4.39 (bs, 2H), 4.21 (bs, 2H), 3.66-3.58 (m, 2H), 3.30-3.24 (m, 2H), 3.09 (s, 3H), 2.26-2.20 (m, 2H), 2.11-2.08 (m, 2H), 1.76 (s, 3H), 1.38 (s, 6H)
1433[Figure (not displayed)]
MS (ESI) m/z 708.50 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.2 Hz, 1H), 8.65 (s, 1H), 8.41 (s, 1H), 7.59 (d, J = 8.6 Hz, 1H), 7.47-7.43 (m, 2H), 7.35 (d, J = 8.8 Hz, 1H), 6.51 (t, J = 53.4 Hz, 1H), 4.38 (s, 4H), 4.21 (s, 2H), 3.07 (bs, 5H), 2.52 (s, 2H), 2.17 (bs, 2H), 2.02 (bs, 2H), 1.75 (s, 3H), 1.11 (t, J = 6.3 Hz, 3H)
1434[Figure (not displayed)]
MS (ESI) m/z 667.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.32 (bs, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.60 (s, 1H), 8.46 (s, 1H), 7.60 (dd, J = 9.2, 2.8 Hz, 1H), 7.44 (dd, J = 15.6 Hz, 2H), 7.35 (d, J = 9.2 Hz, 1H), 4.59 (s, 2H), 4.53 (s, 2H), 4.38 (bs, 4H), 4.24- 4.20 (m, 4H), 3.91- 3.88 (m, 1H), 2.17 (bs, 2H), 2.01 (t, J = 9.6 Hz, 2H), 1.82 (s, 3H), 1.78-1.71 (m, 2H)
1432[Figure (not displayed)]
MS (ESI) m/z 708.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (dd, J = 4.8 Hz, 2 Hz, 1H), 8.61 (d, J = 2 Hz, 1H), 8.40 (s, 1H), 7.61 (d, J = 8.8 Hz, 1H), 7.46 (dd, J = 4.8 Hz, 2 Hz, 1H), 7.43 (d, J = 4.0 Hz, 1H), 7.36 (d, J = 7.2 Hz, 1H), 4.99 (bs, 4H), 4.58 (bs, 1H), 4.39 (s, 2H), 4.21 (s, 2H), 4.0 (bs, 2H), 3.70 (bs, 2H), 3.28 (bs, 1H), 3.09 (s, 3H), 2.33-2.00 (m, 4H), 1.76 (s, 3H)
1436[Figure (not displayed)]
MS (ESI) m/z 682.52 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.5 (bs, 1H), 9.66 (bs, 1H), 8.80 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 9.2, 2.8 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.65-4.45 (m, 8H), 4.40-4.35 (m, 2H), 4.25-4.15 (m, 2H), 2.91 (bs, 1H), 1.80 (s, 3H), 1.17 (s, 3H), 1.06 (s, 3H), 0.85-0.55 (m, 2H)
1437[Figure (not displayed)]
MS (ESI) m/z 667.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.32 (bs, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.60 (s, 1H), 8.46 (s, 1H), 7.60 (dd, J = 9.2, 2.8 Hz, 1H), 7.44 (dd, J = 15.6 Hz, 2H), 7.35 (d, J = 9.2 Hz, 1H), 4.59 (s, 2H), 4.53 (s, 2H), 4.38 (bs, 4H), 4.24- 4.20 (m, 4H), 3.91- 3.88 (m, 1H), 2.17 (bs, 2H), 2.01 (t, J = 9.6 Hz, 2H), 1.82 (s, 3H), 1.78-1.71 (m, 2H)
1435[Figure (not displayed)]
MS (ESI) m/z 718.48 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 9.2, 2.8 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.78-4.59 (m, 4H), 4.40-4.30 (m, 6H), 4.23-4.18 (m, 2H), 3.35-3.15 (m, 2H), 2.80-2.65 (m, 2H), 1.80 (s, 3H), 1.47 (s, 3H)
1439[Figure (not displayed)]
MS (ESI) m/z 692.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.67 (s, 1H), 8.44 (s, 1H), 7.59 (dd, J = 8.8, 2.4 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 6.54 (t, J = 54.8 Hz, 1H), 4.38 (d, J = 4.8 Hz, 2H), 4.22 (d, J = 4.8 Hz, 2H), 4.10 (d, J = 12 Hz, 1H), 3.93 (d, J = 12.4 Hz, 1H), 3.41-3.32 (m, 2H), 3.16-3.13 (m, 3H), 2.02 (bs, 1H),1.76 (s, 3H), 0.53-0.41 (m, 4H)
1440[Figure (not displayed)]
MS (ESI) m/z 693.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.03 (s, 1H), 8.84 (d, J = 4.8 Hz, 1H), 8.33 (s, 1H), 7.65-7.58 (m, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 6.40 (t, J = 62.4 Hz, 1H), 4.41 (s, 2H), 4.28 (d, J = 5.2 Hz, 2H), 3.51-3.05 (m, 8H), 2.50 (bs, 2H), 1.82 (s, 3H), 1.77 (s, 1H)
1438[Figure (not displayed)]
MS (ESI) m/z 710.17 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.67 (s, 1H), 8.46 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.39 (d, J = 4.8 Hz, 2H), 4.29 (bs, 2H), 3.96 (dd, J = 14, 5.2 Hz, 1H), 3.87 (bs, 2H), 3.71 (bs, 1H), 3.59 (t, J = 9.2 Hz, 1H), 3.27 (bs, 1H), 2.90 (d, J = 12.8 Hz, 1H), 2.26 (bs, 1H), 1.76 (s, 3H), 0.58 (d, J = 6.4 Hz, 2H), 0.46 (s, 2H)
1443[Figure (not displayed)]
MS (ESI) m/z 656.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.07 (s, 1H), 8.75 (d, J = 4.8, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.8 Hz, 1H), 7.68 (d, J = 6.8 Hz, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.47 (d, J = 44 Hz, 2H), 3.66 (bs, 4H), 2.96 (bs, 1H), 2.74 (s, 3H), 2.07-2.08 (m, 4H), 1.23 (s, 3H)
1444[Figure (not displayed)]
MS (ESI) m/z 650.47 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.29 (bs, 1H), 8.83 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.70-7.65 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.46 (bs, 2H), 3.53 (bs, 6H), 2.14 (s, 3H), 1.39 (s, 3H), 1.20 (bs, 2H), 0.83 (bs, 2H)
1441[Figure (not displayed)]
MS (ESI) m/z 728.40 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.59 (s, 1H), 8.44 (s, 1H), 7.60-7.58 (dd, J = 2.4, 8.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.38 (bs, 2H), 4.25-4.19 (m, 3H), 3.35-3.30 (m, 2H), 3.07(s, 5H), 2.66-2.59 (m, 2H), 1.92 (d, J = 9.2 Hz, 2H), 1.78-1.72 (m, 5H)
1446[Figure (not displayed)]
MS (ESI) m/z 682.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.66 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.56-4.41 (m, 2H), 3.77-3.06 (m, 8H), 2.23 (s, 3H), 1.23-0.72 (m, 6H)
1447[Figure (not displayed)]
MS (ESI) m/z 664.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.99 (bs, 1H), 9.00 (bs, 1H), 8.83 (bs, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.64 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.37 (bs, 2H), 3.85-3.40 (m, 6H), 2.90-2.80 (m, 1H), 2.13 (s, 3H), 1.38 (s, 3H), 1.07 (s, 3H), 0.95-0.75 (m, 2H)
1445[Figure (not displayed)]
MS (ESI) m/z 668.45 [M + 1]+; 1; H NMR (400 MHz, DMSO-d6) δ 8.79 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.66 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.60 (d, J = 48.4 Hz, 2H), 3.80- 3.50 (m, 4H), 3.30-2.80 (m, 4H), 2.09 (s, 3H), 1.20-0.80 (m, 4H)
1449[Figure (not displayed)]
MS (ESI) m/z 688.47 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.72-4.54 (m, 2H), 4.32 (bs, 2H), 3.14-2.67 (m, 8H), 2.10 (s, 3H), 1.48-1.45 (m, 3H)
1450[Figure (not displayed)]
MS (ESI) m/z 668.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.74 (bs, 1H), 8.46 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.69-7.66 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 5.74 (d, J = 34.0 Hz, 2H), 5.10 (s, 1H), 4.98 (s, 1H), 4.83 (s, 2H), 4.40 (d, J = 20.8 Hz, 2H), 3.96 (bs, 2H), 3.65 (m, 2H), 3.54 (m, 2H), 3.29 (bs, 2H), 2.14 (s, 3H)
1448[Figure (not displayed)]
MS (ESI) m/z 674.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (s, 1H), 8.75 (d, J = 4.4 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.69-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.91-4.83 (m, 6H), 4.12 (bs, 1H), 3.79 (bs, 4H), 3.27 (bs, 4H), 2.10 (s, 3H)
1452[Figure (not displayed)]
MS (ESI) m/z 670.50 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.76 (bs, 1H), 8.84 (s, 1H), 8.76 (d, J = 4.4 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.66 (m, 2H), 7.54 (d, J = 4.8 Hz, 2H), 4.83 (s, 2H), 4.72 (d, J = 46.8 Hz, 2H), 4.46 (d, J = 14.0 Hz, 2H), 3.85-3.50 (m, 4H), 3.40-3.30 (m, 2H), 2.15 (s, 3H), 1.40 (s, 6H)
1453[Figure (not displayed)]
MS (ESI) m/z 670.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.78 (bs, 1H), 8.83 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.71-7.64 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.32 (bs, 2H), 3.85- 3.30 (m, 8H), 2.13 (s, 3H), 1.50 (d, J = 21.2 Hz, 6H)
1451[Figure (not displayed)]
MS (ESI) m/z 664.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.66 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.36 (m, 2H), 3.71-3.57 (m, 4H), 3.30-3.18 (m, 4H), 2.15 (s, 3H), 2.21 (s, 3H), 0.60-0.51 (m, 4H)
1455[Figure (not displayed)]
MS (ESI) m/z 688.32 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.80 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.66 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69-7.67 (m, 2H), 7.54 (d, J = 4.8, 1H), 6.45- 6.14 (m, 1H), 4.82 (s, 2H), 3.98-3.69 (m, 4H), 3.17 (m, 4H), 2.11 (s, 3H), 1.29 (s, 6H)
1456[Figure (not displayed)]
MS (ESI) m/z 674.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.16 (bs, 1H), 8.84 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.67 (t, J = 8.4 Hz, 2H), 7.53 (d, J = 4.8 Hz, 1H), 6.26 (t, J = 56 Hz, 1H), 4.83 (s, 2H), 4.36 (bs, 2H), 3.73 (bs, 2H), 3.37 (bs, 6H), 2.40 (bs, 2H), 2.13 (s, 3H)
1454[Figure (not displayed)]
MS (ESI) m/z 684.48 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8 Hz, 1H), 7.70-7.66 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.74-4.60 (m, 2H), 4.47 (d, J = 13.6 Hz, 2H), 3.75 (d, J = 11.2 Hz, 2H), 3.60- 3.53 (m, 2H), 3.31-3.28 (m, 2H), 2.21-2.15 (m, 5H) 1.42 (s, 6H)
1458[Figure (not displayed)]
MS (ESI) m/z 706.49 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.96 (bs, 1H), 8.84 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.69 (dd, J = 8.4, 2.0 Hz, 1H), 7.65 (d, J = 2.0 Hz, 1H), 7.53 (d, J = 4.8 Hz, 1H), 4.84 (s, 2H), 4.40-4.36 (m, 2H), 3.74-3.72 (m, 2H), 3.29 (bs, 6H), 2.45-2.38 (m, 2H), 2.14 (s, 3H), 1.98-1.93 (m, 2H)
1459[Figure (not displayed)]
MS (ESI) m/z 642.17 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.85 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.69 (dd, J = 8.4 Hz, 2.0 Hz, 1H), 7.65 (s, 1H), 7.53 (d, J = 4.8 Hz, 1H), 5.12-4.93 (m, 2H), 4.84 (s, 2H), 4.44 (dd, J = 42.4 Hz, 14.4 Hz, 1H), 3.54-3.51 (m, 4H), 3.00 (s, 3H), 2.50-2.43 (m, 1H), 2.14 (s, 3H)
1457[Figure (not displayed)]
MS (ESI) m/z 656.39 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (s, 2H), 8.75 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.65 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.65-4.50 (m, 2H), 4.38 (d, J = 13.6 Hz, 2H), 3.46 (bs, 4H), 3.32 (bs, 4H), 2.19-2.06 (m, 5H)
1461[Figure (not displayed)]
MS (ESI) m/z 633.40 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.05 (bs, 1H), 9.51 (bs, 1H), 9.12 (s, 1H), 8.74 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 7.76 (d, J = 9.1 Hz, 1H), 7.81-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.56 (s, 1H), 4.87 (s, 2H), 4.30-4.10 (m, 2H), 3.80 (bs, 1H), 3.01 (bs, 4H), 2.19 (s, 3H), 1.10-0.84 (m, 4H)
1462[Figure (not displayed)]
MS (ESI) m/z 639.37 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.07 (bs, 1H), 10.26 (bs, 1H), 9.12 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 7.76 (d, J = 8.8 Hz, 1H), 7.71-7.66 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.57 (s, 1H), 5.00-4.85 (m, 4H), 4.29-3.95 (m, 2H), 3.90-3.80 (m, 2H), 3.60-3.45 (m, 2H), 3.10-2.90 (m, 2H), 2.18 (s, 3H)
1460[Figure (not displayed)]
MS (ESI) m/z 708.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.85 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.70-7.66 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.84 (s, 2H), 4.66-4.36 (m, 5H), 3.91-3.78 (m, 4H), 2.95 (bs, 3H), 2.13 (s, 3H)
1464[Figure (not displayed)]
MS (ESI) m/z 690.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.04 (bs, 1H), 8.81-8.75 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.68 (d, J = 10.0 Hz, 1H), 7.53 (d, J = 4.4 Hz, 1H), 4.83 (s, 2H), 4.36-4.02 (m, 4H), 3.69-3.59 (m, 4H), 3.36-2.9 (m, 4H), 2.11 (s, 3H)
1465[Figure (not displayed)]
MS (ESI) m/z 680.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (s,1H), 8.76 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.49-4.43 (m, 2H), 3.76-3.46 (m, 8H), 3.26 (s, 3H), 2.49 (s, 1H), 2.12 (s, 3H), 1.25 (bs, 2H), 0.97 (bs, 2H)
1463[Figure (not displayed)]
MS (ESI) m/z 657.40 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.10 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.62 (s, 1H), 7.76 (d, J = 9.2 Hz, 1H), 7.70-7.68 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 6.62-6.34 (m, 2H), 4.86 (s, 2H), 3.41-3.24 (m, 4H), 3.15-2.95 (m, 2H), 2.87 (bs, 2H), 2.16 (s, 3H)
1467[Figure (not displayed)]
MS (ESI) m/z 686.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77-8.74 (m, 2H), 8.64 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.69-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.57-4.55 (m, 4H), 4.24 (d, 2H), 3.21-3.15 (m, 2H), 2.41 (s, 1H), 2.08-2.04 (m, 5H), 1.55 (s, 2H)
1468[Figure (not displayed)]
MS (ESI) m/z 661.37 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.02 (bs, 1H), 9.07 (s, 1H), 8.76 (s, 1H), 8.61 (s, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.69 (s, 2H), 7.53 (s, 1H), 4.87 (s, 2H), 3.90 (s, 2H), 3.50-3.30 (m, merged, 2H), 2.55 (s, 3H), 2.09 (s, 3H)
1466[Figure (not displayed)]
MS (ESI) m/z 674.47 [M + 1]+; 1; H NMR (400 MHz, DMSO-d6) δ 8.80 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69 (bs, 1H), 7.67 (s, 1H), 7.53 (d, J = 4.4 Hz, 1H), 6.31 (t, J = 53.2 Hz, 1H), 4.82 (s, 2H), 3.79 (bs, 4H), 3.11 (bs, 4H), 2.64-2.59 (m, 1H), 2.09 (s, 3H), 1.21 (bs, 3H)
1470[Figure (not displayed)]
MS (ESI) m/z 674.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.74 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.44 (s, 1H), 7.61- 7.58 (dd, J = 2.4, 8.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.41 (d, J = 2.4 Hz, 1H), 7.38 (d, J = 8.8 Hz, 1H), 5.73 (d, J = 30.4 Hz, 2H), 5.09 (s, 1H), 4.98 (s, 1H), 4.40 (d, J = 4.8 Hz, 2H), 4.31 (bs, 2H), 4.24 (d, J = 4.8 Hz, 2H), 3.96 (bs, 2H), 3.63 (m, 2H), 3.32-3.18 (m, 4H), 1.84 (s, 3H)
1471[Figure (not displayed)]
MS (ESI) m/z 724.09 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.45 (s, 1H), 7.60 (dd, J = 2.4, 8.8 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.41 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.39 (s, 2H), 4.32-4.23 (m, 4H), 3.28-2.86 (m, 4H), 1.83 (s, 3H), 1.30-1.21 (m, 4H)
1469[Figure (not displayed)]
MS (ESI) m/z 704.21 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.9 Hz, 1H), 8.70 (s, 1H), 8.40 (s, 1H), 7.55 (dd, J = 2.4, 8.8 Hz, 1H), 7.50 (d, J = 4.9 Hz, 1H), 7.31 (d, J = 2.8 Hz, 2H), 4.46 (t, J = 4.9 Hz, 2H), 4.34 (t, J = 4.9 Hz, 2H), 4.10 (bs, 4H), 3.72 (bs, 4H), 3.61 (s, 2H), 2.11 (s, 3H), 1.99-1.80 (m, 4H), 1.03 (t, J = 7.4 Hz, 6H)
1473[Figure (not displayed)]
MS (ESI) m/z 698.22 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.69 (bs, 1H), 8.45 (s, 1H), 7.59 (dd, J = 2.4, 9.2 Hz, 1H), 7.45 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 4.39 (s, 2H), 4.22 (s, 4H), 3.54 (bs, 6H), 1.98-1.64 (m, 2H), 1.18 (d, J = 7.2 Hz, 2H), 1.10-1.05 (m, 12H)
1474[Figure (not displayed)]
MS (ESI) m/z 700.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 5.2 Hz, 1H), 8.60 (s, 1H), 8.43 (s, 1H), 7.59-7.57 (dd, J = 2.4, 10.8 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.39 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 9.2 Hz, 1H), 4.36 (s, 2H), 4.19 (s, 2H), 3.65 (m, 4H), 4.44- 3.38 (m, 2H), 2.87 (bs, 4H), 1.77 (s, 3H)
1472[Figure (not displayed)]
MS (ESI) m/z 726.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.66 (bs, 1H), 8.45 (s, 1H), 7.59 (dd, J = 2.4, 9.2 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 4.38 (s, 2H), 4.21 (s, 2H), 3.75 (bs, 8H), 2.71 (s, 2H), 1.76 (s, 3H), 1.15 (s, 6H)
1476[Figure (not displayed)]
MS (ESI) m/z 710.49 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.90 (bs, 1H), 8.81 (d, J = 5.2 Hz, 1H), 8.61 (s, H), 8.47 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.63 (s, 2H), 4.59-4.47 (m, 6H), 4.38 (t, J = 4.4 Hz, 2H), 4.21 (d, J = 4.8 Hz, 2H), 2.70 (s, 1H), 1.81 (s, 3H), 1.09 (s, 6H), 1.07 (s, 6H)
1477[Figure (not displayed)]
MS (ESI) m/z 720.50 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.35 (bs, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.40 (s, 1H), 7.59 (dd, J = 2.40, 8.8 Hz, 1H), 7.47 (d, J = 4.4 Hz, 1H), 7.42 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.53 (bs, 1H), 4.39 (bs, 2H), 4.21 (bs, 2H), 3.74 (bs, 1H), 3.58 (bs, 2H), 3.09 (bs, 9H), 2.10 (bs, 4H), 1.77 (s, 3H)
1475[Figure (not displayed)]
MS (ESI) m/z 704.47 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (d, J = 4.8 Hz, 1H), 8.60 (s, 1H), 8.47 (s, 1H), 7.59 (dd, J = 9.2, 2.8 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 9.2 Hz, 1H), 4.53 (bs, 4H),4.45-4.35 (m, 2H), 4.25-4.15 (m, 2H), 3.60- 3.45 (m, 1H), 3.20-2.70 (m, 4H), 2.60-2.40 (m, merged, 4H), 1.81 (s, 3H)
1479[Figure (not displayed)]
MS (ESI) m/z 663.41 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.37 (s, 1H), 7.60 (d, J = 8.4 Hz, 1H), 7.47 (d, J = 4.4 Hz, 1H), 7.42 (bs, 1H), 7.36 (d, J = 8.8 Hz, 1H), 5.47 (d, J = 48.4 Hz, 1H), 4.93 (bs, 1H), 4.82 (bs, 1H), 4.39 (bs, 2H), 4.24 (bs, 2H), 3.68 (bs, 4H), 3.37-3.27 (m, 4H), 2.29-2.10 (m, 1H), 2.01-1.98 (m, 1H), 1.82-1.77 (m, 3H)
1480[Figure (not displayed)]
MS (ESI) m/z 691.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.00 (s, 1H), 8.84 (d, J = 4.8 Hz, 1H), 8.39 (s, 1H), 7.61-7.58 (dd, J = 2.8, 8.8 Hz, 1H), 7.48-7.45 (dd, J = 10.8, 8.8 Hz, 2H), 7.37 (d, J = 9.2 Hz, 1H), 6.46 (m, 1H), 4.40 (t, 2H), 4.25 (bs, 2H), 3.07-2.97 (m, 8H), 2.22 (m, 2H), 2.06 (s, 3H), 1.79 (s, 3H)
1478[Figure (not displayed)]
MS (ESI) m/z 692.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (d, J = 4.8 Hz, 1H), 8.62 (s, 1H), 8.47 (s, 1H), 7.60 (dd, J = 9.2, 2.8 Hz, 1H), 7.45 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 6.41 (t, J = 53.6 Hz, 1H), 4.38-4.37 (m, 2H), 4.21 (s, 2H), 3.91 (bs, 6H), 3.17 (s, 4H), 3.03-2.81 (m, 2H), 1.79 (s, 3H)
1482[Figure (not displayed)]
MS (ESI) m/z 628.33 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.04 (bs, 1H), 9.07 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 7.77 (d, J = 9.2 Hz, 1H), 7.69 (t, J = 3.2 Hz, 1H), 7.54 (d, J = 4.4 Hz, 1H), 6.33 (s, 1H), 4.86 (s, 2H), 2.89-2.84 (m, 4H), 2.29-2.22 (m, 2H), 2.14 (s, 3H)
1483[Figure (not displayed)]
MS (ESI) m/z 753.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.65 (s, 1H), 9.87 (bs, 1H), 8.90 (d, J = 4.8 Hz, 1H), 8.76 (s, H), 8.55 (s, 1H), 7.63 (dd, J = 8.8, 2.4 Hz, 1H), 7.57 (d, J = 4.8 Hz, 1H), 7.44-7.37 (m, 2H), 4.73 (d, J = 46.0 Hz, 2H), 4.50-4.35 (m, 4H), 4.23 (s, 2H), 3.80-3.50 (m, 7H), 3.45-3.22 (m, 2H), 1.85 (s, 3H), 1.42 (s, 6H)
1481[Figure (not displayed)]
MS (ESI) m/z 630.38 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.11 (s, 1H), 8.57 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 7.77-7.75 (m, 1H), 7.69 (dd, J = 2.0, 6.8 Hz, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.86 (s, 2H), 2.53 (s, 1H), 2.17-2.15 (m, 3H), 2.08-2.06 (m, 2H), 2.01 (d, J = 5.6 Hz, 6H)
1485[Figure (not displayed)]
MS (ESI) m/z 639.38 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.96 (s, 1H), 8.82 (d, J = 4.4 Hz, 1H), 8.34 (s, 1H), 7.60 (dd, J = 9.2, 2.8 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 9.2, 1H), 6.36 (t, J = 49.2 Hz, 1H), 4.40 (t, J = 4.8 Hz, 2H), 4.27-4.26 (m, 2H), 3.43 (bs, 4H), 2.73 (bs, 2H), 1.82 (s, 3H)
1486[Figure (not displayed)]
MS (ESI) m/z 769.56 [M + 1]+
1484[Figure (not displayed)]
MS (ESI) m/z 679.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.85 (bs, 1H), 8.96 (s, 1H), 8.82 (d, J = 4.8 Hz ,1H), 8.33 (s, 1H), 7.60 (dd, J = 2.4, 8.8 Hz, 2H), 7.47-7.43 (m, 1H), 7.36 (d, J = 8.8 Hz ,1H), 6.66-6.39 (m, 1H), 4.39 (t, J = 4.4 Hz ,2H), 4.25 (bs, 2H), 3.66-3.51 (m, 4H), 3.05 (d, J = 5.6 Hz, 4H), 2.19 (bs, 1H), 1.80 (s, 6H), 1.63-1.60 (m, 2H)
1488[Figure (not displayed)]
MS (ESI) m/z 719.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.45 (s, 1H), 10.12 (bs, 1H), 8.89 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.79 (s, 1H), 7.77 (d, J = 8.4 Hz, 1H), 7.72-7.69 (m, 1H), 7.66 (d, J = 1.6 Hz, 1H), 7.62 (d, J = 4.8 Hz, 1H), 5.00-4.80 (m, 2H), 4.35 (bs, 2H), 3.82- 3.60 (m, 4H), 3.55 (s, 3H), 3.50-3.22 (m, 4H), 2.03 (s, 3H)
1489[Figure (not displayed)]
MS (ESI) m/z 698.22 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.80 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.68 (d, J = 9.2 Hz, 2H), 7.53 (d, J = 4.4 Hz, 1H), 4.83 (s, 2H), 3.59 (bs, 2H), 3.09 (bs, 8H), 5.19 (s, 5H), 1.82 (bs, 1H)
1487[Figure (not displayed)]
MS (ESI) m/z 737.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.44 (bs, 1H), 8.84-8.80 (m, 3H), 7.77 (d, J = 8.4 Hz, 1H), 7.71-7.66 (m, 2H), 7.61 (d, J = 4.8 Hz, 1H), 6.32 (t, J = 52.0 Hz, 1H), 4.83 (s, 2H), 3.75 (bs, 4H), 3.56 (bs, 3H), 2.95 (bs, 6H), 2.01 (s, 3H)
1491[Figure (not displayed)]
MS (ESI) m/z 680.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) d 8.76 (d, J = 4.8 Hz, 1H), 8.68 (d, J = 8.8 Hz, 2H), 7.75 (d, J = 8.8 Hz, 1H), 7.68 (d, J = 6.4 Hz, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.81 (s, 2H), 3.82 (t, J = 6.8 Hz, 2H), 3.33-3.25 (m, 5H), 2.92 (t, J = 6.8 Hz, 2H), 2.45 (s, 3H), 2.04 (s, 3H)
1492[Figure (not displayed)]
MS (ESI) m/z 633.31 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.11 (s, 1H), 8.73 (d, J = 4.8 Hz 1H), 8.59 (s, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 6.40 (t, J = 50.8 Hz, 1H), 4.87 (s, 2H), 3.49 (bs, 4H), 3.12-2.77 (m, 5H), 2.17 (s, 3H)
1490[Figure (not displayed)]
MS (ESI) m/z 700.41 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.35 (s, 1H), 8.78 (s, 1H), 8.75 (d, J = 4.4 Hz, 1H), 8.64 (s, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.69 (d, J = 9.6 Hz, 2H), 7.54 (d, J = 4.8 Hz, 1H), 6.39 (bs, 1H), 4.83 (s, 2H), 4.37-4.08 (m, 4H), 3.87 (bs, 4H), 3.26 (bs, 2H), 2.18 (bs, 4H), 2.10 (s, 3H)
1494[Figure (not displayed)]
MS (ESI) m/z 689.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.8 Hz, 1H), 8.73 (s, 1H), 8.66 (s, 1H), 7.76 (d, J = 9.2 Hz, 1H), 7.69-7.68 (m, 2H), 7.55 (d, J = 4.4 Hz, 1H), 4.82 (s, 2H), 4.30 (s, 1H), 3.06-3.01 (m, 7H), 2.06 (s, 3H), 1.86-1.83 (m, 4H), 1.25 (dd, J = 8.0 Hz, 5.6 Hz, 2H), 1.05 (dd, J = 7.2, 4.8 Hz, 2H)
1495[Figure (not displayed)]
MS (ESI) m/z 638.41 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79-8.74 (m, 2H), 8.65 (s, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.70-7.68 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.54-4.53 (m, 1H), 3.58-3.55 (m, 2H), 3.20 (bs, 2H), 3.01 (s, 3H), 2.83-2.82 (m, 3H), 2.10 (bs, 7H)
1493[Figure (not displayed)]
MS (ESI) m/z 700.47 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.70-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.43-3.90 (m, 4H), 3.22-2.87 (m, 8H), 2.13 (s, 3H), 1.46 (s, 3H)
1497[Figure (not displayed)]
MS (ESI) m/z 694.46 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.69 (d, J = 6.8 Hz, 1H), 7.76-7.43 (m, 1H), 7.68 (dd, J = 2.0, 4.0 Hz, 1H), 7.54 (d, J = 4.8 Hz, 1H), 4.81 (s, 2H), 3.73-3.70 (m, 2H), 3.27 (bs, 5H), 2.68-2.64 (m, 2H), 2.41 (s, 3H), 2.05 (s, 3H), 1.90 (t, J = 13.6 Hz, 2H)
1498[Figure (not displayed)]
MS (ESI) m/z 595.39 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.11 (bs, 1H), 9.73 (bs, 1H), 9.14 (s, 1H), 8.73 (d, J = 4.8 Hz, 1H), 8.60 (s, 1H), 7.76 (d, J = 9.2 Hz, 1H), 7.71-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 7.39 (d, J = 15.2 Hz, 1H), 7.20-7.10 (m, 1H), 4.88 (s, 2H), 4.16- 4.08 (m, 2H), 2.87 (s, 6H), 2.15 (s, 3H)
1496[Figure (not displayed)]
MS (ESI) m/z 690.46 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.7 Hz 1H), 8.72 (s, 1H), 8.69 (s, 1H), 7.74 (d, J = 8.2 Hz, 1H), 7.66-7.64 (m, 2H), 7.53 (d, J = 4.6 Hz, 1H), 4.83 (s, 2H), 4.60-4.58 (m, 1H), 3.18 (s, 3H), 3.10-3.00 (m, 1H), 2.27 (s, 3H), 1.60-1.57 (m, 1H), 1.30-1.24 (m, 5H), 0.87-0.67 (m, 8H)
1500[Figure (not displayed)]
MS (ESI) m/z 700.47 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.74 (d, J = 4.8 Hz, 1H), 8.63 (s, 1H), 8.60 (s, 1H), 7.75 (d, J = 8 Hz, 1H), 7.68-7.66 (m, 2H), 7.51 (d, J = 4.8 Hz, 1H), 6.15 (tt, J = 4.0, 55.6 Hz, 1H), 4.79 (s, 2H), 4.53 (t, J = 7.2 Hz, 2H), 2.89 (d, J = 11.2 Hz, 2H), 2.77-2.67 (m, 4H), 2.21-2.16 (m, 4H), 2.03 (s, 3H), 1.81 (d, J = 11.6 Hz, 2H)
1501[Figure (not displayed)]
MS (ESI) m/z 783.47 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.47 (s, 1H), 8.81 (d ,J = 5.6 Hz, 2H), 8.75 (s, 1H), 7.78 (d, J = 8.4 Hz, 1H), 7.71-7.68 (dd, J = 2.0, 10.4 Hz, 2H), 7.62 (d, J = 4.4 Hz, 1H), 4.82 (s, 2H), 4.32 (bs, 1H), 3.55 (s, 3H), 3.31 (bs, 2H), 3.10 (bs, 5H), 2.51 (bs, 2H), 1.97 (bs, 5H), 1.82-1.79 (m, 2H)
1499[Figure (not displayed)]
MS (ESI) m/z 672.39 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.26 (bs, 1H), 9.90 (bs, 1H), 8.89 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.69 (s, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.71-7.66 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.48 (t, J = 53.2 Hz, 1H), 5.21-5.02 (m, 2H), 4.82 (s, 2H), 4.53 (bs, 4H), 4.20-3.80 (m, 2H), 2.78-2.63 (m, 2H), 2.18 (s, 3H)
1503[Figure (not displayed)]
MS (ESI) m/z 718.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.08 (bs, 1H), 8.76-8.74 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.69-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 6.79 (t, J = 74.8 Hz, 1H), 4.82 (s, 2H), 4.56 (bs, 1H), 4.23 (s, 2H), 3.65 (bs, 2H), 3.46 (bs, 2H), 3.26-3.19 (m, 2H), 3.11 (s, 3H), 2.26-2.08 (m, 2H), 2.04 (s, 5H)
1504 [Figure (not displayed)]
MS (ESI) m/z 744.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.8 Hz, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.70 (d, J = 2.0 Hz, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.73 (t, J = 75 Hz, 1H), 4.82 (s, 2H), 4.65 (bs, 1H), 4.21 (bs, 2H), 3.09 (s, 3H), 2.70-2.50 (m, 4H), 2.09 (bs, 7H), 1.33 (bs, 2H), 1.12 (bs, 2H)
1502[Figure (not displayed)]
MS (ESI) m/z 716.50 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.57 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.68-7.66 (m, 2H), 7.50 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.28-4.22 (m, 1H), 3.09 (s, 3H), 3.01 (d, J = 11.2 Hz, 2H), 2.75 (t, J = 14.4 Hz, 2H), 2.38-2.32 (m, 2H), 2.05 (s, 3H), 2.01- 1.85 (m, 4H), 1.77 (d, J = 11.6 Hz, 2H), 0.96 (t, J = 7.2 Hz, 3H)
1506[Figure (not displayed)]
MS (ESI) m/z 730.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76-8.74 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 6.0 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.65-4.60 (m, 1H), 3.91-3.78 (m, 2H), 3.41-3.39 (m, 2H), 3.22 (s, 3H), 2.32-2.26 (m, 2H), 2.24- 2.08 (m, 5H), 1.84-1.79 (m, 3H), 1.51 (s, 6H)
1507 [Figure (not displayed)]
MS (ESI) m/z 734.30 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.71 (s, 1H), 8.66 (s, 1H), 7.76 (d, J = 5.2 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, H), 4.81 (s, 2H), 4.30-4.06 (m, 2H), 3.53-3.37 (m, 2H), 3.08 (s, 3H), 2.05 (s, 3H), 1.90-1.86 (m, 4H), 1.33 (s, 6H)
1505[Figure (not displayed)]
MS (ESI) m/z 671.41 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.68 (d, J = 1.6 Hz, 2H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 3H), 3.38-3.28 (m, 4H), 3.11 (s, 9H), 2.02 (s, 3H), 1.97-1.91 (m, 2H), 1.89-1.83 (m, 2H)
1509[Figure (not displayed)]
MS (ESI) m/z 704.38 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.06 (bs, 1H), 9.76 (bs, 1H), 8.84 (s,1H), 8.75 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.65 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 6.71 (t, J = 75.6 Hz, 1H), 4.83 (s, 2H), 4.40-4.36 (m, 2H), 3.94 (t, J = 6.0 Hz, 2H), 3.74-3.71 (m, 2H), 3.60- 3.20 (m, 6H), 2.14 (s, 3H), 2.10-2.05 (m, 2H)
1510[Figure (not displayed)]
MS (ESI) m/z 716.40 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.15 (bs, 1H), 8.79 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.66 (s, 1H), 7.75 (d, J = 9.1 Hz, 1H), 7.69-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 6.68 (t, J = 75.9 Hz, 1H), 4.82 (s, 2H), 4.01 (bs, 2H), 3.40-2.80 (m, 8H), 2.08 (s, 3H), 1.05-0.65 (m, 4H)
1508[Figure (not displayed)]
MS (ESI) m/z, 684.48 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.74 (s, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69 (d, J = 2.0 Hz, 1H), 7.67 (s, 1H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (bs, 4H), 4.68-4.62 (m, 2H), 3.60 (bs, 2H), 3.33 (bs, 2H), 3.11 (s, 3H), 2.24 (bs, 2H), 2.13 (bs, 2H), 2.09 (s, 3H), 1.33 (d, J = 6.8 Hz, 3H)
1512[Figure (not displayed)]
MS (ESI) m/z 745.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.65 (s, 1H), 10.01 (bs, 1H), 8.87 (d, J = 4.8 Hz, 1H ), 8.62 (s, 1H ), 8.60 (s, 1H ), 7.61 (dd, J = 8.8, 4.8 Hz, 1H), 7.54 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.5 Hz, 1H), 7.38 (d, J = 9.0 Hz, 1H), 4.60 (s, 2H), 4.54 (s, 2H), 4.44-4.37 (m, 4H), 4.28-4.16 (m, 4H), 4.00-3.80 (m, 1H), 3.49 (s, 3H), 2.23-2.14 (m, 2H), 2.09-1.95 (m, 2H), 1.85-1.70 (m, 5H)
1513[Figure (not displayed)]
MS (ESI) m/z 724.49 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 8.40 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 6.79 (t, J = 75.2 Hz, 1H), 4.54-4.51 (m, 1H), 4.38 (d, J = 4.4 Hz, 2H), 4.28 (d, J = 4.4 Hz, 4H), 3.67-3.63 (m, 2H), 3.45 (bs, 2H), 3.25-3.22 (m, 2H), 3.09 (s, 3H), 2.21-2.15 (m, 2H), 2.08-2.05 (m, 2H), 1.71 (s, 3H)
1511[Figure (not displayed)]
MS (ESI) m/z 716.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.01 (bs, 1H), 10.04 (bs, 1H), 8.84 (s, 1H), 8.75 (d, J = 4.8 Hz,1H), 8.64 (s,1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.60 (m, 2H), 7.52 (d, J = 4.4 Hz,1H), 6.71 (t, J = 75.2 Hz, 1H), 4.83 (s, 2H), 4.55-4.36 (m, 3H), 3.70- 3.40 (m, 5H), 3.16 (bs, 2H), 2.77 (bs, 2H), 2.50-2.35 (m, 2H), 2.14 (s, 3H)
1515[Figure (not displayed)]
MS (ESI) m/z 744.51 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.60 (s, 1H), 7.85 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 6.57 (t, J = 52 Hz, 1H), 4.38 (d, J = 4.8 Hz, 2H), 4.30-4.02 (m, 3H), 3.30-2.89 (m, 9H), 1.99 (bs, 2H), 1.82 (bs, 2H), 1.74 (s, 3H)
1516[Figure (not displayed)]
MS (ESI) m/z 753.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.66 (s, 1H), 9.81 (bs, 1H), 8.89 (d, J = 4.4 Hz, 1H), 8.75 (s, 1H), 8.57 (s, 1H), 7.59 (dd, J = 2.8, 9.2 Hz, 1H), 7.56 (d, J = 4.8 Hz, 1H), 7.40 (d, J = 8.4 Hz, 2H), 2.26 (s, 2H), 4.23 (s, 4H), 3.80 (bs, 6H), 3.61 (s, 3 H), 3.42 (bs, 2H), 1.81 (s, 3H), 1.53-1.48 (m, 6H)
1514[Figure (not displayed)]
MS (ESI) m/z 740.49 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.8 Hz, 1H), 8.59 (s, 1H), 8.43 (s, 1H), 7.60 (dd, J = 9.2, 2.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.38-4.37 (m, 2H), 4.26 (bs, 2H), 4.19 (s,2H), 3.36 (bs, 2H), 3.05 (s, 3H), 1.83 (bs, 4H), 1.73 (s, 4H), 1.33 (s, 6H)
1519[Figure (not displayed)]
MS (ESI) m/z 680.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.08 (bs, 1H), 8.75 (d, J = 4.8 Hz, 2H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69 (d, J = 2 Hz, 2H), 7.5 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.57 (bs, 2H), 4.34 (bs, 2H), 3.23 (d, J = 11.6 Hz, 2H), 3.19 (s, 1H), 3.11 (s, 3H), 2.31 (m, 2H), 2.21 (s, 3H), 2.10-2.03 (m, 5H)
1520[Figure (not displayed)]
MS (ESI) m/z 720.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.09 (bs, 1H), 8.77-8.75 (m, 2H), 8.65 (s, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.68 (d, J = 9.2 Hz, 2H), 7.55 (d, J = 4.4 Hz, 1H), 4.83 (s, 2H), 4.55 (bs, 1H), 3.70 (bs, 2H), 3.24 (bs, 4H), 3.11 (bs, 3H), 2.89 (bs, 2H), 2.15-2.11 (m, 7H)
1518[Figure (not displayed)]
MS (ESI) m/z 702.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.8 Hz, 1H), 8.74 (s, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69 (s, 1H), 7.67 (s, 1H), 7.55 (d, J = 4.8 Hz, 1H), 6.53 (t, J = 50.0 Hz, 1H), 4.82 (bs, 2H), 4.57 (d, J = 2.4 Hz, 1H), 3.58 (bs, 2H), 3.36 (bs, 2H), 3.16 (s, 3H), 2.98 (bs, 1H), 2.24 (bs, 2H), 2.08 (bs, 5H), 1.35 (s, 3H)
1522[Figure (not displayed)]
MS (ESI) m/z 714.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.71 (s, 1H), 7.66 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.68 (t, J = 2.8 Hz, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.08 (t, J = 56.4 Hz, 1H), 4.81 (s, 2H), 4.09 (bs, 1H), 3.05 (bs, 5H), 2.92 (bs, 2H), 2.05 (s, 3H), 1.79-1.73 (m, 4H), 0.85-0.78 (m, 4H)
1523[Figure (not displayed)]
MS (ESI) m/z 680.48 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 6.4 Hz, 2H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.4 Hz, 1H), 4.82 (s, 2H), 4.80-4.76 (m, 4H), 4.58 (bs, 1H), 4.37 (bs, 1H), 3.55 (d, J = 8.8 Hz, 2H), 3.12 (bs, 5H), 2.15- 2.10 (m, 5H), remainder of protons are merged in moisture peak
1521[Figure (not displayed)]
MS (ESI) m/z 784.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76-8.75 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.56 (dt, J = 47.2, 5.6 Hz, 2H), 4.59-4.57 (m, 1H), 3.68-3.55 (m, 2H), 3.21-3.19 (m, 4H), 3.11 (s, 3H), 2.21-2.05 (m, 9H)
1525[Figure (not displayed)]
MS (ESI) m/z 648.39 [M + 1]; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (s, 1H), 8.76 (d, J = 4.4 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 1H), 7.55 (d, J = 4.8 Hz, 1H), 5.13 (bs, 1H), 4.81-4.67 (m, 6H), 3.97 (bs, 2H), 2.77 (bs, 2H), 2.10 (s, 3H), 0.85 (bs, 4H)
1526[Figure (not displayed)]
MS (ESI) m/z 704.41 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.16 (bs, 1H), 8.79 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.3 Hz, 1H), 7.69-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 3.73 bs, 4H), 3.00 (bs, 4H), 2.70-2.50 (m, merged, 1H), 2.20-2.07 (m, 1H), 2.08 (s, 3H), 1.03-1.08 (m, 2H)
1524[Figure (not displayed)]
MS (ESI) m/z 678.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.06 (bs, 1H), 8.75.-8.74 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz ,1H), 7.68 (d, J = 8.8 Hz ,2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.64 (t, J = 8.4 Hz, 1H), 3.49 (s, 4H), 3.10 (s, 3H), 2.21-2.08 (m, 7H), 1.39 (s, 3H), 1.14 (bs, 2H), 0.81 (bs, 2H)
1528[Figure (not displayed)]
MS (ESI) m/z 625.37 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.66 (s, 1H), 7.75 (d, J = 8.8 Hz, 1H), 7.70-7.65 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.81 (s, 2H), 4.60-4.45 (m, 1H), 4.05-3.95 (m, 2H), 3.65-3.40 (m, 2H), 3.11 (s, 3H), 2.06 (s, 3H), 2.00-1.85 (m, 2H), 1.78 (d, J = 10.8 Hz, 2H)
1529[Figure (not displayed)]
MS (ESI) m/z 696.48 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.00 (bs, 1H), 8.76-8.74 (m, 2H), 8.65 (s, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.70-7.67 (m, 2H), 7.75 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.72-4.66 (m, 2H), 3.65 (bs, 4H), 3.09 (s, 3H), 2.71 (s, 1H), 2.12-2.08 (m, 7H), 1.35 (bs, 2H), 1.16 (bs, 2H)
1527[Figure (not displayed)]
MS (ESI) m/z 664.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.05 (bs, 1H), 8.79 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.71-7.65 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.39 (d, J = 12.4 Hz, 2H), 3.19 (t, J = 12.0 Hz, 2H), 2.95-2.90 (m, 5H), 2.32-2.28 (m, 2H), 2.10 (s, 3H), 2.00-1.80 (m, 2H), 1.02-0.91 (m, 2H), 0.90-0.81 (m, 2H)
1531[Figure (not displayed)]
MS (ESI) m/z 714.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.06 (bs, 1H), 10.53 (bs, 1H), 8.77-8.70 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 4.4 Hz, 1H), 7.69-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.49 (t, J = 56.4 Hz, 1H), 4.82 (s, 2H), 4.57 (bs, 2H), 3.80-3.48 (m, 3H), 3.40- 3.20 (m, 2H), 3.16 (s, 4H), 3.01-2.70 (m, 2H), 2.02-2.15 (m, 2H), 2.06 (s, 3H), 1.80-1.65 (m, 2H)
1532[Figure (not displayed)]
MS (ESI) m/z 670.30 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.05 (bs, 1H), 8.76-8.70 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.8 Hz, 1H), 7.70-7.68 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.96- 4.68 (m, 4H), 4.01-3.95 (m, 1H), 3.65- 3.28 (m, 3H), 3.22 (s, 3H), 2.82 (s, 3H), 2.80- 2.55 (m, 4H), 2.08 (s, 3H)
1530[Figure (not displayed)]
MS (ESI) m/z 732.40 [M + 1]+; 1H NMR (400 MHz, DMSO- d6) δ 8.76 (d, J = 4.8, 1H), 8.70 (s, 1H), 8.65 (s, 1H), 7.79-7.73 (m, 1H), 7.71- 7.65 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.81 (s, 2H), 4.32-4.20 (m, 1H), 3.12-3.10 (m, 5H), 2.81 (t, J = 11.2 Hz, 2H), 2.05 (s, 3H), 1.85-1.65 (m, 4H), 1.06-0.90 (m, 4H)
1534[Figure (not displayed)]
MS (ESI) m/z 597.28 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.35 (s, 1H), 8.79-8.75 (m, 2H), 7.75 (d, J = 8.0 Hz, 1H), 7.71-7.66 (m, 2H), 7.54 (d, J = 4.4 Hz, 1H), 5.00-4.97 (m, 1H), 4.88 (d, J = 18.4 Hz, 1H), 4.77-4.73 (m, 2H), 4.44 (bs, 1H), 3.89 (d, J = 12.0 Hz, 1H), 3.64 (d, J = 12.0 Hz, 1H), 3.57 (s, 3H), 2.13 (s, 3H)
1535[Figure (not displayed)]
MS (ESI) m/z 702.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.4 Hz, 2H), 8.66 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.70-7.68 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 6.51 (bs, 1H), 4.82 (s, 2H), 4.35 (bs, 1H), 3.66-3.51 (m, 6H), 3.06-2.97 (m, 2H), 2.16-2.02 (m, 7H), 1.13 (t, J = 6.8 Hz, 3H)
1533[Figure (not displayed)]
MS (ESI) m/z 698.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.19 (bs, 1H), 8.76-8.75 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.8 Hz, 1H), 7.70-7.68 (m, 2H), 7.55 (d, J = 8.8 Hz, 1H), 4.95-4.82 (m, 4H), 4.35-4.25 (m, 1H), 3.60-3.40 (m, 3H), 3.12 (s, 3H), 2.95-2.90 (m, 3H), 2.13- 1.72(m, 11H)
1537[Figure (not displayed)]
MS (ESI) m/z 768.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.74 (d, J = 5.2 Hz, 1H), 8.70 (s, 1H), 8.63 (s, 1H), 7.83 (bs, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.69 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 6.74-6.60 (m, 1H), 6.48 (bs, 1H), 4.81 (s, 2H), 4.5-4.25 (m, 2H), 4.15-4.05 (bs, 2H), 3.90 (s, 3H), 3.45-3.3 (bs, 2H), 3.09 (s, 3H), 2.2-2.13 (bs, 2H), 2.06 (s, 3H), 2.05-1.9 (bs, 2H)
1538[Figure (not displayed)]
MS (ESI) m/z 811.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.45 (s, 1H), 8.85 (d, J = 4.8 Hz 1H), 8.70 (s, 2H), 8.69 (s, 1H), 7.78- 7.69 (m, 3H), 7.63 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.32 (t, J = 11.6 Hz, 1H), 3.94-3.87 (m, 2H), 3.31 (bs, 2H), 3.10-3.07 (m, 5H), 2.59 (m, 1H), 1.96 (d, J = 9.3 Hz, 2H), 1.90-1.77 (m, 5H), 1.44 (s, 6H)
1536[Figure (not displayed)]
MS (ESI) m/z 768.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.74 (s, 1H), 8.65 (s, 1H), 7.90 (bs, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.70 (d, J = 2.0 Hz, 1H), 7.67 (s, 1H), 7.55 (d, J = 4.8 Hz, 1H), 6.61 (bs, 1H), 4.82 (s, 2H), 4.53-4.24 (m, 5H), 3.92 (s, 3H), 3.53 (m, 2H), 3.09 (s, 5H), 2.00 (s, 5H)
1540[Figure (not displayed)]
MS (ESI) m/z 688.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.80-8.74 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.8 Hz, 1H), 7.70-7.66 (m, 1H), 7.55 (d, J = 4.8 Hz, 1H), 6.47 (t, J = 58.0 Hz, 1H), 4.83 (s, 2H), 4.68 (bs, 1H), 3.70-3.40 (m, 4H), 3.16 (s, 3H), 3.08-2.75 (m, 2H), 2.08 (s, 3H), 2.05-1.75 (m, 4H)
1541[Figure (not displayed)]
MS (ESI) m/z 701.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.92 (bs, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.69-8.66 (m, 2H), 7.76 (d, J = 8.8 Hz, 1H), 7.68 (t, J = 3.6 Hz, 2H), 7.55 (d, J = 4.4 Hz, 1H), 6.59 (bs, 1H), 4.81 (s, 2H), 3.72 (d, J = 6.0 Hz, 2H), 3.40 (bs, 4H), 3.33 (s, 3H), 3.11-2.99 (m, 2H), 2.06 (s, 3H), 1.79 (bs, 4H), 1.47 (bs, 1H)
1539[Figure (not displayed)]
MS (ESI) m/z 833.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.88 (bs, 1H), 8.84-8.83 (m, 2H), 8.73 (s, 1H), 7.77 (d, J = 4.4 Hz, 1H), 7.76-7.69 (m, 2H), 7.63 (d, J = 4.8 Hz, 1H), 6.73-6.46 (tt, J = 54.4, 4.4 Hz, 1H), 4.82 (s, 2H), 4.49 (dt, J = 14.8, 4.0 Hz, 2H), 4.36-4.30 (m, 1H), 3.36 (bs, 2H), 3.10 (s, 5H), 2.66-2.63 (m, 2H), 2.05-1.77 (m, 7H)
1543[Figure (not displayed)]
MS (ESI) m/z 707.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.35 (bs, 1H), 8.38 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.36 (s, 1H), 7.61 (dd, J = 2.4, 8.8 Hz, 1H), 7.59 (d, J = 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 5.46-5.45 (m, 1H), 4.39 (bs, 2H), 4.24 (bs, 2H), 3.92 (m, 1H), 3.60-3.58 (m, 2H), 3.08- 3.05 (m, 8H), 2.14-1.90 (m, 2H), 1.79-1.77 (m, 3H)
1544[Figure (not displayed)]
MS (ESI) m/z 714.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 2H), 8.64 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.69 (t, J = 8.8 Hz, 2H), 7.54 (d, J = 4.8 Hz, 1H), 6.49 (bs, 1H), 4.82 (s, 2H), 4.49 (s, 1H), 3.75 (bs, 8H), 2.97 (s, 2H), 2.08 (bs, 5H), 1.81 (s, 1H), 1.68 (d, J = 12.8 Hz, 2H)
1542[Figure (not displayed)]
MS (ESI) m/z 674.40 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.26 (s, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.73 (s, 1H), 7.77 (d, J = 8.4 Hz, 1H), 7.72-7.69 (m, 2H), 7.57 (d, J = 4.4 Hz, 1H), 6.42-6.15 (m, 1H), 4.90-4.80 (m, 3H), 4.51-4.46 (m, 1H), 3.87-3.84 (m, 2H), 3.68-3.61 (m, 3H), 3.58-3.37 (m, 2H), 3.25-3.17 (m, 2H), 2.87 (bs, 2H), 2.17 (s, 3H)
1546[Figure (not displayed)]
MS (ESI) m/z 811.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.43 (s, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.74 (d, J = 8.0 Hz, 2H), 7.78 (d, J = 8.8 Hz, 1H), 7.70 (d, J = 2.0 Hz, 1H), 7.68 (s, 1H), 7.61 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.29 (t, J = 23.2 Hz, 1H), 3.22 (q, J = 10.0 Hz, 2H), 3.09 (s, 3H), 3.04 (d, J = 19.2 Hz, 10H), 1.92 (d, J = 8.0 Hz, 5H), 1.78 (d, J = 9.6 Hz, 2H)
1547[Figure (not displayed)]
MS (ESI) m/z 809.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.52 (s, 1H), 8.79 (t, J = 8.0 Hz, 2H), 8.73 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70 (d, J = 2 Hz, 2H), 7.60 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.31 (t, J = 21.2 Hz, 1H), 3.29-3.22 (m, 4H), 3.10 (bs, 5H), 2.50 (s, 1H), 1.94 (d, J = 11.7 Hz, 5H), 1.78 (s, 2H), 1.29 (d, J = 3.8 Hz, 2H), 1.26-1.14 (m, 2H)
1545[Figure (not displayed)]
MS (ESI) m/z 714.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 at 353.1 K) 68.15 (s, 1H), 8.77 (d, J = 4.8 Hz, 1H), 8.68 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.67-7.64 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.86-4.80 (m, 2H), 4.08-4.05 (m, 1H), 3.09 (s, 3H), 2.98 (m, 3H), 2.18 (s, 3H), 2.06- 2.01 (m, 1H), 1.67 (t, J = 18.4 Hz, 3H), 1.38- 1.26 (m, 4H)
1549[Figure (not displayed)]
MS (ESI) m/z 859.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.05 (bs, 1H), 8.93 (d, J = 4.8 Hz, 1H), 8.56 (s, 1H), 8.25 (s, 1H), 8.17 (d, J = 7.6 Hz, 1H), 7.77-7.55 (m, 1H), 7.70-7.63 (m, 4H), 7.55-7.51 (m, 1H), 7.45 (d, J = 7.6 Hz, 1H) 4.82 (s, 2H), 4.29 (bs, 1H), 3.31 (bs, 2H), 3.08 (bs, 5H), 2.67 (s, 3H), 2.63-2.58 (m, 2H), 1.94-1.88 (m, 2H). 1.83 (s, 3H), 1.79-1.76 (m, 2H)
1550[Figure (not displayed)]
MS (ESI) m/z 881.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.28 (bs, 1H), 8.94 (d, J = 5.2 Hz, 1H), 8.58 (s, 1H), 8.28 (s, 1H), 8.24- 8.19 (m, 1H), 7.77-7.75 (m, 1H), 7.70-7.68 (m, 2H), 7.66 (d, J = 4.8 Hz, 1H), 7.61-7.56 (m, 1H), 7.48-7.40 (m, 1H), 4.80 (s, 2H), 4.37-4.26 (m, 1H), 3.37 (bs, 2H), 3.12-3.10 (m, 2H), 3.07 (s, 3H), 2.66-2.63 (m, 2H), 1.99-1.88 (m, 2H), 1.85-1.74 (m, 5H)
1548[Figure (not displayed)]
MS (ESI) m/z 845.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.09 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.67 (s, 1H), 8.45 (s, 1H), 8.15 (d, J = 7.2 Hz, 2H), 7.78-7.74 (m, 2H), 7.69-7.66 (m, 4H), 7.61 (d, J = 4.8 Hz, 1H), 4.80 (s, 2H), 4.31 (bs, 1H), 3.28 (bs, 2H), 3.09-3.06 (m, 5H), 2.58-2.50 (m, 2H), 1.94 (d, J = 11.2 Hz, 2H), 1.87 (s, 3H), 1.79 (d, 10.4 Hz, 2H)
1553[Figure (not displayed)]
MS (ESI) m/z 730.17 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.74 (s, 1H), 8.56 (s, 1H), 7.60-7.73 (m, 1H), 7.67-7.66 (m, 2H), 7.51 (d, J = 4.8 Hz, 1H), 6.14-5.56 (m, 1H), 4.82 (s, 2H), 4.59-4.55 (m, 2H), 4.48 (t, J = 6.4 Hz, 2H), 4.34-4.31 (m, 2H), 4.26-4.21 (m, 1H), 3.14-3.03 (m, 4H), 2.87 (t, J = 12.4 Hz, 1H), 2.07 (s, 3H), 1.76 (d, J = 12.0 Hz, 2H), 1.56-1.48 (m, 2H)
1554[Figure (not displayed)]
MS (ESI) m/z 757.34 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.89 (s, 1H), 8.79 (d, J = 4.8 7.71 (d, J = 2.0 Hz, 1H), 7.68 (bs, 1H), 7.58 (d, J = 4.4 Hz, 1H), 6.29 (t, J = 61.2 Hz, 1H), 4.86 (s, 2H), 4.44 (bs, 2H), 4.04 (bs, 4H), 3.25 (bs, 2H), 2.16 (bs, 4H), 2.10 (bs, 3H)
1551[Figure (not displayed)]
MS (ESI) m/z 859.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.05 (bs, 1H), 8.93 (d, J = 4.8 Hz, 1H), 8.56 (s, 1H), 8.25 (s, 1H), 8.17 (d, J = 7.6 Hz, 1H), 7.77-7.55 (m, 1H), 7.70-7.63 (m, 4H), 7.55-7.51 (m, 1H), 7.45 (d, J = 7.6 Hz, 1H) 4.82 (s, 2H), 4.29 (bs, 1H), 3.31 (bs, 2H), 3.08 (bs, 5H), 2.67 (s, 3H), 2.63-2.58 (m, 2H), 1.94-1.88 (m, 2H). 1.83 (s, 3H), 1.79-1.76 (m, 2H)
1556[Figure (not displayed)]
MS (ESI) m/z 700.34 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.04 (s, 1H), 8.77-8.74 (m 2H), 8.65 (s, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.70-7.66 (dd, J = 2.0, 10.4 Hz, 2H), 7.55 (d, J = 4.4 Hz, 1H), 6.54 (bs, 1H), 4.82 (s, 2H), 4.42 (s, 1H), 4.19 (bs, 1H), 3.86-3.59 (bs, 4H), 3.16- 2.74 (bs, 4H), 2.11 (s, 5H), 1.97-1.78 (bs, 2H)
1557[Figure (not displayed)]
MS (ESI) m/z 702.35 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.00 (bs, 1H), 10.03 (bs, Hz, 1H), 8.59 (s, 1H), 7.77 (s, 1H), 7.75 (s, 1H), CI 1H), 8.80-8.68 (m, 3H), 7.74-7.63 (m, 3H), 7.59 (d, J = 5.2 Hz, 1H), 6.53 (t, J = 54.4 Hz, 1H), 5.90-5.40 (m, 1H), 4.48 (bs, 1H), 3.81-3.41 (m, 4H), 3.38-3.10 (m, 2H), 3.09 (s, 3H), 2.40-1.95 (m, 7H), 1.47 (t, J = 6.8 Hz, 3H)
1555[Figure (not displayed)]
MS (ESI) m/z 764.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.13 (bs, 1H), 8.77 (s, 1H), 8.75 (d, J = 7.2 Hz, 1H), 8.65 (s, 1H), 7.76 (s, 1H), 7.70 (d, J = 2.0 Hz, 2H), 7.67-7.54 (m, 6H), 4.82 (s, 2H), 4.56-4.22 (m, 5H), 3.01 (s, 5H), 2.97-2.87 (m, 2H), 2.09 (s, 5H)
1559[Figure (not displayed)]
MS (ESI) m/z 695.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.22 (bs, 1H), 8.78 (d, J = 4.7 Hz, 1H), 8.65 (s, 1H), 8.00-7.99 (m, 2H), 7.77 (d, J = 9.0 Hz, 1H), 7.70-7.66 (m, 4H), 7.56 (d, J = 4.7 Hz, 1H), 6.43 (t, J = 53.4 Hz, 1H), 4.90 (s, 2H), 4.23 (bs, 2H), 3.41 (bs, 2H), 2.66 (bs, 3H), 2.19 (s, 3H)
1560[Figure (not displayed)]
MS (ESI) m/z 703.32 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 11.40 (s, 1H), 9.44 (bs, 1H), 8.73 (s, 1H), 8.68 (d, J = 4.8 Hz, 1H), 8.48 (s, 1H), 7.74-7.72 (m, 1H), 7.66-7.64 (m, 2H), 7.48 (d, J = 4.8 Hz, 1H), 6.45 (b, 1H), 4.80 (s, 2H), 4.49 (bs, 1H), 3.35 (s, 4H), 3.08 (s, 3H), 2.50- 2.47 (m, 2H), 2.08 (bs, 2H), 1.99 (s, 5H)
1558[Figure (not displayed)]
MS (ESI) m/z 707.32 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.18 (s, 1H), 8.79 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.77 (d, J = 8.8 Hz, 1H), 7.70-7.68 (m, 2H), 7.56 (d, J = 4.8 Hz, 1H), 7.49-7.44 (m, 2H), 7.36 (bs, 1H), 6.42 (tt, J = 52.4, 7.4 Hz, 1H), 4.90 (s, 2H), 4.38 (bs, 2H), 3.48 (bs, 2H), 3.24 (bs, 2H), 2.86 (bs, 2H), 2.16 (s, 3H)
1562[Figure (not displayed)]
MS (ESI) m/z 722.38 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.86 (bs, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.46 (s, 1H), 7.61-7.58 (m, 1H), 7.46 (d, J = 4.8 Hz, 1H), 7.41-7.36 (m, 2H), 4.50 (m, 1H), 4.41 (bs, 2H), 4.21 (bs, 2H), 3.65- 3.37 (m, 4H), 3.06 (s, 3H), 2.62 (s, 3H), 2.25 (m, 2H), 2.00 (m, 2H), 1.79-1.69 (m, 8H)
1563[Figure (not displayed)]
MS (ESI) m/z 722.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.59 (s, 1H), 8.41 (bs, 1H), 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.42-7.40 (m, 2H), 7.36 (d, J = 9.2 Hz, 1H), 4.53 (bs, 1H), 4.38 (bs, 2H), 4.21 (bs, 2H), 3.84 (bs, 4H), 3.08 (s, 3H), 3.54 (bs, 2H), 2.70 (s, 3H)), 1.99 (bs, 2H), 1.82 (bs, 5H), 1.76 (bs, 3H)
1561[Figure (not displayed)]
MS (ESI) m/z 757.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.47 (s, 1H), 8.81-8.78 (m, 3H), 7.77 (d, J = 8.4, 1H), 7.72-7.67 (m, 2H), 7.62 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.78 (t, J = 6.8 Hz, 4H), 4.60 (bs, 1H), 4.36 (bs, 1H), 3.58 (bs, 2H), 3.53 (s, 3H), 3.12 (s, 3H), 3.05 (d, J = 14.0 Hz, 2H), 2.14 (bs, 4H), 1.99 (s, 3H)
1565[Figure (not displayed)]
MS (ESI) m/z 708.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.85 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.0 Hz, 1H), 7.70-7.66 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.84 (s, 2H), 4.66-4.36 (m, 5H), 3.91-3.78 (m, 4H), 2.95 (bs, 3H), 2.13 (s, 3H)
1566[Figure (not displayed)]
MS (ESI) m/z 828.47 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.02 (s, 1H), 8.90 (d, J = 4.8 Hz, 1H), 8.71 (d, J = 4.4 Hz, 1H), 8.65 (s, 1H), 8.60 (s, 1H), 8.27-8.18 (m, 2H), 7.77-7.53 (m, 4H), 7.49 (d, J = 5.6 Hz, 1H), 6.66-6.29 (m, 1H), 4.82 (s, 2H), 4.60-4.45 (m, 1H), 3.50-3.15 (m, 6H), 3.09 (s, 3H), 2.30-1.80 (m, 7H)
1564[Figure (not displayed)]
MS (ESI) m/z 668.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.67-7.70 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 5.45 (d, J = 56.8 Hz, 1H), 4.83 (s, 2H), 4.54- 4.29 (m, 5H), 3.52 (bs, 2H), 3.15-3.09 (m, 2H), 2.19-2.09 (m, 5H), 1.60-1.52 (m, 2H)
1569[Figure (not displayed)]
MS (ESI) m/z 618.28 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 614.24 (bs, 1H), 13.11 (bs, 1H), 9.17 (s, 1H), 8.79 (d, J = 4.80 Hz, 1H), 8.67 (s, 1H), 8.52 (d, J = 7.20 Hz, 2H), 7.76 (d, J = 8.00 Hz, 1H), 7.71-7.68 (m, 2H), 7.53 (d, J = 4.80 Hz, 1H), 7.38 (d, J = 7.20 Hz, 2H), 4.89 (s, 2H), 3.69 (s, 3H), 2.23 (s, 3H)
1571[Figure (not displayed)]
MS (ESI) m/z 665.43 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.00 (s, 1H), 8.82 (d, J = 4.4 Hz, 1H), 8.35 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 6.55 (t, J = 53.2 Hz, 1H), 4.40 (d, J = 4.4 Hz, 2H), 4.26 (s, 2H), 3.87 (bs, 1H), 3.47-3.24 (m, 4H), 2.00- 1.89 (m, 4H),1.78 (s, 3H), 1.74-1.67 (m, 2H)
1568[Figure (not displayed)]
MS (ESI) m/z 636.25 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.18 (bs, 1H), 8.84 (s, 1H), 8.75 (d, J = 4.8 Hz,1H), 8.65 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.65 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.84 (s, 2H), 4.38 (m, 2H), 3.79 (m, 2H,), 3.49 (m, 4H), 3.03 (m, 1H), 2.14 (s, 3H), 0.93 (m, 4H)
1573[Figure (not displayed)]
MS (ESI) m/z 685.39 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.06 (s, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.61 (s, 1H), 7.77-7.75 (m, 1H), 7.70-7.68 (m, 2H), 7.55 (d, J = 4.4 Hz, 1H), 6.60 (bs, 1H), 6.41 (s, 1H), 4.86 (s, 2H), 3.99- 3.58 (m, 2H), 3.03-2.76 (m, 4H), 2.54 (s, 3H), 2.29-2.14 (m, 5H), 1.77-1.75 (m, 1H)
1574[Figure (not displayed)]
MS (ESI) m/z 659.38 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.14 (s, 1H), 8.77 (d, J = 4.8 Hz, 1H), 8.60 (s, 1H), 7.76 (d, J = 18.4 Hz, 1H), 7.70 (d, J = 2.0 Hz, 1H), 7.55 (d, J = 4.8 Hz, 2H), 6.55 (t, J = 54.4 Hz, 1H), 4.87 (s, 2H), 3.60- 2.87 (m, 7H), 2.17 (s, 3H), 2.04-1.73 (m, 4H)
1572[Figure (not displayed)]
MS (ESI) m/z 709.45 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.18 (s, 1H), 8.77 (d, J = 4.8 Hz, 1H), 8.63 (s, 1H), 7.76 (d, J = 9.2 Hz, 1H), 7.70 (dd, J = 6.4 Hz, 2.0 Hz, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.89 (s, 2H), 3.78-3.56 (m, 3H), II s ' 3.28-3.19 (m, 2H), 3.00-2.79 (m, 2H), 2.08 (s, 3H), 1.98-1.85 (m, 4H)
1576[Figure (not displayed)]
MS (ESI) m/z 714.55 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.80 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.8 Hz, 1H), 7.68-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 3.81-3.38 (m, 5H), 3.08 (s, 3H), 2.82-2.70 (m, 2H), 2.43-2.33 (m, 2H), 2.06 (s, 3H),1.68-1.53 (m, 7H)
1577[Figure (not displayed)]
MS (ESI) m/z 714.49 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.80 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.8 Hz, 1H), 7.68-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 3.81-3.38 (m, 5H), 3.08 (s, 3H), 2.82-2.70 (m, 2H), 2.43-2.33 (m, 2H), 2.06 (s, 3H), 1.68-1.53 (m, 7H)
1575[Figure (not displayed)]
MS (ESI) m/z 728.08 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.80 (s, 1H), 8.76 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.75 (d, J = 8.8 Hz, 1H), 7.68-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 3.81-3.38 (m, 5H), 3.08 (s, 3H), 2.82-2.70 (m, 2H), 2.43-2.33 (m, 2H), 2.06 (s, 3H), 1.68-1.53 (m, 7H)
1579[Figure (not displayed)]
MS (ESI) m/z 760.64 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.17 (s, 1H), 8.66 (s, 1H), 7.76-7.74 (m, 1H), 7.70-7.68 (m, 2H), 7.56 (d, J = 4.8 Hz, 1H), 6.43-4.15 (m, 1H), 4.81 (s, 2H), 4.30 (bs, 1H), 3.54 (bs, 4H), 3.08 (s, 3H), 2.05 (bs, 7H), 1.83- 1.67 (m, 6H), 1.17 (bs, 3H)
1581[Figure (not displayed)]
MS (ESI) m/z 702.52 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.74-8.70 (m, 2H), 8.37 (s, 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.67-7.64 (m, 2H), 7.44 (d, J = 4.4 Hz, 1H), 6.16 (t, J = 55.6 Hz, 1H), 4.89-4.84 (m, 3H), 3.081 (bs, 4H), 2.80-2.72 (m, 2H), 2.33 (bs, 3H), 2.07-1.98 (m, 4H), 1.90 (bs, 3H), 1.75-1.71 (m, 1H), 1.41 (t, J = 7.2 Hz, 1H)
1578[Figure (not displayed)]
MS (ESI) m/z 771.57 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.48 (s, 1H), 8.82 (d, J = 4.4 Hz, 2H), 8.78 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.72-7.67 (m, 2H), 7.63 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.77-4.75 (m, 4H), 4.44-4.35 (m, 2H), 3.76-3.59 (m, 3H), 3.54 (s, 3H), 3.28- 3.19 (m, 1H), 3.02 (bs, 2H), 2.15 (s, 4H), 1.99 (s, 3H), 1.15 (t, J = 6.8 Hz, 3H)
1583[Figure (not displayed)]
MS (ESI) m/z 744.52 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.66 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.69-7.68 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.81 (s, 2H), 4.26-4.23 (m, 1H), 3.12-3.09 (m, 4H), 2.93 (bs, 3H), 2.57-2.52 (m, 2H), 2.06 (s, 3H), 1.89 (bs, 4H), 1.75-1.72 (m, 7H), 1.22 (bs, 2H)
1584[Figure (not displayed)]
MS (ESI) m/z 724.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.01 (bs, 1H), 8.76-8.74 (m, 2H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.74-7.56 (m, 3H), 3.52-3.49 (m, 2H), 3.32-3.26 (m, 4H), 3.11 (s, 3H), 2.26-2.21 (m, 2H), 2.10 (s, 3H), 2.03-1.91 (m, 8H)
1582[Figure (not displayed)]
MS (ESI) m/z 778.66 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.73 (s, 1H), 8.65 (s, 1H), 7.75 (d, J = 8.8 Hz, 1H), 7.70-7.67 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.58 (bs, 2H), 4.24 (bs, 2H), 3.11 (s, 3H), 2.94-2.67 (m, 6H), 2.32-2.08 (m, 9H)
1586[Figure (not displayed)]
MS (ESI) m/z 748.52 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.8 Hz, 1H), 8.72 (s, 1H), 8.70 (s, 1H), 7.74 (d, J = 8.0 Hz, 1H), 7.70-7.62 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.84 (s, 2H), 4.48-4.30 (m, 1H), 3.40-2.85 (m, 9H), 2.20-1.75 (m, 7H), 1.20 (s, 6H)
1587[Figure (not displayed)]
MS (ESI) m/z 746.54 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.13 (bs, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.65 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.68-7.67 (m, 2H), 7.54 (d, J = 4.8 Hz, 1H), 4.81 (s, 2H), 4.26 (bs, 1H), 3.09 (s, 3H), 3.04 (d, J = 10.8 Hz, 2H), 2.70-2.50 (merged, 2H), 2.10-2.00 (m, 5H), 1.88-1.81 (m, 4H), 0.97 (s, 2H), 0.74 (s, 2H)
1585[Figure (not displayed)]
MS (ESI) m/z 722.42 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.8 Hz, 1H), 8.71 (s, 1H), 8.66 (s, 1H), 7.76-7.74 (m, 1H), 7.69-7.68 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.81 (s, 2H), 4.29-4.27 (m, 1H), 3.44 (bs, 2H), 3.17-3.09 (m, 5H), 2.66 (bs, 2H), 2.05 (s, 3H), 1.94 (d, J = 10.4 Hz, 2H),1.80 (d, J = 10.8 Hz, 2H)
1589[Figure (not displayed)]
MS (ESI) m/z 791.49 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.47 (s, 1H), 9.72 (bs, 1H), 8.81-8.78 (m, 3H), 7.77 (d, J = 8.4 Hz, 1H), 7.72-7.67 (m, 2H), 7.62 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.59 (bs, 1H), 3.82-3.45 (m, 6H), 3.30-2.95 (m, 9H), 2.20-2.14 (m, 4H), 1.99 (s, 3H)
1590[Figure (not displayed)]
MS (ESI) m/z 807.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.47 (s, 1H), 8.80 (d, J = 5.2 Hz 1H), 8.78 (s, 1H), 8.75 (s, 1H), 7.77 (d, J = 8.4 Hz, 1H), 7.70 (dd, J = 10.4 Hz, 2 Hz, 2H), 7.62 (d, J = 4.8 Hz, 1H), 6.45 (t, J = 54.8 Hz, 1H), 4.82 (s, 2H), 4.50 (d, J = 6.8 Hz, 2H), 4.45 (d, J = 6.8 Hz, 2H), 4.34-4.29 (m, 1H), 3.55 (s, 3H), 3.11 (s, 3H), 2.91 (d, J = 10.8 Hz, 2H), 2.60-2.53 (m, 2H),1.96-1.85 (m, 7H)
1588[Figure (not displayed)]
MS (ESI) m/z 760.61 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.05 (bs, 1H), 9.09 (bs, 1H), 8.80-8.70 (m, 2H), 8.65 (s, 1H), 7.75 (d, J = 8.40 Hz, 1H), 7.71-7.63 (m, 2H), 7.54 (d, J = 4.00 Hz, 1H), 4.82 (s, 2H), 4.56 (bs, 1H), 3.70- 3.50 (m, 4H), 3.20-3.20 (merged, 2H), 3.11 (s, 3H), 2.41-2.20 (m, 6H), 2.18-1.94 (m, 7H)
1592[Figure (not displayed)]
MS (ESI) m/z 714.10 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.09 (bs, 1H), 8.75-8.74 (m, 2H), 8.64 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.69-7.67 (m, 2H), 7.53 (d, J = 4.8 Hz, 1H), 4.82 (s, 2H), 4.39 (bs, 2H), 4.01 (bs, 1H), 3.66 (bs, 1H), 3.20-2.95 (m, 5H), 2.72-2.66 (m, 2H), 2.08 (bs, 5H), 1.90-1.60 (m, 4H)
1593[Figure (not displayed)]
MS (ESI) m/z 851.58 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.03 (bs, 1H), 8.87 (d, J = 4.80 Hz, 1H), 8.84 (s, 1H), 8.73 (s, 1H), 7.77 (d, J = 9.20 Hz, 1H), 7.71-7.69 (m, 2H), 7.65 (d, J = 4.80 Hz, 1H), 5.06 (q, J = 9.60 Hz, 2H), 4.82 (s, 2H), 4.32-4.29 (m, 1H), 3.33 (bs, 2H), 3.09 (bs, 5H), 2.58 (bs, 2H), 1.96 (bs, 2H), 1.92 (s, 3H), 1.80 (d, J = 11.2 Hz, 2H)
1591[Figure (not displayed)]
MS (ESI) m/z 857.53 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.85 (d, J = 5.2 Hz, 1H), 8.81 (s, 1H), 8.75 (s, 1H), 7.78 (d, J = 8.8 Hz, 1H), 7.71-7.69 (m, 2H), 7.64 (d, J = 4.8 Hz, 1H), 6.73-6.58 (m, 1H), 6.15-5.87 (m, 1H), 4.82 (s, 2H), 4.59-4.55 (m, 2H), 4.52-4.47 (m, 4H), 4.35-4.22 (m, 4H), 3.16-3.04 (m, 3H), 2.86 (m, 1H), 1.92 (s, 3H), 1.76 (d, J = 11.2 Hz, 2H), 1.56-1.48 (m, 2H)
1595[Figure (not displayed)]
MS (ESI) m/z 847.0 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.06 (bs, 1H), 8.85 (d, J = 4.8 Hz, 1H), 8.83 (s, 1H), 8.75 (s, 1H), 7.78 (d, J = 8.80 Hz, 1H), 7.71 (bs, 2H), 7.65 (d, J = 4.80 Hz, 1H), 5.04 (q, J = 9.60 Hz, 2H), 4.83 (s, 2H), 4.59 (bs, 1H), 3.77 (bs, 4H), 3.37 (bs, 2H), 3.11 (s, 3H), 2.26 (bs, 2H), 2.02 (bs, 2H), 1.95 (s, 3H), 1.76 (t, J = 17.6 Hz, 3H)
1596[Figure (not displayed)]
MS (ESI) m/z 701.0 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6 with D2O) 6 8.68 (s, 1H), 8.67 (s, 1H), 8.39 (s, 1H), 7.71 (d, J = 8.4 Hz, 1H), 7.65-7.63 (m, 1H), 7.57 (d, J = 1.6 Hz, 1H), 7.41 (d, J = 4.8 Hz, 1H), 4.73 (s 2H), 4.55-4.49 (m, 1H), 3.80-3.72 (m, 2H), 3.62-3.57 (m, 2H), 3.28 (t, J = 11.6 Hz, 2H), 3.09 (s, 1H), 2.53 (bs, 1H), 2.32-2.20 (m, 2H), 2.06 (bs, 6H), 1.74 (t, J = 19.6 Hz, 3H)
1594[Figure (not displayed)]
MS (ESI) m/z 705.48 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.68 (s, 1H), 8.67 (s, 1H), 8.45 (s, 1H), 7.72 (d, J = 8.00 Hz, 1H), 7.65 (d, J = 8.40 Hz, 1H), 7.61 (bs, 1H), 7.44 (d, J = 2.40 Hz, 1H), 4.76 (s, 2H), 4.32 (t, J = 12.00 Hz, 1H), 3.49 (d, J = 8.80 Hz, 2H), 3.18 (d, J = 10.80 Hz, 2H), 3.07 (s, 3H), 2.73 (t, J = 11.2 Hz, 2H), 2.02 (s, 3H), 1.96 (d, J = 13.2 Hz, 2H), 1.85 (d, J = 10.8 Hz, 2H)
1598[Figure (not displayed)]
MS (ESI) m/z 758.69 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.94 (bs, 1H), 8.77 (d, J = 4.8 Hz, 1H), 8.64 (s, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.69-7.67 (m, 2H), 7.55 (d, J = 4.4 Hz, 1H), 6.43 (bs, 1H), 4.82 (s, 2H), 4.53 (bs, 1H), 3.79 (bs, 4H), 3.39-3.35 (m, 2H), 3.11 (s, 3H), 2.41 (bs, 2H), 2.32-2.26 (m, 2H), 2.09 (s, 7H), 1.86-1.82 (m, 1H), 1.65-1.60 (m, 1H)
1599[Figure (not displayed)]
MS (ESI) m/z 638.41 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79-8.74 (m, 2H), 8.65 (s, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.70-7.68 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.54-4.53 (m, 1H), 3.58-3.55 (m, 2H), 3.20 (bs, 2H), 3.01 (s, 3H), 2.83-2.82 (m, 3H), 2.10 (bs, 7H)
1597[Figure (not displayed)]
MS (ESI) m/z 833.52 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.08 (bs, 1H), 8.86-8.84 (m, 2H), 7.79-7.769 (m, 1H), 7.71 (t, J = 2.0 Hz, 2H), 7.66 (d, J = 5.2 Hz, 1H), 6.51 (bs, 1H), 5.08-5.01 (m, 2H), 4.83 (s, 2H), 4.52 (bs, 1H), 3.94 (bs, 2H), 3.41 (bs, 4H), 3.21 (s, 3H), 2.15 (bs, 2H), 2.07 (s, 5H)
1601[Figure (not displayed)]
MS (ESI) m/z 805.69 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 12.47 (bs, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.78 (bs, 2H), 7.79 (d, J = 11.6 Hz, 1H), 7.70 (bs, 1H), 7.68 (bs, 1H), 7.63 (d, J = 4.80 Hz, 1H), 4.82 (s, 2H), 4.20 (bs, 1H), 3.65 (g, J = 6.80 Hz, 2H), 3.54 (s, 3H), 2.93-2.90 (m, 2H), 2.69-2.66 (m, 4H), 2.42-2.32 (m, 3H), 1.94 (s, 3H), 1.92-1.89 (m, 4H) 1.11 (t, J = 6.8 Hz, 3H)
1602[Figure (not displayed)]
MS (ESI) m/z 773.67 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.47 (s, 1H), 9.72 (bs, 1H), 8.81-8.78 (m, 3H), 7.77 (d, J = 8.36 Hz, 1H), 7.72-7.67 (m, 2H), 7.62 (d, J = 4.80 Hz, 1H), 5.33-5.14 (dm, 1H), 4.83 (s, 2H), 4.63-4.55 (m, 1H), 4.03-3.97 (m, 1H), 3.60-3.50 (merged, 3H), 3.11 (s, 3H), 3.09-3.02 (m, 2H), 2.76-2.50 (m, 6H), 2.12-2.07 (m, 4H), 1.99 (s, 3H)
1600[Figure (not displayed)]
MS (ESI) m/z 678.56 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.12 (bs, 1H), 8.83-8.73 (m, 3H), 8.66 (s, 1H), 7.76 (d, J = 8.8 Hz, 1H), 7.70-7.68 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.40 (bs, 1H), 3.71-3.57 (m, 4H), 3.40-3.20 (merged, 2H), 2.85 (bs, 1H), 2.18- 2.00 (m, 7H), 1.14 (t, J = 6.4 Hz, 3H), 0.98-0.79 (m, 4H)
1604[Figure (not displayed)]
MS (ESI) m/z 793.67 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 12.45 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.73 (bs, 2H), 7.78 (d, J = 8.4 Hz, 1H), 7.71-7.69 (m, 2H), 7.63 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.61 (bs, 1H), 3.84 (bs, 1H), 3.69-3.65 (m, 2H), 3.11 (s, 3H), 2.02-1.91 (m, 6H), 1.76 (bs, 4H), 1.38 (t, J = 14.4 Hz, 3H)
1605[Figure (not displayed)]
MS (ESI) m/z 793.67 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 12.45 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.73 (bs, 2H), 7.78 (d, J = 8.4 Hz, 1H), 7.71-7.69 (m, 2H), 7.63 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.61 (bs, 1H), 3.84 (bs, 1H), 3.69-3.65 (m, 2H), 3.11 (s, 3H), 2.02-1.91 (m, 6H), 1.76 (bs, 4H), 1.38 (t, J = 14.4 Hz, 3H)
1603[Figure (not displayed)]
MS (ESI) m/z 833.74 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 9.86 (bs, 1H), 8.80-8.78 (d, J = 8.80 Hz, 2H), 8.68 (s, 1H), 7.80-7.67 (m, 4H), 4.88 (s, 2H), 4.54 (bs, 1H), 3.66-3.38 (m, 4H), 3.33-3.27 (m, 2H), 3.09 (s, 3H), 2.40-2.25 (m, 2H), 2.12 (s, 3H), 2.10-1.99 (m, 2H), 1.76 (t, J = 19.2 Hz, 3H)
1607[Figure (not displayed)]
MS (ESI) m/z 829.71 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.49 (s, 1H), 8.81 (d, J = 4.8 Hz, 1H), 8.78 (d, J = 3.0 Hz, 2H), 7.77 (d, J = 8.16 Hz, 1H), 7.70-7.68 (m, 2H), 7.49 (d, J = 6.36 Hz, 1H), 6.56 (tt, J = 4.16 Hz, J = 88.08 Hz, 1H), 4.82 (s, 2H), 4.22-4.16 (m, 1H), 3.65 (d, J = 6.88 Hz, 2H), 3.55 (s, 3H) 3.04-2.94 (m, 4H), 2.49-2.41 (m, 2H), 1.99-1.89 (m, 5H), 1.78 (d, J = 10.68 Hz, 2H), 1.11 (t, J = 6.72 Hz, 3H)
1608[Figure (not displayed)]
MS (ESI) m/z 871.79 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.71 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.78 (s, 1H), 8.72 (s, 1H), 7.77 (d, J = 8.16 Hz, 1H), 7.71-7.69 (m, 2H), 7.64 (d, J = 4.84 Hz, 1H), 6.58 (tt, J = 52.56 Hz, 5.4 Hz, 1H), 5.25-5.20 (m, 1H), 4.98-4.92 (m, 4H), 4.82 (s, 2H), 4.24 (bs, 1H), 3.95 (bs, 2H), 3.68-3.62 (m, 2H), 3.50-3.10 (m, 4H), 2.01-1.97 (m, 2H), 1.90 (s, 3H), 1.86 (bs, 2H), 1.12 (t, J = 6.8 Hz, 3H)
1606[Figure (not displayed)]
MS (ESI) m/z 821.52 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 12.48 (s, 1H), 8.80 (d, J = 4.84 Hz, 1H), 8.78 (d, J = 2.6 Hz, 2H), 7.77 (d, J = 8.31 Hz, 1H), 7.71-7.67 (m, 2H), 7.62 (d, J = 4.80 Hz, 1H), 4.76 (s, 2H), 4.60-4.57 (m, 1H), 3.85-3.58 (m, 4H), 3.49 (s, 3H), 3.32 (t, J = 12 Hz, 2H), 3.10 (s, 3H), 2.32-2.02 (m, 4H), 1.98 (s, 3H), 1.80-1.70 (m, 3H)
1610[Figure (not displayed)]
MS (ESI) m/z 881.27 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 12.71 (s, 1H), 8.81 (d, J = 4.84 Hz, 1H), 8.77 (s, 1H), 8.76 (s, 1H), 7.77 (d, J = 8.36 Hz, 1H), 7.72-7.67 (m, 2H), 7.62 (d, J = 4.84 Hz, 1H), 5.20-5.16 (m, 1H), 4.97- 4.89 (m, 4H), 4.82 (s, 2H), 4.75-4.70 (m, 1H), 4.61-4.57 (m, 1H), 3.54-3.51 (m, 2H), 3.54-3.43 (m, 3H), 3.11 (s, 3H), 3.08-3.06 (m, 2H), 2.87- 2.83 (m, 2H), 2.11-2.08 (m, 4H), 1.95 (s, 3H)
1611[Figure (not displayed)]
MS (ESI) m/z 902.74 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.02 (s, 1H), 8.89 (d, J = 4.80 Hz, 1H), 8.72 (d, J = 4.40 Hz, 1H), 8.64 (s, 1H), 8.61 (s, 1H), 8.27-8.25 (m, 1H), 8.22-8.18 (m, 1H), 7.77-7.73 (m, 2H), 7.71-7.69 (m, 2H), 7.65 (d, J = 4.80 Hz, 1H), 4.83 (s, 2H), 4.75- 4.70 (m, 1H), 4.58 (bs, 1H), 3.67 (bs, 3H), 3.54 (d, J = 10.80 Hz, 2H), 3.42-3.38 (m, 1H), 2.86- 2.84 (m, 2H), 2.85 (bs, 2H), 2.45-2.40 (m, 2H), 2.08 (bs, 4H), 1.95 (s, 3H)
1609[Figure (not displayed)]
MS (ESI) m/z 892.75 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.05 (s, 1H), 8.91 (d, J = 4.4 Hz, 1H), 8.72 (d, J = 3.6 Hz, 1H), 8.65 (s, 1H), 8.60 (s, 1H), 8.28 (d, J = 8.0 Hz, 1H), 8.21 (t, J = 7.6 Hz, 1H), 7.77-7.75 (m, 2H), 7.70-7.66 (m, 3H), 6.58 (t, J = 52.8 Hz, 1H), 4.82 (s, 2H), 4.23 (bs, 1H), 3.62 (d, J = 7.2 Hz, 2H), 3.16- 3.12 (m, 4H), 2.53 (s, 2H), 2.01 (bs, 2H), 1.90- 1.84 (m, 5H), 1.09 (t, J = 6.4 Hz, 3H)
1617[Figure (not displayed)]
MS (ESI) m/z 730.46 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 with D2O) 6 8.67 (bs, 2H), 7.95 (d, J = 7.6 Hz, 1H), 7.50 (d, J = 8.4 Hz, 1H), 7.28 (s, 1H), 7.21 (bs, 2H), 6.28 (m, J = 53.6 Hz, 1H), 4.30 (bs, 2H), 4.21-4.00 (m, 3H), 3.29-3.19 (m, 4H), 2.99 (s, 3H), 2.80 (bs, 2H), 2.03 (bs, 2H), 1.86 (bs, 2H), 1.64 (s, 3H)
1618[Figure (not displayed)]
MS (ESI) m/z 791.49 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.47 (s, 1H), 9.72 (bs, 1H), 8.81-8.78 (m, 3H), 7.77 (d, J = 8.4 Hz, 1H), 7.72-7.67 (m, 2H), 7.62 (d, J = 4.8 Hz, 1H), 4.83 (s, 2H), 4.59 (bs, 1H), 3.82-3.45 (m, 6H), 3.30-2.95 (m, 9H), 2.20-2.14 (m, 4H), 1.99 (s, 3H)
1616[Figure (not displayed)]
MS (ESI) m/z 786.58 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 with D2O) 6 8.77 (d, J = 4.40 Hz, 1H), 8.68 (s, 1H), 8.19 (d, J = 9.60 Hz, 1H), 7.52 (dd, J = 2.2, 8.8 Hz, 1H), 7.35-7.26 (m, 3H), 6.24 (t, J = 54.4 Hz, 1H), 4.33-4.17 (m, 10H), 3.21 (bs, 3H), 3.03 (s, 3H), 2.70 (bs, 1H), 2.58 (bs, 1H), 1.97 (bs, 2H), 1.82 (bs, 2H), 1.55 (s, 3H), 1.28 (t, J = 6.8 Hz, 6H)
1621[Figure (not displayed)]
LCMS: 603.6 [M + H]+; 1H NMR (400 MHz, Methanol-d4) 6 8.31 (s, 1H), 7.54 (dd, J = 8.9, 2.6 Hz, 1H), 7.41 (s, 1H), 7.36-7.25 (m, 2H), 4.46 (t, J = 5.1 Hz, 2H), 4.34 (t, J = 5.1 Hz, 2H), 3.13 (s, 6H), 2.89 (s, 3H), 2.83 (s, 3H), 2.24 (s, 3H)
1622[Figure (not displayed)]
LCMS (ESI) m/z 658.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.62 (s, 1H), 7.69 (tt, J = 8.5, 6.6 Hz, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48-7.43 (m, 2H), 7.40-7.32 (m, 3H), 4.43 (t, J = 5.0 Hz, 2H), 4.27 (t, J = 4.9 Hz, 2H), 2.81 (s, 3H), 2.69 (s, 3H), 1.88 (s, 3H)
1620[Figure (not displayed)]
MS (ESI) m/z 726.41 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.81 (d, J = 4.0 Hz, 1H), 8.57 (s, 1H), 8.34 (s, 1H), 7.58 (d, J = 7.2, 1H), 7.39-7.33 (m, 3H), 4.37 (bs, 2H), 4.25 (bs, 3H), 3.91 (s, 3H), 3.3; 2-3.30 (m, 2H), 3.07-2.72 (m, 5H), 2.44-2.32 (m, 2H), 1.93-1.74 (bs, 4H), 1.69 (s, 3H)
1624[Figure (not displayed)]
LCMS (ESI) m/z 662.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 4.8 Hz, 1H), 8.46 (s, 1H), 7.57 (dd, J = 9.0, 2.6 Hz, 1H), 7.44 (d, J = 4.8 Hz, 1H), 7.39-7.32 (m, 2H), 4.98-4.74 (m, 2H), 4.40 (t, J = 5.1 Hz, 2H), 4.29 (s, 1H), 4.21 (t, J = 5.1 Hz, 2H), 3.64 (s, 3H), 3.56 (s, 1H), 3.47 (s, 1H), 3.31 (s, 2H), 2.63 (s, 3H), 1.86 (s, 3H)
1625[Figure (not displayed)]
MS (ESI) m/z 805.29 [M + 1]+
1623[Figure (not displayed)]
LCMS (ESI) m/z 644.1 [M + 1]+; 1H NMR (400 MHz, Chloroform-d) δ 8.48 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.42-7.37 (m, 2H), 4.42 (d, J = 5.3 Hz, 2H), 4.33 (s, 1H), 4.30 (s, 1H), 4.25 (d, J = 5.0 Hz, 2H), 3.61 (d, J = 12.2 Hz, 2H), 3.44 (d, J = 13.6 Hz, 4H), 3.24 (d, J = 11.0 Hz, 1H), 2.92 (d, J = 4.4 Hz, 3H), 2.73 (s, 3H), 2.66 (s, 4H), 1.98 (s, 3H)
1627[Figure (not displayed)]
MS (ESI) m/z 602.29 [M + 1]+
1628[Figure (not displayed)]
MS (ESI) m/z 608.3 [M + 1]+
1626[Figure (not displayed)]
LCMS (ESI) m/z 599.2 [M + 1]+
1630[Figure (not displayed)]
MS (ESI) m/z 618.09 [M + 1]+
1631[Figure (not displayed)]
1629[Figure (not displayed)]
1633[Figure (not displayed)]
LCMS (ESI) m/z 608.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.70 (d, J = 4.7 Hz, 2H), 8.63 (s, 1H), 8.47 (s, 2H), 7.72 (dd, J = 8.1, 0.8 Hz, 1H), 7.68-7.61 (m, 2H), 7.50 (d, J = 4.8 Hz, 1H), 4.77 (s, 2H), 4.54 (s, 4H), 4.20 (t, J = 6.2 Hz, 4H), 2.06 (s, 3H), 1.20 (s, 1H)
1634[Figure (not displayed)]
MS (ESI) m/z 678.5 [M + 1]+
1632[Figure (not displayed)]
LCMS (ESI) m/z 469.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77-8.71 (m, 2H), 8.66 (s, 1H), 7.75 (dd, J = 8.1, 0.8 Hz, 1H), 7.72-7.64 (m, 2H), 7.54 (d, J = 4.9 Hz, 1H), 4.81 (s, 2H), 4.63 (s, 2H), 4.53 (s, 2H), 4.44 (s, 2H), 4.39 (s, 2H), 3.36 (s, 4H), 2.73-2.62 (m, 1H), 2.10 (s, 3H)
1636[Figure (not displayed)]
MS (ESI) m/z 619.45 [M + 1]+
1637[Figure (not displayed)]
MS (ESI) m/z 638.39 [M + 1]+
1635[Figure (not displayed)]
MS (ESI) m/z 688.48 [M + 1]+
1639[Figure (not displayed)]
MS (ESI) m/z 706.46 [M + 1]+
1640[Figure (not displayed)]
1638[Figure (not displayed)]
MS (ESI) m/z 670.50 [M + 1]+
1642[Figure (not displayed)]
MS (ESI) m/z 710.46 [M + 1]+
1643[Figure (not displayed)]
MS (ESI) m/z 706.47 [M + 1]+
1641[Figure (not displayed)]
MS (ESI) m/z 706.55 [M + 1]
1645[Figure (not displayed)]
MS (ESI) m/z 628.46 [M + 1]+
1646[Figure (not displayed)]
MS (ESI) m/z 668.45 [M + 1]+
1644[Figure (not displayed)]
MS (ESI) m/z 690.47 [M + 1]+
1648[Figure (not displayed)]
LCMS: 2.01 Min, 777.3 [M + H]+
1649[Figure (not displayed)]
MS (ESI) m/z = 706.48 [M + 1]+
1647[Figure (not displayed)]
MS (ESI) m/z 706.46 [M + 1]+
1651[Figure (not displayed)]
1652[Figure (not displayed)]
1650[Figure (not displayed)]
MS (ESI) m/z 720.47 [M + 1]+
1654[Figure (not displayed)]
MS (ESI) m/z, 690.46 [M + 1]+
1655[Figure (not displayed)]
MS (ESI) m/z 704.57 [M + 1]+
1653[Figure (not displayed)]
MS (ESI) m/z 670.43 [M + 1]+
1657[Figure (not displayed)]
1658[Figure (not displayed)]
1656[Figure (not displayed)]
1660[Figure (not displayed)]
1661[Figure (not displayed)]
1659[Figure (not displayed)]
1663[Figure (not displayed)]
MS (ESI) m/z 688.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.72 (d, J = 4.8 Hz, 1H), 8.70 (s, 1H), 8.61 (s, 1H), 7.74-7.71 (m, 1H), 7.67-7.63 (m, 2H), 7.52 (d, J = 4.8 Hz, 1H), 7.03 (d, J = 8.5 Hz, 1H), 6.80 (tt, J = 52.4, 3.5 Hz, 1H), 4.78 (s, 2H), 4.55-4.40 (m, 1H), 4.02 (td, J = 14.3, 3.9 Hz, 2H), 3.69-3.60 (m, 4H), 3.25(s, 3H), 2.32-2.18 (m, 2H), 2.10-2.01 (m, 2H), 2.00 (s, 3H).
  1664[Figure (not displayed)]
1662[Figure (not displayed)]
MS (ESI) m/z 708.54 [M + 1]+
1666[Figure (not displayed)]
1672[Figure (not displayed)]
1676[Figure (not displayed)]
1665[Figure (not displayed)]
MS (ESI) m/z = 714.5 [M + 1]+
1669[Figure (not displayed)]
1670[Figure (not displayed)]
1667[Figure (not displayed)]
1668[Figure (not displayed)]
1673[Figure (not displayed)]
1671[Figure (not displayed)]
1675[Figure (not displayed)]
1677[Figure (not displayed)]
1674[Figure (not displayed)]
1678[Figure (not displayed)]
1679[Figure (not displayed)]
1680[Figure (not displayed)]
1681[Figure (not displayed)]
1683[Figure (not displayed)]
1687[Figure (not displayed)]
1684[Figure (not displayed)]
1686[Figure (not displayed)]
1690[Figure (not displayed)]
MS (ESI) m/z 728.47 [M + 1]+
1682[Figure (not displayed)]
1685[Figure (not displayed)]
1688[Figure (not displayed)]
MS (ESI) m/z 720.47 [M + 1]+
1689[Figure (not displayed)]
MS (ESI) m/z 714.45 [M + 1]+
1691[Figure (not displayed)]
MS (ESI) m/z 714.55 [M + 1]+
1697[Figure (not displayed)]
1700[Figure (not displayed)]
1693[Figure (not displayed)]
1694[Figure (not displayed)]
1702[Figure (not displayed)]
1692[Figure (not displayed)]
1696[Figure (not displayed)]
1695[Figure (not displayed)]
1699[Figure (not displayed)]
1701[Figure (not displayed)]
1698[Figure (not displayed)]
1706[Figure (not displayed)]
MS (ESI) m/z 878.31 [M + 1]+
1703 [Figure (not displayed)]
MS (ESI) m/z 815.32 [M + 1]+
1704[Figure (not displayed)]
MS (ESI) m/z 857.25 [M + 1]+
1705[Figure (not displayed)]
MS (ESI) m/z 878.28 [M + 1]+
1707[Figure (not displayed)]
1711[Figure (not displayed)]
1708[Figure (not displayed)]
1709[Figure (not displayed)]
1710[Figure (not displayed)]
1714[Figure (not displayed)]
1712[Figure (not displayed)]
1713[Figure (not displayed)]
1715[Figure (not displayed)]
1716[Figure (not displayed)]
1717[Figure (not displayed)]
MS (ESI) m/z 762.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.8 Hz, 1H), 8.75 (s, 1H), 8.65 (s, 1H), 7.76 (d, J = 8.2 Hz, 1H), 7.71-7.66 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 7.26 (s, 1H), 4.83 (s, 2H), 4.68-4.55 (m, 1H), 4.22 (d, J = 13.7 Hz, 1H), 3.99-3.71 (m, 7H), 3.20 (s, 3H), 2.70-2.61 (m, 2H), 2.42- 2.30 (m, 2H), 2.18-2.00 (m, 5H)
1721[Figure (not displayed)]
1719[Figure (not displayed)]
1723[Figure (not displayed)]
MS (ESI) m/z 726.28 [M + 1]+
1718[Figure (not displayed)]
1720[Figure (not displayed)]
1725[Figure (not displayed)]
MS (ESI) m/z 732.19 [M + 1]+
1722[Figure (not displayed)]
MS (ESI) m/z 817.25 [M + 1]+
1724[Figure (not displayed)]
MS (ESI) m/z 732.18 [M + 1]+
1728[Figure (not displayed)]
MS (ESI) m/z 809.32 [M + 1]+
1726[Figure (not displayed)]
MS (ESI) m/z 823.30 [M + 1]+
1727[Figure (not displayed)]
MS (ESI) m/z 732.19 [M + 1]+
1729[Figure (not displayed)]
MS (ESI) m/z 823.3 [M + 1]+
1732[Figure (not displayed)]
MS (ESI) m/z 837.31 [M + 1]+
1730[Figure (not displayed)]
MS (ESI) m/z 746.28 [M + 1]+
1731[Figure (not displayed)]
MS (ESI) m/z 823.27 [M + 1]+
1735[Figure (not displayed)]
MS (ESI) m/z 796.33 [M + 1]+
1733[Figure (not displayed)]
MS (ESI) m/z 785.26 [M + 1]+
1734[Figure (not displayed)]
MS (ESI) m/z 839.26 [M + 1]+
1738[Figure (not displayed)]
MS (ESI) m/z 848.33 [M + 1]+
1736[Figure (not displayed)]
MS (ESI) m/z 810.23 [M + 1]+
1737[Figure (not displayed)]
MS (ESI) m/z 838.32 [M + 1]+
1741[Figure (not displayed)]
MS (ESI) m/z 834.32 [M + 1]+
1739[Figure (not displayed)]
MS (ESI) m/z 847.32 [M + 1]+
1740[Figure (not displayed)]
MS (ESI) m/z 834.36 [M + 1]+
1744[Figure (not displayed)]
MS (ESI) m/z 825.21 [M + 1]+
1742[Figure (not displayed)]
MS (ESI) m/z 834.31 [M + 1]+
1743[Figure (not displayed)]
MS (ESI) m/z 788.18 [M + 1]+
1747[Figure (not displayed)]
MS (ESI) m/z 813.29 [M + 1]+
1745[Figure (not displayed)]
MS (ESI) m/z 821.25 [M + 1]+
1746[Figure (not displayed)]
MS (ESI) m/z 799.24 [M + 1]+
1750[Figure (not displayed)]
MS (ESI) m/z 813.22 [M + 1]+
1748[Figure (not displayed)]
MS (ESI) m/z 811.27 [M + 1]+
1749[Figure (not displayed)]
MS (ESI) m/z 797.29 [M + 1]+
1753[Figure (not displayed)]
MS (ESI) m/z 785.32 [M + 1]+
1751[Figure (not displayed)]
MS (ESI) m/z 771.31 [M + 1]+
1752[Figure (not displayed)]
MS (ESI) m/z 708.23 [M + 1]+
1756[Figure (not displayed)]
MS (ESI) m/z 821.28 [M + 1]+
1754[Figure (not displayed)]
MS (ESI) m/z 799.34 [M + 1]+
1755[Figure (not displayed)]
MS (ESI) m/z 821.31 [M + 1]+
1757[Figure (not displayed)]
MS (ESI) m/z 835.45 [M + 1]+
1758[Figure (not displayed)]
MS (ESI) m/z 758.28 [M + 1]+
1759[Figure (not displayed)]
MS (ESI) m/z 835.26 [M + 1]+
1760[Figure (not displayed)]
MS (ESI) m/z 849.43 [M + 1]+
1761[Figure (not displayed)]
LCMS (ESI) m/z 821.4 [M + 1]+
1762[Figure (not displayed)]
LCMS (ESI) m/z 863.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.72 (s, 1H), 9.53 (d, J = 9.3 Hz, 1H), 8.83 (d, J = 4.9 Hz, 1H), 8.78 (d, J = 6.8 Hz, 2H), 7.78 (dd, J = 8.3, 0.5 Hz, 1H), 7.77-7.66 (m, 2H), 7.64 (d, J = 4.9 Hz, 1H), 6.73 (t, J = 21 Hz, 1H), 5.21 (tt, J = 7.8, 6.2 Hz, 1H), 5.00-4.89 (m, 4H), 4.84 (s, 2H), 4.82- 4.74 (m, 1H), 4.60 (p, J = 8.0 Hz, 1H), 3.94 (q, J = 7.8 Hz, 1H), 3.58 (d, J = 11.8 Hz, 2H), 3.13 (s, 3H), 3.05 (s, 2H), 2.78-2.68 (m, 1H), 2.72 (s, 1H), 2.17-2.06 (m, 4H), 1.97 (s, 3H)
1763[Figure (not displayed)]
LCMS (ESI) m/z 884.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.02 (s, 1H), 8.90 (d, J = 4.9 Hz, 1H), 8.72 (ddd, J = 4.7, 1.7, 1.0 Hz, 1H), 8.63 (d, J = 13.4 Hz, 2H), 8.27 (dt, J = 7.9, 1.1 Hz, 1H), 8.24-8.16 (m, 1H), 7.80-7.67 (m, 4H), 7.66 (d, J = 4.8 Hz, 1H), 6.72 (t, J = 76 Hz, 1H), 4.83 (s, 2H), 4.78 (dt, J = 7.3, 3.8 Hz, 1H), 4.58 (d, J = 5.8 Hz, 1H), 3.93 (q, J = 7.6 Hz, 1H), 3.56 (d, J = 11.8 Hz, 2H), 3.04 (s, 1H), 2.72 (dd, J = 14.6, 7.1 Hz, 2H), 2.09 (s, 3H), 1.97 (s, 3H)
1764[Figure (not displayed)]
LCMS (ESI) m/z 884.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.95-8.89 (m, 2H), 8.82 (d, J = 4.9 Hz, 1H), 8.65 (s, 1H), 8.47 (s, 1H), 8.07 76 Hz, 1H) 4.81-4.71 (m, 2H), 4.55 (p, J = 8.0 Hz, 1H), 3.93-3.85 (m, 1H), 3.53 (d, J = 11.7 Hz, 2H), 3.01 (s, 1H), 2.77-2.63 (m, 2H), 2.07 (s, 3H), 1.90 (s, 2H), 1.90 (d, J = 16.7 Hz, OH)
1765[Figure (not displayed)]
LCMS (ESI) m/z 884.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.24 (dd, J = 2.5, 0.8 Hz, 1H), 8.89 (dd, J = 4.8, 1.6 Hz, 1H), 8.81 (d, J = 4.9 Hz, 1H), 8.63 (s, 1H), 8.50 (ddd, J = 8.2, 2.4, 1.6 Hz, 1H), 8.46 (s, 1H), 7.76-7.64 (m, 3H), 7.64-7.57 (m, 2H), 6.69 (t, J = 76 Hz, 1H), 4.76 (d, J = 10.9 Hz, 3H), 4.55 (t, J = 8.0 Hz, 1H), 3.94-3.85 (m, 1H), 3.52 (s, 1H), 3.08 (s, 3H), 3.02 (s, 1H), 2.74-2.64 (m, 2H), 2.08 (s, 4H), 1.88 (s, 3H)
1766[Figure (not displayed)]
MS (ESI) m/z 758.34 [M + 1]+
1767[Figure (not displayed)]
MS (ESI) m/z 835.33 [M + 1]+
1768[Figure (not displayed)]
MS (ESI) m/z 877.29 [M + 1]+
1769[Figure (not displayed)]
MS (ESI) m/z 898.4 [M + 1]+
1770[Figure (not displayed)]
MS (ESI) m/z 898.26 [M + 1]+
1771[Figure (not displayed)]
MS (ESI) m/z 898.29 [M + 1]+
1772[Figure (not displayed)]
MS (ESI) m/z 839.28 [M + 1]+
1773[Figure (not displayed)]
MS (ESI) m/z 902.19 [M + 1]+
1774[Figure (not displayed)]
MS (ESI) m/z 902.23 [M + 1]+
1775[Figure (not displayed)]
MS (ESI) m/z 776.35 [M + 1]+
1776[Figure (not displayed)]
MS (ESI) m/z 853.3 [M + 1]+
1777[Figure (not displayed)]
MS (ESI) m/z 819.33 [M + 1]+
1778[Figure (not displayed)]
MS (ESI) m/z 895.27 [M + 1]+
1779[Figure (not displayed)]
MS (ESI) m/z 916.3 [M + 1]+
1780[Figure (not displayed)]
MS (ESI) m/z 916.27 [M + 1]+
1781[Figure (not displayed)]
MS (ESI) m/z 916.27 [M + 1]+
1782[Figure (not displayed)]
MS (ESI) m/z 762.31 [M + 1]+
1783[Figure (not displayed)]
MS (ESI) m/z 839.26 [M + 1]+
1784[Figure (not displayed)]
MS (ESI) m/z 776.29 [M + 1]+
1785[Figure (not displayed)]
MS (ESI) m/z 853.37 [M + 1]+
1786[Figure (not displayed)]
MS (ESI) m/z 760.31 [M + 1]+
1787[Figure (not displayed)]
MS (ESI) m/z 837.35 [M + 1]+
1788[Figure (not displayed)]
MS (ESI) m/z 851.42 [M + 1]+
1789[Figure (not displayed)]
MS (ESI) m/z 851.41 [M + 1]+
1790[Figure (not displayed)]
MS (ESI) m/z 865.46 [M + 1]+
1791[Figure (not displayed)]
MS (ESI) m/z 815.24 [M + 1]+
1792[Figure (not displayed)]
MS (ESI) m/z 836.27 [M + 1]+
1793[Figure (not displayed)]
MS (ESI) m/z 836.3 [M + 1]+
1794[Figure (not displayed)]
MS (ESI) m/z 836.33 [M + 1]+
1795[Figure (not displayed)]
MS (ESI) m/z 710.25 [M + 1]+
1796[Figure (not displayed)]
MS (ESI) m/z 787.34 [M + 1]+
1797[Figure (not displayed)]
MS (ESI) m/z 829.34 [M + 1]+
1798[Figure (not displayed)]
MS (ESI) m/z 850.31 [M + 1]+
1799[Figure (not displayed)]
MS (ESI) m/z 850.34 [M + 1]+
1800[Figure (not displayed)]
MS (ESI) m/z 850.25 [M + 1]+
1801[Figure (not displayed)]
MS (ESI) m/z 710.28 [M + 1]+
1802[Figure (not displayed)]
MS (ESI) m/z 787.28 [M + 1]+
1803[Figure (not displayed)]
MS (ESI) m/z 801.44 [M + 1]+
1804[Figure (not displayed)]
MS (ESI) m/z 797.32 [M + 1]+
1805[Figure (not displayed)]
MS (ESI) m/z 811.3 [M + 1]+
1806[Figure (not displayed)]
MS (ESI) m/z 770.31 [M + 1]+
1807[Figure (not displayed)]
MS (ESI) m/z 805.28 [M + 1]+
1808[Figure (not displayed)]
MS (ESI) m/z 819.358 [M + 1]+
1809[Figure (not displayed)]
MS (ESI) m/z 817.27 [M + 1]+
1810[Figure (not displayed)]
MS (ESI) m/z 831.26 [M + 1]+
1811[Figure (not displayed)]
MS (ESI) m/z 833.22 [M + 1]+
1812[Figure (not displayed)]
MS (ESI) m/z 833.39 [M + 1]+
1813[Figure (not displayed)]
MS (ESI) m/z 624.2 [M + 1]+
1814[Figure (not displayed)]
MS (ESI) m/z 843.32 [M + 1]+
1815[Figure (not displayed)]
MS (ESI) m/z 787.34 [M + 1]+
1816[Figure (not displayed)]
MS (ESI) m/z 850.31 [M + 1]+
1817[Figure (not displayed)]
MS (ESI) m/z 809.22 [M + 1]+
1818[Figure (not displayed)]
MS (ESI) m/z 845.26 [M + 1]+
1819[Figure (not displayed)]
MS (ESI) m/z 841.17 [M + 1]+
1820[Figure (not displayed)]
MS (ESI) m/z 817.25 [M + 1]+
1821[Figure (not displayed)]
MS (ESI) m/z 863.33 [M + 1]+
1822[Figure (not displayed)]
MS (ESI) m/z 863.38 [M + 1]+
1823[Figure (not displayed)]
MS (ESI) m/z 861.36 [M + 1]+
1824[Figure (not displayed)]
MS (ESI) m/z 895.39 [M + 1]+
1825[Figure (not displayed)]
MS (ESI) m/z 816.24 [M + 1]+
1826[Figure (not displayed)]
MS (ESI) m/z 830.3 [M + 1]+
1827[Figure (not displayed)]
MS (ESI) m/z 858.28 [M + 1]+
1828[Figure (not displayed)]
MS (ESI) m/z 833.34 [M + 1]+
1829[Figure (not displayed)]
MS (ESI) m/z 854.26 [M + 1]+
1830[Figure (not displayed)]
MS (ESI) m/z 854.26 [M + 1]+
1831[Figure (not displayed)]
MS (ESI) m/z 854.22 [M + 1]+
1832[Figure (not displayed)]
MS (ESI) m/z 868.26 [M + 1]+
1833[Figure (not displayed)]
MS (ESI) m/z 867.24 [M + 1]+
1834[Figure (not displayed)]
MS (ESI) m/z 811.4 [M + 1]+
1835[Figure (not displayed)]
MS (ESI) m/z 825.41 [M + 1]+
1836[Figure (not displayed)]
MS (ESI) m/z 819.33 [M + 1]+
1837[Figure (not displayed)]
MS (ESI) m/z 847.35 [M + 1]+
1838[Figure (not displayed)]
MS (ESI) m/z 868.26 [M + 1]+
1839[Figure (not displayed)]
MS (ESI) m/z 868.26 [M + 1]+
1840[Figure (not displayed)]
MS (ESI) m/z 868.29 [M + 1]+
1840[Figure (not displayed)]
MS (ESI) m/z 700.33 [M + 1]+
1842[Figure (not displayed)]
MS (ESI) m/z 777.26 [M + 1]+
1843[Figure (not displayed)]
MS (ESI) m/z 794.33 [M + 1]+
1844[Figure (not displayed)]
MS (ESI) m/z 796.44 [M + 1]+
1845[Figure (not displayed)]
MS (ESI) m/z 841.34 [M + 1]+
1846[Figure (not displayed)]
MS (ESI) m/z 805.38 [M + 1]+
1847[Figure (not displayed)]
MS (ESI) m/z 819.34 [M + 1]+
1848[Figure (not displayed)]
MS (ESI) m/z 823.3 [M + 1]+
1849[Figure (not displayed)]
MS (ESI) m/z 835.36 [M + 1]+
1850[Figure (not displayed)]
MS (ESI) m/z 730.34 [M + 1]+
1851[Figure (not displayed)]
MS (ESI) m/z 807.33 [M + 1]+
1852[Figure (not displayed)]
MS (ESI) m/z 730.36 [M + 1]+
1853[Figure (not displayed)]
MS (ESI) m/z 807.18 [M + 1]+
1854[Figure (not displayed)]
MS (ESI) m/z 746.16 [M + 1]+
1855[Figure (not displayed)]
MS (ESI) m/z 823.36 [M + 1]+
1856[Figure (not displayed)]
MS (ESI) m/z 730.37 [M + 1]+
1857[Figure (not displayed)]
MS (ESI) m/z 807.4 [M + 1]+
1858[Figure (not displayed)]
MS (ESI) m/z 807.3 [M + 1]+
1589[Figure (not displayed)]
MS (ESI) m/z 728.3 [M + 1]+
1860[Figure (not displayed)]
MS (ESI) m/z 805.32 [M + 1]+
1861[Figure (not displayed)]
MS (ESI) m/z 746.31 [M + 1]+
1862[Figure (not displayed)]
MS (ESI) m/z 823.39 [M + 1]+
1863[Figure (not displayed)]
MS (ESI) m/z 704.27 [M + 1]+
1864[Figure (not displayed)]
MS (ESI) m/z 781.26 [M + 1]+
1865[Figure (not displayed)]
MS (ESI) m/z 795.37 [M + 1]+
1866[Figure (not displayed)]
MS (ESI) m/z 718.34 [M + 1]+
1867[Figure (not displayed)]
MS (ESI) m/z 795.35 [M + 1]+
1868[Figure (not displayed)]
MS (ESI) m/z 809.44 [M + 1]+
1869[Figure (not displayed)]
MS (ESI) m/z 720.3 [M + 1]+
1870[Figure (not displayed)]
MS (ESI) m/z 797.35 [M + 1]+
1871[Figure (not displayed)]
MS (ESI) m/z 811.4 [M + 1]+
1872[Figure (not displayed)]
MS (ESI) m/z 728.26 [M + 1]+
1873[Figure (not displayed)]
MS (ESI) m/z 805.26 [M + 1]+
1874[Figure (not displayed)]
MS (ESI) m/z 819.46 [M + 1]+
1875[Figure (not displayed)]
MS (ESI) m/z 819.33 [M + 1]+
1876[Figure (not displayed)]
MS (ESI) m/z 746.28 [M + 1]+
1877[Figure (not displayed)]
MS (ESI) m/z 823.3 [M + 1]+
1878[Figure (not displayed)]
MS (ESI) m/z 746.34 [M + 1]+
1879[Figure (not displayed)]
MS (ESI) m/z 823.33 [M + 1]+
1880[Figure (not displayed)]
MS (ESI) m/z 756.29 [M + 1]+
1881[Figure (not displayed)]
MS (ESI) m/z 833.32 [M + 1]+
1882[Figure (not displayed)]
MS (ESI) m/z 738.34 [M + 1]+
1883[Figure (not displayed)]
MS (ESI) m/z 815.4 [M + 1]+
1884[Figure (not displayed)]
MS (ESI) m/z 692.31 [M + 1]+
1885[Figure (not displayed)]
MS (ESI) m/z 772.35 [M + 1]+
1886[Figure (not displayed)]
MS (ESI) m/z 849.4 [M + 1]+
1887[Figure (not displayed)]
MS (ESI) m/z 758.28 [M + 1]+
1888[Figure (not displayed)]
MS (ESI) m/z 835.26 [M + 1]+
1889[Figure (not displayed)]
MS (ESI) m/z 754.34 [M + 1]+
1890[Figure (not displayed)]
MS (ESI) m/z 831.29 [M + 1]+
1891[Figure (not displayed)]
MS (ESI) m/z 740.33 [M + 1]+
1892[Figure (not displayed)]
MS (ESI) m/z 817.32 [M + 1]+
1893[Figure (not displayed)]
MS (ESI) m/z 722.34 [M + 1]+
1894[Figure (not displayed)]
MS (ESI) m/z 799.27 [M + 1]+
1895[Figure (not displayed)]
MS (ESI) m/z 716.5 [M + 1]+
1896[Figure (not displayed)]
MS (ESI) m/z 716.33 [M + 1]+
1897[Figure (not displayed)]
MS (ESI) m/z 702.46 [M + 1]+
1898[Figure (not displayed)]
LCMS 1.90 (ESI) m/z 669.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.97 (s, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.40 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.50- 7.41 (m, 2H), 7.36 (s, 1H), 7.23- 7.09 (m, 2H), 4.40 (t, J = 5.0 Hz, 2H), 4.24 (t, J = 4.9 Hz, 2H), 3.55 (d, J = 4.8 Hz, 2H), 3.38-3.24 (m, 3H), 2.71-2.62 (m, 2H), 2.46 (s, 3H), 2.33 (p, J = 1.9 Hz, 1H), 1.75 (s, 3H)
1982[Figure (not displayed)]
MS (ESI) m/z 461.0 [M + 1]+
1983[Figure (not displayed)]
MS (ESI) m/z 497.0 [M + 1]+
1984[Figure (not displayed)]
MS (ESI) m/z 655.19 [M + 1]+
1985[Figure (not displayed)]
MS (ESI) m/z 734.34 [M + 1]+
2020[Figure (not displayed)]
MS (ESI) m/z 627.43 [M + 1]+
2021[Figure (not displayed)]
MS (ESI) m/z 806.23 [M + 1]+
2022[Figure (not displayed)]
MS (ESI) m/z 731.29 [M + 1]+
2029[Figure (not displayed)]
MS (ESI) m/z 746.25 [M + 1]+
2023[Figure (not displayed)]
MS (ESI) m/z 790.3 [M + 1]+
2024[Figure (not displayed)]
MS (ESI) m/z 713.31 [M + 1]+
2025[Figure (not displayed)]
MS (ESI) m/z 789.36 [M + 1]+
2032[Figure (not displayed)]
2030[Figure (not displayed)]
MS (ESI) m/z 837.28 [M + 1]+
2031[Figure (not displayed)]
MS (ESI) m/z 705.34 [M + 1]+
2041[Figure (not displayed)]
MS (ESI) m/z 807.38 [M + 1]+
2038[Figure (not displayed)]
MS (ESI) m/z 718.1 [M + 1]+
2039[Figure (not displayed)]
MS (ESI) m/z 734.37 [M + 1]+
2042[Figure (not displayed)]
MS (ESI) m/z 807.38 [M + 1]+

Example 2

The 7-CF3-thienylpyridine and derivative compounds in Table 2 can be synthesized using methods described in Example 2. Many of the reactions described in Example 1 were used to synthesize compounds in Table 2. For some compounds, some of the reactions described in Example 3, below, can be used to prepare the compounds.

[Figure (not displayed)]

To a solution of diisopropyl amine (17.8 mL, 0.123 mol) in dry tetrahydrofuran (200 mL) is added n-butyllithium (1.6 M, 66.5 mL, 0.113 mol) drop wise at −78° C. under argon atmosphere. The reaction mixture is warmed to −10° C. and stirred for 30 min. A solution of 1-bromo-3-fluoro-5-(trifluoromethyl)benzene (1, 25.0 g, 0.102 mol) in dry tetrahydrofuran (50 mL) is added at −78° C. and mixture stirred for 45 min at −78° C. To this reaction mixture carbon dioxide gas is purged for 15 min and the temperature is gradually increased to room temperature in 2 h. After completion, the reaction mixture is cooled to −78° C. and quenched with ice water. The mixture is basified with 1 N aqueous sodium hydroxide solution and washed with diethyl ether. The aqueous layer is acidified with 2 N hydrochloric acid to pH˜1 and extracted with ethyl acetate. The organic layer is separated, dried over anhydrous sodium sulphate, filtered and concentrated to afford 2-bromo-6-fluoro-4-(trifluoromethyl)benzoic acid (2).

[Figure (not displayed)]

To a solution 2-bromo-6-fluoro-4-(trifluoromethyl)benzamide (3, 4.5 g, crude, 15.7 mmol) in N,N-dimethylformamide (40 mL), potassium carbonate (6.5 g, 47.2 mmol) and (2,4-dimethoxyphenyl)methanamine (3.1 mL, 20.45 mmol) are added at room temperature. The reaction mixture is heated to 50° C. and stirred for 16 h. After completion of reaction, the reaction mixture is poured into ice water and extracted with ethyl acetate The organic layer is washed with brine solution, dried over anhydrous sodium sulphate, filtered, concentrated under reduced pressure to get crude. The crude is purified by column chromatography using 5% methanol in dichloromethane as eluent. The desired fractions are concentrated under reduced pressure to afford 2-bromo-6-((2,4-dimethoxybenzyl)amino)-4-(trifluoromethyl)benzamide (4).

To a solution of 2-bromo-6-((2,4-dimethoxybenzyl)amino)-4-(trifluoromethyl)benzamide (4, 1.0 g, 2.30 mmol) in dichloromethane (10 mL) is added trifluoroacetic acid (1.8 mL, 23.0 mmol), and the mixture is stirred for 30 min. After completion of reaction, the reaction mixture is concentrated, and the resulting crude is diluted with dichloromethane and washed with saturated sodium bicarbonate solution, brine solution, dried over anhydrous sodium sulphate and concentrated under reduced pressure to get crude. The crude is purified by column chromatography using 5% methanol in dichloromethane as eluent. The desired fractions are concentrated under reduced to afford 2-amino-6-bromo-4-(trifluoromethyl)benzamide (5).

To a solution of 2-amino-6-bromo-4-(trifluoromethyl)benzamide (5, 2.0 g, 7.06 mmol) in dichloromethane (20 mL) are added triethylamine (2.93 mL, 21 mmol) and 2-fluoroacetyl chloride (1.0 mL, 14.1 mmol) at 0° C., and the reaction mixture is stirred for 30 min at same temperature. After completion of reaction, the reaction mixture is diluted with ice water and extracted with dichloromethane. The organic layer is washed with saturated brine solution, dried over anhydrous sodium sulphate and concentrated under reduced pressure to afford 2-bromo-6-(2-fluoroacetamido)-4-(trifluoromethyl)benzamide (6).

To a solution of 2-bromo-6-(2-fluoroacetamido)-4-(trifluoromethyl)benzamide (6, 0.600 g, 1.749 mmol) in ethanol (5 mL) is added 5% sodium hydroxide (4.0 mL). The mixture is heated to 110° C. and stirred for 30 min. After completion of reaction, the reaction mixture is neutralized with 1 N hydrochloric acid and extracted with ethyl acetate. The organic layer is washed with saturated brine solution, dried over anhydrous sodium sulphate and concentrated under reduced pressure to get crude product. The crude product is purified by column chromatography using silica gel (100-200 mesh) and 0-5% methanol in dichloromethane as eluent. The desired fractions are concentrated under reduced pressure to afford 5-bromo-2-(fluoromethyl)-7-(trifluoromethyl)quinazolin-4(3H)-one (7).

[Figure (not displayed)]

To a solution of 7-bromo-6-fluoro-2-methyl-4-oxo-3,4-dihydroquinazoline-5-carbonitrile (5, 0.200 g, 0.7 mmol) in N,N-dimethylformamide (2 mL), copper(I) iodide (0.159 g, 0.84 mmol) and methyl 2,2-difluoro-2-(fluorosulfonyl)acetate (5a, 0.403 g, 2.1 mmol) are added and reaction mixture is heated at 100° C. for 16 h. After completion, reaction mixture is cooled; water is added to reaction mixture and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulphate, filtered and concentrated to afford 6-fluoro-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (6).

[Figure (not displayed)]

A suspension of copper(I) bromide (89.8 g, 620.1 mmol) and tert-butyl nitrite (63.8 mL, 620.1 mmol) in acetonitrile (2500 mL) is heated at 65° C. for 15 min. A solution of 2-bromo-4-fluoro-6-(trifluoromethyl)aniline (1, 100 g, 387.6 momol) in acetonitrile is added and heated the reaction mixture at 65° C. for 1 h. After completion, the reaction mass is quenched with water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulphate, filtered and concentrated under reduced pressure to get the crude material. The crude compound is purified by column chromatography using 0-5% ethyl acetate in hexanes over silica gel (100-200 mesh) to afford 1,2-dibromo-5-fluoro-3-(trifluoromethyl)benzene (2).

[Figure (not displayed)]

To a stirred solution of 4-fluoro-1-methyl-2-(trifluoromethyl)benzene (1, 1.05 g, 5.89 mmol) in TFA (4 mL) is added sulfuric acid (1.25 mL) and then N-bromosuccinimide (1.05 g, 5.89 mmol). The resulting mixture is capped, covered in aluminum foil to keep light out, and stirred at room temperature overnight. The reaction mixture is poured into vigorously stirred ice water and then extracted with hexanes. The organics are washed with brine, then saturated aqueous sodium bicarbonate. The organics are dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and purified via silica gel chromatography (100% hexanes) to afford 1-bromo-5-fluoro-2-methyl-3-(trifluoromethyl)benzene (2).

[Figure (not displayed)]

To a solution of 2-bromo-4-fluoro-6-(trifluoromethyl)aniline (1, 100.0 g, 389.2 mmol) in acetonitrile (2500 mL) is added p-toluenesulfonic acid (220.9 g, 1160.1 mmol) portion wise at −10° C. A solution of sodium nitrite (51.68 g, 750 mmol) and potassium iodide (157.7 g, 949.2 mmol) in water (100 mL) is added at −10° C. and the mixture is stirred for 45 min at −10° C. After completion, the reaction mixture is quenched with water & extracted with ethyl acetate (5000 mL). The organic layer is washed with aqueous saturated sodium thiosulphate (500 mL). Organic layer is separated, dried over anhydrous sodium sulphate, filtered and concentrated to afford 1-bromo-5-fluoro-2-iodo-3-(trifluoromethyl)benzene (2).

To a solution of 1-bromo-5-fluoro-2-iodo-3-(trifluoromethyl) benzene (2, 80.0 g, 217.3 mmol) in N,N-dimethylformamide (500 mL), copper(I) cyanide (19.4 g, 217.2 mmol) is added at room temperature. The reaction mixture is stirred at 90° C. for 12 h. After completion, it is cooled to room temperature, poured into ice water and extracted with ethyl acetate (2.0 L). The organic layer is washed with brine solution, dried over anhydrous sodium sulphate and concentrated under reduced pressure to get crude. The crude compound is purified by flash column chromatography using 0-5% ethyl acetate in hexanes to afford 2-bromo-4-fluoro-6-(trifluoromethyl)benzonitrile (3).

To a solution 2-bromo-4-fluoro-6-(trifluoromethyl)benzonitrile (3, 12.0 g, 44.9 mmol) in tetrahydrofuran (200 mL), borane in tetrahydrofuran (1 M, 67 mL, 67.1 mmol) is added drop wise at 0° C. The reaction mixture is allowed to stir at 90° C. for 12 h. After completion, the reaction mixture is poured into chilled methanol and concentrated under reduced pressure. The crude compound is purified by flash column chromatography using 0-15% ethyl acetate in hexanes to afford (2-bromo-4-fluoro-6-(trifluoromethyl) phenyl)methanamine (4).

To a solution of (2-bromo-4-fluoro-6-(trifluoromethyl) phenyl)methanamine (4, 6.0 g, 22.6 mmol) in methanol (100 mL), paraformaldehyde (6.0 g, 200.0 mmol) and solution of sodium acetate (5.4 g, 66.0 mmol) in water (10 mL) are added and stirred at room temperature for 1 h. Sodium cyanoborohydride (4.03 g, 66.1 mmol) is added portion wise at 0° C. The reaction mixture is allowed to stir at room temperature for 12 h. After completion, the reaction mixture is concentrated under reduced pressure. Crude residue is diluted with water and extracted with diethyl ether (100 mL). The crude compound is purified by flash column chromatography using 0-15% ethyl acetate in hexanes to afford 1-(2-bromo-4-fluoro-6-(trifluoromethyl)phenyl)-N,N-dimethylmethanamine (5).

[Figure (not displayed)]

To a solution of 5-bromo-6-(hydroxymethyl)-2-methyl-7-(trifluoromethyl)quinazolin-4(3H)-one (A, 0.32 g, 0.94 mmol) in dichlomethane (6 mL) at 0° C., triethyl amine (0.39 mL, 2.84 mmol) and methanesulfonyl chloride (0.11 mL, 1.42 mmol) are added and stirred at 0° C. for 1 h. After completion, the reaction mixture is diluted with water and extracted with dichloromethane. The organic layer is washed with water, saturated brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to afford 5-bromo-6-(chloromethyl)-2-methyl-7-(trifluoromethyl)quinazolin-4(3H)-one (1)

To a solution of 4,4-difluoro piperidine (1a, 2.0 g, 12.7 mmol) in N,N-dimethylformamide (10.0 mL) is added potassium carbonate (1.06 g, 7.62 mmol) at room temperature and the mixture is stirred for 20 min. Then 5-bromo-6-(chloromethyl)-2-methyl-7-(trifluoromethyl)quinazolin-4(3H)-one (1, 0.9 g, 2.54 mmol) is added to the reaction mixture at room temperature and stirring is continued for 24 h. After completion, the reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is washed with water and saturated brine solution, dried over anhydrous sodium sulphate, filtered and concentrated. The crude product is purified by column chromatography using silica gel (100-200 mesh) and 50% ethyl acetate in hexane as eluent. The desired fractions are concentrated under reduced pressure to afford 5-bromo-6-((4,4-difluoropiperidin-1-yl)methyl)-2-methyl-7-(trifluoromethyl)quinazolin-4(3H)-one (2).

[Figure (not displayed)]

To a solution of 6-bromo-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (1, 50 mg, 0.151 mmol) in tetrahydrofuran (3 mL) and water (0.75 mL) are added 1-methyl-4-((trifluoro-λ4-boranyl)methyl)piperazine, potassium salt (1a, 497 mg, 2.25 mmol), cesium carbonate (196 mg, 0.602 mmol) and XPhos Chloro(2-dicyclohexylphosphino-2′,4′,6′-triisopropyl-1,1′-biphenyl)[2-(2′-amino-1,1′-biphenyl)]palladium(II) (24 mg, 0.0301 mmol) and the mixture is sparged with argon for 5 min, then it is sealed and heated to 80° C. for 15 h. After completion, the mixture is concentrated under reduced pressure to get crude product. The crude product obtained is purified by prep-HPLC to afford 2-methyl-6-((4-methylpiperazin-1-yl)methyl)-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (2).

[Figure (not displayed)]

A solution of 6-bromo-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (1, 1.00 g, 3.02 mmol), tert-butyl 4-methylenepiperidine-1-carboxylate (1a, 5.90 g, 30.1 mmol), triethylamine (1.20 mL, 9.03 mmol), and tri (o-tolyl)phosphine (0.366 g, 1.23 mmol) in acetonitrile (10.0 mL) is degassed with argon for 10 min. Palladium (II) acetate (0.134 g, 0.60 mmol) is then added to the reaction mixture and degassing is continued for 5 min. The reaction mixture is heated at 90° C. for 24 h. After this time, the reaction mixture is cooled to room temperature, diluted with ethyl acetate, and concentrated to dryness under reduced pressure. The crude product is purified by silica gel (100-200 mesh) column chromatography using 30-50% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 4-((5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazolin-6-yl)methylene)piperidine-1-carboxylate (2).

To a solution of tert-butyl 4-((5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazolin-6-yl)methylene)piperidine-1-carboxylate (2, 0.90 g, 2.0 mmol) in methanol (20 mL) is added 10% palladium on carbon (1.35 g) at room temperature. The reaction mixture is stirred at room temperature for 2 h under hydrogen atmosphere. Then, the reaction mixture is filtered with Celite. The filtrate is washed with ethyl acetate and concentrated to dryness under reduced pressure to obtain a crude product. The crude product is purified by silica gel (100-200 mesh) column chromatography using 3-5% methanol in dichloromethane as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 4-((5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazolin-6-yl)methyl)piperidine-1-carboxylate (3).

[Figure (not displayed)]
[Figure (not displayed)]

To a solution of 4-fluoro-2-(trifluoromethyl)aniline (1, 100.0 g, 558.66 mmol) in N,N-dimethylformamide (500 mL), N-chlorosuccinamide (78.7 g, 558.66 mmol) is added at room temperature. This reaction mixture is stirred for 16 h. After this time, the mixture is diluted with water and extracted with ethyl acetate. The organic layer is washed with water and then brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product is purified by silica gel (100-200 mesh) column chromatography using hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 2-chloro-4-fluoro-6-(trifluoromethyl)aniline (2).

To a solution of 2-chloro-4-fluoro-6-(trifluoromethyl)aniline (2, 43.0 g, 201.87 mmol) in acetonitrile (200 mL) at −10° C., p-toluenesulfonic acid monohydrate (115.0 g, 605.63 mmol) is added. This reaction mixture is stirred for 15 min at the same temperature. A solution of sodium nitrite (27.85 g, 403.74 mmol) and potassium iodide (83.77 g, 504.67 mmol) in water (50 mL) is added dropwise to the reaction mixture as it is stirred at −10° C. for 30 min. Next, the reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is washed with aqueous saturated sodium thiosulfate solution and then brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product is purified by silica gel (100-200 mesh) column chromatography using hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 1-chloro-5-fluoro-2-iodo-3-(trifluoromethyl)benzene (3).

To a solution of 1-chloro-5-fluoro-2-iodo-3-(trifluoromethyl)benzene (3, 30 g, 92.6 mmol) in N,N-dimethylformamide (200 mL), copper(I) cyanide (12.36 g, 138.88 mmol) is added. This reaction mixture is heated at 100° C. for 16 h. After this time, the mixture is diluted with water and extracted with ethyl acetate. The organic layer is washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product is purified by silica gel (100-200 mesh) column chromatography using 3% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 2-chloro-4-fluoro-6-(trifluoromethyl)benzonitrile (4).

To a solution of 2-chloro-4-fluoro-6-(trifluoromethyl)benzonitrile (4, 15.0 g, 67.26 mmol) in dry dichloromethane (150 mL) at −78° C., diisobutylaluminiumhydride (1.0 M in toluene, 134.52 mL, 134.52 mmol) is added dropwise. The mixture is stirred at same temperature for 30 min. Next, the reaction mixture is quenched with 1 N aqueous hydrochloric acid and extracted with dichloromethane. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to dryness under reduced pressure to afford 2-chloro-4-fluoro-6-(trifluoromethyl)benzaldehyde (5).

To a solution of 2-chloro-4-fluoro-6-(trifluoromethyl)benzaldehyde (5, 17.00 g, 75.22 mmol) in tetrahydrofuran (100 mL), 2-methylpropane-2-sulfinamide (5a, 13.65 g, 112.83 mmol) and titanium ethoxide (34.30 mL, 150.44 mmol) are added dropwise at room temperature. This reaction mixture is stirred at the same temperature for 16 h. After this time, the reaction mixture is quenched with aqueous ammonium chloride solution, filtered with Celite, and washed with ethyl acetate. The filterate is concentrated and the crude residue is purified by Combi-flash (40 g, Redi-Sep column) using 20% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford (E)-N-(2-chloro-4-fluoro-6-(trifluoromethyl)benzylidene)-2-methylpropane-2-sulfinamide (6).

Magnesium turnings (5.0 g) are added to dry tetrahydrofuran (50 mL) followed by iodine (0.002 g) and the mixture is heated to just above room temperature. Then, 2-(2-bromoethyl)-1,3-dioxane (6a, 9.8 mL, 72.94 mmol) is added and the mixture is heated till it became colorless. Then, this mixture is added dropwise to a solution of (E)-N-(2-chloro-4-fluoro-6-(trifluoromethyl)benzylidene)-2-methylpropane-2-sulfinamide (6, 12.00 g, 36.47 mmol) in tetrahydrofuran (50 mL) at room temperature. The resulting mixture is stirred at room temperature for 1 h. Next, the reaction mixture is quenched with aqueous ammonium chloride solution and extracted with ethyl acetate. The organic layer dried over anhydrous sodium sulfate and concentrated. The crude residue is purified by Combi-flash (40 g, Redi-Sep column) using 30% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford N-(1-(2-chloro-4-fluoro-6-(trifluoromethyl)phenyl)-3-(1,3-dioxan-2-yl)propyl)-2-methylpropane-2-sulfinamide (7).

A solution mixture of N-(1-(2-chloro-4-fluoro-6-(trifluoromethyl)phenyl)-3-(1,3-dioxan-2-yl)propyl)-2-methylpropane-2-sulfinamide (7, 12.00 g, 26.96 mmol) in trifluroacetic acid in water (3:1, 180 mL) is stirred at room temperature for 16 h. After this time, the reaction mixture is quenched with aqueous sodium bicarbonate solution and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated. The solid residue is dissolved in methanol, after which sodium borohydrate (8.00 g, 269.66 mmol) is added at 0° C. and the mixture is stirred at room temperature for 8 h. After this time, the reaction mixture is quenched with ice-cold water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to dryness under reduced pressure to afford 2-(2-chloro-4-fluoro-6-(trifluoromethyl)phenyl)pyrrolidine (8).

[Figure (not displayed)]

To a solution of 2,3-difluoro-4-(trifluoromethyl)benzoic acid (1, 5 g, 22.123 mmol) in N,N-dimethylformamide (50 mL), N-iodosuccinimide (7.43 g, 33.185 mmol) is added and purged with argon for 20 min. Then, palladium acetate (1.48 g, 6.637 mmol) is added and reaction mixture is heated at 100° C. for 48 h. After completion, the reaction mixture is cooled, diluted with water and extracted with ethyl acetate. The combined organic layer is washed with cold water and brine solution, dried over anhydrous sodium sulphate, filtered and concentrated under reduced pressure to afford 2,3-difluoro-6-iodo-4-(trifluoromethyl)benzoic acid (2).

[Figure (not displayed)]

To a solution 2-bromo-4-chlorophenol (7, 50.0 g, 241.0 mmol) in aqueous sodium hydroxide (1 M) (1.0 L), tetra-n-butylammonium bromide (11.64 g, 36.15 mmol) and potassium iodide (6.00 g, 36.15 mmol) are added. 1,2-dibromoethane (8,165.6 g, 891.7 mmol) is added at 85° C. and stirred for 16 h at the same temperature. After completion, the reaction mixture is poured into water and extracted with ethyl acetate. Combined organic layer are washed with water, brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to get crude; the crude compound is purified by flash column chromatography (using 0-5% ethyl acetate in hexanes) to afford 2-bromo-1-(2-bromoethoxy)-4-chlorobenzene (9).

[Figure (not displayed)]

A stirred solution of thieno[3,2-b]pyridin-7-ol (1, 2.0 g, 13.2 mmol) in phosphorous oxybromide (7.5 g, 26.4 mmol) and 1,2-dichloroethane is heated at 90° C. for 12 h. After completion of the reaction, the mixture is cooled to room temperature and quenched with saturated aqueous solution of sodium bicarbonate and extracted with ethyl acetate. The organic layer is washed with brine, dried over anhydrous sodium sulphate, filtered and concentrated to afford 7-bromothieno[3,2-b]pyridine (2).

To a stirred solution of 7-bromothieno[3,2-b]pyridine (2, 1.5 g, 7.04 mmol) in dry tetrahydrofuran (20 mL), freshly prepared lithium diisopropylamide (2.0 M in hexane, 8.75 mL, 17.5 mmol) is added at −78° C. and the mixture is stirred at same temperature for 1 h. Hexachloroethane (2.0 mL, 8.44 mmol) is added drop wise and the reaction mixture is allowed to warm up to room temperature over 3 h. The reaction is quenched with aqueous ammonium chloride solution, diluted with water and extracted with ethyl acetate. The organic layer is washed with water and saturated brine solution, dried over anhydrous sodium sulphate, filtered and concentrated. The crude product is purified over a plug of silica gel eluting the compound with ethyl acetate in hexanes (0-10%). The desired fractions are concentrated under reduced pressure to afford 7-bromo-2-chlorothieno[3,2-b]pyridine (3).

To a solution of 7-bromo-2-chlorothieno[3,2-b]pyridine (3, 0.5 g, 2.02 mmol) in dry tetrahydrofuran (10 mL) and the mixture is cooled to −78° C. Lithium diisopropylamide (2 M, 1.5 mL, 3.03 mmol) is added drop wise and the reaction mixture is stirred at −78° C. for 1 h. Carbon dioxide gas is purged through the reaction mass for 20 min at same temperature and is stirred for 1 h at −78° C. The reaction mixture is slowly warmed to 0° C. and stirred for 30 min. After completion, reaction mixture is quenched with water and washed with ethyl acetate. Ethyl acetate layer is discarded and aqueous layer is acidified with aqueous solution of citric acid. It is then extracted with ethyl acetate. The organic layer is separated, dried over anhydrous sodium sulphate, filtered and concentrated under reduced pressure to afford 7-bromo-2-chlorothieno[3,2-b]pyridine-3-carboxylic acid (4).

[Figure (not displayed)]

To a stirred solution of 7-chlorothieno[3,2-b]pyridine (1, 1.5 g, 8.9 mmol) in dry tetrahydrofuran (50 mL) is added drop wise lithium diisopropylamide (11.7 mL, 19.5 mmol) at −78° C. and the mixture is stirred at same temperature for 1 h. Iodine (2.25 g, 8.87 mmol dissolved in tetrahydrofuran, 10 mL) is added drop wise and the reaction mixture is allowed to warm up to room temperature over 4 h. It is quenched with aqueous solution of ammonium chloride and extracted with ethyl acetate. The organic layer is washed with water and saturated brine solution, dried over anhydrous sodium sulphate, filtered and concentrated to dryness under reduced pressure. The crude product is purified by Combiflash (12 g, RediSep column) using 5-10% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 7-chloro-2-iodothieno[3,2-b]pyridine (2).

To a solution of 7-chloro-2-iodothieno[3,2-b]pyridine (2, 1.0 g, 3.4 mmol) in N,N-dimethylformamide (10 mL), N-bromo succinamide is added at room temperature. The reaction mixture is heated and stirred at 70° C. for 12 h. After completion of the reaction, the mixture is diluted with water and extracted with ethyl acetate. The organic layer is washed with water and saturated brine solution, dried over anhydrous sodium sulphate, filtered and concentrated under reduced pressure. The crude product is purified by Combiflash (12 g, RediSep column) using 5-10% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 3-bromo-7-chloro-2-iodothieno[3,2-b]pyridine (3).

A suspension 3-bromo-7-chloro-2-iodothieno[3,2-b]pyridine (3, 1.0 g, 2.7 mmol) and tributyl vinyl tin (1.01 mL, 3.21 mmol) in 1,4-dioxane (10 mL) is degassed using argon for 10 min. Tetrakis(triphenylphosphine)palladium(0) (0.21 g, 0.19 mmol) is added to the reaction mixture at room temperature and the mixture is heated at 100° C. for 1 h. After completion, the reaction mixture is cooled to room temperature, diluted with water and extracted with ethyl acetate. The ethyl acetate layer is dried over sodium sulfate and concentrated to dryness under reduced pressure. The crude product is purified over a plug of silica gel eluting the compound with ethyl acetate:hexanes (1-10%). The desired fractions are concentrated under reduced pressure to afford 3-bromo-7-chloro-2-vinylthieno[3,2-b]pyridine (4).

To a solution of 3-bromo-7-chloro-2-vinylthieno[3,2-b]pyridine (4, 0.6 g, 2.19 mmol) in dry tetrahydrofuran (20 mL) is added drop wise n-Butyl lithium (1.7 mL 1.3 M in hexanes, 2.19 mmol) at −78° C. and reaction mixture is stirred at the same temperature for 2 h. Carbon dioxide gas is purged through the reaction mixture at −78° C. for 30 min and the reaction mixture is stirred for 1 h at the same temperature. The reaction mixture is slowly warmed to 0° C. and stirred for 30 min. After completion, reaction mixture is quenched with water and washed with ethyl acetate. Ethyl acetate layer is discarded and aqueous layer is acidified with aqueous solution of citric acid and extracted with ethyl acetate. The organic layer is separated, dried over anhydrous sodium sulphate, filtered and concentrated under reduced pressure to afford 7-chloro-2-vinylthieno[3,2-b]pyridine-3-carboxylic acid (5).

[Figure (not displayed)]

Methyl 7-bromothieno[3,2-b]pyridine-3-carboxylate (1, 68.0 mg, 0.25 mmol) and bis(trifluoromethylsulfinyloxy)zinc (1a, 139.8 mg, 0.50 mmol) are dissolved in dimethylsulfoxide (1.71 mL) in an oven-dried screw capped vial equipped with a stir bar. The mixture is stirred vigorously at 0° C. while tert-butyl hydroperoxide (0.09 mL, 0.92 mmol) is added slowly. After completion of addition the ice bath is removed and the reaction mixture is heated to 50° C. in a heating block for 2.5 h before being cooled to room temperature. The reaction mixture is diluted with saturated aqueous sodium bicarbonate and ethyl acetate. The layers are separated and the aqueous phase extracted with ethyl acetate three times. The combined organic material is washed with brine and dried over magnesium sulfate. The solids are filtered and solvent removed in vacuo to afford a crude residue that is purified via silica gel chromatography (5 to 40% ethyl acetate in hexanes), affording methyl 7-bromo-2-(trifluoromethyl)thieno[3,2-b]pyridine-3-carboxylate (2).

[Figure (not displayed)]

A solution of tert-butyl 7-bromothieno[3,2-b]pyridine-3-carboxylate (1, 150.0 mg, 0.480 mmol), (3-oxo-1λ{3},2-benziodoxol-1-yl) acetate (417.5 mg, 0.950 mmol), 2-(tert-butyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1a, 132.0 mg, 0.720 mmol) and tris(2,2′-bipyridyl)dichloro-ruthenium(II)hexahydrate (35.7 mg, 0.048 mmol) in hexafluoroisopropanol (1.25 mL) is stirred at room temperature and irradiated with a 60 watt household lamp positioned 10 cm away from the vial for 24 h. After completion, reaction mixture is diluted with dichloromethane and silica gel is added. The solvent is evaporated. The crude silica mixture is purified by flash chromatography using silica gel (100-200 mesh) using 0-10% methanol in dichloromethane as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 7-bromo-2-(tert-butyl)thieno[3,2-b]pyridine-3-carboxylate (2).

[Figure (not displayed)]

Methyl 7-chlorothieno[3,2-b]pyridine-3-carboxylate (1, 0.2 g, 0.88 mmol) is dissolved in dichloromethane (2.2 mL) in an oven-dried screw capped vial equipped with a stir bar. The reaction mixture is stirred at room temperature while 3-chloroperbenzoic acid (0.24 g, 1.41 mmol) is added in 4 portions over 2 min. After 24 h the reaction mixture is poured onto silica gel and purification via silica gel chromatography (50-100% ethyl acetate in hexanes, then 10% methanol in ethyl acetate) afforded 7-chloro-3-(methoxycarbonyl)thieno[3,2-b]pyridine 4-oxide (2).

7-chloro-3-(methoxycarbonyl)thieno[3,2-b]pyridine 4-oxide (2, 0.12 g, 0.47 mmol) is dissolved in dichloromethane (3.3 mL) in an oven-dried screw capped vial equipped with a stir bar. The mixture is stirred at room temperature while methanesulfonyl chloride (0.18 mL, 2.36 mmol) dropwise. After 3 h more methanesulfonyl chloride (0.18 mL, 2.36 mmol) is added dropwise. After 4.5 h the reaction mixture is warmed to 40° C. and stirred an additional 16 h before being cooled to room temperature. The reaction mixture is poured onto silica gel and purification via silica gel chromatography (0-50% ethyl acetate in hexanes) afforded methyl 5,7-dichlorothieno[3,2-b]pyridine-3-carboxylate (3).

Zinc chloride solution (0.5 M, 0.59 mL, 0.29 mmol) is dissolved in tetrahydrofuran (1.0 mL) in an oven-dried screw capped vial equipped with a stir bar. The reaction mixture is stirred at room temperature while bromo(cyclopropyl)magnesium (0.59 mL, 0.29 mmol) solution is added slowly. After 45 min a solution of methyl 5,7-dichlorothieno[3,2-b]pyridine-3-carboxylate (3, 67.0 mg, 0.25 mmol) in tetrahydrofuran (1.5 mL) is added slowly. After 1 min Pd2(dba)3 (28.4 mg, 0.03 mmol) and dppf (30.4 mg, 0.06 mmol) are added and the reaction mixture subsequently heated to 60° C. for 1 h. The reaction mixture is cooled to room temperature and poured onto saturated aqueous NH4Cl. The aq. phase is extracted with ethyl acetate three times. The combined organic material is washed with brine and dried over magnesium sulfate, filtered and solvent removed in vacuo to provide a brown oil. Purification via silica gel chromatography (8-29% ethyl acetate in hexanes) afforded methyl 7-chloro-5-cyclopropylthieno[3,2-b]pyridine-3-carboxylate (4).

[Figure (not displayed)]

7-bromo-3-(methoxycarbonyl)thieno[3,2-b]pyridine 4-oxide (2, 148 mg, 0.514 mmol) is dissolved in chloroform (10 mL) and POCl3 (0.48 mL, 0.79 g, 5.1 mmol) is added. The vial is sealed and the mixture is stirred at 60° C. for 4 h, then over night at room temperature. Then the mixture is concentrated, taken up in DCM, washed with NaHCO3(aq), dried (Na2SO4), filtered, and concentrated. The crude product (140 mg) is dissolved in THF (9 mL) and sodium methanolate (25% in MeOH, 0.12 mL, 0.12 g, 0.52 mmol) is added. The mixture is stirred at room temperature for 2.75 h, and another 0.13 mL NaOMe sln (25% in MeOH) are added. After 30 min another 0.04 mL NaOMe sln (25% in MeOH) are added. After another 10 min another 0.04 mL NaOMe sln (25% in MeOH) are added. Then the mixture is diluted with DCM and washed with water. The organic phase is dried (Na2SO4), filtered, concentrated. Purification by column chromatography yielded 23.9 mg of a 3:1 mixture of 3′ and 3.

[Figure (not displayed)]

To a solution of tert-butyl 7-bromo-5-(bromomethyl)thieno[3,2-b]pyridine-3-carboxylate (2, 200.0 mg, 0.491 mmol) in N,N-dimethylpyrrolidone (3 mL) is added tert-butyl N-tert-butoxycarbonylcarbamate (160.1 mg, 0.736 mmol) and potassium carbonate (203.6 mg, 1.473 mmol) and the reaction mixture is stirred at room temperature for 24 h. After completion, reaction mixture is diluted with dichloromethane and silica gel is added. The solvent is evaporated. The crude silica mixture is purified by Isco column chromatography using 0-10% methanol in dichloromethane as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 5-[[bis(tert-butoxycarbonyl)amino]methyl]-7-bromo-thieno[3,2-b]pyridine-3-carboxylate (3).

[Figure (not displayed)]

A suspension of methyl 7-bromo-5-methylthieno[3,2-b]pyridine-3-carboxylate (1, 3.50 g, 12.3 mmol) in formalin (37-40%) 10 mL is irradiated in microwave at 120° C. for 1 h. After 1 h, the reaction mass is cooled and extracted with ethyl acetate. The starting material is not consumed in 1 h, reaction is irradiated again after work-up 3 times under microwave. The reaction is monitored by LCMS, still 50% starting material is remaining. The reaction mass is cooled and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure. The residue is purified by column chromatography using silica (100-200 mesh) and 0-40% ethyl acetate in hexane to afford methyl 7-bromo-5-(2-hydroxyethyl)thieno[3,2-b]pyridine-3-carboxylate (2).

To a solution of methyl 7-bromo-5-(2-hydroxyethyl)thieno[3,2-b]pyridine-3-carboxylate (2, 0.32 g, 1.01 mmol) in pyridine (10 mL), acetic anhydride (0.115 mL, 1.22 mmol) is added to the reaction mixture. The reaction mixture is stirred at room temperature for 16 h. After completion of reaction as confirmed on thin layer chromatography and LCMS, reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure. The crude is purified by combi flash (4 g, Redi Sep column) using 50% ethyl acetate in hexanes as eluent to afford methyl 5-(2-acetoxyethyl)-7-bromothieno[3,2-b]pyridine-3-carboxylate (3).

[Figure (not displayed)]

To a solution of 4-chloro-3-fluorophenol (1, 3.0 g, 20.59 mmol) in acetone (30 mL) iodomethane (5.2 mL, 82.00 mmol) and potassium carbonate (5.6 g, 41.00 mmol) are added at room temperature and reaction mixture is stirred at 60° C. for 12 h. After completion of reaction as confirmed on thin layer chromatography, reaction mass is evaporated and reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulphate, filtered and concentrated to get afford 1-chloro-2-fluoro-4-methoxybenzene (2).

To a solution of 1-chloro-2-fluoro-4-methoxybenzene (2, 1.9 g, 11.84 mmol) in tetrahydrofuran (20 mL), lithium di-isopropylamide (2 M in tetrahydrofuran) (11.8 mL, 23.75 mmol) is added drop wise at −78° C. and reaction mixture is stirred at same temperature for 1 h. Then Tri-Iso propyl Borate (3.26 mL, 14.16 mmol) is added dropwise at −78° C. The reaction mixture is stirred for 2 h at room temperature. After completion reaction, reaction mixture is quenched with saturated solution of ammonium chloride and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulphate, filtered and concentrated to get crude compound. The crude compound obtained is purified by combi flash chromatography using 12 gm redisep column eluting with 80% ethyl acetate in hexane to afford of (3-chloro-2-fluoro-6-methoxyphenyl)boronic acid (3).

To a solution of (3-chloro-2-fluoro-6-methoxyphenyl)boronic acid (3, 0.35 g, 1.71 mmol) in dichloromethane (5 mL) Boron tribromide (0.324 mL, 3.43 mmol) is added drop wise at 0° C. and reaction mixture is stirred at room temperature for 1 h. After completion of reaction as confirmed on thin layer chromatography the reaction mixture is quenched with ice cold water. The solid precipitated is filtered and washed with pentane to afford as (3-chloro-2-fluoro-6-hydroxyphenyl)boronic acid (4).

A suspension of tert-butyl 7-bromo-5-methylthieno[3,2-b]pyridine-3-carboxylate (4a, 0.230 g 0.8 mmol), (3-chloro-2-fluoro-6-hydroxyphenyl)boronic acid (4, 0.30 g, 1.6 mmol) and potassium carbonate (0.334 g, 2.4 mmol) in 1,4-dioxane (2.0 mL) and water (0.5 mL) is degassed with argon gas 10 min. [1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II),complex with dichloromethane (0.03 g, 0.04 mmol) is added to above suspension and reaction mixture is stirred for 3 h at 90° C. The reaction mixture is monitored with LCMS and thin layer chromatography reaction mixture. After completion, the reaction mass is filtered through Celite bed and washed with ethyl acetate. The crude compound obtained is purified through combi flash chromatography using 4 gm redisep column by eluting with 90% ethyl acetate in hexane to afford tert-butyl 7-(3-chloro-2-fluoro-6-hydroxyphenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (5).

[Figure (not displayed)]

To a solution of 2,5-dimethylpyridine (1, 10.0 g, 93.4 mmol) in Chloroform (100 mL) is added to metachloroperbenzoic acid (19.3 g, 112.1 mmol) at 0° C. under argon atmosphere and mixture is stirred at room temperature for 16 h. After completion, the reaction mixture is diluted with 10% calcium hydroxide solution and the solution is filtered through celite, filtrate is concentrated and dried to afford 2,5-dimethylpyridine 1-oxide (2).

To a solution of 2,5-dimethylpyridine 1-oxide (2, 10.0 g, 81.3 mmol) in dichloromethane (100 ml) is added to Trimethylsilylcyanide (11.2 g, 89.4 mmol) at 0° C. under argon atmosphere and stirred at room temperature for 30 minute, diethylcarbamic chloride (2a, 11.3 mL, 89.4 mmol) is added and stirring continued at room temperature for 24 h. After completion, the reaction mixture is quenched with 10% potassium carbonate solution and extracted with ethyl acetate. Organic layer is dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure. The crude product is purified by column chromatography using silica (100-200 mesh) using 30-40% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 3,6-dimethylpicolinonitrile (3).

To a solution of 3,6-dimethylpicolinonitrile (3, 7.00 g, 46.9 mmol) in Chloroform (70 mL) is added to metachloroperbenzoic acid (8.75 g, 56.6 mmol) at 0° C. under argon atmosphere and stirring continued at room temperature for 16 h. After completion, the reaction mixture is diluted with 10% calcium hydroxide solution and filtered through celite, filtrate is concentrated and dried to afford 2-cyano-3,6-dimethylpyridine 1-oxide (4).

A solution of 2-cyano-3,6-dimethylpyridine 1-oxide (4, 7.0 g, 46.9 mmol) in phosphoryl chloride (50 mL) is stirred at 90° C. for 4 h. After completion, the reaction mixture is concentrated and purified by column chromatography using silica (100-200 mesh) using 20-30% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 4-chloro-3,6-dimethylpicolinonitrile (5).

A solution of 4-chloro-3,6-dimethylpicolinonitrile (5, 4.0 g, 24.0 mmol) in ethanol (20 mL) and 10% Potassium hydroxide solution (20 mL) is stirred at 100° C. for 16 h. After completion, the reaction mixture is cooled and acidified with 2M hydrochloric acid solution up to pH 5 and extracted with ethyl acetate. Organic layer is dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure. To afford 4-chloro-3,6-dimethylpicolinic acid (6).

To a solution of 4-chloro-3,6-dimethylpicolinic acid (6, 1.50 g, 8.10 mmol) in tert-butyl alcohol (9.0 ml) is added di-tert-butyl dicarbanate (0.75 mL, 3.56 mmol) and 4-dimethylamino pyridine (1.48 g, 12.1 mmol) at 0° C. under argon atmosphere and stirred at 90° C. for 4 h. After completion, the reaction mixture is concentrated under reduced pressure. The crude compound is purified by flash column chromatography using 20-30% ethyl acetate in hexane to afford tert-butyl 4-chloro-3,6-dimethylpicolinate (7).

[Figure (not displayed)]

To a stirred solution of thieno [3,2-b]pyridin-7-ol (1, 5.0 g, 33.07 mmol) in 1,2-dichloroethane (50 mL) is added phosphorous oxybromide (143.21 g, 496.09 mmol) portionwise at room temperature and the mixture is stirred at 70° C. for 10 h. The reaction mixture is cooled at 0° C., basified with 10% aqueous solution of sodium hydroxide and extracted with dichloromethane. The organic layer is washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure to afford 7-bromothieno[3,2-b]pyridine (2).

To a stirred solution of 7-bromothieno[3,2-b]pyridine (2, 4.0 g, 18.78 mmol) in dry tetrahydrofuran (40 mL) is added lithium diisopropylamide solution (2.0 M in hexanes, 26.30 mL, 53.60 mmol) drop wise at −78° C. and the mixture is stirred at same temperature for 1 h. Carbon dioxide gas is purged through the reaction mass for 15 min and the reaction mixture is allowed to warm up to room temperature over 4 h. The reaction is quenched with aqueous ammonium chloride solution, diluted with water and extracted with ethyl acetate. The organic layer is washed with saturated brine, dried over anhydrous sodium sulphate, filtered and concentrated to afford 7-bromothieno[3,2-b]pyridine-2-carboxylic acid (3).

[Figure (not displayed)]

To a stirred solution of (4-methoxyphenyl)methanethiol (12.3 g, 87.77 mmol) in N,N-dimethylformamide (150 mL) is added sodium hydride (4.60 g, 119.69 mmol) portion wise at 0° C. After 10 min, 1-bromo-2-fluoro-4-methylbenzene (1, 15.0 g, 79.79 mmol) is added and the reaction is stirred at room temperature for 2 h. After completion, the reaction is poured into ice water and extracted with ethyl acetate. The organic layer is washed with water, brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to get the crude. The crude product is purified by Combiflash (40 g, RediSep column) using 0-5% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford (2-bromo-5-methylphenyl)(4-methoxybenzyl)sulfane (2).

To a solution of (2-bromo-5-methylphenyl)(4-methoxybenzyl)sulfane (2, 18.0 g, 55.90 mmol) in dichloromethane (140 mL) is added a mixture of trifluoroacetic acid (20 mL) and triflic acid (5 mL) in dichloromethane (40 mL) at 0° C. drop wise and the reaction mixture is stirred at room temperature for 2 h. After completion, the reaction is poured into ice-water and extracted with dichloromethane. The organic layer is washed with water, brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to get the crude product 2-bromo-5-methylbenzenethiol (3).

To a solution 2-bromo-5-methylbenzenethiol (3, 4.7 g, 23.27 mmol) in acetone (47.0 mL) is added potassium carbonate (16.0 g, 116.35 mmol) at room temperature and the mixture is stirred for 10 min. 3-Bromo-2-oxopropanoic acid (3a, 11.6 g, 69.80 mmol) is added to the reaction mixture and stirred for 5 h at room temperature. After completion, the acetone is evaporated under reduced pressure; the residue is diluted with water and extracted with ethyl acetate. The organic layer is washed with water, brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to get 3-((2-bromo-5-methylphenyl)thio)-2-oxopropanoic acid (4).

To a solution of 3-((2-bromo-5-methylphenyl)thio)-2-oxopropanoic acid (4, 4.0 g, 13.89 mmol) in dichloromethane (40.0 mL) is added sulfuric acid (10.0 mL) and the reaction mixture is stirred at room temperature for 5 h. After completion, the reaction mixture is poured into ice water, extracted with dichloromethane. The organic layer is washed with water, brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to get 7-bromo-4-methylbenzo[b]thiophene-3-carboxylic acid (5).

To a solution 7-bromo-4-methylbenzo[b]thiophene-3-carboxylic acid (5, 3.0 g, 11.11 mmol) in N,N-dimethylformamide (30.0 mL) is added potassium carbonate (4.6 g, 33.33 mmol) and iodomethane (1.4 mL, 22.22 mmol) at 0° C. and the reaction mixture is stirred at room temperature for 4 h. After completion, the reaction mass is poured into water and extracted with ethyl acetate. The organic layer is washed with water, brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure; the crude product is purified by flash column chromatography using 5% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford methyl 7-bromo-4-methylbenzo[b]thiophene-3-carboxylate (6).

[Figure (not displayed)]

To a solution of tert-butyl 4-bromo-7-chlorobenzo[b]thiophene-3-carboxylate (1, 0.7 g, 2.01 mmol) in N,N-dimethylformamide (2 mL), copper(I) cyanide (0.180 g, 2.01 mmol) is added. This reaction mixture is heated at 90° C. for 2 h. After this time, the reaction mixture is filtered with Celite and washed with ethyl acetate. The filtrate is washed with water and then brine solution, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the crude product. This is purified by column chromatography using silica gel (100-200 mesh) and 30-50% ethyl acetate in hexane as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 7-chloro-4-cyanobenzo[b]thiophene-3-carboxylate (2).

[Figure (not displayed)]

A solution of 2,2-dimethyl-1,3-dioxane-4,6-dione (1, 0.41 g, 2.84 mmol) and diethoxymethoxyethane (50.0 mL) is stirred and heated at 90° C. for 2 h in a closed vessel. Methyl 3-aminothiophene-2-carboxylate hydrochloride (1a, 0.5 g, 2.58 mmol) is added portion wise at 90° C. under argon atmosphere and continued heating at 90° C. for 12 h. After completion, the reaction mass is cooled to room temperature, added water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered and concentrated under vacuo to get crude. The crude is triturated with diethyl ether to afford methyl 3-((1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)ethyl)amino)thiophene-2-carboxylate (2).

A solution of methyl 3-((1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)ethyl)amino)thiophene-2-carboxylate (2, 0.200 g, 0.61 mmol) in N-methyl pyrrolidone (15 mL) is heated in microwave at 200° C. for 30 min. After completion, the reaction mass is cooled to room temperature, filtered and the crude solid is purified by prep-HPLC to afford methyl 4-hydroxy-2-methylthieno[3,4-b]pyridine-7-carboxylate (3).

[Figure (not displayed)]

To a stirred solution of 7-chloro-3-methylthieno[3,2-b]pyridine (1, 1.0 g, 5.44 mmol) in ethyleacetate (10 mL) are added 1-bromopyrrolidine-2,5-dione (1a, 1.93 g, 10.8 mmol) and azobisisobutyronitrile (0.088 g, 0.540 mmol) at room temperature. The reaction is stirred at 60° C. for 4 h. After completion, the reaction mixture is quenched with water and extracted with ethyl acetate. The organic layer is washed with brine solution, dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure. The crude product is purified by Combiflash (12 g, RediSep column) using 1-5% ethylacetate in hexanes as eluent to afford 3-(bromomethyl)-7-chlorothieno[3,2-b]pyridine (2).

To a solution of 3-(bromomethyl)-7-chlorothieno[3,2-b]pyridine (2, 1.50 g, 5.70 mmol) in N,N-dimethylformamide (15 mL) is added sodium cyanide (0.561 g, 11.40 mmol) and the mixture is stirred at room temperature for 3 h. After completion, the reaction is quenched with ice cold water and extracted with ethyl acetate. The organic layer is washed with cold water, dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure to afford 2-(7-chlorothieno[3,2-b]pyridin-3-yl)acetonitrile (3).

To a solution of 2-(7-chlorothieno[3,2-b]pyridin-3-yl)acetonitrile (3, 1.10 g, 5.20 mmol) in a mixture of ethanol and water (1:1, (20 mL) is added potassium hydroxide (2.96 g, 52.8 mmol) and the mixture is stirred at 60° C. for 10 h. After completion, the reaction mixture is concentrated and extracted with diethyl ether. The aqueous layer is acidified with 1 N aqueous hydrochloric acid solution, and extracted with ethyl acetate. The organic layer is washed with saturated brine solution, dried over anhydrous sodium sulphate, filtered and concentrated to afford 2-(7-chlorothieno[3,2-b]pyridin-3-yl)acetic acid (4).

[Figure (not displayed)]
[Figure (not displayed)]

To a solution of 1H-pyrrolo[3,2-b]pyridine (1, 2.5 g, 21 mmol) in DCM (75 mL) at 0° C. is slowly added m-CPBA (5.69 g, 25.4 mmol). The mixture is stirred from 0° C. to rt. After 16 h the reaction is complete as judged by TLC (SiO2, 10% MeOH/DCM). The mixture is concentrated and the residue purified by column chromatography (SiO2, 0-20% MeOH/DCM). The product is isolated as a mixture with m-CBA (ratio ca. 1:0.7 by 1H-NMR). The so-obtained material 1H-pyrrolo[3,2-b]pyridine 4-oxide (2).

1H-pyrrolo[3,2-b]pyridine 4-oxide (2, 3.64 g) in POCl3 (30 mL, 50 g, 0.32 mol) are refluxed overnight under argon (oil-bath, 130° C.). Then the mixture is carefully transferred into an Erlenmeyer flask with crushed ice with stirring. The mixture is then basified with NaOH (aq, 12.5%) to pH ca. 8, and the precipitated material is collected by filtration. The aq. phase is extracted (3×EtOAc), and the combined organic phases are dried (Na2SO4), filtered and concentrated. The precipitated and extracted material are combined, dissolved in DCM and washed with NaHCO3(aq). The organic phase is dried (Na2SO4), filtered and concentrated to afford 7-chloro-1H-pyrrolo[3,2-b]pyridine (3).

The reaction is run in two batches (0.80 g of (3) per batch), and the two batches are combined for purification purposes. To a solution of 7-chloro-1H-pyrrolo[3,2-b]pyridine (3, 0.80 g, 5.2 mmol) in 1,4-dioxane (14 mL) and water (3.5 mL) are added (5-chloro-2-hydroxyphenyl)boronic acid (3a, 1.4 g, 8.1 mmol) and potassium carbonate (2.2 g, 16 mmol) and the mixture is degassed by bubbling argon through it for 5 min. Pd(PPh3)4 (0.61 g, 0.53 mmol) is added, and the mixture is degassed for another 5 min, then placed in a preheated heating block (100° C.) and stirred for 20 h. Then the mixture is cooled down to room temperature. The two batches are combined, diluted with water, extracted with EtOAc. The organic phase is dried (Na2SO4), filtered, and concentrated. Purification by column chromatography (SiO2, 0-20% MeOH/DCM) to afford 4-chloro-2-(1H-pyrrolo[3,2-b]pyridin-7-yl)phenol (4).

To a solution of 4-chloro-2-(1H-pyrrolo[3,2-b]pyridin-7-yl)phenol (4, 37 mg, 0.15 mmol) in DMF (0.7 mL) at 0° C. are added imidazole (23 mg, 0.34 mmol) and tert-butyl-chloro-diphenyl-silane (0.05 mL, 0.05 g, 0.2 mmol), and the mixture is stirred at rt. After 3 h the mixture is diluted with water and EtOAc, and the aq. phase is extracted (3×EtOAc). The combined organic phases are dried (Na2SO4), filtered and concentrated. Purification by column chromatography (SiO2, 0-40% EtOAc/hexane) to afford 7-(2-((tert-butyldiphenylsilyl)oxy)-5-chlorophenyl)-1H-pyrrolo[3,2-b]pyridine (5).

To a solution of 7-(2-((tert-butyldiphenylsilyl)oxy)-5-chlorophenyl)-1H-pyrrolo[3,2-b]pyridine (5; 1.08 g, 2.24 mmol) in THF (20 mL) at 0° C. is added N-Iodosuccinimide (503 mg, 2.24 mmol) and the mixture is stirred for 10 min. Then the reaction is diluted with EtOAc, quenched with Na2S2O3(aq) and water, and extracted (2×EtOAc). The combined organic phases are dried, filtered and concentrated. Purification by column chromatography (SiO2, 0-40% EtOAc/hexane) afforded to afford 7-(2-((tert-butyldiphenylsilyl)oxy)-5-chlorophenyl)-3-iodo-1H-pyrrolo[3,2-b]pyridine (6).

To a solution of 7-(2-((tert-butyldiphenylsilyl)oxy)-5-chlorophenyl)-3-iodo-1H-pyrrolo[3,2-b]pyridine (6, 990 mg, 1.63 mmol) in MeCN (11 mL) at 0° C. are added triethylamine (0.45 mL, 0.33 g, 3.2 mmol), di-tert-butyl dicarbonate (531 mg, 2.43 mmol) in 2 mL MeCN and 4-dimethylaminopyridine (40 mg, 0.33 mmol) and the mixture is stirred at rt. After 1 h water is added, and the mixture is extracted with DCM (3×). The combined organic phases are dried (Na2SO4), filtered and concentrated. Purification by column chromatography (SiO2, 0-20% EtOAc/hexane) to afford tert-butyl 7-(2-((tert-butyldiphenylsilyl)oxy)-5-chlorophenyl)-3-iodo-1H-pyrrolo[3,2-b]pyridine-1-carboxylate (7).

To a solution of tert-butyl 7-(2-((tert-butyldiphenylsilyl)oxy)-5-chlorophenyl)-3-iodo-1H-pyrrolo[3,2-b]pyridine-1-carboxylate (7, 1.06 g, 1.49 mmol) in methanol (11 mL) and DMF (4 mL) are added triethylamine (0.43 mL, 0.31 g, 3.1 mmol) and (Ph3P)2PdCl2 (105 mg, 0.149 mmol). Then the mixture is stirred at 50° C. under a CO atmosphere. After 18 h the mixture is concentrated and purified by column chromatography (SiO2, 0-50% EtOAc/hexane) to afford 1-(tert-butyl) 3-methyl 7-(2-((tert-butyldiphenylsilyl)oxy)-5-chlorophenyl)-1H-pyrrolo[3,2-b]pyridine-1,3-dicarboxylate (8).

[Figure (not displayed)]

To a solution of 3-bromo-7-chlorothieno[3,2-b]pyridine (4, 0.30 g, 1.21 mmol), and ethyl 2-bromo-2,2-difluoroacetate (4a, 0.73 g, 3.62 mmol) in dimethylsulfoxide (12.0 mL), cupper powder (0.11 g, 1.81 mmol) is added at room temperature and the mixture is heated at 60° C. for 16 h. After completion, reaction mass is diluted with ethyl acetate and filtered through Celite. The filterate is washed with water and brine solution, dried over sodium sulfate filtered and concentrated. The crude is purified by flash column chromatography using silica gel (100-200 mesh) and 20-30% ethyl acetate in hexane as eluent. The desired fractions are concentrated under reduced pressure to afford ethyl 2-(7-chlorothieno[3,2-b]pyridin-3-yl)-2,2-difluoroacetate (5).

[Figure (not displayed)]

To a solution of N,N,N′,N′-tetramethylethylenediamine (11.69 g, 100.42 mmol) in tetrahydrofuran (100 mL), n-butyllithium (1.3 M in hexane, 71.1 mL, 92.43 mmol) is added at −78° C., then 6,7-dihydro-5H-cyclopenta[b]pyridine (1, 10.0 g, 84.03 mmol) is added dropwise and the mixture is stirred at −78° C. for 45 min. Then, a solution of dimethyl carbonate (1a, 8.31 g, 92.43 mmol) in tetrahydrofuran (10 mL) is added drop wise and the mixture is allowed to room temperature over an 1 h. The reaction mixture is quenched with saturated ammonium chloride solution and extracted with ethyl acetate. The combined organic layer is dried over anhydrous sodium sulphate, filtered and concentrated. The crude is purified by column chromatography using silica gel (100-200 mesh) and 0-25% ethyl acetate in hexane as eluent to afford methyl 6,7-dihydro-5H-cyclopenta[b]pyridine-7-carboxylate (2).

To a solution of methyl 6,7-dihydro-5H-cyclopenta[b]pyridine-7-carboxylate (2, 2.5 g, 14.12 mmol) in dichloromethane (30 mL), 3-chloroperbenzoic acid (4.85 g, 28.24 mL) is added at 0° C. and the mixture is stirred at the same temperature for 30 min. After completion, the reaction mixture is quenched with saturated sodium bicarbonate solution (10 mL) and extracted with dichloromethane. The combined organic layer is washed brine, dried over anhydrous sodium sulphate, filtered and concentrated. The crude is purified by column chromatography using silica gel (100-200 mesh) and 0-10% methanol in dichloromethane as eluent. The desired fractions are concentrated under reduced pressure to afford 7-(methoxycarbonyl)-6,7-dihydro-5H-cyclopenta[b]pyridine 1-oxide (3).

To a solution of 7-(methoxycarbonyl)-6,7-dihydro-5H-cyclopenta[b]pyridine 1-oxide (3, 1.5 g, 7.77 mmol) in acetonitrile (25 mL), lithium bromide (0.67 g, 7.77 mmol) and phosphorus bromide (22.3 g, 77.72 mmol) are added and the reaction mixture is heated at 80° C. for 24 h. After completion, the reaction mixture is cooled to 0° C., quenched with saturated sodium bicarbonate solution (50 mL) and extracted with ethyl acetate. The combined organic layer is dried over anhydrous sodium sulphate, filtered and concentrated. The crude is purified by column chromatography using silica gel (100-200 mesh) and 0-25% ethyl acetate in hexane to afford methyl 4-bromo-6,7-dihydro-5H-cyclopenta[b]pyridine-7-carboxylate (4).

[Figure (not displayed)]

To a solution of 7-bromothieno[3,2-b]pyridine-3-carbaldehyde (1, 36 mg, 0.148 mmol) in DCM (1 mL) in an oven-dried screw capped vial is equipped with a stir bar. To the mixture is added ethoxyethane trifluoroborane (0.02 mL, 0.163 mmol) with constant stirring at room tem added slowly. Then 1,2-bis((trimethylsilyl)oxy)cyclobut-1-ene (1a, 0.06 mL, 0.222 mmol) is added dropwise and the clear yellow mixture continued to stir at room temperature for 40 min. Water (0.030 mL) is added followed by ethoxyethane; trifluoroborane (0.27 mL, 2.22 mmol) and the reaction is allowed to stir at room temperature overnight. No conversion to pinacol rearrangement product observed so water and DCM added and the aqueous phase extracted with dichloromethane three times. The combined organic material is washed with brine and dried over magnesium sulfate. The solids are filtered and solvent removed in vacuo to afford a crude yellow residue. Aqueous layer is concentrated in vacuum. Both aqueous and organic layer combined and is taken up in TFA (3.5 mL, 0.1480 mmol) and placed in a vial that is sealed and stirred in a heating block at 70° C. for 3 h. The reaction is cooled to room temperature and solvent removed in vacuo. Preparatory HPLC (water with 0.1% TFA) afforded the product 2-(7-bromothieno[3,2-b]pyridin-3-yl)-3-hydroxycyclopent-2-en-1-one (2).

[Figure (not displayed)]

To a stirred solution of methyl 7-chlorothieno[3,2-b]pyridine-3-carboxylate (1, 15.0 g, 65.88 mmol) in methanol, tetrahydrofuran and water (2:1:1, 225 mL) is added lithium hydroxide (13.82 g, 329.43 mmol) at 0° C. and reaction mixture is stirred at room temperature for 16 h. After completion, the solvents are concentrated under reduced pressure and the aqueous layer is acidified with 1 N aqueous hydrochloric acid solution up to pH-3. Solid precipitate obtained is filtered and washed with n-pentane to afford 7-chlorothieno[3,2-b]pyridine-3-carboxylic acid (2).

To a solution of 7-chlorothieno[3,2-b]pyridine-3-carboxylic acid (2, 12.20 g, 57.10 mmol) in N,N-dimethylformamide (50 mL) is added 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (32.5 g, 85.65 mmol) and reaction mixture is stirred for 10 min. The reaction mixture is then cooled to 0° C. and N,N-diisopropylethylamine (29.841 mL, 171.316 mmol) and ammonium chloride (15.2 g, 285.52 mmol) are added and reaction mixture is allowed to warm to room temperature and stirred for 16 h. After completion, the reaction is quenched with ice cold water and extracted with ethyl acetate. The organic layer is washed with cold water, dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure. The crude product is triturated with pentane and dried to afford 7-chlorothieno[3,2-b]pyridine-3-carboxamide (3).

To a solution of 7-chlorothieno[3,2-b]pyridine-3-carboxamide (3, 10.0 g, 51.37 mmol) in N,N-dimethylformamide (100 mL) at 0° C. is added phosphorus oxytrichloride (48.0 mL, 513.76 mmol). The reaction is allowed to warm up to room temperature and stirred for 16 h. After completion, reaction mixture concentrated to dryness under reduced pressure. The reaction mixture is basified with saturated sodium bicarbonate solution up to pH-8 and extracted with ethyl acetate. The organic layer is washed with brine solution, dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure. The crude product is purified by Combiflash (40 g, RediSep column) using 0-20% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 7-chlorothieno[3,2-b]pyridine-3-carbonitrile (4).

To a solution of 7-chlorothieno[3,2-b]pyridine-3-carbonitrile (4, 8.0 g, 41.10 mmol), and (5-chloro-2-hydroxyphenyl)boronic acid (4a, 14.1 g, 82.20 mmol) in 1,4-dioxane (120.0 mL) is added 2 M solution of potassium carbonate (14.2 g, 102.7 mmol) reaction mixture is degassed with argon gas for 10 min. [1,1′-Bis(diphenylphosphino)ferrocene]palladium(II) dichloride (3.0 g, 4.11 mmol) is then added to reaction mixture and reaction mixture is stirred at 110° C. for 2 h. After completion, reaction mixture is cooled to room temperature, diluted with water and extracted with ethyl acetate. The organic layer is washed with brine solution, dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure. The crude product is purified by column chromatography using silica gel (100-200 mesh) and 0-50% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 7-(5-chloro-2-hydroxyphenyl)thieno[3,2-b]pyridine-3-carbonitrile (5).

To a solution of 7-(5-chloro-2-hydroxyphenyl)thieno[3,2-b]pyridine-3-carbonitrile (5, 5.1 g, 17.78 mmol) in N,N-dimethylformamide (50.0 mL) is added sodium azide (5.8 g, 88.93 mmol) at room temperature and the reaction mixture is heated to 110° C. for 36 h. After completion, reaction mixture is concentrated to dryness under reduced pressure. The crude product obtained is triturated with n-pentane to afford 2-(3-(1H-tetrazol-5-yl)thieno[3,2-b]pyridin-7-yl)-4-chlorophenol (6).

[Figure (not displayed)]

To a solution 2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (6, 0.20 g, 0.79 mmol) in N,N-dimethylformamide (5 mL), potassium carbonate (0.33 g, 2.37 mmol) is added at room temperature. After 10 min, 2-bromo-1-(2-bromoethoxy)-4-chlorobenzene (9, 0.25 g, 0.79 mmol) is added and stirred for 16 h at room temperature. After completion, the reaction mixture is poured into water and extracted with ethyl acetate. Combined organic layer is washed with water, brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to get crude; the crude compound is purified by flash column chromatography (using 10-70% ethyl acetate in hexanes) to afford 3-(2-(2-bromo-4-chloro-phenoxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (10).

[Figure (not displayed)]

A solution of 3-(2-(2-bromo-4-chlorophenoxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (10, 1.8 g, 3.71 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (11, 1.13 g, 4.45 mmol) and potassium acetate (0.73 g, 7.42 mmol) in 1,4-dioxane (35 mL) is degassed using argon gas for 10 min. 1,1′-Bis(diphenylphosphino)ferrocene-palladium(II)dichloride (0.217 g, 0.296 mmol) is added and the reaction mixture is degassed for another 10 min. The reaction mixture is heated and stirred at 90° C. for 6 h. After completion, the reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure. The crude compound is purified by flash column chromatography 40% ethyl acetate in hexanes as eluent to afford 3-(2-(4-chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (12).

To a solution methyl 3-bromo-2-iodobenzoate (13, 2.0 g, 5.88 mmol) N,N-dimethylformamide (20 mL), copper(I) cyanide (0.58 g, 6.47 mmol) is added and heated at 60° C. for 4 h. After completion, the reaction mass is diluted with water (100 mL) and extracted with ethyl acetate. Combined organic layer are washed with water, brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to get crude. The crude compound is purified by flash column chromatography (using 0-10% ethyl acetate in hexane) to afford methyl 3-bromo-2-cyanobenzoate (14).

To a solution of 3-(2-(4-chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (12, 0.40 g, 0.75 mmol) and methyl 3-bromo-2-cyanobenzoate (14, 0.215 g, 0.90 mmol) in 1,4-dioxane (8 mL) and water (2 mL), potassium carbonate (0.313 g, 2.25 mmol) is added at room temperature. The reaction mass is degassed by purging argon gas through the reaction mass for 10 min. 1,1′-Bis(diphenylphosphino)ferrocene-palladium(II)dichloride (0.055 g, 0.075 mmol) is added under argon atmosphere, heated and stirred the reaction mixture at 90° C. for 3 h. After completion, the reaction mass is diluted with water, extracted with ethyl acetate; combined organic layer is washed with water, brine and dried over anhydrous sodium sulfate and concentrated under reduced pressure to get crude. The crude compound is purified by flash column chromatography (using 0-50% ethyl acetate in hexane) to afford methyl 5′-chloro-2-cyano-2′-(2-(5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)-[1,1′-biphenyl]-3-carboxylate (15).

[Figure (not displayed)]

To a stirred solution of methyl 5-chloro-7-[5-chloro-2-[2-[5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3-yl]ethoxy]phenyl]thieno[3,2-b]pyridine-3-carboxylate (0.050 g, 0.079 mmol) in N-methyl-2-pyrrolidone and water (9:1, 2 mL) in a microwave vial, zinc cyanide (0.011 g, 0.095 mmol) and zinc dust (0.030 mg, 0.034 mmol) are added and the mixture is degassed with argon for 30 min. After adding 1,1′-bis(diphenylphosphino)ferrocene (0.0131 g, 0.023 mmol) and tris(dibenzylideneacetone)dipalladium(0) (10.8 mg, 0.012 mmol), the vial is sealed and then placed in a preheated heating block at 80° C. for 30 min. After completion of the reaction, the reaction mixture loaded on the Isco silica column. Purification by column chromatography eluting with 0 to 5% methanol/dichloromethane to afford methyl 7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)-5-cyanothieno[3,2-b]pyridine-3-carboxylate (2).

To a solution of methyl 7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)-5-cyanothieno[3,2-b]pyridine-3-carboxylate (2, 25.0 mg, 0.040 mmol) in 1,2-dichloroethane (2 mL), trimethyltin hydroxide (0.029 g, 0.160 mmol) is added at room temperature. The reaction mixture is heated at 90° C. for 16 h. After completion of the reaction, the organic solvent is evaporated and the crude is diluted with 50% dimethyl sulfoxide/methanol. The crude product is purified by prep-HPLC to afford 5-carbamoyl-7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylic acid (Cpd. No. 445F).

[Figure (not displayed)]

To a solution of methyl 7-(2-(2-(5-bromo-6-iodo-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)-5-chlorophenyl)thieno[3,2-b]pyridine-3-carboxylate (5, 0.20 g, 0.256 mmol) in N,N-dimethylformamide is added copper(I) cyanide (0.069 g, 0.770 mmol) and stirred at 85° C. for 2 h. After completion, the reaction mixture is cooled to room temperature and poured into ice-water. The precipitate formed is collected by filtration and dried. The solid is dissolved in 10% methanol in dichloromethane and passed through Celite bed. The filtrate is concentrated under reduced pressure to afford methyl 7-(5-chloro-2-(2-(5, 6-dicyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (6).

[Figure (not displayed)]

To a solution of tert-butyl 7-(2-(2-(6-bromo-5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)-5-chlorophenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (1, 0.20 g, 0.273 mmol) in N-Methyl-2-pyrrolidone (5.0 mL) is added 1-methylpiperazine (1a, 0.06 mL, 0.546 mmol) and the reaction mixture is degassed by argon for 10 min. Then copper(I) iodide (0.005 g, 0.027 mmol) and 1,10-phenanthroline (0.009 g, 0.054 mmol) is added and reaction mixture is heated at 150° C. for 6 h. After completion reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulphate, filtered and concentrated to get crude compound. Crude compound obtained is purified by column chromatography using silica gel (100-200 mesh) and 3-4% methanol in dichloromethane to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-2-methyl-6-(4-methylpiperazin-1-yl)-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (2).

[Figure (not displayed)]

To a solution of tert-butyl 7-(2-(2-(6-bromo-5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)-5-chlorophenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (1, 50 mg, 0.0681 mmol) and 3-fluoro-2-((tributylstannyl)methyl)pyridine (l a, 190 mg, 0.476 mmol) in N,N-dimethylformamide (2 mL), is added copper(II) oxide (11 mg, 0.136 mmol) at room temperature. The reaction mixture is purged with argon gas for 5 min, added bis(triphenylphosphine)palladium(II) dichloride (9.6 mg, 0.0136 mmol) and the vessel is then sealed, microwaved for 1 h at 150° C. After completion, the reaction mixture is then directly loaded on an Isco loading column. Purified by column chromatography using 5 to 80% ethyl acetate in hexane as eluent and product eluted around 60% ethylacetate/hexane. The desired fractions are concentrated under reduced pressure to afford tert-butyl 7-(5-chloro-2-(2-(5-cyano-6-((3-fluoropyridin-2-yl)methyl)-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (2).

Compounds made using one or more of the general methods described above are shown in Table 2. Where provided, characterization data is to the right of the compounds.

TABLE 2
7-CF3-Thienylpyridine and Derivative Compounds
CompoundCharacterization
51[Figure (not displayed)]
MS (ESI) m/z 528.44 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.931 (s, 1H), 8.359 (s, 1H), 8.194 (s, 1H), 7.8409 (d, J = 11.6 Hz, 2H), 7.528 (d, J = 7.6 Hz, 1H), 7.412 (m, 2H), 7.278 (d, J = 2.6 Hz, 1H), 7.212 (d, J = 8.8 Hz, 1H), 4.359 (s, 4H), 2.208 (s, 3H)
58[Figure (not displayed)]
MS (ESI) m/z 553.34 [M + 1]+; UPLC: 98.94%; 1H NMR (400 MHz, DMSO-d6) δ 8.44 (d, J = 3.96, 1H), 8.36 (s, 1H), 8.22 (s, 1H), 7.43 (dd, J = 2.48, 8.88 Hz, 1H), 7.23-7.18 (m, 3H), 4.33 (m, 4H), 4.03 (s, 1H), 2.09 (s, 3H)
59[Figure (not displayed)]
MS (ESI) m/z 578.08 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.91 (s, 1H), 8.28 (s, 1H), 7.84-7.81 (m, 2H), 7.6-7.2 (m, 6H), 4.37 (s, 4H), 2.21 (s, 3H)
60[Figure (not displayed)]
MS (ESI) m/z 527.02 [M + 1]−. 1H NMR (400 MHz, DMSO-d6) δ 8.63 (bs, 1H), 8.37 (s, 1H), 8.19 (s, 1H), 7.98 (bs, 1H), 7.61 (bs, 1H), 7.48 (d, J = 8.68 Hz, 1H), 7.42 (s, 1H), 7.26 (d, J = 8.92 Hz, 1H), 4.39 (s, 4H), 2.20 (s, 3H)
61[Figure (not displayed)]
MS (ESI) m/z 585.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.27 (s, 1H), 8.84 (d, J = 4.76, 1H), 8.37 (d, J = 0.96 Hz, 1H), 8.26 (s, 1H), 8.00 (s, 1H), 7.59 (dd, J = 2.64, 8.92 Hz, 1H), 7.48 (d, J = 4.76 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 8.96, 1H), 4.42-4.23 (m, 4H), 1.74 (s, 3H)
65[Figure (not displayed)]
MS (ESI) m/z 621.17 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.7935 (d, J = 4.8 Hz, 1H), 8.568 (s, 1H), 8.338 (s, 1H), 8.236 (s, 1H), 7.610 (dd, J = 8.8 Hz, 1H), 7.487 (d, J = 4.8 Hz, 1H), 7.441 (d, J = 2.8 Hz, 1H), 7.372 (d, J = 9 Hz, 1H),6.687-6.429 (m, 1H), 4.431-4.355 (m, 4H)
120[Figure (not displayed)]
MS (ESI) m/z 579.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.48 Hz, 1H), 8.59 (s, 1H), 8.41 (s, 1H), 8.14 (s, 1H), 7.76 (d, J = 8.8 Hz, 1H), 7.69 (d, J = 6.04 Hz, 2H), 7.56 (d, J = 4.48 Hz, 1H), 4.88 (s, 2H), 2.10 (s, 3H)
121[Figure (not displayed)]
MS (ESI) m/z 599.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.55 (s, 1H), 8.36 (s, 1H), 8.27 (s, 1H), 7.97 (s, 1H), 7.60-7.57 (dd, J = 2.52 Hz, 1H), 7.41 (s, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.40 (t, J = 4.6 Hz, J = 4.48 Hz, 2H), 4.25 (t, J = 4.04 Hz, J = 5.0 Hz, 2H), 2.69 (s, 3H), 1.81 (s, 3H)
122[Figure (not displayed)]
MS (ESI) m/z 601.98 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.93 (bs, 1H), 8.35 (s, 1H), 8.06 (s, 1H), 7.77 (s, 1H), 7.51 (dd, J = 8.88, 2.6 Hz, 1H), 7.29-7.22 (m, 4H), 4.35 (t, J = 4.4 Hz, 2H), 4.24 (t, J = 4.84 Hz, 2H), 1.77 (s, 3H)
145[Figure (not displayed)]
MS (ESI) m/z 524.41 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.05 (s, 1H), 8.37 (s, 1H), 8.19 (s, 1H), 7.8480-7.726 (m, 3H), 7.4848-7.454 (m, 3H), 7.36 (s, 1H), 6.43 (d, J = 15.68 Hz, 1H), 6.15 (d, J = 15.68 Hz, 1H), 4.83 (d, J = 3.4 Hz, 2H), 2.56 (s, 3H)
146[Figure (not displayed)]
MS (ESI) m/z 526.46 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.98 (bs, 1H), 8.35 (d, J = 1.36 Hz, 1H), 8.177 (s, 1H), 7.767 (s, 1H), 7.744 (s, 1H), 7.58-7.557 (m, 1H), 7.467-7.382 (m, 3H), 7.229 (d, J = 6.4 Hz, 1H), 3.933 (t, J = 7.04 Hz, 2H), 2.611 (t, J = 8.44 Hz, 2H), 2.447 (s, 3H), 1.768 (m, 2H)
156[Figure (not displayed)]
MS (ESI) m/z 552.22 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.92 (bs, 1H), 8.34 (s, 1H), 8.18 (s, 1H), 7.83 (dd, J = 7.64, 1.0 Hz, 1H), 7.44-7.34 (m, 3H), 7.16-7.14 (m, 2H), 4.31 (bs, 4H), 3.73 (s, 1H), 1.98 (s, 3H)
158[Figure (not displayed)]
MS (ESI) m/z 572.49 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.15 (bs, 1H), 8.36 (s, 1H), 8.21 (s, 1H), 7.63 (s, 1H), 7.58 (d, J = 8 Hz, 1H), 7.51 (d, J = 7.6 Hz, 1H), 7.429-7.401 (dd, J = 2.4 Hz, J′ = 8.72 Hz, 1H), 7.33 (d, J = 2.4 Hz, 1H), 7.21 (d, J = 8.8 Hz, 1H), 4.37 (s, 4H), 2.25 (s, 3H)
159[Figure (not displayed)]
MS (ESI) m/z 538 [M + 1]+. 1H NMR (400 MHz, DMSO-d6) δ 8.43 (s, 1H), 8.29 (s, 1H), 8.01 (s, 1H), 7.59 (bs, 1H), 7.38-7.36 (m, 1H), 7.32- 7.30 (m, 1H), 7.20 (d, J = 2.56 Hz, 2H), 7.16 (d, J = 8.76 Hz, 1H), 4.26 (s, 4H), 3.8 (s, 1H)
162[Figure (not displayed)]
MS (ESI) m/z 515.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.63 (d, J = 5.04 Hz, 1H), 8.43 (d, J = 1.08 Hz, 1H), 8.27 (s, 1H), 8.23 (s, 1H), 8.03 (s, 1H), 7.67-7.65 (dd, J = 1.52, 4.96 Hz, 1H), 7.49 (d, J = 2.72 Hz, 1H), 7.47 (s, 1H), 7.25 (d, J = 9.28 Hz, 1H), 4.40-4.37 (m, 4H)
164[Figure (not displayed)]
MS (ESI) m/z 571 [M + 1]; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (s, 1H), 8.43 (d, J = 16.6 Hz, 2H), 8.11 (s, 1H), 7.79 (bs, 1H), 7.60 (s, 1H), 7.46 (m, 2H), 7.35 (m, 1H), 4.40 (s, 2H), 4.20 (s, 2H), 3.89 (s, 1H)
168[Figure (not displayed)]
MS (ESI) m/z 553.20 [M + 1]+. UPLC: 98.95%; 1H NMR (400 MHz, DMSO-d6) δ 13.65 (s, 1H), 8.37 (s, 1H), 8.19 (s, 1H), 8.08 (d, J = 7.68 1H), 7.78-7.76 (t, J = 7.76 Hz, 1H), 7.61 (d, J = 7.24 Hz, 1H), 7.49 (dd, J = 2.4, 8.84 Hz, 1H), 7.28 (d, J = 2.52 Hz, 1H), 7.25 (d, J = 8.92 Hz 1H), 4.32 (m, 4H), 1.95 (s, 3H)
169[Figure (not displayed)]
MS (ESI) m/z 554.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.77 (bs, 1H), 8.36 (s, 1H), 8.17 (s, 1H), 7.71 (d, J = 7.32 Hz, 1H), 7.36-7.28 (m, 2H), 7.23 (d, J = 7.8 Hz, 1H), 7.10 (d, J = 9.56 Hz, 2H), 6.57-6.50 (q, J = 6.32, 11.64 Hz, 1H), 4.88 (d, J = 11.32 Hz, 1H), 4.64 (d, J = 17.52 Hz, 1H), 4.30 (s, 4H), 2.02 (s, 3H)
181[Figure (not displayed)]
MS (ESI) m/z 603.04 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.83 (s, 1H), 8.50 (s, 1H), 8.33 (s, 1H), 8.15 (s, 1H), 7.60-7.36 (m, 4H), 4.72 (d, J = 44 Hz, 2H), 4.39 (bs, 2H), 4.12 (bs, 2H)
182[Figure (not displayed)]
MS (ESI) m/z 546.08 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.40 (s, 1H), 8.30 (s, 1H), 7.87-7.83 (m, 2H), 7.55 (d, J = 7.50 Hz, 1H), 7.45-7.39 (m, 2H), 7.30 (d, J = 2.48 Hz, 1H), 7.20 (d, J = 8.0 Hz, 1H), 5.10 (d, J = 45 Hz, 2H), 4.39 (bs, 4H)
185[Figure (not displayed)]
MS (ESI) m/z 539.07 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.82 (s, 1H), 8.60 (s, 1H), 8.50 (s, 1H), 7.87-7.71 (m, 2H), 7.53-7.51 (d, J = 8 Hz, 1H), 7.43-7.37 (m, 2H), 7.35-7.20 (m, 2H), 4.53 (t, J = 4 Hz, 2H), 4.39 (t, J = 4 Hz, 2H)
186[Figure (not displayed)]
MS (ESI) m/z 530.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.43 (s, 1H), 8.08 (s, 1H), 7.88 (s, 1H), 7.73 (d, J = 7.2 Hz, 1H), 7.65 (s, 2H), 7.41-7.33 (m, 3H), 7.22 (d, J = 8.72, 1H), 4.30-4.27 (t, J = 6 Hz, 2H), 4.22-4.20 (t, J = 5.54 Hz, 2H)
187[Figure (not displayed)]
MS (ESI) m/z 548.03 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.91 (s, 1H), 8.47 (s, 1H), 8.29 (s, 1H), 7.88 (s, 1H), 7.77 (d, J = 7.50 Hz, 1H), 7.59 (d, J = 7.90 Hz, 1H), 7.42-7.38 (m, 2H), 7.31 (d, J = 2.48 Hz, 1H), 7.22 (d, J = 9.0 Hz, 1H), 4.52 (d, J = 4.72 Hz, 2H), 4.38 (d, J = 4.8 Hz, 2H)
199[Figure (not displayed)]
MS (ESI) m/z 584.69 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.50 (s, 1H), 8.72 (d, 4.08 Hz, 1H), 8.29 (s, 1H), 8.08 (s, 1H), 7.70 (s, 1H), 7.58 (dd, J = 2.32, 8.52 Hz, 1H), 7.40 (d, J = 2.36 Hz, 1H), 7.35 (d, J = 8.96 Hz, 2H), 4.42 (s, 2H), 4.26 (s, 2H), 1.81 (s, 3H)
201[Figure (not displayed)]
MS (ESI) m/z 585.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 14.04 (b, 1H), 8.30 (s, 1H), 8.25 (d, J = 5.56 Hz, 1H), 7.96 (d, J = 6.4 Hz, 2H), 7.60-7.58 (m, 2H), 7.50 (dd, J = 8.8 Hz, 1H), 7.30 (d, J = 8.84 Hz, 1H), 4.45 (t, J = 4.72 Hz, 2H), 4.36 (t, J = 4.6 Hz, 2H), 2.18 (s, 1H)
202[Figure (not displayed)]
MS (ESI) m/z 599.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.41 (s, 1H), 8.66 (d, 4.56 Hz, 1H), 8.37 (s, 1H), 8.17 (s, 1H), 7.56 (m, 2H), 7.40 (d, J = 2.44 Hz, 1H), 7.33 (d, J = 9.04 Hz, 1H), 7.26 (d, J = 4.6 Hz, 1H), 4.38 (s, 2H), 4.25 (s, 2H), 3.84 (s, 2H), 1.78 ( s, 3H)
203[Figure (not displayed)]
MS (ESI) m/z 589.91 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.88 (s, 1H), 8.29 (s, 1H), 8.04 (s, 1H), 8.01 (s, 1H), 7.92 (s, 1H), 7.48- 7.44 (m, 2H), 7.29 (d, J = 8.8 Hz, 1H), 4.50 (m, 2H), 4.25 (s, 2H), 2.08 (s, 3H)
205[Figure (not displayed)]
MS (ESI) m/z 599.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 4.96 Hz, 1H), 8.38 (s, 1H), 7.98 (s, 1H), 7.60 (dd, J = 8.88, 2.6 Hz, 1H), 7.53 (d, J = 4.88 Hz, 1H), 7.43 (d, J = 2.56 Hz, 1H), 7.36 (d, J = 8.96 Hz, 1H), 4.43 (s, 2H), 4.27 (s, 2H), 2.34 (s, 3H), 1.85 (s, 3H)
206[Figure (not displayed)]
MS (ESI) m/z 619.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.64 Hz, 1H), 8.36 (s, 1H), 8.07 (s, 1H), 7.60 (d, J = 8.84 Hz, 1H), 7.52 (d, J = 4.4 Hz, 1H), 7.41 (s, 1H), 7.34 (d, J = 8.92 Hz, 1H), 4.44 (s, 2H), 4.28 (s, 2H), 1.81 (s, 3H)
210[Figure (not displayed)]
MS (ESI) m/z 610.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.16 (s, 1H), 8.82 (d, J = 4.64 Hz, 1H), 8.41 (d, J = 9.8 Hz, 2H), 7.6 (dd, J = 8.92, 2.48 Hz, 1H), 7.45 (dd, J = 9.68, 4.72 Hz, 2H), 7.37 (d, J = 8.88 Hz, 1H), 4.42 (t, J = 5.04 Hz , 2H), 4.27 (t, J = 5.2 Hz, 2H), 1.96 (s, 3H)
214[Figure (not displayed)]
MS (ESI) m/z 609.05 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.16 (bs, 1H), 8.86 (d, J = 4.6 Hz, 1H), 8.16 (s, 1H), 8.11 (s, 1H), 7.60 (d, J = 8.96 Hz, 1H), 7.49 (d, J = 4.44 Hz, 1H), 7.42 (s, 1H), 7.36 (d, J = 9.04, 1H), 4.42 (bs, 2H), 4.28 (bs, 2H), 1.74 (s, 3H)
215[Figure (not displayed)]
MS (ESI) m/z 585 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.10 (bs, 1H), 9.33 (s, 1H), 8.38 (s, 2H), 7.98 (s, 1H), 7.64 (dd, J = 8.8, 2.4 Hz, 1H), 7.45 (d, J = 2.4 Hz, 1H), 7.38 (d, J = 9.2 Hz, 1H), 4.45 (s, 2H), 4.27 (s, 2H), 1.77 (s, 3H)
225[Figure (not displayed)]
MS (ESI) m/z 585.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.19 (s, 1H), 8.59 (d, J = 5.56 Hz, 1H), 8.35-8.32 (m, 2H), 8.05 (s, 1H), 7.93 (s, 1H), 7.55 (dd, J = 9.0, 2.56 Hz, 1H), 7.33-7.30 (m, 1H), 4.38 (s, 2H), 4.22 (s, 2H), 1.69 (s, 3H)
226[Figure (not displayed)]
MS (ESI) m/z 585.39 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.54 (s, 1H), 8.38 (s, 1H), 8.18 (s, 1H), 7.97 (t, J = 6.30 Hz, 2H), 7.55-7.52 (dd, J = 2.24, 2.32 Hz, 1H), 7.46 (d, J = 7.8 Hz, 1H), 7.30- 7.25 (m, 2H), 4.45-4.29 (m, 4H), 1.98 (s, 3H)
227[Figure (not displayed)]
MS (ESI) m/z 551.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.96 Hz, 1H), 8.38 (s, 1H), 8.32 (s, 1H), 8.01 (s, 1H), 7.55 (t, J = 7.16 Hz, 1H), 7.50 (d, J = 4.48 Hz, 1H), 7.34 (t, J = 5.6 Hz, 2H), 7.16 (t, J = 7.40 Hz, 1H), 4.41 (s, 2H), 4.27 (s, 2H), 1.80 (s, 3H)
246[Figure (not displayed)]
MS (ESI) m/z 603.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.84 Hz, 1H), 8.64 (s, 1H), 8.40 (d, J = 9.16 Hz, 1H), 7.60 (dd, J = 8.92 Hz, 2.6 Hz, 1H), 7.49 (d, J = 4.84 Hz, 1H), 7.45 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 8.96 Hz, 1H), 4.44 (t, J = 4.8 Hz, 2H), 4.29 (t, J = 4.64 Hz, 2H), 1.99 (s, 3H)
255[Figure (not displayed)]
MS (ESI) m/z 581.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.16 (bs, 1H), 8.83 (s, 1H), 7.77 (d, J = 4.4 Hz, 1H), 8.35 (s, 1H), 8.14 (s, 1H), 7.87 (d, J = 8.8 Hz, 1H), 7.61 (d, J = 8.4 Hz, 1H), 7.53 (s, 1H), 7.42 (d, J = 4.4 Hz, 1H), 6.50-6.44 (m, 1H), 5.98 (d, J = 16.0, 1H), 4.73 (d, J = 4.0, 2H), 2.38 (s, 3H)
259[Figure (not displayed)]
MS (ESI) m/z 586.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.91 (s, 1H), 8.80 (d, J = 4.92 Hz, 1H), 8.39 (d, J = 1.12 Hz, 1H), 8.35 (d, J = 2.80 Hz, 1H), 8.25 (s, 1H), 7.98 (d, J = 2.80 Hz, 1H), 7.49 (d, J = 4.88 Hz, 1H), 4.53 (t, J = 5.4 Hz, 2H), 4.41 (t, J = 5.2 Hz, 2H), 2.62 (s, 3H)
261[Figure (not displayed)]
MS (ESI) m/z 644.23 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83-8.79 (m, 3H), 8.29 (s, 1H), 8.22 (s, 1H), 7.93 (s, 1H), 7.84 (d, J = 5.68 Hz, 2H), 7.59 (dd, J = 2.56, J = 8.84 Hz, 1H), 7.51 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.60 Hz, 1H), 7.34 (d, J = 8.96 Hz, 1H) 4.38 (t, J = 5.76 Hz, 2H), 4.22 (t, J = 4.60 Hz, 2H), 1.69 (s, 3H)
265[Figure (not displayed)]
MS (ESI) m/z 591.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.98 (bs, 1H), 8.9 (s, 1H), 8.28 (s, 1H), 8.16 (s, 1H), 7.68 (d, J = 2.4 Hz, 1H), 7.6 (dd, J = 8.8, 2.3 Hz, 1H), 7.5 (d, J = 9.0 Hz, 1H), 4.76 (t, J = 5.2 Hz, 2H), 4.57 (t, J = 3.6 Hz, 2H), 2.56 (s, 3H)
266[Figure (not displayed)]
MS (ESI) m/z 619.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.64 Hz, 1H), 8.36 (s, 1H), 8.07 (s, 1H), 7.60 (d, J = 8.84 Hz, 1H), 7.52 (d, J = 4.4 Hz, 1H), 7.41 (s, 1H), 7.34 (d, J = 8.92 Hz, 1H), 4.44 (s, 2H), 4.28 (s, 2H), 1.81 (s, 3H)
267[Figure (not displayed)]
MS (ESI) m/z 609.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.04 (bs, 1H), 8.88 (d, J = 4.8 Hz, 1H), 8.30 (d, J = 1.2 Hz, 1H), 8.03 (d, J = 1.4 Hz, 1H), 7.61-7.56 (m, 2H), 7.42 (d, J = 2.8 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.91 (s, 1H), 4.44 (t, J = 4.4 Hz, 2H), 4.26 (d, J = 4.4 Hz, 2H), 1.73 (s, 3H)
27[Figure (not displayed)]
MS (ESI) m/z 586.17 [M + 1]+. 1H NMR (400 MHz, DMSO-d6) δ 13.95 (bs, 1H), 8.98 (d, J = 4.4 Hz, 1H), 8.38 (s, 1H), 8.11 (s, 1H), 7.66 (d, J = 4.0 Hz, 1H), 7.60 (d, J = 9.6 Hz, 1H) 7.49 (s, 1H), 7.36 (d, J = 9.2 Hz, 1H), 4.45 (s, 2H), 4.28 (s, 2H), 1.74 (s, 3H)
275[Figure (not displayed)]
MS (ESI) m/z 601.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 8.85 (d, J = 4.80 Hz, 1H), 8.39 (s, 1H), 7.89 (s, 1H), 7.60 (dd, J = 8.88, 2.36 Hz, 1H), 7.50 (d, J = 4.80 Hz, 1H), 7.42 (d, J = 2.44 Hz, 1H), 7.35 (d, J = 8.96 Hz, 1H), 4.40 (t, J = 5.28 Hz, 2H). 4.23 (t, J = 4.40 Hz, 2H), 1.71 (s, 3H)
285[Figure (not displayed)]
MS (ESI) m/z 552.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.91 (d, J = 4.8 Hz, 1H), 8.79 (d, J = 6.2 Hz, 1H), 8.64 (s, 1H), 8.40 (s, 1H), 8.34 (s, 1H), 8.05 (s, 1H), 7.61 (d, J = 3.1 Hz, 1H), 7.55 (d, J = 4.7 Hz, 1H), 4.62 (t, J = 4.2 Hz, 2H), 4.31 (t, J = 4.7 Hz, 2H), 1.75 (s, 3H)
287[Figure (not displayed)]
MS (ESI) m/z 576.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.28 (bs, 1H), 8.84 (d, J = 4.8 Hz, 1H), 8.38 (s, 1H), 8.26 (s, 1H), 8.05 (dd, J = 8.6, 2.0 Hz, 1H), 8.01 (s, 1H), 7.89 (d, J = 2.0 Hz, 1H), 7.52 (d, J = 3.4 Hz, 1H), 7.5 (s, 1H), 4.51 (t, J = 4.8 Hz, 2H), 4.26 (t, J = 5.9 Hz, 2H), 1.7 (s, 3H)
289[Figure (not displayed)]
MS (ESI) m/z 594.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.85 ( d, J = 4.5 1H), 8.39 (s, 1H), 8.28 (s, 1H), 8.00 (d, J = 8.52, 2H), 7.63 (d, J = 11.4 Hz, 1H), 7.49 (d, J = 4.28 Hz, 1H), 4.527 (s, 2H), 4.26 (s, 2H), 1.683 (s, 3H)
291[Figure (not displayed)]
MS (ESI) m/z 577.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.15 (s, 1H), 8.91 (d, J = 4.72 Hz, 1H), 8.87 (s, 1H), 8.39 (s, 1H), 8.35 (s, 1H), 8.17 (s, 1H), 8.05 (s, 1H), 7.54 (d, J = 4.72 Hz, 1H), 4.66 (s, 2H), 4.27 (s, 2H), 1.79 (s, 3H)
292[Figure (not displayed)]
MS (ESI) m/z 577.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.88 (s, 1H), 8.87 (s, 1H), 8.38 (s, 1H), 8.27 (d, J = 8.7 Hz, 1H), 8.22 (s, 1H), 8.1 (d, J = 4.9 Hz, 1H), 8.04 (d, J = 8.7 Hz, 1H), 4.68 (t, J = 4.2 Hz, 2H), 4.55 (t, J = 4.4 Hz, 2H), 2.37 (s, 3H)
294[Figure (not displayed)]
MS (ESI) m/z 603.17 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.84 Hz, 1H), 8.45 (s, 1H), 8.37 (d, J = 5.28 Hz, 1H), 7.60 (dd, J = 8.56, 6.72, Hz, 1H), 7.49 (d, J = 4.56 Hz 1H), 7.43 (d, J = 2.04 Hz, 1H), 7.37 (d, J = 8.88 Hz, 1H), 4.42 (t, J = 4.90, 2H), 4.27 (t, J = 4.40 Hz, 2H), 1.86 (s, 3H)
295[Figure (not displayed)]
MS (ESI) m/z 634.99 [M + 1]+; 1H NMR (400 MHz, DMSO-d6), 68.76 (d, J = 2.68 Hz 1H), 8.35 (s, 1H), 8.10 (s, 1H), 7.74 (s, 1H), 7.58 (dd, J = 9.24, 2.81 Hz, 1H), 7.42 (d, J = 2.80 Hz, 1H), 7.40 (d, J = 4.40 Hz, 1H), 7.34 (d, J = 8.96 Hz, 1H), 4.45-4.37 (m, 2H), 4.30-4.22 (m, 2H), 1.82 (s, 3H)
296[Figure (not displayed)]
MS (ESI) m/z 599.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.55 (s, 1H), 8.36 (s, 1H), 8.27 (s, 1H), 7.97 (s, 1H), 7.60-7.57 (dd, J = 2.52, 8.8 Hz, 1H), 7.41 (m, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.40 (t, J = 5 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 2.69 (s, 3H), 1.82 (s, 3H)
299[Figure (not displayed)]
MS (ESI) m/z 585.17 [M + 1]+. 1H NMR (400 MHz, DMSO-d6) δ 14.22 (bs, 1H), 8.37 (s, 1H), 8.34 (d, J = 4.8 Hz, 1H), 8.18 (s, 1H), 7.98 (s, 1H), 7.47-7.44 (m, 2H), 7.38 (d, J = 2.4 Hz, 1H), 7.25 (d, J = 9.2 Hz, 1H), 4.34 (t, 4.8 Hz, 2H), 4.25 (t, J = 4.4, 2H), 1.97 (s, 3H)
300[Figure (not displayed)]
MS (ESI) m/z 568.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.19 (s, 1H), 8.33 (s,1H), 8.20 (s, 1H), 8.06 (s, 1H), 7.61 (d, J = 7.28 Hz, 1H), 7.51 (d, J = 7.56 Hz, 1H), 7.47 (d, J = 2.32 Hz, 1H), 7.43 (d, J = 2.2 Hz, 1H), 7.28 (d, J = 8.8 Hz, 1H), 6.97 (t, J = 7.56 Hz, 1H,), 4.43 (s, 2H), 4.32 (s,2H), 2.10 (s, 3H)
301[Figure (not displayed)]
MS (ESI) m/z 583.99 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.46 (bs, 1H), 8.35 (s, 1H), 7.94 (s, 1H), 7.79 (s, 1H), 7.55 (d, J = 7.32 Hz, 1H), 7.49 (dd, J = 8.80, 2.68 Hz, 1H), 7.32-7.27 (m, 3H), 6.89 (t, J = 7.64 Hz, 1H), 4.30 (t, J = 5.08 Hz, 2H), 4.16 (t, J = 5.12 Hz, 2H), 1.92 (s, 3H)
314[Figure (not displayed)]
MS (ESI) m/z 585.94 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.25 (s, 1H), 9.18 (s, 1H), 8.33 (s, 1H), 8.24 (s, 1H), 7.97 ( s, 1H), 7.62 (dd, J = 8.8, 2.7 Hz, 1H), 7.49 (d, J = 2.32 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.44 (t, J = 4.96 Hz, 2H), 4.27 (t, J = 4.96 Hz, 2H), 1.71 (s, 3H)
315[Figure (not displayed)]
MS (ESI) m/z 591.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.54 ( s, 1H), 8.33 (s, 1H), 8.11 (s, 1H), 8.01 (s, 1H), 7.67 (d, J = 2.64 Hz, 1H), 7.59 (dd, J = 8.92, 2.68 Hz, 1H), 7.38 (d, J = 9 Hz, 1H), 4.60 (t, J = 5.24 Hz, 2H), 4.37 (t, J = 5.36 Hz, 2H), 2.14 (s, 3H)
319[Figure (not displayed)]
MS (ESI) m/z 585.2 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO)/ppm = 13.31 (bs, 1H), 9.59 (s, 1H), 8.37 (s, 1H), 8.34 (d, J = 1.9 Hz, 1H), 7.95-7.94 (m, 1H), 7.91 (s, 1H), 7.54 (dd, J = 8.9, 2.6 Hz, 1H), 7.38 (d, J = 2.6 Hz, 1H), 7.30 (d, J = 8.9 Hz, 1H), 4.36 (t, J = 4.7 Hz, 2H), 4.21 (t, J = 4.7 Hz, 2H), 1.70 (s, 3H)
320[Figure (not displayed)]
MS (ESI) m/z 582.1 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) / ppm = 8.49 (d, J = 5.1 Hz, 1H), 8.39 (d, J = 1.5 Hz, 1H), 8.15-8.02 (m, 2H), 7.60 (dd, J = 9.1, 2.6 Hz, 1H), 7.41 (d, J = 2.6 Hz, 1H), 7.30 (d, J = 9.1 Hz, 1H), 7.34-7.20 (m, 1H), 4.46-4.33 (m, 2H), 4.28- 4.20 (m, 2H), 3.16 (s, 3H), 1.66 (s, 3H)
321[Figure (not displayed)]
MS (ESI) m/z 700.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.16 (s, 1H), 8.87-8.81 (m, 1H), 8.24-8.17 (m, 1H), 7.98 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.49 (dd, J = 4.9, 2.0 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.77-4.71 (m, 1H), 4.66-4.59 (m, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.32-4.11 (m, 6H), 3.70-3.53 (m, 2H), 3.23- 3.11 (m, 2H), 1.81 (s, 3H)
322[Figure (not displayed)]
[0503] MS (ESI) m/z 567.2 [M + 1]+; 1H NMR (400 MHz, d6-DMSO) δ/ppm = 11.04 (d, J = 3.2 Hz, 1H), 8.38-8.37 (m, 1H), 8.10-8.08 (m, 1H), 8.02 (d, J = 8.1 Hz, 1H), 7.45 (dd, J = 8.9 Hz, 2.8 Hz, 1H), 7.25-7.15 (m, 4H), 7.02 (dd, J = 7.2, 1.2 Hz, 1H), 4.40-4.35 (m, 2H), 4.22- 4.18 (m, 2H), 1.61 (s, 3H)
323[Figure (not displayed)]
MS (ESI) m/z 568.0 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 13.49 (b, 1H), 8.59 (d, J = 5.6 Hz, 1H), 8.40-8.39 (m, 1H), 8.07- 8.05 (m, 1H), 7.87-7.77 (m, 1H), 7.62 (dd, J = 8.9, 2.6 Hz, 1H), 7.60-7.49 (m, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.34 (d, J = 8.9 Hz, 1H), 4.45 (t, J = 4.6 Hz, 2H), 4.25 (t, J = 4.6 Hz, 2H), 1.76 (s, 3H)
324[Figure (not displayed)]
MS (ESI) m/z 569.0 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.80 (s, 1H), 8.65 (d, J = 4.9 Hz, 1H), 8.53 (d, J = 2.7 Hz, 1H), 8.33 (bd, J = 1.7 Hz, 1H), 8.15-8.14 (m, 1H), 7.69 (d, J = 4.9 Hz, 1H), 7.43 (dd, J = 8.9, 2.7 Hz, 1H), 7.30 (d, J = 8.9 Hz, 1H), 4.55-4.52 (m, 4H), 2.45 (s, 3H)
325[Figure (not displayed)]
MS (ESI) m/z 569.0 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.98-8.90 (m, 1H), 8.54-8.45 (m, 1H), 8.36-8.31 (m, 1H), 8.23-8.18 (m, 1H), 7.64-7.51 (m, 3H), 7.34-7.27 (m, 1H), 4.43-4.34 (m, 2H), 4.34- 4.23 (m, 2H), 1.77 (s, 3H)
326[Figure (not displayed)]
[0506] MS (ESI) m/z 535.1 [M + 1]+
327[Figure (not displayed)]
MS (ESI) m/z 616.4 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.33 (bd, J = 1.7 Hz, 1H), 8.24 (dd, J = 7.8, 0.9 Hz, 1H), 7.95 (s, 1H), 7.76 (dd, J = 7.8, 7.8 Hz, 1H), 7.50 (dd, J = 8.9, 2.6 Hz, 1H), 7.45 (bd, J = 7.8 Hz, 1H), 7.23-7.20 (m, 2H), 7.14 (s, 1H), 4.36-4.21 (m, 4H), 1.84 (s, 3H)
328[Figure (not displayed)]
MS (ESI) m/z 549.3 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.39 (bd, J = 1.7 Hz, 1H), 8.24-8.22 (m, 1H), 7.01-6.87 (m, 3H), 4.52 (t, J = 4.8 Hz, 2H), 4.35 (t, J = 4.8 Hz, 2H), 3.22-3.16 (m, 2H), 2.80 (s, 3H), 2.50-2.43 (m, 2H), 2.13-2.09 (m, 2H), 1.74-1.57 (m, 3H), 1.27-1.11 (m, 2H)
329[Figure (not displayed)]
MS (ESI) m/z 615.0 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.36 (bd, J = 1.6 Hz, 1H), 8.12 (s, 1H), 8.01-8.00 (m, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.39 (d, J = 2.7 Hz, 1H), 7.33 (d, J = 8.9 Hz, 1H), 6.90 (d, J = 0.3 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.26 (t, J = 5.0 Hz, 1H), 4.03 (s, 3H), 1.87 (s, 3H)
330[Figure (not displayed)]
MS (ESI) m/z 613.1 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.37 (bs, 1H), 8.24 (s, 1H), 7.95 (bs, 1H), 7.60 (dd, J = 8.8, 2.6, 1H), 7.47 (s, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.41 (bt, 2H), 4.25 (bt, 2H), 3.01 (q, J = 7.6 Hz, 2H), 1.78 (s, 3H), 1.34 (t, J = 7.6 Hz, 3H)
331[Figure (not displayed)]
MS (ESI) m/z 601.6 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 10.48 (s, 1H), 8.37-8.36 (m, 1H), 7.95 (bs, 1H), 7.78 (bs, 1H), 7.56 (dd, J = 8.7, 2.6, 1H), 7.38 (d, J = 2.6 Hz, 1H), 7.31 (d, J = 8.7 Hz, 1H), 6.36 (bs, 1H), 4.41 (bt, 2H), 4.32 (bt, 2H), 2.15 (s, 3H)
332[Figure (not displayed)]
MS (ESI) m/z 615.1 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 13.35 (b, 1H), 8.32 (d, J = 1.2 Hz, 1H), 8.06-8.04 (m, 1H), 7.68 (s, 1H), 7.51 (dd, J = 8.8, 2.7 Hz, 1H), 7.32 (d, J = 2.7 Hz, 1H), 7.26 (d, J = 8.8 Hz, 1H), 6.35 (s, 1H), 4.35 (bt, 1H), 4.28 (bt, 1H), 3.65 (s, 3H), 2.06 (s, 3H)
333[Figure (not displayed)]
MS (ESI) m/z 616.2 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 12.89 (b, 1H), 8.35 (d, J = 1.5 Hz, 1H), 8.07 (bs, 1H), 7.77 (bs, 1H), 7.50 (dd, J = 8.9, 2.7 Hz, 1H), 7.30-7.26 (m, 2H), 7.19 (d, J = 6.0 Hz, 1H), 4.35 (bt, 2H), 4.25 (bt, 2H), 2.33 (s, 3H), 1.83 (s, 3H)
341[Figure (not displayed)]
MS (ESI) m/z 690.1 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.75 (d, J = 5.3 Hz, 1H), 8.28 (s, 1H), 8.06 (s, 1H), 7.60 (dd, J = 8.9, 2.8 Hz, 1H), 7.59 (s, 1H), 7.52 (bd, J = 5.3 Hz, 1H), 7.45 (s, 1H), 7.42 (d, J = 2.8 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 4.42 (t, J = 5.2 Hz, 2H), 4.28 (t, J = 5.2 Hz, 2H), 2.73 (s, 3H), 2.64 (s, 3H), 1.87 (s, 3H)
342[Figure (not displayed)]
MS (ESI) m/z 694.2 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.82 (d, J = 2.8 Hz, 1H), 8.60-8.59 (m, 1H), 8.28 (s, 1H), 8.11-8.06 (m, 1H), 8.07 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.45 (s, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 4.43 (t, J = 4.9 Hz, 2H), 4.29 (t, J = 4.9 Hz, 2H), 2.73 (s, 3H), 1.89 (s, 3H)
343[Figure (not displayed)]
MS (ESI) m/z 694.5 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.85 (dd, J = 7.5, 5.8 Hz, 1H), 8.79 (d, J = 9.9 Hz, 1H), 8.35 (s, 1H), 8.12 (s 1H), 7.64 (dd, J = 9.8, 5.8 Hz 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (s, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 4.49-4.19 (m, 4H), 2.73 (s, 3H), 1.87 (s, 3H)
344[Figure (not displayed)]
MS (ESI) m/z 694.2 [M + 1]+; 1H-NMR (400 MHz, d6- DMSO) δ/ppm = 8.87 (s, 1H), 8.71 (d, J = 4.7 Hz, 1H), 8.34 (s, 1H), 8.14 (s, 1H), 7.74-7.70 (m, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.45 (s, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 8.9 Hz, 1H), 4.48-4.20 (m, 4H), 2.72 (s, 3H), 1.87 (s, 3H)
347[Figure (not displayed)]
MS (ESI) m/z 682.5 [M + 1]+; 1H-NMR (400 MHz, d6- DMSO) δ/ppm = 9.32 (s, 1H), 8.71 (s, 1H), 8.30 (s, 1H), 8.05 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.44 (s, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 4.42 (t, J = 4.7 Hz, 2H), 4.28 (t, J = 4.7 Hz, 2H), 2.72 (s, 3H), 1.88 (s, 3H)
348[Figure (not displayed)]
MS (ESI) m/z 682.4 [M + 1]+; 1H-NMR (400 MHz, d6- DMSO) δ/ppm = 8.74 (d, J = 1.7 Hz, 1H), 8.31 (s, 1H), 8.06 (s, 1H), 7.67 (d, J = 1.7 Hz, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (s, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 8.6 Hz, 1H), 4.42 (t, J = 4.9 Hz, 2H), 4.28 (t, J = 4.9 Hz, 2H), 2.74 (s, 3H), 1.86 (s, 3H)
349[Figure (not displayed)]
MS (ESI) m/z 704.3 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 8.28 (s, 1H), 8.08 (s, 1H), 7.83-7.77 (m, 1H), 7.60 (dd, J = 9.0, 2.8 Hz, 1H), 7.46 (s, 1H), 7.44 (d, J = 2.8 Hz, 1H), 7.43-7.38 (m, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.47-4.38 (m, 2H), 4.33-4.19 (m, 2H), 2.73 (s, 3H), 2.59 (s, 3H), 2.22 (s, 3H), 1.84 (s, 3H)
350[Figure (not displayed)]
MS (ESI) m/z 704.5 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) □/ppm = 8.47-8.37 (m, 1H), 8.29 (s, 1H), 8.08 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46 (s, 1H), 7.44 (d, J = 2.7 Hz, 1H), 7.43-7.39 (m, 1H), 7.37 (d, J = 8.9 Hz, 1H), 4.47-4.43 (m, 2H), 4.34-4.18 (m, 2H), 2.73 (s, 3H), 2.57 (s, 3H), 2.06 (s, 3H), 1.84 (s, 3H)
352[Figure (not displayed)]
MS (ESI) m/z 599.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.68 (d, J = 4.7 Hz, 1H), 8.38 (dd, J = 1.8, 0.6 Hz, 1H), 8.22 (dt, J = 1.8, 0.8 Hz, 1H), 7.53 (dd, J = 8.9, 2.7 Hz, 1H), 7.42 (s, 1H), 7.39 (d, J = 2.7 Hz, 1H), 7.29 (d, J = 9.0 Hz, 1H), 7.21 (d, J = 4.7 Hz, 1H), 5.43 (s, 1H), 4.37 (t, J = 4.9 Hz, 2H), 4.24 (t, J = 4.9 Hz, 2H), 1.75 (s, 6H), 1.65 (s, 3H)
354[Figure (not displayed)]
MS (ESI) m/z 615.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.87-8.84 (m, 2H), 7.61-7.57 (m, 2H), 7.53-7.51 (m, 2H), 7.38 (d, J = 9.0 Hz, 1H), 7.35 (s, 1H), 4.23 (t, J = 5.5 Hz, 2H), 3.74 (t, J = 5.4 Hz, 2H), 2.75 (s, 3H), 1.07 (s, 6H)
356[Figure (not displayed)]
MS (ESI) m/z 602.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.34 (s, 1H), 8.82 (d, J = 4.9 Hz, 1H), 8.45 (s, 1H), 8.37-8.36 (m, 1H), 8.05-8.04 (m, 1H), 7.95 (s, 1H), 7.52 (d, J = 4.9 Hz, 1H), 4.63 (t, J = 5.0 Hz, 2H), 4.31 (t, J = 5.0 Hz, 2H), 1.90 (s, 3H)
363[Figure (not displayed)]
MS (ESI) m/z 613.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.25 (s, 1H), 7.92 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.41 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 2.71 (s, 3H), 2.70 (s, 3H), 1.85 (s, 3H)
364[Figure (not displayed)]
MS (ESI) m/z 613.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.41 (s, 1H), 8.16 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.38 (d, J = 9.0 Hz, 1H), 4.44 (t, J = 5.0 Hz, 2H), 4.26 (t, J = 5.0 Hz, 2H), 2.68 (s, 3H), 2.69-2.63 (m, 3H), 1.93 (s, 3H)
373[Figure (not displayed)]
MS (ESI) m/z 694.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.09 (s, 1H), 8.25 (d, J = 5.1 Hz, 1H), 7.98 (d, J = 5.3 Hz, 1H), 7.60 (dd, J = 8.9, 2.6 Hz, 1H), 7.44 (s, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 5.95 (s, 1H), 4.41 (t, J = 5.4 Hz, 2H), 4.26 (t, J = 5.1 Hz, 2H), 4.13 (d, J = 17.4 Hz, 1H), 3.84 (d, J = 17.8 Hz, 1H), 3.02-2.88 (m, 5H), 2.73-2.66 (m, 5H), 1.87 (s, 3H)
374[Figure (not displayed)]
MS (ESI) m/z 626.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.74 (s, 1H), 8.15 (s, 1H), 7.83 (dt, J = 7.7, 1.5 Hz, 1H), 7.80 (t, J = 1.8 Hz, 1H), 7.50 (dt, J = 7.7, 1.6 Hz, 1H), 7.45- 7.38 (m, 2H), 7.28 (d, J = 2.7 Hz, 1H), 7.21 (d, J = 8.9 Hz, 1H), 3.85 (t, J = 12.3 Hz, 2H), 3.54 (d, J = 11.7 Hz, 2H), 3.19 (d, J = 12.8 Hz, 2H), 3.12-2.99 (m, 2H), 2.89 (s, 3H), 2.21 (s, 3H)
375[Figure (not displayed)]
MS (ESI) m/z 619.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.25 (s, 1H), 7.92-7.85 (m, 2H), 7.84 (t, J = 1.8 Hz, 1H), 7.54 (dt, J = 7.8, 1.6 Hz, 1H), 7.45 (d, J = 7.6 Hz, 1H), 7.43-7.37 (m, 3H), 7.29 (d, J = 2.6 Hz, 1H), 7.21 (d, J = 8.9 Hz, 1H), 4.40- 4.33 (m, 4H), 2.52 (s, 3H), 2.24 (s, 3H)
376[Figure (not displayed)]
MS (ESI) m/z 717.9 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.8 Hz, 1H), 8.22 (s, 1H), 7.98 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 6.38 (tt, J = 53.3, 3.0 Hz, 1H), 4.42 (t, J = 5.1 Hz, 2H), 4.31-4.25 (m, 6H), 3.87 (td, J = 16.3, 3.0 Hz, 2H), 3.41 (s, 2H), 3.24 (s, 1H), 1.81 (s, 3H)
377[Figure (not displayed)]
MS (ESI) m/z 676.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.13 (s, 1H), 7.85-7.78 (m, 2H), 7.51 (dt, J = 7.7, 1.5 Hz, 1H), 7.44-7.37 (m, 2H), 7.28 (d, J = 2.7 Hz, 1H), 7.21 (d, J = 8.9 Hz, 1H), 6.38 (t, J = 54.0 Hz, 1H), 2.20 (s, 3H). Note: some aliphatic signals were very broad and could not be integrated
378[Figure (not displayed)]
MS (ESI) m/z 654.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.12 (s, 1H), 7.85-7.79 (m, 2H), 7.51 (dt, J = 7.7, 1.6 Hz, 1H), 7.44- 7.37 (m, 2H), 7.27 (d, J = 2.6 Hz, 1H), 7.21 (d, J = 8.9 Hz, 1H), 4.34 (s, 4H), 3.06-2.76 (m, 2H), 2.20 (s, 3H), 2.06 (s, 3H) Note: some aliphatic signals were very broad and could not be integrated
379[Figure (not displayed)]
MS (ESI) m/z 689.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.15 (s, 1H), 8.11 (dd, J = 5.6, 1.9 Hz, 1H), 7.87-7.79 (m, 3H), 7.51 (dt, J = 7.7, 1.6 Hz, 1H), 7.45-7.38 (m, 2H), 7.28 (d, J = 2.7 Hz, 1H), 7.21 (d, J = 8.9 Hz, 2H), 6.85 (t, J = 6.3 Hz, 1H), 4.35 (s, 4H), 2.20 (s, 3H). Note: some aliphatic signals were very broad and could not be integrated
380[Figure (not displayed)]
MS (ESI) m/z 689.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.51 (d, J = 2.9 Hz, 1H), 8.22 (d, J = 5.3 Hz, 1H), 8.15 (s, 1H), 8.08 (dd, J = 8.8, 2.8 Hz, 1H), 7.85 (dt, J = 7.7, 1.5 Hz, 1H), 7.83-7.78 (m, 2H), 7.51 (dt, J = 7.7, 1.6 Hz, 1H), 7.45-7.38 (m, 2H), 7.28 (d, J = 2.7 Hz, 1H), 7.21 (d, J = 8.9 Hz, 1H), 4.35 (s, 4H), 2.20 (s, 3H). Note: some aliphatic signals were very broad and could not be integrated
381[Figure (not displayed)]
MS (ESI) m/z 640.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.13 (s, 1H), 7.84 (dt, J = 7.7, 1.5 Hz, 1H), 7.80 (t, J = 1.8 Hz, 1H), 7.51 (dt, J = 7.7, 1.5 Hz, 1H), 7.45-7.38 (m, 2H), 7.27 (d, J = 2.6 Hz, 1H), 7.21 (d, J = 8.9 Hz, 1H), 4.35 (s, 4H), 2.92 (s, 3H), 2.19 (s, 3H). Note: some aliphatic signals were very broad and could not be integrated
382[Figure (not displayed)]
MS (ESI) m/z 688.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.13 (s, 1H), 7.87-7.80 (m, 2H), 7.52 (dt, J = 7.7, 1.5 Hz, 1H), 7.45-7.37 (m, 2H), 7.30- 7.19 (m, 4H), 7.05-6.99 (m, 2H), 6.83 (t, J = 7.3 Hz, 1H), 4.35 (s, 4H), 2.20 (s, 3H). Note: some aliphatic signals were very broad and could not be integrated
383[Figure (not displayed)]
MS (ESI) m/z 711.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.26 (s, 1H), 7.92 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.1 Hz, 2H), 4.24 (t, J = 5.0 Hz, 2H), 2.94 (s, 3H), 2.72 (s, 3H), 1.82 (s, 3H). Note: some aliphatic signals were very broad and could not be integrated
386[Figure (not displayed)]
MS (ESI) m/z 605.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.80 (d, J = 5.1 Hz, 2H), 8.29 (s, 1H), 7.86 (dt, J = 7.6, 1.6 Hz, 1H), 7.82 (t, J = 1.8 Hz, 1H), 7.55-7.50 (m, 3H), 7.47-7.39 (m, 2H), 7.28 (d, J = 2.7 Hz, 1H), 7.22 (d, J = 8.9 Hz, 1H), 4.43-4.31 (m, 4H), 2.24 (s, 3H)
387[Figure (not displayed)]
MS (ESI) m/z 689.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.24 (d, J = 7.4 Hz, 2H), 7.88 (s, 1H), 7.45-7.34 (m, 5H), 7.26 (d, J = 2.7 Hz, 1H), 7.19 (d, J = 8.9 Hz, 1H), 7.13 (d, J = 7.1 Hz, 2H), 4.31 (s, 4H), 3.85-3.49 (m, 8H), 2.20 (s, 3H)
388[Figure (not displayed)]
MS (ESI) m/z 605.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (dd, J = 4.9, 1.6 Hz, 1H), 8.62 (s, 1H), 8.28 (s, 1H), 7.91 (dt, J = 7.9, 1.9 Hz, 1H), 7.86 (dt, J = 7.6, 1.5 Hz, 1H), 7.82 (t, J = 1.8 Hz, 1H), 7.62 (dd, J = 7.8, 4.8 Hz, 1H), 7.53 (dt, J = 7.7, 1.5 Hz, 1H), 7.48- 7.38 (m, 2H), 7.28 (d, J = 2.6 Hz, 1H), 7.22 (d, J = 8.9 Hz, 1H), 4.42-4.32 (m, J = 2.5 Hz, 4H), 2.24 (s, 3H)
389[Figure (not displayed)]
MS (ESI) m/z 703.9 [M + 1]+;; 1H NMR (400 MHz, DMSO-d6) δ 8.58 (s, 1H), 8.27 (s, 1H), 8.06 (s, 1H), 8.00 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46 (s, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.43 (t, J = 5.0 Hz, 2H), 4.28 (t, J = 4.9 Hz, 2H), 2.73 (s, 3H), 2.64 (s, 3H), 2.42 (s, 3H), 1.88 (s, 3H)
398[Figure (not displayed)]
MS (ESI) m/z 656.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.16 (t, J = 5.4 Hz, 1H), 8.34 (d, J = 1.7 Hz, 1H), 8.14 (s, 1H), 8.05 (dd, J = 1.8, 0.8 Hz, 1H), 7.58 (dd, J = 8.9, 2.7 Hz, 1H), 7.39 (d, J = 2.7 Hz, 1H), 7.34 (d, J = 9.0 Hz, 1H), 7.33 (s, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.26 (t, J = 5.0 Hz, 2H), 4.21 (d, J = 5.4 Hz, 2H), 2.69 (s, 3H), 1.84 (s, 3H)
401[Figure (not displayed)]
MS (ESI) m/z 568.2 [M + H]+; 1H NMR (400 MHz, CD3OD) δ 8.16-8.13 (m, 1H), 8.05-8.02 (m, 1H), 7.97 (s, 1H), 7.90 (dd, J = 7.9, 1.3 Hz, 1H), 7.41 (dd, J = 8.8, 2.7 Hz, 1H), 7.31 (t, J = 7.6 Hz, 1H), 7.23 (d, J = 2.7 Hz, 1H), 7.20 (dd, J = 7.4, 1.3 Hz, 1H), 7.19 (d, J = 8.9 Hz, 1H), 4.40-4.30 (m, 4H), 1.98 (s, 3H)
402[Figure (not displayed)]
MS (ESI) m/z 584.3 [M + H]+; 1H NMR (400 MHz, Methanol-d4) δ 8.52 (dd, J = 8.3, 1.1 Hz, 1H), 8.15 (dd, J = 1.8, 0.6 Hz, 1H), 8.01 (dd, J = 1.7, 0.8 Hz, 1H), 7.77 (s, 1H), 7.51 (dd, J = 8.2, 7.2 Hz, 1H), 7.45 (dd, J = 8.9, 2.7 Hz, 1H), 7.30-7.25 (m, 1H), 7.22 (s, 1H), 7.21-7.16 (m, 1H), 4.40 (t, J = 4.8 Hz, 2H), 4.31 (t, J = 4.8 Hz, 2H), 1.82 (s, 3H)
410[Figure (not displayed)]
MS (ESI) m/z 543.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.37 (d, J = 1.7 Hz, 1H), 8.17 (bs, 1H), 7.77 (bd, J = 1.6 Hz, 1H), 7.48 (bd, J = 1.4 Hz, 1H), 7.47 (dd, J = 8.9, 2.7 Hz, 1H), 7.36 (d, J = 2.7 Hz, 1H), 7.25 (d, J = 8.9 Hz, 1H), 4.39 (bs, 4H), 2.51 (s, 3H), 2.24 (s, 3H)
411[Figure (not displayed)]
MS (ESI) m/z 557.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.40 (d, J = 1.7 Hz, 1H), 8.20 (d, J = 1.7 Hz, 1H), 7.49 (dd, J = 8.9, 2.7 Hz, 1H), 7.46-7.40 (br, 2H), 7.37 (d, J = 2.7 Hz, 1H), 7.26 (d, J = 8.9 Hz, 1H), 4.49-4.35 (m, 4H), 3.86 (s, 2H), 2.53 (s, 3H), 2.31 (s, 3H)
414[Figure (not displayed)]
MS (ESI) m/z 583.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.38 (d, J = 1.8 Hz, 1H), 8.10 (br, 1H), 7.97 (s, 1H), 7.62 (dd, J = 8.9, 2.7 Hz, 1H), 7.53 (d, J = 2.7 Hz, 1H), 7.32 (d, J = 9.0 Hz, 1H), 7.15 (s, 1H), 4.37 (t, J = 4.9 Hz, 2H), 4.25 (t, J = 4.9 Hz, 2H), 2.59 (s, 3H), 1.85 (s, 3H)
415[Figure (not displayed)]
MS (ESI) m/z 599.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (bs, 1H), 8.24 (s, 1H), 7.95 (s, 1H), 7.61 (d, J = 8.8 Hz, 1H), 7.50 (bs, 1H), 7.42 (bs, 1H), 7.36 (d, J = 7.8 Hz), 4.40 (bs, 2H), 4.25 (bs, 2H), 2.72 (s, 3H), 1.76 (s, 3H)
416[Figure (not displayed)]
MS (ESI) m/z 599.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.81 (d, J = 4.6 Hz, 1H), 8.42 (s, 1H), 8.17 (s, 1H), 7.60 (dd, J = 9.4, 2.6 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.44 (t, J = 4.8 Hz, 2H), 4.26 (t, J = 4.8 Hz, 2H), 2.67 (s, 3H), 1.84 (s, 3H)
417[Figure (not displayed)]
MS (ESI) m/z 725.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 7.94 (s, 1H), 7.60 (dd, J = 8.8, 2.6 Hz, 1H), 7.44 (s, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.27 (t, J = 5.0 Hz, 2H), 3.94 (s, 2H), 3.43-3.29 (m, 4H), 2.99-2.82 (m, 4H), 2.78 (d, J = 4.3 Hz, 3H), 2.70 (s, 3H), 2.31 (s, 3H), 1.91 (s, 3H)
421[Figure (not displayed)]
MS (ESI) m/z 690.7 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (dt, J = 4.8, 1.4 Hz, 1H), 8.08-7.99 (m, 2H), 7.65-7.53 (m, 3H), 7.45 (s, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 4.9 Hz, 2H), 4.28 (br, 2H), 2.72 (s, 3H), 2.48 (s, 3H), 1.94 (s, 3H)
422[Figure (not displayed)]
MS (ESI) m/z 668.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.35 (s, 1H), 7.92 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (dd, J = 4.3, 1.8 Hz, 2H), 7.36 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.24 (t, J = 5.0 Hz, 2H), 3.37-3.28 (m, 4H), 2.70 (s, 3H), 2.10-1.99 (m, 4H), 1.82 (s, 3H)
423[Figure (not displayed)]
MS (ESI) m/z 682.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.32 (s, 1H), 7.89 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.44 (s, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 5.04 (br, 6H), 4.39 (t, J = 5.0 Hz, 2H), 4.23 (t, J = 5.0 Hz, 2H), 3.21 (br, 4H), 2.71 (s, 3H), 1.80 (s, 3H)
424[Figure (not displayed)]
MS (ESI) m/z 668.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.18 (s, 1H), 7.95 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.41 (t, J = 5.0 Hz, 2H), 4.26 (t, J = 5.0 Hz, 2H), 4.11-3.92 (m, 4H), 3.39 (br, 2H), 3.35-3.21 (m, 1H), 2.71 (s, 3H), 1.85 (s, 3H)
425[Figure (not displayed)]
MS (ESI) m/z 682.5 [M + 1]+; 1H NMR (400 MHz, CDCl3) δ 8.35 (s, 1H), 8.12 (s, 1H), 7.47 (dd, J = 8.9, 2.6 Hz, 1H), 7.26 (s, 1H), 7.18 (s, 1H), 7.03 (d, J = 8.9 Hz, 1H), 4.56 (t, J = 9.0 Hz, 2H), 4.40 (t, J = 4.8 Hz, 2H), 4.29 (t, J = 4.9 Hz, 2H), 3.84 (t, J = 9.6 Hz, 2H), 3.49 (d, J = 6.6 Hz, 2H), 3.45-3.29 (m, 1H), 2.89 (s, 3H), 2.80 (s, 3H), 1.89 (s, 3H)
428[Figure (not displayed)]
MS (ESI) m/z 747.7 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.91 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 6.38 (br, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.24 (t, J = 5.0 Hz, 3H), 4.06-2.83 (br, 10H), 2.71 (s, 3H), 1.83 (s, 3H)
429[Figure (not displayed)]
MS (ESI) m/z 681.7 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.31 (s, 1H), 7.96 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (dd, J = 7.3, 2.1 Hz, 2H), 7.36 (d, J = 9.0 Hz, 1H), 5.92 (s, 1H), 4.41 (t, J = 5.0 Hz, 2H), 4.29-4.15 (m, 4H), 3.86 (m, 4H), 2.71 (s, 3H), 1.85 (s, 3H)
430[Figure (not displayed)]
MS (ESI) m/z 729.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.25 (s, 1H), 7.93 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.95 (t, J = 4.4 Hz, 1H), 4.82 (d, J = 4.6 Hz, 1H), 4.41 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 3.65-3.03 (br, 10H), 2.72 (s, 3H), 1.85 (s, 3H)
431[Figure (not displayed)]
MS (ESI) m/z 683.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.57 (s, 1H), 8.50 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.40 (s, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.35 (t, J = 5.1 Hz, 2H), 4.26 (t, J = 5.1 Hz, 2H), 3.98 (dd, J = 11.3, 4.0 Hz, 2H), 3.43 (t, J = 11.3 Hz, 2H), 3.22 (m, 1H), 2.72 (s, 3H), 2.08 (s, 3H), 2.03-1.88 (m, 2H), 1.59 (d, J = 12.6 Hz, 2H)
433[Figure (not displayed)]
MS (ESI) m/z 712.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.80 (d, J = 2.4 Hz, 1H), 8.42 (s, 1H), 8.33 (td, J = 9.1, 2.4 Hz, 1H), 8.17 (s, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.45 (d, J = 2.4 Hz, 1H), 7.44 (s, 1H), 7.35 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.27 (t, J = 5.1 Hz, 2H), 2.70 (s, 3H), 1.84 (s, 3H)
434[Figure (not displayed)]
MS (ESI) m/z 708.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.46 (s, 1H), 8.15 (s, 1H), 7.89 (t, J = 8.9 Hz, 1H), 7.62-7.53 (m, 2H), 7.45 (s, 1H), 7.44 (d, J = 2.6, 0.9 Hz, 1H), 7.35 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.28 (d, J = 5.0 Hz, 2H), 2.71 (s, 3H), 2.52 (s, 3H), 1.82 (s, 3H)
437[Figure (not displayed)]
MS (ESI) m/z 705.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.67 (s, 1H), 8.27 (s, 1H), 8.10 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46 (s, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.43 (t, J = 5.1 Hz, 2H), 4.28 (tt, J = 9.5, 5.0 Hz, 2H), 2.74 (s, 3H), 2.71 (s, 3H), 2.23 (s, 3H), 1.85 (s, 3H)
442[Figure (not displayed)]
MS (ESI) m/z 691.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.27 (d, J = 2.1 Hz, 1H), 8.26 (s, 1H), 8.08 (s, 1H), 7.85 (d, J = 2.1 Hz, 1H), 7.60 (dd, J = 8.9, 2.6 Hz, 1H), 7.45 (s, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.43 (t, J = 5.0 Hz, 2H), 4.29 (t, J = 5.0 Hz, 2H), 2.77 (s, 3H), 2.73 (s, 3H), 1.89 (s, 3H)
443[Figure (not displayed)]
MS (ESI) m/z 604.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.58 (d, J = 4.8 Hz, 1H), 8.36-8.32 (m, 1H), 8.15-8.11 (m, 1H), 7.52 (dd, J = 8.9, 2.7 Hz, 1H), 7.38 (d, J = 2.7 Hz, 1H), 7.29 (d, J = 9.0 Hz, 1H), 7.23 (d, J = 4.8 Hz, 1H), 4.36 (t, J = 5.0 Hz, 2H), 4.25 (d, J = 5.0 Hz, 2H), 1.88 (s, 3H), 1.33 (s, 9H)
444[Figure (not displayed)]
MS (ESI) m/z 619.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.34 (d, J = 1.9 Hz, 1H), 8.22 (s, 1H), 7.97 (dd, J = 1.9, 0.8 Hz, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (s, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.31 (d, J = 9.0 Hz, 1H), 4.37 (t, J = 5.0 Hz, 2H), 4.23 (t, J = 5.0 Hz, 2H), 1.79 (s, 3H)
445[Figure (not displayed)]
MS (ESI) m/z 628.7 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.32 (d, J = 1.8 Hz, 1H), 8.25 (s, 1H), 8.01 (d, J = 3.1 Hz, 1H), 7.94 (dd, J = 1.8, 0.9 Hz, 1H), 7.89 (s, 2H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.32 (d, J = 9.0 Hz, 1H), 4.37 (t, J = 5.0 Hz, 2H), 4.20 (t, J = 5.0 Hz, 2H), 1.65 (s, 3H)
446[Figure (not displayed)]
MS (ESI) m/z 610.7 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.41 (d, J = 1.1 Hz, 1H), 8.35 (d, J = 1.7 Hz, 1H), 8.01-7.97 (m, 2H), 7.58 (ddd, J = 9.1, 2.7, 1.0 Hz, 1H), 7.44 (dd, J = 2.6, 1.0 Hz, 1H), 7.33 (d, J = 9.0 Hz, 1H), 4.38 (t, J = 5.0 Hz, 2H), 4.23 (t, J = 5.0 Hz, 2H), 1.71 (s, 3H)
447[Figure (not displayed)]
MS (ESI) m/z 599.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.37-8.31 (m, 1H), 7.97 (d, J = 1.3 Hz, 1H), 7.95 (dt, J = 1.8, 0.8 Hz, 1H), 7.55 (dd, J = 8.9, 2.7 Hz, 1H), 7.35-7.28 (m, 2H), 7.17 (d, J = 0.9 Hz, 1H), 4.36 (t, J = 5.0 Hz, 2H), 4.20 (t, J = 5.0 Hz, 2H), 2.65 (d, J = 0.7 Hz, 3H), 1.86 (s, 3H)
452[Figure (not displayed)]
MS (ESI) m/z 614.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.86 (s, 1H), 8.50-8.37 (m, 4H), 8.30 (s, 1H), 8.01 (s, 1H), 7.62 (dd, J = 8.9, 2.7 Hz, 1H), 7.57 (s, 1H), 7.40-7.35 (m, 2H), 4.44 (q, J = 6.1 Hz, 4H), 4.27 (t, J = 5.2 Hz, 2H), 1.77 (s, 3H)
453[Figure (not displayed)]
MS (ESI) m/z 552.9 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.18 (dd, J = 6.2, 0.7 Hz, H), 8.89-8.84 (m, 2H), 8.37-8.33 (m, 1H), 8.20 (dt, J = 1.8, 0.8 Hz, 1H), 8.07-8.03 (m, 1H), 7.66 (dd, J = 6.2, 0.8 Hz, 1H), 4.63 (t, J = 5.0 Hz, 2H), 4.53 (t, J = 5.0 Hz, 2H), 3.88 (s, 1H), 2.33 (s, 3H)
454[Figure (not displayed)]
MS (ESI) m/z 587.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.99 (s, 1H), 8.96 (s, 1H), 8.93 (d, J = 5.0 Hz, 1H), 8.39-8.37 (m, 1H), 8.26 (d, J = 5.0 Hz, 1H), 8.24 (dd, J = 1.7, 0.8 Hz, 1H), 4.77 (t, J = 5.1 Hz, 2H), 4.62 (t, J = 5.1 Hz, 2H), 2.53 (s, 3H)
455[Figure (not displayed)]
MS (ESI) m/z 578.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.15 (s, 1H), 8.92 (s, 2H), 8.35 (s, 1H), 8.20 (d, J = 4.9 Hz, 2H), 4.83 (s, 2H), 4.60 (s, 2H), 2.56 (2, 3H)
465[Figure (not displayed)]
LCMS: 704.5 [M + H]+; 1H NMR (400 MHz, DMSO- d6) δ 8.25 (s, 1H), 8.05 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.50-7.33 (m, 4H), 4.42 (t, J = 5.0 Hz, 2H), 4.28 (t, J = 5.0 Hz, 2H), 2.73 (s, 3H), 2.62 (s, 6H), 1.87 (s, 3H)
466[Figure (not displayed)]
LCMS: 704.5 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.74-8.65 (m, 1H), 8.32 (s, 1H), 8.09 (s, 1H), 7.80 (d, J = 7.8 Hz, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.49-7.41 (m, 3H), 7.37 (d, J = 9.0 Hz, 1H), 4.52-4.10 (m, 2H), 2.73 (s, 3H), 2.45-2.35 (m, 2H), 1.85 (s, 3H), 1.15 (t, J = 7.5 Hz, 3H)
468[Figure (not displayed)]
LCMS: 704.5 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 5.2 Hz, 1H), 8.29 (s, 1H), 8.06 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.57 (s, 1H), 7.52-7.47 (m, 1H), 7.45 (s, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 5.1 Hz, 2H), 4.29 (d, J = 5.2 Hz, 2H), 2.91 (q, J = 7.5 Hz, 2H), 2.73 (s, 3H), 1.87 (s, 3H), 1.29 (t, J = 7.6 Hz, 3H)
469[Figure (not displayed)]
LCMS: 704.5 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.72 (s, 1H), 8.25 (s, 1H), 8.11 (s, 1H), 7.63-7.58 (m, 2H), 7.47 (s, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.43 (h, J = 5.9 Hz, 2H), 4.27 (dd, J = 11.3, 5.7 Hz, 1H), 2.74 (s, 3H), 2.64 (s, 3H), 2.08 (s, 3H), 1.84 (s, 3H)
470[Figure (not displayed)]
LCMS: 708.5 [M + H]+; 1H NMR (400 MHz, DMSO- d6) δ 8.70-8.65 (m, 1H), 8.27 (d, J = 0.9 Hz, 1H), 8.10 (s, 1H), 7.91 (dd, J = 9.0, 2.9 Hz, 1H), 7.60 (ddd, J = 8.9, 2.6, 1.0 Hz, 1H), 7.47-7.41 (m, 2H), 7.37 (d, J = 8.9 Hz, 1H), 4.43 (d, J = 4.8 Hz, 2H), 4.37-4.17 (m, 2H), 2.74 (d, J = 0.9 Hz, 3H), 2.21 (s, 3H), 1.86 (s, 3H)
471[Figure (not displayed)]
LCMS: 708.6 [M + H]+; 1H NMR (400 MHz, DMSO- d6); 1H NMR (400 MHz, DMSO-d6) δ 8.69 (d, J = 0.8 Hz, 1H), 8.30 (s, 1H), 8.11 (s, 1H), 7.61-7.57 (m, 1H), 7.55 (d, J = 5.6 Hz, 1H), 7.45-7.42 (m, 2H), 7.36 (d, J = 9.0 Hz, 1H), 4.54-4.10 (m, 1H), 2.72 (s, 3H), 2.58 (d, J = 1.0 Hz, 3H), 1.86 (s, 3H)
472[Figure (not displayed)]
LCMS: 708.6 [M + H]+; 1H NMR (400 MHz, DMSO- d6) δ 8.54 (d, J = 4.8 Hz, 1H), 8.33 (s, 1H), 8.12 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.51 (t, J = 5.1 Hz, 1H), 7.46-7.41 (m, 2H), 7.36 (d, J = 9.0 Hz, 1H), 4.57-4.15 (m, 2H), 2.72 (s, 3H), 2.56 (d, J = 3.0 Hz, 3H), 1.87 (s, 3H)
473[Figure (not displayed)]
LCMS: 708.6 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 8.17 (dt, J = 4.7, 1.4 Hz, 1H), 7.99 (s, 1H), 7.77 (ddd, J = 9.8, 8.3, 1.3 Hz, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.45-7.40 (m, 2H), 7.36 (dt, J = 8.4, 1.9 Hz, 2H), 4.66 (s, 2H), 4.42 (t, J = 5.0 Hz, 2H), 4.26 (t, J = 5.1 Hz, 2H), 2.70 (s, 3H), 1.86 (s, 3H)
483[Figure (not displayed)]
MS (ESI) m/z 711.6 [M + 1]+; ; 1H NMR (400 MHz, DMSO-d6) δ 9.36 (s, 1H), 8.38 (s, 1H), 8.27 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46-7.34 (m, 3H), 4.43 (d, J = 5.3 Hz, 2H), 4.27 (s, 2H), 4.14 (s, 2H), 3.30 (d, J = 11.8 Hz, 2H), 2.77 (d, J = 20.8 Hz, 7H), 2.68 (s, 3H), 1.88 (s, 3H)
484[Figure (not displayed)]
MS (ESI) m/z 615.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.37 (d, J = 1.7 Hz, 1H), 8.24 (s, 1H), 7.98-7.94 (m, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.53 (s, 1H), 7.41 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.81 (s, 2H), 4.41 (t, J = 5.1 Hz, 2H), 4.25 (t, J = 5.1 Hz, 2H), 1.77 (s, 3H)
485[Figure (not displayed)]
MS (ESI) m/z 711.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.48 (s, 1H), 8.22 (s, 1H), 7.96 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (d, J = 2.5 Hz, 2H), 7.36 (d, J = 9.0 Hz, 1H), 4.41 (t, J = 5.1 Hz, 2H), 4.26 (d, J = 5.0 Hz, 2H), 3.95 (s, 2H), 3.38 (d, J = 11.4 Hz, 2H), 2.92 (d, J = 11.8 Hz, 4H), 2.78 (d, J = 4.5 Hz, 3H), 2.70 (s, 3H), 1.85 (s, 3H)
486[Figure (not displayed)]
MS (ESI) m/z 711.6 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.96 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (d, J = 2.5 Hz, 2H), 7.36 (d, J = 9.0 Hz, 1H), 4.41 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 3.89 (s, 2H), 3.53 (s, 4H), 2.70 (s, 3H), 1.83 (s, 3H)
487[Figure (not displayed)]
MS (ESI) m/z 791.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 5.0 Hz, 1H), 8.50 (s, 1H), 8.33 (d, J = 1.8 Hz, 1H), 7.96-7.93 (m, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.49 (d, J = 5.0 Hz, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.26 (t, J = 5.1 Hz, 2H), 2.61 (s, 4H), 1.86 (s, 3H)
489[Figure (not displayed)]
MS (ESI) m/z 741.8 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.47 (s, 1H), 8.21 (s, 1H), 7.97 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.48-7.41 (m, 2H), 7.36 (d, J = 9.0 Hz, 1H), 4.74 (s, 2H), 4.41 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 3.94 (s, 2H), 2.92 (d, J = 12.0 Hz, 5H), 2.78 (d, J = 4.2 Hz, 3H), 1.77 (s, 3H)
494[Figure (not displayed)]
MS (ESI) m/z 735.9 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.85 (d, J = 4.8 Hz, 1H), 8.23 (s, 1H), 7.98 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.51 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 4.9 Hz, 2H), 4.26 (t, J = 5.0 Hz, 2H), 4.08- 3.82 (m, 4H), 3.38 (d, J = 6.2 Hz, 2H), 3.16- 3.02 (m, 1H), 1.79 (s, 3H)
495[Figure (not displayed)]
MS (ESI) m/z: 599.01; 1H-NMR (400 MHz, DMSO-d6) δ 8.70 (s, 1H), 8.36 (s, 1H), 8.22 (s, 1H), 8.01 (s, 1H), 7.59-7.56 (m, 1H), 7.37- 7.35 (m, 2H), 4.48-4.44 (m, 1H), 4.27-4.20 (m, 3H), 2.08 (s, 3H), 1.17 (s, 3H)
496[Figure (not displayed)]
MS (ESI) m/z 569.23 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.39 (s, 1H), 8.34 (d, J = 4.28 Hz, 1H), 8.23 (s, 1H), 7.44 (dd, J = 8.80, 2.40 Hz, 1H), 7.25 (d, J = 2.16 Hz, 1H), 7.21 (d, J = 8.84 Hz, 1H), 7.10 (s, 1H), 4.41-4.29 (m, 4H), 4.08 (t, J = 8.48, 1H), 2.12-2.10 (m, 4H), 2.03 (s, 3H)
501[Figure (not displayed)]
MS (ESI) m/z 684.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.8 Hz, 1H), 8.28 (s, 1H), 7.99 (s, 1H), 7.61 (dd, J = 8.92, 2.6 Hz, 1H), 7.51 (d, J = 4.76 Hz, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.00 Hz, 1H), 4.42 (t, J = 5.76 Hz, 2H), 4.26 (t, J = 4.36 Hz, 2H), 3.95 (bs, 2H), 3.55 (bs, 4H), 2.56 (bs, 4H), 1.76 (s, 3H)
502[Figure (not displayed)]
MS (ESI) m/z 697.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.76, 1H), 8.23 (s, 1H), 7.98 (s, 1H), 7.61 (dd, J = 8.84, 2.56 Hz, 1H), 7.48 (d, J = 4.76 Hz, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.00 Hz, 1H), 4.42 (t, J = 3.8 Hz, 2H), 4.26 (t, J = 5.8, 2H), 3.94 (bs, 2H), 3.40 (d, J = 10.68 Hz, 2H), 2.94 (d, J = 10.68 Hz, 4H), 2.79 (d, J = 3.4 Hz, 3H), 2.50 (m, 2H), 1.77 (s, 3H)
503[Figure (not displayed)]
MS (ESI) m/z 660.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.86 (d, J = 4.68 Hz, 1H), 8.11 (s, 1H), 8.07 (s,1H), 7.63 (d, J = 8.36, 1H), 7.57 (d, J = 11.32 Hz, 1H), 7.49 (d, J = 4.72 Hz, 1H), 4.63 (bs, 2H), 4.46 (t, J = 4.64 Hz, 2H), 4.28 (t, J = 4.72 Hz, 2H), 2.89 (bs, 6H), 1.75 (s, 3H)
505[Figure (not displayed)]
MS (ESI) m/z 637.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.86 (d, J = 4.76 Hz, 1H), 8.25 (s, 1H), 8.08 (s, 1H), 7.63 (d, J = 8.32 Hz, 1H), 7.55 (d, J = 11.2 Hz, 1H), 7.50 (d, J = 4.68 Hz, 1H), 4.43 (t, J = 5.00 Hz, 2H), 4.26 (t, J = 4.44 Hz, 2H), 1.68 (s, 3H)
519[Figure (not displayed)]
MS (ESI) m/z 696.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.69 (s, 1H), 8.92 (d, J = 4.44 Hz, 1H), 8.34 (s, 1H), 8.09 (s, 1H), 7.65- 7.54 (m, 2H), 7.45 (d, J = 1.84 Hz, 1H), 7.36 (d, J = 8.84 Hz, 1H), 4.42 (t, J = 4.68 Hz, 2H), 4.24 (t, J = 5.24 Hz, 2H), 3.56 (s, 3H), 1.65 (s, 3H)
521[Figure (not displayed)]
MS (ESI) m/z 648.07 [M + 1]+. 1H NMR (400 MHz, DMSO-d6) δ 12.10 (s, 1H), 8.84 (d, J = 4.80 Hz, 1H), 8.12 (s, 1H), 8.09 (S, 1H), 7.59 (dd, J = 8.88, 2.80 1H), 7.46 (d, J = 4.76 Hz, 1H), 7.41 (d, J = 2.60 Hz,1H), 7.34 (d, J = 9.04 Hz, 1H), 4.42-4.38 (m, 2H), 4.28-4.21 (m, 2H), 3.88 (s, 3H), 1.66 (s, 3H)
522[Figure (not displayed)]
MS (ESI) m/z 718.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.16 Hz, 1H), 8.27 (s, 1H), 8.98 (s, 1H), 7.59 (d, J = 8.52 Hz, 1H), 7.50 (d, J = 4.4 Hz, 1H), 7.43 (s, 1H), 7.36 (d, J = 9.08 Hz, 1H), 4.41 (bs, 2H), 4.24 (bs, 2H), 3.94 (s, 2H), 2.61 (s, 4H), 1.92 (s, 4H), 1.76 (s, 3H)
523[Figure (not displayed)]
MS (ESI) m/z 710.21 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.23 (bs, 1H), 8.82 (d, J = 3.2 Hz, 1H), 8.27 (s, 1H), 7.99 (s, 1H), 7.59 (d, J = 8.88 Hz, 1H), 7.50-7.42 (m, 1H), 7.43 (s, 1H) 7.35 (d, J = 8.24 Hz, 1H), 4.41 (s, 2H), 4.24 (s, 2H), 3.84 (s, 1H), 3.50-3.30 (m, 4H), 3.07 (s, 2H), 2.02 (s, 2H), 1.85- 1.70 (m, 5H)
524[Figure (not displayed)]
MS (ESI) m/z 616.13 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.27 (bs, 1H), 8.82 (s, J = 4.72 Hz, 1H), 8.17 (s, 1H), 8.00 (s, 1H), 7.58 (dd, J = 8.80, 2.44 Hz, 1H ), 7.46 (d, J = 4.76 Hz, 1H), 7.40 (d, J = 2.52 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 5.52 (s, 2H), 4.40 (t, J = 4.28 Hz, 2H), 4.23 (t, J = 5.2 Hz, 2H), 1.73 (s, 3H)
525[Figure (not displayed)]
MS (ESI) m/z 692.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (s, 1H), 8.23 (s, 1H), 7.97 (s, 1H), 7.65-7.26 (m, 4H), 6.16 (t, J = 56.26 Hz, 1H), 4.40 (s, 2H), 4.24 (s, 2H), 4.04 (s, 2H), 2.94 (t, J = 14.2 Hz, 2H), 2.28 (s, 3H), 1.75 (s, 3H)
526[Figure (not displayed)]
MS (ESI) m/z 668.20 [M + 1]+; 1H-NMR (400 MHz, CD3OD) δ 8.80 (d ,J = 4.84 Hz, 1H), 8.27 (s, 1H), 8.19 (s, 1H), 7.57 (dd, J = 2.96, 9.76 Hz, 1H), 7.49 (d, J = 4.84 Hz, 1H), 7.36 (d, J = 2.36 Hz, 1H), 7.31 (d, J = 8.88 Hz, 1H), 4.98 (s, 2H), 4.46 (t, J = 2.36, 2H), 4.37 (t, J = 4.6 Hz, 2H),.3.74 (s, 4H), 2.20 (s, 4H), 2.03 (s, 3H)
527[Figure (not displayed)]
MS (ESI) m/z 670.40 [M + 1]+; 1H-NMR (400 MHz CD3OD) δ 8.78 (d, J = 4.88 Hz, 1H), 8.27 (s, 1H), 8.20 (s, 1H), 7.57 (dd, J = 2.56, 8.92 Hz, 1H), 7.49 (d, J = 4.92 Hz, 1H), 7.36 (d, J = 2.48 Hz, 1H), 7.32 (d, J = 8.84 Hz, 1H), 4.98 (s, 2H), 4.46 (t, J = 4.76, 2H), 4.37 (t, J = 4.5 Hz, 2H),.3.52-3.47 (m, 4H), 2.03 (s, 3H), 1.48-1.29 (m, 6H)
528[Figure (not displayed)]
MS (ESI) m/z 682.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 + D20) δ 8.83 (d, J = 4.80 Hz, 1H), 8.21 (s, 1H), 8.06 (s, 1H), 7.61-7.57 (dd, J = 2.48, 8.80 Hz, 1H), 7.48 (d, J = 4.68 Hz, 1H), 7.44 (d, J = 2.48 Hz, 1H), 7.36 (d, J = 8.92 Hz, 1H), 4.58 (m, 2H), 4.40 (t, J = 6.36 Hz, 2H), 4.26 (t, J = 4.52 Hz, 2H)., 3.29 (m, 4H), 1.75 (m, 7H), 1.54 (m, 2H)
535[Figure (not displayed)]
MS (ESI) m/z 537.11 [M +1]+. 1H NMR (400 MHz, DMSO-d6) δ 12.77 (bs, 1H), 8.39 (s, 1H), 7.23 (s, 1H), 7.03 (d, J = 8.9 Hz), 6.92 (s, 1H), 4.51 (m, 2H), 4.38 (t, J = 4.8 Hz, 3H), 4.19-4.16 (m, 2H), 3.95 (d, J = 11.2 Hz, 1H), 3.63-3.59 (m, 1H), 3.27 (d, J = 9.6 Hz, 1H), 2.94-2.79 (m, 5H)
549[Figure (not displayed)]
MS (ESI) m/z 651.08 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.72 Hz, 1H), 8.22 (s, 1H), 8.07 (s, 1H), 7.61-7.23 (m, 5H), 4.41 (t, J = 4.2 Hz, 2H), 4.26 (t, J = 4.2 Hz, 2H), 1.72 (s, 3H)
553[Figure (not displayed)]
MS (ESI) m/z 636.0 [M + 1]+;; 1H NMR (400 MHz, DMSO-d6) δ 8.74 (d, J = 4.7 Hz, 1H), 8.53 (s, 1H), 8.21 (s, 1H), 7.77 (d, J = 8.1 Hz, 1H), 7.7 (d, J = 2.0 Hz, 1H), 7.68 (s, 1H), 7.54 (d, J = 4.7 Hz, 1H), 4.91 (s, 2H), 4.63 (bs, 2H), 2.87 (bs, 6H), 2.11 (s, 3H)
554[Figure (not displayed)]
MS (ESI) m/z 613.04 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.8 Hz, 1H), 8.55 (s, 1H), 8.22 (s, 1H), 7.76 (d, J = 8.2 Hz, 1H), 7.7 (d, J = 2.0 Hz, 1H), 7.67 (s, 1H), 7.55 (d, J = 4.7 Hz, 1H), 4.88 (s, 2H), 2.07 (s, 3H)
555[Figure (not displayed)]
MS (ESI) m/z 633. [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (d, J = 4.88, 1H), 8.089 (s, 1H), 7.615 (dd, J = 8.92, 8.96, 1H), 7.519 (d, J = 4.88 Hz, 1H), 7.414 (d, J = 2.6, 1H), 7.37 (d, J = 8.96 Hz, 1H), 4.43 (bs, 2H), 4.29 (bs, 2H), 2.41 (s, 3H), 1.89 (s, 3H)
556[Figure (not displayed)]
MS (ESI) m/z 656.21 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 4.76, 1H), 8.088 (s,1H), 7.618 (dd, J = 8.84, 8.72, 1H), 7.517 (d, J = 4.84 Hz, 1H), 7.44 (d, J = 2.16, 1H), 7.36 (d, J = 8.88 Hz, 1H), 4.602 (bs, 2H), 4.419 (bs, 2H), 4.28 (bs, 2H), 2.84 (bs, 6H), 2.34 (s, 3H), 1.83 (s, 3H)
558[Figure (not displayed)]
MS (ESI) m/z 633.10 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.24 (s ,1H), 8.03 (s, 1H), 7.61-7.58 (dd, J = 2.52,J = 8.84 Hz, 1H), 7.44 (s, 1H),-7.41 (d, J = 2.52, 1H),7.37 (d, J = 8.92, 1H), 4.42 (t, J = 5.46 Hz, 2H), 4.27 (t, J = 4.32 Hz, 2H), 2.71 (s, 3H),1.79 (s, 3H)
559[Figure (not displayed)]
MS (ESI) m/z 656.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.48 (s, 1H), 8.06 (bs, 1H), 8.03 (s, 1H), 7.62 (dd, J = 8.92 Hz, 2.52 Hz, 1 H), 7.45-7.34 (m, 2 H), 7.36 (d, J = 8.32 Hz, 1H), 4.75 (s, 2 H), 4.44 (t, J = 3.6 Hz, 2H), 4.29 (t, J = 5.6 Hz, 2 H), 2.99 (s, 6H), 2.72 (s, 3H), 1.82 (s, 3 H)
560[Figure (not displayed)]
MS (ESI) m/z: 593 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.24 (s, 1H), 8.59 (s, 1H), 8.42 (s, 1H), 8.12 (s, 1H), 7.75 (d, J = 8.24 Hz, 1H), 7.68-7.64 (m, 2H), 7.46 (s, 1H), 4.87 (s, 2H), 2.59 (s, 3H), 2.14 (s, 3H)
561[Figure (not displayed)]
MS (ESI) m/z 627.06 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) 13.23 (bs, 1H), 8.54 (s, 1H), 8.20 (s, 1H), 7.75 (d, J = 8.32 Hz, 1H), 7.69 (dd, J = 8.24, 1.96 Hz, 1H), 7.64 (s, 1H), 7.47 (s, 1H), 4.87 (s, 2H). 2.64 (s, 3H), 2.14 (s 3H)
562[Figure (not displayed)]
MS (ESI) m/z 650.17 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.34 (bs, 1H), 8.73 (d, J = 4.7 Hz, 1H), 8.66 (s, 1H), 8.13 (d, J = 9.7 Hz, 1H), 7.76 (d, J = 9.0 Hz, 1H), 7.68 (m, 1H), 7.53 (d, J = 4.7 Hz, 1H), 7.37 (t, J = 53.7 Hz, 1H), 4.88 (s, 2H), 2.22 (s, 3H)
563[Figure (not displayed)]
MS (ESI) m/z 635.09 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.98 (bs, 1H), 8.37 (s, 1H), 8.28 (s, 1H), 8.00 (s, 1H), 7.67 (s, 1H), 7.60 (dd, J = 1.68, 8.56 Hz, 1H), 7.45 (bs, 1H), 7.35 (d, J = 8.88 Hz, 1H), 7.18 (t, J = 54.84 Hz, 1H), 4.39-4.35 (m, 2H), 4.23-4.20 (m, 2H), 1.67 (s, 3H)
564[Figure (not displayed)]
MS (ESI) m/z 655.21 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.06 (s, 1H), 9.45 (s, 1H), 8.18 (s, 1H), 7.50 (dd, J = 2.52 Hz, J = 9.12 Hz, 2H), 7.28-7.25 (m, 2H), 7.15 (d, J = 7.28 Hz, 1H), 4.75 (s, 2H), 4.36 (bs, 2H), 4.24 (bs, 2H), 2.98 (s, 6H), 2.68 (s, 3H), 1.72 (s, 3H)
565[Figure (not displayed)]
MS (ESI) m/z 676.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.02 (bs, 1H), 8.38 (s, 1H), 8.35 (s, 1H), 7.60 (dd, J = 8.80, 2.40 Hz, 1H), 7.47 (s, 1H), 7.42 (d, J = 2.48 Hz, 1H), 7.35 (d, J = 8.16 Hz, 1H), 4.41 (t, J = 5.0 Hz, 2H), 4. 24 (t, J = 4.72 Hz, 2H), 3.56 (s, 3H), 2.68 (s, 3H), 1.78 (s, 3H)
568[Figure (not displayed)]
MS (ESI) m/z 733.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.02 (s, 1H), 8.32 (s, 1H), 7.97 (s, 1H), 7.61-7.59 (m, 1H), 7.48 (s, 1H), 7.43 (s, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.41 (s, 2H), 4.23 (bs, 2H), 3.77 (bs, 2H), 3.55 (s, 3H), 2.69 (s, 3H), 2.22 (s, 6H), 1.75 (s, 3H)
569[Figure (not displayed)]
MS (ESI) m/z 662.07 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.70 (s, 1H), 8.89 (d, J = 4.76 Hz, 1H), 8.39 (s, 2H), 8.02 (s, 1H), 7.63- 7.60 (dd, J = 2.56, 2.44 Hz 1H), 7.56 (d, J = 4.72 Hz, 1H), 7.46 (d, J = 2.44 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.41 (t, J = 4.4 Hz, 2H), 4.24 (t, J = 3.86 Hz, 2H), 3.56 (s, 3H), 1.73 (s, 3H)
571[Figure (not displayed)]
MS (ESI) m/z 617.11 [M + 1]+; 1H NMR (400 MHz, MeOD) δ 8.31 (s, 1H), 8.16 (s, 1H), 8.00 (s, 1H), 7.56 (s, 1H),7.51 (d, J = 8.08 Hz, 1H), 7.34 (d, J = 10.84 Hz, 1H), 4.50 (t, J = 4.80 Hz, 2H), 4.38 (t, J = 5.20 Hz, 2H), 2.96 (s, 3H), 2.03 (s, 3H)
589[Figure (not displayed)]
MS (ESI) m/z 617.11 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.46 (s, 1H), 8.36 (d, J = 5.64 Hz, 1H), 7.60 (dd, J = 8.88, 2.64 Hz, 1H), 7.43-7.39 (m, 2H), 7.36 (d, J = 9.00 Hz, 1H), 4.42 (t, J = 4.52 Hz, 2H), 4.28 (t, J = 4.76 Hz, 2H), 2.69 (s, 3H), 1.94 (s, 3H)
590[Figure (not displayed)]
MS (ESI) m/z 615.23 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.35 (s, 1H), 7.95-7.93 (m, 3H), 7.57 (dd, J = 2.56, 8.92 Hz, 1H), 7.39 (d, J = 2.52 Hz, 1H), 7.33 (d, J = 9.04 Hz, 1H), 4.39 (t, J = 4.48 Hz, 2H), 4.30 (t, J = 4.36 Hz, 2H), 3.69 (s, 3H), 2.10 (s, 3H)
591[Figure (not displayed)]
MS (ESI) m/z 612.91 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 14.09 (bs, 1H), 68.77 (d, J = 4.56 Hz, 1H), 8.37 (s, 1H), 7.97 (s, 1H), 7.59 (d, J = 8.48 Hz, 1H), 7.50 (d, J = 4.56 Hz, 1H), 7.42 (bs, 1H), 7.35 (d, J = 8.84 Hz, 1H), 4.42 (t, J = 4.32 Hz, 2H), 4.26 (t, J = 3.20 Hz, 2H), 2.85-2.79 (m, 2H), 1.85 (s, 3H), 0.97 (t, J = 7.24 Hz, 3H)
595[Figure (not displayed)]
MS (ESI) m/z 629.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.37-8.28 (m, 2H), 7.61 (s, 1H), 7.48-7.43 (m, 1H), 7.31-7.26 (m, 2H), 7.05 (bs, 1H), 4.33 (bs, 2H), 4.24 (bs, 2H), 3.81 (s, 2H), 3.01 (s, 2H), 1.80 (s, 3H)
605[Figure (not displayed)]
MS (ESI) m/z 615.09 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.34 (s, 1H), 8.16 (s, 1H), 7.52 (d, J = 7.44, 1H), 7.36 (s, 1H), 7.29 (d, J = 9.04 Hz, 1H), 6.54 (s, 1H), 6.30 (s, 1H), 4.88 (s, 2H), 4.38 (s, 2H), 4.31 (s, 2H), 2.32 (s, 3H)
610[Figure (not displayed)]
MS (ESI) m/z 670.01 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.22 (s, 1H), 7.93 (s, 1H), 7.59 (dd, J = 8.68, 2.16 Hz, 1H), 7.41-7.34 (m, 3H), 4.40 (t, J = 4.76 Hz, 2H), 4.24 (t, J = 4.68 Hz, 2H), 3.20 (d, J = 7.48 Hz, 2H), 2.69 (s, 3H), 2.57 (d, J = 10.48 Hz, 2H), 2.28 (s, 6H), 1.83 (s, 3H)
614[Figure (not displayed)]
MS (ESI) m/z 617.06 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.38 (s, 1H), 8.14 (bs, 2H), 7.74 (t, J = 8.56 Hz, 1H), 7.29 (bs, 1H), 7.20 (d, J = 9.08 Hz, 1H), 4.41 (bs, 1H), 4.36 (bs, 1H), 4.23 (s, 2H), 2.66 (s, 3H), 1.70 (s, 3H)
615[Figure (not displayed)]
MS (ESI) m/z 691.19 [M + 1]+; ; 1H NMR (400 MHz, DMSO-d6) δ 8.69 (d, J = 4.72 Hz, 1H), 8.48 (s, 1H), 8.06 (s, 1H), 7.73 (d, J = 8.4 Hz, 1H), 7.66 (d, J = 7.1 Hz, 1H), 7.57 (s, 1H), 7.47 (d, J = 4.64, 1H), 4.78 (s, 2H), 3.95 (s, 2H), 3.37 (d, J = 12.5 Hz, 2H), 2.97 (d, J = 10.68 Hz, 4H), 2.75 (s, 3H), 2.58-2.56 (m, 2H), 2.1 (s, 3H)
616[Figure (not displayed)]
MS (ESI) m/z 705.23 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.31 (s, 1H), 9.43 (s, 1H), 8.54 (s, 1H), 8.11 (s, 1H), 7.75 (d, J = 8.32 Hz, 1H), 7.69 (dd, J = 8.36, 6.2 Hz, 1H), 7.65 (d, J = 1.96 Hz, 1H), 7.47 (s, 1H), 4.87 (s, 2H), 3.97 (s, 2H), 2.95 (d, J = 10.08 Hz, 4H), 2.80 (s, 3H), 2.66 (s, 3H), 2.62 (s, 4H), 2.17 (s, 3H)
617[Figure (not displayed)]
MS (ESI) m/z 678.16 [M + 1]+; ; 1H NMR (400 MHz, DMSO-d6) δ 8.73 (d, J = 4.76 Hz, 1H), 8.6 (s, 1H), 8.1 (s, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.69 (d, J = 2.0 Hz, 1H), 7.67 (s, 1H), 7.55 (d, J = 4.76 Hz, 1H), 4.88 (s, 2H), 3.97 (s, 2H), 3.56 (s, 4H), 2.58 (s, 4H), 2.13 (s, 3H)
629[Figure (not displayed)]
MS (ESI) m/z 676.18 [M + 1]+; ; 1H NMR (400 MHz, DMSO-d6) δ 8.78 (d, J = 5.56 Hz, 2H), 8.25 (s, 1H), 8.09 (s, 1H), 7.59 (dd, J = 7.56 Hz, 2.64 Hz, 1H), 7.53 (d, J = 4.88 Hz, 2H), 7.42-7.40 (m, 2H), 7.36 (d, J = 8.92 Hz, 1H), 4.41 (t, J = 4.76 Hz ,2H), 4.28 (t, J = 4.36 Hz, 2H), 2.72 (s, 3H), 1.86 (s, 3H)
630[Figure (not displayed)]
MS (ESI) m/z 676.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 3.7, 1H), 8.69 (s, 1H), 8.31 (s, 1H), 8.05 (s,1H), 7.99 (d, J = 7.8 Hz, 1H), 7.66- 7.58 (m, 2H), 7.45 (s, 1H), 7.424 (d, J = 2.56 Hz, 1H), 7.36 (d, J = 8.9, 1H), 4.42 (t, J = 9.2 Hz, 2H), 4.28 (t, J = 9.6 Hz, 2H), 2.73 (s, 3H), 1.87 (s, 3H)
631[Figure (not displayed)]
MS (ESI) m/z 676.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.74 (d, J = 4.7 Hz, 1H), 8.37 (s, 1H), 8.07 (s, 1H), 8.03 (t, J = 7.8 Hz, 1H), 7.68 (d, J = 7.6 Hz, 1H), 7.61-7.52 (m, 2H), 7.43 (s, 2H), 7.36 (d, J = 8.9 Hz, 1H), 4.40 (s, 2H), 4.26 (s, 2H), 2.72 (s, 3H), 1.83 (s, 3H)
632[Figure (not displayed)]
MS (ESI) m/z 665.30 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6), 13.51 (bs, 1H), 8.26 (s ,1H), 8.09 (s, 1H), 7.98 (s, 1H), 7.60 (dd, J = 2.36, 8.88 Hz, 1H), 7.52 (s, 1H), 7.44 (s, 1H),7.42 (d, J = 2.52 Hz, 1H), 7.37 (d, J = 8.88 Hz, 1H), 7.19 (s, 1H), 4.42 (t, J = 5.28 Hz, 2H), 4.28 (t, J = 4.24 Hz, 2H), 2.73 (s, 3H), 1.87 (s, 3H)
633[Figure (not displayed)]
MS (ESI) m/z 665.23 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) 8.35 (s ,1H), 8.19 (d, J = 2.08 Hz,1H), 8.11 (s, 1H), 7.87 (d, J = 1.52 Hz, 1H), 7.61-7.58 (dd, J = 2.64, 8.88 Hz, 1H), 7.44- 7.42 (m, 2H), 7.37 (d, J = 8.88 Hz, 1H), 6.63 (t, J = 2.24 Hz, 1H), 4.41 (t, J = 4.52 Hz, 2H), 4.28 (t, J = 4.12 Hz, 2H), 2.72 (s, 3H), 1.84 (s, 3H)
634[Figure (not displayed)]
MS (ESI) m/z 697.13 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 13.51 (bs, 1H), 9.75 (bs, 1H), 8.23 (s, 1H), 7.92 (s, 1H), 7.61-7.58 (t, J = 6.5 Hz, 1H), 7.42-7.41 (t, J = 6.5 Hz, 2H), 7.37 (d, J = 8.9 Hz, 1H), 4.40 (t, J = 6.2 Hz, 2H), 4.24 (t, J = 6.1 Hz, 2H), 3.83 (m, 2H), 3.49 (m, 2H), 3.24 (m, 2H), 3.03 (m, 2H), 2.28 (s, 3H), 2.71 (s, 3H), 1.82 (s, 3H)
636[Figure (not displayed)]
MS (ESI) m/z 642.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.87 (bs, 1H), 9.92 (s, 1H), 8.39 (s, 1H), 8.29 (s, 1H), 8.03 (s, 1H), 7.62 (dd, J = 2.40, 8.8 Hz, 1H), 7.57 (s, 1H), 7.42 (d, J = 3.28 Hz, 1H), 7.37 (d, J = 8.92 Hz, 1H), 4.63 (bs, 2H), 4.43 (t, J = 4.84 Hz, 2H), 4.26 (t, J = 4.64 Hz, 2H), 2.96 (s, 6H), 1.76 (s, 3H
637[Figure (not displayed)]
MS (ESI) m/z 725.09 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.18 (s,1H), 7.94 (s, 1H), 7.61-7.59 (dd, J = 8.8, 2.4 Hz, 1H), 7.46 (s, 1H), 7.44 (d, J = 2.48 Hz, 1H), 7.36 (d, J = 8.96 Hz, 1H), 4.41 (t, J = 5.2 Hz, 2H), 4.24 (t, J = 5.2 Hz, 2H), 3.94 (s, 2H), 3.40-3.37 (m, 2H), 3.04-2.98 (m, 2H), 2.92 (m, 4H), 2.78 (d, J = 3.52 Hz, 3H), 2.54 (m, 2H), 1.80 (s, 3H), 1.35 (t, J = 7.2 Hz, 3H)
638[Figure (not displayed)]
MS (ESI) m/z 727.07 [M + 1]+; ; 1H NMR (400 MHz, DMSO-d6) δ 12.7 (bs, 1H), 8.09 (s, 1H), 7.98 (s, 1H), 7.59-7.56 (dd, J = 2.8, 9.2 Hz, 1H), 7.40 (d, J = 2.4 Hz, 1H), 7.34 (d, J = 8.8 Hz, 1H), 6.90 (s, 1H), 4.41 (t, J = 6.4 Hz, 2H), 4.28 (t, J = 5.6 Hz, 2H), 4.07 (s, 3H), 3.94 (s, 2H), 3.39 (d, J = 11.2 Hz, 2H), 2.91 (d, J = 11.2 Hz, 4H), 2.78 (d, J = 3.2 Hz, 2H), 2.56 (d, J = 7.6 Hz, 2H), 1.88 (s, 3H)
640[Figure (not displayed)]
MS (ESI) m/z 751.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.85 (d, J = 4.9 Hz, 1H), 8.32 (s, 1H), 7.93 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.53 (d, J = 4.9 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.41 (t, J = 4.9 Hz, 2H), 4.24 (t, J = 5.0 Hz, 2H), 3.31 (q, J = 10.1 Hz, 2H), 3.07-2.58 (m, 6H), 1.75 (s, 3H). Note: piperazine protons were very broad and could not be properly integrated
641[Figure (not displayed)]
MS (ESI) m/z 642.08 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.74 (d, J = 4.92 Hz, 1H), 8.15 (s, 1H), 7.86 (s, 1H), 7.61 (dd, J = 8.6, 2.4 Hz, 1H), 7.47 (m, 2H), 7.37 (d, J = 9 Hz, 1H), 4.67 (s, 2H), 4.41 (t, J = 5.28 Hz, 2H), 4.25 (t, J = 4.28 Hz, 2H), 2.88 (s, 6H), 2.53 (s, 3H)
642[Figure (not displayed)]
MS (ESI) m/z 726.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.44 (bs, 1H), 8.27 (s, 1H), 7.95 (s, 1H), 7.59 (dd, J = 8.8, 2.5 Hz, 1H), 7.42-7.41 (m, 2H), 7.35 (d, J = 8.9 Hz, 1H), 4.4 (t, J = 5.9 Hz, 2H), 4.24 (t, J = 5.6 Hz, 2H), 3.83 (s, 2H), 3.47-3.43 (m, 2H), 2.68 (s, 3H), 2.62 (d, J = 10.5 Hz, 2H), 1.89 (d, J = 6.2 Hz, 2H), 1.86 (s, 3H), 1.01 (d, J = 6.2 Hz, 6H)
643[Figure (not displayed)]
MS (ESI) m/z 705.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.72 (d, J = 4.84 Hz, 1H), 8.05 (s, 1H), 7.75 (d, J = 8.20 Hz, 1H), 7.69 (d, J = 8.48 Hz, 1H), 7.65 (s, 1H), 7.57 (d, J = 4.76 Hz, 1H), 4.88 (s, 2H), 3.86 (s, 2H), 2.50- 2.32 (m, 8H, merged with moisture peak in DMSO), 2.17 (s, 3H), 2.10 (s, 3H), 1.23 (s, 3H)
644[Figure (not displayed)]
MS (ESI) m/z 743.07 [M + 1]+.;; 1H NMR (400 MHz, DMSO-d6) δ 13.2 (bs, 1H), 8.16 (s, 1H), 7.96 (s, 1H), 7.62-7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.59 (s, 1H), 7.43 (d, J = 2.4 Hz, 1H ), 7.37 (d, J = 8.8 Hz, 1H), 4.99 (t, J = 6.0 Hz, 1H), 4.87 (t, J = 6.0 Hz, 1H), 4.42 (t, J = 6.4 Hz, 2H), 4.26 (t, J = 6.8 Hz, 2H), 3.94 (s, 2H), 3.45 (t, J = 6.0 Hz, 2H), 2.93 (m, 4H), 2.78 (s, 3H), 2.50 (m, 2H), 1.76 (s, 3H)
645[Figure (not displayed)]
MS (ESI) m/z 729.05 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.04 (bs, 1H), 9.40 (s, 1H), 8.26 (s, 1H), 7.99 (s, 1H), 7.60 (dd, J = 2.28, 8.72 Hz, 1H), 7.53 (bs, 1H), 7.44 (d, J = 2.32 Hz, 1H), 7.36 (d, J = 8.92 Hz, 1H), 5.76-5.65 (d, J = 46.8 Hz, 2H), 4.41 (t, J = 5.16 Hz, 2H), 4.25 (t, J = 5.72 Hz, 2H), 3.94 (s, 2H), 3.40-3.37 (m, 2H), 2.93-2.90 (m, 4H), 2.79 (d, J = 3.32 Hz, 3H), 2.56-2.54 (m, 2H), 1.77 (s, 3H)
649[Figure (not displayed)]
MS (ESI) m/z 697.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.52 (bs, 2H), 8.22 (s, 1H), 7.59 (s, 1H), 7.61 (dd, J = 2.76, 8.64 Hz, 1H), 7.42 (s, 2H), 7.37 (d, J = 9.0, 1H), 4.42 (t, J = 4.44 Hz, 2H), 4.26 (t, J = 4.96 Hz, 2H), 3.93 (s, 2H), 3.07 (s, 4H), 2.70 (m, 6H ), 1.84 (s , 3H)
652[Figure (not displayed)]
MS (ESI) m/z 667.97 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.29 (s, 1H), 7.93 (s, 1H), 7.61 (dd, J = 2.56 Hz, 8.8 Hz, 1H), 7.41 (s, 2H), 7.37 (d, J = 9.0 Hz, 1H ), 4.39 (m, 2H), 4.26 (m, 3H), 3.96 (bs, 2H), 3.55 (bs, 2H), 2.70 (s, 3H), 2.35 (s, 3H), 1.85 (s, 3H)
655[Figure (not displayed)]
MS (ESI) m/z 715.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.8 Hz, 1H), 8.25 (s, 1H), 7.96 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.89 (dt, J = 47.3, 4.5 Hz, 2H), 4.41 (t, J = 5.0 Hz, 2H), 4.25 (t, J = 5.0 Hz, 2H), 4.03-3.88 (m, 2H), 3.74-3.09 (m, 8H), 1.77 (s, 3H)
660[Figure (not displayed)]
LCMS (ESI) m/z 553.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.14 (d, J = 2.1 Hz, 1H), 8.71 (d, J = 2.1 Hz, 1H), 8.31 (dd, J = 1.8, 0.7 Hz, 1H), 8.23 (t, J = 2.1 Hz, 1H), 7.80 (dd, J = 1.7, 0.8 Hz, 1H), 7.50-7.39 (m, 2H), 7.26 (d, J = 8.9 Hz, 1H), 4.43-4.31 (m, 4H), 2.11 (s, 3H)
661[Figure (not displayed)]
LCMS (ESI) m/z 569.1 [M + 1+9-; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.3 Hz, 1H), 8.37-8.31 (m, 1H), 8.07 (dt, J = 1.7, 0.8 Hz, 1H), 7.98 (s, 1H), 7.64-7.47 (m, 3H), 7.29 (d, J = 9.0 Hz, 1H), 7.22 (d, J = 4.2 Hz, 1H), 4.35 (t, J = 5.0 Hz, 2H), 4.21 (t, J = 4.9 Hz, 2H), 1.79 (s, 3H)
662[Figure (not displayed)]
LCMS (ESI) m/z 553.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.71 (dd, J = 5.0, 0.8 Hz, 1H), 8.34- 8.28 (m, 1H), 8.05 (dd, J = 1.7, 0.8 Hz, 1H), 7.88 (dd, J = 1.8, 0.8 Hz, 1H), 7.57 (dd, J = 5.0, 1.7 Hz, 1H), 7.52-7.40 (m, 2H), 7.26 (d, J = 8.9 Hz, 1H), 4.44-4.31 (m, 4H), 2.96 (s, 3H), 2.13 (s, 3H).5 (t, J = 4.7 Hz, 2H), 1.69 (s, 3H)
663[Figure (not displayed)]
LCMS (ESI) m/z 557.0 [M + 1]+1H NMR (400 MHz, DMSO-d6) δ 8.60 (d, J = 4.7 Hz, 1H), 8.32 (s, 1H), 8.11 (s, 1H), 7.51 (dd, J = 8.9, 2.7 Hz, 1H), 7.33 (d, J = 2.6 Hz, 1H), 7.28 (d, J = 9.0 Hz, 1H), 7.22 (d, J = 4.4 Hz, 1H), 6.32 (d, J = 1.6 Hz, 1H), 4.34 (s, 2H), 4.23 (s, 2H), 1.81 (s, 3H)
664[Figure (not displayed)]
LCMS (ESI) m/z 615.0 [M + 1]+1H NMR (400 MHz, DMSO-d6) δ 8.65 (d, J = 1.9 Hz, 1H), 8.35 (d, J = 1.9 Hz, 1H), 8.32-8.28 (m, 1H), 8.01 (dd, J = 1.7, 0.8 Hz, 1H), 7.49-7.40 (m, 2H), 7.25 (dd, J = 8.6, 0.6 Hz, 1H), 4.36 (dd, J = 11.4, 4.4 Hz, 4H), 3.85 (s, 3H), 2.19 (s, 3H)
666[Figure (not displayed)]
LCMS (ESI) m/z 653.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.88 (d, J = 4.7 Hz, 1H), 8.38-8.32 (m, 1H), 8.17-8.05 (m, 1H), 7.61- 7.51 (m, 2H), 7.42 (d, J = 2.6 Hz, 1H), 7.32
667[Figure (not displayed)]
LCMS (ESI) m/z 627.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 5.0 Hz, 1H), 8.35 (dd, J = 1.7, 0.6 Hz, 1H), 7.97 (dt, J = 1.7, 0.8 Hz, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.49 (d, J = 5.0 Hz, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.32 (d, J = 9.0 Hz, 1H), 4.37 (t, J = 5.0 Hz, 1H), 4.23 (t, J = 5.1 Hz, 1H), 3.85 (q, J = 6.8 Hz, OH), 1.83 (s, 2H), 0.99 (d, J = 6.8 Hz, 3H)
668[Figure (not displayed)]
LCMS (ESI) m/z 613.3 [M + 1+9-; 1H NMR (400 MHz, DMSO-d6) δ 8.33 (d, J = 1.7 Hz, 1H), 7.93 (dt, J = 1.7, 0.8 Hz, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.42-7.29 (m, 2H), 4.39 (t, J = 5.0 Hz, 1H), 4.24 (t, J = 5.0 Hz, 1H), 2.66 (s, 2H), 2.35 (s, 2H), 1.92 (s, 2H)
670[Figure (not displayed)]
LCMS (ESI) m/z 670.2 [M + 1+9-; 1H NMR (400 MHz, DMSO-d6) δ 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.43- 7.36 (m, 2H), 7.32 (d, J = 9.0 Hz, 1H), 4.38 (t, J = 4.9 Hz, 2H), 2.67 (s, 4H), 2.32 (s, 3H), 1.87 (s, 3H)
672[Figure (not displayed)]
LCMS (ESI) m/z 625.9 [M + 1+9-; 1H NMR (400 MHz, DMSO-d6) δ 8.33 (d, J = 1.7 Hz, 1H), 8.17 (s, 1H), 7.92 (d, J = 1.7 Hz, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.44-7.38 (m, 2H), 7.32 (d, J = 9.0 Hz, 1H), 4.36 (t, J = 5.1 Hz, 2H), 4.23 t, J = 5.1 Hz, 2H), 1.78 (s, 3H)
675[Figure (not displayed)]
LCMS (ESI) m/z 690.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.36 (s, 1H), 8.03 (s, 1H), 7.87 (t, J = 7.8 Hz, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.46-7.36 (m, 5H), 7.33 (d, J = 9.0 Hz, 1H), 4.37 (s, 2H), 4.24 (s, 2H), 2.69 (s, 3H), 2.50 (s, 4H), 1.80 (s, 3H)
684[Figure (not displayed)]
LCMS (ESI) m/z 708.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.36 (s, 1H), 8.06 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.56 (dd, J = 9.3, 2.3 Hz, 1H), 7.43 (dd, J = 6.7, 4.0 Hz, 3H), 7.36 (d, J = 9.0 Hz, 1H), 4.41 (bs, 2H), 4.28 (bs, 2H), 2.73 (s, 3H), 2.56 (s, 3H), 1.85 (s, 3H)
686[Figure (not displayed)]
LCMS (ESI) m/z 704.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.57 (d, J = 5.4 Hz, 1H), 8.27 (s, 1H), 8.08 (s, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.50-7.38 (m, 3H), 7.33 (d, J = 9.0 Hz, 1H), 4.39 (m, 2H), 4.25 (m 2H), 2.70 (s, 3H), 2.61 (s, 3H), 2.00 (s, 3H), 1.81 (s, 3H)
687[Figure (not displayed)]
LCMS (ESI) m/z 690.2 [M + 1+9-; 1H NMR (400 MHz, DMSO-d6) δ 8.34 (s, 1H), 7.85 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.86 (t, J = 12.5 Hz, 4H), 4.39 (t, J = 5.0 Hz, 2H), 4.22 (t, J = 5.0 Hz, 2H), 2.72 (s, 3H), 1.79 (s, 3H)
705[Figure (not displayed)]
MS (ESI) m/z 639.0 [M + 1]+; 1H-NMR (400 MHz, d6- DMSO) δ/ppm = 9.81-9.70 (b, 1H), 8.63 (d, J = 4.7 Hz, 1H), 8.09 (s, 1H), 7.72 (d, J = 5.4 Hz, 1H), 7.56 (dd, J = 8.9, 2.6 Hz, 1H), 7.38 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 5.4 Hz, 1H), 7.33 (d, J = 8.9 Hz, 1H), 7.22 (d, J = 4.7 Hz, 1H), 4.38 (t, J = 4.9 Hz, 2H), 4.27 (t, J = 4.9 Hz, 2H), 3.92-3.82 (m, 2H), 3.59- 3.50 (m, 2H), 3.30-3.20 (m, 2H), 3.14-3.01 (m, 2H), 2.91 (bs, 3H), 1.90 (s, 3H)
706[Figure (not displayed)]
MS (ESI) m/z 650.8 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.71-8.64 (m, 2H), 8.29 (d, J = 0.6 Hz, 1H), 7.90 (dd, J = 9.2, 3.0 Hz, 1H), 7.78 (d, J = 5.6 Hz, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 5.5 Hz, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.33 (d, J = 8.9 Hz, 1H), 7.26 (d, J = 4.7 Hz, 1H), 4.43-4.35 (m, 2H), 4.34-4.15 (m, 1H), 2.19 (d, J = 1.0 Hz, 3H), 1.88 (s, 3H)
708[Figure (not displayed)]
MS (ESI) m/z 682.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.28 (s, 1H), 7.90 (s, 1H), 7.63-7.56 (m, 1H), 7.46-7.38 (m, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.49-4.32 (m, 2H), 4.31-4.18 (m, 2H), 3.70-3.66 (m, 1H), 3.26-3.22 (m, 2H), 2.69 (s, 3H), 2.32-2.22 (m, 2H), 2.22-2.09 (m, 2H), 2.07 (s, 3H), 1.80 (s, 3H)
709[Figure (not displayed)]
MS (ESI) m/z 684.07 [M + 1+9-; 1H NMR (400 MHz, DMSO-d6) 8.23 (s, 1H), 7.94 (s, 1H), 7.60 (dd, J = 8.80, 2.40 Hz, 1H), 7.44-7.38 (m, 2H), 7.36 (d, J = 8.96 Hz, 1H), 4.40 (t, J = 4.76 Hz, 2H), 4.25 (t, J = 4.24 Hz, 2H), 3.05-3.01 (m, 4H), 2.69 (s, 3H), 2.50-2.30 (m, 6H), 1.91- 1.78 (m, 5H)
711[Figure (not displayed)]
MS (ESI) m/z 670.05 [M + 1+9-; 1H NMR (400 MHz, DMSO-d6) δ 8.28 (s, 1H), 7.89 (s, 1H), 7.59 (dd, J = 8.80, 2.40, 1H), 7.45-7.40 (m, 2H), 7.35 (d, J = 8.84 Hz, 1H), 4.39 (t, J = 5.40 Hz, 2H),), 4.30-4.22 (m, 2H) 3.72-3.67 (m, 1H), 2.70 (s, 3H), 2.16 (s, 6H), 1.80 (s, 3H), 1.55 (d, J = 6.68 Hz, 3H)
713[Figure (not displayed)]
MS (ESI) m/z 710.17 [M + 1+9-; 1H NMR (400 MHz, DMSO-d6-FD20) δ 9.18 (bs, 1H), 8.20 (s, 1H), 7.97 (s, 1H), 7.61-7.58 (dd, J = 2.4, 8.8 Hz, 1H), 7.43 (s, 1H), 7.37 (d, J = 9.2 Hz, 1H), 4.42 (t, J = 5.6 Hz, 2H), 4.26 (t, J = 3.6 Hz, 2H), 3.43 (bs, 3H), 3.06 (d, J = 6.8 Hz, 2H), 2.92-2.86 (m, 2H), 2.73-2.70 (m, 3H), 2.02 (bs, 1H), 1.83-1.78 (m, 5H), 1.63-1.54 (m, 2H)
714[Figure (not displayed)]
MS (ESI) m/z 696.11 [M + 1+9-; 1H NMR (400 MHz, DMSO-d6) δ 8.50 (bs, 1H), 8.19-8.15 (m, 2H), 7.97 (s, 1H), 7.61-7.58 (dd, J = 2.8, 9.2 Hz, 1H), 7.43- 7.42 (m, 2H), 7.37 (d, J = 8.8 Hz, 1H), 4.42 (t, J = 4.8 Hz, 2H), 4.26 (t, J = 4.4 Hz, 2H), 3.29 (d, J = 11.2 Hz, 2H), 3.06 (d, J = 11.2 Hz, 2H), 2.83-2.78 (m, 2H), 2.70 (s, 3H), 2.11-2.01 (m, 1H), 1.82 (s, 3H), 1.75 (d, J = 12.4 Hz, 2H), 1.59-1.50 (m, 2H)
717[Figure (not displayed)]
MS (ESI) m/z 621.98 [M + 1+9-; 1H NMR (400 MHz, DMSO-d6) δ 8.69 (d, J = 4.76 Hz, 1H), 8.65 (s, 1H), 8.30 (bs, 2H), 7.75 (d, J = 8.32, 1H), 7.69 (m, 2H), 7.54 (d, J = 4.72 Hz, 1H), 4.85 (s, 2H), 4.48 (s, 2H), 2.77 (s, 6H)
719[Figure (not displayed)]
MS (ESI) m/z 710.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.99 (s, 1H), 8.10 (s, 1H), 7.65 (s, 1H), 7.49 (dd, J = 8.76, 2.48 Hz, 1H), 7.28-7.24 (m, 3H), 7.13 (d, J = 7.32 Hz, 1H), 4.34 (t, J = 5.16 Hz, 2H), 4.22 (t, J = 5.12 Hz, 2H), 3.93 (s, 2H), 3.37 (d, J = 11.32, 2H,), 3.33- 3.29 (m, 2H, merged with moisture peak in DMSO), 2.90-2.88 (m, 4H), 2.78 (s, 3H), 2.67 (s, 3H), 1.72 (s, 3H)
735[Figure (not displayed)]
MS (ESI) m/z 690.35 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.67 (d, J = 3.72 Hz, 1H), 8.29 (s, 1H), 8.09 (s, 1H), 7.86 (d, J = 7.76 Hz, 1H), 7.60 (dd, J = 2.52, 8.84 Hz, 1H), 7.50 (d, J = 4.96 Hz, 1H), 7.48 (s, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.38 (d, J = 8.92 Hz, 1H), 4.43 (t, J = 6.12 Hz, 2H), 4.27 (t, J = 5.32, 2H), 2.73 (s, 3H), 2.24 (s, 3H), 1.84 (s, 3H)
736[Figure (not displayed)]
MS (ESI) m/z 690.04 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.65 (d, J = 4.0 Hz, 1H), 8.56 (s, 1H), 8.29 (s, 1H), 8.09 (s, 1H), 7.60 (dd, J = 8.8, 2.5 Hz, 1H), 7.56 (d, J = 5 Hz, 1H), 7.46 (s, 1H), 7.45 (d, J = 2.5 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 4.43 (bs, 2H), 4.28- 4.26 (m, 2H), 2.73 (s, 3H), 2.11 (s, 3H), 1.84 (s, 3H)
738[Figure (not displayed)]
MS (ESI) m/z 753.46 [M + 1]+.; 1H-NMR (400 MHz, CD3OD) δ 13.50 (bs, 1H), 8.94 (t, J = 8.44 Hz, 1H), 8.21 (s, 1H), 7.96 (s, 1H), 7.57 (dd, J = 2.25, 8.88 Hz, 1H),7.42 (s, 1H), 7.36 (d, J = 8.80 Hz, 1H), 4.41 (t, J = 4.32 Hz, 2H), 4.25 (t, J = 3.24 Hz, 2H), 3.96 (s, 2H),.3.50 (d, J = 10.48 Hz, 2H), 2.95 (d, J = 11.64 Hz, 2H), 2.82 (d, J = 10.52 Hz, 2H), 2.70 (s, 3H), 2.65 (d, J = 11.68 Hz, 2H), 1.85 (s, 3H), 1.30 (s, 9H)
739[Figure (not displayed)]
MS (ESI) m/z 761.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.22 (s, 1H), 7.96 (s, 1H), 7.60 (dd, J = 2.44, 8.88 Hz, 1H), 7.43 (s, 1H), 7.42 (s, 1H), 7.36 (d, J = 8.96 Hz, 1H), 6.58-6.31 (m, 1H), 4.41 (t, J = 4.56 Hz, 2H), 4.25 (t, J = 4.64 Hz, 2H), 3.95 (bs, 2H), 3.60-3.45 (m, 2H), 3.32-3.11 (m, 4H), 2.77-2.72 (m, 4H), 2.70 (s, 3H), 1.83 (s, 3H)
740[Figure (not displayed)]
MS (ESI) m/z 737.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.61 (bs, 1H), 9.01 (bs, 1H), 8.23 (s, 1H), 7.96 (s, 1H), 7.59 (dd, J = 8.88, 2.56 Hz, 1H), 7.42 (s, 2H), 7.37 (d, J = 8.96 Hz, 1H), 4.41 (t, J = 4.16 Hz, 2H), 4.25 (t, J = 4.96 Hz, 2H), 3.93 (s, 2H), 3.43 (s, 2H), 3.32-3.29 (m, 2H), 2.98-2.88 (m, 2H), 2.72 (d, J = 3.60, 3H), 2.69 (s, 3H), 2.18-2.16 (m, 2H), 1.91 (d, J = 8.2 Hz, 2H), 1.84 (s, 3H)
747[Figure (not displayed)]
MS (ESI) m/z 690.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.73 (s, 1H), 8.30 (d, J = 10.6 Hz, 1H), 8.07 (t, J = 9.7 Hz, 2H), 7.66 (bs, 1H), 7.57 (s, 2H), 7.44 (bs, 2H), 7.36-7.29 (m, 1H), 4.39 (bs, 2H), 4.26 (bs, 2H), 3.02 (bs, 2H), 1.77 (d, J = 11.0 Hz, 3H), 1.35 (s, 3H)
751[Figure (not displayed)]
MS (ESI) m/z 693.99 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.86 (s, 1H), 8.71 (d, J = 4.6 Hz, 1H), 8.33 (s, 1H), 8.13 (s, 1H), 7.72 (t, J = 10.4 Hz, 1H), 7.60 (dd, J = 8.84, 2.28 Hz, 1H), 7.45-7.35 (m, 2H), 7.36 (d, J = 8.9 Hz, 1H), 4.44-4.24 (m, 4H), 2.72 (s, 3H), 1.87 (s, 3H)
753[Figure (not displayed)]
MS (ESI) m/z 629.08 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 16.55 (s, 1H), 8.00-7.83 (m, 3H), 7.60-7.52 (m, 1H), 7.40-7.28 (m, 2H), 4.49-4.23 (m, 4H), 3.70 (s, 3H), 2.69 (s, 3H), 2.16 (s, 3H)
754[Figure (not displayed)]
MS (ESI) m/z 622.96 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 16.04 (s, 1H), 8.18 (s, 1H), 8.02 (s, 1H), 8.01 (s, 1H), 7.71 (d, J = 8.36 Hz, 1H), 7.65 (dd, J = 8.36,1.88 Hz, 1H), 7.58 (d, J = 1.72 Hz, 1H), 4.90 (s, 2H) 3.64 (s, 3H), 2.73 (s, 3H), 2.36 (s, 3H)
774[Figure (not displayed)]
MS (ESI) m/z 703.98 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.59 (s, 1H), 8.32 (s, 1H), 8.05 (s, 1H), 7.92 (d, J = 7.2 Hz, 1H), 7.60 (dd, J = 2.56, 8.88 Hz, 1H), 7.54 (d, J = 8.04 Hz, 1H), 7.45 (s, 1H), 7.42 (d, J = 2.60 Hz, 1H), 7.36 (d, J = 8.96 Hz, 1H) 4.42 (t, J = 4.64 Hz, 2H), 4.27 (t, J = 4.20 Hz, 2H), 2.90 (q, J = 7.52 Hz, 2H), 2.73 (s, 3H), 1.87 (s, 3H), 1.32 ( t, J = 7.60 Hz, 3H)
775[Figure (not displayed)]
MS (ESI) m/z 690.05 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.64 (s, 1H), 8.52 (s, 1H), 8.29 (s, 1H), 8.04 (s, 1H), 7.86 (s, 1H), 7.59 (dd, J = 8.84, 2.52 Hz, 1H), 7.45 (s, 1H), 7.41 (d, J = 2.56 Hz, 1H), 7.36 (d, J = 8.96 Hz, 1H), 4.42 (t, J = 5.76 Hz, 2H), 4.28 (t, J = 4.24 Hz, 2H), 2.73 (s, 3H), 2.43 (s, 3H), 1.87 (s, 3H)
776[Figure (not displayed)]
MS (ESI) m/z 704.04 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.42 (s, 1H), 8.06 (s, 1H), 7.92 (t, J = 7.80 Hz, 1H), 7.59 (dd, J = 8.80, 2.40 Hz, 1H), 7.50-7.39 (m, 4H), 7.36 (d, J = 8.88 Hz, 1H), 4.40 (s, 2H), 4.27 (s, 2H), 2.80 (q, J = 7.44 Hz, 2H), 2.72 (s, 3H), 1.84 (s, 3H), 1.22 (q, J = 7.44 Hz, 3H)
777[Figure (not displayed)]
MS (ESI) m/z 693.96 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.85 (dd, J = 5.88, 7.96 Hz, 1H), 8.79 (d, J = 10.04 Hz, 1H), 8.34 (s, 1H), 8.12 (s, 1H), 7.65-7.58 (m, 2H), 7.45 (s, 1H), 7.43 (d, J = 2.56 Hz, 1H), 7.37 (d, J = 8.96 Hz, 1H), 4.45-4.26 (m, 4H), 2.72 (s, 3H), 1.87 (s, 3H)
779[Figure (not displayed)]
MS (ESI) m/z 679.00 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.37 (s, 1H), 8.02 (s, 1H), 7.87 (d, J = 1.92 Hz, 1H), 7.59 (dd, J = 8.88, 2.62 Hz, 1H), 7.42 (d, J = 3.0 Hz, 2H), 7.35 (d, J = 8.96 Hz, 1H), 6.48 (s, 1H), 4.40 (t, J = 6.04 Hz, 2H), 4.25 (t, J = 5.2 Hz, 2H), 3.93 (s, 3H), 2.70 (s, 3H), 1.82 (s, 3H)
789[Figure (not displayed)]
MS (ESI) m/z 670.09 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 with D20) δ 8.24 (s, 1H), 7.97 (s, 1H), 7.56 (dd, J = 8.88, 2.52 Hz, 1H), 7.39-7.37 (m, 2H), 7.31 (d, J = 8.96 Hz, 1H), 4.39-4.34 (m, 2H), 4.22 (bs, 2H), 3.05 (s, 3H), 2.84 (s, 3H), 2.69 (s, 3H), 1.75 (s, 3H)
790[Figure (not displayed)]
MS (ESI) m/z 622.9 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.28 (s, 1H), 7.95 (s, 1H), 7.59 (dd, J = 8.84, 2.52 Hz, 1H), 7.42 (s, 1H), 7.41 (d, J = 2.56 Hz, 1H), 7.35 (d, J = 8.96 Hz, 1H), 5.25 (s, 1H), 4.40 (t, J = 4.52 Hz, 2H), 4.25 (t, J = 2.44 Hz, 2H), 2.70 (s, 3H), 1.79 (s, 3H)
808[Figure (not displayed)]
MS (ESI) m/z 506.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.18 (s, 1H), 7.34-7.24 (m, 2H), 6.98- 6.93 (m, 2H), 4.49 (t, J = 5.2 Hz, 2H), 4.31 (t, J = 5.2 Hz, 2H), 3.85 (t, J = 12.3 Hz, 2H), 3.53 (d, J = 11.8 Hz, 2H), 3.17 (d, J = 12.9 Hz, 2H), 3.05 (d, J = 11.6 Hz, 2H), 2.88 (s, 3H), 2.77 (s, 3H)
832[Figure (not displayed)]
MS (ESI) m/z = 584.1 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 9.85-9.70 (b, 1H), 8.20 (s, 1H), 7.67 (d, J = 2.6 Hz, 1H), 7.40 (dd, J = 8.9, 2.6 Hz, 1H), 7.17 (d, J = 8.9 Hz, 1H), 4.55 (t, J = 4.5 Hz, 2H), 4.39 (t, J = 4.5 Hz, 2H), 3.84 (bt, J = 12.0 Hz, 2H), 3.53 (bd, J = 12.0 Hz, 2H), 3.17 (d, J = 12.5 Hz, 2H), 3.12- 2.97 (m, 2H), 2.92-2.84 (m, 6H)
833[Figure (not displayed)]
MS (ESI) m/z = 582.1 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 9.84-9.70 (b, 1H), 8.22 (s, 1H), 7.37 (dd, J = 8.8, 2.7, 1H), 7.34- 7.24 (m, 5H), 7.23 (d, J = 2.7 Hz, 1H), 7.17 (d, J = 8.8 Hz, 1H), 4.41-4.30 (m, 4H), 3.86 (bt, J = 12.6 Hz, 2H), 3.54 (bd, J = 11.5 Hz, 2H), 3.18 (d, J = 12.5 Hz, 2H), 3.12-2.99 (m, 2H), 2.89 (bs, 3H), 2.23 (s, 3H)
834[Figure (not displayed)]
MS (ESI) m/z = 683.3 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 9.81-9.69 (b, 1H), 8.84 (d, J = 4.7 Hz, 1H), 8.23 (s, 1H), 7.96 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 4.7 Hz, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 8.9 Hz, 1H), 4.41 (t, J = 5.1 Hz, 2H), 4.25 (t, J = 5.1 Hz, 2H), 3.92-3.82 (m, 2H), 3.57 (bd, J = 11.2 Hz, 2H), 3.26 (bd, J = 13.3 Hz, 2H), 3.15-3.02 (m, 2H), 2.92 (bs, 3H), 1.77 (s, 3H)
835[Figure (not displayed)]
MS (ESI) m/z = 611.3 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 9.98-9.85 (b, 1H), 8.15 (s, 1H), 7.73-7.64 (bs, 2H), 7.55 (dd, J = 8.9, 2.8 Hz, 1H), 7.46 (d, J = 2.8 Hz, 1H), 7.31 (d, J = 8.9 Hz, 1H), 4.43 (bs, 4H), 3.85 (bt, J = 11.1 Hz, 2H), 3.54 (bd, J = 11.4 Hz, 2H), 3.17 (bd, J = 12.8 Hz, 2H), 3.12- 2.99 (m, 2H), 2.89 (s, 3H), 2.62 (s, 6H), 2.37 (s, 3H)
836[Figure (not displayed)]
MS (ESI) m/z = 653.0 [M + 1]+; 1H-NMR (400 MHz, d6-DMSO) δ/ppm = 9.85-9.74 (b, 1H), 8.06 (s, 1H), 7.70 (d, J = 5.4 Hz, 1H), 7.55 (dd, J = 8.9, 2.6 Hz, 1H), 7.36 (d, J = 2.6 Hz, 1H), 7.32 (d, J = 8.9 Hz, 1H), 7.25 (d, J = 5.4 Hz, 1H), 7.18 (s, 1H), 4.38 (t, J = 4.7 Hz, 2H), 4.28 (t, J = 4.7 Hz, 2H), 3.87 (bt, J = 13 Hz, 2H), 3.56 (bd, J = 11.7 Hz, 2H), 3.25 (bd, J = 13 Hz, 2H), 3.15-3.01 (m, 2H), 2.91 (bs, 3H), 2.62 (s, 3H), 1.96 (s, 3H)
847[Figure (not displayed)]
LCMS: 694.4.5 [M + H]+; 1H NMR (400 MHz, DMSO- d6) δ 8.88 (d, J = 4.8 Hz, 1H), 8.67 (d, J = 2.9 Hz, 1H), 8.29 (s, 1H), 8.13 (s, 1H), 7.89 (dd, J = 9.0, 2.8 Hz, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.53 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.43 (q, J = 4.9 Hz, 2H), 4.28 (q, J = 6.6, 5.9 Hz, 2H), 2.22 (s, 3H), 1.79 (s, 3H)
852[Figure (not displayed)]
LCMS: 669.6 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 9.70 (s, 1H), 8.59 (d, J = 4.7 Hz, 1H), 8.05 (s, 1H), 7.68 (d, J = 5.5 Hz, 1H), 7.52 (dd, J = 8.9, 2.7 Hz, 1H), 7.38-7.26 (m, 3H), 7.18 (d, J = 4.7 Hz, 1H), 4.35 (t, J = 5.2 Hz, 2H), 4.24 (t, J = 4.9 Hz, 2H), 3.92 (d, J = 12.8 Hz, 2H), 3.76 (t, J = 5.2 Hz, 2H), 3.60 (d, J = 12.0 Hz, 2H), 3.23 (dd, J = 26.4, 8.6 Hz, 4H), 3.09 (s, 3H), 1.86 (s, 3H)
853[Figure (not displayed)]
LCMS: 669.6 [M + H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.61 (d, J = 4.7 Hz, 1H), 8.08 (s, 1H), 7.70 (d, J = 5.5 Hz, 1H), 7.52 (dd, J = 8.9, 2.7 Hz, 1H), 7.42-7.34 (m, 2H), 7.29 (d, J = 9.0 Hz, 1H), 7.19 (d, J = 4.7 Hz, 1H), 4.43 (t, J = 5.4 Hz, 2H), 4.35 (t, J = 5.0 Hz, 2H), 4.23 (t, J = 5.0 Hz, 2H), 3.14 (s, 5H), 3.01 (s, 2H), 2.83 (s, 5H), 1.83 (s, 3H)
855[Figure (not displayed)]
MS (ESI) m/z 625.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 27.2 Hz, 2H), 8.62 (d, J = 4.7 Hz, 1H), 8.08 (s, 1H), 7.72 (d, J = 5.5 Hz, 1H), 7.55 (dd, J = 8.9, 2.7 Hz, 1H), 7.44-7.26 (m, 3H), 7.21 (d, J = 4.7 Hz, 1H), 4.38 (t, J = 5.0 Hz, 2H), 4.27 (t, J = 5.0 Hz, 2H), 3.38 (s, 2H), 3.23 (s, 1H), 3.04 (s, 2H), 1.89 (s, 3H)
856[Figure (not displayed)]
LCMS: 720.9 [M + H]+; 1H NMR (400 MHz, DMSO- d6) δ 9.81 (d, J = 9.6 Hz, 1H), 8.59 (s, 1H), 8.09 (s, 1H), 7.79-7.63 (m, 3H), 7.50 (s, 1H), 4.85 (s, 2H), 4.07-3.92 (m, 2H), 3.87-3.74 (m, 2H), 3.66 (d, J = 11.7 Hz, 2H), 3.29 (d, J = 18.2 Hz, 4H), 3.14 (d, J = 11.5 Hz, 2H), 2.67 (s, 3H), 2.23 (s, 3H)
859[Figure (not displayed)]
LCMS: 707.4 [M + H; ]+. 1H NMR (400 MHz, DMSO- d6) δ 9.79 (s, 1H), 8.77 (d, J = 4.8 Hz, 1H), 8.59 (s, 1H), 8.11 (s, 1H), 7.76 (d, J = 8.3 Hz, 1H), 7.72- 7.66 (m, 2H), 7.57 (d, J = 4.8 Hz, 1H), 4.87 (s, 2H), 3.98 (d, J = 12.8 Hz, 2H), 3.80 (t, J = 5.2 Hz, 2H), 3.72-3.53 (m, 2H), 3.39-3.21 (m, 4H), 3.21- 3.03 (m, 1H), 2.16 (s, 3H)
867[Figure (not displayed)]
MS (ESI) m/z 732.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.22 (s, 1H), 7.91 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.42 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 4.9 Hz, 2H), 4.24 (t, J = 5.0 Hz, 2H), 3.98 (t, J = 11.9 Hz, 2H), 3.50 (d, J = 13.5 Hz, 2H), 3.34 (d, J = 13.5 Hz, 2H), 3.18 (d, J = 12.0 Hz, 2H), 2.72 (s, 3H), 1.81 (s, 3H)
870[Figure (not displayed)]
MS (ESI) m/z 650.8 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.71-8.64 (m, 2H), 8.29 (d, J = 0.6 Hz, 1H), 7.90 (dd, J = 9.2, 3.0 Hz, 1H), 7.78 (d, J = 5.6 Hz, 1H), 7.56 (dd, J = 8.9, 2.7 Hz, 1H), 7.48 (d, J = 5.5 Hz, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.33 (d, J = 8.9 Hz, 1H), 7.26 (d, J = 4.7 Hz, 1H), 4.43-4.35 (m, 2H), 4.34- 4.15 (m, 1H), 2.19 (d, J = 1.0 Hz, 3H), 1.88 (s, 3H)
876[Figure (not displayed)]
LCMS (ESI) m/z 678.8 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.24 (s, 1H), 7.96 (s, 1H), 7.57 (dd, J = 8.9, 2.7 Hz, 1H), 7.43-7.36 (m, 2H), 7.33 (d, J = 9.0 Hz, 1H), 4.38 (t, J = 4.9 Hz, 2H), 4.23 (t, J = 4.9 Hz, 2H), 2.68 (s, 3H), 1.76 (s, 3H)
879[Figure (not displayed)]
LCMS (ESI) m/z 697.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.94 (s, 1H), 8.81 (s, 1H), 7.93 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.49-7.34 (m, 3H), 4.41 (s, 2H), 4.26 (s, 2H), 3.79 (s, 7H), 3.40 (d, J = 12.1 Hz, 2H), 3.18 (d, J = 12.2 Hz, 2H), 3.05 (s, 2H), 2.72 (s, 3H), 2.42 (s, 3H), 1.97 (s, 3H)
887[Figure (not displayed)]
LCMS (ESI) m/z 682.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 11.8 Hz, 1H), 8.76 (d, J = 4.9 Hz, 1H), 8.41 (d, J = 11.5 Hz, 1H), 7.94 (s, 1H), 7.58 (dd, J = 8.9, 2.7 Hz, 1H), 7.49 (d, J = 4.9 Hz, 1H), 7.39 (d, J = 2.7 Hz, 1H), 7.34 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 5.1 Hz, 2H), 4.22 (t, J = 5.0 Hz, 2H), 3.66 (s, 2H), 3.58 (s, 1H), 3.45 (d, J = 12.3 Hz, 2H), 3.35 (s, 1H), 3.15-3.08 (m, 1H), 3.05 (d, J = 12.2 Hz, 1H), 2.75 (d, J = 13.4 Hz, 2H), 2.30 (s, 3H), 1.85 (d, J = 17.3 Hz, 1H), 1.84 (s, 3H
899[Figure (not displayed)]
MS (ESI) m/z 643.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 7.92 (s, 1H), 7.90 (s, 1H), 7.57 (dd, J = 8.80, 2.56 Hz, 1H), 7.31-7.30 (m, 2H), 4.41 (t, J = 4.80 Hz, 2H), 4.33 (t, J = 4.80 Hz, 2H), 3.69 (s, 3H), 2.64 (s, 3H), 2.31 (s, 3H), 2.27 (s, 3H)
901[Figure (not displayed)]
MS (ESI) m/z 690.05 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.71 (s, 1H), 8.65 (d, J = 4.60 Hz, 1H), 8.29 (s, 1H), 8.10 (s, 1H), 7.60 (d, J = 8.88, 2.44 Hz, 1H), 7.48 (bs, 1H), 7.46 (s, 1H), 7.44 (d, J = 2.48 Hz, 1H), 7.36 (d, J = 8.96 Hz, 1H) 4.42 (t, J = 6.20 Hz, 2H), 4.32-4.22 (m, 2H), 2.73 (s, 3H), 2.07 (s, 3H), 1.84 (s, 3H)
902[Figure (not displayed)]
MS (ESI) m/z 704.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.41 (bs, 1H), 8.45 (s, 1H), 8.25 (s, 1H), 8.08 (s, 1H), 7.63-7.57 (m, 2H), 7.46-7.40 (m, 2H), 7.36 (d, J = 8.80 Hz, 1H), 4.45-4.35 (m, 2H), 4.35-4.23 (m, 2H), 2.72 (s, 3H), 2.35 (s, 3H), 2.15 (s, 3H), 1.83 (s, 3H)
903[Figure (not displayed)]
MS (ESI) m/z 704.16 [M +1]+; 1H NMR (400 MHz, DMSO-d6) 8.46 (s, 1H), 8.30 (s, 1H), 8.24 (s, 1H), 7.84 (bs, 1H), 7.58-7.49 (m, 1H), 7.37 (s, 1H), 7.29 (d, J = 8.8 Hz, 1H), 7.16 (s, 1H), 4.37 (t, J = 4.68 Hz, 2H), 4.27 (t, J = 4.2 Hz, 2H), 2.64 (s, 3H), 2.31 (s, 3H), 1.95 (s, 3H), 1.85 (s, 3H)
904[Figure (not displayed)]
MS (ESI) m/z 704.22 [M + 1]+;; 1H NMR (400 MHz, DMSO-d6) δ 8.38 (s, 1H), 8.04 (s, 1H), 7.73 (d, J = 8.0 Hz, 1H), 7.57 (dd, J = 8.88 Hz, 2.4 Hz, 1H), 7.43 (s, 2H), 7.40-7.34 (m, 2H), 4.40 (t, J = 4.48 Hz, 2H), 4.22 (t, J = 5.2 Hz, 2H), 2.72 (s, 3H), 2.50 (s, 3H), 2.36 (s, 3H), 1.82 (s, 3H)
905[Figure (not displayed)]
MS (ESI) m/z 704.03 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.36 (s, 1H), 8.04 (s, 1H), 7.59 (dd, J = 8.84 Hz, 2.60 Hz, 1H), 7.43 (s, 2H), 7.36 (d, J = 8.96 Hz, 1H), 7.30 (s, 1H), 7.25 (s, 1H), 4.40 (s, 2H), 4.27 (s, 2H), 2.72 (s, 3H), 2.50 (s, 3H), 2.39 (s, 3H), 1.82 (s, 3H)
906[Figure (not displayed)]
MS (ESI) m/z 704.03 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.52 (bs, 1H), 8.37 (s, 1H), 8.11 (s, 1H), 7.72 (d, J = 7.88 Hz, 1H), 7.59 (dd, J = 8.88, 2.4 Hz, 1H), 7.45-7.43 (m, 2H), 7.36-7.31 (m, 2H), 4.43 (t, J = 4.36 Hz, 2H), 4.26 (t, J = 5.88 Hz, 2H), 2.72 (s, 3H), 2.46 (s, 3H), 2.04 (s, 3H), 1.80 (s, 3H) MS (ESI) m/z 679.00 [M + 1]+; 1H NMR (400 MHz,
907[Figure (not displayed)]
DMSO-d6) δ 13.56 (bs, 1H), 8.40 (s, 1H), 7.99 (s, 1H), 7.77 (s, 1H), 7.58 (d, J = 7.20 Hz, 1H), 7.42-7.34 (m, 4H), 4.39 (s, 2H), 4.25 (s, 2H), 3.77 (s, 3H), 2.69 (s, 3H), 1.82 (s, 3H)
908[Figure (not displayed)]
MS (ESI) m/z 670.97 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.44 (s, 1H) 9.15 (d, J = 5.08 Hz, 1H), 8.64 (s, 1H), 8.27 (s, 1H), 7.97 (d, J = 5 Hz, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.67 (m, 1H), 7.65 (d, J = 0.84 Hz, 1H), 7.49 (s, 1H), 4.89 (s, 2H), 2.64 (s, 3H), 2.22 (s, 3H)
909[Figure (not displayed)]
MS (ESI) m/z 684.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.57 (bs, 1H), 8.23 (s, 1H), 7.93 (s, 1H), 7.59 (dd, J = 2.44, 8.84 Hz, 1H), 7.41 (d, J = 2.76 Hz, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.40 (t, J = 4.20 Hz, 2H), 4.25 (t, J = 5.88 Hz, 2H), 4.16 (s, 2H), 3.17 (s, 3H), 2.86 (s, 3H), 2.69 (s, 3H), 1.82 (s, 3H)
934[Figure (not displayed)]
MS (ESI) m/z 722.05 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.5 (bs,1H), 8.24 (s, 1H), 8.05 (s, 1H), 7.59 (dd, J = 8.88, 2.4 Hz, 1H), 7.43-7.40 (m, 4H), 7.36 (d, J = 9.2 Hz,1H), 5.55 (d, J = 44 Hz, 2H), 4.41 (t, J = 5.2 Hz, 2H), 4.27 (t, J = 5.2 Hz, 2H), 2.72 (s, 3H), 2.58 (s, 3H), 1.84 (s, 3H)
937[Figure (not displayed)]
MS (ESI) m/z 688.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.28 (s, 1H), 8.06 (s, 1H), 7.41-7.35 (m, 2H), 7.25 (dd, J = 8.56, 2.84 Hz, 1H), 4.38 (t, J = 4.48 Hz, 2H), 4.27 (t, J = 4.32 Hz, 2H), 2.72 (s, 3H), 2.63 (s, 6H), 1.90 (s, 3H)
963[Figure (not displayed)]
MS (ESI) m/z 705.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.54 (bs, 1H), 8.33 (s, 1H), 8.07 (s, 1H), 7.60 (dd, J = 2.48, 8.90 Hz, 1H), 7.55 (s, 1H), 7.43-7.42 (m, 2H), 7.36 (d, J = 8.92 Hz, 1H), 4.41 (bs, 2H), 4.27 (bs, 2H), 2.72 (s, 3H), 2.65 (s, 1H), 2.56 (s, 1H), 1.84 (s, 3H)
964[Figure (not displayed)]
MS (ESI) m/z 709.07 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.57 (bs, 1H), 9.14 (s, 1H), 8.41 (s, 1H), 8.19 (s, 1H), 7.60 (dd, J = 2.56, 8.92 Hz, 1H), 7.44-7.43 (m, 2H), 7.36 (d, J = 8.96 Hz, 1H), 4.42 (t, J = 5.20 Hz, 2H), 4.27 (t, J = 4.52 Hz, 2H), 2.73 (s, 3H), 2.70 (s, 3H), 1.82 (s, 3H)
965[Figure (not displayed)]
MS (ESI) m/z 705.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.41 (s, 1H), 8.11 (s, 1H), 7.58 (d, J = 8.84 Hz, 1H), 7.46-7.39 (m, 3H), 7.34 (d, J = 8.88 Hz, 1H), 4.39 (t, J = 4.76 Hz, 2H), 4.26 (t, J = 4.44, Hz, 2H), 2.70 (s, 3H), 2.49 (s, merged, 6H), 1.77 (s, 3H)
966[Figure (not displayed)]
MS (ESI) m/z 695.07 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.43 (s, 1H) 9.22 (s, 2H), 8.35 (s, 1H), 8.17 (s, 1H), 7.57 (t, J = 6.56 Hz, 1H), 7.42 (d, J = 2.24 Hz, 1H), 7.38 (s, 1H), 7.34 (d, J = 8.88 Hz, 1H), 4.39 (t, J = 2.96 Hz, 2H), 4.27 (t, J = 3.88 Hz, 2H), 2.69 (s, 3H), 1.82 (s, 3H)
967[Figure (not displayed)]
MS (ESI) m/z 691.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.29 (bs, 1H), 8.16 (bs, 1H), 7.94 (bs, 1H), 7.86-7.83 (m, 1H), 7.59 (d, J = 7.16 Hz, 1H), 7.41-7.28 (m, 3H), 4.41 (bs, 2H), 4.30 (bs, 2H), 2.76 (s, 3H), 2.50 (bs, 3H), 1.86 (bs, 3H)
968[Figure (not displayed)]
MS (ESI) m/z 705.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 ) 8.63 (s, 1H), 8.37 (s, 1H), 8.14 (s, 1H), 7.60 (dd, J = 8.88, 2.52 Hz, 1H), 7.48-7.43 (m, 2H), 7.36 (d, J = 8.96 Hz, 1H), 4.48-4.35 (m, 2H), 4.30- 4.24 (m, 2H), 2.73 (m, 3H), 2.52 (m, 3H), 2.29 (m, 3H), 1.80 (s, 3H)
969[Figure (not displayed)]
MS (ESI) m/z 705.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.61 (s, 1H), 8.36 (s, 1H), 8.08 (s, 1H), 7.60 (dd, J = 8.80, 2.48 Hz,1H), 7.45-7.42 (m, 2H), 7.36 (d, J = 8.92, 1H), 4.44-4.38 (m, 2H), 4.31-4.23 (m, 2H), 2.72 (s, 3H), 2.66 (s, 3H), 2.57 (s, 3H), 1.84 (s, 3H)
991[Figure (not displayed)]
MS (ESI) m/z 714.06 [M − 1]−; 1H NMR (400 MHz, DMSO-d6) δ 8.29 (s, 1H), 7.90 (s, 1H), 7.59 (dd, J = 8.84, 2.40 Hz, 1H), 7.46-7.40 (m, 2H), 7.36 (d, J = 9.00, 1H), 4.39 (t, J = 4.48 Hz, 2H), 4.23 (t, J = 4.08 Hz, 3H), 3.60-3.40 (m, 2H), 3.20-3.02 (m, 2H), 3.01- 2.80 (m, 1H), 2.70 (s, 3H), 2.30-2.10 (m, 2H), 2.00- 2.82 (m, 2H), 1.81 (s, 3H)
992[Figure (not displayed)]
MS (ESI) m/z 700.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 8.26 (s, 1H), 7.89 (s, 1H), 7.63-7.58 (m, 1H), 7.44-7.39 (m, 2H), 7.36 (d, J = 8.8 Hz, 1H), 4.39 (s, 2H), 4.23 (s, 2H), 3.71-3.50 (m, merged, 2H), 3.31-3.20 (m, 2H), 2.87-.73 (m, 2H), 2.71 (s, 3H), 2.69-2.60 (m. 2H), 1.80 (s, 3H)
995[Figure (not displayed)]
MS (ESI) m/z 744.09 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.20 (bs, 1H), 8.35 (s, 1H), 8.29-8.25 (m, 1H), 8.22 (s, 1H), 8.09-8.06 (m, 1H), 7.57 (d, J = 9.24 Hz, 1H), 7.43-7.33 (m, 3H), 7.07 (t, J = 54.36 Hz, 1H), 4.39 (bs, 2H), 4.27 (bs, 2H), 2.69 (s, 3H), 1.83 (s, 3H)
996[Figure (not displayed)]
MS (ESI) m/z 642.01 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.33 (s, 1H), 7.89 (s, 1H), 7.59 (dd, J = 2.60, 8.88 Hz, 1H), 7.43 (s, 1H), 7.42 (d, J = 2.64 Hz, 1H), 7.36 (d, J = 8.96 Hz, 1H), 4.39 (t, J = 4.68 Hz, 2H), 4.23 (t, J = 4.64 Hz, 2H), 2.94 (s, 6H), 2.70 (s, 3H), 1.81 (s, 3H)
1009[Figure (not displayed)]
MS (ESI) m/z 684.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.56 (s, 1H), 8.39 (s, 1H), 7.77 (s, 1H), 7.58 (dd, J = 2.44, 8.84 Hz, 1H), 7.41-7.39 (m, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.65-4.62 (m, 2H), 4.37 (bs, 2H), 4.32-4.27 (m, 3H), 4.18 (bs, 2H), 3.37 (s, 3H), 2.70 (s, 3H), 1.74 (s, 3H)
1012[Figure (not displayed)]
MS (ESI) m/z 690.14 [M + 1]+; ; 1H NMR (400 MHz, DMSO-d6): δ 13.74 (s, 1H), 8.71 (d, J = 5.0 Hz, 2H), 8.26 (s,1H), 8.041 (s, 1H), 7.61 (dd, J = 7.2.24 Hz, J = 2.20 Hz,1H), 7.54 (d, J = 4.64 Hz, 2H), 7.48 (s, 1H), 7.44 (d, J = 2.24 Hz, 1H), 7.38 (d, J = 8.88 Hz, 1H), 4.43 (t, J = 4.52 Hz, 2H), 4.27 (t, J = 4.44 Hz, 2H), 3.06 (m, 2H), 1.80 (s, 3H), 1.39 (t, J = 7.52 Hz, 3H)
1013[Figure (not displayed)]
MS (ESI) m/z 690.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.76 (d, J = 4.12 Hz, 1H), 8.69 (s, 1H), 8.26 (s, 1H), 8.04 (s, 1H), 7.98 (d, J = 7.68 Hz, 1H), 7.65-7.59 (m, 2H), 7.49 (s, 1H), 7.44 (d, J = 2.48 Hz, 1H), 7.38 (d, J = 8.96 Hz, 1H), 4.43 (t, J = 4.52 Hz, 2H), 4.27 (t, J = 4.44 Hz, 2H), 3.06 (m, 2H), 1.80 (s, 3H), 1.39 (t, J = 7.52 Hz, 3H)
1014[Figure (not displayed)]
MS (ESI) m/z 693.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.32 (s, 1H), 8.00 (s, 1H), 7.87 (d, J = 2.56 Hz, 1H), 7.60 (dd, J = 2.56, 8.88 Hz, 1H), 7.46 (s, 1H), 7.44 (d, J = 2.44 Hz, 1H), 7.35 (d, J = 9.00 Hz, 1H), 6.48 (s, 1H), 4.40 (t, J = 4.56 Hz, 2H), 4.24 (t, J = 4.72 Hz, 2H), 3.93 (s, 3H), 3.02 (q, J = 7.36, 2H), 1.76 (s, 3H), 1.35 (t, J = 7.52 Hz, 3H)
1017[Figure (not displayed)]
MS (ESI) m/z 722.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.72 (bs, 1H), 8.67 (d, J = 2.68 Hz, 1H), 8.22 (s, 1H), 8.08 (s, 1H), 7.90 (d, J = 6.68 Hz, 1H), 7.59 (dd, J = 2.48, 8.92 Hz, 1H), 7.49 (s, 1H), 7.44 (d, J = 2.48 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.41 (t, J = 3.88 Hz, 2H), 4.28 (bs, 2H), 3.04 (q, J = 7.2 Hz, 2H), 2.21 (s, 3H), 1.79 (s, 3H), 1.39 (t, J = 7.2 Hz, 3H)
1025[Figure (not displayed)]
MS (ESI) m/z 727.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.54 (bs, 1H), 9.24 (s, 1H), 9.22 (s, 1H), 8.34 (s, 1H), 8.14 (s, 1H), 7.60 (dd, J = 2.52, 8.84 Hz, 1H), 7.43-7.17 (m, 4H), 4.42 (bs, 2H), 4.28 (bs, 2H), 2.72 (s, 3H), 1.87 (s, 3H)
1026[Figure (not displayed)]
MS (ESI) m/z 745.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.51 (s, 1H), 9.49 (s, 1H), 8.36 (s, 1H), 8.15 (s, 1H), 7.61 (dd, J = 2.48, 8.8 Hz, 1H), 7.44- 7.42 (m, 2H), 7.37 (d, J = 8.8 Hz, 1H), 4.42 (bs, 2H), 4.30 (bs, 2H), 2.72 (s, 3H), 1.89 (s, 3H)
1027[Figure (not displayed)]
MS (ESI) m/z 693.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.37 (s, 1H), 8.04 (s, 1H), 7.65 (s, 1H), 7.59 (dd, J = 8.92 Hz, 1.48 Hz, 1H), 7.44 (s, 2H), 7.36 (s, 1H),4.41 (s, 2H), 4.25 (s, 2H), 3.86 (s, 3H), 2.71 (s, 3H), 1.86 (s, 3H), 1.79 (s, 3H)
1028[Figure (not displayed)]
MS (ESI) m/z 693.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.57 (s, 1H), 8.32 (s, 1H), 8.07 (s, 1H), 7.61 (dd, J = 2.56 Hz, J = 8.88 Hz, 1H), 7.45- 7.43 (m, 2H), 7.37 (d, J = 9.00 Hz, 1H), 6.27 (s, 1H), 4.41 (bs, 3H), 4.27 (bs, 2H), 3.55 (s, 3H), 2.72 (s, 3H), 2.23 (s, 3H), 1.84 (s, 3H)
1029[Figure (not displayed)]
MS (ESI) m/z 693.00 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.55 (bs, 1H), 8.34 (s, 1H), 8.01 (s, 1H), 7.59 (dd, J = 8.88, 2.4 Hz, 1H), 7.43-7.41 (m, 3H), 7.35 (d, J = 8.8 Hz, 1H), 4.40 (t, J = 6.04 Hz, 2H), 4.25 (t, J = 5.2 Hz, 2H), 3.83 (s, 3H), 2.70 (s, 3H), 2.10 (s, 3H), 1.83 (s, 3H)
1030[Figure (not displayed)]
MS (ESI) m/z 693.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.55 (bs, 1H), 8.26 (s, 1H), 8.10 (s, 1H), 7.61 (dd, J1 = 6.48, J2 = 2.28 Hz 1H), 7.45-7.43 (m, 3H), 7.38 (d, J = 8.88 Hz, 1H), 4.42 (bs, 2H), 4.26 (bs, 2H), 3.57 (s, 3H), 2.72 (s, 3H), 1.82 (s, 6H)
1031[Figure (not displayed)]
MS (ESI) m/z 693.13 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.56 (bs, 1H), 8.34 (s, 1H), 8.00 (s, 1H), 7.77 (s, 1H), 7.59 (dd, J = 8.84, 2.40 Hz, 1H), 7.43 (s, 2H), 7.36 (d, J = 8.96 Hz, 1H), 4.48-4.36 (m, 2H), 4.35-4.19 (m, 2H), 3.86 (s, 3H), 2.70 (s, 3H), 1.97 (s, 3H), 1.84 (s, 3H)
1032[Figure (not displayed)]
MS (ESI) m/z 693.10 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.33 (s, 1H), 8.01 (s, 1H), 7.60 (dd, J = 9.92, 3.32 Hz, 1H), 7.45-7.39 (m, 3H), 7.36 (d, J = 8.88 Hz, 1H), 4.46-4.45 (m, 2H), 4.30-4.20 (m, 2H), 3.83 (s, 3H), 2.70 (s, 3H), 2.10 (s, 3H), 1.83 (s, 3H)
1033[Figure (not displayed)]
MS (ESI) m/z 706.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.60 (d, J = 4.4 Hz, 1H), 8.28 (s, 1H), 8.00-7.95 (m, 2H), 7.72 (d, J = 7.72 Hz, 1H), 7.60 (dd, J = 8.88, 2.56 Hz, 1H), 7.46-7.39 (m, 3H), 7.37 (d, J = 8.96 Hz, 1H), 5.45 (s, 2H), 4.42 (t, J = 3.8 Hz, 2H), 4.25 (t, J = 4.3 Hz, 2H), 2.72 (s, 3H), 1.80 (s, 3H)
1034[Figure (not displayed)]
MS (ESI) m/z 655.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.54 (bs, 1H), 8.29 (s, 1H), 7.90 (s, 1H), 7.59 (dd, J = 8.92, 2.32 Hz, 1H), 7.42 (s, 2H), 7.36 (d, J = 8.92 Hz, 1H), 4.77-4.70 (m, 1H), 4.40 (t, J = 6.64 Hz, 2H), 4.23 (t, J = 5.12 Hz, 2H), 2.70 (s, 3H), 1.76 (s, 3H), 0.92-0.75 (m, 4H)
1035[Figure (not displayed)]
MS (ESI) m/z 792.25 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.45 (bs, 1H), 8.44 (d, J = 2.52 Hz, 1H), 8.38 (d, J = 3.32 Hz, 1H), 8.34 (s, 1H), 8.11 (s, 1H), 7.60 (dd, J = 2.55, 8.88 Hz, 1H), 7.49-7.42 (m, 4H), 7.35 (d, J = 8.90 Hz, 1H), 4.41 (t, J = 5.24 Hz, 2H), 4.05 (t, J = 4.0 Hz, 2H), 2.72 (s, 3H), 1.77 (s, 3H)
1036[Figure (not displayed)]
MS (ESI) m/z 629.11 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.91 (s, 1H), 7.60 (dd, J = 8.92, 2.56 Hz, 1H), 7.43 (s, 1H)- 7.42, (d, J = 2.80 Hz, 1H), 7.36 (d, J = 8.96 Hz, 1H), 4.40 (t, J = 4.72 Hz, 2H), 4.24 (t, J = 4.48 Hz, 2H), 4.13 (s, 3H), 2.71 (s, 3H), 1.78 (s, 3H)
1046[Figure (not displayed)]
MS (ESI) m/z 639.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.90 (s, 1H), 7.59 (dd, J = 8.84, 2.40 Hz, 1H), 7.44-7.39 (m, 2H), 7.35 (d, J = 8.92 Hz, 1H), 4.38 (t, J = 5.56 Hz, 2H), 4.24 (t, J = 6.04 Hz, 2H), 2.69 (s, 3H), 2.30-2.18 (m, 1H) 1.83 (s, 3H), 1.26-1.12 (m, 2 h), 1.00-0.90 (m, 2H)
1049[Figure (not displayed)]
MS (ESI) m/z 639.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.90 (s, 1H), 7.59 (dd, J = 8.84, 2.40 Hz, 1H), 7.44-7.39 (m, 2H), 7.35 (d, J = 8.92 Hz, 1H), 4.38 (t, J = 5.56 Hz, 2H), 4.24 (t, J = 6.04 Hz, 2H), 2.69 (s, 3H), 2.30-2.18 (m, 1H) 1.83 (s, 3H), 1.26-1.12 (m, 2 h), 1.00-0.90 (m, 2H)
1055[Figure (not displayed)]
MS (ESI) m/z 684.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.55 (s, 1H), 8.40 (s, 1H), 7.77 (s, 1H), 7.59 (dd, J = 2.28 Hz, J = 8.84 Hz, 1H), 7.42 (d, J = 2.40 Hz, 1H), 7.40 (s, 1H), 7.35 (d, J = 8.88, 1H), 5.72 (s, 1H), 4.39-4.30 (m, 6H), 4.18 (t, J = 6.68, 2H), 2.70 (s, 3H), 1.73 (s, 3H), 1.45 (s, 3H)
1058[Figure (not displayed)]
MS (ESI) m/z 706.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.49 (bs, 1H), 8.27 (s, 1H), 8.05 (s, 1H), 7.56-7.48 (m, 2H), 7.39 (s, 1H), 4.41 (t, J = 5.52 Hz, 2H), 4.27 (t, J = 5.04 Hz), 2.72 (s, 3H), 2.61 (s, 6H), 1.86 (s, 3H)
1059[Figure (not displayed)]
MS (ESI) m/z 710.5 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 8.57 (d, J = 1.6 Hz, 1H), 8.27 (s, 1H), 8.10-8.03 (m, 2H), 7.79 (d, J = 8.2 Hz,1H), 7.60 (dd, J = 8.8, 2.6 Hz, 1H), 7.45 (s, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 8.9 Hz, 1H), 4.42 (t, J = 4.24 Hz, 2H), 4.28 (t, J = 5.4 Hz, 2H), 2.73 (s, 3H), 1.87 (s, 3H)
1030[Figure (not displayed)]
MS (ESI) m/z 667.06 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.53 (bs, 1H), 8.35 (d, J = 2.68 Hz, 1H), 8.29 (s, 1H), 8.08 (s, 1H), 7.60 (dd, J = 8.84, 2.36 Hz, 1H), 7.46-7.40 (m, 3H), 7.36 (d, J = 8.96 Hz, 1H), 4.50-4.20 (m, 4H), 3.86 (s, 3H), 2.72 (s, 3H), 2.12 (s, 3H), 1.86 (s, 3H)
1073[Figure (not displayed)]
MS (ESI) m/z 643.20 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.91 (s, 1H), 7.59 (dd, J = 8.84 Hz, 2.56 Hz, 1H), 7.43-7.41 (m, 2H), 7.36 (d, J = 8.96 Hz, 1H), 4.40-4.35 (m, 4H), 4.23 (t, J = 4.16 Hz, 2H), 2.70 (s, 3H), 1.78 (s, 3H), 1.46 (t, J = 6.96 Hz, 3H)
1074[Figure (not displayed)]
MS (ESI) m/z 697.14 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 ) 8.21 (s, 1H), 7.96 (s, 1H), 7.59 (d, J = 8.96 Hz, 1H), 7.43 (s, 1H), 7.41 (s, 1H), 7.36 (d, J = 8.96 Hz, 1H), 5.00 (q, J = 8.40 Hz, 2H), 4.41 (t, J = 5.24 Hz, 2H), 4.25 (t, J = 4.8 Hz, 2H), 2.72 (s, 3H), 1.79 (s, 3H)
1075[Figure (not displayed)]
MS (ESI) m/z 711.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.24 (s, 1H), 8.06 (s, 1H), 7.59 (d, J = 8.84 Hz, 1H), 7.43 (d, J = 5.5 Hz, 2H), 7.36 (d, J = 8.9 Hz, 1H), 4.46-3.64 (m, 10H), 2.82 (s, 3H), 2.71 (s, 3H), 1.85 (s, 3H)
1079[Figure (not displayed)]
MS (ESI) m/z 767.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 with D20) δ 8.00 (d, J = 6.4 Hz, 2H), 7.53 (d, J = 7.2 Hz, 1H), 7.33 (s, 1H), 7.27 (d, J = 8.4 Hz, 1H), 7.19 (s, 1H), 4.33 (bs, 2H), 4.20 (bs, 2H), 2.54 (s, 3H), 2.19 (s, 3H), 1.67 (s, 3H)
1080[Figure (not displayed)]
MS (ESI) m/z 751.17 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.06 (s, 1H), 7.94 (s, 1H), 7.53 (dd, J = 8.76, 2.16 Hz, 1H), 7.40 (d, J = 2.16 Hz, 1H), 7.29 (d, J = 8.92 Hz, 1H), 7.19 (s, 1H), 7.00 (d, J = 6.52, Hz, 1H), 5.76-5.68 (m, 1H), 4.40-4.30 (m, 2H), 4.30-4.15 (m, 2H), 3.70-3.45 (m, 2H), 3.10-2.70 (m, 2H), 2.60 (s, 3H), 2.35-1.90 (m, 7H), 1.69 (s, 3H)
1081[Figure (not displayed)]
MS (ESI) m/z 805.02 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.67 (d, J = 2.76 Hz, 1H), 8.26 (s, 1H), 8.12 (s, 1H), 7.97 (d, J = 6.76 Hz, 1H), 7.57 (dd, J = 2.56, 8.8 Hz, 1H), 7.36 (t, J = 2.56 Hz, 2H), 7.28 (s, 1H), 4.41-4.21 (m, 6H), 2.82 (bs, 2H), 2.64 (s, 3H), 2.50 (s, 4H), 2.19 (s, 3H), 1.91 (s, 3H), 1.69 (s, 4H)
1082[Figure (not displayed)]
MS (ESI) m/z, 867.35 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.42 (s, 1H), 7.96 (s, 1H), 7.57 (dd, J = 2.52, 8.88 Hz, 1H), 7.36 (d, J = 2.52 Hz, 1H), 7.32 (d, J = 9.0 Hz, 1H), 7.27 (s, 1H), 6.94-6.90 (m, 1H), 4.61-4.56 (m, 1H), 4.37 (bs, 2H), 4.23 (bs, 2H), 3.60 (bs, 2H), 2.95 (bs, 2H), 2.63 (s, 3H), 2.24 (s, 4H), 1.84 (bs, 2H), 1.75 (s, 3H), 1.63 (d, J = 5.36 Hz, 6H), 1.44-1.39 (m, 4H), 1.33-1.20 (m, 4H)
1085[Figure (not displayed)]
MS (ESI) m/z 711.21 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.19 (s, 1H), 7.91 (s, 1H), 7.61 (dd, J = 8.9 Hz, 2.44 Hz, 1H), 7.47 (s, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.9 Hz, 1H), 4.40 (t, J = 5.0 Hz, 2H), 4.24 (t, J = 4.0 Hz, 2H), 3.86 (t, J = 9.2 Hz, 2H), 3.55 (bs, 2H), 3.32 (bs, 2H), 3.10 (bs, 2H), 3.02 (q, J = 15.0 Hz, 2H), 2.89 (s, 3H), 1.79 (s, 3H), 1.36 (t, J = 7.5 Hz, 3H)
1087[Figure (not displayed)]
MS (ESI) m/z 725.29 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 14.50 (bs, 1H), 7.92 (s, 1H), 7.60 (dd, J = 2.52, 9.28 Hz, 1H), 7.47 (s, 1H), 7.43 (d, J = 2.28 Hz, 1H), 7.36 (d, J = 8.88 Hz, 2H), 4.40 (t, J = 5.56 Hz, 2H), 4.24 (t, J = 5.76 Hz, 2H), 3.86 (t, J = 11.28 Hz, 2H), 3.56 (d, J = 11.44 Hz, 2H), 3.21-3.18 (m, 2H), 3.08 (d, J = 10.4 Hz, 2H), 3.01 (q, J = 7.6 Hz, 2H), 2.90 (bs, 3H), 2.37 (s, 3H), 1.90 (s, 3H), 1.36 (t, J = 7.6 Hz, 3H)
1088[Figure (not displayed)]
MS (ESI) m/z 708.25 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.60 (s, 1H), 10.02 (bs,1H), 8.21 (d, J = 5.4 Hz, 1H), 7.97 (d, J = 5.48 Hz, 1H), 7.62 (d, J = 2.28 Hz, 1H), 7.47 (s, 1H), 7.43 (d, J = 2.24 Hz, 1H), 7.37 (d, J = 8.96 Hz, 1H), 5.95 (s, 1H), 4.42 (bs, 2H), 4.39 (bs, 2H), 4.26 (d, J = 4.55 Hz, 1H), 3.85- 3.65 (m, 2H), 3.4-3.33 (m, 1H), 3.04-2.99 (m, 6H), 2.67 (bs, 1H), 1.86 (s, 3H), 1.36 (t, J = 7.52, 3H)
1093[Figure (not displayed)]
MS (ESI) m/z 697.18 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (d, J = 4.9 Hz, 1H), 7.95 (s, 1H), 7.61 (dd, J = 2.5, 8.8 Hz, 1H), 7.52 (d, J = 4.8 Hz, 1H), 7.37 (d, J = 2.5 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 4.8 Hz, 2H), 4.26 (t, J = 4.3 Hz, 2H), 3.90-3.83 (m, 2H), 3.57-3.54 (m, 2H), 3.21-3.18 (m, 2H), 3.10-3.08 (m, 2H), 2.91 (s, 3H), 2.39 (s, 3H), 1.85 (s, 3H)
1151[Figure (not displayed)]
MS (ESI) m/z 760.31 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.56 (bs, 1H), 8.89 (d, J = 4.8 Hz, 1H), 8.36 (s, 1H), 7.97 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.53 (d, J = 4.8 Hz, 1H), 7.45 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 4.45-4.38 (m, 2H), 4.26-4.19 (m, 2H), 3.80-3.40 (m, 5H), 3.20-2.75 (m, 4H), 2.65- 2.50 (s, 2H), 2.27 (s, 3H), 1.68 (s, 3H)
1153[Figure (not displayed)]
MS (ESI) m/z 683.16 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 13.12 (bs, 1H), 8.85 (d, J = 4.8 Hz, 1H), 8.23 (s, 1H), 7.99 (s, 1H), 7.60 (d, J = 9.2, 2.4 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 5.00 (q, J = 8.4 Hz, 2H), 4.41 (s, 2H), 4.25 (s, 2H), 1.73 (s, 3H)
1154[Figure (not displayed)]
MS (ESI) m/z 620.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.79 (bs, 1H), 8.17 (s, 1H), 7.91 (s, 1H), 7.67-7.62 (m, 3H), 7.51 (bs, 2H), 7.37 (bs, 1H), 5.02 (s, 2H), 3.87-3.45 (m, 4H), 3.21-2.91 (m, 4H), 3.02 (bs, 3H), 2.85 (bs, 3H)
1156[Figure (not displayed)]
MS (ESI) m/z 765.30 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.26 (bs, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.28 (s, 1H), 7.93 (s, 1H), 7.59 (d, J = 8.8 Hz, 1H), 7.46 (d, J = 4.4 Hz, 1H), 7.42 (s, 1H), 7.35 (d, J = 10.8 Hz, 1H), 4.39 (bs, 2H), 4.23 (bs, 2H), 3.63 (bs, 2H), 3.31 (bs, 2H), 2.95 (m, 4H), 2.60 (t, J = 7.2 Hz, 4H), 1.71 (s, 3H)
1158[Figure (not displayed)]
MS (ESI) m/z 721.16 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.8 Hz, 1H), 8.41 (s, 1H), 7.83 (s, 1H), 7.60 (dd, J = 2.4, 8.4 Hz, 1H), 7.44 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.71 (s, 2H), 4.63 (s, 2H), 4.40-4.20 (m, 8H), 3.05 (bs, 1H), 1.73 (s, 3H), 0.79-0.77 (m, 4H)
1159[Figure (not displayed)]
MS (ESI) m/z 709.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.4 Hz, 1H), 8.23 (s, 1H), 7.96 (s, 1H), 7.60 (dd, J = 6.4 Hz, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.40 (s, 2H), 4.24 (s, 2H), 3.85 (s, 4H), 3.29 (bs, 4H), 3.12 (bs, 1H), 1.76 (s, 3H), 1.01 (s, 2H), 0.85 (s, 2H)
1178[Figure (not displayed)]
MS (ESI) m/z 715.47 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 5.2 Hz, 1H), 8.66 (s, 1H), 7.93 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.66 (m, 2H), 7.56 (d, J = 4.4 Hz, 1H), 4.82 (s, 2H), 4.73-4.41 (m, 8H), 3.05 (bs, 1H), 2.11 (s, 3H), 0.77 (bs, 4H)
1179[Figure (not displayed)]
MS (ESI) m/z 786.04 [M + 1]+. 1H-NMR (400 MHz, DMSO-d6) δ 12.70 (s, 1H), 8.94 (d, J = 4.8 Hz, 1H), 8.31 (s, 1H), 7.97 (s, 1H), 7.63- 7.58 (m, 2H), 7.45 (d, J = 2.40 Hz, 1H), 7.37 (d, J = 9.20 Hz, 1H), 4.42 (bs, 2H), 4.22 (bs, 2H), 3.86-3.66 (m, 4H), 3.57 (s, 3H), 3.28- 3.122 (m, 5H), 1.67 (s, 3H), 2.01-0.84 (m, 4H)
1192[Figure (not displayed)]
MS (ESI) m/z 717.23 [M + 1]+; 1H NMR (400 MHz, DMSO) δ 13.50 (bs, 1H), 8.27 (s, 1H), 8.05 (s, 1H), 7.81 (d, J = 8.0 Hz, 1H), 7.59 (dd, J = 8.0, 4.0 Hz, 1H), 7.43 (s, 2H), 7.36 (d, J = 8.0 Hz, 1H), 6.66 (s, 1H), 6.42 (d, J = 4.0 Hz, 1H), 4.41 (s, 2H), 4.26 (s, 2H), 3.46 (t, J = 8.0 Hz, 2H), 2.83-2.60 (m, 5H), 1.84 (s, 3H)
1197[Figure (not displayed)]
MS (ESI) m/z 679.22 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.46 (bs, 1H), 8.23 (s, 1H), 7.94 (s, 1H), 7.59 (d, J = 8.0 Hz, 1H), 7.42 (s, 1H), 7.41 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 6.46 (t, J = 52.0 Hz, 1H), 4.70-4.60 (m, 2H), 4.41 (s, 2H), 4.24 (s, 2H), 2.71 (s, 3H), 1.79 (s, 3H)
1200[Figure (not displayed)]
MS (ESI) m/z 684.22 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 14.29 (bs, 1H), δ 10.03 (bs, 1H), δ 7.98 (s, 1H), δ 7.61 (dd, J = 9.0 Hz, 2.46 Hz, 1H), 7.43 (s, 1H), 7.42 (s, 1H), 7.35 (d, J = 9.2 Hz, 1H), 4.41 (t, J = 5.1 Hz, 2H), 4.28 (t, J = 4.5 Hz, 2H), 3.42 (bs, 2H), 3.32 (bs, 2H), 2.93 (s, 6H), 2.70 (s, 3H), 2.34 (s, 3H), 1.96 (s, 3H)
1206[Figure (not displayed)]
MS (ESI) m/z 723.34 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.82 (d, J = 4.6 Hz, 1H), 8.19 (s, 1H), 7.90 (s ,1H), 7.58 (dd, J = 2.48, 8.92 Hz, 1H), 7.38 (d, J = 3.16 Hz, 1H), 7.33 (d, J = 8.96 Hz, 1H), 4.39 (t, J = 5.4 Hz, 2H), 4.22 (t, J = 5.2 Hz, 2H), 3.89 (s, 3H), 3.80-3.40 (m, 4H), 3.10-2.90 (m, 4H), 1.69 (s, 3H), 0.47- 0.35 (m, 4H)
1207[Figure (not displayed)]
MS (ESI) m/z 779.28 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 14.32 (bs, 1H), 7.90 (s, 1H), 7.60 (dd, J = 2.6, 8.9 Hz, 1H), 7.41 (m, 2H), 7.36 (d, J = 8.9 Hz, 1H), 4.40 (s, 2H), 4.26 (s, 2H), 3.66 (m, 2H), 3.20 (m, 2H), 2.97 (m, 2H), 2.70 (s, 3H), 2.66 (m, 1H), 2.49 (s, 3H), 2.44 (s, 3H), 1.97 (s, 3H)
1212[Figure (not displayed)]
MS (ESI) m/z 677.23 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.11 (bs, 1H), 8.77 (d, J = 4.8 Hz, 1H), 8.59 (s, 1H), 8.11 (s, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.71-7.67 (m, 2H), 7.56 (d, J = 4.8 Hz, 1H), 4.86 (s, 2H), 3.89-3.86 (m, 2H), 3.59-3.56 (m, 2H), 3.29 (d, J = 11.6 Hz, 2H), 3.11 (bs, 2H), 2.92 (s, 3H), 2.17 (s, 3H)
1213[Figure (not displayed)]
MS (ESI) m/z 691.29 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.31 (s, 1H), 9.77 (s, 1H), 8.58 (s, 1H), 8.09 (s, 1H), 7.76-7.64 (m, 3H), 7.50 (s, 1H), 4.84 (s, 2H), 3.93-3.88 (m, 2H), 3.61-3.58 (m, 2H), 3.32-3.29 (m, 2H), 3.12 (bs, 2H), 2.92 (s, 3H), 2.67 (s, 3H), 2.23 (s, 3H)
1214[Figure (not displayed)]
MS (ESI) m/z 700.25 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.83 (bs, 1H), 8.01 (s, 1H), 7.79 (s, 1H), 7.52-7.50 (m, 1H), 7.29-7.20 (m, 4H), 4.34 (bs, 2H), 4.22 (bs, 2H), 3.60-3.38 (m, 2H), 3.25 (bs, 2H), 3.19-2.98 (m, 4H), 2.24 (s, 3H), 1.79 (s, 3H)
1215[Figure (not displayed)]
MS (ESI) m/z 713.31 [M + 1]+;1H NMR (400 MHz, DMSO-d6) δ 13.66 (bs, 1H), 9.74 (bs, 1H), 8.22 (s, 1H), 7.92 (s, 1H), 7.60-7.54 (m, 2H), 7.44 (s, 1H), 4.39 (bs, 2H), 4.23 (bs, 2 H), 3.86 (m, 2H), 3.58 (m, 2H), 3.26-2.98 (m, 6H), 2.89 (s, 3H), 1.79 (s, 3H), 1.35 (t, J = 7.6 Hz, 3H)
1218[Figure (not displayed)]
MS (ESI) m/z 696.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.98 (s, 1H), 8.02 (s, 1H), 7.66 (s, 1H), 7.50 (dd, J = 2.4 Hz, J = 8.8 Hz, 1H), 7.27-7.25 (m, 3H), 7.13 (d, J = 7.6 Hz, 1H), 4.34 (t, J = 4.8 Hz, 2H), 4.22 (t, J = 4.8 Hz, 2H), 3.86 (t, J = 10.8, 2H), 3.55-3.53 (m, 2H), 3.24-3.21 (m, 2H), 3.07 (bs, 2H), 2.89 (s, 3H), 2.68 (s, 3H), 1.7 (s, 3H)
1221[Figure (not displayed)]
MS (ESI) m/z 627.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.02 (bs, 1H), 9.72 (bs, 1H), 8.58 (d, J = 4.4 Hz, 1H), 8.15 (s, 1H), 7.90 (s, 1H), 7.54 (d, J = 4.2 Hz, 1H), 7.48 (dd, J = 8.8, 2.5 Hz, 1H), 7.40 (d, J = 2.4 Hz, 1H), 7.25 (d, J = 9.6 Hz, 1H), 4.39 (s, 4H), 3.85 (t, J = 11.3 Hz, 2H), 3.52 (t, J = 11.2 Hz, 2H), 3.21 (d, J = 11.8 Hz, 2H), 3.07 (bs, 2H), 2.89 (s, 3H), 2.24 (s, 3H)
1222[Figure (not displayed)]
MS (ESI) m/z 641.28 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.73 (bs, 1H), 8.10 (s, 1H), 7.70 (s, 1H), 7.50-7.40 (m, 2H), 7.35 (d, J = 2.8 Hz, 1H), 7.25 (d, J = 9.2 Hz, 1H), 4.38 (s, 4H), 3.85 (t, J = 22.8 Hz, 2H), 3.54 (d, J = 11.2 Hz, 2H), 3.21 (d, J = 11.6 Hz, 2H), 3.13-2.98 (m, 2H), 2.89 (s, 3H), 2.26 (s, 3H)
1223[Figure (not displayed)]
MS (ESI) m/z 655.38 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.89 (bs, 1H), 9.74 (bs, 1H), 8.10 (s, 1H), 7.72 (s, 1H), 7.48-7.44 (m, 2H), 7.36 (d, J = 2.4 Hz, 1H), 7.24 (d, J = 9.2 Hz, 1H), 4.37 (s, 4H), 4.02- 4.00 (m, 2H), 3.91-3.75 (m, 2H), 3.54 (d, J = 10.4 Hz, 2H), 3.19 (d, J = 12.0 Hz, 2H), 3.15-2.98 (m, 2H), 2.89 (s, 3H), 2.80 (q, J = 8.0 Hz, 2H), 2.29 (s, 3H), 1.22 (t, J = 7.6 Hz, 3H)
1224[Figure (not displayed)]
MS (ESI) m/z 656.30 [M +1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.93 (bs, 1H), 8.05 (s, 1H), 7.52 (s, 1H), 7.46 (dd, J = 8.8, 2.4 Hz, 1H), 7.34 (d, J = 2.4 Hz, 1H), 7.23 (d, J = 8.8 Hz, 1H), 6.95 (s, 1H), 4.36 (bs, 4H), 3.91 (s, 3H), 3.75-3.50 (m, 2H), 3.20-2.70 (m, 6H), 2.26 (s, 3H), 2.24 (s, 3H)
1225[Figure (not displayed)]
MS (ESI) m/z 670.31 [M +1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.39 (bs, 1H), 8.04 (s, 1H), 7.42 (dd, J = 8.0, 4.0 Hz, 1H), 7.28 (d, J = 4.0 Hz, 1H), 7.20 (d, J = 8.0 Hz, 1H), 7.09 (s, 1H), 6.63 (s, 1H), 4.34 (s, 4H), 3.82-3.35 (m, 4H), 2.99 (s, 6H), 2.95-2.69 (m, 4H), 2.24 (s, 3H), 2.22 (s, 3H)
1226[Figure (not displayed)]
MS (ESI) m/z 655.29 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.93 (bs, 1H), 8.09 (s, 1H), 7.46-7.44 (dd, J = 2.0, 8.8 Hz, 1H), 7.21- 7.16 (m, 2H), 7.08 (s, 1H), 4.30 (bs, 4H), 3.78 (bs, 2H), 3.14 (m, 4H), 2.91 (bs, 2H), 2.74 (s, 3H), 2.45 (s, 3H), 2.02 (s, 3H), 1.88 (s, 3H)
1228[Figure (not displayed)]
MS (ESI) m/z 707.30 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.87 (d, J = 4 Hz, 1H), 8.19 (s, 1H), 7.68 (s, 1H), 7.60-7.58 (dd, J = 2.4, 8.8 Hz, 1H), 7.45 (t, J = 4 Hz, 2H), 7.37 (d, J = 8.8 Hz, 1H), 4.41 (bs, 2H), 4.23 (bs, 2H), 3.86- 2.64 (m, 8H), 2.32 (s, 3H), 1.74 (s, 3H)
1237[Figure (not displayed)]
MS (ESI) m/z 729.25 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 13.62 (bs, 1H), 7.96 (s, 1H), 7.63-7.60 (dd, J = 2.4, 8.8 Hz, 1H), 7.52 (s, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 5.79 (d, J = 46.4 Hz, 2H), 4.41 (bs, 2H), 4.26 (bs, 2H), 3.89 (t, J = 12.4 Hz, 2H), 3.56 (t, J = 10.4 Hz, 2H), 3.20 (t, J = 12.8 Hz, 2H), 3.09 (bs, 2H), 2.90 (s, 3H), 2.39 (s, 3H), 1.88 (s, 3H)
1238[Figure (not displayed)]
MS (ESI) m/z 741.31 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 13.98 (bs, 1H), 7.93 (s, 1H), 7.62-7.60 ( m, 1H), 7.48 (s, 1H), 7.43 (bs, 1H), 7.37 (d, J = 8.8 Hz, 1H), 4.75 (s, 2H), 4.41 (bs, 2H), 4.25 (bs, 2H), 3.57 (t, J = 12.0 Hz, 2H), 3.44 (bs, 2H), 3.40 (s, 3H), 3.21 (t, J = 10.8 Hz, 2H), 3.10 (bs, 2H), 2.90 (s, 3H), 2.39 (s, 3H), 1.89 (s, 3H)
1239[Figure (not displayed)]
MS (ESI) m/z 733.30 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.02 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.27 (s, 1H), 7.94 (s, 1H), 7.60 (dd, J = 8.8, 2.8 Hz 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 6.47-6.19 (m, 1H), 4.40 (s, 2H), 4.24 (s, 2H), 3.70-3.50 (merged, 2H), 3.30-2.80 (m, 8H), 1.75 (s, 3H)
1241[Figure (not displayed)]
MS (ESI) m/z 725.25 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.77 (bs, 1H), 8.83 (d, J = 4.64 Hz, 1H), 8.24 (s, 1H), 7.96 (s, 1H), 7.11 (dd, J = 8.9 Hz, 2.16 Hz, 1H), 7.48 (d, J = 4.6 Hz, 1H), 7.43 (s, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.74 (bs, 4H), 4.59 (bs, 1H), 4.41 (s, 2H), 4.25 (s, 2H), 4.07 (bs, 2H), 3.54 (bs, 2H), 3.30 (bs, 2H), 2.93 (bs, 2H), 1.76 (s, 3H)
1242[Figure (not displayed)]
MS (ESI) m/z 739.32 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.46 (s, 1H), 8.24 (s, 1H), 7.92 (s, 1H), 7.60 (d, J = 8.8 Hz, 1H), 7.42 (d, J = 6 Hz, 2H), 7.36 (d, J = 8.8 Hz, 1H), 4.78- 4.73 (m, 4H), 4.59 (bs, 1H), 4.40 (s, 2H), 4.25- (s, 2H), 3.91 (bs, 4H), 3.29 (bs, 2H), 2.92 (bs, 2H), 2.72 (s, 3H), 1.84 (s, 3H)
1243[Figure (not displayed)]
MS (ESI) m/z 727.33 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.81 (s, 1H), 8.84 (d, J = 4.8 Hz, 1H), 8.26 (s, 1H), 7.96 (s, 1H), 7.62 (dd, J = 2.4, 9.2 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 4.42 (t, J = 4.8 Hz, 2H), 4.26 (t, J = 4.8 Hz, 2H), 3.95 (bs, 2H), 3.71 (m, 2H), 3.58 (m, 2H), 3.44 (m, 2H), 3.35 (s, 3H), 3.12 (d, J = 10 Hz, 2H), 3.12 (t, J = 10 Hz, 2H), 1.77 (s, 3H)
1244[Figure (not displayed)]
MS (ESI) m/z 663.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.71 (bs, 1H), 8.73 (d, J = 4.4 Hz, 1H), 8.12 (s, 1H), 7.62 (s, 1H), 7.56 (dd, J = 8.8, 2.4 Hz, 1H), 7.38-7.31 (m, 3H), 4.68 (s, 1H), 4.40 (s, 2H), 4.26 (s, 2H), 3.86 (t, J = 12.0 Hz, 2H), 3.54 (d, J = 11.6 Hz, 2H), 3.22 (d, J = 12.8 Hz, 2H), 3.15-3.00 (m, 2H), 2.91 (s, 3H), 1.82 (s, 3H)
1245[Figure (not displayed)]
MS (ESI) m/z 664.29 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.90 (d, J = 4.4 Hz, 1H), 8.41 (s, 1H), 8.10 (s, 1H), 7.60 (dd, J = 8.8, 2.4 Hz, 1H), 7.56 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz, 1H), 4.43-4.43 (m, 2H), 4.24 (s, 2H), 3.65- 3.49 (m, 2H), 2.99-2.89 (m, 4H), 2.74 (s, 2H), 2.24 (s, 3H), 1.69 (s, 3H)
1246[Figure (not displayed)]
MS (ESI) m/z 673.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.68 (s, 1H), 8.08 (s, 1H), 7.56 (d, J = 7.84, 1H), 7.45 (s, 1H), 7.37-7.31 (m, 3H), 4.40 (s, 2H), 4.27 (s, 2H), 3.72-3.51 (m, 2H), 2.90 (bs, 4H), 2.25 (s, 5H), 1.83 (s, 3H)
1247[Figure (not displayed)]
MS (ESI) m/z 673.19 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 4.8 Hz, 1H), 8.01 (s, 1H), 7.58 (dd, J = 2.8, 8.8 Hz, 1H), 7.51 (s, 1H), 7.41 (d, J = 4.8 Hz, 1H), 7.37 (d, J = 2.4 Hz, 1H), 7.34 (d, J = 6.8 Hz, 1H), 4.39 (t, J = 4.8 Hz, 2H), 4.24 (t, J = 4.0 Hz, 2H), 3.62 (bs, 2H), 2.81 (bs, 6H), 2.24 (s, 3H),
1248[Figure (not displayed)]
MS (ESI) m/z 653.30 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.54 (s, 1H), 8.06 (s, 1H), 7.52 (s, 1H), 7.31 (t, J = 9.9 Hz, 2H), 7.13 (s, 1H), 7.06 (s, 1H), 4.36 (s, 2H), 4.26 (s, 2H), 3.91-3.42 (m, 2H), 3.22-2.71 (m, 4H), 2.63- 2.21 (m, 5H), 2.12 (s, 3H), 1.86 (s, 3H)
1249[Figure (not displayed)]
MS (ESI) m/z 653.31 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.73 (bs, 1H), 8.66 (d, J = 4.8 Hz, 1H), 8.05 (s, 1H), 7.55 (dd, J = 8.8, 2.4 Hz, 1H), 7.34-7.31 (m, 2H), 7.24 (d, J = 4.8 Hz, 1H), 7.13 (s, 1H), 4.41-4.34 (m, 2H), 4.30- 4.20 (m, 2H), 3.87 (t, J = 11.6 Hz, 2H), 3.56 (d, J = 11.6 Hz, 2H), 3.26 (d, J = 12.0 Hz, 2H), 3.15-3.00 (m, 2H), 2.91 (s, 3H), 2.36 (s, 3H), 1.81 (s, 3H)
1250[Figure (not displayed)]
MS (ESI) m/z 640.24 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.74 (bs, 1H), 9.16 (s, 1H), 8.07 (s, 1H), 8.01 (d, J = 5.32 Hz, 1H), 7.62 (dd, J = 8.9, 2.6 Hz, 1H), 7.46 (d, J = 2.6 Hz, 1H) 7.42 (d, J = 5.4 Hz, 1H) 7.36 (d, J = 9.0 Hz, 1H), 4.43 (t, J = 4.9 Hz, 2H), 4.29 (t, J = 4.32 Hz, 2H), 3.87 (t, J = 11.2 Hz, 2H), 3.55 (d, J = 11.6 Hz, 2H), 3.25 (d, 12.36 Hz, 2H), 3.15-3.00 (m, 2H), 2.90 (s, 3H), 1.93 (s, 3H)
1251[Figure (not displayed)]
MS (ESI) m/z 640.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.10 (s, 1H), 8.84 (d, J = 4.5 Hz, 1H), 8.05 (s, 1H), 7.58 (dd, J = 9.0 Hz, 2.5 Hz, 1H), 7.55 (d, J = 4.5 Hz, 1H), 7.47 (d, J = 2.5 Hz, 1H), 7.35 (d, J = 8.9 Hz, 1H), 4.43 (t, J = 4.16 Hz, 2H), 4.27 (t, J = 4.36 Hz, 2H), 3.61 (bs, 4H), 2.96 (bs, 4H), 2.24 (s, 3H), 1.88 (s, 3H)
1252[Figure (not displayed)]
MS (ESI) m/z 667.36 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.60 (d, J = 4.7 Hz, 1H),), 8.01 (s, 1H), 7.54-7.51 (dd, J = 8.8, J = 2.5 Hz, 1H), 7.30 (m, 2H), 7.18 (d, J = 4.6 Hz, 1H), 4.37 (t, J = 12.7 Hz, 2H), 4.23 (t, J = 3.4 Hz, 2H), 3.64 (m, 4H), 2.89 (m, 4H), 2.23 (s, 6H), 1.97 (s, 3H), 1.79 (s, 3H)
1253[Figure (not displayed)]
MS (ESI) m/z 671.22 [M +1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.01 (s, 1H), 7.78 (d, J = 5.6 Hz, 1H), 7.57 (dd, J = 2.80, 8.8 Hz, 1H), 7.39 (d, J = 2.8 Hz, 1H), 7.37 (d, J = 9.6 Hz, 1H), 7.34-7.31 (m, 2H), 5.59 (d, J = 46.8 Hz, 2H), 4.36 (t, J = 4.4 Hz, 2H), 4.25 (t, J = 4.0 Hz, 2H), 3.61 (bs, 2H), 2.93 (bs, 2H), 2.50 (bs, 2H), 2.25 (bs, 5H), 1.85 (s, 3H)
1254[Figure (not displayed)]
MS (ESI) m/z 664.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.48 (s, 1H), 8.03 (s, 1H), 7.61 (dd, J = 2.4, 11.2 Hz, 1H), 7.50 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.4 Hz, 1H), 7.37 (d, J = 8.8 Hz, 1H), 4.40 (bs, 2H), 4.26 (bs, 2H), 3.57 (m, 2H), 3.02 (m, 4H), 2.60 (m, 2H), 2.24 (s, 3H), 1.76 (s, 3H)
1255[Figure (not displayed)]
MS (ESI) m/z 612.23 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.99 (bs, 1H), 68.63 (d, J = 4.8 Hz, 1H), 68.10 (s, 1H), 7.66 (d, J = 5.6 Hz, 1H), 7.54 (dd, J = 8.7 Hz, 2.5 Hz, 1H), 7.37 (d, J = 2.4 Hz, 1H), 7.33-31 (m, 2H), 7.21 (d, J = 4.4 Hz, 1H), 4.37 (t, J = 5.1 Hz, 2H), 4.27 (t, J = 4.5 Hz, 2H), 3.45-3.43 (m, 2H), 3.32 (bs, 2H), 2.95 (s, 6H), 1.96 (s, 3H)
1256[Figure (not displayed)]
MS (ESI) m/z 653.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.63 (d, J = 4.8 Hz, 1H), 8.05 (s, 1H), 7.72 (d, J = 5.6 Hz, 1H), 7.55 (dd, J = 2.4, 8.8 Hz, 1H), 7.42 (d, J = 5.6, Hz, 1H), 7.39 (d, J = 2.4 Hz, 1H), 7.32 (d, J = 8.8 Hz, 1H), 7.22 (d, J = 4.4 Hz, 1H), 4.38 (t, J = 4.4 Hz, 2H), 4.25 (t, J = 5.2 Hz, 2H), 3.85 (s, 2H), 2.47 (m, 4H), 2.27 (m, 4H), 1.83 (s, 3H), 1.23 (s, 3H)
1259[Figure (not displayed)]
MS (ESI) m/z 666.25 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.38 (d, J = 4.0 Hz 1H), 8.20 (s, 1H), 8.02 (s, 1H), 7.58 (d, J = 6.4 Hz, 1H), 7.42 (d, J = 9.2 Hz, 2H), 7.33 (d, J = 8.8 Hz 1H), 4.39 (s, 2H), 4.23 (s, 2H), 3.67 (s, 2H), 2.32 (s, 6H), 1.68 (s, 3H)
1260[Figure (not displayed)]
MS (ESI) m/z 638.08 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.28 (s, 1H), 8.84 (d, J = 4.8 Hz, 1H), 8.47 (bs, 3H), 8.31 (s, 1H), 8.04 (s, 1H), 7.61 (dd, J = 8.8, 2.4 Hz, 1H), 7.49 (d, J = 4.4 Hz, 1H), 7.44 (d, J = 2.8 Hz, 1H), 7.37 (d, J = 9.2 Hz, 1H), 4.41 (bs, 2H), 4.27 (bs, 4H), 1.74 (s, 3H)
1261[Figure (not displayed)]
MS (ESI) m/z 713. 27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.25 (bs, 1H), 9.60 (bs, 1H), 8.84 (d, J = 4.8 Hz, 1H), 8.21 (s, 1H), 7.95 (s, 1H), 7.61 (dd, J = 2.4, 8.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 5.69 (bs, 1H), 4.41 (s, 2H), 4.24 (s, 2H), 3.95-3.89 (m, 3H), 3.63-3.58 (m, 2H), 3.22-3.30 (m, 6H), 2.96-2.89 (m, 4H), 1.75 (s, 3H)
1262[Figure (not displayed)]
MS (ESI) m/z 749.29 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.37 (bs, 1H), 8.84 (d, J = 4.8 Hz, 1H), 8.24 (s, 1H), 7.94 (s, 1H), 7.59 (dd, J = 2.4, 8.8 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 9.2 Hz, 1H), 4.40 (s, 2H), 4.23 (s, 2H), 3.96 (m, 2H), 3.48 (m, 4H), 3.24 (m, 1H), 2.96 (s, 3H), 1.72 (s, 3H)
1263[Figure (not displayed)]
MS (ESI) m/z 682.0 [M + 1]+; ; 1H NMR (400 MHz, DMSO-d6) δ 8.28 (s, 1H), 7.90 (s, 1H), 7.63-7.56 (m, 1H), 7.46-7.38 (m, 2H), 7.35 (d, J = 8.96 Hz, 1H), 4.49-4.32 (m, 2H), 4.31-4.18 (m, 2H), 3.70-3.66 (m, 1H), 3.26-3.22 (m, 2H), 2.69 (s, 3H), 2.32-2.22 (m, 2H), 2.22-2.09 (m, 2H), 2.07 (s, 3H), 1.80 (s, 3H)
1269[Figure (not displayed)]
MS (ESI) m/z 699.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.12 (bs, 1H), 8.94 (s, 1H), 8.91 (d, J = 4.8 Hz, 1H), 8.15 (s, 1H), 7.75 (d, J = 9.2 Hz, 1H), 7.57 (d, J = 4.4 Hz, 1H), 7.49 (bs, 2H), 4.18 (t, J = 6.0 Hz, 2H), 3.87 (bs, 2H), 3.54 (d, J = 12.4 Hz, 2H), 3.33 (bs, 2H), 3.22 (d, J = 11.6 Hz, 2H), 3.08 (bs, 2H), 2.90 (s, 3H), 2.52 (s, 3H)
1270[Figure (not displayed)]
MS (ESI) m/z 691.31 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.11 (bs, 1H), 8.7 (d, J = 4.7 Hz, 1H), 8.62 (s, 1H), 8.26 (s, 1H), 7.76 (d, J = 8.1 Hz, 1H), 7.72-7.66 (m, 2H), 7.25 (d, J = 4.7 Hz, 1H), 5.01- 4.45 (m, 2H), 4.20-3.82 (m, 4H), 3.70-3.45 (m, 2H), 2.88 (s, 3H), 2.16 (s, 3H)
1271[Figure (not displayed)]
MS (ESI) m/z 691.28 [M + 1]+; ; 1H NMR (400 MHz, DMSO-d6) δ 13.75 (bs, 1H), 9.75 (bs, 1H), 8.74 (d, J = 4.8 Hz, 1H), 8.11 (s, 1H), 7.76-7.69 (m, 2H), 7.65 (s, 1H), 7.58 (d, J = 4.8 Hz, 1H), 4.86 (s, 2H), 3.89 (t, J = 22.4 Hz, 2H), 3.59 (d, J = 11.2 Hz, 2H), 3.30 (d, J = 11.2 Hz, 2H), 3.11 (d, J = 8 Hz, 2H), 2.92 (bs, 3H), 2.64 (s, 3H), 2.22 (s, 3H)
1272[Figure (not displayed)]
MS (ESI) m/z 711.31 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.8 (d, J = 4.8 Hz, 1H), 8.09 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.50 (d, J = 4.8 Hz, 1H), 7.44 (d, J = 2.4 Hz, 1H), 7.35 (d, J = 8.8 Hz 1H), 4.42 (bs, 2H), 4.28 (bs, 2H), 4.08-3.55 (m, 6H), 2.87 (s, 3H), 2.37 (s, 3H), 1.82 (s, 3H)
1275[Figure (not displayed)]
MS (ESI) m/z 724.28 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) 13.73 (bs, 1H), 8.17 (s, 1H), 7.96 (s, 1H), 7.62-7.59 (dd, J = 2.8, 9.2 Hz, 1H), 7.47-7.44 (m, 2H), 7.37 (d, J = 8.8 Hz, 1H), 4.41 (bs, 2H), 4.24 (bs, 2H), 3.43-3.40 (m, 2H), 3.23-2.86 (m, 6H), 2.73 (s, 3H), 2.02 (bs, 1H), 1.79 (bs, 5H), 1.64-1.55 (m, 2H), 1.37 (t, J = 7.6 Hz, 3H)
1276[Figure (not displayed)]
MS (ESI) m/z 710.27 [M + 1]+; ; 1H NMR (400 MHz, DMSO-d6) δ 13.70 (bs, 1H), 8.45 (bs, 1H), 8.17 (s, 1H), 7.96 (s, 1H), 7.61-7.59 (dd, J = 6.8, 8.8 Hz, 1H), 7.46-7.43 (m, 2H), 7.37 (d, J = 8.8 Hz, 1H), 4.41 (bs, 2H), 4.24 (bs, 2H), 3.30 (m, 2H), 3.06-2.98 (m, 4H), 2.84 (m, 2H), 2.08 (bs, 1H), 1.79 (s, 3H), 1.75 (d, J = 13.6 Hz, 2H), 1.60 (t, J = 10.0 Hz, 2H), 1.37 (t, J = 7.6 Hz, 3H)
1283[Figure (not displayed)]
MS (ESI) m/z 682.22 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 14.06 (bs, 1H), 8.79 (d, J = 5.2 Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 7.61 (dd, J = 2.8, 9.2 Hz, 1H), 7.52 (d, J = 4.8 Hz, 1H), 7.9 (d, J = 2.4 Hz, 1H), 7.38 (d, J = 9.2 Hz, 1H), 4.42 (bs, 2H), 4.27 (bs, 2H), 4.20 (d, J = 6.0 Hz, 2H), 4.02 (d, J = 8.0 Hz, 2H), 3.95 (bs, 1H), 3.38 (d, J = 5.6 Hz, 2H), 2.85 (d, J = 4.8 Hz, 3H), 2.33 (s, 3H), 1.88 (s, 3H)
1286[Figure (not displayed)]
MS (ESI) m/z 714.39 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.23 (bs, 1H), 8.14 (s, 1H), 7.52 (dd, J = 8.8 Hz, 2.5 Hz, 1H), 7.27-7.25 (m, 2H), 7.23- 7.21 (m, 2H), 4.34-4.33 (m, 2H), 4.27-4.25 (m, 2H), 3.87 (t, J = 12.3 Hz, 2H), 3.55-3.53 (m, 2H), 3.18- 3.15 (m, 2H), 3.08-3.06 (m, 2H), 2.89 (s, 3H), 2.04 (s, 3H), 1.83 (s, 3H)
1287[Figure (not displayed)]
MS (ESI) m/z 704.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.8 Hz, 1H), 8.20 (s, 1H), 7.98 (s, 1H), 7.60 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 7.49 (d, J = 4.4 Hz, 1H), 7.42-7.36 (m, 2H), 4.41 (bs, 6H), 4.24 (s, 2H), 3.31 (d, J = 6.4 Hz, 2H), 3.21 (d, J = 4.8 Hz, 2H), 1.81 (s, 3H)
1288[Figure (not displayed)]
MS (ESI) m/z 706.37 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.4 Hz 1H), 8.21 (s, 1H), 7.98 (s, 1H) 7.59 (dd, J = 8.9, 2.6 Hz, 1H), 7.49 (d, J = 4.8 Hz 1H), 7.42 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 6.18-6.46 (m, 1H), 4.41 (t, J = 6.02 Hz, 2H), 4.25 (t, J = 8.0 Hz, 2H), 3.39 (s, 4H), 3.09 (s, 2H), 2.73 (s, 3H), 1.77 (s, 3H)
1259[Figure (not displayed)]
MS (ESI) m/z 620.27 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 12.79 (bs, 1H), 8.17 (s, 1H), 7.91 (s, 1H), 7.67-7.62 (m, 3H), 7.51 (bs, 2H), 7.37 (bs, 1H), 5.02 (s, 2H), 3.87-3.45 (m, 4H), 3.21-2.91 (m, 4H), 3.02 (bs, 3H), 2.85 (bs, 3H)
1291[Figure (not displayed)]
MS (ESI) m/z 709.12 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.83 (d, J = 4.4 Hz, 1H), 8.23 (s, 1H), 7.96 (s, 1H), 7.60 (dd, J = 6.4 Hz, 2.4 Hz, 1H), 7.48 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.40 (s, 2H), 4.24 (s, 2H), 3.85 (s, 4H), 3.29 (bs, 4H), 3.12 (bs, 1H), 1.76 (s, 3H), 1.01 (s, 2H), 0.85 (s, 2H)
1292[Figure (not displayed)]
MS (ESI) m/z 759.38 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.30 (bs, 1H), 8.83 (d, J = 4.8 Hz, 1H), 8.25 (s, 1H), 7.96 (s, 1H), 7.60 (dd, J = 6.4, 9.2 Hz, 1H), 7.47 (d, J = 4.8 Hz, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.40 (s, 2H), 4.24 (s, 2H), 3.85-3.52 (m, 5H), 3.02 (m, 8H), 1.75 (m, 3H)
1293[Figure (not displayed)]
MS (ESI) m/z 765.30 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.26 (bs, 1H), 8.82 (d, J = 4.8 Hz, 1H), 8.28 (s, 1H), 7.93 (s, 1H), 7.59 (d, J = 8.8 Hz, 1H), 7.46 (d, J = 4.4 Hz, 1H), 7.42 (s, 1H), 7.35 (d, J = 10.8 Hz, 1H), 4.39 (bs, 2H), 4.23 (bs, 2H), 3.63 (bs, 2H), 3.31 (bs, 2H), 2.95 (m, 4H), 2.60 (t, J = 7.2 Hz, 4H), 1.71 (s, 3H)
1298[Figure (not displayed)]
MS (ESI) m/z 650.26 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 13.06 (bs, 1H), 8.75 (d, J = 4.8 Hz, 1H), 8.57 (s, 1H), 8.14 (s, 1H), 7.77 (d, J = 8.0 Hz, 1H), 7.70-7.66 (m, 2H), 7.55 (d, J = 4.8 Hz, 1H), 4.88 (s, 2H), 3.38-3.23 (m, 4H), 3.18-3.08 (m, 2H), 2.78 (s, 6H), 2.16 (s, 3H)
1372[Figure (not displayed)]
MS (ESI) m/z 606.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.63 (dd, J = 5.0, 0.8 Hz, 1H), 8.38 (d, J = 1.7 Hz, 1H), 8.26 (dd, J = 1.7, 0.8 Hz, 1H), 8.03 (dd, J = 1.7, 0.8 Hz, 1H), 7.70 (dd, J = 5.0, 1.8 Hz, 1H), 7.57-7.39 (m, 2H), 7.27 (d, J = 8.9 Hz, 1H), 4.40 (s, 4H), 3.39 (s, 3H), 2.23 (s, 3H)
1374[Figure (not displayed)]
MS (ESI) m/z 628.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.36 (d, J = 1.7 Hz, 1H), 8.25 (s, 3H), 7.99 (d, J = 1.7 Hz, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.45 (s, 1H), 7.39-7.34 (m, 2H), 4.41 (d, J = 5.1 Hz, 2H), 4.27 (t, J = 5.1 Hz, 2H), 3.41 (d, J = 6.0 Hz, 2H), 3.28 (t, J = 6.5 Hz, 2H), 1.83 (s, 3H)
1375[Figure (not displayed)]
MS (ESI) m/z 624.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 11.41 (s, 1H), 8.83 (d, J = 4.7 Hz, 1H), 8.34 (d, J = 1.6 Hz, 1H), 7.95 (s, 1H), 7.81 (d, J = 1.6 Hz, 1H), 7.59 (dd, J = 8.9, 2.7 Hz, 1H), 7.45-7.39 (m, 2H), 7.35 (d, J = 9.0 Hz, 1H), 6.92 (s, 1H), 4.40 (d, J = 5.0 Hz, 2H), 4.25 (t, J = 4.9 Hz, 2H), 1.74 (s, 3H)
1376[Figure (not displayed)]
MS (ESI) m/z 714.3 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.95 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.46-7.40 (m, 2H), 7.36 (d, J = 9.0 Hz, 1H), 4.40 (d, J = 5.0 Hz, 2H), 4.25 (s, 2H), 3.91 (s, 2H), 2.70 (s, 5H), 2.58 (s, 2H), 1.83 (s, 3H)
1377[Figure (not displayed)]
MS (ESI) m/z 746.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.31 (s, 1H), 8.16 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.45-7.34 (m, 3H), 5.49 (d, J = 22.9 Hz, 2H), 4.58 (t, J = 13.1 Hz, 2H), 4.42 (s, 2H), 4.29 (s, 2H), 3.82 (s, 2H), 2.72 (s, 3H), 1.84 (s, 3H)
1380[Figure (not displayed)]
MS (ESI) m/z 690.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.60-8.48 (m, 1H), 8.37 (s, 1H), 8.12 (s, 1H), 7.86 (d, J = 7.8 Hz, 1H), 7.60 (dd, J = 8.9, 2.8 Hz, 1H), 7.52-7.42 (m, 3H), 7.36 (d, J = 9.0 Hz, 1H), 4.50-4.34 (m, 2H), 4.27 (d, J = 5.4 Hz, 2H), 2.72 (s, 3H), 2.10 (s, 3H), 1.81 (s, 3H)
1381[Figure (not displayed)]
MS (ESI) m/z 694.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.87 (s, 1H), 8.76-8.65 (m, 1H), 8.34 (s, 1H), 8.14 (s, 1H), 7.73 (t, J = 5.5 Hz, 1H), 7.60 (dd, J = 8.9, 2.6 Hz, 1H), 7.49-7.40 (m, 2H), 7.37 (d, J = 9.0 Hz, 1H), 4.50-4.18 (m, 4H), 2.72 (s, 3H), 1.87 (s, 3H)
1383[Figure (not displayed)]
MS (ESI) m/z 708.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.42 (s, 1H), 8.28 (s, 1H), 8.05 (s, 1H), 7.98-7.90 (m, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.47-7.40 (m, 2H), 7.37 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.29 (d, J = 4.9 Hz, 2H), 2.73 (s, 3H), 2.58 (d, J = 2.9 Hz, 3H), 1.88 (s, 3H)
1384[Figure (not displayed)]
MS (ESI) m/z 728.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.72 (d, J = 9.9 Hz, 1H), 8.31 (s, 1H), 8.13 (s, 1H), 8.03 (d, J = 9.1 Hz, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.45 (s, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.53-4.20 (m, 4H), 2.72 (s, 3H), 1.88 (s, 3H)
1388[Figure (not displayed)]
MS (ESI) m/z 708.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.63-8.59 (m, 1H), 8.33 (s, 1H), 8.11 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.50 (d, J = 10.7 Hz, 1H), 7.45 (s, 1H), 7.43 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.53-4.02 (m, 4H), 2.72 (s, 3H), 2.62 (s, 3H), 1.85 (s, 3H)
1389[Figure (not displayed)]
MS (ESI) m/z 706.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.03 (s, 1H), 9.47 (s, 1H), 9.18 (s, 1H), 8.23 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.49 (s, 1H), 7.41 (d, J = 9.0 Hz, 1H), 7.30 (d, J = 2.7 Hz, 1H), 7.19 (s, 1H), 4.53 (t, J = 5.2 Hz, 2H), 4.15 (t, J = 5.2 Hz, 2H), 2.67 (d, J = 0.7 Hz, 3H), 2.33 (s, 3H), 2.29 (s, 3H)
1391[Figure (not displayed)]
MS (ESI) m/z 711.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.13 (s, 1H), 7.93 (s, 1H), 7.58 (dd, J = 8.9, 2.7 Hz, 1H), 7.39-7.31 (m, 2H), 7.28 (s, 1H), 4.40 (s, 2H), 4.26 (s, 2H), 3.87 (s, 5H), 3.57 (d, J = 11.7 Hz, 2H), 3.27 (d, J = 12.9 Hz, 2H), 3.09 (d, J = 10.7 Hz, 2H), 2.91 (d, J = 4.2 Hz, 3H), 2.66 (s, 3H), 1.83 (s, 3H)
1392[Figure (not displayed)]
MS (ESI) m/z 740.9 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.79 (s, 1H), 7.93 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.44 (s, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 5.35 (s, 1H), 4.41 (t, J = 5.0 Hz, 2H), 4.26 (t, J = 5.0 Hz, 2H), 3.97 (t, J = 12.1 Hz, 2H), 3.79 (t, J = 5.2 Hz, 2H), 3.64 (d, J = 11.8 Hz, 2H), 3.15 (dd, J = 29.0, 12.1 Hz, 4H), 2.71 (s, 3H), 2.43 (s, 3H), 1.97 (s, 3H)
1393[Figure (not displayed)]
[01858] MS (ESI) m/z 741.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.59 (s, 2H), 7.93 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.43 (s, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.36 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 5.6 Hz, 4H), 4.26 (t, J = 5.0 Hz, 2H), 3.16 (s, 4H), 3.00 (s, 2H), 2.82 (s, 4H), 2.70 (s, 3H), 2.40 (s, 3H), 1.92 (s, 3H)
1394[Figure (not displayed)]
MS (ESI) m/z 696.4 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.77 (s, 1H), 9.59 (s, 1H), 8.15 (d, J = 5.8 Hz, 1H), 7.94 (d, J = 2.2 Hz, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.47 (s, 1H), 7.44 (d, J = 2.6 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.42 (t, J = 5.0 Hz, 2H), 4.35-4.18 (m, 3H), 4.01 (dt, J = 22.5, 10.9 Hz, 2H), 3.11 (d, J = 8.1 Hz, 1H), 3.01 (q, J = 7.5 Hz, 2H), 2.86 (dd, J = 11.5, 5.1 Hz, 2H), 1.81 (s, 3H), 1.36 (t, J = 7.5 Hz, 3H)
1416[Figure (not displayed)]
MS (ESI) m/z 711.0 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.75 (s, 1H), 7.93 (s, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.44 (s, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 4.40 (t, J = 4.9 Hz, 2H), 4.26 (t, J = 5.0 Hz, 2H), 3.86 (t, J = 12.3 Hz, 2H), 3.56 (d, J = 11.4 Hz, 3H), 3.20 (d, J = 12.6 Hz, 2H), 3.09 (q, J = 11.2 Hz, 2H), 2.95-2.87 (m, 3H), 2.71 (s, 3H), 2.42 (s, 3H), 1.96 (s, 3H)
1417[Figure (not displayed)]
MS (ESI) m/z 708.1 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 10.05 (s, 1H), 8.04-7.95 (m, 1H), 7.61 (dd, J = 8.9, 2.7 Hz, 1H), 7.45 (s, 1H), 7.41 (d, J = 2.7 Hz, 1H), 7.37 (d, J = 9.0 Hz, 1H), 6.54 (s, 1H), 5.91 (s, 1H), 4.42 (t, J = 5.1 Hz, 2H), 4.34- 4.21 (m, 2H), 4.13 (d, J = 17.4 Hz, 1H), 3.84 (d, J = 16.9 Hz, 1H), 3.70-3.57 (m, 1H), 3.40-3.27 (m, 1H), 3.02-2.89 (m, 3H), 2.71 (s, 3H), 2.64 (s, 1H), 2.41 (s, 3H), 1.98 (s, 3H)
1420[Figure (not displayed)]
MS (ESI) m/z 723.2 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 9.37 (s, 1H), 7.78 (s, 1H), 7.60 (dd, J = 8.9, 2.7 Hz, 1H), 7.42-7.40 (m, 2H), 7.36 (d, J = 8.9 Hz, 1H), 4.70 (s, 2H), 4.61 (s, 2H), 4.49-4.39 (m, 2H), 4.38 (t, J = 5.0 Hz, 2H), 4.27-4.17 (m, 4H), 2.82 (d, J = 5.2 Hz, 3H), 2.70 (s, 3H), 1.92 (s, 3H)
1570[Figure (not displayed)]
MS (ESI) m/z 715.47 [M + 1]+; 1H-NMR (400 MHz, DMSO-d6) δ 8.77 (d, J = 5.2 Hz, 1H), 8.66 (s, 1H), 7.93 (s, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.70-7.66 (m, 2H), 7.56 (d, J = 4.4 Hz, 1H), 4.82 (s, 2H), 4.73-4.41 (m, 8H), 3.05 (bs, 1H), 2.11 (s, 3H), 0.77 (bs, 4H)
1612[Figure (not displayed)]
MS (ESI) m/z 775.53 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 with D20) δ 8.75 (d, J = 4.68 Hz 1H), 8.10 (d, J = 9.44 Hz, 1H), 8.03 (s, 1H), 7.53 (dd, J = 2.56, 8.92 Hz, 1H), 7.34 (d, J = 2.60 Hz, 1H), 7.31 (d, J = 4.68 Hz, 1H), 7.27 (d, J = 9.0 Hz, 1H), 4.35 (bs, 2H), 4.25-4.20 (m, 6H), 3.55 (bs, 2H), 2.93 (bs, 2H), 2.50 (bs, 2H), 2.20 (s, 5H), 1.58 (s, 3H), 1.27 (t, J = 7.04 Hz, 6H)
1613[Figure (not displayed)]
MS (ESI) m/z 719.52 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 with D20) δ 8.60 (d, J = 4.00 Hz 1H), 8.14 (s, 1H), 7.97 (d, J = 8.80 Hz, 1H), 7.49 (dd, J = 2.40, 8.80 Hz, 1H), 7.34 (d, J = 2.00 Hz, 1H), 7.24 (d, J = 9.20 Hz, 1H), 7.13 (d, J = 4.80 Hz, 1H), 4.32 (bs, 2H), 4.21 (bs, 2H), 3.67 (bs, 2H), 3.11 (bs, 4H), 2.76 (bs, 2H), 2.59 (s, 3H), 1.74 (s, 3H)
1614[Figure (not displayed)]
MS (ESI) m/z 801.60 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 with D20) δ 8.75 (d, J = 4.80 Hz, 1H), 8.09 (d, J = 9.60 Hz, 1H), 8.03 (s, 1H), 7.53 (dd, J = 2.40, 8.80 Hz, 1H), 7.33- 7.30 (m, 2H), 7.26 (d, J = 8.80 Hz, 1H), 4.34 (s, 2H), 4.23-4.19 (m, 6H), 3.50 (bs, 2H), 2.79 (bs, 5H), 1.67 (bs, 2H), 1.58 (s, 3H), 1.27 (t, J = 6.80 Hz, 6H), 0.43 (bs, 2H), 0 .35 (bs, 2H)
1615[Figure (not displayed)]
MS (ESI) m/z 745.50 [M + 1]+; 1H NMR (400 MHz, DMSO-d6 with D20) δ 8.63 (d, J = 4.80 Hz, 1H), 8.12 (s, 1H), 7.98 (d, J = 8.80 Hz, 1H), 7.49 (dd, J = 2.40, 8.80 Hz, 1H), 7.32 (d, J = 2.40 Hz, 1H), 7.23 (d, J = 9.20 Hz, 1H), 7.14 (d, J = 4.4 Hz, 1H), 4.31 (s, 2H), 4.20 (s, 2H), 3.49 (bs, 3H), 2.84 (bs, 4H), 1.75 (bs, 2H), 1.70 (s, 3H), 0.44 (d, J = 6.00 Hz, 2H), 0.38 (bs, 2H)
1619[Figure (not displayed)]
MS (ESI) m/z 642.01[M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.33 (s, 1H), 7.89 (s, 1H), 7.59 (dd, J = 2.60, 8.88 Hz, 1H), 7.43 (s, 1H), 7.42 (d, J = 2.64 Hz, 1H), 7.36 (d, J = 8.96 Hz, 1H), 4.39 (t, J = 4.68 Hz, 2H), 4.23 (t, J = 4.64 Hz, 2H), 2.94 (s, 6H), 2.70 (s, 3H), 1.81 (s, 3H)
1899[Figure (not displayed)]
MS (ESI) m/z 571 [M + 1]; 1H NMR (400 MHz, DMSO-d6) δ 8.79 (s, 1H), 8.43 (d, J = 16.6 Hz, 2H), 8.11 (s, 1H), 7.79 (bs, 1H), 7.60 (s, 1H), 7.46 (m, 2H), 7.35 (m, 1H), 4.40 (s, 2H), 4.20 (s, 2H), 3.89 (s, 1H)
1900[Figure (not displayed)]
MS (ESI) m/z 599.1 [M + 1]
1901[Figure (not displayed)]
MS (ESI) m/z 579.15 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.75 (d, J = 4.48 Hz, 1H), 8.59 (s, 1H), 8.41 (s, 1H), 8.14 (s, 1H), 7.76 (d, J = 8.8 Hz, 1H), 7.69 (d, J = 6.04 Hz, 2H), 7.56 (d, J = 4.48 Hz, 1H), 4.88 (s, 2H), 2.10 (s, 3H)
1902[Figure (not displayed)]
MS (ESI) m/z 627.8 [M + 1]+
1903[Figure (not displayed)]
MS (ESI) m/z 603.21 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.84 (d, J = 4.8 Hz, 1H), 8.38 (bs, 1H), 8.28 (s, 1H), 8.01 (bs, 1H), 7.63 (d, J = 8.4 Hz, 1H), 7.54 (d, J = 11.4 Hz, 1H), 7.49 (d, J = 4.8 Hz, 1H), 4.43 (t, J = 4.4 Hz, 2H), 4.25 (t, J = 4.4 Hz, 2H), 1.73 (s, 3H)
1904[Figure (not displayed)]
MS (ESI) m/z 619.07 [M + 1]+; 1H NMR (400 MHz, DMSO-d6) δ 8.86 (d, J = 4.4 Hz, 1H), 8.24 (s, 1H), 8.08 (s, 1H), 7.60 (dd, J = 8.8, 2.6 Hz, 1H), 7.51 (d, J = 4.8 Hz, 1H), 7.43 (d, J = 2.6 Hz, 1H), 7.36 (d, J = 8.8 Hz, 1H), 4.41 (t, J = 4.7 Hz, 2H), 4.25 (t, J = 4.7 Hz, 2H), 1.69 (s, 3H)
1905[Figure (not displayed)]
MS (ESI) m/z 633.04 [M + 1]+
1906[Figure (not displayed)]
1907[Figure (not displayed)]
MS (ESI) m/z 656.15 [M + 1]
1908[Figure (not displayed)]
MS (ESI) m/z 724.6 [M + 1]+
1909[Figure (not displayed)]
MS (ESI) m/z 708.1 [M + 1]+
1910[Figure (not displayed)]
MS (ESI) m/z 690.3 [M + 1]+
1911[Figure (not displayed)]
MS (ESI) m/z 722.0 [M + 1]+
1912[Figure (not displayed)]
MS (ESI) m/z 773.3 [M + 1]+
1913[Figure (not displayed)]
MS (ESI) m/z 850.3 [M + 1]+
1914[Figure (not displayed)]
1915[Figure (not displayed)]
1916[Figure (not displayed)]
1917[Figure (not displayed)]
1918[Figure (not displayed)]
1919[Figure (not displayed)]
1920[Figure (not displayed)]
1921[Figure (not displayed)]
1922[Figure (not displayed)]
1923[Figure (not displayed)]
1924[Figure (not displayed)]
1925[Figure (not displayed)]
1926[Figure (not displayed)]
1927[Figure (not displayed)]
1928[Figure (not displayed)]
1929[Figure (not displayed)]
1930[Figure (not displayed)]
1931[Figure (not displayed)]
1932[Figure (not displayed)]
1933[Figure (not displayed)]
1934[Figure (not displayed)]
1994[Figure (not displayed)]
2015[Figure (not displayed)]
2016[Figure (not displayed)]
2018[Figure (not displayed)]
2019[Figure (not displayed)]
MS (ESI) m/z 626.05 [M + 1]+
2028[Figure (not displayed)]
MS (ESI) m/z 624.0 [M + 1]+
2036[Figure (not displayed)]
MS (ESI) m/z 747.2 [M + 1]+
2037[Figure (not displayed)]
MS (ESI) m/z 615.1 [M + 1]+

Example 3

Compounds in Table 3 can be synthesized using methods described in Example 3. Many of the reactions described in Examples 1 and 2 were also used to synthesize compounds in Table 3.

[Figure (not displayed)]

3-amino-6-chloropicolinamide (1, 3.00 g, 16.6 mmol) is dissolved in 1,1,1-triethoxyethane (45 mL, 16.6 mmol) in a flame dried round bottom flask equipped with a stir bar. The reaction mixture heated to 110° C. for 90 min then cooled to 10° C. and diluted with cold ether. The solids are filtered and washed several times with cold ether. Drying the solids in vacuo afforded 6-chloro-2-methylpyrido[3,2-d]pyrimidin-4(3H)-one (2).

6-chloro-2-methylpyrido[3,2-d]pyrimidin-4(3H)-one (2, 1.00 g, 5.1 mmol) is dissolved in DMSO (30 mL) in a round bottomed flask equipped with a stir bar. The reaction mixture is stirred at 10° C. while bis(trifluoromethylsulfonyl)zinc (4.23 g, 12.8 mmol) is added in 1 portion. tert-Butyl hydroperoxide (3.53 mL, 19.2 mmol) is then added dropwise via addition funnel. After 5 min the reaction mixture is warmed to room temperature and after an additional 5 min it is warmed to 50° C. for 6.5 h. The reaction mixture is cooled to room temperature and then the reaction mixture is diluted with saturated sodium bicarbonate and ethyl acetate. The layers are separated and the aqueous phase extracted with ethyl acetate three times. The combined organic material is washed with brine and dried over magnesium sulfate. The solids are filtered and solvent removed in vacuo to afford 6-chloro-2-methyl-7-(trifluoromethyl)pyrido[3,2-d]pyrimidin-4(3H)-one (3).

[Figure (not displayed)]

A solution of 6-bromo-2-methyl-7-(trifluoromethyl)pyrido[3,2-d]pyrimidin-4(3H)-one (1, 0.3 g, 0.977 mmol), sodium thiomethoxide (0.102 g, 1.46 mmol), N,N-diisopropylethylamine (0.378 g, 2.93 mmol), and Xantphos (0.056 g, 0.097 mmol) in toluene (3 mL) is degassed for 10 min using argon. Then, tris(dibenzylideneacetone)dipalladium(0) (0.042 g, 0.048 mmol) is added and the mixture is degassed again with argon for 5 min. The reaction mixture is stirred at 90° C. for 2 h. After this time, the reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated to dryness under reduced pressure to obtain the crude product. This is purified by flash column chromatography using silica gel (100-200 mesh) and 60-80% ethyl acetate in hexanes as eluent to afford 2-methyl-6-(methylthio)-7-(trifluoromethyl)pyrido[3,2-d]pyrimidin-4(3H)-one (2).

To a solution of 2-methyl-6-(methylthio)-7-(trifluoromethyl)pyrido[3,2-d]pyrimidin-4(3H)-one (2, 0.2 g, 0.727 mmol) in ethyl acetate (4.0 mL) and water (1.0 mL) is added ruthenium(III) chloride (0.007 g, 0.0363 mmol) followed by sodium periodate (0.929 g, 4.36 mmol). The reaction mixture is stirred at room temperature for 30 min. After this time, the reaction mixture is filtered and the filtrate is concentrated under reduced pressure to obtain the crude product. This is purified by pentane wash to afford 2-methyl-6-(methylsulfonyl)-7-(trifluoromethyl)pyrido[3,2-d]pyrimidin-4(3H)-one (3).

[Figure (not displayed)]

6-chloro-2-methylpyrido[3,2-d]pyrimidin-4(3H)-one (1, 1.00 g, 5.1 mmol) is dissolved in dimethyl sulfoxide (30 mL) in a round bottomed flask equipped with a stir bar. The reaction mixture is stirred at 10° C. while bis(trifluoromethylsulfonyl)zinc (4.23 g, 12.8 mmol) is added in 1 portion. tert-Butyl hydroperoxide (3.53 mL, 19.2 mmol) is then added dropwise via addition funnel. After 5 min the reaction mixture is warmed to room temperature and after an additional 5 min it is warmed to 50° C. for 6.5 h. The reaction mixture is cooled to room temperature and then diluted with saturated aqueous sodium bicarbonate and ethyl acetate. The layers are separated and the aqueous phase extracted with ethyl acetate three times. The combined organic material is washed with brine and dried over magnesium sulfate. The solids are filtered and solvent removed in vacuo to afford a mixture of 6-chloro-2-methyl-8-(trifluoromethyl)pyrido[3,2-d]pyrimidin-4(3H)-one (2).

[Figure (not displayed)]

5-bromo-6-chloro-3-(4-methoxybenzyl)-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (1, 50 mg, 0.13 mmol) and copper(I) iodide (26.5 mg, 0.139 mmol) are combined in a sealable vessel with a stirbar and suspended in 1 mL 2-(dimethylamino)ethan-1-ol (1a). The resulting mixture is sparged with argon for 3 min and then sealed, vigorously stirred, and heated at 100° C. After 10 min LCMS shows complete consumption of the starting material. The mixture is cooled to room temperature and concentrated. The residue is taken up in MeCN/DMSO and purified by prep-HPLC (MeCN/water+0.1% TFA) to afford 6-chloro-5-(2-(dimethylamino)ethoxy)-3-(4-methoxybenzyl)-2-methylpyrido[3,4-d]pyrimidin-4(3H)-one (2).

[Figure (not displayed)]

To a solution of 3-bromo-2-chloroisonicotinic acid (1, 3.0 g, 12.76 mmol) in dichloromethane (20 mL) is added N,N-dimethylformamide (0.09 mL, 1.27 mmol) at 0° C. followed by oxalyl chloride (1.7 mL, 19.14 mmol). Then the reaction mixture is stirred at −25° C. for 2 h. After completion, the reaction mixture is evaporated to dryness under reduced pressure. Crude reaction mixture is diluted with dichloromethane (10 mL) and poured into ice cold aqueous ammonia in a drop wise manner. Precipitated solid is filtered through sintered funnel and dried under vacuum to afford 3-bromo-2-chloroisonicotinamide (2).

To a solution of 3-bromo-2-chloroisonicotinamide (2, 2.5 g, 10.68 mmol), pentamethylcyclopentadienylrhodium(III) chloride dimer (0.33 g, 0.53 mmol) and cesium acetate (1.02 g, 5.34 mmol) in 1,2-dichloroethane (25 mL) is added tert-butyl 2-diazo-3-oxobutanoate (2b, 2.96 g, 16.00 mmol) to the reaction mixture at room temperature under nitrogen atmosphere. Reaction mixture is heated to 100° C. for 16 h. After completion, the reaction mixture is cooled to room temperature, concentrated to dryness under reduced pressure followed by washing with ether and pentane to afford tert-butyl 8-bromo-7-chloro-3-methyl-1-oxo-1,2-dihydro-2,6-naphthyridine-4-carboxylate (3).

To tert-butyl 8-bromo-7-chloro-3-methyl-1-oxo-1,2-dihydro-2,6-naphthyridine-4-carboxylate (3, 3.0 g, 8.00 mmol) 30% hydrobromic acid in acetic acid (30 mL) is added and the reaction mixture is stirred at 80° C. for 16 h. After completion, the reaction is quenched with ice cold water and extracted with ethyl acetate. The organic layer is washed with cold water, dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure to afford crude 8-bromo-7-chloro-3-methyl-2,6-naphthyridin-1(2H)-one (4).

[Figure (not displayed)]

4-Amino-6-methylnicotinic acid (1, 700 mg, 4.6 mmol) and ammonium acetate (1.58 g, 20.6 mmol) are dissolved in 1,4-dioxane (8 mL) and acetic anhydride (1a, 1.74 mL, 18.4 mmol) in an oven-dried microwave vial equipped with a stir bar. The reaction mixture is stirred at 200° C. in a microwave reactor for 24 h. Solvent is removed in vacuo. Ethyl acetate is added and the precipitate is filtered and washed once with ethyl acetate. Solids are dried under vacuum to afford 2,7-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one (2).

2,7-Dimethylpyrido[4,3-d]pyrimidin-4(3H)-one (2, 92 mg, 0.50 mmol) and 1-(chloromethyl)-4-methoxybenzene (2a, 0.08 mL, 0.60 mmol) are dissolved in N,N dimethylformamide (2.5 mL) in an oven-dried screw capped vial equipped with a stir bar. The reaction mixture is stirred at room temperature while potassium carbonate (137.9 mg, 1 mmol) and potassium iodide (16.5 mg, 0.10 mmol) are added sequentially. After 20 h the reaction mixture is diluted with ethyl acetate and then washed with a 50:50 water:brine solution and then twice more with 100% brine. The organic material is then dried over magnesium sulfate, filtered and solvent removed in vacuo. Purification via silica gel chromatography (25-100% ethyl acetate in hexanes) afforded the 3-(4-methoxybenzyl)-2,7-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one (3).

3-(4-Methoxybenzyl)-2,7-dimethylpyrido[4,3-d]pyrimidin-4(3H)-one (3, 109 mg, 0.37 mmol) is dissolved in dichloromethane (2 mL) in an oven-dried screw capped vial equipped with a stir bar. The reaction mixture is stirred at 0° C. while is 3-chlorobenzenecarboperoxoic acid (84 mg, 0.49 mmol) added slowly. After 5 min the reaction mixture is warmed to room temperature. After 3 h the reaction mixture is diluted with saturated aqueous sodium bicarbonate and dichloromethane. The layers are separated and the aqueous phase extracted with dichloromethane once. The combined organic material is washed with brine and dried over magnesium sulfate. The solids are filtered and solvent removed in vacuo to afford 3-(4-methoxybenzyl)-2,7-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidine 6-oxide (4).

3-(4-Methoxybenzyl)-2,7-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidine 6-oxide (4, 25 mg, 0.06 mmol) is dissolved in dichloromethane (1 mL) in an oven-dried screw capped vial equipped with a stir bar. The reaction mixture is stirred at 25° C. and then trimethylsilyl cyanide (0.04 mL, 0.32 mmol) and N,N-dimethylcarbamoyl chloride (0.03 mL, 0.32 mmol) are added sequentially. After 45 min the reaction mixture is warmed to 45° C. After 14 h the reaction mixture is cooled to room temperature and solvent is removed in vacuo. Purification via silica gel chromatography (25-80% ethyl acetate in dichloromethane) afforded 3-(4-methoxybenzyl)-2,7-dimethyl-4-oxo-3,4-dihydropyrido[4,3-d]pyrimidine-5-carbonitrile (5).

[Figure (not displayed)]

A solution of 5-chloro-6-(trifluoromethyl)pyridin-2-amine (1, 100 mg, 0.51 mmol) and N-Bromosuccinimide (91 mg, 0.51 mmol) in MeCN (4 mL) heated at 80° C. for 1 hr. After this time, the reaction mixture is concentrated, diluted with water and extracted with ethyl acetate. The combined organic layer is washed with water and brine solution, dried over sodium sulfate and concentrated. The crude material then directly loaded on an Isco loading column. Purified by column chromatography using 5 to 40% ethyl acetate in hexane as eluent and product eluted around 20% ethylacetate/hexane. The desired fractions are concentrated under reduced pressure to afford 3-bromo-5-chloro-6-(trifluoromethyl)pyridin-2-amine (2).

A solution of 3-bromo-5-chloro-6-(trifluoromethyl)pyridin-2-amine (2, 50 mg, 0.18 mmol) and dicyanozinc (24 mg, 0.19 mmol) in NMP (3 mL) is purged with argon-gas for 5-min, then Pd(PPh3)4 (21 mg, 0.018 mmol) is added. The mixture is heated at 120° C. for 30 min in microwave. After completion, the reaction mixture is directly loaded on the silica column. Purified by column chromatography using 0 to 20% methanol in dichloromethane as eluent and product eluted around 10% methanol/dicholomethane. The desired fractions are concentrated under reduced pressure to afford 2-amino-5-chloro-6-(trifluoromethyl)nicotinonitrile (3).

2-amino-5-chloro-6-(trifluoromethyl)nicotinonitrile (3, 550 mg, 2.5 mmol) is dissolved in concentrated sulfuric acid (1 mL) in a round bottom flask, and the mixture is stirred at 90° C. for 15 min. After this time, the reaction stopped and the mixture is cooled to room temperature. The reaction mixture is poured into ice-water and adjusted to pH 8 with saturated sodium hydrogen carbonate solution. The precipitate is collected by filtration and washed with cold water and dried in high vacuum to afford 2-amino-5-chloro-6-(trifluoromethyl)nicotinamide (4).

A solution of 2-amino-5-chloro-6-(trifluoromethyl)nicotinamide (4, 65 mg, 0.27 mmol), 1,1,1-triethoxyethane (0.13 mL, 1.09 mmol) and ethanol (2 mL) in a vial is heated to 120° C. in oil bath for 3 h. After this time, the reaction mixture is diluted with 50% DMSO/MeOH, filtered and the crude is purified by HPLC (C18, prep column, 5-35% MeCN/water+0.1% TFA) to afford 6-chloro-2-methyl-7-(trifluoromethyl)pyrido[2,3-d]pyrimidin-4(3H)-one (5).

[Figure (not displayed)]

A solution of 2,6-dichloro-4-(trifluoromethyl)pyridine (1, 10.0 g, 4.6 mmol), ammonium hydroxide (50 mL) is heated at 180° C. for 4 h. After completion, the reaction mixture is filtered, washed with water & dried to afford 6-chloro-4-(trifluoromethyl)pyridin-2-amine (2).

To a mixture of 6-chloro-4-(trifluoromethyl)pyridin-2-amine (2, 2.2 g, 1.0 mmol) in phosphorous oxychloride (5 mL), 3-acetyldihydrofuran-2(3H)-one (2a, 0.256 g, 2.0 mmol) is added at room temperature followed by heating and stirring at 20° C. for 1.5 h. After completion, the reaction mixture is poured into crushed ice & extracted with ethyl acetate. Organic layer is dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure to afford 6-chloro-3-(2-chloroethyl)-2-methyl-8-(trifluoromethyl)-4H-pyrido[1,2-a]pyrimidin-4-one (3).

[Figure (not displayed)]

To a solution of 3-methyl-1-oxo-6-(trifluoromethyl)-1,2-dihydroisoquinoline-8-carbonitrile (6, 0.2 g, 0.793 mmol) in acetonitrile (2 mL), 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) or selectfluor (0.42 g, 1.190 mmol) and catalytic amount of acetic acid are added and the reaction mixture is stirred at 60° C. for 8 h. After completion, the reaction mixture is quenched with water and extracted with ethyl acetate. The organic layer is washed with brine solution, dried over anhydrous sodium sulphate, filtered and concentrated under reduced pressure. The crude is purified by column chromatography using silica gel (100-200 mesh) and 0-40% ethyl acetate in hexane as eluent. The desired fractions are concentrated under reduced pressure to afford 4-fluoro-3-methyl-1-oxo-6-(trifluoromethyl)-1,2-dihydroisoquinoline-8-carbonitrile (7).

[Figure (not displayed)]

A bottle of 1,4-dioxane is sparged with argon gas for 10 min. Methyl 2-bromo-6-chlorobenzoate (1, 257.7 mg, 1.0 mmol), SPhos (37.0 mg, 0.09 mmol), palladium(II) acetate (6.7 mg, 0.03 mmol), potassium carbonate (276.9 mg, 2.0 mmol) and 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (1a, 257.7 mg, 1.0 mmol) are dissolved in 1,4-dioxane (2 mL) and water (0.20 mL) in an oven-dried screw cap vial equipped with a stir bar. The vial is sealed and the reaction mixture sparged with argon gas for 5 min. The reaction mixture is stirred vigorously at 100° C. for 13 h. The reaction mixture is then cooled to room temperature and diluted with water (20 mL). The solids are filtered to afford a thick yellow semisolid that is taken up in dichloromethane (20 mL) and filtered again. The white solids that remained are collected and dried, affording 7-chlorophenanthridin-6(5H)-one (2).

[Figure (not displayed)]

To a stirred solution of 3,5-bis(trifluoromethyl)aniline (1, 10 g, 43.64 mmol) and 402f (1a, 8.66 g, 52.37 mmol) in water (90 mL) is added hydroxyl amine hydrochloride (10.91 g, 157.11 mmol), followed by sodium sulphate (13.63 g, 96.01 mmol) at room temperature and the mixture is stirred at same temperature for 10 min. Concentrated hydrochloric acid (10.0 mL) is added slowly. The reaction mixture is heated to reflux for 16 h and allowed to cool to room temperature. The solid precipitate formed is filtered and washed with diethyl ether and dried under vacuum to afford (E)-N-(3,5-bis(trifluoromethyl)phenyl)-2-(hydroxyimino)acetamide (2).

A solution of (E)-N-(3,5-bis(trifluoromethyl)phenyl)-2-(hydroxyimino)acetamide (2, 8.0 g, 26.65 mmol) in concentrated sulfuric acid (60.0 mL) is heated to 85° C. and stirred for 4 h. After completion, the reaction is quenched with ice cold water. Solid is obtained, filtered, washed with water and dry under vacuum to afford 4, 6-bis (trifluoromethyl) indoline-2, 3-dione (3).

To a stirred solution of 4, 6-bis (trifluoromethyl) indoline-2, 3-dione (3, 6.5 g, 22.96 mmol) in 1 N sodium hydroxide solution (120.0 mL) is added hydrogen peroxide solution (30% in water, 9.10 mL, 80.36 mmol) drop wise at 0° C. The reaction is allowed to warm up to room temperature and stirred for 4 h. After completion, the reaction mixture is quenched with 1 N hydrochloric acid and extracted with ethyl acetate. The organic layer is washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure to afford 2-amino-4,6-bis(trifluoromethyl)benzoic acid (4).

[Figure (not displayed)]

To a solution of 7-chloro-6-fluoro-2-methyl-4-oxo-3,4-dihydroquinazoline-5-carbonitrile (5, 0.280 g, 1.17 mmol) in ethanol (3 mL), methylhydrazine (7, 0.33 mL, 5.85 mmol) is added. This mixture is heated at 100° C. for 16 h. The reaction mixture is cooled and the resulting precipitate is collected by filtration and dried to afford 1-amino-4-chloro-3,7-dimethyl-3,8-dihydro-9H-pyrazolo[4,3-f]quinazolin-9-one (6).

To a solution of 1-amino-4-chloro-3,7-dimethyl-3,8-dihydro-9H-pyrazolo[4,3-f]quinazolin-9-one (6, 0.100 g, 0.37 mmol) in tetrahydrofuran (2 mL), tert-butyl nitrite (0.14 mL, 1.1 mmol) is added. This mixture is heated at 70° C. for 16 h. The reaction mixture is cooled, diluted with water, and extracted with 10% methanol in dichloromethane. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product is purified by silica gel (100-200 mesh) column chromatography using 0-70% ethyl acetate in hexanes as eluent to afford 4-chloro-3,7-dimethyl-3,8-dihydro-9H-pyrazolo[4,3-f]quinazolin-9-one (7).

[Figure (not displayed)]

p-Toluenesulfonic acid monohydrate (74.7 mg, 0.39 mmol) is added to a stirred solution of 5-benzyloxypentan-2-one (5, 3.02 g, 15.7 mmol) in methanol (15 mL) and trimethyl orthoformate (3.44 mL, 31.4 mmol) at room temperature under a reflux condenser under argon. The resulting reaction mixture is heated at 50° C. under a reflux condenser under argon for 1.5 h. After cooling to room temperature, sodium methoxide (25 wt. % in methanol) (0.18 mL, 0.78 mmol) is added and then most of the solvent is removed on a rotary evaporator. The residue is partitioned between ethyl acetate and brine with a little 0.1 N NaOH in it. The organics are washed with brine, dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and dried under high vacuum to afford crude (((4,4-dimethoxypentyl)oxy)methyl)benzene (6).

2-Bromo-6-(methylamino)-4-(trifluoromethyl)benzamide (4, 1.11 g, 3.7 mmol), (((4,4-dimethoxypentyl)oxy)methyl)benzene (6, 1.33 g, 5.6 mmol), p-toluenesulfonic acid monohydrate (35.5 mg, 0.19 mmol) and toluene (20 mL) are combined in a 100 mL round bottom flask with a stirbar, stirred vigorously, and heated at 100° C. under argon for 40 min. Most of the volatiles are removed on a rotary evaporator. The residue is purified via silica gel chromatography (10-80% ethyl acetate in hexanes) to afford 2-(3-(benzyloxy)propyl)-5-bromo-1,2-dimethyl-7-(trifluoromethyl)-2,3-dihydroquinazolin-4(1H)-one (7).

2-(3-(benzyloxy)propyl)-5-bromo-1,2-dimethyl-7-(trifluoromethyl)-2,3-dihydroquinazolin-4(1H)-one (7, 1.64 g, 3.48 mmol), acetic anhydride (11.1 mL, 118 mmol), and pyridine (1.12 mL, 13.9 mmol) are combined in a sealable vessel with a stirbar, sealed, stirred, and heated at 110° C. with a block heater for 16 h. Most of the volatiles are removed on a rotary evaporator. The residue is taken up in ethyl acetate and purified via silica gel chromatography (30-90% ethyl acetate in hexanes) to afford 2-(3-(benzyloxy)propyl)-5-bromo-1-methyl-7-(trifluoromethyl)quinolin-4(1H)-one (8) and 3-(2-(benzyloxy)ethyl)-5-bromo-1,2-dimethyl-7-(trifluoromethyl)quinolin-4(1H)-one (9).

[Figure (not displayed)]

To a solution of 4-(4-methylpiperazin-1-yl)-5-(trifluoromethyl)benzene-1,2-diamine (3, 12.0 g, 43.7 mmol) in ethanol (120 mL) at 0° C. is added ethyl pyruvate (10.0 g, 87.5 mmol) and the reaction mixture is stirred for 3 h at room temperature. After completion, the reaction mixture is cooled to 0° C., filtered and washed with diethyl ether which is dried under reduced pressure to afford 3-methyl-7-(4-methylpiperazin-1-yl)-6-(trifluoromethyl)quinoxalin-2(1H)-one (4).

To a solution of 3-methyl-7-(4-methylpiperazin-1-yl)-6-(trifluoromethyl)quinoxalin-2(1H)-one (4, 4.3 g, 13.1 mmol) is added phosphoryl chloride (43 mL) at room temperature. Then the reaction mixture is stirred for 6 h at 90° C. After completion, the reaction mixture is quenched with icec-cold water, adjusted the pH 8 with 1 N aqueous hydrochloric acid solution and extracted with ethyl acetate, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to get the crude mass. The crude compound is purified by Combi flash (12 g, Redi Sep column) using 4% methanol in dichloromethane as eluent. The desired fractions are concentrated under reduced pressure to afford 2-chloro-3-methyl-7-(4-methylpiperazin-1-yl)-6-(trifluoromethyl)quinoxaline (5).

[Figure (not displayed)]

To 4-benzyloxy-1-[2-fluoro-6-prop-1-ynyl-4-(trifluoromethyl)phenyl]butan-1-one (1, 50 mg, 0.13200 mmol) in 1,4-Dioxane (1 mL) and water (0.01 mL, 0.79000 mmol) is added dichloroplatinum (3.52 mg, 0.01320 mmol) and CO (29.6 mg, 1.06 mmol) is bubbled through the reaction mixture for 5 mins. The mixture is stirred at 25° C. for 30 min followed by heating to 100 for 12 hr to afford 2-(2-(benzyloxy)ethyl)-8-fluoro-3-methyl-6-(trifluoromethyl)naphthalen-1-ol (2) after workup.

[Figure (not displayed)]

A mixture of 2-amino-6-bromo-3-fluorobenzoic acid (2.00 g, 8.55 mmol) and urea (4.00 g, 66.60 mmol) is heated at 180° C. for 3 h, then cooled to 80° C. Water (7-10 mL) is added. The reaction is stirred at reflux for 10 m. The resulting mixture is cooled to room temperature and filtered. The dark brown solid is washed with water and ethyl ether, and dried under vacuum to afford 5-bromo-8-fluoroquinazoline-2,4(1H,3H)-dione (2).

To a solution of 5-bromo-8-fluoroquinazoline-2,4(1H,3H)-dione (2, 445 mg, 1.72 mmol) in phosphorus oxychloride (6.2 mL) is added N,N-diisopropylethylamine (1.20 mL, 6.89 mmol) dropwise. The reaction is stirred at 120° C. overnight. The resulting mixture is cooled to room temperature and azeptroped with toluene. The crude is diluted with ethyl acetate and washed with water. The combined organics are dried over sodium sulfate, decanted and concentrated. The crude is purified via column chromatography (silica, ethyl acetate/hexanes=0-10%) to afford 5-bromo-2,4-dichloro-8-fluoroquinazoline (3).

To a solution of 5-bromo-2,4-dichloro-8-fluoroquinazoline (3, 395 mg, 1.33 mmol) in tetrahydrofuran (2 mL) is added 1 M sodium hydroxide solution (6.70 mL, 6.70 mmol). The reaction is stirred at room temperature for 1 h 45 min. The resulting mixture is acidified to ˜pH 4 with acetic acid. The precipitate is filtered, washed with ethyl ether and dried under vacuum to afford 5-bromo-2-chloro-8-fluoroquinazolin-4(3H)-one (4).

To a solution of 5-bromo-2-chloro-8-fluoroquinazolin-4(3H)-one (4, 100 mg, 0.36 mmol) in N,N-dimethylformamide (2 mL) is added 1-(4-methoxyphenyl)-N-methylmethanamine (68 uL, 0.45 mmol). The reaction is microwaved at 120° C. for 10 m. The resulting mixture is cooled to room temperature and sit for 90 min. The precipitate is filtered and washed with ethyl ether. The filtrate is concentrated and triturated with ethyl acetate. The combined solids are dried under vacuum to afford 5-bromo-8-fluoro-2-((4-methoxybenzyl)(methyl)amino)quinazolin-4(3H)-one (5).

[Figure (not displayed)]

To a solution of 2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine (1, 25.0 g, 132.9 mmol) in tetrahydrofuran (250 mL), N-iodosuccinimide (35.89 g, 159.5 mmol) is added portion wise over a period of 10 min and the reaction mixture is allowed to stir at room temperature for 30 h. After completion, the reaction mixture is quenched with water and extracted with ethyl acetate. The organic layer is washed with water, separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to afford 2,4-dichloro-7-iodo-5H-pyrrolo[3,2-d]pyrimidine (2).

To a solution of 2,4-dichloro-7-iodo-5H-pyrrolo[3,2-d]pyrimidine (2, 30.0 g, 95.5 mmol) in methanol (600 mL), potassium carbonate (39.62 g, 286.7 mmol) is added portion wise over a period of 10 min and the reaction mixture is allowed to stir at 80° C. for 24 h. After completion, the reaction mixture is concentrated, diluted with water and extracted with ethyl acetate. The organic layer is washed with water, separated, dried over anhydrous sodium sulphate and concentrated under reduced pressure to get crude. The crude is triturated with diethyl ether to afford 2-chloro-7-iodo-4-methoxy-5H-pyrrolo[3,2-d]pyrimidine (3).

To a solution of 2-chloro-7-iodo-4-methoxy-5H-pyrrolo[3,2-d]pyrimidine (3, 24.0 g, 77.54 mmol) in N,N-dimethylformamide (240 mL), zinc cyanide (9.11 g, 77.54 mmol), zinc acetate (14.22 g, 77.54 mmol) and zinc dust (2.02 g, 31.01 mmol) are added at room temperature. The reaction mixture is degassed with argon for 15 min. [1,1′-Bis(diphenylphosphino)ferrocene]palladium(II) (5.67 g, 7.75 mmol) and palladium acetate (0.87 g, 3.87 mmol) are added and mixture is heated at 80° C. for 1 h. After completion, the reaction mass is diluted with ethyl acetate and washed with cold water. The organic layer is separated, dried over anhydrous sodium sulphate, filtered and concentrated to get crude. The crude is purified by column chromatography over silica gel (100-200 mesh) using 0-50% ethyl acetate in hexanes as eluent. The desired fractions are concentrated in vacuo to afford 2-chloro-4-methoxy-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile (4).

To a solution of 2-chloro-4-methoxy-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile (4, 10.0 g, 47.9 mmol) in isopropanol (100 mL), aniline (5, 43.76 mL, 479.3 mmol) and p-toluene sulfonic acid monohydrate (10.93 g, 57.48 mmol) are added. The reaction mixture is allowed to stir at 80° C. for 16 h. After completion, the reaction mixture is quenched with water and extracted with ethyl acetate. The organic layer is washed with water, brine, dried over anhydrous sodium sulphate and concentrated under reduced pressure to get crude. The crude is triturated with n-pentane, diethyl ether and dried under high vacuo to afford 4-methoxy-2-(phenylamino)-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile (6).

[Figure (not displayed)]
[Figure (not displayed)]

A solution of 4-bromo-1-chloro-2-fluorobenzene (1, 20.0 g, 95.69 mmol) in tetrahydrofuran (200 mL) is cooled at −78° C., then lithium di-isopropyl amide (2 M in tetrahydrofuran) (57.2 mL, 114.83 mmol) is added dropwise to the mixture and reaction mixture is stirred at −78° C. for 1 h. Then, N,N-dimethylformamide (20.0 mL) is added drop wise for 15 min at −78° C. and reaction mixture is stirred for 30 min. After completion reaction mixture is quenched with ammonium chloride solution, diluted with water, and extracted with diethyl ether. The organic layer is dried over anhydrous sodium sulphate, filtered and concentrated to get crude compound. Crude compound obtained is washed with pentane to afford 6-bromo-3-chloro-2-fluorobenzaldehyde (2).

To a solution of 6-bromo-3-chloro-2-fluorobenzaldehyde (2, 18.0 g, 75.94 mmol), in acetonitrile (180.0 mL) and dimethylsulphoxide (48.0 mL), triethyl amine (31.96 mL, 227.84 mmol) is added at 0° C. followed by ethyl 2-mercaptoacetate (2a, 18.2 g, 151.89 mmol) and continued stirring at 50° C. for 4 h. After completion, reaction mixture is diluted with water and extracted with ethyl acetate, washed with 1 N hydrochloric acid, water and brine solution. Organic layer is dried over sodium sulfate and concentrated to dryness under reduced pressure. Triturated with ethanol, filtered and dried to afford ethyl 4-bromo-7-chlorobenzo[b]thiophene-2-carboxylate (3).

To a solution of ethyl ethyl 4-bromo-7-chlorobenzo[b]thiophene-2-carboxylate (3, 18.0 g, 56.42 mmol) and in tetrahydrofuran:water:methanol (90.0 mL: 45 mL: 45 mL), lithium hydroxide (13.54 g, 564.26 mmol) is added, and the reaction mixture is continued stirring for 2 h. After completion, reaction mixture is poured on chilled 1 N aqueous hydrochloric acid, and extracted with ethyl acetate, washed with water and brine solution. Organic layer is dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure. Triturated with ether, filtered and dried to afford 4-bromo-7-chlorobenzo[b]thiophene-2-carboxylic acid (4).

To a solution of 4-bromo-7-chlorobenzo[b]thiophene-2-carboxylic acid (4, 15.0 g, 51.90 mmol), in N,N-dimethyl acetamide (150.0 mL), 1, 8-diazabicyclo (5.4.0) undec-7-ene (39.55 g, 259.51 mmol) is added and mixture is heated at 180° C. for 4 h. After completion, reaction mixture is cooled to room temperature diluted with water and acidified by 1 N hydrochloric acid and extracted with ethyl acetate, washed with, water and brine solution. Organic layer is dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure to afford 4-bromo-7-chlorobenzo[b]thiophene (5).

To a solution of 4-bromo-7-chlorobenzo[b]thiophene (5, 4.00 g, 16.19 mmol) in dichloromethane (100.0 mL), dichloro(methoxy)methane (5a, 4.59 g, 24.29 mmol) is added at 0° C. followed by titanium tetrachloride (2.79 g, 24.29 mmol) at same temperature and the reaction mixture is continued stirring for 16 h at room temperature. After completion, reaction mixture is quenched with 1 N aqueous hydrochloric acid and continued stirring for 2 h, diluted with water and extracted with dichloromethane, washed with water and brine solution. Organic layer is dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure. The crude product is purified by flash chromatography using silica (100-200 mesh) using 0-10% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 4-bromo-7-chlorobenzo[b]thiophene-3-carbaldehyde (6).

To a solution of 4-bromo-7-chlorobenzo[b]thiophene-3-carbaldehyde (6, 2.50 g, 9.12 mmol) in 1,4-dioxane (24.0 mL) and water (8.0 mL), (3:1 ratio) is added sodium chlorite (1.24 g, 13.68 mmol), followed by sulfamic acid (5.30 g, 54.74 mmol) at room temperature and the mixture is continued stirring for 16 h. After completion, reaction mixture is concentrated under reduced pressure; residue is acidified to pH-2 by 2 N hydrochloric acid and extracted with ethyl acetate, washed with water and brine solution. Organic layer is dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure. The residue is triturated with n-pentane, filtered and dried to afford 4-bromo-7-chlorobenzo[b]thiophene-3-carboxylic acid (7).

To a solution of 4-bromo-7-chlorobenzo[b]thiophene-3-carboxylic acid (7, 1.40 g, 4.81 mmol) in t-butanol (15.0 mL), di-tert-butyl dicarbonate (2.0 g, 9.62 mmol) followed by dimethylaminopyridine (0.586 g, 4.81 mmol) is added at room temperature. The solution is heated at 90° C. and continued stirring for 16 h. After completion, reaction mixture is concentrated under reduced pressure; diluted with water and extracted with ethyl acetate, washed with water and brine solution. Organic layer is dried over sodium sulfate and concentrated to dryness under reduced pressure. The crude is purified by flash chromatography using silica (100-200 mesh) by eluting with gradient of 5-10% ethyl acetate in hexanes. The desired fractions are concentrated under reduced pressure to afford tert-butyl 4-bromo-7-chlorobenzo[b]thiophene-3-carboxylate (8).

A solution of tert-butyl 4-bromo-7-chlorobenzo[b]thiophene-3-carboxylate (8, 1.10 g, 3.17 mmol) and tributyl(vinyl)stannane (1.20 g, 3.80 mmol) in N,N-dimethylformamide (11 mL) is degassed using argon for 15 min. Bis(triphenylphosphine)palladium dichloride (0.222 g, 0.3170 mmol) is added to the reaction mixture and heated at 90° C. for 2 h. The reaction mixture is cooled to room temperature, diluted with ethyl acetate and water. The organic layer is separated, washed with brine, dried over anhydrous sodium sulphate, filtered and concentrated under reduced pressure to get the crude. The crude is purified by column chromatography using silica (100-200 mesh) and 2.0-5.0% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 7-chloro-4-vinylbenzo[b]thiophene-3-carboxylate (9).

A solution of tert-butyl 7-chloro-4-vinylbenzo[b]thiophene-3-carboxylate (9, 0.6 g, (2.04 mmol) in acetone (10 mL) and water (2 mL) is cooled to 0° C. and osmium tetraoxide (4% solution in water)(1.3 mL, 0.2040 mmol) followed by sodium periodate (1.3 g, 6.12 mmol) is added. The mixture is stirred at room temperature for 1 h. After completion, the reaction mixture is filtered and filtrate is concentrated under reduced pressure to get the crude product. The crude is purified by pentane wash to afford tert-butyl 7-chloro-4-formylbenzo[b]thiophene-3-carboxylate (10).

To a stirred solution of tert-butyl 7-chloro-4-formylbenzo[b]thiophene-3-carboxylate (10, 0.550 g, 1.85 mmol) in dichloromethane (10 mL), diethylaminosulfur trifluoride (0.503 g, 2.77 mmol) is added at 0° C. The reaction is allowed to warm at room temperature and stirred for 4 h. After completion, reaction mixture is concentrated under reduced pressure to get crude. The crude is purified by column chromatography using silica (100-200 mesh) and 5.0-10.0% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford tert-butyl 7-chloro-4-(difluoromethyl)benzo[b]thiophene-3-carboxylate (11).

[Figure (not displayed)]

A solution of 3′-bromo-5-chloro-[1,1′-biphenyl]-2-01 (3, 0.5 g, 1.7 mmol), diisopropyl phosphonate (4, 0.585 g, 3.5 mmol), and triethyl amine (0.533 g, 5.2 mmol) in isopropyl alcohol is degassed with argon for 10 min followed by the addition of bis(diphenylphosphino) ferrocene-palladium(II)dichloride.dichloromethane complex The reaction mixture is stirred at 100° C. for 16 h. After completion, the volatiles are removed under reduced pressure. Crude is purified by flash column chromatography using 30% ethyl acetate hexanes to afford diisopropyl (5′-chloro-2′-hydroxy-[1,1′-biphenyl]-3-yl)phosphonate (5).

[Figure (not displayed)]

To a solution of 7-bromo-5-methylthieno[3,2-b]pyridine-3-carboxamide (3, 1.50 g, 5.55 mmol) in N,N-dimethylformamide (20 mL), sodium hydride is added at 0° C. and stirred for 10 min. Then, dimethylcarbamic chloride (3a, 0.71 g, 6.66 mmol) is added and the mixture is stirred at room temperature for 2 h. After completion, the reaction mixture is diluted with ethyl acetate, washed with cold water and brine, dried over anhydrous sodium sulphate, filtered and concentrated. The crude product is triturated with diethyl ether and pentane and dried to afford 7-bromo-N-(dimethylcarbamoyl)-5-methylthieno[3,2-b]pyridine-3-carboxamide (4).

[Figure (not displayed)]

Methyl 2-hydroxythieno[3,2-b]pyridine-3-carboxylate (1, 748 mg, 3.6 mmol) is dissolved in N,N-dimethylformamide (20 mL) in an oven dried screw cap vial equipped with a stir bar. Potassium carbonate (210 mg, 1.52 mmol) is added, followed by the dropwise addition of 1-(chloromethyl)-4-methoxybenzene (1a, 0.42 mL, 4.2 mmol). The vial is sealed and heated to 75° C. After 22 h additional 4-methoxybenzyl chloride (0.42 mL, 4.2 mmol) and potassium carbonate (946.2 mg, 6.8 mmol) are added and the reaction mixture continued to stir at 75° C. After 3 h the reaction mixture is cooled to room temperature and diluted with ethyl acetate and water. The layers are separated and the aqueous phase is extracted with ethyl acetate twice. The combined organic material is washed with brine, dried over magnesium sulfate, filtered, and solvent removed in vacuo to afford a dark brown oil. Purification via silica gel chromatography, eluting with hexanes and ethyl acetate afforded methyl 2-((4-methoxybenzyl)oxy)thieno[3,2-b]pyridine-3-carboxylate (2).

A bottle of tetrahydrofuran is sparged with argon gas for 1 h. An oven dried microwave vial equipped with a stir bar is charged with bis(pinacolato)diboron (308.4 mg, 1.21 mmol), methyl 2-((4-methoxybenzyl)oxy)thieno[3,2-b]pyridine-3-carboxylate (2, 381 mg, 1.16 mmol), 3,4,7,8-tetramethyl-1,10-phenanthroline (2a, 21.8 mg, 0.093 mmol), and (1Z,5Z)-cycloocta-1,5-diene; methoxyiridium (30.6 mg, 0.046 mmol). Tetrahydrofuran (2.3 mL) is added, the vial is sealed and placed under an atmosphere of argon before being stirred in an oil bath at 80° C. After 16 h the reaction mixture is cooled to room temperature and solvent removed in vacuo. The crude residue is used without further purification for the subsequent reaction. Methyl 2-((4-methoxybenzyl)oxy)-7-(4,4,5-trimethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-b]pyridine-3-carboxylate (3).

[Figure (not displayed)]

To a solution of 3-(benzylthio)-7-chloro-5-methylthieno[3,2-b]pyridine (1, 0.7 g, 2.3 mmol) in a mixture of acetonitrile, acetic acid and water (40:2:1) (10.0 mL) at 0° C. 1,3-Dichloro-5,5-dimethylimidazolidine-2,4-dione (1a, 0.9 g, 4.60 mmol) at 0° C. and the mixture is stirred for 1 h. Ammonium hydroxide (35% in water, 6.0 mL) is added is added to the reaction mixture at 0° C. and stirring is continued for 2 h. After completion, the reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is washed with water and saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is washed with n-pentanes to afford 7-chloro-5-methylthieno[3,2-b]pyridine-3-sulfonamide (2).

To a solution of methyl 7-chloro-5-methylthieno[3,2-b]pyridine-3-sulfonamide (2, 0.50 g, 1.9 mmol) in acetic anhydride (6.0 mL) is added zinc chloride (0.08 g, 0.57 mmol) at room temperature and the mixture is heated and stirred for 16 h at 75° C. After completion, the reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is washed with water, saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated. The crude product is purified by washing with diethyl ether and n-pentanes to afford N-((7-chloro-5-methylthieno[3,2-b]pyridin-3-yl)sulfonyl)acetamide (3).

[Figure (not displayed)]

A solution of 5-(1-((4-bromothiophen-3-yl)amino)ethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione (1, 0.250 g, 0.722 mmol) in N-methyl pyrrolidone (2 mL) is heated in microwave at 200° C. for 30 min. After completion, the reaction mixture is diluted with dichloromethane and then silica gel is added. The solvent is then evaporated and the free flow silica gel is then loaded on the Isco column and purified via silica gel chromatography eluting with methanol/ethylacetate. The desired fractions are concentrated under reduced pressure to afford 3-bromo-5-methylthieno[3,2-b]pyridin-7-ol (2).

To a solution of 3-bromo-5-methylthieno[3,2-b]pyridin-7-ol (2, 177 mg, 0.725 mmol), phenylmethanethiol (2a, 0.361 g, 2.91 mmol) and N,N-diisopropylethylamine (0.379 mL, 2.15 mmol) in monoglyme (4 mL) is added premixed solution of tris(dibenzylideneacetone)dipalladium(0) (132 mg, 0.145 mmol) and (R)-1-[(Sp)-2-(dicyclohexylphosphino)ferrocenyl]ethyldi-tert-butylphosphine (80 mg, 0.145 mmol) in monoglyme (1 mL) at room temperature. The reaction mixture is purged with argon gas for 5 min, and the mixture is heated at 110° C. for 15 h. After completion, the reaction mixture is diluted with dichloromethane and then silica gel is added. The solvent is then evaporated and the free flow silica gel is then loaded on the Isco column and purified via silica gel chromatography eluting with Ethylacetate/hexanes. The desired fractions are concentrated under reduced pressure to afford 3-(benzylthio)-5-methylthieno[3,2-b]pyridin-7-ol (3).

To a solution of 3-(benzylthio)-5-methylthieno[3,2-b]pyridin-7-ol (3, 0.100 g, 0.347 mmol) in 1,2-dichloroethane (3.0 mL), phosphoryl trichloride (0.1 mL, 1.04 mmol) and catalytic amount of N,N-dimethylformamide (0.050 mL) are added at room temperature. The reaction mixture is heated at 90° C. for 2 h. After completion, the reaction mixture is diluted with dichloromethane and then silica gel is added. The solvent is then evaporated and the free flow silica gel is then loaded on the Isco column and purified via silica gel chromatography eluting with methanol/dichloromethane to afford 3-(benzylthio)-7-chloro-5-methylthieno[3,2-b]pyridine (4).

A solution of 3-(benzylthio)-7-chloro-5-methylthieno[3,2-b]pyridine (4, 50 mg, 0.163 mmol) and 1,3-dichloro-5,5-dimethyl-imidazolidine-2,4-dione (4a, 64 mg, 0.329 mmol) in mixture of acetonitrile (3 mL)/water (2 mL)/acetic acid (0.4 mL) is stirred at room temperature for 1 h. To this mixture is then added hydroxyl(trimethylstannane) (295 mg, 1.63 mmol) and then stirred for 15 h at 50° C. The reaction mixture is then concentrated to afford crude 7-chloro-5-methylthieno[3,2-b]pyridine-3-sulfonic acid (5).

[Figure (not displayed)]

To a solution of methyl 7-bromo-5-methylthieno[3,2-b]pyridine-3-carboxylate (1, 3.00 g, 10.4 mmol) in dichloromethane (30.0 mL) at −78° C., diisobutylaluminium hydride (10.40 mL, 15.7 mmol) is added. The reaction mixture is stirred this temperature for 3 h. After this time, the reaction mixture is diluted with water and extracted with dichloromethane. The organic layer is washed with water and then brine, dried over anhydrous sodium sulfate, and concentrated to dryness under reduced pressure to afford (7-bromo-5-methylthieno[3,2-b]pyridin-3-yl)methanol (2).

To a solution of (7-bromo-5-methylthieno[3,2-b]pyridin-3-yl)methanol (2, 1.70 g, 3.87 mmol) in dichloromethane (20.0 mL) at 0° C., 1,1,1-tris(acetyloxy)-1,1-dihyro-1,2-benziodoxol-3-(1H)-one (3.28 g, 7.75 mmol) is added. The reaction mixture is stirred at room temperature for 3 h. After this time, the reaction mixture is filtered with Celite and washed with dichloromethane. The filtrate is concentrated to dryness under reduced pressure to obtain the crude product. This is purified by silica gel (100-200 mesh) column chromatography using 30-50% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 7-bromo-5-methylthieno[3,2-b]pyridine-3-carbaldehyde (3).

To a solution of 7-bromo-5-methylthieno[3,2-b]pyridine-3-carbaldehyde (3, 0.50 g, 1.95 mmol) in dichloromethane (5.0 mL) at 0° C., trifluoromethyltrimethylsilane (0.416 g, 2.92 mmol) and cesium carbonate (3.17 g 9.75 mmol) is added. The reaction mixture is stirred at room temperature for 1 h. Then, the reaction mixture is diluted with water and extracted with dichloromethane. The organic layer is washed with water and then brine solution, dried over anhydrous sodium sulfate, and concentrated to dryness under reduced pressure to afford 7-bromo-5-methyl-3-(2,2,2-trifluoro-1-((trimethylsilyl)oxy)ethyl)thieno[3,2-b]pyridine (4).

[Figure (not displayed)]

To a stirred solution of 2-fluoro-4-hydroxybenzonitrile (1, 20 g, 145.0 mmol) in acetonitrile (80 mL) are added sodium iodide (24 g, 160.0 mmol) and chloramine tetrahydrate (45 g, 160.0 mmol) and stirred at room temperature for 16 h. The reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is washed with water and saturated brine, dried over anhydrous sodium sulphate, filtered and concentrated. The crude product is purified by column chromatography using silica gel (100-200 mesh) and 10% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 2-fluoro-4-hydroxy-5-iodobenzonitrile (2).

To a solution of 2-fluoro-4-hydroxy-5-iodobenzonitrile (2, 7.0 g, 26.6 mmol) in 1,4-dioxane (70 mL), sodium acetate (4.36 g, 53.23 mmol) and bis pinacolato diboron (20.26 g, 79.8 mmol) are added at room temperature and the mixture is degassed with argon for 10 min. [1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium dichloromethane complex (1.9 g, 2.66 mmol), is added to the reaction mixture and degassed for another 15 min. The reaction mixture is heated at 75° C. for 16 h. After completion, the reaction mass is diluted with water and extracted with ethyl acetate. The organic layer is washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure. The crude product is purified by Combiflash (12 g, RediSep column) using 20% ethyl acetate in hexanes as eluent. The desired fractions are concentrated under reduced pressure to afford 2-fluoro-4-hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (3).

[Figure (not displayed)]

A solution of 2,2-dimethyl-1,3-dioxane-4,6-dione (1a, 1.048 g, 7.27 mmol) and 1,1,1-triethoxyethane (10.0 mL) is stirred and heated at 90° C. for 2 h in a closed vessel. Methyl 2-aminobenzoate (1, 1 g, 6.62 mmol) is added portion wise at 90° C. under argon atmosphere and continued heating at 90° C. for 6 h. After completion, the reaction mass is cooled to room temperature, added water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered and concentrated under vacuo to get crude. The crude methyl 2-((1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)ethyl)amino)benzoate (2).

A solution of methyl 2-((1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)ethyl)amino)benzoate (2, 0.900 g, 2.82 mmol) in N-methyl pyrrolidone (1 mL) is heated in microwave at 200° C. for 30 min. After completion, the reaction mixture is diluted with dichloromethane and then silica gel is added. The solvent is then evaporated and the free flow silica gel is then loaded on the Isco column and purified via silica gel chromatography eluting with methanol/ethylacetate. The desired fractions are concentrated under reduced pressure to afford methyl 4-hydroxy-2-methylquinoline-8-carboxylate (3).

[Figure (not displayed)]

A solution of methyl 5-formylthiophene-3-carboxylate (1, 2.00 g, 11.7 mmol) and 4-methylbenzenesulfonohydrazide (2.19 g, 11.7 mmol) in 1,4-dioxane (20 mL) is heated at 90° C. for 16 h. The reaction mixture is cooled at room temperature, concentrated under reduced pressure to get the crude. The crude is washed with diethyl ether and dried under vacuum to afford methyl (Z)-5-((2-tosylhydrazineylidene)methyl)thiophene-3-carboxylate (2).

To a solution of methyl (Z)-5-((2-tosylhydrazineylidene)methyl)thiophene-3-carboxylate (2, 0.50 g, 1.47 mmol), (5-chloro-2-hydroxyphenyl)boronic acid (2a, 0.307 g, 1.77 mmol) and potassium carbonate (0.40 g, 2.94 mmol) in 1,4-dioxane:water (4:1, 5 mL) is added and reaction mixture is stirred at 90° C. for 16 h. After completion, the reaction mixture is diluted with water and extracted with ethyl acetate. The organic layer is dried over anhydrous sodium sulfate, filtered and concentrated to dryness under reduced pressure to get crude. The crude is purified by flash column chromatography using silica (100-200 mesh) and 10-20% ethyl acetate in hexanes as eluent to afford methyl 5-(5-chloro-2-hydroxybenzyl)thiophene-3-carboxylate (3).

[Figure (not displayed)]

To a cooled solution of tert-butyl 5′-chloro-2′-hydroxy-[1,1′-biphenyl]-3-carboxylate (1, 2.65 g, 8.7 mmol), but-3-yn-1-ol (2, 0.66 mL, 8.7 mmol) and triphenylphosphine (2.28 g, 8.7 mmol) in tetrahydrofuran (14 mL) at 5° C. is added diisopropyl azodicarboxylate (1.71 mL, 8.7 mmol) via syringe over ca. 2 min. This is warmed to room temperature after 15 min and stirred for an additional 18 h. The solvent is removed in vacuo and residue purified via automated flash chromatography, eluting with hexanes and ethyl acetate to afford tert-butyl 2′-(but-3-yn-1-yloxy)-5′-chloro-[1,1′-biphenyl]-3-carboxylate (3).

A flame-dried round bottom flask is charged with ethyl 2,2,2-trifluoroacetate (4, 0.26 mL, 2.18 mmol) and tetrahydrofuran (13 mL). It is cooled to −78° C. and boron trifluoride diethyl etherate (0.29 mL, 2.32 mmol) is added dropwise. After 50 min tert-butyl 2′-(but-3-yn-1-yloxy)-5′-chloro-[1,1′-biphenyl]-3-carboxylate (3, 460 mg, 1.29 mmol) is added slowly followed by slow addition of n-butyllithium solution (2.5 M in hexanes, 0.62 mL, 1.55 mmol). After 1 h the reaction is quenched at −78° C. with the slow addition of saturated aqueous ammonium chloride solution. The solution is warmed to room temperature and ethyl acetate is added. The layers are separated, and the aqueous phase is extracted with ethyl acetate twice. The combined organic material is washed with brine, dried over magnesium sulfate, filtered, and concentrated. Purification via automated flash chromatography, eluting with hexanes and ethyl acetate, afforded tert-butyl 5′-chloro-2′-((6,6,6-trifluoro-5-oxohex-3-yn-1-yl)oxy)-[1,1′-biphenyl]-3-carboxylate (5)

[Figure (not displayed)]

Sodium methoxide (25 wt. % in methanol) (3.16 mL, 13.8 mmol) is added to a stirred solution of 3-chloro-2,6-difluoro-pyridine (2a, 2.01 g, 13.4 mmol) in Methanol (5 mL) at 0° C. The cold bath is removed and the resulting cloudy mixture is stirred at room temperature under argon for 35 min. The reaction mixture is poured into water (100 mL). Solids are collected by vacuum filtration, washed thoroughly with water, and air dried using vacuum suction for 30 min. The solids are dried under high vacuum to afford 3-chloro-6-fluoro-2-methoxypyridine (2b).

Potassium carbonate (1.82 g, 13.2 mmol) is added to a stirred solution of 2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (1, 835 mg, 3.30 mmol) and 1,2-dibromoethane (2.84 mL, 33.0 mmol) in DMA (15 mL) at room temperature under argon. The resulting mixture is heated at 60° C. under argon for 3 h. Water (0.59 mL, 33.0 mmol) is added. The resulting mixture is heated at 60° C. under argon for 1 h 15 min. After cooling to room temperature the reaction mixture is partitioned between ethyl acetate and water. The organics are washed three times with brine, dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and purified via silica gel chromatography (20-90% ethyl acetate in hexanes) to afford 3-(2-hydroxyethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (2).

3-(2-Hydroxyethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (2, 390 mg, 1.31 mmol) is dissolved in DMF (4 mL) with stirring under argon. THE (6 mL) is added and the resulting solution is cooled to −78° C. Sodium hydride (34.6 mg, 1.44 mmol) is added and the resulting cloudy mixture is stirred at −78° C. under argon for 10 min. 3-Chloro-6-fluoro-2-methoxypyridine (2b, 254 mg, 1.57 mmol) is added and the cold bath is removed. The resulting mixture is stirred at room temperature under argon for 20 min and then heated at 50° C. under a reflux condenser under argon for 2.5 h. After cooling to room temperature the resulting mixture is partitioned between ethyl acetate and a mixture of brine and saturated aqueous ammonium chloride. The organics are washed twice more with brine, concentrated on a rotary evaporator with silica gel, and purified via silica gel chromatography (0-100% ethyl acetate in hexanes) to afford impure 3-(2-((5-chloro-6-methoxypyridin-2-yl)oxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (3).

[Figure (not displayed)]

To a solution of tert-butyl 7-(5-chloro-2-hydroxyphenyl)thieno[3,2-b]pyridine-3-carboxylate (3a, 2.0 g, 5.5 mmol) in tetrahydrofuran (15 mL), sodium hydride (0.276 g, 6.9 mmol) is added at 0° C. and the mixture is stirred for 0.5 h. 6-Chloro-3-(2-chloroethyl)-2-methyl-8-(trifluoromethyl)-4H-pyrido[1,2-a]pyrimidin-4-one (3, 1.5 g, 4.6 mmol) in tetrahydrofuran is added to the reaction mixture and stirred for 16 h. After completion, the reaction mixture is poured into crushed ice and extracted with ethyl acetate. Organic layer is dried over anhydrous sodium sulfate and concentrated to dryness under reduced pressure. The crude compound obtained is purified through column chromatography using 0-50% ethyl acetate in hexanes as eluent; the fractions containing desired product is distilled off under reduced pressure to afford tert-butyl 7-(5-chloro-2-(2-(6-chloro-2-methyl-4-oxo-8-(trifluoromethyl)-4H-pyrido[1,2-a]pyrimidin-3-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (4).

[Figure (not displayed)]

To a mixture of 5-bromo-8-fluoro-2-((4-methoxybenzyl)(methyl)amino)quinazolin-4(3H)-one (5, 95 mg, 0.23 mmol), tert-butyl 2′-(2-bromoethoxy)-5′-chloro-[1,1′-biphenyl]-3-carboxylate (5a, 99 mg, 0.24 mmol), nickel(II) iodide hydrate (30 mg, 0.08 mmol), sodium iodide (17 mg, 0.12 mmol), p-tolunitrile (11 mg, 0.09 mmol), 4,4′-dimethoxy-2,2′-bipyridine (20 mg, 0.09 mmol) in freshly sparged N,N-dimethylacetamide (1.2 mL) are added chlorotrimethylsilane (1 drop), pyridine (1 drop) and manganese (25 mg, 0.46 mmol). The reaction is stirred at 80° C. overnight. The resulting mixture is cooled to room temperature and filtered through a pad of Celite. The filtrate is extracted with ethyl acetate and water. The combined organics are dried over sodium sulfate, decanted and concentrated. The crude is purified via column chromatography (silica, ethyl acetate/hexanes=0-40%) to afford 5′-chloro-2′-(2-(8-fluoro-2-((4-methoxybenzyl)(methyl)amino)-4-oxo-3,4-dihydroquinazolin-5-yl)ethoxy)-[1,1′-biphenyl]-3-carboxylic acid (6).

[Figure (not displayed)]

6-Amino-2-(phenylamino)pyrimidin-4-ol (6, 114 mg, 0.45 mmol) is dissolved in dimethylsulfoxide (1.1 mL) and tert-butyl 5′-chloro-2′-((6,6,6-trifluoro-5-oxohex-3-yn-1-yl)oxy)-[1,1′-biphenyl]-3-carboxylate (5, 203 mg, 0.45 mmol) is added in 1 portion. The neon solution is stirred at room temperature for 19 h. The reaction mixture is diluted with water and filtered. The solid is dried in a vacuum oven for 2 h to afford tert-butyl 5′-chloro-2′-(2-(4-oxo-2-(phenylamino)-7-(trifluoromethyl)-3,4-dihydropyrido[2,3-d]pyrimidin-5-yl)ethoxy)-[1,1′-biphenyl]-3-carboxylate (7)

[Figure (not displayed)]

Methylmagnesium bromide (3 M in diethyl ether) (0.051 mL, 0.152 mmol) is added to a stirred solution of methyl 7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylate (1, 30.3 mg, 0.051 mmol) in THF (2.5 mL) at −78° C. under argon. The reaction mixture quickly became dark yellow colored. After 20 min the reaction mixture is quenched with saturated aqueous ammonium chloride (0.5 mL), diluted with water (0.5 mL), and partitioned between ethyl acetate and brine. The organics are dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and dried under high vacuum at 40° C. for 45 min to afford an orange residue. This is dissolved in THF (2.5 mL) with stirring and cooled to −78° C. under argon. Methylmagnesium bromide (3 M in diethyl ether) (0.051 mL, 0.152 mmol) is added and the reaction mixture is stirred at −78° C. under argon for 20 min. The reaction mixture is quenched with saturated aqueous ammonium chloride (0.5 mL), diluted with water (0.5 mL), and partitioned between ethyl acetate and brine. The organics are dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and purified via preparatory HPLC (15-57% acetonitrile in water with 0.1% TFA). Fractions containing desired product are combined and neutralized with saturated aqueous sodium bicarbonate. The acetonitrile is removed on a rotary evaporator. The residual aqueous phase is extracted three times with dichloromethane. The combined organics are dried over sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue is taken up in acetonitrile and water and lyophilized to dryness to afford 3-(2-(4-chloro-2-(3-(2-hydroxypropan-2-yl)thieno[3,2-b]pyridin-7-yl)phenoxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (Cpd. No. 352F).

[Figure (not displayed)]

To a solution 7-(5-chloro-2-(2-(5-cyano-6-(difluoromethyl)-8-fluoro-2-methyl-4-oxoquinazolin-3(4H)-yl)ethoxy)phenyl)thieno[3,2-b]pyridine-3-carboxylic acid (8, 0.10 g, 0.171 mmol) in N,N-dimethylformamide (2.0 mL), 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (0.098 g, 0.256 mmol) is added and mixture is stirred at room temperature for 15 min. The reaction mixture is cooled to 0° C., N,N-diisopropylethylamine (0.12 mL, 0.684 mmol) and O-methylhydroxylamine hydrochloride (8a, 0.017 g, 0.205 mmol) are added and the mixture is stirred at room temperature for 1.5 h. After completion, the reaction mixture is diluted with ethyl acetate and washed with cold water and brine solution, dried over anhydrous sodium sulphate and concentrated under reduced pressure. The crude is purified by prep-HPLC to afford 7-(5-chloro-2-(2-(5-cyano-6-(difluoromethyl)-8-fluoro-2-methyl-4-oxoquinazolin-3(4H)-yl)ethoxy)phenyl)-N-methoxythieno[3,2-b]pyridine-3-carboxamide (Cpd. No. 303F).

[Figure (not displayed)]

N,N-diisopropylethylamine (0.028 mL, 0.163 mmol) is added to a stirred mixture of 7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylic acid (1, 32.5 mg, 0.054 mmol) and HATU (22.7 mg, 0.060 mmol) in DMF (0.3 mL) at room temperature under argon. All solids dissolved within 5 min and then shortly thereafter a lot of solids precipitated. After 20 min glycine (6.1 mg, 0.081 mmol) is added followed by more DMF (0.2 mL). The resulting mixture is sealed and stirred vigorously at room temperature for 20 min. More glycine (18.0 mg, 0.240 mmol) is added. The resulting mixture is sealed, stirred vigorously, and heated at 40° C. with a heating block for 14 h. The reaction mixture is diluted with methanol, filtered, and purified via preparatory HPLC (20-70% acetonitrile in water with 0.1% TFA). Fractions containing the desired product are combined and lyophilized to dryness to afford (7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carbonyl)glycine (Cpd. No. 398F).

[Figure (not displayed)]

1-Methylpiperazine (0.05 mL, 0.73 mmol) and methyl 7-(5-chloro-2-(2-(5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)-3-((4-methoxybenzyl)oxy)thieno[3,2-b]pyridine-2-carboxylate (4, 82 mg, 0.11 mmol) are dissolved in N-methyl pyrrolidinone (1.8 mL) in a screw capped vial equipped with a stir bar. The vial is sealed and heated in a heating block at 145° C. for 4.5 h. The reaction mixture is cooled to room temperature. The reaction mixture is diluted with ethyl acetate and filtered through Celite and volatile solvent removed in vacuo. The residual material is diluted with dimethylsulfoxide and purified via RP-HPLC to afford 3-(2-(4-chloro-2-(3-hydroxythieno[3,2-b]pyridin-7-yl)phenoxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (Cpd. No. 663F).

[Figure (not displayed)]

To a solution of methyl 2′-(2-(6-cyano-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-5′-formyl-[1,1′-biphenyl]-3-carboxylate (7, 0.10 g, 0.22 mmol) in dichloromethane (8 mL), diethylaminosulfur trifluoride (0.052 g, 0.33 mmol) is added at 0° C. The reaction mixture is stirred at room temperature for 16 h. After completion, the reaction mixture is quenched with 10% aqueous sodium hydroxide solution at 0° C. to pH ˜7 and extracted with dichloromethane (50 mL). The organic layer is washed with water (50 mL), brine (20 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure to get crude. The crude is purified by combiflash column (4 g, Redisep) using 10-50% ethyl acetate in hexanes to afford methyl 2′-(2-(6-cyano-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)ethoxy)-5′-(difluoromethyl)-[1,1′-biphenyl]-3-carboxylate (8).

[Figure (not displayed)]

N-bromosuccinimide (39.2 mg, 0.22 mmol) is added to a stirred solution of 3-(2-((5-chloro-6-methoxypyridin-2-yl)oxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (3, 92 mg, 0.21 mmol) in DMF (1 mL) at room temperature. The resulting clear yellow reaction mixture is capped and stirred at room temperature for 3.5 h. More N-bromosuccinimide (19.0 mg, 0.11 mmol) is added and the reaction mixture is capped and stirred at room temperature for 2 h. The reaction mixture is diluted with ethyl acetate and washed three times with brine. The organics are dried over magnesium sulfate, filtered, concentrated on a rotary evaporator, and purified via silica gel chromatography (0-100% ethyl acetate in hexanes) to afford 3-(2-((3-bromo-5-chloro-6-methoxypyridin-2-yl)oxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (4).

3-(2-((3-Bromo-5-chloro-6-methoxypyridin-2-yl)oxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (4, 76.3 mg, 0.147 mmol), potassium acetate (43.4 mg, 0.44 mmol), bis(pinacolato)diboron (44.9 mg, 0.177 mmol), PdCl2(dppf).CH2Cl2 (12 mg, 0.015 mmol), and 1,4-dioxane (0.5 mL) are combined in a 1 dram vial with a stirbar and sparged with argon gas for 1 min. The resulting mixture is sealed, stirred vigorously, and heated at 90° C. with a heating block for 3 h. The reaction mixture is loaded directly onto a silica gel loading column and purified via silica gel chromatography (0-80% ethyl acetate in hexanes) to afford impure 3-(2-((5-chloro-6-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)oxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (5)

[Figure (not displayed)]

To a solution of 3-(2-((3-chloropyridazin-4-yl)oxy)ethyl)-2-methyl-4-oxo-7-(trifluoromethyl)-3,4-dihydroquinazoline-5-carbonitrile (2d, 20.0 mg, 0.049 mmol), methyl (3-(methoxycarbonyl)thieno[3,2-b]pyridin-7-yl)boronic acid (2, 15.58 mg, 0.049 mmol), Potassium Carbonate (0.15 mL, 0.150 mmol) in 1,4-dioxane (1.5 mL) is added tetrakis(triphenylphosphine)palladium(0) (5.64 mg, 0.0049 mmol) at room temperature and the mixture is degassed by bubbling argon through it for 5 min. The reaction mixture is heated to 90° C. for 16 h. After completion of the reaction, the reaction is diluted with water and extracted with ethyl acetate. The organic layer is washed with water and saturated brine solution, dried over anhydrous sodium sulphate, filtered, and concentrated to dryness under reduced pressure. The crude product is purified by Combiflash (12 g, RediSep column) using 1-5% methanol in dichloromethane as eluent to afford methyl 7-(4-(2-(5-cyano-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)pyridazin-3-yl)thieno[3,2-b]pyridine-3-carboxylate (3).

[Figure (not displayed)]

A flame-dried vial is charged with tert-butyl 7-(2-(2-(5-bromo-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)-5-chlorophenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (2, 106 mg, 0.150 mmol), 3,4,7,8-tetramethyl-1,10-phenanthroline (10.8 mg, 0.0457 mmol), copper(I) iodide (6.2 mg, 0.033 mmol), and cesium carbonate (94 mg, 0.290 mmol). The vial is evacuated and backfilled with argon twice. Toluene (1.4 mL) and (4-methoxyphenyl)methanol (29 uL, 33 mg, 0.24 mmol) are added, and the mixture is degassed for 5 min, then stirred at 110° C. After 4 h, the mixture is allowed to cool down to room temperature and stir an additional 14 h, then diluted with EtOAc, then washed with water. The aq. phase is extracted (3×EtOAc), and the combined organic phases are dried (Na2SO4), filtered, and concentrated. Purification by column chromatography (SiO2, 0-50% EtOAc/hexane) provided 61 mg of a ca. 1:1 mixture of products tert-butyl 7-(5-chloro-2-(2-(5-((4-methoxybenzyl)oxy)-2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (3) and tert-butyl 7-(5-chloro-2-(2-(2-methyl-4-oxo-7-(trifluoromethyl)quinazolin-3(4H)-yl)ethoxy)phenyl)-5-methylthieno[3,2-b]pyridine-3-carboxylate (4).

Compounds made using one or more of the general methods described above are shown in Table 3. Where provided, characterization data is to the right of the compounds.

Full text: Click here
Patent 2022

Top products related to «Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether»

More about "Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether"

Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, also known as HFVE or hexafluoropropylene oxide (HFPO), is a complex organic compound with a wide range of applications in chemical processes and research.
This versatile molecule features a unique molecular structure, containing fluorine atoms and a trifluoromethyl group, which contribute to its distinctive properties and functionalities.
Researchers and scientists working with HFVE can benefit from the AI-powered platform of PubCompare.ai, which helps optimize their research by identifying the most effective protocols from published literature, preprints, and patents.
The platform's advanced comparison capabilities enable users to streamline their research and achive better results, saving time and resources.
HFVE has applications in various fields, including polymer synthesis, material science, and specialty chemical production.
Its thermal stability, chemical resistance, and low surface energy make it a valuable precursor in the manufacturing of fluoropolymers, which are widely used in industries such as aerospace, electronics, and high-performance coatings.
Additionally, HFVE is an important intermediate in the synthesis of other fluorinated compounds, which are crucial in areas like pharmaceuticals, agrochemicals, and electronic materials.
Researchers studying the reactivity, properties, and potential applications of HFVE can leverage the insights and tools provided by PubCompare.ai to optimize their work and stay ahead of the curve.
By harnessing the power of PubCompare.ai's AI-driven platform, researchers can effeciently navigate the vast amount of information available on HFVE, identify the most effective protocols, and accelerate their progress in this dynamic and innovative field of chemistry.